{"meta":{"query_hash":"f7360692ed4a","filters":{"venue":"Value in Health"},"cohort_total":2971,"direct_labels_cover":30,"predictions_cover":2971,"exported":2971,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f7360692ed4a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Value+in+Health"},"results":[{"id":"W1480482130","doi":"10.1016/j.jval.2015.03.084","title":"Improving Parameter Estimation For A Decision-Analytic Markov Model To Evaluate The Use Of Novel Biomarker Led Strategies For Prevetion Of Cardiovascular Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Censoring (clinical trials); Covariate; Markov model; Proportional hazards model; Markov chain; Computer science; Econometrics; Statistics; Mathematics; Machine learning","score_opus":0.6550297222477515,"score_gpt":0.45902683171259495,"score_spread":0.19600289053515652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480482130","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054126367,0.000403655,0.942692,0.0009816738,0.000050217855,0.00015550306,0.00029185897,0.00035410243,0.0009445911],"genre_scores_gemma":[0.81301695,0.0005017861,0.18344346,0.00035252896,0.0000879469,0.00037345916,0.00085883524,0.00013283081,0.001232212],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9947765,0.0037727864,0.0002822208,0.00051461,0.000373482,0.0002804185],"domain_scores_gemma":[0.8693067,0.12347154,0.0029122094,0.001679644,0.0019593488,0.00067055906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020425534,0.0014816088,0.002597289,0.0020356672,0.000658715,0.002176579,0.0020175714,0.0023540356,0.004410869],"category_scores_gemma":[0.100328,0.001389978,0.0017701751,0.0011338936,0.0009954723,0.0029733302,0.0019166606,0.004194019,0.00047263227],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022980478,0.000107625085,0.0028082149,0.0000628705,0.00014512624,0.000036482274,0.00005226184,0.9681425,0.00028926638,0.012747284,0.00045354135,0.01492506],"study_design_scores_gemma":[0.000021546643,0.00002392144,0.00013676281,0.000010335401,0.000016315169,0.000005798343,0.000004571782,0.99359596,0.00008334693,0.006036138,0.000059225727,0.0000059732806],"about_ca_topic_score_codex":0.016157731,"about_ca_topic_score_gemma":0.009291682,"teacher_disagreement_score":0.020425534,"about_ca_system_score_codex":0.0021114373,"about_ca_system_score_gemma":0.0044932384,"threshold_uncertainty_score":0.108021796},"labels":[],"label_agreement":null},{"id":"W1481790705","doi":"10.1111/j.1524-4733.2007.00176.x","title":"Regarding Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?","year":2007,"lang":"en","type":"letter","venue":"Value in Health","topic":"Bayesian Modeling and Causal Inference","field":"Computer Science","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PQ Corporation (Canada); McGill University","funders":"","keywords":"Probabilistic logic; Computer science; Probabilistic analysis of algorithms; Artificial intelligence","score_opus":0.0832889424429008,"score_gpt":0.303975947972131,"score_spread":0.2206870055292302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481790705","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004128316,0.002748068,0.008389288,0.98530024,0.0013291425,0.0000072659745,0.000051681272,0.000027580913,0.001733919],"genre_scores_gemma":[0.049787663,0.012674326,0.041268725,0.8265441,0.06549195,0.0001866545,0.00011700598,0.00017393252,0.003755603],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98457146,0.009966642,0.00083500653,0.0012649194,0.0028924833,0.00046954496],"domain_scores_gemma":[0.74445647,0.23673248,0.0039270595,0.00454044,0.007967893,0.0023756684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03378155,0.00088132056,0.0026439768,0.0011779172,0.0025719835,0.007988803,0.004545182,0.036436886,0.008131936],"category_scores_gemma":[0.17204368,0.0008011486,0.0011373921,0.001299667,0.021922575,0.019345881,0.003074592,0.059276626,0.0037154707],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025934924,0.00009697515,0.000788587,0.0003879505,0.00010711213,0.00090543967,0.00057164754,0.0019025212,0.00021576005,0.42616796,0.50230616,0.06629057],"study_design_scores_gemma":[0.00006331773,0.000014812812,0.00018646572,0.00031563666,0.000024541481,0.00048404286,0.0004347902,0.0035635699,0.000101564874,0.93318766,0.061570834,0.00005270991],"about_ca_topic_score_codex":0.0033923215,"about_ca_topic_score_gemma":0.005616962,"teacher_disagreement_score":0.036436886,"about_ca_system_score_codex":0.0044541676,"about_ca_system_score_gemma":0.00417007,"threshold_uncertainty_score":0.17865604},"labels":[],"label_agreement":null},{"id":"W1485338727","doi":"10.1016/j.jval.2015.03.875","title":"The Impact Of Stroke Centers On The Length Of Stay Among Ischechemic Stroke Patients In Alberta","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Stroke (engine); Medicine; Physical medicine and rehabilitation; Engineering","score_opus":0.049314928782137675,"score_gpt":0.35757093685525687,"score_spread":0.3082560080731192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1485338727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978928,0.00025312847,0.000019634777,0.0003607686,0.000012103364,0.0000056690114,0.0002458467,0.000001805193,0.0012082334],"genre_scores_gemma":[0.99923396,0.00012585577,0.00002004113,0.00007189658,0.0000068142176,0.0000021744477,0.00017589258,0.0000012680003,0.0003621466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896824,0.00024211354,0.00005851297,0.000068217705,0.0001804662,0.00048252582],"domain_scores_gemma":[0.99773574,0.00027673753,0.00041629843,0.00006322029,0.00045938813,0.0010487122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066654925,0.00023685895,0.00037182862,0.0009830311,0.0017170928,0.0015726688,0.0011644823,0.00071096746,0.0017655897],"category_scores_gemma":[0.0024401438,0.0002734556,0.0006623435,0.0023896724,0.0009152967,0.000529235,0.0011003856,0.0013385988,0.00014080814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016647312,0.00015534148,0.9964238,0.000009180109,0.000086629254,0.00007761273,0.00042351414,0.00013506912,0.000057690406,0.000079272744,0.0003659415,0.002019525],"study_design_scores_gemma":[0.000005676798,0.000033693294,0.9980616,0.000007548574,0.000019532847,0.00001546489,0.0015986902,0.000118540134,0.000009389202,0.000026506796,0.000098320554,0.000004978219],"about_ca_topic_score_codex":0.90165734,"about_ca_topic_score_gemma":0.950516,"teacher_disagreement_score":0.09834266,"about_ca_system_score_codex":0.010351535,"about_ca_system_score_gemma":0.00960433,"threshold_uncertainty_score":0.19784361},"labels":[],"label_agreement":null},{"id":"W1502280143","doi":"10.1016/j.jval.2014.03.1657","title":"Canadian Burden Of Choroidal Neovascularization Secondary To Pathologic Myopia: Final Results","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Novartis (Canada)","funders":"","keywords":"Choroidal neovascularization; Medicine; Visual acuity; Medical record; Ophthalmology; Retrospective cohort study; Optometry; Surgery","score_opus":0.028599848927018345,"score_gpt":0.2893380672824501,"score_spread":0.26073821835543176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502280143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4586387,0.016970258,0.00097188243,0.011936627,0.0006128764,0.0006841883,0.44496453,0.000234364,0.06498662],"genre_scores_gemma":[0.85040367,0.013500473,0.0022120934,0.0013480305,0.00029308564,0.00022459401,0.11619965,0.000085872765,0.015732553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978219,0.00014074561,0.000081993065,0.00014798412,0.0012417801,0.0005655477],"domain_scores_gemma":[0.99583817,0.00011622911,0.0003059532,0.000082431354,0.0030061079,0.000651203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013804244,0.0010850648,0.0007662457,0.003258721,0.0018602676,0.0018818806,0.0015018379,0.000666845,0.0058192257],"category_scores_gemma":[0.0050929133,0.0005241782,0.0016027266,0.008326587,0.00045779024,0.0006957163,0.0014016659,0.0010042815,0.0006944458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014450859,0.00024661384,0.8084157,0.0007355981,0.0010072092,0.00044806284,0.00079060346,0.0030063721,0.00027743925,0.0025410478,0.12655966,0.054526605],"study_design_scores_gemma":[0.00022738539,0.00009352734,0.96961266,0.000184975,0.00065178296,0.0002467506,0.0009059658,0.001007516,0.00021432625,0.0002503022,0.02652957,0.00007519701],"about_ca_topic_score_codex":0.99636143,"about_ca_topic_score_gemma":0.9970445,"teacher_disagreement_score":0.050028186,"about_ca_system_score_codex":0.050028186,"about_ca_system_score_gemma":0.089122124,"threshold_uncertainty_score":0.36298162},"labels":[],"label_agreement":null},{"id":"W1507803005","doi":"10.1016/j.jval.2015.03.874","title":"The Expansion Of Stroke Centers And The Reduction Of In-Hospital Mortality Of Ischechemic Stroke Patients In Alberta","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Stroke (engine); Medicine; Reduction (mathematics); Emergency medicine; Engineering","score_opus":0.037127052017663774,"score_gpt":0.3329939989086497,"score_spread":0.29586694689098597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1507803005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706585,0.0007448262,0.00014766431,0.0046584993,0.000062252024,0.000016148786,0.0005991819,0.000013190617,0.0066923597],"genre_scores_gemma":[0.99705005,0.00037112876,0.000105107974,0.00047639452,0.000033686185,0.0000044044587,0.00032571444,0.0000036335343,0.0016298945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921143,0.00017952164,0.000028221864,0.000056013476,0.00013186407,0.00039288573],"domain_scores_gemma":[0.9984854,0.0001775486,0.0002714604,0.000056943318,0.0003917438,0.00061696104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006227838,0.00017175765,0.00027381093,0.0007043247,0.0014751027,0.001525461,0.0012739137,0.0006688502,0.002715192],"category_scores_gemma":[0.0025003026,0.00015940939,0.00043363377,0.001736277,0.00078499917,0.00035865128,0.0008414596,0.0011974719,0.00010139083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006573662,0.0004571606,0.9636514,0.000036564077,0.00016320864,0.00032752255,0.0006210735,0.0010107501,0.00033791116,0.0015865817,0.0064096022,0.024740791],"study_design_scores_gemma":[0.000057050645,0.000036539164,0.9955829,0.000026769563,0.00006289909,0.000058512105,0.0015659317,0.00069120387,0.00008396592,0.00033429725,0.001490355,0.00000969387],"about_ca_topic_score_codex":0.9535786,"about_ca_topic_score_gemma":0.9769629,"teacher_disagreement_score":0.04642141,"about_ca_system_score_codex":0.012591646,"about_ca_system_score_gemma":0.01967898,"threshold_uncertainty_score":0.09338951},"labels":[],"label_agreement":null},{"id":"W1756786330","doi":"10.1016/j.jval.2015.03.1336","title":"Health Impact of Trivalent, Trivalent High Dose and Quadrivalent Influenza Vaccines In older adults In ontario, Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Influenza vaccine; Seasonal influenza; Health care; Influenza season; Emergency department; Vaccination; Gerontology; Coronavirus disease 2019 (COVID-19); Internal medicine; Virology; Nursing","score_opus":0.10939010485294352,"score_gpt":0.3949918054173741,"score_spread":0.28560170056443057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1756786330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98212415,0.0052872165,0.000048776652,0.0019505519,0.00007577751,0.00010838792,0.006525974,0.000007393003,0.0038717217],"genre_scores_gemma":[0.9930883,0.002558192,0.0001041214,0.0005225367,0.000025415406,0.000042827047,0.0016537103,0.0000033930894,0.0020015908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983918,0.00018574059,0.00014422183,0.0001336365,0.00045580132,0.000688676],"domain_scores_gemma":[0.99588287,0.00025668347,0.00062021596,0.00006405457,0.0016754727,0.0015007044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010294836,0.00037979204,0.00074389105,0.000901208,0.002461405,0.0013095513,0.0012189384,0.00077836146,0.0015006077],"category_scores_gemma":[0.0034931973,0.00031978596,0.0013799716,0.003182783,0.0006623009,0.0004669573,0.0009656841,0.0011244382,0.0001081938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012080364,0.00018861462,0.98365283,0.00026333195,0.00035158696,0.00014886617,0.0012842225,0.00031469952,0.00017607209,0.00021735906,0.0030608927,0.009133477],"study_design_scores_gemma":[0.00007871161,0.00013994375,0.9959699,0.00012404195,0.00017770292,0.00002851787,0.0020755418,0.0001986081,0.00004074973,0.000023243841,0.0011270726,0.000015997777],"about_ca_topic_score_codex":0.99798954,"about_ca_topic_score_gemma":0.9987392,"teacher_disagreement_score":0.055217233,"about_ca_system_score_codex":0.055217233,"about_ca_system_score_gemma":0.054658085,"threshold_uncertainty_score":0.40063095},"labels":[],"label_agreement":null},{"id":"W1823241341","doi":"10.1016/j.jval.2015.03.668","title":"Measuring Spending Trends For Those With Employer-Sponsored Insurance Using Administrative Data","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Insurance and Financial Risk Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Per capita; Context (archaeology); Prescription drug; Medical Expenditure Panel Survey; Health care; Demographic economics; Business; Actuarial science; Population; Quarter (Canadian coin); Medicine; Health insurance; Economics; Geography; Economic growth; Environmental health","score_opus":0.5335295156441321,"score_gpt":0.3729396798673468,"score_spread":0.16058983577678532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1823241341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782381,0.0001575632,0.0009286889,0.00026888965,0.000014324862,0.000015521608,0.018688409,0.000029093802,0.0016593527],"genre_scores_gemma":[0.97499985,0.00015823242,0.0011288534,0.000048009268,0.000032985245,0.0000340035,0.022942876,0.000012264898,0.0006428735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990497,0.00024053764,0.0001404073,0.00019194989,0.00020447033,0.00017284414],"domain_scores_gemma":[0.99151564,0.0018394961,0.004519258,0.0004909205,0.001135395,0.00049920904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011742237,0.00024294917,0.00027355703,0.0026200511,0.00024578508,0.0008659303,0.0004334137,0.00036288385,0.0010613413],"category_scores_gemma":[0.00822909,0.00019128899,0.000657025,0.004036785,0.00012849578,0.00086060376,0.0004719567,0.00071353384,0.00041169205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057630823,0.000040035913,0.9937698,0.000015310135,0.0001104487,0.000011012291,0.00007084712,0.00069201493,0.00013247323,0.00024628613,0.0011449426,0.0037091756],"study_design_scores_gemma":[0.0000035476983,0.000039754792,0.99555343,0.000008446237,0.0000358514,0.00004007672,0.0002144055,0.0024799285,0.0002481137,0.00012387935,0.0012475763,0.0000049110495],"about_ca_topic_score_codex":0.029201046,"about_ca_topic_score_gemma":0.032433055,"teacher_disagreement_score":0.029201046,"about_ca_system_score_codex":0.0007079958,"about_ca_system_score_gemma":0.00070899515,"threshold_uncertainty_score":0.058062136},"labels":[],"label_agreement":null},{"id":"W1842465981","doi":"10.1016/j.jval.2015.04.001","title":"Why Did the Randomized Clinical Trial Become the Primary Focus of My Career?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Randomized controlled trial; Focus (optics); Primary (astronomy); Medicine; Medical education; Psychology; Internal medicine; Physics","score_opus":0.4361407828971169,"score_gpt":0.5114739791592267,"score_spread":0.07533319626210977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1842465981","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047197664,0.0071430397,0.0036519421,0.9741509,0.013160765,0.00009634885,0.000033554876,0.000031553107,0.0012598576],"genre_scores_gemma":[0.019133931,0.006020917,0.018810758,0.913706,0.03919481,0.00076518056,0.00003719769,0.00014214378,0.002189037],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8324694,0.11748031,0.011382179,0.010914264,0.023492254,0.0042616082],"domain_scores_gemma":[0.32564315,0.530526,0.020017445,0.019642306,0.06764407,0.036527075],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.37127265,0.0011445001,0.005506464,0.0025559927,0.0046028034,0.012184596,0.006154535,0.034086764,0.012022469],"category_scores_gemma":[0.6083932,0.0016107293,0.0031696546,0.0025461647,0.022648117,0.016062874,0.0058202217,0.05808723,0.0048335],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020568795,0.0007269974,0.004309127,0.0030202398,0.0010521279,0.00038976985,0.0024137816,0.00097108085,0.00066803664,0.20327374,0.6335385,0.1475797],"study_design_scores_gemma":[0.0067837476,0.0012914286,0.003864553,0.012358594,0.000574133,0.0008362996,0.0020282466,0.003543842,0.0014715365,0.43733835,0.5294181,0.0004911654],"about_ca_topic_score_codex":0.0052045123,"about_ca_topic_score_gemma":0.005385365,"teacher_disagreement_score":0.6287273,"about_ca_system_score_codex":0.012388053,"about_ca_system_score_gemma":0.0264562,"threshold_uncertainty_score":0.77533275},"labels":[],"label_agreement":null},{"id":"W1862306556","doi":"10.1016/j.jval.2015.03.401","title":"Evolution of the Market for oral Antidiabetic agents In Canada after Introduction of Dipeptidyl Peptidase-4 Inhibitors","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dipeptidyl peptidase-4; Dipeptidyl peptidase; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Business; Medicine; Data science; Chemistry; Diabetes mellitus; Biochemistry; Endocrinology; Computer science; Enzyme; Type 2 diabetes","score_opus":0.02902168888322419,"score_gpt":0.26516004712297164,"score_spread":0.23613835823974746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1862306556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51629144,0.031794082,0.0023438006,0.2615456,0.0030238412,0.00032803908,0.019721955,0.00043442537,0.16451684],"genre_scores_gemma":[0.90076333,0.010765056,0.0033881054,0.034181707,0.0005588503,0.000060985247,0.003302485,0.00020978673,0.046769757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963683,0.00016101642,0.00012851655,0.0002556413,0.0019359257,0.0011506486],"domain_scores_gemma":[0.98257345,0.0010031533,0.0013342156,0.00013744358,0.0092957355,0.005655937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022256635,0.00031418924,0.000548144,0.003061332,0.0031062353,0.006344952,0.0015244801,0.0021189284,0.011526182],"category_scores_gemma":[0.00804593,0.0004351815,0.0009343174,0.0043320595,0.0020403524,0.0011958936,0.0010344229,0.0034615085,0.0007549195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040179333,0.00074476737,0.33623964,0.0010729382,0.0004221558,0.004392724,0.0036116908,0.0044558486,0.008351649,0.10798018,0.26142108,0.26728943],"study_design_scores_gemma":[0.00032852363,0.0002544456,0.5407684,0.00079385104,0.00014354901,0.0011011974,0.004344166,0.0042622574,0.0021067904,0.002583787,0.4431339,0.00017917702],"about_ca_topic_score_codex":0.98383766,"about_ca_topic_score_gemma":0.9906465,"teacher_disagreement_score":0.12460353,"about_ca_system_score_codex":0.12460353,"about_ca_system_score_gemma":0.16155602,"threshold_uncertainty_score":0.90406615},"labels":[],"label_agreement":null},{"id":"W1868928463","doi":"10.1016/j.jval.2015.03.365","title":"The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Metformin; Medicine; Saxagliptin; Type 2 Diabetes Mellitus; Post-hoc analysis; Sitagliptin; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.04172977108381095,"score_gpt":0.2832846464763343,"score_spread":0.24155487539252332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1868928463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800826,0.00858825,0.000105847736,0.003459403,0.000080243364,0.00014342713,0.0038114344,0.000012733838,0.0037161617],"genre_scores_gemma":[0.99551815,0.0024438784,0.00018878139,0.00045249736,0.000028220602,0.0000231971,0.00080849096,0.0000041160292,0.00053278694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983627,0.0002905463,0.00015177057,0.0001377807,0.00046683708,0.00059035915],"domain_scores_gemma":[0.99626774,0.00076719426,0.0005920802,0.00005671648,0.00086043,0.0014558859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093069335,0.00038262134,0.0009783113,0.0009536889,0.0013035261,0.0016520842,0.0013095321,0.00093056605,0.0022950647],"category_scores_gemma":[0.007824783,0.0003807371,0.0020276592,0.0030091584,0.0007398504,0.0006000549,0.00078891363,0.001313565,0.00007555589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02246899,0.0013758452,0.8398604,0.0017505735,0.003443356,0.0006464413,0.00083877565,0.013940978,0.00059651665,0.0027906538,0.015257346,0.09703007],"study_design_scores_gemma":[0.0038537532,0.0017915695,0.96332633,0.0008231946,0.003739887,0.00033826072,0.0022402555,0.018504048,0.0003430501,0.0009361856,0.003951549,0.00015197422],"about_ca_topic_score_codex":0.98987865,"about_ca_topic_score_gemma":0.99380434,"teacher_disagreement_score":0.07863291,"about_ca_system_score_codex":0.07863291,"about_ca_system_score_gemma":0.057740014,"threshold_uncertainty_score":0.5705244},"labels":[],"label_agreement":null},{"id":"W1899218298","doi":"10.1016/j.jval.2015.09.1114","title":"The Economic Burden of Primary Brain Tumors in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Indirect costs; Total cost; Brain tumor; Epidemiology; Economic cost; Population; Cost estimate; Environmental health; Emergency medicine; Pathology; Business","score_opus":0.3509244040244836,"score_gpt":0.3841116246959568,"score_spread":0.03318722067147317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899218298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85879236,0.018240169,0.0003000182,0.05509772,0.00046619307,0.000085262116,0.037931323,0.00004116924,0.029045817],"genre_scores_gemma":[0.9845903,0.007289717,0.00013600112,0.00074604846,0.00008764445,0.000013314816,0.0041563907,0.000011462587,0.0029689972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979938,0.00015490681,0.000110644956,0.00009797067,0.0008219632,0.0008206951],"domain_scores_gemma":[0.9916225,0.0006224733,0.0012667057,0.000091079804,0.004222348,0.0021747984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000810048,0.0002930332,0.0005502997,0.0028750217,0.0023846964,0.00330354,0.0011799729,0.00089009653,0.0038899784],"category_scores_gemma":[0.009413692,0.00032510527,0.0008504559,0.008467269,0.0011915109,0.00074178615,0.0013954703,0.0021284039,0.00017890068],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007034009,0.00016127237,0.85929304,0.00037836842,0.00057350064,0.0012693508,0.0010500406,0.008801207,0.00021891852,0.020598592,0.06654688,0.04040532],"study_design_scores_gemma":[0.00010974896,0.000053231965,0.9630365,0.00041131908,0.00023001661,0.00056279096,0.0035700493,0.006800092,0.00014325135,0.0023897549,0.022598056,0.00009530828],"about_ca_topic_score_codex":0.9984023,"about_ca_topic_score_gemma":0.99874157,"teacher_disagreement_score":0.14390118,"about_ca_system_score_codex":0.14390118,"about_ca_system_score_gemma":0.14225556,"threshold_uncertainty_score":0.9929533},"labels":[],"label_agreement":null},{"id":"W1899938335","doi":"10.1016/j.jval.2015.09.2160","title":"Do Free Medications Improve Observance Among Diabetic Patients?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Diabetes mellitus; Drug; Family medicine; Test (biology); Revenue; Pharmacology; Finance","score_opus":0.10052485943721029,"score_gpt":0.33842842202055123,"score_spread":0.23790356258334094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899938335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95962346,0.011802679,0.00032549136,0.017469984,0.00029541683,0.00004528316,0.00044695093,0.000034191566,0.009956593],"genre_scores_gemma":[0.99562484,0.0019455098,0.00042935167,0.0013420593,0.00018568459,0.000012833075,0.00010052427,0.000004470462,0.00035484403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804795,0.0009455479,0.0002193358,0.00012308083,0.00044091232,0.0002231511],"domain_scores_gemma":[0.98525524,0.0067339884,0.004617582,0.00047757002,0.00076556863,0.0021500573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023942227,0.00022300008,0.00070339034,0.00065621745,0.00061061356,0.0013963744,0.00040760246,0.0010804748,0.003909966],"category_scores_gemma":[0.024154723,0.00022418285,0.00094601425,0.0011714217,0.00036607985,0.0015485185,0.0005432879,0.001579491,0.00020360142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018446601,0.003100094,0.83245885,0.00028429047,0.0006192414,0.00009091696,0.00056914653,0.00016143329,0.00020444751,0.00038119644,0.002238624,0.1580471],"study_design_scores_gemma":[0.0003826456,0.001632268,0.9915079,0.0003118854,0.00061869464,0.00016218575,0.0008703739,0.0006373183,0.00026750113,0.001094217,0.0024861414,0.000028794399],"about_ca_topic_score_codex":0.0071292343,"about_ca_topic_score_gemma":0.016574569,"teacher_disagreement_score":0.0071292343,"about_ca_system_score_codex":0.0009643414,"about_ca_system_score_gemma":0.0013957402,"threshold_uncertainty_score":0.014175475},"labels":[],"label_agreement":null},{"id":"W1903355409","doi":"10.1016/j.jval.2015.09.2429","title":"The Budget Impact of Orphan Drugs In The Us and Canada: A 2007-2013 Midas Sales Data Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Incentive; Medicine; Economics; Bioinformatics","score_opus":0.12856453629218972,"score_gpt":0.3496087187334243,"score_spread":0.22104418244123458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903355409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7343244,0.0063302256,0.00038294014,0.006790606,0.00009218249,0.00018045117,0.23597187,0.000104417,0.015822947],"genre_scores_gemma":[0.8963521,0.0051751733,0.00089177623,0.00078210555,0.000062005645,0.000085365245,0.0879688,0.00006166232,0.008621013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997445,0.00015352761,0.00014181281,0.00015541083,0.0013995721,0.0007045976],"domain_scores_gemma":[0.9900851,0.0007828195,0.0015487238,0.00015989685,0.006371307,0.0010520078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015478447,0.00048360284,0.00074702676,0.005564236,0.0013722889,0.0026880722,0.0012254051,0.0005685336,0.0022722678],"category_scores_gemma":[0.008347323,0.0004437408,0.0010671254,0.013224839,0.0007104185,0.0009113495,0.0011232434,0.0012895119,0.00031659775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010302981,0.0002302201,0.8081326,0.0005514094,0.0009850366,0.00051554246,0.0009091885,0.018813504,0.00029595304,0.00855296,0.12406171,0.035921462],"study_design_scores_gemma":[0.00007706492,0.00005805815,0.91933435,0.00028319863,0.0003538869,0.000113983224,0.0025544248,0.01309481,0.0006885163,0.00055344525,0.06280647,0.00008175401],"about_ca_topic_score_codex":0.9969553,"about_ca_topic_score_gemma":0.99749774,"teacher_disagreement_score":0.068165,"about_ca_system_score_codex":0.068165,"about_ca_system_score_gemma":0.09242882,"threshold_uncertainty_score":0.494574},"labels":[],"label_agreement":null},{"id":"W1903365719","doi":"10.1016/j.jval.2015.09.2063","title":"Heterogeneity in the Definition of Drug Induced Hypoglycemia in Clinical Trials: A Review","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University","funders":"","keywords":"Medicine; Bedtime; Hypoglycemia; Morning; Evening; Randomized controlled trial; Internal medicine; Diabetes mellitus; Type 2 diabetes; Concordance; Clinical trial; Insulin; Pediatrics; Endocrinology","score_opus":0.7507564226154089,"score_gpt":0.5918680830648588,"score_spread":0.15888833955055004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903365719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000096625365,0.9992705,0.00020062794,0.00021544404,0.00007459292,0.00002821648,0.000033004424,0.0000023932325,0.00007852875],"genre_scores_gemma":[0.0047085774,0.99296147,0.0011351497,0.00079421024,0.00020024405,0.000095053656,0.00006475714,0.0000054113557,0.000035176934],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96824527,0.0113281235,0.012914651,0.0024324146,0.0047213845,0.00035805686],"domain_scores_gemma":[0.8487167,0.13409805,0.011768275,0.0013651126,0.0035869158,0.00046494056],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03323125,0.0018003244,0.01373354,0.01214479,0.00061890687,0.0052947174,0.0036087036,0.0027862128,0.0026593187],"category_scores_gemma":[0.0993151,0.0011945309,0.008199849,0.0111102825,0.0022069446,0.0046137134,0.003345828,0.0029025478,0.00023610001],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050995604,0.000043944212,0.0016915898,0.5915575,0.017339507,0.00014333181,0.00037715255,0.0005469809,0.00023034279,0.004270889,0.0046266513,0.37866214],"study_design_scores_gemma":[0.0007478173,0.00036458563,0.0063269865,0.74225366,0.09188591,0.0016349603,0.0007202931,0.00071243464,0.00045118618,0.015301194,0.1394014,0.00019956357],"about_ca_topic_score_codex":0.0025390766,"about_ca_topic_score_gemma":0.0057158195,"teacher_disagreement_score":0.96676874,"about_ca_system_score_codex":0.0038369189,"about_ca_system_score_gemma":0.0069796904,"threshold_uncertainty_score":0.17574573},"labels":[],"label_agreement":null},{"id":"W1905546942","doi":"10.1016/j.jval.2015.08.007","title":"Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Cinacalcet; Medicine; Quality-adjusted life year; Cost-effectiveness analysis; Economic evaluation; Cost effectiveness; Internal medicine; Secondary hyperparathyroidism; Risk analysis (engineering)","score_opus":0.22693385308720265,"score_gpt":0.42405269583422944,"score_spread":0.1971188427470268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905546942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8795241,0.07797648,0.0014643586,0.014637688,0.0017890627,0.002460319,0.008270324,0.00013079123,0.0137469545],"genre_scores_gemma":[0.98346287,0.008860996,0.00074344303,0.0019800754,0.00036750978,0.0007877146,0.0021983534,0.000021674014,0.0015771836],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9955974,0.0035880557,0.00013336494,0.00018189581,0.0002595055,0.00023971443],"domain_scores_gemma":[0.9932602,0.0040450403,0.0012561415,0.00032611686,0.0002762602,0.0008361914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004748964,0.001190905,0.0027307812,0.0005896074,0.00039561008,0.0018160145,0.0006476559,0.0018888003,0.004665911],"category_scores_gemma":[0.017789187,0.00030484627,0.0036506962,0.0009503188,0.0011181927,0.001379961,0.00082141603,0.0031310024,0.00029189],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9252934,0.0019632173,0.0049194563,0.0026245597,0.008760388,0.00015143875,0.000051112314,0.006014989,0.00030467845,0.002686657,0.008129987,0.039100174],"study_design_scores_gemma":[0.91539335,0.03189462,0.013570075,0.0015221616,0.013152937,0.00023302223,0.00023139855,0.0075562056,0.00065226364,0.0038794044,0.011807551,0.00010695133],"about_ca_topic_score_codex":0.0059766746,"about_ca_topic_score_gemma":0.006418316,"teacher_disagreement_score":0.0059766746,"about_ca_system_score_codex":0.0033836097,"about_ca_system_score_gemma":0.002876716,"threshold_uncertainty_score":0.025115252},"labels":[],"label_agreement":null},{"id":"W1925827074","doi":"10.1016/j.jval.2015.09.916","title":"A Discrete Choice Experiment (Dce) To Elicit Preferences For Attributes Of A Bedside Pharmacogenetic Test – Preliminary Results","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Toronto Public Health; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Willingness to pay; Mixed logit; Pharmacogenetics; Test (biology); Population; Logistic regression; Statistics; Internal medicine; Mathematics","score_opus":0.29704127454172824,"score_gpt":0.4739883772428298,"score_spread":0.17694710270110153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1925827074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97195035,0.00006207923,0.021075247,0.00029954853,0.00010686988,0.0030596037,0.00035005674,0.000028882161,0.0030674],"genre_scores_gemma":[0.8998188,0.00021804278,0.088477634,0.0006841194,0.00009387227,0.0062246495,0.00038022696,0.000026763419,0.004075884],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9936533,0.004367332,0.0003939975,0.0006268138,0.0007428408,0.00021573475],"domain_scores_gemma":[0.9599835,0.03573694,0.0010225979,0.0013126936,0.00079417136,0.0011499488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008909897,0.0008592202,0.00093809684,0.0002463627,0.0006998629,0.0010616254,0.0006697655,0.0016763636,0.005355551],"category_scores_gemma":[0.019186467,0.0003825139,0.0005479925,0.00033708342,0.0007995082,0.00089066115,0.00067876175,0.0018179613,0.0005985236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2685203,0.26003754,0.03275765,0.0020961417,0.0006840853,0.00036638507,0.004314614,0.025905633,0.22928405,0.014925058,0.0027279474,0.1583807],"study_design_scores_gemma":[0.07189768,0.4624351,0.056832846,0.00020502463,0.000996952,0.0004853606,0.0019001259,0.15135594,0.21303383,0.023879264,0.01639326,0.0005845762],"about_ca_topic_score_codex":0.0011276809,"about_ca_topic_score_gemma":0.0011654506,"teacher_disagreement_score":0.008909897,"about_ca_system_score_codex":0.00059981196,"about_ca_system_score_gemma":0.00135837,"threshold_uncertainty_score":0.04712057},"labels":[],"label_agreement":null},{"id":"W1935780438","doi":"10.1016/j.jval.2015.07.008","title":"Quality of Life and Asthma Symptom Control: Room for Improvement in Care and Measurement","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Asthma; Medicine; Quality of life (healthcare); EQ-5D; Disease control; Disease burden; Physical therapy; Disease; Pediatrics; Environmental health; Health related quality of life; Internal medicine","score_opus":0.08501690939907565,"score_gpt":0.34603635819109024,"score_spread":0.2610194487920146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1935780438","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0155027,0.4692569,0.009825233,0.4914907,0.007881272,0.00007263483,0.00072211854,0.0001542594,0.0050941054],"genre_scores_gemma":[0.5457749,0.3076329,0.041346457,0.076585464,0.024739059,0.00040659987,0.001403051,0.00021202752,0.0018995432],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9765179,0.013861616,0.0023000357,0.0016932032,0.004269778,0.0013574613],"domain_scores_gemma":[0.78929895,0.15687795,0.012567213,0.007814319,0.02494286,0.0084986305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058914177,0.0014310477,0.0062539387,0.0034720302,0.002039866,0.012203314,0.0033149458,0.006465762,0.005672457],"category_scores_gemma":[0.1318097,0.001055651,0.0025905888,0.00662353,0.008980721,0.02447775,0.0058425693,0.020661358,0.0006336316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012164217,0.0007375357,0.13970715,0.005583506,0.0015791805,0.00013970304,0.0020932457,0.0026502688,0.00048536368,0.11991043,0.09652251,0.6293747],"study_design_scores_gemma":[0.000561424,0.0010757799,0.3555292,0.02374461,0.0015672365,0.0006418907,0.009175535,0.014546131,0.0008427418,0.43397623,0.15717866,0.0011605971],"about_ca_topic_score_codex":0.024616018,"about_ca_topic_score_gemma":0.02148388,"teacher_disagreement_score":0.058914177,"about_ca_system_score_codex":0.0113647515,"about_ca_system_score_gemma":0.018288601,"threshold_uncertainty_score":0.31157166},"labels":[],"label_agreement":null},{"id":"W1945804284","doi":"10.1016/j.jval.2015.09.1452","title":"Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Health Care Resource Utilization In Asthma","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Eosinophil; Asthma; Sputum; Lung function; Correlation; Emergency department; Pulmonary function testing; Internal medicine; Intensive care medicine; Lung; Pathology","score_opus":0.15439750822267204,"score_gpt":0.36841733153849704,"score_spread":0.214019823315825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1945804284","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077522933,0.98992926,0.00016352128,0.00025900584,0.0001694961,0.00021177962,0.0012205972,0.000008729309,0.00028528765],"genre_scores_gemma":[0.16901486,0.8267014,0.001166351,0.0011688973,0.00022345108,0.00056938984,0.0009185941,0.000011627416,0.00022535639],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9885626,0.004455056,0.0045010336,0.0009272821,0.0012267715,0.00032727557],"domain_scores_gemma":[0.9596463,0.030956924,0.0067825443,0.0006607787,0.0015847124,0.00036867033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007968634,0.0011938307,0.009350544,0.0049009575,0.0005289292,0.0020040341,0.0014179932,0.0014296508,0.0032321913],"category_scores_gemma":[0.047961477,0.0011549818,0.015623566,0.005783673,0.000841032,0.0011488764,0.0014264557,0.0013240423,0.00021108864],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007994896,0.000028229892,0.010617888,0.7896368,0.1812198,0.00014086194,0.00014405341,0.00017918095,0.00015245123,0.00012781816,0.0012669212,0.01568646],"study_design_scores_gemma":[0.0013764545,0.00042382805,0.040802307,0.26249325,0.68659765,0.00040608583,0.00023226108,0.00015194107,0.00016431067,0.00030949528,0.0069717118,0.00007058353],"about_ca_topic_score_codex":0.017864108,"about_ca_topic_score_gemma":0.049494147,"teacher_disagreement_score":0.017864108,"about_ca_system_score_codex":0.002451507,"about_ca_system_score_gemma":0.0071764374,"threshold_uncertainty_score":0.04214269},"labels":[],"label_agreement":null},{"id":"W1955030956","doi":"10.1016/j.jval.2015.04.012","title":"Economic Evaluations in the Diagnosis and Management of Traumatic Brain Injury: A Systematic Review and Analysis of Quality","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Traumatic brain injury; Economic evaluation; Neurointensive care; MEDLINE; Intensive care medicine; Psychiatry; Pathology","score_opus":0.24905171037924498,"score_gpt":0.4754365974934808,"score_spread":0.2263848871142358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955030956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022342375,0.9965508,0.00021139109,0.00021877736,0.00008604094,0.00022610105,0.00029386388,0.0000042471806,0.00017464107],"genre_scores_gemma":[0.08667729,0.90984094,0.0018702393,0.0005060051,0.00013139295,0.00057793467,0.00030444606,0.000007893063,0.00008393476],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96415526,0.019850668,0.009421376,0.0011941005,0.0047561787,0.0006224521],"domain_scores_gemma":[0.9086334,0.07599682,0.011479784,0.00074740604,0.0026586743,0.00048386503],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028619219,0.0017585694,0.014283195,0.0089990515,0.0006438804,0.0041821306,0.0019482028,0.0019686308,0.0035671026],"category_scores_gemma":[0.12173292,0.0010495151,0.014719026,0.010043575,0.0012155523,0.0027847984,0.0024674758,0.0024245048,0.00010748683],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020724314,0.000072518065,0.0033502034,0.8178948,0.114346765,0.00009189061,0.00017838072,0.0006288144,0.00008128201,0.0006805254,0.00089557003,0.059706822],"study_design_scores_gemma":[0.0033834043,0.0006075541,0.011918844,0.5157271,0.45349717,0.00042213072,0.00046565998,0.00096969627,0.00024986814,0.0022512982,0.010395438,0.00011182428],"about_ca_topic_score_codex":0.008356355,"about_ca_topic_score_gemma":0.018082455,"teacher_disagreement_score":0.9713808,"about_ca_system_score_codex":0.0066879173,"about_ca_system_score_gemma":0.008583606,"threshold_uncertainty_score":0.15135467},"labels":[],"label_agreement":null},{"id":"W1955830745","doi":"10.1016/j.jval.2015.06.001","title":"David Sackett 1934–2015","year":2015,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Ottawa","funders":"","keywords":"Library science; Medicine; Critical appraisal; Checklist; Scopus; Alternative medicine; Family medicine; Clinical epidemiology; Biostatistics; Publication; Health care; MEDLINE; Political science; Medical education; Public health; Psychology; Epidemiology; Law; Nursing; Pathology; Computer science","score_opus":0.5992760393427071,"score_gpt":0.45880057111097233,"score_spread":0.1404754682317348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955830745","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032868134,0.0058979555,0.000172578,0.95148623,0.02640252,0.000026968642,0.00015017993,0.000020034553,0.015514862],"genre_scores_gemma":[0.0054627685,0.0019741552,0.00013228689,0.90227675,0.025898108,0.000094523864,0.000038697777,0.00002882609,0.06409388],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938937,0.0018557825,0.0004503176,0.0009809105,0.0017126042,0.0011066371],"domain_scores_gemma":[0.99071664,0.0058772983,0.0006588294,0.0002774773,0.0012108515,0.0012588672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064951796,0.0011423151,0.0013991273,0.00093014596,0.005241464,0.010449547,0.0014641776,0.059136186,0.011105207],"category_scores_gemma":[0.051483206,0.00072954193,0.0011238722,0.0007279654,0.005122086,0.004681327,0.00347676,0.044592723,0.0083303675],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004454629,0.0000124212565,0.00013001628,0.000027484431,0.000008215856,0.00017438566,0.00008375179,0.00003938833,0.00003156176,0.015243749,0.9805997,0.0036048794],"study_design_scores_gemma":[0.00008493214,0.00002890095,0.000785818,0.00047254548,0.00001902404,0.00015469157,0.00021774667,0.0002463168,0.00012596874,0.026720395,0.9710886,0.000055057077],"about_ca_topic_score_codex":0.025472533,"about_ca_topic_score_gemma":0.0492825,"teacher_disagreement_score":0.059136186,"about_ca_system_score_codex":0.0103199575,"about_ca_system_score_gemma":0.0064124735,"threshold_uncertainty_score":0.074876904},"labels":[],"label_agreement":null},{"id":"W1963595383","doi":"10.1016/j.jval.2014.03.103","title":"Risk Factors Of Adverse Drug Reaction–Related Hospitalizations Among Seniors, 2006 To 2011","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Drug; Medical prescription; Adverse effect; Drug class; Emergency medicine; Adverse drug reaction; Pharmacoepidemiology; Drug reaction; Risk factor; Intensive care medicine; Medical emergency; Internal medicine; Pharmacology","score_opus":0.05026214460626317,"score_gpt":0.35691763878873684,"score_spread":0.3066554941824737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963595383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99565923,0.0004337933,0.00003979608,0.00015529276,0.000025926247,0.000010410964,0.0026062396,0.000007661532,0.0010618682],"genre_scores_gemma":[0.997617,0.00018743708,0.000043304073,0.000077878074,0.000020978296,0.0000063244997,0.0017192019,0.0000017095676,0.0003262769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999448,0.000056482535,0.00012068802,0.00009348487,0.00012164397,0.00015964355],"domain_scores_gemma":[0.9978682,0.00013994424,0.0012378418,0.000060337487,0.0002469417,0.00044667633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005086305,0.00025682198,0.00030133716,0.0011659291,0.00045506575,0.000724175,0.00038278697,0.000644479,0.0014303705],"category_scores_gemma":[0.0020901563,0.00024600053,0.0008323931,0.001522057,0.00019780568,0.0006110362,0.0007148352,0.0010052943,0.00021820336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049104685,0.000026111655,0.99890053,0.000008975197,0.00003101099,0.00002755958,0.00003305346,0.000016766404,0.000036234123,0.0000075741586,0.0002438631,0.0006191017],"study_design_scores_gemma":[0.0000015733978,0.000023109867,0.99961406,0.000006161899,0.000009161287,0.0000649758,0.000119490556,0.000038438964,0.000009791784,0.0000032907274,0.00010835773,0.000001658089],"about_ca_topic_score_codex":0.04566583,"about_ca_topic_score_gemma":0.08058118,"teacher_disagreement_score":0.04566583,"about_ca_system_score_codex":0.00089583837,"about_ca_system_score_gemma":0.0009288224,"threshold_uncertainty_score":0.09080005},"labels":[],"label_agreement":null},{"id":"W1963700528","doi":"10.1016/j.jval.2014.03.516","title":"Cost Effectiveness of Different Digital Mammography Screening Scenarios for Breast Cancer in the Canadian Context","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Context (archaeology); Mammography; Medicine; Breast cancer; Demography; Breast cancer screening; Cohort; Cost effectiveness; Incidence (geometry); Cost–benefit analysis; Cancer; Internal medicine; Geography; Mathematics","score_opus":0.09650100022139844,"score_gpt":0.3590670957760673,"score_spread":0.26256609555466887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963700528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96810025,0.003696926,0.0006337818,0.0048628855,0.00008283292,0.00022899055,0.004737016,0.000045627265,0.017611591],"genre_scores_gemma":[0.9966053,0.0009871271,0.00070574513,0.00016885747,0.000010185331,0.000025016245,0.00074817985,0.0000058998235,0.0007437028],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99799794,0.00072960055,0.0000793263,0.00014777032,0.00042846156,0.00061687164],"domain_scores_gemma":[0.99660516,0.0019516943,0.00026259097,0.000081317565,0.0005251086,0.00057418074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002251209,0.0009379033,0.00077286584,0.001407067,0.0016982129,0.0025726527,0.0015124255,0.0013268043,0.005508762],"category_scores_gemma":[0.012141855,0.00037350066,0.0020755867,0.0021442815,0.00090155797,0.00085120054,0.0011111298,0.001272964,0.00015403799],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018654006,0.002084573,0.25960383,0.0015232239,0.0022073048,0.0013192089,0.00087591185,0.5462174,0.0017824825,0.039312802,0.017327683,0.10909159],"study_design_scores_gemma":[0.0029669837,0.003671711,0.42555335,0.0008218339,0.0036966887,0.0011030375,0.0079436125,0.5193368,0.0018628367,0.01905373,0.01330216,0.0006872772],"about_ca_topic_score_codex":0.9644658,"about_ca_topic_score_gemma":0.97505504,"teacher_disagreement_score":0.06014002,"about_ca_system_score_codex":0.06014002,"about_ca_system_score_gemma":0.031377982,"threshold_uncertainty_score":0.43634844},"labels":[],"label_agreement":null},{"id":"W1963844670","doi":"10.1016/j.jval.2011.08.394","title":"PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada); McMaster University","funders":"","keywords":"Medicine; Osteoporosis; Osteopenia; Bone mineral; Femoral neck; Cohort; Internal medicine; Population; Pediatrics; Physical therapy","score_opus":0.19307638303079624,"score_gpt":0.449858662495608,"score_spread":0.2567822794648118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963844670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980414,0.0015456424,0.00008623684,0.0007590714,0.000035171277,0.00006508989,0.0135223325,0.000014629389,0.0035579219],"genre_scores_gemma":[0.99427336,0.0006413388,0.0001586364,0.00013180172,0.000018820176,0.000035952537,0.0037485815,0.000005896328,0.000985545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820447,0.00018003715,0.000121918005,0.00023997821,0.00080294954,0.00045050832],"domain_scores_gemma":[0.9981723,0.00009733511,0.00035193,0.0000854841,0.0008948781,0.00039800626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009267994,0.0006200735,0.0009300958,0.0023486665,0.0030365614,0.0014030047,0.002150374,0.001327631,0.002524148],"category_scores_gemma":[0.0034354958,0.0007772223,0.0013451959,0.006446651,0.0006102976,0.00046336,0.0011117635,0.0012540432,0.00030162142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020208894,0.00004266096,0.99522215,0.00003093332,0.00012881486,0.000078086436,0.00022956771,0.00004610766,0.00012656346,0.00009178789,0.0018830306,0.0019182116],"study_design_scores_gemma":[0.000011862861,0.0000087257795,0.99932444,0.0000098250575,0.000029830853,0.00004308645,0.00015932677,0.00006399262,0.000013679069,0.000010781745,0.00031862146,0.000005866625],"about_ca_topic_score_codex":0.97871083,"about_ca_topic_score_gemma":0.9832364,"teacher_disagreement_score":0.02128917,"about_ca_system_score_codex":0.01042818,"about_ca_system_score_gemma":0.012190836,"threshold_uncertainty_score":0.07566208},"labels":[],"label_agreement":null},{"id":"W1963919392","doi":"10.1016/j.jval.2013.02.004","title":"Updating the Canadian Hemophilia Outcomes–Kids Life Assessment Tool (CHO-KLAT Version2.0)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Hospital for Sick Children; Laurentian University","funders":"Canadian Institutes of Health Research; Bayer Canada; Canada Research Chairs","keywords":"Debriefing; Concordance; Quality of life (healthcare); Medicine; Reliability (semiconductor); Psychology; Physical therapy; Pediatrics; Gerontology; Internal medicine","score_opus":0.061492248775396025,"score_gpt":0.3657297734890976,"score_spread":0.3042375247137016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963919392","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2760321,0.046965886,0.037921883,0.05783625,0.009419607,0.006402072,0.34642443,0.004432209,0.21456549],"genre_scores_gemma":[0.5660026,0.021110142,0.16685309,0.012739366,0.0009265724,0.005742626,0.19515215,0.0012720685,0.030201372],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907913,0.001273317,0.001223784,0.00036563835,0.0057048453,0.0006412109],"domain_scores_gemma":[0.96755344,0.0029083234,0.0012133367,0.0006726734,0.026545303,0.0011068605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0095564695,0.00083152705,0.00095517345,0.0036142906,0.0014943066,0.002784838,0.0024794398,0.0010038151,0.0060613267],"category_scores_gemma":[0.041030236,0.0004367322,0.001966944,0.0043006106,0.00065560197,0.0014107709,0.0019413689,0.002287408,0.0021012772],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026309994,0.00012463117,0.13062842,0.00093227223,0.00035362967,0.00012971881,0.0006245063,0.0009796375,0.00024745383,0.0026199762,0.54650116,0.31659546],"study_design_scores_gemma":[0.0002670404,0.00009800641,0.5000559,0.0028031147,0.00058353133,0.0005402638,0.0009457739,0.0025988887,0.0012199964,0.0029616887,0.4876258,0.00030002635],"about_ca_topic_score_codex":0.8068567,"about_ca_topic_score_gemma":0.87019515,"teacher_disagreement_score":0.8068567,"about_ca_system_score_codex":0.017996952,"about_ca_system_score_gemma":0.036940258,"threshold_uncertainty_score":0.3885615},"labels":[],"label_agreement":null},{"id":"W1964066387","doi":"10.1016/j.jval.2011.08.016","title":"CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL: A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Quality of life (healthcare); Internal medicine; Clinical trial; Multivariate analysis; Prognostic variable; Multivariate statistics; Survival analysis; Physical therapy; Confidence interval; Statistics","score_opus":0.8648338287129885,"score_gpt":0.5589995219205318,"score_spread":0.3058343067924567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964066387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9374081,0.011884307,0.021389017,0.0004290291,0.00025425557,0.0027246652,0.021606283,0.0002480923,0.0040563024],"genre_scores_gemma":[0.97324973,0.0006141789,0.004508203,0.00035631677,0.00009191126,0.0011484772,0.019273682,0.000120838005,0.00063668954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.93614864,0.051471528,0.0031724146,0.0041956087,0.0041637598,0.0008481446],"domain_scores_gemma":[0.82870173,0.10556105,0.015724959,0.03651002,0.011385165,0.002117166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.121989414,0.0021319888,0.0034196132,0.0011925289,0.0008977661,0.0021066933,0.002772828,0.0015274797,0.0032945448],"category_scores_gemma":[0.1279407,0.0007156085,0.008064413,0.0026171757,0.001230619,0.0013544977,0.0023861544,0.0018007682,0.00080777874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3169069,0.0017701664,0.35538748,0.004798879,0.22283162,0.00036989295,0.0008467903,0.015160048,0.0049799494,0.0012640432,0.010444257,0.06523999],"study_design_scores_gemma":[0.07960171,0.021735305,0.6900781,0.001107173,0.14574541,0.0011204462,0.00034937265,0.03500824,0.0040947283,0.002508227,0.018210452,0.00044074963],"about_ca_topic_score_codex":0.0075857583,"about_ca_topic_score_gemma":0.009625025,"teacher_disagreement_score":0.121989414,"about_ca_system_score_codex":0.0013540088,"about_ca_system_score_gemma":0.0040437947,"threshold_uncertainty_score":0.6451494},"labels":[],"label_agreement":null},{"id":"W1964141029","doi":"10.1016/s1098-3015(10)70195-9","title":"PCN15 MODELING THE COST IMPACT OF POSSIBLE CROSS-PROTECTION DIFFERENCES OF TWO CERVICAL CANCERVACCINES IN CANADA USING MULTIPLE PROBABILISTIC SENSITIVITY ANALYSIS","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sensitivity (control systems); Probabilistic logic; Statistics; Computer science; Econometrics; Mathematics; Engineering","score_opus":0.5241988251709215,"score_gpt":0.443166574491618,"score_spread":0.08103225067930353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964141029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9289438,0.0015268936,0.030414514,0.003278689,0.00017446419,0.00043689154,0.008084691,0.00026579184,0.026874341],"genre_scores_gemma":[0.9895353,0.00021945652,0.0028028686,0.00017562986,0.0000127936155,0.000100521385,0.00092602475,0.000035443827,0.0061920276],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99800783,0.0007420854,0.00005466717,0.00023393304,0.00021412004,0.00074738904],"domain_scores_gemma":[0.98919684,0.007973469,0.00064990786,0.00027235996,0.0015008753,0.00040655187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004346794,0.0011437187,0.0014502897,0.0020063433,0.0012877648,0.0025842746,0.002828952,0.0024989555,0.0067318277],"category_scores_gemma":[0.01490656,0.0014338946,0.0027987051,0.0023049049,0.0014843654,0.0008890803,0.0011601173,0.0022228432,0.00022453493],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077994264,0.00002000153,0.0013397852,0.000014748808,0.000051562714,0.000035561123,0.00001280016,0.99571335,0.00005419389,0.0016544188,0.0003692454,0.000656318],"study_design_scores_gemma":[0.00004493418,0.000035985653,0.002122005,0.000014486177,0.000090987414,0.000013570027,0.00004634171,0.9955309,0.000099565324,0.0014130406,0.00056563946,0.000022484246],"about_ca_topic_score_codex":0.9440045,"about_ca_topic_score_gemma":0.8728975,"teacher_disagreement_score":0.055995524,"about_ca_system_score_codex":0.033343215,"about_ca_system_score_gemma":0.016126713,"threshold_uncertainty_score":0.24192303},"labels":[],"label_agreement":null},{"id":"W1964955762","doi":"10.1111/j.1524-4733.2007.00208.x","title":"Estimates of Costs of Hospital Stay for Variceal and Nonvariceal Upper Gastrointestinal Bleeding in the United States","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Upper gastrointestinal bleeding; Medicine; Hemostasis; Intensive care medicine; Surgery; Endoscopy","score_opus":0.03206507280561069,"score_gpt":0.3178627909209059,"score_spread":0.2857977181152952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964955762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92566615,0.016030563,0.0038618757,0.0018019504,0.00015631784,0.00010047952,0.0433242,0.000074347714,0.008984047],"genre_scores_gemma":[0.98665327,0.002219473,0.0009323532,0.00012091216,0.000036105466,0.00006382564,0.009275494,0.000006904564,0.0006915976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890375,0.0005048296,0.00013993739,0.00007210631,0.00028556702,0.00009385576],"domain_scores_gemma":[0.99734974,0.0010694057,0.00074259326,0.000081180275,0.00061340915,0.00014365463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010792715,0.0004684319,0.00033504688,0.0026057246,0.00021895989,0.0008749257,0.00044442213,0.00040876845,0.00089878635],"category_scores_gemma":[0.006328688,0.0003776867,0.0014684127,0.0022425319,0.00016562371,0.0007044768,0.00052754855,0.0006872706,0.00014454474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007292798,0.00012439236,0.89431554,0.00041146434,0.0029841675,0.00025750842,0.00022569294,0.05439207,0.00023124769,0.0031171376,0.011471301,0.031740222],"study_design_scores_gemma":[0.00008778067,0.00014038205,0.96830606,0.0002605028,0.0006553929,0.00058895984,0.0005952781,0.02064352,0.0003152899,0.001291444,0.0070600407,0.000055298515],"about_ca_topic_score_codex":0.069765255,"about_ca_topic_score_gemma":0.072958514,"teacher_disagreement_score":0.069765255,"about_ca_system_score_codex":0.0032896649,"about_ca_system_score_gemma":0.0010796536,"threshold_uncertainty_score":0.13871837},"labels":[],"label_agreement":null},{"id":"W1965012816","doi":"10.1016/j.jval.2011.02.228","title":"PCV41 AN ESTIMATE OF SOCIETAL MONETARY BENEFITS OF SIMVASTATIN IN CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Trade and Competitiveness","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Simvastatin; Productivity; Revenue; Population; Health care; Demographic economics; Economics; Medicine; Actuarial science; Demography; Environmental health; Economic growth; Finance; Internal medicine","score_opus":0.06462865795004176,"score_gpt":0.2467718705227876,"score_spread":0.18214321257274585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965012816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72937965,0.023339644,0.0024839733,0.008374936,0.00038647625,0.00026370527,0.15405293,0.0002170248,0.081501596],"genre_scores_gemma":[0.9533535,0.008367301,0.0011275165,0.0004640388,0.0000863819,0.000053712778,0.020434115,0.00002956267,0.016083835],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986889,0.00012980145,0.00006219999,0.00009361828,0.0007271365,0.00029833085],"domain_scores_gemma":[0.9974579,0.00018535425,0.00015722516,0.000045957215,0.0019254796,0.00022817536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060933636,0.0005017445,0.00054479943,0.0028612972,0.0012967038,0.0016962262,0.0008241032,0.0005125439,0.0030913667],"category_scores_gemma":[0.0037648093,0.00031011223,0.00126994,0.0061166496,0.00029797407,0.000348052,0.0005885942,0.0009638283,0.00036096168],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028296376,0.00019543704,0.6979052,0.0013259937,0.002457718,0.0018978437,0.0006526028,0.053805236,0.0016730564,0.02039671,0.08335304,0.13350762],"study_design_scores_gemma":[0.00016206632,0.000108428416,0.9110254,0.0002657856,0.00063355034,0.00032786134,0.0009903718,0.013165481,0.0010859643,0.0012767275,0.07086136,0.00009703363],"about_ca_topic_score_codex":0.9917299,"about_ca_topic_score_gemma":0.9878819,"teacher_disagreement_score":0.041405268,"about_ca_system_score_codex":0.041405268,"about_ca_system_score_gemma":0.033889357,"threshold_uncertainty_score":0.30041766},"labels":[],"label_agreement":null},{"id":"W1965258441","doi":"10.1016/j.jval.2012.03.253","title":"PMS64 Foqus Study (Study on Factors for Osteoporosis QOL in Japanese Subjects) - Interim Report","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Visual analogue scale; Osteoporosis; Quality of life (healthcare); McGill Pain Questionnaire; Physical therapy; Interim; Interim analysis; Osteoarthritis; Internal medicine; Clinical trial; Alternative medicine","score_opus":0.14271093447585653,"score_gpt":0.428631187741249,"score_spread":0.28592025326539244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965258441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96159273,0.0028938735,0.00047237807,0.0005168557,0.00023036452,0.0007963179,0.02885288,0.000032515225,0.0046120645],"genre_scores_gemma":[0.9484851,0.0013553994,0.00083692203,0.00037112943,0.00029451353,0.0017015635,0.04033341,0.000033556917,0.0065883533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916565,0.0003709379,0.00010786722,0.00009825731,0.00013223442,0.00012505265],"domain_scores_gemma":[0.99865294,0.00019396034,0.00028997986,0.0001526806,0.00037012668,0.00034027986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002357207,0.0010583935,0.0012686502,0.0011597908,0.0010221598,0.0010687414,0.0007062087,0.0009175347,0.0038238424],"category_scores_gemma":[0.0024786533,0.00074619,0.0017574145,0.0018808766,0.000411926,0.0006949347,0.0009290396,0.00070657424,0.000911679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024966933,0.00078110484,0.95339555,0.0003497784,0.0016285453,0.00028497702,0.000252724,0.000157003,0.0008243418,0.000097170814,0.00617101,0.011090796],"study_design_scores_gemma":[0.0033587266,0.0015925919,0.990681,0.000036368932,0.0009873942,0.00010283526,0.00020243798,0.00006450966,0.0002545588,0.000041846575,0.002660355,0.000017411474],"about_ca_topic_score_codex":0.018918231,"about_ca_topic_score_gemma":0.017781083,"teacher_disagreement_score":0.018918231,"about_ca_system_score_codex":0.00069252524,"about_ca_system_score_gemma":0.0014138214,"threshold_uncertainty_score":0.037616193},"labels":[],"label_agreement":null},{"id":"W1965362673","doi":"10.1016/j.jval.2012.08.1611","title":"PRM148 Sample Size and Power Considerations in Network Meta-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Sample size determination; Meta-analysis; Sample (material); Power analysis; Statistics; Computer science; Statistical power; Power (physics); Network analysis; Data mining; Mathematics; Algorithm; Medicine; Engineering","score_opus":0.8668655682702049,"score_gpt":0.5548614285702957,"score_spread":0.31200413969990914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965362673","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011270568,0.026786985,0.8040863,0.09076715,0.016978212,0.019404834,0.0028204015,0.0011955162,0.026689965],"genre_scores_gemma":[0.2628366,0.004177831,0.61031586,0.044189945,0.006753573,0.06198865,0.00066454196,0.0008729769,0.008199994],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.27966973,0.6441683,0.040095057,0.0121618565,0.022752866,0.0011521478],"domain_scores_gemma":[0.12312722,0.8408217,0.0057499767,0.021483626,0.008132154,0.0006854475],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.50046915,0.0022386047,0.008229592,0.0051035625,0.0024433797,0.0066200667,0.005129814,0.011901024,0.01755575],"category_scores_gemma":[0.8430539,0.0034654632,0.010683159,0.0060523734,0.0075653777,0.007741543,0.005076662,0.015759394,0.0025015587],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025568537,0.00048592192,0.008842496,0.053154405,0.04654246,0.0025259897,0.0044390326,0.012249114,0.0022270053,0.2598953,0.107726514,0.47634327],"study_design_scores_gemma":[0.028362438,0.003182358,0.012555846,0.019368961,0.027885033,0.0026905772,0.00054843246,0.06415792,0.0054133427,0.65946543,0.1759163,0.00045337962],"about_ca_topic_score_codex":0.0018632226,"about_ca_topic_score_gemma":0.002296984,"teacher_disagreement_score":0.49953085,"about_ca_system_score_codex":0.0023391251,"about_ca_system_score_gemma":0.0047371513,"threshold_uncertainty_score":0.61601055},"labels":[],"label_agreement":null},{"id":"W1965378925","doi":"10.1016/j.jval.2013.03.319","title":"The Usage Of 2-Octyl Cyanoacrylate Post Cesarean-Section In Canadian Hospitals: A Budget Impact Analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Surgical Sutures and Adhesives","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cyanoacrylate; Incidence (geometry); Population; Surgery; Adhesive","score_opus":0.012964735258339065,"score_gpt":0.2947798845468047,"score_spread":0.2818151492884656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965378925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96157455,0.0063979174,0.0004024691,0.004745011,0.000047442125,0.00034712863,0.01492277,0.000020692238,0.011541952],"genre_scores_gemma":[0.99020094,0.004032378,0.000598644,0.0003864051,0.000022952276,0.000079129975,0.003006172,0.000007071636,0.0016662099],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938664,0.0009317536,0.00037002823,0.00020859316,0.0022520844,0.0023712325],"domain_scores_gemma":[0.987822,0.0024684302,0.0029282332,0.00013357415,0.0045473683,0.0021003778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025932454,0.0006858661,0.0006268528,0.00532884,0.0019731752,0.0022081987,0.0017043307,0.001127167,0.003391269],"category_scores_gemma":[0.014297779,0.00052912405,0.0021359792,0.011582456,0.00089796755,0.0007798549,0.0012725161,0.0011689534,0.00012243583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017103818,0.00050230656,0.9137932,0.00095429324,0.00083155197,0.00063873915,0.0008087999,0.017627891,0.00046991603,0.0028716684,0.005884632,0.05390652],"study_design_scores_gemma":[0.000067883084,0.00035249387,0.985158,0.00026348655,0.00057622156,0.00017179966,0.0019457302,0.0067644753,0.00022173536,0.00017612253,0.0042388896,0.000063041676],"about_ca_topic_score_codex":0.98836106,"about_ca_topic_score_gemma":0.9915667,"teacher_disagreement_score":0.13495103,"about_ca_system_score_codex":0.13495103,"about_ca_system_score_gemma":0.104832396,"threshold_uncertainty_score":0.9791428},"labels":[],"label_agreement":null},{"id":"W1965585875","doi":"10.1016/j.jval.2012.03.1352","title":"PSS8 Productivity Losses Associated with Vision Impairment in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Visual impairment; Productivity; Visual acuity; Medicine; Near vision; Work productivity; Socioeconomic status; Demography; Gerontology; Environmental health; Psychiatry; Surgery; Economics; Population","score_opus":0.028623988313947114,"score_gpt":0.2868870698889689,"score_spread":0.25826308157502176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965585875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637875,0.0015404193,0.00010231352,0.0028809686,0.00008898737,0.000061255676,0.018730622,0.000030308465,0.012777481],"genre_scores_gemma":[0.9922087,0.0008496916,0.000049603965,0.00020121994,0.00002766319,0.00001162842,0.0036581464,0.000007529211,0.002985698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986185,0.00007574964,0.000091975795,0.00007035585,0.00042256928,0.0007207335],"domain_scores_gemma":[0.99486285,0.00017648451,0.0009750087,0.00004867629,0.0022795992,0.0016573884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003216297,0.00030788893,0.00036429163,0.0025901268,0.0021964095,0.0016562452,0.0009273284,0.000545194,0.0063953707],"category_scores_gemma":[0.0030541979,0.00027019228,0.0007063618,0.0054872236,0.00056477083,0.000311556,0.0011066255,0.0012994034,0.00040713703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021981087,0.00007160298,0.981488,0.00005579643,0.00007732832,0.00052807305,0.00037855734,0.0005166711,0.000089332076,0.00029954262,0.006848048,0.009427334],"study_design_scores_gemma":[0.000009824186,0.000024259947,0.9967014,0.000031977415,0.000017710625,0.00014658217,0.0009936081,0.00033848255,0.000031388026,0.000036818383,0.0016601774,0.0000076892975],"about_ca_topic_score_codex":0.99383295,"about_ca_topic_score_gemma":0.9934675,"teacher_disagreement_score":0.029702734,"about_ca_system_score_codex":0.029702734,"about_ca_system_score_gemma":0.04681092,"threshold_uncertainty_score":0.21550947},"labels":[],"label_agreement":null},{"id":"W1965694052","doi":"10.1016/j.jval.2012.03.884","title":"PRM28 Physicians as Pseudo-Agents in a Hospital Emergency Department Discrete Event Simulation","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Emergency department; Medicine; Discrete event simulation; Medical emergency; Event (particle physics); Hierarchy; Emergency medicine; Nursing; Simulation; Computer science","score_opus":0.09030045872833936,"score_gpt":0.4611188133448615,"score_spread":0.37081835461652213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965694052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78342354,0.00010722578,0.19100836,0.0019555741,0.00023152286,0.00030958987,0.0006814674,0.00036683856,0.021915875],"genre_scores_gemma":[0.97569966,0.00003404686,0.019154126,0.00009205953,0.000019069474,0.000109126944,0.00014766958,0.000019893896,0.0047244173],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989611,0.00058754144,0.000032392934,0.000106074476,0.00011862026,0.00019425922],"domain_scores_gemma":[0.99677604,0.0021741532,0.00018081462,0.00017934643,0.0002760514,0.00041363703],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017099124,0.0004224656,0.00081852183,0.00044817544,0.0007029163,0.0013329465,0.0014062049,0.0018871165,0.0060615395],"category_scores_gemma":[0.0049241316,0.0005678345,0.00064546254,0.0004883782,0.0007713719,0.0007848955,0.001152706,0.0014007618,0.00041833168],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013628621,0.000082737795,0.0011139959,0.000008174771,0.000013001056,0.00006283438,0.000027763766,0.9913617,0.000114241106,0.0055512316,0.0002759095,0.0012520897],"study_design_scores_gemma":[0.000032983324,0.00002319001,0.00008739941,0.0000010183345,0.0000029435084,0.000004225817,0.000014146165,0.99891365,0.000057299185,0.00071811076,0.00014234311,0.000002623259],"about_ca_topic_score_codex":0.016821114,"about_ca_topic_score_gemma":0.0098122675,"teacher_disagreement_score":0.016821114,"about_ca_system_score_codex":0.0010158365,"about_ca_system_score_gemma":0.002121622,"threshold_uncertainty_score":0.03344643},"labels":[],"label_agreement":null},{"id":"W1965757011","doi":"10.1016/j.jval.2011.08.217","title":"PIN30 Cost Analysis of Voriconazole Versus Itraconazole for Prophylaxis of Invasive Fungal Infection (IFI) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Canada, France, Germany, and the United States","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Voriconazole; Medicine; Itraconazole; Tolerability; Internal medicine; Concomitant; Hematopoietic stem cell transplantation; Clinical trial; Randomized controlled trial; Surgery; Gastroenterology; Adverse effect; Antifungal; Transplantation; Dermatology","score_opus":0.03852618626752976,"score_gpt":0.2633188192122173,"score_spread":0.22479263294468751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965757011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97938156,0.008029844,0.0006115457,0.0009682427,0.000066776665,0.00024358873,0.0049664644,0.000047228583,0.005684736],"genre_scores_gemma":[0.9965702,0.00066992454,0.00024950926,0.00022469148,0.000015106891,0.000046517944,0.0016077707,0.0000068995864,0.0006093404],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99752325,0.0014255245,0.000110801804,0.00014243416,0.00038735085,0.00041062685],"domain_scores_gemma":[0.997203,0.0016439904,0.00039475848,0.00006694277,0.00038640315,0.0003050198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024968395,0.00079257233,0.0018506012,0.00123906,0.00034700226,0.0016337414,0.0010539141,0.0007447813,0.0039812336],"category_scores_gemma":[0.006392257,0.0004872102,0.0033573825,0.0021802639,0.00040078524,0.0006449236,0.0006148091,0.0008270146,0.00015639639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19753543,0.002466675,0.17984562,0.0028899896,0.014357148,0.0013817981,0.00018835138,0.45808628,0.0020307486,0.007145005,0.015598112,0.11847483],"study_design_scores_gemma":[0.01861836,0.02676829,0.59102964,0.0007045169,0.016249482,0.0014008227,0.0013939075,0.32989246,0.0019173378,0.0027528766,0.009041252,0.0002311019],"about_ca_topic_score_codex":0.18927431,"about_ca_topic_score_gemma":0.171538,"teacher_disagreement_score":0.8107257,"about_ca_system_score_codex":0.011849753,"about_ca_system_score_gemma":0.0056504514,"threshold_uncertainty_score":0.37634522},"labels":[],"label_agreement":null},{"id":"W1966085183","doi":"10.1016/j.jval.2012.03.924","title":"PDB3 Risk of Complications in Type II Diabetic Patients With Renal Impairment: an Analysis of the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hypoglycemia; Internal medicine; Incidence (geometry); Diabetes mellitus; Kidney disease; Metabolic acidosis; Type 2 Diabetes Mellitus; Type 2 diabetes; Endocrinology","score_opus":0.04019185679009446,"score_gpt":0.33410937749969566,"score_spread":0.2939175207096012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966085183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363219,0.00078103645,0.000105987296,0.00015332107,0.000009376902,0.000023346354,0.061665278,0.000025376909,0.0009144147],"genre_scores_gemma":[0.9456626,0.00041857458,0.0003747038,0.00014587044,0.000023390654,0.00005572182,0.05298468,0.000016235534,0.00031822833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876404,0.0003039524,0.0002295371,0.0003485355,0.00024079128,0.00011316398],"domain_scores_gemma":[0.9950245,0.0015150165,0.0021699746,0.0005561724,0.00042315663,0.00031120036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012421671,0.00027661378,0.00089666544,0.0018702968,0.0002745426,0.0010683454,0.00078412774,0.00048613397,0.0029090452],"category_scores_gemma":[0.006340346,0.00019863444,0.0010811692,0.0048976913,0.00019453731,0.0005514157,0.00072867615,0.000539858,0.00054037175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013565468,0.000051312752,0.9923693,0.00007883281,0.00048351134,0.00010212324,0.00004489514,0.00024693174,0.00012010427,0.00011885238,0.0022234225,0.002804134],"study_design_scores_gemma":[0.00015323442,0.00007747383,0.995999,0.00003094318,0.00028281866,0.00044365315,0.00018528994,0.001013443,0.0001056545,0.00010613854,0.001586307,0.000016149033],"about_ca_topic_score_codex":0.021796037,"about_ca_topic_score_gemma":0.014137318,"teacher_disagreement_score":0.97820395,"about_ca_system_score_codex":0.0007615551,"about_ca_system_score_gemma":0.00075715006,"threshold_uncertainty_score":0.04333836},"labels":[],"label_agreement":null},{"id":"W1966117900","doi":"10.1016/j.jval.2014.03.1179","title":"A microsoft-excel based tool for running and critically appraising simple network meta-analyses using winbugs – an overview and application","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Scientific Computing and Data Management","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Computer science; Microsoft excel; Software; Data mining; Programming language; Operating system","score_opus":0.6345220704923602,"score_gpt":0.5416845861432095,"score_spread":0.09283748434915073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966117900","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009152474,0.0022509438,0.68458587,0.0014976183,0.0015132151,0.014180915,0.062176935,0.21807152,0.006570554],"genre_scores_gemma":[0.009239029,0.0006668075,0.9507733,0.00026197167,0.0001322331,0.022856746,0.00505563,0.008267467,0.0027469299],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9791508,0.010598543,0.00601603,0.001544469,0.0022401088,0.00044997816],"domain_scores_gemma":[0.72895193,0.23937099,0.012720398,0.007729698,0.009703052,0.0015240468],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0581663,0.005531911,0.0068824734,0.018263834,0.0013192577,0.0058055725,0.0045315563,0.0022399523,0.09585357],"category_scores_gemma":[0.14870383,0.004988062,0.0054416102,0.013190297,0.0016067512,0.0042365934,0.005486885,0.005074829,0.012875687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008382037,0.0010306366,0.00538301,0.056910463,0.01390146,0.0018556442,0.0035714146,0.019978814,0.010999499,0.040848963,0.34225616,0.49488193],"study_design_scores_gemma":[0.01016804,0.0021268586,0.01674543,0.019593077,0.014641509,0.002943703,0.0019172442,0.1818501,0.038272854,0.20131257,0.5084683,0.0019603625],"about_ca_topic_score_codex":0.002894666,"about_ca_topic_score_gemma":0.004387243,"teacher_disagreement_score":0.9418337,"about_ca_system_score_codex":0.00200369,"about_ca_system_score_gemma":0.0095049795,"threshold_uncertainty_score":0.32066214},"labels":[],"label_agreement":null},{"id":"W1966122728","doi":"10.1016/j.jval.2014.03.703","title":"A Systematic Review, Critical Appraisal And Analysis Of The Quality Of Economic Evaluations In Stroke Imaging","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; CINAHL; Thrombolysis; Stroke (engine); Checklist; MEDLINE; Modified Rankin Scale; Psychological intervention; Critical appraisal; Emergency medicine; Intensive care medicine; Physical therapy; Internal medicine; Alternative medicine; Ischemic stroke; Pathology","score_opus":0.045801260799386914,"score_gpt":0.4299377434217208,"score_spread":0.3841364826223339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966122728","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00929116,0.9769176,0.0031191716,0.0031140891,0.0010845491,0.0046012197,0.0010992617,0.00003701869,0.00073582906],"genre_scores_gemma":[0.38130757,0.5662044,0.028192043,0.005030156,0.0013983741,0.016089022,0.0013004374,0.00007774122,0.00040023855],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.61135507,0.26339248,0.08613234,0.007132517,0.029737651,0.0022499824],"domain_scores_gemma":[0.37700063,0.5194373,0.06538673,0.011654059,0.024563638,0.0019576547],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22943203,0.0029727013,0.020420313,0.013238149,0.0017396268,0.008152577,0.0037082215,0.005074158,0.0028025536],"category_scores_gemma":[0.59912986,0.002459014,0.024292802,0.009212934,0.0032893475,0.0055518495,0.004594411,0.004435456,0.00018090472],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067102057,0.00009259589,0.004694474,0.6984235,0.24096285,0.0001508675,0.000546167,0.00078150997,0.00017574159,0.0011051069,0.0026127947,0.043744147],"study_design_scores_gemma":[0.01022485,0.00097420317,0.011169878,0.38215676,0.5821349,0.00026003548,0.0004420639,0.0012917252,0.00036583765,0.0032543768,0.007561369,0.00016391007],"about_ca_topic_score_codex":0.012541672,"about_ca_topic_score_gemma":0.020790443,"teacher_disagreement_score":0.77056795,"about_ca_system_score_codex":0.015882777,"about_ca_system_score_gemma":0.027072124,"threshold_uncertainty_score":0.95024747},"labels":[],"label_agreement":null},{"id":"W1966139427","doi":"10.1016/j.jval.2014.03.1301","title":"Long-acting injectable antipsychotics treatment patterns: A RAMQ database analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Antipsychotic; Concomitant; Schizoaffective disorder; Database; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Psychosis; Psychiatry","score_opus":0.16959042647042963,"score_gpt":0.4637416308851458,"score_spread":0.2941512044147162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966139427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86733764,0.0017046765,0.00073332124,0.00035936994,0.0000142900435,0.00013342423,0.12871662,0.000058269718,0.0009422943],"genre_scores_gemma":[0.86712223,0.0009372119,0.0022747074,0.00022232877,0.000018438164,0.00017661492,0.12863673,0.000038480142,0.00057338824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720603,0.0006123112,0.00088050286,0.00063660473,0.00048635562,0.00017813721],"domain_scores_gemma":[0.9892475,0.004642449,0.003313521,0.0012446417,0.0011949186,0.0003569231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023292103,0.0002559769,0.0008231457,0.0034524966,0.00029382994,0.0012223654,0.0006842134,0.0004293924,0.0028763672],"category_scores_gemma":[0.012048062,0.00024141042,0.0016437725,0.0043468494,0.0002008666,0.0007220116,0.0007466481,0.0005655268,0.00068091863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017192904,0.00013145602,0.9678553,0.00041972363,0.0017234453,0.000263007,0.00016948424,0.0004932872,0.00080106535,0.0003651224,0.0053981855,0.020660669],"study_design_scores_gemma":[0.00015971428,0.00023703066,0.9876096,0.00014669183,0.0010998583,0.001149639,0.0006107452,0.0027215576,0.00048455165,0.00017076732,0.005576714,0.000033100652],"about_ca_topic_score_codex":0.013088094,"about_ca_topic_score_gemma":0.01356922,"teacher_disagreement_score":0.9869119,"about_ca_system_score_codex":0.0007867065,"about_ca_system_score_gemma":0.0009994326,"threshold_uncertainty_score":0.026023865},"labels":[],"label_agreement":null},{"id":"W1966201494","doi":"10.1016/s1098-3015(10)73453-7","title":"PSS21 DISEASE BURDEN AND PRODUCTIVITY LOSS IN A CANADIAN ONLINE SURVEY POPULATION OF INDIVIDUALS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plaque psoriasis; Psoriasis; Productivity; Medicine; Disease; Disease burden; Demography; Gerontology; Dermatology; Internal medicine; Economics; Economic growth; Sociology","score_opus":0.06316237289037334,"score_gpt":0.34948721845064845,"score_spread":0.2863248455602751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966201494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99653,0.000227213,0.000019072888,0.00015171258,0.0000052137793,0.000017273744,0.001798465,0.0000030150704,0.0012479571],"genre_scores_gemma":[0.99843353,0.00019909689,0.000028984885,0.000048824306,0.0000050150998,0.000007731436,0.00080328423,0.0000014400424,0.00047209382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999286,0.000083316074,0.00005074596,0.00009365039,0.000228161,0.0002581823],"domain_scores_gemma":[0.9985299,0.00009712977,0.00039495894,0.000048608974,0.0004969408,0.00043237762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004971166,0.00035170894,0.00044711487,0.0016953867,0.002093199,0.0013023186,0.0008421439,0.0005667625,0.0027669012],"category_scores_gemma":[0.002855866,0.00032745255,0.0007404735,0.0038422865,0.0004776007,0.00042386013,0.00074562064,0.0008509086,0.000334577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008614915,0.000049318904,0.99759007,0.000010967499,0.000039865576,0.0000595315,0.00034873508,0.000034149893,0.00008696016,0.000022294804,0.000393926,0.0012781686],"study_design_scores_gemma":[0.0000040400164,0.000015366488,0.9992299,0.0000042656593,0.000012817307,0.00004347849,0.00048493702,0.000062039086,0.000007068925,0.000006498984,0.00012527614,0.0000043130117],"about_ca_topic_score_codex":0.96595776,"about_ca_topic_score_gemma":0.95665663,"teacher_disagreement_score":0.03404224,"about_ca_system_score_codex":0.005983069,"about_ca_system_score_gemma":0.006376981,"threshold_uncertainty_score":0.06848538},"labels":[],"label_agreement":null},{"id":"W1966337915","doi":"10.1016/j.jval.2013.08.1399","title":"Health Care Resource Utilization and Costs Associated with Atypical Antipsychotics Use in Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Quebec, Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Centre of Excellence for Child and Youth Mental Health; Group for Research in Decision Analysis; Université de Montréal","funders":"","keywords":"Medicine; Quetiapine; Risperidone; Medical prescription; Attention deficit hyperactivity disorder; Psychiatry; Stimulant; Pediatrics; Anxiety; Health care; Schizophrenia (object-oriented programming)","score_opus":0.02550305477666069,"score_gpt":0.2854499051537697,"score_spread":0.259946850377109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966337915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882732,0.002108923,0.000055778506,0.0012414246,0.000026814632,0.00003611787,0.005705434,0.000010899152,0.002541388],"genre_scores_gemma":[0.99606943,0.0011317754,0.00013236357,0.00023149235,0.000013302573,0.000023353245,0.0015686913,0.000004879655,0.00082467805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991352,0.00009898858,0.00007737493,0.00007178512,0.00024392294,0.0003726926],"domain_scores_gemma":[0.99748933,0.00020503682,0.0006703947,0.000030447763,0.00081830105,0.0007864835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036012815,0.00030424324,0.0004617927,0.0011997386,0.0019265714,0.0013484001,0.0013513048,0.0006654235,0.0026667085],"category_scores_gemma":[0.0022229701,0.00034019657,0.0010706332,0.0036124468,0.00055609713,0.00040394318,0.0007070667,0.0012426771,0.00014149377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005438725,0.00005086694,0.9935928,0.000041009116,0.000105563224,0.00020903192,0.00027694373,0.00037173566,0.000056478868,0.00014505298,0.0019027338,0.0031934842],"study_design_scores_gemma":[0.00001127313,0.000014969235,0.9979792,0.00005497421,0.000034913654,0.00007198326,0.0008758077,0.00044151605,0.000020183055,0.000016538334,0.00047029133,0.000008278489],"about_ca_topic_score_codex":0.9970657,"about_ca_topic_score_gemma":0.9983423,"teacher_disagreement_score":0.048844084,"about_ca_system_score_codex":0.048844084,"about_ca_system_score_gemma":0.035686895,"threshold_uncertainty_score":0.35439026},"labels":[],"label_agreement":null},{"id":"W1966628110","doi":"10.1016/j.jval.2013.03.1269","title":"Harmonization Of Health Technology Assessement And Regulatory Processes And Evidentiary Requirements For Drugs And Devices: Opportunities And Challenges","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Harmonization; Restructuring; Process (computing); Health technology; Process management; Risk analysis (engineering); Management science; Business; Computer science; Health care; Political science; Engineering; Law","score_opus":0.6155175674371229,"score_gpt":0.43070224839889176,"score_spread":0.18481531903823117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966628110","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055470917,0.029812377,0.5006682,0.35385022,0.0046811756,0.0024448484,0.0014179287,0.0011492799,0.050505042],"genre_scores_gemma":[0.49323392,0.009413329,0.4210545,0.062541015,0.004908702,0.0019229299,0.0023892643,0.0006489285,0.003887349],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.7223351,0.15528536,0.034683205,0.017363556,0.06371811,0.006614711],"domain_scores_gemma":[0.43904942,0.27002877,0.052121636,0.09850762,0.13338612,0.0069064554],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3703269,0.00094698457,0.0043017017,0.0043953676,0.0028317377,0.01761834,0.014869493,0.011986981,0.0024869423],"category_scores_gemma":[0.3621116,0.0015867929,0.0031701848,0.0050159427,0.012358807,0.017901115,0.009578334,0.01279533,0.00083424564],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036219458,0.00096189865,0.00837086,0.0021253238,0.00053105206,0.00020610674,0.002635943,0.0175992,0.0029580554,0.5383774,0.0415858,0.38428617],"study_design_scores_gemma":[0.00041665294,0.00091233954,0.028525613,0.004698848,0.00026994038,0.0004917257,0.0030720877,0.025384469,0.006377797,0.72516423,0.20432164,0.00036466378],"about_ca_topic_score_codex":0.007465811,"about_ca_topic_score_gemma":0.0042028325,"teacher_disagreement_score":0.6296731,"about_ca_system_score_codex":0.012353174,"about_ca_system_score_gemma":0.04056144,"threshold_uncertainty_score":0.77649903},"labels":[],"label_agreement":null},{"id":"W1966821681","doi":"10.1016/j.jval.2012.03.1215","title":"PCN98 The Development of an Internationally-Valid Cancer-Specific Multi-Attribute Utility Instrument (MAUI) From the Eortc Core Health-Related Quality of Life (HRQOL) Questionnaire, QLQ-C30","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Rasch model; Quality of life (healthcare); Differential item functioning; Cancer; Item response theory; Descriptive statistics; Psychology; Medicine; Clinical psychology; Psychometrics; Statistics; Developmental psychology; Mathematics; Nursing","score_opus":0.6553345438472162,"score_gpt":0.46497874096596586,"score_spread":0.19035580288125037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966821681","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3253233,0.0022980187,0.24459884,0.0042611496,0.0015951783,0.034868255,0.10683246,0.0038546333,0.27636817],"genre_scores_gemma":[0.43848807,0.0014929015,0.31724158,0.0014314266,0.00023480927,0.040190846,0.12814592,0.0018232997,0.070951134],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98841256,0.003693022,0.0013977753,0.0009140331,0.005048952,0.0005336045],"domain_scores_gemma":[0.9801364,0.004866346,0.0014126627,0.0020284513,0.010903159,0.0006530562],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016556865,0.00063914026,0.0007355854,0.0035028877,0.0008308629,0.0020584331,0.001969533,0.00083563675,0.007356084],"category_scores_gemma":[0.052783355,0.0005363244,0.0011168018,0.0038920804,0.0006064669,0.0011591656,0.002938748,0.0018904851,0.0035730444],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008208341,0.00094537326,0.14053723,0.00049056753,0.00015873491,0.00014179002,0.0008436505,0.0022485997,0.0014045046,0.011691338,0.0874391,0.7532783],"study_design_scores_gemma":[0.00042069113,0.0011222672,0.47964293,0.0006423543,0.0002081746,0.000576448,0.00060924416,0.014683231,0.009865697,0.0077656046,0.48430243,0.00016096325],"about_ca_topic_score_codex":0.015716664,"about_ca_topic_score_gemma":0.021378139,"teacher_disagreement_score":0.98344314,"about_ca_system_score_codex":0.002721648,"about_ca_system_score_gemma":0.0075799846,"threshold_uncertainty_score":0.087562084},"labels":[],"label_agreement":null},{"id":"W1966839561","doi":"10.1016/s1098-3015(10)65887-1","title":"PHP28 THE ORGANIZED REGISTER OF CANADIAN HEALTH INFORMATION DATABASES (ORCHID) PROJECT: A RESEARCHER INTERFACE","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Register (sociolinguistics); Interface (matter); Database; World Wide Web; Computer science; Operating system","score_opus":0.5064793351875118,"score_gpt":0.5122980396560683,"score_spread":0.00581870446855659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966839561","genre_codex":"dataset","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008347043,0.0003656204,0.07296017,0.009620186,0.00050004106,0.010335955,0.57640344,0.07469863,0.24676894],"genre_scores_gemma":[0.08861656,0.00094583986,0.31693804,0.0031442808,0.00067707966,0.020157749,0.29010886,0.041334517,0.23807718],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9940017,0.002347147,0.0006718914,0.0003672571,0.0021620912,0.00044998486],"domain_scores_gemma":[0.92058396,0.05338095,0.0015395595,0.005023313,0.015689112,0.0037830584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018890586,0.000621447,0.0007835149,0.004964364,0.0016578576,0.004192502,0.0017099157,0.0010588005,0.2730564],"category_scores_gemma":[0.072027385,0.0009164416,0.00039575377,0.008706877,0.00082311156,0.0025139782,0.0033217047,0.0008671865,0.06431047],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029896753,0.00010130946,0.002195021,0.00060754386,0.00001625819,0.00006207979,0.0014583833,0.00012968581,0.0007521708,0.007215357,0.8802206,0.10694259],"study_design_scores_gemma":[0.0005420115,0.000040650222,0.0049763685,0.00018276725,0.000023899724,0.000046242272,0.0009394504,0.0013751616,0.0011419794,0.004151373,0.98653305,0.00004710946],"about_ca_topic_score_codex":0.16224849,"about_ca_topic_score_gemma":0.21590462,"teacher_disagreement_score":0.99552584,"about_ca_system_score_codex":0.0044741896,"about_ca_system_score_gemma":0.017951988,"threshold_uncertainty_score":0.9134646},"labels":[],"label_agreement":null},{"id":"W1966858810","doi":"10.1016/j.jval.2012.08.1677","title":"PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; Lawson Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Cohort; Diabetes mellitus; Cohort study; Intervention (counseling); Pediatrics; Emergency medicine; Internal medicine","score_opus":0.46010924351039006,"score_gpt":0.4369976809492666,"score_spread":0.023111562561123455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966858810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8932412,0.008550917,0.0007675698,0.022702638,0.0002516811,0.0024027561,0.022232763,0.000041034946,0.04980932],"genre_scores_gemma":[0.9856311,0.0025727933,0.0014615502,0.001220889,0.00005998782,0.00035281182,0.00392644,0.000015523246,0.004758669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942194,0.0022439857,0.0005114509,0.00020932818,0.001550985,0.0012648641],"domain_scores_gemma":[0.97953266,0.0035928492,0.0022371558,0.00028141544,0.007845806,0.0065099983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042403066,0.00039541043,0.0008457373,0.0016701133,0.0026379367,0.0030613714,0.0012278027,0.0009744541,0.0044255136],"category_scores_gemma":[0.023397582,0.0005231889,0.0011632323,0.003713311,0.00077069516,0.00051405496,0.0010986091,0.0013087989,0.00017442238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00925854,0.0017608756,0.73638135,0.0020409643,0.0021621406,0.0011214742,0.0016935982,0.04155335,0.00037323785,0.011817169,0.10463871,0.08719863],"study_design_scores_gemma":[0.004192768,0.0008508009,0.92514765,0.0014952142,0.0008255459,0.00024255294,0.0036424182,0.041602664,0.00021790691,0.0015429995,0.020068534,0.0001709673],"about_ca_topic_score_codex":0.9952447,"about_ca_topic_score_gemma":0.9977108,"teacher_disagreement_score":0.11756916,"about_ca_system_score_codex":0.11756916,"about_ca_system_score_gemma":0.18779026,"threshold_uncertainty_score":0.853028},"labels":[],"label_agreement":null},{"id":"W1967147071","doi":"10.1016/s1098-3015(10)72644-9","title":"PMS58 HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Medicine; Family medicine; Physical therapy; Internal medicine","score_opus":0.021618522551746577,"score_gpt":0.2916455201595928,"score_spread":0.2700269976078462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967147071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877242,0.00035308715,0.00003562211,0.00042311524,0.000011670548,0.000036394733,0.0073280553,0.0000071211407,0.004080714],"genre_scores_gemma":[0.9953694,0.00024303209,0.000055262277,0.00006429315,0.000013036966,0.000016067675,0.0018850486,0.0000032620994,0.002350563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911755,0.00009007785,0.000087979104,0.000074130854,0.00031854125,0.00031173253],"domain_scores_gemma":[0.9970204,0.00024393652,0.0009857181,0.00006055896,0.00079247775,0.00089676044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037316952,0.00022984504,0.00036690405,0.0012727143,0.001765277,0.0010362417,0.0009772759,0.0004621183,0.005461468],"category_scores_gemma":[0.0030719012,0.00043480517,0.0008928078,0.003294501,0.00050946453,0.0003939316,0.00092664873,0.0006649424,0.00032191558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096059266,0.000031912066,0.9968316,0.000026840895,0.000047650115,0.00010374782,0.0002907291,0.00012591665,0.00005879466,0.00007909619,0.0008745842,0.001433075],"study_design_scores_gemma":[0.000006777845,0.000014669075,0.9990767,0.000008557905,0.000011603374,0.000028043865,0.000313659,0.000100680765,0.000009096786,0.000010224563,0.000416665,0.0000032751177],"about_ca_topic_score_codex":0.9856279,"about_ca_topic_score_gemma":0.99202204,"teacher_disagreement_score":0.019821836,"about_ca_system_score_codex":0.019821836,"about_ca_system_score_gemma":0.022227868,"threshold_uncertainty_score":0.1438182},"labels":[],"label_agreement":null},{"id":"W1967213632","doi":"10.1016/s1098-3015(10)70359-4","title":"PMH9 RETENTION RATES FOR ORAL AND DEPOT ANTIPSYCHOTIC MEDICATIONS OVER ONE YEAR IN ONTARIO, CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Radioactivity and Radon Measurements","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depot; Antipsychotic; Medicine; Psychiatry; Family medicine; Geography; Schizophrenia (object-oriented programming); Archaeology","score_opus":0.22605271134452629,"score_gpt":0.4099362084477653,"score_spread":0.183883497103239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967213632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933083,0.0009644197,0.000106757936,0.000258292,0.000010624426,0.000023614746,0.0032158147,0.000017467208,0.002094598],"genre_scores_gemma":[0.99486107,0.00050007936,0.00013287239,0.00010811334,0.0000060170087,0.000009083394,0.0011677165,0.000007603064,0.0032074729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941695,0.000027542867,0.000038574108,0.00008800648,0.00027428125,0.00015460208],"domain_scores_gemma":[0.99870145,0.00006866835,0.0002958989,0.000026074353,0.0006829579,0.00022489752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033589153,0.00020699129,0.0004016332,0.00079081114,0.0016701913,0.0008802111,0.00086837274,0.00041059207,0.0017107414],"category_scores_gemma":[0.0013004972,0.00031033167,0.00064430584,0.0015300375,0.0004378926,0.00029703949,0.0004914714,0.00056190917,0.00023444653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033164438,0.00004337936,0.9894594,0.000042272037,0.000072471885,0.00010877701,0.0008972315,0.00009715843,0.0005120805,0.000048163973,0.0011935122,0.007193926],"study_design_scores_gemma":[0.0000067914925,0.000044405693,0.99826545,0.0000097411,0.000030643274,0.000064846136,0.0004945819,0.0001319453,0.000121239624,0.000005532534,0.0008176564,0.0000072241714],"about_ca_topic_score_codex":0.9907047,"about_ca_topic_score_gemma":0.99284256,"teacher_disagreement_score":0.018205078,"about_ca_system_score_codex":0.018205078,"about_ca_system_score_gemma":0.016815554,"threshold_uncertainty_score":0.13208771},"labels":[],"label_agreement":null},{"id":"W1967300065","doi":"10.1016/j.jval.2010.10.012","title":"Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Abbott Laboratories","keywords":"Ankylosing spondylitis; Medicine; Physical therapy; Health Utilities Index; Quality of life (healthcare); Correlation; Discriminative model; Convergent validity; Health related quality of life; Psychometrics; Disease; Internal medicine; Mathematics; Clinical psychology; Artificial intelligence","score_opus":0.08882071676749032,"score_gpt":0.32093821966311437,"score_spread":0.23211750289562405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967300065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88375896,0.04031031,0.0078086597,0.024358623,0.0013007006,0.00028962857,0.016052771,0.000090688554,0.026029697],"genre_scores_gemma":[0.99190325,0.0020930818,0.0017195292,0.0015083152,0.00018424787,0.00015789825,0.0021543799,0.000014777416,0.00026456625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99162865,0.0046753604,0.0013741459,0.00036813243,0.0012961902,0.00065763755],"domain_scores_gemma":[0.97463757,0.01475581,0.0063531646,0.0014922017,0.0021682922,0.0005930589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010401332,0.00054898,0.0019207433,0.0016004246,0.00048764513,0.002281929,0.0010532531,0.001679805,0.0019540966],"category_scores_gemma":[0.062016647,0.0002258395,0.0034851844,0.0031983699,0.00078173325,0.0025583557,0.0007689668,0.0018631696,0.00053046853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019668113,0.00018281602,0.8670749,0.0005102369,0.0014861568,0.00015144638,0.00026795798,0.0007559617,0.00015737931,0.0020617608,0.007558261,0.1178263],"study_design_scores_gemma":[0.0003781044,0.00104329,0.9580989,0.0013349646,0.0014488874,0.0010676123,0.0009793828,0.006692882,0.00060688984,0.015613356,0.012584161,0.00015160024],"about_ca_topic_score_codex":0.0029763668,"about_ca_topic_score_gemma":0.004503014,"teacher_disagreement_score":0.010401332,"about_ca_system_score_codex":0.0013285796,"about_ca_system_score_gemma":0.0014983881,"threshold_uncertainty_score":0.055008173},"labels":[],"label_agreement":null},{"id":"W1967399362","doi":"10.1016/s1098-3015(11)72093-9","title":"PDB35 COST-CONSEQUENCE ANALYSIS OF CSII VS. MDI:A CANADIAN PERSPECTIVE","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Medicine; Computer science; Artificial intelligence","score_opus":0.34466576956920136,"score_gpt":0.4378200209320594,"score_spread":0.09315425136285804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967399362","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22532977,0.07640116,0.030077213,0.12123041,0.0012329135,0.0011875859,0.06405327,0.00030632157,0.4801813],"genre_scores_gemma":[0.9524911,0.013954522,0.008103098,0.0034712171,0.00031144216,0.00015972288,0.004502689,0.00009700385,0.01690928],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99447966,0.001730937,0.00026699933,0.00030012184,0.0020977482,0.0011245154],"domain_scores_gemma":[0.98907065,0.0041330527,0.00051487616,0.00024414517,0.0052849874,0.0007521449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006124383,0.0011287841,0.001886955,0.0061977636,0.001724789,0.0055019613,0.0023670844,0.0016684771,0.012245634],"category_scores_gemma":[0.021413216,0.0006505536,0.0029776476,0.008480635,0.0014436797,0.0014117884,0.0010141834,0.0028381622,0.00026212735],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023613407,0.00023842817,0.04288519,0.002196032,0.0029311369,0.0006739114,0.00046341773,0.1660622,0.00068821246,0.59966576,0.06839441,0.11344004],"study_design_scores_gemma":[0.0019235471,0.00086858805,0.19346586,0.0034145557,0.009630203,0.0013788396,0.0035094013,0.2825831,0.0016276718,0.30439368,0.19627663,0.00092786923],"about_ca_topic_score_codex":0.9794279,"about_ca_topic_score_gemma":0.97879523,"teacher_disagreement_score":0.9122234,"about_ca_system_score_codex":0.08777661,"about_ca_system_score_gemma":0.09442973,"threshold_uncertainty_score":0.6368668},"labels":[],"label_agreement":null},{"id":"W1967491409","doi":"10.1016/j.jval.2011.02.431","title":"PUK16 COST-EFFECTIVENESS OF VALGANCICLOVIR 200 DAYS PROPHYLAXIS VERSUS 100 DAYS PROPHYLAXIS IN KIDNEY TRANSPLANT PATIENTS AT HIGH-RISK FOR DEVELOPING CYTOMEGALOVIRUS DISEASE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Roche (Canada); University of Alberta; Thornhill Medical (Canada)","funders":"","keywords":"Valganciclovir; Medicine; Cost-effectiveness analysis; Cost effectiveness; Dialysis; Kidney transplantation; Intensive care medicine; Internal medicine; Emergency medicine; Transplantation; Ganciclovir; Human cytomegalovirus; Immunology; Virus","score_opus":0.08356463954446439,"score_gpt":0.33028964010695827,"score_spread":0.24672500056249388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967491409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593204,0.0028331631,0.000107589614,0.00029287452,0.000067394285,0.00003521988,0.00012656825,0.0000068204026,0.00059835234],"genre_scores_gemma":[0.9994203,0.00029811062,0.000065044296,0.00004436088,0.000016539168,0.000009517975,0.000054977514,9.916812e-7,0.00009020891],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993691,0.00031897685,0.000045185694,0.00007536585,0.000042605832,0.00014879323],"domain_scores_gemma":[0.99906856,0.0004709174,0.00016948176,0.000028577091,0.00001963245,0.00024282606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007147851,0.00051963615,0.0014997557,0.00032309655,0.00018403445,0.00082039787,0.00046537252,0.0009296386,0.0039871656],"category_scores_gemma":[0.0029861305,0.00032230033,0.0027870953,0.0003541989,0.00036357896,0.0006733667,0.00039426936,0.0010318196,0.00014231836],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7477696,0.0042681107,0.07401727,0.0010234847,0.005033055,0.0005441407,0.0001168461,0.023155736,0.0030289043,0.001105079,0.0009687756,0.13896893],"study_design_scores_gemma":[0.18894435,0.2775508,0.43504944,0.00076734414,0.019299317,0.001961183,0.0008935155,0.06460679,0.005035344,0.0034826926,0.0021974263,0.00021178252],"about_ca_topic_score_codex":0.003594569,"about_ca_topic_score_gemma":0.003243866,"teacher_disagreement_score":0.0039871656,"about_ca_system_score_codex":0.0012579917,"about_ca_system_score_gemma":0.0010354661,"threshold_uncertainty_score":0.013338387},"labels":[],"label_agreement":null},{"id":"W1967590582","doi":"10.1016/j.jval.2011.08.575","title":"PHP24 How Does the Committee to Evaluate Drugs (CED) Make Decisions about Ambulatory Pharmaceutical Funding in Ontario?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Reimbursement; Government (linguistics); Pharmaceutical care; Business; Medicine; Family medicine; Quality (philosophy); Health care; Actuarial science; Public economics; Economics; Pharmacy; Economic growth","score_opus":0.6263405301257549,"score_gpt":0.459053481697028,"score_spread":0.16728704842872688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967590582","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04175145,0.003222772,0.0012431007,0.7920292,0.0021194776,0.00066961074,0.006806403,0.00009351341,0.15206449],"genre_scores_gemma":[0.5766441,0.004895478,0.007226883,0.15285787,0.0044933544,0.0008402857,0.0041504353,0.0002475794,0.24864402],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.98190665,0.0039568134,0.0010671467,0.0005858237,0.008007067,0.0044764364],"domain_scores_gemma":[0.90445065,0.027223509,0.003935048,0.0017005227,0.04351676,0.019173503],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022481583,0.00032671474,0.0006172318,0.0019056367,0.0063359127,0.00684942,0.0017282763,0.007064815,0.0242557],"category_scores_gemma":[0.0897766,0.00073708186,0.001030114,0.0024535062,0.0031884068,0.002482697,0.002122458,0.0041382182,0.0018017954],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020375861,0.0000852733,0.06655254,0.00019855927,0.00011090731,0.0004652433,0.001542075,0.0007212739,0.000230509,0.028561303,0.84944266,0.05188579],"study_design_scores_gemma":[0.00034705197,0.000090422174,0.18362863,0.0006310424,0.00013557171,0.00019279691,0.0030585083,0.0022526565,0.00047209964,0.010509463,0.79850674,0.00017501319],"about_ca_topic_score_codex":0.9609024,"about_ca_topic_score_gemma":0.9799982,"teacher_disagreement_score":0.97751844,"about_ca_system_score_codex":0.069994606,"about_ca_system_score_gemma":0.22478834,"threshold_uncertainty_score":0.5078488},"labels":[],"label_agreement":null},{"id":"W1967607156","doi":"10.1016/j.jval.2011.08.460","title":"PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Canadian Arthritis Patient Alliance; Université de Montréal","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Hydroxychloroquine; Logistic regression; Comorbidity; Rheumatology; Disease","score_opus":0.07496639590177324,"score_gpt":0.2898749092248766,"score_spread":0.21490851332310335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967607156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.931107,0.012931164,0.00049989525,0.007934283,0.00024402131,0.00021623627,0.015779432,0.00010480633,0.031183263],"genre_scores_gemma":[0.9799662,0.0034447499,0.00053984375,0.0014837962,0.000060596725,0.000044803943,0.0019321537,0.00002338247,0.0125043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986675,0.00017456694,0.000104130675,0.00013904543,0.0005823128,0.00033243414],"domain_scores_gemma":[0.99657273,0.00025568472,0.00067263807,0.000041708226,0.0016116416,0.0008455846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067421136,0.0003117292,0.00040986802,0.0014049038,0.0021871452,0.0012558104,0.0012566246,0.00071026414,0.005931471],"category_scores_gemma":[0.0019865695,0.00029616035,0.00078703463,0.0029316647,0.00052554073,0.00032585868,0.0004139405,0.0010315394,0.00042008876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049178797,0.00018253112,0.92301196,0.00033243938,0.0002940742,0.0012512036,0.00089858845,0.0008560044,0.0014865051,0.0016468106,0.021900758,0.04764723],"study_design_scores_gemma":[0.000067089044,0.0001122534,0.98141676,0.00019428473,0.00009157008,0.0003765765,0.0010117424,0.0008652352,0.00023719804,0.000044252876,0.0155527415,0.000030202713],"about_ca_topic_score_codex":0.9972168,"about_ca_topic_score_gemma":0.9983115,"teacher_disagreement_score":0.048096105,"about_ca_system_score_codex":0.048096105,"about_ca_system_score_gemma":0.05774064,"threshold_uncertainty_score":0.34896332},"labels":[],"label_agreement":null},{"id":"W1967740245","doi":"10.1016/s1098-3015(10)61276-4","title":"PCV5 COST IMPACT OF AMLODIPINE IN BRITISH COLUMBIA BASED ON THE PREVENT TRIAL RESULTS","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic, Social, and Public Health Issues in Russia and Globally","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amlodipine; Medicine; Internal medicine","score_opus":0.20224064265165737,"score_gpt":0.4183248879272593,"score_spread":0.21608424527560194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967740245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583975,0.0024478703,0.00019364276,0.0034315735,0.00011348041,0.00018639606,0.025897622,0.000043693806,0.009288331],"genre_scores_gemma":[0.9894357,0.0008451754,0.0001973205,0.00049492775,0.0000460017,0.00006995543,0.005597897,0.000017527778,0.0032954914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982192,0.00083438965,0.00011385525,0.00012279286,0.00038924773,0.00032048154],"domain_scores_gemma":[0.9965083,0.0016189547,0.00044008103,0.00020025737,0.0006054555,0.0006268655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020208806,0.00049632846,0.0011490997,0.0007111653,0.00058868085,0.0014246127,0.0010186179,0.00087525666,0.0035437308],"category_scores_gemma":[0.007857,0.0002605526,0.0012787599,0.0015190222,0.00037212545,0.0004372452,0.00046800452,0.0014879686,0.00033548844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25643927,0.0015084634,0.5318991,0.001181667,0.007746861,0.0012744762,0.00023393336,0.036850464,0.0013081271,0.00406958,0.06660637,0.090881824],"study_design_scores_gemma":[0.025799835,0.0042763758,0.9055641,0.0004110092,0.012787116,0.00034611617,0.00073147716,0.028901998,0.0017209357,0.0024224757,0.016859522,0.0001790585],"about_ca_topic_score_codex":0.80374134,"about_ca_topic_score_gemma":0.88318634,"teacher_disagreement_score":0.19625866,"about_ca_system_score_codex":0.009869081,"about_ca_system_score_gemma":0.0152834095,"threshold_uncertainty_score":0.39482892},"labels":[],"label_agreement":null},{"id":"W1967772029","doi":"10.1016/j.jval.2012.03.1204","title":"PCN87 Cost-Effectiveness of Hormone Therapies for ER+ Women with Early Breast Cancer in Canada: Exploring the Potential for the Cyp2D6 Genetic Test","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto Public Health; St. Michael's Hospital","funders":"","keywords":"Tamoxifen; Medicine; Letrozole; Breast cancer; Oncology; Population; CYP2D6; Internal medicine; Gynecology; Aromatase; Cancer","score_opus":0.307823623645486,"score_gpt":0.37128906578781945,"score_spread":0.06346544214233346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967772029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95446783,0.0075691836,0.00059603906,0.009309417,0.000098624034,0.00020804787,0.016665598,0.000033247143,0.011051901],"genre_scores_gemma":[0.99276346,0.0018705273,0.0005947617,0.0004108839,0.0000308953,0.000037334645,0.0030678094,0.000010121848,0.001214179],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970214,0.0011098348,0.00017785287,0.00018717464,0.0009102971,0.0005935268],"domain_scores_gemma":[0.9923395,0.0036724717,0.000831884,0.00021285884,0.0018013983,0.0011418483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029875648,0.0004431868,0.00084742607,0.0008779575,0.00082040566,0.0014173243,0.0014629972,0.0007314329,0.0027806817],"category_scores_gemma":[0.019891743,0.00029224364,0.001810528,0.0027136933,0.000721426,0.00053537084,0.000823208,0.0012633685,0.00012251023],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008357616,0.0005411754,0.8388092,0.00076116633,0.0024678716,0.00037731524,0.00038698758,0.030164797,0.00024754024,0.007174488,0.016229412,0.09448244],"study_design_scores_gemma":[0.0014041794,0.0007535448,0.94909483,0.00035967494,0.0019734355,0.00019687765,0.00089431234,0.0370842,0.00026644277,0.0018651908,0.006038917,0.000068410285],"about_ca_topic_score_codex":0.98758626,"about_ca_topic_score_gemma":0.98964345,"teacher_disagreement_score":0.052994672,"about_ca_system_score_codex":0.052994672,"about_ca_system_score_gemma":0.060274918,"threshold_uncertainty_score":0.38450503},"labels":[],"label_agreement":null},{"id":"W1967883554","doi":"10.1016/j.jval.2014.03.1346","title":"Indirect Comparison Of The Efficacy Of Recombinant Factor Ix Fc Fusion Protein And Other Factor Ix Products For Prophylaxis: Simulating The Effect Of Compliance On Real-World Effectiveness","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Factor IX; Clinical trial; Pre-exposure prophylaxis; Internal medicine; Immunology","score_opus":0.11160240341549436,"score_gpt":0.4026727983690793,"score_spread":0.29107039495358494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967883554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99016905,0.001089898,0.0047465255,0.00015822928,0.00004831813,0.000207227,0.0007184024,0.000032099142,0.0028302972],"genre_scores_gemma":[0.99715567,0.00014341301,0.0019866128,0.000032819913,0.000011960166,0.000103867686,0.00018885548,0.000008613427,0.00036814407],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97375804,0.022979548,0.00064413965,0.0008751043,0.0013195251,0.00042364543],"domain_scores_gemma":[0.8367911,0.15239602,0.0040814774,0.004567303,0.001563218,0.0006009138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020563949,0.0008428359,0.0014491198,0.00066240126,0.0001555144,0.0013259939,0.0012053078,0.0016063467,0.0044348533],"category_scores_gemma":[0.07752605,0.0004416668,0.002586033,0.00076799316,0.0010445715,0.0013576981,0.00096857006,0.001397804,0.00037642394],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19811107,0.009939266,0.14998525,0.0041264705,0.020342031,0.0004308086,0.0009449067,0.4622341,0.008900665,0.01620209,0.0016449444,0.12713838],"study_design_scores_gemma":[0.022390615,0.18280883,0.2298895,0.00082583755,0.021272639,0.0011432128,0.00063027866,0.49351627,0.029015642,0.012728105,0.005431431,0.00034765925],"about_ca_topic_score_codex":0.0016989779,"about_ca_topic_score_gemma":0.0007225399,"teacher_disagreement_score":0.020563949,"about_ca_system_score_codex":0.0014098817,"about_ca_system_score_gemma":0.0010799571,"threshold_uncertainty_score":0.10875386},"labels":[],"label_agreement":null},{"id":"W1968405533","doi":"10.1016/s1098-3015(10)65607-0","title":"PPN12 TURKISH MCGILL PAIN QUESTIONNAIRE: RELIABILITY AND VALIDATION","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Turkish; McGill Pain Questionnaire; Reliability (semiconductor); Physical therapy; Psychology; Medicine; Philosophy; Physics","score_opus":0.037345918207389826,"score_gpt":0.3351686657688498,"score_spread":0.29782274756146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968405533","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97598505,0.0032720328,0.005298646,0.0006047445,0.00041223833,0.0010402233,0.003814114,0.0001381289,0.009434942],"genre_scores_gemma":[0.97906816,0.00096177746,0.008088682,0.00036163884,0.00016259585,0.0018897929,0.0047575017,0.000087473716,0.0046224194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934936,0.0017241589,0.0011217193,0.00048670478,0.002785103,0.00038878666],"domain_scores_gemma":[0.99097425,0.0026304743,0.0012870459,0.000569322,0.0042697303,0.00026920054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056910072,0.0008152587,0.0009280263,0.0014502655,0.0005850543,0.00068739767,0.0015084622,0.00095806725,0.0037363658],"category_scores_gemma":[0.018123066,0.00042201378,0.0015725731,0.0010376119,0.00062010216,0.0010045704,0.0015195617,0.0007175599,0.001346027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004964594,0.0008719954,0.8074333,0.0006692455,0.0010560335,0.00036495787,0.0014607214,0.0015291012,0.0046771085,0.00067390065,0.010432503,0.16586654],"study_design_scores_gemma":[0.00033374265,0.0010657014,0.9885005,0.00010214224,0.00020924993,0.00062450656,0.0003125344,0.001544788,0.0011948439,0.0002543262,0.005802947,0.000054684326],"about_ca_topic_score_codex":0.004933575,"about_ca_topic_score_gemma":0.0066288244,"teacher_disagreement_score":0.0056910072,"about_ca_system_score_codex":0.0011796183,"about_ca_system_score_gemma":0.001167901,"threshold_uncertainty_score":0.030097306},"labels":[],"label_agreement":null},{"id":"W1968800010","doi":"10.1016/s1098-3015(10)72458-x","title":"PHP78 UNDERSTANDING DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE COMMON DRUG REVIEW (CDR)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Business; Medicine; Pharmacology; Political science; Law; Health care","score_opus":0.1478424321879946,"score_gpt":0.33522112337367155,"score_spread":0.18737869118567696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968800010","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06891198,0.02216326,0.0071945065,0.46544975,0.0019320375,0.00047349394,0.03773636,0.000634915,0.3955037],"genre_scores_gemma":[0.74105674,0.015873339,0.018005729,0.039595645,0.0021057243,0.00019324399,0.009062046,0.00032338616,0.1737841],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.993401,0.0012515057,0.0002772816,0.0005031761,0.0031758612,0.0013911681],"domain_scores_gemma":[0.9702931,0.0099546015,0.001390914,0.0006797599,0.015759267,0.001922353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007182391,0.00050609244,0.0006755048,0.0035817048,0.002810792,0.009502744,0.0010079248,0.0040586167,0.015018021],"category_scores_gemma":[0.03851971,0.00048030497,0.0009800867,0.004583799,0.0016080567,0.00230954,0.0009407869,0.0024841453,0.0014590722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011183317,0.00005475738,0.013066591,0.00024088746,0.00011069093,0.00026162105,0.00056075514,0.010958043,0.00018612866,0.15124133,0.7734324,0.049774956],"study_design_scores_gemma":[0.00012445894,0.00006107927,0.055923857,0.00074626104,0.00022412057,0.00011959652,0.0015380059,0.030828599,0.0007084411,0.07720746,0.8323133,0.00020480106],"about_ca_topic_score_codex":0.9761752,"about_ca_topic_score_gemma":0.98481905,"teacher_disagreement_score":0.92571187,"about_ca_system_score_codex":0.07428811,"about_ca_system_score_gemma":0.13542427,"threshold_uncertainty_score":0.5390005},"labels":[],"label_agreement":null},{"id":"W1969110034","doi":"10.1016/j.jval.2011.02.962","title":"PCN108 CLINICAL EFFICACY AND ONCOLOGY REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE INTERIM JOINT ONCOLOGY DRUG REVIEW (IJODR)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); McMaster University","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Oncology; Reimbursement; Surrogate endpoint; Interim analysis; Clinical trial; Interim; Progression-free survival; Quality of life (healthcare); Cancer; Overall survival; Health care","score_opus":0.7149667211583635,"score_gpt":0.5177786426742309,"score_spread":0.19718807848413256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969110034","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011321485,0.23535979,0.0017316205,0.5453559,0.023823498,0.0020711753,0.04304791,0.0004433627,0.13684532],"genre_scores_gemma":[0.17035693,0.24594954,0.020714818,0.3145006,0.0138745885,0.0018607436,0.041562513,0.0006664599,0.19051382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9804441,0.0030010438,0.0019486352,0.00063660764,0.011606669,0.0023629959],"domain_scores_gemma":[0.93458885,0.0099887205,0.004154155,0.00079080457,0.04365491,0.0068225404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024347452,0.0009232936,0.0021676177,0.005886672,0.0020471546,0.007876942,0.0033423922,0.008746471,0.00796571],"category_scores_gemma":[0.049201205,0.0009781631,0.002373405,0.007957308,0.001621715,0.001113218,0.0010029944,0.0060478514,0.002070001],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003149636,0.00006931282,0.0022936687,0.00079380546,0.00014187969,0.0000743901,0.00006168515,0.0007042009,0.00013896826,0.004899443,0.9418601,0.048647594],"study_design_scores_gemma":[0.0009923048,0.0001825764,0.03693726,0.004523587,0.000936763,0.00014170642,0.00015379021,0.0012616726,0.00046795397,0.0018344077,0.9524206,0.00014742135],"about_ca_topic_score_codex":0.90921897,"about_ca_topic_score_gemma":0.9613018,"teacher_disagreement_score":0.94720525,"about_ca_system_score_codex":0.052794777,"about_ca_system_score_gemma":0.2528969,"threshold_uncertainty_score":0.38305473},"labels":[],"label_agreement":null},{"id":"W1969129739","doi":"10.1016/j.jval.2012.08.215","title":"PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Exploring Impacts of Herd Immunity and Patterns of Breastfeedingof","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Herd immunity; Breastfeeding; Vaccination; Medicine; Rotavirus; Immunization; Rotavirus vaccine; Environmental health; Diarrhea; Pediatrics; Immunology; Immune system","score_opus":0.15002575779478663,"score_gpt":0.3885499570710366,"score_spread":0.23852419927625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969129739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808383,0.00049807876,0.00008488644,0.00037098693,0.000009392358,0.000015042332,0.00035130198,0.0000019594377,0.00058452226],"genre_scores_gemma":[0.99940526,0.00016567233,0.00008038743,0.000030562216,0.000004659779,0.000008280173,0.0001326022,0.0000010472285,0.00017153098],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986475,0.0008406066,0.00006818007,0.0000813876,0.00009112346,0.00027121257],"domain_scores_gemma":[0.99703467,0.0015998913,0.0005683432,0.00008685133,0.00017008654,0.0005400903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020893249,0.00025642733,0.00036381872,0.00040636558,0.00028376322,0.00073338556,0.00048809714,0.00044997208,0.0020934278],"category_scores_gemma":[0.0068191797,0.0002173632,0.0012826865,0.00069204066,0.00027631538,0.00076515303,0.00050592655,0.0006699347,0.000068762085],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033739908,0.0010496927,0.9537745,0.00022389012,0.0014337571,0.00037004123,0.0003204412,0.009946166,0.00030344087,0.0007753395,0.0004734721,0.027955258],"study_design_scores_gemma":[0.00019554261,0.002453826,0.9736642,0.0001037073,0.00081634324,0.0002629901,0.0010887146,0.01992232,0.0002997778,0.0005073487,0.0006675485,0.000017685466],"about_ca_topic_score_codex":0.07694819,"about_ca_topic_score_gemma":0.058575142,"teacher_disagreement_score":0.07694819,"about_ca_system_score_codex":0.003200175,"about_ca_system_score_gemma":0.0031401,"threshold_uncertainty_score":0.1530006},"labels":[],"label_agreement":null},{"id":"W1969206447","doi":"10.1016/s1098-3015(10)61621-x","title":"RX4 PATTERNS OF USE OF COXIBS AND NON-SELECTIVE NSAIDS IN THE ELDERLY POPULATION OF QUEBEC (CANADA)","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Environmental health","score_opus":0.04631080743906615,"score_gpt":0.3135544990431718,"score_spread":0.26724369160410566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969206447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170566,0.0010017962,0.00006218038,0.00028697398,0.000008111601,0.000026615948,0.0048794467,0.0000113429205,0.0020179506],"genre_scores_gemma":[0.99559,0.0004956197,0.00013184693,0.00016082407,0.0000064307483,0.000015133712,0.0014665545,0.000005686519,0.0021279939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995301,0.00004819271,0.000056885598,0.00009016292,0.00011280064,0.00016188208],"domain_scores_gemma":[0.9984194,0.00009986972,0.00040461088,0.000037418304,0.0007069499,0.0003317246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038769597,0.0002679591,0.00039599004,0.0013906546,0.0014919797,0.0009291154,0.0008511259,0.0006592589,0.0042384164],"category_scores_gemma":[0.0013259174,0.00026937126,0.00074105524,0.003457635,0.00045384,0.00037620278,0.0005017808,0.0005631402,0.00038904083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010091464,0.000019669473,0.9961283,0.00002161689,0.00004935718,0.00008134085,0.00035208414,0.000054408072,0.00015834505,0.000055487948,0.0006607603,0.0023177366],"study_design_scores_gemma":[0.0000048063857,0.000031426785,0.99867755,0.000016127691,0.000018264456,0.000067739325,0.00058318954,0.000105343424,0.000024410936,0.0000067607243,0.0004582998,0.000005929013],"about_ca_topic_score_codex":0.98624367,"about_ca_topic_score_gemma":0.99000823,"teacher_disagreement_score":0.013756335,"about_ca_system_score_codex":0.010024552,"about_ca_system_score_gemma":0.008032169,"threshold_uncertainty_score":0.07273352},"labels":[],"label_agreement":null},{"id":"W1969317201","doi":"10.1016/j.jval.2013.03.674","title":"Incremental Cost Of Brain Metastases Among Patients With Metastatic Melanoma","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Brain metastasis; Emergency department; Melanoma; Retrospective cohort study; Metastatic melanoma; Internal medicine; Population; Metastasis; Emergency medicine; Pediatrics; Cancer","score_opus":0.03632281848010789,"score_gpt":0.24369294415924497,"score_spread":0.2073701256791371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969317201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002063,0.0017954484,0.00055777223,0.0025718072,0.000061642124,0.000013440665,0.0020193104,0.000013693071,0.0029463326],"genre_scores_gemma":[0.9987093,0.00034694836,0.000076918266,0.00004472411,0.000043965563,0.000003016611,0.00046248222,0.0000014561664,0.00031123334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996427,0.0001263229,0.000031634867,0.00003422809,0.00006452442,0.000100610785],"domain_scores_gemma":[0.9983125,0.0008535516,0.00039805612,0.000065979504,0.000112900074,0.00025700682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035087552,0.00025332344,0.0003187043,0.0005012519,0.0001967904,0.00080752093,0.00044445047,0.000745274,0.00425946],"category_scores_gemma":[0.0072037294,0.00019232667,0.0010206316,0.00058908976,0.00025433797,0.000749144,0.0004160576,0.001202047,0.00021475398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043633664,0.00056073075,0.88088447,0.00024603814,0.0013071954,0.0033857666,0.00012685121,0.0431431,0.0013602511,0.0088808695,0.003996342,0.051745],"study_design_scores_gemma":[0.00029682167,0.0011234124,0.90200454,0.000110143825,0.0013105831,0.008930478,0.0006514986,0.069020316,0.00075261464,0.013464997,0.0022751098,0.00005952062],"about_ca_topic_score_codex":0.016110431,"about_ca_topic_score_gemma":0.017354144,"teacher_disagreement_score":0.016110431,"about_ca_system_score_codex":0.001950785,"about_ca_system_score_gemma":0.0007667402,"threshold_uncertainty_score":0.032033265},"labels":[],"label_agreement":null},{"id":"W1969707302","doi":"10.1016/s1098-3015(10)61967-5","title":"PPN1 TOPIRAMATE FOR THE TREATMENT OF PERIPHERAL DIABETIC NEUROPATHY: CANADIAN CLINICAL EXPERIENCE","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Topiramate; Peripheral neuropathy; Medicine; Peripheral; Diabetic neuropathy; Diabetes mellitus; Internal medicine; Endocrinology; Psychiatry","score_opus":0.1567455549542584,"score_gpt":0.3745554657895177,"score_spread":0.2178099108352593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969707302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5682552,0.2520158,0.0032599561,0.031491593,0.0014275806,0.00080245716,0.0019645395,0.0001292708,0.14065364],"genre_scores_gemma":[0.7216313,0.24533159,0.0061598867,0.007043918,0.0010267638,0.00015702608,0.0016614724,0.00009579598,0.016892212],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995197,0.00009677905,0.000033722285,0.000055744014,0.00020295464,0.0000911207],"domain_scores_gemma":[0.9989604,0.0001507788,0.000066987624,0.000027745811,0.00048609995,0.00030799204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010807094,0.0007079341,0.00075494614,0.00054579374,0.0017176365,0.0009456758,0.0009310942,0.0008931651,0.0038747906],"category_scores_gemma":[0.0015243602,0.00017895833,0.00041558273,0.0017189354,0.000828147,0.00054356887,0.00038015135,0.0014177138,0.0004663008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009829931,0.003911546,0.024797723,0.001506873,0.0003853085,0.007855277,0.0025190674,0.0018101049,0.013976992,0.0050359606,0.06575459,0.8626166],"study_design_scores_gemma":[0.014128467,0.014561648,0.234832,0.0018468339,0.0015632717,0.027660936,0.002833823,0.0027731534,0.008715592,0.002328158,0.68834174,0.0004143459],"about_ca_topic_score_codex":0.5760712,"about_ca_topic_score_gemma":0.76577306,"teacher_disagreement_score":0.4239288,"about_ca_system_score_codex":0.006771399,"about_ca_system_score_gemma":0.013055668,"threshold_uncertainty_score":0.8528508},"labels":[],"label_agreement":null},{"id":"W1969916397","doi":"10.1016/j.jval.2013.03.211","title":"Examination of patient preferences: subgroup comparisons of time trade-off and standard gamble results","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Rank correlation; Correlation; Post hoc; Medicine; Spearman's rank correlation coefficient; Demography; Post-hoc analysis; Positive correlation; Statistics; Internal medicine; Mathematics","score_opus":0.07920540595452429,"score_gpt":0.27737406434152034,"score_spread":0.19816865838699604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969916397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99761117,0.00021284171,0.0008963275,0.0001263723,0.000014143519,0.00002115227,0.0005456023,0.000011187741,0.0005611667],"genre_scores_gemma":[0.9992316,0.000026316437,0.00017845992,0.00003477217,0.0000072388357,0.000013783719,0.00029128598,0.0000073811025,0.00020903411],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956536,0.002986032,0.0003141218,0.000449051,0.00030869228,0.00028841058],"domain_scores_gemma":[0.9733147,0.019699693,0.002036102,0.0037094164,0.00057489204,0.00066522346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009100083,0.00051942986,0.0015222048,0.0008815398,0.00027737013,0.0009687186,0.0007963011,0.0008257968,0.007068285],"category_scores_gemma":[0.03110278,0.00019992061,0.0037402997,0.0007695716,0.00040700822,0.0013572767,0.00089555845,0.0011763138,0.0003823207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13748688,0.0020069857,0.738735,0.000468509,0.035009634,0.0008928396,0.0026301194,0.0058488306,0.0063648256,0.004017183,0.0040483195,0.062490903],"study_design_scores_gemma":[0.0023146265,0.016702399,0.92307526,0.00007373116,0.012237241,0.0012703271,0.0055804043,0.019644085,0.0027184454,0.0140680885,0.0021711371,0.00014423695],"about_ca_topic_score_codex":0.0011370633,"about_ca_topic_score_gemma":0.00093367894,"teacher_disagreement_score":0.009100083,"about_ca_system_score_codex":0.00025606013,"about_ca_system_score_gemma":0.00039902248,"threshold_uncertainty_score":0.0481264},"labels":[],"label_agreement":null},{"id":"W1970090444","doi":"10.1016/s1098-3015(10)75265-7","title":"PSS28 COST-EFFECTIVENESS OF USTEKINUMAB VERSUS ETANERCEPT IN SEVERE PLAQUE PSORIASIS PATIENTS: A CANADIAN PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Etanercept; Plaque psoriasis; Medicine; Dermatology; Perspective (graphical); Psoriasis; Internal medicine; Adalimumab; Tumor necrosis factor alpha; Computer science; Artificial intelligence","score_opus":0.30958894698844674,"score_gpt":0.4208621471682949,"score_spread":0.11127320017984815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970090444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6361859,0.16045414,0.0017064145,0.0738502,0.00078436325,0.00053931423,0.017184226,0.000059864517,0.10923563],"genre_scores_gemma":[0.97881716,0.01404868,0.0010614465,0.0016497151,0.00017866232,0.000044331053,0.0015939458,0.000015349386,0.0025907503],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968079,0.0012011183,0.00019113746,0.00014855352,0.0009824684,0.0006687835],"domain_scores_gemma":[0.996606,0.0011180701,0.00029934448,0.000039682862,0.0012013424,0.0007355118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003193606,0.0008185858,0.0018527481,0.0015401931,0.0016303918,0.0033937567,0.0011918162,0.0013943599,0.0071453936],"category_scores_gemma":[0.009864106,0.00044553087,0.0031909128,0.0032159125,0.0008687335,0.0007102936,0.00063678477,0.0023726511,0.00019867177],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09375462,0.001764319,0.1734291,0.008493164,0.019470189,0.0022655816,0.0016364394,0.14919469,0.0043976847,0.06503486,0.076678805,0.4038806],"study_design_scores_gemma":[0.027804304,0.005677124,0.6972781,0.006173468,0.035737112,0.0019177385,0.0055188746,0.11596777,0.002286932,0.024896974,0.07556856,0.0011730589],"about_ca_topic_score_codex":0.9529176,"about_ca_topic_score_gemma":0.970509,"teacher_disagreement_score":0.061090063,"about_ca_system_score_codex":0.061090063,"about_ca_system_score_gemma":0.059151176,"threshold_uncertainty_score":0.44324154},"labels":[],"label_agreement":null},{"id":"W1970310544","doi":"10.1016/s1098-3015(10)61081-9","title":"PMH15 PREVALENCE AND COSTS OF TREATMENT-RESISTANT DEPRESSION IN A CANADIAN CLAIMS DATABASE","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depression (economics); Treatment-resistant depression; Database; Medicine; Business; Psychiatry; Computer science; Economics; Major depressive disorder","score_opus":0.18937100839147772,"score_gpt":0.40805489499402336,"score_spread":0.21868388660254565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970310544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8883417,0.0020332031,0.00029864212,0.0014371151,0.00003840319,0.00011242892,0.10375591,0.00006543776,0.00391703],"genre_scores_gemma":[0.97518945,0.00095197925,0.0005791412,0.00017145376,0.000020184752,0.000047498655,0.021974029,0.000010534243,0.0010556525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997789,0.00022887714,0.00025483465,0.0003297346,0.0009597275,0.0004378313],"domain_scores_gemma":[0.99363387,0.0013375867,0.0018110339,0.0004630661,0.0020621275,0.00069241825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016804121,0.00048927055,0.00093806814,0.0036863133,0.0017026666,0.0017590984,0.0031600178,0.0011592419,0.0046326546],"category_scores_gemma":[0.014771592,0.0006768384,0.0017256481,0.0076554604,0.00068078074,0.00061673904,0.0009171553,0.0012989319,0.00028446532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047187085,0.0000938459,0.9789956,0.00014618336,0.0005394333,0.00015806718,0.00019814198,0.0016397106,0.000095590854,0.001259784,0.010126686,0.006275031],"study_design_scores_gemma":[0.00007052469,0.000018255409,0.9937557,0.000053392345,0.00019442764,0.00013921685,0.00022717415,0.0038692618,0.000049919436,0.00019284562,0.0014012028,0.000027989185],"about_ca_topic_score_codex":0.99355763,"about_ca_topic_score_gemma":0.99210656,"teacher_disagreement_score":0.030729808,"about_ca_system_score_codex":0.030729808,"about_ca_system_score_gemma":0.030771112,"threshold_uncertainty_score":0.22296143},"labels":[],"label_agreement":null},{"id":"W1970411568","doi":"10.1016/s1098-3015(10)72921-1","title":"PIN14 REDUCTION OF ACUTE OTITIS MEDIA IN CHILDREN: A COST-CONSEQUENCE ANALYSIS OF A 7-, 10-AND 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute otitis media; Pneumococcal conjugate vaccine; Conjugate; Reduction (mathematics); Medicine; Otitis; Conjugate vaccine; Pediatrics; Streptococcus pneumoniae; Microbiology; Immunology; Mathematics; Surgery; Biology; Immunization","score_opus":0.014390081505446545,"score_gpt":0.2774793763016168,"score_spread":0.26308929479617027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970411568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866735,0.0042027575,0.00027515544,0.0010353934,0.000043901266,0.0003128198,0.0050677103,0.000021882988,0.00236686],"genre_scores_gemma":[0.9956382,0.0018298549,0.00030798028,0.00022595777,0.000014350394,0.00004061583,0.001245722,0.000005719897,0.00069169886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968267,0.0006287712,0.00015600657,0.00018491149,0.0011424384,0.0010610935],"domain_scores_gemma":[0.9976768,0.00046522747,0.00040591214,0.00004916732,0.0008279809,0.00057485135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016743715,0.0008495742,0.0016268232,0.0010753071,0.00085800164,0.0014681498,0.001491638,0.0009280209,0.0018457341],"category_scores_gemma":[0.004429547,0.0004807184,0.0034840268,0.0027470747,0.00079162396,0.0004293695,0.0007163757,0.0013495403,0.00008949089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057485458,0.0018925657,0.7581022,0.003380237,0.010102549,0.002495508,0.00060695055,0.076937854,0.0027706758,0.0024749215,0.0067300173,0.077021234],"study_design_scores_gemma":[0.003024608,0.006265078,0.9612562,0.00025357355,0.005457374,0.00045038667,0.0009325765,0.018149426,0.0009558357,0.00031031735,0.0028597552,0.00008494688],"about_ca_topic_score_codex":0.9709834,"about_ca_topic_score_gemma":0.9720029,"teacher_disagreement_score":0.054237153,"about_ca_system_score_codex":0.054237153,"about_ca_system_score_gemma":0.05806722,"threshold_uncertainty_score":0.39351994},"labels":[],"label_agreement":null},{"id":"W1970724291","doi":"10.1046/j.1524-4733.2001.40202-274.x","title":"PHP14: COST ANALYSIS OF PHARMACEUTICAL SERVICES IN A TEACHING INSTITUTION","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Institution; Business; Computer science; Sociology; Social science","score_opus":0.165586853516898,"score_gpt":0.47971218228590284,"score_spread":0.31412532876900484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970724291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821254,0.00015707943,0.0022477307,0.0004047924,0.000018459148,0.00012536967,0.008984649,0.00010831458,0.0058281766],"genre_scores_gemma":[0.9882377,0.0000744063,0.003823975,0.000032030362,0.00001796545,0.00007518136,0.0047083315,0.000035889756,0.0029947076],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99900454,0.0003338247,0.000052872456,0.000083312465,0.0002871695,0.000238377],"domain_scores_gemma":[0.99695945,0.0017472293,0.0002475672,0.00014596677,0.00065116823,0.00024864712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009729535,0.00052962836,0.00053136,0.0023034622,0.00056706724,0.00096756336,0.0011577532,0.0008966291,0.008470052],"category_scores_gemma":[0.005664287,0.00039240802,0.00092499616,0.0032831875,0.0003007422,0.0009862233,0.0008698169,0.0007542454,0.00059053814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034048567,0.0015786196,0.2982906,0.0004508283,0.0005522326,0.0011037929,0.00021263819,0.56296957,0.0020525092,0.008979837,0.023087488,0.09731702],"study_design_scores_gemma":[0.0002896726,0.0012853936,0.419523,0.000042173655,0.00019353977,0.00056528446,0.0010408452,0.56685036,0.0031420435,0.0024377485,0.00455172,0.00007814249],"about_ca_topic_score_codex":0.10559138,"about_ca_topic_score_gemma":0.06590682,"teacher_disagreement_score":0.10559138,"about_ca_system_score_codex":0.00478499,"about_ca_system_score_gemma":0.0028617503,"threshold_uncertainty_score":0.20995355},"labels":[],"label_agreement":null},{"id":"W1970946065","doi":"10.1016/j.jval.2012.03.044","title":"DR3 Establishment of an Innovative Collaborative Between the Drug Safety and Effectiveness Network in Canada and ISPOR for Application and Development of Network Meta-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Knowledge translation; General partnership; Systematic review; Collaborative network; Best practice; Knowledge management; Medicine; Management science; Medical education; Process management; Computer science; Engineering; Business; MEDLINE; Political science","score_opus":0.47159501745563465,"score_gpt":0.4677137395965703,"score_spread":0.003881277859064336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970946065","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027514925,0.01148031,0.48477805,0.3155803,0.01673206,0.057338737,0.024234194,0.008730228,0.05361116],"genre_scores_gemma":[0.096279055,0.0023758013,0.8184483,0.02854295,0.0032743532,0.012833108,0.0071216393,0.002288275,0.028836451],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.78860325,0.11476712,0.015668346,0.012168142,0.06112292,0.007670118],"domain_scores_gemma":[0.32784608,0.18310052,0.02239713,0.05417281,0.35416147,0.05832196],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.31068745,0.0018367087,0.0023965894,0.012747563,0.0043409886,0.007681175,0.007439083,0.0046227113,0.027670093],"category_scores_gemma":[0.42142683,0.0017947954,0.003664567,0.006970991,0.0018701695,0.0048286077,0.010588277,0.007465143,0.005000462],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053978665,0.0018420911,0.0406198,0.0029197596,0.0028350984,0.000790414,0.0022161514,0.008343318,0.0064031137,0.03066625,0.40737137,0.49059469],"study_design_scores_gemma":[0.0073437514,0.0019482633,0.061104234,0.003575234,0.0029242083,0.00078703737,0.0011669095,0.050422393,0.016042706,0.021332346,0.8328095,0.00054341165],"about_ca_topic_score_codex":0.36799872,"about_ca_topic_score_gemma":0.5085205,"teacher_disagreement_score":0.9700606,"about_ca_system_score_codex":0.029939417,"about_ca_system_score_gemma":0.27193198,"threshold_uncertainty_score":0.8500451},"labels":[],"label_agreement":null},{"id":"W1971335991","doi":"10.1016/j.jval.2013.03.112","title":"Why are the findings of cost-effectiveness analyses of biologic treatment for rheumatoid arthritis so different?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Cost effectiveness; Rheumatoid arthritis; Cost–benefit analysis; Confidence interval; Intensive care medicine; Actuarial science; Risk analysis (engineering); Internal medicine; Economics","score_opus":0.5440513385772044,"score_gpt":0.462304561334613,"score_spread":0.08174677724259144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971335991","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04432348,0.47109997,0.006505793,0.44321328,0.014449705,0.0002204364,0.003415907,0.00008913353,0.016682299],"genre_scores_gemma":[0.5380849,0.102773406,0.010458185,0.31682068,0.026892,0.0003594288,0.0025470126,0.00036958634,0.0016947713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8981345,0.064729966,0.011408196,0.0058261473,0.017356263,0.002544873],"domain_scores_gemma":[0.40961733,0.5301405,0.019427733,0.013480216,0.02429276,0.0030414762],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.160786,0.0016879297,0.0057331165,0.005586337,0.000760066,0.0073485738,0.005184413,0.0075502773,0.006285052],"category_scores_gemma":[0.43273082,0.0011603395,0.01115671,0.0052619525,0.00728888,0.010060244,0.0029480571,0.011215535,0.0010749041],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018498199,0.0011259274,0.06513607,0.041727163,0.10910322,0.0007195817,0.0024466543,0.008372529,0.0023344925,0.112713724,0.17767152,0.46015102],"study_design_scores_gemma":[0.0125532495,0.0030855332,0.16871068,0.040092856,0.09834608,0.001215974,0.006417163,0.0049856,0.004761421,0.4823989,0.1765438,0.0008887717],"about_ca_topic_score_codex":0.010660282,"about_ca_topic_score_gemma":0.008480804,"teacher_disagreement_score":0.83921397,"about_ca_system_score_codex":0.0049822787,"about_ca_system_score_gemma":0.0039368784,"threshold_uncertainty_score":0.85032785},"labels":[],"label_agreement":null},{"id":"W1971405938","doi":"10.1016/j.jval.2012.03.891","title":"PRM35 Empirical Examination of Starting Point Bias with the Bidding Game in a Willingness-to-Pay Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Consumer Market Behavior and Pricing","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Bidding; Willingness to pay; Actuarial science; Preference; Population; Medicine; Economics; Environmental health; Microeconomics","score_opus":0.09765982867390809,"score_gpt":0.3187534071860312,"score_spread":0.22109357851212308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971405938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549901,0.00035946304,0.027009534,0.0015980455,0.000060671307,0.00020055597,0.00043264622,0.000100837606,0.015248192],"genre_scores_gemma":[0.99501306,0.000041287643,0.0020906618,0.00014121215,0.000032701206,0.000025378476,0.0001603908,0.000023896118,0.0024712998],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98832905,0.008065114,0.0005012083,0.0010378173,0.0013819352,0.00068492815],"domain_scores_gemma":[0.67739385,0.28502533,0.015614008,0.013933113,0.0059054745,0.002128269],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029674271,0.00045639073,0.0010300478,0.0012251915,0.00084204314,0.0029165389,0.002972434,0.0019737752,0.013632853],"category_scores_gemma":[0.13077483,0.0004769655,0.0020316888,0.0013410547,0.0021005375,0.0030042885,0.0015292931,0.00463795,0.0012425398],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029145954,0.002539001,0.72905946,0.00042516223,0.0014744329,0.00073550345,0.0033821056,0.025957393,0.0024870383,0.14639671,0.0075607686,0.07706782],"study_design_scores_gemma":[0.00063868385,0.003135583,0.53659165,0.00017629599,0.0017145083,0.0009321682,0.0064892797,0.34055418,0.0034359845,0.098118335,0.008000721,0.00021264219],"about_ca_topic_score_codex":0.008585587,"about_ca_topic_score_gemma":0.005688746,"teacher_disagreement_score":0.9703257,"about_ca_system_score_codex":0.0010081524,"about_ca_system_score_gemma":0.00129591,"threshold_uncertainty_score":0.15693444},"labels":[],"label_agreement":null},{"id":"W1972092694","doi":"10.1016/s1098-3015(10)65093-0","title":"PMH43 POTENTIAL DRUG-DRUG INTERACTIONS WITH RISPERIDONE AND THE RISK OF DISCONTINUATION: A RETROSPECTIVE ANALYSIS OF PATIENTS IN QUEBEC, CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Risperidone; Drug; Medicine; Retrospective cohort study; Pharmacology; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.015473192956747525,"score_gpt":0.3206852237765723,"score_spread":0.3052120308198248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972092694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992292,0.0016492002,0.0001651535,0.0003038675,0.000014874066,0.000059253747,0.0033562828,0.000015552534,0.0021439432],"genre_scores_gemma":[0.99793494,0.000397586,0.00011799479,0.00017726111,0.000011721815,0.000016014199,0.0008084089,0.00000703389,0.0005290016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846774,0.00019930395,0.00015871388,0.00025997136,0.000497011,0.00041719823],"domain_scores_gemma":[0.99516064,0.0005086625,0.0017191657,0.00021995754,0.0016205363,0.00077098416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007366272,0.00046986804,0.00081370026,0.0013487822,0.002621072,0.0014446224,0.0015454685,0.00086965197,0.002066406],"category_scores_gemma":[0.003082474,0.0005322655,0.00097024045,0.0048982813,0.00075594604,0.00044835533,0.0005494687,0.0011221087,0.00022556448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006959424,0.000019273537,0.99809045,0.000012669934,0.000067897614,0.00011208888,0.0001281918,0.000049014772,0.00008658098,0.000028768281,0.0003132176,0.0010223538],"study_design_scores_gemma":[0.0000111814425,0.000032593132,0.9988502,0.00001550793,0.000049667702,0.00013795243,0.00023760328,0.00020395475,0.0000373556,0.000008250948,0.00040771795,0.000008000114],"about_ca_topic_score_codex":0.97489244,"about_ca_topic_score_gemma":0.9802151,"teacher_disagreement_score":0.025107563,"about_ca_system_score_codex":0.017343389,"about_ca_system_score_gemma":0.014161377,"threshold_uncertainty_score":0.12583566},"labels":[],"label_agreement":null},{"id":"W1972734786","doi":"10.1016/j.jval.2011.02.751","title":"PMS68 ANALYSIS OF INFLIXIMAB DOSE CHANGES OVER TIME IN MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dosing; Infliximab; Rheumatoid arthritis; Medicaid; Quarter (Canadian coin); Internal medicine; Disease","score_opus":0.030209241115813586,"score_gpt":0.2812213840236658,"score_spread":0.25101214290785223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972734786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978142,0.0005817753,0.000055964763,0.00007153737,0.0000066417697,0.0000063679313,0.001083073,0.000003257798,0.00037715706],"genre_scores_gemma":[0.99832743,0.0001346368,0.000066941604,0.000033866392,0.000019104025,0.00001002976,0.0010866374,0.0000017019001,0.00031967286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992632,0.0002680174,0.000084146384,0.00011661975,0.0001741458,0.00009386124],"domain_scores_gemma":[0.99739754,0.00083684176,0.0013038018,0.00011031278,0.00016724253,0.00018418676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077860634,0.00019812223,0.00048747688,0.00097196683,0.00016527082,0.00044047213,0.00027888105,0.00042615688,0.0018457166],"category_scores_gemma":[0.0042853667,0.0001891699,0.0010790814,0.0011136747,0.00011929515,0.0003631922,0.00035219526,0.0003922567,0.00024687083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055647963,0.00006233592,0.98327786,0.000053650485,0.0005953986,0.00008930929,0.000042841955,0.00030403738,0.00062469137,0.00004861231,0.00038413296,0.008952334],"study_design_scores_gemma":[0.00008013254,0.00044425388,0.9981744,0.0000086716045,0.00016128506,0.00012836896,0.000047737154,0.00046162854,0.0001018545,0.000019805879,0.00036838232,0.000003470993],"about_ca_topic_score_codex":0.006332416,"about_ca_topic_score_gemma":0.005262477,"teacher_disagreement_score":0.006332416,"about_ca_system_score_codex":0.00039577132,"about_ca_system_score_gemma":0.00032314152,"threshold_uncertainty_score":0.012591124},"labels":[],"label_agreement":null},{"id":"W1972895961","doi":"10.1111/j.1524-4733.2010.00749.x","title":"Contemporary Challenges in Deriving Summary Estimates of Comparative Effectiveness Using Meta-Analysis","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Technology Assessment and Management","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Meta-analysis; Econometrics; Data science; Computer science; Economics; Medicine; Internal medicine","score_opus":0.2589534241723927,"score_gpt":0.37356113978385524,"score_spread":0.11460771561146255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972895961","genre_codex":"review","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008817562,0.46959713,0.45006832,0.056261677,0.0047939685,0.0012655063,0.002235841,0.001087517,0.0058724633],"genre_scores_gemma":[0.28849253,0.11576516,0.5552574,0.023900334,0.007239034,0.00546884,0.0015396676,0.0012975513,0.0010395037],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.28365722,0.621308,0.054950584,0.012095017,0.027206117,0.00078308786],"domain_scores_gemma":[0.05505667,0.9173186,0.007424716,0.012228702,0.007456793,0.0005145413],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.59304124,0.00444447,0.021502825,0.016503733,0.001876398,0.0169911,0.012543905,0.006649552,0.0039468575],"category_scores_gemma":[0.8812083,0.0034347742,0.016528215,0.017594034,0.009546022,0.01334601,0.00884144,0.0131184375,0.00095472345],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001962899,0.00020698097,0.015428735,0.07362185,0.16838397,0.0005567814,0.0031900837,0.02184865,0.00044866116,0.06432482,0.022753712,0.6272729],"study_design_scores_gemma":[0.002483669,0.0014078084,0.015141093,0.047750358,0.08222512,0.0021486648,0.002953958,0.030469434,0.0016465455,0.75225717,0.060730763,0.00078544155],"about_ca_topic_score_codex":0.0072957086,"about_ca_topic_score_gemma":0.007659468,"teacher_disagreement_score":0.40695876,"about_ca_system_score_codex":0.005006359,"about_ca_system_score_gemma":0.008088358,"threshold_uncertainty_score":0.50185263},"labels":[],"label_agreement":null},{"id":"W1972926194","doi":"10.1016/s1098-3015(10)74749-5","title":"PMH30 A DYNAMIC MARKOV APPROACH ASSESSING THE BURDEN OF ILLNESS OF GENERALIZED ANXIETY (GAD) DISORDER IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalized anxiety disorder; Psychiatry; Anxiety; Markov chain; Psychology; Computer science; Machine learning","score_opus":0.031004992854886625,"score_gpt":0.32127003824042577,"score_spread":0.29026504538553916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972926194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97456926,0.00039715442,0.011801012,0.0017255369,0.000041050203,0.00016824387,0.0077335853,0.000097489436,0.0034667423],"genre_scores_gemma":[0.99323857,0.00016310302,0.0034756225,0.0000638555,0.000012944409,0.000053057953,0.0017080634,0.000009214324,0.0012755658],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992592,0.00027428294,0.000023441597,0.00012670002,0.000102204,0.00021420581],"domain_scores_gemma":[0.99675924,0.0018878237,0.00021604473,0.000104897,0.00065591704,0.00037618622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017076838,0.00043427476,0.0008661973,0.0012624268,0.0012093063,0.0010463792,0.0014693205,0.00067122665,0.0043206126],"category_scores_gemma":[0.008305926,0.00044047774,0.0008498159,0.0015253577,0.0005468633,0.00054914353,0.0007191097,0.0008037075,0.00013663956],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094549725,0.00027179677,0.30455133,0.00011324632,0.0005581212,0.0003283642,0.00032588918,0.64582896,0.0003211219,0.0142790405,0.0075259395,0.024950664],"study_design_scores_gemma":[0.000066166955,0.000063576335,0.06035907,0.000025254092,0.00005054406,0.000044861197,0.00029642013,0.93451715,0.000057821813,0.0037006678,0.0007869426,0.00003154947],"about_ca_topic_score_codex":0.9747907,"about_ca_topic_score_gemma":0.9663511,"teacher_disagreement_score":0.025209308,"about_ca_system_score_codex":0.016143244,"about_ca_system_score_gemma":0.01854506,"threshold_uncertainty_score":0.117128015},"labels":[],"label_agreement":null},{"id":"W1972980211","doi":"10.1046/j.1524-4733.2001.40202-297.x","title":"PMA3: DOES WHERE YOU LIVE AFFECT IF AND HOW YOU DISCOUNT FUTURE COSTS AND BENEFITS IN ECONOMIC EVALUATION? SHOULD IT?","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Affect (linguistics); Economics; Public economics; Business; Psychology","score_opus":0.2715108484049103,"score_gpt":0.4127739445030147,"score_spread":0.1412630960981044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972980211","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029490467,0.005166902,0.022040227,0.59843004,0.005362823,0.000212663,0.011350715,0.0007179423,0.32722825],"genre_scores_gemma":[0.7567055,0.00461472,0.026858024,0.05042966,0.007389233,0.0008992812,0.0056357966,0.00121753,0.14625017],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9970049,0.0016654466,0.00021361397,0.00022729722,0.00068528985,0.00020342018],"domain_scores_gemma":[0.9709899,0.01881326,0.001778909,0.0009890436,0.006204229,0.0012246404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009951812,0.0004226237,0.0004743661,0.0007230038,0.0012464504,0.004699425,0.00073455926,0.003155071,0.06045755],"category_scores_gemma":[0.08831349,0.00030126306,0.00060403347,0.0012369504,0.0015876096,0.0053203776,0.0019694918,0.0041197,0.010843992],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007572576,0.00008702796,0.014738884,0.000672737,0.000061244435,0.00016263229,0.0017775873,0.0005525779,0.00035550472,0.086940356,0.72926694,0.16462734],"study_design_scores_gemma":[0.00019727764,0.00013517405,0.058616832,0.0020942988,0.00019276651,0.00057726016,0.0029016456,0.0042605577,0.0017418751,0.29219773,0.63693345,0.00015109035],"about_ca_topic_score_codex":0.0069504497,"about_ca_topic_score_gemma":0.01015954,"teacher_disagreement_score":0.06045755,"about_ca_system_score_codex":0.0024127823,"about_ca_system_score_gemma":0.0025040146,"threshold_uncertainty_score":0.20225066},"labels":[],"label_agreement":null},{"id":"W1972985601","doi":"10.1016/s1098-3015(10)74825-7","title":"PND31 HEALTH UTILITY SCORES ASSOCIATED WITH A HYPOTHETICAL MODERATE ALZHEIMER'S DISEASE HEALTH STATE: A CANADIAN SURVEY OF THE GENERAL PUBLIC","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health Policies and Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Public health; Gerontology; State (computer science); Medicine; Alzheimer's disease; Psychology; Psychiatry; Computer science; Pathology","score_opus":0.2160236708222191,"score_gpt":0.4403588013999428,"score_spread":0.22433513057772372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972985601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782033,0.00023164038,0.00008549755,0.00039780687,0.000010426755,0.00010460314,0.013766522,0.000013169684,0.007187079],"genre_scores_gemma":[0.9935296,0.0002288222,0.00015319149,0.0000767543,0.0000048042225,0.00003107887,0.0045478377,0.0000029820337,0.001424773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878496,0.00013083182,0.000099046796,0.00010417977,0.0005033183,0.00037768876],"domain_scores_gemma":[0.9961534,0.00036042463,0.00083268754,0.00011468277,0.001494326,0.0010444033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010777259,0.0003629866,0.0003610644,0.0023273162,0.0014700489,0.0010679979,0.0013231031,0.0007232074,0.0046011214],"category_scores_gemma":[0.006134855,0.00034020012,0.0012395751,0.0042409105,0.000777987,0.0005162425,0.0012351966,0.0012162136,0.00043153547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007376206,0.000057118887,0.9960905,0.000015430343,0.000028147588,0.000026528647,0.0002789196,0.00014099844,0.000026215153,0.00013306795,0.001248044,0.0018812624],"study_design_scores_gemma":[0.0000063693255,0.000020467312,0.9987143,0.000009214789,0.000010972688,0.000020485862,0.00044065504,0.00025477025,0.000010690626,0.0000321228,0.00047317217,0.000006932192],"about_ca_topic_score_codex":0.9870956,"about_ca_topic_score_gemma":0.98877877,"teacher_disagreement_score":0.016741445,"about_ca_system_score_codex":0.016741445,"about_ca_system_score_gemma":0.013236399,"threshold_uncertainty_score":0.121468246},"labels":[],"label_agreement":null},{"id":"W1973090847","doi":"10.1016/j.jval.2012.06.011","title":"Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Western University; Public Health Ontario; University of Toronto","funders":"","keywords":"Task force; Transmission (telecommunications); Set (abstract data type); Task (project management); Computer science; Population; Intervention (counseling); Disease transmission; Management science; Medicine; Risk analysis (engineering); Engineering; Environmental health; Virology; Political science; Systems engineering; Telecommunications","score_opus":0.6358651762576123,"score_gpt":0.5585132473413879,"score_spread":0.07735192891622444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973090847","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020262584,0.016560547,0.7481015,0.12371923,0.0027293402,0.003871074,0.028092641,0.0028870318,0.05377612],"genre_scores_gemma":[0.09164085,0.027221657,0.812677,0.0074452627,0.0018798541,0.0052035577,0.035275456,0.0026924536,0.015963856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.949193,0.03058544,0.002703242,0.0016376332,0.014624595,0.0012560518],"domain_scores_gemma":[0.8281631,0.08506314,0.009756744,0.018297778,0.05450789,0.0042113713],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15260038,0.0025127982,0.002661295,0.0050387545,0.0020434258,0.0059685754,0.00867173,0.004280273,0.007950512],"category_scores_gemma":[0.17515233,0.0026306591,0.004368554,0.005936731,0.0012831185,0.004950226,0.006881349,0.0064284527,0.0032486569],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005458171,0.00085865514,0.023985801,0.0029000724,0.0009777468,0.00023252942,0.0012400162,0.10766018,0.0019752197,0.10302514,0.3802916,0.37630725],"study_design_scores_gemma":[0.00057011546,0.00046576178,0.01710287,0.011926219,0.0016473797,0.00030907113,0.001273343,0.25358772,0.009696937,0.12939882,0.5735745,0.00044726476],"about_ca_topic_score_codex":0.08179389,"about_ca_topic_score_gemma":0.08853898,"teacher_disagreement_score":0.8473996,"about_ca_system_score_codex":0.007233839,"about_ca_system_score_gemma":0.040762592,"threshold_uncertainty_score":0.8070376},"labels":[],"label_agreement":null},{"id":"W1973146203","doi":"10.1016/j.jval.2012.03.410","title":"PSU7 Economic Burden of Obesity and the Impact of Bariatric Surgery on Health Care Costs and Utilization","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Underweight; Obesity; Overweight; Health care; Psychological intervention; Emergency medicine; Inpatient care; Environmental health; Internal medicine; Nursing","score_opus":0.054130828405876935,"score_gpt":0.33751195300593373,"score_spread":0.2833811246000568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973146203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85863674,0.012777394,0.00052025524,0.028376348,0.00047790117,0.00004773794,0.01719611,0.000029259032,0.081938244],"genre_scores_gemma":[0.98777467,0.003491457,0.0002260801,0.0004432339,0.0003380436,0.000019085435,0.0043321527,0.0000091871025,0.0033661867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994375,0.00022152055,0.000030384295,0.000019728493,0.00018431881,0.00010648415],"domain_scores_gemma":[0.9978096,0.0007051695,0.00059447944,0.00005145686,0.00044071625,0.00039862734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005229127,0.00013046552,0.00020024895,0.001574062,0.00031813298,0.0012588941,0.00019544161,0.00035494356,0.012667091],"category_scores_gemma":[0.0058025927,0.00012205861,0.000502161,0.002513617,0.0002829201,0.0005383857,0.0006233972,0.0006429299,0.0006404793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056633493,0.00018550034,0.86542886,0.00019667811,0.00046120575,0.0003202555,0.000167997,0.0019940769,0.00016019122,0.012752639,0.046999067,0.07076724],"study_design_scores_gemma":[0.000028073891,0.00006539288,0.97716534,0.0001447808,0.00011519442,0.00022070162,0.00048933265,0.0023008299,0.00011568212,0.004761028,0.014580179,0.000013358728],"about_ca_topic_score_codex":0.025938755,"about_ca_topic_score_gemma":0.029411903,"teacher_disagreement_score":0.025938755,"about_ca_system_score_codex":0.0015783033,"about_ca_system_score_gemma":0.0017306347,"threshold_uncertainty_score":0.05157554},"labels":[],"label_agreement":null},{"id":"W1973412039","doi":"10.1016/s1098-3015(11)72233-1","title":"PRS1 RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS IN SPECIAL POPULATIONS","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Respiratory system; Medicine; Virology; Virus; Internal medicine","score_opus":0.13285530061458942,"score_gpt":0.3847665239487345,"score_spread":0.25191122333414506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973412039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309534,0.0021439474,0.000047360005,0.0011388124,0.000036954847,0.000011601188,0.0003058432,0.000001985816,0.0032181838],"genre_scores_gemma":[0.999042,0.0005782283,0.000026277441,0.00008043366,0.000042789918,0.000004327233,0.00009355291,6.0884867e-7,0.00013183654],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989832,0.0005691583,0.000086061635,0.000072087154,0.00012895526,0.00016046723],"domain_scores_gemma":[0.9962572,0.0014126715,0.0012268184,0.00015233264,0.00025892942,0.00069210946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080304104,0.000120379125,0.00022205719,0.0010478527,0.00040429065,0.00043619028,0.00015909187,0.00030561193,0.0022247436],"category_scores_gemma":[0.006891726,0.00007273147,0.00019142308,0.0015567087,0.00034536232,0.00039047038,0.00039930386,0.0005141701,0.00014693537],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020268132,0.00010763092,0.97652406,0.000077352604,0.0000321989,0.00015094754,0.00021712537,0.00003752318,0.00020223703,0.00024891552,0.00074605324,0.02145327],"study_design_scores_gemma":[0.000013248898,0.00031790748,0.9972248,0.00005442346,0.000027014763,0.00036884667,0.00069444854,0.00006851347,0.00014103374,0.00019430774,0.000893237,0.0000022375648],"about_ca_topic_score_codex":0.0056046657,"about_ca_topic_score_gemma":0.0062554204,"teacher_disagreement_score":0.0056046657,"about_ca_system_score_codex":0.0004932045,"about_ca_system_score_gemma":0.0007785507,"threshold_uncertainty_score":0.011144042},"labels":[],"label_agreement":null},{"id":"W1973753171","doi":"10.1016/j.jval.2011.08.525","title":"PND59 A Common Road Map for Rational Clinical and Policy Decisionmaking: Application of the MCDA-Based Evidem Framework to Growth Hormone Use in Patients with Prader-Willi Syndrome","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Context (archaeology); Stakeholder; Population; Medicine; Scientific evidence; Psychology; Operations research; Political science; Geography; Public relations; Environmental health; Engineering","score_opus":0.05530843422811118,"score_gpt":0.33005054087963487,"score_spread":0.2747421066515237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973753171","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013526696,0.00593255,0.32366806,0.6080458,0.001531624,0.0021264888,0.000813453,0.00017047714,0.04418479],"genre_scores_gemma":[0.4829676,0.0026134872,0.48269877,0.025930433,0.0011275808,0.002512556,0.00036235485,0.000063127765,0.0017242429],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8326005,0.13933153,0.0092725605,0.004172885,0.011731261,0.0028912725],"domain_scores_gemma":[0.80816007,0.15512535,0.006263663,0.0061026504,0.017003393,0.0073448834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15222444,0.0015189543,0.0054893577,0.008035974,0.0043269023,0.01979196,0.0061194366,0.017787294,0.006821583],"category_scores_gemma":[0.24960043,0.0017115453,0.0034204714,0.0038486249,0.016713886,0.011840366,0.01643301,0.018218106,0.00082385],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001816133,0.00016766781,0.0016185173,0.001093198,0.00044853694,0.0005789664,0.0014671071,0.016694607,0.00013459529,0.91613054,0.014806332,0.046678457],"study_design_scores_gemma":[0.00014097065,0.000054653396,0.00030509246,0.0013048506,0.00008723873,0.00008974682,0.00049936865,0.010608629,0.00010373697,0.9767854,0.009967718,0.000052562013],"about_ca_topic_score_codex":0.010167561,"about_ca_topic_score_gemma":0.0133607155,"teacher_disagreement_score":0.15222444,"about_ca_system_score_codex":0.015786635,"about_ca_system_score_gemma":0.046563044,"threshold_uncertainty_score":0.8050494},"labels":[],"label_agreement":null},{"id":"W1974003121","doi":"10.1111/j.1524-4733.2004.75013.x","title":"Estimating Survival for Cost-Effectiveness Analyses: A Case Study in Atherothrombosis","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology; McGill University","funders":"","keywords":"Medicine; Life expectancy; Observational study; Hazard ratio; Stroke (engine); Survival analysis; Myocardial infarction; Proportional hazards model; Population; Disease; Internal medicine; Confidence interval","score_opus":0.24333627678275432,"score_gpt":0.47391388457684486,"score_spread":0.23057760779409053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974003121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9448372,0.0034739326,0.043419275,0.0030224046,0.000051304778,0.0003249507,0.00060015614,0.00004972981,0.004221098],"genre_scores_gemma":[0.980451,0.00073617103,0.018058442,0.000054016436,0.00002751349,0.00010174299,0.00017899844,0.00002136482,0.00037083906],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9891255,0.009330805,0.00037374796,0.00029479573,0.0005152682,0.00035985123],"domain_scores_gemma":[0.88176686,0.11234015,0.0018729671,0.0015291903,0.0017494266,0.00074142945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02249879,0.0012022508,0.0012757891,0.0025164543,0.0011422585,0.0023893588,0.0014400868,0.0038004785,0.0025630398],"category_scores_gemma":[0.08016055,0.00075169455,0.0025652254,0.002011237,0.0011043213,0.0017413169,0.001128739,0.0022870381,0.00020254713],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0102092065,0.0042940327,0.3159522,0.001520627,0.0015344999,0.013652493,0.0021712168,0.44077498,0.00206909,0.028279882,0.0051269406,0.17441481],"study_design_scores_gemma":[0.0009903422,0.0037462304,0.060830288,0.0005367954,0.0011453012,0.009708007,0.0026775934,0.8888643,0.002264148,0.02563136,0.0033991723,0.0002065134],"about_ca_topic_score_codex":0.016161475,"about_ca_topic_score_gemma":0.012090534,"teacher_disagreement_score":0.02249879,"about_ca_system_score_codex":0.0033458697,"about_ca_system_score_gemma":0.0020641594,"threshold_uncertainty_score":0.11898637},"labels":[],"label_agreement":null},{"id":"W1974343881","doi":"10.1016/s1098-3015(10)74012-2","title":"PND5 CLINICAL CONSEQUENCES OF GENERIC SWITCHES OF ANTIEPILEPTIC DRUGS-TRANSFER OF CANADIAN CLAIMS DATABASE RESULTS TO GERMANY","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antiepileptic drug; Database; Transfer (computing); Epilepsy; Medicine; Computer science; Psychiatry; Parallel computing","score_opus":0.23252911995462644,"score_gpt":0.4461672821767221,"score_spread":0.21363816222209564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974343881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90563154,0.0011102394,0.0005683919,0.0018367514,0.00012097554,0.00017858697,0.06892171,0.00006953776,0.021562297],"genre_scores_gemma":[0.98408496,0.00027697955,0.00034085347,0.00030396704,0.000012299634,0.000020687427,0.013217138,0.000014351438,0.0017287687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995074,0.0004907744,0.00042681283,0.0005294485,0.0021701322,0.0013087804],"domain_scores_gemma":[0.98980755,0.0015514173,0.001987919,0.0007212686,0.0048803007,0.001051561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003060232,0.00027535053,0.00044205898,0.0026216104,0.0016790351,0.0024486328,0.0011150398,0.0007625416,0.0031286948],"category_scores_gemma":[0.017337848,0.0002652814,0.00078547205,0.005003122,0.0006032731,0.0004913503,0.0010818781,0.0008619916,0.000288795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011613128,0.00008585343,0.9568944,0.0001437921,0.00038779023,0.00066791725,0.0007693478,0.0015515812,0.00044855467,0.0018029219,0.01369402,0.022392567],"study_design_scores_gemma":[0.000034069613,0.00002989341,0.99161726,0.00006873357,0.00010380211,0.00022985248,0.00058705267,0.0013041579,0.0005354668,0.0000931801,0.005367015,0.000029582978],"about_ca_topic_score_codex":0.97715193,"about_ca_topic_score_gemma":0.9633386,"teacher_disagreement_score":0.97108006,"about_ca_system_score_codex":0.028919907,"about_ca_system_score_gemma":0.037259027,"threshold_uncertainty_score":0.20982957},"labels":[],"label_agreement":null},{"id":"W1974514641","doi":"10.1016/j.jval.2013.03.344","title":"Psychometric Development Of A New Pro Instrument: The Face-Q Scales For Facelift Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Virtual Reality Applications and Impacts","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Patient-reported outcome; Checklist; Differential item functioning; Psychology; Patient satisfaction; Medicine; Psychometrics; Item response theory; Quality of life (healthcare); Clinical psychology; Surgery; Developmental psychology; Cognitive psychology","score_opus":0.1038277765233961,"score_gpt":0.3239041417923375,"score_spread":0.22007636526894142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974514641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509916,0.0004476654,0.032600958,0.0012709068,0.00040766867,0.0034283195,0.0015453376,0.00022055402,0.009087093],"genre_scores_gemma":[0.9371245,0.00042313567,0.052216075,0.00054490846,0.00015134843,0.005003011,0.0018369268,0.00013905439,0.0025610784],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99546635,0.0016278148,0.000544573,0.00024485722,0.0019464213,0.00016996823],"domain_scores_gemma":[0.9813219,0.008106257,0.001961229,0.0010840793,0.006843322,0.00068317796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009158349,0.0004576822,0.00046249136,0.0012099354,0.00059586915,0.001015344,0.0007036116,0.0005967885,0.0029961786],"category_scores_gemma":[0.030872172,0.00029431444,0.0011717159,0.00073673564,0.00053011527,0.0017438751,0.001522486,0.0014823363,0.0005833652],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001860993,0.0026125507,0.44390216,0.00035232634,0.00023060261,0.00013544437,0.002987366,0.002007771,0.005769733,0.0017154664,0.009235358,0.5291902],"study_design_scores_gemma":[0.0005985224,0.008279246,0.9389498,0.0003167852,0.00020722685,0.00083472015,0.0028651603,0.019271633,0.0054739937,0.0029094073,0.020132672,0.00016082043],"about_ca_topic_score_codex":0.0011267725,"about_ca_topic_score_gemma":0.0017738322,"teacher_disagreement_score":0.009158349,"about_ca_system_score_codex":0.00057114335,"about_ca_system_score_gemma":0.0017115549,"threshold_uncertainty_score":0.048434556},"labels":[],"label_agreement":null},{"id":"W1974850672","doi":"10.1016/j.jval.2013.03.466","title":"Treatment patterns in pediatric antibiotic formulations: An analysis of the ramq database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Antibiotics; Azithromycin; Medicine; Amoxicillin; Clarithromycin; Pediatrics; Population; Cephalosporin; Reimbursement; Internal medicine; Environmental health; Biology","score_opus":0.14458472495067942,"score_gpt":0.427859487462494,"score_spread":0.2832747625118146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974850672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86231214,0.004837746,0.00056808535,0.00046834355,0.000016787197,0.00011953819,0.129463,0.00008000121,0.0021343047],"genre_scores_gemma":[0.8647526,0.0030273504,0.0030119608,0.00040631994,0.000042020096,0.00026452466,0.12786777,0.00007401538,0.00055341644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944037,0.0011300626,0.0016959576,0.0011965183,0.0012591934,0.00031459425],"domain_scores_gemma":[0.96790844,0.01336246,0.013036311,0.002132166,0.0028788003,0.0006818621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032954297,0.00030659363,0.001100243,0.005469239,0.00031617063,0.0012258271,0.0011296726,0.00070516096,0.0026870356],"category_scores_gemma":[0.023503494,0.00031419704,0.0013603664,0.009535578,0.00030495558,0.001050637,0.0009422043,0.00073995185,0.0008432552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012179442,0.00010780961,0.96486324,0.0006975032,0.0006571557,0.0002514552,0.0003914527,0.0005101984,0.00044392628,0.0004454388,0.006385824,0.024028052],"study_design_scores_gemma":[0.0000898443,0.00015085112,0.98521787,0.00025251968,0.00033222698,0.0010440132,0.0007558437,0.0015672211,0.0005127854,0.00012100889,0.0099268025,0.000028950186],"about_ca_topic_score_codex":0.017341714,"about_ca_topic_score_gemma":0.012904506,"teacher_disagreement_score":0.98265827,"about_ca_system_score_codex":0.0014923321,"about_ca_system_score_gemma":0.0020106272,"threshold_uncertainty_score":0.034481525},"labels":[],"label_agreement":null},{"id":"W1974989328","doi":"10.1016/j.jval.2013.08.224","title":"Health Care Resource Utilization and Adherence to Antiretroviral Treatment (ART) by HIV Patients: An Analysis with the Quebec (Canada) Public Drug Plan Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Regimen; Reimbursement; Medical record; Health plan; Retrospective cohort study; Health care; Emergency medicine; Internal medicine","score_opus":0.041847306996415215,"score_gpt":0.3230754393085002,"score_spread":0.281228132312085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974989328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6337068,0.002827275,0.0004113629,0.0009195847,0.000034669993,0.0004915319,0.35809553,0.0000826421,0.0034305938],"genre_scores_gemma":[0.8514328,0.0022599157,0.0013440937,0.0005709926,0.00004181347,0.00054256007,0.14109877,0.000045331424,0.0026637395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972579,0.00044064858,0.0004477462,0.00037665648,0.001005076,0.00047211573],"domain_scores_gemma":[0.9883475,0.0015565555,0.0026625143,0.00056923646,0.005500861,0.0013633178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020485169,0.00070261955,0.0013624844,0.0054719807,0.0017907874,0.0022099307,0.0024173902,0.00090300274,0.0042961966],"category_scores_gemma":[0.010651495,0.000633423,0.0021499854,0.02230994,0.0004645198,0.0008979141,0.0013395139,0.0012079087,0.0005192232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028668542,0.000076513155,0.98486507,0.00015524894,0.00056859234,0.000045729368,0.00013639696,0.0007143512,0.000032101103,0.00014729954,0.009157968,0.0038140116],"study_design_scores_gemma":[0.000068088586,0.000030387362,0.9952514,0.000098876415,0.00020771836,0.00005453121,0.00026401464,0.0015019205,0.000045944016,0.000021940383,0.0024338632,0.000021338788],"about_ca_topic_score_codex":0.99271446,"about_ca_topic_score_gemma":0.9924615,"teacher_disagreement_score":0.032043308,"about_ca_system_score_codex":0.032043308,"about_ca_system_score_gemma":0.03454961,"threshold_uncertainty_score":0.23249155},"labels":[],"label_agreement":null},{"id":"W1975421074","doi":"10.1016/j.jval.2011.02.210","title":"PCV22 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN IN PATIENTS WITH UNSTABLE CORONARY ARTERY DISEASE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Enoxaparin sodium; Unstable angina; Internal medicine; Low molecular weight heparin; Meta-analysis; Randomized controlled trial; Relative risk; Angina; Heparin; Cardiology; Confidence interval; Myocardial infarction","score_opus":0.042920077049483044,"score_gpt":0.27334860265593436,"score_spread":0.23042852560645133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975421074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46394643,0.4581341,0.047424667,0.0027005638,0.007342507,0.0028176652,0.009485003,0.0014557734,0.00669326],"genre_scores_gemma":[0.9734779,0.011507327,0.0071668187,0.0016498418,0.0009136168,0.0012136016,0.0014928451,0.00017404785,0.0024039124],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96820307,0.02511043,0.0019467842,0.0026608906,0.0015083641,0.0005704321],"domain_scores_gemma":[0.9652219,0.029008249,0.0017646707,0.002555735,0.0009979038,0.0004514471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021578087,0.0032635848,0.011947485,0.0019816104,0.00060378306,0.0023643498,0.0019922573,0.0025576463,0.0065815705],"category_scores_gemma":[0.05383167,0.0017487063,0.03220433,0.0026689807,0.0007468068,0.0016540941,0.0019223244,0.004966711,0.0006243938],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07810699,0.00005482047,0.009078639,0.0056098723,0.89766747,0.000112981426,0.000033035805,0.0011200373,0.00035761454,0.00017984713,0.0007199459,0.0069588916],"study_design_scores_gemma":[0.030844737,0.002766769,0.008675082,0.00040261145,0.95144534,0.00014394562,0.00002868468,0.0029521713,0.00038873623,0.00071041967,0.001598173,0.00004342143],"about_ca_topic_score_codex":0.0050332784,"about_ca_topic_score_gemma":0.0049397005,"teacher_disagreement_score":0.021578087,"about_ca_system_score_codex":0.0010112913,"about_ca_system_score_gemma":0.00129923,"threshold_uncertainty_score":0.114117205},"labels":[],"label_agreement":null},{"id":"W1975492177","doi":"10.1016/j.jval.2012.03.1115","title":"PIH83 Health Technology Assessment in Child Health","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Psychosocial; Quality of life (healthcare); Disease; Mental health; Pediatrics; Gerontology; Psychiatry","score_opus":0.4265506633807722,"score_gpt":0.47995517106010144,"score_spread":0.05340450767932925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975492177","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065358076,0.03961656,0.04182826,0.06356484,0.008587119,0.0013493912,0.022121942,0.001210101,0.8151861],"genre_scores_gemma":[0.29847842,0.07066696,0.073862225,0.012049379,0.01692657,0.004545628,0.024446987,0.0010065449,0.49801728],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935456,0.0038271034,0.00031006263,0.00042854677,0.0015541605,0.00033443153],"domain_scores_gemma":[0.98886687,0.0057099145,0.00058797555,0.0011512289,0.0031438034,0.00054015423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008584171,0.0007564858,0.0013051821,0.0027490337,0.00059362897,0.0029682359,0.0010445934,0.0021059236,0.08055961],"category_scores_gemma":[0.027680133,0.0003350261,0.00090221624,0.004595988,0.00065520813,0.0016105045,0.0019292057,0.0029606803,0.02549389],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021098083,0.00010968969,0.002399822,0.0009728637,0.00007509815,0.0000948478,0.00005543329,0.0022231808,0.00014402413,0.08486851,0.3998009,0.50904465],"study_design_scores_gemma":[0.00021689909,0.00027017196,0.022834437,0.0012109422,0.00009571072,0.0002764046,0.00006616335,0.008497966,0.0014708228,0.07369363,0.8913177,0.000049081944],"about_ca_topic_score_codex":0.0064377426,"about_ca_topic_score_gemma":0.0022580086,"teacher_disagreement_score":0.08055961,"about_ca_system_score_codex":0.0033203855,"about_ca_system_score_gemma":0.004771754,"threshold_uncertainty_score":0.26949877},"labels":[],"label_agreement":null},{"id":"W1976011722","doi":"10.1046/j.1524-4733.2001.40202-256.x","title":"PWM4: PHARMACIST-INITIATED EMERGENCY CONTRACEPTION IN BRITISH COLUMBIA","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacist; Emergency contraception; Family medicine; Medicine; Medical emergency; Pharmacy; Family planning; Environmental health; Population","score_opus":0.08539963754696987,"score_gpt":0.365738016015765,"score_spread":0.2803383784687951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976011722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94835246,0.0011777581,0.00015764,0.008503874,0.00017245999,0.00030153923,0.012868607,0.00010771089,0.028358117],"genre_scores_gemma":[0.9414666,0.001431523,0.00038683662,0.004626688,0.00008484757,0.00018276546,0.0042030406,0.000073692245,0.04754397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928397,0.000116895426,0.00005843386,0.00005413162,0.0001346458,0.00035189014],"domain_scores_gemma":[0.9972972,0.0003874282,0.0002724921,0.000056861783,0.000789732,0.001196264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005583703,0.00026154242,0.00028146055,0.00094682665,0.0025516818,0.0011407852,0.0013982335,0.0014738763,0.011504343],"category_scores_gemma":[0.0028362116,0.00034888336,0.00023795974,0.002038301,0.0005052795,0.0004922809,0.0010703049,0.0017610304,0.000999296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015812628,0.00078054774,0.85235864,0.00036364674,0.00008506109,0.0050005843,0.002075503,0.00073458836,0.0007924163,0.0008025687,0.070144884,0.06528029],"study_design_scores_gemma":[0.00023731843,0.00028633082,0.97123444,0.00019134379,0.000060147926,0.0009778969,0.0071132006,0.0009478498,0.00031922292,0.000135953,0.018443612,0.00005266211],"about_ca_topic_score_codex":0.9742088,"about_ca_topic_score_gemma":0.9851783,"teacher_disagreement_score":0.025791228,"about_ca_system_score_codex":0.01578322,"about_ca_system_score_gemma":0.029401984,"threshold_uncertainty_score":0.11451584},"labels":[],"label_agreement":null},{"id":"W1976152155","doi":"10.1016/j.jval.2011.12.011","title":"Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States","year":2012,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"EQ-5D; Anxiety; Medicine; Depression (economics); Value (mathematics); Family medicine; Health care; Disease; Psychology; Psychiatry; Gerontology; Political science; Statistics; Health related quality of life; Pathology","score_opus":0.6581043205769681,"score_gpt":0.3950368595126414,"score_spread":0.2630674610643267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976152155","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023637769,0.00025693057,0.00011552285,0.99293065,0.004414678,0.000012927863,0.00010162183,0.000018943181,0.00191235],"genre_scores_gemma":[0.0010838613,0.00010081639,0.00013255287,0.99112177,0.0049406327,0.000039436203,0.000023004335,0.0000138609785,0.002544053],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98464084,0.005747073,0.0022029425,0.0014680108,0.0040042005,0.0019368535],"domain_scores_gemma":[0.93271,0.053938355,0.002443864,0.0010597343,0.0067191045,0.0031289486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019037027,0.0011436745,0.0021625801,0.0013752012,0.007657735,0.0061558154,0.0045455485,0.12207171,0.010610425],"category_scores_gemma":[0.09994336,0.0020298809,0.0025667509,0.0017270312,0.0060311006,0.0065063094,0.0039830604,0.079530805,0.007734602],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069811686,0.000021662961,0.0004224274,0.00003969519,0.0000142215695,0.00044233233,0.000328165,0.000060162096,0.00006503411,0.0055852067,0.98983127,0.0031200405],"study_design_scores_gemma":[0.0003263955,0.000096825584,0.0040894747,0.0010558829,0.00009261596,0.0011548849,0.0013290741,0.0011807882,0.0003573256,0.018460488,0.9716333,0.00022272975],"about_ca_topic_score_codex":0.0518637,"about_ca_topic_score_gemma":0.08024699,"teacher_disagreement_score":0.12207171,"about_ca_system_score_codex":0.011755675,"about_ca_system_score_gemma":0.009543588,"threshold_uncertainty_score":0.103123665},"labels":[],"label_agreement":null},{"id":"W1976155214","doi":"10.1016/s1098-3015(11)71663-1","title":"PHP2: GASTROINTESTINAL DRUG POLICY, DRUG SELECTION AND RESOURCE UTILIZATION—A COMPARISON OF THE CANADIAN PROVINCES OF QUEBEC AND ONTARIO","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Selection (genetic algorithm); Resource (disambiguation); Business; Geography; Medicine; Pharmacology; Computer science","score_opus":0.04418445564258011,"score_gpt":0.30875411420654564,"score_spread":0.2645696585639655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976155214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93199235,0.005061527,0.0005656375,0.0072920863,0.00008512877,0.0002360009,0.039970424,0.00007852608,0.014718406],"genre_scores_gemma":[0.986244,0.0013767184,0.00054469146,0.0005899167,0.000023647084,0.00007995495,0.0060887495,0.000020962567,0.0050313785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976739,0.0002767283,0.00011529296,0.00014289872,0.00079345296,0.0009977665],"domain_scores_gemma":[0.9918899,0.0008445958,0.0013954437,0.00018008534,0.0034458095,0.0022441787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019095206,0.00049160677,0.0007402379,0.002676634,0.0037129743,0.0027151778,0.001981667,0.0009277831,0.004469835],"category_scores_gemma":[0.006761638,0.0004602789,0.0016661842,0.010786236,0.0011308677,0.00080596074,0.0013414698,0.00083419395,0.00021357616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059019553,0.00010128216,0.94609874,0.00035370656,0.00048119875,0.00023620669,0.0019664858,0.0036252,0.00021723348,0.0036509368,0.024079926,0.01859887],"study_design_scores_gemma":[0.000056673663,0.000034612443,0.98888355,0.00009342598,0.000080316175,0.00004967029,0.0020030409,0.0014636947,0.000083793886,0.00010330402,0.007120297,0.000027511622],"about_ca_topic_score_codex":0.99956197,"about_ca_topic_score_gemma":0.99976915,"teacher_disagreement_score":0.87309796,"about_ca_system_score_codex":0.12690204,"about_ca_system_score_gemma":0.14535329,"threshold_uncertainty_score":0.9207431},"labels":[],"label_agreement":null},{"id":"W1976493216","doi":"10.1016/j.jval.2013.03.1535","title":"New oral anticoagulants versus warfarin for stroke prevention in atrial fibrillation: Development of coverage decision frameworks","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Warfarin; Medicine; Actuarial science; Economic evaluation; Atrial fibrillation; Cost–benefit analysis; Risk analysis (engineering); Business; Health care; Economics","score_opus":0.412273028987657,"score_gpt":0.4529828278979083,"score_spread":0.04070979891025128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976493216","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20806596,0.03521373,0.6840095,0.030702675,0.00066639617,0.0015762717,0.0013829332,0.00017783509,0.038204737],"genre_scores_gemma":[0.8796347,0.00658481,0.109742165,0.0011144055,0.00039232816,0.00070240314,0.0004079766,0.000030553718,0.0013907542],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9762561,0.019283516,0.00076767086,0.0007850109,0.0022916542,0.0006162279],"domain_scores_gemma":[0.89457095,0.098932326,0.0029294877,0.0006707944,0.002108755,0.000787656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.052125353,0.0011169752,0.0023616427,0.0037228279,0.0005530801,0.0049113934,0.0017754381,0.0022440518,0.0035645578],"category_scores_gemma":[0.09828705,0.0008021608,0.0020580648,0.0022656,0.002233511,0.0056212093,0.0029687805,0.0033297054,0.00011727062],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059715676,0.000365405,0.0059133796,0.0007638603,0.0007416824,0.00007314658,0.00042790343,0.40627337,0.0001339932,0.45107734,0.0039275917,0.12970522],"study_design_scores_gemma":[0.00024609844,0.00023666672,0.001561668,0.00075161795,0.00046073543,0.000035470748,0.00016527137,0.6774088,0.00016585841,0.31490988,0.0040167263,0.000041204672],"about_ca_topic_score_codex":0.0048432737,"about_ca_topic_score_gemma":0.0059260363,"teacher_disagreement_score":0.052125353,"about_ca_system_score_codex":0.005603938,"about_ca_system_score_gemma":0.00454271,"threshold_uncertainty_score":0.2756685},"labels":[],"label_agreement":null},{"id":"W1976878541","doi":"10.1016/j.jval.2014.08.2666","title":"Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); AstraZeneca (Canada)","funders":"","keywords":"Medicine; Diclofenac; Misoprostol; Celecoxib; Medical prescription; Osteoarthritis; Rheumatoid arthritis; Internal medicine; Concomitant; Naproxen; Esomeprazole; Ankylosing spondylitis; Pharmacy; Ketorolac; Analgesic; Anesthesia; Pharmacology; Alternative medicine; Pregnancy","score_opus":0.016329745552759595,"score_gpt":0.265600392951297,"score_spread":0.2492706473985374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976878541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034065,0.00675599,0.000069714646,0.00017534955,0.00005226208,0.000009885782,0.0005331253,0.0000059557665,0.0020570627],"genre_scores_gemma":[0.99754804,0.0016730551,0.00012156207,0.00008960792,0.00006836021,0.0000052687706,0.00027220603,0.0000010547263,0.00022080525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996222,0.000090784124,0.00008940511,0.00005225608,0.000096111624,0.00004920652],"domain_scores_gemma":[0.9986318,0.0004132665,0.00062750676,0.000032986885,0.00007211426,0.00022228688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022904413,0.00018405709,0.00045184055,0.00082702324,0.00032388268,0.00042353096,0.00014993131,0.00047032605,0.0017919495],"category_scores_gemma":[0.0016698589,0.00018346802,0.0005518253,0.0010385534,0.00016276356,0.0003436117,0.00022085596,0.000490271,0.00016004297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005111371,0.00006376106,0.99484456,0.000053185573,0.00012353202,0.00029389616,0.00003803431,0.000025339188,0.00039339295,0.000011267942,0.00009747569,0.003544366],"study_design_scores_gemma":[0.000028329436,0.0002698571,0.99773955,0.000025546815,0.00012246857,0.001185202,0.00010363693,0.00013798749,0.000105656094,0.000017581779,0.0002592262,0.0000050338876],"about_ca_topic_score_codex":0.0034238216,"about_ca_topic_score_gemma":0.008044899,"teacher_disagreement_score":0.0034238216,"about_ca_system_score_codex":0.0002510345,"about_ca_system_score_gemma":0.0002935992,"threshold_uncertainty_score":0.0068077445},"labels":[],"label_agreement":null},{"id":"W1976920602","doi":"10.1111/j.1524-4733.2007.00258.x","title":"Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Bone and Joint Health Institute; McMaster University; University of Toronto","funders":"","keywords":"WOMAC; Osteoarthritis; Physical therapy; Sample (material); Sample size determination; Statistics; Predictive validity; Index (typography); Medicine; Mathematics; Computer science","score_opus":0.1743607917446644,"score_gpt":0.3722174669120764,"score_spread":0.197856675167412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976920602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.966458,0.00020475333,0.030800924,0.00037213785,0.00009483199,0.00013994185,0.0009190166,0.00015766139,0.0008528387],"genre_scores_gemma":[0.9933942,0.00005621585,0.0050043087,0.00007046429,0.00001895367,0.00008468796,0.0011041365,0.000014066016,0.0002529637],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969119,0.0020909433,0.00020720159,0.0003255681,0.00032153216,0.00014276504],"domain_scores_gemma":[0.9621511,0.03225591,0.0009807753,0.0013921058,0.0028865547,0.0003335228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016077563,0.0008544966,0.00090933533,0.00095414335,0.00042285482,0.0011467645,0.0011349455,0.0014224653,0.001229708],"category_scores_gemma":[0.037040673,0.00044351324,0.001028965,0.00073446543,0.0004375648,0.00067104725,0.00077328685,0.0013186659,0.00059050525],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007274014,0.003541449,0.603186,0.00015411884,0.0014524377,0.00023688618,0.0003999449,0.26951104,0.0019115164,0.000988394,0.0040039504,0.1073402],"study_design_scores_gemma":[0.00030177916,0.0007542648,0.054602213,0.0000234735,0.00014724369,0.00009250762,0.00006652521,0.9424712,0.0007570754,0.00054124783,0.00021933242,0.00002318392],"about_ca_topic_score_codex":0.010020342,"about_ca_topic_score_gemma":0.004270904,"teacher_disagreement_score":0.016077563,"about_ca_system_score_codex":0.0009876414,"about_ca_system_score_gemma":0.0014016471,"threshold_uncertainty_score":0.08502728},"labels":[],"label_agreement":null},{"id":"W1977624528","doi":"10.1016/j.jval.2013.03.1093","title":"Factors That Influence Ulcerative Colitis Patients' Anxiety And Depression Following The Colectomy Surgery","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Stoma care and complications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Calgary","funders":"","keywords":"Anxiety; Depression (economics); Hospital Anxiety and Depression Scale; Medicine; Ulcerative colitis; Absenteeism; Logistic regression; Presenteeism; Colectomy; Patient Health Questionnaire; Psychiatry; Disease; Internal medicine; Psychology; Depressive symptoms","score_opus":0.04328662357815313,"score_gpt":0.2979284949735191,"score_spread":0.254641871395366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977624528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848783,0.0002358198,0.000014095167,0.00016445252,0.000011457453,0.0000064674637,0.000046496825,8.4369043e-7,0.001032621],"genre_scores_gemma":[0.9997111,0.00007621271,0.000016441807,0.000032375145,0.000010668322,0.0000018035307,0.00002925601,3.7347846e-7,0.00012175284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995529,0.0001281306,0.00005157056,0.00003220762,0.00009048827,0.00014469985],"domain_scores_gemma":[0.9975885,0.0005647946,0.00090091035,0.00005092841,0.00017134869,0.0007234305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003061707,0.00013177068,0.00028457763,0.00042521686,0.0006185115,0.0009085239,0.00018075902,0.00040445005,0.002164531],"category_scores_gemma":[0.0044599753,0.00013949395,0.00055526977,0.00063560397,0.00028262005,0.0002778542,0.00032038867,0.0009481573,0.00015503854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018057821,0.0001740724,0.99708515,0.0000104382,0.00006494544,0.00016171727,0.00019978428,0.000023651652,0.00010323013,0.000020774367,0.0000920407,0.0018837058],"study_design_scores_gemma":[0.0000044464678,0.00007254556,0.99917454,0.0000052629816,0.000029308289,0.00012378287,0.00042042267,0.00004566089,0.000017108014,0.000016672515,0.000087015076,0.0000031155412],"about_ca_topic_score_codex":0.009212098,"about_ca_topic_score_gemma":0.020584388,"teacher_disagreement_score":0.009212098,"about_ca_system_score_codex":0.0004737676,"about_ca_system_score_gemma":0.00068475713,"threshold_uncertainty_score":0.018316984},"labels":[],"label_agreement":null},{"id":"W1978008071","doi":"10.1016/j.jval.2013.03.1633","title":"Does the Process of Deliberation Change Individuals’ Health State Valuations? An Exploratory Study Using the Person Trade-Off Technique","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Deliberation; Preference; Exploratory analysis; Exploratory research; Valuation (finance); Psychology; Social psychology; Process (computing); Actuarial science; Economics; Political science; Microeconomics; Computer science; Sociology","score_opus":0.5538658593092457,"score_gpt":0.45438533273355936,"score_spread":0.09948052657568635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978008071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892603,0.000037496407,0.0071226936,0.00025801285,0.000009101257,0.00007296107,0.000030314937,0.0000082210145,0.0032010057],"genre_scores_gemma":[0.9968617,0.000023452176,0.0026362047,0.000047701113,0.0000061133746,0.00009550833,0.000017136916,0.0000092644605,0.0003030314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97658074,0.020252233,0.0005233809,0.00088076096,0.0010646846,0.0006981546],"domain_scores_gemma":[0.6479721,0.32915726,0.011962687,0.0077298754,0.0019851907,0.0011929019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02373895,0.00024787843,0.00063986494,0.00085780583,0.0009117676,0.002833261,0.0008178338,0.0018562089,0.00360616],"category_scores_gemma":[0.14770573,0.00045189698,0.00085329247,0.0013777596,0.002316499,0.004317643,0.001994687,0.0021612367,0.00025298432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0130527895,0.008214411,0.5768718,0.0005446547,0.0012752058,0.0011685742,0.13580625,0.017639477,0.0075367233,0.07402759,0.0012182293,0.16264427],"study_design_scores_gemma":[0.0015065216,0.008182241,0.5741188,0.0002512164,0.00086433545,0.0012629244,0.09037305,0.15278625,0.0077929087,0.15443274,0.007980763,0.00044833394],"about_ca_topic_score_codex":0.0011608563,"about_ca_topic_score_gemma":0.00085268164,"teacher_disagreement_score":0.02373895,"about_ca_system_score_codex":0.0007996834,"about_ca_system_score_gemma":0.000747947,"threshold_uncertainty_score":0.12554508},"labels":[],"label_agreement":null},{"id":"W1978260336","doi":"10.1111/j.1524-4733.2008.00446.x","title":"A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada","year":2008,"lang":"en","type":"review","venue":"Value in Health","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre; McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Abdominal aortic aneurysm; Perioperative; Observational study; Cohort; Cost effectiveness; Surgery; Quality-adjusted life year; Time horizon; Aneurysm; Risk analysis (engineering); Finance; Internal medicine","score_opus":0.18235106453002858,"score_gpt":0.40460089825751894,"score_spread":0.22224983372749035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978260336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08892383,0.8749425,0.008759584,0.006392409,0.0006247444,0.00068669213,0.0064520235,0.00007500226,0.013143193],"genre_scores_gemma":[0.57439095,0.4129604,0.006640822,0.0008436346,0.00016115642,0.0003421114,0.0020024506,0.000018151846,0.0026403023],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99846447,0.00080716383,0.00008865479,0.00009616708,0.00033871835,0.00020476707],"domain_scores_gemma":[0.9962592,0.0027699184,0.00021617989,0.000031457752,0.000610816,0.00011244309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029834872,0.0012790912,0.0032232164,0.002436954,0.0005215547,0.0018191256,0.0020114626,0.0012203901,0.0032995937],"category_scores_gemma":[0.0091280695,0.000516672,0.0032917089,0.004830538,0.00054129836,0.00069300254,0.00040702446,0.001110762,0.00013487363],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052557504,0.0005377396,0.0256291,0.042110004,0.021863557,0.0007922659,0.00024571404,0.57260656,0.0005178429,0.020549634,0.02134127,0.28855065],"study_design_scores_gemma":[0.00870203,0.0030373286,0.08475192,0.037679467,0.10509649,0.0021192215,0.0015014809,0.6044735,0.0012995251,0.030977221,0.11987348,0.00048837316],"about_ca_topic_score_codex":0.81833035,"about_ca_topic_score_gemma":0.8151182,"teacher_disagreement_score":0.18166965,"about_ca_system_score_codex":0.036346924,"about_ca_system_score_gemma":0.037427388,"threshold_uncertainty_score":0.36547905},"labels":[],"label_agreement":null},{"id":"W1978573187","doi":"10.1016/j.jval.2014.08.101","title":"Hospital Costs Associated with Platinum-Based Doublets in the First-Line Setting for Advanced Non-Squamous Non-Small Cell Lung Cancer in China: A Retrospective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Internal medicine; Vinorelbine; Docetaxel; Gemcitabine; Oncology; Lung cancer; Chemotherapy; Retrospective cohort study; Platinum; Cancer; Cisplatin","score_opus":0.012308531618133299,"score_gpt":0.24813489041028497,"score_spread":0.23582635879215166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978573187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988556,0.00027681285,0.00002590126,0.00004750573,0.0000055189785,0.0000063630073,0.0006453125,0.000001504084,0.0001354455],"genre_scores_gemma":[0.998992,0.00013880902,0.000023083046,0.000024461113,0.000009381398,0.0000061619717,0.0006876314,0.0000011736206,0.00011715027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994248,0.00007047607,0.00007814184,0.00014029775,0.00008882092,0.00019740562],"domain_scores_gemma":[0.9982596,0.00014237194,0.00084022485,0.00015398832,0.00019396977,0.0004098511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004021905,0.00044782952,0.00063622487,0.0009711537,0.00064516976,0.00083972426,0.00072824926,0.0005837724,0.0012608952],"category_scores_gemma":[0.001430156,0.00058729696,0.0014589598,0.00221378,0.0003223406,0.0006092138,0.00057847705,0.0010914021,0.00012889129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013433547,0.000035069006,0.99871564,0.000011289542,0.00014038177,0.0001236885,0.000034085126,0.00010063315,0.00006995288,0.0000233266,0.00012227021,0.0004893779],"study_design_scores_gemma":[0.000008818169,0.000054118176,0.9991511,0.0000045446404,0.000076498625,0.0001481869,0.00011994591,0.00028570695,0.000026871658,0.000030276187,0.0000870279,0.0000068002796],"about_ca_topic_score_codex":0.048103247,"about_ca_topic_score_gemma":0.051045295,"teacher_disagreement_score":0.048103247,"about_ca_system_score_codex":0.002204752,"about_ca_system_score_gemma":0.0017138843,"threshold_uncertainty_score":0.0956465},"labels":[],"label_agreement":null},{"id":"W1978857580","doi":"10.1016/j.jval.2014.03.726","title":"COMORBIDITIES AND HEALTH RESOURCE USE OF CHRONIC PLAQUE PSORIASIS PATIENTS IN CANADA: A MATCHED-COHORT STUDY","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Helminth infection and control","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Université de Montréal; Novartis (Canada)","funders":"","keywords":"Medicine; Psoriasis; Cohort; Medical record; Depression (economics); Internal medicine; Anxiety; Retrospective cohort study; Cohort study; Dermatology; Psychiatry","score_opus":0.07810382300530012,"score_gpt":0.31020363440996324,"score_spread":0.23209981140466313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978857580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630487,0.0003660357,0.00004293496,0.00013575157,0.0000118270045,0.00003857006,0.002342501,0.000005355384,0.0007520495],"genre_scores_gemma":[0.99797446,0.00026429203,0.000075103366,0.00010348156,0.00000824708,0.000016096092,0.0010477463,0.0000036676026,0.0005069918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988464,0.00010157791,0.00007879957,0.00020888323,0.00024883353,0.00051537476],"domain_scores_gemma":[0.9980488,0.00010129112,0.00048212768,0.00010931218,0.0005178156,0.0007407208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000498267,0.00048131513,0.0007333289,0.0013423087,0.003189263,0.0018500763,0.001382467,0.0010971245,0.0031140032],"category_scores_gemma":[0.0016870807,0.0007529233,0.0012425801,0.0048999833,0.0008054325,0.0007558323,0.0010416182,0.0014658915,0.00038436335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012217181,0.00008800797,0.9984326,0.000008939768,0.0000824865,0.000058615155,0.00017138085,0.000026173102,0.00006534367,0.000029186262,0.00030658065,0.0006084933],"study_design_scores_gemma":[0.000018679368,0.000043662854,0.9986745,0.000012621146,0.000040427163,0.000059481743,0.00074401055,0.00013903818,0.000015334677,0.00001796552,0.00022520995,0.000009189473],"about_ca_topic_score_codex":0.970892,"about_ca_topic_score_gemma":0.97239786,"teacher_disagreement_score":0.029107988,"about_ca_system_score_codex":0.012878887,"about_ca_system_score_gemma":0.015131936,"threshold_uncertainty_score":0.093443334},"labels":[],"label_agreement":null},{"id":"W1978872749","doi":"10.1016/j.jval.2013.08.1356","title":"Statins in Canada: The Case for Disinvestment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Disinvestment; Reimbursement; Atorvastatin; Statin; Unit (ring theory); Medicine; Unit cost; Generic drug; Public health; Business; Operations management; Health care; Economics; Drug; Internal medicine; Pharmacology; Mathematics","score_opus":0.13835606983133678,"score_gpt":0.3103241599661802,"score_spread":0.1719680901348434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978872749","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21798594,0.029137956,0.0012186639,0.65732807,0.00089162233,0.00011644079,0.0065427497,0.00008638188,0.086692184],"genre_scores_gemma":[0.94802547,0.009029029,0.0011385052,0.028207289,0.00048491976,0.000026059086,0.0007101983,0.000052145246,0.012326423],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937972,0.0006386083,0.00025297463,0.00041017085,0.0019220673,0.00297911],"domain_scores_gemma":[0.9805714,0.0034361987,0.0024372991,0.0005033689,0.007180385,0.0058712335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003961111,0.000325618,0.0010872912,0.0017216909,0.0040112534,0.006767334,0.0020088733,0.0057680756,0.006893587],"category_scores_gemma":[0.020228324,0.00035579153,0.0011831102,0.0033975358,0.0026101896,0.0018554351,0.0014833128,0.0068625333,0.00025373534],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017029155,0.0002908251,0.24706206,0.0006967352,0.0006323808,0.0021122,0.0022066468,0.005363584,0.0007547387,0.3640409,0.24248813,0.13264884],"study_design_scores_gemma":[0.00077909144,0.0002035619,0.47103724,0.0024743814,0.0012499372,0.0016128161,0.00928617,0.015286512,0.0015653045,0.0989935,0.39707896,0.00043240818],"about_ca_topic_score_codex":0.9941513,"about_ca_topic_score_gemma":0.9966673,"teacher_disagreement_score":0.10166614,"about_ca_system_score_codex":0.10166614,"about_ca_system_score_gemma":0.2402317,"threshold_uncertainty_score":0.7376429},"labels":[],"label_agreement":null},{"id":"W1978914151","doi":"10.1016/j.jval.2011.02.011","title":"CO2 REAL-WORLD COST-EFFECTIVENESS ANALYSIS OF CANCER DRUGS: COMPARATIVE EFFECTIVENESS RESEARCH USING RETROSPECTIVE CANADIAN REGISTRY DATA BEFORE AND AFTER DRUG APPROVAL","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Toronto Public Health; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","funders":"","keywords":"Medicine; Propensity score matching; Rituximab; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.2396598784848678,"score_gpt":0.4013781695286586,"score_spread":0.16171829104379082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978914151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8852247,0.029630572,0.0028246322,0.0016001608,0.00012017545,0.0006063591,0.07149916,0.00007631069,0.008417857],"genre_scores_gemma":[0.9720367,0.005334345,0.0013660325,0.00020393508,0.00005517683,0.00012854593,0.01994231,0.000025981397,0.00090694625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9899609,0.004102684,0.000733286,0.00084794336,0.0031473655,0.0012077363],"domain_scores_gemma":[0.9689886,0.014339956,0.008105711,0.001980616,0.00569116,0.0008939054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012632673,0.0011402192,0.001664051,0.0050165257,0.0009257879,0.0022628186,0.0021107493,0.00071752735,0.0026244097],"category_scores_gemma":[0.036441013,0.0005945012,0.0039254515,0.012500396,0.00095029984,0.0011097911,0.0008394111,0.0014377286,0.00019281417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032504022,0.0011905893,0.7065276,0.005440263,0.03261801,0.00037040492,0.0007238985,0.08796652,0.000990015,0.007987199,0.013953056,0.10972833],"study_design_scores_gemma":[0.0024336197,0.0021022805,0.94215935,0.0005346771,0.013548649,0.00035778628,0.00067994825,0.021721803,0.0013648402,0.00086341164,0.0139511,0.00028249482],"about_ca_topic_score_codex":0.94726604,"about_ca_topic_score_gemma":0.9373932,"teacher_disagreement_score":0.052733958,"about_ca_system_score_codex":0.037444755,"about_ca_system_score_gemma":0.030565254,"threshold_uncertainty_score":0.27168196},"labels":[],"label_agreement":null},{"id":"W1979163175","doi":"10.1016/j.jval.2013.08.615","title":"Population Based Utilization of Radiation Therapy by a Canadian Breast Cancer Cohort","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Health Sciences Centre; Juravinski Cancer Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Cohort; Medicine; Breast cancer; Stage (stratigraphy); Population; Radiation therapy; Cancer; Cancer registry; Internal medicine; Oncology; Biology; Environmental health","score_opus":0.08946777351266681,"score_gpt":0.36046273229740905,"score_spread":0.2709949587847422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979163175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883492,0.0006181952,0.000091545524,0.00033769233,0.000013376971,0.000037094134,0.008083967,0.000019493507,0.0024493798],"genre_scores_gemma":[0.9953537,0.0005325201,0.00013779318,0.000102671336,0.000008133897,0.000015891655,0.0030334068,0.000007624565,0.0008082499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907184,0.00005861131,0.000053863296,0.00016561722,0.00034373792,0.00030638868],"domain_scores_gemma":[0.9983845,0.000084435895,0.00029417526,0.00008882007,0.0007430532,0.00040499592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006687406,0.00054871663,0.0005158345,0.0027353885,0.0024423178,0.0016824061,0.001563088,0.00091072527,0.0034142274],"category_scores_gemma":[0.0019650878,0.0006580135,0.0014792673,0.0054217903,0.00065972307,0.0006060272,0.00093629526,0.0011976629,0.0004284959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001291058,0.000044885535,0.9960155,0.000016042373,0.00012477077,0.0000683215,0.00035315732,0.0001620383,0.00016121089,0.000099481724,0.0011057262,0.0017197051],"study_design_scores_gemma":[0.00000885868,0.000024239418,0.9980533,0.000012611731,0.00004950522,0.00009605747,0.0007559685,0.00033860857,0.000031296455,0.000022697479,0.0005880828,0.00001867886],"about_ca_topic_score_codex":0.99367493,"about_ca_topic_score_gemma":0.9942088,"teacher_disagreement_score":0.025042798,"about_ca_system_score_codex":0.025042798,"about_ca_system_score_gemma":0.02516991,"threshold_uncertainty_score":0.1816991},"labels":[],"label_agreement":null},{"id":"W1979178718","doi":"10.1016/j.jval.2011.02.648","title":"PIN16 COST COMPARISON OF LINEZOLID VERSUS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTION CAUSED BY MRSA IN QUEBEC","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Linezolid; Vancomycin; Medicine; Pneumonia; Antibiotics; Intensive care medicine; Internal medicine; Emergency medicine; Staphylococcus aureus; Microbiology; Bacteria; Biology","score_opus":0.46201091256911625,"score_gpt":0.4536473642016599,"score_spread":0.008363548367456342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979178718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754578,0.011298626,0.00048065567,0.0009682893,0.00018302847,0.00035442782,0.0050097746,0.000035704496,0.006211708],"genre_scores_gemma":[0.99470323,0.0011247533,0.00032374889,0.00021748907,0.000025946869,0.000076222175,0.0014462337,0.000009218896,0.00207306],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.998376,0.0008890868,0.000107753294,0.00011037384,0.00027763622,0.00023910402],"domain_scores_gemma":[0.99828076,0.0005548908,0.00030159493,0.00005021939,0.00040857703,0.00040400395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015976575,0.000646829,0.0016085866,0.0006479803,0.0004888901,0.0013294017,0.0012812086,0.000816991,0.008561334],"category_scores_gemma":[0.004565808,0.0003159886,0.002185702,0.001118371,0.00035655315,0.00053595594,0.0005885353,0.0008542223,0.00022170792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5401954,0.004730841,0.1047411,0.0047605652,0.01716318,0.00087984203,0.00032537396,0.08434114,0.0050030462,0.0025174331,0.019363884,0.21597816],"study_design_scores_gemma":[0.08176773,0.05925017,0.7584923,0.0012009218,0.00999829,0.0004787102,0.0008845183,0.07647157,0.0016916745,0.00047690663,0.009006243,0.00028101655],"about_ca_topic_score_codex":0.862311,"about_ca_topic_score_gemma":0.86649936,"teacher_disagreement_score":0.137689,"about_ca_system_score_codex":0.027622381,"about_ca_system_score_gemma":0.011466802,"threshold_uncertainty_score":0.2769997},"labels":[],"label_agreement":null},{"id":"W1979446181","doi":"10.1016/j.jval.2012.05.007","title":"Costs of Adverse Drug Events in German Hospitals—A Microcosting Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Helmholtz Zentrum München","keywords":"Medicine; Concomitant; Propensity score matching; Emergency medicine; Adverse effect; Resource use; Medical record; Drug reaction; Drug; Surgery; Internal medicine","score_opus":0.11483599506774046,"score_gpt":0.47773021674634986,"score_spread":0.3628942216786094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979446181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978137,0.0005090183,0.000090019596,0.00009172865,0.0000048587895,0.0000165232,0.0010539091,0.0000036727379,0.00041655338],"genre_scores_gemma":[0.99884725,0.00019051998,0.0000601111,0.00004136836,0.000009099364,0.000011643749,0.0007087224,0.0000022939425,0.00012897732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981341,0.0007069373,0.00018228014,0.00030043256,0.0003035878,0.00037271317],"domain_scores_gemma":[0.9945675,0.0015494678,0.0024352383,0.0003242788,0.00038507645,0.00073838845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090223167,0.00064428436,0.0004885894,0.0028711504,0.00043283505,0.0012526333,0.0007045241,0.0008915658,0.0016730934],"category_scores_gemma":[0.0042179907,0.0004529298,0.0013344657,0.0035661568,0.00058185065,0.00095368025,0.00082227506,0.0007259328,0.00021952303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013628997,0.00042825117,0.9880006,0.00008776435,0.0006561957,0.0003793858,0.00024376293,0.0021203072,0.00016286809,0.00029784083,0.00079190894,0.0054682093],"study_design_scores_gemma":[0.000061754225,0.0003146132,0.9968526,0.000018209585,0.00022123182,0.00021225295,0.0003240347,0.0015218459,0.0000944805,0.000053496507,0.00030718162,0.000018357796],"about_ca_topic_score_codex":0.053500243,"about_ca_topic_score_gemma":0.03755288,"teacher_disagreement_score":0.053500243,"about_ca_system_score_codex":0.0050602625,"about_ca_system_score_gemma":0.0010405122,"threshold_uncertainty_score":0.10637766},"labels":[],"label_agreement":null},{"id":"W1979792032","doi":"10.1016/s1098-3015(10)67721-2","title":"PHP20 GENERIC DRUG PRICES REMAIN HIGHER IN CANADA THAN IN THE UNITED STATES","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Business; Economics; Medicine; Pharmacology","score_opus":0.09635049559894734,"score_gpt":0.29200393933434815,"score_spread":0.1956534437354008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979792032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73222417,0.01663859,0.00092548947,0.11771684,0.00059612707,0.000036370224,0.024009591,0.0001785748,0.10767427],"genre_scores_gemma":[0.97509277,0.0033680534,0.00031244173,0.0039465595,0.000109371525,0.000004777448,0.002962276,0.000033286517,0.014170442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884665,0.000061258776,0.000027364085,0.00008180556,0.00046630276,0.00051663886],"domain_scores_gemma":[0.99606174,0.00035162424,0.0006307009,0.0000619093,0.00199801,0.0008959076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007565377,0.0001657667,0.00033800842,0.0009781357,0.0017278057,0.0041546337,0.00054558075,0.0010667666,0.009434311],"category_scores_gemma":[0.004762472,0.00014234727,0.00056196353,0.003103998,0.00071212935,0.001163751,0.0004776237,0.0014238402,0.00052404834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024174198,0.0001749991,0.61505634,0.0003272975,0.0003439794,0.0006848739,0.0008400575,0.002942324,0.0015583913,0.036673293,0.18071038,0.1582706],"study_design_scores_gemma":[0.00008473857,0.000056426205,0.9254865,0.00008466038,0.00010084628,0.00020676058,0.001749163,0.0017725382,0.0010944218,0.0017566874,0.06756978,0.00003752027],"about_ca_topic_score_codex":0.9867126,"about_ca_topic_score_gemma":0.99091107,"teacher_disagreement_score":0.03619202,"about_ca_system_score_codex":0.03619202,"about_ca_system_score_gemma":0.036050323,"threshold_uncertainty_score":0.26259267},"labels":[],"label_agreement":null},{"id":"W1980134073","doi":"10.1016/j.jval.2013.03.743","title":"Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Cancer; Prostate cancer screening; Population; Prostate; Internal medicine; Cancer screening; Gynecology; Oncology; Prostate-specific antigen; Environmental health","score_opus":0.11495073201935023,"score_gpt":0.38708975788268785,"score_spread":0.2721390258633376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980134073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92252934,0.013209668,0.0140787605,0.0061599123,0.00032324408,0.00083636655,0.03644504,0.00011539778,0.006302338],"genre_scores_gemma":[0.9816436,0.0021218518,0.0038633521,0.00031399648,0.00010648913,0.00028149257,0.010655771,0.000021458236,0.0009919386],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9877829,0.010335742,0.0005699523,0.000409944,0.0005739932,0.00032742377],"domain_scores_gemma":[0.967001,0.028319355,0.0022235345,0.0012765452,0.0007612451,0.0004182279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013816738,0.0011013326,0.0024948677,0.0017580446,0.00023293056,0.0018418386,0.0013674313,0.0012398065,0.0024449225],"category_scores_gemma":[0.05028468,0.0008423489,0.003919194,0.0028887307,0.00047899672,0.0016507737,0.0008984182,0.0016682906,0.00029952638],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045082573,0.0012141787,0.38497272,0.0031458251,0.025408108,0.0006461607,0.00011909959,0.40809673,0.0005878988,0.010588363,0.016745763,0.10339263],"study_design_scores_gemma":[0.017872205,0.0057347342,0.24087808,0.0011476043,0.030505909,0.0013669895,0.00033203056,0.6524075,0.0016774659,0.033749208,0.014086626,0.00024169908],"about_ca_topic_score_codex":0.017279387,"about_ca_topic_score_gemma":0.013911744,"teacher_disagreement_score":0.017279387,"about_ca_system_score_codex":0.0019978173,"about_ca_system_score_gemma":0.0021500345,"threshold_uncertainty_score":0.073070824},"labels":[],"label_agreement":null},{"id":"W1980548624","doi":"10.1016/s1098-3015(10)62159-6","title":"PCN17 THE HEALTH CARE COST OF SMOKING IN CANADA","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental health; Health care; Business; Medicine; Economics; Economic growth","score_opus":0.36986206873539157,"score_gpt":0.4110139966545315,"score_spread":0.04115192791913991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980548624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56590563,0.022695001,0.0007162096,0.06253042,0.0014214732,0.00027086338,0.23333234,0.0002057958,0.11292223],"genre_scores_gemma":[0.93434995,0.008764217,0.000544138,0.0018772591,0.0003066623,0.00006813083,0.02115089,0.000060651448,0.032878097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770594,0.00018303531,0.00012376263,0.00012453031,0.0010973242,0.00076535356],"domain_scores_gemma":[0.993447,0.00068878365,0.000592982,0.00010762187,0.003572805,0.0015908031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090072467,0.00035783794,0.00070650654,0.0028038893,0.0020688057,0.0031646534,0.0011920609,0.0011922631,0.008904189],"category_scores_gemma":[0.009305858,0.00042972618,0.00096404686,0.006481698,0.00075597304,0.0005255478,0.00076321774,0.0019137193,0.00046563052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094827655,0.00024060823,0.5281502,0.0008129815,0.0008527732,0.0008639646,0.0005430195,0.021080757,0.00023348766,0.03274208,0.31558928,0.09794253],"study_design_scores_gemma":[0.0003697622,0.000110404224,0.8483373,0.0005041226,0.0004901782,0.0004800408,0.0015650005,0.021246271,0.00038472583,0.003980599,0.12241018,0.0001213246],"about_ca_topic_score_codex":0.9983759,"about_ca_topic_score_gemma":0.99866986,"teacher_disagreement_score":0.866609,"about_ca_system_score_codex":0.133391,"about_ca_system_score_gemma":0.13007322,"threshold_uncertainty_score":0.9678239},"labels":[],"label_agreement":null},{"id":"W1980689904","doi":"10.1016/j.jval.2013.08.256","title":"RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Hazard ratio; Respiratory system; Bronchopulmonary dysplasia; Birth weight; Internal medicine; Pregnancy; Confidence interval","score_opus":0.03527261394622639,"score_gpt":0.31807774398471705,"score_spread":0.28280513003849067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980689904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971083,0.001550802,0.00014808487,0.0004373206,0.00005893286,0.000084622,0.023343569,0.000026865193,0.0032669161],"genre_scores_gemma":[0.99074733,0.000779471,0.00015870067,0.00014038422,0.00001991235,0.000027594879,0.007485488,0.00000630591,0.00063476973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842453,0.00008062402,0.00012477412,0.00022378631,0.00053719344,0.0006091717],"domain_scores_gemma":[0.9973465,0.00009235458,0.000792095,0.00008674173,0.0010718557,0.0006104292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007870987,0.00057903555,0.00052272336,0.001961121,0.0017439232,0.0011353294,0.0022066052,0.00095720997,0.0021325864],"category_scores_gemma":[0.0027218058,0.00054367847,0.001048354,0.004910937,0.0005011554,0.00059454737,0.0011608845,0.0012557481,0.00020658293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063187734,0.000018237854,0.996336,0.000034284403,0.000057286055,0.000100490695,0.00013378848,0.00008467961,0.00008426666,0.00007987213,0.0017246344,0.001283405],"study_design_scores_gemma":[0.0000040768073,0.000013455898,0.99895537,0.000031517746,0.000022272363,0.0000830291,0.00033857138,0.00014724834,0.000028458382,0.00000900685,0.00036070906,0.000006357328],"about_ca_topic_score_codex":0.9794408,"about_ca_topic_score_gemma":0.9886497,"teacher_disagreement_score":0.020559192,"about_ca_system_score_codex":0.017296359,"about_ca_system_score_gemma":0.02593776,"threshold_uncertainty_score":0.12549448},"labels":[],"label_agreement":null},{"id":"W1980721312","doi":"10.1016/j.jval.2013.03.609","title":"Associations between inhibitors, treatment regimen, and bleed frequency and health care practitioner utilisation in the haemophilia treatment centre (HTC): Global results from the haemophilia experiences, results and opportunities (HERO) study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haemophilia; Bleed; Medicine; Regimen; Haemophilia A; On demand; Pediatrics; Physical therapy; Internal medicine; Surgery","score_opus":0.15742800027807105,"score_gpt":0.3701846942367826,"score_spread":0.21275669395871152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980721312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980477,0.00067512016,0.000029147868,0.000117950854,0.000004912847,0.0000047536732,0.00062525977,0.0000019346323,0.00049333484],"genre_scores_gemma":[0.99928373,0.0002550889,0.00002947576,0.00002892048,0.0000076125334,0.0000041433327,0.00027297548,0.0000018607163,0.00011609737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898785,0.00051173463,0.00011192015,0.00008785535,0.00015018779,0.00015048643],"domain_scores_gemma":[0.99427515,0.0016079828,0.0028866783,0.00021455581,0.00026036924,0.00075520115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001058759,0.00017749635,0.00034028772,0.0006542918,0.00036163194,0.0008708627,0.00040843908,0.00077205064,0.0016731961],"category_scores_gemma":[0.005732127,0.00027448582,0.0007133465,0.0020040646,0.00030521592,0.0006118238,0.0007339085,0.0010071635,0.00018481187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015250567,0.000050707516,0.99833953,0.00001851892,0.000118487456,0.000025514659,0.0001558047,0.00003574882,0.000028292483,0.000012863439,0.000106830936,0.00095516193],"study_design_scores_gemma":[0.0000065231366,0.00006176774,0.99931633,0.000008124774,0.00004670809,0.000054348566,0.0003353084,0.000055888035,0.00001018151,0.000009537483,0.000091463786,0.0000037380175],"about_ca_topic_score_codex":0.016563542,"about_ca_topic_score_gemma":0.01921739,"teacher_disagreement_score":0.016563542,"about_ca_system_score_codex":0.00047577044,"about_ca_system_score_gemma":0.0003508302,"threshold_uncertainty_score":0.03293425},"labels":[],"label_agreement":null},{"id":"W1980903352","doi":"10.1016/j.jval.2014.03.1123","title":"Identifying and characterizing trajectories of qol in persons with advanced cancer: Important contributors to decreasing QOL in people with cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rasch model; Quality of life (healthcare); Trajectory; Sample (material); Cancer; Medicine; Psychology; Gerontology; Clinical psychology; Statistics; Developmental psychology; Mathematics","score_opus":0.020390998609687055,"score_gpt":0.3062792508983643,"score_spread":0.2858882522886772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980903352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948906,0.0011408547,0.0008122599,0.0009867443,0.000018108281,0.000048458372,0.00053272885,0.0000110435785,0.0015591553],"genre_scores_gemma":[0.9972326,0.0007176869,0.0012363734,0.00008040637,0.0000067346605,0.000023295517,0.0004916278,0.000004389614,0.000206909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919087,0.00035170873,0.00011322184,0.00006539443,0.00014653601,0.00013229503],"domain_scores_gemma":[0.99615026,0.0012291084,0.0014783704,0.00014005028,0.0005164455,0.00048578187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017120285,0.00030747472,0.00036389785,0.0008362644,0.0008008116,0.0015876649,0.0004010398,0.00046261173,0.0009617859],"category_scores_gemma":[0.01252782,0.000193229,0.00060996064,0.0016667228,0.00030485762,0.0014338585,0.0013051927,0.0013891238,0.000107434564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036598227,0.00008922308,0.98399484,0.000042905995,0.000045315126,0.000020031406,0.00065035996,0.00019434697,0.000064643864,0.00011026546,0.0002663666,0.014485209],"study_design_scores_gemma":[0.000002534027,0.000110546884,0.9946162,0.00009069937,0.000037099686,0.00008479821,0.0026484358,0.0011231655,0.00009891051,0.00046359046,0.000713348,0.000010791734],"about_ca_topic_score_codex":0.011609509,"about_ca_topic_score_gemma":0.02614384,"teacher_disagreement_score":0.011609509,"about_ca_system_score_codex":0.00077044143,"about_ca_system_score_gemma":0.0015610913,"threshold_uncertainty_score":0.023083866},"labels":[],"label_agreement":null},{"id":"W1981020961","doi":"10.1111/j.1524-4733.2008.00390.x","title":"Satisfaction and Adherence in Patients with Iron Overload Receiving Iron Chelation Therapy as Assessed by a Newly Developed Patient Instrument","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology","funders":"","keywords":"Information and Communications Technology; Discriminant validity; Proxy (statistics); Medicine; Psychology; Clinical psychology; Internal consistency; Psychometrics; Statistics; Computer science; Mathematics","score_opus":0.025753772580764993,"score_gpt":0.2679021752747526,"score_spread":0.24214840269398757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981020961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981805,0.000105896914,0.00015805673,0.000109037246,0.000012857552,0.000059647344,0.00016977999,0.000006297627,0.0011980095],"genre_scores_gemma":[0.99829143,0.00011470817,0.0006725626,0.000106373605,0.00001603984,0.000087802386,0.00027174543,0.0000026185915,0.00043667428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978315,0.0010257602,0.00038707393,0.0000904771,0.00047119136,0.00019397572],"domain_scores_gemma":[0.9904694,0.004020579,0.0032694184,0.00029413655,0.0007752105,0.0011712302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032002965,0.00031023257,0.0009239339,0.0010753645,0.0006506869,0.0010060449,0.0003649077,0.0006840266,0.0017755699],"category_scores_gemma":[0.009563554,0.00023352719,0.0014229795,0.0010494111,0.00038041093,0.0005358625,0.00087161805,0.0014242078,0.00017510843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063751533,0.000842356,0.98466533,0.00004713364,0.00030471885,0.000043318923,0.00079247047,0.0002528141,0.00024736545,0.00010088602,0.00034257522,0.0117236385],"study_design_scores_gemma":[0.00011176296,0.001078764,0.9960675,0.000011590025,0.000101908845,0.000105631945,0.0007744984,0.0011897514,0.00013447466,0.0000601646,0.00034729645,0.00001649702],"about_ca_topic_score_codex":0.0023543953,"about_ca_topic_score_gemma":0.0039729965,"teacher_disagreement_score":0.0032002965,"about_ca_system_score_codex":0.00073230616,"about_ca_system_score_gemma":0.0006338397,"threshold_uncertainty_score":0.016924977},"labels":[],"label_agreement":null},{"id":"W1981095025","doi":"10.1016/s1098-3015(10)68752-9","title":"PDB35 ESTIMATING HEALTH-RELATED QUALITY OF LIFE FROM HYPOGLYCEMIA ELICITED FROM NON-DIABETIC AND DIABETIC RESPONDENTS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypoglycemia; Medicine; Diabetes mellitus; Quality (philosophy); Internal medicine; Gerontology; Demography; Endocrinology; Sociology","score_opus":0.0407051014722163,"score_gpt":0.3132564774822903,"score_spread":0.272551376010074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981095025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308383,0.00012495418,0.00007247445,0.0001240506,0.000005320942,0.00006461243,0.0046239267,0.0000036529864,0.0018970965],"genre_scores_gemma":[0.995624,0.00014563701,0.0002744997,0.000093406656,0.0000031657005,0.000030449166,0.0031257204,0.0000025541083,0.00070062844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896264,0.00021187581,0.00011247092,0.000076444536,0.0003625181,0.00027414845],"domain_scores_gemma":[0.9963141,0.000508446,0.0004961209,0.00008673445,0.001773773,0.000820829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012325605,0.00023554241,0.00037732054,0.0010667345,0.0014373199,0.0010375867,0.0007458651,0.00040698028,0.0013684233],"category_scores_gemma":[0.0059294724,0.00022732843,0.000663723,0.0033544495,0.0003022233,0.00023374837,0.00058547215,0.0006760825,0.00023622476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010666669,0.000068001376,0.99610424,0.000016834749,0.000034181696,0.000034161494,0.0002478318,0.00019978217,0.00005157961,0.000047546826,0.00051914493,0.0025699467],"study_design_scores_gemma":[0.000010318125,0.000032517044,0.9982572,0.000010652359,0.000012856137,0.00001910915,0.0007868815,0.0004057197,0.000042408647,0.000015469397,0.0004017639,0.0000052119744],"about_ca_topic_score_codex":0.98750466,"about_ca_topic_score_gemma":0.98790807,"teacher_disagreement_score":0.015665045,"about_ca_system_score_codex":0.015665045,"about_ca_system_score_gemma":0.011865816,"threshold_uncertainty_score":0.11365843},"labels":[],"label_agreement":null},{"id":"W1981434189","doi":"10.1016/j.jval.2012.08.1392","title":"PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Golimumab; Psoriatic arthritis; Infliximab; Physical therapy; Internal medicine; Psoriasis; Arthritis; Rheumatoid arthritis; Dermatology; Disease","score_opus":0.4996306489840518,"score_gpt":0.44468598770321616,"score_spread":0.05494466128083564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981434189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7258707,0.0077761556,0.1342264,0.019067535,0.0003301042,0.0008005496,0.013522789,0.00045175306,0.09795399],"genre_scores_gemma":[0.97177255,0.0010208314,0.0046188314,0.00021308208,0.000049404705,0.00030368307,0.0011730943,0.000030112544,0.020818511],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99743974,0.0015564207,0.00010142548,0.00020556815,0.00019239026,0.00050442433],"domain_scores_gemma":[0.99650097,0.0025884511,0.0002675203,0.00010321355,0.00030188382,0.00023802214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045278575,0.0011969312,0.002319794,0.001840299,0.00063517917,0.0037619453,0.0015884489,0.0031628532,0.008161133],"category_scores_gemma":[0.010444115,0.0010205378,0.0015307721,0.0017424338,0.0012672293,0.0016844276,0.0012134619,0.0018143015,0.000714715],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039037544,0.00007918442,0.0016370056,0.00015404151,0.00017991597,0.00038241912,0.00007421463,0.89308643,0.00017715467,0.092808425,0.0037629502,0.0072678826],"study_design_scores_gemma":[0.00038798992,0.0001284317,0.0026507548,0.00009974988,0.00020442026,0.000113050504,0.000109100576,0.9564654,0.00014476282,0.036803227,0.0028505626,0.00004250948],"about_ca_topic_score_codex":0.07082767,"about_ca_topic_score_gemma":0.022098336,"teacher_disagreement_score":0.07082767,"about_ca_system_score_codex":0.006796682,"about_ca_system_score_gemma":0.0036549692,"threshold_uncertainty_score":0.14083081},"labels":[],"label_agreement":null},{"id":"W1981444985","doi":"10.1016/j.jval.2012.03.1205","title":"PCN88 Cost-Effectiveness Analysis of Plerixafor for Stem Cell Mobilization for Poor Mobilizers in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plerixafor; Medicine; Apheresis; Mobilization; Transplantation; Autologous stem-cell transplantation; Stem cell; Oncology; Internal medicine; Surgery; CXCR4; Inflammation","score_opus":0.06590964393684261,"score_gpt":0.35433582077139053,"score_spread":0.2884261768345479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981444985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96488255,0.007057043,0.00072972954,0.0039289314,0.00006810688,0.0012805938,0.013812771,0.00007413179,0.008166175],"genre_scores_gemma":[0.9905821,0.0026760984,0.0009916315,0.0005577821,0.000030158046,0.00027476647,0.0031122859,0.0000163637,0.0017588936],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9965612,0.0011667197,0.00017572667,0.00019489847,0.0009473805,0.0009539749],"domain_scores_gemma":[0.99576676,0.0011716321,0.0006723617,0.00007497325,0.0011841735,0.0011301299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024259377,0.0007383596,0.0014385326,0.0015647805,0.00087038195,0.0019812125,0.0015076057,0.0007367833,0.0039367215],"category_scores_gemma":[0.008257712,0.00046845083,0.0026900263,0.0032478045,0.00067842484,0.00044976303,0.0007882118,0.0011993959,0.00015763831],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13266297,0.004037061,0.36110088,0.0055816653,0.0098871,0.0009972919,0.0006099036,0.1749806,0.0025973422,0.008790254,0.03859426,0.2601607],"study_design_scores_gemma":[0.030497067,0.017130658,0.80776405,0.0016187124,0.010629173,0.00056062365,0.0020055242,0.10795309,0.0017809939,0.001263292,0.01849521,0.00030160064],"about_ca_topic_score_codex":0.976599,"about_ca_topic_score_gemma":0.97762316,"teacher_disagreement_score":0.096494615,"about_ca_system_score_codex":0.096494615,"about_ca_system_score_gemma":0.10770939,"threshold_uncertainty_score":0.7001207},"labels":[],"label_agreement":null},{"id":"W1981640814","doi":"10.1016/j.jval.2012.03.903","title":"PRM47 Bayesian Regression Models for Estimation of Illness-Attributable Cost from Aggregate Data","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Public Health","funders":"","keywords":"Heteroscedasticity; Econometrics; Statistics; Bayesian probability; Linear regression; Deviance information criterion; Linear model; Regression analysis; Deviance (statistics); Regression; Aggregate (composite); Computer science; Mathematics; Bayesian inference","score_opus":0.5553241385409977,"score_gpt":0.46242685935298067,"score_spread":0.09289727918801705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981640814","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011147118,0.0014202034,0.98067254,0.00090683706,0.00009127038,0.000112218026,0.0023451534,0.001090427,0.002214228],"genre_scores_gemma":[0.42435816,0.0048351055,0.5151255,0.0008147491,0.0006258168,0.0018675049,0.017231405,0.0015538649,0.03358789],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9939587,0.0043248185,0.00024059728,0.00059519784,0.00061983045,0.0002607975],"domain_scores_gemma":[0.9807685,0.015742755,0.0008325705,0.0012985854,0.0012118388,0.00014572879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01349191,0.001227902,0.002686461,0.0024336458,0.00060134684,0.0020244487,0.0032708754,0.0027304539,0.010875863],"category_scores_gemma":[0.055281654,0.0025512534,0.0035141457,0.0033185016,0.0008034613,0.0025029846,0.0015720287,0.004020866,0.0039967876],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024101186,0.00010857134,0.0027174565,0.00024138771,0.00042421222,0.0000889309,0.0000725772,0.81297976,0.00034063857,0.07440398,0.009528673,0.09885282],"study_design_scores_gemma":[0.000036414673,0.0000290561,0.00090473716,0.000047541675,0.0000508367,0.000030329735,0.000005824753,0.9615644,0.00014666493,0.034362864,0.0027990856,0.000022292983],"about_ca_topic_score_codex":0.024549725,"about_ca_topic_score_gemma":0.015754387,"teacher_disagreement_score":0.024549725,"about_ca_system_score_codex":0.0016088187,"about_ca_system_score_gemma":0.0022085926,"threshold_uncertainty_score":0.0713529},"labels":[],"label_agreement":null},{"id":"W1981750179","doi":"10.1016/j.jval.2012.10.017","title":"Core Domains for a Person-Focused Outcome Measurement System in Cancer (PROMS-Cancer Core) for Routine Care: A Scoping Review and Canadian Delphi Consensus","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Cancer Care Ontario; Laurentian University; Sunnybrook Hospital; University of Toronto; University Health Network","funders":"","keywords":"Delphi method; Patient-reported outcome; Delphi; Medicine; Outcome (game theory); Relevance (law); Data collection; Quality of life (healthcare); Family medicine; Psychology; Nursing; Computer science; Artificial intelligence; Political science","score_opus":0.7098607806527949,"score_gpt":0.5635107219169783,"score_spread":0.14635005873581663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981750179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031456843,0.97572124,0.008238278,0.003453954,0.0004950246,0.005132836,0.0009875838,0.000049207454,0.0027761678],"genre_scores_gemma":[0.033084676,0.86977196,0.08135838,0.0020658695,0.000087612796,0.0110052265,0.0019704865,0.000052275842,0.00060343446],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9321935,0.030602513,0.02147281,0.0025241345,0.012220571,0.0009865281],"domain_scores_gemma":[0.9319687,0.0504032,0.0063086036,0.0018315407,0.008835406,0.00065265386],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13797832,0.0020586357,0.00854886,0.017012306,0.0022805561,0.0067082783,0.0038231923,0.002916697,0.0025107851],"category_scores_gemma":[0.112904824,0.0017049968,0.009002935,0.015183999,0.0030133834,0.0043832334,0.0054706,0.0042266278,0.00039892894],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000225454,0.00010193067,0.0023239572,0.4731658,0.002008034,0.00011987208,0.0032540187,0.000812966,0.00069829443,0.009883475,0.006203333,0.50120276],"study_design_scores_gemma":[0.00018396489,0.00021277425,0.007917334,0.8674421,0.00877613,0.00031473686,0.003267226,0.0007649868,0.0009516556,0.0045254366,0.10548045,0.00016316316],"about_ca_topic_score_codex":0.020607501,"about_ca_topic_score_gemma":0.05307904,"teacher_disagreement_score":0.9847963,"about_ca_system_score_codex":0.015203685,"about_ca_system_score_gemma":0.07558889,"threshold_uncertainty_score":0.72970784},"labels":[],"label_agreement":null},{"id":"W1981868458","doi":"10.1016/j.jval.2011.08.801","title":"PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian Analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Acute coronary syndrome; Myocardial infarction; Stroke (engine); Internal medicine; Cardiology; Emergency medicine; Intensive care medicine","score_opus":0.13223122112659944,"score_gpt":0.30803283665559306,"score_spread":0.17580161552899362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981868458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674616,0.008596689,0.00028818264,0.0017030422,0.00005039652,0.00027387796,0.014397273,0.000023677976,0.007205227],"genre_scores_gemma":[0.9883767,0.0028630174,0.0003884466,0.00037495745,0.000052165204,0.00006799747,0.006759479,0.000026860542,0.0010902891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773055,0.0006035694,0.0001238467,0.00025514213,0.0007010494,0.0005858984],"domain_scores_gemma":[0.99482614,0.0019119666,0.001146569,0.00032615138,0.0008346954,0.00095447426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027422716,0.001025844,0.0020313312,0.0012077154,0.0009942629,0.002056428,0.0018162074,0.0011492798,0.0026051311],"category_scores_gemma":[0.008700791,0.0005703893,0.0058790953,0.00442781,0.000929682,0.0008334125,0.0010953487,0.0024849703,0.0001920289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14958946,0.0020171655,0.6812923,0.0025959339,0.020353185,0.0006073302,0.0012273269,0.02407801,0.0010260995,0.0074514686,0.0250808,0.084680915],"study_design_scores_gemma":[0.016406719,0.0021283557,0.94754446,0.0003967029,0.011921477,0.00016588134,0.0010577947,0.013820593,0.00028382783,0.0013121851,0.004716457,0.0002455398],"about_ca_topic_score_codex":0.9484789,"about_ca_topic_score_gemma":0.95649046,"teacher_disagreement_score":0.051521122,"about_ca_system_score_codex":0.026344918,"about_ca_system_score_gemma":0.0298983,"threshold_uncertainty_score":0.19114667},"labels":[],"label_agreement":null},{"id":"W1981949269","doi":"10.1016/s1098-3015(10)68895-x","title":"PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Celecoxib; Osteoarthritis; Medicine; Physical therapy; Internal medicine; Alternative medicine","score_opus":0.05299187663136262,"score_gpt":0.33012523879893735,"score_spread":0.2771333621675747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981949269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92839074,0.019436942,0.0002676368,0.008218867,0.00026667654,0.00039390652,0.018479666,0.000067529414,0.024478054],"genre_scores_gemma":[0.9914499,0.0032401308,0.00026585913,0.0005600842,0.000048195416,0.000036464317,0.0021122394,0.000011113641,0.0022759608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877185,0.00029385218,0.00007902968,0.00007398954,0.00042092023,0.00036034407],"domain_scores_gemma":[0.9983687,0.00027842887,0.00020706926,0.00002154043,0.0006581106,0.0004661223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006089604,0.0003073519,0.0009141284,0.00089131825,0.0008673865,0.001360374,0.000823075,0.00069179334,0.006274625],"category_scores_gemma":[0.0048196157,0.0002783609,0.0015682598,0.001917876,0.0003858809,0.00027346006,0.00040308133,0.0007761295,0.00016400692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0971739,0.0021637084,0.46030933,0.004788901,0.0071627484,0.0015775638,0.0005735893,0.053835344,0.0027488654,0.008664009,0.08280004,0.278202],"study_design_scores_gemma":[0.012602826,0.0032257955,0.9180371,0.0007303794,0.005190444,0.00060552143,0.0012462169,0.03875146,0.00094876473,0.00087649043,0.017625313,0.00015983295],"about_ca_topic_score_codex":0.9877741,"about_ca_topic_score_gemma":0.9908948,"teacher_disagreement_score":0.047455553,"about_ca_system_score_codex":0.047455553,"about_ca_system_score_gemma":0.05569938,"threshold_uncertainty_score":0.3443157},"labels":[],"label_agreement":null},{"id":"W1982075712","doi":"10.1016/j.jval.2014.03.239","title":"Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Ulcerative colitis; Odds ratio; Endoscopy; Placebo; Predictive value; Colonoscopy; Randomized controlled trial; Surgery; Colorectal cancer; Pathology","score_opus":0.009956226513502874,"score_gpt":0.25571165718539535,"score_spread":0.24575543067189248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982075712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981864,0.0005457326,0.0000667345,0.0001184929,0.0000147431565,0.0000043311493,0.00017776359,0.0000033101078,0.00088243035],"genre_scores_gemma":[0.9997148,0.00007083793,0.000041294585,0.000014905928,0.000012966424,0.0000015960362,0.00010207533,7.6033456e-7,0.00004081139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993754,0.00026482865,0.00009405422,0.000053272055,0.000105414416,0.0001071149],"domain_scores_gemma":[0.99492633,0.0018624549,0.0018999113,0.00017218706,0.00028296086,0.00085609336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007939715,0.00033150928,0.0004459118,0.00094313297,0.00034987793,0.00088410964,0.00033740475,0.0006771436,0.0013040296],"category_scores_gemma":[0.0066429437,0.00013209702,0.0005641381,0.0010605757,0.0004335077,0.00043740572,0.00062287814,0.0010975532,0.00014949447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019908688,0.000027484537,0.99871755,0.000006632869,0.000035329234,0.0000557979,0.00002116757,0.000044754644,0.000059414968,0.00001362197,0.000026267955,0.0007928987],"study_design_scores_gemma":[0.000007502992,0.0001603042,0.99880147,0.0000075206726,0.000052769483,0.00023158599,0.0001511383,0.0003840629,0.00005728319,0.00007256981,0.000068723304,0.000005170263],"about_ca_topic_score_codex":0.0013257446,"about_ca_topic_score_gemma":0.0016950704,"teacher_disagreement_score":0.0013257446,"about_ca_system_score_codex":0.00026950228,"about_ca_system_score_gemma":0.0002791681,"threshold_uncertainty_score":0.0043624043},"labels":[],"label_agreement":null},{"id":"W1982238087","doi":"10.1016/j.jval.2012.08.1650","title":"PDB7 Clinical and Resource Utilization Outcomes: Elderly Type 2 Diabetes Patients Initiating Insulin Pens Versus Vials","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Glycemic; Type 2 diabetes; Hazard ratio; Diabetes mellitus; Vial; Insulin; Emergency medicine; Basal (medicine); Confounding; Internal medicine; Emergency department; Retrospective cohort study; Proportional hazards model; Cohort; Basal insulin; Endocrinology; Confidence interval; Nursing","score_opus":0.260492809157935,"score_gpt":0.43904066903157063,"score_spread":0.17854785987363564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982238087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983463,0.00034003233,0.000026297837,0.000064657295,0.000017186221,0.000008198082,0.00028663786,0.0000014557205,0.0009092],"genre_scores_gemma":[0.99861443,0.00023730537,0.00005990848,0.000111991685,0.000028558517,0.00000971714,0.00055462855,0.0000017588193,0.0003817023],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971014,0.00008314486,0.000031754098,0.000047390917,0.000040866267,0.000086699234],"domain_scores_gemma":[0.9989968,0.00032849217,0.0003028712,0.000029088875,0.000051577572,0.0002912498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005319136,0.00018711197,0.00056149316,0.0002844778,0.00025525744,0.0008759663,0.00017035367,0.00033198716,0.004022566],"category_scores_gemma":[0.0025385476,0.000105077794,0.00093931943,0.0005744893,0.00014804977,0.00057921855,0.0003675391,0.0006172821,0.00024819482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060005523,0.0012716826,0.90001017,0.00012099482,0.0006520039,0.00016012281,0.00017019255,0.0006488977,0.0006945456,0.0002203821,0.001247252,0.03479827],"study_design_scores_gemma":[0.0023211935,0.012165831,0.97804505,0.00010544883,0.001074459,0.00036074762,0.0013089302,0.0022575066,0.00061090454,0.00036751645,0.0013487863,0.000033629272],"about_ca_topic_score_codex":0.0038990984,"about_ca_topic_score_gemma":0.0053373873,"teacher_disagreement_score":0.004022566,"about_ca_system_score_codex":0.0005140697,"about_ca_system_score_gemma":0.00050565175,"threshold_uncertainty_score":0.013456821},"labels":[],"label_agreement":null},{"id":"W1982378721","doi":"10.1016/j.jval.2013.08.1748","title":"Estimating Chronic Disease PREVALENCE from Claims Data: Reducing Bias by Accounting for Diseased Individuals Who Do Not Generate Claims","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Bayes' theorem; Disease; Poisson distribution; Medicine; Statistics; Estimator; Prevalence; Sampling bias; Demography; Econometrics; Bayesian probability; Epidemiology; Mathematics; Sample size determination; Internal medicine","score_opus":0.615827141474533,"score_gpt":0.5471703359299652,"score_spread":0.06865680554456777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982378721","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063105285,0.0035492762,0.92559946,0.0038030993,0.00032768966,0.0006261458,0.0013441587,0.00042922248,0.001215662],"genre_scores_gemma":[0.6558623,0.0017132331,0.33481035,0.0019774116,0.00079366553,0.0013008474,0.002026431,0.00019596473,0.0013198493],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.82269365,0.15319781,0.008378367,0.006940689,0.007816438,0.0009730929],"domain_scores_gemma":[0.43941155,0.48743623,0.020529883,0.046426307,0.005394174,0.00080182013],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18386166,0.0016530355,0.0040686093,0.0030953398,0.0010064269,0.003945596,0.0039117644,0.0037557385,0.0017005954],"category_scores_gemma":[0.5095242,0.0015287981,0.0038460991,0.0044212006,0.0028277256,0.004146978,0.0033903166,0.0038401482,0.00041059346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006513513,0.00088062254,0.29666454,0.0029056263,0.011749156,0.00078171137,0.0023128917,0.07003686,0.0019447067,0.08196648,0.0113451425,0.5128988],"study_design_scores_gemma":[0.0013970971,0.0012471759,0.07499055,0.0009935197,0.0063800556,0.0017319988,0.0003682177,0.4670728,0.00527181,0.42740166,0.01290615,0.00023907657],"about_ca_topic_score_codex":0.0032777134,"about_ca_topic_score_gemma":0.002525631,"teacher_disagreement_score":0.8161383,"about_ca_system_score_codex":0.0010890799,"about_ca_system_score_gemma":0.0027912068,"threshold_uncertainty_score":0.972365},"labels":[],"label_agreement":null},{"id":"W1982640454","doi":"10.1016/j.jval.2011.08.821","title":"PCV101 Population Based Study : Impact of Adherence to Antihypertensive Agents on Cardiovascular Issues","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Stroke (engine); Dyslipidemia; Diabetes mellitus; Cohort; Atrial fibrillation; Myocardial infarction; Antihypertensive drug; Confounding; Cardiology; Population; Cohort study; Disease; Blood pressure","score_opus":0.2572403119841725,"score_gpt":0.4145455327213656,"score_spread":0.15730522073719305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982640454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799913,0.00009120848,0.00009533213,0.000066427,0.000012415814,0.00003337558,0.0006343068,0.0000054673706,0.0010623856],"genre_scores_gemma":[0.99784243,0.00005754753,0.000098485696,0.000114009876,0.000027138898,0.000046767746,0.0009585124,0.000008901503,0.0008462558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974509,0.001070065,0.00015695304,0.00036911224,0.00057434256,0.00037866848],"domain_scores_gemma":[0.99788874,0.00052353507,0.00042674562,0.00025154668,0.00035373092,0.00055564044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013382789,0.00071269553,0.00081007,0.0010679059,0.001497672,0.00229926,0.0009803431,0.0014496834,0.0034052345],"category_scores_gemma":[0.0031446528,0.0007181389,0.00093413226,0.0025151693,0.00059220346,0.00096155086,0.00091083895,0.002523747,0.00091756345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012143255,0.00070217904,0.99472624,0.000012337424,0.0001706797,0.00025761942,0.00017938808,0.000031463733,0.00038227142,0.000048500762,0.0003611994,0.0019137136],"study_design_scores_gemma":[0.00007025413,0.0006826712,0.99806803,0.000003957627,0.00007820025,0.0002937258,0.0003687131,0.00015936716,0.00006780937,0.000023581992,0.00017581035,0.000007864723],"about_ca_topic_score_codex":0.024083922,"about_ca_topic_score_gemma":0.024894556,"teacher_disagreement_score":0.024083922,"about_ca_system_score_codex":0.0010475197,"about_ca_system_score_gemma":0.0012980242,"threshold_uncertainty_score":0.047887444},"labels":[],"label_agreement":null},{"id":"W1982661893","doi":"10.1016/s1098-3015(10)62692-7","title":"PCV51 SHORT AND LONG-TERM COST-EFFECTIVENESS OF EARLY AND SUSTAINED DUAL ORAL ANTIPLATELET THERAPY WITH CLOPIDROGREL FOLLOWING PERCUTANEOUS CORONARY INTERVENTION:A CANADIAN ECONOMIC ANALYSIS","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Percutaneous coronary intervention; Medicine; Dual (grammatical number); Term (time); Cardiology; Intervention (counseling); Internal medicine; Intensive care medicine; Myocardial infarction; Nursing","score_opus":0.023288697709602253,"score_gpt":0.3016375212899182,"score_spread":0.278348823580316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982661893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9069991,0.04472488,0.00217558,0.0040693595,0.00024766015,0.0015704444,0.026274137,0.00008063385,0.013858146],"genre_scores_gemma":[0.9883627,0.00471599,0.0010604872,0.00025660777,0.00003554357,0.00012874337,0.004203524,0.000016383532,0.0012199685],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9957242,0.0019789895,0.0002737963,0.0002229747,0.000989174,0.0008108194],"domain_scores_gemma":[0.9930246,0.0039997348,0.0008110903,0.00019912119,0.0011522651,0.00081310584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051938132,0.0014205456,0.0024051836,0.0028622632,0.0011484913,0.0034712185,0.002241204,0.0016394445,0.0039691753],"category_scores_gemma":[0.0220776,0.0010781828,0.006276525,0.0046135187,0.0011144095,0.0010868671,0.00091006607,0.0026101377,0.00013028004],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22957763,0.0029551305,0.19527406,0.012957489,0.04660351,0.0019876882,0.00081118284,0.29861453,0.0024901512,0.02042513,0.032223366,0.15608022],"study_design_scores_gemma":[0.056686804,0.011420993,0.4795239,0.003104003,0.06752125,0.0018108996,0.0019073449,0.34364715,0.0014187383,0.0068746153,0.024945363,0.0011389297],"about_ca_topic_score_codex":0.9148527,"about_ca_topic_score_gemma":0.89501655,"teacher_disagreement_score":0.08514732,"about_ca_system_score_codex":0.060557134,"about_ca_system_score_gemma":0.041505806,"threshold_uncertainty_score":0.4393748},"labels":[],"label_agreement":null},{"id":"W1982873545","doi":"10.1016/j.jval.2012.03.530","title":"PMH85 An Application of Group-Based Modeling Approach for Trajectory Recognition: The Developmental Courses of Hyperactivity and Inattentive Symptoms","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multinomial logistic regression; Trajectory; Demography; Socioeconomic status; Baseline (sea); Multinomial distribution; Psychology; Longitudinal study; Logistic regression; Joint (building); Medicine; Mathematics; Statistics; Population","score_opus":0.11572012945685523,"score_gpt":0.34815249365856743,"score_spread":0.2324323642017122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982873545","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1459398,0.00009604447,0.84607536,0.00038923282,0.000080165315,0.00016607519,0.0016502127,0.0028558634,0.0027472952],"genre_scores_gemma":[0.71636295,0.00007631332,0.2776448,0.000053612737,0.000032606862,0.00025765842,0.0014515509,0.0002720106,0.0038485462],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996191,0.00016429034,0.000017393186,0.00011676101,0.000056398487,0.000026080497],"domain_scores_gemma":[0.9986349,0.0009708835,0.00006939395,0.00014606824,0.00013183261,0.000046931018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010629218,0.00047851933,0.000610284,0.0007674986,0.00042485117,0.00083409256,0.0010239615,0.0006824827,0.004644808],"category_scores_gemma":[0.0039952104,0.0003008067,0.00094808056,0.00060848263,0.00017236698,0.00057688693,0.0006811523,0.0007751701,0.00054214185],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004449636,0.00039780463,0.043932755,0.00013451642,0.00063638296,0.00037454776,0.0007264992,0.59871125,0.0032439951,0.01717973,0.006854235,0.32736325],"study_design_scores_gemma":[0.000007362017,0.000028627372,0.00180293,0.000003904449,0.000021068881,0.000023766333,0.00003150603,0.9937285,0.0003097216,0.0034114781,0.00062471133,0.0000064398228],"about_ca_topic_score_codex":0.028273415,"about_ca_topic_score_gemma":0.021458376,"teacher_disagreement_score":0.028273415,"about_ca_system_score_codex":0.0005163646,"about_ca_system_score_gemma":0.0011503027,"threshold_uncertainty_score":0.05621767},"labels":[],"label_agreement":null},{"id":"W1983266155","doi":"10.1016/j.jval.2012.03.095","title":"PHP18 The Impact of Patent Expiries on Future Drug Spending in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Generic drug; Prescription drug; Market share; Competition (biology); Business; Audit; Medical prescription; Drug; Drug prices; Product (mathematics); Brand names; Public economics; Marketing; Medicine; Economics; Pharmacology; Accounting","score_opus":0.1685645391951565,"score_gpt":0.3302935532945758,"score_spread":0.16172901409941934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983266155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5129524,0.014536566,0.00055444986,0.24211863,0.001401061,0.00015210874,0.07459132,0.0002210291,0.15347253],"genre_scores_gemma":[0.93377125,0.004699052,0.000245825,0.005351739,0.00054412056,0.00003039028,0.0059085614,0.000076929995,0.049372237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941637,0.0003236773,0.00021152564,0.00030658802,0.002543069,0.002451397],"domain_scores_gemma":[0.9699074,0.005798218,0.0030205578,0.00041488468,0.013799795,0.007059126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030349207,0.00030287696,0.00090808247,0.0029787915,0.0031755522,0.008458123,0.0013780522,0.003218128,0.01437024],"category_scores_gemma":[0.023082167,0.00044674697,0.0016055997,0.0037988906,0.0015282604,0.0012422191,0.0012580989,0.004420021,0.0007056335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014779504,0.0002963585,0.43298593,0.0005976649,0.00081967283,0.001187152,0.0012302436,0.019789424,0.0006053932,0.1127728,0.37037808,0.05785933],"study_design_scores_gemma":[0.00032251823,0.0001378595,0.7881999,0.00035066847,0.00049230433,0.000274557,0.002260137,0.014264438,0.000980842,0.007084002,0.18542638,0.00020643046],"about_ca_topic_score_codex":0.99623966,"about_ca_topic_score_gemma":0.9973314,"teacher_disagreement_score":0.14049959,"about_ca_system_score_codex":0.14049959,"about_ca_system_score_gemma":0.177694,"threshold_uncertainty_score":0.99689865},"labels":[],"label_agreement":null},{"id":"W1983493219","doi":"10.1016/j.jval.2010.09.002","title":"Another Study Showing that Two Preference-Based Measures of Health-Related Quality of Life (EQ-5D and SF-6D) are Not Interchangeable. But Why Should We Expect Them to be?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Comparability; EQ-5D; Descriptive statistics; Framing (construction); Quality of life (healthcare); Framing effect; Valuation (finance); Psychology; Medicine; Applied psychology; Social psychology; Statistics; Health related quality of life; Mathematics","score_opus":0.9434072829642454,"score_gpt":0.4452543826606597,"score_spread":0.49815290030358567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983493219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7778221,0.02058312,0.029921595,0.057819817,0.0033747435,0.00061874604,0.0042867507,0.00009509881,0.10547804],"genre_scores_gemma":[0.9444203,0.005959673,0.010531935,0.023313468,0.00080917624,0.00045054345,0.0014251433,0.00010324334,0.012986651],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98502296,0.009611588,0.0010457496,0.0013883121,0.0024296397,0.0005017219],"domain_scores_gemma":[0.73351634,0.23069432,0.009875464,0.008486732,0.016034389,0.0013927937],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.026394106,0.00083529524,0.00090728945,0.002599093,0.0016536942,0.0026434448,0.0009824084,0.002304556,0.014156],"category_scores_gemma":[0.16677521,0.000403109,0.0030034361,0.0042113303,0.0013920274,0.0027955887,0.0018853588,0.0037677381,0.0011423342],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015925111,0.0036235154,0.355202,0.008757304,0.010298221,0.0025260272,0.021055335,0.0020437515,0.0029780907,0.10290691,0.11098993,0.36369383],"study_design_scores_gemma":[0.005018715,0.0049518417,0.48371512,0.008543646,0.02354897,0.0058713006,0.023448845,0.005687019,0.015509535,0.0955692,0.32745877,0.00067700783],"about_ca_topic_score_codex":0.016848657,"about_ca_topic_score_gemma":0.017945819,"teacher_disagreement_score":0.9736059,"about_ca_system_score_codex":0.0027130896,"about_ca_system_score_gemma":0.0038418556,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W1983498363","doi":"10.1016/j.jval.2012.03.963","title":"PDB42 Health Care Resources Utilization and Cost for Hypoglycemia and Metabolic Acidosis in Type Ii Diabetes: an Analysis of the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hypoglycemia; Metabolic acidosis; Intensive care medicine; Diabetes mellitus; Acidosis; Type 2 diabetes; Emergency medicine; Complication; Pediatrics; Internal medicine; Endocrinology","score_opus":0.09970736455137315,"score_gpt":0.38521560358663337,"score_spread":0.28550823903526024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983498363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5979414,0.000911912,0.00037584084,0.0002994846,0.00002332198,0.00010066889,0.39841586,0.00016314466,0.001768397],"genre_scores_gemma":[0.653089,0.00053889595,0.0012742536,0.00024682787,0.00003560314,0.00025782653,0.34371698,0.00006975831,0.0007709121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974663,0.00075714826,0.00045655417,0.0005637912,0.00059508363,0.00016103515],"domain_scores_gemma":[0.98763275,0.0066823536,0.0025017362,0.0012913523,0.001387545,0.00050423277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025950945,0.00044907737,0.0012567275,0.0033327248,0.00027841586,0.0015570015,0.0013153595,0.0006123249,0.0057795173],"category_scores_gemma":[0.016764428,0.00035300184,0.0017445425,0.008892275,0.00023700105,0.00081524043,0.00081707316,0.00055166485,0.0010314913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00531753,0.00035717947,0.9293004,0.0009506346,0.00300367,0.00029044691,0.00020077308,0.006742247,0.00032013885,0.0010078333,0.030027395,0.022481773],"study_design_scores_gemma":[0.0007646839,0.00024510687,0.975901,0.00012893075,0.0007371152,0.000633421,0.00039498924,0.010588168,0.0003368372,0.0003585868,0.009855543,0.000055621702],"about_ca_topic_score_codex":0.047529675,"about_ca_topic_score_gemma":0.023238376,"teacher_disagreement_score":0.047529675,"about_ca_system_score_codex":0.0017342832,"about_ca_system_score_gemma":0.001641647,"threshold_uncertainty_score":0.094506025},"labels":[],"label_agreement":null},{"id":"W1983883585","doi":"10.1016/j.jval.2012.08.2151","title":"PCN111 The Value of Personalizing Medicine: Medical Oncologists' and Patients' Perspectives on Genomic Testing of Breast Tumours in Chemotherapy Treatment Decisions","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Medicine; Breast cancer; Personalized medicine; Family medicine; Oncology; Internal medicine; Test (biology); Adjuvant chemotherapy; Precision medicine; Clinical trial; Qualitative research; Cancer; Bioinformatics; Pathology","score_opus":0.041398487211644436,"score_gpt":0.3378483142578909,"score_spread":0.29644982704624645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983883585","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010709443,0.0063270014,0.00072734564,0.9149439,0.0015135675,0.000011047632,0.000057576697,0.000008428515,0.065701716],"genre_scores_gemma":[0.69108236,0.014424333,0.0032459083,0.26554254,0.007756609,0.000060797778,0.00008647282,0.00007851933,0.017722443],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9840894,0.011879777,0.00033260428,0.00038026102,0.0024968085,0.00082126906],"domain_scores_gemma":[0.938148,0.04624316,0.0024573896,0.000909883,0.0057193264,0.006522233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01409041,0.00024533205,0.0005377039,0.0007592146,0.0041339053,0.011180081,0.0011782073,0.007261447,0.009466012],"category_scores_gemma":[0.049624015,0.0003361127,0.0004101291,0.00089994445,0.011808146,0.0047704955,0.0043672766,0.012187346,0.00082141056],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006432052,0.00027012447,0.025971549,0.00048492858,0.00013876938,0.002685717,0.015183332,0.0023181846,0.0007293629,0.20551209,0.472399,0.27366382],"study_design_scores_gemma":[0.00019247897,0.00022524285,0.016186243,0.0015310758,0.00010553135,0.0031092972,0.025967335,0.002229613,0.0007224391,0.28828254,0.66121393,0.00023430686],"about_ca_topic_score_codex":0.014924972,"about_ca_topic_score_gemma":0.04304168,"teacher_disagreement_score":0.014924972,"about_ca_system_score_codex":0.009161122,"about_ca_system_score_gemma":0.013953493,"threshold_uncertainty_score":0.074518085},"labels":[],"label_agreement":null},{"id":"W1984056668","doi":"10.1016/j.jval.2014.03.1610","title":"Expected Cost-Utility Of Quadrivalent Influenza Vaccine Under A Universal Influenza Immunization Program In Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Influenza season; Vaccination; Context (archaeology); Influenza vaccine; Family medicine; Virology; Environmental health; Geography","score_opus":0.10796801393252238,"score_gpt":0.37866680626958577,"score_spread":0.2706987923370634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984056668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9409558,0.008078608,0.001158225,0.005542463,0.00011538355,0.0002677927,0.029933726,0.00004851178,0.01389941],"genre_scores_gemma":[0.99074286,0.0018767986,0.0005026998,0.00029571174,0.000016911858,0.000033408316,0.0033729512,0.000007905155,0.0031508387],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99788946,0.00047478138,0.00015435608,0.00015777815,0.0005014839,0.00082201796],"domain_scores_gemma":[0.9962781,0.0006746013,0.00053161307,0.000077820885,0.0015518366,0.00088604074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016896455,0.00042743742,0.0008545589,0.00079350866,0.0009350699,0.0017800608,0.0014564826,0.0007564451,0.0030839574],"category_scores_gemma":[0.0070308913,0.0004802851,0.0018591372,0.0023284878,0.0005916979,0.0005178741,0.00055223674,0.0010810822,0.0001597385],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051349928,0.0003017486,0.8515767,0.00087199936,0.0029575047,0.000965846,0.00056414393,0.08150146,0.0007868097,0.00934808,0.015439246,0.030551482],"study_design_scores_gemma":[0.0007824038,0.00046582415,0.93412846,0.00037442642,0.0016171467,0.00040029173,0.001191021,0.05222412,0.00042776464,0.0013171933,0.0069689914,0.0001021916],"about_ca_topic_score_codex":0.9958281,"about_ca_topic_score_gemma":0.99559975,"teacher_disagreement_score":0.11074585,"about_ca_system_score_codex":0.11074585,"about_ca_system_score_gemma":0.069680065,"threshold_uncertainty_score":0.80352116},"labels":[],"label_agreement":null},{"id":"W1984365279","doi":"10.1016/s1098-3015(10)72617-6","title":"PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Methotrexate; Medicine; Internal medicine; Physical therapy; Rituximab","score_opus":0.03102628711597862,"score_gpt":0.32510420139191865,"score_spread":0.29407791427594004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984365279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6083555,0.10910495,0.0024360975,0.010021103,0.0010900795,0.0053482056,0.21100959,0.0002533223,0.052381214],"genre_scores_gemma":[0.9428396,0.01456996,0.002852393,0.001995264,0.00021779243,0.0008287201,0.030727092,0.000051908246,0.0059171226],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99509525,0.002066857,0.00028191414,0.0002524126,0.0017503221,0.0005531768],"domain_scores_gemma":[0.99479693,0.0015968784,0.00079099135,0.0001609102,0.001727941,0.00092638144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038072767,0.0014242803,0.0028901787,0.0022849285,0.0007975374,0.0015566042,0.0018070026,0.00085928576,0.0065235286],"category_scores_gemma":[0.012976407,0.000765549,0.007281684,0.0050748554,0.00048582474,0.0004983634,0.00077409786,0.0015293187,0.00032385797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.345438,0.0015537387,0.11887136,0.02414674,0.06496482,0.00097383035,0.00039581867,0.116864264,0.002592856,0.0105477385,0.12155537,0.19209546],"study_design_scores_gemma":[0.14213,0.011580719,0.64638996,0.0051392852,0.059599444,0.00077320734,0.00048870326,0.0651924,0.00096475985,0.0017971041,0.06534978,0.00059461343],"about_ca_topic_score_codex":0.9582603,"about_ca_topic_score_gemma":0.95813775,"teacher_disagreement_score":0.06305187,"about_ca_system_score_codex":0.06305187,"about_ca_system_score_gemma":0.061757296,"threshold_uncertainty_score":0.45747548},"labels":[],"label_agreement":null},{"id":"W1984409207","doi":"10.1016/j.jval.2013.03.495","title":"Cost-effectiveness of onabotulinumtoxinA for prophylaxis of headaches in adults with chronic migraine in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Allergan (Canada)","funders":"","keywords":"Medicine; Headaches; Chronic Migraine; Migraine; Absenteeism; Cost effectiveness; Quality of life (healthcare); Placebo; Presenteeism; Cohort; Quality-adjusted life year; Observational study; Physical therapy; Pediatrics; Internal medicine; Psychiatry; Alternative medicine","score_opus":0.043580499574816675,"score_gpt":0.3023273814371241,"score_spread":0.25874688186230743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984409207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95473576,0.028065428,0.00008764254,0.003557526,0.00015754384,0.00029524433,0.005503857,0.000010184767,0.0075868564],"genre_scores_gemma":[0.99155325,0.006140225,0.00017289545,0.00037715756,0.00003518773,0.000034452165,0.0011374464,0.0000024472063,0.0005467582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821174,0.00052078464,0.00018804063,0.000090935704,0.00057598186,0.00041261315],"domain_scores_gemma":[0.9968911,0.0007312921,0.00064350275,0.000057490088,0.0009907422,0.0006859216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011542037,0.0003321027,0.00088771567,0.00088007574,0.00082282966,0.0012520427,0.0008872658,0.0006804198,0.0019945283],"category_scores_gemma":[0.008860871,0.00027318668,0.0017622085,0.0024880974,0.0005013965,0.0004457709,0.0005942174,0.0009042753,0.000053341875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03088742,0.001360941,0.8255679,0.0043655545,0.007434413,0.00051628746,0.00052990316,0.0082070865,0.0005154467,0.0025266204,0.01185913,0.10622928],"study_design_scores_gemma":[0.005720302,0.0018569438,0.9704846,0.0015716256,0.0060852617,0.00027943513,0.001129187,0.0068446114,0.00023167358,0.00040636834,0.0053092977,0.00008066341],"about_ca_topic_score_codex":0.9732276,"about_ca_topic_score_gemma":0.98360324,"teacher_disagreement_score":0.95359117,"about_ca_system_score_codex":0.046408836,"about_ca_system_score_gemma":0.04520771,"threshold_uncertainty_score":0.33672124},"labels":[],"label_agreement":null},{"id":"W1984627843","doi":"10.1016/j.jval.2012.03.1088","title":"PIH56 Measuring Quality of Life in Facial Aesthetic Patients: Field-Testing of a New Modular System (the FACE-Q)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Cronbach's alpha; Scale (ratio); Face validity; Patient satisfaction; Patient-reported outcome; Quality of life (healthcare); Medicine; Physical therapy; Psychology; Psychometrics; Clinical psychology; Surgery; Nursing; Developmental psychology","score_opus":0.19312952834844882,"score_gpt":0.35915619842530067,"score_spread":0.16602667007685185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984627843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970714,0.000031090443,0.00066278124,0.00005549849,0.000022363727,0.00029831074,0.00025712093,0.000016777443,0.0015847969],"genre_scores_gemma":[0.9947903,0.00004395002,0.0027270562,0.00009329801,0.000018751685,0.00039302916,0.00040279955,0.000012881566,0.001517957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988514,0.00044512574,0.00009639538,0.0001302052,0.00036970805,0.000107033724],"domain_scores_gemma":[0.9981822,0.000826624,0.00023050338,0.00017774537,0.0003653835,0.00021756106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028507905,0.0004777072,0.00038961557,0.00063123443,0.00032099526,0.00043879575,0.0004413297,0.00044098633,0.0046724924],"category_scores_gemma":[0.003989625,0.00020118056,0.0007978354,0.0003990569,0.00039794727,0.00066810386,0.00085592875,0.0006365797,0.000808686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016844548,0.0075778514,0.73474145,0.0001479721,0.0002923512,0.00019396255,0.0015008152,0.0017827477,0.021284461,0.0005583634,0.0023548063,0.21272068],"study_design_scores_gemma":[0.0011087223,0.021155322,0.96485615,0.000022536187,0.0001212156,0.0003638832,0.0006356764,0.0030052925,0.0062420494,0.0003457451,0.0020958993,0.00004744857],"about_ca_topic_score_codex":0.0012890514,"about_ca_topic_score_gemma":0.001110988,"teacher_disagreement_score":0.0046724924,"about_ca_system_score_codex":0.0003506737,"about_ca_system_score_gemma":0.00038422726,"threshold_uncertainty_score":0.01563108},"labels":[],"label_agreement":null},{"id":"W1984790513","doi":"10.1111/j.1524-4733.2009.00531.x","title":"Economic Evaluation of Atorvastatin for Prevention of Recurrent Stroke Based on the SPARCL Trial","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Atorvastatin; Stroke (engine); Life expectancy; Quality-adjusted life year; Emergency medicine; Clinical trial; Cost–benefit analysis; Economic evaluation; Health care; Cost effectiveness; Internal medicine; Environmental health; Population","score_opus":0.11316720568272373,"score_gpt":0.3796711519156389,"score_spread":0.2665039462329152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984790513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93405366,0.041482396,0.003871856,0.006322482,0.001151598,0.001484629,0.0038303987,0.00014032399,0.007662592],"genre_scores_gemma":[0.99411976,0.0025795929,0.0007501292,0.0005114086,0.00020848741,0.0002609241,0.0009915532,0.0000111420495,0.00056706707],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.98645616,0.011820585,0.0004001398,0.0003285105,0.0005661661,0.0004283149],"domain_scores_gemma":[0.9908188,0.0063404953,0.0010722559,0.0005392644,0.00041883282,0.0008102833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010657573,0.001634409,0.0043743756,0.0007504348,0.00032853417,0.0015237108,0.0009070539,0.0016788025,0.004394441],"category_scores_gemma":[0.018811844,0.0005066205,0.0053154086,0.0006474353,0.00088236923,0.0011450032,0.00090082217,0.0025965367,0.0002935435],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9396247,0.0009541126,0.0043115853,0.0021091548,0.015602725,0.00013293637,0.000040914783,0.007156909,0.00047137678,0.0013932263,0.0020560273,0.026146267],"study_design_scores_gemma":[0.81609106,0.051481824,0.027911374,0.0011625957,0.050576936,0.0003521979,0.00020626819,0.040026147,0.0009812803,0.0057961447,0.005231284,0.00018285574],"about_ca_topic_score_codex":0.0035864827,"about_ca_topic_score_gemma":0.0033697307,"teacher_disagreement_score":0.010657573,"about_ca_system_score_codex":0.0025818446,"about_ca_system_score_gemma":0.0018355743,"threshold_uncertainty_score":0.056363344},"labels":[],"label_agreement":null},{"id":"W1985698909","doi":"10.1016/j.jval.2011.08.1153","title":"PCN52 Economic Impact of Healthcare Resource Utilisation Patterns Among Patients Diagnosed with Advanced Melanoma in the UK, Italy, and France: Results From a Retrospective, Longitudinal Survey (Melody Study)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Observational study; Health care; Emergency medicine; Indirect costs; Demography; Longitudinal study; Retrospective cohort study; Family medicine; Total cost; Pediatrics; Internal medicine","score_opus":0.2575587007074151,"score_gpt":0.3797984415554727,"score_spread":0.12223974084805761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985698909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991383,0.00044388807,0.00003970562,0.00019030039,0.000010883866,0.000009290935,0.0070078583,0.000005888744,0.000909182],"genre_scores_gemma":[0.994261,0.00013892972,0.00003632856,0.000040513107,0.000011470548,0.000014670579,0.004954899,0.0000036705594,0.00053848996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926907,0.00031359342,0.000074623764,0.000086608095,0.00011872203,0.00013737669],"domain_scores_gemma":[0.9971411,0.00058242865,0.0013163371,0.00020241181,0.00035230588,0.00040535018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009662203,0.00024492142,0.0002652905,0.0013699842,0.00020635006,0.00091983937,0.0003895034,0.00052622723,0.0029363893],"category_scores_gemma":[0.004624048,0.00018476078,0.0009490295,0.0019674394,0.00018110148,0.00047948663,0.0007437592,0.00047565773,0.0005100899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015047338,0.000020607707,0.99774534,0.000010026082,0.000098887096,0.000038032642,0.000036303252,0.00013587682,0.000027575528,0.000017703627,0.0005956357,0.0011236109],"study_design_scores_gemma":[0.0000038964567,0.0000148988165,0.999744,0.000002941054,0.000008866514,0.000021499027,0.00003174724,0.00005434331,0.0000049388004,0.000003019572,0.00010845225,0.0000014373372],"about_ca_topic_score_codex":0.0656644,"about_ca_topic_score_gemma":0.044387575,"teacher_disagreement_score":0.0656644,"about_ca_system_score_codex":0.0011130827,"about_ca_system_score_gemma":0.00043844705,"threshold_uncertainty_score":0.13056439},"labels":[],"label_agreement":null},{"id":"W1985863126","doi":"10.1016/j.jval.2014.03.487","title":"Partially Covered Self-Expandable Metal Stents are More Cost-Effective When Compared to Plastic Stents for Patients with Distal Malignant Biliary Obstruction","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Endoscopic retrograde cholangiopancreatography; Stent; Occlusion; Surgery; Percutaneous; Randomized controlled trial; Radiology; Palliative care; Cost effectiveness","score_opus":0.019947464601942938,"score_gpt":0.26772380129703904,"score_spread":0.2477763366950961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985863126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99088895,0.006808662,0.0001352287,0.00064771017,0.00007455905,0.000012919059,0.00015269882,0.000009919302,0.0012693553],"genre_scores_gemma":[0.9980551,0.0011960381,0.0001646775,0.00016042046,0.000082754355,0.0000035839164,0.00018427797,0.0000027842977,0.00015036672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977595,0.00008781681,0.000032128683,0.000022173645,0.000048366335,0.00003347667],"domain_scores_gemma":[0.9989322,0.0006016774,0.00023739312,0.000031325893,0.000055102744,0.00014218688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002484143,0.00020214081,0.00059619837,0.00045334513,0.00014410986,0.0005759606,0.00012302086,0.00039179463,0.002490854],"category_scores_gemma":[0.0036431577,0.000100326564,0.0009318321,0.00060620566,0.00015933081,0.00059451675,0.0002273616,0.00035333232,0.00018033192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03226335,0.0008701174,0.6578586,0.0006629578,0.0013939866,0.0013962256,0.00017719915,0.0010980983,0.0055929385,0.000395978,0.0019362357,0.2963542],"study_design_scores_gemma":[0.0010216959,0.007720736,0.98129565,0.00016455248,0.0013881832,0.0025894505,0.00035374376,0.0012628847,0.0012489319,0.0003986428,0.0025258043,0.000029743329],"about_ca_topic_score_codex":0.0003585118,"about_ca_topic_score_gemma":0.0007376109,"teacher_disagreement_score":0.002490854,"about_ca_system_score_codex":0.00022920559,"about_ca_system_score_gemma":0.00032106077,"threshold_uncertainty_score":0.008332729},"labels":[],"label_agreement":null},{"id":"W1985932235","doi":"10.1016/j.jval.2014.03.446","title":"A Canadian Cost Impact Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide in Multiple Myeloma Patients Ineligible for Stem Cell Transplant","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Ottawa Hospital; Thames Valley Children's Centre","funders":"","keywords":"Lenalidomide; Multiple myeloma; Bortezomib; Medicine; Internal medicine; Adverse effect; Oncology; Pharmacist; Pharmacy; Family medicine","score_opus":0.06781060032788233,"score_gpt":0.32664158267949694,"score_spread":0.2588309823516146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985932235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88470256,0.04557497,0.0017156063,0.01444014,0.00077588204,0.0020946846,0.027185503,0.00010922012,0.023401314],"genre_scores_gemma":[0.9781482,0.0067225466,0.0023240168,0.0021727772,0.00015098072,0.00031981952,0.007543503,0.000037189955,0.002580905],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99564725,0.0015369231,0.00022478653,0.00032151164,0.0011583444,0.0011111527],"domain_scores_gemma":[0.9933143,0.0025308866,0.00082637323,0.00019663663,0.0016429801,0.001488776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030865606,0.0018290961,0.0025263557,0.002206173,0.0019605742,0.003191148,0.0029782818,0.0016898917,0.0066126357],"category_scores_gemma":[0.012674284,0.00091801863,0.0073233466,0.005813502,0.0012208364,0.0008955682,0.0014271819,0.0033172434,0.00022114802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28567323,0.0048418185,0.219916,0.008879612,0.041641053,0.0019869031,0.0007122777,0.17358589,0.0023867649,0.01714022,0.08175986,0.16147637],"study_design_scores_gemma":[0.12215459,0.016058432,0.610366,0.004301917,0.061106656,0.0014746112,0.002629136,0.13090229,0.0013158103,0.006755004,0.0417838,0.0011516418],"about_ca_topic_score_codex":0.97370726,"about_ca_topic_score_gemma":0.9706087,"teacher_disagreement_score":0.12386624,"about_ca_system_score_codex":0.12386624,"about_ca_system_score_gemma":0.094138205,"threshold_uncertainty_score":0.8987167},"labels":[],"label_agreement":null},{"id":"W1985991035","doi":"10.1111/j.1524-4733.2006.00140.x","title":"Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medtronic","keywords":"Amiodarone; Medicine; Sudden cardiac death; Implantable cardioverter-defibrillator; Euros; Cardiology; Internal medicine; Heart failure; Emergency medicine; Intensive care medicine; Atrial fibrillation","score_opus":0.04944143327188163,"score_gpt":0.32448441750422835,"score_spread":0.27504298423234674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985991035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769126,0.01507806,0.0014737017,0.00094258774,0.00049163273,0.0008630217,0.0018903163,0.00003972831,0.002308283],"genre_scores_gemma":[0.99531794,0.0021881314,0.00062822294,0.0002624029,0.00018119869,0.0002501446,0.000616253,0.0000063997686,0.0005493189],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99614835,0.0029485975,0.00017421295,0.00020316888,0.000196735,0.00032889337],"domain_scores_gemma":[0.9925033,0.0058300947,0.0006272941,0.00026063254,0.00021754619,0.00056114275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053195297,0.0027113482,0.0037785247,0.00118732,0.00038011148,0.0013447284,0.001582193,0.0021200133,0.0068717366],"category_scores_gemma":[0.0111508835,0.0012397687,0.009629513,0.00095725694,0.0011246498,0.0016262276,0.001030405,0.0033639243,0.0002866034],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9569014,0.001789708,0.0039696093,0.0016032287,0.014531788,0.00014649729,0.00004594389,0.008972921,0.000894939,0.00055376574,0.00038246255,0.010207725],"study_design_scores_gemma":[0.68136555,0.15158233,0.039197348,0.0005107678,0.09179413,0.00043066655,0.00029713855,0.028988397,0.0013424469,0.0024552324,0.0018414534,0.00019463718],"about_ca_topic_score_codex":0.006183395,"about_ca_topic_score_gemma":0.004753988,"teacher_disagreement_score":0.0068717366,"about_ca_system_score_codex":0.002481946,"about_ca_system_score_gemma":0.0013117372,"threshold_uncertainty_score":0.028132737},"labels":[],"label_agreement":null},{"id":"W1986048654","doi":"10.1016/j.jval.2013.03.657","title":"Cost Of Lost Productivity Due To Prostate Cancer: Evidence From Us National Survey Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Medical Expenditure Panel Survey; Cancer; Prostate; Demography; Indirect costs; Population; Gynecology; Health care; Internal medicine; Environmental health; Health insurance","score_opus":0.7484706441441304,"score_gpt":0.49857626945084527,"score_spread":0.24989437469328518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986048654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8490407,0.06369315,0.0021088417,0.0057580597,0.00048419915,0.00010349089,0.07177895,0.0000767091,0.006955857],"genre_scores_gemma":[0.9749921,0.009323333,0.00034277127,0.00032070497,0.000113302056,0.000045338176,0.014443553,0.000009263221,0.00040961563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917041,0.0046681683,0.0009215772,0.00042578118,0.0018440502,0.00043644878],"domain_scores_gemma":[0.9271257,0.04470528,0.018644875,0.002780321,0.00544976,0.0012941766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007432621,0.0004920355,0.0008626139,0.0050816955,0.00027631142,0.0014814868,0.0014111338,0.00083631696,0.0019728774],"category_scores_gemma":[0.06987278,0.00061834964,0.002634583,0.00837478,0.0007697528,0.0014958455,0.001121357,0.0017263801,0.00028596772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015941389,0.00022884658,0.94871616,0.001627819,0.005248049,0.00014061901,0.00016378248,0.0055373725,0.000033550565,0.0009813027,0.006689128,0.029039223],"study_design_scores_gemma":[0.00021679646,0.0002979323,0.98603606,0.00082034984,0.0019543993,0.00035557617,0.0004372961,0.0030490027,0.00010182629,0.0016774962,0.0050066076,0.000046705405],"about_ca_topic_score_codex":0.04238536,"about_ca_topic_score_gemma":0.029989239,"teacher_disagreement_score":0.04238536,"about_ca_system_score_codex":0.002269881,"about_ca_system_score_gemma":0.0013661003,"threshold_uncertainty_score":0.08427733},"labels":[],"label_agreement":null},{"id":"W1986511872","doi":"10.1016/j.jval.2012.08.808","title":"PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in Germany","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Studies","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Quarter (Canadian coin); Medicine; Psychiatry; Indirect costs; Health care; Diagnosis of schizophrenia; Inpatient care; Psychosis; Geography; Business","score_opus":0.06400115011933152,"score_gpt":0.39382248393996316,"score_spread":0.3298213338206316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986511872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99873453,0.0003159276,0.0000124845665,0.0001598785,0.0000034734576,0.0000014480491,0.00039951678,0.0000010155239,0.00037176907],"genre_scores_gemma":[0.99940157,0.00017464944,0.000017195087,0.000025496707,0.0000041290286,0.0000021747333,0.00022918583,8.638167e-7,0.00014471672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963164,0.000092295224,0.000049742266,0.0000353188,0.000054298453,0.00013668112],"domain_scores_gemma":[0.99926955,0.00011907337,0.0003810624,0.000018762057,0.000051066603,0.00016049408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020614003,0.00012835581,0.00019660003,0.0011896685,0.0003962302,0.00068728044,0.00021062364,0.00036659726,0.002029118],"category_scores_gemma":[0.0014328,0.00015671554,0.00035014725,0.0018087976,0.00024990615,0.0003822817,0.0004702023,0.00037267126,0.00014715185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002381276,0.00005788311,0.994447,0.000022813456,0.00009291947,0.00017280721,0.0002037402,0.00018391285,0.00016105853,0.00015712998,0.00037908414,0.0038834913],"study_design_scores_gemma":[0.000004005689,0.000027101742,0.99912924,0.0000106872885,0.000021152076,0.00011244678,0.00033028523,0.00013335644,0.000024328041,0.000032033087,0.0001716076,0.0000038108626],"about_ca_topic_score_codex":0.04106079,"about_ca_topic_score_gemma":0.052107733,"teacher_disagreement_score":0.04106079,"about_ca_system_score_codex":0.0015467162,"about_ca_system_score_gemma":0.00086590595,"threshold_uncertainty_score":0.08164358},"labels":[],"label_agreement":null},{"id":"W1986612822","doi":"10.1016/j.jval.2012.08.1982","title":"PND58 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis: Findings From the Phase 3 Confirm Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Placebo; Medicine; Quality of life (healthcare); Glatiramer acetate; Expanded Disability Status Scale; Visual analogue scale; Multiple sclerosis; Relapsing remitting; Internal medicine; Physical therapy; Clinical endpoint; Randomized controlled trial; Psychiatry","score_opus":0.570892913816223,"score_gpt":0.4504607870046034,"score_spread":0.12043212681161958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986612822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982343,0.0007488802,0.000062383115,0.00013003543,0.000018551522,0.000039539646,0.0003882365,0.000009345272,0.00036861803],"genre_scores_gemma":[0.9985172,0.00041724913,0.0001663136,0.000084313855,0.000024447507,0.00006992471,0.00033460406,0.000006373123,0.0003796167],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99872404,0.000872815,0.0000496927,0.000086156484,0.00014844953,0.00011886771],"domain_scores_gemma":[0.9971836,0.0013973339,0.00061212486,0.00026199748,0.00014534498,0.00039961658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020880934,0.00052631047,0.001304524,0.0002640263,0.00034074966,0.00058380794,0.000508471,0.00087061134,0.001929988],"category_scores_gemma":[0.00457343,0.00025736887,0.0011456595,0.000560955,0.0006624411,0.0006064594,0.0005984497,0.0013521004,0.0003166998],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78029644,0.01602659,0.10154554,0.00040047275,0.0024031072,0.00019268293,0.000283038,0.0018022959,0.0034789778,0.00023091561,0.0011756072,0.09216427],"study_design_scores_gemma":[0.043404005,0.15191847,0.79605764,0.00017026262,0.0024794869,0.00015871372,0.00026456386,0.0015390186,0.0014665627,0.00061446923,0.0018766419,0.000050216004],"about_ca_topic_score_codex":0.0044322917,"about_ca_topic_score_gemma":0.003147906,"teacher_disagreement_score":0.0044322917,"about_ca_system_score_codex":0.0004739706,"about_ca_system_score_gemma":0.0009747708,"threshold_uncertainty_score":0.011043072},"labels":[],"label_agreement":null},{"id":"W1986691999","doi":"10.1016/s1098-3015(10)70208-4","title":"PCN30 COSTS RELATED TO ADVERSE EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Tyrosine kinase; Medicine; Adverse effect; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Cancer research; Pharmacology; Cancer; Receptor","score_opus":0.014335736900875546,"score_gpt":0.24540235617157014,"score_spread":0.23106661927069458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986691999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96524787,0.004097189,0.00013546878,0.005964155,0.00008241144,0.000087183565,0.012221865,0.000016460626,0.012147421],"genre_scores_gemma":[0.99314994,0.0019386999,0.000104384184,0.00055948034,0.00004054888,0.00001742918,0.0023108872,0.000005521491,0.0018730419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988921,0.00013352405,0.000082932915,0.000071431576,0.00038264517,0.00043744172],"domain_scores_gemma":[0.9959417,0.0003220361,0.0010846554,0.000028864331,0.0013242911,0.001298389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034400422,0.00020408617,0.00038722853,0.0011198194,0.0013197882,0.0012204614,0.00074837054,0.0005172476,0.0037767282],"category_scores_gemma":[0.0036134424,0.00023743893,0.00083359046,0.003200082,0.00042505254,0.0002719108,0.00059491297,0.001109081,0.00013394954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005326981,0.0000753481,0.9731568,0.00010982809,0.00019220398,0.00043452354,0.0002210449,0.0015941757,0.00012941899,0.00095814647,0.007792087,0.014803777],"study_design_scores_gemma":[0.00007100382,0.000051539606,0.9944171,0.000061824765,0.0000762432,0.00021108336,0.0005319916,0.0012378191,0.000058947713,0.00011785917,0.0031499297,0.00001472382],"about_ca_topic_score_codex":0.990625,"about_ca_topic_score_gemma":0.9940069,"teacher_disagreement_score":0.052079026,"about_ca_system_score_codex":0.052079026,"about_ca_system_score_gemma":0.043513145,"threshold_uncertainty_score":0.3778615},"labels":[],"label_agreement":null},{"id":"W1986874544","doi":"10.1016/j.jval.2014.03.108","title":"Impact Of Drug Reimbursement Modalities On Treatment Adherence In Patients Covered By Private Drug Insurance","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Reimbursement; Medicine; Cohort; Retrospective cohort study; Drug; Internal medicine; Private insurance; Drug class; Emergency medicine; Family medicine; Medicaid; Pharmacology; Health care","score_opus":0.06202613729766446,"score_gpt":0.31449148139421884,"score_spread":0.2524653440965544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986874544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924436,0.0016454004,0.00009262949,0.0035466123,0.000054242857,0.000016339915,0.00045785424,0.0000036268814,0.0017396925],"genre_scores_gemma":[0.99899143,0.00022562608,0.000063361644,0.00023304544,0.000060594073,0.0000051091038,0.00017356116,0.0000014625855,0.00024585833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958134,0.002195423,0.00036583838,0.00026867425,0.0004074634,0.00094915973],"domain_scores_gemma":[0.97161365,0.016725445,0.0073674256,0.0006997085,0.0006325569,0.0029613243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028823772,0.0001855188,0.0009146633,0.00055650773,0.0006892061,0.002004429,0.00056396367,0.001843175,0.0061549805],"category_scores_gemma":[0.031605374,0.00031563276,0.0028704936,0.0010947274,0.00056710135,0.0011029236,0.0011031196,0.0031159474,0.00019964002],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006583206,0.0018321875,0.9611094,0.00009367139,0.001291882,0.0002159145,0.00023384318,0.001865142,0.00015992194,0.0017606487,0.0010533602,0.02380077],"study_design_scores_gemma":[0.00030091245,0.001278542,0.9893777,0.00008374793,0.0007088211,0.0001833217,0.00066670123,0.004941781,0.00008979274,0.0018140179,0.0005302556,0.000024348712],"about_ca_topic_score_codex":0.01787744,"about_ca_topic_score_gemma":0.018995129,"teacher_disagreement_score":0.01787744,"about_ca_system_score_codex":0.0017796898,"about_ca_system_score_gemma":0.0018608076,"threshold_uncertainty_score":0.03554672},"labels":[],"label_agreement":null},{"id":"W1986924310","doi":"10.1016/j.jval.2014.08.591","title":"Cost-Utility of Cancer Therapies – the 'Cost' of Different Utility Generation Strategies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Quality-adjusted life year; Medicine; Nice; Cost effectiveness; Population; Cost–utility analysis; Cost–benefit analysis; Incremental cost-effectiveness ratio; Cancer; Economic evaluation; Statistics; Actuarial science; Computer science; Mathematics; Environmental health; Internal medicine; Economics; Risk analysis (engineering)","score_opus":0.5830415155944473,"score_gpt":0.4660530533402498,"score_spread":0.11698846225419746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986924310","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37393987,0.060669553,0.4130594,0.046481676,0.0012538347,0.0009805637,0.0044279904,0.0003672738,0.09881989],"genre_scores_gemma":[0.9729074,0.0054483525,0.017081188,0.00072785816,0.000324876,0.00018571314,0.00036681924,0.000066113564,0.0028916793],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98742664,0.00945543,0.0003510647,0.00046993102,0.0018403984,0.0004565356],"domain_scores_gemma":[0.9592316,0.036383677,0.0010333059,0.0017733746,0.0012505994,0.00032738532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013005069,0.0010921354,0.001487751,0.0018514884,0.00040722842,0.0044289203,0.0016608317,0.0023600413,0.00603418],"category_scores_gemma":[0.06428408,0.0006617224,0.0017915699,0.00250599,0.0022266633,0.007034035,0.0015337587,0.0034050648,0.0003546395],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020784477,0.00033518992,0.011221536,0.0009005733,0.0013949701,0.0002629328,0.00027227835,0.37729126,0.00097214984,0.3544604,0.0050658016,0.24574448],"study_design_scores_gemma":[0.0003457558,0.00088304083,0.01742482,0.0008896344,0.0013082393,0.0010271646,0.0006026584,0.33990708,0.0019605304,0.6197722,0.015674658,0.00020419649],"about_ca_topic_score_codex":0.0030201008,"about_ca_topic_score_gemma":0.0022801852,"teacher_disagreement_score":0.013005069,"about_ca_system_score_codex":0.004277979,"about_ca_system_score_gemma":0.0017503125,"threshold_uncertainty_score":0.06877816},"labels":[],"label_agreement":null},{"id":"W1987053400","doi":"10.1016/j.jval.2011.08.931","title":"PIH27 Potential Health and Economic Impact of Adding Rotarixtm to Routine Infant Vaccination Programs in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Vaccination; Rotavirus; Cohort; Health care; Emergency department; Pediatrics; Cost-effectiveness analysis; Emergency medicine; Demography; Environmental health; Cost effectiveness; Diarrhea; Immunology; Internal medicine","score_opus":0.0748640361117848,"score_gpt":0.34427337451938295,"score_spread":0.2694093384075982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987053400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93226635,0.00994467,0.00023028064,0.025918769,0.00026499905,0.00022870112,0.009958161,0.00005032528,0.021137897],"genre_scores_gemma":[0.9880085,0.004088276,0.0004677367,0.0014865543,0.00007088802,0.00003987881,0.0013990204,0.00001082396,0.004428256],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99766314,0.00042667074,0.00008076146,0.000103315586,0.0006323912,0.0010937562],"domain_scores_gemma":[0.99452704,0.00064798346,0.0006102828,0.00006297624,0.0022044415,0.0019471658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013030773,0.00028555086,0.00048129194,0.0009397513,0.0013323405,0.0016830284,0.0013858533,0.0007815213,0.0058182385],"category_scores_gemma":[0.006565108,0.0002537956,0.0010481487,0.0022477147,0.0006361952,0.00035974366,0.00067440997,0.0012812054,0.00018869559],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008092346,0.0014742092,0.75837,0.0011272914,0.00091436517,0.0011485807,0.00069687393,0.0070902104,0.0012939358,0.0039117173,0.029842554,0.186038],"study_design_scores_gemma":[0.0007582218,0.0009913561,0.9763382,0.00042801187,0.0008482713,0.00018927798,0.002107537,0.0044135656,0.00070653664,0.00036209964,0.012808247,0.000048660142],"about_ca_topic_score_codex":0.99366355,"about_ca_topic_score_gemma":0.9963814,"teacher_disagreement_score":0.08491597,"about_ca_system_score_codex":0.08491597,"about_ca_system_score_gemma":0.11243694,"threshold_uncertainty_score":0.6161114},"labels":[],"label_agreement":null},{"id":"W1987123109","doi":"10.1016/j.jval.2014.03.1067","title":"Validation of the telephone-administered of the age and stage questionnaire and the revised-prescreening denver questionnaire: Results from the otis antidepressants in pregnancy study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TeraXion (Canada); Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Gross motor skill; Concordance; Intraclass correlation; Medicine; Cohort; Confidence interval; Pregnancy; Telephone interview; Pediatrics; Motor skill; Psychiatry; Clinical psychology; Psychometrics; Internal medicine","score_opus":0.03645342907750296,"score_gpt":0.3077229454974272,"score_spread":0.27126951641992425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987123109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99553573,0.00017821151,0.00064965227,0.00013474966,0.000047675203,0.00060656806,0.0011576168,0.000008645466,0.0016812366],"genre_scores_gemma":[0.991734,0.00023724708,0.001853841,0.00024457928,0.000027904925,0.0013186937,0.0024482084,0.000014128965,0.00212138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948803,0.002873938,0.00052523863,0.000494624,0.0009674806,0.0002583613],"domain_scores_gemma":[0.9928745,0.0028721674,0.0012556345,0.00079655426,0.0018274464,0.00037364897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070642233,0.000464431,0.0006118871,0.00068515365,0.0006096018,0.00084868824,0.0007858853,0.0012302944,0.0013994784],"category_scores_gemma":[0.016618881,0.0004895521,0.0006665616,0.0006495366,0.00040716014,0.0006062346,0.0009410155,0.0010284558,0.00056711136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061183743,0.0009822861,0.9790522,0.000048645376,0.00014666226,0.00009892371,0.002289442,0.00016846065,0.0012200812,0.00010936717,0.00080127554,0.01447088],"study_design_scores_gemma":[0.000084415085,0.0004899409,0.9975751,0.000015789978,0.000035562167,0.000094001356,0.0005695362,0.00022163636,0.00021555962,0.000029392124,0.0006624951,0.0000065717177],"about_ca_topic_score_codex":0.0136471465,"about_ca_topic_score_gemma":0.018344767,"teacher_disagreement_score":0.0136471465,"about_ca_system_score_codex":0.0007783259,"about_ca_system_score_gemma":0.0010758025,"threshold_uncertainty_score":0.037359655},"labels":[],"label_agreement":null},{"id":"W1987412734","doi":"10.1016/j.jval.2013.08.254","title":"Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Bronchopulmonary dysplasia; Pediatrics; Gestational age; Respiratory system; Internal medicine; Pregnancy","score_opus":0.09605046312300822,"score_gpt":0.39031027203190183,"score_spread":0.2942598089088936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987412734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8718677,0.0024563593,0.00030525532,0.0019945994,0.00013015677,0.0002741927,0.10945195,0.00006699494,0.0134528605],"genre_scores_gemma":[0.97839946,0.0008827833,0.00033117132,0.00029321382,0.000033816377,0.00006671467,0.018832775,0.000011876383,0.0011481325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715316,0.00019834499,0.00021794283,0.00033193454,0.001193532,0.0009050191],"domain_scores_gemma":[0.9941942,0.00024358091,0.0011790447,0.00021752833,0.002996661,0.001168942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015082347,0.000564033,0.00062185875,0.0034667002,0.0026920983,0.0014775074,0.0022309378,0.00078064454,0.0033720743],"category_scores_gemma":[0.0067302627,0.00049346033,0.0011615106,0.0073207477,0.00058952085,0.00075113314,0.0015436118,0.0011390884,0.0002853843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010084275,0.000029060662,0.98602146,0.000062716936,0.00011383364,0.00006128742,0.00021559905,0.00015731636,0.00008588493,0.00039962417,0.009494079,0.0032583375],"study_design_scores_gemma":[0.00001213281,0.00001097428,0.9977672,0.000044241664,0.000033236498,0.000055795597,0.0004316174,0.00029218805,0.000035843612,0.00003958931,0.0012645784,0.000012514009],"about_ca_topic_score_codex":0.99529064,"about_ca_topic_score_gemma":0.9974534,"teacher_disagreement_score":0.039167076,"about_ca_system_score_codex":0.039167076,"about_ca_system_score_gemma":0.06724425,"threshold_uncertainty_score":0.28417838},"labels":[],"label_agreement":null},{"id":"W1987741018","doi":"10.1016/j.jval.2010.10.008","title":"Improvements in Participation in Usual Daily Activities in Patients with Rheumatoid Arthritis Treated with Abatacept","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Ottawa","funders":"Versus Arthritis; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Physical therapy; Internal medicine; Rheumatism; Placebo; Quality of life (healthcare); Clinical trial; Alternative medicine; Nursing; Rituximab","score_opus":0.028578445677749857,"score_gpt":0.28439325525925424,"score_spread":0.2558148095815044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987741018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633646,0.0017631899,0.00006384827,0.000101259386,0.000026037103,0.000016575526,0.0001585226,0.000010828332,0.0015234092],"genre_scores_gemma":[0.9991666,0.0002740583,0.00006973064,0.000040893505,0.00001640509,0.000010443842,0.00013116408,9.3398927e-7,0.0002896488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997111,0.000106772335,0.00003439864,0.000028428463,0.000056467885,0.000062731946],"domain_scores_gemma":[0.99942786,0.00019255343,0.00013642733,0.000023086774,0.0000701694,0.00014993003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040911773,0.0002802791,0.00075183925,0.00030091888,0.00028109425,0.00034716405,0.00019753014,0.00034915487,0.0019427014],"category_scores_gemma":[0.0015486164,0.00011414045,0.0004480385,0.00042545,0.00014633693,0.00022341764,0.00017022247,0.0004793276,0.00019353122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0345649,0.004177701,0.76746976,0.0005957224,0.0016268264,0.0007052624,0.0007538564,0.0006061355,0.008809591,0.000049839236,0.0015641351,0.17907627],"study_design_scores_gemma":[0.000683918,0.0037009919,0.9939313,0.000018506307,0.00026398423,0.00031340652,0.00014243013,0.00028850345,0.00023524654,0.000042286647,0.00037001888,0.000009348305],"about_ca_topic_score_codex":0.0022164816,"about_ca_topic_score_gemma":0.0036369404,"teacher_disagreement_score":0.0022164816,"about_ca_system_score_codex":0.00022160183,"about_ca_system_score_gemma":0.0001891324,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W1987879827","doi":"10.1111/j.1524-4733.2010.00737.x","title":"Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CHOP; Rituximab; Medicine; Diffuse large B-cell lymphoma; Vincristine; Population; Cost effectiveness; Internal medicine; Oncology; Cohort; Lymphoma; Cyclophosphamide; Chemotherapy; Environmental health","score_opus":0.036195372987913865,"score_gpt":0.29702635170920827,"score_spread":0.2608309787212944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987879827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972364,0.0012874568,0.000027567587,0.0003179712,0.00002028986,0.000022814764,0.00066694827,0.0000043463206,0.00041618093],"genre_scores_gemma":[0.99878925,0.00046425994,0.00005969237,0.00009410176,0.000009282525,0.000010321596,0.00041070083,0.0000018193836,0.00016050876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982002,0.00053693657,0.0001479242,0.00025209546,0.00035375258,0.00050902466],"domain_scores_gemma":[0.99698585,0.00078849704,0.0007152023,0.00013616304,0.0005749273,0.0007993719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010492022,0.00051890034,0.0011908959,0.0006755225,0.0009788306,0.001487072,0.0015308236,0.0012227835,0.0010803281],"category_scores_gemma":[0.006729679,0.0004870916,0.0020438917,0.0019056693,0.0006857697,0.0004019306,0.00053884316,0.0012908642,0.00009659404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009022965,0.0007953928,0.9701515,0.00016809648,0.002144105,0.00051911897,0.00023670116,0.0032881154,0.000459774,0.00013959018,0.001700186,0.011374379],"study_design_scores_gemma":[0.00064953946,0.00070834724,0.9910773,0.00008521314,0.0013866744,0.00021956848,0.0006441593,0.004642083,0.00009229198,0.000096570475,0.00035711302,0.000041110805],"about_ca_topic_score_codex":0.9483458,"about_ca_topic_score_gemma":0.9564235,"teacher_disagreement_score":0.05165422,"about_ca_system_score_codex":0.02725003,"about_ca_system_score_gemma":0.016502796,"threshold_uncertainty_score":0.19771373},"labels":[],"label_agreement":null},{"id":"W1987943429","doi":"10.1016/s1098-3015(10)70708-7","title":"PDB20 COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NPH INSULIN FOR TYPE I DIABETES MELLITUS (TIDM) IN THE CANADIAN PAYER SETTING: MODELING ANALYSIS USING A RANDOMIZED CONTROLLED TRIAL","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Natural Products and Biological Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin detemir; NPH insulin; Medicine; Randomized controlled trial; Insulin; Type 2 Diabetes Mellitus; Diabetes mellitus; Internal medicine; Pediatrics; Endocrinology; Type 2 diabetes; Insulin glargine","score_opus":0.20318198252822156,"score_gpt":0.41479132676936425,"score_spread":0.2116093442411427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987943429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644882,0.010646511,0.007140218,0.002006962,0.0007400591,0.0038014122,0.005496339,0.00035620757,0.0053240326],"genre_scores_gemma":[0.9919681,0.0015479705,0.0025297666,0.00041999618,0.00012711443,0.0006984979,0.0015020166,0.000025265248,0.0011812163],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9873841,0.009788418,0.0004286387,0.00079136575,0.00068000145,0.0009274994],"domain_scores_gemma":[0.97891414,0.015688432,0.001894311,0.0011279283,0.00093002187,0.0014451422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021121731,0.00267662,0.0062266598,0.0010426248,0.0007587402,0.002454069,0.0033559373,0.0027847956,0.0082913],"category_scores_gemma":[0.029555464,0.0014876229,0.011946821,0.0015518072,0.001818246,0.0012469087,0.0012892196,0.0049342825,0.0004619657],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9046062,0.0020519893,0.009367742,0.0015568141,0.024663351,0.00010234832,0.00010247088,0.035838164,0.00043144033,0.001778788,0.0017746569,0.017725926],"study_design_scores_gemma":[0.65593314,0.052606747,0.02329615,0.00055272377,0.06755479,0.00013432225,0.00023352151,0.19341867,0.00064961653,0.0030913157,0.0022514267,0.00027756064],"about_ca_topic_score_codex":0.28596762,"about_ca_topic_score_gemma":0.16590524,"teacher_disagreement_score":0.7140324,"about_ca_system_score_codex":0.011713217,"about_ca_system_score_gemma":0.014117051,"threshold_uncertainty_score":0.5686062},"labels":[],"label_agreement":null},{"id":"W1988040543","doi":"10.1016/j.jval.2011.02.355","title":"PSY22 ANALYSING THE BENEFITS AND COST SAVING OF ORAL VERSUS IV FLUDARABINE FOR MANAGEMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Fludarabine; Medicine; Adverse effect; Dose; Internal medicine; Cyclophosphamide; Gastroenterology; Chemotherapy","score_opus":0.13124816543485762,"score_gpt":0.3501985851498948,"score_spread":0.2189504197150372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988040543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811064,0.010796894,0.001422243,0.0011890732,0.00014662309,0.00023613888,0.001888225,0.000024198152,0.0031901742],"genre_scores_gemma":[0.99656206,0.0011748238,0.0004738804,0.0001826869,0.00007007932,0.00006414118,0.0005841876,0.000009561853,0.00087862863],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9989121,0.0006609722,0.00006116028,0.00008798367,0.00011138142,0.00016641969],"domain_scores_gemma":[0.9967583,0.0023593658,0.0004462174,0.00011873641,0.00012189217,0.00019550242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019171614,0.00063138816,0.0012049174,0.00046180456,0.00014814892,0.001149046,0.0004193182,0.0005954851,0.0062204665],"category_scores_gemma":[0.0069744578,0.0001936549,0.0026956454,0.0007728055,0.00034292007,0.0006663072,0.0005119238,0.0009943856,0.00032084258],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4896173,0.0015301034,0.070513,0.002934714,0.010317916,0.0005576169,0.00021610734,0.04660889,0.004034289,0.0024932201,0.003274091,0.36790273],"study_design_scores_gemma":[0.070167676,0.27500817,0.43707532,0.0027334064,0.05876531,0.0017790177,0.0014967872,0.09198163,0.013291497,0.015274233,0.032166146,0.000260821],"about_ca_topic_score_codex":0.006106894,"about_ca_topic_score_gemma":0.005342085,"teacher_disagreement_score":0.0062204665,"about_ca_system_score_codex":0.0026411328,"about_ca_system_score_gemma":0.001602867,"threshold_uncertainty_score":0.020809531},"labels":[],"label_agreement":null},{"id":"W1988058236","doi":"10.1016/j.jval.2013.03.280","title":"Properties of propensity score matching procedures on covariate balancing and estimation: Influence of the number of propensity score digits used on matched sets created","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Propensity score matching; Covariate; Confounding; Statistics; Matching (statistics); Confidence interval; Numerical digit; Demography; Mathematics; Medicine; Arithmetic","score_opus":0.22731307978205686,"score_gpt":0.3683948052331946,"score_spread":0.14108172545113776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988058236","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055183213,0.00071953825,0.9396523,0.0013246235,0.00011436389,0.00036301793,0.00040654748,0.00046936588,0.0017670785],"genre_scores_gemma":[0.51245147,0.0016245595,0.47858256,0.0010004193,0.0006467508,0.0012484068,0.0015313606,0.0010517212,0.0018627088],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.84959114,0.12693888,0.005572434,0.0073365853,0.008976465,0.001584422],"domain_scores_gemma":[0.08423024,0.86322737,0.012180974,0.03414028,0.0051846337,0.0010364255],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2574831,0.001601626,0.0040825307,0.003930519,0.002868214,0.005164158,0.004874874,0.0045783105,0.004773881],"category_scores_gemma":[0.7314806,0.0020489672,0.0029246316,0.006014612,0.007795555,0.012492129,0.0069460054,0.0055787005,0.0008738425],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051032915,0.0008196716,0.055369366,0.0011907399,0.0024700626,0.00051515026,0.002827353,0.28705293,0.0040836884,0.35990825,0.0074761105,0.27318332],"study_design_scores_gemma":[0.0006712996,0.0004775495,0.00879493,0.0003733728,0.00059928064,0.0004229188,0.00032665444,0.5817201,0.0044918843,0.3995442,0.0024449122,0.00013290481],"about_ca_topic_score_codex":0.0033931,"about_ca_topic_score_gemma":0.002256958,"teacher_disagreement_score":0.7425169,"about_ca_system_score_codex":0.0012418175,"about_ca_system_score_gemma":0.0064391,"threshold_uncertainty_score":0.91565555},"labels":[],"label_agreement":null},{"id":"W1988090710","doi":"10.1016/j.jval.2011.08.288","title":"PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program: Analysis Versus Canada and Australia","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Impact and Responses","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Christian ministry; Distribution (mathematics); Drug pricing; Drug prices; Business; Human immunodeficiency virus (HIV); Actuarial science; Economics; Public economics; Medicine; Political science; Family medicine","score_opus":0.13049657053327746,"score_gpt":0.31909414017295407,"score_spread":0.1885975696396766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988090710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87107146,0.0037378445,0.0010283564,0.0063264873,0.00011854185,0.00025030776,0.008481312,0.00009113778,0.108894475],"genre_scores_gemma":[0.9835684,0.001382564,0.000582384,0.00030790622,0.00002125572,0.000068176705,0.0017677782,0.000026859989,0.012274716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986505,0.0003979832,0.000026087946,0.00007056439,0.00041935706,0.00043555943],"domain_scores_gemma":[0.9975121,0.00092175574,0.00023434278,0.000116739575,0.00091163407,0.0003034319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013741232,0.0004258641,0.0006105533,0.0011810507,0.00061307644,0.0016924499,0.0005995579,0.0005762327,0.0060482356],"category_scores_gemma":[0.0073923133,0.00026226632,0.0011536925,0.0029242951,0.0005267642,0.00084668025,0.0009663192,0.0012618966,0.00024644024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059424676,0.0009458482,0.36206344,0.0017860013,0.0016069346,0.0016226516,0.0010835472,0.14686261,0.0015579148,0.10799502,0.057198673,0.3113349],"study_design_scores_gemma":[0.000370575,0.000874603,0.8196754,0.00048814263,0.0020641792,0.00067185966,0.0056323367,0.10581117,0.0021906868,0.012213115,0.049912665,0.00009523491],"about_ca_topic_score_codex":0.7167299,"about_ca_topic_score_gemma":0.803019,"teacher_disagreement_score":0.28327012,"about_ca_system_score_codex":0.019688813,"about_ca_system_score_gemma":0.015167986,"threshold_uncertainty_score":0.5698767},"labels":[],"label_agreement":null},{"id":"W1988518807","doi":"10.1016/j.jval.2014.03.259","title":"Budget Impact Of Converting Standard Treatment Of Flail Chest From Supportive Therapy To Surgical Fixation With Contoured Titanium Plates In Canadian Hospitals","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma Management and Diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flail chest; Medicine; Mechanical ventilation; Activity-based costing; Emergency medicine; Surgery; Anesthesia","score_opus":0.025231408577159324,"score_gpt":0.3139404790844509,"score_spread":0.28870907050729155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988518807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90132284,0.0034553092,0.0006747792,0.043667745,0.0006493102,0.0005816713,0.009904051,0.00012859094,0.039615806],"genre_scores_gemma":[0.9864711,0.0013604077,0.0013701463,0.0029746047,0.00011964689,0.0000959169,0.0023728523,0.000028091476,0.0052073225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936428,0.000966885,0.00026885467,0.00024420832,0.0018029567,0.003074255],"domain_scores_gemma":[0.9844252,0.0017222342,0.0015397985,0.00021129436,0.005515161,0.0065864087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002393741,0.00058301643,0.00040076097,0.0021955497,0.00335158,0.0033822272,0.002609441,0.0015367211,0.010855117],"category_scores_gemma":[0.015546042,0.00052907516,0.001454398,0.003070799,0.0012434224,0.0007274713,0.0020787397,0.0017139259,0.00034734613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008031826,0.0018767526,0.551687,0.0017947791,0.0009966289,0.0016480738,0.0017599011,0.054088168,0.0034894815,0.015068622,0.11880361,0.24075517],"study_design_scores_gemma":[0.00057465554,0.0009917165,0.9533769,0.0006523833,0.00034774834,0.00036637535,0.005470025,0.008760624,0.0006080162,0.0007803837,0.027925175,0.0001459385],"about_ca_topic_score_codex":0.9835513,"about_ca_topic_score_gemma":0.9903077,"teacher_disagreement_score":0.80639035,"about_ca_system_score_codex":0.19360964,"about_ca_system_score_gemma":0.19472407,"threshold_uncertainty_score":0.9352985},"labels":[],"label_agreement":null},{"id":"W1988921809","doi":"10.1016/s1098-3015(10)64198-8","title":"PPT5: LONG TERM COST OF ILLNESS STUDY FOR SEVERE HEMOPHILIC CHILDREN IN TORONTO","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Medicine; Pediatrics; Physics","score_opus":0.0536040164469517,"score_gpt":0.38237059990812156,"score_spread":0.3287665834611698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988921809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877638,0.00048547547,0.00006739246,0.00048371952,0.000011778414,0.000070594564,0.009576162,0.000004810347,0.0015362432],"genre_scores_gemma":[0.9931384,0.0005013972,0.00016154203,0.00008583541,0.000014816686,0.00008053807,0.00478489,0.000004193579,0.0012284396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952877,0.00013437639,0.0000338549,0.00004277367,0.00010074544,0.00015941696],"domain_scores_gemma":[0.9988165,0.00009926666,0.00037673587,0.000035698973,0.00023299218,0.00043878608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047274333,0.0003880515,0.00036407064,0.0004797653,0.0010390383,0.0006708666,0.00054219144,0.00038478823,0.0017738526],"category_scores_gemma":[0.0017826691,0.00024052382,0.0006177041,0.0019070158,0.00028674744,0.0003541079,0.00081000477,0.0006623956,0.00014370863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011683652,0.00016950854,0.98756903,0.00011804691,0.00024711541,0.00034587027,0.0007277766,0.00042877093,0.00017934533,0.00032030692,0.0044864696,0.00423928],"study_design_scores_gemma":[0.00010020892,0.0001770054,0.99802846,0.000025592379,0.00007052535,0.00007155444,0.00049814663,0.00017676264,0.00002794629,0.000019457275,0.000797352,0.0000069948796],"about_ca_topic_score_codex":0.8624094,"about_ca_topic_score_gemma":0.9004351,"teacher_disagreement_score":0.13759059,"about_ca_system_score_codex":0.010580058,"about_ca_system_score_gemma":0.006970895,"threshold_uncertainty_score":0.2768017},"labels":[],"label_agreement":null},{"id":"W1988994559","doi":"10.1016/j.jval.2013.08.1213","title":"Indirect Treatment Comparison and Economic Evaluation of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in the Netherlands","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Stroke (engine); Dabigatran; Atrial fibrillation; Randomized controlled trial; Confidence interval; Relative risk; Internal medicine; Cost effectiveness; Warfarin; Intensive care medicine","score_opus":0.442145353400005,"score_gpt":0.44459944641158367,"score_spread":0.002454093011578673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988994559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95541805,0.031244084,0.0028644965,0.0019538696,0.00051359774,0.00096899626,0.0028006956,0.000015156474,0.004221045],"genre_scores_gemma":[0.9934675,0.0028646097,0.0009839736,0.00017533457,0.00011100699,0.0005024519,0.0011648354,0.0000077189525,0.0007227012],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97106445,0.025120672,0.001624053,0.0006276123,0.00087606325,0.0006872556],"domain_scores_gemma":[0.97378796,0.021479484,0.0025220597,0.00059416733,0.0008144037,0.000801877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017630568,0.0012001519,0.003357759,0.0013607285,0.00041444667,0.002923123,0.0011407498,0.0014486361,0.004458011],"category_scores_gemma":[0.055792157,0.00077254296,0.0067805103,0.0014293785,0.0007972069,0.0017213795,0.0016170872,0.002010473,0.00015318712],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57123244,0.00667014,0.105185695,0.012025917,0.12300355,0.0008333068,0.000867452,0.08512071,0.00057381083,0.011342558,0.0035401206,0.079604425],"study_design_scores_gemma":[0.33304772,0.06132887,0.22175388,0.00496047,0.15698643,0.0011620643,0.0025470662,0.18894537,0.0014968284,0.016306091,0.010791154,0.00067408424],"about_ca_topic_score_codex":0.025550138,"about_ca_topic_score_gemma":0.017646622,"teacher_disagreement_score":0.025550138,"about_ca_system_score_codex":0.0069215447,"about_ca_system_score_gemma":0.0037713728,"threshold_uncertainty_score":0.09324044},"labels":[],"label_agreement":null},{"id":"W1989114084","doi":"10.1016/s1098-3015(10)73144-2","title":"QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Estimation; Type 2 diabetes; Medicine; Quality of life (healthcare); Quality (philosophy); Statistics; Gerontology; Diabetes mellitus; Demography; Intensive care medicine; Mathematics; Economics; Endocrinology; Nursing; Sociology; Philosophy","score_opus":0.2744320914219942,"score_gpt":0.38707467306777016,"score_spread":0.11264258164577595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989114084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814088,0.0006385127,0.0016204542,0.000523976,0.0000127998765,0.00016935046,0.011143228,0.000034912202,0.004448127],"genre_scores_gemma":[0.993455,0.00015899561,0.00088121754,0.00003847917,0.0000036636966,0.000046780697,0.004191444,0.0000092406835,0.0012152543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913603,0.0002510682,0.00005704045,0.00009060065,0.00019291732,0.00027231895],"domain_scores_gemma":[0.9959825,0.0013003662,0.00040070928,0.00012565206,0.0017599029,0.00043078396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024380498,0.00044077158,0.000760733,0.0010255625,0.0011964793,0.0013163653,0.0011528719,0.0003564694,0.0031795728],"category_scores_gemma":[0.01066651,0.00033337218,0.0012617367,0.002843395,0.0005398438,0.00028499876,0.00075356103,0.00072341284,0.00020255562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011102016,0.00015148825,0.900067,0.00018985523,0.0005632272,0.00023330687,0.00076872675,0.0659909,0.00019344549,0.0019635947,0.007980693,0.020787591],"study_design_scores_gemma":[0.00020034215,0.000063002466,0.90929556,0.000093157454,0.00012375948,0.00005861006,0.0008977,0.08656643,0.00011835031,0.00053595525,0.0020012094,0.000045799577],"about_ca_topic_score_codex":0.9962663,"about_ca_topic_score_gemma":0.9949759,"teacher_disagreement_score":0.04217336,"about_ca_system_score_codex":0.04217336,"about_ca_system_score_gemma":0.024920484,"threshold_uncertainty_score":0.30599052},"labels":[],"label_agreement":null},{"id":"W1989124972","doi":"10.1016/j.jval.2011.08.328","title":"PMH26 Direct Cost of Schizophrenia in Quebec, Canada: An Incidence-Based Microsimulation Monte-Carlo Markov Model","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Microsimulation; Health care; Cohort; Schizophrenia (object-oriented programming); Markov model; Medicine; Indirect costs; Markov chain Monte Carlo; Psychiatry; Markov chain; Monte Carlo method; Statistics; Business; Economics; Mathematics; Internal medicine; Engineering","score_opus":0.3444568625588406,"score_gpt":0.37244288263095465,"score_spread":0.027986020072114037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989124972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86756605,0.002975948,0.0470892,0.008850728,0.00023283431,0.00052618526,0.04069659,0.00067075243,0.031391714],"genre_scores_gemma":[0.9750474,0.0008079029,0.004060696,0.000270194,0.000046914272,0.00016486099,0.004036493,0.000064812055,0.015500665],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991105,0.00023219247,0.00003546999,0.00011361552,0.00013393501,0.0003742127],"domain_scores_gemma":[0.99570173,0.0024224524,0.0004384782,0.00019316743,0.00086274685,0.00038145413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019874054,0.0007617497,0.0018719371,0.0019231885,0.0016441966,0.0026664194,0.0036705798,0.0025052035,0.010639984],"category_scores_gemma":[0.008342782,0.0011569292,0.0015476282,0.003050753,0.001535831,0.0011139835,0.0008271387,0.002067441,0.0006152449],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012736417,0.000058477068,0.008821055,0.000038664955,0.00008254229,0.00014527213,0.000045043398,0.9698916,0.00007638181,0.013900568,0.0038138984,0.0029991313],"study_design_scores_gemma":[0.000064892265,0.000022137026,0.0052494905,0.000037476253,0.000056918096,0.000032626045,0.000071607916,0.99022245,0.0000483365,0.0030162283,0.0011417296,0.000036093603],"about_ca_topic_score_codex":0.9779507,"about_ca_topic_score_gemma":0.96450126,"teacher_disagreement_score":0.03551064,"about_ca_system_score_codex":0.03551064,"about_ca_system_score_gemma":0.026995407,"threshold_uncertainty_score":0.25764894},"labels":[],"label_agreement":null},{"id":"W1989436692","doi":"10.1016/j.jval.2012.08.794","title":"PMH4 Mirror Image Studies of Risperidone Long-Acting Injection for Chronic Schizophrenia and Schizoaffective Disorder","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Risperidone; Schizoaffective disorder; Schizophrenia (object-oriented programming); Confounding; MEDLINE; Randomization; Clinical trial; Psychiatry; Pediatrics; Internal medicine; Psychosis","score_opus":0.05931818404221899,"score_gpt":0.38127795402868736,"score_spread":0.32195976998646836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989436692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981152,0.0006158927,0.00006125269,0.00006176596,0.000017406015,0.00006262129,0.00010180466,0.0000037977843,0.0009603668],"genre_scores_gemma":[0.99890435,0.00024372057,0.00011615106,0.000045156707,0.000016991356,0.000027608772,0.00006171226,0.0000022314543,0.0005819201],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99953616,0.000289131,0.000023962202,0.00003502249,0.0000699591,0.00004580492],"domain_scores_gemma":[0.9994104,0.00022383303,0.00018421943,0.000057634334,0.00004848694,0.00007541498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008680782,0.00030617623,0.0005374354,0.00035896446,0.0002568061,0.00046913835,0.00036678498,0.00045157442,0.0041755587],"category_scores_gemma":[0.002079834,0.0002914084,0.0005076946,0.00020852272,0.00053373276,0.00043572026,0.00029443312,0.0005458822,0.0002395612],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6578565,0.011453339,0.11294625,0.0009578265,0.0034831883,0.00064721855,0.0009388661,0.0006656167,0.04302158,0.0012712402,0.00093248993,0.16582592],"study_design_scores_gemma":[0.052188184,0.23021227,0.6943828,0.00010674472,0.003956877,0.0009877166,0.0008006912,0.001997127,0.0106203575,0.0012475303,0.003404202,0.00009546952],"about_ca_topic_score_codex":0.0029176706,"about_ca_topic_score_gemma":0.0035974476,"teacher_disagreement_score":0.0041755587,"about_ca_system_score_codex":0.00074650865,"about_ca_system_score_gemma":0.0005226725,"threshold_uncertainty_score":0.013968706},"labels":[],"label_agreement":null},{"id":"W1989477992","doi":"10.1016/j.jval.2011.02.169","title":"PHP100 PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Reimbursement; Formulary; Agency (philosophy); Business; Market access; User fee; Scope (computer science); Health care; Public economics; Family medicine; Medicine; Economic growth; Political science; Geography; Economics","score_opus":0.39635368018055533,"score_gpt":0.37684578199316726,"score_spread":0.019507898187388073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989477992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85536444,0.0125243105,0.001241124,0.044452798,0.0003418217,0.00019917007,0.017475395,0.00015939942,0.0682416],"genre_scores_gemma":[0.9839978,0.00263372,0.0005954964,0.0012827001,0.00008254258,0.00002137441,0.0019070081,0.00003408417,0.009445274],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716175,0.00028501658,0.00010790517,0.00015540968,0.00131866,0.0009712744],"domain_scores_gemma":[0.99026275,0.0021893166,0.0010613505,0.00015802213,0.004094373,0.002234111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021784035,0.00024231576,0.00052139175,0.0019173155,0.0014100913,0.0037403458,0.0013805308,0.0013486351,0.004247736],"category_scores_gemma":[0.014284748,0.00038544156,0.00090193684,0.0035786647,0.0011284627,0.0006052401,0.00071789464,0.0019243208,0.000189595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039864876,0.0005247973,0.42736933,0.0007555323,0.000608721,0.0022222304,0.0013897413,0.055484004,0.001360106,0.15973543,0.17480801,0.17175564],"study_design_scores_gemma":[0.0009400609,0.00029453024,0.80654216,0.00053709786,0.00036238896,0.00081803696,0.0015799438,0.07463589,0.0011189182,0.00854847,0.10442076,0.00020167061],"about_ca_topic_score_codex":0.9928844,"about_ca_topic_score_gemma":0.9939937,"teacher_disagreement_score":0.8808574,"about_ca_system_score_codex":0.11914261,"about_ca_system_score_gemma":0.109086536,"threshold_uncertainty_score":0.86444414},"labels":[],"label_agreement":null},{"id":"W1989931913","doi":"10.1046/j.1524-4733.2002.54128.x","title":"A Comparison of Methods for Analyzing Health-Related Quality-of-Life Measures","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Tobit model; Censored regression model; Censoring (clinical trials); Statistics; Econometrics; Regression analysis; Ceiling effect; Ordinary least squares; Regression; Medicine; Demography; Mathematics","score_opus":0.8212655393404127,"score_gpt":0.5810041040688738,"score_spread":0.24026143527153887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989931913","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14454909,0.026073353,0.81180197,0.001963622,0.0006695654,0.002141124,0.0033691372,0.0007240519,0.008708091],"genre_scores_gemma":[0.34154892,0.011600096,0.6357381,0.00036765294,0.00028856721,0.0039005016,0.0036052698,0.00049100094,0.002459977],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9282529,0.054087643,0.0036015168,0.0024010625,0.010998414,0.0006583964],"domain_scores_gemma":[0.59178215,0.3764276,0.0063111647,0.009602044,0.015198467,0.0006784863],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09040269,0.001743192,0.0023352792,0.009358724,0.0006881049,0.0043338696,0.0027169345,0.0024125448,0.0030452758],"category_scores_gemma":[0.24492052,0.0009682135,0.0037367353,0.0072845556,0.0012227311,0.004591372,0.0024911987,0.0026041425,0.0006243432],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0066762976,0.0008236217,0.12440021,0.0034640369,0.006706638,0.00011328444,0.0037728297,0.0217234,0.0015016857,0.083178446,0.0074875345,0.74015206],"study_design_scores_gemma":[0.003255304,0.0040042913,0.3885366,0.0034139312,0.004884982,0.0010391512,0.004875023,0.36246714,0.0056365523,0.19245991,0.028513618,0.00091341976],"about_ca_topic_score_codex":0.006310892,"about_ca_topic_score_gemma":0.0065974365,"teacher_disagreement_score":0.9095973,"about_ca_system_score_codex":0.002702226,"about_ca_system_score_gemma":0.002269366,"threshold_uncertainty_score":0.47810084},"labels":[],"label_agreement":null},{"id":"W1990043119","doi":"10.1016/j.jval.2011.08.388","title":"PMS2 Risk and Cost of Infections in Rheumatoid Arthritis Patients Treated with anti-TNF therapy in Alberta, Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Institute of Health Economics","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Proportional hazards model; Hazard ratio; Cohort; Etanercept","score_opus":0.019355005633822777,"score_gpt":0.24977358452894055,"score_spread":0.23041857889511777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990043119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98739386,0.0026473857,0.00012612276,0.0016714225,0.00004883778,0.00003444494,0.0031013207,0.0000132368195,0.0049634716],"genre_scores_gemma":[0.99568427,0.0012496939,0.00015148424,0.00022124835,0.000024847843,0.000008546181,0.00091661257,0.000005226418,0.00173799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991798,0.00011936646,0.00004959145,0.000051892945,0.0003041758,0.0002952078],"domain_scores_gemma":[0.99835193,0.00012972053,0.00031818484,0.000025092468,0.00055115164,0.0006239372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037246314,0.0003052523,0.00045092404,0.0009712489,0.0015963826,0.0011874529,0.0011907615,0.000587718,0.002698507],"category_scores_gemma":[0.0015739293,0.00037870865,0.000776975,0.0027791548,0.0005271098,0.00023507373,0.0005664601,0.0010871523,0.0001639941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036503913,0.0000759761,0.9890743,0.00004626709,0.00014031016,0.0004017304,0.00020965294,0.00069129904,0.00015870594,0.000361258,0.0024716891,0.0060038143],"study_design_scores_gemma":[0.00005472483,0.000053157393,0.99662054,0.000057514513,0.00006905685,0.00024108152,0.00079944223,0.0009803624,0.000046518344,0.00006592525,0.0009971011,0.000014626231],"about_ca_topic_score_codex":0.99347275,"about_ca_topic_score_gemma":0.99501145,"teacher_disagreement_score":0.027235087,"about_ca_system_score_codex":0.027235087,"about_ca_system_score_gemma":0.025350105,"threshold_uncertainty_score":0.19760531},"labels":[],"label_agreement":null},{"id":"W1990327895","doi":"10.1016/s1098-3015(10)73565-8","title":"PDB21 ECONOMIC EVALUATION OF RAPID-ACTING INSULIN ANALOGUES FOR THE TREATMENT OF PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Type 2 Diabetes Mellitus; Insulin; Type (biology); Medicine; Type 2 diabetes; Internal medicine; Endocrinology; Diabetes mellitus; Biology","score_opus":0.04562122178715243,"score_gpt":0.2896453177501117,"score_spread":0.24402409596295926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990327895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9212511,0.024400631,0.0006899061,0.009711646,0.0004417688,0.0019157197,0.011632228,0.000053367665,0.029903572],"genre_scores_gemma":[0.9899228,0.0048859385,0.00069844717,0.0006507518,0.00007991326,0.00012771819,0.001634065,0.0000071502086,0.001993195],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977397,0.0011584002,0.00013173578,0.00007946423,0.00058675365,0.00030398546],"domain_scores_gemma":[0.99484503,0.0014709937,0.0005463831,0.000059603062,0.0015363053,0.0015417374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024602097,0.00037306832,0.00096671237,0.00073723955,0.0007252559,0.0015202196,0.0007062935,0.00063159096,0.004036927],"category_scores_gemma":[0.010915149,0.00023435806,0.0013311957,0.0012538371,0.00038598283,0.00029307287,0.00046208614,0.0009162198,0.000102188125],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34289587,0.0065983757,0.17187743,0.004282929,0.0043509835,0.001232383,0.0003595387,0.06592961,0.0018236146,0.008857634,0.042766713,0.3490249],"study_design_scores_gemma":[0.12847778,0.03784027,0.6605062,0.00220647,0.0067354944,0.00091285066,0.0014999266,0.10750644,0.0013276224,0.0016762567,0.051017206,0.00029359251],"about_ca_topic_score_codex":0.89300704,"about_ca_topic_score_gemma":0.91373837,"teacher_disagreement_score":0.10699296,"about_ca_system_score_codex":0.044372983,"about_ca_system_score_gemma":0.059646435,"threshold_uncertainty_score":0.32195002},"labels":[],"label_agreement":null},{"id":"W1990505650","doi":"10.1016/j.jval.2014.03.1325","title":"Cost Analysis Of Implementing Expanded Umbilical Cord Blood Graft In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Umbilical cord; Cord blood; Indirect costs; Surgery; Internal medicine; Immunology","score_opus":0.050929017935551775,"score_gpt":0.33245185259112797,"score_spread":0.2815228346555762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990505650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96301955,0.0025786965,0.0006451948,0.004977351,0.00009954023,0.0004078054,0.008727114,0.000051642855,0.019493036],"genre_scores_gemma":[0.9920338,0.0011728804,0.00070754753,0.0005055327,0.000020112757,0.000043576376,0.001786744,0.000013814557,0.0037159617],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9957545,0.00046070947,0.00016175487,0.00016756954,0.0015779894,0.0018774158],"domain_scores_gemma":[0.99263304,0.0011170135,0.0007259629,0.00010164216,0.0039663627,0.0014559769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013356082,0.0005471402,0.00075607933,0.0025963108,0.002140127,0.004072622,0.0017487729,0.001040825,0.004314544],"category_scores_gemma":[0.008929384,0.0004920048,0.0014938533,0.0064235115,0.00088153523,0.00070204295,0.0011175361,0.0015387154,0.00016433833],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004023943,0.0012519474,0.6602465,0.0011229524,0.0017286276,0.0020396903,0.001226381,0.16177036,0.0013878016,0.029154783,0.035182945,0.1008641],"study_design_scores_gemma":[0.0005893712,0.0010256758,0.8468645,0.0005054816,0.0016238907,0.0005692137,0.010282462,0.108467124,0.0016071827,0.0022179035,0.026030283,0.00021693044],"about_ca_topic_score_codex":0.9942234,"about_ca_topic_score_gemma":0.9951834,"teacher_disagreement_score":0.18044035,"about_ca_system_score_codex":0.18044035,"about_ca_system_score_gemma":0.15832226,"threshold_uncertainty_score":0.950573},"labels":[],"label_agreement":null},{"id":"W1990511704","doi":"10.1016/j.jval.2011.02.1133","title":"PND23 ECONOMIC EVALUATION OF DEXMEDETOMIDINE FOR SEDATION IN THE INTENSIVE CARE UNIT","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dexmedetomidine; Sedation; Midazolam; Intensive care unit; Medicine; Delirium; Mechanical ventilation; Anesthesia; Intensive care; Emergency medicine; Intensive care medicine","score_opus":0.3215562547503459,"score_gpt":0.4066438160324588,"score_spread":0.08508756128211292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990511704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9071773,0.022524307,0.0065725506,0.006024149,0.0006512983,0.0036754645,0.013324624,0.0001274748,0.039922792],"genre_scores_gemma":[0.99277896,0.0017469532,0.0016257341,0.0002615464,0.00006648245,0.0004876012,0.0013834492,0.000011073045,0.0016381445],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99227,0.0058977157,0.0002896989,0.00022910163,0.0009197353,0.00039376412],"domain_scores_gemma":[0.98954916,0.0074736155,0.0008449592,0.00024224412,0.0010421865,0.0008478166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007237144,0.0009864306,0.0014010106,0.0015695228,0.00032552832,0.0022666967,0.00090280996,0.0010971669,0.0071847825],"category_scores_gemma":[0.029996397,0.00042787078,0.0025651092,0.001045348,0.0005067359,0.0009186359,0.00097438815,0.001330175,0.00029605022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3022754,0.0046344334,0.06243737,0.0069669303,0.009373262,0.0010636249,0.00017126721,0.25619966,0.0025255631,0.017539013,0.018532524,0.31828102],"study_design_scores_gemma":[0.079841465,0.09421308,0.26089713,0.0037738222,0.016869517,0.0020106516,0.0014210773,0.4602632,0.007459652,0.016171293,0.05663542,0.00044372727],"about_ca_topic_score_codex":0.013114684,"about_ca_topic_score_gemma":0.0072350004,"teacher_disagreement_score":0.013114684,"about_ca_system_score_codex":0.009168761,"about_ca_system_score_gemma":0.00717521,"threshold_uncertainty_score":0.06652433},"labels":[],"label_agreement":null},{"id":"W1990529789","doi":"10.1016/j.jval.2014.03.1662","title":"Health Care Costs In Psoriasis Patients Newly Initiated On A Biologic Therapy Or Methotrexate","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psoriasis; Medical prescription; Pharmacy; Methotrexate; Health care; Managed care; Ambulatory care; Emergency medicine; Intensive care medicine; Family medicine; Internal medicine; Dermatology; Pharmacology","score_opus":0.24153656875190177,"score_gpt":0.46779943540024216,"score_spread":0.2262628666483404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990529789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936748,0.0020645857,0.000031486124,0.0010543481,0.000024950965,0.00001164106,0.00065257103,0.0000015100359,0.0024839924],"genre_scores_gemma":[0.9986665,0.00061172404,0.00004114379,0.00011996906,0.000034935867,0.0000060046514,0.00028818328,8.834312e-7,0.00023077363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999295,0.00025717192,0.00011254076,0.00005500104,0.00011249762,0.00016776218],"domain_scores_gemma":[0.9970546,0.0010440558,0.0012562271,0.00004580123,0.000121109304,0.0004782389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032638785,0.00013271504,0.00032845928,0.0008576567,0.00054440834,0.000914479,0.00024440401,0.00066209293,0.0029150292],"category_scores_gemma":[0.0049702446,0.0002054562,0.001109669,0.0011180717,0.00018343425,0.0006223732,0.00047590464,0.0011177927,0.00010773453],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008040619,0.00022865259,0.98864543,0.00006284721,0.00026800274,0.00034161567,0.00013022231,0.0003094165,0.00012457996,0.00035075427,0.00062950834,0.008104943],"study_design_scores_gemma":[0.000063104686,0.00021931606,0.9967122,0.00005196134,0.00016759783,0.00069413264,0.0004824636,0.00072983204,0.000055124143,0.00020686041,0.0006065678,0.000010720109],"about_ca_topic_score_codex":0.017159916,"about_ca_topic_score_gemma":0.023799513,"teacher_disagreement_score":0.017159916,"about_ca_system_score_codex":0.0016458037,"about_ca_system_score_gemma":0.00084361725,"threshold_uncertainty_score":0.034120083},"labels":[],"label_agreement":null},{"id":"W1990560008","doi":"10.1016/j.jval.2012.08.1503","title":"PRM39 Evaluation of Patient Centered Outcomes Using Individual Data From a Quality Registry and Patient Reported Abilities and Ratings of Quality in Health Care, in Diabetes Patients in Sweden","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Health care; Population; Family medicine; Environmental health","score_opus":0.29903272821268967,"score_gpt":0.4570436263931738,"score_spread":0.15801089818048414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990560008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848133,0.00012182977,0.00015170305,0.000034495923,0.0000071875074,0.000028428063,0.0007935455,0.0000055848923,0.0003759723],"genre_scores_gemma":[0.9970156,0.000103206396,0.00054312224,0.000024833867,0.000011593978,0.00012266703,0.0019225968,0.000008360009,0.00024791856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934942,0.0038506354,0.000826839,0.00049083546,0.0008794666,0.0004580444],"domain_scores_gemma":[0.98590267,0.0052200393,0.0038057081,0.0009686519,0.003277517,0.0008253995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009969031,0.00049050845,0.0009843567,0.00250363,0.0007776361,0.003020177,0.000618319,0.0007007612,0.0013043737],"category_scores_gemma":[0.021172866,0.0003766666,0.0019095804,0.003362174,0.00038631156,0.0010282188,0.0017809422,0.0008019594,0.00039011415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077178306,0.00016233523,0.9930721,0.000058103244,0.00032505195,0.0000457158,0.00036832003,0.00029186477,0.00009710328,0.00003506439,0.00017494934,0.004597693],"study_design_scores_gemma":[0.00009960925,0.00093692954,0.99555427,0.000057145655,0.00036962994,0.00013218969,0.0010463669,0.00084316987,0.00041870962,0.00003999516,0.00047933633,0.000022575963],"about_ca_topic_score_codex":0.019041901,"about_ca_topic_score_gemma":0.010348991,"teacher_disagreement_score":0.019041901,"about_ca_system_score_codex":0.0015553226,"about_ca_system_score_gemma":0.0020294993,"threshold_uncertainty_score":0.052721858},"labels":[],"label_agreement":null},{"id":"W1990596085","doi":"10.1016/s1098-3015(11)71621-7","title":"PMH12: THE COST OF TREATING SCHIZOPHRENIA IN ROUTINE CLINICAL PRACTICE: RESULTS FROM THE CANADIAN NATIONAL OUTCOMES MEASUREMENT STUDY IN SCHIZOPHRENIA (CNOMSS)","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Psychiatry; Clinical Practice; Medicine; Psychology; Family medicine","score_opus":0.2009828727177178,"score_gpt":0.429784363418869,"score_spread":0.2288014907011512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990596085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9125014,0.007898486,0.00021228695,0.010937057,0.00018205254,0.00027697027,0.06284929,0.000089177636,0.0050532254],"genre_scores_gemma":[0.97587115,0.0035816368,0.0009620764,0.0010362549,0.00013214366,0.00018876177,0.01697439,0.000027470738,0.0012261036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962901,0.0009419321,0.00041949132,0.00021445513,0.0015551652,0.0005788974],"domain_scores_gemma":[0.9889446,0.0023062387,0.0037136062,0.00025251822,0.0026377346,0.0021453856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025155304,0.0008421218,0.0011766119,0.0019302801,0.0012548597,0.0013105284,0.0023108514,0.0015333234,0.0022316948],"category_scores_gemma":[0.027849508,0.00054502126,0.0016187362,0.00592825,0.00072418747,0.0010947129,0.002052249,0.002008575,0.00029460245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029638768,0.0004098416,0.9172225,0.0005372141,0.0007781007,0.00009195442,0.0004219649,0.0016633027,0.00006280232,0.00067417586,0.026023334,0.04915087],"study_design_scores_gemma":[0.00020955403,0.00017126363,0.99563,0.00012221558,0.00021770502,0.000060545888,0.0003449,0.0013557259,0.000028194394,0.00012752943,0.0017005983,0.00003186761],"about_ca_topic_score_codex":0.92381144,"about_ca_topic_score_gemma":0.92574316,"teacher_disagreement_score":0.076188564,"about_ca_system_score_codex":0.027563674,"about_ca_system_score_gemma":0.029992804,"threshold_uncertainty_score":0.19998938},"labels":[],"label_agreement":null},{"id":"W1990728316","doi":"10.1111/j.1524-4733.2010.00761.x","title":"Persistence Patterns with Oral Antidiabetes Drug Treatment in Newly Treated Patients—A Population-Based Study","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec; Université Laval","funders":"Merck Canada","keywords":"Discontinuation; Medicine; Persistence (discontinuity); Metformin; Hazard ratio; Proportional hazards model; Internal medicine; Medical prescription; Population; Cohort; Cohort study; Pharmacology; Confidence interval; Insulin","score_opus":0.052002486493362234,"score_gpt":0.3143623215129684,"score_spread":0.26235983501960614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990728316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988525,0.00019251215,0.000054558994,0.000045280845,0.0000031541724,0.00001641209,0.0006555267,0.0000026570476,0.00017757475],"genre_scores_gemma":[0.9992023,0.00006618566,0.000058565653,0.000028627128,0.0000061496357,0.000009056248,0.00052294147,0.000001275414,0.00010479541],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992111,0.00014548459,0.000077236895,0.00019332579,0.00020357867,0.00016929011],"domain_scores_gemma":[0.99689627,0.00038648638,0.0016389231,0.00014185219,0.00046221554,0.00047426837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094256207,0.00024363112,0.00046625145,0.00081864087,0.00061549066,0.00090220425,0.00057681376,0.000554782,0.0015548667],"category_scores_gemma":[0.0031037468,0.00024554643,0.0005628563,0.0012500023,0.00027000508,0.0005447338,0.00040642428,0.0007714914,0.00020444355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005947904,0.000027540978,0.99921405,0.000004278041,0.000034956687,0.000023242688,0.000042332336,0.000016164386,0.00004998912,0.0000041690328,0.000048081725,0.00047575793],"study_design_scores_gemma":[0.000007953183,0.000078403384,0.9994617,0.0000047145413,0.000012217947,0.00007666778,0.000073455216,0.0001655716,0.000014059057,0.0000040975415,0.00009744012,0.0000037201526],"about_ca_topic_score_codex":0.13029675,"about_ca_topic_score_gemma":0.12640339,"teacher_disagreement_score":0.13029675,"about_ca_system_score_codex":0.0015088315,"about_ca_system_score_gemma":0.0012008661,"threshold_uncertainty_score":0.2590767},"labels":[],"label_agreement":null},{"id":"W1991070138","doi":"10.1016/j.jval.2013.01.007","title":"Assessing the Value of Symptom Relief for Patients with Gastroesophageal Reflux Disease Treatment: Willingness to Pay Using a Discrete Choice Experiment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of Calgary; McMaster University","funders":"","keywords":"GERD; Willingness to pay; Medicine; Disease; Reflux; Physical therapy; Internal medicine","score_opus":0.035716385358246346,"score_gpt":0.35500222480766047,"score_spread":0.31928583944941413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991070138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946021,0.000088303095,0.002737149,0.00042609486,0.00009006438,0.00077630836,0.000116736745,0.000013735712,0.001149485],"genre_scores_gemma":[0.99235475,0.0000840743,0.0053396663,0.00019753516,0.00005236258,0.001341079,0.00007831491,0.0000043208847,0.0005479043],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.98935986,0.008067907,0.0006260613,0.0006684865,0.00083000935,0.00044760676],"domain_scores_gemma":[0.91729695,0.07412801,0.0035445234,0.0019208214,0.00063059764,0.0024791246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01384544,0.0011244762,0.001406292,0.00052715646,0.00077262725,0.0022786073,0.0011061223,0.003126401,0.007086014],"category_scores_gemma":[0.048050065,0.0006985502,0.0014902232,0.00047442853,0.0017307254,0.0020569144,0.0009990352,0.0033183692,0.0005606266],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46931806,0.26789472,0.072967425,0.0015223845,0.003221029,0.0004054826,0.003969232,0.043057967,0.020627229,0.013762195,0.0017213883,0.10153277],"study_design_scores_gemma":[0.14540276,0.4595302,0.08074226,0.0003045417,0.0026866933,0.00048004845,0.0023463632,0.26219985,0.012838368,0.029062012,0.0037248041,0.00068216055],"about_ca_topic_score_codex":0.00048276782,"about_ca_topic_score_gemma":0.00041393243,"teacher_disagreement_score":0.01384544,"about_ca_system_score_codex":0.0010705945,"about_ca_system_score_gemma":0.0015516253,"threshold_uncertainty_score":0.07322258},"labels":[],"label_agreement":null},{"id":"W1991089695","doi":"10.1016/s1098-3015(10)72550-x","title":"PMH55 CANADIAN COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RISPERIDONE VERSUS ORAL ATYPICAL AND CONVENTIONAL DEPOT ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA AT HIGH-RISK OF NON-COMPLIANCE: UPDATED BASED ON NEW CLINICAL DATA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Medicine; Psychiatry; Compliance (psychology); Psychology","score_opus":0.1113448249204588,"score_gpt":0.4060005917665752,"score_spread":0.2946557668461164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991089695","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19979672,0.1535015,0.0030761966,0.008475697,0.0016713592,0.0056353854,0.5879085,0.00054534094,0.039389305],"genre_scores_gemma":[0.78599554,0.04302785,0.008309236,0.004876467,0.0008739714,0.0024905703,0.14462914,0.00019660465,0.009600625],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.993665,0.00212827,0.0005399729,0.00038688016,0.0027392094,0.0005406753],"domain_scores_gemma":[0.9925889,0.0021148736,0.0014960774,0.00029694274,0.0028321303,0.00067100866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055560605,0.0019005637,0.004314006,0.003701985,0.000612446,0.0020600047,0.0034590566,0.0010951431,0.007950358],"category_scores_gemma":[0.020122569,0.0013477171,0.011386341,0.008234201,0.0004816284,0.0010312501,0.00091456756,0.0023635523,0.00046646487],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2270016,0.0006375968,0.08948035,0.038419623,0.13955383,0.0006683108,0.00037077352,0.051714543,0.0012192108,0.005565681,0.2294571,0.21591145],"study_design_scores_gemma":[0.15701348,0.0039931606,0.5760674,0.008092665,0.13347341,0.00066248147,0.00029435282,0.027041985,0.0010131733,0.0022156918,0.08936394,0.0007683384],"about_ca_topic_score_codex":0.93884486,"about_ca_topic_score_gemma":0.94606274,"teacher_disagreement_score":0.06115514,"about_ca_system_score_codex":0.05948568,"about_ca_system_score_gemma":0.05300389,"threshold_uncertainty_score":0.43160087},"labels":[],"label_agreement":null},{"id":"W1991140087","doi":"10.1016/j.jval.2014.03.988","title":"Comparative Costs And Effectiveness Of Asthma Controller Therapies After Discharge From An Asthma-Related Hospitalization","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Asthma; Confounding; Cohort; Propensity score matching; Adverse effect; Emergency medicine; Inhaled corticosteroids; Cohort study; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.012005756692663107,"score_gpt":0.29687091039680974,"score_spread":0.2848651537041466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991140087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99079645,0.00468943,0.00015251503,0.00043199546,0.000073677205,0.000032439573,0.001496884,0.0000057222455,0.0023207995],"genre_scores_gemma":[0.9980399,0.0005813312,0.000089559646,0.00004542325,0.00003991909,0.000016289629,0.0010090471,0.0000025524096,0.00017602382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661595,0.0017861504,0.0002944189,0.000208444,0.00046807184,0.0006270139],"domain_scores_gemma":[0.9862277,0.009842234,0.001952737,0.0005417502,0.0005632656,0.0008724277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028729243,0.00046258463,0.0012426552,0.0018764518,0.00047381726,0.0016974605,0.0011280355,0.0014428659,0.0038616995],"category_scores_gemma":[0.021510515,0.00037518973,0.004748509,0.0020163571,0.00074691034,0.001587674,0.00094354193,0.0017997468,0.00017879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19895187,0.005771696,0.6048739,0.0019510944,0.018928247,0.0012414453,0.00066146924,0.03947557,0.0016868463,0.009240021,0.003664458,0.11355342],"study_design_scores_gemma":[0.00457214,0.0097603565,0.95835406,0.00035305414,0.00626682,0.00074922753,0.0014372129,0.012739328,0.0007383262,0.003876321,0.0010417302,0.00011142807],"about_ca_topic_score_codex":0.011225121,"about_ca_topic_score_gemma":0.012410138,"teacher_disagreement_score":0.011225121,"about_ca_system_score_codex":0.0038496852,"about_ca_system_score_gemma":0.0012645478,"threshold_uncertainty_score":0.027931571},"labels":[],"label_agreement":null},{"id":"W1991212328","doi":"10.1016/j.jval.2013.03.170","title":"Assesing parameter importance in health economics models. Can we make it faster?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Analysis of covariance; Statistics; Dominance (genetics); Econometrics; Subgroup analysis; Regression analysis; Mathematics; Computer science; Data mining","score_opus":0.47067665487411037,"score_gpt":0.41125062353245356,"score_spread":0.059426031341656804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991212328","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08770052,0.022381783,0.7704803,0.09175642,0.0032473898,0.0001304441,0.000525131,0.0010194513,0.022758545],"genre_scores_gemma":[0.87083524,0.013976588,0.093511656,0.0057017487,0.003349375,0.00018184292,0.00036154434,0.0008649836,0.011216905],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9937358,0.0046471963,0.00020492105,0.0005292763,0.0005460253,0.00033676843],"domain_scores_gemma":[0.8626126,0.11883279,0.005186963,0.0087664975,0.0031228291,0.0014784493],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018866032,0.0020612658,0.0025051618,0.0017317004,0.0009067091,0.0048892065,0.002517666,0.004517315,0.007866317],"category_scores_gemma":[0.21553667,0.0015010086,0.0011994856,0.0020584213,0.003802404,0.028647201,0.0039230133,0.00985912,0.0014967694],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000661238,0.00025862147,0.0129162595,0.0006282149,0.00050743564,0.00030075837,0.00068915065,0.31078678,0.0007923709,0.5092302,0.027003806,0.1362252],"study_design_scores_gemma":[0.0000568608,0.000044701093,0.0010974656,0.00018133165,0.00006105751,0.000098411605,0.00009314331,0.33500773,0.00029117992,0.6584506,0.0045530614,0.000064532454],"about_ca_topic_score_codex":0.007342573,"about_ca_topic_score_gemma":0.0040314305,"teacher_disagreement_score":0.98113394,"about_ca_system_score_codex":0.0015480695,"about_ca_system_score_gemma":0.001915087,"threshold_uncertainty_score":0.0997743},"labels":[],"label_agreement":null},{"id":"W1991222191","doi":"10.1111/j.1524-4733.2008.00433.x","title":"Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in Chronic Kidney Disease","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Intraclass correlation; Medicine; Health Utilities Index; Psychology; Internal medicine; Physical therapy; Psychometrics; Clinical psychology; Disease; Health related quality of life","score_opus":0.10349825238547762,"score_gpt":0.2955851727326257,"score_spread":0.19208692034714808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991222191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940474,0.002642752,0.00075601565,0.0003464679,0.00008475423,0.000051218427,0.0009525881,0.000011234736,0.001107549],"genre_scores_gemma":[0.9981918,0.00034639274,0.0006319754,0.00007492326,0.00003249198,0.00004684278,0.00051011745,0.0000051778356,0.00016024441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965501,0.0024105771,0.00024654827,0.0001873045,0.0004333524,0.00017209677],"domain_scores_gemma":[0.99194545,0.0065225502,0.00075909327,0.00022972056,0.00026442794,0.0002787636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055781235,0.0005791771,0.0013402177,0.00081621757,0.0002058048,0.00086554757,0.0006309818,0.00088381814,0.0022771605],"category_scores_gemma":[0.016909499,0.000219057,0.002927731,0.0011583577,0.000367558,0.0015461772,0.0009821347,0.0014098287,0.00021476341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26316577,0.002418836,0.56186104,0.0010099026,0.01441088,0.0001553844,0.00053903245,0.014639865,0.0009252312,0.0022422445,0.0044754893,0.1341564],"study_design_scores_gemma":[0.014807517,0.0387414,0.8811396,0.00022286482,0.007178139,0.0003148868,0.00078033697,0.04948009,0.0012648978,0.003606195,0.0022813696,0.00018282287],"about_ca_topic_score_codex":0.004855532,"about_ca_topic_score_gemma":0.004090091,"teacher_disagreement_score":0.0055781235,"about_ca_system_score_codex":0.0009798902,"about_ca_system_score_gemma":0.0005712452,"threshold_uncertainty_score":0.029500306},"labels":[],"label_agreement":null},{"id":"W1991289860","doi":"10.1016/j.jval.2013.03.555","title":"Health care resource utilization (HRU) and costs associated with disease activity in systemic lupus erythematosus (SLE): A retrospective observational cohort analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Cohort; Observational study; Retrospective cohort study; Emergency medicine; Medical record; Medical prescription; Health care; Diagnosis code; Rheumatology; Pharmacy; Internal medicine; Intensive care unit; Family medicine; Population; Environmental health","score_opus":0.046898916535208904,"score_gpt":0.3240767267311913,"score_spread":0.2771778101959824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991289860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99860674,0.00019920533,0.000087722896,0.000022801169,0.000005390704,0.000009750771,0.0009595971,0.0000025682818,0.00010632859],"genre_scores_gemma":[0.9984687,0.00013298212,0.00010261647,0.000025965433,0.000010780118,0.000015653224,0.0011402944,0.000002806985,0.00010022922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998425,0.00046104874,0.00023543126,0.00038000522,0.00019677792,0.00030178932],"domain_scores_gemma":[0.99545175,0.00072969054,0.0021531682,0.0006977559,0.0003569438,0.00061060855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016794933,0.000609666,0.0007619653,0.0015976393,0.00078041287,0.0013599817,0.00090867275,0.0009916088,0.0012072208],"category_scores_gemma":[0.0036228627,0.0010871559,0.002332652,0.0031509104,0.00050191744,0.0011263828,0.001214609,0.0014995263,0.0003050155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019028249,0.000047859576,0.9990922,0.00000598805,0.00021071795,0.000050700517,0.00003296485,0.000041610478,0.000059540398,0.000012641122,0.00005740603,0.0001980796],"study_design_scores_gemma":[0.000019615492,0.00011070136,0.9988636,0.0000060534426,0.00012597506,0.00021753668,0.00017964715,0.00033573934,0.00003296482,0.000017705885,0.00008165737,0.000008707959],"about_ca_topic_score_codex":0.023182316,"about_ca_topic_score_gemma":0.020666964,"teacher_disagreement_score":0.023182316,"about_ca_system_score_codex":0.0009929361,"about_ca_system_score_gemma":0.0010474309,"threshold_uncertainty_score":0.046094716},"labels":[],"label_agreement":null},{"id":"W1991297890","doi":"10.1111/j.1524-4733.2005.03086.x","title":"Probabilistic Markov Model to Assess the Cost-Effectiveness of Bronchodilator Therapy in COPD Patients in Different Countries","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Salmeterol; Ipratropium; Medicine; COPD; Exacerbation; Anticholinergic; Bronchodilator; Tiotropium bromide; Quality of life (healthcare); Physical therapy; Randomized controlled trial; Intensive care medicine; Internal medicine; Asthma; Lung function; Lung","score_opus":0.06925652454250496,"score_gpt":0.3641312806389096,"score_spread":0.2948747560964046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991297890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7207681,0.002139539,0.2600664,0.00482156,0.00021162092,0.0003767228,0.0046942993,0.00043115186,0.0064905356],"genre_scores_gemma":[0.9859552,0.000425051,0.010095086,0.00018655368,0.000051192,0.00022640542,0.0014520566,0.00002383539,0.0015846285],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971275,0.0021013487,0.000099128105,0.00024731323,0.00014591454,0.00027874383],"domain_scores_gemma":[0.96920836,0.028183902,0.001128912,0.0004865868,0.00052044523,0.0004717295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0081236595,0.0009893107,0.002610941,0.0019252305,0.0006897581,0.0018256744,0.0022274717,0.0027568908,0.0065009054],"category_scores_gemma":[0.025038704,0.0012216892,0.0023366283,0.0016692398,0.0012974766,0.0022744124,0.0011750808,0.0021936784,0.00047234603],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007263446,0.00010766694,0.008319754,0.000039644772,0.00027791952,0.00010049282,0.000041594503,0.9734185,0.00010371801,0.01229023,0.0007322434,0.0038419408],"study_design_scores_gemma":[0.00013660903,0.0001170424,0.0025474923,0.000014834986,0.00008445158,0.000060809285,0.00002179099,0.98689216,0.00004853862,0.009877763,0.00017762378,0.000020887672],"about_ca_topic_score_codex":0.018154424,"about_ca_topic_score_gemma":0.00998038,"teacher_disagreement_score":0.018154424,"about_ca_system_score_codex":0.0029031066,"about_ca_system_score_gemma":0.0015841519,"threshold_uncertainty_score":0.04296255},"labels":[],"label_agreement":null},{"id":"W1991488768","doi":"10.1016/j.jval.2012.08.2068","title":"PSS21 Evaluation of Health Utility in Patients With Retinal Vein Occlusion","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); St Joseph's Health Care","funders":"","keywords":"Medicine; Context (archaeology); Central retinal vein occlusion; Branch retinal vein occlusion; Visual acuity; Occlusion; Observational study; Ophthalmology; Optometry; Macular edema; Internal medicine; Geography","score_opus":0.4419316813334235,"score_gpt":0.4389533432612799,"score_spread":0.0029783380721435937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991488768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815471,0.002119243,0.00090151554,0.00078968296,0.000037211143,0.00011014663,0.0038370027,0.000016035205,0.010641994],"genre_scores_gemma":[0.9978315,0.00025909263,0.00030571717,0.00003143108,0.000020121743,0.000031901003,0.0011606921,0.000002812102,0.00035669567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996402,0.0022923516,0.00037499095,0.00014203574,0.0005788239,0.00020977232],"domain_scores_gemma":[0.99017066,0.005276977,0.0020871258,0.00035706905,0.0014462075,0.000661915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004514434,0.0004654171,0.001131024,0.0016793822,0.00035196953,0.0017485372,0.0002906304,0.0006581465,0.0038290063],"category_scores_gemma":[0.030368363,0.000118597614,0.0019151105,0.0022181936,0.00035868637,0.00073205115,0.0007457561,0.0006878862,0.0004928417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00782876,0.00046970788,0.89752483,0.00044782305,0.0016303277,0.00054694223,0.00035638388,0.010183782,0.00032913065,0.0020757231,0.003911374,0.07469525],"study_design_scores_gemma":[0.00047158965,0.0051174904,0.96260417,0.00023114031,0.0010545194,0.0008206683,0.00055427325,0.02205429,0.00056205573,0.0024747613,0.003996444,0.000058741985],"about_ca_topic_score_codex":0.005286123,"about_ca_topic_score_gemma":0.003555013,"teacher_disagreement_score":0.005286123,"about_ca_system_score_codex":0.0016270796,"about_ca_system_score_gemma":0.0010601499,"threshold_uncertainty_score":0.023874938},"labels":[],"label_agreement":null},{"id":"W1992633728","doi":"10.1016/s1098-3015(11)73249-1","title":"PIH4 COST OF PUBLIC HEALTH DELIVERY OF CHILDHOOD IMMUNIZATIONS IN NOVA SCOTIA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Impact and Responses","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Nova (rocket); Medicine; Pediatrics; History; Engineering; Ethnology","score_opus":0.08054979427281597,"score_gpt":0.28772185169424175,"score_spread":0.20717205742142578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992633728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9497151,0.0013483755,0.00023600165,0.0071089775,0.00019695541,0.0001530045,0.023924174,0.000054686076,0.017262746],"genre_scores_gemma":[0.98585224,0.00062017515,0.00017373043,0.0004246264,0.000048588197,0.00003807771,0.0025971166,0.000007378731,0.0102381185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983302,0.0004212926,0.000091229515,0.000060398594,0.0003844149,0.0007124513],"domain_scores_gemma":[0.99604815,0.0011558904,0.0009291066,0.000084860134,0.0008065654,0.00097543193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079581334,0.00032086307,0.00043821346,0.001200946,0.0006375767,0.0013251745,0.0009412742,0.0010339706,0.0047512567],"category_scores_gemma":[0.008279546,0.0004281013,0.00078823883,0.0015245003,0.0005191742,0.00032596808,0.00090796483,0.0012542647,0.00035301715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029598759,0.0004008768,0.8264755,0.0005666212,0.0007045994,0.0063471734,0.000488547,0.07162426,0.001253601,0.008392884,0.04677236,0.034013666],"study_design_scores_gemma":[0.00043672562,0.00040837875,0.9531532,0.00015213805,0.00022287367,0.0010824401,0.0014401964,0.031045293,0.0005242779,0.0007681186,0.010728619,0.000037669666],"about_ca_topic_score_codex":0.9410013,"about_ca_topic_score_gemma":0.9372601,"teacher_disagreement_score":0.058998704,"about_ca_system_score_codex":0.026126219,"about_ca_system_score_gemma":0.019721266,"threshold_uncertainty_score":0.18955988},"labels":[],"label_agreement":null},{"id":"W1992859792","doi":"10.1016/j.jval.2014.03.027","title":"How Canadians Value Rare Diseases Given Their Opportunity Cost?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Value (mathematics); Medicine; Mathematics; Statistics","score_opus":0.07074710787147058,"score_gpt":0.29251430695483643,"score_spread":0.22176719908336584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992859792","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.089005455,0.008230505,0.0005689917,0.7725874,0.0016090097,0.000033348693,0.0012840341,0.000025829167,0.12665552],"genre_scores_gemma":[0.9205035,0.0065971,0.00050404103,0.05689718,0.0011482182,0.00002136868,0.00033733062,0.000030955092,0.013960441],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9940094,0.00097342656,0.00012704589,0.0002213023,0.0020354968,0.002633424],"domain_scores_gemma":[0.97692126,0.003663098,0.0018730786,0.00042015171,0.008250039,0.00887233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004326637,0.00025432147,0.0004406317,0.002322453,0.0069010206,0.009225165,0.0013270051,0.0036034626,0.014461981],"category_scores_gemma":[0.03805653,0.0002616609,0.000534728,0.0046055326,0.0055756355,0.00293456,0.0015830322,0.0043711867,0.00058742764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034693372,0.00014006924,0.13222025,0.00023734744,0.00028895127,0.0010198355,0.00955717,0.0011187672,0.00024263524,0.24686988,0.4783357,0.12962234],"study_design_scores_gemma":[0.00017350355,0.000087605906,0.15812042,0.0012734258,0.00028873497,0.001325796,0.04922624,0.0016621652,0.00026987874,0.094312,0.69292474,0.00033545276],"about_ca_topic_score_codex":0.969914,"about_ca_topic_score_gemma":0.98008347,"teacher_disagreement_score":0.05569233,"about_ca_system_score_codex":0.05569233,"about_ca_system_score_gemma":0.10360492,"threshold_uncertainty_score":0.404078},"labels":[],"label_agreement":null},{"id":"W1993141230","doi":"10.1016/s1098-3015(10)70938-4","title":"PSS43 WORK RELATED LOST PRODUCTIVITY AND ITS ECONOMIC IMPACT IN CANADIAN PATIENTS WITH MODERATE TO SEVERE PSORIASIS","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work productivity; Productivity; Psoriasis; Work (physics); Economics; Medicine; Business; Demographic economics; Dermatology; Economic growth; Engineering; Mechanical engineering","score_opus":0.020301276297253402,"score_gpt":0.2753116829952242,"score_spread":0.25501040669797076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993141230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898235,0.0013570865,0.000025017967,0.0010826724,0.000024912424,0.000023737051,0.0012066178,0.000002971525,0.0064534005],"genre_scores_gemma":[0.9986596,0.00047136232,0.000030338531,0.000089375855,0.0000146355405,0.0000043993255,0.00027639163,0.0000012621721,0.00045257533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916446,0.00008454007,0.00005282457,0.000041688596,0.0002988406,0.00035775683],"domain_scores_gemma":[0.9980141,0.00016153393,0.00043956315,0.000025964724,0.00067138416,0.0006874504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039093095,0.00027361,0.00044077283,0.0013333148,0.002688145,0.0013626737,0.00066836085,0.00054851087,0.004200407],"category_scores_gemma":[0.002920338,0.00019276896,0.00067305675,0.0040439214,0.0005877796,0.00038109167,0.000671617,0.0011813134,0.00027715837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031223093,0.00011685022,0.9885395,0.0000483759,0.00005745306,0.0007957,0.00074914517,0.00011438694,0.00012535937,0.0001841028,0.0012526078,0.007704275],"study_design_scores_gemma":[0.000010584311,0.00003734806,0.9967809,0.000028449076,0.000030594172,0.000420497,0.001738583,0.00012877065,0.000011820261,0.00004008895,0.00076094735,0.000011443672],"about_ca_topic_score_codex":0.9472467,"about_ca_topic_score_gemma":0.94991845,"teacher_disagreement_score":0.05275333,"about_ca_system_score_codex":0.012666458,"about_ca_system_score_gemma":0.012776949,"threshold_uncertainty_score":0.10612798},"labels":[],"label_agreement":null},{"id":"W1993515803","doi":"10.1016/j.jval.2014.03.274","title":"Cost Of Drug Therapy For Ankylosing Spondylitis In The Brazilian Public Health System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Adalimumab; Ankylosing spondylitis; Infliximab; Etanercept; Sulfasalazine; Internal medicine; BASDAI; Pediatrics; Disease; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.08611378252083714,"score_gpt":0.3474435951617377,"score_spread":0.26132981264090055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993515803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9402495,0.025859695,0.0004797579,0.015294393,0.00010603929,0.000070315655,0.004639911,0.000016675696,0.013283727],"genre_scores_gemma":[0.99629045,0.002875297,0.000126424,0.00013904757,0.00002603508,0.0000122668735,0.0002748538,0.0000018839078,0.00025385953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976376,0.0012841495,0.0001624428,0.000078106765,0.00049365376,0.00034396126],"domain_scores_gemma":[0.99644274,0.0011587649,0.0010763797,0.000115642506,0.00062551163,0.0005809507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013469349,0.00021340395,0.00034874238,0.0018597868,0.0003752139,0.0008907142,0.00055288506,0.00051853847,0.0017933301],"category_scores_gemma":[0.0087453835,0.00019202709,0.00075592514,0.002995744,0.0005193796,0.00051192404,0.0006230432,0.00050168904,0.000059599242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054007675,0.00038149112,0.8815774,0.0011581811,0.0010648175,0.0010123476,0.0010220084,0.0040923962,0.000757986,0.014393461,0.0062713134,0.087728605],"study_design_scores_gemma":[0.00005424972,0.00019083521,0.98569995,0.00038398488,0.0004047565,0.000691863,0.0013172571,0.0033323127,0.00010885549,0.001314369,0.0064831297,0.000018467572],"about_ca_topic_score_codex":0.19069463,"about_ca_topic_score_gemma":0.23236679,"teacher_disagreement_score":0.19069463,"about_ca_system_score_codex":0.012408945,"about_ca_system_score_gemma":0.0058249524,"threshold_uncertainty_score":0.37916934},"labels":[],"label_agreement":null},{"id":"W1993551769","doi":"10.1016/j.jval.2014.03.656","title":"Intra-Hospital Cost Of Implanting A Left Ventricular Assistance Device: A Canadian Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Institut National d'Excellence en Santé et en Services Sociaux; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Activity-based costing; Ventricular assist device; Emergency medicine; Total cost; Average cost; Index (typography); Resource use; Medical emergency; Surgery; Heart failure; Cardiology","score_opus":0.01427494557019083,"score_gpt":0.24615116988540528,"score_spread":0.23187622431521446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993551769","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.293411,0.07045471,0.0015279595,0.39756045,0.0024428228,0.00022254058,0.024008278,0.00007080321,0.21030153],"genre_scores_gemma":[0.883838,0.066755235,0.0018366235,0.023217905,0.001462245,0.000064621156,0.004796504,0.000090377456,0.017938558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966264,0.00027220597,0.00015142585,0.00018721951,0.0015210675,0.0012416071],"domain_scores_gemma":[0.99105245,0.0004921334,0.0008215873,0.000044414926,0.0047246995,0.002864754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013198428,0.0010094243,0.0008523782,0.0038498624,0.003949483,0.005493355,0.0019876114,0.0030804689,0.014242342],"category_scores_gemma":[0.006502184,0.00049791473,0.001951331,0.006766238,0.0014282152,0.0014767711,0.0011776322,0.0051449384,0.00058631925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003180824,0.0010355668,0.32162252,0.0024664884,0.0022943667,0.0060010995,0.003905046,0.014540789,0.002481721,0.1053307,0.31937754,0.21776332],"study_design_scores_gemma":[0.0007879301,0.00078685104,0.70626986,0.0049295793,0.0018783123,0.0037151983,0.016602455,0.0095312605,0.00063195813,0.009491761,0.2444045,0.00097028824],"about_ca_topic_score_codex":0.99184823,"about_ca_topic_score_gemma":0.9953585,"teacher_disagreement_score":0.14323598,"about_ca_system_score_codex":0.14323598,"about_ca_system_score_gemma":0.14656426,"threshold_uncertainty_score":0.9937248},"labels":[],"label_agreement":null},{"id":"W1993753125","doi":"10.1016/j.jval.2014.03.291","title":"Health Care Resource Utilization In The Management Of Knee Osteoarthritis With Hyaluronic Acid In A Canadian Real-World Population","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Western University","funders":"","keywords":"Medicine; Osteoarthritis; Physical therapy; Observational study; Population; Health care; Knee pain; Emergency medicine; Internal medicine; Alternative medicine","score_opus":0.023654662536083844,"score_gpt":0.28561463170526064,"score_spread":0.2619599691691768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993753125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945457,0.0009459839,0.000045474244,0.0011004469,0.000011476328,0.000041738866,0.0014406523,0.000004415363,0.0018641186],"genre_scores_gemma":[0.99855775,0.0005658303,0.00008180896,0.00013325602,0.000007991984,0.000010951409,0.0004766417,0.000001620913,0.00016422156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864596,0.00015243367,0.00012277298,0.00010632617,0.0004403879,0.0005321655],"domain_scores_gemma":[0.9982514,0.00017040751,0.0005231263,0.000030286825,0.00047149076,0.00055331265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056828384,0.00027697638,0.00043551452,0.0011277501,0.0017930355,0.0015153425,0.0012061129,0.00087251933,0.0018296787],"category_scores_gemma":[0.0035783977,0.00027930038,0.0011259757,0.0042577595,0.0007083525,0.0005218653,0.00079459336,0.0011553257,0.00010518736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015473992,0.00020203937,0.9910555,0.00007220188,0.0001237191,0.00029870163,0.0006999679,0.00040951915,0.00011738035,0.00025323418,0.0013812443,0.005231722],"study_design_scores_gemma":[0.000019825551,0.00007644243,0.99532074,0.000047523612,0.000063514584,0.00016895197,0.0025825405,0.0010228548,0.0000324505,0.000045625406,0.0005950757,0.000024438761],"about_ca_topic_score_codex":0.98570246,"about_ca_topic_score_gemma":0.9867981,"teacher_disagreement_score":0.031061327,"about_ca_system_score_codex":0.031061327,"about_ca_system_score_gemma":0.02610068,"threshold_uncertainty_score":0.22536677},"labels":[],"label_agreement":null},{"id":"W1993841889","doi":"10.1016/s1098-3015(10)72639-5","title":"PMS53 UTILISATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN QUEBEC, CANADA: IS THERE A CHANGE IN THE PATIENT RISK PROFILE AFTER THE WITHDRAWAL OF ROFECOXIB?","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rofecoxib; Nonsteroidal; Medicine; Pharmacology; Intensive care medicine; Cyclooxygenase; Chemistry","score_opus":0.015298626307932946,"score_gpt":0.2627011976653525,"score_spread":0.24740257135741955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993841889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775149,0.005163242,0.00012291572,0.006003273,0.0000678785,0.00004408463,0.006049449,0.000013118613,0.005020972],"genre_scores_gemma":[0.99484766,0.0017360685,0.00012615329,0.000750199,0.000026824262,0.000011205267,0.0010246956,0.0000055897367,0.0014716169],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897146,0.00014537538,0.000090744834,0.0001026885,0.00039564114,0.00029410247],"domain_scores_gemma":[0.9960563,0.00034564346,0.0009992421,0.000077577075,0.0018270662,0.0006942358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074608834,0.00018368333,0.0004074286,0.00084938,0.001109531,0.0009940289,0.00089586567,0.000738469,0.002794127],"category_scores_gemma":[0.0038226093,0.00019041968,0.00055776496,0.0035209884,0.0004504111,0.00043333732,0.00030443212,0.0007908929,0.000210004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023468018,0.000036593927,0.9867595,0.0000596758,0.000070874674,0.00016898446,0.00028589743,0.00010370054,0.00019354901,0.00012938783,0.0017795985,0.0101775825],"study_design_scores_gemma":[0.000010929947,0.000030186065,0.99812835,0.00003299951,0.000024990211,0.000051273604,0.00036726825,0.000171353,0.000043853204,0.000011751893,0.0011198209,0.000007290239],"about_ca_topic_score_codex":0.99244905,"about_ca_topic_score_gemma":0.9949656,"teacher_disagreement_score":0.022811903,"about_ca_system_score_codex":0.022811903,"about_ca_system_score_gemma":0.029981824,"threshold_uncertainty_score":0.16551274},"labels":[],"label_agreement":null},{"id":"W1993902708","doi":"10.1016/j.jval.2013.08.1529","title":"Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis: Results from the Open-Label Extension Study of Rapid1","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Presenteeism; Absenteeism; Randomized controlled trial; Rheumatoid arthritis; Work productivity; Productivity; Bristol-Myers; Internal medicine; Physical therapy; Family medicine; Demography; Psychology","score_opus":0.17862936133495377,"score_gpt":0.4155487041716613,"score_spread":0.2369193428367075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993902708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982052,0.0010736393,0.0000692662,0.000049709903,0.00002980918,0.00009512121,0.00028495287,0.000007252492,0.00018496193],"genre_scores_gemma":[0.9975483,0.00068831735,0.00024250374,0.000118710224,0.00010191154,0.00019039292,0.000548965,0.0000041278386,0.0005567671],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99867237,0.0005773148,0.00011079919,0.00024129834,0.00014999109,0.00024815204],"domain_scores_gemma":[0.997929,0.0006337335,0.0006399673,0.00027365462,0.00010561539,0.00041799876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028150897,0.0012082901,0.002021525,0.0005096736,0.0006001776,0.00081947516,0.0006827237,0.0015325455,0.0018288917],"category_scores_gemma":[0.0020921573,0.00067427463,0.0022005194,0.00061493804,0.0010587642,0.0012065927,0.0005645733,0.0020850333,0.00037245764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9010094,0.028240876,0.022791458,0.00041678376,0.0020436503,0.00013162749,0.0002373947,0.00058345235,0.005666013,0.000040625033,0.000337691,0.03850102],"study_design_scores_gemma":[0.30500913,0.45999762,0.22610322,0.00010417798,0.004267092,0.00024747002,0.00025891166,0.00074818754,0.0019213378,0.00016754003,0.0010552972,0.00011997585],"about_ca_topic_score_codex":0.00204318,"about_ca_topic_score_gemma":0.0025436117,"teacher_disagreement_score":0.0028150897,"about_ca_system_score_codex":0.00057543244,"about_ca_system_score_gemma":0.0006882072,"threshold_uncertainty_score":0.01488775},"labels":[],"label_agreement":null},{"id":"W1993993055","doi":"10.1016/j.jval.2011.08.368","title":"PMH69 Deprivation and Use of Atipycal Antipsychotics in Schizophrenia","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Université de Sherbrooke; Université Laval","funders":"","keywords":"Social deprivation; Cohort; Schizophrenia (object-oriented programming); Medicine; Population; Psychiatry; Cohort study; Public health; Diagnosis of schizophrenia; Pediatrics; Demography; Gerontology; Psychosis; Internal medicine; Environmental health","score_opus":0.14186572682858725,"score_gpt":0.33816296625425524,"score_spread":0.19629723942566799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993993055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977623,0.00067933806,0.000019557088,0.00014990702,0.000012055244,0.0000045812085,0.00045565143,0.0000043988157,0.000912282],"genre_scores_gemma":[0.9987816,0.0002824026,0.00003738593,0.00005962296,0.000016106069,0.0000032918274,0.00034300517,0.0000027354279,0.00047387942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999577,0.0001185287,0.000051044914,0.000031520613,0.00011057966,0.00011132745],"domain_scores_gemma":[0.9973273,0.0006297614,0.0011561036,0.000111542904,0.00013809433,0.00063714257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039714077,0.00021806505,0.0006121901,0.0005181753,0.0004121607,0.0007748374,0.00029397706,0.00073180004,0.0031745925],"category_scores_gemma":[0.0036001408,0.0003097405,0.0005646691,0.0006817069,0.0003443842,0.00061729597,0.00057052315,0.0010572275,0.0002552095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036202405,0.0011357653,0.93867964,0.00011613805,0.00078484486,0.000520767,0.00023632991,0.00035028806,0.006263428,0.00024003601,0.0006824529,0.014787957],"study_design_scores_gemma":[0.00008932826,0.0010514556,0.9975274,0.000011625978,0.00007632131,0.00020835189,0.00014196025,0.0002295883,0.00023258144,0.0000935845,0.00032585798,0.000011954622],"about_ca_topic_score_codex":0.015419746,"about_ca_topic_score_gemma":0.024305232,"teacher_disagreement_score":0.015419746,"about_ca_system_score_codex":0.0009840112,"about_ca_system_score_gemma":0.001134892,"threshold_uncertainty_score":0.030659974},"labels":[],"label_agreement":null},{"id":"W1994369386","doi":"10.1016/j.jval.2011.02.695","title":"PMS9 COST CONSEQUENCE OF COLCHICINE APPROVAL IN THE MEDICAID PROGRAMS IN THE UNITED STATES","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Medicine; Medical prescription; Prescription drug; Colchicine; Quarter (Canadian coin); Cost sharing; Medicare Part D; Family medicine; Business; Health care; Pharmacology; Internal medicine; Economics; Geography; Nursing","score_opus":0.15071151779282413,"score_gpt":0.32807904393824644,"score_spread":0.1773675261454223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994369386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699462,0.0006253994,0.00011657693,0.009398808,0.000090133595,0.000066261935,0.0032120324,0.000026097678,0.016518429],"genre_scores_gemma":[0.99524325,0.00023362879,0.000078192796,0.0014878396,0.000088519926,0.000018254268,0.00080338854,0.0000047522744,0.002042082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979025,0.00072011404,0.000116037,0.000096750264,0.0005986495,0.0005660919],"domain_scores_gemma":[0.99340963,0.0020912779,0.0022264286,0.00014320466,0.0010677816,0.0010616516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000989659,0.00013461061,0.00023129443,0.0006860697,0.0009558207,0.0013098508,0.0003831632,0.0009504732,0.0051888833],"category_scores_gemma":[0.0076759,0.00013994373,0.0007376436,0.00091670884,0.00039470897,0.00043208373,0.00071416213,0.001265757,0.0002434665],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043709483,0.0014145223,0.8669638,0.00015996973,0.0005907244,0.0027121324,0.00037819523,0.0033810749,0.0016269488,0.0070091356,0.043641374,0.0677513],"study_design_scores_gemma":[0.00021724087,0.00070110965,0.9813644,0.00008504265,0.00036550954,0.0009926757,0.0013670233,0.0036227207,0.0010211573,0.00094328244,0.009291556,0.000028291335],"about_ca_topic_score_codex":0.06953295,"about_ca_topic_score_gemma":0.1545421,"teacher_disagreement_score":0.06953295,"about_ca_system_score_codex":0.0048103873,"about_ca_system_score_gemma":0.004391588,"threshold_uncertainty_score":0.13825649},"labels":[],"label_agreement":null},{"id":"W1994471959","doi":"10.1016/j.jval.2012.09.006","title":"A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Latent tuberculosis; Isoniazid; Tuberculosis; Vaccination; Tuberculin; Internal medicine; Demography; Pediatrics; Immunology; Mycobacterium tuberculosis; Pathology","score_opus":0.10680985462292221,"score_gpt":0.41154076528345557,"score_spread":0.30473091066053337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994471959","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24371207,0.012420632,0.7179444,0.008205009,0.00033600212,0.00086475327,0.0010969011,0.0003827745,0.015037528],"genre_scores_gemma":[0.9646243,0.0012724894,0.031058995,0.0004829827,0.00027190743,0.000207692,0.00017569833,0.000049103626,0.0018567462],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98844147,0.009826267,0.0001727254,0.00036581972,0.00076877355,0.00042501325],"domain_scores_gemma":[0.9561237,0.04130648,0.0008155113,0.0007686556,0.00058475125,0.00040084595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018188935,0.0018378961,0.0029035704,0.0026871136,0.00038501353,0.0026112152,0.0019327371,0.0019786563,0.003845359],"category_scores_gemma":[0.043846954,0.0009286374,0.0024223765,0.001113699,0.0019234756,0.0030950573,0.0015131263,0.0024655976,0.0001472007],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003916265,0.00076408323,0.0081182765,0.0014589566,0.0027090113,0.0003507512,0.00019814682,0.721314,0.0015844195,0.17601927,0.0025560313,0.08101078],"study_design_scores_gemma":[0.0006679529,0.0012523616,0.0042745173,0.00019513317,0.0022138017,0.0002643573,0.0001076121,0.7883169,0.0005085571,0.20038909,0.0017218004,0.00008795617],"about_ca_topic_score_codex":0.0027054148,"about_ca_topic_score_gemma":0.0014297467,"teacher_disagreement_score":0.018188935,"about_ca_system_score_codex":0.0020392353,"about_ca_system_score_gemma":0.00194251,"threshold_uncertainty_score":0.09619343},"labels":[],"label_agreement":null},{"id":"W1994544362","doi":"10.1016/j.jval.2013.08.1189","title":"Real-World Utilization Data Over 4 Years of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Care; Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Macular degeneration; Regimen; Ophthalmology; Surgery; Chemotherapy; Bevacizumab","score_opus":0.09718450744588003,"score_gpt":0.3532856428395149,"score_spread":0.2561011353936349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994544362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89704615,0.008323196,0.0003147665,0.0022897478,0.00004236024,0.00008035809,0.087574154,0.00005052813,0.004278602],"genre_scores_gemma":[0.9815631,0.0033235326,0.00034333995,0.00036320894,0.000020882482,0.00002422787,0.013659908,0.000010995945,0.0006908615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983072,0.00014239176,0.00025384416,0.00020432967,0.00070426747,0.00038787516],"domain_scores_gemma":[0.99446154,0.0005247767,0.0016937804,0.00011845932,0.0025013385,0.00070006336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007998156,0.00029965088,0.0006604141,0.0017778727,0.00087995577,0.0014266424,0.0009672292,0.0005475231,0.0016230599],"category_scores_gemma":[0.004561606,0.00035767426,0.0011025397,0.0075277262,0.00047879224,0.000514606,0.0004987086,0.00093053817,0.00015188335],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048304626,0.0000662214,0.97892064,0.00028153748,0.0006405854,0.00021838263,0.00028571315,0.0015733532,0.00020022284,0.00045379577,0.006891324,0.009985279],"study_design_scores_gemma":[0.000035112327,0.00003111011,0.9941538,0.00009152887,0.00019887272,0.00017522159,0.00044478476,0.0018237355,0.00009918704,0.00004341876,0.0028752498,0.000028046363],"about_ca_topic_score_codex":0.9955214,"about_ca_topic_score_gemma":0.99568605,"teacher_disagreement_score":0.036834463,"about_ca_system_score_codex":0.036834463,"about_ca_system_score_gemma":0.034059253,"threshold_uncertainty_score":0.267254},"labels":[],"label_agreement":null},{"id":"W1994898532","doi":"10.1016/j.jval.2014.03.1152","title":"Meta-analysis of preference-based quality of life values in heart failure","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Pooling; Medicine; Meta-analysis; Covariate; Meta-regression; Population; Statistics; Matching (statistics); Preference; Demography; Internal medicine; Environmental health; Mathematics; Computer science; Pathology","score_opus":0.7562204205864942,"score_gpt":0.46230247832421945,"score_spread":0.29391794226227475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994898532","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1332837,0.8556076,0.0057974127,0.00076592114,0.0008959881,0.00033710766,0.0018654933,0.00009852209,0.0013482982],"genre_scores_gemma":[0.9403027,0.05368101,0.0031682155,0.0007859269,0.0003402591,0.00032509517,0.0008944608,0.000055269524,0.00044689252],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.95663905,0.032739528,0.0056510638,0.0025414852,0.0019202442,0.000508708],"domain_scores_gemma":[0.91551465,0.07158127,0.0062822136,0.004556655,0.0015769756,0.0004883403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03514685,0.002667764,0.011705337,0.00281354,0.00066540163,0.0041478267,0.002196234,0.0026101437,0.0036348554],"category_scores_gemma":[0.09574002,0.0015277454,0.03931578,0.004003144,0.0012058595,0.0020870802,0.0018631491,0.0034153878,0.00022884441],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008198045,0.000024477255,0.0060904394,0.017717289,0.9634653,0.000041859657,0.00005866538,0.0004265086,0.00008832437,0.00018077724,0.00018189127,0.003526497],"study_design_scores_gemma":[0.0036904651,0.000523268,0.008161499,0.0020368597,0.98322356,0.00009840132,0.00006180583,0.0005091285,0.00011240131,0.0009550822,0.00059256476,0.000034952245],"about_ca_topic_score_codex":0.005599541,"about_ca_topic_score_gemma":0.007201376,"teacher_disagreement_score":0.03514685,"about_ca_system_score_codex":0.0018731786,"about_ca_system_score_gemma":0.0010823219,"threshold_uncertainty_score":0.18587649},"labels":[],"label_agreement":null},{"id":"W1994994165","doi":"10.1016/j.jval.2013.03.1477","title":"Cost-effectiveness of catheter-based renal denervation for resistant hypertension – a canadian perspective","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université de Montréal; University of Alberta; Medtronic (Canada)","funders":"","keywords":"Medicine; Stroke (engine); Life expectancy; Internal medicine; Framingham Risk Score; Cohort; Cardiology; Relative risk; Blood pressure; Coronary artery disease; Framingham Heart Study; Clinical trial; Emergency medicine; Cost effectiveness; Confidence interval; Disease; Population","score_opus":0.13440615050639138,"score_gpt":0.3361803147857972,"score_spread":0.2017741642794058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994994165","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31362316,0.37935188,0.0015242364,0.18648143,0.0022356352,0.000504153,0.027690768,0.000071853,0.088516995],"genre_scores_gemma":[0.8589537,0.121214345,0.002055048,0.0076813623,0.0012034262,0.00011514695,0.005388626,0.000033001037,0.0033553648],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99375945,0.0020436298,0.00035113786,0.0002712113,0.0022152038,0.0013593764],"domain_scores_gemma":[0.9896511,0.0026751058,0.0010694679,0.0001228691,0.004525532,0.0019559234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048669023,0.0011756014,0.0023515779,0.002909564,0.0017039996,0.0041511334,0.0023245267,0.0024885267,0.0075090243],"category_scores_gemma":[0.015296999,0.00050588336,0.0037739917,0.0073824846,0.0013948088,0.0013666227,0.0010704385,0.0034658173,0.00022627962],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037839707,0.0023122649,0.22393805,0.020599473,0.028922753,0.0022616265,0.0015830233,0.049411252,0.0025354412,0.07032577,0.14078021,0.41949052],"study_design_scores_gemma":[0.012214439,0.00528034,0.7603172,0.018902745,0.039215453,0.0018259126,0.0060800547,0.02282167,0.001017916,0.014419514,0.11681217,0.0010925499],"about_ca_topic_score_codex":0.9747308,"about_ca_topic_score_gemma":0.9820994,"teacher_disagreement_score":0.09451683,"about_ca_system_score_codex":0.09451683,"about_ca_system_score_gemma":0.10464349,"threshold_uncertainty_score":0.6857708},"labels":[],"label_agreement":null},{"id":"W1995179131","doi":"10.1016/j.jval.2012.08.2030","title":"PRS31 Cost-Effectiveness of an Intensive Intervention Program in the Control of Allergic Rhinitis Due to Ragweed Pollen in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Santé Montérégie; Université de Montréal","funders":"","keywords":"Ragweed; Medicine; Population; Psychological intervention; Pollen; Context (archaeology); Economic evaluation; Demography; Environmental health; Allergy; Immunology; Geography; Botany; Pathology; Psychiatry; Biology","score_opus":0.03565311623246579,"score_gpt":0.3247470897121378,"score_spread":0.289093973479672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995179131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885222,0.002804474,0.00026258538,0.0011927627,0.00010125587,0.00094517187,0.002054064,0.000047047688,0.004070477],"genre_scores_gemma":[0.99598974,0.00073941686,0.0004991761,0.00023996491,0.000029326391,0.00016604694,0.000643426,0.000004359053,0.0016886452],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986332,0.0005164159,0.000068380235,0.00012918047,0.00025168917,0.00040118644],"domain_scores_gemma":[0.9981527,0.00023804884,0.00018812921,0.000036004254,0.0003512602,0.0010338516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008562175,0.000581829,0.00076674385,0.0004844123,0.0011835108,0.00080086204,0.001241523,0.0008273823,0.006253942],"category_scores_gemma":[0.002143851,0.00028648676,0.0013691005,0.00071425264,0.00047479087,0.00026694222,0.0005648268,0.0008850245,0.00019542019],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18092006,0.037401844,0.22126088,0.003060439,0.0036331997,0.0013599731,0.0008115088,0.058905803,0.004572811,0.0019360684,0.028516995,0.45762038],"study_design_scores_gemma":[0.03253349,0.0299935,0.8969402,0.0005343555,0.0016475011,0.00014401994,0.0008210969,0.032463092,0.00062917144,0.00017417807,0.0040122415,0.000107194566],"about_ca_topic_score_codex":0.98333645,"about_ca_topic_score_gemma":0.98552126,"teacher_disagreement_score":0.039105453,"about_ca_system_score_codex":0.039105453,"about_ca_system_score_gemma":0.04618687,"threshold_uncertainty_score":0.28373122},"labels":[],"label_agreement":null},{"id":"W1995578096","doi":"10.1111/j.1524-4733.2009.00613.x","title":"Impact of the 1997 Canadian Guidelines on the Conduct of Canadian-Based Economic Evaluations in the Published Literature","year":2009,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Economic evaluation; Discounting; Actuarial science; Valuation (finance); Systematic review; Equity (law); Health technology; Cost–benefit analysis; Health economics; Perspective (graphical); Presentation (obstetrics); Public economics; Medicine; Psychology; MEDLINE; Accounting; Economics; Health care; Political science; Public health; Computer science; Nursing; Finance; Economic growth","score_opus":0.6841444648732653,"score_gpt":0.5303070318286566,"score_spread":0.15383743304460873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995578096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019148049,0.8260363,0.00318828,0.118666224,0.008903384,0.0020192391,0.008609001,0.00013564203,0.030527145],"genre_scores_gemma":[0.03657091,0.8466838,0.040530812,0.051215257,0.0029496427,0.0033402224,0.008728791,0.0003253728,0.009655121],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.8572411,0.03089393,0.025858369,0.0041017435,0.076907344,0.004997496],"domain_scores_gemma":[0.534498,0.13430111,0.023653846,0.0076808142,0.2918661,0.008000146],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1932608,0.0023375656,0.006185587,0.020259414,0.004697266,0.010931073,0.008320589,0.0059218495,0.006897848],"category_scores_gemma":[0.37012437,0.0019877448,0.0051233717,0.034536924,0.0051966673,0.0046776845,0.005377251,0.009386359,0.0012848256],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008834132,0.000125897,0.0037260393,0.06689387,0.001313964,0.00019333194,0.0010789994,0.0014859813,0.00029579687,0.03657483,0.4774585,0.40996948],"study_design_scores_gemma":[0.00064415415,0.00009891273,0.024017978,0.18455935,0.0037464832,0.00022331093,0.0005986829,0.00066577725,0.0007219332,0.0071271453,0.77729666,0.0002996392],"about_ca_topic_score_codex":0.88244456,"about_ca_topic_score_gemma":0.93099236,"teacher_disagreement_score":0.97974056,"about_ca_system_score_codex":0.106406994,"about_ca_system_score_gemma":0.38552302,"threshold_uncertainty_score":0.9948531},"labels":[],"label_agreement":null},{"id":"W1995681843","doi":"10.1016/j.jval.2013.11.009","title":"Specification of the Utility Function in Discrete Choice Experiments","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Function (biology); Specification; Valuation (finance); Econometrics; Marginal utility; Contingent valuation; Willingness to pay; Discrete choice; Expected utility hypothesis; Economics; Nonlinear system; Computer science; Mathematical optimization; Mathematical economics; Microeconomics; Mathematics; Accounting","score_opus":0.1865132108318176,"score_gpt":0.2666681982838322,"score_spread":0.0801549874520146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995681843","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046500478,0.0003954186,0.9445066,0.0017604865,0.00006063449,0.00051064836,0.0010631633,0.00022158625,0.00498105],"genre_scores_gemma":[0.7713392,0.0009248644,0.21464671,0.00054022594,0.000119232725,0.0028976114,0.0011651422,0.000090667265,0.008276314],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9837886,0.013549279,0.00048458806,0.0009171045,0.00060872466,0.0006517105],"domain_scores_gemma":[0.91031545,0.08298109,0.0025039236,0.0028520238,0.0008196362,0.00052781205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025561174,0.0016359782,0.0029347579,0.0015491695,0.00040598804,0.0038448789,0.0031966646,0.0047749933,0.009403076],"category_scores_gemma":[0.06638492,0.0018111048,0.0023935211,0.0017876346,0.0024781371,0.0045054317,0.0015296603,0.004108749,0.0009954448],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044467777,0.00033095828,0.0022776406,0.00031299793,0.00017142287,0.00016450397,0.00024540783,0.2508769,0.0007327667,0.7267521,0.0009655411,0.016725091],"study_design_scores_gemma":[0.0002993434,0.00012584601,0.00080993003,0.00004550041,0.000063807165,0.00005083339,0.000047298956,0.5890067,0.00045953126,0.40827656,0.0007825027,0.00003213359],"about_ca_topic_score_codex":0.0033903022,"about_ca_topic_score_gemma":0.002136463,"teacher_disagreement_score":0.025561174,"about_ca_system_score_codex":0.0028374633,"about_ca_system_score_gemma":0.002528297,"threshold_uncertainty_score":0.13518202},"labels":[],"label_agreement":null},{"id":"W1995707423","doi":"10.1111/j.1524-4733.2009.00532.x","title":"The Impact of Drug Vintage on Patient Survival: A Patient-Level Analysis Using Quebec's Provincial Health Plan Data","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto","funders":"GlaxoSmithKline","keywords":"Medicine; Medical prescription; Prescription drug; Hazard ratio; Confidence interval; Demography; Drug; Proportional hazards model; Population; Residence; Vintage; Gerontology; Environmental health; Internal medicine; Pharmacology","score_opus":0.19530042698819106,"score_gpt":0.41335030030419107,"score_spread":0.218049873316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995707423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97585547,0.0005854526,0.000825867,0.00068679673,0.000021317108,0.00006619713,0.02065965,0.000051509367,0.0012478201],"genre_scores_gemma":[0.9921262,0.0001055589,0.00042288,0.000089497524,0.000010203188,0.00003246292,0.0064362036,0.000014971679,0.0007620105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938192,0.0030943423,0.00035260583,0.0006236429,0.0010870168,0.0010232474],"domain_scores_gemma":[0.975656,0.013240799,0.003527174,0.001360943,0.004313933,0.001901157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006238707,0.00041923305,0.0011990378,0.0016118989,0.0010636557,0.0016462386,0.0016923686,0.00065957813,0.0032261515],"category_scores_gemma":[0.01731573,0.00034578517,0.0024581556,0.006399099,0.00053901214,0.0006486344,0.0008109118,0.0016349007,0.00019898951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000486905,0.00004132567,0.99091667,0.00002534989,0.00093297247,0.00005397208,0.00007773432,0.0033422532,0.000058350717,0.00009864717,0.0014891642,0.002476651],"study_design_scores_gemma":[0.00004480937,0.000082276005,0.9886672,0.000009169658,0.00026007966,0.000028265607,0.00012721494,0.010196865,0.00004682923,0.00002796877,0.0004966361,0.000012672581],"about_ca_topic_score_codex":0.972523,"about_ca_topic_score_gemma":0.97317183,"teacher_disagreement_score":0.027477026,"about_ca_system_score_codex":0.015939133,"about_ca_system_score_gemma":0.014735729,"threshold_uncertainty_score":0.11564702},"labels":[],"label_agreement":null},{"id":"W1995866174","doi":"10.1016/s1098-3015(10)62979-8","title":"PDB46 WILLINGNESS-TO-PAY FOR INHALED INSULIN—A CANADIAN PERSPECTIVE","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Willingness to pay; Perspective (graphical); Business; Economics; Public economics; Microeconomics; Computer science; Artificial intelligence","score_opus":0.07237457608782537,"score_gpt":0.3685482669494155,"score_spread":0.2961736908615901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995866174","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22673918,0.043349,0.002156565,0.4017932,0.0016082596,0.00012389195,0.0059143524,0.0000357011,0.3182799],"genre_scores_gemma":[0.9369969,0.021183627,0.0018130364,0.013759044,0.0006220538,0.000042606902,0.0007966424,0.00002947362,0.024756527],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9976381,0.0003713815,0.00009002015,0.00017555371,0.0010338333,0.0006911609],"domain_scores_gemma":[0.99381965,0.0012690717,0.00023226078,0.00008288007,0.0033160916,0.0012801002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027818044,0.00061909563,0.0010015267,0.0028003517,0.004335154,0.00522017,0.0014460565,0.0031920914,0.013554593],"category_scores_gemma":[0.0086165415,0.00036549402,0.0016711304,0.0045334,0.0015921209,0.0013642034,0.0007590312,0.004346464,0.00036060897],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019829734,0.0006155697,0.13001043,0.0010552661,0.0007891199,0.0033872868,0.006968497,0.0108571695,0.001458347,0.38533628,0.22131829,0.2362208],"study_design_scores_gemma":[0.0009780384,0.00043122715,0.4310868,0.0038703883,0.0016697259,0.0023892834,0.02440175,0.022104194,0.00095007557,0.067878224,0.4431557,0.0010845717],"about_ca_topic_score_codex":0.9922117,"about_ca_topic_score_gemma":0.9921588,"teacher_disagreement_score":0.08028505,"about_ca_system_score_codex":0.08028505,"about_ca_system_score_gemma":0.08291522,"threshold_uncertainty_score":0.58251154},"labels":[],"label_agreement":null},{"id":"W1996179381","doi":"10.1046/j.1524-4733.2001.40202-183.x","title":"PID25: ECONOMIC EVALUATION OF MACROLIDES AND FLUOROQUINOLONES FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Respiratory tract infections; Respiratory tract; Medicine; Intensive care medicine; Respiratory system; Internal medicine","score_opus":0.12896302962989714,"score_gpt":0.39270221464208416,"score_spread":0.263739185012187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996179381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7690324,0.08573192,0.026674265,0.0086766165,0.0019345928,0.006707554,0.024934102,0.0006544849,0.075653955],"genre_scores_gemma":[0.9784822,0.005488792,0.0070483433,0.00056089857,0.0001758339,0.00096628256,0.003493393,0.000031932286,0.0037524148],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913594,0.006698245,0.00023762179,0.00019586559,0.0011397038,0.00036908255],"domain_scores_gemma":[0.99323785,0.004933633,0.00045704184,0.00016379656,0.00062382105,0.00058379886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01225082,0.0016327158,0.0020709292,0.0020675203,0.00032226532,0.0021249077,0.0011271203,0.001248971,0.0069443975],"category_scores_gemma":[0.023389913,0.00048410278,0.0020770095,0.0015097787,0.0006054582,0.00087628176,0.0009191853,0.0011648517,0.00030720458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20395619,0.004334922,0.011882269,0.009131689,0.00821836,0.0006607846,0.00012576127,0.3917916,0.0017869867,0.022559935,0.04636925,0.29918227],"study_design_scores_gemma":[0.13677856,0.08086083,0.068090245,0.0038714677,0.021544747,0.0010576632,0.00080133067,0.54650784,0.0069800885,0.017853295,0.115226015,0.00042795265],"about_ca_topic_score_codex":0.010901232,"about_ca_topic_score_gemma":0.0062705567,"teacher_disagreement_score":0.01225082,"about_ca_system_score_codex":0.0055986363,"about_ca_system_score_gemma":0.0056960713,"threshold_uncertainty_score":0.064789355},"labels":[],"label_agreement":null},{"id":"W1996198481","doi":"10.1111/j.1524-4733.2009.00515.x","title":"QALYs: The Basics","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":754,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"U.S. Public Health Service; Agency for Healthcare Research and Quality","keywords":"Computer science","score_opus":0.5249616492072903,"score_gpt":0.44856372384064697,"score_spread":0.0763979253666433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996198481","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046737464,0.08465353,0.5939097,0.092357345,0.00869374,0.0009890486,0.03788153,0.005994712,0.17084675],"genre_scores_gemma":[0.23707409,0.11070123,0.45596316,0.021724163,0.02500946,0.0058834963,0.030986762,0.0047821403,0.10787545],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9936248,0.0038459045,0.00059829437,0.0005036321,0.0012189775,0.00020844741],"domain_scores_gemma":[0.9900641,0.0051946607,0.00084181275,0.0018734068,0.0016639448,0.00036209595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010118484,0.0015564404,0.0024276967,0.0038130737,0.0007929886,0.0049783117,0.0021968568,0.0024506324,0.060832627],"category_scores_gemma":[0.050257865,0.0007543022,0.0017502243,0.005193069,0.0025302821,0.008230506,0.003242212,0.006755725,0.027478082],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002213834,0.00009996333,0.0015885262,0.0011722422,0.00014010741,0.00006017477,0.00019865016,0.0040619215,0.0001659121,0.4143249,0.27866837,0.2992978],"study_design_scores_gemma":[0.000096031275,0.000096027434,0.0019272713,0.0010375791,0.00007196952,0.00043341672,0.000096829885,0.0055431304,0.00027161354,0.61255926,0.3777982,0.00006870832],"about_ca_topic_score_codex":0.0021729565,"about_ca_topic_score_gemma":0.0011254315,"teacher_disagreement_score":0.060832627,"about_ca_system_score_codex":0.0019577453,"about_ca_system_score_gemma":0.0029147589,"threshold_uncertainty_score":0.2035054},"labels":[],"label_agreement":null},{"id":"W1996276843","doi":"10.1016/s1098-3015(10)67180-x","title":"QL6 ADALIMUMAB REDUCES FATIGUE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS (AS)—6-MONTH RESULTS OF A CANADIAN AS STUDY","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ankylosing spondylitis; Adalimumab; Medicine; Spondylitis; Physical therapy; Internal medicine; Tumor necrosis factor alpha","score_opus":0.03898885411725983,"score_gpt":0.30641082877210996,"score_spread":0.2674219746548501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996276843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930601,0.0035946532,0.000044584212,0.0005278436,0.000046153174,0.00018093582,0.00085910794,0.000010741629,0.0016757966],"genre_scores_gemma":[0.9945726,0.0021866462,0.00027304026,0.0003812015,0.00007824899,0.00006259113,0.00090943533,0.000004804484,0.0015314411],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99941206,0.00016884557,0.000028004602,0.00005950978,0.00017351702,0.00015816138],"domain_scores_gemma":[0.9989858,0.00010764928,0.00015487516,0.000038728907,0.00034546398,0.0003673831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014198276,0.0006886232,0.0012553075,0.0003313996,0.0012553362,0.0007843523,0.0007101663,0.0007303534,0.0013875463],"category_scores_gemma":[0.0012714978,0.00027115023,0.0011170253,0.00085983943,0.00072204496,0.0003767097,0.00025942895,0.0012915166,0.00021794076],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5157047,0.028362228,0.21173565,0.001791489,0.005187253,0.00059016055,0.0014160895,0.0011751708,0.013405426,0.00028438916,0.013320875,0.20702659],"study_design_scores_gemma":[0.06583438,0.05215256,0.87039125,0.00012944188,0.0031045896,0.0002878245,0.0007410063,0.00079678977,0.00095022947,0.00007401906,0.00542735,0.00011059603],"about_ca_topic_score_codex":0.5527419,"about_ca_topic_score_gemma":0.6460021,"teacher_disagreement_score":0.4472581,"about_ca_system_score_codex":0.00559068,"about_ca_system_score_gemma":0.0061191376,"threshold_uncertainty_score":0.8997842},"labels":[],"label_agreement":null},{"id":"W1996510950","doi":"10.1016/j.jval.2011.08.1228","title":"PCN127 Health State Utility Assessment for Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Visual analogue scale; Breast cancer; Tamoxifen; Disease; Quality of life (healthcare); Health care; Physical therapy; Scale (ratio); Cancer; Oncology; Family medicine; Internal medicine; Nursing","score_opus":0.6324016376744286,"score_gpt":0.49387811206445414,"score_spread":0.13852352560997444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996510950","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33812118,0.004727086,0.1588935,0.0033586582,0.0005199534,0.002545915,0.10567758,0.0026258444,0.3835303],"genre_scores_gemma":[0.8856982,0.0010146606,0.039049223,0.00015728002,0.000087263455,0.0007020109,0.035243046,0.00018985909,0.03785851],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99873227,0.00052043697,0.000036496844,0.00007191039,0.0005587293,0.00008015186],"domain_scores_gemma":[0.99816704,0.0008281449,0.000084033156,0.00014590002,0.00071089953,0.000064081716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017907498,0.0003761146,0.00046077103,0.0014342763,0.00023681852,0.0007637139,0.0005002202,0.0003399889,0.019886786],"category_scores_gemma":[0.009430902,0.0001323647,0.00055658014,0.0015705953,0.00014520895,0.00037176642,0.00041139763,0.0004169227,0.0019899227],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015223649,0.00030219415,0.02683091,0.0004033648,0.00014679319,0.00023197137,0.000058394144,0.13743018,0.00076477404,0.02150032,0.16713248,0.6436762],"study_design_scores_gemma":[0.00041581428,0.00082901743,0.069884226,0.00026595395,0.00013374828,0.0004842192,0.00009289749,0.8040775,0.00446924,0.025443029,0.09382476,0.00007959262],"about_ca_topic_score_codex":0.031125277,"about_ca_topic_score_gemma":0.022586517,"teacher_disagreement_score":0.031125277,"about_ca_system_score_codex":0.0016526317,"about_ca_system_score_gemma":0.0015534748,"threshold_uncertainty_score":0.06652796},"labels":[],"label_agreement":null},{"id":"W1996668070","doi":"10.1016/j.jval.2013.02.016","title":"Measuring the Quality of a Childhood Cancer Care Delivery System: Assessing Stakeholder Agreement","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Pediatric Oncology Group; University of Toronto; Hamilton Health Sciences; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Multidisciplinary approach; Delphi method; Stakeholder; Medicine; Stakeholder engagement; Panel discussion; Quality (philosophy); Delphi; Family medicine; Nursing; Business; Computer science; Public relations","score_opus":0.1951986824977106,"score_gpt":0.37222408206902846,"score_spread":0.17702539957131785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996668070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98578644,0.00012699534,0.007043535,0.0009021749,0.000016386035,0.00025183233,0.000107201886,0.000013384597,0.0057519902],"genre_scores_gemma":[0.99747664,0.000030792537,0.0021688219,0.000050097893,0.000003674755,0.00012494606,0.00006001385,0.0000030986237,0.00008194132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.89975804,0.074242316,0.0060450914,0.0018232263,0.015096976,0.003034415],"domain_scores_gemma":[0.7645624,0.1694643,0.029050805,0.0068017244,0.024670219,0.0054504965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10529311,0.00028103875,0.0006251575,0.0031767495,0.0022021814,0.0028972423,0.0013087547,0.0009601804,0.0014084942],"category_scores_gemma":[0.19854975,0.000301729,0.00092396163,0.0021831829,0.0023523688,0.0027547472,0.005471179,0.0013832676,0.00013544042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052246853,0.00049327395,0.8734691,0.0003722785,0.00060046243,0.00010524618,0.046513252,0.002738944,0.0011650773,0.0046179723,0.00085756154,0.06854428],"study_design_scores_gemma":[0.00010883168,0.0017006436,0.8429511,0.00048848294,0.0002892841,0.00027608,0.102191225,0.027598098,0.004171843,0.014264841,0.0057944953,0.00016493889],"about_ca_topic_score_codex":0.0036490385,"about_ca_topic_score_gemma":0.0042951074,"teacher_disagreement_score":0.10529311,"about_ca_system_score_codex":0.005642789,"about_ca_system_score_gemma":0.0055838237,"threshold_uncertainty_score":0.55684984},"labels":[],"label_agreement":null},{"id":"W1997046311","doi":"10.1016/s1098-3015(10)63222-6","title":"PHP4 ASSESSING THERAPEUTIC IMPROVEMENT IN CANADA AND FRANCE: A COMPARISON OF PMPRB AND ASMR CLASSIFICATIONS","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regional science; Geography","score_opus":0.3544075399784798,"score_gpt":0.4285324704531383,"score_spread":0.07412493047465851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997046311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94715756,0.00818223,0.002055374,0.00541834,0.00010681113,0.00016767494,0.020391436,0.00012369742,0.01639675],"genre_scores_gemma":[0.9882786,0.0011736102,0.0017865953,0.00028507362,0.000036540892,0.000077254146,0.0058751157,0.00003446351,0.0024527295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993602,0.0017474189,0.00032378884,0.00031498462,0.0029903892,0.0010213081],"domain_scores_gemma":[0.98350495,0.004057931,0.002625248,0.00035510492,0.0074455836,0.002011],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0061521926,0.00043744303,0.0010265787,0.006288918,0.0009552981,0.002548629,0.0019740222,0.000927754,0.0032533586],"category_scores_gemma":[0.019957053,0.00022357405,0.0013826255,0.006751171,0.0010701815,0.001123741,0.0017518663,0.0011119801,0.0002670178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022898826,0.00016314798,0.88645464,0.0003533426,0.00068442983,0.0001841633,0.0009039732,0.0073936405,0.00027611776,0.0051763617,0.0148257455,0.081294574],"study_design_scores_gemma":[0.0000717728,0.00016323212,0.9876088,0.00011965506,0.00011201268,0.00010058147,0.0008533508,0.00460742,0.00023532094,0.0005669188,0.00552474,0.000036217443],"about_ca_topic_score_codex":0.9261258,"about_ca_topic_score_gemma":0.8810147,"teacher_disagreement_score":0.9938478,"about_ca_system_score_codex":0.031936064,"about_ca_system_score_gemma":0.030270435,"threshold_uncertainty_score":0.23171347},"labels":[],"label_agreement":null},{"id":"W1997146792","doi":"10.1111/j.1524-4733.2005.03074.x","title":"Comparing the Discriminative Validity of Two Generic and One Disease-Specific Health-Related Quality of Life Measures in a Sample of Patients with Dry Eye","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Quality of life (healthcare); Medicine; Visual analogue scale; Discriminative model; KERATOCONJUNCTIVITIS SICCA; Disease; Severity of illness; SF-36; EQ-5D; Scale (ratio); Physical therapy; Internal medicine; Health related quality of life; Ophthalmology","score_opus":0.1864433561320804,"score_gpt":0.3380318615003349,"score_spread":0.15158850536825447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997146792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99979967,0.00003616916,0.000036478785,0.00001398402,0.0000036726638,0.0000049688297,0.000025566333,5.394079e-7,0.000078904704],"genre_scores_gemma":[0.99974316,0.000019675539,0.000049507576,0.000026097045,0.0000052502514,0.000006759997,0.00011393928,0.0000010180881,0.000034718116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847096,0.000632937,0.00017441079,0.00019226619,0.00031787792,0.00021149602],"domain_scores_gemma":[0.9956534,0.002833416,0.00059653714,0.00023029314,0.0003417123,0.00034456782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020855714,0.00035396515,0.00080501474,0.001003544,0.0005549684,0.0008407543,0.00037774196,0.0007726902,0.0009027059],"category_scores_gemma":[0.013174436,0.0002830491,0.0007218445,0.000843385,0.0008192284,0.00061405916,0.0009350771,0.00085009413,0.00018197874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015919134,0.00028234,0.9927983,0.000022198848,0.00017670156,0.00006901878,0.0007579461,0.00006491671,0.00072464044,0.00004947315,0.00007110137,0.003391347],"study_design_scores_gemma":[0.00015840388,0.0010329594,0.9970697,0.000006489543,0.000064937805,0.00023086544,0.0006583534,0.00044598235,0.00015017115,0.00006748904,0.00010678689,0.000007932076],"about_ca_topic_score_codex":0.0022613732,"about_ca_topic_score_gemma":0.0023533874,"teacher_disagreement_score":0.0022613732,"about_ca_system_score_codex":0.0004550265,"about_ca_system_score_gemma":0.00030087843,"threshold_uncertainty_score":0.011029661},"labels":[],"label_agreement":null},{"id":"W1997197001","doi":"10.1016/j.jval.2013.08.1800","title":"Potential Predictors of Alzheimer’s Disease: An Analysis with the Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Université de Montréal","funders":"","keywords":"Rivastigmine; Medicine; Donepezil; Galantamine; Dementia; Disease; Neuroticism; Retrospective cohort study; Psychiatry; Internal medicine; Pediatrics; Personality; Psychology","score_opus":0.07531625157706488,"score_gpt":0.38963183489439124,"score_spread":0.31431558331732634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997197001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9018929,0.00089244306,0.00028877662,0.000817578,0.000019229452,0.00022410623,0.09372379,0.000038552418,0.0021025264],"genre_scores_gemma":[0.9461162,0.00062088855,0.00079210335,0.00027452593,0.000027603586,0.0002611538,0.05055617,0.000023077873,0.0013282686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753535,0.00046930727,0.00030208277,0.0003682918,0.0008665343,0.0004585079],"domain_scores_gemma":[0.98673254,0.00263193,0.003184769,0.00068226975,0.005340376,0.0014280218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019956802,0.00054707605,0.0010613524,0.0041503,0.001637606,0.0014968592,0.0018776978,0.0008005987,0.00367178],"category_scores_gemma":[0.014041615,0.00042053073,0.0012625477,0.012964362,0.00041097918,0.0007790334,0.00109626,0.0010692048,0.00051143655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014622787,0.000047785426,0.99300545,0.000034884833,0.00015412783,0.000047708887,0.00007481799,0.00024065416,0.00003202345,0.00005245806,0.0040625,0.0021013885],"study_design_scores_gemma":[0.0000307059,0.000018773257,0.9968516,0.000027343569,0.00006945857,0.000055491288,0.00017747731,0.0016090675,0.00002788931,0.000016202213,0.0011062461,0.000009803616],"about_ca_topic_score_codex":0.9801825,"about_ca_topic_score_gemma":0.98297876,"teacher_disagreement_score":0.020198116,"about_ca_system_score_codex":0.020198116,"about_ca_system_score_gemma":0.024306051,"threshold_uncertainty_score":0.14654827},"labels":[],"label_agreement":null},{"id":"W1997204561","doi":"10.1016/s1098-3015(10)62661-7","title":"PCV20 DECREASING HOSPITALIZATIONS FOR HEART FAILURE IN BRITISH COLUMBIA, CANADA, 1993-2001","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Demography; Gerontology; Geography; Cardiology; Sociology","score_opus":0.03761294726238197,"score_gpt":0.3726367960521882,"score_spread":0.33502384878980623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997204561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93537295,0.0068983845,0.00022031936,0.0052589313,0.0001763789,0.00011926122,0.038769923,0.00010632977,0.013077576],"genre_scores_gemma":[0.9771867,0.0034201276,0.0002996651,0.0008605653,0.000044225224,0.000047092773,0.007174483,0.000024433133,0.010942853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898237,0.000062744715,0.000086198495,0.0001106321,0.00037558758,0.00038237078],"domain_scores_gemma":[0.99638164,0.0001247431,0.00037138312,0.000054038523,0.002198169,0.00086991716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051890133,0.00040264163,0.00053637964,0.0011965305,0.0026542018,0.0012840384,0.0023802514,0.00092672335,0.002745488],"category_scores_gemma":[0.0030917195,0.00041119786,0.00061007024,0.004066071,0.00057791214,0.0004896788,0.0006353817,0.0015613411,0.00043006282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045467258,0.00015748617,0.9507054,0.00020553081,0.00014086739,0.00023424946,0.0005941823,0.0006140922,0.0002541818,0.00025512994,0.022836495,0.023547646],"study_design_scores_gemma":[0.000030752344,0.00003519965,0.99416476,0.00007136102,0.00007057095,0.000079598874,0.00085536955,0.0003758289,0.00010576511,0.000022074168,0.0041759904,0.000012917394],"about_ca_topic_score_codex":0.9984616,"about_ca_topic_score_gemma":0.9993493,"teacher_disagreement_score":0.04158483,"about_ca_system_score_codex":0.04158483,"about_ca_system_score_gemma":0.057681352,"threshold_uncertainty_score":0.3017205},"labels":[],"label_agreement":null},{"id":"W1997577436","doi":"10.1111/j.1524-4733.2008.00485.x","title":"Cost-Effectiveness of Disease-Modifying Therapies in the Management of Multiple Sclerosis for the Medicare Population","year":2009,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"U.S. Public Health Service","keywords":"Medicine; Cost effectiveness; Discontinuation; Quality-adjusted life year; Glatiramer acetate; Intensive care medicine; Population; Incremental cost-effectiveness ratio; Cohort; Disease management; Physical therapy; Disease; Internal medicine; Environmental health","score_opus":0.42943937149323447,"score_gpt":0.4730947963063267,"score_spread":0.04365542481309226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997577436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038705248,0.9992785,0.000032853044,0.00009714263,0.000033488428,0.0000056544495,0.00003513458,0.0000010299717,0.0001292844],"genre_scores_gemma":[0.006907063,0.9926836,0.0001850404,0.000079835954,0.000053085638,0.000009955469,0.00004172943,6.5869597e-7,0.000039154245],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99850535,0.0005703865,0.00028758167,0.00010041278,0.00048772138,0.00004865578],"domain_scores_gemma":[0.99392635,0.005026675,0.00068169506,0.00004396645,0.0002639585,0.000057344918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027316227,0.0007864285,0.003913039,0.0029238346,0.00015575423,0.00090780866,0.0011231856,0.0010303736,0.0025932626],"category_scores_gemma":[0.010067622,0.000334734,0.0031283721,0.0039213183,0.0003782243,0.00084829296,0.00047794043,0.0010392823,0.00015846491],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016806931,0.0001094543,0.0014744626,0.23509206,0.0130802365,0.00013276814,0.00006278884,0.0010165668,0.00029817704,0.0017156228,0.007268347,0.7380689],"study_design_scores_gemma":[0.0051545002,0.0026497778,0.059407882,0.399073,0.1809584,0.004155904,0.0006980269,0.002778591,0.002092408,0.010203701,0.3326021,0.00022566454],"about_ca_topic_score_codex":0.004565938,"about_ca_topic_score_gemma":0.008087075,"teacher_disagreement_score":0.004565938,"about_ca_system_score_codex":0.0016939291,"about_ca_system_score_gemma":0.0015442027,"threshold_uncertainty_score":0.014446378},"labels":[],"label_agreement":null},{"id":"W1997794981","doi":"10.1016/j.jval.2012.10.018","title":"Need for Speed: An Efficient Algorithm for Calculation of Single-Parameter Expected Value of Partial Perfect Information","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Probabilistic and Robust Engineering Design","field":"Decision Sciences","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Estimator; Maximization; Probabilistic logic; Sensitivity (control systems); Computer science; Sequence (biology); Computation; Monte Carlo method; Mathematical optimization; Measure (data warehouse); Algorithm; Fraction (chemistry); Expected value; Mathematics; Data mining; Statistics; Artificial intelligence","score_opus":0.1062230686482538,"score_gpt":0.341457258818786,"score_spread":0.2352341901705322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997794981","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016119939,0.000095333446,0.9961235,0.00010841604,0.000053315736,0.00005177177,0.00004858029,0.0010665737,0.0008404715],"genre_scores_gemma":[0.052734587,0.00013040366,0.9437772,0.00012271969,0.00007225501,0.00030238385,0.00015076049,0.0005580458,0.0021515498],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984977,0.0004910228,0.00011434529,0.00021577935,0.0005644802,0.000116681644],"domain_scores_gemma":[0.9914955,0.0061624083,0.00019597974,0.0010352222,0.0009760916,0.00013482136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040831417,0.0017346125,0.0014082285,0.00146132,0.000841387,0.002381648,0.0024057832,0.0014839598,0.014281397],"category_scores_gemma":[0.031640485,0.0008522211,0.0011393798,0.0015698688,0.0010898187,0.004277991,0.0025898693,0.0029937183,0.004952613],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006874145,0.00011127834,0.0013954536,0.00033176018,0.00014851984,0.00023611404,0.00028308376,0.17807737,0.005773705,0.17240693,0.016925953,0.6236224],"study_design_scores_gemma":[0.000111007794,0.000049751925,0.00027888812,0.000043412736,0.000043698306,0.00015233936,0.000037053745,0.86725813,0.0046081143,0.12088854,0.006489933,0.000039090228],"about_ca_topic_score_codex":0.003130144,"about_ca_topic_score_gemma":0.0034281914,"teacher_disagreement_score":0.014281397,"about_ca_system_score_codex":0.0011589768,"about_ca_system_score_gemma":0.002596596,"threshold_uncertainty_score":0.047776043},"labels":[],"label_agreement":null},{"id":"W1998396770","doi":"10.1016/j.jval.2014.03.025","title":"Preferences For Prostate Cancer Outcomes: A Comparison Of Patient And General Population Perspectives","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Medicine; Population; Sexual function; Health Utilities Index; Preference; Cancer; Demography; Gynecology; Statistics; Environmental health; Internal medicine; Disease; Mathematics","score_opus":0.3908310125194966,"score_gpt":0.46740650632291003,"score_spread":0.07657549380341344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998396770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924844,0.0013666291,0.00049403595,0.00063244085,0.000015720221,0.000016713562,0.0005060276,0.000004207104,0.0044797696],"genre_scores_gemma":[0.9992761,0.00023425333,0.00010142748,0.000111613444,0.000011889957,0.0000047039302,0.00016548324,0.0000019074305,0.00009256115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975381,0.0015918575,0.00013904388,0.00013167123,0.00041674936,0.00018263036],"domain_scores_gemma":[0.99058855,0.006473718,0.0014501124,0.00034723495,0.00046532776,0.000675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047788746,0.00020421969,0.000656436,0.0015495694,0.00028887182,0.0013062205,0.0002886623,0.00067760964,0.006073022],"category_scores_gemma":[0.017245112,0.00012490561,0.0014356956,0.0015446418,0.00051847665,0.0010971015,0.000890755,0.000751514,0.00023695065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037923842,0.00035760895,0.92617637,0.00028061957,0.0017654262,0.00033456582,0.0024311924,0.0014638285,0.00066907256,0.0022003616,0.0015824605,0.058946148],"study_design_scores_gemma":[0.00017653687,0.0015154503,0.98382205,0.00011248238,0.0005467431,0.0009507982,0.0050655445,0.0019231606,0.000280678,0.003472293,0.0020790626,0.000055215725],"about_ca_topic_score_codex":0.0012219726,"about_ca_topic_score_gemma":0.0015223512,"teacher_disagreement_score":0.006073022,"about_ca_system_score_codex":0.0004949765,"about_ca_system_score_gemma":0.0002656081,"threshold_uncertainty_score":0.025273442},"labels":[],"label_agreement":null},{"id":"W1998532326","doi":"10.1111/j.1524-4733.2010.00775.x","title":"Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Discrete event simulation; Event (particle physics); Computer science; Markov chain; Health care; Markov model; Risk analysis (engineering); Management science; Operations research; Data science; Machine learning; Simulation; Medicine; Economics; Mathematics","score_opus":0.1450206997427288,"score_gpt":0.518710997552107,"score_spread":0.37369029780937824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998532326","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011342711,0.0015849827,0.9661923,0.013416841,0.0009008825,0.00017929991,0.00073846057,0.00048696442,0.0051576216],"genre_scores_gemma":[0.4864067,0.0054899342,0.49742335,0.0036574898,0.0009603184,0.0008641621,0.00081021804,0.00070549286,0.0036823142],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9801587,0.01737109,0.00056689937,0.0004845175,0.0012412906,0.00017746448],"domain_scores_gemma":[0.9113651,0.076891534,0.0034433198,0.004550714,0.0027830787,0.00096622296],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033744264,0.0007789871,0.0021936388,0.0012553643,0.0004021943,0.004376808,0.0021344074,0.0020364395,0.0113055],"category_scores_gemma":[0.1529623,0.00064972206,0.0012016555,0.0026997959,0.0013664353,0.005687875,0.0014861348,0.005088851,0.0014513342],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018457883,0.00050008873,0.011152887,0.0017973679,0.0016042407,0.00023643511,0.00062955276,0.29223135,0.0007517484,0.4033265,0.03865238,0.24727172],"study_design_scores_gemma":[0.000549612,0.0003337706,0.0009390665,0.0008180715,0.0001869721,0.00012867879,0.00044834183,0.59605294,0.00063393847,0.37721172,0.022593925,0.00010297642],"about_ca_topic_score_codex":0.0028070814,"about_ca_topic_score_gemma":0.0026922687,"teacher_disagreement_score":0.9662557,"about_ca_system_score_codex":0.00071664,"about_ca_system_score_gemma":0.0026991821,"threshold_uncertainty_score":0.17845887},"labels":[],"label_agreement":null},{"id":"W1998810596","doi":"10.1016/j.jval.2013.03.481","title":"Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS): An integrated analysis of the phase 3 define and confirm studies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Multiple sclerosis; Relapsing remitting; Internal medicine; Confidence interval; Dimethyl fumarate; Clinical endpoint; Population; Cohort; Stock options; Clinical trial; Pathology; Immunology","score_opus":0.14270224083334035,"score_gpt":0.3908760924970197,"score_spread":0.24817385166367936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998810596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969079,0.0024696772,0.00006611156,0.000044968787,0.000009467449,0.000050486913,0.00027844575,0.0000035032965,0.00016951535],"genre_scores_gemma":[0.998689,0.00041322163,0.00018119428,0.000049618026,0.00002425518,0.000035460704,0.0005300838,0.0000038586786,0.00007329552],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969189,0.0020634013,0.00023981046,0.00029131107,0.0002553787,0.0002312293],"domain_scores_gemma":[0.9954075,0.002090625,0.0012223833,0.00035459845,0.00041107475,0.00051381893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057823076,0.0010596551,0.002669034,0.0015516409,0.00072456955,0.0009485332,0.0005932525,0.0009677823,0.0006473708],"category_scores_gemma":[0.0053480477,0.0005424274,0.0026100904,0.001340351,0.00056288106,0.0010384505,0.0007610056,0.0008463181,0.00011888134],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21928631,0.0018563156,0.7384471,0.00031049896,0.012688919,0.00012113977,0.0003559267,0.00042391272,0.004593078,0.00006687868,0.0003453458,0.021504529],"study_design_scores_gemma":[0.01110554,0.017072668,0.9621734,0.000046631736,0.0070168125,0.00020564352,0.00031831625,0.00036888054,0.0009900572,0.00013043702,0.0005226256,0.000048929847],"about_ca_topic_score_codex":0.0021922437,"about_ca_topic_score_gemma":0.0049480046,"teacher_disagreement_score":0.0057823076,"about_ca_system_score_codex":0.0007024963,"about_ca_system_score_gemma":0.0008951895,"threshold_uncertainty_score":0.030580103},"labels":[],"label_agreement":null},{"id":"W1999287793","doi":"10.1016/j.jval.2013.08.849","title":"Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cost sharing; Reimbursement; Medicine; Quarter (Canadian coin); Population; Average cost; Business; Public economics; Environmental health; Economics; Health care; Economic growth; Geography","score_opus":0.22237617927370337,"score_gpt":0.36778010867386485,"score_spread":0.14540392940016147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999287793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826104,0.0012109387,0.00029147282,0.0041812737,0.000038497405,0.000021931668,0.0003446807,0.00001012601,0.011290683],"genre_scores_gemma":[0.9984932,0.00047486706,0.000053526124,0.00011329707,0.00002085195,0.0000045421248,0.000096324606,0.0000023281216,0.0007411263],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9986644,0.00049964414,0.00008451258,0.00013675606,0.00022704847,0.00038769306],"domain_scores_gemma":[0.9967739,0.0017767854,0.00080335484,0.00012525449,0.00022525368,0.0002953898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014581915,0.00021833155,0.00064553635,0.001022772,0.0003722867,0.003706818,0.00056188,0.0016346547,0.0021037553],"category_scores_gemma":[0.0061775018,0.0002509644,0.0007594654,0.0014953185,0.0013383172,0.0014019929,0.0016932801,0.0015331783,0.00011237996],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034706558,0.001826743,0.25642177,0.0011423314,0.0019499934,0.009156677,0.0018295745,0.32527694,0.005717611,0.3149267,0.009275199,0.06900583],"study_design_scores_gemma":[0.0005689943,0.0011817736,0.7387147,0.0003999765,0.0009109653,0.0009779534,0.013772972,0.09408116,0.0041998765,0.10632988,0.038700167,0.00016160725],"about_ca_topic_score_codex":0.03101241,"about_ca_topic_score_gemma":0.021210035,"teacher_disagreement_score":0.03101241,"about_ca_system_score_codex":0.006739095,"about_ca_system_score_gemma":0.0040010745,"threshold_uncertainty_score":0.061663806},"labels":[],"label_agreement":null},{"id":"W1999763833","doi":"10.1016/j.jval.2013.03.693","title":"The Cost-Effectiveness Of Companion Diagnostics In Cancer Therapy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cancer therapy; Medicine; Cancer; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.03923871380500899,"score_gpt":0.32846259437408654,"score_spread":0.28922388056907755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999763833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5092612,0.261093,0.030417275,0.096010484,0.0022895474,0.00028875607,0.0039951475,0.00020307656,0.0964416],"genre_scores_gemma":[0.9799197,0.0139649175,0.002853328,0.00097043224,0.0005886485,0.000038275295,0.00032747135,0.000020056112,0.0013172275],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99617,0.0025990235,0.0001235469,0.00016519004,0.0007551273,0.0001871181],"domain_scores_gemma":[0.9793727,0.017135527,0.0012589365,0.00047738428,0.0010688461,0.0006866569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041938,0.0004954198,0.00079546456,0.0013037726,0.0002914998,0.0024922653,0.0006502006,0.001654317,0.008896697],"category_scores_gemma":[0.03078265,0.00021901961,0.0011095041,0.0012542671,0.0009073214,0.0019104469,0.00081858115,0.0014580674,0.0005742126],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008641963,0.0006957239,0.08181857,0.0013227474,0.0011363785,0.0009409573,0.00017331503,0.048263673,0.0018312194,0.05963913,0.020027852,0.7755085],"study_design_scores_gemma":[0.0020196785,0.008895158,0.30004275,0.004308709,0.0047750515,0.009812537,0.0022168327,0.20114613,0.00823862,0.3168731,0.1413082,0.00036323056],"about_ca_topic_score_codex":0.0025438599,"about_ca_topic_score_gemma":0.0021754028,"teacher_disagreement_score":0.008896697,"about_ca_system_score_codex":0.0034147697,"about_ca_system_score_gemma":0.0015168713,"threshold_uncertainty_score":0.029762447},"labels":[],"label_agreement":null},{"id":"W2000010128","doi":"10.1016/j.jval.2014.03.1584","title":"Costs Of Adverse Events Associated With Treatment Of Hepatitis C Virus Infection: An Analysis Using The Quebec Provincial Drug Reimbursement Program Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Telaprevir; Boceprevir; Ribavirin; Reimbursement; Rash; Pharmacy; Adverse effect; Pegylated interferon; Hepatitis C; Emergency medicine; Internal medicine; Hepatitis C virus; Health care; Pediatrics; Family medicine; Immunology; Virus","score_opus":0.058357585096954274,"score_gpt":0.3828190457100333,"score_spread":0.324461460613079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000010128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8536703,0.0036281669,0.0004545105,0.00093848753,0.00003315284,0.00031249804,0.13824993,0.000051729738,0.0026612284],"genre_scores_gemma":[0.9451652,0.0014175265,0.00064701773,0.0003079843,0.000028536844,0.00019701335,0.050947852,0.000020790696,0.001268159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634284,0.0009238033,0.00048733523,0.0004006765,0.0013202606,0.0005250575],"domain_scores_gemma":[0.9822276,0.0046434896,0.0048430017,0.00062183884,0.006175737,0.0014883653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002254552,0.00062574167,0.0012109654,0.0051687215,0.0011246476,0.0016626908,0.0018089053,0.0007644657,0.0029110971],"category_scores_gemma":[0.017759457,0.0005374088,0.0023441457,0.012229501,0.00038398994,0.0007268213,0.00094066735,0.0012586837,0.00024217486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062135333,0.000083991086,0.9845295,0.00017457614,0.0009995537,0.000100463316,0.00007032357,0.002428528,0.00003847428,0.00016865597,0.0059797615,0.0048048384],"study_design_scores_gemma":[0.000079449754,0.000050763818,0.99153227,0.000077168246,0.00028434716,0.000089157205,0.00013805789,0.0062274653,0.00003631565,0.000029598785,0.00143637,0.000019053527],"about_ca_topic_score_codex":0.9745422,"about_ca_topic_score_gemma":0.97014636,"teacher_disagreement_score":0.034954537,"about_ca_system_score_codex":0.034954537,"about_ca_system_score_gemma":0.02018754,"threshold_uncertainty_score":0.25361407},"labels":[],"label_agreement":null},{"id":"W2000345837","doi":"10.1016/j.jval.2012.08.1803","title":"PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psoriatic arthritis; Pharmacy; Medical prescription; Health care; Methotrexate; Emergency medicine; Internal medicine; Disease; Family medicine; Pharmacology","score_opus":0.07261658889146184,"score_gpt":0.3644348889219784,"score_spread":0.29181830003051656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000345837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846581,0.0009070562,0.00006336776,0.00047565365,0.000036583697,0.000031433825,0.009385861,0.000009544228,0.004432263],"genre_scores_gemma":[0.99509275,0.00026794113,0.000062431965,0.00009635059,0.0000331082,0.000019148843,0.0036194138,0.000001998789,0.0008068983],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960345,0.00011348613,0.000060706414,0.00004063155,0.00008459576,0.00009724041],"domain_scores_gemma":[0.9986785,0.0002750815,0.00063987717,0.000023205012,0.00008657062,0.00029673168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000224542,0.0001818646,0.00032722938,0.0005820145,0.00023455566,0.00045218263,0.00024925463,0.00041901908,0.0059136082],"category_scores_gemma":[0.0021738727,0.00014384957,0.0010363355,0.00078904076,0.00011480675,0.00050280953,0.00045049246,0.00072713936,0.00038552022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018966055,0.00024487762,0.9801783,0.00014189428,0.00032841295,0.00031810693,0.00008354416,0.0010522843,0.0002600697,0.0003577811,0.0044064415,0.010731755],"study_design_scores_gemma":[0.000066160705,0.0001915437,0.99746346,0.000021242484,0.00005557758,0.00033267424,0.000104836756,0.0010054864,0.00004647934,0.00012242266,0.00058288284,0.000007159831],"about_ca_topic_score_codex":0.019670947,"about_ca_topic_score_gemma":0.017584946,"teacher_disagreement_score":0.019670947,"about_ca_system_score_codex":0.00087327446,"about_ca_system_score_gemma":0.0006198224,"threshold_uncertainty_score":0.039112866},"labels":[],"label_agreement":null},{"id":"W2000828606","doi":"10.1016/j.jval.2012.08.2198","title":"PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing & Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Bone and Joint Health Institute; Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Cohort; Breast cancer; Oncology; Odds ratio; Cancer registry; Cancer","score_opus":0.33491114660301574,"score_gpt":0.46467707360967625,"score_spread":0.1297659270066605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000828606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38684744,0.012009687,0.0023753443,0.32957333,0.0018217929,0.0022057018,0.012431193,0.0003128804,0.25242266],"genre_scores_gemma":[0.80019546,0.010588029,0.017117828,0.07020425,0.00040469537,0.0007040037,0.003997428,0.00018531627,0.09660304],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99618006,0.00035968123,0.00037625298,0.00021593648,0.0015835954,0.0012845646],"domain_scores_gemma":[0.98007536,0.0015000413,0.0011896966,0.0001942467,0.009989237,0.0070513953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032512732,0.00024178381,0.0003079723,0.0017062122,0.006988315,0.0023473597,0.0022444692,0.0019209794,0.0055060172],"category_scores_gemma":[0.009408428,0.00048937945,0.00056109164,0.0032474524,0.0013797613,0.0004929023,0.0012157874,0.0019734078,0.00037542108],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023003397,0.0006732407,0.28574923,0.0010098389,0.00010076412,0.004994012,0.012705894,0.0021385304,0.0032516385,0.024962787,0.5001319,0.1640522],"study_design_scores_gemma":[0.00019119456,0.00016343751,0.50339836,0.001850303,0.000090083086,0.0016174621,0.014176851,0.0022177415,0.0008341846,0.001408101,0.47384846,0.00020377708],"about_ca_topic_score_codex":0.99595815,"about_ca_topic_score_gemma":0.9985506,"teacher_disagreement_score":0.10179653,"about_ca_system_score_codex":0.10179653,"about_ca_system_score_gemma":0.4099479,"threshold_uncertainty_score":0.738589},"labels":[],"label_agreement":null},{"id":"W2000963673","doi":"10.1016/j.jval.2011.08.401","title":"PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intelligent Mechatronic Systems (Canada)","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Infliximab; Psoriatic arthritis; Rheumatoid arthritis; Ankylosing spondylitis; Internal medicine; Discontinuation; Psoriasis; Population; Surgery; Tumor necrosis factor alpha; Dermatology","score_opus":0.14651859472891726,"score_gpt":0.3822495205097888,"score_spread":0.23573092578087151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000963673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006736,0.00058110006,0.0003568917,0.00011213529,0.000010146121,0.0000147293595,0.008168592,0.000017244081,0.0006718573],"genre_scores_gemma":[0.9944964,0.00015783857,0.00022266303,0.000051441817,0.000009606533,0.000011877676,0.0048487983,0.0000037304117,0.00019758123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989215,0.00035686948,0.00023496928,0.00021246541,0.000176051,0.00009818975],"domain_scores_gemma":[0.99639916,0.0012181246,0.0018161391,0.0001516591,0.00024436455,0.0001705349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010490698,0.0002485145,0.00044207138,0.0013610622,0.00013692977,0.0007028667,0.00048322012,0.00047247732,0.0019885586],"category_scores_gemma":[0.0060913293,0.00027578953,0.001402051,0.0017540199,0.00025471166,0.0006347331,0.0004735764,0.00053984043,0.00025009422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011333736,0.00007157832,0.9869617,0.000061446044,0.00065453904,0.00013790201,0.000054727287,0.0039881836,0.00018321794,0.00028090618,0.0013248634,0.0051476024],"study_design_scores_gemma":[0.00007506144,0.00024826694,0.99093413,0.000029290806,0.00025801154,0.0005511852,0.0001254901,0.006540199,0.00025101213,0.00012194032,0.00085367693,0.000011822293],"about_ca_topic_score_codex":0.017766621,"about_ca_topic_score_gemma":0.0112617565,"teacher_disagreement_score":0.017766621,"about_ca_system_score_codex":0.0010730701,"about_ca_system_score_gemma":0.00051486824,"threshold_uncertainty_score":0.03532642},"labels":[],"label_agreement":null},{"id":"W2001099147","doi":"10.1016/s1098-3015(10)70638-0","title":"PCV50 UP-TITRATION OF STATIN THERAPY TO MEET CANADIAN TARGET LIPID GOALS: ECONOMIC IMPACT OFTITRATION ASSOCIATED WITH COMPARATIVE EFFICACY OF ROSUVASTATIN, ATORVASTATIN, SIMVASTATIN AND PRAVASTATIN","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Pravastatin; Simvastatin; Atorvastatin; Statin; Medicine; Pharmacology; Internal medicine; Cholesterol","score_opus":0.053754054396429926,"score_gpt":0.3198960244048216,"score_spread":0.2661419700083917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001099147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9662148,0.013121452,0.0006292974,0.0051181624,0.00028521958,0.00046524042,0.0034573157,0.000047904723,0.010660684],"genre_scores_gemma":[0.99634284,0.0011894284,0.0004244918,0.00031765387,0.00007517691,0.000036142617,0.0010761054,0.0000072753865,0.0005308795],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99298954,0.004009316,0.0003539048,0.0003216448,0.0014375198,0.0008879839],"domain_scores_gemma":[0.9902547,0.0056307865,0.0009742194,0.00031549222,0.00087825407,0.001946525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057009105,0.00067621074,0.0014571353,0.000748326,0.00071221316,0.0018204993,0.0011987614,0.0014086583,0.0069478443],"category_scores_gemma":[0.026866276,0.00037002962,0.003254452,0.0014141599,0.0009061469,0.0009791772,0.0013260847,0.0022905902,0.00017273931],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7306142,0.003703554,0.0493126,0.0010390206,0.0046411897,0.00023130947,0.00022841698,0.011622167,0.0006161521,0.0034564435,0.0055616787,0.18897341],"study_design_scores_gemma":[0.095275626,0.061397817,0.752305,0.0009232348,0.016246438,0.00048436687,0.0009781638,0.055398446,0.0012757783,0.0036597056,0.011761514,0.00029394968],"about_ca_topic_score_codex":0.40022165,"about_ca_topic_score_gemma":0.3898962,"teacher_disagreement_score":0.59977835,"about_ca_system_score_codex":0.014581921,"about_ca_system_score_gemma":0.019163433,"threshold_uncertainty_score":0.7957842},"labels":[],"label_agreement":null},{"id":"W2001113760","doi":"10.1016/j.jval.2013.08.262","title":"Factors Associated with Compliance with Palivizumab Prophylaxis in the Canadian RSV Evaluation Study for Synagis (CARESS) Registry (2005-2012)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Respiratory system; Internal medicine; Pregnancy","score_opus":0.283670720677122,"score_gpt":0.4190594965825489,"score_spread":0.13538877590542686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001113760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883137,0.0004944452,0.00010551208,0.00041738717,0.0000320083,0.000038235157,0.008584103,0.000022440923,0.0019921926],"genre_scores_gemma":[0.9953489,0.00013462944,0.000100739846,0.00010454469,0.000017068209,0.00002072874,0.0039473516,0.0000070921765,0.00031899885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978765,0.0002940248,0.00028860715,0.00030174464,0.00065930665,0.00057992846],"domain_scores_gemma":[0.9932429,0.00078467396,0.0029635972,0.00042429814,0.0016868026,0.000897647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020919503,0.0002476809,0.00038874053,0.0014046665,0.0007531497,0.0008071578,0.001395216,0.0008479439,0.0014173513],"category_scores_gemma":[0.008899373,0.00035869816,0.00077506294,0.0034039193,0.0003877274,0.0005120004,0.0005083982,0.0011516628,0.0001775219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004713097,0.000016811926,0.9988825,0.0000051271127,0.000031721578,0.00001746209,0.00003047093,0.000031602514,0.00002010628,0.000012044172,0.00047024453,0.00043476617],"study_design_scores_gemma":[0.0000027927597,0.000010229217,0.9996573,0.0000057136726,0.0000112878,0.00002508297,0.00005952597,0.00009534056,0.000009818128,0.0000027682636,0.000117934964,0.0000021091878],"about_ca_topic_score_codex":0.67996466,"about_ca_topic_score_gemma":0.75984126,"teacher_disagreement_score":0.32003534,"about_ca_system_score_codex":0.003533713,"about_ca_system_score_gemma":0.007936353,"threshold_uncertainty_score":0.6438402},"labels":[],"label_agreement":null},{"id":"W2001433987","doi":"10.1016/s1098-3015(10)63952-6","title":"PES8: BURDEN OF ILLNESS OF ECZEMA IN CANADA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.06479325149091672,"score_gpt":0.3910864457120979,"score_spread":0.3262931942211812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001433987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94057727,0.0021472087,0.00010482173,0.0021426664,0.000058330173,0.000100160774,0.045099527,0.000030155568,0.009739843],"genre_scores_gemma":[0.9853753,0.0017214878,0.00017555157,0.00018344438,0.000026452177,0.000023092272,0.0081944475,0.000007890495,0.004292368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993992,0.00003538579,0.00004035007,0.000042576205,0.0002500444,0.00023241286],"domain_scores_gemma":[0.9987,0.00003219991,0.0002242412,0.000014754021,0.00062616053,0.0004025417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025707996,0.00030125416,0.00031001557,0.0018976604,0.001443758,0.0011226739,0.0008662658,0.00047104526,0.0049155876],"category_scores_gemma":[0.0015557611,0.00021776566,0.000582792,0.0044735055,0.00034159468,0.00045183944,0.0008828713,0.0007960295,0.0002833458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022619008,0.000048941114,0.9789779,0.0000894655,0.000110037414,0.00027272338,0.0004908502,0.0004131991,0.00018905089,0.00045265703,0.0072602676,0.011468726],"study_design_scores_gemma":[0.000009919535,0.000015948175,0.996899,0.000029213415,0.000018155395,0.000100457095,0.000585467,0.00023607364,0.000021948576,0.000033707434,0.0020423622,0.0000076595525],"about_ca_topic_score_codex":0.99568886,"about_ca_topic_score_gemma":0.99659914,"teacher_disagreement_score":0.024204018,"about_ca_system_score_codex":0.024204018,"about_ca_system_score_gemma":0.032586146,"threshold_uncertainty_score":0.17561322},"labels":[],"label_agreement":null},{"id":"W2001616961","doi":"10.1016/j.jval.2011.02.665","title":"PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Live attenuated influenza vaccine; Medicine; Vaccination; Pediatrics; Christian ministry; Influenza vaccine; Cost–benefit analysis; Immunology","score_opus":0.10758982972760871,"score_gpt":0.3787116477136801,"score_spread":0.2711218179860714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001616961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85070854,0.10746237,0.0017527423,0.0028286898,0.00031347398,0.0034303975,0.017819552,0.000055898985,0.015628401],"genre_scores_gemma":[0.96500355,0.026188515,0.0025794776,0.00052461243,0.00006520939,0.00048011,0.003290586,0.000025009893,0.0018429579],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9946607,0.0027343149,0.00029755855,0.00025419708,0.0013128096,0.00074040814],"domain_scores_gemma":[0.9949961,0.0026972017,0.00058525574,0.00012318049,0.0009909212,0.0006074123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00630969,0.0018826884,0.0030849294,0.002375677,0.0008421824,0.0019320502,0.0020324963,0.001007738,0.004051614],"category_scores_gemma":[0.012963014,0.0007979456,0.007407146,0.004692707,0.0007352014,0.0007331203,0.0008927559,0.0023934655,0.00012116095],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3056673,0.0041373386,0.1683229,0.03146825,0.09268823,0.00097360613,0.0011029048,0.08565935,0.0022182188,0.009130109,0.02163493,0.2769969],"study_design_scores_gemma":[0.109526746,0.03246237,0.5145079,0.007866063,0.21368542,0.0009217397,0.0026057917,0.0880425,0.0020280564,0.002560332,0.025061922,0.0007311445],"about_ca_topic_score_codex":0.95143354,"about_ca_topic_score_gemma":0.9514202,"teacher_disagreement_score":0.059919525,"about_ca_system_score_codex":0.059919525,"about_ca_system_score_gemma":0.049071476,"threshold_uncertainty_score":0.4347486},"labels":[],"label_agreement":null},{"id":"W2001762110","doi":"10.1016/s1098-3015(10)74861-0","title":"PSY18 THE BURDEN OF OBESITY IN ONTARIO","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Obesity; Medicine; Gerontology; Internal medicine","score_opus":0.058757583248402384,"score_gpt":0.36054247986881355,"score_spread":0.3017848966204112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001762110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96323174,0.0012116645,0.00008581387,0.0046457564,0.000047328405,0.000057388042,0.014396675,0.000016887361,0.016306771],"genre_scores_gemma":[0.98781383,0.0012248982,0.00014159454,0.00037296768,0.000022429422,0.000044144148,0.0018366612,0.000012583997,0.008530845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904996,0.00009249344,0.000057097575,0.00006823175,0.00032898653,0.00040328418],"domain_scores_gemma":[0.9973781,0.00013984698,0.0006524924,0.0000808209,0.00074960454,0.0009991406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045537428,0.0001725051,0.0003405514,0.0013981981,0.003505615,0.0015440747,0.00083931355,0.0004886001,0.0057482054],"category_scores_gemma":[0.0021115076,0.00038288787,0.00063678634,0.0050237207,0.00074028055,0.0004989511,0.0014346056,0.00069719506,0.00032735418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016118231,0.000042047515,0.9763168,0.000116859155,0.00010703941,0.0003162871,0.003151763,0.0002017028,0.00024010436,0.0008745188,0.008296146,0.010175506],"study_design_scores_gemma":[0.000010855848,0.0000135742885,0.9920094,0.00003706924,0.000018192837,0.000041694886,0.0024057906,0.00007956124,0.000025649017,0.00006663878,0.0052835005,0.000008004746],"about_ca_topic_score_codex":0.9958763,"about_ca_topic_score_gemma":0.99859923,"teacher_disagreement_score":0.043534532,"about_ca_system_score_codex":0.043534532,"about_ca_system_score_gemma":0.071219094,"threshold_uncertainty_score":0.3158666},"labels":[],"label_agreement":null},{"id":"W2001790155","doi":"10.1016/j.jval.2013.03.255","title":"Determining the current state-of-play for variants of the ‘short form' health-related quality of life instrument in spinal cord injury: A systematic literature review","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Praxis Spinal Cord Institute; University of British Columbia","funders":"","keywords":"Descriptive statistics; Spinal cord injury; Quality of life (healthcare); Systematic review; SF-36; Medicine; Missing data; Data collection; Psychology; Gerontology; MEDLINE; Health related quality of life; Statistics; Spinal cord; Psychiatry; Disease; Pathology; Mathematics","score_opus":0.17875907636888982,"score_gpt":0.4633291999414676,"score_spread":0.28457012357257777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001790155","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026863895,0.969793,0.00032766425,0.00043293714,0.00013006266,0.00019438606,0.0018286201,0.000006299892,0.00042318797],"genre_scores_gemma":[0.33570147,0.6568713,0.0030420274,0.0007447326,0.0001245618,0.0005855081,0.0027809567,0.000014736584,0.00013476104],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9830684,0.0041338643,0.007907806,0.0018422952,0.0026086776,0.00043897468],"domain_scores_gemma":[0.89597136,0.07888445,0.016529871,0.0014353157,0.0064860536,0.000693031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023498453,0.0009936222,0.0068589686,0.013451648,0.00075035327,0.003783852,0.002014503,0.0023753638,0.0016207279],"category_scores_gemma":[0.09406804,0.0011618077,0.011454313,0.014818179,0.00161246,0.003687476,0.0018673659,0.0017068272,0.00018372886],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017639394,0.00015578873,0.22120327,0.49065542,0.07212153,0.00041617377,0.002464735,0.00046918268,0.00032920268,0.0009791942,0.0028697678,0.2065718],"study_design_scores_gemma":[0.00069756334,0.0007055497,0.3211563,0.4318066,0.2211489,0.0014733472,0.004531934,0.0005525294,0.00045527265,0.001128314,0.016031865,0.00031194492],"about_ca_topic_score_codex":0.021067863,"about_ca_topic_score_gemma":0.054749947,"teacher_disagreement_score":0.023498453,"about_ca_system_score_codex":0.0038846221,"about_ca_system_score_gemma":0.010977097,"threshold_uncertainty_score":0.12427324},"labels":[],"label_agreement":null},{"id":"W2001855618","doi":"10.1016/j.jval.2011.12.006","title":"Guidelines for Health Technologies: Specific Guidance for Oncology Products in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of Alberta; Toronto Public Health; BC Cancer Agency; University of Ottawa; University of Calgary; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Canadian Agency for Drugs and Technologies in Health; University of British Columbia; Artificial Intelligence in Medicine (Canada); Health Sciences Centre; University Health Network; University of Toronto; Hamilton Health Sciences; McMaster University; Group for Research in Decision Analysis","funders":"","keywords":"Agency (philosophy); Health technology; Government (linguistics); Medicine; Time horizon; Quality (philosophy); Economic evaluation; Oncology; Health care; Business; Political science; Finance; Pathology","score_opus":0.7003080386820904,"score_gpt":0.49854132817164004,"score_spread":0.2017667105104503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001855618","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076319925,0.09421816,0.038798083,0.19339651,0.011205308,0.010054343,0.110039786,0.005679496,0.52897626],"genre_scores_gemma":[0.034018394,0.088279665,0.24392863,0.13410035,0.0024377576,0.008560461,0.048936617,0.0029466432,0.43679154],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.985408,0.0019140723,0.002781597,0.0005669054,0.007703141,0.0016262061],"domain_scores_gemma":[0.9351737,0.013325625,0.0038087673,0.0012299444,0.043489546,0.0029724445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0119459145,0.0025540253,0.0027259586,0.01423696,0.0047816304,0.008939006,0.007028032,0.018963115,0.029837115],"category_scores_gemma":[0.04105745,0.0024655622,0.004859144,0.017560834,0.003222858,0.0035608439,0.0026826856,0.010235836,0.012181681],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043816304,0.00011144839,0.0012646643,0.00086431537,0.000028342647,0.000181546,0.0002868485,0.0015407499,0.0003196406,0.00882346,0.94883,0.037705127],"study_design_scores_gemma":[0.00014679148,0.00004205177,0.013206725,0.0051484033,0.00015448319,0.0003122176,0.00040781946,0.0013376363,0.0005583782,0.0077966736,0.9706797,0.00020927662],"about_ca_topic_score_codex":0.9228075,"about_ca_topic_score_gemma":0.9527964,"teacher_disagreement_score":0.077192485,"about_ca_system_score_codex":0.0495972,"about_ca_system_score_gemma":0.17403387,"threshold_uncertainty_score":0.35985458},"labels":[],"label_agreement":null},{"id":"W2001887499","doi":"10.1016/j.jval.2011.08.539","title":"PUK4 Comparing Projected Outcomes of Renal Transplant Recipients Based on Trial Endpoint of Renal Function and Receiving Different Immunosuppressive Regimens in the United States","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Belatacept; Medicine; Dialysis; Tacrolimus; Renal function; Urology; Kidney transplantation; Quality of life (healthcare); Clinical endpoint; Transplantation; Internal medicine; Clinical trial; Kidney transplant","score_opus":0.09503194658494024,"score_gpt":0.31417667175080133,"score_spread":0.2191447251658611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001887499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968683,0.00030213394,0.00027665438,0.00018549233,0.00001771702,0.000010074781,0.0017176912,0.000007112927,0.0006148559],"genre_scores_gemma":[0.99832064,0.00006499318,0.00006393937,0.00004502745,0.000009800747,0.0000090529,0.0013594079,0.0000021893943,0.00012500552],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99843055,0.00090048404,0.00011964767,0.00020576845,0.00012146662,0.00022199553],"domain_scores_gemma":[0.99499667,0.0020514466,0.0017325142,0.0003080156,0.00032883062,0.0005825898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028876993,0.00030507278,0.000601542,0.00043773878,0.00018254823,0.0010438394,0.00047160615,0.00041024346,0.0017968187],"category_scores_gemma":[0.006983797,0.00020744708,0.001802473,0.00078403106,0.00027527203,0.00088897056,0.0008784332,0.00082050345,0.0001511693],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02418613,0.00024211699,0.9512369,0.0001287163,0.0032802443,0.000072504976,0.00009897109,0.0077407905,0.00028883692,0.00094992004,0.0017921205,0.009982798],"study_design_scores_gemma":[0.0013948095,0.0036719944,0.9738902,0.000061220475,0.0021181025,0.00020924957,0.00039456994,0.01441994,0.00061464927,0.0021519717,0.001026926,0.000046350455],"about_ca_topic_score_codex":0.0037911534,"about_ca_topic_score_gemma":0.0037787633,"teacher_disagreement_score":0.0037911534,"about_ca_system_score_codex":0.000583433,"about_ca_system_score_gemma":0.0006401934,"threshold_uncertainty_score":0.015271783},"labels":[],"label_agreement":null},{"id":"W2001978706","doi":"10.1016/j.jval.2014.03.903","title":"Vitamin B12 Status In Frail Older Adults Admitted In A Geriatric Assessment Unit: Can The Use Of Certain Drugs Be Determinant?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Gériatrie de Montréal; Université de Montréal","funders":"","keywords":"Metformin; Medicine; Vitamin B12; Vitamin D and neurology; Internal medicine; Calcium; Pharmacist; Diabetes mellitus; Endocrinology; Pharmacy; Family medicine","score_opus":0.05766473200620884,"score_gpt":0.3572564103019301,"score_spread":0.29959167829572125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001978706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99677026,0.001454948,0.000044042747,0.00047546282,0.00002308171,0.000006162103,0.00019996628,0.000002505516,0.0010235818],"genre_scores_gemma":[0.9990314,0.0005454226,0.00005692873,0.000100751124,0.000028827963,0.0000031240916,0.00012857662,0.0000010650698,0.000103807935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958044,0.00010132127,0.00008732099,0.00004827923,0.00008416571,0.00009850935],"domain_scores_gemma":[0.99751043,0.0006694525,0.0010116599,0.00008503117,0.0002732546,0.00045006524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005172022,0.00033687524,0.000729438,0.0008710025,0.000530181,0.0009004231,0.00046438078,0.0010795683,0.001406215],"category_scores_gemma":[0.0062210327,0.0002534643,0.00059699215,0.0017089654,0.00044598532,0.0007581385,0.0004255648,0.0012454399,0.00019110394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014910172,0.00006036826,0.9981305,0.000014816737,0.000049404433,0.00011245507,0.00007844298,0.00001562995,0.000059062524,0.000015741709,0.00008484798,0.0012296576],"study_design_scores_gemma":[0.0000073378837,0.000119148724,0.9989574,0.000021334237,0.00006205701,0.00018163421,0.00030684273,0.00014973644,0.000031747535,0.000056724595,0.0001012026,0.000004787674],"about_ca_topic_score_codex":0.022015467,"about_ca_topic_score_gemma":0.031317342,"teacher_disagreement_score":0.022015467,"about_ca_system_score_codex":0.000449242,"about_ca_system_score_gemma":0.0006152097,"threshold_uncertainty_score":0.043774605},"labels":[],"label_agreement":null},{"id":"W2002055673","doi":"10.1111/j.1524-4733.2007.00227.x","title":"Costs Associated with Diffuse Large B-Cell Lymphoma Patient Treatment in a Canadian Integrated Cancer Care Center","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Rituximab; CHOP; Diffuse large B-cell lymphoma; Vincristine; Context (archaeology); Cancer; Intensive care medicine; Lymphoma; Cyclophosphamide; Internal medicine; Chemotherapy","score_opus":0.0221471912515148,"score_gpt":0.24127005745096178,"score_spread":0.219122866199447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002055673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98943454,0.000804256,0.00009945514,0.0035461334,0.000036122125,0.00007911467,0.002096733,0.000012084521,0.003891486],"genre_scores_gemma":[0.99775416,0.00033003296,0.00013103252,0.00029913773,0.000022818904,0.00001463921,0.0007195005,0.0000036765557,0.0007249365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802375,0.0003017771,0.00011314007,0.00010186361,0.00040527337,0.0010542104],"domain_scores_gemma":[0.9952069,0.00055786944,0.0010515051,0.000050904404,0.00084711885,0.0022857075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004997491,0.00040264698,0.00049686193,0.0012227289,0.0028488543,0.0020628113,0.001970437,0.0012574393,0.0045264484],"category_scores_gemma":[0.0050434135,0.00047325826,0.0011017323,0.0028801837,0.00069991726,0.0005273303,0.0015562752,0.0023088437,0.00014099666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001276524,0.0010302225,0.92877835,0.00013986987,0.0005260482,0.0022896694,0.00084821973,0.016964542,0.00042759135,0.0024322309,0.016447404,0.028839292],"study_design_scores_gemma":[0.0001146846,0.00026348684,0.97895616,0.000083596184,0.00021829727,0.0006992781,0.0034317658,0.013165544,0.00011348455,0.00050349126,0.0023811418,0.000068993075],"about_ca_topic_score_codex":0.9563243,"about_ca_topic_score_gemma":0.97792244,"teacher_disagreement_score":0.08690646,"about_ca_system_score_codex":0.08690646,"about_ca_system_score_gemma":0.028650545,"threshold_uncertainty_score":0.6305535},"labels":[],"label_agreement":null},{"id":"W2002325793","doi":"10.1016/j.jval.2013.03.1625","title":"Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ministry of Health and Long Term Care; Toronto Public Health","funders":"","keywords":"Medicine; Breast cancer; Oncology; Adjuvant; Cohort; Internal medicine; Cost effectiveness; Estrogen receptor; Cancer; Gynecology; Risk analysis (engineering)","score_opus":0.05785129053001063,"score_gpt":0.3413311520532718,"score_spread":0.28347986152326116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002325793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746099,0.012734694,0.003833266,0.0022753354,0.00014172295,0.00012272681,0.00078691397,0.000018136765,0.0054771663],"genre_scores_gemma":[0.99641657,0.001242234,0.001583402,0.0001171265,0.000039199553,0.000023430752,0.00015176808,0.0000043487034,0.00042195452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99589443,0.0033582307,0.000086459375,0.00011686591,0.00042791865,0.00011618825],"domain_scores_gemma":[0.9794694,0.01853578,0.00062438485,0.00034346667,0.0007037834,0.00032305552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004264369,0.0005576648,0.0007816632,0.0010000941,0.00018363516,0.0011922625,0.0005980198,0.0009597026,0.0028462086],"category_scores_gemma":[0.02409831,0.00023042629,0.0009401664,0.0008221721,0.00054195453,0.000741626,0.00042691742,0.00065034686,0.00020061205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055932198,0.0017048857,0.51149046,0.0007153032,0.0018973124,0.00047360262,0.000172911,0.0896057,0.0038667521,0.005860638,0.0022720594,0.32600814],"study_design_scores_gemma":[0.003126403,0.027596598,0.48737654,0.00066655007,0.0074987635,0.0021557477,0.0009531195,0.43288863,0.012828983,0.016457807,0.008183207,0.00026766062],"about_ca_topic_score_codex":0.0064981556,"about_ca_topic_score_gemma":0.0066951783,"teacher_disagreement_score":0.0064981556,"about_ca_system_score_codex":0.0021002346,"about_ca_system_score_gemma":0.0011890149,"threshold_uncertainty_score":0.02255243},"labels":[],"label_agreement":null},{"id":"W2002396150","doi":"10.1016/j.jval.2014.03.411","title":"A Comparison of Toxicity and Supportive Care Use Between Four Cytotoxic Agents Used in the Management of Metastatic Breast Cancer (MBC))","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Metastatic breast cancer; Capecitabine; Anemia; Toxicity; Gemcitabine; Adverse effect; Vinorelbine; Breast cancer; Eribulin; Cancer; Oncology; Chemotherapy; Colorectal cancer","score_opus":0.17380227733604714,"score_gpt":0.4436858291776548,"score_spread":0.26988355184160767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002396150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99757594,0.0013786693,0.00009445903,0.000036831785,0.000012333644,0.000035192894,0.00014252674,0.000003748228,0.00072035124],"genre_scores_gemma":[0.9989699,0.00038977418,0.0001556517,0.000035595116,0.000017054568,0.000023100283,0.00018369117,0.000001520975,0.00022365696],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99889165,0.00059206184,0.00015497507,0.000095283256,0.00018988486,0.00007611814],"domain_scores_gemma":[0.9965928,0.0018769136,0.00081912027,0.00011527253,0.00026406784,0.00033172898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001310081,0.00015383968,0.00047133813,0.0006414399,0.00022692888,0.0004572366,0.000280787,0.00044363886,0.0013104753],"category_scores_gemma":[0.004481208,0.00007072919,0.0008284675,0.0007379361,0.00027709047,0.00042386094,0.000311488,0.0004417746,0.00011812605],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.429332,0.007745757,0.3287539,0.0010028332,0.0033290042,0.0003887873,0.0006154155,0.0018564418,0.01726529,0.00044484696,0.00065948267,0.20860618],"study_design_scores_gemma":[0.0049631707,0.17987461,0.8022472,0.00009240238,0.001827235,0.0005327135,0.0005734479,0.0015201232,0.0050182375,0.00025031675,0.0030543983,0.000046096553],"about_ca_topic_score_codex":0.001253517,"about_ca_topic_score_gemma":0.0015876369,"teacher_disagreement_score":0.0013104753,"about_ca_system_score_codex":0.00080103375,"about_ca_system_score_gemma":0.00043858044,"threshold_uncertainty_score":0.006928444},"labels":[],"label_agreement":null},{"id":"W2002657022","doi":"10.1016/j.jval.2014.08.2673","title":"Evolution of Drug Reimbursement in Canada: The Pan-Canadian Pharmaceutical Alliance for New Drugs","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fulbright Canada; Global Affairs Canada; Institute of Health Economics; University of Ottawa","funders":"","keywords":"Negotiation; Reimbursement; Alliance; Business; Agency (philosophy); Pharmaceutical care; Health care; Process (computing); Drug prices; Pharmaceutical industry; Public relations; Public economics; Political science; Economic growth; Economics; Medicine; Pharmacology; Law; Sociology; Pharmacy","score_opus":0.31515287839522266,"score_gpt":0.40830782513114877,"score_spread":0.09315494673592611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002657022","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15583487,0.06802417,0.004559532,0.5938692,0.003489469,0.00036615066,0.00645129,0.00039847926,0.1670068],"genre_scores_gemma":[0.8969402,0.018427733,0.008051996,0.04109318,0.0011951294,0.00009057844,0.0020349359,0.0001720141,0.031994265],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98565996,0.0015031802,0.0005345543,0.00092689315,0.008136189,0.003239292],"domain_scores_gemma":[0.9465551,0.0039889263,0.0024594544,0.0008538511,0.03127065,0.014872097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01257762,0.00066680816,0.0009167263,0.0065256855,0.005732624,0.011908254,0.0024572099,0.0053423312,0.0058910907],"category_scores_gemma":[0.03209903,0.0007406083,0.0012338609,0.009518173,0.0054201996,0.002498492,0.0025752576,0.0055757943,0.00041447414],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00083949184,0.00037393157,0.07470011,0.00061490916,0.0003533641,0.0005988982,0.0021008474,0.007968843,0.0015117137,0.45803487,0.23991665,0.21298651],"study_design_scores_gemma":[0.00018399063,0.00012667845,0.34102723,0.0009232715,0.00014055739,0.00037465192,0.0019172839,0.005891213,0.00074114616,0.01409166,0.6343581,0.00022415792],"about_ca_topic_score_codex":0.9857619,"about_ca_topic_score_gemma":0.9911111,"teacher_disagreement_score":0.7083621,"about_ca_system_score_codex":0.29163787,"about_ca_system_score_gemma":0.3283099,"threshold_uncertainty_score":0.82159966},"labels":[],"label_agreement":null},{"id":"W2002712595","doi":"10.1016/j.jval.2014.03.021","title":"Benefits From Incorporating Network Meta-Analysis Within Stratified Cost-Effectiveness Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Dabigatran; Medicine; Apixaban; Rivaroxaban; Warfarin; Internal medicine; Atrial fibrillation; Cost-effectiveness analysis; Clinical trial; Stroke (engine); Cost effectiveness; Risk analysis (engineering)","score_opus":0.5991842699832463,"score_gpt":0.4407767059495713,"score_spread":0.15840756403367495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002712595","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023611564,0.056672696,0.8751547,0.02395704,0.004413782,0.0024311831,0.0036388328,0.0020506673,0.008069609],"genre_scores_gemma":[0.3376663,0.010253933,0.6346677,0.0071375086,0.0035758659,0.0026488781,0.0015073944,0.0007446269,0.0017977773],"study_design_codex":"meta_analysis","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.6434613,0.33221236,0.0125163505,0.005813985,0.0053617773,0.0006342572],"domain_scores_gemma":[0.3601137,0.5779013,0.009654158,0.041418478,0.009586473,0.0013259025],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20302728,0.004472189,0.008881637,0.0064090993,0.0008928218,0.006445965,0.00373141,0.0048192,0.008257532],"category_scores_gemma":[0.54169023,0.0028596676,0.021882256,0.008232387,0.0015566649,0.010389697,0.0057491697,0.00661293,0.00091570534],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016341114,0.00074972434,0.036383957,0.022253526,0.39524418,0.00071703125,0.0015682267,0.14095132,0.001460205,0.030509407,0.017104747,0.33671653],"study_design_scores_gemma":[0.0083093485,0.0031205711,0.017054481,0.009936501,0.2987388,0.00085503317,0.00057797774,0.30593044,0.0017386667,0.31753698,0.035476852,0.0007243674],"about_ca_topic_score_codex":0.00907324,"about_ca_topic_score_gemma":0.016463788,"teacher_disagreement_score":0.79697275,"about_ca_system_score_codex":0.00180202,"about_ca_system_score_gemma":0.004516955,"threshold_uncertainty_score":0.98280925},"labels":[],"label_agreement":null},{"id":"W2002858450","doi":"10.1016/j.jval.2014.03.503","title":"Parameter Values Associated with the Development of a Global Economic Model to Value Companion Diagnostics in Advanced/Metastatic Cancer Treatment","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Value (mathematics); Medicine; Cancer; Oncology; Intensive care medicine; Internal medicine; Statistics; Mathematics","score_opus":0.065465505589564,"score_gpt":0.2995608975078517,"score_spread":0.2340953919182877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002858450","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31719673,0.0027500123,0.59149057,0.014590742,0.00042009467,0.00022062854,0.0027728272,0.00035776867,0.070200615],"genre_scores_gemma":[0.96362036,0.0008461718,0.02323583,0.00040765392,0.0000721425,0.00017910628,0.0006143421,0.000116308845,0.010908043],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992785,0.00042618372,0.000020592483,0.000108373846,0.000061939936,0.000104473875],"domain_scores_gemma":[0.9938782,0.004811439,0.00048719932,0.00021731055,0.00037526488,0.00023062759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029910652,0.0010747839,0.0013255607,0.0011420045,0.0005248874,0.0037321954,0.0012499165,0.0034222014,0.0068113594],"category_scores_gemma":[0.016979976,0.00074143667,0.001233385,0.0013236167,0.0017596612,0.0032994198,0.001487436,0.0038622643,0.0004722641],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047475245,0.000021607631,0.0014147487,0.000024963143,0.000027513088,0.00010006945,0.00004073573,0.94014096,0.00019654105,0.053850874,0.0011956586,0.0029388622],"study_design_scores_gemma":[0.00003736998,0.000031781856,0.001039424,0.000040339506,0.000043586846,0.00008530311,0.000068009496,0.9154613,0.00023875367,0.08089502,0.0020234317,0.000035581397],"about_ca_topic_score_codex":0.0071233236,"about_ca_topic_score_gemma":0.004708118,"teacher_disagreement_score":0.0071233236,"about_ca_system_score_codex":0.0024743762,"about_ca_system_score_gemma":0.0016770797,"threshold_uncertainty_score":0.02278626},"labels":[],"label_agreement":null},{"id":"W2003499981","doi":"10.1016/j.jval.2013.03.1080","title":"Economic Burden Associated With Ulcerative Colitis In Canada: An Analysis Using The Ramq Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Reimbursement; Retrospective cohort study; Infliximab; Internal medicine; Health care; Disease; Database","score_opus":0.017332666108628873,"score_gpt":0.2584357248386728,"score_spread":0.2411030587300439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003499981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7467393,0.003045904,0.000135393,0.0010112245,0.000022193039,0.000118949996,0.24536185,0.000044845838,0.0035204282],"genre_scores_gemma":[0.91610473,0.0031039882,0.00043938519,0.00029113048,0.000025089848,0.00010380864,0.078611866,0.000026699905,0.0012932088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998398,0.0001616739,0.00022004452,0.00020402734,0.00062782783,0.00038842295],"domain_scores_gemma":[0.9929618,0.0007824488,0.0018571437,0.00025022015,0.0030594459,0.00108898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080203393,0.00044225788,0.0009641967,0.005263908,0.0013584587,0.0019688255,0.0015642019,0.0006409523,0.0037643693],"category_scores_gemma":[0.008388723,0.00037317822,0.0012994547,0.019539453,0.00050517626,0.00050806423,0.0012182356,0.00094872835,0.00035150614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048065037,0.00006412658,0.97962636,0.00026712526,0.000607314,0.00020269677,0.00020729293,0.0010758319,0.00004963926,0.00045777674,0.010964861,0.005996321],"study_design_scores_gemma":[0.000060760074,0.000027035345,0.9931178,0.00014190767,0.00022834985,0.00016436228,0.00063453324,0.0015900629,0.00003880543,0.000068159505,0.0039027028,0.000025501819],"about_ca_topic_score_codex":0.9929507,"about_ca_topic_score_gemma":0.9917339,"teacher_disagreement_score":0.026892513,"about_ca_system_score_codex":0.026892513,"about_ca_system_score_gemma":0.034329392,"threshold_uncertainty_score":0.19511974},"labels":[],"label_agreement":null},{"id":"W2003988980","doi":"10.1016/j.jval.2014.03.1003","title":"Long-Acting Muscarinic Antagonists (Lama) In Chronic Obstructive Pulmonary Disease (Copd): A Rare Events Meta Analysis Of Clinically Relevant Adverse Events","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Adverse effect; COPD; Placebo; Relative risk; Internal medicine; Lama; Randomized controlled trial; Mace; Tiotropium bromide; Clinical trial; Meta-analysis; Intensive care medicine; Confidence interval; Myocardial infarction; Lung; Lung function","score_opus":0.05684557326132262,"score_gpt":0.36583496113924896,"score_spread":0.30898938787792635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003988980","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13197292,0.8543401,0.007848538,0.00078819843,0.001120719,0.0004157235,0.0018905879,0.00027662222,0.0013465922],"genre_scores_gemma":[0.93106306,0.06129625,0.0039089145,0.0013538497,0.0005452464,0.00028235372,0.0008253745,0.00008418626,0.00064066186],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98298234,0.011608707,0.0021126969,0.0018668984,0.0009830501,0.00044634964],"domain_scores_gemma":[0.97465205,0.01902081,0.0030906696,0.0019170183,0.0008937049,0.00042572545],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.018092833,0.0028360132,0.011360681,0.001989368,0.0007072749,0.0023946601,0.0019321302,0.0023268468,0.0024802112],"category_scores_gemma":[0.031439416,0.0015892067,0.042737275,0.0024029901,0.0005769858,0.0015739001,0.0016988234,0.0028594015,0.00024420858],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012652978,0.000023414663,0.008742898,0.011664699,0.96142787,0.00012066909,0.000028420345,0.00047974725,0.0003055731,0.00008129968,0.00033030976,0.0041421787],"study_design_scores_gemma":[0.0022736883,0.0004359839,0.0060367635,0.0005426671,0.98940724,0.00010790001,0.000020310947,0.0003566551,0.00009937892,0.00021302354,0.0004873712,0.000018907851],"about_ca_topic_score_codex":0.0048436443,"about_ca_topic_score_gemma":0.009867818,"teacher_disagreement_score":0.9886393,"about_ca_system_score_codex":0.0012433828,"about_ca_system_score_gemma":0.00089649804,"threshold_uncertainty_score":0.095685124},"labels":[],"label_agreement":null},{"id":"W2004185897","doi":"10.1016/j.jval.2012.08.2065","title":"PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK: A Cost-Utility Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Branch retinal vein occlusion; Macular edema; Central retinal vein occlusion; Cost effectiveness; Visual acuity; Ophthalmology; Optometry; Surgery; Bevacizumab","score_opus":0.40044308701219467,"score_gpt":0.4503677563069999,"score_spread":0.04992466929480521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004185897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9637626,0.025231939,0.0032915266,0.0016413471,0.000047262813,0.00030522922,0.002166013,0.000023522054,0.0035305282],"genre_scores_gemma":[0.9955681,0.0026219578,0.0007865551,0.00007348107,0.000012502942,0.00006210185,0.0004578219,0.0000048422726,0.00041267226],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970542,0.0020562503,0.00022784213,0.00011445713,0.0003789665,0.00016826963],"domain_scores_gemma":[0.99671185,0.0024632376,0.0004761725,0.000054225267,0.00016898106,0.0001255502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032733371,0.000774981,0.0013250937,0.0013961238,0.00019382594,0.0014398216,0.00043162864,0.0009476926,0.0032616819],"category_scores_gemma":[0.0111939795,0.00050442707,0.0024045934,0.0015415539,0.00047715448,0.0009023594,0.0008871403,0.0011021937,0.00016131521],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12681471,0.0013420708,0.14478806,0.009007979,0.011747866,0.003886745,0.0008352584,0.35744658,0.0044122087,0.010096036,0.007236709,0.3223858],"study_design_scores_gemma":[0.025069311,0.038068246,0.38208395,0.0044810222,0.02795296,0.010031712,0.0015194854,0.4798328,0.0025229284,0.00993545,0.017933285,0.00056880363],"about_ca_topic_score_codex":0.01529983,"about_ca_topic_score_gemma":0.011207357,"teacher_disagreement_score":0.01529983,"about_ca_system_score_codex":0.0055799573,"about_ca_system_score_gemma":0.0011887788,"threshold_uncertainty_score":0.04048568},"labels":[],"label_agreement":null},{"id":"W2004203873","doi":"10.1016/j.jval.2011.02.356","title":"PSY23 ECONOMIC EVALUATION OF ERYTHROPOIESIS STIMULATING AGENTS IN CRITICALLY ILL TRAUMA PATIENTS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Randomized controlled trial; Population; Intensive care medicine; Emergency medicine; Critically ill; Economic evaluation; Relative risk; Intensive care unit; Cost–benefit analysis; Quality-adjusted life year; Cost effectiveness; Surgery; Internal medicine; Confidence interval; Risk analysis (engineering); Environmental health","score_opus":0.4413554712897895,"score_gpt":0.4875394786313302,"score_spread":0.046184007341540656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004203873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9319655,0.03678816,0.002350369,0.0062156743,0.0004398356,0.002389332,0.0048691775,0.000039970222,0.014942015],"genre_scores_gemma":[0.99215347,0.0045619793,0.0009644369,0.00026991984,0.00007629917,0.0004906943,0.00077295065,0.0000065480926,0.0007036554],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9942958,0.004514578,0.0003080056,0.00011525982,0.0004546405,0.00031160982],"domain_scores_gemma":[0.991927,0.005322441,0.0011762668,0.0001684808,0.00054194644,0.0008638297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005295034,0.00078929117,0.0015355189,0.0011720167,0.00032279143,0.0018135027,0.0005511619,0.0009247102,0.0065622753],"category_scores_gemma":[0.024072057,0.00030296127,0.0029891373,0.0011297707,0.00048319323,0.00079961447,0.00081150007,0.0014049694,0.00021954167],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4927476,0.005021677,0.05059781,0.006548052,0.015533246,0.0006799072,0.00020271004,0.09325612,0.0014806855,0.010897241,0.009109124,0.3139259],"study_design_scores_gemma":[0.18963271,0.2563514,0.243524,0.008746802,0.03546982,0.0019944275,0.002314692,0.18505405,0.006467099,0.015849473,0.054163434,0.00043198938],"about_ca_topic_score_codex":0.0059693162,"about_ca_topic_score_gemma":0.004122964,"teacher_disagreement_score":0.0065622753,"about_ca_system_score_codex":0.005359169,"about_ca_system_score_gemma":0.004835824,"threshold_uncertainty_score":0.038883686},"labels":[],"label_agreement":null},{"id":"W2004686712","doi":"10.1111/j.1524-4733.2009.00523.x","title":"Challenges of Patient-Reported Outcome Assessment in Hemophilia Care—a State of the Art Review","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"Medicine; Quality of life (healthcare); Perspective (graphical); Health care; Patient-reported outcome; Disease; MEDLINE; Outcomes research; Inclusion (mineral); Family medicine; Alternative medicine; Nursing; Psychology","score_opus":0.1379055901142577,"score_gpt":0.41872518914176254,"score_spread":0.28081959902750486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004686712","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036346177,0.9267101,0.0040387493,0.062394623,0.0009253847,0.000089416746,0.00011610341,0.000030240224,0.0020607887],"genre_scores_gemma":[0.09089712,0.87930375,0.013575778,0.01002428,0.0050404263,0.00039360477,0.0003046053,0.00003631526,0.00042403737],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.941914,0.036402546,0.009494788,0.001629107,0.0097176805,0.00084179506],"domain_scores_gemma":[0.59748363,0.3481742,0.015300282,0.0031871912,0.03348828,0.0023664387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11414217,0.0008179531,0.0058926023,0.0032947375,0.0011740895,0.009067527,0.0043484536,0.004500894,0.0018326968],"category_scores_gemma":[0.17383432,0.0007372156,0.0016456633,0.004286537,0.0036465882,0.009314275,0.0032297263,0.004978437,0.00059190945],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018991633,0.00020443484,0.015884722,0.008658091,0.00047867146,0.00018105515,0.0011470682,0.00047058077,0.00008811134,0.005525271,0.016438024,0.9507341],"study_design_scores_gemma":[0.00058764435,0.0024278294,0.089356095,0.19617656,0.004927,0.008435641,0.026409505,0.016483488,0.0015365169,0.083302654,0.5693242,0.0010329523],"about_ca_topic_score_codex":0.004526173,"about_ca_topic_score_gemma":0.0086742425,"teacher_disagreement_score":0.11414217,"about_ca_system_score_codex":0.0031450223,"about_ca_system_score_gemma":0.010083916,"threshold_uncertainty_score":0.6036487},"labels":[],"label_agreement":null},{"id":"W2004994781","doi":"10.1016/j.jval.2014.01.010","title":"Sharing Risk between Payer and Provider by Leasing Health Technologies: An Affordable and Effective Reimbursement Strategy for Innovative Technologies?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research","keywords":"Reimbursement; Health technology; Payment; Business; Health care; Cost sharing; Actuarial science; Risk analysis (engineering); Finance; Medicine; Economics; Nursing","score_opus":0.3155536276160359,"score_gpt":0.4309103615139781,"score_spread":0.11535673389794221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004994781","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18651266,0.0097350115,0.23495881,0.47943056,0.0020806193,0.000653102,0.000674779,0.0006671078,0.08528739],"genre_scores_gemma":[0.96699923,0.0012016864,0.01487602,0.009924756,0.0019237649,0.00013694436,0.00007778641,0.000048197082,0.004811585],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9810647,0.010557254,0.0009004819,0.0016242268,0.0038503676,0.0020029321],"domain_scores_gemma":[0.92805165,0.046041448,0.012507225,0.00731707,0.0028172205,0.003265338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023414284,0.0009962019,0.001948112,0.0014009485,0.0015484757,0.010648476,0.003112732,0.014087715,0.015756266],"category_scores_gemma":[0.092071615,0.0008332736,0.0015867453,0.0013113425,0.004981147,0.016212627,0.004114407,0.0076186685,0.0015182319],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007718309,0.0011075954,0.02000359,0.0003431014,0.0006940925,0.000786571,0.0012593925,0.015860789,0.0013312178,0.66181946,0.048778784,0.24724352],"study_design_scores_gemma":[0.00063556444,0.0006172163,0.0089795785,0.0007439857,0.00046390636,0.00087595463,0.0013816118,0.058760878,0.0010891008,0.8932506,0.032950427,0.00025131486],"about_ca_topic_score_codex":0.0037400227,"about_ca_topic_score_gemma":0.003608623,"teacher_disagreement_score":0.023414284,"about_ca_system_score_codex":0.004127158,"about_ca_system_score_gemma":0.008157641,"threshold_uncertainty_score":0.12382805},"labels":[],"label_agreement":null},{"id":"W2005055126","doi":"10.1016/j.jval.2014.08.2332","title":"Resources Utilization for the Investigation of Pulmonary Nodules in a University Hospital Center in Quebec, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Nodule (geology); Thoracoscopy; Thoracotomy; Solitary pulmonary nodule; Lung cancer screening; Radiology; Lung; Medical record; Surgery; Internal medicine","score_opus":0.025447363524502182,"score_gpt":0.253704586114502,"score_spread":0.22825722258999978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005055126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98456246,0.001469607,0.00016538583,0.0047036842,0.000041884257,0.00011289892,0.0033035555,0.00003141228,0.0056090695],"genre_scores_gemma":[0.99579585,0.00061442197,0.0002550134,0.00077496277,0.000019514617,0.000021568436,0.0006017533,0.000008713506,0.0019083689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990024,0.000118481126,0.000065223285,0.00009340719,0.00022204051,0.0004985322],"domain_scores_gemma":[0.9960944,0.00028148494,0.00056259223,0.000039026956,0.0009449372,0.0020775765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039111264,0.00029418367,0.000327888,0.0008392903,0.0034009363,0.0017254805,0.0016708035,0.00082307984,0.0045984993],"category_scores_gemma":[0.002185933,0.00038049888,0.00047222403,0.0021824765,0.0008090089,0.00039949515,0.0009780895,0.0011753018,0.0002864141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014178365,0.00019529602,0.9709778,0.00013597631,0.0001058504,0.0012625641,0.0014434702,0.0010096015,0.00053286884,0.00047754598,0.010744817,0.012972458],"study_design_scores_gemma":[0.0000254525,0.0000538282,0.9919103,0.00011452758,0.000033981734,0.00024346556,0.0044542127,0.0013888142,0.000085352134,0.000060110884,0.0016044567,0.00002564061],"about_ca_topic_score_codex":0.9958111,"about_ca_topic_score_gemma":0.99827516,"teacher_disagreement_score":0.073819,"about_ca_system_score_codex":0.073819,"about_ca_system_score_gemma":0.07592291,"threshold_uncertainty_score":0.53559685},"labels":[],"label_agreement":null},{"id":"W2005078632","doi":"10.1016/s1098-3015(10)73341-6","title":"PCN105 GUIDELINES AND CANCER SCREENING IN THE UNITED STATES AND CANADIAN HEALTH SYSTEMS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Family medicine; Medicine; Environmental health; Internal medicine","score_opus":0.13371601050493395,"score_gpt":0.32103323820038426,"score_spread":0.1873172276954503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005078632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7122383,0.025243571,0.00055765506,0.10574148,0.0005402811,0.0002075454,0.08832146,0.000100551515,0.06704924],"genre_scores_gemma":[0.97542226,0.0054136966,0.0003568553,0.0025209386,0.000116478055,0.000041060826,0.01073256,0.000019921079,0.0053762095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958949,0.0005515579,0.00026672197,0.00022189258,0.0015105108,0.0015544177],"domain_scores_gemma":[0.9753541,0.004101315,0.0049469043,0.00033269273,0.009824044,0.005441065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024609517,0.00022784965,0.000509066,0.0028828362,0.0018831374,0.003035342,0.0017007199,0.0018579741,0.0064791623],"category_scores_gemma":[0.028712276,0.00036672517,0.0012675226,0.009666668,0.00090543006,0.0011028197,0.0010519165,0.0023654238,0.00024795238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030921202,0.0001637271,0.84812796,0.00020488308,0.00024625132,0.00017827886,0.0008108721,0.0038962434,0.000030849085,0.011802949,0.102151275,0.032077573],"study_design_scores_gemma":[0.000062914034,0.0000347674,0.9778399,0.00021528061,0.00013271873,0.000090791335,0.0015781564,0.002752444,0.000037999722,0.0014634447,0.015750874,0.00004072085],"about_ca_topic_score_codex":0.9965161,"about_ca_topic_score_gemma":0.99827063,"teacher_disagreement_score":0.92747086,"about_ca_system_score_codex":0.07252913,"about_ca_system_score_gemma":0.08941505,"threshold_uncertainty_score":0.52623814},"labels":[],"label_agreement":null},{"id":"W2005158100","doi":"10.1016/s1098-3015(10)70028-0","title":"CA4 THE EARLY CLINICAL AND ECONOMIC BENEFITS OF ATORVASTATIN IN A CANADIAN SETTING","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Economics; Medicine; Internal medicine","score_opus":0.052219693821782334,"score_gpt":0.3114592046918989,"score_spread":0.2592395108701166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005158100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8387608,0.011913845,0.00028450816,0.07156939,0.00041552956,0.00017247481,0.00971905,0.00003692738,0.067127414],"genre_scores_gemma":[0.9897188,0.002724695,0.00037458105,0.001641724,0.000116877876,0.0000192221,0.00083490036,0.00001208753,0.0045571537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819225,0.00027738346,0.00006561529,0.00009560197,0.0005021741,0.0008670797],"domain_scores_gemma":[0.99442685,0.0005594317,0.00045132334,0.00007620557,0.0020898585,0.002396391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011031028,0.00035537576,0.00043463963,0.0011412433,0.0045478386,0.0027564268,0.0008964835,0.001150329,0.00896413],"category_scores_gemma":[0.0076997518,0.0002494498,0.00074895774,0.003062415,0.00086407695,0.0004892477,0.00071694294,0.0019589895,0.00025526964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064839385,0.00082254776,0.7417277,0.00049498846,0.00058193936,0.0026261227,0.0019371535,0.0025946428,0.0009704616,0.012788977,0.103526734,0.12544483],"study_design_scores_gemma":[0.0005827176,0.00023637534,0.96099335,0.00034854756,0.00046811244,0.0005195025,0.00422329,0.0020402174,0.0003227466,0.0015269292,0.028579768,0.00015833465],"about_ca_topic_score_codex":0.99554634,"about_ca_topic_score_gemma":0.99819225,"teacher_disagreement_score":0.07664947,"about_ca_system_score_codex":0.07664947,"about_ca_system_score_gemma":0.122063816,"threshold_uncertainty_score":0.55613345},"labels":[],"label_agreement":null},{"id":"W2005161350","doi":"10.1016/j.jval.2012.03.1309","title":"PIN33 Pharmacoeconomic Evaluation of 13-Valent Pneumococcal Conjugate and 23-Valent Pneumococcal Polysaccharide Vaccine in Canadian Adults","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Pfizer (Canada); Institute of Health Economics","funders":"","keywords":"Medicine; Pneumococcal conjugate vaccine; Pneumococcal polysaccharide vaccine; Pneumococcal pneumonia; Streptococcus pneumoniae; Vaccination; Population; Herd immunity; Pneumococcal disease; Conjugate vaccine; Pneumonia; Pediatrics; Meningitis; Serotype; Intensive care medicine; Immunology; Internal medicine; Environmental health; Immunization; Biology; Antibiotics; Microbiology","score_opus":0.041745774133618914,"score_gpt":0.33577031721905665,"score_spread":0.29402454308543774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005161350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688186,0.008139881,0.00018874943,0.0024038486,0.00016544783,0.0009174286,0.0077088755,0.00004193442,0.01161515],"genre_scores_gemma":[0.9932423,0.0023326161,0.00037184186,0.0007852012,0.00006913835,0.00016428478,0.0016654955,0.000006019743,0.0013630646],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99778396,0.0003954641,0.00012267988,0.00018633873,0.0009834829,0.0005281796],"domain_scores_gemma":[0.99847394,0.00023937228,0.00023864607,0.000031461303,0.0005895073,0.00042706146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015714555,0.0007968522,0.0013041346,0.0005235224,0.0009465366,0.00092222716,0.0007593608,0.00085127796,0.0028375767],"category_scores_gemma":[0.004967873,0.00032935233,0.0015583957,0.0017695802,0.00045288447,0.0004422514,0.00039105432,0.0009820884,0.00020242935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35975897,0.008033632,0.32898644,0.0024979315,0.0038469678,0.00093814085,0.00088868255,0.009109156,0.0036379348,0.0016188456,0.02172041,0.2589629],"study_design_scores_gemma":[0.013995419,0.032178774,0.93248725,0.0002499764,0.0028269219,0.00026848496,0.0006050321,0.004149085,0.0012768485,0.00014895815,0.011708653,0.000104685874],"about_ca_topic_score_codex":0.9176477,"about_ca_topic_score_gemma":0.95087427,"teacher_disagreement_score":0.08235228,"about_ca_system_score_codex":0.03266982,"about_ca_system_score_gemma":0.04902046,"threshold_uncertainty_score":0.23703724},"labels":[],"label_agreement":null},{"id":"W2005279725","doi":"10.1016/j.jval.2012.08.1106","title":"PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Neisseria meningitidis; Medicine; Booster (rocketry); Vaccination; Booster dose; Meningococcal disease; Meningococcal vaccine; Incidence (geometry); Cost effectiveness; Pediatrics; Immunization; Immunology; Immune system","score_opus":0.035238139365360764,"score_gpt":0.28721243780360745,"score_spread":0.2519742984382467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005279725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96458167,0.0028871014,0.00092019816,0.0014614159,0.00005993748,0.00048246369,0.016663486,0.000053933676,0.0128898695],"genre_scores_gemma":[0.99110764,0.0009692696,0.00047455114,0.00030663324,0.000009352209,0.00005048476,0.0029363346,0.000012341691,0.00413346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977932,0.00035419004,0.00006686573,0.00016594023,0.00079114037,0.000828772],"domain_scores_gemma":[0.9973929,0.00050583953,0.00021704161,0.000052897827,0.0014530737,0.00037825556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017097107,0.0006492083,0.0010437951,0.0014045454,0.0008205077,0.0018415696,0.0014068546,0.00070646015,0.003788746],"category_scores_gemma":[0.004533716,0.00043208146,0.0014689035,0.0029586835,0.0004217339,0.0003958877,0.000609625,0.0009452362,0.00019951975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022163466,0.0010441055,0.5223474,0.0015925938,0.004038638,0.0025505922,0.0005339117,0.31391224,0.003782973,0.012378077,0.023051644,0.09260438],"study_design_scores_gemma":[0.001276591,0.0032363534,0.83531845,0.00025038945,0.0032012763,0.0006563905,0.00221625,0.13116099,0.0027555386,0.0016176405,0.018146241,0.00016390759],"about_ca_topic_score_codex":0.98645717,"about_ca_topic_score_gemma":0.9803608,"teacher_disagreement_score":0.0723647,"about_ca_system_score_codex":0.0723647,"about_ca_system_score_gemma":0.05273629,"threshold_uncertainty_score":0.52504516},"labels":[],"label_agreement":null},{"id":"W2005425729","doi":"10.1016/j.jval.2011.02.733","title":"PMS48 IMPACT OF ANTI-TNF ON HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ALBERTA, CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Institute of Health Economics","funders":"","keywords":"Medicine; Rheumatoid arthritis; Propensity score matching; Ambulatory; Cohort; TNF inhibitor; Emergency department; Confidence interval; Emergency medicine; Health care; Family medicine; Internal medicine; Adalimumab; Nursing","score_opus":0.023800642146917884,"score_gpt":0.28404052632327254,"score_spread":0.26023988417635463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005425729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831828,0.0028221316,0.00007362981,0.002160226,0.00004899277,0.00005134261,0.0042567463,0.000014183837,0.0073899487],"genre_scores_gemma":[0.9946755,0.0012142961,0.00018287622,0.00033991385,0.000026820822,0.000014521651,0.0013128927,0.0000070516994,0.0022260696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865603,0.00020267989,0.000076204335,0.00006767356,0.0005063121,0.00049111183],"domain_scores_gemma":[0.9974516,0.00023381626,0.00031670777,0.000038157734,0.0012420724,0.00071750575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064874656,0.0002754285,0.0005772994,0.0010364027,0.0019235829,0.0014813268,0.0011353332,0.00059953216,0.0028207118],"category_scores_gemma":[0.0025147733,0.00029130618,0.0007782251,0.0035280455,0.00057110743,0.00025855334,0.00062948465,0.00088760187,0.0002228309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008264578,0.00017453531,0.978782,0.00009780996,0.00020518836,0.0004215021,0.00036126724,0.0010040156,0.00020847567,0.00034635267,0.0042723557,0.01330017],"study_design_scores_gemma":[0.00008143417,0.00005496759,0.9969573,0.000057135832,0.00007804822,0.00009763194,0.00089158566,0.00063433056,0.000042172855,0.000037932467,0.0010526124,0.000014769656],"about_ca_topic_score_codex":0.996876,"about_ca_topic_score_gemma":0.9982114,"teacher_disagreement_score":0.039990697,"about_ca_system_score_codex":0.039990697,"about_ca_system_score_gemma":0.04611503,"threshold_uncertainty_score":0.29015416},"labels":[],"label_agreement":null},{"id":"W2006235275","doi":"10.1016/j.jval.2013.03.348","title":"Responsiveness Of The Face-Q: A New Pro For Facial Aesthetic Paitents","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Patient satisfaction; Medicine; Patient-reported outcome; Significant difference; Mean difference; Facial symmetry; Psychology; Audiology; Orthodontics; Surgery; Internal medicine; Quality of life (healthcare); Developmental psychology","score_opus":0.07493864893221157,"score_gpt":0.34224721310071254,"score_spread":0.26730856416850096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006235275","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11882933,0.012090447,0.42322093,0.02174036,0.004338746,0.0015534193,0.0031197036,0.0064414837,0.40866557],"genre_scores_gemma":[0.6143903,0.006935172,0.272873,0.008592308,0.0025242302,0.0018174924,0.0012425844,0.0018693026,0.08975554],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99622226,0.001736166,0.0001527665,0.0002544983,0.0015010742,0.00013321139],"domain_scores_gemma":[0.990551,0.0057866937,0.00059548224,0.00088454963,0.0016377644,0.0005445022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004997687,0.0008275234,0.0005892192,0.0023630643,0.00077587,0.0028486305,0.0012067978,0.0012018078,0.030733867],"category_scores_gemma":[0.019900082,0.0002478926,0.0009017891,0.0010965243,0.0014009705,0.0031456503,0.0028378614,0.001809118,0.005834172],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068342756,0.00026313172,0.013885414,0.0004964953,0.00006445388,0.00024488804,0.0013647625,0.0008064472,0.0074057938,0.034381203,0.033988692,0.9064153],"study_design_scores_gemma":[0.00040707106,0.0041933875,0.10190139,0.0023368204,0.00055656524,0.012548302,0.0066779074,0.03436877,0.020442124,0.1707328,0.6451227,0.00071212027],"about_ca_topic_score_codex":0.0011301339,"about_ca_topic_score_gemma":0.0016550488,"teacher_disagreement_score":0.030733867,"about_ca_system_score_codex":0.0011676981,"about_ca_system_score_gemma":0.0013299729,"threshold_uncertainty_score":0.10281497},"labels":[],"label_agreement":null},{"id":"W2006311134","doi":"10.1016/j.jval.2013.03.983","title":"Designing a patient preferences survey on specialist referral for total joint replacement patient choice with alternative specifications of the status-quo","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Manitoba; BC Cancer Agency; Concordia Hospital; Dalhousie University; University of Calgary","funders":"","keywords":"Reputation; Referral; Status quo; Medicine; Waiting list; Health care; Patient choice; Family medicine; Operations management; Surgery; Economics; Political science","score_opus":0.3492325743885576,"score_gpt":0.4178022307521056,"score_spread":0.068569656363548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006311134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954608,0.000034240045,0.0011105251,0.00031559615,0.000015856303,0.0006943367,0.00044432777,0.000010044393,0.0019140643],"genre_scores_gemma":[0.9896499,0.000071717375,0.006922267,0.0004402579,0.000016754513,0.0017416422,0.0004798221,0.000007717855,0.00066988985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914892,0.0054662325,0.0012301236,0.00032620822,0.0009069103,0.00058134936],"domain_scores_gemma":[0.9605489,0.029132865,0.004882674,0.0009463939,0.003196839,0.0012923586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016668877,0.00024982158,0.00048149523,0.00095913623,0.0010977617,0.0015810973,0.0003229475,0.000837791,0.0060906014],"category_scores_gemma":[0.042151954,0.0003441049,0.0010730972,0.0011031659,0.0006476667,0.0014833269,0.00084822386,0.0013668265,0.0007574619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003491812,0.007301807,0.8851789,0.00044530368,0.00031688347,0.00027169695,0.016006222,0.0018673727,0.001815346,0.0015027123,0.0038368164,0.077965036],"study_design_scores_gemma":[0.0015360428,0.025660893,0.8628364,0.00031137007,0.00039051764,0.0006560923,0.07286232,0.011854296,0.004369334,0.0027300185,0.01649462,0.00029803143],"about_ca_topic_score_codex":0.0025825151,"about_ca_topic_score_gemma":0.00403778,"teacher_disagreement_score":0.016668877,"about_ca_system_score_codex":0.0018407177,"about_ca_system_score_gemma":0.0023278145,"threshold_uncertainty_score":0.088154495},"labels":[],"label_agreement":null},{"id":"W2006347360","doi":"10.1016/j.jval.2013.08.597","title":"A Prospective Time and Motion Analysis Comparing Intravenous (IV) Vesus Subcutaneous (SC) Bortezomib in Patients with Multiple Myeloma (MM)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Premedication; Vial; Clinical trial; Surgery; Internal medicine","score_opus":0.017021210463844503,"score_gpt":0.2620738018861646,"score_spread":0.24505259142232008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006347360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990777,0.00030243708,0.0001132142,0.000011765314,0.000004489942,0.000018196217,0.0002254683,0.0000020880946,0.00024460143],"genre_scores_gemma":[0.99919266,0.00007307,0.00015603019,0.000017903125,0.000008927942,0.00001831479,0.00037496723,0.0000014573992,0.0001566494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997427,0.000074279385,0.000029845272,0.00006688247,0.000026146681,0.000060219063],"domain_scores_gemma":[0.9992994,0.00016094829,0.00026367852,0.000048839393,0.00007405495,0.0001530256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041324974,0.00031253835,0.00046782926,0.00060888694,0.00026627418,0.0005151537,0.00022232096,0.0003696966,0.001583703],"category_scores_gemma":[0.0010535145,0.0001679944,0.00060628715,0.00082806725,0.0001846854,0.0003363119,0.00041815362,0.00041197785,0.00021429153],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038076326,0.00044340183,0.9422017,0.00006903437,0.00045800733,0.00012971406,0.00010600652,0.0004314468,0.0036441619,0.00007715603,0.00018681386,0.014176369],"study_design_scores_gemma":[0.0007518984,0.009547194,0.9865688,0.000014163912,0.00044250794,0.00024105496,0.00024790227,0.00097148214,0.0006561615,0.0000621107,0.00048117663,0.00001554833],"about_ca_topic_score_codex":0.0025563464,"about_ca_topic_score_gemma":0.0024575172,"teacher_disagreement_score":0.0025563464,"about_ca_system_score_codex":0.00039213803,"about_ca_system_score_gemma":0.0003367306,"threshold_uncertainty_score":0.0052980185},"labels":[],"label_agreement":null},{"id":"W2006395984","doi":"10.1016/s1098-3015(10)67196-3","title":"PR2 PERCEIVED UTILITY OF HEALTH STATES INDUCED BY CHRONIC HEPATITIS B: ESTIMATES FROM UNINFECTED PERSONS IN CANADA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic hepatitis; Environmental health; Medicine; Virology; Gerontology","score_opus":0.23937722452857832,"score_gpt":0.3778678338727331,"score_spread":0.13849060934415477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006395984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895158,0.00043442711,0.00016329375,0.00026198095,0.000006606884,0.00004455696,0.008091756,0.0000074762215,0.0014741482],"genre_scores_gemma":[0.99432963,0.0003725984,0.00015256586,0.000045149467,0.0000041845465,0.000013869868,0.003993262,0.0000039055817,0.001084977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992269,0.00020601723,0.00007337628,0.00008120619,0.00020985508,0.0002026301],"domain_scores_gemma":[0.9947773,0.0010972116,0.00076186244,0.00021005076,0.0019875232,0.0011659436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013682533,0.00041115552,0.00047660992,0.0012009678,0.0012597003,0.0011653894,0.0010404479,0.00045879456,0.0024770752],"category_scores_gemma":[0.006579485,0.00025390886,0.0014318759,0.0028466405,0.00059977133,0.00040970353,0.0008490203,0.0012407039,0.00018304463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032098306,0.000077815814,0.9920236,0.000040272218,0.00018060138,0.000066359804,0.00039756295,0.0017542446,0.000052259307,0.0002486556,0.0012076914,0.0036299792],"study_design_scores_gemma":[0.000026916035,0.000044118748,0.99669504,0.000015139014,0.00006107164,0.000035558387,0.00070609996,0.0018042357,0.00004690937,0.00005447039,0.0004964808,0.000013985338],"about_ca_topic_score_codex":0.9951119,"about_ca_topic_score_gemma":0.99204344,"teacher_disagreement_score":0.018754935,"about_ca_system_score_codex":0.018754935,"about_ca_system_score_gemma":0.0133082885,"threshold_uncertainty_score":0.13607723},"labels":[],"label_agreement":null},{"id":"W2006608952","doi":"10.1016/j.jval.2010.09.004","title":"Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Population Health Research Institute; McMaster University; Hospital for Sick Children; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; GERD; Randomized controlled trial; Cost–utility analysis; Heartburn; Quality of life (healthcare); Nissen fundoplication; Quality-adjusted life year; Physical therapy; Cost effectiveness; Reflux; Economic evaluation; Internal medicine; Disease","score_opus":0.06775329233822375,"score_gpt":0.3586556570420004,"score_spread":0.2909023647037767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006608952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97705406,0.013585136,0.0017231888,0.0010544194,0.0009256777,0.0029737141,0.0011773561,0.00008207493,0.001424317],"genre_scores_gemma":[0.9941275,0.002004531,0.0010314393,0.00030157293,0.00027999617,0.0011913093,0.0005126192,0.000012931183,0.0005380542],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99494886,0.0035657305,0.00033839385,0.00047914742,0.000291772,0.00037613732],"domain_scores_gemma":[0.99261594,0.0044336887,0.0014960204,0.0003927729,0.00027094595,0.00079063175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005236847,0.00306644,0.0056601283,0.0012607191,0.0007729867,0.0020394295,0.0018203858,0.0036955713,0.007063053],"category_scores_gemma":[0.010476938,0.0018255902,0.009005862,0.0010483844,0.002987934,0.0027282164,0.0012872644,0.005032034,0.000483595],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9914684,0.0014991756,0.00055887096,0.0004367041,0.0019735282,0.000022888873,0.000016279113,0.00066092366,0.0001470814,0.00008583618,0.000093127914,0.003037222],"study_design_scores_gemma":[0.9413063,0.047860056,0.002221202,0.00011032526,0.005120285,0.0000446312,0.00005074809,0.0023390641,0.00025520992,0.00039184617,0.0002577771,0.000042696858],"about_ca_topic_score_codex":0.003511879,"about_ca_topic_score_gemma":0.0022907483,"teacher_disagreement_score":0.007063053,"about_ca_system_score_codex":0.00289653,"about_ca_system_score_gemma":0.0018009149,"threshold_uncertainty_score":0.027695417},"labels":[],"label_agreement":null},{"id":"W2006764012","doi":"10.1016/j.jval.2012.03.1044","title":"PIH12 Budget Impact Analysis of Adding a New Fixed-Dose Combination Therapy of Dutasteride and Tamsulosin to the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Tamsulosin; Dutasteride; Doxazosin; Medicine; Urology; Alfuzosin; Population; Fixed-dose combination; Internal medicine; Hyperplasia; Prostate; Lower urinary tract symptoms","score_opus":0.17197680642209104,"score_gpt":0.3917688298033008,"score_spread":0.21979202338120976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006764012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9361478,0.008166155,0.0024830294,0.005292456,0.0001977916,0.0025466227,0.025935832,0.00016787124,0.019062366],"genre_scores_gemma":[0.9908783,0.0009088118,0.0010661073,0.00041364698,0.000032216903,0.00029197332,0.0031083112,0.0000141809205,0.0032864297],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9940958,0.0031498235,0.0001940499,0.00026632086,0.0006943524,0.001599726],"domain_scores_gemma":[0.992543,0.00314961,0.00085034635,0.00017907818,0.0018653651,0.0014126553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056153084,0.0011990299,0.0023848768,0.0014946508,0.0010145144,0.0019617996,0.0025340854,0.0012095406,0.009152271],"category_scores_gemma":[0.012189935,0.00086429564,0.0030070937,0.0027085892,0.000930332,0.0005742438,0.001010657,0.001555619,0.00031984178],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069108605,0.0026775596,0.05191159,0.001290802,0.005262436,0.00046284375,0.00013735976,0.7902449,0.0011922471,0.0032658617,0.012229184,0.062216576],"study_design_scores_gemma":[0.029826121,0.016204072,0.26724097,0.0007195838,0.010889859,0.00028411116,0.0010647959,0.65577316,0.0013914827,0.0018473756,0.014421337,0.00033718228],"about_ca_topic_score_codex":0.96988714,"about_ca_topic_score_gemma":0.9622081,"teacher_disagreement_score":0.07855251,"about_ca_system_score_codex":0.07855251,"about_ca_system_score_gemma":0.058089808,"threshold_uncertainty_score":0.569941},"labels":[],"label_agreement":null},{"id":"W2006914242","doi":"10.1016/j.jval.2012.03.348","title":"PMD8 Efficacy of Systemic Hyperbaric Oxygen Therapy for Non-Healing Diabetic Ulcers of the Lower Limb: Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Amputation; Observational study; Randomized controlled trial; Diabetes mellitus; Diabetic foot; Relative risk; Cochrane Library; Hyperbaric oxygen; MEDLINE; Meta-analysis; Systematic review; Clinical trial; Internal medicine; Surgery; Confidence interval","score_opus":0.06908462568192623,"score_gpt":0.34239596643679754,"score_spread":0.2733113407548713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006914242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.050254524,0.9462509,0.0011137576,0.00028234746,0.0005280416,0.0003835566,0.00058667397,0.000049773498,0.0005505067],"genre_scores_gemma":[0.73260313,0.26228106,0.0020345068,0.00092684844,0.0004870724,0.00058289035,0.0005189662,0.000032128817,0.00053341],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9937651,0.003352628,0.0012454024,0.00076873205,0.0006665669,0.00020142701],"domain_scores_gemma":[0.987316,0.009476266,0.001906908,0.00049215456,0.0005740122,0.00023458377],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.008573513,0.0018557141,0.013630776,0.0021009143,0.0005015793,0.0017530092,0.0014537624,0.0018486407,0.0030999903],"category_scores_gemma":[0.022222346,0.0011536827,0.026483105,0.0025452322,0.00073664647,0.0011295477,0.0012094191,0.002010658,0.0002235229],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020311696,0.0000683019,0.0057546045,0.11680198,0.84244347,0.00010427438,0.00008426763,0.00035778838,0.00039663698,0.000067005174,0.00035758028,0.013252389],"study_design_scores_gemma":[0.00585609,0.00090675725,0.0057371026,0.0040170243,0.9822364,0.00007588816,0.00004132536,0.00016737122,0.00015729941,0.00010254369,0.0006817621,0.000020458237],"about_ca_topic_score_codex":0.0042260857,"about_ca_topic_score_gemma":0.008273003,"teacher_disagreement_score":0.99142647,"about_ca_system_score_codex":0.0013488759,"about_ca_system_score_gemma":0.0010680895,"threshold_uncertainty_score":0.04534161},"labels":[],"label_agreement":null},{"id":"W2007128909","doi":"10.1016/j.jval.2013.03.1151","title":"Effect Of Certolizumab Pegol On The Multiple Facets Of Psoriatic Arthritis As Reported By Patients: 24-Week Patient Reported Outcome Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Placebo; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Psoriasis; Physical therapy; Arthritis; Etanercept; Rheumatoid arthritis; Dermatology","score_opus":0.04403238897080384,"score_gpt":0.3055460466635542,"score_spread":0.26151365769275037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007128909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919938,0.003955453,0.00052345847,0.00035368954,0.0002681501,0.0014610648,0.0006248078,0.00010015546,0.00071933965],"genre_scores_gemma":[0.99282724,0.0019498272,0.00097614224,0.0007302424,0.00045646614,0.0013945776,0.0005865461,0.000031340835,0.0010477058],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987337,0.00066664384,0.00009300949,0.00020823911,0.00012049645,0.00017790076],"domain_scores_gemma":[0.9975224,0.0010050661,0.0005691428,0.00023045979,0.00015068198,0.00052221084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028395553,0.0020527148,0.004720759,0.0006460031,0.0008097547,0.0012023075,0.0012843503,0.0037756,0.0036644398],"category_scores_gemma":[0.0026690809,0.0010715813,0.0034220943,0.00054652937,0.002125298,0.0014774421,0.0005191027,0.0040158816,0.0007364215],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9807084,0.007925448,0.0005233398,0.0003019282,0.0006537247,0.000029166518,0.000042842254,0.00016790561,0.002069236,0.000021042544,0.00018690861,0.007369998],"study_design_scores_gemma":[0.91441697,0.081228144,0.0028374654,0.000016328135,0.0005441425,0.000020009255,0.000020250158,0.00022175038,0.00048956316,0.000051251493,0.00013492387,0.0000191069],"about_ca_topic_score_codex":0.0013051131,"about_ca_topic_score_gemma":0.0014742216,"teacher_disagreement_score":0.004720759,"about_ca_system_score_codex":0.0006236412,"about_ca_system_score_gemma":0.0010318687,"threshold_uncertainty_score":0.015017152},"labels":[],"label_agreement":null},{"id":"W2007252444","doi":"10.1016/s1098-3015(10)62293-0","title":"PNL20 UTILIZATION OF IMMUNOMODULATORY DRUG THERAPIES IN MULTIPLE SCLEROSIS (MS) IN NOVA SCOTIA, CANADA 1998—2003","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Multiple sclerosis; Nova (rocket); Drug; Medicine; Pharmacology; Geography; Psychiatry; Engineering; Archaeology; Aeronautics","score_opus":0.10492736208862953,"score_gpt":0.3177903009562386,"score_spread":0.2128629388676091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007252444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91793644,0.0150295235,0.00048724335,0.008649446,0.0003106932,0.0003111507,0.030807141,0.000108284825,0.02636019],"genre_scores_gemma":[0.9605059,0.00724058,0.0009811221,0.0026480672,0.00010090956,0.00012501028,0.005952103,0.000034788536,0.022411589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987729,0.00011123726,0.00013219733,0.00010132548,0.0004747583,0.0004075925],"domain_scores_gemma":[0.9955646,0.00016937802,0.0008425713,0.00004024723,0.0021680293,0.0012153026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057753443,0.00031980823,0.00044263262,0.0019069975,0.001954701,0.0013641742,0.0013874143,0.0006741924,0.002415743],"category_scores_gemma":[0.0024515407,0.00036188663,0.0004945226,0.0037893343,0.00056830636,0.00037769263,0.0008915863,0.0008915926,0.00038534202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014089808,0.00019393404,0.9000231,0.0008815491,0.0002475279,0.0021879007,0.0014649602,0.0013110689,0.0027191702,0.001413995,0.025302805,0.06284497],"study_design_scores_gemma":[0.000050968247,0.00008257608,0.97981334,0.00016182728,0.000050671053,0.0004024339,0.0007003248,0.00045657888,0.0003028451,0.000024581588,0.017937856,0.0000160222],"about_ca_topic_score_codex":0.9966785,"about_ca_topic_score_gemma":0.9982634,"teacher_disagreement_score":0.055072546,"about_ca_system_score_codex":0.055072546,"about_ca_system_score_gemma":0.08552869,"threshold_uncertainty_score":0.39958113},"labels":[],"label_agreement":null},{"id":"W2007354604","doi":"10.1016/j.jval.2014.03.1279","title":"Antidepressant adherence in older adults and different quality of life outcome measures","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Treatment and Access","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Quality of life (healthcare); Anxiety; Medicine; Depression (economics); Mental health; Antidepressant; Polypharmacy; Psychiatry; Visual analogue scale; Population; Clinical psychology; Gerontology; Psychology; Physical therapy; Internal medicine","score_opus":0.15862155233194938,"score_gpt":0.43420717676112586,"score_spread":0.27558562442917645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007354604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99788123,0.001062411,0.00004674798,0.0001176085,0.000011648862,0.00000792645,0.00026399427,0.000001695833,0.0006066448],"genre_scores_gemma":[0.99909556,0.00023614183,0.00005413597,0.000073422,0.000017827955,0.000006478322,0.00032578438,0.0000011040757,0.0001894399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988827,0.00039076776,0.00023895674,0.00013944524,0.00017560719,0.0001723996],"domain_scores_gemma":[0.99481404,0.0017211635,0.0023386846,0.0002512046,0.00042541392,0.00044947577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020165471,0.00029040937,0.0007526575,0.0009078896,0.0004580727,0.0011879693,0.00029954096,0.0010437429,0.0013610861],"category_scores_gemma":[0.010856469,0.0002658658,0.001558375,0.0012947761,0.0003053367,0.00087597873,0.0007506233,0.0010785521,0.0001229805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040424956,0.00008969814,0.9962542,0.000023347824,0.00039372317,0.00002678626,0.000122039724,0.000040724917,0.000038103353,0.000030434809,0.00006408071,0.0025125095],"study_design_scores_gemma":[0.000015884658,0.000104688086,0.9993144,0.000013738743,0.0001355121,0.00003738134,0.0001282971,0.00012210678,0.000015637539,0.00005066239,0.000057035184,0.0000046016303],"about_ca_topic_score_codex":0.009896531,"about_ca_topic_score_gemma":0.017753204,"teacher_disagreement_score":0.009896531,"about_ca_system_score_codex":0.000571558,"about_ca_system_score_gemma":0.0002752471,"threshold_uncertainty_score":0.019677818},"labels":[],"label_agreement":null},{"id":"W2007554762","doi":"10.1016/j.jval.2014.03.415","title":"Have New Therapies Changed the Face of Metastatic Castrate-Resistant Prostate Cancer Treatment in Canada?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Cabazitaxel; Docetaxel; Medicine; Prostate cancer; Abiraterone acetate; Denosumab; Oncology; Internal medicine; Abiraterone; Ketoconazole; Zoledronic acid; Prednisone; Taxane; Regimen; Chemotherapy; Cancer; Androgen deprivation therapy; Androgen receptor; Breast cancer; Dermatology","score_opus":0.09755681097515691,"score_gpt":0.3626020282345248,"score_spread":0.2650452172593679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007554762","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.099283785,0.033794105,0.00026194725,0.82521486,0.0022648997,0.000035887813,0.001734255,0.000035615325,0.03737459],"genre_scores_gemma":[0.8527985,0.034842346,0.0011184546,0.0971457,0.0018968831,0.000025492327,0.0010118288,0.0000916713,0.011069013],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99524385,0.00065441855,0.00019570923,0.00022388755,0.002056213,0.0016259275],"domain_scores_gemma":[0.9805161,0.0018736064,0.0019021922,0.00019289329,0.0074237105,0.008091568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029110585,0.00019765127,0.00063041283,0.0010637809,0.0052207992,0.0054090573,0.0019145437,0.0026296785,0.012522565],"category_scores_gemma":[0.016560996,0.0002898114,0.0007138675,0.0032600204,0.0038429291,0.0019279692,0.0012771708,0.005396238,0.00039791444],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015637107,0.0003879939,0.18136698,0.0014187732,0.00040812048,0.001592932,0.006006877,0.0024596201,0.0010383334,0.063157715,0.3905758,0.35002312],"study_design_scores_gemma":[0.00045478813,0.00035915783,0.38904268,0.0035426721,0.00055169617,0.0015292468,0.025851352,0.0023748397,0.0009862371,0.014967958,0.5599715,0.00036791843],"about_ca_topic_score_codex":0.98453057,"about_ca_topic_score_gemma":0.995231,"teacher_disagreement_score":0.10683415,"about_ca_system_score_codex":0.10683415,"about_ca_system_score_gemma":0.21941538,"threshold_uncertainty_score":0.77513963},"labels":[],"label_agreement":null},{"id":"W2007566316","doi":"10.1016/s1098-3015(10)62659-9","title":"PCV18 USE OF β-BLOCKERS FOR TREATING HEART FAILURE AMONG THE ELDERLY IN BRITISH COLUMBIA, CANADA, 1993-2001","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Gerontology; Internal medicine","score_opus":0.05280241733596275,"score_gpt":0.362250066577057,"score_spread":0.30944764924109425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007566316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475651,0.0073157786,0.00019384506,0.0022999942,0.00012987336,0.00010010265,0.034413595,0.000059801107,0.007921926],"genre_scores_gemma":[0.9827603,0.0042468156,0.00024463033,0.0006813918,0.000057805068,0.00004373341,0.007070743,0.0000173313,0.0048773796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989334,0.00006756942,0.00013265127,0.00012541012,0.00045234466,0.00028861483],"domain_scores_gemma":[0.9961998,0.00017891059,0.0007207938,0.000056341934,0.0020705666,0.00077361823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005713197,0.00040913257,0.00060921203,0.0015573915,0.001809999,0.0013814917,0.0020166747,0.0008867588,0.0016745182],"category_scores_gemma":[0.0029135938,0.000471419,0.0007232447,0.004741582,0.00045703395,0.00046541286,0.00055111595,0.0013777404,0.0002978633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019803758,0.000055836223,0.98626155,0.00011602228,0.00009888088,0.00014057038,0.0003302297,0.00016641042,0.00011386179,0.00007003524,0.0054404903,0.007007988],"study_design_scores_gemma":[0.000016444059,0.00001872084,0.9976184,0.000051212715,0.00005457464,0.00008276234,0.00047212426,0.00018144435,0.00004527254,0.000008604046,0.0014424403,0.000007931168],"about_ca_topic_score_codex":0.99543494,"about_ca_topic_score_gemma":0.99759394,"teacher_disagreement_score":0.023607608,"about_ca_system_score_codex":0.023607608,"about_ca_system_score_gemma":0.02989376,"threshold_uncertainty_score":0.17128599},"labels":[],"label_agreement":null},{"id":"W2007708250","doi":"10.1016/j.jval.2011.08.771","title":"PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); University of Toronto; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Atrial fibrillation; Emergency medicine; Ambulatory; Healthcare Cost and Utilization Project; Emergency department; Hospital admission; Medical emergency; Pediatrics; Health care; Internal medicine","score_opus":0.3089192706438901,"score_gpt":0.3535026320569011,"score_spread":0.044583361413011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007708250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9351357,0.007812114,0.00022312315,0.005272724,0.00017278294,0.00010405324,0.036164552,0.000049469912,0.01506539],"genre_scores_gemma":[0.9900171,0.002069976,0.00010853421,0.00032895833,0.00005771282,0.000016831384,0.0055519403,0.000010944571,0.0018380188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983708,0.00013501475,0.00016937923,0.0001362408,0.0005842193,0.0006042856],"domain_scores_gemma":[0.9935175,0.00050319795,0.0015910169,0.00009592964,0.002569634,0.0017228674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043889074,0.0003593781,0.0007574712,0.0027310331,0.0018459784,0.0023169497,0.0013648454,0.00094311003,0.0050603943],"category_scores_gemma":[0.0065216743,0.00043737842,0.0016097748,0.0059643527,0.00069332856,0.0005085352,0.0010627335,0.0022299488,0.00023224752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042872474,0.000079762496,0.97186524,0.00016693676,0.0004465551,0.00055598957,0.00018992696,0.002744973,0.00010179911,0.0017120378,0.010841531,0.010866559],"study_design_scores_gemma":[0.000058842856,0.000034888417,0.99431485,0.00009731524,0.00012541667,0.00028000434,0.00047617804,0.0020879828,0.000042022904,0.00022824449,0.0022235047,0.00003073494],"about_ca_topic_score_codex":0.9958562,"about_ca_topic_score_gemma":0.99613297,"teacher_disagreement_score":0.06241292,"about_ca_system_score_codex":0.06241292,"about_ca_system_score_gemma":0.05115643,"threshold_uncertainty_score":0.45283955},"labels":[],"label_agreement":null},{"id":"W2007726673","doi":"10.1016/j.jval.2013.08.1167","title":"Economic Evaluation of Ranibuzumab for the Treatment of Myopic Choroidal Neovascularization in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Cost effectiveness; Quality-adjusted life year; Quality of life (healthcare); Cohort; Optometry; Demography; Bevacizumab; Surgery; Nursing","score_opus":0.0442521457096476,"score_gpt":0.31507671043253466,"score_spread":0.2708245647228871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007726673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89320374,0.033372633,0.0011453243,0.021189976,0.00035416952,0.0016250421,0.011628409,0.0000629342,0.037417732],"genre_scores_gemma":[0.99008524,0.0049481955,0.0006735924,0.00090902246,0.000074047515,0.00012594441,0.0012362032,0.000010297371,0.0019375267],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99487996,0.0023189813,0.00024526156,0.00018894342,0.0013684438,0.0009984684],"domain_scores_gemma":[0.98821473,0.004292639,0.0012917487,0.00015237866,0.0035551067,0.0024933836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039752894,0.00045983927,0.0009256727,0.0010840622,0.0010930169,0.002363025,0.001140273,0.0007317024,0.0029644477],"category_scores_gemma":[0.017971577,0.00028301292,0.0013287239,0.0019491832,0.0008376022,0.00042383466,0.0006792189,0.0012387094,0.00008014989],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1311763,0.005342382,0.23036845,0.0067050415,0.009197879,0.0021947494,0.00087428413,0.16055836,0.0030251415,0.04122971,0.072776966,0.33655077],"study_design_scores_gemma":[0.047819547,0.018208792,0.56499606,0.0037420676,0.012560687,0.001495239,0.0028429024,0.24528152,0.0025420892,0.0065935957,0.09344348,0.0004740051],"about_ca_topic_score_codex":0.9471225,"about_ca_topic_score_gemma":0.9577252,"teacher_disagreement_score":0.10305305,"about_ca_system_score_codex":0.10305305,"about_ca_system_score_gemma":0.12983838,"threshold_uncertainty_score":0.7477057},"labels":[],"label_agreement":null},{"id":"W2007759454","doi":"10.1016/j.jval.2011.02.324","title":"PSS22 SYSTEMATIC REVIEW OF THE QUALITY OF LIFE LITERATURE IN CHILDREN WITH ATOPIC DERMATITIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Atopic dermatitis; Quality of life (healthcare); Medicine; Dermatology Life Quality Index; MEDLINE; Population; Family medicine; Pediatrics; Dermatology; Environmental health","score_opus":0.04034031361524508,"score_gpt":0.3146911391873157,"score_spread":0.27435082557207063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007759454","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016402686,0.9795828,0.00014279128,0.00038165253,0.00011935915,0.00030229604,0.0024861216,0.000005367565,0.00057695503],"genre_scores_gemma":[0.21684302,0.778085,0.001275694,0.00089575944,0.0001707791,0.0008222734,0.0016876017,0.000009466231,0.00021044102],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9844504,0.006009557,0.0063810507,0.0009828161,0.0018167306,0.00035935864],"domain_scores_gemma":[0.9501808,0.03665758,0.008916992,0.0008018874,0.0030015667,0.0004411456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009434093,0.000992423,0.0064126807,0.010932846,0.0006328036,0.0020759087,0.0008708071,0.0010953284,0.0031880261],"category_scores_gemma":[0.051050596,0.00084742485,0.008784153,0.011772233,0.0007859992,0.0012032246,0.0014599353,0.00095125503,0.00017630045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008711572,0.000048688307,0.025327258,0.84939605,0.07019689,0.0004938578,0.00074494636,0.00020825893,0.00028947886,0.00018287418,0.0023111498,0.049929425],"study_design_scores_gemma":[0.0011782289,0.00053081394,0.11741127,0.55682546,0.30264324,0.0016361412,0.0010382693,0.000119567616,0.00031109128,0.0003173381,0.017899694,0.000088918845],"about_ca_topic_score_codex":0.014113129,"about_ca_topic_score_gemma":0.04689312,"teacher_disagreement_score":0.014113129,"about_ca_system_score_codex":0.0034380532,"about_ca_system_score_gemma":0.00972634,"threshold_uncertainty_score":0.049892843},"labels":[],"label_agreement":null},{"id":"W2008044647","doi":"10.1016/j.jval.2011.02.716","title":"PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAIN","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Public Health Ontario; University of Toronto; Toronto Public Health","funders":"","keywords":"Medicine; Neck pain; Adverse effect; Incremental cost-effectiveness ratio; Cost effectiveness; Willingness to pay; Quality-adjusted life year; Economic evaluation; Population; Cost–benefit analysis; Quality of life (healthcare); Physical therapy; Internal medicine; Alternative medicine; Environmental health","score_opus":0.09779977955075692,"score_gpt":0.3682265488186903,"score_spread":0.2704267692679334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008044647","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26284096,0.20627041,0.009627135,0.06741953,0.030768624,0.0032761807,0.31364235,0.0007514831,0.10540335],"genre_scores_gemma":[0.7937178,0.0647053,0.010445537,0.0073122308,0.017255481,0.003043532,0.06126342,0.00027653394,0.041980255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997239,0.0016146196,0.00025344148,0.00015749571,0.00066704454,0.00006834992],"domain_scores_gemma":[0.9704522,0.025217634,0.0021034626,0.00031085723,0.0013599561,0.0005560184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037788907,0.0007322343,0.0017835295,0.0017847746,0.00018336886,0.0013305076,0.0007102631,0.001425824,0.06944035],"category_scores_gemma":[0.03789168,0.00026382424,0.0016810794,0.0026997635,0.00032226995,0.00092333544,0.00063257833,0.00086254824,0.0046316325],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.056416553,0.00046694154,0.017374827,0.03161714,0.006686441,0.0002861155,0.00013878802,0.010433892,0.0010927599,0.0061056223,0.41872653,0.45065445],"study_design_scores_gemma":[0.07640893,0.01986485,0.39822432,0.029601106,0.020614382,0.0031827195,0.0006232181,0.03171362,0.0071344557,0.026820803,0.3853115,0.0005001465],"about_ca_topic_score_codex":0.0014358152,"about_ca_topic_score_gemma":0.001903204,"teacher_disagreement_score":0.06944035,"about_ca_system_score_codex":0.0013364963,"about_ca_system_score_gemma":0.0022832581,"threshold_uncertainty_score":0.23230112},"labels":[],"label_agreement":null},{"id":"W2008076313","doi":"10.1016/j.jval.2012.03.739","title":"PGI12 The Impact of TNF Inhibitors for Crohn'S Disease on Health Care Resource Utilization: an Analysis Using the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Western University; Université de Montréal","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Medical prescription; Health care; Internal medicine; Population; Prednisone; Cohort; Disease; Crohn's disease; Retrospective cohort study; Physical therapy; Pharmacology; Environmental health","score_opus":0.05615533555198375,"score_gpt":0.371480929344842,"score_spread":0.31532559379285824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008076313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82967603,0.0011824127,0.00035097016,0.00027906653,0.000011609025,0.000044779426,0.16735509,0.00008962658,0.0010103985],"genre_scores_gemma":[0.8856671,0.00052141974,0.0011534502,0.00012312978,0.0000214181,0.00013458778,0.11176917,0.000049875096,0.00055985054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998055,0.0006735312,0.00029722904,0.00039621507,0.00041744398,0.00016061148],"domain_scores_gemma":[0.98967755,0.005711411,0.0028575335,0.0006712077,0.0006424455,0.00043986057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021040505,0.00034375113,0.0010361213,0.0024811341,0.00017619778,0.0011389793,0.0010470558,0.0005268892,0.003878367],"category_scores_gemma":[0.009759864,0.00023658946,0.0018602845,0.0060269656,0.00022707302,0.0005850975,0.0007436954,0.0006701487,0.0006333291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033168616,0.0001685235,0.96743,0.00033928177,0.0023676641,0.000115381314,0.00008102226,0.0038328802,0.00018030583,0.00031356953,0.0060596997,0.01579469],"study_design_scores_gemma":[0.00031727692,0.00031641364,0.9856765,0.00006342483,0.000724496,0.00035398817,0.00018563359,0.00732562,0.00025939706,0.00018330982,0.004564829,0.000028976148],"about_ca_topic_score_codex":0.026452571,"about_ca_topic_score_gemma":0.017124904,"teacher_disagreement_score":0.97354746,"about_ca_system_score_codex":0.00091451436,"about_ca_system_score_gemma":0.0010031181,"threshold_uncertainty_score":0.052597225},"labels":[],"label_agreement":null},{"id":"W2008220621","doi":"10.1016/j.jval.2012.03.725","title":"PCV122 An Assessment of the Modified Rankin Scale As a Stroke Outcome Measure in Economic Analyses of Acute Ischemic Stroke Outcomes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Modified Rankin Scale; Medicine; Reliability (semiconductor); Stroke (engine); Physical therapy; Face validity; Scale (ratio); Measure (data warehouse); Physical medicine and rehabilitation; Psychometrics; Ischemic stroke; Clinical psychology; Computer science; Data mining; Psychiatry; Ischemia","score_opus":0.09426771280421589,"score_gpt":0.41603464618201474,"score_spread":0.3217669333777988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008220621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8661025,0.07967931,0.01031609,0.0046962253,0.0009800192,0.0012152259,0.009959436,0.000078620054,0.026972614],"genre_scores_gemma":[0.9917157,0.0023646792,0.0030601441,0.0002200515,0.00020575905,0.00034909917,0.0013888391,0.000016224738,0.0006794132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95865685,0.03231574,0.0021270665,0.0006693552,0.0056448365,0.0005861383],"domain_scores_gemma":[0.97469145,0.017071065,0.0053583975,0.00095005,0.0013139899,0.0006150165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015818756,0.00096192246,0.0023508507,0.0038461047,0.0004384088,0.0027220363,0.0008447511,0.0009348294,0.0021369176],"category_scores_gemma":[0.057513848,0.00038439906,0.002453873,0.005059391,0.00066364394,0.0021684542,0.0013182183,0.0018792758,0.00024483993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035086684,0.0010156522,0.7183955,0.003353619,0.018086514,0.00042918723,0.0003068685,0.006488066,0.0006874676,0.011621131,0.011107964,0.19342136],"study_design_scores_gemma":[0.0030127158,0.008353656,0.9192863,0.0018779198,0.006026432,0.0012510741,0.0005494242,0.029790014,0.0010478906,0.013930491,0.0146460105,0.00022791595],"about_ca_topic_score_codex":0.0028915105,"about_ca_topic_score_gemma":0.005167361,"teacher_disagreement_score":0.015818756,"about_ca_system_score_codex":0.0016314586,"about_ca_system_score_gemma":0.0020975969,"threshold_uncertainty_score":0.083658576},"labels":[],"label_agreement":null},{"id":"W2008422538","doi":"10.1016/j.jval.2012.08.1386","title":"PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Golimumab; Adalimumab; Medicine; Etanercept; Psoriatic arthritis; Infliximab; Internal medicine; Psoriasis; Physical therapy; Arthritis; Rheumatoid arthritis; Dermatology","score_opus":0.5709032516440831,"score_gpt":0.47133191755514803,"score_spread":0.09957133408893504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008422538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90896803,0.029379195,0.003788878,0.009267083,0.00050051056,0.001190023,0.008156418,0.000103667,0.038646076],"genre_scores_gemma":[0.9922097,0.0016497878,0.001093326,0.0003129968,0.00016559022,0.00030559814,0.002240085,0.000013952813,0.0020089531],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.994773,0.004507564,0.00011722965,0.00009372926,0.0003058388,0.0002026621],"domain_scores_gemma":[0.9958711,0.002937,0.0004700699,0.00016028664,0.00023597466,0.0003254966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007187977,0.0006431383,0.0009104888,0.00090750435,0.00015348042,0.0009924008,0.0003511317,0.00064681546,0.0043949024],"category_scores_gemma":[0.013360868,0.00021472225,0.0016348944,0.0007731278,0.00039383923,0.00027400602,0.0006225716,0.0007889366,0.0003015024],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24024415,0.0044045243,0.068281405,0.007403309,0.009103032,0.0015316783,0.00030319468,0.32124335,0.0025715104,0.023670794,0.06412411,0.25711894],"study_design_scores_gemma":[0.118110545,0.04150905,0.42860404,0.0033217801,0.009576887,0.0022896752,0.00069295516,0.29264674,0.002662273,0.013482038,0.08685123,0.00025281546],"about_ca_topic_score_codex":0.0062027876,"about_ca_topic_score_gemma":0.004218774,"teacher_disagreement_score":0.007187977,"about_ca_system_score_codex":0.0024969487,"about_ca_system_score_gemma":0.002136273,"threshold_uncertainty_score":0.038014114},"labels":[],"label_agreement":null},{"id":"W2008583396","doi":"10.1016/j.jval.2012.03.1378","title":"MO1 New Concepts in Discrete Choice Preference Measurement: An Application to Drug Treatment for Juvenile Idiopathic Arthritis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Cancer Agency","funders":"","keywords":"Willingness to pay; Population; Mixed logit; Face validity; Statistics; Discrete choice; Econometrics; Medicine; Logistic regression; Mathematics; Psychometrics; Economics; Environmental health","score_opus":0.377698079506034,"score_gpt":0.5160363231796056,"score_spread":0.13833824367357156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008583396","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037783723,0.0009048058,0.95328027,0.00089047826,0.00021026965,0.00039284443,0.00064942526,0.00035858972,0.0055296146],"genre_scores_gemma":[0.40097535,0.0009730927,0.58866847,0.00073051447,0.0002524291,0.0022955902,0.0004307297,0.0001313555,0.0055424753],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99180263,0.0061080456,0.00028909004,0.00061507965,0.0010354284,0.000149715],"domain_scores_gemma":[0.95165503,0.04329334,0.0014945263,0.0014443814,0.0016755395,0.00043716026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010704695,0.0009331457,0.0014977234,0.0018231884,0.0007460396,0.0017914003,0.0012317278,0.0010649104,0.008532955],"category_scores_gemma":[0.043249276,0.00043903635,0.0018460776,0.0028428205,0.001188335,0.0018039716,0.0016077284,0.0029783044,0.0009064293],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010605517,0.0006835963,0.032478295,0.0009243528,0.00062300527,0.00014212567,0.001315148,0.027086439,0.0026141673,0.32223153,0.0049274215,0.60591334],"study_design_scores_gemma":[0.00030467665,0.0027280415,0.04268254,0.0004944575,0.00029743894,0.00040670828,0.0007387932,0.5323753,0.0018321493,0.39457944,0.023246419,0.00031410003],"about_ca_topic_score_codex":0.005163874,"about_ca_topic_score_gemma":0.004962043,"teacher_disagreement_score":0.010704695,"about_ca_system_score_codex":0.0014362424,"about_ca_system_score_gemma":0.0012948138,"threshold_uncertainty_score":0.05661249},"labels":[],"label_agreement":null},{"id":"W2008651219","doi":"10.1046/j.1524-4733.2003.00213.x","title":"Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for Canada","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph's Hospital","funders":"","keywords":"Oseltamivir; Medicine; Formulary; Neuraminidase inhibitor; Confidence interval; Randomized controlled trial; Quality-adjusted life year; Emergency medicine; Internal medicine; Placebo; Pediatrics; Cost effectiveness; Intensive care medicine; Family medicine; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.2790570195396019,"score_gpt":0.4654737312966299,"score_spread":0.186416711757028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008651219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5323149,0.2925611,0.048130233,0.017573377,0.001942412,0.0145811,0.062159244,0.0012024724,0.029535195],"genre_scores_gemma":[0.9392676,0.025210774,0.019953866,0.0022219296,0.0002288072,0.0022333271,0.0071897344,0.00014023313,0.003553838],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97022104,0.02441312,0.0012862033,0.0013389832,0.0016237213,0.0011168382],"domain_scores_gemma":[0.9646429,0.027143778,0.0028350274,0.0010646842,0.0032215854,0.0010919378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046602536,0.0036915846,0.013266739,0.0055592363,0.00095143454,0.003969392,0.004082944,0.002826036,0.004481861],"category_scores_gemma":[0.06299645,0.0021614365,0.02105864,0.0060843495,0.0014610313,0.0016842594,0.0018265158,0.0038942955,0.000286395],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1622366,0.0005587835,0.045834564,0.030750006,0.47611612,0.0006414322,0.00062315876,0.17766987,0.0005809005,0.0105536515,0.016777428,0.07765746],"study_design_scores_gemma":[0.083495215,0.0033380345,0.038511172,0.0044515855,0.6792692,0.00030430272,0.00042354778,0.16657445,0.00040459595,0.011431145,0.0114857005,0.00031106456],"about_ca_topic_score_codex":0.7070642,"about_ca_topic_score_gemma":0.66862833,"teacher_disagreement_score":0.2929358,"about_ca_system_score_codex":0.026305074,"about_ca_system_score_gemma":0.02716859,"threshold_uncertainty_score":0.58932185},"labels":[],"label_agreement":null},{"id":"W2008857237","doi":"10.1111/j.1524-4733.2007.00296.x","title":"Time and Expected Value of Sample Information Wait for No Patient","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Accrual; Sample size determination; Time horizon; Population; Randomized controlled trial; Medicine; Sample (material); Clinical trial; Actuarial science; Statistics; Econometrics; Economics; Accounting; Mathematics; Surgery; Finance; Internal medicine","score_opus":0.35320465913671856,"score_gpt":0.5024651963903233,"score_spread":0.14926053725360472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008857237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.890734,0.0050943308,0.0524867,0.01818072,0.00055273256,0.0004057526,0.0018073091,0.0003734786,0.030365074],"genre_scores_gemma":[0.9933775,0.00030841836,0.0026789464,0.00036408764,0.00009804418,0.000058590707,0.0001948607,0.000032862867,0.0028867193],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9895838,0.006200415,0.0006452428,0.00073056895,0.0014382114,0.0014016808],"domain_scores_gemma":[0.64527476,0.3192208,0.015706867,0.0072309766,0.0051261852,0.0074403905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020244507,0.00042057244,0.00083784765,0.0010769038,0.000606891,0.002833773,0.001235795,0.0024200133,0.018272873],"category_scores_gemma":[0.19245823,0.00047951154,0.0014586492,0.0008018917,0.001282761,0.003186628,0.0010268644,0.0034576368,0.0010910301],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033078656,0.00493113,0.4193298,0.000708976,0.0027004622,0.0020588792,0.0019278933,0.06813395,0.0031580033,0.24554893,0.013485724,0.20493764],"study_design_scores_gemma":[0.0018844188,0.011001228,0.22809108,0.0006734861,0.0035493558,0.007864064,0.0037858873,0.32978198,0.0064944183,0.3933638,0.013205371,0.00030493058],"about_ca_topic_score_codex":0.001713156,"about_ca_topic_score_gemma":0.0018828302,"teacher_disagreement_score":0.020244507,"about_ca_system_score_codex":0.0021887938,"about_ca_system_score_gemma":0.0025967627,"threshold_uncertainty_score":0.107064486},"labels":[],"label_agreement":null},{"id":"W2009048225","doi":"10.1016/j.jval.2014.03.845","title":"An Examination Of Disparity In Access To Mental Health Services Among People Living With Human Immunodeficiency Virus (Hiv) And Co-Morbid Depression In Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Toronto Public Health; Institute for Clinical Evaluative Sciences; Ontario HIV Treatment Network; McMaster University; University Health Network; University of Toronto","funders":"","keywords":"Mental health; Depression (economics); Medicine; Cohort; Specialty; Logistic regression; Psychiatry; Population; Distress; Cohort study; Family medicine; Environmental health; Clinical psychology; Internal medicine","score_opus":0.033242445306943307,"score_gpt":0.3732077589229016,"score_spread":0.3399653136159583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009048225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386543,0.0003340976,0.000044162392,0.00080870214,0.000007609085,0.0000503834,0.0013419332,0.00000295759,0.0035447313],"genre_scores_gemma":[0.9986811,0.00023435421,0.000069085494,0.00011663109,0.0000035232474,0.000019386529,0.00029129215,0.0000019464792,0.0005826226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984864,0.00020583373,0.00013215486,0.00012472617,0.0004327909,0.000618159],"domain_scores_gemma":[0.99690044,0.00033341747,0.0009701748,0.00009025468,0.00089088886,0.0008147438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008850502,0.00016353236,0.00036228914,0.0016288892,0.0044128695,0.0013855201,0.0013597322,0.00051681045,0.002332013],"category_scores_gemma":[0.0046054604,0.00038980073,0.000667269,0.006014857,0.0010482745,0.00078736426,0.0021557584,0.0008273661,0.00014249461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006681839,0.000047072677,0.98678046,0.00005648172,0.000034005596,0.00012767328,0.008019201,0.000046293982,0.000098959805,0.0003745735,0.00072155567,0.003626992],"study_design_scores_gemma":[0.0000046250757,0.000014747718,0.9925368,0.000025700467,0.000010114212,0.000031786698,0.006601818,0.00007694689,0.0000142325625,0.00002929582,0.0006496721,0.0000043761156],"about_ca_topic_score_codex":0.9904951,"about_ca_topic_score_gemma":0.9961175,"teacher_disagreement_score":0.029688107,"about_ca_system_score_codex":0.029688107,"about_ca_system_score_gemma":0.028627729,"threshold_uncertainty_score":0.21540326},"labels":[],"label_agreement":null},{"id":"W2009287143","doi":"10.1016/j.jval.2013.03.085","title":"Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Boceprevir; Telaprevir; Medicine; Meta-analysis; Internal medicine; Pegylated interferon; Hepatitis C virus; Ribavirin; Immunology; Virus","score_opus":0.5103839472343782,"score_gpt":0.5053342467469973,"score_spread":0.005049700487380848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009287143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012215629,0.9955195,0.0007269358,0.0009245367,0.00049151585,0.00028855412,0.00031597435,0.0000060082116,0.00050545216],"genre_scores_gemma":[0.06856203,0.91676,0.005814745,0.005423902,0.0006926491,0.0018009342,0.0005320131,0.00004400294,0.00036971222],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.89063275,0.06503459,0.029664874,0.00507669,0.008612018,0.0009790118],"domain_scores_gemma":[0.6634836,0.2959294,0.024092557,0.006057984,0.009708526,0.0007278453],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09370191,0.0022435584,0.011691841,0.0076686176,0.00092856534,0.006304233,0.0034575036,0.0030812097,0.006230208],"category_scores_gemma":[0.34033749,0.0019090635,0.017035214,0.008943803,0.0032323233,0.004743455,0.003950567,0.0037883285,0.0004654925],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023695435,0.000045246885,0.003256001,0.75163966,0.15354672,0.00010598421,0.0005909555,0.00021230071,0.00021509803,0.002579497,0.001767927,0.08367106],"study_design_scores_gemma":[0.0030829355,0.00059857266,0.00857027,0.46572185,0.48753527,0.00037811496,0.0007857894,0.00012599907,0.00045367694,0.006588354,0.026057925,0.00010122399],"about_ca_topic_score_codex":0.00952518,"about_ca_topic_score_gemma":0.016257018,"teacher_disagreement_score":0.9062981,"about_ca_system_score_codex":0.0062720417,"about_ca_system_score_gemma":0.009972054,"threshold_uncertainty_score":0.49554896},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2009316549","doi":"10.1111/j.1524-4733.2010.00754.x","title":"Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries","year":2010,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Health technology; Value (mathematics); Medicine; Political science; Computer science; Health care; Law","score_opus":0.3929639032331637,"score_gpt":0.4719043599450187,"score_spread":0.07894045671185501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009316549","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014594883,0.12501927,0.00029170606,0.12196151,0.7499374,0.00002965232,0.00020373476,0.00003344932,0.0023772337],"genre_scores_gemma":[0.0051019327,0.060486954,0.0006369493,0.052842975,0.8745423,0.000097243974,0.00008960893,0.00008574364,0.0061163143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9720977,0.014104133,0.003765895,0.001434722,0.008008047,0.0005895324],"domain_scores_gemma":[0.7252494,0.23602311,0.005311834,0.0022385027,0.027598474,0.0035787479],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.050536476,0.0032768738,0.0081379535,0.007989574,0.0028423732,0.012461889,0.0047801924,0.018998422,0.0065588164],"category_scores_gemma":[0.18587737,0.001516215,0.002297362,0.0085189,0.010322798,0.010734449,0.0024087422,0.02291893,0.0019497725],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000619245,0.000013874887,0.00007724457,0.0011323193,0.0001376944,0.000055524113,0.000096707125,0.00005967501,0.00001549594,0.0031418821,0.98274475,0.012463046],"study_design_scores_gemma":[0.00036514326,0.000064799155,0.0016063254,0.008893017,0.0007675861,0.00023236893,0.0006778994,0.0006145932,0.0001660463,0.018265741,0.96822023,0.00012619254],"about_ca_topic_score_codex":0.014302235,"about_ca_topic_score_gemma":0.02949037,"teacher_disagreement_score":0.94946355,"about_ca_system_score_codex":0.009378829,"about_ca_system_score_gemma":0.008482392,"threshold_uncertainty_score":0.26726556},"labels":[],"label_agreement":null},{"id":"W2009416878","doi":"10.1016/j.jval.2013.08.814","title":"A 10-Year Review of the Canadian Common Drug Review: Pharmaceutical Manufacturers’ Success Rate","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Formulary; Medicine; Reimbursement; Listing (finance); Family medicine; Business; Health care; Political science","score_opus":0.18501130182309475,"score_gpt":0.3940084444685437,"score_spread":0.20899714264544897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009416878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034132178,0.99329364,0.00005087578,0.003759136,0.0005796142,0.00003052362,0.0005033131,0.0000098874325,0.0014317585],"genre_scores_gemma":[0.0071869823,0.9882201,0.00027512902,0.0025660968,0.0005456233,0.000023004262,0.0004362198,0.000010892933,0.0007359525],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98829275,0.0014501609,0.0013452222,0.00057098764,0.007691335,0.00064955634],"domain_scores_gemma":[0.93534845,0.014336838,0.0068953987,0.0007863637,0.04007787,0.0025550683],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018599318,0.001084794,0.0032653846,0.014548644,0.00096341694,0.0039754217,0.0021461055,0.0020287645,0.004863663],"category_scores_gemma":[0.048609678,0.0006101871,0.002093431,0.019554427,0.0016218463,0.0020172563,0.0013389374,0.0020941163,0.0007990139],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050763227,0.000051664294,0.0030773336,0.074300885,0.0018790063,0.000098513025,0.00017356087,0.00040382348,0.00041258737,0.0040704235,0.29007715,0.62494737],"study_design_scores_gemma":[0.00013540075,0.0001355544,0.027866699,0.05963354,0.0036158026,0.00030343363,0.00017512188,0.00023193596,0.00038526687,0.00068166654,0.90673745,0.00009822773],"about_ca_topic_score_codex":0.34905598,"about_ca_topic_score_gemma":0.638542,"teacher_disagreement_score":0.98140067,"about_ca_system_score_codex":0.028540542,"about_ca_system_score_gemma":0.06691273,"threshold_uncertainty_score":0.6940485},"labels":[],"label_agreement":null},{"id":"W2009563819","doi":"10.1016/s1098-3015(10)65228-x","title":"PCN70 UTILITYVALUES FOR HEALTH STATES FOR CHRONIC MYELOGENOUS LEUKAEMIA (CML): ESTIMATES FROM LAYPERSONS IN AUSTRALIA, THE UNITED KINGDOM (UK) AND CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Kingdom; Family medicine; Chronic myelogenous leukemia; Environmental health; Gerontology; Leukemia; Immunology; Biology","score_opus":0.0916650070418641,"score_gpt":0.3684696056787971,"score_spread":0.276804598636933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009563819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726437,0.00554115,0.0013467274,0.00092026935,0.0000187689,0.00008975498,0.012049344,0.000018713334,0.0073716845],"genre_scores_gemma":[0.9948085,0.0014346568,0.0002969003,0.00006730594,0.00000742615,0.000018684266,0.0028226636,0.0000036531062,0.00054026756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983094,0.000634367,0.00013455335,0.000105769985,0.00055637263,0.00025953504],"domain_scores_gemma":[0.98924106,0.0044542234,0.002348618,0.00033263408,0.002679818,0.00094372017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034544296,0.0003138569,0.00046348237,0.0020870594,0.00044520228,0.0012053738,0.0005524626,0.00042157044,0.0013374825],"category_scores_gemma":[0.014019945,0.00031042992,0.0015101366,0.0036893983,0.00070911605,0.0007674057,0.0010420672,0.0009339049,0.00011920214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039903366,0.000035867743,0.9729571,0.0001638215,0.00051965594,0.00011108116,0.0010199676,0.0049258224,0.000058424837,0.0014966739,0.0034087456,0.01490399],"study_design_scores_gemma":[0.000024585781,0.00006115425,0.9908082,0.000089340276,0.00019912841,0.00012186774,0.001305893,0.004754763,0.0000664703,0.00037030378,0.002172338,0.000025933436],"about_ca_topic_score_codex":0.8219658,"about_ca_topic_score_gemma":0.80364794,"teacher_disagreement_score":0.17803419,"about_ca_system_score_codex":0.008067382,"about_ca_system_score_gemma":0.0028680952,"threshold_uncertainty_score":0.35816532},"labels":[],"label_agreement":null},{"id":"W2010336850","doi":"10.1016/s1098-3015(10)61943-2","title":"PNM4 COST-EFFECTIVENESS STUDY OF RIZATRIPTAN VS. USUAL CARE IN THE TREATMENT OF MIGRAINE IN CANADA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Migration, Health and Trauma","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rizatriptan; Migraine; Medicine; Intensive care medicine; Anesthesia; Internal medicine; Sumatriptan","score_opus":0.05855402618442098,"score_gpt":0.3673086918477131,"score_spread":0.3087546656632921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010336850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98284894,0.0069444953,0.00017551209,0.0007937055,0.00011378706,0.0019247493,0.0036451623,0.000030159108,0.0035234832],"genre_scores_gemma":[0.9937179,0.0022301162,0.0007477437,0.0003266009,0.0000881991,0.00057195604,0.001261029,0.00000730354,0.0010490327],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970521,0.0015358258,0.00020090451,0.00018603662,0.00051156245,0.00051360746],"domain_scores_gemma":[0.9975184,0.0006778952,0.00044786956,0.00007599654,0.0004640393,0.00081590615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018199328,0.0008567472,0.0020468642,0.0012332916,0.0013015653,0.0011527247,0.0017623655,0.0012305676,0.0061933887],"category_scores_gemma":[0.006758369,0.0006165078,0.003277229,0.0021418598,0.00093620736,0.0007044356,0.00075726554,0.0015237718,0.00021063889],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83440274,0.011947154,0.03551811,0.0037074834,0.008194887,0.00026719272,0.00022088128,0.010064562,0.0011569882,0.0009836936,0.004052336,0.08948393],"study_design_scores_gemma":[0.51834935,0.09973444,0.33535382,0.0010010332,0.014084501,0.0003314265,0.00079164386,0.023442205,0.00095161475,0.0005542188,0.0050780433,0.00032774432],"about_ca_topic_score_codex":0.84831434,"about_ca_topic_score_gemma":0.84876376,"teacher_disagreement_score":0.15168566,"about_ca_system_score_codex":0.03773694,"about_ca_system_score_gemma":0.034082193,"threshold_uncertainty_score":0.3051579},"labels":[],"label_agreement":null},{"id":"W2010515258","doi":"10.1016/j.jval.2011.02.459","title":"PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Ministry of Health and Long Term Care; Juravinski Cancer Centre; University of Toronto","funders":"","keywords":"Gefitinib; Medicine; Epidermal growth factor receptor; Oncology; Cost effectiveness; Lung cancer; Internal medicine; Mutation; Cost-effectiveness analysis; Gene mutation; Cancer; Gene; Biology; Genetics","score_opus":0.0712671127274582,"score_gpt":0.26850658738859984,"score_spread":0.19723947466114164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010515258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923225,0.0009225758,0.00011517607,0.0016912271,0.00002132822,0.00005125849,0.0017366399,0.000007800173,0.0031315808],"genre_scores_gemma":[0.99897397,0.00018766428,0.000059819733,0.000058446047,0.000010963071,0.000008631092,0.00035054455,0.0000017663624,0.00034815312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899,0.0003297168,0.00007866071,0.0001017169,0.00022761733,0.00027228668],"domain_scores_gemma":[0.9964593,0.0010837271,0.0009380576,0.000081946244,0.000419215,0.0010177831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092667,0.00019909085,0.00044984987,0.00034849276,0.00048621552,0.000874974,0.0006890427,0.00045445908,0.0020024413],"category_scores_gemma":[0.007161541,0.0002218424,0.00089092343,0.00083557545,0.0004427069,0.00037613342,0.00057307066,0.00047535516,0.00009705422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011859309,0.00045066394,0.8997672,0.00028852603,0.000589497,0.00056191103,0.000409565,0.019283248,0.00080759544,0.0012193513,0.005924138,0.058839034],"study_design_scores_gemma":[0.000981398,0.0009268073,0.9822203,0.000055992812,0.00034905918,0.00019718852,0.00039659365,0.012645263,0.00023552708,0.00029258922,0.0016742963,0.000025077765],"about_ca_topic_score_codex":0.86749756,"about_ca_topic_score_gemma":0.90062433,"teacher_disagreement_score":0.13250244,"about_ca_system_score_codex":0.02993469,"about_ca_system_score_gemma":0.014849733,"threshold_uncertainty_score":0.2665655},"labels":[],"label_agreement":null},{"id":"W2010653668","doi":"10.1016/s1098-3015(10)73690-1","title":"PRS27 ASTHMA-RELATED PRODUCTIVITY LOSSES IN ALBERTA, CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Occupational exposure and asthma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Productivity; Agricultural economics; Business; Natural resource economics; Environmental science; Economics; Economic growth","score_opus":0.015606436745457048,"score_gpt":0.27620653984825494,"score_spread":0.2606001031027979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010653668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9490942,0.0025846185,0.00032837008,0.0027020173,0.00012951612,0.00011078501,0.021676283,0.00008080854,0.023293378],"genre_scores_gemma":[0.974398,0.0015373798,0.00027987114,0.00034819866,0.00003227279,0.000028065626,0.006189909,0.000021281088,0.017165087],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985487,0.00010451632,0.000059982856,0.000089059555,0.0006590043,0.0005387158],"domain_scores_gemma":[0.99745005,0.00010007046,0.0002776892,0.000038632956,0.0015077147,0.0006258763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007156023,0.0003681981,0.0004167493,0.0021328868,0.002388443,0.001634787,0.0014083077,0.000543196,0.00422992],"category_scores_gemma":[0.0016416416,0.00026641614,0.0005791699,0.003972387,0.00048098422,0.00025462377,0.000712051,0.00086753984,0.00047680462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005528754,0.00018069391,0.939386,0.0001130387,0.00016203569,0.0008443091,0.0008176479,0.0020468207,0.00046526728,0.00083976524,0.0206578,0.0339337],"study_design_scores_gemma":[0.000021091242,0.000036403424,0.992845,0.00003741096,0.000024716335,0.00010079798,0.0013506191,0.0007709064,0.0000757573,0.000039896557,0.004685977,0.000011466409],"about_ca_topic_score_codex":0.99844235,"about_ca_topic_score_gemma":0.99905175,"teacher_disagreement_score":0.049988385,"about_ca_system_score_codex":0.049988385,"about_ca_system_score_gemma":0.057025418,"threshold_uncertainty_score":0.36269283},"labels":[],"label_agreement":null},{"id":"W2010793469","doi":"10.1016/j.jval.2014.03.684","title":"Cost-Effectiveness Of Rivaroxaban For The Treatment Of Pulmonary Embolism In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Vitamin K antagonist; Deep vein; Low molecular weight heparin; Thrombosis; Venous thrombosis; Internal medicine; Surgery; Atrial fibrillation; Warfarin","score_opus":0.43154489897013504,"score_gpt":0.4254823225805965,"score_spread":0.006062576389538554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010793469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9107299,0.027798519,0.00056674884,0.024949681,0.00039423918,0.00029272848,0.019754393,0.000065421715,0.015448497],"genre_scores_gemma":[0.99072826,0.0045607733,0.00029027427,0.00061225874,0.000062741914,0.00003329739,0.0022766707,0.000011880887,0.0014238782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971244,0.00059352134,0.00024777188,0.00019998981,0.0011165692,0.000717876],"domain_scores_gemma":[0.9912547,0.0017481571,0.0010400426,0.00011394959,0.0037089873,0.0021341662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017075993,0.00044061572,0.0011190387,0.0019698273,0.001496642,0.00249607,0.0017826231,0.0011976565,0.0030142344],"category_scores_gemma":[0.01500891,0.00041942214,0.0017333472,0.0039795474,0.0008671064,0.0005841291,0.00071837165,0.0017936187,0.00008769797],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012502996,0.0012808281,0.70369923,0.002687126,0.0055150366,0.0013907137,0.0008032094,0.06463361,0.0008347999,0.022262467,0.071861126,0.11252887],"study_design_scores_gemma":[0.0044529983,0.0007788314,0.900674,0.001048867,0.0036163442,0.0006362638,0.0016543776,0.07028963,0.0005367294,0.0023804484,0.013680054,0.00025156935],"about_ca_topic_score_codex":0.9963503,"about_ca_topic_score_gemma":0.9967788,"teacher_disagreement_score":0.13207267,"about_ca_system_score_codex":0.13207267,"about_ca_system_score_gemma":0.13691197,"threshold_uncertainty_score":0.9582588},"labels":[],"label_agreement":null},{"id":"W2010942314","doi":"10.1016/j.jval.2011.02.381","title":"PSY48 A WORKPLACE HEALTH PROGRAM FOR BRITISH COLUMBIA PUBLIC SERVICE AGENCY (CANADA)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); GlaxoSmithKline (Canada); Canadian Sport Centre Pacific; Abbott (Canada); McMaster University","funders":"","keywords":"Psychological intervention; Medicine; Agency (philosophy); Public health; Intervention (counseling); Health care; Family medicine; Nursing; Gerontology; Environmental health; Political science","score_opus":0.09298624747056707,"score_gpt":0.3683094388361123,"score_spread":0.27532319136554523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010942314","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34099033,0.002217626,0.0021798797,0.046954054,0.002291834,0.004157537,0.019720897,0.0019442642,0.5795436],"genre_scores_gemma":[0.1583296,0.0006989114,0.0022550756,0.006143342,0.00010520945,0.0005028892,0.0027005814,0.000115185576,0.82914925],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9987143,0.00010034093,0.000020862139,0.000093271316,0.0003623226,0.00070891844],"domain_scores_gemma":[0.99308586,0.00018568257,0.00008280719,0.00009363225,0.0022494716,0.0043026577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006973762,0.0004083124,0.00027264285,0.0012155968,0.007107009,0.0015237558,0.0015421874,0.002147597,0.12016555],"category_scores_gemma":[0.0020431352,0.00060028286,0.00035797735,0.0006419552,0.0005980948,0.00038586618,0.0016406337,0.0020554448,0.011647922],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063440466,0.0020485965,0.04126455,0.00020134523,0.000033430635,0.000562674,0.0008711979,0.00046651563,0.0031811846,0.0013373822,0.69473994,0.2546588],"study_design_scores_gemma":[0.0005210308,0.0013074152,0.35988367,0.00041613093,0.00006277083,0.00030432816,0.0063431435,0.0019705642,0.0014958072,0.00046510992,0.62715673,0.00007334637],"about_ca_topic_score_codex":0.9301273,"about_ca_topic_score_gemma":0.9876802,"teacher_disagreement_score":0.12016555,"about_ca_system_score_codex":0.016376697,"about_ca_system_score_gemma":0.1195236,"threshold_uncertainty_score":0.4019938},"labels":[],"label_agreement":null},{"id":"W2010984173","doi":"10.1016/j.jval.2011.02.296","title":"PCV109 BEYOND CASE FATALITY: A NEW METHOD TO ESTIMATE THE EFFECT OF INCREASING TREATMENT UPTAKE ON MORTALITY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Toronto Public Health","funders":"","keywords":"Case fatality rate; Medicine; Population; Epidemiology; Mortality rate; Polypharmacy; Estimation; Incidence (geometry); Demography; Statistics; Intensive care medicine; Environmental health; Internal medicine; Mathematics","score_opus":0.5126907974081895,"score_gpt":0.51407341029486,"score_spread":0.00138261288667052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010984173","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2781898,0.0051621464,0.68581516,0.0016512278,0.0006029394,0.0025345434,0.015268179,0.0015290588,0.009246838],"genre_scores_gemma":[0.7715733,0.0009470756,0.21206181,0.00056106725,0.00038796302,0.0034635896,0.0052523967,0.0004326571,0.005320178],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97981226,0.014054596,0.0008616407,0.0018341254,0.0029830362,0.00045436854],"domain_scores_gemma":[0.88848346,0.09607019,0.0050517335,0.0074145636,0.002127215,0.00085276744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024694461,0.001360264,0.0028714929,0.007915817,0.00061459315,0.0017487287,0.0023841793,0.002409604,0.005515498],"category_scores_gemma":[0.10357238,0.0006303501,0.0030391193,0.0066680913,0.0012770388,0.0027803988,0.0016678371,0.003218997,0.0008207619],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061187698,0.001024643,0.35802358,0.0013846644,0.0096526425,0.00032425293,0.0007320936,0.060428526,0.0016566291,0.027705792,0.013953698,0.51899457],"study_design_scores_gemma":[0.00094529067,0.002875837,0.22084518,0.0005093961,0.0025751747,0.0011911963,0.0003111926,0.6760517,0.0045370082,0.06712814,0.022683565,0.00034637202],"about_ca_topic_score_codex":0.010692618,"about_ca_topic_score_gemma":0.0054775393,"teacher_disagreement_score":0.024694461,"about_ca_system_score_codex":0.0013594546,"about_ca_system_score_gemma":0.0018530637,"threshold_uncertainty_score":0.1305983},"labels":[],"label_agreement":null},{"id":"W2011263698","doi":"10.1016/j.jval.2011.08.923","title":"PIH19 Public Health Costs Associated with Outbreaks of Meningoccocal Disease: A Systematic Review","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Toronto Public Health","funders":"","keywords":"Outbreak; Medicine; Public health; Attack rate; Environmental health; Demography; Virology; Pathology","score_opus":0.12511865870328998,"score_gpt":0.33442628377403394,"score_spread":0.20930762507074396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011263698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024722638,0.9958831,0.00008143739,0.00020813268,0.000091842376,0.00009939103,0.0008660203,0.0000050887015,0.00029278276],"genre_scores_gemma":[0.036786415,0.9618028,0.00046463872,0.0002388958,0.000090737594,0.0001281234,0.00040591203,0.0000031826855,0.00007945431],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99560046,0.0012579381,0.0014938663,0.00033425295,0.001080904,0.00023254029],"domain_scores_gemma":[0.98449206,0.0099351145,0.0040999763,0.00017385244,0.0010840794,0.00021487412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004519895,0.0013014941,0.006027474,0.0076156724,0.000380484,0.0016004195,0.0014819962,0.0014406925,0.004748164],"category_scores_gemma":[0.02918935,0.0009408914,0.008941592,0.010816055,0.000561373,0.0016038081,0.001604898,0.0012573849,0.00018849273],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007708527,0.0000392682,0.008046117,0.83557945,0.052869562,0.00028996574,0.00014955411,0.00041911777,0.000108232685,0.00032264047,0.0038321735,0.09757304],"study_design_scores_gemma":[0.0013074663,0.0006508719,0.06844131,0.5246241,0.36343303,0.0015974897,0.0007701787,0.0003954188,0.0003125137,0.00093736366,0.03739907,0.00013111542],"about_ca_topic_score_codex":0.018749697,"about_ca_topic_score_gemma":0.03857282,"teacher_disagreement_score":0.018749697,"about_ca_system_score_codex":0.0033421286,"about_ca_system_score_gemma":0.0064162607,"threshold_uncertainty_score":0.037281096},"labels":[],"label_agreement":null},{"id":"W2011510968","doi":"10.1016/j.jval.2014.03.585","title":"Reimbursement Recommendations for Cancer Products Without Statistically Significant Overall Survival Data: A Review of Canadian Pcodr Decisions","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Clinical trial; Randomized controlled trial; Clinical endpoint; Confounding; Internal medicine; Overall survival; Cancer; Oncology; Family medicine; Health care","score_opus":0.788566139445565,"score_gpt":0.5512781060284331,"score_spread":0.2372880334171319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011510968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038969092,0.99384093,0.00015424867,0.0036432124,0.00015015408,0.00003451802,0.0003654527,0.0000067569754,0.0014150396],"genre_scores_gemma":[0.0077721435,0.9872126,0.0011078044,0.0030481725,0.00016518212,0.000037843267,0.00033554388,0.000008630987,0.00031210543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9903114,0.0020942537,0.0016709829,0.0005745006,0.00489068,0.00045828463],"domain_scores_gemma":[0.95970535,0.024529098,0.0049083466,0.00040107736,0.009422721,0.0010334086],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020262895,0.0011189833,0.0032178513,0.008666247,0.001040483,0.003975225,0.0031582294,0.0024831765,0.0062484383],"category_scores_gemma":[0.052979898,0.0005950295,0.0035700032,0.013631314,0.0018607465,0.0019343753,0.0013774591,0.003089708,0.00040968516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005999066,0.00006660875,0.0025825158,0.08471625,0.0019163272,0.00011786608,0.00025580858,0.0011914534,0.00022844423,0.009020565,0.092606045,0.8066982],"study_design_scores_gemma":[0.00053166196,0.00012668951,0.0157169,0.21022475,0.008118103,0.0004974931,0.00042399453,0.00069162913,0.00038813602,0.0053014457,0.75776726,0.00021182859],"about_ca_topic_score_codex":0.34150064,"about_ca_topic_score_gemma":0.5281481,"teacher_disagreement_score":0.9797371,"about_ca_system_score_codex":0.02894189,"about_ca_system_score_gemma":0.06539835,"threshold_uncertainty_score":0.67902577},"labels":[],"label_agreement":null},{"id":"W2011853618","doi":"10.1016/j.jval.2011.08.1443","title":"PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary Disease","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Education and Validation","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Content validity; Respondent; CLARITY; Pulmonary disease; COPD; Medicine; Qualitative research; Cognitive interview; Physical therapy; Psychology; Clinical psychology; Psychometrics; Cognition; Psychiatry; Internal medicine","score_opus":0.2722016692258324,"score_gpt":0.3456475280748192,"score_spread":0.0734458588489868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011853618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413776,0.000289983,0.00064890913,0.00016634578,0.000041221872,0.0002372311,0.0012995071,0.000014034549,0.0031649887],"genre_scores_gemma":[0.99684805,0.00014959807,0.00087087404,0.00009021587,0.000024769008,0.00020612919,0.0012721887,0.000007537742,0.0005307694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950112,0.0017041628,0.0010607718,0.0003691538,0.0014892606,0.00036556215],"domain_scores_gemma":[0.99328595,0.0027099738,0.0015944795,0.0003934817,0.0017162267,0.00029979504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006616374,0.00047192076,0.0008268479,0.0013592415,0.00063697057,0.0010660909,0.00053876714,0.0006547509,0.0015048161],"category_scores_gemma":[0.01767742,0.00024319066,0.0015122866,0.0012413806,0.00056842744,0.000748754,0.0014475445,0.00088990957,0.0005642196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022394811,0.00018265462,0.9836692,0.00007183977,0.00020672171,0.000040811607,0.00035844668,0.0002950558,0.00047937527,0.00009235676,0.00039397,0.013985544],"study_design_scores_gemma":[0.00003669758,0.00035429272,0.99745065,0.000025386724,0.00006134369,0.000114076356,0.00022654665,0.00064528576,0.00030151,0.0000737904,0.000701219,0.000009240497],"about_ca_topic_score_codex":0.0026755217,"about_ca_topic_score_gemma":0.003107055,"teacher_disagreement_score":0.006616374,"about_ca_system_score_codex":0.0005630079,"about_ca_system_score_gemma":0.0009614616,"threshold_uncertainty_score":0.034991145},"labels":[],"label_agreement":null},{"id":"W2012056050","doi":"10.1016/j.jval.2011.05.046","title":"Elicitation of Informed General Population Health State Utility Values: A Review of the Literature","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"Chongqing University of Arts and Sciences; Canadian Institutes of Health Research; University of Sheffield","keywords":"Population; Health care; Deliberation; Context (archaeology); Population health; Resource (disambiguation); Actuarial science; Medicine; Management science; Computer science; Business; Economics; Environmental health; Economic growth; Political science; Geography","score_opus":0.5271155693396244,"score_gpt":0.4932220970146238,"score_spread":0.03389347232500067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012056050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046306723,0.965713,0.021774208,0.00263428,0.00014039545,0.00013851839,0.0006374842,0.0000411146,0.0042902767],"genre_scores_gemma":[0.050152153,0.9213307,0.025364913,0.0009487305,0.00034509998,0.00029617533,0.00083521096,0.000021691323,0.00070526125],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9918454,0.004428771,0.0007990629,0.0006030533,0.002213845,0.000109823486],"domain_scores_gemma":[0.9316932,0.06160357,0.0026449389,0.0013492551,0.00257737,0.00013166472],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016602026,0.0012539045,0.003760664,0.0029843452,0.00025773424,0.0030896524,0.0021995897,0.0021044472,0.0036248013],"category_scores_gemma":[0.0652585,0.0005500451,0.0015196906,0.005636093,0.0010453525,0.0033730054,0.0015262157,0.0014931856,0.0008536197],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018997042,0.00014697286,0.0017924266,0.02257609,0.00033219528,0.00006735482,0.00023803939,0.0029682256,0.00031245165,0.009809672,0.0063261455,0.95524055],"study_design_scores_gemma":[0.0005481704,0.0010295924,0.040604215,0.1514813,0.00394108,0.0033489803,0.0035215968,0.032045517,0.007297959,0.27415887,0.48133382,0.00068883563],"about_ca_topic_score_codex":0.0024589603,"about_ca_topic_score_gemma":0.0026437028,"teacher_disagreement_score":0.98339796,"about_ca_system_score_codex":0.001448289,"about_ca_system_score_gemma":0.0024528038,"threshold_uncertainty_score":0.08780092},"labels":[],"label_agreement":null},{"id":"W2012100061","doi":"10.1111/j.1524-4733.2007.00254.x","title":"Assessing the Impact of Censoring of Costs and Effects on Health-Care Decision-Making: an Example Using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Censoring (clinical trials); Econometrics; Medicine; Actuarial science; Statistics; Economics; Mathematics","score_opus":0.4008945131707424,"score_gpt":0.49100570927550086,"score_spread":0.09011119610475848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012100061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8781574,0.010233677,0.08583545,0.012826735,0.00034359773,0.00034245013,0.003068862,0.00013514174,0.009056766],"genre_scores_gemma":[0.9770802,0.0012464449,0.019220756,0.0006321279,0.00016235487,0.00008599239,0.00058341725,0.000044218297,0.0009445538],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9199852,0.074410975,0.0013458672,0.001464126,0.0019990036,0.0007948428],"domain_scores_gemma":[0.27798203,0.6934436,0.010768319,0.012338735,0.0044616964,0.0010056042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13026154,0.0012074421,0.0024075499,0.0016234415,0.0014378916,0.0036828753,0.0025632835,0.0038561712,0.003138177],"category_scores_gemma":[0.27025995,0.00049922947,0.003950751,0.004027783,0.0025271764,0.0031620776,0.0029577522,0.005777148,0.000209521],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011180529,0.002265887,0.4909248,0.0013533948,0.0125667965,0.0025421034,0.003307904,0.2360746,0.00076319196,0.06533505,0.010880871,0.1628049],"study_design_scores_gemma":[0.0023338275,0.0035350013,0.23169582,0.00091599976,0.009790424,0.0019131171,0.0031384304,0.5721411,0.0038422977,0.1554306,0.0146174915,0.00064588763],"about_ca_topic_score_codex":0.024123298,"about_ca_topic_score_gemma":0.023358058,"teacher_disagreement_score":0.13026154,"about_ca_system_score_codex":0.0021485884,"about_ca_system_score_gemma":0.0019891027,"threshold_uncertainty_score":0.68889713},"labels":[],"label_agreement":null},{"id":"W2012247185","doi":"10.1016/j.jval.2012.03.556","title":"PSY22 Health Care Costs for Inflammatory Bowel Disease Patients who are Adherent Versus Non-Adherent With Infliximab Therapy","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Infliximab; Inflammatory bowel disease; Ulcerative colitis; Internal medicine; Rheumatoid arthritis; Propensity score matching; Crohn's disease; Gastroenterology; Methotrexate; Disease","score_opus":0.08736662849698322,"score_gpt":0.41016364263869937,"score_spread":0.32279701414171613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012247185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945221,0.00054093165,0.000035029658,0.0002924945,0.00002117764,0.000017674918,0.001866111,0.0000030529454,0.0027013058],"genre_scores_gemma":[0.9971826,0.00017492086,0.000044992765,0.00010672373,0.000025965519,0.00001604969,0.0016187652,0.0000015813862,0.00082840945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995009,0.00012139093,0.000069086695,0.000047818827,0.000110732806,0.00015014659],"domain_scores_gemma":[0.9988702,0.0003307675,0.00042499468,0.000027337708,0.00010092814,0.00024567972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003684825,0.00016972361,0.0005434976,0.00070032757,0.00031188916,0.0009344073,0.0002470538,0.0003967805,0.007339817],"category_scores_gemma":[0.0031885447,0.00015109596,0.0011488847,0.0009996311,0.0001425116,0.0006396287,0.00055812235,0.00083027047,0.00031532836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003760166,0.00031565677,0.97139853,0.000098844175,0.00076872046,0.000324113,0.00013828596,0.0012697836,0.00031535438,0.00039589815,0.0019868338,0.019227756],"study_design_scores_gemma":[0.00017278086,0.0004011144,0.99647385,0.000026099318,0.00017677131,0.00027085128,0.00035069633,0.0012776399,0.00006971516,0.00016934979,0.0006031185,0.00000803634],"about_ca_topic_score_codex":0.01268817,"about_ca_topic_score_gemma":0.013012227,"teacher_disagreement_score":0.01268817,"about_ca_system_score_codex":0.0008851746,"about_ca_system_score_gemma":0.0005701896,"threshold_uncertainty_score":0.02522862},"labels":[],"label_agreement":null},{"id":"W2012363877","doi":"10.1016/j.jval.2013.03.182","title":"Valuing EQ-5D-5L: Can latent utilities derived from a discrete choice model be transformed to health utilities derived from time trade-off tasks?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Econometrics; EQ-5D; Parametric statistics; Mathematics; Statistics; Transformation (genetics); Polynomial regression; Polynomial; Regression; Computer science; Mathematical optimization; Medicine","score_opus":0.3432951478116914,"score_gpt":0.3684009967356993,"score_spread":0.025105848924007912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012363877","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16138993,0.000959779,0.8156302,0.0111913495,0.0004360612,0.00013069081,0.0020136114,0.000420523,0.00782788],"genre_scores_gemma":[0.9162151,0.0006838859,0.077755176,0.00054228446,0.0001274918,0.00021390377,0.0015977616,0.00018516243,0.002679257],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966552,0.002386977,0.00013013293,0.00031104285,0.00037709266,0.0001395304],"domain_scores_gemma":[0.9876645,0.009890414,0.0006987034,0.0009751766,0.0005983681,0.00017287824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008789675,0.0006520806,0.0008731884,0.0009558157,0.00023616261,0.0030450774,0.0013637681,0.0012263095,0.0062702377],"category_scores_gemma":[0.069755,0.00041147566,0.0010835484,0.0014710719,0.0016553963,0.0065370724,0.0014628328,0.0029017874,0.0015017692],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007704953,0.0004717232,0.037457865,0.00053320837,0.0003971145,0.00025804,0.0014460529,0.1423933,0.00074234843,0.41305432,0.015496128,0.38697943],"study_design_scores_gemma":[0.00005636192,0.00009472517,0.007411462,0.00015125208,0.00003853749,0.00008608711,0.00036848118,0.4220621,0.000438587,0.56567365,0.0035600895,0.000058623165],"about_ca_topic_score_codex":0.0057953373,"about_ca_topic_score_gemma":0.0020641182,"teacher_disagreement_score":0.008789675,"about_ca_system_score_codex":0.001394156,"about_ca_system_score_gemma":0.0013811897,"threshold_uncertainty_score":0.04648477},"labels":[],"label_agreement":null},{"id":"W2012735388","doi":"10.1016/j.jval.2011.08.967","title":"PIH65 What Are We Missing in Meningococcal Disease Modelling to Better Understand the Health and Economic Impact of New Vaccines?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; University of Guelph; University of Saskatchewan","funders":"","keywords":"Neisseria meningitidis; Meningococcal disease; Herd immunity; Carriage; Population; Outbreak; Transmission (telecommunications); Vaccination; Meningococcal vaccine; Medicine; Disease; Epidemiology; Bacteremia; Meningitis; Immunology; Intensive care medicine; Environmental health; Virology; Biology; Immunization; Pediatrics; Computer science; Microbiology; Immune system","score_opus":0.11830472906280515,"score_gpt":0.3202182206712417,"score_spread":0.20191349160843658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012735388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54855376,0.040199503,0.24136183,0.119382635,0.002902423,0.00026863167,0.004449438,0.00058359577,0.042298216],"genre_scores_gemma":[0.9442403,0.009760264,0.0405667,0.0018277543,0.00045914014,0.00013448313,0.0005775821,0.00012849565,0.0023052408],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979615,0.0011929712,0.000094672694,0.00010563778,0.00041261278,0.00023264205],"domain_scores_gemma":[0.9927791,0.004455347,0.0007543979,0.00041093872,0.0009737157,0.0006264732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059472565,0.001182816,0.0023932992,0.00056677224,0.00050236494,0.003440709,0.0019850158,0.0021221603,0.0057049603],"category_scores_gemma":[0.017076967,0.000582612,0.0008799076,0.00097548426,0.0013813318,0.008086227,0.0012386929,0.0037150208,0.00091947615],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014176269,0.00075868017,0.053944085,0.0020417147,0.0010965213,0.0010032463,0.00063483574,0.6076818,0.013566417,0.11923458,0.020448072,0.17817242],"study_design_scores_gemma":[0.00017654484,0.00082268787,0.012484485,0.0010538723,0.0003600512,0.0005103615,0.0016132373,0.6042679,0.003602358,0.33764455,0.037245616,0.00021827567],"about_ca_topic_score_codex":0.008169224,"about_ca_topic_score_gemma":0.011008741,"teacher_disagreement_score":0.008169224,"about_ca_system_score_codex":0.0013886066,"about_ca_system_score_gemma":0.0022177694,"threshold_uncertainty_score":0.031452477},"labels":[],"label_agreement":null},{"id":"W2012773708","doi":"10.1016/j.jval.2012.08.503","title":"MO1 Comprehensive Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Depression","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tolerability; Discontinuation; Medicine; Health care; Major depressive disorder; Time horizon; Cohort; Clinical trial; Depression (economics); Adverse effect; Actuarial science; Psychiatry; Internal medicine; Economics; Finance","score_opus":0.6168177502446268,"score_gpt":0.513549665098622,"score_spread":0.10326808514600483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012773708","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2625693,0.0019570705,0.6830748,0.0049447753,0.00027856702,0.00067677035,0.010643311,0.0014112802,0.034444075],"genre_scores_gemma":[0.94882506,0.0007030665,0.031581406,0.00030781882,0.000078150246,0.0007105384,0.002363733,0.000091496644,0.015338718],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989028,0.0006221177,0.000044109453,0.00012093571,0.00011772946,0.00019225763],"domain_scores_gemma":[0.99467456,0.0039901556,0.00033326334,0.00016524641,0.0005401454,0.0002965932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024869104,0.0009222307,0.0020009333,0.0014127297,0.00061637943,0.0018437165,0.0022009644,0.0028246618,0.010540796],"category_scores_gemma":[0.013349696,0.0007332542,0.0013100054,0.0015796677,0.00077500247,0.000974319,0.0012119348,0.002132226,0.0008417479],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009294932,0.000027356826,0.00067944085,0.000024662399,0.000040612627,0.00003487212,0.00001876748,0.98558027,0.00005411778,0.010835946,0.0006515268,0.0019594992],"study_design_scores_gemma":[0.000047600028,0.000017133181,0.00021984395,0.000008705966,0.00001529446,0.0000073806777,0.0000053125245,0.9959927,0.000028318998,0.0033167205,0.0003344827,0.000006432436],"about_ca_topic_score_codex":0.06278252,"about_ca_topic_score_gemma":0.027559418,"teacher_disagreement_score":0.06278252,"about_ca_system_score_codex":0.0026118588,"about_ca_system_score_gemma":0.0026819305,"threshold_uncertainty_score":0.12483418},"labels":[],"label_agreement":null},{"id":"W2013217692","doi":"10.1016/j.jval.2012.08.058","title":"PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan: The Road Ahead?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Delphi method; Mainland China; Health care; Medicine; Government (linguistics); Economic growth; China; Epidemiology; Business; Environmental health; Political science","score_opus":0.263109887327422,"score_gpt":0.43093615130429613,"score_spread":0.1678262639768741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013217692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98544365,0.00040876633,0.00030579668,0.0099065425,0.000024212008,0.000026152298,0.00089020527,0.000005373777,0.002989251],"genre_scores_gemma":[0.99897563,0.0000781445,0.00009691871,0.00017086192,0.000009057993,0.000011664307,0.00034397337,0.0000015323604,0.0003122732],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985916,0.0006081423,0.00006524921,0.000084915526,0.000102852006,0.0005472719],"domain_scores_gemma":[0.9956463,0.0013060863,0.0007677935,0.00012979333,0.0006607455,0.001489243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026314852,0.00025233367,0.0004459539,0.00083630625,0.00067278807,0.0022372867,0.0008408597,0.00076467486,0.0038768232],"category_scores_gemma":[0.0073336386,0.00018434269,0.00067018566,0.0018376153,0.0008358024,0.0020373177,0.0016109508,0.0013406089,0.00017645955],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006153764,0.0003112286,0.92291117,0.0001370525,0.00041190255,0.00074863195,0.0021204827,0.009677597,0.0001727617,0.012645202,0.008721253,0.041527264],"study_design_scores_gemma":[0.0001335464,0.00028181862,0.90660614,0.00022558871,0.00017686136,0.00017430048,0.024001194,0.041993905,0.00040618939,0.021126073,0.0048134746,0.00006092518],"about_ca_topic_score_codex":0.12244527,"about_ca_topic_score_gemma":0.1267828,"teacher_disagreement_score":0.12244527,"about_ca_system_score_codex":0.004562448,"about_ca_system_score_gemma":0.0054430966,"threshold_uncertainty_score":0.24346513},"labels":[],"label_agreement":null},{"id":"W2013825351","doi":"10.1016/j.jval.2011.01.005","title":"Bridging Trial and Decision: A Checklist to Frame Health Technology Assessments for Resource Allocation Decisions","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international","keywords":"Checklist; Bridging (networking); Resource allocation; Computer science; Resource (disambiguation); Frame (networking); Management science; Operations research; Psychology; Engineering; Computer security; Telecommunications","score_opus":0.6475406595978148,"score_gpt":0.5445912012304652,"score_spread":0.10294945836734959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013825351","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022805338,0.13494147,0.59172356,0.082367204,0.0071560796,0.14645188,0.012784994,0.008160798,0.01413355],"genre_scores_gemma":[0.003399829,0.013887383,0.9290403,0.006359866,0.00053428166,0.042503156,0.0023974956,0.00031735937,0.0015602767],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.71593475,0.16123281,0.084081806,0.003502489,0.033262268,0.0019858608],"domain_scores_gemma":[0.56845397,0.29668003,0.044213135,0.018932102,0.06465811,0.0070626414],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25588182,0.005722007,0.010781083,0.016533766,0.0041150423,0.015130458,0.008471899,0.01092207,0.012030084],"category_scores_gemma":[0.35483977,0.0053529222,0.01141779,0.01354616,0.0071682706,0.012218792,0.01088738,0.017503668,0.00801152],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010735152,0.00028835118,0.0015745144,0.05872801,0.0016914802,0.00035279559,0.0025345907,0.0028153802,0.0009066353,0.043476887,0.2387632,0.64779454],"study_design_scores_gemma":[0.0035988626,0.0006444377,0.0045343307,0.13380297,0.0040921876,0.0010257945,0.0014682162,0.0074818237,0.0028305007,0.11427865,0.72558326,0.00065899757],"about_ca_topic_score_codex":0.006467058,"about_ca_topic_score_gemma":0.015967654,"teacher_disagreement_score":0.7441182,"about_ca_system_score_codex":0.013515444,"about_ca_system_score_gemma":0.07031236,"threshold_uncertainty_score":0.9176302},"labels":[],"label_agreement":null},{"id":"W2013955204","doi":"10.1016/j.jval.2014.03.875","title":"Impact Of Educational Intervention On Quality Of Life Of Patients Nearing End Of Life: An Evidence Based Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Medicine; Quality of life (healthcare); Psychological intervention; Cohort; Intervention (counseling); End-of-life care; Cohort study; Protocol (science); Population; Randomized controlled trial; Disease; Family medicine; Health care; Physical therapy; Alternative medicine; Palliative care; Internal medicine; Nursing; Pathology","score_opus":0.3214730691888535,"score_gpt":0.5314031706523847,"score_spread":0.20993010146353125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013955204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93297005,0.056296498,0.0007686644,0.0012009855,0.00026312625,0.0034300447,0.0015969189,0.000025606025,0.0034479583],"genre_scores_gemma":[0.9869343,0.009995139,0.0012500145,0.00032975106,0.000096764204,0.0007222803,0.00034862134,0.0000047592816,0.00031835874],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9907799,0.00475399,0.0016298814,0.0005684099,0.001659167,0.000608589],"domain_scores_gemma":[0.9721308,0.02158963,0.0039476017,0.0003955314,0.0010702854,0.00086619274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071944008,0.0007285693,0.0041555297,0.0018475833,0.00062566117,0.0014134881,0.00094217464,0.0017294522,0.0058479365],"category_scores_gemma":[0.02227445,0.0004821203,0.009641339,0.002195303,0.0009129737,0.0010552462,0.001005174,0.0022835461,0.00026971407],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35477215,0.035504553,0.0916713,0.06883602,0.11611354,0.00045410698,0.0012441474,0.0026104888,0.0015241688,0.0008388802,0.0012765025,0.32515422],"study_design_scores_gemma":[0.17472039,0.24622792,0.2877186,0.022158578,0.25558305,0.0004173148,0.002170119,0.00216434,0.0024759416,0.001062966,0.0050335974,0.00026715136],"about_ca_topic_score_codex":0.0037532004,"about_ca_topic_score_gemma":0.0084378,"teacher_disagreement_score":0.0071944008,"about_ca_system_score_codex":0.0028827472,"about_ca_system_score_gemma":0.0033592896,"threshold_uncertainty_score":0.03804809},"labels":[],"label_agreement":null},{"id":"W2014207635","doi":"10.1016/s1098-3015(10)63265-2","title":"PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Rituximab; Medicine; Physical therapy; Internal medicine; Lymphoma","score_opus":0.026475969947324877,"score_gpt":0.2964060608218043,"score_spread":0.26993009087447944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014207635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647409,0.005114536,0.0009245092,0.0027062022,0.000054124685,0.0003844748,0.0151844,0.00006919425,0.010821578],"genre_scores_gemma":[0.99453133,0.0009917368,0.00065350014,0.00022644912,0.00002087969,0.00004010428,0.0021198792,0.000011325339,0.0014047787],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99825984,0.00061234215,0.000076178905,0.00012916715,0.00048230393,0.00044023234],"domain_scores_gemma":[0.997143,0.0010872341,0.0003236213,0.0000646926,0.0008704295,0.000510871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013211677,0.0005522854,0.0014157932,0.0013374602,0.00077974045,0.0018654845,0.0013192025,0.0008075847,0.0044264486],"category_scores_gemma":[0.00806995,0.0004712936,0.0019607467,0.0038252776,0.00059948553,0.00045218802,0.0005279522,0.000979041,0.0002135884],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061476324,0.0011390214,0.47755435,0.0017656118,0.0062055425,0.0018771498,0.00046182948,0.3018659,0.0022448574,0.008233798,0.02547867,0.111697026],"study_design_scores_gemma":[0.0071726344,0.003371984,0.70344174,0.00031019366,0.004996961,0.00089592376,0.0012098702,0.26409066,0.0011051055,0.0018691057,0.011290386,0.00024541016],"about_ca_topic_score_codex":0.96852714,"about_ca_topic_score_gemma":0.96282333,"teacher_disagreement_score":0.053474132,"about_ca_system_score_codex":0.053474132,"about_ca_system_score_gemma":0.03443253,"threshold_uncertainty_score":0.3879838},"labels":[],"label_agreement":null},{"id":"W2014308842","doi":"10.1016/j.jval.2012.08.860","title":"PMD11 The Cost of Poor Sample Quality: Assessing the Financial Impact of Sample Rejection and Recollection in Health Care Insitutions","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Sample (material); Sample size determination; Total cost; Health care; Medicine; Statistics; Financial institution; Equating; Demography; Actuarial science; Operations management; Finance; Economics; Accounting; Mathematics; Economic growth","score_opus":0.18342515748719224,"score_gpt":0.4029019156364297,"score_spread":0.21947675814923745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014308842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.811063,0.004062516,0.04853458,0.070998795,0.0012688083,0.002328881,0.020832442,0.00065891794,0.040252022],"genre_scores_gemma":[0.9759866,0.0003687585,0.0128217,0.002398704,0.00041126003,0.00095211476,0.0023012739,0.00009064588,0.004668877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8993124,0.08170036,0.004545009,0.0019112955,0.010645604,0.0018853573],"domain_scores_gemma":[0.29781863,0.6086525,0.053829752,0.016622022,0.017724441,0.0053526433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06816018,0.00056046684,0.0007021443,0.002364733,0.0011211439,0.002850339,0.002726598,0.0037712227,0.016642097],"category_scores_gemma":[0.53554094,0.0005564237,0.0019841033,0.0038962269,0.0017726894,0.0024137902,0.0036408857,0.0036400189,0.0012165513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00648267,0.00092757866,0.6582982,0.0008217516,0.0013802258,0.0007617963,0.0009021329,0.025730927,0.0003134625,0.01868926,0.060894325,0.22479767],"study_design_scores_gemma":[0.0020137262,0.0045547467,0.69993144,0.0013566621,0.0020925005,0.0017594433,0.0026694778,0.21053103,0.0048899096,0.03216922,0.037708975,0.00032295493],"about_ca_topic_score_codex":0.011591472,"about_ca_topic_score_gemma":0.010265347,"teacher_disagreement_score":0.06816018,"about_ca_system_score_codex":0.004577213,"about_ca_system_score_gemma":0.0041526416,"threshold_uncertainty_score":0.36046976},"labels":[],"label_agreement":null},{"id":"W2014318252","doi":"10.1016/j.jval.2011.07.003","title":"The MacNew Heart Disease Health-Related Quality of Life Questionnaire in Patients with Angina and Patients with Ischemic Heart Failure","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary","funders":"U.S. Food and Drug Administration; European Society of Cardiology; Canadian Cardiovascular Society","keywords":"Medicine; Angina; Heart failure; Myocardial infarction; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Heart disease; Physical therapy; Anxiety; Cardiology; Internal medicine; Psychiatry","score_opus":0.023634926980018157,"score_gpt":0.28810727050774754,"score_spread":0.26447234352772936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014318252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995385,0.00080133503,0.00007852185,0.00021207855,0.000034147506,0.00007230986,0.0015550174,0.00000405602,0.0018574657],"genre_scores_gemma":[0.99734205,0.00029096124,0.00016379343,0.00013365179,0.000036856596,0.00007103204,0.0014835675,0.000001580564,0.0004765686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999316,0.00023230378,0.00013185485,0.00006447356,0.00014376211,0.00011161428],"domain_scores_gemma":[0.99787223,0.00047893406,0.000994203,0.000048287544,0.00020117547,0.0004050959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010259374,0.00046120695,0.0010498911,0.0011721244,0.00040279923,0.00081245136,0.0005465436,0.0007934243,0.0021189777],"category_scores_gemma":[0.0047998526,0.0002423294,0.0014599952,0.0011995358,0.00026870513,0.0009863822,0.00088737404,0.001063175,0.00020089209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005723513,0.00019423944,0.995567,0.000049608137,0.00040613004,0.0000818141,0.00010012951,0.00012739396,0.000077679215,0.000035555284,0.00041407152,0.0023740106],"study_design_scores_gemma":[0.000055395307,0.00016249972,0.99907947,0.0000096115655,0.00007635961,0.00008187802,0.00012310596,0.00020512722,0.000011208332,0.000027438206,0.00016009487,0.000007874113],"about_ca_topic_score_codex":0.0050482373,"about_ca_topic_score_gemma":0.010362057,"teacher_disagreement_score":0.0050482373,"about_ca_system_score_codex":0.00069851725,"about_ca_system_score_gemma":0.00041102344,"threshold_uncertainty_score":0.01003772},"labels":[],"label_agreement":null},{"id":"W2014505829","doi":"10.1046/j.1524-4733.2000.36006.x","title":"Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pravastatin; Cohort; Statin; Persistence (discontinuity); Population; Medical record; Demography; Pediatrics; Internal medicine; Environmental health","score_opus":0.07645816296236467,"score_gpt":0.35671550069685415,"score_spread":0.28025733773448946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014505829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996487,0.00007972622,0.000014848532,0.00004234906,0.0000015361226,0.0000042538877,0.00011161748,8.7065825e-7,0.00009612645],"genre_scores_gemma":[0.9995579,0.000041798467,0.000015568901,0.000017135075,0.0000068548693,0.0000033905112,0.00029162073,6.199692e-7,0.000065028005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954224,0.00008258882,0.000045390138,0.00009320986,0.00010718817,0.00012936565],"domain_scores_gemma":[0.99695,0.0004123373,0.0015106192,0.00012106738,0.00044020894,0.00056576903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006921102,0.00017956803,0.00038242713,0.0006355155,0.00059018115,0.0007424555,0.00035238315,0.0004044566,0.0013130677],"category_scores_gemma":[0.003290847,0.0001658981,0.00028997113,0.00072846573,0.0003832048,0.00038045173,0.0003711552,0.000578205,0.00014402594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046006528,0.00001529548,0.9994361,0.0000014977846,0.000010735196,0.000024292802,0.000023848257,0.0000113471615,0.00004818519,0.0000029988178,0.00003612485,0.00034361787],"study_design_scores_gemma":[0.000004234218,0.00003242974,0.9996995,0.0000019642293,0.000005716437,0.00005215611,0.00005806406,0.00009773844,0.000009145606,0.0000031833306,0.000035080495,9.853629e-7],"about_ca_topic_score_codex":0.07662894,"about_ca_topic_score_gemma":0.07089842,"teacher_disagreement_score":0.07662894,"about_ca_system_score_codex":0.00081025064,"about_ca_system_score_gemma":0.0009898844,"threshold_uncertainty_score":0.1523658},"labels":[],"label_agreement":null},{"id":"W2014624650","doi":"10.1016/j.jval.2014.03.899","title":"Cardiovascular Agents - Most Common Class Involved In Adverse Drug Reactions In Indian Elderly Inpatients","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Drug reaction; Drug; Observational study; Drug class; Adverse drug reaction; Adverse effect; Internal medicine; Pharmacology; Intensive care medicine","score_opus":0.1203278776865381,"score_gpt":0.3797380571844018,"score_spread":0.2594101794978637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014624650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945076,0.0019950485,0.00006309506,0.00020848286,0.000019771114,0.000015627596,0.00031895214,0.0000064348674,0.0028648956],"genre_scores_gemma":[0.9983493,0.0009653671,0.00009193847,0.00014423633,0.000023195837,0.000003947263,0.00013906012,0.0000016628197,0.00028125095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995431,0.00006119507,0.00009501626,0.00003743563,0.00016805173,0.00009538769],"domain_scores_gemma":[0.9985141,0.00016541935,0.00093831186,0.000041352432,0.00015084402,0.0001899846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021972679,0.00013461782,0.0003739414,0.0006735133,0.0004956434,0.0005683237,0.00018021314,0.00023226414,0.0017892256],"category_scores_gemma":[0.0014655099,0.000095440126,0.0004929559,0.000987265,0.00012666504,0.00021549364,0.00028995928,0.0006881232,0.00016246879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016298234,0.00008407241,0.9911624,0.00007850061,0.000051372193,0.0007736108,0.00022961914,0.000021633401,0.00052538165,0.000031929187,0.00022230143,0.00665625],"study_design_scores_gemma":[0.0000041555195,0.00013776975,0.99509335,0.000043163473,0.000093608985,0.0024818857,0.0010933339,0.00006840173,0.00021732718,0.000032348675,0.0007288076,0.0000058916426],"about_ca_topic_score_codex":0.0065016667,"about_ca_topic_score_gemma":0.008909556,"teacher_disagreement_score":0.0065016667,"about_ca_system_score_codex":0.00038907272,"about_ca_system_score_gemma":0.00057018065,"threshold_uncertainty_score":0.012927651},"labels":[],"label_agreement":null},{"id":"W2014744074","doi":"10.1016/s1098-3015(10)67771-6","title":"PMH25 EFFECTIVENESS AND TOLERABILITY OUTCOMES OF RISPERIDONE LONG-ACTING INJECTION COMPARED TO CONVENTIONAL DEPOT ANTIPSYCHOTICS IN A LARGE CANADIAN PSYCHIATRIC HOSPITAL","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Tolerability; Psychiatry; Medicine; Depot; Schizophrenia (object-oriented programming); Pharmacology; Adverse effect; Political science","score_opus":0.2874956640059928,"score_gpt":0.5048416024944938,"score_spread":0.21734593848850103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014744074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986596,0.00028652142,0.000013247832,0.00014021025,0.000005549825,0.00003376764,0.00026703445,0.000004126632,0.00058987224],"genre_scores_gemma":[0.99900514,0.00015587064,0.000060544306,0.00010008349,0.00001090919,0.000014342513,0.00019486173,0.0000022061047,0.00045600283],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925226,0.0000978509,0.000035698846,0.000098912795,0.00019186911,0.0003232588],"domain_scores_gemma":[0.99854565,0.00022355322,0.00031079023,0.00003053709,0.00025623024,0.00063326035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004655178,0.00027420803,0.00047468324,0.00036812804,0.0009796652,0.0009182207,0.0008210533,0.00042096028,0.0023075282],"category_scores_gemma":[0.0020224238,0.00021400137,0.0006186724,0.00068806193,0.0006784678,0.00027470206,0.00040732764,0.0006885713,0.00015432393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041306525,0.00394778,0.8427452,0.0003999989,0.0006907316,0.0007846229,0.0022867857,0.0019752197,0.003505818,0.00032468367,0.005594638,0.09643805],"study_design_scores_gemma":[0.0009545013,0.0043683834,0.9912503,0.000033455985,0.00021319352,0.00010791075,0.001034981,0.0011099008,0.0003701081,0.000028316439,0.00048229852,0.00004658722],"about_ca_topic_score_codex":0.85455686,"about_ca_topic_score_gemma":0.931378,"teacher_disagreement_score":0.14544314,"about_ca_system_score_codex":0.021253055,"about_ca_system_score_gemma":0.014620657,"threshold_uncertainty_score":0.29259932},"labels":[],"label_agreement":null},{"id":"W2014803877","doi":"10.1016/s1098-3015(10)71995-1","title":"HT3 MULTICRITERIA DECISION ANALYSIS (MCDA) FOR DRUG COVERAGE DECISION BY A PUBLIC HEALTH PLAN: CASE STUDY OF TRAMADOL FOR CHRONIC NON-CANCER PAIN (CNCP) IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tramadol; Multiple-criteria decision analysis; Decision analysis; Plan (archaeology); Medicine; Operations research; Engineering; Pharmacology; Analgesic; Mathematics; Statistics; Geography","score_opus":0.17389799455223806,"score_gpt":0.43364011490538434,"score_spread":0.25974212035314626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014803877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88071287,0.0005208315,0.06619368,0.0052137375,0.000104108265,0.0029866456,0.0046470733,0.00041332003,0.039207656],"genre_scores_gemma":[0.9533533,0.00013622307,0.041940138,0.00021028354,0.000024392166,0.00029016196,0.00042705605,0.000030952964,0.0035875577],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9961514,0.002437254,0.00012491186,0.0002736339,0.0003424017,0.00067043916],"domain_scores_gemma":[0.98746955,0.010711868,0.00030619427,0.0002122757,0.00086592045,0.00043422056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054956013,0.00079376274,0.0014525891,0.0021270965,0.0025774266,0.0028216413,0.0019000535,0.0027128702,0.014364232],"category_scores_gemma":[0.013604662,0.00082281197,0.0019002733,0.002238709,0.0011672142,0.0010197865,0.0012019291,0.0015924658,0.00040211],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022809305,0.0011275156,0.020320332,0.0004999311,0.00037577972,0.0017122144,0.0006942465,0.90054196,0.001048415,0.016410107,0.008287482,0.046701044],"study_design_scores_gemma":[0.00040914258,0.00030656665,0.0040817573,0.00004740209,0.000114500974,0.00014977701,0.00085500407,0.9871516,0.00036488206,0.0045228396,0.0019448095,0.000051712155],"about_ca_topic_score_codex":0.6050746,"about_ca_topic_score_gemma":0.5939523,"teacher_disagreement_score":0.9855815,"about_ca_system_score_codex":0.014418469,"about_ca_system_score_gemma":0.020971986,"threshold_uncertainty_score":0.7945024},"labels":[],"label_agreement":null},{"id":"W2014915905","doi":"10.1016/j.jval.2013.03.887","title":"Use Of Biologic Agents In The Treatment Of Psoriasis: An Analysis Of The Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Adalimumab; Golimumab; Etanercept; Ustekinumab; Infliximab; Tocilizumab; Psoriasis; Psoriatic arthritis; Abatacept; Internal medicine; Rituximab; Rheumatoid arthritis; Physical therapy; Dermatology; Disease; Lymphoma","score_opus":0.2732841672577958,"score_gpt":0.45399428710685424,"score_spread":0.18071011984905844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014915905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75558054,0.0055195633,0.00044180785,0.001983503,0.000039386054,0.00039551582,0.22895165,0.00009006964,0.0069978833],"genre_scores_gemma":[0.9269795,0.002285699,0.0009494947,0.0006169395,0.00003437168,0.00025285824,0.06687303,0.000031989446,0.001976203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959125,0.0006354332,0.0005471535,0.00048021195,0.0019505105,0.00047417756],"domain_scores_gemma":[0.9744666,0.0055918545,0.0071931635,0.00088526163,0.010057278,0.0018057821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023556992,0.00035820948,0.00092996826,0.005180978,0.0013074707,0.0015007184,0.0018377029,0.0007376865,0.004139197],"category_scores_gemma":[0.017692737,0.00033800036,0.0010761772,0.017036235,0.00035059682,0.0005900543,0.0007395786,0.0008614402,0.00044034322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003791007,0.0000642922,0.9754971,0.000229311,0.0003373641,0.000085982276,0.00021653286,0.0004672741,0.000091579604,0.00021607039,0.013297773,0.009117508],"study_design_scores_gemma":[0.000039937044,0.000023653909,0.9941134,0.00009375809,0.00010580594,0.00007458114,0.00018126302,0.0015818481,0.000057050544,0.000018476085,0.0036963748,0.000013819589],"about_ca_topic_score_codex":0.9823539,"about_ca_topic_score_gemma":0.9860362,"teacher_disagreement_score":0.03592569,"about_ca_system_score_codex":0.03592569,"about_ca_system_score_gemma":0.035308037,"threshold_uncertainty_score":0.2606603},"labels":[],"label_agreement":null},{"id":"W2015115414","doi":"10.1016/j.jval.2011.08.1666","title":"PMH1 Comparing The Effectiveness Of Paliperidone Palmitate Versus Olanzapine Pamoate For Relapse Prevention In Schizophrenia: Post Hoc Indirect Analysis Using Published Placebo-Controlled Studies","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Olanzapine; Placebo; Medicine; Post-hoc analysis; Internal medicine; Schizophrenia (object-oriented programming); Paliperidone; Randomization; Relapse prevention; Randomized controlled trial; Atypical antipsychotic; Antipsychotic; Psychiatry","score_opus":0.13928824246581012,"score_gpt":0.3663091897198219,"score_spread":0.22702094725401178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015115414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9507297,0.030353323,0.0052472334,0.0008937161,0.0015368103,0.0029581166,0.0039080726,0.00035160358,0.004021402],"genre_scores_gemma":[0.98999935,0.0030538926,0.0026542356,0.00022674796,0.0003324852,0.0011976518,0.0007640041,0.00004516021,0.0017264213],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97994804,0.016941907,0.0010187402,0.0008881412,0.0006785652,0.00052455085],"domain_scores_gemma":[0.9800214,0.015725115,0.002342917,0.0009115574,0.0005705017,0.00042859733],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.012902418,0.0034545527,0.00899486,0.0013301458,0.00058584975,0.0016388132,0.0018537882,0.0022958203,0.010960446],"category_scores_gemma":[0.020870999,0.0017390215,0.015230981,0.001181754,0.0013932687,0.0015361008,0.0016286224,0.0036883766,0.0006438835],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92915887,0.00073568884,0.001124193,0.0030094436,0.053797856,0.000054733384,0.00006064428,0.001143955,0.0005380197,0.000114008595,0.00023921634,0.010023369],"study_design_scores_gemma":[0.65714335,0.1119921,0.017455122,0.0006512683,0.2012626,0.00013723799,0.00015549721,0.0060749217,0.0027389105,0.0008314467,0.0014267573,0.00013075335],"about_ca_topic_score_codex":0.0042159962,"about_ca_topic_score_gemma":0.004209901,"teacher_disagreement_score":0.9910051,"about_ca_system_score_codex":0.0017278107,"about_ca_system_score_gemma":0.0013977381,"threshold_uncertainty_score":0.06823534},"labels":[],"label_agreement":null},{"id":"W2015168093","doi":"10.1016/j.jval.2013.03.1478","title":"Cost-effectiveness of ticagrelor versus generic clopidogrel in patients with acute coronary syndromes in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University Health Network; St. Paul's Hospital; McMaster University; Programs for Assessment of Technology in Health Research Institute; AstraZeneca (Canada); University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Quality-adjusted life year; Internal medicine; Stroke (engine); Emergency medicine; Cardiology; Aspirin; Cost effectiveness","score_opus":0.03387759758753904,"score_gpt":0.2694890968173862,"score_spread":0.23561149922984714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015168093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97919,0.0068674204,0.00007590747,0.0050735623,0.000089244124,0.0000949085,0.0023750341,0.000010793263,0.00622305],"genre_scores_gemma":[0.9964652,0.0017400716,0.00014332903,0.00046108186,0.00003848925,0.00001252321,0.0006880806,0.000003758407,0.00044751362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988926,0.0002165288,0.00009820209,0.00009331163,0.0002873639,0.00041200838],"domain_scores_gemma":[0.99696285,0.0006088196,0.0005406842,0.00004132995,0.00078643137,0.0010599357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006397567,0.0002705034,0.0007918495,0.0007634356,0.0013531157,0.0017079236,0.00097650755,0.0008450187,0.002982955],"category_scores_gemma":[0.0068512913,0.00028815772,0.0012250417,0.0023652867,0.0007625457,0.00047740017,0.00057993224,0.001183459,0.00008802438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012780548,0.001048446,0.8994907,0.0009337727,0.0016418335,0.00067307526,0.0005183541,0.009155752,0.00039192947,0.0024319214,0.013919312,0.057014316],"study_design_scores_gemma":[0.0024279833,0.000872534,0.97774005,0.00042788658,0.0014301221,0.0002855679,0.001797839,0.011509659,0.00016989557,0.0006552261,0.002598363,0.00008478111],"about_ca_topic_score_codex":0.9791334,"about_ca_topic_score_gemma":0.989679,"teacher_disagreement_score":0.062240254,"about_ca_system_score_codex":0.062240254,"about_ca_system_score_gemma":0.053272855,"threshold_uncertainty_score":0.45158678},"labels":[],"label_agreement":null},{"id":"W2015241337","doi":"10.1016/j.jval.2014.08.877","title":"Systematic Review of the Economics of Multiple Sclerosis in Latin America","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fingolimod; Latin Americans; MEDLINE; Medicine; Work productivity; Multiple sclerosis; Natalizumab; Family medicine; Productivity; Political science; Economic growth; Economics; Psychiatry","score_opus":0.03738025541272694,"score_gpt":0.25585409724819513,"score_spread":0.2184738418354682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015241337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008962915,0.988223,0.00019781475,0.0009203197,0.000105947955,0.0001543081,0.0009747592,0.0000048737356,0.00045604384],"genre_scores_gemma":[0.21905616,0.7768914,0.0012014754,0.0014027058,0.00018066604,0.00047009168,0.0005819665,0.000009873382,0.00020560897],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9786461,0.013355217,0.0049864077,0.0008314132,0.0017120912,0.00046880147],"domain_scores_gemma":[0.9161932,0.063613005,0.01468882,0.0013769027,0.0035871214,0.000541056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02127401,0.0012734757,0.0064256606,0.009759984,0.0005223859,0.002924202,0.0013114286,0.0019023998,0.003271393],"category_scores_gemma":[0.08930947,0.00086093805,0.008178927,0.01169522,0.000981724,0.0013399669,0.0018913886,0.0011286578,0.00012392119],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025710627,0.00005845035,0.017597774,0.7580417,0.18214582,0.00037409435,0.00032008224,0.00076620287,0.0002453173,0.0011730094,0.002015443,0.03469112],"study_design_scores_gemma":[0.0026522917,0.0004564674,0.04956939,0.43306708,0.49238062,0.00071517454,0.00075004314,0.00041400938,0.00023191818,0.0018871148,0.017807983,0.00006789391],"about_ca_topic_score_codex":0.02521383,"about_ca_topic_score_gemma":0.06196934,"teacher_disagreement_score":0.02521383,"about_ca_system_score_codex":0.006941855,"about_ca_system_score_gemma":0.01234051,"threshold_uncertainty_score":0.11250907},"labels":[],"label_agreement":null},{"id":"W2015267237","doi":"10.1016/j.jval.2013.08.2069","title":"Acute Exposure of Bisphenol-A from Electronic Gadgets Does Not Induce Oxidative Stress in the Rat Brain","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Effects and risks of endocrine disrupting chemicals","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Oxidative stress; Glutathione peroxidase; Superoxide dismutase; Catalase; Glutathione; Endocrinology; Internal medicine; Striatum; Chemistry; Antioxidant; Glutathione reductase; Biochemistry; Biology; Enzyme; Medicine; Dopamine","score_opus":0.012976075739126094,"score_gpt":0.3153462837023737,"score_spread":0.30237020796324765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015267237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99804807,0.0003543746,0.00071551476,0.00006474027,0.00004890535,0.00001329126,0.00012766833,0.000016493354,0.0006109209],"genre_scores_gemma":[0.9921532,0.001173815,0.0010003175,0.00011408944,0.000022373732,0.00005677549,0.0007571914,0.000020547215,0.004701648],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998528,0.00001758873,0.000009822446,0.0000367727,0.000031665724,0.000051334177],"domain_scores_gemma":[0.9996927,0.00004219462,0.00007233855,0.00005488457,0.000051053845,0.00008688958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011807165,0.00072443247,0.00023992559,0.0005786132,0.00042412142,0.00044790722,0.0004193456,0.00054856733,0.0026069542],"category_scores_gemma":[0.00024207955,0.00039206436,0.00036784547,0.00029089043,0.0007239611,0.00064350374,0.0003710788,0.0008531603,0.0004287112],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034737806,0.00030909246,0.0012650392,0.00007672429,0.00005360123,0.00015694562,0.00007409495,0.00005681544,0.99135923,0.00013110672,0.00007992899,0.002963597],"study_design_scores_gemma":[0.000060427927,0.0029360887,0.0156190945,0.000022563261,0.00010597929,0.00030064787,0.0003547584,0.0003359001,0.9788537,0.00030565946,0.0010912982,0.000013885425],"about_ca_topic_score_codex":0.0026151787,"about_ca_topic_score_gemma":0.0040774834,"teacher_disagreement_score":0.0026151787,"about_ca_system_score_codex":0.00033798988,"about_ca_system_score_gemma":0.0005513886,"threshold_uncertainty_score":0.008721173},"labels":[],"label_agreement":null},{"id":"W2015321922","doi":"10.1046/j.1524-4733.2001.45038.x","title":"The Impact of Risk on Preference Values: Implications for Evaluations of Postmenopausal Osteoporosis Therapy","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Raloxifene; Breast cancer; Osteoporosis; Hormone replacement therapy (female-to-male); Population; Physical therapy; Hip fracture; Menopause; Disease; Demography; Gynecology; Internal medicine; Cancer; Environmental health; Tamoxifen","score_opus":0.17587978099360377,"score_gpt":0.4486038905858972,"score_spread":0.27272410959229343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015321922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87383866,0.0051196157,0.03145038,0.009377078,0.00023699379,0.00048536903,0.0008764006,0.000036463225,0.078579046],"genre_scores_gemma":[0.9930171,0.0005521611,0.0052130343,0.0004105397,0.000048646994,0.00010043716,0.0000989756,0.00000790068,0.00055117515],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9868276,0.010106071,0.0003835009,0.0003161361,0.002114027,0.00025269313],"domain_scores_gemma":[0.8370064,0.15330909,0.0032809535,0.0022694794,0.0028825481,0.0012515542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020069532,0.00064741925,0.0010549673,0.0010374399,0.0005893602,0.003821812,0.0007565352,0.0014931721,0.009902701],"category_scores_gemma":[0.15875253,0.00032250906,0.0014425458,0.0014593217,0.0020899137,0.0041941805,0.001418025,0.0022550207,0.00023185415],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023549097,0.0049431035,0.18177171,0.0032890695,0.002869694,0.0009116873,0.005920467,0.034649372,0.0030179478,0.20039418,0.007666104,0.5310176],"study_design_scores_gemma":[0.00209182,0.006771337,0.19386038,0.001578086,0.002329407,0.0011465639,0.008787935,0.108842365,0.002638659,0.66123104,0.010352031,0.00037027354],"about_ca_topic_score_codex":0.002040262,"about_ca_topic_score_gemma":0.0043641226,"teacher_disagreement_score":0.020069532,"about_ca_system_score_codex":0.0018857421,"about_ca_system_score_gemma":0.0010933117,"threshold_uncertainty_score":0.106139064},"labels":[],"label_agreement":null},{"id":"W2015813113","doi":"10.1016/j.jval.2012.08.515","title":"UT3 Estimating Preference-Based Index from Cancer-Specific Quality of Life Measures for Use in Cost-Utility-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Statistics; Mean squared error; Ordinary least squares; Econometrics; Standard error; Mathematics; Preference; Health Utilities Index; Quality of life (healthcare); Regression; Quality-adjusted life year; Linear regression; Medicine; Demography; Health related quality of life; Cost effectiveness; Internal medicine","score_opus":0.8132519896969925,"score_gpt":0.48554798356360784,"score_spread":0.3277040061333847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015813113","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40166157,0.00053752493,0.57614887,0.00034411732,0.00009031588,0.000429456,0.011916991,0.0009346267,0.007936659],"genre_scores_gemma":[0.76233494,0.00013772698,0.22747678,0.000055521316,0.000021388068,0.0003086667,0.007237627,0.00012937203,0.0022980366],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99928206,0.00035393256,0.00005779485,0.0000926608,0.0001439817,0.00006956646],"domain_scores_gemma":[0.9981395,0.0009820275,0.00014438738,0.0002005827,0.0004853229,0.000048187478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023649998,0.000477562,0.000582224,0.001832082,0.00023836618,0.0011477394,0.0005980061,0.00061422953,0.008168941],"category_scores_gemma":[0.012750608,0.00021957034,0.0013212211,0.0026000512,0.00012224964,0.00061150175,0.0006659631,0.0005367688,0.00084930594],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00206113,0.00045250318,0.14800528,0.0006635812,0.0010214169,0.00031739485,0.00015083064,0.2821076,0.006004225,0.015650788,0.016407276,0.5271579],"study_design_scores_gemma":[0.00010927255,0.00023369081,0.048220195,0.00005312634,0.00013190857,0.00019206885,0.00008140575,0.9298808,0.0054320577,0.012331512,0.003286644,0.00004741328],"about_ca_topic_score_codex":0.01969259,"about_ca_topic_score_gemma":0.011357292,"teacher_disagreement_score":0.01969259,"about_ca_system_score_codex":0.00086110906,"about_ca_system_score_gemma":0.0010640372,"threshold_uncertainty_score":0.03915596},"labels":[],"label_agreement":null},{"id":"W2015965950","doi":"10.1016/j.jval.2011.08.1289","title":"PCN190 Use of Surrogate Measures of Survival in Economic Evaluations of Metastatic Breast Cancer Treatments","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Context (archaeology); Breast cancer; Pearson product-moment correlation coefficient; Metastatic breast cancer; Oncology; Population; Internal medicine; Covariate; Clinical trial; Progression-free survival; Cancer; Overall survival; Statistics","score_opus":0.7290232337247132,"score_gpt":0.47050470245681997,"score_spread":0.25851853126789326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015965950","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3199121,0.04149332,0.15624754,0.03048823,0.0036059734,0.0024461,0.03486306,0.00062056305,0.4103231],"genre_scores_gemma":[0.9534872,0.004147854,0.027623907,0.0008184014,0.00044677468,0.0009669298,0.005573973,0.0001472541,0.0067876303],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9529609,0.04117485,0.0011245494,0.00049875124,0.0039485455,0.00029239262],"domain_scores_gemma":[0.9090877,0.06783683,0.007637245,0.005037052,0.009144822,0.0012562835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03061257,0.0005516215,0.0007062249,0.0024602576,0.00041055377,0.0027803262,0.00054413103,0.00063949125,0.008923023],"category_scores_gemma":[0.15081123,0.00030825488,0.0008428901,0.0029958698,0.0008488335,0.0014658239,0.0014408928,0.0016457385,0.0011695531],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006219403,0.00061951816,0.10150994,0.0019672709,0.001041473,0.0003993992,0.00032838932,0.038438424,0.00060215156,0.10903218,0.09783893,0.642003],"study_design_scores_gemma":[0.0026162788,0.0044341595,0.22317748,0.00608493,0.00081848976,0.0017119795,0.0005540762,0.36344925,0.00538244,0.18544021,0.20598331,0.00034742383],"about_ca_topic_score_codex":0.006431639,"about_ca_topic_score_gemma":0.008481197,"teacher_disagreement_score":0.03061257,"about_ca_system_score_codex":0.0026550714,"about_ca_system_score_gemma":0.002528297,"threshold_uncertainty_score":0.1618967},"labels":[],"label_agreement":null},{"id":"W2016226558","doi":"10.1016/j.jval.2011.08.1274","title":"PCN175 Reimbursement of Anticancer Drugs in Canada: What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Nice; Medicine; Reimbursement; Excellence; Formulary; Drug; Family medicine; Pharmacology; Health care","score_opus":0.44875200289416417,"score_gpt":0.43011521313592066,"score_spread":0.01863678975824351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016226558","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01319224,0.05856036,0.001336721,0.89379066,0.0052711316,0.00026592886,0.0034815308,0.00014948116,0.023951938],"genre_scores_gemma":[0.35479948,0.11013815,0.025816966,0.46778437,0.010213656,0.0008280414,0.0073419414,0.0004648567,0.022612544],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95170957,0.011417817,0.003913632,0.00174739,0.0257907,0.0054207845],"domain_scores_gemma":[0.78533876,0.05874403,0.0107620135,0.002454022,0.117749944,0.024951188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044442993,0.0010878935,0.0026748588,0.0042715087,0.003898911,0.015622862,0.0046595926,0.012171746,0.005650229],"category_scores_gemma":[0.17807771,0.0008320632,0.0023318003,0.007593121,0.005421945,0.005491371,0.0021657331,0.009329353,0.00068703387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009047189,0.0001435988,0.02066755,0.0027920373,0.0005018734,0.00045692865,0.0013424644,0.003696348,0.00042135772,0.056300674,0.7704256,0.14234689],"study_design_scores_gemma":[0.001366133,0.0003945483,0.17585203,0.015324883,0.000874893,0.0004899535,0.0025899317,0.0107175885,0.0005303464,0.022974838,0.76795137,0.0009334114],"about_ca_topic_score_codex":0.965402,"about_ca_topic_score_gemma":0.986153,"teacher_disagreement_score":0.8721202,"about_ca_system_score_codex":0.12787978,"about_ca_system_score_gemma":0.37960738,"threshold_uncertainty_score":0.92783713},"labels":[],"label_agreement":null},{"id":"W2016421052","doi":"10.1016/j.jval.2012.08.2019","title":"PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial Hypertension","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; PharmIdeas (Canada)","funders":"","keywords":"Treprostinil; Medicine; Cohort; Population; Pulmonary hypertension; Willingness to pay; Emergency medicine; Internal medicine; Environmental health; Economics","score_opus":0.12435056726254615,"score_gpt":0.36138201002754905,"score_spread":0.2370314427650029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016421052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8165476,0.059915178,0.03698952,0.012153359,0.0010158478,0.0033964633,0.013694513,0.00048450351,0.0558031],"genre_scores_gemma":[0.9884051,0.0031148917,0.0033508046,0.000688181,0.0001978663,0.00026440094,0.0014717524,0.000023024857,0.0024840264],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99627256,0.0028165546,0.00010832828,0.00018311045,0.0003891257,0.00023043656],"domain_scores_gemma":[0.9951833,0.003973884,0.00027294073,0.00013641694,0.00020331125,0.00023011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048348284,0.0011668847,0.0021609508,0.0014272451,0.0001862549,0.0016354292,0.0008773052,0.0015716113,0.011298834],"category_scores_gemma":[0.012576016,0.0003884788,0.005180229,0.001052199,0.00049270387,0.0012472264,0.0007485985,0.0018493552,0.00053704216],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33157182,0.0029071104,0.017062698,0.00541605,0.017131513,0.0010124661,0.0001352714,0.25077602,0.007355627,0.02653905,0.0146902045,0.32540208],"study_design_scores_gemma":[0.104948126,0.0981762,0.12407916,0.0024942749,0.07440254,0.003656202,0.0007232586,0.48701736,0.0065310043,0.049746446,0.0478254,0.00040001757],"about_ca_topic_score_codex":0.003579226,"about_ca_topic_score_gemma":0.0021375064,"teacher_disagreement_score":0.011298834,"about_ca_system_score_codex":0.0020763248,"about_ca_system_score_gemma":0.0019727629,"threshold_uncertainty_score":0.037798345},"labels":[],"label_agreement":null},{"id":"W2017147270","doi":"10.1016/j.jval.2014.08.2664","title":"What Could the Future Hold? Simulating the Demand for Osteoarthritis (oa) Care in Alberta to Plan a Sustainable Oa Care System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Interprofessional Education and Collaboration","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Waterloo; University of Toronto; University of Saskatchewan; Alberta Innovates; University of Calgary","funders":"","keywords":"Operations management; Medicine; Population; Psychological intervention; Sustainability; Population ageing; Business; Medical emergency; Nursing; Engineering; Environmental health","score_opus":0.023281904578395768,"score_gpt":0.3861871882145921,"score_spread":0.36290528363619634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017147270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873554,0.000091934075,0.0012017086,0.002268296,0.000040971892,0.000041762578,0.0011158907,0.000041062718,0.007843086],"genre_scores_gemma":[0.9956499,0.00007300373,0.0013360119,0.00013357322,0.000005726465,0.000016037693,0.0005538355,0.00001009179,0.0022219275],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99949944,0.00014186348,0.000015442496,0.00003780092,0.00007548783,0.00022988798],"domain_scores_gemma":[0.9988206,0.00035033465,0.00007056949,0.00004100746,0.00031155878,0.00040581613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077747495,0.0005033142,0.00035890372,0.0004743659,0.0014413813,0.0017162935,0.0016304774,0.0017596973,0.0057777204],"category_scores_gemma":[0.0023391417,0.00038317376,0.0005546868,0.0011285207,0.0010925079,0.00088208175,0.0011160456,0.0011498618,0.00024235345],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061290234,0.00047147943,0.06397243,0.0000766455,0.000069966176,0.000696959,0.0006216645,0.9103199,0.0010010271,0.009800912,0.0058763735,0.006479704],"study_design_scores_gemma":[0.00014211143,0.00018904825,0.024042534,0.000026177768,0.000037583344,0.000043404616,0.005585608,0.96361494,0.00030055997,0.0023813285,0.003586888,0.00004984657],"about_ca_topic_score_codex":0.8975899,"about_ca_topic_score_gemma":0.92534757,"teacher_disagreement_score":0.10241008,"about_ca_system_score_codex":0.020272745,"about_ca_system_score_gemma":0.01318679,"threshold_uncertainty_score":0.20602632},"labels":[],"label_agreement":null},{"id":"W2017249113","doi":"10.1016/j.jval.2012.02.007","title":"Cost-Effectiveness of Expanded Newborn Screening in Texas","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Newborn screening; Quality-adjusted life year; Population; Cohort; Cost effectiveness; Cost–benefit analysis; Medical Expenditure Panel Survey; Pediatrics; Health care; Health insurance; Environmental health; Economics","score_opus":0.06399642146045026,"score_gpt":0.34178277459631434,"score_spread":0.2777863531358641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017249113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882465,0.0009479635,0.00035015633,0.0044828746,0.000055149,0.0000513353,0.0010705038,0.00003571083,0.0047597736],"genre_scores_gemma":[0.99788994,0.00040029932,0.00024816862,0.00022619814,0.00002735008,0.000021371643,0.00027298887,0.000003683542,0.0009100029],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896204,0.0006000468,0.000036597543,0.00007754463,0.000100824,0.000222979],"domain_scores_gemma":[0.9972963,0.0011035594,0.0004920609,0.00010294483,0.0002153915,0.0007897704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010520286,0.000312589,0.00034140196,0.0006191104,0.00030186854,0.0007560678,0.0006351976,0.00073413097,0.0063753733],"category_scores_gemma":[0.005638245,0.0001618673,0.00083259656,0.0007215394,0.00039334115,0.00049859384,0.00091680407,0.0005338226,0.00019006831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024309268,0.00279359,0.63319147,0.00041824998,0.00064776954,0.0021714226,0.00055197155,0.082129054,0.0019783317,0.008723137,0.022031594,0.2210542],"study_design_scores_gemma":[0.0024112065,0.009205874,0.91715163,0.00039955214,0.0010366569,0.00212835,0.0023314264,0.052893825,0.0012483344,0.0029076869,0.008213855,0.000071638555],"about_ca_topic_score_codex":0.05015285,"about_ca_topic_score_gemma":0.04205357,"teacher_disagreement_score":0.05015285,"about_ca_system_score_codex":0.0055632764,"about_ca_system_score_gemma":0.0037264342,"threshold_uncertainty_score":0.09972185},"labels":[],"label_agreement":null},{"id":"W2017734769","doi":"10.1016/j.jval.2011.05.002","title":"Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases: The Fabry Outcome Survey (FOS)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Fabry disease; Medicine; Enzyme replacement therapy; Observational study; Natural history; Disease; Blood pressure; Internal medicine; Intensive care medicine","score_opus":0.24879448948216032,"score_gpt":0.4349657942901129,"score_spread":0.18617130480795258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017734769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8285596,0.01380153,0.056756265,0.043911237,0.002787086,0.005499451,0.035689425,0.0006482483,0.012347273],"genre_scores_gemma":[0.95213455,0.0016609455,0.03352238,0.0030884433,0.00058733637,0.0021565952,0.0063339327,0.000060238548,0.00045552195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.76024824,0.21577217,0.008432653,0.0028152142,0.011088309,0.0016434356],"domain_scores_gemma":[0.41171798,0.48285317,0.045381464,0.028833026,0.024417287,0.006797126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18666577,0.0016835596,0.0020472987,0.0029022233,0.00052270066,0.002522824,0.002076147,0.0026199066,0.0020577172],"category_scores_gemma":[0.3635604,0.0004383852,0.0025951786,0.0052240742,0.0012504946,0.002712224,0.00441014,0.002043852,0.00021652837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007513092,0.0012496212,0.77499133,0.0021550693,0.0058238283,0.00008482845,0.0011965438,0.005909259,0.0002685696,0.0060661123,0.011680294,0.18306135],"study_design_scores_gemma":[0.00259193,0.006727352,0.9400946,0.0016048417,0.003401016,0.00017311542,0.00081321545,0.021611303,0.0010574742,0.0075416737,0.014189562,0.00019389541],"about_ca_topic_score_codex":0.010684409,"about_ca_topic_score_gemma":0.0064916206,"teacher_disagreement_score":0.18666577,"about_ca_system_score_codex":0.0026189613,"about_ca_system_score_gemma":0.0077842474,"threshold_uncertainty_score":0.9871948},"labels":[],"label_agreement":null},{"id":"W2018123025","doi":"10.1016/j.jval.2014.03.156","title":"Dissecting The Delays: The Impact Of New Policies And Practices On Total Time To Reimbursement In Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Reimbursement; Receipt; Notice; Business; Medicine; Actuarial science; Operations management; Accounting; Family medicine; Health care; Economics; Political science","score_opus":0.15040004591590553,"score_gpt":0.37749601616266476,"score_spread":0.22709597024675923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018123025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96769834,0.0011554979,0.0003709757,0.020587565,0.00005451609,0.000039531435,0.0018479122,0.000014978335,0.008230653],"genre_scores_gemma":[0.9965833,0.00040726893,0.00016410941,0.00037800116,0.000023862722,0.000010481273,0.00021587026,0.000009850491,0.0022073484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941016,0.0009300062,0.00033385778,0.00033065592,0.0018083759,0.0024955517],"domain_scores_gemma":[0.9714848,0.008767552,0.0074442457,0.0005021791,0.0056693708,0.006131785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033584852,0.00018202698,0.00041623373,0.0010739419,0.002508443,0.0026446558,0.0013917311,0.0012166469,0.004466688],"category_scores_gemma":[0.032260146,0.00037184224,0.000673695,0.0031373221,0.0017007509,0.0016235776,0.0018915217,0.0020618103,0.00016661003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011077038,0.00030134025,0.86918193,0.00034003204,0.00027543228,0.00069874665,0.01794333,0.013737628,0.00055266026,0.026805552,0.021776907,0.047278706],"study_design_scores_gemma":[0.00009723075,0.00015065254,0.9513054,0.00013136139,0.00012160836,0.00011821901,0.017167414,0.0073493295,0.00025055668,0.00359378,0.019652762,0.000061687264],"about_ca_topic_score_codex":0.9866638,"about_ca_topic_score_gemma":0.99327916,"teacher_disagreement_score":0.89539766,"about_ca_system_score_codex":0.10460237,"about_ca_system_score_gemma":0.117660865,"threshold_uncertainty_score":0.75894684},"labels":[],"label_agreement":null},{"id":"W2018206144","doi":"10.1016/j.jval.2011.08.975","title":"PSY2 Coexistence of Immuno-Mediated Inflammatory Diseases: an Analysis of the Quebec Administrative Health Databases","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Medicine; Medical diagnosis; Cohort; Rheumatoid arthritis; Ankylosing spondylitis; Psoriatic arthritis; Population; Psoriasis; Medical prescription; Internal medicine; Inflammatory bowel disease; Comorbidity; Adalimumab; Disease; Database; Dermatology; Pathology","score_opus":0.15194359115498005,"score_gpt":0.39158991520259373,"score_spread":0.23964632404761368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018206144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8209449,0.0037158781,0.00051022426,0.0010811315,0.000024261433,0.00022438532,0.17026342,0.000061014765,0.0031748414],"genre_scores_gemma":[0.9437908,0.0012685958,0.0008028282,0.00029623252,0.000025253785,0.00019078626,0.05283799,0.00002483996,0.0007626507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943837,0.0012438337,0.00078232744,0.0009466461,0.0015852763,0.0010582024],"domain_scores_gemma":[0.9667613,0.008072262,0.010393924,0.0019810174,0.010699814,0.002091717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037099484,0.00069192157,0.001244237,0.0089174835,0.002238721,0.0024204175,0.0029691658,0.00097370706,0.0039876923],"category_scores_gemma":[0.024186319,0.00049055123,0.00134477,0.0311356,0.00067322806,0.0011449127,0.0016342836,0.0009435131,0.00039002864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014897689,0.000022002005,0.9914771,0.00010923682,0.00041773956,0.000071348186,0.00024942655,0.00029556564,0.00006190525,0.00020990205,0.0043392684,0.002597604],"study_design_scores_gemma":[0.000021170468,0.000015054087,0.9961526,0.00008201443,0.00012156835,0.00007464979,0.00041634342,0.0012286725,0.000044186414,0.000034562527,0.0017939244,0.000015191037],"about_ca_topic_score_codex":0.9839829,"about_ca_topic_score_gemma":0.98466533,"teacher_disagreement_score":0.025168039,"about_ca_system_score_codex":0.025168039,"about_ca_system_score_gemma":0.023639843,"threshold_uncertainty_score":0.18260777},"labels":[],"label_agreement":null},{"id":"W2018405956","doi":"10.1016/j.jval.2012.08.2121","title":"PCN81 Cost Effectiveness of Pazopanib in Soft Tissue Sarcoma","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Pazopanib; Medicine; Placebo; Ifosfamide; Oncology; Internal medicine; Nintedanib; Soft tissue sarcoma; Adverse effect; Urology; Sarcoma; Chemotherapy; Cancer; Sunitinib","score_opus":0.06680090485340451,"score_gpt":0.3659782292824633,"score_spread":0.2991773244290588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018405956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538758,0.01974306,0.00052442,0.0039135744,0.00022017182,0.0001095511,0.0017486794,0.00003852672,0.019826254],"genre_scores_gemma":[0.99594504,0.0023024792,0.00021022673,0.00018917781,0.000074260635,0.000022372958,0.00050382194,0.0000047940216,0.0007480162],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99914074,0.0005039886,0.00004337534,0.00006459296,0.00013302722,0.00011423675],"domain_scores_gemma":[0.99910647,0.0005552173,0.00012816978,0.000027380811,0.00005010783,0.0001326735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010170174,0.00036967982,0.00085997465,0.00041534944,0.00014551042,0.000714042,0.0002847345,0.00044703536,0.0047875317],"category_scores_gemma":[0.003990667,0.00014964164,0.0013533004,0.0005718439,0.000262526,0.0007712561,0.00036105237,0.00085186545,0.0002662262],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1846389,0.0023390017,0.038319435,0.001411288,0.0035616925,0.0006572388,0.00006698544,0.06698742,0.0039583463,0.0056146085,0.012483039,0.6799621],"study_design_scores_gemma":[0.071783364,0.121656686,0.5329217,0.0011563,0.0155373635,0.004850456,0.00072740356,0.17416587,0.007998765,0.021234121,0.047742527,0.00022539822],"about_ca_topic_score_codex":0.0046354616,"about_ca_topic_score_gemma":0.005866882,"teacher_disagreement_score":0.0047875317,"about_ca_system_score_codex":0.0020044309,"about_ca_system_score_gemma":0.0012312399,"threshold_uncertainty_score":0.016015887},"labels":[],"label_agreement":null},{"id":"W2018452892","doi":"10.1016/j.jval.2011.02.032","title":"CE3 COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ASSESSMENT: A GRAPHICAL WAY TO COMBINE THE TWO FOR THE AID OF DECISION-MAKERS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Budget constraint; Health technology; Cost effectiveness; Economic evaluation; Incremental cost-effectiveness ratio; Operations research; Computer science; Cost-effectiveness analysis; Health care; Operations management; Risk analysis (engineering); Economics; Actuarial science; Environmental economics; Business; Microeconomics; Engineering","score_opus":0.3345532783764616,"score_gpt":0.4825495918838026,"score_spread":0.147996313507341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018452892","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026611236,0.0009288885,0.9709372,0.0022102576,0.0002719795,0.0003108261,0.0031051158,0.0028050258,0.016769625],"genre_scores_gemma":[0.12920873,0.001085947,0.8559781,0.000941139,0.00036091672,0.0015893957,0.0021801463,0.0013060148,0.0073496206],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9877824,0.009307461,0.0006791677,0.0004671583,0.0015308914,0.00023285687],"domain_scores_gemma":[0.9498869,0.042722818,0.002046773,0.0024631787,0.0023698164,0.0005106363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013320121,0.0033644408,0.002463233,0.010918264,0.000576612,0.0061844233,0.001985149,0.0030391929,0.04862636],"category_scores_gemma":[0.07013343,0.0012751167,0.0040219584,0.006210014,0.0013404174,0.0051330277,0.002944628,0.0033644647,0.005638082],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011707492,0.00030702943,0.0023720101,0.0026906813,0.0013023041,0.00038104007,0.00049952185,0.1189856,0.0025972202,0.5179075,0.059912473,0.29187378],"study_design_scores_gemma":[0.0005653934,0.0002703844,0.0016296604,0.0008306802,0.00066023844,0.0004814493,0.00014522158,0.33087477,0.0023202049,0.5757608,0.08622309,0.0002381443],"about_ca_topic_score_codex":0.006408814,"about_ca_topic_score_gemma":0.0061958344,"teacher_disagreement_score":0.04862636,"about_ca_system_score_codex":0.0015409992,"about_ca_system_score_gemma":0.002304465,"threshold_uncertainty_score":0.16267139},"labels":[],"label_agreement":null},{"id":"W2018514398","doi":"10.1016/j.jval.2013.08.225","title":"Tobramycin Powder for Inhalation for the Treatment of Cystic Fibrosis: Analysis of the RAMQ Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Tobramycin; Reimbursement; Inhalation; Antibiotics; Pediatrics; Population; Emergency medicine; Internal medicine; Health care; Anesthesia; Environmental health","score_opus":0.08666310165572542,"score_gpt":0.3470194326840225,"score_spread":0.2603563310282971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018514398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9250169,0.0013343069,0.0033905995,0.00049746555,0.000028098695,0.00019933142,0.063478716,0.00030115573,0.0057534464],"genre_scores_gemma":[0.9257961,0.0005510207,0.0059033055,0.00010911715,0.000020057116,0.00012482301,0.06610418,0.00008881811,0.0013026128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974591,0.00076513423,0.0002080267,0.00024359782,0.0011403322,0.00018384347],"domain_scores_gemma":[0.9891806,0.006246753,0.0014209383,0.0011107599,0.0018826431,0.00015828025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004827309,0.0002919824,0.00046168483,0.002513715,0.00017304662,0.0005849596,0.00057019887,0.00032630292,0.0024651403],"category_scores_gemma":[0.010309269,0.00010179258,0.00085588475,0.0024265354,0.00029003088,0.0004325556,0.000580677,0.0005062652,0.0008989683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047283135,0.00083658076,0.71414655,0.0013805118,0.0011630729,0.00094276544,0.00045453105,0.018001502,0.021139521,0.0045323875,0.021732276,0.21094197],"study_design_scores_gemma":[0.00020033769,0.0012095126,0.90712035,0.00014701801,0.00034782192,0.0010151298,0.0007228011,0.03387502,0.010054358,0.0011523603,0.044070374,0.00008502578],"about_ca_topic_score_codex":0.0069607724,"about_ca_topic_score_gemma":0.005527333,"teacher_disagreement_score":0.0069607724,"about_ca_system_score_codex":0.0006162578,"about_ca_system_score_gemma":0.00086327794,"threshold_uncertainty_score":0.025529563},"labels":[],"label_agreement":null},{"id":"W2018622513","doi":"10.1016/j.jval.2013.08.1531","title":"Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis: 48-Week Results from the Rapid-PsA Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Psoriatic arthritis; Randomized controlled trial; Work productivity; Bristol-Myers; Internal medicine; Productivity; Arthritis; Rheumatoid arthritis; Adalimumab; Alternative medicine","score_opus":0.1213449115631311,"score_gpt":0.31204295326556436,"score_spread":0.19069804170243326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018622513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998283,0.0010933164,0.000047571863,0.000064207656,0.000009693648,0.000025673891,0.00028252826,0.0000042547945,0.00018979775],"genre_scores_gemma":[0.99901617,0.00036147682,0.00008115222,0.00004313864,0.000024882085,0.000020788453,0.00031791232,0.0000016179991,0.00013275439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899226,0.0005255743,0.000095294585,0.00012694225,0.00015316294,0.000106785956],"domain_scores_gemma":[0.9970757,0.0010221314,0.0010255069,0.00026375853,0.00022331481,0.0003895623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003092994,0.00073789817,0.0011937182,0.00042588255,0.0002105347,0.0007549436,0.00042234964,0.00077091774,0.00083098206],"category_scores_gemma":[0.0044412776,0.00033325335,0.0016723019,0.0006925971,0.00038752359,0.0007851963,0.00048539892,0.00110955,0.00019614617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16177827,0.008189059,0.7258216,0.0006691534,0.005778242,0.00034847372,0.0006250835,0.0019311293,0.0031419755,0.00010745826,0.0013314928,0.09027799],"study_design_scores_gemma":[0.010245428,0.019835727,0.96516776,0.000044230583,0.0020584497,0.00024319309,0.00030801646,0.00081612234,0.0005149733,0.00012139556,0.0005914,0.000053311476],"about_ca_topic_score_codex":0.0020003307,"about_ca_topic_score_gemma":0.0018847344,"teacher_disagreement_score":0.003092994,"about_ca_system_score_codex":0.0004135583,"about_ca_system_score_gemma":0.00042233514,"threshold_uncertainty_score":0.016357481},"labels":[],"label_agreement":null},{"id":"W2018660330","doi":"10.1016/j.jval.2014.08.2321","title":"The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Canadian Centre for Applied Research in Cancer Control; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Docetaxel; Medicine; Pemetrexed; Lung cancer; Oncology; Internal medicine; Cost effectiveness; Chemotherapy; Cisplatin","score_opus":0.02990311617713927,"score_gpt":0.373961673780633,"score_spread":0.34405855760349374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018660330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92954683,0.0546426,0.0007910511,0.005390946,0.00028901067,0.00014812975,0.0022958294,0.000054278797,0.0068413652],"genre_scores_gemma":[0.9951285,0.003327847,0.00024678567,0.00027700563,0.00008099059,0.000021479515,0.00056893914,0.000005459094,0.00034292936],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99891675,0.00053668075,0.00008486188,0.00012186756,0.0001640658,0.00017570984],"domain_scores_gemma":[0.998706,0.00064184016,0.0002554303,0.00003752297,0.00007721464,0.00028197543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013203205,0.0006195915,0.0014707933,0.00061908766,0.00018839502,0.0014275019,0.00057932973,0.0008845192,0.0030037286],"category_scores_gemma":[0.0051990934,0.0002256843,0.0029163253,0.0007296093,0.00028459146,0.00086344,0.00040785395,0.0013834916,0.00019885959],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22049065,0.0019803797,0.09555191,0.0031384942,0.013792804,0.001319262,0.00012518291,0.06633077,0.005397421,0.003686539,0.011386389,0.5768002],"study_design_scores_gemma":[0.05215993,0.07152692,0.6179658,0.0019909644,0.04423323,0.0074272593,0.0011788415,0.16395561,0.006249413,0.007802259,0.025159629,0.000350076],"about_ca_topic_score_codex":0.01155736,"about_ca_topic_score_gemma":0.015538724,"teacher_disagreement_score":0.01155736,"about_ca_system_score_codex":0.0055092634,"about_ca_system_score_gemma":0.0015971517,"threshold_uncertainty_score":0.039972663},"labels":[],"label_agreement":null},{"id":"W2018708446","doi":"10.1016/j.jval.2014.03.997","title":"Respiratory Syncytial Virus Prophylaxis In Down Syndrome: A Prospective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Incidence (geometry); Rate ratio; Pediatrics; Prospective cohort study; Respiratory tract infections; Cohort; Poisson regression; Lower respiratory tract infection; Cohort study; Internal medicine; Respiratory system; Confidence interval; Population","score_opus":0.04908918480151305,"score_gpt":0.37501298333502725,"score_spread":0.3259237985335142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018708446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990206,0.0003338421,0.00007059755,0.000038958824,0.000014287907,0.000007596678,0.00035131813,0.0000018904075,0.00016088574],"genre_scores_gemma":[0.9989434,0.00024327797,0.000075231656,0.000035340017,0.000012509657,0.000009704484,0.00036291755,0.0000025534828,0.00031510924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888545,0.0003042881,0.000109206805,0.0003318649,0.00011800719,0.00025122872],"domain_scores_gemma":[0.9977398,0.0004266864,0.00070670556,0.0003684337,0.00023427315,0.000524063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011354166,0.0007732802,0.0007433475,0.000983789,0.0013097852,0.0015311015,0.00084361766,0.0012886617,0.002269581],"category_scores_gemma":[0.0030070494,0.0010764309,0.0013443289,0.0017370782,0.0006053001,0.0012217875,0.0009191906,0.0017014398,0.00034162807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030026902,0.000082302984,0.99849963,0.000005913592,0.00016539534,0.00017219927,0.00008861937,0.000015336804,0.00020138682,0.000022859094,0.000060096485,0.0003858946],"study_design_scores_gemma":[0.000032070664,0.00029394732,0.99836844,0.000010370763,0.00015226724,0.00043262215,0.00039250916,0.00011595851,0.00004456394,0.000031163858,0.00011655421,0.000009619237],"about_ca_topic_score_codex":0.018875925,"about_ca_topic_score_gemma":0.015663171,"teacher_disagreement_score":0.018875925,"about_ca_system_score_codex":0.0005885468,"about_ca_system_score_gemma":0.0007389576,"threshold_uncertainty_score":0.03753209},"labels":[],"label_agreement":null},{"id":"W2018803855","doi":"10.1016/j.jval.2011.08.1488","title":"PSS23 Pharmacoeconomic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis: Comparative Results From 5 European Countries","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Child Nutrition and Feeding Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Christian ministry; Medicine; Infant formula; Atopic dermatitis; Pediatrics; Environmental health; Dermatology; Theology","score_opus":0.18388614880415427,"score_gpt":0.3936753880208357,"score_spread":0.2097892392166814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018803855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631447,0.0030189743,0.00009707597,0.000027104164,0.0000055378378,0.000023446166,0.0001517961,0.000003111931,0.00035852674],"genre_scores_gemma":[0.99832267,0.0011682363,0.00018117257,0.00002950484,0.0000063355615,0.000010618147,0.00018586752,0.0000025881698,0.00009300882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978454,0.0013737073,0.00017790447,0.00015821763,0.00033509274,0.00010965876],"domain_scores_gemma":[0.99881124,0.0004288745,0.00032419924,0.00008388283,0.00026489203,0.00008686084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024160934,0.00048974087,0.00080198457,0.0010471985,0.00025303257,0.0005469999,0.00024369595,0.000556507,0.00080883893],"category_scores_gemma":[0.0024694144,0.00018181086,0.0011846585,0.0015869818,0.00043567605,0.00025807924,0.00028225573,0.00023836187,0.000111910296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24323338,0.0059141023,0.39443225,0.0022601367,0.0073056896,0.0016666258,0.0014708384,0.003305904,0.047486898,0.00034517105,0.00061573077,0.29196334],"study_design_scores_gemma":[0.0042465446,0.07186545,0.8917926,0.00017361651,0.005449177,0.0014486966,0.0008042287,0.000621168,0.020411503,0.000071111346,0.0030685642,0.000047326434],"about_ca_topic_score_codex":0.0023086788,"about_ca_topic_score_gemma":0.0022364906,"teacher_disagreement_score":0.0024160934,"about_ca_system_score_codex":0.0004968342,"about_ca_system_score_gemma":0.00047769627,"threshold_uncertainty_score":0.0127776265},"labels":[],"label_agreement":null},{"id":"W2018946414","doi":"10.1016/j.jval.2013.08.368","title":"Measuring Pros That Matter to Bariatric and Body Contouring Surgery: The Body-Q","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Body Contouring and Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Body contouring; Medicine; Quality of life (healthcare); Physical therapy; Quality (philosophy); Scars; Health care; Surgery; Weight loss; Psychology; Obesity; Nursing","score_opus":0.06139275314795122,"score_gpt":0.2628801023407883,"score_spread":0.20148734919283706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018946414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95554674,0.0060370923,0.0031337126,0.0044799107,0.00039258378,0.00018841728,0.002272725,0.00003681863,0.027912023],"genre_scores_gemma":[0.9938682,0.00090294314,0.0020514086,0.0006688371,0.00012438631,0.00008124899,0.00053074554,0.000018699318,0.0017536256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689144,0.0016478405,0.00024709417,0.00023535924,0.0007479544,0.000230296],"domain_scores_gemma":[0.97674406,0.012398783,0.0059172073,0.00087971275,0.0025843796,0.001475855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041742604,0.00046597686,0.00067478954,0.0010874792,0.0005799148,0.0017083489,0.00048623685,0.0010780955,0.006131071],"category_scores_gemma":[0.030294986,0.00023023128,0.0017432533,0.0011110589,0.001464322,0.0019461076,0.0016495743,0.0012590092,0.0007342163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097056286,0.00018388685,0.9238815,0.00029327584,0.0009827961,0.00009000249,0.00046025997,0.000501016,0.00042317514,0.0023902603,0.0026786628,0.067144684],"study_design_scores_gemma":[0.00009168041,0.0007727756,0.985298,0.0002972574,0.0004206022,0.00041822932,0.0008440741,0.0013001795,0.00038079088,0.0037547317,0.0063786437,0.000043246502],"about_ca_topic_score_codex":0.0022812495,"about_ca_topic_score_gemma":0.0031258275,"teacher_disagreement_score":0.006131071,"about_ca_system_score_codex":0.0008464012,"about_ca_system_score_gemma":0.0009454357,"threshold_uncertainty_score":0.022075891},"labels":[],"label_agreement":null},{"id":"W2019871381","doi":"10.1016/j.jval.2011.10.014","title":"Comparative Health-Care Cost Advantage of Ipratropium over Tiotropium in COPD Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health; University of British Columbia","funders":"National Institute on Aging","keywords":"Ipratropium; Medicine; COPD; Indirect costs; Health care; Propensity score matching; Confounding; Percentile; Emergency medicine; Asthma; Internal medicine; Bronchodilator; Statistics; Business","score_opus":0.043932319701181645,"score_gpt":0.3801277253972995,"score_spread":0.33619540569611783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019871381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917579,0.0051145516,0.000082174134,0.00047194667,0.000073156225,0.000036639438,0.0005874777,0.0000042396973,0.0018719343],"genre_scores_gemma":[0.9987908,0.0005699179,0.00007735631,0.00008086432,0.00005754929,0.00001393397,0.00029845975,0.0000011568518,0.00011004314],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99892265,0.0005939374,0.0000859334,0.00008112714,0.00013335966,0.00018296776],"domain_scores_gemma":[0.9983469,0.0009377432,0.0002664656,0.00007709036,0.00009624649,0.00027546604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011698807,0.00048384373,0.0012257869,0.0008766493,0.00031666478,0.0009053318,0.00047590077,0.0010779508,0.003895457],"category_scores_gemma":[0.0062046433,0.00025095817,0.0028283454,0.0010319897,0.00036754576,0.0009498277,0.00054310303,0.00083650544,0.00022758063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.64416444,0.003342177,0.21512046,0.0015662265,0.009233756,0.0007853547,0.0002979702,0.0065548574,0.004479857,0.0018792254,0.0019236048,0.110652044],"study_design_scores_gemma":[0.035916753,0.06549327,0.86655545,0.00032934078,0.014260163,0.0011643468,0.0009219732,0.0086755995,0.0022369716,0.0020843374,0.0022074978,0.00015426052],"about_ca_topic_score_codex":0.0047143176,"about_ca_topic_score_gemma":0.0055013457,"teacher_disagreement_score":0.0047143176,"about_ca_system_score_codex":0.0019063869,"about_ca_system_score_gemma":0.0007125587,"threshold_uncertainty_score":0.013831794},"labels":[],"label_agreement":null},{"id":"W2019980223","doi":"10.1016/j.jval.2012.08.488","title":"RU1 Cholinesterase Inhibitors: A Population-Based Assessment of Resource Utilization and Costs for Patients With Alzheimer'S Dementia","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Galantamine; Rivastigmine; Donepezil; Medicine; Medical prescription; Dementia; Formulary; Health care; Gerontology; Disease; Environmental health; Family medicine; Nursing; Internal medicine","score_opus":0.0662050661486376,"score_gpt":0.36189544733122103,"score_spread":0.29569038118258345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019980223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987411,0.00024242976,0.00003931904,0.000047110727,0.000002600837,0.000015703103,0.00063223945,0.0000027791525,0.00027673173],"genre_scores_gemma":[0.9989134,0.00016573789,0.00008343909,0.000026643082,0.000006880259,0.000024235726,0.00070497004,9.338631e-7,0.00007375857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935454,0.0002872093,0.00009409469,0.00007489873,0.0001104265,0.00007882882],"domain_scores_gemma":[0.998874,0.00023309852,0.0005614865,0.000047166093,0.00013184744,0.00015250745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009913967,0.00053389306,0.0007170967,0.001828023,0.00041514693,0.0008046205,0.00043179718,0.0008400892,0.0008224177],"category_scores_gemma":[0.0031651785,0.0002952638,0.0014383305,0.002293983,0.00021617192,0.0009934064,0.00066394726,0.00071665295,0.00016755222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007172467,0.0001722443,0.9959766,0.000022939092,0.00034339138,0.000045645676,0.00006718188,0.00024591625,0.000053292373,0.000017651797,0.00017447337,0.0021633613],"study_design_scores_gemma":[0.000058000365,0.0004919771,0.99752253,0.000010397414,0.00017547914,0.00016858791,0.00028663574,0.0010586103,0.000038093327,0.00003941026,0.00013744202,0.000012881958],"about_ca_topic_score_codex":0.012766187,"about_ca_topic_score_gemma":0.0117913755,"teacher_disagreement_score":0.012766187,"about_ca_system_score_codex":0.0012398969,"about_ca_system_score_gemma":0.00045741446,"threshold_uncertainty_score":0.02538377},"labels":[],"label_agreement":null},{"id":"W2020038531","doi":"10.1016/j.jval.2011.02.306","title":"PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Atopic dermatitis; Medicine; Epidemiology; Incidence (geometry); Population; Demography; Asthma; Prevalence; Pediatrics; Systematic review; Allergy; MEDLINE; Dermatology; Environmental health; Pathology; Immunology","score_opus":0.06742044411482051,"score_gpt":0.3369425972754791,"score_spread":0.2695221531606586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020038531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009521197,0.98581994,0.00016807271,0.00036741138,0.00014798003,0.00029132425,0.0031741392,0.0000067753654,0.00050320383],"genre_scores_gemma":[0.10942469,0.8856244,0.0011448152,0.0007329515,0.00022566818,0.0006774234,0.0018506784,0.000008855274,0.000310445],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9813254,0.0077058743,0.007292948,0.0012161569,0.0020256625,0.00043390342],"domain_scores_gemma":[0.9495967,0.03399902,0.011210525,0.0011163796,0.003637762,0.00043966973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009468873,0.001206172,0.0056521613,0.015502207,0.00062118703,0.0018260168,0.0009075518,0.0011154398,0.004555718],"category_scores_gemma":[0.055425473,0.0010221803,0.008805309,0.015946487,0.00070515857,0.0010831992,0.0015495849,0.0007276412,0.00028255404],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012110993,0.000044237306,0.030497793,0.8245024,0.08841781,0.00046639564,0.00045677167,0.00022808764,0.00038025557,0.0002102236,0.003625472,0.04995934],"study_design_scores_gemma":[0.0010649761,0.00049315364,0.10936317,0.5173643,0.3438532,0.0013086189,0.0005744275,0.00009610395,0.00040304262,0.00034680453,0.025060732,0.00007154888],"about_ca_topic_score_codex":0.014537956,"about_ca_topic_score_gemma":0.045555115,"teacher_disagreement_score":0.015502207,"about_ca_system_score_codex":0.0029486725,"about_ca_system_score_gemma":0.011541704,"threshold_uncertainty_score":0.050076783},"labels":[],"label_agreement":null},{"id":"W2020143870","doi":"10.1016/j.jval.2012.03.048","title":"MA2 Comparison of Health Care Costs for Crohn's Disease Patients Who are Adherent Versus Intermittently Adherent with Infliximab Therapy","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Infliximab; Internal medicine; Tolerability; Rheumatoid arthritis; Propensity score matching; Crohn's disease; Gastroenterology; Disease; Surgery; Adverse effect","score_opus":0.1784092953410798,"score_gpt":0.46343330872369903,"score_spread":0.28502401338261923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020143870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889627,0.0013794771,0.0003260128,0.00019167754,0.000050313763,0.000073347255,0.0075030336,0.000011349929,0.0015020979],"genre_scores_gemma":[0.99162227,0.0003898586,0.0002507858,0.000074123156,0.00004540297,0.00014716554,0.0064916047,0.0000067314318,0.0009720771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769187,0.0010761612,0.0003478107,0.00025021328,0.00034883723,0.00028521675],"domain_scores_gemma":[0.99577737,0.0020082332,0.0013363137,0.00019671445,0.0003294262,0.00035203545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021802066,0.0003635563,0.0011643647,0.0017418591,0.0001953358,0.0009633252,0.0009508686,0.00051098043,0.006846089],"category_scores_gemma":[0.0075287586,0.0002294052,0.0033304305,0.0021730235,0.00017725838,0.00074191904,0.0009265922,0.0009812962,0.0004254928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0301203,0.00051350816,0.91726524,0.0007637685,0.01779015,0.000287098,0.00017892335,0.0043972875,0.0006715948,0.00077367347,0.00411988,0.023118664],"study_design_scores_gemma":[0.0010168753,0.0030624531,0.98539066,0.000108871165,0.00203078,0.00025102714,0.00033466358,0.0058477265,0.00015432462,0.00033221743,0.0014445615,0.000025808811],"about_ca_topic_score_codex":0.008522593,"about_ca_topic_score_gemma":0.0055932314,"teacher_disagreement_score":0.008522593,"about_ca_system_score_codex":0.0008982315,"about_ca_system_score_gemma":0.0004981922,"threshold_uncertainty_score":0.022902489},"labels":[],"label_agreement":null},{"id":"W2020394649","doi":"10.1016/j.jval.2011.07.009","title":"Development of a Composite Questionnaire, the Valuation of Lost Productivity, to Value Productivity Losses: Application in Rheumatoid Arthritis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Canadian Arthritis Network; Pfizer","keywords":"Presenteeism; Absenteeism; Productivity; Valuation (finance); Wage; Medicine; Operations management; Economics; Actuarial science; Demographic economics; Business; Psychology; Labour economics; Social psychology; Accounting; Economic growth","score_opus":0.05540399910224962,"score_gpt":0.3113782031732845,"score_spread":0.2559742040710349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020394649","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81476706,0.0021148173,0.14643188,0.0017322641,0.0007974621,0.008098717,0.006758444,0.00042162757,0.01887775],"genre_scores_gemma":[0.7893475,0.001565167,0.19453566,0.00035305487,0.00013713275,0.005783325,0.003814849,0.0001067721,0.004356543],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965282,0.0014569167,0.00048303397,0.00014817754,0.001230958,0.00015275368],"domain_scores_gemma":[0.9896299,0.0045609856,0.0011684148,0.0005090562,0.0035029505,0.00062862324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077860677,0.0004762618,0.00066896534,0.0019712548,0.00037949163,0.0011897711,0.0007889332,0.00060336565,0.0031427208],"category_scores_gemma":[0.022103336,0.00020671653,0.001581436,0.0013842784,0.00031648038,0.0010443093,0.0010032519,0.0012704011,0.0005918113],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014664375,0.0019972334,0.19602162,0.0008399846,0.0004302452,0.0002111583,0.0014532622,0.003456168,0.0047690407,0.0024030998,0.008984127,0.7779677],"study_design_scores_gemma":[0.000909461,0.007934957,0.8886354,0.0008418658,0.0008277902,0.002056823,0.002617723,0.033205178,0.009384346,0.0075592184,0.04575065,0.00027656322],"about_ca_topic_score_codex":0.0016565378,"about_ca_topic_score_gemma":0.0023060213,"teacher_disagreement_score":0.0077860677,"about_ca_system_score_codex":0.00068300165,"about_ca_system_score_gemma":0.0022594268,"threshold_uncertainty_score":0.041177154},"labels":[],"label_agreement":null},{"id":"W2020568545","doi":"10.1016/j.jval.2012.03.1048","title":"PIH16 Cost-Effectiveness of a New Fixed-Dose Combination of Dutasteride and Tamsulosin for the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hôpital Saint-François d'Assise; GlaxoSmithKline (Canada)","funders":"","keywords":"Tamsulosin; Medicine; Dutasteride; Urology; Cohort; Population; Cost effectiveness; International Prostate Symptom Score; Economic evaluation; Combination therapy; Benign prostatic hyperplasia (BPH); Prostate; Hyperplasia; Gynecology; Internal medicine; Lower urinary tract symptoms","score_opus":0.06336307415147649,"score_gpt":0.35540785252499585,"score_spread":0.2920447783735194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020568545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769135,0.011228242,0.00033014058,0.001736767,0.00011543501,0.00048856146,0.0040004216,0.00006110838,0.005125812],"genre_scores_gemma":[0.99560755,0.0014343022,0.0003417295,0.00022184188,0.00003592728,0.000052662228,0.0009850104,0.0000056999547,0.0013150974],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992937,0.00023246703,0.000047830305,0.00008685631,0.00018297098,0.0001561496],"domain_scores_gemma":[0.99891615,0.00018740592,0.00018015639,0.000022036591,0.00018722423,0.00050711964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068861427,0.0005548455,0.0012909079,0.0005668565,0.0005652207,0.00082961406,0.001218039,0.0007194833,0.005105541],"category_scores_gemma":[0.0017831797,0.00030150384,0.0019772463,0.00093413226,0.00047818373,0.00028703903,0.0003177659,0.0007589832,0.00021195042],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4088397,0.0065207086,0.15013804,0.0022440143,0.008751723,0.0010121209,0.00026628643,0.088283464,0.006925561,0.0015162879,0.01864954,0.30685252],"study_design_scores_gemma":[0.09506397,0.053682774,0.7478609,0.0007454181,0.01100587,0.000769883,0.0006850773,0.07568586,0.0016483854,0.00039513415,0.012182243,0.00027445029],"about_ca_topic_score_codex":0.9436114,"about_ca_topic_score_gemma":0.9674137,"teacher_disagreement_score":0.056388617,"about_ca_system_score_codex":0.0445889,"about_ca_system_score_gemma":0.023592597,"threshold_uncertainty_score":0.3235166},"labels":[],"label_agreement":null},{"id":"W2020672080","doi":"10.1016/j.jval.2012.08.1567","title":"PRM104 Examination of Patient Preference: Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; PharmIdeas (Canada)","funders":"","keywords":"Data extraction; Time-trade-off; Medicine; MEDLINE; Systematic review; Population; Quality of life (healthcare); Preference; Inclusion and exclusion criteria; Health related quality of life; Quality-adjusted life year; Disease; Family medicine; Alternative medicine; Statistics; Environmental health; Cost effectiveness; Nursing; Pathology","score_opus":0.34955987864284616,"score_gpt":0.38648002668605114,"score_spread":0.03692014804320498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020672080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408619,0.004050144,0.020107668,0.0021333743,0.00029989707,0.0005266548,0.010469619,0.00019047009,0.021360291],"genre_scores_gemma":[0.9900114,0.00029417558,0.0048653325,0.0002716318,0.00006545897,0.00015703597,0.0021921948,0.00007864085,0.0020641626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9657489,0.030245645,0.00088009314,0.0006423859,0.0020676046,0.00041532633],"domain_scores_gemma":[0.71920174,0.26214173,0.0057553304,0.008403814,0.0033904128,0.0011070042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03924408,0.0008639271,0.0015995482,0.0024182976,0.00032120344,0.0014060583,0.0013378373,0.0013582057,0.029821057],"category_scores_gemma":[0.17081311,0.00030416407,0.0050359536,0.002208745,0.0011863478,0.0028233982,0.0024235293,0.0021597832,0.0015833647],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17834035,0.0060623954,0.3029056,0.005131879,0.01688698,0.00054980256,0.00204957,0.03444901,0.0014125231,0.060864285,0.03887003,0.35247758],"study_design_scores_gemma":[0.013932751,0.05379422,0.681431,0.0011808913,0.008446958,0.0016977094,0.0049151983,0.14838913,0.0045370255,0.061085362,0.020032952,0.0005568223],"about_ca_topic_score_codex":0.0018600613,"about_ca_topic_score_gemma":0.0011284057,"teacher_disagreement_score":0.03924408,"about_ca_system_score_codex":0.0008569052,"about_ca_system_score_gemma":0.0009602641,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"opus","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2020694466","doi":"10.1016/j.jval.2014.08.1855","title":"Development Of A Global Economic Model To Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Population; Health care; Cancer; Prostate cancer; Cost effectiveness; Oncology; Intensive care medicine; Internal medicine; Environmental health; Risk analysis (engineering)","score_opus":0.14076879950580196,"score_gpt":0.3665633751447875,"score_spread":0.22579457563898553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020694466","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22757244,0.002551595,0.656263,0.011708817,0.00042675564,0.00039552248,0.005506948,0.00040997387,0.095164955],"genre_scores_gemma":[0.91562825,0.0014391032,0.06512903,0.00066490384,0.00011553712,0.00056065456,0.0017567097,0.00013425415,0.014571546],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994429,0.00034768597,0.00001745833,0.0000637828,0.00005020838,0.00007800581],"domain_scores_gemma":[0.99780804,0.0016649395,0.00013498975,0.00005982917,0.00021246025,0.00011974585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021644041,0.0009803202,0.0014692338,0.0011267053,0.00045822948,0.0021068016,0.0014395001,0.0025274663,0.007436678],"category_scores_gemma":[0.005850554,0.0007169703,0.0014056514,0.0014836603,0.00085752225,0.0015135962,0.0013271715,0.0021204967,0.00047669056],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027664326,0.000015651583,0.0006355684,0.00001669761,0.000027896886,0.00006351448,0.000008577654,0.9825167,0.000052601958,0.014229129,0.0006264639,0.0017795529],"study_design_scores_gemma":[0.00005367099,0.0000325222,0.00036166166,0.000013763372,0.00003555697,0.00003509252,0.000023914408,0.9876166,0.000062613675,0.010364018,0.0013908782,0.000009690957],"about_ca_topic_score_codex":0.021878425,"about_ca_topic_score_gemma":0.012200522,"teacher_disagreement_score":0.021878425,"about_ca_system_score_codex":0.0026866577,"about_ca_system_score_gemma":0.002932476,"threshold_uncertainty_score":0.043502152},"labels":[],"label_agreement":null},{"id":"W2021006304","doi":"10.1111/j.1524-4733.2008.00334.x","title":"Cost-Effectiveness of LTBI Treatment for TB Contacts in British Columbia","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Tuberculin; Latent tuberculosis; Vaccination; Cost effectiveness; Tuberculosis; Demography; Family medicine; Mycobacterium tuberculosis; Immunology; Risk analysis (engineering)","score_opus":0.18480053028488877,"score_gpt":0.4209927875626003,"score_spread":0.2361922572777115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021006304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929878,0.0018822841,0.00003701589,0.0014546898,0.000026022752,0.000025352922,0.0011411917,0.0000074235245,0.002438213],"genre_scores_gemma":[0.9981704,0.0005573941,0.00004009854,0.00011551469,0.0000065510776,0.00001058226,0.00030759297,0.0000024536573,0.0007894328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851376,0.0005204288,0.00012446889,0.00008663917,0.00029460955,0.00046008496],"domain_scores_gemma":[0.99673754,0.0010463315,0.00044842338,0.00008261415,0.0007148619,0.0009702725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009553805,0.00031904964,0.00083132496,0.00091849285,0.0011083194,0.0015009907,0.0014306443,0.0010217888,0.0027458838],"category_scores_gemma":[0.008372923,0.0003425267,0.0007569019,0.0014932972,0.00048293464,0.00047099387,0.0008775147,0.0011407889,0.00014725713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005103256,0.00096726516,0.91968626,0.0005069642,0.0010447624,0.000884082,0.00071716437,0.01525037,0.0005675916,0.0012805099,0.0071327514,0.046859134],"study_design_scores_gemma":[0.00030626234,0.0004483765,0.9814496,0.00023224803,0.00057765556,0.0002431695,0.0020193143,0.012913551,0.00017903965,0.00038344247,0.0012057336,0.000041605083],"about_ca_topic_score_codex":0.9625488,"about_ca_topic_score_gemma":0.9790831,"teacher_disagreement_score":0.037451208,"about_ca_system_score_codex":0.036102936,"about_ca_system_score_gemma":0.017502077,"threshold_uncertainty_score":0.26194638},"labels":[],"label_agreement":null},{"id":"W2021231893","doi":"10.1016/s1098-3015(10)63543-7","title":"PMH11 RATIONAL CHOICE OF TREATMENT STRATEGY IN MODERATE TO SEVERE ALZHEIMER'S DISEASE PATIENTS LIVING IN CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Medicine; Gerontology; Alzheimer's disease; Pediatrics; Internal medicine","score_opus":0.19072651486364875,"score_gpt":0.4512488658251738,"score_spread":0.2605223509615251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021231893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97298867,0.0016779674,0.00019747723,0.0077060256,0.000051965613,0.000090951566,0.0007830506,0.000014322416,0.016489545],"genre_scores_gemma":[0.99788576,0.00044051497,0.00028547412,0.0005097413,0.000019412239,0.0000111450445,0.00015919711,0.0000027025335,0.000686083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996666,0.00007155845,0.000019679004,0.000029749428,0.00006254798,0.00014995997],"domain_scores_gemma":[0.9992532,0.00011658143,0.000109373985,0.000011014107,0.00016667062,0.00034311067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002898418,0.00011929503,0.0003128979,0.00035456597,0.0016039801,0.00081824226,0.0004233166,0.00044921137,0.0036626502],"category_scores_gemma":[0.0024484117,0.000096630065,0.00031998055,0.00076223584,0.00028481704,0.00022290763,0.00028081136,0.00059468736,0.00019280148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027972471,0.00075624377,0.87444174,0.0000922348,0.00013509998,0.0012492067,0.0006056976,0.0012284347,0.00064747327,0.0011862032,0.014223549,0.10263678],"study_design_scores_gemma":[0.00045882585,0.0007067645,0.9751915,0.00020875168,0.00030161985,0.0014986489,0.003149166,0.0056507336,0.00067858776,0.0016924787,0.010406158,0.000056758854],"about_ca_topic_score_codex":0.7773314,"about_ca_topic_score_gemma":0.90267175,"teacher_disagreement_score":0.22266859,"about_ca_system_score_codex":0.008055485,"about_ca_system_score_gemma":0.013276429,"threshold_uncertainty_score":0.44795984},"labels":[],"label_agreement":null},{"id":"W2021469786","doi":"10.1016/j.jval.2012.03.149","title":"PHP73 Budget Impact Analysis: Do Canadian Guidelines Meet the Needs of Public Drug Plan Managers?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Allowance (engineering); Liberian dollar; Business; Population; Pharmacy; Plan (archaeology); Actuarial science; Marketing; Medicine; Operations management; Family medicine; Environmental health; Finance; Geography; Economics","score_opus":0.47771202601597984,"score_gpt":0.44708418151341905,"score_spread":0.030627844502560786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021469786","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012510624,0.0243503,0.0076991827,0.66286093,0.004161063,0.0012384803,0.029659662,0.00056800456,0.2569517],"genre_scores_gemma":[0.48466426,0.05566763,0.10772636,0.21250965,0.00564188,0.0030910382,0.029322159,0.0015442094,0.09983272],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.95631844,0.012002705,0.003032728,0.00090666517,0.023520235,0.0042192913],"domain_scores_gemma":[0.8154795,0.037245672,0.005696043,0.0034999652,0.12945081,0.008627924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04273744,0.001287416,0.0015163334,0.00907863,0.0033499522,0.008869079,0.0048155715,0.0041949986,0.015970817],"category_scores_gemma":[0.22193325,0.00083810074,0.0015655458,0.014005569,0.0022152574,0.0045059924,0.0018625091,0.0047137453,0.001630181],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013616412,0.000060075534,0.008451402,0.00091532816,0.00015603271,0.000052084437,0.00042224766,0.0029601844,0.00008265264,0.054416526,0.8363396,0.096007764],"study_design_scores_gemma":[0.00038050135,0.00007104462,0.07017111,0.0065176054,0.00053307705,0.00009483901,0.001777055,0.0072053242,0.0003442996,0.03712898,0.8754955,0.0002807405],"about_ca_topic_score_codex":0.9717246,"about_ca_topic_score_gemma":0.98453486,"teacher_disagreement_score":0.9283771,"about_ca_system_score_codex":0.0716229,"about_ca_system_score_gemma":0.31718418,"threshold_uncertainty_score":0.519663},"labels":[],"label_agreement":null},{"id":"W2021488729","doi":"10.1016/j.jval.2012.08.1859","title":"PHS86 A Population-Based Study of the Resource Utilization and Costs of Treating Resectable Non-Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cohort; Lung cancer; Retrospective cohort study; Cancer registry; Population; Cancer; Chemotherapy; Cohort study; Surgery; Emergency medicine; Internal medicine","score_opus":0.06515700393521344,"score_gpt":0.29259252724216994,"score_spread":0.2274355233069565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021488729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886347,0.0001748848,0.00011656262,0.00020112692,0.000019027182,0.00008511791,0.009974229,0.000007882318,0.0007864879],"genre_scores_gemma":[0.98800915,0.00027542416,0.00018788745,0.00026838176,0.0000980137,0.00016696622,0.009400404,0.0000088839015,0.0015848129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982206,0.0009418376,0.00015905034,0.00022794603,0.00020946848,0.00024109536],"domain_scores_gemma":[0.99582326,0.00075277535,0.001427999,0.0005132047,0.00045363905,0.0010291731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019204007,0.00078579027,0.0006927678,0.0015731609,0.0010702014,0.001155373,0.00083915604,0.0012185263,0.0031110295],"category_scores_gemma":[0.004703218,0.0009406753,0.0016170078,0.0035954078,0.00046361363,0.0010129686,0.0012082544,0.0015749325,0.0009706629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003266572,0.0010715137,0.9884404,0.00006726738,0.00083545764,0.00017267348,0.00019420424,0.00040288898,0.00017275683,0.00011551673,0.0026036305,0.0026571725],"study_design_scores_gemma":[0.00039575837,0.00083385955,0.99699724,0.000013322725,0.00022018785,0.00015026651,0.00026253072,0.00032951726,0.00003747624,0.000038040132,0.0007091545,0.000012556213],"about_ca_topic_score_codex":0.035517264,"about_ca_topic_score_gemma":0.0269807,"teacher_disagreement_score":0.035517264,"about_ca_system_score_codex":0.001189058,"about_ca_system_score_gemma":0.0014247024,"threshold_uncertainty_score":0.07062107},"labels":[],"label_agreement":null},{"id":"W2021663333","doi":"10.1016/j.jval.2014.03.1026","title":"Cost-Effectiveness Analysis Of Nurse-Administered Oral Corticosteroids At Triage In Pediatric Asthma","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Triage; Emergency department; Asthma; Emergency medicine; Confounding; Health care; Pediatrics; Internal medicine; Nursing","score_opus":0.07824416446811817,"score_gpt":0.3822319371602224,"score_spread":0.30398777269210425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021663333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97409725,0.02103509,0.0007975686,0.00054687506,0.00012824184,0.0004617763,0.0011564413,0.000015409103,0.0017614631],"genre_scores_gemma":[0.9959699,0.0027436563,0.0005153625,0.00007601604,0.00004337124,0.000116844225,0.00037109974,0.0000029907726,0.00016082254],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99422836,0.004377119,0.00029393382,0.00021160135,0.00044558127,0.00044335827],"domain_scores_gemma":[0.9878963,0.009875393,0.0011931602,0.000238178,0.0003621678,0.00043478335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00439041,0.0012479092,0.0025441889,0.0014790412,0.0002918925,0.0014615804,0.0012282109,0.0011297028,0.0028591496],"category_scores_gemma":[0.018731821,0.0005385033,0.0066218227,0.0015896881,0.0006430231,0.0014608944,0.0007714976,0.0018796308,0.00010790284],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5280112,0.01050931,0.12327378,0.009414032,0.05759534,0.0006931133,0.00035757304,0.12917463,0.0015690636,0.0046729567,0.002096663,0.13263242],"study_design_scores_gemma":[0.1187036,0.1858642,0.3522404,0.0034501837,0.12619714,0.0015888993,0.0023365032,0.19793396,0.0031587451,0.0038199592,0.00430563,0.000400867],"about_ca_topic_score_codex":0.020593878,"about_ca_topic_score_gemma":0.012574075,"teacher_disagreement_score":0.020593878,"about_ca_system_score_codex":0.0066838698,"about_ca_system_score_gemma":0.0025848954,"threshold_uncertainty_score":0.048495114},"labels":[],"label_agreement":null},{"id":"W2021695117","doi":"10.1016/s1098-3015(10)70232-1","title":"PCN54 A COST-UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS VERSUS SECONDARY PROPHYLAXIS WITH COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH DIFFUSE AGGRESSIVE LYMPHOMA RECEIVING CURATIVE-INTENT CHEMOTHERAPY USING ONTARIO HEALTH ECONOMIC DATA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secondary prophylaxis; Lymphoma; Chemotherapy; Intensive care medicine; Oncology; Internal medicine","score_opus":0.09503515220976427,"score_gpt":0.31487770632662865,"score_spread":0.21984255411686437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021695117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9729978,0.005474944,0.001317982,0.00066978746,0.000038076832,0.0007109043,0.013770901,0.000031399057,0.0049882727],"genre_scores_gemma":[0.99476814,0.000578803,0.0006107365,0.000059239017,0.00000909926,0.00010788335,0.0032181526,0.0000055032656,0.0006423853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820113,0.001040832,0.00010076315,0.000115935756,0.00031975773,0.00022160549],"domain_scores_gemma":[0.99712974,0.0016995741,0.00036088316,0.00011455906,0.00040994806,0.00028529073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028230678,0.00080235495,0.0015553841,0.0015963239,0.00044524687,0.0013570802,0.0010536922,0.00046266045,0.003355902],"category_scores_gemma":[0.011361719,0.0005489431,0.0031007433,0.002734906,0.0005071196,0.00044918546,0.0006052122,0.00075176434,0.00012097497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07573059,0.0010923585,0.42439708,0.0028364281,0.015791569,0.0011513616,0.00039957688,0.36692348,0.0015262878,0.006064082,0.014331192,0.089756],"study_design_scores_gemma":[0.00880607,0.0033562172,0.61524296,0.00047756883,0.008293174,0.0003962811,0.00039205313,0.3521791,0.0004811208,0.0017439828,0.00846218,0.00016932213],"about_ca_topic_score_codex":0.70185983,"about_ca_topic_score_gemma":0.63053507,"teacher_disagreement_score":0.70185983,"about_ca_system_score_codex":0.028959824,"about_ca_system_score_gemma":0.010854057,"threshold_uncertainty_score":0.59979194},"labels":[],"label_agreement":null},{"id":"W2021792499","doi":"10.1016/j.jval.2014.03.1130","title":"The inherent bias from using partitioned survival models in economic evaluation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; University of Ottawa","funders":"","keywords":"Survival analysis; Clinical trial; Markov model; Medicine; Randomized controlled trial; Progression-free survival; Markov chain; Overall survival; Statistics; Oncology; Internal medicine; Mathematics","score_opus":0.659809391040091,"score_gpt":0.4838394291682127,"score_spread":0.17596996187187824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021792499","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015189789,0.0039470904,0.9712468,0.005672895,0.00025931542,0.000104620936,0.00024010884,0.00017776979,0.0031616585],"genre_scores_gemma":[0.66353947,0.004915137,0.32201958,0.0029277247,0.00091855356,0.00058629084,0.0003184539,0.00026790742,0.004506853],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9208544,0.07100094,0.0016208163,0.0024926632,0.0035235342,0.00050763524],"domain_scores_gemma":[0.47660097,0.49898937,0.0060674194,0.014725847,0.0032096833,0.00040666858],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10568117,0.00093879603,0.0021576777,0.0015736305,0.0007127312,0.0032932707,0.0025700843,0.0024450424,0.006748415],"category_scores_gemma":[0.37740907,0.0010875029,0.0015072074,0.0023900762,0.0037003448,0.006697763,0.0027329857,0.0059142974,0.0005943805],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042550615,0.00011726946,0.008049957,0.00069721695,0.0011674172,0.00017531584,0.00068041094,0.066004574,0.00024023106,0.7955824,0.0047585536,0.12210111],"study_design_scores_gemma":[0.00006524289,0.00004542481,0.0005404577,0.000102437974,0.00013169285,0.000071222545,0.000052001884,0.068683505,0.0002506491,0.92829025,0.0017525983,0.000014592906],"about_ca_topic_score_codex":0.0025704901,"about_ca_topic_score_gemma":0.0027824237,"teacher_disagreement_score":0.8943188,"about_ca_system_score_codex":0.0014069069,"about_ca_system_score_gemma":0.0020991964,"threshold_uncertainty_score":0.55890214},"labels":[],"label_agreement":null},{"id":"W2021838863","doi":"10.1016/s1098-3015(10)70844-5","title":"PMS42 A COMPARISON OF PROVINCIAL PRESCRIPTION-ONLY PHARMACEUTICAL DATABASE WITH SELF-REPORTED USAGE OF ACETAMINOPHEN AND NSAIDS ACCORDING TO OSTEOARTHRITIS STAGE IN BRITISH COLUMBIA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acetaminophen; Medical prescription; Medicine; Stage (stratigraphy); Osteoarthritis; Database; Alternative medicine; Pharmacology; Computer science","score_opus":0.16174659231288674,"score_gpt":0.41356990151361844,"score_spread":0.2518233092007317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021838863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762023,0.00026388647,0.00011699576,0.00012132567,0.000009738918,0.00004091804,0.021448473,0.000019225952,0.0017771715],"genre_scores_gemma":[0.9893076,0.00012119872,0.0001138953,0.0000524126,0.0000034424377,0.000020943187,0.009082868,0.000008837123,0.0012888347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836355,0.00030332245,0.00022121603,0.0002500391,0.0005490549,0.00031284767],"domain_scores_gemma":[0.9930112,0.0012003253,0.0011187233,0.00034236588,0.0035878422,0.0007395399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011446668,0.00021727121,0.0006413834,0.002419057,0.00096123305,0.0011613667,0.0010024861,0.00034606454,0.0036682175],"category_scores_gemma":[0.008249632,0.00040939008,0.00079340243,0.007093288,0.0002750291,0.0004002843,0.00081834325,0.00039485333,0.0005886677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028501026,0.000023596644,0.99630237,0.00003595853,0.00014573276,0.00004418109,0.000094481235,0.00012367235,0.00012339232,0.000030688454,0.0009703267,0.0018204283],"study_design_scores_gemma":[0.000012038827,0.000014892985,0.99900204,0.000007861948,0.0000434254,0.000026478336,0.00016078948,0.00032585577,0.000061030838,0.000005071506,0.000336808,0.000003740033],"about_ca_topic_score_codex":0.9550554,"about_ca_topic_score_gemma":0.9614415,"teacher_disagreement_score":0.044944584,"about_ca_system_score_codex":0.0060433275,"about_ca_system_score_gemma":0.008450576,"threshold_uncertainty_score":0.09041852},"labels":[],"label_agreement":null},{"id":"W2021865256","doi":"10.1016/j.jval.2014.08.1050","title":"Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue: A Comparison In Usa, Canada, Japan and Australia","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Life expectancy; Productivity; Revenue; Human capital; Government (linguistics); Economics; Present value; Value (mathematics); Tax revenue; Net profit; Economic growth; Public economics; Demography; Finance; Population; Sociology","score_opus":0.05357586082127073,"score_gpt":0.41037441252761336,"score_spread":0.3567985517063426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021865256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985297,0.0030079877,0.00028052117,0.0015016419,0.000043117314,0.000012161077,0.0013044663,0.000005591058,0.00854751],"genre_scores_gemma":[0.99850863,0.0005600932,0.000076036005,0.000034264856,0.000011145387,0.0000024758115,0.00027661165,0.0000025101228,0.0005281734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994617,0.00013326656,0.000023150526,0.000036036003,0.00016444111,0.0001814509],"domain_scores_gemma":[0.9975654,0.0007815606,0.00038304453,0.000060783805,0.0006564895,0.0005527785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087302615,0.00022236907,0.0003319226,0.0019736728,0.0005661705,0.0016162288,0.00081347045,0.000579699,0.0026415726],"category_scores_gemma":[0.005634776,0.00013175019,0.0011277271,0.002917034,0.0005861908,0.0010251645,0.0007001915,0.0009609043,0.00013224989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019330692,0.0003935873,0.8678251,0.00033590966,0.00073521375,0.0012376646,0.0028665876,0.015105396,0.0005024779,0.028351419,0.005958757,0.074754916],"study_design_scores_gemma":[0.000024633126,0.00024209457,0.97588557,0.000112906026,0.00021767379,0.00064907473,0.005702273,0.0076455334,0.00017440876,0.0041719973,0.0051359627,0.000037861366],"about_ca_topic_score_codex":0.23568754,"about_ca_topic_score_gemma":0.31268135,"teacher_disagreement_score":0.76431245,"about_ca_system_score_codex":0.011148029,"about_ca_system_score_gemma":0.0027654422,"threshold_uncertainty_score":0.4686314},"labels":[],"label_agreement":null},{"id":"W2022638664","doi":"10.1016/j.jval.2013.03.1175","title":"Reduction Of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan In The Randomized Controlled Trial Seraphin","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Placebo; Endothelin receptor antagonist; Bosentan; Post-hoc analysis; Proportional hazards model; Randomized controlled trial; Endothelin receptor; Receptor; Pathology","score_opus":0.024120504382993947,"score_gpt":0.2797003736023233,"score_spread":0.25557986921932935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022638664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825995,0.012033928,0.00036161722,0.0010483963,0.00080339686,0.0006324963,0.00043220498,0.000050846458,0.0020375303],"genre_scores_gemma":[0.9945734,0.0028413876,0.0004654814,0.00052274775,0.00018323118,0.00041349005,0.00021266322,0.000005949857,0.0007817137],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989267,0.00067131175,0.000092468894,0.00012241298,0.0000761042,0.00011093125],"domain_scores_gemma":[0.99913484,0.00034560516,0.00020038732,0.00006143022,0.000060795308,0.00019702752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016197014,0.0007282024,0.0022294873,0.00028334986,0.00026583739,0.0008774791,0.00067018985,0.0008352586,0.003856316],"category_scores_gemma":[0.002910087,0.00035776972,0.0020977526,0.00025316264,0.00061696745,0.00065572007,0.00040676593,0.0024616974,0.00022384067],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97333527,0.0013131594,0.0020027119,0.001355864,0.0032295785,0.000033813038,0.00004006443,0.00016966961,0.0010321802,0.00018131737,0.0004888156,0.016817596],"study_design_scores_gemma":[0.9581351,0.024362251,0.010895241,0.00022806617,0.0042859395,0.000028224698,0.000079641075,0.00054008287,0.000444784,0.00022108051,0.0007598274,0.000019755418],"about_ca_topic_score_codex":0.0019833143,"about_ca_topic_score_gemma":0.0046516466,"teacher_disagreement_score":0.003856316,"about_ca_system_score_codex":0.0006690504,"about_ca_system_score_gemma":0.0010251275,"threshold_uncertainty_score":0.012900591},"labels":[],"label_agreement":null},{"id":"W2023573506","doi":"10.1016/j.jval.2011.08.1043","title":"PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries: Case of Côte d'Ivoire","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Formulary; Reimbursement; Listing (finance); Actuarial science; Medicine; Prior authorization; Family medicine; Business; Health care; Finance; Economics; Pharmacology; Economic growth","score_opus":0.12049046560661278,"score_gpt":0.3506844670838989,"score_spread":0.2301940014772861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023573506","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.098038,0.0020861805,0.4645171,0.028848736,0.0006619613,0.0008759595,0.0037026051,0.0008575755,0.40041193],"genre_scores_gemma":[0.82067984,0.00079690723,0.11137511,0.0009951115,0.0004016609,0.000404271,0.0007848831,0.00009859752,0.06446356],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99621767,0.002102938,0.0001471716,0.0005112543,0.00046970934,0.00055134244],"domain_scores_gemma":[0.99560565,0.0022096152,0.00049841503,0.00058636256,0.00089868676,0.00020133064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040508946,0.00054103014,0.00095740665,0.0018277116,0.00210558,0.0054639573,0.0029520388,0.004515853,0.037149325],"category_scores_gemma":[0.011428156,0.00050491485,0.0019920403,0.0028543577,0.0016769456,0.003915798,0.0020001945,0.0025682587,0.0014106869],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024376222,0.000057642672,0.001250166,0.00007508692,0.00002954884,0.00042879436,0.00020400932,0.01679408,0.000091535294,0.9591135,0.009422835,0.012508433],"study_design_scores_gemma":[0.00016126283,0.0001767417,0.0042287568,0.0001779586,0.00010421527,0.0005469151,0.0009747311,0.22512303,0.00040031105,0.7143028,0.053708978,0.000094380885],"about_ca_topic_score_codex":0.04010486,"about_ca_topic_score_gemma":0.040661886,"teacher_disagreement_score":0.04010486,"about_ca_system_score_codex":0.0029999958,"about_ca_system_score_gemma":0.0040379837,"threshold_uncertainty_score":0.124276936},"labels":[],"label_agreement":null},{"id":"W2024206659","doi":"10.1016/j.jval.2013.02.005","title":"Authors’ Response to “Comparative Effectiveness and Personalized Medicine” by Dr. J.C. Hornberger","year":2013,"lang":"en","type":"letter","venue":"Value in Health","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Indeterminate; Malignancy; Thyroid cancer; Population; Thyroid nodules; Test (biology); Cohort; General surgery; Cancer; Radiology; Internal medicine","score_opus":0.06390139838189203,"score_gpt":0.36656782235860574,"score_spread":0.3026664239767137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024206659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013661534,0.0006644551,0.000044417186,0.988458,0.0094086705,0.000010071861,0.00006820765,0.00002200371,0.0011875427],"genre_scores_gemma":[0.0017265459,0.00052440783,0.00015292928,0.9793881,0.015232945,0.000032123386,0.000025220113,0.000016098244,0.0029015648],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946214,0.0021570793,0.00062258344,0.0006437829,0.0014422288,0.00051291153],"domain_scores_gemma":[0.9823162,0.011373971,0.0011766694,0.0003137454,0.0033356503,0.0014838068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051366207,0.00081703695,0.0017468344,0.00078640034,0.00313483,0.0032339706,0.001956541,0.04262651,0.010412569],"category_scores_gemma":[0.04426029,0.0007175581,0.0012797053,0.0010433864,0.0028230008,0.0033299334,0.001054998,0.036006495,0.0076514403],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006234111,0.00001299369,0.0001850876,0.000036520887,0.0000074053396,0.000390127,0.000052970714,0.00002908488,0.0000431781,0.00082003494,0.995271,0.00308928],"study_design_scores_gemma":[0.000245941,0.00011749721,0.0012626203,0.0005965055,0.000044006356,0.0022892521,0.00057253,0.0006307012,0.00037099095,0.007225096,0.9865371,0.000107759304],"about_ca_topic_score_codex":0.006692287,"about_ca_topic_score_gemma":0.010467639,"teacher_disagreement_score":0.04262651,"about_ca_system_score_codex":0.0051011587,"about_ca_system_score_gemma":0.0047698747,"threshold_uncertainty_score":0.037011683},"labels":[],"label_agreement":null},{"id":"W2024319360","doi":"10.1016/s1098-3015(10)66206-7","title":"CASE2 DOTECHNOLOGY EVALUATIONS BASED ON EVIDENCE FROM CONDITIONAL FUNDING LEAD TO AN INCREASE IN POLICY FORMATION?: FINDINGS FROM, AND IMPLICATIONS OF, ONTARIO'S EVIDENCE-BASED HTA PROCESS","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Qualitative Comparative Analysis Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lead (geology); Process (computing); Real world evidence; Economics; Psychology; Public economics; Positive economics; Computer science; Medicine; Internal medicine; Biology","score_opus":0.4399434492178733,"score_gpt":0.5455695355291414,"score_spread":0.10562608631126813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024319360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69292057,0.004867792,0.00681085,0.13737552,0.0007426925,0.0064068376,0.002717448,0.00009885007,0.14805947],"genre_scores_gemma":[0.97411114,0.0008814726,0.0063246763,0.008708315,0.000060027654,0.0019684744,0.0002938274,0.00003734781,0.0076146014],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9457781,0.034572825,0.003170997,0.0026260524,0.007885051,0.0059669437],"domain_scores_gemma":[0.7528974,0.193659,0.014129484,0.010480872,0.023423655,0.005409589],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.091339946,0.000495204,0.00092882727,0.0016692153,0.010747292,0.00564848,0.0021737348,0.0052739517,0.010182285],"category_scores_gemma":[0.21606635,0.0005633093,0.0010127852,0.0043973126,0.0071263365,0.006764966,0.0056261793,0.0042852,0.00045830043],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011218929,0.0018361083,0.11503167,0.009941174,0.0009844057,0.003636514,0.27796713,0.0023181099,0.004313613,0.20917481,0.07749323,0.28608435],"study_design_scores_gemma":[0.00509078,0.0030418274,0.21527301,0.018998219,0.003605646,0.0011261757,0.30598235,0.0040082852,0.01868323,0.07116966,0.35250387,0.00051689125],"about_ca_topic_score_codex":0.6038009,"about_ca_topic_score_gemma":0.76736444,"teacher_disagreement_score":0.9376805,"about_ca_system_score_codex":0.062319502,"about_ca_system_score_gemma":0.11059764,"threshold_uncertainty_score":0.7970648},"labels":[],"label_agreement":null},{"id":"W2024334414","doi":"10.1111/j.1524-4733.2009.00650.x","title":"Cost-Effectiveness of Using Recombinant Human Thyroid-Stimulating Hormone before Radioiodine Ablation for Thyroid Cancer: The Canadian Perspective","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Context (archaeology); Ablation; Thyroid cancer; Thyroid; Hormone; Surgery; Urology; Internal medicine","score_opus":0.09952962790393761,"score_gpt":0.39659389500315745,"score_spread":0.29706426709921985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024334414","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28075388,0.18167312,0.0032938085,0.3226279,0.0025617115,0.00040213132,0.018868675,0.00016934898,0.1896494],"genre_scores_gemma":[0.9329077,0.044419315,0.0023283176,0.011094606,0.001036639,0.000062886225,0.002102493,0.000032175423,0.006015921],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99653673,0.00096966827,0.00016846163,0.00022718203,0.0011647694,0.0009331133],"domain_scores_gemma":[0.9952602,0.0014168726,0.0003875735,0.00004242949,0.0016821334,0.0012107417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00231878,0.00094235374,0.0013652146,0.0021386447,0.0014672392,0.0037916016,0.0020466705,0.004042963,0.010733765],"category_scores_gemma":[0.011263514,0.000460101,0.0024957126,0.003954763,0.0016691866,0.00087843987,0.00072331395,0.002835346,0.00034949058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023912642,0.0013495847,0.1200351,0.0073886733,0.009250934,0.0036772382,0.0011894958,0.111453876,0.005978611,0.10088076,0.16895582,0.4459272],"study_design_scores_gemma":[0.012292213,0.005934597,0.5298704,0.008916811,0.02231488,0.0055988175,0.006650482,0.07674892,0.0028439797,0.049223144,0.2780303,0.001575477],"about_ca_topic_score_codex":0.9631256,"about_ca_topic_score_gemma":0.96888787,"teacher_disagreement_score":0.09543435,"about_ca_system_score_codex":0.09543435,"about_ca_system_score_gemma":0.09401353,"threshold_uncertainty_score":0.69242793},"labels":[],"label_agreement":null},{"id":"W2024886597","doi":"10.1016/s1098-3015(10)67256-7","title":"PCN18 LETROZOLE (FEMARA) IS A COST-EFFECTIVE TREATMENT IN THE EXTENDED ADJUVANT SETTING IN WOMEN WITH EARLY BREAST CANCER: AN APPLICATION TO CANADA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Letrozole; Adjuvant; Medicine; Breast cancer; Oncology; Cancer; Internal medicine; Gynecology; Tamoxifen","score_opus":0.013551900936592733,"score_gpt":0.2988200622366946,"score_spread":0.28526816130010185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024886597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90789133,0.018100224,0.0014297989,0.020925,0.00019597437,0.00061040506,0.0078813005,0.00012191905,0.04284408],"genre_scores_gemma":[0.98706114,0.00555931,0.0023861192,0.00038229628,0.00003486076,0.000046904064,0.00073220814,0.000008566133,0.0037886135],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99942625,0.00017196896,0.000024119312,0.00003779368,0.0002170941,0.0001229131],"domain_scores_gemma":[0.99890697,0.0003476593,0.00008119482,0.00002484269,0.00038584223,0.00025355277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077938644,0.0002518938,0.0004471055,0.0007978913,0.0006559213,0.0009777849,0.0005481192,0.00037944515,0.0031318627],"category_scores_gemma":[0.004622784,0.0000973073,0.00052338117,0.0015347535,0.00033767457,0.00025716674,0.0003941303,0.000483149,0.000079462225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01769,0.0010499458,0.24734837,0.0010065972,0.00062826026,0.00090197584,0.00048157637,0.021051163,0.0017498954,0.011490195,0.042115107,0.6544869],"study_design_scores_gemma":[0.0056758793,0.0064195087,0.7876306,0.00086107187,0.004110774,0.0010995358,0.0039301403,0.0715287,0.0035278536,0.005050632,0.109960586,0.00020473443],"about_ca_topic_score_codex":0.94259065,"about_ca_topic_score_gemma":0.97354215,"teacher_disagreement_score":0.057409346,"about_ca_system_score_codex":0.02653831,"about_ca_system_score_gemma":0.04547383,"threshold_uncertainty_score":0.19254982},"labels":[],"label_agreement":null},{"id":"W2025010019","doi":"10.1111/j.1524-4733.2010.00770.x","title":"Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"WOMAC; Statistics; Sample size determination; EQ-5D; Mathematics; Confidence interval; Estimator; Osteoarthritis; Mean squared error; Medicine; Physical therapy; Internal medicine; Disease","score_opus":0.6357394324851724,"score_gpt":0.41937057721580606,"score_spread":0.21636885526936633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025010019","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75917,0.009674308,0.20341644,0.0039438754,0.00027953173,0.0007493838,0.0040745353,0.00032677688,0.01836515],"genre_scores_gemma":[0.96399176,0.0010628526,0.033163976,0.00020344197,0.000039005132,0.00021144413,0.0009135985,0.000041031613,0.00037303087],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98601764,0.010136515,0.0011057504,0.0006152949,0.0018206731,0.00030425598],"domain_scores_gemma":[0.9664599,0.023816181,0.004097176,0.0018963163,0.0032615203,0.0004690054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016666485,0.00084963866,0.0012173831,0.005822322,0.0003942132,0.0034318978,0.00069817546,0.0009884457,0.001783814],"category_scores_gemma":[0.11344759,0.00028326857,0.0015750868,0.006282473,0.0009403788,0.0028213784,0.002463723,0.0018629681,0.00028616737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010986232,0.00058348104,0.5312092,0.0011445073,0.0014265367,0.00018433716,0.0011385101,0.0148501815,0.0016588296,0.023030745,0.0039742757,0.41970086],"study_design_scores_gemma":[0.00015262398,0.0018374737,0.7873903,0.001457539,0.0013844315,0.00097261096,0.0015478341,0.107893646,0.0055289743,0.08115936,0.0104159955,0.00025921047],"about_ca_topic_score_codex":0.0031232566,"about_ca_topic_score_gemma":0.0018708995,"teacher_disagreement_score":0.016666485,"about_ca_system_score_codex":0.00097224937,"about_ca_system_score_gemma":0.0012604226,"threshold_uncertainty_score":0.08814186},"labels":[],"label_agreement":null},{"id":"W2025042808","doi":"10.1016/j.jval.2013.03.1158","title":"Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Patients With Psoriatic Arthritis: Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Presenteeism; Medicine; Placebo; Work productivity; Absenteeism; Psoriatic arthritis; Productivity; Bristol-Myers; Randomized controlled trial; Internal medicine; Physical therapy; Arthritis; Rheumatoid arthritis; Adalimumab; Alternative medicine; Psychology","score_opus":0.030234618528876364,"score_gpt":0.26830918071231474,"score_spread":0.23807456218343837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025042808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945754,0.0031731108,0.0003015621,0.00019576961,0.00016669046,0.00067231344,0.00034216398,0.000069927606,0.00050307345],"genre_scores_gemma":[0.99491537,0.0017257266,0.0005423584,0.00038190605,0.00032043166,0.00070314924,0.000374926,0.000018223524,0.0010178817],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99916124,0.0003803868,0.00007149656,0.00014279083,0.00009234228,0.00015183227],"domain_scores_gemma":[0.99845815,0.0005413253,0.00038431317,0.00013262659,0.000094642055,0.00038892715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00182481,0.0017335056,0.0041644266,0.0005936555,0.0006436641,0.0008667805,0.0010685495,0.00228899,0.003500658],"category_scores_gemma":[0.0018884895,0.0008817699,0.00296079,0.00056651165,0.0015847915,0.00104744,0.00036437204,0.0031191602,0.00055629906],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9575614,0.017357277,0.0011161412,0.00051948446,0.0010378474,0.000048630754,0.00006477144,0.00021176902,0.0041124304,0.000017241995,0.0002575031,0.017695665],"study_design_scores_gemma":[0.81135017,0.17202239,0.013974016,0.00002694209,0.0009863361,0.00004911775,0.000035897425,0.00028174912,0.0009460031,0.000056953188,0.00024008623,0.000030314726],"about_ca_topic_score_codex":0.0011268514,"about_ca_topic_score_gemma":0.0014755783,"teacher_disagreement_score":0.0041644266,"about_ca_system_score_codex":0.0004926592,"about_ca_system_score_gemma":0.00070317026,"threshold_uncertainty_score":0.011710882},"labels":[],"label_agreement":null},{"id":"W2025551428","doi":"10.1016/j.jval.2014.03.1250","title":"Cost-effectiveness of guanfacine extended-release versus atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Atomoxetine; Attention deficit hyperactivity disorder; Guanfacine; Discontinuation; Medicine; Methylphenidate; Psychiatry; Pediatrics; Internal medicine","score_opus":0.03802359208698872,"score_gpt":0.3245071610614566,"score_spread":0.2864835689744679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025551428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9783142,0.010195317,0.00016246182,0.003300343,0.00013777977,0.00044596608,0.0029161961,0.000029416082,0.004498382],"genre_scores_gemma":[0.99526924,0.0025859915,0.0003811016,0.00034987577,0.000030109732,0.000052680592,0.0006190664,0.00000468146,0.0007072078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989525,0.00029341306,0.00008022337,0.00009078735,0.00029005745,0.0002929366],"domain_scores_gemma":[0.99821764,0.00037893574,0.00027493254,0.000022910115,0.00035960047,0.0007459983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006897473,0.0003639362,0.0010235372,0.0006452313,0.00080524985,0.0011575045,0.0011511692,0.00084714877,0.00434557],"category_scores_gemma":[0.004356641,0.00031283408,0.0017115609,0.0010516118,0.00055843097,0.0005105912,0.0006476939,0.0011305576,0.000087440436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1765066,0.0066044116,0.3866822,0.0048748944,0.008859842,0.001406261,0.00078311993,0.043550476,0.0023836873,0.0054525803,0.026798602,0.33609727],"study_design_scores_gemma":[0.042140264,0.015532838,0.84794056,0.0018365099,0.010603693,0.0007521558,0.0028109213,0.06822639,0.0011111475,0.0010804895,0.0077157128,0.0002494059],"about_ca_topic_score_codex":0.95653313,"about_ca_topic_score_gemma":0.9811047,"teacher_disagreement_score":0.057000972,"about_ca_system_score_codex":0.057000972,"about_ca_system_score_gemma":0.048029587,"threshold_uncertainty_score":0.4135729},"labels":[],"label_agreement":null},{"id":"W2025672805","doi":"10.1016/j.jval.2012.08.1772","title":"PSY49 Treatment Patterns in Psoriatic Arthritis (PSA) Patients Newly Initiated on Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Discontinuation; Psoriatic arthritis; Internal medicine; Methotrexate; Rheumatoid arthritis; Ankylosing spondylitis; Sulfasalazine; Disease","score_opus":0.05877108886640592,"score_gpt":0.32845779078471077,"score_spread":0.26968670191830485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025672805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772376,0.00059791637,0.000040014827,0.00010662118,0.0000063532575,0.0000075469115,0.0002976304,0.0000030246156,0.0012171679],"genre_scores_gemma":[0.9993438,0.00018993892,0.000031276224,0.000049622915,0.000007933218,0.0000038969256,0.00016986135,0.0000017658962,0.00020189471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996648,0.00007325527,0.00005124974,0.00005391007,0.0000720166,0.00008488057],"domain_scores_gemma":[0.99893564,0.0003294078,0.0004694764,0.000022223632,0.00005812453,0.00018519598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018052218,0.00011725127,0.00031272552,0.0005224083,0.000256139,0.00040007982,0.00016725676,0.00039778146,0.0033109966],"category_scores_gemma":[0.0015792144,0.00011679944,0.0004808646,0.00080380286,0.00015544784,0.0003304629,0.00023439358,0.00050818484,0.00037445905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010434805,0.0001229269,0.9868483,0.00002959895,0.00008240975,0.00020663269,0.00014759543,0.00006355815,0.0013342195,0.000037000736,0.00029101665,0.009793169],"study_design_scores_gemma":[0.000019845595,0.00024006887,0.9985959,0.000009003901,0.00003324352,0.00047227013,0.00018579733,0.00012521147,0.000086048625,0.000026199883,0.0002031875,0.0000031814484],"about_ca_topic_score_codex":0.003884257,"about_ca_topic_score_gemma":0.007167195,"teacher_disagreement_score":0.003884257,"about_ca_system_score_codex":0.00021605857,"about_ca_system_score_gemma":0.00031699036,"threshold_uncertainty_score":0.01107645},"labels":[],"label_agreement":null},{"id":"W2025771461","doi":"10.1016/j.jval.2014.03.1100","title":"Evaluation of current data sources in Europe for the conduct of real-world studies on lung and renal cell carcinoma: A systematic literature review","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Renal cell carcinoma; Cancer; Real world data; Population; Kidney cancer; Clinical trial; MEDLINE; Cancer registry; Cohort; Oncology; Systematic review; Internal medicine; Intensive care medicine; Data science; Computer science; Environmental health","score_opus":0.2568931885691528,"score_gpt":0.47826495939832736,"score_spread":0.22137177082917459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025771461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013497864,0.9626988,0.0036201356,0.0024916623,0.00045683503,0.002049346,0.013816691,0.000055900236,0.0013126815],"genre_scores_gemma":[0.30974057,0.6295027,0.029207895,0.0065970114,0.0004407419,0.0096257385,0.014465959,0.00015923035,0.00026022005],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.77218276,0.07989502,0.12059967,0.010291483,0.0151793305,0.0018516907],"domain_scores_gemma":[0.3978926,0.47044235,0.084188044,0.015788093,0.029258562,0.0024303375],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.15643768,0.001685574,0.014150012,0.03653156,0.0014321064,0.008502917,0.0045385263,0.004064959,0.004713253],"category_scores_gemma":[0.43040222,0.0022338638,0.015667317,0.03523833,0.0031479164,0.0068819458,0.0068883104,0.0021027105,0.0004079809],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007094711,0.000048606977,0.018758688,0.84404474,0.08410906,0.00027598985,0.0017087854,0.00042390643,0.00029446144,0.0013989093,0.0027638245,0.04546349],"study_design_scores_gemma":[0.0008386765,0.00017474886,0.027700903,0.757484,0.19077218,0.00041211676,0.0016440633,0.00022676984,0.0003712124,0.0010676221,0.019178137,0.00012968955],"about_ca_topic_score_codex":0.010817683,"about_ca_topic_score_gemma":0.031315766,"teacher_disagreement_score":0.98585,"about_ca_system_score_codex":0.007289299,"about_ca_system_score_gemma":0.026089203,"threshold_uncertainty_score":0.8273314},"labels":[],"label_agreement":null},{"id":"W2025792594","doi":"10.1111/j.1524-4733.2007.00171.x","title":"Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Decile; Inflammatory bowel disease; Crohn's disease; Medicine; Statistics; Mathematics; Disease; Physical therapy; Internal medicine","score_opus":0.055559435881920846,"score_gpt":0.28396766535511914,"score_spread":0.22840822947319828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025792594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878306,0.0006628322,0.00923149,0.0003539294,0.000021462984,0.000036634912,0.00064247206,0.000053077492,0.001167572],"genre_scores_gemma":[0.99726284,0.0000803947,0.0018812191,0.000030967352,0.000008483679,0.000030704185,0.00042511805,0.000027695518,0.00025262032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98526704,0.012324049,0.000324363,0.00095892366,0.00077917136,0.0003464037],"domain_scores_gemma":[0.91015035,0.07862249,0.004281892,0.0037862593,0.0021822657,0.0009768558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011234594,0.00085844076,0.0011879937,0.0026006114,0.00049289997,0.001748772,0.0018241657,0.0009080496,0.0036665953],"category_scores_gemma":[0.047973968,0.00046536405,0.002449128,0.0037020417,0.0010610173,0.0011270205,0.0023424984,0.002426915,0.0006312552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011115377,0.00014491656,0.9661797,0.000082985185,0.0018182617,0.00018707583,0.0009998647,0.0035318283,0.0008728705,0.0010345215,0.00047616017,0.023560235],"study_design_scores_gemma":[0.000058238344,0.00053532666,0.97305876,0.000028568553,0.00038649145,0.0005190242,0.00092212553,0.020714682,0.00022840867,0.0028665452,0.00063871517,0.000043067594],"about_ca_topic_score_codex":0.006727041,"about_ca_topic_score_gemma":0.002909499,"teacher_disagreement_score":0.011234594,"about_ca_system_score_codex":0.00040572364,"about_ca_system_score_gemma":0.00080433383,"threshold_uncertainty_score":0.059414923},"labels":[],"label_agreement":null},{"id":"W2025890050","doi":"10.1016/j.jval.2013.03.997","title":"Age-related emergency department reliance (EDR) and health care resource utilization in patients with sickle cell disease (SCD)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Emergency department; Ambulatory; Medicaid; Emergency medicine; Complication; Odds ratio; Ambulatory care; Disease; Public health; Health care; Pediatrics; Internal medicine","score_opus":0.01604863529426406,"score_gpt":0.2601304947168928,"score_spread":0.24408185942262875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025890050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986753,0.00033996976,0.000024590257,0.00015077717,0.000008452289,0.0000032066525,0.00026290215,0.0000016374184,0.00053310994],"genre_scores_gemma":[0.9994005,0.00014623084,0.000038747683,0.00006196275,0.000018199164,0.0000025798886,0.00023057727,0.0000010903701,0.000100042256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957365,0.00013158996,0.000093157425,0.00004506513,0.00006544431,0.00009106941],"domain_scores_gemma":[0.99589986,0.0011556885,0.0019082999,0.0001383572,0.00020879979,0.000688974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060087704,0.00016955055,0.0002890338,0.00072085386,0.000344301,0.0007043046,0.0002675509,0.0006186668,0.0024032772],"category_scores_gemma":[0.004690247,0.00023727123,0.0006606961,0.0010083421,0.000201236,0.0007198632,0.0005769336,0.0012453254,0.00018056178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003848088,0.000040951865,0.9992422,0.0000043575183,0.000028574997,0.000036994104,0.00003218066,0.00003128659,0.00001954076,0.000014484572,0.00006038566,0.00045059],"study_design_scores_gemma":[0.0000028763652,0.000052840245,0.9992161,0.0000072080616,0.000019026334,0.00013039816,0.00024961168,0.00020183368,0.000013449273,0.00003688573,0.00006642072,0.0000032019486],"about_ca_topic_score_codex":0.007823651,"about_ca_topic_score_gemma":0.010227231,"teacher_disagreement_score":0.007823651,"about_ca_system_score_codex":0.00045356085,"about_ca_system_score_gemma":0.00047897437,"threshold_uncertainty_score":0.015556216},"labels":[],"label_agreement":null},{"id":"W2026063780","doi":"10.1016/j.jval.2012.06.016","title":"Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Conceptualization; Management science; Computer science; Process (computing); Problem statement; Health care; Set (abstract data type); Outcomes research; Knowledge management; Medicine; Artificial intelligence; Engineering; Political science","score_opus":0.7933000356806883,"score_gpt":0.5493459970661612,"score_spread":0.24395403861452714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026063780","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014922086,0.011838236,0.6837553,0.20017818,0.001132791,0.0019319225,0.00619487,0.00086402195,0.07918259],"genre_scores_gemma":[0.14394079,0.015020065,0.80221546,0.015163429,0.00096744363,0.0031527665,0.008681257,0.00090695044,0.009951948],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9740156,0.015569139,0.0014546285,0.0014074977,0.006685028,0.00086815236],"domain_scores_gemma":[0.95568126,0.025158796,0.0030736218,0.004860763,0.009319038,0.0019065341],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05761812,0.0016669283,0.0014928835,0.0054070232,0.0026095319,0.010728252,0.0054665185,0.005466767,0.0076940884],"category_scores_gemma":[0.06710484,0.001806682,0.0031280303,0.0064557437,0.0041819024,0.009329062,0.0061202683,0.0082986355,0.0017440951],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036128065,0.00010759301,0.0024168843,0.0004984672,0.00007815347,0.00007215459,0.00064798276,0.023368083,0.0003774247,0.86937433,0.059905052,0.04311775],"study_design_scores_gemma":[0.000055686083,0.000050156807,0.0015300566,0.002417239,0.00013000358,0.00011949966,0.00067101384,0.05538656,0.001097405,0.7060063,0.23242211,0.00011395964],"about_ca_topic_score_codex":0.038951904,"about_ca_topic_score_gemma":0.04219024,"teacher_disagreement_score":0.94238186,"about_ca_system_score_codex":0.0146964025,"about_ca_system_score_gemma":0.034266535,"threshold_uncertainty_score":0.30471742},"labels":[],"label_agreement":null},{"id":"W2026414768","doi":"10.1016/j.jval.2014.03.704","title":"Factors Influencing Management Of Patients With Atrial Fibrillation In Canada And Sweden","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Medicine; Atrial fibrillation; Stroke (engine); Retrospective cohort study; Major bleeding; Internal medicine; Emergency medicine; Pediatrics","score_opus":0.05125982074651023,"score_gpt":0.2968373017688667,"score_spread":0.24557748102235646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026414768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316794,0.0010081817,0.000033834942,0.0016010177,0.00003195312,0.000011533166,0.00057871436,0.000004009679,0.0035628593],"genre_scores_gemma":[0.9985279,0.0004846869,0.000051694853,0.00015957188,0.000014220031,0.000005469114,0.0004227228,0.0000039724764,0.00032972742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808264,0.00032293092,0.00021020831,0.0001481513,0.0005298312,0.00070627424],"domain_scores_gemma":[0.9918389,0.0011665631,0.0019720357,0.00011696494,0.0018656654,0.0030399116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006725367,0.00020169858,0.00051285955,0.0014072915,0.0024021503,0.0025925091,0.0010085771,0.000923573,0.0023334834],"category_scores_gemma":[0.009074363,0.00024746492,0.0006168528,0.003931497,0.0007782295,0.00043487686,0.0011060692,0.0017340296,0.00012824778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000690743,0.00005197232,0.9959611,0.000015058861,0.000048349928,0.00014321049,0.0005760121,0.00007096759,0.000027776496,0.00012848903,0.0006911684,0.0022168376],"study_design_scores_gemma":[0.0000093931085,0.000023080847,0.994642,0.000071989285,0.000037848415,0.00015573847,0.004081642,0.00020047452,0.00002272286,0.0000906074,0.0006490703,0.000015385425],"about_ca_topic_score_codex":0.9279143,"about_ca_topic_score_gemma":0.94737715,"teacher_disagreement_score":0.07208568,"about_ca_system_score_codex":0.01289163,"about_ca_system_score_gemma":0.027432818,"threshold_uncertainty_score":0.14502037},"labels":[],"label_agreement":null},{"id":"W2026670035","doi":"10.1016/j.jval.2012.03.079","title":"PHP2 Value of Patient Submissions in Drug Coverage Processes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Deliberation; Session (web analytics); Family medicine; Medicine; Drug; Value (mathematics); Actuarial science; Psychology; Computer science; Business; Political science; Psychiatry; Advertising","score_opus":0.3020330375488585,"score_gpt":0.41064183416976036,"score_spread":0.10860879662090184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026670035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58405316,0.0028406144,0.11654686,0.02840259,0.0010691212,0.0012506769,0.07694982,0.0020794095,0.1868077],"genre_scores_gemma":[0.9644198,0.00030013072,0.0061793,0.0003656677,0.0004122742,0.00019256788,0.005710459,0.000113395625,0.022306472],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98825675,0.005406035,0.0005541416,0.0012928142,0.0031390258,0.0013511506],"domain_scores_gemma":[0.8352936,0.13883194,0.008511161,0.0059666447,0.008325175,0.0030714842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016090995,0.00048728148,0.0008748061,0.0024438007,0.000752275,0.0051102345,0.001141278,0.0022610733,0.03898452],"category_scores_gemma":[0.12634179,0.000494434,0.0009538325,0.0025918866,0.00090150733,0.0041442676,0.0014941535,0.0026195939,0.0028403548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051263287,0.00062472984,0.20279777,0.0014820835,0.00061073195,0.0012529241,0.0010932452,0.1774636,0.002096245,0.2431252,0.12063542,0.24369176],"study_design_scores_gemma":[0.00039787535,0.00092938327,0.17781423,0.00035233403,0.00024422904,0.0011059763,0.0013418295,0.4413891,0.00662232,0.32029346,0.049301945,0.00020729208],"about_ca_topic_score_codex":0.0050559905,"about_ca_topic_score_gemma":0.0029130576,"teacher_disagreement_score":0.03898452,"about_ca_system_score_codex":0.0035693608,"about_ca_system_score_gemma":0.0025857363,"threshold_uncertainty_score":0.13041615},"labels":[],"label_agreement":null},{"id":"W2026842194","doi":"10.1016/j.jval.2014.03.268","title":"Cost-Of-Illness Studies For Juvenile Idiopathic Arthritis: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Mount Sinai Hospital; York University; University of Toronto","funders":"","keywords":"Medicine; Indirect costs; Arthritis; MEDLINE; Medical costs; Medical record; Family medicine; Internal medicine; Health care","score_opus":0.37859998596425676,"score_gpt":0.5323551595095677,"score_spread":0.15375517354531093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026842194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015864582,0.9976198,0.00009242316,0.0000964034,0.00006914647,0.00009231728,0.00032642687,0.000004151626,0.00011279129],"genre_scores_gemma":[0.04849935,0.9495837,0.0008291515,0.000420717,0.000085499894,0.00018516598,0.00030644602,0.0000058508363,0.00008411448],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99323225,0.0020777723,0.0027197073,0.00056434417,0.0011420615,0.00026378574],"domain_scores_gemma":[0.9762739,0.018006105,0.004091445,0.0002939778,0.0010633315,0.00027114447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068459823,0.00180056,0.010939814,0.008653205,0.0005016075,0.0025855175,0.0019583828,0.0018407572,0.0045970306],"category_scores_gemma":[0.034813434,0.0012208476,0.014259142,0.010877766,0.0008487332,0.0024753474,0.00186676,0.001938695,0.00017503783],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067173166,0.000036166897,0.003613139,0.8685327,0.098511375,0.0001341287,0.00011418191,0.00020566057,0.0001028216,0.00024564774,0.0012317694,0.02660064],"study_design_scores_gemma":[0.0011626927,0.0003126244,0.01808393,0.33332968,0.6338817,0.0005967401,0.00044241094,0.00022967097,0.00013364661,0.0007488553,0.010988273,0.00008980528],"about_ca_topic_score_codex":0.009552809,"about_ca_topic_score_gemma":0.037919443,"teacher_disagreement_score":0.010939814,"about_ca_system_score_codex":0.0034247001,"about_ca_system_score_gemma":0.0048357095,"threshold_uncertainty_score":0.03620541},"labels":[],"label_agreement":null},{"id":"W2027067783","doi":"10.1016/s1098-3015(10)73444-6","title":"PSS12 COST-UTILITY ANALYSIS OF POSTERIOR LAMELLAR KERATOPLASTY IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Optometry; Ophthalmology; Medicine","score_opus":0.03120846788730503,"score_gpt":0.3045202192584103,"score_spread":0.27331175137110525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027067783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93371576,0.010065829,0.00034203994,0.0018241401,0.0000575549,0.00032987056,0.0460204,0.000036415884,0.0076079844],"genre_scores_gemma":[0.98213917,0.0035226163,0.00032406772,0.00030879848,0.000023963657,0.00009519708,0.0107463505,0.000018559811,0.002821328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972664,0.0007956046,0.00019914619,0.0001902511,0.0008485174,0.0007001173],"domain_scores_gemma":[0.99360436,0.0012642251,0.0008211742,0.00017459429,0.003182007,0.0009536822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020360267,0.00075354666,0.0016050893,0.0027689515,0.0014449774,0.00197957,0.0018119394,0.0006960011,0.004168732],"category_scores_gemma":[0.009578484,0.00061157194,0.0034683412,0.010618667,0.0006800286,0.0005472938,0.00091469864,0.0013342148,0.00018327324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02057868,0.0007034118,0.8670539,0.0018926668,0.007862603,0.0007895364,0.00056668185,0.035395984,0.0005683688,0.0049467613,0.022762768,0.036878616],"study_design_scores_gemma":[0.0016725471,0.0007732529,0.97190577,0.00036644092,0.002902064,0.00022326034,0.001150198,0.014223051,0.00027315144,0.00038996586,0.006003793,0.00011669186],"about_ca_topic_score_codex":0.99656975,"about_ca_topic_score_gemma":0.995669,"teacher_disagreement_score":0.09229855,"about_ca_system_score_codex":0.09229855,"about_ca_system_score_gemma":0.07464332,"threshold_uncertainty_score":0.669676},"labels":[],"label_agreement":null},{"id":"W2027256506","doi":"10.1016/j.jval.2012.08.1711","title":"PDB68 Physician Beliefs About Insulin Pens Versus Vials, Therapy Choice Factors, and Patient Characteristics Among Elderly Type 2 Diabetes Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Vial; Medicine; Diabetes mellitus; Type 2 diabetes; Basal (medicine); Insulin; Internal medicine; Family medicine; Emergency medicine; Endocrinology","score_opus":0.0624983580471539,"score_gpt":0.3137289067175666,"score_spread":0.25123054867041267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027256506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991698,0.00013388717,0.000013337096,0.000102373284,0.000004113091,0.0000033661502,0.00006960934,5.7540717e-7,0.0005028346],"genre_scores_gemma":[0.9996137,0.000066916975,0.000028909591,0.00009412789,0.000010717329,0.0000027475755,0.000044223427,5.516048e-7,0.00013812451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995277,0.00017439318,0.00007113477,0.000041540967,0.000108251596,0.00007699319],"domain_scores_gemma":[0.9961104,0.0015712234,0.0015668883,0.00007795976,0.0001934466,0.0004802105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007505446,0.00014490756,0.00033244386,0.00046667145,0.00046809108,0.0007115595,0.00011962824,0.00048352196,0.0037764162],"category_scores_gemma":[0.0057701655,0.00018111356,0.00048325173,0.00061352714,0.00019680391,0.0004245589,0.0002185763,0.0005868059,0.00020937022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024814752,0.00017138933,0.99764806,0.000009834427,0.000054973894,0.000053138054,0.00015152688,0.00002826181,0.00007887875,0.000013812826,0.000095057505,0.0014469079],"study_design_scores_gemma":[0.000039456,0.00032228226,0.9982204,0.000016371294,0.00005871637,0.00021982814,0.000642371,0.0002244732,0.000043197033,0.00003443206,0.00017299555,0.000005520563],"about_ca_topic_score_codex":0.0041864123,"about_ca_topic_score_gemma":0.006387349,"teacher_disagreement_score":0.0041864123,"about_ca_system_score_codex":0.00033404698,"about_ca_system_score_gemma":0.000329625,"threshold_uncertainty_score":0.012633324},"labels":[],"label_agreement":null},{"id":"W2027282720","doi":"10.1016/s1098-3015(10)63601-7","title":"PSU3 DEMOGRAPHIC PREDICTORS OF RESOURCE UTILIZATION AND COSTS OF SOLID ORGAN TRANSPLANTATION IN BRITISH COLUMBIA, CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Mining and Resource Management","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transplantation; Resource (disambiguation); Solid organ; Organ transplantation; Demography; Medicine; Geography; Computer science; Internal medicine; Sociology","score_opus":0.008579645426126922,"score_gpt":0.19597561194551089,"score_spread":0.18739596651938395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027282720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545074,0.0005190243,0.00010305306,0.00069483643,0.000025976426,0.00002623352,0.00864787,0.000025493098,0.004506757],"genre_scores_gemma":[0.99360186,0.00036251734,0.00010468196,0.00011661812,0.000008704295,0.000018426097,0.0023441946,0.000015547763,0.0034275071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993673,0.00005569715,0.000059598155,0.000077437944,0.00015548168,0.00028459166],"domain_scores_gemma":[0.99632215,0.00024916968,0.00047534285,0.000092162554,0.0017551102,0.0011061527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041066433,0.00033053223,0.000460071,0.0019048306,0.0028826403,0.0014626252,0.0018404427,0.0006488907,0.0071612084],"category_scores_gemma":[0.002669025,0.00036184714,0.0008041851,0.0036203607,0.00054811104,0.00039539573,0.00081259303,0.0013066971,0.00063651113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079889585,0.000037899572,0.99326694,0.000016837832,0.00005806573,0.00010556504,0.0002466872,0.00029751848,0.00008328064,0.00014293278,0.002799556,0.0028649478],"study_design_scores_gemma":[0.000009134125,0.000011176805,0.99700016,0.00003127476,0.000032419688,0.000060826813,0.0013070158,0.0005990281,0.000051092175,0.000052446543,0.00083280826,0.000012530053],"about_ca_topic_score_codex":0.9966182,"about_ca_topic_score_gemma":0.9979296,"teacher_disagreement_score":0.018347755,"about_ca_system_score_codex":0.018347755,"about_ca_system_score_gemma":0.03264238,"threshold_uncertainty_score":0.13312292},"labels":[],"label_agreement":null},{"id":"W2027804344","doi":"10.1016/j.jval.2012.08.1217","title":"PCN24 Treatment and Response Patterns in Chronic Myeloid Leukemia: Evidence from a Retrospective Study in Canada, Australia, and South Korea","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nilotinib; Dasatinib; Imatinib; Myeloid leukemia; Internal medicine; Pediatrics; Demography","score_opus":0.07667985724548108,"score_gpt":0.330722337570888,"score_spread":0.2540424803254069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027804344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972933,0.0012525427,0.000037125825,0.000071600545,0.000004416251,0.00002361412,0.0007614787,0.0000017745012,0.0005542208],"genre_scores_gemma":[0.9985267,0.0005961266,0.000045291206,0.00006413837,0.0000042801894,0.000012129013,0.000595168,0.0000023684343,0.00015382445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984579,0.0003067604,0.00020808633,0.00028374058,0.00039199012,0.00035156624],"domain_scores_gemma":[0.9956488,0.0004905332,0.0019352622,0.00026238203,0.0010835936,0.0005793588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012371805,0.0002486126,0.00061064586,0.001246667,0.0011777607,0.0011144122,0.000722586,0.0004386406,0.0009774682],"category_scores_gemma":[0.00362087,0.0003487951,0.0006771326,0.00555951,0.00095333054,0.0004045914,0.0005743702,0.0005868915,0.000112954855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001490526,0.000020249408,0.99829394,0.000028476994,0.000121400895,0.000037025886,0.0001524715,0.00002026156,0.00006400203,0.000014886076,0.00008280306,0.0010154623],"study_design_scores_gemma":[0.000010833364,0.00003905354,0.9989254,0.000018256134,0.00011722002,0.00008946122,0.00042550993,0.000049861,0.000031745793,0.000007874881,0.0002797846,0.0000050034646],"about_ca_topic_score_codex":0.60687876,"about_ca_topic_score_gemma":0.68086773,"teacher_disagreement_score":0.39312124,"about_ca_system_score_codex":0.0038787534,"about_ca_system_score_gemma":0.0063814507,"threshold_uncertainty_score":0.7908728},"labels":[],"label_agreement":null},{"id":"W2027823501","doi":"10.1016/j.jval.2014.03.1200","title":"Exploring the impact of structural uncertainty in partitioned survival models for oncology","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Survival analysis; Hazard ratio; Parametric statistics; Marginal structural model; Set (abstract data type); Statistics; Extrapolation; Econometrics; Proportional hazards model; Medicine; Computer science; Mathematics; Confidence interval","score_opus":0.7358476749632621,"score_gpt":0.4907542901269787,"score_spread":0.2450933848362834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027823501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7650467,0.0032571552,0.21902531,0.007700596,0.00013727594,0.00010018001,0.00082130055,0.00016395329,0.0037475508],"genre_scores_gemma":[0.99155664,0.00056705624,0.0058304025,0.00018142867,0.000073868374,0.00003892219,0.0002628467,0.000038653263,0.0014501059],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9951207,0.003923768,0.00009070981,0.00029263063,0.00016591995,0.0004061902],"domain_scores_gemma":[0.8064378,0.18664958,0.0037875308,0.0012901863,0.0009590316,0.0008759026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015487201,0.0012572699,0.0020143085,0.0009256212,0.0008384287,0.0032000593,0.0022476888,0.0025514283,0.004467506],"category_scores_gemma":[0.09576843,0.0016226015,0.0016168832,0.001209293,0.0024415872,0.0038741026,0.0026321332,0.004654315,0.00018702599],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021434971,0.0000748736,0.00701731,0.00007372229,0.00021324561,0.00012924123,0.00032979707,0.94143915,0.000100988465,0.044539932,0.00077903917,0.005088306],"study_design_scores_gemma":[0.000060255592,0.000084077554,0.0014448963,0.000027513166,0.0000875524,0.000024784047,0.00018128479,0.92528296,0.00009418673,0.07235828,0.00032948976,0.000024664032],"about_ca_topic_score_codex":0.02540548,"about_ca_topic_score_gemma":0.020881657,"teacher_disagreement_score":0.02540548,"about_ca_system_score_codex":0.0024017834,"about_ca_system_score_gemma":0.0018552876,"threshold_uncertainty_score":0.08190507},"labels":[],"label_agreement":null},{"id":"W2028081096","doi":"10.1016/j.jval.2011.08.335","title":"PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Toronto","funders":"","keywords":"Paliperidone; Paliperidone Palmitate; Olanzapine; Medicine; Economic evaluation; Schizophrenia (object-oriented programming); Psychiatry; Antipsychotic","score_opus":0.28181152279169774,"score_gpt":0.4357920238968458,"score_spread":0.15398050110514805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028081096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735015,0.019251812,0.0012314104,0.00075084757,0.0002431402,0.0005115484,0.0023427398,0.000023248274,0.0021437823],"genre_scores_gemma":[0.99567443,0.0018628736,0.00084422354,0.00013574048,0.000044798675,0.00016935632,0.0009481266,0.0000058571,0.00031453097],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99604553,0.003028154,0.00021816007,0.00019404964,0.00026898357,0.0002451871],"domain_scores_gemma":[0.9984351,0.000977439,0.00029158834,0.000051944393,0.00007863082,0.00016522936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035757413,0.00058579165,0.001828976,0.0005414983,0.00016409297,0.0008943059,0.00063035847,0.00067069015,0.0028624784],"category_scores_gemma":[0.0068623573,0.0004861129,0.0048133237,0.0005082265,0.0004268983,0.0007235766,0.0006835027,0.0009121374,0.00009425009],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7095489,0.0019303038,0.033969056,0.005874731,0.017555105,0.0009191096,0.00019238466,0.10693404,0.0038394753,0.0019293514,0.002602664,0.1147049],"study_design_scores_gemma":[0.25001308,0.18311241,0.3603694,0.0038563411,0.05708972,0.0019922564,0.001275094,0.12106644,0.0035703664,0.00327596,0.013917446,0.00046138975],"about_ca_topic_score_codex":0.029298056,"about_ca_topic_score_gemma":0.022408884,"teacher_disagreement_score":0.029298056,"about_ca_system_score_codex":0.0050416384,"about_ca_system_score_gemma":0.0029667416,"threshold_uncertainty_score":0.058255076},"labels":[],"label_agreement":null},{"id":"W2028224503","doi":"10.1016/s1098-3015(10)61076-5","title":"PMH10 THE BURDEN OF DEPRESSION IN CANADA","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depression (economics); Medicine; Psychiatry; Economics; Keynesian economics","score_opus":0.0967378677926974,"score_gpt":0.3867573053891308,"score_spread":0.2900194375964334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028224503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86509585,0.012987231,0.00013374849,0.03870312,0.00063280616,0.000122078,0.051561005,0.000065035776,0.030699125],"genre_scores_gemma":[0.97939545,0.006041958,0.00014648441,0.0015562432,0.00015873415,0.000030454614,0.0049593193,0.000014331063,0.0076969494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906427,0.00006306453,0.000044907316,0.000044180666,0.0003113885,0.00047210653],"domain_scores_gemma":[0.99700135,0.00009157989,0.00034472087,0.0000323807,0.0011824488,0.0013474891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037924858,0.00025299133,0.00044620558,0.0016211044,0.002701478,0.0017778304,0.0012033278,0.0008514192,0.008090113],"category_scores_gemma":[0.0025689504,0.0003085139,0.0006852503,0.004622284,0.00057675934,0.0004655247,0.0010109214,0.0014175314,0.00036552013],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035312347,0.0001202053,0.9002705,0.00027363884,0.00017674714,0.0003391869,0.000771482,0.0006076643,0.00017625462,0.0011420721,0.05426297,0.041506045],"study_design_scores_gemma":[0.00003541511,0.000026164067,0.9903718,0.00010700344,0.000035903344,0.00007678754,0.0010736685,0.0002593743,0.000032614138,0.000095783165,0.007870903,0.00001451721],"about_ca_topic_score_codex":0.9977756,"about_ca_topic_score_gemma":0.9985973,"teacher_disagreement_score":0.045353968,"about_ca_system_score_codex":0.045353968,"about_ca_system_score_gemma":0.07882736,"threshold_uncertainty_score":0.3290676},"labels":[],"label_agreement":null},{"id":"W2028440405","doi":"10.1016/s1098-3015(10)73886-9","title":"PIH18 A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10- VALENT PNEUMOCOCCAL NON- TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN SWEDEN","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Haemophilus influenzae; Conjugate vaccine; Medicine; Vaccination; Pneumococcal conjugate vaccine; Conjugate; Haemophilus; Pneumococcal disease; Virology; Microbiology; Streptococcus pneumoniae; Immunization; Immunology; Biology; Antibody; Bacteria; Antibiotics; Genetics; Mathematics","score_opus":0.036978897905005,"score_gpt":0.33256284719297496,"score_spread":0.29558394928796994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028440405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99317193,0.003811794,0.0005708537,0.000345235,0.00008009118,0.0002023996,0.0007262386,0.000023172799,0.0010682343],"genre_scores_gemma":[0.9973828,0.00095498364,0.0003606981,0.00010376164,0.000031624186,0.00013205047,0.00060293014,0.000005787199,0.0004252738],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9953126,0.0034564682,0.00015419611,0.00023750897,0.00028521306,0.00055390166],"domain_scores_gemma":[0.9966054,0.0023647328,0.00033074032,0.00010036479,0.00022766486,0.00037111843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003302989,0.0014103517,0.0026156302,0.001297531,0.00031183386,0.0014455506,0.0009920482,0.0015920323,0.0034970536],"category_scores_gemma":[0.008329812,0.0009226354,0.006589697,0.0013330277,0.00062308594,0.0010186208,0.0010723977,0.0015197672,0.00019243985],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3679242,0.0060080104,0.07044694,0.0070508174,0.029495966,0.0020124274,0.0003622064,0.41646612,0.0033806148,0.0020574708,0.002865022,0.09193019],"study_design_scores_gemma":[0.09661699,0.21193174,0.35415065,0.0019890522,0.057790592,0.0023569523,0.0016173517,0.26080975,0.0037621667,0.0027987475,0.0057020327,0.00047397794],"about_ca_topic_score_codex":0.030063134,"about_ca_topic_score_gemma":0.011748033,"teacher_disagreement_score":0.030063134,"about_ca_system_score_codex":0.0066387034,"about_ca_system_score_gemma":0.0030791366,"threshold_uncertainty_score":0.059776247},"labels":[],"label_agreement":null},{"id":"W2028465701","doi":"10.1016/j.jval.2013.03.608","title":"Key cost drivers in the cost of care for sickle cell disease patients: Results of a systematic literature search and a survey of payers and key opinion leaders","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Key (lock); Disease; Opinion leadership; Medicine; Business; Intensive care medicine; Actuarial science; Computer science; Political science; Public relations; Computer security; Pathology","score_opus":0.03862994519277962,"score_gpt":0.3004888794024748,"score_spread":0.2618589342096952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028465701","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35924092,0.58532625,0.0010563635,0.012303181,0.00021995444,0.0013115436,0.03726161,0.000029981446,0.0032502247],"genre_scores_gemma":[0.7917785,0.19247635,0.003905671,0.0028932607,0.0001953764,0.0011466001,0.0073401313,0.000022801236,0.00024133499],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9770429,0.0065280334,0.011001564,0.0012706966,0.0034880317,0.00066881935],"domain_scores_gemma":[0.83675504,0.11266981,0.03830081,0.0014044307,0.009582565,0.0012873604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021542238,0.0006614944,0.0038986206,0.015975073,0.000680834,0.0032868532,0.0011737109,0.0018829252,0.0021569456],"category_scores_gemma":[0.10853638,0.0008341769,0.0072692954,0.023665538,0.00072635565,0.0039176955,0.0022683903,0.001366436,0.00016811024],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011200035,0.00015168807,0.62958384,0.19589621,0.030060677,0.00069214037,0.005547776,0.00069235987,0.00047476657,0.0018254729,0.0072100535,0.12674496],"study_design_scores_gemma":[0.000702623,0.00044912027,0.73731494,0.13868415,0.08131146,0.0018346059,0.014989593,0.001205077,0.00046951108,0.0021906032,0.020583121,0.00026530086],"about_ca_topic_score_codex":0.016428716,"about_ca_topic_score_gemma":0.02996505,"teacher_disagreement_score":0.021542238,"about_ca_system_score_codex":0.004427962,"about_ca_system_score_gemma":0.012121151,"threshold_uncertainty_score":0.1139276},"labels":[],"label_agreement":null},{"id":"W2028649541","doi":"10.1016/j.jval.2011.08.240","title":"PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared with 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal conjugate vaccine; Medicine; Pneumococcal disease; Vaccination; Dosing; Streptococcus pneumoniae; Immunization; Population; Environmental health; Immunology; Internal medicine; Antibiotics; Microbiology; Biology; Antigen","score_opus":0.04973701197539053,"score_gpt":0.2954728751303512,"score_spread":0.24573586315496065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028649541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97404695,0.007750654,0.0003635738,0.002804364,0.00028535494,0.0006791643,0.00490264,0.00006961025,0.0090976935],"genre_scores_gemma":[0.99443567,0.0020070693,0.00041510354,0.00044501756,0.000056504683,0.00007092393,0.0010365488,0.000009216054,0.0015238792],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977786,0.0007693916,0.00011601307,0.00020823767,0.00051081594,0.0006169902],"domain_scores_gemma":[0.99828374,0.0005403828,0.00023364004,0.000046971552,0.000388938,0.00050642854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012722325,0.00076148217,0.0015303945,0.00067267334,0.0006162261,0.0011709365,0.001306679,0.0014063048,0.005719238],"category_scores_gemma":[0.0066172825,0.00046222558,0.0025890085,0.0010220751,0.0006036737,0.00060204475,0.00058175664,0.0012775377,0.00020557572],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41381803,0.006613805,0.13684995,0.0033007425,0.008172115,0.0010257034,0.00037846717,0.11388222,0.0033360438,0.0029733682,0.020489817,0.2891598],"study_design_scores_gemma":[0.0744478,0.05167146,0.77625203,0.0010480095,0.011949148,0.0005840895,0.0010536814,0.0725649,0.0025623937,0.0011065266,0.0064433804,0.00031653378],"about_ca_topic_score_codex":0.9372258,"about_ca_topic_score_gemma":0.93408203,"teacher_disagreement_score":0.06277418,"about_ca_system_score_codex":0.03746246,"about_ca_system_score_gemma":0.043104652,"threshold_uncertainty_score":0.2718104},"labels":[],"label_agreement":null},{"id":"W2028678413","doi":"10.1016/s1098-3015(10)66890-8","title":"PMC52 LINGUISTIC VALIDATION OF THE FRENCH FOR CANADA WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE, GENERAL HEALTHVERSION (WPAI:GH)","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work productivity; Productivity; Work (physics); Psychology; Linguistics; Geography; Engineering; Economics; Economic growth; Philosophy","score_opus":0.10837437364863692,"score_gpt":0.40818280225358705,"score_spread":0.29980842860495016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028678413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88739,0.0013624303,0.008348051,0.001778251,0.0008833914,0.0048739673,0.033459865,0.00024439543,0.06165957],"genre_scores_gemma":[0.8923964,0.0007094372,0.017714208,0.0021700466,0.00029779892,0.009689124,0.032786384,0.00034195246,0.04389475],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9911067,0.0033382587,0.0012212468,0.0010609312,0.002551543,0.0007214419],"domain_scores_gemma":[0.975317,0.0043322844,0.0010120855,0.0013099244,0.0175275,0.0005011706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013201984,0.0008645374,0.0008488165,0.0033822593,0.0032229684,0.001973283,0.0012799504,0.00087160023,0.014595151],"category_scores_gemma":[0.03625446,0.00034376752,0.00088068977,0.0021520886,0.0012158187,0.00085871894,0.0021528525,0.000864196,0.0054218676],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027734276,0.0025114417,0.53472584,0.0014001875,0.00046925078,0.0019380802,0.038379274,0.00068721495,0.016690992,0.0049882573,0.11242764,0.28300837],"study_design_scores_gemma":[0.00052149827,0.0007348128,0.8888715,0.00050748594,0.00022347075,0.0011575529,0.0076490063,0.00070344255,0.0031143932,0.00060818624,0.09579746,0.000111275825],"about_ca_topic_score_codex":0.21009548,"about_ca_topic_score_gemma":0.23762675,"teacher_disagreement_score":0.78990453,"about_ca_system_score_codex":0.0040813717,"about_ca_system_score_gemma":0.008520994,"threshold_uncertainty_score":0.41774517},"labels":[],"label_agreement":null},{"id":"W2028726004","doi":"10.1016/j.jval.2012.03.1167","title":"PCN50 A Pilot Assessment to Determine Cost of Apheresis Treatment","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Apheresis; Medicine; Context (archaeology); Activity-based costing; Protocol (science); Transplantation; Emergency medicine; Surgery; Internal medicine; Business","score_opus":0.1437139223347846,"score_gpt":0.4393718895048983,"score_spread":0.2956579671701137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028726004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790298,0.00066471176,0.0021839854,0.0009908805,0.00009619447,0.0015996537,0.0033655588,0.000070841,0.0119984625],"genre_scores_gemma":[0.9903324,0.00022923178,0.0034502363,0.00025705888,0.000043009888,0.0008103135,0.0016716288,0.000017645481,0.0031885044],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99780077,0.0011530647,0.00008536741,0.00017763917,0.0006017771,0.0001813177],"domain_scores_gemma":[0.99490523,0.0027713068,0.0005097218,0.00024249032,0.0010169587,0.00055425236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027875672,0.00045749205,0.0005661943,0.0006474485,0.0003496722,0.000843291,0.00083531387,0.00067277136,0.009810183],"category_scores_gemma":[0.008134713,0.00016817501,0.00078464014,0.000740161,0.0004396304,0.000661617,0.00046793674,0.000816426,0.0010040231],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1981747,0.018264681,0.295652,0.00096892024,0.0011894798,0.001160963,0.00059082505,0.016874958,0.020508457,0.0053158742,0.025469888,0.41582927],"study_design_scores_gemma":[0.017298067,0.14889975,0.7079939,0.00036725856,0.0016055788,0.0017063009,0.0008683717,0.056730136,0.024195239,0.0029976643,0.03717738,0.00016026193],"about_ca_topic_score_codex":0.009471517,"about_ca_topic_score_gemma":0.0066684512,"teacher_disagreement_score":0.009810183,"about_ca_system_score_codex":0.0024606532,"about_ca_system_score_gemma":0.0018076098,"threshold_uncertainty_score":0.032818317},"labels":[],"label_agreement":null},{"id":"W2028730671","doi":"10.1016/s1098-3015(10)70711-7","title":"PDB23 COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INJECTION VS. MULTIPLE DAILY INJECTIONS IN TYPE I DIABETES PATIENTS: A CANADIAN PERSPECTIVE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Medicine; Type 2 diabetes; Insulin; Subcutaneous injection; Diabetes mellitus; Internal medicine; Type 1 diabetes; Intensive care medicine; Endocrinology; Computer science; Artificial intelligence","score_opus":0.034423426643432516,"score_gpt":0.2995289651068589,"score_spread":0.2651055384634264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028730671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72526664,0.103755295,0.0071005253,0.0349366,0.0010932754,0.0024140854,0.04954128,0.0002123763,0.07567991],"genre_scores_gemma":[0.9780116,0.00978289,0.0033481321,0.0018079268,0.00019669688,0.00018362039,0.003846843,0.000037654743,0.002784625],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99545443,0.0020145075,0.000205026,0.00030212986,0.0011317369,0.000892079],"domain_scores_gemma":[0.9950659,0.0023237257,0.0004331548,0.00007571244,0.0012316018,0.0008697541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042320276,0.0015441381,0.0029681185,0.002155491,0.0010478507,0.0037496504,0.0020138572,0.0017846827,0.010174421],"category_scores_gemma":[0.011822247,0.0007681107,0.0062563187,0.0050001633,0.00077059824,0.00075437943,0.00077353156,0.002438147,0.00029556063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14867912,0.002269718,0.09210124,0.010655815,0.031784683,0.0015367811,0.00055131956,0.32657927,0.004385345,0.039077453,0.055264384,0.28711486],"study_design_scores_gemma":[0.0813649,0.018905362,0.3837118,0.0057244767,0.076832496,0.0022572463,0.0030926121,0.3490694,0.003423534,0.015445743,0.05875833,0.0014141555],"about_ca_topic_score_codex":0.9275353,"about_ca_topic_score_gemma":0.9162005,"teacher_disagreement_score":0.08574871,"about_ca_system_score_codex":0.08574871,"about_ca_system_score_gemma":0.06915429,"threshold_uncertainty_score":0.62215334},"labels":[],"label_agreement":null},{"id":"W2028744677","doi":"10.1016/j.jval.2013.03.724","title":"Patient Preferences: Understanding Risk-Benefit Trade-Offs Of Genomic Testing In Chemotherapy Decisions For Breast Cancer Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Mixed logit; Oncology; Internal medicine; Logistic regression; Cancer; Family medicine","score_opus":0.3589665301960837,"score_gpt":0.408837780949174,"score_spread":0.04987125075309029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028744677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.928483,0.0036696375,0.01006354,0.03261029,0.00011172086,0.000099314864,0.00060622336,0.00002373329,0.02433255],"genre_scores_gemma":[0.9971059,0.00031026843,0.0017067352,0.00064244494,0.000034229128,0.00001450655,0.000052183528,0.0000033447895,0.00013037729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99119824,0.0071304217,0.0003231978,0.00028990943,0.00072975864,0.00032846502],"domain_scores_gemma":[0.91874343,0.07439378,0.0038958283,0.0005633618,0.0013674302,0.00103616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010927459,0.00031223873,0.00038129027,0.0008791504,0.0005939003,0.0028654619,0.0004901983,0.0017141649,0.0063716406],"category_scores_gemma":[0.08113354,0.00028581344,0.00086219073,0.0006231456,0.0011178736,0.0029417889,0.0010395413,0.0026788788,0.00036657366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006395464,0.0019385617,0.60244524,0.0009845158,0.0015434226,0.0016893486,0.00881765,0.038066484,0.0014489583,0.045943882,0.010942658,0.2797839],"study_design_scores_gemma":[0.0010145705,0.003878475,0.40828264,0.0016579713,0.00168503,0.0043019517,0.027255557,0.16800772,0.0028013564,0.35979292,0.020907495,0.0004143079],"about_ca_topic_score_codex":0.002576489,"about_ca_topic_score_gemma":0.00409266,"teacher_disagreement_score":0.010927459,"about_ca_system_score_codex":0.0021661166,"about_ca_system_score_gemma":0.0012011355,"threshold_uncertainty_score":0.057790577},"labels":[],"label_agreement":null},{"id":"W2028802309","doi":"10.1016/j.jval.2014.08.1262","title":"Paliperidone Versus Atypical Long-Acting Antipsychotics for Relapsed Chronic Schizophrenia: an Economic Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone; Schizophrenia (object-oriented programming); Paliperidone Palmitate; Medicine; Psychiatry; Antipsychotic","score_opus":0.37381317833837174,"score_gpt":0.4468566755425673,"score_spread":0.07304349720419556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028802309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94819105,0.03474944,0.0047611147,0.0031467697,0.00031253125,0.0008857961,0.001576639,0.0000529444,0.0063237627],"genre_scores_gemma":[0.99458754,0.003613687,0.00063719216,0.00018557519,0.000067860026,0.00010578678,0.00025123268,0.0000069853504,0.000544262],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9925855,0.0064101256,0.00019849178,0.00014312188,0.00027345013,0.00038930465],"domain_scores_gemma":[0.9865002,0.01176586,0.00086594245,0.00013556008,0.0001799823,0.0005525002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0082573835,0.001537669,0.002555013,0.0016566869,0.00040435925,0.0019905535,0.00095188885,0.0015716772,0.004462589],"category_scores_gemma":[0.022091702,0.0007850597,0.005080531,0.0012511583,0.0010834375,0.0018993936,0.0011941377,0.0025458047,0.00012629585],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.531272,0.0053541474,0.033788994,0.0068228343,0.030480236,0.0013862639,0.0003918547,0.22529289,0.0016908319,0.022799395,0.005625334,0.13509524],"study_design_scores_gemma":[0.12525539,0.073622175,0.07764217,0.0029642754,0.08042435,0.0017491161,0.0029093,0.58437645,0.0015879808,0.038570385,0.010360932,0.0005374658],"about_ca_topic_score_codex":0.008642589,"about_ca_topic_score_gemma":0.007867136,"teacher_disagreement_score":0.008642589,"about_ca_system_score_codex":0.00510951,"about_ca_system_score_gemma":0.00218722,"threshold_uncertainty_score":0.04366976},"labels":[],"label_agreement":null},{"id":"W2029108361","doi":"10.1016/j.jval.2014.03.513","title":"Cost–Effectiveness Analysis Parallel to a Randomized Controlled Trial Comparing Vertical Scar Reduction (VSR) and Inverted T-Shaped Reduction (ITR) Mammoplasty","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto; McMaster University","funders":"","keywords":"Randomized controlled trial; Medicine; Cost-effectiveness analysis; Quality-adjusted life year; Quality of life (healthcare); Reduction Mammoplasty; EQ-5D; Economic evaluation; Cost–benefit analysis; Physical therapy; Cost effectiveness; Surgery; Internal medicine; Health related quality of life; Nursing; Risk analysis (engineering); Breast cancer; Pathology","score_opus":0.047619420798137524,"score_gpt":0.32097462633369855,"score_spread":0.27335520553556103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029108361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8603593,0.029793395,0.017169686,0.0046278313,0.009704778,0.05936383,0.005059518,0.00069727615,0.013224484],"genre_scores_gemma":[0.9619871,0.0028970696,0.009327166,0.0016589076,0.0013394098,0.017497053,0.0013864348,0.000057981077,0.003848922],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9891117,0.0075855027,0.00081716495,0.001182753,0.00048454333,0.00081844244],"domain_scores_gemma":[0.98667777,0.008425648,0.0020168293,0.00089520676,0.0008666263,0.0011178469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009933919,0.0038519388,0.009187884,0.0015682082,0.0007277161,0.0023421394,0.0017748541,0.0041359984,0.025624093],"category_scores_gemma":[0.019159248,0.0018144767,0.015217898,0.0011617186,0.0021326067,0.0030245648,0.001390405,0.006016882,0.0013312586],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98894185,0.0013262902,0.00015342905,0.0009863608,0.0040340433,0.000030251154,0.000015625692,0.0006537378,0.00026892297,0.00021908179,0.00021159825,0.0031588331],"study_design_scores_gemma":[0.97399306,0.018453205,0.0004667797,0.000117586285,0.0050074616,0.0000184241,0.000015162595,0.0010384234,0.00013102256,0.00039771514,0.00034052818,0.000020654508],"about_ca_topic_score_codex":0.0027081706,"about_ca_topic_score_gemma":0.002117885,"teacher_disagreement_score":0.025624093,"about_ca_system_score_codex":0.0028554206,"about_ca_system_score_gemma":0.0031270017,"threshold_uncertainty_score":0.085721135},"labels":[],"label_agreement":null},{"id":"W2029111709","doi":"10.1016/j.jval.2011.09.009","title":"A Review of the Cost of Atrial Fibrillation","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System; Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Atrial fibrillation; Medicine; Cardiology","score_opus":0.3126281603514576,"score_gpt":0.4505405811053328,"score_spread":0.13791242075387522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029111709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006239081,0.99926895,0.00003076692,0.00033542694,0.00009874668,0.0000034361576,0.000037679165,0.0000010771922,0.00016151798],"genre_scores_gemma":[0.0006494303,0.9989593,0.00007712948,0.00015680291,0.000092085575,0.0000046999194,0.000019175168,6.1331156e-7,0.000040770123],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983582,0.00039456086,0.00045337126,0.00012764955,0.00059585494,0.000070316986],"domain_scores_gemma":[0.99442047,0.0039481516,0.0008584592,0.00005963714,0.0006096334,0.000103506056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002609054,0.0012272344,0.0035794692,0.0065317447,0.0003062133,0.002019534,0.0011520765,0.0016485795,0.004029838],"category_scores_gemma":[0.010590111,0.00058021944,0.0021447008,0.010257219,0.00070144975,0.0022171924,0.0010402263,0.001842705,0.00041147432],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023883526,0.00005613973,0.00084887707,0.2083858,0.0018997487,0.00016579869,0.000080492486,0.00068359484,0.00017468163,0.00424722,0.045303397,0.7379155],"study_design_scores_gemma":[0.00023256162,0.00021557718,0.00979461,0.33155867,0.009233559,0.0021187016,0.00034640825,0.0005625338,0.00024188429,0.0065939324,0.63899714,0.00010447413],"about_ca_topic_score_codex":0.007914783,"about_ca_topic_score_gemma":0.014745971,"teacher_disagreement_score":0.007914783,"about_ca_system_score_codex":0.0031645857,"about_ca_system_score_gemma":0.004620983,"threshold_uncertainty_score":0.022960782},"labels":[],"label_agreement":null},{"id":"W2029343549","doi":"10.1016/j.jval.2011.02.705","title":"PMS20 HEALTH CARE RESOURCES UTILIZATION IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS: ANALYSES WITH THE RAMQ DATABASE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Psychological intervention; Arthritis; Rheumatoid arthritis; Juvenile rheumatoid arthritis; Health care; Health plan; Utilization management; Database; Emergency medicine; Internal medicine; Pediatrics; Physical therapy","score_opus":0.283381160982861,"score_gpt":0.4478998170322493,"score_spread":0.1645186560493883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029343549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94924766,0.00053660903,0.00013133488,0.00016426102,0.0000075797147,0.000057980094,0.049010415,0.000027495835,0.0008166458],"genre_scores_gemma":[0.94776165,0.00032714472,0.00047081264,0.00014677942,0.000037594546,0.0002463448,0.05063543,0.000021091906,0.00035307917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972657,0.0009489407,0.00054610654,0.0004768603,0.0005743586,0.00018802265],"domain_scores_gemma":[0.99202746,0.0026207985,0.0038548307,0.0005034741,0.000604677,0.00038871748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021955161,0.00038607998,0.0007808525,0.0025649152,0.00023637142,0.0007702686,0.00090100017,0.00051278743,0.0024044767],"category_scores_gemma":[0.0101578375,0.00032124046,0.0014479671,0.0048319385,0.00020152537,0.0007760578,0.001078679,0.00059754803,0.000438497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072736404,0.000059215312,0.9934477,0.00009624334,0.00054563984,0.00004823601,0.0000512458,0.00032427005,0.00007769897,0.00006267227,0.0018497517,0.0027099126],"study_design_scores_gemma":[0.00010022671,0.000102826656,0.9975223,0.000018194003,0.000161803,0.00015199954,0.000097036944,0.0008400259,0.000056144505,0.00002600299,0.00091636035,0.0000070270535],"about_ca_topic_score_codex":0.020539552,"about_ca_topic_score_gemma":0.015062537,"teacher_disagreement_score":0.9794605,"about_ca_system_score_codex":0.0009685137,"about_ca_system_score_gemma":0.00090643537,"threshold_uncertainty_score":0.04083997},"labels":[],"label_agreement":null},{"id":"W2029549447","doi":"10.1016/j.jval.2011.02.887","title":"PCN29 TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING RITUXIMAB (R) WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C): ASSESSING THE FINANCIAL IMPACT OF THE ROUTE OF ADMINISTRATION AT PRINCESS MARGARET HOSPITAL (PMH)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Roche (Canada)","funders":"","keywords":"Medicine; Fludarabine; Rituximab; Dosing; Cyclophosphamide; Route of administration; Regimen; Internal medicine; Chemotherapy; Lymphoma","score_opus":0.048381589222184065,"score_gpt":0.3374780089602432,"score_spread":0.28909641973805916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029549447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978529,0.00072568026,0.000055100198,0.00017722811,0.000011234143,0.000118824755,0.00006554746,0.0000023776001,0.0009911876],"genre_scores_gemma":[0.9988715,0.00038438645,0.00021700775,0.00007587274,0.000015991423,0.000057850608,0.000108955304,0.0000010792702,0.00026743728],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990903,0.00060883316,0.000036463716,0.000051308678,0.00012844829,0.000084720865],"domain_scores_gemma":[0.999119,0.00029898208,0.00018787473,0.00003341185,0.000048862115,0.0003119733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015582762,0.000244811,0.00039594056,0.00028512295,0.00026746624,0.0004799297,0.00041548387,0.00063606596,0.0022044145],"category_scores_gemma":[0.0019082975,0.000121269484,0.00048650138,0.00026183383,0.00043506717,0.00045678788,0.00039790096,0.00065501244,0.00025610824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34762216,0.024878645,0.119357064,0.0006922581,0.0008030044,0.0013930451,0.00047534032,0.006542781,0.015911851,0.0010881872,0.0023249525,0.47891074],"study_design_scores_gemma":[0.035840496,0.6483464,0.2926127,0.0002277828,0.0006336914,0.0016990142,0.0005073465,0.006952789,0.0051235147,0.00042728955,0.007576591,0.00005237835],"about_ca_topic_score_codex":0.0022446548,"about_ca_topic_score_gemma":0.004117924,"teacher_disagreement_score":0.0022446548,"about_ca_system_score_codex":0.0012695054,"about_ca_system_score_gemma":0.0012359369,"threshold_uncertainty_score":0.009210944},"labels":[],"label_agreement":null},{"id":"W2029582792","doi":"10.1016/s1098-3015(10)62723-4","title":"PHPI2 SOCIAL AND ECONOMIC FACTORS AFFECTING INTENTIONAL PRESCRIPTION DRUG NON-COMPLIANCE AMONG NOVA SCOTIA SENIORS","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Medical prescription; Compliance (psychology); Nova (rocket); Drug; Prescription drug; Medicine; Psychology; Gerontology; Psychiatry; Sociology; Nursing; Social psychology; Engineering; Aeronautics","score_opus":0.08421301469231025,"score_gpt":0.34973813814937554,"score_spread":0.2655251234570653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029582792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863476,0.00004109264,0.000008174792,0.00009337691,0.0000049806317,0.000010121049,0.00036768243,8.3392337e-7,0.0008389676],"genre_scores_gemma":[0.9992588,0.000022729597,0.00001767622,0.000034649973,0.0000034303341,0.0000063507377,0.00017541365,6.519362e-7,0.0004802579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947613,0.00008453821,0.000047439913,0.000038705373,0.000109179506,0.00024404668],"domain_scores_gemma":[0.997649,0.00025554476,0.00078598555,0.0000545554,0.00051190244,0.0007430141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004391707,0.00019590376,0.00022902188,0.0009152854,0.001152234,0.00078719994,0.00038284078,0.00040635845,0.0029348542],"category_scores_gemma":[0.003188969,0.00017480983,0.00039101517,0.0010006812,0.0002971967,0.00025224398,0.00074550876,0.0005452865,0.00030353488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033233344,0.000033041644,0.9989188,0.0000041635863,0.000008725224,0.00006800284,0.00016678766,0.000010423165,0.000034466437,0.00000792072,0.00014181081,0.00057259825],"study_design_scores_gemma":[0.0000014915222,0.000025542917,0.9993851,0.0000036334334,0.00000372461,0.00003052356,0.00045407334,0.000033184206,0.0000066303623,0.000003446295,0.00005166976,9.776568e-7],"about_ca_topic_score_codex":0.56924987,"about_ca_topic_score_gemma":0.6315102,"teacher_disagreement_score":0.43075013,"about_ca_system_score_codex":0.002266001,"about_ca_system_score_gemma":0.0030319775,"threshold_uncertainty_score":0.8665738},"labels":[],"label_agreement":null},{"id":"W2030159996","doi":"10.1016/j.jval.2011.08.1467","title":"PSS2 Prevalence, Demographics and Treatment Characteristics of Visual Impairment Due to Diabetic Macular Edema in A Representative Canadian Cohort","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Cohort; Diabetes mellitus; Diabetic retinopathy; Demographics; Comorbidity; Diabetic macular edema; Visual acuity; Medical record; Concomitant; Pediatrics; Ophthalmology; Internal medicine; Demography","score_opus":0.03386000403553887,"score_gpt":0.3236163984960389,"score_spread":0.28975639446050006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030159996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994263,0.0001923048,0.00008632194,0.00014188011,0.0000076713195,0.00003768466,0.003463357,0.000009860122,0.0017978465],"genre_scores_gemma":[0.9963393,0.00022713248,0.00015248837,0.000111452486,0.00000728258,0.00002272123,0.002184239,0.0000075813705,0.0009478246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990921,0.000045764013,0.000052544612,0.0001864804,0.00026552402,0.0003576364],"domain_scores_gemma":[0.9987147,0.000047923597,0.00019989391,0.000053607222,0.0006283197,0.00035556525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005640832,0.0006408832,0.00050738355,0.0021767064,0.0038670262,0.001156673,0.0012668341,0.0007079071,0.003594914],"category_scores_gemma":[0.0016018318,0.0006709091,0.0011604445,0.0035322926,0.0006473754,0.00055313285,0.0007120323,0.0008909845,0.00049073645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096516094,0.000044180706,0.9969247,0.000011351966,0.000050421895,0.00014129104,0.0004718871,0.000040079525,0.00021595554,0.000042957654,0.0007314026,0.001229259],"study_design_scores_gemma":[0.000008190459,0.000026693238,0.9984487,0.000006602757,0.000021277057,0.0001777369,0.00077061914,0.00011258827,0.000027103591,0.000011750935,0.0003786096,0.000010120389],"about_ca_topic_score_codex":0.9880385,"about_ca_topic_score_gemma":0.9865118,"teacher_disagreement_score":0.012689904,"about_ca_system_score_codex":0.012689904,"about_ca_system_score_gemma":0.014616425,"threshold_uncertainty_score":0.09207213},"labels":[],"label_agreement":null},{"id":"W2030487647","doi":"10.1016/s1098-3015(10)62211-5","title":"PMH14 CANADIAN NETWORK FOR BIPOLAR DISORDER (CAN-BD): FREQUENCY OF RELAPSE IN AN OBSERVATIONAL STUDY","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Bipolar disorder; Psychiatry; Medicine; Psychology; Internal medicine; Cognition","score_opus":0.5468399153985716,"score_gpt":0.440128909151986,"score_spread":0.10671100624658558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030487647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9169033,0.002315709,0.00023622956,0.0013254519,0.000097101365,0.00055789377,0.07379739,0.000034282202,0.0047327466],"genre_scores_gemma":[0.9573018,0.0013996187,0.00063308387,0.0006384537,0.00009099994,0.0005127175,0.037188042,0.00003837207,0.002196872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650407,0.00058588455,0.00033877755,0.00040096213,0.0014723111,0.00069793814],"domain_scores_gemma":[0.986148,0.0010717573,0.0034560738,0.0010920498,0.005926479,0.0023056737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00333345,0.0009611603,0.0014582527,0.0030051814,0.004489889,0.0016712666,0.003484199,0.0020323908,0.004261477],"category_scores_gemma":[0.016009755,0.00065552356,0.0015027233,0.009327534,0.0008546265,0.00090241357,0.0016266328,0.002073203,0.0006448587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045818635,0.000111769565,0.9885507,0.00006700583,0.00024161483,0.000063225976,0.00018978224,0.000076862794,0.00003701285,0.00015235244,0.0070815305,0.0029700543],"study_design_scores_gemma":[0.000058836096,0.00003573753,0.99813086,0.000040479477,0.000084516425,0.00006085266,0.0001953034,0.0001632266,0.000014944364,0.000049501323,0.0011471565,0.000018738696],"about_ca_topic_score_codex":0.9698426,"about_ca_topic_score_gemma":0.9734471,"teacher_disagreement_score":0.030157387,"about_ca_system_score_codex":0.024292111,"about_ca_system_score_gemma":0.031639025,"threshold_uncertainty_score":0.17625242},"labels":[],"label_agreement":null},{"id":"W2030870464","doi":"10.1016/j.jval.2014.03.1243","title":"Analysis perspective for assessing the financial impact of interventions used in rural/remote settings – a canadian case study of fomepizole for toxic alcohol poisoning","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Psychological intervention; Medical emergency; Health care; Ethylene glycol poisoning; Rural area; Environmental health; Nursing","score_opus":0.13102339261074783,"score_gpt":0.5209401950551297,"score_spread":0.38991680244438187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030870464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7696735,0.008177344,0.015840065,0.082050204,0.0004384655,0.0016396906,0.0049627335,0.00006405155,0.11715394],"genre_scores_gemma":[0.98672897,0.0015671403,0.0063110273,0.001844085,0.00007163196,0.00017251134,0.00039699825,0.00001228364,0.0028953403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586004,0.0020006825,0.000105386185,0.00019372471,0.0007927335,0.0010473178],"domain_scores_gemma":[0.9958968,0.0012554748,0.0004888017,0.00011249914,0.0016442164,0.00060213095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004199499,0.00092983135,0.0005827392,0.0032342535,0.0047808522,0.0038155015,0.0019683018,0.0013231888,0.0056949826],"category_scores_gemma":[0.007442305,0.0002661115,0.0013013615,0.0036836488,0.0021921645,0.001192655,0.0016081104,0.0021322293,0.00016787062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001364448,0.0025737819,0.46300036,0.0021249189,0.0022112979,0.008634508,0.02576385,0.019504542,0.0047883135,0.22895212,0.047550865,0.19353102],"study_design_scores_gemma":[0.00042429895,0.001981754,0.59023535,0.0031803781,0.0020460836,0.002860753,0.20457383,0.042632602,0.0027482724,0.052856352,0.096180566,0.00027981627],"about_ca_topic_score_codex":0.88777435,"about_ca_topic_score_gemma":0.9275764,"teacher_disagreement_score":0.11222565,"about_ca_system_score_codex":0.036876738,"about_ca_system_score_gemma":0.0518816,"threshold_uncertainty_score":0.26756072},"labels":[],"label_agreement":null},{"id":"W2030895155","doi":"10.1016/j.jval.2011.02.177","title":"PHP108 THE CASE OF RARE DISEASE DRUGS BEFORE AND AFTER THE INTRODUCTION OF PRICING BODIES: LESSONS LEARNED FROM BRAZIL AND CANADA, IMPLICATIONS FOR THE UNITED STATES","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Drug prices; Purchasing; Natalizumab; Drug pricing; Disease; Economics; Business; Public economics; Actuarial science; Medicine; Marketing; Pathology","score_opus":0.10565085449068398,"score_gpt":0.323450803452887,"score_spread":0.21779994896220303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030895155","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16379085,0.007887543,0.0032194972,0.38617158,0.0010018509,0.00013876437,0.0011663716,0.00006240111,0.4365612],"genre_scores_gemma":[0.8263518,0.004984121,0.002452305,0.0699761,0.0007329974,0.000058946003,0.0002914792,0.000101871716,0.09505039],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99320304,0.0008691547,0.00018110982,0.0006742047,0.0024150624,0.0026573746],"domain_scores_gemma":[0.9843203,0.006703386,0.0011169466,0.0007946944,0.005237975,0.0018267593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004793697,0.00026902786,0.00055055623,0.0012739102,0.009876782,0.0069950954,0.0015827474,0.013765355,0.013947381],"category_scores_gemma":[0.022954324,0.0003434966,0.0009937561,0.002090549,0.007310397,0.0040212674,0.002393667,0.01149956,0.0005719888],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018564834,0.00014300416,0.029628502,0.0001591309,0.00008912578,0.011067411,0.007179467,0.0010291607,0.00084640057,0.79557693,0.104452804,0.049642473],"study_design_scores_gemma":[0.00019248866,0.00016170123,0.08535969,0.0010630066,0.00036639153,0.0073258877,0.024107153,0.0046061384,0.0027101007,0.141429,0.7323228,0.00035554482],"about_ca_topic_score_codex":0.91795474,"about_ca_topic_score_gemma":0.9350842,"teacher_disagreement_score":0.08204526,"about_ca_system_score_codex":0.03637205,"about_ca_system_score_gemma":0.055040296,"threshold_uncertainty_score":0.2638989},"labels":[],"label_agreement":null},{"id":"W2031005096","doi":"10.1016/j.jval.2012.03.241","title":"PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism: Analysis Based on Patient Reported Outcomes from 3 Phase III Clinical Trials of Golimumab","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Rheumatism; Rheumatology; Golimumab; Placebo; Bristol-Myers; Physical therapy; Complete remission; Gastroenterology; Etanercept; Alternative medicine; Chemotherapy","score_opus":0.11017951032015214,"score_gpt":0.399706067098394,"score_spread":0.2895265567782419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031005096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935994,0.0031682046,0.0008530417,0.00012930347,0.00009207036,0.00016252323,0.0010859394,0.00002221892,0.0008873849],"genre_scores_gemma":[0.9969958,0.00022251168,0.000458405,0.0001272463,0.00006371565,0.00013067121,0.0017638924,0.000010228657,0.00022762465],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98813254,0.007528137,0.0010524966,0.0012748911,0.0016020787,0.00040980196],"domain_scores_gemma":[0.98386395,0.007787696,0.004728736,0.0018958459,0.0011474523,0.0005763766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017959783,0.0010635296,0.0018146823,0.00096452,0.00048945105,0.0013227969,0.0010602297,0.0011416766,0.0018302902],"category_scores_gemma":[0.018488983,0.0005606261,0.0021555412,0.00089052913,0.0010365824,0.00078313163,0.000856092,0.0010186261,0.0007557778],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08794114,0.00062118546,0.8565451,0.00041184755,0.006660147,0.000105822255,0.0002379026,0.0017530991,0.009648379,0.0002287276,0.0013647423,0.034481898],"study_design_scores_gemma":[0.010887365,0.010542197,0.96732575,0.000068025714,0.0024349228,0.00057902676,0.0000802524,0.002938431,0.0029604735,0.00020163372,0.0019383705,0.00004373008],"about_ca_topic_score_codex":0.00053765957,"about_ca_topic_score_gemma":0.001003467,"teacher_disagreement_score":0.017959783,"about_ca_system_score_codex":0.00047291303,"about_ca_system_score_gemma":0.000512068,"threshold_uncertainty_score":0.09498155},"labels":[],"label_agreement":null},{"id":"W2031046511","doi":"10.1016/s1098-3015(10)63267-6","title":"PAR8 TRENDS IN PRESCRIPTION CLAIMS FOLLOWING THE WITHDRAWAL OF ROFECOXIB FROM THE CANADIAN MARKET","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rofecoxib; Medical prescription; Business; Medicine; Pharmacology; Chemistry","score_opus":0.3219178323889248,"score_gpt":0.4965416050266483,"score_spread":0.1746237726377235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031046511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9423179,0.0017290759,0.00013117491,0.002175133,0.000051609346,0.00007161375,0.039475102,0.00007976507,0.01396874],"genre_scores_gemma":[0.98046863,0.0007838726,0.00015565733,0.00037387357,0.0000455748,0.000018926068,0.012567123,0.000013183902,0.00557324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838567,0.000049079514,0.00008905351,0.00013270098,0.00092477136,0.00041876073],"domain_scores_gemma":[0.9919418,0.00049783743,0.001813909,0.00010854689,0.004732325,0.00090552116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068916247,0.00025789623,0.0004416489,0.0028727984,0.001102346,0.0019251317,0.0014295317,0.0013735775,0.0058300556],"category_scores_gemma":[0.006142192,0.00026567598,0.0008155195,0.0044885124,0.00035499295,0.00073401444,0.00056764967,0.0017563801,0.00073014805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00174634,0.00014611651,0.96514153,0.00016418546,0.00019931649,0.0003084758,0.0006217842,0.0004615533,0.0007566452,0.0005936655,0.012045179,0.017815256],"study_design_scores_gemma":[0.000008660856,0.000031344174,0.9968135,0.000011879832,0.000022069054,0.000051686973,0.000257847,0.0003067483,0.000102461,0.000013293315,0.0023689535,0.000011517797],"about_ca_topic_score_codex":0.9835933,"about_ca_topic_score_gemma":0.98422885,"teacher_disagreement_score":0.022117393,"about_ca_system_score_codex":0.022117393,"about_ca_system_score_gemma":0.02202796,"threshold_uncertainty_score":0.16047364},"labels":[],"label_agreement":null},{"id":"W2031248090","doi":"10.1016/j.jval.2011.02.927","title":"PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care; University of Toronto","funders":"","keywords":"Medicine; Oncology; Breast cancer; Internal medicine; Adjuvant chemotherapy; Chemotherapy; Stage (stratigraphy); Adjuvant; Gynecology; Cancer","score_opus":0.3458329580443284,"score_gpt":0.4306384910490784,"score_spread":0.08480553300475002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031248090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916998,0.0051099127,0.001296078,0.00046626423,0.000031481166,0.000112639194,0.00056635955,0.000013883407,0.0007036574],"genre_scores_gemma":[0.99710375,0.0011954161,0.0010263018,0.00007688313,0.000019342237,0.000043346892,0.00034515202,0.0000028851018,0.00018691306],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99884427,0.0007653894,0.00004403441,0.00011339908,0.00015417421,0.0000786083],"domain_scores_gemma":[0.99805886,0.001559269,0.0001747796,0.00006137518,0.000060413684,0.00008528336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024294804,0.000689963,0.001244816,0.000839116,0.00015589151,0.0008646177,0.0003912551,0.00071012607,0.0015131407],"category_scores_gemma":[0.0048050093,0.0003104968,0.0023202498,0.00076346286,0.0004795751,0.000619831,0.00039277534,0.00060340075,0.0001118976],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20714372,0.0052149207,0.19697349,0.0011162993,0.008299311,0.0003562506,0.0001726424,0.13390397,0.0048729014,0.001473955,0.0019585588,0.4385139],"study_design_scores_gemma":[0.024718123,0.07652895,0.4620934,0.0005390018,0.030913178,0.0012140317,0.0008814094,0.38295847,0.009869592,0.0047500175,0.005259992,0.00027385526],"about_ca_topic_score_codex":0.005662372,"about_ca_topic_score_gemma":0.005892624,"teacher_disagreement_score":0.005662372,"about_ca_system_score_codex":0.0016917266,"about_ca_system_score_gemma":0.000738425,"threshold_uncertainty_score":0.012848496},"labels":[],"label_agreement":null},{"id":"W2031368239","doi":"10.1016/j.jval.2013.08.1826","title":"The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glatiramer acetate; Discontinuation; Expanded Disability Status Scale; Multiple sclerosis; Dimethyl fumarate; Quality-adjusted life year; Adverse effect; Relapsing remitting; Cost effectiveness; Quality of life (healthcare); Physical therapy; Pediatrics; Internal medicine; Psychiatry","score_opus":0.44461160527161564,"score_gpt":0.3869448230535893,"score_spread":0.05766678221802635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031368239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9427245,0.031934038,0.00041744608,0.010327082,0.00024376644,0.0003750426,0.006444687,0.00004603243,0.007487441],"genre_scores_gemma":[0.99243224,0.004961647,0.00029618715,0.0003162255,0.000037771282,0.000035414207,0.00092776376,0.0000059798194,0.0009868538],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982552,0.00067535235,0.00012200493,0.00008957819,0.00044971175,0.00040812942],"domain_scores_gemma":[0.9960068,0.0010220226,0.0004743032,0.000048675083,0.001308907,0.0011392378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014017693,0.00038941336,0.0009930913,0.0010118686,0.001036184,0.0012235432,0.0012592654,0.00088846334,0.0026935132],"category_scores_gemma":[0.007607132,0.00024645153,0.0012564493,0.0019320614,0.00081176264,0.000388732,0.00061627047,0.0013388966,0.00007407737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14014849,0.003711211,0.27999246,0.0066359746,0.0070925388,0.001325079,0.0010424675,0.07390522,0.002680284,0.0108288145,0.04000113,0.43263638],"study_design_scores_gemma":[0.02931052,0.009791922,0.8486557,0.00231926,0.008181028,0.00064447057,0.002674088,0.074316904,0.0016942943,0.0023250757,0.019744275,0.00034244324],"about_ca_topic_score_codex":0.9859947,"about_ca_topic_score_gemma":0.99020165,"teacher_disagreement_score":0.07413004,"about_ca_system_score_codex":0.07413004,"about_ca_system_score_gemma":0.07255184,"threshold_uncertainty_score":0.5378536},"labels":[],"label_agreement":null},{"id":"W2031464368","doi":"10.1016/j.jval.2012.03.1381","title":"MO4 Economic Evaluation of Treatment Strategies for Late-Presentation Acute Ischemic Stroke","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Thrombolysis; Medicine; Willingness to pay; Economic evaluation; Stroke (engine); Emergency medicine; Cost effectiveness; Activity-based costing; Cost–benefit analysis; Quality-adjusted life year; Randomized controlled trial; Surgery; Internal medicine; Myocardial infarction","score_opus":0.0956277062667423,"score_gpt":0.3880759459339206,"score_spread":0.29244823966717826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031464368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9173772,0.018496126,0.010433033,0.010594622,0.00060374016,0.0031909847,0.0068675973,0.00012306185,0.032313608],"genre_scores_gemma":[0.9929691,0.0014331591,0.0026672422,0.00025059312,0.00007129416,0.00041845482,0.00089257373,0.00001256087,0.001285075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99035054,0.007850415,0.00043766247,0.00017337187,0.00061584066,0.0005722262],"domain_scores_gemma":[0.9872334,0.009607335,0.0011659361,0.00034130315,0.00091912854,0.00073288335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00929599,0.0009617667,0.0019805252,0.0022479296,0.0004094736,0.0018668283,0.00094377075,0.0010948334,0.010357838],"category_scores_gemma":[0.04129678,0.0003522421,0.0028293678,0.0014602761,0.0004610966,0.0011575216,0.0010336033,0.0012322923,0.0002902394],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2066118,0.009325553,0.08936193,0.004355459,0.015621928,0.00029963223,0.00024737878,0.17673612,0.0007030095,0.025544904,0.013478892,0.45771345],"study_design_scores_gemma":[0.055575345,0.07392791,0.21338765,0.004336472,0.024791505,0.0006093188,0.0018074261,0.5229139,0.0036435649,0.064816296,0.033866085,0.0003246311],"about_ca_topic_score_codex":0.009103011,"about_ca_topic_score_gemma":0.0065497905,"teacher_disagreement_score":0.010357838,"about_ca_system_score_codex":0.004852234,"about_ca_system_score_gemma":0.0056554475,"threshold_uncertainty_score":0.049162447},"labels":[],"label_agreement":null},{"id":"W2031638627","doi":"10.1016/j.jval.2012.08.1813","title":"PHS40 An Example of Irrational Decision Making in the Elderly: Why are Pharmacological Therapies Preferentially Reimbursed Over Non-Pharmacological Therapies for Insomnia?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cognitive behavioral therapy for insomnia; Medicine; Adverse effect; Insomnia; Cognition; Psychological intervention; Cognitive therapy; Reimbursement; Psychiatry; Intensive care medicine; Cognitive behavioral therapy; Internal medicine; Health care","score_opus":0.5709257559665363,"score_gpt":0.48488125502769336,"score_spread":0.08604450093884292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031638627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51878256,0.0039539333,0.02603089,0.30817333,0.0012032393,0.00019871,0.0019838256,0.00017116254,0.13950235],"genre_scores_gemma":[0.97298694,0.0009041965,0.0064432174,0.014384579,0.000435825,0.000070241455,0.00018677453,0.000031404816,0.0045569083],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.995672,0.0028163644,0.00024193451,0.0002796932,0.0005720048,0.00041805446],"domain_scores_gemma":[0.9797784,0.014108901,0.0017651673,0.0012191264,0.0019272071,0.0012011663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01043512,0.00027717318,0.00047891974,0.00069981185,0.0013626141,0.0017507435,0.00051927293,0.0033075414,0.009845239],"category_scores_gemma":[0.031177482,0.00016222314,0.0007646938,0.0011295871,0.0025700685,0.0016154966,0.0012644322,0.0035548308,0.0005428582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003133287,0.0007545769,0.11233788,0.0005200618,0.00039216975,0.0111716,0.0076621748,0.0072343107,0.0012751153,0.46727985,0.12635173,0.26188725],"study_design_scores_gemma":[0.0008953165,0.0007194194,0.07378285,0.0006369415,0.00016011609,0.0070307883,0.009014298,0.027738743,0.0017218684,0.72516537,0.15293127,0.00020307701],"about_ca_topic_score_codex":0.010790912,"about_ca_topic_score_gemma":0.007159381,"teacher_disagreement_score":0.010790912,"about_ca_system_score_codex":0.0021483584,"about_ca_system_score_gemma":0.002282335,"threshold_uncertainty_score":0.055186868},"labels":[],"label_agreement":null},{"id":"W2031741473","doi":"10.1111/j.1524-4733.2008.00355.x","title":"Health State Utilities in Latent and Active Tuberculosis","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Providence Health Care; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Health Utilities Index; Construct validity; Tuberculosis; Public health; Quality of life (healthcare); Latent tuberculosis; Ceiling effect; Population; Visual analogue scale; Health related quality of life; Physical therapy; Gerontology; Environmental health; Psychometrics; Alternative medicine; Internal medicine; Clinical psychology; Mycobacterium tuberculosis; Pathology; Nursing; Disease","score_opus":0.4461640304858526,"score_gpt":0.4130930283048962,"score_spread":0.03307100218095643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031741473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932312,0.0010741072,0.0025726496,0.0005987202,0.00002009912,0.000016557451,0.0009072877,0.0000064380115,0.0015728256],"genre_scores_gemma":[0.99913114,0.000108160566,0.00011486686,0.000014953592,0.000011091263,0.000009122624,0.0003116797,0.0000015227184,0.0002975708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981554,0.0012876728,0.00010618439,0.00008920652,0.00010732863,0.00025417397],"domain_scores_gemma":[0.9777835,0.01851222,0.0017777607,0.0005137274,0.00047656786,0.00093618175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005580298,0.00033324573,0.0006652758,0.0012615126,0.00022251606,0.0015763605,0.00049230014,0.00066294667,0.002850403],"category_scores_gemma":[0.025299694,0.00023987616,0.00087853067,0.0014440344,0.0010343238,0.002063637,0.0009989586,0.0013437369,0.0001439109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006413261,0.0009476102,0.80917716,0.0002787304,0.0009377956,0.0006350513,0.0014111779,0.083798535,0.00040975682,0.058872193,0.0022432425,0.034875583],"study_design_scores_gemma":[0.00021829586,0.0010264094,0.67001265,0.00019789115,0.00055250106,0.0008557623,0.0022215112,0.23070265,0.0004689579,0.091992445,0.0016437247,0.00010719664],"about_ca_topic_score_codex":0.0057075955,"about_ca_topic_score_gemma":0.0040752226,"teacher_disagreement_score":0.0057075955,"about_ca_system_score_codex":0.0013191163,"about_ca_system_score_gemma":0.0005348983,"threshold_uncertainty_score":0.02951175},"labels":[],"label_agreement":null},{"id":"W2031771150","doi":"10.1016/j.jval.2012.08.2176","title":"PCN136 Expenditures on Orphan Drugs in Canada, Europe (EU5 + Belgium, Sweden and the Netherlands) and Australia in 2009","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Orphan drug; Per capita; Authorization; Agency (philosophy); Eu countries; European union; Medicine; Demography; Business; Environmental health; International trade; Population; Biology","score_opus":0.09226563942851991,"score_gpt":0.3095126234444604,"score_spread":0.2172469840159405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031771150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86521536,0.0054708086,0.0002214315,0.0035685264,0.00011306121,0.00004992342,0.10449136,0.00007267245,0.020796886],"genre_scores_gemma":[0.9208145,0.0070356894,0.00044841057,0.00078311516,0.000070388436,0.00004124763,0.04694962,0.000030242147,0.023826981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989489,0.00010031167,0.00009156314,0.00011222253,0.00041273437,0.00033433174],"domain_scores_gemma":[0.9984158,0.00009904664,0.00065330643,0.000029724393,0.0004577477,0.0003443038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004118697,0.0002816227,0.000456045,0.0015294891,0.00054500124,0.001148267,0.0005122892,0.0006564075,0.002674392],"category_scores_gemma":[0.002129056,0.00032480105,0.0010085726,0.003873674,0.00031307575,0.00051932345,0.0008831918,0.0013050485,0.0003852737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024691797,0.00024995126,0.83076185,0.0008435301,0.00090875156,0.0013389146,0.000869448,0.004652921,0.0012082249,0.011471144,0.083582506,0.061643574],"study_design_scores_gemma":[0.00002478841,0.000054166212,0.9634061,0.00009081737,0.00012939735,0.00033752498,0.0003209409,0.0011079834,0.0004001353,0.00014476925,0.0339669,0.000016412288],"about_ca_topic_score_codex":0.89362246,"about_ca_topic_score_gemma":0.91127497,"teacher_disagreement_score":0.10637754,"about_ca_system_score_codex":0.015854748,"about_ca_system_score_gemma":0.013453894,"threshold_uncertainty_score":0.21400797},"labels":[],"label_agreement":null},{"id":"W2031786236","doi":"10.1111/j.1524-4733.2009.00554.x","title":"Health Technology Assessment in Canada: 20 Years Strong?","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Regional science; Political science; Geography","score_opus":0.30957318467275047,"score_gpt":0.4359357859488792,"score_spread":0.12636260127612875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031786236","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007959965,0.16709766,0.00058042083,0.7997486,0.008996553,0.000065810484,0.0020486577,0.00007411228,0.013428271],"genre_scores_gemma":[0.3410241,0.29409808,0.006829337,0.31818822,0.014160662,0.00016134733,0.0035910113,0.00015452827,0.02179279],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.975448,0.0030266792,0.0021755535,0.0016654286,0.011693615,0.005990714],"domain_scores_gemma":[0.82828116,0.017357983,0.006972029,0.0026432683,0.11300009,0.031745497],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.044823397,0.0012657992,0.0022518055,0.00467214,0.0073119234,0.01971169,0.004664808,0.01203822,0.011005487],"category_scores_gemma":[0.07820516,0.0009580635,0.0015824527,0.011584818,0.009282907,0.010460869,0.006095687,0.011713416,0.0012344433],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085156475,0.00032313212,0.036322635,0.0034813075,0.00053578085,0.00038922668,0.0016036961,0.0011292951,0.0004300073,0.05455035,0.55656457,0.34381852],"study_design_scores_gemma":[0.0002882971,0.00022155623,0.13068214,0.008785006,0.0006921879,0.0002587566,0.004880912,0.0023472558,0.00044940165,0.022106426,0.82890177,0.0003862097],"about_ca_topic_score_codex":0.9788042,"about_ca_topic_score_gemma":0.98629826,"teacher_disagreement_score":0.9788042,"about_ca_system_score_codex":0.1365619,"about_ca_system_score_gemma":0.46355182,"threshold_uncertainty_score":0.9908306},"labels":[],"label_agreement":null},{"id":"W2031866730","doi":"10.1016/s1098-3015(10)62952-x","title":"PDB19 COLLECTION OF COST DATA FOR DIABETES COMPLICATIONS IN CANADA AND AUSTRALIA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Data collection; Medicine; Diabetes mellitus; Optometry; Statistics; Mathematics; Endocrinology","score_opus":0.14772263675935948,"score_gpt":0.3702852720350237,"score_spread":0.22256263527566422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031866730","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44045907,0.003220689,0.0009957971,0.0020218606,0.00015723165,0.0006673336,0.52305925,0.00026151186,0.029157368],"genre_scores_gemma":[0.68190074,0.0031240878,0.004157168,0.0009463114,0.00007331013,0.0004964073,0.2931274,0.0001581795,0.016016385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611497,0.0002901632,0.00047472966,0.0002649073,0.0022347516,0.0006204558],"domain_scores_gemma":[0.9781172,0.00094522274,0.0022881154,0.0005363533,0.015645083,0.0024678947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018158123,0.0005731816,0.0010742581,0.008182695,0.0020760174,0.0023760905,0.0013780338,0.00041615934,0.00306834],"category_scores_gemma":[0.013346242,0.00064929057,0.0007528817,0.022152588,0.00038748834,0.00055067096,0.0012582318,0.00091502775,0.00075207395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006012226,0.00018825728,0.85795283,0.00054414524,0.00038926897,0.00030218228,0.0006857497,0.0021698296,0.00037719833,0.0012012882,0.09283204,0.042755995],"study_design_scores_gemma":[0.000028656,0.000032733482,0.97425723,0.00011380804,0.000059149974,0.00009901865,0.00041662098,0.0010365731,0.00020137177,0.00006299948,0.023667727,0.000024181314],"about_ca_topic_score_codex":0.99471575,"about_ca_topic_score_gemma":0.9936347,"teacher_disagreement_score":0.043181214,"about_ca_system_score_codex":0.043181214,"about_ca_system_score_gemma":0.07804581,"threshold_uncertainty_score":0.31330305},"labels":[],"label_agreement":null},{"id":"W2031928304","doi":"10.1016/j.jval.2011.02.368","title":"PSY35 VALIDATION OF THE LUPUS IMPACT TRACKER","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Construct validity; Cronbach's alpha; Convergent validity; Psychology; Scale (ratio); Quality of life (healthcare); Reliability (semiconductor); Anxiety; Physical therapy; SF-36; Criterion validity; Rating scale; Clinical psychology; Medicine; Internal medicine; Psychometrics; Disease; Internal consistency; Psychiatry; Developmental psychology; Health related quality of life; Cartography","score_opus":0.11830893730476091,"score_gpt":0.37147213210857666,"score_spread":0.25316319480381577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031928304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6194962,0.002204767,0.037924048,0.0063602924,0.0013602031,0.0048061293,0.082200095,0.0052243653,0.24042378],"genre_scores_gemma":[0.8637687,0.00095879135,0.040807318,0.0014002128,0.0003525115,0.0040113227,0.054635342,0.00094641274,0.03311949],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98416615,0.0049961507,0.0013638067,0.0011375308,0.007716797,0.0006194488],"domain_scores_gemma":[0.93572426,0.03161355,0.004707222,0.004373409,0.021322018,0.0022596244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023431165,0.00048773552,0.00053763366,0.00258046,0.00064505264,0.003215567,0.00089462247,0.0009782219,0.0151540795],"category_scores_gemma":[0.074142255,0.00034961553,0.00079550623,0.0019435264,0.0005949325,0.0018315188,0.0021535587,0.0011633475,0.009805983],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041463324,0.0015072612,0.44123408,0.0009619306,0.00037945103,0.00024257945,0.0021346826,0.0027806142,0.002797962,0.011186261,0.12113717,0.4114917],"study_design_scores_gemma":[0.0011007715,0.0027895542,0.6391459,0.0007690822,0.00032993473,0.00064794935,0.00095108146,0.012058686,0.0075030806,0.0054136026,0.32916856,0.00012171985],"about_ca_topic_score_codex":0.0059834206,"about_ca_topic_score_gemma":0.0052735065,"teacher_disagreement_score":0.023431165,"about_ca_system_score_codex":0.0016070916,"about_ca_system_score_gemma":0.00431619,"threshold_uncertainty_score":0.12391734},"labels":[],"label_agreement":null},{"id":"W2031933270","doi":"10.1016/j.jval.2012.03.1054","title":"PIH22 Quality of Pediatric Cost-Utility Analyses 1997-2009","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dalhousie University; Hospital for Sick Children","funders":"","keywords":"Medicine; Quality (philosophy); Prospective cohort study; MEDLINE; Health care; Population; Economic evaluation; Regression analysis; Cost–utility analysis; Confidence interval; Sample size determination; Family medicine; Pediatrics; Demography; Environmental health; Statistics; Cost effectiveness; Surgery; Pathology; Internal medicine","score_opus":0.44011271817740993,"score_gpt":0.4370819508789966,"score_spread":0.0030307672984133394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031933270","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41585433,0.0060851974,0.0029807421,0.0025426995,0.00015223495,0.00015049738,0.55456215,0.00020535976,0.017466767],"genre_scores_gemma":[0.79074275,0.0019922624,0.0016249885,0.0003877019,0.00013345519,0.00014303418,0.20017613,0.00015644824,0.0046431683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954332,0.0012673048,0.0004236531,0.00050840655,0.0018808721,0.00048660743],"domain_scores_gemma":[0.976705,0.008961098,0.006114057,0.001718417,0.005719727,0.0007815789],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0051494343,0.00040798986,0.000769293,0.0034819248,0.0002792245,0.0014923391,0.0011026311,0.00046637835,0.0075093866],"category_scores_gemma":[0.030400366,0.0004281854,0.0020440426,0.012175394,0.00034065644,0.0010591984,0.0009563436,0.0012923504,0.0009051249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009852909,0.000082149665,0.8371444,0.0006082092,0.002491797,0.00017410418,0.00016515038,0.023423258,0.00011616213,0.0039138505,0.08471428,0.046181306],"study_design_scores_gemma":[0.000058523103,0.00006920808,0.9795563,0.00011969173,0.00037967862,0.00017864894,0.000102882404,0.0040227156,0.0002859393,0.00041010554,0.0147994505,0.000016820513],"about_ca_topic_score_codex":0.158205,"about_ca_topic_score_gemma":0.12433376,"teacher_disagreement_score":0.9948506,"about_ca_system_score_codex":0.006406986,"about_ca_system_score_gemma":0.004175543,"threshold_uncertainty_score":0.31456828},"labels":[],"label_agreement":null},{"id":"W2032037488","doi":"10.1016/j.jval.2014.03.1145","title":"How well do generic promis fatigue measures perform in rheumatoid arthritis?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Patient-Reported Outcomes Measurement Information System; Medicine; Computerized adaptive testing; Rheumatoid arthritis; Physical therapy; Item response theory; Convergent validity; Item bank; Quality of life (healthcare); Concurrent validity; Psychometrics; Clinical psychology; Internal medicine; Nursing","score_opus":0.04755227641084049,"score_gpt":0.28930159731955235,"score_spread":0.24174932090871187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032037488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8391616,0.09590677,0.0058797617,0.0188405,0.0015442292,0.0002685913,0.003920688,0.0001348,0.03434315],"genre_scores_gemma":[0.98455065,0.0082209455,0.0023688157,0.002112566,0.00044964228,0.00010072181,0.001235849,0.000036221143,0.00092448376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9901985,0.0051207175,0.0012742408,0.000632215,0.002109527,0.0006648108],"domain_scores_gemma":[0.96284664,0.023440838,0.0069629666,0.0014221462,0.0043871454,0.0009402717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021410398,0.00080584554,0.0022700778,0.0012350137,0.000527208,0.0025121768,0.0008376381,0.0015147316,0.0018232437],"category_scores_gemma":[0.07111581,0.0003246119,0.0025318228,0.0017937876,0.001019228,0.003162117,0.0009985922,0.0010711056,0.00076430367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020874585,0.0002722589,0.73041403,0.0014964034,0.0036596495,0.000088626206,0.0014893517,0.0015108938,0.00041274703,0.0012742551,0.008711524,0.24858277],"study_design_scores_gemma":[0.0002081033,0.0013847315,0.97890365,0.0011918606,0.0014884264,0.00033928754,0.0015994859,0.002822995,0.0004789848,0.0025316074,0.008952417,0.00009836142],"about_ca_topic_score_codex":0.003917621,"about_ca_topic_score_gemma":0.009913099,"teacher_disagreement_score":0.021410398,"about_ca_system_score_codex":0.0014516251,"about_ca_system_score_gemma":0.0009269335,"threshold_uncertainty_score":0.11323035},"labels":[],"label_agreement":null},{"id":"W2032492472","doi":"10.1016/s1098-3015(10)74430-2","title":"PIH9 PREVALENCE AND BURDEN OF ILLNESS OF MENOPAUSE: A CANADIAN OBSERVATIONAL STUDY","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Evolutionary Psychology and Human Behavior","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Menopause; Medicine; Environmental health; Gerontology; Internal medicine","score_opus":0.125764171995935,"score_gpt":0.39647342798392626,"score_spread":0.2707092559879912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032492472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98758113,0.00088706234,0.00015795924,0.00028405804,0.000018830955,0.000117709074,0.008862629,0.000012036029,0.0020785183],"genre_scores_gemma":[0.9934521,0.0010981582,0.0003920229,0.00023360565,0.000015873235,0.00006867489,0.0037040242,0.0000114686945,0.0010240729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983564,0.0001354447,0.00010996969,0.00032890736,0.0005785842,0.0004906538],"domain_scores_gemma":[0.9961993,0.00021507806,0.0008807476,0.0002444097,0.001488637,0.0009718317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011789959,0.0008545467,0.00094697275,0.002151773,0.005106347,0.0016304424,0.0026972562,0.0014455933,0.0030667915],"category_scores_gemma":[0.0037742208,0.0013562074,0.0017382742,0.007601707,0.001407504,0.00090233056,0.0014627449,0.0020772456,0.00042934067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015063793,0.000086248474,0.9960303,0.00004577722,0.00012764701,0.00009292356,0.00076679344,0.00005829739,0.0001858878,0.00009886673,0.0009810674,0.0013754781],"study_design_scores_gemma":[0.000017576293,0.000032593885,0.9986142,0.00002119944,0.000039544924,0.00008229657,0.00054377003,0.00010115057,0.00001813362,0.000020039477,0.00049050857,0.000019029278],"about_ca_topic_score_codex":0.99246126,"about_ca_topic_score_gemma":0.9941434,"teacher_disagreement_score":0.022762338,"about_ca_system_score_codex":0.022762338,"about_ca_system_score_gemma":0.02652369,"threshold_uncertainty_score":0.16515309},"labels":[],"label_agreement":null},{"id":"W2032565720","doi":"10.1016/j.jval.2014.08.2365","title":"Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Asymptomatic; Quality of life (healthcare); Internal medicine; Placebo; Spinal cord compression; Oncology; Surgery; Cancer; Pathology; Spinal cord","score_opus":0.06869137059026577,"score_gpt":0.386963759052084,"score_spread":0.31827238846181827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032565720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053127,0.0042552203,0.00019681617,0.00048016928,0.00002905717,0.000020007357,0.00085745763,0.0000108672875,0.003619163],"genre_scores_gemma":[0.9970511,0.00097147655,0.00014753849,0.00013263208,0.000025658552,0.000004258238,0.0005268025,0.0000024393723,0.001137901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997491,0.00009498393,0.000019168672,0.000021001091,0.00006634369,0.000049316834],"domain_scores_gemma":[0.99956614,0.0001072838,0.00019511196,0.000015687237,0.000040688894,0.00007516629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030360027,0.00021416631,0.00029799424,0.00022850907,0.00017852543,0.00039926922,0.00013421357,0.0002569942,0.0032431446],"category_scores_gemma":[0.0015537248,0.00010576649,0.0005320804,0.0003119061,0.00014093684,0.00020544464,0.000340516,0.00043457208,0.00023957719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010024417,0.00042122844,0.90240335,0.00018423072,0.00063604687,0.00018001626,0.00012490238,0.0004564801,0.0020404381,0.00014547023,0.0011631578,0.09124211],"study_design_scores_gemma":[0.00001852046,0.00038559284,0.9979315,0.000013487383,0.00011928238,0.00020929839,0.000069721995,0.00021959002,0.00017693941,0.00007568815,0.0007771166,0.0000033351155],"about_ca_topic_score_codex":0.00313445,"about_ca_topic_score_gemma":0.01127441,"teacher_disagreement_score":0.0032431446,"about_ca_system_score_codex":0.00020449307,"about_ca_system_score_gemma":0.00024857186,"threshold_uncertainty_score":0.010849416},"labels":[],"label_agreement":null},{"id":"W2032796993","doi":"10.1016/j.jval.2014.03.734","title":"Screening For Type 2 Diabetes: A Methodological Review And Cost Analysis","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Observational study; CINAHL; Randomized controlled trial; MEDLINE; Type 2 diabetes; Systematic review; Meta-analysis; Family medicine; Pediatrics; Intensive care medicine; Diabetes mellitus; Internal medicine; Psychological intervention; Psychiatry","score_opus":0.4163917733336442,"score_gpt":0.48618512545398085,"score_spread":0.06979335212033666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032796993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000288517,0.99867094,0.0003497177,0.00021723623,0.000068895424,0.00014985834,0.0001410541,0.0000028008224,0.00011101692],"genre_scores_gemma":[0.0091884555,0.98700607,0.0026427028,0.00048983993,0.00008212375,0.00037017203,0.00014225034,0.0000054042903,0.00007295974],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9789306,0.009905859,0.006907436,0.0010147145,0.0028842653,0.000357069],"domain_scores_gemma":[0.9406603,0.048812293,0.006155366,0.0010639246,0.0030354995,0.00027264367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027825044,0.0020801004,0.011150389,0.0099110585,0.00050024857,0.004162167,0.002782798,0.0021769197,0.004333382],"category_scores_gemma":[0.08688622,0.0013236394,0.015789147,0.012195063,0.0010078023,0.0024150948,0.0023942557,0.0020499513,0.00029935365],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009146875,0.000052249,0.0015331425,0.77907026,0.060909994,0.00009369013,0.00012747046,0.00055420405,0.00014095988,0.0015526363,0.0024032923,0.15264742],"study_design_scores_gemma":[0.0012711899,0.00039714304,0.0056526973,0.5395167,0.41349158,0.00054940965,0.00029953071,0.0005613968,0.00024834595,0.0040169535,0.033883214,0.00011185132],"about_ca_topic_score_codex":0.0076240953,"about_ca_topic_score_gemma":0.020421527,"teacher_disagreement_score":0.027825044,"about_ca_system_score_codex":0.0057286,"about_ca_system_score_gemma":0.009864009,"threshold_uncertainty_score":0.14715463},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2033131912","doi":"10.1016/j.jval.2011.02.831","title":"PRM23 MEASURING THE IMPACT OF PREVIOUS TREATMENT CYCLES ON HEALTH UTILITY IN PATIENTS RECEIVING BOTULINUM TOXIN TYPE A (BONTA) IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY: MOBILITY STUDY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; West Park Healthcare Centre; Children's & Women's Health Centre of British Columbia; London Health Sciences Centre; McGill University; Allergan (Canada)","funders":"","keywords":"Medicine; Internal medicine; Observational study","score_opus":0.15797226487274912,"score_gpt":0.3619040065768854,"score_spread":0.20393174170413625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033131912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991192,0.00022619747,0.00005688244,0.000037121932,0.000006696119,0.000010683635,0.00034740288,0.0000025255072,0.00019325456],"genre_scores_gemma":[0.9993824,0.00008260789,0.000058275877,0.000030111642,0.000011573401,0.00001088292,0.00029652368,0.0000021954463,0.00012540573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988121,0.00045846295,0.00013564744,0.00022335326,0.0001567982,0.00021372846],"domain_scores_gemma":[0.996139,0.00072470465,0.002024717,0.00034903942,0.00020294156,0.00055965333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014581153,0.0006360048,0.00079860626,0.00078319653,0.00060972525,0.0014092147,0.0008451806,0.0012851481,0.0015136711],"category_scores_gemma":[0.0055277753,0.00049621565,0.0023348927,0.0014387277,0.00038676627,0.0008547377,0.0008547674,0.001456147,0.0003403169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077030784,0.00016684721,0.99704415,0.000011346475,0.000419048,0.00004560179,0.000044629658,0.000050889357,0.00015191219,0.00001405885,0.00007396094,0.0012072502],"study_design_scores_gemma":[0.000038708513,0.00053647434,0.9987006,0.0000043811797,0.00015818252,0.00014508613,0.00006589484,0.00021137488,0.00004320945,0.000019249233,0.00006959763,0.00000716621],"about_ca_topic_score_codex":0.0061088833,"about_ca_topic_score_gemma":0.005147302,"teacher_disagreement_score":0.0061088833,"about_ca_system_score_codex":0.00062616763,"about_ca_system_score_gemma":0.0004671465,"threshold_uncertainty_score":0.012146652},"labels":[],"label_agreement":null},{"id":"W2033160068","doi":"10.1111/j.1524-4733.2004.71249.x","title":"Modeling the Efficiency of Reaching a Target Intermediate End Point: A Case Study in Type 2 Diabetes in the United States","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology; McGill University","funders":"","keywords":"Glycemic; Nateglinide; Medicine; Metformin; Postprandial; Type 2 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.04393572366586446,"score_gpt":0.31595252541208896,"score_spread":0.2720168017462245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033160068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98353,0.00041386357,0.010834528,0.0013601081,0.00002033325,0.00007843029,0.000390253,0.000043908636,0.0033286205],"genre_scores_gemma":[0.9948413,0.00015489949,0.0037022363,0.000059093,0.000009319122,0.000042284453,0.00018290669,0.00001592315,0.000992091],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99760664,0.0015953698,0.00007171113,0.0002250333,0.000110344954,0.00039084957],"domain_scores_gemma":[0.95354605,0.0424972,0.0014677785,0.00068007875,0.0009984701,0.00081037637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069328845,0.0011169295,0.0014682729,0.0011613651,0.00096622756,0.0024741255,0.0025556777,0.0035308849,0.0029154422],"category_scores_gemma":[0.031013636,0.000991196,0.0016090468,0.0019716844,0.0011193163,0.0021494105,0.0013455759,0.0028860564,0.0001958298],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058224006,0.00054898974,0.021538809,0.00004058147,0.00011978946,0.00021496155,0.00018463319,0.9657059,0.00012472454,0.005817303,0.000681172,0.004441022],"study_design_scores_gemma":[0.0000744949,0.00016632184,0.0036409886,0.000011894464,0.000053533688,0.00003750457,0.00020278724,0.99310404,0.00008470837,0.0024548096,0.00015122848,0.000017745513],"about_ca_topic_score_codex":0.12606053,"about_ca_topic_score_gemma":0.068263315,"teacher_disagreement_score":0.12606053,"about_ca_system_score_codex":0.0053164046,"about_ca_system_score_gemma":0.002758513,"threshold_uncertainty_score":0.25065356},"labels":[],"label_agreement":null},{"id":"W2033202473","doi":"10.1016/j.jval.2011.05.003","title":"Patient Preference for Latent Tuberculosis Infection Preventive Treatment: A Discrete Choice Experiment","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Providence Health Care Research Institute; Centre for Advancing Health Outcomes; University of British Columbia","funders":"British Columbia Centre for Disease Control","keywords":"Medicine; Latent class model; Preference; Latent tuberculosis; Tuberculosis; Covariate; Active tuberculosis; Demography; Statistics; Mycobacterium tuberculosis","score_opus":0.16554978235422713,"score_gpt":0.38474586200098937,"score_spread":0.21919607964676224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033202473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929992,0.00011079247,0.0021998598,0.0010562111,0.00017716746,0.0009624265,0.0004263277,0.000032306587,0.002035704],"genre_scores_gemma":[0.9937715,0.00008666803,0.0032119309,0.00050108135,0.00011876747,0.00085997547,0.00016581592,0.0000071651702,0.0012770302],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9884461,0.008607421,0.0006567866,0.0008082936,0.00071550877,0.0007658589],"domain_scores_gemma":[0.8940332,0.09330259,0.0050650034,0.003483821,0.0005934821,0.0035219002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015933517,0.0013282476,0.0016841415,0.00047573232,0.0009925152,0.0027818626,0.0012106553,0.004869388,0.02087512],"category_scores_gemma":[0.049012423,0.0011342997,0.0014825404,0.00044485866,0.0024793798,0.002108309,0.00086504495,0.0040488504,0.0016704942],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7861372,0.124932945,0.019696087,0.00081659184,0.0015612262,0.00042081674,0.0020068062,0.013608093,0.009846236,0.009185402,0.002158412,0.02963012],"study_design_scores_gemma":[0.3598752,0.47710788,0.028580008,0.00023734687,0.0025320754,0.0006705529,0.0014638375,0.09304818,0.007021714,0.025149051,0.0037123864,0.00060174847],"about_ca_topic_score_codex":0.0008621143,"about_ca_topic_score_gemma":0.00054593553,"teacher_disagreement_score":0.02087512,"about_ca_system_score_codex":0.0010758144,"about_ca_system_score_gemma":0.0022293918,"threshold_uncertainty_score":0.08426547},"labels":[],"label_agreement":null},{"id":"W2033419530","doi":"10.1016/j.jval.2012.08.2093","title":"PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc): Analysis of Prescription Claims From the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Odds ratio; Medical prescription; Internal medicine; Confidence interval; Logistic regression; Persistence (discontinuity); Diabetes mellitus; Ulcerative colitis; Retrospective cohort study; Database; Pediatrics; Disease","score_opus":0.06828120501300997,"score_gpt":0.28442082283523773,"score_spread":0.21613961782222776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033419530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991768,0.001098066,0.000045194574,0.00035107695,0.000013496179,0.000019198007,0.0056270994,0.0000072823022,0.0010705088],"genre_scores_gemma":[0.99599814,0.0005187529,0.00012667217,0.000108079184,0.000017776532,0.000010856808,0.0029025883,0.000004561661,0.0003125631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986461,0.0001510756,0.00016043219,0.00017854884,0.0005180775,0.000345707],"domain_scores_gemma":[0.99473864,0.0007685611,0.0021920907,0.00030846155,0.00123506,0.00075726106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000964293,0.00039705465,0.0007157701,0.0015609128,0.0014518547,0.0014370559,0.0014319167,0.00094883505,0.00243654],"category_scores_gemma":[0.0053488645,0.0003934572,0.0013047571,0.0061612963,0.00051695993,0.00047868106,0.00070820126,0.0014844934,0.00021423023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121939345,0.000044880115,0.9978042,0.00002129165,0.00010788216,0.000035589743,0.0001016294,0.000043261625,0.000051592746,0.000032907596,0.0003858289,0.0012489548],"study_design_scores_gemma":[0.000009460397,0.000013915077,0.9991721,0.000014771838,0.000045993405,0.000054502852,0.0001709464,0.00022079868,0.000014631437,0.000009665405,0.00026661003,0.0000067028946],"about_ca_topic_score_codex":0.89294076,"about_ca_topic_score_gemma":0.9015532,"teacher_disagreement_score":0.10705924,"about_ca_system_score_codex":0.0065979054,"about_ca_system_score_gemma":0.008766963,"threshold_uncertainty_score":0.21537942},"labels":[],"label_agreement":null},{"id":"W2033426385","doi":"10.1016/j.jval.2013.03.656","title":"The Direct Health Care Cost Of Prostate Cancer: Evidence From Us National Survey Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Medical Expenditure Panel Survey; Cancer; Health care; National Health Interview Survey; Demography; Indirect costs; Prostate; Population; Disease burden; Disease; Gerontology; Family medicine; Environmental health; Health insurance; Internal medicine","score_opus":0.6712998744756645,"score_gpt":0.49669409387577823,"score_spread":0.1746057805998863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033426385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77442336,0.11559681,0.002158439,0.01008759,0.0004837651,0.00014650672,0.08325489,0.00004649161,0.013802191],"genre_scores_gemma":[0.9583226,0.018427316,0.0005083633,0.00060253567,0.00016171143,0.000054743403,0.021327939,0.000010835396,0.00058393244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9904038,0.00578518,0.00093092216,0.00047216043,0.0020851956,0.000322835],"domain_scores_gemma":[0.8982004,0.07339985,0.018875113,0.0030780348,0.005359845,0.001086797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009691034,0.00050713966,0.000898087,0.005007378,0.0002717548,0.0015882236,0.0012547893,0.0010077846,0.0026246994],"category_scores_gemma":[0.08767785,0.00061757106,0.0018931474,0.009832265,0.00089780166,0.0017770916,0.001190063,0.001573823,0.00029749778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014631082,0.0002335903,0.93506426,0.0027394916,0.0058097807,0.00009835939,0.00018179491,0.005944939,0.000031687927,0.0022769172,0.011098444,0.035057556],"study_design_scores_gemma":[0.00032919718,0.0002700506,0.97402996,0.0017140668,0.0037900428,0.00032344533,0.00058167905,0.003882897,0.00016981209,0.0035300679,0.011316554,0.0000622419],"about_ca_topic_score_codex":0.05278746,"about_ca_topic_score_gemma":0.04952801,"teacher_disagreement_score":0.05278746,"about_ca_system_score_codex":0.0020529062,"about_ca_system_score_gemma":0.0015532019,"threshold_uncertainty_score":0.10496038},"labels":[],"label_agreement":null},{"id":"W2033722427","doi":"10.1016/j.jval.2012.08.304","title":"PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Number Needed to Treat (NNT) Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Number needed to treat; Lenalidomide; Bortezomib; Multiple myeloma; Thalidomide; Refractory (planetary science); Clinical trial; Internal medicine; Oncology; Confidence interval; Relative risk","score_opus":0.10816854373297373,"score_gpt":0.39398734399835283,"score_spread":0.2858188002653791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033722427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89920056,0.06692731,0.011821447,0.0030225795,0.002516607,0.002407424,0.0036604023,0.0001919976,0.010251646],"genre_scores_gemma":[0.98698145,0.0047213696,0.003380677,0.0009269148,0.0005007684,0.00049073575,0.0007655475,0.000062040104,0.002170506],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.98402935,0.012695554,0.0007552484,0.00074066914,0.0012030889,0.0005761012],"domain_scores_gemma":[0.98308784,0.013397485,0.001591313,0.0006503389,0.00036094297,0.0009119494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015178346,0.0014675055,0.008737765,0.0013491445,0.0004326154,0.0014289669,0.0018505105,0.0021481928,0.0074597676],"category_scores_gemma":[0.014765242,0.0007053451,0.016185671,0.0011529695,0.0010015903,0.0027771245,0.0013579832,0.004103387,0.0004498947],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89887,0.0010068511,0.0059061246,0.001987288,0.027362332,0.00014494335,0.0000638368,0.0062714466,0.00079395296,0.00066980935,0.0011477149,0.055775717],"study_design_scores_gemma":[0.38814023,0.2578945,0.06439349,0.0016043179,0.19575119,0.0012891523,0.00066634436,0.057196695,0.003924732,0.017207138,0.011512559,0.00041966236],"about_ca_topic_score_codex":0.0012525611,"about_ca_topic_score_gemma":0.0020847982,"teacher_disagreement_score":0.015178346,"about_ca_system_score_codex":0.001823815,"about_ca_system_score_gemma":0.0012513024,"threshold_uncertainty_score":0.08027178},"labels":[],"label_agreement":null},{"id":"W2033845558","doi":"10.1016/s1098-3015(10)63441-9","title":"PCN11 PHARMACOECONOMIC ANALYSES OF ERLOTINIB COMPARED WITH BEST SUPPORTIVE CARE (BSC) FOR THE TREATMENT OF RELAPSED NON-SMALL CELL LUNG CANCER (NSCLC) FROM THE CANADIAN PUBLIC HEALTH CARE PERSPECTIVE","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Perspective (graphical); Health care; Public health; Public health care; Intensive care medicine; Oncology; Internal medicine; Cancer; Nursing; Health policy; Political science; Computer science","score_opus":0.09596028306643296,"score_gpt":0.3300170494965055,"score_spread":0.23405676643007256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033845558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515375,0.017419416,0.0011985858,0.004649304,0.00011595364,0.0003777311,0.012317937,0.00005910703,0.012324399],"genre_scores_gemma":[0.99613416,0.0012223439,0.00023402933,0.0002303246,0.000036671172,0.000026780785,0.0014619352,0.0000053950675,0.0006483504],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997044,0.0014483726,0.0001251358,0.0001478022,0.00076950225,0.00046520826],"domain_scores_gemma":[0.99277264,0.004927263,0.0008406986,0.00019124968,0.00077327556,0.00049486896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004173971,0.0006545194,0.0016742798,0.00075879367,0.00039002544,0.0010672265,0.0010375155,0.0007640509,0.004147248],"category_scores_gemma":[0.01194896,0.00034011534,0.0030889853,0.001731796,0.0005349011,0.00048129997,0.00036389023,0.0015174716,0.00012793351],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3217734,0.0020380064,0.14150965,0.0024253614,0.023051789,0.00089832995,0.00021693009,0.25461248,0.003179221,0.008548238,0.020738995,0.22100767],"study_design_scores_gemma":[0.035273712,0.018771557,0.7046167,0.00036957138,0.038166888,0.0006777689,0.00065161596,0.17302768,0.003826691,0.0059154206,0.018375902,0.00032644666],"about_ca_topic_score_codex":0.52888846,"about_ca_topic_score_gemma":0.6533311,"teacher_disagreement_score":0.98758274,"about_ca_system_score_codex":0.012417234,"about_ca_system_score_gemma":0.013933275,"threshold_uncertainty_score":0.947772},"labels":[],"label_agreement":null},{"id":"W2034329485","doi":"10.1016/j.jval.2012.08.2066","title":"PSS19 Economic Evaluation of Ranibizumab for the Treatment of Macular Edema Secondary to Branch and Central Retinal Vein Occlusion in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Quality-adjusted life year; Branch retinal vein occlusion; Central retinal vein occlusion; Macular edema; Cost effectiveness; Visual acuity; Optometry; Emergency medicine; Ophthalmology; Surgery; Bevacizumab","score_opus":0.26521633392205735,"score_gpt":0.4028775755391202,"score_spread":0.13766124161706284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034329485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9263043,0.015360617,0.0008847791,0.007878629,0.00018985836,0.0019802146,0.015021425,0.000041350464,0.032338787],"genre_scores_gemma":[0.99043286,0.0030129012,0.0006102591,0.00045860535,0.000054874214,0.00014484285,0.0024747753,0.00000925154,0.002801497],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965229,0.0014584889,0.00019912737,0.00010584828,0.0010599577,0.0006537011],"domain_scores_gemma":[0.99342245,0.0016664449,0.0007269166,0.00008464225,0.0028155677,0.0012839984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003416037,0.0004873289,0.001010324,0.0012027055,0.0012009987,0.0020642527,0.0008087264,0.0006923332,0.0028465064],"category_scores_gemma":[0.011317531,0.00028827094,0.0016175667,0.0020577435,0.000577913,0.00028307876,0.0005477909,0.0010307844,0.00012986912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17462422,0.0065592066,0.21815519,0.0061399303,0.011486243,0.003805697,0.00079010834,0.2014979,0.005166669,0.021508733,0.06690672,0.28335944],"study_design_scores_gemma":[0.044979725,0.019194072,0.60642433,0.0023848698,0.01027356,0.0013898826,0.0020250801,0.24514247,0.0030250088,0.0026852668,0.06205532,0.00042044654],"about_ca_topic_score_codex":0.9506862,"about_ca_topic_score_gemma":0.9560154,"teacher_disagreement_score":0.06462256,"about_ca_system_score_codex":0.06462256,"about_ca_system_score_gemma":0.07942971,"threshold_uncertainty_score":0.46887165},"labels":[],"label_agreement":null},{"id":"W2034399548","doi":"10.1016/j.jval.2014.03.1251","title":"Cost-effectiveness of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant versus long-acting stimulant monotherapy for the treatment of attention-deficit/hyperactivity disorder in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Stimulant; Guanfacine; Methylphenidate; Attention deficit hyperactivity disorder; Medicine; Psychiatry; Amphetamine; Internal medicine; Dopamine","score_opus":0.10477924058421971,"score_gpt":0.3917650936636607,"score_spread":0.28698585307944097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034399548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98138624,0.010122003,0.00016775732,0.0018836233,0.00011434851,0.00038222905,0.0021527414,0.000031921947,0.0037591448],"genre_scores_gemma":[0.99618727,0.0021711893,0.00030977157,0.00018285678,0.000035452795,0.00003812078,0.00046775048,0.000003305035,0.00060427334],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991725,0.00023947534,0.000058512993,0.000084543484,0.00024982347,0.00019521247],"domain_scores_gemma":[0.99823016,0.00030816722,0.00025452414,0.000021680173,0.00028292934,0.00090252125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005924547,0.00035921592,0.00091425906,0.00063638104,0.0005895866,0.00092054333,0.00090763654,0.00071908196,0.004189714],"category_scores_gemma":[0.0034429382,0.00025620518,0.0014127997,0.00093801005,0.0005143861,0.0004127159,0.00054646056,0.0009406964,0.000105371684],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22091946,0.00735708,0.26640287,0.0032942896,0.0051469984,0.0012264033,0.00051030813,0.02736421,0.0040331353,0.0025953797,0.015489476,0.44566047],"study_design_scores_gemma":[0.041254103,0.033662837,0.8594156,0.0012903316,0.00878503,0.0009882397,0.0013346325,0.043925185,0.0013370436,0.00061100174,0.007179106,0.00021689436],"about_ca_topic_score_codex":0.8674818,"about_ca_topic_score_gemma":0.9250685,"teacher_disagreement_score":0.13251817,"about_ca_system_score_codex":0.037535492,"about_ca_system_score_gemma":0.028052144,"threshold_uncertainty_score":0.2723403},"labels":[],"label_agreement":null},{"id":"W2034399712","doi":"10.1016/s1098-3015(10)73802-x","title":"PCV40 COST-EFFECTIVENESS ANALYSIS OF THE INSERTABLE CARDIAC MONITOR FOR DETECTING RECURRENT ATRIAL FIBRILLATION (AF) FOLLOWING RADIOFREQUENCY CATHETER ABLATION (RCA): A CANADIAN PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atrial fibrillation; Cardiology; Medicine; Internal medicine; Radiofrequency catheter ablation; Catheter ablation; Perspective (graphical); Catheter; Ablation; Radiofrequency ablation; Surgery; Computer science; Artificial intelligence","score_opus":0.03712866215844075,"score_gpt":0.34552907054276283,"score_spread":0.3084004083843221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034399712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77246815,0.07526544,0.007577208,0.029796368,0.0006110273,0.0014591076,0.039567072,0.00014755785,0.0731081],"genre_scores_gemma":[0.9796587,0.009530021,0.0033676904,0.0012572887,0.00019778872,0.00009850736,0.00368244,0.000020543337,0.002186954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955996,0.0014980658,0.00019564314,0.0003094991,0.001759749,0.000637404],"domain_scores_gemma":[0.9953499,0.002001885,0.00044623646,0.00006910727,0.0015179421,0.0006149029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030032934,0.0013090489,0.0015330549,0.0024835025,0.0008350994,0.0029580842,0.0019006613,0.001677685,0.0062445784],"category_scores_gemma":[0.012820369,0.00055689487,0.0037782553,0.0040180315,0.00076584204,0.0007481741,0.00061549764,0.0018937133,0.00022336184],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034999397,0.0015465536,0.2769526,0.006467045,0.01703337,0.0020378134,0.0006882135,0.23631711,0.0044058557,0.033969842,0.043249138,0.34233305],"study_design_scores_gemma":[0.0074651022,0.00839546,0.722189,0.002064852,0.024740225,0.0019151043,0.0015296957,0.18853393,0.0016739048,0.006791283,0.034031186,0.00067030935],"about_ca_topic_score_codex":0.9381697,"about_ca_topic_score_gemma":0.9315694,"teacher_disagreement_score":0.061830282,"about_ca_system_score_codex":0.055965446,"about_ca_system_score_gemma":0.04829325,"threshold_uncertainty_score":0.40605962},"labels":[],"label_agreement":null},{"id":"W2034571284","doi":"10.1016/j.jval.2011.02.948","title":"PCN93 ATTACHMENT STYLE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PROSTATE CANCER","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Attachment theory; Psychosocial; Affect (linguistics); Sexual orientation; Quality of life (healthcare); Social support; Prostate cancer; Psychology; Clinical psychology; Mental health; Sexual function; Medicine; Developmental psychology; Cancer; Psychiatry; Social psychology; Psychotherapist; Internal medicine","score_opus":0.08976130765903019,"score_gpt":0.34704290429588636,"score_spread":0.2572815966368562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034571284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976568,0.00025874109,0.000024213065,0.00016926035,0.000020032296,0.000009795221,0.00013846348,0.0000012227963,0.0017215421],"genre_scores_gemma":[0.9992287,0.00011504768,0.000035734316,0.00006103014,0.00001043573,0.000005228562,0.00013462102,9.65712e-7,0.00040820558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995134,0.00013642939,0.000047866786,0.00003369298,0.0001467019,0.00012192918],"domain_scores_gemma":[0.9976355,0.00040933184,0.00077341986,0.000062836116,0.00028083017,0.0008381969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048447715,0.00025809204,0.00032832997,0.0006764192,0.00083982234,0.0010440104,0.0003201139,0.0005486717,0.0037585585],"category_scores_gemma":[0.0047037606,0.00016975663,0.00058223284,0.0011432322,0.00039253166,0.00043002408,0.0008271931,0.0012822206,0.00026849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009239656,0.00014771296,0.99588615,0.00001129091,0.00007176046,0.00007488077,0.00024170218,0.000071230614,0.00008110189,0.000033860666,0.00018035228,0.0031075408],"study_design_scores_gemma":[0.0000053399513,0.00008979017,0.9988802,0.000007767598,0.000018521881,0.00009262133,0.0005158181,0.00014135262,0.000015132005,0.000051367795,0.00017704499,0.0000050227104],"about_ca_topic_score_codex":0.009789376,"about_ca_topic_score_gemma":0.019747298,"teacher_disagreement_score":0.009789376,"about_ca_system_score_codex":0.00067796337,"about_ca_system_score_gemma":0.0005526751,"threshold_uncertainty_score":0.01946479},"labels":[],"label_agreement":null},{"id":"W2034652315","doi":"10.1016/j.jval.2011.08.1103","title":"PCN2 A Retrospective Longitudinal Study of Treatment Patterns and Outcomes Among Patients with Unresectable Stage IIIc/IV Melanoma in Canada (Melody)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Melanoma; Adverse effect; Randomized controlled trial; Stage (stratigraphy); Internal medicine; Clinical trial; Disease; Retrospective cohort study; Medical record; Surgery; Oncology","score_opus":0.036569155253819936,"score_gpt":0.2600523915613234,"score_spread":0.2234832363075035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034652315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469614,0.00014747793,0.000052730105,0.00011599146,0.000008155685,0.000034245673,0.0040987562,0.000005620029,0.00084080047],"genre_scores_gemma":[0.9958682,0.000121304605,0.00007454191,0.00010538474,0.000006896896,0.000023866709,0.0029879503,0.0000053588906,0.00080648117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902296,0.00007970511,0.000059929673,0.00018352582,0.0002152073,0.00043864414],"domain_scores_gemma":[0.9976271,0.00009036614,0.0004697075,0.000115296236,0.0009328923,0.0007646733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004339104,0.00045010613,0.00040376474,0.0011197062,0.0022838807,0.0012255891,0.0010687312,0.0007031015,0.001709779],"category_scores_gemma":[0.0016290142,0.00050457515,0.00060065056,0.0038740677,0.0005768173,0.0005276064,0.0008155361,0.0011901525,0.0003707874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060197763,0.000029412453,0.9989203,0.000003506046,0.000023530165,0.000045156918,0.00011170274,0.00002148115,0.00007221011,0.000012850746,0.00027322542,0.00042642406],"study_design_scores_gemma":[0.000006659405,0.00002927197,0.99887425,0.00000524789,0.000016703385,0.00006786681,0.00052218424,0.0000888772,0.000030718245,0.000007256551,0.00034585127,0.0000051595716],"about_ca_topic_score_codex":0.96120805,"about_ca_topic_score_gemma":0.9605511,"teacher_disagreement_score":0.038791955,"about_ca_system_score_codex":0.01341564,"about_ca_system_score_gemma":0.017067805,"threshold_uncertainty_score":0.09733772},"labels":[],"label_agreement":null},{"id":"W2035091359","doi":"10.1016/s1098-3015(10)61688-9","title":"PCV44 PHARMACOECONOMIC EVALUATION OF VASOTEC® IN HYPERTENSIVE PATIENTS WITH CONGESTIVE HEART FAILURE: AN UPDATE OF THE RETROSPECTIVE CANADIAN ANALYSIS BASED ON THE STUDIES OF LEFT VENTRICULAR DYSFUNCTION (SOLVD)","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine","score_opus":0.04538850401264468,"score_gpt":0.3076127527828836,"score_spread":0.2622242487702389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035091359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8144651,0.07537929,0.0026413,0.004011463,0.00042422212,0.00055197347,0.07452343,0.0001864048,0.027816873],"genre_scores_gemma":[0.94763565,0.023835046,0.004440584,0.0020033082,0.00042553103,0.00012373377,0.019630708,0.00009376372,0.0018116063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99475265,0.0010782342,0.0006203445,0.00030818125,0.0030093964,0.00023115016],"domain_scores_gemma":[0.98223156,0.003982915,0.002921289,0.00072817993,0.009484223,0.0006517995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004714074,0.0005345214,0.0011472147,0.0031958974,0.0007719252,0.0019018378,0.0008977191,0.0004494495,0.0012168527],"category_scores_gemma":[0.014639128,0.00030064213,0.001484955,0.01191478,0.00041624566,0.00043371003,0.00040907096,0.00062547094,0.00014704358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048556533,0.00010311922,0.8743566,0.001109541,0.0026862866,0.00022882341,0.0002666765,0.0007855547,0.00074116094,0.0005105509,0.013340033,0.10101597],"study_design_scores_gemma":[0.00040016932,0.00023869418,0.9857572,0.00017568159,0.0016559332,0.00022629973,0.0000983856,0.0005826687,0.00049510825,0.00004866327,0.010272945,0.000048402733],"about_ca_topic_score_codex":0.7701704,"about_ca_topic_score_gemma":0.8414563,"teacher_disagreement_score":0.9933864,"about_ca_system_score_codex":0.006613619,"about_ca_system_score_gemma":0.015828513,"threshold_uncertainty_score":0.46236622},"labels":[],"label_agreement":null},{"id":"W2035535489","doi":"10.1016/j.jval.2014.03.430","title":"The Utilization of Video-Assisted Thoracic Surgery (VATS) Versus Open Thoracotomy for Stage 1 And Stage 2 Non-Small Cell Lung Cancer in Canadian Hospitals: A Budget Impact Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thoracotomy; Activity-based costing; Lung cancer; Cardiothoracic surgery; Surgery; General surgery; Emergency medicine; Internal medicine","score_opus":0.054754742431034835,"score_gpt":0.4035281241172074,"score_spread":0.34877338168617256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035535489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587282,0.008135203,0.00042139986,0.0052168802,0.00009070444,0.0004062854,0.01611188,0.00002546382,0.0108638285],"genre_scores_gemma":[0.9936784,0.002122093,0.00043723758,0.00038310108,0.000023225266,0.00007672372,0.00229885,0.000007605477,0.00097272714],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.991572,0.0016493559,0.00046769285,0.0003297139,0.0022778134,0.003703354],"domain_scores_gemma":[0.9884651,0.003876052,0.0023265465,0.00015285252,0.002843935,0.0023355386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004229886,0.00086724816,0.0011810788,0.003155887,0.0016933914,0.0029960675,0.0022286123,0.0012659047,0.003981922],"category_scores_gemma":[0.0234061,0.0006401281,0.0033419332,0.00812811,0.0011457818,0.0012405963,0.0013713529,0.001549407,0.00011938209],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070359213,0.00091753114,0.8529545,0.0015079982,0.002901024,0.0003372218,0.0007920338,0.04670741,0.000551752,0.0049570333,0.010567247,0.070770375],"study_design_scores_gemma":[0.0004447005,0.0010597797,0.9677672,0.00044522353,0.0017193732,0.00019588807,0.0027303265,0.020019991,0.00031515918,0.0007279458,0.004447939,0.00012652866],"about_ca_topic_score_codex":0.98403144,"about_ca_topic_score_gemma":0.9876396,"teacher_disagreement_score":0.1519782,"about_ca_system_score_codex":0.1519782,"about_ca_system_score_gemma":0.10329086,"threshold_uncertainty_score":0.9835851},"labels":[],"label_agreement":null},{"id":"W2035548232","doi":"10.1016/s1098-3015(11)72692-4","title":"PHP27 COMPARISON OF THE USE OF PRESCRIBED MEDICATIONS BETWEEN QUEBEC RESIDENTS COVERED BY PUBLIC AND PRIVATE DRUG INSURANCE:THE REMED REGISTRY","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Private insurance; Drug; Public health insurance; Medicine; Business; Family medicine; Actuarial science; Health insurance; Pharmacology; Political science; Health care; Law","score_opus":0.24982172217399892,"score_gpt":0.4252768541333004,"score_spread":0.17545513195930149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035548232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91582566,0.00065991085,0.0003144827,0.0005793074,0.00003698364,0.0001995783,0.075147405,0.000045200228,0.007191332],"genre_scores_gemma":[0.97163403,0.0003551199,0.00036561946,0.00022632696,0.000030409143,0.00018787748,0.02351344,0.000024802419,0.003662415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979874,0.00040434676,0.00017182212,0.00026506835,0.00075571967,0.0004156464],"domain_scores_gemma":[0.9891344,0.0013116683,0.0031104488,0.0004457582,0.004884795,0.0011130095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018040016,0.0003748973,0.0006984826,0.002108355,0.0012214693,0.0012297414,0.0013126394,0.000596281,0.00554807],"category_scores_gemma":[0.0083762305,0.0002908222,0.0008616639,0.0057849777,0.00042705948,0.0007455535,0.0009313897,0.00071494177,0.0005794551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003642302,0.000040968378,0.9893566,0.000039191033,0.00019866627,0.000030803727,0.00015916918,0.00011866707,0.00007410892,0.0000870216,0.005747879,0.0037827205],"study_design_scores_gemma":[0.000030936895,0.000036177178,0.9984365,0.000013997795,0.00003784851,0.000017975632,0.00014770293,0.00016786055,0.00004015229,0.0000068219215,0.0010581523,0.000005931218],"about_ca_topic_score_codex":0.9607263,"about_ca_topic_score_gemma":0.9709052,"teacher_disagreement_score":0.9883528,"about_ca_system_score_codex":0.011647229,"about_ca_system_score_gemma":0.01164808,"threshold_uncertainty_score":0.08450693},"labels":[],"label_agreement":null},{"id":"W2035660013","doi":"10.1016/s1098-3015(10)65058-9","title":"PMH8 RISPERIDONE LONG-ACTING INJECTION (RLAI) IN THE TREATMENT OF SCHIZOPHRENIA: 3 MONTH PRELIMINARY RESULTS FROM E-STAR PROJECT IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Psychiatry","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Psychology; Psychiatry; Medicine","score_opus":0.06554929625418444,"score_gpt":0.29274705405158813,"score_spread":0.2271977577974037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035660013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99074566,0.000958255,0.00021280171,0.00083944824,0.000039123035,0.0009855407,0.0022463119,0.000060829032,0.0039120573],"genre_scores_gemma":[0.9869021,0.0015173667,0.0013721331,0.0005607972,0.00005358288,0.00030300426,0.0024386896,0.000017880568,0.0068344083],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999027,0.0002380886,0.00004579831,0.00006386507,0.00029384968,0.00033138183],"domain_scores_gemma":[0.9979017,0.00021609543,0.00017159614,0.000049790426,0.0008204534,0.0008404411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012024163,0.0003254383,0.0007039768,0.0004645302,0.0012034298,0.00059357035,0.00060811907,0.00055196916,0.0021591636],"category_scores_gemma":[0.0014474288,0.00017866389,0.00053430593,0.00077900704,0.0005135165,0.00026190426,0.00042817398,0.0007841315,0.00036759183],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1567209,0.056143302,0.15272273,0.00084635563,0.00058101944,0.0014532137,0.0026002931,0.0029779074,0.014883557,0.0005572121,0.019006034,0.5915075],"study_design_scores_gemma":[0.028062882,0.062385913,0.88931435,0.00014733688,0.0006387016,0.00034408117,0.00215013,0.0027649372,0.003687019,0.00018703498,0.010235314,0.0000823891],"about_ca_topic_score_codex":0.8219661,"about_ca_topic_score_gemma":0.872571,"teacher_disagreement_score":0.17803389,"about_ca_system_score_codex":0.006677374,"about_ca_system_score_gemma":0.01972711,"threshold_uncertainty_score":0.35816467},"labels":[],"label_agreement":null},{"id":"W2036228685","doi":"10.1016/j.jval.2012.08.258","title":"PRM6 Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Gross domestic product; Meta-analysis; Medicine; Per capita; Econometrics; Statistics; Meta-regression; Indirect costs; Bootstrapping (finance); Demography; Mathematics; Economics; Environmental health; Population; Internal medicine","score_opus":0.7227879199059023,"score_gpt":0.5048307046954711,"score_spread":0.2179572152104312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036228685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004599461,0.9918459,0.0011384474,0.00026514122,0.00020788303,0.00024212214,0.0011950595,0.000027666581,0.00047838842],"genre_scores_gemma":[0.28026935,0.7093249,0.005052734,0.0011685573,0.00062847516,0.0010773482,0.0017888981,0.00006882562,0.00062088016],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9727989,0.015039202,0.00573856,0.0021763428,0.0037843287,0.00046260626],"domain_scores_gemma":[0.9426535,0.046273954,0.006530578,0.002272464,0.0020445203,0.00022508147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027786797,0.0026376056,0.013787686,0.0061283633,0.00041194467,0.0031614478,0.0024914155,0.0023383475,0.0071370425],"category_scores_gemma":[0.10846586,0.0015026218,0.036250945,0.006903011,0.0012465703,0.0025153176,0.0028386118,0.0031726977,0.00038247305],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028983918,0.000032436183,0.0063083107,0.3132197,0.6270261,0.00009937491,0.00009217722,0.00073958875,0.00009103524,0.00063254614,0.0013496865,0.047510587],"study_design_scores_gemma":[0.0023210456,0.0003175596,0.014428094,0.043621425,0.9318749,0.00034414732,0.000073624054,0.00045574096,0.00015420854,0.0014079612,0.0049429936,0.00005831528],"about_ca_topic_score_codex":0.005938378,"about_ca_topic_score_gemma":0.009055568,"teacher_disagreement_score":0.027786797,"about_ca_system_score_codex":0.0032388621,"about_ca_system_score_gemma":0.0030725743,"threshold_uncertainty_score":0.14695233},"labels":[],"label_agreement":null},{"id":"W2036347212","doi":"10.1016/j.jval.2012.08.973","title":"PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Percentile; Rehabilitation; Demographics; Database; Emergency medicine; Population; Hospital discharge; Heart failure; Internal medicine; Physical therapy; Demography","score_opus":0.0930934804347014,"score_gpt":0.47058053726861687,"score_spread":0.3774870568339155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036347212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978835,0.0033738946,0.00036707654,0.00031819128,0.000016956183,0.000041718115,0.015905524,0.000017234805,0.001124476],"genre_scores_gemma":[0.98676443,0.0005852035,0.000335871,0.00007951227,0.00002935494,0.000056373498,0.011884779,0.000006416758,0.00025795805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974911,0.0010246913,0.00031374503,0.00041985465,0.00044776336,0.00030273412],"domain_scores_gemma":[0.99476814,0.0018080567,0.001641242,0.00036052664,0.0010727461,0.00034939512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023357114,0.00067469705,0.0011224716,0.0042766365,0.0004393824,0.00134802,0.0008401649,0.0006041281,0.0017993837],"category_scores_gemma":[0.0073668784,0.00032211083,0.0027186312,0.0044204663,0.00022234829,0.0006138883,0.0006958453,0.00049900135,0.0001588716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005131055,0.000047731934,0.98829436,0.00011231922,0.0014718577,0.00010744725,0.000068438596,0.0009254039,0.00007440269,0.00016902907,0.0018076916,0.006408093],"study_design_scores_gemma":[0.0000367025,0.000066996094,0.997417,0.000038046204,0.0002491715,0.00019424011,0.000083570805,0.0011768845,0.00003187069,0.000031608834,0.0006650162,0.000008944636],"about_ca_topic_score_codex":0.15423852,"about_ca_topic_score_gemma":0.09450748,"teacher_disagreement_score":0.15423852,"about_ca_system_score_codex":0.004404351,"about_ca_system_score_gemma":0.0029055,"threshold_uncertainty_score":0.3066815},"labels":[],"label_agreement":null},{"id":"W2036561689","doi":"10.1016/j.jval.2011.02.973","title":"PCN119 VALIDATION OF A NEW MEASURE OF PATIENT EMPOWERMENT IN ONCOLOGY: FIVE HEALTH EDUCATION IMPACT QUESTIONNAIRE (HEIQ) SCALES","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McGill University; Université Laval","funders":"","keywords":"Structural equation modeling; Confirmatory factor analysis; Cronbach's alpha; Construct validity; Psychometrics; Population; Empowerment; Psychology; Clinical psychology; Medicine; Context (archaeology); Statistics","score_opus":0.05665829154552438,"score_gpt":0.36670900290939484,"score_spread":0.31005071136387047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036561689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95874935,0.00020371962,0.007174334,0.0005955771,0.00017467256,0.0031067578,0.0030314648,0.000076132805,0.02688809],"genre_scores_gemma":[0.97652394,0.00016578626,0.010619786,0.00030365048,0.000053717642,0.0038608436,0.003706629,0.000051590185,0.0047141965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928954,0.0022685707,0.0009219982,0.0004040878,0.0030536696,0.00045623857],"domain_scores_gemma":[0.9829928,0.008716876,0.0018403721,0.0009546797,0.0046921168,0.000803248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009958664,0.0003094188,0.00037873446,0.0017395134,0.00065636315,0.0008851093,0.0006902221,0.0005410072,0.005031557],"category_scores_gemma":[0.02351703,0.00024089424,0.0008091083,0.0009800587,0.00072814827,0.0010157634,0.0017354576,0.0014091147,0.0007262553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010541368,0.0023156314,0.7904188,0.00018984335,0.00026996378,0.000101676604,0.0021224343,0.0011576583,0.002391281,0.0018261139,0.0058718845,0.19228055],"study_design_scores_gemma":[0.00022324506,0.0011012416,0.9835941,0.000077161356,0.00006913653,0.0001284937,0.0007625684,0.001474523,0.0019444773,0.0005216572,0.010076636,0.000026699741],"about_ca_topic_score_codex":0.0028251559,"about_ca_topic_score_gemma":0.004234982,"teacher_disagreement_score":0.009958664,"about_ca_system_score_codex":0.0010452365,"about_ca_system_score_gemma":0.0018517502,"threshold_uncertainty_score":0.05266708},"labels":[],"label_agreement":null},{"id":"W2036598552","doi":"10.1016/s1098-3015(10)72344-5","title":"PGI26 CANADIAN COST-UTILITY ANALYSIS OF INITIATION AND MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS FOR REFRACTORY CROHN'S DISEASE","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Crohn's disease; Medicine; Disease; Tumor necrosis factor alpha; Maintenance therapy; Intensive care medicine; Internal medicine; Biology; Chemotherapy","score_opus":0.014365908025332524,"score_gpt":0.2726173675196867,"score_spread":0.25825145949435413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036598552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80169725,0.026816716,0.002085763,0.008280064,0.00027882005,0.0011107691,0.11873847,0.00022645156,0.04076573],"genre_scores_gemma":[0.9692189,0.0035566534,0.001699583,0.0007357029,0.00007882939,0.00020732723,0.02057531,0.000045982182,0.0038817362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967309,0.0013606496,0.00011406647,0.0002561422,0.0010992821,0.0004389335],"domain_scores_gemma":[0.9959889,0.0012880935,0.0006570098,0.00015971536,0.0010767177,0.0008294719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029680212,0.0011463774,0.0019143678,0.0022444627,0.0007533101,0.0018832127,0.0021920507,0.00090403104,0.0051356973],"category_scores_gemma":[0.01121672,0.0005843995,0.0038677172,0.0054006595,0.0006603071,0.0005062548,0.0007341411,0.0018009088,0.00035944613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.116931446,0.0012829105,0.39699894,0.0026293956,0.013598852,0.0011647738,0.00040448783,0.20573713,0.0025411334,0.01232231,0.09496467,0.15142408],"study_design_scores_gemma":[0.012316757,0.003622617,0.8607816,0.00061824516,0.006923031,0.0006973786,0.00040633048,0.081587695,0.00053228025,0.0012661068,0.03092835,0.0003196157],"about_ca_topic_score_codex":0.9456301,"about_ca_topic_score_gemma":0.92920405,"teacher_disagreement_score":0.06290511,"about_ca_system_score_codex":0.06290511,"about_ca_system_score_gemma":0.041690882,"threshold_uncertainty_score":0.45641065},"labels":[],"label_agreement":null},{"id":"W2036769704","doi":"10.1016/j.jval.2014.03.1652","title":"Prevalence, Incidence And Characteristics Of Patients With Choroidal Neovascularization Secondary To Pathologic Myopia In A Representative Canadian Cohort","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Université de Montréal; Novartis (Canada)","funders":"","keywords":"Incidence (geometry); Cohort; Medicine; Choroidal neovascularization; Ophthalmology; Optometry; Neovascularization; Demography; Internal medicine; Macular degeneration; Angiogenesis; Optics","score_opus":0.009413417416776492,"score_gpt":0.2539320940616185,"score_spread":0.244518676644842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036769704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941122,0.00029856843,0.00007771623,0.00013511427,0.0000076293672,0.000033441756,0.003459341,0.000012068046,0.0018638596],"genre_scores_gemma":[0.99718374,0.00030633478,0.00013647336,0.000075656964,0.000007437445,0.00001669792,0.0017718512,0.000006212008,0.00049555145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999113,0.000036968377,0.00005637101,0.00017021158,0.00027135893,0.00035215757],"domain_scores_gemma":[0.99854267,0.00006363753,0.00026637857,0.00006144254,0.000654567,0.00041134746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047516602,0.00053534866,0.00048395974,0.0030696793,0.0033769913,0.0013101477,0.0014152372,0.0007965087,0.00282078],"category_scores_gemma":[0.0016408226,0.0006370091,0.0009085806,0.004370475,0.000824554,0.0005633383,0.0007705105,0.00089077145,0.0003805638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051001465,0.000031912976,0.9977875,0.000010311243,0.000035052894,0.00013348965,0.00032884598,0.00003112731,0.00016729771,0.000044084914,0.0004991452,0.00088028057],"study_design_scores_gemma":[0.0000045364727,0.000022954795,0.9983423,0.000007912066,0.00001567051,0.0002780442,0.0008481603,0.0001093411,0.000022771881,0.0000122410265,0.00032613534,0.000010004202],"about_ca_topic_score_codex":0.9827937,"about_ca_topic_score_gemma":0.9793722,"teacher_disagreement_score":0.017206311,"about_ca_system_score_codex":0.014455472,"about_ca_system_score_gemma":0.014786324,"threshold_uncertainty_score":0.1048823},"labels":[],"label_agreement":null},{"id":"W2037559088","doi":"10.1016/j.jval.2014.03.043","title":"The Potential Impact Of Recommendations Made Through The Common Drug Review Program At The Canadian Agency For Drugs And Technologies In Health","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Formulary; Counterfactual thinking; Agency (philosophy); Listing (finance); Cost–benefit analysis; Medicine; Actuarial science; Operations research; Business; Family medicine; Finance; Engineering","score_opus":0.25731075421596555,"score_gpt":0.4578073954217232,"score_spread":0.20049664120575766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037559088","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070042987,0.004813651,0.0022629912,0.92811143,0.008078604,0.0005655811,0.002949557,0.00016722563,0.04604672],"genre_scores_gemma":[0.22748621,0.012110509,0.033015244,0.6743083,0.01046358,0.0008896663,0.002898015,0.00027166976,0.038556892],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.7655378,0.11760191,0.012863729,0.0065582115,0.0856931,0.011745171],"domain_scores_gemma":[0.31935057,0.3633363,0.035680573,0.016918428,0.24034604,0.02436806],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18045542,0.0012114628,0.0014036275,0.007122656,0.004101684,0.013430403,0.00576324,0.033884943,0.017490683],"category_scores_gemma":[0.58106315,0.0012299804,0.0034258007,0.0078100627,0.0040239133,0.0075864154,0.003124951,0.013960646,0.0021217463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006406238,0.00044252665,0.015192819,0.0012448815,0.0007716406,0.0003917373,0.00053579774,0.0037189831,0.0003370065,0.05721032,0.84285027,0.07666338],"study_design_scores_gemma":[0.002537375,0.00077925675,0.07222259,0.006650006,0.0023318517,0.00046902866,0.0019463674,0.021862352,0.0022679784,0.050798494,0.8371906,0.0009440727],"about_ca_topic_score_codex":0.5454249,"about_ca_topic_score_gemma":0.70218694,"teacher_disagreement_score":0.97039044,"about_ca_system_score_codex":0.029609576,"about_ca_system_score_gemma":0.16979548,"threshold_uncertainty_score":0.9543509},"labels":[],"label_agreement":null},{"id":"W2037604674","doi":"10.1016/s1098-3015(10)70902-5","title":"PSS7 THE COST-EFFECTIVENESS OF RANIBIZUMAB COMPARED TO PDT-VAND BSC FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Macular degeneration; Ranibizumab; Medicine; Ophthalmology; Oncology; Internal medicine; Optometry; Chemotherapy","score_opus":0.11774405482990875,"score_gpt":0.3684899964738832,"score_spread":0.25074594164397446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037604674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93363214,0.02705307,0.00041323973,0.009363337,0.00024592248,0.0005013323,0.0107751,0.000056818164,0.017959142],"genre_scores_gemma":[0.98900014,0.0057010334,0.00041870127,0.0006241171,0.00007167904,0.000050709183,0.0014424653,0.000012607632,0.0026786851],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984523,0.00044282855,0.0001157423,0.000100567486,0.0005363734,0.00035228365],"domain_scores_gemma":[0.9977456,0.0005256606,0.000317402,0.00003555915,0.00083807594,0.000537631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094537897,0.000367097,0.0008609175,0.0008913509,0.00082738785,0.0013858712,0.0007221396,0.0006644027,0.004995162],"category_scores_gemma":[0.0051499642,0.00028591047,0.0015649109,0.0020216107,0.0004949876,0.0003880241,0.00038837068,0.00079396664,0.00016768262],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16720565,0.0021419376,0.26950985,0.004326107,0.008129363,0.0014859822,0.0005647338,0.04105983,0.004758083,0.0071874917,0.039553486,0.4540775],"study_design_scores_gemma":[0.027902946,0.01188622,0.8649704,0.0013579106,0.013905799,0.001090613,0.001733425,0.044665392,0.0026499052,0.0014145806,0.028099494,0.00032338148],"about_ca_topic_score_codex":0.967604,"about_ca_topic_score_gemma":0.9768598,"teacher_disagreement_score":0.054055404,"about_ca_system_score_codex":0.054055404,"about_ca_system_score_gemma":0.047521457,"threshold_uncertainty_score":0.39220124},"labels":[],"label_agreement":null},{"id":"W2037626000","doi":"10.1016/j.jval.2012.08.874","title":"PMD25 Financial Impact of Adaptive Cardiac Resynchronization Therapy (ACRT) Device Algorithms in the United Kigdom, Germany, Australia and Canada: Are There Savings Associated With Device Selection?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Cardiac resynchronization therapy; Medicine; Algorithm; Heart failure; Finance; Emergency medicine; Cardiology; Computer science; Ejection fraction; Business","score_opus":0.06930863501827055,"score_gpt":0.33728759712808537,"score_spread":0.2679789621098148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037626000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93084186,0.00856572,0.0003687988,0.018864354,0.0002834958,0.00016282714,0.018567836,0.00002836617,0.022316735],"genre_scores_gemma":[0.99257576,0.0013876641,0.0003514611,0.00094837457,0.00008274351,0.000033432738,0.0029281862,0.000006068913,0.0016863914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982845,0.0006844498,0.00010834579,0.00009951077,0.000552115,0.00027118926],"domain_scores_gemma":[0.99534166,0.0015727007,0.00082603045,0.0001912774,0.0012857424,0.00078255776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022392143,0.00021124106,0.0003812892,0.00084780203,0.00035399178,0.0017225246,0.000631217,0.00050942885,0.0035192873],"category_scores_gemma":[0.015602078,0.00013369892,0.00065769,0.0018165791,0.0004562622,0.0005547675,0.0006211684,0.00070877786,0.00019280132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008869493,0.00042588083,0.7142921,0.00046714253,0.0010214796,0.00025470965,0.00023970834,0.007289712,0.00038740443,0.0058179204,0.0323861,0.22854833],"study_design_scores_gemma":[0.0005868527,0.00070779043,0.9815501,0.0002874124,0.00057432835,0.00011180505,0.00044313027,0.0040683937,0.00034818053,0.00063147536,0.010661637,0.000028995362],"about_ca_topic_score_codex":0.4801343,"about_ca_topic_score_gemma":0.57495135,"teacher_disagreement_score":0.5198657,"about_ca_system_score_codex":0.0077739647,"about_ca_system_score_gemma":0.010711054,"threshold_uncertainty_score":0.95467925},"labels":[],"label_agreement":null},{"id":"W2037713656","doi":"10.1016/j.jval.2012.08.611","title":"PHP69 United States Valuation of Child Health Outcomes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Valuation (finance); Quality of life (healthcare); Child health; Informatics; Quality-adjusted life year; Health care; Gerontology; Family medicine; Nursing; Cost effectiveness","score_opus":0.5145116243981976,"score_gpt":0.4549319923069301,"score_spread":0.05957963209126754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037713656","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026655419,0.0017265043,0.006015794,0.0035352923,0.00073735305,0.00026100408,0.3752999,0.0012175217,0.5845513],"genre_scores_gemma":[0.43704703,0.0032941997,0.013539717,0.0012227717,0.00064235524,0.0009272034,0.32217118,0.0005830973,0.22057246],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9989705,0.00027016274,0.000047688918,0.00009527425,0.0004946354,0.000121749814],"domain_scores_gemma":[0.99713945,0.0008700858,0.0002575862,0.00030610332,0.0012308735,0.00019593356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016573288,0.000568957,0.0003100862,0.002431542,0.0005219496,0.0015788873,0.00099534,0.00075130025,0.04939521],"category_scores_gemma":[0.0076544606,0.00036621565,0.00048623572,0.0029004482,0.00019464546,0.0011344752,0.0007609722,0.0011671187,0.009432408],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029780724,0.0001478302,0.0078091496,0.00017636403,0.00004632205,0.00016472896,0.00005340296,0.005619715,0.0002688105,0.029280148,0.8740194,0.082116365],"study_design_scores_gemma":[0.00018274522,0.00019402325,0.09110241,0.00033760734,0.0000748286,0.00030505547,0.00021632972,0.021494439,0.0027972409,0.015351731,0.8678748,0.00006873013],"about_ca_topic_score_codex":0.040949363,"about_ca_topic_score_gemma":0.020704435,"teacher_disagreement_score":0.04939521,"about_ca_system_score_codex":0.0018553443,"about_ca_system_score_gemma":0.0017325116,"threshold_uncertainty_score":0.16524345},"labels":[],"label_agreement":null},{"id":"W2037809152","doi":"10.1016/j.jval.2012.04.012","title":"Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":460,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transparency (behavior); Documentation; Face validity; External validity; Computer science; Rigour; Management science; Health care; Medicine; Engineering; Psychology; Political science","score_opus":0.789119629476609,"score_gpt":0.5333343149104329,"score_spread":0.25578531456617604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037809152","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019092765,0.03921876,0.38600728,0.3913155,0.012394424,0.04250233,0.009134345,0.0047939527,0.09554069],"genre_scores_gemma":[0.06024275,0.02959742,0.76120234,0.0579471,0.0033450811,0.041679695,0.01602891,0.004736574,0.025220154],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.33018076,0.316683,0.07576695,0.01525263,0.2470571,0.015059622],"domain_scores_gemma":[0.18997277,0.3957052,0.068771064,0.07125761,0.25627452,0.018018784],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7157676,0.0064853868,0.0060050953,0.017776443,0.011559479,0.03102876,0.022916896,0.029451046,0.00506916],"category_scores_gemma":[0.6536687,0.00695231,0.014162084,0.015362449,0.012926708,0.017774837,0.02935815,0.034976702,0.004751162],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004582783,0.001526505,0.014939801,0.011379397,0.0012969916,0.0011053815,0.019575084,0.018294247,0.0040497705,0.106667,0.49393392,0.3267736],"study_design_scores_gemma":[0.0004240474,0.0007087641,0.0135126505,0.06251744,0.0011390002,0.00087605615,0.00638304,0.022970997,0.0097849425,0.046845756,0.8335907,0.0012466239],"about_ca_topic_score_codex":0.08296526,"about_ca_topic_score_gemma":0.05985683,"teacher_disagreement_score":0.28423238,"about_ca_system_score_codex":0.044661373,"about_ca_system_score_gemma":0.24684231,"threshold_uncertainty_score":0.35050917},"labels":[],"label_agreement":null},{"id":"W2038104538","doi":"10.1016/j.jval.2014.03.1624","title":"Health State Utility Values Of Hiv Infected Patients In Kenya","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Asymptomatic; Human immunodeficiency virus (HIV); Depression (economics); Population; Cohort; Internal medicine; Analysis of variance; Post-hoc analysis; Diarrhea; Immunology; Environmental health","score_opus":0.05912182703972757,"score_gpt":0.4219660423674894,"score_spread":0.36284421532776184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038104538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99865353,0.00008004281,0.00001819021,0.000137403,0.000001211917,0.0000032652183,0.00010302872,3.5597245e-7,0.0010029526],"genre_scores_gemma":[0.99981445,0.000042796753,0.00001653596,0.000010428869,7.6651975e-7,0.0000017307743,0.000032567277,2.2292771e-7,0.00008061247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995449,0.00021468554,0.000039364724,0.000028197566,0.000046834895,0.0001259659],"domain_scores_gemma":[0.9979963,0.00089226925,0.0005866018,0.00003952977,0.00016314171,0.00032210915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006670639,0.000106577754,0.00021942762,0.00058157207,0.0010014194,0.0010476196,0.00025450898,0.00033857557,0.0030749443],"category_scores_gemma":[0.0062214397,0.0001671281,0.00020056346,0.0011379828,0.00052021473,0.0006652447,0.00065827445,0.0007943537,0.00021154218],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022849739,0.00011404334,0.99288416,0.000014065205,0.00002164638,0.00021696468,0.0017193962,0.00020623853,0.00006601762,0.000640662,0.00021744813,0.0036708957],"study_design_scores_gemma":[0.000025821933,0.00037810314,0.9818626,0.00004834636,0.00004681102,0.00066121836,0.0130077,0.0020851754,0.00012490989,0.0009925007,0.0007424082,0.000024303215],"about_ca_topic_score_codex":0.027585162,"about_ca_topic_score_gemma":0.033528447,"teacher_disagreement_score":0.027585162,"about_ca_system_score_codex":0.0017287814,"about_ca_system_score_gemma":0.00086997193,"threshold_uncertainty_score":0.054849148},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2038154696","doi":"10.1016/j.jval.2012.08.1362","title":"PMS7 Biologic Disease-Modifying Anti-Rheumatic Drugs and the Risk of Non-Vertebral Osteoporotic Fractures in Patients With Rheumatoid Arthritis Aged 50 Years and Over","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Osteoporosis; Odds ratio; Confidence interval; Hazard ratio; Rheumatology; Logistic regression; Physical therapy; Surgery","score_opus":0.010155705536033854,"score_gpt":0.2638107750659042,"score_spread":0.2536550695298704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038154696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955597,0.002789607,0.000046068963,0.00014402052,0.00003857055,0.0000058071605,0.00030510436,0.0000033591482,0.0011077422],"genre_scores_gemma":[0.99828076,0.00073952705,0.00004814372,0.00007456084,0.00005717819,0.0000038847547,0.0002506025,0.0000010239959,0.00054442446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997706,0.00007048056,0.000029007482,0.000021293405,0.00006359801,0.00004499516],"domain_scores_gemma":[0.9992962,0.0001685951,0.0003085431,0.000025753925,0.00005368623,0.00014712547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031920636,0.00022797003,0.0004027278,0.00047813702,0.00024466,0.0005071353,0.00019625618,0.00055288477,0.0016960907],"category_scores_gemma":[0.0013194688,0.00024726117,0.0007955449,0.0006363489,0.00015414304,0.00023616846,0.00022455763,0.00065518596,0.00018875353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00101616,0.00007815094,0.9954782,0.000019586483,0.00019106243,0.00012193642,0.00002637407,0.00004559078,0.00024146198,0.000020750482,0.00013404834,0.0026266288],"study_design_scores_gemma":[0.000047020312,0.00030754664,0.99851316,0.0000112622,0.0001847998,0.0003136585,0.00008765429,0.00020266404,0.000043992783,0.000035023535,0.0002491952,0.0000040132036],"about_ca_topic_score_codex":0.0038493325,"about_ca_topic_score_gemma":0.0064510694,"teacher_disagreement_score":0.0038493325,"about_ca_system_score_codex":0.00017918303,"about_ca_system_score_gemma":0.00020971386,"threshold_uncertainty_score":0.0076538324},"labels":[],"label_agreement":null},{"id":"W2038404497","doi":"10.1016/j.jval.2012.08.1991","title":"PND67 The Impact of Memantine and Cholinesterase Inhibitors Initiation for Alzheimer'S Disease on the Use of Antipsychotics Agents: Analysis Using the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Memantine; Antipsychotic; Medical prescription; Galantamine; Medicine; Dementia; Donepezil; Psychiatry; Internal medicine; Pharmacology; Disease; Schizophrenia (object-oriented programming)","score_opus":0.5645188513476347,"score_gpt":0.514326525692037,"score_spread":0.050192325655597725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038404497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483044,0.0015922508,0.00015375814,0.00015172483,0.000014049828,0.00003651474,0.048709888,0.000019088311,0.0010183211],"genre_scores_gemma":[0.96035886,0.00064281264,0.0003248712,0.00010013329,0.00002836152,0.000068767,0.03804027,0.000018275949,0.0004176245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99746644,0.0008400918,0.0004627861,0.0005162328,0.00049849064,0.00021601994],"domain_scores_gemma":[0.9903715,0.0037897783,0.0043707564,0.0005606192,0.0004936314,0.00041379165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019171212,0.00035892698,0.0010813212,0.0020333321,0.00017019114,0.00085474784,0.00087380887,0.00055067067,0.0027655514],"category_scores_gemma":[0.008471069,0.0003514959,0.00329241,0.0038139848,0.00021144519,0.0007034534,0.0008328179,0.00091328914,0.00038029798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039567016,0.00008784678,0.98427665,0.00023194768,0.0036846097,0.00013334797,0.00003978756,0.0007788139,0.00017218765,0.00010422119,0.0015363877,0.0049975696],"study_design_scores_gemma":[0.00026568794,0.00027305624,0.99549896,0.000041743064,0.0011830733,0.00023493457,0.00009851233,0.001199822,0.0000939736,0.00005063263,0.0010453075,0.000014340425],"about_ca_topic_score_codex":0.021639967,"about_ca_topic_score_gemma":0.021321977,"teacher_disagreement_score":0.021639967,"about_ca_system_score_codex":0.0007726766,"about_ca_system_score_gemma":0.00093434856,"threshold_uncertainty_score":0.043028057},"labels":[],"label_agreement":null},{"id":"W2038468017","doi":"10.1016/j.jval.2011.02.749","title":"PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Placebo; Physical therapy; Internal medicine; Rheumatology; Quality of life (healthcare); Absenteeism; Arthritis; Rheumatoid arthritis; Etanercept; Alternative medicine","score_opus":0.10356296293681677,"score_gpt":0.3664057822691256,"score_spread":0.26284281933230885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038468017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898392,0.00661968,0.00019844764,0.0008003219,0.00020449336,0.00015610196,0.00077489053,0.00008108284,0.0013256713],"genre_scores_gemma":[0.99457365,0.002265615,0.00027482014,0.0005682286,0.00022318824,0.000092972,0.00094215927,0.000012812973,0.0010466395],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995154,0.00024249927,0.000034056902,0.00005209953,0.000061141225,0.000094753384],"domain_scores_gemma":[0.99871564,0.0003732733,0.00043535777,0.0000944495,0.000041218744,0.00034003166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012741024,0.0008566558,0.0019502178,0.00030234607,0.00027084714,0.0008783821,0.0003956876,0.00087408995,0.0040895534],"category_scores_gemma":[0.0016790369,0.00040866673,0.0017601395,0.00042135254,0.0006642928,0.0005700402,0.0003577583,0.0025254402,0.0006387426],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8707868,0.00538901,0.015519239,0.00081760954,0.0025970496,0.00020494706,0.00008243263,0.0007913234,0.00842815,0.00017386783,0.003201704,0.09200788],"study_design_scores_gemma":[0.6750988,0.1480089,0.16781639,0.000120891375,0.002344314,0.00072774955,0.00010258891,0.00080553605,0.0014912697,0.00039253052,0.0030224617,0.000068597976],"about_ca_topic_score_codex":0.0005476538,"about_ca_topic_score_gemma":0.0015860458,"teacher_disagreement_score":0.0040895534,"about_ca_system_score_codex":0.00034395355,"about_ca_system_score_gemma":0.00058188057,"threshold_uncertainty_score":0.013680935},"labels":[],"label_agreement":null},{"id":"W2039340241","doi":"10.1016/s1098-3015(10)73442-2","title":"PSS10 ECONOMIC BURDEN OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Dermatology","score_opus":0.21867146087439654,"score_gpt":0.37677347320939225,"score_spread":0.1581020123349957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039340241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9207205,0.0032422417,0.00011510683,0.004433048,0.00007529061,0.00008649317,0.057825286,0.00003130174,0.0134707205],"genre_scores_gemma":[0.9864894,0.00161837,0.00009145722,0.00019265937,0.000025783977,0.000016096637,0.008627352,0.000008711721,0.0029302307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998635,0.00011421616,0.00010199464,0.00010514101,0.00054028694,0.00050339533],"domain_scores_gemma":[0.995362,0.0002678782,0.00084267464,0.0000666227,0.0019990897,0.0014617237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054953806,0.00029499314,0.00061306014,0.0020045913,0.0017930714,0.002207749,0.0009253448,0.00066163315,0.0062985304],"category_scores_gemma":[0.0043764818,0.00030627343,0.0011055224,0.0050139627,0.00057645596,0.00034970738,0.00094390113,0.0014449849,0.0003514175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066803006,0.00007814567,0.96894306,0.00012444142,0.00029498758,0.00041693094,0.0003304908,0.001667851,0.0001512725,0.0019603486,0.014530623,0.01083385],"study_design_scores_gemma":[0.000049219954,0.00003225289,0.9938478,0.00007248463,0.00007578119,0.00017153782,0.0007639336,0.0013418216,0.000038553095,0.00016394137,0.00341715,0.000025568068],"about_ca_topic_score_codex":0.9973579,"about_ca_topic_score_gemma":0.99748945,"teacher_disagreement_score":0.04903446,"about_ca_system_score_codex":0.04903446,"about_ca_system_score_gemma":0.068295635,"threshold_uncertainty_score":0.3557716},"labels":[],"label_agreement":null},{"id":"W2039395549","doi":"10.1016/s1098-3015(10)70193-5","title":"PCN13 BUDGET IMPACT ANALYSIS OF SORAFENIB IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sorafenib; Hepatocellular carcinoma; Oncology; Internal medicine; Medicine; Business","score_opus":0.05953024344832142,"score_gpt":0.25438323346857195,"score_spread":0.19485299002025053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039395549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486133,0.0051868143,0.0014066392,0.0069505353,0.00009981546,0.00037512026,0.02126422,0.00006340948,0.016040068],"genre_scores_gemma":[0.9921731,0.0010191213,0.00047875574,0.00022542491,0.000020563919,0.00005248977,0.0032619846,0.000015822847,0.0027527025],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99674267,0.00086914754,0.00013971509,0.00015555175,0.0007777614,0.0013150905],"domain_scores_gemma":[0.99413884,0.001470901,0.0006684278,0.0001353254,0.0026510758,0.00093546545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031484251,0.00047432815,0.0014968921,0.0017746709,0.0009384933,0.0022650633,0.001221108,0.0007090238,0.0040134676],"category_scores_gemma":[0.012345865,0.0005202261,0.001476973,0.004425024,0.0005934895,0.00047963244,0.00084583473,0.0014306075,0.00015214876],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053969407,0.0005037924,0.18865958,0.00065255765,0.0017399768,0.0006482483,0.00026942854,0.7104583,0.0006715381,0.019141529,0.023857042,0.048001092],"study_design_scores_gemma":[0.0019351682,0.0007022535,0.5308745,0.00037732493,0.0016288634,0.00026209396,0.001552323,0.43067977,0.0012516669,0.0044960813,0.026055474,0.00018455304],"about_ca_topic_score_codex":0.9899157,"about_ca_topic_score_gemma":0.99049777,"teacher_disagreement_score":0.90617627,"about_ca_system_score_codex":0.09382372,"about_ca_system_score_gemma":0.08620407,"threshold_uncertainty_score":0.6807419},"labels":[],"label_agreement":null},{"id":"W2039558840","doi":"10.1016/j.jval.2013.10.009","title":"Health Utility Scores in Alzheimer’s Disease: Differences Based on Calculation With American and Canadian Preference Weights","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Intraclass correlation; Preference; Medicine; Quality of life (healthcare); Demography; Population; EQ-5D; Correlation; Gerontology; Disease; Physical therapy; Psychometrics; Clinical psychology; Statistics; Health related quality of life; Environmental health; Mathematics; Internal medicine","score_opus":0.35809334277501637,"score_gpt":0.38547374206667473,"score_spread":0.027380399291658364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039558840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93968546,0.0033381477,0.018881178,0.0010625545,0.00027244707,0.0002666142,0.007145644,0.000106793115,0.029241117],"genre_scores_gemma":[0.98945904,0.00057574135,0.006520416,0.000074150026,0.000010199931,0.00005908554,0.0018182211,0.000029209934,0.0014540574],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9951036,0.0017859659,0.000324474,0.0002120085,0.0021922162,0.00038176237],"domain_scores_gemma":[0.99133486,0.003760734,0.00047168395,0.00044583075,0.003422382,0.00056457537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008531769,0.0005364686,0.00052069046,0.0036018381,0.0007820663,0.0017739522,0.0011562213,0.0004028328,0.0030503133],"category_scores_gemma":[0.051122185,0.00022370862,0.001456158,0.0047523757,0.000705168,0.00096621603,0.0013063288,0.0010818957,0.0002793398],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006091517,0.00031566134,0.600043,0.00064135453,0.0017649609,0.0002331314,0.004080803,0.018194398,0.0012490277,0.034095462,0.030101847,0.3031889],"study_design_scores_gemma":[0.00026733035,0.00034361595,0.94017994,0.0003325562,0.00074198964,0.00035921257,0.002482276,0.032477148,0.001055241,0.010502452,0.0110622,0.00019598038],"about_ca_topic_score_codex":0.8474867,"about_ca_topic_score_gemma":0.831998,"teacher_disagreement_score":0.15251333,"about_ca_system_score_codex":0.010036869,"about_ca_system_score_gemma":0.0064705913,"threshold_uncertainty_score":0.30682296},"labels":[],"label_agreement":null},{"id":"W2039662438","doi":"10.1016/j.jval.2013.03.1170","title":"Use Of Biologic Agents In The Treatment Of Rheumatoid Arthritis: An Analysis Of The Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Adalimumab; Golimumab; Etanercept; Infliximab; Ustekinumab; Tocilizumab; Abatacept; Concomitant; Rheumatoid arthritis; Psoriatic arthritis; Internal medicine; Psoriasis; Rituximab; Reimbursement; Physical therapy; Dermatology; Health care; Tumor necrosis factor alpha","score_opus":0.080934973597592,"score_gpt":0.3508776962823573,"score_spread":0.2699427226847653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039662438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71794075,0.0061633163,0.00044414977,0.002205771,0.000046012126,0.00040636223,0.2654875,0.00009126968,0.007214823],"genre_scores_gemma":[0.9167578,0.0026684983,0.00092887646,0.0006304561,0.000035419132,0.00026532015,0.07633963,0.00003202135,0.002342042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618465,0.00058813434,0.00048294093,0.0004089524,0.0018666404,0.000468727],"domain_scores_gemma":[0.97748137,0.004543772,0.006060718,0.0007624918,0.009439163,0.0017125211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022837361,0.00038033025,0.0009570938,0.0052356096,0.0013117846,0.0014797759,0.0018822504,0.0007195213,0.0041328534],"category_scores_gemma":[0.016985612,0.00034220616,0.0011538166,0.018533831,0.0003454817,0.0005774609,0.000760109,0.0008560361,0.00042035917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038089097,0.0000641429,0.9718739,0.00025544484,0.0004033477,0.000094467374,0.00020917352,0.00059811457,0.00008387668,0.00025286255,0.016561566,0.009222289],"study_design_scores_gemma":[0.000041412775,0.000023040187,0.99357843,0.00009568525,0.00011735773,0.000071882816,0.00019055945,0.0018163975,0.000049230224,0.00002115559,0.0039799665,0.00001486062],"about_ca_topic_score_codex":0.98722595,"about_ca_topic_score_gemma":0.9897939,"teacher_disagreement_score":0.039628513,"about_ca_system_score_codex":0.039628513,"about_ca_system_score_gemma":0.039983653,"threshold_uncertainty_score":0.2875263},"labels":[],"label_agreement":null},{"id":"W2039766872","doi":"10.1016/j.jval.2014.03.1589","title":"Assessment Of Real-Life Predictive Power Of A New Cost-Effectiveness Model In Hiv: Antiretroviral Analysis By Monte Carlo Individual Simulation (ARAMIS-DTG)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Observational study; Cohort; Incidence (geometry); Cohort study; Population; Human immunodeficiency virus (HIV); Demography; Internal medicine; Immunology; Environmental health","score_opus":0.06561090207368656,"score_gpt":0.41923851700285714,"score_spread":0.3536276149291706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039766872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.869472,0.0012109622,0.120215125,0.001127244,0.00009994112,0.00032642452,0.000800043,0.00031530164,0.006433001],"genre_scores_gemma":[0.9820848,0.00016600241,0.016949533,0.0000816462,0.000014160338,0.000116072864,0.00017066437,0.000022516775,0.00039461136],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983308,0.0012756045,0.000046594436,0.0001121071,0.00013896647,0.00009592669],"domain_scores_gemma":[0.97077304,0.027306693,0.00054396695,0.00046668964,0.0006451111,0.00026437055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007861444,0.00080132886,0.0013004724,0.00096946565,0.0003226865,0.0013559607,0.0013319725,0.001648071,0.0019737724],"category_scores_gemma":[0.02156162,0.0005918152,0.0009922236,0.00075037155,0.0005311868,0.0010572184,0.0006724176,0.0015296319,0.00014051683],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000303058,0.00006411734,0.0010855547,0.000031593554,0.00005764997,0.000018180392,0.000011341597,0.994466,0.00006943,0.0010257768,0.00009642757,0.002770934],"study_design_scores_gemma":[0.000050611758,0.000112941016,0.0002981465,0.000009305655,0.000029260984,0.000009492142,0.0000046810965,0.99868315,0.00007296542,0.0006623135,0.00006119404,0.0000059546246],"about_ca_topic_score_codex":0.014130588,"about_ca_topic_score_gemma":0.006203249,"teacher_disagreement_score":0.014130588,"about_ca_system_score_codex":0.0018111547,"about_ca_system_score_gemma":0.002035893,"threshold_uncertainty_score":0.04157585},"labels":[],"label_agreement":null},{"id":"W2039799345","doi":"10.1016/j.jval.2014.03.1178","title":"Survival crossover adjustment and cost effectiveness analysis: An empirical and methodological review with application","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McMaster University","funders":"","keywords":"Crossover; Crossover study; Weighting; Ranking (information retrieval); Meta-analysis; Medicine; Statistics; Inverse probability weighting; Survival analysis; MEDLINE; Study heterogeneity; Placebo; Internal medicine; Computer science; Mathematics; Propensity score matching; Alternative medicine; Artificial intelligence; Pathology","score_opus":0.578580919710754,"score_gpt":0.5312975249278556,"score_spread":0.047283394782898336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039799345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042050155,0.9704442,0.020754155,0.002063306,0.00045526435,0.00027814708,0.00042538706,0.000034234945,0.0013403607],"genre_scores_gemma":[0.1721042,0.7781584,0.04052742,0.0035103692,0.002566882,0.001338088,0.00096530735,0.00013081181,0.0006984355],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96880037,0.02329748,0.003128301,0.0016748124,0.0028073934,0.00029159887],"domain_scores_gemma":[0.720328,0.26332894,0.008140633,0.0041988273,0.0036174378,0.00038623426],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.056138456,0.0010629867,0.0049453946,0.0052427496,0.00034515088,0.0026101833,0.002140472,0.0019173211,0.006282455],"category_scores_gemma":[0.17417741,0.0006261894,0.0077259694,0.010647115,0.0021359182,0.0026538924,0.001484996,0.0034129152,0.0002654638],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003861402,0.00023255384,0.00912655,0.064545095,0.018651586,0.00007833859,0.00035445418,0.008196,0.0001580206,0.03289805,0.008702085,0.85319585],"study_design_scores_gemma":[0.00879061,0.0068960334,0.08613875,0.15024684,0.14620002,0.003361073,0.0009942222,0.041426957,0.0024702137,0.31419924,0.23850618,0.00076989527],"about_ca_topic_score_codex":0.003210088,"about_ca_topic_score_gemma":0.0024316912,"teacher_disagreement_score":0.94386154,"about_ca_system_score_codex":0.002972414,"about_ca_system_score_gemma":0.0033252127,"threshold_uncertainty_score":0.2968921},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2040123860","doi":"10.1016/j.jval.2014.03.385","title":"Reimbursement Based Economics: An Application To Triptans For Migraine Therapy","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Triptans; Reimbursement; Migraine; Health economics; Activity-based costing; Business; Public economics; Medicine; Actuarial science; Health care; Economics; Marketing; Psychiatry; Economic growth","score_opus":0.405138943961024,"score_gpt":0.4416399727600366,"score_spread":0.03650102879901257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040123860","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15246038,0.026042847,0.59260166,0.10636992,0.0036487682,0.0013357883,0.0018010602,0.0009912319,0.11474838],"genre_scores_gemma":[0.8365022,0.0105288625,0.12480892,0.0040742396,0.002404244,0.000563351,0.00038226898,0.0002461495,0.020489687],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968569,0.0021887932,0.00013022707,0.00017703805,0.00047372415,0.00017327143],"domain_scores_gemma":[0.97815543,0.01963026,0.00046537202,0.00032761393,0.0009487697,0.00047255543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006423134,0.0012811042,0.0015931786,0.0021026933,0.0013270488,0.004086187,0.0011818317,0.005545576,0.010958627],"category_scores_gemma":[0.04254409,0.0005690807,0.001634384,0.0031246063,0.0022444031,0.0037531469,0.0026133535,0.004676841,0.00047117574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037580586,0.00045359033,0.009613609,0.00041173122,0.00017824571,0.0010757078,0.00034909532,0.12160535,0.0003917746,0.6883228,0.04059532,0.13662697],"study_design_scores_gemma":[0.00039924248,0.00023180475,0.00654679,0.00029452756,0.00022252576,0.0005678678,0.00051621447,0.34775883,0.0002793058,0.6180869,0.024985673,0.000110422145],"about_ca_topic_score_codex":0.023440998,"about_ca_topic_score_gemma":0.014408504,"teacher_disagreement_score":0.023440998,"about_ca_system_score_codex":0.0046412223,"about_ca_system_score_gemma":0.005222352,"threshold_uncertainty_score":0.046609104},"labels":[],"label_agreement":null},{"id":"W2040162225","doi":"10.1016/j.jval.2014.08.2668","title":"Parents’ Willingness to Pay for Biologic Treatments in Juvenile Idiopathic Arthritis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; SickKids Foundation; University of Toronto; Institute for Clinical Evaluative Sciences; Public Health Ontario; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Willingness to pay; Medicine; Confidence interval; Arthritis; Logistic regression; Physical therapy; Mixed logit; Internal medicine; Economics","score_opus":0.0550804887820391,"score_gpt":0.342290654409629,"score_spread":0.28721016562758994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040162225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955511,0.00038257035,0.0000444847,0.0016948916,0.000022930033,0.0000025767224,0.000061936305,0.0000010823981,0.0022384392],"genre_scores_gemma":[0.9996631,0.00005669661,0.000019402762,0.00007299238,0.0000051337483,0.0000011311321,0.000015677004,5.8714375e-7,0.00016532897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867344,0.000771681,0.00008399933,0.00006992198,0.0001978703,0.00020305703],"domain_scores_gemma":[0.98125994,0.011041616,0.004713767,0.00032536458,0.00074275606,0.001916556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020053487,0.00008858977,0.00017458544,0.00044530438,0.00053479633,0.001009786,0.00025483096,0.00096538564,0.005532176],"category_scores_gemma":[0.024196899,0.00017578898,0.00033618129,0.00045461595,0.0005966338,0.00077017065,0.0004458672,0.0017563392,0.00024101578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041072824,0.0002916073,0.9796021,0.000027567348,0.00008178373,0.0008100475,0.0044876654,0.00020864618,0.00021612113,0.000732242,0.0011658706,0.011965607],"study_design_scores_gemma":[0.000033888253,0.0002101293,0.9827145,0.000067196466,0.00006414072,0.0013596558,0.011595111,0.0010947116,0.00017723744,0.0011683685,0.0014876751,0.000027329175],"about_ca_topic_score_codex":0.010075551,"about_ca_topic_score_gemma":0.009423288,"teacher_disagreement_score":0.010075551,"about_ca_system_score_codex":0.0010569507,"about_ca_system_score_gemma":0.00054790004,"threshold_uncertainty_score":0.020033777},"labels":[],"label_agreement":null},{"id":"W2040419430","doi":"10.1016/s1098-3015(10)63173-7","title":"CV3 COST-EFFECTIVENESSS OF INTENSIVE STATIN THERAPY COMPARED TO MODERATE STATIN THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: ANALYSIS FROM CANADA, GERMANY AND THE UK","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute coronary syndrome; Medicine; Statin; Internal medicine; Cardiology; Physical therapy; Myocardial infarction","score_opus":0.01443540087236686,"score_gpt":0.25798223398127923,"score_spread":0.24354683310891237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040419430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98135054,0.011700965,0.00008440589,0.00057568407,0.000039692284,0.00005610817,0.004784438,0.000007602284,0.001400583],"genre_scores_gemma":[0.9948974,0.0019883679,0.00008742305,0.00017479583,0.000022756067,0.000018775465,0.002562053,0.0000043492346,0.00024413173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977647,0.00078045274,0.00025538047,0.0001943197,0.00047576582,0.0005293463],"domain_scores_gemma":[0.9941262,0.0024591824,0.0012974303,0.00022746918,0.0009222145,0.0009674832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015144381,0.00052342407,0.0021213526,0.0011831366,0.0006101784,0.0017042924,0.0010664683,0.0011214702,0.0018807864],"category_scores_gemma":[0.010062965,0.00048953807,0.004238531,0.003929363,0.00075253774,0.00049221003,0.00086164044,0.0014820019,0.00008963317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0532707,0.00029586672,0.88441986,0.0017607121,0.017839469,0.00063042913,0.0003659047,0.012581641,0.00038071643,0.00083814625,0.00369625,0.023920314],"study_design_scores_gemma":[0.0017880094,0.0007133376,0.9880248,0.0002771134,0.0046377853,0.00021709019,0.0004069923,0.0028863999,0.00008929012,0.00015974743,0.0007266817,0.000072823255],"about_ca_topic_score_codex":0.8171444,"about_ca_topic_score_gemma":0.80964607,"teacher_disagreement_score":0.1828556,"about_ca_system_score_codex":0.015048367,"about_ca_system_score_gemma":0.0098870415,"threshold_uncertainty_score":0.3678649},"labels":[],"label_agreement":null},{"id":"W2041764633","doi":"10.1016/s1098-3015(10)74033-x","title":"PND26 UTILITIES FOR MODERATE ALZHEIMER'S DISEASE: RESULTS FROM A SURVEY OF THE GENERAL PUBLIC IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Gerontology; Medicine; Geography; Pathology","score_opus":0.05602174317592969,"score_gpt":0.28365728067656093,"score_spread":0.22763553750063123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041764633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773073,0.00083689153,0.000110671084,0.0006057879,0.00001240508,0.00007652938,0.017503273,0.000015887506,0.0035313873],"genre_scores_gemma":[0.99369955,0.00070997095,0.00014019315,0.00018374764,0.0000058607716,0.00002450646,0.003949144,0.000006400255,0.0012807635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867696,0.00012374611,0.00011349433,0.00015642766,0.0005139941,0.00041539271],"domain_scores_gemma":[0.9963923,0.00020312135,0.00059491105,0.0000673365,0.0017976284,0.00094462326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007996236,0.0003724612,0.0005619145,0.0017846029,0.0016539107,0.001270271,0.0011717717,0.0005882459,0.0020481222],"category_scores_gemma":[0.0031723236,0.00034980208,0.0010574033,0.0069313776,0.00067789195,0.00043956251,0.0009127833,0.00095603836,0.00028331313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005658965,0.00003769252,0.9963899,0.000019915273,0.0000339217,0.0000360759,0.00028781273,0.000103423336,0.000032500047,0.0000755736,0.0009986601,0.0019278409],"study_design_scores_gemma":[0.0000061064634,0.000015950252,0.9987991,0.0000112813805,0.000012568593,0.000019754267,0.00049306115,0.00016758636,0.000012345187,0.000014712684,0.0004419578,0.0000054773914],"about_ca_topic_score_codex":0.99555475,"about_ca_topic_score_gemma":0.995811,"teacher_disagreement_score":0.028722173,"about_ca_system_score_codex":0.028722173,"about_ca_system_score_gemma":0.02193341,"threshold_uncertainty_score":0.20839494},"labels":[],"label_agreement":null},{"id":"W2041778976","doi":"10.1016/j.jval.2012.08.813","title":"PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Risperidone; Medicine; Paliperidone; Olanzapine; Schizophrenia (object-oriented programming); Emergency medicine; Pediatrics; Psychiatry","score_opus":0.11804106600118082,"score_gpt":0.41254212276617264,"score_spread":0.29450105676499183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041778976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565686,0.00922153,0.0007087225,0.00043093364,0.00005157972,0.00032936034,0.0021946125,0.0000151775885,0.0013912818],"genre_scores_gemma":[0.99728715,0.0009032454,0.00045637053,0.00006101073,0.000026477694,0.00011860798,0.0009772594,0.00000264536,0.00016714193],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963425,0.0026032173,0.00021743652,0.00021032307,0.000288343,0.0003380934],"domain_scores_gemma":[0.99717796,0.0020807052,0.0003415088,0.000073367504,0.000115198505,0.00021125298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003478077,0.0009886152,0.0018032616,0.0012422825,0.0002645711,0.0014308514,0.00072443014,0.001122322,0.0038299703],"category_scores_gemma":[0.008559107,0.00053731195,0.006419374,0.0013075517,0.00034988063,0.0009204701,0.00079524255,0.0007878341,0.00014630651],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43436712,0.002826224,0.12117555,0.011982458,0.06469411,0.0027244699,0.00036124195,0.21033181,0.00492601,0.0030584894,0.0024439276,0.14110866],"study_design_scores_gemma":[0.11201163,0.089859545,0.52748233,0.0021324216,0.12320616,0.003485652,0.0012058463,0.124771394,0.004771378,0.0023161448,0.008217611,0.00053983583],"about_ca_topic_score_codex":0.012753399,"about_ca_topic_score_gemma":0.007091508,"teacher_disagreement_score":0.012753399,"about_ca_system_score_codex":0.0045995316,"about_ca_system_score_gemma":0.0028295224,"threshold_uncertainty_score":0.033372045},"labels":[],"label_agreement":null},{"id":"W2042085280","doi":"10.1016/j.jval.2013.03.1631","title":"Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Lawson Health Research Institute; Centre for Advancing Health Outcomes; Western University","funders":"","keywords":"Medicine; Psychological intervention; Medication adherence; MEDLINE; Randomized controlled trial; Clinical trial; Intensive care medicine; Blood pressure; Intervention (counseling); Alternative medicine; Narrative review; Family medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.11344278995458666,"score_gpt":0.36572879870923475,"score_spread":0.2522860087546481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042085280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030044387,0.995814,0.000107558815,0.00016923089,0.00015391875,0.0003049801,0.00023441843,0.000010553403,0.00020097144],"genre_scores_gemma":[0.05804838,0.9392395,0.0012137962,0.00060463033,0.00011750506,0.00043065532,0.00015857126,0.000006551106,0.00018043793],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99546546,0.001521417,0.0015057742,0.0004393711,0.000876903,0.00019106873],"domain_scores_gemma":[0.9909803,0.0064380523,0.0016450046,0.00013105737,0.0006146083,0.0001909004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053251465,0.0012995333,0.009581592,0.003250133,0.00043949002,0.0018308121,0.0012829792,0.001980614,0.0038491823],"category_scores_gemma":[0.019438583,0.00094675267,0.0112310285,0.003503051,0.00050095073,0.0013265124,0.001122445,0.0022220598,0.00019047307],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002329686,0.0001326395,0.0014007206,0.8594533,0.072516315,0.00009725904,0.00020446505,0.00014085657,0.00024809854,0.00015207425,0.0012035177,0.06212115],"study_design_scores_gemma":[0.005514387,0.0014843094,0.013841281,0.34704822,0.61790675,0.00025751046,0.00034991626,0.0002487662,0.00033110945,0.00025039088,0.01268976,0.00007760647],"about_ca_topic_score_codex":0.010322549,"about_ca_topic_score_gemma":0.031811275,"teacher_disagreement_score":0.010322549,"about_ca_system_score_codex":0.002239993,"about_ca_system_score_gemma":0.0046158447,"threshold_uncertainty_score":0.02816242},"labels":[],"label_agreement":null},{"id":"W2042180137","doi":"10.1016/s1098-3015(11)72413-5","title":"PCV70 COST SAVINGS OF ENOXAPARIN OVER UFH IN MEDICAL PATIENTS IN CANADIAN HOSPITAL SETTING","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Emergency medicine; Medical costs; Operations management; Business; Economics; Health care","score_opus":0.018170281145432798,"score_gpt":0.3092774166623963,"score_spread":0.2911071355169635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042180137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98462003,0.0033414478,0.00012809463,0.0038130644,0.000058010024,0.00005106874,0.00097129575,0.000018877405,0.0069981962],"genre_scores_gemma":[0.9978296,0.00069859304,0.00019389564,0.00026521404,0.000025819118,0.0000060520338,0.00022317996,0.0000027569165,0.0007548619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993637,0.000097284705,0.000027014832,0.00004357111,0.00017323469,0.00029513912],"domain_scores_gemma":[0.99924064,0.00012660731,0.00010030087,0.0000115497405,0.0001589589,0.00036202258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037198904,0.00025311607,0.00037578898,0.00050375506,0.00090365816,0.0011031785,0.00051517825,0.00056894426,0.004055518],"category_scores_gemma":[0.0026234877,0.00014291181,0.0006483862,0.000980465,0.00033182892,0.00032999663,0.00039998812,0.00067278615,0.00011861649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020178573,0.0011513499,0.57709485,0.0006691878,0.0008571509,0.002431805,0.00077664916,0.012892269,0.0030246356,0.004545017,0.033783223,0.34259537],"study_design_scores_gemma":[0.0006826266,0.0015872308,0.97251904,0.00019765711,0.0005363386,0.0013181202,0.0018780462,0.00855425,0.0009344211,0.00048894534,0.01122925,0.00007404265],"about_ca_topic_score_codex":0.8708139,"about_ca_topic_score_gemma":0.91513413,"teacher_disagreement_score":0.1291861,"about_ca_system_score_codex":0.028838899,"about_ca_system_score_gemma":0.021865802,"threshold_uncertainty_score":0.25989377},"labels":[],"label_agreement":null},{"id":"W2042215339","doi":"10.1016/s1098-3015(11)70806-3","title":"PMDH6: AN ECONOMIC EVALUATION OF PHARMACEUTICAL COST CONTAINMENT POLICIES IN ALBERTA, CANADA","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Containment (computer programming); Business; Computer science","score_opus":0.13911449783376312,"score_gpt":0.3716451540720326,"score_spread":0.23253065623826946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042215339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9416243,0.0028479758,0.0013621066,0.004738655,0.0001668705,0.0010623664,0.014167045,0.00013713726,0.03389345],"genre_scores_gemma":[0.9820287,0.0013366819,0.0019840444,0.00043246482,0.000043138374,0.00014716176,0.0048016054,0.000021807282,0.009204429],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9950877,0.0016064555,0.00018770328,0.00023399248,0.0018045716,0.0010796017],"domain_scores_gemma":[0.9924279,0.0024257805,0.00048739696,0.00021352315,0.0033060913,0.001139273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006176275,0.0012095049,0.0011486165,0.0029262868,0.0026112713,0.0039866585,0.0026241927,0.0017865917,0.0036952363],"category_scores_gemma":[0.0157094,0.0006628102,0.0009940392,0.004975039,0.0018236188,0.0011371629,0.001766167,0.0019690674,0.00022015396],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01586318,0.003526873,0.11245649,0.0016190407,0.0010054483,0.0009716611,0.0006405131,0.68198633,0.0012902813,0.03680406,0.05621208,0.08762395],"study_design_scores_gemma":[0.009576433,0.0045378455,0.30338836,0.00059661083,0.0014882826,0.0002717743,0.0073110242,0.60794854,0.0035723092,0.009584076,0.051177073,0.0005476401],"about_ca_topic_score_codex":0.99285865,"about_ca_topic_score_gemma":0.9929437,"teacher_disagreement_score":0.867141,"about_ca_system_score_codex":0.132859,"about_ca_system_score_gemma":0.1280626,"threshold_uncertainty_score":0.9639641},"labels":[],"label_agreement":null},{"id":"W2042321639","doi":"10.1016/j.jval.2014.03.1629","title":"Determinants Of Quality Of Life In Newly Diagnosed Hiv Infected Patients In Kenya","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Depression (economics); Anxiety; Internal medicine; Diarrhea; Appetite; Disease; Human immunodeficiency virus (HIV); Coping (psychology); Physical therapy; Psychiatry; Immunology","score_opus":0.060584411557581694,"score_gpt":0.3959434982699557,"score_spread":0.33535908671237397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042321639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990101,0.0002617984,0.000009871314,0.00020446202,0.0000040536793,0.0000053881718,0.00010247256,4.273423e-7,0.00040142628],"genre_scores_gemma":[0.99973005,0.000117268806,0.000014775718,0.000025290632,0.000002785143,0.0000025591764,0.000048283877,2.8047273e-7,0.000058775007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996117,0.00012971339,0.0000415793,0.000031434705,0.000046108173,0.00013948182],"domain_scores_gemma":[0.9985511,0.00029504937,0.0006159152,0.00001836871,0.00008004948,0.0004396638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035712213,0.0001710084,0.00028298862,0.00047525164,0.0010340824,0.0008902849,0.00032507582,0.00043832543,0.0016415666],"category_scores_gemma":[0.0028496643,0.0002525455,0.0002829838,0.000843019,0.0004038885,0.00051606883,0.0005504812,0.0012296799,0.00010962415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007804616,0.000095047544,0.99789834,0.000012201326,0.000019060846,0.00010594364,0.00040013704,0.000024128301,0.00005809253,0.00005198539,0.00011639672,0.0011405766],"study_design_scores_gemma":[0.0000093774015,0.000095553034,0.9976756,0.00001882488,0.000016716613,0.00013773987,0.0017162984,0.00012362098,0.000022407046,0.000036504534,0.00014106587,0.000006249163],"about_ca_topic_score_codex":0.037946533,"about_ca_topic_score_gemma":0.05931346,"teacher_disagreement_score":0.037946533,"about_ca_system_score_codex":0.0013917424,"about_ca_system_score_gemma":0.0011031243,"threshold_uncertainty_score":0.075451314},"labels":[],"label_agreement":null},{"id":"W2042503957","doi":"10.1016/s1098-3015(10)75091-9","title":"PIN33 POTENTIAL HEALTH AND ECONOMIC IMPACT OF NEW PNEUMOCOCCAL VACCINES IN CANADA: A MARKOV MODELLING APPROACH","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Markov chain; Markov model; Pneumococcal disease; Medicine; Virology; Computer science; Streptococcus pneumoniae; Biology; Machine learning; Microbiology","score_opus":0.034273044790419614,"score_gpt":0.29680151148760725,"score_spread":0.26252846669718766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042503957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8422195,0.0036169451,0.039594706,0.016386209,0.00024428454,0.00061592757,0.027943814,0.00036898817,0.06900959],"genre_scores_gemma":[0.9756866,0.0014452194,0.0030163287,0.00027141432,0.00003877224,0.0001371097,0.0021219165,0.000033320008,0.017249381],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99881613,0.00029975697,0.00003573057,0.00013770848,0.00019933794,0.0005113808],"domain_scores_gemma":[0.9961647,0.0023215355,0.0003104039,0.000094772535,0.0007571409,0.00035147215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022055148,0.0008052192,0.0014095805,0.0021821973,0.0017385174,0.003477472,0.0021338551,0.0022931776,0.008102861],"category_scores_gemma":[0.0084872935,0.0010740852,0.0019183343,0.0027909318,0.0010449786,0.001244583,0.0008871222,0.0023332748,0.0004197971],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021660632,0.000059864065,0.015040758,0.00006994241,0.00014945015,0.000240253,0.00009971661,0.948267,0.00014204373,0.025692007,0.0038823455,0.006140089],"study_design_scores_gemma":[0.00007957096,0.000042336374,0.007989781,0.00004846373,0.00013560786,0.000038987,0.00018335218,0.978525,0.00011615483,0.0098228445,0.0029646794,0.000053131193],"about_ca_topic_score_codex":0.98022467,"about_ca_topic_score_gemma":0.96924734,"teacher_disagreement_score":0.04412082,"about_ca_system_score_codex":0.04412082,"about_ca_system_score_gemma":0.044500805,"threshold_uncertainty_score":0.32012045},"labels":[],"label_agreement":null},{"id":"W2042746249","doi":"10.1016/s1098-3015(10)64509-3","title":"PMH8 COST-EFFECTIVENESS OF VENLAFAXINE: A CANADIAN PERSPECTIVE","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venlafaxine; Perspective (graphical); Medicine; Psychiatry; Computer science; Artificial intelligence; Anxiety","score_opus":0.09630133463843947,"score_gpt":0.3330484847993053,"score_spread":0.23674715016086584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042746249","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071240775,0.2059407,0.002440047,0.48057783,0.0014383947,0.00013969048,0.00859846,0.000073722644,0.22955039],"genre_scores_gemma":[0.83636993,0.11866204,0.0038537455,0.02188751,0.0025674575,0.00007670336,0.001782508,0.000056759596,0.014743431],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99517125,0.0013103297,0.00020124338,0.00028643614,0.00199911,0.0010317038],"domain_scores_gemma":[0.9901125,0.0030277695,0.00065949,0.000109735265,0.004888961,0.0012015973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004822995,0.0010111531,0.0016166045,0.0030869085,0.0018710473,0.0046358174,0.0024988863,0.0033973034,0.011229886],"category_scores_gemma":[0.016545191,0.000425422,0.0018678743,0.0038843674,0.0021004495,0.0011663551,0.00067929726,0.0035620485,0.0003010058],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007753699,0.00039984196,0.0306377,0.004343155,0.002785802,0.0016359309,0.0007261362,0.07364493,0.0025410256,0.33949697,0.17979836,0.35623634],"study_design_scores_gemma":[0.0046229432,0.0018056057,0.21473429,0.009386318,0.008127819,0.0022226162,0.004159695,0.05079952,0.0028281796,0.13826798,0.562088,0.0009570236],"about_ca_topic_score_codex":0.9742697,"about_ca_topic_score_gemma":0.9762532,"teacher_disagreement_score":0.109897144,"about_ca_system_score_codex":0.109897144,"about_ca_system_score_gemma":0.104151495,"threshold_uncertainty_score":0.79736334},"labels":[],"label_agreement":null},{"id":"W2042960958","doi":"10.1016/j.jval.2012.09.005","title":"Cost-Effectiveness of Gene-Expression Profiling for Tumor-Site Origin","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Medicaid; Confidence interval; Regimen; Internal medicine; Observational study; Chemotherapy; Medical diagnosis; Chemotherapy regimen; Oncology; Emergency medicine; Health care; Pathology","score_opus":0.10286865395309963,"score_gpt":0.38247872336414457,"score_spread":0.27961006941104494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042960958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946974,0.016653212,0.019166622,0.0049055717,0.00020173266,0.00027596395,0.0022013024,0.00012215243,0.009499538],"genre_scores_gemma":[0.99499124,0.000935819,0.0032069765,0.00013942437,0.000039864462,0.000027522368,0.00026092355,0.000008386934,0.00038983364],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835384,0.0010086622,0.000058113506,0.0001330404,0.00035001672,0.000096347176],"domain_scores_gemma":[0.9931758,0.0057179946,0.00046881757,0.00016919253,0.00027765054,0.00019059688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018168074,0.0004835526,0.00080939056,0.00092768634,0.00016309883,0.0010636734,0.0004646664,0.00061687187,0.0044154217],"category_scores_gemma":[0.01099787,0.00013477361,0.0009930275,0.0008599787,0.00023941825,0.0006577182,0.00040981098,0.0004910408,0.00025391395],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02317363,0.0012504564,0.2209729,0.0007398697,0.0011608998,0.0004914394,0.00013168444,0.05680344,0.010118956,0.004248301,0.0032397027,0.6776687],"study_design_scores_gemma":[0.0015775557,0.010673324,0.55644363,0.0006919147,0.004708869,0.0024922532,0.00096543255,0.3770978,0.018027648,0.01705489,0.010090786,0.00017589414],"about_ca_topic_score_codex":0.0026745955,"about_ca_topic_score_gemma":0.002937498,"teacher_disagreement_score":0.0044154217,"about_ca_system_score_codex":0.0012111235,"about_ca_system_score_gemma":0.0010451886,"threshold_uncertainty_score":0.014771044},"labels":[],"label_agreement":null},{"id":"W2043068352","doi":"10.1111/j.1524-4733.2010.00747.x","title":"Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Field (mathematics); Data science; Computer science; Mathematics","score_opus":0.34842160670139555,"score_gpt":0.5381083385528902,"score_spread":0.18968673185149465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043068352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6865223,0.004036976,0.023730885,0.06949235,0.000442828,0.021597344,0.057691813,0.0025727993,0.13391265],"genre_scores_gemma":[0.86137426,0.0017579483,0.054020286,0.007016389,0.00012247264,0.009245379,0.015766736,0.00022162173,0.05047484],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9868961,0.0053048176,0.00087218307,0.0009021359,0.0038353044,0.0021893897],"domain_scores_gemma":[0.93492186,0.020034242,0.0043498673,0.005565226,0.020608176,0.014520682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027017036,0.00043443724,0.00050914875,0.0014610437,0.0035918376,0.0024797102,0.0035029976,0.0019039134,0.015936606],"category_scores_gemma":[0.056051683,0.000756542,0.0008778111,0.0022847936,0.0014066397,0.0016966083,0.00480488,0.0015780132,0.0012262459],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011104462,0.0035479232,0.23626009,0.0027465648,0.0005354785,0.00069305726,0.0049954713,0.0075371545,0.003322488,0.020144837,0.22445516,0.48465726],"study_design_scores_gemma":[0.0072121173,0.0043223645,0.7446213,0.0014322286,0.00085438957,0.00041971172,0.0017209376,0.013029626,0.0033690112,0.0067221406,0.21609782,0.00019838335],"about_ca_topic_score_codex":0.8460731,"about_ca_topic_score_gemma":0.93641543,"teacher_disagreement_score":0.9535584,"about_ca_system_score_codex":0.046441622,"about_ca_system_score_gemma":0.31403175,"threshold_uncertainty_score":0.33695912},"labels":[],"label_agreement":null},{"id":"W2043105813","doi":"10.1111/j.1524-4733.2009.00565.x","title":"Why Do Patients with Inflammatory Arthritis Often Score States “Worse than Death” on the EQ-5D? An Investigation of the EQ-5D Classification System","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"Versus Arthritis","keywords":"EQ-5D; Medicine; Arthritis; Quality of life (healthcare); Feeling; Physical therapy; Internal medicine; Health related quality of life; Disease; Psychology","score_opus":0.3782288335853667,"score_gpt":0.3338093192686601,"score_spread":0.0444195143167066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043105813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9378927,0.007991547,0.0070969774,0.02990947,0.00045032625,0.00012449823,0.0025124077,0.000033522978,0.013988592],"genre_scores_gemma":[0.99471825,0.0012508697,0.0019049599,0.0013902244,0.00013035393,0.000026290574,0.00037977615,0.000007787906,0.0001914517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930097,0.0038704153,0.0007564976,0.00060211006,0.0014563042,0.00030504612],"domain_scores_gemma":[0.95593286,0.029080674,0.008505016,0.0015732561,0.0044139726,0.00049425405],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013353772,0.00029581692,0.000742626,0.0018153465,0.0007425167,0.0022168378,0.00085928047,0.0011134258,0.0015424438],"category_scores_gemma":[0.07524562,0.00018430542,0.00075578975,0.003652813,0.0014904595,0.003058273,0.00095653074,0.0015237319,0.00028568268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040030864,0.0000925457,0.93091345,0.0001505241,0.00020292295,0.000068182846,0.0013528538,0.00039012887,0.00014418142,0.0067918324,0.0047685127,0.054724567],"study_design_scores_gemma":[0.0000798345,0.00020711246,0.9584629,0.00032807866,0.0002358386,0.00057399983,0.004076233,0.009993914,0.00029372008,0.020183,0.0054897163,0.00007572894],"about_ca_topic_score_codex":0.0078051616,"about_ca_topic_score_gemma":0.011093573,"teacher_disagreement_score":0.98664623,"about_ca_system_score_codex":0.001352452,"about_ca_system_score_gemma":0.0011550538,"threshold_uncertainty_score":0.070622385},"labels":[],"label_agreement":null},{"id":"W2043111603","doi":"10.1016/j.jval.2012.03.993","title":"PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weight loss; Type 2 diabetes; Weight gain; Medicine; Weight change; Body mass index; Psychosocial; Obesity; Diabetes mellitus; Demography; Body weight; Gerontology; Internal medicine; Endocrinology; Psychiatry","score_opus":0.014891815029242444,"score_gpt":0.25271789705141107,"score_spread":0.23782608202216862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043111603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736086,0.002963153,0.000079257436,0.0031358572,0.00007897887,0.000037713562,0.006591579,0.000012337359,0.013492615],"genre_scores_gemma":[0.9964122,0.00069804356,0.00012934224,0.00023999186,0.000020215633,0.0000068429413,0.001611226,0.000003951299,0.0008781975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890757,0.00018752892,0.00006408463,0.00007868528,0.0004261157,0.00033611408],"domain_scores_gemma":[0.99729973,0.00035657184,0.00042670936,0.00005893485,0.0010432047,0.0008148875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008666827,0.00028361147,0.0005707151,0.000647261,0.0017027128,0.0012856587,0.00070056954,0.00047224903,0.003654158],"category_scores_gemma":[0.006600272,0.0002085778,0.0014097044,0.0028855228,0.000334212,0.00039541002,0.0005968533,0.0013870734,0.00019039844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014774997,0.00023016588,0.9631019,0.00008841686,0.0003905654,0.00009837911,0.00024478912,0.0007273195,0.000101233156,0.00040836708,0.005261264,0.027870053],"study_design_scores_gemma":[0.0000774126,0.0000838208,0.99669826,0.00004686217,0.00017271267,0.000052454718,0.0003795986,0.00054137496,0.000035944387,0.000101242855,0.0017892519,0.000021071632],"about_ca_topic_score_codex":0.973178,"about_ca_topic_score_gemma":0.98184675,"teacher_disagreement_score":0.027309714,"about_ca_system_score_codex":0.027309714,"about_ca_system_score_gemma":0.023807878,"threshold_uncertainty_score":0.19814676},"labels":[],"label_agreement":null},{"id":"W2043167021","doi":"10.1016/j.jval.2013.08.2140","title":"Comparative Efficacy of Blood Pressure Lowering Drugs in Primary Prevention for Elderly Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Université du Québec à Trois-Rivières; Université de Sherbrooke","funders":"","keywords":"Medicine; Internal medicine; Comorbidity; Odds ratio; Diabetes mellitus; Cohort; Blood pressure; Logistic regression; Disease; Medical prescription; Population","score_opus":0.05176733157603818,"score_gpt":0.3213225125935554,"score_spread":0.2695551810175172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043167021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808775,0.017106496,0.00009804835,0.00011835115,0.0001475035,0.00013755551,0.00028654022,0.000007356187,0.0012205814],"genre_scores_gemma":[0.99224263,0.0061408887,0.00019392437,0.0001935674,0.00038725315,0.00011087108,0.00036692794,0.0000030904648,0.00036081715],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9965004,0.0023902368,0.000361498,0.00025047566,0.0002591537,0.00023824957],"domain_scores_gemma":[0.99476814,0.0031768023,0.00065364334,0.0003955561,0.00028434675,0.0007215015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041804016,0.0008276082,0.0038318357,0.0011033787,0.0005612984,0.0008447917,0.00063159975,0.001378354,0.0031836196],"category_scores_gemma":[0.0060235816,0.00061717094,0.0032899275,0.0010755413,0.0008978396,0.0012091922,0.00057119894,0.0015937187,0.00028683085],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9569594,0.005931851,0.0118118785,0.0009588736,0.005736124,0.000078506506,0.00018304541,0.00013109304,0.0009664416,0.00009206779,0.00018693195,0.016963722],"study_design_scores_gemma":[0.44417176,0.40140298,0.13142446,0.00026913654,0.018850842,0.0001810998,0.00037687624,0.00036414416,0.0013923513,0.00026340495,0.0012153614,0.00008752154],"about_ca_topic_score_codex":0.0015676796,"about_ca_topic_score_gemma":0.0034336776,"teacher_disagreement_score":0.0041804016,"about_ca_system_score_codex":0.0006893799,"about_ca_system_score_gemma":0.0007038138,"threshold_uncertainty_score":0.022108316},"labels":[],"label_agreement":null},{"id":"W2043172649","doi":"10.1016/j.jval.2011.08.1460","title":"PRS73 Systematic Review of the Guidelines on the Prevention of Allergic Manifestations in Children","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Infant Health and Development","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Context (archaeology); Medicine; MEDLINE; Breastfeeding; Family medicine; Systematic review; Atopic dermatitis; Medical literature; Pediatrics; Pathology; Dermatology; Political science","score_opus":0.22239571024502794,"score_gpt":0.444569469168676,"score_spread":0.22217375892364807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043172649","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016386526,0.98459125,0.0010569756,0.0034820188,0.0011308213,0.0019066574,0.0041085533,0.00004745518,0.0020375515],"genre_scores_gemma":[0.025580592,0.9517029,0.009719474,0.005081962,0.00067054364,0.0030890326,0.003039912,0.000048090045,0.0010674387],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97079694,0.010228577,0.01338071,0.0012300863,0.0038731215,0.0004906318],"domain_scores_gemma":[0.9479285,0.027859004,0.0141020985,0.0011563902,0.00825351,0.00070044684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018009372,0.001670484,0.0070087914,0.010602724,0.0007225385,0.0020490666,0.0031947857,0.0026916182,0.004698591],"category_scores_gemma":[0.07312225,0.0016679309,0.010798052,0.00792123,0.0010853151,0.0019660587,0.0022490667,0.0022330286,0.0006868496],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009814865,0.000042357053,0.001688253,0.8372194,0.018694779,0.0001617144,0.0003227663,0.00023352192,0.0004811752,0.00046200838,0.02273119,0.11698125],"study_design_scores_gemma":[0.001937479,0.0003510721,0.010461314,0.827084,0.08491173,0.0003663387,0.00020732176,0.000121495556,0.00042321478,0.0005871263,0.07348168,0.00006726209],"about_ca_topic_score_codex":0.021376716,"about_ca_topic_score_gemma":0.074633636,"teacher_disagreement_score":0.021376716,"about_ca_system_score_codex":0.003959339,"about_ca_system_score_gemma":0.01682471,"threshold_uncertainty_score":0.09524381},"labels":[],"label_agreement":null},{"id":"W2043188252","doi":"10.1016/j.jval.2014.03.453","title":"Cost Comparison of Different Forms of Androgen Ablative Therapies in Metastatic Castration-Resistant Prostate Cancer in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cabazitaxel; Prostate cancer; Docetaxel; Castration; Goserelin; Androgen deprivation therapy; Enzalutamide; Abiraterone; Oncology; Abiraterone acetate; Urology; Androgen; Internal medicine; Cancer; Gynecology; Hormone; Androgen receptor","score_opus":0.09347933362338731,"score_gpt":0.38975220975759584,"score_spread":0.2962728761342085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043188252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9392176,0.028140998,0.0005272119,0.0063443,0.00017883489,0.00037856476,0.009542236,0.000043850956,0.015626397],"genre_scores_gemma":[0.9900675,0.005357061,0.00043101326,0.00046877516,0.000044652264,0.00004841908,0.0018282869,0.000015252762,0.0017390696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977018,0.00047018396,0.00017742044,0.00015551936,0.0009049335,0.0005900724],"domain_scores_gemma":[0.99672914,0.00054633146,0.0004265848,0.000047576425,0.0012058667,0.0010445255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011403402,0.000424288,0.0011675283,0.0020436407,0.0013934823,0.0021465835,0.0013703111,0.0006223916,0.003538199],"category_scores_gemma":[0.005685131,0.00030543134,0.0019347952,0.005058616,0.00078040024,0.0005237071,0.0008798347,0.0009135563,0.00009974933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03996325,0.0015166884,0.45648542,0.0042010387,0.004884062,0.0010009957,0.0012039455,0.056670588,0.0022793813,0.013805951,0.03446527,0.38352346],"study_design_scores_gemma":[0.0024997052,0.002999061,0.9534375,0.000762991,0.0027226554,0.0006501949,0.0021548609,0.016367622,0.0006802998,0.0010613507,0.016496528,0.00016732948],"about_ca_topic_score_codex":0.9835471,"about_ca_topic_score_gemma":0.9903441,"teacher_disagreement_score":0.12318832,"about_ca_system_score_codex":0.12318832,"about_ca_system_score_gemma":0.06013099,"threshold_uncertainty_score":0.893798},"labels":[],"label_agreement":null},{"id":"W2043316051","doi":"10.1016/j.jval.2012.08.2082","title":"PSS35 Frequency of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration: Canadian Real-World Utilization Data","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Care; Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Macular degeneration; Regimen; Ophthalmology; Surgery; Chemotherapy; Bevacizumab","score_opus":0.18199751143387952,"score_gpt":0.3924994368099349,"score_spread":0.21050192537605536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043316051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74806374,0.019584764,0.0007691832,0.0026441189,0.00007666233,0.00019888715,0.20623314,0.00016473392,0.022264712],"genre_scores_gemma":[0.9544913,0.00976925,0.0010903635,0.0005519924,0.00003589621,0.000063360545,0.03236473,0.00004223875,0.0015909324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738795,0.00020683941,0.00031995002,0.00026088223,0.001464574,0.00035986435],"domain_scores_gemma":[0.9924791,0.0007790743,0.002166189,0.00024183533,0.0036367772,0.00069695985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011439278,0.00044157397,0.0006445137,0.003527551,0.000981618,0.0012440889,0.0013907268,0.0005686675,0.0040169684],"category_scores_gemma":[0.006844222,0.00044185674,0.001426745,0.01168342,0.0004301971,0.0004914332,0.00048040165,0.0009964311,0.00038993196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005773068,0.000063517335,0.9528139,0.0005604977,0.0006806197,0.00019811206,0.00041324564,0.0008005737,0.00029923214,0.00071823865,0.016431259,0.026443573],"study_design_scores_gemma":[0.000039928487,0.000032804895,0.9935411,0.00010523779,0.00021841512,0.00024236417,0.00024758623,0.0006661269,0.00009835178,0.000040769002,0.0047327415,0.00003452492],"about_ca_topic_score_codex":0.99214,"about_ca_topic_score_gemma":0.9932573,"teacher_disagreement_score":0.02700694,"about_ca_system_score_codex":0.02700694,"about_ca_system_score_gemma":0.026738139,"threshold_uncertainty_score":0.19594997},"labels":[],"label_agreement":null},{"id":"W2043318040","doi":"10.1111/j.1524-4733.2008.00318.x","title":"The Hanover Consensus: Helpful for German Decision-Makers?","year":2008,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"German; Business; Computer science; History; Archaeology","score_opus":0.4163924085645023,"score_gpt":0.44269240579141084,"score_spread":0.02629999722690851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043318040","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015282203,0.0006329466,0.000078892546,0.9955936,0.0024174287,0.000002497716,0.000012968557,0.000002858745,0.0011059986],"genre_scores_gemma":[0.008453134,0.00060328783,0.0003084363,0.98210686,0.005930791,0.000026197717,0.000018253406,0.000014919308,0.0025380985],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9707955,0.015341256,0.0024700628,0.0023091794,0.0054798387,0.0036040968],"domain_scores_gemma":[0.9382322,0.039461643,0.00311438,0.0019882205,0.009784694,0.007418923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04040147,0.00090190425,0.0020508128,0.0013690972,0.0067008575,0.010738758,0.0030454437,0.08295252,0.008814291],"category_scores_gemma":[0.12423194,0.00093886757,0.0011050823,0.001485061,0.011128801,0.011405036,0.005274054,0.05481989,0.0032611068],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006402025,0.000015955608,0.00047862262,0.000065873246,0.000032617554,0.00054951623,0.00057425647,0.000065202046,0.00005325286,0.046719797,0.9383386,0.013042282],"study_design_scores_gemma":[0.0003705285,0.0000447499,0.0016508668,0.0013666308,0.000102122875,0.0008401926,0.004056736,0.0007937301,0.0002469144,0.16923702,0.82110584,0.00018460208],"about_ca_topic_score_codex":0.016996618,"about_ca_topic_score_gemma":0.028799428,"teacher_disagreement_score":0.08295252,"about_ca_system_score_codex":0.012297339,"about_ca_system_score_gemma":0.016725276,"threshold_uncertainty_score":0.21366596},"labels":[],"label_agreement":null},{"id":"W2043401953","doi":"10.1111/j.1524-4733.2009.00578.x","title":"Cost–Benefit Analysis of Preventing Nosocomial Bloodstream Infections among Hemodialysis Patients in Canada in 2004","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Public Health Agency of Canada","funders":"","keywords":"Medicine; Hemodialysis; Infection control; Investment (military); Disease control; Cost–benefit analysis; Total cost; Incidence (geometry); Bloodstream infection; Emergency medicine; Intensive care medicine; Environmental health; Business; Surgery","score_opus":0.022917383750277513,"score_gpt":0.3002798418810529,"score_spread":0.27736245813077537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043401953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97963506,0.0054288916,0.0003276714,0.0026211052,0.000074900905,0.0002723724,0.008402783,0.000031862044,0.00320537],"genre_scores_gemma":[0.99491584,0.0012378686,0.00046901588,0.00038823867,0.000022209691,0.000033458484,0.0018267975,0.0000039737874,0.0011026505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983375,0.00046913713,0.00012061441,0.00010418874,0.00050016365,0.0004683544],"domain_scores_gemma":[0.9976634,0.00045503958,0.00033118902,0.000042435633,0.00089519843,0.0006127477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010867525,0.00056859106,0.0010798234,0.0014602566,0.0011819899,0.001731805,0.0013979159,0.0009904442,0.0016919908],"category_scores_gemma":[0.005808014,0.00047041458,0.0022114075,0.003650325,0.00059681153,0.00043157785,0.0005250188,0.0011795391,0.000073077696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030001959,0.0018659541,0.81992257,0.0016130048,0.0057667983,0.0011951795,0.00045181313,0.062237795,0.0013854188,0.0028820795,0.01209812,0.0605794],"study_design_scores_gemma":[0.0022439887,0.0016541536,0.956466,0.00026308268,0.0038553276,0.00039369028,0.00079526484,0.029011032,0.00052480854,0.00052848546,0.004166109,0.00009799932],"about_ca_topic_score_codex":0.98425275,"about_ca_topic_score_gemma":0.9876209,"teacher_disagreement_score":0.08441489,"about_ca_system_score_codex":0.08441489,"about_ca_system_score_gemma":0.059810136,"threshold_uncertainty_score":0.61247575},"labels":[],"label_agreement":null},{"id":"W2043684445","doi":"10.1016/j.jval.2011.08.1166","title":"PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Everolimus; Medicine; Quality-adjusted life year; Renal cell carcinoma; Cost-effectiveness analysis; Cost effectiveness; Internal medicine; Oncology; Incremental cost-effectiveness ratio; Markov model; Cost–benefit analysis; Intensive care medicine; Markov chain; Statistics","score_opus":0.29771767826339157,"score_gpt":0.35571420652786806,"score_spread":0.05799652826447649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043684445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861348,0.004061214,0.00013331347,0.0014415827,0.000066347406,0.00015366869,0.0033344903,0.000017291766,0.0046573393],"genre_scores_gemma":[0.99752325,0.00082126976,0.00012501639,0.00008199401,0.000010999843,0.000018196431,0.0009477132,0.0000020711577,0.0004694692],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99901485,0.00031282168,0.00006451083,0.000085668435,0.00023378395,0.00028834923],"domain_scores_gemma":[0.9984816,0.00027390907,0.00026438117,0.000027118962,0.00032095244,0.00063214806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076255837,0.00040863774,0.00090233056,0.00048172774,0.000558617,0.0010791827,0.0008561821,0.0005535687,0.0022195533],"category_scores_gemma":[0.004152888,0.0002469099,0.0019318515,0.0011936266,0.00054870587,0.0003472248,0.0005654379,0.00083679333,0.00008566785],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16220883,0.0038330788,0.39200994,0.0029699276,0.007971271,0.0008622844,0.0005420984,0.17644462,0.0017223688,0.0050290534,0.023734577,0.222672],"study_design_scores_gemma":[0.021338116,0.0121632535,0.8658665,0.00074075564,0.0062941415,0.00070808316,0.0015697358,0.081514075,0.0011388068,0.0013353486,0.0071388795,0.00019232136],"about_ca_topic_score_codex":0.95467705,"about_ca_topic_score_gemma":0.9598375,"teacher_disagreement_score":0.045322955,"about_ca_system_score_codex":0.03512456,"about_ca_system_score_gemma":0.032574452,"threshold_uncertainty_score":0.2548477},"labels":[],"label_agreement":null},{"id":"W2043769648","doi":"10.1016/j.jval.2013.03.755","title":"Lessons Learned From The Dedicated Oncology Drug Review Process In Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Population; Clinical trial; Oncology; Cancer; Internal medicine; Intensive care medicine; Family medicine; Health care; Environmental health","score_opus":0.5594581036707623,"score_gpt":0.47084717646158847,"score_spread":0.08861092720917385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043769648","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05784618,0.013759161,0.0022695332,0.87549603,0.0024758435,0.00021625852,0.00088667165,0.00014105397,0.046909273],"genre_scores_gemma":[0.79757786,0.010692666,0.0058290353,0.15764733,0.002089867,0.00015582667,0.00059978507,0.00021158802,0.02519604],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9635704,0.008942484,0.0019821445,0.0024116875,0.012392552,0.010700645],"domain_scores_gemma":[0.78930783,0.0776998,0.0066459496,0.0034819145,0.07857496,0.04428957],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043598533,0.00048149936,0.0011845975,0.0033980105,0.0105692465,0.019231422,0.003722202,0.009193142,0.008293928],"category_scores_gemma":[0.10918858,0.0007081466,0.0011121236,0.0049910876,0.008058831,0.0048440853,0.004114972,0.012027426,0.00056961057],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007506045,0.0004978106,0.05321169,0.0010088242,0.00045177026,0.0020824522,0.011532247,0.011714851,0.00078774616,0.22112961,0.50880396,0.18802842],"study_design_scores_gemma":[0.00079738424,0.0004061524,0.18973875,0.0029258789,0.00040738718,0.00064031,0.02098368,0.008963877,0.0012420958,0.054776445,0.71842045,0.0006976466],"about_ca_topic_score_codex":0.9852106,"about_ca_topic_score_gemma":0.9919154,"teacher_disagreement_score":0.9852106,"about_ca_system_score_codex":0.1931906,"about_ca_system_score_gemma":0.42109466,"threshold_uncertainty_score":0.9357845},"labels":[],"label_agreement":null},{"id":"W2043816730","doi":"10.1016/j.jval.2012.09.004","title":"What Is Wrong with Orphan Drug Policies?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Orphan drug; Business; Bioinformatics; Biology","score_opus":0.1068436613679914,"score_gpt":0.32903839067299734,"score_spread":0.22219472930500594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043816730","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013820301,0.028485779,0.0037862079,0.91409236,0.004990003,0.000014519368,0.0003049657,0.000047578396,0.03445827],"genre_scores_gemma":[0.6801578,0.035739176,0.003748533,0.25452694,0.018472318,0.00008699647,0.00022111209,0.00012218051,0.0069250152],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97142845,0.017732585,0.0012199504,0.0017221639,0.0058579287,0.0020389224],"domain_scores_gemma":[0.8909903,0.08146923,0.009200776,0.004517791,0.00872993,0.0050918832],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028555082,0.00057745044,0.0021579918,0.002092417,0.0021808613,0.01025903,0.0020494247,0.010918253,0.00901278],"category_scores_gemma":[0.14359193,0.0004038273,0.0011300585,0.0024979666,0.016958334,0.018898014,0.003115146,0.011726749,0.00073949195],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028556658,0.00011475339,0.0050105476,0.00045261148,0.00030136897,0.0002927236,0.00046677122,0.0013585495,0.000085030195,0.8653489,0.058654755,0.06762845],"study_design_scores_gemma":[0.0000731992,0.00003902282,0.0013301187,0.00085120363,0.00006870032,0.0001626227,0.00046424597,0.00090127025,0.0001366037,0.9447521,0.051195636,0.00002525081],"about_ca_topic_score_codex":0.006935987,"about_ca_topic_score_gemma":0.0062008104,"teacher_disagreement_score":0.028555082,"about_ca_system_score_codex":0.0061878213,"about_ca_system_score_gemma":0.008356446,"threshold_uncertainty_score":0.15101552},"labels":[],"label_agreement":null},{"id":"W2045171199","doi":"10.1016/j.jval.2013.08.1566","title":"Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Prior probability; Bayesian probability; Meta-analysis; Frequentist inference; Markov chain Monte Carlo; Statistics; Econometrics; Medicine; Bayesian inference; Mathematics; Internal medicine","score_opus":0.8488595570590012,"score_gpt":0.639732342098657,"score_spread":0.20912721496034414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045171199","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015724273,0.0028313207,0.9932041,0.0012581644,0.00010853794,0.0002683856,0.000100879646,0.00023010596,0.00042609897],"genre_scores_gemma":[0.07792447,0.0020800044,0.91639954,0.0010369687,0.00033537028,0.0013814981,0.00017019728,0.00021656291,0.00045529022],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7295618,0.25213447,0.0063784122,0.005128227,0.0062853056,0.00051181135],"domain_scores_gemma":[0.34172958,0.63411987,0.0061345752,0.014637634,0.0027031181,0.0006751625],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21843354,0.0047109295,0.009125771,0.006259444,0.0011308123,0.0063386005,0.007033742,0.005974505,0.004595316],"category_scores_gemma":[0.47741863,0.004938782,0.008597553,0.005369104,0.0033974664,0.010000759,0.008062979,0.013443411,0.00065436756],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037270654,0.00058643665,0.0033417898,0.011119216,0.02384408,0.00058081705,0.0014942936,0.34212846,0.001464456,0.17463662,0.007112835,0.429964],"study_design_scores_gemma":[0.0010716735,0.00032847826,0.0005518073,0.0014389668,0.0040505314,0.00019807383,0.000056778874,0.43153617,0.0010990191,0.55513775,0.0043539153,0.00017682157],"about_ca_topic_score_codex":0.0019828584,"about_ca_topic_score_gemma":0.0024920816,"teacher_disagreement_score":0.78156644,"about_ca_system_score_codex":0.002034576,"about_ca_system_score_gemma":0.0044886167,"threshold_uncertainty_score":0.96381056},"labels":[],"label_agreement":null},{"id":"W2045458376","doi":"10.1016/j.jval.2012.03.1066","title":"PIH34 Impact of Medicare Part D Coverage Gap on Beneficiaries' Adherence to Prescription Medications","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Medicare Part D; Medicine; Medicaid; Prescription drug; Medication adherence; Quarter (Canadian coin); Family medicine; Internal medicine; Health care; Pharmacology","score_opus":0.14756406454640125,"score_gpt":0.40628327471426595,"score_spread":0.2587192101678647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045458376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9771367,0.0007524262,0.000111137815,0.004897233,0.00008327181,0.000038188366,0.0064655,0.000045079145,0.0104704015],"genre_scores_gemma":[0.9968958,0.00006544719,0.000046533765,0.000338722,0.00005323265,0.00001714296,0.0012723244,0.0000040651835,0.0013067313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973115,0.00082190934,0.00014512565,0.00019116727,0.00058968074,0.0009406703],"domain_scores_gemma":[0.9903808,0.0040768976,0.002075822,0.00035381626,0.0009151923,0.002197441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024100395,0.00021105021,0.0006003223,0.0011830741,0.0007511471,0.0016275987,0.0007296813,0.0012825375,0.014969485],"category_scores_gemma":[0.0150824,0.00020065089,0.0017631232,0.0014083111,0.00038543018,0.0010830726,0.0018826266,0.0016402714,0.0009148904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018873863,0.00046889938,0.97515476,0.000042259628,0.0003398893,0.00016617498,0.00014139072,0.0006631942,0.00015916569,0.0010623178,0.0042984416,0.015616087],"study_design_scores_gemma":[0.00005674073,0.00022025857,0.9971311,0.000013660673,0.00011020583,0.000061045415,0.0002643007,0.00086922006,0.00010131145,0.00017989724,0.0009860841,0.000006150546],"about_ca_topic_score_codex":0.047536794,"about_ca_topic_score_gemma":0.026848368,"teacher_disagreement_score":0.047536794,"about_ca_system_score_codex":0.0017061911,"about_ca_system_score_gemma":0.0030992297,"threshold_uncertainty_score":0.09452021},"labels":[],"label_agreement":null},{"id":"W2045580548","doi":"10.1016/s1098-3015(10)70642-2","title":"PCV54 THE COST-UTILITY OF ALISKIREN IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. A CANADIAN HEALTH CARE SYSTEM PERSPECTIVE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aliskiren; Perspective (graphical); Medicine; Intensive care medicine; Health care; Internal medicine; Economics; Computer science; Renin–angiotensin system; Economic growth; Blood pressure; Artificial intelligence","score_opus":0.1723879157701996,"score_gpt":0.36863286731372774,"score_spread":0.19624495154352814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045580548","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11767795,0.29758626,0.0033351923,0.35629052,0.0030695212,0.00033024387,0.025260787,0.0001877824,0.19626182],"genre_scores_gemma":[0.8719983,0.08857781,0.0037561767,0.01698315,0.0025155218,0.00009830344,0.0047483924,0.000051354506,0.011270975],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977557,0.0006317963,0.00011113731,0.000108894434,0.0009593102,0.00043331433],"domain_scores_gemma":[0.9966918,0.00075333705,0.00023179741,0.000052271163,0.0016148362,0.0006558834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017508735,0.0006817358,0.0009062195,0.0016758036,0.00082733535,0.0030416227,0.0013535809,0.0021149535,0.0088415025],"category_scores_gemma":[0.008366445,0.00021985757,0.0016045604,0.0024637487,0.0007559609,0.00061288016,0.0006250073,0.0020957452,0.00040754204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053551253,0.00029913397,0.0424353,0.0030826963,0.002896221,0.0014268137,0.0002855523,0.026144309,0.0019563441,0.064531565,0.3207378,0.5308491],"study_design_scores_gemma":[0.0027621712,0.0014743082,0.3613851,0.0104549425,0.007345415,0.0024511022,0.0019086747,0.037374448,0.0016410208,0.031829696,0.5407435,0.0006296375],"about_ca_topic_score_codex":0.90415,"about_ca_topic_score_gemma":0.9303699,"teacher_disagreement_score":0.9661231,"about_ca_system_score_codex":0.03387692,"about_ca_system_score_gemma":0.054765433,"threshold_uncertainty_score":0.24579537},"labels":[],"label_agreement":null},{"id":"W2045655256","doi":"10.1016/j.jval.2011.02.839","title":"PRM32 VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN VALUE IN HEALTH (1998-2010): A SYSTEMATIC REVIEW","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discriminant validity; Construct validity; External validity; Criterion validity; Convergent validity; Content validity; Predictive validity; Medicine; Internal validity; Outcomes research; MEDLINE; Systematic review; Psychology; Psychometrics; Clinical psychology; Alternative medicine; Social psychology; Political science; Pathology","score_opus":0.6947092138980646,"score_gpt":0.4952521304909449,"score_spread":0.1994570834071197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045655256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026082203,0.99056107,0.0011576926,0.0010909582,0.00053772103,0.0012612271,0.0017360555,0.000027097969,0.0010199293],"genre_scores_gemma":[0.07506335,0.90668374,0.0068832347,0.0026439335,0.00058288284,0.004674218,0.0027415412,0.00009206351,0.0006350329],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8475903,0.05209987,0.06586671,0.007336695,0.025550272,0.0015562542],"domain_scores_gemma":[0.5354203,0.3297841,0.08339231,0.011608213,0.038103674,0.0016913224],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.124157466,0.0020779388,0.012201142,0.02414776,0.0013546377,0.007401612,0.0042094113,0.0054521644,0.0070124227],"category_scores_gemma":[0.49069124,0.0023011337,0.017341504,0.019710032,0.004833741,0.006857735,0.006656037,0.0030786449,0.0008705648],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009817709,0.00003560841,0.006440094,0.86367726,0.031640686,0.00013292895,0.00077541434,0.00013786169,0.00017692274,0.0008523939,0.0036007972,0.09154815],"study_design_scores_gemma":[0.0013927702,0.00024294989,0.019025987,0.8176934,0.1313226,0.00047291094,0.0005716732,0.00012131443,0.00043727184,0.0016519631,0.026943464,0.00012365807],"about_ca_topic_score_codex":0.0100986445,"about_ca_topic_score_gemma":0.019851085,"teacher_disagreement_score":0.8758425,"about_ca_system_score_codex":0.0067930776,"about_ca_system_score_gemma":0.024540493,"threshold_uncertainty_score":0.65661526},"labels":[],"label_agreement":null},{"id":"W2045754070","doi":"10.1016/j.jval.2011.08.1155","title":"PCN54 Hospital Costs Related to Hepatitis C Virus Infection: First Analysis of the French Hospital National Data Base","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Internal medicine; Hepatitis C virus; Hepatitis C; Liver cancer; Liver transplantation; Hepatitis; Emergency medicine; Virus; Transplantation; Virology","score_opus":0.08819980210912574,"score_gpt":0.35306261405267914,"score_spread":0.2648628119435534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045754070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6988551,0.004619594,0.0006264003,0.0007976552,0.000045801524,0.000098707096,0.29057306,0.00013377224,0.0042498563],"genre_scores_gemma":[0.7467344,0.0014854103,0.0007922004,0.0002108595,0.000087532586,0.0002559003,0.24873021,0.0000549469,0.0016486115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954686,0.0014869054,0.0004984653,0.0005507183,0.0013551849,0.0006401184],"domain_scores_gemma":[0.9833613,0.0073118955,0.0026375793,0.0012431483,0.004707627,0.00073840976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044236714,0.00082476303,0.0014101953,0.0082849115,0.0006542456,0.0018493341,0.0012377388,0.0008106186,0.0046627475],"category_scores_gemma":[0.016618617,0.00041283548,0.002068903,0.010072889,0.00031059392,0.00076697586,0.00084952684,0.0006758548,0.00094303815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016628284,0.00014082046,0.9212502,0.00047826266,0.0019533678,0.00031874873,0.00022579594,0.0054939734,0.00019778634,0.00065659,0.04114486,0.026476664],"study_design_scores_gemma":[0.0000960461,0.000098927885,0.98761624,0.00010313542,0.00022974327,0.00024397991,0.00016579,0.0021902309,0.0001255708,0.00005516047,0.009053399,0.000021668742],"about_ca_topic_score_codex":0.4015051,"about_ca_topic_score_gemma":0.2238364,"teacher_disagreement_score":0.4015051,"about_ca_system_score_codex":0.007963193,"about_ca_system_score_gemma":0.0045568617,"threshold_uncertainty_score":0.7983362},"labels":[],"label_agreement":null},{"id":"W2045905486","doi":"10.1111/j.1524-4733.2010.00755.x","title":"An Ounce of Prevention Is Worth a Pound of Cure: A Cost-Effectiveness Analysis of Incidentally Detected Aneurysms in Functional MRI Research","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes","funders":"Institute of Neurosciences, Mental Health and Addiction; National Institute of Mental Health; Canadian Institutes of Health Research; National Institutes of Health; Vancouver Coastal Health Research Institute; Canada Research Chairs","keywords":"Medicine; Family history; Cost effectiveness; Quality-adjusted life year; Cost–benefit analysis; Cost–utility analysis; Pound (networking); Cost-effectiveness analysis; Magnetic resonance imaging; Medical physics; Surgery; Radiology; Computer science","score_opus":0.17259730777231916,"score_gpt":0.4202609213229881,"score_spread":0.24766361355066893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045905486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8938782,0.08140467,0.006523245,0.01240162,0.0005044784,0.0005047744,0.0013644702,0.00009117864,0.0033273944],"genre_scores_gemma":[0.98783433,0.0073356237,0.003476349,0.000805282,0.00012969266,0.000075890406,0.00019230647,0.000008782087,0.00014173299],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98986304,0.008476243,0.00040507075,0.00030329256,0.0006625922,0.00028974513],"domain_scores_gemma":[0.9674319,0.028709594,0.0018422811,0.00063288957,0.000523442,0.00085987075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010525575,0.0011827507,0.0026160197,0.0025604093,0.00040974887,0.002077658,0.0007421867,0.0023220044,0.0022598838],"category_scores_gemma":[0.038331762,0.00058826164,0.0051557473,0.001994627,0.0012111362,0.0026299937,0.0009935545,0.0019509521,0.000096927775],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1648907,0.004475878,0.1761451,0.008646313,0.054909725,0.002011564,0.00052144716,0.056081943,0.0060966513,0.017572427,0.008051342,0.50059694],"study_design_scores_gemma":[0.05721672,0.06813787,0.35921592,0.0064321477,0.23166332,0.004633373,0.002658839,0.20307049,0.00533761,0.043820158,0.016744925,0.0010686185],"about_ca_topic_score_codex":0.004762447,"about_ca_topic_score_gemma":0.0056463615,"teacher_disagreement_score":0.010525575,"about_ca_system_score_codex":0.002733217,"about_ca_system_score_gemma":0.001922566,"threshold_uncertainty_score":0.055665195},"labels":[],"label_agreement":null},{"id":"W2045934399","doi":"10.1016/s1098-3015(10)69128-0","title":"PMC30 GUIDELINES FOR BUDGET IMPACT ANALYSIS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.4295872366019313,"score_gpt":0.5961427506262914,"score_spread":0.16655551402436009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045934399","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006737869,0.027870202,0.069005415,0.04823672,0.0067084916,0.010100291,0.0974838,0.006454194,0.7274031],"genre_scores_gemma":[0.052177414,0.037187006,0.40937343,0.02344778,0.0017945163,0.012523409,0.06469847,0.004557657,0.3942402],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9722989,0.0044274554,0.004475422,0.00070832734,0.01565088,0.002439032],"domain_scores_gemma":[0.9025644,0.011371663,0.0022601148,0.0018260585,0.079235464,0.0027422581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019096654,0.002261681,0.002225528,0.01708704,0.00488107,0.008696438,0.007060856,0.006189378,0.04091199],"category_scores_gemma":[0.07451423,0.0025413795,0.0041863625,0.022611752,0.0020598127,0.0025898716,0.002861296,0.0054707457,0.01262489],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005436881,0.00008402587,0.0015729713,0.00082383817,0.000060084385,0.0002018727,0.0003565007,0.004570881,0.00016338704,0.0205715,0.8948486,0.07669188],"study_design_scores_gemma":[0.00014618092,0.000034800472,0.012244424,0.002866704,0.00011931849,0.00021091607,0.00044437256,0.0033374988,0.0003113317,0.0104659265,0.96968085,0.00013771522],"about_ca_topic_score_codex":0.97280836,"about_ca_topic_score_gemma":0.9775728,"teacher_disagreement_score":0.93016636,"about_ca_system_score_codex":0.06983365,"about_ca_system_score_gemma":0.29492438,"threshold_uncertainty_score":0.50668097},"labels":[],"label_agreement":null},{"id":"W2046059662","doi":"10.1016/j.jval.2013.03.156","title":"Impact of multiple treatment comparison meta-analysis on value of information evaluations: a case study of pharmacotherapies for chronic obstructive pulmonary diseases","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemodynamic Monitoring and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Medicine; COPD; Placebo; Pulmonary disease; Randomized controlled trial; Bayesian probability; Bayes' theorem; Internal medicine; Statistics; Mathematics; Pathology","score_opus":0.13615359724571932,"score_gpt":0.4536132285066741,"score_spread":0.3174596312609548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046059662","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16201127,0.70545334,0.10644634,0.007148834,0.0054505584,0.002665227,0.0028097357,0.0008314969,0.007183161],"genre_scores_gemma":[0.9323552,0.022289544,0.03819586,0.0029278586,0.0009697031,0.0013883142,0.00067411776,0.00030282838,0.000896464],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.5805411,0.38299593,0.016157651,0.01170882,0.006931124,0.0016653633],"domain_scores_gemma":[0.2935098,0.67961633,0.009390267,0.012843115,0.0037334166,0.00090695295],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2120232,0.005733048,0.019481156,0.0035503441,0.0014422869,0.0064775907,0.0049974876,0.008100555,0.0045534414],"category_scores_gemma":[0.38057256,0.0025280553,0.059961677,0.0039548078,0.002873923,0.0059055462,0.0033047649,0.009247636,0.00032023448],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02718801,0.000076505974,0.0059562605,0.012353505,0.9425181,0.0003799347,0.00018159299,0.0018048671,0.00025410153,0.0007973102,0.0006430308,0.007846818],"study_design_scores_gemma":[0.0062407413,0.0010069371,0.0033107412,0.0012086536,0.98116726,0.00018848621,0.00009043823,0.0029484546,0.00022299709,0.0025394866,0.0009944275,0.000081324615],"about_ca_topic_score_codex":0.005683503,"about_ca_topic_score_gemma":0.0058938866,"teacher_disagreement_score":0.7879768,"about_ca_system_score_codex":0.002597694,"about_ca_system_score_gemma":0.0023268845,"threshold_uncertainty_score":0.9717157},"labels":[],"label_agreement":null},{"id":"W2046214493","doi":"10.1111/j.1524-4733.2008.00445.x","title":"The Costs of Change: Direct Medical Costs of Solid Organ Transplantation in British Columbia, Canada, 1995–2003","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver Native Health Society; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Transplantation; Liver transplantation; Activity-based costing; Population; Emergency medicine; Total cost; Indirect costs; Organ transplantation; Intensive care medicine; Surgery; Environmental health; Business","score_opus":0.04258307607988245,"score_gpt":0.30753770257338936,"score_spread":0.26495462649350693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046214493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.873544,0.014729465,0.00034992507,0.019742792,0.0002995966,0.00008541305,0.07584768,0.000071901544,0.015329214],"genre_scores_gemma":[0.9690795,0.00738472,0.0003297741,0.00086910423,0.000063212006,0.000034726098,0.0110185165,0.000018671717,0.01120176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859375,0.000115361516,0.00015375148,0.000099145764,0.0006075569,0.0004303723],"domain_scores_gemma":[0.9953744,0.00026259752,0.0008459728,0.000065162916,0.0024499611,0.0010018974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005799717,0.0004158504,0.0005300006,0.0020326076,0.0018313184,0.0023961915,0.0019251965,0.0012089325,0.002850247],"category_scores_gemma":[0.005655021,0.00045489942,0.00077875954,0.006865078,0.00087765517,0.00068001915,0.0009925663,0.0021409518,0.0002635286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006575831,0.00016430768,0.9072048,0.00038410438,0.0005869121,0.0007865752,0.0010429884,0.0050435024,0.0002629112,0.0031338853,0.048323724,0.03240878],"study_design_scores_gemma":[0.00005514988,0.000024392411,0.9795051,0.00024462168,0.0002238714,0.00027623793,0.0021441947,0.0027142088,0.00018838563,0.0003417051,0.014234693,0.000047404894],"about_ca_topic_score_codex":0.9987501,"about_ca_topic_score_gemma":0.99938214,"teacher_disagreement_score":0.11830778,"about_ca_system_score_codex":0.11830778,"about_ca_system_score_gemma":0.09990007,"threshold_uncertainty_score":0.858387},"labels":[],"label_agreement":null},{"id":"W2046353944","doi":"10.1016/j.jval.2014.03.1273","title":"Investigating economic risk factors that impact mental health status of former army personnel","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Employment and Welfare Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mental health; Military personnel; Anxiety; Educational attainment; Logistic regression; Probit model; Medicine; Environmental health; Psychology; Gerontology; Psychiatry; Statistics; Economics; Geography","score_opus":0.11811398967294795,"score_gpt":0.4173879733712102,"score_spread":0.29927398369826225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046353944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99928504,0.0001739919,0.000011288075,0.00007269778,0.000003515373,0.0000030668677,0.00006156515,1.6404138e-7,0.00038863794],"genre_scores_gemma":[0.9995473,0.0001537887,0.000020282934,0.000024060635,0.000007823236,0.0000030536735,0.00006205311,3.1829688e-7,0.00018127824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994629,0.00022549783,0.000040828156,0.00002951798,0.000053026724,0.0001881546],"domain_scores_gemma":[0.9974976,0.0007896911,0.00094596064,0.00008442946,0.00015239784,0.00052982825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088682724,0.0001790821,0.00016628373,0.00080115587,0.00087931886,0.00094599527,0.00031498825,0.0004499571,0.0023131743],"category_scores_gemma":[0.0054749367,0.00018267831,0.0004560026,0.001117005,0.00038755758,0.00060370157,0.00078985543,0.0005463986,0.00017166072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013717476,0.00013067754,0.9971439,0.000011479336,0.00004615354,0.000044931163,0.00029192868,0.000016605594,0.000056772096,0.000050900177,0.00004513632,0.0020241868],"study_design_scores_gemma":[0.000002440307,0.000064474574,0.9983163,0.0000089759205,0.000019288695,0.000026749247,0.0014062022,0.00003217167,0.000014724993,0.000027955602,0.00007936213,0.000001397331],"about_ca_topic_score_codex":0.02060242,"about_ca_topic_score_gemma":0.04198868,"teacher_disagreement_score":0.02060242,"about_ca_system_score_codex":0.0005677874,"about_ca_system_score_gemma":0.0009526464,"threshold_uncertainty_score":0.04096496},"labels":[],"label_agreement":null},{"id":"W2046640806","doi":"10.1016/j.jval.2012.08.267","title":"PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov Model","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Markov model; Quality-adjusted life year; Cohort; Quality of life (healthcare); Cancer; Actuarial science; Computer science; Markov chain; Cost effectiveness; Internal medicine; Risk analysis (engineering); Machine learning","score_opus":0.49866942640792916,"score_gpt":0.5256237887241147,"score_spread":0.026954362316185587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046640806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974568,0.00025425194,0.022704126,0.00023624262,0.000042440723,0.00019762696,0.00062765414,0.00016082532,0.0012087793],"genre_scores_gemma":[0.9876874,0.0000733891,0.010195837,0.00006178773,0.000012695303,0.00016547684,0.0010638656,0.000030164267,0.0007092232],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9933622,0.005388381,0.00019673501,0.00047279373,0.00035080372,0.00022914128],"domain_scores_gemma":[0.8930984,0.095501095,0.0026304484,0.004866405,0.0030981642,0.0008054778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025315303,0.0010089811,0.001329779,0.00092398666,0.0004932988,0.0009192965,0.002043353,0.0019016694,0.002002339],"category_scores_gemma":[0.051495515,0.0007963155,0.0016897708,0.0005452514,0.00084455626,0.0010838825,0.001027544,0.0020218878,0.0003621567],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053342306,0.0020635852,0.024325164,0.00015917304,0.0006340032,0.00008255002,0.00012976553,0.94565314,0.00072276144,0.0027775844,0.0009000008,0.017218007],"study_design_scores_gemma":[0.00040586674,0.0011316896,0.0045107,0.000023801938,0.000103671315,0.00003125601,0.00002607578,0.99181765,0.0006730714,0.001008499,0.00024621922,0.000021535601],"about_ca_topic_score_codex":0.010535745,"about_ca_topic_score_gemma":0.0054905633,"teacher_disagreement_score":0.025315303,"about_ca_system_score_codex":0.0018297291,"about_ca_system_score_gemma":0.002062192,"threshold_uncertainty_score":0.13388169},"labels":[],"label_agreement":null},{"id":"W2046655585","doi":"10.1111/j.1524-4733.2004.75007.x","title":"Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Glatiramer acetate; Medicine; Cost effectiveness; Quality-adjusted life year; Life expectancy; Quality of life (healthcare); Interferon beta-1b; Internal medicine; Interferon beta; Multiple sclerosis; Interferon beta-1a; Population; Physical therapy; Immunology; Disease; Environmental health","score_opus":0.14525115917866463,"score_gpt":0.36734868299023504,"score_spread":0.2220975238115704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046655585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799359,0.017817972,0.00008404406,0.00062175415,0.00009427634,0.00007845341,0.0004322908,0.000008038342,0.0009273126],"genre_scores_gemma":[0.99753404,0.0018115854,0.00011186583,0.000102380014,0.00004463239,0.000033687338,0.00019054751,0.0000014868923,0.0001698316],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974438,0.0019768332,0.00015467136,0.00008869688,0.00017121277,0.00016472187],"domain_scores_gemma":[0.9963871,0.0025032903,0.00053015177,0.00009177151,0.00011265461,0.0003751483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021886637,0.00070965727,0.0015645854,0.0010152522,0.00027037604,0.00074856955,0.0006448095,0.0012146166,0.0020938744],"category_scores_gemma":[0.008458139,0.00034558977,0.0033449077,0.00096334954,0.00045700432,0.00095949403,0.0005132161,0.0010835159,0.00010112164],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7347874,0.0052618803,0.112688966,0.002635302,0.014624433,0.0006768387,0.0002636931,0.017133668,0.0012719078,0.0011467007,0.0013427158,0.108166434],"study_design_scores_gemma":[0.17503503,0.12048502,0.62675494,0.001216723,0.03697554,0.001650743,0.001156684,0.029016644,0.0022996303,0.0022659996,0.0029027222,0.00024032682],"about_ca_topic_score_codex":0.011754107,"about_ca_topic_score_gemma":0.011423755,"teacher_disagreement_score":0.011754107,"about_ca_system_score_codex":0.00313788,"about_ca_system_score_gemma":0.0011756372,"threshold_uncertainty_score":0.023371339},"labels":[],"label_agreement":null},{"id":"W2046709389","doi":"10.1016/j.jval.2014.03.1259","title":"Resource use and associated costs of long acting injectable antipsychotics: A RAMQ database analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Database; Resource (disambiguation); Computer science; Medicine","score_opus":0.06428476794766586,"score_gpt":0.3503839857935865,"score_spread":0.28609921784592063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046709389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9067349,0.0021670053,0.0003366781,0.00031902484,0.000011780814,0.0001319641,0.08920478,0.000029856086,0.0010640589],"genre_scores_gemma":[0.95299536,0.0010751574,0.0006492157,0.00019096411,0.000022538601,0.00018135273,0.044430945,0.000019316418,0.00043526565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997056,0.0009857661,0.0006985472,0.0004954774,0.0004985683,0.0002656595],"domain_scores_gemma":[0.990035,0.0045533916,0.0036930002,0.0006142133,0.0007320447,0.0003723756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021701946,0.00042290983,0.0011569379,0.0033897352,0.00025875555,0.0014075058,0.0009965659,0.00069108856,0.0029992585],"category_scores_gemma":[0.011969886,0.000561292,0.004341704,0.006413962,0.00023183358,0.0011308043,0.0010229402,0.0010010069,0.00039729796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005201304,0.00028715,0.9656916,0.00084320724,0.0076123504,0.00026216538,0.00013596268,0.0044409903,0.00023170195,0.0005358525,0.0044942843,0.010263433],"study_design_scores_gemma":[0.00059503736,0.00046332294,0.9810214,0.00022026378,0.0037770732,0.00077613234,0.00053663197,0.008706249,0.00020802017,0.00025824882,0.0033742876,0.000063351275],"about_ca_topic_score_codex":0.03967397,"about_ca_topic_score_gemma":0.026581755,"teacher_disagreement_score":0.03967397,"about_ca_system_score_codex":0.0021703432,"about_ca_system_score_gemma":0.0014801789,"threshold_uncertainty_score":0.07888609},"labels":[],"label_agreement":null},{"id":"W2046807908","doi":"10.1016/s1098-3015(10)73673-1","title":"PRS10 RETURN ON INVESTMENT FROM SMOKING CESSATION INSURANCE COVERAGE IN THE WORKPLACE: A CANADIAN EMPLOYER'S PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Retirement, Disability, and Employment","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Investment (military); Actuarial science; Business; Health insurance; Smoking cessation; Economics; Medicine; Political science; Law; Economic growth; Health care; Computer science","score_opus":0.1605810974715046,"score_gpt":0.4042600981576011,"score_spread":0.24367900068609652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046807908","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17217566,0.017915163,0.0021195745,0.24565709,0.0010240834,0.00011417945,0.009430034,0.00015088197,0.55141336],"genre_scores_gemma":[0.9277774,0.010667231,0.0010977867,0.007115941,0.0009011865,0.00002522762,0.0014266432,0.000048180762,0.05094044],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99499243,0.0003632827,0.00011611556,0.000212739,0.0023660325,0.0019493044],"domain_scores_gemma":[0.9898269,0.0013885365,0.0006716477,0.00015570052,0.005750367,0.0022068967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023988546,0.00060181814,0.00067593914,0.0042324555,0.0028472575,0.00778606,0.0018233984,0.0041782125,0.011075675],"category_scores_gemma":[0.009236874,0.00028290393,0.0011585712,0.003656381,0.0017194,0.0011461371,0.0010527817,0.0040048384,0.00055259926],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053546845,0.00037534043,0.089933984,0.00042501622,0.00029141124,0.0011224388,0.001729003,0.014547818,0.0016119101,0.5687772,0.18420635,0.13644408],"study_design_scores_gemma":[0.00014191431,0.0003615124,0.4427736,0.0015361836,0.00056004204,0.00092796574,0.009634035,0.026596991,0.0014440636,0.084852144,0.43069392,0.0004776193],"about_ca_topic_score_codex":0.9741665,"about_ca_topic_score_gemma":0.984055,"teacher_disagreement_score":0.0709319,"about_ca_system_score_codex":0.0709319,"about_ca_system_score_gemma":0.08969966,"threshold_uncertainty_score":0.51464933},"labels":[],"label_agreement":null},{"id":"W2046820446","doi":"10.1016/j.jval.2014.03.1435","title":"Burden of illness of diabetic foot ulcers in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Emergency medicine; Incidence (geometry); Emergency department; Population; Psychological intervention; Foot (prosody); Diabetes mellitus; Pediatrics; Environmental health","score_opus":0.017907920729721968,"score_gpt":0.2722092171650025,"score_spread":0.25430129643528054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046820446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655784,0.0061007454,0.00010759862,0.0044993707,0.00009772434,0.00006371853,0.011141865,0.000019456027,0.012391095],"genre_scores_gemma":[0.99497753,0.0024883877,0.00009556492,0.00019192595,0.000018495848,0.0000068091563,0.0012062326,0.0000031229845,0.001012017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988171,0.000092301925,0.000075679636,0.00006198035,0.0005162254,0.00043668572],"domain_scores_gemma":[0.9975097,0.00010072831,0.0004397304,0.000025173074,0.00090432883,0.001020263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036264487,0.00021100877,0.00043494155,0.00194716,0.002086118,0.0017056551,0.00088871137,0.00046010167,0.0031406407],"category_scores_gemma":[0.002503107,0.0002646203,0.0007064884,0.0050809747,0.000542308,0.00040278575,0.0009883124,0.0011093192,0.00012570845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018791656,0.000098102864,0.9766163,0.000117762065,0.0001627078,0.00027495503,0.0006434489,0.00037135324,0.00012447622,0.0006949688,0.0053535537,0.015354441],"study_design_scores_gemma":[0.000014326577,0.00002425384,0.99555486,0.00010293584,0.000045901652,0.00011477882,0.0017484239,0.0004856318,0.000022598746,0.00008546101,0.0017845066,0.000016403616],"about_ca_topic_score_codex":0.9964508,"about_ca_topic_score_gemma":0.99753076,"teacher_disagreement_score":0.0420485,"about_ca_system_score_codex":0.0420485,"about_ca_system_score_gemma":0.051187593,"threshold_uncertainty_score":0.30508465},"labels":[],"label_agreement":null},{"id":"W2047307438","doi":"10.1016/j.jval.2011.02.896","title":"PCN38 FIRST-YEAR COSTS FOR THE 19 MOST COMMON CANCER DIAGNOSES IN ONTARIO","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Cancer; Cancer registry; Radiation therapy; Medical diagnosis; Activity-based costing; Total cost; Prostate cancer; Health care; Emergency medicine; Diagnosis code; Skin cancer; Pediatrics; Surgery; Internal medicine; Environmental health; Pathology","score_opus":0.13361914292070673,"score_gpt":0.28096325793350385,"score_spread":0.14734411501279712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047307438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91688794,0.002120648,0.00018796546,0.0028656092,0.00005202601,0.00007601484,0.06479974,0.000035555342,0.0129743805],"genre_scores_gemma":[0.9807583,0.0011346178,0.0001646284,0.00014050881,0.000023325458,0.000031047904,0.011657747,0.0000116942865,0.006078053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991252,0.000066767265,0.000074227144,0.000085991174,0.00034439846,0.00030336427],"domain_scores_gemma":[0.9976948,0.00019454861,0.00075281,0.000053241896,0.000717771,0.00058674463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004150609,0.0002460282,0.00039805312,0.0012817039,0.0012877795,0.0010065271,0.0009114124,0.00048219017,0.0055318717],"category_scores_gemma":[0.003463285,0.0003954423,0.001163986,0.0035937084,0.00039374013,0.0004663428,0.0007903083,0.0007045859,0.00030194482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000307621,0.000052810658,0.9672732,0.00021636268,0.00024563418,0.00034501223,0.00058153446,0.00268579,0.00016880322,0.001029342,0.016037254,0.011056637],"study_design_scores_gemma":[0.00002898134,0.000025043066,0.99341846,0.000041049927,0.000049225255,0.00012464274,0.00057272206,0.0011140165,0.000043308846,0.000107394866,0.0044626934,0.0000125057495],"about_ca_topic_score_codex":0.9925208,"about_ca_topic_score_gemma":0.9958919,"teacher_disagreement_score":0.057628162,"about_ca_system_score_codex":0.057628162,"about_ca_system_score_gemma":0.030431535,"threshold_uncertainty_score":0.41812354},"labels":[],"label_agreement":null},{"id":"W2047325091","doi":"10.1016/j.jval.2013.03.660","title":"The Labor Productivity Effects Of Prostate Cancer Patients On Spouses And Other Family Members: Evidence From Us National Survey Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retirement, Disability, and Employment","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Productivity; Medicine; Spillover effect; Medical Expenditure Panel Survey; Demography; Cancer; Prostate; Population; Gynecology; Environmental health; Health care; Internal medicine; Economics; Economic growth","score_opus":0.3553784444461985,"score_gpt":0.46235816298782006,"score_spread":0.10697971854162158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047325091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872677,0.0044227275,0.00015534859,0.0008590721,0.000037358124,0.0000117237505,0.0053801034,0.000004055153,0.0018620378],"genre_scores_gemma":[0.9960998,0.0013937647,0.0000413493,0.000111079076,0.00002547566,0.0000059135627,0.0020635216,0.0000012653621,0.00025779562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655426,0.0022014743,0.00025908812,0.00022827605,0.00040675944,0.00035015366],"domain_scores_gemma":[0.9655762,0.019796837,0.009408269,0.0019000096,0.0016365108,0.0016822232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003949016,0.00033934385,0.0004623567,0.0018772833,0.0004640529,0.000888769,0.0007403257,0.0005890802,0.0031512743],"category_scores_gemma":[0.024123063,0.00036147077,0.0014672288,0.003075456,0.00052450487,0.00078165834,0.0010488434,0.0008941304,0.00032712054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024170791,0.00006465568,0.994232,0.000048843827,0.0005747136,0.0000409343,0.00008686287,0.00018858982,0.000018964174,0.00006292712,0.0003949649,0.004044913],"study_design_scores_gemma":[0.000020028518,0.00006648128,0.9984365,0.00004610697,0.00023278475,0.000046837467,0.00035602364,0.00016709248,0.000026792886,0.00010145424,0.0004946395,0.0000052408445],"about_ca_topic_score_codex":0.046437744,"about_ca_topic_score_gemma":0.058478214,"teacher_disagreement_score":0.046437744,"about_ca_system_score_codex":0.0005370447,"about_ca_system_score_gemma":0.0006487599,"threshold_uncertainty_score":0.09233487},"labels":[],"label_agreement":null},{"id":"W2047386501","doi":"10.1016/j.jval.2011.08.1477","title":"PSS12 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study): Three-Month Findings","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Observational study; Visual acuity; Quality of life (healthcare); Macular edema; Diabetes mellitus; Diabetic macular edema; Diabetic retinopathy; Ophthalmology; Telephone interview; Optometry; Internal medicine","score_opus":0.19398659916561622,"score_gpt":0.35620017870497095,"score_spread":0.16221357953935472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047386501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9331917,0.0020507104,0.00013841971,0.0015948537,0.000076391545,0.0001593382,0.056913182,0.000033587625,0.005841649],"genre_scores_gemma":[0.9717747,0.0007463836,0.0002697305,0.00030308135,0.000060574082,0.00007248565,0.025719007,0.000010789743,0.0010432984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802136,0.00021980841,0.00016852573,0.0002012182,0.0008708777,0.00051831844],"domain_scores_gemma":[0.99440336,0.00032000785,0.0017458595,0.00024691928,0.0020823476,0.001201449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00214323,0.0007705387,0.0009122155,0.0016385901,0.0016862521,0.001485402,0.0017649493,0.0013970374,0.0018350668],"category_scores_gemma":[0.0070537725,0.0004620853,0.0014429691,0.0048218877,0.00047059802,0.0009968341,0.001671028,0.0016527609,0.00025015767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004889865,0.000074027295,0.99425393,0.0000381648,0.00016590575,0.00005052409,0.00013563863,0.000057004767,0.000051469266,0.00006483024,0.0024447388,0.0021748333],"study_design_scores_gemma":[0.000015445528,0.000021816486,0.999403,0.000008013256,0.00004394331,0.000019784582,0.00011252534,0.00004155449,0.0000072929524,0.000011209994,0.00030943038,0.0000060187203],"about_ca_topic_score_codex":0.92268974,"about_ca_topic_score_gemma":0.92056054,"teacher_disagreement_score":0.077310264,"about_ca_system_score_codex":0.009063072,"about_ca_system_score_gemma":0.014098269,"threshold_uncertainty_score":0.15553105},"labels":[],"label_agreement":null},{"id":"W2047429877","doi":"10.1016/j.jval.2012.08.2107","title":"PCN67 Economic Evaluation of Mono and Sequential Hormone Therapies for ER+ Women With Early Breast Cancer in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Ministry of Health and Long Term Care; Toronto Public Health; St. Michael's Hospital","funders":"","keywords":"Breast cancer; Tamoxifen; Medicine; Quality-adjusted life year; Oncology; Aromatase; Cancer; Cost effectiveness; Gynecology; Internal medicine; Risk analysis (engineering)","score_opus":0.2859693099425884,"score_gpt":0.395296503625064,"score_spread":0.10932719368247562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047429877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9135407,0.021968754,0.00110254,0.01085517,0.0003207956,0.0014643786,0.023210451,0.0000518009,0.027485246],"genre_scores_gemma":[0.98902446,0.0033606337,0.000711608,0.0004921208,0.0000460168,0.00016923154,0.0033358266,0.000012252302,0.0028479036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493116,0.0021858588,0.00023334513,0.00018092734,0.0013719844,0.0010967494],"domain_scores_gemma":[0.98987085,0.0032249026,0.00081853336,0.00017307747,0.0033714871,0.0025411774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054232976,0.00056660076,0.0011856586,0.0012653942,0.001242221,0.0022329714,0.0010126155,0.00078526285,0.0035099187],"category_scores_gemma":[0.020045051,0.0003603476,0.0018679952,0.0024323103,0.00078313315,0.00049523235,0.0009543611,0.0013306056,0.000118972406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0858628,0.0034423997,0.28993654,0.004877168,0.006101951,0.0007383061,0.00065768964,0.26004535,0.0010484619,0.023385525,0.07073144,0.2531723],"study_design_scores_gemma":[0.02180989,0.012511141,0.6412153,0.0032683488,0.0056989025,0.0006266097,0.0033141568,0.26302293,0.0013787234,0.005082783,0.041675974,0.00039519102],"about_ca_topic_score_codex":0.9748468,"about_ca_topic_score_gemma":0.9814585,"teacher_disagreement_score":0.08676748,"about_ca_system_score_codex":0.08676748,"about_ca_system_score_gemma":0.11332416,"threshold_uncertainty_score":0.6295451},"labels":[],"label_agreement":null},{"id":"W2047594089","doi":"10.1016/j.jval.2012.08.1610","title":"PRM147 Comparison of Indirect and Mixed Treatment Comparison (MTC) Meta-Analysis Techniques Used in the Evaluation of New Protease Inhibitors for the Treatment of Chronic Hepatitis C","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Telaprevir; Boceprevir; Ribavirin; Medicine; Meta-analysis; Internal medicine; Publication bias; Chronic hepatitis; Oncology; Gastroenterology; Virology","score_opus":0.4475224363997746,"score_gpt":0.49907620779884393,"score_spread":0.051553771399069304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047594089","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2263622,0.5903138,0.14676169,0.0018983776,0.010604853,0.008120198,0.0066973586,0.0019956033,0.007246003],"genre_scores_gemma":[0.9145631,0.025371334,0.042805117,0.0016496464,0.0008911337,0.00879866,0.0012950217,0.00045448187,0.0041714176],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8802111,0.10421301,0.007396888,0.004316554,0.0029095078,0.00095295464],"domain_scores_gemma":[0.9519474,0.041131347,0.0024214687,0.0031587584,0.0010139279,0.00032714717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04794935,0.00418428,0.01995153,0.003304611,0.0009655185,0.00367896,0.0030199657,0.004322617,0.007582011],"category_scores_gemma":[0.08132017,0.0024504156,0.056313507,0.0029898197,0.0011127807,0.00300905,0.0023717382,0.007070832,0.0006064993],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07540705,0.000060544375,0.0015865662,0.016608773,0.8942063,0.00011057821,0.00008843582,0.0016853133,0.00038066058,0.0007242907,0.00061237987,0.008529116],"study_design_scores_gemma":[0.048123408,0.003824126,0.0039381413,0.001627903,0.9298217,0.00020937891,0.00009639006,0.0066744047,0.0007386075,0.0028087313,0.0020020772,0.00013508313],"about_ca_topic_score_codex":0.006232449,"about_ca_topic_score_gemma":0.006446068,"teacher_disagreement_score":0.04794935,"about_ca_system_score_codex":0.0017222171,"about_ca_system_score_gemma":0.001660031,"threshold_uncertainty_score":0.2535835},"labels":[],"label_agreement":null},{"id":"W2048142373","doi":"10.1016/j.jval.2012.03.472","title":"PMH27 Economic Impact Associated with Antidepressant Use in Depression and Anxiety in Community Living Older Adults","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Sherbrooke","funders":"","keywords":"Depression (economics); Anxiety; Antidepressant; Medicine; Mental health; Psychiatry; Population; Demography; Gerontology; Environmental health","score_opus":0.045695538816775884,"score_gpt":0.3473912005392989,"score_spread":0.301695661722523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048142373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99646664,0.0005598871,0.000029657425,0.00046320754,0.00002316362,0.000008292732,0.0011274884,0.0000018044483,0.001319809],"genre_scores_gemma":[0.9987496,0.00024215455,0.000028977362,0.000060976097,0.00004107601,0.0000061932055,0.00054459844,0.0000011340704,0.00032510742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995433,0.00012019732,0.000059063153,0.000036340523,0.00007869318,0.00016244623],"domain_scores_gemma":[0.99829966,0.00031408947,0.0007038032,0.00006426772,0.0001506213,0.00046749858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004413909,0.00019840087,0.00029787695,0.0007331493,0.0004950025,0.00081999967,0.00034654356,0.0004886793,0.004494926],"category_scores_gemma":[0.0046419497,0.00018831328,0.0011149001,0.0011917152,0.00020382303,0.0004809134,0.0010651102,0.00089760363,0.00020383508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031109658,0.000110774265,0.995336,0.000020872365,0.00018010385,0.00009401344,0.000052076346,0.000098100594,0.000040498424,0.00008874111,0.00030256936,0.0033652403],"study_design_scores_gemma":[0.0000068831337,0.00002803586,0.9995233,0.000007961445,0.00003621856,0.00003063878,0.000106947715,0.0001130866,0.000008095106,0.000036379046,0.00010040669,0.0000019732547],"about_ca_topic_score_codex":0.030301174,"about_ca_topic_score_gemma":0.033690155,"teacher_disagreement_score":0.030301174,"about_ca_system_score_codex":0.0006123103,"about_ca_system_score_gemma":0.0006051187,"threshold_uncertainty_score":0.060249627},"labels":[],"label_agreement":null},{"id":"W2048344726","doi":"10.1016/j.jval.2010.10.019","title":"Cost-Effectiveness of Transdermal Nitroglycerin Use for Preterm Labor","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Preterm Birth and Chorioamnionitis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Public Health Ontario; University of Toronto; Kingston General Hospital; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gestational age; Neonatal intensive care unit; Randomized controlled trial; Placebo; Cost effectiveness; Obstetrics; Pregnancy; Pediatrics; Surgery","score_opus":0.1579969204747736,"score_gpt":0.3458991948890179,"score_spread":0.18790227441424429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048344726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833666,0.010581934,0.00046031256,0.0017665729,0.00011663963,0.00010710561,0.00058036216,0.000023782222,0.0029967797],"genre_scores_gemma":[0.998415,0.0010505703,0.00015738502,0.00007395612,0.000033801116,0.000017068503,0.000090027206,0.0000015560602,0.00016057077],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99881774,0.0007741688,0.000076691336,0.000072908406,0.00013171435,0.00012673745],"domain_scores_gemma":[0.99677014,0.0023753024,0.0004236844,0.000063832704,0.00009226162,0.00027482858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092476216,0.00048289757,0.0010189619,0.00080154644,0.00019607585,0.0007662084,0.0004615843,0.0011261324,0.0037071262],"category_scores_gemma":[0.007105839,0.0002628541,0.0026754464,0.00054568215,0.00038813622,0.0007995874,0.00049257075,0.0009499296,0.0001377371],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32545996,0.0065012,0.13879827,0.0028211637,0.011946562,0.0015998083,0.00026974804,0.07146037,0.004859539,0.0038531548,0.0025322146,0.42989808],"study_design_scores_gemma":[0.046381503,0.14513373,0.59778225,0.0018511523,0.03407195,0.0046869433,0.0014799152,0.1493719,0.0065072943,0.006904041,0.0055063264,0.00032295243],"about_ca_topic_score_codex":0.006860207,"about_ca_topic_score_gemma":0.0066172793,"teacher_disagreement_score":0.006860207,"about_ca_system_score_codex":0.002806457,"about_ca_system_score_gemma":0.0013049479,"threshold_uncertainty_score":0.020362377},"labels":[],"label_agreement":null},{"id":"W2048399100","doi":"10.1016/j.jval.2013.08.892","title":"Canadian Private Payers’ Perceptions and Expectations of Submission Requests for Drug Reimbursement Submitted by the Pharmaceutical Industry","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Reimbursement; Agency (philosophy); Business; Actuarial science; Population; Productivity; Private sector; Family medicine; Health care; Medicine; Economics; Environmental health","score_opus":0.3024639696780433,"score_gpt":0.43516995105489825,"score_spread":0.13270598137685496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048399100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9559879,0.00054153526,0.00017078279,0.013871111,0.000059903876,0.00008302391,0.000687657,0.000016003863,0.02858202],"genre_scores_gemma":[0.99534094,0.00032660068,0.000115277355,0.0013759085,0.00002963364,0.000019599944,0.00024898793,0.000012381824,0.0025306009],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.98329043,0.0030193757,0.001066714,0.00059588545,0.008904577,0.003123077],"domain_scores_gemma":[0.8719917,0.05123513,0.02134911,0.001804377,0.034542788,0.019076852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012320684,0.0002135615,0.00036360463,0.002895214,0.0054671634,0.008074627,0.0012585608,0.002497558,0.007893284],"category_scores_gemma":[0.099945255,0.0004384253,0.00069715653,0.0036361874,0.002915776,0.0015367476,0.0019687226,0.002772907,0.00062348787],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012425125,0.00053123076,0.77832615,0.00020600557,0.00012538942,0.0007974049,0.13549435,0.0007851535,0.0012354831,0.008041264,0.038775057,0.034439944],"study_design_scores_gemma":[0.00007516815,0.00015565015,0.83013666,0.00023582038,0.00004373636,0.00020707557,0.14438982,0.0012703863,0.00026362264,0.0007948399,0.022254765,0.00017262535],"about_ca_topic_score_codex":0.9295111,"about_ca_topic_score_gemma":0.9263763,"teacher_disagreement_score":0.9510699,"about_ca_system_score_codex":0.04893012,"about_ca_system_score_gemma":0.045658506,"threshold_uncertainty_score":0.35501456},"labels":[],"label_agreement":null},{"id":"W2048879818","doi":"10.1016/j.jval.2014.08.119","title":"Abraxane Versus Taxol For Patients with Advanced Breast Cancer: A Prospective Time and Motion Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Premedication; Breast cancer; Paclitaxel; Adverse effect; Cancer; Psychological intervention; Emergency medicine; Internal medicine; Anesthesia","score_opus":0.008759623679871185,"score_gpt":0.329815392597895,"score_spread":0.3210557689180238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048879818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793494,0.0013598951,0.00010000802,0.000107084416,0.0000069564658,0.000017994587,0.00015137457,9.816285e-7,0.00032080582],"genre_scores_gemma":[0.99913436,0.00039797256,0.00006323638,0.0000559124,0.000016066157,0.000008591855,0.0002222442,0.0000010315827,0.0001005275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995357,0.00015982435,0.000038489063,0.00007585783,0.000056030585,0.00013412727],"domain_scores_gemma":[0.9985374,0.00056399876,0.00056757964,0.000053971118,0.000090915164,0.00018605933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009672596,0.00026151174,0.0007222776,0.00074758683,0.00039979312,0.00063967344,0.00029542542,0.0003459141,0.0020936313],"category_scores_gemma":[0.0022669844,0.00015741886,0.0015637603,0.001326714,0.0003617895,0.0006490221,0.00046587363,0.0007114086,0.000085730695],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028360825,0.00046505049,0.94227904,0.00020376238,0.0023684176,0.00032325002,0.0002963221,0.0016847495,0.0008685693,0.0006009225,0.00036379986,0.022185216],"study_design_scores_gemma":[0.0010589749,0.005460772,0.98178816,0.00004011578,0.0038662248,0.00016808181,0.0011237598,0.0050798054,0.00026659525,0.00047132428,0.00063900877,0.0000370686],"about_ca_topic_score_codex":0.010442883,"about_ca_topic_score_gemma":0.014471649,"teacher_disagreement_score":0.010442883,"about_ca_system_score_codex":0.0010033203,"about_ca_system_score_gemma":0.0013270627,"threshold_uncertainty_score":0.020764172},"labels":[],"label_agreement":null},{"id":"W2049697547","doi":"10.1016/s1098-3015(10)61262-4","title":"PHP24 USE OF POLICY MODELING TO PROMOTE INFORMED DECISION MAKING: DEVELOPMENT AND APPLICATION OF THE CANADIAN STROKE POLICY MODEL","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stroke (engine); Policy making; Policy development; Business; Actuarial science; Public administration; Political science; Engineering","score_opus":0.47286894067765156,"score_gpt":0.43394753715072243,"score_spread":0.03892140352692913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049697547","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01922303,0.0008699281,0.37472302,0.032889444,0.00043746948,0.001494321,0.010186249,0.0012254495,0.558951],"genre_scores_gemma":[0.5070933,0.0025463186,0.41494742,0.0014403806,0.00014610407,0.0013990834,0.0038838293,0.0004940193,0.0680495],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996305,0.001443509,0.0001192548,0.0002028819,0.0015613035,0.00036802774],"domain_scores_gemma":[0.98778594,0.004972814,0.0003050433,0.00053297385,0.0059371036,0.00046606796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008420018,0.00091802253,0.00057337584,0.0035719732,0.0024703543,0.0043304595,0.00241692,0.001574523,0.0192832],"category_scores_gemma":[0.030050024,0.0005581593,0.00093459076,0.0034157431,0.0013898879,0.0018466744,0.0018310908,0.0017356302,0.0014276244],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042991585,0.00008793666,0.0034328422,0.00016679238,0.000063659725,0.000086799686,0.00035733392,0.3010774,0.00013314762,0.563234,0.06640417,0.06491294],"study_design_scores_gemma":[0.00006148947,0.00002325647,0.0026749216,0.00023685026,0.00006671691,0.00004158384,0.00041914167,0.7027511,0.00043195445,0.1533028,0.1399138,0.00007637476],"about_ca_topic_score_codex":0.91807264,"about_ca_topic_score_gemma":0.8956,"teacher_disagreement_score":0.08192736,"about_ca_system_score_codex":0.037703957,"about_ca_system_score_gemma":0.08638764,"threshold_uncertainty_score":0.27356267},"labels":[],"label_agreement":null},{"id":"W2049719754","doi":"10.1016/j.jval.2013.03.574","title":"Cost to society due to underemployment in persons with hemophilia A and B – hemophilia utilization group study v (HUGS V)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Underemployment; Medicine; Earnings; Wage; Pediatrics; Demography; Compensation (psychology); Unemployment; Psychology; Labour economics; Economics; Finance; Social psychology","score_opus":0.12784024138465724,"score_gpt":0.37361998689373804,"score_spread":0.2457797455090808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049719754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98802304,0.002044241,0.000061565406,0.001125911,0.00012264182,0.000031924064,0.006385117,0.000011142427,0.0021945136],"genre_scores_gemma":[0.99332523,0.0014476832,0.00008523758,0.00015684305,0.000084245745,0.000019004914,0.003590918,0.0000033626866,0.0012875678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994809,0.00020302788,0.000058246176,0.000022819191,0.00009033569,0.0001447525],"domain_scores_gemma":[0.99870396,0.00015216204,0.00047441345,0.000048213897,0.00012667467,0.0004945826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035828477,0.00033005895,0.0002588318,0.0010851616,0.00048672679,0.00072775665,0.0003395341,0.00047224335,0.0026314012],"category_scores_gemma":[0.0026113866,0.00020888449,0.0010428136,0.0011991496,0.00019187976,0.00041449745,0.0010473835,0.0006623259,0.00015686534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053834234,0.00020635639,0.976602,0.00007952387,0.00029329324,0.00029450603,0.00012912971,0.00030544883,0.00007685712,0.00036158384,0.005450329,0.015662638],"study_design_scores_gemma":[0.00006282507,0.00020075629,0.99580353,0.00006857116,0.00014958576,0.00031740233,0.0006711536,0.00045562556,0.000041731793,0.00017927281,0.0020401394,0.000009435916],"about_ca_topic_score_codex":0.04181003,"about_ca_topic_score_gemma":0.0532956,"teacher_disagreement_score":0.04181003,"about_ca_system_score_codex":0.0009776875,"about_ca_system_score_gemma":0.0012183825,"threshold_uncertainty_score":0.08313334},"labels":[],"label_agreement":null},{"id":"W2049810647","doi":"10.1016/j.jval.2012.08.740","title":"PHP198 From Science to Service: The Ontario Patient Reported Outcomes of Symptoms and Toxicity (On-PROST) Research Unit","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Prom; Standardization; Medicine; Quality of life (healthcare); Health care; Family medicine; Nursing; Computer science; Political science","score_opus":0.14552885857160391,"score_gpt":0.40306017889567075,"score_spread":0.25753132032406684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049810647","genre_codex":"dataset","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24699658,0.0034314054,0.0007742642,0.06453776,0.0017418853,0.010919178,0.46449062,0.00048083023,0.2066274],"genre_scores_gemma":[0.5089272,0.006986423,0.008068047,0.024811322,0.001701703,0.012465268,0.17840838,0.00063668366,0.2579949],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99732375,0.00033742303,0.00016584097,0.00014608612,0.0014557434,0.0005711592],"domain_scores_gemma":[0.97615576,0.0014183751,0.0017308466,0.0007159133,0.010824984,0.0091540655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035778144,0.00043244677,0.0007516003,0.0017208912,0.003303011,0.0029887399,0.0015377129,0.0010636197,0.038294677],"category_scores_gemma":[0.009879995,0.00049883843,0.00087312807,0.0034589549,0.0010374058,0.00082937186,0.0020066947,0.0014799689,0.00474909],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035756908,0.0009237768,0.19684069,0.00046821227,0.00016673851,0.00019738902,0.00057674083,0.0002769045,0.0006674236,0.0011267861,0.69286776,0.10231191],"study_design_scores_gemma":[0.001983362,0.00076574733,0.8548398,0.00047238026,0.00009993459,0.00004181979,0.000798429,0.00036309363,0.0002992072,0.00043368185,0.13985647,0.00004601331],"about_ca_topic_score_codex":0.9020387,"about_ca_topic_score_gemma":0.97201836,"teacher_disagreement_score":0.96344686,"about_ca_system_score_codex":0.03655314,"about_ca_system_score_gemma":0.104158446,"threshold_uncertainty_score":0.2652129},"labels":[],"label_agreement":null},{"id":"W2050050244","doi":"10.1016/j.jval.2012.03.351","title":"PMD11 Budget Impact of Converting Standard Treatment of Menorrhagia from Rollerball to Thermal Balloon Ablation in Canadian Hospitals","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Balloon; Ablation; Surgery; Activity-based costing; Environmental science; Business","score_opus":0.029963244373344435,"score_gpt":0.27413896234862156,"score_spread":0.24417571797527712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050050244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7452911,0.004161802,0.0012701164,0.042058706,0.0009852699,0.00074713875,0.111219384,0.00031201847,0.09395441],"genre_scores_gemma":[0.9609306,0.0014414877,0.00096334773,0.0020627014,0.00014875646,0.00011733078,0.016351817,0.00004481818,0.017939046],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9954158,0.00070542505,0.00015890185,0.00018820511,0.0011489611,0.0023826845],"domain_scores_gemma":[0.98867714,0.0023793054,0.0010488546,0.00020031873,0.005088365,0.0026060927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002613453,0.0005180192,0.0007401313,0.0019165357,0.0015830157,0.0030911434,0.0012354783,0.0010860489,0.020125214],"category_scores_gemma":[0.01986972,0.00048055343,0.0017231379,0.0028657562,0.00060959044,0.00055742747,0.0011542366,0.0015560226,0.00068952155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01483294,0.0009184379,0.29634348,0.0015576351,0.0012847452,0.0009331023,0.0004175508,0.19031888,0.002053664,0.025311358,0.32047865,0.1455495],"study_design_scores_gemma":[0.0023610112,0.0010604021,0.8454349,0.00050163467,0.00095831236,0.00031625305,0.0024238818,0.06831493,0.0020976267,0.002246243,0.07405963,0.00022522836],"about_ca_topic_score_codex":0.9868182,"about_ca_topic_score_gemma":0.9880165,"teacher_disagreement_score":0.8850087,"about_ca_system_score_codex":0.11499128,"about_ca_system_score_gemma":0.107482255,"threshold_uncertainty_score":0.834324},"labels":[],"label_agreement":null},{"id":"W2050130923","doi":"10.1016/j.jval.2014.03.069","title":"Role Of Patient Input In The Cedac Drug Reimbursement Decision Making Process","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Reimbursement; Medicine; Drug; Placebo; Agency (philosophy); Logistic regression; Family medicine; Internal medicine; Health care; Pharmacology; Alternative medicine; Political science","score_opus":0.20506975669043787,"score_gpt":0.4179627945694909,"score_spread":0.21289303787905306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050130923","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22895601,0.009299038,0.26084134,0.22675541,0.002048858,0.0031407445,0.0038439264,0.0010368299,0.2640779],"genre_scores_gemma":[0.93579525,0.0010642187,0.052644946,0.0057810238,0.0006334712,0.00032172175,0.00046023724,0.00013634526,0.00316267],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.86675113,0.10881702,0.0053248405,0.002620392,0.01212498,0.0043616574],"domain_scores_gemma":[0.44205752,0.5222789,0.00822447,0.004863285,0.01684593,0.005729856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10939203,0.0013102887,0.0026749477,0.0035035918,0.0021641694,0.022441043,0.0017728843,0.0054291342,0.025199525],"category_scores_gemma":[0.33417544,0.0010270395,0.0015597474,0.0020815588,0.0018591275,0.0065466263,0.004594603,0.0078107393,0.0022555925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061365217,0.0019523773,0.09070989,0.0017702305,0.0009944653,0.0018873384,0.0047151027,0.09140726,0.0016648158,0.1234639,0.05301808,0.62228],"study_design_scores_gemma":[0.0016624681,0.0020230527,0.051290795,0.005364031,0.0010048478,0.0020602522,0.0060931067,0.42206126,0.012748287,0.35656226,0.13839084,0.0007387958],"about_ca_topic_score_codex":0.004317524,"about_ca_topic_score_gemma":0.0040938007,"teacher_disagreement_score":0.9931152,"about_ca_system_score_codex":0.0068848305,"about_ca_system_score_gemma":0.017402632,"threshold_uncertainty_score":0.5785273},"labels":[],"label_agreement":null},{"id":"W2050176772","doi":"10.1016/j.jval.2013.03.1357","title":"Excite – A New Collaborative Model Of Pre-Market Evaluation Of Health Technologies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care; Ottawa Hospital; University of Ottawa; University of Toronto; McMaster University; Programs for Assessment of Technology in Health Research Institute; Toronto Public Health; MaRS","funders":"","keywords":"Health technology; Commercialization; Government (linguistics); Reimbursement; Excellence; Business; Public relations; Health care; Marketing; Political science","score_opus":0.4841969374519139,"score_gpt":0.44856431479494646,"score_spread":0.03563262265696743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050176772","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023542434,0.0006311044,0.8596132,0.008420727,0.00028796573,0.0002495934,0.00057808525,0.0004526761,0.10622435],"genre_scores_gemma":[0.73269403,0.00096191047,0.17707174,0.0012444593,0.0006257914,0.0006090984,0.00062983064,0.00043555052,0.08572755],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9914727,0.005443666,0.00025382833,0.0010228881,0.001355969,0.0004508417],"domain_scores_gemma":[0.97779673,0.016268007,0.0014280379,0.0019423899,0.0014261679,0.0011387625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008885038,0.0012161881,0.0017982039,0.001887935,0.0015498336,0.006987634,0.0039890446,0.0053519784,0.03523243],"category_scores_gemma":[0.050741367,0.0008509374,0.0020209162,0.001916729,0.0036972682,0.014844272,0.0049807876,0.0038357563,0.0026575627],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010510672,0.00009392548,0.00083425565,0.00005856087,0.000088564295,0.00018172941,0.00027086848,0.079198904,0.00015031725,0.89475405,0.0050858976,0.019177727],"study_design_scores_gemma":[0.000076068354,0.00006243985,0.00027007825,0.000029292305,0.000028422905,0.00007640251,0.00007266666,0.20477712,0.00017306599,0.7837743,0.010631658,0.000028386878],"about_ca_topic_score_codex":0.0074017663,"about_ca_topic_score_gemma":0.0053946874,"teacher_disagreement_score":0.03523243,"about_ca_system_score_codex":0.0032163665,"about_ca_system_score_gemma":0.0034244661,"threshold_uncertainty_score":0.11786419},"labels":[],"label_agreement":null},{"id":"W2050192040","doi":"10.1016/s1098-3015(10)70023-1","title":"CASE 2 DRUG ELUTING STENTS—AN EXAMPLE OFTHETRANSITION FROM EVIDENCETO POLICYTHROUGHTHE ONTARIO COMPREHENSIVE APPROACHTOTHE DIFFUSION OF HEALTHTECHNOLOGIES","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Diffusion; Drug-eluting stent; Medicine; Internal medicine; Pharmacology; Stent; Physics; Thermodynamics; Restenosis","score_opus":0.3444027444756034,"score_gpt":0.32492176232762154,"score_spread":0.01948098214798183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050192040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45280918,0.001485264,0.012137644,0.21299924,0.00047339805,0.0007383148,0.00133341,0.000088119275,0.31793538],"genre_scores_gemma":[0.94337136,0.0008039467,0.0042771865,0.015054484,0.00013669393,0.00013120715,0.00018416945,0.00003853185,0.03600241],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.993046,0.001260638,0.00022993091,0.0003328824,0.0018809821,0.0032496427],"domain_scores_gemma":[0.9912287,0.0037008221,0.0010385088,0.00048626092,0.0016549072,0.0018907286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040806294,0.00038485907,0.00046190253,0.0013799585,0.008443487,0.003733398,0.0013785281,0.0077977423,0.010832021],"category_scores_gemma":[0.016632158,0.000392716,0.00084653025,0.0020034297,0.004816488,0.0021916346,0.0036637606,0.004980213,0.0003407854],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005687532,0.0007685865,0.07629662,0.0004069073,0.00011348679,0.071781866,0.034394566,0.007109114,0.0049709002,0.6511328,0.09234784,0.06010851],"study_design_scores_gemma":[0.0005807073,0.00044087978,0.1218463,0.0008425575,0.00022853723,0.02417551,0.052861046,0.013151803,0.0062206252,0.1371229,0.64208996,0.00043915465],"about_ca_topic_score_codex":0.8007306,"about_ca_topic_score_gemma":0.8983698,"teacher_disagreement_score":0.96926737,"about_ca_system_score_codex":0.030732624,"about_ca_system_score_gemma":0.04941642,"threshold_uncertainty_score":0.40088588},"labels":[],"label_agreement":null},{"id":"W2050365725","doi":"10.1016/j.jval.2014.03.492","title":"Cost-Effectiveness of Arsenic Trioxide in the Treatment of Relapsed/Refractory Acute Promyelocytic Lymphoma LEUKEMIA in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Arsenic trioxide; Acute promyelocytic leukemia; Refractory (planetary science); Internal medicine; Adverse effect; Oncology; Retinoic acid; Arsenic","score_opus":0.022179697083158992,"score_gpt":0.273917739624355,"score_spread":0.251738042541196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050365725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666011,0.011041303,0.0002624108,0.009013768,0.00010921762,0.0002484432,0.0044691185,0.000036722162,0.0082179215],"genre_scores_gemma":[0.9947797,0.002769319,0.00023635241,0.0003953201,0.000030351071,0.000025100493,0.00058037566,0.000005528896,0.0011779453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989778,0.0003180766,0.00007207356,0.000056421028,0.0002950716,0.0002805841],"domain_scores_gemma":[0.99796885,0.00025399923,0.00030514956,0.000020176822,0.0006393846,0.0008124512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006286366,0.00023235717,0.0005500902,0.0009988811,0.000773585,0.0012617974,0.0008747956,0.0005353749,0.0025424482],"category_scores_gemma":[0.002657176,0.0001672767,0.00090273254,0.0019179435,0.00053008593,0.00026403312,0.0005699573,0.00062235806,0.00008022911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034041185,0.002066279,0.510037,0.0028830005,0.0029595005,0.002002611,0.00080807373,0.06482821,0.0048932363,0.00921643,0.027185878,0.33907858],"study_design_scores_gemma":[0.004674623,0.004486489,0.9182172,0.0007999355,0.0035273305,0.0010038055,0.0030631735,0.039580714,0.0016373538,0.0014904496,0.02135952,0.00015948589],"about_ca_topic_score_codex":0.97456247,"about_ca_topic_score_gemma":0.9868209,"teacher_disagreement_score":0.07789203,"about_ca_system_score_codex":0.07789203,"about_ca_system_score_gemma":0.06584112,"threshold_uncertainty_score":0.56514883},"labels":[],"label_agreement":null},{"id":"W2050464419","doi":"10.1016/j.jval.2013.03.153","title":"Modelling drug class effects in bayesian multiple treatment comparison meta-analysis: Applications in early and advanced parkinson's disease","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Drug class; Drug; Medicine; Random effects model; Parkinson's disease; Class (philosophy); Pharmacology; Disease; Internal medicine; Computer science; Meta-analysis; Artificial intelligence","score_opus":0.4652705594039648,"score_gpt":0.5116672727313282,"score_spread":0.04639671332736339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050464419","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009256718,0.02107986,0.96491086,0.002528476,0.0003936533,0.00042945758,0.00039009756,0.00047497076,0.00053589814],"genre_scores_gemma":[0.25340235,0.013754591,0.7236941,0.00204758,0.0008464479,0.0026410487,0.0005788966,0.00047599824,0.0025589673],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.85876304,0.13326381,0.0022257105,0.0029928198,0.0023009265,0.00045366382],"domain_scores_gemma":[0.5407391,0.4460672,0.005269077,0.0050550327,0.0021591547,0.00071043056],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15165924,0.00381336,0.010863826,0.0037303965,0.0009833814,0.00471847,0.0052472847,0.005182898,0.003508518],"category_scores_gemma":[0.2906597,0.003013896,0.011111896,0.0042507323,0.0024163509,0.004343254,0.0035021568,0.0078111016,0.00048853725],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006587423,0.00037669286,0.004866224,0.0076393806,0.04329527,0.00044359048,0.0007088911,0.6553175,0.0006145288,0.10134816,0.006380245,0.17242216],"study_design_scores_gemma":[0.0018841461,0.00055419107,0.0012812101,0.00090280717,0.010147558,0.00023653446,0.00007328726,0.7442157,0.00035222952,0.23631215,0.0038885726,0.0001515207],"about_ca_topic_score_codex":0.008112376,"about_ca_topic_score_gemma":0.010314753,"teacher_disagreement_score":0.84834075,"about_ca_system_score_codex":0.002272455,"about_ca_system_score_gemma":0.0045012953,"threshold_uncertainty_score":0.80206025},"labels":[],"label_agreement":null},{"id":"W2050640972","doi":"10.1046/j.1524-4733.2001.40202-259.x","title":"PWM7: THE EFFECT AND ECONOMIC IMPACT OF STANDARDIZED ORDERS ON THE PREVENTION AND TREATMENT OF PONV IN HOSPITALIZED GYNECOLOGICAL SURGERY PATIENTS","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Intensive care medicine; General surgery; Surgery","score_opus":0.023877990398167206,"score_gpt":0.31673299721049153,"score_spread":0.29285500681232435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050640972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667704,0.00024019464,0.00007425046,0.0009287578,0.00004959789,0.00008736787,0.00036563136,0.000012775578,0.0015645378],"genre_scores_gemma":[0.9987172,0.00017616375,0.00028049058,0.00013065076,0.00005916006,0.000050881303,0.00029609128,0.0000033402855,0.00028611528],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99875057,0.00072430004,0.000108270324,0.000069259906,0.00013196135,0.00021575188],"domain_scores_gemma":[0.9935695,0.0032476059,0.0011519529,0.00019388448,0.00023280698,0.0016042003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001614551,0.0003468498,0.0004965111,0.00057230814,0.00036367675,0.00078038714,0.00055205513,0.00089912425,0.00928606],"category_scores_gemma":[0.014450229,0.00020350942,0.0010738387,0.00057899556,0.00035518254,0.0007803741,0.0008395324,0.0010104275,0.0003421173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16731451,0.02514942,0.32743615,0.00094749173,0.0016415833,0.000584952,0.00035998347,0.006372446,0.0010075489,0.0017945064,0.008242929,0.45914844],"study_design_scores_gemma":[0.03500798,0.11581821,0.82569575,0.00045608848,0.0015312731,0.0004052647,0.0014115771,0.013843528,0.0014149542,0.0013847079,0.002935714,0.00009497138],"about_ca_topic_score_codex":0.007952969,"about_ca_topic_score_gemma":0.0077784676,"teacher_disagreement_score":0.00928606,"about_ca_system_score_codex":0.0017079756,"about_ca_system_score_gemma":0.004445013,"threshold_uncertainty_score":0.031064928},"labels":[],"label_agreement":null},{"id":"W2050988623","doi":"10.1016/j.jval.2013.03.009","title":"Adjusting For Inflation In Economic Evaluations Of Health Technologies: Are We Doing It Wrong?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Inflation (cosmology); Economics; Discounting; Real interest rate; Econometrics; Interest rate; Macroeconomics","score_opus":0.4809796062102137,"score_gpt":0.46421806928495524,"score_spread":0.016761536925258447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050988623","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2901278,0.12421958,0.09032206,0.45866543,0.011872828,0.00040179028,0.00323636,0.0004422586,0.020711845],"genre_scores_gemma":[0.9510576,0.007317853,0.015338081,0.021532912,0.003178421,0.00022878041,0.00062022114,0.00016411248,0.00056187867],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.73811066,0.22639441,0.013059966,0.0034963933,0.016323034,0.0026155056],"domain_scores_gemma":[0.36163133,0.5405633,0.055291165,0.018125001,0.02049231,0.00389695],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19955601,0.0013901202,0.0035694437,0.0024818326,0.0009141027,0.0067161247,0.0023745107,0.0054251393,0.002255613],"category_scores_gemma":[0.6792646,0.000791768,0.0024397634,0.006174063,0.004524152,0.011570282,0.0026223275,0.010228645,0.00040690886],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034672334,0.0007740314,0.39453483,0.0031263917,0.014277835,0.0002702796,0.0035554143,0.016027717,0.00020829565,0.087394,0.059733417,0.4166305],"study_design_scores_gemma":[0.0014069928,0.0014222534,0.31666717,0.008895157,0.007572728,0.0005637127,0.0035840354,0.05334064,0.0017497547,0.5597947,0.044105478,0.00089737406],"about_ca_topic_score_codex":0.009007629,"about_ca_topic_score_gemma":0.0065492815,"teacher_disagreement_score":0.800444,"about_ca_system_score_codex":0.003089642,"about_ca_system_score_gemma":0.00424388,"threshold_uncertainty_score":0.98708993},"labels":[],"label_agreement":null},{"id":"W2051446824","doi":"10.1016/j.jval.2011.02.913","title":"PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; St. Michael's Hospital","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Aromatase; Internal medicine; Genetic testing; CYP2D6; Aromatase inhibitor; Hormone therapy; Cancer; Gynecology","score_opus":0.01956320537545525,"score_gpt":0.2750943489068541,"score_spread":0.25553114353139883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051446824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7212525,0.09092141,0.005047278,0.10721393,0.0028693995,0.0003983208,0.0024804736,0.0003346976,0.069482],"genre_scores_gemma":[0.9792215,0.009653063,0.0021277608,0.003956697,0.0015534115,0.00005873454,0.00046639962,0.000027431308,0.0029350219],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989986,0.00046629185,0.000059101945,0.00010931045,0.0002518341,0.000114873306],"domain_scores_gemma":[0.9972505,0.0015991988,0.00044883732,0.00009351741,0.00015390545,0.00045396783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009130303,0.00052228256,0.0014172662,0.0007841487,0.00022867059,0.000979977,0.0005674896,0.0014072191,0.011927278],"category_scores_gemma":[0.0068785017,0.00022752423,0.0012347061,0.00093189784,0.0005195418,0.00079692167,0.0003650166,0.0010453576,0.001105065],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032811817,0.0017501795,0.14017375,0.00073254225,0.0020619184,0.004975063,0.000081854014,0.0039790445,0.0054662423,0.0028240955,0.018229792,0.7869138],"study_design_scores_gemma":[0.014098214,0.033972055,0.7297109,0.002414694,0.008896898,0.029503906,0.0010847072,0.013327597,0.011686796,0.015551185,0.13945316,0.00029993383],"about_ca_topic_score_codex":0.0021865843,"about_ca_topic_score_gemma":0.0059728655,"teacher_disagreement_score":0.011927278,"about_ca_system_score_codex":0.0012056213,"about_ca_system_score_gemma":0.0013594293,"threshold_uncertainty_score":0.03990072},"labels":[],"label_agreement":null},{"id":"W2051531643","doi":"10.1016/j.jval.2012.08.1227","title":"PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Context (archaeology); Progression-free survival; Chronic lymphocytic leukemia; Oncology; Surrogate endpoint; Population; Clinical endpoint; Overall survival; Clinical trial; Leukemia","score_opus":0.10165529097467764,"score_gpt":0.3796639260114467,"score_spread":0.2780086350367691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051531643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977309,0.0009790905,0.00008133942,0.00015233089,0.000008048503,0.0000045918155,0.00016107695,0.000004134607,0.0008784394],"genre_scores_gemma":[0.9992237,0.00017352885,0.000054156753,0.000026333402,0.000014449701,0.0000028373915,0.00017462985,0.0000017009768,0.00032863507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997861,0.00006942381,0.000015580788,0.000022305408,0.00004331313,0.0000633458],"domain_scores_gemma":[0.9984621,0.00048773744,0.00056223426,0.00004851444,0.00017473387,0.00026463307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004530468,0.00014024563,0.00016624536,0.00078660867,0.00033688408,0.0006221715,0.00034550723,0.000361051,0.00181255],"category_scores_gemma":[0.002980578,0.000097384705,0.0001654146,0.0011686472,0.00032635112,0.0003687158,0.00040399056,0.0006366394,0.00013107654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007728642,0.000048880258,0.98742175,0.000014123733,0.00004050666,0.00008643316,0.000054912183,0.00015358716,0.0006094962,0.00016334478,0.00029802765,0.010335958],"study_design_scores_gemma":[0.000014503793,0.000104427316,0.9979685,0.0000077997365,0.000040300532,0.00016813891,0.0001135203,0.00045959896,0.00019925217,0.00025692536,0.0006630329,0.0000039390575],"about_ca_topic_score_codex":0.0061378395,"about_ca_topic_score_gemma":0.007017468,"teacher_disagreement_score":0.0061378395,"about_ca_system_score_codex":0.00062292,"about_ca_system_score_gemma":0.00038564188,"threshold_uncertainty_score":0.01220423},"labels":[],"label_agreement":null},{"id":"W2051978677","doi":"10.1016/j.jval.2012.03.279","title":"PMS90 the Influence of ‘Weak Links' on Comparative Treatment Effects in Multiple Treatment Comparison Meta-Analysis: A Simulation Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Meta-analysis; Spurious relationship; Statistics; Cluster (spacecraft); Treatment effect; Confidence interval; Treatment and control groups; Multiple comparisons problem; Medicine; Econometrics; Mathematics; Computer science; Internal medicine","score_opus":0.8576107612714143,"score_gpt":0.6472244818715237,"score_spread":0.21038627939989063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051978677","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38573253,0.045448262,0.5317324,0.011095219,0.001319211,0.00291224,0.002875092,0.0013143913,0.017570745],"genre_scores_gemma":[0.92482567,0.0023494053,0.06833933,0.0013036515,0.00016153642,0.0012481449,0.00036091974,0.0002058361,0.0012055138],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.738043,0.25202605,0.003584546,0.003152345,0.002504268,0.000689743],"domain_scores_gemma":[0.122904375,0.86028445,0.005645564,0.008462747,0.0022127857,0.000490153],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2058899,0.00200671,0.005386657,0.0018455208,0.000860785,0.0032124952,0.0027645708,0.0047814874,0.0063973772],"category_scores_gemma":[0.5389632,0.0018448215,0.012259414,0.0027313475,0.0032504683,0.003999729,0.002935157,0.006913489,0.0004986374],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067873314,0.0012797276,0.025685007,0.012801341,0.111408174,0.0026662634,0.0020116675,0.54649514,0.0012591666,0.085569404,0.0107486695,0.13220215],"study_design_scores_gemma":[0.025309708,0.006245311,0.0062167156,0.0029743763,0.055994317,0.0011159896,0.00032768352,0.7330118,0.0013993015,0.16040413,0.006701643,0.00029905204],"about_ca_topic_score_codex":0.004550408,"about_ca_topic_score_gemma":0.0025242872,"teacher_disagreement_score":0.7941101,"about_ca_system_score_codex":0.0018637904,"about_ca_system_score_gemma":0.0027463355,"threshold_uncertainty_score":0.97927916},"labels":[],"label_agreement":null},{"id":"W2052331218","doi":"10.1016/j.jval.2014.08.180","title":"Loyalty To A Pharmacy Is Associated With A Better Quality Of Antidiabetes Drug Use","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski; Université Laval","funders":"","keywords":"Pharmacy; Medicine; Drug; Medical prescription; Odds ratio; Pharmacology; Internal medicine; Family medicine","score_opus":0.25734515814398945,"score_gpt":0.45994033944541707,"score_spread":0.20259518130142762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052331218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477094,0.0006139485,0.00024008307,0.0011021035,0.000044481945,0.000011080427,0.0001503594,0.0000071250493,0.0030600415],"genre_scores_gemma":[0.998711,0.00013171746,0.00017581895,0.00030581892,0.00004236275,0.0000034033728,0.00010932308,0.000004817901,0.00051577814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968135,0.0012095808,0.00037379627,0.00030769376,0.00073110586,0.0005642785],"domain_scores_gemma":[0.94985217,0.014765943,0.023089275,0.0016363795,0.0029569804,0.0076991785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020307135,0.00018200614,0.00048292382,0.0010288282,0.0009992346,0.0025068698,0.00061986287,0.0019256923,0.00728418],"category_scores_gemma":[0.019290779,0.00034863333,0.0013356119,0.001545487,0.00077082,0.0006443356,0.0012002393,0.0031922022,0.00033739817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015494647,0.00023895557,0.9953432,0.00001790462,0.00023363263,0.000031694664,0.000086813205,0.000052594896,0.00009865475,0.00010962753,0.00016529932,0.0034666536],"study_design_scores_gemma":[0.000009374253,0.000074300544,0.9988864,0.0000182942,0.00006309691,0.000081457154,0.00021513153,0.0002580756,0.000044305187,0.00016368856,0.00017916894,0.0000065715694],"about_ca_topic_score_codex":0.011567251,"about_ca_topic_score_gemma":0.013826156,"teacher_disagreement_score":0.011567251,"about_ca_system_score_codex":0.0009555679,"about_ca_system_score_gemma":0.0016250792,"threshold_uncertainty_score":0.024368048},"labels":[],"label_agreement":null},{"id":"W2052523186","doi":"10.1016/j.jval.2012.08.2162","title":"PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pegfilgrastim; Filgrastim; Breast cancer; Willingness to pay; Febrile neutropenia; Granulocyte colony-stimulating factor; Population; Internal medicine; Cancer; Intensive care medicine; Emergency medicine; Chemotherapy; Neutropenia; Family medicine","score_opus":0.07195591865236585,"score_gpt":0.3759923843507202,"score_spread":0.30403646569835435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052523186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99458754,0.000020883022,0.00019624831,0.00023390922,0.000010942709,0.00044332072,0.0024034933,0.000010687183,0.0020930388],"genre_scores_gemma":[0.99498725,0.000038616552,0.0005233664,0.0003182134,0.000016102427,0.0008367735,0.0020546666,0.000004881503,0.001220138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886405,0.00046637314,0.00011508195,0.00011043011,0.00021520857,0.00022893895],"domain_scores_gemma":[0.9966202,0.00095290656,0.0007807576,0.0001853682,0.00064702943,0.00081373524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002016098,0.0003650046,0.00032483137,0.00066097203,0.0006760838,0.0006987279,0.0005137892,0.0009213225,0.0038909821],"category_scores_gemma":[0.0051901313,0.0003719337,0.0005354755,0.0010522212,0.0003369711,0.00055422256,0.0005520578,0.0012463578,0.0015543891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011776399,0.0030316794,0.98151714,0.000034950834,0.00005881084,0.00019428106,0.00059187174,0.00035061155,0.0004933563,0.00006936368,0.0035306164,0.008949714],"study_design_scores_gemma":[0.00016479215,0.0024671133,0.9935042,0.000013990004,0.000027689723,0.00016001826,0.0009051243,0.0010618535,0.00019495525,0.000031608335,0.0014557801,0.000012880233],"about_ca_topic_score_codex":0.028852096,"about_ca_topic_score_gemma":0.02735285,"teacher_disagreement_score":0.028852096,"about_ca_system_score_codex":0.0018306604,"about_ca_system_score_gemma":0.0013154855,"threshold_uncertainty_score":0.057368338},"labels":[],"label_agreement":null},{"id":"W2052701606","doi":"10.1016/j.jval.2014.03.540","title":"Physicians’ Preferences for Bone Metastases Treatments in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Logistic regression; Web survey; Ordered logit; Internal medicine; Physical therapy; Cancer","score_opus":0.06192680202814914,"score_gpt":0.3237420691066812,"score_spread":0.26181526707853203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052701606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9210566,0.0030398488,0.00016185838,0.030239884,0.00014925675,0.00006612083,0.0024060789,0.000011682389,0.04286866],"genre_scores_gemma":[0.99448895,0.00077261374,0.00012271656,0.0022808164,0.000024179448,0.000007726948,0.00023184204,0.000008420061,0.0020627214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967495,0.0004946373,0.00019069621,0.00024353646,0.0012457378,0.0010758339],"domain_scores_gemma":[0.9851474,0.0028355804,0.0022335837,0.00013223321,0.0038303055,0.0058209784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001226563,0.00013823365,0.00040229037,0.0011820084,0.004324891,0.0026110203,0.00088345865,0.0013051188,0.008660726],"category_scores_gemma":[0.012638973,0.0003263362,0.0005694203,0.003318639,0.0012631882,0.00047077704,0.00075922185,0.0018916576,0.0002600736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010908134,0.00028441273,0.87887603,0.00024478658,0.00032335968,0.0011698101,0.012504086,0.0017764629,0.00060907594,0.0071615973,0.055441123,0.040518418],"study_design_scores_gemma":[0.00022412754,0.00010138152,0.93888944,0.00039733996,0.00015440285,0.00057402975,0.024328422,0.0022575564,0.0002783225,0.0009750067,0.03167381,0.00014618527],"about_ca_topic_score_codex":0.9924797,"about_ca_topic_score_gemma":0.99786973,"teacher_disagreement_score":0.06594511,"about_ca_system_score_codex":0.06594511,"about_ca_system_score_gemma":0.06252319,"threshold_uncertainty_score":0.47846752},"labels":[],"label_agreement":null},{"id":"W2052781276","doi":"10.1016/j.jval.2013.03.915","title":"A cost-minimization analysis of a new fixed-dose combination of dutasteride and tamsulosin compared to concomitant administration of both monotherapies for the treatment of symptomatic benign prostatic hyperplasia in Quebec, Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hôpital Saint-François d'Assise; GlaxoSmithKline (Canada)","funders":"","keywords":"Dutasteride; Tamsulosin; Concomitant; Medicine; Combination therapy; Urology; Cohort; Hyperplasia; Internal medicine; Prostate","score_opus":0.057907778313355134,"score_gpt":0.34207798974834147,"score_spread":0.28417021143498633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052781276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97826093,0.007878911,0.003271973,0.0017680048,0.00010946423,0.0010482896,0.0021389797,0.00008926486,0.005434176],"genre_scores_gemma":[0.9962915,0.00058613514,0.0012948769,0.00019261077,0.00001742718,0.000086709326,0.0003860684,0.000009317127,0.0011354125],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9983827,0.00091408537,0.000054089967,0.0001206919,0.00021071194,0.00031785495],"domain_scores_gemma":[0.99743026,0.001389993,0.0002736859,0.00005164029,0.00038564898,0.00046873852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002276844,0.0012573393,0.0020509104,0.0010155694,0.00069175876,0.0015355297,0.002236198,0.0011183439,0.0064065494],"category_scores_gemma":[0.005254383,0.0007370141,0.0027765594,0.0010210581,0.0007155205,0.00046771622,0.0006063553,0.0011198758,0.00017534618],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16424954,0.0036750727,0.026393382,0.001378782,0.007216155,0.000525224,0.00012730013,0.7091331,0.003253595,0.0022301828,0.0046484196,0.07716926],"study_design_scores_gemma":[0.051962983,0.031677015,0.11241841,0.00051978615,0.015020331,0.00046327064,0.00068299845,0.77909553,0.0015273022,0.001384818,0.0049904156,0.00025712344],"about_ca_topic_score_codex":0.77844876,"about_ca_topic_score_gemma":0.73548204,"teacher_disagreement_score":0.22155124,"about_ca_system_score_codex":0.035429686,"about_ca_system_score_gemma":0.019201437,"threshold_uncertainty_score":0.44571197},"labels":[],"label_agreement":null},{"id":"W2052823328","doi":"10.1016/j.jval.2012.08.1031","title":"PCV88 Venous Thromboembolism: A Systematic Literature Review to Identify Multi-Attribute Utility Values for Use in Economic Models","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Venous thromboembolism; Preference; Medicine; Rivaroxaban; Population; Systematic review; Economic evaluation; MEDLINE; Actuarial science; Statistics; Surgery; Internal medicine; Economics; Pathology; Environmental health; Mathematics","score_opus":0.5817296022474935,"score_gpt":0.48568281790191614,"score_spread":0.09604678434557734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052823328","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011516032,0.98025984,0.003000297,0.00064709724,0.00008283081,0.0006550704,0.0027035382,0.000023265096,0.0011119085],"genre_scores_gemma":[0.24832885,0.736295,0.010374301,0.00062604935,0.00011463351,0.001694614,0.002290178,0.000024016324,0.00025235626],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98198223,0.009547297,0.00443675,0.0009112183,0.0028989352,0.00022353762],"domain_scores_gemma":[0.9025715,0.08533539,0.007565578,0.0011254508,0.0030614915,0.0003405895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02229177,0.001030408,0.0059195003,0.00999543,0.00043659008,0.0024580094,0.0014493321,0.0015302969,0.0030305856],"category_scores_gemma":[0.118548706,0.00071915594,0.010229935,0.010750036,0.00074681034,0.0022874745,0.0014808438,0.0014276454,0.00018241479],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013146754,0.000126818,0.02072267,0.560081,0.050636567,0.00025506923,0.00032594323,0.00330487,0.00012698042,0.0031049652,0.003993666,0.35600677],"study_design_scores_gemma":[0.001856022,0.0010260137,0.057319663,0.6674086,0.20834273,0.0013772831,0.0007114191,0.006215037,0.0005423791,0.012381282,0.042620096,0.0001995461],"about_ca_topic_score_codex":0.0050706803,"about_ca_topic_score_gemma":0.010205455,"teacher_disagreement_score":0.02229177,"about_ca_system_score_codex":0.0025135118,"about_ca_system_score_gemma":0.0074287136,"threshold_uncertainty_score":0.11789155},"labels":[],"label_agreement":null},{"id":"W2053237380","doi":"10.1016/j.jval.2013.03.1195","title":"The Humanistic And Economic Impact Of Following Evidence-Based Asthma Controller Therapy: A Simulation Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Asthma; Status quo; Medicine; Guideline; Exacerbation; Actuarial science; Intensive care medicine; Environmental health; Economics; Internal medicine","score_opus":0.46680825583966806,"score_gpt":0.4745853399092269,"score_spread":0.007777084069558848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053237380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997235,0.00045406018,0.00301624,0.0013925753,0.00006119538,0.00020935616,0.0005048653,0.000016402795,0.004372855],"genre_scores_gemma":[0.99790514,0.00014303137,0.0009940482,0.00009809425,0.000012226616,0.00010604757,0.00013764798,0.000004449772,0.0005993574],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99620795,0.0029473302,0.00012973485,0.00018951834,0.0001462148,0.00037935836],"domain_scores_gemma":[0.877712,0.11132717,0.003918571,0.0020255004,0.0016278309,0.0033889092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008612266,0.00087121624,0.0009365077,0.0010527491,0.00082641945,0.0019569043,0.0015252888,0.0032442007,0.009631969],"category_scores_gemma":[0.058229234,0.0007044594,0.0019576661,0.00091138756,0.0019457864,0.002084849,0.0015670798,0.0026046888,0.00037407118],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014210306,0.016394978,0.05352618,0.000423583,0.0015088094,0.00065520476,0.0006744107,0.87037903,0.0004938668,0.021195155,0.003275488,0.017262934],"study_design_scores_gemma":[0.004162191,0.00951457,0.017700734,0.00016022034,0.0007106792,0.0003122227,0.0012305807,0.9463393,0.00039766825,0.017973946,0.0013605345,0.00013738853],"about_ca_topic_score_codex":0.023317337,"about_ca_topic_score_gemma":0.013444265,"teacher_disagreement_score":0.023317337,"about_ca_system_score_codex":0.0044864933,"about_ca_system_score_gemma":0.0030253155,"threshold_uncertainty_score":0.046363235},"labels":[],"label_agreement":null},{"id":"W2053356357","doi":"10.1016/j.jval.2011.08.1468","title":"PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian Cohort","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Cohort; Incidence (geometry); Retinal Vein; Macular edema; Occlusion; Visual acuity; Comorbidity; Pediatrics; Ophthalmology; Optometry; Surgery; Internal medicine","score_opus":0.020360646970622544,"score_gpt":0.28634583049189966,"score_spread":0.2659851835212771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053356357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448085,0.00019469982,0.00006654436,0.000111507485,0.0000066836697,0.00002869928,0.003235736,0.000010486849,0.0018649368],"genre_scores_gemma":[0.9968887,0.00019468085,0.00009740352,0.000068848734,0.0000069738503,0.000014646053,0.002142244,0.000006269331,0.0005801766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991085,0.00004191944,0.00005583513,0.00017139452,0.00026124425,0.00036106107],"domain_scores_gemma":[0.9985948,0.000058156587,0.00027044202,0.000063908585,0.00059846236,0.00041427006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004674539,0.0005506237,0.0005482647,0.0024559083,0.0030829664,0.0012583259,0.0012461636,0.0007809477,0.0034228277],"category_scores_gemma":[0.001573468,0.000641942,0.0011657547,0.0042757695,0.0006634431,0.0005137997,0.00070749974,0.00095446577,0.00047959108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008322123,0.000028376042,0.99802375,0.0000074859404,0.000047754394,0.00013634133,0.00022515809,0.000043638192,0.00017194115,0.00004198413,0.0004557043,0.00073463423],"study_design_scores_gemma":[0.000006276072,0.000022369735,0.99889743,0.0000048620955,0.00001719051,0.00020154603,0.00043903553,0.00011059684,0.000020606825,0.000012359596,0.00025851495,0.000009217462],"about_ca_topic_score_codex":0.9710368,"about_ca_topic_score_gemma":0.9656455,"teacher_disagreement_score":0.028963208,"about_ca_system_score_codex":0.010809727,"about_ca_system_score_gemma":0.01230323,"threshold_uncertainty_score":0.078430474},"labels":[],"label_agreement":null},{"id":"W2053407368","doi":"10.1016/s1098-3015(10)72231-2","title":"PCN143 COST-EFFECTIVENESS OBSERVATIONS AND ONCOLOGY DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE JOINT ONCOLOGY DRUG REVIEW","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Medicine; Oncology; Internal medicine; Cancer drugs; Medical physics; Pharmacology; Health care; Political science","score_opus":0.5093231635004623,"score_gpt":0.45965030460700906,"score_spread":0.04967285889345319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053407368","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062272117,0.30471057,0.0018877995,0.36686143,0.008732135,0.0009841793,0.1092467,0.00032812217,0.14497696],"genre_scores_gemma":[0.612685,0.20150875,0.008343954,0.057523087,0.0055530495,0.0004976791,0.047057826,0.00039970403,0.06643092],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98746455,0.0020013994,0.0010538449,0.00039263355,0.007897658,0.0011899018],"domain_scores_gemma":[0.913235,0.015260632,0.0034911933,0.000993979,0.064161785,0.0028573421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015319922,0.00049428653,0.0011825433,0.0063480586,0.0015193577,0.0057141883,0.0017816841,0.002229693,0.007749235],"category_scores_gemma":[0.06462269,0.00055248284,0.001228174,0.013502925,0.001011471,0.0009496839,0.00064730016,0.0023969314,0.0008877817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065152004,0.000082005165,0.021635555,0.0015079383,0.00037896747,0.00013118866,0.00018714256,0.003979767,0.00014352988,0.0127309,0.8507678,0.1078037],"study_design_scores_gemma":[0.0008356627,0.0001390556,0.24847202,0.0058150357,0.0014476473,0.00014886327,0.00066143693,0.0073268777,0.00084314507,0.004160905,0.7299302,0.00021910403],"about_ca_topic_score_codex":0.98252064,"about_ca_topic_score_gemma":0.99002165,"teacher_disagreement_score":0.9280522,"about_ca_system_score_codex":0.071947806,"about_ca_system_score_gemma":0.20083834,"threshold_uncertainty_score":0.52202034},"labels":[],"label_agreement":null},{"id":"W2053604687","doi":"10.1016/j.jval.2012.08.744","title":"PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University","funders":"","keywords":"Referral; Bridging (networking); Health care; Bridge (graph theory); Process (computing); Discrete event simulation; Process management; Resource (disambiguation); Healthcare system; Work (physics); Risk analysis (engineering); Medicine; Operations management; Computer science; Management science; Nursing; Business; Engineering; Political science; Simulation","score_opus":0.43726074280246835,"score_gpt":0.4912338118245542,"score_spread":0.05397306902208587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053604687","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08383904,0.0006142672,0.7525102,0.022970242,0.00052809314,0.0005482378,0.0059755216,0.0058941455,0.12712026],"genre_scores_gemma":[0.6738905,0.00042647394,0.30757657,0.0007809451,0.0002282117,0.0003529879,0.0037175785,0.0007334342,0.012293312],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99734735,0.0013761094,0.00009336831,0.00024037615,0.000689873,0.00025293947],"domain_scores_gemma":[0.99120504,0.005557014,0.00055126095,0.0008907769,0.0014183231,0.0003776143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005354106,0.00039637677,0.00041197785,0.0012118316,0.0008394216,0.004225642,0.00088845065,0.00074316905,0.021917555],"category_scores_gemma":[0.012040658,0.00043002327,0.00046666965,0.002331973,0.0006354183,0.003125116,0.002644948,0.0012333591,0.002172118],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054079934,0.0005293757,0.021404993,0.0007073821,0.00015292998,0.00016465521,0.0007447823,0.09871412,0.0026910747,0.25200748,0.08338537,0.538957],"study_design_scores_gemma":[0.00013281868,0.00027151813,0.010448426,0.00024387566,0.00004790628,0.000081322476,0.0011566939,0.55857015,0.0068724067,0.30669367,0.11543728,0.000043954315],"about_ca_topic_score_codex":0.007546537,"about_ca_topic_score_gemma":0.0059711556,"teacher_disagreement_score":0.021917555,"about_ca_system_score_codex":0.0020749231,"about_ca_system_score_gemma":0.0063206926,"threshold_uncertainty_score":0.07332152},"labels":[],"label_agreement":null},{"id":"W2053813657","doi":"10.1016/s1098-3015(10)75067-1","title":"PIN8 BUDGET-IMPACT ANALYSIS OF ADDING THE NEW 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION (PHID-CV) TO ROUTINE INFANT VACCINATION IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vaccination; Medicine; Pneumococcal vaccination; Pneumococcal conjugate vaccine; Pediatrics; Conjugate vaccine; Virology; Immunization; Immunology; Streptococcus pneumoniae; Microbiology; Biology","score_opus":0.03519441871529376,"score_gpt":0.38077839402442115,"score_spread":0.3455839753091274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053813657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8746101,0.0048039416,0.0016537395,0.0084732035,0.00033619246,0.002206852,0.058799934,0.00022877345,0.048887108],"genre_scores_gemma":[0.979734,0.0016402565,0.0016172386,0.0009068418,0.000047906684,0.00024409084,0.006615393,0.000029989018,0.009164364],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99272364,0.0015426745,0.00023714997,0.00030451562,0.0016725471,0.0035194983],"domain_scores_gemma":[0.9925372,0.00180453,0.00051177474,0.00014751851,0.0035541386,0.0014449642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032783803,0.0012123539,0.0019342786,0.002574266,0.0019390013,0.0035064449,0.0023930464,0.001499066,0.008882683],"category_scores_gemma":[0.014713054,0.0010142346,0.0028320167,0.005023821,0.0009496762,0.00094084075,0.001387125,0.002276816,0.00039767724],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02151304,0.0020048353,0.16587935,0.0023106893,0.004094387,0.0012783664,0.00035588816,0.6862323,0.0016819291,0.013482802,0.043385517,0.05778093],"study_design_scores_gemma":[0.0061615813,0.0034435862,0.57411206,0.00075737725,0.0064827404,0.00026979198,0.0033846837,0.36122292,0.0026070068,0.0049698423,0.03613798,0.00045044668],"about_ca_topic_score_codex":0.99500304,"about_ca_topic_score_gemma":0.9945826,"teacher_disagreement_score":0.15148969,"about_ca_system_score_codex":0.15148969,"about_ca_system_score_gemma":0.17236638,"threshold_uncertainty_score":0.98415166},"labels":[],"label_agreement":null},{"id":"W2053867416","doi":"10.1016/s1098-3015(10)74367-9","title":"PCN116 A SURVIVAL BASED COST-EFFECTIVENESS ANALYSIS OF 5 YEARS LETROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER: CANADIAN PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Letrozole; Tamoxifen; Medicine; Oncology; Postmenopausal women; Breast cancer; Adjuvant; Perspective (graphical); Adjuvant therapy; Internal medicine; Gynecology; Cancer; Computer science","score_opus":0.20833622063429436,"score_gpt":0.4100900685544098,"score_spread":0.20175384792011547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053867416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7517663,0.08363448,0.011214795,0.019421171,0.0010697956,0.00466396,0.05991087,0.00021956851,0.06809902],"genre_scores_gemma":[0.9702232,0.0103227515,0.0052015395,0.0011291816,0.00017091101,0.0003479718,0.0080889715,0.0000355381,0.0044798823],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954295,0.0028373764,0.00018751223,0.00017911577,0.000909454,0.0004570672],"domain_scores_gemma":[0.9961761,0.002220192,0.000332883,0.00010172973,0.0007972357,0.00037192137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056775613,0.0012975599,0.0022838232,0.0018923302,0.00065905316,0.0024587077,0.001692786,0.0011012265,0.0064487536],"category_scores_gemma":[0.014853388,0.0006635345,0.0047003105,0.003574063,0.0006681224,0.000662323,0.00068912376,0.0020652008,0.00021223394],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0879535,0.0014713102,0.04998292,0.010974144,0.029037397,0.0010748792,0.0002936088,0.5470064,0.0024813407,0.025521435,0.04074989,0.20345317],"study_design_scores_gemma":[0.057225622,0.013672906,0.24476813,0.005520773,0.07284051,0.0010989486,0.0012680969,0.53325987,0.0022186665,0.015410067,0.05195606,0.0007602848],"about_ca_topic_score_codex":0.8854271,"about_ca_topic_score_gemma":0.88824755,"teacher_disagreement_score":0.962232,"about_ca_system_score_codex":0.037767995,"about_ca_system_score_gemma":0.04159023,"threshold_uncertainty_score":0.27402723},"labels":[],"label_agreement":null},{"id":"W2054041177","doi":"10.1046/j.1524-4733.2001.40202-108.x","title":"PCV34: DECISION ANALYSIS MODEL OF ABCIXIMAB, EPTIFIBATIDE OR STANDARD THERAPY IN ELECTIVE STENT PLACEMENT: A CANADIAN PERSPECTIVE","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Eptifibatide; Abciximab; Perspective (graphical); Medicine; Stent; Computer science; Internal medicine; Artificial intelligence; Conventional PCI","score_opus":0.4078045772591365,"score_gpt":0.4431745297970234,"score_spread":0.035369952537886884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054041177","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31375185,0.008015375,0.47936317,0.046584565,0.0007691249,0.0010383666,0.013313813,0.0010500216,0.1361137],"genre_scores_gemma":[0.9112,0.0020577647,0.043223746,0.00092348905,0.00026110632,0.0003563037,0.0019783527,0.00013692054,0.039862365],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99848205,0.0005924981,0.000042438107,0.0001799133,0.0002886917,0.00041441413],"domain_scores_gemma":[0.9966323,0.002057738,0.00014477434,0.000047549078,0.00080219266,0.00031545476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033879846,0.0015652097,0.002168839,0.0017133093,0.0015027369,0.0046067573,0.003324867,0.0033693942,0.011541263],"category_scores_gemma":[0.008688988,0.0013477247,0.0016697756,0.0018498369,0.0016220841,0.0013174978,0.0010075633,0.0024414768,0.0006688907],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001376443,0.00003455303,0.0006443625,0.000040765408,0.000037782036,0.000107655425,0.000031602016,0.9704661,0.00008541883,0.016713243,0.0048474986,0.006853321],"study_design_scores_gemma":[0.000071248316,0.0000149396155,0.00029206238,0.000011489742,0.000025152953,0.00001699229,0.000019737641,0.9933295,0.000033122265,0.0052006766,0.0009663641,0.000018734705],"about_ca_topic_score_codex":0.89937556,"about_ca_topic_score_gemma":0.8052132,"teacher_disagreement_score":0.10062444,"about_ca_system_score_codex":0.02371694,"about_ca_system_score_gemma":0.032408338,"threshold_uncertainty_score":0.202434},"labels":[],"label_agreement":null},{"id":"W2054212101","doi":"10.1016/j.jval.2011.02.213","title":"PCV25 MANAGEMENT OF ACUTE ISCHEMIC STROKE AND ITS LONG TERM EVOLUTION IN THE UNITED STATES AND CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Medicine; Acute stroke; Stroke (engine); Ischemic stroke; Intensive care medicine; Cardiology; Internal medicine; Ischemia; Engineering; Physics","score_opus":0.029079602563535933,"score_gpt":0.2677637973450324,"score_spread":0.2386841947814965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054212101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9253203,0.023961974,0.00026769892,0.022997456,0.00025217416,0.00012376142,0.0047225454,0.000037715166,0.02231637],"genre_scores_gemma":[0.98544145,0.008837472,0.00027856271,0.0014510896,0.00010758432,0.000028752023,0.0019142176,0.000011825628,0.0019290701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980736,0.00012386683,0.00013441013,0.00011990275,0.0009390578,0.0006090343],"domain_scores_gemma":[0.99330574,0.00031152766,0.00089123735,0.000069633235,0.0033268968,0.0020949584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092985306,0.00017628532,0.0005451337,0.0016402573,0.0022921164,0.0024023594,0.0014221931,0.00074366207,0.001220761],"category_scores_gemma":[0.0055568637,0.00019743637,0.00053786533,0.0060419124,0.0009959523,0.0006015251,0.0007988943,0.0015587978,0.00012438455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000744518,0.00048515075,0.89051133,0.00017622522,0.00025627835,0.0005612116,0.00077370903,0.0012153998,0.00026994606,0.0017842968,0.015287836,0.08793422],"study_design_scores_gemma":[0.000057123812,0.00011402519,0.98935497,0.00017346967,0.00009107855,0.000283909,0.0015763128,0.0008102695,0.00009121589,0.0002270713,0.007190941,0.000029638526],"about_ca_topic_score_codex":0.9882544,"about_ca_topic_score_gemma":0.99411607,"teacher_disagreement_score":0.072351225,"about_ca_system_score_codex":0.072351225,"about_ca_system_score_gemma":0.08721067,"threshold_uncertainty_score":0.52494735},"labels":[],"label_agreement":null},{"id":"W2054319555","doi":"10.1016/s1098-3015(10)69035-3","title":"PIN14 A CANADIAN COST-EFFECTIVENESS ANALYSIS OF DARUNAVIR FOR HIV INFECTION IN TREATMENTEXPERIENCED ADULTS","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Darunavir; Human immunodeficiency virus (HIV); Medicine; Virology; Antiretroviral therapy; Viral load","score_opus":0.05760583743073214,"score_gpt":0.4241122929084349,"score_spread":0.3665064554777028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054319555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61503434,0.13453026,0.0042373887,0.010403622,0.001095759,0.008720142,0.16104123,0.00038234715,0.06455491],"genre_scores_gemma":[0.9263671,0.025626706,0.005734829,0.002116405,0.00021112071,0.0011162962,0.030791325,0.000082522056,0.007953701],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9934629,0.0029791805,0.0003735249,0.00030113888,0.0021059224,0.000777311],"domain_scores_gemma":[0.9954448,0.0016074182,0.00055869925,0.00017829382,0.0016013775,0.0006094582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048097274,0.001930079,0.0026480414,0.0028876062,0.00097526493,0.0024015503,0.0021359276,0.0010887365,0.0075072516],"category_scores_gemma":[0.015547114,0.000845322,0.0092909755,0.0060747718,0.00047617237,0.000665986,0.0010388948,0.0022557986,0.0003358622],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21485941,0.0022429414,0.118533365,0.029797642,0.09164064,0.0014637767,0.0004657397,0.13177943,0.00224693,0.011646431,0.094479084,0.3008446],"study_design_scores_gemma":[0.099060945,0.011422565,0.6081408,0.006770482,0.11146042,0.001034274,0.0008578789,0.078689806,0.0012141352,0.00302318,0.07747646,0.0008490641],"about_ca_topic_score_codex":0.9604476,"about_ca_topic_score_gemma":0.9625202,"teacher_disagreement_score":0.067514606,"about_ca_system_score_codex":0.067514606,"about_ca_system_score_gemma":0.06787014,"threshold_uncertainty_score":0.48985505},"labels":[],"label_agreement":null},{"id":"W2054449667","doi":"10.1016/s1098-3015(10)70784-1","title":"PIH10 THE COST-EFFECTIVENESS OF ROUTINE SCREENING FOR VASA PREVIA AT 18-20 WEEKS GESTATION IN ONTARIO","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Banana Cultivation and Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gestation; Medicine; Obstetrics; Pregnancy; Biology","score_opus":0.25225103845987457,"score_gpt":0.3499825312487835,"score_spread":0.09773149278890891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054449667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609678,0.004209918,0.00023390618,0.006565181,0.00006954461,0.00019706081,0.010837632,0.000037944803,0.016881052],"genre_scores_gemma":[0.9915175,0.0021084878,0.00027927224,0.00027921845,0.000029575458,0.000061449624,0.0016662237,0.000009995888,0.0040482907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834466,0.00040815177,0.00009757797,0.000117801676,0.0005009253,0.0005309231],"domain_scores_gemma":[0.9963231,0.00093177916,0.00064504455,0.00009352111,0.00075815734,0.0012484164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009790629,0.00029701652,0.00046337477,0.00068007555,0.0009760634,0.001014699,0.0010329324,0.0007889761,0.004658328],"category_scores_gemma":[0.0071497248,0.00038697687,0.00105061,0.0019082505,0.0005234044,0.00038267768,0.0006972147,0.0006251712,0.00020347972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005383622,0.00040146496,0.9016714,0.00077415135,0.00065193936,0.00086068275,0.0008311715,0.009721491,0.00060234364,0.0019559795,0.014036499,0.06310926],"study_design_scores_gemma":[0.00048353476,0.00043142572,0.9897681,0.00015362316,0.00024269016,0.00017493407,0.0006219697,0.0044399346,0.00011576547,0.00022116861,0.0033187997,0.000028196868],"about_ca_topic_score_codex":0.988561,"about_ca_topic_score_gemma":0.99026066,"teacher_disagreement_score":0.06423698,"about_ca_system_score_codex":0.06423698,"about_ca_system_score_gemma":0.0526453,"threshold_uncertainty_score":0.4660741},"labels":[],"label_agreement":null},{"id":"W2055167882","doi":"10.1016/j.jval.2011.08.708","title":"PHP158 Determining the Monetary Value of a Quality-Adjusted Life Year (QALY): Systematic Review of the Evidence","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Valuation (finance); Quality-adjusted life year; Medicine; Actuarial science; Economics; Econometrics; Cost effectiveness; Accounting","score_opus":0.6681938736228007,"score_gpt":0.4472842326389003,"score_spread":0.22090964098390037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055167882","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026577206,0.9880618,0.0008806102,0.0023677696,0.00045964099,0.000646445,0.0034092157,0.000024360825,0.0014924791],"genre_scores_gemma":[0.07936391,0.90977216,0.004235348,0.0023628317,0.00064945815,0.0013252698,0.001772373,0.000032422526,0.00048613292],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97910905,0.012157824,0.0038045922,0.0007526777,0.0039464766,0.00022938674],"domain_scores_gemma":[0.881517,0.09299035,0.01610239,0.0017171958,0.007026051,0.00064706156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025431478,0.0011196566,0.006115711,0.0072078803,0.0003408018,0.0020561784,0.0016174875,0.002515478,0.00967768],"category_scores_gemma":[0.1441345,0.0011984555,0.008854713,0.007912519,0.0011392528,0.0019163057,0.0021427302,0.0023275353,0.0007347063],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037806693,0.000059626163,0.0051690037,0.6891395,0.044749107,0.0001269199,0.000105272484,0.00056995393,0.00018744597,0.0010918045,0.01661424,0.23840648],"study_design_scores_gemma":[0.010095651,0.0010792181,0.03791703,0.7308588,0.15672575,0.0007737386,0.00025691398,0.0008971597,0.00072788406,0.0059278337,0.054589745,0.0001502674],"about_ca_topic_score_codex":0.008429143,"about_ca_topic_score_gemma":0.013422856,"teacher_disagreement_score":0.025431478,"about_ca_system_score_codex":0.0030300438,"about_ca_system_score_gemma":0.0068137087,"threshold_uncertainty_score":0.13449615},"labels":[],"label_agreement":null},{"id":"W2055539075","doi":"10.1016/j.jval.2014.03.314","title":"what happens when personalized medicine guidelines don’t agree? A systematic review of clinical guidelines for thiopurine methyltransferase testing for dose selection of thiopurines","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Dosing; Pharmacogenomics; Azathioprine; Mercaptopurine; MEDLINE; Family medicine; Intensive care medicine; Internal medicine; Disease; Pharmacology","score_opus":0.4437603056896165,"score_gpt":0.5448023567234817,"score_spread":0.10104205103386515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055539075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007665366,0.99337536,0.00039349703,0.004242855,0.00035323945,0.00022190757,0.0002978604,0.0000086276095,0.00034003996],"genre_scores_gemma":[0.02601588,0.9582248,0.004211111,0.010040192,0.00035326532,0.0006214885,0.00039783816,0.000017249185,0.00011817845],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.94338757,0.027099313,0.021166237,0.0023501657,0.00537609,0.00062067277],"domain_scores_gemma":[0.8288726,0.1340972,0.024186073,0.0018973162,0.010143633,0.00080309267],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.039620936,0.0010709882,0.00928728,0.0063930415,0.00083607994,0.0038504149,0.003194637,0.0038769962,0.0028407571],"category_scores_gemma":[0.18875362,0.0016373596,0.008676962,0.007166608,0.0016095502,0.0049528945,0.0022231466,0.003759426,0.00026925417],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054709194,0.00002855608,0.0022264393,0.8136766,0.034684464,0.00015191101,0.0010544026,0.0002806382,0.00019668778,0.001553879,0.009737866,0.13586152],"study_design_scores_gemma":[0.001036545,0.00013023773,0.0037807408,0.8730859,0.07816491,0.00026004296,0.000700859,0.00019813974,0.00018731836,0.002047222,0.040321615,0.00008627568],"about_ca_topic_score_codex":0.012836299,"about_ca_topic_score_gemma":0.039970458,"teacher_disagreement_score":0.9907127,"about_ca_system_score_codex":0.004424018,"about_ca_system_score_gemma":0.015105339,"threshold_uncertainty_score":0.20953804},"labels":[],"label_agreement":null},{"id":"W2055783092","doi":"10.1016/j.jval.2012.03.1248","title":"PCN131 Patients' Out-of-Pocket (OOP) Costs for Granulocyte Colony-Stimulating Factors (G-CSF)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pegfilgrastim; Filgrastim; Medicine; Quarter (Canadian coin); Pharmacy; Emergency medicine; Internal medicine; Granulocyte colony-stimulating factor; Chemotherapy; Family medicine","score_opus":0.08375457258882472,"score_gpt":0.36424041647867067,"score_spread":0.28048584388984593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055783092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93178463,0.0021181768,0.0006426517,0.0077877864,0.00017547804,0.00010003625,0.002747167,0.00007972536,0.054564375],"genre_scores_gemma":[0.9914688,0.00053541985,0.0007137257,0.0009814884,0.00006297267,0.000030884654,0.00071330817,0.000009555573,0.0054838653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999448,0.00014681842,0.000037476933,0.000030605348,0.0002022617,0.00013470797],"domain_scores_gemma":[0.99774927,0.00094043143,0.0005535821,0.000047255086,0.00014249687,0.0005669743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040043908,0.0001330446,0.00012540745,0.00030647556,0.0003018884,0.00067854516,0.00015580175,0.00027730456,0.01678955],"category_scores_gemma":[0.0049112234,0.00008558986,0.00034264344,0.00031784223,0.00016849217,0.00037606078,0.00042688366,0.0009496241,0.00061530794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002487833,0.0009596569,0.53425163,0.0002238775,0.0002493638,0.000727762,0.00038229965,0.0015528965,0.0031008269,0.0034372257,0.044409566,0.4082171],"study_design_scores_gemma":[0.0003276018,0.001632732,0.8964724,0.00018308136,0.00024616794,0.0033480995,0.0008136817,0.003090329,0.0021359026,0.0015274709,0.09017471,0.000047823793],"about_ca_topic_score_codex":0.006758132,"about_ca_topic_score_gemma":0.016443532,"teacher_disagreement_score":0.01678955,"about_ca_system_score_codex":0.0015811431,"about_ca_system_score_gemma":0.0018614331,"threshold_uncertainty_score":0.05616665},"labels":[],"label_agreement":null},{"id":"W2056341565","doi":"10.1016/j.jval.2010.11.018","title":"Trends in Health Care Utilization in British Columbia Following Public Coverage for Tiotropium","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Confidence interval; Emergency medicine; Public health; Emergency department; Health care; Medical emergency; Environmental health; Internal medicine","score_opus":0.10419377702165145,"score_gpt":0.34219033860804804,"score_spread":0.2379965615863966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056341565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98367715,0.0006696729,0.000046780227,0.000678409,0.00002026783,0.000025418594,0.0114749605,0.000025123012,0.003382201],"genre_scores_gemma":[0.9891803,0.00070480694,0.00007664551,0.00027678712,0.0000097161,0.000021919888,0.005626579,0.000010552018,0.004092762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926025,0.000062852436,0.00008503951,0.00007476022,0.00022163191,0.00029541072],"domain_scores_gemma":[0.9954136,0.00038678665,0.00081967626,0.0000845246,0.002228938,0.0010663966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043780555,0.0002046218,0.00036413432,0.0018096045,0.0010702003,0.0014094583,0.0012145014,0.00092061574,0.0039805113],"category_scores_gemma":[0.0028765448,0.0003177683,0.0005486306,0.004661367,0.00042849837,0.00055314414,0.000726563,0.0012905459,0.00054421666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039033708,0.00013449989,0.98917,0.00004498553,0.00008579578,0.00012685117,0.00041955267,0.00025030662,0.00017846486,0.000075603246,0.004135258,0.0049883253],"study_design_scores_gemma":[0.000008585387,0.000022411245,0.9978549,0.000022968261,0.000020548228,0.000033680535,0.0010198293,0.00027276512,0.000057381705,0.000010248469,0.00066873844,0.000007931723],"about_ca_topic_score_codex":0.9823152,"about_ca_topic_score_gemma":0.9903176,"teacher_disagreement_score":0.017684817,"about_ca_system_score_codex":0.015595941,"about_ca_system_score_gemma":0.013957817,"threshold_uncertainty_score":0.113157034},"labels":[],"label_agreement":null},{"id":"W2056901430","doi":"10.1016/j.jval.2014.08.612","title":"Nice's Proposed Value-Based Assessment of Health Technologies: Concerns of Inconsistent Consideration of Social Values","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Nice; Value (mathematics); Data science; Psychology; Computer science; Statistics; Mathematics","score_opus":0.39677503866398867,"score_gpt":0.4619698324915159,"score_spread":0.06519479382752724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056901430","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077030165,0.028266424,0.15789324,0.695987,0.013586205,0.0013136104,0.0024213817,0.00050329283,0.09232588],"genre_scores_gemma":[0.28533408,0.007213787,0.4136139,0.27268398,0.012474872,0.003132676,0.00087316876,0.00042937396,0.004244155],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.5421212,0.2971911,0.032562647,0.009989335,0.11186083,0.0062749237],"domain_scores_gemma":[0.55091465,0.3262408,0.015298134,0.021041594,0.07759402,0.008910804],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23127781,0.003754561,0.009762966,0.016846927,0.004973569,0.031627055,0.017932244,0.048038207,0.0036425414],"category_scores_gemma":[0.47272772,0.003093741,0.01289302,0.011098302,0.035655785,0.017136151,0.015611704,0.048408758,0.0011769016],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034770134,0.00015513077,0.002156153,0.002504983,0.0013633358,0.00021961729,0.0017845015,0.005256161,0.00019146704,0.8166777,0.12294111,0.046402123],"study_design_scores_gemma":[0.00065790303,0.0004666241,0.0033500986,0.007661964,0.0014491084,0.0008069549,0.0006300033,0.011557685,0.00073750893,0.8272705,0.14484897,0.0005626307],"about_ca_topic_score_codex":0.01651558,"about_ca_topic_score_gemma":0.022010397,"teacher_disagreement_score":0.23127781,"about_ca_system_score_codex":0.017245477,"about_ca_system_score_gemma":0.027531013,"threshold_uncertainty_score":0.94797134},"labels":[],"label_agreement":null},{"id":"W2057094301","doi":"10.1016/j.jval.2014.03.421","title":"Mammographic Density in Association with Smoking Status and Smoking Histories in a Sample of Postmenopausal Women: Results From a Cross-Sectional Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Body mass index; Family history; Hormone replacement therapy (female-to-male); Anthropometry; Cross-sectional study; Menopause; Demography; Gynecology; Internal medicine; Risk factor; Obstetrics; Cancer; Oncology","score_opus":0.019237735544096368,"score_gpt":0.2757718721181258,"score_spread":0.25653413657402946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057094301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997274,0.000060185645,0.000035212335,0.000011567463,0.0000022882564,0.000004353452,0.000065605556,0.0000010441253,0.000092401475],"genre_scores_gemma":[0.99950016,0.00006364512,0.00005762115,0.000031684638,0.0000048303928,0.0000075253447,0.0001550692,0.0000019353354,0.00017750968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994367,0.0002049004,0.000054184624,0.00012199019,0.000100948695,0.00008126221],"domain_scores_gemma":[0.9988323,0.00033237456,0.0002373406,0.00012435799,0.00016842381,0.0003053428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089288224,0.00039704065,0.00057082286,0.0008381595,0.00093339256,0.0009123095,0.0005311316,0.00071795075,0.0011932311],"category_scores_gemma":[0.0024301254,0.00092230097,0.0005149527,0.0012538054,0.00065070455,0.00058832695,0.00062834163,0.0007864037,0.0003181718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013723098,0.0000997444,0.9987225,0.0000033878712,0.000071200746,0.00006221098,0.0002286255,0.0000065026998,0.00035386105,0.0000054473626,0.000021031809,0.00028820714],"study_design_scores_gemma":[0.0000086304435,0.00012259005,0.9990876,0.0000015527932,0.00003908738,0.00016151101,0.00045831568,0.000036178644,0.00003295514,0.000005072337,0.00004414476,0.00000239156],"about_ca_topic_score_codex":0.0155048035,"about_ca_topic_score_gemma":0.018588826,"teacher_disagreement_score":0.0155048035,"about_ca_system_score_codex":0.00030552072,"about_ca_system_score_gemma":0.00029557277,"threshold_uncertainty_score":0.030829132},"labels":[],"label_agreement":null},{"id":"W2057212052","doi":"10.1016/j.jval.2014.03.940","title":"A Cost-Minimization Analysis Of Carbetocin For The Prevention Of Postpartum Hemorrhage In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Caesarean section; Uterine atony; Uterotonic; Obstetrics; Total cost; Cost-minimization analysis; Clinical Practice; Emergency medicine; Intensive care medicine; Pregnancy; Oxytocin; Family medicine; Surgery; Hysterectomy; Internal medicine","score_opus":0.05148314105794193,"score_gpt":0.3302652339010418,"score_spread":0.27878209284309985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057212052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739412,0.008366064,0.002331998,0.0040816627,0.00008923009,0.0010260467,0.0028472203,0.000066171575,0.007250375],"genre_scores_gemma":[0.99529463,0.0013652833,0.001355697,0.00030470244,0.000014470259,0.00006464848,0.00050567323,0.000008344099,0.0010865774],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978257,0.0008420402,0.00008385306,0.00013035264,0.00048388343,0.00063417933],"domain_scores_gemma":[0.99708265,0.0013518872,0.00025658985,0.000048848025,0.00074971345,0.0005103266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018671189,0.00086786237,0.0016204624,0.0016175066,0.0011659935,0.0022885087,0.0017830889,0.0011917118,0.0033482586],"category_scores_gemma":[0.008766097,0.0007378598,0.0021808883,0.0022067071,0.00068917824,0.000499411,0.00082021847,0.001376132,0.00008705615],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04605672,0.0035406612,0.13957167,0.002749925,0.005527985,0.0016057465,0.00035268086,0.6598464,0.002445779,0.009513742,0.012105229,0.11668347],"study_design_scores_gemma":[0.012243696,0.007831422,0.24172422,0.0009716636,0.0094937645,0.0007617345,0.0019257038,0.71019495,0.0017131486,0.003035454,0.00984543,0.00025882],"about_ca_topic_score_codex":0.9492059,"about_ca_topic_score_gemma":0.9339295,"teacher_disagreement_score":0.06539224,"about_ca_system_score_codex":0.06539224,"about_ca_system_score_gemma":0.06059963,"threshold_uncertainty_score":0.47445613},"labels":[],"label_agreement":null},{"id":"W2057335144","doi":"10.1016/j.jval.2012.08.1059","title":"PCV116 Impact of the Type of Drug Insurance on Cost of Statins and Anti-Depressants","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cohort; Medical prescription; Statin; Prescription drug; Drug; Antidepressant; Cohort study; Emergency medicine; Internal medicine; Psychiatry; Pharmacology","score_opus":0.2471445488612375,"score_gpt":0.48627114832293605,"score_spread":0.23912659946169856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057335144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717529,0.0021154948,0.00021728843,0.0025791891,0.00021740036,0.000036425157,0.013248103,0.00004447137,0.009788747],"genre_scores_gemma":[0.9926373,0.00024591116,0.000072452836,0.0001857827,0.000108311426,0.000010481033,0.003385714,0.00001849879,0.003335621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770504,0.00060779415,0.00015397384,0.00025476096,0.00045532445,0.000823127],"domain_scores_gemma":[0.9869152,0.0064051887,0.002919063,0.00042043222,0.00065602263,0.0026840938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012242707,0.00031457708,0.00081865216,0.00096640526,0.00037718654,0.0019809287,0.0011573893,0.0012983629,0.032552943],"category_scores_gemma":[0.014742009,0.0003427939,0.0037863657,0.0018711969,0.00038708493,0.0009310277,0.0010072811,0.002321724,0.0015668769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013062873,0.00074930367,0.9387567,0.00019136426,0.0021403125,0.00026567135,0.00007071504,0.0024426628,0.00035297516,0.00097277237,0.007111209,0.033883385],"study_design_scores_gemma":[0.0002727643,0.00092429813,0.9928362,0.00007179789,0.0008448366,0.0001604692,0.00020863325,0.0023159576,0.00020655275,0.00032062587,0.0018164883,0.000021380287],"about_ca_topic_score_codex":0.06393575,"about_ca_topic_score_gemma":0.043462664,"teacher_disagreement_score":0.06393575,"about_ca_system_score_codex":0.0015803697,"about_ca_system_score_gemma":0.0030397866,"threshold_uncertainty_score":0.12712723},"labels":[],"label_agreement":null},{"id":"W2057347108","doi":"10.1016/j.jval.2011.02.768","title":"PRS7 USE OF INHALED TOBRAMYCIN IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CYSTIC FIBROSIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Tobramycin; Cystic fibrosis; Internal medicine; Odds ratio; Underweight; Surgery; Body mass index; Pseudomonas aeruginosa; Overweight","score_opus":0.07752399317682819,"score_gpt":0.32210120288856214,"score_spread":0.24457720971173397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057347108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951363,0.0021740384,0.00011541259,0.00059889856,0.000062622545,0.0000070210644,0.0002833214,0.00001313445,0.0016092565],"genre_scores_gemma":[0.99860376,0.00044780306,0.00008689216,0.00012488678,0.000090003705,0.0000038669764,0.0002747822,0.0000034563727,0.00036461168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99940276,0.00019655048,0.00005393707,0.00007210244,0.00016376475,0.00011078002],"domain_scores_gemma":[0.99695706,0.00076959253,0.0014082002,0.00018169696,0.00025723074,0.00042622222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043850977,0.00033913797,0.0006812886,0.00031270643,0.0002828446,0.0007730887,0.00034125338,0.00071028783,0.0026439577],"category_scores_gemma":[0.0032686342,0.00017844494,0.0010378595,0.00055296277,0.00028860482,0.00038901248,0.00037511965,0.0014839033,0.0002836591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018271813,0.00015874782,0.9864768,0.00004813382,0.00047124256,0.00024307957,0.000047652327,0.00008935153,0.0015707882,0.000059254642,0.00040990452,0.008597936],"study_design_scores_gemma":[0.00004553772,0.0003481963,0.9980818,0.000016862396,0.00020354727,0.0003568818,0.00008422518,0.00026871468,0.00021260245,0.000075656746,0.00030023698,0.000005832214],"about_ca_topic_score_codex":0.0021017303,"about_ca_topic_score_gemma":0.0022625097,"teacher_disagreement_score":0.0026439577,"about_ca_system_score_codex":0.00024463926,"about_ca_system_score_gemma":0.00037934727,"threshold_uncertainty_score":0.008844972},"labels":[],"label_agreement":null},{"id":"W2057593057","doi":"10.1016/s1098-3015(10)66669-7","title":"PDB22 COST-EFFECTIVENESS OF INSULIN GLARGINE COMPARED TO INSULIN DETEMIR FOR TYPE 1 (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin detemir; Insulin glargine; Medicine; Internal medicine; Type 1 diabetes; Type 2 Diabetes Mellitus; Endocrinology; Insulin; Diabetes mellitus; Hypoglycemia","score_opus":0.06534911467961803,"score_gpt":0.31825093423238787,"score_spread":0.25290181955276986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057593057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97051483,0.011446047,0.00017155657,0.002958435,0.0002027717,0.00023736976,0.0040772883,0.000063296095,0.010328366],"genre_scores_gemma":[0.9970741,0.001058781,0.00020008047,0.00026901977,0.000034614564,0.000019854586,0.0008355937,0.0000048135466,0.0005030867],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99871504,0.00045572067,0.000084748026,0.00012412587,0.00026322118,0.00035714565],"domain_scores_gemma":[0.99756926,0.00087316456,0.00033023625,0.00007113616,0.00024385069,0.0009122264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011403918,0.0006458462,0.0016861182,0.00078025967,0.00068077527,0.0016309533,0.0010202078,0.0011242968,0.0070931436],"category_scores_gemma":[0.0069457553,0.0003440649,0.0028231456,0.0016209872,0.00051698263,0.00057236763,0.0005599292,0.0013515186,0.00018122204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45334962,0.005939324,0.19541872,0.0033076897,0.009114726,0.00084120117,0.0004356796,0.039128155,0.0018676964,0.005206422,0.023255063,0.26213577],"study_design_scores_gemma":[0.069440864,0.030927122,0.81446236,0.0010077605,0.0122410515,0.0009299414,0.0016507795,0.05729403,0.00104107,0.0025075038,0.008068403,0.00042916212],"about_ca_topic_score_codex":0.7648636,"about_ca_topic_score_gemma":0.7819123,"teacher_disagreement_score":0.97772807,"about_ca_system_score_codex":0.022271924,"about_ca_system_score_gemma":0.016583664,"threshold_uncertainty_score":0.4730423},"labels":[],"label_agreement":null},{"id":"W2057727326","doi":"10.1016/j.jval.2014.03.589","title":"Comparison of Oncology Therapy Reimbursement Recommendations Made by Health Technology Assessment Agencies in Australia, Canada, Sweden, And United Kingdom","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Reimbursement; Excellence; Health technology; Agency (philosophy); Medicine; Health care; Cost effectiveness; Family medicine; Product (mathematics); Advisory committee; Business; Political science; Public administration","score_opus":0.6039519350051378,"score_gpt":0.5326902229922519,"score_spread":0.07126171201288589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057727326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9088354,0.026019925,0.0009047772,0.028627994,0.00044306103,0.00024480748,0.0053389673,0.00005391371,0.029531231],"genre_scores_gemma":[0.99112284,0.0034579893,0.0006375628,0.0018673978,0.000054677603,0.000054670978,0.0014177429,0.000020810552,0.0013661503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9763848,0.009094473,0.0033041458,0.0007100468,0.0077980855,0.0027084253],"domain_scores_gemma":[0.92075425,0.03797173,0.011589711,0.0012293134,0.025087215,0.0033677712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015177448,0.00022332564,0.0008971803,0.003955828,0.0009818517,0.003753468,0.0011690625,0.0019144434,0.0020414258],"category_scores_gemma":[0.08536704,0.00035518134,0.001682821,0.0053011077,0.00081758795,0.0009779889,0.0015894921,0.002043806,0.00016168927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058494397,0.00039087914,0.66910976,0.0025673148,0.0023069165,0.0008502995,0.0054512117,0.015729282,0.000783642,0.022672145,0.05189623,0.2223929],"study_design_scores_gemma":[0.00020869593,0.00020351863,0.97615904,0.00094792334,0.00041978425,0.00017834696,0.0031109324,0.0030275702,0.00024352253,0.0004953109,0.014936377,0.000068823574],"about_ca_topic_score_codex":0.59547377,"about_ca_topic_score_gemma":0.6523829,"teacher_disagreement_score":0.40452623,"about_ca_system_score_codex":0.022131711,"about_ca_system_score_gemma":0.015827978,"threshold_uncertainty_score":0.81381714},"labels":[],"label_agreement":null},{"id":"W2057903895","doi":"10.1016/j.jval.2012.08.941","title":"PMD92 Inhaler Use in Five European Countries: Analysis of Sales Data From Q4 2005 to Q4 2011","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Inhaler; Metered-dose inhaler; Quarter (Canadian coin); Asthma; Internal medicine","score_opus":0.13740169962952348,"score_gpt":0.35055419160383117,"score_spread":0.2131524919743077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057903895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710207,0.0016016585,0.00021527977,0.00005185774,0.000012340385,0.00001696659,0.025670784,0.000028773693,0.0013814943],"genre_scores_gemma":[0.96459377,0.0008502318,0.00046407117,0.000060832033,0.000013605926,0.00002505474,0.03309047,0.0000129484415,0.000888941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913627,0.00016011573,0.00018760243,0.00022732696,0.00015800014,0.00013062322],"domain_scores_gemma":[0.997505,0.00056892296,0.0013035679,0.00011869647,0.00035457028,0.00014929746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011846664,0.0005209898,0.00061974797,0.0028491686,0.0002147241,0.00089113566,0.0004443772,0.0005635292,0.0012986147],"category_scores_gemma":[0.0016791512,0.000299939,0.0014225052,0.0050365794,0.0002713936,0.0005886736,0.00068381283,0.0003559654,0.000411948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006118381,0.000046343346,0.986636,0.00021119145,0.0006476272,0.0002437333,0.00019112995,0.0013029953,0.0002989771,0.000108602624,0.0016048736,0.008096762],"study_design_scores_gemma":[0.000009841592,0.00009705275,0.99666625,0.000036505706,0.00010187028,0.00019685437,0.0002504887,0.0003194686,0.00022338115,0.000010234563,0.0020786969,0.000009445117],"about_ca_topic_score_codex":0.026732331,"about_ca_topic_score_gemma":0.016648177,"teacher_disagreement_score":0.026732331,"about_ca_system_score_codex":0.000695413,"about_ca_system_score_gemma":0.0005074242,"threshold_uncertainty_score":0.053153455},"labels":[],"label_agreement":null},{"id":"W2057906239","doi":"10.1016/j.jval.2013.03.083","title":"Composite endpoints in treatment of type-2 diabetes","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Exenatide; Sitagliptin; Liraglutide; Metformin; Type 2 diabetes; Internal medicine; Clinical endpoint; Randomized controlled trial; Hypoglycemia; Diabetes mellitus; Insulin; Endocrinology","score_opus":0.035271391749435894,"score_gpt":0.2928516543339031,"score_spread":0.2575802625844672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057906239","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6125595,0.31081805,0.017441142,0.0100489585,0.0031054413,0.00048059822,0.0057179364,0.0001986118,0.039629757],"genre_scores_gemma":[0.9734423,0.015619796,0.0061257724,0.0007131778,0.0007942492,0.00030151042,0.0019574217,0.000024722001,0.001021091],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98906064,0.008112604,0.0006583909,0.00028407096,0.001660978,0.00022336528],"domain_scores_gemma":[0.98188627,0.011552951,0.0037052196,0.00043528757,0.0011810911,0.0012392433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009644828,0.00082257914,0.0025186564,0.0017408312,0.00046633257,0.0022649288,0.00064499304,0.0005571085,0.0020464913],"category_scores_gemma":[0.022998456,0.00018974961,0.0017277211,0.0023504973,0.0003854008,0.0010953649,0.00151789,0.0030467224,0.00022663135],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06391748,0.003056163,0.3547178,0.006641378,0.009336179,0.00029384287,0.0006935334,0.0077907783,0.0009635367,0.018723179,0.0265337,0.50733244],"study_design_scores_gemma":[0.0071206023,0.017012052,0.787371,0.003985862,0.007635755,0.000984615,0.0011056501,0.027992085,0.0023746346,0.10989129,0.034208838,0.00031760352],"about_ca_topic_score_codex":0.00079095055,"about_ca_topic_score_gemma":0.0011111817,"teacher_disagreement_score":0.009644828,"about_ca_system_score_codex":0.0011728917,"about_ca_system_score_gemma":0.001251132,"threshold_uncertainty_score":0.05100727},"labels":[],"label_agreement":null},{"id":"W2058235380","doi":"10.1016/s1098-3015(10)61147-3","title":"PIN12 COSTS OF TREATMENT FOR AMBULATORY LOWER RESPIRATORY TRACT INFECTION IN QUEBEC SENIORS","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ambulatory; Respiratory tract infections; Medicine; Respiratory tract; Respiratory system; Intensive care medicine; Lower respiratory tract infection; Gerontology; Internal medicine","score_opus":0.13581580391997225,"score_gpt":0.40969890809713094,"score_spread":0.27388310417715866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058235380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97186047,0.0015227968,0.00008142018,0.0024623051,0.000057400106,0.000060820246,0.015170989,0.00002180554,0.008761996],"genre_scores_gemma":[0.9907115,0.00049080147,0.000103137994,0.00034930086,0.000030960437,0.00002706249,0.0028976651,0.00000549725,0.0053840084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913186,0.00015536859,0.000058912912,0.000053381522,0.00022388977,0.0003765397],"domain_scores_gemma":[0.99733704,0.00020652078,0.00065055495,0.00003298121,0.0007717232,0.0010011586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039232292,0.0002581127,0.00035121688,0.0011383286,0.0012001878,0.0011779015,0.0008923371,0.00081517873,0.008811842],"category_scores_gemma":[0.0032605738,0.00024065044,0.0008447229,0.0018450903,0.00028775336,0.00042329522,0.00064333755,0.0010344421,0.0003683629],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034550639,0.00014789023,0.97010267,0.00008714904,0.00018662123,0.0002919747,0.00021461665,0.0010673688,0.00010123243,0.00037472724,0.010109822,0.016970323],"study_design_scores_gemma":[0.000016542692,0.00006233931,0.9974934,0.000029634632,0.000030078756,0.00006678968,0.00032698154,0.0007108311,0.000016026586,0.000020392385,0.001220566,0.0000063803254],"about_ca_topic_score_codex":0.9800981,"about_ca_topic_score_gemma":0.9876524,"teacher_disagreement_score":0.031417184,"about_ca_system_score_codex":0.031417184,"about_ca_system_score_gemma":0.012655246,"threshold_uncertainty_score":0.22794867},"labels":[],"label_agreement":null},{"id":"W2058239771","doi":"10.1016/s1098-3015(10)70269-2","title":"PCN93 THREE SCIENTIFIC PARADIGMS IN HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES OF THE COMMITTEE TO EVALUATE DRUGS IN ONTARIO, CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health technology; Engineering ethics; Medicine; Management science; Political science; Engineering; Health care; Law","score_opus":0.19027085715727324,"score_gpt":0.4226542366476403,"score_spread":0.23238337949036705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058239771","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24290097,0.013461438,0.0050993725,0.62470186,0.0017935298,0.0018107815,0.0011454106,0.00008868207,0.10899792],"genre_scores_gemma":[0.84269834,0.007233069,0.01377122,0.06241167,0.00096994796,0.0006111082,0.0006170147,0.00016321041,0.07152445],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.93920964,0.02006254,0.0024680863,0.0018191942,0.026889216,0.009551305],"domain_scores_gemma":[0.8560855,0.047869887,0.0050716978,0.002714833,0.054747988,0.033510145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06630975,0.00044043598,0.0005998222,0.0018277463,0.02312678,0.011219549,0.0030024755,0.009032811,0.0038103363],"category_scores_gemma":[0.059898593,0.0007946956,0.00090218446,0.0032966435,0.00977568,0.0018647095,0.0053531923,0.00737829,0.00031701455],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001486862,0.0012041182,0.20363745,0.0010876558,0.00042587327,0.005026158,0.07792017,0.007871263,0.0046232296,0.0895363,0.36374164,0.24343935],"study_design_scores_gemma":[0.00033875997,0.00046626807,0.23190396,0.00071603025,0.000115133626,0.00039546378,0.037113138,0.0034152193,0.0013196202,0.0062223384,0.7176866,0.0003074584],"about_ca_topic_score_codex":0.97870183,"about_ca_topic_score_gemma":0.9910176,"teacher_disagreement_score":0.83426106,"about_ca_system_score_codex":0.16573897,"about_ca_system_score_gemma":0.47476164,"threshold_uncertainty_score":0.96762455},"labels":[],"label_agreement":null},{"id":"W2058288379","doi":"10.1016/s1098-3015(11)72234-3","title":"PRS2 CARESS:THE CANADIAN REGISTRY OF SYNAGIS (2006–2009)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Wine Industry and Tourism","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.02808434884272132,"score_gpt":0.24670058702261327,"score_spread":0.21861623817989195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058288379","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03850713,0.0033522085,0.0006717139,0.0010270192,0.0002996968,0.0006311748,0.9295357,0.0003010414,0.02567432],"genre_scores_gemma":[0.19226205,0.0065047033,0.0024938406,0.0010535389,0.00025113503,0.00089599576,0.7667343,0.00023938688,0.029565088],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9965835,0.000126463,0.00046172825,0.00043845174,0.0015039616,0.0008859549],"domain_scores_gemma":[0.9832892,0.00039361767,0.0022220372,0.0006865059,0.011927217,0.0014814032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018257509,0.0013665778,0.0010325463,0.014091955,0.0026956212,0.00261444,0.0029966047,0.00094801723,0.01879992],"category_scores_gemma":[0.0103372615,0.00079039147,0.0011461715,0.028148107,0.0005346661,0.00102483,0.0018566303,0.0011696874,0.0049611717],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052775117,0.000047035657,0.26125944,0.001124326,0.00032715572,0.0004987259,0.00054656505,0.000507972,0.000303587,0.0026086527,0.7022424,0.030006388],"study_design_scores_gemma":[0.00015091733,0.000047025544,0.713658,0.00092089147,0.00024252001,0.0006589668,0.0010759312,0.0010959981,0.0005004342,0.00044690626,0.28105476,0.00014765027],"about_ca_topic_score_codex":0.9866019,"about_ca_topic_score_gemma":0.986534,"teacher_disagreement_score":0.025868358,"about_ca_system_score_codex":0.025868358,"about_ca_system_score_gemma":0.0934906,"threshold_uncertainty_score":0.18768895},"labels":[],"label_agreement":null},{"id":"W2058457641","doi":"10.1016/s1098-3015(10)73868-7","title":"PCV110 DO CANADIAN PHYSICIANS CORRECTLY IDENTIFY HIGH RISK CV PATIENTS?","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Business","score_opus":0.036664136060565705,"score_gpt":0.38392735764746,"score_spread":0.34726322158689427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058457641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7932849,0.011903948,0.0008222071,0.05920752,0.0011036773,0.0001587236,0.0086099,0.00013267976,0.12477645],"genre_scores_gemma":[0.98989946,0.0017768434,0.0007014488,0.0033333534,0.00024815628,0.0000172477,0.0012128262,0.000017281222,0.0027933617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973968,0.00029048146,0.00013329889,0.0001830163,0.001237928,0.0007583558],"domain_scores_gemma":[0.9908812,0.0017094408,0.0014425114,0.00026381467,0.004585177,0.0011178625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016543532,0.00043048302,0.0005801705,0.0016532588,0.0018438762,0.0020144773,0.0015886606,0.0018106919,0.0080135595],"category_scores_gemma":[0.022232391,0.0003075272,0.0006960976,0.002739558,0.0006172686,0.001188567,0.00044907673,0.0013491741,0.001416087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017748654,0.00009610817,0.93736374,0.00008210507,0.000048315436,0.00025802624,0.00037262944,0.00017134016,0.0000740784,0.0004069264,0.032165278,0.028783832],"study_design_scores_gemma":[0.000064531814,0.000066343986,0.9755425,0.00035075878,0.00013287063,0.0007201685,0.0020991564,0.0020090907,0.00025775115,0.000590808,0.018126236,0.000039862978],"about_ca_topic_score_codex":0.9032366,"about_ca_topic_score_gemma":0.94097555,"teacher_disagreement_score":0.09676337,"about_ca_system_score_codex":0.012789964,"about_ca_system_score_gemma":0.0193689,"threshold_uncertainty_score":0.19466639},"labels":[],"label_agreement":null},{"id":"W2058645160","doi":"10.1016/s1098-3015(11)70578-2","title":"PSG11: COST ANALYSIS OF INHALED AGENTS IN CANADIAN PEDIATRIC HOSPITALS","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Business; Medical emergency","score_opus":0.0815528420381569,"score_gpt":0.3081901838395258,"score_spread":0.2266373418013689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058645160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84472865,0.003603257,0.005181688,0.009066937,0.00023435855,0.0005760144,0.10814997,0.00044836782,0.028010843],"genre_scores_gemma":[0.9616301,0.0012034053,0.003326513,0.00033735647,0.000077836776,0.00012616228,0.023679467,0.00007506793,0.009544086],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9982339,0.00029958968,0.000058167458,0.00012526209,0.000543181,0.0007397815],"domain_scores_gemma":[0.9961487,0.0013290831,0.00030764815,0.00014533877,0.0016413268,0.00042780914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018432487,0.001188845,0.0009917548,0.0023187094,0.0010671808,0.0020634858,0.0019031452,0.0015283136,0.009430452],"category_scores_gemma":[0.010807871,0.0005901361,0.0014309837,0.005416959,0.000575475,0.00092908397,0.00077549554,0.0015646882,0.00042987036],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023929658,0.0004534482,0.091328226,0.0007642374,0.00054546923,0.0005884002,0.00016288323,0.72843397,0.00057806954,0.016798103,0.10858274,0.04937143],"study_design_scores_gemma":[0.0009220217,0.0005720338,0.32439217,0.00022917111,0.00052254077,0.00031588506,0.0015452795,0.6383931,0.0018082609,0.0042565498,0.02683006,0.00021300883],"about_ca_topic_score_codex":0.9744347,"about_ca_topic_score_gemma":0.96587837,"teacher_disagreement_score":0.952015,"about_ca_system_score_codex":0.04798504,"about_ca_system_score_gemma":0.040300224,"threshold_uncertainty_score":0.34815747},"labels":[],"label_agreement":null},{"id":"W2058723778","doi":"10.1111/j.1524-4733.2006.00156.x","title":"The Cost-Effectiveness of Expanding Newborn Screening for up to 21 Inherited Metabolic Disorders Using Tandem Mass Spectrometry: Results from a Decision-Analytic Model","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Newborn screening; Medicine; Formulary; Cohort; Cost effectiveness; Pediatrics; Health technology; Environmental health; Family medicine; Health care; Internal medicine; Risk analysis (engineering)","score_opus":0.06360169128029618,"score_gpt":0.3648034541926976,"score_spread":0.3012017629124014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058723778","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738762,0.0010944988,0.019566398,0.0018563393,0.000052112417,0.00028252287,0.00092051714,0.0000973266,0.0022541212],"genre_scores_gemma":[0.9923804,0.00024331258,0.0063947407,0.0001322976,0.000021038592,0.000100124,0.00035929034,0.0000149865855,0.0003538854],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9916264,0.007008773,0.0001929626,0.00040813343,0.00031990645,0.00044393225],"domain_scores_gemma":[0.83096516,0.16412358,0.0016049984,0.0010633882,0.0011516301,0.0010912765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016449356,0.002059551,0.0028881594,0.0018257849,0.0007565843,0.0024428046,0.002084709,0.0019742015,0.00460404],"category_scores_gemma":[0.04330609,0.0009169613,0.00313832,0.0014938932,0.0014050431,0.0020054374,0.0013687706,0.002318157,0.0002719033],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014914178,0.0010043514,0.022370463,0.00017417893,0.00071628205,0.00019879531,0.00014865755,0.92708,0.00025853328,0.003772039,0.0008261349,0.028536407],"study_design_scores_gemma":[0.00092825695,0.0014173612,0.005705947,0.00003926136,0.0006709295,0.000104803745,0.00014725798,0.9849582,0.00024171307,0.005528719,0.00020603287,0.000051568626],"about_ca_topic_score_codex":0.018566404,"about_ca_topic_score_gemma":0.006127536,"teacher_disagreement_score":0.018566404,"about_ca_system_score_codex":0.003976687,"about_ca_system_score_gemma":0.00385456,"threshold_uncertainty_score":0.086993575},"labels":[],"label_agreement":null},{"id":"W2058872565","doi":"10.1016/j.jval.2013.03.047","title":"Examining Ontario's Universal Influenza Immunization Program With A New Dynamic Influenza Model","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); University of Guelph; GlaxoSmithKline (Canada)","funders":"","keywords":"Immunization; Demography; Homogeneous; Influenza A virus subtype H5N1; Influenza vaccine; Medicine; Attack rate; Confidence interval; Epidemic model; Age groups; Geography; Virology; Statistics; Mathematics; Immunology; Internal medicine; Vaccination; Antibody; Combinatorics; Environmental health; Virus; Outbreak; Population","score_opus":0.15035310682991376,"score_gpt":0.3855507249212832,"score_spread":0.23519761809136946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058872565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96056575,0.00089274714,0.0024298995,0.0070266193,0.00006465102,0.00029960234,0.003176503,0.000035710735,0.025508411],"genre_scores_gemma":[0.99116486,0.00045196954,0.0011602845,0.00027614133,0.000019686402,0.00009707247,0.00063646474,0.0000073126666,0.0061860895],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99806553,0.000912427,0.000048489717,0.00018381966,0.00020684577,0.0005827655],"domain_scores_gemma":[0.9903494,0.0060516237,0.0009787661,0.00035073695,0.0013716195,0.0008979427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041542095,0.0005341898,0.0009059168,0.000740004,0.0016959978,0.002293361,0.002056161,0.0008751975,0.005519959],"category_scores_gemma":[0.010323075,0.0003353367,0.00092765933,0.0017647948,0.0011639694,0.0013332347,0.0012472449,0.0010779214,0.00020448216],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037111617,0.0016437606,0.35062307,0.00096007856,0.0016693835,0.00094213546,0.0034615141,0.3786324,0.0011864889,0.18462421,0.025296148,0.047249693],"study_design_scores_gemma":[0.0018937789,0.0023775361,0.38094383,0.00029176095,0.0025795114,0.00011232275,0.016115442,0.5256521,0.00071669533,0.033816893,0.03530537,0.00019472519],"about_ca_topic_score_codex":0.9710137,"about_ca_topic_score_gemma":0.9790907,"teacher_disagreement_score":0.056885976,"about_ca_system_score_codex":0.056885976,"about_ca_system_score_gemma":0.038380656,"threshold_uncertainty_score":0.41273856},"labels":[],"label_agreement":null},{"id":"W2058901727","doi":"10.1111/j.1524-4733.2009.00511.x","title":"The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant; Economic evaluation; Relative risk; Demography; Cancer; Confidence interval","score_opus":0.057001828599170044,"score_gpt":0.3867357524686461,"score_spread":0.3297339238694761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058901727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854214,0.008491076,0.0010266821,0.00081318425,0.00009683042,0.00013915352,0.0029827934,0.000020426434,0.0010084311],"genre_scores_gemma":[0.9951573,0.0015517096,0.00039725998,0.0002126552,0.0000715797,0.00006435312,0.0022342114,0.000011622914,0.00029932527],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99707365,0.0019322737,0.00017466223,0.00026095446,0.00033095258,0.00022756992],"domain_scores_gemma":[0.99364156,0.0042864396,0.0010633877,0.00040320345,0.00022331935,0.0003821803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047139847,0.0010858818,0.0023831755,0.00079201895,0.00016157153,0.0010380984,0.00084006245,0.00075579045,0.0015920177],"category_scores_gemma":[0.0108664185,0.00047657106,0.0048184586,0.0015725992,0.00043194313,0.0010914973,0.00059496827,0.001679375,0.00013385034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6099126,0.0012094104,0.18468775,0.0017974471,0.03152993,0.0005804923,0.00015850854,0.0667023,0.002090722,0.0016383495,0.00437638,0.09531613],"study_design_scores_gemma":[0.107314244,0.040452752,0.6192367,0.0005830105,0.09415687,0.0016209973,0.00039981928,0.1176258,0.0027355936,0.006893753,0.0087097725,0.0002707065],"about_ca_topic_score_codex":0.004979358,"about_ca_topic_score_gemma":0.0050679506,"teacher_disagreement_score":0.004979358,"about_ca_system_score_codex":0.001820696,"about_ca_system_score_gemma":0.0009951859,"threshold_uncertainty_score":0.024930239},"labels":[],"label_agreement":null},{"id":"W2058930342","doi":"10.1016/j.jval.2011.08.714","title":"PHP164 A Typology of Outcomes for Health Research","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Typology; Health care; Consistency (knowledge bases); Medicine; Quality of life (healthcare); Outcomes research; Quality (philosophy); Nursing; Psychology; Alternative medicine; Political science","score_opus":0.8994448236542348,"score_gpt":0.5845002268700461,"score_spread":0.31494459678418874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058930342","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017514067,0.00853588,0.3350938,0.056379486,0.0026354054,0.0007446489,0.008731306,0.00039911288,0.5699663],"genre_scores_gemma":[0.650147,0.0117643075,0.18812646,0.010860357,0.0052343984,0.0059373006,0.007895956,0.0006111102,0.119423024],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9910664,0.005034768,0.00085091376,0.00078330695,0.0017240439,0.00054062874],"domain_scores_gemma":[0.98948765,0.0059813494,0.0007540475,0.0015174414,0.0017511607,0.00050830655],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008337497,0.00075564504,0.0006925717,0.004971943,0.0021464967,0.0071778363,0.0013459899,0.0032123285,0.021225637],"category_scores_gemma":[0.020368753,0.0003864602,0.001295821,0.011063069,0.006220184,0.009756777,0.003494743,0.0038805595,0.003409665],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000551815,0.000005805456,0.00041575916,0.00006174807,0.0000044351,0.000045354307,0.00021145213,0.00010694394,0.000025636526,0.98263156,0.007482901,0.009002783],"study_design_scores_gemma":[0.000007961194,0.000012209801,0.00068665924,0.00013521689,0.000005668702,0.00018435888,0.0003112227,0.0005107816,0.00006337857,0.9293429,0.06872956,0.000010122841],"about_ca_topic_score_codex":0.0023773771,"about_ca_topic_score_gemma":0.0014565387,"teacher_disagreement_score":0.9916625,"about_ca_system_score_codex":0.0032511265,"about_ca_system_score_gemma":0.0027528992,"threshold_uncertainty_score":0.071006835},"labels":[],"label_agreement":null},{"id":"W2059131296","doi":"10.1016/j.jval.2013.03.1104","title":"Patient Outcomes Of Hip Resurfacing Compared To Total Hip Arthroplasty: A Systematic Review","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Health Services; University of Alberta; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Hip resurfacing; Adverse effect; Surgery; Systematic review; Arthroplasty; MEDLINE; Internal medicine","score_opus":0.1004289237552772,"score_gpt":0.36014630645227863,"score_spread":0.2597173826970014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059131296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031620364,0.9961236,0.00006790238,0.000104849205,0.0000766177,0.000075823074,0.00027127893,0.0000035491444,0.00011421254],"genre_scores_gemma":[0.05957183,0.93899703,0.00043897328,0.00049384707,0.000094900955,0.00012780407,0.0001915062,0.000005082287,0.00007898983],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99393713,0.0017447373,0.0025172613,0.0006129021,0.0009992031,0.00018870749],"domain_scores_gemma":[0.98562706,0.009428212,0.0035825067,0.00016555551,0.0009492522,0.00024743212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045660227,0.0011452754,0.009163468,0.004606414,0.00037355695,0.0019122434,0.0012896745,0.0014461137,0.003083009],"category_scores_gemma":[0.023895739,0.00087549025,0.008841967,0.0064094546,0.0008050868,0.001690084,0.0014779958,0.0015160865,0.00016654587],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011786266,0.000032093143,0.004655525,0.8904084,0.07094401,0.00014439499,0.0002041715,0.00011776186,0.00019104706,0.00013310259,0.0010836929,0.030907195],"study_design_scores_gemma":[0.0020129646,0.0008190966,0.022564631,0.35029703,0.6098029,0.00088411866,0.00076680095,0.0001827195,0.00027700813,0.00044716336,0.0118465535,0.00009901702],"about_ca_topic_score_codex":0.005547862,"about_ca_topic_score_gemma":0.022769112,"teacher_disagreement_score":0.009163468,"about_ca_system_score_codex":0.0020965561,"about_ca_system_score_gemma":0.004227007,"threshold_uncertainty_score":0.024147749},"labels":[],"label_agreement":null},{"id":"W2059731285","doi":"10.1016/j.jval.2012.03.552","title":"PSY18 Economic Burden of Psoriasis (PSO) and Obesity in Patients With Psoriasis in the United States","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Poisson regression; Body mass index; Obesity; Psoriasis; Comorbidity; Psoriatic arthritis; Demography; Internal medicine; Population; Environmental health","score_opus":0.021890551546225996,"score_gpt":0.24641965959571305,"score_spread":0.22452910804948706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059731285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933207,0.0011689145,0.000039920236,0.0007536538,0.00002867072,0.00000718122,0.002798167,0.0000032548855,0.0018795637],"genre_scores_gemma":[0.99749833,0.0006697317,0.000043593678,0.00014518993,0.000045422254,0.0000054732686,0.001263412,0.0000011898354,0.00032770899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99973637,0.00007640801,0.00004120696,0.000025255265,0.00006408533,0.000056582034],"domain_scores_gemma":[0.99928695,0.00006685059,0.00040483198,0.000016105152,0.00006565556,0.00015975168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019992577,0.00013197299,0.00019175629,0.0008665435,0.0002812213,0.00054144184,0.00013792292,0.00033186722,0.002097536],"category_scores_gemma":[0.0011101,0.0001266643,0.0004494791,0.0016405924,0.0001377769,0.0003235694,0.00035481772,0.00055140833,0.00017177795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007499458,0.000030551982,0.9971136,0.000007663715,0.000060867682,0.00007347269,0.000018094337,0.000044560424,0.00004213255,0.000041644907,0.00054482225,0.0019476061],"study_design_scores_gemma":[0.000004462684,0.0000198134,0.99935955,0.0000058972464,0.000019270203,0.00012875644,0.000082872,0.00008842256,0.0000064679944,0.000019965106,0.0002630888,0.0000014407484],"about_ca_topic_score_codex":0.020489216,"about_ca_topic_score_gemma":0.027512094,"teacher_disagreement_score":0.020489216,"about_ca_system_score_codex":0.000424818,"about_ca_system_score_gemma":0.00043325053,"threshold_uncertainty_score":0.040739894},"labels":[],"label_agreement":null},{"id":"W2060451477","doi":"10.1016/j.jval.2011.08.1013","title":"PSY41 Health Status and Health-Related Quality of Life Reported by Females with Bleeding Disorders from the Canadian National Haemophilia Registry","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; Utilities Kingston (Canada)","funders":"","keywords":"Medicine; Haemophilia; Quality of life (healthcare); Health Utilities Index; Demography; Statistical significance; Population; Normative; Physical therapy; Gerontology; Pediatrics; Disease; Health related quality of life; Internal medicine; Environmental health","score_opus":0.23724394420194225,"score_gpt":0.38585226076112955,"score_spread":0.1486083165591873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060451477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9519462,0.0004978079,0.00006165145,0.00042209268,0.000020350959,0.00006541313,0.040319234,0.000016312424,0.0066509927],"genre_scores_gemma":[0.97969556,0.0004287356,0.00010468931,0.00012838001,0.0000151917375,0.000051112223,0.017955346,0.0000068738914,0.0016140805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990507,0.00007931711,0.00007635297,0.00009526844,0.00037853594,0.0003199487],"domain_scores_gemma":[0.99761033,0.00013111462,0.00059134274,0.00007830294,0.0011097695,0.0004791388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007333317,0.00033243053,0.0004908637,0.002830342,0.0017686068,0.0009861985,0.001060408,0.0004606876,0.0039744214],"category_scores_gemma":[0.0032029792,0.00031795923,0.0008836354,0.0058138683,0.00038461495,0.00046134854,0.00088328024,0.0008683777,0.00048224852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030653977,0.000014185025,0.9971486,0.000013370993,0.000034119257,0.000023666016,0.00013848326,0.0000333514,0.000028471679,0.000039699054,0.0016273158,0.0008681232],"study_design_scores_gemma":[0.000002373538,0.0000048151664,0.9992995,0.0000068543,0.000008305631,0.00002132793,0.00018011712,0.000035460427,0.000007312393,0.0000040106606,0.00042624227,0.0000036837919],"about_ca_topic_score_codex":0.96372914,"about_ca_topic_score_gemma":0.97646195,"teacher_disagreement_score":0.036270857,"about_ca_system_score_codex":0.006896075,"about_ca_system_score_gemma":0.008381948,"threshold_uncertainty_score":0.0729689},"labels":[],"label_agreement":null},{"id":"W2060461219","doi":"10.1016/j.jval.2011.08.502","title":"PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III Trial","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Teriflunomide; Medicine; Relapsing remitting; Quality of life (healthcare); Physical therapy; Internal medicine; Immunology; Fingolimod","score_opus":0.47951139703153695,"score_gpt":0.3949137589754587,"score_spread":0.08459763805607823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060461219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99812394,0.0008020314,0.00007188982,0.00007900727,0.0000039525903,0.000014058393,0.0006405848,0.0000016796425,0.00026283792],"genre_scores_gemma":[0.99913555,0.000117058546,0.00010051219,0.000027300985,0.0000062866143,0.000009897139,0.0005470726,0.0000017812343,0.000054505694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984164,0.0008833275,0.00021040339,0.00016505839,0.0002004794,0.00012435851],"domain_scores_gemma":[0.9888342,0.005833445,0.0037422257,0.00047753588,0.0003760413,0.00073652534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021716428,0.0003570903,0.00087377225,0.0006195422,0.0002739373,0.0011088379,0.00040144142,0.00054340495,0.0016219335],"category_scores_gemma":[0.011238996,0.00017180646,0.0016428134,0.0015679387,0.0003317967,0.00070472993,0.0005626174,0.001031,0.00014850491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007991433,0.00015457832,0.98428357,0.00007736641,0.001384781,0.000050789447,0.00009743649,0.00045465387,0.00021827266,0.00010023268,0.00020201808,0.0049847886],"study_design_scores_gemma":[0.00036738222,0.00084186107,0.9948473,0.000040508974,0.00080163387,0.00018541896,0.00017396203,0.0018857368,0.0001477715,0.0002626716,0.00042046435,0.000025419564],"about_ca_topic_score_codex":0.002971595,"about_ca_topic_score_gemma":0.0030431729,"teacher_disagreement_score":0.002971595,"about_ca_system_score_codex":0.00059396116,"about_ca_system_score_gemma":0.00048629806,"threshold_uncertainty_score":0.011484861},"labels":[],"label_agreement":null},{"id":"W2060573155","doi":"10.1046/j.1524-4733.2001.004001016.x","title":"A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Venlafaxine; Major depressive disorder; Economic evaluation; Psychiatry; Medicine; Antidepressant; Cost-effectiveness analysis; Cost effectiveness; Psychology; Mood","score_opus":0.10573103869184178,"score_gpt":0.4449140680461696,"score_spread":0.33918302935432787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060573155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928833,0.0037265269,0.00037749944,0.00055105076,0.000076778226,0.0006188759,0.0009957463,0.000013955178,0.0007562636],"genre_scores_gemma":[0.9962838,0.0010609829,0.0010079026,0.00031335122,0.00007171747,0.0002863828,0.00069682236,0.0000064787287,0.00027248272],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9936795,0.00544783,0.0001984742,0.00023022442,0.00029680133,0.00014698182],"domain_scores_gemma":[0.9933374,0.0040442175,0.0012144175,0.000315304,0.00030592852,0.0007826932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007295805,0.0015409095,0.0021416885,0.0009585588,0.00044229775,0.0010528484,0.001088765,0.0015478875,0.0025475563],"category_scores_gemma":[0.010074163,0.00062823744,0.0040449086,0.0009492646,0.0009868484,0.0011827366,0.0008982877,0.0018118297,0.00014367096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.90157723,0.0063137533,0.02618492,0.0010934514,0.010063807,0.00016135254,0.00014511961,0.008926711,0.0014904416,0.00036202607,0.00078945444,0.042891696],"study_design_scores_gemma":[0.5438072,0.28612185,0.11696625,0.000502373,0.02774008,0.00046135698,0.00053305173,0.01895889,0.0016105551,0.0005268787,0.002605073,0.000166498],"about_ca_topic_score_codex":0.010682464,"about_ca_topic_score_gemma":0.014496569,"teacher_disagreement_score":0.010682464,"about_ca_system_score_codex":0.0037215105,"about_ca_system_score_gemma":0.0023037635,"threshold_uncertainty_score":0.03858435},"labels":[],"label_agreement":null},{"id":"W2060709908","doi":"10.1016/j.jval.2012.08.1727","title":"PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Comparative Effectiveness Analysis Using Indirect Statistical Techniques","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Bortezomib; Internal medicine; Randomization; Clinical trial; Randomized controlled trial; Multiple myeloma; Surgery; Oncology","score_opus":0.17379470947664805,"score_gpt":0.4471904382956076,"score_spread":0.27339572881895957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060709908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8981756,0.060455803,0.026384184,0.0013721484,0.00061824726,0.002503573,0.0022952987,0.00008003194,0.0081151165],"genre_scores_gemma":[0.9823413,0.00570519,0.009955429,0.00017943917,0.00013128464,0.00082286185,0.0003704113,0.00002125025,0.0004729148],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.8989644,0.09465382,0.0018449427,0.0008453791,0.0030162546,0.0006752302],"domain_scores_gemma":[0.91673917,0.07762826,0.0030805876,0.0011874842,0.00086528854,0.00049921486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036428165,0.0011648362,0.003457604,0.0033164553,0.00034947708,0.0011036247,0.0012764789,0.0010218745,0.004817624],"category_scores_gemma":[0.05262808,0.0004407621,0.008705461,0.0024151993,0.0014560437,0.0013247889,0.0015521138,0.0016553213,0.000115161456],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4844243,0.004537323,0.03770138,0.0164651,0.13017817,0.0001937536,0.0007904389,0.02990365,0.0012869826,0.017497204,0.0013909516,0.27563077],"study_design_scores_gemma":[0.17979375,0.26951957,0.11038854,0.00505071,0.27597755,0.00096743443,0.0024196634,0.10984424,0.0059234346,0.029455354,0.010172959,0.00048678464],"about_ca_topic_score_codex":0.0033408345,"about_ca_topic_score_gemma":0.0025500306,"teacher_disagreement_score":0.036428165,"about_ca_system_score_codex":0.0025816334,"about_ca_system_score_gemma":0.0022253543,"threshold_uncertainty_score":0.19265288},"labels":[],"label_agreement":null},{"id":"W2060731727","doi":"10.1016/j.jval.2012.03.599","title":"PSY65 Meta-Analysis of Health-Related Quality of Life Outcomes – Methods for Enhancing Interpretability of Findings","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Resilience and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Interpretability; Medicine; Psychological intervention; Odds ratio; Meta-analysis; Odds; Physical therapy; Quality of life (healthcare); Strictly standardized mean difference; Internal medicine; Computer science; Artificial intelligence; Logistic regression","score_opus":0.3513708642939531,"score_gpt":0.5762473485840216,"score_spread":0.2248764842900685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060731727","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.114656106,0.52850544,0.30144402,0.0028315412,0.0076646316,0.022775624,0.011860746,0.0034545094,0.006807329],"genre_scores_gemma":[0.8252847,0.022699658,0.12218838,0.0021270681,0.0008384589,0.021243356,0.0020281777,0.0008138914,0.0027763438],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.80055135,0.15639874,0.024430398,0.009733008,0.007813654,0.0010727578],"domain_scores_gemma":[0.82612777,0.14548513,0.009070646,0.015403701,0.0033236286,0.0005890058],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.103167064,0.0048065376,0.017669871,0.007752653,0.0015175648,0.0043774564,0.0033591317,0.0033140888,0.008109284],"category_scores_gemma":[0.21536563,0.0023142595,0.058486994,0.006848018,0.001906759,0.0027715785,0.0035461143,0.005218331,0.00055537326],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005073661,0.000037000565,0.00262437,0.021816555,0.96081626,0.00009342749,0.000099324236,0.0005014354,0.0003904954,0.00031465816,0.0005608791,0.0076719215],"study_design_scores_gemma":[0.007452944,0.0008247835,0.005966345,0.0021037543,0.9742012,0.00012886376,0.00008234376,0.0020728875,0.0006728288,0.0029006891,0.0035142668,0.00007907835],"about_ca_topic_score_codex":0.003903642,"about_ca_topic_score_gemma":0.0096419,"teacher_disagreement_score":0.89683294,"about_ca_system_score_codex":0.0014455472,"about_ca_system_score_gemma":0.0022184511,"threshold_uncertainty_score":0.54560614},"labels":[],"label_agreement":null},{"id":"W2060830215","doi":"10.1016/j.jval.2013.02.014","title":"NICE’s Selective Application of Differential Discounting: Ambiguous, Inconsistent, and Unjustified","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Discounting; Nice; Differential (mechanical device); Life expectancy; Actuarial science; Psychological intervention; Medicine; Psychology; Economics; Computer science; Psychiatry; Environmental health; Engineering","score_opus":0.2352479979104761,"score_gpt":0.3863833612284052,"score_spread":0.15113536331792912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060830215","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022616647,0.014787387,0.20389073,0.60303277,0.010160967,0.0004002206,0.0015741987,0.0010124581,0.14252469],"genre_scores_gemma":[0.63173044,0.004120061,0.1563122,0.18887787,0.007504581,0.000465801,0.00048170573,0.00095899,0.0095484005],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.8518297,0.101479225,0.008440591,0.006196657,0.02888497,0.0031688614],"domain_scores_gemma":[0.678866,0.26845488,0.00653366,0.026434341,0.016192162,0.0035190226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.106693976,0.001132548,0.0027249567,0.0022816076,0.001523024,0.010394052,0.00483372,0.013969649,0.0058994605],"category_scores_gemma":[0.46062067,0.0014251813,0.0036225475,0.0020116935,0.010111966,0.009384669,0.0061419676,0.023517594,0.0008604287],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010913021,0.00007949343,0.0034018508,0.0007839056,0.0009256824,0.000319517,0.00117065,0.005354929,0.00035145134,0.6990835,0.1583741,0.12906364],"study_design_scores_gemma":[0.0005383513,0.00014883245,0.0022203012,0.0013229002,0.00058507465,0.00056581676,0.00018657037,0.012131866,0.0011724427,0.85138476,0.12950271,0.00024042258],"about_ca_topic_score_codex":0.008735919,"about_ca_topic_score_gemma":0.009424303,"teacher_disagreement_score":0.106693976,"about_ca_system_score_codex":0.0046227816,"about_ca_system_score_gemma":0.007691013,"threshold_uncertainty_score":0.56425846},"labels":[],"label_agreement":null},{"id":"W2061161840","doi":"10.1016/j.jval.2011.08.617","title":"PHP66 Impact of Type of Drug Insurance on the Use of Health Care Services Among Users of Antidepressants","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Prescription drug; Logistic regression; Retrospective cohort study; Emergency department; Emergency medicine; Public health; Health insurance; Family medicine; Private insurance; Antidepressant; Psychiatry; Health care; Internal medicine; Pharmacology","score_opus":0.5730610181554715,"score_gpt":0.43495048787518775,"score_spread":0.13811053028028375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061161840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98439467,0.0008027428,0.000094639225,0.0012133325,0.000052017407,0.000025558207,0.009900902,0.000009161929,0.0035069373],"genre_scores_gemma":[0.9959714,0.00026028245,0.00004778421,0.00014068998,0.000064688356,0.000013082876,0.0019458537,0.0000055675655,0.0015507155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985618,0.0004795464,0.00015843289,0.00014222204,0.00023662148,0.00042139174],"domain_scores_gemma":[0.98717505,0.0056156786,0.0040487098,0.00042682694,0.0006284333,0.002105286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013947788,0.00024693485,0.00051448954,0.0009949105,0.0004934347,0.0014600244,0.0006954992,0.0011962451,0.01841531],"category_scores_gemma":[0.013096559,0.00042741402,0.0031404793,0.0018158262,0.00033290024,0.0008281766,0.001157456,0.0024085257,0.00088531926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095697114,0.00012721038,0.9932273,0.000035835885,0.00048042036,0.00007793267,0.0000430707,0.00023310863,0.000060118244,0.00010960731,0.0007646896,0.0038837015],"study_design_scores_gemma":[0.00002077885,0.00006807071,0.99920064,0.000013191528,0.0001381732,0.000033721393,0.00007289116,0.00025673033,0.000023228904,0.000042566044,0.00012625982,0.0000038130402],"about_ca_topic_score_codex":0.063327014,"about_ca_topic_score_gemma":0.041602045,"teacher_disagreement_score":0.063327014,"about_ca_system_score_codex":0.0009038635,"about_ca_system_score_gemma":0.0011759822,"threshold_uncertainty_score":0.12591684},"labels":[],"label_agreement":null},{"id":"W2061177824","doi":"10.1016/s1098-3015(10)61762-7","title":"PMH4 2-YEAR OUTCOMES OF RISPERDAL® CONSTATM-THE FIRST ATYPICAL LONG ACTING INJECTABLE ANTIPSYCHOTIC: RESULTS FROM THE CANADIAN NATIONAL OUTCOMES MEASUREMENT STUDY IN SCHIZOPHRENIA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Atypical antipsychotic; Antipsychotic; Psychiatry; Negative symptom; Pediatrics; Psychosis","score_opus":0.11280805076470828,"score_gpt":0.35279425058833297,"score_spread":0.23998619982362468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061177824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99254143,0.00054855086,0.000052277614,0.00014633681,0.000019319841,0.00005009914,0.005735646,0.000012093068,0.0008942281],"genre_scores_gemma":[0.99283093,0.00027681238,0.000085000065,0.00007887113,0.00002132617,0.000039091472,0.005730074,0.0000049819005,0.00093284366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998323,0.0002919652,0.00008699691,0.00018207435,0.0006574795,0.00045840675],"domain_scores_gemma":[0.99639136,0.0003646441,0.0013661154,0.00022430821,0.0009603539,0.0006932934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020334336,0.0008924043,0.0011276428,0.001081401,0.00095625885,0.0009813256,0.0016331917,0.0013348598,0.0011819516],"category_scores_gemma":[0.005175199,0.0004897563,0.0021636405,0.0018005479,0.0005926574,0.00090244535,0.0010981467,0.0017158205,0.00026040955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008322081,0.0003363927,0.98316437,0.0000577801,0.0006306756,0.000054548444,0.00017651496,0.00037998022,0.00017850303,0.000059755854,0.0010548646,0.0055845757],"study_design_scores_gemma":[0.00013766075,0.0002715129,0.9989128,0.000006477137,0.00018610497,0.000012917357,0.000060751838,0.00014651354,0.000055082553,0.000015514212,0.00018253636,0.000012171845],"about_ca_topic_score_codex":0.6334323,"about_ca_topic_score_gemma":0.6486433,"teacher_disagreement_score":0.36656767,"about_ca_system_score_codex":0.0056574745,"about_ca_system_score_gemma":0.005780745,"threshold_uncertainty_score":0.7374529},"labels":[],"label_agreement":null},{"id":"W2061182213","doi":"10.1016/j.jval.2011.08.1213","title":"PCN112 Cost-Utility of Treatment for Acute Lymphoblastic Leukemia (ALL) in Childhood","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Utilities Kingston (Canada); McMaster University","funders":"","keywords":"Medicine; Pediatrics; Confidence interval; Quality of life (healthcare); Quality-adjusted life year; Economic evaluation; Ambulatory; Demography; Cost effectiveness; Internal medicine","score_opus":0.09980374962432322,"score_gpt":0.36196723210034437,"score_spread":0.26216348247602117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061182213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87034833,0.01457263,0.0037018363,0.013918647,0.00035799397,0.00047595616,0.028287994,0.00019550924,0.06814114],"genre_scores_gemma":[0.99131197,0.0017673627,0.0010727287,0.00019066059,0.000053139487,0.000057902165,0.0037173927,0.000014355264,0.0018144592],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975382,0.0014576007,0.00009196028,0.00009739154,0.00056839874,0.0002464454],"domain_scores_gemma":[0.9974111,0.0013216313,0.00040181438,0.000104407016,0.00032564785,0.00043544246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012254975,0.0003528313,0.00055860105,0.0008733248,0.00016858603,0.0010920314,0.0005303768,0.0005144829,0.0070146346],"category_scores_gemma":[0.011297759,0.00016040397,0.0009747935,0.001566207,0.0003455288,0.00048216287,0.0005874836,0.0009831379,0.00043421017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011859826,0.0005835034,0.35588253,0.0008516027,0.0017253387,0.00060866814,0.00015514919,0.084487945,0.0012075963,0.012482842,0.032015115,0.49814],"study_design_scores_gemma":[0.0019150955,0.004865675,0.8260029,0.0006373682,0.0022925187,0.0027654818,0.00068411295,0.09974569,0.0021041296,0.010647754,0.04826179,0.000077430996],"about_ca_topic_score_codex":0.040965453,"about_ca_topic_score_gemma":0.041314054,"teacher_disagreement_score":0.040965453,"about_ca_system_score_codex":0.005150233,"about_ca_system_score_gemma":0.003829934,"threshold_uncertainty_score":0.08145398},"labels":[],"label_agreement":null},{"id":"W2061389534","doi":"10.1016/j.jval.2012.03.075","title":"UT3 Firm- and Drug-Specific Patterns of Generic Drug Prices Experienced by United States Medicaid Programs: 1991-2008","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Generic drug; Reimbursement; Unit price; Drug prices; Quarter (Canadian coin); Drug; Business; Relative price; Economics; Actuarial science; Demographic economics; Monetary economics; Medicine; Health care; Pharmacology; Microeconomics; Economic growth","score_opus":0.09323204748075149,"score_gpt":0.30785787904224043,"score_spread":0.21462583156148896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061389534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9528926,0.00034699275,0.00012720672,0.0008492924,0.000015404723,0.000021719417,0.042430155,0.000038764345,0.003277704],"genre_scores_gemma":[0.9734071,0.00020840908,0.00015417294,0.00018785593,0.000021351672,0.000018390167,0.022357283,0.000011260525,0.0036342004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951255,0.00003776463,0.00005680101,0.000090717906,0.000099686964,0.00020238648],"domain_scores_gemma":[0.99570066,0.0007567651,0.0026046867,0.00007952608,0.00044272223,0.0004155864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005220228,0.00013131648,0.00020239326,0.0011493979,0.00031891372,0.00091087585,0.00056573865,0.0005972261,0.0063204947],"category_scores_gemma":[0.002989703,0.0001968557,0.00053046807,0.0023287092,0.0002465535,0.0005700543,0.0007478659,0.00071846996,0.00056055206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002735347,0.00007214344,0.98216945,0.00005095077,0.000114545466,0.000076084725,0.0001780702,0.0005280594,0.00036290826,0.00042542024,0.010626337,0.0051225317],"study_design_scores_gemma":[0.0000053670237,0.000022296374,0.9974377,0.000009440509,0.000020533977,0.00003987363,0.0002625866,0.000432088,0.00019916045,0.000028411843,0.0015385759,0.0000038595927],"about_ca_topic_score_codex":0.14749208,"about_ca_topic_score_gemma":0.20539378,"teacher_disagreement_score":0.14749208,"about_ca_system_score_codex":0.0013345032,"about_ca_system_score_gemma":0.0011600201,"threshold_uncertainty_score":0.2932672},"labels":[],"label_agreement":null},{"id":"W2061477176","doi":"10.1016/j.jval.2014.03.1457","title":"Cost-effectiveness analysis of hCG and human gonadotropins in men with hypogonadotropic hypogonadism in the context of an assisted reproduction program","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian function and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Human chorionic gonadotropin; Context (archaeology); Medicine; Infertility; Fertility; Gynecology; Human reproduction; Hypogonadotropic hypogonadism; Gonadotropin; Spermatogenesis; Obstetrics; Pregnancy; Andrology; Internal medicine; Population; Hormone; Biology","score_opus":0.06000457560296947,"score_gpt":0.34694920745879676,"score_spread":0.2869446318558273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061477176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98471504,0.009907233,0.00071615586,0.0013141399,0.00009646709,0.0005312333,0.0006378476,0.00001823872,0.0020636062],"genre_scores_gemma":[0.9983041,0.000963274,0.0002589485,0.00010201804,0.00003547694,0.000060007125,0.00014610594,0.000001678495,0.0001282399],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9964887,0.0025707989,0.0001395373,0.00017388136,0.00022716024,0.00039991317],"domain_scores_gemma":[0.99557966,0.0031276224,0.0005528139,0.000056946254,0.000110373716,0.000572575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025930111,0.0009790442,0.0019664902,0.0012642244,0.00037125446,0.0016288706,0.0008752833,0.0013663456,0.00353186],"category_scores_gemma":[0.010351925,0.0005037971,0.0052341567,0.0011429694,0.0006821758,0.0009888757,0.00091607193,0.0016682303,0.00009790045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41992995,0.011882118,0.15996817,0.004397274,0.032250874,0.0019740197,0.00034182164,0.22138299,0.0023505876,0.006232734,0.002355894,0.13693355],"study_design_scores_gemma":[0.09531359,0.17795084,0.38825005,0.0017362769,0.061028138,0.0020718279,0.0031600164,0.2586864,0.0022312466,0.004819952,0.0043728366,0.00037886377],"about_ca_topic_score_codex":0.018780453,"about_ca_topic_score_gemma":0.016388437,"teacher_disagreement_score":0.018780453,"about_ca_system_score_codex":0.0060287686,"about_ca_system_score_gemma":0.0033850218,"threshold_uncertainty_score":0.043742},"labels":[],"label_agreement":null},{"id":"W2061597312","doi":"10.1016/j.jval.2014.03.998","title":"Prevalence And Incidence Of Interstitial Pulmonary Diseases With Fibrosis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Incidence (geometry); COPD; Interstitial lung disease; Pulmonary fibrosis; Mortality rate; Internal medicine; Epidemiology; Pediatrics; Lung","score_opus":0.01085552478387926,"score_gpt":0.2564979780784433,"score_spread":0.24564245329456405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061597312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924274,0.0026331877,0.00019937112,0.00018350976,0.000015497679,0.000012921262,0.0012247666,0.000012464961,0.0032908332],"genre_scores_gemma":[0.99887115,0.0004179563,0.00009658592,0.00001799907,0.000020598874,0.0000050077756,0.00036963815,0.0000015297356,0.00019960287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991497,0.00026138863,0.000122575,0.00013426215,0.00020905746,0.00012308914],"domain_scores_gemma":[0.9964318,0.0007183016,0.0019322844,0.00017593507,0.00036378397,0.00037785058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070748053,0.00017179582,0.00033061637,0.0021227885,0.000385738,0.0007751184,0.00036098284,0.00044602572,0.0043386994],"category_scores_gemma":[0.00399188,0.00021968594,0.0005290714,0.0021029876,0.00042465358,0.00085600343,0.0005877449,0.00077040185,0.00037135553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003765734,0.000019972558,0.998173,0.000013195617,0.000029973553,0.000034755412,0.000048935362,0.000015967062,0.00009018634,0.00005231705,0.0000877466,0.0013963506],"study_design_scores_gemma":[0.000001572436,0.00003894399,0.9988067,0.000009435911,0.000015018527,0.00058570976,0.00019220174,0.0000917004,0.000023583649,0.000057465368,0.0001751087,0.0000025376899],"about_ca_topic_score_codex":0.0027795422,"about_ca_topic_score_gemma":0.0028248134,"teacher_disagreement_score":0.0043386994,"about_ca_system_score_codex":0.00025122368,"about_ca_system_score_gemma":0.00022026882,"threshold_uncertainty_score":0.014514446},"labels":[],"label_agreement":null},{"id":"W2061621007","doi":"10.1016/s1098-3015(10)74332-1","title":"PCN81 COST EFFECTIVENESS ANALYSIS OF BORTEZOMIB IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA PATIENTS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bortezomib; Multiple myeloma; Oncology; Internal medicine; Medicine","score_opus":0.0321674714575426,"score_gpt":0.32276034153599403,"score_spread":0.2905928700784514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061621007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97758454,0.0054448578,0.00020342437,0.0018665782,0.00004288013,0.00022889093,0.007770133,0.000021085567,0.006837574],"genre_scores_gemma":[0.99448204,0.0016830341,0.00024599582,0.00024665357,0.000019206569,0.000044604767,0.002143964,0.0000060752127,0.0011284075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982374,0.00039822492,0.00009863289,0.00012074247,0.0005846283,0.00056040665],"domain_scores_gemma":[0.9976234,0.000523259,0.00035757004,0.000043169886,0.0008971616,0.0005554106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001011038,0.00048668293,0.0013342204,0.0015257072,0.0012066127,0.0020021428,0.0011123657,0.0006551026,0.00263943],"category_scores_gemma":[0.004555757,0.0004084615,0.002155452,0.004768517,0.00060565356,0.00042631474,0.0006211021,0.0009256768,0.00012398358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031035854,0.0014889376,0.73473364,0.0017432871,0.0054816394,0.0013594665,0.0005150415,0.11148571,0.0012841811,0.005200346,0.016431497,0.0892404],"study_design_scores_gemma":[0.0036260986,0.0017248812,0.9362733,0.00035044676,0.00287739,0.00043542217,0.001355608,0.045933153,0.00048850424,0.000725813,0.00610259,0.00010671202],"about_ca_topic_score_codex":0.9890854,"about_ca_topic_score_gemma":0.9896333,"teacher_disagreement_score":0.0913012,"about_ca_system_score_codex":0.0913012,"about_ca_system_score_gemma":0.0632726,"threshold_uncertainty_score":0.6624397},"labels":[],"label_agreement":null},{"id":"W2061626579","doi":"10.1016/j.jval.2014.03.1150","title":"Integrating the child’s voice in adverse event reporting in oncology trials: Initial steps in the pediatric pro-ctcae initiative","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Common Terminology Criteria for Adverse Events; Medicine; Adverse effect; Grading (engineering); Clinical trial; Terminology; MEDLINE; Family medicine; Pediatric cancer; Pediatric oncology; Physical therapy; Cancer; Internal medicine","score_opus":0.1989368860584612,"score_gpt":0.45933098145925555,"score_spread":0.2603940954007944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061626579","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029771974,0.01600556,0.037072852,0.88418984,0.0041602086,0.0045180283,0.0018045527,0.00062910194,0.021847844],"genre_scores_gemma":[0.34803608,0.019709894,0.34065005,0.26164806,0.010704653,0.011743871,0.003243497,0.00077997235,0.003483912],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.56497055,0.3329595,0.03244255,0.0057569114,0.058405515,0.005464957],"domain_scores_gemma":[0.25526258,0.5433339,0.07155913,0.022665476,0.069465294,0.03771361],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4831076,0.00091153005,0.0021320628,0.0032511374,0.0021380058,0.016990421,0.006372196,0.008152732,0.0027517513],"category_scores_gemma":[0.53931844,0.0010085232,0.002613479,0.00327848,0.0046989745,0.0098976195,0.01677911,0.020369701,0.0007222821],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014990482,0.0010272505,0.10207845,0.002766316,0.0012071962,0.00023114437,0.0054894565,0.0015908326,0.0007776804,0.030146437,0.122504056,0.730682],"study_design_scores_gemma":[0.002007466,0.006190801,0.15454426,0.017136399,0.0013397435,0.0010619587,0.00813869,0.010387681,0.0048532523,0.03616042,0.7575669,0.0006124864],"about_ca_topic_score_codex":0.009113233,"about_ca_topic_score_gemma":0.023492971,"teacher_disagreement_score":0.51689243,"about_ca_system_score_codex":0.009852926,"about_ca_system_score_gemma":0.06345909,"threshold_uncertainty_score":0.63742036},"labels":[],"label_agreement":null},{"id":"W2061702676","doi":"10.1016/j.jval.2014.08.598","title":"Health Utility in Patients Following Cardiovascular Events","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myocardial infarction; Angina; Stroke (engine); Unstable angina; Diabetes mellitus; Quality of life (healthcare); EQ-5D; Demographics; Canadian Cardiovascular Society; Emergency medicine; Internal medicine; Disease; Physical therapy; Health related quality of life; Demography","score_opus":0.032618380386977675,"score_gpt":0.3279255276756159,"score_spread":0.2953071472886382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061702676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834325,0.0055045,0.00026858543,0.0015819869,0.00007091047,0.000036288264,0.0012880464,0.0000069311945,0.0078102546],"genre_scores_gemma":[0.9988269,0.00045449275,0.00007622028,0.000101518985,0.000035746492,0.0000055700884,0.00034546602,0.0000013302057,0.00015261346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982217,0.00093572255,0.00021662556,0.00009332547,0.00025255716,0.0002801849],"domain_scores_gemma":[0.9934041,0.0029728853,0.0018299038,0.00018177173,0.0007228301,0.0008885918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015983741,0.0003255218,0.00085106306,0.0017583166,0.00052492524,0.0017731366,0.00038145296,0.00070124154,0.002590585],"category_scores_gemma":[0.022031838,0.00014747493,0.0010208207,0.002431448,0.0003659038,0.0011393386,0.0009534336,0.0015141519,0.00026088892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059620064,0.00015068766,0.9858035,0.00006341189,0.00025801422,0.00020490705,0.00013481737,0.00038379384,0.000028583807,0.000357308,0.00062064116,0.011398184],"study_design_scores_gemma":[0.000063312014,0.00057480054,0.98983943,0.00014336954,0.00036043476,0.00061526196,0.0009248424,0.0033820071,0.00009382421,0.0027680441,0.0012050628,0.000029514962],"about_ca_topic_score_codex":0.0066388105,"about_ca_topic_score_gemma":0.008005164,"teacher_disagreement_score":0.0066388105,"about_ca_system_score_codex":0.0011014007,"about_ca_system_score_gemma":0.00067472726,"threshold_uncertainty_score":0.013200343},"labels":[],"label_agreement":null},{"id":"W2061800352","doi":"10.1016/j.jval.2012.03.386","title":"PMD46 Doctor Knows Best: The Effect of Yea-Saying Bias on Willingness to Pay in Choice-Format Conjoint-Analysis Studies","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Conjoint analysis; Test (biology); Respondent; Willingness to pay; Colonoscopy; Preference; Medicine; Actuarial science; Psychology; Ordered probit; Econometrics; Social psychology; Statistics; Demography; Family medicine; Economics; Cancer; Mathematics; Colorectal cancer; Political science; Internal medicine; Microeconomics","score_opus":0.2860897329741851,"score_gpt":0.32753943633819854,"score_spread":0.041449703364013435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061800352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9417997,0.0058794282,0.014718341,0.018919395,0.001490483,0.00040143722,0.0021052118,0.00009065995,0.014595359],"genre_scores_gemma":[0.98996234,0.00034174317,0.0036555636,0.0028854127,0.00044508764,0.00024156901,0.0002872062,0.00005983291,0.0021212155],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.90284777,0.083044454,0.0043679434,0.003971134,0.004808572,0.000960058],"domain_scores_gemma":[0.35957798,0.58870566,0.02563052,0.017947497,0.005271911,0.002866499],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.090956815,0.0005019868,0.0010945633,0.0008971628,0.0014450344,0.0030513476,0.0018220979,0.0044107893,0.026304586],"category_scores_gemma":[0.39341143,0.00055374234,0.002642149,0.0019562468,0.003061076,0.0026241352,0.0017808506,0.004513997,0.0016513586],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044028606,0.0022624228,0.8103849,0.0013410172,0.0045232386,0.00092838577,0.004941784,0.0017920824,0.0012578003,0.014421233,0.014736306,0.09938222],"study_design_scores_gemma":[0.0036623818,0.0035090817,0.9233252,0.001044522,0.0066256956,0.0018148884,0.003710951,0.0147614265,0.003282002,0.026862407,0.011115736,0.00028569755],"about_ca_topic_score_codex":0.004693545,"about_ca_topic_score_gemma":0.003270813,"teacher_disagreement_score":0.9090432,"about_ca_system_score_codex":0.00092490885,"about_ca_system_score_gemma":0.0010735844,"threshold_uncertainty_score":0.48103136},"labels":[],"label_agreement":null},{"id":"W2061917309","doi":"10.1016/j.jval.2014.03.1053","title":"Chronic Obstructive Pulmonary Disease (Copd) Drug Utilization: An Analysis With The Ramq Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"COPD; Medicine; Pulmonary disease; Fixed-dose combination; Database; Asthma; Drug; Population; Internal medicine; Compliance (psychology); Pediatrics; Pharmacology","score_opus":0.04095539428027161,"score_gpt":0.32998720421437844,"score_spread":0.2890318099341068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061917309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91229886,0.0012614251,0.00021681943,0.00034130187,0.000013901457,0.0000985894,0.08487805,0.00003228372,0.0008588048],"genre_scores_gemma":[0.91023153,0.0007982312,0.00076622673,0.00022991931,0.000048297232,0.00024580277,0.087227456,0.000033082102,0.00041946376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99536705,0.001443482,0.0008259101,0.0010793802,0.00092812907,0.00035612614],"domain_scores_gemma":[0.9884815,0.004218693,0.0045116483,0.0010402553,0.0011207885,0.00062722946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030179208,0.0005047413,0.0015811665,0.0036201698,0.00036542417,0.0015357601,0.001319993,0.00079371023,0.0028447513],"category_scores_gemma":[0.012480845,0.00046391026,0.0024955857,0.00854364,0.00030917051,0.0013900719,0.0013929105,0.0009145501,0.00068256597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010457956,0.00013974974,0.989888,0.00024184154,0.0013380338,0.00009954628,0.000088964625,0.00038005566,0.00009957866,0.00012101889,0.003118396,0.0034390762],"study_design_scores_gemma":[0.00014520898,0.00012740935,0.9957072,0.0000581661,0.0004695255,0.00027477674,0.0002524467,0.0015139646,0.000075344346,0.000051195984,0.0013062366,0.000018425737],"about_ca_topic_score_codex":0.029045114,"about_ca_topic_score_gemma":0.02127954,"teacher_disagreement_score":0.9709549,"about_ca_system_score_codex":0.0013378047,"about_ca_system_score_gemma":0.0013263576,"threshold_uncertainty_score":0.057752073},"labels":[],"label_agreement":null},{"id":"W2062039889","doi":"10.1016/j.jval.2012.03.551","title":"PSY17 Economic Burden Associated With Workplace Productivity Losses (WPL) in Patients With Psoriasis in a Population in the United States","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Absenteeism; Medicine; Psoriatic arthritis; Sick leave; Confounding; Population; Indirect costs; Psoriasis; Demography; Presenteeism; Physical therapy; Environmental health; Internal medicine; Psychology","score_opus":0.2019867242562362,"score_gpt":0.36899198346965506,"score_spread":0.16700525921341886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062039889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981933,0.00025659776,0.000031041443,0.0001936955,0.000008105209,0.000004853426,0.0007317197,0.0000019124363,0.00057877967],"genre_scores_gemma":[0.99934584,0.00012058502,0.000016777143,0.000036396843,0.000014595374,0.000003152043,0.00036759296,6.3183506e-7,0.00009451712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955386,0.00013390771,0.00007160703,0.00005280435,0.000091280206,0.00009647016],"domain_scores_gemma":[0.99818254,0.00027253557,0.0010316183,0.00005216853,0.00015612731,0.00030500977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034943793,0.00014609266,0.0002908355,0.0008794842,0.00034189882,0.0007561197,0.00016965534,0.0003848418,0.0017141437],"category_scores_gemma":[0.0025687048,0.00013883416,0.00065236154,0.0015575532,0.00019637335,0.00041111183,0.0005313633,0.00077975314,0.0001732733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009337322,0.000041303767,0.9979061,0.000008406244,0.00007413608,0.00009397875,0.000032799224,0.0000998637,0.000051414696,0.000024042423,0.00019027368,0.0013844434],"study_design_scores_gemma":[0.000004014246,0.000028614131,0.99942327,0.000004450562,0.00002001257,0.00011808616,0.0001342258,0.00015840314,0.000008134451,0.000020937741,0.000077755765,0.0000020285108],"about_ca_topic_score_codex":0.014503158,"about_ca_topic_score_gemma":0.013125829,"teacher_disagreement_score":0.014503158,"about_ca_system_score_codex":0.00048826233,"about_ca_system_score_gemma":0.00043167945,"threshold_uncertainty_score":0.028837442},"labels":[],"label_agreement":null},{"id":"W2062069494","doi":"10.1016/j.jval.2011.02.1143","title":"PND33 UTILIZING A PAPER STANDARD GAMBLE INSTRUMENT TO ASSESS HEALTH UTILITY IN PATIENTS WITH HEMOPHILIA B","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rank correlation; Visual analogue scale; Reliability (semiconductor); Spearman's rank correlation coefficient; Physical therapy; Test (biology); Convergent validity; Correlation; Statistics; Surgery; Patient satisfaction; Mathematics; Internal consistency","score_opus":0.15506022220186508,"score_gpt":0.3641884533417673,"score_spread":0.20912823113990223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062069494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917646,0.00052631163,0.0010984624,0.0002598798,0.000028230343,0.00017867582,0.00059510634,0.000028641289,0.005520069],"genre_scores_gemma":[0.9967127,0.00023059048,0.0014034072,0.00013203199,0.00001216928,0.000103513485,0.00034143263,0.0000048176476,0.0010593747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907863,0.0004317713,0.000095326635,0.000070600974,0.00023103227,0.00009267145],"domain_scores_gemma":[0.99835265,0.000657127,0.00051665725,0.00007251548,0.00021529789,0.00018585732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010537173,0.00042226407,0.0004145243,0.0007024431,0.00026216358,0.00069166144,0.00026489748,0.00048505966,0.0031224415],"category_scores_gemma":[0.006113659,0.00012305289,0.0005038643,0.00077946857,0.00025672652,0.0005022108,0.0005746013,0.0009476263,0.0007161272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030065118,0.0010357203,0.9206721,0.00010801155,0.00014288735,0.0003506309,0.0003831064,0.0006227092,0.0011849462,0.000549501,0.0023924396,0.0695514],"study_design_scores_gemma":[0.00031452547,0.0049561528,0.9800469,0.00008680108,0.00013773872,0.001809272,0.00044394474,0.005850779,0.0021947497,0.0007855496,0.0033340517,0.000039480125],"about_ca_topic_score_codex":0.0012685776,"about_ca_topic_score_gemma":0.0012564001,"teacher_disagreement_score":0.0031224415,"about_ca_system_score_codex":0.00038707705,"about_ca_system_score_gemma":0.00036925348,"threshold_uncertainty_score":0.010445654},"labels":[],"label_agreement":null},{"id":"W2062373581","doi":"10.1016/j.jval.2011.11.011","title":"An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Singapore General Hospital; National University of Singapore","keywords":"Medicine; Quality of life (healthcare); Physical therapy; Health related quality of life; Osteoarthritis; Univariate analysis; Knee replacement; Test (biology); Surgery; Internal medicine; Arthroplasty; Multivariate analysis","score_opus":0.03437952248052896,"score_gpt":0.31169052694669946,"score_spread":0.2773110044661705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062373581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9998161,0.000011185096,0.000015037762,0.000015405445,0.0000010914937,0.000010756488,0.00004378632,4.769648e-7,0.000086196334],"genre_scores_gemma":[0.99973935,0.000010133577,0.000025803265,0.000035681456,0.0000024350663,0.000019104446,0.00009397495,6.1705487e-7,0.00007288213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859947,0.0005921368,0.00017908723,0.0001520372,0.000166801,0.00031058447],"domain_scores_gemma":[0.997308,0.00061269506,0.0009541937,0.00013442762,0.00034050562,0.00065015245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011612152,0.0003258935,0.0006312013,0.0008111862,0.0011823401,0.0011372415,0.0004961419,0.0005930078,0.0018910078],"category_scores_gemma":[0.0035437646,0.0003830067,0.00082597625,0.0014660542,0.0007143919,0.00083419593,0.0012535529,0.0012286046,0.00039695908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002913367,0.00034141546,0.99682695,0.000011873288,0.000042051444,0.00017384137,0.0014054489,0.000026004202,0.00017262479,0.000014319309,0.00004093849,0.0006532339],"study_design_scores_gemma":[0.000031078103,0.0011606403,0.9913775,0.000006225569,0.000024911424,0.00020372549,0.006808596,0.00019165911,0.000055953074,0.000018427994,0.00010942456,0.0000119857805],"about_ca_topic_score_codex":0.012704644,"about_ca_topic_score_gemma":0.015668215,"teacher_disagreement_score":0.012704644,"about_ca_system_score_codex":0.0012736437,"about_ca_system_score_gemma":0.0015410505,"threshold_uncertainty_score":0.025261402},"labels":[],"label_agreement":null},{"id":"W2062614029","doi":"10.1016/j.jval.2012.03.365","title":"PMD25 Comparison of Statistical Methods Used to Model Health Care Costs by Dialysis Modality in the Treatment of Kidney Failure","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Covariate; Censoring (clinical trials); Statistics; Medicine; Confidence interval; Dialysis; Regression analysis; Econometrics; Hemodialysis; Regression; Linear regression; Censored regression model; Mathematics; Internal medicine","score_opus":0.500834585883865,"score_gpt":0.5381588928736892,"score_spread":0.03732430698982425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062614029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4805105,0.011320712,0.44692445,0.0049258685,0.0026231427,0.002716197,0.03285834,0.002849296,0.015271601],"genre_scores_gemma":[0.8358519,0.0025252756,0.14203146,0.0009871766,0.00039523887,0.0025033476,0.011473108,0.00069798244,0.0035343368],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9575176,0.037140593,0.0015397456,0.0012396893,0.0021133902,0.00044902405],"domain_scores_gemma":[0.7432337,0.23376265,0.003966983,0.010128104,0.0078852475,0.0010233315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.061403867,0.0011075077,0.0021088999,0.0022414888,0.00048781294,0.0020342448,0.0024920923,0.001355696,0.00988607],"category_scores_gemma":[0.14989373,0.00067121326,0.005971538,0.0029748643,0.00071610167,0.0011635193,0.0011942505,0.002251816,0.0007393446],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022370316,0.0017505159,0.07492301,0.0032386445,0.01928443,0.00033078194,0.00030486635,0.5256747,0.0009615844,0.04504366,0.047262058,0.25885546],"study_design_scores_gemma":[0.0042688334,0.0038936932,0.07292573,0.0009958396,0.0037459196,0.0003484002,0.0003140287,0.85980636,0.002739027,0.03164099,0.019052263,0.00026893595],"about_ca_topic_score_codex":0.011855338,"about_ca_topic_score_gemma":0.0050387974,"teacher_disagreement_score":0.061403867,"about_ca_system_score_codex":0.0022125905,"about_ca_system_score_gemma":0.0027798342,"threshold_uncertainty_score":0.32473856},"labels":[],"label_agreement":null},{"id":"W2062656631","doi":"10.1016/j.jval.2012.03.1227","title":"PCN110 Health-Related Quality of Life in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Lung cancer; Disease; Palliative care; Performance status; Stage (stratigraphy); Health care; Cancer; Internal medicine; Physical therapy","score_opus":0.04398484578602466,"score_gpt":0.3838714521447991,"score_spread":0.33988660635877443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062656631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972524,0.00043306805,0.000024482106,0.00012660159,0.000009342207,0.0000054425927,0.0007261702,0.000001677456,0.001420749],"genre_scores_gemma":[0.9988097,0.00010346244,0.000021355221,0.00003068303,0.0000056654826,0.0000035905002,0.0007434516,6.881903e-7,0.00028129885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997944,0.000040922598,0.0000215517,0.000032250013,0.0000522753,0.000058534562],"domain_scores_gemma":[0.9993825,0.0001072553,0.00026041956,0.000014558679,0.00006294351,0.00017233132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024045617,0.00014466333,0.00025009352,0.00038521254,0.00023216406,0.00059207843,0.00021669421,0.00032091816,0.0021571324],"category_scores_gemma":[0.0016275351,0.0000840773,0.00048143076,0.0008584792,0.00019050612,0.00039321106,0.00040473623,0.0005403828,0.00018879007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046769003,0.000058536207,0.99414814,0.0000184449,0.0000830938,0.000069899164,0.000044349246,0.000121872945,0.00018378116,0.000042629064,0.00030068605,0.0044609085],"study_design_scores_gemma":[0.00001444925,0.00013995674,0.99902856,0.0000050394588,0.00003464744,0.00013229145,0.00008562093,0.00019976005,0.000045959794,0.00004849061,0.00026236085,0.0000029043854],"about_ca_topic_score_codex":0.005883869,"about_ca_topic_score_gemma":0.0075618196,"teacher_disagreement_score":0.005883869,"about_ca_system_score_codex":0.0005595586,"about_ca_system_score_gemma":0.00028648073,"threshold_uncertainty_score":0.011699259},"labels":[],"label_agreement":null},{"id":"W2062933247","doi":"10.1016/j.jval.2014.03.1236","title":"Antidepressant use during pregnancy and risk of autism spectrum disorders in children: A population-based cohort study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Pregnancy; Antidepressant; Hazard ratio; Confounding; Cohort study; Cohort; Autism spectrum disorder; Proportional hazards model; Population; Obstetrics; Confidence interval; Autism; Pediatrics; Psychiatry; Internal medicine; Environmental health; Biology","score_opus":0.013287872478203585,"score_gpt":0.27712179179133295,"score_spread":0.2638339193131294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062933247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99848264,0.0002473182,0.00006165855,0.000049484115,0.000010662337,0.000013763828,0.00087932596,0.0000037424652,0.00025125462],"genre_scores_gemma":[0.99860054,0.00032384193,0.00010899412,0.00005236122,0.000011128304,0.000025682597,0.00056452246,0.0000046694563,0.0003083142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930847,0.00015374168,0.000074751566,0.00022438873,0.00009817646,0.00014052632],"domain_scores_gemma":[0.99862814,0.00018866056,0.00049456395,0.00022678898,0.00014779258,0.00031423598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006380536,0.0006709197,0.000712735,0.000989955,0.0012702213,0.0012612628,0.0008594295,0.0012485505,0.0015294411],"category_scores_gemma":[0.0017581593,0.0012885205,0.00162973,0.0021438827,0.0004922694,0.0009606096,0.00084307237,0.0016457723,0.00039523613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017850898,0.00008729153,0.99839264,0.000007667219,0.00027411984,0.00015296752,0.00014573314,0.000017862061,0.0002831619,0.0000116758465,0.00009941113,0.00034907507],"study_design_scores_gemma":[0.000019042589,0.000098988814,0.99899834,0.0000063361144,0.00011555914,0.00025536356,0.00032581354,0.00005709256,0.000030776224,0.000008015376,0.000077946126,0.0000066384937],"about_ca_topic_score_codex":0.04534,"about_ca_topic_score_gemma":0.047585547,"teacher_disagreement_score":0.04534,"about_ca_system_score_codex":0.00081344834,"about_ca_system_score_gemma":0.0007617913,"threshold_uncertainty_score":0.090152204},"labels":[],"label_agreement":null},{"id":"W2062977654","doi":"10.1016/s1098-3015(10)73443-4","title":"PSS11 ECONOMIC BURDEN OF SEVERE CHRONIC HAND ECZEMA/ DERMATITIS IN CANADIAN ADULTS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hand eczema; Medicine; Dermatology; Hand dermatitis; Allergic contact dermatitis; Allergy; Contact dermatitis; Immunology","score_opus":0.045542947335915566,"score_gpt":0.3570987363039822,"score_spread":0.3115557889680666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062977654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506862,0.0019663891,0.00006420393,0.0020706446,0.00003745668,0.00008552883,0.028767431,0.000015268703,0.016306838],"genre_scores_gemma":[0.98957586,0.0017571773,0.00016172299,0.00026177958,0.000024511519,0.000022157285,0.005000281,0.000005569042,0.0031908469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989635,0.00007221715,0.000081220714,0.00005860998,0.00041656152,0.0004079225],"domain_scores_gemma":[0.9983443,0.00006787532,0.000363505,0.000025489511,0.0007969151,0.00040190856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043373276,0.00034137006,0.00036924958,0.0023928417,0.0022458814,0.0014592515,0.0006750134,0.0005181792,0.007642145],"category_scores_gemma":[0.00253525,0.00029322828,0.0007919374,0.005804868,0.00038400863,0.0003585498,0.0007520252,0.0007005495,0.00043105625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024206495,0.000054672073,0.9762195,0.000120202814,0.000110247835,0.00038496207,0.00052348897,0.00022161583,0.0001252016,0.00053999654,0.0076901894,0.0137680415],"study_design_scores_gemma":[0.0000112950465,0.000020894026,0.996671,0.00004191375,0.000034854325,0.000143878,0.00089705596,0.00015861198,0.00002374509,0.000023584493,0.0019635656,0.000009602158],"about_ca_topic_score_codex":0.99615294,"about_ca_topic_score_gemma":0.99665064,"teacher_disagreement_score":0.02656114,"about_ca_system_score_codex":0.02656114,"about_ca_system_score_gemma":0.038975365,"threshold_uncertainty_score":0.19271547},"labels":[],"label_agreement":null},{"id":"W2063170531","doi":"10.1016/j.jval.2011.02.310","title":"PSS8 SYSTEMATIC REVIEW OF THE ECONOMIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Economic evaluation; Atopic dermatitis; Medicine; Homeopathy; Medical prescription; MEDLINE; Family medicine; Population; Systematic review; Quality of life (healthcare); Health care; Pediatrics; Alternative medicine; Environmental health; Dermatology; Political science; Economic growth; Nursing; Economics; Pathology","score_opus":0.07955682508136554,"score_gpt":0.36506516751533974,"score_spread":0.2855083424339742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063170531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009304089,0.9859925,0.00016054849,0.0006683163,0.00012574706,0.0003530427,0.002543264,0.0000048818742,0.000847646],"genre_scores_gemma":[0.12912954,0.86632055,0.001113591,0.0009179381,0.00022775035,0.00081531605,0.0011304406,0.000008936664,0.00033591207],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9757877,0.011112039,0.0085875075,0.0009856398,0.0030045812,0.00052241323],"domain_scores_gemma":[0.91238093,0.06552898,0.017128501,0.0011724668,0.0032337008,0.0005554294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0140318405,0.0011827254,0.0063203573,0.014293095,0.0005576422,0.0024778682,0.0010182803,0.0013533004,0.0065280423],"category_scores_gemma":[0.089906275,0.0008872764,0.0075883213,0.014982905,0.0008991088,0.0012862612,0.0017693597,0.00090229925,0.0002628556],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014165977,0.000046110505,0.010318325,0.8642952,0.07031386,0.00036892996,0.00030410232,0.00021690695,0.00016945119,0.00039992048,0.0025404883,0.049610157],"study_design_scores_gemma":[0.0018210798,0.00046087336,0.051299464,0.64670736,0.27398112,0.0010648265,0.00054221175,0.0001359437,0.00028147112,0.00063142664,0.023015557,0.000058594593],"about_ca_topic_score_codex":0.011650402,"about_ca_topic_score_gemma":0.036656052,"teacher_disagreement_score":0.014293095,"about_ca_system_score_codex":0.004481708,"about_ca_system_score_gemma":0.011872471,"threshold_uncertainty_score":0.07420838},"labels":[],"label_agreement":null},{"id":"W2063375359","doi":"10.1016/j.jval.2013.03.891","title":"Cost-Effectiveness Of Dexamethasone Intravitreal Implant In The Treatment Of Macular Edema (ME) Following Central Retinal Vein Occlusion (CRVO)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Allergan (Canada)","funders":"","keywords":"Central retinal vein occlusion; Medicine; Visual acuity; Macular edema; Emergency medicine; Intensive care medicine; Optometry; Surgery","score_opus":0.04709375615256383,"score_gpt":0.3497714693295924,"score_spread":0.3026777131770286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063375359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97877353,0.018022742,0.00024009777,0.0010468998,0.00014562042,0.00012413891,0.00031226143,0.000012307087,0.0013224194],"genre_scores_gemma":[0.9985061,0.0011113826,0.00012012138,0.000059223024,0.00003057152,0.000016288257,0.00006788146,8.731768e-7,0.00008753889],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99911445,0.00042983974,0.000099015226,0.00006360624,0.00015686512,0.000136276],"domain_scores_gemma":[0.9988695,0.0005100808,0.00027548068,0.000028095088,0.000062471045,0.00025424012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006349025,0.00039131593,0.0010833761,0.00071222946,0.00027094968,0.0008020974,0.00047036598,0.0008014998,0.0019689146],"category_scores_gemma":[0.0035352276,0.0001540894,0.0019479693,0.00061527774,0.00028314625,0.00058209995,0.0004983701,0.0009409636,0.00007830113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34055892,0.010175684,0.14896487,0.0030239325,0.0079026455,0.0017042615,0.00031766653,0.019957988,0.0037264454,0.0022572016,0.0021348959,0.4592756],"study_design_scores_gemma":[0.049122974,0.13281156,0.71598595,0.0019245272,0.024656182,0.0038649284,0.0019314082,0.056713007,0.0042352765,0.0026625183,0.0057622204,0.0003294188],"about_ca_topic_score_codex":0.008523932,"about_ca_topic_score_gemma":0.01197661,"teacher_disagreement_score":0.008523932,"about_ca_system_score_codex":0.002669637,"about_ca_system_score_gemma":0.0014002896,"threshold_uncertainty_score":0.019369602},"labels":[],"label_agreement":null},{"id":"W2063551124","doi":"10.1016/j.jval.2013.08.1785","title":"The 2013 Revision to Nice’s Discounting Guidelines: Differential Discounting Has Gone But Unjustified Selective Application Remains","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nice; Discounting; Differential (mechanical device); Actuarial science; Excellence; Medicine; Economics; Computer science; Political science; Finance; Law; Engineering","score_opus":0.3863733243511255,"score_gpt":0.43466809500455084,"score_spread":0.048294770653425356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063551124","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011328746,0.014570299,0.009646075,0.9151671,0.03971065,0.00019165615,0.0017471756,0.00066225027,0.01717198],"genre_scores_gemma":[0.019220145,0.0072669373,0.023510858,0.91254455,0.02687024,0.0005200094,0.001694035,0.0008674567,0.0075057526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.80887824,0.06629196,0.040927388,0.009163294,0.06748872,0.007250412],"domain_scores_gemma":[0.535222,0.2700668,0.028993832,0.025705319,0.12727751,0.012734604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14924967,0.0017780284,0.005688577,0.0042020585,0.0030893188,0.017768476,0.014361323,0.052537493,0.010161966],"category_scores_gemma":[0.52780807,0.002723888,0.009329279,0.006261162,0.012227434,0.0097062895,0.00712751,0.06926671,0.006366351],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025668807,0.000043277178,0.00044076843,0.00071812695,0.00017986952,0.00014092748,0.00042170956,0.00026762247,0.0001398616,0.041464888,0.91638774,0.039538488],"study_design_scores_gemma":[0.00040540713,0.00009932267,0.002652858,0.009210395,0.00052309205,0.00063640904,0.0003406283,0.0011228804,0.00049292354,0.049370628,0.93481386,0.00033150462],"about_ca_topic_score_codex":0.03956516,"about_ca_topic_score_gemma":0.03498743,"teacher_disagreement_score":0.14924967,"about_ca_system_score_codex":0.013493135,"about_ca_system_score_gemma":0.03664609,"threshold_uncertainty_score":0.78931713},"labels":[],"label_agreement":null},{"id":"W2063564660","doi":"10.1016/j.jval.2011.08.293","title":"PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients: An Analysis with the RAMQ Database","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Tobramycin; Medicine; Cystic fibrosis; Reimbursement; Pharmacy; Drug; Internal medicine; Database; Pseudomonas aeruginosa; Aminoglycoside; Pediatrics; Incidence (geometry); Antibiotics; Gentamicin; Health care; Pharmacology","score_opus":0.06548265668506846,"score_gpt":0.3332555487297448,"score_spread":0.2677728920446763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063564660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.936454,0.0010568312,0.00017259769,0.0002201713,0.00000838177,0.00005112479,0.06080945,0.0000322664,0.0011951667],"genre_scores_gemma":[0.9496643,0.0005094321,0.0003677501,0.00015604783,0.00002098963,0.00009927255,0.048897415,0.000018068293,0.0002667644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765956,0.00058104034,0.00042761632,0.00058673567,0.00056749687,0.00017740749],"domain_scores_gemma":[0.9918499,0.0026855133,0.0038261702,0.00073466566,0.0005748852,0.0003288741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014150807,0.0002816525,0.00092184765,0.0021245768,0.00019527323,0.0011301845,0.00083441334,0.0005504993,0.0023789057],"category_scores_gemma":[0.008589822,0.00025434524,0.0013510224,0.004724984,0.00020961511,0.0007993265,0.00078540994,0.00063932454,0.00055593386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013602317,0.0000666197,0.9901698,0.00015976938,0.0006915884,0.000109109125,0.000053185886,0.0003322267,0.000186846,0.00012289341,0.002021029,0.004726607],"study_design_scores_gemma":[0.00011567558,0.00015431744,0.9956571,0.00005163164,0.00035098664,0.0004186291,0.00019704497,0.001213648,0.00018046872,0.000051241073,0.0015956899,0.000013596983],"about_ca_topic_score_codex":0.011036134,"about_ca_topic_score_gemma":0.0071753897,"teacher_disagreement_score":0.98896384,"about_ca_system_score_codex":0.0008306927,"about_ca_system_score_gemma":0.00075353554,"threshold_uncertainty_score":0.021943808},"labels":[],"label_agreement":null},{"id":"W2063601276","doi":"10.1016/j.jval.2011.08.909","title":"PIH4 A Comparative Study of Respiratory Syncytial Virus (RSV) Prophylaxis in Premature Infants","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Respiratory system; Group B; Birth weight; Pregnancy; Internal medicine","score_opus":0.22659380654776934,"score_gpt":0.4325750486823068,"score_spread":0.20598124213453745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063601276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989255,0.0005421065,0.000022351385,0.000014314288,0.000008384543,0.000011930781,0.000054586664,8.663274e-7,0.00041997628],"genre_scores_gemma":[0.9992648,0.00024674222,0.000042996075,0.000020054691,0.000014253561,0.000016177066,0.000081387356,8.62667e-7,0.00031274452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992951,0.0004119205,0.00004277999,0.00006411438,0.00008890287,0.00009717233],"domain_scores_gemma":[0.999087,0.00044087286,0.00010809464,0.000050943167,0.00011666346,0.00019628853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009868104,0.0002752563,0.00066566205,0.00047004793,0.0003549796,0.00036780548,0.00033206187,0.00044504914,0.002181589],"category_scores_gemma":[0.0029168369,0.0001194651,0.00042415597,0.0005594738,0.000301532,0.00033292372,0.00027978144,0.00045895862,0.00019352807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37756112,0.007212303,0.43543756,0.0010033532,0.0011402867,0.0023811066,0.0016973563,0.00068490184,0.026750708,0.0010287076,0.00062218687,0.14448045],"study_design_scores_gemma":[0.00332201,0.20527329,0.7795183,0.00006666796,0.00073918427,0.0012253406,0.0010782715,0.00056877895,0.0057071387,0.00020731459,0.0022685663,0.000024980038],"about_ca_topic_score_codex":0.0019973798,"about_ca_topic_score_gemma":0.0013317207,"teacher_disagreement_score":0.002181589,"about_ca_system_score_codex":0.0007793037,"about_ca_system_score_gemma":0.0005234004,"threshold_uncertainty_score":0.0072981715},"labels":[],"label_agreement":null},{"id":"W2063782400","doi":"10.1016/s1098-3015(10)60913-8","title":"PHP54 PREVENTABLE DRUG-RELATED MORBIDITY IN OLDER ADULTS IN NOVA SCOTIA, CANADA: DEVELOPMENT OF QUALITY INDICATORS","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Medicine; Nova (rocket); Drug; Gerontology; Geography; Psychiatry; Engineering","score_opus":0.07128710831080154,"score_gpt":0.344993820162382,"score_spread":0.27370671185158046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063782400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87384063,0.00783189,0.0029314377,0.0043103467,0.0002459376,0.0031670039,0.08265129,0.00017355304,0.024848009],"genre_scores_gemma":[0.9679524,0.0036202965,0.006457499,0.0005303017,0.00004315566,0.0010549941,0.017229272,0.000023752447,0.0030884254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964914,0.00046568038,0.0004526543,0.00018437709,0.0018827161,0.0005230929],"domain_scores_gemma":[0.9841404,0.00059708575,0.002114877,0.00020944374,0.01123932,0.0016987601],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045939134,0.00040954986,0.0006857361,0.0029108275,0.0011398118,0.0014539866,0.0011140609,0.00040034784,0.000693613],"category_scores_gemma":[0.013055521,0.0002653016,0.0007465012,0.005964949,0.000364649,0.00052872224,0.0012341111,0.000676722,0.00014925661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015522807,0.00007131186,0.9687404,0.00022865628,0.000109553024,0.000032267344,0.00021932986,0.00045512972,0.000081232654,0.00024093129,0.0058622933,0.023803758],"study_design_scores_gemma":[0.000018728446,0.00004316386,0.9974813,0.000093756964,0.000035058685,0.000011105871,0.00013159457,0.00050889293,0.00006478012,0.000025579959,0.001580001,0.0000061048313],"about_ca_topic_score_codex":0.9827187,"about_ca_topic_score_gemma":0.98549634,"teacher_disagreement_score":0.030582516,"about_ca_system_score_codex":0.030582516,"about_ca_system_score_gemma":0.065608196,"threshold_uncertainty_score":0.22189271},"labels":[],"label_agreement":null},{"id":"W2063912686","doi":"10.1016/s1098-3015(10)61281-8","title":"PCV10 COST OF UNCONTROLLED HYPERTENSION IN CANADA","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Business","score_opus":0.44516032277882844,"score_gpt":0.3652437628175603,"score_spread":0.07991655996126812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063912686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83910954,0.012194326,0.0006984091,0.023057364,0.00054877077,0.00019000657,0.09478034,0.00017939795,0.029241936],"genre_scores_gemma":[0.9811699,0.0032176317,0.00027553822,0.0007556781,0.00011767716,0.000027932363,0.008690129,0.000022391947,0.0057231504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977295,0.00023861622,0.00015357346,0.00015121789,0.000983767,0.00074344437],"domain_scores_gemma":[0.99386406,0.0006611743,0.0008946857,0.00008810362,0.0024321608,0.0020597847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069386826,0.0003929579,0.0007651701,0.0019739245,0.0015068329,0.0025805542,0.0016445561,0.001061933,0.0045543085],"category_scores_gemma":[0.007779134,0.000441029,0.0015997156,0.0045051,0.00076432916,0.00050704996,0.00084984914,0.0025374976,0.00024543126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002622883,0.00038756564,0.81107515,0.0006900481,0.0015774533,0.0016664118,0.00043191767,0.022078399,0.00041915328,0.01474565,0.076029494,0.06827594],"study_design_scores_gemma":[0.00057331804,0.00027607786,0.9496671,0.0003289775,0.00082421,0.0011368014,0.0011078875,0.024621336,0.00032829127,0.0016714323,0.019342618,0.00012190837],"about_ca_topic_score_codex":0.99731207,"about_ca_topic_score_gemma":0.9970806,"teacher_disagreement_score":0.107500754,"about_ca_system_score_codex":0.107500754,"about_ca_system_score_gemma":0.09399523,"threshold_uncertainty_score":0.77997625},"labels":[],"label_agreement":null},{"id":"W2064958574","doi":"10.1016/j.jval.2011.08.005","title":"Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases: A Simulation Cohort Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta","funders":"Institute of Nutrition, Metabolism and Diabetes; Ministry of Health, Saskatchewan; Canadian Institutes of Health Research; Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Metformin; Medicine; Hazard ratio; Sulfonylurea; Cohort; Drug; Formulary; Confidence interval; Database; Proportional hazards model; Internal medicine; Pharmacology; Computer science","score_opus":0.31609772792014873,"score_gpt":0.4528445267944198,"score_spread":0.13674679887427105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064958574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99314004,0.0001220579,0.0052960715,0.00025050246,0.00002339965,0.0002041574,0.0006674178,0.000031059488,0.00026521742],"genre_scores_gemma":[0.9944331,0.00006977745,0.004350921,0.00008205937,0.000013387511,0.0001733047,0.0005968728,0.000008340295,0.00027228068],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98448306,0.0124229025,0.0005288305,0.0013886738,0.0005076734,0.0006688622],"domain_scores_gemma":[0.79706526,0.17103125,0.009236559,0.016280595,0.004356246,0.0020300858],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.051027372,0.0013352958,0.0018160967,0.0011516783,0.0011607413,0.0023290806,0.0034322029,0.0036030589,0.0023455266],"category_scores_gemma":[0.084766045,0.0016092607,0.004598997,0.0012756852,0.0013095202,0.0018632351,0.0019877998,0.0027726805,0.00032348922],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020939803,0.007170855,0.61181,0.00024581043,0.007591968,0.00089553616,0.0010360619,0.32734752,0.00088142644,0.004540303,0.0020281356,0.015512607],"study_design_scores_gemma":[0.0024610423,0.004553465,0.07127112,0.000069166665,0.0025005825,0.00046145625,0.00042936302,0.9142758,0.0008552351,0.0024137318,0.000575887,0.000133138],"about_ca_topic_score_codex":0.045653738,"about_ca_topic_score_gemma":0.021654429,"teacher_disagreement_score":0.94897264,"about_ca_system_score_codex":0.0028426747,"about_ca_system_score_gemma":0.0034528342,"threshold_uncertainty_score":0.26986176},"labels":[],"label_agreement":null},{"id":"W2064960060","doi":"10.1016/j.jval.2012.03.895","title":"PRM39 Examination of Starting Point Bias with the Bidding Game: Evidence from a Systematic Review of the Literature on Willingness-to-Pay Analyses","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Bidding; Willingness to pay; Population; Publication bias; Point (geometry); Inclusion (mineral); Percentage point; Willingness to accept; Medicine; Actuarial science; Psychology; Demography; Economics; Meta-analysis; Statistics; Social psychology; Marketing; Business; Environmental health; Mathematics; Sociology; Pathology","score_opus":0.7213534432219904,"score_gpt":0.506946011328283,"score_spread":0.21440743189370737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064960060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008971827,0.9739464,0.0076303883,0.002021037,0.0004905108,0.0013647096,0.0015260049,0.000028313461,0.0040208995],"genre_scores_gemma":[0.33135685,0.6421619,0.014293583,0.004900524,0.00079312996,0.0034288876,0.0014689917,0.00008735566,0.0015087464],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.90940696,0.061177157,0.015538535,0.0037314936,0.0095571065,0.00058868923],"domain_scores_gemma":[0.5458059,0.41275832,0.029603744,0.004962865,0.0064411936,0.00042806217],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.099190585,0.001616409,0.0077529727,0.0038519262,0.0004416885,0.0038666017,0.0031860238,0.0036057045,0.015378614],"category_scores_gemma":[0.3483147,0.0010007084,0.014440074,0.0058006425,0.0019788106,0.0037103188,0.0022105963,0.0031971403,0.00075616763],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006160392,0.00018132335,0.010528764,0.54221904,0.13793577,0.00015964995,0.00040221208,0.0011955525,0.00018987489,0.008200601,0.00510911,0.28771773],"study_design_scores_gemma":[0.007972403,0.002229467,0.035056725,0.402029,0.4748529,0.001051685,0.00071456085,0.003107111,0.0010531519,0.02590614,0.045803018,0.00022378207],"about_ca_topic_score_codex":0.003830964,"about_ca_topic_score_gemma":0.006212007,"teacher_disagreement_score":0.9008094,"about_ca_system_score_codex":0.0024776796,"about_ca_system_score_gemma":0.005463543,"threshold_uncertainty_score":0.5245762},"labels":[],"label_agreement":null},{"id":"W2065035332","doi":"10.1016/j.jval.2014.03.1009","title":"Economic Impact Of Alberta’s Pcv7 Childhood Immunization Program (2003-2008)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Institute of Health Economics","funders":"","keywords":"Herd immunity; Vaccination; Medicine; Population; Environmental health; Incidence (geometry); Economic impact analysis; Disease burden; Demography; Immunology; Economics","score_opus":0.015383546183351105,"score_gpt":0.31791061161648443,"score_spread":0.30252706543313335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065035332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9152647,0.003978476,0.0001750229,0.010686938,0.00025707987,0.000055007255,0.035947435,0.00004753486,0.033587694],"genre_scores_gemma":[0.9743707,0.0015664952,0.00024887046,0.0005399695,0.00005570188,0.000013857705,0.011694376,0.0000082544475,0.011501757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903405,0.00010928796,0.000029509762,0.00003860227,0.00036451267,0.0004239547],"domain_scores_gemma":[0.9988439,0.000089819885,0.00018045476,0.000019827234,0.00052624854,0.0003395555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075299863,0.00025693147,0.00020993553,0.0009422626,0.0005400229,0.0014894216,0.0007803767,0.0005648569,0.0020877756],"category_scores_gemma":[0.0028153504,0.0001771038,0.00040302525,0.0017371402,0.00032585868,0.00030542695,0.0009103869,0.000853852,0.00018842466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024532909,0.00041601664,0.8382905,0.00027302507,0.0005129963,0.001046988,0.00040034606,0.012131179,0.0006212336,0.0053372607,0.07536316,0.06315401],"study_design_scores_gemma":[0.000064085834,0.00007225312,0.977817,0.00008690515,0.00011960085,0.00012356472,0.00086763344,0.0021323434,0.00026931267,0.0002263454,0.018209087,0.000012010737],"about_ca_topic_score_codex":0.96773446,"about_ca_topic_score_gemma":0.9848839,"teacher_disagreement_score":0.032265544,"about_ca_system_score_codex":0.026540557,"about_ca_system_score_gemma":0.025258563,"threshold_uncertainty_score":0.1925661},"labels":[],"label_agreement":null},{"id":"W2065048462","doi":"10.1016/j.jval.2011.02.071","title":"QA2 CROSS-WALKING CANCER-SPECIFIC INSTRUMENTS TO THE EQ-5D AND SF-6D","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"EQ-5D; Quality of life (healthcare); Statistics; Medicine; Sample (material); Cancer; Psychological intervention; Physical therapy; Econometrics; Mathematics; Health related quality of life; Internal medicine; Psychiatry; Disease","score_opus":0.6856772738266621,"score_gpt":0.4328283091010654,"score_spread":0.2528489647255967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065048462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.464323,0.008140441,0.09876397,0.0015406184,0.001490634,0.003529714,0.31861046,0.0022043122,0.101396866],"genre_scores_gemma":[0.79008496,0.0012032118,0.04695449,0.001399284,0.00021540174,0.004483892,0.14230369,0.00027777164,0.013077241],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99169064,0.004872544,0.0009188801,0.000740854,0.0013453763,0.0004316705],"domain_scores_gemma":[0.99285215,0.0024680076,0.0015644726,0.0009114341,0.0020417797,0.00016219144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006910488,0.0009698965,0.0012308594,0.0042478815,0.00039025626,0.0015718029,0.0010360754,0.0007549594,0.020117862],"category_scores_gemma":[0.030967258,0.00036354415,0.0030485187,0.006394247,0.00034143237,0.0011947084,0.0020900378,0.0014972449,0.0040524765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008129302,0.0013618297,0.4236682,0.0037884596,0.005679548,0.00013003242,0.00084003335,0.027696611,0.0024482985,0.024803886,0.06974176,0.4317119],"study_design_scores_gemma":[0.001321075,0.0029222849,0.8044394,0.0011352664,0.00235489,0.00064103847,0.00048497264,0.042409178,0.0060741263,0.016697219,0.121301256,0.0002193209],"about_ca_topic_score_codex":0.0066607264,"about_ca_topic_score_gemma":0.006826123,"teacher_disagreement_score":0.020117862,"about_ca_system_score_codex":0.0013478333,"about_ca_system_score_gemma":0.0013740223,"threshold_uncertainty_score":0.067300916},"labels":[],"label_agreement":null},{"id":"W2065155741","doi":"10.1016/j.jval.2014.03.1099","title":"Real world research in latin america: Opportunities, sources and barriers","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Latin Americans; Principal (computer security); Medicine; Data sharing; Population; Corporate governance; Political science; Family medicine; Geography; Environmental health; Business; Alternative medicine; Pathology","score_opus":0.7550532230897441,"score_gpt":0.6019259355331338,"score_spread":0.15312728755661031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065155741","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0746689,0.034968622,0.0040066456,0.8474409,0.000567603,0.00015255155,0.00019855947,0.00003179097,0.037964378],"genre_scores_gemma":[0.88591754,0.026479809,0.008323996,0.074410625,0.0012198244,0.0006248983,0.00016235322,0.00008129487,0.0027796722],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.89959294,0.08208375,0.003940523,0.0021600504,0.006723405,0.0054993522],"domain_scores_gemma":[0.58380085,0.3438111,0.023175541,0.009539571,0.019286402,0.020386493],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15019824,0.00036280288,0.0011412384,0.0033363458,0.006887074,0.018789204,0.0023731196,0.0043912856,0.006918998],"category_scores_gemma":[0.16200256,0.000666159,0.0005494433,0.0060361763,0.017502118,0.008247253,0.013037985,0.007142637,0.00034734214],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024276077,0.00047064706,0.12093032,0.0062749772,0.00026614586,0.0020581405,0.14514291,0.00039857416,0.0014529504,0.4676747,0.036411867,0.21867606],"study_design_scores_gemma":[0.0001922832,0.0001627429,0.08247804,0.019703286,0.00016790979,0.0016776015,0.33002496,0.0006881922,0.0006202771,0.25600561,0.3081317,0.00014739722],"about_ca_topic_score_codex":0.018357787,"about_ca_topic_score_gemma":0.0336475,"teacher_disagreement_score":0.8498018,"about_ca_system_score_codex":0.016390804,"about_ca_system_score_gemma":0.059245083,"threshold_uncertainty_score":0.7943337},"labels":[],"label_agreement":null},{"id":"W2065391462","doi":"10.1111/j.1524-4733.2005.00049.x","title":"Health and Economic Consequences of Sevelamer Use for Hyperphosphatemia in Patients on Hemodialysis","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Sevelamer; Hyperphosphatemia; Medicine; Phosphate binder; Hemodialysis; Population; Kidney disease; Internal medicine; Cohort; End stage renal disease; Calcification; Intensive care medicine; Environmental health","score_opus":0.042040039044323255,"score_gpt":0.3172889578808493,"score_spread":0.2752489188365261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065391462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950287,0.0011935099,0.000039933846,0.0011378878,0.000023797018,0.000010979735,0.0003658905,0.0000019788636,0.0021974063],"genre_scores_gemma":[0.9992555,0.0002991724,0.00003386143,0.00009869837,0.000025977988,0.0000024829833,0.00015528795,4.77806e-7,0.00012857493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991273,0.0004076242,0.00009587331,0.000037504666,0.00012650511,0.00020516735],"domain_scores_gemma":[0.996461,0.0011898059,0.001096533,0.0001131352,0.00032586866,0.00081369374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008844079,0.0001956775,0.00037703718,0.00095380517,0.0008484578,0.00093800476,0.00028785295,0.000861363,0.0027633784],"category_scores_gemma":[0.0057798764,0.00018043064,0.0015799009,0.0012960525,0.00050744496,0.0005984702,0.0006716794,0.0013139484,0.00012948838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032763786,0.00058176724,0.9843575,0.000041870666,0.00038906638,0.0010372299,0.00009236516,0.00047542542,0.00017709038,0.00026612522,0.00041494126,0.008890255],"study_design_scores_gemma":[0.000120710305,0.00095978664,0.9945263,0.0000307372,0.00036183145,0.0010871867,0.0006639656,0.0010855662,0.000093280185,0.0004532079,0.00059710216,0.000020330934],"about_ca_topic_score_codex":0.011805837,"about_ca_topic_score_gemma":0.02127884,"teacher_disagreement_score":0.011805837,"about_ca_system_score_codex":0.0014980335,"about_ca_system_score_gemma":0.0010445805,"threshold_uncertainty_score":0.023474216},"labels":[],"label_agreement":null},{"id":"W2065516393","doi":"10.1016/j.jval.2014.03.1102","title":"Overview of patient-centered outcome measures available in the patient-reported outcome and quality of life instruments database (PROQOLID) for use in Quebec","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Outcome (game theory); Patient-reported outcome; Database; Medicine; Quality (philosophy); Quality of life (healthcare); Computer science; Nursing; Economics","score_opus":0.6962402521865839,"score_gpt":0.45332900488758443,"score_spread":0.2429112472989995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065516393","genre_codex":"dataset","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021274682,0.008617523,0.011552396,0.0010065254,0.00009179944,0.002613669,0.9311535,0.0013570326,0.022332788],"genre_scores_gemma":[0.119355306,0.012633252,0.052797563,0.0010685464,0.00009310957,0.009190055,0.7952579,0.0005890978,0.00901513],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962141,0.00074345514,0.00095615373,0.00031227208,0.0014815211,0.0002925172],"domain_scores_gemma":[0.9810994,0.0036839885,0.0017780218,0.0010393178,0.011931354,0.00046795807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006852651,0.000804757,0.0013199678,0.0070622275,0.0009629357,0.002089341,0.0015568681,0.000474273,0.016238589],"category_scores_gemma":[0.021001542,0.00038715248,0.0015037289,0.01274733,0.00023471742,0.0007456523,0.00070305826,0.0009021974,0.0031020583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014103502,0.0003434464,0.21357022,0.0043480746,0.0011124548,0.00014724348,0.00043597564,0.0029333595,0.0012688729,0.005405342,0.3824162,0.38660854],"study_design_scores_gemma":[0.00039665392,0.00015292825,0.6077442,0.0025713623,0.00053653104,0.00018653221,0.00031399465,0.0037406983,0.0015823349,0.0014715644,0.38110307,0.00020019659],"about_ca_topic_score_codex":0.81269324,"about_ca_topic_score_gemma":0.8639734,"teacher_disagreement_score":0.18730676,"about_ca_system_score_codex":0.011866186,"about_ca_system_score_gemma":0.020780528,"threshold_uncertainty_score":0.37681967},"labels":[],"label_agreement":null},{"id":"W2065529416","doi":"10.1016/j.jval.2012.08.903","title":"PMD54 Trans-Catheter Aortic Valve Implantation for the Non-Operative Management of Aortic Stenosis: A Cost-Effectiveness Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Cost effectiveness; Stenosis; Aortic valve replacement; Incremental cost-effectiveness ratio; Quality-adjusted life year; Emergency medicine; Aortic valve; Cost-effectiveness analysis; Cohort; Internal medicine","score_opus":0.045736385803368314,"score_gpt":0.4078133234805198,"score_spread":0.3620769376771515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065529416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94826037,0.0307899,0.00593358,0.0012327202,0.00017811514,0.0011752596,0.004963087,0.00006923304,0.007397746],"genre_scores_gemma":[0.99288094,0.003460943,0.0018245865,0.0001510942,0.00005846393,0.00019586485,0.0010540609,0.000007795287,0.00036624126],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99558336,0.0033260833,0.00021911427,0.00018403628,0.00042361926,0.00026385675],"domain_scores_gemma":[0.99351937,0.005486258,0.00045673863,0.0001190655,0.00017923707,0.00023944258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043621254,0.0012814569,0.002840464,0.002720487,0.00019539111,0.0018311293,0.0009807233,0.0011102358,0.005134922],"category_scores_gemma":[0.011302212,0.0006240886,0.00799278,0.0023681563,0.00046222674,0.0011862507,0.0008832988,0.0014255064,0.000253791],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32864955,0.0034553562,0.095489055,0.010990254,0.06063473,0.0018568623,0.00021203849,0.12880848,0.0053641107,0.008613219,0.0042697955,0.35165656],"study_design_scores_gemma":[0.07626747,0.09930169,0.37609267,0.0033570598,0.1519509,0.0051215803,0.0009557049,0.26153463,0.0043250876,0.0073679336,0.0131997485,0.0005255646],"about_ca_topic_score_codex":0.0042742025,"about_ca_topic_score_gemma":0.0029164364,"teacher_disagreement_score":0.005134922,"about_ca_system_score_codex":0.0033898172,"about_ca_system_score_gemma":0.0013174252,"threshold_uncertainty_score":0.024594963},"labels":[],"label_agreement":null},{"id":"W2065815846","doi":"10.1016/j.jval.2013.03.1242","title":"Public Engagment Mechanisms In Health Technology Assessment (HTA): An Early Assessment Of Canada's National HTA Public Engagement Initiatives","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Public engagement; Transparency (behavior); Public relations; Agency (philosophy); Accountability; Political science; Health technology; Equity (law); Public health; Public involvement; Feeling; Psychology; Business; Medicine; Health care; Social psychology; Nursing; Sociology","score_opus":0.495847758993547,"score_gpt":0.4499077397856174,"score_spread":0.04594001920792962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065815846","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23141302,0.0063266256,0.030202892,0.42915928,0.0015698051,0.0043111676,0.001724748,0.00047658416,0.29481584],"genre_scores_gemma":[0.93157756,0.0013465144,0.012535823,0.02613745,0.00034865073,0.0010551861,0.00025848934,0.00006272294,0.026677677],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.9154592,0.028187135,0.002301724,0.0033504067,0.03271588,0.017985642],"domain_scores_gemma":[0.7217396,0.17375757,0.010647009,0.013078888,0.054950338,0.025826612],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11925868,0.00080902776,0.0009429308,0.0057775257,0.015419513,0.020345274,0.0057778438,0.01323955,0.0129241645],"category_scores_gemma":[0.22578782,0.0016588594,0.001902764,0.0043314854,0.011841085,0.008414039,0.015397253,0.0146095725,0.0005367413],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004294935,0.0010875282,0.072935075,0.0005977234,0.00021612029,0.0006189025,0.016021622,0.004375614,0.0013315319,0.7162972,0.057637345,0.12845184],"study_design_scores_gemma":[0.00091354706,0.0008004451,0.24607429,0.00258931,0.0004800947,0.00039443784,0.022913862,0.018375456,0.0044177263,0.13422614,0.5682016,0.00061307324],"about_ca_topic_score_codex":0.8676811,"about_ca_topic_score_gemma":0.8879903,"teacher_disagreement_score":0.8807413,"about_ca_system_score_codex":0.13500047,"about_ca_system_score_gemma":0.33703774,"threshold_uncertainty_score":0.97950155},"labels":[],"label_agreement":null},{"id":"W2065957912","doi":"10.1016/j.jval.2011.08.1137","title":"PCN36 The Economic Impact of Treating Early Lung Cancer: A Systematic Review","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; MEDLINE; Systematic review; Thoracotomy; Intensive care medicine; Cost–benefit analysis; Surgery; General surgery; Oncology","score_opus":0.09985187474057891,"score_gpt":0.4319987463059518,"score_spread":0.3321468715653729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065957912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014421601,0.9971602,0.000085899264,0.00029678195,0.00013364806,0.000075126445,0.00036551172,0.0000035854598,0.00043710324],"genre_scores_gemma":[0.04575348,0.95283407,0.00043713933,0.0003869248,0.0001178431,0.00012188349,0.00016753019,0.0000041764783,0.00017695052],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955456,0.0020500724,0.00088875124,0.0002874734,0.001037391,0.00019068307],"domain_scores_gemma":[0.98594135,0.010718863,0.002236979,0.00014571322,0.0007308688,0.00022625741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048528076,0.0009605061,0.0058328365,0.004400094,0.00033800086,0.0016980901,0.001014583,0.0015218613,0.0067039365],"category_scores_gemma":[0.029694188,0.00078592164,0.007894116,0.0063324044,0.00058828795,0.0012727749,0.0013208211,0.0018167885,0.00024203939],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001800909,0.00006782473,0.0031788284,0.7991228,0.06805735,0.00019759132,0.00008929748,0.00071916374,0.00013250227,0.0006580771,0.004935717,0.12103991],"study_design_scores_gemma":[0.0041393745,0.0008297212,0.027378663,0.4833493,0.43489343,0.00087928114,0.00033984584,0.00070186425,0.00031544667,0.0020697208,0.044998292,0.000105073166],"about_ca_topic_score_codex":0.016204232,"about_ca_topic_score_gemma":0.045215994,"teacher_disagreement_score":0.016204232,"about_ca_system_score_codex":0.003886008,"about_ca_system_score_gemma":0.0057265395,"threshold_uncertainty_score":0.032219827},"labels":[],"label_agreement":null},{"id":"W2066154496","doi":"10.1016/s1098-3015(11)70796-3","title":"PNR8: A CANADIAN ADAPTATION OF A DECISION ANALYTIC MODEL FOR THE ECONOMIC EVALUATION OF OPIOIDS FOR CHRONIC PAIN","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adaptation (eye); Chronic pain; Medicine; Psychology; Psychiatry; Neuroscience","score_opus":0.1976929358220843,"score_gpt":0.34649293925527536,"score_spread":0.14880000343319105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066154496","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04823166,0.0012408958,0.8352793,0.0060940185,0.0007187887,0.0017277832,0.011615928,0.004522723,0.090568885],"genre_scores_gemma":[0.37173545,0.0014022908,0.58402103,0.0009484886,0.00019086443,0.0014350016,0.005193479,0.001200301,0.03387313],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975321,0.0010340379,0.000119671415,0.00023465633,0.0008009682,0.00027851146],"domain_scores_gemma":[0.99584526,0.0018481497,0.00018264675,0.0002218208,0.0016527729,0.00024933633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005609986,0.0015608275,0.0012489841,0.0017749809,0.0010721495,0.002975993,0.0033403614,0.0014875393,0.014373599],"category_scores_gemma":[0.018301183,0.0007589264,0.0018530876,0.0021298614,0.0007717616,0.0013427442,0.0018345051,0.0022345304,0.0018023195],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034168447,0.00013683674,0.0024663147,0.00023832046,0.00018678821,0.00019278663,0.0001649932,0.83278036,0.00041079987,0.072139874,0.025844218,0.065097064],"study_design_scores_gemma":[0.00012815243,0.000041226976,0.00077314413,0.000051574138,0.000057106095,0.000044903525,0.000045003413,0.957837,0.00016557545,0.018277975,0.022533529,0.000044903914],"about_ca_topic_score_codex":0.71478707,"about_ca_topic_score_gemma":0.6481307,"teacher_disagreement_score":0.28521293,"about_ca_system_score_codex":0.014113779,"about_ca_system_score_gemma":0.027918182,"threshold_uncertainty_score":0.5737852},"labels":[],"label_agreement":null},{"id":"W2066322049","doi":"10.1016/j.jval.2013.08.2092","title":"Contribution of Latin America to Mental Health in Pregnancy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mental health; Pregnancy; Latin Americans; Medicine; Anxiety; Psychiatry; Systematic review; Abortion; MEDLINE; Postpartum depression; Substance abuse; Family medicine; Environmental health; Political science","score_opus":0.03246864860856583,"score_gpt":0.32582488741472737,"score_spread":0.2933562388061615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066322049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82468456,0.05359566,0.0003731502,0.0523545,0.000308819,0.000022884416,0.0006938359,0.00001279013,0.06795384],"genre_scores_gemma":[0.9736545,0.02287207,0.0001834991,0.001826477,0.00016582775,0.00001560251,0.00010491611,0.0000081655735,0.0011689737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99950564,0.00025565605,0.00002004811,0.000029765522,0.0000399307,0.0001490286],"domain_scores_gemma":[0.99827504,0.0007188216,0.00047683154,0.00007934091,0.0001719705,0.00027798436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080313097,0.00016766984,0.0001957107,0.0010334305,0.001017598,0.0019728793,0.0004016604,0.00050557364,0.003082162],"category_scores_gemma":[0.0036129511,0.00012041128,0.00030217087,0.0027918676,0.0012009763,0.00068124675,0.001564038,0.0010743529,0.000075007345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017032881,0.00015104219,0.86268586,0.00041499385,0.00020578304,0.0013033932,0.012386085,0.00019611906,0.0005156043,0.022796188,0.0037660121,0.09540862],"study_design_scores_gemma":[0.000022780261,0.0000423092,0.9328007,0.0014600308,0.00018049058,0.0006784343,0.020734487,0.00022756106,0.00013437157,0.0045276517,0.03917374,0.000017382166],"about_ca_topic_score_codex":0.15226477,"about_ca_topic_score_gemma":0.172719,"teacher_disagreement_score":0.15226477,"about_ca_system_score_codex":0.0023793152,"about_ca_system_score_gemma":0.0031227206,"threshold_uncertainty_score":0.30275697},"labels":[],"label_agreement":null},{"id":"W2066572766","doi":"10.1016/s1098-3015(10)70687-2","title":"PCV102 THE ASSESSING CARDIOVASCULAR TARGETS (ACT '07) PROGRAM: PRELIMINARY RESULTS FROM A PRACTICE REFLECTIVE ASSESSMENT ACROSS CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical education","score_opus":0.05575158235247265,"score_gpt":0.38110445431533446,"score_spread":0.32535287196286183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066572766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739171,0.00033141117,0.0026473745,0.0042151525,0.00010327839,0.0050587165,0.0018938318,0.00019031632,0.01164269],"genre_scores_gemma":[0.9596843,0.00070162327,0.020835908,0.0019308758,0.000050798306,0.00311017,0.0015300459,0.0000930266,0.012063246],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9830889,0.005497581,0.0007699463,0.0010177976,0.007911101,0.0017146802],"domain_scores_gemma":[0.9435527,0.0067356466,0.0029157284,0.0018429842,0.034270074,0.010682943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018506696,0.00046170753,0.00069188466,0.0017215057,0.0080826245,0.0031454274,0.003258741,0.0012926402,0.0017207724],"category_scores_gemma":[0.030032573,0.0008596158,0.0006594405,0.0024301175,0.0017537352,0.0009782512,0.0035268122,0.0023166453,0.000494998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022748993,0.014459793,0.49298504,0.0005246086,0.00019172538,0.00048023794,0.070209794,0.0018954603,0.0029738736,0.0011907232,0.030817937,0.38199592],"study_design_scores_gemma":[0.0007932764,0.0032475765,0.9253418,0.0003754348,0.0001515734,0.00013537543,0.03717739,0.0044655516,0.0022643753,0.0006450651,0.025220133,0.00018248454],"about_ca_topic_score_codex":0.95770925,"about_ca_topic_score_gemma":0.9817962,"teacher_disagreement_score":0.95770925,"about_ca_system_score_codex":0.048296735,"about_ca_system_score_gemma":0.19659548,"threshold_uncertainty_score":0.35041898},"labels":[],"label_agreement":null},{"id":"W2067131555","doi":"10.1016/j.jval.2011.08.079","title":"PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease: A Bayesian Meta-analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Degenerative disc disease; Randomized controlled trial; Meta-analysis; Lumbar; Oswestry Disability Index; Physical therapy; Adverse effect; Surgery; Cochrane Library; Internal medicine; Low back pain","score_opus":0.2500162964736499,"score_gpt":0.36580496006000934,"score_spread":0.11578866358635942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067131555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57009375,0.37908167,0.03804306,0.0018912245,0.0025924458,0.0012266383,0.0031534256,0.0006053959,0.0033123817],"genre_scores_gemma":[0.98376405,0.009299015,0.004351246,0.00050267763,0.00039724365,0.00030762138,0.0005484041,0.000053264022,0.0007764447],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96950006,0.02275269,0.0020531858,0.0037323872,0.0014162788,0.0005455078],"domain_scores_gemma":[0.9516991,0.03931891,0.0036386673,0.0035215446,0.0011294609,0.0006923813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038359024,0.003365272,0.011430553,0.00199132,0.00070805824,0.0025451812,0.0031653289,0.004181863,0.005129627],"category_scores_gemma":[0.06832353,0.0026772486,0.045023672,0.0017051267,0.0016414954,0.0020597763,0.0019027692,0.004855689,0.00050559005],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15895122,0.00016004975,0.013897329,0.009144778,0.7984266,0.00015103158,0.00013872964,0.0047457344,0.0007443505,0.0003554786,0.00043718444,0.012847464],"study_design_scores_gemma":[0.028583076,0.0050893566,0.009995289,0.00060124864,0.94718385,0.000160938,0.00005427414,0.006033087,0.00030884525,0.0011951865,0.00072334585,0.00007155686],"about_ca_topic_score_codex":0.005158277,"about_ca_topic_score_gemma":0.004392328,"teacher_disagreement_score":0.038359024,"about_ca_system_score_codex":0.0013526414,"about_ca_system_score_gemma":0.00093771436,"threshold_uncertainty_score":0.20286435},"labels":[],"label_agreement":null},{"id":"W2067294597","doi":"10.1016/j.jval.2014.03.906","title":"Follow-Up Of Psychoactive Drug Use In Newly Diagnosed Patients With Autism Spectrum Disorder (Asd) In Quebec (Canada)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hôpital Rivière-des-Prairies; Université de Montréal","funders":"","keywords":"Cohort; Medicine; Psychoactive drug; Gee; Pediatrics; Drug; Cohort study; Autism; Psychiatry; Generalized estimating equation; Internal medicine","score_opus":0.02254508124643511,"score_gpt":0.2725899782287596,"score_spread":0.25004489698232446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067294597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993238,0.00081953924,0.00006908143,0.00034411222,0.00002008148,0.000047127905,0.00373299,0.000012521293,0.0017164868],"genre_scores_gemma":[0.9966221,0.00036275614,0.00009477347,0.00018122185,0.000008491572,0.000017375816,0.0014983948,0.0000040475975,0.0012108702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994466,0.000046252004,0.00005962403,0.00009624349,0.0001559495,0.00019539511],"domain_scores_gemma":[0.99742067,0.0001680434,0.00047722057,0.00004619947,0.0011496274,0.0007382056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003293787,0.00028714084,0.0004743304,0.0011529998,0.002394511,0.0012865051,0.0013730963,0.0010152058,0.002647879],"category_scores_gemma":[0.001641361,0.00029890393,0.0008216814,0.002212103,0.000456488,0.0005913605,0.00066799816,0.0012515569,0.00037777598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005697184,0.00004482351,0.99769634,0.000010043591,0.000027784505,0.00016070956,0.0002011047,0.00004195515,0.000089035995,0.0000129121745,0.00036237552,0.0012958868],"study_design_scores_gemma":[0.0000069879648,0.000032269952,0.99866915,0.000013956117,0.000020589388,0.00010616105,0.00066670345,0.00016729231,0.000033191533,0.0000055917476,0.00027078763,0.0000073548695],"about_ca_topic_score_codex":0.9830078,"about_ca_topic_score_gemma":0.98994,"teacher_disagreement_score":0.018640215,"about_ca_system_score_codex":0.018640215,"about_ca_system_score_gemma":0.012150522,"threshold_uncertainty_score":0.13524485},"labels":[],"label_agreement":null},{"id":"W2067438068","doi":"10.1016/j.jval.2014.11.004","title":"Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes: A Comparison of Sample Size Requirements for an Incontinence Treatment Trial","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Sample size determination; Medicine; Sample (material); Quality of life (healthcare); Quality (philosophy); Minimal clinically important difference; Randomized controlled trial; Internal medicine; Statistics; Nursing; Mathematics","score_opus":0.7902993482473498,"score_gpt":0.5689957086966181,"score_spread":0.22130363955073173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067438068","genre_codex":"empirical","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51081157,0.056383345,0.23640662,0.08720057,0.028671682,0.043096866,0.005828334,0.0011048095,0.030496275],"genre_scores_gemma":[0.90658176,0.0015249462,0.054781068,0.016854145,0.0020258601,0.01550199,0.00095835637,0.00020266193,0.0015693041],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.42908973,0.5160451,0.02165966,0.011646179,0.019279202,0.0022801894],"domain_scores_gemma":[0.119395606,0.8492108,0.010406201,0.013642709,0.004193109,0.003151596],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4332693,0.0026203727,0.011740589,0.002080725,0.001666987,0.0051086275,0.006549458,0.012127303,0.012072664],"category_scores_gemma":[0.72537273,0.001689586,0.013971323,0.0016692795,0.0075052017,0.008493921,0.004959498,0.015160551,0.0007738235],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74468887,0.0030172453,0.011220946,0.0068651196,0.033935264,0.00059643737,0.0018788294,0.010058156,0.0015289123,0.052707653,0.0120838955,0.121418566],"study_design_scores_gemma":[0.58188987,0.071642235,0.033538595,0.0039711795,0.049350433,0.0009580953,0.000958994,0.09018111,0.003934906,0.14907168,0.013802495,0.0007004898],"about_ca_topic_score_codex":0.0016340191,"about_ca_topic_score_gemma":0.0011570635,"teacher_disagreement_score":0.56673074,"about_ca_system_score_codex":0.0030150886,"about_ca_system_score_gemma":0.005530277,"threshold_uncertainty_score":0.69887984},"labels":[],"label_agreement":null},{"id":"W2067469511","doi":"10.1016/j.jval.2014.08.2137","title":"Health State Utilities for Pressure Ulcers – A Comparison of Condition-Specific and Generic Measures and Time-Trade-Off (Tto)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"EQ-5D; Medicine; Time-trade-off; Multivariate statistics; Body mass index; Quality of life (healthcare); Demographics; Wheelchair; Explanatory power; Demography; Physical therapy; Internal medicine; Health related quality of life; Statistics; Mathematics","score_opus":0.3339837931306228,"score_gpt":0.41160672769014556,"score_spread":0.07762293455952274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067469511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731636,0.0072921375,0.010617492,0.00032682973,0.00012470629,0.00013881683,0.004287186,0.00006454129,0.003984699],"genre_scores_gemma":[0.99637455,0.00046771887,0.0012653474,0.000034670265,0.000030999072,0.000049038794,0.0013771113,0.000017975397,0.0003825822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931623,0.0051517547,0.00029396493,0.00035645295,0.00078771566,0.00024792485],"domain_scores_gemma":[0.97402126,0.021772694,0.0020937705,0.0012109254,0.00057190034,0.00032959838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013922515,0.00058751105,0.0011891526,0.0026078792,0.00017400029,0.0011126508,0.00077517156,0.0006715094,0.0035081063],"category_scores_gemma":[0.031380385,0.00022685641,0.0037218132,0.002785777,0.00057709584,0.0020563675,0.0011140003,0.00096493453,0.0002620344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07207585,0.00180833,0.46936554,0.0030664436,0.018030742,0.00023838959,0.0016191772,0.08009537,0.0019510479,0.02786702,0.010205382,0.31367666],"study_design_scores_gemma":[0.0017387891,0.01237992,0.83700466,0.0005147769,0.005554029,0.00082497194,0.0015559703,0.10584872,0.001889473,0.02332064,0.009058941,0.00030912913],"about_ca_topic_score_codex":0.0027954823,"about_ca_topic_score_gemma":0.0019433026,"teacher_disagreement_score":0.013922515,"about_ca_system_score_codex":0.0010607595,"about_ca_system_score_gemma":0.00043763092,"threshold_uncertainty_score":0.073630154},"labels":[],"label_agreement":null},{"id":"W2067896112","doi":"10.1016/j.jval.2011.02.724","title":"PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psychological intervention; CINAHL; Raloxifene; Osteoporosis; Randomized controlled trial; MEDLINE; Concordance; Cochrane Library; Physical therapy; Intensive care medicine; Internal medicine; Nursing; Breast cancer","score_opus":0.16436579111409882,"score_gpt":0.3968226440368519,"score_spread":0.2324568529227531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067896112","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9552933,0.0145321395,0.0020477003,0.0040179035,0.0008492579,0.0011655501,0.0013986574,0.0002123874,0.020483227],"genre_scores_gemma":[0.9811132,0.0047869515,0.005533121,0.00091164303,0.00025567404,0.0006113248,0.0004539399,0.000024455392,0.0063097286],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995004,0.00019990088,0.000055385517,0.00007274494,0.00012197016,0.000049565795],"domain_scores_gemma":[0.99966383,0.00013916915,0.000071791954,0.000017606517,0.000030686024,0.00007705965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006899044,0.00028287506,0.0007314274,0.0005323069,0.0003181994,0.0003738373,0.00028583742,0.00060018536,0.023343556],"category_scores_gemma":[0.0018421778,0.00019269931,0.00065323693,0.00030744864,0.00020025465,0.00045740398,0.00037498234,0.00081249623,0.0011049175],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08383656,0.008755833,0.0042089066,0.002231525,0.00050986256,0.00025358808,0.00022733786,0.00055993046,0.02035654,0.001533816,0.007433191,0.870093],"study_design_scores_gemma":[0.14279747,0.2585073,0.3215947,0.0047046477,0.006120565,0.002459488,0.0014280028,0.006874075,0.061382156,0.007635425,0.18630376,0.0001924824],"about_ca_topic_score_codex":0.00068734784,"about_ca_topic_score_gemma":0.0014776953,"teacher_disagreement_score":0.023343556,"about_ca_system_score_codex":0.00029387197,"about_ca_system_score_gemma":0.0008746839,"threshold_uncertainty_score":0.07809198},"labels":[],"label_agreement":null},{"id":"W2067975415","doi":"10.1016/j.jval.2015.04.009","title":"Comparison Costs of ERCP and MRCP in Patients with Suspected Biliary Obstruction Based on a Randomized Trial","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Magnetic resonance cholangiopancreatography; Medicine; Endoscopic retrograde cholangiopancreatography; Randomized controlled trial; Indirect costs; Medical costs; Cost analysis; Surgery; Radiology; General surgery; Operations research","score_opus":0.03561002533832573,"score_gpt":0.31008351287254776,"score_spread":0.274473487534222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067975415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97529674,0.010709468,0.0021852306,0.0021895568,0.0021937636,0.0026647972,0.0011809747,0.00008876679,0.0034906734],"genre_scores_gemma":[0.9950954,0.001154755,0.00087330147,0.00065397716,0.00044618553,0.00072633335,0.0005265838,0.000016432015,0.0005071485],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98634976,0.01011794,0.0009944331,0.00114567,0.00058071135,0.00081145694],"domain_scores_gemma":[0.9664532,0.024884705,0.0037713049,0.0016877396,0.0007896088,0.002413399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008986256,0.0028879617,0.0065307394,0.0010408638,0.00064387853,0.0029041062,0.00213005,0.004222279,0.010604945],"category_scores_gemma":[0.026167378,0.0017796424,0.010743789,0.00092824735,0.0029035362,0.0038019575,0.0018534748,0.0063341656,0.0007274536],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9880613,0.00085715967,0.0016943896,0.00056216185,0.004345191,0.000033888246,0.000028988972,0.0007996821,0.00014779504,0.00023659534,0.0001884296,0.0030443554],"study_design_scores_gemma":[0.94546854,0.036691017,0.0035910462,0.00022813586,0.009306958,0.00006171943,0.00006470214,0.002847732,0.00025674747,0.0010508681,0.0003781913,0.00005433626],"about_ca_topic_score_codex":0.0020390102,"about_ca_topic_score_gemma":0.0017181687,"teacher_disagreement_score":0.010604945,"about_ca_system_score_codex":0.0032423802,"about_ca_system_score_gemma":0.0018517625,"threshold_uncertainty_score":0.047524393},"labels":[],"label_agreement":null},{"id":"W2068001764","doi":"10.1016/j.jval.2014.08.869","title":"Epidemiology of Multiple Sclerosis in Latin America: Critical Analysis of the Literature","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Latin Americans; Epidemiology; Incidence (geometry); Medicine; Multiple sclerosis; Demography; Pediatrics; MEDLINE; SciELO; Internal medicine; Immunology","score_opus":0.18200729017780698,"score_gpt":0.40457932834523613,"score_spread":0.22257203816742915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068001764","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016707445,0.95894593,0.00037088795,0.02127687,0.0006834942,0.00013523096,0.00047960272,0.000008311352,0.001392238],"genre_scores_gemma":[0.33199096,0.648831,0.0023270885,0.012055971,0.0036420666,0.00037379074,0.0005718074,0.000020581776,0.0001866938],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.970358,0.019247206,0.0050114975,0.0013366153,0.0033844842,0.00066216243],"domain_scores_gemma":[0.6311474,0.3061039,0.032291867,0.005088961,0.023561513,0.0018063799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055822335,0.00087704655,0.0025629813,0.027434038,0.0012615336,0.005859494,0.0020097252,0.0022466604,0.0022708392],"category_scores_gemma":[0.16713831,0.0006493679,0.0027576748,0.01837657,0.0029664554,0.0039319675,0.002810486,0.0018224735,0.0001511693],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002659535,0.00032258572,0.3239585,0.20938088,0.031172425,0.0015496251,0.008508402,0.0012090437,0.00072178605,0.014654719,0.022584874,0.38327762],"study_design_scores_gemma":[0.00075232284,0.0007353591,0.42785594,0.33350742,0.065397866,0.0021965653,0.024907287,0.0013156849,0.0006273807,0.013655901,0.1288119,0.00023633751],"about_ca_topic_score_codex":0.019975409,"about_ca_topic_score_gemma":0.0354327,"teacher_disagreement_score":0.055822335,"about_ca_system_score_codex":0.008303719,"about_ca_system_score_gemma":0.015741637,"threshold_uncertainty_score":0.2952202},"labels":[],"label_agreement":null},{"id":"W2068004048","doi":"10.1016/s1098-3015(10)70811-1","title":"PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS):A CANADIAN PERSPECTIVE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Medicine; Methotrexate; Perspective (graphical); Tumor necrosis factor alpha; Alpha (finance); Internal medicine; Surgery; Computer science; Patient satisfaction","score_opus":0.028544803212729692,"score_gpt":0.29906851359808084,"score_spread":0.27052371038535117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068004048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3788811,0.23536399,0.002029907,0.21804821,0.0019343445,0.00040577896,0.018179752,0.00007821699,0.1450787],"genre_scores_gemma":[0.9494272,0.03655213,0.0019416275,0.0050169607,0.0006769023,0.000049131584,0.0017709126,0.000016427133,0.0045486526],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99847394,0.00046354698,0.000109815985,0.00009326648,0.0005522714,0.00030708266],"domain_scores_gemma":[0.9975769,0.0006364232,0.00023700546,0.000023346402,0.00089091965,0.0006353365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016194854,0.0005854685,0.0009262754,0.0011545764,0.0009174817,0.0022288954,0.001050549,0.001428637,0.0072815763],"category_scores_gemma":[0.005708256,0.00029896066,0.0017338736,0.001742749,0.0007112842,0.0006121787,0.00041053828,0.0014817809,0.00028198404],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035123523,0.00084662257,0.16213548,0.0065482724,0.008793996,0.0027161525,0.00086914306,0.057719465,0.004030284,0.049885206,0.12196309,0.54936886],"study_design_scores_gemma":[0.016334817,0.0052794344,0.6532158,0.008329711,0.019946907,0.004592542,0.0040122606,0.054482255,0.0021757076,0.01890072,0.2120577,0.0006721258],"about_ca_topic_score_codex":0.8952498,"about_ca_topic_score_gemma":0.9319866,"teacher_disagreement_score":0.104750216,"about_ca_system_score_codex":0.043249335,"about_ca_system_score_gemma":0.0462168,"threshold_uncertainty_score":0.3137974},"labels":[],"label_agreement":null},{"id":"W2068006815","doi":"10.1016/s1098-3015(10)64399-9","title":"PAR18 HEALTH-RELATED QUALITY OF LIFE (HRQL) IN OSTEOARTHRITIS: A SYSTEMATIC REVIEW TO ASSESS THE MEASUREMENT PROPERTIES OFTHEWOMAC (WESTERN ONTARIO MCMASTER OSTEOARTHRITIS INDEX) FOR DISCRIMINATIVE AND EVALUATIVE RESEARCH","year":2006,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoarthritis; Discriminative model; Medicine; Physical therapy; Index (typography); Quality of life (healthcare); Health related quality of life; Gerontology; Alternative medicine; Computer science; Artificial intelligence; Internal medicine; World Wide Web; Pathology; Nursing","score_opus":0.649206594847244,"score_gpt":0.5016871108665037,"score_spread":0.14751948398074022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068006815","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015610586,0.9961521,0.0002746312,0.00016999808,0.000119893404,0.00073004374,0.0006423439,0.000016210945,0.00033363202],"genre_scores_gemma":[0.027755655,0.967025,0.0025997674,0.0004973347,0.00007586024,0.0013683849,0.00042661864,0.000012400815,0.0002390471],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9877293,0.00470252,0.004081311,0.0008152621,0.0024036684,0.00026789564],"domain_scores_gemma":[0.9720143,0.019218808,0.0056689405,0.0005396577,0.002216765,0.00034152518],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012878052,0.0016425906,0.012384222,0.008632168,0.0007958585,0.0023066455,0.0017050236,0.0016165598,0.005647858],"category_scores_gemma":[0.049014546,0.001138513,0.011769072,0.010143469,0.0011304321,0.002075584,0.0022161114,0.0016820143,0.0003498189],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045804612,0.000030849504,0.0018631257,0.8922678,0.031234808,0.00006873593,0.00015788658,0.00011659694,0.0001617231,0.000284397,0.0020816824,0.07127437],"study_design_scores_gemma":[0.0020493872,0.00063984375,0.023100987,0.635912,0.30516502,0.00057870545,0.00036995223,0.0002770438,0.0004452055,0.0006754276,0.030677924,0.00010837598],"about_ca_topic_score_codex":0.009774668,"about_ca_topic_score_gemma":0.040417686,"teacher_disagreement_score":0.98712194,"about_ca_system_score_codex":0.004333987,"about_ca_system_score_gemma":0.009097469,"threshold_uncertainty_score":0.06810641},"labels":[],"label_agreement":null},{"id":"W2068373153","doi":"10.1016/j.jval.2011.08.890","title":"PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate: A Cost-Effectiveness Analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Sucralfate; Medicine; Stress ulcer; Intensive care medicine; Intensive care; Internal medicine; Pneumonia","score_opus":0.07665271134877463,"score_gpt":0.3218228923073096,"score_spread":0.24517018095853496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068373153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8283776,0.13023762,0.0106744915,0.003474695,0.00044158348,0.0024639312,0.009250397,0.00012323228,0.014956453],"genre_scores_gemma":[0.980792,0.013044136,0.0030734483,0.00039854154,0.00014856392,0.0003143854,0.0014747445,0.000021546823,0.00073257234],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.994173,0.004403597,0.00028282264,0.00022154929,0.0005703846,0.0003486224],"domain_scores_gemma":[0.9905128,0.008321154,0.0005226387,0.00014235156,0.0002457863,0.00025522098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050158855,0.0018622254,0.0048306915,0.003818185,0.0003015576,0.0024380614,0.0012211435,0.0015578417,0.007499372],"category_scores_gemma":[0.013325455,0.0009977677,0.012928484,0.003759455,0.0005943193,0.0020737415,0.00091032183,0.0019254384,0.00030962625],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33624288,0.0030649933,0.060195446,0.014810489,0.10685979,0.001496021,0.00024052303,0.14458588,0.0033547524,0.008427131,0.004938925,0.31578323],"study_design_scores_gemma":[0.10362265,0.067280345,0.17225394,0.0047767987,0.34726182,0.00403584,0.0012987069,0.26852277,0.004167375,0.012200287,0.013969341,0.0006101022],"about_ca_topic_score_codex":0.0074682143,"about_ca_topic_score_gemma":0.005840227,"teacher_disagreement_score":0.007499372,"about_ca_system_score_codex":0.004732569,"about_ca_system_score_gemma":0.0018108842,"threshold_uncertainty_score":0.03433734},"labels":[],"label_agreement":null},{"id":"W2068481437","doi":"10.1016/j.jval.2011.08.157","title":"PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Context (archaeology); Health technology; Psychological intervention; Economic evaluation; Medicine; Actuarial science; Systematic review; Univariate; MEDLINE; Health care; Computer science; Pathology; Business; Nursing; Multivariate statistics; Economics","score_opus":0.7813519360318189,"score_gpt":0.5588575542055235,"score_spread":0.22249438182629533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068481437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009782441,0.99488246,0.0004053742,0.0004775207,0.00022121296,0.00072642905,0.0015058478,0.000017763632,0.0007851616],"genre_scores_gemma":[0.02040127,0.97358364,0.0021662265,0.0010385475,0.00019699306,0.0014294164,0.00075622037,0.000020020816,0.00040765278],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9770089,0.0106010875,0.0073138676,0.0010651469,0.0036386354,0.00037245252],"domain_scores_gemma":[0.93811244,0.046317387,0.010534251,0.0007315302,0.0039033066,0.00040120192],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.022435844,0.0023439005,0.010397863,0.010096166,0.0005668103,0.0033994124,0.0019428364,0.002480866,0.011818627],"category_scores_gemma":[0.10263876,0.001180327,0.011669317,0.011026267,0.0011037355,0.002424544,0.00205084,0.0021009662,0.0005852501],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001022132,0.00002576773,0.0006950533,0.9072042,0.026044553,0.000082081235,0.00007897078,0.00018476065,0.000114377355,0.0004912207,0.0040039397,0.060053077],"study_design_scores_gemma":[0.0020156498,0.00035792188,0.0056357584,0.77254647,0.18570864,0.0003744595,0.00013539125,0.00018139342,0.00027628586,0.0009624842,0.031739164,0.00006629564],"about_ca_topic_score_codex":0.0072895605,"about_ca_topic_score_gemma":0.02111797,"teacher_disagreement_score":0.98960215,"about_ca_system_score_codex":0.004753,"about_ca_system_score_gemma":0.010061346,"threshold_uncertainty_score":0.118653476},"labels":[],"label_agreement":null},{"id":"W2068563979","doi":"10.1111/j.1524-4733.2010.00757.x","title":"Clustering Rasch Results: A Novel Method for Developing Rheumatoid Arthritis States for Use in Valuation Studies","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Rasch model; Polytomous Rasch model; Valuation (finance); Rheumatoid arthritis; Cluster analysis; Medicine; Physical therapy; Dimension (graph theory); Psychology; Psychometrics; Computer science; Artificial intelligence; Clinical psychology; Item response theory; Mathematics","score_opus":0.6305306781792499,"score_gpt":0.5016083572936013,"score_spread":0.1289223208856486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068563979","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007533626,0.000076068165,0.9889959,0.00006658522,0.000030783864,0.00013257153,0.0005543059,0.0015721375,0.0010379587],"genre_scores_gemma":[0.23280121,0.00013913224,0.76134443,0.000069789894,0.0000814698,0.0006467311,0.0020682195,0.0005582414,0.0022906424],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9943066,0.0035867097,0.00033918527,0.00060936273,0.0009798397,0.00017822775],"domain_scores_gemma":[0.9726503,0.01848216,0.0013838036,0.003956058,0.0032385346,0.00028908713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008345441,0.0012794592,0.0014952124,0.0059746406,0.001156263,0.0019077113,0.0013740519,0.0008245925,0.009291177],"category_scores_gemma":[0.046317548,0.00053629786,0.0018610522,0.005235483,0.000718838,0.0019633174,0.0016612776,0.0017087929,0.0018802286],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000831376,0.0003922864,0.023787098,0.00046048663,0.0014690775,0.00023816097,0.0013293817,0.12941617,0.0031427448,0.116374366,0.019164246,0.7033946],"study_design_scores_gemma":[0.00015847602,0.0002307128,0.011877211,0.00009599818,0.00028785245,0.00021267499,0.0003365065,0.81084275,0.0032715981,0.16247362,0.010025986,0.00018650561],"about_ca_topic_score_codex":0.008835154,"about_ca_topic_score_gemma":0.012564623,"teacher_disagreement_score":0.009291177,"about_ca_system_score_codex":0.00070484146,"about_ca_system_score_gemma":0.0015529083,"threshold_uncertainty_score":0.04413545},"labels":[],"label_agreement":null},{"id":"W2068570909","doi":"10.1016/s1098-3015(10)65092-9","title":"PMH42 THE PREVALENCE OF POTENTIAL DRUG-DRUG INTERACTIONS ASSOCIATED WITH ATYPICAL ANTIPSYCHOTICS WITHIN ONTARIO DRUG BENEFIT CLAIMS","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Medicine; Antipsychotic drug; Psychiatry; Schizophrenia (object-oriented programming); Antipsychotic","score_opus":0.06552113906250694,"score_gpt":0.3735865414050376,"score_spread":0.30806540234253066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068570909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899306,0.0005215281,0.0000943265,0.0006159754,0.000007767797,0.000032932745,0.003131663,0.00000979263,0.005655379],"genre_scores_gemma":[0.99811244,0.00019580331,0.000096362644,0.00007860975,0.000009677056,0.000011134189,0.0006903006,0.000002291499,0.0008035354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792826,0.0002750647,0.00017342588,0.000160991,0.0011714491,0.00029080012],"domain_scores_gemma":[0.9920041,0.0013077256,0.0037383197,0.00021846857,0.0017827748,0.0009485051],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008354437,0.00015566364,0.00023945067,0.0018967431,0.0011177976,0.0008408197,0.00078920956,0.0004753486,0.004191624],"category_scores_gemma":[0.009762297,0.00029029336,0.0005015413,0.0026615732,0.00046865054,0.0005051481,0.0007292948,0.0004640947,0.00019622868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000509508,0.000013009496,0.9960759,0.00002090233,0.000039979805,0.00008070761,0.00024892148,0.000030917636,0.00013837637,0.00007048114,0.0005331515,0.0026966743],"study_design_scores_gemma":[0.0000021146632,0.000007824087,0.9992748,0.000006113848,0.000008179579,0.000062255356,0.00014879779,0.00009256377,0.000028920716,0.000012992894,0.00035344312,0.000002036909],"about_ca_topic_score_codex":0.79390544,"about_ca_topic_score_gemma":0.8414273,"teacher_disagreement_score":0.20609456,"about_ca_system_score_codex":0.006086475,"about_ca_system_score_gemma":0.0067160423,"threshold_uncertainty_score":0.41461658},"labels":[],"label_agreement":null},{"id":"W2069120076","doi":"10.1016/s1098-3015(10)61255-7","title":"PHP16 GENERIC DRUG PRICES ARE TYPICALLY HIGHER IN CANADA THAN IN THE UNITED STATES","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Business; Drug prices; Economics; Medicine; Public economics; Pharmacology","score_opus":0.14704572244072,"score_gpt":0.3536881509725271,"score_spread":0.2066424285318071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069120076","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39859322,0.017320987,0.0018554957,0.047451608,0.0005937592,0.00024798582,0.031764627,0.00043409373,0.5017382],"genre_scores_gemma":[0.8961559,0.010650469,0.0037500719,0.0068578147,0.00029512946,0.00006956973,0.010618846,0.00010762189,0.07149441],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99856347,0.00016092442,0.000049664905,0.0000921704,0.0008394708,0.0002943984],"domain_scores_gemma":[0.9937284,0.0014498931,0.0009838924,0.00015536927,0.0025252302,0.0011571578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011884709,0.00014089169,0.00028950817,0.0013903322,0.0012125808,0.0023012452,0.00038927828,0.000581564,0.024891922],"category_scores_gemma":[0.00687078,0.00012609224,0.0003879864,0.0032328488,0.0005167363,0.00061161944,0.00043893067,0.00066578167,0.0014832194],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014595268,0.00021027299,0.298348,0.0006679681,0.00021994597,0.00077275187,0.0006868529,0.00079123146,0.0042491,0.017330153,0.2252066,0.4500576],"study_design_scores_gemma":[0.00012998885,0.00018301827,0.7207465,0.00019736431,0.000078757075,0.0009316941,0.00094827876,0.00037727715,0.003672875,0.00083181245,0.27186206,0.000040365674],"about_ca_topic_score_codex":0.74675614,"about_ca_topic_score_gemma":0.8355658,"teacher_disagreement_score":0.25324386,"about_ca_system_score_codex":0.013887058,"about_ca_system_score_gemma":0.018944446,"threshold_uncertainty_score":0.5094705},"labels":[],"label_agreement":null},{"id":"W2069289436","doi":"10.1016/j.jval.2014.03.1482","title":"Persistence rate and adherence level to oral antidiabetics and their associated determinants","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition, Health and Food Behavior","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Persistence (discontinuity); Dyslipidemia; Cohort; Logistic regression; Medical prescription; Proportional hazards model; Internal medicine; Cohort study; Demography; Disease","score_opus":0.13437080323293193,"score_gpt":0.33503806515445633,"score_spread":0.2006672619215244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069289436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834967,0.00041684945,0.0000839914,0.000092607545,0.000008596519,0.0000105503395,0.00034387293,0.0000060195944,0.0006879017],"genre_scores_gemma":[0.9990263,0.00013426121,0.000078622776,0.000017357688,0.000012619945,0.000007646322,0.00031609554,0.0000032088842,0.0004039201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989072,0.00024138039,0.00023290339,0.00016442324,0.00021236857,0.00024172594],"domain_scores_gemma":[0.9912169,0.0028317608,0.0034916943,0.0005962924,0.00070832815,0.0011549436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019126711,0.0002471869,0.0005474036,0.0010922971,0.0006927711,0.0016113642,0.0005979409,0.000994082,0.004293346],"category_scores_gemma":[0.009694596,0.00030557084,0.0017662824,0.0018047146,0.00034526177,0.0009760895,0.000664446,0.0023019295,0.0004894093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015204138,0.00018318104,0.9980242,0.000008139744,0.00008282104,0.000020670162,0.00006815474,0.000033348166,0.000034221986,0.000018889948,0.00003309928,0.0013411867],"study_design_scores_gemma":[0.000004108969,0.00015718208,0.9989492,0.000006686219,0.0000482963,0.00010380177,0.00029540638,0.0002926006,0.000018967165,0.00004288108,0.00007578961,0.0000051819875],"about_ca_topic_score_codex":0.008703325,"about_ca_topic_score_gemma":0.0060965274,"teacher_disagreement_score":0.008703325,"about_ca_system_score_codex":0.00047982042,"about_ca_system_score_gemma":0.00094540964,"threshold_uncertainty_score":0.017305315},"labels":[],"label_agreement":null},{"id":"W2069316653","doi":"10.1016/j.jval.2011.08.200","title":"PIN12 Epidemiology, Outcomes, and Costs of Hospitalization Due to Pneumonia, Meningitis, and Septicemia in Canada from 2004 to 2010","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Dalhousie University","funders":"","keywords":"Medicine; Incidence (geometry); Case fatality rate; Meningitis; Pneumonia; Epidemiology; Pediatrics; Population; Diagnosis code; Internal medicine; Environmental health","score_opus":0.04894306927741858,"score_gpt":0.3030747949701776,"score_spread":0.254131725692759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069316653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.918633,0.005965707,0.00020711782,0.0017650967,0.00010990999,0.00008068641,0.06521858,0.00007534692,0.0079445075],"genre_scores_gemma":[0.9744709,0.0027672504,0.00023060695,0.00040335086,0.00003443189,0.00003905993,0.019775331,0.000013668358,0.0022653006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986772,0.000053000298,0.00011126903,0.00013830312,0.00045635333,0.0005638612],"domain_scores_gemma":[0.99646914,0.00008058838,0.00077561836,0.000051877676,0.0018063255,0.0008165806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003744194,0.00053598813,0.0006207222,0.0026789873,0.0020850135,0.0015570682,0.0016331776,0.000780851,0.0020714751],"category_scores_gemma":[0.0025663504,0.00050530746,0.0014626948,0.0066490006,0.0005566608,0.0005965755,0.0011252991,0.001492342,0.00022038876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002014688,0.000044065033,0.9868628,0.00008397701,0.00017116038,0.00016122253,0.00017981541,0.00039103784,0.000096556796,0.00020468674,0.006221744,0.0053814985],"study_design_scores_gemma":[0.000011390937,0.000020253508,0.9971163,0.00006396501,0.000054565593,0.00015714225,0.00045866836,0.00034704187,0.000042350326,0.000028318329,0.0016857897,0.000014269652],"about_ca_topic_score_codex":0.99643326,"about_ca_topic_score_gemma":0.996977,"teacher_disagreement_score":0.047757227,"about_ca_system_score_codex":0.047757227,"about_ca_system_score_gemma":0.058218885,"threshold_uncertainty_score":0.3465045},"labels":[],"label_agreement":null},{"id":"W2069328529","doi":"10.1016/s1098-3015(10)72318-4","title":"PDB76 AN OPEN-SOURCE, INTERACTIVE MODEL TO ASSESS THE OUTCOMES AND ECONOMICS OF DIABETES INTERVENTIONS IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Open source; Economics; Public economics; Environmental economics; Computer science; Medicine; Nursing; Operating system","score_opus":0.10419690314383404,"score_gpt":0.3726661779194348,"score_spread":0.2684692747756008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069328529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6723449,0.0012513222,0.12828352,0.0067098686,0.00046436075,0.0013539409,0.108666115,0.00682587,0.07410004],"genre_scores_gemma":[0.93459606,0.00040675353,0.040971316,0.00026564227,0.00004037019,0.0005847618,0.009408587,0.0002562624,0.013470361],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993457,0.00023647188,0.000029967701,0.00011440302,0.0001121233,0.00016124167],"domain_scores_gemma":[0.99530077,0.003083821,0.0001656222,0.00014084339,0.000964207,0.00034462713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016992238,0.0009711356,0.0011243155,0.0017149836,0.0011770402,0.0023217713,0.003254978,0.0020223006,0.0219496],"category_scores_gemma":[0.00880824,0.0006623606,0.00126236,0.0023288038,0.00073518255,0.00092456,0.0010529567,0.0011233686,0.0009979954],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039377992,0.00020595248,0.013257653,0.00012255555,0.00016898106,0.00012054957,0.00009395854,0.95191485,0.00008201494,0.010264426,0.010253073,0.013122117],"study_design_scores_gemma":[0.00029472166,0.000042374097,0.0029657208,0.000026631482,0.000069498245,0.000026478343,0.000082074555,0.98807853,0.000075435746,0.004342494,0.0039621014,0.00003391069],"about_ca_topic_score_codex":0.9428947,"about_ca_topic_score_gemma":0.91784424,"teacher_disagreement_score":0.9785328,"about_ca_system_score_codex":0.02146719,"about_ca_system_score_gemma":0.025247548,"threshold_uncertainty_score":0.15575612},"labels":[],"label_agreement":null},{"id":"W2069359870","doi":"10.1016/s1098-3015(10)64771-7","title":"PHP22 PRESCRIPTION DRUG PRICE COMPARISONS BETWEEN CANADIAN AND US ON-LINE PHARMACIES OVER A SIX-MONTH PERIOD","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Pharmacy; Period (music); Prescription drug; Medicine; Drug; Family medicine; Pharmacology","score_opus":0.11288744499185155,"score_gpt":0.3256395606394327,"score_spread":0.21275211564758117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069359870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80010957,0.0008761505,0.00030531277,0.002052764,0.00014291977,0.00014914734,0.17465459,0.00015954988,0.021550046],"genre_scores_gemma":[0.9447732,0.00026896654,0.00027733276,0.0003665797,0.00007895531,0.000036351645,0.04538846,0.000021498709,0.008788668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982351,0.00010788388,0.00007885317,0.00015430884,0.0010346507,0.00038910992],"domain_scores_gemma":[0.9907419,0.0010894933,0.0012793979,0.00016299712,0.0057709212,0.000955305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009993303,0.00030411998,0.00046550672,0.00217742,0.0010681384,0.0015877775,0.0008790352,0.00065009063,0.0056408574],"category_scores_gemma":[0.0085498905,0.00021254904,0.0006262186,0.004805956,0.00030054242,0.00050051545,0.0005307576,0.0007872558,0.00058007485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070181154,0.00042050806,0.844636,0.0003413453,0.00060650276,0.00043209037,0.00037198336,0.005181678,0.0008879325,0.0012706413,0.09410107,0.044732146],"study_design_scores_gemma":[0.000043580418,0.00008448365,0.9938075,0.000007176584,0.000031520496,0.000041049636,0.0001722505,0.00091729884,0.00027939669,0.00003323632,0.004567274,0.0000152227485],"about_ca_topic_score_codex":0.96995753,"about_ca_topic_score_gemma":0.97350717,"teacher_disagreement_score":0.03004247,"about_ca_system_score_codex":0.018447157,"about_ca_system_score_gemma":0.014481494,"threshold_uncertainty_score":0.13384414},"labels":[],"label_agreement":null},{"id":"W2069609467","doi":"10.1016/j.jval.2013.03.1465","title":"Estimating the costs of cardiac rehabilitation programs in heart failure (HF) in colombia: construction based on expert consensus","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rehabilitation; Reimbursement; Session (web analytics); Health care; Negotiation; Medicine; Service provider; Matching (statistics); Delphi; Delphi method; Systematic review; Actuarial science; Physical therapy; Computer science; Service (business); Business; MEDLINE; Political science; Artificial intelligence","score_opus":0.21066911102537772,"score_gpt":0.3844284712451952,"score_spread":0.17375936021981747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069609467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96611583,0.0033518262,0.013260231,0.001311139,0.0000531984,0.00067624566,0.0057806484,0.000050276623,0.009400536],"genre_scores_gemma":[0.98825294,0.00065789366,0.008419191,0.000041362633,0.000016762964,0.00020074405,0.0021037213,0.000007092378,0.00030034885],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99270016,0.004559392,0.00078196364,0.00054905476,0.0010000332,0.00040929645],"domain_scores_gemma":[0.9625586,0.02733089,0.002785254,0.0010046449,0.0057913647,0.000529317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012015527,0.0010700057,0.0010661462,0.007269261,0.0007116856,0.0025824155,0.0011985786,0.00089548895,0.0019014286],"category_scores_gemma":[0.043797117,0.000542201,0.001430767,0.0034303064,0.0007074714,0.0009437726,0.0014605917,0.00090569764,0.0001135592],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014794504,0.0004162564,0.5994279,0.002849425,0.003264484,0.0005807031,0.002717096,0.21994554,0.0004981561,0.012550801,0.007066812,0.14920345],"study_design_scores_gemma":[0.00036658437,0.00026659333,0.5919235,0.002261695,0.0028647988,0.00017223382,0.008808645,0.36835033,0.0012690367,0.014142048,0.009407204,0.00016738907],"about_ca_topic_score_codex":0.11946118,"about_ca_topic_score_gemma":0.11716535,"teacher_disagreement_score":0.11946118,"about_ca_system_score_codex":0.008533524,"about_ca_system_score_gemma":0.005468992,"threshold_uncertainty_score":0.23753166},"labels":[],"label_agreement":null},{"id":"W2069921048","doi":"10.1016/j.jval.2014.03.914","title":"Budget Impact Of Utilizing Various Types Of Advanced Bipolar Energy (Abe) Devices Versus Conventional Bipolar Energy (Cbe) In Total Laparoscopic Hysterectomy In Canadian Hospitals","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid and Parathyroid Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Randomized controlled trial; Medicine; Health care; Business; Surgery; Accounting; Economics","score_opus":0.017538782439533895,"score_gpt":0.29350409919183323,"score_spread":0.27596531675229935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069921048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96006334,0.003013977,0.0004931937,0.007963561,0.00009921687,0.00019903503,0.007178181,0.00003037842,0.020959161],"genre_scores_gemma":[0.9938372,0.0011855764,0.00063797715,0.00051116967,0.00002545085,0.000037323556,0.0010818252,0.000009868635,0.0026735896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975178,0.0005274878,0.00011798687,0.00009864934,0.00064557977,0.0010925393],"domain_scores_gemma":[0.9951385,0.00084170885,0.00087178126,0.000067446315,0.0014936781,0.0015867839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010334536,0.00027163123,0.00025052548,0.0014176435,0.0012192781,0.0016374572,0.00096952886,0.000500041,0.0066995625],"category_scores_gemma":[0.007589981,0.00027170766,0.0009849328,0.0023695403,0.0005920604,0.00047120513,0.0011506802,0.00064142223,0.00014331478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038232764,0.0004026659,0.78322256,0.00084073463,0.0008532291,0.00042974405,0.00072873617,0.022302033,0.00200265,0.0067650513,0.018047178,0.16058218],"study_design_scores_gemma":[0.00012271579,0.00046014975,0.9831215,0.0002470855,0.0002805041,0.00018674218,0.0026023146,0.0039896714,0.0003654953,0.00038672556,0.00818511,0.00005201468],"about_ca_topic_score_codex":0.94802684,"about_ca_topic_score_gemma":0.9787224,"teacher_disagreement_score":0.06507673,"about_ca_system_score_codex":0.06507673,"about_ca_system_score_gemma":0.04951498,"threshold_uncertainty_score":0.47216696},"labels":[],"label_agreement":null},{"id":"W2069995897","doi":"10.1016/j.jval.2011.08.894","title":"PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq Database","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Ulcerative colitis; Persistence (discontinuity); Statistical significance; Internal medicine; Retrospective cohort study; Health care; Disease","score_opus":0.07067016900751559,"score_gpt":0.3155075950698969,"score_spread":0.2448374260623813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069995897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73631215,0.003620705,0.00017079715,0.0014095565,0.000035140863,0.00010082079,0.2543323,0.00005511452,0.003963408],"genre_scores_gemma":[0.9298506,0.0017867615,0.00047229853,0.00024931712,0.000025775153,0.000098136494,0.065458186,0.000029420713,0.0020294571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753237,0.00043506804,0.000327449,0.0002843114,0.0009215982,0.0004990905],"domain_scores_gemma":[0.98890465,0.0017558264,0.0035160696,0.00062815927,0.0037189992,0.0014763348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017463273,0.00039455885,0.0010079229,0.0030386886,0.0011637183,0.0020801777,0.0018106728,0.0007380574,0.004214587],"category_scores_gemma":[0.014709797,0.00041440898,0.0020085243,0.012585014,0.000494686,0.00057804823,0.0013428669,0.0013756485,0.00035674832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047271626,0.000043793905,0.98838985,0.000114800285,0.00069034065,0.0000594736,0.00008744863,0.00086140336,0.000018918694,0.00026804334,0.005109666,0.003883601],"study_design_scores_gemma":[0.00007157321,0.000030009996,0.99544287,0.00007368717,0.00027564695,0.000064546715,0.0002300412,0.0012416719,0.000028184579,0.00005187884,0.0024730307,0.00001680242],"about_ca_topic_score_codex":0.9897251,"about_ca_topic_score_gemma":0.98844737,"teacher_disagreement_score":0.019605093,"about_ca_system_score_codex":0.019605093,"about_ca_system_score_gemma":0.02738309,"threshold_uncertainty_score":0.14224559},"labels":[],"label_agreement":null},{"id":"W2070028004","doi":"10.1016/j.jval.2014.03.485","title":"Cost Effectiveness of Trametinib as First-Line (1l) Treatment for Braf V600 Positive Advanced or Metastatic Melanoma — A Canadian Societal Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Trametinib; Dacarbazine; Vemurafenib; Medicine; Internal medicine; Oncology; Melanoma; Metastatic melanoma; Chemotherapy; Cancer research; Biology","score_opus":0.0471651896086674,"score_gpt":0.34261534361423285,"score_spread":0.29545015400556546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070028004","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24846071,0.17080727,0.0021808203,0.40648997,0.00269244,0.00025917476,0.029111017,0.0001484529,0.13985017],"genre_scores_gemma":[0.9309218,0.047061935,0.0016658161,0.010436781,0.0011907321,0.00004699826,0.0038210433,0.000038393704,0.0048164236],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99691015,0.0007930323,0.00012618503,0.0001613754,0.0012263283,0.000782958],"domain_scores_gemma":[0.9929361,0.0012316144,0.00078947336,0.0000625152,0.0031681813,0.0018120478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002511559,0.0007910132,0.0010054135,0.0022930915,0.0014966968,0.0047225766,0.0015153872,0.0025054098,0.007076392],"category_scores_gemma":[0.011447814,0.0003050507,0.0020959107,0.0039337627,0.0011224289,0.0011443883,0.00093813345,0.00288993,0.00027532506],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008820375,0.00087822764,0.14283627,0.0037640869,0.005655734,0.0015782332,0.001038158,0.0714494,0.0026111675,0.10467522,0.239463,0.4172302],"study_design_scores_gemma":[0.0027254717,0.0025383944,0.5754866,0.0085776765,0.010604979,0.00241308,0.0065323887,0.07169677,0.0014859836,0.035733428,0.28119186,0.001013419],"about_ca_topic_score_codex":0.9508193,"about_ca_topic_score_gemma":0.9606139,"teacher_disagreement_score":0.08935536,"about_ca_system_score_codex":0.08935536,"about_ca_system_score_gemma":0.09236475,"threshold_uncertainty_score":0.6483215},"labels":[],"label_agreement":null},{"id":"W2070034803","doi":"10.1016/j.jval.2010.11.015","title":"Economic Impact of Nonpersistence with Antidepressant Treatment in the Adult Population of Quebec: A Comparative Cost-Effectiveness Approach","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Université de Montréal","funders":"","keywords":"Venlafaxine; Paroxetine; Medicine; Citalopram; Fluoxetine; Discontinuation; Antidepressant; Population; Health care; Retrospective cohort study; Fluvoxamine; Psychiatry; Internal medicine; Environmental health; Anxiety; Serotonin","score_opus":0.13052952788326674,"score_gpt":0.36672598097144404,"score_spread":0.2361964530881773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070034803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9454081,0.03702473,0.0013074474,0.001604228,0.00023186996,0.001548488,0.0045667132,0.000023020435,0.008285516],"genre_scores_gemma":[0.99483997,0.0029259718,0.00069629843,0.00018935233,0.000046638987,0.0001965838,0.00067929935,0.0000030729816,0.0004228688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906715,0.0071998714,0.00033217037,0.0002596476,0.000998328,0.00053844246],"domain_scores_gemma":[0.99319106,0.004873719,0.0006647926,0.00023203553,0.0006558859,0.00038245646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008344892,0.001132549,0.0023258298,0.0028033734,0.0006200839,0.0018275732,0.0016734805,0.0018691018,0.0033427163],"category_scores_gemma":[0.01647206,0.00044330867,0.0048420886,0.00408813,0.0010190756,0.0010928737,0.0011647169,0.0014745586,0.00006858265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2612444,0.009539007,0.2766089,0.013579803,0.12022116,0.0015346576,0.0008980488,0.10974137,0.0021852106,0.013767647,0.005591163,0.18508859],"study_design_scores_gemma":[0.04896038,0.050226312,0.6768395,0.0035672048,0.092850335,0.0011394612,0.0029932568,0.106798954,0.001332352,0.0056098844,0.009259131,0.0004232857],"about_ca_topic_score_codex":0.42716178,"about_ca_topic_score_gemma":0.41065872,"teacher_disagreement_score":0.5728382,"about_ca_system_score_codex":0.025763169,"about_ca_system_score_gemma":0.008575827,"threshold_uncertainty_score":0.84935087},"labels":[],"label_agreement":null},{"id":"W2070061188","doi":"10.1016/j.jval.2013.03.756","title":"Comparison Of Cancer Therapy Reimbursement Decisions Made In Canada To Australia, Sweden And The United Kingdom","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Reimbursement; Excellence; Medicine; Family medicine; Agency (philosophy); Health care; Political science","score_opus":0.6697425343161323,"score_gpt":0.508924229910039,"score_spread":0.16081830440609324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070061188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841945,0.0031143408,0.00011627351,0.0036487065,0.000067397414,0.000044561926,0.0012058234,0.000009274629,0.007599048],"genre_scores_gemma":[0.99699867,0.0007003544,0.000092310576,0.00030186586,0.00000914294,0.000007783052,0.00054452516,0.0000048990796,0.0013405127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99577194,0.00096193596,0.00028360027,0.00016400707,0.001367981,0.0014505932],"domain_scores_gemma":[0.98573816,0.0052042226,0.0019170752,0.00014807885,0.00483851,0.0021539377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002429513,0.00021766248,0.0006893014,0.0017207299,0.0014947648,0.0028625343,0.00085311924,0.0011884063,0.0022719176],"category_scores_gemma":[0.021973778,0.00026778926,0.0009935205,0.0041001043,0.0009741343,0.00051302655,0.0009976788,0.0013287296,0.00011940656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009131837,0.00046988,0.8248945,0.0007110963,0.0011788647,0.0018463245,0.003961459,0.038238954,0.00078149757,0.011830477,0.024202393,0.08275273],"study_design_scores_gemma":[0.00019870752,0.0002654655,0.9745855,0.00023279455,0.00023898334,0.00022315799,0.005931972,0.0076855766,0.0003907781,0.0004319206,0.009726921,0.00008817904],"about_ca_topic_score_codex":0.97320676,"about_ca_topic_score_gemma":0.98394114,"teacher_disagreement_score":0.061817348,"about_ca_system_score_codex":0.061817348,"about_ca_system_score_gemma":0.033804376,"threshold_uncertainty_score":0.44851834},"labels":[],"label_agreement":null},{"id":"W2070290298","doi":"10.1016/j.jval.2014.03.1562","title":"Development Of Risk-Index Tool To Predict Surgical Site Infections","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Logistic regression; Stepwise regression; Emergency medicine; Surgical site infection; Bivariate analysis; Risk factor; Risk assessment; Internal medicine; Multivariate analysis; Surgery; Statistics","score_opus":0.020828293263380423,"score_gpt":0.2954117848195151,"score_spread":0.27458349155613465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070290298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595443,0.0018555891,0.024970762,0.00086294924,0.0002593916,0.0015546734,0.0035390568,0.00068431016,0.0067288647],"genre_scores_gemma":[0.9481205,0.00051315717,0.04630607,0.00015014301,0.000090839865,0.00087125594,0.0031454253,0.000027798018,0.00077479356],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966144,0.0010441365,0.0006361094,0.00026528392,0.0011722739,0.00026787168],"domain_scores_gemma":[0.9900954,0.0043832087,0.0022721319,0.0002122574,0.002486941,0.0005499936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004829981,0.0010851,0.0012234162,0.005412888,0.00029712505,0.0013230294,0.0009179784,0.0007087073,0.0013905904],"category_scores_gemma":[0.020331593,0.0003008308,0.0015006099,0.0021876872,0.00021101398,0.0010244299,0.0009225013,0.00094862486,0.00049102097],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034614772,0.0003589517,0.9465298,0.00014739245,0.0002602084,0.00014066821,0.00011426029,0.0018952027,0.0004192584,0.0002794154,0.0023969042,0.047111787],"study_design_scores_gemma":[0.00015234257,0.0018048141,0.9306577,0.0002448402,0.00040415837,0.0010115866,0.00034385288,0.05784477,0.0019038036,0.0010905862,0.004440882,0.00010073407],"about_ca_topic_score_codex":0.001772044,"about_ca_topic_score_gemma":0.002468396,"teacher_disagreement_score":0.005412888,"about_ca_system_score_codex":0.0006805728,"about_ca_system_score_gemma":0.001186023,"threshold_uncertainty_score":0.02554375},"labels":[],"label_agreement":null},{"id":"W2070396091","doi":"10.1016/j.jval.2014.03.416","title":"Evolving Treatment Patterns in Metastatic Melanoma in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vemurafenib; Trametinib; Dacarbazine; Internal medicine; Metastatic melanoma; Ipilimumab; Oncology; Salvage therapy; Melanoma; Lomustine; Temozolomide; Targeted therapy; Cancer; Chemotherapy; Vincristine; Immunotherapy","score_opus":0.06466749246790013,"score_gpt":0.34066119184665805,"score_spread":0.27599369937875795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070396091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9402166,0.007091338,0.00050252705,0.022682248,0.00015311396,0.00014104873,0.007163917,0.000064646694,0.021984562],"genre_scores_gemma":[0.99064726,0.002615171,0.00032210053,0.0014244972,0.000028909728,0.000021666743,0.0010073523,0.000035314388,0.003897645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975955,0.00016775931,0.00015478519,0.00021272941,0.0007347544,0.0011344417],"domain_scores_gemma":[0.99293315,0.00040509924,0.0012575566,0.000083223764,0.0026897185,0.0026312878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007902846,0.00019568198,0.00036319808,0.0026914862,0.0029325695,0.0021001017,0.001560919,0.00078050356,0.0059763966],"category_scores_gemma":[0.0054188934,0.00028924938,0.00054908206,0.007278799,0.0010457922,0.00055656134,0.0009998941,0.001361107,0.0002668824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038294742,0.00016114456,0.9204265,0.00019992092,0.00008275779,0.0006236377,0.0033519925,0.0012498002,0.00092588476,0.0037674245,0.016841503,0.05198649],"study_design_scores_gemma":[0.0000376536,0.00007542842,0.96594864,0.00025974223,0.000054372027,0.00058185216,0.011410923,0.0015276392,0.00037627848,0.0005059046,0.019163629,0.000058003654],"about_ca_topic_score_codex":0.99398345,"about_ca_topic_score_gemma":0.99756515,"teacher_disagreement_score":0.08660805,"about_ca_system_score_codex":0.08660805,"about_ca_system_score_gemma":0.09649986,"threshold_uncertainty_score":0.62838835},"labels":[],"label_agreement":null},{"id":"W2070404256","doi":"10.1111/j.1524-4733.2010.00694.x","title":"Quantifying Women's Stated Benefit–Risk Trade-Off Preferences for IBS Treatment Outcomes","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Seriousness; Irritable bowel syndrome; Diarrhea; Preference; Adverse effect; Constipation; Risk perception; Risk assessment; Internal medicine; Psychology; Statistics","score_opus":0.091878811014854,"score_gpt":0.350731241562248,"score_spread":0.258852430547394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070404256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949308,0.00044103427,0.0020262895,0.0003555133,0.000009839091,0.000025966347,0.00030541132,0.000006978571,0.0018981613],"genre_scores_gemma":[0.9990312,0.00006340399,0.00066391175,0.000032074546,0.0000042559695,0.0000137532,0.00007149734,0.0000011135933,0.00011873147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768126,0.0016745693,0.00013233902,0.00014812309,0.00023619828,0.00012747971],"domain_scores_gemma":[0.9814612,0.01604712,0.0014989418,0.0004441739,0.00026620724,0.0002822819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058119283,0.0003640316,0.00038747393,0.0004964385,0.00016620717,0.0011359239,0.00022068674,0.00062612194,0.0034096697],"category_scores_gemma":[0.028325647,0.00015967697,0.00091359724,0.000525787,0.00039132542,0.0006931799,0.000528687,0.00064896554,0.0002307178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014939227,0.000850976,0.7806736,0.0005177828,0.0030491918,0.0003353961,0.0026234614,0.026082005,0.0072381874,0.0054559913,0.0009429607,0.15729123],"study_design_scores_gemma":[0.0008399118,0.013149626,0.8438594,0.0003651568,0.002692785,0.0014280918,0.006654313,0.092913,0.008651016,0.025197543,0.004012693,0.00023652942],"about_ca_topic_score_codex":0.00068867626,"about_ca_topic_score_gemma":0.0011224711,"teacher_disagreement_score":0.0058119283,"about_ca_system_score_codex":0.00048313377,"about_ca_system_score_gemma":0.00028783045,"threshold_uncertainty_score":0.030736804},"labels":[],"label_agreement":null},{"id":"W2070706497","doi":"10.1016/j.jval.2011.08.447","title":"PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Certolizumab pegol; Medicine; Correlation; Internal medicine; Mathematics; Tumor necrosis factor alpha; Adalimumab","score_opus":0.055732624353642936,"score_gpt":0.3028389791417251,"score_spread":0.24710635478808216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070706497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932728,0.0037171396,0.00026746152,0.00048651543,0.00026765597,0.0007475293,0.0004882687,0.00006407828,0.000688609],"genre_scores_gemma":[0.99451774,0.0015449445,0.0007042736,0.0004794434,0.00045733456,0.00064085005,0.00064495765,0.00001057691,0.0009997729],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998787,0.0007315846,0.000085863496,0.00015392576,0.00011086899,0.00013077982],"domain_scores_gemma":[0.9981798,0.0006983195,0.00048071257,0.00016638238,0.00008567318,0.00038910506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028615706,0.0014160859,0.0041011227,0.00044038793,0.00036821893,0.0011623584,0.00090372446,0.0021729418,0.005261878],"category_scores_gemma":[0.0025290258,0.00092380494,0.0028277833,0.0004195817,0.0012912276,0.0010313803,0.0005690685,0.0029955436,0.00059357035],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97644025,0.0039623324,0.0023561018,0.000441126,0.0013506007,0.000034937108,0.00003994794,0.00030167334,0.0017162056,0.000058421225,0.0003572613,0.012941158],"study_design_scores_gemma":[0.90306515,0.08164502,0.013628673,0.000034566965,0.00062125584,0.000036154044,0.000022986827,0.00040956278,0.00022761822,0.00005809949,0.00022925629,0.000021795291],"about_ca_topic_score_codex":0.0009071541,"about_ca_topic_score_gemma":0.0011654716,"teacher_disagreement_score":0.005261878,"about_ca_system_score_codex":0.00050762616,"about_ca_system_score_gemma":0.00069636636,"threshold_uncertainty_score":0.017602682},"labels":[],"label_agreement":null},{"id":"W2070810062","doi":"10.1016/j.jval.2011.02.837","title":"PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSIS","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"EQ-5D; Valuation (finance); Preference; Scoring system; Population; MEDLINE; Medicine; Actuarial science; Statistics; Computer science; Mathematics; Environmental health; Health related quality of life; Disease; Pathology","score_opus":0.9174960492409031,"score_gpt":0.5352999173954806,"score_spread":0.38219613184542256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070810062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013515484,0.99245656,0.0012111313,0.0006596322,0.0002712512,0.0014142198,0.0020717743,0.000027893928,0.00053599617],"genre_scores_gemma":[0.052519005,0.9191932,0.01384256,0.0031422253,0.00030751713,0.0070795035,0.0031702362,0.00009535043,0.0006503845],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9015178,0.034583613,0.044166587,0.004289231,0.014455412,0.0009873804],"domain_scores_gemma":[0.849872,0.112051435,0.022837356,0.004166349,0.010540053,0.0005327431],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.070096776,0.0020641694,0.012360897,0.012817599,0.00082295516,0.0038573493,0.0029524376,0.0024254369,0.007853537],"category_scores_gemma":[0.23779687,0.001619823,0.018063445,0.014444356,0.0018593045,0.002770121,0.003813898,0.0020098228,0.00063975336],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008131526,0.000021459336,0.002914006,0.8358069,0.062726654,0.00008075762,0.00022538437,0.00016480243,0.00017750767,0.0008795378,0.0051681255,0.091021754],"study_design_scores_gemma":[0.0024607321,0.00036047652,0.020161042,0.56841695,0.37148795,0.00054949813,0.00032008442,0.0002957488,0.00041434963,0.0017928571,0.033589024,0.00015120806],"about_ca_topic_score_codex":0.009630859,"about_ca_topic_score_gemma":0.022742517,"teacher_disagreement_score":0.9299032,"about_ca_system_score_codex":0.00650004,"about_ca_system_score_gemma":0.015754351,"threshold_uncertainty_score":0.37071162},"labels":[],"label_agreement":null},{"id":"W2070812863","doi":"10.1016/j.jval.2013.08.448","title":"Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Bendamustine; Population; Ofatumumab; Rituximab; Internal medicine; Leukemia; Oncology; Chemotherapy; Lymphoma; Environmental health; Cyclophosphamide","score_opus":0.0337281984678595,"score_gpt":0.329314392531407,"score_spread":0.29558619406354747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070812863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97104025,0.018480824,0.00075331423,0.0032233018,0.00015873175,0.00007630683,0.00032900195,0.000039682527,0.005898613],"genre_scores_gemma":[0.9976793,0.0013647989,0.00024486758,0.00015210266,0.00006334084,0.000014237,0.00011056632,0.0000042460215,0.0003664131],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995796,0.0002213172,0.00002025811,0.000023883482,0.00005467567,0.00010022636],"domain_scores_gemma":[0.9994547,0.00023119882,0.00010652894,0.000019874147,0.00003094716,0.00015671663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061130914,0.00037694324,0.0005575473,0.00030561397,0.00019971789,0.00082241656,0.00040930713,0.0005546826,0.003188387],"category_scores_gemma":[0.0016356348,0.00012385372,0.00080888555,0.00038694404,0.0002958358,0.00049167196,0.00041321764,0.00091227423,0.00027172267],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21022819,0.0036534641,0.047839746,0.00086131634,0.002156726,0.004103839,0.00017010164,0.022920012,0.044080228,0.003820718,0.0057296725,0.654436],"study_design_scores_gemma":[0.039799444,0.16570622,0.596816,0.001381888,0.01289474,0.016490355,0.001446903,0.048695553,0.047203,0.010689498,0.058583412,0.0002930403],"about_ca_topic_score_codex":0.0018024327,"about_ca_topic_score_gemma":0.0034042865,"teacher_disagreement_score":0.003188387,"about_ca_system_score_codex":0.0013978294,"about_ca_system_score_gemma":0.0008781956,"threshold_uncertainty_score":0.010666251},"labels":[],"label_agreement":null},{"id":"W2070916539","doi":"10.1016/j.jval.2012.08.1693","title":"PDB50 Health Care Resource Utilization in the Management of Cushing Disease: An Analysis From South-Western Ontario","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Population; Retrospective cohort study; Diabetes mellitus; Dyslipidemia; Cushing's disease; Internal medicine; Surgery; Disease; Endocrinology","score_opus":0.06842937746593254,"score_gpt":0.33636194579491374,"score_spread":0.2679325683289812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070916539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902102,0.0007113005,0.00006748274,0.00034129436,0.000007259673,0.00007693707,0.0057994286,0.0000058343576,0.0027801944],"genre_scores_gemma":[0.9950498,0.0008072036,0.00013599756,0.00020305478,0.000009321974,0.00006245964,0.0026109589,0.000007918982,0.0011132911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849796,0.0001536123,0.00020262133,0.00014665618,0.0005982531,0.00040094738],"domain_scores_gemma":[0.99577963,0.00031322578,0.0015440786,0.00011491515,0.0012191536,0.0010289871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006386942,0.00030965608,0.0005327305,0.0020799164,0.0020873444,0.0014385224,0.0013012108,0.00047877207,0.002218332],"category_scores_gemma":[0.003231681,0.0004938043,0.0011870706,0.008929605,0.00065367785,0.0004624314,0.0014689818,0.0006118177,0.00022660477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000753906,0.000028927148,0.99593276,0.000058668527,0.00009078427,0.000096765594,0.000850237,0.000085112406,0.00008444297,0.00008183634,0.0007062663,0.0019088945],"study_design_scores_gemma":[0.0000078952535,0.000013567418,0.9983979,0.00002597481,0.000027554275,0.000034687273,0.0009520529,0.00008784735,0.0000134050315,0.0000074479854,0.00042677528,0.0000049261803],"about_ca_topic_score_codex":0.98548084,"about_ca_topic_score_gemma":0.99320483,"teacher_disagreement_score":0.030005192,"about_ca_system_score_codex":0.030005192,"about_ca_system_score_gemma":0.031195987,"threshold_uncertainty_score":0.21770394},"labels":[],"label_agreement":null},{"id":"W2070984843","doi":"10.1016/j.jval.2013.08.1684","title":"Development of an Interviewer-Administered Version of the Asthma Control Questionnaire (ACQ-IA) for 6-10 Year Old Patients in 11 Languages","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wheeze; Cognitive interview; Norwegian; Interview; Asthma; Medicine; Psychology; Cognition; Psychiatry; Linguistics; Political science","score_opus":0.02048521501703865,"score_gpt":0.3135804685956585,"score_spread":0.2930952535786199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070984843","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767662,0.00010319343,0.007895431,0.00028187214,0.00006567385,0.0070456215,0.0032382978,0.00011708255,0.0044866945],"genre_scores_gemma":[0.9091713,0.00038490357,0.059796154,0.00039726528,0.000039605042,0.016455082,0.008875658,0.00009788853,0.0047822194],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9970433,0.0013088817,0.00056632404,0.00031005137,0.00047765416,0.00029369467],"domain_scores_gemma":[0.99578553,0.0012155747,0.00044327095,0.00030938632,0.001949983,0.00029628802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007863835,0.0005064203,0.00064778834,0.0011295575,0.0007830383,0.0007849879,0.0005793099,0.00032474162,0.0025369471],"category_scores_gemma":[0.009287925,0.00052170095,0.00094291684,0.0006867579,0.00036915054,0.0007830032,0.0011857072,0.0011556256,0.0008032316],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000934067,0.0034781203,0.8485517,0.0002764232,0.00012098225,0.0005677702,0.016113576,0.0008845897,0.00951419,0.0004726895,0.0043130848,0.11477281],"study_design_scores_gemma":[0.0004169505,0.002651622,0.9756826,0.00011714365,0.000081320126,0.00037972972,0.006988493,0.0015185972,0.0035349147,0.00025596019,0.008302333,0.000070275775],"about_ca_topic_score_codex":0.014864912,"about_ca_topic_score_gemma":0.02339908,"teacher_disagreement_score":0.014864912,"about_ca_system_score_codex":0.0009941477,"about_ca_system_score_gemma":0.00333879,"threshold_uncertainty_score":0.041588426},"labels":[],"label_agreement":null},{"id":"W2070989950","doi":"10.1016/s1098-3015(10)68992-9","title":"PGI10 INCORPORATING NON-ADHERENCE RESULTING FROM MULTIPLE DAILY DOSE REGIMENS INTO ECONOMIC MODELS: COST-UTILITY ANALYSIS OF ALTERNATIVE GASTROINTESTINAL PROPHYLAXIS STRATEGIES IN PREVENTING NSAID ASSOCIATED GASTROINTESTINAL COMPLICATIONS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine; Economic analysis; Economics","score_opus":0.05623047274190623,"score_gpt":0.3094703326098955,"score_spread":0.25323985986798925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070989950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96554995,0.005447683,0.010523741,0.0032887256,0.00011468943,0.0009688673,0.0044906666,0.00011220127,0.009503542],"genre_scores_gemma":[0.9939506,0.0010325962,0.0023929286,0.00010597401,0.000015849198,0.00010364349,0.00056156085,0.000011716073,0.0018251044],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99626166,0.0024163448,0.00011151514,0.00020448313,0.00034675517,0.0006591304],"domain_scores_gemma":[0.9862525,0.011298562,0.0006336003,0.0002692077,0.0009807143,0.00056541665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009209862,0.0015304491,0.002802739,0.0015380329,0.0009363345,0.003405123,0.0033150245,0.0018526008,0.0043451185],"category_scores_gemma":[0.024372071,0.0012072633,0.0031869705,0.0028338323,0.0014580297,0.0015417432,0.0011758915,0.0028860797,0.00014129638],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052815806,0.00041441785,0.014480581,0.00032572917,0.0011522333,0.00020671538,0.000089885136,0.9575838,0.00013537142,0.005880701,0.0012572441,0.013191756],"study_design_scores_gemma":[0.0016507906,0.00084921095,0.0123927435,0.00014047022,0.0022727312,0.00008321093,0.00023074527,0.97756654,0.00022219779,0.0032005655,0.0013126091,0.00007814343],"about_ca_topic_score_codex":0.83886534,"about_ca_topic_score_gemma":0.7404442,"teacher_disagreement_score":0.16113466,"about_ca_system_score_codex":0.04147887,"about_ca_system_score_gemma":0.029553752,"threshold_uncertainty_score":0.3241672},"labels":[],"label_agreement":null},{"id":"W2071460680","doi":"10.1111/j.1524-4733.2007.00278.x","title":"Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience","year":2007,"lang":"en","type":"review","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Queen's University; Telus (Canada)","funders":"","keywords":"Concordance; Clinical trial; Quality of life (healthcare); Medicine; Protocol (science); Attrition; Cancer; Alternative medicine; Data quality; Missing data; Nursing; Operations management; Internal medicine; Pathology; Computer science","score_opus":0.8816006046583914,"score_gpt":0.7031660732317366,"score_spread":0.17843453142665477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071460680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031784014,0.9909775,0.00069879636,0.0018269552,0.00013505481,0.00085525407,0.00087590795,0.000023757295,0.0014283063],"genre_scores_gemma":[0.041162968,0.9465565,0.0076724617,0.0015670503,0.00019172729,0.0011256646,0.0011672403,0.000041213003,0.0005151464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95278555,0.024596894,0.0056086355,0.0014513031,0.014857417,0.0007002502],"domain_scores_gemma":[0.81774116,0.12657736,0.016425699,0.0028370062,0.033358105,0.0030607425],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09403313,0.0014958931,0.009759786,0.0040284754,0.0008735812,0.00466545,0.002686448,0.0015804666,0.0016056601],"category_scores_gemma":[0.14052711,0.0007290763,0.0040052966,0.0107933255,0.0018464273,0.0013722276,0.0015416935,0.0024144894,0.00019562375],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046494883,0.00022606405,0.0073046023,0.09920883,0.017166937,0.000091003305,0.0006354903,0.0017545804,0.00046140028,0.002934064,0.03195494,0.8336126],"study_design_scores_gemma":[0.013050626,0.0032480075,0.158075,0.29865912,0.10875759,0.0010258565,0.0012862073,0.0037328,0.0021205642,0.00899367,0.400501,0.0005495663],"about_ca_topic_score_codex":0.17330042,"about_ca_topic_score_gemma":0.325124,"teacher_disagreement_score":0.9715717,"about_ca_system_score_codex":0.028428327,"about_ca_system_score_gemma":0.05184346,"threshold_uncertainty_score":0.49730068},"labels":[],"label_agreement":null},{"id":"W2071777263","doi":"10.1016/s1098-3015(10)64192-7","title":"PDB27: RISKING HEALTH TO AVOIDING INJECTIONS—STATED PREFERENCES OF TYPE 2 DIABETICS IN THE US AND CANADA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Type (biology); Medicine; Business; Biology","score_opus":0.05050798770985763,"score_gpt":0.3116711660891891,"score_spread":0.26116317837933145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071777263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922931,0.00023878127,0.000043912878,0.0012480099,0.000021661797,0.000038002414,0.0007246396,0.0000021827352,0.0053897295],"genre_scores_gemma":[0.9973316,0.00030298927,0.00013264775,0.0005454608,0.0000074090817,0.000016340455,0.00024668657,0.0000037881207,0.0014130647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989058,0.00023934178,0.00008191424,0.000050155562,0.00042024502,0.0003026219],"domain_scores_gemma":[0.9960723,0.0007425253,0.0005339439,0.000063940955,0.0010903117,0.0014970227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001431047,0.00017685675,0.00029460862,0.00055119896,0.0021176634,0.0017385565,0.00057169236,0.00064813695,0.0034330739],"category_scores_gemma":[0.006044805,0.0001739915,0.0006541437,0.0012604131,0.0007883981,0.000409578,0.0006736446,0.0010828251,0.00025647576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048750752,0.0002792025,0.9661045,0.000047305424,0.00006603236,0.0002446407,0.008198522,0.00028647145,0.00016758614,0.0004489102,0.006133152,0.017536175],"study_design_scores_gemma":[0.00011119971,0.00022118396,0.9429392,0.00014379584,0.00007455749,0.00025188987,0.04698716,0.0014032129,0.00018423771,0.00022835725,0.0073852395,0.00006981939],"about_ca_topic_score_codex":0.96595687,"about_ca_topic_score_gemma":0.9813431,"teacher_disagreement_score":0.034043133,"about_ca_system_score_codex":0.011070051,"about_ca_system_score_gemma":0.014800037,"threshold_uncertainty_score":0.080319285},"labels":[],"label_agreement":null},{"id":"W2072633689","doi":"10.1016/j.jval.2013.08.1598","title":"Assessment of a Canadian Primary Care Electronic Medical Record Database for Use in Observational Studies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); AstraZeneca (Canada)","funders":"","keywords":"Observational study; Medicine; Medical prescription; Medical diagnosis; Family medicine; Population; Demographics; Medical record; Primary care; Electronic medical record; Health care; Pediatrics; Demography; Environmental health; Internal medicine","score_opus":0.5934330804911623,"score_gpt":0.5291985014007754,"score_spread":0.06423457909038688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072633689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6282022,0.009065057,0.018842066,0.014421615,0.00090088195,0.019330395,0.27584246,0.00086211023,0.03253317],"genre_scores_gemma":[0.874598,0.002554049,0.053915903,0.0023925025,0.00019844239,0.006490079,0.057719775,0.000108924476,0.0020223756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.90358585,0.021824755,0.016722187,0.004689436,0.049915843,0.0032619142],"domain_scores_gemma":[0.6601638,0.060319163,0.02790447,0.014957161,0.22953185,0.0071234675],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.071088955,0.0012670266,0.0017188886,0.012010937,0.004897103,0.0070944834,0.0057723843,0.0016552545,0.0031547935],"category_scores_gemma":[0.28220764,0.00093138526,0.0026378152,0.020703202,0.00097588636,0.0026825976,0.003031241,0.0012977207,0.00040030526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014878839,0.00056569005,0.86176,0.003387792,0.001863418,0.00023254185,0.0025229156,0.0016690642,0.0006678489,0.0048866062,0.036006913,0.084949255],"study_design_scores_gemma":[0.00025082013,0.00021152357,0.97253126,0.00092564715,0.00083883683,0.00013037432,0.0013180417,0.0061699366,0.00042140688,0.0003593823,0.016724708,0.00011803819],"about_ca_topic_score_codex":0.9778179,"about_ca_topic_score_gemma":0.9762266,"teacher_disagreement_score":0.9778179,"about_ca_system_score_codex":0.063453,"about_ca_system_score_gemma":0.16228238,"threshold_uncertainty_score":0.46038586},"labels":[],"label_agreement":null},{"id":"W2073059673","doi":"10.1016/j.jval.2012.03.538","title":"PSY4 Prevalence of Autoimmune Diseases and Other Comorbidities in Patients With Psoriasis in the United States","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psoriatic arthritis; Comorbidity; Ankylosing spondylitis; Psoriasis; Internal medicine; Rheumatoid arthritis; McNemar's test; Population; Immunology","score_opus":0.028100096501049172,"score_gpt":0.25833581647333254,"score_spread":0.23023571997228337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073059673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997727,0.00041050767,0.000036403577,0.00012695,0.00000909364,0.000003863257,0.00063032267,0.0000040527843,0.0010519003],"genre_scores_gemma":[0.9992787,0.00019500694,0.00003333469,0.000057185647,0.000013606001,0.000002687346,0.0002865539,9.3773934e-7,0.00013204383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978,0.0000522287,0.000028293936,0.00004042948,0.000048956124,0.000050133815],"domain_scores_gemma":[0.99934095,0.00007797948,0.00032804706,0.000020488242,0.000079779544,0.0001526093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018817294,0.00014327872,0.00025111638,0.00096078624,0.00039182397,0.00048402944,0.00020389672,0.00037828612,0.0020984726],"category_scores_gemma":[0.00068225805,0.00016210129,0.00040645525,0.0014009718,0.00018254858,0.00036374037,0.0002766921,0.00046054684,0.00016129891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038336148,0.00001866093,0.99869305,0.000004749793,0.000025886673,0.000057639834,0.000023548828,0.000014101762,0.00014831021,0.000013969341,0.0001409381,0.00082082767],"study_design_scores_gemma":[0.0000020984796,0.00001983795,0.99946564,0.0000033406568,0.000011827077,0.00021483113,0.00012208568,0.00004114829,0.000017138656,0.000009677211,0.000090940855,0.000001382635],"about_ca_topic_score_codex":0.01542926,"about_ca_topic_score_gemma":0.016160391,"teacher_disagreement_score":0.01542926,"about_ca_system_score_codex":0.000289173,"about_ca_system_score_gemma":0.00031548113,"threshold_uncertainty_score":0.030678928},"labels":[],"label_agreement":null},{"id":"W2073148411","doi":"10.1016/s1098-3015(10)73421-5","title":"PMS46 PHYSICAL ACTIVITY IN CANADIAN ADULTS WITH ARTHRITIS: A POPULATION-BASED STUDY","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Physical activity; Medicine; Gerontology; Physical therapy","score_opus":0.012541118848318595,"score_gpt":0.3033424882101355,"score_spread":0.2908013693618169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073148411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99262416,0.00068931404,0.00007419041,0.00031746522,0.000027834778,0.00008620054,0.0036676514,0.00000819371,0.002505043],"genre_scores_gemma":[0.9959423,0.00062636007,0.00014996485,0.00021666913,0.000023666935,0.00005513296,0.0017598076,0.0000060727716,0.0012200635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983708,0.0001233689,0.00011655772,0.00022246609,0.00061235065,0.0005545311],"domain_scores_gemma":[0.9981231,0.00007223517,0.0003147571,0.00006486187,0.0009252823,0.0004997978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008293569,0.00090393506,0.0010971678,0.0022964224,0.005046305,0.0019530896,0.0015958067,0.0013459098,0.0027427007],"category_scores_gemma":[0.0024305473,0.00084151217,0.0017293436,0.008503617,0.00081763946,0.00068690523,0.0009455529,0.0014771642,0.000514765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013778685,0.00011618361,0.99640095,0.000031939315,0.00008901355,0.00009004177,0.0006450307,0.000026531021,0.00012207995,0.000038201684,0.000686889,0.0016154128],"study_design_scores_gemma":[0.000014611856,0.000032841737,0.99876416,0.000011797863,0.000037134374,0.000046239336,0.0006905642,0.000051796716,0.000011917584,0.000007491487,0.00032334073,0.000008118897],"about_ca_topic_score_codex":0.986155,"about_ca_topic_score_gemma":0.99024665,"teacher_disagreement_score":0.01427796,"about_ca_system_score_codex":0.01427796,"about_ca_system_score_gemma":0.016564196,"threshold_uncertainty_score":0.1035943},"labels":[],"label_agreement":null},{"id":"W2073289375","doi":"10.1016/j.jval.2014.03.713","title":"Impact Of Access To Transcatheter Aortic Valve Replacement On The Inoperable Aortic Stenosis Mortality In The Canadian Health Care System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Medicine; Population; Stenosis; Economic shortage; Health care; Aortic valve replacement; Aortic valve stenosis; Emergency medicine; Medical emergency; Intensive care medicine; Cardiology; Environmental health; Economic growth; Government (linguistics)","score_opus":0.13341399667018136,"score_gpt":0.34920080602151116,"score_spread":0.2157868093513298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073289375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9266426,0.0071476465,0.0002774171,0.039115526,0.00021010594,0.00004326236,0.01024463,0.000028137129,0.016290644],"genre_scores_gemma":[0.9958845,0.0014068424,0.00007683702,0.0005247319,0.000057669193,0.000004037834,0.0012162144,0.0000042238157,0.00082488946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957081,0.00048782668,0.00018608625,0.00024356316,0.0011901781,0.0021841545],"domain_scores_gemma":[0.98874485,0.0016840372,0.002092804,0.00022787356,0.003259909,0.0039905813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017509584,0.00035614514,0.00064527185,0.002123059,0.0027198459,0.003935998,0.0020526883,0.0018609707,0.0046300367],"category_scores_gemma":[0.01498247,0.00035070046,0.0018744754,0.0046545444,0.0020565044,0.0011784111,0.0021096244,0.003169168,0.00016103705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040191866,0.00022082527,0.9442632,0.00016198256,0.00046425138,0.00046039504,0.0006366686,0.009031604,0.00018920873,0.015269835,0.012510294,0.01638979],"study_design_scores_gemma":[0.000051999174,0.000051964475,0.9858832,0.00015236488,0.00021011701,0.00012741773,0.0018011029,0.006233106,0.00009277514,0.0017071374,0.0036267294,0.00006204481],"about_ca_topic_score_codex":0.9939131,"about_ca_topic_score_gemma":0.9961345,"teacher_disagreement_score":0.08204539,"about_ca_system_score_codex":0.08204539,"about_ca_system_score_gemma":0.08447822,"threshold_uncertainty_score":0.59528375},"labels":[],"label_agreement":null},{"id":"W2073345699","doi":"10.1016/s1098-3015(10)61453-2","title":"PES1 COST OF ILLNESS OF GLAUCOMA IN CANADA: ANALYSES BASED ON VISUAL FIELD MEASUREMENTS AND PHYSICIAN'S ASSESSMENT","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glaucoma; Optometry; Visual field; Ophthalmology; Medicine; Field (mathematics); Audiology; Mathematics","score_opus":0.07698847291706483,"score_gpt":0.3584319520229234,"score_spread":0.28144347910585854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073345699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549558,0.00313216,0.00029279297,0.0009994654,0.00003830666,0.00010581489,0.03623801,0.00003805981,0.0041997097],"genre_scores_gemma":[0.9869031,0.0011908181,0.0003230654,0.00013699908,0.000021685291,0.000029301722,0.009328117,0.000014627037,0.0020524098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975097,0.00051300816,0.00020500952,0.0001828294,0.0009881044,0.0006012953],"domain_scores_gemma":[0.9922294,0.0014853037,0.001804177,0.00022138243,0.0030940878,0.0011657133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013002909,0.00060792326,0.0008107461,0.0029955008,0.0010432214,0.0016707344,0.0017361622,0.0007980095,0.0029443384],"category_scores_gemma":[0.0129213,0.0005335553,0.0030956622,0.006683718,0.0007007017,0.0007005435,0.0011247157,0.0014338202,0.00020385005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092456344,0.000063148225,0.988379,0.000097691685,0.0007763925,0.00010066701,0.000086030035,0.0030419643,0.000045565845,0.00047632452,0.0016913902,0.0043173106],"study_design_scores_gemma":[0.0000541936,0.000074636824,0.9942524,0.000038519313,0.00033096227,0.00011820737,0.0002500284,0.0037404373,0.000049581624,0.000121661236,0.0009473469,0.000021966658],"about_ca_topic_score_codex":0.9917984,"about_ca_topic_score_gemma":0.98956525,"teacher_disagreement_score":0.043861024,"about_ca_system_score_codex":0.043861024,"about_ca_system_score_gemma":0.03415665,"threshold_uncertainty_score":0.31823552},"labels":[],"label_agreement":null},{"id":"W2073444771","doi":"10.1016/j.jval.2014.03.113","title":"Use Of Economic Evidence To Inform Drug Reimbursement Decision Making: The Case For Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Formulary; Reimbursement; Logistic regression; Medicine; Evidence-based medicine; Actuarial science; Family medicine; Business; Alternative medicine; Economics; Economic growth; Health care","score_opus":0.6180299669526403,"score_gpt":0.479337443169149,"score_spread":0.13869252378349134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073444771","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06056392,0.038989346,0.0067051766,0.78675056,0.0006646854,0.0002893951,0.0026351784,0.000056181274,0.10334556],"genre_scores_gemma":[0.9157998,0.027923021,0.017949084,0.032261737,0.00072763144,0.0001407392,0.0008249486,0.00007368186,0.0042992765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96126467,0.020170512,0.0031157166,0.0012141577,0.011624493,0.0026103414],"domain_scores_gemma":[0.6273178,0.25935453,0.017067129,0.008979571,0.07949396,0.0077869734],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.065656945,0.0005595533,0.0012598424,0.005170237,0.0032358784,0.010479242,0.002311633,0.004109313,0.0036415032],"category_scores_gemma":[0.25299266,0.00065924,0.0012302499,0.0067942776,0.0057472647,0.0060352073,0.003488468,0.0059024566,0.00018683527],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010313692,0.0002361877,0.20564096,0.004764346,0.0023521977,0.0017846943,0.006941284,0.015407558,0.0005788495,0.22700563,0.16054046,0.37371647],"study_design_scores_gemma":[0.0009415903,0.00020469354,0.19787723,0.020912578,0.0024703462,0.00066254963,0.0066912435,0.025148574,0.0012740968,0.30433103,0.4389286,0.0005574483],"about_ca_topic_score_codex":0.89794993,"about_ca_topic_score_gemma":0.95492876,"teacher_disagreement_score":0.93434304,"about_ca_system_score_codex":0.07321764,"about_ca_system_score_gemma":0.15423603,"threshold_uncertainty_score":0.53123367},"labels":[],"label_agreement":null},{"id":"W2073559015","doi":"10.1111/j.1524-4733.2007.00298.x","title":"The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Alberta","funders":"","keywords":"Reimbursement; Transparency (behavior); Formulary; Context (archaeology); Actuarial science; Medicine; Public relations; Public economics; Political science; Psychology; Family medicine; Business; Economics; Law; Geography","score_opus":0.34604171872337475,"score_gpt":0.4530476766272725,"score_spread":0.10700595790389777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073559015","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025862182,0.16033545,0.006642969,0.73714715,0.0025823193,0.00012104154,0.0018500106,0.00006176251,0.06539712],"genre_scores_gemma":[0.8578218,0.07206285,0.010741624,0.05051956,0.0031901058,0.000092760776,0.00070811063,0.000115969655,0.0047471756],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.950291,0.022570923,0.0030549702,0.0018951679,0.017978102,0.0042098984],"domain_scores_gemma":[0.5469671,0.2962514,0.010445405,0.007635117,0.12594335,0.012757608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09675937,0.00112864,0.0027365242,0.013390538,0.005721432,0.023114752,0.00513828,0.0059748953,0.007279402],"category_scores_gemma":[0.39157975,0.00092127774,0.0014612094,0.01325915,0.017067613,0.011245887,0.0053764787,0.009126383,0.00024567894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006849233,0.0001056741,0.043629646,0.0034988115,0.0012921577,0.00039592903,0.0029171072,0.0101144,0.00016187939,0.5552281,0.13104476,0.25092652],"study_design_scores_gemma":[0.000394357,0.000106064464,0.08768246,0.017011287,0.0016600257,0.00026757328,0.006580451,0.023673762,0.00070014474,0.5934769,0.26770335,0.00074369163],"about_ca_topic_score_codex":0.9571206,"about_ca_topic_score_gemma":0.9695212,"teacher_disagreement_score":0.8833715,"about_ca_system_score_codex":0.11662854,"about_ca_system_score_gemma":0.21683404,"threshold_uncertainty_score":0.84620327},"labels":[],"label_agreement":null},{"id":"W2073646785","doi":"10.1016/j.jval.2012.08.387","title":"PIN18 Antimicrobial Resistance (AMR) in Thailand: A Systematic Review","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Antibiotic resistance; CLARITY; Epidemiology; Intensive care medicine; Environmental health; Health care; Economic growth; Pathology; Antibiotics","score_opus":0.06234755627801146,"score_gpt":0.32160753529680125,"score_spread":0.2592599790187898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073646785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011143832,0.9981883,0.000031670043,0.00013493407,0.000039845756,0.00004111511,0.0002532742,0.0000024798087,0.00019394685],"genre_scores_gemma":[0.010989342,0.98824745,0.00022422551,0.00027326902,0.000035342448,0.000055596436,0.0001088923,0.0000012700277,0.000064634856],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99650526,0.0009170247,0.0015168703,0.00027598217,0.0006399529,0.0001448983],"domain_scores_gemma":[0.9887861,0.0062044607,0.0038135857,0.00013005901,0.00081305497,0.00025280326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040380415,0.0011697949,0.004000892,0.0080854725,0.00037626232,0.002058668,0.00097112125,0.0013950918,0.0043175486],"category_scores_gemma":[0.012807737,0.000658308,0.004265621,0.01281097,0.0006846804,0.0016235582,0.0015905042,0.00097231835,0.00019955858],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039776793,0.000054665583,0.0063988883,0.841283,0.008669689,0.0005566918,0.00033334616,0.00018001534,0.0002932751,0.00018305676,0.0032082272,0.13844135],"study_design_scores_gemma":[0.00046467286,0.00069460983,0.041377243,0.76233107,0.121522285,0.0032102142,0.0012600438,0.00013929556,0.00053999573,0.00033746724,0.06801647,0.00010657299],"about_ca_topic_score_codex":0.009082218,"about_ca_topic_score_gemma":0.028680379,"teacher_disagreement_score":0.009082218,"about_ca_system_score_codex":0.0017306661,"about_ca_system_score_gemma":0.008412353,"threshold_uncertainty_score":0.02135545},"labels":[],"label_agreement":null},{"id":"W2073702283","doi":"10.1016/j.jval.2013.03.1142","title":"Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tocilizumab; Medicine; Methotrexate; Internal medicine; Arthritis; Placebo; Indirect costs; Physical therapy; Rheumatoid arthritis; Alternative medicine","score_opus":0.14257477856525244,"score_gpt":0.4194890069655089,"score_spread":0.2769142284002565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073702283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9789507,0.010122527,0.004607714,0.00136174,0.00007359827,0.0002567323,0.0012561758,0.000055723034,0.003315019],"genre_scores_gemma":[0.99838734,0.00051210244,0.00054210005,0.00005950838,0.000013289718,0.00003265657,0.00023922622,0.0000041018625,0.00020954461],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9977028,0.0017614487,0.00007748773,0.000096136064,0.00019956402,0.00016251384],"domain_scores_gemma":[0.9959739,0.0032817945,0.0002978974,0.00008167903,0.00014990513,0.00021476687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027704411,0.0009590599,0.001730442,0.0013861319,0.0002443127,0.0015012831,0.00086116156,0.0008441681,0.0030344115],"category_scores_gemma":[0.009195736,0.00042629318,0.002697818,0.00118966,0.0004550291,0.0007299421,0.0005623504,0.0011812582,0.0001370276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11394426,0.0024289796,0.07358225,0.0016953582,0.012737301,0.0010638252,0.00016589677,0.655854,0.003341115,0.007855159,0.0038346096,0.123497255],"study_design_scores_gemma":[0.009430611,0.012488794,0.095715515,0.00045894439,0.01209898,0.0009814897,0.00046370618,0.859656,0.0011894964,0.0048905564,0.0024763083,0.00014969647],"about_ca_topic_score_codex":0.012952341,"about_ca_topic_score_gemma":0.0071618017,"teacher_disagreement_score":0.012952341,"about_ca_system_score_codex":0.0045715678,"about_ca_system_score_gemma":0.0016195764,"threshold_uncertainty_score":0.03316921},"labels":[],"label_agreement":null},{"id":"W2073777169","doi":"10.1016/s1098-3015(10)63610-8","title":"PAA8 A COMPARISON OF CLAIMS RATIO BETWEEN PRIMARY AND SECONDARY DRUGS IN THE MANAGEMENT OF ASTHMA. A CANADIAN ANALYSIS","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary (astronomy); Asthma; Asthma management; Medicine; Family medicine; Internal medicine; Physics","score_opus":0.02109791865848181,"score_gpt":0.3012188155261278,"score_spread":0.28012089686764596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073777169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6611982,0.020739058,0.00390108,0.0045430763,0.00049595674,0.00095766695,0.25491944,0.00040161732,0.052843887],"genre_scores_gemma":[0.95947164,0.0024362805,0.0019213692,0.0004809639,0.000086102984,0.00014131199,0.027648931,0.00008362548,0.0077296286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925869,0.0011562498,0.00033465156,0.0005841071,0.0044838106,0.0008543444],"domain_scores_gemma":[0.9899288,0.0019164416,0.0011444741,0.00040301186,0.005744044,0.0008632256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038986467,0.000745561,0.0010068906,0.005435812,0.0015689885,0.0017877945,0.0025995416,0.00064808846,0.009021857],"category_scores_gemma":[0.016963445,0.000514827,0.0035275426,0.008808065,0.0004964922,0.00060841534,0.0007468858,0.0015452155,0.00056739245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008374692,0.00031860176,0.80567604,0.0015436761,0.006174911,0.0004421542,0.0004926823,0.004908245,0.0007246047,0.00893134,0.105308935,0.05710407],"study_design_scores_gemma":[0.00058669614,0.00027345904,0.97387004,0.00016526003,0.0022592216,0.0002955213,0.0005040351,0.005467715,0.00044945988,0.00039143264,0.015643114,0.000093942035],"about_ca_topic_score_codex":0.9888037,"about_ca_topic_score_gemma":0.98257554,"teacher_disagreement_score":0.02589485,"about_ca_system_score_codex":0.02589485,"about_ca_system_score_gemma":0.04074541,"threshold_uncertainty_score":0.18788117},"labels":[],"label_agreement":null},{"id":"W2073893218","doi":"10.1016/j.jval.2011.08.1494","title":"PSS29 Treatment Patterns of Psoriasis Patients and Trends Over Time","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Psoriasis; Medicine; Body mass index; Psoriasis Area and Severity Index; Population; Dermatology; Internal medicine; Body surface area; Retrospective cohort study","score_opus":0.03972298619910637,"score_gpt":0.25619942129535445,"score_spread":0.2164764350962481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073893218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938445,0.0012200164,0.00010511513,0.00022641665,0.000006462367,0.000010297242,0.001115489,0.000010085332,0.0034615279],"genre_scores_gemma":[0.9980952,0.00047059503,0.00007695312,0.000059029862,0.000010935631,0.000007561726,0.00065971597,0.0000044614567,0.0006156311],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994629,0.000110780355,0.00008884091,0.0000770546,0.00012843957,0.000131991],"domain_scores_gemma":[0.9978859,0.00045059936,0.0009976444,0.000057510155,0.00031726505,0.0002909933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032874124,0.00010247364,0.00035384364,0.0010997489,0.00038444911,0.0005921436,0.00016114212,0.00035012554,0.0033154166],"category_scores_gemma":[0.001970182,0.00009997216,0.00044592415,0.0020505239,0.00014848792,0.0004052934,0.0002359373,0.00057374896,0.00057839684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044276728,0.00008471454,0.9843456,0.000033327564,0.00005511282,0.000120365985,0.00018365194,0.00005383423,0.00069628516,0.00004943373,0.00032460343,0.013610303],"study_design_scores_gemma":[0.0000071407053,0.00015677493,0.99769294,0.000011461353,0.000030976986,0.0006031847,0.00028098456,0.00008968593,0.00015111952,0.000028163016,0.00094326696,0.000004248141],"about_ca_topic_score_codex":0.003904432,"about_ca_topic_score_gemma":0.0043214266,"teacher_disagreement_score":0.003904432,"about_ca_system_score_codex":0.00037046286,"about_ca_system_score_gemma":0.0003039119,"threshold_uncertainty_score":0.011091173},"labels":[],"label_agreement":null},{"id":"W2073944554","doi":"10.1016/j.jval.2014.08.2598","title":"The Costs of Diagnosis and Treatment of Ankle Sprains and Fractures, 1980-2013: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Foot and Ankle Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ankle; CINAHL; MEDLINE; Ankle sprain; Psychological intervention; Physical therapy; Systematic review; Surgery","score_opus":0.08916200535843594,"score_gpt":0.38326918283172184,"score_spread":0.2941071774732859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073944554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0024231223,0.99624497,0.00004579434,0.00015005236,0.00006407395,0.000031626718,0.0008778349,0.0000031445531,0.00015944302],"genre_scores_gemma":[0.04110801,0.95775324,0.00027079703,0.00023542922,0.00007442745,0.00006256252,0.00041888704,0.0000033355968,0.000073335636],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99546957,0.0010646782,0.001823232,0.00035322757,0.0010888387,0.00020051106],"domain_scores_gemma":[0.98738796,0.00806108,0.0034552717,0.00012018152,0.00079587137,0.00017966454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003336152,0.0010414445,0.005248408,0.0069309347,0.00029671795,0.0015735704,0.0012450182,0.0014002442,0.0024457856],"category_scores_gemma":[0.02237961,0.0010629492,0.008365366,0.010284864,0.0005808826,0.0013992158,0.0012731185,0.0013667861,0.0001538655],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008434484,0.000040987798,0.013693516,0.84633356,0.06290713,0.00020470812,0.00018614958,0.0005262138,0.00012797864,0.00034937516,0.0037940324,0.07099287],"study_design_scores_gemma":[0.0013343885,0.00035621074,0.086017884,0.48423117,0.39441884,0.0017395683,0.0007947988,0.0005008965,0.00024477008,0.0008987812,0.02933004,0.00013269052],"about_ca_topic_score_codex":0.028089209,"about_ca_topic_score_gemma":0.069226384,"teacher_disagreement_score":0.028089209,"about_ca_system_score_codex":0.0035916432,"about_ca_system_score_gemma":0.005192131,"threshold_uncertainty_score":0.0558514},"labels":[],"label_agreement":null},{"id":"W2073954775","doi":"10.1016/j.jval.2014.03.018","title":"Real-World Cost Effectiveness Of The Mitraclip For The Treatment Of High-Risk Mitral Regurgitation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"MitraClip; Medicine; Mitral regurgitation; Heart failure; Mitral valve repair; Cardiology; Internal medicine; Surgery; Emergency medicine","score_opus":0.03276416190139207,"score_gpt":0.3755307631934019,"score_spread":0.3427666012920098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073954775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861422,0.006248831,0.00084712,0.002271057,0.000103033264,0.000059192706,0.002310529,0.000023822799,0.0019942373],"genre_scores_gemma":[0.9986444,0.0004409752,0.00020369077,0.000069156515,0.000040741026,0.000012467698,0.0004948612,0.0000023924833,0.00009128712],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9985727,0.0009096031,0.00009743194,0.00013560097,0.00014402803,0.00014066962],"domain_scores_gemma":[0.9940825,0.004427172,0.0007875449,0.00014745485,0.00016709237,0.00038822883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021881245,0.00048114563,0.00096012326,0.00057441485,0.00020895203,0.0012667128,0.00043233673,0.0009674256,0.0027768868],"category_scores_gemma":[0.011219106,0.00022745937,0.0016520836,0.0006980225,0.00043894656,0.0012662912,0.00048568775,0.0012544522,0.00015176233],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17697154,0.0048531713,0.26129213,0.00239747,0.01221186,0.0015410356,0.0002856705,0.32043692,0.0031488824,0.010304112,0.012721277,0.19383588],"study_design_scores_gemma":[0.01647239,0.034460954,0.5715449,0.0007513306,0.01035835,0.002609909,0.00096597127,0.34535062,0.001992544,0.009054513,0.0061021755,0.00033631202],"about_ca_topic_score_codex":0.005289692,"about_ca_topic_score_gemma":0.003748094,"teacher_disagreement_score":0.005289692,"about_ca_system_score_codex":0.002010013,"about_ca_system_score_gemma":0.000747729,"threshold_uncertainty_score":0.014583766},"labels":[],"label_agreement":null},{"id":"W2074096414","doi":"10.1016/j.jval.2013.08.589","title":"Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Epirubicin; Medicine; Docetaxel; Breast cancer; Cyclophosphamide; Population; Chemotherapy; Internal medicine; Doxorubicin; Cancer; Stage (stratigraphy); Oncology; Regimen; Surgery","score_opus":0.09369422543786671,"score_gpt":0.40639499045647415,"score_spread":0.31270076501860744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074096414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950147,0.00042285235,0.000042826476,0.0003255714,0.0000075787543,0.000023530956,0.0017542159,0.0000058685396,0.0024027398],"genre_scores_gemma":[0.99832624,0.0003217142,0.00007382806,0.00008766614,0.000005124317,0.0000065251998,0.00063191564,0.0000032285973,0.00054373476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992236,0.00005158249,0.000042531923,0.0000958606,0.00025968428,0.00032681949],"domain_scores_gemma":[0.998374,0.00010438867,0.00041994642,0.000038338847,0.0005993377,0.0004638563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043079458,0.00030068803,0.00039062768,0.0017754508,0.0019426913,0.0011797566,0.0011626984,0.00062518456,0.0033296503],"category_scores_gemma":[0.0021358381,0.00037316047,0.00096064486,0.0039174594,0.0006475488,0.0004353267,0.00070508465,0.0009897335,0.00022336887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009135172,0.000038486618,0.99662435,0.000011579983,0.00003376209,0.000078523255,0.00041017524,0.00008578894,0.00012360784,0.00007007968,0.00050628395,0.001926124],"study_design_scores_gemma":[0.0000047573253,0.000025517062,0.99817264,0.000009612151,0.000023746396,0.00008265975,0.0010654414,0.00019769,0.000026365753,0.0000209269,0.0003601246,0.000010618009],"about_ca_topic_score_codex":0.9881974,"about_ca_topic_score_gemma":0.99325883,"teacher_disagreement_score":0.023840325,"about_ca_system_score_codex":0.023840325,"about_ca_system_score_gemma":0.020235758,"threshold_uncertainty_score":0.17297447},"labels":[],"label_agreement":null},{"id":"W2074289341","doi":"10.1111/j.1524-4733.2009.00510.x","title":"The Impact of Two Pharmaceutical Risk-Sharing Agreements on Pricing, Promotion, and Net Health Benefits","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ontario Ministry of Research and Innovation; Organisation de Coopération et de Développement Économiques","keywords":"Business; Formulary; Actuarial science; Cost sharing; Risk management; Promotion (chess); Risk analysis (engineering); Finance; Medicine","score_opus":0.47412836305372663,"score_gpt":0.5044659273780143,"score_spread":0.03033756432428769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074289341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90947795,0.0020763855,0.008816273,0.01904957,0.00049627374,0.00038054548,0.0011236449,0.00020014665,0.05837935],"genre_scores_gemma":[0.9955863,0.00016223591,0.00080629945,0.00054298143,0.00012250566,0.000053072712,0.00006485944,0.000008417478,0.0026533445],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9800613,0.0111676315,0.00068986794,0.0012616119,0.0025245512,0.004295107],"domain_scores_gemma":[0.7875019,0.18512678,0.011107292,0.0045244033,0.003910464,0.007829136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031139135,0.0011917038,0.0024167048,0.0013454631,0.001823079,0.008045691,0.0036576004,0.009507488,0.016973874],"category_scores_gemma":[0.106658466,0.0009845017,0.0026427775,0.0011401193,0.0048932238,0.0054066745,0.00423769,0.009063312,0.0007681714],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04346982,0.011482369,0.063266285,0.0006903563,0.0013564279,0.0014340993,0.0016011989,0.22605027,0.004433522,0.53277874,0.015675724,0.09776124],"study_design_scores_gemma":[0.0103859585,0.008072995,0.11260322,0.00030486257,0.0032576376,0.0007188156,0.0034065207,0.32802382,0.0047476795,0.5165101,0.011375745,0.00059264386],"about_ca_topic_score_codex":0.010851626,"about_ca_topic_score_gemma":0.0065297587,"teacher_disagreement_score":0.031139135,"about_ca_system_score_codex":0.007392681,"about_ca_system_score_gemma":0.008060524,"threshold_uncertainty_score":0.16468143},"labels":[],"label_agreement":null},{"id":"W2074469810","doi":"10.1016/j.jval.2012.08.1742","title":"PSY19 A Cost-Consequence Analysis of Patient Self-Management Versus Physician-Managed Monitoring of Long-Term Oral Anticoagulation Therapy in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Context (archaeology); Pharmacist; Health care; Quality of life (healthcare); Perspective (graphical); Pharmacy; Family medicine; Nursing","score_opus":0.04092273519297076,"score_gpt":0.3086628603900941,"score_spread":0.26774012519712337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074469810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99063474,0.0012509999,0.00016571568,0.00081476336,0.000025802645,0.00016491118,0.004630203,0.000010686677,0.0023022501],"genre_scores_gemma":[0.9974038,0.0003641218,0.000178542,0.00016865917,0.000014408618,0.000017877328,0.0012856851,0.00000408569,0.0005627943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974523,0.0005992985,0.00016130833,0.00023240031,0.0008491856,0.00070540886],"domain_scores_gemma":[0.9936779,0.0014771279,0.0013695644,0.00014449256,0.001900773,0.001430134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017251257,0.0004249899,0.0010952391,0.0012733035,0.0011956122,0.0017339067,0.0014013015,0.00070377864,0.0027027195],"category_scores_gemma":[0.009738164,0.0003707068,0.002382881,0.0033595085,0.00076013146,0.0005129439,0.0006919849,0.0013019689,0.000080767604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008096595,0.00048476362,0.9638214,0.0002291398,0.0018939801,0.00039295544,0.00019729308,0.009329305,0.000264169,0.0012870764,0.002848863,0.011154531],"study_design_scores_gemma":[0.0009369652,0.00075327884,0.9776923,0.000073970594,0.0013136476,0.00023091011,0.00063404045,0.016684925,0.00019582384,0.00025277984,0.0011757367,0.000055614903],"about_ca_topic_score_codex":0.98167026,"about_ca_topic_score_gemma":0.978092,"teacher_disagreement_score":0.05162443,"about_ca_system_score_codex":0.05162443,"about_ca_system_score_gemma":0.04765352,"threshold_uncertainty_score":0.37456322},"labels":[],"label_agreement":null},{"id":"W2074540431","doi":"10.1046/j.1524-4733.2001.40202-231.x","title":"PPN9: HOW IS PAIN FELT ACROSS COUNTRIES? THE SHORT-FORM MCGILL PAIN QUESTIONNAIRE (SF-MPQ) IN 10 LANGUAGES","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"McGill Pain Questionnaire; Psychology; Medicine; Physical therapy","score_opus":0.025725501928478094,"score_gpt":0.34005244138416124,"score_spread":0.31432693945568313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074540431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739411,0.0010328334,0.0017719029,0.0014398774,0.00012916457,0.00012844341,0.009242931,0.000027466705,0.012286379],"genre_scores_gemma":[0.99123585,0.00039213162,0.0020293565,0.0002698534,0.000025609666,0.00025318871,0.0044879783,0.000037165522,0.0012688433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99593663,0.002130194,0.00061731186,0.00032112544,0.00050863496,0.00048602984],"domain_scores_gemma":[0.9979316,0.00086958276,0.00052382797,0.00011058404,0.0004173864,0.00014705576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042178184,0.0005050631,0.0005782568,0.0011032127,0.0005109045,0.0018322837,0.0005645741,0.00044541855,0.0040147067],"category_scores_gemma":[0.009100628,0.00026710183,0.0011584768,0.0024314274,0.00086116075,0.0020070986,0.0023583455,0.0008654263,0.00081200636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017605685,0.00014762851,0.86760604,0.0005621418,0.000809936,0.0007011157,0.0116769625,0.0007358319,0.0019649114,0.0019803848,0.008962965,0.10309152],"study_design_scores_gemma":[0.00009666135,0.0002766861,0.9779267,0.00032910553,0.00017599302,0.0007387749,0.009657171,0.00051798264,0.00052513584,0.0007975984,0.008907915,0.000050254537],"about_ca_topic_score_codex":0.011321389,"about_ca_topic_score_gemma":0.01078271,"teacher_disagreement_score":0.011321389,"about_ca_system_score_codex":0.00078180816,"about_ca_system_score_gemma":0.0010191106,"threshold_uncertainty_score":0.022511005},"labels":[],"label_agreement":null},{"id":"W2075000311","doi":"10.1016/j.jval.2013.08.921","title":"Analysis of Transparency Amongst International Health Technology Assessment Organizations","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of Toronto","funders":"","keywords":"Transparency (behavior); Excellence; Reimbursement; Health technology; Accounting; Medicine; Delphi method; Stakeholder; Health care; Political science; Business; Family medicine; Public administration; Public relations","score_opus":0.2629132221712331,"score_gpt":0.43963578407233767,"score_spread":0.17672256190110458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075000311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9171521,0.0016732296,0.0071445475,0.0111392215,0.00007561039,0.00017706642,0.000861778,0.000049776932,0.061726563],"genre_scores_gemma":[0.9986865,0.000080225276,0.0003872994,0.00018524675,0.000025068724,0.000026741056,0.00011695808,0.000007107006,0.00048483603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9553389,0.027668092,0.001989659,0.0016090652,0.009568651,0.0038256976],"domain_scores_gemma":[0.43971175,0.46454042,0.05252685,0.014036843,0.025338527,0.0038455965],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.053480614,0.0002167035,0.00044583637,0.0040559056,0.0025444224,0.0063454276,0.0008364625,0.0015952642,0.0036922547],"category_scores_gemma":[0.24908166,0.00034505545,0.0005621465,0.0044592004,0.0022182928,0.0036606987,0.0025004905,0.0032828178,0.0002184719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021863321,0.0006597525,0.55174786,0.00049605494,0.0004994178,0.00063830655,0.054401413,0.008859554,0.0014690496,0.25180003,0.017177146,0.11006508],"study_design_scores_gemma":[0.00026895085,0.00060838973,0.7713653,0.0012411642,0.000526155,0.0004114377,0.041276492,0.036723863,0.0038531402,0.09141683,0.052091178,0.00021715011],"about_ca_topic_score_codex":0.009036269,"about_ca_topic_score_gemma":0.0045801885,"teacher_disagreement_score":0.9465194,"about_ca_system_score_codex":0.005080507,"about_ca_system_score_gemma":0.0046322346,"threshold_uncertainty_score":0.2828359},"labels":[],"label_agreement":null},{"id":"W2075229705","doi":"10.1016/j.jval.2013.03.443","title":"Discriminative Ability Of The Sf-12 In Kiswahili By Hiv Stage In Patients In Kenya","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Linguistics and Cultural Studies","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of British Columbia","funders":"","keywords":"Viral load; Kenya; Medicine; Internal medicine; Population; Human immunodeficiency virus (HIV); Immunology; Biology; Environmental health","score_opus":0.05185623428332612,"score_gpt":0.25490239113841134,"score_spread":0.20304615685508523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075229705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99943465,0.00012756206,0.00000920181,0.0000659395,0.00000318877,0.00000519589,0.00014252837,6.534896e-7,0.00021102933],"genre_scores_gemma":[0.9996872,0.000070266964,0.000027913722,0.000019108767,0.0000028043305,0.0000062126664,0.00011646002,6.476291e-7,0.000069301524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949,0.00018465135,0.00006503922,0.00006527074,0.00005348261,0.0001415401],"domain_scores_gemma":[0.9991726,0.00032387918,0.00025627232,0.000033749624,0.000075249205,0.0001380762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007299244,0.00040345115,0.00054008723,0.0008179101,0.00096372777,0.0009662939,0.0006125038,0.0006506847,0.0014553415],"category_scores_gemma":[0.0045848475,0.0004890148,0.0004951868,0.0011455073,0.0005109831,0.0006843249,0.0006822499,0.0010706466,0.00023927221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014917951,0.000037479826,0.9983076,0.00000908072,0.000028214705,0.00005591586,0.0003759271,0.000025679741,0.00010642484,0.00002181655,0.000058328184,0.0008243553],"study_design_scores_gemma":[0.000016943572,0.00009012486,0.997658,0.000020499961,0.000041205338,0.00012450996,0.0016819686,0.00018093578,0.000050166578,0.000032553082,0.000095440606,0.000007682625],"about_ca_topic_score_codex":0.039999925,"about_ca_topic_score_gemma":0.05997589,"teacher_disagreement_score":0.039999925,"about_ca_system_score_codex":0.00082621473,"about_ca_system_score_gemma":0.0008305451,"threshold_uncertainty_score":0.07953423},"labels":[],"label_agreement":null},{"id":"W2075638718","doi":"10.1016/j.jval.2014.08.2164","title":"Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Trastuzumab; Medicine; Adjuvant; Internal medicine; Breast cancer; Oncology; Stage (stratigraphy); Adjuvant therapy; Cancer; Clinical trial; Clinical Practice; Surgery; Physical therapy","score_opus":0.026365130467483195,"score_gpt":0.33172896818348613,"score_spread":0.30536383771600295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075638718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971316,0.0007609697,0.00002415243,0.00063667836,0.000013009901,0.0000049935034,0.00025122878,0.0000024325811,0.0011749219],"genre_scores_gemma":[0.99913603,0.00025381465,0.000017719347,0.00020042922,0.000014561212,0.00000317985,0.00017561254,8.0141376e-7,0.00019794684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996481,0.000105276784,0.000026827165,0.00006535201,0.000042170494,0.00011225621],"domain_scores_gemma":[0.9993037,0.00013798571,0.00022844222,0.000015950187,0.00006487076,0.00024897547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027100006,0.00011154688,0.0002588145,0.00032386786,0.00037752758,0.00060031924,0.00021562024,0.0003585243,0.0013307007],"category_scores_gemma":[0.0017697302,0.00010955099,0.00024016152,0.00061417423,0.00018798321,0.0003703451,0.00043666043,0.0005761849,0.00011083048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024492148,0.00008499681,0.9943488,0.000009560036,0.00004092998,0.00014825052,0.000095897994,0.00008109238,0.00010081097,0.000034814297,0.00060724624,0.0042026206],"study_design_scores_gemma":[0.000052471634,0.00033207686,0.99735534,0.00001955109,0.00005791073,0.0003908566,0.0006922066,0.00027445753,0.00006804816,0.00009146827,0.0006602241,0.0000053738636],"about_ca_topic_score_codex":0.014106112,"about_ca_topic_score_gemma":0.03251724,"teacher_disagreement_score":0.014106112,"about_ca_system_score_codex":0.0010126643,"about_ca_system_score_gemma":0.00083461136,"threshold_uncertainty_score":0.028048038},"labels":[],"label_agreement":null},{"id":"W2075738853","doi":"10.1016/j.jval.2013.01.009","title":"Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Apixaban; Dabigatran; Medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Cost effectiveness; Stroke (engine); Quality-adjusted life year; Internal medicine; Anesthesia","score_opus":0.10777609511540608,"score_gpt":0.34251584165148924,"score_spread":0.23473974653608315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075738853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831408,0.013034252,0.00016335274,0.0013119923,0.00019005679,0.000059510847,0.00036343577,0.000005590343,0.0017308994],"genre_scores_gemma":[0.9975164,0.0017131278,0.00015483699,0.00016461655,0.000098961,0.000018832576,0.00020461906,0.0000012610975,0.00012733556],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9983694,0.00091633986,0.00022438257,0.000115802024,0.00020049309,0.00017357571],"domain_scores_gemma":[0.9973068,0.001754858,0.0004686546,0.00007379615,0.00009284163,0.00030300312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00151726,0.00046516603,0.0016369778,0.0007472823,0.00032237134,0.00120883,0.00044935764,0.0010542048,0.0023742667],"category_scores_gemma":[0.008376159,0.0003410012,0.0036565857,0.0007654783,0.00034225965,0.0012551969,0.00059717626,0.0011813404,0.00008675176],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3403994,0.0056166947,0.4517185,0.002258437,0.021620333,0.0008413781,0.0003453086,0.017506046,0.0012481265,0.0018297606,0.002604886,0.15401103],"study_design_scores_gemma":[0.054304592,0.04846239,0.8171723,0.00095554546,0.02779674,0.0013322552,0.0013112089,0.04128378,0.0009963334,0.0040454147,0.0021316316,0.00020775304],"about_ca_topic_score_codex":0.006150447,"about_ca_topic_score_gemma":0.007697406,"teacher_disagreement_score":0.006150447,"about_ca_system_score_codex":0.001690367,"about_ca_system_score_gemma":0.0009245608,"threshold_uncertainty_score":0.01226455},"labels":[],"label_agreement":null},{"id":"W2076434268","doi":"10.1016/j.jval.2013.03.1595","title":"Evaluation of health related quality of life outcomes among patients with schizophrenia switched to lurasidone from other antipsychotics","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lurasidone; Quality of life (healthcare); Psychosocial; Schizophrenia (object-oriented programming); Medicine; Clinical endpoint; Antipsychotic; Psychiatry; Psychology; Internal medicine; Clinical trial","score_opus":0.09874209941898587,"score_gpt":0.3699057994241986,"score_spread":0.2711637000052127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076434268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995191,0.00014018085,0.000014959555,0.000020043275,0.0000025308323,0.000012307706,0.000090485126,6.8620625e-7,0.00019974455],"genre_scores_gemma":[0.9995989,0.00006468301,0.000038021764,0.000014441348,0.000003381318,0.000012746912,0.00020753135,3.3239894e-7,0.000059924154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993741,0.00028480618,0.00006872521,0.00005322116,0.00011174859,0.00010739707],"domain_scores_gemma":[0.99858886,0.0003704799,0.0004943497,0.00004989799,0.00021588468,0.00028047006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012536097,0.0002744246,0.0006375004,0.0006974456,0.00041253926,0.00075107696,0.0002553222,0.00032400346,0.0008227485],"category_scores_gemma":[0.0028648719,0.0001270732,0.0013428682,0.00075915636,0.0002929399,0.00050672743,0.0004308786,0.0004871308,0.00011443623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0141577525,0.00093433855,0.96864945,0.00009050572,0.00071863487,0.000069035115,0.00020824684,0.00031149894,0.0005102931,0.000035984453,0.000101995276,0.014212406],"study_design_scores_gemma":[0.00075053354,0.010357975,0.9864681,0.000027177068,0.0004803151,0.00009916887,0.00049128244,0.0007030973,0.00034958485,0.00006113406,0.00019579509,0.00001585649],"about_ca_topic_score_codex":0.00507762,"about_ca_topic_score_gemma":0.0062031494,"teacher_disagreement_score":0.00507762,"about_ca_system_score_codex":0.001366162,"about_ca_system_score_gemma":0.00071739644,"threshold_uncertainty_score":0.010096133},"labels":[],"label_agreement":null},{"id":"W2076572084","doi":"10.1016/s1098-3015(10)74873-7","title":"PSY30 COST-UTILITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMPARED WITH CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic inflammatory demyelinating polyneuropathy; Medicine; Guillain-Barre syndrome; Antibody; Intravenous Immunoglobulins; Polyneuropathy; Polyradiculoneuropathy; Immunology; Internal medicine","score_opus":0.022655251409575347,"score_gpt":0.2752466484121199,"score_spread":0.2525913970025445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076572084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97402036,0.007824741,0.00016814815,0.0038069151,0.00009589285,0.00015240723,0.004684994,0.000030408071,0.009216128],"genre_scores_gemma":[0.99617624,0.0015055293,0.00015642334,0.00020504478,0.000019194644,0.000014381363,0.0006306007,0.0000055774326,0.0012870784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922657,0.00014721866,0.000046087025,0.000059378843,0.00025291173,0.0002678568],"domain_scores_gemma":[0.9983846,0.00023555086,0.00019119823,0.000017703454,0.000560901,0.00061003835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047367797,0.0002971848,0.0006720197,0.0005759323,0.0006829434,0.0010868913,0.00067823735,0.00049107475,0.0042795027],"category_scores_gemma":[0.003295865,0.00020110117,0.0008544632,0.001273918,0.0004137787,0.00028669112,0.00040974555,0.00074662676,0.00013291641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04239903,0.0018186618,0.6334532,0.0014430187,0.0022288503,0.0012716342,0.00065480283,0.040702153,0.0022862582,0.0048635975,0.030125327,0.23875354],"study_design_scores_gemma":[0.0033357043,0.0028285156,0.95432115,0.00041403715,0.0014608687,0.00046476212,0.0012300651,0.028199097,0.0006312163,0.0005007991,0.006523908,0.00008995238],"about_ca_topic_score_codex":0.98368883,"about_ca_topic_score_gemma":0.9867583,"teacher_disagreement_score":0.049581975,"about_ca_system_score_codex":0.049581975,"about_ca_system_score_gemma":0.04230915,"threshold_uncertainty_score":0.35974407},"labels":[],"label_agreement":null},{"id":"W2076711619","doi":"10.1016/j.jval.2011.02.072","title":"QA3 DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Life expectancy; Expectancy theory; Gerontology; Medicine; Psychology; Environmental health; Social psychology","score_opus":0.3683636880228536,"score_gpt":0.3924260390934216,"score_spread":0.024062351070568033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076711619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81822866,0.070157416,0.02304948,0.05093361,0.0017637787,0.0003729759,0.00910489,0.000130918,0.02625818],"genre_scores_gemma":[0.9929558,0.0015616954,0.0013531616,0.0025846718,0.0004609715,0.00004122268,0.00077463663,0.000017988687,0.00024990772],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98996806,0.0077550747,0.00079615257,0.00045433047,0.00059101597,0.000435372],"domain_scores_gemma":[0.9378846,0.0518892,0.0055951057,0.0018230805,0.0018784084,0.00092949433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019643283,0.00073293346,0.0028591335,0.0016290125,0.0002938529,0.0016674505,0.0008255706,0.0019149,0.0065086493],"category_scores_gemma":[0.07952233,0.00028940383,0.0054662847,0.0019719407,0.0009741121,0.0026738984,0.0006043458,0.0018531564,0.000632961],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03734668,0.0008549827,0.62718904,0.003493983,0.028780142,0.00032788157,0.00030314332,0.026776692,0.0018196049,0.0179689,0.014530467,0.24060838],"study_design_scores_gemma":[0.0065559265,0.008292812,0.7156294,0.0023397498,0.037541844,0.0016204616,0.000682153,0.09887409,0.0027001258,0.10164312,0.023783948,0.00033642916],"about_ca_topic_score_codex":0.0018095882,"about_ca_topic_score_gemma":0.001864367,"teacher_disagreement_score":0.019643283,"about_ca_system_score_codex":0.0012424174,"about_ca_system_score_gemma":0.0009546476,"threshold_uncertainty_score":0.103884816},"labels":[],"label_agreement":null},{"id":"W2077261810","doi":"10.1016/j.jval.2011.02.369","title":"PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Confirmatory factor analysis; Goodness of fit; Stepwise regression; Index (typography); Psychology; Statistics; Medicine; Regression analysis; Clinical psychology; Mathematics; Structural equation modeling; Computer science","score_opus":0.07404468639528143,"score_gpt":0.3596493479168701,"score_spread":0.28560466152158864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077261810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70169157,0.007765691,0.048046287,0.010995101,0.0011801248,0.01111535,0.09118778,0.012101731,0.11591639],"genre_scores_gemma":[0.78217345,0.0049464586,0.14189203,0.002212386,0.0005739869,0.007723846,0.031907618,0.0006841819,0.027885985],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979366,0.0005898315,0.00049044646,0.00013854883,0.000719409,0.0001251559],"domain_scores_gemma":[0.9922841,0.0026189426,0.00211122,0.0003022074,0.0018824539,0.00080105296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031280303,0.0006365157,0.00081363827,0.0024304087,0.00038906588,0.0010390017,0.00040484642,0.000513776,0.008384211],"category_scores_gemma":[0.0133720795,0.00034017322,0.0012207453,0.0011160154,0.00016244431,0.0011506606,0.0010062328,0.0011276745,0.00289758],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019770854,0.00088441005,0.3874276,0.0008556731,0.00043945917,0.00027457214,0.00060167414,0.0010319263,0.0016129431,0.0007206445,0.08467255,0.5195014],"study_design_scores_gemma":[0.0007882318,0.002068527,0.8569402,0.00047154815,0.00058627164,0.001732301,0.0003258012,0.0054487516,0.00479833,0.0015587714,0.12509552,0.0001858065],"about_ca_topic_score_codex":0.00220492,"about_ca_topic_score_gemma":0.0050831907,"teacher_disagreement_score":0.008384211,"about_ca_system_score_codex":0.0006109858,"about_ca_system_score_gemma":0.0016002412,"threshold_uncertainty_score":0.02804792},"labels":[],"label_agreement":null},{"id":"W2077906229","doi":"10.1016/j.jval.2012.03.1200","title":"PCN83 Novel Targeted Drug Therapies in the Cancer Setting: A Descriptive Comparison of Efficacy and Cost","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Oncology; Internal medicine; Multiple myeloma; Clinical trial; Rituximab; Trastuzumab; Cancer; Breast cancer; Lymphoma","score_opus":0.11164825978064685,"score_gpt":0.3199651482289862,"score_spread":0.20831688844833934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077906229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98308045,0.007129272,0.0013709725,0.00052082003,0.000019827816,0.00007427135,0.003944321,0.000011208657,0.0038488782],"genre_scores_gemma":[0.99683607,0.00091891125,0.00026301024,0.00008465443,0.00002165733,0.000028939832,0.0015146898,0.0000066723996,0.0003253658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971132,0.0017892065,0.0002542066,0.00020620486,0.00046257456,0.00017449317],"domain_scores_gemma":[0.9786144,0.016647281,0.003134758,0.00075830554,0.0005103684,0.0003348693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057924837,0.00026177618,0.00097017013,0.0013034492,0.0001785898,0.0010768863,0.0005220683,0.0004430989,0.0045918385],"category_scores_gemma":[0.017813772,0.0001672153,0.0018206674,0.0025170015,0.00053162064,0.0010881667,0.0007205771,0.0010582347,0.0004043504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074152924,0.0029040484,0.6310438,0.0021939122,0.015594393,0.0006303685,0.00047353152,0.042407937,0.0028814734,0.019309528,0.0092679905,0.19914003],"study_design_scores_gemma":[0.0019316596,0.013915865,0.90631366,0.00045256162,0.00748643,0.0019744132,0.0013675212,0.038887154,0.0027600015,0.012144614,0.012650086,0.00011614366],"about_ca_topic_score_codex":0.0022693628,"about_ca_topic_score_gemma":0.0025188434,"teacher_disagreement_score":0.0057924837,"about_ca_system_score_codex":0.0014557351,"about_ca_system_score_gemma":0.0007696464,"threshold_uncertainty_score":0.030633926},"labels":[],"label_agreement":null},{"id":"W2078226086","doi":"10.1111/j.1524-4733.2009.00690.x","title":"Impact of Waist Circumference Difference on Health-Care Cost among Overweight and Obese Subjects: The PROCEED Cohort","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Overweight; Medicine; Waist; Body mass index; Obesity; Circumference; Demography; Cohort; Health care; Prospective cohort study; Gerontology; Internal medicine","score_opus":0.037634788514898994,"score_gpt":0.36020839509979025,"score_spread":0.32257360658489126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078226086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991026,0.000046130554,0.000025133544,0.000033808465,0.000005902188,0.0000047651324,0.00056555413,0.0000023276816,0.00021375802],"genre_scores_gemma":[0.9974286,0.000083780935,0.00004319534,0.000030530082,0.000016581911,0.00001342716,0.0013773862,0.000007047345,0.0009994671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958915,0.000102446036,0.000024156327,0.00011550316,0.000064158085,0.00010462982],"domain_scores_gemma":[0.99898595,0.0001423446,0.0002488645,0.00024485108,0.00008843267,0.00028942496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083653175,0.0006836154,0.0006528296,0.0005742698,0.0006129094,0.0010438672,0.0006198381,0.000675924,0.0022133768],"category_scores_gemma":[0.0014042358,0.0006426643,0.0016403573,0.0008878925,0.00039138377,0.00079161825,0.00088144664,0.0014343113,0.00035746905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015169062,0.0001995993,0.99608505,0.0000054942207,0.00038660932,0.00022993356,0.00013231592,0.00008162054,0.00038107546,0.00007022027,0.00029769834,0.0006134676],"study_design_scores_gemma":[0.000109090855,0.00031498523,0.99811137,0.0000026536154,0.0002756867,0.00014609724,0.000478775,0.00022879262,0.000067450164,0.000038677448,0.00021681037,0.000009626917],"about_ca_topic_score_codex":0.04696654,"about_ca_topic_score_gemma":0.04671556,"teacher_disagreement_score":0.04696654,"about_ca_system_score_codex":0.00041090418,"about_ca_system_score_gemma":0.00068817864,"threshold_uncertainty_score":0.09338635},"labels":[],"label_agreement":null},{"id":"W2078308946","doi":"10.1016/j.jval.2011.08.961","title":"PIH59 Are Older Mothers More prone to Having Children with Disabilities? Lifetime Disability Outcomes Versus Multiple Birth Reductions Arising from In-Vitro Fertilization (IVF) Treatments in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Assisted Reproductive Technology and Twin Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Multiple birth; Demography; Medicine; Fertility; Confidence interval; Live birth; Birth rate; Multiple disabilities; Pregnancy; Population; Psychology; Environmental health; Biology","score_opus":0.049108507840925124,"score_gpt":0.2869369968429913,"score_spread":0.23782848900206616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078308946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951337,0.0004187977,0.00002318319,0.00053912867,0.000013884897,0.000015334774,0.0016150862,0.0000021281,0.0022387614],"genre_scores_gemma":[0.9976382,0.00044705812,0.000040100713,0.000109432825,0.000008512698,0.000006803374,0.00061011617,0.0000024662243,0.0011372747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992378,0.000055381162,0.000038746548,0.00008651928,0.00018455669,0.00039706178],"domain_scores_gemma":[0.99713695,0.00017511129,0.000792471,0.00006136734,0.0007240953,0.0011099397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035949663,0.00024310789,0.00041829556,0.0011288099,0.0029115167,0.0011786962,0.0011034764,0.00052626635,0.0034720183],"category_scores_gemma":[0.002608971,0.00027630644,0.00064704724,0.0033235508,0.000709496,0.00041138037,0.00078857696,0.0011533668,0.00020961111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013087866,0.000058840316,0.99498427,0.000012323231,0.000035737743,0.00012519986,0.00051647925,0.00004010656,0.0000645496,0.00012463827,0.0005603705,0.0033467233],"study_design_scores_gemma":[0.00001414035,0.000030978787,0.99732095,0.000019860541,0.000034040288,0.00006944503,0.0019508511,0.000095924384,0.000025119298,0.00003802154,0.00039352122,0.000007033519],"about_ca_topic_score_codex":0.99063045,"about_ca_topic_score_gemma":0.993672,"teacher_disagreement_score":0.012614961,"about_ca_system_score_codex":0.012614961,"about_ca_system_score_gemma":0.01583716,"threshold_uncertainty_score":0.091528416},"labels":[],"label_agreement":null},{"id":"W2078796473","doi":"10.1111/j.1524-4733.2008.00437.x","title":"Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health; University Health Network; Monsanto (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Per capita; Pandemic; Transmission (telecommunications); Microsimulation; Closure (psychology); Influenza pandemic; Medicine; Environmental health; Economic cost; Cost–benefit analysis; Pandemic influenza; Economics; Coronavirus disease 2019 (COVID-19); Population; Computer science; Political science; Microeconomics","score_opus":0.5550505989832692,"score_gpt":0.49947935587985953,"score_spread":0.05557124310340972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078796473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96259665,0.0007244343,0.024314288,0.0022292007,0.000072053765,0.000117045514,0.0005461146,0.000051514053,0.009348585],"genre_scores_gemma":[0.9974419,0.00014515598,0.0015116205,0.000040624927,0.000011485723,0.000028528577,0.00009212167,0.00000526818,0.00072317687],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989926,0.000711248,0.00002900186,0.0000647373,0.000077464,0.00012496853],"domain_scores_gemma":[0.993356,0.005467932,0.0005064706,0.00011963661,0.00029532224,0.00025469446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028659771,0.00083815434,0.0010673775,0.0009216847,0.00048675854,0.0014537782,0.0009326493,0.0014399353,0.0025693304],"category_scores_gemma":[0.0093267355,0.0005421069,0.0008914843,0.00082472176,0.0006863761,0.0014241915,0.00087667396,0.0011799475,0.000093151444],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017741208,0.000078966594,0.0010649421,0.000023414943,0.000045720455,0.000040092666,0.000009329005,0.99090356,0.00010898815,0.0057280357,0.00023422147,0.0015853281],"study_design_scores_gemma":[0.000045157598,0.00010662977,0.0005436677,0.0000061933706,0.000036007445,0.00000758468,0.000035534023,0.99724776,0.000081751445,0.0017896263,0.0000924801,0.000007562168],"about_ca_topic_score_codex":0.032446653,"about_ca_topic_score_gemma":0.014757123,"teacher_disagreement_score":0.032446653,"about_ca_system_score_codex":0.0035304555,"about_ca_system_score_gemma":0.0021108014,"threshold_uncertainty_score":0.06451559},"labels":[],"label_agreement":null},{"id":"W2078865041","doi":"10.1016/s1098-3015(10)63725-4","title":"PEY19 PROSTAGLANDIN AGONIST USE WITH AND WITHOUT ADJUNCTIVE THERAPY FOR THE TREATMENT OF GLAUCOMA: A CANADIAN POPULATION BASED ANALYSIS","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glaucoma; Agonist; Medicine; Prostaglandin analogue; Prostaglandin; Ophthalmology; Internal medicine; Receptor","score_opus":0.024606585280628694,"score_gpt":0.2820566062511154,"score_spread":0.2574500209704867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078865041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922294,0.0018152744,0.00009513171,0.00023530735,0.000019059942,0.00008975524,0.003418361,0.000010191062,0.0020875796],"genre_scores_gemma":[0.9959884,0.0013921962,0.00022216498,0.00016332483,0.000017388184,0.000031361684,0.0016534086,0.000006804299,0.00052491145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980414,0.00014984675,0.0001540904,0.00029173645,0.00094168243,0.0004212338],"domain_scores_gemma":[0.99721515,0.00024840274,0.0005881748,0.000097395656,0.0012610866,0.0005897188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088817766,0.0008210376,0.0011907377,0.002089494,0.0022845895,0.0012910406,0.0015089142,0.001193754,0.0024057226],"category_scores_gemma":[0.0024119904,0.00083404133,0.0027928902,0.00694156,0.0008806147,0.0005280255,0.0007686086,0.0015247596,0.00021456936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000904001,0.00011184052,0.9933066,0.000065868335,0.0004928987,0.0002082956,0.00022952059,0.00010117815,0.0003033092,0.00009469766,0.0007017291,0.0034802489],"study_design_scores_gemma":[0.00009939507,0.00014342541,0.9982066,0.000016563474,0.00034999562,0.00016366315,0.00032301695,0.0002000872,0.0000503592,0.000015450698,0.00040678665,0.000024452933],"about_ca_topic_score_codex":0.97976685,"about_ca_topic_score_gemma":0.9815356,"teacher_disagreement_score":0.020233154,"about_ca_system_score_codex":0.017338065,"about_ca_system_score_gemma":0.025157548,"threshold_uncertainty_score":0.1257971},"labels":[],"label_agreement":null},{"id":"W2079213767","doi":"10.1016/j.jval.2012.08.928","title":"PMD79 A Population-Based Study on the Use of Blood Glucose Monitoring Test Strips","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); Université Laval","funders":"","keywords":"Medicine; Metformin; Insulin; Cohort; Sulfonylurea; Glucose test; Population; Diabetes mellitus; Internal medicine; Cohort study; Endocrinology; Environmental health","score_opus":0.14458997614660202,"score_gpt":0.3360439226074668,"score_spread":0.19145394646086478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079213767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649566,0.00053644006,0.00016811685,0.000081253595,0.00003131482,0.000029985891,0.0010439111,0.000008912874,0.0016043597],"genre_scores_gemma":[0.9985104,0.00015631733,0.0000920083,0.000100348945,0.00004218043,0.000032867727,0.0006393675,0.000009546747,0.0004169247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710923,0.0010011916,0.000290511,0.0006374366,0.00074276543,0.00021891936],"domain_scores_gemma":[0.9959194,0.0012448439,0.0015118148,0.00032397162,0.00046148305,0.00053856574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013111264,0.0006737364,0.0009525088,0.0012742766,0.0008621904,0.0013486403,0.0007258457,0.0014654777,0.001884633],"category_scores_gemma":[0.0053002755,0.00095772865,0.0012253989,0.0032193505,0.00044290992,0.00093985524,0.0007915451,0.0018293746,0.0007305511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052764534,0.0001124038,0.99736434,0.000020163041,0.00024097494,0.00012381352,0.00007666714,0.000023603285,0.00042408291,0.000027672939,0.00018251063,0.0008760535],"study_design_scores_gemma":[0.000026125042,0.00018517544,0.9990287,0.0000059330155,0.00007681961,0.00026785178,0.00007015662,0.00010492358,0.00003902645,0.000017778764,0.00017263359,0.00000489963],"about_ca_topic_score_codex":0.0066035646,"about_ca_topic_score_gemma":0.003810841,"teacher_disagreement_score":0.0066035646,"about_ca_system_score_codex":0.0005604521,"about_ca_system_score_gemma":0.00048626168,"threshold_uncertainty_score":0.013130248},"labels":[],"label_agreement":null},{"id":"W2079685634","doi":"10.1016/j.jval.2011.08.1310","title":"PDB7 Prevalence, Demographics and Treatment Characteristics of Diabetes with Lantus, NPH and Premix Insulin in a Representative Canadian Cohort","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Diabetes mellitus; Population; Incidence (geometry); Internal medicine; NPH insulin; Insulin; Type 2 diabetes; Comorbidity; Cohort; Pediatrics; Endocrinology; Insulin glargine; Environmental health","score_opus":0.031495247184333934,"score_gpt":0.2588369720333785,"score_spread":0.22734172484904458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079685634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99111336,0.0002679632,0.00008076904,0.00014878626,0.000007950352,0.00003329541,0.005196081,0.000012506622,0.0031394048],"genre_scores_gemma":[0.9945798,0.00035589354,0.00024036129,0.0001461469,0.0000067009228,0.00002188576,0.002981917,0.000010511242,0.0016567176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923253,0.00003331659,0.000037391463,0.00012891859,0.00026552792,0.00030226997],"domain_scores_gemma":[0.99914324,0.000029679572,0.00014764574,0.000032524964,0.00036987214,0.00027705764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003728376,0.0004401841,0.0003984502,0.0017246512,0.002909925,0.001127994,0.0011079942,0.0005309759,0.0038956886],"category_scores_gemma":[0.0009542497,0.0005012436,0.0008990214,0.0032954533,0.0005504188,0.00035393712,0.0005412424,0.00069592387,0.0005459014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112325804,0.000045520963,0.9959777,0.000015457243,0.000045993685,0.00012859293,0.00034420553,0.00004407804,0.0002519351,0.0000725317,0.0011072977,0.0018544677],"study_design_scores_gemma":[0.000007954003,0.000033154705,0.9977714,0.000012427172,0.000021295458,0.0002025216,0.0009686241,0.00012102819,0.000042082975,0.00001667594,0.00079145626,0.000011352467],"about_ca_topic_score_codex":0.9876089,"about_ca_topic_score_gemma":0.98813397,"teacher_disagreement_score":0.0134753175,"about_ca_system_score_codex":0.0134753175,"about_ca_system_score_gemma":0.01244019,"threshold_uncertainty_score":0.09777069},"labels":[],"label_agreement":null},{"id":"W2079700016","doi":"10.1016/j.jval.2012.08.525","title":"CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Bayesian probability; Markov chain Monte Carlo; Computer science; Calibration; Bayesian inference; Meta-analysis; Statistics; Frequentist inference; Econometrics; Mathematics; Medicine; Internal medicine","score_opus":0.8366525448897001,"score_gpt":0.5640449137754371,"score_spread":0.272607631114263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079700016","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040375027,0.007072234,0.97632265,0.002110917,0.00037534497,0.0019113233,0.0016034945,0.0025798697,0.0039866236],"genre_scores_gemma":[0.14263105,0.001591801,0.8410283,0.002381141,0.00029510914,0.0064663314,0.0014786668,0.002086995,0.0020405941],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.5629585,0.40808302,0.0096355425,0.0076603307,0.0107689975,0.00089355337],"domain_scores_gemma":[0.3378382,0.61696947,0.009372511,0.02488413,0.010147808,0.0007878796],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.294828,0.0035461243,0.007856316,0.009704489,0.0009834789,0.0071454234,0.006416689,0.0083029065,0.018580407],"category_scores_gemma":[0.65970206,0.0044944333,0.018371426,0.007900344,0.0020505853,0.005723736,0.0074019944,0.009862779,0.0024988318],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0134033235,0.0003223166,0.0069817,0.016700571,0.042807404,0.00043701255,0.0008841778,0.31819305,0.0011595079,0.08952505,0.03128992,0.478296],"study_design_scores_gemma":[0.004684436,0.0009920432,0.0031483755,0.0052759927,0.016405314,0.00052690966,0.00011727547,0.67431897,0.0019099315,0.25353667,0.03875037,0.000333788],"about_ca_topic_score_codex":0.004631349,"about_ca_topic_score_gemma":0.002858223,"teacher_disagreement_score":0.705172,"about_ca_system_score_codex":0.003813373,"about_ca_system_score_gemma":0.0047754035,"threshold_uncertainty_score":0.8696026},"labels":[],"label_agreement":null},{"id":"W2079882865","doi":"10.1016/j.jval.2014.03.176","title":"Evidence-Based Practice Recommendations: Health Quality Ontario’s Approach","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Best practice; Evidence-based practice; Health care; Timeline; Relevance (law); Evidence-based medicine; Medicine; Systematic review; MEDLINE; Medical education; Public relations; Psychology; Political science; Alternative medicine","score_opus":0.7211036529612455,"score_gpt":0.504715750597193,"score_spread":0.21638790236405248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079882865","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089595385,0.05470955,0.013886893,0.88817024,0.011931716,0.0018108907,0.0021108023,0.00015546805,0.026328571],"genre_scores_gemma":[0.08855692,0.08245741,0.20405863,0.59072727,0.015890563,0.0067854244,0.0021748682,0.00021013578,0.009138863],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.85798776,0.061916575,0.02861875,0.0058111623,0.041663956,0.004001678],"domain_scores_gemma":[0.64435047,0.15981828,0.021565916,0.010084783,0.15026434,0.013916249],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11724723,0.0031597142,0.007324255,0.021206804,0.006122796,0.015164673,0.012982907,0.029710487,0.011135809],"category_scores_gemma":[0.3385514,0.0027262648,0.007152129,0.016268218,0.009831318,0.009067732,0.010775928,0.02386042,0.0021617932],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033679957,0.00035433966,0.004373223,0.03510145,0.004042511,0.00065231306,0.003267306,0.0029684303,0.00029954262,0.09860359,0.6672702,0.18273035],"study_design_scores_gemma":[0.0026421957,0.00025760266,0.012159348,0.13051112,0.006228732,0.00039773862,0.002218515,0.0032976032,0.0004368421,0.18689437,0.65443987,0.0005160962],"about_ca_topic_score_codex":0.43684915,"about_ca_topic_score_gemma":0.594323,"teacher_disagreement_score":0.94956636,"about_ca_system_score_codex":0.050433636,"about_ca_system_score_gemma":0.2129563,"threshold_uncertainty_score":0.8686128},"labels":[],"label_agreement":null},{"id":"W2079932358","doi":"10.1016/s1098-3015(10)66668-5","title":"PDB21 COST-EFFECTIVENESS OF INSULIN GLARGINE PLUS ORAL ANTIDIABETIC DRUGS (OADS) COMPARED TO PREMIXED INSULIN FOR TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin glargine; Medicine; Insulin; Type 2 Diabetes Mellitus; Diabetes mellitus; Type 2 diabetes; Internal medicine; Pharmacology; Endocrinology","score_opus":0.06785303927349089,"score_gpt":0.34792985404669796,"score_spread":0.28007681477320706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079932358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733734,0.010564024,0.00018881446,0.0022449328,0.00018767145,0.00020089997,0.003995596,0.000051942352,0.009192662],"genre_scores_gemma":[0.99740785,0.00094257656,0.00020519318,0.00020686978,0.000026840435,0.00001366436,0.0007349193,0.0000036440013,0.0004583389],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99896526,0.00033552194,0.00007576958,0.0001003805,0.0002124194,0.000310591],"domain_scores_gemma":[0.9983302,0.00056292873,0.00024739743,0.00005620455,0.0002027193,0.00060060277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093331555,0.0005031986,0.0012829626,0.0005972833,0.00053427176,0.0013750723,0.00094967167,0.000932075,0.006979558],"category_scores_gemma":[0.0055478597,0.0003163048,0.002646518,0.0012883316,0.00041387006,0.00044276175,0.00045943464,0.0011388584,0.00016214828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3961671,0.0051731924,0.24668375,0.0029663264,0.010277697,0.00086582964,0.0003607718,0.048233174,0.0024469441,0.005002021,0.024052378,0.25777078],"study_design_scores_gemma":[0.049538292,0.024951331,0.83946216,0.00074520096,0.015284904,0.0008333245,0.0011539764,0.056613643,0.0013202259,0.0020129122,0.007755895,0.00032825748],"about_ca_topic_score_codex":0.7738722,"about_ca_topic_score_gemma":0.7983206,"teacher_disagreement_score":0.2261278,"about_ca_system_score_codex":0.017221393,"about_ca_system_score_gemma":0.015996322,"threshold_uncertainty_score":0.45491898},"labels":[],"label_agreement":null},{"id":"W2080012507","doi":"10.1016/j.jval.2014.03.1345","title":"Indirect Comparison Of The Efficacy Of Recombinant Factor Viii Fc Fusion Protein And Other Factor Viii Products For ProphylaxisModeling The Effect Of Compliance","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bleed; Pooled analysis; Clinical trial; Internal medicine; Poisson regression; Surgery; Meta-analysis; Population","score_opus":0.11426605902276414,"score_gpt":0.3796847273387593,"score_spread":0.26541866831599514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080012507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99139565,0.0024073413,0.0014736861,0.00016144136,0.000080937025,0.00011671359,0.0012074709,0.000026482267,0.0031303184],"genre_scores_gemma":[0.9956457,0.0005524184,0.00096024125,0.00006482614,0.00004276745,0.00009218478,0.00059240387,0.000011638948,0.002037927],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9931899,0.00493797,0.00021556937,0.00056445063,0.00083651504,0.0002556295],"domain_scores_gemma":[0.97555065,0.020000234,0.0020261314,0.0014632957,0.0005537828,0.00040591997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044611464,0.000951473,0.0012922154,0.0005070224,0.00020584739,0.0007616549,0.000763384,0.0010898608,0.012104421],"category_scores_gemma":[0.014152646,0.00043175125,0.0024351382,0.00047648817,0.00076687103,0.000913969,0.00094374694,0.0015022433,0.0007855443],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47102237,0.021900676,0.18891916,0.0057352525,0.029207926,0.00030431052,0.0007690485,0.02457128,0.023182685,0.0063089617,0.003097794,0.2249805],"study_design_scores_gemma":[0.021945484,0.23889828,0.60143167,0.0008377525,0.026849976,0.0009308338,0.00050458056,0.042906005,0.05243575,0.004486313,0.008565529,0.00020771593],"about_ca_topic_score_codex":0.001909836,"about_ca_topic_score_gemma":0.001546122,"teacher_disagreement_score":0.012104421,"about_ca_system_score_codex":0.000871572,"about_ca_system_score_gemma":0.00065428775,"threshold_uncertainty_score":0.04049331},"labels":[],"label_agreement":null},{"id":"W2080026856","doi":"10.1016/j.jval.2013.08.223","title":"Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings: An Individual Patient Data Network Meta-Analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Psychological intervention; Medicine; Randomized controlled trial; Meta-analysis; Odds ratio; Confidence interval; MEDLINE; Family medicine; Physical therapy; Internal medicine; Psychiatry","score_opus":0.2155514973063242,"score_gpt":0.43392805823790376,"score_spread":0.21837656093157956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080026856","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28090775,0.6964212,0.011881217,0.0012784522,0.0018638608,0.002065949,0.002755856,0.0004498013,0.0023759317],"genre_scores_gemma":[0.9642673,0.027195442,0.005082855,0.0008622467,0.00021063218,0.0010551584,0.00067025097,0.00008204493,0.00057407026],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9659571,0.025577951,0.0032330647,0.0027884066,0.0015394865,0.0009040345],"domain_scores_gemma":[0.9717407,0.021210643,0.003041318,0.0023383864,0.0010961093,0.00057292386],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.025531664,0.0040385416,0.014277994,0.002532996,0.0011258459,0.0030818412,0.002718678,0.0031286057,0.0048916335],"category_scores_gemma":[0.04958163,0.0025174948,0.04697998,0.0030338676,0.0011546962,0.0025441162,0.0024215034,0.0048643555,0.00041254185],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017679343,0.000101150545,0.004753888,0.010574719,0.96291363,0.00004178509,0.00006717938,0.0004395938,0.00009630576,0.00006099288,0.00019844965,0.0030729785],"study_design_scores_gemma":[0.0072151823,0.00062546553,0.003227674,0.00083990424,0.98717016,0.000028370203,0.000036698788,0.00036507583,0.000062362116,0.00013232288,0.00027822127,0.00001853656],"about_ca_topic_score_codex":0.0097320685,"about_ca_topic_score_gemma":0.016389275,"teacher_disagreement_score":0.985722,"about_ca_system_score_codex":0.0024009154,"about_ca_system_score_gemma":0.0018256239,"threshold_uncertainty_score":0.13502598},"labels":[],"label_agreement":null},{"id":"W2080084883","doi":"10.1111/j.1524-4733.2007.00249.x","title":"Cost-Effectiveness of Intraperitoneal Chemohyperthermia in the Treatment of Peritoneal Carcinomatosis from Colorectal Cancer","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Peritoneal carcinomatosis; Confidence interval; Colorectal cancer; Cost effectiveness; Surgery; Palliative care; Chemotherapy; Cancer; Oncology; Internal medicine","score_opus":0.06107763484381537,"score_gpt":0.34520580408878027,"score_spread":0.28412816924496487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080084883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280656,0.010618689,0.00093130185,0.0018195858,0.000097660624,0.00008176832,0.00023603521,0.000020539985,0.0033877941],"genre_scores_gemma":[0.99917245,0.0004878941,0.00013139295,0.00004960816,0.000022111537,0.000009781467,0.0000571408,9.0084586e-7,0.00006872963],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9990503,0.000676417,0.0000503289,0.000035137648,0.00009333553,0.00009440387],"domain_scores_gemma":[0.9985593,0.00086783874,0.00023451363,0.000031050608,0.00005416959,0.00025316837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006663552,0.00028180506,0.00061274815,0.00059497845,0.00018281056,0.0006188358,0.0003087752,0.00059087033,0.0020085156],"category_scores_gemma":[0.0044398396,0.00014197205,0.0013796701,0.00054914516,0.0002801351,0.00043353252,0.0004092839,0.0007188319,0.000069359994],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1308166,0.0050900644,0.17969033,0.00178869,0.006102694,0.0016065228,0.00018931659,0.13352051,0.0037221063,0.0051199077,0.0032377844,0.52911544],"study_design_scores_gemma":[0.016975334,0.06368499,0.68588257,0.00088338566,0.011890756,0.004445769,0.0010519521,0.19684772,0.0042899614,0.008230586,0.00562052,0.00019643751],"about_ca_topic_score_codex":0.0035985815,"about_ca_topic_score_gemma":0.0040909788,"teacher_disagreement_score":0.0035985815,"about_ca_system_score_codex":0.0015146523,"about_ca_system_score_gemma":0.00079920504,"threshold_uncertainty_score":0.010989666},"labels":[],"label_agreement":null},{"id":"W2080332677","doi":"10.1016/j.jval.2011.02.1009","title":"PGI12 DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENT","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Infliximab; Adalimumab; Medicine; Internal medicine; Cohort; Retrospective cohort study; Confidence interval; Gastroenterology; Disease","score_opus":0.024289072830972844,"score_gpt":0.27428448758075485,"score_spread":0.249995414749782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080332677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6775024,0.18886237,0.0026358026,0.054459002,0.0008574838,0.0006318627,0.0098984325,0.00013300877,0.06501969],"genre_scores_gemma":[0.9263054,0.05814625,0.004945728,0.0046062316,0.0004859193,0.00012757085,0.0020532652,0.000054322307,0.0032753123],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9893992,0.0023784696,0.00081415515,0.0007325268,0.006115144,0.00056051183],"domain_scores_gemma":[0.98204833,0.0044849087,0.00276705,0.0004235913,0.008717213,0.0015589184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009298181,0.00048729568,0.0015501376,0.0014167764,0.0016877732,0.0019548296,0.0016457716,0.0011880961,0.0020012779],"category_scores_gemma":[0.018005654,0.0004747063,0.0014070442,0.0056404457,0.0015873784,0.00076608727,0.0007220395,0.0020065086,0.00018768519],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028383762,0.0010210383,0.36101285,0.002356024,0.0026569616,0.0006575639,0.0020163762,0.0034687286,0.0023018417,0.0028914646,0.02243706,0.5707964],"study_design_scores_gemma":[0.0050258143,0.002996035,0.9223824,0.0011611185,0.0037258142,0.000903686,0.0010782141,0.0022277972,0.0009193318,0.0004862108,0.058828637,0.0002648615],"about_ca_topic_score_codex":0.89558154,"about_ca_topic_score_gemma":0.93849534,"teacher_disagreement_score":0.10441846,"about_ca_system_score_codex":0.041794233,"about_ca_system_score_gemma":0.05934497,"threshold_uncertainty_score":0.30323982},"labels":[],"label_agreement":null},{"id":"W2080411162","doi":"10.1016/j.jval.2014.03.611","title":"Systematic Review And Network Meta-Analysis Of All Agents For Stroke Prevention In Patients With Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Toronto","funders":"","keywords":"Medicine; Dabigatran; Rivaroxaban; Apixaban; Warfarin; Aspirin; Stroke (engine); Atrial fibrillation; Edoxaban; Internal medicine; Placebo; Randomized controlled trial; Relative risk; Clopidogrel; Meta-analysis; Anesthesia; Cardiology; Confidence interval","score_opus":0.1562548928342169,"score_gpt":0.3848907493300748,"score_spread":0.22863585649585788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080411162","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02479025,0.96877486,0.0019433063,0.0005239894,0.00084753986,0.0005908961,0.0016065147,0.00009219479,0.0008303357],"genre_scores_gemma":[0.7408499,0.24669097,0.0055828732,0.002511125,0.00090999063,0.0013404052,0.0013384738,0.000100337005,0.00067586533],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9653667,0.020619564,0.007918776,0.0031169145,0.0021336076,0.00084443256],"domain_scores_gemma":[0.95208883,0.034879304,0.006996328,0.0030757827,0.0023758742,0.00058385776],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.020084402,0.0037860957,0.020216884,0.005659133,0.0010746609,0.0036583685,0.0022872863,0.0031401615,0.0038916531],"category_scores_gemma":[0.07662304,0.0025661867,0.057263926,0.005463553,0.0010021639,0.0027084735,0.0027784863,0.003409647,0.00039159486],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003147042,0.000015441019,0.003505752,0.04443585,0.9458746,0.00004911167,0.000042388867,0.0001878593,0.000079703794,0.00004691814,0.0002505284,0.002364772],"study_design_scores_gemma":[0.001591666,0.00012671044,0.0023343377,0.0023832757,0.9928068,0.000036088197,0.000016019692,0.00008150086,0.000031976062,0.00010760885,0.0004706048,0.000013408668],"about_ca_topic_score_codex":0.011867756,"about_ca_topic_score_gemma":0.02894219,"teacher_disagreement_score":0.9797831,"about_ca_system_score_codex":0.0031512503,"about_ca_system_score_gemma":0.0035860008,"threshold_uncertainty_score":0.10621768},"labels":[],"label_agreement":null},{"id":"W2080445759","doi":"10.1016/j.jval.2012.08.1361","title":"PMS6 Anti-Tumour Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis (PsA)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Golimumab; Adalimumab; Medicine; Psoriatic arthritis; Etanercept; Infliximab; Internal medicine; Psoriasis; Oncology; Psoriasis Area and Severity Index; Meta-analysis; Tumor necrosis factor alpha; Rheumatoid arthritis; Physical therapy; Dermatology","score_opus":0.04878508233628078,"score_gpt":0.28875065714799253,"score_spread":0.23996557481171174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080445759","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3865437,0.5601807,0.0028789672,0.011247544,0.003343215,0.00015984426,0.0006675217,0.00025466032,0.034723885],"genre_scores_gemma":[0.8435736,0.12114137,0.0028537218,0.0015770828,0.0014967776,0.00005627326,0.0004894491,0.000013738177,0.028797947],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998878,0.00003419762,0.000010160099,0.000008044247,0.000043927866,0.000015811138],"domain_scores_gemma":[0.99989426,0.000021275455,0.00003389135,0.0000043121604,0.000019468958,0.000026827222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019482353,0.00013973837,0.00022546963,0.00022163714,0.00017311476,0.0002384212,0.00011572706,0.00028666953,0.0038873449],"category_scores_gemma":[0.0002621006,0.00004255261,0.00024036472,0.00016364749,0.0001102111,0.0001148603,0.00013143187,0.00060447055,0.0007378932],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075289453,0.0007800961,0.0026815473,0.0011811462,0.00014359778,0.00096465077,0.000055205503,0.00023171054,0.07193654,0.0018967718,0.017372392,0.89522743],"study_design_scores_gemma":[0.0072109895,0.036408503,0.07910082,0.000829524,0.0006874402,0.02058598,0.0002627313,0.0016591415,0.16353562,0.003189774,0.68646944,0.0000600021],"about_ca_topic_score_codex":0.00021504823,"about_ca_topic_score_gemma":0.000810229,"teacher_disagreement_score":0.0038873449,"about_ca_system_score_codex":0.0001478379,"about_ca_system_score_gemma":0.00022831546,"threshold_uncertainty_score":0.013004482},"labels":[],"label_agreement":null},{"id":"W2080514612","doi":"10.1016/j.jval.2012.03.274","title":"PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Rheumatoid arthritis; MEDLINE; Clinical trial; Systematic review; Inclusion and exclusion criteria; Set (abstract data type); Intensive care medicine; Alternative medicine; Internal medicine; Pathology; Computer science","score_opus":0.29114910579217845,"score_gpt":0.4201042715320374,"score_spread":0.12895516573985893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080514612","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032966875,0.47879702,0.11417735,0.30488387,0.043977015,0.0024373066,0.0042295996,0.000749783,0.01778112],"genre_scores_gemma":[0.58458424,0.07103137,0.11020005,0.17823206,0.04280442,0.005190229,0.0023198086,0.001365133,0.004272714],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.49229562,0.37832597,0.06639182,0.015729494,0.045515094,0.0017420375],"domain_scores_gemma":[0.16609272,0.744267,0.029909384,0.03300309,0.025578639,0.0011491389],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4423644,0.0012607042,0.0036159342,0.006990089,0.0016554878,0.0067898002,0.004554946,0.0044286996,0.005057505],"category_scores_gemma":[0.7210309,0.0013025531,0.0056681125,0.007575424,0.007765998,0.0046364777,0.0045599192,0.004718777,0.0010057243],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065142526,0.00017517612,0.07090106,0.06971454,0.06688992,0.0012222416,0.0106265005,0.0013837223,0.0019102542,0.092730455,0.12655057,0.55138135],"study_design_scores_gemma":[0.004931171,0.0018661247,0.13009739,0.07412422,0.050597962,0.0027079587,0.006990623,0.0058895876,0.0058253785,0.44281006,0.2733832,0.00077630347],"about_ca_topic_score_codex":0.0032351115,"about_ca_topic_score_gemma":0.003852991,"teacher_disagreement_score":0.5576356,"about_ca_system_score_codex":0.0028732289,"about_ca_system_score_gemma":0.0044024447,"threshold_uncertainty_score":0.68766403},"labels":[],"label_agreement":null},{"id":"W2080705326","doi":"10.1111/j.1524-4733.2007.00297.x","title":"The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Hepatocellular carcinoma; Quality of life (healthcare); Environmental health; Mainland China; China; Demography; Geography; Internal medicine; Nursing","score_opus":0.4000795073752126,"score_gpt":0.44576979118670296,"score_spread":0.04569028381149037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080705326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952734,0.00010801737,0.000019228199,0.00005808291,0.0000017055081,0.0000034261157,0.00015414934,3.487004e-7,0.00012775297],"genre_scores_gemma":[0.99944955,0.00008207474,0.000022580867,0.00002972635,0.0000040799996,0.0000049097553,0.0003105321,0.0000012279855,0.00009536466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833953,0.0011494608,0.00009830021,0.0001146776,0.00010516505,0.00019279994],"domain_scores_gemma":[0.9907845,0.0038753857,0.002742992,0.00057290867,0.00045960484,0.0015645821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044044554,0.00044948788,0.0004886644,0.00087925885,0.0007329978,0.0013550041,0.00072614005,0.0008645464,0.0011314114],"category_scores_gemma":[0.009763017,0.00037010617,0.0011878472,0.0016503329,0.00077296275,0.0013851257,0.0014493454,0.0013347714,0.00016410313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005318611,0.00019016296,0.99724364,0.000008932342,0.00020397792,0.00005889732,0.00045302516,0.00018029663,0.000037254707,0.00004983153,0.000084658685,0.00095741486],"study_design_scores_gemma":[0.000020872505,0.00020102326,0.99803823,0.000009427051,0.0000703685,0.00007264711,0.0010561816,0.00036921425,0.000017594104,0.00004130939,0.00009452794,0.000008557191],"about_ca_topic_score_codex":0.03897132,"about_ca_topic_score_gemma":0.035402376,"teacher_disagreement_score":0.03897132,"about_ca_system_score_codex":0.0010401501,"about_ca_system_score_gemma":0.000517505,"threshold_uncertainty_score":0.07748896},"labels":[],"label_agreement":null},{"id":"W2080840536","doi":"10.1016/j.jval.2014.08.1845","title":"Validation of A Global Economic Model to Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment Using Kras Testing For Cetuximab Therapy In Metastatic Colorectal Cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cetuximab; KRAS; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Cost effectiveness; Cost-effectiveness analysis; Clinical trial","score_opus":0.18990676041061058,"score_gpt":0.44365032983370684,"score_spread":0.2537435694230963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080840536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87332916,0.0020659675,0.095286615,0.0033626335,0.00032985362,0.0007163801,0.0056798426,0.00026704604,0.01896249],"genre_scores_gemma":[0.9841723,0.00035950833,0.01232538,0.00018709694,0.000023029288,0.00025975987,0.0014058505,0.000041555944,0.001225634],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99821055,0.0012421851,0.0000569498,0.00018621601,0.00010907703,0.00019497563],"domain_scores_gemma":[0.98447835,0.013662555,0.0004901269,0.0003132827,0.00068973587,0.00036599993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073803747,0.001817834,0.00238427,0.001802684,0.0005291427,0.002661768,0.002003112,0.0026494018,0.004988235],"category_scores_gemma":[0.01678719,0.00090167485,0.0022109866,0.0018119895,0.0012510528,0.0017163296,0.001447519,0.002389784,0.00025932782],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037521333,0.000084939165,0.0015351408,0.000051607407,0.00008959761,0.000052725543,0.000009222887,0.99411607,0.00006981257,0.0014900501,0.00033732492,0.0017883552],"study_design_scores_gemma":[0.0002626725,0.00024567617,0.0011925331,0.000030247504,0.00012255732,0.00004008649,0.000041969277,0.9955967,0.000113529924,0.0019154303,0.00042373786,0.0000148622885],"about_ca_topic_score_codex":0.032074377,"about_ca_topic_score_gemma":0.011608293,"teacher_disagreement_score":0.032074377,"about_ca_system_score_codex":0.0047654924,"about_ca_system_score_gemma":0.0043049785,"threshold_uncertainty_score":0.06377542},"labels":[],"label_agreement":null},{"id":"W2081004753","doi":"10.1016/s1098-3015(10)73922-x","title":"PIH56 CARESS: THE CANADIAN REGISTRY OF SYNAGIS, SUMMARY OF 2006–2008 RSV SEASONS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Conferences and Exhibitions Management","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.04848283894594548,"score_gpt":0.318694454467332,"score_spread":0.27021161552138656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081004753","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10570582,0.001953117,0.00048479464,0.0007925558,0.00015526719,0.0007808032,0.86591315,0.00033434932,0.023880163],"genre_scores_gemma":[0.39179635,0.004400284,0.002683928,0.0008601763,0.000145875,0.0009358566,0.5774503,0.0001787995,0.021548517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808985,0.00008415657,0.00021949419,0.00021333371,0.00088088034,0.0005122277],"domain_scores_gemma":[0.9934221,0.00014306586,0.0008321707,0.0002238937,0.004581352,0.00079744676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015609508,0.0008840978,0.0006861979,0.0072427,0.0026012002,0.0013836873,0.0023987817,0.0005886172,0.009276205],"category_scores_gemma":[0.005389021,0.00066279405,0.000791231,0.0135426745,0.0003482123,0.0006432275,0.0011834393,0.0008702099,0.0019656518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038841553,0.00006674731,0.6009485,0.0008586629,0.00027367176,0.00020238497,0.00065489236,0.0006467749,0.00041726258,0.00070901157,0.3697148,0.025118792],"study_design_scores_gemma":[0.000046739908,0.000023959468,0.9626999,0.00016355752,0.00006449443,0.00009735554,0.00047324024,0.0004526493,0.00014065254,0.000052952346,0.035748012,0.000036384903],"about_ca_topic_score_codex":0.9946802,"about_ca_topic_score_gemma":0.99641067,"teacher_disagreement_score":0.023850443,"about_ca_system_score_codex":0.023850443,"about_ca_system_score_gemma":0.08338509,"threshold_uncertainty_score":0.1730479},"labels":[],"label_agreement":null},{"id":"W2081303573","doi":"10.1016/j.jval.2011.08.712","title":"PHP162 Impact of AMNOG on Pharmaceutical Pricing Trends in Germany","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Inflation (cosmology); Deflation; German; Biosimilar; Price setting; Health care; Business; Product (mathematics); Economics; Reference price; Monetary economics; Monetary policy; Geography; Medicine; Economic growth; Microeconomics","score_opus":0.26620551699215866,"score_gpt":0.40005730019361646,"score_spread":0.1338517832014578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081303573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710373,0.0011097013,0.00035837933,0.0055251573,0.00013483662,0.00000899105,0.0080736615,0.000103359554,0.013648506],"genre_scores_gemma":[0.99418783,0.00045538004,0.00010003992,0.0002222609,0.00006116524,0.000004045697,0.0016977933,0.000016561798,0.0032548874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995003,0.00007315205,0.000033672106,0.000066283035,0.000114529335,0.00021207679],"domain_scores_gemma":[0.99820936,0.0004739737,0.00060236524,0.00009084907,0.0002809788,0.00034247123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009226702,0.00013258007,0.00019402843,0.0012353584,0.00019016929,0.001969236,0.00024229658,0.0006337793,0.004321909],"category_scores_gemma":[0.0035660672,0.00011989923,0.00027529564,0.0013172859,0.00025462403,0.0006252424,0.00057959405,0.00059470575,0.00082595256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038653943,0.00050272973,0.63157946,0.00041029608,0.0004379366,0.0014605462,0.0006390117,0.02558987,0.0033424713,0.05498682,0.07318722,0.20399827],"study_design_scores_gemma":[0.00006631532,0.00025227806,0.9421965,0.00007326923,0.0001371353,0.00025604517,0.0004392521,0.010439956,0.003030348,0.00208331,0.040991172,0.00003442891],"about_ca_topic_score_codex":0.024994034,"about_ca_topic_score_gemma":0.012946642,"teacher_disagreement_score":0.024994034,"about_ca_system_score_codex":0.0017714176,"about_ca_system_score_gemma":0.0016190538,"threshold_uncertainty_score":0.0496971},"labels":[],"label_agreement":null},{"id":"W2081456183","doi":"10.1016/s1098-3015(10)75101-9","title":"PIN43 COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Conjugate; Vaccination; Pneumococcal vaccination; Pneumococcal conjugate vaccine; Medicine; Virology; Streptococcus pneumoniae; Microbiology; Mathematics; Biology; Antibiotics","score_opus":0.032753104143381985,"score_gpt":0.31742763592056944,"score_spread":0.28467453177718743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081456183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424697,0.017352011,0.00042775713,0.004727675,0.00040353328,0.00041610523,0.013216018,0.00010226859,0.020884808],"genre_scores_gemma":[0.9921084,0.002750723,0.00040487509,0.00044097292,0.000038523078,0.00004833503,0.001501475,0.000015594193,0.002691094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756277,0.00055521424,0.0001382297,0.00018579212,0.0007498813,0.00080818025],"domain_scores_gemma":[0.9976891,0.00056634675,0.0002524241,0.00004039941,0.0007715254,0.000680247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013660424,0.0006158703,0.0014961767,0.000933969,0.0009113238,0.0019520518,0.0011663262,0.0010040322,0.006454934],"category_scores_gemma":[0.00725495,0.00044936384,0.0026765207,0.0020120898,0.0005858238,0.0005471582,0.0007395152,0.0012756323,0.00022949051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1587738,0.0027473297,0.35694456,0.004416782,0.008357746,0.0014288739,0.000737457,0.13255161,0.0024178554,0.00893643,0.04634646,0.27634108],"study_design_scores_gemma":[0.011250554,0.006467507,0.8994094,0.00083880505,0.007025131,0.00049608765,0.0014431414,0.060409296,0.0014411671,0.001485367,0.009500829,0.0002327592],"about_ca_topic_score_codex":0.9896359,"about_ca_topic_score_gemma":0.9879958,"teacher_disagreement_score":0.071971975,"about_ca_system_score_codex":0.071971975,"about_ca_system_score_gemma":0.091399126,"threshold_uncertainty_score":0.5221957},"labels":[],"label_agreement":null},{"id":"W2081978352","doi":"10.1016/j.jval.2013.08.1903","title":"Cost-Effectiveness of Expanded Newborn Screening in Texas—Author Response to Letter to the Editor","year":2013,"lang":"en","type":"letter","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Paragraph; Medicine; Cost effectiveness; Value (mathematics); Sentence; Newborn screening; Pediatrics; Actuarial science; Family medicine; Statistics; Computer science; Artificial intelligence; Mathematics","score_opus":0.04811401227154429,"score_gpt":0.3318210681264939,"score_spread":0.28370705585494965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081978352","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074596484,0.0018242637,0.000047646205,0.9821018,0.004843051,0.000011340129,0.0003098744,0.000014714035,0.0033875445],"genre_scores_gemma":[0.13366616,0.0042313207,0.00034540694,0.82380056,0.026951738,0.000095590585,0.00035019248,0.00003392805,0.010525189],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978909,0.0011245065,0.00015116276,0.00014272438,0.00030890506,0.00038177546],"domain_scores_gemma":[0.9863347,0.009490794,0.0009882044,0.00018350307,0.0015509238,0.0014518462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032725749,0.0002794578,0.00076887594,0.00047698666,0.00090012455,0.0019738832,0.0011523861,0.010982777,0.009246069],"category_scores_gemma":[0.024698274,0.0002695231,0.000844906,0.0006629084,0.0007577058,0.00088227924,0.0007611974,0.0053154514,0.0009701637],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011391784,0.000106802145,0.008750087,0.00009697931,0.00008501045,0.0013494847,0.00010189558,0.00085379736,0.0001432447,0.0021129854,0.9669102,0.01835043],"study_design_scores_gemma":[0.0042925617,0.001605807,0.10856198,0.0030029262,0.0010897228,0.005597339,0.0033690182,0.011067332,0.0019209831,0.015139062,0.8439673,0.00038596982],"about_ca_topic_score_codex":0.025057308,"about_ca_topic_score_gemma":0.034240447,"teacher_disagreement_score":0.025057308,"about_ca_system_score_codex":0.0073754825,"about_ca_system_score_gemma":0.005796772,"threshold_uncertainty_score":0.05351311},"labels":[],"label_agreement":null},{"id":"W2082013793","doi":"10.1016/j.jval.2011.01.006","title":"Cost Utility Analysis Based on a Head-to-Head Phase 3 Trial Comparing Ustekinumab and Etanercept in Patients with Moderate-to-Severe Plaque Psoriasis: A Canadian Perspective","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Ustekinumab; Etanercept; Medicine; Psoriasis; Clinical trial; Randomized controlled trial; Population; Physical therapy; Dermatology; Internal medicine; Infliximab; Disease; Environmental health","score_opus":0.08889802513076007,"score_gpt":0.3092991665688152,"score_spread":0.22040114143805511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082013793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81213516,0.075024724,0.014406336,0.015758857,0.0007458781,0.0044163587,0.037064552,0.00021449292,0.04023366],"genre_scores_gemma":[0.9809316,0.0058055473,0.004290924,0.0015052679,0.00012902415,0.00028835688,0.004637013,0.0000349912,0.0023773033],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9950564,0.0032308628,0.00021322636,0.0002550698,0.0006735819,0.00057082745],"domain_scores_gemma":[0.99366695,0.004293101,0.0005556454,0.00014435296,0.00079777336,0.00054209615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061925934,0.0019005283,0.0038753306,0.0011602648,0.0005554251,0.0027390136,0.001744652,0.0014584936,0.0075804046],"category_scores_gemma":[0.013482158,0.0006780715,0.007935925,0.002621224,0.0007083748,0.00072220364,0.00076186174,0.0024903016,0.0002650301],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32695115,0.0017065859,0.057689387,0.0070955637,0.061277766,0.0016600912,0.00050949364,0.34070843,0.0038798233,0.019007415,0.034191944,0.14532246],"study_design_scores_gemma":[0.14330943,0.02854963,0.20770094,0.002869951,0.16000034,0.0017696304,0.0017745221,0.3924697,0.0023442227,0.02221041,0.035968605,0.0010326218],"about_ca_topic_score_codex":0.54936075,"about_ca_topic_score_gemma":0.55321807,"teacher_disagreement_score":0.45063925,"about_ca_system_score_codex":0.02847954,"about_ca_system_score_gemma":0.01967868,"threshold_uncertainty_score":0.9065863},"labels":[],"label_agreement":null},{"id":"W2082026256","doi":"10.1016/s1098-3015(10)60907-2","title":"PHP47 CHILDREN IN NEED OF PHARMACARE: ANALYSIS OF MEDICATION FUNDING REQUESTS AT THE TORONTO HOSPITAL FOR SICK CHILDREN","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sick child; Family medicine; Medicine; Business; Pediatrics","score_opus":0.08456651502037711,"score_gpt":0.4036211430551177,"score_spread":0.3190546280347406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082026256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465525,0.00032197055,0.00003481652,0.0003150113,0.0000040876635,0.000027685712,0.0032077283,0.000005051867,0.001428421],"genre_scores_gemma":[0.99672216,0.0003740009,0.00014489722,0.00013493314,0.000014674362,0.000024131185,0.0018655293,0.000006764929,0.0007129547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980666,0.0002735332,0.00019625737,0.00014548477,0.0006647874,0.0006533664],"domain_scores_gemma":[0.99425006,0.0009730974,0.0024376134,0.00013377678,0.0008967941,0.0013088026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006063273,0.00033515357,0.00035375985,0.0027974478,0.0012107522,0.0010750976,0.0005501508,0.0006628228,0.0037092613],"category_scores_gemma":[0.004342741,0.00048753657,0.00065195194,0.0060983226,0.00056053576,0.00038453468,0.00088938355,0.0007783285,0.0004195925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008304801,0.000019625302,0.99561405,0.00004119491,0.00003225138,0.00071786984,0.0008449411,0.000074125746,0.00015594106,0.00006779778,0.0008188314,0.0015304051],"study_design_scores_gemma":[0.000003033246,0.000029245919,0.9984812,0.000009883519,0.000011643001,0.00020380631,0.0008232753,0.00006542168,0.00004614528,0.0000044720864,0.00031845403,0.0000033793735],"about_ca_topic_score_codex":0.55964303,"about_ca_topic_score_gemma":0.6474118,"teacher_disagreement_score":0.44035697,"about_ca_system_score_codex":0.0077407337,"about_ca_system_score_gemma":0.008198213,"threshold_uncertainty_score":0.8859006},"labels":[],"label_agreement":null},{"id":"W2082478455","doi":"10.1016/s1098-3015(10)72646-2","title":"PMS60 UTILIZING HEALTH SURVEY AND ADMINISTRATIVE DATA TO ESTIMATE THE BURDEN OF OSTEO-ARTHRITIS IN ONTARIO","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Survey data collection; Environmental health; Medicine; Business; Statistics; Mathematics","score_opus":0.31362382286303836,"score_gpt":0.5164293495869549,"score_spread":0.2028055267239165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082478455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98508495,0.00017353115,0.00027376256,0.000232394,0.000006280918,0.00008089034,0.01153534,0.000019290914,0.0025935317],"genre_scores_gemma":[0.9895236,0.00021777458,0.0006493381,0.000052504496,0.000008272308,0.000053770113,0.007794031,0.0000074388427,0.0016933765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989122,0.00016810607,0.00011790619,0.00011406562,0.00046478916,0.000223017],"domain_scores_gemma":[0.9978504,0.0002618426,0.00069948327,0.00012856886,0.00080995896,0.0002498334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012055252,0.00035895265,0.00038492895,0.0014229551,0.0008897688,0.00088443153,0.0006776978,0.00032354626,0.0015434009],"category_scores_gemma":[0.0052781436,0.00042835195,0.00079210836,0.0040890793,0.00037298707,0.00040414536,0.00091476494,0.00028866643,0.00024256932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012004096,0.00003654993,0.99161166,0.00004546631,0.00012416912,0.000047720547,0.00035474298,0.0008796626,0.00011829864,0.00013310368,0.001717544,0.0048109386],"study_design_scores_gemma":[0.000015555179,0.000013494239,0.99784577,0.000007734138,0.000024149544,0.000009961564,0.00022598416,0.0010469825,0.000024424822,0.000022757515,0.00075951085,0.000003687041],"about_ca_topic_score_codex":0.98914206,"about_ca_topic_score_gemma":0.9921687,"teacher_disagreement_score":0.01596764,"about_ca_system_score_codex":0.01596764,"about_ca_system_score_gemma":0.020165838,"threshold_uncertainty_score":0.115853846},"labels":[],"label_agreement":null},{"id":"W2082533143","doi":"10.1016/j.jval.2013.03.259","title":"Methodological challenges in mapping a disease specific psychometric instrument to a disease specific utility instrument: The effect of alternate utility transformations and within-instrument sub-scale correlations on model fit","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Public Health","funders":"","keywords":"Statistics; Regression; Linear regression; Mean squared error; Scale (ratio); Regression analysis; Goodness of fit; Correlation; Bayesian multivariate linear regression; Mathematics; Computer science; Cartography","score_opus":0.6579624753232105,"score_gpt":0.416521617926628,"score_spread":0.2414408573965825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082533143","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13608952,0.0009849966,0.8548566,0.0028821775,0.00046986114,0.00107676,0.00063964975,0.00031989577,0.0026805908],"genre_scores_gemma":[0.72307384,0.0003145253,0.2711572,0.0010071417,0.0001427461,0.0027361833,0.00063758716,0.0003897418,0.00054105517],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.612354,0.34643283,0.01776844,0.011357304,0.010948684,0.0011387478],"domain_scores_gemma":[0.34978995,0.5526588,0.014312583,0.066956796,0.015320574,0.0009613834],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.35215914,0.0013149868,0.0019900932,0.0018301053,0.0023224354,0.0061338753,0.003369758,0.0020509886,0.0019327465],"category_scores_gemma":[0.68641275,0.0014927833,0.0035827104,0.004402173,0.0055605066,0.0044678967,0.005228616,0.0067472043,0.0006307813],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002402235,0.0010913181,0.3805769,0.0020330045,0.0070902733,0.00094852265,0.017495811,0.08645705,0.0035097015,0.18523785,0.011777118,0.30138016],"study_design_scores_gemma":[0.0010970453,0.0015820912,0.2009471,0.0015383001,0.0021560735,0.0018724852,0.006562352,0.27537915,0.0075750034,0.48460728,0.016071642,0.00061157387],"about_ca_topic_score_codex":0.0049721836,"about_ca_topic_score_gemma":0.005014591,"teacher_disagreement_score":0.35215914,"about_ca_system_score_codex":0.0019363334,"about_ca_system_score_gemma":0.004753794,"threshold_uncertainty_score":0.7989031},"labels":[],"label_agreement":null},{"id":"W2082535293","doi":"10.1016/j.jval.2012.03.1306","title":"PIN30 Economic Evaluation of a Cluster Randomized Controlled Trial of an Influenza Immunization Program Directed at Healthy Children","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Herd immunity; Randomized controlled trial; Immunization; Vaccination; Population; Herd; Cost effectiveness; Environmental health; Demography; Immunology; Internal medicine; Veterinary medicine","score_opus":0.10687086818048355,"score_gpt":0.44761079756559446,"score_spread":0.3407399293851109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082535293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9215131,0.014529634,0.007219096,0.0035139744,0.0026988918,0.03157376,0.006283702,0.00053105294,0.012136926],"genre_scores_gemma":[0.97707784,0.002026303,0.004479939,0.0010372167,0.00030437807,0.010976836,0.0013649419,0.000034179142,0.0026982483],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.98697937,0.010285284,0.0005733865,0.0007959272,0.0006885945,0.0006774064],"domain_scores_gemma":[0.9901765,0.0062632984,0.0014164433,0.0006409979,0.0005723532,0.00093043165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009573622,0.0025561822,0.004249146,0.0010369819,0.00071414816,0.0014045815,0.0016811019,0.0028946951,0.0155690685],"category_scores_gemma":[0.017792702,0.0012547385,0.007509074,0.0009800722,0.0015861153,0.0013408535,0.0011566448,0.0044697225,0.00087043084],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98229074,0.0023072287,0.00025590035,0.0014158905,0.0037553916,0.000028581379,0.000023568835,0.001113384,0.00024071915,0.00024457526,0.0005012881,0.007822613],"study_design_scores_gemma":[0.9629202,0.031028382,0.0009725612,0.0001495503,0.0025084617,0.000013611963,0.00002437031,0.0015161287,0.00018117724,0.00027387775,0.000389593,0.000022141983],"about_ca_topic_score_codex":0.008341697,"about_ca_topic_score_gemma":0.005708773,"teacher_disagreement_score":0.0155690685,"about_ca_system_score_codex":0.0029812013,"about_ca_system_score_gemma":0.0041085477,"threshold_uncertainty_score":0.05208367},"labels":[],"label_agreement":null},{"id":"W2082690813","doi":"10.1016/j.jval.2013.08.1319","title":"Validity of Self-Reported Dose of Patients Using Wafarin in Clinical Practice","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Warfarin; Medicine; Concordance; Atrial fibrillation; Internal medicine; Prospective cohort study; Therapeutic index; Cohort; Oral anticoagulant; Clinical trial; Drug","score_opus":0.1972261527360083,"score_gpt":0.4797327177595128,"score_spread":0.2825065650235045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082690813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580514,0.0005970056,0.00022169703,0.00016731361,0.000018494804,0.000049400493,0.00017304042,0.000008290365,0.002959492],"genre_scores_gemma":[0.9990115,0.00016370125,0.00042098432,0.00007549863,0.0000105225345,0.000023013135,0.000104181745,0.0000032487276,0.00018733123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940739,0.0025491875,0.00090929016,0.00040776184,0.001868073,0.0001917619],"domain_scores_gemma":[0.94284016,0.035712607,0.013273802,0.0027143226,0.0040343422,0.0014248553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005405303,0.00021079139,0.0006798736,0.001432319,0.0004458213,0.0011650521,0.00059615605,0.0009485382,0.0011126795],"category_scores_gemma":[0.0570105,0.00026949585,0.0005400224,0.0010119501,0.00075853226,0.0010226911,0.0006549909,0.0008897603,0.00024938062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003040848,0.000279148,0.98757964,0.00006828235,0.00013824941,0.00003490992,0.0007892645,0.000060152914,0.0003020005,0.000055782115,0.00009500566,0.010293578],"study_design_scores_gemma":[0.000035815778,0.0010285573,0.9957781,0.00006368859,0.00009681324,0.00030012045,0.0007841297,0.0007272983,0.0005235182,0.000104807834,0.000542295,0.000014918824],"about_ca_topic_score_codex":0.0018659045,"about_ca_topic_score_gemma":0.0023334248,"teacher_disagreement_score":0.005405303,"about_ca_system_score_codex":0.00057014235,"about_ca_system_score_gemma":0.0007348792,"threshold_uncertainty_score":0.028586328},"labels":[],"label_agreement":null},{"id":"W2082760996","doi":"10.1111/j.1524-4733.2007.00206.x","title":"Prices for Innovative Pharmaceutical Products That Provide Health Gain: A Comparison Between Australia and the United States","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Drug prices; Quarter (Canadian coin); Public economics; Business; Food and drug administration; Constraint (computer-aided design); Economics; Agricultural economics; Monetary economics","score_opus":0.7125117756802034,"score_gpt":0.5351256106638428,"score_spread":0.17738616501636062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082760996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9712697,0.007291702,0.0007904446,0.0029155058,0.00011524864,0.000042355936,0.0006236239,0.000019123316,0.016932279],"genre_scores_gemma":[0.99677116,0.0009271211,0.00033165325,0.00027022325,0.00002693247,0.000010298619,0.00025343883,0.0000074058853,0.0014016317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982401,0.00046911102,0.00011267526,0.00010879779,0.00089983596,0.00016937676],"domain_scores_gemma":[0.9932653,0.00274959,0.0017597609,0.00013390134,0.0015950988,0.00049643934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019655996,0.00016365388,0.00046670547,0.001813633,0.0004893552,0.0023653936,0.00040181895,0.00070691475,0.0027748698],"category_scores_gemma":[0.012596206,0.0002401984,0.0009860444,0.0021073811,0.0006377469,0.0013393965,0.0008873969,0.0010193052,0.00019198388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011167266,0.0010571588,0.545191,0.0016255374,0.0018578611,0.001733018,0.0049682446,0.015453698,0.0061799376,0.06342945,0.027890211,0.31944662],"study_design_scores_gemma":[0.00033522872,0.0009022546,0.96220684,0.00018695623,0.00049242965,0.0007924001,0.0017723489,0.011590395,0.001036233,0.0031018155,0.01751798,0.000064978565],"about_ca_topic_score_codex":0.046698216,"about_ca_topic_score_gemma":0.060599755,"teacher_disagreement_score":0.046698216,"about_ca_system_score_codex":0.004723785,"about_ca_system_score_gemma":0.0012556871,"threshold_uncertainty_score":0.09285277},"labels":[],"label_agreement":null},{"id":"W2083054115","doi":"10.1016/j.jval.2013.08.1912","title":"Pulse Pressure and Stroke Risk: Development and Validation of a Stroke Risk Equation","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Stroke (engine); Blood pressure; Risk factor; Pulse pressure; Internal medicine; Proportional hazards model; Cardiology; Physical therapy","score_opus":0.028986974064044588,"score_gpt":0.2849339085897046,"score_spread":0.25594693452566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083054115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74055403,0.0008414161,0.24500838,0.0016037397,0.00034258625,0.0024186564,0.002920879,0.00071656535,0.0055936365],"genre_scores_gemma":[0.8114873,0.00045942058,0.1827398,0.00018832245,0.00008160154,0.0015706272,0.0020789201,0.00008853068,0.0013054266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99277025,0.003113382,0.0008445074,0.00071430585,0.0023914238,0.00016608051],"domain_scores_gemma":[0.9787153,0.012626711,0.0014148225,0.0017511771,0.0052373135,0.00025459204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018924056,0.00068402465,0.0008290886,0.0018666213,0.0006599976,0.0017880669,0.0013690653,0.0011332964,0.0011548151],"category_scores_gemma":[0.044982754,0.00071705156,0.0014580388,0.0013609547,0.0005536415,0.0010721097,0.0016980554,0.0021245629,0.00043222873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051527674,0.0016067553,0.8265093,0.00016691406,0.00096387806,0.000110362285,0.00092167495,0.009054027,0.0019518298,0.0049597193,0.0032539386,0.14998637],"study_design_scores_gemma":[0.0007777423,0.0013623826,0.71435916,0.00038659672,0.0019018181,0.00066253514,0.0005350534,0.25802007,0.007745451,0.005444886,0.0086916145,0.000112746435],"about_ca_topic_score_codex":0.007399119,"about_ca_topic_score_gemma":0.0064965645,"teacher_disagreement_score":0.018924056,"about_ca_system_score_codex":0.0009246948,"about_ca_system_score_gemma":0.003225937,"threshold_uncertainty_score":0.100081205},"labels":[],"label_agreement":null},{"id":"W2083428221","doi":"10.1016/j.jval.2014.03.886","title":"Developing A Population-Based Palliative And End-Of-Life Care Decision-Analytic Policy Model","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Public Health Ontario; Sunnybrook Hospital; Toronto Public Health","funders":"","keywords":"Palliative care; Medicine; End-of-life care; Population; Cohort; Health care; Psychological intervention; Population health; Quality of life (healthcare); Gerontology; Nursing; Environmental health","score_opus":0.1948322112482882,"score_gpt":0.45928779008196297,"score_spread":0.26445557883367476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083428221","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058675744,0.00022404123,0.90263444,0.013456653,0.00012446889,0.0009282841,0.0010554893,0.00024489782,0.022656016],"genre_scores_gemma":[0.684946,0.00033861477,0.30598947,0.0010767026,0.00013631054,0.0016596459,0.00077820616,0.000054623124,0.0050204606],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99284184,0.0051533943,0.00023675269,0.00065722066,0.00061510317,0.0004957239],"domain_scores_gemma":[0.9819402,0.015575083,0.000546237,0.00034538982,0.0010469707,0.0005462008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0139994,0.0008497451,0.0015542014,0.0026079684,0.0011503531,0.005140099,0.0030552389,0.00329282,0.0089706555],"category_scores_gemma":[0.030195419,0.0010139148,0.0014250645,0.0028589214,0.0015203658,0.0049933805,0.0028290248,0.0035348127,0.00076564134],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015173295,0.00044077312,0.0054534078,0.00009350725,0.00020171021,0.00025462778,0.00045911176,0.6694515,0.0001833215,0.29936093,0.0029064987,0.021043],"study_design_scores_gemma":[0.00006317215,0.000044680695,0.00035688916,0.000024122077,0.00004703617,0.000052333755,0.0002589838,0.86443913,0.000074390344,0.13287036,0.0017514282,0.000017469134],"about_ca_topic_score_codex":0.017290791,"about_ca_topic_score_gemma":0.012045088,"teacher_disagreement_score":0.017290791,"about_ca_system_score_codex":0.0065907207,"about_ca_system_score_gemma":0.008175458,"threshold_uncertainty_score":0.07403678},"labels":[],"label_agreement":null},{"id":"W2083448577","doi":"10.1016/s1098-3015(10)72690-5","title":"PND28 CROSS CULTURAL EVALUATION OF THE SHORT FORM 8 ITEM PARKINSON'S DISEASE QUESTIONNAIRE: RESULTS FROM AMERICA, CANADA, JAPAN, ITALY AND SPAIN","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Parkinson's disease; Disease; Geography; Medicine; Psychology; Gerontology; Demography; Family medicine; Sociology; Pathology","score_opus":0.03256228623691846,"score_gpt":0.3183591899501326,"score_spread":0.28579690371321415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083448577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956422,0.0005283923,0.0001140582,0.000088244495,0.000031482916,0.00007644138,0.0012073395,0.000004688174,0.0023071875],"genre_scores_gemma":[0.9964199,0.0004459013,0.00023581622,0.000089463065,0.000012403429,0.00006861367,0.0019327183,0.000008741612,0.00078652904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834144,0.0005069241,0.00015973604,0.00019116187,0.00059305236,0.00020770065],"domain_scores_gemma":[0.9964347,0.0005863683,0.00039017343,0.00014101919,0.0019357224,0.0005119761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030154267,0.0006112019,0.00066675793,0.001025419,0.0008023737,0.0007729616,0.0004773244,0.00036487554,0.0008987636],"category_scores_gemma":[0.0056428076,0.00022606096,0.001033585,0.0019131866,0.00061883166,0.00040646904,0.0011093926,0.0005955305,0.00023686506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060201675,0.00020376501,0.98438543,0.000080288955,0.00039637636,0.00012328988,0.001969221,0.00025137447,0.0003861437,0.000047767837,0.0009393025,0.010614984],"study_design_scores_gemma":[0.000044148524,0.00011074969,0.99760085,0.000020127185,0.000069783164,0.000055428754,0.00120725,0.00010624752,0.000092161135,0.000013319519,0.00067102077,0.000008942345],"about_ca_topic_score_codex":0.28720626,"about_ca_topic_score_gemma":0.32800546,"teacher_disagreement_score":0.7127937,"about_ca_system_score_codex":0.002195953,"about_ca_system_score_gemma":0.0024444715,"threshold_uncertainty_score":0.57106906},"labels":[],"label_agreement":null},{"id":"W2083802324","doi":"10.1016/j.jval.2013.03.1495","title":"Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Dabigatran; Warfarin; Medicine; Cochrane Library; Cost effectiveness; Atrial fibrillation; MEDLINE; Intensive care medicine; Systematic review; Meta-analysis; Emergency medicine; Internal medicine; Risk analysis (engineering)","score_opus":0.5688434990308752,"score_gpt":0.5244889395306325,"score_spread":0.044354559500242696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083802324","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01342525,0.9821937,0.0007021345,0.00041613012,0.0002866797,0.00072441716,0.0016293123,0.000025282206,0.0005971403],"genre_scores_gemma":[0.33857474,0.6526734,0.0036887561,0.0013729763,0.00032598033,0.0014208835,0.0016067158,0.000042458763,0.00029401967],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96796876,0.015421012,0.01089095,0.0017222745,0.0034758549,0.0005212311],"domain_scores_gemma":[0.9350565,0.047710456,0.011676106,0.0013377947,0.003667066,0.0005520322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021844406,0.0021143158,0.014351598,0.0075619556,0.00059728953,0.0028015145,0.0018483592,0.0017467105,0.0034495706],"category_scores_gemma":[0.08917454,0.0016616953,0.024918647,0.00789904,0.0011830955,0.0021078836,0.0018141554,0.0025624572,0.00018692971],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005579737,0.000044060536,0.00379081,0.50768495,0.4561719,0.000135668,0.00014935156,0.00071114104,0.00022164613,0.00030894994,0.001086434,0.024115426],"study_design_scores_gemma":[0.0048929434,0.00068880554,0.01004312,0.081653886,0.8968272,0.00025763165,0.00014541122,0.00030935046,0.00020373522,0.0004716732,0.004459205,0.000046948608],"about_ca_topic_score_codex":0.013345501,"about_ca_topic_score_gemma":0.03481104,"teacher_disagreement_score":0.021844406,"about_ca_system_score_codex":0.0065897717,"about_ca_system_score_gemma":0.007312692,"threshold_uncertainty_score":0.1155256},"labels":[],"label_agreement":null},{"id":"W2083812156","doi":"10.1111/j.1524-4733.2004.74005.x","title":"Cost–Utility of Adjuvant High-Dose Interferon Alpha Therapy in Stage III Cutaneous Melanoma in Quebec","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Watchful waiting; Melanoma; Adjuvant; Population; Adjuvant therapy; Alpha interferon; Demography; Internal medicine; Oncology; Interferon; Immunology; Cancer; Environmental health","score_opus":0.04530097712677076,"score_gpt":0.3087643641052053,"score_spread":0.2634633869784345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083812156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98694104,0.0042734663,0.00023886077,0.0019972234,0.00003365502,0.00006199002,0.0013757291,0.00001581687,0.0050622215],"genre_scores_gemma":[0.9981875,0.00048361663,0.00014945104,0.00008857866,0.0000076052406,0.0000100268435,0.00023018036,0.0000018574507,0.0008411766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956805,0.00020517783,0.000018348092,0.000025013873,0.00006363275,0.00011973476],"domain_scores_gemma":[0.999116,0.00026318527,0.00014117431,0.000014908398,0.00020257861,0.0002621887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061336637,0.00017344819,0.000291564,0.0003822265,0.00044465688,0.0007176997,0.00047251963,0.0004059637,0.002867415],"category_scores_gemma":[0.002355398,0.00008399572,0.0004758366,0.0006304874,0.0002547894,0.00020300322,0.00025269893,0.0003823874,0.00010476662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008945758,0.00085994217,0.7792695,0.00034824203,0.00065880216,0.0012569276,0.00020825255,0.03782501,0.0020113536,0.0012258021,0.009427528,0.1579628],"study_design_scores_gemma":[0.00058643037,0.0017382568,0.9570412,0.00020767745,0.0004728635,0.0004129761,0.00050997006,0.03425523,0.0004452261,0.00028978847,0.0040072817,0.00003317801],"about_ca_topic_score_codex":0.92260045,"about_ca_topic_score_gemma":0.9482011,"teacher_disagreement_score":0.07739955,"about_ca_system_score_codex":0.023228133,"about_ca_system_score_gemma":0.010420123,"threshold_uncertainty_score":0.16853267},"labels":[],"label_agreement":null},{"id":"W2083835995","doi":"10.1016/j.jval.2013.03.947","title":"Costs and health care resource utilization associated with asthma in canada: A systematic review","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Asthma; Medicine; Emergency department; Asthma medication; Asthma management; Health care; MEDLINE; Emergency medicine; Pediatrics; Family medicine; Internal medicine; Psychiatry","score_opus":0.20392814923903718,"score_gpt":0.46536707099998215,"score_spread":0.26143892176094496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083835995","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040532122,0.99379855,0.000046587007,0.00031948093,0.0000776975,0.000090288544,0.001318702,0.0000054499997,0.00029000876],"genre_scores_gemma":[0.049085703,0.94921815,0.00042131275,0.0005118813,0.000061459126,0.00009924655,0.00047861793,0.0000043448645,0.0001192801],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953377,0.000756573,0.0015430334,0.00037624937,0.0016854383,0.00030086414],"domain_scores_gemma":[0.9843305,0.00812327,0.0040931846,0.00021474052,0.0027405138,0.0004977819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00415176,0.0011475086,0.005596967,0.011471501,0.0010719401,0.0030870067,0.0018022174,0.0015219251,0.002867929],"category_scores_gemma":[0.029903725,0.0010093543,0.009313043,0.020219935,0.0009535758,0.001189698,0.0015215338,0.001545222,0.000101841615],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007197699,0.000112514754,0.047456462,0.76847774,0.06369291,0.00035901307,0.00047162964,0.00067931286,0.00012285507,0.0005316983,0.009960348,0.107415766],"study_design_scores_gemma":[0.00082721777,0.00026724607,0.17218685,0.4864691,0.2999643,0.00095860194,0.001342525,0.0006244637,0.00020127748,0.00063599943,0.03631089,0.00021156698],"about_ca_topic_score_codex":0.6331788,"about_ca_topic_score_gemma":0.83019704,"teacher_disagreement_score":0.9813534,"about_ca_system_score_codex":0.018646605,"about_ca_system_score_gemma":0.048421025,"threshold_uncertainty_score":0.737963},"labels":[],"label_agreement":null},{"id":"W2083869330","doi":"10.1016/j.jval.2011.02.741","title":"PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Internal medicine; Placebo; Population; Physical therapy; Clinical trial; Methotrexate; Visual analogue scale; Etanercept","score_opus":0.38332310201543657,"score_gpt":0.5059408522909685,"score_spread":0.12261775027553196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083869330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658689,0.016511228,0.009606074,0.0004862804,0.00030402624,0.00052490394,0.003026852,0.0001488731,0.003522956],"genre_scores_gemma":[0.9947484,0.0008794062,0.0016301008,0.00020573758,0.00016289281,0.00021162341,0.0017078986,0.0000487571,0.00040502902],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97059387,0.020556299,0.002210201,0.002707037,0.0033387016,0.00059382775],"domain_scores_gemma":[0.94199747,0.040665023,0.010190024,0.004986933,0.0015826548,0.0005779366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041081496,0.0011886786,0.0038917104,0.0013941309,0.00047753967,0.0020810657,0.0008537548,0.0012305008,0.002725697],"category_scores_gemma":[0.04858469,0.0006719041,0.0062451935,0.0015002649,0.0010546156,0.0015222578,0.0016063146,0.0019382142,0.00047980895],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19166751,0.0006009039,0.550928,0.0025894046,0.13952446,0.00027353034,0.00043998112,0.0058143544,0.008492505,0.0008027471,0.0028135169,0.09605314],"study_design_scores_gemma":[0.023372333,0.022861743,0.84327465,0.00025395563,0.0857908,0.00097251404,0.00020640877,0.010534038,0.005006238,0.0022528577,0.0053159907,0.00015840345],"about_ca_topic_score_codex":0.00037856103,"about_ca_topic_score_gemma":0.000540993,"teacher_disagreement_score":0.041081496,"about_ca_system_score_codex":0.00035167873,"about_ca_system_score_gemma":0.00060353905,"threshold_uncertainty_score":0.21726233},"labels":[],"label_agreement":null},{"id":"W2084102355","doi":"10.1016/j.jval.2014.08.1582","title":"A Utility Algorithm forthe Pressure Ulcer Quality of Life – Utility Instrument (Puqol-Ui)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"EQ-5D; Valuation (finance); Quality-adjusted life year; Medicine; Quality of life (healthcare); Population; Health care; Predictive validity; Economic evaluation; Criterion validity; Actuarial science; Econometrics; Construct validity; Cost effectiveness; Psychometrics; Mathematics; Risk analysis (engineering); Clinical psychology; Environmental health; Economics; Health related quality of life; Nursing","score_opus":0.4302763309359921,"score_gpt":0.4269512398961211,"score_spread":0.0033250910398709976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084102355","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004626248,0.00016535116,0.9912196,0.0005013535,0.00004545115,0.0004754732,0.0005619559,0.0005619894,0.0018425711],"genre_scores_gemma":[0.0748412,0.00020485342,0.9200972,0.00016370621,0.00003872517,0.00093476695,0.0012225988,0.00013310403,0.0023638294],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976738,0.0011285148,0.00021369227,0.0003362369,0.00050327694,0.00014435044],"domain_scores_gemma":[0.99755186,0.0012373567,0.000119732686,0.000171473,0.0008635581,0.00005601738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054311585,0.0009825302,0.0009809331,0.00215275,0.00068328454,0.0028325256,0.0013591754,0.0012298586,0.008103662],"category_scores_gemma":[0.013617056,0.00046418427,0.0011438428,0.0017794135,0.0004508924,0.0020478638,0.001840617,0.0017711543,0.0017529941],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025886027,0.00036067175,0.0074838265,0.00024431574,0.00012390484,0.0001535208,0.00023056843,0.0888508,0.0017421081,0.12688307,0.023790333,0.74987805],"study_design_scores_gemma":[0.00016709814,0.0001333837,0.0025382522,0.00014634673,0.00006739391,0.00031691155,0.000107869586,0.80018145,0.0034803601,0.17161196,0.021199217,0.000049760445],"about_ca_topic_score_codex":0.0024753863,"about_ca_topic_score_gemma":0.0018134235,"teacher_disagreement_score":0.008103662,"about_ca_system_score_codex":0.0011822167,"about_ca_system_score_gemma":0.0018140483,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2084263669","doi":"10.1016/j.jval.2014.03.1364","title":"Values Of The Canadian Public Towards Pharmaceutical Reimbursement Decisions","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reimbursement; Equity (law); Actuarial science; Population; Socioeconomic status; Pairwise comparison; Disease; Analytic hierarchy process; Public health; Medicine; Public economics; Environmental health; Business; Health care; Operations research; Economics; Statistics; Political science; Mathematics; Economic growth; Nursing","score_opus":0.6291567395035133,"score_gpt":0.4772411318254326,"score_spread":0.15191560767808066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084263669","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12678821,0.010466906,0.002575884,0.45668072,0.0008342148,0.00010137382,0.0014937106,0.00005265217,0.4010064],"genre_scores_gemma":[0.9747552,0.0032090377,0.00070972956,0.013865297,0.0004071951,0.000016893096,0.00019922547,0.000019878658,0.0068175863],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9683279,0.009361572,0.00068899745,0.00089340017,0.015870642,0.004857472],"domain_scores_gemma":[0.9223961,0.025397675,0.0035145117,0.0014127713,0.03997508,0.00730383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01936089,0.00039489003,0.0006301047,0.0045515485,0.0074702003,0.018943675,0.0014469925,0.0049648993,0.006126569],"category_scores_gemma":[0.10246809,0.00036381025,0.00066370843,0.005664268,0.009084591,0.0026251888,0.0023474935,0.0060809567,0.00030671584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006632871,0.0001426658,0.05900214,0.0003797047,0.0003676656,0.000611679,0.009039508,0.0077464706,0.00045801283,0.6382644,0.16022924,0.123095185],"study_design_scores_gemma":[0.00028378886,0.00013872072,0.16697995,0.0024808906,0.0006327728,0.0004504537,0.023391925,0.012767532,0.001461148,0.28949848,0.5011619,0.00075233256],"about_ca_topic_score_codex":0.97014195,"about_ca_topic_score_gemma":0.973055,"teacher_disagreement_score":0.17117569,"about_ca_system_score_codex":0.17117569,"about_ca_system_score_gemma":0.17200635,"threshold_uncertainty_score":0.96131873},"labels":[],"label_agreement":null},{"id":"W2084408716","doi":"10.1016/j.jval.2011.08.106","title":"PMD34 Cost Effectivness of Ambulatory Cardiac Monitor versus Holter","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Implantable loop recorder; Ambulatory; Medicine; Atrial fibrillation; Holter monitor; Ambulatory ECG; Stroke (engine); Probabilistic logic; Emergency medicine; Medical emergency; Cardiology; Computer science; Electrocardiography; Internal medicine; Engineering; Artificial intelligence","score_opus":0.08720318173375785,"score_gpt":0.3638927683078665,"score_spread":0.27668958657410864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084408716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98169726,0.003933229,0.0017395488,0.0015420236,0.0003765861,0.00014391409,0.0020041035,0.00010619698,0.0084571475],"genre_scores_gemma":[0.997834,0.0002887033,0.0004481886,0.00016633618,0.00012426796,0.00003120081,0.00032883405,0.000009598742,0.000768892],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987802,0.0007112528,0.000077815406,0.00013240824,0.00014104492,0.00015723058],"domain_scores_gemma":[0.9954364,0.003419108,0.00044960706,0.00018536461,0.00011324025,0.00039638314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014248786,0.00045348518,0.0012508061,0.00054299925,0.00018960096,0.0009691936,0.00043282576,0.00071537524,0.016827282],"category_scores_gemma":[0.009341366,0.00016224386,0.0021484862,0.00044376787,0.00032351018,0.0007385608,0.0005705786,0.0013679648,0.00046904155],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60467494,0.0041964725,0.061247714,0.00091976504,0.0029752369,0.00038646703,0.000104350176,0.010531511,0.0042719194,0.0033396278,0.005089848,0.3022622],"study_design_scores_gemma":[0.056513473,0.18727186,0.6476708,0.00093982887,0.010566537,0.002044887,0.000643975,0.06218168,0.012663096,0.008585727,0.010696723,0.00022124905],"about_ca_topic_score_codex":0.0016102593,"about_ca_topic_score_gemma":0.0014048952,"teacher_disagreement_score":0.016827282,"about_ca_system_score_codex":0.0007997893,"about_ca_system_score_gemma":0.00056742004,"threshold_uncertainty_score":0.05629289},"labels":[],"label_agreement":null},{"id":"W2084435843","doi":"10.1016/j.jval.2014.03.1318","title":"Increasing Bariatric Procedure Volume In British Columbia, CanadaA Budget Impact Analysis Over 10 Years","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Activity-based costing; Health care; Population health; Health economics; Population; Obesity; Emergency medicine; Surgery; Environmental health; Public health; Accounting; Nursing; Business; Economics","score_opus":0.09675279162230384,"score_gpt":0.3563918498950329,"score_spread":0.2596390582727291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084435843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8885426,0.010632909,0.0002884503,0.00861928,0.00017161014,0.00013041262,0.076792315,0.00008652288,0.014735952],"genre_scores_gemma":[0.9582956,0.007102795,0.00043051402,0.0009571683,0.00004084233,0.00007079504,0.020486152,0.000029847139,0.012586289],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99740356,0.00020625998,0.0002464069,0.0002235532,0.0009726929,0.00094750646],"domain_scores_gemma":[0.99153733,0.000551586,0.0013067606,0.00015788907,0.0044760564,0.00197047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012327689,0.00045601738,0.0006742098,0.0039532813,0.002010676,0.0026973202,0.0017421916,0.0012018849,0.005036761],"category_scores_gemma":[0.00847133,0.00058370276,0.0015256556,0.010450416,0.0006343494,0.0008164292,0.0012140006,0.0015548932,0.00036684948],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094045163,0.00023516652,0.90687877,0.0004954233,0.00070656376,0.0004465744,0.00057294226,0.0063232942,0.00031239385,0.0013985401,0.03863029,0.043059625],"study_design_scores_gemma":[0.00005097893,0.000033164968,0.9914008,0.00018365015,0.00014990073,0.00007527576,0.00090274034,0.0013886048,0.00009085864,0.00007293639,0.005618459,0.000032601354],"about_ca_topic_score_codex":0.9985728,"about_ca_topic_score_gemma":0.99924016,"teacher_disagreement_score":0.1048535,"about_ca_system_score_codex":0.1048535,"about_ca_system_score_gemma":0.10606404,"threshold_uncertainty_score":0.760769},"labels":[],"label_agreement":null},{"id":"W2084509185","doi":"10.1111/j.1524-4733.2007.00247.x","title":"Comparison of Persistence Rates with Angiotensin-Converting Enzyme Inhibitors Used in Secondary and Primary Prevention of Cardiovascular Disease","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Quinapril; Medicine; Ramipril; Enalapril; Fosinopril; Cohort; Internal medicine; Lisinopril; Dyslipidemia; ACE inhibitor; Angiotensin-converting enzyme; Disease; Blood pressure","score_opus":0.08006682659150459,"score_gpt":0.3360284285008638,"score_spread":0.2559616019093592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084509185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885404,0.0004138766,0.00007562205,0.000049483362,0.000007706089,0.000009690307,0.00021365164,0.0000048344755,0.0003711693],"genre_scores_gemma":[0.9994211,0.00012802234,0.000055411292,0.000020288711,0.000011691162,0.000006574906,0.00022143326,0.0000026088376,0.00013289994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980617,0.00074553257,0.0002795667,0.00022780933,0.0004255974,0.0002597534],"domain_scores_gemma":[0.9867143,0.007434306,0.0033653448,0.00081486715,0.00079113594,0.00088001584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030625504,0.00018509246,0.0010330288,0.0010116507,0.00035967422,0.0006592916,0.000489268,0.0007973881,0.0017443582],"category_scores_gemma":[0.015236683,0.0002597876,0.0015669551,0.0013401239,0.00024863015,0.0007610625,0.0003963779,0.00091892,0.0001586167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007727503,0.00036239083,0.9806793,0.00006371902,0.00048018602,0.00007461602,0.00018946995,0.00012058451,0.0002709674,0.000044285876,0.000110879584,0.0098762065],"study_design_scores_gemma":[0.00015343832,0.0018733713,0.99661773,0.000011944882,0.0002469368,0.00021560572,0.00017437086,0.00042212885,0.00013680484,0.000034704597,0.00010605489,0.0000068997447],"about_ca_topic_score_codex":0.0025255159,"about_ca_topic_score_gemma":0.0020736884,"teacher_disagreement_score":0.0030625504,"about_ca_system_score_codex":0.0003645108,"about_ca_system_score_gemma":0.0005004444,"threshold_uncertainty_score":0.01619649},"labels":[],"label_agreement":null},{"id":"W2084578199","doi":"10.1016/j.jval.2011.02.430","title":"PUK15 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Therapeutic Uses of Natural Elements","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Kingston General Hospital; St. Paul's Hospital; Queen's University; University of Toronto; Dalhousie University","funders":"","keywords":"Hyperphosphatemia; Medicine; Lanthanum carbonate; Sevelamer; Internal medicine; Dialysis; Urology; Kidney disease","score_opus":0.13749410801536666,"score_gpt":0.40339003614109176,"score_spread":0.2658959281257251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084578199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5138751,0.15779892,0.002483092,0.15306303,0.0011017141,0.0005317972,0.029518526,0.00013542497,0.1414923],"genre_scores_gemma":[0.9632053,0.024031762,0.002198142,0.0032767123,0.00040994133,0.000055746244,0.0030147017,0.000030680076,0.0037769745],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99675494,0.0008474185,0.0002248712,0.00015304786,0.0012692603,0.0007504598],"domain_scores_gemma":[0.9950511,0.0010362322,0.00048491234,0.000055288143,0.0022395595,0.0011329373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022038512,0.0005661198,0.001111673,0.0017179021,0.0011713783,0.0033693977,0.0012043059,0.0012967718,0.0073540476],"category_scores_gemma":[0.009298967,0.00028898643,0.0026698795,0.003357847,0.0006515023,0.00064384576,0.0007615373,0.0015946855,0.00020432739],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02432578,0.0010141412,0.23924635,0.009273443,0.015311445,0.0017711244,0.0010550682,0.057515554,0.0038462407,0.060463846,0.094303265,0.49187377],"study_design_scores_gemma":[0.007524056,0.002930938,0.7435371,0.0072230976,0.019854048,0.002591708,0.0033676177,0.044459563,0.0022763798,0.014480049,0.15100694,0.0007483991],"about_ca_topic_score_codex":0.9453106,"about_ca_topic_score_gemma":0.95618093,"teacher_disagreement_score":0.065233104,"about_ca_system_score_codex":0.065233104,"about_ca_system_score_gemma":0.08956569,"threshold_uncertainty_score":0.47330153},"labels":[],"label_agreement":null},{"id":"W2084635253","doi":"10.1016/j.jval.2012.08.2038","title":"PRS39 Preference and Willingness to Pay for a Treatment of Pulmonary Arterial Hypertension","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McMaster University; PharmIdeas (Canada)","funders":"","keywords":"Treprostinil; Medicine; Willingness to pay; Preference; Population; Confidence interval; Descriptive statistics; Pulmonary hypertension; Demography; Physical therapy; Internal medicine; Environmental health; Economics; Statistics","score_opus":0.26733216273145527,"score_gpt":0.33045040279658777,"score_spread":0.0631182400651325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084635253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.976429,0.0004891791,0.00151591,0.004320904,0.000053390315,0.000026083095,0.00048630568,0.000011669945,0.016667578],"genre_scores_gemma":[0.9984775,0.000064272186,0.00017687104,0.0001217926,0.000043249223,0.0000036400693,0.00011116375,0.0000025535774,0.0009989659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886644,0.0006544783,0.00009600224,0.00007330728,0.00014538325,0.00016449449],"domain_scores_gemma":[0.9857531,0.009434974,0.0023572806,0.00057777367,0.00046721872,0.0014096497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002346404,0.00014086267,0.0002740141,0.00047813726,0.00023493661,0.0012111542,0.00025397423,0.0014523447,0.02056832],"category_scores_gemma":[0.0173084,0.00013148513,0.0007142077,0.00043382726,0.00039123738,0.00054612913,0.00032018102,0.0016020729,0.0012536801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012751486,0.003176726,0.78234255,0.0003050602,0.0013163245,0.0020132628,0.00057183625,0.015507378,0.005817311,0.046001904,0.006541227,0.12365489],"study_design_scores_gemma":[0.0007349529,0.0027484961,0.8773093,0.00012990172,0.00032798192,0.0053423196,0.0013510257,0.037358847,0.0011416789,0.06561608,0.007847439,0.00009202603],"about_ca_topic_score_codex":0.0016131764,"about_ca_topic_score_gemma":0.0010505675,"teacher_disagreement_score":0.02056832,"about_ca_system_score_codex":0.00048433704,"about_ca_system_score_gemma":0.00039646143,"threshold_uncertainty_score":0.06880784},"labels":[],"label_agreement":null},{"id":"W2084753710","doi":"10.1016/j.jval.2013.03.251","title":"Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Checklist; Valuation (finance); Respondent; EQ-5D; Cochrane Library; Population; Systematic review; Medicine; MEDLINE; Data extraction; Economic evaluation; Health care; Actuarial science; Family medicine; Meta-analysis; Psychology; Environmental health; Business; Political science; Accounting","score_opus":0.952289120364427,"score_gpt":0.6028001586182684,"score_spread":0.3494889617461586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084753710","genre_codex":"protocol","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010738997,0.21290028,0.04379795,0.0059644906,0.0019021662,0.6646746,0.054799207,0.001185809,0.0040365364],"genre_scores_gemma":[0.019619007,0.043559454,0.16400094,0.0020670933,0.00026383213,0.7567282,0.0122558335,0.00019337184,0.0013123433],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7345153,0.06598199,0.1764958,0.0053664176,0.016326569,0.0013138774],"domain_scores_gemma":[0.72931135,0.1558158,0.06299119,0.013636267,0.036170013,0.002075251],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.151131,0.004187536,0.017135134,0.021753341,0.0029077744,0.006064221,0.0052963854,0.004442091,0.013260348],"category_scores_gemma":[0.2808332,0.004044972,0.027760314,0.017795954,0.0036011522,0.004625718,0.007505475,0.0057696863,0.0015553522],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021977946,0.00018472415,0.0041218963,0.8782079,0.018437639,0.00026079314,0.0019104286,0.0008137139,0.0011502992,0.0028011312,0.020353613,0.069559984],"study_design_scores_gemma":[0.014528867,0.0011713888,0.02399054,0.6993873,0.09218907,0.0009338476,0.0025357946,0.0019194632,0.0029824928,0.010327912,0.1493352,0.00069818937],"about_ca_topic_score_codex":0.0047064107,"about_ca_topic_score_gemma":0.015141526,"teacher_disagreement_score":0.84886897,"about_ca_system_score_codex":0.008387578,"about_ca_system_score_gemma":0.038764063,"threshold_uncertainty_score":0.7992667},"labels":[],"label_agreement":null},{"id":"W2084778838","doi":"10.1111/j.1524-4733.2008.00408.x","title":"Prevention and Management of Hyperphosphatemia with Sevelamer in Canada: Health and Economic Consequences","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Sevelamer; Medicine; Hyperphosphatemia; Population; Cohort; End stage renal disease; Internal medicine; Kidney disease; Hemodialysis; Intensive care medicine; Environmental health","score_opus":0.03477023672075777,"score_gpt":0.2830222133734211,"score_spread":0.24825197665266333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084778838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91097957,0.032090858,0.00044833135,0.0320933,0.00017725718,0.00028485066,0.0026301292,0.00009611845,0.021199474],"genre_scores_gemma":[0.984775,0.009174967,0.00090139103,0.0016309746,0.000066664215,0.000024951254,0.0005862178,0.000008292805,0.0028315124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998896,0.00016878107,0.00005573208,0.0000535707,0.0004800355,0.00034589478],"domain_scores_gemma":[0.9979778,0.00019296033,0.00027589832,0.000024755635,0.0005387633,0.0009897707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077448157,0.0001974486,0.00040972873,0.0011511922,0.001555259,0.0011044088,0.0009287242,0.0007427867,0.0028740854],"category_scores_gemma":[0.0024773793,0.0001617747,0.000571918,0.0025512474,0.00077960745,0.0002550835,0.000584636,0.0013037173,0.00010311018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064317374,0.002691225,0.6146327,0.0011332538,0.0005326093,0.0024587626,0.00090112427,0.0021951087,0.002220266,0.0031976083,0.020025274,0.34358034],"study_design_scores_gemma":[0.0017487421,0.0014288002,0.963425,0.0008075416,0.00070579397,0.001737329,0.00239655,0.0031028825,0.0010022128,0.0009697118,0.022608647,0.000066785164],"about_ca_topic_score_codex":0.9724664,"about_ca_topic_score_gemma":0.9877051,"teacher_disagreement_score":0.029239893,"about_ca_system_score_codex":0.029239893,"about_ca_system_score_gemma":0.09006903,"threshold_uncertainty_score":0.21215129},"labels":[],"label_agreement":null},{"id":"W2084784038","doi":"10.1111/j.1524-4733.2009.00675.x","title":"A Median Model for Predicting United States Population-Based EQ-5D Health State Preferences","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Agency for Healthcare Research and Quality","keywords":"EQ-5D; Statistics; Econometrics; Population; Least absolute deviations; Robustness (evolution); Mathematics; Valuation (finance); Regression; Medicine; Economics; Environmental health","score_opus":0.5862599467820748,"score_gpt":0.4348619440241706,"score_spread":0.15139800275790422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084784038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70705503,0.001349295,0.27701792,0.002058116,0.00022939843,0.00010845205,0.00783791,0.00064986455,0.0036939424],"genre_scores_gemma":[0.9758212,0.00023737486,0.018968664,0.00014130045,0.00007838056,0.00012597341,0.0024944723,0.000030571166,0.0021020363],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991242,0.0004461242,0.000046483794,0.00019963576,0.00006299474,0.000120579214],"domain_scores_gemma":[0.9951546,0.0039194985,0.00025492744,0.00020728656,0.0002792385,0.00018446262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047247373,0.0005021928,0.0016441708,0.0008886034,0.00044648984,0.0013284512,0.0015054961,0.0011241094,0.006090241],"category_scores_gemma":[0.010005698,0.00045569628,0.0012713094,0.0011592186,0.00034891898,0.0014313816,0.0009840191,0.0014743325,0.00077258126],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015384463,0.00037929186,0.07516962,0.00006350853,0.0005203571,0.00014316781,0.00012810492,0.83619845,0.00030757132,0.013882007,0.007372601,0.064296864],"study_design_scores_gemma":[0.000024170802,0.000054963904,0.00397232,0.00000852172,0.000019581525,0.000018264664,0.000028583809,0.988943,0.000037250073,0.0066494695,0.00023403867,0.000009744145],"about_ca_topic_score_codex":0.017954191,"about_ca_topic_score_gemma":0.010297545,"teacher_disagreement_score":0.017954191,"about_ca_system_score_codex":0.0012008877,"about_ca_system_score_gemma":0.0009365553,"threshold_uncertainty_score":0.035699368},"labels":[],"label_agreement":null},{"id":"W2085523854","doi":"10.1016/j.jval.2011.08.830","title":"PCV110 Health-Related Quality of Life After Venous Thromboembolism","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Dabigatran; Warfarin; Body mass index; Internal medicine; Quality of life (healthcare); Deep vein; Randomized controlled trial; Venous thrombosis; Pediatrics; Thrombosis; Atrial fibrillation","score_opus":0.1100382159669182,"score_gpt":0.325878656340998,"score_spread":0.2158404403740798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085523854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90682554,0.009342527,0.00045653127,0.0023013453,0.0003252782,0.00029600118,0.011011585,0.00006782526,0.0693734],"genre_scores_gemma":[0.9889346,0.0011818822,0.00040119892,0.00028402935,0.00008285724,0.00009597612,0.004884055,0.000009649535,0.004125694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881905,0.00033929586,0.00008924268,0.00006628779,0.0004345914,0.0002514155],"domain_scores_gemma":[0.9976169,0.00074511004,0.00050262274,0.00007034094,0.00047984984,0.00058519334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009490728,0.00023191294,0.00059088075,0.0009845814,0.00043384652,0.0012319402,0.0004181644,0.0004462464,0.008330423],"category_scores_gemma":[0.005904062,0.000072206334,0.00070023816,0.0018233401,0.00026485807,0.0005351415,0.00057296664,0.0010189217,0.0009828293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035546971,0.0011887304,0.7226712,0.0005496258,0.0007151221,0.00022307949,0.00021237992,0.00078342634,0.0004326848,0.0011057114,0.01560245,0.25296083],"study_design_scores_gemma":[0.0001895782,0.0011835566,0.9867556,0.00011799536,0.00014036517,0.00032706608,0.00015994915,0.0005951742,0.00040258697,0.0005491333,0.00956021,0.000018766794],"about_ca_topic_score_codex":0.0078043006,"about_ca_topic_score_gemma":0.0074778344,"teacher_disagreement_score":0.008330423,"about_ca_system_score_codex":0.0013813917,"about_ca_system_score_gemma":0.00092779467,"threshold_uncertainty_score":0.027868092},"labels":[],"label_agreement":null},{"id":"W2085934885","doi":"10.1016/s1098-3015(10)70812-3","title":"PMS10 THE COST-EFFECTIVENESS OF ABATACEPT VERSUS RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A PERSPECTIVE OF THE CANADIAN PUBLICLY FUNDED HEALTH CARE SYSTEM","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Rituximab; Medicine; Perspective (graphical); Health care; Physical therapy; Intensive care medicine; Family medicine; Internal medicine; Immunology; Economic growth; Computer science; Economics; Antibody","score_opus":0.05506993528079645,"score_gpt":0.3258128338802294,"score_spread":0.27074289859943296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085934885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6246123,0.07791895,0.0007163068,0.1957234,0.0007952208,0.00024210737,0.012103833,0.00006231675,0.087825574],"genre_scores_gemma":[0.9865801,0.0066695237,0.0004968413,0.0032220916,0.00029042165,0.000025864198,0.0010690952,0.0000092689925,0.0016368774],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946274,0.001862358,0.00021733587,0.00020319344,0.0015487993,0.0015409063],"domain_scores_gemma":[0.99195224,0.003135227,0.00083908025,0.00013368251,0.0023334897,0.001606132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034607996,0.0005049622,0.0011124897,0.001367992,0.0016929567,0.0039640563,0.0015825363,0.0019796772,0.006344096],"category_scores_gemma":[0.016627885,0.000344505,0.0021690126,0.0037555867,0.0013133736,0.00077007303,0.00071755605,0.0022334696,0.0001795891],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0307084,0.0009367844,0.33232388,0.0038325756,0.008152702,0.0016570674,0.0018119991,0.05716647,0.002284728,0.067969136,0.1141795,0.37897682],"study_design_scores_gemma":[0.00796521,0.0030106718,0.8367542,0.0037820942,0.008981694,0.0012333762,0.006351412,0.04275487,0.0011205177,0.01420928,0.07332599,0.0005106594],"about_ca_topic_score_codex":0.947207,"about_ca_topic_score_gemma":0.9731531,"teacher_disagreement_score":0.9077333,"about_ca_system_score_codex":0.092266686,"about_ca_system_score_gemma":0.08352348,"threshold_uncertainty_score":0.6694448},"labels":[],"label_agreement":null},{"id":"W2085952377","doi":"10.1016/j.jval.2012.08.280","title":"PRM29 Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI: CHRI) in Germany and Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Infant Development and Preterm Care","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Presenteeism; Absenteeism; Medicine; Productivity; Demography; Gerontology; Psychology","score_opus":0.016833975793303847,"score_gpt":0.25982972108898056,"score_spread":0.24299574529567672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085952377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842672,0.00046227037,0.00081656553,0.00028510467,0.0000618361,0.00092327985,0.0078032645,0.000025419633,0.00535517],"genre_scores_gemma":[0.9838791,0.00044163704,0.0017781593,0.00018125802,0.00002264331,0.0011024029,0.010226093,0.000035218723,0.0023334988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99530137,0.001004931,0.0003967185,0.00046361235,0.0018091536,0.0010241467],"domain_scores_gemma":[0.9914663,0.000887907,0.00062508025,0.0003746031,0.0059424834,0.00070362794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066501596,0.0007671666,0.000708681,0.0016538012,0.002230443,0.0014955527,0.0018556964,0.0005748572,0.0015757934],"category_scores_gemma":[0.016484277,0.00038996688,0.0011072668,0.0023057677,0.000897397,0.0006281132,0.0017621113,0.0010088807,0.0006138658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031364127,0.00022706485,0.980492,0.00009191835,0.00012978211,0.0001462282,0.0025381357,0.00026026982,0.00045549448,0.0002133498,0.0028758282,0.012256318],"study_design_scores_gemma":[0.000018464449,0.000083862025,0.99701726,0.000040039384,0.00002757591,0.000037739424,0.00091187336,0.00015084559,0.00019643396,0.000018456369,0.0014900893,0.0000074405666],"about_ca_topic_score_codex":0.86770165,"about_ca_topic_score_gemma":0.89508057,"teacher_disagreement_score":0.13229835,"about_ca_system_score_codex":0.009389188,"about_ca_system_score_gemma":0.016959582,"threshold_uncertainty_score":0.26615494},"labels":[],"label_agreement":null},{"id":"W2086355585","doi":"10.1016/j.jval.2014.03.586","title":"Insights Into the Pan-Canadian Oncology Drug Revew Recommendations - Three Years After its Inception","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Limiting; Clinical trial; Cost effectiveness; Family medicine; Oncology; Internal medicine; Environmental health; Risk analysis (engineering)","score_opus":0.2974276300427056,"score_gpt":0.4120224945462408,"score_spread":0.11459486450353518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086355585","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042381696,0.022067305,0.0011137614,0.92951787,0.0066225673,0.00011299867,0.003837328,0.00009128031,0.032398734],"genre_scores_gemma":[0.18438275,0.04906457,0.021335678,0.6647246,0.009255421,0.00036547193,0.0054526096,0.00032017543,0.065098725],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9622322,0.0060884133,0.002214616,0.0014328569,0.02370203,0.0043299203],"domain_scores_gemma":[0.85573417,0.034272026,0.005538069,0.0033222141,0.08518333,0.015950201],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04583164,0.00095785584,0.0014482313,0.004119269,0.0045492267,0.014082649,0.0050170063,0.015059871,0.0071269465],"category_scores_gemma":[0.1237642,0.00081697275,0.002201135,0.00616649,0.006464007,0.003914764,0.0030025567,0.018300394,0.0011105599],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020983737,0.00007846369,0.0050986204,0.0005010714,0.00015796951,0.00018406103,0.0007590391,0.0017910186,0.00015745423,0.08683491,0.83291113,0.071316466],"study_design_scores_gemma":[0.000119279066,0.00005304376,0.017504059,0.0018364085,0.00014460129,0.00007931919,0.00086422364,0.0011405456,0.00026261384,0.013447688,0.9643591,0.0001890752],"about_ca_topic_score_codex":0.95791495,"about_ca_topic_score_gemma":0.9805792,"teacher_disagreement_score":0.9541684,"about_ca_system_score_codex":0.089767985,"about_ca_system_score_gemma":0.27069554,"threshold_uncertainty_score":0.65131533},"labels":[],"label_agreement":null},{"id":"W2086591936","doi":"10.1111/j.1524-4733.2009.00611.x","title":"Cost-Effectiveness of 21 Alternative Cervical Cancer Screening Strategies","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Papanicolaou stain; Medicine; Triage; Pap test; Cervical cancer; Cost effectiveness; Cohort; Cervical cancer screening; Family medicine; Emergency medicine; Cancer; Internal medicine","score_opus":0.19472672086650325,"score_gpt":0.4735913633878683,"score_spread":0.278864642521365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086591936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9623594,0.0035129618,0.017189786,0.0011696441,0.000079197605,0.00091577397,0.0019487496,0.00009167373,0.0127328215],"genre_scores_gemma":[0.9942398,0.0008075109,0.0035368192,0.00011836944,0.000009030756,0.00022640175,0.00032210813,0.000006559297,0.00073340244],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99764484,0.0014257772,0.00010750221,0.00022216466,0.00030445124,0.00029523397],"domain_scores_gemma":[0.9944094,0.0042105555,0.00067976926,0.00014006764,0.0002916956,0.00026849663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038677852,0.0012048802,0.0009811607,0.0013221898,0.00036311967,0.0018900441,0.0012887599,0.0013830601,0.005903808],"category_scores_gemma":[0.011900211,0.00048246118,0.002290975,0.0009469918,0.0005936728,0.0012284858,0.0010197199,0.00097372604,0.00023141266],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019925789,0.0005045314,0.011835831,0.00035902046,0.00071112433,0.00013902552,0.000039860322,0.957563,0.0004456239,0.0037855734,0.00036209004,0.022261666],"study_design_scores_gemma":[0.0014040436,0.0064476216,0.017639853,0.0003849799,0.0017570491,0.00036871413,0.00025467516,0.9600207,0.0012787696,0.0076572397,0.0026906359,0.00009580852],"about_ca_topic_score_codex":0.010929568,"about_ca_topic_score_gemma":0.007131942,"teacher_disagreement_score":0.010929568,"about_ca_system_score_codex":0.004453345,"about_ca_system_score_gemma":0.0032379264,"threshold_uncertainty_score":0.03231144},"labels":[],"label_agreement":null},{"id":"W2087528411","doi":"10.1016/s1098-3015(10)70887-1","title":"PRS39 THE IMPACT OF FORMULARY POLICIES ON THE USE OF MEDICATION FOR RESPIRATORY DISEASE: A COMPARISON OF DRUG UTILIZATION IN THE PROVINCES OF ONTARIO AND ALBERTA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Medicine; Drug; Disease; Environmental health; Intensive care medicine; Business; Family medicine; Pharmacology; Internal medicine","score_opus":0.6622703420405391,"score_gpt":0.4726263640761462,"score_spread":0.18964397796439292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087528411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97699463,0.0009300554,0.00012856601,0.0024672141,0.000037069232,0.00006253062,0.0073722135,0.000023318771,0.011984293],"genre_scores_gemma":[0.9938454,0.00041990392,0.00015983617,0.00020029601,0.000010614429,0.000015038168,0.001959423,0.000006505881,0.0033828558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762267,0.0003234628,0.000106937645,0.00010676645,0.0009372274,0.0009029695],"domain_scores_gemma":[0.9947825,0.0007890297,0.00081361167,0.00016151778,0.0024229502,0.0010303669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013352298,0.00024074063,0.0004641898,0.001366738,0.0016363839,0.0020074437,0.0011894312,0.0006044311,0.002959481],"category_scores_gemma":[0.006882914,0.00031420932,0.0010728851,0.0037449861,0.0009214744,0.00047665124,0.00095071364,0.00061644026,0.00015335549],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016631349,0.00015142445,0.9523465,0.00021270632,0.0005050785,0.00040706494,0.0013642942,0.008780051,0.0006425399,0.004365716,0.011232372,0.018329073],"study_design_scores_gemma":[0.00006046464,0.000049924573,0.99374986,0.000024834833,0.000060558534,0.000032619908,0.0014663863,0.0016783758,0.000111089066,0.00011412437,0.002636787,0.0000150467495],"about_ca_topic_score_codex":0.9984043,"about_ca_topic_score_gemma":0.9987937,"teacher_disagreement_score":0.9351467,"about_ca_system_score_codex":0.06485328,"about_ca_system_score_gemma":0.07675929,"threshold_uncertainty_score":0.4705457},"labels":[],"label_agreement":null},{"id":"W2087879942","doi":"10.1016/j.jval.2011.02.315","title":"PSS13 INCREMENTAL COST-UTILITY ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSION","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Macular edema; Visual acuity; Retinal Vein; Central retinal vein occlusion; Dexamethasone; Implant; Ophthalmology; Occlusion; Surgery; Internal medicine","score_opus":0.42723641359147124,"score_gpt":0.43144971600393767,"score_spread":0.004213302412466424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087879942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690295,0.0052651837,0.013567242,0.0012011243,0.000116414885,0.0005175502,0.004176413,0.00011798603,0.006008554],"genre_scores_gemma":[0.9973314,0.0003437095,0.0011711688,0.000047247097,0.000016418477,0.000049636797,0.00057148526,0.0000060630123,0.0004628653],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99881184,0.0008144227,0.0000482816,0.000058689562,0.00014089653,0.00012595854],"domain_scores_gemma":[0.9940362,0.0050666397,0.00027242184,0.00011877565,0.0003255783,0.00018028717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032101427,0.0009704687,0.0015096306,0.0013351191,0.0002327139,0.001406945,0.0008742032,0.000938424,0.005680747],"category_scores_gemma":[0.0117023485,0.00040992387,0.002837856,0.0013876673,0.00043904642,0.00063108857,0.00053023704,0.0010327598,0.00021131843],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025844814,0.0008762921,0.017543651,0.00090610806,0.002335528,0.00054614857,0.00004329331,0.8910099,0.0015074225,0.0044207317,0.0022609043,0.05270517],"study_design_scores_gemma":[0.0024313775,0.005039132,0.02307849,0.00021398152,0.0037595385,0.00033867903,0.00010421875,0.9593286,0.0011949782,0.0032610227,0.001176834,0.000073140574],"about_ca_topic_score_codex":0.01716229,"about_ca_topic_score_gemma":0.009023886,"teacher_disagreement_score":0.01716229,"about_ca_system_score_codex":0.0037944776,"about_ca_system_score_gemma":0.0021330563,"threshold_uncertainty_score":0.03412479},"labels":[],"label_agreement":null},{"id":"W2087950211","doi":"10.1016/j.jval.2011.08.1478","title":"PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United States","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Psoriasis; Medicine; Diabetes mellitus; Population; Internal medicine; Dermatology; Endocrinology; Environmental health","score_opus":0.026312052098932743,"score_gpt":0.22934285807486096,"score_spread":0.2030308059759282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087950211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98315847,0.0013797266,0.00007542292,0.0012891558,0.00004118647,0.000015850597,0.009578576,0.0000073085635,0.004454309],"genre_scores_gemma":[0.9948939,0.00081803586,0.000068825604,0.00018251351,0.000048809266,0.000009865975,0.003364814,0.0000021182902,0.0006111563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943024,0.00017733432,0.00010651435,0.00004097649,0.00014556633,0.00009935665],"domain_scores_gemma":[0.998838,0.000120029836,0.00064242864,0.000027817148,0.00015148756,0.00022029018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034166977,0.00015094245,0.0002398963,0.0010089215,0.00035190865,0.0007887321,0.00017287114,0.00035171866,0.0031822522],"category_scores_gemma":[0.0017972505,0.00013269352,0.00065910217,0.0024980868,0.00014446276,0.00029301812,0.0004987369,0.00045790483,0.0002863333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001403625,0.000038312308,0.99417627,0.000017661914,0.000095323376,0.00010095856,0.000025690828,0.0001236194,0.000040605806,0.000075525466,0.00157407,0.0035915398],"study_design_scores_gemma":[0.000008455939,0.000024985615,0.9988065,0.000011189978,0.000033558554,0.00016198255,0.00012136724,0.0001886975,0.000013201637,0.00003174355,0.00059581216,0.0000025357294],"about_ca_topic_score_codex":0.03630839,"about_ca_topic_score_gemma":0.03786174,"teacher_disagreement_score":0.03630839,"about_ca_system_score_codex":0.00080096733,"about_ca_system_score_gemma":0.00082638126,"threshold_uncertainty_score":0.0721941},"labels":[],"label_agreement":null},{"id":"W2088184121","doi":"10.1016/j.jval.2013.08.1891","title":"Impact of Major Clinical Events on Utilities in the Context of Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) Treated with Dialysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Humber River Regional Hospital; Dalhousie University","funders":"","keywords":"Medicine; Secondary hyperparathyroidism; Kidney disease; Dialysis; Physical therapy; Population; Stroke (engine); Context (archaeology); Parathyroidectomy; Myocardial infarction; Internal medicine; Environmental health; Parathyroid hormone","score_opus":0.02813419561552772,"score_gpt":0.3283664095623736,"score_spread":0.3002322139468459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088184121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963414,0.0011131989,0.00015637185,0.00037427686,0.000033692017,0.000010077555,0.00046925497,0.0000051331504,0.0014965484],"genre_scores_gemma":[0.99959403,0.00009063009,0.000035555044,0.000027645467,0.000015866783,0.0000014051527,0.00015550984,0.0000010951213,0.00007830735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986627,0.0006498839,0.00012473739,0.00013307622,0.00015055803,0.00027902343],"domain_scores_gemma":[0.994439,0.0020028227,0.0014564517,0.00017146219,0.00041975162,0.0015105208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014008838,0.00030057767,0.0007768314,0.00053959974,0.00044434716,0.0015217148,0.00037435035,0.0004847331,0.0021611596],"category_scores_gemma":[0.0089996,0.00017569934,0.0015630889,0.00088882784,0.00026761417,0.00079448015,0.00092511514,0.0016142682,0.00013323898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018615405,0.0001604143,0.99120164,0.000043209442,0.0007771453,0.00017932086,0.00005553072,0.00049961335,0.00008570356,0.00015958073,0.00022599293,0.0047501544],"study_design_scores_gemma":[0.000025246845,0.00046063264,0.996429,0.00001636601,0.0004005152,0.00025000004,0.00020481397,0.0016017078,0.00005605377,0.00034461697,0.00019663942,0.0000145585755],"about_ca_topic_score_codex":0.005665928,"about_ca_topic_score_gemma":0.007899601,"teacher_disagreement_score":0.005665928,"about_ca_system_score_codex":0.00071049464,"about_ca_system_score_gemma":0.0007536415,"threshold_uncertainty_score":0.011265874},"labels":[],"label_agreement":null},{"id":"W2088189626","doi":"10.1016/j.jval.2014.03.449","title":"A Canadian Cost Analysis Comparing the Use of Bortezomib or Lenalidomide as Maintenance Therapies in Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thames Valley Children's Centre; Ottawa Hospital; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Lenalidomide; Bortezomib; Multiple myeloma; Medicine; Internal medicine; Oncology; Autologous stem-cell transplantation; Pharmacist; Adverse effect; Pharmacy; Family medicine","score_opus":0.10385737084964787,"score_gpt":0.3223793400241688,"score_spread":0.21852196917452094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088189626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9071861,0.029941926,0.0010456323,0.0121779395,0.00049796706,0.0012110597,0.025007296,0.00007292406,0.022859186],"genre_scores_gemma":[0.9828986,0.0051427283,0.0013874215,0.0020000173,0.00009851299,0.00018913115,0.0059976634,0.00002711607,0.0022587688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996119,0.0009926668,0.00022455721,0.0002825699,0.0012313284,0.0011499285],"domain_scores_gemma":[0.9932347,0.0020016117,0.0009980157,0.0001844482,0.001971591,0.0016096185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022877227,0.001345613,0.0019172681,0.002075821,0.002068845,0.0029527112,0.0026977602,0.0015500129,0.005714473],"category_scores_gemma":[0.011535177,0.0008319328,0.0058540413,0.006510657,0.0010406937,0.00079253345,0.0013285544,0.0028275899,0.00017645955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14281456,0.003143229,0.3955765,0.008019154,0.02811527,0.0020529244,0.0010032987,0.15104148,0.0022225154,0.023467548,0.08787045,0.15467316],"study_design_scores_gemma":[0.04865682,0.007136488,0.76775396,0.0031523309,0.033070467,0.0014120474,0.0033642456,0.09124277,0.0010841794,0.004128036,0.03812638,0.00087230734],"about_ca_topic_score_codex":0.9860913,"about_ca_topic_score_gemma":0.98712695,"teacher_disagreement_score":0.15940192,"about_ca_system_score_codex":0.15940192,"about_ca_system_score_gemma":0.108237155,"threshold_uncertainty_score":0.97497463},"labels":[],"label_agreement":null},{"id":"W2088252986","doi":"10.1016/s1098-3015(11)72361-0","title":"PCV18 COMPARISON OF MIXED DYSLIPIDEMIAS AMONG HIGH CARDIOVASCULAR RISK PRIMARY CARE PATIENTS: RESULTS OF A POOLED ANALYSIS OF PRIMULA DATA FROM CANADA, SPAIN, SWEDEN, AND THE UNITED KINGDOM","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primula; Primary care; Medicine; Environmental health; Pooled analysis; Geography; Demography; Family medicine; Internal medicine; Biology; Meta-analysis; Botany","score_opus":0.02002227789510858,"score_gpt":0.25984833166880383,"score_spread":0.23982605377369526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088252986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764524,0.018285327,0.00044263806,0.00008826484,0.00008820248,0.0000911619,0.003779976,0.00002196543,0.00074995926],"genre_scores_gemma":[0.9945425,0.0017719035,0.00030028998,0.000083359686,0.00005126549,0.000066167195,0.0029626451,0.000018178063,0.00020368845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9894936,0.00521748,0.0014007052,0.0017548677,0.0014172292,0.0007161369],"domain_scores_gemma":[0.9900774,0.0037409067,0.0018420229,0.0014329568,0.002285726,0.00062098086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007176651,0.001610858,0.0068550073,0.0024670756,0.00070491567,0.0028298118,0.0012506918,0.0016007327,0.0013639501],"category_scores_gemma":[0.013235708,0.0014508677,0.007919675,0.0049646352,0.0005994333,0.0006913092,0.001471432,0.0008702634,0.00020125118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07111634,0.000094519215,0.78803074,0.0011327146,0.12826103,0.0003425792,0.00033890933,0.00061553624,0.00086464576,0.000078232915,0.0009133032,0.008211382],"study_design_scores_gemma":[0.0035298844,0.00139515,0.9246588,0.00017067109,0.067563474,0.00025863288,0.00049864536,0.0006587137,0.0002891875,0.00007242876,0.0008360843,0.00006830025],"about_ca_topic_score_codex":0.091820665,"about_ca_topic_score_gemma":0.097797975,"teacher_disagreement_score":0.90817934,"about_ca_system_score_codex":0.0018101525,"about_ca_system_score_gemma":0.0016495954,"threshold_uncertainty_score":0.18257242},"labels":[],"label_agreement":null},{"id":"W2088464345","doi":"10.1016/j.jval.2014.12.001","title":"Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research—The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Authority; University of Saskatchewan; Alberta Bone and Joint Health Institute; University of Calgary","funders":"Agency for Healthcare Research and Quality","keywords":"Checklist; Task force; Computer science; Task (project management); Management science; Medicine; Systems engineering; Psychology; Engineering; Political science","score_opus":0.47942807207061616,"score_gpt":0.6345859861084787,"score_spread":0.15515791403786255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088464345","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00094227464,0.960021,0.018706989,0.013565404,0.0013726199,0.000980811,0.0007161765,0.00015010156,0.0035446582],"genre_scores_gemma":[0.007096705,0.9418408,0.04563889,0.0024542543,0.00041417242,0.0009751779,0.00083671993,0.00009619384,0.00064695196],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9812197,0.009773583,0.0027976704,0.00058603566,0.005370907,0.00025205678],"domain_scores_gemma":[0.8759205,0.08989878,0.0070714075,0.0030384706,0.022733113,0.0013377881],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06616102,0.0017324266,0.0029815969,0.005500177,0.00081307057,0.0034899635,0.0042741583,0.0024046574,0.0024827784],"category_scores_gemma":[0.09796918,0.0012174156,0.00395223,0.0063620056,0.0010184806,0.0029037418,0.0032113637,0.005427077,0.0009942931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011883129,0.00019845195,0.001848393,0.04820971,0.0011077018,0.00006268213,0.0004063253,0.0054568355,0.0003221927,0.013084988,0.053661626,0.87552226],"study_design_scores_gemma":[0.0002470378,0.00037343928,0.004278974,0.1782466,0.0030188786,0.00023023773,0.00048641048,0.0070683816,0.0014872043,0.017918348,0.78646606,0.00017851338],"about_ca_topic_score_codex":0.0195468,"about_ca_topic_score_gemma":0.037337195,"teacher_disagreement_score":0.93383896,"about_ca_system_score_codex":0.0047348877,"about_ca_system_score_gemma":0.02591145,"threshold_uncertainty_score":0.3498971},"labels":[],"label_agreement":null},{"id":"W2088539861","doi":"10.1016/s1098-3015(10)70200-x","title":"PCN22 IS CAPECITABINE A COST-EFFECTIVE ADJUVANT TREATMENT OF STAGE III COLON CANCER IN ONTARIO?","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Capecitabine; Stage (stratigraphy); Colorectal cancer; Oncology; Adjuvant; Medicine; Internal medicine; Cancer; Biology","score_opus":0.07148523536523044,"score_gpt":0.35015278678222267,"score_spread":0.27866755141699223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088539861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91221255,0.01946358,0.00010453002,0.039777234,0.00015954132,0.00012270676,0.005413062,0.000009797997,0.02273704],"genre_scores_gemma":[0.99173963,0.0048363563,0.00016253105,0.0010419367,0.000082035986,0.000021109068,0.0006903575,0.0000033494132,0.0014227732],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990287,0.00022692302,0.00007368623,0.00006626655,0.00032031286,0.00028407582],"domain_scores_gemma":[0.9958402,0.0007398136,0.0013022317,0.00007461862,0.0010429305,0.0010001663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008406242,0.00015841446,0.00044036438,0.0006041762,0.00065378565,0.0012577286,0.00063909363,0.00059445243,0.0039612595],"category_scores_gemma":[0.008300853,0.00016390093,0.00052169943,0.002591195,0.0006429928,0.00057240063,0.00043989051,0.0004687439,0.00013801672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060933554,0.00023289442,0.8248573,0.0016349369,0.0005932767,0.00074939936,0.0008759916,0.0012350099,0.0010598777,0.0030945612,0.016269494,0.14330393],"study_design_scores_gemma":[0.0004280614,0.0003092093,0.98081857,0.0004665521,0.0005080294,0.00020530944,0.0010890543,0.00065172795,0.00016308675,0.0004157653,0.014920635,0.000024042476],"about_ca_topic_score_codex":0.9375671,"about_ca_topic_score_gemma":0.9788548,"teacher_disagreement_score":0.062432885,"about_ca_system_score_codex":0.033191375,"about_ca_system_score_gemma":0.04880086,"threshold_uncertainty_score":0.24082142},"labels":[],"label_agreement":null},{"id":"W2088589445","doi":"10.1016/s1098-3015(10)70623-9","title":"PCV35 GADOFOSVESET IN THE MANAGEMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE IN CANADA-A MODEL APPROACH FOCUSING ON DIAGNOSTIC CONFIDENCE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral; Peripheral arterial occlusive disease; Arterial disease; Confidence interval; Vascular disease; Radiology; Internal medicine","score_opus":0.06984753578411113,"score_gpt":0.31307918440210514,"score_spread":0.243231648617994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088589445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87891036,0.008987988,0.011783055,0.052080292,0.00033972922,0.00035975807,0.0017965583,0.0001862398,0.045556027],"genre_scores_gemma":[0.99049896,0.0026123805,0.004324083,0.00061349483,0.000039766084,0.000022730015,0.00014145277,0.000017812874,0.0017292373],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99907184,0.00036190258,0.000027212222,0.000078034725,0.00025352475,0.00020754183],"domain_scores_gemma":[0.9988219,0.00036762893,0.00009491656,0.0000383813,0.00039497347,0.00028218355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014714306,0.00032661695,0.00046304628,0.0006014153,0.00085719506,0.0024451888,0.0011712316,0.0007291402,0.0018316794],"category_scores_gemma":[0.00493029,0.00021096409,0.00040820165,0.0012402141,0.0012887333,0.0006942548,0.0005468532,0.0012450721,0.00015181689],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070612277,0.0018106132,0.40560636,0.00058920356,0.000783422,0.0018551309,0.0019446537,0.08879473,0.0035410114,0.10822939,0.027839087,0.3519451],"study_design_scores_gemma":[0.0032915254,0.0035705836,0.52331,0.0007562303,0.0018754493,0.0031429722,0.0075036716,0.3296564,0.0059551545,0.055758752,0.064732656,0.0004466357],"about_ca_topic_score_codex":0.9496509,"about_ca_topic_score_gemma":0.9641872,"teacher_disagreement_score":0.050349116,"about_ca_system_score_codex":0.034837075,"about_ca_system_score_gemma":0.06867517,"threshold_uncertainty_score":0.25276184},"labels":[],"label_agreement":null},{"id":"W2089020463","doi":"10.1016/j.jval.2011.08.408","title":"PMS22 The Burden of Illness of Osteoporosis in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University; Centre hospitalier de l'Université Laval; University of Manitoba; McMaster University","funders":"","keywords":"Medicine; Osteoporosis; Medical prescription; Emergency department; Health care; Emergency medicine; Diagnosis code; Population; Indirect costs; Family medicine; Environmental health; Internal medicine; Nursing","score_opus":0.06398796774920942,"score_gpt":0.3133601141662412,"score_spread":0.2493721464170318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089020463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.716491,0.027146732,0.00024878094,0.061168022,0.0009843752,0.00020119871,0.11833885,0.00009299488,0.075328],"genre_scores_gemma":[0.9698297,0.009388787,0.00021067161,0.0015458087,0.00019667658,0.000029243069,0.009340271,0.000018891533,0.009439887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830973,0.0001155447,0.000103520375,0.00007830801,0.00079688366,0.0005960255],"domain_scores_gemma":[0.99612314,0.00013028755,0.0005394082,0.000045362918,0.0016902087,0.0014715868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044604618,0.00026912533,0.0005313015,0.002158266,0.0023941807,0.0018423224,0.00083912484,0.0008137127,0.008736315],"category_scores_gemma":[0.0045017935,0.00031531003,0.00077486766,0.0072872937,0.0005720619,0.00042614224,0.0009037305,0.0014059794,0.00043423727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035313002,0.00009457138,0.88524705,0.00024937373,0.00024897238,0.00040924287,0.00055586925,0.0008542077,0.00015422438,0.0022376615,0.06404304,0.045552693],"study_design_scores_gemma":[0.000054403066,0.000030857507,0.97760755,0.00015946945,0.000070874696,0.00016082366,0.0010524612,0.00060831726,0.000053820353,0.0002390997,0.019937946,0.000024281251],"about_ca_topic_score_codex":0.9975089,"about_ca_topic_score_gemma":0.9984242,"teacher_disagreement_score":0.04757138,"about_ca_system_score_codex":0.04757138,"about_ca_system_score_gemma":0.105265036,"threshold_uncertainty_score":0.34515613},"labels":[],"label_agreement":null},{"id":"W2089080067","doi":"10.1016/s1098-3015(11)72174-x","title":"PMS21 THE ACUTE CARE COSTS OF OSTEOPOROSIS-RELATED FRACTURES IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoporosis; Medicine; Intensive care medicine; Emergency medicine; Internal medicine","score_opus":0.01577848480748095,"score_gpt":0.32667215193456717,"score_spread":0.3108936671270862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089080067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76443315,0.019096753,0.00027976185,0.06825189,0.0009842312,0.00024801903,0.085931994,0.000101957405,0.060672197],"genre_scores_gemma":[0.9658691,0.007419681,0.00026532268,0.002503124,0.00031805827,0.000045894983,0.009495851,0.00002466596,0.014058351],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977982,0.0001820651,0.00017285645,0.00010640473,0.0010057451,0.0007348623],"domain_scores_gemma":[0.9928082,0.00043777763,0.0010750944,0.00007716615,0.0030563686,0.002545421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005837952,0.0002979718,0.00057802344,0.0023677193,0.0025685558,0.0022471584,0.0013609709,0.0014243401,0.009672308],"category_scores_gemma":[0.009167521,0.00047852093,0.0011213303,0.0056653987,0.0005966554,0.00051884475,0.000988928,0.0020766389,0.00046692154],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052102696,0.00021003123,0.8559744,0.00033094903,0.00044156238,0.0005829179,0.00038734687,0.002421999,0.00013661441,0.0037498523,0.082750306,0.052493054],"study_design_scores_gemma":[0.00013957954,0.000052309544,0.9733034,0.0001926613,0.00015733781,0.0002543881,0.0009852492,0.0019172935,0.000080518555,0.00036264758,0.022521565,0.00003292754],"about_ca_topic_score_codex":0.9966329,"about_ca_topic_score_gemma":0.99793124,"teacher_disagreement_score":0.081881315,"about_ca_system_score_codex":0.081881315,"about_ca_system_score_gemma":0.11528408,"threshold_uncertainty_score":0.5940933},"labels":[],"label_agreement":null},{"id":"W2089179132","doi":"10.1016/j.jval.2014.03.1112","title":"Optimal information acquisition policies: Application to hepatitis c screening","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hepatitis C; Hepatitis C virus; Demography; Quality-adjusted life year; Markov decision process; Cost effectiveness; Statistics; Immunology; Markov process; Risk analysis (engineering); Mathematics; Virus","score_opus":0.03451200899937069,"score_gpt":0.3539474941461517,"score_spread":0.319435485146781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089179132","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24558099,0.0063755075,0.6953826,0.01643209,0.00063385343,0.0017991983,0.0019450504,0.0013129892,0.030537741],"genre_scores_gemma":[0.9052731,0.0026371086,0.08425932,0.0008292288,0.00043171726,0.00042349347,0.00036622176,0.00016144053,0.0056183306],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9900733,0.0070481584,0.0003569238,0.0008466336,0.0008173788,0.0008576156],"domain_scores_gemma":[0.76737005,0.2164785,0.0058027958,0.0036484483,0.004223202,0.0024770142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021918697,0.0023812617,0.0051024174,0.0030418236,0.0014610335,0.0057676905,0.0030391929,0.0052710054,0.008144206],"category_scores_gemma":[0.13131161,0.0016360445,0.0013917144,0.003040953,0.003180675,0.0071378937,0.0030128518,0.0055402457,0.0006893097],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026606123,0.0017420157,0.0057459883,0.0005812711,0.00026743786,0.00043903769,0.00036423668,0.7248501,0.001018851,0.16320787,0.009412871,0.089709565],"study_design_scores_gemma":[0.0005016551,0.00032498915,0.0011258923,0.0001071214,0.00015526552,0.000100911675,0.00017979811,0.83341,0.00045026047,0.16220753,0.0013655198,0.00007100741],"about_ca_topic_score_codex":0.009438772,"about_ca_topic_score_gemma":0.005385155,"teacher_disagreement_score":0.021918697,"about_ca_system_score_codex":0.005872697,"about_ca_system_score_gemma":0.008561334,"threshold_uncertainty_score":0.11591852},"labels":[],"label_agreement":null},{"id":"W2089490629","doi":"10.1016/j.jval.2012.08.433","title":"PND7 Economic Impact of Dementia in the Community-Dwelling Elderly Population of Quebec (Canada)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Dementia; Medicine; Rivastigmine; Cohort; Galantamine; Gerontology; Population; Cohort study; Retrospective cohort study; Donepezil; Environmental health; Surgery; Internal medicine; Disease","score_opus":0.37056599405166657,"score_gpt":0.42933135579479637,"score_spread":0.058765361743129796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089490629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86599815,0.0076525244,0.000228795,0.008528171,0.000213295,0.00012924527,0.091360115,0.000041661344,0.025848107],"genre_scores_gemma":[0.97289264,0.0025399998,0.00029251687,0.0005636029,0.000044750384,0.00004115873,0.014876016,0.000009582774,0.008739731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991893,0.0001400332,0.00005317931,0.00004334602,0.00027324219,0.000300941],"domain_scores_gemma":[0.9970817,0.00022204602,0.00028549446,0.000044998764,0.0015339026,0.00083179516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007483313,0.00026410687,0.00035137445,0.0017561937,0.00125144,0.0017108032,0.00065788784,0.0005288324,0.00514286],"category_scores_gemma":[0.004076806,0.00015577917,0.0008600185,0.0033428115,0.0003885749,0.00040111263,0.0008296734,0.0007545294,0.0002553826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041045007,0.00018394376,0.9264689,0.00025324489,0.00042101974,0.00038183303,0.00024143928,0.0043336665,0.0000927733,0.0023903903,0.039311532,0.025510898],"study_design_scores_gemma":[0.000041144805,0.000034666635,0.9891895,0.00013509569,0.000074697484,0.00007508294,0.0004933648,0.002525792,0.000057483983,0.00018574984,0.0071691875,0.000018178322],"about_ca_topic_score_codex":0.9971808,"about_ca_topic_score_gemma":0.9976393,"teacher_disagreement_score":0.04957401,"about_ca_system_score_codex":0.04957401,"about_ca_system_score_gemma":0.04105229,"threshold_uncertainty_score":0.35968632},"labels":[],"label_agreement":null},{"id":"W2090016518","doi":"10.1016/s1098-3015(10)67762-5","title":"PMH16 EFFECT OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD) ON COST OF CARE IN THE CANADIAN OUTCOMES STUDY IN DEMENTIA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Gerontology; Medicine; Psychiatry; Psychology; Disease","score_opus":0.12665287068158737,"score_gpt":0.4840669581968342,"score_spread":0.35741408751524684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090016518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97595894,0.003442119,0.00005375527,0.0015535463,0.00014847599,0.000106920204,0.014240551,0.000013092974,0.004482603],"genre_scores_gemma":[0.99018717,0.0013399811,0.00017947832,0.0003712183,0.00009378676,0.00008646338,0.006275617,0.000011348192,0.0014549518],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738806,0.00059536507,0.00020781322,0.00022789712,0.00075471355,0.00082613487],"domain_scores_gemma":[0.99443275,0.0007045671,0.0010451059,0.00019896287,0.0018998818,0.0017186645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025041646,0.0011213997,0.0012976576,0.0014570882,0.0031449986,0.00213706,0.0028155057,0.001430553,0.003672422],"category_scores_gemma":[0.0111562,0.00075146783,0.003284055,0.0049163275,0.0009775623,0.0009567856,0.0017262215,0.0023242491,0.00024659935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002754388,0.00025121364,0.9861567,0.00015502943,0.0010296239,0.00006273858,0.00032853204,0.00025552374,0.000046293364,0.00020493334,0.003822743,0.004932114],"study_design_scores_gemma":[0.00012874384,0.00006476969,0.9987663,0.000041586114,0.00020760503,0.000015553502,0.00018256597,0.000124519,0.000014261294,0.000028015082,0.00040660895,0.00001948301],"about_ca_topic_score_codex":0.98381823,"about_ca_topic_score_gemma":0.9860552,"teacher_disagreement_score":0.021034975,"about_ca_system_score_codex":0.021034975,"about_ca_system_score_gemma":0.028066209,"threshold_uncertainty_score":0.15262014},"labels":[],"label_agreement":null},{"id":"W2090035412","doi":"10.1016/j.jval.2014.08.518","title":"Cost-Effectiveness of Antiviral Therapy for Chronic Hepatitis B: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Entecavir; Lamivudine; Telbivudine; Internal medicine; Adefovir; Chronic hepatitis; Pegylated interferon; Gastroenterology; Immunology; Virus","score_opus":0.18711286790757406,"score_gpt":0.44642041802870064,"score_spread":0.2593075501211266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090035412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018709005,0.9973271,0.00010891422,0.0001271807,0.000086965665,0.000081768085,0.00023214234,0.000005040865,0.00015992322],"genre_scores_gemma":[0.050452635,0.9478878,0.0007251087,0.00039281542,0.00010343028,0.00015444847,0.00018344691,0.000005158313,0.00009508028],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99438804,0.0025106338,0.0016058879,0.00037100003,0.00093071116,0.00019380046],"domain_scores_gemma":[0.9814051,0.014945177,0.0025105798,0.00020898475,0.00074302533,0.00018720717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064051314,0.0015180396,0.009880952,0.004978333,0.0003902453,0.0021904786,0.0016891226,0.0018193282,0.0045679435],"category_scores_gemma":[0.029698871,0.0011261952,0.0122446595,0.006902593,0.0007516963,0.0017973927,0.0013409646,0.0019124474,0.00018660259],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014361746,0.000044133292,0.0022345795,0.8430965,0.11495554,0.000118091724,0.00008019855,0.00037604172,0.00013026947,0.0003091477,0.0011857796,0.03603345],"study_design_scores_gemma":[0.0023674937,0.0005300229,0.011619399,0.2892231,0.6845037,0.0004421521,0.0002733572,0.0003918689,0.00019291048,0.0008919512,0.009487453,0.00007661179],"about_ca_topic_score_codex":0.009766872,"about_ca_topic_score_gemma":0.0264297,"teacher_disagreement_score":0.009880952,"about_ca_system_score_codex":0.0035729462,"about_ca_system_score_gemma":0.004086094,"threshold_uncertainty_score":0.033873975},"labels":[],"label_agreement":null},{"id":"W2090049620","doi":"10.1016/j.jval.2012.03.367","title":"PMD27 Cost-Effectiveness of Sacral Nerve Stimulation in Refractory Overactive Bladder: A Canadian Perspective","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Foothills Medical Centre; Toronto Western Hospital; Jewish General Hospital; Royal Alexandra Hospital; Queen Elizabeth II Health Sciences Centre; Moncton Hospital; Medtronic (Canada)","funders":"","keywords":"Medicine; Sacral nerve stimulation; Formulary; Overactive bladder; Incremental cost-effectiveness ratio; Refractory (planetary science); Cost effectiveness; Emergency medicine; Quality-adjusted life year; Surgery; Family medicine","score_opus":0.09103576255316277,"score_gpt":0.4043551031762139,"score_spread":0.31331934062305117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090049620","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14488626,0.15180486,0.002622036,0.38431218,0.0029817126,0.00045683805,0.028560987,0.00011319543,0.28426188],"genre_scores_gemma":[0.88594466,0.075234614,0.004176872,0.014192447,0.002234142,0.00015476084,0.0049918974,0.00006071826,0.0130099105],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952017,0.0011336856,0.000249388,0.00022247164,0.0021759693,0.0010168157],"domain_scores_gemma":[0.99126023,0.0018517365,0.0005217263,0.00006912354,0.0043365196,0.0019606906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036116382,0.0009628224,0.0013851448,0.0031670057,0.0016612057,0.005029526,0.0018843549,0.002676895,0.013695847],"category_scores_gemma":[0.015369179,0.00042115437,0.0026039616,0.004762969,0.0012533721,0.0009554552,0.0010445019,0.003032002,0.00039633634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010595773,0.0007342026,0.06335288,0.007583736,0.0052035786,0.0016997303,0.0010803968,0.0599754,0.0025187158,0.13068755,0.25193977,0.46462822],"study_design_scores_gemma":[0.007385427,0.0025944829,0.40098467,0.01649166,0.010406554,0.0025272772,0.005069723,0.04843835,0.0018338849,0.035501447,0.46767327,0.0010932367],"about_ca_topic_score_codex":0.9705813,"about_ca_topic_score_gemma":0.9717478,"teacher_disagreement_score":0.11173783,"about_ca_system_score_codex":0.11173783,"about_ca_system_score_gemma":0.13543971,"threshold_uncertainty_score":0.81071854},"labels":[],"label_agreement":null},{"id":"W2090057746","doi":"10.1016/j.jval.2012.08.1657","title":"PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; Lawson Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Glycemic; Diabetes mellitus; Cohort; Demography; Epidemiology; Cohort study; Gerontology; Internal medicine; Endocrinology","score_opus":0.01655303372385288,"score_gpt":0.2573064008188452,"score_spread":0.24075336709499232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090057746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095356,0.0002333508,0.000028739933,0.00017917069,0.000009517892,0.000052634656,0.003476887,0.0000043756904,0.0050617247],"genre_scores_gemma":[0.99498606,0.00024300058,0.00008593427,0.00011765442,0.0000070172932,0.00003177189,0.0017699606,0.0000054545976,0.0027531954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993699,0.00003037378,0.000062136955,0.000070219416,0.00019704795,0.0002702496],"domain_scores_gemma":[0.9989404,0.00003289038,0.00019375398,0.000021516109,0.0004989036,0.00031254432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020891793,0.00027261063,0.00041978134,0.0014545996,0.0034012222,0.001088613,0.00088515016,0.00044486823,0.003961367],"category_scores_gemma":[0.0010556092,0.00030926015,0.00059910427,0.0034825357,0.00053066557,0.00030862127,0.00073243,0.0005985473,0.0005508271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047641723,0.00003906181,0.9954059,0.000025427096,0.000020728503,0.0002740405,0.0015486523,0.00003283674,0.00016008301,0.00005537457,0.0008395837,0.0015507501],"study_design_scores_gemma":[0.0000037547982,0.000020030353,0.99589574,0.000015601574,0.000011518349,0.00014762775,0.0031550906,0.0000379663,0.00001952348,0.00001030861,0.0006774489,0.000005443322],"about_ca_topic_score_codex":0.9844542,"about_ca_topic_score_gemma":0.99022955,"teacher_disagreement_score":0.015545785,"about_ca_system_score_codex":0.011764275,"about_ca_system_score_gemma":0.014020869,"threshold_uncertainty_score":0.085356176},"labels":[],"label_agreement":null},{"id":"W2090096004","doi":"10.1016/j.jval.2011.08.1316","title":"PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; Sanofi (Canada); University of Toronto","funders":"","keywords":"Medicine; Diabetes mellitus; Insulin; Type 2 Diabetes Mellitus; Internal medicine; Prospective cohort study; Type 2 diabetes; Population; Type 1 diabetes; Logistic regression; Odds ratio; Endocrinology","score_opus":0.017002703349487922,"score_gpt":0.24817811634583484,"score_spread":0.23117541299634692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090096004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8680249,0.00038027574,0.00068732415,0.00015369174,0.00003312937,0.00069286354,0.12668675,0.0000926093,0.0032485726],"genre_scores_gemma":[0.823117,0.00036685495,0.0017725123,0.00030255562,0.00006300514,0.0015491137,0.17098936,0.000058469566,0.0017811018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847573,0.00033167438,0.00032335246,0.00038207936,0.0002951591,0.00019191792],"domain_scores_gemma":[0.99380714,0.00054505875,0.0033475524,0.0005382737,0.0008906984,0.0008713138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014390546,0.00064589793,0.0012200001,0.002230563,0.0007209006,0.00145245,0.001337873,0.0005051324,0.0029748317],"category_scores_gemma":[0.0040533254,0.0005322868,0.0008725289,0.005146274,0.00026189876,0.0010357858,0.0013227239,0.0009027236,0.0013280509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014423672,0.0002070987,0.9931363,0.00005520665,0.00015438013,0.00007021084,0.0000386896,0.000054612356,0.00019199967,0.000050897175,0.002524449,0.0020737697],"study_design_scores_gemma":[0.000478768,0.00040078838,0.9965502,0.000019950416,0.00014137609,0.00027832141,0.000116639676,0.00024482873,0.00021835534,0.000036065674,0.0014999559,0.000014735745],"about_ca_topic_score_codex":0.018702943,"about_ca_topic_score_gemma":0.018641653,"teacher_disagreement_score":0.018702943,"about_ca_system_score_codex":0.0011230396,"about_ca_system_score_gemma":0.0021651192,"threshold_uncertainty_score":0.037188172},"labels":[],"label_agreement":null},{"id":"W2090440337","doi":"10.1016/s1098-3015(10)61790-1","title":"PUK7 DITROPAN XL VERSUS DETROL IN CANADA: ECONOMIC ANALYSIS","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Scientific Measurement and Uncertainty Evaluation","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economics","score_opus":0.3559867338754549,"score_gpt":0.41029475907202934,"score_spread":0.05430802519657446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090440337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87680066,0.080835186,0.0017747711,0.013329495,0.0002599019,0.0013811759,0.008575201,0.000077364086,0.016966207],"genre_scores_gemma":[0.979833,0.013851502,0.0015495978,0.0007067631,0.00007047813,0.00017011302,0.0011027341,0.000020941417,0.0026948936],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9949102,0.0028250935,0.00023580856,0.00024186517,0.0011454135,0.0006416581],"domain_scores_gemma":[0.99130905,0.0046853586,0.0010136443,0.00013376666,0.0013208209,0.0015373538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006767007,0.00097149285,0.0021087846,0.0015722722,0.0013247088,0.0029548614,0.0013842289,0.0017076154,0.0065076943],"category_scores_gemma":[0.01932209,0.0004567091,0.0022015048,0.0034252407,0.0014291375,0.00086569804,0.0011817906,0.0023820458,0.00019371658],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4473721,0.004070934,0.07128654,0.0073233424,0.009740812,0.00062027876,0.0006465274,0.06320241,0.0011948469,0.021280242,0.02172552,0.35153654],"study_design_scores_gemma":[0.109489776,0.06726622,0.39260957,0.010047566,0.061336275,0.0014461069,0.006517832,0.26166618,0.0052652946,0.019705681,0.06344066,0.0012088761],"about_ca_topic_score_codex":0.9373351,"about_ca_topic_score_gemma":0.9449773,"teacher_disagreement_score":0.0980096,"about_ca_system_score_codex":0.0980096,"about_ca_system_score_gemma":0.079829335,"threshold_uncertainty_score":0.71111274},"labels":[],"label_agreement":null},{"id":"W2090794354","doi":"10.1016/j.jval.2012.08.1720","title":"PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University; Lawson Health Research Institute","funders":"","keywords":"Medicine; Diabetes mellitus; Glycemic; Cohort; Epidemiology; Hyperlipidemia; Baseline (sea); Diabetes management; Demography; Cohort study; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.02483377153740551,"score_gpt":0.25485371831148845,"score_spread":0.23001994677408294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090794354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839738,0.0004732763,0.000053255313,0.00042241046,0.000019568959,0.00004791038,0.0063681453,0.000007747422,0.008633954],"genre_scores_gemma":[0.99448156,0.0003358978,0.00009049969,0.00023110963,0.000012836369,0.000026302976,0.0027020033,0.000006052258,0.0021138168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991702,0.000048138205,0.00010075234,0.000110120636,0.00022377518,0.00034704126],"domain_scores_gemma":[0.9977156,0.00010301484,0.0005236629,0.000049153146,0.00088880636,0.00071977807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026341205,0.00025710717,0.00048001346,0.0012468357,0.0028712568,0.0012663099,0.000903186,0.0005024945,0.005459474],"category_scores_gemma":[0.0017152842,0.00030658397,0.00055157,0.0043519046,0.00052352913,0.00039297028,0.00070585846,0.0006519644,0.0005642849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004548199,0.000030001785,0.9973272,0.000013316398,0.000016305248,0.0001657519,0.00031183937,0.000032095748,0.00007368802,0.00004612941,0.00088216783,0.0010560376],"study_design_scores_gemma":[0.000007867418,0.000020812846,0.9971854,0.00002171125,0.000013667776,0.00015624201,0.0016350358,0.000062626656,0.000018096089,0.00001504656,0.0008572541,0.000006376081],"about_ca_topic_score_codex":0.97190046,"about_ca_topic_score_gemma":0.9852315,"teacher_disagreement_score":0.028099537,"about_ca_system_score_codex":0.015418759,"about_ca_system_score_gemma":0.019530984,"threshold_uncertainty_score":0.11187148},"labels":[],"label_agreement":null},{"id":"W2091052539","doi":"10.1016/j.jval.2014.03.889","title":"Comparing Public Influenza Immunization Programmes In Ontario And Québec, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brock University; Université de Montréal","funders":"","keywords":"Pharmacy; Medicine; Government (linguistics); Christian ministry; Family medicine; Public health; Population; Health care; Rural area; Nursing; Environmental health; Economic growth; Political science","score_opus":0.1559249845413938,"score_gpt":0.35731532416037054,"score_spread":0.20139033961897673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091052539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740559,0.008004276,0.00021003095,0.0034186637,0.00009500482,0.00020686547,0.0069157574,0.000017013424,0.007076455],"genre_scores_gemma":[0.993679,0.0016940817,0.00018535298,0.00045054653,0.000021109401,0.000092231625,0.0015056415,0.0000073115957,0.0023648455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945056,0.0013055477,0.0003533658,0.00036925502,0.0012663979,0.002199843],"domain_scores_gemma":[0.9834238,0.0027020306,0.003548008,0.00039021482,0.0060240994,0.0039117294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038180489,0.0005180207,0.0010394948,0.0022057581,0.0045303344,0.0022298542,0.0022202663,0.0010387582,0.002733373],"category_scores_gemma":[0.012791326,0.00045817724,0.001305082,0.009182985,0.0016183401,0.0009284057,0.001625114,0.0013307014,0.00017155093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001260179,0.00030276054,0.9701666,0.00039191783,0.00078030454,0.00012409208,0.003479519,0.00080945186,0.00016964857,0.0011864491,0.005460003,0.015869003],"study_design_scores_gemma":[0.00013042046,0.00012810079,0.992732,0.0001943793,0.00027408323,0.000020136145,0.0036422687,0.00034889264,0.00007714235,0.00006400225,0.0023653908,0.000023159972],"about_ca_topic_score_codex":0.99905545,"about_ca_topic_score_gemma":0.9995098,"teacher_disagreement_score":0.1225897,"about_ca_system_score_codex":0.1225897,"about_ca_system_score_gemma":0.12757584,"threshold_uncertainty_score":0.8894547},"labels":[],"label_agreement":null},{"id":"W2091114523","doi":"10.1016/j.jval.2014.03.819","title":"Creating The Canada Pro Network","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"SWOT analysis; Process management; Business; Relevance (law); Action plan; Strategic planning; Sustainability; Process (computing); Plan (archaeology); Quality (philosophy); Knowledge management; Health care; Public relations; Political science; Computer science; Marketing","score_opus":0.26768701807157097,"score_gpt":0.48210780314110446,"score_spread":0.2144207850695335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091114523","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00900179,0.0014116443,0.0051444527,0.664323,0.0048400974,0.0002999744,0.0007044603,0.00040210667,0.31387252],"genre_scores_gemma":[0.23232341,0.0030186076,0.021937646,0.2025849,0.0020384397,0.0005616658,0.0013017249,0.0008937721,0.5353398],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97693187,0.005279946,0.0003234541,0.0012762861,0.010675961,0.005512536],"domain_scores_gemma":[0.90064454,0.007300515,0.0014782615,0.003062623,0.034447134,0.053066853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016753623,0.0006802256,0.00041301086,0.0035245186,0.020510226,0.018751616,0.0025359725,0.008313502,0.033880167],"category_scores_gemma":[0.037991926,0.0008893988,0.00053198054,0.0023194288,0.009178547,0.007212973,0.011303011,0.009532813,0.005024341],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023903664,0.000078309924,0.0030047675,0.000031237145,0.0000117026975,0.00018835085,0.0016164006,0.00027875157,0.00022499134,0.14814863,0.8139382,0.03245471],"study_design_scores_gemma":[0.000010579614,0.0000125744145,0.0017465025,0.00007387272,0.0000045729525,0.000040769475,0.0023570557,0.0003354428,0.00012621879,0.009755897,0.9855106,0.000025996813],"about_ca_topic_score_codex":0.876065,"about_ca_topic_score_gemma":0.95271856,"teacher_disagreement_score":0.9240307,"about_ca_system_score_codex":0.075969286,"about_ca_system_score_gemma":0.3925535,"threshold_uncertainty_score":0.55119836},"labels":[],"label_agreement":null},{"id":"W2091403456","doi":"10.1111/j.1524-4733.2009.00573.x","title":"A Multinational Study of Health State Preference Values Associated with Chronic Myelogenous Leukemia","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Demography; Preference; Population; Estimation; Disease; Environmental health; Leukemia; Internal medicine; Statistics; Economics","score_opus":0.05893333800666009,"score_gpt":0.3183134830426154,"score_spread":0.2593801450359553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091403456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99952865,0.000037716465,0.000018490615,0.000076004224,0.000001290616,0.0000040016726,0.00011641345,2.5262298e-7,0.00021719154],"genre_scores_gemma":[0.99957234,0.000032085893,0.000027607164,0.000025964328,0.0000022189613,0.0000055033483,0.00015799285,5.9227546e-7,0.0001756274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887043,0.0007709185,0.000047740563,0.00009079963,0.00008095974,0.0001391424],"domain_scores_gemma":[0.99074066,0.004294264,0.0031878615,0.00040822473,0.00043903108,0.0009299759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026580822,0.0002265417,0.00033712646,0.00056376745,0.000897006,0.0011968856,0.00048128,0.00049639685,0.0026148043],"category_scores_gemma":[0.008789576,0.00020859987,0.00046150136,0.0015521419,0.00065417675,0.00074465596,0.0010100554,0.0011264205,0.00014971443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037078137,0.00026027614,0.9969213,0.00000677596,0.000083805986,0.00005114858,0.00053290883,0.00010257398,0.000054135537,0.00015702058,0.00012251773,0.0013367074],"study_design_scores_gemma":[0.000054234697,0.0002580473,0.9939101,0.000011880119,0.000086990985,0.00009288702,0.0043136785,0.0006031488,0.00004707496,0.00013010364,0.0004829179,0.000009044333],"about_ca_topic_score_codex":0.052555747,"about_ca_topic_score_gemma":0.067893,"teacher_disagreement_score":0.052555747,"about_ca_system_score_codex":0.0013869334,"about_ca_system_score_gemma":0.0008357673,"threshold_uncertainty_score":0.10449964},"labels":[],"label_agreement":null},{"id":"W2091498187","doi":"10.1016/j.jval.2011.02.584","title":"PDB76 DESIGNING A SERVICE FRAMEWORK FOR ELECTRONIC PERSONAL HEALTH RECORDS: A PATIENT-CENTRED APPROACH","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Service (business); Conjoint analysis; Preference; Latent class model; Sample (material); Pairwise comparison; Type 2 diabetes; Willingness to pay; Psychology; Medicine; Marketing; Business; Computer science; Diabetes mellitus; Statistics; Economics","score_opus":0.21226584666806306,"score_gpt":0.39688217013485244,"score_spread":0.18461632346678938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091498187","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018150503,0.00011911636,0.92787755,0.0056170514,0.00016095153,0.0018233809,0.0006009011,0.0040257196,0.04162478],"genre_scores_gemma":[0.1317395,0.0001643584,0.84610677,0.0008046376,0.000041394884,0.0005614247,0.0011250945,0.00063968456,0.018817157],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9872624,0.006081758,0.0010325089,0.00087987765,0.003571464,0.0011719597],"domain_scores_gemma":[0.9930854,0.0017484918,0.00033035633,0.0010964397,0.0025576025,0.001181642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011634967,0.00046888154,0.0006334296,0.0020833644,0.0029904793,0.009761206,0.00302185,0.0033470578,0.009235316],"category_scores_gemma":[0.014758161,0.0010739308,0.0012288428,0.0020441427,0.0022751475,0.0050574015,0.0052524223,0.0023657097,0.0033985274],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024249361,0.000776148,0.008614471,0.0007088926,0.00009815551,0.001220147,0.007853554,0.023583107,0.021580191,0.6464087,0.047435407,0.24147882],"study_design_scores_gemma":[0.00020912876,0.00030617815,0.0023940788,0.00050734635,0.00011881211,0.0010905339,0.00649277,0.16327515,0.020659607,0.1055223,0.69923425,0.00018986518],"about_ca_topic_score_codex":0.020165646,"about_ca_topic_score_gemma":0.021513611,"teacher_disagreement_score":0.020165646,"about_ca_system_score_codex":0.004975105,"about_ca_system_score_gemma":0.014585018,"threshold_uncertainty_score":0.06153232},"labels":[],"label_agreement":null},{"id":"W2091627021","doi":"10.1016/j.jval.2012.08.1694","title":"PDB51 Resource Utilization in the Management of Acromegaly: An Analysis From Southwest Ontario","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Acromegaly; Retrospective cohort study; Population; Pegvisomant; Transsphenoidal surgery; Dyslipidemia; Internal medicine; Pediatrics; Surgery; Pituitary adenoma; Adenoma; Obesity","score_opus":0.07125471215382204,"score_gpt":0.3252908177454708,"score_spread":0.2540361055916488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091627021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888278,0.0008328693,0.000087185115,0.00057545723,0.0000079978445,0.00006289148,0.006097789,0.000008543062,0.0034994802],"genre_scores_gemma":[0.995226,0.0010152315,0.00016459246,0.00024595574,0.000009556905,0.000047583166,0.0021055383,0.000010796662,0.0011747014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998588,0.00017541445,0.0001591107,0.00012895727,0.0005035656,0.00044482338],"domain_scores_gemma":[0.9954555,0.0003209544,0.0018557399,0.00012016556,0.001177905,0.0010697065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056445115,0.00026287665,0.0004579537,0.0017563801,0.0018675784,0.0012494583,0.0010534062,0.0003713775,0.0027101662],"category_scores_gemma":[0.0028498457,0.00039424305,0.0007796394,0.006864155,0.00054665515,0.00035681683,0.0011566052,0.0004956597,0.00024460614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010265729,0.00003288213,0.99281824,0.000074155745,0.00007697774,0.00016203173,0.00089281437,0.0001361548,0.00015302429,0.0001284677,0.0014695418,0.003952956],"study_design_scores_gemma":[0.0000072926287,0.000017867224,0.9975038,0.000031601427,0.00002389023,0.000068328445,0.0013028338,0.00010245309,0.000022817096,0.00000963426,0.0009039587,0.0000055916657],"about_ca_topic_score_codex":0.97025824,"about_ca_topic_score_gemma":0.9873833,"teacher_disagreement_score":0.029741764,"about_ca_system_score_codex":0.025945991,"about_ca_system_score_gemma":0.029008111,"threshold_uncertainty_score":0.18825221},"labels":[],"label_agreement":null},{"id":"W2092311018","doi":"10.1046/j.1524-4733.2001.43017.x","title":"Diabetes in Canada: Direct Medical Costs of Major Macrovascular Complications","year":2001,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Canadian Association of Radiation Oncology","funders":"","keywords":"Medicine; Health care; Indirect costs; Medical emergency; Intensive care medicine; Stroke (engine); Emergency medicine; Myocardial infarction; Formulary; Acute care; Business; Family medicine; Economics","score_opus":0.04498942896979092,"score_gpt":0.3179939853166421,"score_spread":0.27300455634685117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092311018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004923794,0.9950653,0.00005688986,0.0014712822,0.00027517343,0.000008904606,0.00026937027,0.000008931175,0.0023517378],"genre_scores_gemma":[0.0036322314,0.9949929,0.00015498222,0.00032651573,0.00011479852,0.0000054464376,0.00012841151,0.0000015578448,0.0006431509],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99911696,0.000068593086,0.00007623762,0.000055713637,0.00059858285,0.000083931875],"domain_scores_gemma":[0.99750817,0.0005249641,0.0003415346,0.000025321908,0.0013567078,0.00024333631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012337951,0.001076632,0.0022284563,0.0049961484,0.000859599,0.0022050845,0.0009622932,0.0010969955,0.004072009],"category_scores_gemma":[0.0036285575,0.00031002384,0.0008046696,0.014708858,0.0006690029,0.0006059327,0.000561265,0.0015723708,0.0004918827],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016783408,0.00006959319,0.0042432486,0.014363072,0.0005294489,0.00015533502,0.000076404736,0.00067452126,0.00010518414,0.002842908,0.12497494,0.8517976],"study_design_scores_gemma":[0.000141499,0.00010612815,0.0566043,0.028718317,0.0023834766,0.0013036326,0.0004980373,0.0007464054,0.00027017112,0.0029459512,0.90618294,0.00009910758],"about_ca_topic_score_codex":0.79307604,"about_ca_topic_score_gemma":0.890383,"teacher_disagreement_score":0.20692396,"about_ca_system_score_codex":0.01853846,"about_ca_system_score_gemma":0.041899696,"threshold_uncertainty_score":0.4162851},"labels":[],"label_agreement":null},{"id":"W2092377177","doi":"10.1016/j.jval.2013.08.343","title":"Resource Utilization and Costs Associated with Rituximab Treatment in Patients with Pemphigus and Pemphigoid: A Comparison of 6 Months Before and 6 Months After Treatment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Adverse effect; Pemphigus; Bullous pemphigoid; Cohort; Pemphigoid; Internal medicine; Pediatrics; Dermatology; Immunology; Lymphoma; Antibody","score_opus":0.018961041333150148,"score_gpt":0.2733268364263216,"score_spread":0.2543657950931715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092377177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981598,0.0010005862,0.000029078643,0.00011029166,0.000010359376,0.0000054787847,0.00027337982,0.0000012581198,0.00040965775],"genre_scores_gemma":[0.99943095,0.00017828796,0.000025111804,0.000024732171,0.000011239275,0.0000052417286,0.00026465653,8.0007993e-7,0.000058919308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897885,0.0003920735,0.00013663876,0.0000936651,0.00012594237,0.00027286747],"domain_scores_gemma":[0.9976083,0.0007714349,0.0010448345,0.00006127416,0.00014540784,0.00036868002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067378004,0.00026891322,0.00067592144,0.0009907788,0.00032178304,0.0008647293,0.0003968416,0.00079119706,0.0013337244],"category_scores_gemma":[0.004249205,0.00020030049,0.0019443867,0.0016898013,0.00027348584,0.0007775686,0.0006672677,0.0008176297,0.00011471482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007153491,0.00043509272,0.9797158,0.00009766931,0.0010899847,0.00029291277,0.00017980108,0.0013450609,0.00023975135,0.00014077664,0.00028764538,0.009021911],"study_design_scores_gemma":[0.00009040621,0.0010265898,0.99628925,0.00002596228,0.0003630045,0.00022273196,0.000534281,0.0010629987,0.00006334393,0.00008309229,0.00022137963,0.000016857284],"about_ca_topic_score_codex":0.011051629,"about_ca_topic_score_gemma":0.009243343,"teacher_disagreement_score":0.011051629,"about_ca_system_score_codex":0.0017527464,"about_ca_system_score_gemma":0.00059235585,"threshold_uncertainty_score":0.021974623},"labels":[],"label_agreement":null},{"id":"W2092399991","doi":"10.1016/j.jval.2014.03.1136","title":"EQ-5D health utilities are estimated subject to considerable uncertainty","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Standard deviation; Statistics; Mean squared error; Confidence interval; Bayesian probability; Econometrics; Mathematics; Mean absolute error; Geometric mean; Valuation (finance); Economics","score_opus":0.6195816174981952,"score_gpt":0.4378684003712079,"score_spread":0.1817132171269873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092399991","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13700967,0.03235348,0.7734361,0.017350305,0.0018763468,0.0005149549,0.015334827,0.0005173753,0.021606818],"genre_scores_gemma":[0.9132183,0.010946836,0.058937233,0.0032879838,0.0015102231,0.0006547123,0.006668347,0.00020533148,0.0045709987],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.97166014,0.018936813,0.0023324178,0.0025865173,0.0038655049,0.0006186197],"domain_scores_gemma":[0.765846,0.21748601,0.0067996196,0.0063104336,0.0033408643,0.00021700733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04000377,0.0009906763,0.0023893828,0.0025202865,0.0005678591,0.003971606,0.0015484529,0.0013800478,0.0029750695],"category_scores_gemma":[0.21508916,0.000956679,0.001757843,0.005985616,0.0018107453,0.0040025986,0.0018096899,0.00394077,0.0009835927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006999886,0.00016155663,0.07619411,0.0017474726,0.0031650818,0.0010178279,0.0007857697,0.3663732,0.0009866928,0.19571762,0.027557498,0.32559317],"study_design_scores_gemma":[0.00012530635,0.00020183143,0.102116674,0.001560494,0.0010305081,0.0012247441,0.0006938515,0.23959972,0.0022664997,0.6187636,0.032110095,0.0003066302],"about_ca_topic_score_codex":0.008402923,"about_ca_topic_score_gemma":0.0035371182,"teacher_disagreement_score":0.04000377,"about_ca_system_score_codex":0.0026462423,"about_ca_system_score_gemma":0.00094955316,"threshold_uncertainty_score":0.21156263},"labels":[],"label_agreement":null},{"id":"W2092595881","doi":"10.1016/s1098-3015(10)70656-2","title":"PCV70 PATIENT ADHERENCE TO CHOLESTEROL TREATMENT (PACT): CANADIAN PHYSICIAN AND PATIENT PERSPECTIVES","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pact; Medicine; Family medicine; Medication adherence; Internal medicine; Political science; Law","score_opus":0.18007793387330448,"score_gpt":0.3952069943918495,"score_spread":0.215129060518545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092595881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.579793,0.031926602,0.00020001832,0.2327769,0.00046827423,0.00008514077,0.0029161451,0.000017244474,0.15181668],"genre_scores_gemma":[0.97691,0.010729153,0.00030578682,0.009099043,0.0002158699,0.0000180701,0.00038145148,0.000007968162,0.002332585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993672,0.001214152,0.00024070847,0.00023082815,0.0031938804,0.0014484108],"domain_scores_gemma":[0.9810798,0.0046107317,0.0017733312,0.00014154923,0.0081488425,0.004245691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005055478,0.00020242664,0.00048565067,0.0017336031,0.0064030476,0.004025203,0.0010853186,0.0018749981,0.0091576],"category_scores_gemma":[0.02277517,0.0002880089,0.0005978705,0.004644515,0.0017480537,0.00093731063,0.0010529928,0.0026877758,0.00022091893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009961359,0.00042646338,0.700898,0.0007078653,0.00025491617,0.0007896111,0.03466473,0.00046825802,0.00036609705,0.0150077,0.096003875,0.1494164],"study_design_scores_gemma":[0.00020018007,0.00017475094,0.8814989,0.0009979315,0.00026949868,0.0004083911,0.038787965,0.00055288314,0.00016381503,0.0010503121,0.075748585,0.00014679383],"about_ca_topic_score_codex":0.9864222,"about_ca_topic_score_gemma":0.99307114,"teacher_disagreement_score":0.049587723,"about_ca_system_score_codex":0.049587723,"about_ca_system_score_gemma":0.082376845,"threshold_uncertainty_score":0.3597858},"labels":[],"label_agreement":null},{"id":"W2092941629","doi":"10.1046/j.1524-4733.2001.40201-16.x","title":"HP4: ASSESSING LIFESTYLE DRUGS FOR DRUG BENEFIT FORMULARIES: A COST-UTILITY ANALYSIS OF ORLISTAT AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN ADULTS","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Orlistat; Sibutramine; Formulary; Medicine; Obesity; Drug; Pharmacology; Weight loss; Internal medicine","score_opus":0.04225855685409968,"score_gpt":0.3690607201494313,"score_spread":0.3268021632953316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092941629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517408,0.0028896003,0.017844308,0.002152167,0.000076363365,0.0026241376,0.014901429,0.0006941743,0.0070771216],"genre_scores_gemma":[0.95428187,0.0009322678,0.033279933,0.0004891337,0.00008190553,0.0011051891,0.006031577,0.00010025891,0.003697815],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972535,0.0021397984,0.00007433359,0.00010153224,0.00036607267,0.000064870976],"domain_scores_gemma":[0.99389184,0.004807104,0.0006045731,0.00018517129,0.00027860585,0.00023268427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038791718,0.0011079884,0.0012192363,0.0013377864,0.00016307255,0.0009610916,0.00089913665,0.000778774,0.008062273],"category_scores_gemma":[0.01339982,0.0004998225,0.002053948,0.00092971,0.00034949725,0.0010142877,0.0007922809,0.0009566306,0.00039772238],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18275325,0.0050039906,0.1267305,0.0021459397,0.012046966,0.00073323294,0.00019361726,0.09928672,0.0041777063,0.0038936993,0.027137471,0.5358969],"study_design_scores_gemma":[0.05559521,0.04132105,0.30548543,0.00038190008,0.016805977,0.0017214596,0.00041886518,0.54130983,0.0098953955,0.00568467,0.02096557,0.0004145605],"about_ca_topic_score_codex":0.00810119,"about_ca_topic_score_gemma":0.00559373,"teacher_disagreement_score":0.00810119,"about_ca_system_score_codex":0.0015052474,"about_ca_system_score_gemma":0.0017085423,"threshold_uncertainty_score":0.026970983},"labels":[],"label_agreement":null},{"id":"W2093013705","doi":"10.1016/s1098-3015(11)72158-1","title":"PMS5 PRIMARY ANTI-TNF FAILURES EXPERIENCE SUPERIOR CLINICAL RESPONSES TO A SECOND ANTI-TNF AGENT THAN SECONDARY FAILURES: ANALYSIS OF THE ALBERTA RHEUMATOID ARTHRITIS BIOLOGICS REGISTRY","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Medicine; Tumor necrosis factor alpha; TNF inhibitor; Primary (astronomy); Adalimumab; Internal medicine; Oncology","score_opus":0.03540350763035594,"score_gpt":0.3397166157148023,"score_spread":0.30431310808444634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093013705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970493,0.00037056545,0.00008464315,0.00006712697,0.000005890867,0.000016631468,0.0013273105,0.000006104783,0.001072437],"genre_scores_gemma":[0.9983339,0.00008520555,0.00006503397,0.000035318622,0.0000059033814,0.000005512299,0.0011302837,0.0000059609215,0.00033284866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764794,0.0006058243,0.00013310097,0.00027853076,0.000916648,0.00041797428],"domain_scores_gemma":[0.9927994,0.0012481497,0.003098438,0.00070943125,0.0012313104,0.0009133016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024304606,0.0003085339,0.00052322156,0.0016732074,0.00079936377,0.0012425565,0.0011281107,0.0003587067,0.0022921404],"category_scores_gemma":[0.0060302773,0.00028057292,0.0005394606,0.002916141,0.00069552904,0.00037938583,0.00089232984,0.00046162235,0.00026175173],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037039726,0.00001545846,0.9973022,0.00000626633,0.00007482529,0.000035905574,0.000077269666,0.000059537764,0.00008912755,0.00004828882,0.00034261306,0.001578],"study_design_scores_gemma":[0.0000204817,0.000058155776,0.99907243,0.0000041787625,0.00004307657,0.000085316984,0.00017427818,0.00015899338,0.000041006417,0.0000175281,0.00032107712,0.0000034337654],"about_ca_topic_score_codex":0.30790207,"about_ca_topic_score_gemma":0.4196937,"teacher_disagreement_score":0.30790207,"about_ca_system_score_codex":0.0027258757,"about_ca_system_score_gemma":0.0040593045,"threshold_uncertainty_score":0.61221975},"labels":[],"label_agreement":null},{"id":"W2093052141","doi":"10.1016/s1098-3015(10)63160-9","title":"ES2 DIRECT MEDICAL COSTS OF SOLID ORGAN TRANSPLANT IN BRITISH COLUMBIA, CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Solid organ; Medical costs; Organ transplantation; Medicine; Intensive care medicine; Surgery; Transplantation; Political science; Health care; Law","score_opus":0.009667657662049313,"score_gpt":0.25184442666789014,"score_spread":0.24217676900584084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093052141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8071083,0.008555221,0.0003393376,0.015183524,0.00050934876,0.00017900158,0.10903645,0.00012968865,0.058959123],"genre_scores_gemma":[0.9062876,0.0064193066,0.0004107858,0.0017804481,0.000101515645,0.000069570946,0.015519567,0.0000557745,0.069355346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990349,0.00008697065,0.00008253681,0.000069886744,0.000278374,0.00044743533],"domain_scores_gemma":[0.996833,0.00023808966,0.00029494986,0.000039287883,0.0016115538,0.0009830594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003413105,0.000528883,0.00056871085,0.0022182253,0.0025293976,0.0022314568,0.0014371591,0.0011181984,0.0123226745],"category_scores_gemma":[0.003138326,0.00046028197,0.0008952475,0.0039239624,0.0004878348,0.000509798,0.0009892263,0.0019104542,0.0007773697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007946523,0.00024637496,0.77158755,0.0005168044,0.0004702223,0.0017253713,0.0007386905,0.0060323114,0.00046074798,0.0047883987,0.16082376,0.051815107],"study_design_scores_gemma":[0.00020035639,0.000058487807,0.9560116,0.0003695715,0.0003056393,0.00050345197,0.0036608349,0.005736282,0.0003569367,0.00062216,0.03208765,0.000087063265],"about_ca_topic_score_codex":0.9989436,"about_ca_topic_score_gemma":0.99949443,"teacher_disagreement_score":0.07870283,"about_ca_system_score_codex":0.07870283,"about_ca_system_score_gemma":0.09247066,"threshold_uncertainty_score":0.5710317},"labels":[],"label_agreement":null},{"id":"W2093303851","doi":"10.1016/s1098-3015(10)66066-4","title":"PMC19 CHRONIC DISEASE SCORES AMONG SENIORS IN ALBERTA, CANADA","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Nuts composition and effects","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gerontology; Medicine; Disease; Internal medicine","score_opus":0.010814259644764698,"score_gpt":0.2604966128093655,"score_spread":0.24968235316460077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093303851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331844,0.00046489717,0.000039144285,0.00023240702,0.000018862445,0.000020793024,0.002689977,0.000007065934,0.0032083746],"genre_scores_gemma":[0.996789,0.00025224878,0.00007812284,0.00007697226,0.0000061730475,0.000007893053,0.000996555,0.0000026046705,0.0017905242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993594,0.00004955984,0.000041143132,0.00007255497,0.0002333771,0.00024392466],"domain_scores_gemma":[0.99882275,0.00003663084,0.00016531827,0.000022647597,0.00049974193,0.00045300424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043281855,0.00033650963,0.00044923107,0.0016983907,0.002196188,0.001066224,0.0010363893,0.00048692472,0.0023215087],"category_scores_gemma":[0.0012370758,0.0003081306,0.000494409,0.0038897605,0.0004860582,0.00033303897,0.00081567996,0.00060525315,0.00031391377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006624176,0.00004383627,0.9962017,0.000010895313,0.000018872834,0.00006227344,0.00027795276,0.000035562076,0.00004895394,0.00003533018,0.00079588644,0.0024023962],"study_design_scores_gemma":[0.0000048501965,0.000021015094,0.9987809,0.000010920042,0.000011295018,0.000026556527,0.00080495205,0.000054144628,0.000011421177,0.000012423065,0.0002583453,0.0000030145582],"about_ca_topic_score_codex":0.99013925,"about_ca_topic_score_gemma":0.99491185,"teacher_disagreement_score":0.011619875,"about_ca_system_score_codex":0.011619875,"about_ca_system_score_gemma":0.0110985115,"threshold_uncertainty_score":0.084308505},"labels":[],"label_agreement":null},{"id":"W2093339032","doi":"10.1016/j.jval.2014.08.438","title":"Detection and Evaluation of the Medication Errors in Different Hospitals in Province of the Punjab, Pakistan","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical prescription; Teaching hospital; Quarter (Canadian coin); Medication error; Pediatrics; Family medicine; Health care; Nursing; Patient safety; Geography","score_opus":0.11584463991812799,"score_gpt":0.4284501205661476,"score_spread":0.31260548064801963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093339032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991073,0.00006328806,0.000049790902,0.00012961826,0.0000035572161,0.00001435516,0.00023466874,0.0000023809068,0.00039508162],"genre_scores_gemma":[0.9994779,0.00009179029,0.00014998615,0.000031717882,0.0000024924789,0.00000646918,0.00011714602,6.8050707e-7,0.00012171307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989145,0.00017905148,0.00019389868,0.00015633585,0.00026704764,0.00028912784],"domain_scores_gemma":[0.9961708,0.0007141393,0.0017669575,0.00009349762,0.00083174807,0.00042284006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068631076,0.00026094937,0.0002859977,0.0012564444,0.0012609223,0.0009171937,0.0005519773,0.00050156954,0.0012462611],"category_scores_gemma":[0.003730882,0.00029251486,0.00035066434,0.0019477672,0.0007749695,0.0005395665,0.00084674277,0.0007443325,0.00012320552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034770997,0.000057348298,0.99602026,0.000031632913,0.000013541641,0.00026891642,0.0008502852,0.00006584936,0.0001414534,0.000036681387,0.00009936103,0.0023799913],"study_design_scores_gemma":[0.0000030626768,0.00013556244,0.9910965,0.000026272584,0.000013417482,0.0005688506,0.007507668,0.00020474783,0.00016225767,0.000040021918,0.00023081245,0.000010682017],"about_ca_topic_score_codex":0.10348796,"about_ca_topic_score_gemma":0.12066612,"teacher_disagreement_score":0.10348796,"about_ca_system_score_codex":0.0019093135,"about_ca_system_score_gemma":0.004909802,"threshold_uncertainty_score":0.20577121},"labels":[],"label_agreement":null},{"id":"W2093551652","doi":"10.1016/j.jval.2014.08.1336","title":"Persistence And Adherence With Mirabegron, A New Beta-3 Receptor Agonist, Versus Antimuscarinics In Overactive Bladder: Early Experience In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Mirabegron; Oxybutynin; Overactive bladder; Medicine; Solifenacin; Hazard ratio; Tolterodine; Persistence (discontinuity); Internal medicine; Cohort; Urology; Proportional hazards model; Confidence interval","score_opus":0.09343225368972251,"score_gpt":0.3257674470512033,"score_spread":0.23233519336148079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093551652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99412364,0.002459006,0.000043707885,0.00096704444,0.00002571751,0.000049263865,0.00035960204,0.0000033174695,0.0019688134],"genre_scores_gemma":[0.995497,0.0024908802,0.00015781817,0.00037769217,0.00002021834,0.000017041697,0.00027942302,0.000006580029,0.0011535196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781173,0.00023391139,0.00010012717,0.00013556487,0.00097048486,0.00074815814],"domain_scores_gemma":[0.99281466,0.00090517686,0.00082388375,0.00009092576,0.0028597584,0.002505588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018454135,0.00020498032,0.0009043051,0.0005812091,0.0035979284,0.0023902946,0.0010425707,0.0008913229,0.001857783],"category_scores_gemma":[0.007109187,0.00032521406,0.0008707046,0.0029812013,0.0011132944,0.00074465596,0.0008466912,0.0017166465,0.0001231576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023281244,0.0013561451,0.93991745,0.00016797676,0.00023202266,0.00028270422,0.006321003,0.00016237696,0.00040162134,0.00034631832,0.001989139,0.046495136],"study_design_scores_gemma":[0.00021403609,0.00091765163,0.9858116,0.00015861975,0.00020451924,0.0001732357,0.009173704,0.00048176176,0.00021790319,0.000076703276,0.0025118,0.000058413298],"about_ca_topic_score_codex":0.9832239,"about_ca_topic_score_gemma":0.98880506,"teacher_disagreement_score":0.033269502,"about_ca_system_score_codex":0.033269502,"about_ca_system_score_gemma":0.054675665,"threshold_uncertainty_score":0.24138826},"labels":[],"label_agreement":null},{"id":"W2093833819","doi":"10.1111/j.1524-4733.2010.00797.x","title":"Cost-Effectiveness of Specialized Multidisciplinary Heart Failure Clinics in Ontario, Canada","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; St. Michael's Hospital; Ministry of Health and Long Term Care; Toronto Public Health; Health Sciences Centre; University Health Network; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; University of Toronto; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Life expectancy; Confidence interval; Cohort; Christian ministry; Emergency medicine; Cost effectiveness; Relative risk; Activity-based costing; Incremental cost-effectiveness ratio; Hazard ratio; Cost-effectiveness analysis; Pediatrics; Internal medicine; Population; Environmental health","score_opus":0.057231753523017855,"score_gpt":0.34958784531021114,"score_spread":0.2923560917871933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093833819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97496223,0.0040022708,0.00013015143,0.0059873965,0.000102896796,0.00028630326,0.0035801986,0.000025050465,0.010923541],"genre_scores_gemma":[0.9954971,0.0011707089,0.00026275517,0.0005303226,0.00003403265,0.000054224147,0.00067656353,0.0000059349495,0.0017683601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773514,0.0004006143,0.00014813912,0.00018241227,0.00063924707,0.0008942593],"domain_scores_gemma":[0.991852,0.000891201,0.0010479135,0.00009854066,0.0018855628,0.0042248303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008521245,0.0003666467,0.0006876388,0.00084106845,0.0032975823,0.0022519105,0.0017914582,0.0010491342,0.004501505],"category_scores_gemma":[0.0059500313,0.00046337038,0.00094121863,0.0021466408,0.0009968764,0.00053717016,0.0012213902,0.0010390274,0.00014907894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052194465,0.0021101558,0.8642564,0.0012242987,0.0008612288,0.0010280563,0.0020569048,0.00902758,0.00085306197,0.0027713743,0.028027833,0.08256358],"study_design_scores_gemma":[0.0009781355,0.00048965134,0.9878763,0.0003216468,0.00030333316,0.00016312646,0.0023089284,0.0045108474,0.0000967971,0.0002254772,0.002674228,0.000051546103],"about_ca_topic_score_codex":0.99613035,"about_ca_topic_score_gemma":0.9987405,"teacher_disagreement_score":0.12863183,"about_ca_system_score_codex":0.12863183,"about_ca_system_score_gemma":0.124412596,"threshold_uncertainty_score":0.93329364},"labels":[],"label_agreement":null},{"id":"W2093861069","doi":"10.1016/s1098-3015(10)74036-5","title":"PND29 CANADIAN PATIENT SURVEY TO ASSESS PATIENTS' PLIGHT TO MOVEMENT DISORDER DIAGNOSES AND BOTULINUM TOXIN TYPE-A (BONTA) TREATMENT – FINAL RESULTS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Botulinum toxin; Medicine; Toxin; Surgery; Biology; Microbiology","score_opus":0.07448415369451299,"score_gpt":0.3142366595570627,"score_spread":0.2397525058625497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093861069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64543396,0.0012756577,0.00040379164,0.0017077196,0.00017744565,0.0018677164,0.3063479,0.00014654484,0.042639203],"genre_scores_gemma":[0.83660597,0.0019261192,0.0014395189,0.0018836263,0.000080166305,0.001630715,0.135197,0.0000728802,0.021163912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985567,0.0000958213,0.00011137089,0.000118230106,0.00073422753,0.00038366477],"domain_scores_gemma":[0.995622,0.000108716085,0.00045316128,0.000057540234,0.0030041703,0.00075442257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009678326,0.0007966453,0.00085210905,0.0027647861,0.0025463426,0.00078047905,0.0016807817,0.00077103236,0.008060184],"category_scores_gemma":[0.002612925,0.000506112,0.0012355514,0.0053909044,0.00040711218,0.00047005893,0.0009894897,0.0010429353,0.0022143535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004172275,0.00032374056,0.9390778,0.00012765317,0.0001310868,0.000185934,0.0003329902,0.0002923097,0.0002729716,0.0001192412,0.051475678,0.0072433236],"study_design_scores_gemma":[0.00004388608,0.00004977979,0.99488467,0.000024328037,0.00001676842,0.00005772305,0.00021147101,0.00014204196,0.00006907754,0.000009503177,0.0044774716,0.000013186483],"about_ca_topic_score_codex":0.9829615,"about_ca_topic_score_gemma":0.986647,"teacher_disagreement_score":0.021013968,"about_ca_system_score_codex":0.021013968,"about_ca_system_score_gemma":0.022908079,"threshold_uncertainty_score":0.15246773},"labels":[],"label_agreement":null},{"id":"W2094049860","doi":"10.1111/j.1524-4733.2010.00706.x","title":"International Development of the Unidimensional Fatigue Impact Scale (U-FIS)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Dalhousie University","funders":"","keywords":"Debriefing; Psychology; Scale (ratio); Construct validity; German; Internal consistency; Content validity; Reliability (semiconductor); Clinical psychology; Cognition; Face validity; Psychometrics; Applied psychology; Social psychology; Psychiatry; Linguistics; Geography; Cartography","score_opus":0.11824150345295172,"score_gpt":0.4112257258776765,"score_spread":0.29298422242472477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094049860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76776654,0.019682787,0.079280384,0.0040727826,0.0018509937,0.009589231,0.019440994,0.00079694577,0.09751934],"genre_scores_gemma":[0.84846526,0.0046231635,0.11254099,0.000773405,0.00030239843,0.010725656,0.013324458,0.00010531581,0.009139406],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.994518,0.0020578282,0.0009673238,0.00031337835,0.0017843992,0.0003591027],"domain_scores_gemma":[0.98711175,0.003430844,0.0018840845,0.00063919794,0.0060911695,0.00084293104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011272507,0.0006735277,0.0009905046,0.0054096906,0.0007179983,0.0011280107,0.000944045,0.000602738,0.003631757],"category_scores_gemma":[0.019005673,0.0002396871,0.0015272406,0.0029672312,0.0005568587,0.0013051628,0.002167239,0.0012871,0.00062518276],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067820057,0.0005910355,0.38397846,0.0005621014,0.0005321565,0.000071535316,0.0012731211,0.0009872735,0.0013198284,0.0054070223,0.012546815,0.59205246],"study_design_scores_gemma":[0.00015661554,0.0012849965,0.947251,0.0009236243,0.00021182,0.0003584928,0.0010867235,0.0030698625,0.0019037594,0.0033503608,0.04028556,0.00011712928],"about_ca_topic_score_codex":0.0053746756,"about_ca_topic_score_gemma":0.00997122,"teacher_disagreement_score":0.011272507,"about_ca_system_score_codex":0.0015013781,"about_ca_system_score_gemma":0.0034014923,"threshold_uncertainty_score":0.059615433},"labels":[],"label_agreement":null},{"id":"W2094227379","doi":"10.1016/j.jval.2011.08.1306","title":"PDB3 Hypoglycaemia-Related Emergency Department Visits and Hypoglycaemia-Related Hospitalizations Among News Users of Antidiabetes Treatments","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Emergency department; Incidence (geometry); Cohort; Population; Hypoglycemia; Emergency medicine; Pediatrics; Diabetes mellitus; Insulin; Internal medicine","score_opus":0.03634705197058996,"score_gpt":0.2902369194408759,"score_spread":0.2538898674702859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094227379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99534875,0.00031714,0.000043530774,0.00022316033,0.00003514642,0.000009280823,0.0012247586,0.000006855406,0.0027913605],"genre_scores_gemma":[0.99756384,0.00018090266,0.000054137578,0.00014254052,0.00005218828,0.0000062570916,0.00095405354,0.000003827303,0.0010422234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993474,0.0001404147,0.00010308339,0.000066785105,0.00019305367,0.00014923353],"domain_scores_gemma":[0.9964257,0.00082106073,0.0017549822,0.00011752064,0.00029803682,0.0005826914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033309803,0.00014570216,0.00025958556,0.0008528007,0.0004786594,0.0008857379,0.00026437468,0.00047161747,0.007909906],"category_scores_gemma":[0.004445422,0.0002175438,0.0005350571,0.0009967877,0.00013958722,0.0005916009,0.0004926022,0.0007949899,0.00044108913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017386803,0.000053615757,0.99724317,0.000009766958,0.00003144297,0.000092200615,0.00005607026,0.000010094625,0.000073916955,0.0000144518035,0.00028314194,0.001958231],"study_design_scores_gemma":[0.000009318235,0.000046107303,0.99882764,0.000009119113,0.000028195342,0.00028492583,0.0003440118,0.0000802712,0.000050087827,0.00001140781,0.0003050239,0.0000038508283],"about_ca_topic_score_codex":0.012440077,"about_ca_topic_score_gemma":0.014666148,"teacher_disagreement_score":0.012440077,"about_ca_system_score_codex":0.0004039584,"about_ca_system_score_gemma":0.0003712417,"threshold_uncertainty_score":0.026461244},"labels":[],"label_agreement":null},{"id":"W2094268264","doi":"10.1016/j.jval.2013.08.1156","title":"Canadian Burden of Choroidal Neovascularization Secondary to Pathologic Myopia: Baseline Characteristics of Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Novartis (Canada)","funders":"","keywords":"Medicine; Choroidal neovascularization; Visual acuity; Ophthalmology; Medical record; Retrospective cohort study; Pediatrics; Optometry; Surgery","score_opus":0.013072875465228404,"score_gpt":0.25386555870110916,"score_spread":0.24079268323588077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094268264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901052,0.0006487687,0.000038507013,0.00020753381,0.0000080770205,0.000059079597,0.0061257556,0.000008110807,0.002799051],"genre_scores_gemma":[0.99606484,0.00032814054,0.000067085704,0.00007684596,0.000010994262,0.000021168118,0.003062119,0.0000027852934,0.0003660716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993266,0.00003149556,0.000049183338,0.00011778311,0.00024348435,0.00023145619],"domain_scores_gemma":[0.9985436,0.00006148657,0.00037050922,0.000038975817,0.00057230814,0.00041311656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034491485,0.00032279606,0.00046406992,0.0014525392,0.0023508866,0.001052136,0.0008734251,0.00054310693,0.002409031],"category_scores_gemma":[0.0017894113,0.00031597598,0.0003999313,0.003931245,0.0004620899,0.00039762948,0.00067767355,0.00065398414,0.00031925656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080637044,0.00002718669,0.9975702,0.000017352733,0.000027073082,0.00014329843,0.00019217428,0.000052912426,0.00009467555,0.00004263717,0.0005203656,0.0012313665],"study_design_scores_gemma":[0.000008438258,0.000032198248,0.9986228,0.000009124297,0.000014112097,0.00023284063,0.0004083093,0.00010356064,0.00001613308,0.000014822023,0.0005296722,0.000008034713],"about_ca_topic_score_codex":0.933964,"about_ca_topic_score_gemma":0.934593,"teacher_disagreement_score":0.066035986,"about_ca_system_score_codex":0.012179913,"about_ca_system_score_gemma":0.011800714,"threshold_uncertainty_score":0.1328497},"labels":[],"label_agreement":null},{"id":"W2094281515","doi":"10.1016/j.jval.2012.08.1691","title":"PDB48 Health Care Resources Utilization and Costs Associated With the Management of Patients With Acromegaly: An Analysis Based on the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Acromegaly; Pegvisomant; Lanreotide; Cohort; Retrospective cohort study; Pediatrics; Health care; Population; Pituitary adenoma; Emergency medicine; Internal medicine; Adenoma; Environmental health; Growth hormone","score_opus":0.032422634401388456,"score_gpt":0.29679873202124646,"score_spread":0.26437609761985803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094281515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159093,0.0009259829,0.00014972502,0.00023446154,0.000011936886,0.00006482207,0.081425525,0.00002816278,0.0012501806],"genre_scores_gemma":[0.9434819,0.00050659763,0.00027878326,0.00014939734,0.00003055763,0.00014544318,0.055065528,0.000014610163,0.00032708605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809474,0.00062877964,0.00035573466,0.00033312204,0.0003851373,0.00020249162],"domain_scores_gemma":[0.99287885,0.0027048131,0.0029980554,0.00040051035,0.00058287027,0.00043484813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012910456,0.00037579972,0.001094984,0.003111538,0.00025997567,0.0009796073,0.0008140101,0.0005038773,0.003319418],"category_scores_gemma":[0.007719308,0.00031959792,0.0020349738,0.0068748062,0.00022630292,0.0007000894,0.0008339917,0.0008054402,0.0005091832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014520488,0.000102521364,0.98850596,0.00017601126,0.0012254181,0.00011108071,0.000056523044,0.00094191695,0.00007505281,0.00014876437,0.0032729213,0.0039318656],"study_design_scores_gemma":[0.00018023279,0.00013530777,0.99553007,0.000041887935,0.00034916287,0.00031662805,0.00019371927,0.0017238179,0.00005280618,0.00006267236,0.0013965777,0.000017145356],"about_ca_topic_score_codex":0.0326875,"about_ca_topic_score_gemma":0.016647507,"teacher_disagreement_score":0.0326875,"about_ca_system_score_codex":0.0016356449,"about_ca_system_score_gemma":0.0011060718,"threshold_uncertainty_score":0.064994454},"labels":[],"label_agreement":null},{"id":"W2094313296","doi":"10.1016/j.jval.2014.03.329","title":"Preliminary Results Of Multidisciplinary Systematic Follow-Up Of Fragility Fractures In Orthopaedic Clinic","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Fragility fracture; Fragility; Ankle; Hip fracture; Physical therapy; Osteoporosis; Surgery; Internal medicine; Bone mineral","score_opus":0.038647282770936264,"score_gpt":0.35032148147875813,"score_spread":0.31167419870782187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094313296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99697614,0.0009856503,0.00018287211,0.00014468833,0.000013964078,0.00022180962,0.0006983507,0.000007209036,0.0007693431],"genre_scores_gemma":[0.99765354,0.00039457387,0.00060990243,0.00009173571,0.00001928168,0.00019752688,0.0007744325,0.0000024605743,0.0002565243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962774,0.0021693478,0.00039848237,0.00028020324,0.00050497905,0.0003695376],"domain_scores_gemma":[0.98904616,0.0045183664,0.0014725608,0.0005647775,0.0029566977,0.0014413974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029621008,0.000301108,0.00067130977,0.0010453137,0.0010845053,0.00051255827,0.0004370773,0.0006134596,0.0016063054],"category_scores_gemma":[0.01599582,0.0002292141,0.0009813023,0.0013102151,0.00019598746,0.00036842556,0.0013585032,0.00035641124,0.00024808128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015896392,0.0009002629,0.9639315,0.00021794738,0.00014214875,0.00015222727,0.0010452106,0.00018256075,0.00050661527,0.00002054839,0.00030707763,0.031004287],"study_design_scores_gemma":[0.00009289985,0.0009700963,0.997505,0.000050377395,0.00016180526,0.000085059175,0.000603609,0.00019347004,0.000103777915,0.000022280785,0.00020469518,0.000006967648],"about_ca_topic_score_codex":0.03250567,"about_ca_topic_score_gemma":0.054902975,"teacher_disagreement_score":0.03250567,"about_ca_system_score_codex":0.0010357221,"about_ca_system_score_gemma":0.003360628,"threshold_uncertainty_score":0.06463289},"labels":[],"label_agreement":null},{"id":"W2094358619","doi":"10.1016/j.jval.2012.03.1209","title":"PCN92 The Lifecycle Value of Oncology Medicines","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Innovator; Azacitidine; Product (mathematics); Medicine; Business; Finance","score_opus":0.48077720230712706,"score_gpt":0.47360065173735677,"score_spread":0.00717655056977029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094358619","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07644345,0.01312786,0.04586968,0.02163635,0.0013715205,0.0002444068,0.012565169,0.0003006903,0.8284409],"genre_scores_gemma":[0.8663632,0.0065092845,0.011310378,0.00086297264,0.0008028075,0.00021937462,0.005122195,0.00018929354,0.10862054],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99679863,0.0011316744,0.00011770104,0.0002590578,0.0014241849,0.00026868936],"domain_scores_gemma":[0.99145645,0.0038955652,0.00076188584,0.0009237559,0.0025017646,0.000460565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029725386,0.00037438425,0.0004332148,0.0020181714,0.0006703377,0.003909186,0.0006432361,0.0013436467,0.025365582],"category_scores_gemma":[0.029182015,0.00028217203,0.00060607336,0.0025576365,0.0011375839,0.003716491,0.0011509527,0.001661647,0.0023463771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025446757,0.000066450055,0.0045154653,0.00027632614,0.000052880874,0.00014105265,0.0001115415,0.021792144,0.00032138036,0.6759467,0.06848987,0.22803172],"study_design_scores_gemma":[0.00004935007,0.000110265006,0.0104409605,0.0005506125,0.000040278122,0.00032466612,0.00014598019,0.058435418,0.0012050502,0.64619756,0.2824317,0.000068099194],"about_ca_topic_score_codex":0.010460184,"about_ca_topic_score_gemma":0.007627257,"teacher_disagreement_score":0.025365582,"about_ca_system_score_codex":0.0061355066,"about_ca_system_score_gemma":0.003445549,"threshold_uncertainty_score":0.08485633},"labels":[],"label_agreement":null},{"id":"W2094436672","doi":"10.1016/j.jval.2014.03.040","title":"Cadth Recommendations As Predictors For Drug Availability In British Columbia And Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Medicine; Listing (finance); Reimbursement; Family medicine; Agency (philosophy); Drug; Health care; Business; Pharmacology; Finance; Political science","score_opus":0.22962417074795277,"score_gpt":0.37769642851862795,"score_spread":0.14807225777067518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094436672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8960618,0.0035144065,0.0006115591,0.01330531,0.00016050039,0.0002112464,0.057131894,0.00012546135,0.028877828],"genre_scores_gemma":[0.975754,0.00110759,0.00096852705,0.00062709907,0.000043584463,0.000073396564,0.0089937905,0.00005429293,0.0123776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757415,0.00044999292,0.00031163887,0.00021494378,0.0009347094,0.0005145642],"domain_scores_gemma":[0.96990216,0.0074483776,0.0052080792,0.000874078,0.011646441,0.004920979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002911637,0.000199159,0.00050979195,0.0020017324,0.0019616447,0.002357844,0.0017870553,0.0008929856,0.0072689136],"category_scores_gemma":[0.024350498,0.00034894442,0.0007837367,0.0036764385,0.00064918696,0.0008549079,0.0008744135,0.0016144033,0.0005877606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002544913,0.00008466455,0.95822215,0.00013317546,0.00010946985,0.00011329033,0.0006741567,0.0012102311,0.000051779032,0.001073279,0.025179137,0.012894102],"study_design_scores_gemma":[0.000033675453,0.00003722027,0.981887,0.00018834676,0.000071437666,0.00007681191,0.0018093995,0.0035045228,0.00013991339,0.0002843702,0.011934916,0.000032502878],"about_ca_topic_score_codex":0.9901119,"about_ca_topic_score_gemma":0.9956001,"teacher_disagreement_score":0.02909263,"about_ca_system_score_codex":0.02909263,"about_ca_system_score_gemma":0.036967605,"threshold_uncertainty_score":0.21108282},"labels":[],"label_agreement":null},{"id":"W2094487322","doi":"10.1016/s1098-3015(10)65671-9","title":"DB2 LABOR MARKET EFFECTS OF INSULIN DEPENDENT AND NON-INSULIN DEPENDENT DIABETES AMONG CANADIAN LABOR FORCE","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Economics; Diabetes mellitus; Internal medicine; Medicine; Labour economics; Endocrinology","score_opus":0.008624518365078299,"score_gpt":0.2586698282210919,"score_spread":0.2500453098560136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094487322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770842,0.0010783948,0.000044089207,0.0011692726,0.000054095006,0.000036128604,0.014360973,0.000016428428,0.006156521],"genre_scores_gemma":[0.98614824,0.0003987599,0.000059414935,0.00018421035,0.00002304278,0.000017645654,0.0044420254,0.000008385528,0.0087183565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989931,0.000091721704,0.000044337226,0.000088382716,0.00017386975,0.00060859043],"domain_scores_gemma":[0.9967025,0.0004595483,0.0005156333,0.000115552684,0.00086818135,0.0013385639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008916525,0.0005450958,0.0005045386,0.0017190418,0.0018571685,0.0014888183,0.0014109443,0.0009312402,0.0142420605],"category_scores_gemma":[0.004035317,0.00031146896,0.0013836583,0.002153251,0.0005693978,0.0006203549,0.0009938901,0.0015754985,0.0005500501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062723446,0.00012934709,0.9912951,0.000020384121,0.00010164649,0.00007544201,0.0002910953,0.00017233459,0.00012697949,0.00039405123,0.0028963697,0.003869935],"study_design_scores_gemma":[0.000026128062,0.000047564707,0.99657094,0.000015008005,0.00006310152,0.00002727023,0.0011224222,0.00036503433,0.00005670442,0.00006374531,0.0016297533,0.0000123722275],"about_ca_topic_score_codex":0.9921936,"about_ca_topic_score_gemma":0.9926118,"teacher_disagreement_score":0.017133078,"about_ca_system_score_codex":0.017133078,"about_ca_system_score_gemma":0.024940288,"threshold_uncertainty_score":0.12430978},"labels":[],"label_agreement":null},{"id":"W2094708298","doi":"10.1016/j.jval.2012.08.2028","title":"PRS29 Queuing Statistical Model - A New Tool for Preliminary Cost-Effectiveness Assessments","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Quarter (Canadian coin); Population; Emergency medicine; Statistics; Mathematics; Geography; Environmental health","score_opus":0.41015833601274315,"score_gpt":0.5745464888026014,"score_spread":0.16438815278985824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094708298","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041747955,0.00020361731,0.9902057,0.0002637143,0.0000632495,0.00020611238,0.0008253626,0.0018407742,0.002216699],"genre_scores_gemma":[0.33599544,0.0008235906,0.65005016,0.00057284924,0.00025219435,0.0016554372,0.0026476895,0.0008538087,0.007148894],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971228,0.0015332887,0.00019961053,0.00021442528,0.00079277117,0.00013711875],"domain_scores_gemma":[0.9884409,0.009073586,0.00052467786,0.00061473285,0.001140158,0.00020596865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007554395,0.0012429695,0.001865465,0.0016432444,0.000399496,0.0016362431,0.0018707472,0.0011562108,0.015054934],"category_scores_gemma":[0.02243229,0.0006937,0.0019319989,0.0014079221,0.00039362867,0.0018459097,0.0009536857,0.0018726981,0.00192332],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003119423,0.00018431417,0.0014468372,0.00026229472,0.00020429639,0.00008638434,0.000032479318,0.85527897,0.0008991271,0.031178912,0.007921726,0.102192655],"study_design_scores_gemma":[0.000030485257,0.00009686652,0.00013762966,0.000012802907,0.000031588927,0.000024681993,0.000004330612,0.98893845,0.0002869655,0.008826882,0.001598505,0.000010946804],"about_ca_topic_score_codex":0.0071806163,"about_ca_topic_score_gemma":0.004976987,"teacher_disagreement_score":0.015054934,"about_ca_system_score_codex":0.0014653563,"about_ca_system_score_gemma":0.0038183501,"threshold_uncertainty_score":0.05036378},"labels":[],"label_agreement":null},{"id":"W2094733423","doi":"10.1016/s1098-3015(10)72965-x","title":"PRS9 COMPARISON OF CHRONIC BRONCHITIS IN ONTARIO, CANADA BETWEEN 2003 AND 2009","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic bronchitis; Bronchitis; Medicine; Geography; Internal medicine","score_opus":0.07484444963051308,"score_gpt":0.3839269769530248,"score_spread":0.30908252732251174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094733423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92560405,0.004375117,0.00021228666,0.0019749359,0.00012374732,0.00015311534,0.056335483,0.000043590866,0.011177645],"genre_scores_gemma":[0.98169166,0.0012900862,0.00017384665,0.00029889215,0.000028027876,0.000043176737,0.012015262,0.00001256933,0.0044465736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979724,0.00009591055,0.00019511006,0.00021276454,0.0008068287,0.0007169328],"domain_scores_gemma":[0.9949704,0.00013050751,0.00089115306,0.00007145687,0.003032859,0.00090374105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076521316,0.00042815742,0.00067028723,0.0020916138,0.002436524,0.0015353682,0.0017503076,0.0009148102,0.0021541868],"category_scores_gemma":[0.0025403667,0.00041035473,0.0011940945,0.0062764296,0.0006654686,0.0005537985,0.0011437207,0.0010362244,0.00031197033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052310445,0.000038265043,0.9843688,0.00020560426,0.00016927617,0.00021859822,0.001185627,0.0002208607,0.00032505253,0.00022574062,0.0056013013,0.0069177756],"study_design_scores_gemma":[0.0000054184084,0.000017741422,0.9973667,0.000032590728,0.00002407023,0.000036025274,0.00076855894,0.00006173272,0.000030200334,0.0000064458877,0.0016442603,0.000006330292],"about_ca_topic_score_codex":0.99770516,"about_ca_topic_score_gemma":0.99870884,"teacher_disagreement_score":0.049787253,"about_ca_system_score_codex":0.049787253,"about_ca_system_score_gemma":0.057089552,"threshold_uncertainty_score":0.36123347},"labels":[],"label_agreement":null},{"id":"W2095042410","doi":"10.1016/j.jval.2012.06.017","title":"Cost-Effectiveness of Using a Molecular Diagnostic Test to Improve Preoperative Diagnosis of Thyroid Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Test (biology); Cancer; Thyroid cancer; Diagnostic test; Thyroid; Computer science; Radiology; Internal medicine; Pediatrics; Biology","score_opus":0.06402909451622811,"score_gpt":0.3777649230658495,"score_spread":0.3137358285496214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095042410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96082914,0.010369316,0.003877952,0.014430871,0.00039456473,0.00023346374,0.00088869437,0.00009040599,0.008885563],"genre_scores_gemma":[0.99725395,0.00073229894,0.0011803152,0.00036731779,0.000094498886,0.000023617491,0.00016673977,0.0000033720992,0.00017781956],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99720013,0.001728729,0.00016422194,0.00014376287,0.00046263693,0.00030057656],"domain_scores_gemma":[0.99284357,0.0053690933,0.0007157391,0.00017599667,0.00035532308,0.0005403659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015846421,0.00049560703,0.000970049,0.0011164848,0.0002665963,0.0010328267,0.00073070603,0.0018814317,0.0041030375],"category_scores_gemma":[0.017215278,0.000317336,0.001999693,0.0007648651,0.00046930072,0.0009463495,0.00068417785,0.0010620048,0.00026116043],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037117932,0.006531812,0.30642015,0.001310619,0.0036938384,0.0014974718,0.00019966291,0.09634751,0.0054407557,0.0041883443,0.0068508866,0.530401],"study_design_scores_gemma":[0.0058723157,0.026011629,0.7222429,0.0011053075,0.009670544,0.0036890204,0.00092198513,0.20856042,0.0058778543,0.009814289,0.0059849764,0.0002487733],"about_ca_topic_score_codex":0.0068795243,"about_ca_topic_score_gemma":0.0054732338,"teacher_disagreement_score":0.0068795243,"about_ca_system_score_codex":0.002353094,"about_ca_system_score_gemma":0.0020946485,"threshold_uncertainty_score":0.017072916},"labels":[],"label_agreement":null},{"id":"W2096303420","doi":"10.1016/j.jval.2014.03.1109","title":"The impact of alternative estimates of disutilities associated with hypoglycemia on net qalys: Canagliflozin versus sitagliptin as add-on therapy in individuals with type 2 diabetes mellitus (T2DM) inadequately controlled on a background of metformin (MET) plus sulfonylurea (SU) in the canadian setting","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Sitagliptin; Medicine; Hypoglycemia; Type 2 Diabetes Mellitus; Adverse effect; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.044760867475298415,"score_gpt":0.315457924689682,"score_spread":0.2706970572143836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096303420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93316036,0.027258456,0.010278398,0.00789422,0.0002988206,0.00062667305,0.006301619,0.00015216527,0.014029371],"genre_scores_gemma":[0.9942789,0.0011774792,0.003114651,0.00030615865,0.000025045641,0.000034296107,0.00067142403,0.000015435573,0.00037652394],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98763615,0.0091120405,0.00048145215,0.0006389803,0.0014067618,0.0007246111],"domain_scores_gemma":[0.9585223,0.036069844,0.0015033528,0.00087250926,0.0020640814,0.0009677868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021071274,0.001493165,0.0019346763,0.0018245043,0.0008280425,0.0043403744,0.002774317,0.0015558936,0.0027630685],"category_scores_gemma":[0.05858983,0.0006832301,0.0036881596,0.002778913,0.0016002952,0.0018238437,0.0018323743,0.0026522346,0.000115386676],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073271595,0.0012585301,0.11139665,0.0028380787,0.015414459,0.00059739855,0.0011589436,0.6443045,0.0007114799,0.031544022,0.007793475,0.109710775],"study_design_scores_gemma":[0.008674353,0.005093166,0.20788775,0.0018377982,0.020121528,0.0006161244,0.002737058,0.7067484,0.0014151145,0.0359615,0.008108754,0.0007984508],"about_ca_topic_score_codex":0.6625974,"about_ca_topic_score_gemma":0.59959704,"teacher_disagreement_score":0.33740258,"about_ca_system_score_codex":0.027506562,"about_ca_system_score_gemma":0.019482955,"threshold_uncertainty_score":0.67877924},"labels":[],"label_agreement":null},{"id":"W2096576489","doi":"10.1016/j.jval.2015.09.131","title":"Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Propensity score matching; Medicine; Confounding; Population; Randomized controlled trial; Abdominal aortic aneurysm; Surgery; Internal medicine; Aneurysm","score_opus":0.3116162339286345,"score_gpt":0.31267160447487585,"score_spread":0.0010553705462413299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096576489","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35312742,0.022721708,0.57859915,0.017373126,0.0053031854,0.006208924,0.0031067026,0.00053280324,0.013027018],"genre_scores_gemma":[0.9138884,0.0014656242,0.07525775,0.0037728124,0.0011385118,0.0021245833,0.0010571189,0.00009671777,0.0011986102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6823893,0.25724858,0.03172111,0.0140929,0.012442832,0.0021051976],"domain_scores_gemma":[0.4481047,0.422762,0.048929058,0.07000961,0.008350268,0.0018443719],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.29279524,0.0012719436,0.004885584,0.0028825116,0.0016287628,0.0037566896,0.003011364,0.003542145,0.004182637],"category_scores_gemma":[0.4712211,0.0016314036,0.005733603,0.0048387116,0.0033669518,0.004932255,0.0029309958,0.0027465457,0.0005913264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027208595,0.002197388,0.3629282,0.009074379,0.12284948,0.0012377129,0.0025016335,0.0134223765,0.002462653,0.10060769,0.022920327,0.3325895],"study_design_scores_gemma":[0.017061332,0.009479021,0.27762675,0.004262743,0.08293319,0.0018860301,0.0013045953,0.08790575,0.0062283175,0.47154224,0.03914377,0.0006262681],"about_ca_topic_score_codex":0.0016986108,"about_ca_topic_score_gemma":0.002460925,"teacher_disagreement_score":0.70720476,"about_ca_system_score_codex":0.0011305355,"about_ca_system_score_gemma":0.0031883402,"threshold_uncertainty_score":0.8721094},"labels":[],"label_agreement":null},{"id":"W2097158867","doi":"10.1016/j.jval.2015.09.2158","title":"The Impact of Healthcare Policy Based on Drug Plan Perspective Versus The Ministry of Health Perspective: A Case Study of The Odprn Recommendations of Restricting Reimbursement of Testosterone Replacement Therapy For Hypogonadism In Ontario, Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Centre; Mount Sinai Hospital","funders":"","keywords":"Reimbursement; Christian ministry; Medical prescription; Prescription drug; Actuarial science; Medicaid; Medicine; Health care; Business; Economics; Economic growth; Nursing; Political science","score_opus":0.14694393282769785,"score_gpt":0.41286666122688165,"score_spread":0.2659227283991838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097158867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9077809,0.00097114313,0.00026268128,0.046361208,0.000083716455,0.00011839285,0.00022402892,0.0000062191516,0.04419158],"genre_scores_gemma":[0.994833,0.00045515306,0.0002236701,0.002173386,0.000016373584,0.00001595993,0.00003715866,0.0000067635656,0.0022386203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914587,0.0028232243,0.00019915903,0.0002814636,0.0015136844,0.0037237627],"domain_scores_gemma":[0.98345757,0.007346568,0.0015244693,0.0003221992,0.0035502452,0.0037989318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005038515,0.000307587,0.00057859614,0.0012600434,0.02231102,0.007944838,0.002285296,0.0044018365,0.0036549482],"category_scores_gemma":[0.017989788,0.00051148166,0.00064532505,0.0037440774,0.008051165,0.0017185443,0.0033411914,0.0054742773,0.000123783],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075707666,0.0012260041,0.4437129,0.00042131633,0.00035797016,0.028915951,0.2713713,0.005208709,0.0013086551,0.17502789,0.03867262,0.033019535],"study_design_scores_gemma":[0.00034624303,0.0002476141,0.21667145,0.00081212656,0.00029633945,0.0026751608,0.6945345,0.005462206,0.0005479319,0.0075738844,0.07064776,0.00018487351],"about_ca_topic_score_codex":0.9931971,"about_ca_topic_score_gemma":0.99660206,"teacher_disagreement_score":0.1829749,"about_ca_system_score_codex":0.1829749,"about_ca_system_score_gemma":0.19743524,"threshold_uncertainty_score":0.9476333},"labels":[],"label_agreement":null},{"id":"W2097255304","doi":"10.1016/j.jval.2014.08.181","title":"Content Analysis And Effectiveness Of Interventions To Enhance Oral Antidiabetic Drug (Oad) Adherence In Adults With Type 2 Diabetes: A Systematic Review And Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Meta-analysis; Psychological intervention; CINAHL; Medicine; Cochrane Library; Systematic review; Intervention (counseling); MEDLINE; Physical therapy; Internal medicine; Nursing","score_opus":0.2200424433132902,"score_gpt":0.4832915272636818,"score_spread":0.2632490839503916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097255304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014463118,0.98200893,0.00084535166,0.00018689391,0.00022549924,0.001422866,0.00046834943,0.000037845475,0.0003410127],"genre_scores_gemma":[0.25737023,0.7323644,0.005508845,0.0009952363,0.00019860677,0.002546629,0.0005323835,0.000035279914,0.00044839183],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9895181,0.0042318273,0.0034165045,0.00089431944,0.001656148,0.00028312323],"domain_scores_gemma":[0.9831275,0.011699,0.003359561,0.00046779442,0.0011263631,0.00021975931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014932945,0.002356985,0.018288044,0.0063199196,0.0006734671,0.002929384,0.00212786,0.0018612002,0.003069192],"category_scores_gemma":[0.040269684,0.0015534475,0.027571242,0.0060744556,0.0010386968,0.002097063,0.0021810937,0.0020308613,0.00018389816],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032057704,0.00013136219,0.0024737748,0.54478073,0.42204842,0.00005960293,0.00026492227,0.0002608026,0.00025439326,0.000106981424,0.0003955749,0.026017645],"study_design_scores_gemma":[0.002280631,0.00043055537,0.004040241,0.041933086,0.94939667,0.00006167109,0.00012147852,0.00014698511,0.00017701996,0.00013321592,0.0012470302,0.000031453455],"about_ca_topic_score_codex":0.008008254,"about_ca_topic_score_gemma":0.019558696,"teacher_disagreement_score":0.018288044,"about_ca_system_score_codex":0.0037164616,"about_ca_system_score_gemma":0.0044801445,"threshold_uncertainty_score":0.07897389},"labels":[],"label_agreement":null},{"id":"W2097492743","doi":"10.1016/j.jval.2011.08.021","title":"MT1 Impact of the Choice of Prior Distribution on relative Effect Sizes Using Bayesian Network Meta-Analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverse Approaches in Healthcare and Education Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Prior probability; Statistics; Deviance information criterion; Belatacept; Bayesian probability; Mathematics; Econometrics; Meta-analysis; Kidney transplant; Bayesian inference; Medicine; Kidney transplantation; Internal medicine; Transplantation","score_opus":0.37055078473436476,"score_gpt":0.4346680340335975,"score_spread":0.06411724929923274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097492743","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13530068,0.05126278,0.77400786,0.014123589,0.0018787779,0.002035711,0.005656883,0.003247778,0.012485891],"genre_scores_gemma":[0.85426337,0.0036499398,0.13392065,0.0021321476,0.00045848876,0.0016616065,0.0011167048,0.0007688662,0.002028252],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.65266675,0.3245319,0.007472844,0.009595711,0.004848643,0.00088415376],"domain_scores_gemma":[0.2817704,0.69546884,0.0061806384,0.0129619995,0.0027682416,0.0008498828],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2419438,0.0032825978,0.006973309,0.0043957597,0.0014225608,0.0052628512,0.0041321977,0.006162403,0.013163734],"category_scores_gemma":[0.5510543,0.0027872755,0.018480487,0.0053972285,0.0027310643,0.006885701,0.0032912225,0.00745034,0.000862501],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065129004,0.0004936735,0.035256013,0.021522833,0.42674637,0.0013636327,0.0014112536,0.17039302,0.0030057554,0.025962701,0.009987522,0.23872826],"study_design_scores_gemma":[0.01854656,0.003988377,0.019521436,0.0060189646,0.39204794,0.0011630721,0.00033179973,0.42740855,0.0040646014,0.11689714,0.009436868,0.00057473686],"about_ca_topic_score_codex":0.007874475,"about_ca_topic_score_gemma":0.00591506,"teacher_disagreement_score":0.75805616,"about_ca_system_score_codex":0.0020974712,"about_ca_system_score_gemma":0.0025727835,"threshold_uncertainty_score":0.93481827},"labels":[],"label_agreement":null},{"id":"W2097672482","doi":"10.1016/j.jval.2012.06.009","title":"An Evaluation Framework for Funding Drugs for Rare Diseases","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ministry of Health and Long Term Care; Kingston General Hospital; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; Western University; St. Michael's Hospital; University of Toronto; Queen's University; London Health Sciences Centre","funders":"","keywords":"Orphan drug; Dilemma; Enzyme replacement therapy; Medicine; Accountability; Disease; Rare disease; Drug; Business; Risk analysis (engineering); Public economics; Intensive care medicine; Political science; Pharmacology; Bioinformatics; Economics","score_opus":0.1606582134000392,"score_gpt":0.46329318029258376,"score_spread":0.30263496689254454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097672482","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011356103,0.009617004,0.1822784,0.46489334,0.0086589055,0.007148334,0.0033975262,0.001628316,0.311022],"genre_scores_gemma":[0.473655,0.0059943865,0.3237003,0.110606454,0.008926406,0.012497057,0.0034597856,0.0008903829,0.06027023],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.72284645,0.1598939,0.018507116,0.008923194,0.0716332,0.018196106],"domain_scores_gemma":[0.66879845,0.14376841,0.016272847,0.012426114,0.12923163,0.029502576],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2587029,0.0030044157,0.00543831,0.010423579,0.0076621724,0.035158325,0.008438961,0.026615644,0.012685041],"category_scores_gemma":[0.28423336,0.0021087334,0.0043043266,0.0050072586,0.009822446,0.015977943,0.015433831,0.01280282,0.0028609082],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006782892,0.00033329395,0.0028280546,0.0006043505,0.00047798303,0.00026526646,0.00057229504,0.0070368354,0.00037521866,0.80923474,0.12224679,0.05534695],"study_design_scores_gemma":[0.0017798959,0.0008515099,0.0061395657,0.0031960641,0.0008582494,0.0003590025,0.0011885498,0.024424355,0.0010507025,0.5540863,0.40551525,0.0005504653],"about_ca_topic_score_codex":0.044662587,"about_ca_topic_score_gemma":0.033166137,"teacher_disagreement_score":0.7412971,"about_ca_system_score_codex":0.033422973,"about_ca_system_score_gemma":0.14763057,"threshold_uncertainty_score":0.9141513},"labels":[],"label_agreement":null},{"id":"W2097730523","doi":"10.1016/j.jval.2013.08.019","title":"Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Respondent; Statistics; Choice set; Consistency (knowledge bases); Econometrics; Preference; Demography; Mathematics","score_opus":0.7304774727936757,"score_gpt":0.47317367564234347,"score_spread":0.2573037971513322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097730523","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23027848,0.0011278393,0.75116336,0.0070020524,0.00026892315,0.00036878677,0.0012129497,0.0001587697,0.008418781],"genre_scores_gemma":[0.88857573,0.0005665191,0.10242447,0.0009437163,0.00017916525,0.0006508197,0.0010210588,0.00013519937,0.0055033443],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.96596164,0.025297575,0.0013580401,0.0048374915,0.0015363228,0.0010089104],"domain_scores_gemma":[0.7332479,0.24376975,0.011279512,0.006681058,0.0038536584,0.0011682302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09119251,0.0009729703,0.0052888067,0.0021014442,0.0015603653,0.0053581297,0.0043574804,0.003565061,0.007657543],"category_scores_gemma":[0.18968122,0.001707048,0.0036085614,0.0022644242,0.0052893884,0.0076008495,0.004927458,0.006022811,0.00046504283],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008302612,0.00027626628,0.048486985,0.0002759174,0.001006728,0.00047422518,0.00096999353,0.32625014,0.0002684343,0.59582174,0.0024510021,0.022888184],"study_design_scores_gemma":[0.00014202477,0.00018399855,0.006543422,0.00017596422,0.00018230031,0.0001639091,0.0003114031,0.7072405,0.00018770975,0.28299803,0.0017784684,0.00009225015],"about_ca_topic_score_codex":0.023325808,"about_ca_topic_score_gemma":0.013813086,"teacher_disagreement_score":0.09119251,"about_ca_system_score_codex":0.003795896,"about_ca_system_score_gemma":0.0039026276,"threshold_uncertainty_score":0.48227787},"labels":[],"label_agreement":null},{"id":"W2097779933","doi":"10.1016/j.jval.2012.08.1916","title":"PIH44 Contraceptive Utilization in Women Who Had an Abortion: A Canadian Cohort-Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Abortion; Levonorgestrel; Obstetrics; Family planning; Unintended pregnancy; Gynecology; Long-acting reversible contraception; Pregnancy; Population; Intrauterine device; Medical prescription; Medroxyprogesterone acetate; Pill; Research methodology; Estrogen; Nursing; Environmental health","score_opus":0.06737318277486573,"score_gpt":0.35682318718661316,"score_spread":0.2894500044117474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097779933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98553723,0.0017474585,0.00011215701,0.00062581757,0.000039730192,0.00011801298,0.008264918,0.000016242211,0.0035385801],"genre_scores_gemma":[0.9932295,0.0012635626,0.00021863187,0.00029876648,0.000021065935,0.000066704015,0.002293785,0.00001479218,0.002593211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982351,0.00011840978,0.00011347744,0.00029577597,0.00047213642,0.00076494965],"domain_scores_gemma":[0.99661344,0.00016631944,0.00069315307,0.00023225203,0.0013357778,0.0009591683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010482391,0.0008438665,0.0009671873,0.0023449298,0.0058536613,0.0021490066,0.002581545,0.0017967708,0.0049374904],"category_scores_gemma":[0.0029806206,0.0014423885,0.002356467,0.008526934,0.0009299067,0.00095620827,0.0012385949,0.002509892,0.0006327927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016139635,0.00010257196,0.9951578,0.000040206734,0.00018351903,0.00014706157,0.0008745169,0.000045038294,0.00017117978,0.00012514147,0.0011211373,0.0018703461],"study_design_scores_gemma":[0.000020688962,0.000035222525,0.9977247,0.000033723285,0.00007913611,0.00008292871,0.001009147,0.000108001004,0.000025386533,0.000022249296,0.00083614606,0.000022651284],"about_ca_topic_score_codex":0.99122775,"about_ca_topic_score_gemma":0.99324256,"teacher_disagreement_score":0.020574838,"about_ca_system_score_codex":0.020574838,"about_ca_system_score_gemma":0.029559322,"threshold_uncertainty_score":0.14928162},"labels":[],"label_agreement":null},{"id":"W2097900603","doi":"10.1016/j.jval.2014.03.130","title":"The Effect Of Massachusetts Health Care Reform On Hospital Inpatient Use","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Index (typography); Legislation; Health care; Demography; Population; Quarter (Canadian coin); Inpatient care; Hospital bed; Medicine; Variables; Unemployment; Health care reform; Natural experiment; Demographic economics; Economics; Statistics; Geography; Health policy; Environmental health; Political science; Economic growth; Nursing; Mathematics","score_opus":0.034448519207874714,"score_gpt":0.27197718268119475,"score_spread":0.23752866347332002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097900603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93439835,0.0028965913,0.00041881096,0.048658155,0.00024523865,0.000028266812,0.0033661667,0.000042748867,0.009945536],"genre_scores_gemma":[0.99589044,0.000324577,0.000060158207,0.0010029103,0.0002608293,0.000013479039,0.0004851705,0.0000047761896,0.0019578335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956826,0.0018858018,0.00016649245,0.0003069153,0.0006517908,0.0013063888],"domain_scores_gemma":[0.9763466,0.010388804,0.007320305,0.0008567012,0.0023942331,0.0026933276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032428904,0.0003207799,0.0005726658,0.0014375473,0.0006503831,0.0027732013,0.0013200772,0.0021294106,0.0063679796],"category_scores_gemma":[0.03161709,0.0003059323,0.0010341037,0.002067113,0.0011804332,0.0012971429,0.0013760424,0.0021489381,0.0004357394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016299788,0.0009734868,0.8784164,0.00019084928,0.0011590788,0.0006762888,0.0012302992,0.013517885,0.0009166633,0.033716504,0.036181808,0.031390805],"study_design_scores_gemma":[0.000108046086,0.00026258745,0.9886486,0.00003937458,0.00031658326,0.000059054542,0.0006900059,0.0028732908,0.0004272735,0.001481427,0.0050724507,0.000021332118],"about_ca_topic_score_codex":0.26118135,"about_ca_topic_score_gemma":0.31358567,"teacher_disagreement_score":0.26118135,"about_ca_system_score_codex":0.012209139,"about_ca_system_score_gemma":0.0045234,"threshold_uncertainty_score":0.5193222},"labels":[],"label_agreement":null},{"id":"W2098317659","doi":"10.1016/j.jval.2014.03.564","title":"First Two Years of Health System Resources and Costs Following a Stage Defined Breast Cancer Diagnosis: A Population Based Approach","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Cancer Care Ontario; McMaster University; Ontario Institute for Cancer Research; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cohort; Breast cancer; Stage (stratigraphy); Public health; Health care; Cancer registry; Cancer; Cohort study; Population; Total cost; Demography; Pediatrics; Internal medicine; Environmental health; Pathology","score_opus":0.03728103854955966,"score_gpt":0.2585107166206832,"score_spread":0.22122967807112354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098317659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757304,0.0019721733,0.00396385,0.0011463682,0.00009893336,0.00019176226,0.012939746,0.000047483867,0.003909179],"genre_scores_gemma":[0.98448366,0.001029672,0.0008120851,0.0002695881,0.00012867323,0.00025509513,0.0079106,0.000016340131,0.005094362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980755,0.0006050911,0.00015414505,0.00031989926,0.00022106174,0.0006242047],"domain_scores_gemma":[0.9918914,0.0037303579,0.0018751505,0.00048023128,0.0006877457,0.0013352875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035721057,0.0006809306,0.0016071637,0.0032518776,0.00089632336,0.0025968319,0.0025369823,0.0028667238,0.009661781],"category_scores_gemma":[0.015159846,0.00090250175,0.0037328515,0.0035452296,0.00080676866,0.0030368303,0.0027361913,0.0032251473,0.00083157857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001511256,0.0006642453,0.95931566,0.00023852586,0.0014340531,0.00078224763,0.0007725283,0.016687678,0.00015731758,0.0037217725,0.0020766517,0.012638094],"study_design_scores_gemma":[0.00006815868,0.0017154575,0.9611515,0.00014936888,0.0012739885,0.0014892673,0.0027566785,0.023031972,0.00025833028,0.0039811437,0.004024001,0.00010031424],"about_ca_topic_score_codex":0.048273988,"about_ca_topic_score_gemma":0.047521144,"teacher_disagreement_score":0.048273988,"about_ca_system_score_codex":0.0024216499,"about_ca_system_score_gemma":0.0023089743,"threshold_uncertainty_score":0.09598601},"labels":[],"label_agreement":null},{"id":"W2098724822","doi":"10.1016/j.jval.2014.08.2672","title":"Toward a Functional Definition of a “Rare Disease” for Regulatory Authorities and Funding Agencies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Kingston General Hospital; London Health Sciences Centre; Queen's University; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Reimbursement; Disease; Medicine; Sample size determination; Population; Orphan drug; Actuarial science; Identification (biology); Randomized controlled trial; Negotiation; Clinical trial; Business; Family medicine; Public economics; Environmental health; Political science; Health care; Economics; Surgery; Internal medicine; Statistics; Economic growth","score_opus":0.0746525955204533,"score_gpt":0.27052615852297884,"score_spread":0.19587356300252556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098724822","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072302558,0.0076626865,0.27669334,0.585109,0.016251337,0.0004456037,0.00037236555,0.00057575724,0.105659656],"genre_scores_gemma":[0.3009218,0.008439664,0.42159125,0.21509406,0.028349793,0.0023561988,0.0015090621,0.0008806744,0.020857433],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8974711,0.05537748,0.014173941,0.0068385466,0.020151505,0.0059874435],"domain_scores_gemma":[0.762303,0.08749228,0.016741656,0.016606089,0.09507138,0.021785576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12957187,0.0022015308,0.0042652786,0.011996099,0.013539764,0.03675444,0.008536329,0.02468167,0.0062303375],"category_scores_gemma":[0.125377,0.00177702,0.0038051195,0.005722832,0.051483404,0.02582807,0.014003824,0.03821761,0.0026657917],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027052502,0.0000590828,0.0006354254,0.0001770228,0.000026979485,0.00012252624,0.0010025057,0.00040004405,0.00032343826,0.95019174,0.032748815,0.014285254],"study_design_scores_gemma":[0.00006011143,0.000118990676,0.0016546668,0.0017577885,0.00010813506,0.0005569101,0.003208454,0.0019309156,0.00060099654,0.7883255,0.20151545,0.0001620242],"about_ca_topic_score_codex":0.010184953,"about_ca_topic_score_gemma":0.009567506,"teacher_disagreement_score":0.12957187,"about_ca_system_score_codex":0.011084572,"about_ca_system_score_gemma":0.04936966,"threshold_uncertainty_score":0.68524975},"labels":[],"label_agreement":null},{"id":"W2099062624","doi":"10.1016/j.jval.2013.03.189","title":"Development of the 6-10 year interviewer-administered version of the asthma control questionnaire (ACQ-IA) in Spanish for guatemala and Peru","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cognitive interview; Interview; Psychology; Debriefing; Test (biology); Age appropriate; Cognition; Developmental psychology; Psychiatry; Social psychology; Political science","score_opus":0.025300383355330792,"score_gpt":0.29902753819593014,"score_spread":0.27372715484059934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099062624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491732,0.00108138,0.018352482,0.0015014475,0.00017494062,0.009249471,0.010998742,0.00035526516,0.009113135],"genre_scores_gemma":[0.8720222,0.00165559,0.07777534,0.00065668835,0.00008691949,0.026493786,0.01595355,0.00028956536,0.0050663976],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965539,0.002201652,0.00035273714,0.00031353303,0.00034123324,0.00023707241],"domain_scores_gemma":[0.99612695,0.0011397963,0.0004648112,0.0003331019,0.0017347123,0.00020067084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010254897,0.000773169,0.00068302895,0.0017570725,0.00060063915,0.0010992959,0.0010104054,0.00044889416,0.002446785],"category_scores_gemma":[0.01573632,0.0006486062,0.0012603716,0.0014683302,0.0003924544,0.0009197842,0.0017222458,0.0012444496,0.00063381187],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074624346,0.0011661767,0.7651174,0.0007492213,0.00037990924,0.0007808997,0.022227043,0.0012014591,0.0041763987,0.0010070747,0.010137559,0.19231068],"study_design_scores_gemma":[0.00024440087,0.0009210847,0.97177786,0.00026551867,0.00017608673,0.00030728852,0.007227488,0.0017470083,0.0012054454,0.00036177682,0.015711071,0.000054974756],"about_ca_topic_score_codex":0.055374596,"about_ca_topic_score_gemma":0.07285026,"teacher_disagreement_score":0.055374596,"about_ca_system_score_codex":0.0016452544,"about_ca_system_score_gemma":0.0038587002,"threshold_uncertainty_score":0.11010456},"labels":[],"label_agreement":null},{"id":"W2099070683","doi":"10.1016/j.jval.2012.03.376","title":"PMD36 The Use of Chlorhexidine Gluconate Impregnated Sponge Dressings to Prevent Central-Line Associated Bloodstream Infections and Local Site Infections in Canadian Hospitals: An Economic Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chlorhexidine gluconate; Hygiene; Chlorhexidine; Emergency medicine; Intensive care medicine; Intensive care unit; Activity-based costing; Infection control; Dentistry; Business","score_opus":0.030552365887835196,"score_gpt":0.2955000746289338,"score_spread":0.2649477087410986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099070683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93379474,0.022908498,0.0009539812,0.004956192,0.00015708053,0.0015895693,0.016509483,0.000039886643,0.01909061],"genre_scores_gemma":[0.99254686,0.0037444374,0.0006908878,0.0003868469,0.000040484854,0.00012516513,0.0015710181,0.000004212652,0.0008901854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941995,0.0017568772,0.0003119659,0.00021832049,0.0022561084,0.0012572011],"domain_scores_gemma":[0.99224794,0.0031480265,0.0014018528,0.00013446792,0.0013691935,0.0016986483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004348284,0.000901735,0.0010759291,0.0030901297,0.0012503453,0.0024653429,0.0016962803,0.0012926365,0.004533802],"category_scores_gemma":[0.018097263,0.00072666444,0.004075695,0.0045348895,0.00091970654,0.0005865403,0.0009054698,0.0017011315,0.00010591658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.079269186,0.0033771398,0.5529166,0.008678496,0.010747421,0.0011367956,0.0006099563,0.06492307,0.0016709431,0.012304729,0.02278222,0.24158354],"study_design_scores_gemma":[0.0053627957,0.008588336,0.9147012,0.0016521928,0.007112481,0.0006203161,0.001140932,0.045958154,0.00063805014,0.0013153462,0.012670527,0.00023965318],"about_ca_topic_score_codex":0.9009537,"about_ca_topic_score_gemma":0.91392016,"teacher_disagreement_score":0.09904629,"about_ca_system_score_codex":0.078111276,"about_ca_system_score_gemma":0.05020522,"threshold_uncertainty_score":0.5667396},"labels":[],"label_agreement":null},{"id":"W2100194586","doi":"10.1016/j.jval.2014.03.769","title":"Cost Of Patient Care At Different Stages Of Treatment Within The Public Health Model Of Hiv Care; Analysis From An Urban Hiv Centre In Uganda","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Human immunodeficiency virus (HIV); Antiretroviral therapy; Tuberculosis; Health care; Average cost; Family medicine; Total cost; Public health; Emergency medicine; Pediatrics; Viral load; Nursing","score_opus":0.06599841589178027,"score_gpt":0.35137737897711807,"score_spread":0.28537896308533783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100194586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992674,0.00011023275,0.000051871168,0.00010752169,0.0000016646283,0.000019326875,0.00019241276,0.0000014302311,0.0002480904],"genre_scores_gemma":[0.99954045,0.00010572392,0.00009591194,0.000021847784,0.0000028787401,0.000020138854,0.000111434805,0.0000015633104,0.00010007649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758756,0.0013264201,0.0001127841,0.00011795641,0.00014993966,0.0007054198],"domain_scores_gemma":[0.9949242,0.0025672794,0.0009206296,0.0001333709,0.00035737985,0.0010971822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014523517,0.0006344404,0.00070578046,0.0016981328,0.0019542947,0.0022139677,0.0018598037,0.0014575849,0.002557548],"category_scores_gemma":[0.00670907,0.00080471404,0.0014664116,0.0033342359,0.0015537513,0.0014565353,0.0020727224,0.0019356672,0.00019629585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038570955,0.0019672594,0.945659,0.00038086507,0.0007547003,0.0037936266,0.0034854133,0.022053292,0.00035744839,0.0018478383,0.0012488328,0.0145946285],"study_design_scores_gemma":[0.00028695737,0.0022979751,0.9549802,0.00016231516,0.00042632455,0.002014079,0.017857095,0.020472798,0.00027814132,0.000539335,0.0005829511,0.000101794656],"about_ca_topic_score_codex":0.094292246,"about_ca_topic_score_gemma":0.1381479,"teacher_disagreement_score":0.094292246,"about_ca_system_score_codex":0.011611287,"about_ca_system_score_gemma":0.0030529655,"threshold_uncertainty_score":0.18748683},"labels":[],"label_agreement":null},{"id":"W2100225964","doi":"10.1111/j.1524-4733.2007.00243.x","title":"Advanced Cutaneous Malignant Melanoma: A Systematic Review of Economic and Quality-of-Life Studies","year":2007,"lang":"en","type":"review","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dacarbazine; Quality of life (healthcare); Temozolomide; MEDLINE; Meta-analysis; Cost effectiveness; Randomized controlled trial; Melanoma; Quality-adjusted life year; Internal medicine; Systematic review; Oncology; Chemotherapy","score_opus":0.17123403755941305,"score_gpt":0.4334472991656458,"score_spread":0.2622132616062327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100225964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022076468,0.9968996,0.00008800871,0.00013021997,0.000041869225,0.00008259213,0.00038410956,0.0000020546643,0.00016396421],"genre_scores_gemma":[0.043074664,0.95556194,0.0005970573,0.00025311572,0.000050977822,0.00016304909,0.00023452505,0.0000025513912,0.0000622115],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99435353,0.0021542353,0.0020227693,0.0003961461,0.0009169874,0.00015628939],"domain_scores_gemma":[0.9779568,0.015844129,0.004633332,0.00026464372,0.0010845747,0.0002166216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073769833,0.0010687704,0.007134519,0.007385969,0.00041457842,0.0019218406,0.001123862,0.0010083469,0.0026358678],"category_scores_gemma":[0.030091496,0.0007450528,0.0062592486,0.010874185,0.0005848876,0.0013622962,0.0013175023,0.0009459533,0.000109017856],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007192633,0.000039106206,0.0064907405,0.85182923,0.0769747,0.0002046267,0.00017360647,0.0002493224,0.00013487825,0.0002894501,0.0017855862,0.061109524],"study_design_scores_gemma":[0.0012848465,0.00045922754,0.039566454,0.4678599,0.4607197,0.0011615948,0.0005186392,0.00025070296,0.00024317658,0.0011578532,0.026681356,0.00009660382],"about_ca_topic_score_codex":0.0059156935,"about_ca_topic_score_gemma":0.023030465,"teacher_disagreement_score":0.007385969,"about_ca_system_score_codex":0.002188113,"about_ca_system_score_gemma":0.004005457,"threshold_uncertainty_score":0.039013684},"labels":[],"label_agreement":null},{"id":"W2100305434","doi":"10.1016/j.jval.2014.03.776","title":"Cost-Effectiveness Analysis Of Government Insured Routine Eye Examination: Evidence From Prince Edwards Island, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kensington Health; Health PEI; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Eye examination; Medicine; Christian ministry; Quality-adjusted life year; Cost effectiveness; Incidence (geometry); Health care; Eye care; Demography; Cost–benefit analysis; Population; Optometry; Gerontology; Environmental health; Visual acuity; Ophthalmology","score_opus":0.033594714680181846,"score_gpt":0.31142753234559145,"score_spread":0.2778328176654096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100305434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85726357,0.12085364,0.00039942484,0.0034245683,0.0002841449,0.0010565245,0.007979844,0.000034429486,0.008703839],"genre_scores_gemma":[0.97790056,0.018386923,0.0005992949,0.0006276928,0.00007308374,0.00017127988,0.0016819851,0.0000069562193,0.00055215793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99363285,0.0028301952,0.0005171566,0.0003833686,0.0017910043,0.00084552745],"domain_scores_gemma":[0.98637474,0.0067809895,0.002058346,0.00043145032,0.0029686466,0.0013858809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045858053,0.0007967239,0.001956016,0.0016534297,0.0010782866,0.0016816758,0.001671012,0.0011534101,0.0029460492],"category_scores_gemma":[0.026004406,0.0005212861,0.005249578,0.0033147642,0.0010852085,0.00055417896,0.0008843641,0.0019538335,0.000096324904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15496771,0.0039855633,0.4610465,0.034689892,0.05879613,0.00076424464,0.001071317,0.01553033,0.00068039185,0.003225841,0.018675404,0.24656661],"study_design_scores_gemma":[0.048183512,0.010203369,0.8370753,0.015571074,0.06574769,0.00044047955,0.0016183845,0.009661147,0.0004180591,0.0011049266,0.009725334,0.00025066538],"about_ca_topic_score_codex":0.940556,"about_ca_topic_score_gemma":0.96152276,"teacher_disagreement_score":0.05944401,"about_ca_system_score_codex":0.050094128,"about_ca_system_score_gemma":0.05320489,"threshold_uncertainty_score":0.36346006},"labels":[],"label_agreement":null},{"id":"W2100475597","doi":"10.1016/j.jval.2013.03.871","title":"Perspectives on complementary data sources in diabetes health technology assessment: An enrolling practice-based research network and a large commercial health plan","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicaid; Medicine; Population; Type 2 diabetes; Population health; Family medicine; Health care; Health information technology; Medical record; Cohort; Health plan; Diabetes mellitus; Gerontology; Demography; Environmental health; Internal medicine","score_opus":0.7130318583908806,"score_gpt":0.5501841862972764,"score_spread":0.16284767209360418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100475597","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06354422,0.009369767,0.028285857,0.8471584,0.001602755,0.0006279706,0.007538001,0.000098710625,0.041774374],"genre_scores_gemma":[0.6323808,0.010461105,0.15109748,0.17697439,0.006128659,0.0050778966,0.009776866,0.00043643816,0.007666382],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.7287327,0.23035182,0.009431094,0.005763853,0.022651015,0.003069602],"domain_scores_gemma":[0.16463315,0.7590253,0.015590651,0.018215535,0.035303403,0.007231922],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.28753302,0.0009871526,0.0025959762,0.009412207,0.004582259,0.022747397,0.008304453,0.011492662,0.015170558],"category_scores_gemma":[0.49122354,0.0012695671,0.00230792,0.016069388,0.0070655416,0.021316076,0.012225021,0.009613946,0.0010590965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015036614,0.0012292532,0.15638338,0.0024119795,0.00111664,0.001615712,0.015868299,0.004401644,0.0008831362,0.47778293,0.16940336,0.16740005],"study_design_scores_gemma":[0.0012700981,0.0007336485,0.08179475,0.01702138,0.0012788249,0.002085682,0.04665698,0.028749522,0.0022615828,0.5578473,0.2595465,0.00075369154],"about_ca_topic_score_codex":0.04030382,"about_ca_topic_score_gemma":0.060337197,"teacher_disagreement_score":0.71246696,"about_ca_system_score_codex":0.011609929,"about_ca_system_score_gemma":0.020036886,"threshold_uncertainty_score":0.87859863},"labels":[],"label_agreement":null},{"id":"W2100617583","doi":"10.1016/j.jval.2013.08.2053","title":"Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of Diabetes","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Diabetes mellitus; Reimbursement; Emergency medicine; Population; Public health; Health care; Pediatrics; Intensive care medicine; Environmental health","score_opus":0.09491532251127154,"score_gpt":0.4299714442135625,"score_spread":0.33505612170229093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100617583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939674,0.0011675714,0.00007211149,0.00059745734,0.000012137209,0.0000068911413,0.003033429,0.000009210802,0.0011338458],"genre_scores_gemma":[0.9964012,0.00076885946,0.00008236462,0.00010052823,0.000028011635,0.00000992834,0.0022697304,0.0000037785858,0.0003355596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999298,0.00012763454,0.00014806006,0.00011153268,0.00016094405,0.00015377777],"domain_scores_gemma":[0.99579275,0.0009331915,0.0020481078,0.00010990834,0.00067609607,0.0004400656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007668476,0.00012126578,0.00033966088,0.0013412174,0.00031616882,0.0008651851,0.0004457095,0.0007441981,0.00176964],"category_scores_gemma":[0.004982634,0.00018276229,0.0008404976,0.0032028363,0.00021764525,0.00097992,0.00037924948,0.0010605312,0.0002751487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017885597,0.00005496355,0.99608576,0.00002132322,0.000056311907,0.000023329609,0.00006795719,0.00012454276,0.000055736007,0.00006245066,0.00052060315,0.0027482025],"study_design_scores_gemma":[0.0000044192875,0.000038271817,0.9991198,0.000008383504,0.000018416755,0.000064044594,0.000168579,0.0003095915,0.000028040637,0.000023667391,0.00021366875,0.0000032119342],"about_ca_topic_score_codex":0.05566614,"about_ca_topic_score_gemma":0.06455725,"teacher_disagreement_score":0.05566614,"about_ca_system_score_codex":0.0013454759,"about_ca_system_score_gemma":0.001025825,"threshold_uncertainty_score":0.110684276},"labels":[],"label_agreement":null},{"id":"W2100650176","doi":"10.1016/j.jval.2013.08.227","title":"Hepatitis C Virus Infection Treatment Completion: An Analysis of the Quebec Provincial Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Boceprevir; Telaprevir; Medicine; Ribavirin; Pegylated interferon; Internal medicine; Reimbursement; Hepatitis C virus; Hepatitis C; Pediatrics; Virology; Virus","score_opus":0.08245448752150777,"score_gpt":0.38983497159545366,"score_spread":0.3073804840739459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100650176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8053621,0.0022883618,0.00035825316,0.0014604223,0.00003578738,0.00042929067,0.18617485,0.00006774058,0.0038231476],"genre_scores_gemma":[0.8933747,0.0011670678,0.000852032,0.0005442442,0.00003373327,0.0003720635,0.10137496,0.000041372357,0.002239797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99290997,0.001550302,0.00089147384,0.00087683875,0.002703482,0.0010679124],"domain_scores_gemma":[0.95803237,0.010523893,0.009897961,0.001977575,0.016373064,0.003195209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004628077,0.00051270245,0.0013229487,0.005182215,0.0017352566,0.0021396982,0.0022724268,0.000888708,0.0048757303],"category_scores_gemma":[0.033602253,0.0004831946,0.0013366396,0.020708239,0.00050454243,0.00090409385,0.0012316133,0.0011196166,0.0006585675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054566795,0.00008798181,0.9780687,0.00014924363,0.00039145784,0.00006528184,0.0002833543,0.0005381199,0.0000582244,0.0001553255,0.013029123,0.0066275084],"study_design_scores_gemma":[0.00004186373,0.00003224804,0.9952584,0.00006350049,0.00008808354,0.000046536617,0.00028867717,0.0017317878,0.000037684957,0.000017672506,0.0023796228,0.000013904434],"about_ca_topic_score_codex":0.97570455,"about_ca_topic_score_gemma":0.9777744,"teacher_disagreement_score":0.035294272,"about_ca_system_score_codex":0.035294272,"about_ca_system_score_gemma":0.03873198,"threshold_uncertainty_score":0.25607908},"labels":[],"label_agreement":null},{"id":"W2100848218","doi":"10.1016/j.jval.2014.08.1394","title":"Comparing Actual Patient Level Hospital Costs To The Canadian Cmg+ Costing Estimates For Acute Myocardial Infarction","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Myocardial infarction; Emergency medicine; Outlier; Statistics; Internal medicine; Mathematics","score_opus":0.2544127783207831,"score_gpt":0.43514464078935705,"score_spread":0.18073186246857398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100848218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86246884,0.0027921344,0.002318668,0.0036780208,0.00022629276,0.00016284386,0.099994734,0.00017882034,0.02817961],"genre_scores_gemma":[0.973175,0.00059722015,0.0021338258,0.0002682385,0.000031376425,0.000042356376,0.021599332,0.000026423919,0.0021262872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724305,0.00048270402,0.00018015146,0.0001865399,0.0014623943,0.00044529524],"domain_scores_gemma":[0.99277776,0.0015645111,0.00049719703,0.00023754456,0.0045769224,0.00034609283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017969495,0.00047855175,0.00038890014,0.0023676327,0.0008966124,0.0014842884,0.0015659432,0.00046728726,0.0036928002],"category_scores_gemma":[0.016880123,0.00025356148,0.0009167176,0.005392664,0.0003252423,0.0006269048,0.00070911535,0.0010638341,0.0002510721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031874394,0.0003452602,0.73821974,0.0008091523,0.0015288922,0.0002446769,0.0006483623,0.08562161,0.00048778774,0.013033234,0.07694628,0.078927584],"study_design_scores_gemma":[0.00016523385,0.00010380312,0.9578456,0.000112860915,0.00029852093,0.000117467185,0.0008161097,0.026558096,0.00039996835,0.00068829453,0.012819613,0.0000745382],"about_ca_topic_score_codex":0.99004716,"about_ca_topic_score_gemma":0.99151707,"teacher_disagreement_score":0.99004716,"about_ca_system_score_codex":0.05417831,"about_ca_system_score_gemma":0.02868847,"threshold_uncertainty_score":0.393093},"labels":[],"label_agreement":null},{"id":"W2100857136","doi":"10.1016/j.jval.2012.08.1858","title":"PHS85 The Cost of Public Cancer Prevention in Alberta","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Christian ministry; Government (linguistics); Cancer prevention; Public health; Environmental health; Business; Behavioral Risk Factor Surveillance System; Medicine; Cancer; Political science; Nursing","score_opus":0.595256386592312,"score_gpt":0.4768351141783591,"score_spread":0.11842127241395284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100857136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83135664,0.0044449344,0.00065725174,0.02232435,0.000456688,0.00021368857,0.028029554,0.00015361054,0.11236341],"genre_scores_gemma":[0.9555736,0.0015691682,0.00035726005,0.00072997663,0.00011034798,0.000032019667,0.0042893924,0.000016059677,0.03732225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984956,0.00028771933,0.000048122172,0.00006493418,0.00063997897,0.00046368167],"domain_scores_gemma":[0.99795216,0.00048175702,0.00017005742,0.000065419204,0.00056982297,0.00076083955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010316672,0.00021087723,0.0003299608,0.0011290244,0.00079820986,0.0015397612,0.0012778912,0.0010233476,0.00814329],"category_scores_gemma":[0.0051916386,0.0003268752,0.0004712247,0.0018985891,0.00073086756,0.0003665165,0.0010148605,0.0009690878,0.0003654198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045738425,0.00067039655,0.50143135,0.000543474,0.00067907956,0.0020822065,0.000582239,0.09073245,0.0007064024,0.037310112,0.18054792,0.18014058],"study_design_scores_gemma":[0.0008701611,0.0004821987,0.8655405,0.00023554497,0.00032237257,0.0007867993,0.002742785,0.04257371,0.0005810032,0.00533595,0.08044454,0.00008441422],"about_ca_topic_score_codex":0.96756405,"about_ca_topic_score_gemma":0.9787779,"teacher_disagreement_score":0.052772034,"about_ca_system_score_codex":0.052772034,"about_ca_system_score_gemma":0.039629582,"threshold_uncertainty_score":0.3828897},"labels":[],"label_agreement":null},{"id":"W2100894147","doi":"10.1016/j.jval.2013.03.515","title":"How can we use discrete event simulation to improve access to health care: an assessment of increasing access to care for children with medically refractory epilepsy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Programs for Assessment of Technology in Health Research Institute; McMaster University","funders":"","keywords":"Multidisciplinary approach; Discrete event simulation; Resource (disambiguation); Limiting; Health care; Computer science; Operations management; Unit (ring theory); Medicine; Simulation; Engineering; Psychology","score_opus":0.24991299687988316,"score_gpt":0.47635157636593367,"score_spread":0.2264385794860505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100894147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7586314,0.0016794188,0.18628815,0.0377349,0.0008176007,0.000777811,0.0017559619,0.001187227,0.011127452],"genre_scores_gemma":[0.9547053,0.00042209055,0.04298744,0.0008819232,0.000054318607,0.00022669628,0.0003123195,0.000049207363,0.00036080278],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995168,0.0037988846,0.00021298566,0.00022606397,0.00035338436,0.0002407437],"domain_scores_gemma":[0.9473561,0.044522844,0.002997964,0.0018730273,0.0019165088,0.0013335706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010137515,0.0007481912,0.0010358766,0.0008605374,0.00037570673,0.0025372645,0.0013184902,0.0019615663,0.0028375848],"category_scores_gemma":[0.08893889,0.00042094904,0.0013953216,0.0009057917,0.0007764613,0.0030456465,0.0011720591,0.0021419656,0.00026215432],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014189819,0.0013863269,0.048021585,0.0003589254,0.0014019501,0.00008230899,0.00035062092,0.87352246,0.00022792984,0.01473913,0.0035334108,0.0549564],"study_design_scores_gemma":[0.00074739655,0.00046070493,0.0048781084,0.00011265452,0.00025058747,0.00003120249,0.0002836589,0.9663286,0.0003896016,0.024824902,0.0016495456,0.00004292295],"about_ca_topic_score_codex":0.02125932,"about_ca_topic_score_gemma":0.015156081,"teacher_disagreement_score":0.02125932,"about_ca_system_score_codex":0.0019914517,"about_ca_system_score_gemma":0.003921471,"threshold_uncertainty_score":0.053612947},"labels":[],"label_agreement":null},{"id":"W2100930670","doi":"10.1016/j.jval.2014.03.900","title":"Ovarian Stimulation Use, Including Clomiphene Citrate, And Intrauterine Insemination Use And The Risk Of Multiplicity And Major Congenital Malformations: A Meta-Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Assisted Reproductive Technology and Twin Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Intrauterine insemination; Relative risk; Randomized controlled trial; Gynecology; Observational study; Adverse effect; Obstetrics; Infertility; Pregnancy; Internal medicine; Confidence interval","score_opus":0.09358449022296159,"score_gpt":0.31336403048643924,"score_spread":0.21977954026347765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100930670","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3086211,0.68233466,0.004028989,0.0005970133,0.000959162,0.00023103319,0.0019630855,0.00017816345,0.00108679],"genre_scores_gemma":[0.95461863,0.041514147,0.0015840806,0.00046759355,0.00029365422,0.00015953694,0.0006880949,0.000042673393,0.000631732],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99527526,0.0023127545,0.0007735152,0.0009509048,0.00039172135,0.0002957518],"domain_scores_gemma":[0.9904614,0.006898397,0.0010119183,0.0008532355,0.000488801,0.00028629403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005927508,0.002537879,0.008302207,0.0019413466,0.0008240066,0.002245676,0.0018335006,0.0026216977,0.0024872548],"category_scores_gemma":[0.013157245,0.001814026,0.036993902,0.0037559043,0.00064803474,0.0009813135,0.0010357877,0.002218906,0.0002431654],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016261026,0.000055427143,0.04414521,0.0073726135,0.9273666,0.0001843142,0.000051029165,0.0005861192,0.00057541224,0.000065758366,0.00027944386,0.003057029],"study_design_scores_gemma":[0.0013917235,0.00043000275,0.017363437,0.0003497505,0.9791949,0.00012015206,0.000036912454,0.00044285608,0.00015525125,0.00013394143,0.00035966898,0.00002141075],"about_ca_topic_score_codex":0.0103116,"about_ca_topic_score_gemma":0.013624514,"teacher_disagreement_score":0.0103116,"about_ca_system_score_codex":0.00094198575,"about_ca_system_score_gemma":0.0011359638,"threshold_uncertainty_score":0.03134799},"labels":[],"label_agreement":null},{"id":"W2101080120","doi":"10.1016/j.jval.2013.03.696","title":"Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Toronto Public Health; Ontario Institute for Cancer Research; University Health Network; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Medicine; Lung cancer; Oncology; Internal medicine; Cost effectiveness","score_opus":0.03934213499226,"score_gpt":0.33639221429708416,"score_spread":0.2970500793048242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101080120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819103,0.0038861306,0.00014232569,0.0035322565,0.00005814158,0.0001308304,0.0021056202,0.000015313686,0.008218948],"genre_scores_gemma":[0.99793375,0.00063605554,0.000113945636,0.00018953421,0.000025308347,0.000018264138,0.00044546238,0.0000021647406,0.00063548435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911934,0.00023210906,0.00006958564,0.0000912494,0.00021766483,0.0002700157],"domain_scores_gemma":[0.9983695,0.00031061837,0.0004960899,0.000027137545,0.00018775815,0.000608914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005081066,0.00030282582,0.0006245417,0.0003288729,0.00053999486,0.00089269516,0.0008296501,0.00055650406,0.0025095805],"category_scores_gemma":[0.003592527,0.00021856649,0.0015028364,0.0009167626,0.00039417655,0.00042610976,0.000596685,0.00053505,0.00009850435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04795524,0.0015560894,0.71722186,0.001310383,0.003449946,0.0015429921,0.0006982737,0.026619095,0.0024480931,0.0019247346,0.016541174,0.17873225],"study_design_scores_gemma":[0.005234892,0.005002565,0.959481,0.00029745206,0.0033004403,0.00054687064,0.0010040822,0.017074721,0.0005250028,0.00052758335,0.0069232304,0.00008212668],"about_ca_topic_score_codex":0.86152536,"about_ca_topic_score_gemma":0.9356899,"teacher_disagreement_score":0.13847464,"about_ca_system_score_codex":0.032087605,"about_ca_system_score_gemma":0.020956296,"threshold_uncertainty_score":0.27858025},"labels":[],"label_agreement":null},{"id":"W2101232021","doi":"10.1016/j.jval.2011.02.421","title":"PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Hemodialysis; Randomized controlled trial; Low molecular weight heparin; Heparin; Meta-analysis; Thrombosis; Systematic review; Internal medicine; Extracorporeal; Intensive care medicine; MEDLINE","score_opus":0.19284003563198815,"score_gpt":0.40258645464300774,"score_spread":0.2097464190110196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101232021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013653573,0.98459375,0.0005601988,0.00019840573,0.00017039855,0.00017929455,0.00037647254,0.000022108135,0.00024569678],"genre_scores_gemma":[0.3839151,0.6106129,0.0026248922,0.0011515087,0.00026889984,0.00047891613,0.00048628473,0.000021533444,0.00043991968],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954348,0.0020274492,0.0012631326,0.00051364757,0.0005710081,0.0001898968],"domain_scores_gemma":[0.98999923,0.0068806442,0.002031717,0.00032815433,0.0005737387,0.00018657255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067339744,0.0015957344,0.012600091,0.0022939185,0.00043680047,0.0017654039,0.0014125636,0.0016301513,0.0034662324],"category_scores_gemma":[0.019285697,0.0011394878,0.019706182,0.0035420794,0.0005750525,0.0012995383,0.0012038546,0.0016761316,0.00020779808],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069449865,0.00006329711,0.0076034996,0.23153204,0.72484124,0.00014689523,0.00010441884,0.00031991067,0.0003297149,0.00010708126,0.0008307092,0.027176153],"study_design_scores_gemma":[0.002045095,0.00036896148,0.004865763,0.007492973,0.9834448,0.00010223797,0.000036528858,0.00012358533,0.000116829935,0.000115648785,0.0012639022,0.00002361109],"about_ca_topic_score_codex":0.004444127,"about_ca_topic_score_gemma":0.0141483685,"teacher_disagreement_score":0.012600091,"about_ca_system_score_codex":0.0015846835,"about_ca_system_score_gemma":0.002230562,"threshold_uncertainty_score":0.03561306},"labels":[],"label_agreement":null},{"id":"W2101820986","doi":"10.1016/j.jval.2014.03.464","title":"Health Care Resource Utilization in the Management of Chronic Lymphocytic Leukemia at an Ontario Cancer Centre","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Credit Valley Hospital; McMaster University; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Fludarabine; Chlorambucil; Chronic lymphocytic leukemia; Cohort; Internal medicine; Alemtuzumab; Rituximab; Retrospective cohort study; Chemotherapy regimen; Cancer; Chemotherapy; Oncology; Leukemia; Transplantation; Lymphoma; Cyclophosphamide","score_opus":0.05192244247625553,"score_gpt":0.3482144586261496,"score_spread":0.29629201614989403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101820986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912499,0.0007289495,0.00004598091,0.0035146892,0.000021322872,0.00008270054,0.00050782826,0.0000054402285,0.0038431827],"genre_scores_gemma":[0.9970599,0.000813074,0.00014825149,0.00048070605,0.00002709435,0.000030006704,0.00021596464,0.000004398436,0.001220717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876,0.00021870162,0.000089706526,0.00006775693,0.00027662958,0.0005873554],"domain_scores_gemma":[0.9966601,0.00026198558,0.00070705457,0.000031828804,0.00059027766,0.0017487331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047368294,0.00017222471,0.00022525134,0.00062932057,0.0027795422,0.0015541206,0.00092460046,0.00047225558,0.0025818618],"category_scores_gemma":[0.0026152546,0.00028047236,0.00027661218,0.0019529262,0.00079202576,0.0004625207,0.0010940045,0.0007736381,0.0001129206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025296918,0.0002918391,0.9654537,0.00015764541,0.00006964161,0.0021909398,0.006476573,0.0005787056,0.0005523775,0.0005388335,0.0066570854,0.016779652],"study_design_scores_gemma":[0.000032674852,0.00016480961,0.9856749,0.000108702625,0.000030230542,0.00039555226,0.009345215,0.0007137192,0.000079775185,0.000084798776,0.0033474322,0.000022260585],"about_ca_topic_score_codex":0.943808,"about_ca_topic_score_gemma":0.9747482,"teacher_disagreement_score":0.05619198,"about_ca_system_score_codex":0.04683973,"about_ca_system_score_gemma":0.046242863,"threshold_uncertainty_score":0.33984762},"labels":[],"label_agreement":null},{"id":"W2101840350","doi":"10.1046/j.1524-4733.2002.54145.x","title":"Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Heartburn; Medicine; Quality-adjusted life year; Cost effectiveness; Intensive care medicine; Actuarial science; Risk analysis (engineering); Disease; Business; Internal medicine; Reflux","score_opus":0.1432677669857264,"score_gpt":0.39053039659987576,"score_spread":0.24726262961414935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101840350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96075726,0.025534578,0.0034823273,0.003060231,0.00015746432,0.00023312101,0.0013005956,0.000044550303,0.0054298076],"genre_scores_gemma":[0.9978179,0.001071825,0.0006024501,0.0000708229,0.00003562942,0.000029922172,0.00023583153,0.0000019910774,0.00013364837],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99767286,0.0016703659,0.00014606482,0.00009357977,0.00024086611,0.00017631621],"domain_scores_gemma":[0.99183637,0.006694403,0.0005770862,0.00016927918,0.00029923164,0.0004235692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028678526,0.0006480378,0.0012144321,0.0012333315,0.00028042184,0.001041508,0.0006774127,0.0011726203,0.0033347954],"category_scores_gemma":[0.015915021,0.0002583242,0.0026783338,0.0011833975,0.0004998313,0.001205193,0.0006066811,0.0010369903,0.00014323514],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10146544,0.006967873,0.23512015,0.0025080454,0.011771906,0.00092215167,0.00034551416,0.15103473,0.0019789666,0.0067485976,0.004085782,0.4770509],"study_design_scores_gemma":[0.013008271,0.043007758,0.64692,0.0014766522,0.023383725,0.0029817007,0.0014874972,0.24534194,0.0022513336,0.015818983,0.0040084347,0.0003137142],"about_ca_topic_score_codex":0.0064252466,"about_ca_topic_score_gemma":0.0048655234,"teacher_disagreement_score":0.0064252466,"about_ca_system_score_codex":0.0025226334,"about_ca_system_score_gemma":0.0012166093,"threshold_uncertainty_score":0.018303037},"labels":[],"label_agreement":null},{"id":"W2102472721","doi":"10.1016/j.jval.2014.01.001","title":"Projecting Long-Term Graft and Patient Survival after Transplantation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Belatacept; Immunosuppression; Renal function; Kidney transplantation; Transplantation; Internal medicine; Urology; Kidney transplant","score_opus":0.033645014228331487,"score_gpt":0.316239323781763,"score_spread":0.2825943095534315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102472721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672848,0.0015951082,0.003637476,0.012183989,0.00018468918,0.000032775733,0.007502717,0.00004632044,0.007532114],"genre_scores_gemma":[0.99610114,0.00044202956,0.00067651004,0.00024668738,0.00006373648,0.0000108357735,0.002069399,0.0000039989723,0.0003856186],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975107,0.0014094943,0.00016168851,0.00017158387,0.00028659357,0.00045996194],"domain_scores_gemma":[0.98617864,0.0044176048,0.0033684566,0.00064134016,0.0016629015,0.003731026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004373696,0.00051825924,0.00049724005,0.0015097564,0.00069903897,0.0023710502,0.0009698743,0.00096603465,0.0036200238],"category_scores_gemma":[0.01723953,0.0002173624,0.0011805838,0.0022078867,0.00091713556,0.0020192002,0.0024157073,0.0021404058,0.00063063967],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012538227,0.00017382456,0.9715423,0.00006137511,0.0004378785,0.00005740759,0.00017394761,0.004184826,0.000059387472,0.003078453,0.00255576,0.017549558],"study_design_scores_gemma":[0.0000356004,0.0005733733,0.9347757,0.00030739038,0.00046913786,0.00031641734,0.0028722628,0.023415703,0.00060151325,0.03161402,0.0049274336,0.00009160399],"about_ca_topic_score_codex":0.014728469,"about_ca_topic_score_gemma":0.023964897,"teacher_disagreement_score":0.014728469,"about_ca_system_score_codex":0.0020056437,"about_ca_system_score_gemma":0.0027121066,"threshold_uncertainty_score":0.02928543},"labels":[],"label_agreement":null},{"id":"W2102734493","doi":"10.1016/j.jval.2012.08.716","title":"PHP174 Physical Activity Matters: The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 Years","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Physical Activity and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University; Statistics Canada","funders":"","keywords":"Body mass index; Medicine; Quality of life (healthcare); Demography; Gerontology; Physical activity; Leisure time; Health related quality of life; Population; Baseline (sea); Physical therapy; Environmental health; Disease","score_opus":0.16314197463775906,"score_gpt":0.42998727917368507,"score_spread":0.26684530453592603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102734493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9632957,0.0053159003,0.000994538,0.016163936,0.0011631353,0.000026651282,0.0061897403,0.000053996417,0.006796466],"genre_scores_gemma":[0.99219304,0.00050619186,0.00014930745,0.0010631385,0.000628003,0.000013435914,0.0012218435,0.000019496152,0.004205428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929225,0.00027281465,0.000048363177,0.00018127485,0.000082600294,0.00012268467],"domain_scores_gemma":[0.9973441,0.001066655,0.00066061097,0.00019902385,0.00015064026,0.0005790441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010922019,0.0004388715,0.00052870886,0.0005050761,0.0004193084,0.0012563828,0.00063930324,0.0016463537,0.01934418],"category_scores_gemma":[0.0073223314,0.00029848926,0.001447499,0.0011852003,0.00043349943,0.0012291213,0.0009727533,0.002171649,0.001592844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006043773,0.000081582446,0.9843615,0.000054212956,0.00055659824,0.00012419757,0.00010412814,0.00020443548,0.00030730286,0.00033764716,0.0028140591,0.010449996],"study_design_scores_gemma":[0.000021006985,0.00013638822,0.99693596,0.000030884425,0.00022230913,0.00010751284,0.00013813758,0.0005125921,0.00007896307,0.00041312753,0.0013962244,0.000006988542],"about_ca_topic_score_codex":0.010686113,"about_ca_topic_score_gemma":0.010413487,"teacher_disagreement_score":0.01934418,"about_ca_system_score_codex":0.00022711007,"about_ca_system_score_gemma":0.00083617086,"threshold_uncertainty_score":0.0647127},"labels":[],"label_agreement":null},{"id":"W2103616822","doi":"10.1016/j.jval.2013.08.1406","title":"Cost-Effectiveness of Injectable Atypical Long-Acting Antipsychotics for Chronic Schizophrenia in Poland","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Medicine; Risperidone; Paliperidone; Marginal cost; Cost effectiveness; Quality-adjusted life year; Antipsychotic; Emergency medicine; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.08950215865121984,"score_gpt":0.385559855557367,"score_spread":0.29605769690614714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103616822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99715567,0.0018140683,0.00008835773,0.00022634103,0.0000063186812,0.000018921124,0.00022395636,0.0000021408885,0.00046435007],"genre_scores_gemma":[0.99917126,0.0005450728,0.000086500404,0.0000173541,0.000003188486,0.000008224442,0.000091182024,8.845827e-7,0.00007629078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992717,0.0003674106,0.00009806337,0.000043831067,0.00010081717,0.00011820627],"domain_scores_gemma":[0.99906105,0.00039770777,0.00030595003,0.000028471275,0.00007279956,0.00013400747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085615437,0.00019211425,0.00036500706,0.00066873577,0.00012259412,0.0006427333,0.00025121504,0.00029945013,0.0009669786],"category_scores_gemma":[0.0034743159,0.00017462108,0.0010763566,0.00057172915,0.00026939414,0.0004430759,0.0005810742,0.00033130674,0.000037281334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061714686,0.0020446004,0.6760964,0.0017713232,0.004623788,0.00095991854,0.00046284733,0.028089749,0.003353178,0.0030311255,0.0010035852,0.21684885],"study_design_scores_gemma":[0.003306153,0.00701203,0.96853507,0.0002721291,0.0032615159,0.0007734923,0.0008113911,0.012631323,0.00085368915,0.0010824936,0.0014096064,0.000051095372],"about_ca_topic_score_codex":0.013833406,"about_ca_topic_score_gemma":0.018578785,"teacher_disagreement_score":0.013833406,"about_ca_system_score_codex":0.0029803866,"about_ca_system_score_gemma":0.0016390199,"threshold_uncertainty_score":0.027505755},"labels":[],"label_agreement":null},{"id":"W2104767470","doi":"10.1016/j.jval.2013.08.234","title":"An Assessment of Unemployment Among People Living with HIV/AIDS in Canada and Europe","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Unemployment; Depression (economics); Medicine; Anxiety; Logistic regression; Quality of life (healthcare); Human immunodeficiency virus (HIV); Psychiatry; Demography; Gerontology; Internal medicine; Cognition; Family medicine","score_opus":0.01874260407395505,"score_gpt":0.31143662271881145,"score_spread":0.2926940186448564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104767470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960865,0.00092849304,0.00003274357,0.00026373492,0.00001285429,0.000024986915,0.0011173615,0.0000017035281,0.0015316586],"genre_scores_gemma":[0.99789715,0.00061439554,0.000060588456,0.00009519847,0.000007770713,0.000012218859,0.00071726035,0.000002009172,0.0005934086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888283,0.00014250199,0.00011660794,0.000074515636,0.00036213186,0.0004215021],"domain_scores_gemma":[0.99761486,0.00012526574,0.00030592724,0.000025354075,0.0011069829,0.0008216566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009627596,0.000269073,0.0005109434,0.002860187,0.003502455,0.0019334658,0.0010724125,0.0007771749,0.00094863126],"category_scores_gemma":[0.0023968196,0.00024147188,0.0008018688,0.0055821934,0.00067389145,0.00057375,0.0015328892,0.00091839134,0.0000980735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008216363,0.000051425024,0.99410146,0.000032130723,0.000052981428,0.00013004954,0.0018905215,0.00007386843,0.000058657846,0.00009070293,0.00033415735,0.0031019174],"study_design_scores_gemma":[0.0000018683963,0.000018332432,0.9950453,0.000026256266,0.000011171851,0.000041293235,0.0042601186,0.00007982947,0.000012800176,0.000010472566,0.0004865577,0.0000060021084],"about_ca_topic_score_codex":0.979427,"about_ca_topic_score_gemma":0.9851955,"teacher_disagreement_score":0.02057302,"about_ca_system_score_codex":0.016607516,"about_ca_system_score_gemma":0.018281985,"threshold_uncertainty_score":0.12049651},"labels":[],"label_agreement":null},{"id":"W2105018961","doi":"10.1016/j.jval.2011.05.010","title":"Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department for International Development, UK Government; Cancer Research UK; International Development Research Centre; American Cancer Society","keywords":"Tobacco control; Microsimulation; Latin Americans; Psychological intervention; Environmental health; Medicine; Economics; Political science; Engineering; Public health; Nursing; Transport engineering","score_opus":0.13046863903575207,"score_gpt":0.36128430342886064,"score_spread":0.23081566439310858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105018961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72723615,0.0008802766,0.25158793,0.0022760688,0.00023774985,0.0008939417,0.001781234,0.00032713826,0.014779552],"genre_scores_gemma":[0.96529406,0.00024823312,0.031291615,0.00012547518,0.000023728568,0.0007157198,0.0005283168,0.000034383247,0.0017385508],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990245,0.0006638086,0.000044130396,0.0000818028,0.0000637482,0.000121981284],"domain_scores_gemma":[0.9915828,0.0071382616,0.00033976202,0.00014790046,0.00061494444,0.00017639183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049726553,0.0009961966,0.0018408116,0.0011464903,0.0005918522,0.0015111536,0.0019141356,0.0017316978,0.003192014],"category_scores_gemma":[0.012275859,0.0006933662,0.0013671552,0.0009361263,0.0006274595,0.0009455244,0.0012538998,0.0015904042,0.00017105373],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008507906,0.000063422995,0.00092226936,0.000023809584,0.000049392598,0.000022570897,0.000010361558,0.9953831,0.00006787125,0.0018979307,0.00012410869,0.0013499775],"study_design_scores_gemma":[0.000050573475,0.00004464073,0.0002464859,0.000006088129,0.000025397705,0.0000044183107,0.000012346033,0.99887425,0.000053406406,0.00056128396,0.00011734522,0.0000037142272],"about_ca_topic_score_codex":0.047394488,"about_ca_topic_score_gemma":0.01774105,"teacher_disagreement_score":0.047394488,"about_ca_system_score_codex":0.0030822835,"about_ca_system_score_gemma":0.004411244,"threshold_uncertainty_score":0.09423721},"labels":[],"label_agreement":null},{"id":"W2105086787","doi":"10.1016/j.jval.2014.03.1334","title":"A Cost-Effectiveness Analysis Of Maternal Genotyping To Guide Treatment For Postpartum Pain And Avert Infant Adverse Events","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Adverse effect; Population; Pharmacotherapy; Genotyping; Breastfeeding; Dosing; Codeine; Pediatrics; Cost effectiveness; Intensive care medicine; Emergency medicine; Anesthesia; Internal medicine; Morphine; Environmental health; Genotype; Risk analysis (engineering)","score_opus":0.12684867591096954,"score_gpt":0.44454549336347055,"score_spread":0.317696817452501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105086787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9118016,0.033794593,0.027608525,0.005674447,0.00062194903,0.0048134117,0.004386711,0.00025662372,0.01104225],"genre_scores_gemma":[0.9898046,0.0018863294,0.006302792,0.00049797585,0.00009322396,0.0003842045,0.00048179494,0.000012955269,0.00053614826],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9852798,0.012340398,0.00046649206,0.0006495705,0.0007034036,0.00056023506],"domain_scores_gemma":[0.9629197,0.033629075,0.0016016,0.00063252775,0.00048154793,0.0007354594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010905063,0.001962842,0.0036131695,0.002451219,0.00042553153,0.0027237027,0.0018146555,0.0029626386,0.0077917753],"category_scores_gemma":[0.03856771,0.0012594417,0.00788275,0.001730377,0.0011298008,0.0022374538,0.0013162964,0.0033970836,0.00032843518],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42514762,0.009602417,0.039881054,0.0059731295,0.049100496,0.0007605379,0.000278565,0.234405,0.0022153081,0.009026557,0.0037181391,0.21989127],"study_design_scores_gemma":[0.13627423,0.08729891,0.0693297,0.0023353307,0.12379309,0.0015523948,0.0008771441,0.5565462,0.0019702383,0.014355039,0.005208301,0.00045938094],"about_ca_topic_score_codex":0.010923806,"about_ca_topic_score_gemma":0.0063054697,"teacher_disagreement_score":0.010923806,"about_ca_system_score_codex":0.006127359,"about_ca_system_score_gemma":0.0032878672,"threshold_uncertainty_score":0.057672143},"labels":[],"label_agreement":null},{"id":"W2106175264","doi":"10.1016/j.jval.2014.08.187","title":"TC-325 in the Management of Upper and Lower GI Bleeding: A Two-Year Experience at a Single Institution","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Hemostasis; Upper gastrointestinal bleeding; Retrospective cohort study; Endoscopy; Adverse effect; Surgery; Internal medicine","score_opus":0.046505411315161664,"score_gpt":0.30863843592049245,"score_spread":0.2621330246053308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106175264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467707,0.0019917474,0.00071294745,0.000508711,0.00002834715,0.00006725451,0.00004152912,0.000026215755,0.0019461552],"genre_scores_gemma":[0.9942806,0.0020146943,0.002082896,0.00040556057,0.0001319483,0.00002873918,0.00015539514,0.000027449909,0.00087278534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991573,0.00025988035,0.00010747438,0.00009656127,0.0001840799,0.00019477695],"domain_scores_gemma":[0.9987208,0.0002510312,0.00018696641,0.00007191758,0.000093212606,0.00067599927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009635313,0.00055944157,0.0005647436,0.0005414147,0.0009909497,0.0011822247,0.00062953774,0.0009717479,0.0011906078],"category_scores_gemma":[0.002648209,0.0002724651,0.0007987969,0.0008439449,0.00053220114,0.0005747062,0.0006378125,0.0015004664,0.0004517193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00715576,0.019480463,0.5346849,0.00028727096,0.0007590176,0.0671844,0.0045749806,0.0028691432,0.021598853,0.0005366012,0.0039709928,0.33689767],"study_design_scores_gemma":[0.002255706,0.05161895,0.7535912,0.00023188385,0.0008981348,0.15853949,0.0048902235,0.0070227743,0.009467463,0.00036370888,0.010921475,0.00019895952],"about_ca_topic_score_codex":0.0038408139,"about_ca_topic_score_gemma":0.0059799645,"teacher_disagreement_score":0.0038408139,"about_ca_system_score_codex":0.0010460359,"about_ca_system_score_gemma":0.0013118933,"threshold_uncertainty_score":0.0076369047},"labels":[],"label_agreement":null},{"id":"W2106468952","doi":"10.1016/j.jval.2013.08.1107","title":"Interim Results from the Burden of Bowel Dysfunction in Spinal Cord Injury Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spinal Hematomas and Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Toronto Rehabilitation Institute; Providence Health Care; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Spinal cord injury; Observational study; Physical therapy; Cohort; Cohort study; Demographics; Interim; Internal medicine; Demography; Spinal cord; Psychiatry","score_opus":0.08505414104281642,"score_gpt":0.38060058499916455,"score_spread":0.2955464439563481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106468952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83646166,0.00344115,0.0011493994,0.0018965435,0.00041886859,0.0003478781,0.14748795,0.000113047994,0.00868339],"genre_scores_gemma":[0.8539569,0.0013303146,0.0013270454,0.0008200467,0.000663468,0.0008244159,0.13630296,0.00007486528,0.0047000535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691737,0.0014592018,0.0002835168,0.0002461438,0.0006105739,0.00048307286],"domain_scores_gemma":[0.9908558,0.0022892922,0.0026882733,0.0013365904,0.0013817459,0.0014482908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066771964,0.0009439848,0.0020222159,0.0010088009,0.00086907425,0.0025997641,0.0012670665,0.001025931,0.005166447],"category_scores_gemma":[0.0129951695,0.00080669945,0.0030560845,0.0024493646,0.00036584787,0.0016745365,0.002610412,0.0018288784,0.0011410579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042107724,0.0010204234,0.9035262,0.00040043684,0.0064995117,0.00022047386,0.00021306891,0.0018099722,0.00034259277,0.0005255477,0.024405548,0.018928625],"study_design_scores_gemma":[0.001367188,0.0012825965,0.99112004,0.00005187852,0.0025758347,0.000084149266,0.00016314893,0.00032264664,0.00017421455,0.00028725318,0.0025324088,0.00003864826],"about_ca_topic_score_codex":0.0089021195,"about_ca_topic_score_gemma":0.010770262,"teacher_disagreement_score":0.0089021195,"about_ca_system_score_codex":0.00081444,"about_ca_system_score_gemma":0.001411039,"threshold_uncertainty_score":0.03531283},"labels":[],"label_agreement":null},{"id":"W2106526054","doi":"10.1016/j.jval.2011.08.508","title":"PND42 Impact of Relapses Leading to Hospitalisation on Health-Related Quality of Life, Fatigue and Health Care Resource Utilisation in A Population with A Relapsing Form of Multiple Sclerosis (RMS) Using Data from Temso A Teriflunonomide Pivotal Phase III Trial","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Population; Multiple sclerosis; Physical therapy; Health care; Emergency medicine; Internal medicine; Psychiatry; Environmental health","score_opus":0.5087239630918277,"score_gpt":0.453494236243787,"score_spread":0.05522972684804067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106526054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670273,0.0013509565,0.000049508246,0.00008770983,0.000018127255,0.000037447844,0.0009939393,0.0000029808584,0.0007564547],"genre_scores_gemma":[0.9980281,0.00030386867,0.00007027637,0.00006793359,0.00002196493,0.000058447647,0.0010402091,0.0000026189596,0.00040657682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857175,0.00085633463,0.0001184522,0.00015195875,0.0001689928,0.00013241546],"domain_scores_gemma":[0.9979615,0.00092149805,0.00054568093,0.00013566953,0.0001512718,0.00028435345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026845618,0.00037547867,0.0009712291,0.00032716856,0.00030961444,0.00090845244,0.00043532756,0.00055832876,0.0024200974],"category_scores_gemma":[0.004295244,0.0002224081,0.0019387964,0.0006393337,0.0002616377,0.0006600325,0.000609257,0.0009789598,0.00023467556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2147576,0.0015149248,0.72619027,0.0005497441,0.010079768,0.00024380094,0.0002065104,0.0014333734,0.0019221004,0.00016048971,0.00137493,0.04156635],"study_design_scores_gemma":[0.0052276873,0.0099043045,0.9798743,0.000060970477,0.0027270666,0.00017571954,0.0001339858,0.0005959734,0.00027698823,0.00012924461,0.0008703569,0.000023427974],"about_ca_topic_score_codex":0.0030586175,"about_ca_topic_score_gemma":0.004828569,"teacher_disagreement_score":0.0030586175,"about_ca_system_score_codex":0.0003846522,"about_ca_system_score_gemma":0.00056101574,"threshold_uncertainty_score":0.014197469},"labels":[],"label_agreement":null},{"id":"W2106752242","doi":"10.1016/s1098-3015(10)73674-3","title":"PRS11 QUANTIFYING COSTS AND BENEFITS OF TIMING PHARMACEUTICAL INTERVENTION: AN ECONOMIC SIMULATION MODEL OF ASTHMA IN ALBERTA, CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Asthma; Intervention (counseling); Economics; Actuarial science; Medicine; Psychiatry; Immunology","score_opus":0.25241543499388713,"score_gpt":0.453650870974838,"score_spread":0.2012354359809509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106752242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96179956,0.0005630378,0.0053631,0.0027024322,0.00011374973,0.00033156847,0.0047113183,0.00014096405,0.024274329],"genre_scores_gemma":[0.98649454,0.00032713116,0.0029066815,0.00016862553,0.00001991055,0.0001229839,0.0016033449,0.000024693541,0.008332105],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99881727,0.00038008692,0.00003975491,0.00011753754,0.00017106113,0.0004742621],"domain_scores_gemma":[0.9950059,0.0027690402,0.00023436785,0.00011474135,0.0012218411,0.0006541448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022140227,0.0014786109,0.001734947,0.0019418956,0.0026694338,0.0032427963,0.0039749914,0.004193541,0.008163643],"category_scores_gemma":[0.0071994914,0.0015609738,0.001932454,0.0027943698,0.0024219782,0.0009669841,0.0013364167,0.0023565309,0.0003492181],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027061987,0.00015898458,0.0046238527,0.000027605887,0.00004365214,0.00008877479,0.000033852742,0.990262,0.00006337633,0.0020379906,0.0010108018,0.0013784594],"study_design_scores_gemma":[0.00029798038,0.00009825508,0.0030839618,0.000017807473,0.00006093859,0.00001344476,0.00020579156,0.9946849,0.00008232098,0.00071935594,0.00070184184,0.00003347631],"about_ca_topic_score_codex":0.9826712,"about_ca_topic_score_gemma":0.96746516,"teacher_disagreement_score":0.043380674,"about_ca_system_score_codex":0.043380674,"about_ca_system_score_gemma":0.046026282,"threshold_uncertainty_score":0.3147503},"labels":[],"label_agreement":null},{"id":"W2107033706","doi":"10.1016/j.jval.2014.03.112","title":"Real-World Clinical Evidence Development: An Analysis Of Relevant International Models For The Potential Implementation Of Such A Program In Quebec","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"InterDigital (Canada); Montréal InVivo; Université de Montréal","funders":"","keywords":"Reimbursement; Government (linguistics); Listing (finance); Business; Real world evidence; MEDLINE; Health care; Public relations; Medicine; Political science; Finance","score_opus":0.5424621394796939,"score_gpt":0.5464388467296969,"score_spread":0.0039767072500029865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107033706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6315786,0.028456923,0.07410288,0.09107833,0.00039954807,0.0031046912,0.020496033,0.000584924,0.15019804],"genre_scores_gemma":[0.9749689,0.003029584,0.01009455,0.0014767782,0.000039878047,0.000405687,0.0013403725,0.000065606415,0.008578605],"study_design_codex":"simulation_or_modeling","study_design_gemma":"qualitative","domain_scores_codex":[0.9847366,0.010600457,0.00047786086,0.0006710348,0.00116738,0.0023466558],"domain_scores_gemma":[0.925649,0.059015475,0.003525917,0.0014881399,0.0074290354,0.0028924043],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.034347665,0.0010416335,0.0016038875,0.0027948285,0.0018037845,0.008436934,0.002701401,0.002594833,0.010279255],"category_scores_gemma":[0.09145385,0.0008287418,0.002496812,0.006045633,0.0025103649,0.002403788,0.0021359164,0.0028474024,0.00031071744],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014116875,0.00037992932,0.067210086,0.0009128583,0.0019278959,0.0007273747,0.00079068873,0.58371925,0.00023148877,0.28081685,0.019356405,0.042515587],"study_design_scores_gemma":[0.00093848474,0.0008206862,0.12833634,0.0015258904,0.002427945,0.00035787743,0.0021185398,0.762578,0.00047197603,0.066568166,0.033547316,0.00030874892],"about_ca_topic_score_codex":0.8861624,"about_ca_topic_score_gemma":0.87398577,"teacher_disagreement_score":0.96565235,"about_ca_system_score_codex":0.08045662,"about_ca_system_score_gemma":0.0684859,"threshold_uncertainty_score":0.5837564},"labels":[],"label_agreement":null},{"id":"W2107072358","doi":"10.1111/j.1524-4733.2008.00371.x","title":"A Study on Indirect and Intangible Costs for Patients with Knee Osteoarthritis in Singapore","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Indirect costs; Human capital; Earnings; Willingness to pay; Medicine; Business; Economics; Finance; Accounting","score_opus":0.10239179691380541,"score_gpt":0.23705208760399138,"score_spread":0.13466029069018598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107072358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99930835,0.00008624612,0.0000121684125,0.00009087115,0.000001979706,0.0000052065566,0.00017225477,3.1464512e-7,0.0003225511],"genre_scores_gemma":[0.9995103,0.00008207378,0.000014380863,0.000033878205,0.0000036704107,0.000005152508,0.00019123753,4.981526e-7,0.00015873271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935454,0.00019039636,0.00013036872,0.00006396819,0.000077804776,0.00018297827],"domain_scores_gemma":[0.99677235,0.0007276941,0.0013564408,0.00010278601,0.00028620262,0.0007544642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007783644,0.00035648316,0.000716586,0.0010434253,0.0010441093,0.0015544528,0.00041666644,0.000961675,0.0033542614],"category_scores_gemma":[0.0040868954,0.0003834292,0.0012709493,0.0027932688,0.0005944145,0.0012560496,0.0010767961,0.0016618313,0.00033051206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018197739,0.0001776031,0.9967727,0.000025340862,0.00008805123,0.00042657967,0.0008171597,0.00007005844,0.00003703599,0.00010538352,0.000099510275,0.0011986187],"study_design_scores_gemma":[0.00002118069,0.00030927232,0.9942536,0.000021108075,0.00006906381,0.0005650716,0.0040664594,0.00028713263,0.000017208797,0.00007262482,0.0003006064,0.000016617067],"about_ca_topic_score_codex":0.041783683,"about_ca_topic_score_gemma":0.05150717,"teacher_disagreement_score":0.041783683,"about_ca_system_score_codex":0.0023998157,"about_ca_system_score_gemma":0.0016905691,"threshold_uncertainty_score":0.08308095},"labels":[],"label_agreement":null},{"id":"W2107089384","doi":"10.1016/j.jval.2015.09.802","title":"Burden of Dyslipidaemia in Patients at High Risk for Cardiovascular (Cv) Events: Results of a Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Amgen (Canada); Université de Montréal","funders":"","keywords":"Medicine; Statin; Internal medicine; Cohort; Body mass index; Risk factor; Medical prescription; Diabetes mellitus; Cohort study; Ezetimibe; Obesity; Endocrinology; Pharmacology","score_opus":0.039038384304523714,"score_gpt":0.27406148344453884,"score_spread":0.23502309914001512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107089384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861829,0.0018346932,0.00013678543,0.00065792305,0.000031048432,0.00014147986,0.0085710995,0.0000116704305,0.0024324628],"genre_scores_gemma":[0.9904355,0.001920062,0.00048252195,0.0003049851,0.000034091638,0.000073920644,0.0055103716,0.000014276522,0.0012242583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836737,0.00020292879,0.00012663162,0.00027834298,0.0006211303,0.0004035717],"domain_scores_gemma":[0.99639374,0.0002026306,0.0005153699,0.00016532079,0.0018657657,0.00085709605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021488296,0.0012540772,0.0014765883,0.0016214526,0.0042322204,0.002120764,0.001996879,0.0015959524,0.0016831949],"category_scores_gemma":[0.0036691225,0.0009950949,0.0024475174,0.0074667158,0.0010375273,0.0009251067,0.0015493628,0.0020621438,0.00025869635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011012796,0.00024085744,0.9903936,0.0001060839,0.0005117439,0.00013914524,0.000904022,0.00017140736,0.00023568378,0.00015571954,0.0018598314,0.0041804886],"study_design_scores_gemma":[0.00010252163,0.000052340558,0.99845016,0.000026311009,0.00019454873,0.000043637316,0.0004976222,0.00013300654,0.000022676555,0.000019217556,0.0004339239,0.000023988727],"about_ca_topic_score_codex":0.98951715,"about_ca_topic_score_gemma":0.99104756,"teacher_disagreement_score":0.02503828,"about_ca_system_score_codex":0.02503828,"about_ca_system_score_gemma":0.027113834,"threshold_uncertainty_score":0.18166625},"labels":[],"label_agreement":null},{"id":"W2107338834","doi":"10.1016/j.jval.2013.08.1477","title":"Patients as a Source for Cost of Rheumatoid Arthritis Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Management and Organizational Practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Quarter (Canadian coin); Activity-based costing; Tariff; Physical therapy; Indirect costs; Internal medicine; Family medicine; Pediatrics","score_opus":0.025814030811021633,"score_gpt":0.2601759662571636,"score_spread":0.23436193544614198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107338834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950918,0.00030763957,0.000039616978,0.00030730854,0.000016544624,0.000053929467,0.0028576571,0.0000020843647,0.0013235466],"genre_scores_gemma":[0.99795616,0.00015674229,0.00007625769,0.00011126041,0.000049272538,0.0000542984,0.0011058424,0.0000021370727,0.00048812767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984919,0.00071017153,0.00019191153,0.00010994581,0.00024019067,0.00025591435],"domain_scores_gemma":[0.99326307,0.0011298608,0.0031784547,0.00027137715,0.00045607527,0.001701121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085981574,0.00034663672,0.00048153242,0.0015915941,0.0010547894,0.0014244404,0.00077828654,0.00094500795,0.0034196915],"category_scores_gemma":[0.0052027274,0.00047129724,0.0010319935,0.0022574628,0.0004659376,0.00077154906,0.001408246,0.001719216,0.00032726466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029182006,0.0005132862,0.9914751,0.00008019925,0.0005453963,0.00024371131,0.00021795573,0.00011449513,0.000085160485,0.00028738484,0.00104431,0.0024747474],"study_design_scores_gemma":[0.000506774,0.0008822893,0.9943071,0.000049998416,0.00057910004,0.0005982344,0.001348713,0.00029294286,0.00007337323,0.000104801526,0.0012280224,0.00002872219],"about_ca_topic_score_codex":0.023337485,"about_ca_topic_score_gemma":0.022610882,"teacher_disagreement_score":0.023337485,"about_ca_system_score_codex":0.0022559457,"about_ca_system_score_gemma":0.0020064723,"threshold_uncertainty_score":0.04640329},"labels":[],"label_agreement":null},{"id":"W2107388543","doi":"10.1016/j.jval.2010.10.005","title":"Trajectory Classes of Decline in Health-Related Quality of Life in Parkinson's Disease: A Pilot Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Public Health Ontario; University of Toronto","funders":"Bundesministerium für Bildung und Forschung","keywords":"Quality of life (healthcare); Medicine; Disease; Depression (economics); Beck Depression Inventory; Parkinson's disease; Rating scale; Gerontology; Physical therapy; Internal medicine; Psychology; Psychiatry; Anxiety","score_opus":0.1627446575740878,"score_gpt":0.36060696727486063,"score_spread":0.19786230970077284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107388543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991153,0.00003565109,0.00006613201,0.000014854911,0.0000029040918,0.00013857745,0.0003306216,0.0000031730892,0.00029287147],"genre_scores_gemma":[0.99834025,0.00003278278,0.00017356897,0.000011694902,0.0000054711377,0.00022317283,0.00070210284,0.0000037065565,0.0005072146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993741,0.00023174308,0.000041906038,0.000109709516,0.00009541897,0.00014714817],"domain_scores_gemma":[0.9974026,0.0006434671,0.0005542076,0.00032043198,0.00032870632,0.0007505715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017868399,0.0005508413,0.0008670407,0.0010870964,0.0014602691,0.0009646538,0.0008700871,0.00080271205,0.0029735437],"category_scores_gemma":[0.0040809377,0.00032910093,0.0011474529,0.0010985327,0.00054691365,0.0018932653,0.0013461924,0.0014698012,0.0005455755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028665002,0.00853102,0.9446214,0.000052043404,0.00028989164,0.00024913694,0.0020803993,0.00051917916,0.00071210926,0.00022917865,0.00057694246,0.013473766],"study_design_scores_gemma":[0.0004736014,0.007905765,0.9897473,0.000007091745,0.000050418977,0.00007631247,0.0007368143,0.0005133854,0.000088652356,0.00015987949,0.00022476463,0.00001600776],"about_ca_topic_score_codex":0.017435694,"about_ca_topic_score_gemma":0.012926373,"teacher_disagreement_score":0.017435694,"about_ca_system_score_codex":0.0010786487,"about_ca_system_score_gemma":0.0008255497,"threshold_uncertainty_score":0.034668446},"labels":[],"label_agreement":null},{"id":"W2107448287","doi":"10.1016/j.jval.2014.03.148","title":"Comparison Of Two Agents For The Reversal Of Neuromuscular Blockade: A Discrete Event Simulation Model Of Operating Room Efficiency In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Sugammadex; Neostigmine; Medicine; Neuromuscular Blockade; Anesthesia; Rocuronium; Intubation","score_opus":0.06494444858335226,"score_gpt":0.37208185045543196,"score_spread":0.3071374018720797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107448287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827428,0.00043317318,0.006090043,0.0020645997,0.00008151248,0.00021420124,0.0016640371,0.00008865648,0.006620974],"genre_scores_gemma":[0.9937557,0.0002005543,0.0019920263,0.00014003925,0.000015327947,0.00010311656,0.0006460515,0.000019224672,0.0031280047],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99835616,0.00061415345,0.000055580127,0.00022551314,0.00017045661,0.0005781037],"domain_scores_gemma":[0.9825346,0.012859625,0.0006999683,0.0002616521,0.0021317767,0.0015124023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038135194,0.0013508436,0.0023467701,0.0013739655,0.0018025194,0.0032620353,0.0036777663,0.0041547855,0.0053480957],"category_scores_gemma":[0.015508212,0.0011360402,0.0024054376,0.0014341207,0.002023347,0.0013567946,0.0012955638,0.0031421564,0.0003156827],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006456622,0.00033823424,0.0050940416,0.000035316905,0.00008745461,0.00005870261,0.00007007568,0.98929495,0.00007218574,0.0025633804,0.00071785616,0.0010220928],"study_design_scores_gemma":[0.00033194255,0.00017658244,0.00323749,0.000014008073,0.000076124525,0.000008118803,0.00016079163,0.99505603,0.00005776758,0.0005678367,0.00027890108,0.000034443445],"about_ca_topic_score_codex":0.9176226,"about_ca_topic_score_gemma":0.80184513,"teacher_disagreement_score":0.082377374,"about_ca_system_score_codex":0.0243842,"about_ca_system_score_gemma":0.022149459,"threshold_uncertainty_score":0.1769206},"labels":[],"label_agreement":null},{"id":"W2107567298","doi":"10.1016/j.jval.2014.08.1513","title":"Regional Variation in Hospital Mortality, Length of Stay and Cost of Ischemic Stroke Patients in Alberta","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Workforce Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Ischemic stroke; Medicine; Regional variation; Variation (astronomy); Stroke (engine); Emergency medicine; Demography; Medical emergency; Internal medicine; Business; Ischemia; Engineering","score_opus":0.045557371011762174,"score_gpt":0.3852976551243438,"score_spread":0.3397402841125816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107567298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979468,0.00021343236,0.000059409158,0.00015567953,0.000007047174,0.0000050322114,0.00061215414,0.000006822303,0.0009937313],"genre_scores_gemma":[0.9987955,0.00011712556,0.00006543392,0.000043143144,0.0000051256493,0.0000024325957,0.00046056602,0.0000036677227,0.0005070028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928135,0.00014310125,0.0000479006,0.00011386383,0.00016685185,0.0002469582],"domain_scores_gemma":[0.998454,0.00028982505,0.00028668874,0.00007075723,0.00052734656,0.00037133053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008659418,0.000218867,0.0003053539,0.0013750775,0.0009594963,0.0010725055,0.0013632819,0.0005638433,0.001749199],"category_scores_gemma":[0.002345771,0.0002504106,0.00049122365,0.0026859434,0.0007910821,0.00030685303,0.00076370663,0.00046846244,0.00019005073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020010085,0.000043217104,0.9945582,0.000011301864,0.00009289974,0.00017058954,0.0004866918,0.0006017117,0.00018468396,0.00013434443,0.0006858996,0.0028304115],"study_design_scores_gemma":[0.000004148201,0.000012385233,0.99857044,0.0000053255626,0.000014496413,0.000046587935,0.00078537565,0.00034117914,0.000021282005,0.000024970515,0.00016818274,0.000005617121],"about_ca_topic_score_codex":0.943853,"about_ca_topic_score_gemma":0.9647796,"teacher_disagreement_score":0.05614698,"about_ca_system_score_codex":0.009730143,"about_ca_system_score_gemma":0.0058164042,"threshold_uncertainty_score":0.11295521},"labels":[],"label_agreement":null},{"id":"W2108278188","doi":"10.1111/j.1524-4733.2004.75009.x","title":"Comparing Medications in a Therapeutic Area Using an NNT Model","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology; McGill University; Royal Victoria Hospital","funders":"","keywords":"Number needed to treat; Medicine; Population; Statistics; Confidence interval; Relative risk; Internal medicine; Mathematics; Environmental health","score_opus":0.4117238955176505,"score_gpt":0.430291325657453,"score_spread":0.0185674301398025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108278188","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07928387,0.01039723,0.88755155,0.002917796,0.0031437199,0.0076390537,0.001844889,0.000567836,0.006654081],"genre_scores_gemma":[0.6659799,0.0032667236,0.30844924,0.0023550147,0.0010553352,0.014439844,0.0015143723,0.00015061353,0.0027889414],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6214451,0.34023422,0.0105336895,0.012590257,0.013852851,0.0013438761],"domain_scores_gemma":[0.68811035,0.2924766,0.0076114764,0.008067696,0.0030501732,0.00068366976],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23709217,0.0037625725,0.01175392,0.00522395,0.0008821468,0.0043102265,0.0040090955,0.005203663,0.005494186],"category_scores_gemma":[0.28295517,0.0010515527,0.013789728,0.0036287592,0.0035106342,0.005744892,0.002792752,0.006952175,0.00075969915],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024916131,0.0014422094,0.059091553,0.009488035,0.0978036,0.0014201696,0.001154627,0.4872924,0.0013100856,0.11245242,0.0077723972,0.1958564],"study_design_scores_gemma":[0.0048851077,0.008595534,0.010365194,0.0013681363,0.013792004,0.0012086888,0.00026873304,0.6853354,0.00095084746,0.26402774,0.008911501,0.00029115292],"about_ca_topic_score_codex":0.0024722198,"about_ca_topic_score_gemma":0.0014426565,"teacher_disagreement_score":0.23709217,"about_ca_system_score_codex":0.0034897928,"about_ca_system_score_gemma":0.002097001,"threshold_uncertainty_score":0.9408012},"labels":[],"label_agreement":null},{"id":"W2108489849","doi":"10.1111/j.1524-4733.2010.00768.x","title":"Functional Impairment and Disability across Mood States in Bipolar Disorder","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mania; Bipolar disorder; Psychosocial; Psychology; Depression (economics); Mood; Clinical psychology; Global Assessment of Functioning; Psychiatry; Bipolar I disorder; Functional impairment; Population; Medicine; Cognition","score_opus":0.0206892286380205,"score_gpt":0.31293046490420645,"score_spread":0.2922412362661859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108489849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772614,0.0006604236,0.000017746665,0.00008689301,0.0000093243525,0.000008430954,0.00012268692,8.318657e-7,0.0013675162],"genre_scores_gemma":[0.9995882,0.00012878748,0.000019310894,0.00001702395,0.0000045798765,0.00000347981,0.00011424344,4.1654602e-7,0.00012399613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995546,0.0001176058,0.000060507624,0.000033716835,0.000100873316,0.00013258927],"domain_scores_gemma":[0.9987759,0.00016741027,0.00043121335,0.000026279762,0.00014112261,0.00045807616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071492745,0.0002388592,0.0005200345,0.0010777895,0.0007529677,0.0009405037,0.00030411335,0.00047151875,0.0016492758],"category_scores_gemma":[0.0031755613,0.00017078823,0.00067142624,0.0009301959,0.00047673236,0.00072172127,0.0011944091,0.0008467384,0.00013546755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007155719,0.00016811972,0.9903196,0.000030860538,0.00018260173,0.0001265282,0.00053262437,0.00012082044,0.00017035456,0.000100874866,0.00021585352,0.007316266],"study_design_scores_gemma":[0.000009380172,0.000119232434,0.9989492,0.000013610597,0.000027615648,0.000079253856,0.00049883995,0.00008925124,0.000012327465,0.0001157914,0.00008183502,0.000003746986],"about_ca_topic_score_codex":0.01744322,"about_ca_topic_score_gemma":0.03664893,"teacher_disagreement_score":0.01744322,"about_ca_system_score_codex":0.0009140313,"about_ca_system_score_gemma":0.00038219697,"threshold_uncertainty_score":0.034683347},"labels":[],"label_agreement":null},{"id":"W2109018400","doi":"10.1016/j.jval.2013.08.1157","title":"Costs of Incidence-Based Central Retinal Vein Occlusion in France","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Central retinal vein occlusion; Medicine; Indirect costs; Incidence (geometry); Optometry; Retinal Disorder; Retinal Vein; Ophthalmology; Pediatrics; Emergency medicine; Visual acuity; Macular edema; Retinal; Business; Accounting","score_opus":0.019168429592560286,"score_gpt":0.3033580958608818,"score_spread":0.28418966626832154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109018400","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037286572,0.9525204,0.00021870212,0.0013366219,0.00013726862,0.00022633628,0.005238889,0.000021493015,0.0030136856],"genre_scores_gemma":[0.49098176,0.49953273,0.0016578296,0.0011559789,0.00033659773,0.0007953379,0.004628292,0.0000163936,0.00089501933],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9930212,0.003306836,0.0016132055,0.00045725994,0.0013931716,0.00020824748],"domain_scores_gemma":[0.9870236,0.0070526,0.004387762,0.00015581743,0.0012127409,0.00016752935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00612411,0.00079976424,0.0021854672,0.012406602,0.0003988816,0.0029831764,0.0008002822,0.0012909091,0.0063892286],"category_scores_gemma":[0.01895127,0.0004620873,0.006731685,0.008065916,0.00035776838,0.0011604378,0.0006527415,0.00072496256,0.0002530893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005532656,0.0002783082,0.10356564,0.47813505,0.058765423,0.0020204051,0.0007183528,0.0029740685,0.00039735882,0.0051909424,0.019779341,0.3226424],"study_design_scores_gemma":[0.004815978,0.0032650963,0.4352551,0.3479707,0.08452659,0.009706108,0.0021005287,0.0030301402,0.0008002813,0.0028355706,0.10541084,0.00028317087],"about_ca_topic_score_codex":0.039016057,"about_ca_topic_score_gemma":0.040521473,"teacher_disagreement_score":0.039016057,"about_ca_system_score_codex":0.010019689,"about_ca_system_score_gemma":0.006521199,"threshold_uncertainty_score":0.07757795},"labels":[],"label_agreement":null},{"id":"W2109517979","doi":"10.1111/j.1524-4733.2010.00695.x","title":"Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Tobit model; Estimator; Econometrics; Mathematics; Nonparametric statistics; Statistics; Ordinary least squares; Censoring (clinical trials); Confidence interval; Truncation (statistics)","score_opus":0.5131673730727903,"score_gpt":0.42776352995092504,"score_spread":0.08540384312186522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109517979","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4601177,0.0024484692,0.5151532,0.009224572,0.00019738855,0.0004133204,0.0041408273,0.0005349049,0.0077695837],"genre_scores_gemma":[0.9618276,0.00056099176,0.031230045,0.00069998764,0.00007164619,0.00030700554,0.0027056145,0.000119312484,0.0024778051],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9790557,0.017189,0.0006583052,0.0012138413,0.00090447115,0.0009786265],"domain_scores_gemma":[0.8457825,0.13697585,0.0063332887,0.007341504,0.0027095936,0.0008572628],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04241197,0.0009026281,0.0029055565,0.0018865623,0.0005595832,0.003384785,0.002911763,0.0029166802,0.004957317],"category_scores_gemma":[0.18391955,0.00095318333,0.0018516285,0.0032881375,0.0017707,0.0056871846,0.0021550755,0.0056427484,0.0010366822],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004042154,0.00077175006,0.27265322,0.0012128468,0.0016262197,0.0010312177,0.002580796,0.1797641,0.0009011037,0.23892376,0.026172236,0.27032065],"study_design_scores_gemma":[0.00011909808,0.00033463704,0.07806175,0.000441735,0.0002727936,0.0006818078,0.001083052,0.6603701,0.0012276334,0.25001818,0.0072817574,0.00010746149],"about_ca_topic_score_codex":0.004783755,"about_ca_topic_score_gemma":0.0039125914,"teacher_disagreement_score":0.957588,"about_ca_system_score_codex":0.0012019102,"about_ca_system_score_gemma":0.0009786843,"threshold_uncertainty_score":0.2242986},"labels":[],"label_agreement":null},{"id":"W2110380449","doi":"10.1111/j.1524-4733.2009.00588.x","title":"Relationship between Health-Related Quality of Life, Pain, and Functional Disability in Neuropathic Pain Patients with Failed Back Surgery Syndrome","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina General Hospital","funders":"Medtronic","keywords":"Medicine; Oswestry Disability Index; Visual analogue scale; Quality of life (healthcare); Physical therapy; Neuropathic pain; Physical medicine and rehabilitation; Low back pain; Anesthesia; Alternative medicine","score_opus":0.06539276988189979,"score_gpt":0.3019693009767458,"score_spread":0.236576531094846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110380449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99927205,0.00020474572,0.000016661885,0.00007131537,0.0000049935343,0.0000024641197,0.00005729575,5.543389e-7,0.0003699036],"genre_scores_gemma":[0.99983,0.000037732192,0.000012886245,0.000015548967,0.0000045297784,0.0000016404034,0.00005216914,2.0052337e-7,0.000045239656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996381,0.00011636593,0.00006354181,0.000027984395,0.00007906218,0.00007498318],"domain_scores_gemma":[0.9973801,0.0009239289,0.00086317316,0.000049127295,0.00023761338,0.00054611557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005233455,0.00021420226,0.00040682917,0.00066448434,0.0003712088,0.00060686155,0.00026624426,0.0005341883,0.0020201758],"category_scores_gemma":[0.0046512317,0.00014635199,0.00045487625,0.0006391853,0.00034821813,0.00035603176,0.0004157729,0.000711956,0.00013982314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018027674,0.00007376793,0.9982431,0.000010451199,0.000080884514,0.00014326631,0.00006221262,0.00006558559,0.00009873491,0.0000145478525,0.000040686107,0.0009864516],"study_design_scores_gemma":[0.000012078818,0.00014321433,0.9990101,0.000004822654,0.000033012944,0.00025587043,0.0001864169,0.00026405964,0.000016653546,0.000032373366,0.00003776181,0.0000037480936],"about_ca_topic_score_codex":0.0036580039,"about_ca_topic_score_gemma":0.005449784,"teacher_disagreement_score":0.0036580039,"about_ca_system_score_codex":0.00039710617,"about_ca_system_score_gemma":0.0002760013,"threshold_uncertainty_score":0.0072734356},"labels":[],"label_agreement":null},{"id":"W2110579557","doi":"10.1111/j.1524-4733.2009.00513.x","title":"Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data","year":2009,"lang":"en","type":"review","venue":"Value in Health","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reimbursement; Sirolimus; Coronary artery disease; Internal medicine; Drug-eluting stent; Stent; Cost-effectiveness analysis; Confidence interval; Cost effectiveness; Restenosis; Health care","score_opus":0.2893822188551691,"score_gpt":0.4988045960906108,"score_spread":0.20942237723544166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110579557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071792984,0.9915255,0.00027425576,0.0001822769,0.00003786265,0.000018709476,0.00042459863,0.0000044095086,0.00035324146],"genre_scores_gemma":[0.09269824,0.9043159,0.0015080217,0.0001602902,0.000097439326,0.00003982369,0.00095598475,0.0000065604754,0.00021773556],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9987638,0.0004919311,0.00017805718,0.00011489758,0.00039340998,0.000057836427],"domain_scores_gemma":[0.9956911,0.0034247532,0.00049435435,0.000052706142,0.00028887042,0.000048135473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023788353,0.0008024635,0.0037275406,0.0029604998,0.00010882923,0.000987942,0.0010739825,0.0004896006,0.0013587764],"category_scores_gemma":[0.006786698,0.0003766228,0.0042725145,0.004811022,0.00020434064,0.00069449114,0.000348637,0.0006841332,0.00015582686],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030108513,0.00021746148,0.022243965,0.094448894,0.051646177,0.0002946814,0.000087166416,0.00762104,0.00039764412,0.0022329078,0.01199063,0.8058087],"study_design_scores_gemma":[0.0036903175,0.0039451662,0.32828456,0.09013026,0.2906943,0.0055911927,0.0007071324,0.028310273,0.002034599,0.011698563,0.2344392,0.00047452401],"about_ca_topic_score_codex":0.0050281966,"about_ca_topic_score_gemma":0.008370311,"teacher_disagreement_score":0.0050281966,"about_ca_system_score_codex":0.00171463,"about_ca_system_score_gemma":0.0012436522,"threshold_uncertainty_score":0.012580633},"labels":[],"label_agreement":null},{"id":"W2110717830","doi":"10.1016/j.jval.2014.08.1633","title":"Impact of Biologics Use on Depression and Anxiety Frequency and Health Care Resource Utilization In Psoriasis: An Analysis Using the Quebec Provincial Drug Reimbursement Program Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Université de Montréal","funders":"","keywords":"Medicine; Psoriasis; Reimbursement; Depression (economics); Anxiety; Database; Quality of life (healthcare); Health care; Internal medicine; Psychiatry; Dermatology","score_opus":0.06619317030901606,"score_gpt":0.3472439568685518,"score_spread":0.28105078655953575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110717830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9189115,0.0017719568,0.0002692136,0.0005428264,0.00002593444,0.00016710833,0.07562429,0.000043913307,0.0026431591],"genre_scores_gemma":[0.97814786,0.0006542291,0.00039755506,0.00024508408,0.000016733991,0.00010934902,0.01919824,0.000019240233,0.0012116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765354,0.00049455126,0.0002958417,0.00036300553,0.0007468605,0.00044619644],"domain_scores_gemma":[0.9909696,0.0016025169,0.0026577278,0.00040802534,0.0033236968,0.001038478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016351794,0.00047410646,0.0010162077,0.0031307212,0.0013638942,0.0017491616,0.0017449312,0.00075801316,0.0035050255],"category_scores_gemma":[0.008246285,0.00046348415,0.0019666709,0.010327032,0.00044673402,0.00067363656,0.0009410367,0.0011029247,0.00038948873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019677977,0.00004856512,0.99453235,0.00004501978,0.0002899153,0.0000291489,0.000071119466,0.00029824543,0.000029519117,0.000040660965,0.0022488167,0.002169845],"study_design_scores_gemma":[0.000026255895,0.000022961722,0.9980343,0.000028760382,0.00009596792,0.000030493582,0.0001402979,0.0009736139,0.000021102856,0.0000085989195,0.00060794107,0.000009671447],"about_ca_topic_score_codex":0.984968,"about_ca_topic_score_gemma":0.9856983,"teacher_disagreement_score":0.984968,"about_ca_system_score_codex":0.024043458,"about_ca_system_score_gemma":0.016608668,"threshold_uncertainty_score":0.17444831},"labels":[],"label_agreement":null},{"id":"W2110934964","doi":"10.1016/j.jval.2015.09.813","title":"Impact of Genetic Factors on Gastrointestinal Bleeding in a Prospective Cohort of new Warfarin users","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Warfarin; Internal medicine; Bleed; Prospective cohort study; VKORC1; Cohort; Incidence (geometry); Atrial fibrillation; Anticoagulant; CYP2C9; Surgery","score_opus":0.16029525941492928,"score_gpt":0.3954544786121989,"score_spread":0.23515921919726962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110934964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992174,0.00017297408,0.00004832825,0.000058681933,0.000010192063,0.0000032679998,0.00020772553,0.000001761967,0.0002795103],"genre_scores_gemma":[0.99920374,0.0001264869,0.000061847124,0.0000426389,0.000018879045,0.000003819057,0.0002792606,0.0000027529047,0.00026064002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993413,0.00017707031,0.00007346366,0.0001896635,0.00009357166,0.00012495613],"domain_scores_gemma":[0.997785,0.000483645,0.0007876971,0.00026377555,0.00015673543,0.000523112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054281246,0.00040279998,0.00051829556,0.0009610673,0.0009195449,0.0013352393,0.0005259948,0.00094678026,0.0025474133],"category_scores_gemma":[0.003108008,0.0005730816,0.0011853188,0.0014444428,0.00050799426,0.0008382162,0.00067651883,0.0015044407,0.0003223483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022278386,0.00006813211,0.99869627,0.0000032105145,0.00013431672,0.00013349102,0.000057247176,0.000017920393,0.00021031087,0.000018023606,0.000051112413,0.00038721878],"study_design_scores_gemma":[0.00001281183,0.000119233846,0.9989201,0.0000039820147,0.00008773318,0.0003488517,0.0002113161,0.00014468493,0.000035542085,0.000030883333,0.00007809016,0.000006668124],"about_ca_topic_score_codex":0.0104410155,"about_ca_topic_score_gemma":0.0096195685,"teacher_disagreement_score":0.0104410155,"about_ca_system_score_codex":0.0003183575,"about_ca_system_score_gemma":0.00041236723,"threshold_uncertainty_score":0.020760477},"labels":[],"label_agreement":null},{"id":"W2112192429","doi":"10.1016/j.jval.2013.03.188","title":"Are canadians different from americans in stated preferences for health? valuing EQ-5D-5L health states using discrete choice experiments","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"EQ-5D; Anxiety; Discrete choice; Demography; Depression (economics); Medicine; Logistic regression; Dimension (graph theory); Psychology; Gerontology; Statistics; Mathematics; Psychiatry; Economics","score_opus":0.26433970907792953,"score_gpt":0.30935213094279884,"score_spread":0.04501242186486931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112192429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862099,0.00049490173,0.0006239633,0.0023362269,0.000059222235,0.0000707772,0.0007439203,0.0000043295177,0.009456781],"genre_scores_gemma":[0.99637467,0.0002607922,0.0005322987,0.0009480314,0.000013466393,0.0000375924,0.00040145908,0.0000036759218,0.001428039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975458,0.0009630551,0.00008717665,0.00025459522,0.0006898988,0.00045942224],"domain_scores_gemma":[0.9915274,0.0044470807,0.0011654024,0.00061460637,0.0013761785,0.00086929934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006266154,0.0003343892,0.0004985271,0.00044722357,0.0022955812,0.002454105,0.0007562004,0.0012302264,0.004655216],"category_scores_gemma":[0.022111021,0.0002466198,0.00077850395,0.0011942283,0.0021804443,0.0010669999,0.00055229967,0.001319707,0.00027277286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014419235,0.0028555344,0.84680724,0.0002489621,0.0018305255,0.00048420377,0.014231032,0.0044045546,0.0031304639,0.034634065,0.01267806,0.06427607],"study_design_scores_gemma":[0.0020159415,0.0014656337,0.9225963,0.00029110382,0.00088662736,0.0002479122,0.023036756,0.00859032,0.0010867993,0.018339595,0.020986553,0.00045653374],"about_ca_topic_score_codex":0.9006748,"about_ca_topic_score_gemma":0.8834034,"teacher_disagreement_score":0.09932518,"about_ca_system_score_codex":0.00761082,"about_ca_system_score_gemma":0.0071978453,"threshold_uncertainty_score":0.19982022},"labels":[],"label_agreement":null},{"id":"W2112440837","doi":"10.1016/j.jval.2012.08.1569","title":"PRM106 Examination of Preferences Elicited From the General Public: Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Brock University; PharmIdeas (Canada)","funders":"","keywords":"Time-trade-off; Medicine; Population; Data extraction; MEDLINE; Public health; Preference; Inclusion (mineral); Systematic review; Quality of life (healthcare); Family medicine; Demography; Psychology; Statistics; Environmental health; Mathematics; Social psychology; Pathology; Nursing","score_opus":0.40078522737947014,"score_gpt":0.400590321035027,"score_spread":0.00019490634444313537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112440837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97175354,0.00044410475,0.0076835887,0.0005122429,0.000047816575,0.00020940507,0.0037986005,0.000080085556,0.015470557],"genre_scores_gemma":[0.9910166,0.00015472928,0.0034787918,0.0001435001,0.00002647305,0.00012659974,0.0026989742,0.000030814474,0.0023234491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.988059,0.009921667,0.0003545145,0.00037755817,0.0010217458,0.00026543287],"domain_scores_gemma":[0.8264201,0.16014858,0.0034146358,0.0069739698,0.0023275295,0.0007151581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020474149,0.0005857546,0.0009791739,0.0016299993,0.00030566787,0.0013010089,0.0009278764,0.0011306105,0.020560699],"category_scores_gemma":[0.090192325,0.00019450726,0.002354971,0.0018843468,0.0008296671,0.0018238617,0.0021693087,0.0017811158,0.0017777305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06891854,0.0099067725,0.4458436,0.0034416309,0.003990361,0.00086770894,0.004319628,0.06076922,0.004493189,0.06714454,0.022790764,0.30751407],"study_design_scores_gemma":[0.003225733,0.015301106,0.7806008,0.00042855472,0.0014621712,0.0007115972,0.005905301,0.125997,0.007291878,0.045084506,0.013720745,0.00027058655],"about_ca_topic_score_codex":0.0024463825,"about_ca_topic_score_gemma":0.0012022475,"teacher_disagreement_score":0.020560699,"about_ca_system_score_codex":0.00051413535,"about_ca_system_score_gemma":0.0005593928,"threshold_uncertainty_score":0.10827893},"labels":[],"label_agreement":null},{"id":"W2112744491","doi":"10.1016/j.jval.2011.02.1157","title":"PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB): HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA B","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Visual analogue scale; Quality of life (healthcare); Physical therapy; EQ-5D; Health related quality of life; Joint pain; Internal medicine; Disease","score_opus":0.16132879338756312,"score_gpt":0.35787421176471546,"score_spread":0.19654541837715234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112744491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890598,0.0018708989,0.00010423186,0.0005066625,0.00007601948,0.000059143767,0.006638681,0.0000048041256,0.0016797474],"genre_scores_gemma":[0.9913271,0.0007328415,0.00012464798,0.00021548376,0.0000996641,0.00012018564,0.0064026,0.000005611746,0.0009719147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998659,0.0008363419,0.00009568536,0.00009886407,0.00016242173,0.00014771105],"domain_scores_gemma":[0.9984915,0.00018118731,0.000654634,0.00008924337,0.000115732284,0.00046766514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013201168,0.00073091284,0.0006822285,0.0008850465,0.00059758616,0.0013177037,0.0006378982,0.001015198,0.0021552683],"category_scores_gemma":[0.0028462736,0.000324598,0.0009806397,0.0025432874,0.0003271121,0.0005717003,0.0012896826,0.0012287567,0.00031356205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014648469,0.00017326909,0.9926484,0.000044457778,0.00055738015,0.00009878856,0.00008169967,0.000101984435,0.00014899566,0.00012730209,0.0015751721,0.0029778297],"study_design_scores_gemma":[0.00013568782,0.00013691476,0.9986739,0.000020575804,0.00014794177,0.00009812639,0.00007684545,0.00008495031,0.00003316106,0.00004335321,0.0005440616,0.0000045377074],"about_ca_topic_score_codex":0.0102670565,"about_ca_topic_score_gemma":0.010145576,"teacher_disagreement_score":0.0102670565,"about_ca_system_score_codex":0.0006276907,"about_ca_system_score_gemma":0.00047364095,"threshold_uncertainty_score":0.02041459},"labels":[],"label_agreement":null},{"id":"W2112931924","doi":"10.1016/j.jval.2013.08.046","title":"Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cognitive Functions and Memory","field":"Psychology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cronbach's alpha; Major depressive disorder; Patient Health Questionnaire; Geriatric Depression Scale; Quality of life (healthcare); Depression (economics); Clinical psychology; Psychology; Medicine; Construct validity; Cognition; Psychiatry; Gerontology; Psychometrics; Depressive symptoms","score_opus":0.02175454803241391,"score_gpt":0.2944295655860353,"score_spread":0.2726750175536214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112931924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997993,0.00028213442,0.00019974966,0.00013417863,0.000026953092,0.00012289765,0.00030231162,0.0000040673685,0.0009346685],"genre_scores_gemma":[0.9984958,0.00011313585,0.0004804059,0.00013037179,0.000014335392,0.000083131345,0.0004475775,0.000001918978,0.00023336409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917245,0.0002443246,0.00019796652,0.00008449544,0.00022138494,0.00007939444],"domain_scores_gemma":[0.99792635,0.0006585908,0.0005958284,0.00011437724,0.00045481478,0.0002499985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001884217,0.00026710564,0.00047525187,0.0006826138,0.00042555606,0.0005842494,0.00034131648,0.00056633324,0.0010301778],"category_scores_gemma":[0.006729176,0.00022772151,0.0006199353,0.0004895929,0.00030514228,0.00033030825,0.00070056424,0.0007928262,0.00026296213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023896982,0.00038187375,0.9897655,0.00004191126,0.00013084791,0.00006313684,0.00033266703,0.000084975465,0.000597271,0.000040131377,0.0004377866,0.0078850305],"study_design_scores_gemma":[0.000065377404,0.0005297901,0.99802905,0.000017393759,0.0000445386,0.0002588317,0.00021850427,0.00023701093,0.00014728993,0.00004186912,0.000404806,0.0000054924],"about_ca_topic_score_codex":0.001534652,"about_ca_topic_score_gemma":0.003276558,"teacher_disagreement_score":0.001884217,"about_ca_system_score_codex":0.0004033129,"about_ca_system_score_gemma":0.0003983507,"threshold_uncertainty_score":0.009964824},"labels":[],"label_agreement":null},{"id":"W2113215455","doi":"10.1046/j.1524-4733.2003.65253.x","title":"The Pediatric Quality Appraisal Questionnaire: An Instrument for Evaluation of the Pediatric Health Economics Literature","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Inter-rater reliability; Economic evaluation; Reliability (semiconductor); Psychological intervention; Medicine; Test (biology); Population; Health care; Family medicine; Face validity; Psychology; Actuarial science; Applied psychology; Clinical psychology; Psychometrics; Nursing; Environmental health; Rating scale; Business; Developmental psychology","score_opus":0.361869871736556,"score_gpt":0.46547141386548424,"score_spread":0.10360154212892825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113215455","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.700665,0.012589664,0.06620591,0.012999341,0.0011699953,0.037860405,0.114818364,0.00209796,0.051593408],"genre_scores_gemma":[0.72290707,0.008596817,0.15925926,0.0024234818,0.00059110497,0.059354108,0.040506013,0.0005067149,0.005855357],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.987976,0.0052322545,0.0028885389,0.00025793508,0.0031776323,0.00046759532],"domain_scores_gemma":[0.92067564,0.03793272,0.02022301,0.002238966,0.015497103,0.003432559],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022430578,0.0006980561,0.0014848107,0.006734587,0.0004916443,0.0012569466,0.0008021826,0.0007700513,0.005228772],"category_scores_gemma":[0.07750415,0.0003846036,0.0022270912,0.004700237,0.0005436564,0.002476022,0.002232164,0.0017344226,0.0011750842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015811493,0.00139062,0.48438692,0.0023342983,0.0009162303,0.00026954338,0.0023413189,0.0046279756,0.0009036502,0.005090379,0.13236438,0.3637935],"study_design_scores_gemma":[0.00055140746,0.0015923856,0.91849303,0.0010110212,0.00033370653,0.000716391,0.0012672222,0.005118232,0.00096802856,0.0037057279,0.06608931,0.0001535154],"about_ca_topic_score_codex":0.0017302048,"about_ca_topic_score_gemma":0.0025957292,"teacher_disagreement_score":0.9775694,"about_ca_system_score_codex":0.0021678188,"about_ca_system_score_gemma":0.003630694,"threshold_uncertainty_score":0.1186257},"labels":[],"label_agreement":null},{"id":"W2113745570","doi":"10.1016/j.jval.2011.02.096","title":"PHP24 NUMBER AND TYPE OF DRUGS USED BY SENIORS ON PUBLIC DRUG PROGRAMS IN CANADA, 2002 TO 2008","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Drug; Drug class; Medicine; Medical prescription; Public health; Population; Adverse effect; Gerontology; Pharmacology; Family medicine; Environmental health; Pathology","score_opus":0.2671727288241618,"score_gpt":0.389536600902513,"score_spread":0.1223638720783512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113745570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8208091,0.0030562235,0.00022491034,0.0025805607,0.00014548027,0.00014323807,0.15653038,0.0001717595,0.016338306],"genre_scores_gemma":[0.960916,0.0017422786,0.0003561628,0.0008210394,0.000050269005,0.0000636492,0.02506185,0.000024478139,0.010964274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987093,0.000044531866,0.00011628619,0.00012645315,0.0005726586,0.00043069106],"domain_scores_gemma":[0.99419856,0.00017584972,0.0012373287,0.00005923023,0.002743799,0.0015852586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047384462,0.00031068278,0.00053494546,0.0030886466,0.0015359371,0.0011419653,0.0015608707,0.00071507535,0.0045685656],"category_scores_gemma":[0.003299962,0.0003599483,0.0009593305,0.006086449,0.0004256928,0.0005796178,0.00080877537,0.0010760941,0.0005986742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016004867,0.00005986631,0.9747233,0.00012572217,0.00009157401,0.000079591686,0.00030213388,0.00017719828,0.000086697466,0.000114239585,0.01511341,0.008966225],"study_design_scores_gemma":[0.00000822332,0.000017177685,0.9965276,0.0000417127,0.000022264283,0.000053528256,0.00043810342,0.00012092899,0.00005292487,0.000008588272,0.0027019884,0.000006976239],"about_ca_topic_score_codex":0.9936732,"about_ca_topic_score_gemma":0.99576926,"teacher_disagreement_score":0.024390917,"about_ca_system_score_codex":0.024390917,"about_ca_system_score_gemma":0.03676671,"threshold_uncertainty_score":0.17696935},"labels":[],"label_agreement":null},{"id":"W2113782760","doi":"10.1016/j.jval.2014.03.852","title":"Impact Of The Pan-Canadian Pricing Alliance (Pcpa) On Access To Drug Treatment Options For Canadian Patients","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Formulary; Listing (finance); Drug; Pharmacotherapy; Medical prescription; Emergency medicine; Internal medicine; Intensive care medicine; Family medicine; Pharmacology; Business; Finance","score_opus":0.13799005764256228,"score_gpt":0.3637228376764445,"score_spread":0.2257327800338822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113782760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3924489,0.016201463,0.0012734863,0.35617396,0.0025300577,0.00026217918,0.017474534,0.00024185162,0.21339352],"genre_scores_gemma":[0.9676898,0.0024474657,0.0011435406,0.01784921,0.0005834357,0.000039060065,0.0017911438,0.00005024647,0.008406038],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9916127,0.0011614803,0.00024171479,0.00036500735,0.003935373,0.0026836589],"domain_scores_gemma":[0.9559993,0.0088677285,0.0029988699,0.00065046205,0.012653057,0.01883062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072168224,0.00041669465,0.0006075945,0.0019830556,0.0039085713,0.006363251,0.0021541896,0.0035099739,0.013201238],"category_scores_gemma":[0.04870072,0.00045055366,0.0017515495,0.0027440481,0.0021974014,0.0018245277,0.002832601,0.0044340324,0.000379104],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003430633,0.00084971316,0.20000583,0.000683552,0.00062284555,0.00067299017,0.0011643358,0.016925884,0.0005740429,0.26038274,0.39965752,0.11502999],"study_design_scores_gemma":[0.0013682994,0.0005437339,0.6776944,0.0012473237,0.0008149978,0.00080862886,0.0035722915,0.023562968,0.0008433555,0.020006616,0.2690975,0.00044000172],"about_ca_topic_score_codex":0.9833445,"about_ca_topic_score_gemma":0.98893446,"teacher_disagreement_score":0.89619106,"about_ca_system_score_codex":0.10380894,"about_ca_system_score_gemma":0.1672974,"threshold_uncertainty_score":0.7531901},"labels":[],"label_agreement":null},{"id":"W2114177140","doi":"10.1016/j.jval.2014.03.1263","title":"Pharmacoeconomic analysis of paliperidone palmitate for chronic relapsing schizophrenia in Finland","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Schizophrenia (object-oriented programming); Paliperidone; Medicine; Psychiatry; Antipsychotic","score_opus":0.0436828072457451,"score_gpt":0.3492657551623805,"score_spread":0.30558294791663543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114177140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951874,0.0030493224,0.0001435414,0.00032906217,0.000019822308,0.00006370534,0.0004853702,0.000004935833,0.00071675755],"genre_scores_gemma":[0.998621,0.00071062683,0.0001393897,0.00009391486,0.00001378631,0.000023560742,0.0002648426,0.00000153541,0.00013128675],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99898356,0.00053828215,0.00011526268,0.0000900327,0.00016530468,0.00010759003],"domain_scores_gemma":[0.99905723,0.0004277415,0.00025638548,0.000040164035,0.000079763435,0.00013861673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011568089,0.00019805423,0.0005083881,0.00044825044,0.00029583467,0.00047424494,0.0002253175,0.0005187535,0.0012765938],"category_scores_gemma":[0.0030500032,0.0001246926,0.0009823912,0.000551257,0.00030425398,0.0003070327,0.0002887377,0.00046065816,0.0000774837],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50278777,0.004903359,0.23706228,0.0027516412,0.007888464,0.0027980774,0.00070754974,0.007330281,0.023789525,0.0011062586,0.0015892051,0.20728557],"study_design_scores_gemma":[0.019911539,0.067985475,0.872573,0.00042217266,0.0130840195,0.00171611,0.001280125,0.0053981645,0.010060555,0.0008467011,0.006565341,0.00015677055],"about_ca_topic_score_codex":0.005260962,"about_ca_topic_score_gemma":0.0073484313,"teacher_disagreement_score":0.005260962,"about_ca_system_score_codex":0.001321349,"about_ca_system_score_gemma":0.0018188016,"threshold_uncertainty_score":0.010460675},"labels":[],"label_agreement":null},{"id":"W2114652540","doi":"10.1016/j.jval.2014.08.825","title":"Cost-Utility Analysis Of Screening Strategies For Nonalcoholic Steatohepatitis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Saint-Luc","funders":"","keywords":"Medicine; Nonalcoholic fatty liver disease; Transient elastography; Liver biopsy; Population; Elastography; Internal medicine; Cost effectiveness; Quality-adjusted life year; Fatty liver; Biopsy; Radiology; Disease; Ultrasound; Environmental health","score_opus":0.11269870764277062,"score_gpt":0.37385507350653957,"score_spread":0.26115636586376895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114652540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633972,0.010523024,0.016050316,0.0018617513,0.00009346036,0.000750722,0.0025438813,0.00010736837,0.0046721185],"genre_scores_gemma":[0.9962232,0.000684105,0.002251008,0.00006481545,0.000014525701,0.000067410714,0.0004452605,0.000006278556,0.00024330113],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99593264,0.0031617077,0.00012843746,0.00018857527,0.00031799465,0.00027073955],"domain_scores_gemma":[0.98396087,0.014268055,0.0006047688,0.00027647777,0.000513193,0.00037667376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049044467,0.0013321248,0.0017809896,0.0023945828,0.00023860518,0.0017088221,0.0012204627,0.0009520457,0.0040238732],"category_scores_gemma":[0.025888462,0.00039534314,0.0025422124,0.001971676,0.0005883968,0.0011701583,0.00080505764,0.0011064954,0.00020748527],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05115593,0.002938135,0.10999034,0.0015151349,0.006697232,0.0005395689,0.00020954362,0.6226288,0.0019932773,0.01095916,0.003398011,0.18797491],"study_design_scores_gemma":[0.0030344855,0.009672445,0.089698926,0.0003864057,0.0060810796,0.000652175,0.0005522708,0.8781384,0.0012093029,0.008903305,0.0015410226,0.00013007445],"about_ca_topic_score_codex":0.012355846,"about_ca_topic_score_gemma":0.00555849,"teacher_disagreement_score":0.012355846,"about_ca_system_score_codex":0.0037423314,"about_ca_system_score_gemma":0.0021004016,"threshold_uncertainty_score":0.027152658},"labels":[],"label_agreement":null},{"id":"W2115230664","doi":"10.1016/j.jval.2014.03.1639","title":"Real World Drug Utilization Of Hiv Therapies In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Cohort; Medicine; Darunavir; Pharmacy; Internal medicine; Pediatrics; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral load; Family medicine","score_opus":0.03396572503607699,"score_gpt":0.28732043045250916,"score_spread":0.2533547054164322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115230664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94682276,0.0050557484,0.00023596648,0.0059468844,0.00006107406,0.000073863615,0.032804653,0.000055413908,0.008943765],"genre_scores_gemma":[0.9924172,0.0021177612,0.00021669685,0.00037168412,0.00001710701,0.000010151588,0.0032895866,0.0000114768145,0.0015482778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981881,0.00018128743,0.00014752401,0.0001617909,0.0007882288,0.00053301535],"domain_scores_gemma":[0.9941755,0.00058777607,0.0011898864,0.00009936426,0.002477833,0.0014697472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006210669,0.0002915668,0.0004693949,0.001991232,0.002169125,0.003214916,0.0013719577,0.00095724285,0.003596954],"category_scores_gemma":[0.004896462,0.00041131175,0.00069208903,0.008101961,0.0010116155,0.00076072384,0.0009376509,0.0014788518,0.00032588386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000430011,0.00019628172,0.9597407,0.00027864767,0.00027985006,0.00067080825,0.0010608295,0.0038865397,0.0001901546,0.0022465042,0.012972571,0.018046973],"study_design_scores_gemma":[0.00005330412,0.0000687824,0.97907877,0.00015269114,0.00011548054,0.00039339374,0.0049676877,0.0051350854,0.00023673115,0.00027612402,0.009439307,0.000082657985],"about_ca_topic_score_codex":0.99750656,"about_ca_topic_score_gemma":0.99814045,"teacher_disagreement_score":0.08801569,"about_ca_system_score_codex":0.08801569,"about_ca_system_score_gemma":0.05687714,"threshold_uncertainty_score":0.63860154},"labels":[],"label_agreement":null},{"id":"W2115235341","doi":"10.1046/j.1524-4733.2000.31004.x","title":"Economic Evaluation of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in Canada","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Letrozole; Megestrol acetate; Medicine; Megestrol; Breast cancer; Internal medicine; Cancer; Oncology; Gynecology; Tamoxifen","score_opus":0.009119252127290237,"score_gpt":0.2725535202311246,"score_spread":0.26343426810383436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115235341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563373,0.017077519,0.00041769014,0.009591622,0.000120445366,0.0008362208,0.0036686906,0.000021492493,0.011929086],"genre_scores_gemma":[0.9949556,0.0029638263,0.0003007799,0.0003777574,0.000027717218,0.00006431074,0.0004761279,0.0000035254723,0.00083036197],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99640536,0.001919399,0.0001684211,0.00009357129,0.00081112265,0.00060215977],"domain_scores_gemma":[0.9939984,0.0020555726,0.00068918825,0.000063668325,0.0014913635,0.0017018609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030248065,0.00036711467,0.0008813009,0.0010219208,0.001135608,0.0017513903,0.000809759,0.0007760019,0.002121816],"category_scores_gemma":[0.01264945,0.00021543939,0.0011793397,0.0018470285,0.00069606316,0.00032947733,0.0006429594,0.00095728936,0.00005743928],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19791286,0.0053538624,0.33787328,0.005419111,0.0065745665,0.0012710706,0.00091312674,0.10602999,0.0021886022,0.011036441,0.019118264,0.3063089],"study_design_scores_gemma":[0.036319964,0.027968623,0.73972464,0.0024611566,0.009718656,0.0007939996,0.00427011,0.13370734,0.0020569619,0.0030974033,0.039539795,0.00034146188],"about_ca_topic_score_codex":0.93144464,"about_ca_topic_score_gemma":0.952087,"teacher_disagreement_score":0.07871601,"about_ca_system_score_codex":0.07871601,"about_ca_system_score_gemma":0.07874736,"threshold_uncertainty_score":0.5711273},"labels":[],"label_agreement":null},{"id":"W2115993828","doi":"10.1016/j.jval.2014.03.224","title":"Cost-effectiveness of adalimumab for the treatment of moderately to severely active ulcerative colitis in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); University of Calgary","funders":"","keywords":"Adalimumab; Medicine; Infliximab; Ulcerative colitis; Golimumab; Internal medicine; Disease","score_opus":0.035570966416430795,"score_gpt":0.30337296838836847,"score_spread":0.26780200197193765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115993828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419946,0.024106676,0.00023568947,0.011635108,0.000256033,0.00026934865,0.008210743,0.000039334544,0.013252389],"genre_scores_gemma":[0.993414,0.0035756282,0.0002354993,0.00048377554,0.00004471027,0.000026494254,0.0010206777,0.0000062804966,0.0011929882],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99878997,0.00029876622,0.00009427411,0.000081914426,0.0003881199,0.00034697898],"domain_scores_gemma":[0.9969206,0.0005205214,0.00033210815,0.00003087744,0.0008519045,0.0013440173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006455643,0.0002954474,0.00077132444,0.0010417278,0.001098412,0.0017494645,0.0010759665,0.0007167674,0.0034607977],"category_scores_gemma":[0.0054359613,0.0002640452,0.0012785334,0.0019510828,0.0005851238,0.0003555772,0.00059169845,0.0010691059,0.00009824235],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034226414,0.0020100777,0.64651823,0.0033291965,0.0045455773,0.0013083193,0.00075966795,0.030223928,0.001547127,0.0073412783,0.042083405,0.22610675],"study_design_scores_gemma":[0.006026159,0.0021082312,0.9424788,0.0012068317,0.003766743,0.0006234113,0.0017085625,0.026749145,0.00045858658,0.000987154,0.013734598,0.00015177063],"about_ca_topic_score_codex":0.9865697,"about_ca_topic_score_gemma":0.991763,"teacher_disagreement_score":0.073939845,"about_ca_system_score_codex":0.073939845,"about_ca_system_score_gemma":0.06891376,"threshold_uncertainty_score":0.53647363},"labels":[],"label_agreement":null},{"id":"W2116298731","doi":"10.1016/j.jval.2014.08.864","title":"Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Number needed to treat; Dimethyl fumarate; Number needed to harm; Hazard ratio; Placebo; Confidence interval; Clinical endpoint; Absolute risk reduction; Relative risk; Multiple sclerosis; Internal medicine; Clinical trial; Fingolimod; Psychiatry; Alternative medicine","score_opus":0.4437821032719421,"score_gpt":0.5073067453736835,"score_spread":0.06352464210174136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116298731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51455325,0.17152718,0.24810705,0.0054605044,0.008695719,0.017223034,0.014691067,0.0008067744,0.018935416],"genre_scores_gemma":[0.9366257,0.0035976747,0.04563558,0.0013042067,0.0007756876,0.009009184,0.0017700085,0.00017009744,0.0011119008],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.40891814,0.528651,0.03396892,0.0098796645,0.016495263,0.0020870338],"domain_scores_gemma":[0.46253967,0.4913767,0.020540422,0.01788678,0.006071164,0.0015852524],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.28443018,0.003802021,0.017830942,0.008718614,0.0013659936,0.0045385156,0.0037806416,0.0048258156,0.005078162],"category_scores_gemma":[0.31697586,0.0012466136,0.03581097,0.00685817,0.003361107,0.0074611623,0.0062645865,0.005652426,0.00029278078],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13523006,0.0007762432,0.095703684,0.027873904,0.63244754,0.00068240776,0.0012684166,0.005775494,0.0026078434,0.006679881,0.0026485105,0.08830606],"study_design_scores_gemma":[0.0633894,0.054205418,0.16989309,0.0060216105,0.5669956,0.0017239769,0.0025989164,0.040637683,0.010902527,0.05828383,0.024290478,0.0010573941],"about_ca_topic_score_codex":0.0008015652,"about_ca_topic_score_gemma":0.001255781,"teacher_disagreement_score":0.996198,"about_ca_system_score_codex":0.001986317,"about_ca_system_score_gemma":0.0016256975,"threshold_uncertainty_score":0.882425},"labels":[],"label_agreement":null},{"id":"W2116948576","doi":"10.1016/j.jval.2013.03.514","title":"Effect of neurologist ambulatory visits on use of disease-specific pharmacotherapies for chronic neurological conditions","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Medical prescription; Medical Expenditure Panel Survey; Ambulatory; Disease; Population; Ambulatory care; Prescription drug; Health care; Physical therapy; Pediatrics; Family medicine; Internal medicine; Health insurance; Environmental health","score_opus":0.40776735081666327,"score_gpt":0.4341040026653271,"score_spread":0.02633665184866385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116948576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883224,0.0035717092,0.00015846553,0.0017860702,0.00012947549,0.000024617731,0.002785907,0.00002093524,0.0026907222],"genre_scores_gemma":[0.99739695,0.0005960547,0.00005839286,0.00016207855,0.00012066832,0.000008637032,0.00094357535,0.0000041416433,0.00070952374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979559,0.00095932704,0.00014731847,0.00028120048,0.0001484664,0.00050781725],"domain_scores_gemma":[0.98025835,0.013868342,0.0030662357,0.0005064761,0.00030796998,0.0019927693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024655026,0.00038143588,0.0011378396,0.000629007,0.00032264285,0.0012726428,0.0007911432,0.0019737901,0.0071021863],"category_scores_gemma":[0.0160998,0.000457847,0.0057692025,0.0007927276,0.00042200898,0.00082549505,0.00076792145,0.002918725,0.0002699688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061361108,0.0023846745,0.89244145,0.0004157598,0.009265577,0.0006658961,0.000116065945,0.008594073,0.0004923115,0.00079609663,0.003441992,0.020025102],"study_design_scores_gemma":[0.0016842069,0.003106625,0.9818564,0.00007152236,0.00409745,0.00021495405,0.00023159877,0.007392571,0.00014903668,0.00063449744,0.00052340725,0.000037660924],"about_ca_topic_score_codex":0.04300475,"about_ca_topic_score_gemma":0.04081525,"teacher_disagreement_score":0.04300475,"about_ca_system_score_codex":0.001171631,"about_ca_system_score_gemma":0.0014325714,"threshold_uncertainty_score":0.08550888},"labels":[],"label_agreement":null},{"id":"W2117521501","doi":"10.1016/j.jval.2014.08.2659","title":"An Assessment of the Association Between Rural Status and Health Service Resource Use Among Patients With Ankle Sprains in Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Rurality; Ambulatory care; Health care; Population; Environmental health; Ankle; Ambulatory; Rural area; Family medicine; Gerontology; Medical emergency","score_opus":0.17278008996928249,"score_gpt":0.46201978121283527,"score_spread":0.28923969124355275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117521501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986198,0.00008114757,0.000023030938,0.0002225309,0.0000026000323,0.000015330314,0.00024636294,0.0000011808262,0.00078789995],"genre_scores_gemma":[0.9995646,0.0000668867,0.000049998212,0.000042461314,0.0000031144398,0.000009723575,0.00010833522,7.4058147e-7,0.00015419464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998825,0.00019364849,0.00013561765,0.000112002905,0.00038324925,0.00035041894],"domain_scores_gemma":[0.995621,0.0006354257,0.0017949363,0.00009616906,0.0009825899,0.0008698054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093188236,0.00015279703,0.00027022732,0.00083281123,0.002052127,0.0011605595,0.0006477504,0.00040304518,0.00140258],"category_scores_gemma":[0.0051351683,0.00032718104,0.000488361,0.0024945922,0.0007569048,0.0005228165,0.0008706876,0.00068386656,0.00009384939],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026245738,0.000034616503,0.99778724,0.000012270058,0.000017732404,0.000026558459,0.0010789911,0.000017256589,0.000032726148,0.00002322985,0.000121974364,0.00082119176],"study_design_scores_gemma":[0.0000038640405,0.000031956562,0.99785894,0.000007738461,0.000008125026,0.000015567719,0.0018177056,0.00007792527,0.0000067606998,0.000008541778,0.00016000074,0.000002791524],"about_ca_topic_score_codex":0.9054177,"about_ca_topic_score_gemma":0.95900023,"teacher_disagreement_score":0.09458232,"about_ca_system_score_codex":0.011802321,"about_ca_system_score_gemma":0.014467242,"threshold_uncertainty_score":0.19027859},"labels":[],"label_agreement":null},{"id":"W2117819319","doi":"10.1016/j.jval.2013.03.204","title":"Health utilities index®: Extending the age range to pre-schoolers","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Utilities Kingston (Canada); McMaster University","funders":"","keywords":"Health Utilities Index; Gerontology; Quality of life (healthcare); Health care; Quality (philosophy); Statistics; Psychology; Medicine; Mathematics; Demography; Health related quality of life; Nursing; Pathology; Sociology","score_opus":0.10765607583187435,"score_gpt":0.45147429586694826,"score_spread":0.3438182200350739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117819319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72639924,0.019106295,0.05771257,0.005027063,0.0007867625,0.0018413336,0.115357734,0.0028051746,0.07096383],"genre_scores_gemma":[0.9165776,0.0047729146,0.043282025,0.0010064824,0.00038550908,0.0020263868,0.024188826,0.00030319503,0.007457057],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99908555,0.00030508603,0.00016649779,0.00007999126,0.00025308714,0.00010983988],"domain_scores_gemma":[0.9976515,0.00097353524,0.0005463814,0.00015313558,0.00047979807,0.00019569273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024315824,0.00076231896,0.0010522814,0.0034747699,0.00016328649,0.0012888402,0.00061590195,0.00048187407,0.0061688772],"category_scores_gemma":[0.009653298,0.00022700743,0.0013317334,0.0036466364,0.00017236221,0.0016660001,0.0012325698,0.0012269795,0.0013221061],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029889555,0.0005903129,0.40889066,0.0009635845,0.0008192159,0.00027253665,0.00050108525,0.0057399957,0.0009876019,0.0033977244,0.068471745,0.5063766],"study_design_scores_gemma":[0.00041913585,0.0012081426,0.88672704,0.00080921594,0.0006580837,0.0015211889,0.00066022854,0.019705372,0.00238722,0.010290897,0.075403534,0.00020992657],"about_ca_topic_score_codex":0.0034734474,"about_ca_topic_score_gemma":0.002934719,"teacher_disagreement_score":0.0061688772,"about_ca_system_score_codex":0.0004109537,"about_ca_system_score_gemma":0.00046831736,"threshold_uncertainty_score":0.020636916},"labels":[],"label_agreement":null},{"id":"W2117861533","doi":"10.1016/j.jval.2012.08.2150","title":"PCN110 Differences in Health-Related Quality of Life Between Children Treated for Acute Lymphoblastic Leukemia (ALL) on Dana Farber Cancer Institute (DFCI) Protocols","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Utilities Kingston (Canada); McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Lymphoblastic Leukemia; Pediatrics; Childhood cancer; Internal medicine; Health related quality of life; Cancer; Leukemia; Disease","score_opus":0.14343582252455087,"score_gpt":0.41971786320293614,"score_spread":0.27628204067838524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117861533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875323,0.0001304521,0.00015512816,0.00017153838,0.00001557333,0.00019480677,0.006304746,0.000011645025,0.0054837237],"genre_scores_gemma":[0.98574823,0.00011211696,0.0003519715,0.00010437601,0.0000089803425,0.00037539226,0.011014085,0.000016699172,0.002268199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851817,0.00041516035,0.00013882895,0.0001902811,0.0003482688,0.00038932273],"domain_scores_gemma":[0.9980173,0.00035451175,0.0005289287,0.0002103207,0.000405162,0.00048384967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010229714,0.00017958139,0.00036590485,0.0011150133,0.0007749345,0.000833091,0.00075462926,0.00029220656,0.0047241612],"category_scores_gemma":[0.0040435316,0.00016663785,0.00037577,0.002348673,0.00043214142,0.0005654298,0.00096371584,0.00062243815,0.000475212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022846842,0.00025687797,0.98243237,0.00002262041,0.00008613373,0.000056053155,0.00039379482,0.0002025314,0.0004908895,0.00040580324,0.0018096303,0.0115586715],"study_design_scores_gemma":[0.00011336649,0.0005079258,0.9954585,0.0000123649825,0.000035658064,0.00010108279,0.00052728865,0.00009788986,0.00037959786,0.00012735385,0.002632731,0.0000061990427],"about_ca_topic_score_codex":0.053049725,"about_ca_topic_score_gemma":0.064648084,"teacher_disagreement_score":0.053049725,"about_ca_system_score_codex":0.003078658,"about_ca_system_score_gemma":0.0026401973,"threshold_uncertainty_score":0.10548186},"labels":[],"label_agreement":null},{"id":"W2118267528","doi":"10.1111/j.1524-4733.2010.00767.x","title":"International Development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Dalhousie University","funders":"Multiple Sclerosis International Federation; Multiple Sclerosis Society","keywords":"Debriefing; Rasch model; Psychology; Construct validity; Scale (ratio); Quality of life (healthcare); Medicine; Clinical psychology; Psychometrics; Social psychology; Developmental psychology; Cartography; Geography","score_opus":0.21124798927657415,"score_gpt":0.3785889414697671,"score_spread":0.16734095219319298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118267528","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57142127,0.05719748,0.12625243,0.016235132,0.004227898,0.007615807,0.0815854,0.00094158336,0.13452302],"genre_scores_gemma":[0.8220702,0.008177936,0.12180323,0.0010393193,0.00053295825,0.009953315,0.03091249,0.00015513533,0.0053555546],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98798674,0.005990236,0.0019303506,0.000627435,0.0030952354,0.0003700128],"domain_scores_gemma":[0.9617367,0.010819108,0.008753375,0.002421173,0.013734773,0.0025348593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029699298,0.0009909917,0.001258197,0.006795446,0.0006389259,0.0020312953,0.0015281127,0.00064605894,0.0023772153],"category_scores_gemma":[0.0354591,0.0003201258,0.0014338476,0.0053821653,0.0006292972,0.0014562745,0.00334555,0.001947312,0.0006381533],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015758364,0.0005030426,0.5674135,0.0015292041,0.0016115895,0.000083601066,0.00096281007,0.0015488493,0.000932018,0.01471764,0.0187465,0.39037544],"study_design_scores_gemma":[0.0003538874,0.0016090256,0.9024548,0.0015736889,0.000753032,0.0003994981,0.00086927833,0.0029443647,0.0023978895,0.005741063,0.08082725,0.00007635091],"about_ca_topic_score_codex":0.0034426146,"about_ca_topic_score_gemma":0.0032951839,"teacher_disagreement_score":0.029699298,"about_ca_system_score_codex":0.0021811342,"about_ca_system_score_gemma":0.005346909,"threshold_uncertainty_score":0.15706676},"labels":[],"label_agreement":null},{"id":"W2118339612","doi":"10.1111/j.1524-4733.2007.00255.x","title":"Reliability of Two Instruments for Critical Assessment of Economic Evaluations","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Reliability (semiconductor); Intraclass correlation; Generalizability theory; Cronbach's alpha; Quality (philosophy); Inter-rater reliability; Variance (accounting); Statistics; Psychology; Scale (ratio); Rating scale; Mathematics; Psychometrics; Economics; Accounting; Geography","score_opus":0.4349332589155737,"score_gpt":0.5530560586814062,"score_spread":0.11812279976583245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118339612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57334185,0.005480348,0.38867515,0.0013772898,0.0010972336,0.0037467226,0.004384007,0.00058316224,0.02131422],"genre_scores_gemma":[0.94315463,0.00043251994,0.051493164,0.00021333391,0.0001602326,0.00247371,0.0015489511,0.00008713357,0.00043638333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.75718504,0.15965219,0.026992904,0.012229492,0.041458867,0.002481458],"domain_scores_gemma":[0.11611112,0.7795309,0.032891646,0.02898589,0.041142117,0.0013383748],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19524369,0.0018886342,0.0025050642,0.010024481,0.0010661117,0.004575664,0.0019989023,0.0037186847,0.0022609248],"category_scores_gemma":[0.68239075,0.00076868176,0.0028685126,0.006286803,0.0042478694,0.0043312795,0.003718358,0.0030391465,0.0007524567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009473047,0.0011832904,0.658531,0.001505628,0.0045417445,0.00027077843,0.006018016,0.018391335,0.0020054793,0.051325012,0.00732753,0.23942707],"study_design_scores_gemma":[0.0018942711,0.0068229837,0.6558572,0.0018280987,0.0032157432,0.0012411856,0.0023988641,0.17844489,0.010809667,0.11697468,0.019747015,0.0007654489],"about_ca_topic_score_codex":0.0012487206,"about_ca_topic_score_gemma":0.00062581146,"teacher_disagreement_score":0.8047563,"about_ca_system_score_codex":0.0021653932,"about_ca_system_score_gemma":0.0026886705,"threshold_uncertainty_score":0.9924078},"labels":[],"label_agreement":null},{"id":"W2118440667","doi":"10.1016/j.jval.2013.06.021","title":"Cost-Utility of Metal-on-Metal Hip Resurfacing Compared to Conventional Total Hip Replacement in Young Active Patients with Osteoarthritis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Osteoarthritis; Hip resurfacing; Medicine; Total hip replacement; Surgery; Physical therapy; Arthroplasty; Alternative medicine","score_opus":0.03932006322385087,"score_gpt":0.2950556041248372,"score_spread":0.2557355409009864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118440667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968225,0.002280872,0.000033771772,0.00020520459,0.000020868762,0.00000963128,0.00011196933,0.0000016777261,0.00051364227],"genre_scores_gemma":[0.9994849,0.0003412337,0.000033084816,0.000025732026,0.000013181697,0.0000025982552,0.00004962831,3.8983694e-7,0.00004917551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995753,0.00020541955,0.00004778387,0.000027750633,0.000073968244,0.00006971979],"domain_scores_gemma":[0.99895275,0.00044985267,0.00029235642,0.000021382086,0.000056828725,0.00022688521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005149463,0.00029121732,0.00069338107,0.0006347897,0.0002131642,0.00057768024,0.00027290217,0.0005287827,0.0019439731],"category_scores_gemma":[0.0041347886,0.00014541263,0.0013373202,0.00060956116,0.00025712483,0.00048771044,0.00048927194,0.00035155172,0.0001144705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021507228,0.00096189603,0.9058643,0.0004068584,0.00096936314,0.0008460876,0.00028234607,0.0017434623,0.00082623033,0.00031577476,0.00060982164,0.06566657],"study_design_scores_gemma":[0.00070657197,0.0072139376,0.9862519,0.000089053516,0.0007551074,0.0010769252,0.0008159127,0.0023350255,0.00020810902,0.00022707738,0.0002875297,0.00003287595],"about_ca_topic_score_codex":0.00511304,"about_ca_topic_score_gemma":0.009166764,"teacher_disagreement_score":0.00511304,"about_ca_system_score_codex":0.00091946695,"about_ca_system_score_gemma":0.0005491067,"threshold_uncertainty_score":0.010166526},"labels":[],"label_agreement":null},{"id":"W2119091090","doi":"10.1016/j.jval.2015.09.1287","title":"Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc): A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Corporate Identity and Reputation","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lenvatinib; Multiple-criteria decision analysis; Weighting; Medicine; Actuarial science; Context (archaeology); Public economics; Thyroid cancer; Business; Economics; Cancer; Geography; Operations research; Internal medicine; Engineering","score_opus":0.14538296077883522,"score_gpt":0.36211909871805126,"score_spread":0.21673613793921603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119091090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985008,0.00035165393,0.00042185598,0.00016405694,0.0000062597683,0.00003797211,0.00008390723,0.0000010893885,0.00043234648],"genre_scores_gemma":[0.999014,0.00015817786,0.0006828368,0.00003117155,0.000002785315,0.000014083778,0.0000583625,9.922694e-7,0.000037461446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994409,0.0044269958,0.00026646783,0.00023439084,0.00034654365,0.00031660468],"domain_scores_gemma":[0.98475003,0.011118895,0.0025182476,0.00020952233,0.0007861086,0.0006172182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065877405,0.00042692764,0.0009160963,0.0015402107,0.00071497215,0.0027206633,0.00069943245,0.0010557234,0.00088172924],"category_scores_gemma":[0.021547033,0.00042487693,0.0017437954,0.002474941,0.001088528,0.0014514868,0.0015787279,0.0012503547,0.00008134678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00791281,0.002373218,0.85929376,0.00093209994,0.0038409175,0.0015166688,0.0052646445,0.032148715,0.0010971134,0.0027229004,0.0012280655,0.081668966],"study_design_scores_gemma":[0.0006779659,0.011498505,0.817516,0.00085041404,0.0029711765,0.0017280481,0.039081514,0.11524569,0.0017793301,0.005180008,0.0032291086,0.00024226285],"about_ca_topic_score_codex":0.010222622,"about_ca_topic_score_gemma":0.013735214,"teacher_disagreement_score":0.010222622,"about_ca_system_score_codex":0.0033045323,"about_ca_system_score_gemma":0.0018410735,"threshold_uncertainty_score":0.03483975},"labels":[],"label_agreement":null},{"id":"W2119189721","doi":"10.1016/j.jval.2013.03.392","title":"The use of antimicrobial impregnated external ventricular drain catheter to prevent cerebrospinal fluid infection in canadian hospitals: An economic analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Catheter; Activity-based costing; Emergency medicine; External ventricular drain; Randomized controlled trial; Incidence (geometry); Clinical trial; Infection control; Intensive care medicine; Surgery; Cerebrospinal fluid; Internal medicine","score_opus":0.028350654933270977,"score_gpt":0.27572064163684445,"score_spread":0.24736998670357346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119189721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542975,0.017202944,0.00081206526,0.006687388,0.00013206442,0.00075104256,0.008027595,0.000019864194,0.012069536],"genre_scores_gemma":[0.9926012,0.0041958624,0.0005336698,0.00052648236,0.000039326384,0.00006698913,0.0013122478,0.0000046398054,0.0007195828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908276,0.0020418917,0.00052820396,0.000338174,0.0031291172,0.0031349685],"domain_scores_gemma":[0.9865674,0.0046007535,0.0024422696,0.00018161068,0.0035647522,0.0026432606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055345874,0.0012060468,0.0014619331,0.005015997,0.0031486151,0.004577322,0.0029111456,0.0023984462,0.003822159],"category_scores_gemma":[0.025396997,0.00097618386,0.0044444134,0.008360157,0.0017000125,0.0011054565,0.0017130726,0.0027364502,0.00009369361],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015280925,0.0023397824,0.79207146,0.0035792438,0.008729694,0.001546875,0.001199186,0.06391144,0.00081309077,0.021748377,0.013943959,0.07483599],"study_design_scores_gemma":[0.0014674859,0.0026448881,0.8830246,0.0016083715,0.0076823146,0.0007777829,0.0051506455,0.084849246,0.0004891212,0.0024204205,0.009480713,0.00040459432],"about_ca_topic_score_codex":0.97767544,"about_ca_topic_score_gemma":0.9805031,"teacher_disagreement_score":0.18227291,"about_ca_system_score_codex":0.18227291,"about_ca_system_score_gemma":0.093953215,"threshold_uncertainty_score":0.9484475},"labels":[],"label_agreement":null},{"id":"W2119679249","doi":"10.1016/j.jval.2013.08.2291","title":"Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Health care; Psychological intervention; Pharmacoeconomics; Health economics; Population; Medicine; Intervention (counseling); Listing (finance); Outcomes research; Executive summary; Task force; Health policy; Business; Accounting; Political science; Economic growth; Alternative medicine; Nursing; Public administration; Economics; Environmental health; Finance; Intensive care medicine","score_opus":0.18108804844949064,"score_gpt":0.4433726510131616,"score_spread":0.2622846025636709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119679249","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004005127,0.05612302,0.5053745,0.30379298,0.008197281,0.0073156874,0.006926568,0.003422394,0.104842424],"genre_scores_gemma":[0.046862375,0.04000333,0.84829706,0.033457574,0.0041317935,0.007446991,0.0055652065,0.0023266866,0.011908977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7779414,0.11521221,0.030602803,0.0039844215,0.06752941,0.004729761],"domain_scores_gemma":[0.64082575,0.16970703,0.026911424,0.02366011,0.13188685,0.007008742],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.26046917,0.00311671,0.005479597,0.013939683,0.0032696226,0.021138161,0.0093063675,0.013432261,0.004908155],"category_scores_gemma":[0.46549195,0.004197992,0.0042814193,0.016753718,0.009434261,0.008992344,0.009278369,0.022612892,0.005333809],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015022716,0.00024723422,0.0030026352,0.0031767655,0.00041615983,0.00011819274,0.0019361177,0.0095191505,0.00044575825,0.157032,0.57339466,0.25056118],"study_design_scores_gemma":[0.00022677949,0.00010109836,0.005393599,0.01920002,0.00029147763,0.0001658107,0.0008719938,0.0057276837,0.0014508213,0.27414978,0.6920951,0.00032581776],"about_ca_topic_score_codex":0.036670357,"about_ca_topic_score_gemma":0.034167044,"teacher_disagreement_score":0.7395308,"about_ca_system_score_codex":0.0126990415,"about_ca_system_score_gemma":0.0624713,"threshold_uncertainty_score":0.9119732},"labels":[],"label_agreement":null},{"id":"W2119888109","doi":"10.1016/j.jval.2013.08.162","title":"Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Telaprevir; Boceprevir; Ribavirin; Rash; Adverse effect; Pegylated interferon; Hepatitis C virus; Hepatitis C; Internal medicine; Emergency medicine; Sofosbuvir; Health care; Medical record; Pediatrics; Virus; Immunology","score_opus":0.06804439381656101,"score_gpt":0.3442519245583697,"score_spread":0.2762075307418087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119888109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799621,0.0039547193,0.00014446053,0.0019002449,0.000054072,0.0000619851,0.0100067705,0.00001864527,0.0038969824],"genre_scores_gemma":[0.994938,0.001247937,0.0001477203,0.0002316227,0.000017670323,0.000021770758,0.002008588,0.0000065045915,0.0013801815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989334,0.0001906902,0.000107995285,0.00008313019,0.00026253506,0.00042224364],"domain_scores_gemma":[0.9954619,0.00043995693,0.0010670017,0.00006120247,0.0015149873,0.0014549413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061687396,0.00036587645,0.0005302593,0.0015926765,0.0020842438,0.0015504956,0.0014169673,0.00073676865,0.003602071],"category_scores_gemma":[0.0037459366,0.0003679626,0.0012340278,0.004174524,0.0006233271,0.0004691665,0.0007828328,0.0012692497,0.00018159827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001589621,0.00006648047,0.9900671,0.00006981234,0.0001916831,0.00017582449,0.00024372221,0.0008593569,0.00006474616,0.00026623424,0.0033177135,0.004518366],"study_design_scores_gemma":[0.000019577079,0.000024687684,0.99767596,0.000065218854,0.00004678809,0.00005941649,0.00053474534,0.00082850555,0.000017915116,0.000035678073,0.000676025,0.00001553993],"about_ca_topic_score_codex":0.99764925,"about_ca_topic_score_gemma":0.99808526,"teacher_disagreement_score":0.057641562,"about_ca_system_score_codex":0.057641562,"about_ca_system_score_gemma":0.03508468,"threshold_uncertainty_score":0.41822082},"labels":[],"label_agreement":null},{"id":"W2119953457","doi":"10.1016/j.jval.2013.08.394","title":"Cost-Effectiveness of School-Based Health Promotion in Canada: A Life-Course Modeling Approach","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Overweight; Medicine; Obesity; Cost effectiveness; Population; Health promotion; Cost–benefit analysis; Investment (military); Childhood obesity; Return on investment; Promotion (chess); Gerontology; Environmental health; Demography; Public health; Economics; Nursing; Political science; Production (economics)","score_opus":0.10974496607161327,"score_gpt":0.3390924758598985,"score_spread":0.22934750978828522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119953457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96886116,0.0033225052,0.008553276,0.0035523328,0.0001031059,0.0006325454,0.0077287657,0.00015583231,0.0070904344],"genre_scores_gemma":[0.9921279,0.0008603695,0.0027095184,0.00017117237,0.000015680624,0.00015568844,0.0015148974,0.000023574854,0.0024211062],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980792,0.0009440142,0.00007331464,0.00018706202,0.0002009466,0.0005155307],"domain_scores_gemma":[0.9924676,0.005519395,0.00039490373,0.00015193042,0.0008010177,0.0006651908],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049857344,0.0011724662,0.0024498003,0.0019529874,0.0015533661,0.0024834352,0.0035873041,0.0020629202,0.005303734],"category_scores_gemma":[0.014235542,0.0010813876,0.0030949898,0.0028454375,0.001010724,0.0009893087,0.0009324094,0.0025928803,0.00023650036],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022679144,0.000914228,0.045678154,0.00026972004,0.0012107154,0.00018179088,0.0001612413,0.9273132,0.00013755432,0.0053948048,0.0023023682,0.014168209],"study_design_scores_gemma":[0.0005862581,0.00043977427,0.023969727,0.00012456017,0.0013303307,0.000059984002,0.0003767933,0.96967995,0.00015059138,0.0019339083,0.00128784,0.000060439015],"about_ca_topic_score_codex":0.9643021,"about_ca_topic_score_gemma":0.9344495,"teacher_disagreement_score":0.94229245,"about_ca_system_score_codex":0.057707544,"about_ca_system_score_gemma":0.039387114,"threshold_uncertainty_score":0.4186995},"labels":[],"label_agreement":null},{"id":"W2120645476","doi":"10.1016/j.jval.2014.03.523","title":"The Cost-Effectiveness of 2nd Line Crizotinib in EML4-Alk Rearranged Advanced NSCLC in Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Docetaxel; Medicine; Pemetrexed; Lung cancer; Oncology; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.047150660884849434,"score_gpt":0.37851540281673596,"score_spread":0.33136474193188653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120645476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97586876,0.0046204403,0.0001295483,0.005892817,0.000045901026,0.000119858625,0.006756032,0.000016130087,0.0065504224],"genre_scores_gemma":[0.99539375,0.0017403244,0.00013901811,0.00031115473,0.000029001325,0.000029566643,0.0012271517,0.000005268012,0.0011248768],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99895287,0.00019258933,0.000086274085,0.000086088985,0.00027562722,0.00040658307],"domain_scores_gemma":[0.99761826,0.00030711718,0.0006624027,0.00004251493,0.00040452613,0.00096502923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057735055,0.00028002268,0.00053230714,0.0006044017,0.0007468709,0.0013048651,0.00096844276,0.000594259,0.0023350513],"category_scores_gemma":[0.0038233574,0.00030940672,0.0013095265,0.0019030292,0.00054072624,0.00048197558,0.0007078315,0.0006690574,0.00009778019],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014248496,0.0005252209,0.84613883,0.0014735875,0.0020008667,0.0012144182,0.0009852964,0.020237057,0.0020336534,0.003783654,0.020875674,0.08648321],"study_design_scores_gemma":[0.0019411269,0.0010125749,0.9765112,0.00024101943,0.0010794235,0.00032902666,0.0011584731,0.008383766,0.0003582337,0.0004931349,0.0084230425,0.000068937814],"about_ca_topic_score_codex":0.97549814,"about_ca_topic_score_gemma":0.98874795,"teacher_disagreement_score":0.09003453,"about_ca_system_score_codex":0.09003453,"about_ca_system_score_gemma":0.052679498,"threshold_uncertainty_score":0.65324926},"labels":[],"label_agreement":null},{"id":"W2121226306","doi":"10.1016/j.jval.2011.02.603","title":"PIH18 THE IMPACT OF LONG-TERM DISABILITY COSTS ARISING FROM IN-VITRO FERTILIZATION (IVF) TREATMENT: THE COST-EFFECTIVENESS ANALYSIS OF REDUCING MULTIPLE BIRTHS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Demography; Fertility; Cost effectiveness; Cost–benefit analysis; Medicine; Live birth; Birth rate; Range (aeronautics); Statistics; Population; Mathematics; Pregnancy; Environmental health; Biology","score_opus":0.4693579293730064,"score_gpt":0.4575737909097473,"score_spread":0.011784138463259097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121226306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62861973,0.105715744,0.029145129,0.06870155,0.0028892162,0.0020307945,0.019767268,0.00029970577,0.14283082],"genre_scores_gemma":[0.9710966,0.01329333,0.004714045,0.0017996408,0.00085809035,0.00038862936,0.0014978405,0.000036441303,0.006315436],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9940308,0.0048396788,0.00013582953,0.00014299469,0.00057891203,0.00027186133],"domain_scores_gemma":[0.9876956,0.010767422,0.00060368807,0.00022486865,0.00042347898,0.00028491035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007026113,0.00076098857,0.0015239568,0.0014094495,0.00024131562,0.0017178481,0.0007491694,0.0014556389,0.010575706],"category_scores_gemma":[0.025185911,0.00039544475,0.0023924662,0.0016349037,0.0005855221,0.0011725047,0.0007515387,0.0023494924,0.00026670078],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020123487,0.0015961858,0.054748833,0.0059057614,0.013300396,0.0010009455,0.00022306142,0.26142123,0.0010174792,0.09668246,0.04870127,0.4952789],"study_design_scores_gemma":[0.0165453,0.016640287,0.17845334,0.0042824782,0.029171677,0.002226367,0.0011301668,0.4640986,0.004764835,0.17527293,0.10704492,0.00036910106],"about_ca_topic_score_codex":0.007015675,"about_ca_topic_score_gemma":0.004816986,"teacher_disagreement_score":0.010575706,"about_ca_system_score_codex":0.0030873192,"about_ca_system_score_gemma":0.003595097,"threshold_uncertainty_score":0.037158072},"labels":[],"label_agreement":null},{"id":"W2121248749","doi":"10.1016/j.jval.2013.08.1188","title":"Physician Experience with Rituximab to Treat Pemphigus Vulgaris in Canada: A Questionnaire-Based Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Azathioprine; Rituximab; Pemphigus vulgaris; Adverse effect; Reimbursement; Dermatology; Family medicine; Internal medicine; Disease; Lymphoma","score_opus":0.017333070931804875,"score_gpt":0.27149783733932115,"score_spread":0.2541647664075163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121248749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995146,0.00055969297,0.000033727672,0.0006030838,0.0000137246125,0.00006152347,0.00050836505,0.0000033427928,0.0030705417],"genre_scores_gemma":[0.99803215,0.0005138805,0.00008403438,0.0004063544,0.000014418878,0.000016581851,0.00023401371,0.0000034758377,0.0006952133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988028,0.00022173165,0.00009638737,0.000098863406,0.0004650965,0.0003150748],"domain_scores_gemma":[0.99396825,0.0011325541,0.0013565586,0.00006152671,0.0017685656,0.0017124828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063657516,0.00015179518,0.0003460716,0.00082391786,0.0019510224,0.0010532772,0.00066698,0.00077030127,0.0030066005],"category_scores_gemma":[0.00531902,0.0002591214,0.00045026297,0.0019021573,0.00070805755,0.000464244,0.0005380202,0.0008124746,0.00022625459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020406315,0.00031003682,0.99084854,0.000058155827,0.00004401562,0.00033537266,0.002691011,0.00008218465,0.00019884256,0.000053029817,0.0008231553,0.0043515563],"study_design_scores_gemma":[0.000027885502,0.00013582049,0.99489886,0.000034430617,0.000026754413,0.00022502194,0.0034806905,0.00017506785,0.000036878755,0.000009931122,0.00093299866,0.00001556546],"about_ca_topic_score_codex":0.91186666,"about_ca_topic_score_gemma":0.93960255,"teacher_disagreement_score":0.088133335,"about_ca_system_score_codex":0.0124773085,"about_ca_system_score_gemma":0.013811197,"threshold_uncertainty_score":0.17730469},"labels":[],"label_agreement":null},{"id":"W2121619367","doi":"10.1016/j.jval.2010.11.013","title":"Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2033,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Conjoint analysis; Checklist; Task (project management); Preference; Preference elicitation; Pharmacoeconomics; Health care; Outcomes research; Research design; Management science; Computer science; Psychology; Applied psychology; Medical education; Medicine; Engineering; Political science; Statistics; Alternative medicine; Mathematics","score_opus":0.355792075055,"score_gpt":0.36722108065583964,"score_spread":0.011429005600839648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121619367","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065376344,0.042858463,0.73781395,0.063492864,0.003939821,0.08994038,0.016044702,0.01318686,0.026185445],"genre_scores_gemma":[0.0059208684,0.016855141,0.92085046,0.0056436523,0.0006333512,0.036334004,0.007482663,0.0015321365,0.0047477814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7624326,0.13084868,0.06177688,0.002238673,0.041088708,0.001614503],"domain_scores_gemma":[0.35660952,0.4140405,0.03342899,0.03444461,0.15479945,0.006676945],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21771999,0.003407865,0.00418171,0.01328241,0.0043909457,0.009598018,0.008329368,0.0077491873,0.010502493],"category_scores_gemma":[0.41649324,0.0049727615,0.0067185746,0.016124988,0.0043131863,0.005495669,0.011194471,0.015235925,0.00994442],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000575492,0.0014385084,0.004755527,0.017528085,0.00042531514,0.0006085262,0.0031640336,0.00352872,0.0027589838,0.010101237,0.44658282,0.50853276],"study_design_scores_gemma":[0.0009142834,0.0010634054,0.03119515,0.05449246,0.00087918056,0.0030553753,0.0031365568,0.011737409,0.0072734077,0.042001534,0.8434241,0.00082722184],"about_ca_topic_score_codex":0.007463052,"about_ca_topic_score_gemma":0.018065766,"teacher_disagreement_score":0.78228,"about_ca_system_score_codex":0.0048671286,"about_ca_system_score_gemma":0.030940568,"threshold_uncertainty_score":0.9646905},"labels":[],"label_agreement":null},{"id":"W2121627749","doi":"10.1016/j.jval.2013.01.013","title":"Health-Related Quality of Life of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes—Results from the PLATO Trial","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Quality of life (healthcare); Stroke (engine); Internal medicine; Population; Emergency medicine","score_opus":0.053571034764102334,"score_gpt":0.3010175903735779,"score_spread":0.24744655560947557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121627749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994311,0.0019106522,0.00012371635,0.00074724446,0.000104124796,0.0000864243,0.0012087245,0.000012157845,0.001496054],"genre_scores_gemma":[0.99499583,0.0010497124,0.00024195337,0.00051429484,0.0003408616,0.00018608582,0.0022481638,0.000008096322,0.00041485523],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.999041,0.0005379549,0.00005579894,0.00013960603,0.00010042814,0.00012511459],"domain_scores_gemma":[0.9983725,0.00062760647,0.000478005,0.00013491522,0.000049292434,0.0003377292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015805938,0.0010764592,0.0019695219,0.00027556115,0.0003065007,0.001284551,0.00054354244,0.00079792965,0.0015181408],"category_scores_gemma":[0.0026826079,0.00032152634,0.0023988502,0.0006242623,0.0007307801,0.0010618789,0.0008600033,0.0020753588,0.0002501803],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8175335,0.004108033,0.12673378,0.00065830536,0.008785818,0.00022162624,0.00017288573,0.001956773,0.0014966087,0.0006541467,0.0037227203,0.033955887],"study_design_scores_gemma":[0.27870047,0.049276676,0.641719,0.00026076086,0.017191514,0.0002980426,0.00043275105,0.0053644804,0.00085737434,0.0027753483,0.0029565485,0.00016714625],"about_ca_topic_score_codex":0.0011590939,"about_ca_topic_score_gemma":0.0017263376,"teacher_disagreement_score":0.0019695219,"about_ca_system_score_codex":0.00056733814,"about_ca_system_score_gemma":0.00063848915,"threshold_uncertainty_score":0.008359075},"labels":[],"label_agreement":null},{"id":"W2121937091","doi":"10.1016/j.jval.2013.03.878","title":"Utilization trends of various formulations of testosterone: An analysis of the ramq database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Testosterone (patch); Testosterone replacement; Medicine; Incidence (geometry); Reimbursement; Androgen; Internal medicine; Database; Pediatrics; Hormone; Mathematics; Health care; Computer science","score_opus":0.10194910071594279,"score_gpt":0.361114729947429,"score_spread":0.2591656292314862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121937091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9368034,0.0046484005,0.00016692012,0.00018446757,0.00000895715,0.00002393524,0.056540586,0.000028435188,0.0015949281],"genre_scores_gemma":[0.9584596,0.0026083672,0.00045319018,0.0001818212,0.000024044832,0.00004884,0.037685495,0.000023193305,0.0005154306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851984,0.0003499347,0.00035164118,0.00033803476,0.0003279682,0.00011265375],"domain_scores_gemma":[0.99457633,0.0017720829,0.0023567025,0.00031911777,0.00078937,0.00018641439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013308763,0.00017998664,0.0005866717,0.0028417245,0.00019032529,0.0007022497,0.00053090183,0.00034989245,0.0015303851],"category_scores_gemma":[0.0048090797,0.00019104984,0.0009351536,0.0067494153,0.00016026928,0.0005726964,0.00045537038,0.00037927207,0.0004076038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007288745,0.000041674455,0.986578,0.00016912556,0.00043276095,0.000058923833,0.00011244369,0.00017731915,0.00020239863,0.000116473755,0.0017835294,0.009598504],"study_design_scores_gemma":[0.000024728814,0.000071548704,0.99624735,0.000039959585,0.00017045593,0.00021451876,0.00024707348,0.00041076174,0.00016527489,0.00002145493,0.00237841,0.000008499955],"about_ca_topic_score_codex":0.026552264,"about_ca_topic_score_gemma":0.021617295,"teacher_disagreement_score":0.97344774,"about_ca_system_score_codex":0.0008021092,"about_ca_system_score_gemma":0.0007147613,"threshold_uncertainty_score":0.05279541},"labels":[],"label_agreement":null},{"id":"W2122091982","doi":"10.1111/j.1524-4733.2006.00098.x","title":"What Decision-Makers Want and What They Have Been Getting","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Business; Data science; Computer science","score_opus":0.2529515640936211,"score_gpt":0.4057684587264326,"score_spread":0.1528168946328115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122091982","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20385076,0.047246814,0.014420399,0.6719391,0.004176089,0.00006816956,0.00079802645,0.00006530256,0.057435412],"genre_scores_gemma":[0.9437192,0.012292804,0.006290296,0.030336501,0.001860121,0.000056104935,0.00030937837,0.00005447542,0.0050811144],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.98845017,0.007199996,0.00046780612,0.00039962228,0.0017756918,0.0017066892],"domain_scores_gemma":[0.9707889,0.015926264,0.0032879293,0.00081576995,0.0054443176,0.0037369248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018451449,0.0004351066,0.0012162611,0.0011530085,0.0018030977,0.012268056,0.0008286364,0.005257265,0.0054814965],"category_scores_gemma":[0.0615508,0.00034119224,0.0007886705,0.0024073585,0.0043429695,0.010914469,0.0016385488,0.0057330374,0.0006244396],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014795546,0.00076799147,0.101447046,0.0032860686,0.0015796627,0.00065341714,0.008435564,0.0055581224,0.0015714564,0.44999874,0.06897486,0.35624757],"study_design_scores_gemma":[0.0001519731,0.00022145238,0.046355043,0.0022996077,0.0003659204,0.00039526264,0.022648685,0.0048293294,0.0020606238,0.8601629,0.060247254,0.00026186253],"about_ca_topic_score_codex":0.0047992533,"about_ca_topic_score_gemma":0.0054732678,"teacher_disagreement_score":0.018451449,"about_ca_system_score_codex":0.004059004,"about_ca_system_score_gemma":0.003509837,"threshold_uncertainty_score":0.097581744},"labels":[],"label_agreement":null},{"id":"W2122781333","doi":"10.1016/j.jval.2013.11.011","title":"Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Manitoba; University of Alberta; University of Saskatchewan","funders":"","keywords":"Medicine; Meta-analysis; Socioeconomic status; Confidence interval; Medical prescription; Study heterogeneity; MEDLINE; Random effects model; Systematic review; Demography; Internal medicine; Environmental health; Population; Pharmacology","score_opus":0.18533711431793576,"score_gpt":0.42073455815054744,"score_spread":0.23539744383261169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122781333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076754596,0.99116874,0.00025321794,0.0001444074,0.0001212054,0.00013642495,0.0003312764,0.00001276867,0.00015652673],"genre_scores_gemma":[0.23154578,0.7641021,0.0019962068,0.0009681975,0.00021215643,0.00042729167,0.00039116104,0.00001645766,0.00034065422],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9941565,0.0022903972,0.0020153623,0.0006118599,0.000682661,0.00024332767],"domain_scores_gemma":[0.98769593,0.0082788,0.0027595893,0.00036790594,0.00069170777,0.00020613281],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.007565149,0.0022474579,0.012713374,0.004402819,0.00061347365,0.002326371,0.001622434,0.0023598976,0.0040622745],"category_scores_gemma":[0.023852743,0.0016568075,0.025648773,0.0056889784,0.00075501873,0.0017008665,0.0016539516,0.0018669456,0.00022527626],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018426161,0.0000667413,0.009572741,0.32889718,0.64391476,0.00018083437,0.00015571066,0.00020853027,0.00017923504,0.00009950154,0.0006131115,0.014268967],"study_design_scores_gemma":[0.0006839748,0.00017614063,0.006789473,0.01762734,0.97303617,0.000115325965,0.0000783621,0.000089895984,0.00005641918,0.000101837715,0.0012196216,0.00002551407],"about_ca_topic_score_codex":0.008929524,"about_ca_topic_score_gemma":0.0316456,"teacher_disagreement_score":0.9872866,"about_ca_system_score_codex":0.0017638239,"about_ca_system_score_gemma":0.0030760234,"threshold_uncertainty_score":0.040008843},"labels":[],"label_agreement":null},{"id":"W2123243801","doi":"10.1016/j.jval.2013.08.1620","title":"Modeling a Switch from Trivalent to Quadrivalent Influenza Vaccine in Canada and the United Kingdom","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; GlaxoSmithKline (Canada)","funders":"","keywords":"Influenza vaccine; Transmission (telecommunications); Population; Demography; Trivalent influenza vaccine; Seasonal influenza; Virology; Live attenuated influenza vaccine; Medicine; Geography; Vaccination; Environmental health; Internal medicine; Disease; Coronavirus disease 2019 (COVID-19); Computer science","score_opus":0.1579258293550882,"score_gpt":0.3764033495677578,"score_spread":0.21847752021266958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123243801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97750103,0.0009942895,0.0013502749,0.002958733,0.000082243365,0.0001340569,0.0039450713,0.00004248806,0.012991784],"genre_scores_gemma":[0.98504835,0.00048480544,0.0009903876,0.00030693333,0.000010151404,0.00006494845,0.0011430436,0.000023528919,0.011927845],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989742,0.00024299609,0.000027360431,0.00010178341,0.000074782314,0.00057884236],"domain_scores_gemma":[0.9964747,0.001946927,0.00018911061,0.000069682515,0.00076335744,0.00055618706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015054202,0.0007558589,0.0012279418,0.0007876412,0.0015017599,0.002468057,0.0026225909,0.002695889,0.008510422],"category_scores_gemma":[0.005542014,0.0009252214,0.0012900303,0.0013515797,0.0014244431,0.0010188275,0.00094016426,0.0018233237,0.0004271564],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010861348,0.00023628995,0.01775932,0.00008414345,0.00013512262,0.00034596256,0.00017549434,0.9637635,0.00039841604,0.008020255,0.0043993895,0.003596025],"study_design_scores_gemma":[0.00062604167,0.0003504741,0.018937355,0.00006773561,0.0002616098,0.000060574486,0.0019817592,0.9696611,0.00042428242,0.0027070686,0.004825506,0.00009649516],"about_ca_topic_score_codex":0.9849702,"about_ca_topic_score_gemma":0.9691185,"teacher_disagreement_score":0.04047791,"about_ca_system_score_codex":0.04047791,"about_ca_system_score_gemma":0.023648046,"threshold_uncertainty_score":0.29368913},"labels":[],"label_agreement":null},{"id":"W2123341140","doi":"10.1016/j.jval.2014.03.1114","title":"Predicting heart failure recurrence after aortic valve replacement using a competing-risks model","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Heart failure; Medicine; Atrial fibrillation; Proportional hazards model; Cardiology; Internal medicine; Hazard ratio; Multivariate statistics; valvular heart disease; Aortic valve replacement; Coronary artery disease; Population; Cohort; Multivariate analysis; Statistics; Confidence interval; Mathematics; Stenosis","score_opus":0.05513091515091708,"score_gpt":0.3821759210014847,"score_spread":0.3270450058505676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123341140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9567739,0.0011665443,0.03716479,0.0028727187,0.00019635615,0.00006017946,0.0008802091,0.00012581567,0.000759546],"genre_scores_gemma":[0.99519145,0.00020579172,0.0029701348,0.000088202614,0.00012239054,0.000034652854,0.00057319953,0.000009621337,0.0008046287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975369,0.0014184421,0.0001569597,0.0004254681,0.00014732657,0.000314876],"domain_scores_gemma":[0.97056323,0.02523178,0.0016206749,0.00088358426,0.0005493302,0.0011513972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009283679,0.0011164742,0.0018248978,0.0015555781,0.00065744907,0.0021075616,0.0023587472,0.0021262283,0.0026459908],"category_scores_gemma":[0.019295922,0.00066619605,0.003035244,0.0008618951,0.00065587694,0.0013390306,0.0012107332,0.002608271,0.00036632945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064230207,0.0016349402,0.7305887,0.00021894852,0.003639949,0.0008837252,0.00041684948,0.20605902,0.0006353553,0.009363393,0.0029186385,0.03721755],"study_design_scores_gemma":[0.00017896076,0.00073572417,0.038066924,0.000035405403,0.00075141183,0.00031234865,0.00010942783,0.9530332,0.00014087198,0.0062689506,0.00030964494,0.00005705982],"about_ca_topic_score_codex":0.008330104,"about_ca_topic_score_gemma":0.0067470954,"teacher_disagreement_score":0.009283679,"about_ca_system_score_codex":0.00073677214,"about_ca_system_score_gemma":0.0010141873,"threshold_uncertainty_score":0.04909736},"labels":[],"label_agreement":null},{"id":"W2123471793","doi":"10.1016/j.jval.2013.03.1098","title":"Treatment Patterns Of Adalimumab And Infliximab In The Treatment Of Crohn's Disease Over A Three-Year Period: A Canadian Assessment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Adalimumab; Infliximab; Medicine; Cohort; Internal medicine; Retrospective cohort study; Confidence interval; Disease","score_opus":0.014502820346654864,"score_gpt":0.2739747627152827,"score_spread":0.25947194236862786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123471793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859455,0.005950856,0.00014011624,0.0016815626,0.000025806356,0.000048953832,0.0027818806,0.00001239625,0.0034128516],"genre_scores_gemma":[0.9947937,0.0030437731,0.0003586951,0.0002235005,0.000018306573,0.000015549927,0.0010181377,0.0000055162336,0.0005229109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691087,0.000429604,0.00037777217,0.00029146878,0.0015900452,0.0004002051],"domain_scores_gemma":[0.99182,0.000835539,0.0022317553,0.00014394277,0.003957998,0.0010107285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024730808,0.00025097947,0.00072840886,0.001920323,0.0016800954,0.0011165487,0.0012937001,0.00086706923,0.0007815861],"category_scores_gemma":[0.008696129,0.00029237795,0.0010578331,0.006137269,0.00063004915,0.0007668227,0.00073157623,0.00094764744,0.00010609054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008931936,0.00015240906,0.9765146,0.0001588029,0.00022835888,0.00014308526,0.0009006657,0.000191459,0.0002781133,0.000095111835,0.0008419843,0.019602148],"study_design_scores_gemma":[0.000025155678,0.00010568305,0.99814355,0.000023784662,0.00008135615,0.00011669767,0.0005132074,0.00016933017,0.000036269525,0.00001055432,0.0007600049,0.000014473146],"about_ca_topic_score_codex":0.9252991,"about_ca_topic_score_gemma":0.94730294,"teacher_disagreement_score":0.07470089,"about_ca_system_score_codex":0.018713705,"about_ca_system_score_gemma":0.01997828,"threshold_uncertainty_score":0.15028161},"labels":[],"label_agreement":null},{"id":"W2124193153","doi":"10.1016/j.jval.2011.08.1655","title":"PIN1 The Epidemiologic Burden Of Hepatitis C Virus Infection In Latin America","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Latin Americans; Medicine; Population; Hepatitis C virus; Hepatitis C; Asymptomatic; Disease burden; Public health; Environmental health; Demography; Immunology; Virus; Internal medicine; Pathology","score_opus":0.1905698921064476,"score_gpt":0.388271085789511,"score_spread":0.19770119368306338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124193153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95049113,0.012484368,0.0003190443,0.00624492,0.00008586274,0.000018145973,0.004262042,0.000017931488,0.026076483],"genre_scores_gemma":[0.99411005,0.003421512,0.00012027044,0.00028149056,0.00007277351,0.000008405054,0.00089933805,0.0000070772585,0.0010789597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962795,0.00015603016,0.000019260566,0.000049123857,0.000073769814,0.000073776355],"domain_scores_gemma":[0.998654,0.00024458818,0.00064206443,0.000073193485,0.00023754459,0.0001486098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006172821,0.000171932,0.00018042926,0.0011262965,0.0003906052,0.0010889169,0.0002843395,0.0002607601,0.0039872983],"category_scores_gemma":[0.0034116502,0.00011567951,0.00018551065,0.0026654266,0.00034182792,0.00046786692,0.0006068216,0.00051736564,0.00026773592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013023929,0.000022934168,0.9735108,0.00008254162,0.000055021133,0.00009979586,0.0003029749,0.00010276723,0.00038057473,0.00089137175,0.0018706669,0.02255025],"study_design_scores_gemma":[0.000005990549,0.000017918926,0.9922087,0.00009089635,0.000025442612,0.00017944211,0.00064464234,0.00012117438,0.00008158051,0.00025515206,0.0063656443,0.000003428541],"about_ca_topic_score_codex":0.037154872,"about_ca_topic_score_gemma":0.03125465,"teacher_disagreement_score":0.037154872,"about_ca_system_score_codex":0.0011401002,"about_ca_system_score_gemma":0.00072771014,"threshold_uncertainty_score":0.073877215},"labels":[],"label_agreement":null},{"id":"W2124307672","doi":"10.1016/j.jval.2014.03.661","title":"Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Apixaban; Medicine; Atrial fibrillation; Warfarin; Internal medicine; Hazard ratio; Discontinuation; Aspirin; Vitamin K antagonist; Cardiology; Stroke (engine); Proportional hazards model; Confidence interval; Rivaroxaban","score_opus":0.2519116091192355,"score_gpt":0.3885560578023482,"score_spread":0.1366444486831127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124307672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866723,0.0006753324,0.00784916,0.0010458156,0.000091095746,0.0001663748,0.0016858267,0.00005636732,0.0017576915],"genre_scores_gemma":[0.9973787,0.000103462604,0.0013648861,0.00006675423,0.000015374457,0.00006876889,0.00081934023,0.000008139508,0.00017462087],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99646735,0.0027733746,0.00019508018,0.00027141836,0.00014318683,0.00014961825],"domain_scores_gemma":[0.9458001,0.05059894,0.0011360791,0.00087432546,0.0011340182,0.00045651966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013457206,0.00080768636,0.0015332755,0.0006904174,0.0003782203,0.0020976819,0.0012021053,0.0015685061,0.0032306],"category_scores_gemma":[0.04339866,0.0004608378,0.001776164,0.0006277502,0.00047655925,0.0010324882,0.00074928184,0.0020612825,0.00035993938],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012252903,0.002361402,0.072950095,0.00042823397,0.0022341856,0.00027964107,0.000116175215,0.8774403,0.0005188396,0.0039071864,0.0024157073,0.025095377],"study_design_scores_gemma":[0.0016062694,0.0016787788,0.017885033,0.00010270946,0.00051309547,0.00013653692,0.00006348824,0.9747746,0.00044514867,0.0021091723,0.0006529959,0.00003224714],"about_ca_topic_score_codex":0.009027093,"about_ca_topic_score_gemma":0.0031987012,"teacher_disagreement_score":0.013457206,"about_ca_system_score_codex":0.0024803905,"about_ca_system_score_gemma":0.0023441792,"threshold_uncertainty_score":0.07116938},"labels":[],"label_agreement":null},{"id":"W2124367552","doi":"10.1016/j.jval.2014.03.1042","title":"The Disease Burden Associated With Infant Hospitalization For A Lower Respiratory Tract Infection (Lrti) In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Absenteeism; Pediatrics; Lower respiratory tract infection; Respiratory tract infections; Presenteeism; Socioeconomic status; Emergency medicine; Intensive care medicine; Respiratory system; Population; Environmental health; Internal medicine","score_opus":0.03956911137277135,"score_gpt":0.3345925613996971,"score_spread":0.29502345002692576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124367552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97740626,0.004204523,0.00015179504,0.0031782854,0.00007437458,0.000044761757,0.009066271,0.000020514915,0.00585327],"genre_scores_gemma":[0.99529135,0.0021679956,0.00010089112,0.00016974981,0.000023085036,0.0000070820074,0.001426813,0.000004814178,0.0008082293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988065,0.00007669434,0.00007263982,0.00010024879,0.0003432215,0.0006006558],"domain_scores_gemma":[0.9971392,0.00010821963,0.00058960414,0.000041852938,0.0010818697,0.0010393008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033214068,0.00033050985,0.0004319322,0.0016725033,0.0021565454,0.0015653446,0.001201319,0.0006166976,0.0033782334],"category_scores_gemma":[0.0024856038,0.00037312345,0.00097125134,0.0038677738,0.0006197105,0.0004138446,0.0011867925,0.0016162205,0.00017916237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060968894,0.000024626144,0.9924623,0.00004365278,0.00007299548,0.00018119026,0.000279756,0.00022601357,0.000104643594,0.00024105665,0.0018298102,0.0044728955],"study_design_scores_gemma":[0.0000036718754,0.000011039768,0.998257,0.000049314236,0.000025776533,0.00007899527,0.0007018147,0.00024301879,0.000020760117,0.00002986992,0.0005719548,0.00000676279],"about_ca_topic_score_codex":0.997586,"about_ca_topic_score_gemma":0.99839103,"teacher_disagreement_score":0.04202463,"about_ca_system_score_codex":0.04202463,"about_ca_system_score_gemma":0.05413094,"threshold_uncertainty_score":0.30491143},"labels":[],"label_agreement":null},{"id":"W2124545744","doi":"10.1016/j.jval.2015.02.017","title":"Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes: Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Quebec Population Health Research Network","funders":"Université Laval; Pfizer Canada; Sanofi; Merck Canada; AstraZeneca Canada; AstraZeneca; Pfizer","keywords":"Meta-analysis; Drug; Medicine; Psychological intervention; Diabetes mellitus; Type 2 diabetes; Intensive care medicine; Pharmacology; Internal medicine; Endocrinology; Nursing","score_opus":0.2656848519104055,"score_gpt":0.4594744193420192,"score_spread":0.19378956743161374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124545744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01705463,0.97869706,0.0010424431,0.00022009175,0.00027047464,0.0016661052,0.00056402833,0.000048285674,0.0004368644],"genre_scores_gemma":[0.3071594,0.6810166,0.0062440094,0.0010769714,0.0002192237,0.0030784148,0.0006015813,0.000043138734,0.00056068785],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9879546,0.005559823,0.0035896967,0.00093765167,0.0016130852,0.00034504052],"domain_scores_gemma":[0.98122853,0.013794439,0.0031276178,0.0005513304,0.0010755303,0.00022258224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015842425,0.0025630812,0.018932521,0.0054832986,0.0006585358,0.002932532,0.0022048047,0.0019504181,0.0037147067],"category_scores_gemma":[0.0445434,0.0015927244,0.027481815,0.005523405,0.0010629365,0.0022054433,0.0022156455,0.0023611025,0.00021792912],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042774254,0.000113076254,0.001669455,0.49847907,0.47401348,0.000059208996,0.00022666033,0.00028083572,0.00022862559,0.000114441784,0.00034362392,0.020194042],"study_design_scores_gemma":[0.002709036,0.00044101218,0.0027421678,0.03063597,0.9617993,0.00004984497,0.00010438777,0.00014620245,0.00015157928,0.00013760998,0.0010554879,0.000027302738],"about_ca_topic_score_codex":0.007824198,"about_ca_topic_score_gemma":0.018953456,"teacher_disagreement_score":0.018932521,"about_ca_system_score_codex":0.0035414468,"about_ca_system_score_gemma":0.0042767096,"threshold_uncertainty_score":0.083783746},"labels":[],"label_agreement":null},{"id":"W2125093326","doi":"10.1111/j.1524-4733.2008.00368.x","title":"Applying the Expectancy-Value Model to Understand Health Values","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Cultural Differences and Values","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Expectancy theory; Likert scale; Explanatory power; Statistics; Psychology; Univariate; Marital status; Bivariate analysis; Regression analysis; Variables; Life expectancy; Descriptive statistics; Multilevel model; Linear regression; Demography; Social psychology; Medicine; Mathematics; Environmental health; Multivariate statistics; Population","score_opus":0.3214172782029153,"score_gpt":0.42031896520742157,"score_spread":0.09890168700450624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125093326","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20593724,0.005429408,0.541263,0.045083396,0.00041145645,0.00027083154,0.0006953404,0.00012488662,0.20078447],"genre_scores_gemma":[0.9754038,0.0011206497,0.021187073,0.0007866309,0.00010786998,0.00013653244,0.00012180457,0.000009571905,0.0011261596],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9983265,0.0011911946,0.00005358853,0.00008064378,0.00024346556,0.00010461402],"domain_scores_gemma":[0.9914035,0.007094919,0.00050603173,0.0002782762,0.00043113332,0.00028605087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038402115,0.0005170302,0.00051080174,0.0013525583,0.0005774268,0.0023515967,0.0008989268,0.0016316591,0.005477243],"category_scores_gemma":[0.01534808,0.00020955356,0.00061143906,0.0013967329,0.0027922767,0.005036546,0.0009966262,0.0021924137,0.00025660585],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026632983,0.000059962174,0.0038174044,0.000081735954,0.000051586518,0.00008012691,0.0014218284,0.005145653,0.00011187184,0.9747351,0.0008018214,0.013666291],"study_design_scores_gemma":[0.000012241602,0.000033654313,0.0019439219,0.00005652551,0.000014726308,0.00007850919,0.0005302401,0.008186235,0.000054650623,0.98716986,0.0019100172,0.000009426419],"about_ca_topic_score_codex":0.0026065898,"about_ca_topic_score_gemma":0.0017019187,"teacher_disagreement_score":0.005477243,"about_ca_system_score_codex":0.0027149145,"about_ca_system_score_gemma":0.0011986666,"threshold_uncertainty_score":0.02030921},"labels":[],"label_agreement":null},{"id":"W2125447577","doi":"10.1016/j.jval.2015.09.1322","title":"Assessment of Burden and Economic Impact of the Vandetanib Restricted Distribution Program in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; AstraZeneca (Canada)","funders":"","keywords":"Vandetanib; Medicine; Health care; Guideline; Family medicine; Internal medicine; Political science","score_opus":0.04757995002017015,"score_gpt":0.30314649689723383,"score_spread":0.2555665468770637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125447577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9683517,0.0031278331,0.00023635807,0.0076852874,0.00005435017,0.00011176919,0.010480941,0.000019490002,0.009932222],"genre_scores_gemma":[0.9932748,0.0017500765,0.00015399212,0.0002739957,0.000018404387,0.000013473635,0.0022382713,0.000007732159,0.002269274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997971,0.00024594145,0.00007626238,0.000092240545,0.000782273,0.0008321941],"domain_scores_gemma":[0.99468493,0.00051122694,0.0010257672,0.00010137925,0.0022747517,0.0014018758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001213863,0.00025970762,0.00047152463,0.0019494783,0.001402071,0.0021090514,0.0015614332,0.0005288079,0.002678172],"category_scores_gemma":[0.0062601264,0.00029431694,0.0007499562,0.0055177794,0.0009282398,0.00045156563,0.001215315,0.0013588675,0.00012701881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012092057,0.0003042224,0.92576575,0.00020907282,0.0005123108,0.00054581714,0.0008006139,0.009312277,0.00031423976,0.006093518,0.015889449,0.039043438],"study_design_scores_gemma":[0.000106255364,0.00010130491,0.98595154,0.000118458905,0.00020081035,0.000101637415,0.0019279246,0.0046852995,0.00015159622,0.0003430678,0.0062802536,0.000031916734],"about_ca_topic_score_codex":0.9977431,"about_ca_topic_score_gemma":0.99836105,"teacher_disagreement_score":0.0954906,"about_ca_system_score_codex":0.0954906,"about_ca_system_score_gemma":0.093813345,"threshold_uncertainty_score":0.69283605},"labels":[],"label_agreement":null},{"id":"W2125510303","doi":"10.1016/j.jval.2014.03.257","title":"Epidemiology And Biologic Treatment Patterns Of Systemic Juvenile Idiopathic Arthritis In Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cohort; Rheumatology; Etanercept; Arthritis; Epidemiology; Internal medicine; Pediatrics; Macrophage activation syndrome; Juvenile; Physical therapy; Rheumatoid arthritis","score_opus":0.07554338867944468,"score_gpt":0.3305031508176961,"score_spread":0.25495976213825144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125510303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906494,0.0012949824,0.00009845855,0.0006553833,0.0000122605,0.000041149724,0.0032228793,0.000009726688,0.004015797],"genre_scores_gemma":[0.9972614,0.00078690465,0.00011319314,0.000089595174,0.000008077573,0.000016821401,0.0006585217,0.000006013916,0.001059442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863607,0.000120395765,0.00016941164,0.0001852708,0.00049625314,0.00039254458],"domain_scores_gemma":[0.9960998,0.00028229886,0.0018556328,0.000104531005,0.0008671121,0.000790696],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00040557532,0.00021270475,0.00036383158,0.0017796855,0.0018599179,0.0010124848,0.00095883844,0.00039371537,0.0029247052],"category_scores_gemma":[0.002794722,0.0004738381,0.0005405729,0.005521464,0.0007595406,0.0004498231,0.0009491443,0.0005251204,0.00018925886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069850554,0.000023307279,0.99503654,0.00004710926,0.000029997518,0.0001550245,0.00091942045,0.000050396662,0.0002606728,0.00013154198,0.00046502665,0.0028111362],"study_design_scores_gemma":[0.0000062764348,0.000019981022,0.9977641,0.0000268374,0.000013225278,0.00012054456,0.0011735618,0.000070837596,0.000035195135,0.000023404067,0.0007405611,0.000005413474],"about_ca_topic_score_codex":0.97168714,"about_ca_topic_score_gemma":0.98689485,"teacher_disagreement_score":0.9996362,"about_ca_system_score_codex":0.01897277,"about_ca_system_score_gemma":0.026302313,"threshold_uncertainty_score":0.1376577},"labels":[],"label_agreement":null},{"id":"W2125776201","doi":"10.1016/j.jval.2011.04.002","title":"Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1042,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Randomized controlled trial; Meta-analysis; Psychological intervention; Health care; Terminology; Systematic review; Pairwise comparison; Management science; Medicine; Internal validity; MEDLINE; Psychology; Computer science; Nursing; Artificial intelligence; Economics; Political science","score_opus":0.8990592469292574,"score_gpt":0.6101353465479792,"score_spread":0.28892390038127824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125776201","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065079583,0.3122178,0.6115061,0.029990308,0.010965096,0.0137453275,0.0065430226,0.0012566646,0.007267754],"genre_scores_gemma":[0.099986814,0.05355992,0.8016109,0.008989622,0.004541016,0.026170649,0.0023731673,0.0012696328,0.0014983753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.19968624,0.7196938,0.04948149,0.0075215413,0.023046471,0.000570427],"domain_scores_gemma":[0.1024981,0.84185374,0.020028694,0.02108354,0.013885438,0.0006503783],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5388279,0.0063577686,0.016554777,0.016146015,0.0029470355,0.012363482,0.0075825136,0.0078988755,0.00847437],"category_scores_gemma":[0.84112555,0.0055365614,0.032707512,0.01319558,0.0060402607,0.005853023,0.007815593,0.013898961,0.0012764563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063368212,0.00022188073,0.013155932,0.18707938,0.3255232,0.0004843583,0.0036446906,0.010422686,0.0010737624,0.03910141,0.06359549,0.34936035],"study_design_scores_gemma":[0.010758983,0.0016582281,0.014162166,0.15464377,0.41720793,0.001357793,0.0009984068,0.030056834,0.006831753,0.27132285,0.089816004,0.0011852868],"about_ca_topic_score_codex":0.0058299834,"about_ca_topic_score_gemma":0.0104712155,"teacher_disagreement_score":0.4611721,"about_ca_system_score_codex":0.0056593716,"about_ca_system_score_gemma":0.012293048,"threshold_uncertainty_score":0.56870735},"labels":[],"label_agreement":null},{"id":"W2126156851","doi":"10.1016/j.jval.2013.08.503","title":"Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research; University of Toronto; Toronto Public Health; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Medicine; Oncology; Population; Lung cancer; Internal medicine; Cost effectiveness; ALK inhibitor; Environmental health","score_opus":0.030345237848856524,"score_gpt":0.3114200689726865,"score_spread":0.28107483112382997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126156851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753186,0.0043685865,0.00012370001,0.005908462,0.00007347199,0.00024778218,0.006756484,0.000027309468,0.007175479],"genre_scores_gemma":[0.9961009,0.00079353276,0.00020721632,0.00040511522,0.000029593772,0.000031845426,0.0013697692,0.0000038021897,0.0010583005],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9980599,0.0005149513,0.000119572236,0.00016178246,0.00039083368,0.0007528762],"domain_scores_gemma":[0.99563193,0.00081425166,0.0009793069,0.00008100622,0.00063996244,0.0018535781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011019029,0.00040003407,0.00086308096,0.00040773652,0.0009507803,0.0015546549,0.0012734326,0.0010473188,0.003857485],"category_scores_gemma":[0.007071475,0.00036675332,0.0018685814,0.001631517,0.00078435836,0.00058488373,0.000936496,0.0010238634,0.0001515934],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028719394,0.0016191937,0.7977685,0.00117828,0.0027449194,0.0009032329,0.0006988564,0.031961534,0.00085970695,0.002725195,0.036946036,0.093875185],"study_design_scores_gemma":[0.004147121,0.0022350866,0.96789885,0.00031253687,0.0016545155,0.0003129425,0.0010594323,0.017721802,0.00022209366,0.00041683286,0.003923348,0.00009533672],"about_ca_topic_score_codex":0.9813856,"about_ca_topic_score_gemma":0.9908887,"teacher_disagreement_score":0.08798604,"about_ca_system_score_codex":0.08798604,"about_ca_system_score_gemma":0.07192137,"threshold_uncertainty_score":0.63838637},"labels":[],"label_agreement":null},{"id":"W2126806511","doi":"10.1016/j.jval.2011.02.099","title":"PHP27 CANADIAN PUBLIC DRUG PROGRAM SPENDING ON SENIORS, 2002 TO 2008","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medical prescription; Drug; Population; Drug class; Medicine; Public health; Gerontology; Business; Demography; Environmental health; Pharmacology; Sociology; Nursing","score_opus":0.19514812031918582,"score_gpt":0.3033648646397582,"score_spread":0.10821674432057238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126806511","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04420216,0.0069416277,0.0002825974,0.013804252,0.0010111395,0.00015091177,0.8578465,0.000616927,0.07514392],"genre_scores_gemma":[0.3778048,0.01881145,0.0012537199,0.0051889555,0.000687715,0.00028151134,0.34579292,0.00021538348,0.24996355],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9977189,0.00006611785,0.00008272522,0.00012333089,0.0013277149,0.0006811375],"domain_scores_gemma":[0.9948718,0.0001570874,0.00040510786,0.000069993825,0.0035965603,0.0008994197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093719177,0.00074182963,0.00067825645,0.005683681,0.0018736726,0.0022734532,0.0014409758,0.0008744098,0.017885312],"category_scores_gemma":[0.0061589843,0.00041921905,0.0010209442,0.009014978,0.00051171525,0.00064430555,0.0008639177,0.0013069907,0.0026685568],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027077194,0.000052187952,0.04031012,0.00052446476,0.00013732842,0.00007786579,0.0001497801,0.0011429617,0.0000772731,0.0032207463,0.918739,0.035297487],"study_design_scores_gemma":[0.00011335524,0.00004925099,0.45841727,0.0003328755,0.00016635912,0.00011633525,0.000527088,0.0010502274,0.00043479996,0.00024293033,0.53850245,0.000047033376],"about_ca_topic_score_codex":0.996222,"about_ca_topic_score_gemma":0.9974427,"teacher_disagreement_score":0.06736213,"about_ca_system_score_codex":0.06736213,"about_ca_system_score_gemma":0.13929491,"threshold_uncertainty_score":0.48874873},"labels":[],"label_agreement":null},{"id":"W2127095817","doi":"10.1111/j.1524-4733.2007.00196.x","title":"Measuring Patient Preferences for Colorectal Cancer Screening Using a Choice-Format Survey","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Colonoscopy; Medicine; Modalities; Test (biology); Preference; Colorectal cancer; Patient satisfaction; Fecal occult blood; Family medicine; Statistics; Surgery; Cancer; Internal medicine; Mathematics","score_opus":0.21552187787478527,"score_gpt":0.3700994276911555,"score_spread":0.15457754981637023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127095817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966635,0.00007613727,0.0004702208,0.0002676071,0.00001713426,0.0002732169,0.0006883453,0.000013577694,0.0015303202],"genre_scores_gemma":[0.9952998,0.00014616751,0.002601753,0.00034609114,0.00003249029,0.00038987887,0.0006267529,0.0000056444533,0.00055136427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963559,0.0019538503,0.0005390274,0.00018270328,0.00066781946,0.00030072848],"domain_scores_gemma":[0.97806746,0.014246792,0.004182372,0.0006071258,0.001175617,0.0017206089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046583326,0.0005401403,0.0007953308,0.0012338861,0.00056928623,0.0008931609,0.00036728097,0.0010319557,0.0061328383],"category_scores_gemma":[0.01962039,0.00036072638,0.0011170257,0.0011978237,0.00038761113,0.0010077663,0.0006496286,0.0011478318,0.0008843628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050221607,0.0042057615,0.9506941,0.0001655933,0.000477116,0.00020486809,0.0009985026,0.0011791632,0.0012463959,0.00031581093,0.001834705,0.03365586],"study_design_scores_gemma":[0.0019732518,0.0154554825,0.9608039,0.00009044442,0.00035981502,0.0010106454,0.0024628933,0.011056126,0.0024736943,0.0008361734,0.0033275532,0.00015009094],"about_ca_topic_score_codex":0.0015118136,"about_ca_topic_score_gemma":0.002288931,"teacher_disagreement_score":0.0061328383,"about_ca_system_score_codex":0.0009142251,"about_ca_system_score_gemma":0.00080371863,"threshold_uncertainty_score":0.024635851},"labels":[],"label_agreement":null},{"id":"W2127105530","doi":"10.1111/j.1524-4733.2006.00113.x","title":"Managing Meningococcal Disease in the United States: Hospital Case Characteristics and Costs by Age","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Case fatality rate; Emergency medicine; Demographics; Pediatrics; Meningococcal disease; Diagnosis code; Health care; Disease; Demography; Population; Neisseria meningitidis; Environmental health; Internal medicine","score_opus":0.013928945559640518,"score_gpt":0.26037091664314643,"score_spread":0.2464419710835059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127105530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751943,0.00045965725,0.00005223191,0.00026640444,0.000009282303,0.000009206634,0.0006447898,0.000003801277,0.0010351514],"genre_scores_gemma":[0.998912,0.0002521256,0.00006368913,0.000089396475,0.000019167348,0.0000072904886,0.0005083765,0.0000023549217,0.0001455894],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992575,0.00018182916,0.00013296134,0.00006795063,0.00014777026,0.00021194301],"domain_scores_gemma":[0.99590695,0.0006870046,0.002138908,0.00006232475,0.0003352654,0.00086957234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044235424,0.0002433602,0.00031115318,0.0014080079,0.00042967804,0.00077502424,0.000380607,0.00065382774,0.00230411],"category_scores_gemma":[0.0047884653,0.00027282175,0.00049057486,0.0017250552,0.0002738924,0.0009270453,0.00066771556,0.00064129324,0.00022619357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005170052,0.000038458176,0.997792,0.0000045965435,0.000025853502,0.00011682145,0.00004220571,0.00014197353,0.00003649306,0.000023829018,0.00027874185,0.0014473072],"study_design_scores_gemma":[0.0000040966083,0.00007981149,0.9982436,0.0000096102585,0.000013022508,0.0005358117,0.0004543207,0.00040491502,0.00002812414,0.000050814222,0.00017138601,0.000004612279],"about_ca_topic_score_codex":0.012935594,"about_ca_topic_score_gemma":0.02010535,"teacher_disagreement_score":0.012935594,"about_ca_system_score_codex":0.00134188,"about_ca_system_score_gemma":0.0007885236,"threshold_uncertainty_score":0.025720596},"labels":[],"label_agreement":null},{"id":"W2127840248","doi":"10.1016/j.jval.2015.12.020","title":"An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Stakeholders’ Risk Tolerance for Hip Replacement Surgery","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Logit; Mixed logit; Hip replacement; Medicine; Preference; Population; Logistic regression; Physical therapy; Statistics; Arthroplasty; Surgery; Mathematics; Environmental health","score_opus":0.36313376151044174,"score_gpt":0.38080480377763987,"score_spread":0.017671042267198123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127840248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767511,0.00013670852,0.021218298,0.000259105,0.00010210814,0.00016970836,0.00016929761,0.000039596172,0.0011540417],"genre_scores_gemma":[0.99118596,0.000028860833,0.008040015,0.00007179519,0.000028456721,0.0001833498,0.00016404426,0.0000092509235,0.00028820473],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97540843,0.021263938,0.0006915833,0.0013770207,0.0008844219,0.00037458565],"domain_scores_gemma":[0.3901105,0.5861115,0.009102261,0.010809181,0.002716929,0.0011496057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055011515,0.0007741562,0.0010460903,0.00097318535,0.00059325225,0.0019099377,0.0015217738,0.002237441,0.0036826774],"category_scores_gemma":[0.17280169,0.0005363408,0.0014594197,0.0008516666,0.0024159465,0.0033329953,0.00116091,0.002303243,0.00031609618],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07433995,0.033246897,0.4210284,0.0015884852,0.004280497,0.00041425962,0.0050946083,0.25782484,0.0052883094,0.06404282,0.0036094107,0.12924154],"study_design_scores_gemma":[0.0037976631,0.018693902,0.15134399,0.00018077972,0.0008582039,0.00021375049,0.002624987,0.77406013,0.0034911619,0.042054024,0.002384176,0.0002971642],"about_ca_topic_score_codex":0.002433281,"about_ca_topic_score_gemma":0.0014032451,"teacher_disagreement_score":0.055011515,"about_ca_system_score_codex":0.0014199987,"about_ca_system_score_gemma":0.000961906,"threshold_uncertainty_score":0.29093218},"labels":[],"label_agreement":null},{"id":"W2128145795","doi":"10.1016/j.jval.2013.08.1172","title":"A Quebec Economic Evaluation for 36 Months of Ranibizumab for the Treatment of Diabetic Macular Edema","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Quality-adjusted life year; Quality of life (healthcare); Visual acuity; Cost effectiveness; Optometry; Ophthalmology; Surgery; Bevacizumab","score_opus":0.05163743765846752,"score_gpt":0.3501458834083518,"score_spread":0.2985084457498843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128145795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.873068,0.06601312,0.0016592464,0.010438417,0.00057516457,0.0026010845,0.018205613,0.00007098505,0.027368471],"genre_scores_gemma":[0.9880521,0.0038753292,0.00096954725,0.00131495,0.00007400301,0.00036692803,0.0023882622,0.000011267374,0.0029475975],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99482006,0.003396761,0.00021183735,0.00022564597,0.0008747004,0.0004710398],"domain_scores_gemma":[0.9920989,0.0034932585,0.0011771328,0.00017473755,0.0019829678,0.001073041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053271195,0.0006000429,0.0012488151,0.0007669408,0.0010701403,0.0017622438,0.0010949945,0.0011540393,0.0048364094],"category_scores_gemma":[0.013459783,0.00030761078,0.0025227843,0.0014642864,0.00059193454,0.0005907107,0.00062279415,0.0015214846,0.00016599936],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4762011,0.007836266,0.099478796,0.006685525,0.020413987,0.0013524413,0.0005836142,0.055469066,0.003885963,0.007833408,0.054669164,0.26559067],"study_design_scores_gemma":[0.13843367,0.044420373,0.6530724,0.0035898911,0.019571926,0.000668814,0.0011875785,0.08134727,0.0010232198,0.0012692263,0.05493354,0.0004821471],"about_ca_topic_score_codex":0.8532285,"about_ca_topic_score_gemma":0.87733704,"teacher_disagreement_score":0.14677149,"about_ca_system_score_codex":0.046869084,"about_ca_system_score_gemma":0.025257546,"threshold_uncertainty_score":0.3400606},"labels":[],"label_agreement":null},{"id":"W2128317172","doi":"10.1016/j.jval.2013.08.344","title":"Health and Social Care Resource Use by Individuals with Fragile X Syndrome: Results of Two Delphi Panels","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Victoria; Queen's University; University of British Columbia; Novartis (Canada)","funders":"","keywords":"Confidence interval; Checklist; Delphi method; Demography; Medicine; Proxy (statistics); Psychology; Resource (disambiguation); Statistics; Mathematics; Computer science; Sociology","score_opus":0.09574644426963977,"score_gpt":0.3931382330911975,"score_spread":0.2973917888215577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128317172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968471,0.000042972337,0.00032306803,0.00021474759,0.000010370466,0.0004454293,0.00021080156,0.000002595964,0.0019029012],"genre_scores_gemma":[0.9947061,0.00013535935,0.0014725951,0.00040879077,0.000011317848,0.0015693405,0.00031593817,0.0000068412314,0.0013738971],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9901895,0.006063583,0.0007098088,0.0003967006,0.0009874766,0.0016529113],"domain_scores_gemma":[0.99053067,0.00495821,0.0007246119,0.0003806175,0.0026504546,0.00075545436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012158355,0.00052426144,0.0005741272,0.0014603706,0.002820206,0.0011612993,0.0005243214,0.0012896212,0.0021980372],"category_scores_gemma":[0.016529022,0.00041128293,0.0015310023,0.00089136325,0.0010213645,0.001011654,0.0044288575,0.0013602983,0.0004339925],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022430585,0.0020175152,0.6611029,0.00048346075,0.00025186624,0.0012753174,0.26867738,0.00082918536,0.0051878183,0.00053817005,0.0034491415,0.053944226],"study_design_scores_gemma":[0.00013871361,0.0024874394,0.7183389,0.00023196488,0.00014711436,0.00057929783,0.26734945,0.0012155528,0.0029512928,0.00041642447,0.0060017137,0.0001420852],"about_ca_topic_score_codex":0.00885532,"about_ca_topic_score_gemma":0.010954994,"teacher_disagreement_score":0.012158355,"about_ca_system_score_codex":0.0017426154,"about_ca_system_score_gemma":0.002280807,"threshold_uncertainty_score":0.06430024},"labels":[],"label_agreement":null},{"id":"W2128605658","doi":"10.1016/j.jval.2015.09.2882","title":"Psychiatric Healthcare Utilization and Related Costs In Newly Diagnosed Individuals With Autism Spectrum Disorder (Asd) In Quebec (Canada)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Cohort; Medicine; Autism spectrum disorder; Psychiatry; Pediatrics; Cohort study; Diagnosis code; Health care; Autism; Population; Internal medicine; Environmental health","score_opus":0.04932327497405896,"score_gpt":0.314032585600703,"score_spread":0.26470931062664405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128605658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804843,0.0019790302,0.00008521762,0.0015684986,0.000039566694,0.000057628033,0.012402024,0.000014795926,0.0033687917],"genre_scores_gemma":[0.9929108,0.001201607,0.00017617267,0.00042167102,0.000016777816,0.000027202612,0.00320506,0.0000058614946,0.0020348395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993406,0.0000632434,0.00007485114,0.00007757232,0.00016199963,0.00028171984],"domain_scores_gemma":[0.99752027,0.00015730414,0.0005965068,0.000034683297,0.000883836,0.0008074055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032421632,0.00032240452,0.00040464135,0.0012576171,0.0022922014,0.0015392159,0.0015023357,0.0010091383,0.004259737],"category_scores_gemma":[0.0020833544,0.0003642925,0.0010817678,0.0039782887,0.0005285212,0.00065411255,0.0009364215,0.0013064899,0.00028701275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062310646,0.00005279583,0.99302727,0.000040058454,0.000077269935,0.00016584697,0.0002802168,0.0002747969,0.00004920296,0.0001450866,0.0024533174,0.003371895],"study_design_scores_gemma":[0.000011450244,0.000020788737,0.99701107,0.00006781461,0.00003499607,0.00009346687,0.001487328,0.00050332554,0.000021492398,0.00002617752,0.0007099781,0.0000119535625],"about_ca_topic_score_codex":0.99760914,"about_ca_topic_score_gemma":0.9987324,"teacher_disagreement_score":0.0480975,"about_ca_system_score_codex":0.0480975,"about_ca_system_score_gemma":0.0313802,"threshold_uncertainty_score":0.3489734},"labels":[],"label_agreement":null},{"id":"W2129109417","doi":"10.1016/j.jval.2012.08.1874","title":"PIH2 Duloxetine Use in Pregnancy: A Prospective, Comparative Study of Exposed Infants","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Duloxetine; Obstetrics; Medicine; Pregnancy; Alternative medicine; Biology","score_opus":0.1200776870789199,"score_gpt":0.37089626596797187,"score_spread":0.25081857888905196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129109417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996489,0.00008025373,0.00002039043,0.0000068722707,0.0000018974215,0.00000781896,0.00007320069,6.284133e-7,0.00016009067],"genre_scores_gemma":[0.99935025,0.00019840663,0.000046141067,0.000029025083,0.0000048383486,0.000018699246,0.0001460894,0.0000015936721,0.00020493347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993598,0.000215081,0.000062570296,0.00014835871,0.00007760311,0.00013670717],"domain_scores_gemma":[0.9991786,0.0002353276,0.00023821625,0.00009312816,0.000075655924,0.00017911299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052235427,0.00047457282,0.00056087994,0.0007845328,0.00097299856,0.00072024134,0.00043896833,0.0008793217,0.0019620003],"category_scores_gemma":[0.0021389113,0.00067182025,0.0006745228,0.0011376835,0.00046123026,0.00068868685,0.00076856825,0.000885124,0.00039558197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012380474,0.00064277306,0.99391115,0.000026518006,0.0001724986,0.0005155956,0.0009107167,0.00002003271,0.0007472803,0.000029865849,0.000040208906,0.0017454547],"study_design_scores_gemma":[0.00004464408,0.0016332658,0.9958788,0.000009493677,0.0001080716,0.0006117636,0.0014514406,0.000053324962,0.0001060353,0.000014784525,0.000079942685,0.000008413242],"about_ca_topic_score_codex":0.010140917,"about_ca_topic_score_gemma":0.008138242,"teacher_disagreement_score":0.010140917,"about_ca_system_score_codex":0.00042291527,"about_ca_system_score_gemma":0.00037346652,"threshold_uncertainty_score":0.020163774},"labels":[],"label_agreement":null},{"id":"W2129357788","doi":"10.1016/j.jval.2014.08.514","title":"Clinical Outcomes and Hospital Costs Associated with Empirical Treatment of Hospital-Acquired Pneumonia with Vancomycin or Linezolid in a Chinese Tertiary Care Hospital: A Retrospective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Linezolid; Propensity score matching; Vancomycin; Retrospective cohort study; Odds ratio; Pneumonia; Internal medicine; Logistic regression; Hospital-acquired pneumonia; Intensive care medicine; Staphylococcus aureus","score_opus":0.017916440284492397,"score_gpt":0.3488390113081961,"score_spread":0.3309225710237037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129357788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997004,0.000067182846,0.00001770256,0.000014887784,0.000002329732,0.0000073964907,0.00010942867,6.995591e-7,0.000079882484],"genre_scores_gemma":[0.9995876,0.00005398544,0.000027218117,0.000025345455,0.000007235106,0.0000104155515,0.00023357378,9.848724e-7,0.000053680487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991666,0.00011000603,0.00012618546,0.00021359503,0.000118708725,0.00026493522],"domain_scores_gemma":[0.9982822,0.00018673713,0.0007119294,0.00013445732,0.0002093993,0.00047532172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053317094,0.00064458314,0.0008212634,0.0013905844,0.0011944511,0.0010431678,0.00078655855,0.0008581194,0.0013409919],"category_scores_gemma":[0.0016937274,0.00079971924,0.0013669938,0.0023914818,0.0007670201,0.0009115191,0.00082379306,0.0009821764,0.0001716473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000896546,0.000048981594,0.9992066,0.0000069708794,0.00007388838,0.000161515,0.000097057586,0.000021799222,0.00008686705,0.000009620438,0.00002877953,0.00016822715],"study_design_scores_gemma":[0.000010989978,0.00013505683,0.99852484,0.0000052806236,0.00006806509,0.00027827252,0.00071443047,0.00015855233,0.000036423724,0.000014944917,0.000043220512,0.000009908283],"about_ca_topic_score_codex":0.027069133,"about_ca_topic_score_gemma":0.02422126,"teacher_disagreement_score":0.027069133,"about_ca_system_score_codex":0.0019526548,"about_ca_system_score_gemma":0.002002488,"threshold_uncertainty_score":0.053823113},"labels":[],"label_agreement":null},{"id":"W2129984566","doi":"10.1016/j.jval.2013.08.1875","title":"Economics of Dialysis Dependence Following Acute Kidney Injury (AKI) in the Intensive Care Unit (ICU)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Renal replacement therapy; Dialysis; Medicine; Acute kidney injury; Intensive care unit; Intensive care medicine; Logistic regression; Emergency medicine; Internal medicine","score_opus":0.0585108468849773,"score_gpt":0.3631161792049629,"score_spread":0.3046053323199856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129984566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98873633,0.0015945527,0.0004312366,0.0044723623,0.00003662412,0.000032711512,0.0006402536,0.0000048488796,0.0040510683],"genre_scores_gemma":[0.9991973,0.000326509,0.00007681009,0.000091013855,0.000029954737,0.000004062625,0.000121561636,0.000001597192,0.00015128877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871624,0.00064056984,0.00014427502,0.00007172164,0.00017047417,0.00025668638],"domain_scores_gemma":[0.9901271,0.003570809,0.0034905307,0.00013606314,0.0006634089,0.0020119774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096346886,0.00018781265,0.00030632367,0.0013307774,0.0004550974,0.0016592005,0.00054440496,0.0006498921,0.005031285],"category_scores_gemma":[0.011452202,0.00023740565,0.0006968493,0.0011670057,0.00055780273,0.0014803143,0.0016157996,0.0012465898,0.00014936125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057416124,0.00039581666,0.9769711,0.000072686074,0.00019670566,0.0007940578,0.00016762201,0.0028547707,0.00015350882,0.0075615556,0.0015692842,0.00868885],"study_design_scores_gemma":[0.000043693803,0.0003145345,0.9771081,0.00010765545,0.00009571331,0.00141289,0.0022378075,0.009054046,0.000112299815,0.008465032,0.0010170926,0.000031117568],"about_ca_topic_score_codex":0.011381425,"about_ca_topic_score_gemma":0.013513632,"teacher_disagreement_score":0.011381425,"about_ca_system_score_codex":0.0031984048,"about_ca_system_score_gemma":0.0018178879,"threshold_uncertainty_score":0.023206115},"labels":[],"label_agreement":null},{"id":"W2130332930","doi":"10.1016/s1098-3015(10)70314-4","title":"PIN16 COST-EFFECTIVENESS OF POSACONAZOLE VS. FLUCONAZOLE IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH GRAFT-VERSUS-HOST DISEASE IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Posaconazole; Fluconazole; Medicine; Disease; Host (biology); Antifungal; Fungal disease; Internal medicine; Dermatology; Biology; Amphotericin B; Ecology","score_opus":0.030325303225254396,"score_gpt":0.27378790863176433,"score_spread":0.24346260540650994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130332930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817893,0.009536244,0.00012472415,0.001986334,0.000085663225,0.000110161716,0.0020145897,0.0000127944395,0.0043401457],"genre_scores_gemma":[0.9974141,0.0013147965,0.000095501215,0.00015418518,0.00002462992,0.00001074113,0.00045202987,0.00000255722,0.0005313763],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914145,0.00022657408,0.000075705364,0.00007467922,0.00020171123,0.00027972934],"domain_scores_gemma":[0.9987822,0.0002786547,0.00020493423,0.000020514628,0.0002484519,0.00046524082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062107365,0.0003323507,0.0009984919,0.0005892456,0.00054869364,0.0012755255,0.00070044305,0.00063117215,0.0031058309],"category_scores_gemma":[0.0033803422,0.00022860758,0.0016371438,0.0012814678,0.00039432084,0.00040927765,0.0004244381,0.0008160807,0.00011312839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.118845046,0.0020431732,0.5867867,0.0021315117,0.005137316,0.0015446629,0.00044824427,0.04879363,0.0017919838,0.0033007376,0.012576434,0.21660054],"study_design_scores_gemma":[0.0066525014,0.0070305504,0.9482817,0.00045527497,0.0039958633,0.0005918344,0.0010672024,0.027244186,0.00067841465,0.00051606685,0.003386551,0.000099767814],"about_ca_topic_score_codex":0.89151216,"about_ca_topic_score_gemma":0.92308795,"teacher_disagreement_score":0.108487844,"about_ca_system_score_codex":0.026264928,"about_ca_system_score_gemma":0.01926755,"threshold_uncertainty_score":0.21825343},"labels":[],"label_agreement":null},{"id":"W2131309958","doi":"10.1016/j.jval.2015.01.006","title":"Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Complex Systems and Decision Making","field":"Decision Sciences","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Authority; University of Saskatchewan; University of Calgary; Alberta Health Services","funders":"Agency for Healthcare Research and Quality","keywords":"Modeling and simulation; System dynamics; Computer science; Stakeholder; Dynamic simulation; Management science; Health care; Simulation modeling; Task (project management); Checklist; Discrete event simulation; Process management; Operations research; Systems engineering; Risk analysis (engineering); Simulation; Medicine; Engineering; Artificial intelligence; Psychology","score_opus":0.6122622296140255,"score_gpt":0.6332515898710395,"score_spread":0.020989360257013923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131309958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017147963,0.84222674,0.12552042,0.017185448,0.0021275722,0.001735234,0.000992384,0.00024049019,0.008256892],"genre_scores_gemma":[0.014658814,0.74630815,0.22903198,0.004042934,0.0007865601,0.0022175931,0.0011872865,0.00022651115,0.0015402349],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9777215,0.014512768,0.001872894,0.0008792626,0.004739332,0.00027426548],"domain_scores_gemma":[0.90105224,0.08036955,0.0028267654,0.0017782956,0.013336908,0.0006362076],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06560958,0.0018884597,0.004393354,0.0068200585,0.00077297783,0.0056433026,0.003981315,0.0029398943,0.0045460295],"category_scores_gemma":[0.073230065,0.0014537555,0.0040261075,0.0068684737,0.0012342728,0.0045774523,0.0023580738,0.0057062726,0.0016445786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012622718,0.00019669354,0.00195615,0.03430429,0.0013175869,0.00007382693,0.00033432574,0.010312046,0.0005900972,0.047724884,0.036240604,0.8668233],"study_design_scores_gemma":[0.0005003038,0.0004892937,0.0042220177,0.13802068,0.004415555,0.00034813085,0.0008432479,0.038394418,0.0030385065,0.07978661,0.729578,0.00036320998],"about_ca_topic_score_codex":0.017426247,"about_ca_topic_score_gemma":0.027501754,"teacher_disagreement_score":0.9343904,"about_ca_system_score_codex":0.0061254306,"about_ca_system_score_gemma":0.018462209,"threshold_uncertainty_score":0.34698075},"labels":[],"label_agreement":null},{"id":"W2131719895","doi":"10.1111/j.1524-4733.2008.00361.x","title":"Validity, Feasibility and Acceptability of Time Trade-Off and Standard Gamble Assessments in Health Valuation Studies: A Study in a Multiethnic Asian Population in Singapore","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Interquartile range; Medicine; Visual analogue scale; Wilcoxon signed-rank test; Demography; Time-trade-off; Population; Quality of life (healthcare); Physical therapy; Mann–Whitney U test; Surgery; Internal medicine; Environmental health","score_opus":0.6314274364455043,"score_gpt":0.5205502382811612,"score_spread":0.11087719816434305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131719895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986118,0.00009056901,0.0005249409,0.00009139722,0.0000052878318,0.000049473627,0.000029237666,0.0000011916385,0.00059611624],"genre_scores_gemma":[0.999059,0.00004752805,0.0006419041,0.000031429496,0.000005967914,0.000057402205,0.000051297433,0.000003318358,0.00010221121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9699103,0.022915801,0.002658531,0.0010491575,0.002939297,0.00052684266],"domain_scores_gemma":[0.7672031,0.18010998,0.025649333,0.01353514,0.011112444,0.0023899542],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05878223,0.000585864,0.0008682403,0.0016171334,0.0009698166,0.0030577555,0.0018904004,0.0015735562,0.0019266944],"category_scores_gemma":[0.21248546,0.0005765406,0.0021620102,0.0017564245,0.0026277083,0.0038886098,0.0025408827,0.0024281265,0.00031428452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002300219,0.0010867837,0.9670243,0.00008044452,0.00032847055,0.00032943962,0.014583309,0.0007610246,0.0002895678,0.0015468918,0.00018155234,0.011488012],"study_design_scores_gemma":[0.00031206926,0.004285933,0.9436102,0.0002026315,0.00029658544,0.0013499539,0.020704623,0.02350667,0.0005304692,0.004148138,0.00089596235,0.00015675646],"about_ca_topic_score_codex":0.008347959,"about_ca_topic_score_gemma":0.0054019457,"teacher_disagreement_score":0.9412178,"about_ca_system_score_codex":0.0012064052,"about_ca_system_score_gemma":0.0011783319,"threshold_uncertainty_score":0.31087387},"labels":[],"label_agreement":null},{"id":"W2131783795","doi":"10.1016/j.jval.2013.06.016","title":"ISPOR-SMDM Task Force’s Recommendations for Good Modeling Practices—Reply to Letter to the Editor by Corro Ramos","year":2013,"lang":"en","type":"letter","venue":"Value in Health","topic":"Scientific Computing and Data Management","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Task force; Task (project management); Computer science; Political science; Economics; Management; Public administration","score_opus":0.23778923009139066,"score_gpt":0.4265909927890908,"score_spread":0.18880176269770013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131783795","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004168255,0.00034424083,0.00015886387,0.9823069,0.01631829,0.000012666425,0.00012854481,0.000030289464,0.0006584498],"genre_scores_gemma":[0.0005440514,0.00033948,0.0005807865,0.97783124,0.018840132,0.00006484838,0.00007132322,0.00006507264,0.001663066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9685509,0.010587189,0.0069489363,0.0022747794,0.009209959,0.002428254],"domain_scores_gemma":[0.84408045,0.09096131,0.010872508,0.005139281,0.03758725,0.011359246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.052618906,0.0016506041,0.0034461399,0.002802779,0.0072856,0.011314869,0.0075092446,0.09287216,0.008792148],"category_scores_gemma":[0.20579472,0.0024966353,0.0048641823,0.003907703,0.006714992,0.007705729,0.005039333,0.07743702,0.010464064],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013897774,0.000008520693,0.00010482155,0.000029780895,0.000008931653,0.000059650327,0.00004501977,0.00004544987,0.000010448097,0.0007895714,0.9975414,0.0013424908],"study_design_scores_gemma":[0.00012764541,0.000021839012,0.00076871907,0.0010854704,0.000057948782,0.00014912208,0.0003400737,0.0007662049,0.00016858582,0.009157429,0.9872343,0.00012258602],"about_ca_topic_score_codex":0.035951678,"about_ca_topic_score_gemma":0.041923385,"teacher_disagreement_score":0.09287216,"about_ca_system_score_codex":0.011552142,"about_ca_system_score_gemma":0.031672247,"threshold_uncertainty_score":0.2782787},"labels":[],"label_agreement":null},{"id":"W2131824242","doi":"10.1016/j.jval.2014.03.1137","title":"Lam employment absence and productivity scale (LEAPS): Further validation studies in major depressive disorder","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LEAPS; Cronbach's alpha; Major depressive disorder; Scale (ratio); Psychology; Clinical psychology; Depression (economics); Medicine; Psychiatry; Psychometrics; Mood","score_opus":0.050941792659685174,"score_gpt":0.3495037221209459,"score_spread":0.2985619294612607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131824242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520737,0.00072968326,0.00044165654,0.00021403052,0.000053649113,0.00036359692,0.0009183842,0.000009028086,0.0020626977],"genre_scores_gemma":[0.994517,0.00043053218,0.0011879627,0.00014685885,0.00003796928,0.0004401883,0.002126554,0.000008586964,0.0011043577],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850816,0.00063419534,0.0002107933,0.00011388212,0.00038838078,0.00014454075],"domain_scores_gemma":[0.99557084,0.0016235004,0.00088218105,0.00031304546,0.0012053433,0.00040515693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004347483,0.000654667,0.0009198349,0.0011902228,0.00084746885,0.001247328,0.0010999837,0.0008573732,0.0018293661],"category_scores_gemma":[0.010431186,0.00034836953,0.0010336628,0.0010621586,0.0005587267,0.0008763132,0.001218499,0.0012504965,0.0005623938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016605579,0.0014136728,0.95171595,0.0001870307,0.00034305858,0.00020705315,0.000641954,0.00022618698,0.000993384,0.00018827501,0.0010799936,0.041342966],"study_design_scores_gemma":[0.00024075517,0.00081609737,0.9964101,0.00006058778,0.00012411666,0.00018299851,0.000498024,0.0004909302,0.00017710237,0.00014631715,0.0008401755,0.000012779565],"about_ca_topic_score_codex":0.006635293,"about_ca_topic_score_gemma":0.009847745,"teacher_disagreement_score":0.006635293,"about_ca_system_score_codex":0.0009356893,"about_ca_system_score_gemma":0.0009802876,"threshold_uncertainty_score":0.022992015},"labels":[],"label_agreement":null},{"id":"W2132058335","doi":"10.1111/j.1524-4733.2009.00595.x","title":"Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of British Columbia","funders":"","keywords":"Medicine; Irritable bowel syndrome; Placebo; Relative risk; Confidence interval; Meta-analysis; Internal medicine; Decision analysis; Statistics; Alternative medicine","score_opus":0.3299377744357388,"score_gpt":0.46811849109529247,"score_spread":0.13818071665955367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132058335","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14653823,0.0019761892,0.8088152,0.005767615,0.00015775398,0.0005764975,0.00029067637,0.00014510004,0.035732675],"genre_scores_gemma":[0.90029156,0.0005219138,0.09655895,0.00013072666,0.000054703527,0.00017211628,0.00005376572,0.000038641112,0.002177572],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9904784,0.008143641,0.00018089896,0.00027337237,0.00062436186,0.00029930653],"domain_scores_gemma":[0.9527583,0.04502534,0.0005605906,0.0005508498,0.00086820335,0.00023668319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016403148,0.0012365903,0.001259297,0.0015539452,0.0009520362,0.0044089993,0.0018234348,0.0025459575,0.0050061643],"category_scores_gemma":[0.034618862,0.00065509207,0.0012097849,0.0014451762,0.0022286824,0.0046090297,0.0018585109,0.0031641857,0.00021763549],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032097442,0.0002797791,0.0025369446,0.00021979997,0.00019166927,0.0004927229,0.00043787464,0.6180523,0.0005630744,0.31981277,0.0014419118,0.055650182],"study_design_scores_gemma":[0.00006664137,0.00016982984,0.0006232189,0.000060835548,0.00009791929,0.00016912581,0.00023788908,0.7785693,0.00033481608,0.21749927,0.002118031,0.000053174474],"about_ca_topic_score_codex":0.006880645,"about_ca_topic_score_gemma":0.00690056,"teacher_disagreement_score":0.016403148,"about_ca_system_score_codex":0.0034480353,"about_ca_system_score_gemma":0.0026987086,"threshold_uncertainty_score":0.086749196},"labels":[],"label_agreement":null},{"id":"W2132532466","doi":"10.1046/j.1524-4733.2003.64262.x","title":"Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia; InStream Fisheries Research (Canada)","funders":"","keywords":"Medicine; Reimbursement; Emergency department; Upper gastrointestinal bleeding; Emergency medicine; Endoscopy; Proton-pump inhibitor; Incidence (geometry); General surgery; Intensive care medicine; Surgery; Internal medicine; Health care","score_opus":0.06830799306038579,"score_gpt":0.33606885142421816,"score_spread":0.26776085836383234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132532466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.845736,0.014350962,0.0019332271,0.09283544,0.0014040036,0.00037752293,0.0005884836,0.00013215884,0.042642124],"genre_scores_gemma":[0.99139106,0.0023418714,0.00094571937,0.003545119,0.00084324053,0.00004846541,0.00013035788,0.000011285446,0.0007429166],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99828464,0.0010114386,0.00012859586,0.000050130348,0.00028750443,0.00023764886],"domain_scores_gemma":[0.9933106,0.0032600032,0.0011643488,0.00009936751,0.00074625213,0.0014194367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007673458,0.00050742296,0.0005867033,0.0009440122,0.0009421909,0.001146237,0.00051271415,0.0019865155,0.005103933],"category_scores_gemma":[0.018680338,0.00032822767,0.00074698473,0.00055923744,0.00046686656,0.00081840844,0.00074692356,0.001983067,0.00034682467],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011649135,0.002933977,0.37756196,0.00064492604,0.00083008915,0.019164836,0.0006578556,0.011706603,0.0029388901,0.0031578753,0.04949113,0.51926273],"study_design_scores_gemma":[0.0022632328,0.011656944,0.88852537,0.0015908199,0.0019514746,0.024246214,0.006776987,0.023749301,0.0028941259,0.008533796,0.027525011,0.0002867032],"about_ca_topic_score_codex":0.0078090136,"about_ca_topic_score_gemma":0.010106737,"teacher_disagreement_score":0.0078090136,"about_ca_system_score_codex":0.0022309483,"about_ca_system_score_gemma":0.0025723835,"threshold_uncertainty_score":0.017074406},"labels":[],"label_agreement":null},{"id":"W2132849147","doi":"10.1016/j.jval.2013.03.582","title":"Web-based study of patients and caregivers in the United States and Canada: Perspectives on improvements in stability of factor VIII products for hemophilia A","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Factor IX; Coagulation; Internal medicine","score_opus":0.04403416976802308,"score_gpt":0.3077854249119063,"score_spread":0.2637512551438832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132849147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970919,0.00024473554,0.000027449849,0.0004990644,0.000011400917,0.00008692874,0.0007878931,0.000002074921,0.0012485156],"genre_scores_gemma":[0.99745506,0.0004608267,0.00010444468,0.00056733575,0.000010833192,0.00006279576,0.00062539877,0.000004345711,0.0007088988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981976,0.0003839678,0.00014404919,0.00014967636,0.00048788826,0.00063677],"domain_scores_gemma":[0.993588,0.0007490805,0.0010080686,0.00013163024,0.0028722915,0.0016509818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015884808,0.00039207414,0.00087479816,0.0014053595,0.0065432624,0.002938388,0.0011783509,0.0010888734,0.0028854595],"category_scores_gemma":[0.006360939,0.00044798065,0.00078332686,0.005078083,0.001347395,0.0011997633,0.0021460932,0.0020159387,0.00039649886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027549829,0.0007424025,0.9641489,0.00008739605,0.00007786565,0.00024776516,0.026269093,0.000042328884,0.00006995438,0.00017630143,0.0019608652,0.005901614],"study_design_scores_gemma":[0.000063114094,0.00018133635,0.8873988,0.00011855198,0.000064025764,0.00013269647,0.11002278,0.00019592536,0.00004678827,0.000053977605,0.0016837618,0.00003827005],"about_ca_topic_score_codex":0.9636077,"about_ca_topic_score_gemma":0.9773561,"teacher_disagreement_score":0.03639227,"about_ca_system_score_codex":0.020363722,"about_ca_system_score_gemma":0.025183441,"threshold_uncertainty_score":0.14774978},"labels":[],"label_agreement":null},{"id":"W2133267529","doi":"10.1016/j.jval.2014.03.784","title":"Cost-Efectiveness Analysis Of Insulin Glargine (Lantus) Initiation By Pharmacists In A Canadian Setting: The Rxing Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); University of Alberta","funders":"","keywords":"Medicine; Pharmacist; Insulin glargine; Hypoglycemia; Medical prescription; Insulin; Insulin pen; Type 2 diabetes; Diabetes mellitus; Pharmacy; Emergency medicine; Pediatrics; Internal medicine; Family medicine; Nursing; Endocrinology","score_opus":0.16975047061483284,"score_gpt":0.45061513872849784,"score_spread":0.280864668113665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133267529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092203,0.00245504,0.00019490137,0.0007702341,0.00003171311,0.0005574478,0.0032868662,0.000015464051,0.0017663619],"genre_scores_gemma":[0.99501306,0.0013683131,0.00079670106,0.0004948306,0.000035577552,0.00013480459,0.001661982,0.000009622199,0.00048515905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951403,0.0015445249,0.000283975,0.0004409795,0.0013485249,0.0012417638],"domain_scores_gemma":[0.98924214,0.0030601711,0.0026730923,0.00042203086,0.0020859083,0.0025167817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004415034,0.0017279924,0.0017657216,0.0014860526,0.0022117987,0.0021816937,0.002794624,0.001817604,0.0032418931],"category_scores_gemma":[0.013349966,0.0008788778,0.0051879236,0.004671734,0.0015281294,0.0009918701,0.0014911395,0.002937741,0.0001543513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.075806975,0.008959715,0.8184289,0.0032030344,0.014589263,0.00065258075,0.0012836403,0.012020112,0.0010567212,0.0021708873,0.008790709,0.053037368],"study_design_scores_gemma":[0.019530538,0.012956554,0.9287771,0.000785473,0.012268862,0.0003502264,0.0022772676,0.018374292,0.00050450873,0.0003917086,0.0033952082,0.00038824114],"about_ca_topic_score_codex":0.9551084,"about_ca_topic_score_gemma":0.9639861,"teacher_disagreement_score":0.07404087,"about_ca_system_score_codex":0.07404087,"about_ca_system_score_gemma":0.06157538,"threshold_uncertainty_score":0.53720665},"labels":[],"label_agreement":null},{"id":"W2133828904","doi":"10.1016/j.jval.2014.03.1668","title":"Using A Crossover Study Design For Early Hospital-Based Health Technology Assessment: The Cost-Effectiveness Of Clinic-Based Chloral Hydrate Sedation Versus General Anaesthesia For Paediatric Ophthalmological Procedures","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chloral hydrate; Sedation; Cohort; Emergency medicine; Adverse effect; Anesthesia; Internal medicine","score_opus":0.20055795121420958,"score_gpt":0.44404342215727355,"score_spread":0.24348547094306397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133828904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94874424,0.0028581664,0.014693819,0.0008028725,0.0039542294,0.02482341,0.0018008885,0.00023742307,0.0020849213],"genre_scores_gemma":[0.9536807,0.0004817558,0.014306954,0.0008217278,0.0008745194,0.026868612,0.0008822976,0.000059429443,0.002024094],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9692322,0.023412641,0.0018380877,0.002911088,0.0013092608,0.0012966623],"domain_scores_gemma":[0.9566798,0.032107797,0.0043400694,0.003599928,0.0018048914,0.0014674264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023139412,0.0034697442,0.006743977,0.0014104451,0.00088190066,0.0032092596,0.002171348,0.005668994,0.008863732],"category_scores_gemma":[0.042002052,0.0018131281,0.009511622,0.0013652354,0.0025046244,0.003430085,0.0014407857,0.008807125,0.00080459146],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97178125,0.015534989,0.0014272641,0.0004297899,0.003378964,0.000056082117,0.0001399505,0.0010395136,0.0008950691,0.0006213399,0.00033421625,0.0043615485],"study_design_scores_gemma":[0.75907695,0.21882889,0.00613367,0.00009610723,0.0048456076,0.00004586775,0.00008428602,0.007260046,0.0013336482,0.0012288563,0.00093464216,0.00013139733],"about_ca_topic_score_codex":0.0019443164,"about_ca_topic_score_gemma":0.0010438955,"teacher_disagreement_score":0.023139412,"about_ca_system_score_codex":0.002093174,"about_ca_system_score_gemma":0.0028269205,"threshold_uncertainty_score":0.122374415},"labels":[],"label_agreement":null},{"id":"W2134384347","doi":"10.1016/j.jval.2013.08.792","title":"An Analysis of Priscription and Reimbursement of Potentially Inappropriate Medication (PIM) in a German Practice Network","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Reimbursement; Medicine; German; Quarter (Canadian coin); Health care; Family medicine; Pediatrics; Emergency medicine; Pharmacology","score_opus":0.06302499118083692,"score_gpt":0.41393594256460786,"score_spread":0.35091095138377093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134384347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956411,0.0007968869,0.0003346109,0.00045221415,0.0000041622907,0.00004288639,0.0014207793,0.0000050328285,0.0013022097],"genre_scores_gemma":[0.9983108,0.0002776141,0.00024604253,0.0001273161,0.0000060224374,0.000026431415,0.00081717863,0.0000043042555,0.00018425383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9904255,0.004639344,0.00097152585,0.0010774998,0.0017021168,0.0011840174],"domain_scores_gemma":[0.9688465,0.013371297,0.0116650555,0.00095312326,0.0023939728,0.0027700819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048573227,0.00028334878,0.00046214476,0.0040896814,0.00069783756,0.0023119377,0.0008463108,0.00089475804,0.0018516697],"category_scores_gemma":[0.021761663,0.0003581697,0.0009126581,0.007427859,0.0007185822,0.0010634566,0.0017718897,0.00069587247,0.00020088958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022872949,0.000089354355,0.9911458,0.00011131502,0.0002574558,0.00021769122,0.0010839563,0.00055049337,0.00009513727,0.0007457877,0.0005180311,0.0049563525],"study_design_scores_gemma":[0.00001632528,0.00013285207,0.9944887,0.00009223762,0.00020579061,0.00023614179,0.0017081561,0.0018099758,0.000086231026,0.00011109122,0.0010984299,0.00001409698],"about_ca_topic_score_codex":0.08154655,"about_ca_topic_score_gemma":0.085587166,"teacher_disagreement_score":0.08154655,"about_ca_system_score_codex":0.0067630312,"about_ca_system_score_gemma":0.0045469427,"threshold_uncertainty_score":0.16214377},"labels":[],"label_agreement":null},{"id":"W2134553529","doi":"10.1016/j.jval.2015.09.1195","title":"Economic Evaluations Of Glioblastoma","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Economic evaluation; Temozolomide; Glioblastoma; Medicine; Time horizon; MEDLINE; Bevacizumab; Carmustine; Oncology; Actuarial science; Medical physics; Internal medicine; Chemotherapy; Pathology; Mathematics; Cyclophosphamide","score_opus":0.480746801554645,"score_gpt":0.4682818930161314,"score_spread":0.01246490853851362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134553529","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6535577,0.17665681,0.012260838,0.032173567,0.0013003577,0.00069106603,0.008875786,0.000059655853,0.11442422],"genre_scores_gemma":[0.99013925,0.006513605,0.0008748962,0.00036141838,0.00016167885,0.00009403566,0.0008733814,0.00000858771,0.0009731058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98394245,0.013109419,0.0006147889,0.00022271583,0.0016512154,0.00045950062],"domain_scores_gemma":[0.9738635,0.017013537,0.0033361453,0.0007462985,0.003719892,0.0013205827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016463272,0.00045817925,0.0009167774,0.002111179,0.00029942303,0.0019121851,0.00037685534,0.0006520607,0.0028377858],"category_scores_gemma":[0.08116522,0.00012602097,0.0013510282,0.0023858207,0.0007872412,0.0012323551,0.00079633377,0.001154064,0.00019064039],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023735818,0.0013736563,0.12382627,0.004436213,0.008099979,0.00047516904,0.0006529159,0.098236464,0.0005497673,0.15118696,0.044695415,0.54273134],"study_design_scores_gemma":[0.0027426733,0.012067123,0.27240404,0.010129322,0.011271487,0.0025411549,0.002804322,0.16972946,0.0034422819,0.33880696,0.17360783,0.00045339728],"about_ca_topic_score_codex":0.0047529275,"about_ca_topic_score_gemma":0.004449454,"teacher_disagreement_score":0.016463272,"about_ca_system_score_codex":0.0052478174,"about_ca_system_score_gemma":0.00235345,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2135361259","doi":"10.1016/j.jval.2013.03.217","title":"Perceptions of individuals living with spinal cord injury toward preference-based quality of life instruments: A qualitative exploration","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Praxis Spinal Cord Institute; Sunnybrook Health Science Centre; Centre for Advancing Health Outcomes; Simon Fraser University","funders":"","keywords":"Focus group; Nonprobability sampling; Context (archaeology); Qualitative research; Health Utilities Index; Quality of life (healthcare); Population; Medicine; Applied psychology; Psychology; Preference; Spinal cord injury; Medical education; Nursing; Health related quality of life; Environmental health; Psychiatry; Marketing; Sociology; Geography; Social science; Disease; Pathology; Business","score_opus":0.3870599605776871,"score_gpt":0.49153877063198487,"score_spread":0.10447881005429777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135361259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964449,0.00021582092,0.00070463464,0.0009338191,0.000021922075,0.00010104505,0.000110281435,0.000002859735,0.0014647885],"genre_scores_gemma":[0.99774915,0.0002517164,0.00055838935,0.0005573072,0.0000060778852,0.0001596976,0.000047405705,0.000005525756,0.00066471857],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9900122,0.0072992337,0.00040998912,0.0003368287,0.00084787735,0.0010939447],"domain_scores_gemma":[0.97918093,0.015734753,0.0013949353,0.0003552332,0.0019888217,0.0013453667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015214891,0.000421058,0.00073239306,0.0016449022,0.00665488,0.0040638587,0.0011571479,0.0013237995,0.0027589563],"category_scores_gemma":[0.026048308,0.00057144015,0.0006256495,0.0016276195,0.0056527555,0.0027299244,0.0049182824,0.0032196916,0.000194938],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045234647,0.00007313097,0.01019622,0.000105094696,0.000010393089,0.00019919557,0.985007,0.000023916178,0.00043409338,0.0005983089,0.00015558288,0.0031518277],"study_design_scores_gemma":[0.0000044493077,0.000046639037,0.0031081487,0.000075159805,0.000004703342,0.000096929914,0.9954248,0.00003862934,0.00011875649,0.00015561226,0.0009145176,0.000011655969],"about_ca_topic_score_codex":0.013826117,"about_ca_topic_score_gemma":0.02092525,"teacher_disagreement_score":0.015214891,"about_ca_system_score_codex":0.0050130803,"about_ca_system_score_gemma":0.0050694365,"threshold_uncertainty_score":0.08046502},"labels":[],"label_agreement":null},{"id":"W2135772515","doi":"10.1016/j.jval.2013.03.694","title":"Economic Evaluations Of Companion Diagnostics In Cancer Therapy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Breast cancer; Companion diagnostic; Colorectal cancer; Lung cancer; Oncology; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.7216186709408293,"score_gpt":0.6334271941979627,"score_spread":0.08819147674286665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135772515","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28491062,0.20858741,0.37135237,0.053984843,0.0036420133,0.0042311437,0.002287255,0.0003365927,0.07066771],"genre_scores_gemma":[0.96283394,0.010093347,0.02241341,0.0012099119,0.0006093014,0.00088834245,0.00022823496,0.000045239573,0.001678441],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8781843,0.116448075,0.0012851164,0.000821826,0.0027690271,0.0004916778],"domain_scores_gemma":[0.64312804,0.34014517,0.0076268013,0.00426215,0.003252575,0.0015851951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08551146,0.0015645913,0.0036197552,0.0016130797,0.00044721717,0.00370131,0.0011416,0.0025795875,0.0069813896],"category_scores_gemma":[0.28489473,0.00057738245,0.0018269201,0.0014381633,0.002933745,0.003550724,0.0016739522,0.0036605105,0.000292979],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04422697,0.001719938,0.0100422455,0.006619445,0.0056105563,0.000334451,0.00041978163,0.2600387,0.0005546336,0.32094446,0.013442913,0.33604595],"study_design_scores_gemma":[0.0066037863,0.007526977,0.005649665,0.0037170025,0.0035884292,0.00043988327,0.00035702795,0.41672924,0.0011481489,0.53592646,0.018179044,0.00013426536],"about_ca_topic_score_codex":0.0011776093,"about_ca_topic_score_gemma":0.00084167696,"teacher_disagreement_score":0.08551146,"about_ca_system_score_codex":0.004281031,"about_ca_system_score_gemma":0.0042658276,"threshold_uncertainty_score":0.45223325},"labels":[],"label_agreement":null},{"id":"W2135877248","doi":"10.1016/j.jval.2013.08.1823","title":"Health Care Resources Utilization in Alzheimer’s Disease: An Analysis with the Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Université de Montréal","funders":"","keywords":"Medicine; Rivastigmine; Reimbursement; Donepezil; Galantamine; Health care; Dementia; Disease; Emergency medicine; Family medicine; Pediatrics; Gerontology; Internal medicine","score_opus":0.14409761779369384,"score_gpt":0.4352954344856202,"score_spread":0.29119781669192635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135877248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8000242,0.0018461406,0.0004368462,0.0010408604,0.000034428427,0.0004365982,0.19304347,0.00007206018,0.0030653656],"genre_scores_gemma":[0.9130346,0.00096909294,0.0009946787,0.0004663397,0.000032163905,0.00046343493,0.08232616,0.00003590002,0.0016774723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961559,0.00070824625,0.0005413116,0.000547014,0.0014628283,0.0005847829],"domain_scores_gemma":[0.98240834,0.003054626,0.004186225,0.000790746,0.007925543,0.0016345715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027093892,0.0006377356,0.0012523618,0.0054727485,0.0016466288,0.002034723,0.002224175,0.00080965593,0.0034615363],"category_scores_gemma":[0.017616797,0.00052202825,0.0018446941,0.020524768,0.00047749552,0.00092351186,0.001349248,0.0010886773,0.00049230555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022105963,0.0000652492,0.9867486,0.00010166236,0.00041083473,0.000046878118,0.00014233873,0.0005247215,0.000035170648,0.00010099673,0.0078934785,0.0037090245],"study_design_scores_gemma":[0.000046644305,0.000023051596,0.99589044,0.000059775044,0.00011789486,0.000042100615,0.00021102649,0.0018345852,0.00003643296,0.000018850047,0.0017041069,0.000015062618],"about_ca_topic_score_codex":0.988371,"about_ca_topic_score_gemma":0.9891928,"teacher_disagreement_score":0.038500465,"about_ca_system_score_codex":0.038500465,"about_ca_system_score_gemma":0.032810286,"threshold_uncertainty_score":0.27934176},"labels":[],"label_agreement":null},{"id":"W2136043478","doi":"10.1016/j.jval.2015.09.2210","title":"Economic Evaluations of Treatments for Inflammatory Bowel Diseases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Infliximab; Inflammatory Bowel Diseases; MEDLINE; Systematic review; Inflammatory bowel disease; Intensive care medicine; Internal medicine; Disease","score_opus":0.032419110136495975,"score_gpt":0.32587812726136395,"score_spread":0.293459017124868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136043478","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44587702,0.3451869,0.024568437,0.04433473,0.0031762533,0.0027927957,0.0072706,0.00013278106,0.12666044],"genre_scores_gemma":[0.9803171,0.014306509,0.0024603612,0.00070167973,0.0002958593,0.00034617475,0.00040742973,0.000010889366,0.0011539356],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9692104,0.026814464,0.000759012,0.00029370957,0.0024396472,0.00048288426],"domain_scores_gemma":[0.95097816,0.042264886,0.003112042,0.00075403985,0.0016757561,0.001215088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016710328,0.0007842641,0.0018199059,0.001626316,0.00032766146,0.002180247,0.0005735603,0.0013646394,0.006136513],"category_scores_gemma":[0.07250394,0.0002462277,0.0019979647,0.0014622756,0.0010985683,0.0012476578,0.00080979406,0.0020455078,0.00021321968],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10103841,0.0029504814,0.030430602,0.010667248,0.015006995,0.0003932784,0.00034064963,0.096458085,0.0010690906,0.08629188,0.019142548,0.63621074],"study_design_scores_gemma":[0.042054385,0.05605592,0.14606965,0.027334448,0.035393666,0.002240482,0.0031711855,0.2124897,0.0045487434,0.31739575,0.15269189,0.0005542164],"about_ca_topic_score_codex":0.0020119587,"about_ca_topic_score_gemma":0.0017641229,"teacher_disagreement_score":0.016710328,"about_ca_system_score_codex":0.003430988,"about_ca_system_score_gemma":0.0023968641,"threshold_uncertainty_score":0.08837372},"labels":[],"label_agreement":null},{"id":"W2136254236","doi":"10.1016/j.jval.2012.08.1692","title":"PDB49 Cost and Health Care Resources Utilization in the Management of Cushing'S Disease: An Analysis Based on the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Medical diagnosis; Psychological intervention; Retrospective cohort study; Cushing's disease; Health care; Disease; Cohort; Intervention (counseling); Emergency medicine; Health plan; Pediatrics; Internal medicine; Nursing; Pathology","score_opus":0.09272178615220884,"score_gpt":0.3662852407929567,"score_spread":0.2735634546407479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136254236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7861751,0.0016397478,0.0004106569,0.00040354376,0.00002020821,0.00010285582,0.20913264,0.00007036549,0.0020448505],"genre_scores_gemma":[0.87024164,0.00066933635,0.0006917164,0.00018800424,0.000035099456,0.00018165815,0.12750292,0.000038310875,0.0004512913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971571,0.0010194501,0.0005200797,0.00045302237,0.0006300657,0.00022039376],"domain_scores_gemma":[0.98451126,0.008497732,0.004284919,0.00085907074,0.0012799542,0.0005670267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023143895,0.00034625077,0.0012486414,0.004356419,0.0002590177,0.0012961599,0.0010408281,0.00062215433,0.005332304],"category_scores_gemma":[0.016195895,0.00032163365,0.002283606,0.008931887,0.00024337435,0.0008241228,0.0008020049,0.0007121086,0.00079196726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027506906,0.00016817576,0.972693,0.00040682527,0.0020498792,0.00015274173,0.00006803805,0.0030765492,0.000114748145,0.00048038838,0.008205508,0.009833462],"study_design_scores_gemma":[0.00033617625,0.00021033963,0.98701525,0.00009117295,0.0007818736,0.0004856475,0.0002367735,0.0068000425,0.00013375432,0.00017686428,0.0036993693,0.00003278469],"about_ca_topic_score_codex":0.035319936,"about_ca_topic_score_gemma":0.015740352,"teacher_disagreement_score":0.9646801,"about_ca_system_score_codex":0.0016830877,"about_ca_system_score_gemma":0.0012715529,"threshold_uncertainty_score":0.070228696},"labels":[],"label_agreement":null},{"id":"W2136665547","doi":"10.1111/j.1524-4733.2008.00500.x","title":"Health-Care Costs of Pediatric Clients Developing Adverse Events during Treatment with Antipsychotics","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medicaid; Antipsychotic; Emergency medicine; Adverse effect; Medical prescription; Pharmacy; Retrospective cohort study; Emergency department; Medical record; Health care; Psychiatry; Pediatrics; Schizophrenia (object-oriented programming); Family medicine; Internal medicine","score_opus":0.04199900881760675,"score_gpt":0.35390610984123855,"score_spread":0.3119071010236318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136665547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99489427,0.0010196627,0.00005680419,0.00053321954,0.000009147436,0.000014079467,0.001173163,0.000005961064,0.0022937679],"genre_scores_gemma":[0.99818075,0.0007591502,0.00012992421,0.00006275311,0.00001470084,0.000010771152,0.00045404956,0.0000024923488,0.00038527278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994172,0.00018992697,0.000065254164,0.000034077402,0.00012523106,0.0001683337],"domain_scores_gemma":[0.9977586,0.00062054495,0.0009857304,0.000039181366,0.00019613864,0.00039983806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003323545,0.00016343557,0.000305367,0.00054112787,0.00047010527,0.0006921303,0.00038885933,0.00052675465,0.0033247434],"category_scores_gemma":[0.0049326695,0.00028968707,0.001027808,0.0007321851,0.00014905806,0.0004158403,0.00048659922,0.0011020163,0.00018130259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046534472,0.00015137623,0.9800607,0.00004693457,0.0001735729,0.00067315483,0.00018661779,0.0006743207,0.0001817123,0.000369326,0.0008839538,0.01613306],"study_design_scores_gemma":[0.0000308121,0.00020892387,0.9948613,0.000055918845,0.0001731016,0.0016903094,0.0007011618,0.0014314126,0.00014440755,0.00013704633,0.00055704,0.000008601364],"about_ca_topic_score_codex":0.06596425,"about_ca_topic_score_gemma":0.088116474,"teacher_disagreement_score":0.06596425,"about_ca_system_score_codex":0.0032939718,"about_ca_system_score_gemma":0.0017149044,"threshold_uncertainty_score":0.13116062},"labels":[],"label_agreement":null},{"id":"W2136940899","doi":"10.1016/j.jval.2014.08.1325","title":"Cost-Effectiveness Of Mirabegron 50mg Compared To Tolterodine Er 4mg In The Treatment Of Patients With Overactive Bladder In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Mirabegron; Overactive bladder; Tolterodine; Urology; Medicine; Alternative medicine","score_opus":0.07046665692339814,"score_gpt":0.3508326581457938,"score_spread":0.28036600122239563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136940899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702085,0.019122016,0.00009430119,0.0035410146,0.0001221742,0.00022185448,0.0018445723,0.000026597554,0.0048190253],"genre_scores_gemma":[0.99551433,0.0029390939,0.00018816559,0.00031215633,0.000037321206,0.000022499424,0.000442974,0.0000042480387,0.00053930376],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99915266,0.00028196274,0.00007584019,0.00007975196,0.00019599841,0.00021369147],"domain_scores_gemma":[0.99861264,0.00030030616,0.00028024838,0.00002037755,0.00017318208,0.00061326957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059303484,0.0003275206,0.0012317894,0.00061835704,0.00067465816,0.0011359,0.0007515398,0.0007276062,0.003857045],"category_scores_gemma":[0.003562641,0.00032516386,0.0021111881,0.0011680779,0.0005523821,0.00041525718,0.0005139653,0.0010738831,0.00011526703],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40565163,0.00483145,0.22506796,0.0058894237,0.009274598,0.001141595,0.0007356719,0.025380107,0.0029234474,0.00310977,0.01705289,0.2989415],"study_design_scores_gemma":[0.07150772,0.026131226,0.8386985,0.002543736,0.014949284,0.0007851374,0.0022607062,0.031181328,0.001083501,0.00095609465,0.009608707,0.0002939803],"about_ca_topic_score_codex":0.8307252,"about_ca_topic_score_gemma":0.91685086,"teacher_disagreement_score":0.1692748,"about_ca_system_score_codex":0.030125141,"about_ca_system_score_gemma":0.020715624,"threshold_uncertainty_score":0.3405434},"labels":[],"label_agreement":null},{"id":"W2136950115","doi":"10.1111/j.1524-4733.2006.00139.x","title":"A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":633,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Checklist; Consistency (knowledge bases); Retrospective cohort study; Compliance (psychology); Persistence (discontinuity); Pharmacoeconomics; Medicine; Database; Family medicine; Computer science; Psychology; Intensive care medicine; Internal medicine","score_opus":0.3757732714154876,"score_gpt":0.4425560263490459,"score_spread":0.06678275493355829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136950115","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08165871,0.008392846,0.5976685,0.0126941865,0.002843519,0.19048104,0.06374023,0.026818693,0.01570233],"genre_scores_gemma":[0.039757993,0.0022250186,0.8050738,0.0013925981,0.0003096952,0.1339451,0.01440084,0.0008242137,0.0020707652],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7530007,0.08035106,0.1486496,0.0022848935,0.014347176,0.0013666747],"domain_scores_gemma":[0.45865363,0.3218721,0.05473953,0.054253805,0.10632423,0.004156631],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16475993,0.0025100077,0.0038193185,0.021920731,0.0030930922,0.0030783273,0.0026470805,0.0023046986,0.005959221],"category_scores_gemma":[0.27056986,0.0031001093,0.004519194,0.010890713,0.001201204,0.0041478267,0.0047270814,0.0032030176,0.0029366391],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038669738,0.001598339,0.09026793,0.033916105,0.0020936872,0.0022616351,0.007945521,0.0018987489,0.0114793945,0.0062536933,0.19373743,0.64468044],"study_design_scores_gemma":[0.0052946904,0.004657999,0.23987845,0.05011325,0.00418888,0.007840178,0.012567185,0.0145782605,0.03590122,0.009171851,0.6145623,0.0012457197],"about_ca_topic_score_codex":0.0013991406,"about_ca_topic_score_gemma":0.0031422086,"teacher_disagreement_score":0.83524007,"about_ca_system_score_codex":0.001940818,"about_ca_system_score_gemma":0.01094287,"threshold_uncertainty_score":0.8713442},"labels":[],"label_agreement":null},{"id":"W2137204969","doi":"10.1016/j.jval.2014.03.1472","title":"Methodological challenges in calculation of daily average consumption (DACON) for GLP-1 receptor agonist injectables from claims data","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Liraglutide; Medicine; Type 2 diabetes; Dosing; Internal medicine; Diabetes mellitus; Pediatrics; Animal science; Urology; Endocrinology","score_opus":0.40653566832348687,"score_gpt":0.41289773706279104,"score_spread":0.006362068739304172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137204969","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040559992,0.011925742,0.8971761,0.017059434,0.0045290445,0.0037165813,0.011110248,0.001111269,0.012811633],"genre_scores_gemma":[0.34205362,0.0031929149,0.62833005,0.008052984,0.002246521,0.006970314,0.0060810368,0.0009101994,0.0021624328],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.51996446,0.37945616,0.044241,0.016412294,0.038669337,0.0012568501],"domain_scores_gemma":[0.24634525,0.65786034,0.021880273,0.037963986,0.034744646,0.0012054964],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3329265,0.0014367178,0.00291477,0.0051391795,0.002192968,0.012176392,0.008216141,0.0022204416,0.003128707],"category_scores_gemma":[0.7208648,0.00156506,0.0030478465,0.009805292,0.0035332043,0.0040363926,0.005948999,0.0073687546,0.0016714394],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022446339,0.0007532864,0.14913443,0.013834253,0.01132734,0.0011523946,0.008677293,0.030457446,0.0022042794,0.1658543,0.07540442,0.53895605],"study_design_scores_gemma":[0.0010237277,0.0007619814,0.10284648,0.010347097,0.002573707,0.0027191942,0.006849042,0.13262662,0.005945661,0.5483139,0.18538347,0.00060914113],"about_ca_topic_score_codex":0.022525184,"about_ca_topic_score_gemma":0.014233996,"teacher_disagreement_score":0.3329265,"about_ca_system_score_codex":0.003042875,"about_ca_system_score_gemma":0.006104114,"threshold_uncertainty_score":0.8226204},"labels":[],"label_agreement":null},{"id":"W2138260098","doi":"10.1016/j.jval.2013.03.275","title":"Underestimation of uncertainties in health utilities dervied from mapping algorithms involving health-related quality of life measures: statistical explanations and potential remedies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Energy and Environment Impacts","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Public Health Ontario; University of Toronto","funders":"","keywords":"Estimator; Variance (accounting); Statistics; Parametric statistics; Mean squared error; Ordinary least squares; Minimum-variance unbiased estimator; Mathematics; Econometrics; Computer science; Algorithm","score_opus":0.10446381595069708,"score_gpt":0.29590750768574137,"score_spread":0.19144369173504427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138260098","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33361486,0.0029776297,0.64569026,0.0074467505,0.00047136756,0.00030309317,0.0020248042,0.0010059889,0.0064652013],"genre_scores_gemma":[0.95336443,0.0003283805,0.043681677,0.00086938974,0.00022753325,0.00008181696,0.00080377655,0.00014935891,0.00049373286],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9484189,0.03150152,0.0045930687,0.006313296,0.008025035,0.0011481625],"domain_scores_gemma":[0.571004,0.35512513,0.024786973,0.031246543,0.017268168,0.0005692085],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08575308,0.0012438376,0.0013612781,0.0024356954,0.00086892355,0.0045466535,0.0019084329,0.0014921784,0.0014327167],"category_scores_gemma":[0.36270675,0.00084856007,0.0018636937,0.0038814482,0.0017790316,0.0044842213,0.002517902,0.002782683,0.00025075607],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013332651,0.00032514508,0.4989145,0.0010954628,0.0028112582,0.00093431753,0.0026795797,0.24668156,0.0033258076,0.068972856,0.006228855,0.16669746],"study_design_scores_gemma":[0.00015399889,0.0004101091,0.23786576,0.0009228727,0.0010461955,0.0015523394,0.0014460504,0.5632517,0.015828699,0.1685646,0.008630221,0.00032746614],"about_ca_topic_score_codex":0.0059798257,"about_ca_topic_score_gemma":0.0045180805,"teacher_disagreement_score":0.9142469,"about_ca_system_score_codex":0.0015040225,"about_ca_system_score_gemma":0.0015113637,"threshold_uncertainty_score":0.45351106},"labels":[],"label_agreement":null},{"id":"W2138328847","doi":"10.1016/s1098-3015(10)73104-1","title":"VA2 COST EFFECTIVENESS ANALYSIS OF THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Conjugate vaccine; Haemophilus influenzae; Pneumococcal conjugate vaccine; Medicine; Conjugate; Virology; Haemophilus; Pneumococcal disease; Microbiology; Streptococcus pneumoniae; Biology; Immunization; Immunology; Genetics; Antigen; Bacteria; Mathematics","score_opus":0.024455562045806914,"score_gpt":0.29797455336864515,"score_spread":0.27351899132283825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138328847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94456065,0.015971016,0.0010882935,0.00255351,0.0001998971,0.00070062256,0.02460737,0.00008134331,0.01023742],"genre_scores_gemma":[0.98921764,0.0030446094,0.0007423661,0.00039757483,0.000034636818,0.00010349503,0.003902325,0.000017984536,0.0025393157],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.997134,0.00095640204,0.00013897034,0.00020063171,0.0007425817,0.0008274831],"domain_scores_gemma":[0.9971476,0.0009047081,0.00027824324,0.00006455996,0.0010061712,0.0005986737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023147154,0.0011529361,0.0019136328,0.0016606466,0.00087318046,0.0020364183,0.0018220971,0.00093106495,0.0043197917],"category_scores_gemma":[0.007566459,0.0006865917,0.0040972354,0.0034063642,0.0006000995,0.00059672276,0.0008383276,0.0014128872,0.00017398834],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.093518294,0.0021920477,0.24663806,0.005089996,0.018445332,0.0014866823,0.00035845037,0.49691176,0.0024832329,0.008621244,0.028550673,0.09570415],"study_design_scores_gemma":[0.017715931,0.0101172915,0.6208638,0.0010985935,0.018136805,0.0008294655,0.0015332701,0.3099114,0.001899436,0.0020035256,0.015486735,0.0004037674],"about_ca_topic_score_codex":0.98766685,"about_ca_topic_score_gemma":0.983352,"teacher_disagreement_score":0.099372186,"about_ca_system_score_codex":0.099372186,"about_ca_system_score_gemma":0.060603425,"threshold_uncertainty_score":0.720999},"labels":[],"label_agreement":null},{"id":"W2138378555","doi":"10.1016/j.jval.2011.02.637","title":"PIN5 THE PREVALENCE AND ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN CANADA AND LATIN AMERICA: A SYSTEMATIC REVIEW","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Latin Americans; Medicine; Population; Environmental health; Systematic review; Prevalence; MEDLINE; Demography; Geography; Political science","score_opus":0.08042740352937418,"score_gpt":0.28116001817932224,"score_spread":0.20073261464994807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138378555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013179178,0.9963387,0.00005780058,0.00034451377,0.00007140435,0.00008986338,0.001370053,0.000004437668,0.00040525544],"genre_scores_gemma":[0.01725342,0.98131585,0.00034063842,0.0003211718,0.000043769363,0.0000768509,0.0004961197,0.000003448441,0.00014870269],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99668854,0.0007352032,0.00088468764,0.00027902584,0.0012211466,0.00019136423],"domain_scores_gemma":[0.9844074,0.007676514,0.0034136781,0.0002555324,0.0037593925,0.0004873518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006338876,0.0010449239,0.0049989917,0.011788948,0.0007823499,0.0029817573,0.0019081351,0.0013563721,0.004108823],"category_scores_gemma":[0.033773754,0.00073211984,0.0059445705,0.019721422,0.0009939389,0.0012051959,0.0015510243,0.0011248646,0.00018673697],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004885706,0.000038756465,0.020770999,0.7978033,0.032271147,0.00021092122,0.00028503616,0.00057443033,0.00016227648,0.001031808,0.010849284,0.1355135],"study_design_scores_gemma":[0.0005025038,0.00016358483,0.08659871,0.6752022,0.16124973,0.0006036968,0.0006986902,0.00032361085,0.00024014889,0.000979799,0.07331079,0.00012658867],"about_ca_topic_score_codex":0.5238962,"about_ca_topic_score_gemma":0.73476875,"teacher_disagreement_score":0.47610378,"about_ca_system_score_codex":0.015486371,"about_ca_system_score_gemma":0.06120835,"threshold_uncertainty_score":0.9578153},"labels":[],"label_agreement":null},{"id":"W2138660129","doi":"10.1111/j.1524-4733.2009.00583.x","title":"Relationship between Adherence Level to Statins, Clinical Issues and Health-Care Costs in Real-Life Clinical Setting","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dyslipidemia; Confidence interval; Internal medicine; Odds ratio; Cohort; Coronary artery disease; Health care; Statin; Disease; Physical therapy; Emergency medicine; Intensive care medicine","score_opus":0.3191217327825773,"score_gpt":0.5003246325631929,"score_spread":0.1812028997806156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138660129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889356,0.00015530249,0.00005164326,0.0002228009,0.0000074918216,0.000007014442,0.00019431445,0.000002599979,0.00046528096],"genre_scores_gemma":[0.9996176,0.00003777303,0.00005815733,0.000037235033,0.000013094144,0.000005039853,0.00015093051,0.0000015583789,0.00007850967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997726,0.0010751154,0.0004110373,0.00018223499,0.00030263624,0.00030301374],"domain_scores_gemma":[0.9691611,0.0141983265,0.010987312,0.0007595393,0.0014699843,0.0034237225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018879853,0.00020296703,0.0006192503,0.00097137986,0.00059843686,0.0017742654,0.0005145648,0.0012161968,0.0028327182],"category_scores_gemma":[0.026176654,0.00030049085,0.00073272997,0.0015361528,0.0004678457,0.00089325756,0.00070783054,0.0023527907,0.00025211196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023823725,0.0001445525,0.9986312,0.0000068530544,0.000089674686,0.000041316915,0.000039614824,0.00010193153,0.0000221506,0.000019534398,0.000056828692,0.000608015],"study_design_scores_gemma":[0.000011683706,0.00023447374,0.9983542,0.000004758204,0.000041465457,0.00015096851,0.00020223929,0.00085480436,0.000014861428,0.00005889862,0.00006277264,0.000009006668],"about_ca_topic_score_codex":0.005822283,"about_ca_topic_score_gemma":0.007116814,"teacher_disagreement_score":0.005822283,"about_ca_system_score_codex":0.0007600703,"about_ca_system_score_gemma":0.00066670007,"threshold_uncertainty_score":0.011576772},"labels":[],"label_agreement":null},{"id":"W2139092547","doi":"10.1016/j.jval.2012.08.1172","title":"PSU14 Economic Impact of Scoliosis in Canada: A RAMQ Database Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Scoliosis diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Scoliosis; Database; Business; Computer science; Medicine; Surgery","score_opus":0.06186934127925453,"score_gpt":0.36039921479546216,"score_spread":0.29852987351620763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139092547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6620323,0.0021563368,0.0001713719,0.0008637101,0.000020799964,0.00027918833,0.33029747,0.000053427517,0.0041253394],"genre_scores_gemma":[0.8762642,0.0020872706,0.0005492897,0.00031659775,0.000023385353,0.00017437064,0.11798931,0.000030616062,0.002564887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699545,0.0002456968,0.00031038027,0.00027853076,0.0014794668,0.0006903979],"domain_scores_gemma":[0.9907047,0.0010948466,0.0018057459,0.0003616041,0.0049444474,0.0010886588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014347804,0.00061627803,0.001147864,0.0059301783,0.001480886,0.0021750168,0.0017943317,0.0007136858,0.004136195],"category_scores_gemma":[0.009965747,0.00048798294,0.0021087374,0.018845662,0.00054668303,0.0005428978,0.0010753281,0.00096576056,0.00042465256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012588486,0.00018065746,0.95548445,0.0005136077,0.0018018918,0.0003401406,0.00023152477,0.0037750404,0.00010440058,0.00082912995,0.023883116,0.011597134],"study_design_scores_gemma":[0.00016746557,0.000066472574,0.98850703,0.00015163387,0.0005570603,0.00015299229,0.0006969592,0.0036299492,0.0001125773,0.00008310078,0.005839289,0.000035496596],"about_ca_topic_score_codex":0.99533373,"about_ca_topic_score_gemma":0.9945649,"teacher_disagreement_score":0.040784437,"about_ca_system_score_codex":0.040784437,"about_ca_system_score_gemma":0.068695776,"threshold_uncertainty_score":0.29591316},"labels":[],"label_agreement":null},{"id":"W2139264675","doi":"10.1016/j.jval.2014.03.1569","title":"Budget Impact Analysis Of Dolutegravir In The Treatment Of Human Immunodeficiency Virus (Hiv) In Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Dolutegravir; Medicine; Regimen; Formulary; Population; Pharmacy; Internal medicine; Human immunodeficiency virus (HIV); Pediatrics; Demography; Family medicine; Viral load; Environmental health; Antiretroviral therapy","score_opus":0.026532311481493216,"score_gpt":0.30557076732917104,"score_spread":0.27903845584767784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139264675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8933119,0.009179995,0.0010531634,0.0134406835,0.00016201692,0.0015017012,0.037333675,0.00007346921,0.043943454],"genre_scores_gemma":[0.98540163,0.0029494965,0.0010693122,0.0006964816,0.000030976826,0.00018824328,0.0039764186,0.000020004605,0.0056672907],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9951119,0.0012656408,0.00025866975,0.00015109901,0.0014543383,0.001758279],"domain_scores_gemma":[0.9923126,0.0015500409,0.0008292888,0.00011616453,0.003382861,0.001809176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003225995,0.0004744643,0.0009726199,0.0022679577,0.0017222795,0.0027177536,0.0016033105,0.00075078214,0.004115763],"category_scores_gemma":[0.010644453,0.0005964001,0.0012945659,0.0049924,0.0007433553,0.0005651173,0.0011086102,0.0011193611,0.00013888316],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008331073,0.0014098085,0.49262074,0.0038026932,0.0035214038,0.002040571,0.001963068,0.27639604,0.0016168276,0.028281312,0.067158744,0.11285775],"study_design_scores_gemma":[0.0018512532,0.0010808154,0.8585315,0.0011219737,0.0018447711,0.0003654478,0.005239935,0.07895329,0.00066004123,0.002004168,0.048151072,0.0001957665],"about_ca_topic_score_codex":0.99626875,"about_ca_topic_score_gemma":0.99768865,"teacher_disagreement_score":0.17364176,"about_ca_system_score_codex":0.17364176,"about_ca_system_score_gemma":0.17709269,"threshold_uncertainty_score":0.9584584},"labels":[],"label_agreement":null},{"id":"W2139637702","doi":"10.1016/j.jval.2013.03.690","title":"Cost-Effectiveness Of Bendamustine+Rituximab Versus Fludarabine+Rituximab In The Treatment Of Relapsed Indolent Non-Hodgkin's And Mantle Cell Lymphomas In Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Rituximab; Fludarabine; Bendamustine; Mantle cell lymphoma; Internal medicine; Oncology; Adverse effect; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.045726813580193156,"score_gpt":0.29543919753835685,"score_spread":0.2497123839581637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139637702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861016,0.0063092015,0.00011452817,0.0021692496,0.000068268266,0.0001332692,0.0012773392,0.000015387695,0.0038112036],"genre_scores_gemma":[0.99754626,0.0011697861,0.0001602662,0.00020212457,0.000018036122,0.000017500292,0.00035587448,0.0000033873293,0.00052681734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915636,0.000263487,0.0000571649,0.00006631282,0.00015400001,0.00030271366],"domain_scores_gemma":[0.9986663,0.00027230778,0.00017520317,0.000019258872,0.00022928033,0.000637675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005459535,0.00031079506,0.0007254557,0.00054885785,0.00063155394,0.0010402913,0.0010084127,0.00069210754,0.003029145],"category_scores_gemma":[0.0027989524,0.00024478344,0.0011816234,0.0010257106,0.0006045417,0.00033991892,0.00058653136,0.00078387297,0.000092523245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17851728,0.0049300035,0.347996,0.0027539432,0.00564396,0.0015957879,0.0008810802,0.11271755,0.0038683054,0.0065889345,0.021414485,0.31309268],"study_design_scores_gemma":[0.027096549,0.014737949,0.86022836,0.00085286534,0.006917915,0.0010273585,0.002542808,0.07294513,0.0015802226,0.0018787462,0.009922657,0.00026957315],"about_ca_topic_score_codex":0.94697267,"about_ca_topic_score_gemma":0.96864307,"teacher_disagreement_score":0.054844182,"about_ca_system_score_codex":0.054844182,"about_ca_system_score_gemma":0.033533964,"threshold_uncertainty_score":0.3979243},"labels":[],"label_agreement":null},{"id":"W2139655503","doi":"10.1016/j.jval.2014.03.746","title":"The Determinants Of Place Of Death In An End-Of-Life Or Palliative Care Population","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Observational study; Palliative care; Population; Odds ratio; End-of-life care; Psychological intervention; Systematic review; Cohort study; Multidisciplinary approach; Family medicine; MEDLINE; Emergency medicine; Nursing; Internal medicine; Environmental health","score_opus":0.2260430103256356,"score_gpt":0.4686069567085623,"score_spread":0.2425639463829267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139655503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793065,0.00016328556,0.000066953355,0.0005950283,0.000012039686,0.00000476046,0.00010433854,0.0000012689021,0.001121731],"genre_scores_gemma":[0.9997974,0.000043488413,0.00001418045,0.000020850512,0.000006375272,8.1867955e-7,0.000033878663,9.2751037e-7,0.000082262566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991277,0.00033976263,0.000058428064,0.000071993076,0.000096007476,0.00030609214],"domain_scores_gemma":[0.9934889,0.0017354931,0.0017707482,0.00023545374,0.0004904042,0.0022789848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007189401,0.00016809197,0.00029711935,0.001023531,0.0010700179,0.0017111942,0.00082445424,0.0008018276,0.0043547153],"category_scores_gemma":[0.008874395,0.00019960711,0.0006334933,0.001358784,0.0010366614,0.0013375856,0.0016008028,0.0020530869,0.0003493157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009242007,0.00012574787,0.99679714,0.0000061328033,0.000041773834,0.00015651308,0.0005865436,0.000068993846,0.00005794702,0.0002967364,0.00015327257,0.0016167851],"study_design_scores_gemma":[0.000005354778,0.00012322332,0.9902172,0.00001869017,0.00002915453,0.00041955468,0.0074400725,0.00049440877,0.00003563136,0.0008892054,0.00031363298,0.00001399398],"about_ca_topic_score_codex":0.015056023,"about_ca_topic_score_gemma":0.017133912,"teacher_disagreement_score":0.015056023,"about_ca_system_score_codex":0.0007504059,"about_ca_system_score_gemma":0.0009858627,"threshold_uncertainty_score":0.02993673},"labels":[],"label_agreement":null},{"id":"W2140120733","doi":"10.1016/j.jval.2014.03.172","title":"Consistency In Reimbursement Decisions At Canadian Hta Agencies: Inesss Versus Cdr","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Formulary; Health technology; Medicine; Family medicine; Medical prescription; Health care; Political science; Nursing","score_opus":0.5637319130110012,"score_gpt":0.43502488652110854,"score_spread":0.12870702648989268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140120733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50183725,0.016067106,0.023494598,0.14939557,0.002199647,0.0018134953,0.03578585,0.0007176587,0.26868877],"genre_scores_gemma":[0.9767046,0.0008937909,0.00814798,0.0049166097,0.00036237165,0.00011622857,0.0040336847,0.00009714632,0.004727698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.8805427,0.03701623,0.010521336,0.007365731,0.053635754,0.010918242],"domain_scores_gemma":[0.5293086,0.24311663,0.032183997,0.024558729,0.15962835,0.0112036],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13835037,0.00048907887,0.0018552894,0.007848942,0.0029303895,0.009836671,0.0053562447,0.0021402724,0.0050447797],"category_scores_gemma":[0.47592044,0.00076932076,0.0016243128,0.011649941,0.0030923737,0.004082434,0.003348795,0.0038215527,0.0003862272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022172406,0.0002636693,0.5173231,0.00094893307,0.0016212307,0.00017451143,0.002583409,0.026534423,0.00033860866,0.07851072,0.134612,0.23487228],"study_design_scores_gemma":[0.00064986624,0.00032303896,0.7627063,0.0017733609,0.0014804407,0.00023134003,0.004247047,0.0765052,0.0013989655,0.032349974,0.11784095,0.0004935819],"about_ca_topic_score_codex":0.9483188,"about_ca_topic_score_gemma":0.95867294,"teacher_disagreement_score":0.9115395,"about_ca_system_score_codex":0.08846053,"about_ca_system_score_gemma":0.12529099,"threshold_uncertainty_score":0.7316754},"labels":[],"label_agreement":null},{"id":"W2140659972","doi":"10.1016/j.jval.2013.03.1154","title":"Ustekinumab Improves Arthritis-Related And Skin-Related Quality Of Life In Patients With Active Psoriatic Arthritis: Patient Reported Outcomes From Randomized And Double Blinded Phase Iii Psummit I Trial","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Internal medicine; Physical therapy; Quality of life (healthcare); Randomization; Randomized controlled trial; Gastroenterology; Arthritis; Disease; Infliximab","score_opus":0.03695963094610567,"score_gpt":0.3223150798160095,"score_spread":0.2853554488699038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140659972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880185,0.0077483803,0.0003883347,0.0005115063,0.00021903636,0.0007280301,0.0008450501,0.00006939793,0.0014716735],"genre_scores_gemma":[0.99388146,0.0027145275,0.000518094,0.0006113777,0.00025133914,0.0005857852,0.00070007314,0.00001057808,0.0007267931],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99918157,0.0004766073,0.00005617164,0.00009881727,0.00006940394,0.00011731898],"domain_scores_gemma":[0.9989542,0.00036189638,0.0003219467,0.0000853003,0.000054403008,0.00022217318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016997958,0.0012806905,0.002776162,0.0003328936,0.00038181097,0.001002501,0.00062873156,0.0012925294,0.0033823876],"category_scores_gemma":[0.001851566,0.00044306534,0.00290346,0.0003954255,0.0009185891,0.0008967466,0.00047620348,0.0025625266,0.0004153015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9636801,0.0031813786,0.0017192309,0.00080765603,0.0032208788,0.000028811008,0.000052726748,0.00044718813,0.0017918351,0.00009063922,0.0007577461,0.024221782],"study_design_scores_gemma":[0.9381544,0.05035165,0.0075831236,0.000074864896,0.0023965829,0.000038113936,0.00003405906,0.00042523714,0.00043644285,0.00015753346,0.00032955906,0.000018336024],"about_ca_topic_score_codex":0.0008206419,"about_ca_topic_score_gemma":0.0016803528,"teacher_disagreement_score":0.0033823876,"about_ca_system_score_codex":0.00062253367,"about_ca_system_score_gemma":0.00067635026,"threshold_uncertainty_score":0.011315227},"labels":[],"label_agreement":null},{"id":"W2140892477","doi":"10.1016/j.jval.2014.03.1398","title":"Clinical effectiveness of surgical therapies, radiotherapy and medical interventions in cushing’s disease; A systematic literature review","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hypopituitarism; Cushing's disease; Cochrane Library; Population; Transsphenoidal surgery; Observational study; Systematic review; Radiation therapy; Adrenalectomy; Surgery; Pediatrics; Disease; MEDLINE; Internal medicine; Pituitary adenoma; Randomized controlled trial; Adenoma","score_opus":0.04133927102740052,"score_gpt":0.3953527818645443,"score_spread":0.3540135108371438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140892477","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021553084,0.9971499,0.000052231037,0.00011068537,0.00006429621,0.00006875416,0.00024145238,0.0000025247873,0.00015492836],"genre_scores_gemma":[0.06349161,0.9346096,0.0007143427,0.0005166848,0.00013543507,0.00020157435,0.000247413,0.0000044690996,0.00007883797],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99089456,0.0027692155,0.0040853648,0.00079152075,0.0012563937,0.00020305479],"domain_scores_gemma":[0.94710785,0.040621758,0.009070504,0.00054413837,0.0021536346,0.00050213904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009601528,0.0009136212,0.0078063505,0.00874528,0.00050891994,0.0023809047,0.0013559201,0.0019797923,0.0030584345],"category_scores_gemma":[0.047941517,0.0010472853,0.009044907,0.008610372,0.0010823539,0.0019759585,0.0013058722,0.0012479668,0.00019426724],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012259914,0.00005863177,0.006987285,0.88127023,0.07196939,0.00017297431,0.0002502442,0.000156056,0.00021669081,0.00019742873,0.0010675599,0.036427487],"study_design_scores_gemma":[0.0015721455,0.00068136834,0.025188776,0.4610948,0.49715438,0.00063718215,0.00063882495,0.00017358671,0.00020821458,0.00037704478,0.012195734,0.00007797078],"about_ca_topic_score_codex":0.0067286086,"about_ca_topic_score_gemma":0.025020361,"teacher_disagreement_score":0.009601528,"about_ca_system_score_codex":0.002550234,"about_ca_system_score_gemma":0.0063080997,"threshold_uncertainty_score":0.05077839},"labels":[],"label_agreement":null},{"id":"W2140920559","doi":"10.1016/j.jval.2014.03.428","title":"Treatment and Survival Patterns Among Alk+ Nsclc Patients Following Crizotinib Discontinuation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Crizotinib; Medicine; Discontinuation; Regimen; Internal medicine; Lung cancer; Oncology; Chemotherapy; Surgery","score_opus":0.024100602778406022,"score_gpt":0.333350544246424,"score_spread":0.309249941468018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140920559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770457,0.0006251664,0.000022336779,0.00014810791,0.0000073275487,0.00000539835,0.00056698883,0.0000029721537,0.00091708],"genre_scores_gemma":[0.99876595,0.00016016512,0.00001152096,0.00007059328,0.000011976088,0.0000039070005,0.0006709468,0.0000019316096,0.00030305804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995807,0.000055786553,0.000048905396,0.0000787643,0.000044795976,0.00019109985],"domain_scores_gemma":[0.9980769,0.000377484,0.00092975766,0.000062932304,0.00013460185,0.00041842766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038254345,0.00011402905,0.00043335688,0.00051387225,0.00029754173,0.0006714522,0.0002802791,0.00059571274,0.0024183746],"category_scores_gemma":[0.0028385846,0.00011482426,0.0008731464,0.0009092721,0.00022322175,0.00056767836,0.0003635265,0.0009072384,0.00024158564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019195984,0.00007425993,0.9919865,0.000013720052,0.000103509046,0.00016877876,0.00007613269,0.00016957626,0.00043467243,0.000051136227,0.0002513197,0.004750812],"study_design_scores_gemma":[0.00002040261,0.00030094598,0.9985447,0.000009862745,0.000057858044,0.00021187708,0.0002021479,0.00019091745,0.00006502959,0.00006517139,0.0003244987,0.00000656847],"about_ca_topic_score_codex":0.009276792,"about_ca_topic_score_gemma":0.012102906,"teacher_disagreement_score":0.009276792,"about_ca_system_score_codex":0.00067155936,"about_ca_system_score_gemma":0.0005901435,"threshold_uncertainty_score":0.018445611},"labels":[],"label_agreement":null},{"id":"W2141663349","doi":"10.1016/j.jval.2014.01.003","title":"Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Credibility; Distrust; Relevance (law); Dissemination; Management science; Health care; Task (project management); Computer science; Psychology; Knowledge management; Political science; Engineering; Economics; Management","score_opus":0.4817310823231186,"score_gpt":0.5263420092578712,"score_spread":0.044610926934752604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141663349","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.568745,0.008662732,0.15346953,0.05801472,0.0042314376,0.08836391,0.033691466,0.00252491,0.08229628],"genre_scores_gemma":[0.6003311,0.0065086936,0.27605093,0.01559637,0.0015305054,0.08216872,0.009296007,0.0007261401,0.00779151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9534798,0.02407319,0.011895893,0.00083804043,0.008711351,0.0010016711],"domain_scores_gemma":[0.3518985,0.52426124,0.036105227,0.016996011,0.064809255,0.0059297555],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10122884,0.00083715224,0.0015436927,0.0077202613,0.001668748,0.0022789217,0.0012228837,0.0037931888,0.00995724],"category_scores_gemma":[0.35216486,0.00090030296,0.0027522827,0.0022494113,0.0017925851,0.003389906,0.0040418534,0.005599271,0.003132314],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003604585,0.0091661,0.24030545,0.014819702,0.0026749948,0.0013693849,0.046216175,0.006715236,0.0074740183,0.014037212,0.21248804,0.4411291],"study_design_scores_gemma":[0.0060861497,0.005774755,0.26527834,0.028285455,0.0030460362,0.0029266512,0.033012092,0.0369035,0.011467329,0.038679656,0.56700546,0.0015345726],"about_ca_topic_score_codex":0.0013721929,"about_ca_topic_score_gemma":0.0016559646,"teacher_disagreement_score":0.89877117,"about_ca_system_score_codex":0.0024517213,"about_ca_system_score_gemma":0.00599415,"threshold_uncertainty_score":0.5353557},"labels":[],"label_agreement":null},{"id":"W2141667151","doi":"10.1016/j.jval.2012.03.013","title":"CO2 Advancing the Methods of Cost-Effectiveness Analysis: Why It's Time to Move on from ICERs and Thresholds","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Nuclear and radioactivity studies","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Equity (law); Interpretation (philosophy); Actuarial science; Computer science; Decision analysis; Operations research; Risk analysis (engineering); Management science; Economics; Medicine; Political science; Mathematical economics; Mathematics; Law","score_opus":0.037788192031435804,"score_gpt":0.3424586716799383,"score_spread":0.3046704796485025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141667151","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012987692,0.11375875,0.27679873,0.56365204,0.009008069,0.00060743006,0.0006224109,0.0005202377,0.022044692],"genre_scores_gemma":[0.42069137,0.05140046,0.3558983,0.1495858,0.015562597,0.0017576814,0.00035148297,0.0010402284,0.0037120357],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7828802,0.18423949,0.0066795605,0.0038711436,0.020463388,0.0018662533],"domain_scores_gemma":[0.29807895,0.652737,0.008279816,0.011460163,0.027082197,0.002361866],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19724129,0.0019691675,0.0049199373,0.0033207324,0.0012823939,0.01351381,0.003705441,0.0071914042,0.006354616],"category_scores_gemma":[0.47903368,0.0011619289,0.0039123124,0.004362009,0.010037081,0.021728246,0.005198684,0.024494896,0.0011926258],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017000654,0.00027268418,0.007222691,0.0050819577,0.0027653873,0.00019345373,0.0019952771,0.018493576,0.0006954024,0.29442647,0.086057484,0.58109564],"study_design_scores_gemma":[0.000523929,0.00065823307,0.0044099456,0.009539224,0.0013049071,0.0002547591,0.0013122502,0.026375074,0.0013017171,0.8422998,0.11164489,0.00037522518],"about_ca_topic_score_codex":0.013945938,"about_ca_topic_score_gemma":0.013286917,"teacher_disagreement_score":0.8027587,"about_ca_system_score_codex":0.009055435,"about_ca_system_score_gemma":0.014250464,"threshold_uncertainty_score":0.9899444},"labels":[],"label_agreement":null},{"id":"W2141925402","doi":"10.1016/j.jval.2014.03.930","title":"Cost-Effectiveness Of Long-Acting Reversible Contraception: Lng-Ius 13.5mg, A Low-Dose Contraceptive Levonorgestrel Intrauterine System Versus Oral Contraceptives","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Levonorgestrel; Medicine; Discontinuation; Family planning; Gynecology; Obstetrics; Population; Demography; Environmental health; Research methodology; Internal medicine","score_opus":0.08168405079042831,"score_gpt":0.3569799785499842,"score_spread":0.2752959277595559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141925402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94380873,0.044740997,0.00088477205,0.0022140618,0.0005588066,0.00044266097,0.0019492414,0.00006275523,0.0053377924],"genre_scores_gemma":[0.994603,0.0030957418,0.0005013736,0.00019769627,0.0001273998,0.00008657921,0.0004499141,0.00000772247,0.0009304499],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997471,0.0017797626,0.00015398471,0.00016489517,0.0002167378,0.00021359014],"domain_scores_gemma":[0.9969228,0.0021179775,0.00043820983,0.00006521943,0.000090014306,0.0003658089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023378269,0.0007331696,0.0020833297,0.00093293056,0.0001904856,0.0009963737,0.0007563867,0.0014037183,0.011612502],"category_scores_gemma":[0.006083323,0.00030977651,0.004317122,0.00075327023,0.00047752965,0.0012346491,0.0005886284,0.0012995859,0.00032038594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.813511,0.0026137214,0.011656118,0.0027107864,0.007553045,0.00024079475,0.00007731043,0.01113619,0.0014469271,0.001522086,0.0016607265,0.14587134],"study_design_scores_gemma":[0.33661723,0.31578892,0.16668528,0.003523293,0.071903616,0.0019867583,0.0009408813,0.0819602,0.0058197626,0.0060602366,0.008270358,0.0004434649],"about_ca_topic_score_codex":0.0048353975,"about_ca_topic_score_gemma":0.0053603486,"teacher_disagreement_score":0.011612502,"about_ca_system_score_codex":0.0025840166,"about_ca_system_score_gemma":0.0014494538,"threshold_uncertainty_score":0.038847685},"labels":[],"label_agreement":null},{"id":"W2142200501","doi":"10.1016/j.jval.2014.08.2512","title":"Cost-Effectiveness of Fecal Microbiota Transplant in Treating Clostridium Difficile Infection in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clostridium difficile; Medicine; Fecal bacteriotherapy; Population; Internal medicine; Antibiotics; Environmental health; Microbiology; Biology","score_opus":0.04992519523411869,"score_gpt":0.3194485559266452,"score_spread":0.26952336069252647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142200501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95515025,0.019534856,0.0003489598,0.010741003,0.00028544408,0.00022180345,0.0033942612,0.000041086605,0.010282242],"genre_scores_gemma":[0.99410385,0.003739991,0.00026679918,0.0005042047,0.000047591926,0.000020684023,0.00057698216,0.0000064714673,0.00073340745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782795,0.00045392802,0.00014150405,0.00013101709,0.0006574368,0.00078811427],"domain_scores_gemma":[0.99574214,0.0006052228,0.000638097,0.00005038894,0.001111188,0.0018529702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000968356,0.00034554346,0.0008172375,0.0011021112,0.0013815246,0.0021002346,0.0012258908,0.00094227743,0.003552553],"category_scores_gemma":[0.0075548347,0.00026059782,0.001604549,0.0024983184,0.0007270607,0.0004811044,0.0008993556,0.0013971027,0.00008701224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02154197,0.0037026878,0.6166576,0.0029092191,0.0034216368,0.0012001274,0.00071091973,0.03628485,0.001366811,0.0076541067,0.028301368,0.27624875],"study_design_scores_gemma":[0.0032581426,0.003155105,0.95158434,0.0012955614,0.0028946176,0.00059203623,0.0022847378,0.025110008,0.000539034,0.0011637696,0.007998144,0.00012453656],"about_ca_topic_score_codex":0.9814532,"about_ca_topic_score_gemma":0.9895577,"teacher_disagreement_score":0.1038934,"about_ca_system_score_codex":0.1038934,"about_ca_system_score_gemma":0.096473746,"threshold_uncertainty_score":0.7538029},"labels":[],"label_agreement":null},{"id":"W2142297729","doi":"10.1016/s1098-3015(10)70319-3","title":"PIN21 COST-EFFECTIVENESS OF ANIDULAFUNGIN THERAPY IN CONFIRMED CANDIDEMIA AND OTHER FORMS OF INVASIVE CANDIDIASIS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anidulafungin; Invasive candidiasis; Echinocandins; Echinocandin; Medicine; Antifungal; Intensive care medicine; Micafungin; Dermatology; Fluconazole; Caspofungin","score_opus":0.06833240508313643,"score_gpt":0.3329543894010664,"score_spread":0.26462198431793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142297729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97140527,0.008698128,0.00015769957,0.0028506087,0.00008738932,0.0001877283,0.0066193743,0.000032617467,0.00996111],"genre_scores_gemma":[0.9950878,0.0020545851,0.000136856,0.00021373169,0.000019237521,0.00001717927,0.0010191314,0.0000043891923,0.0014470343],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884075,0.00022217931,0.00006977155,0.000078487115,0.0004552261,0.0003336076],"domain_scores_gemma":[0.99798477,0.00034672886,0.00026042986,0.000025964211,0.0007038805,0.00067813264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057891826,0.00029523566,0.0007274204,0.0010026362,0.00093784166,0.0014961284,0.000944408,0.0006078308,0.0035236496],"category_scores_gemma":[0.0044039185,0.0002354178,0.0011168848,0.0019640191,0.00037968197,0.00031937406,0.0004946933,0.00076272554,0.00014254027],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021452613,0.0018574627,0.75400996,0.001152321,0.0018547189,0.001535705,0.000400138,0.022171756,0.0014893808,0.0028738533,0.017709235,0.17349282],"study_design_scores_gemma":[0.0012637537,0.0012267262,0.9807968,0.00016684135,0.0007658478,0.00041912403,0.00064419326,0.010355524,0.00038117627,0.00017322467,0.0037604196,0.000046398793],"about_ca_topic_score_codex":0.9867346,"about_ca_topic_score_gemma":0.99043125,"teacher_disagreement_score":0.051629167,"about_ca_system_score_codex":0.051629167,"about_ca_system_score_gemma":0.05265736,"threshold_uncertainty_score":0.3745976},"labels":[],"label_agreement":null},{"id":"W2142475605","doi":"10.1016/j.jval.2014.08.385","title":"Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ranibizumab; Medicine; Bevacizumab; Macular degeneration; Dosing; Regimen; Quality-adjusted life year; Economic evaluation; Ophthalmology; Cost effectiveness; Internal medicine","score_opus":0.28532994394400635,"score_gpt":0.40733061895069456,"score_spread":0.12200067500668821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142475605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902535,0.007229609,0.0004104075,0.0008743282,0.00002705803,0.000114840936,0.0002544873,0.000004882958,0.00083090045],"genre_scores_gemma":[0.99854493,0.00086054986,0.0001458146,0.00006597422,0.000015090413,0.00003772156,0.00017900865,0.0000015234455,0.00014940751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956547,0.0028316923,0.00028644933,0.00016339941,0.00053107674,0.00053282594],"domain_scores_gemma":[0.99529797,0.0023668322,0.0009342359,0.00011878666,0.0005612163,0.00072099065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00723881,0.0005992054,0.0015709125,0.0019394655,0.0005166683,0.0013447745,0.00063752383,0.0006303901,0.0012071477],"category_scores_gemma":[0.012053994,0.00028891393,0.00204639,0.0015824015,0.0007609363,0.00076142815,0.00079493865,0.00066767645,0.000034496567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06562415,0.0049058204,0.4870158,0.0058676694,0.013905529,0.0027979086,0.00069917133,0.2529278,0.003230678,0.011475333,0.0056539658,0.14589618],"study_design_scores_gemma":[0.012409927,0.012706722,0.50312465,0.0010427673,0.016116632,0.0008035783,0.0014535543,0.4383311,0.0019634673,0.004974838,0.006788708,0.00028412728],"about_ca_topic_score_codex":0.061924566,"about_ca_topic_score_gemma":0.040305607,"teacher_disagreement_score":0.061924566,"about_ca_system_score_codex":0.011649716,"about_ca_system_score_gemma":0.008782159,"threshold_uncertainty_score":0.123128295},"labels":[],"label_agreement":null},{"id":"W2143020284","doi":"10.1016/j.jval.2014.03.529","title":"Cost-Utility Analysis of Practice Deviations From Guidelines in HER2-Targeted Testing and Treatment for Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary; Ontario Institute for Cancer Research; McMaster University","funders":"","keywords":"Medicine; Trastuzumab; Observational study; Breast cancer; Companion diagnostic; Population; Oncology; Internal medicine; Disease; Personalized medicine; Cancer; Bioinformatics; Environmental health; Biology","score_opus":0.6188629693344477,"score_gpt":0.5111760297159271,"score_spread":0.1076869396185206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143020284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777594,0.0023622464,0.013845691,0.0018635519,0.000064900785,0.00041637238,0.0011441705,0.0000851635,0.0024584525],"genre_scores_gemma":[0.99734855,0.00014457708,0.0019216063,0.00006919659,0.000012972166,0.000056506135,0.00026918648,0.0000067816836,0.0001705641],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.97674835,0.019612456,0.0006852102,0.0007440381,0.0013495106,0.00086040405],"domain_scores_gemma":[0.8151735,0.17049655,0.0066249906,0.0030356825,0.0035551277,0.0011142094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029744126,0.0012088687,0.0018043726,0.0018467639,0.00033148238,0.00239683,0.001928353,0.002044133,0.0026746069],"category_scores_gemma":[0.15392885,0.000732392,0.0020810538,0.002362127,0.0017724464,0.0019342878,0.0015513794,0.0026208474,0.00019084648],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011564686,0.0013741284,0.062225536,0.00040415197,0.0019476064,0.00017610729,0.00020246391,0.8793513,0.00030511574,0.009055611,0.0015149544,0.031878334],"study_design_scores_gemma":[0.0009795813,0.0037864551,0.039157096,0.00014071957,0.0014212227,0.00018808928,0.00035917008,0.94399375,0.000405207,0.008834833,0.00064785656,0.00008603122],"about_ca_topic_score_codex":0.016284991,"about_ca_topic_score_gemma":0.0058427746,"teacher_disagreement_score":0.029744126,"about_ca_system_score_codex":0.006712941,"about_ca_system_score_gemma":0.0029569722,"threshold_uncertainty_score":0.15730387},"labels":[],"label_agreement":null},{"id":"W2143025931","doi":"10.1016/j.jval.2013.02.002","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2058,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Institute of Health Economics","funders":"Medical Research Council; Kela","keywords":"Task force; Elaboration; Health economics; Economic evaluation; Accounting; Task (project management); Business; Medicine; Political science; Health care; Economics; Public administration; Economic growth; Management","score_opus":0.5234036790781761,"score_gpt":0.5271619286619199,"score_spread":0.0037582495837438223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143025931","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038182782,0.02623027,0.19277373,0.13138287,0.030388076,0.08277367,0.49152997,0.0074815312,0.033621598],"genre_scores_gemma":[0.016152693,0.022177385,0.44896695,0.040642373,0.0053780084,0.13657866,0.3173529,0.0024774286,0.010273634],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.6536936,0.14594513,0.121771075,0.004180806,0.068890974,0.0055184755],"domain_scores_gemma":[0.40622756,0.22007921,0.075405486,0.043531734,0.25121823,0.0035378023],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2821434,0.00405285,0.0062506204,0.024432521,0.0015437845,0.011463857,0.012191997,0.01141604,0.018400958],"category_scores_gemma":[0.59222674,0.0038879118,0.01461083,0.035956454,0.0037842598,0.0068630916,0.007103639,0.023974111,0.0158319],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005528633,0.00025836512,0.0021506941,0.012062128,0.0005615086,0.0000712247,0.00033048666,0.0016546316,0.00028678818,0.013579181,0.9104499,0.058042206],"study_design_scores_gemma":[0.0016433271,0.00032053012,0.02401009,0.035816967,0.0013566801,0.00029435975,0.00070400955,0.0035473378,0.0031212897,0.029767253,0.8989547,0.00046355018],"about_ca_topic_score_codex":0.018346837,"about_ca_topic_score_gemma":0.009551767,"teacher_disagreement_score":0.7178566,"about_ca_system_score_codex":0.011325212,"about_ca_system_score_gemma":0.0364399,"threshold_uncertainty_score":0.88524497},"labels":[],"label_agreement":null},{"id":"W2143677294","doi":"10.1016/j.jval.2015.06.007","title":"What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic Review","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Presentation (obstetrics); Viewpoints; Glossary; Terminology; Economic evaluation; Transparency (behavior); Economic data; Economic statistics; Actuarial science; Management science; Computer science; Medicine; Economics; Macroeconomics","score_opus":0.6837311489823416,"score_gpt":0.5444814760980674,"score_spread":0.13924967288427414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143677294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002331036,0.98998964,0.0014650727,0.0059739263,0.00090014184,0.0003425638,0.0004317997,0.00001919032,0.00064452563],"genre_scores_gemma":[0.0075381435,0.9770996,0.007854928,0.0051825955,0.0007541123,0.0010226403,0.0002643689,0.000024228239,0.00025934234],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95620036,0.025319695,0.012447164,0.0011061613,0.0044144746,0.00051216595],"domain_scores_gemma":[0.8424832,0.13143668,0.012712571,0.0020107361,0.010579598,0.0007771891],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.074020155,0.0020112647,0.011371386,0.015119974,0.00080687203,0.006848674,0.0025249238,0.0045011416,0.007722347],"category_scores_gemma":[0.27366695,0.0017157847,0.007941574,0.0110594435,0.002402341,0.0078667635,0.0024363326,0.004253807,0.00084085576],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045867806,0.00004925383,0.001053209,0.6164574,0.015992934,0.000091315414,0.0002720627,0.0006290677,0.00014041526,0.009207753,0.027883621,0.3277643],"study_design_scores_gemma":[0.0008773326,0.00012084873,0.0020995385,0.8419804,0.039152022,0.00013352162,0.0003076461,0.0004755927,0.00018646632,0.017844286,0.09672873,0.000093640425],"about_ca_topic_score_codex":0.00872234,"about_ca_topic_score_gemma":0.020696305,"teacher_disagreement_score":0.92597985,"about_ca_system_score_codex":0.0056907427,"about_ca_system_score_gemma":0.018068131,"threshold_uncertainty_score":0.39146066},"labels":[],"label_agreement":null},{"id":"W2143845636","doi":"10.1016/j.jval.2015.09.142","title":"The Cost and Length of Stay of Hospital Emergency Department Visits for Chronic Heart Failure Patients in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Heart failure; Emergency department; Ambulatory; Emergency medicine; Demographics; Retrospective cohort study; Healthcare Cost and Utilization Project; Acute care; Patient discharge; Hospital discharge; Health care; Medical emergency; Database; MEDLINE; Intensive care medicine; Internal medicine; Demography","score_opus":0.021917497148799696,"score_gpt":0.2918268766253127,"score_spread":0.269909379476513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143845636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838098,0.003517526,0.000061815386,0.0021795495,0.000055582223,0.00003444859,0.0069248807,0.00000789684,0.00340844],"genre_scores_gemma":[0.9959086,0.0013511713,0.000066620894,0.00023547414,0.000023316052,0.000008309638,0.0016916707,0.0000041998983,0.000710669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998628,0.00015473542,0.00013228861,0.000097329605,0.0004485996,0.0005390793],"domain_scores_gemma":[0.9936708,0.0006473123,0.0013885553,0.0001056126,0.0022025774,0.0019852046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006483294,0.00033734718,0.00059930445,0.00174482,0.0020774691,0.0017900177,0.0017127979,0.00094177923,0.0029472148],"category_scores_gemma":[0.00693272,0.0004553515,0.0013293087,0.005346531,0.00076695066,0.0007914357,0.0010801423,0.0019454483,0.00013629186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016850785,0.00006194306,0.9932318,0.00007557231,0.00017991362,0.00012133183,0.0002386218,0.00033203085,0.000033409815,0.00029491665,0.0021599354,0.0031021147],"study_design_scores_gemma":[0.000016340407,0.000017847706,0.9979443,0.000059907,0.00005459445,0.000056559355,0.0008945675,0.00035715982,0.000012901646,0.00004946692,0.0005235692,0.000012690025],"about_ca_topic_score_codex":0.99326754,"about_ca_topic_score_gemma":0.9957203,"teacher_disagreement_score":0.05032531,"about_ca_system_score_codex":0.05032531,"about_ca_system_score_gemma":0.04056349,"threshold_uncertainty_score":0.3651374},"labels":[],"label_agreement":null},{"id":"W2144934383","doi":"10.1016/j.jval.2013.10.008","title":"A Synthesis of Drug Reimbursement Decision-Making Processes in Organisation for Economic Co-operation and Development Countries","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Alberta; University of Calgary","funders":"","keywords":"Formulary; Reimbursement; Transparency (behavior); Business; Medical prescription; Actuarial science; Public economics; Medicine; Economics; Health care; Family medicine; Computer science; Pharmacology; Economic growth","score_opus":0.19700052114875882,"score_gpt":0.4067100004600565,"score_spread":0.2097094793112977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144934383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10991042,0.6751362,0.06357818,0.016138341,0.0012231123,0.002628233,0.08614477,0.00027731797,0.044963337],"genre_scores_gemma":[0.60129005,0.26265457,0.095032424,0.0021462096,0.00042459808,0.003478055,0.0307055,0.000127645,0.004140906],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9869751,0.006301023,0.0025765128,0.00085240725,0.0023694853,0.0009254779],"domain_scores_gemma":[0.9244418,0.062017128,0.0043729916,0.0016883698,0.006961986,0.0005176164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016747765,0.0010272176,0.0024779178,0.013160563,0.0009068396,0.0067220437,0.0008668966,0.0013963651,0.012644585],"category_scores_gemma":[0.0537445,0.00082952995,0.0034017395,0.03346338,0.00059763406,0.0028440116,0.0017748154,0.0015699787,0.000750339],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013368201,0.00035526758,0.028460331,0.06798356,0.0044137007,0.00028399745,0.0053749857,0.05779935,0.00051886117,0.13761722,0.044509187,0.65134674],"study_design_scores_gemma":[0.00057381275,0.00068363064,0.26812592,0.099136576,0.009789525,0.00024162693,0.009547909,0.02055,0.00177468,0.07510813,0.5141857,0.00028244415],"about_ca_topic_score_codex":0.051816963,"about_ca_topic_score_gemma":0.047379307,"teacher_disagreement_score":0.051816963,"about_ca_system_score_codex":0.0130432695,"about_ca_system_score_gemma":0.018303128,"threshold_uncertainty_score":0.10303074},"labels":[],"label_agreement":null},{"id":"W2145695460","doi":"10.1016/j.jval.2015.05.008","title":"Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":604,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Terminology; Orphan drug; Rare disease; Disease; Medicine; Descriptive statistics; Family medicine; Diversity (politics); Actuarial science; Demography; Statistics; Business; Pathology; Political science; Mathematics","score_opus":0.09712492353042428,"score_gpt":0.34315913216346045,"score_spread":0.24603420863303616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145695460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033964548,0.9977436,0.00014957618,0.00043451696,0.00014210671,0.00006154697,0.00084636576,0.000007677711,0.0002750327],"genre_scores_gemma":[0.0023761978,0.9954684,0.00066476443,0.0006004968,0.00010058087,0.00009376831,0.0005921187,0.0000059074755,0.000097749304],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967096,0.00069660146,0.0014483349,0.00035327082,0.0006629061,0.00012924851],"domain_scores_gemma":[0.9907714,0.0052705123,0.002628661,0.00014449467,0.0009857172,0.00019918465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057714866,0.0012720738,0.0045705894,0.018173,0.0003851481,0.002225676,0.001732529,0.0012762077,0.0041393545],"category_scores_gemma":[0.015278307,0.00057038775,0.0040417267,0.017208124,0.00093836506,0.0023790717,0.0024585393,0.0014761763,0.0006140124],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004608139,0.000037958926,0.0031044688,0.5454339,0.0047063637,0.00022514652,0.00039813915,0.00045397063,0.00066624314,0.0025925443,0.048443962,0.39347658],"study_design_scores_gemma":[0.00047959053,0.00017388644,0.015752686,0.5459936,0.03386277,0.00213626,0.00069498457,0.000257487,0.00043375272,0.002782523,0.39728102,0.00015147883],"about_ca_topic_score_codex":0.005621387,"about_ca_topic_score_gemma":0.013275418,"teacher_disagreement_score":0.018173,"about_ca_system_score_codex":0.0019407803,"about_ca_system_score_gemma":0.009374355,"threshold_uncertainty_score":0.030522883},"labels":[],"label_agreement":null},{"id":"W2145838058","doi":"10.1016/j.jval.2015.03.162","title":"Examining The Relationship Between Health-Related Quality Of Life And Increasing Numbers Of Diseases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Multiplicative function; Medical diagnosis; Linear model; Additive model; Statistics; Quality of life (healthcare); Mathematics; Medicine; EQ-5D; Demography; Econometrics; Health related quality of life; Psychology; Disease","score_opus":0.7419016618334474,"score_gpt":0.468172556957525,"score_spread":0.2737291048759224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145838058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992504,0.0026121738,0.0007447724,0.001981429,0.00002985601,0.000011657488,0.0006426241,0.000004659304,0.0014689247],"genre_scores_gemma":[0.9984296,0.0006400221,0.00024152442,0.000087966924,0.000041867075,0.000008683837,0.00028357937,0.0000017317857,0.00026495272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806696,0.0012999002,0.0001251652,0.00015381657,0.00014360763,0.0002105961],"domain_scores_gemma":[0.9336963,0.04870194,0.012795811,0.001157724,0.0012346294,0.002413635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042965454,0.00032134648,0.00037731152,0.0017087668,0.00031274726,0.0013659514,0.0006101374,0.001038175,0.0038483872],"category_scores_gemma":[0.035185035,0.00026951052,0.000969376,0.0031328695,0.000764579,0.0017700882,0.0010972192,0.0024429406,0.00020580126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014293936,0.00011178257,0.9933222,0.000040429597,0.0003597541,0.000047965153,0.00007803838,0.0012213939,0.000027848988,0.0008099067,0.00018439553,0.0036534749],"study_design_scores_gemma":[0.000021524951,0.0002510408,0.9898732,0.000040530427,0.0002841848,0.00013625338,0.0006234474,0.005329654,0.00006991858,0.0028366072,0.0005212442,0.00001250364],"about_ca_topic_score_codex":0.008331755,"about_ca_topic_score_gemma":0.008185025,"teacher_disagreement_score":0.008331755,"about_ca_system_score_codex":0.0006638055,"about_ca_system_score_gemma":0.000643916,"threshold_uncertainty_score":0.022722542},"labels":[],"label_agreement":null},{"id":"W2146146912","doi":"10.1016/j.jval.2013.03.1610","title":"The use of selected psychotropic drugs among seniors on public drug programs in canada, 2001 to 2010","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Psychotropic drug; Medical prescription; Drug; Drug class; Nursing homes; Psychotropic Agent; Psychiatry; Gerontology; Family medicine; Nursing","score_opus":0.07605956238046473,"score_gpt":0.32846199918812735,"score_spread":0.2524024368076626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146146912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727305,0.0021899557,0.000097706376,0.0008191262,0.00007293666,0.00007697265,0.019469757,0.000031616448,0.0045114495],"genre_scores_gemma":[0.99031687,0.0013929245,0.00014331346,0.00038052248,0.000025562458,0.000026426418,0.005252605,0.00000777658,0.0024538673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904734,0.00003368803,0.00009870153,0.00009721088,0.00043491297,0.00028812687],"domain_scores_gemma":[0.9969156,0.00007894136,0.0006244731,0.00003253497,0.0014947108,0.00085373543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037425882,0.00034673407,0.0004989635,0.0022104175,0.001956488,0.0011926839,0.0013623292,0.00095932314,0.0013112456],"category_scores_gemma":[0.0019906538,0.00035875302,0.00084425096,0.0045768092,0.00047042491,0.0005407669,0.0008605747,0.0013911481,0.00023852258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090600435,0.00006470723,0.9936838,0.00005733574,0.00006560511,0.000053239306,0.0002786711,0.000061550294,0.00008495658,0.000035456334,0.001873526,0.0036505272],"study_design_scores_gemma":[0.0000046127348,0.000019996702,0.9983327,0.000032557145,0.000023722381,0.000047640475,0.00056360377,0.00010188367,0.000032007214,0.000006047237,0.00083001325,0.00000521561],"about_ca_topic_score_codex":0.989499,"about_ca_topic_score_gemma":0.9949181,"teacher_disagreement_score":0.01891105,"about_ca_system_score_codex":0.01891105,"about_ca_system_score_gemma":0.025683818,"threshold_uncertainty_score":0.13720989},"labels":[],"label_agreement":null},{"id":"W2146368704","doi":"10.1016/s1098-3015(10)73116-8","title":"HT2 HEALTH TECHNOLOGY ASSESSMENT – A COMPREHENSIVE FRAMEWORK FOR EVIDENCE-BASED RECOMMENDATIONS IN ONTARIO","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health technology; Data science; Environmental planning; Computer science; Medicine; Health care; Political science; Environmental science","score_opus":0.30291084601221,"score_gpt":0.5329287889984506,"score_spread":0.23001794298624062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146368704","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019886054,0.10063233,0.18542606,0.43551913,0.0033106927,0.032496862,0.025039302,0.0015392465,0.19615032],"genre_scores_gemma":[0.19816668,0.051181152,0.6926184,0.02108086,0.0011441829,0.014691123,0.00915201,0.0002914846,0.011674139],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8550871,0.058839466,0.031226309,0.0029494367,0.047659844,0.0042378022],"domain_scores_gemma":[0.82406706,0.07045653,0.016297359,0.0043840534,0.0760058,0.008789212],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.104704626,0.0022327185,0.004061667,0.018212797,0.007034641,0.015215026,0.0066406727,0.008757583,0.0066957967],"category_scores_gemma":[0.20725514,0.0024236676,0.006416975,0.018662667,0.0045945374,0.0061643776,0.0077563473,0.0072974423,0.0011582115],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005265968,0.0004724234,0.027413098,0.0419827,0.0041334773,0.0011944864,0.011045566,0.019194758,0.0010003555,0.12322887,0.27689233,0.49291542],"study_design_scores_gemma":[0.0016025288,0.0007208609,0.07316836,0.11306473,0.007252427,0.0004856849,0.005713039,0.029616747,0.0015723539,0.098021016,0.66790134,0.00088097446],"about_ca_topic_score_codex":0.81313294,"about_ca_topic_score_gemma":0.88036186,"teacher_disagreement_score":0.89530057,"about_ca_system_score_codex":0.10469944,"about_ca_system_score_gemma":0.33013538,"threshold_uncertainty_score":0.7596512},"labels":[],"label_agreement":null},{"id":"W2146957057","doi":"10.1016/j.jval.2014.08.1594","title":"Family Preferences in the Volume Verse Outcome Debate: Implications for the Delivery of Complex Pediatric Care","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Outcome (game theory); Medicine; Absolute risk reduction; Demography; Relative risk; Actuarial science; Medical emergency; Business; Economics; Environmental health; Confidence interval; Microeconomics","score_opus":0.2044707153921128,"score_gpt":0.428977529961082,"score_spread":0.2245068145689692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146957057","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04733771,0.004308475,0.0029526947,0.9017084,0.0016029199,0.00003217164,0.00013552648,0.000013623733,0.041908465],"genre_scores_gemma":[0.86128926,0.003953794,0.0023813,0.124705106,0.004538703,0.00016199025,0.00008833645,0.000096714124,0.00278478],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9401907,0.04494524,0.0021291522,0.0019846363,0.007197343,0.0035529502],"domain_scores_gemma":[0.66200536,0.29843396,0.009336919,0.00354475,0.009418634,0.017260373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09985669,0.00035465418,0.00095920434,0.0018683244,0.0064310175,0.012928254,0.0032741807,0.015087713,0.017386317],"category_scores_gemma":[0.28227845,0.0004947848,0.0012254344,0.0023531602,0.018898549,0.01253287,0.0053183995,0.014838597,0.00064138765],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008310745,0.0006272158,0.022908298,0.00032800666,0.00019941166,0.0005831568,0.018795123,0.0015071142,0.0002036929,0.8174105,0.04872207,0.08788417],"study_design_scores_gemma":[0.00044045752,0.0003453533,0.02309301,0.0035809837,0.00012715565,0.00067575707,0.04777758,0.0015752346,0.00040430066,0.8224583,0.09933696,0.00018499927],"about_ca_topic_score_codex":0.008738149,"about_ca_topic_score_gemma":0.018577524,"teacher_disagreement_score":0.09985669,"about_ca_system_score_codex":0.012992321,"about_ca_system_score_gemma":0.019035472,"threshold_uncertainty_score":0.52809894},"labels":[],"label_agreement":null},{"id":"W2147052884","doi":"10.1016/j.jval.2014.03.832","title":"Increased In Acute Health Care Use Among People Living With Human Immunodeficiency Virus (Hiv) And Co-Morbid Depression In Ontario: A Longitudinal Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Toronto Public Health; Institute for Clinical Evaluative Sciences; Ontario HIV Treatment Network; McMaster University; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Depression (economics); Triage; Cohort; Population; Cohort study; Emergency department; Distress; Longitudinal study; Acute care; Psychiatry; Health care; Internal medicine; Environmental health","score_opus":0.04653396919134637,"score_gpt":0.3660595469849168,"score_spread":0.3195255777935704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147052884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952401,0.0004750979,0.000064255066,0.00040245338,0.000017282886,0.000058818525,0.0025808613,0.0000064508367,0.0011546118],"genre_scores_gemma":[0.9965222,0.00033828875,0.000100053294,0.0001806405,0.000010458157,0.000046575806,0.0012098273,0.0000044925223,0.0015875982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895585,0.00013198104,0.000098149314,0.00016254565,0.00026087626,0.0003905929],"domain_scores_gemma":[0.99659085,0.00015005078,0.0010268663,0.0001745402,0.0010807571,0.0009770181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076566613,0.0004039665,0.0005766227,0.0010365117,0.0035973233,0.0017264418,0.0017025976,0.001400505,0.0022459626],"category_scores_gemma":[0.002997089,0.0009056364,0.001288877,0.0034652275,0.0008020679,0.0012115482,0.0017114239,0.0017807804,0.00038083203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049536484,0.000063355896,0.9977069,0.000014353671,0.000042292962,0.000046104567,0.0012442045,0.000013899244,0.00006320598,0.000021346501,0.00024204733,0.00049266056],"study_design_scores_gemma":[0.0000042748097,0.0000143693715,0.9988192,0.000010757728,0.000014639066,0.000016081978,0.0008851819,0.000037516664,0.000007676582,0.000005726937,0.0001802893,0.0000044045287],"about_ca_topic_score_codex":0.9716143,"about_ca_topic_score_gemma":0.9850072,"teacher_disagreement_score":0.028385699,"about_ca_system_score_codex":0.016121197,"about_ca_system_score_gemma":0.015769864,"threshold_uncertainty_score":0.116967976},"labels":[],"label_agreement":null},{"id":"W2147121365","doi":"10.1016/j.jval.2014.03.150","title":"Impact Of The Pan Canadian Pricing Alliance On Time To Listing In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Intelligent Mechatronic Systems (Canada)","funders":"","keywords":"Formulary; Listing (finance); Business; Medicine; Negotiation; Accounting; Actuarial science; Family medicine; Political science; Finance","score_opus":0.36086119259712857,"score_gpt":0.5169666617294307,"score_spread":0.15610546913230217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147121365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53339356,0.008050764,0.0013241712,0.23495546,0.0026074452,0.0002905929,0.008661447,0.00041439134,0.21030222],"genre_scores_gemma":[0.94164926,0.0015775851,0.00075311924,0.018653058,0.0003115791,0.000040731218,0.0013815648,0.00011642617,0.035516612],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9884172,0.0007247939,0.00032379534,0.0006287595,0.0056730416,0.0042322865],"domain_scores_gemma":[0.9507234,0.005547797,0.00275143,0.0005640934,0.018767187,0.021646148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00675057,0.00030114016,0.0006081087,0.0028449448,0.006073082,0.010169379,0.0026460863,0.0038148654,0.012296714],"category_scores_gemma":[0.029390678,0.0005806086,0.0011379323,0.0036080023,0.00235374,0.0019963137,0.0026830276,0.004842102,0.00051018887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0021871654,0.00077395537,0.26010877,0.00034964504,0.00032256122,0.0011664531,0.0034363212,0.0102131115,0.0013066297,0.16436277,0.44152457,0.11424815],"study_design_scores_gemma":[0.00045192143,0.00033533637,0.62394583,0.0005078052,0.00025681357,0.00041392285,0.008280827,0.009796191,0.0010424764,0.0053319484,0.34926447,0.00037252615],"about_ca_topic_score_codex":0.9927214,"about_ca_topic_score_gemma":0.9961777,"teacher_disagreement_score":0.8371915,"about_ca_system_score_codex":0.16280846,"about_ca_system_score_gemma":0.2686918,"threshold_uncertainty_score":0.9710235},"labels":[],"label_agreement":null},{"id":"W2147408140","doi":"10.1016/j.jval.2012.08.505","title":"MO3 Lessons Learned From a Cross-Validation Between a Discrete-Event Simulation Model and a Markov Model for Personalized Breast Cancer Treatment","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"","keywords":"Breast cancer; Markov model; Discrete event simulation; Event (particle physics); Computer science; Medicine; Cohort; Econometrics; Markov chain; Statistics; Cancer; Machine learning; Simulation; Internal medicine; Mathematics","score_opus":0.6086760173766933,"score_gpt":0.5163141255591167,"score_spread":0.09236189181757659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147408140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.52935255,0.0007718736,0.4542845,0.003541972,0.00020981109,0.00018399199,0.0015080172,0.0014805407,0.008666809],"genre_scores_gemma":[0.95808315,0.00007099114,0.03881292,0.00033362594,0.000035425648,0.000076092314,0.0010100674,0.0001183508,0.0014594379],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9958324,0.0032253244,0.00015126148,0.0004307527,0.00021976161,0.00014059886],"domain_scores_gemma":[0.91848975,0.07405766,0.0010169507,0.0032700694,0.0026428192,0.00052278786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019126654,0.00061501976,0.0008202459,0.0005926893,0.00062199513,0.0011330012,0.0015617961,0.001522199,0.005209069],"category_scores_gemma":[0.069294855,0.0005838021,0.000847208,0.00039349814,0.0006081504,0.0013435475,0.0009820439,0.0022131947,0.00060403603],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005801116,0.00029103595,0.015150848,0.00008384889,0.00030723872,0.00008903223,0.000103124294,0.9457878,0.00055532553,0.0067964355,0.0025935646,0.027661642],"study_design_scores_gemma":[0.00003910134,0.000044215223,0.0010775018,0.000015493526,0.000017422099,0.000008287599,0.000011976785,0.99457526,0.00022870196,0.003738745,0.00023601127,0.00000728253],"about_ca_topic_score_codex":0.03267128,"about_ca_topic_score_gemma":0.02792379,"teacher_disagreement_score":0.03267128,"about_ca_system_score_codex":0.0010293821,"about_ca_system_score_gemma":0.0020774622,"threshold_uncertainty_score":0.1011526},"labels":[],"label_agreement":null},{"id":"W2147546274","doi":"10.1111/j.1524-4733.2007.00180.x","title":"The Cost-Effectiveness of Stem Cell Transplantations from Unrelated Donors in Adult Patients with Acute Leukemia","year":2007,"lang":"en","type":"review","venue":"Value in Health","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cord blood; Transplantation; Stem cell; Acute leukemia; Cost effectiveness; Haematopoiesis; Leukemia; Hematopoietic stem cell transplantation; Bone marrow; Surgery; Internal medicine; Oncology; Biology","score_opus":0.05235193059888549,"score_gpt":0.34201199137865906,"score_spread":0.2896600607797736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147546274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021413084,0.9992487,0.000037017213,0.0002225995,0.000052202242,0.0000015265443,0.00001629434,7.281427e-7,0.00020670955],"genre_scores_gemma":[0.0040366473,0.9953843,0.00012531388,0.00019314674,0.00016091554,0.000004261982,0.000025791927,6.630642e-7,0.000069066235],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993523,0.00021403993,0.00010962868,0.000060713097,0.00023484697,0.000028510882],"domain_scores_gemma":[0.99777335,0.0016462967,0.0003138667,0.00001726135,0.00021348971,0.000035704223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013759899,0.00059643027,0.0022028196,0.0014368513,0.00009928528,0.00078571535,0.0007546908,0.00088466454,0.0018182504],"category_scores_gemma":[0.0037117763,0.00019548839,0.0010553956,0.0024949152,0.0004231016,0.0007168907,0.000300165,0.0009941155,0.00025415712],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040655112,0.000048952934,0.0013233204,0.029143455,0.0010953179,0.00017569482,0.000025633766,0.00087677006,0.00021370855,0.0024455516,0.014443506,0.9498015],"study_design_scores_gemma":[0.00093023037,0.0011362128,0.03322492,0.07734593,0.01123889,0.0076813875,0.0004649181,0.0016511806,0.0012381723,0.012538791,0.85240287,0.00014650183],"about_ca_topic_score_codex":0.0017753332,"about_ca_topic_score_gemma":0.003520781,"teacher_disagreement_score":0.0022028196,"about_ca_system_score_codex":0.001027452,"about_ca_system_score_gemma":0.0011000601,"threshold_uncertainty_score":0.0074546933},"labels":[],"label_agreement":null},{"id":"W2147598538","doi":"10.1016/j.jval.2014.08.1028","title":"The Trend of the Prices Of New Marketed Drugs in Turkey","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Christian ministry; Factory (object-oriented programming); Government (linguistics); Business; Quarter (Canadian coin); Health care; Descriptive statistics; Consumption (sociology); Agricultural economics; Agricultural science; Geography; Economics; Economic growth; Mathematics; Political science; Statistics; Computer science; Environmental science","score_opus":0.07080932889010885,"score_gpt":0.30057025108409685,"score_spread":0.229760922193988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147598538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870402,0.0019386229,0.00033555692,0.003283186,0.00013969737,0.000005047631,0.0025135109,0.000031634885,0.0047124466],"genre_scores_gemma":[0.9969031,0.0008272568,0.00017716837,0.00014462875,0.00007528923,0.0000025137608,0.000857744,0.00000929584,0.0010029578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994783,0.00006381743,0.00007590905,0.00012134282,0.00012766184,0.00013304145],"domain_scores_gemma":[0.9976592,0.00031763734,0.00089880207,0.00005491582,0.000908524,0.00016102297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005817497,0.00024335485,0.00030235128,0.0011582738,0.00024339384,0.0018229532,0.00053120253,0.0011181292,0.0017990231],"category_scores_gemma":[0.0024307233,0.00021847755,0.00044946154,0.0019274013,0.00041201833,0.0010424068,0.00043482217,0.0011195847,0.00043766244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035371457,0.0002873213,0.80049515,0.0010204364,0.00057045463,0.0044507906,0.0022070897,0.021604659,0.008375933,0.031248778,0.042898633,0.08330359],"study_design_scores_gemma":[0.00004213799,0.00016885974,0.9679976,0.00005812924,0.00008607183,0.0010151281,0.001288495,0.008458614,0.0013187935,0.0011060018,0.018403137,0.00005704767],"about_ca_topic_score_codex":0.020819966,"about_ca_topic_score_gemma":0.0135752205,"teacher_disagreement_score":0.020819966,"about_ca_system_score_codex":0.0031923812,"about_ca_system_score_gemma":0.0012739773,"threshold_uncertainty_score":0.04139757},"labels":[],"label_agreement":null},{"id":"W2147874776","doi":"10.1016/j.jval.2012.08.1471","title":"PRM7 Increasing Physical Activity in Patients With Chronic Disease: What is the Literature Telling Us?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Physical therapy; Psychological intervention; Intervention (counseling); Randomized controlled trial; Aerobic exercise; Clinical trial; Quality of life (healthcare); Internal medicine","score_opus":0.028750937671518022,"score_gpt":0.3192341156498267,"score_spread":0.29048317797830864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147874776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037752052,0.85761356,0.00019726998,0.13042611,0.0028685005,0.00005085089,0.00032889855,0.000013169825,0.004726494],"genre_scores_gemma":[0.07017034,0.851015,0.0016801034,0.060783755,0.014850102,0.00018980695,0.0004067762,0.000031097035,0.00087306695],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9916373,0.004305734,0.001513882,0.00060110656,0.0015855847,0.0003564075],"domain_scores_gemma":[0.87500054,0.106052965,0.0070007974,0.0012004763,0.009031553,0.0017137233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016916245,0.0007370288,0.004828583,0.0020205681,0.0010455806,0.005827817,0.0031261619,0.006796923,0.014663372],"category_scores_gemma":[0.0848384,0.0007593036,0.0028228853,0.004545846,0.0029610363,0.0043836767,0.002244087,0.008097149,0.001850536],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004116199,0.0005504995,0.01304739,0.08551812,0.006495058,0.00031192438,0.0013176207,0.00029390014,0.00023172803,0.0078621395,0.07213074,0.80812466],"study_design_scores_gemma":[0.0072923754,0.003287781,0.06826331,0.40144795,0.021530725,0.0011475368,0.007658783,0.00092027255,0.00066758227,0.030144893,0.4572183,0.00042050335],"about_ca_topic_score_codex":0.008680289,"about_ca_topic_score_gemma":0.014171833,"teacher_disagreement_score":0.016916245,"about_ca_system_score_codex":0.0029791442,"about_ca_system_score_gemma":0.0078726495,"threshold_uncertainty_score":0.0894627},"labels":[],"label_agreement":null},{"id":"W2149721949","doi":"10.1016/j.jval.2014.03.162","title":"Shortcutting Drug Development: Economic Benefits Of Using Genome-Wide Association Studies (Gwas) To Reposition Existing Drugs To Other Therapeutic Areas","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Genome-wide association study; Denosumab; Drug; Disease; Intensive care medicine; Environmental health; Osteoporosis; Pharmacology; Internal medicine; Single-nucleotide polymorphism; Biology","score_opus":0.4197334507513929,"score_gpt":0.4311975924285054,"score_spread":0.011464141677112516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149721949","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13680191,0.16126221,0.28499642,0.3163495,0.009266357,0.0011035064,0.0078663835,0.0019286487,0.08042502],"genre_scores_gemma":[0.82427984,0.033241745,0.09877752,0.03132206,0.0046800384,0.00030076402,0.0013002594,0.00018835158,0.0059094075],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98376197,0.011323369,0.00081320334,0.0008708688,0.0030164896,0.00021409134],"domain_scores_gemma":[0.7945105,0.1751662,0.010506477,0.0106545305,0.0068746484,0.0022876202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029718788,0.0015723807,0.002029823,0.0036309096,0.00045845206,0.0039894446,0.0016292684,0.0052345414,0.008019691],"category_scores_gemma":[0.12578829,0.00059238094,0.0016385284,0.0035367229,0.0033996808,0.005319789,0.002023011,0.004023313,0.00087965856],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051923646,0.0007423624,0.037355393,0.0021010607,0.003542939,0.0004906466,0.00018188964,0.033459388,0.0024740729,0.08660908,0.04005184,0.78779906],"study_design_scores_gemma":[0.0026386003,0.002958514,0.040648855,0.0018891714,0.003237314,0.001158847,0.0003710054,0.081711136,0.004035632,0.76903707,0.09197729,0.00033650847],"about_ca_topic_score_codex":0.004275031,"about_ca_topic_score_gemma":0.0036364808,"teacher_disagreement_score":0.029718788,"about_ca_system_score_codex":0.0018711578,"about_ca_system_score_gemma":0.004720609,"threshold_uncertainty_score":0.15716982},"labels":[],"label_agreement":null},{"id":"W2150353433","doi":"10.1016/j.jval.2014.03.1720","title":"Comparison of Contemporaneous EQ-5D and SF-6D Responses Using Scoring Algorithms Derived from Similar Valuation Exercises","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Simon Fraser University; Vancouver Coastal Health","funders":"","keywords":"Comparability; EQ-5D; Intraclass correlation; Statistics; Valuation (finance); Descriptive statistics; Mathematics; Medicine; Population; Health related quality of life; Psychometrics","score_opus":0.7350037959906607,"score_gpt":0.4650026736951401,"score_spread":0.2700011222955206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150353433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9539165,0.00028272907,0.039148834,0.00017158691,0.00010231891,0.00018428313,0.0023655936,0.00022825568,0.003599924],"genre_scores_gemma":[0.97482955,0.000110088455,0.02121556,0.00004125605,0.000021113128,0.00010062208,0.002924901,0.000056246452,0.0007006199],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99696153,0.0019161355,0.00025494548,0.00037187204,0.00039267907,0.000102880054],"domain_scores_gemma":[0.9708062,0.02312117,0.0009601786,0.0019467303,0.0029845093,0.00018114918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011307824,0.00050740654,0.00045970277,0.0015952558,0.0002446269,0.0010447442,0.00088761456,0.0009551926,0.003449166],"category_scores_gemma":[0.052890886,0.00018943778,0.0009801148,0.0013808866,0.00026022838,0.0010032788,0.00075023784,0.0006967906,0.00086451473],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013135986,0.0017502231,0.42891747,0.00063925545,0.0016396275,0.00043840162,0.0009958055,0.16065316,0.0062831533,0.0101142125,0.007839266,0.36759347],"study_design_scores_gemma":[0.00068251055,0.0019407773,0.42559433,0.00012641573,0.0004571291,0.00062016863,0.0005812107,0.55363005,0.005979925,0.006778609,0.003480689,0.00012813309],"about_ca_topic_score_codex":0.0035957766,"about_ca_topic_score_gemma":0.0032064982,"teacher_disagreement_score":0.011307824,"about_ca_system_score_codex":0.00063410884,"about_ca_system_score_gemma":0.00048510378,"threshold_uncertainty_score":0.059802175},"labels":[],"label_agreement":null},{"id":"W2150483767","doi":"10.1016/j.jval.2013.03.610","title":"Associations between negative impact on employment or relationships and haemophilia treatment centre (HTC) and health care practioner utilisation: Global results from the haemophilia experiences, results and opportunities (HERO) study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haemophilia; Medicine; Psychology; Pediatrics","score_opus":0.3016209411341109,"score_gpt":0.4207595362603023,"score_spread":0.1191385951261914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150483767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99767965,0.0004243254,0.000021283593,0.00021767414,0.000009232514,0.000005365357,0.0005644401,0.0000014984971,0.0010764144],"genre_scores_gemma":[0.99916744,0.00025359256,0.000023550108,0.000038578903,0.000011123721,0.0000051304296,0.0002676844,0.0000022618185,0.00023074124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871254,0.00066423125,0.0001262055,0.00008248556,0.00017363255,0.00024096953],"domain_scores_gemma":[0.992728,0.0016208743,0.0034373582,0.00026028338,0.00045377153,0.0014997828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014527128,0.00025245425,0.00031303754,0.0010241269,0.00071381713,0.0011964518,0.000479935,0.00072375656,0.002424589],"category_scores_gemma":[0.005794324,0.00024323494,0.00070593756,0.0026290705,0.0007405106,0.0008544746,0.0018839651,0.0009977687,0.00027487025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007039395,0.00007113765,0.9971507,0.000021991229,0.00009678651,0.000040675084,0.00051058724,0.000029044204,0.000023571036,0.000029112425,0.00014237336,0.0018136026],"study_design_scores_gemma":[0.0000032511136,0.000046580913,0.9982352,0.000012093876,0.000029130444,0.000047311663,0.001378178,0.000023843128,0.000011137024,0.00001800687,0.00019150389,0.0000037469297],"about_ca_topic_score_codex":0.015079743,"about_ca_topic_score_gemma":0.02213173,"teacher_disagreement_score":0.015079743,"about_ca_system_score_codex":0.00047870388,"about_ca_system_score_gemma":0.00050292263,"threshold_uncertainty_score":0.029983938},"labels":[],"label_agreement":null},{"id":"W2151380149","doi":"10.1016/j.jval.2014.03.1128","title":"The impact of two different case definitions of major congenital malformations identified from Quebec (Canada) administrative databases on their association with asthma controller medications taken during pregnancy","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Congenital malformations; Pregnancy; Medical diagnosis; Diagnosis code; Asthma; Epidemiology; Odds ratio; Pediatrics; Cohort; Database; Internal medicine; Environmental health","score_opus":0.09188650106104558,"score_gpt":0.37451128148151624,"score_spread":0.2826247804204707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151380149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680287,0.0029213354,0.00086734426,0.0036312672,0.00013650609,0.00015734247,0.019627398,0.000035494228,0.0045945914],"genre_scores_gemma":[0.9916255,0.00054869713,0.0008851465,0.00060581206,0.000031397467,0.00008671259,0.0056442185,0.000017159215,0.0005553336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98659444,0.00523539,0.0013700502,0.0019061434,0.0027545975,0.0021394056],"domain_scores_gemma":[0.94529164,0.027721293,0.011615669,0.0020871616,0.009913573,0.0033705889],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009017829,0.0008609876,0.00096897664,0.0026830265,0.001993848,0.0034958676,0.0031596362,0.0012761604,0.002002119],"category_scores_gemma":[0.06520368,0.00057979405,0.0021657094,0.0044859587,0.0011809162,0.0010147338,0.0021632225,0.0016870486,0.00013594207],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027328648,0.000030656014,0.9940767,0.000046478923,0.00041741852,0.00007712885,0.00026553287,0.0005281457,0.000062942505,0.0003226314,0.0014664559,0.0024324507],"study_design_scores_gemma":[0.00005581641,0.00004336329,0.9947412,0.00014492885,0.0003563993,0.00010831403,0.0009987797,0.0023190177,0.00011817213,0.00008673803,0.0010033239,0.000023836155],"about_ca_topic_score_codex":0.9834051,"about_ca_topic_score_gemma":0.98216194,"teacher_disagreement_score":0.9909822,"about_ca_system_score_codex":0.026459217,"about_ca_system_score_gemma":0.035808753,"threshold_uncertainty_score":0.19197595},"labels":[],"label_agreement":null},{"id":"W2151569515","doi":"10.1016/j.jval.2013.08.1429","title":"Psychoactive Drug Use, Polypharmacy and Co-Morbidities in Newly Diagnosed Patients with Pervasive Development Disorder in the Province of Quebec","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Rivière-des-Prairies; McMaster University; Université de Montréal","funders":"","keywords":"Polypharmacy; Cohort; Medicine; Antipsychotic; Pediatrics; Pervasive developmental disorder; Autism; Population; Psychiatry; Cohort study; Autism spectrum disorder; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.03654978086207198,"score_gpt":0.3174010573518409,"score_spread":0.2808512764897689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151569515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605715,0.000723365,0.000046254645,0.00035195914,0.000020233309,0.000024696637,0.0012955802,0.0000055083897,0.0014751692],"genre_scores_gemma":[0.9983909,0.0003881765,0.000070226204,0.00011876598,0.000007715637,0.000009649893,0.0004214575,0.0000024519768,0.00059071794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954945,0.00006290422,0.000043139076,0.00006594079,0.000115598195,0.00016292943],"domain_scores_gemma":[0.9987394,0.00014669725,0.0002898952,0.00002483234,0.00040400017,0.0003951658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030372042,0.00034360107,0.0004526527,0.001128304,0.0026568372,0.0012080985,0.0011262875,0.00070440763,0.003293388],"category_scores_gemma":[0.0016452811,0.00040324757,0.00063398347,0.0023246119,0.00058957445,0.0005455093,0.0006115186,0.0010689537,0.00020993834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030700416,0.00005254159,0.99757797,0.000017255914,0.00003664669,0.0001885445,0.00035139712,0.000057829053,0.00010742767,0.000029243853,0.00037414825,0.0011762402],"study_design_scores_gemma":[0.000009086193,0.000028105851,0.99758875,0.000030155852,0.000022210905,0.00016109392,0.0016166037,0.00026068822,0.000023714472,0.000012612234,0.00023876285,0.000008071567],"about_ca_topic_score_codex":0.98842037,"about_ca_topic_score_gemma":0.993148,"teacher_disagreement_score":0.01572264,"about_ca_system_score_codex":0.01572264,"about_ca_system_score_gemma":0.010916549,"threshold_uncertainty_score":0.11407626},"labels":[],"label_agreement":null},{"id":"W2151657070","doi":"10.1016/j.jval.2014.03.620","title":"The Use Of Pillbox And Time In Therapeutic Range Among New Users Of Warfarin: A Propective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Warfarin; Medicine; Atrial fibrillation; Concomitant; Dyslipidemia; Internal medicine; Cohort; Anticoagulant; Cohort study","score_opus":0.494861419169059,"score_gpt":0.5097098356320982,"score_spread":0.014848416463039138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151657070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979126,0.00014984154,0.00020381498,0.000039954677,0.000020715466,0.000036391604,0.0010388414,0.0000067224096,0.0005911246],"genre_scores_gemma":[0.99681747,0.00014098351,0.00019241055,0.000117679585,0.000032679938,0.000050548046,0.0010874049,0.000012121388,0.0015487531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984505,0.00042725637,0.00016445453,0.00041495686,0.0002372827,0.00030537695],"domain_scores_gemma":[0.9969969,0.00048613054,0.0010749255,0.00068625086,0.00027361733,0.00048226808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013316415,0.0007495711,0.00063037925,0.001213952,0.001160267,0.0018625257,0.0010494656,0.0014848759,0.004328205],"category_scores_gemma":[0.0034458912,0.0010836605,0.002430863,0.0016425585,0.00065768184,0.00217024,0.0013301052,0.002087719,0.0011098519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013424084,0.0003684469,0.9957228,0.000016538781,0.00061119604,0.00012108856,0.00028131524,0.000031349075,0.00039864946,0.000044268098,0.00016542008,0.0008964572],"study_design_scores_gemma":[0.00009672803,0.00079047395,0.99722797,0.000008465086,0.00023102321,0.0002254928,0.00065832754,0.00023569728,0.000090758615,0.00004712471,0.0003636922,0.00002436349],"about_ca_topic_score_codex":0.017522506,"about_ca_topic_score_gemma":0.015851267,"teacher_disagreement_score":0.017522506,"about_ca_system_score_codex":0.00057784416,"about_ca_system_score_gemma":0.0006736763,"threshold_uncertainty_score":0.03484106},"labels":[],"label_agreement":null},{"id":"W2152497461","doi":"10.1016/j.jval.2011.02.465","title":"PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Stenosis; Aortic valve replacement; Aortic valve; Incremental cost-effectiveness ratio; Cardiology; Quality-adjusted life year; Surgery; Cost-effectiveness analysis; Cost effectiveness; Internal medicine","score_opus":0.019571072331127346,"score_gpt":0.2981575987015084,"score_spread":0.278586526370381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152497461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9636096,0.013293473,0.001450596,0.0047272737,0.00041204927,0.00020229437,0.0071750297,0.000060269977,0.009069278],"genre_scores_gemma":[0.9969414,0.000705723,0.0005076282,0.00026602496,0.00011158495,0.000043748707,0.0010298822,0.000004267066,0.00038964083],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978588,0.0015108188,0.0001447192,0.00014181917,0.00022506765,0.00011875806],"domain_scores_gemma":[0.9915775,0.0063720746,0.000983837,0.00025136396,0.00027206648,0.00054306525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002169989,0.00048737513,0.0010487365,0.0007886359,0.0001605091,0.0011289131,0.0005940965,0.00069097924,0.0069901757],"category_scores_gemma":[0.019261943,0.00020756481,0.0024225933,0.0010538012,0.00037795777,0.00082308875,0.0008238358,0.00090970326,0.00024078469],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19465736,0.0017675067,0.41729242,0.002304072,0.010357489,0.0007473118,0.00025850823,0.033504236,0.0010476038,0.003810245,0.016001342,0.318252],"study_design_scores_gemma":[0.018960595,0.028610427,0.8553655,0.0012327938,0.009446296,0.001158882,0.00043734914,0.06484675,0.0021969716,0.0074470025,0.0100818975,0.00021558111],"about_ca_topic_score_codex":0.0030021886,"about_ca_topic_score_gemma":0.0027482556,"teacher_disagreement_score":0.0069901757,"about_ca_system_score_codex":0.0016348874,"about_ca_system_score_gemma":0.00086910283,"threshold_uncertainty_score":0.023384452},"labels":[],"label_agreement":null},{"id":"W2152532978","doi":"10.1016/j.jval.2012.06.005","title":"Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Canadian Institute for Health Information; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Telbivudine; Entecavir; Lamivudine; Medicine; Internal medicine; Hepatitis B; Cost-effectiveness analysis; Chronic hepatitis; Cost effectiveness; Virology; Risk analysis (engineering); Virus","score_opus":0.15173603591052232,"score_gpt":0.41691097069973554,"score_spread":0.2651749347892132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152532978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004091822,0.994212,0.00005817016,0.00029583054,0.000064003834,0.00006470854,0.00053070486,0.000002983638,0.00067984307],"genre_scores_gemma":[0.07278672,0.9258006,0.00039956893,0.00027403003,0.000054032163,0.00006377422,0.00037297237,0.0000029158994,0.00024540265],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981654,0.00051753205,0.00031742777,0.00009644241,0.0007486075,0.00015461301],"domain_scores_gemma":[0.99526805,0.0026701267,0.000744934,0.00005158701,0.0010907309,0.00017450079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033794828,0.00093487307,0.004145415,0.004257226,0.00048779687,0.0016011974,0.0013356437,0.0007139508,0.0031314013],"category_scores_gemma":[0.010958456,0.00047798755,0.006028037,0.00896949,0.00056680496,0.0004946813,0.0005867452,0.0010892842,0.00007637984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007512958,0.00024942987,0.012415995,0.46773353,0.06515217,0.00034426278,0.00024805588,0.0057346663,0.00041660905,0.0025099127,0.012558497,0.42512387],"study_design_scores_gemma":[0.008160973,0.0019584275,0.15059683,0.33292285,0.36312935,0.0013188799,0.0009295076,0.0047352226,0.00093843596,0.0034198344,0.13165112,0.00023860077],"about_ca_topic_score_codex":0.61171365,"about_ca_topic_score_gemma":0.7706795,"teacher_disagreement_score":0.38828635,"about_ca_system_score_codex":0.028230289,"about_ca_system_score_gemma":0.026984708,"threshold_uncertainty_score":0.7811461},"labels":[],"label_agreement":null},{"id":"W2153012086","doi":"10.1111/j.1524-4733.2009.00602.x","title":"Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part III","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":290,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Causal inference; Inference; Confounding; Statistical inference; Comparative effectiveness research; Marginal structural model; Medicine; Propensity score matching; Instrumental variable; Outcomes research; Research design; Computer science; Econometrics; Management science; Statistics; Machine learning; Alternative medicine; Artificial intelligence; Engineering; Mathematics","score_opus":0.8166517374954501,"score_gpt":0.7018213479349174,"score_spread":0.11483038956053271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153012086","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007430957,0.0063399733,0.974567,0.005983197,0.0008310063,0.007809747,0.00086774386,0.00096649455,0.0018917179],"genre_scores_gemma":[0.0055483025,0.0013530938,0.98064834,0.00072128186,0.00021126682,0.010941559,0.00016423565,0.00024274862,0.00016915212],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.1846051,0.6939537,0.06974253,0.0068140347,0.044064023,0.0008206039],"domain_scores_gemma":[0.068709925,0.7520049,0.022843193,0.107571244,0.04724993,0.0016208022],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6625069,0.0045049936,0.008170646,0.014673661,0.004130589,0.008334371,0.008192461,0.009741425,0.00858853],"category_scores_gemma":[0.85819036,0.008448055,0.008323249,0.013923876,0.010181987,0.007947354,0.008001915,0.018891452,0.0038864457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015401662,0.00061617716,0.006060954,0.043675218,0.00830146,0.0003621519,0.010879524,0.005616106,0.0019280501,0.13466388,0.110014126,0.6763422],"study_design_scores_gemma":[0.005615057,0.0015032677,0.013216229,0.07513554,0.0102809835,0.0022390073,0.0019329594,0.03648195,0.014895748,0.64448065,0.19331583,0.0009027511],"about_ca_topic_score_codex":0.002488,"about_ca_topic_score_gemma":0.0038120467,"teacher_disagreement_score":0.33749312,"about_ca_system_score_codex":0.004597995,"about_ca_system_score_gemma":0.01878429,"threshold_uncertainty_score":0.41618913},"labels":[],"label_agreement":null},{"id":"W2153034074","doi":"10.1016/j.jval.2014.03.092","title":"Point Of Care Tests: The Long And Winding Road To Reimbursement In The United States And Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Test (biology); Payment; Health care; Health technology; Business; Market access; Actuarial science; Medicine; Medical emergency; Finance; Economics; Economic growth","score_opus":0.21356528357411972,"score_gpt":0.38418255162819087,"score_spread":0.17061726805407115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153034074","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12793742,0.06878693,0.002542778,0.7486474,0.0028541028,0.00016407945,0.0073178103,0.00014930902,0.041600235],"genre_scores_gemma":[0.8526348,0.06268847,0.005627067,0.05742674,0.0016643694,0.00009598834,0.004221081,0.00020522065,0.015436281],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99069595,0.0013301851,0.00051399955,0.0004958144,0.0048372946,0.002126845],"domain_scores_gemma":[0.957211,0.006343138,0.002632458,0.00052244775,0.019822093,0.013468733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007688775,0.000411592,0.00101588,0.0035741054,0.0031997338,0.006957046,0.002758152,0.0038686432,0.0050663855],"category_scores_gemma":[0.034350116,0.000494132,0.00095017307,0.008023656,0.004511737,0.002914353,0.0023892883,0.0060749077,0.0002895744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006861383,0.0002880876,0.20515901,0.00062654086,0.0002499684,0.00069739716,0.0014239274,0.0038895244,0.00038613947,0.100270584,0.37015396,0.31616887],"study_design_scores_gemma":[0.00035141656,0.0002148609,0.6824331,0.0032218704,0.0002978966,0.00087220146,0.0067007984,0.010115842,0.00048144232,0.029989379,0.26491746,0.00040371052],"about_ca_topic_score_codex":0.99278307,"about_ca_topic_score_gemma":0.9958585,"teacher_disagreement_score":0.14583196,"about_ca_system_score_codex":0.14583196,"about_ca_system_score_gemma":0.23413152,"threshold_uncertainty_score":0.99071383},"labels":[],"label_agreement":null},{"id":"W2153056334","doi":"10.1016/s1098-3015(10)61559-8","title":"DB1 ACARBOSE FOR THE PREVENTION OF TYPE II DIABETES IN CANADA: AN ECONOMIC EVALUATION","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acarbose; Type 2 diabetes; Medicine; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.10449373803712238,"score_gpt":0.3787518018687417,"score_spread":0.2742580638316193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153056334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9153462,0.049722183,0.0007442708,0.0075306054,0.00030273455,0.0027012844,0.0077914153,0.000058113164,0.015803218],"genre_scores_gemma":[0.98112905,0.01438325,0.0009822837,0.000861116,0.000086846965,0.00021615517,0.0011697302,0.000006654226,0.00116485],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99396354,0.0031573528,0.00028733566,0.00022037997,0.0017416216,0.00062969077],"domain_scores_gemma":[0.9927061,0.0023259448,0.0009048035,0.0001396036,0.0017141628,0.0022093817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051613194,0.00092844904,0.0016965793,0.0019809383,0.0018210912,0.0018465258,0.0014582666,0.0016609883,0.0029003061],"category_scores_gemma":[0.01252815,0.0004403541,0.0023439964,0.0031574953,0.0014204577,0.00063077133,0.00081540796,0.0017908403,0.00009905501],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5528665,0.010460049,0.09119357,0.007431451,0.00910956,0.000671023,0.0004886794,0.018828794,0.0014576463,0.0056269537,0.013408214,0.2884575],"study_design_scores_gemma":[0.2471812,0.11168357,0.45832586,0.006603083,0.06380951,0.0011515745,0.0029677427,0.05478261,0.0028289678,0.0036048156,0.04650391,0.00055711257],"about_ca_topic_score_codex":0.909433,"about_ca_topic_score_gemma":0.9230487,"teacher_disagreement_score":0.09056699,"about_ca_system_score_codex":0.05451843,"about_ca_system_score_gemma":0.0665731,"threshold_uncertainty_score":0.39556074},"labels":[],"label_agreement":null},{"id":"W2153343914","doi":"10.1016/j.jval.2012.08.821","title":"PMH31 Genetic Testing in Combination With Preventive Donepezil Treatment for Amnestic Mild Cognitive Impairment Patients: An Exploratory Economic Evaluation of Personalized Medicine","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Hospital for Sick Children; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Donepezil; Medicine; Genetic testing; Cost–utility analysis; Dementia; Cost effectiveness; Intensive care medicine; Internal medicine; Risk analysis (engineering); Disease","score_opus":0.48579837440529383,"score_gpt":0.44838688554465406,"score_spread":0.037411488860639774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153343914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901057,0.0028651606,0.0015875127,0.0009271827,0.000071243114,0.0009894528,0.0010163074,0.000020301788,0.0024170855],"genre_scores_gemma":[0.9982956,0.0003428955,0.0007492723,0.000067739704,0.000023271694,0.00019348493,0.0001996866,0.0000024177637,0.00012551928],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9902462,0.008290742,0.00027719108,0.000368278,0.00044744735,0.0003702688],"domain_scores_gemma":[0.9849878,0.011969203,0.0013592097,0.00050781574,0.00030707635,0.00086892734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0104813045,0.002016975,0.0023540468,0.0012254665,0.0006825344,0.0017123293,0.00106051,0.0025621706,0.0039668945],"category_scores_gemma":[0.022415256,0.0006767765,0.0046270094,0.0010109228,0.0015239228,0.0015322412,0.0013563696,0.0019657782,0.00022546557],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84085226,0.01345991,0.022950768,0.0012560609,0.008689135,0.0006402096,0.00019414873,0.042592376,0.0014628732,0.0028204275,0.0009413147,0.06414047],"study_design_scores_gemma":[0.334632,0.3980284,0.06799964,0.0009097913,0.03935415,0.0012530192,0.001022232,0.1408562,0.002742612,0.009502631,0.0033105602,0.0003887511],"about_ca_topic_score_codex":0.004667955,"about_ca_topic_score_gemma":0.003746517,"teacher_disagreement_score":0.0104813045,"about_ca_system_score_codex":0.004296984,"about_ca_system_score_gemma":0.0026115766,"threshold_uncertainty_score":0.055431068},"labels":[],"label_agreement":null},{"id":"W2153434255","doi":"10.1111/j.1524-4733.2009.00600.x","title":"Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":410,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Comparative effectiveness research; Observational study; Medicine; Outcomes research; Research design; MEDLINE; Management science; Medical education; Alternative medicine; Political science","score_opus":0.827067872307364,"score_gpt":0.6782163137175784,"score_spread":0.1488515585897856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153434255","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026086846,0.028451553,0.8551591,0.041641288,0.004527185,0.05206628,0.003922966,0.0023635959,0.009259432],"genre_scores_gemma":[0.011723814,0.0053060916,0.94130754,0.004026701,0.0008203619,0.035165764,0.00065260153,0.0004787897,0.0005182768],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.07467246,0.727362,0.1487023,0.005365074,0.042896297,0.001001934],"domain_scores_gemma":[0.03152167,0.71007997,0.04355283,0.13438125,0.07832268,0.0021415977],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.8188614,0.004278625,0.009915556,0.022719547,0.006520698,0.015469158,0.012684575,0.015987273,0.0057026134],"category_scores_gemma":[0.9128755,0.010650094,0.010172428,0.022344345,0.018065698,0.009132237,0.010010248,0.02305412,0.0050095734],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022072983,0.00077344145,0.0118009485,0.06770996,0.0074018305,0.0006186959,0.027346881,0.003605696,0.0034499892,0.09682884,0.19254196,0.5857146],"study_design_scores_gemma":[0.0054057217,0.002235779,0.032868102,0.19027258,0.009962453,0.0037192297,0.005144582,0.012725346,0.019770388,0.28660047,0.42988905,0.0014063378],"about_ca_topic_score_codex":0.0048467065,"about_ca_topic_score_gemma":0.0076370765,"teacher_disagreement_score":0.18113858,"about_ca_system_score_codex":0.006934171,"about_ca_system_score_gemma":0.040728934,"threshold_uncertainty_score":0.22337615},"labels":[],"label_agreement":null},{"id":"W2153437086","doi":"10.1016/j.jval.2015.09.896","title":"Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Université de Montréal","funders":"","keywords":"Medicine; Statin; Myopathy; Pharmacogenomics; Rhabdomyolysis; Physical therapy; Test (biology); Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.08329011053762649,"score_gpt":0.3353127573321463,"score_spread":0.25202264679451986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153437086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9577851,0.004597234,0.015345422,0.006758482,0.00039133153,0.0039032202,0.002798529,0.00009181004,0.008328847],"genre_scores_gemma":[0.9956488,0.00028780336,0.0027251025,0.00028740233,0.00005465656,0.00036267174,0.0003216765,0.000004271404,0.00030767624],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9811817,0.015597522,0.00059649936,0.0007667868,0.0011730534,0.0006844589],"domain_scores_gemma":[0.92504674,0.065693155,0.0037492644,0.0012196347,0.0017427003,0.0025486185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01785484,0.0013499561,0.0021821256,0.0012854475,0.0004794231,0.0020086914,0.001460139,0.00269741,0.0059399824],"category_scores_gemma":[0.07907092,0.00054753356,0.0029101009,0.0007917333,0.001360801,0.0013856186,0.0014331875,0.0020523523,0.00027225426],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4307209,0.013680328,0.12478598,0.0021849528,0.009938952,0.0012364071,0.00022039292,0.22386976,0.002163907,0.013110693,0.004317852,0.17376985],"study_design_scores_gemma":[0.0768837,0.13812135,0.11906811,0.001259633,0.016965164,0.0012709048,0.0007106407,0.62177473,0.002448891,0.015483019,0.005662956,0.00035092948],"about_ca_topic_score_codex":0.005285577,"about_ca_topic_score_gemma":0.0026690124,"teacher_disagreement_score":0.01785484,"about_ca_system_score_codex":0.003887247,"about_ca_system_score_gemma":0.0046983124,"threshold_uncertainty_score":0.09442657},"labels":[],"label_agreement":null},{"id":"W2154184053","doi":"10.1016/j.jval.2014.03.926","title":"Cost Utility Analysis In Child Health: Will The Growth Spurt Be Sustained?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Economic evaluation; Cost–utility analysis; Citation; Cost–benefit analysis; Cost effectiveness; Computer science; Library science; Risk analysis (engineering)","score_opus":0.33921743501037516,"score_gpt":0.41768611312104587,"score_spread":0.07846867811067071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154184053","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19210191,0.23448221,0.24912219,0.2829933,0.0027859043,0.00021561854,0.0016973976,0.000103110564,0.03649842],"genre_scores_gemma":[0.9258248,0.044178292,0.017570663,0.004768119,0.0024879395,0.000209071,0.00048270368,0.00007476607,0.00440362],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99405175,0.005225528,0.00009135197,0.00010988886,0.00032749015,0.00019396286],"domain_scores_gemma":[0.953554,0.042808086,0.0010251894,0.0005173087,0.0014490678,0.0006463513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013097391,0.00082804717,0.0013911023,0.0012292385,0.00025758907,0.0024316437,0.0012360517,0.0018861297,0.004395868],"category_scores_gemma":[0.07558082,0.00037282018,0.000787994,0.0025415993,0.0021585638,0.0045691747,0.0009492456,0.0046995026,0.00020227616],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000670363,0.00028953995,0.022494597,0.0015742773,0.00078699866,0.0002855198,0.0006548682,0.10753547,0.0001617013,0.63455063,0.029664338,0.20133165],"study_design_scores_gemma":[0.00011911889,0.00017405156,0.012960586,0.0015764828,0.00029407904,0.00027145003,0.0009917618,0.13939615,0.00020129023,0.82187384,0.022072008,0.00006921048],"about_ca_topic_score_codex":0.008751426,"about_ca_topic_score_gemma":0.005708253,"teacher_disagreement_score":0.013097391,"about_ca_system_score_codex":0.0039586946,"about_ca_system_score_gemma":0.0027736814,"threshold_uncertainty_score":0.06926644},"labels":[],"label_agreement":null},{"id":"W2154499481","doi":"10.1016/j.jval.2013.03.716","title":"Return Of Incidental Findings In Genomic Medicine: Measuring What Patients Value","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Salience (neuroscience); Comprehension; Disease; Medicine; Set (abstract data type); Genetic testing; Intervention (counseling); Precision medicine; Psychology; Computer science; Internal medicine; Cognitive psychology; Psychiatry; Pathology","score_opus":0.3103361593143038,"score_gpt":0.37963300308310804,"score_spread":0.06929684376880424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154499481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499626,0.0062733563,0.0052657197,0.02642709,0.00021144045,0.00006858466,0.0019792488,0.00003829577,0.009773691],"genre_scores_gemma":[0.9970228,0.00067090086,0.0007801867,0.0007603202,0.00018825312,0.000012473656,0.00029928784,0.000008147956,0.00025764154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98408127,0.011048031,0.0010449063,0.0006904588,0.0023387477,0.0007965977],"domain_scores_gemma":[0.8047318,0.14279027,0.032316174,0.0070149987,0.00709159,0.0060551786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013822723,0.00035902145,0.0009073621,0.0019806093,0.00044318993,0.0029347383,0.0008919512,0.0026529827,0.0031992411],"category_scores_gemma":[0.18778588,0.00022263595,0.0008838169,0.002350968,0.0017563791,0.0037084436,0.0019034813,0.0024207204,0.0005478303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012215844,0.00040596444,0.91278934,0.00017746915,0.00050702796,0.0007408072,0.00044808412,0.0034614047,0.00029133415,0.008563706,0.003718205,0.06767512],"study_design_scores_gemma":[0.00022051642,0.002701164,0.8289336,0.00065847446,0.001494184,0.006130906,0.0033990142,0.028456144,0.0034714525,0.112535715,0.0118234195,0.00017545525],"about_ca_topic_score_codex":0.0018170824,"about_ca_topic_score_gemma":0.0013065266,"teacher_disagreement_score":0.013822723,"about_ca_system_score_codex":0.0018108384,"about_ca_system_score_gemma":0.0013461431,"threshold_uncertainty_score":0.073102415},"labels":[],"label_agreement":null},{"id":"W2155067918","doi":"10.1016/j.jval.2014.03.118","title":"A Comparison Of The Medicare Average Sales Price And The Average Wholesaler Price","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicaid; Medicine; Business; Actuarial science; Health care; Economics","score_opus":0.07900655963932553,"score_gpt":0.32525023505912637,"score_spread":0.24624367541980086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155067918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96088713,0.002891339,0.003938363,0.0029092361,0.00021397442,0.00002084479,0.0017636887,0.0000619343,0.027313538],"genre_scores_gemma":[0.9973441,0.00025173827,0.0008670782,0.00010665849,0.00008925684,0.000004245833,0.000492639,0.000012681522,0.0008315901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986802,0.00054918707,0.000044072207,0.00012407599,0.00050776347,0.000094785515],"domain_scores_gemma":[0.98807716,0.009222547,0.0008297399,0.00046895936,0.0010543248,0.00034737014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023480565,0.00013064753,0.00037058262,0.0010061441,0.00030385103,0.0014411261,0.0006473295,0.0006500958,0.0039390745],"category_scores_gemma":[0.019019682,0.00010091184,0.0005646163,0.0018397578,0.00040265714,0.0013366529,0.00041795295,0.0005988691,0.0002562306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009921055,0.00048069176,0.333097,0.0006988597,0.0010363864,0.0008479283,0.0011638395,0.07572706,0.005366405,0.32730252,0.038352042,0.20600614],"study_design_scores_gemma":[0.0005135913,0.0021010726,0.79896206,0.00010347365,0.00046431023,0.0009304879,0.0018474762,0.13170291,0.003090035,0.037586614,0.0225968,0.00010125999],"about_ca_topic_score_codex":0.011901905,"about_ca_topic_score_gemma":0.009236176,"teacher_disagreement_score":0.011901905,"about_ca_system_score_codex":0.0020980302,"about_ca_system_score_gemma":0.00076529954,"threshold_uncertainty_score":0.02366525},"labels":[],"label_agreement":null},{"id":"W2155097838","doi":"10.1016/j.jval.2013.08.554","title":"Utility Mapping of the EORTC QLQ-C30 onto EQ-5D in Patients with Soft Tissue Sarcoma","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Statistics; Mean squared error; Mathematics; Quality of life (healthcare); Gee; Population; Ordinary least squares; Medicine; Standard error; Linear regression; Soft tissue sarcoma; Generalized estimating equation; Surgery; Soft tissue","score_opus":0.05963277054384196,"score_gpt":0.28651713207416063,"score_spread":0.22688436153031866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155097838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951165,0.0010483828,0.0009596553,0.00027619483,0.000014866713,0.000016319857,0.0005155109,0.000009830591,0.0020428451],"genre_scores_gemma":[0.9995377,0.000077884826,0.00014112229,0.000025734198,0.0000027002236,0.0000045105708,0.00014247592,0.000002383662,0.000065529646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993068,0.00042656416,0.000034346973,0.00006547179,0.00008267613,0.0000842207],"domain_scores_gemma":[0.99804735,0.0013334189,0.00024262667,0.00010744184,0.00018384577,0.00008542287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017913798,0.0002422467,0.00037802887,0.00088156207,0.0001427722,0.0010262051,0.00034237586,0.0002786878,0.001504561],"category_scores_gemma":[0.010086163,0.00011086376,0.00081355264,0.0012732544,0.00040292784,0.0006968138,0.0008388382,0.0005687938,0.00016997545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012502791,0.00006147619,0.94644403,0.0000807959,0.00030602756,0.00008150006,0.00026495973,0.006406568,0.0004751334,0.00078483194,0.00071916415,0.043125264],"study_design_scores_gemma":[0.00007273534,0.00063440984,0.97710484,0.000056064186,0.0002770379,0.00017128095,0.0006793213,0.01782123,0.00033673143,0.002089612,0.000735171,0.000021534426],"about_ca_topic_score_codex":0.0071775,"about_ca_topic_score_gemma":0.0050455006,"teacher_disagreement_score":0.0071775,"about_ca_system_score_codex":0.00088558544,"about_ca_system_score_gemma":0.00046456628,"threshold_uncertainty_score":0.014271438},"labels":[],"label_agreement":null},{"id":"W2155788143","doi":"10.1016/j.jval.2010.11.009","title":"Brief, Valid Measures of Dyspnea and Related Functional Limitations in Chronic Obstructive Pulmonary Disease (COPD)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"COPD; Medicine; Intraclass correlation; Physical therapy; Pulmonary function testing; Pulmonary disease; Item response theory; Computerized adaptive testing; Internal medicine; Cardiology; Psychometrics; Clinical psychology","score_opus":0.14041724518298293,"score_gpt":0.3151660855557331,"score_spread":0.17474884037275018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155788143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9677413,0.0039010777,0.003316822,0.0012575976,0.0002589019,0.0034322608,0.005807297,0.000121968624,0.01416281],"genre_scores_gemma":[0.9691096,0.0021746992,0.014388216,0.0010323335,0.0001716722,0.004139483,0.004482615,0.00002207227,0.004479271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775213,0.0005523189,0.00045179125,0.00017073602,0.0008464287,0.00022673488],"domain_scores_gemma":[0.9931292,0.002472162,0.0023066192,0.0002619827,0.001044939,0.00078514096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029341162,0.000654478,0.0010129744,0.0010541711,0.0007859321,0.0007510999,0.0007327578,0.0013322567,0.0030562223],"category_scores_gemma":[0.009723695,0.0003333938,0.0011819697,0.0006232787,0.00041587857,0.0011873959,0.0013807031,0.0017765369,0.0004932132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022961146,0.0063361735,0.7588204,0.0011356039,0.0011629807,0.00025630902,0.00202253,0.0013960875,0.00406997,0.0014519872,0.020643808,0.20040806],"study_design_scores_gemma":[0.0002501061,0.0013357463,0.992493,0.00012568473,0.00012474258,0.00030662495,0.00035742027,0.0006000972,0.00042366126,0.0007008384,0.0032371276,0.000045090397],"about_ca_topic_score_codex":0.0018387651,"about_ca_topic_score_gemma":0.008687218,"teacher_disagreement_score":0.0030562223,"about_ca_system_score_codex":0.0007388744,"about_ca_system_score_gemma":0.00096983183,"threshold_uncertainty_score":0.015517235},"labels":[],"label_agreement":null},{"id":"W2155814518","doi":"10.1016/j.jval.2011.05.015","title":"The Use of a Decision Board to Elicit Brazilian Patients' and Physicians' Preferences for Treatment: The Case of Lupus Nephritis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Logistic regression; Medicine; Lupus nephritis; Systemic lupus erythematosus; Descriptive statistics; Family medicine; Demography; Internal medicine; Disease; Statistics","score_opus":0.33016596157574774,"score_gpt":0.4136750218684872,"score_spread":0.08350906029273947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155814518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97454333,0.00019589283,0.012508574,0.0029543538,0.00008223899,0.00077854487,0.00019572009,0.000040842857,0.008700471],"genre_scores_gemma":[0.980339,0.00012619808,0.018043753,0.00041228364,0.000019291592,0.00047425306,0.00011032551,0.0000076120828,0.00046722937],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9662222,0.031008344,0.0011336193,0.00043511207,0.0006693083,0.0005313431],"domain_scores_gemma":[0.7991527,0.18638909,0.0046700346,0.0032480904,0.0048658396,0.0016742499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029219734,0.0004101547,0.0006055555,0.0011332635,0.0013534867,0.00188055,0.00048665144,0.0012634047,0.0028104447],"category_scores_gemma":[0.150139,0.00035824807,0.0005281437,0.0010007756,0.0010858425,0.0010197316,0.0011865072,0.0012511428,0.00033706558],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013590937,0.007430724,0.36225438,0.0011386737,0.0006470012,0.0021922141,0.06611299,0.020991968,0.010273256,0.023260133,0.011569282,0.48053846],"study_design_scores_gemma":[0.008590382,0.013653923,0.30050144,0.0022224986,0.001629956,0.003361632,0.10340481,0.41324285,0.02236157,0.06788708,0.06236683,0.0007770358],"about_ca_topic_score_codex":0.0078096865,"about_ca_topic_score_gemma":0.009794465,"teacher_disagreement_score":0.029219734,"about_ca_system_score_codex":0.0023371119,"about_ca_system_score_gemma":0.0042768396,"threshold_uncertainty_score":0.15453058},"labels":[],"label_agreement":null},{"id":"W2156246270","doi":"10.1016/j.jval.2014.03.831","title":"Exploring The Impact Of Clinical, Functional And Social Factors On Hip Fracture Patient Hospitalization Costs: Informing The Design Of A New Case Mix Payment System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care","funders":"","keywords":"Medicine; Reimbursement; Residence; Case mix index; Hip fracture; Comorbidity; Activities of daily living; Payment; Cohort; Cohort study; Health care; Physical therapy; Demography; Psychiatry; Finance; Osteoporosis; Business","score_opus":0.248287518166459,"score_gpt":0.386733059497946,"score_spread":0.138445541331487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156246270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97088474,0.00025753214,0.011581604,0.011840989,0.000127349,0.001092368,0.00073543016,0.00002664705,0.0034534317],"genre_scores_gemma":[0.9767909,0.00013430681,0.021374948,0.00076201634,0.00005907739,0.0004589461,0.00021829667,0.000007899689,0.00019361587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97091424,0.023986949,0.0013246817,0.00067023805,0.0021769253,0.00092704],"domain_scores_gemma":[0.93563974,0.05029406,0.0067349253,0.0016440753,0.0035722489,0.0021150548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034323294,0.000382007,0.00069561915,0.0014154284,0.0011008641,0.004794273,0.0015599115,0.0010054441,0.0033069018],"category_scores_gemma":[0.10445479,0.0004903383,0.00086271175,0.0016667228,0.0008484154,0.0033699435,0.002492179,0.0017941069,0.00017779582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015292411,0.0033019953,0.8897391,0.00022900291,0.00052861706,0.00009708121,0.0014333732,0.011723192,0.00064769964,0.009444551,0.0026597385,0.07866645],"study_design_scores_gemma":[0.0009768552,0.004490773,0.748321,0.00043456673,0.00074990425,0.00019427521,0.005029569,0.2109579,0.0012762168,0.023448868,0.003950015,0.00017007576],"about_ca_topic_score_codex":0.009731094,"about_ca_topic_score_gemma":0.01872662,"teacher_disagreement_score":0.034323294,"about_ca_system_score_codex":0.0052104876,"about_ca_system_score_gemma":0.010599492,"threshold_uncertainty_score":0.18152106},"labels":[],"label_agreement":null},{"id":"W2156776528","doi":"10.1111/j.1524-4733.2008.00457.x","title":"The Willingness to Pay for Reducing Pain and Pain-Related Disability","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Willingness to pay; Medicine; Chronic pain; Physical therapy; Psychological intervention; Quality of life (healthcare); Nursing; Economics","score_opus":0.12095091136642114,"score_gpt":0.24863215887101756,"score_spread":0.12768124750459642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156776528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8634703,0.0055037565,0.07529896,0.014006551,0.00037798056,0.00024518438,0.0017993423,0.000101691694,0.039196275],"genre_scores_gemma":[0.9941208,0.0006232381,0.0021839475,0.00020977083,0.0001403042,0.00004118313,0.00020431905,0.000009412767,0.0024669522],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9977303,0.0014749792,0.00011368949,0.00014053461,0.00029269792,0.00024781656],"domain_scores_gemma":[0.9875321,0.009887612,0.0009777168,0.0005264549,0.00045973688,0.00061641424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003867515,0.0006395375,0.0009455168,0.0014211459,0.00028670454,0.0023351803,0.0009903263,0.0034609477,0.008065577],"category_scores_gemma":[0.024976678,0.00047827102,0.0013697258,0.001331722,0.0015447617,0.002815984,0.00073024863,0.002420862,0.00039076604],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049071503,0.0022857897,0.2013025,0.0010572686,0.0028626702,0.0016966423,0.0010013407,0.16410513,0.00689191,0.37131944,0.006286983,0.23628312],"study_design_scores_gemma":[0.00044937254,0.001890314,0.22097148,0.0003421725,0.0012154217,0.005261863,0.0021269603,0.20210294,0.0019093971,0.55243343,0.011041314,0.00025529694],"about_ca_topic_score_codex":0.0015159213,"about_ca_topic_score_gemma":0.0011280612,"teacher_disagreement_score":0.008065577,"about_ca_system_score_codex":0.001288334,"about_ca_system_score_gemma":0.0006504125,"threshold_uncertainty_score":0.026982069},"labels":[],"label_agreement":null},{"id":"W2156822431","doi":"10.1016/j.jval.2014.03.1654","title":"Characteristics Of Chronic Plaque Psoriasis In Canada: A Retrospective Database Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Psoriasis; Adalimumab; Infliximab; Acitretin; Ustekinumab; Etanercept; Dermatology; Palmoplantar pustulosis; Retrospective cohort study; Plaque psoriasis; Methotrexate; Internal medicine; Etretinate; Database; Disease; Rheumatoid arthritis","score_opus":0.0229398275402995,"score_gpt":0.2518703270930761,"score_spread":0.2289304995527766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156822431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821484,0.0012147856,0.00013865258,0.00031820327,0.000014799597,0.00009352956,0.013740602,0.00001509302,0.0023159664],"genre_scores_gemma":[0.99481,0.0007421921,0.00016320847,0.00019871836,0.0000115516605,0.00003262987,0.003498551,0.000008867175,0.0005343261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981286,0.00013174716,0.00021043161,0.0003189475,0.00063145714,0.0005787888],"domain_scores_gemma":[0.99459237,0.00029946992,0.0015435596,0.00020595048,0.0022124331,0.0011462417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060529035,0.00042290258,0.0007830376,0.0032839037,0.0029435977,0.0023553104,0.0014208063,0.0008836536,0.0030127098],"category_scores_gemma":[0.0032517107,0.00064594374,0.00082765036,0.011527895,0.00094952504,0.00079001463,0.001184773,0.0010451254,0.00038493867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050132418,0.000032623713,0.99783367,0.000025911675,0.000049881277,0.00012422372,0.00020331434,0.000032716343,0.000069999434,0.000054048567,0.00064104557,0.0008825515],"study_design_scores_gemma":[0.000008478836,0.000023472048,0.99763787,0.00003335036,0.000041555253,0.00023363811,0.0010871551,0.00014153485,0.0000363248,0.000020831483,0.000723753,0.000012105719],"about_ca_topic_score_codex":0.97528195,"about_ca_topic_score_gemma":0.9770149,"teacher_disagreement_score":0.024718046,"about_ca_system_score_codex":0.022724502,"about_ca_system_score_gemma":0.03066775,"threshold_uncertainty_score":0.16487855},"labels":[],"label_agreement":null},{"id":"W2156885958","doi":"10.1016/j.jval.2013.03.1556","title":"Trends in buprenorphine and methadone sales and utilization in the United States, 1997-2012","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; Methadone; Medicine; Ambulatory; Pharmacy; Medical prescription; (+)-Naloxone; Quarter (Canadian coin); Emergency medicine; Narcotic; Family medicine; Opioid; Psychiatry; Nursing; Internal medicine; Geography","score_opus":0.06071966891400729,"score_gpt":0.3300558783171848,"score_spread":0.2693362094031775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156885958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93870264,0.0023339684,0.00013294366,0.0005192127,0.00003581274,0.000025133691,0.05533782,0.000050757946,0.002861748],"genre_scores_gemma":[0.9556208,0.0030629537,0.00028385775,0.00032261212,0.000042797954,0.000050977415,0.038042083,0.000012065157,0.0025617855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962044,0.000042248506,0.00009277567,0.00007072258,0.000098930555,0.00007480086],"domain_scores_gemma":[0.99835783,0.00015699361,0.0009054508,0.000027399201,0.00037851793,0.00017382581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033566135,0.00021280191,0.00026211384,0.0016488504,0.0003117411,0.0007100692,0.0004785305,0.0004787657,0.002093988],"category_scores_gemma":[0.0012203122,0.0002473524,0.00064297224,0.0035987678,0.00014965021,0.0007306903,0.0004211704,0.00064251554,0.00043262407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015453187,0.0000615317,0.9927376,0.00008745984,0.00011201645,0.000053095002,0.00008986631,0.00012667225,0.00014806747,0.000044616812,0.0025013327,0.0038833134],"study_design_scores_gemma":[0.0000044123904,0.000029387715,0.9980477,0.000028710152,0.000030467972,0.00011896248,0.00028333793,0.00019783083,0.00007822551,0.0000066562043,0.0011703267,0.0000039151305],"about_ca_topic_score_codex":0.12408699,"about_ca_topic_score_gemma":0.20198289,"teacher_disagreement_score":0.12408699,"about_ca_system_score_codex":0.0011910417,"about_ca_system_score_gemma":0.0010719661,"threshold_uncertainty_score":0.24672943},"labels":[],"label_agreement":null},{"id":"W2157686333","doi":"10.1016/j.jval.2015.09.2634","title":"Zrx Mcdm: A Fully Flexible Tool to Support The Local Adaptation of Multiple-Criteria Decision Criteria In Health Care","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Multiple-criteria decision analysis; Context (archaeology); Decision support system; Decision analysis; Computer science; Management science; Risk analysis (engineering); Operations research; Data mining; Medicine; Mathematics; Engineering; Statistics","score_opus":0.4879166609596166,"score_gpt":0.4695274744499399,"score_spread":0.01838918650967669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157686333","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005796596,0.00011126916,0.96516657,0.00034946445,0.00007544121,0.000370836,0.003251831,0.020020142,0.0048578316],"genre_scores_gemma":[0.05947773,0.00011109627,0.933052,0.00015927273,0.000028213542,0.0007841376,0.0019338776,0.0018587016,0.0025949483],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9964122,0.0019681684,0.00033245073,0.0003212086,0.0007947314,0.0001711486],"domain_scores_gemma":[0.9891676,0.0073577273,0.00048697673,0.0013468241,0.0013694445,0.00027133664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00992015,0.0013941394,0.0017766175,0.0024397608,0.0008653071,0.0023559593,0.0030564475,0.0014539161,0.057620462],"category_scores_gemma":[0.026760146,0.0011686394,0.0015999776,0.0024841581,0.0005045925,0.0023217637,0.005459645,0.0021253221,0.007754132],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008972121,0.00043512354,0.0041231043,0.0015612977,0.0005701336,0.00053448934,0.0013842725,0.27313876,0.004240833,0.05706148,0.089115016,0.5669383],"study_design_scores_gemma":[0.00046987453,0.000092570735,0.0011285724,0.00023937767,0.000087664695,0.00014106712,0.00018110096,0.89002526,0.0022729733,0.04391883,0.061348572,0.00009422475],"about_ca_topic_score_codex":0.009668043,"about_ca_topic_score_gemma":0.014896284,"teacher_disagreement_score":0.057620462,"about_ca_system_score_codex":0.00095530454,"about_ca_system_score_gemma":0.0024146342,"threshold_uncertainty_score":0.19275963},"labels":[],"label_agreement":null},{"id":"W2158417834","doi":"10.1016/j.jval.2011.02.593","title":"PIH8 THE ECONOMIC IMPACT ATTRIBUTABLE TO THE INAPPROPRIATE PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY LIVING IN THE COMMUNITY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medical prescription; Health care; Medicine; Cohort; Gerontology; Multivariate analysis; Environmental health; Family medicine; Demography; Nursing; Internal medicine","score_opus":0.34028999296284723,"score_gpt":0.4280999674762898,"score_spread":0.08780997451344258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158417834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590179,0.0030796796,0.00023854942,0.013758286,0.00017574875,0.000021788894,0.0018954799,0.00000844895,0.021804027],"genre_scores_gemma":[0.9971998,0.0011230517,0.00007049751,0.0004466786,0.0001670527,0.0000054745274,0.00026497233,0.0000015166027,0.00072095846],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993888,0.00029482075,0.000033502856,0.00001956705,0.00013733195,0.00012593987],"domain_scores_gemma":[0.9974618,0.0007979476,0.0007754664,0.00007429448,0.0004134592,0.00047697956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005753203,0.00014711088,0.00015480528,0.0007137114,0.000408914,0.0007010702,0.00015893842,0.000475106,0.0039489837],"category_scores_gemma":[0.0067190863,0.00007658296,0.0005040262,0.0008423762,0.00030083023,0.0003869582,0.0006382825,0.0007073632,0.00020526236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008364206,0.00023044867,0.9297766,0.000106038184,0.00035770176,0.0011302598,0.00013288947,0.0011169986,0.00023242184,0.0021686445,0.0082215145,0.055690043],"study_design_scores_gemma":[0.000051361425,0.00030484708,0.9867337,0.00010160238,0.00017752955,0.0011215522,0.0006963939,0.0020717832,0.00019414254,0.0022101868,0.0063212677,0.000015641599],"about_ca_topic_score_codex":0.010933676,"about_ca_topic_score_gemma":0.019041995,"teacher_disagreement_score":0.010933676,"about_ca_system_score_codex":0.0010983434,"about_ca_system_score_gemma":0.001061221,"threshold_uncertainty_score":0.021740079},"labels":[],"label_agreement":null},{"id":"W2158558263","doi":"10.1016/j.jval.2015.05.007","title":"Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Medicine; Entecavir; HBeAg; Pegylated interferon; Internal medicine; Chronic hepatitis; Hepatitis B; Hepatitis B virus; Immunology; Virus; HBsAg; Lamivudine; Ribavirin","score_opus":0.17890162080293107,"score_gpt":0.41184280708667237,"score_spread":0.2329411862837413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158558263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93536013,0.058270976,0.0008039745,0.0009971764,0.00017418951,0.0004100104,0.0018711847,0.0000150498445,0.0020972758],"genre_scores_gemma":[0.9952799,0.0035526785,0.00038975326,0.00012064358,0.00002201206,0.00011142874,0.00036339412,0.0000022735103,0.00015778754],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98841906,0.009267373,0.00086384383,0.00032184718,0.00061655964,0.00051126705],"domain_scores_gemma":[0.9865827,0.0102452645,0.0016451394,0.0002575841,0.0006956462,0.00057363533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053605777,0.00095126685,0.003144414,0.0019118204,0.00029779517,0.0016531959,0.000973119,0.0014189923,0.0032951275],"category_scores_gemma":[0.021801379,0.00075532316,0.0071026636,0.0017167145,0.00075126666,0.001389458,0.0013905242,0.0014266424,0.000094439645],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.37985533,0.0034254973,0.13182762,0.022800852,0.057324555,0.0014788512,0.00074375066,0.22317313,0.0022530998,0.0070778984,0.0033353784,0.16670409],"study_design_scores_gemma":[0.092272595,0.10413114,0.5400183,0.008247903,0.08716194,0.003236879,0.0037750832,0.14348415,0.0022610312,0.004817366,0.009950818,0.0006428167],"about_ca_topic_score_codex":0.053561766,"about_ca_topic_score_gemma":0.038017195,"teacher_disagreement_score":0.053561766,"about_ca_system_score_codex":0.013060528,"about_ca_system_score_gemma":0.0025877443,"threshold_uncertainty_score":0.10650003},"labels":[],"label_agreement":null},{"id":"W2159936838","doi":"10.1016/j.jval.2012.08.2223","title":"Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1809,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Calgary","funders":"","keywords":"Conjoint analysis; Management science; Task (project management); Computer science; Preference; Checklist; Preference elicitation; Health care; Operations research; Engineering; Systems engineering; Psychology; Mathematics","score_opus":0.4394866308800806,"score_gpt":0.3964888750498891,"score_spread":0.0429977558301915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159936838","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069658123,0.0049946024,0.9266305,0.0070741414,0.0013644252,0.037741847,0.0036764615,0.0012423227,0.010309958],"genre_scores_gemma":[0.010795006,0.0020748738,0.9607735,0.00090257725,0.00023756998,0.022049192,0.0011323268,0.00040458573,0.0016302691],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.44699386,0.45388466,0.022187337,0.005442222,0.06884492,0.0026471103],"domain_scores_gemma":[0.15045097,0.6741894,0.02571977,0.06249357,0.08275898,0.0043873824],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5713374,0.0028738778,0.003688373,0.0073802,0.003644719,0.006310802,0.006866678,0.004187327,0.008428123],"category_scores_gemma":[0.6369861,0.003964704,0.0067039332,0.0062710135,0.006942875,0.0038990874,0.007054313,0.012670168,0.0023568168],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044880626,0.0029888975,0.006551035,0.0061402256,0.0013090174,0.00009412597,0.00456704,0.012475933,0.0072311293,0.07967183,0.0893914,0.7850912],"study_design_scores_gemma":[0.009369974,0.0071468633,0.048935488,0.01609016,0.0054369094,0.00036567444,0.0021275796,0.05808108,0.109339915,0.20902802,0.5325267,0.0015516151],"about_ca_topic_score_codex":0.012323818,"about_ca_topic_score_gemma":0.018908743,"teacher_disagreement_score":0.4286626,"about_ca_system_score_codex":0.010371935,"about_ca_system_score_gemma":0.038756635,"threshold_uncertainty_score":0.5286174},"labels":[],"label_agreement":null},{"id":"W2160795370","doi":"10.1016/j.jval.2011.08.258","title":"PIN72 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Results and Challenges","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Immunization; Rotavirus vaccine; Vaccination; Context (archaeology); Rotavirus; Environmental health; Cohort; Pediatrics; Virology; Immunology; Geography","score_opus":0.2580390877728648,"score_gpt":0.38686088713331734,"score_spread":0.12882179936045257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160795370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94925016,0.013239694,0.0010038223,0.009420413,0.00028328993,0.00024617492,0.0050794627,0.000032345244,0.021444578],"genre_scores_gemma":[0.992822,0.00357467,0.00071684184,0.00030785456,0.00006824684,0.00007978399,0.00094401394,0.0000134763695,0.0014731374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950427,0.0038637568,0.00017731615,0.00013446396,0.00043965384,0.00034217947],"domain_scores_gemma":[0.9953793,0.0027155003,0.000569848,0.00012702667,0.0008451078,0.0003632452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054086824,0.00052349793,0.00060869957,0.0007557044,0.0003117001,0.0018915684,0.0007103037,0.00036683917,0.0053697536],"category_scores_gemma":[0.010861406,0.00020493694,0.0009494134,0.0019253094,0.00036162403,0.0012348514,0.00074718654,0.00069117127,0.00024333817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013926943,0.001719235,0.5149599,0.0036839494,0.0028791248,0.0007564339,0.0011088375,0.018279511,0.00069244776,0.0073483414,0.009824638,0.42482063],"study_design_scores_gemma":[0.001958003,0.010824326,0.9063085,0.0036403816,0.004760176,0.0008701161,0.010618679,0.023638781,0.0028747837,0.0059316424,0.028457558,0.00011717835],"about_ca_topic_score_codex":0.06775072,"about_ca_topic_score_gemma":0.058869492,"teacher_disagreement_score":0.06775072,"about_ca_system_score_codex":0.0056774323,"about_ca_system_score_gemma":0.0050073494,"threshold_uncertainty_score":0.13471276},"labels":[],"label_agreement":null},{"id":"W2162067341","doi":"10.1016/j.jval.2013.08.458","title":"Cost of Care with Everolimus Versus Axitinib for Second-Line Metastatic Renal Cell Carcinoma Patients in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Axitinib; Everolimus; Medicine; Sunitinib; Renal cell carcinoma; Adverse effect; Oncology; Internal medicine","score_opus":0.05688945370193173,"score_gpt":0.2468252040780568,"score_spread":0.1899357503761251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162067341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96664244,0.008450407,0.00014529476,0.010568701,0.00015369049,0.00008161335,0.0074763387,0.000023439907,0.0064581125],"genre_scores_gemma":[0.9946843,0.001957597,0.00014075133,0.00046656956,0.000043949738,0.000014529897,0.0015953543,0.000007435285,0.0010895694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885523,0.00015538988,0.0000791246,0.00010383042,0.000312352,0.00049406016],"domain_scores_gemma":[0.9968952,0.00037079593,0.0005952662,0.000035322693,0.00075540174,0.001347911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004938217,0.00032079977,0.0009393373,0.00083090767,0.0013736502,0.0021286355,0.0013868555,0.0008312921,0.0036935303],"category_scores_gemma":[0.005103773,0.00030283682,0.0017111681,0.0026166132,0.00066420605,0.0005288949,0.00072881783,0.0017314397,0.00010435135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007442651,0.0007293997,0.8690172,0.00069736573,0.0020819185,0.0013384551,0.00047906692,0.025628677,0.00047773926,0.005929211,0.034367725,0.051810704],"study_design_scores_gemma":[0.0016925011,0.0006610277,0.9593809,0.00042265886,0.0012080099,0.0008297172,0.0026249955,0.023628065,0.00031880516,0.0011273967,0.007980499,0.0001253564],"about_ca_topic_score_codex":0.99167824,"about_ca_topic_score_gemma":0.9956221,"teacher_disagreement_score":0.1113615,"about_ca_system_score_codex":0.1113615,"about_ca_system_score_gemma":0.074183784,"threshold_uncertainty_score":0.80798805},"labels":[],"label_agreement":null},{"id":"W2164067273","doi":"10.1016/j.jval.2014.03.949","title":"The Canadian Eq-5d Valuation Study: Estimating Time Trade-Off Values For The Eq-5d-5l","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Alberta; Centre for Advancing Health Outcomes; University of British Columbia; St. Joseph’s Healthcare Hamilton; Hospital for Sick Children; McMaster University","funders":"","keywords":"EQ-5D; Akaike information criterion; Statistics; Estimator; Mathematics; Valuation (finance); Standard error; Time-trade-off; Population; Mean squared error; Econometrics; Medicine; Demography; Quality of life (healthcare); Economics","score_opus":0.45905142674650434,"score_gpt":0.4091317431102169,"score_spread":0.04991968363628746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164067273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8907612,0.010095705,0.009611119,0.004679205,0.00028636283,0.0011104164,0.0699443,0.00013070197,0.013380997],"genre_scores_gemma":[0.95144606,0.0027798377,0.011056328,0.00051656575,0.000054372467,0.00071663014,0.02981005,0.00009997633,0.0035202713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974819,0.0008847469,0.00012840818,0.00024664163,0.0009666094,0.0002917231],"domain_scores_gemma":[0.99170965,0.003368598,0.00078282703,0.0006190295,0.0027984912,0.0007213299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008082815,0.0012840506,0.001295694,0.0033898929,0.0018885983,0.0019498095,0.0030029893,0.0012144644,0.0029702021],"category_scores_gemma":[0.031206578,0.0005313488,0.002398502,0.009443705,0.0009850946,0.0013190239,0.0016590569,0.0020296064,0.0003319384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056712395,0.00099085,0.73144543,0.0010195757,0.0033257124,0.00042573232,0.0009159591,0.035320766,0.00037120466,0.021228192,0.07676067,0.12252473],"study_design_scores_gemma":[0.0010703264,0.00036633413,0.88971937,0.00045541523,0.0008863736,0.0003135039,0.0014236383,0.08316234,0.00026648273,0.0034354997,0.01866538,0.00023525361],"about_ca_topic_score_codex":0.9852594,"about_ca_topic_score_gemma":0.9792336,"teacher_disagreement_score":0.03592781,"about_ca_system_score_codex":0.03592781,"about_ca_system_score_gemma":0.03435619,"threshold_uncertainty_score":0.26067573},"labels":[],"label_agreement":null},{"id":"W2164226634","doi":"10.1016/j.jval.2013.03.957","title":"Costs associated with hospital admission for heart failure in two hospitals in the city of bogota, Colombia","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Heart failure; Emergency medicine; Medical costs; Indirect costs; Health care; Medical emergency; Internal medicine; Business","score_opus":0.030573509566831924,"score_gpt":0.3596948851986936,"score_spread":0.32912137563186167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164226634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986235,0.00021787321,0.000033578555,0.00025837825,0.000006891381,0.000013844579,0.0003059601,0.0000021892336,0.0005378057],"genre_scores_gemma":[0.9995857,0.00009372083,0.00002770565,0.000027630844,0.000004215011,0.0000063586767,0.00014607156,8.501983e-7,0.00010784148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993143,0.00021940957,0.000051752544,0.00005600418,0.00006003606,0.00029855352],"domain_scores_gemma":[0.9985234,0.00030534854,0.00039834532,0.000040355026,0.00018987207,0.00054267043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026335756,0.0004664126,0.00043365773,0.001029391,0.0012140244,0.0012213297,0.00082308217,0.000947221,0.0018198625],"category_scores_gemma":[0.0020797125,0.0003126209,0.0006308321,0.0009789892,0.0006514442,0.00037208552,0.0013999962,0.0009517854,0.00008327205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024856886,0.00022315721,0.99195284,0.00007584928,0.00016922124,0.0012286042,0.0010406872,0.0005198709,0.00035670795,0.00025422894,0.00063365954,0.0032964777],"study_design_scores_gemma":[0.000011695024,0.0000399439,0.9947373,0.000021630538,0.000036439986,0.00019675087,0.004241986,0.00042499913,0.000033465054,0.00005145109,0.00019164116,0.000012628994],"about_ca_topic_score_codex":0.42283064,"about_ca_topic_score_gemma":0.51505846,"teacher_disagreement_score":0.42283064,"about_ca_system_score_codex":0.006728105,"about_ca_system_score_gemma":0.0020892862,"threshold_uncertainty_score":0.840739},"labels":[],"label_agreement":null},{"id":"W2164799229","doi":"10.1016/j.jval.2011.08.445","title":"PMS59 Inadequate Pain Relief in Knee Osteoarthritis and Patient Reported outcomes: A Survey of Osteoarthritis Real World Therapies (SORT) in the United Kingdom","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Physical therapy; Quality of life (healthcare); Observational study; WOMAC; Brief Pain Inventory; Knee pain; Clinical trial; Internal medicine; Chronic pain; Alternative medicine","score_opus":0.08814191868334788,"score_gpt":0.30068884601546303,"score_spread":0.21254692733211517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164799229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691916,0.001250744,0.000022876364,0.00022471359,0.000009241961,0.0000150687765,0.0009222223,0.0000014451911,0.0006345054],"genre_scores_gemma":[0.99860865,0.0005935351,0.000024456367,0.00014440923,0.000007767346,0.000010722208,0.00044379613,0.0000012927254,0.00016547147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997905,0.00055214256,0.0006022913,0.0001575988,0.0005764235,0.00020647766],"domain_scores_gemma":[0.9933873,0.00081837445,0.0044728904,0.0001444277,0.0006367762,0.0005403082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010736795,0.00019926557,0.00057671755,0.0010915092,0.00033335757,0.0009355039,0.0003633979,0.0007020025,0.0019264047],"category_scores_gemma":[0.005573648,0.00028659194,0.0006611868,0.0023618203,0.0005094369,0.00045643162,0.0011917129,0.00048073256,0.00027003855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000147626,0.000022019074,0.9964909,0.000079566125,0.000061152554,0.000085549524,0.00044576364,0.000018456989,0.00020261055,0.000022786342,0.00025205337,0.0021713849],"study_design_scores_gemma":[0.00000535763,0.0000626746,0.999241,0.000016155065,0.000009583306,0.00010209519,0.00033691138,0.000010066453,0.000012025503,0.0000018996774,0.00019973888,0.0000025617815],"about_ca_topic_score_codex":0.042953983,"about_ca_topic_score_gemma":0.04561511,"teacher_disagreement_score":0.042953983,"about_ca_system_score_codex":0.0010689736,"about_ca_system_score_gemma":0.00079895026,"threshold_uncertainty_score":0.08540791},"labels":[],"label_agreement":null},{"id":"W2165145690","doi":"10.1016/j.jval.2012.09.001","title":"Binary Choice Health State Valuation and Mode of Administration: Head-to-Head Comparison of Online and CAPI","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; University of Sheffield","keywords":"Valuation (finance); Probit model; Descriptive statistics; Psychology; Population; Medicine; Actuarial science; Social psychology; Econometrics; Statistics; Economics; Environmental health; Accounting; Mathematics","score_opus":0.5023191586192964,"score_gpt":0.5025873552970823,"score_spread":0.0002681966777858813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165145690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817809,0.00037981555,0.0045912503,0.00042983383,0.000104320614,0.0014507461,0.0014693938,0.00008001324,0.009713774],"genre_scores_gemma":[0.99259347,0.00020276979,0.0028689527,0.00039283515,0.000085199004,0.0015021453,0.00080008205,0.00002557328,0.0015289163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9873376,0.008593902,0.0007936782,0.00091373286,0.0017062303,0.0006549426],"domain_scores_gemma":[0.9227074,0.053218335,0.013474225,0.0040208716,0.0038738786,0.0027052362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015005288,0.00042490487,0.0008982517,0.0013874387,0.00058739074,0.0019466811,0.0008744827,0.0007991243,0.01979506],"category_scores_gemma":[0.064866304,0.00044387233,0.0008496289,0.002419804,0.001024204,0.0024906478,0.0017569872,0.0010225782,0.002577721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038269542,0.0085454825,0.700461,0.0017466247,0.0010227109,0.00024553353,0.006079868,0.0012255737,0.0019785143,0.0028133865,0.0058189575,0.23179273],"study_design_scores_gemma":[0.0016454892,0.019457653,0.9498134,0.0004472737,0.00045792613,0.0004198355,0.007288867,0.0058664284,0.0024605088,0.003280464,0.008701151,0.00016101309],"about_ca_topic_score_codex":0.0015695826,"about_ca_topic_score_gemma":0.001362197,"teacher_disagreement_score":0.01979506,"about_ca_system_score_codex":0.0007287654,"about_ca_system_score_gemma":0.00090736814,"threshold_uncertainty_score":0.07935649},"labels":[],"label_agreement":null},{"id":"W2165222989","doi":"10.1016/j.jval.2012.09.002","title":"Economic Appraisal of a Community-Wide Cardiovascular Health Awareness Program","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; McMaster University; Université de Montréal; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; Élisabeth Bruyère Hospital; Institute for Clinical Evaluative Sciences; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Economic appraisal; Environmental health; Medicine; Public economics; Economics","score_opus":0.06255899736176887,"score_gpt":0.37568634344279295,"score_spread":0.3131273460810241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165222989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9260283,0.013478964,0.0030490623,0.019103982,0.0011984912,0.00956934,0.0047029853,0.00008894644,0.022779986],"genre_scores_gemma":[0.9906667,0.0026314629,0.0018268934,0.0010101739,0.00023005629,0.0014799305,0.0008714037,0.000014432881,0.0012690058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9679778,0.024721304,0.0010957974,0.00043427444,0.0039016122,0.0018691998],"domain_scores_gemma":[0.96216637,0.025637,0.0023864666,0.0008233117,0.0044760765,0.0045108944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01724234,0.0013689708,0.001554666,0.003522764,0.0017524593,0.002907263,0.0018611202,0.0021953762,0.007309719],"category_scores_gemma":[0.05378843,0.0006281162,0.0032440124,0.0026805652,0.0015148123,0.0014704886,0.0029012205,0.0025768592,0.00028605742],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.33710355,0.04066037,0.08541832,0.011083194,0.00533948,0.0011352635,0.0009111382,0.061379135,0.0024168363,0.014929772,0.018888569,0.42073435],"study_design_scores_gemma":[0.1082193,0.20117012,0.49581355,0.006416802,0.018173106,0.0008657859,0.008527599,0.11495882,0.0037544472,0.00961412,0.03176607,0.0007204274],"about_ca_topic_score_codex":0.03826648,"about_ca_topic_score_gemma":0.036918584,"teacher_disagreement_score":0.03826648,"about_ca_system_score_codex":0.021551702,"about_ca_system_score_gemma":0.021683255,"threshold_uncertainty_score":0.15636927},"labels":[],"label_agreement":null},{"id":"W2165408725","doi":"10.1016/j.jval.2012.08.1169","title":"PSU11 Medical Costs Comparison Between Internal Fixation and Arthoplasty in Patients With Hip Femoral Neck Fractures","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cohort; Femoral neck; Hip fracture; Internal fixation; Surgery; Retrospective cohort study; Cohort study; Total hip replacement; Population; Osteoporosis; Internal medicine","score_opus":0.027724041674508825,"score_gpt":0.3345674907958502,"score_spread":0.30684344912134137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165408725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962727,0.0010060907,0.000059141348,0.00015229521,0.000031562875,0.000026840687,0.00092002726,0.0000021452806,0.0015291489],"genre_scores_gemma":[0.9985567,0.0002090747,0.000065518856,0.000041546904,0.000029694102,0.000019354431,0.00081169256,0.0000014404508,0.0002650777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986363,0.0005388083,0.00017923804,0.000105034924,0.00027784848,0.00026267534],"domain_scores_gemma":[0.99822456,0.0007772211,0.00040946677,0.000048974773,0.00026577082,0.0002740865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008568068,0.00039662377,0.0011677041,0.001777151,0.0004916649,0.0011850569,0.0004157531,0.0007093584,0.0062603937],"category_scores_gemma":[0.0043637636,0.00022840756,0.0023422153,0.0024506897,0.0003118606,0.0006021601,0.0007227451,0.00062007795,0.0004207196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051673062,0.001221428,0.88083255,0.00067707855,0.002717071,0.00039810187,0.00022053669,0.0036098578,0.0007544912,0.00067153206,0.0020158752,0.055208445],"study_design_scores_gemma":[0.0012782456,0.008033906,0.98540384,0.00009841902,0.0009878072,0.00038197718,0.0007469954,0.0015561344,0.00034857218,0.00022965527,0.0008967681,0.00003766375],"about_ca_topic_score_codex":0.009188743,"about_ca_topic_score_gemma":0.007828016,"teacher_disagreement_score":0.009188743,"about_ca_system_score_codex":0.0023784135,"about_ca_system_score_gemma":0.0011170534,"threshold_uncertainty_score":0.020943105},"labels":[],"label_agreement":null},{"id":"W2165853796","doi":"10.1016/j.jval.2013.03.054","title":"Treating acute heart failure in the elderly: A comparison of three inpatient treatment alternatives in the United States","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Nesiritide; Heart failure; Cardiogenic shock; Propensity score matching; Internal medicine; Mortality rate; Emergency medicine; Myocardial infarction; Natriuretic peptide","score_opus":0.06826388410850617,"score_gpt":0.35295986210938785,"score_spread":0.28469597800088164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165853796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99039406,0.0048545715,0.00025593885,0.0011837732,0.000094137045,0.0001815768,0.00026280506,0.000009574217,0.0027634965],"genre_scores_gemma":[0.9949528,0.003268518,0.00056373706,0.00064308045,0.000057058867,0.000108450055,0.00027684582,0.0000028221348,0.00012677924],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983693,0.0009489853,0.00018944018,0.00006539265,0.00025492642,0.00017201036],"domain_scores_gemma":[0.99585897,0.001570164,0.0009714932,0.00009866268,0.00028920083,0.0012115671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020202498,0.000253889,0.0009097704,0.00056888897,0.0007493665,0.0011882603,0.0005593096,0.0008167135,0.0019544305],"category_scores_gemma":[0.006302357,0.00018394305,0.0010385212,0.00092300604,0.00047017317,0.0007052228,0.00090973836,0.0010414034,0.00008684148],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13244143,0.029048098,0.29538798,0.0027376579,0.002633836,0.00058967335,0.002044626,0.00883956,0.0019179791,0.004233983,0.007054253,0.5130709],"study_design_scores_gemma":[0.02339813,0.08556618,0.85459554,0.0017697101,0.0031363552,0.00059484283,0.009590943,0.01103716,0.0010450416,0.001929174,0.007195118,0.0001418473],"about_ca_topic_score_codex":0.0108590815,"about_ca_topic_score_gemma":0.0297912,"teacher_disagreement_score":0.0108590815,"about_ca_system_score_codex":0.0021834143,"about_ca_system_score_gemma":0.0023894499,"threshold_uncertainty_score":0.021591723},"labels":[],"label_agreement":null},{"id":"W2166529181","doi":"10.1016/j.jval.2014.03.714","title":"Economic Impact Of Insertable Cardiac Monitors For Diagnosis Of Unexplained Syncope On The Canadian Health Care System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Syncope (phonology); Medicine; Emergency department; Cohort; Emergency medicine; Health care; Medical emergency; Pediatrics; Internal medicine","score_opus":0.018096593499339318,"score_gpt":0.2833671066616564,"score_spread":0.26527051316231703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166529181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7547546,0.020449074,0.0007926504,0.117929325,0.00079410087,0.00034967624,0.019146383,0.00008231015,0.085702024],"genre_scores_gemma":[0.9893917,0.004056058,0.0003770303,0.002033025,0.00018164351,0.000024997657,0.001855117,0.000009001585,0.0020714116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99417925,0.0011453986,0.0002473182,0.00020322336,0.0026344857,0.001590349],"domain_scores_gemma":[0.984617,0.0042018006,0.002415295,0.00020984255,0.0048195138,0.0037364035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020947412,0.00042556197,0.00046046101,0.0025204746,0.0021039927,0.0028173793,0.0015470335,0.0016799027,0.0053036604],"category_scores_gemma":[0.028256357,0.0003747501,0.0014583535,0.0036467058,0.0011850789,0.0008115055,0.0017129448,0.0020273305,0.00013824657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016749601,0.00056267757,0.7707997,0.00073033466,0.0008695465,0.0015497286,0.0008696352,0.017063528,0.0004294065,0.017077053,0.0694868,0.11888665],"study_design_scores_gemma":[0.00022003369,0.00023085649,0.96409947,0.00053744833,0.00048619334,0.00047702141,0.0020154996,0.015841097,0.00014181751,0.0012414517,0.014609286,0.000099767094],"about_ca_topic_score_codex":0.9832623,"about_ca_topic_score_gemma":0.98733276,"teacher_disagreement_score":0.91010225,"about_ca_system_score_codex":0.08989775,"about_ca_system_score_gemma":0.08321615,"threshold_uncertainty_score":0.6522569},"labels":[],"label_agreement":null},{"id":"W2166586678","doi":"10.1016/j.jval.2013.03.712","title":"Importance, Anticipated Burden, And Function: Validity Of Utilities For Impotence And Urinary Incontinence","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Sexual function; Urinary incontinence; Prostate cancer; Medicine; Logistic regression; Prostate; Gynecology; Urology; Internal medicine; Cancer","score_opus":0.1333749853497329,"score_gpt":0.2984593673293045,"score_spread":0.1650843819795716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166586678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700394,0.004171508,0.01505286,0.0030241655,0.00016097173,0.00007585919,0.001955315,0.00004834271,0.00547152],"genre_scores_gemma":[0.99849355,0.0002213854,0.00070551323,0.00009387484,0.000054803473,0.000010760838,0.00031104946,0.000008058297,0.000101019774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9826438,0.013734683,0.0008444876,0.0011409012,0.0011738008,0.00046235882],"domain_scores_gemma":[0.6596152,0.30365783,0.016073402,0.01424948,0.0041097994,0.0022942293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02985659,0.0011924879,0.0013395477,0.0025822474,0.00047410507,0.0031248739,0.0019284226,0.0020691238,0.0019512539],"category_scores_gemma":[0.21437578,0.0005515053,0.0031519337,0.00274615,0.0035106759,0.004407545,0.0024684526,0.0033673628,0.00031790862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015109148,0.0001730815,0.9584275,0.00012957827,0.0014905838,0.00010098209,0.00033017923,0.011254759,0.0000539409,0.0077004316,0.0008389377,0.01798905],"study_design_scores_gemma":[0.00019935927,0.0008139263,0.77697074,0.00026315125,0.0010271365,0.00065535953,0.0009760141,0.13873145,0.0002858251,0.078601524,0.0013287102,0.00014684783],"about_ca_topic_score_codex":0.007601577,"about_ca_topic_score_gemma":0.0037850654,"teacher_disagreement_score":0.02985659,"about_ca_system_score_codex":0.0012032476,"about_ca_system_score_gemma":0.0012447147,"threshold_uncertainty_score":0.15789866},"labels":[],"label_agreement":null},{"id":"W2166653378","doi":"10.1016/j.jval.2014.03.522","title":"Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary; Ontario Institute for Cancer Research; McMaster University","funders":"","keywords":"CISH; Trastuzumab; Medicine; Chromogenic in situ hybridization; Oncology; Breast cancer; Internal medicine; Cost effectiveness; Cancer; Biology; In situ hybridization","score_opus":0.1293870136368234,"score_gpt":0.426012675525422,"score_spread":0.2966256618885986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166653378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9450695,0.009941342,0.025042025,0.0023427862,0.00010890832,0.0005600424,0.0033332354,0.0001124629,0.013489674],"genre_scores_gemma":[0.9936581,0.0007979702,0.0039704926,0.0001294208,0.000030586492,0.00005874587,0.0006587105,0.0000117472455,0.0006843054],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99815136,0.0011621995,0.000049995186,0.00013233737,0.00029244274,0.00021165873],"domain_scores_gemma":[0.98811126,0.010008205,0.0005396975,0.0002703759,0.0007691422,0.0003012751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003683435,0.0008335007,0.0008313828,0.0016353326,0.00020942352,0.0015488244,0.0011216005,0.000712684,0.0043620714],"category_scores_gemma":[0.014204061,0.00031487233,0.0014935047,0.001570265,0.00043570634,0.0010866771,0.00062963885,0.00097459333,0.00019908609],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010135724,0.0010480569,0.05665112,0.00045650054,0.00093688554,0.00043370508,0.00009142933,0.786991,0.0024424684,0.01805426,0.0045746155,0.11818425],"study_design_scores_gemma":[0.00056785526,0.0026667432,0.046230167,0.00013952907,0.0010897923,0.00045256637,0.00025295562,0.9373957,0.0015043279,0.0065344158,0.0030982739,0.000067633686],"about_ca_topic_score_codex":0.011823651,"about_ca_topic_score_gemma":0.006658856,"teacher_disagreement_score":0.011823651,"about_ca_system_score_codex":0.004014053,"about_ca_system_score_gemma":0.0019118049,"threshold_uncertainty_score":0.0291242},"labels":[],"label_agreement":null},{"id":"W2166681211","doi":"10.1111/j.1524-4733.2010.00746.x","title":"Health Technology Assessment and Comparative Effectiveness in Sweden","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health technology; Medicine; Data science; Computer science; Health care; Economics; Economic growth","score_opus":0.4970367936624877,"score_gpt":0.5154297704456807,"score_spread":0.018392976783193016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166681211","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.431384,0.48421705,0.0076746726,0.013672342,0.00073070836,0.00007823541,0.0015772904,0.000073324336,0.0605924],"genre_scores_gemma":[0.9714874,0.025117675,0.001232734,0.00032599963,0.00020476105,0.00008056893,0.00044484332,0.000017352848,0.0010886155],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9523687,0.03955426,0.0022372424,0.0010684006,0.0036434226,0.0011279534],"domain_scores_gemma":[0.899887,0.09079847,0.0037362252,0.0014227128,0.0035290897,0.0006264057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022662021,0.00053619355,0.0019566063,0.011456364,0.0006033044,0.005220703,0.0007419883,0.0018102601,0.0027659487],"category_scores_gemma":[0.08851583,0.0003515904,0.0015507842,0.011602726,0.0030638478,0.0031485881,0.0025094012,0.001383684,0.00016578281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047572856,0.00062805,0.15749802,0.007306238,0.007691002,0.0014238216,0.0037531024,0.071647406,0.00026931867,0.41974014,0.014633903,0.31065184],"study_design_scores_gemma":[0.0011850222,0.00185169,0.274565,0.011066874,0.005693797,0.0037392147,0.009138612,0.0450825,0.0011819561,0.5739298,0.07223083,0.0003347675],"about_ca_topic_score_codex":0.017836647,"about_ca_topic_score_gemma":0.0062608384,"teacher_disagreement_score":0.022662021,"about_ca_system_score_codex":0.008282671,"about_ca_system_score_gemma":0.004799219,"threshold_uncertainty_score":0.11984968},"labels":[],"label_agreement":null},{"id":"W2166839079","doi":"10.1016/j.jval.2012.08.1244","title":"PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Capecitabine; Taxane; Medicine; Internal medicine; Docetaxel; Oncology; Pharmacy; Metastatic breast cancer; Adverse effect; Cancer; Breast cancer; Colorectal cancer","score_opus":0.027592431451381228,"score_gpt":0.30222845176798424,"score_spread":0.274636020316603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166839079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949384,0.0016646181,0.00009104668,0.00010910118,0.000006376874,0.00008445912,0.0013926104,0.0000048462393,0.0017085244],"genre_scores_gemma":[0.9976712,0.0005562959,0.00022885448,0.000057970185,0.000015072307,0.00004401055,0.0011001013,0.0000013993129,0.00032498813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945825,0.00019632142,0.000070949885,0.00005608532,0.00015137189,0.00006709813],"domain_scores_gemma":[0.99821067,0.00041732917,0.00093099853,0.00005671891,0.00019148934,0.00019278958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067164196,0.00021896615,0.0005428112,0.00071443303,0.00021438819,0.00034149567,0.0002565418,0.0002506502,0.0013570854],"category_scores_gemma":[0.0023995303,0.00012295062,0.00074918615,0.0012475871,0.00011316184,0.00036287465,0.0002803411,0.0004547832,0.00011142717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008261845,0.00034233832,0.95737743,0.00014584037,0.0006101959,0.00011315808,0.000035294048,0.00077055366,0.00046073511,0.000064014115,0.00053075294,0.031287998],"study_design_scores_gemma":[0.00019407475,0.0020482014,0.9959331,0.000018302877,0.00023104958,0.00019719453,0.000028970007,0.0006497743,0.0001514038,0.000037201637,0.0005042526,0.0000065142403],"about_ca_topic_score_codex":0.004817663,"about_ca_topic_score_gemma":0.01119332,"teacher_disagreement_score":0.004817663,"about_ca_system_score_codex":0.0008964336,"about_ca_system_score_gemma":0.00073549786,"threshold_uncertainty_score":0.009579241},"labels":[],"label_agreement":null},{"id":"W2167206949","doi":"10.1016/j.jval.2010.10.033","title":"The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; Canadian Institutes of Health Research","keywords":"Medicine; Statin; Hazard ratio; Adverse effect; Incidence (geometry); Proportional hazards model; Regimen; Physical therapy; Gerontology; Internal medicine; Confidence interval","score_opus":0.04563419773232072,"score_gpt":0.2963434746695832,"score_spread":0.2507092769372625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167206949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965898,0.0018273024,0.00010891967,0.00026496206,0.00002784964,0.0000041696826,0.0002733901,0.000004201585,0.0008994812],"genre_scores_gemma":[0.9988373,0.0005502261,0.000068306676,0.000076036595,0.0000696436,0.000003371564,0.00019003214,0.0000014882756,0.00020363397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941623,0.0001902386,0.00011097482,0.00008797403,0.00008032433,0.00011431849],"domain_scores_gemma":[0.9962953,0.0011994701,0.0014043851,0.00034764482,0.0002141221,0.0005390375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008973744,0.0003732156,0.00061165355,0.0006269505,0.00041510226,0.0008708062,0.00034540775,0.0010709832,0.0014609353],"category_scores_gemma":[0.0050197872,0.00046946312,0.0013123364,0.0011921591,0.0003113345,0.0005525953,0.00062602025,0.0016179065,0.0001604771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008080925,0.00007694168,0.99666095,0.000021939231,0.00036992988,0.00007933079,0.000036998154,0.00003454216,0.00018926938,0.000040183833,0.000050326606,0.0016315333],"study_design_scores_gemma":[0.000016493017,0.000093509014,0.9992562,0.000005506899,0.00020172824,0.000097482625,0.000037544858,0.00012650913,0.000026778032,0.00006612443,0.000068624955,0.0000034360776],"about_ca_topic_score_codex":0.00724791,"about_ca_topic_score_gemma":0.01099828,"teacher_disagreement_score":0.00724791,"about_ca_system_score_codex":0.00026591241,"about_ca_system_score_gemma":0.000401091,"threshold_uncertainty_score":0.014411449},"labels":[],"label_agreement":null},{"id":"W2167282503","doi":"10.1016/j.jval.2013.11.012","title":"Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discontinuation; Time horizon; Tolerability; Economic evaluation; Medicine; Health care; Major depressive disorder; Adverse effect; Quality-adjusted life year; Actuarial science; Computer science; Psychiatry; Cost effectiveness; Economics; Risk analysis (engineering)","score_opus":0.13057743283339684,"score_gpt":0.424721745264861,"score_spread":0.29414431243146416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167282503","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2034054,0.00058901485,0.77215475,0.0017948519,0.00017447665,0.0005146399,0.0014954361,0.0005379397,0.019333541],"genre_scores_gemma":[0.968661,0.00023803624,0.024342392,0.00013588299,0.000032054977,0.00044688745,0.0004247022,0.000038141483,0.005680916],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99827254,0.001063186,0.00006478139,0.00016029527,0.00020407098,0.00023509827],"domain_scores_gemma":[0.99164337,0.006602984,0.000436031,0.00018861704,0.00078894646,0.00034001193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032984945,0.0010085746,0.0020835132,0.0010156981,0.0005361872,0.0018731963,0.002214013,0.0021406147,0.006159285],"category_scores_gemma":[0.013429261,0.00075307785,0.001108038,0.0008126875,0.0009248812,0.001193722,0.0014508974,0.0021179537,0.0004209025],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008365327,0.000037188278,0.00044245724,0.000019723926,0.000025796442,0.0000300512,0.000023425113,0.988381,0.00008226553,0.009439907,0.00021292582,0.0012216152],"study_design_scores_gemma":[0.0000217726,0.00001404793,0.00007385339,0.00000332641,0.0000065439685,0.0000033396875,0.0000052015375,0.99785197,0.00002822882,0.0019136166,0.00007516064,0.0000029824548],"about_ca_topic_score_codex":0.025809627,"about_ca_topic_score_gemma":0.0102377,"teacher_disagreement_score":0.025809627,"about_ca_system_score_codex":0.0024081706,"about_ca_system_score_gemma":0.0027871071,"threshold_uncertainty_score":0.051318765},"labels":[],"label_agreement":null},{"id":"W2167984747","doi":"10.1111/j.1524-4733.2010.00738.x","title":"How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Sunitinib; Reimbursement; Medicine; Context (archaeology); Oncology; Internal medicine; Tyrosine-kinase inhibitor; Sorafenib; Renal cell carcinoma; Cabozantinib; Kidney cancer; Cancer; Hepatocellular carcinoma","score_opus":0.26172057196591403,"score_gpt":0.41423857386000407,"score_spread":0.15251800189409004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167984747","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3145555,0.0637678,0.013850472,0.44712606,0.0014051904,0.00054428226,0.021655135,0.00029686536,0.13679871],"genre_scores_gemma":[0.9566538,0.014479451,0.015104987,0.0092453575,0.00039783397,0.000058346865,0.0019818316,0.00005125029,0.0020271698],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9898928,0.005446718,0.00047909797,0.00035087828,0.0028909897,0.00093956373],"domain_scores_gemma":[0.9511622,0.030310238,0.002050696,0.00090530526,0.014220072,0.0013514968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0120363645,0.00085188414,0.0018836206,0.0029672142,0.0021134748,0.006258759,0.0012696559,0.0023285365,0.0029197952],"category_scores_gemma":[0.069061555,0.00041418226,0.0017922394,0.006243782,0.0017520214,0.002165891,0.0009069632,0.0036380342,0.00021790856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039032097,0.00038456655,0.21193889,0.003405627,0.0061136764,0.0013059641,0.0014459523,0.16337246,0.0010446736,0.103095755,0.13149633,0.37249294],"study_design_scores_gemma":[0.0022416743,0.0007094307,0.39225653,0.0076854164,0.009766537,0.00093867216,0.004879814,0.24984296,0.0021307361,0.14969835,0.17903224,0.0008177136],"about_ca_topic_score_codex":0.95082265,"about_ca_topic_score_gemma":0.9761513,"teacher_disagreement_score":0.941141,"about_ca_system_score_codex":0.058858965,"about_ca_system_score_gemma":0.101591565,"threshold_uncertainty_score":0.42705363},"labels":[],"label_agreement":null},{"id":"W2168524487","doi":"10.1016/j.jval.2013.12.011","title":"A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Ottawa","funders":"National Center for Research Resources; Translational Research Institute, University of Arkansas for Medical Sciences; National Pharmaceutical Council","keywords":"Observational study; Credibility; Relevance (law); Observational methods in psychology; Task (project management); Psychological intervention; Psychology; Applied psychology; Consistency (knowledge bases); Medical education; Management science; Medicine; Computer science; Political science; Engineering; Artificial intelligence; Psychiatry","score_opus":0.7929635680932674,"score_gpt":0.6169698499817562,"score_spread":0.1759937181115112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168524487","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23661025,0.02735393,0.29525322,0.07387889,0.0068243328,0.2776577,0.032707956,0.0036186336,0.046095237],"genre_scores_gemma":[0.16162142,0.011534304,0.5206998,0.017801227,0.002005097,0.2753599,0.006879549,0.0005611369,0.0035376037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.78753364,0.09487361,0.090127535,0.0031751725,0.022333728,0.0019563367],"domain_scores_gemma":[0.15603305,0.7303154,0.047800828,0.016127605,0.046343174,0.0033799594],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27723542,0.001692057,0.004191785,0.012336808,0.0020596508,0.003253034,0.0016391854,0.005270291,0.008490717],"category_scores_gemma":[0.5585613,0.0017761127,0.006380616,0.0047908956,0.0030429966,0.0069484557,0.0060496605,0.0077040195,0.0034889788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050529107,0.004136986,0.096005164,0.050463676,0.0059493403,0.0006574021,0.025378482,0.0034861343,0.006810318,0.010503268,0.16679758,0.6247587],"study_design_scores_gemma":[0.019546185,0.0075497455,0.20880747,0.08589588,0.008397303,0.0035142205,0.022622256,0.023751305,0.010594316,0.060725063,0.5455222,0.0030740157],"about_ca_topic_score_codex":0.0010621146,"about_ca_topic_score_gemma":0.0020152088,"teacher_disagreement_score":0.7227646,"about_ca_system_score_codex":0.00403442,"about_ca_system_score_gemma":0.009560587,"threshold_uncertainty_score":0.8912974},"labels":[],"label_agreement":null},{"id":"W2168898013","doi":"10.1016/j.jval.2014.03.1185","title":"Hybrid time and motion, patient survey and chart review study methodology: A case study of subcutaneous allergen immunotherapy in the United States and Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalizability theory; Observational study; Medicine; Data collection; Chart; Health care; Medical emergency; Psychology; Internal medicine","score_opus":0.06935201784366178,"score_gpt":0.3217893230386833,"score_spread":0.2524373051950215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168898013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99718297,0.00017200616,0.00030212037,0.00018170502,0.000007507469,0.00018267577,0.0002499586,0.000004234029,0.0017168322],"genre_scores_gemma":[0.9980438,0.00026477178,0.0007785673,0.0001600786,0.000006728142,0.000051868556,0.00015128385,0.000005812746,0.00053708896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953725,0.0011254135,0.00036014398,0.0003714258,0.0016800032,0.0010905521],"domain_scores_gemma":[0.99284714,0.0011407787,0.0013884831,0.00025346127,0.0035838608,0.0007864049],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025174255,0.00043259005,0.0003639559,0.0033293702,0.004319017,0.0016092843,0.0015486557,0.00081915857,0.000907923],"category_scores_gemma":[0.00795521,0.0005511816,0.0003604388,0.005807004,0.0017874202,0.00056683546,0.001610309,0.0010115051,0.00013302265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049290204,0.00019816309,0.96880865,0.000051003077,0.000031693846,0.0046049547,0.019583391,0.00009409412,0.00044303897,0.00024766324,0.0004998653,0.005388271],"study_design_scores_gemma":[0.000010517378,0.00017458359,0.9178589,0.00006396697,0.00004956768,0.0033926284,0.075425334,0.0007034706,0.00041383898,0.00006349641,0.0018119807,0.000031790125],"about_ca_topic_score_codex":0.9643774,"about_ca_topic_score_gemma":0.98472124,"teacher_disagreement_score":0.9974826,"about_ca_system_score_codex":0.025976727,"about_ca_system_score_gemma":0.035283975,"threshold_uncertainty_score":0.18847519},"labels":[],"label_agreement":null},{"id":"W2169288904","doi":"10.1016/j.jval.2013.03.1627","title":"Measuring the Quality of a Childhood Cancer Care Delivery System: Quality Indicator Development","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Pediatric Oncology Group; University of Toronto; Hamilton Health Sciences; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Quality (philosophy); Health care; Stakeholder; Process management; Business","score_opus":0.23318617317849002,"score_gpt":0.4257284403671275,"score_spread":0.19254226718863746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169288904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004504397,0.9974234,0.0007586049,0.00074162544,0.000099976685,0.000034401484,0.000088227185,0.000006933407,0.0003964321],"genre_scores_gemma":[0.0057012136,0.99081564,0.002824435,0.00024766783,0.000090069145,0.000065138775,0.00014067965,0.0000033776623,0.00011191448],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948096,0.0017863597,0.0008421937,0.00040968615,0.0019741713,0.00017790872],"domain_scores_gemma":[0.9832997,0.011103727,0.0028164764,0.00021072375,0.0022489924,0.00032038026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010508921,0.0015000533,0.0036483952,0.007078805,0.00038073162,0.0024465465,0.0020344018,0.0013367935,0.0012192399],"category_scores_gemma":[0.022781936,0.0005375809,0.0020809972,0.011232709,0.0009648302,0.002307796,0.001522294,0.0024426943,0.00024264753],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041501327,0.0000857847,0.006009852,0.035733752,0.0008609249,0.000026213429,0.000114760864,0.00082024845,0.00013838882,0.0049684374,0.006807493,0.9443926],"study_design_scores_gemma":[0.00017576263,0.00073119014,0.085486315,0.25969893,0.008424583,0.0016613386,0.0017643305,0.004852747,0.0029356475,0.026756326,0.6071925,0.0003203505],"about_ca_topic_score_codex":0.008763189,"about_ca_topic_score_gemma":0.011139769,"teacher_disagreement_score":0.010508921,"about_ca_system_score_codex":0.004174078,"about_ca_system_score_gemma":0.008353515,"threshold_uncertainty_score":0.05557716},"labels":[],"label_agreement":null},{"id":"W2169495494","doi":"10.1016/j.jval.2012.08.2213","title":"Cost-Effectiveness Analysis: Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Stress ulcer; Medicine; Complication; Ventilator-associated pneumonia; Intensive care medicine; Pneumonia; Internal medicine","score_opus":0.044810535994988486,"score_gpt":0.33661048458353743,"score_spread":0.29179994858854896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169495494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79652435,0.12373722,0.020801209,0.0074853785,0.001247066,0.004599598,0.022486713,0.0003423492,0.02277623],"genre_scores_gemma":[0.98273474,0.007757636,0.0035365524,0.0008141882,0.00026152874,0.000505159,0.0027479914,0.00003143651,0.0016107702],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9926609,0.0057893544,0.00027745392,0.00031740006,0.0004315303,0.00052327354],"domain_scores_gemma":[0.99173754,0.0069579785,0.0005278827,0.00017307112,0.00026090577,0.00034267842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005633045,0.002290273,0.005380121,0.0030538915,0.00033470686,0.0029260947,0.0015321639,0.0017629979,0.010582085],"category_scores_gemma":[0.016802331,0.0011906441,0.011524243,0.002849021,0.0006252132,0.0021077422,0.0012391,0.002764268,0.00041454623],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.265609,0.0031210303,0.034769945,0.01578575,0.099469535,0.0014106451,0.00016570956,0.401397,0.0028391625,0.010452868,0.011755814,0.15322365],"study_design_scores_gemma":[0.112090625,0.053539343,0.13136646,0.00500667,0.19551958,0.0033146203,0.001325941,0.45895532,0.003521218,0.017273413,0.017501378,0.0005854721],"about_ca_topic_score_codex":0.013611095,"about_ca_topic_score_gemma":0.008822355,"teacher_disagreement_score":0.013611095,"about_ca_system_score_codex":0.0053023375,"about_ca_system_score_gemma":0.003264469,"threshold_uncertainty_score":0.03847134},"labels":[],"label_agreement":null},{"id":"W2169789362","doi":"10.1016/j.jval.2014.01.002","title":"Discrete Choice Experiment to Estimate Breast Cancer Patients’ Preferences and Willingness to Pay for Prophylactic Granulocyte Colony-Stimulating Factors","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Amgen","keywords":"Medicine; Febrile neutropenia; Chemotherapy; Willingness to pay; Granulocyte colony-stimulating factor; Breast cancer; Neutropenia; Oncology; Internal medicine; Cancer; Intensive care medicine","score_opus":0.04201486244759908,"score_gpt":0.3745239640668622,"score_spread":0.33250910161926317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169789362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893884,0.000051243383,0.0075311163,0.0003606229,0.00010376227,0.0010105575,0.00049731374,0.00003322941,0.0010236965],"genre_scores_gemma":[0.9839199,0.00004712271,0.011584855,0.00029737514,0.000044244058,0.0019260944,0.00029849177,0.0000050376707,0.0018769314],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99584866,0.0031384483,0.00019126445,0.00031457611,0.00023524987,0.00027172573],"domain_scores_gemma":[0.9456648,0.04961738,0.0017903007,0.001358388,0.000451638,0.0011175063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008881268,0.0012132989,0.0012348813,0.00054459233,0.0007902326,0.0012034734,0.0010177798,0.0023835362,0.012992717],"category_scores_gemma":[0.020454621,0.0008238197,0.0012769654,0.0003904071,0.0014660199,0.0010169161,0.0006100368,0.0025021704,0.0009557005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.46342868,0.19055583,0.08606959,0.0012623025,0.0035052507,0.0011424036,0.003012562,0.13222179,0.0268457,0.022443062,0.0035852813,0.0659276],"study_design_scores_gemma":[0.13191116,0.21664777,0.042267058,0.00011500561,0.0010694303,0.00055559096,0.0015539906,0.57208407,0.013237451,0.016035482,0.0040930253,0.0004300236],"about_ca_topic_score_codex":0.0010835314,"about_ca_topic_score_gemma":0.00061183784,"teacher_disagreement_score":0.012992717,"about_ca_system_score_codex":0.001044092,"about_ca_system_score_gemma":0.0010756908,"threshold_uncertainty_score":0.046969235},"labels":[],"label_agreement":null},{"id":"W2169989438","doi":"10.1016/j.jval.2011.02.441","title":"PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Vagus nerve stimulation; Medicaid; Epilepsy; Univariate analysis; Incidence (geometry); Pediatrics; Emergency medicine; Multivariate analysis; Health care; Internal medicine; Psychiatry; Vagus nerve","score_opus":0.10095795357983417,"score_gpt":0.41192736739092123,"score_spread":0.31096941381108706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169989438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593663,0.00020869821,0.000021447197,0.00083856145,0.000011081008,0.0000052225405,0.0005338029,0.0000014333265,0.0024431613],"genre_scores_gemma":[0.9992017,0.0000986731,0.000021385087,0.00012930308,0.000015247755,0.0000051185,0.0003342783,9.4568577e-7,0.00019327604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996549,0.00012061553,0.000023994686,0.000024932473,0.000056296038,0.00011935285],"domain_scores_gemma":[0.9984585,0.00046617846,0.0006666239,0.0000369524,0.0000864176,0.00028530636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032629515,0.00008244636,0.00015506086,0.00024127329,0.00032087226,0.0005772557,0.00021130552,0.00035151347,0.004074938],"category_scores_gemma":[0.0041189524,0.000070108574,0.0004850742,0.00048780482,0.00021301751,0.00039393877,0.00052608707,0.0004668421,0.00012214197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029039625,0.0004551714,0.9620173,0.000038558654,0.00021971809,0.0002563657,0.000104295694,0.0009787093,0.00035224864,0.0008852452,0.0019397617,0.02984884],"study_design_scores_gemma":[0.00009256724,0.00028995224,0.9966949,0.00003063717,0.00009650914,0.00018650638,0.00027460558,0.0012147526,0.00009855574,0.00038505095,0.0006288938,0.00000709102],"about_ca_topic_score_codex":0.014901541,"about_ca_topic_score_gemma":0.028752336,"teacher_disagreement_score":0.014901541,"about_ca_system_score_codex":0.0010286008,"about_ca_system_score_gemma":0.001115714,"threshold_uncertainty_score":0.029629648},"labels":[],"label_agreement":null},{"id":"W2170239385","doi":"10.1016/j.jval.2012.06.012","title":"Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":755,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Task (project management); Task force; Computer science; Management science; Best practice; Health care; Work (physics); Data science; Systems engineering; Engineering; Political science","score_opus":0.876793190886648,"score_gpt":0.6051287336837298,"score_spread":0.2716644572029182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170239385","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011642224,0.18466371,0.5252404,0.1938673,0.002365758,0.0062814704,0.017374977,0.0046590976,0.053905103],"genre_scores_gemma":[0.063171536,0.14092101,0.7455737,0.012571599,0.001916048,0.00657385,0.022286264,0.0017795572,0.005206439],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7751482,0.13969822,0.021959512,0.007757286,0.050931558,0.004505241],"domain_scores_gemma":[0.51555485,0.25759262,0.049583882,0.051101524,0.11834193,0.007825181],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.32246932,0.0030990914,0.003142004,0.0172058,0.0022397586,0.013774044,0.007913871,0.006834304,0.004352793],"category_scores_gemma":[0.35617706,0.002994995,0.0048864605,0.02299339,0.003047919,0.010551142,0.01120656,0.0073966053,0.003015299],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027331238,0.00047623995,0.019508937,0.00899703,0.0012467705,0.00015211994,0.0017672874,0.02558183,0.0009891109,0.102989025,0.2352435,0.602775],"study_design_scores_gemma":[0.0002942038,0.00036869833,0.016918411,0.044313636,0.0017069587,0.00046717175,0.001368811,0.038939185,0.005149079,0.16432643,0.72568005,0.00046738546],"about_ca_topic_score_codex":0.023436816,"about_ca_topic_score_gemma":0.033459727,"teacher_disagreement_score":0.67753065,"about_ca_system_score_codex":0.014146473,"about_ca_system_score_gemma":0.050418902,"threshold_uncertainty_score":0.835516},"labels":[],"label_agreement":null},{"id":"W2170943640","doi":"10.1016/j.jval.2012.08.1026","title":"PCV83 Adherence to Antihypertensive Agents After a Recent Ischemic Stroke and Risk of Cardiovascular Outcomes : A Population Based Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Stroke (engine); Cohort; Diabetes mellitus; Atrial fibrillation; Cohort study; Population; Disease; Coronary artery disease; Logistic regression; Cardiology; Endocrinology","score_opus":0.053487780854221595,"score_gpt":0.3165928188727096,"score_spread":0.26310503801848806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170943640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891746,0.00014950143,0.00008443296,0.00005472211,0.000013650708,0.000023627237,0.00025833285,0.000003890793,0.000494452],"genre_scores_gemma":[0.9988997,0.00012881358,0.00008278388,0.00010002397,0.000039854312,0.000028783728,0.00033678152,0.0000043668056,0.00037891735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982455,0.00053367874,0.00018671816,0.00033040528,0.0003775899,0.00032612335],"domain_scores_gemma":[0.99703085,0.00055765564,0.0010514632,0.00032088617,0.00037755366,0.0006614233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012578915,0.00082160113,0.0010632651,0.0014082663,0.001596571,0.0022007246,0.0010831733,0.0024945117,0.0025185067],"category_scores_gemma":[0.004141765,0.0014524609,0.0021006055,0.0037040294,0.0007613334,0.0016179127,0.0010729091,0.0034697475,0.0006699548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005162492,0.0007105813,0.99655104,0.00001453655,0.0004956536,0.00012774445,0.00021896046,0.000028518976,0.00013645158,0.000024178524,0.0001343311,0.0010417935],"study_design_scores_gemma":[0.00008219868,0.0005045714,0.99829537,0.00000744911,0.00024130341,0.00022436636,0.0003156279,0.00015777716,0.00002219588,0.000028260707,0.000109196844,0.000011690139],"about_ca_topic_score_codex":0.013796805,"about_ca_topic_score_gemma":0.014663592,"teacher_disagreement_score":0.013796805,"about_ca_system_score_codex":0.0007309744,"about_ca_system_score_gemma":0.00068408856,"threshold_uncertainty_score":0.027432978},"labels":[],"label_agreement":null},{"id":"W2171310617","doi":"10.1016/j.jval.2012.04.013","title":"Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":238,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Task force; Discrete event simulation; Computer science; Task (project management); Event (particle physics); Management science; Simulation; Engineering; Systems engineering; Political science; Physics","score_opus":0.7916444466274899,"score_gpt":0.5722622029564016,"score_spread":0.21938224367108827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171310617","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0117800515,0.008809617,0.9048306,0.03988567,0.0010192093,0.0016198305,0.008923069,0.0031528194,0.019979203],"genre_scores_gemma":[0.0865347,0.021851873,0.8542233,0.003408504,0.0009588213,0.003009218,0.021416532,0.0021764303,0.006420549],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.955244,0.028849546,0.0027028536,0.0015304401,0.010781297,0.00089198415],"domain_scores_gemma":[0.83897555,0.098956205,0.0070346943,0.018550511,0.033599135,0.0028839477],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11369198,0.0021699527,0.0030103032,0.004419618,0.0011058917,0.0056572896,0.0062467977,0.003332408,0.0048327064],"category_scores_gemma":[0.13733931,0.0020984716,0.004886414,0.0055149645,0.0012245744,0.0046632853,0.004943311,0.0052675367,0.0025305587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000537884,0.0007294163,0.015517835,0.0018217219,0.0011595022,0.00013277851,0.00058355334,0.37919316,0.0021922668,0.10206563,0.14921246,0.34685388],"study_design_scores_gemma":[0.0003521735,0.00024074472,0.0047708913,0.0028897894,0.00064672984,0.00010590843,0.0002514217,0.6994983,0.007548434,0.09779462,0.18563117,0.00026983273],"about_ca_topic_score_codex":0.052283656,"about_ca_topic_score_gemma":0.046706643,"teacher_disagreement_score":0.886308,"about_ca_system_score_codex":0.0053800778,"about_ca_system_score_gemma":0.020660982,"threshold_uncertainty_score":0.6012678},"labels":[],"label_agreement":null},{"id":"W2171436100","doi":"10.1016/j.jval.2015.08.003","title":"Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Universitetet i Oslo","keywords":"Context (archaeology); Psychological intervention; Triage; Cervical cancer; Medicine; Norwegian; Cervical screening; Cost–utility analysis; Actuarial science; Decision tree; Incremental cost-effectiveness ratio; Gynecology; Cost-effectiveness analysis; Computer science; Cost effectiveness; Risk analysis (engineering); Cancer; Business; Data mining; Emergency medicine; Internal medicine","score_opus":0.3930505713572423,"score_gpt":0.498982152553361,"score_spread":0.10593158119611867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171436100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70191926,0.0020222424,0.27649873,0.003938296,0.00020808882,0.002596908,0.0017554724,0.00027248226,0.0107884975],"genre_scores_gemma":[0.87078536,0.00076396146,0.12528923,0.00024685505,0.00004542224,0.0009886103,0.0005482319,0.00005622555,0.0012761338],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98942065,0.008974672,0.00025593076,0.0004658117,0.000403412,0.00047959364],"domain_scores_gemma":[0.86535555,0.13019204,0.0015229151,0.0008743205,0.0012665556,0.0007885536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020746384,0.0024275663,0.0025068747,0.0018452448,0.0012212029,0.0025262823,0.0016961036,0.0018465118,0.0033091418],"category_scores_gemma":[0.058536485,0.0011133623,0.0035869346,0.001755372,0.0013439519,0.0013086569,0.00190575,0.0032601012,0.00012867038],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014974383,0.0009144639,0.009563363,0.0004412159,0.0006340688,0.00020625701,0.00060218497,0.9449316,0.00027659576,0.0188763,0.0010683408,0.020988157],"study_design_scores_gemma":[0.0002679371,0.00025162345,0.0018443097,0.000058479636,0.00019987974,0.000028088929,0.00025314558,0.9836668,0.00016349828,0.01250695,0.00072524796,0.000033998138],"about_ca_topic_score_codex":0.099275745,"about_ca_topic_score_gemma":0.049381815,"teacher_disagreement_score":0.099275745,"about_ca_system_score_codex":0.006557623,"about_ca_system_score_gemma":0.010000334,"threshold_uncertainty_score":0.1973958},"labels":[],"label_agreement":null},{"id":"W2171436500","doi":"10.1016/j.jval.2015.09.2397","title":"Modeling The Impact of Potential Differences In Real-Wolrd Adherence With Extended-Half-Life Vs. Conventional Factor Viii And Ix on Bleeding","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Regimen; Haemophilia; Haemophilia A; Clinical trial; Internal medicine; Pediatrics","score_opus":0.17797058423390083,"score_gpt":0.40017316550295823,"score_spread":0.2222025812690574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171436500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908987,0.00020101445,0.0049911663,0.00086464925,0.00005960387,0.000034637695,0.0006572162,0.000030635918,0.0022623134],"genre_scores_gemma":[0.99569964,0.00005590718,0.001235586,0.00011462715,0.00001365228,0.000032840755,0.00028933914,0.000008385474,0.0025500946],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981652,0.000988998,0.00006217069,0.00029551674,0.00008445092,0.0004037336],"domain_scores_gemma":[0.9873914,0.010000908,0.0009445301,0.00054697803,0.0005216161,0.00059450394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004931656,0.00062634965,0.0007609654,0.00035016524,0.00040748922,0.0020199066,0.002160956,0.0021263722,0.008121551],"category_scores_gemma":[0.018782813,0.0005165169,0.0013369675,0.0004355544,0.0007076734,0.0012250259,0.00078498304,0.0021611142,0.0004895521],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013127297,0.0006701498,0.057365287,0.00005077456,0.00024557317,0.00015919987,0.0001463946,0.9256596,0.00056770555,0.0064802603,0.0007287662,0.006613529],"study_design_scores_gemma":[0.0001510622,0.0005396887,0.014685845,0.000021551989,0.00015358411,0.00005078243,0.00024774496,0.97994345,0.00032764862,0.0031267419,0.00072431174,0.000027682143],"about_ca_topic_score_codex":0.03748337,"about_ca_topic_score_gemma":0.022022244,"teacher_disagreement_score":0.03748337,"about_ca_system_score_codex":0.001853554,"about_ca_system_score_gemma":0.0019400923,"threshold_uncertainty_score":0.07453036},"labels":[],"label_agreement":null},{"id":"W2174482767","doi":"10.1016/j.jval.2015.03.050","title":"A Review And Update To The Guidance Document For The Costing Process In The Canadian Health Care Setting","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Operations Management Techniques","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Activity-based costing; Health care; Process (computing); Agency (philosophy); Medicine; Business; Process management; Computer science; Political science; Marketing","score_opus":0.29365138881754643,"score_gpt":0.5430054948231564,"score_spread":0.24935410600560998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174482767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017780354,0.9827153,0.00070750836,0.010517768,0.001697085,0.00012875718,0.0008963229,0.000031800293,0.0031276776],"genre_scores_gemma":[0.0012947025,0.9890742,0.003536977,0.0034014406,0.0004551691,0.00009310276,0.00062502694,0.000014695524,0.0015047428],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99212193,0.0010260325,0.0012570434,0.0002870791,0.004879547,0.00042830544],"domain_scores_gemma":[0.96583074,0.009817814,0.00278995,0.00047589676,0.019964894,0.0011206175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013447833,0.0017156671,0.0033284097,0.013979261,0.0013085933,0.0036546441,0.0036500131,0.0027336227,0.0053376937],"category_scores_gemma":[0.03318898,0.00077903306,0.0030070192,0.020167036,0.0017641607,0.0023756656,0.0013712784,0.003646148,0.001401581],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008766849,0.00007955867,0.00057339686,0.066503584,0.00032222507,0.00016386881,0.00024592958,0.0006751879,0.00026496768,0.008274573,0.3360956,0.58671343],"study_design_scores_gemma":[0.00005202052,0.00004266964,0.00345878,0.05479489,0.0006775066,0.00021808874,0.00012222522,0.0001541773,0.00018457498,0.0013279314,0.93889034,0.00007677393],"about_ca_topic_score_codex":0.63561875,"about_ca_topic_score_gemma":0.7817499,"teacher_disagreement_score":0.9688072,"about_ca_system_score_codex":0.031192787,"about_ca_system_score_gemma":0.17062041,"threshold_uncertainty_score":0.7330543},"labels":[],"label_agreement":null},{"id":"W2179942617","doi":"10.1016/j.jval.2015.09.2938","title":"The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroethics, Human Enhancement, Biomedical Innovations","field":"Neuroscience","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Conceptualization; Randomized controlled trial; Identification (biology); Narrative; Narrative review; Health care; Electroencephalography; Psychology; Computer science; Medicine; Artificial intelligence; Psychotherapist; Psychiatry; Political science","score_opus":0.42939299169784917,"score_gpt":0.4339454096475236,"score_spread":0.0045524179496744255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179942617","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022100806,0.4135694,0.045615617,0.3699074,0.004113002,0.00011737699,0.0001430256,0.00005695278,0.14437641],"genre_scores_gemma":[0.8022922,0.12806836,0.011791659,0.04461679,0.009462841,0.00047365192,0.000081943,0.000084226114,0.0031281966],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98884225,0.0069676153,0.0006088254,0.0012176712,0.0017462225,0.00061729737],"domain_scores_gemma":[0.9181191,0.07507696,0.002461736,0.0013716018,0.0020484712,0.00092222367],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028295891,0.0008988065,0.0015608022,0.0060776314,0.0035091,0.012152642,0.002545144,0.009141483,0.0039744345],"category_scores_gemma":[0.035232704,0.0006289791,0.00070691336,0.006142192,0.06986308,0.017867045,0.0065336144,0.010023038,0.0002991103],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022265729,0.000026175634,0.00021689037,0.00024348621,0.000007746562,0.000026908741,0.00135407,0.00009883792,0.00002942335,0.98759556,0.001147616,0.009231006],"study_design_scores_gemma":[0.000034606895,0.0000715072,0.0011538719,0.0019450049,0.000019344072,0.00022772321,0.0031468256,0.00046895523,0.00017040057,0.9331005,0.0596331,0.000028243006],"about_ca_topic_score_codex":0.002318426,"about_ca_topic_score_gemma":0.0019202415,"teacher_disagreement_score":0.9717041,"about_ca_system_score_codex":0.008589432,"about_ca_system_score_gemma":0.008730305,"threshold_uncertainty_score":0.14964473},"labels":[],"label_agreement":null},{"id":"W2182580458","doi":"10.1016/j.jval.2015.09.2658","title":"Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) – First Step Towards a Pro Measure in Lpld","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Pancreatitis; Physical therapy; Internal medicine; Nursing","score_opus":0.10602216413324121,"score_gpt":0.35951827755916194,"score_spread":0.2534961134259207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182580458","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34445223,0.094378375,0.021876534,0.49404207,0.004796447,0.00032513242,0.0015135651,0.00012475759,0.03849098],"genre_scores_gemma":[0.9598972,0.012358549,0.013228841,0.0098036425,0.002117298,0.00018317082,0.0005739908,0.000026224887,0.0018110183],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9952427,0.0028535014,0.0005329606,0.00010799753,0.0010667241,0.00019618047],"domain_scores_gemma":[0.988372,0.0040362393,0.0019469715,0.00039915272,0.0032074596,0.0020379915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009683033,0.0006655104,0.00091914984,0.0017646049,0.0010324238,0.003436696,0.00099852,0.0013063791,0.0016907807],"category_scores_gemma":[0.020471351,0.00019185177,0.0005596123,0.0011769044,0.0014346644,0.003975418,0.002592132,0.0053360355,0.0002608332],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009859934,0.0016740176,0.44706365,0.0014001656,0.0005751732,0.0008540658,0.003029561,0.00096579496,0.0011891872,0.03121557,0.039531905,0.47151497],"study_design_scores_gemma":[0.0001646815,0.0044111107,0.71647424,0.0056135156,0.00054951344,0.0035129122,0.025106214,0.005523193,0.0022669723,0.1287475,0.10734259,0.00028759253],"about_ca_topic_score_codex":0.0025417856,"about_ca_topic_score_gemma":0.003924495,"teacher_disagreement_score":0.009683033,"about_ca_system_score_codex":0.002329822,"about_ca_system_score_gemma":0.0024979406,"threshold_uncertainty_score":0.05120933},"labels":[],"label_agreement":null},{"id":"W2182833508","doi":"10.1016/j.jval.2015.09.592","title":"Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology; Novartis (Canada)","funders":"","keywords":"Presenteeism; Medicine; Absenteeism; Observational study; Medical Expenditure Panel Survey; Cohort study; Emergency medicine; Physical therapy; Pediatrics; Health care; Internal medicine","score_opus":0.021654272794636824,"score_gpt":0.2752514868678591,"score_spread":0.2535972140732223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182833508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997846,0.00029416836,0.000027290644,0.00004352959,0.0000074979744,0.000014324559,0.0014452159,0.0000021282117,0.00031984033],"genre_scores_gemma":[0.9972746,0.00015935746,0.000039912873,0.000026976462,0.00001900629,0.000017469949,0.002268876,0.0000017668051,0.00019215341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908435,0.00030573868,0.00012015313,0.00010048767,0.00021151236,0.00017774034],"domain_scores_gemma":[0.9985404,0.00020617137,0.00064568094,0.00011754329,0.00019755887,0.0002926047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013175581,0.0006127225,0.00054401695,0.0012703182,0.0006193937,0.0010866413,0.0005033673,0.00060471427,0.0012583314],"category_scores_gemma":[0.0027140148,0.00032936645,0.001000708,0.001768467,0.00031911596,0.00076482823,0.001205701,0.00060757797,0.00022267501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027414504,0.00009433204,0.9984816,0.000011518943,0.0000858203,0.00002013466,0.00007069579,0.000020372583,0.00004927169,0.0000064039914,0.00011742735,0.0007683339],"study_design_scores_gemma":[0.0000121821295,0.000062801686,0.9996996,0.0000019057583,0.000018979512,0.000026600683,0.00009476489,0.000026023288,0.000009151365,0.0000040481573,0.00004247491,0.0000015528439],"about_ca_topic_score_codex":0.010285224,"about_ca_topic_score_gemma":0.014753288,"teacher_disagreement_score":0.010285224,"about_ca_system_score_codex":0.00058926974,"about_ca_system_score_gemma":0.00040273758,"threshold_uncertainty_score":0.020450711},"labels":[],"label_agreement":null},{"id":"W2183363260","doi":"10.1016/j.jval.2015.09.2463","title":"Systematic Review of Economic Evaluations of Treatments In Epilepsy","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Lamotrigine; Lacosamide; Epilepsy; Oxcarbazepine; Adjunctive treatment; Levetiracetam; Systematic review; Lennox–Gastaut syndrome; Pediatrics; MEDLINE; Meta-analysis; Population; Internal medicine; Psychiatry; Carbamazepine","score_opus":0.12485810096399477,"score_gpt":0.43745510282345057,"score_spread":0.3125970018594558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183363260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010616224,0.9842418,0.00082012906,0.0007800518,0.00045176648,0.0007646841,0.0013870604,0.000023115676,0.0009153057],"genre_scores_gemma":[0.34396175,0.64780027,0.003295756,0.0014028512,0.00038417493,0.0016357598,0.0010870945,0.000030693613,0.0004016075],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9493439,0.035144757,0.0099056475,0.0013485942,0.003603753,0.0006532973],"domain_scores_gemma":[0.90699106,0.07627744,0.011714589,0.0015496259,0.0028171833,0.00065013306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029017566,0.0023862387,0.013036009,0.006093852,0.0005580082,0.0031294583,0.0017350453,0.0023204,0.004839931],"category_scores_gemma":[0.13457753,0.0013765758,0.015814852,0.00573288,0.0013673004,0.0022867369,0.001894916,0.0029443786,0.00021531884],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008981059,0.000071483155,0.0021976342,0.65617543,0.30209062,0.00013929118,0.00014047847,0.00082338543,0.00015358589,0.00070457545,0.0015582758,0.026964108],"study_design_scores_gemma":[0.01202608,0.0012046328,0.009244656,0.19987212,0.7647918,0.00038025243,0.00024735523,0.00075922796,0.0002630495,0.0024669617,0.0086570885,0.000086814114],"about_ca_topic_score_codex":0.009120396,"about_ca_topic_score_gemma":0.020430515,"teacher_disagreement_score":0.029017566,"about_ca_system_score_codex":0.0052358583,"about_ca_system_score_gemma":0.0064357086,"threshold_uncertainty_score":0.1534614},"labels":[],"label_agreement":null},{"id":"W2184615100","doi":"10.1016/j.jval.2015.09.1516","title":"Exploring Attitudes and Perceptions of Patients and Staff Towards a Fee For Service “After Hours” Clinic Supplementing Free Hiv Services in Uganda: A Qualitative Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Focus group; Medicine; Thematic analysis; Qualitative research; Family medicine; Service delivery framework; Service (business); Nursing; Business; Marketing","score_opus":0.22925083437157096,"score_gpt":0.4711787936409006,"score_spread":0.24192795926932964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184615100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99746275,0.00018806732,0.00019198889,0.0011440469,0.000025547548,0.00003686633,0.000025073921,0.000003085388,0.00092262216],"genre_scores_gemma":[0.99785477,0.00027043832,0.00026415172,0.00089421903,0.000011097989,0.000058288886,0.000013047016,0.000005210996,0.00062879245],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99032694,0.0070177685,0.00032332138,0.00023044854,0.0005141786,0.00158736],"domain_scores_gemma":[0.98141736,0.011527469,0.002024902,0.00030617285,0.0013858989,0.0033381074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009253231,0.00035741963,0.00065778807,0.0009245812,0.011543483,0.0038416402,0.0016880392,0.0019464996,0.002574435],"category_scores_gemma":[0.017602583,0.00086978293,0.00038351546,0.0010710699,0.0061806324,0.0028401022,0.0038524256,0.0037132334,0.00025346503],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057042933,0.00013298495,0.010489736,0.000089235305,0.000008232466,0.00053776783,0.9848188,0.000019147301,0.0004979472,0.00028957386,0.00036319968,0.0026964545],"study_design_scores_gemma":[0.0000033662725,0.000068627334,0.0025669036,0.000054854034,0.0000043311106,0.00013015718,0.99550605,0.000021426316,0.00009622281,0.000042332,0.0014963066,0.000009299932],"about_ca_topic_score_codex":0.01251872,"about_ca_topic_score_gemma":0.024514802,"teacher_disagreement_score":0.01251872,"about_ca_system_score_codex":0.005272346,"about_ca_system_score_gemma":0.0073673488,"threshold_uncertainty_score":0.048936367},"labels":[],"label_agreement":null},{"id":"W2184885738","doi":"10.1016/j.jval.2015.10.010","title":"Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Myocardial infarction; Stroke (engine); Diabetes mellitus; Quality of life (healthcare); Heart failure; Amputation; EQ-5D; Disease; Physical therapy; Confidence interval; Heart disease; Internal medicine; Surgery; Health related quality of life","score_opus":0.6296680235757864,"score_gpt":0.4616103344648133,"score_spread":0.16805768911097313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184885738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980186,0.0003334364,0.0000640403,0.0001015158,0.000006963647,0.000010614863,0.0011384349,0.0000026082669,0.00032376221],"genre_scores_gemma":[0.9968695,0.00041142612,0.00014750838,0.00004100205,0.000032191103,0.00002098262,0.002143013,0.0000039478377,0.00033041716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998481,0.00083923934,0.000120637495,0.0001737107,0.0002585741,0.00012687682],"domain_scores_gemma":[0.98341596,0.007795178,0.0049867467,0.0013568336,0.0007478672,0.0016974611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034433522,0.00044692075,0.00071808073,0.0010775088,0.00029988095,0.0007222236,0.00056606473,0.00079489435,0.0016929053],"category_scores_gemma":[0.012690357,0.0003148231,0.0018420473,0.0021461505,0.0005117545,0.0012918187,0.0011160148,0.0015014705,0.00023588535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01228011,0.0017620574,0.97164345,0.00010000363,0.0015508339,0.00016796161,0.00038639258,0.0010999041,0.00012117692,0.00026750492,0.0010615491,0.009558936],"study_design_scores_gemma":[0.00026257316,0.0009237288,0.99709463,0.00001059431,0.00034272755,0.0001292331,0.00022703905,0.00041093628,0.00005576772,0.00011639652,0.00041252538,0.000013817453],"about_ca_topic_score_codex":0.009602584,"about_ca_topic_score_gemma":0.0066990075,"teacher_disagreement_score":0.009602584,"about_ca_system_score_codex":0.0005283859,"about_ca_system_score_gemma":0.00039218552,"threshold_uncertainty_score":0.019093394},"labels":[],"label_agreement":null},{"id":"W2185447473","doi":"10.1016/j.jval.2015.09.859","title":"The Cost Of Acute Care Hospitalizations Associated With Chronic Heart Failure In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Heart failure; Ambulatory; Emergency medicine; Disease; Demographics; Acute care; Hospital discharge; Intensive care medicine; Health care; Internal medicine","score_opus":0.02067910244001095,"score_gpt":0.2759418896224015,"score_spread":0.2552627871823906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185447473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91615087,0.012490534,0.00032221052,0.023455309,0.00046027536,0.00010431077,0.027467031,0.00004855905,0.019500948],"genre_scores_gemma":[0.99066585,0.0033544484,0.00015941175,0.00069969875,0.00008319178,0.000012868017,0.0028052267,0.000009546743,0.0022097172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831367,0.00013806016,0.00013514525,0.00009889805,0.00061921024,0.00069494173],"domain_scores_gemma":[0.99401546,0.0003516892,0.00096404523,0.00007056237,0.0022884,0.00230976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004869161,0.0003262883,0.00054344116,0.001990667,0.0022825946,0.0022278924,0.0017018011,0.0010696535,0.0042090435],"category_scores_gemma":[0.0064061666,0.0004900577,0.0012430914,0.0044711553,0.00077492936,0.00066794024,0.0012593607,0.0021940647,0.0001682419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028993294,0.00013271478,0.94998074,0.00023164526,0.00042173528,0.0005078916,0.00039433903,0.0019415177,0.00013730208,0.0027609626,0.022043966,0.021157207],"study_design_scores_gemma":[0.0000586519,0.000033916152,0.9899857,0.00021143994,0.00014670522,0.00026135155,0.0014181247,0.00234817,0.00005033671,0.00033348377,0.0051158248,0.000036312125],"about_ca_topic_score_codex":0.9970611,"about_ca_topic_score_gemma":0.9982868,"teacher_disagreement_score":0.087878846,"about_ca_system_score_codex":0.087878846,"about_ca_system_score_gemma":0.08939682,"threshold_uncertainty_score":0.63760865},"labels":[],"label_agreement":null},{"id":"W2186044971","doi":"10.1016/j.jval.2015.09.2007","title":"Comparative Analysis of The Reimbursement Landscape of Orphan Drugs on An International Level","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Orphan drug; Reimbursement; Listing (finance); Medicine; Family medicine; Business; Public economics; Health care; Economic growth; Economics; Finance; Bioinformatics","score_opus":0.3080938908832449,"score_gpt":0.39867403604382745,"score_spread":0.09058014516058255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186044971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8409202,0.013880098,0.0050787367,0.009602505,0.00011691353,0.00004974557,0.0016462208,0.000039664217,0.1286659],"genre_scores_gemma":[0.99460465,0.0015335198,0.0006732546,0.00021930654,0.00005510808,0.000011829498,0.0005021557,0.000021813728,0.002378368],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99818146,0.00077096367,0.00006693526,0.00015412216,0.00045443195,0.00037208482],"domain_scores_gemma":[0.99546105,0.0020664781,0.0010477906,0.00020079044,0.00079315616,0.00043066515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002325229,0.00021220036,0.00059637765,0.0020944523,0.000425272,0.0034064031,0.00049344834,0.00081252726,0.008130632],"category_scores_gemma":[0.009401161,0.00013771608,0.0008818477,0.0036187682,0.0008361967,0.0015832908,0.0011754591,0.0012362159,0.00029197126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027463299,0.0005101294,0.10912614,0.00058497675,0.0008560587,0.0008898181,0.0011762688,0.033636186,0.004219439,0.68623143,0.015834192,0.14418912],"study_design_scores_gemma":[0.00028183332,0.0013067153,0.73386586,0.00060426653,0.0010653653,0.0013402775,0.007163344,0.035323635,0.003572768,0.12313673,0.092221655,0.00011752567],"about_ca_topic_score_codex":0.0053199055,"about_ca_topic_score_gemma":0.00865271,"teacher_disagreement_score":0.008130632,"about_ca_system_score_codex":0.0029166623,"about_ca_system_score_gemma":0.0012927977,"threshold_uncertainty_score":0.027199686},"labels":[],"label_agreement":null},{"id":"W2186241165","doi":"10.1016/j.jval.2015.09.2359","title":"Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Presenteeism; Psoriatic arthritis; Minimal clinically important difference; Physical therapy; Placebo; Internal medicine; Absenteeism; Clinical trial; Arthritis; Randomized controlled trial; Rheumatoid arthritis; Adalimumab; Alternative medicine; Psychology","score_opus":0.05133715215097627,"score_gpt":0.311548618452561,"score_spread":0.2602114663015847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186241165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99883384,0.0004802586,0.000044022025,0.00008416125,0.000012719276,0.0000055413675,0.00006115112,0.0000027727335,0.00047552132],"genre_scores_gemma":[0.99965215,0.00007362189,0.000024640687,0.00004004849,0.000011047229,0.0000032704165,0.00005453159,6.703784e-7,0.00013996559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914193,0.00037536627,0.000085415,0.00009604429,0.00013523325,0.00016604258],"domain_scores_gemma":[0.9971629,0.00079138816,0.0012667144,0.00012223342,0.00018387003,0.00047291655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000791435,0.00024022268,0.0004780787,0.00030235012,0.00022628481,0.0006288023,0.00021373322,0.0005001127,0.0015615819],"category_scores_gemma":[0.0034829774,0.00014631126,0.00072756526,0.00039941314,0.00023601518,0.00031367983,0.0003536732,0.00083370844,0.00018885145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050340495,0.0008021116,0.9733332,0.000059771184,0.00048593027,0.00014592631,0.00016109219,0.00017993632,0.001458674,0.00001783411,0.000245124,0.018076397],"study_design_scores_gemma":[0.000071553644,0.0006475696,0.9986172,0.0000068503705,0.00010001381,0.00008692814,0.00010999579,0.00014288086,0.000097905075,0.000025781897,0.00008851037,0.0000047015587],"about_ca_topic_score_codex":0.0011049776,"about_ca_topic_score_gemma":0.0015293398,"teacher_disagreement_score":0.0015615819,"about_ca_system_score_codex":0.00023709438,"about_ca_system_score_gemma":0.00021681884,"threshold_uncertainty_score":0.0052239895},"labels":[],"label_agreement":null},{"id":"W2186348405","doi":"10.1016/j.jval.2015.09.349","title":"Knowledge, Attitude And Practices Towards Medication Use Among Post-Graduate Pharmacy Students","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacy; Discontinuation; Family medicine; Medicine; Quarter (Canadian coin); Feeling; Alternative medicine; Medical prescription; Promotion (chess); Psychology; Nursing; Psychiatry","score_opus":0.17294461812540407,"score_gpt":0.42724365150014293,"score_spread":0.25429903337473886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186348405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99875164,0.00014341944,0.00001522302,0.00018385588,0.0000065392956,0.0000104966475,0.000052196036,0.0000011678692,0.00083544565],"genre_scores_gemma":[0.9987797,0.0002174786,0.000048258502,0.00016024568,0.000010456718,0.000008430799,0.00004779344,9.2533617e-7,0.00072670414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915564,0.00014143933,0.00008889029,0.000075739226,0.00034202673,0.0001962938],"domain_scores_gemma":[0.99537885,0.0009999528,0.0015136832,0.00010304522,0.0005490771,0.0014554479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011656027,0.00023382038,0.00048734932,0.0013079303,0.0011500376,0.0022067009,0.0003249844,0.0011866767,0.004071572],"category_scores_gemma":[0.0055567212,0.00038451087,0.00061238324,0.0009639996,0.00053956296,0.0010990724,0.0010905728,0.0016572943,0.0007634618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073606556,0.00089714467,0.98973686,0.0000386408,0.000032452448,0.000110937464,0.0023301085,0.000029737155,0.00033785473,0.000034338158,0.00015486714,0.0062234197],"study_design_scores_gemma":[0.000009553063,0.0007075447,0.9901455,0.000058471804,0.000034387307,0.00030554662,0.007583166,0.00019402934,0.00018663323,0.000055376677,0.00070641434,0.000013439269],"about_ca_topic_score_codex":0.0061447835,"about_ca_topic_score_gemma":0.0073075597,"teacher_disagreement_score":0.0061447835,"about_ca_system_score_codex":0.0006311616,"about_ca_system_score_gemma":0.0014673279,"threshold_uncertainty_score":0.013620734},"labels":[],"label_agreement":null},{"id":"W2186391570","doi":"10.1016/j.jval.2015.09.1142","title":"Economic Burden of Patients with Alk+ Mutation non-Small Cell Lung Cancer After Treatment with Crizotinib: a Canadian Retrospective Observational Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Novartis (Canada)","funders":"","keywords":"Crizotinib; Ceritinib; Anaplastic lymphoma kinase; Medicine; Lung cancer; ALK inhibitor; Internal medicine; Oncology; Targeted therapy; Cancer","score_opus":0.03972989836728169,"score_gpt":0.32777090872210174,"score_spread":0.28804101035482005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186391570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97196096,0.003409062,0.0001068531,0.0015888052,0.00004325506,0.000091472684,0.020063242,0.000008316091,0.002728099],"genre_scores_gemma":[0.9887687,0.0018951053,0.00015537215,0.00049115525,0.000043577504,0.000049939892,0.008010404,0.000009555805,0.0005759773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790406,0.0001802265,0.00019096081,0.00029861854,0.00058827753,0.0008379078],"domain_scores_gemma":[0.9946038,0.000347851,0.0020331054,0.00018192235,0.0015853423,0.0012480062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092221843,0.00062650663,0.0010123454,0.0016879548,0.0022136318,0.0020350725,0.0017942983,0.0012186732,0.0023446353],"category_scores_gemma":[0.0046825605,0.00064620207,0.002042657,0.007216323,0.0006809592,0.00063930714,0.0009979194,0.002345722,0.0002224452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004285799,0.000083449166,0.99380577,0.000089495785,0.0004640957,0.00019356786,0.00020963317,0.00022963747,0.00008086335,0.0002443224,0.0025963862,0.0015741859],"study_design_scores_gemma":[0.00006006082,0.000056015302,0.9965575,0.0000779798,0.00021417213,0.00021336543,0.0006341633,0.0004615667,0.0000307909,0.000058036498,0.0015970559,0.00003939666],"about_ca_topic_score_codex":0.97382057,"about_ca_topic_score_gemma":0.975745,"teacher_disagreement_score":0.03730343,"about_ca_system_score_codex":0.03730343,"about_ca_system_score_gemma":0.030675558,"threshold_uncertainty_score":0.2706566},"labels":[],"label_agreement":null},{"id":"W2187996704","doi":"10.1016/j.jval.2015.09.1502","title":"High-Dose Inactivated Influenza Vaccine can Reduce Costs and Improve Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Influenza vaccine; Vaccination; Randomized controlled trial; Quality of life (healthcare); Medical costs; Influenza season; Emergency medicine; Health care; Internal medicine; Immunology","score_opus":0.0953828035936588,"score_gpt":0.40271583590456445,"score_spread":0.30733303231090564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187996704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96762675,0.0084184585,0.00013178372,0.0064765117,0.0003180402,0.000110053545,0.0038813753,0.00001149343,0.013025596],"genre_scores_gemma":[0.994245,0.002480469,0.00021207884,0.0009433614,0.00006564874,0.000025175199,0.0009027962,0.00000370226,0.0011218158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983814,0.00021934902,0.00009889994,0.00011324517,0.00043455677,0.0007525724],"domain_scores_gemma":[0.99609035,0.000369905,0.0005436531,0.00008616842,0.0016988243,0.0012110745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019858056,0.00039947598,0.0006793743,0.0008629058,0.0025701576,0.0015815934,0.001054015,0.00082849985,0.003866712],"category_scores_gemma":[0.0086849965,0.0002441469,0.001640697,0.0031475541,0.0005070756,0.0005589997,0.0006438181,0.0014281833,0.00018151948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033872782,0.0006715211,0.93687254,0.0006147192,0.0007878569,0.00015700376,0.0010709377,0.0003438796,0.00020354122,0.0008273584,0.013501105,0.041562203],"study_design_scores_gemma":[0.00033044044,0.00046058182,0.99070054,0.00054054183,0.00056981517,0.000057667796,0.0026008969,0.00037531898,0.000089200665,0.00022113325,0.004015188,0.000038694547],"about_ca_topic_score_codex":0.9846704,"about_ca_topic_score_gemma":0.9906205,"teacher_disagreement_score":0.024407212,"about_ca_system_score_codex":0.024407212,"about_ca_system_score_gemma":0.048050933,"threshold_uncertainty_score":0.17708755},"labels":[],"label_agreement":null},{"id":"W2188925989","doi":"10.1016/j.jval.2015.09.762","title":"Modeling Of Risks And Benefits Of Lung Cancer Screening Strategies Using Low-Dose Helical Ct (Ldct) Technology In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Lung cancer; Lung cancer screening; National Lung Screening Trial; Prostate cancer; Cancer; Lung; Radiology; Internal medicine","score_opus":0.13909235477478196,"score_gpt":0.3868244521373954,"score_spread":0.24773209736261345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188925989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9517166,0.0014245025,0.006686682,0.0044028983,0.000055049713,0.00020775248,0.00717405,0.00016399988,0.02816852],"genre_scores_gemma":[0.9869307,0.0005954059,0.0019040146,0.00015695886,0.000009096779,0.000038832968,0.0008634566,0.000028359913,0.009473173],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988945,0.00027132983,0.000037057882,0.00016581934,0.00016292612,0.00046848654],"domain_scores_gemma":[0.99469215,0.0028944262,0.00039716595,0.00010003351,0.0014018893,0.0005143401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014874246,0.00093194353,0.0009804682,0.0014034878,0.0015717676,0.0030909537,0.0026946918,0.0019681887,0.0052600186],"category_scores_gemma":[0.007002804,0.0011744587,0.0014953577,0.0024505963,0.0015927168,0.0009706689,0.00071962696,0.0015487486,0.00031425993],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000183655,0.00008196016,0.023714792,0.00004323819,0.000081297374,0.00014350188,0.000085991545,0.96303403,0.00020369235,0.007677294,0.0017403227,0.0030101168],"study_design_scores_gemma":[0.00010319696,0.00007366768,0.015720868,0.00003376894,0.00017342335,0.00007489803,0.00038983952,0.97794056,0.0002664874,0.0027494086,0.00240388,0.00006993999],"about_ca_topic_score_codex":0.9877366,"about_ca_topic_score_gemma":0.9754547,"teacher_disagreement_score":0.05787927,"about_ca_system_score_codex":0.05787927,"about_ca_system_score_gemma":0.040809605,"threshold_uncertainty_score":0.41994548},"labels":[],"label_agreement":null},{"id":"W2189616167","doi":"10.1016/j.jval.2015.09.2199","title":"The Cost-Effectiveness of Referring Patients With Irritable Bowel Syndrome To A Gastroenterologist In The Uk","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverticular Disease and Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Irritable bowel syndrome; Confidence interval; Referral; Internal medicine; Attendance; Cost effectiveness; Quality-adjusted life year; Nice; Health care; Family medicine; Pediatrics","score_opus":0.07031384614793691,"score_gpt":0.3220204932857413,"score_spread":0.2517066471378044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189616167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9328451,0.028793002,0.00014408556,0.027140705,0.0005073573,0.00007627641,0.0010431777,0.000017161072,0.009433218],"genre_scores_gemma":[0.9941999,0.0036500066,0.00015736952,0.0013252432,0.00016645568,0.000020508292,0.00020231155,0.000003857707,0.0002744555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918486,0.0049870135,0.0010899877,0.00034701082,0.0009374995,0.00078987394],"domain_scores_gemma":[0.982743,0.008249954,0.0045532035,0.0002628156,0.0012041949,0.0029867732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017325884,0.00039516413,0.00077983004,0.001318155,0.00071904046,0.002334595,0.000807009,0.0031341698,0.0061080987],"category_scores_gemma":[0.035480507,0.0005194858,0.0016234522,0.0019168339,0.0011281972,0.001696022,0.0021219715,0.0021358503,0.00029179873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01257753,0.0010658157,0.76497614,0.0034126404,0.001963616,0.0058972137,0.0022715856,0.00935203,0.00063435343,0.0025464897,0.02197721,0.17332537],"study_design_scores_gemma":[0.0015019475,0.0044296975,0.9597786,0.0035237246,0.0016333039,0.0074968254,0.0063414196,0.008187134,0.00017189386,0.001907036,0.004822469,0.00020593003],"about_ca_topic_score_codex":0.05898254,"about_ca_topic_score_gemma":0.0617263,"teacher_disagreement_score":0.05898254,"about_ca_system_score_codex":0.009825248,"about_ca_system_score_gemma":0.0030868687,"threshold_uncertainty_score":0.11727846},"labels":[],"label_agreement":null},{"id":"W2190698754","doi":"10.1016/j.jval.2015.09.1650","title":"Cost-Effectiveness Analyses In France, England And Canada: Comparative Analysis Of Structural Choices, Results And Perspectives","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health technology; Actuarial science; Time horizon; Pharmacoeconomics; Cost-effectiveness analysis; Agency (philosophy); Cost effectiveness; Health economics; Economic evaluation; Medicine; Health care; Public economics; Business; Economics; Risk analysis (engineering); Economic growth; Sociology; Finance; Intensive care medicine; Social science","score_opus":0.6384699876591354,"score_gpt":0.49620371452472123,"score_spread":0.1422662731344142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190698754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8882355,0.08067865,0.0021050803,0.0069066747,0.00006147307,0.00047743504,0.010168559,0.000049604547,0.011317012],"genre_scores_gemma":[0.9835427,0.009918858,0.0017069555,0.00039644665,0.000033203756,0.00014974993,0.003223891,0.000024483288,0.0010037491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98330885,0.010518562,0.0008449915,0.00044876858,0.0030655018,0.0018132557],"domain_scores_gemma":[0.9252064,0.059766326,0.0038882322,0.0012644194,0.008740197,0.0011343856],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018072994,0.00092728995,0.002874788,0.0067910478,0.0011891485,0.0036386342,0.0021647555,0.0012474059,0.0052974685],"category_scores_gemma":[0.065755196,0.0004840027,0.0046939054,0.012697356,0.0018030455,0.0017337359,0.0019169479,0.001574119,0.00016276388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020159636,0.0017963491,0.52058613,0.008986813,0.025694998,0.00053912675,0.0034648723,0.14904459,0.00074147613,0.0718293,0.013260308,0.18389648],"study_design_scores_gemma":[0.0027935738,0.0017063807,0.9055666,0.0029840888,0.015654001,0.000306157,0.006361975,0.035802767,0.0010421183,0.013670907,0.013748137,0.00036346188],"about_ca_topic_score_codex":0.9192455,"about_ca_topic_score_gemma":0.9180978,"teacher_disagreement_score":0.981927,"about_ca_system_score_codex":0.058021516,"about_ca_system_score_gemma":0.03604449,"threshold_uncertainty_score":0.42097753},"labels":[],"label_agreement":null},{"id":"W2192127796","doi":"10.1016/j.jval.2015.09.2524","title":"Non-Comparative Trials To Supplement Network Meta-Analyses Using Arm-Specific Meta-Regression: An Application To Combination Therapies In Hiv","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Confidence interval; Medicine; Regimen; Meta-analysis; Efavirenz; Dolutegravir; Odds ratio; Meta-regression; Adverse effect; Randomized controlled trial; Antiretroviral therapy; Internal medicine; Viral load; Human immunodeficiency virus (HIV); Family medicine","score_opus":0.9682328278909286,"score_gpt":0.6638114378019201,"score_spread":0.3044213900890085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192127796","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03986778,0.24206279,0.6659336,0.011142296,0.010565201,0.007013832,0.01351249,0.0044850893,0.00541686],"genre_scores_gemma":[0.40066856,0.025520198,0.54981226,0.004842525,0.0023206763,0.007942346,0.0039422987,0.0019270115,0.0030240421],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.602036,0.3601024,0.021568043,0.008835744,0.0068676188,0.0005901525],"domain_scores_gemma":[0.38233292,0.5578588,0.014017583,0.03643334,0.008210674,0.0011466407],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25920573,0.0066473596,0.01857941,0.010318915,0.001036067,0.0067482903,0.0064634527,0.0044964626,0.010180444],"category_scores_gemma":[0.59490013,0.003452613,0.033331215,0.01183185,0.0013665707,0.009143134,0.007251777,0.007634016,0.001297117],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013732962,0.0002916559,0.010704575,0.03555557,0.7907948,0.00036319287,0.00062756136,0.015652787,0.0005144967,0.0059916284,0.0129331695,0.112837695],"study_design_scores_gemma":[0.019598326,0.0022074021,0.010453344,0.010221321,0.7585165,0.0005526932,0.00041038377,0.104481295,0.0014195101,0.060816478,0.030726172,0.0005966241],"about_ca_topic_score_codex":0.0068937563,"about_ca_topic_score_gemma":0.013475608,"teacher_disagreement_score":0.7407943,"about_ca_system_score_codex":0.0015861343,"about_ca_system_score_gemma":0.004345098,"threshold_uncertainty_score":0.91353124},"labels":[],"label_agreement":null},{"id":"W2197961565","doi":"10.1016/j.jval.2015.09.035","title":"Impact of Financial Incentives on Access to Services and Quality of Care","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Incentive; Context (archaeology); Medicine; Health care; Quality (philosophy); Business; Finance; Emergency medicine; Physical therapy; Actuarial science; Operations management; Economics; Geography; Economic growth","score_opus":0.269063394569115,"score_gpt":0.5791720217777451,"score_spread":0.3101086272086301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2197961565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232496,0.0019923416,0.0008475894,0.037419938,0.00039505796,0.00013793752,0.0009867458,0.000030874442,0.03493991],"genre_scores_gemma":[0.99753124,0.00019049918,0.00015277609,0.00083390926,0.00012392306,0.00002246388,0.000084585925,0.000004882922,0.0010557335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.983906,0.008379345,0.00076668,0.0003906642,0.0018112519,0.0047461246],"domain_scores_gemma":[0.8645891,0.08496319,0.025313342,0.001947031,0.006559393,0.01662797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016236281,0.00032953167,0.00060378533,0.0012976589,0.0014136342,0.0044451584,0.0010825467,0.0027297812,0.014125787],"category_scores_gemma":[0.093562886,0.0003479306,0.001006528,0.0014396631,0.0018908333,0.0024816557,0.003365205,0.0025601194,0.00028049538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0061863586,0.004513158,0.7745615,0.00044432958,0.00063451583,0.00085939345,0.001414966,0.013233534,0.0006993373,0.08656194,0.012527168,0.098363824],"study_design_scores_gemma":[0.0013259992,0.002010394,0.93297005,0.0005699664,0.0003679278,0.00051009934,0.004194319,0.008180721,0.0006513428,0.031837665,0.01724554,0.00013599744],"about_ca_topic_score_codex":0.016884549,"about_ca_topic_score_gemma":0.02244027,"teacher_disagreement_score":0.016884549,"about_ca_system_score_codex":0.007010976,"about_ca_system_score_gemma":0.011524918,"threshold_uncertainty_score":0.08586663},"labels":[],"label_agreement":null},{"id":"W2198052525","doi":"10.1016/j.jval.2015.09.2591","title":"Contrasting Model Predicted Life Expectancy In Patients With Type 2 Diabetes Across Different Mortality Risk Prediction Models Versus Data From The Canadian Chronic Disease Surveillance System","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diabetes mellitus; Life expectancy; Medicine; Type 2 diabetes; Demography; Gerontology; Framingham Risk Score; Cohort; United Kingdom Prospective Diabetes Study; Disease; Internal medicine; Population; Environmental health; Endocrinology","score_opus":0.1098995386314231,"score_gpt":0.3113615942232346,"score_spread":0.20146205559181152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198052525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98291475,0.0010658996,0.0012237715,0.0014899825,0.00008469568,0.00004601971,0.011455611,0.00008214211,0.0016371891],"genre_scores_gemma":[0.9845793,0.00025413354,0.0010670904,0.00023840055,0.000022993661,0.00002213298,0.013129631,0.000026561827,0.00065976975],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99824655,0.0007158868,0.000091292364,0.00036673804,0.00030266657,0.0002769072],"domain_scores_gemma":[0.9874676,0.007975514,0.000625308,0.00049168244,0.0028358148,0.00060418365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065598697,0.0008781525,0.0009156892,0.0010508202,0.00081682135,0.0015657112,0.0017662487,0.00086750684,0.0017463821],"category_scores_gemma":[0.019877838,0.00030593696,0.0017955303,0.0015567361,0.0006014603,0.00066590344,0.00067157025,0.0013920028,0.00037688753],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069194706,0.00045179582,0.862613,0.00034903488,0.0030475243,0.00015665565,0.0004315403,0.08365383,0.0005530436,0.0013051432,0.013355652,0.027163245],"study_design_scores_gemma":[0.0005750874,0.00057652884,0.71692836,0.00021249012,0.0014143022,0.00015257276,0.0008321515,0.27244768,0.00081263174,0.0015784752,0.004300216,0.00016951858],"about_ca_topic_score_codex":0.9105536,"about_ca_topic_score_gemma":0.8843822,"teacher_disagreement_score":0.089446425,"about_ca_system_score_codex":0.010342252,"about_ca_system_score_gemma":0.011667375,"threshold_uncertainty_score":0.17994636},"labels":[],"label_agreement":null},{"id":"W2198542719","doi":"10.1016/j.jval.2015.03.044","title":"Life At A Premium: Considering An End-Of-Life Premium In Value-Based Reimbursement","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Reimbursement; Willingness to pay; Value (mathematics); Opportunity cost; Health technology; Actuarial science; Value proposition; Equity (law); Economics; Business; Health care; Microeconomics; Marketing; Computer science","score_opus":0.5804740816994101,"score_gpt":0.4403174948757067,"score_spread":0.14015658682370336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198542719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36763224,0.015195875,0.18203004,0.31862858,0.00572941,0.00030371017,0.0007824438,0.00015509897,0.109542646],"genre_scores_gemma":[0.98230547,0.00077569135,0.00880286,0.003102366,0.0021650873,0.000036403297,0.000075218486,0.00003101224,0.002705955],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9911538,0.004522135,0.000404402,0.0008385252,0.0017978437,0.0012833558],"domain_scores_gemma":[0.97437334,0.019031934,0.0012572577,0.0006750403,0.0019238453,0.002738634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010833793,0.00095039123,0.0017141886,0.0014302691,0.0014397962,0.0077040633,0.0022727987,0.009674021,0.0055456497],"category_scores_gemma":[0.053802498,0.00070042274,0.0016769095,0.0011643698,0.004052209,0.010878049,0.002511424,0.010271191,0.00023579407],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003517322,0.0003814988,0.009991092,0.0001612019,0.00017439542,0.0014048559,0.00052360876,0.04226514,0.0004373568,0.8919319,0.013679405,0.038697727],"study_design_scores_gemma":[0.00013510905,0.00025710618,0.007366117,0.00033483244,0.00025871673,0.00089455955,0.0008162717,0.11139219,0.00027125905,0.8650313,0.01312952,0.000113033275],"about_ca_topic_score_codex":0.009937422,"about_ca_topic_score_gemma":0.009940674,"teacher_disagreement_score":0.010833793,"about_ca_system_score_codex":0.0052628936,"about_ca_system_score_gemma":0.0054318896,"threshold_uncertainty_score":0.057295322},"labels":[],"label_agreement":null},{"id":"W2201411497","doi":"10.1016/j.jval.2015.09.2940","title":"Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; York University; NYU Langone Medical Center","keywords":"Human immunodeficiency virus (HIV); Business; Operations management; Medicine; Family medicine; Economics","score_opus":0.16891659550194746,"score_gpt":0.43538842250288023,"score_spread":0.26647182700093275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201411497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974905,0.00024704562,0.00038415,0.00025814172,0.000025070123,0.0005889749,0.00012534285,0.00001826651,0.00086249225],"genre_scores_gemma":[0.99905485,0.00008067392,0.0005755633,0.000023708817,0.000004487374,0.00014128607,0.000028783255,8.6888974e-7,0.00008984056],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9925591,0.005604956,0.00032615627,0.0003060698,0.0003229931,0.0008806479],"domain_scores_gemma":[0.97716784,0.017313503,0.0021302686,0.0005695226,0.00062869774,0.0021900858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070136786,0.0013427052,0.0010717211,0.0012420362,0.0011892165,0.001413758,0.0023137773,0.0021582772,0.0060471063],"category_scores_gemma":[0.025486834,0.00070634193,0.0022060869,0.0011893021,0.001802251,0.0017165346,0.0018842645,0.001594678,0.00023505242],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21275668,0.10240159,0.06360945,0.0024995,0.0026950075,0.0005894068,0.0018719755,0.3883488,0.0023273518,0.007070154,0.0010356123,0.21479446],"study_design_scores_gemma":[0.058899987,0.4051246,0.13561474,0.0011445101,0.0082160495,0.0003050364,0.0052133077,0.36809114,0.007336634,0.008141838,0.001476089,0.00043614887],"about_ca_topic_score_codex":0.022262597,"about_ca_topic_score_gemma":0.019459073,"teacher_disagreement_score":0.022262597,"about_ca_system_score_codex":0.008544937,"about_ca_system_score_gemma":0.0047738245,"threshold_uncertainty_score":0.06199813},"labels":[],"label_agreement":null},{"id":"W2204430666","doi":"10.1016/j.jval.2015.03.243","title":"Budget impact of Percutaneous Endovascular Abdominal Aorta Aneurysm (AAA) repair compared to standard Endovascular repair in Canadian Hospitals","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endovascular aneurysm repair; Surgery; Aortic repair; Percutaneous; Activity-based costing; Abdominal aortic aneurysm; Aneurysm","score_opus":0.027192418931060523,"score_gpt":0.3174504882971147,"score_spread":0.2902580693660542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204430666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92271686,0.0063754003,0.0003741385,0.034310624,0.00037359263,0.00014397348,0.009983699,0.000037363126,0.0256844],"genre_scores_gemma":[0.99480814,0.001295971,0.0002725258,0.0008260531,0.000057317684,0.000020504367,0.001395318,0.000009578947,0.0013146871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931804,0.0012412154,0.00030104778,0.00023741821,0.0019977721,0.003042114],"domain_scores_gemma":[0.9843821,0.0023407124,0.0022267927,0.00021379627,0.0056058606,0.0052308063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023152374,0.00040566231,0.00057943497,0.002022418,0.002543653,0.003096208,0.0015700991,0.0011391769,0.0058659557],"category_scores_gemma":[0.02249482,0.00032621706,0.0012417773,0.004303019,0.0011373456,0.00092485955,0.0018005858,0.0013452069,0.00015287253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030984276,0.0005205384,0.83625853,0.0007181526,0.0008638048,0.00050934794,0.001338501,0.018858898,0.000518746,0.013213221,0.042265534,0.081836216],"study_design_scores_gemma":[0.00017433355,0.00023141321,0.97963655,0.00033172828,0.00024781335,0.00013671348,0.0038063535,0.0054741804,0.00016235716,0.0008392482,0.008885756,0.00007350801],"about_ca_topic_score_codex":0.987616,"about_ca_topic_score_gemma":0.9924005,"teacher_disagreement_score":0.14124864,"about_ca_system_score_codex":0.14124864,"about_ca_system_score_gemma":0.14646976,"threshold_uncertainty_score":0.99602985},"labels":[],"label_agreement":null},{"id":"W2205841310","doi":"10.1016/j.jval.2015.03.1013","title":"Assure-Csu Canadian Results: Assessing Health Utility In Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; EQ-5D; Visual analogue scale; Quality of life (healthcare); Cohort; Depression (economics); Anxiety; Disease; DASS; Socioeconomic status; Physical therapy; Internal medicine; Psychiatry; Health related quality of life; Environmental health; Population","score_opus":0.1550900429154329,"score_gpt":0.3523675286360341,"score_spread":0.1972774857206012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205841310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5495511,0.0151541615,0.0043485565,0.002775039,0.0005175171,0.0019302595,0.34629133,0.0005163413,0.07891566],"genre_scores_gemma":[0.87520903,0.0038302252,0.013009749,0.0009188688,0.00013148155,0.0012919881,0.095975004,0.00018659889,0.009447124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551904,0.0007267437,0.0002906957,0.00029819558,0.0028011964,0.00036401008],"domain_scores_gemma":[0.99427503,0.00082272035,0.00049363426,0.00015815388,0.0038529912,0.0003974472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049999114,0.0010504304,0.0015852745,0.0034074686,0.0014347619,0.0020704886,0.0021279207,0.0007956283,0.00637579],"category_scores_gemma":[0.018313436,0.00030108474,0.003628011,0.0047633783,0.00052578875,0.00078762916,0.0013779845,0.0011781299,0.0010619896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005034893,0.0006252132,0.71209055,0.0020095818,0.0042963433,0.00025114825,0.00064350996,0.005648398,0.00051642675,0.005820544,0.12902488,0.13403852],"study_design_scores_gemma":[0.0007768264,0.00030122796,0.96307194,0.00043534537,0.0010173123,0.00021396288,0.0003751468,0.0042421212,0.0003157574,0.0006077155,0.028509883,0.00013263559],"about_ca_topic_score_codex":0.92844015,"about_ca_topic_score_gemma":0.9424333,"teacher_disagreement_score":0.92844015,"about_ca_system_score_codex":0.015821598,"about_ca_system_score_gemma":0.02163763,"threshold_uncertainty_score":0.1439625},"labels":[],"label_agreement":null},{"id":"W2211596172","doi":"10.1016/j.jval.2015.03.023","title":"Coverage Limits On Blood Glucose Test Strip Reimbursement For Diabetics In Canada: Utilization Impact For Diabetic Patients In The Ontario Public Drug Program (OPDP)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Reimbursement; Cohort; Insulin; Glucose test; Emergency medicine; Environmental health; Internal medicine; Health care; Endocrinology","score_opus":0.10288296190582509,"score_gpt":0.30537139815169817,"score_spread":0.2024884362458731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211596172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94100714,0.0033602975,0.00030254535,0.022706054,0.00012401099,0.00016604399,0.014956314,0.00005930364,0.017318467],"genre_scores_gemma":[0.99020505,0.0008845629,0.00040596112,0.0033433093,0.00005035151,0.000045428886,0.0023024634,0.000013945355,0.0027488095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925343,0.00085541763,0.00035861958,0.00029014825,0.0031438426,0.0028177074],"domain_scores_gemma":[0.97771466,0.003797292,0.0040407125,0.0003707807,0.006723397,0.007353153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003413637,0.0002518338,0.00054782693,0.001544516,0.0023751073,0.0031568604,0.0023891975,0.0017092616,0.0029288714],"category_scores_gemma":[0.017736947,0.00050270004,0.0012523946,0.0035584301,0.0010853317,0.00069848396,0.0015278625,0.001655881,0.00016208089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008153425,0.00035033748,0.93050295,0.0001290624,0.00024909026,0.00022241194,0.0012432536,0.002618421,0.00029877436,0.0044192285,0.033230443,0.02592075],"study_design_scores_gemma":[0.00007562027,0.000061362865,0.9912202,0.00012396737,0.00009866853,0.000049337395,0.0009836426,0.0029128534,0.000094020696,0.00020997378,0.004143406,0.000027020717],"about_ca_topic_score_codex":0.99693537,"about_ca_topic_score_gemma":0.997875,"teacher_disagreement_score":0.09535051,"about_ca_system_score_codex":0.09535051,"about_ca_system_score_gemma":0.13532656,"threshold_uncertainty_score":0.6918196},"labels":[],"label_agreement":null},{"id":"W2212133229","doi":"10.1016/j.jval.2015.03.030","title":"Extrapolating All-Cause Mortality Estimates In Economic Evaluations: A Simulation Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Alberta; University of Toronto","funders":"","keywords":"Life table; Estimation; Demography; Mortality rate; Statistics; Intervention (counseling); Duration (music); Medicine; Markov model; Discounting; Quality-adjusted life year; Mathematics; Cost effectiveness; Markov chain; Population; Surgery; Economics","score_opus":0.4465278382060636,"score_gpt":0.6000172579652606,"score_spread":0.153489419759197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212133229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7947014,0.0031577135,0.17845845,0.0033009406,0.00021863656,0.0012904454,0.0030631935,0.00021660971,0.01559268],"genre_scores_gemma":[0.9674048,0.0007252408,0.02848992,0.00030187963,0.00003262287,0.00061555905,0.0006336331,0.000044717854,0.0017515589],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9899629,0.008763999,0.0002909379,0.0003293069,0.0003419766,0.0003108831],"domain_scores_gemma":[0.78212255,0.20957337,0.0029012866,0.0020271752,0.0024491376,0.0009263929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024315136,0.0016797571,0.0028240103,0.0017904608,0.00075174606,0.002926359,0.00258713,0.0036139318,0.006554909],"category_scores_gemma":[0.12300178,0.0015285261,0.0034797469,0.0020560327,0.0010594523,0.0035025813,0.0018255537,0.0046299226,0.0004289144],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005873671,0.00019835647,0.0028137427,0.00011838534,0.00021114857,0.000096051655,0.000070356706,0.9870962,0.000050114795,0.00455145,0.00040935597,0.0037974245],"study_design_scores_gemma":[0.00027002854,0.00026489966,0.00076725933,0.00011967712,0.00021080323,0.000044127595,0.00007570404,0.98938704,0.00012530971,0.008399504,0.0003075907,0.000028085447],"about_ca_topic_score_codex":0.024197683,"about_ca_topic_score_gemma":0.012059209,"teacher_disagreement_score":0.024315136,"about_ca_system_score_codex":0.0031706053,"about_ca_system_score_gemma":0.003201832,"threshold_uncertainty_score":0.12859225},"labels":[],"label_agreement":null},{"id":"W2212634673","doi":"10.1016/j.jval.2015.03.025","title":"Economic Value Of Improved Accuracy For Self-Monitoring Of Blood Glucose Devices For Type 1 Diabetes","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Medicine; Statistics; Computer science; Emergency medicine; Mathematics","score_opus":0.09158345175768533,"score_gpt":0.3831031645632488,"score_spread":0.29151971280556344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212634673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6624381,0.032931313,0.038095236,0.14368281,0.0036202397,0.00021979556,0.0039099744,0.00022780646,0.11487468],"genre_scores_gemma":[0.99211943,0.0014290297,0.003126642,0.0011271357,0.0006306561,0.000016713297,0.0002448403,0.000017600765,0.0012879262],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9866008,0.00830171,0.00051284017,0.00040254896,0.0037673323,0.00041477586],"domain_scores_gemma":[0.9004751,0.07705532,0.008144313,0.004829251,0.008022437,0.0014736316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010178671,0.00045240598,0.00050176797,0.0016460379,0.00038525733,0.0028700489,0.001027586,0.0017079829,0.004770563],"category_scores_gemma":[0.10439587,0.00022837687,0.0008329347,0.0012768954,0.001196941,0.001954798,0.0010671344,0.0017491241,0.00038536018],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008803662,0.0012120568,0.24668522,0.0006037189,0.0010489972,0.0005899566,0.00036372038,0.036358904,0.0017435,0.06438548,0.022913234,0.6152915],"study_design_scores_gemma":[0.0009810391,0.0039271815,0.62598747,0.0021922628,0.002478299,0.0032609543,0.0017731165,0.17718297,0.0072230957,0.11842732,0.056216847,0.0003494372],"about_ca_topic_score_codex":0.005216925,"about_ca_topic_score_gemma":0.0036593578,"teacher_disagreement_score":0.010178671,"about_ca_system_score_codex":0.002552784,"about_ca_system_score_gemma":0.001672747,"threshold_uncertainty_score":0.053830624},"labels":[],"label_agreement":null},{"id":"W2216744387","doi":"10.1016/j.jval.2015.03.1009","title":"Assure-Csu Canadian Results: Assessing The Impact Of Chronic Spontaneous /Idiopathic Urticaria On Work Productivity And Indirect Costs","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Toronto","funders":"","keywords":"Medicine; Absenteeism; Productivity; Angioedema; Indirect costs; Presenteeism; Work productivity; Cohort; Sick leave; Demography; Gerontology; Physical therapy; Internal medicine","score_opus":0.04496010086699842,"score_gpt":0.3312604726239584,"score_spread":0.28630037175696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216744387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5585631,0.005072725,0.00092998624,0.0017125475,0.0002088419,0.0007435208,0.39586705,0.00019744724,0.036704764],"genre_scores_gemma":[0.8571212,0.0024122354,0.003324372,0.0005073973,0.00010513431,0.00051703287,0.12399738,0.000112556256,0.01190257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963051,0.0004752946,0.00018051834,0.00020421103,0.0023581986,0.00047670802],"domain_scores_gemma":[0.9922495,0.0006757466,0.00070401723,0.00017920563,0.0052450527,0.00094647816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036794825,0.0013370508,0.0012388104,0.0037542363,0.0015087633,0.0017433779,0.0023167094,0.0007522319,0.005579632],"category_scores_gemma":[0.0106052905,0.00033706994,0.0031701338,0.005596728,0.00046578058,0.0005519936,0.001089029,0.0007740618,0.0008033388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058310283,0.00056380895,0.8613397,0.0012173536,0.0033131363,0.00020146373,0.00034215287,0.0062775575,0.0003154341,0.0021166864,0.07575384,0.042727977],"study_design_scores_gemma":[0.00044185453,0.00027502564,0.9841045,0.0001281089,0.00062038837,0.00009179232,0.0002562834,0.0013618686,0.00019431488,0.000111580965,0.012362966,0.00005127223],"about_ca_topic_score_codex":0.9868242,"about_ca_topic_score_gemma":0.98911065,"teacher_disagreement_score":0.029902963,"about_ca_system_score_codex":0.029902963,"about_ca_system_score_gemma":0.055368133,"threshold_uncertainty_score":0.21696222},"labels":[],"label_agreement":null},{"id":"W2217393992","doi":"10.1016/j.jval.2015.03.043","title":"Interventions For Ultra-Rare Disorders (Urds) And The Logic Of Cost Effectiveness","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute","funders":"","keywords":"Psychological intervention; Cost effectiveness; Economic evaluation; Actuarial science; Health technology; Health care; Quality-adjusted life year; Cost-effectiveness analysis; Medicine; Health economics; Cost–benefit analysis; Public economics; Business; Economics; Risk analysis (engineering); Political science; Nursing","score_opus":0.5896618772233545,"score_gpt":0.4867647613279303,"score_spread":0.10289711589542422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217393992","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040530507,0.19585128,0.16876368,0.5307091,0.0041722464,0.00037873734,0.00067796296,0.00016707217,0.0587494],"genre_scores_gemma":[0.90080017,0.034004107,0.030517377,0.026978925,0.0052952953,0.0005903983,0.00011612391,0.000072586554,0.0016250842],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9570256,0.036609992,0.0011956939,0.0013629141,0.002853866,0.0009518191],"domain_scores_gemma":[0.73806417,0.24941422,0.0047185714,0.0031224429,0.0032031967,0.0014773413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0527065,0.0010803718,0.002874807,0.0041643297,0.0011459428,0.007230127,0.0021759619,0.004916087,0.0042533833],"category_scores_gemma":[0.15122013,0.0006772014,0.001091267,0.0024084304,0.019523304,0.013412465,0.0032532443,0.008277901,0.00018738103],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002490056,0.00007347048,0.0014009911,0.0007813837,0.0003041871,0.000068259615,0.00020823834,0.005543871,0.00004899971,0.94738114,0.004600508,0.039340034],"study_design_scores_gemma":[0.00008035778,0.00003658555,0.0003482329,0.00051124516,0.00005605647,0.00003352585,0.00009563321,0.0029524195,0.00003555559,0.9926583,0.0031738654,0.00001835387],"about_ca_topic_score_codex":0.0044812313,"about_ca_topic_score_gemma":0.0025520143,"teacher_disagreement_score":0.0527065,"about_ca_system_score_codex":0.0076131937,"about_ca_system_score_gemma":0.004073251,"threshold_uncertainty_score":0.2787419},"labels":[],"label_agreement":null},{"id":"W2218765681","doi":"10.1016/j.jval.2015.03.1772","title":"Canadian retrospective claims data analysis of Biologics switching and retention patterns in Psoriasis Patients","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Adalimumab; Ustekinumab; Etanercept; Infliximab; Retrospective cohort study; Psoriasis; Concomitant; Internal medicine; Dermatology; Tumor necrosis factor alpha","score_opus":0.5354432688194635,"score_gpt":0.4263239789790373,"score_spread":0.10911928984042618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218765681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9476412,0.00297998,0.00026299446,0.000749684,0.00003363893,0.0001093265,0.04526316,0.00003549508,0.0029245322],"genre_scores_gemma":[0.97568876,0.0010444826,0.00034563956,0.0001839407,0.000023455637,0.000041816547,0.02163828,0.00001832579,0.001015185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99563855,0.00042615915,0.000551716,0.0005426349,0.0018105987,0.001030415],"domain_scores_gemma":[0.97632253,0.0029506024,0.007196417,0.0015362233,0.009680338,0.0023138637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003283331,0.0005819857,0.0010418781,0.0054167532,0.0022191438,0.0028218478,0.0025301846,0.0011295172,0.004509688],"category_scores_gemma":[0.017589742,0.00086097367,0.0020339282,0.0172235,0.00080850575,0.0008494051,0.0009868329,0.0018698694,0.0006722234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007969395,0.00010443616,0.98486876,0.00012260371,0.00037875836,0.00012556289,0.00039888834,0.00064105657,0.00014532555,0.00045238627,0.005422538,0.0065426948],"study_design_scores_gemma":[0.00007414007,0.00004099209,0.994531,0.000076586155,0.00018058982,0.0001470316,0.0005123101,0.001762769,0.00009558801,0.00007625077,0.0024646528,0.000038158614],"about_ca_topic_score_codex":0.98407054,"about_ca_topic_score_gemma":0.98101586,"teacher_disagreement_score":0.034385957,"about_ca_system_score_codex":0.034385957,"about_ca_system_score_gemma":0.03600134,"threshold_uncertainty_score":0.24948877},"labels":[],"label_agreement":null},{"id":"W2228393730","doi":"10.1016/j.jval.2015.03.168","title":"Usability Testing Of The Web-Based Versions Of The Standardised Asthma Quality Of Life Questionnaire For 12 Years And Older (Aqlq(S)+12) And The Asthma Control Questionnaire (Acq-6)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Legibility; Session (web analytics); Usability; Test (biology); Font; Quality of life (healthcare); Interview; Quality (philosophy); Asthma; Medicine; Psychology; Applied psychology; Medical education; Computer science; World Wide Web; Advertising; Nursing; Human–computer interaction; Artificial intelligence","score_opus":0.07698931878010727,"score_gpt":0.3966652145707423,"score_spread":0.319675895790635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228393730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956131,0.00013501187,0.0020113958,0.00005459084,0.00006425414,0.001128066,0.00013737506,0.00006443326,0.00079174835],"genre_scores_gemma":[0.9812402,0.00022581189,0.012638273,0.0002113546,0.00006820759,0.002897083,0.00061539176,0.000068960224,0.0020347738],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9913817,0.0040510325,0.0015258206,0.0009034921,0.0017678925,0.00037009892],"domain_scores_gemma":[0.9570517,0.028729385,0.0014688623,0.0023370588,0.009640295,0.0007726562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016581502,0.0008624048,0.0009979203,0.0011164417,0.00065669446,0.0009376313,0.00055928086,0.0007440024,0.0015304595],"category_scores_gemma":[0.048056737,0.00051872805,0.0019610762,0.00061983423,0.00058703974,0.0010401297,0.0011518284,0.00073903083,0.00049467204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02008813,0.06332462,0.32497403,0.005173206,0.0020806051,0.0011102514,0.07649954,0.004430861,0.039820883,0.000941019,0.006655797,0.4549011],"study_design_scores_gemma":[0.004054589,0.11606599,0.8192247,0.00076722656,0.001769068,0.0009927637,0.01088523,0.0129683465,0.018865697,0.00065304467,0.013274198,0.00047918176],"about_ca_topic_score_codex":0.003270297,"about_ca_topic_score_gemma":0.00455821,"teacher_disagreement_score":0.016581502,"about_ca_system_score_codex":0.0006705243,"about_ca_system_score_gemma":0.000815896,"threshold_uncertainty_score":0.08769244},"labels":[],"label_agreement":null},{"id":"W2236351295","doi":"10.1016/j.jval.2015.03.1362","title":"Cost-Utility Analysis of Influenza Vaccines From Societal Perspective: a Comparison of The Human Capital Approach And Friction Costs Approach In The Valuation of Productivity Costs Among Seniors In Ontario Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Productivity; Demography; Population; Cost-effectiveness analysis; Human capital; Indirect costs; Cost effectiveness; Environmental health; Economics; Economic growth","score_opus":0.21641064792101283,"score_gpt":0.40995797525127314,"score_spread":0.1935473273302603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236351295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848171,0.0028566632,0.0027277442,0.0019499413,0.000035832374,0.0002430463,0.0020787118,0.000013879954,0.005277112],"genre_scores_gemma":[0.9977718,0.0005080825,0.0007650159,0.000056126635,0.000008493945,0.000030965282,0.0003074936,0.000003682565,0.0005483781],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99675447,0.001614491,0.00013177801,0.00016778677,0.00052851136,0.0008028865],"domain_scores_gemma":[0.99220484,0.0049199313,0.00048478902,0.00020610764,0.0015745498,0.0006097189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053273216,0.0008083339,0.0011744798,0.0016282961,0.0011656849,0.0032379215,0.0018840168,0.0009788708,0.0027884434],"category_scores_gemma":[0.018501114,0.0004828571,0.0019597681,0.003653931,0.0009809723,0.0010516475,0.0011888132,0.001435489,0.000083336876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00634116,0.00095493,0.36010528,0.0013328254,0.0030335183,0.00087545766,0.0025171929,0.5152523,0.0010469481,0.0301194,0.0068154708,0.07160558],"study_design_scores_gemma":[0.0008382541,0.0012027808,0.365263,0.00067644636,0.0024985583,0.00034545086,0.008600495,0.6055679,0.00058726844,0.008273938,0.0059141065,0.00023182856],"about_ca_topic_score_codex":0.95914805,"about_ca_topic_score_gemma":0.9434628,"teacher_disagreement_score":0.0792008,"about_ca_system_score_codex":0.0792008,"about_ca_system_score_gemma":0.032856595,"threshold_uncertainty_score":0.5746447},"labels":[],"label_agreement":null},{"id":"W2239810687","doi":"10.1016/j.jval.2015.12.003","title":"Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":721,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"University of Hartford","keywords":"Multiple-criteria decision analysis; Decision analysis; Management science; Health care; Decision aids; Medicine; Process management; Risk analysis (engineering); Operations research; Business; Engineering; Political science; Economics","score_opus":0.29694563709483,"score_gpt":0.4876890487715731,"score_spread":0.19074341167674308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239810687","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012667805,0.22093356,0.70728976,0.041637667,0.00513271,0.0007981804,0.0018739183,0.00038277742,0.020684713],"genre_scores_gemma":[0.016155021,0.11568405,0.8481978,0.0047945525,0.0054676714,0.0011534911,0.0015149994,0.00033829347,0.006694105],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9859387,0.0087091345,0.0010534715,0.0005743206,0.0034812472,0.00024319738],"domain_scores_gemma":[0.9777851,0.017042883,0.00081367575,0.000593265,0.0034925677,0.00027250982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016540233,0.0020501288,0.0020297812,0.005896287,0.0008279257,0.004286567,0.002641408,0.0033801093,0.008047856],"category_scores_gemma":[0.027304048,0.001284737,0.002180409,0.008862342,0.0017422048,0.0044910316,0.0027147827,0.0073101027,0.0026693183],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008937207,0.00035024804,0.0010995789,0.006473561,0.00020785794,0.00012624246,0.00038898655,0.03580641,0.00094132556,0.1995148,0.2550837,0.49991786],"study_design_scores_gemma":[0.000076853816,0.00012789067,0.0019713442,0.0077587888,0.000087849956,0.00026288474,0.0003134815,0.07229177,0.0011064226,0.43389243,0.48186728,0.00024309994],"about_ca_topic_score_codex":0.008770358,"about_ca_topic_score_gemma":0.015402176,"teacher_disagreement_score":0.016540233,"about_ca_system_score_codex":0.0036076957,"about_ca_system_score_gemma":0.004709503,"threshold_uncertainty_score":0.08747417},"labels":[],"label_agreement":null},{"id":"W2256209496","doi":"10.1016/j.jval.2015.03.931","title":"The Economic Value of Tofacitinib 5 Mg Bid In The Treatment of Moderate To Severe Rheumatoid Arthritis: A Canadian Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute; St Joseph's Health Care; Pfizer (Canada)","funders":"","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Adverse effect; Internal medicine; Quality of life (healthcare); Physical therapy","score_opus":0.05176418846745655,"score_gpt":0.3124097995938347,"score_spread":0.26064561112637813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256209496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7570384,0.12973051,0.0015946437,0.018733336,0.00031234918,0.0007196971,0.034702346,0.00006114065,0.05710749],"genre_scores_gemma":[0.95769155,0.030745348,0.0011927366,0.0017961869,0.000105168176,0.00006740109,0.0055030375,0.00004687953,0.002851575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966383,0.00055214047,0.00018056632,0.00022264538,0.001862236,0.0005440715],"domain_scores_gemma":[0.9919927,0.0019514043,0.0011908804,0.00017246755,0.0034867078,0.0012058171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004125833,0.0008653595,0.0012847547,0.003404497,0.001759462,0.0026333805,0.0014991409,0.000727714,0.0031719047],"category_scores_gemma":[0.012561222,0.0005302871,0.0034799548,0.0075747315,0.0013464681,0.0005853516,0.00089986983,0.00251111,0.00014233464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05193745,0.00088525383,0.40669444,0.011345601,0.018624267,0.002543661,0.0019024025,0.015454285,0.003576645,0.03542532,0.10777634,0.34383437],"study_design_scores_gemma":[0.0078089796,0.0015308856,0.85749704,0.0035933433,0.021387087,0.0018215135,0.0023076662,0.010898394,0.0012395568,0.0029804087,0.088405006,0.00053007575],"about_ca_topic_score_codex":0.98457515,"about_ca_topic_score_gemma":0.9873707,"teacher_disagreement_score":0.08533933,"about_ca_system_score_codex":0.08533933,"about_ca_system_score_gemma":0.095694125,"threshold_uncertainty_score":0.61918306},"labels":[],"label_agreement":null},{"id":"W2256565383","doi":"10.1016/j.jval.2015.03.1019","title":"A review of health-related quality of life (hrql) claims in labels of asthma products – can we consider the asthma quality of life questionnaire (aqlq) as a potentially acceptable measure for qualification?","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Fluticasone propionate; Salmeterol; Quality of life (healthcare); Asthma; Formoterol; Omalizumab; Mometasone furoate; Clinical trial; Physical therapy; Budesonide; Internal medicine; Corticosteroid; Immunoglobulin E","score_opus":0.2317163844128498,"score_gpt":0.44666753894435807,"score_spread":0.21495115453150826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256565383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026223867,0.99903774,0.00004763526,0.00020784473,0.00008735476,0.000015528114,0.00014728618,0.000002113289,0.00019235275],"genre_scores_gemma":[0.0028606756,0.99608636,0.00028178963,0.00047979338,0.0000572456,0.000022158873,0.00012781353,0.0000014890934,0.00008266677],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99713206,0.0006071671,0.0010768265,0.00026513255,0.0008380345,0.00008075066],"domain_scores_gemma":[0.99158746,0.005784862,0.0016913948,0.00012435036,0.00074028753,0.000071545015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048243455,0.00081251294,0.003536602,0.0050907657,0.00028163532,0.0015594978,0.0012879346,0.0013079348,0.003193814],"category_scores_gemma":[0.013822307,0.00053091627,0.004583598,0.0053471522,0.0005613602,0.0017781418,0.0011439174,0.0013750115,0.00038879263],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002914216,0.00005811963,0.0012833553,0.49940258,0.0049228584,0.00008413392,0.00014196036,0.00015683292,0.00044922525,0.001308769,0.0124050835,0.47949573],"study_design_scores_gemma":[0.00026648788,0.00040047668,0.019061781,0.5272988,0.03243316,0.0010228774,0.0004169407,0.0001978684,0.00061727676,0.0019699119,0.41619873,0.00011568207],"about_ca_topic_score_codex":0.0043102163,"about_ca_topic_score_gemma":0.010588323,"teacher_disagreement_score":0.0050907657,"about_ca_system_score_codex":0.0014158046,"about_ca_system_score_gemma":0.003115783,"threshold_uncertainty_score":0.025513828},"labels":[],"label_agreement":null},{"id":"W2263474571","doi":"10.1016/j.jval.2015.03.1051","title":"Cost-effectiveness of Secukinumab compared to current treatments for the treatment of moderate to severe plaque Psoriasis in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Secukinumab; Ustekinumab; Medicine; Etanercept; Adalimumab; Infliximab; Ixekizumab; Psoriasis; Quality-adjusted life year; Cost effectiveness; Dermatology; Internal medicine; Psoriatic arthritis; Disease; Tumor necrosis factor alpha","score_opus":0.12951627574653257,"score_gpt":0.33807852997998106,"score_spread":0.20856225423344849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263474571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95396596,0.018046964,0.00020927917,0.007881079,0.000232515,0.00023065232,0.00779074,0.000032539738,0.011610256],"genre_scores_gemma":[0.9929783,0.0037799545,0.00020955813,0.00043195733,0.000039174345,0.000026239257,0.0010274148,0.000007531056,0.0014999451],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985851,0.00033867304,0.00009595644,0.000101234764,0.00048522017,0.00039380725],"domain_scores_gemma":[0.99718,0.0005462821,0.00034318896,0.000036750163,0.0009543096,0.0009394571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007487176,0.0002961606,0.0008191769,0.0008462701,0.00096837396,0.0016737881,0.0010440004,0.00064735784,0.0047166497],"category_scores_gemma":[0.0054942826,0.0002653985,0.0015937482,0.0018418018,0.00056259835,0.00040758416,0.00054960046,0.0010260127,0.000106768886],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06123031,0.0027932988,0.5610194,0.0039795223,0.005524332,0.0009619544,0.0007886137,0.03396587,0.0018531322,0.0096854465,0.049289048,0.2689091],"study_design_scores_gemma":[0.009209059,0.0037857594,0.930564,0.0014408029,0.0054452373,0.000586932,0.002211645,0.030588843,0.0008271047,0.0011471473,0.013991725,0.00020175864],"about_ca_topic_score_codex":0.98476297,"about_ca_topic_score_gemma":0.9902928,"teacher_disagreement_score":0.07422357,"about_ca_system_score_codex":0.07422357,"about_ca_system_score_gemma":0.063623205,"threshold_uncertainty_score":0.53853226},"labels":[],"label_agreement":null},{"id":"W2266804440","doi":"10.1016/j.jval.2015.09.2396","title":"Factor Consumption for Prophylaxis and Treatment of Bleeding: Recombinant Factor Ix Fc Fusion Protein Compared With Conventional Recombinant Factor Ix","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bleed; Medicine; Factor IX; Surgery; Internal medicine","score_opus":0.20293857326682366,"score_gpt":0.3721418863158486,"score_spread":0.16920331304902494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266804440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906749,0.00722422,0.000379065,0.0004192683,0.000087828026,0.000019968207,0.00009748424,0.000021446043,0.0010758857],"genre_scores_gemma":[0.9967926,0.0016690696,0.00037532728,0.00008930639,0.000058111065,0.000009529668,0.00010806302,0.0000068604418,0.0008911226],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99944013,0.00024879415,0.000031940486,0.0000765371,0.00013088195,0.000071636656],"domain_scores_gemma":[0.99939954,0.00030459545,0.000117331256,0.00003916975,0.00003918888,0.00010009817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097385497,0.00028677203,0.00075422885,0.00025908562,0.00014479886,0.00052535994,0.00038489484,0.00051715045,0.00431427],"category_scores_gemma":[0.0021855752,0.00010200315,0.0005303685,0.00035579252,0.00028233134,0.00054765464,0.0002013646,0.00067140296,0.0002121971],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6114613,0.0052551585,0.027405437,0.0011974712,0.0016670839,0.00018660726,0.0005545212,0.0015881687,0.028329447,0.0017642818,0.0021494254,0.3184411],"study_design_scores_gemma":[0.03230741,0.29029313,0.5529158,0.0007664785,0.015425513,0.002142255,0.0013452687,0.01640768,0.055254992,0.002679032,0.030275866,0.000186537],"about_ca_topic_score_codex":0.003090385,"about_ca_topic_score_gemma":0.0019736455,"teacher_disagreement_score":0.00431427,"about_ca_system_score_codex":0.00063243037,"about_ca_system_score_gemma":0.0007525901,"threshold_uncertainty_score":0.014432669},"labels":[],"label_agreement":null},{"id":"W2267586496","doi":"10.1016/j.jval.2015.03.1358","title":"Cost-Utility analysis of three types of Influenza Vaccines (Trivalent, Trivalent High dose and quadrivalent) in adults aged 65 and Older Under Universal Influenza Immunization Program (UIIP) In Ontario, Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vaccination; Economic evaluation; Health care; Influenza vaccine; Cost-effectiveness analysis; Cost effectiveness; Family medicine; Environmental health; Demography; Virology; Economic growth","score_opus":0.13718110344870818,"score_gpt":0.37527816981581985,"score_spread":0.23809706636711167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267586496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862574,0.004617401,0.00028299473,0.00054065505,0.000025839445,0.00038782685,0.0061083506,0.000009874387,0.0017697203],"genre_scores_gemma":[0.9961577,0.00086965534,0.0003666627,0.00009428273,0.000007420127,0.00007097232,0.0018720932,0.0000026146097,0.00055873353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753857,0.000972383,0.00022623282,0.00020142451,0.0004772893,0.00058418064],"domain_scores_gemma":[0.99597436,0.0015487691,0.0006208422,0.00011098557,0.0010065124,0.00073862844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027720926,0.0008397312,0.0016920231,0.0011935653,0.0008500966,0.0016819407,0.0016902173,0.00073071365,0.0022706578],"category_scores_gemma":[0.009689007,0.0006957879,0.0036124517,0.0030868102,0.0007024723,0.00052952644,0.00094164256,0.0009931471,0.00008903439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032720648,0.0010523122,0.8294826,0.0021624644,0.011174741,0.0005873887,0.0007161099,0.08270224,0.0007171159,0.0023320087,0.005983171,0.030369237],"study_design_scores_gemma":[0.0033239408,0.002359925,0.9146045,0.00055608863,0.0071596303,0.00023721039,0.0017642326,0.06670094,0.00023281675,0.0004975043,0.0024176384,0.00014558299],"about_ca_topic_score_codex":0.97817546,"about_ca_topic_score_gemma":0.9743594,"teacher_disagreement_score":0.07397203,"about_ca_system_score_codex":0.07397203,"about_ca_system_score_gemma":0.028165996,"threshold_uncertainty_score":0.53670716},"labels":[],"label_agreement":null},{"id":"W2271692729","doi":"10.1016/j.jval.2015.09.609","title":"Published Diagnostic Discordance Of Lymphoma And Potential For Impact On Patient Care","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Lymphoma; Confidence interval; Meta-analysis; Pathological; Random effects model; Internal medicine","score_opus":0.0718707913085147,"score_gpt":0.36536190401531066,"score_spread":0.29349111270679595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271692729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72338384,0.068678215,0.0047042174,0.08023387,0.006159263,0.00014384474,0.00870057,0.00017799965,0.10781815],"genre_scores_gemma":[0.9878705,0.0036068328,0.0013940833,0.0029887555,0.0015316035,0.000025838104,0.0013698854,0.000039457213,0.0011728962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9655957,0.018916382,0.0054056277,0.0017058238,0.007200172,0.0011763293],"domain_scores_gemma":[0.58653694,0.28324538,0.051822152,0.020606574,0.054200776,0.0035880755],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03557704,0.00024941293,0.00061549677,0.008208847,0.0009753155,0.005100883,0.0019702606,0.001526013,0.008100896],"category_scores_gemma":[0.3413365,0.00036634936,0.0005926394,0.0062315925,0.0022369204,0.0023489448,0.0021888327,0.0015405165,0.00068240694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010916501,0.0001337566,0.7728604,0.00254942,0.00081272336,0.004355876,0.006757975,0.0008925824,0.0008284549,0.019656375,0.030652683,0.15940815],"study_design_scores_gemma":[0.00027983994,0.00044935933,0.74019504,0.011491784,0.001954384,0.02651604,0.013551346,0.005217715,0.0078088734,0.0520452,0.14027202,0.00021848267],"about_ca_topic_score_codex":0.005118214,"about_ca_topic_score_gemma":0.004749999,"teacher_disagreement_score":0.96442294,"about_ca_system_score_codex":0.0041461964,"about_ca_system_score_gemma":0.002430329,"threshold_uncertainty_score":0.18815166},"labels":[],"label_agreement":null},{"id":"W2276197862","doi":"10.1016/j.jval.2015.03.1748","title":"Use of infliximab within a Patient support program: positive perception of iv Infusions from Patients’ perspective","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Memorial University of Newfoundland; Dalhousie University; University of Toronto","funders":"","keywords":"Infliximab; Perspective (graphical); Perception; Medicine; Psychology; Internal medicine; Computer science; Tumor necrosis factor alpha; Artificial intelligence; Neuroscience","score_opus":0.4223732349461116,"score_gpt":0.42077679225130254,"score_spread":0.0015964426948090749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276197862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822781,0.00081496825,0.0003778813,0.008120697,0.00012402114,0.0000142745885,0.000062833475,0.0000040762807,0.008203087],"genre_scores_gemma":[0.99891174,0.00013694345,0.00009133882,0.0006607747,0.000030381347,0.0000030504136,0.000014942697,0.0000016452891,0.00014920006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953892,0.0026587995,0.00025828794,0.00014884103,0.0010593471,0.00048545428],"domain_scores_gemma":[0.97337884,0.011207811,0.007648973,0.00036503666,0.002992905,0.00440643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005375043,0.00012714339,0.0002609852,0.00061188504,0.00091816735,0.002427646,0.000319825,0.00095356494,0.0027344546],"category_scores_gemma":[0.028704247,0.00014134381,0.00043444056,0.00034609108,0.0012442536,0.0012557715,0.0014446795,0.0022792383,0.0001384323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011782588,0.00057416275,0.87463176,0.00027804644,0.00047116895,0.0012020263,0.046871297,0.00046840802,0.0017922646,0.0035949762,0.0069486024,0.06198914],"study_design_scores_gemma":[0.0001325378,0.0013599597,0.78499556,0.000499591,0.0002879493,0.002959221,0.18511121,0.0017045925,0.0007859658,0.0033709435,0.018651946,0.00014053183],"about_ca_topic_score_codex":0.001988779,"about_ca_topic_score_gemma":0.002132009,"teacher_disagreement_score":0.005375043,"about_ca_system_score_codex":0.0013741566,"about_ca_system_score_gemma":0.0010202004,"threshold_uncertainty_score":0.02842629},"labels":[],"label_agreement":null},{"id":"W2278335914","doi":"10.1016/j.jval.2015.03.1766","title":"Dosing pattern analysis for Biologics in the treatment of Psoriasis in Canada: indication-specific information retrieved from Administrative Claims Database","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Novartis (Canada)","funders":"","keywords":"Psoriasis; Dosing; Medicine; Database; Pharmacology; Dermatology; Computer science","score_opus":0.5940231185700675,"score_gpt":0.4298134159621341,"score_spread":0.16420970260793338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278335914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8269607,0.009916384,0.0014261559,0.0014452304,0.00004938016,0.00036512865,0.1551931,0.0001270929,0.0045167613],"genre_scores_gemma":[0.9559529,0.0028360717,0.0019283566,0.00034228727,0.000027865479,0.00007396011,0.037762612,0.000032754684,0.0010431333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971692,0.00030844947,0.00043761023,0.00035048233,0.0014598704,0.0002744754],"domain_scores_gemma":[0.99102473,0.0016406882,0.003134782,0.0004294778,0.003277775,0.0004925469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019053447,0.00033513474,0.0010044035,0.003553191,0.00057201204,0.0013438629,0.0011820304,0.0005015379,0.0023333905],"category_scores_gemma":[0.013147125,0.00031090973,0.0019577818,0.011481844,0.0002724602,0.00043396957,0.00039163817,0.0009023078,0.00024238438],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014746105,0.00011817365,0.96240324,0.00048719844,0.0012953025,0.00008761309,0.00009148698,0.0024297533,0.0003133598,0.0005525989,0.008769886,0.02197683],"study_design_scores_gemma":[0.00015787997,0.00005344366,0.98956734,0.0001245516,0.0007233834,0.00010897142,0.00010334243,0.0050016954,0.00023501176,0.00017571547,0.0037226325,0.000025973035],"about_ca_topic_score_codex":0.9646837,"about_ca_topic_score_gemma":0.9668874,"teacher_disagreement_score":0.03531629,"about_ca_system_score_codex":0.01947913,"about_ca_system_score_gemma":0.026676256,"threshold_uncertainty_score":0.14133161},"labels":[],"label_agreement":null},{"id":"W2283234840","doi":"10.1016/j.jval.2015.11.012","title":"Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control; University of British Columbia","funders":"National Cancer Institute","keywords":"Prostate cancer; Medicine; Population; Sexual function; Cancer; Prostate; Disease; Gynecology; Demography; Internal medicine; Environmental health","score_opus":0.2942641226204339,"score_gpt":0.4539909077868291,"score_spread":0.1597267851663952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283234840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502975,0.0009126099,0.0003735589,0.00077354984,0.00001846703,0.000013461728,0.00026980983,0.0000018520037,0.0026070124],"genre_scores_gemma":[0.99927896,0.00023064137,0.00011348305,0.0001443537,0.000013719062,0.0000044860867,0.000114902694,0.0000012723966,0.0000983173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980615,0.0013341786,0.000081534934,0.000098134224,0.00026330946,0.00016138544],"domain_scores_gemma":[0.99384403,0.003997315,0.00090360513,0.00020925075,0.00027546284,0.0007703321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036613788,0.00027708174,0.0006626763,0.00095179904,0.00031653527,0.0013950511,0.0003262407,0.0008067502,0.004820837],"category_scores_gemma":[0.012369767,0.00014610533,0.0017642095,0.0010652046,0.00059073436,0.0010818002,0.00086830824,0.0010729505,0.00016580289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008998826,0.0011511798,0.90252644,0.0003999125,0.004196623,0.00086652645,0.0031998174,0.005775292,0.0009339962,0.005872492,0.0023793725,0.06369954],"study_design_scores_gemma":[0.00068907836,0.0053627947,0.95685905,0.00022283712,0.0017036906,0.0021741658,0.010350953,0.008970343,0.00048017825,0.009612412,0.003451372,0.00012308899],"about_ca_topic_score_codex":0.001817976,"about_ca_topic_score_gemma":0.0029366196,"teacher_disagreement_score":0.004820837,"about_ca_system_score_codex":0.00067445333,"about_ca_system_score_gemma":0.00038813695,"threshold_uncertainty_score":0.019363463},"labels":[],"label_agreement":null},{"id":"W2283517602","doi":"10.1016/j.jval.2015.03.355","title":"The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian setting","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Sitagliptin; Medicine; Metformin; Internal medicine; Population; Placebo; Type 2 Diabetes Mellitus; Sulfonylurea; Surgery; Diabetes mellitus; Endocrinology; Insulin; Environmental health","score_opus":0.06972131726292441,"score_gpt":0.33978473491633193,"score_spread":0.2700634176534075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283517602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9416967,0.029162887,0.00030935343,0.009754626,0.00024473172,0.00028554467,0.0052232,0.00004220739,0.013280657],"genre_scores_gemma":[0.99362856,0.0038236086,0.0005941779,0.00045586887,0.000051922107,0.00002650311,0.000940299,0.000009203641,0.0004698116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976618,0.0006168433,0.00015628833,0.00018550392,0.00066224905,0.00071737025],"domain_scores_gemma":[0.99598914,0.0010733347,0.0005685101,0.00007237023,0.0007815792,0.0015150962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017589243,0.00069496315,0.0013073705,0.0012788591,0.0017395423,0.0025366032,0.0016011891,0.0012226333,0.0041713775],"category_scores_gemma":[0.011501957,0.00035946,0.0028901019,0.0032807605,0.0008368336,0.0009648289,0.000953246,0.0018869234,0.0001106405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12302572,0.0051288838,0.41020003,0.005035766,0.008608843,0.0012964979,0.0011765591,0.04584002,0.0013861046,0.011512926,0.042356726,0.34443185],"study_design_scores_gemma":[0.016860927,0.007998344,0.8815128,0.0022838765,0.012308253,0.000958607,0.0036691097,0.057053234,0.000703915,0.002982099,0.01314801,0.00052084273],"about_ca_topic_score_codex":0.97281057,"about_ca_topic_score_gemma":0.98013544,"teacher_disagreement_score":0.089293696,"about_ca_system_score_codex":0.089293696,"about_ca_system_score_gemma":0.064069524,"threshold_uncertainty_score":0.6478741},"labels":[],"label_agreement":null},{"id":"W2286537043","doi":"10.1016/j.jval.2015.09.2393","title":"Comparisons of Factor Consumption for Routine Prophylaxis And Bleeding During Episodic Therapy With Recombinant Factor Viii Fc Fusion Protein and Conventional Recombinant Factor Viii","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bleed; Medicine; Haemophilia A; Haemophilia; Internal medicine; Surgery","score_opus":0.13738247714349572,"score_gpt":0.35313786483227244,"score_spread":0.21575538768877672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286537043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991179,0.0003514115,0.000044933295,0.000014542838,0.0000067556216,0.0000062997306,0.00017587366,0.0000026539644,0.00027952436],"genre_scores_gemma":[0.9990509,0.00014974874,0.00007816,0.000019065634,0.00001078985,0.000009435554,0.0003586617,0.0000034909524,0.0003196697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990081,0.00038404253,0.000094785355,0.00015117333,0.00022374849,0.0001381496],"domain_scores_gemma":[0.99586785,0.002370829,0.00090829143,0.00022083799,0.00023276253,0.00039936532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013498822,0.00026352008,0.0005990092,0.0005031689,0.000232209,0.00060156407,0.00041068444,0.0005541832,0.001510179],"category_scores_gemma":[0.005106101,0.00018464983,0.0009078092,0.00082198676,0.00026003542,0.0004949657,0.00028207843,0.000629581,0.00016651602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16927871,0.0013501529,0.78983593,0.00028097286,0.0018575822,0.00016983491,0.0008881363,0.0004314033,0.0054374305,0.00023789935,0.00036737692,0.029864546],"study_design_scores_gemma":[0.00023618343,0.007613396,0.9896143,0.000014655448,0.00043007993,0.00012717384,0.00035339882,0.0003882802,0.0007441934,0.000048666287,0.00041712815,0.000012446342],"about_ca_topic_score_codex":0.0033591953,"about_ca_topic_score_gemma":0.0031319417,"teacher_disagreement_score":0.0033591953,"about_ca_system_score_codex":0.0006840087,"about_ca_system_score_gemma":0.00042400093,"threshold_uncertainty_score":0.0071389675},"labels":[],"label_agreement":null},{"id":"W2293743219","doi":"10.1016/j.jval.2015.09.1703","title":"Use of Economic Evaluations of Health Technologies In Dutch Healthcare Decision-Making: Barriers And Facilitators","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health","funders":"","keywords":"Incentive; Health care; Economic evaluation; Ambiguity; Macro; Population; Business; Public economics; Medicine; Economics; Environmental health; Economic growth; Computer science","score_opus":0.49513683150337773,"score_gpt":0.4773785594470162,"score_spread":0.017758272056361546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293743219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80304176,0.044224404,0.020794135,0.06265487,0.00053622155,0.0007907687,0.0027539374,0.00006325282,0.06514078],"genre_scores_gemma":[0.98897016,0.00473478,0.0043571596,0.0008044951,0.00010151491,0.00023780172,0.00040038332,0.000035653342,0.00035806798],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.6286115,0.31478983,0.025775831,0.0044165384,0.021474212,0.004932028],"domain_scores_gemma":[0.13176757,0.8228156,0.023583133,0.005758603,0.013273642,0.0028015145],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25863102,0.0008602623,0.0020289673,0.0056747487,0.001401746,0.014149572,0.0025797507,0.0024118952,0.004690955],"category_scores_gemma":[0.68777376,0.0010156706,0.002144255,0.009059275,0.0028908371,0.012361846,0.0050934614,0.004605896,0.00027690877],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034339384,0.0018514066,0.40932178,0.008482259,0.004244064,0.0009048396,0.0384951,0.01874088,0.00029244853,0.0668124,0.012655173,0.43476567],"study_design_scores_gemma":[0.0011252172,0.0014709572,0.48018685,0.055084355,0.003628716,0.0019350604,0.0625706,0.11723574,0.0030713228,0.19680856,0.07585412,0.0010285014],"about_ca_topic_score_codex":0.03603763,"about_ca_topic_score_gemma":0.02315084,"teacher_disagreement_score":0.741369,"about_ca_system_score_codex":0.011463225,"about_ca_system_score_gemma":0.013819786,"threshold_uncertainty_score":0.91423994},"labels":[],"label_agreement":null},{"id":"W2294402265","doi":"10.1016/j.jval.2015.12.016","title":"Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":462,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"","keywords":"Multiple-criteria decision analysis; Checklist; Management science; Task (project management); Decision analysis; Process management; Health care; Computer science; Decision support system; Risk analysis (engineering); Operations research; Medicine; Business; Engineering; Systems engineering; Psychology; Political science; Data mining; Mathematics","score_opus":0.46074126753535605,"score_gpt":0.5493276149831208,"score_spread":0.08858634744776472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294402265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019812214,0.80326307,0.16126415,0.022533234,0.000928516,0.0010574155,0.0006311344,0.0001820263,0.008159242],"genre_scores_gemma":[0.033435676,0.44309577,0.5147866,0.0034750493,0.0008024721,0.0019541907,0.0012264916,0.00014318785,0.0010805288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.95150584,0.03137727,0.004818117,0.0012202838,0.01055738,0.0005211298],"domain_scores_gemma":[0.88555515,0.089267485,0.0059554987,0.0029651262,0.015535616,0.0007210965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06936599,0.002095137,0.0048398348,0.007824954,0.0007690331,0.00470684,0.0044771405,0.003041883,0.002954476],"category_scores_gemma":[0.10272085,0.0013620009,0.0042032376,0.010469516,0.00201121,0.0034273656,0.0039211507,0.006389889,0.0007564429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011814214,0.00024207927,0.0011359944,0.02997852,0.0011150481,0.000062457715,0.0004657237,0.012059465,0.00026913232,0.056373432,0.037040748,0.86113936],"study_design_scores_gemma":[0.00050557376,0.0003869314,0.0051092636,0.12634185,0.0021216562,0.00043750217,0.0007822005,0.05538896,0.0021219589,0.325387,0.4810944,0.00032280158],"about_ca_topic_score_codex":0.015806777,"about_ca_topic_score_gemma":0.026748067,"teacher_disagreement_score":0.06936599,"about_ca_system_score_codex":0.0073229065,"about_ca_system_score_gemma":0.01733148,"threshold_uncertainty_score":0.3668468},"labels":[],"label_agreement":null},{"id":"W2296758021","doi":"10.1016/j.jval.2015.03.1096","title":"Prioritization of Comparative Effectiveness Research Questions Based On Identification of The Most Relevant Outcomes To Improve Clinical Practice: An Application of Mcda To Dialysis Research Planning","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple-criteria decision analysis; Ranking (information retrieval); Context (archaeology); Prioritization; Medicine; Identification (biology); Management science; Comparative effectiveness research; Computer science; Operations research; Alternative medicine; Mathematics; Engineering; Information retrieval","score_opus":0.7318248946125977,"score_gpt":0.6417965724853991,"score_spread":0.09002832212719858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296758021","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06409065,0.015552777,0.84864044,0.030277224,0.0007475969,0.02187212,0.0029574616,0.0005355059,0.015326167],"genre_scores_gemma":[0.14318252,0.0008668298,0.8509291,0.001181413,0.0000998001,0.003191361,0.0003196725,0.000040719682,0.00018860832],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.6898817,0.26632857,0.018738061,0.0061884923,0.017029613,0.0018336332],"domain_scores_gemma":[0.45739082,0.504382,0.010486174,0.007466875,0.017368525,0.0029056207],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.31209204,0.0026961635,0.007994546,0.023029529,0.0038951666,0.009282149,0.0054827,0.0045115803,0.009699262],"category_scores_gemma":[0.44722092,0.0025715213,0.006811762,0.011925058,0.0038882329,0.0076075075,0.007693219,0.006862696,0.0005569604],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059439144,0.0023306224,0.030786853,0.029870525,0.0083391145,0.0008111141,0.0088559,0.06262431,0.0030086464,0.13347542,0.0154156685,0.698538],"study_design_scores_gemma":[0.0058291177,0.0020346951,0.01802669,0.009156866,0.0071840375,0.00070994033,0.0059179105,0.25507057,0.0050667133,0.6657831,0.024621015,0.00059937016],"about_ca_topic_score_codex":0.006876603,"about_ca_topic_score_gemma":0.013254728,"teacher_disagreement_score":0.68790793,"about_ca_system_score_codex":0.010213339,"about_ca_system_score_gemma":0.024246803,"threshold_uncertainty_score":0.848313},"labels":[],"label_agreement":null},{"id":"W2302496677","doi":"10.1016/j.jval.2015.03.1633","title":"“Number Needed to treat” analysis to Assess the comparative outcomes from Teriflunomide and dimethyl fumarate studies in relapsing multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Dimethyl fumarate; Multiple sclerosis; Medicine; Oncology; Immunology; Fingolimod","score_opus":0.6348523267055757,"score_gpt":0.4886598500314978,"score_spread":0.14619247667407786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302496677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.549268,0.13848276,0.19887851,0.0069140587,0.023105456,0.03655592,0.018872922,0.0016297488,0.02629271],"genre_scores_gemma":[0.90278053,0.0031059044,0.051894147,0.0046267775,0.0013031504,0.028020494,0.002570182,0.00030128774,0.0053974846],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.7670278,0.20507243,0.010547421,0.0070363935,0.006765291,0.00355058],"domain_scores_gemma":[0.86993396,0.11283018,0.006081973,0.006960015,0.002791957,0.001401995],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09375872,0.0043821847,0.018349554,0.004045948,0.0010643976,0.0024620572,0.0028549577,0.0049463892,0.014679647],"category_scores_gemma":[0.10463757,0.0013109965,0.035078973,0.0026601916,0.0023860524,0.0051688584,0.0038374201,0.007677593,0.0005718951],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4037463,0.00090716255,0.019245328,0.025917942,0.49455464,0.00074795,0.0004512968,0.003700279,0.0032525086,0.0045888224,0.005622552,0.03726523],"study_design_scores_gemma":[0.25088143,0.06718053,0.082785025,0.0046951594,0.47631368,0.0014552932,0.0012189366,0.04047244,0.0077015515,0.025566833,0.040979117,0.0007499302],"about_ca_topic_score_codex":0.00082447665,"about_ca_topic_score_gemma":0.0014997626,"teacher_disagreement_score":0.9062413,"about_ca_system_score_codex":0.0018227058,"about_ca_system_score_gemma":0.0015234229,"threshold_uncertainty_score":0.49584943},"labels":[],"label_agreement":null},{"id":"W2311957294","doi":"10.1016/j.jval.2015.03.366","title":"Evaluating the Cost of Bringing People with type 2 Diabetes mellitus to multiple targets of Treatment In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liraglutide; Medicine; Exenatide; Sitagliptin; Pioglitazone; Glycemic; Type 2 diabetes; Insulin glargine; Insulin detemir; Internal medicine; Sulfonylurea; Hypoglycemia; Diabetes mellitus; Endocrinology; Insulin","score_opus":0.07310793442859402,"score_gpt":0.32670698901806644,"score_spread":0.2535990545894724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311957294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669584,0.0034427654,0.00025012146,0.0091141155,0.000118009375,0.00024392834,0.006842122,0.00002501786,0.013005444],"genre_scores_gemma":[0.9944817,0.0017759221,0.00058443035,0.000642753,0.000029464401,0.00003791966,0.0012572226,0.0000092178,0.0011812408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720395,0.000484666,0.00021271508,0.00014269716,0.0011049334,0.00085112976],"domain_scores_gemma":[0.99088705,0.0015250163,0.0010679679,0.00011571092,0.004010303,0.0023940436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011657948,0.00045454683,0.0007055068,0.0017462558,0.002835439,0.0023109084,0.0017010164,0.00085935247,0.003095184],"category_scores_gemma":[0.012209283,0.0004439885,0.00132084,0.0051406864,0.0008820557,0.00075832737,0.001191453,0.0015767321,0.00012077441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016118734,0.00086344744,0.9004326,0.000675334,0.00084037054,0.0006399772,0.0009639193,0.010696919,0.00019477721,0.0031010928,0.020397762,0.05958199],"study_design_scores_gemma":[0.0005389544,0.0004895206,0.96303725,0.0006051593,0.000994844,0.00036003967,0.0061059385,0.020024655,0.00025612817,0.00091838575,0.006551407,0.000117782416],"about_ca_topic_score_codex":0.99758065,"about_ca_topic_score_gemma":0.99856263,"teacher_disagreement_score":0.14073834,"about_ca_system_score_codex":0.14073834,"about_ca_system_score_gemma":0.1355272,"threshold_uncertainty_score":0.9966217},"labels":[],"label_agreement":null},{"id":"W2312811400","doi":"10.1016/j.jval.2014.08.1252","title":"Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"","keywords":"Depression (economics); Treatment-resistant depression; Medicine; Major depressive disorder; Plaintiff; Cohort; Antidepressant; Medical prescription; Psychiatry; Family medicine; Internal medicine; Pharmacology; Mood","score_opus":0.03032870401264633,"score_gpt":0.2944124915454887,"score_spread":0.2640837875328424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312811400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8891863,0.002843147,0.0002109664,0.0016778655,0.00005147422,0.00015673088,0.09987812,0.00003918907,0.005956057],"genre_scores_gemma":[0.973155,0.0012050081,0.00029003705,0.00019537307,0.000031860673,0.000053110514,0.023822682,0.000008421659,0.001238352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978078,0.00018525153,0.00023903676,0.00021494842,0.0010453609,0.0005076693],"domain_scores_gemma":[0.99330515,0.0009785531,0.0018732569,0.00021310053,0.002552128,0.0010778403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089121336,0.0005167373,0.0009022119,0.0041556875,0.0017601739,0.002002084,0.0017761372,0.0009249265,0.0031966525],"category_scores_gemma":[0.009521577,0.0005396319,0.0016391971,0.0069073737,0.0004532568,0.00064284814,0.00084348384,0.00124116,0.00026525432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000639259,0.00017993286,0.9693765,0.00027714716,0.0007159638,0.000327756,0.0002881729,0.0027461692,0.00013616972,0.0011891345,0.014416877,0.009706951],"study_design_scores_gemma":[0.00007050344,0.000043159755,0.99110186,0.00012655099,0.00029408254,0.00022203806,0.00053147576,0.004440444,0.000059865746,0.00014708396,0.002917216,0.000045673947],"about_ca_topic_score_codex":0.98215693,"about_ca_topic_score_gemma":0.983146,"teacher_disagreement_score":0.04004528,"about_ca_system_score_codex":0.04004528,"about_ca_system_score_gemma":0.03136257,"threshold_uncertainty_score":0.29055017},"labels":[],"label_agreement":null},{"id":"W2313074705","doi":"10.1016/j.jval.2012.03.482","title":"PMH37 Cost-Effectiveness of Asenapine in the Treatment of Bipolar I Disorder in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Asenapine; Olanzapine; Medicine; Bipolar I disorder; Schizophrenia (object-oriented programming); Antipsychotic; Psychiatry; Bipolar disorder; Mania; Lithium (medication)","score_opus":0.044291764828827386,"score_gpt":0.32002920800584056,"score_spread":0.27573744317701315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313074705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94199395,0.017794248,0.00033429527,0.010502594,0.00018221971,0.00042639906,0.0062862146,0.00004996788,0.022430075],"genre_scores_gemma":[0.9930269,0.0038901283,0.00035605446,0.0005299646,0.000055979395,0.000043376494,0.00083249446,0.000006255417,0.0012588832],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989317,0.00033211548,0.00006355999,0.0000633131,0.00037048108,0.00023882768],"domain_scores_gemma":[0.9983393,0.00028855627,0.00025041625,0.000018502957,0.00046159784,0.000641561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059593475,0.00021625891,0.00062593847,0.0006976218,0.00064753,0.00096442085,0.0007786943,0.00052041956,0.00420417],"category_scores_gemma":[0.0035758961,0.00017622682,0.0011008794,0.0011363741,0.0003739776,0.00030395013,0.00047720908,0.0007224741,0.00009620346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05667969,0.0022402338,0.26850426,0.0041736113,0.0041539953,0.0016099017,0.00054149714,0.045782145,0.0025986065,0.008635071,0.048447426,0.55663365],"study_design_scores_gemma":[0.009951928,0.0060439366,0.91775155,0.0015532686,0.0030982487,0.0010774806,0.0014170146,0.035537615,0.00095497456,0.0013767551,0.021093676,0.00014352356],"about_ca_topic_score_codex":0.9435773,"about_ca_topic_score_gemma":0.9753195,"teacher_disagreement_score":0.05642271,"about_ca_system_score_codex":0.041432247,"about_ca_system_score_gemma":0.041263897,"threshold_uncertainty_score":0.3006134},"labels":[],"label_agreement":null},{"id":"W2313172310","doi":"10.1016/j.jval.2013.08.1665","title":"A Bayesian Dynamic Model of Asthma in the Real Life","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical prescription; Asthma; Observational study; Quarter (Canadian coin); Proxy (statistics); Exacerbation; Demographics; Bayesian probability; Epidemiology; Pediatrics; Emergency medicine; Demography; Internal medicine; Statistics","score_opus":0.02851148503749497,"score_gpt":0.30487583070861735,"score_spread":0.2763643456711224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313172310","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22817054,0.0062234825,0.68461585,0.04249211,0.00047306964,0.00015973815,0.004931798,0.0005107372,0.03242272],"genre_scores_gemma":[0.94543487,0.0034050115,0.024292467,0.0010738219,0.00049021636,0.00017905883,0.0011465849,0.0000666235,0.023911431],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99900085,0.00043968356,0.000032376312,0.0002503276,0.0001288555,0.0001478827],"domain_scores_gemma":[0.9945294,0.004246237,0.00044338257,0.00015668898,0.00030518856,0.00031902848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026840423,0.0006994035,0.0017759071,0.0011088306,0.0005362066,0.003076528,0.002445808,0.003971945,0.007423231],"category_scores_gemma":[0.012765418,0.0010403021,0.0009474872,0.0015487043,0.0016275336,0.0035769152,0.001076749,0.003425065,0.0009846996],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002162824,0.00014351125,0.004551013,0.0000980994,0.000118113545,0.00042557146,0.00029523924,0.66951096,0.0004322312,0.29595727,0.006930713,0.021321058],"study_design_scores_gemma":[0.00010468894,0.000053233496,0.0017393575,0.00004256848,0.000049340426,0.00018918233,0.000061273946,0.82778364,0.00004215126,0.16758247,0.002306575,0.000045459346],"about_ca_topic_score_codex":0.024114812,"about_ca_topic_score_gemma":0.019688794,"teacher_disagreement_score":0.024114812,"about_ca_system_score_codex":0.002158758,"about_ca_system_score_gemma":0.0015865209,"threshold_uncertainty_score":0.047948897},"labels":[],"label_agreement":null},{"id":"W2313368310","doi":"10.1016/j.jval.2013.03.529","title":"Reliability and validity of current perception threshold test in mechanical neck disorder","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reliability (semiconductor); Neck pain; Construct validity; Physical therapy; Test (biology); Concurrent validity; Physical medicine and rehabilitation; Internal consistency; Psychometrics; Clinical psychology; Pathology","score_opus":0.04321297370014897,"score_gpt":0.33929675444880386,"score_spread":0.2960837807486549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313368310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951343,0.0007049431,0.0013511861,0.00008958133,0.000119659824,0.00004875997,0.00013916411,0.000016242995,0.0023961358],"genre_scores_gemma":[0.9987908,0.00012131348,0.00053144136,0.000038478505,0.000028394357,0.000020225742,0.00014887388,0.0000074938303,0.00031300753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942821,0.0015969084,0.0007553069,0.0006862469,0.0023497806,0.00032967053],"domain_scores_gemma":[0.9666825,0.019518957,0.0030742337,0.001776977,0.008056443,0.0008909045],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.007290268,0.000400778,0.0006235386,0.001980645,0.0005063436,0.0012080381,0.0009812542,0.000998041,0.0012359087],"category_scores_gemma":[0.040013652,0.00043209217,0.0010882859,0.0008821112,0.0011184631,0.0012728361,0.0010063732,0.00081025757,0.000506209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045828702,0.0002261561,0.9881953,0.000044735436,0.00013332462,0.00007577795,0.00059553713,0.00031250285,0.0012921927,0.00016314474,0.0001830787,0.008320096],"study_design_scores_gemma":[0.000040301053,0.0005522614,0.9936138,0.000043508473,0.00010476821,0.00041835528,0.000516389,0.0031955745,0.0007771776,0.00024674417,0.00047503118,0.000016111144],"about_ca_topic_score_codex":0.0045748656,"about_ca_topic_score_gemma":0.004507214,"teacher_disagreement_score":0.99270976,"about_ca_system_score_codex":0.0006660679,"about_ca_system_score_gemma":0.0006973257,"threshold_uncertainty_score":0.038555086},"labels":[],"label_agreement":null},{"id":"W2313419446","doi":"10.1016/j.jval.2014.03.1113","title":"Frontiers in pediatric health technology assessment: Development of a discrete event simulation model for economic evaluation of screening, diagnosis and treatment strategies in autism spectrum disorder","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Autism spectrum disorder; Autism; Population; Discrete event simulation; Medicine; Psychiatry; Psychology; Pediatrics; Computer science; Simulation","score_opus":0.27793461371931627,"score_gpt":0.44910737329610856,"score_spread":0.1711727595767923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313419446","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093643546,0.0005369997,0.8900896,0.0026098771,0.00011082456,0.0003192035,0.0007408465,0.00021125464,0.011737881],"genre_scores_gemma":[0.80330914,0.0006040438,0.18987027,0.00028498113,0.00007322893,0.0009005686,0.00049922516,0.00008423472,0.004374245],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99886,0.0008313146,0.000042924017,0.0000820919,0.00009668354,0.00008707799],"domain_scores_gemma":[0.99029154,0.008558198,0.000301663,0.00011966082,0.0005046997,0.00022432083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044837277,0.00067518494,0.0011164709,0.00074746076,0.0004841279,0.0016163174,0.0012978405,0.0018562285,0.0041960767],"category_scores_gemma":[0.01652231,0.00062352256,0.0009096343,0.00073177426,0.0007315954,0.0013508191,0.0014722939,0.0021022642,0.00025918667],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026633837,0.000033528686,0.000914991,0.00002225801,0.000021288768,0.000036700578,0.00003206202,0.9789306,0.00006364125,0.016440563,0.00038193492,0.0030957581],"study_design_scores_gemma":[0.000013038791,0.000009348035,0.00010562313,0.0000069889193,0.0000052802043,0.0000058287674,0.000006353684,0.9956292,0.00004028329,0.0038741375,0.00030088253,0.0000031364295],"about_ca_topic_score_codex":0.018828033,"about_ca_topic_score_gemma":0.008088793,"teacher_disagreement_score":0.018828033,"about_ca_system_score_codex":0.0023164516,"about_ca_system_score_gemma":0.0033132478,"threshold_uncertainty_score":0.037436903},"labels":[],"label_agreement":null},{"id":"W2314849528","doi":"10.1016/j.jval.2012.03.742","title":"PGI15 The Economic Burden of Unmet Treatment Needs in Medicaid Patients with Chronic Constipation","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Gender, Labor, and Family Dynamics","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Constipation; Fecal impaction; Medicaid; Medical prescription; Chronic constipation; Adverse effect; Emergency medicine; Health care; Intensive care medicine; Internal medicine","score_opus":0.03085724378491901,"score_gpt":0.29887209967741946,"score_spread":0.26801485589250046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314849528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889922,0.00056830957,0.000017767195,0.004467623,0.000036039168,0.000014935633,0.0010834051,0.000001718926,0.0048179426],"genre_scores_gemma":[0.9985221,0.00031603608,0.00004621557,0.00030974433,0.000043529515,0.00001394882,0.00042800765,0.0000014102151,0.00031900694],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914145,0.0002743351,0.00009417652,0.000036055393,0.00015220648,0.00030169496],"domain_scores_gemma":[0.9968389,0.0005391296,0.0013769415,0.000038581864,0.00021003408,0.0009965131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005832571,0.00009810548,0.00019639675,0.0007922608,0.0009109817,0.0009583877,0.00023734204,0.0005130121,0.0061913407],"category_scores_gemma":[0.006697944,0.00014215465,0.0005061419,0.0014530553,0.00037933973,0.0006743624,0.0013828699,0.0008264443,0.00017377613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021054057,0.00012753734,0.98130816,0.00003938365,0.00007564743,0.00030406506,0.00039394057,0.00015872184,0.00006446711,0.0005280048,0.0028433187,0.013946062],"study_design_scores_gemma":[0.00002126646,0.00008094135,0.9949921,0.000100805395,0.00003310738,0.00033255175,0.0019822028,0.0003218321,0.000022387927,0.00024730756,0.0018569245,0.000008602274],"about_ca_topic_score_codex":0.023866152,"about_ca_topic_score_gemma":0.04942612,"teacher_disagreement_score":0.023866152,"about_ca_system_score_codex":0.0015617105,"about_ca_system_score_gemma":0.0025812197,"threshold_uncertainty_score":0.047454476},"labels":[],"label_agreement":null},{"id":"W2314925473","doi":"10.1016/j.jval.2014.08.139","title":"Incretin Therapy and Risk of Pancreatitis in Type 2 Diabetes Mellitus: Systematic Review of Randomized and Non-Randomized Studies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Medicine; Exenatide; Sitagliptin; Internal medicine; Randomized controlled trial; Pancreatitis; Incretin; Type 2 diabetes; Hazard ratio; Type 2 Diabetes Mellitus; Diabetes mellitus; Cohort study; Endocrinology; Confidence interval","score_opus":0.02188000461485413,"score_gpt":0.2939801133482795,"score_spread":0.2721001087334254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314925473","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010311318,0.9876315,0.0003654391,0.00018267434,0.00018932173,0.0004871404,0.00059927383,0.00001921657,0.00021401099],"genre_scores_gemma":[0.21045089,0.7835611,0.0023896098,0.0012195287,0.0002762249,0.0009507686,0.0008839938,0.00002531481,0.00024255663],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895558,0.0043477956,0.0036618554,0.0010989925,0.0010558605,0.0002796876],"domain_scores_gemma":[0.9630765,0.026463438,0.007821688,0.000911648,0.0013455987,0.00038116841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012731653,0.0015672438,0.012882149,0.0029637136,0.00053898053,0.0025764117,0.0020747168,0.0024724314,0.0035160647],"category_scores_gemma":[0.044826604,0.00154255,0.01738661,0.0040707467,0.0011004206,0.0017036565,0.0016148484,0.001806123,0.00022100573],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007642251,0.000060852417,0.0060116686,0.6204536,0.34977135,0.000103281425,0.00012212648,0.00020463945,0.00024170162,0.000105125604,0.0006952422,0.014588286],"study_design_scores_gemma":[0.009242779,0.00064061146,0.010809943,0.06698538,0.90918595,0.0001782651,0.00011798458,0.00012675027,0.00016095083,0.0002744671,0.002228843,0.000047990474],"about_ca_topic_score_codex":0.006405402,"about_ca_topic_score_gemma":0.015833884,"teacher_disagreement_score":0.012882149,"about_ca_system_score_codex":0.0022201396,"about_ca_system_score_gemma":0.003490166,"threshold_uncertainty_score":0.06733227},"labels":[],"label_agreement":null},{"id":"W2315635257","doi":"10.1016/j.jval.2014.03.981","title":"Comparison Of Tools To Evaluate Prescribing In The Elderly","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Digoxin; Family medicine; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.4741277231895074,"score_gpt":0.5220056716006493,"score_spread":0.047877948411141846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315635257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97839,0.0083884755,0.0028889696,0.0006281312,0.00021460553,0.0009790002,0.0027613037,0.000087998196,0.0056615327],"genre_scores_gemma":[0.9814245,0.0041651763,0.0103580905,0.00030464798,0.00009622216,0.001203349,0.0018387139,0.000028431064,0.0005808586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9795669,0.011379927,0.0035953962,0.000581071,0.004346324,0.0005304949],"domain_scores_gemma":[0.87375957,0.10049341,0.014864786,0.0016048878,0.0074925898,0.0017848138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016383281,0.0011376927,0.0022899986,0.006822562,0.000518427,0.002488172,0.0009958494,0.0015712993,0.0019374874],"category_scores_gemma":[0.08000753,0.00044921692,0.0034207872,0.0043206513,0.00055219175,0.002568502,0.00188234,0.0011266496,0.0003127586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025582261,0.0020211327,0.80533826,0.0030240675,0.0050513768,0.00011633401,0.0024210021,0.0015323649,0.00028500188,0.0013227359,0.002406189,0.15089932],"study_design_scores_gemma":[0.004348935,0.015468234,0.9397119,0.002728435,0.0038809776,0.00060837565,0.005022995,0.018028546,0.0015495075,0.002998109,0.005338615,0.0003152866],"about_ca_topic_score_codex":0.0037955192,"about_ca_topic_score_gemma":0.006312899,"teacher_disagreement_score":0.016383281,"about_ca_system_score_codex":0.0018558264,"about_ca_system_score_gemma":0.0020696544,"threshold_uncertainty_score":0.08664405},"labels":[],"label_agreement":null},{"id":"W2316528672","doi":"10.1016/j.jval.2012.03.336","title":"PRS52 The Stability of Additive Treatment Effects in Multiple Treatment Comparison Meta-Analysis: a Simulation Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Additive function; Additive model; Bayesian probability; Mathematics; Statistics; Generalized additive model; Stability (learning theory); Meta-analysis; Econometrics; Treatment effect; Medicine; Computer science; Internal medicine; Machine learning","score_opus":0.894881949415654,"score_gpt":0.5919447796015943,"score_spread":0.3029371698140597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316528672","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22978546,0.027036339,0.71097606,0.0072673624,0.0008650914,0.0040544374,0.0030524007,0.0016122361,0.015350747],"genre_scores_gemma":[0.83076024,0.0021854388,0.16094364,0.0009812809,0.00014259298,0.0020432547,0.0006666187,0.0003207461,0.0019562186],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.83551025,0.15224,0.004132164,0.0043087527,0.0030615802,0.0007472837],"domain_scores_gemma":[0.30859584,0.6568327,0.009002942,0.018851226,0.005918412,0.00079888164],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1507057,0.0018677027,0.0042176703,0.0023031125,0.00086297776,0.0029891704,0.0022801699,0.0038696611,0.0101492535],"category_scores_gemma":[0.49666792,0.0017840059,0.012901622,0.0027750032,0.002483728,0.004842254,0.0025297874,0.0062469547,0.0009066621],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.054947402,0.0012022267,0.02707766,0.011961033,0.06829705,0.0024808773,0.0015641415,0.45621923,0.0021650454,0.12575226,0.015297132,0.2330359],"study_design_scores_gemma":[0.015729114,0.007474689,0.006915822,0.001862796,0.028579976,0.0019093713,0.00030919857,0.7814124,0.0025052058,0.1427792,0.010227895,0.00029421353],"about_ca_topic_score_codex":0.004391071,"about_ca_topic_score_gemma":0.0019047317,"teacher_disagreement_score":0.8492943,"about_ca_system_score_codex":0.0019928794,"about_ca_system_score_gemma":0.00300577,"threshold_uncertainty_score":0.79701746},"labels":[],"label_agreement":null},{"id":"W2316887046","doi":"10.1016/j.jval.2016.02.010","title":"Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Agency for Healthcare Research and Quality","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Cancer; Breast cancer; Cancer registry; Cervical cancer; Population; Mental health; Internal medicine; Psychiatry; Environmental health","score_opus":0.12538931497847072,"score_gpt":0.3851906164332247,"score_spread":0.259801301454754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316887046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985012,0.0002514165,0.00022437067,0.000051623418,0.000009914976,0.0000102360145,0.000635402,0.000007531889,0.00030836996],"genre_scores_gemma":[0.99899465,0.00007791611,0.000091877686,0.000021214757,0.000011887164,0.000014153628,0.0005727564,0.00000391455,0.00021159988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844104,0.00059488066,0.00013685203,0.00040488082,0.00017181909,0.00025051873],"domain_scores_gemma":[0.99723876,0.0010058002,0.00074226886,0.00036867772,0.00024161328,0.00040289026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016710883,0.00042515405,0.0008600893,0.0012091715,0.0007149224,0.0011069524,0.0008131651,0.0011874427,0.003230345],"category_scores_gemma":[0.0037520363,0.0006990014,0.0030342124,0.0026546535,0.00056293304,0.0011423663,0.00101022,0.0018324676,0.00033595605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000586135,0.0001452718,0.9967481,0.000015101001,0.0011970595,0.000067075154,0.00006624024,0.00011750072,0.0001529667,0.00001923158,0.000102571605,0.00078279036],"study_design_scores_gemma":[0.000024421799,0.0003436316,0.99829334,0.000003462255,0.0004453731,0.000104887156,0.00016677784,0.0004499589,0.000028123532,0.000027631566,0.00010288877,0.000009462548],"about_ca_topic_score_codex":0.011924692,"about_ca_topic_score_gemma":0.011444938,"teacher_disagreement_score":0.011924692,"about_ca_system_score_codex":0.0005158052,"about_ca_system_score_gemma":0.00051849347,"threshold_uncertainty_score":0.023710549},"labels":[],"label_agreement":null},{"id":"W2317105954","doi":"10.1016/j.jval.2014.08.288","title":"Minimum Clinically Important Difference in the Calgary Depression Scale for Schizophrenia","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Depression (economics); Scale (ratio); Psychiatry; Psychology; Clinical psychology; Medicine; Geography; Cartography; Economics; Keynesian economics","score_opus":0.04792377707150689,"score_gpt":0.3558825864731058,"score_spread":0.30795880940159887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317105954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96604306,0.0040078536,0.0043723728,0.0012958798,0.00050874945,0.00083656085,0.008396308,0.00018058662,0.014358672],"genre_scores_gemma":[0.9904529,0.00026577496,0.0051686713,0.00013159952,0.000039354603,0.00040474243,0.002783625,0.00001849408,0.00073484785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611807,0.0014390347,0.00059473625,0.00018765302,0.0014512336,0.00020931872],"domain_scores_gemma":[0.99415576,0.0031191427,0.0010701418,0.00032140157,0.0008350296,0.00049849314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034884948,0.00062526617,0.001558573,0.0011321278,0.00051188306,0.00075392885,0.00095380255,0.00084745104,0.003031123],"category_scores_gemma":[0.019141952,0.00020792928,0.0010186475,0.00064730016,0.0003680524,0.0006366935,0.00091111753,0.0014564242,0.00038648394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05353103,0.0011448761,0.793795,0.0008916636,0.0039654044,0.00077527016,0.00071185007,0.0026413957,0.005711528,0.0033575397,0.017459568,0.11601493],"study_design_scores_gemma":[0.0016742032,0.0015499465,0.9875159,0.00009951555,0.00025641487,0.000386398,0.00022035095,0.0033398962,0.00096464966,0.0021462278,0.0017869241,0.00005955422],"about_ca_topic_score_codex":0.0031444153,"about_ca_topic_score_gemma":0.008759169,"teacher_disagreement_score":0.0034884948,"about_ca_system_score_codex":0.000845508,"about_ca_system_score_gemma":0.0010215602,"threshold_uncertainty_score":0.018449128},"labels":[],"label_agreement":null},{"id":"W2317694604","doi":"10.1016/j.jval.2014.08.1447","title":"Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Amiodarone; Medicine; Cardioversion; Atrial fibrillation; Sinus rhythm; Emergency department; Internal medicine; Cardiology; Anesthesia","score_opus":0.10577330563873298,"score_gpt":0.38508923422199165,"score_spread":0.27931592858325865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317694604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816294,0.0042302855,0.00028345903,0.007822186,0.00012615227,0.000011267412,0.0013424358,0.00001822323,0.004536586],"genre_scores_gemma":[0.9977272,0.0008761082,0.00018051639,0.0002707157,0.0000528509,0.0000068484705,0.00038263787,0.000010098494,0.00049299956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984072,0.00080344616,0.000109527304,0.00009260864,0.00021924365,0.0003680464],"domain_scores_gemma":[0.9977239,0.0006778574,0.0005604053,0.000036427253,0.0002605478,0.00074081554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008718224,0.00021061461,0.00031919233,0.0009440873,0.00029256058,0.0018854378,0.0004551371,0.00088596315,0.0022287394],"category_scores_gemma":[0.005031292,0.00017368337,0.0011128215,0.0009869857,0.0003358587,0.0004598638,0.000678961,0.0010549256,0.00013462886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005833136,0.0012616521,0.81547827,0.0004924477,0.0015133243,0.0048784926,0.0005803328,0.02774454,0.0012101989,0.01363071,0.016707802,0.110669054],"study_design_scores_gemma":[0.00023547621,0.0007606124,0.95987403,0.00048431294,0.00052867125,0.0039154165,0.00160175,0.015519942,0.0005644952,0.0015104875,0.014946841,0.0000579482],"about_ca_topic_score_codex":0.0987209,"about_ca_topic_score_gemma":0.058317956,"teacher_disagreement_score":0.0987209,"about_ca_system_score_codex":0.007441259,"about_ca_system_score_gemma":0.0038122858,"threshold_uncertainty_score":0.19629258},"labels":[],"label_agreement":null},{"id":"W2317727536","doi":"10.1016/j.jval.2014.08.404","title":"Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Revenue; Total revenue; Business; Quarter (Canadian coin); Stock price; Stock (firearms); Agricultural economics; Commerce; Finance; Economics; Engineering","score_opus":0.2048130438536943,"score_gpt":0.3792123093480543,"score_spread":0.17439926549435997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317727536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99130005,0.00056834024,0.00081723765,0.0011958819,0.000028710798,0.000011836951,0.00060950144,0.000032965,0.0054355725],"genre_scores_gemma":[0.998192,0.00010916732,0.00004872134,0.00003843307,0.000026738115,0.0000017523139,0.00020395004,0.0000031568043,0.001376033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989882,0.00025787012,0.00006859183,0.00014602186,0.00019617238,0.00034311326],"domain_scores_gemma":[0.9791651,0.014270215,0.0037313036,0.0005722773,0.0011524928,0.001108685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002554069,0.00026342136,0.00042720503,0.00085126626,0.00035265152,0.0025585736,0.00074088323,0.0012503637,0.006503558],"category_scores_gemma":[0.015302358,0.00025218888,0.001087806,0.000791478,0.0007106237,0.00168382,0.00068927085,0.0019671014,0.0006969496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036149065,0.001068475,0.8352723,0.0001610625,0.0009193284,0.002124506,0.00026749287,0.10791031,0.0039799726,0.013542802,0.003926566,0.02721234],"study_design_scores_gemma":[0.00012761402,0.0010773793,0.7569757,0.00003368882,0.0008183721,0.00047393795,0.0008213394,0.22076921,0.004846781,0.0118002985,0.0021659748,0.000089602836],"about_ca_topic_score_codex":0.012035554,"about_ca_topic_score_gemma":0.009071817,"teacher_disagreement_score":0.012035554,"about_ca_system_score_codex":0.0015820498,"about_ca_system_score_gemma":0.0010898251,"threshold_uncertainty_score":0.023930967},"labels":[],"label_agreement":null},{"id":"W2318080223","doi":"10.1016/j.jval.2012.03.234","title":"PMS45 Parents' Preferences for Drug Treatments in Juvenile Idiopathic Arthritis: A Discrete Choice Experiment","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Multinomial logistic regression; Medicine; Arthritis; Preference; Juvenile; Discrete choice; Mixed logit; Physical therapy; Sample (material); Logistic regression; Demography; Internal medicine; Statistics","score_opus":0.13427478666760834,"score_gpt":0.43975025230582604,"score_spread":0.3054754656382177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318080223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991197,0.000010620362,0.00016307588,0.00007814265,0.000012952392,0.00009417582,0.000044610453,0.0000029688513,0.00047369004],"genre_scores_gemma":[0.9972247,0.000032457305,0.0008131161,0.00010793751,0.00001422655,0.00043861748,0.000062666644,0.0000023679324,0.0013038202],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976629,0.0015403086,0.00014719125,0.0002178732,0.00019820749,0.0002334698],"domain_scores_gemma":[0.98345184,0.013277118,0.0013029407,0.0006714823,0.00014028653,0.0011563246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004482506,0.0004697055,0.0006318282,0.00022940563,0.00081355806,0.0014725646,0.0005464692,0.0017129439,0.00876497],"category_scores_gemma":[0.011825278,0.0005907042,0.0005797059,0.00021302624,0.00093120156,0.0005764878,0.0004963384,0.0017684966,0.0008044384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36164296,0.33647284,0.14373985,0.0004829554,0.0007028206,0.0017587423,0.012892094,0.012664854,0.044677738,0.011335249,0.0028854087,0.070744485],"study_design_scores_gemma":[0.123853385,0.44822875,0.29398543,0.00018843258,0.0015517707,0.00090676633,0.010556173,0.07693436,0.019275414,0.014720474,0.009382179,0.00041694925],"about_ca_topic_score_codex":0.0025919704,"about_ca_topic_score_gemma":0.0018603755,"teacher_disagreement_score":0.00876497,"about_ca_system_score_codex":0.0007015811,"about_ca_system_score_gemma":0.0011322006,"threshold_uncertainty_score":0.02932179},"labels":[],"label_agreement":null},{"id":"W2319188720","doi":"10.1016/j.jval.2014.08.308","title":"Examining Opioid-Dependent Chronic Pain Patients Experiences On Buprenorphine Maintenance Therapy In The Texas Workers Compensation System: Pilot Study - Part 2","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic pain; Brief Pain Inventory; Beck Depression Inventory; Physical therapy; Depression (economics); Visual analogue scale; McGill Pain Questionnaire; Buprenorphine; Anxiety; Opioid; Internal medicine; Psychiatry","score_opus":0.06003061404178575,"score_gpt":0.29561340347083476,"score_spread":0.235582789429049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319188720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996339,0.000010036299,0.000014786024,0.000029764517,0.0000017216124,0.00008261923,0.00007441737,3.954195e-7,0.00015227644],"genre_scores_gemma":[0.99866104,0.00004617657,0.00018630024,0.00011297698,0.000007271765,0.00023274632,0.00025262637,8.9540805e-7,0.0004999928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930656,0.00026774927,0.000045996832,0.000064770866,0.000088531444,0.0002263627],"domain_scores_gemma":[0.99827015,0.00028304616,0.00054083485,0.00007431691,0.00031423988,0.0005173381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013349889,0.00033872665,0.00028808246,0.0006662891,0.0023022778,0.0008668198,0.00061766023,0.00051358604,0.0021900316],"category_scores_gemma":[0.002113538,0.00038569482,0.00053827924,0.00063680543,0.0005982281,0.0007952729,0.0012525212,0.00093766744,0.00026892938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046311063,0.004223617,0.98263836,0.00003796125,0.0000444055,0.00018892408,0.006026123,0.00007855761,0.0009922216,0.000042700525,0.00037771612,0.0048862905],"study_design_scores_gemma":[0.00008122056,0.0020074856,0.98058766,0.000013473675,0.000023940547,0.00006756462,0.01661732,0.0001115013,0.00017645005,0.0000161818,0.0002903518,0.00000675941],"about_ca_topic_score_codex":0.03677165,"about_ca_topic_score_gemma":0.10073767,"teacher_disagreement_score":0.03677165,"about_ca_system_score_codex":0.0022469652,"about_ca_system_score_gemma":0.0039297086,"threshold_uncertainty_score":0.07311523},"labels":[],"label_agreement":null},{"id":"W2319467302","doi":"10.1016/j.jval.2014.08.1859","title":"Development Of A Model To Assess The Cost-Effectiveness Of Therapies For Patients With Type 2 Diabetes Mellitus (T2DM) Following A Reference Model Framework","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Comparability; Credibility; Construct (python library); Identification (biology); Consistency (knowledge bases); Computer science; Systematic review; Risk analysis (engineering); Health care; Logic model; Management science; Medicine; MEDLINE; Artificial intelligence; Engineering","score_opus":0.49757006457306285,"score_gpt":0.43968782400359224,"score_spread":0.05788224056947061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319467302","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08393292,0.0011582996,0.87941706,0.0045808405,0.00017885385,0.00034472815,0.0022901876,0.00043446058,0.027662624],"genre_scores_gemma":[0.83250654,0.0010599066,0.14711837,0.00052161247,0.00009648009,0.0009015565,0.0015462482,0.00012300584,0.016126273],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991841,0.00049439183,0.000028691544,0.000101374346,0.0000905696,0.00010097017],"domain_scores_gemma":[0.9970289,0.002322681,0.00015932671,0.0000651612,0.00032128603,0.000102633574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029701993,0.00088194973,0.0013314075,0.0010193508,0.0005179264,0.0020375154,0.002674486,0.002962036,0.0055174055],"category_scores_gemma":[0.008094491,0.000566391,0.0017367392,0.0014131208,0.000725269,0.0013029049,0.00090363016,0.0019027701,0.0005038912],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004262171,0.000031501273,0.0005144244,0.000028578372,0.00004111606,0.00006796992,0.000016470949,0.97323257,0.000080406804,0.02223732,0.00058333774,0.0031235865],"study_design_scores_gemma":[0.000044467943,0.000043640644,0.00020854064,0.000013906031,0.00003229015,0.00002628425,0.00001160921,0.98956877,0.00007083197,0.009125144,0.00084525725,0.000009248416],"about_ca_topic_score_codex":0.031338293,"about_ca_topic_score_gemma":0.016752053,"teacher_disagreement_score":0.031338293,"about_ca_system_score_codex":0.0030544605,"about_ca_system_score_gemma":0.0034807867,"threshold_uncertainty_score":0.06231177},"labels":[],"label_agreement":null},{"id":"W2320313413","doi":"10.1016/j.jval.2014.03.538","title":"Sandostatin Lar Patient Journey","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Pediatrics; Surgery; Internal medicine; General surgery","score_opus":0.040451993657536156,"score_gpt":0.3070610992098326,"score_spread":0.26660910555229644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320313413","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10547312,0.033444267,0.0031349994,0.505495,0.009625188,0.00012654987,0.00070763775,0.00039095012,0.3416023],"genre_scores_gemma":[0.55969226,0.04672908,0.0057300096,0.13789429,0.014570759,0.000113187256,0.0014575296,0.00025978382,0.23355319],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.999691,0.000052045907,0.00002664209,0.00002719296,0.000113341834,0.00008974598],"domain_scores_gemma":[0.99900335,0.00012092539,0.000075662785,0.000018197657,0.00012730216,0.00065458304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002967621,0.00024129741,0.0003154745,0.0004294133,0.001681426,0.0015921792,0.00030831102,0.0017680487,0.019135443],"category_scores_gemma":[0.0019487416,0.00010539439,0.0003518065,0.00029336306,0.00049129786,0.0013603509,0.0013557348,0.0034001123,0.0055674193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021410355,0.00038029763,0.014938191,0.0003127072,0.000068456604,0.19995096,0.0014810922,0.00055461255,0.0027311197,0.02723947,0.5484971,0.20363186],"study_design_scores_gemma":[0.000029551227,0.00018643476,0.004015936,0.00066493906,0.00003284517,0.24010022,0.0020671282,0.00038216152,0.00064918154,0.011433629,0.74040484,0.00003309173],"about_ca_topic_score_codex":0.00077574793,"about_ca_topic_score_gemma":0.0024399015,"teacher_disagreement_score":0.019135443,"about_ca_system_score_codex":0.0010050606,"about_ca_system_score_gemma":0.0022989025,"threshold_uncertainty_score":0.064014435},"labels":[],"label_agreement":null},{"id":"W2320786904","doi":"10.1016/j.jval.2012.03.278","title":"PMS89 Simulation Modeling with System Dynamics (SD) Using Real-World Observational Data to Plan Osteoarthritis Care Delivery in Alberta","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Alberta Health Services; Alberta Bone and Joint Health Institute; University of Saskatchewan; University of Calgary","funders":"","keywords":"Observational study; Health care; Process management; Operations management; Medicine; Engineering","score_opus":0.659170241629875,"score_gpt":0.4448800553627272,"score_spread":0.21429018626714785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320786904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96981937,0.0002820014,0.017509341,0.0010436218,0.000071649236,0.0001235749,0.002908276,0.00027296646,0.007969254],"genre_scores_gemma":[0.9916819,0.00011957026,0.004271062,0.000053437656,0.000010799001,0.00005097015,0.0013391393,0.000021376949,0.0024518096],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99934417,0.0002894233,0.00003845744,0.00009041831,0.0000938718,0.00014358817],"domain_scores_gemma":[0.99638957,0.0022763826,0.00017894825,0.000145917,0.0007726621,0.00023649074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022610528,0.00065147126,0.0007734616,0.00089589,0.00089932984,0.0014450062,0.0018711053,0.0013923104,0.0032946435],"category_scores_gemma":[0.0064924266,0.0008899515,0.00095577654,0.001125772,0.00095005176,0.00055846456,0.00083342806,0.00119785,0.00022370924],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007984801,0.000070568174,0.007182447,0.000014130361,0.000031894713,0.000038381015,0.000026400197,0.9892456,0.000044222004,0.0011308694,0.0005387638,0.0015969274],"study_design_scores_gemma":[0.000032936,0.000015924656,0.001987434,0.00000406276,0.000009950104,0.000002571879,0.000034155917,0.9973273,0.00003285983,0.00031054544,0.00023463702,0.0000075470643],"about_ca_topic_score_codex":0.9158912,"about_ca_topic_score_gemma":0.8538932,"teacher_disagreement_score":0.08410883,"about_ca_system_score_codex":0.009745767,"about_ca_system_score_gemma":0.010547239,"threshold_uncertainty_score":0.16920829},"labels":[],"label_agreement":null},{"id":"W2321364635","doi":"10.1016/j.jval.2015.03.1301","title":"Financial impacts of using Omeprazole oral suspension for preventing upper Gastrointestinal bleeding early after Intensive Care admission","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Omeprazole; Pantoprazole; Medicine; Upper gastrointestinal bleeding; Proton-pump inhibitor; Gastrointestinal bleeding; Pharmacy; Intensive care unit; Intensive care; Randomized controlled trial; Clinical trial; Emergency medicine; Intensive care medicine; Internal medicine; Endoscopy; Nursing","score_opus":0.08354942885343165,"score_gpt":0.3516670995337875,"score_spread":0.26811767068035586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321364635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98142576,0.0030080422,0.00007877842,0.009516287,0.00019397879,0.000037655394,0.00059809315,0.000007102944,0.0051343804],"genre_scores_gemma":[0.99843913,0.0006628223,0.000078497396,0.00032438023,0.00011297482,0.0000075989287,0.00018836833,8.638387e-7,0.00018538588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843377,0.00064509566,0.00013459552,0.00005895035,0.00023411926,0.0004934045],"domain_scores_gemma":[0.99302775,0.0020006776,0.0022099174,0.0000873152,0.0006215357,0.0020528655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009280178,0.00020727706,0.00029214026,0.0004622573,0.0006070062,0.0010227092,0.0004717168,0.00090541196,0.0038578697],"category_scores_gemma":[0.013601054,0.00015161162,0.0014322958,0.00061935,0.00037157224,0.0006495406,0.001158813,0.0014562468,0.00014642863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010918858,0.0038673407,0.8547135,0.00043376378,0.0010778813,0.0014269385,0.00018757458,0.0030177087,0.00050793437,0.0012903141,0.0056160325,0.11694218],"study_design_scores_gemma":[0.00032243162,0.002274965,0.9917904,0.00019807798,0.00052076974,0.00029173528,0.00074936857,0.0018693097,0.00014752918,0.00050649676,0.0013027237,0.000026231648],"about_ca_topic_score_codex":0.014365204,"about_ca_topic_score_gemma":0.0233911,"teacher_disagreement_score":0.014365204,"about_ca_system_score_codex":0.0017835048,"about_ca_system_score_gemma":0.0026525196,"threshold_uncertainty_score":0.028563142},"labels":[],"label_agreement":null},{"id":"W2321369595","doi":"10.1016/j.jval.2013.03.742","title":"A Comparison Of Medical Computed Tomographic Utilization And Potential Related Cancer Risks In The United States And In Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pelvis; Population; Nuclear medicine; Demography; Abdomen; Computed tomography; Radiology; Environmental health","score_opus":0.07496348365208488,"score_gpt":0.37450306100223674,"score_spread":0.29953957735015185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321369595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918465,0.0013231543,0.000101183316,0.0005725552,0.000013129826,0.00002516472,0.002965208,0.000009504463,0.0031436468],"genre_scores_gemma":[0.9979114,0.0006758129,0.00009040301,0.000083628336,0.00000481313,0.0000041065086,0.00073420274,0.0000041127405,0.0004915436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900836,0.000098018274,0.00009545675,0.0001186381,0.00036193602,0.00031756255],"domain_scores_gemma":[0.996572,0.0003867074,0.00065244024,0.00006724941,0.0015124679,0.00080911646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054991955,0.0002538089,0.00036669127,0.0025752664,0.0017134021,0.0015309762,0.0012144129,0.0006768842,0.001810006],"category_scores_gemma":[0.0036454932,0.00036367105,0.00090256706,0.00794867,0.00089197967,0.00048266773,0.0009383417,0.0008894789,0.00013047286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001405269,0.000033423516,0.99544793,0.000023371482,0.00007366949,0.00012028916,0.00033844222,0.00019670188,0.00007542033,0.00025129944,0.00048628848,0.0028125825],"study_design_scores_gemma":[0.000007669163,0.000020167261,0.9974589,0.000023355979,0.000040753985,0.00009491169,0.0013988138,0.00037305578,0.000048253823,0.00003786811,0.00048602658,0.000010292259],"about_ca_topic_score_codex":0.99418724,"about_ca_topic_score_gemma":0.9956346,"teacher_disagreement_score":0.025106601,"about_ca_system_score_codex":0.025106601,"about_ca_system_score_gemma":0.025567008,"threshold_uncertainty_score":0.18216199},"labels":[],"label_agreement":null},{"id":"W2321379008","doi":"10.1016/j.jval.2014.08.191","title":"Drug Utilization Review of Acid Suppressants (Durable) – an Audit to Assess the Utilization of Proton Pump Inhibitors and Histamine H2-Receptor Antagonists in Canadian Hospitals","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bolus (digestion); Internal medicine; Proton-pump inhibitor; Drug; Gastroenterology; Pharmacology","score_opus":0.059823437321906224,"score_gpt":0.35758435217423856,"score_spread":0.29776091485233236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321379008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4288031,0.41399375,0.0008219869,0.023418264,0.0019923532,0.0016642141,0.081595756,0.00034202271,0.047368612],"genre_scores_gemma":[0.7582847,0.18119594,0.0035377257,0.018285625,0.0008723687,0.00037796755,0.031581644,0.00009585669,0.0057681086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9880492,0.0007547752,0.0021545049,0.00056301826,0.0075942394,0.00088417204],"domain_scores_gemma":[0.9303138,0.0053624944,0.013647561,0.0007233542,0.045650683,0.004302022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051557305,0.000422882,0.00091679615,0.009540312,0.0016903493,0.0017906528,0.0015836081,0.0009979479,0.0009112404],"category_scores_gemma":[0.018822525,0.00046943448,0.0014866868,0.022845494,0.0005694892,0.0006965004,0.0007206001,0.0008309175,0.00019549885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010730277,0.00024686393,0.6961113,0.013788376,0.0018881217,0.0010296784,0.0011197047,0.0008978531,0.0013018477,0.0006982288,0.12686494,0.15498003],"study_design_scores_gemma":[0.00006775907,0.00017445046,0.9392724,0.0028466173,0.0005747836,0.00044715015,0.0005543474,0.00039653826,0.00036176806,0.00003142653,0.055207912,0.00006488031],"about_ca_topic_score_codex":0.94589835,"about_ca_topic_score_gemma":0.9626943,"teacher_disagreement_score":0.054101646,"about_ca_system_score_codex":0.040303145,"about_ca_system_score_gemma":0.090188086,"threshold_uncertainty_score":0.2924211},"labels":[],"label_agreement":null},{"id":"W2321480971","doi":"10.1016/j.jval.2014.03.935","title":"Cost Effectiveness Of Hysteroscopic Tubal Sterilization (Hts) Compared To Laparoscopic Tubal Sterilization (Lts) For Permanent Birth Control","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Protocol (science); Medicine; Sterilization (economics); Laparoscopy; Family planning; Operations management; Gynecology; Obstetrics; Surgery; Business; Population; Environmental health; Research methodology; Economics","score_opus":0.06471390297819084,"score_gpt":0.35544872890796697,"score_spread":0.2907348259297761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321480971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99065244,0.0053250417,0.00039382264,0.0009264471,0.00013590495,0.00008576218,0.00040361023,0.000020763138,0.0020562971],"genre_scores_gemma":[0.9991266,0.00040118335,0.00013897172,0.00004569215,0.00003594191,0.000015619116,0.00007805255,0.0000016713016,0.00015623326],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9990715,0.0005501142,0.000058623136,0.000078383906,0.0000906464,0.00015073245],"domain_scores_gemma":[0.9972933,0.0018446607,0.0003885927,0.00007011161,0.000070161645,0.00033313397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009869307,0.00041145863,0.00096759835,0.00069636037,0.00022917762,0.0006025089,0.0004605857,0.0007845721,0.009019329],"category_scores_gemma":[0.0051607788,0.00021612267,0.0021719125,0.00043958242,0.00044450304,0.0008242163,0.0005818994,0.0006648543,0.00014760718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5543723,0.0067153233,0.082146496,0.0022957763,0.004174823,0.0006061904,0.00025154822,0.03548882,0.003274835,0.004659809,0.0024758042,0.30353823],"study_design_scores_gemma":[0.07949852,0.20965943,0.5507276,0.0012149756,0.019152232,0.0020056176,0.0021313343,0.11647261,0.0067973644,0.0077788895,0.004273433,0.00028807443],"about_ca_topic_score_codex":0.006374703,"about_ca_topic_score_gemma":0.0051647583,"teacher_disagreement_score":0.009019329,"about_ca_system_score_codex":0.0015650176,"about_ca_system_score_gemma":0.0011859818,"threshold_uncertainty_score":0.030172586},"labels":[],"label_agreement":null},{"id":"W2321591904","doi":"10.1016/j.jval.2012.03.1071","title":"PIH39 Eliciting Preferences to the EQ-5D-5L Health States: Discrete Choice Experiment or Multiprofile Case of Best-Worst Scaling","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Intraclass correlation; Statistics; Set (abstract data type); Task (project management); Random effects model; Psychology; EQ-5D; Mathematics; Test (biology); Computer science; Medicine; Psychometrics; Meta-analysis","score_opus":0.5606600062268362,"score_gpt":0.47342971996031075,"score_spread":0.08723028626652546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321591904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88009465,0.00022502737,0.09296647,0.0016419232,0.00021821595,0.0023875106,0.0023488074,0.00018824096,0.01992908],"genre_scores_gemma":[0.94962215,0.00012649912,0.04445975,0.00031580043,0.000040922896,0.0022762213,0.0005094865,0.000020201021,0.0026290878],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99146795,0.006724287,0.00031773842,0.00058041484,0.0006410172,0.00026858927],"domain_scores_gemma":[0.98182297,0.01587439,0.00067050505,0.0011038693,0.00025998117,0.00026834465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012253763,0.0006834369,0.001038729,0.0003527667,0.0004179783,0.0014804637,0.0005501403,0.00230886,0.014864549],"category_scores_gemma":[0.028879056,0.00039240092,0.0012429837,0.0006065285,0.0009323557,0.0014313045,0.00085020385,0.0014074644,0.0010895359],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09692151,0.022644684,0.07398602,0.0036810327,0.0021035871,0.001187241,0.002784959,0.1317086,0.08270668,0.1301271,0.012264562,0.439884],"study_design_scores_gemma":[0.010829293,0.043083977,0.061327253,0.00043151926,0.00088768883,0.00053620304,0.0016336599,0.58780503,0.050933458,0.22180429,0.0201665,0.00056112226],"about_ca_topic_score_codex":0.000639675,"about_ca_topic_score_gemma":0.0005072523,"teacher_disagreement_score":0.014864549,"about_ca_system_score_codex":0.00049986155,"about_ca_system_score_gemma":0.00061078585,"threshold_uncertainty_score":0.06480485},"labels":[],"label_agreement":null},{"id":"W2321778362","doi":"10.1016/j.jval.2014.03.1541","title":"Cost Implications Of Early Discontinuation And Restart Of Insulin In The Treatment Of Type 2 Diabetes Mellitus","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Discontinuation; Insulin; Emergency department; Diabetes mellitus; Emergency medicine; Type 2 diabetes; Medical costs; Type 2 Diabetes Mellitus; Drug; Cohort; Ambulatory care; Health care; Intensive care medicine; Internal medicine; Endocrinology; Pharmacology","score_opus":0.20986195255704124,"score_gpt":0.4337609850629297,"score_spread":0.22389903250588847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321778362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93993556,0.02182555,0.0008762356,0.025702687,0.00040729606,0.000060599286,0.00048397825,0.000024025507,0.010684115],"genre_scores_gemma":[0.99725646,0.0015289986,0.00025286525,0.0005448686,0.00020048878,0.000008232481,0.00006467627,0.0000030182298,0.0001405453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99575317,0.0025196695,0.00037367863,0.0001224741,0.0007981449,0.00043288385],"domain_scores_gemma":[0.97654575,0.014364821,0.0056948285,0.00030213984,0.0010351394,0.0020573183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029204562,0.0002659753,0.0005693069,0.0009309057,0.00069144694,0.0017247021,0.0005492799,0.0011984691,0.0022024654],"category_scores_gemma":[0.032344416,0.00020893668,0.0013252231,0.0009828883,0.00039823225,0.0007937681,0.0008690221,0.0020846208,0.0000899692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009738993,0.0022154823,0.63808244,0.0005499509,0.0011540991,0.0019555835,0.0004105434,0.0086962115,0.00057925226,0.003695481,0.005771811,0.32715017],"study_design_scores_gemma":[0.0005501916,0.0028236983,0.9648502,0.00087234215,0.0017778568,0.0023577004,0.0015779596,0.016791735,0.00049805315,0.004369863,0.003438378,0.00009208454],"about_ca_topic_score_codex":0.015034894,"about_ca_topic_score_gemma":0.019653363,"teacher_disagreement_score":0.015034894,"about_ca_system_score_codex":0.0031948327,"about_ca_system_score_gemma":0.003259508,"threshold_uncertainty_score":0.02989477},"labels":[],"label_agreement":null},{"id":"W2321815323","doi":"10.1016/j.jval.2014.08.916","title":"Humanistic Research Outcomes in Multiple Sclerosis: Review of the Literature from Latin America","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Quality of life (healthcare); Anxiety; Mental health; Cognition; Medicine; Latin Americans; MEDLINE; Depression (economics); Gerontology; Clinical psychology; Psychiatry; Psychology; Nursing","score_opus":0.27839139513768657,"score_gpt":0.42114285717501887,"score_spread":0.1427514620373323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321815323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017924581,0.99072015,0.00010023303,0.00527221,0.00016177757,0.00001733085,0.000083165556,0.0000026282887,0.001849938],"genre_scores_gemma":[0.027742833,0.968807,0.00055910257,0.0023873353,0.00024321354,0.0000688334,0.00007900266,0.0000053904555,0.00010730875],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98528916,0.008993006,0.0025648684,0.0005710925,0.002243378,0.00033841928],"domain_scores_gemma":[0.8727927,0.1045375,0.01096127,0.0013086603,0.00930444,0.0010954315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03906098,0.00061490637,0.002263356,0.01523888,0.0016255558,0.007401641,0.0013145618,0.0014926695,0.0029696967],"category_scores_gemma":[0.071929246,0.00036603448,0.001124691,0.027823618,0.0041551744,0.0026055374,0.0032579512,0.0013040501,0.00019534065],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040009758,0.00014614701,0.02568016,0.21241313,0.0017728793,0.000674901,0.015626444,0.00020093433,0.00033817135,0.013510803,0.015254581,0.7139817],"study_design_scores_gemma":[0.00020859925,0.00018992227,0.08187254,0.5346766,0.0036899874,0.0017471691,0.029051188,0.00012503822,0.00030002947,0.00937958,0.3386493,0.00010999533],"about_ca_topic_score_codex":0.02402304,"about_ca_topic_score_gemma":0.055593736,"teacher_disagreement_score":0.03906098,"about_ca_system_score_codex":0.007309477,"about_ca_system_score_gemma":0.02346175,"threshold_uncertainty_score":0.2065767},"labels":[],"label_agreement":null},{"id":"W2322121107","doi":"10.1016/j.jval.2013.03.1236","title":"Rsv Hospitalization In Infants With Neuromuscular Disease In The Canadian Registry Of Synagis® (Caress) Following Prophylaxis (2005-2012)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Hazard ratio; Observational study; Atopy; Respiratory system; Internal medicine; Asthma; Pregnancy","score_opus":0.030431733453145638,"score_gpt":0.3162749531770787,"score_spread":0.28584321972393306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322121107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96364224,0.002191974,0.00013976812,0.00042700436,0.00006271884,0.00008515765,0.029642308,0.000028921311,0.0037798556],"genre_scores_gemma":[0.9876605,0.0009126494,0.00015961195,0.0001589988,0.00002270802,0.000029849529,0.010308651,0.0000067864617,0.0007402552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984976,0.00007197534,0.00012766787,0.00022316842,0.0005175781,0.00056204945],"domain_scores_gemma":[0.99749136,0.000076995355,0.0007180611,0.00008230311,0.0010379977,0.00059324846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000828762,0.0005945289,0.0006194143,0.002118755,0.001841608,0.0012169848,0.0020766833,0.0009564625,0.0019031034],"category_scores_gemma":[0.0027649072,0.00052718614,0.0011058374,0.0052031986,0.00044045868,0.00062498945,0.0010770726,0.0012458609,0.000214642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102143094,0.000019910072,0.9958134,0.000045108776,0.00007306405,0.00008742138,0.00012241624,0.00008008264,0.00008495268,0.00007599808,0.0019741291,0.0015213278],"study_design_scores_gemma":[0.00000565475,0.000014677604,0.99896765,0.00003647631,0.000027191509,0.00006889172,0.00027128294,0.00012915893,0.000025964413,0.0000079088795,0.00043835453,0.000006747871],"about_ca_topic_score_codex":0.9835286,"about_ca_topic_score_gemma":0.9906363,"teacher_disagreement_score":0.018637873,"about_ca_system_score_codex":0.018637873,"about_ca_system_score_gemma":0.027379885,"threshold_uncertainty_score":0.13522786},"labels":[],"label_agreement":null},{"id":"W2322499817","doi":"10.1016/j.jval.2012.03.1257","title":"PCN140 Managing the Risk of Exposure to Low-Ionizing Radiation in Canada: A Population Model","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Ionizing radiation; Medicine; Radiation exposure; Medical radiation; Environmental health; Population; Radiation protection; Nuclear medicine; Medical physics; Irradiation","score_opus":0.029871809854959665,"score_gpt":0.28016753188024995,"score_spread":0.25029572202529027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322499817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89169186,0.0010974122,0.023486597,0.010036513,0.00016574797,0.0010200881,0.008132546,0.0003036545,0.06406553],"genre_scores_gemma":[0.97173744,0.00075245096,0.0075877677,0.00052797305,0.000034096418,0.0002473326,0.0013056708,0.000039113293,0.017768245],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99864405,0.00035539674,0.00002596452,0.00018391342,0.0001842387,0.0006063676],"domain_scores_gemma":[0.99781287,0.00061913487,0.00014083026,0.00007062163,0.00081891706,0.0005375857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001931323,0.00089861336,0.0012972616,0.0013008775,0.0019946918,0.0031281551,0.0033498853,0.0022679328,0.009281956],"category_scores_gemma":[0.004854051,0.0007686301,0.0015086031,0.0022982704,0.001613582,0.0009481072,0.0013543546,0.0017598531,0.00061780127],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084502075,0.0010395768,0.08551895,0.00013771348,0.00037723652,0.0007834358,0.00072000007,0.8154494,0.00036732908,0.04246364,0.016503481,0.035794146],"study_design_scores_gemma":[0.00036862597,0.0004160977,0.026066298,0.00008271773,0.00036056267,0.00028808147,0.0015522736,0.9520954,0.00013928187,0.011195925,0.007343577,0.000091214],"about_ca_topic_score_codex":0.9729119,"about_ca_topic_score_gemma":0.96250993,"teacher_disagreement_score":0.03687381,"about_ca_system_score_codex":0.03687381,"about_ca_system_score_gemma":0.053113695,"threshold_uncertainty_score":0.26753944},"labels":[],"label_agreement":null},{"id":"W2322803466","doi":"10.1016/j.jval.2015.03.272","title":"Cost-effectiveness analyses of Lung Cancer screening strategies using low dose computed tomography – a systematic review","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University; University of British Columbia","funders":"","keywords":"Medicine; Lung cancer screening; Lung cancer; Quality-adjusted life year; Stage (stratigraphy); MEDLINE; Systematic review; Cost effectiveness; Cancer; Intensive care medicine; Oncology; Internal medicine; Risk analysis (engineering)","score_opus":0.35035322040226513,"score_gpt":0.5270772850067253,"score_spread":0.17672406460446022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322803466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025531515,0.99606884,0.00018274962,0.00019089575,0.00012797449,0.00016024905,0.000409607,0.000007868553,0.00029853504],"genre_scores_gemma":[0.07806829,0.9183576,0.0014140005,0.0008752233,0.0001805538,0.0003385344,0.00052739267,0.000010231069,0.0002281748],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941858,0.0027710437,0.0014668736,0.00038255815,0.0009566722,0.0002370214],"domain_scores_gemma":[0.98869085,0.0089985775,0.0015039244,0.00015141205,0.00054642704,0.0001088697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068426244,0.0017002587,0.00904039,0.0038383808,0.00030505008,0.0022504334,0.0016307693,0.0015289715,0.005543749],"category_scores_gemma":[0.024724022,0.0010106388,0.01891539,0.0044663292,0.0006515883,0.0015780493,0.0012060961,0.0021561144,0.00026701475],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003462152,0.00008154332,0.002050082,0.7648579,0.15802594,0.00008889359,0.000066003806,0.0007912704,0.00023075458,0.00048105864,0.0018358409,0.06802865],"study_design_scores_gemma":[0.0048605073,0.0010509886,0.010616258,0.1893081,0.7796149,0.00035398023,0.00016867228,0.00062667293,0.0003071878,0.0010987014,0.011923523,0.000070509006],"about_ca_topic_score_codex":0.00943088,"about_ca_topic_score_gemma":0.02507221,"teacher_disagreement_score":0.00943088,"about_ca_system_score_codex":0.0035557095,"about_ca_system_score_gemma":0.0041411966,"threshold_uncertainty_score":0.03618771},"labels":[],"label_agreement":null},{"id":"W2323065943","doi":"10.1016/j.jval.2014.03.465","title":"Cost & Resource Utilization of Cervical Cancer in British Columbia","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Cervical cancer; Resource (disambiguation); Business; Medicine; Operations management; Cancer; Computer science; Economics; Internal medicine; Computer network","score_opus":0.09299818825124438,"score_gpt":0.2945068443549896,"score_spread":0.2015086561037452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323065943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523161,0.0025788327,0.00011982197,0.004528874,0.000053952135,0.00004525798,0.026252406,0.000026787757,0.0140780555],"genre_scores_gemma":[0.9871076,0.0016212414,0.00010696306,0.00023332398,0.0000136734725,0.000021133987,0.0031357151,0.000010314666,0.0077500455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991861,0.00014306931,0.000090877365,0.000057276397,0.0002320752,0.00029062014],"domain_scores_gemma":[0.9971712,0.00046895165,0.0005777491,0.000067990004,0.0009736217,0.0007405771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044665055,0.00018308757,0.00032270898,0.0021159712,0.0009256724,0.0014854366,0.000982488,0.00054223975,0.0051430184],"category_scores_gemma":[0.0053493744,0.00027396186,0.00042836298,0.004967948,0.0004595301,0.00040323028,0.00085627957,0.0008760965,0.00034075064],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028531218,0.00011224817,0.9412576,0.0002663994,0.00021677048,0.00062088936,0.00045911188,0.0072313184,0.00021450201,0.00227981,0.017654732,0.02940132],"study_design_scores_gemma":[0.000027724023,0.000039282702,0.9811172,0.00018045347,0.00010127979,0.00028418654,0.0027419354,0.006531748,0.00015512729,0.00048297105,0.008304681,0.000033472887],"about_ca_topic_score_codex":0.98873657,"about_ca_topic_score_gemma":0.9936005,"teacher_disagreement_score":0.035660516,"about_ca_system_score_codex":0.035660516,"about_ca_system_score_gemma":0.02446741,"threshold_uncertainty_score":0.25873637},"labels":[],"label_agreement":null},{"id":"W2323335983","doi":"10.1016/j.jval.2014.03.1168","title":"A systematic review of methodological frameworks for evaluation of ethical considerations in health technology assessment","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Normative; Scope (computer science); Engineering ethics; Context (archaeology); Health technology; Management science; Identification (biology); Value (mathematics); Process (computing); Computer science; Political science; Health care; Engineering","score_opus":0.8187216557482284,"score_gpt":0.6365590466668659,"score_spread":0.1821626090813625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323335983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040429074,0.99222237,0.002660234,0.0017915937,0.00038112703,0.00174242,0.0003242895,0.000016343314,0.00045734746],"genre_scores_gemma":[0.015906671,0.9536706,0.019657407,0.0029796234,0.000345972,0.006870577,0.00033617188,0.000027866,0.00020512848],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8066053,0.10341226,0.061274722,0.004618719,0.02297664,0.0011122316],"domain_scores_gemma":[0.6276896,0.305812,0.03915152,0.006018273,0.019915542,0.0014130526],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14818151,0.0028128414,0.0122736795,0.020847354,0.0021044482,0.0077407006,0.004539483,0.00528295,0.005266075],"category_scores_gemma":[0.41856942,0.0019250554,0.013661885,0.017578144,0.0046356265,0.0067387726,0.0057537397,0.006071016,0.00040168737],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039094666,0.000034085824,0.0006832574,0.83660275,0.016839478,0.000076734956,0.00054400053,0.0002718825,0.00010789789,0.0039164787,0.0035197872,0.13701274],"study_design_scores_gemma":[0.0004339786,0.000107939,0.000983092,0.92256576,0.049127035,0.00014495665,0.00027107904,0.00017786445,0.00016372302,0.004228839,0.021740548,0.00005520882],"about_ca_topic_score_codex":0.010262837,"about_ca_topic_score_gemma":0.029192694,"teacher_disagreement_score":0.8518185,"about_ca_system_score_codex":0.013389706,"about_ca_system_score_gemma":0.044915173,"threshold_uncertainty_score":0.7836681},"labels":[],"label_agreement":null},{"id":"W2323376865","doi":"10.1016/j.jval.2014.03.584","title":"An Online Patient-Oriented Radiation Risk Assessment Tool to Project Cancer Risk Following Exposure to Low–Ionizing Radiation in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ionizing radiation; Medicine; Cancer; Nuclear medicine; Incidence (geometry); Risk assessment; Population; Lifetime risk; Radiation exposure; Absolute risk reduction; Attributable risk; Low Dose Radiation; Cancer incidence; Internal medicine; Irradiation; Environmental health","score_opus":0.01975626606883038,"score_gpt":0.32835380701600214,"score_spread":0.30859754094717173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323376865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8840047,0.0019390429,0.0058973017,0.008720466,0.00023074924,0.002831103,0.032149497,0.0017602331,0.062466912],"genre_scores_gemma":[0.9427236,0.002185301,0.026931237,0.0016109665,0.000059167098,0.0011204724,0.00800779,0.00015494249,0.017206624],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99881256,0.00024637335,0.00013572916,0.000089181776,0.0005199479,0.00019614257],"domain_scores_gemma":[0.9902024,0.0023712658,0.00070744834,0.0001747225,0.004684263,0.0018598856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016113289,0.00030590722,0.00038916976,0.0022265222,0.0017769734,0.0012830275,0.0011622261,0.00047188974,0.009186222],"category_scores_gemma":[0.010929537,0.00028280469,0.0005235326,0.0028998991,0.00025690795,0.000540935,0.0010152265,0.0007693791,0.0010164774],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005202835,0.0018654052,0.57419723,0.00049882807,0.0001324698,0.00049309083,0.002802303,0.0020961827,0.0005173442,0.0007707602,0.11700017,0.29910597],"study_design_scores_gemma":[0.00028590535,0.0004318508,0.8998507,0.00079153513,0.00022477467,0.00043800563,0.00499156,0.012567876,0.0011490362,0.00058394094,0.07851043,0.00017447335],"about_ca_topic_score_codex":0.9634219,"about_ca_topic_score_gemma":0.98262805,"teacher_disagreement_score":0.03657812,"about_ca_system_score_codex":0.022260668,"about_ca_system_score_gemma":0.052546646,"threshold_uncertainty_score":0.16151321},"labels":[],"label_agreement":null},{"id":"W2324160126","doi":"10.1016/j.jval.2014.08.209","title":"Impact of Demographics on Health Preferences in China: An Exploratory Analysis of China EQ-5D-5L Valuation Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Beijing; Demography; Demographics; Valuation (finance); China; Medicine; Descriptive statistics; Bivariate analysis; Logistic regression; Univariate; Time-trade-off; Multivariate statistics; Statistics; Geography; Mathematics; Quality of life (healthcare); Economics; Finance","score_opus":0.4585301583251546,"score_gpt":0.4515130220376479,"score_spread":0.0070171362875066645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324160126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992638,0.00007256782,0.00007317158,0.000070023256,0.0000018600141,0.000007045138,0.00019811495,0.000001315351,0.00031210363],"genre_scores_gemma":[0.99946254,0.000029558423,0.000027327114,0.00002045918,0.00000282164,0.000004677384,0.00030538286,0.0000010168477,0.00014617493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989685,0.00035835587,0.000068079426,0.00012610284,0.00017972429,0.00029923796],"domain_scores_gemma":[0.996496,0.0012051691,0.0008447131,0.00026752742,0.00048051443,0.0007060491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001994765,0.00041529044,0.0005900878,0.0021542974,0.00076624315,0.00088250753,0.0005945267,0.00037723818,0.0025813768],"category_scores_gemma":[0.0031585626,0.00021005285,0.0016315504,0.0030610468,0.00075245963,0.00086948345,0.0012178208,0.00073264574,0.00016365638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009680976,0.00010358158,0.99470866,0.000018291294,0.00024125162,0.00022064698,0.0005914739,0.0005598029,0.000119826254,0.0004211184,0.00030536292,0.0026132206],"study_design_scores_gemma":[0.0000064331552,0.00005257004,0.99689865,0.0000061537403,0.00006922305,0.00004709823,0.00090788637,0.0016683504,0.000034050317,0.0001152026,0.0001849758,0.000009360106],"about_ca_topic_score_codex":0.06265748,"about_ca_topic_score_gemma":0.060522433,"teacher_disagreement_score":0.06265748,"about_ca_system_score_codex":0.0016895618,"about_ca_system_score_gemma":0.0016987878,"threshold_uncertainty_score":0.12458551},"labels":[],"label_agreement":null},{"id":"W2324258277","doi":"10.1016/j.jval.2012.03.608","title":"PCV5 Intra-Arterial Thrombolysis Versus Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Thrombolysis; Randomized controlled trial; Stroke (engine); Meta-analysis; Relative risk; Internal medicine; MEDLINE; Clinical trial; Anesthesia; Confidence interval; Myocardial infarction","score_opus":0.09391463183452164,"score_gpt":0.36035342872256665,"score_spread":0.266438796888045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324258277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009238654,0.9886,0.00057261484,0.0001741173,0.0002780742,0.00032510696,0.0004994655,0.00003622169,0.00027573557],"genre_scores_gemma":[0.3104842,0.6826785,0.0029050766,0.001416171,0.0003691216,0.00084918615,0.0005946423,0.000046935234,0.00065613387],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947837,0.002298254,0.0015347403,0.0006206322,0.0005189328,0.00024372789],"domain_scores_gemma":[0.99301004,0.004486879,0.0016663084,0.00024286308,0.00043941525,0.00015453344],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0068682358,0.0029190206,0.018116152,0.0036556965,0.0005709896,0.0024188843,0.0019374203,0.0023156516,0.0049353573],"category_scores_gemma":[0.018221261,0.0017891608,0.032008994,0.0042480123,0.0007295756,0.0016888967,0.001603202,0.0024273356,0.0003633217],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056272782,0.000048323625,0.0021071346,0.2542248,0.7245083,0.00010476727,0.000087483255,0.00031293122,0.00023429064,0.00008981539,0.0005360732,0.012118855],"study_design_scores_gemma":[0.0020552312,0.00028040307,0.0016945759,0.008149497,0.9865611,0.00005247857,0.000034150606,0.00009316337,0.00006752167,0.0000973211,0.0008954762,0.00001899689],"about_ca_topic_score_codex":0.0075884005,"about_ca_topic_score_gemma":0.02253776,"teacher_disagreement_score":0.9818838,"about_ca_system_score_codex":0.0026561753,"about_ca_system_score_gemma":0.0026291783,"threshold_uncertainty_score":0.03632307},"labels":[],"label_agreement":null},{"id":"W2324348467","doi":"10.1016/j.jval.2012.03.188","title":"PHP112 Investment and Disinvestment of Health Technologies: The Need for Two Cost-Effectiveness Thresholds","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Disinvestment; Productivity; Health care; Investment (military); Set (abstract data type); Health technology; Economics; Underpinning; Public economics; Actuarial science; Business; Risk analysis (engineering); Microeconomics; Computer science; Engineering; Political science; Incentive; Economic growth","score_opus":0.5229541883152121,"score_gpt":0.46853289646427565,"score_spread":0.05442129185093647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324348467","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19939515,0.028670091,0.2733199,0.3102638,0.002269869,0.0012407628,0.0031356364,0.0005378221,0.18116695],"genre_scores_gemma":[0.9605884,0.0030920538,0.02064949,0.010469025,0.0010587184,0.00062396214,0.00035437066,0.00008523587,0.0030787832],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9766583,0.014064011,0.001562884,0.0016453811,0.0044295667,0.0016397975],"domain_scores_gemma":[0.7237388,0.25894538,0.006646145,0.004128756,0.0040777097,0.0024632658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04082784,0.0008767542,0.0026635095,0.0027697287,0.0007728224,0.010126047,0.0019353834,0.008176812,0.0090848785],"category_scores_gemma":[0.19602783,0.00089024927,0.0016176006,0.001867725,0.006314792,0.01790867,0.003950359,0.011275341,0.00044560924],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010463997,0.00021020135,0.008620643,0.000687587,0.00018662562,0.00019856305,0.00027494604,0.010172393,0.00033205995,0.886528,0.007134438,0.08460807],"study_design_scores_gemma":[0.00022341426,0.0002121907,0.009591547,0.00040349137,0.00014995533,0.00028472726,0.000280906,0.017152341,0.0006298586,0.96459675,0.0063983263,0.00007661475],"about_ca_topic_score_codex":0.0020520303,"about_ca_topic_score_gemma":0.0011425638,"teacher_disagreement_score":0.04082784,"about_ca_system_score_codex":0.004660336,"about_ca_system_score_gemma":0.004437804,"threshold_uncertainty_score":0.21592087},"labels":[],"label_agreement":null},{"id":"W2324485580","doi":"10.1016/j.jval.2014.03.1665","title":"Cost-Effectiveness Analysis Of Insured Eye Care Services By Optometrists In Prince Edwards Island (Pei): An Example Of Diabetic Retinopathy Management","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Imaging and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Diabetic retinopathy; Cohort; Cost effectiveness; Optometry; Health care; Incidence (geometry); Incremental cost-effectiveness ratio; Quality-adjusted life year; Emergency medicine; Diabetes mellitus; Internal medicine; Economics; Risk analysis (engineering)","score_opus":0.02888171654967731,"score_gpt":0.34837967969806394,"score_spread":0.31949796314838663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324485580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974668,0.00041994572,0.00022574888,0.00022707183,0.000011423448,0.00010528095,0.0004760245,0.0000072315797,0.0010604659],"genre_scores_gemma":[0.99859315,0.00021072038,0.00058203243,0.000057050955,0.000011173918,0.00004396653,0.00029766283,0.000001708211,0.00020246004],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974953,0.0018178353,0.00009569151,0.00013342194,0.00020399397,0.0002537081],"domain_scores_gemma":[0.99560565,0.0032410026,0.0003867038,0.00012334602,0.0002566311,0.00038671374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026354464,0.0005972366,0.00079256215,0.0013665727,0.00044332622,0.00096554606,0.0008580184,0.0010268904,0.002713341],"category_scores_gemma":[0.006767603,0.0002897064,0.0027828815,0.0017118067,0.00053331885,0.0006825142,0.00093538576,0.001252078,0.00009604295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0402885,0.011413648,0.73151505,0.0026796097,0.01335839,0.0026171173,0.0010529812,0.10511657,0.0027014208,0.005834377,0.004179825,0.079242475],"study_design_scores_gemma":[0.0047188876,0.029389158,0.81364346,0.00035817327,0.006980918,0.0012830208,0.005327913,0.13335165,0.001143934,0.0018526333,0.0017811214,0.0001691882],"about_ca_topic_score_codex":0.06862554,"about_ca_topic_score_gemma":0.07054518,"teacher_disagreement_score":0.93137443,"about_ca_system_score_codex":0.0041860705,"about_ca_system_score_gemma":0.0021937075,"threshold_uncertainty_score":0.1364522},"labels":[],"label_agreement":null},{"id":"W2324633634","doi":"10.1016/j.jval.2012.08.681","title":"PHP139 Which Criteria are Considered in Health Care Decisions? Insights from an International Survey of Policy and Clinical Decision Makers","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Snowball sampling; Health care; Stakeholder; Context (archaeology); Actuarial science; Population; Psychology; Medicine; Business; Environmental health; Public relations; Economics; Political science; Geography; Economic growth","score_opus":0.5770856334302498,"score_gpt":0.5438272755373071,"score_spread":0.033258357892942625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324633634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74642456,0.003702046,0.0034571243,0.16324419,0.00035234407,0.0006851783,0.0032892467,0.000049520797,0.07879586],"genre_scores_gemma":[0.98289365,0.0020637983,0.0019904352,0.009943002,0.00018988564,0.0004419268,0.0005929517,0.000026714208,0.0018576409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9782064,0.016539408,0.001176714,0.0005453837,0.0020107727,0.0015213628],"domain_scores_gemma":[0.8559598,0.12093207,0.009628439,0.0016550287,0.0057464107,0.0060782996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029941862,0.00020584582,0.00040015706,0.0017609306,0.0019905895,0.004937901,0.00081375265,0.0016330448,0.017203035],"category_scores_gemma":[0.08999391,0.00036223163,0.0003985982,0.0035213565,0.0027795448,0.004109687,0.003240898,0.002799188,0.0009917445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007426075,0.0013083578,0.39674994,0.0024487919,0.0001173882,0.0020026467,0.18384773,0.0009213061,0.0006496327,0.030371077,0.11843462,0.26240593],"study_design_scores_gemma":[0.00018498489,0.00078116456,0.3864463,0.0041297087,0.000047097084,0.0010015364,0.4128792,0.002819471,0.00053997897,0.03155922,0.15949197,0.000119339245],"about_ca_topic_score_codex":0.0060760733,"about_ca_topic_score_gemma":0.0045565376,"teacher_disagreement_score":0.029941862,"about_ca_system_score_codex":0.003466654,"about_ca_system_score_gemma":0.0075822375,"threshold_uncertainty_score":0.15834957},"labels":[],"label_agreement":null},{"id":"W2325065405","doi":"10.1016/j.jval.2014.03.1378","title":"Consideration For Rare Diseases In Drug Reimbursement Decision-Making","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Reimbursement; Scopus; Grey literature; Government (linguistics); Medical prescription; EconLit; MEDLINE; Medicine; Business; Orphan drug; Health care; Resource (disambiguation); Actuarial science; Family medicine; Public economics; Political science; Economic growth; Nursing; Economics; Computer science; Bioinformatics","score_opus":0.3119112693452439,"score_gpt":0.44578753927732473,"score_spread":0.13387626993208085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325065405","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12033342,0.055583064,0.15815419,0.5574708,0.0062393313,0.0006245585,0.0009017127,0.00016452116,0.100528404],"genre_scores_gemma":[0.93490666,0.006068157,0.029065294,0.019622635,0.007046103,0.0001662766,0.00017325637,0.000063560205,0.00288811],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9418879,0.044226065,0.003082562,0.0016703386,0.0077654365,0.0013676785],"domain_scores_gemma":[0.655495,0.3131384,0.010324776,0.003371963,0.012400979,0.0052688224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049361188,0.00082377257,0.0021303399,0.002762643,0.0020056206,0.009021141,0.0018165713,0.00897854,0.008196077],"category_scores_gemma":[0.27271593,0.00084290816,0.002257497,0.0020113795,0.00524905,0.0071482523,0.002586295,0.010242818,0.00043747682],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016979718,0.00045643802,0.040715545,0.0016924484,0.0013934327,0.004488705,0.001721711,0.07662627,0.00092859106,0.5192822,0.052525904,0.29847068],"study_design_scores_gemma":[0.00037203668,0.0006597203,0.019321369,0.0037391633,0.00087372644,0.0051123076,0.0016292988,0.08124816,0.0008031311,0.8046419,0.08133668,0.00026255878],"about_ca_topic_score_codex":0.0058100796,"about_ca_topic_score_gemma":0.012559933,"teacher_disagreement_score":0.049361188,"about_ca_system_score_codex":0.0056090923,"about_ca_system_score_gemma":0.009173167,"threshold_uncertainty_score":0.26105},"labels":[],"label_agreement":null},{"id":"W2325424462","doi":"10.1016/j.jval.2013.03.590","title":"Longitudinal changes in health-related quality of life for chronic diseases: An example from the hemophilia utilization group study part va (HUGS Va)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psychosocial; Observational study; Quality of life (healthcare); Population; Longitudinal study; Disease; Health related quality of life; Pediatrics; Gerontology; Physical therapy; Internal medicine; Psychiatry; Environmental health","score_opus":0.3067279196871002,"score_gpt":0.4150973137108014,"score_spread":0.10836939402370116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325424462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933036,0.00086377386,0.0002846235,0.00067306194,0.000030915617,0.000027757995,0.0036150536,0.0000070117235,0.001194319],"genre_scores_gemma":[0.99265313,0.0006096266,0.0005353963,0.00026153398,0.000041365412,0.000045443754,0.0052774157,0.0000073013725,0.0005687481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910456,0.000520223,0.000044097415,0.00009607505,0.00009920499,0.0001358143],"domain_scores_gemma":[0.99805945,0.00064317894,0.00029908886,0.00029043033,0.00039642115,0.00031132344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025607941,0.00026158858,0.0003975802,0.00090030854,0.0008785257,0.00083532144,0.00048225038,0.00080508913,0.0008822137],"category_scores_gemma":[0.0036595804,0.0001964593,0.0009880447,0.0020724642,0.00025542203,0.00059552933,0.0012044406,0.0012310522,0.0002123643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060743204,0.00022855046,0.9856899,0.000042333908,0.00027516097,0.00037477212,0.0012503233,0.00012082682,0.00025651982,0.00033193157,0.00332821,0.00749411],"study_design_scores_gemma":[0.000024246092,0.00012038218,0.9974241,0.000018129482,0.00007410458,0.00016010039,0.0009588716,0.00013520986,0.000045443005,0.00008685071,0.0009428432,0.000009771599],"about_ca_topic_score_codex":0.053006876,"about_ca_topic_score_gemma":0.07117804,"teacher_disagreement_score":0.053006876,"about_ca_system_score_codex":0.0006271202,"about_ca_system_score_gemma":0.0007353882,"threshold_uncertainty_score":0.10539669},"labels":[],"label_agreement":null},{"id":"W2325832068","doi":"10.1016/j.jval.2012.03.110","title":"PHP34 Eliciting Preferences for Reimbursed Drugs Selection Criteria in Cote d'Ivoire","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Formulary; Listing (finance); Transparency (behavior); Health care; Medicine; Population; Actuarial science; Family medicine; Business; Environmental health; Computer science; Economics; Finance; Economic growth","score_opus":0.18082155817440582,"score_gpt":0.37261353063410063,"score_spread":0.19179197245969482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325832068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98178124,0.00024043443,0.0077073593,0.0015942636,0.000027611104,0.0003351895,0.0007819021,0.000066106986,0.007465774],"genre_scores_gemma":[0.9859222,0.00008959782,0.010142883,0.00014802814,0.000010453007,0.00015446253,0.00033431477,0.00001820568,0.003179833],"study_design_codex":"simulation_or_modeling","study_design_gemma":"qualitative","domain_scores_codex":[0.99714965,0.0020248992,0.00008205622,0.00016966937,0.00019930983,0.00037448117],"domain_scores_gemma":[0.9854961,0.012672924,0.00026311338,0.00024367726,0.0006422975,0.00068185007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068472526,0.0005034236,0.0009481077,0.00069881283,0.00077850505,0.0018098052,0.00060066144,0.0015408751,0.00991977],"category_scores_gemma":[0.017908636,0.00047651978,0.0005709964,0.0008859514,0.00047704144,0.0006723756,0.00082011067,0.0014163211,0.0004769383],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01948171,0.006863462,0.11702757,0.0013764782,0.00063094235,0.0028920083,0.0022833063,0.4863657,0.017221281,0.03839031,0.038308155,0.26915908],"study_design_scores_gemma":[0.0024773376,0.0035445618,0.1648042,0.00025076288,0.0001721495,0.00034508022,0.0030079323,0.781078,0.006903442,0.020822324,0.016431326,0.00016292214],"about_ca_topic_score_codex":0.10593925,"about_ca_topic_score_gemma":0.09927302,"teacher_disagreement_score":0.10593925,"about_ca_system_score_codex":0.0047979485,"about_ca_system_score_gemma":0.0040907925,"threshold_uncertainty_score":0.2106452},"labels":[],"label_agreement":null},{"id":"W2327578339","doi":"10.1016/j.jval.2013.08.219","title":"Resource Use and Outcomes of Patients Treated with Vancomycin or Linezolid in a Tertiary Hospital in Shanghai","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Linezolid; Vancomycin; Medicine; Internal medicine; Antibiotics; Surgery; Staphylococcus aureus","score_opus":0.01858928770902873,"score_gpt":0.2706803258838304,"score_spread":0.25209103817480166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327578339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9996991,0.0000504193,0.000009383357,0.000039937782,0.000002172292,0.0000015460782,0.00010684459,0.0000012314778,0.00008934124],"genre_scores_gemma":[0.9997749,0.00003187318,0.000008336315,0.000018795208,0.0000026583625,0.000001748707,0.000118243464,4.5117338e-7,0.000042980173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956733,0.00007850378,0.00005452483,0.000048596965,0.000042466734,0.00020856602],"domain_scores_gemma":[0.9987998,0.000112995585,0.00041310632,0.00002719324,0.000121554076,0.0005252831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019716153,0.0003355503,0.0003627038,0.0009922468,0.0007222993,0.00090032315,0.00037577946,0.00041366692,0.0012367159],"category_scores_gemma":[0.00087070046,0.00032106627,0.0006225678,0.001542858,0.0005349763,0.00037866336,0.00074398605,0.0005631048,0.000097302654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067402994,0.00003457826,0.9988984,0.000008284233,0.000038803268,0.00021931197,0.00018122172,0.00007893454,0.00009436872,0.000017832699,0.00007117811,0.00028970887],"study_design_scores_gemma":[0.0000064743713,0.00009628325,0.99821776,0.0000050112767,0.000025373365,0.00011867961,0.0011693804,0.00026338536,0.000031121643,0.000014191639,0.000045543402,0.000006720785],"about_ca_topic_score_codex":0.1072732,"about_ca_topic_score_gemma":0.09921477,"teacher_disagreement_score":0.1072732,"about_ca_system_score_codex":0.0024354337,"about_ca_system_score_gemma":0.002017677,"threshold_uncertainty_score":0.2132976},"labels":[],"label_agreement":null},{"id":"W2327908421","doi":"10.1016/j.jval.2012.08.2186","title":"PCN146 Trends in Computed Tomography Use in Canada: Low-Dose Ionizing Radiation and the Potential Related Cancer Risk","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Effective dose (radiation); Nuclear medicine; Ionizing radiation; Population; Computed tomography; Collective dose; Cancer; Attributable risk; Radiation exposure; Per capita; Demography; Radiology; Environmental health; Internal medicine; Irradiation","score_opus":0.02078450507690863,"score_gpt":0.2692869405959078,"score_spread":0.24850243551899917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327908421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589637,0.003775385,0.00039618407,0.003988444,0.00005193923,0.000043155826,0.021401223,0.000047652436,0.011332423],"genre_scores_gemma":[0.9920657,0.0015429198,0.000272776,0.0003566931,0.0000276687,0.000008452435,0.0035058754,0.00001581549,0.0022041285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924904,0.000041460527,0.000058718277,0.00008108278,0.00034882186,0.00022088602],"domain_scores_gemma":[0.99666387,0.0002254865,0.0007704801,0.000076804296,0.0016571298,0.00060619914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003299573,0.00022534799,0.00029433012,0.0016890086,0.00096828124,0.0011523196,0.0010499851,0.0007293594,0.0040624673],"category_scores_gemma":[0.0032119332,0.00026698317,0.00070118374,0.005444318,0.0004951011,0.00043951478,0.0004702698,0.0012466605,0.00027535867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008502342,0.000023265291,0.9931331,0.000028546336,0.000044785098,0.000066843735,0.00008990675,0.0001807475,0.00016446658,0.00018632131,0.0015172872,0.004479758],"study_design_scores_gemma":[0.0000041218577,0.000014903324,0.9975803,0.000027821496,0.00003286208,0.000088057044,0.00027235248,0.00040748742,0.00010398488,0.000052986943,0.0014083424,0.0000067595593],"about_ca_topic_score_codex":0.98667836,"about_ca_topic_score_gemma":0.9897327,"teacher_disagreement_score":0.016558075,"about_ca_system_score_codex":0.016558075,"about_ca_system_score_gemma":0.024893789,"threshold_uncertainty_score":0.12013781},"labels":[],"label_agreement":null},{"id":"W2328765601","doi":"10.1016/j.jval.2014.08.1797","title":"Modelling Dependence Between Disability Status and Health Service Costs of People With Rheumatoid Arthritis in Hungary","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bivariate analysis; Index (typography); Goodness of fit; Medicine; Rheumatoid arthritis; Actuarial science; Quarter (Canadian coin); Statistics; Physical therapy; Demography; Econometrics; Gerontology; Mathematics; Economics; Computer science; Internal medicine; Geography","score_opus":0.03760505716649635,"score_gpt":0.3062275381893089,"score_spread":0.26862248102281255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328765601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997063,0.00018845777,0.0008647514,0.0002452193,0.0000118378775,0.000016899277,0.0010096257,0.000012597126,0.0005875007],"genre_scores_gemma":[0.9984906,0.000070922244,0.0003190346,0.000015490965,0.0000042999227,0.000016012635,0.000594643,0.0000061645255,0.00048284692],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988293,0.0004760178,0.000068117995,0.00015819944,0.000072521885,0.00039586826],"domain_scores_gemma":[0.992957,0.0057263738,0.00036533907,0.00016905638,0.00031879303,0.00046354657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016680238,0.0006337735,0.0011970607,0.00089339796,0.00043151592,0.0021241424,0.0018129806,0.001571716,0.0030794248],"category_scores_gemma":[0.008221734,0.0007206279,0.0017919886,0.0011520502,0.0007959233,0.000907455,0.0013242698,0.0016787347,0.00030671497],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012258912,0.00068929227,0.17831336,0.00013336517,0.0005458537,0.00080042315,0.00034721426,0.8052418,0.00033505564,0.004827984,0.001224655,0.0063150884],"study_design_scores_gemma":[0.0001777556,0.00027915428,0.14474046,0.000061016788,0.0002838574,0.0002319768,0.001066103,0.8493039,0.00022275464,0.0027729627,0.0007899281,0.00007012361],"about_ca_topic_score_codex":0.20922486,"about_ca_topic_score_gemma":0.076345585,"teacher_disagreement_score":0.20922486,"about_ca_system_score_codex":0.004699971,"about_ca_system_score_gemma":0.0019849034,"threshold_uncertainty_score":0.41601413},"labels":[],"label_agreement":null},{"id":"W2328991141","doi":"10.1016/j.jval.2012.03.343","title":"PMD3 Does Current Perception Threshold Test Can Differentiate Categories of Mechanical Neck Disorder?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Receiver operating characteristic; Logistic regression; Discriminative model; Analysis of variance; Covariate; Audiology; Medicine; Post-hoc analysis; Statistics; Internal medicine; Mathematics; Artificial intelligence","score_opus":0.026933148413723358,"score_gpt":0.317172241587408,"score_spread":0.2902390931736846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328991141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95104915,0.011252954,0.0024802652,0.008020169,0.00066610245,0.00007145282,0.0009820177,0.000066036504,0.025411863],"genre_scores_gemma":[0.9968046,0.00075891666,0.00045411318,0.0005411478,0.00023943858,0.00001535916,0.00022095087,0.000008925344,0.0009565244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993051,0.000117270174,0.00010457974,0.000100641664,0.00022793202,0.00014448185],"domain_scores_gemma":[0.9977024,0.0009704299,0.0003996072,0.00010370248,0.0006146017,0.00020914781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012881083,0.00043722417,0.00075709017,0.00106533,0.0002850474,0.0010792619,0.0008507817,0.0015090716,0.005662117],"category_scores_gemma":[0.008452706,0.00016351428,0.00071009964,0.0008300834,0.00061955367,0.0015835877,0.00042538025,0.00071940303,0.0014315349],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009829811,0.00015976658,0.92236227,0.00015560254,0.00011401911,0.0019832437,0.00013961921,0.00016914576,0.0043390566,0.0004742175,0.0030744346,0.06604566],"study_design_scores_gemma":[0.000059367885,0.00055846357,0.9729498,0.0002541083,0.00014815236,0.012015183,0.0006881665,0.003505036,0.002548575,0.0024260958,0.0048125843,0.000034440593],"about_ca_topic_score_codex":0.0029091353,"about_ca_topic_score_gemma":0.0026463268,"teacher_disagreement_score":0.005662117,"about_ca_system_score_codex":0.00050718436,"about_ca_system_score_gemma":0.00045538708,"threshold_uncertainty_score":0.01894164},"labels":[],"label_agreement":null},{"id":"W2329257750","doi":"10.1016/j.jval.2014.08.1843","title":"The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Public Health","funders":"","keywords":"Prostate cancer; Statistics; Cancer; Medicine; Demography; Internal medicine; Mathematics","score_opus":0.050381120872785526,"score_gpt":0.34380930711470165,"score_spread":0.29342818624191613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329257750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5741916,0.0075301984,0.13747825,0.12114418,0.0011618754,0.0011044196,0.022859033,0.0010988672,0.1334317],"genre_scores_gemma":[0.9400335,0.0018802279,0.0057874904,0.0025727171,0.00031944766,0.00039818833,0.0012224467,0.00008215678,0.047703814],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99613047,0.0025360053,0.00006192054,0.0003370257,0.00020287403,0.0007318186],"domain_scores_gemma":[0.99235207,0.0060723685,0.0006003266,0.00017671598,0.00024522,0.0005532625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004929525,0.0013413517,0.0030399803,0.0016381767,0.0008179585,0.0051230364,0.0028645003,0.004069301,0.031642355],"category_scores_gemma":[0.012322588,0.0011817473,0.0018977228,0.001666799,0.0017756511,0.0033376715,0.0021967492,0.004898251,0.0020206815],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027764884,0.0011712926,0.024446521,0.000513586,0.0016453791,0.00063548394,0.00038503672,0.5746795,0.0005334446,0.33955783,0.017734922,0.035920657],"study_design_scores_gemma":[0.002053062,0.0012080262,0.012613151,0.00024673846,0.0018386694,0.000478159,0.0006813473,0.6888857,0.000363275,0.2754422,0.016006675,0.00018297597],"about_ca_topic_score_codex":0.029210042,"about_ca_topic_score_gemma":0.02155114,"teacher_disagreement_score":0.031642355,"about_ca_system_score_codex":0.0042295023,"about_ca_system_score_gemma":0.0041170125,"threshold_uncertainty_score":0.10585421},"labels":[],"label_agreement":null},{"id":"W2329585923","doi":"10.1016/j.jval.2014.08.2320","title":"Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc): A Cost Utility Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Metastatic breast cancer; Neutropenia; Oncology; Chemotherapy; Febrile neutropenia; Breast cancer; Internal medicine; Cancer; Pharmacology","score_opus":0.050255009929361424,"score_gpt":0.44049519122943914,"score_spread":0.3902401813000777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329585923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94878083,0.029964356,0.0056695575,0.0022305928,0.000110905916,0.00057811645,0.0011453733,0.00003301934,0.011487103],"genre_scores_gemma":[0.9946885,0.0034978269,0.000931516,0.0001322392,0.00003119519,0.000058563273,0.00017263091,0.0000054373977,0.00048200527],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981591,0.0012116157,0.000066955465,0.000110884066,0.00024430337,0.00020706863],"domain_scores_gemma":[0.99856335,0.0009991709,0.0001982521,0.00002897895,0.00007526345,0.00013504503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021928917,0.00079049804,0.0011993736,0.0018728105,0.00024586477,0.0016327882,0.0008420656,0.000819317,0.003947926],"category_scores_gemma":[0.0050010504,0.00031730725,0.0026075232,0.001804054,0.00070494355,0.0010947839,0.0005582181,0.0010471042,0.00008906131],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059447005,0.0021086447,0.061021194,0.003356849,0.0057096696,0.002067732,0.00033778494,0.4377364,0.0036965364,0.032629143,0.004679228,0.38720977],"study_design_scores_gemma":[0.008319373,0.02620709,0.10514884,0.0013832444,0.026065819,0.0023452602,0.0024015314,0.77424353,0.0040821396,0.034094825,0.015404555,0.00030386657],"about_ca_topic_score_codex":0.012849828,"about_ca_topic_score_gemma":0.011306071,"teacher_disagreement_score":0.012849828,"about_ca_system_score_codex":0.005261027,"about_ca_system_score_gemma":0.0036856462,"threshold_uncertainty_score":0.03817165},"labels":[],"label_agreement":null},{"id":"W2329982161","doi":"10.1016/j.jval.2014.08.2301","title":"Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nilotinib; Value of information; Quality-adjusted life year; Dasatinib; Population; Time horizon; Actuarial science; Oncology; Cost effectiveness; Internal medicine; Myeloid leukemia; Imatinib; Environmental health; Economics; Risk analysis (engineering)","score_opus":0.06702508704875788,"score_gpt":0.4088890275643781,"score_spread":0.34186394051562025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329982161","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17757522,0.16477035,0.21625109,0.37261382,0.004507363,0.0078015686,0.013957558,0.0007312889,0.041791756],"genre_scores_gemma":[0.75809884,0.02277493,0.18980195,0.01770967,0.0037233771,0.0026049037,0.0043813214,0.00015552534,0.0007495099],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.63428754,0.30397937,0.029212456,0.0056578866,0.023824502,0.0030382173],"domain_scores_gemma":[0.13029774,0.7995605,0.02192411,0.013535254,0.029885462,0.004796978],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3235317,0.0019926243,0.00649008,0.026586408,0.0021812785,0.015073583,0.0050107646,0.004077809,0.0056752386],"category_scores_gemma":[0.62006587,0.0010571772,0.005527424,0.013493389,0.0014336994,0.0112910755,0.0072924043,0.006907396,0.0004656927],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006591571,0.00086257723,0.14428909,0.023260621,0.012363298,0.00075892074,0.0030882615,0.011058519,0.0010549144,0.039665107,0.030532813,0.7264742],"study_design_scores_gemma":[0.005799764,0.003949306,0.13283113,0.054232888,0.05422575,0.0015583569,0.009962196,0.08703908,0.005631006,0.528704,0.11501963,0.001047019],"about_ca_topic_score_codex":0.0078515895,"about_ca_topic_score_gemma":0.012253383,"teacher_disagreement_score":0.6764683,"about_ca_system_score_codex":0.0074094217,"about_ca_system_score_gemma":0.026848163,"threshold_uncertainty_score":0.83420587},"labels":[],"label_agreement":null},{"id":"W2330316144","doi":"10.1016/j.jval.2012.03.510","title":"PMH65 Comparison of Deviation Rates from the Labeled Daily Average Consumption in Patients Initiated on Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Stimulant; Medicine; Methylphenidate; Cohort; Logistic regression; Attention deficit hyperactivity disorder; Pediatrics; Dextroamphetamine; Internal medicine; Psychiatry; Amphetamine","score_opus":0.13731344501412718,"score_gpt":0.4012100227276671,"score_spread":0.2638965777135399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330316144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99685174,0.00023715165,0.00010539218,0.000026104162,0.00001677541,0.000009922575,0.0013802828,0.000012269151,0.001360468],"genre_scores_gemma":[0.9982356,0.000074687836,0.00006285761,0.000015844706,0.000012545077,0.000009719272,0.0012555623,0.000004226115,0.00032906176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904543,0.00032336052,0.0001368333,0.00017080577,0.00020101994,0.0001225081],"domain_scores_gemma":[0.9959039,0.0019403121,0.0012141208,0.00021546197,0.00041910162,0.00030712408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093696197,0.00024744112,0.00047823868,0.0011627659,0.00018883347,0.00058923406,0.0003190308,0.0005216815,0.0026193187],"category_scores_gemma":[0.005229462,0.00022003477,0.0007031719,0.0010506226,0.00017898138,0.0005082677,0.00040502416,0.00052683376,0.00037856336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010637752,0.00013396074,0.97749513,0.00005799065,0.00036751287,0.00009967115,0.00018385837,0.00025871475,0.0007935931,0.00012209089,0.00053433224,0.009315321],"study_design_scores_gemma":[0.000044268065,0.000755062,0.9978485,0.0000071622803,0.000055225897,0.00013851453,0.00016286,0.00050258776,0.00021418632,0.000036422978,0.00022714463,0.000008008563],"about_ca_topic_score_codex":0.0041544326,"about_ca_topic_score_gemma":0.0027868196,"teacher_disagreement_score":0.0041544326,"about_ca_system_score_codex":0.0003281582,"about_ca_system_score_gemma":0.00024249814,"threshold_uncertainty_score":0.008762538},"labels":[],"label_agreement":null},{"id":"W2331163759","doi":"10.1016/j.jval.2012.08.385","title":"PIN16 Cost-Effectiveness of Rotavirus Immunization in Indonesia Taking Breastfeeding Patterns Into Account","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breastfeeding; Medicine; Rotavirus vaccine; Per capita; Immunization; Rotavirus; Environmental health; Population; Vaccination; Cohort; Demography; Pediatrics; Diarrhea; Immunology","score_opus":0.08780985788658595,"score_gpt":0.3975333606647045,"score_spread":0.30972350277811855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331163759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552006,0.0028043902,0.0011496677,0.0011388861,0.000091024944,0.00009302708,0.0019718907,0.000031310483,0.0071997046],"genre_scores_gemma":[0.99684465,0.00058076176,0.0007978179,0.00005613762,0.000017850718,0.000049005957,0.0005523333,0.000009332173,0.0010920577],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99840814,0.0009412477,0.00017253113,0.00009704738,0.00020971172,0.0001713412],"domain_scores_gemma":[0.9984048,0.00084433105,0.00035668115,0.00008347363,0.00017486438,0.00013586397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017512635,0.00043959502,0.000668659,0.0005927599,0.00015786363,0.0010337096,0.00048579858,0.00038614825,0.0035132759],"category_scores_gemma":[0.007230559,0.0003255103,0.0019083585,0.000986314,0.00015258374,0.0008050788,0.00067009794,0.000793908,0.0002337555],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012382306,0.0012349751,0.70718586,0.0012122834,0.0029027327,0.0010167331,0.00017436637,0.062649325,0.0011471146,0.0016214548,0.0023402676,0.20613265],"study_design_scores_gemma":[0.0005666418,0.0034187692,0.85771036,0.0004161447,0.0042521106,0.0012652059,0.000695182,0.12407791,0.0028263303,0.0016832257,0.0030194467,0.00006865124],"about_ca_topic_score_codex":0.019724585,"about_ca_topic_score_gemma":0.014018943,"teacher_disagreement_score":0.019724585,"about_ca_system_score_codex":0.002394839,"about_ca_system_score_gemma":0.0018285904,"threshold_uncertainty_score":0.03921956},"labels":[],"label_agreement":null},{"id":"W2331485444","doi":"10.1016/j.jval.2012.08.1226","title":"PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Progression-free survival; Oncology; Breast cancer; Linear regression; Population; Cancer; Overall survival; Statistics; Mathematics","score_opus":0.0920146967092638,"score_gpt":0.43226656311668654,"score_spread":0.3402518664074228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331485444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861558,0.007077737,0.0014843468,0.00054460816,0.00003152724,0.000028225015,0.0007058556,0.000022835004,0.003949062],"genre_scores_gemma":[0.99824667,0.00061497395,0.00043466722,0.000039100134,0.0000106965,0.00001659491,0.00028323827,0.00000390485,0.00035009632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992275,0.00050404586,0.00002891083,0.000035855766,0.00013207826,0.00007150921],"domain_scores_gemma":[0.9984043,0.00066948583,0.00055446936,0.0000728091,0.00013341777,0.00016546236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014001649,0.00021862611,0.0003179695,0.00053565315,0.00014318585,0.0005585366,0.0002384903,0.00028614092,0.0010781157],"category_scores_gemma":[0.0037851213,0.00010109599,0.00027242512,0.0007221682,0.00027290607,0.00030722478,0.0004668425,0.000908926,0.0001957848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017389357,0.000337823,0.7870586,0.00034543773,0.00034978957,0.00054392504,0.00046286857,0.006629248,0.007783182,0.0037989765,0.0046739727,0.1706269],"study_design_scores_gemma":[0.00013772937,0.0037939928,0.96177024,0.00013772922,0.0002296581,0.0017964024,0.00030600105,0.015799556,0.0042277346,0.0036286146,0.008137114,0.00003522334],"about_ca_topic_score_codex":0.0025024607,"about_ca_topic_score_gemma":0.003541482,"teacher_disagreement_score":0.0025024607,"about_ca_system_score_codex":0.001074792,"about_ca_system_score_gemma":0.0005722367,"threshold_uncertainty_score":0.007798195},"labels":[],"label_agreement":null},{"id":"W2331544916","doi":"10.1016/j.jval.2012.03.197","title":"PMS8 Estimating Incidence and Prevalence of Osteoarthritis (OA) in Alberta Using Administrative Claims Data","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Saskatchewan; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Incidence (geometry); Population; Ambulatory; Diagnosis code; Health care; Demography; Epidemiology; Ambulatory care; Gerontology; Environmental health; Internal medicine","score_opus":0.2007830577198568,"score_gpt":0.43048428077143547,"score_spread":0.22970122305157867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331544916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841541,0.0003324654,0.0027520233,0.00031626225,0.000013403607,0.000079808284,0.008266205,0.00012153885,0.003964104],"genre_scores_gemma":[0.98368627,0.00018830829,0.006380094,0.000052883956,0.000011857221,0.000044172255,0.0076013515,0.00001091725,0.0020240706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905235,0.00023114037,0.00006624443,0.00011923007,0.00037047145,0.0001605904],"domain_scores_gemma":[0.99713767,0.00096553663,0.00042669906,0.00014052373,0.0011515074,0.00017807355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019606648,0.00048446632,0.00035129543,0.0035180151,0.00057270186,0.000953952,0.0013016731,0.00048663164,0.0015947593],"category_scores_gemma":[0.009579307,0.00041585517,0.0006700235,0.0030358515,0.00029839142,0.00031608954,0.0007796532,0.00045367156,0.0002263517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051720237,0.00012290574,0.93413,0.00006768643,0.00027301552,0.00016503324,0.00014929543,0.033696935,0.0003039429,0.0009332394,0.0034996446,0.026141068],"study_design_scores_gemma":[0.0001458603,0.00009389137,0.86670786,0.000051390904,0.00015531693,0.000110364985,0.0004821204,0.12841955,0.00038027222,0.00083358533,0.0025964708,0.000023365685],"about_ca_topic_score_codex":0.9607336,"about_ca_topic_score_gemma":0.95514905,"teacher_disagreement_score":0.039266407,"about_ca_system_score_codex":0.0078100488,"about_ca_system_score_gemma":0.010318229,"threshold_uncertainty_score":0.07899523},"labels":[],"label_agreement":null},{"id":"W2332053036","doi":"10.1016/j.jval.2014.03.692","title":"Real-World Health Care Resource Utilisation Among Patients With Chronic Heart Failure: A Canadian Assessment","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Ottawa; Lawson Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Medical record; Cohort; Internal medicine; Retrospective cohort study; Population; Emergency medicine; Cohort study; Cardiology","score_opus":0.016190246174759025,"score_gpt":0.2869236777620532,"score_spread":0.2707334315872942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332053036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679107,0.0032795167,0.0002838511,0.0035839651,0.000043424123,0.00021585051,0.017660158,0.000018280869,0.0070042294],"genre_scores_gemma":[0.9881253,0.0032760287,0.00079152116,0.00057912845,0.000026073247,0.00011426195,0.006373248,0.000011978529,0.0007023706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969303,0.0002678084,0.00029054724,0.0002454232,0.0015576121,0.00070838735],"domain_scores_gemma":[0.9908901,0.0007024716,0.0013967872,0.00016612808,0.0050715203,0.0017730345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027332574,0.00070076156,0.00091299426,0.003960231,0.0048707607,0.002991843,0.0024525824,0.0013669599,0.0021704372],"category_scores_gemma":[0.007866939,0.0006369426,0.002137007,0.014525617,0.0011317494,0.0016974419,0.0022867632,0.0023133096,0.00021567616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030244852,0.00030130098,0.97447926,0.000376262,0.00038190876,0.00027933263,0.0029496949,0.0005889521,0.00010361539,0.0006780892,0.0070036678,0.012555352],"study_design_scores_gemma":[0.00005378539,0.00007242317,0.9926075,0.00017231508,0.00013035288,0.000113914066,0.003488326,0.000955527,0.000033957946,0.00006108975,0.0022409018,0.00006998266],"about_ca_topic_score_codex":0.99632144,"about_ca_topic_score_gemma":0.9975497,"teacher_disagreement_score":0.085358344,"about_ca_system_score_codex":0.085358344,"about_ca_system_score_gemma":0.08097697,"threshold_uncertainty_score":0.619321},"labels":[],"label_agreement":null},{"id":"W2332192593","doi":"10.1016/j.jval.2015.09.1761","title":"Quantitative Assessment of Canadian Provincial Public Funding Decisions for Oncology Drugs Following Pcodr Economic Evaluations for 2013 and 2014","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Negotiation; Medicine; Family medicine; Business; Internal medicine; Finance; Political science; Economic growth; Economics; Health care","score_opus":0.6885981843053318,"score_gpt":0.5449113063524272,"score_spread":0.14368687795290458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332192593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7226259,0.004563859,0.0029118748,0.019839825,0.0002724438,0.0011189114,0.1726611,0.000193433,0.07581262],"genre_scores_gemma":[0.96210945,0.00078634225,0.002339451,0.00083845184,0.000057062265,0.00035307734,0.024738668,0.00003486337,0.008742628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97468805,0.0039245007,0.0015059529,0.00090974313,0.015129981,0.0038417622],"domain_scores_gemma":[0.8838587,0.028537927,0.013729535,0.002028821,0.06736577,0.0044793137],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.016879529,0.0004612566,0.00073313154,0.007101349,0.0020504126,0.004448441,0.001860049,0.00096627267,0.0042503267],"category_scores_gemma":[0.11521944,0.00043433707,0.0016368197,0.014529917,0.0011757247,0.0013277408,0.001823263,0.0019533045,0.00030252256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003304979,0.00031493788,0.65121096,0.0013541804,0.0016690581,0.00017475485,0.0027192396,0.0410303,0.0004114484,0.034448996,0.16020635,0.10315488],"study_design_scores_gemma":[0.00019843978,0.0001795781,0.913956,0.00032740427,0.00029864747,0.000046672463,0.0026559457,0.019917913,0.0005658082,0.0019700173,0.059725575,0.0001580313],"about_ca_topic_score_codex":0.9927409,"about_ca_topic_score_gemma":0.9948513,"teacher_disagreement_score":0.98312044,"about_ca_system_score_codex":0.13552396,"about_ca_system_score_gemma":0.1561977,"threshold_uncertainty_score":0.98329973},"labels":[],"label_agreement":null},{"id":"W2332235717","doi":"10.1016/j.jval.2012.03.1058","title":"PIH26 Public Funding for Infertility Treatments in Canada: Eligibility and Demand for IVF in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Technologies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Infertility; Medicine; Fertility; Demography; Population; Family medicine; Gynecology; Obstetrics; Environmental health; Pregnancy","score_opus":0.13707630352228503,"score_gpt":0.36615109839489896,"score_spread":0.22907479487261392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332235717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8245188,0.0071338993,0.00034225022,0.046408698,0.00026203372,0.00028363313,0.063459605,0.0001281209,0.057462968],"genre_scores_gemma":[0.9578068,0.0033891357,0.00062136346,0.0042774105,0.00008902225,0.000085718966,0.0069316914,0.000052099433,0.026746638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968335,0.00015751037,0.00015701125,0.00017325612,0.001147328,0.0015314996],"domain_scores_gemma":[0.980609,0.0013561373,0.0024158382,0.0002045642,0.0074898945,0.007924663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010903572,0.0002620334,0.0005893781,0.002830265,0.0051157917,0.0038788144,0.0020093636,0.0014521941,0.01783506],"category_scores_gemma":[0.007399256,0.0006147203,0.0011251641,0.0070108334,0.0011034879,0.0006221273,0.0013910625,0.0019434387,0.00067041663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004833296,0.00020971477,0.8452672,0.0004263295,0.00017985921,0.00068990164,0.0022552419,0.0010139978,0.0004094,0.009900492,0.09259238,0.04657221],"study_design_scores_gemma":[0.00011416194,0.000041404837,0.95839894,0.00039017346,0.000084381965,0.00019285775,0.0041023586,0.0012922402,0.00020512869,0.00042739403,0.03470021,0.00005075766],"about_ca_topic_score_codex":0.99886984,"about_ca_topic_score_gemma":0.9995498,"teacher_disagreement_score":0.114446774,"about_ca_system_score_codex":0.114446774,"about_ca_system_score_gemma":0.24345678,"threshold_uncertainty_score":0.83037335},"labels":[],"label_agreement":null},{"id":"W2332982938","doi":"10.1016/j.jval.2014.08.1899","title":"The Influence Of Gene Expression Profiling (GEP) On Decisional Conflict In Chemotherapy Treatment Decision-Making For Early-Stage Breast Cancer (BRCA)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; McMaster University; University of Calgary","funders":"","keywords":"Chemotherapy; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Adjuvant chemotherapy; CLARITY; Breast cancer; Adjuvant; Cancer","score_opus":0.1646164422493876,"score_gpt":0.45516687113779847,"score_spread":0.29055042888841087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332982938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945537,0.00035927832,0.0007944217,0.001782939,0.000043029744,0.000015023475,0.00011953801,0.000008104518,0.0023239155],"genre_scores_gemma":[0.9991603,0.000058120415,0.00046597054,0.00018553057,0.000016031829,0.0000064715164,0.000031650914,0.0000043283317,0.000071611816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946127,0.0039353706,0.0001942749,0.00030833337,0.000505129,0.0004442025],"domain_scores_gemma":[0.9368153,0.05687688,0.0035081839,0.0006850396,0.0010450345,0.0010694169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006829383,0.00017491035,0.00032452433,0.00053544994,0.0007040489,0.002305747,0.00042093702,0.0008048487,0.0018781582],"category_scores_gemma":[0.060582194,0.00017756507,0.00038544065,0.00061831373,0.00087713933,0.0008778128,0.00081380893,0.0016493418,0.00019393429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010007989,0.0013212505,0.8556594,0.00019896116,0.0006166969,0.0006306345,0.002387337,0.011118498,0.0056155818,0.002329678,0.001616905,0.10849695],"study_design_scores_gemma":[0.00011101686,0.0010714203,0.945066,0.00012691163,0.00034436496,0.0004717054,0.0029044978,0.03509268,0.004025119,0.008993203,0.001731159,0.000061892104],"about_ca_topic_score_codex":0.003233491,"about_ca_topic_score_gemma":0.0036237317,"teacher_disagreement_score":0.006829383,"about_ca_system_score_codex":0.0010745488,"about_ca_system_score_gemma":0.0013526215,"threshold_uncertainty_score":0.036117673},"labels":[],"label_agreement":null},{"id":"W2333056877","doi":"10.1016/j.jval.2012.03.099","title":"PHP22 Exploration of Claims-Based Utilization Measures for Detecting Non-Medical Use of Prescription Drugs","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medical prescription; Ranking (information retrieval); Medicine; Population; Prescription drug; Oxycodone; Drug; Substance abuse; Cohort; Lorenz curve; Measure (data warehouse); Statistics; Computer science; Mathematics; Data mining; Pharmacology; Opioid; Artificial intelligence; Internal medicine; Psychiatry; Environmental health","score_opus":0.5374060750734523,"score_gpt":0.479697506306406,"score_spread":0.057708568767046275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333056877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94354737,0.0010280209,0.011207039,0.0014377083,0.00005433922,0.0002525983,0.03298745,0.00028092443,0.0092045665],"genre_scores_gemma":[0.988089,0.00015998821,0.005338436,0.00012541677,0.0000432971,0.00014506646,0.005246732,0.00002008868,0.00083198596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994207,0.00320519,0.000438522,0.00045005593,0.0014496455,0.00024963816],"domain_scores_gemma":[0.9719105,0.020678224,0.003320489,0.0010477458,0.0025183253,0.00052471197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007996652,0.0005442462,0.0005971592,0.002595833,0.00030561368,0.0017335578,0.0008314965,0.000527873,0.0039710756],"category_scores_gemma":[0.03527366,0.00020609444,0.0015553278,0.002808514,0.0001934912,0.0006392554,0.00091232674,0.0006094731,0.0004987467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094851723,0.00025614313,0.9442556,0.0002892697,0.0008996843,0.00010772736,0.00016030815,0.0016975045,0.0007021124,0.001181717,0.0031872545,0.046314105],"study_design_scores_gemma":[0.00008025013,0.0007550181,0.97101015,0.00009215546,0.0004017377,0.0002960669,0.00032284408,0.020906651,0.0016310514,0.0012478066,0.0032325555,0.000023730627],"about_ca_topic_score_codex":0.009669495,"about_ca_topic_score_gemma":0.007135803,"teacher_disagreement_score":0.009669495,"about_ca_system_score_codex":0.00057903497,"about_ca_system_score_gemma":0.001569682,"threshold_uncertainty_score":0.042290807},"labels":[],"label_agreement":null},{"id":"W2333359243","doi":"10.1016/j.jval.2013.03.394","title":"The use of antimicrobial impregnated catheter to prevent shunt-related cerebrospinal fluid infection in canadian hospitals: An economic analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Shunt (medical); Medicine; Catheter; Activity-based costing; Emergency medicine; Cerebrospinal fluid; Infection control; Surgery; Intensive care medicine; Internal medicine; Business","score_opus":0.029888220701862738,"score_gpt":0.276486431122755,"score_spread":0.24659821042089228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333359243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94819456,0.0182576,0.00091798574,0.008113261,0.0001383784,0.0007485339,0.010607336,0.00002352283,0.012998864],"genre_scores_gemma":[0.9918898,0.0045340694,0.0005557643,0.0005169887,0.000037777896,0.00006380747,0.0016002129,0.000005084631,0.00079656416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918948,0.001713662,0.00045972073,0.0003086631,0.002674022,0.0029490879],"domain_scores_gemma":[0.9873104,0.0040682526,0.0023883067,0.00017649688,0.0034671172,0.0025894286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050370526,0.0011510426,0.0014155005,0.0052681486,0.0030937674,0.0044333213,0.0028287154,0.0022966843,0.00401719],"category_scores_gemma":[0.024647051,0.0009579713,0.004332331,0.008908609,0.001567561,0.0011375031,0.0016331488,0.0027230629,0.00009205883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010655598,0.002012507,0.8060465,0.0031348362,0.00831495,0.0014271662,0.0011429704,0.061707813,0.0006579477,0.023241088,0.01556659,0.06609202],"study_design_scores_gemma":[0.0012199453,0.0018325689,0.88146216,0.0015388511,0.0069964486,0.000722314,0.0050652656,0.087503195,0.0004276201,0.0027361605,0.010120431,0.00037504724],"about_ca_topic_score_codex":0.98325807,"about_ca_topic_score_gemma":0.98507035,"teacher_disagreement_score":0.17455092,"about_ca_system_score_codex":0.17455092,"about_ca_system_score_gemma":0.09536643,"threshold_uncertainty_score":0.95740396},"labels":[],"label_agreement":null},{"id":"W2333435420","doi":"10.1016/j.jval.2013.03.287","title":"The effects of excluding treatments from network meta-analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Meta-analysis; Statistics; Mathematics; Node (physics); Medicine; Internal medicine; Physics","score_opus":0.31138420815061735,"score_gpt":0.47575655145856827,"score_spread":0.16437234330795092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333435420","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08991411,0.6881984,0.14174394,0.013712931,0.033683173,0.0054941517,0.012581943,0.001841945,0.012829457],"genre_scores_gemma":[0.8898093,0.0297687,0.051952153,0.010366735,0.0041090697,0.0058844998,0.0029880635,0.0011115711,0.0040097777],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.5811143,0.35169938,0.031029593,0.02460095,0.008526033,0.003029718],"domain_scores_gemma":[0.46988288,0.47945014,0.012427782,0.03029208,0.005494116,0.0024529693],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21654007,0.008639206,0.023179956,0.00713786,0.0031550871,0.0069441805,0.006541567,0.010515875,0.013032875],"category_scores_gemma":[0.45339966,0.0047426648,0.10066217,0.0076490585,0.0045341016,0.011266164,0.006267404,0.017258363,0.0011049901],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02419507,0.00007779362,0.0059532127,0.018852701,0.930081,0.00032504197,0.0002597997,0.0018391599,0.0003847952,0.0015384434,0.0030611856,0.013431845],"study_design_scores_gemma":[0.010097719,0.00091581984,0.005552154,0.0023138311,0.96642596,0.00022942816,0.00011691533,0.0022560437,0.0004129018,0.0078223655,0.0037479687,0.00010894081],"about_ca_topic_score_codex":0.011737109,"about_ca_topic_score_gemma":0.017658131,"teacher_disagreement_score":0.7834599,"about_ca_system_score_codex":0.0027960835,"about_ca_system_score_gemma":0.003763677,"threshold_uncertainty_score":0.9661456},"labels":[],"label_agreement":null},{"id":"W2333600240","doi":"10.1016/j.jval.2014.08.079","title":"HBA1C Control Predictive Validity of Four Self-Reported Measures of Antidiabetes Medication Adherence","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Glycemic; Receiver operating characteristic; Predictive validity; Likert scale; Medication adherence; Scale (ratio); Physical therapy; Clinical psychology; Internal medicine; Psychology; Insulin","score_opus":0.14447326265526966,"score_gpt":0.33967501669715966,"score_spread":0.19520175404189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333600240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981528,0.00023959785,0.00018195687,0.000055327833,0.00003052572,0.00002662206,0.00021076149,0.000009421392,0.0010929137],"genre_scores_gemma":[0.99897456,0.000092568705,0.000345344,0.000029453602,0.000016374353,0.000024804287,0.0002610638,0.0000033090207,0.00025263723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973628,0.0010960641,0.00029823976,0.00030028488,0.00075803924,0.0001846082],"domain_scores_gemma":[0.9775,0.0149823,0.0037794386,0.00093859807,0.0018889616,0.00091072434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004086024,0.0006434231,0.00068175106,0.001588855,0.00045976826,0.0012133868,0.0006477022,0.000896662,0.0011513354],"category_scores_gemma":[0.01869474,0.000422289,0.0011966508,0.0011131607,0.0005292993,0.0006809861,0.0007147374,0.0011410618,0.00019018524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037114354,0.00028814594,0.9948073,0.000013661004,0.00026877498,0.000014146079,0.0001423785,0.00020577488,0.0001263589,0.000042183765,0.0000754473,0.0036446757],"study_design_scores_gemma":[0.000055634584,0.0003701956,0.99643,0.00001571483,0.00015748761,0.00004734303,0.0001505197,0.0022545466,0.0002747235,0.00009002371,0.00014327913,0.000010605477],"about_ca_topic_score_codex":0.0073464247,"about_ca_topic_score_gemma":0.008855077,"teacher_disagreement_score":0.0073464247,"about_ca_system_score_codex":0.00066186616,"about_ca_system_score_gemma":0.0005227375,"threshold_uncertainty_score":0.021609187},"labels":[],"label_agreement":null},{"id":"W2333786748","doi":"10.1016/j.jval.2013.03.1315","title":"Does Continuity Of Care Matter?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"CINAHL; Medicine; Psychological intervention; Emergency department; Continuity of care; MEDLINE; Cochrane Library; Health care; Observational study; Cohort study; Family medicine; Emergency medicine; Meta-analysis; Nursing; Internal medicine","score_opus":0.046253440534179194,"score_gpt":0.2772095580237803,"score_spread":0.2309561174896011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333786748","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28017193,0.057048164,0.013976615,0.5967866,0.003900865,0.0001620295,0.002249648,0.000081783386,0.045622353],"genre_scores_gemma":[0.9852775,0.003175595,0.001247674,0.007916405,0.0013909944,0.000030362527,0.00018816696,0.00002467884,0.00074866676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9787431,0.013410479,0.0013379507,0.0012995037,0.0024888073,0.002720306],"domain_scores_gemma":[0.763126,0.1780755,0.030909311,0.0060754376,0.0076812967,0.014132493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02852719,0.00029255584,0.0017464884,0.0015438183,0.0013283202,0.007306201,0.0021450284,0.005281444,0.015087508],"category_scores_gemma":[0.21590072,0.0004876665,0.0014702681,0.0032663252,0.004486314,0.012879646,0.0016519616,0.005540698,0.0004284667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038743287,0.0010041393,0.37659952,0.0015257072,0.0025549326,0.0005911621,0.002006568,0.0066801426,0.00015903208,0.3294648,0.03946275,0.23607698],"study_design_scores_gemma":[0.0013542334,0.0010986928,0.26561472,0.004657507,0.0019708858,0.001625639,0.0075862855,0.012776079,0.00054642477,0.6569865,0.045608316,0.00017480798],"about_ca_topic_score_codex":0.007783018,"about_ca_topic_score_gemma":0.0068569686,"teacher_disagreement_score":0.02852719,"about_ca_system_score_codex":0.0063833864,"about_ca_system_score_gemma":0.0088309245,"threshold_uncertainty_score":0.150868},"labels":[],"label_agreement":null},{"id":"W2333950381","doi":"10.1016/j.jval.2014.08.734","title":"Examining The Role Of Insulin Pen Devices In Acute Care Settings: A Review And Analysis of Health Resource Utilization","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Insulin pen; Syringe; Acute care; Context (archaeology); Insulin; Diabetes management; Health care; Glycemic; Diabetes mellitus; Vial; Medical emergency; Emergency medicine; Nursing; Type 2 diabetes; Internal medicine","score_opus":0.1237205158643456,"score_gpt":0.42116565305898085,"score_spread":0.2974451371946353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333950381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030806928,0.9993167,0.000032934513,0.00013600518,0.000025761603,0.0000059765907,0.000050029503,9.796935e-7,0.00012362705],"genre_scores_gemma":[0.0023591358,0.9972168,0.00017886571,0.0001435636,0.000035140056,0.000008732816,0.00003740918,8.8056515e-7,0.000019441395],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9967654,0.00087665155,0.0010846194,0.0003478256,0.0007912141,0.00013426147],"domain_scores_gemma":[0.9819449,0.014226382,0.002595914,0.00015365188,0.00090370927,0.00017542174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005152229,0.0009617369,0.0036173365,0.0076527838,0.00034039174,0.0026174407,0.0014607273,0.0013612878,0.0028845211],"category_scores_gemma":[0.01788387,0.0005743965,0.0042582895,0.01227417,0.00069506187,0.002243109,0.0013540135,0.0015619722,0.00024221437],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036988736,0.00009226035,0.005927848,0.29758587,0.0047549475,0.00013987554,0.0002577656,0.0004583024,0.00021673398,0.0014399487,0.0058223954,0.68293417],"study_design_scores_gemma":[0.00029452908,0.00061375706,0.043943673,0.6218753,0.0353471,0.0021609853,0.0016772273,0.00061987236,0.0007517291,0.003238994,0.28926325,0.00021359016],"about_ca_topic_score_codex":0.005987483,"about_ca_topic_score_gemma":0.013941419,"teacher_disagreement_score":0.0076527838,"about_ca_system_score_codex":0.0019261607,"about_ca_system_score_gemma":0.0054799323,"threshold_uncertainty_score":0.027247906},"labels":[],"label_agreement":null},{"id":"W2333999389","doi":"10.1016/j.jval.2014.08.210","title":"Valuing Health in the Uae: An Investigation of the Feasibility and Cultural Appropriateness of Using the TTO and DCE Methods to Generate Health State Values","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Debriefing; Valuation (finance); Face validity; Public health; Psychology; Protocol (science); Actuarial science; Time-trade-off; Social psychology; EQ-5D; Medicine; Applied psychology; Nursing; Quality of life (healthcare); Clinical psychology; Psychometrics; Alternative medicine; Economics; Accounting","score_opus":0.6242107965641388,"score_gpt":0.5110562733151321,"score_spread":0.11315452324900666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333999389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98686486,0.00010729143,0.005245004,0.000424059,0.000029923745,0.00021153074,0.00009895703,0.00000694816,0.0070114224],"genre_scores_gemma":[0.9876316,0.00012743668,0.011356565,0.0001262665,0.0000085733245,0.00031250037,0.00006993444,0.000008517208,0.0003586641],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9760374,0.021248339,0.0006224982,0.0003379397,0.0013740166,0.0003798714],"domain_scores_gemma":[0.8773837,0.10320635,0.004854769,0.0046457583,0.008717039,0.0011923957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028899703,0.00045373684,0.00046622037,0.002329834,0.0020060905,0.002402508,0.0009649318,0.000609145,0.0014963796],"category_scores_gemma":[0.11808657,0.00025521536,0.0006628721,0.0032438075,0.0022405218,0.0014079356,0.0023625798,0.0015252569,0.00017369712],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021998282,0.0035497656,0.61441356,0.00038607282,0.0004209505,0.0008007892,0.12063333,0.0066016023,0.0018717245,0.046982948,0.002191857,0.19994763],"study_design_scores_gemma":[0.0006461237,0.0059899804,0.53696716,0.0015719048,0.0005330239,0.0011818144,0.27849475,0.0974796,0.0081967,0.03911242,0.029329259,0.0004973008],"about_ca_topic_score_codex":0.025125671,"about_ca_topic_score_gemma":0.023006167,"teacher_disagreement_score":0.028899703,"about_ca_system_score_codex":0.0026645586,"about_ca_system_score_gemma":0.0024941023,"threshold_uncertainty_score":0.15283805},"labels":[],"label_agreement":null},{"id":"W2334113653","doi":"10.1016/j.jval.2013.03.662","title":"The Impact Of Prostate Cancer On Quality Of Life","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Quality of life (healthcare); Anxiety; Cancer; Prostate; Internal medicine; Depression (economics); Oncology; Gynecology; Psychiatry","score_opus":0.08084443251925662,"score_gpt":0.4115411833551345,"score_spread":0.3306967508358779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334113653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8812985,0.052251365,0.00046132444,0.018157305,0.00042580318,0.000025670637,0.0010679011,0.000012036015,0.04630008],"genre_scores_gemma":[0.9950223,0.004121248,0.00007417684,0.00024538508,0.0001139109,0.0000028234197,0.00010807745,0.00000198219,0.00031003167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983494,0.0008264144,0.00006605404,0.00005007755,0.00047283355,0.00023520632],"domain_scores_gemma":[0.9932721,0.0036392491,0.0011422056,0.00016368649,0.0006966173,0.0010861895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014501874,0.00015328736,0.00030583664,0.0007432466,0.00044604976,0.0015364798,0.00031447635,0.0004357778,0.0033207403],"category_scores_gemma":[0.011046924,0.000120369026,0.000758994,0.0011721819,0.00080570887,0.00094427215,0.00092464767,0.0012910559,0.00017382998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005962072,0.0005710512,0.7891699,0.0003936623,0.00090745825,0.00039200994,0.0007281403,0.0013196503,0.00047343457,0.0063994676,0.0054548685,0.1935941],"study_design_scores_gemma":[0.000014205218,0.00024841542,0.9899829,0.00015513657,0.00017511711,0.0003217243,0.00076291966,0.0004796328,0.00011165322,0.0037430977,0.0039835703,0.000021624333],"about_ca_topic_score_codex":0.005154085,"about_ca_topic_score_gemma":0.010512938,"teacher_disagreement_score":0.005154085,"about_ca_system_score_codex":0.0011631199,"about_ca_system_score_gemma":0.0010138772,"threshold_uncertainty_score":0.011109054},"labels":[],"label_agreement":null},{"id":"W2334258853","doi":"10.1016/j.jval.2014.03.200","title":"Comparative Analysis Of The Lsht Sector Concerning Wealth Creation And Economic Growth For Selected Lsht Sub-Sectors In Selected Canadian Provinces And United States As Well As European Regions","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"InterDigital (Canada); Montréal InVivo; Université de Montréal","funders":"","keywords":"Christian ministry; Economic sector; Gross domestic product; Private sector; Geography; Economy; Economics; Economic growth; Business; Political science","score_opus":0.07607839639171073,"score_gpt":0.36505440025786284,"score_spread":0.28897600386615213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334258853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776079,0.0011468536,0.00010957994,0.00029862177,0.000009156677,0.000030062838,0.009087954,0.000013193249,0.01169659],"genre_scores_gemma":[0.9937411,0.0006903339,0.00010821153,0.00003931834,0.0000035695894,0.000008878656,0.0037960957,0.000003702304,0.0016087122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992698,0.000048444996,0.0000380901,0.00004642973,0.00018875423,0.00040844159],"domain_scores_gemma":[0.9976847,0.0002307698,0.00025865802,0.000060484293,0.0013753683,0.00038999214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075353804,0.0002442808,0.00029252516,0.00549656,0.001661631,0.0022249138,0.00067299843,0.00023939885,0.0029535214],"category_scores_gemma":[0.0021243587,0.00015750984,0.0005328544,0.014554498,0.0006101208,0.0004898527,0.0011819782,0.00036029555,0.00016360037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030409056,0.00004216059,0.96968687,0.00011480971,0.00021771829,0.00022057141,0.0025770483,0.000909973,0.00043246927,0.003446261,0.004299546,0.017748402],"study_design_scores_gemma":[0.0000027260703,0.0000075894222,0.9929491,0.000021368858,0.000031436288,0.000025206513,0.004471651,0.0002799183,0.000106695836,0.000053527583,0.002043968,0.0000067805213],"about_ca_topic_score_codex":0.9876721,"about_ca_topic_score_gemma":0.994514,"teacher_disagreement_score":0.018110504,"about_ca_system_score_codex":0.018110504,"about_ca_system_score_gemma":0.028083416,"threshold_uncertainty_score":0.13140154},"labels":[],"label_agreement":null},{"id":"W2334759232","doi":"10.1016/j.jval.2014.03.359","title":"Cost-Effectiveness Of Stiripentol In The Treatment Of Severe Myoclonic Epilepsy In Infancy In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dravet syndrome; Medicine; Myoclonic epilepsy; Cost–utility analysis; Clobazam; Pediatrics; Epilepsy; Psychiatry; Cost effectiveness","score_opus":0.12664159487864426,"score_gpt":0.41271527046781853,"score_spread":0.2860736755891743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334759232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9568713,0.020867653,0.00020834115,0.0082816845,0.00011803076,0.00023524943,0.0039876644,0.000029501303,0.00940052],"genre_scores_gemma":[0.99053395,0.007110807,0.0002882982,0.00037833123,0.00003907564,0.000026322485,0.00074233767,0.00000411298,0.0008768009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991386,0.00022037204,0.00007825696,0.000043585478,0.0002871007,0.0002321204],"domain_scores_gemma":[0.998168,0.00033231635,0.00031789907,0.000015655689,0.000485817,0.00068024284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051233626,0.00024138764,0.0004886278,0.0009814098,0.00051445595,0.0008993247,0.00066114555,0.0005209598,0.002189816],"category_scores_gemma":[0.0036252388,0.00013741673,0.0008929669,0.0014438494,0.00043043296,0.0002542623,0.00040293398,0.0005973613,0.000059518938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03423364,0.0022463968,0.4516631,0.004757174,0.0032916237,0.0022547299,0.000677365,0.031077664,0.0024925058,0.007383269,0.02597535,0.43394712],"study_design_scores_gemma":[0.006982388,0.005529429,0.9365656,0.0018514158,0.003274754,0.0011193117,0.0020586448,0.02516799,0.0011971293,0.0008094997,0.015317251,0.00012661086],"about_ca_topic_score_codex":0.9403448,"about_ca_topic_score_gemma":0.97376716,"teacher_disagreement_score":0.05965519,"about_ca_system_score_codex":0.03921288,"about_ca_system_score_gemma":0.041462254,"threshold_uncertainty_score":0.28451073},"labels":[],"label_agreement":null},{"id":"W2335126779","doi":"10.1016/j.jval.2013.08.1696","title":"Meta-Analysis of Quality of Life in Coronary Heart Disease","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Multivariate statistics; Medicine; Quality of life (healthcare); Meta-analysis; Coronary heart disease; Multivariate analysis; EQ-5D; Preference; SF-36; Regression analysis; Statistics; Bayesian multivariate linear regression; Physical therapy; Health related quality of life; Internal medicine; Disease; Mathematics","score_opus":0.7196864791014979,"score_gpt":0.47782325953083665,"score_spread":0.2418632195706612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335126779","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066555254,0.9240609,0.0048339413,0.0006825319,0.0012409559,0.00021992481,0.0014128344,0.00013269267,0.00086098793],"genre_scores_gemma":[0.8863885,0.10516204,0.0039796988,0.0011282938,0.00096298475,0.0004237147,0.0011838177,0.000112717265,0.00065805984],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9557995,0.03240095,0.0054933336,0.0033765365,0.002219264,0.00071051775],"domain_scores_gemma":[0.9321924,0.054161225,0.0054292036,0.005972406,0.0017164248,0.0005283531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034098532,0.0033850134,0.01540175,0.0037507354,0.0007671272,0.004469812,0.0026156527,0.0033152134,0.003065331],"category_scores_gemma":[0.09239586,0.002150457,0.050127383,0.004380999,0.0011926929,0.002232571,0.0020606862,0.0037328762,0.00027707516],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004122058,0.000012814896,0.004682332,0.010434332,0.9780206,0.00003867745,0.00002406855,0.00033662267,0.000084950014,0.000104075574,0.00018171352,0.0019577818],"study_design_scores_gemma":[0.0016821913,0.00023600731,0.005815264,0.0010441293,0.98987657,0.0000609064,0.000023904482,0.00029770908,0.000078211626,0.00045811638,0.00040925734,0.000017702609],"about_ca_topic_score_codex":0.006189889,"about_ca_topic_score_gemma":0.008296894,"teacher_disagreement_score":0.034098532,"about_ca_system_score_codex":0.0020427648,"about_ca_system_score_gemma":0.0014952195,"threshold_uncertainty_score":0.18033242},"labels":[],"label_agreement":null},{"id":"W2335184425","doi":"10.1016/j.jval.2014.03.489","title":"Mobilizing Autologous Hematopoietic Stem Cells in Patients with Myeloma: A Economic Comparison of 4 Common Mobilization Strategies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Plerixafor; Medicine; Multiple myeloma; Mobilization; Autologous stem-cell transplantation; Transplantation; Adverse effect; Oncology; Internal medicine; CXCR4","score_opus":0.025411076232148,"score_gpt":0.30138548621840466,"score_spread":0.27597440998625666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335184425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97620356,0.017358823,0.00072012894,0.0016378722,0.00009638351,0.0004648615,0.0005986584,0.000011160649,0.002908624],"genre_scores_gemma":[0.9963515,0.0025145814,0.00050139765,0.00016155143,0.00003614576,0.000119369375,0.00019719047,0.0000027517092,0.00011557425],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99616563,0.0024496624,0.00028084515,0.00017540563,0.00056815357,0.0003603445],"domain_scores_gemma":[0.99380445,0.003920223,0.001356196,0.00016055677,0.00016345171,0.0005950028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004555532,0.0007590081,0.0011536189,0.002119854,0.0004949633,0.0018055823,0.00075686764,0.0013089492,0.0048215855],"category_scores_gemma":[0.012237406,0.00030602008,0.003043963,0.001669294,0.001105851,0.0013665713,0.0018866603,0.0012502522,0.00012846147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32708976,0.007753575,0.124771655,0.0035344462,0.0069163884,0.0005068247,0.00058828614,0.043379553,0.002012573,0.010605821,0.0030603283,0.4697808],"study_design_scores_gemma":[0.10252131,0.2902808,0.47040614,0.0045871967,0.02094285,0.002061687,0.0063575814,0.06759714,0.004477011,0.014292368,0.015964763,0.000511162],"about_ca_topic_score_codex":0.0032107425,"about_ca_topic_score_gemma":0.0039996663,"teacher_disagreement_score":0.005145588,"about_ca_system_score_codex":0.005145588,"about_ca_system_score_gemma":0.0022652175,"threshold_uncertainty_score":0.037334085},"labels":[],"label_agreement":null},{"id":"W2335677341","doi":"10.1016/j.jval.2014.03.486","title":"Cost-Effectiveness of Arsenic Trioxide + All-Trans Retinoic Acid Compared with All-Trans Retinoic Acid + Idarubicin in the Treatment of Newly Diagnosed Acute Promyelocytic Lymphoma LEUKEMIA in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Idarubicin; Arsenic trioxide; Internal medicine; Adverse effect; Tretinoin; Oncology; Retinoic acid; Leukemia; Gastroenterology; Cytarabine; Arsenic; Chemistry","score_opus":0.02496892279889427,"score_gpt":0.2736665815657923,"score_spread":0.24869765876689806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335677341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831964,0.007832416,0.00015959976,0.0026390704,0.00009419736,0.00027035098,0.0019699521,0.000019947865,0.0038181383],"genre_scores_gemma":[0.99668956,0.0017552469,0.00023313372,0.00020306726,0.000024452333,0.000027292544,0.00038549196,0.0000035352389,0.00067804387],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990508,0.00033672169,0.000073095725,0.00007743188,0.00018894086,0.00027299905],"domain_scores_gemma":[0.99855775,0.0002312435,0.00023929971,0.000020076637,0.00028245515,0.00066923595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054194295,0.00030810563,0.00085526885,0.00054483995,0.00061117136,0.0010058346,0.0008866121,0.0006013196,0.0031925512],"category_scores_gemma":[0.0024727124,0.0002299301,0.0013128051,0.0011467967,0.00051517604,0.00029823926,0.00054825685,0.0006641972,0.00009704431],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2335502,0.0043012975,0.34711322,0.003241714,0.0050782934,0.0015391879,0.0006472469,0.07950334,0.005214947,0.0043192524,0.0143548045,0.30113652],"study_design_scores_gemma":[0.036737297,0.028106878,0.8504423,0.0010770119,0.0105938865,0.0011135704,0.0027940944,0.05215013,0.0025424988,0.0013058156,0.012891086,0.00024550201],"about_ca_topic_score_codex":0.9357569,"about_ca_topic_score_gemma":0.9674058,"teacher_disagreement_score":0.9357569,"about_ca_system_score_codex":0.052569393,"about_ca_system_score_gemma":0.04053115,"threshold_uncertainty_score":0.38141942},"labels":[],"label_agreement":null},{"id":"W2335683441","doi":"10.1016/j.jval.2014.03.861","title":"The Impact Of Pharmacist-Delivered Vaccination On Influenza Immunization Rates And Perception In Canada: An Ecological Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunization; Vaccination policy; Vaccination; Residence; Medicine; Odds; Logistic regression; Demography; Odds ratio; Environmental health; Immunology","score_opus":0.14163170005954048,"score_gpt":0.45956597883806016,"score_spread":0.31793427877851965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335683441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976936,0.00030775787,0.00006945375,0.00038950332,0.000008504674,0.00004357752,0.0005376209,0.000003819126,0.00094614376],"genre_scores_gemma":[0.9985298,0.00023131334,0.00016885104,0.00016607573,0.0000046552263,0.000021205531,0.00026537763,0.00000432381,0.00060835143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961578,0.0010127586,0.00015691784,0.0003858883,0.00093378517,0.0013529029],"domain_scores_gemma":[0.9917082,0.0015910089,0.0013452026,0.0002436041,0.0024782903,0.0026337008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002552829,0.00052828394,0.00068172347,0.0014081581,0.0061526913,0.0027092656,0.0021665958,0.0011777562,0.0023384085],"category_scores_gemma":[0.007426063,0.00067148096,0.0013157092,0.004296688,0.002556981,0.0010063066,0.0017895323,0.0021917599,0.00020319395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002770749,0.0008197813,0.98592883,0.000053685304,0.00013696855,0.000095642994,0.0067500058,0.000192573,0.00016991915,0.00026525752,0.0008203056,0.004490011],"study_design_scores_gemma":[0.000018589706,0.00013516066,0.98941046,0.000034071007,0.00004753544,0.000026608519,0.00928362,0.00044413074,0.000056968158,0.000045815425,0.0004719481,0.000025052903],"about_ca_topic_score_codex":0.9971246,"about_ca_topic_score_gemma":0.9979157,"teacher_disagreement_score":0.9971246,"about_ca_system_score_codex":0.06429598,"about_ca_system_score_gemma":0.0628143,"threshold_uncertainty_score":0.46650213},"labels":[],"label_agreement":null},{"id":"W2339084570","doi":"10.1016/j.jval.2015.03.593","title":"Analysis Of Ethical Theories And Principles Embedded In Holistic Mcda: A Primer To Ethics-Based Appraisal Of Value In Healthcare","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Consequentialism; Deontological ethics; Utilitarianism; Beneficence; Economic Justice; Health care; Bioethics; Normative ethics; Respect for persons; Engineering ethics; Autonomy; Sociology; Political science; Law","score_opus":0.6033695268346663,"score_gpt":0.5176661552260051,"score_spread":0.08570337160866115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339084570","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077297427,0.008061047,0.7927552,0.11930122,0.0006403963,0.00055921706,0.00016231921,0.00007945617,0.07071139],"genre_scores_gemma":[0.3433975,0.005339464,0.63439137,0.007596573,0.0006377408,0.0014840475,0.00016215528,0.00011979329,0.0068714],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9635933,0.027887426,0.0017175291,0.0010267927,0.0049936734,0.00078120857],"domain_scores_gemma":[0.922599,0.06441093,0.0028891193,0.0036385953,0.0055400375,0.00092226546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047015324,0.0010232169,0.0015530563,0.005268371,0.0045721577,0.0138500035,0.0037945835,0.0066113733,0.0054701716],"category_scores_gemma":[0.056529794,0.0010177337,0.0020991545,0.0047356947,0.038994856,0.013637143,0.00611881,0.011909016,0.00065860327],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036715148,0.000019465853,0.00015694335,0.00009470145,0.000012133431,0.000038420076,0.0019339612,0.000821801,0.0000642553,0.9888171,0.0010843051,0.006953309],"study_design_scores_gemma":[0.0000042731317,0.000005424469,0.00013492815,0.00034145336,0.0000042605416,0.0000426983,0.0013243069,0.0019001208,0.000104585946,0.9830679,0.013059712,0.00001036375],"about_ca_topic_score_codex":0.005374192,"about_ca_topic_score_gemma":0.006638782,"teacher_disagreement_score":0.047015324,"about_ca_system_score_codex":0.011135011,"about_ca_system_score_gemma":0.015975036,"threshold_uncertainty_score":0.24864376},"labels":[],"label_agreement":null},{"id":"W2339218474","doi":"10.1016/j.jval.2015.09.797","title":"Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events: Results of a Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Amgen (Canada); Université de Montréal","funders":"","keywords":"Medicine; Statin; Internal medicine; Rhabdomyolysis; Medical prescription; Incidence (geometry); Population; Cohort; Retrospective cohort study; Pharmacology","score_opus":0.03743217193023744,"score_gpt":0.27884559185169244,"score_spread":0.24141341992145499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339218474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032277,0.0026377202,0.0001056134,0.0007480532,0.000040950817,0.00027501115,0.002463147,0.000008920012,0.0033977618],"genre_scores_gemma":[0.9935289,0.002175764,0.00063612947,0.000587526,0.00004014674,0.00009688075,0.002172811,0.000008834786,0.0007529166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983448,0.0002801895,0.00014410587,0.00020272129,0.00061941735,0.00040877977],"domain_scores_gemma":[0.9959305,0.00046626324,0.0007180853,0.00015042645,0.0017581395,0.00097654195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026409205,0.00077123335,0.0013448443,0.000660539,0.002513421,0.0014681191,0.0013683646,0.0011772879,0.0014185983],"category_scores_gemma":[0.004838749,0.0005902118,0.0017913977,0.0036619962,0.0008789029,0.0006491248,0.0007303474,0.0016889627,0.00017441972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00843629,0.0021999779,0.96160495,0.00033431943,0.0010969065,0.00014844391,0.0008156307,0.00024231893,0.00040902768,0.00016835006,0.0027780398,0.021765824],"study_design_scores_gemma":[0.0012914997,0.0006272167,0.9949451,0.000098444754,0.00080073654,0.00006319781,0.00066254556,0.00026970764,0.00006435878,0.00004676868,0.0010884922,0.000041976702],"about_ca_topic_score_codex":0.93846476,"about_ca_topic_score_gemma":0.9614251,"teacher_disagreement_score":0.06153524,"about_ca_system_score_codex":0.01708599,"about_ca_system_score_gemma":0.024130926,"threshold_uncertainty_score":0.123968124},"labels":[],"label_agreement":null},{"id":"W2342441589","doi":"10.1016/j.jval.2015.03.318","title":"Ideglira Versus other Intensification Strategies In Patients With Type 2 Diabetes Inadequately Controlled on Basal Insulin – An Indirect Statistical Comparison","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Insulin aspart; Liraglutide; Insulin degludec; Insulin glargine; Type 2 diabetes; Hypoglycemia; Basal (medicine); Insulin; Internal medicine; Basal insulin; Diabetes mellitus; Endocrinology","score_opus":0.09327190028223893,"score_gpt":0.33845534585790626,"score_spread":0.24518344557566735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342441589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95416886,0.029986098,0.00179984,0.0016321287,0.0019527914,0.0009200199,0.001158953,0.000057915047,0.008323498],"genre_scores_gemma":[0.98959315,0.004675802,0.0022241045,0.0007158395,0.00046604336,0.00045140626,0.00049062015,0.000014479205,0.0013685189],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.992515,0.006051168,0.00043059624,0.00036399587,0.0003180676,0.00032119933],"domain_scores_gemma":[0.9909837,0.0070426064,0.00086423376,0.0003828139,0.00020478292,0.0005218982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061686765,0.0014646574,0.0034208975,0.0007770264,0.00031442926,0.0012557984,0.0009679427,0.0015345563,0.008949705],"category_scores_gemma":[0.00975722,0.0006298651,0.007203855,0.00063981034,0.0009547049,0.001699185,0.0012557368,0.0035995904,0.000441393],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94312346,0.0017031345,0.0031758007,0.0017759692,0.00973855,0.000033463435,0.000083372295,0.00082841323,0.00030845296,0.0004982493,0.00050319434,0.03822801],"study_design_scores_gemma":[0.6240582,0.2693579,0.035583515,0.001437339,0.05293413,0.00016320357,0.00059743685,0.0068793194,0.0014532628,0.0033743517,0.0040276526,0.00013367523],"about_ca_topic_score_codex":0.0013231119,"about_ca_topic_score_gemma":0.0021341527,"teacher_disagreement_score":0.008949705,"about_ca_system_score_codex":0.0014695522,"about_ca_system_score_gemma":0.0010776273,"threshold_uncertainty_score":0.03262347},"labels":[],"label_agreement":null},{"id":"W2342537895","doi":"10.1016/j.jval.2015.03.661","title":"Factors Impacting Personalized Medicine Test Adoption: Evaluating Patient Preferences And Willingness To Pay","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Willingness to pay; Ranking (information retrieval); Thematic analysis; Payment; Test (biology); Population; Focus group; Norwegian; Family medicine; Mixed logit; Logistic regression; Medicine; Health care; Psychology; Actuarial science; Marketing; Business; Computer science; Qualitative research; Environmental health; Economics; Internal medicine; Artificial intelligence","score_opus":0.8132172749068709,"score_gpt":0.6162580089685087,"score_spread":0.19695926593836222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342537895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971187,0.00019708145,0.0001964144,0.00058216404,0.0000090214235,0.000023979137,0.0001482932,0.0000034453362,0.0017209377],"genre_scores_gemma":[0.9994874,0.000045739,0.00020370918,0.00009499049,0.0000075377466,0.0000082893075,0.000062367144,0.0000015140733,0.000088538596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963425,0.0019741901,0.00041506125,0.00023031344,0.00065906986,0.00037881263],"domain_scores_gemma":[0.95883757,0.02741168,0.009179719,0.0008824463,0.0011106475,0.0025779554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045675444,0.0002280146,0.00039524722,0.0007965796,0.0004695021,0.0016011297,0.00033120852,0.0011692435,0.005299672],"category_scores_gemma":[0.038341314,0.00016832726,0.0011808178,0.0009879777,0.0005005918,0.0009629187,0.0005237567,0.001229256,0.00035730583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008374348,0.0006656795,0.9829999,0.000042473162,0.00030014972,0.000095939,0.00036984135,0.0005482712,0.00019060147,0.00020110764,0.00032074293,0.013427829],"study_design_scores_gemma":[0.00009021786,0.0015113786,0.9895152,0.000049382244,0.00025680338,0.00045891793,0.0015581062,0.0045564766,0.00037367918,0.000854458,0.00073293666,0.00004243862],"about_ca_topic_score_codex":0.0023020238,"about_ca_topic_score_gemma":0.0029266682,"teacher_disagreement_score":0.005299672,"about_ca_system_score_codex":0.0007164983,"about_ca_system_score_gemma":0.00093932607,"threshold_uncertainty_score":0.024155796},"labels":[],"label_agreement":null},{"id":"W2342574247","doi":"10.1016/j.jval.2015.09.1106","title":"The Cost of Radiotherapy: What Do We Know? a Systematic Search of the Literature Between 1981 and 2015","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Activity-based costing; Systematic review; Medicine; Medical physics; Radiation therapy; MEDLINE; Cost effectiveness; Computer science; Operations management; Risk analysis (engineering); Business; Surgery; Accounting; Economics","score_opus":0.030827967374937922,"score_gpt":0.3431024084104465,"score_spread":0.31227444103550855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342574247","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01133134,0.9799621,0.00012584245,0.0011779135,0.000100135054,0.000053162763,0.0064613465,0.0000047707426,0.0007833287],"genre_scores_gemma":[0.11829837,0.8769184,0.0006424662,0.0011206722,0.00016325343,0.00015774777,0.0025032433,0.000012829799,0.0001830866],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9926818,0.0018881339,0.0031944243,0.0005801094,0.0014143399,0.00024119622],"domain_scores_gemma":[0.93181896,0.048094224,0.015214761,0.00065216294,0.0036506874,0.0005692439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00584496,0.0006956205,0.003738406,0.018082865,0.0003594994,0.0021360584,0.0011416837,0.00152342,0.0033588186],"category_scores_gemma":[0.06263718,0.0008396091,0.00441755,0.025968978,0.001071915,0.0028004688,0.0014376286,0.0012715777,0.00025485817],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011827565,0.000063181644,0.08264881,0.6681585,0.022308111,0.00054954,0.0010501922,0.0010226743,0.00023545386,0.0025361083,0.016931843,0.2033129],"study_design_scores_gemma":[0.00044693722,0.00031124303,0.21601465,0.64544904,0.04898723,0.0021511302,0.0020033095,0.00056517153,0.00026997316,0.00202975,0.08161012,0.00016152936],"about_ca_topic_score_codex":0.03223865,"about_ca_topic_score_gemma":0.06489152,"teacher_disagreement_score":0.03223865,"about_ca_system_score_codex":0.0052039125,"about_ca_system_score_gemma":0.0088741435,"threshold_uncertainty_score":0.06410205},"labels":[],"label_agreement":null},{"id":"W2342720801","doi":"10.1016/j.jval.2015.03.1003","title":"Cost-Effectiveness of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Canada, Sweden And The Uk","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; COPD; Cohort; Anticholinergic; Relative risk; Clinical trial; Lung function; Emergency medicine; Intensive care medicine; Internal medicine; Lung; Confidence interval","score_opus":0.06231783804597246,"score_gpt":0.3387742684138032,"score_spread":0.27645643036783074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342720801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96660167,0.02604101,0.000040925162,0.002374642,0.00013946179,0.00006408464,0.0018640582,0.00000994507,0.002864294],"genre_scores_gemma":[0.9965544,0.0022888843,0.000052563915,0.0002094937,0.000025336642,0.000014533342,0.0005113354,0.0000030933918,0.00034036106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803084,0.0006772546,0.00019544219,0.00012356348,0.00042254018,0.000550224],"domain_scores_gemma":[0.9960521,0.0012735099,0.0006569092,0.000063947096,0.0005692519,0.0013843967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012513335,0.00045745415,0.0014501322,0.0009899366,0.00074799167,0.002221024,0.0009508839,0.0014030695,0.0024223272],"category_scores_gemma":[0.0088746175,0.00033181123,0.0026421063,0.0017131339,0.00076287455,0.00069533713,0.0010735308,0.0013732028,0.00007990805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19673663,0.0023544175,0.5685227,0.008527103,0.011506052,0.0017937601,0.0014643616,0.033368234,0.0014427103,0.0039096964,0.01910679,0.15126753],"study_design_scores_gemma":[0.006491941,0.0056900843,0.95993465,0.0021611536,0.0056078495,0.0005778379,0.0025339334,0.011978532,0.0003175574,0.0006728803,0.0038352602,0.00019831493],"about_ca_topic_score_codex":0.854742,"about_ca_topic_score_gemma":0.8639589,"teacher_disagreement_score":0.14525801,"about_ca_system_score_codex":0.030099627,"about_ca_system_score_gemma":0.016454967,"threshold_uncertainty_score":0.2922269},"labels":[],"label_agreement":null},{"id":"W2342894105","doi":"10.1016/j.jval.2015.03.211","title":"Advancing Methods Of Hta: Optimising Monitoring Tests To Meet Value Targets","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cut-point; Population; Confidence interval; Medicine; Test (biology); Statistics; Cut-off; Interval (graph theory); Mathematics; Engineering","score_opus":0.32530382179132933,"score_gpt":0.5769264330535419,"score_spread":0.2516226112622125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342894105","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071056867,0.0018441614,0.9825493,0.0026612259,0.00034044916,0.0002241138,0.00037845888,0.0012953462,0.0036012137],"genre_scores_gemma":[0.15922292,0.0012692306,0.83354604,0.0016255287,0.00039293364,0.00036033828,0.00046785545,0.00043312387,0.0026821033],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9756271,0.012838105,0.0007975029,0.0018626897,0.008406184,0.00046835784],"domain_scores_gemma":[0.9086605,0.056928672,0.0061536236,0.008315323,0.018922916,0.001019112],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024083043,0.0017440602,0.0014698685,0.0023842405,0.00055420725,0.0058676773,0.0032108189,0.002896153,0.0047045816],"category_scores_gemma":[0.10249216,0.0010736545,0.001369975,0.0015766616,0.0015616072,0.005686778,0.0026357071,0.0032154052,0.0030751314],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096465123,0.00068629684,0.049202263,0.0017058662,0.0005184668,0.00016526121,0.000952494,0.055090677,0.056348592,0.047429394,0.02144359,0.7654925],"study_design_scores_gemma":[0.00027732793,0.001167132,0.019004706,0.0010582788,0.000497974,0.00093532726,0.0005376476,0.5949665,0.13273913,0.18327996,0.06517339,0.00036276327],"about_ca_topic_score_codex":0.004025842,"about_ca_topic_score_gemma":0.0033575338,"teacher_disagreement_score":0.975917,"about_ca_system_score_codex":0.0023778228,"about_ca_system_score_gemma":0.0052322354,"threshold_uncertainty_score":0.12736487},"labels":[],"label_agreement":null},{"id":"W2342897353","doi":"10.1016/j.jval.2015.03.1741","title":"Kidney involvement in Tuberous Sclerosis Complex: the impact on Health Care resource use and costs in the Netherlands","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Renal function; Kidney disease; Tuberous sclerosis; Population; Cohort; Creatinine; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Pathology","score_opus":0.2693416566261356,"score_gpt":0.39063539476081605,"score_spread":0.12129373813468047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342897353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877995,0.0052896617,0.00008858352,0.002250498,0.000039166014,0.000011984302,0.0018523446,0.0000020857833,0.002666092],"genre_scores_gemma":[0.99625045,0.0025471337,0.00007001111,0.00011818438,0.000022513419,0.000017023169,0.00051950646,0.0000059230424,0.00044911262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985203,0.00065303285,0.00017147539,0.00016505463,0.00019497213,0.00029506165],"domain_scores_gemma":[0.9980457,0.00065030734,0.00067991274,0.000037639606,0.00016992146,0.00041645672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081429374,0.00019433207,0.0005217024,0.0009504252,0.00028417556,0.0019192976,0.0005761157,0.0006544159,0.002301081],"category_scores_gemma":[0.0057878913,0.00026799718,0.0008117484,0.003353162,0.0004641672,0.0010387186,0.0009826808,0.00069127104,0.00012232194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071724836,0.00029841615,0.9652982,0.0005012724,0.0010889958,0.0021938307,0.0018808348,0.0019082676,0.00025414466,0.0018633446,0.0031997815,0.020795617],"study_design_scores_gemma":[0.00008024648,0.0000814508,0.9895181,0.0003190218,0.00040434574,0.0008631959,0.0030644264,0.002046782,0.000077296914,0.0006440716,0.0028677906,0.000033257864],"about_ca_topic_score_codex":0.25922307,"about_ca_topic_score_gemma":0.20134377,"teacher_disagreement_score":0.25922307,"about_ca_system_score_codex":0.0037291627,"about_ca_system_score_gemma":0.0027007896,"threshold_uncertainty_score":0.5154284},"labels":[],"label_agreement":null},{"id":"W2343042405","doi":"10.1016/j.jval.2015.03.276","title":"Screening high-risk populations for Latent Tuberculosis: a systematic review of cost-utility analyses","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tuberculin; Latent tuberculosis; Interferon gamma release assay; Cost effectiveness; Tuberculosis; Population; Health care; Cost-effectiveness analysis; Intensive care medicine; Environmental health; Mycobacterium tuberculosis; Risk analysis (engineering); Pathology","score_opus":0.48641200468434564,"score_gpt":0.5382376938789364,"score_spread":0.05182568919459074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343042405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012009876,0.99789536,0.00021537131,0.00011866086,0.00004378431,0.000085054,0.00032648156,0.000005223154,0.00010907755],"genre_scores_gemma":[0.03975784,0.957684,0.0014979524,0.00037586683,0.00007204076,0.00018273576,0.00036132167,0.00000764161,0.000060569313],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9874867,0.0054581906,0.0039302283,0.0008291737,0.0020016495,0.000293983],"domain_scores_gemma":[0.9593555,0.034008663,0.004260446,0.00050931005,0.0016181711,0.00024802753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01427429,0.0019796442,0.012687734,0.0075065796,0.00040177835,0.0029774308,0.002307865,0.0015736388,0.0036214858],"category_scores_gemma":[0.059342813,0.0012292408,0.015814243,0.010599499,0.0007499169,0.0023491157,0.0019562757,0.0021757942,0.00019294642],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012763268,0.00004625017,0.0042906934,0.7690113,0.14642447,0.00009156635,0.0001293675,0.0006380025,0.00012913576,0.00045778218,0.001566626,0.075938374],"study_design_scores_gemma":[0.0011844612,0.00036648026,0.014415482,0.2587295,0.7119569,0.00046370056,0.00023993758,0.0006067307,0.0002055278,0.0014249738,0.010314816,0.000091545655],"about_ca_topic_score_codex":0.0076214126,"about_ca_topic_score_gemma":0.023882542,"teacher_disagreement_score":0.01427429,"about_ca_system_score_codex":0.0034454884,"about_ca_system_score_gemma":0.0051136687,"threshold_uncertainty_score":0.075490534},"labels":[],"label_agreement":null},{"id":"W2343082747","doi":"10.1016/j.jval.2015.03.1145","title":"Systematic Review of Economic Evaluations in allogeneic Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Myeloid leukemia; Imatinib; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Leukemia; Population","score_opus":0.0664844557251473,"score_gpt":0.368939050238855,"score_spread":0.3024545945137077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343082747","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008162028,0.9878237,0.00059374695,0.0006694841,0.00033547488,0.00058181735,0.0011349877,0.00001576608,0.0006829578],"genre_scores_gemma":[0.2878105,0.7044006,0.0027572145,0.0018012,0.00037710296,0.001450344,0.0010447861,0.000031898773,0.0003264142],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.93753535,0.04132829,0.014711955,0.0016594295,0.0040411507,0.000723894],"domain_scores_gemma":[0.8718099,0.10247546,0.018865472,0.0020048996,0.004087041,0.0007571453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03347867,0.0020652292,0.013238796,0.0060151396,0.0005246258,0.0034119783,0.0017587519,0.0021106547,0.0045273807],"category_scores_gemma":[0.15181893,0.0013005524,0.014895297,0.0066627744,0.0014569875,0.001948788,0.0020457201,0.0027075834,0.00019883265],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004356787,0.00004183728,0.0022985272,0.7534598,0.21396443,0.00012412407,0.00013566026,0.00063922914,0.0001361472,0.000515943,0.0014125624,0.022914901],"study_design_scores_gemma":[0.0065975315,0.000810055,0.008731899,0.27679837,0.69482994,0.00033752082,0.00023482511,0.00048954773,0.00024907338,0.001592143,0.009257041,0.00007211814],"about_ca_topic_score_codex":0.008715334,"about_ca_topic_score_gemma":0.02159138,"teacher_disagreement_score":0.03347867,"about_ca_system_score_codex":0.0058367806,"about_ca_system_score_gemma":0.008257962,"threshold_uncertainty_score":0.17705423},"labels":[],"label_agreement":null},{"id":"W2343169668","doi":"10.1016/j.jval.2015.03.486","title":"A Literature review and Micro costing approach to determine the cost of one hour of operating time in Canada","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Inclusion (mineral); Total absorption costing; Operations management; Cost driver; Operations research; Total cost; Inclusion and exclusion criteria; Business; Actuarial science; Computer science; Medicine; Economics; Engineering; Marketing; Accounting; Psychology","score_opus":0.1042738472373787,"score_gpt":0.3423772443800925,"score_spread":0.23810339714271378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343169668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00242625,0.9928428,0.00017856038,0.001032817,0.00015555981,0.00009257638,0.001516532,0.0000067484775,0.001748239],"genre_scores_gemma":[0.019949017,0.97782,0.0009599506,0.0004277928,0.00006910926,0.000071046845,0.00043700598,0.000004293913,0.00026178698],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967565,0.00037282828,0.0007802212,0.00018376739,0.0016914221,0.00021529115],"domain_scores_gemma":[0.9867845,0.0067428914,0.0016570963,0.00011941299,0.0044050384,0.00029105254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033078936,0.0010297965,0.002829376,0.023208285,0.0011938006,0.003134502,0.0018692414,0.0010588287,0.0048634643],"category_scores_gemma":[0.019557262,0.0005271753,0.004113518,0.04034735,0.00081699924,0.0014268156,0.001087532,0.0013460591,0.00022375703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003411962,0.00009847233,0.021042993,0.4675414,0.0067060716,0.0008041065,0.0008090733,0.0016908566,0.00023343138,0.0060252943,0.034804646,0.45990252],"study_design_scores_gemma":[0.000175821,0.00017755132,0.09678529,0.61496896,0.042498846,0.0017590577,0.0026454816,0.0014716806,0.00045424188,0.0028154398,0.23603034,0.00021730538],"about_ca_topic_score_codex":0.68874353,"about_ca_topic_score_gemma":0.8321397,"teacher_disagreement_score":0.31125647,"about_ca_system_score_codex":0.024385404,"about_ca_system_score_gemma":0.06468331,"threshold_uncertainty_score":0.626179},"labels":[],"label_agreement":null},{"id":"W2343183069","doi":"10.1016/j.jval.2015.03.731","title":"Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Drugs in Canada, 2010-2014","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Atomoxetine; Medical prescription; Methylphenidate; Medicine; Stimulant; Attention deficit hyperactivity disorder; Atomoxetine hydrochloride; Psychiatry; Drug; Pediatrics; Pharmacology","score_opus":0.0946887750190298,"score_gpt":0.3312450946067302,"score_spread":0.2365563195877004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343183069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.720634,0.019436464,0.0005944918,0.010878321,0.00064048555,0.00030010194,0.22242154,0.00024031599,0.024854293],"genre_scores_gemma":[0.93710274,0.011215633,0.0009960324,0.002409788,0.00011706355,0.000112511516,0.03538212,0.000038800554,0.01262543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980862,0.000061992614,0.00020210077,0.00018567895,0.000916815,0.00054714415],"domain_scores_gemma":[0.99511176,0.00012953712,0.0008448548,0.000035971258,0.002705556,0.0011723082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005365653,0.00044309953,0.00063864037,0.0031750302,0.002514588,0.0020077263,0.0021007243,0.0009997764,0.0030571844],"category_scores_gemma":[0.003620567,0.0004926684,0.001385007,0.008191908,0.00065834285,0.00082240085,0.0011891027,0.0017290069,0.00038238976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021747038,0.00011833846,0.9492175,0.0004619743,0.00026332142,0.00023121976,0.00055167964,0.0004388856,0.0001902205,0.0005237963,0.029377522,0.018408142],"study_design_scores_gemma":[0.000019349587,0.000030726274,0.9877532,0.00025184004,0.00011067142,0.00016670438,0.0014647355,0.0004544886,0.00013128827,0.000047883103,0.009546371,0.000022730346],"about_ca_topic_score_codex":0.9985896,"about_ca_topic_score_gemma":0.9993656,"teacher_disagreement_score":0.07418978,"about_ca_system_score_codex":0.07418978,"about_ca_system_score_gemma":0.12290569,"threshold_uncertainty_score":0.53828704},"labels":[],"label_agreement":null},{"id":"W2343203314","doi":"10.1016/j.jval.2015.03.1234","title":"Metastatic Melanoma Patient Characteristics as A Determening Factor for Braf Gene Mutation Testing and Treatment In Canada – A Retrospective Cohort Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Ipilimumab; Metastatic melanoma; Melanoma; Internal medicine; Oncology; Cohort; Retrospective cohort study; Mutation; Cancer; Disease; Stage (stratigraphy); Gene; Cancer research; Immunotherapy; Genetics","score_opus":0.047629491895566256,"score_gpt":0.2770613135548097,"score_spread":0.22943182165924342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343203314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928812,0.0005007936,0.00015206725,0.0003163764,0.000025734405,0.000041567328,0.004057713,0.00001586045,0.0020088123],"genre_scores_gemma":[0.99678016,0.0002637455,0.0001324267,0.00020057829,0.000015033347,0.000018726976,0.0015494827,0.000013317677,0.0010265622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984268,0.00012033438,0.00011668905,0.00036265934,0.00034753195,0.000626097],"domain_scores_gemma":[0.9964394,0.00020117265,0.0007913028,0.00027309163,0.0012433535,0.0010516695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006637103,0.0005037121,0.0006919911,0.0016015284,0.003209513,0.0017227918,0.0016548551,0.0010426025,0.0043544117],"category_scores_gemma":[0.0024897915,0.000853238,0.0013381017,0.005283363,0.0010838913,0.0006744151,0.0011461764,0.0015716089,0.0005141772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097623444,0.000031177584,0.99791497,0.0000076145207,0.00008428301,0.00014601697,0.00020130059,0.000053191317,0.00012733093,0.00006520294,0.00060031266,0.0006710761],"study_design_scores_gemma":[0.00001614354,0.000042650918,0.9970197,0.000021287087,0.000079219906,0.00028106797,0.0010726572,0.00030763948,0.00006669389,0.000043457017,0.0010249614,0.000024518491],"about_ca_topic_score_codex":0.96643794,"about_ca_topic_score_gemma":0.9746868,"teacher_disagreement_score":0.033562064,"about_ca_system_score_codex":0.01594234,"about_ca_system_score_gemma":0.024482593,"threshold_uncertainty_score":0.11567032},"labels":[],"label_agreement":null},{"id":"W2343262083","doi":"10.1016/j.jval.2015.03.1422","title":"Cost of Adminstration of a Single dose of Rotavirus Vaccine in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Rotavirus vaccine; Medicine; Rotavirus; Administration (probate law); Cohort; Schedule; Vaccination; Family medicine; Pediatrics; Virology; Internal medicine; Diarrhea; Economics; Political science","score_opus":0.18745011529479547,"score_gpt":0.3819548649969418,"score_spread":0.19450474970214635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343262083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9305385,0.01237051,0.0006066009,0.018511567,0.000465666,0.0002230645,0.011750622,0.00011800409,0.025415454],"genre_scores_gemma":[0.9879764,0.004419934,0.000413827,0.0010667655,0.00006337294,0.00002799116,0.0011397403,0.000018771383,0.004873268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980616,0.0002531957,0.00012640766,0.00011637336,0.00070302264,0.0007394267],"domain_scores_gemma":[0.9951873,0.0005364921,0.00078350044,0.000057947527,0.0015711804,0.0018635297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006102177,0.0003172737,0.00055411615,0.0014703632,0.001463634,0.0020470659,0.0016232483,0.0010489303,0.0052738315],"category_scores_gemma":[0.0069971965,0.00054185896,0.0011144499,0.0031686407,0.00071023096,0.0004999397,0.0008316744,0.001612745,0.00025004701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002519502,0.00059997913,0.80137575,0.00087609864,0.0008263525,0.0020075704,0.00082424,0.0147888865,0.001127056,0.007502712,0.04064018,0.1269117],"study_design_scores_gemma":[0.00027604614,0.00049291516,0.96520776,0.00047541907,0.0006343737,0.0009341717,0.0024832047,0.012161359,0.00047152184,0.0005882848,0.01619635,0.0000785869],"about_ca_topic_score_codex":0.9963431,"about_ca_topic_score_gemma":0.9971938,"teacher_disagreement_score":0.15354998,"about_ca_system_score_codex":0.15354998,"about_ca_system_score_gemma":0.111873284,"threshold_uncertainty_score":0.98176205},"labels":[],"label_agreement":null},{"id":"W2343275026","doi":"10.1016/j.jval.2015.03.1168","title":"Bevacizumab for front-Line Treatment of Epithelial Ovarian, Fallopian tube or Primary Peritoneal Cancer Patients With High Risk of Relapse: a Cost Effective option for Canadian Patients","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Calgary","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Fallopian tube cancer; Oncology; Internal medicine; Fallopian tube; Debulking; Population; Chemotherapy; Carboplatin; Randomized controlled trial; Gynecology; Surgery; Cancer","score_opus":0.030159287082776955,"score_gpt":0.29893055403457947,"score_spread":0.26877126695180253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343275026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45094436,0.21157424,0.0027849344,0.1863294,0.0027111946,0.0008889143,0.0072088055,0.0004668956,0.13709122],"genre_scores_gemma":[0.9105241,0.052304137,0.006591814,0.011341351,0.00085748284,0.0001109325,0.0025129789,0.000045404286,0.01571175],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99979764,0.000032939082,0.000007081141,0.000015433925,0.00006761027,0.000079353485],"domain_scores_gemma":[0.9994929,0.000045270615,0.00004941802,0.0000061651904,0.000097288,0.00030886705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024138835,0.00017269222,0.00039860202,0.00046707108,0.0006527363,0.001087228,0.00056109997,0.0005669911,0.011224545],"category_scores_gemma":[0.0013262792,0.00010144307,0.0004900687,0.00058228004,0.00021705731,0.0003999761,0.00035877887,0.0010137999,0.00037143801],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052948305,0.00070711004,0.038863916,0.0009502143,0.00032949846,0.0011673588,0.000113000446,0.0016169109,0.0030791995,0.004887183,0.12961514,0.81337565],"study_design_scores_gemma":[0.0098282285,0.0038282988,0.328241,0.0039120675,0.0025731004,0.006541828,0.0013404083,0.013865457,0.0034284166,0.008395437,0.61779636,0.00024935184],"about_ca_topic_score_codex":0.50425917,"about_ca_topic_score_gemma":0.80671513,"teacher_disagreement_score":0.49574083,"about_ca_system_score_codex":0.011178253,"about_ca_system_score_gemma":0.017830607,"threshold_uncertainty_score":0.9973207},"labels":[],"label_agreement":null},{"id":"W2343292785","doi":"10.1016/j.jval.2015.03.587","title":"Evaluation Of A Pharmaceutical Risk-Sharing Agreement When Patients Are Screened For The Probability Of Success","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Formulary; Subsidy; Stackelberg competition; Outcome (game theory); Listing (finance); Actuarial science; Business; Microeconomics; Welfare; Population; Distribution (mathematics); Prescription drug; Social Welfare; Economics; Medical prescription; Finance; Medicine; Pharmacology","score_opus":0.43066247223099796,"score_gpt":0.40867515345984246,"score_spread":0.021987318771155506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343292785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8608448,0.00081336504,0.066570975,0.014869771,0.00047344604,0.0046221744,0.001440351,0.0004931431,0.049871925],"genre_scores_gemma":[0.9894174,0.000082332626,0.0064842007,0.00037466487,0.00009247526,0.00053376553,0.00015522935,0.0000194458,0.0028405583],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.94968903,0.038028207,0.0011630583,0.0026782681,0.00408347,0.004358049],"domain_scores_gemma":[0.75052124,0.2192618,0.008317203,0.0062180166,0.0058901804,0.009791573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07030081,0.0021397432,0.004507154,0.0014476314,0.0017536508,0.006177613,0.00561283,0.009980507,0.018774467],"category_scores_gemma":[0.1515404,0.0012383832,0.0025609415,0.00103637,0.0038009807,0.0066831075,0.005368167,0.0071881814,0.0009132557],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0405228,0.0071383202,0.011049043,0.00095032796,0.0009896514,0.00060019887,0.0007699199,0.74811786,0.0018576272,0.13564539,0.006158648,0.046200283],"study_design_scores_gemma":[0.009447554,0.012750817,0.0055761966,0.0001954728,0.0007834262,0.00019818897,0.0010218945,0.88855654,0.0015486719,0.0773427,0.0023987226,0.00017981148],"about_ca_topic_score_codex":0.008055462,"about_ca_topic_score_gemma":0.0030140209,"teacher_disagreement_score":0.07030081,"about_ca_system_score_codex":0.0085159885,"about_ca_system_score_gemma":0.017397871,"threshold_uncertainty_score":0.37179065},"labels":[],"label_agreement":null},{"id":"W2343330905","doi":"10.1016/j.jval.2015.09.2481","title":"Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Hôpital Notre-Dame; Health Canada; Novartis (Canada)","funders":"","keywords":"Fingolimod; Natalizumab; Discontinuation; Medicine; Teriflunomide; Glatiramer acetate; Internal medicine; Multiple sclerosis; Pharmacy; Physical therapy; Family medicine; Disease; Immunology","score_opus":0.1648320629122082,"score_gpt":0.3993700747735055,"score_spread":0.2345380118612973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343330905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874672,0.002137489,0.0002133067,0.0002404187,0.000017319375,0.00010053723,0.008419987,0.00002118514,0.001382565],"genre_scores_gemma":[0.9924544,0.000832028,0.00039590546,0.000130577,0.000018815186,0.000059811762,0.0056191385,0.000017463697,0.00047189297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99140036,0.0011906729,0.0012518468,0.0011897319,0.0037601918,0.0012073017],"domain_scores_gemma":[0.97119844,0.0053513627,0.010225408,0.0017552291,0.0097170975,0.001752516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063100723,0.0007850399,0.0014012341,0.004745472,0.0023001814,0.0023650213,0.0030335102,0.0014708535,0.0019979293],"category_scores_gemma":[0.023970902,0.0010685322,0.003412531,0.0120637715,0.0009397366,0.0009775218,0.0012722906,0.0015919214,0.00019880556],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010947207,0.00007788899,0.9935854,0.00011127648,0.0010055955,0.00008329709,0.00039082937,0.00019202955,0.00010904752,0.00014794963,0.0006578857,0.002544108],"study_design_scores_gemma":[0.00010012629,0.00008316061,0.9976907,0.00004125517,0.00038731948,0.0001019783,0.00032257172,0.0006974155,0.000049175647,0.000020644955,0.00047592452,0.000029747083],"about_ca_topic_score_codex":0.9616714,"about_ca_topic_score_gemma":0.9414439,"teacher_disagreement_score":0.038328588,"about_ca_system_score_codex":0.0243474,"about_ca_system_score_gemma":0.026837215,"threshold_uncertainty_score":0.17665356},"labels":[],"label_agreement":null},{"id":"W2343331314","doi":"10.1016/j.jval.2015.03.1425","title":"HIV Antiretroviral drug utilization and Expenditures In Medicaid 1991-2014","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Reimbursement; Medicine; Quarter (Canadian coin); Human immunodeficiency virus (HIV); Family medicine; Demography; Business; Health care; Geography; Economic growth; Economics","score_opus":0.08934957252520419,"score_gpt":0.3933177646291998,"score_spread":0.3039681921039956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343331314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9551239,0.0013247516,0.00010080702,0.0015248408,0.00006128125,0.000033518405,0.038875062,0.000019935715,0.0029359201],"genre_scores_gemma":[0.9563958,0.0013503615,0.0001135083,0.00035063658,0.000078174504,0.00004511441,0.037558448,0.00000996263,0.0040978957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990638,0.00015632805,0.00011591308,0.00010404392,0.00019503475,0.0003648614],"domain_scores_gemma":[0.99692756,0.00036834672,0.0018057525,0.0000691718,0.00034524378,0.00048399734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007964324,0.00024018192,0.00028223929,0.0016890656,0.0005196277,0.0008661622,0.0009073011,0.00075439346,0.0032727537],"category_scores_gemma":[0.0042846464,0.0003835864,0.0011579953,0.0033961604,0.00028749747,0.0010164372,0.0014331009,0.0014727112,0.00041247025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022807306,0.00011901705,0.9899889,0.000044937537,0.00019512234,0.000060154005,0.0001128077,0.00047473257,0.00005554186,0.00028603905,0.0048839683,0.0035505882],"study_design_scores_gemma":[0.0000063281204,0.000019759513,0.9977323,0.000027582584,0.000045764617,0.00007556537,0.00024057901,0.00021498605,0.00005731018,0.00003276813,0.0015428534,0.0000041232993],"about_ca_topic_score_codex":0.23284802,"about_ca_topic_score_gemma":0.35848677,"teacher_disagreement_score":0.23284802,"about_ca_system_score_codex":0.002857754,"about_ca_system_score_gemma":0.0028072349,"threshold_uncertainty_score":0.4629854},"labels":[],"label_agreement":null},{"id":"W2343433672","doi":"10.1016/j.jval.2015.03.430","title":"Analysis of the Drug price reviews performed by the Canadian Patented Medicine Prices review Board (1998-2014)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Notice; Drug prices; Business; Database transaction; Descriptive statistics; Medicine; Economics; Monetary economics; Law","score_opus":0.1724730036183695,"score_gpt":0.34448059725966984,"score_spread":0.17200759364130033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343433672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5953536,0.08483803,0.0018383749,0.007852946,0.00047165758,0.0010298786,0.25923708,0.000361699,0.04901673],"genre_scores_gemma":[0.86083484,0.020544916,0.0026828528,0.002028926,0.0005161684,0.00045739714,0.08840363,0.00011986205,0.024411451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9800116,0.0011213208,0.0012091165,0.00091723085,0.015028467,0.0017123263],"domain_scores_gemma":[0.9088285,0.021161214,0.025350342,0.0009408755,0.042044804,0.0016743242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068554166,0.00072719576,0.0010113717,0.027292702,0.0012623834,0.0031320208,0.0012043552,0.0010651448,0.003175581],"category_scores_gemma":[0.048969515,0.00058621727,0.0013466931,0.034897592,0.0005075006,0.0007897956,0.00076991966,0.0009656666,0.0006658146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021304737,0.0002068508,0.5467731,0.0072045852,0.003269829,0.0009217322,0.0012534936,0.006410797,0.00234478,0.0062016407,0.24214946,0.1811333],"study_design_scores_gemma":[0.000058261336,0.00007056766,0.9471534,0.0003457525,0.00054570124,0.00015899692,0.0002955204,0.002247141,0.0010513086,0.000108142296,0.047913708,0.00005160728],"about_ca_topic_score_codex":0.8414444,"about_ca_topic_score_gemma":0.89829814,"teacher_disagreement_score":0.97306246,"about_ca_system_score_codex":0.026937556,"about_ca_system_score_gemma":0.03654797,"threshold_uncertainty_score":0.31897873},"labels":[],"label_agreement":null},{"id":"W2343465675","doi":"10.1016/j.jval.2015.03.361","title":"Impact Of Weight-Related Utilities On The Cost-Effectiveness Of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Third-Line Therapy In Type 2 Diabetes Mellitus (T2dm) In A Canadian Setting","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Medicine; Sitagliptin; Metformin; Weight loss; Type 2 Diabetes Mellitus; Dipeptidyl peptidase-4 inhibitor; Internal medicine; Weight gain; Diabetes mellitus; Endocrinology; Obesity; Body weight","score_opus":0.07152820302960439,"score_gpt":0.3415893340382168,"score_spread":0.2700611310086124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343465675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97640187,0.009896303,0.00024313356,0.0029713863,0.00008723109,0.00013710844,0.003597521,0.00001851515,0.006647064],"genre_scores_gemma":[0.9974522,0.0009427961,0.0003177808,0.00015163443,0.000016809656,0.0000125635115,0.0008613462,0.0000055613723,0.00023939429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756974,0.0008847586,0.00017964096,0.00016808648,0.00052505115,0.0006726634],"domain_scores_gemma":[0.99590105,0.0018557278,0.0005534611,0.000100592435,0.0006061319,0.0009830202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002834943,0.0005745214,0.0011273957,0.0007888569,0.0008873787,0.0019777957,0.0013154747,0.000855676,0.0035496072],"category_scores_gemma":[0.014859034,0.00031381205,0.0033674175,0.00185357,0.0006196201,0.0008936887,0.00082729047,0.0017243237,0.00009681656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09068042,0.0033437135,0.6134005,0.0022617804,0.011719402,0.0006997838,0.00073405355,0.07214078,0.00097417913,0.008649611,0.013950357,0.18144532],"study_design_scores_gemma":[0.005965171,0.0051151854,0.89295244,0.00087297236,0.010002394,0.000489441,0.0015141027,0.07550859,0.00056985073,0.0024235314,0.004276533,0.00030975556],"about_ca_topic_score_codex":0.9005073,"about_ca_topic_score_gemma":0.92132866,"teacher_disagreement_score":0.09949273,"about_ca_system_score_codex":0.03770222,"about_ca_system_score_gemma":0.027864177,"threshold_uncertainty_score":0.27355003},"labels":[],"label_agreement":null},{"id":"W2343468630","doi":"10.1016/j.jval.2015.03.1241","title":"Priority Access for the Biggest – Variable Provincial Access to Oncology Drugs In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Per capita; Population; Demography; Government (linguistics); Medicine; Socioeconomics; Geography; Gross domestic product; Agricultural economics; Economic growth; Economics; Sociology","score_opus":0.5344055687052214,"score_gpt":0.4800827372557793,"score_spread":0.054322831449442055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343468630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9114292,0.0046223043,0.0006217798,0.027608022,0.00020130927,0.0001771057,0.021854425,0.00007998927,0.03340581],"genre_scores_gemma":[0.9921097,0.0008877904,0.00038547072,0.00083281455,0.000022310023,0.00001756305,0.0017718222,0.000017637207,0.0039548236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689096,0.000229927,0.00013769443,0.00018949586,0.00085229444,0.0016995439],"domain_scores_gemma":[0.9876145,0.0011133499,0.001340791,0.00021426994,0.004480358,0.0052368306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013230375,0.00021723848,0.00064406387,0.0018028986,0.0033533706,0.004060533,0.0016332616,0.00069432927,0.0057623386],"category_scores_gemma":[0.009457378,0.00036375667,0.00089588575,0.0051484373,0.0010680691,0.0008093925,0.0015826885,0.0019237404,0.00017214919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007320227,0.00024134346,0.8250098,0.00047559635,0.00043673403,0.00058059,0.0019009981,0.0062197926,0.00042673104,0.03829771,0.06805407,0.05762463],"study_design_scores_gemma":[0.00013688444,0.00007471021,0.9597686,0.00026746796,0.00014894232,0.000256126,0.0041225464,0.0070606656,0.0003443838,0.0032028167,0.02454415,0.000072707924],"about_ca_topic_score_codex":0.9987362,"about_ca_topic_score_gemma":0.99943763,"teacher_disagreement_score":0.86282116,"about_ca_system_score_codex":0.13717885,"about_ca_system_score_gemma":0.19968693,"threshold_uncertainty_score":0.9953069},"labels":[],"label_agreement":null},{"id":"W2343513074","doi":"10.1016/j.jval.2015.03.1386","title":"Projected Cost Savings of Introducing fecal Microbiota Transplant Treatment for Clostridium Difficile Infection In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clostridium difficile; Fecal bacteriotherapy; Clostridium Infections; Feces; Medicine; Microbiology; Intensive care medicine; Biology; Antibiotics","score_opus":0.0784325005619221,"score_gpt":0.327169128031578,"score_spread":0.2487366274696559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343513074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75199735,0.022572637,0.0038587595,0.12134046,0.002023097,0.00036219865,0.04141413,0.0003108253,0.056120526],"genre_scores_gemma":[0.9671988,0.008765128,0.0021925424,0.00556866,0.00024211658,0.000060837196,0.005287899,0.000028469722,0.010655472],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973189,0.000298908,0.0000941877,0.00010107892,0.00094391336,0.001243078],"domain_scores_gemma":[0.9954295,0.000254664,0.00042937204,0.000030024621,0.0022694909,0.0015869921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009293571,0.0005968858,0.0005164342,0.0011763681,0.0015401432,0.0029667686,0.0014065198,0.0018043021,0.008305993],"category_scores_gemma":[0.004836813,0.00033699666,0.0024078726,0.0017921294,0.0006761131,0.0006892315,0.0009192988,0.0023456628,0.00050424726],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005786185,0.0011354743,0.4644651,0.0017985854,0.0028356458,0.003711686,0.00078920467,0.08457621,0.005164275,0.034578703,0.1742381,0.22092074],"study_design_scores_gemma":[0.0013878668,0.0014574787,0.7965359,0.001859576,0.0028787411,0.0023323228,0.004645047,0.06843305,0.0032539254,0.005209491,0.111672215,0.00033446873],"about_ca_topic_score_codex":0.98461944,"about_ca_topic_score_gemma":0.988853,"teacher_disagreement_score":0.12222177,"about_ca_system_score_codex":0.12222177,"about_ca_system_score_gemma":0.11587449,"threshold_uncertainty_score":0.88678515},"labels":[],"label_agreement":null},{"id":"W2343754603","doi":"10.1016/j.jval.2015.03.1279","title":"Optimising market access of Cancer Drugs in Canada: a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer drugs; Clinical trial; Actuarial science; Order (exchange); Family medicine; Drug; Internal medicine; Pharmacology; Business; Finance","score_opus":0.5066928672916171,"score_gpt":0.49149817194873313,"score_spread":0.01519469534288398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343754603","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3172593,0.48355725,0.001920578,0.085995056,0.0005753464,0.0018769164,0.046874277,0.00012638673,0.061814874],"genre_scores_gemma":[0.8827757,0.09954243,0.0027528289,0.0070890808,0.00028228565,0.00035167922,0.004004414,0.0000590242,0.0031425462],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97442293,0.010199137,0.0018809055,0.0009824577,0.009865047,0.0026496272],"domain_scores_gemma":[0.8579415,0.079349294,0.019818533,0.0017127355,0.0364637,0.00471429],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02511413,0.0006725928,0.0015852473,0.0070169307,0.0017399399,0.0073769377,0.0013846391,0.0018946887,0.0026639693],"category_scores_gemma":[0.15552856,0.0006166576,0.0024343114,0.019891879,0.0011797644,0.001796197,0.0011742125,0.0021048367,0.00010458037],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009569708,0.00078978634,0.2821802,0.029122729,0.0168517,0.00045863705,0.0037421982,0.03136939,0.0007329394,0.067200735,0.23549077,0.32249126],"study_design_scores_gemma":[0.0025892125,0.00079083,0.74101555,0.013877769,0.017751226,0.00025157153,0.0032664514,0.021343514,0.000830864,0.0070991362,0.19072787,0.0004559544],"about_ca_topic_score_codex":0.97368526,"about_ca_topic_score_gemma":0.9856828,"teacher_disagreement_score":0.9748859,"about_ca_system_score_codex":0.116820924,"about_ca_system_score_gemma":0.15614834,"threshold_uncertainty_score":0.8475991},"labels":[],"label_agreement":null},{"id":"W2343830121","doi":"10.1016/j.jval.2015.03.1171","title":"Cost-Effectiveness of Radium-223 Dichloride (Radium-223) In Alsympca: A Cost-Effectiveness Analysis of Radium-223+Best Standard of Care (Bsoc) Compared With Placebo+Bsoc In Treatment of Castration-Resistant Prostate Cancer (Crpc) And Symptomatic Bone Metastases In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Bayer (Canada)","funders":"","keywords":"Radium-223; Radium; Prostate cancer; Medicine; Placebo; Internal medicine; Radiochemistry; Chemistry; Cancer","score_opus":0.0750774025053075,"score_gpt":0.30887230809299104,"score_spread":0.23379490558768354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343830121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97712564,0.01669642,0.0005211124,0.0009554835,0.00008215778,0.0006040268,0.0017042761,0.000031049593,0.0022799426],"genre_scores_gemma":[0.99696106,0.0019276744,0.0002919024,0.00008216261,0.000018820656,0.000053394368,0.00037631745,0.0000034397754,0.0002852493],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99712604,0.0016871315,0.00015964462,0.00019139877,0.00044960083,0.00038617992],"domain_scores_gemma":[0.9972704,0.0013421831,0.0005204568,0.0000689297,0.00029715858,0.0005007973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002705618,0.00084810983,0.0018390749,0.00095239544,0.0003697297,0.0011554131,0.0011609647,0.0008779872,0.002232541],"category_scores_gemma":[0.0073283296,0.0004197541,0.0046118395,0.0015568659,0.0009328941,0.00054982706,0.0006153232,0.0012139342,0.00008654437],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62200737,0.0054198424,0.057784874,0.005723405,0.024112197,0.00034754502,0.00026109355,0.10956044,0.0025248139,0.0025666538,0.0033286968,0.16636309],"study_design_scores_gemma":[0.18869853,0.14188953,0.39534461,0.0023052602,0.08869392,0.0007510256,0.0013808939,0.1659735,0.0037945549,0.0028869926,0.007837479,0.00044376164],"about_ca_topic_score_codex":0.56310475,"about_ca_topic_score_gemma":0.52917284,"teacher_disagreement_score":0.43689525,"about_ca_system_score_codex":0.025006507,"about_ca_system_score_gemma":0.01434131,"threshold_uncertainty_score":0.8789364},"labels":[],"label_agreement":null},{"id":"W2343855777","doi":"10.1016/j.jval.2015.03.1174","title":"Use of Abiraterone in The Management of Castration-Resistant Prostate Cancer: a Real-Life Cost-Effectiveness Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Internal medicine; Abiraterone acetate; Oncology; Cabazitaxel; Cohort; Proportional hazards model; Chemotherapy; Androgen deprivation therapy; Cancer","score_opus":0.28544486676665515,"score_gpt":0.4453572295609907,"score_spread":0.15991236279433557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343855777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859437,0.011571846,0.00029879666,0.0002481805,0.000039241764,0.00021633109,0.00072105695,0.000009300207,0.00095153967],"genre_scores_gemma":[0.996033,0.0031846312,0.00023824301,0.00006086687,0.000039746075,0.00006012695,0.0002803502,0.0000025975621,0.00010030801],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99611723,0.0025154003,0.00030859222,0.00022996994,0.00057655206,0.00025220696],"domain_scores_gemma":[0.9933175,0.0041477503,0.001531956,0.00024657723,0.0002099434,0.0005463678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031803541,0.0010414068,0.0019465941,0.0013933132,0.00031785257,0.001528967,0.00076157035,0.0011620275,0.0018571563],"category_scores_gemma":[0.009938647,0.0004403906,0.004391454,0.0021974894,0.0010200989,0.0013706511,0.0006856962,0.0016550629,0.00013909362],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.65397847,0.015239503,0.1150469,0.0056307735,0.021415472,0.00074016635,0.000487396,0.02830903,0.0019027836,0.0013486177,0.0010401699,0.15486075],"study_design_scores_gemma":[0.16749792,0.30020103,0.3977417,0.002346321,0.061218344,0.0028079953,0.0017948576,0.054157186,0.002306457,0.0026181159,0.0066973343,0.00061269465],"about_ca_topic_score_codex":0.007825731,"about_ca_topic_score_gemma":0.0066850414,"teacher_disagreement_score":0.007825731,"about_ca_system_score_codex":0.004058761,"about_ca_system_score_gemma":0.0017540691,"threshold_uncertainty_score":0.02944851},"labels":[],"label_agreement":null},{"id":"W2343886336","doi":"10.1016/j.jval.2015.03.1343","title":"Respiratory Related Hospitalizations In Premature Infants Prophylaxed With Palivizumab In the Canadian Registry of Palivizumab (Caress)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Incidence (geometry); Respiratory system; Internal medicine; Pregnancy; Biology","score_opus":0.07059980997668107,"score_gpt":0.35171558280925036,"score_spread":0.2811157728325693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343886336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96729773,0.0019518352,0.00020027184,0.00058884476,0.00006604504,0.00007634532,0.026110278,0.00003948373,0.0036690917],"genre_scores_gemma":[0.99103093,0.0008018409,0.00020001586,0.00021562184,0.000022726135,0.000033963268,0.007092047,0.000008559623,0.000594325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833447,0.00012223427,0.00015697646,0.0002857534,0.0005478293,0.00055284286],"domain_scores_gemma":[0.9963085,0.00022375415,0.0010340477,0.0002016079,0.0015686534,0.0006633867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009394609,0.00060471566,0.0006181072,0.0018350362,0.0019722173,0.0010176513,0.0022997032,0.0009044739,0.002204796],"category_scores_gemma":[0.0039969035,0.000664962,0.0010842867,0.004355731,0.00048349198,0.00048552966,0.0009278114,0.00143097,0.00018737066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106684565,0.000015135649,0.99492764,0.000043791486,0.00008394437,0.000095184856,0.00012401253,0.000096890006,0.000107194086,0.00012582351,0.0025210825,0.0017525827],"study_design_scores_gemma":[0.000013504333,0.000024611974,0.9984464,0.000043448665,0.00004703695,0.00011162654,0.00035545655,0.00023447169,0.000057207802,0.000023498376,0.0006315488,0.000011327887],"about_ca_topic_score_codex":0.9773451,"about_ca_topic_score_gemma":0.9861005,"teacher_disagreement_score":0.022654891,"about_ca_system_score_codex":0.016598625,"about_ca_system_score_gemma":0.027550494,"threshold_uncertainty_score":0.12043202},"labels":[],"label_agreement":null},{"id":"W2343913309","doi":"10.1016/j.jval.2015.03.212","title":"The Processes For A Common Quality Assurance Approach To Multi-Centre Clinical Trials – The Mars Excite Experience","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University Health Network; University of Toronto; St. Joseph’s Healthcare Hamilton; Occupational Cancer Research Centre; MaRS","funders":"","keywords":"Protocol (science); Reimbursement; Quality assurance; Mandate; Consistency (knowledge bases); Clinical trial; Excellence; Health technology; Harmonization; Patient safety; Quality (philosophy); Directive; Medicine; Process management; Health care; Engineering management; Business; Computer science; Engineering; Operations management; Political science; Alternative medicine","score_opus":0.8958734595184378,"score_gpt":0.6102145894217075,"score_spread":0.2856588700967303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343913309","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003276551,0.008096586,0.6257178,0.3416384,0.006055117,0.004784732,0.00021515478,0.0012866075,0.008929071],"genre_scores_gemma":[0.083370075,0.0036579461,0.81957096,0.07316157,0.0055609737,0.008926625,0.0004066356,0.0007210947,0.0046240482],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.2721125,0.5894926,0.046118807,0.022134492,0.06320477,0.006936794],"domain_scores_gemma":[0.17053975,0.35544598,0.054300226,0.20952244,0.17453638,0.0356552],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.74392855,0.0025830297,0.004512287,0.010236721,0.009274794,0.037398264,0.012782736,0.023859465,0.0073354137],"category_scores_gemma":[0.7065939,0.004360229,0.0077672,0.008315409,0.037252355,0.02696071,0.036323667,0.06339078,0.0043879095],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006868511,0.00085562223,0.0035384216,0.0032595713,0.0012513369,0.0005641958,0.015769064,0.0067226766,0.001999731,0.5733373,0.12982348,0.26219183],"study_design_scores_gemma":[0.0011782282,0.0015227979,0.006590276,0.0064856466,0.0002887024,0.00075116626,0.0025316193,0.0098067075,0.0019366766,0.66916585,0.298912,0.0008302677],"about_ca_topic_score_codex":0.009901929,"about_ca_topic_score_gemma":0.0071849455,"teacher_disagreement_score":0.25607145,"about_ca_system_score_codex":0.03215251,"about_ca_system_score_gemma":0.10760388,"threshold_uncertainty_score":0.3157817},"labels":[],"label_agreement":null},{"id":"W2344022877","doi":"10.1016/j.jval.2015.03.1353","title":"Comparing First- and Second-Season Palivizumab Prophylaxis In Patients with Hemodynamically Significant Congenital Heart Disease in the Caress Database (2005-2014)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Heart disease; Demographics; Respiratory system; Internal medicine; Demography","score_opus":0.032058679219712935,"score_gpt":0.2700274605698912,"score_spread":0.23796878135017824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344022877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821592,0.003909133,0.00008582391,0.00026275014,0.00007001597,0.00003304918,0.012554927,0.000007751647,0.0009174809],"genre_scores_gemma":[0.9923239,0.00059936935,0.00008768675,0.0001683559,0.0000431663,0.000025838413,0.006556339,0.0000035991561,0.00019180712],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973054,0.00068420515,0.00052514963,0.0005813556,0.00038366925,0.0005202275],"domain_scores_gemma":[0.9947364,0.0011853387,0.0025027958,0.00037039755,0.00068524556,0.00051982177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00216215,0.00040130442,0.0009895132,0.0014598276,0.00034411115,0.0010677776,0.0011110356,0.0007956655,0.0012479917],"category_scores_gemma":[0.0086253,0.0004137105,0.002444204,0.0028633426,0.00030134464,0.000829104,0.0009858016,0.0010770193,0.0001267241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012650309,0.000033799024,0.9940798,0.00013365314,0.0014034254,0.00004065479,0.000053933178,0.000110051275,0.00006448759,0.000061203995,0.0013110588,0.0014429928],"study_design_scores_gemma":[0.00017624495,0.00019966655,0.99772054,0.000080674195,0.0006659844,0.00010584731,0.00022843579,0.00020150335,0.00006214087,0.000023186754,0.00052857987,0.000007148602],"about_ca_topic_score_codex":0.08574785,"about_ca_topic_score_gemma":0.12274655,"teacher_disagreement_score":0.08574785,"about_ca_system_score_codex":0.0015641958,"about_ca_system_score_gemma":0.00196559,"threshold_uncertainty_score":0.17049748},"labels":[],"label_agreement":null},{"id":"W2344055717","doi":"10.1016/j.jval.2015.03.244","title":"Safety pen needle (SPN) devices in the actue care setting: an analysis of health resource utilization (HRU) in the United States","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Occupational Health and Safety Research","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Vial; Medicine; Insulin; Health care; Acute care; Operations management; Emergency medicine; Internal medicine; Engineering","score_opus":0.27832197914548423,"score_gpt":0.518206704374128,"score_spread":0.23988472522864374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344055717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997303,0.00043168472,0.00010977186,0.00016179489,0.0000078848425,0.000017872539,0.0012740172,0.0000040621844,0.00069004245],"genre_scores_gemma":[0.9983463,0.00032695665,0.000099756,0.00015141618,0.000008289633,0.00001561472,0.00089526974,0.0000030827537,0.00015316639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860805,0.0004234762,0.00021896427,0.00019510702,0.00026081255,0.00029368163],"domain_scores_gemma":[0.99667054,0.0005834238,0.0016613406,0.000114029535,0.00039626606,0.00057441834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010666944,0.0002727492,0.00034512303,0.0020003486,0.00064375,0.0011443583,0.00065416895,0.00062133005,0.0014192511],"category_scores_gemma":[0.002850247,0.00037004217,0.0012247663,0.0035411622,0.0003971707,0.0008540603,0.0012998272,0.00088653865,0.00020396923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047949095,0.00007781496,0.9977016,0.0000121017365,0.00007871391,0.000032334632,0.00011043558,0.00008490912,0.00005220415,0.00003543589,0.00024038355,0.0015261483],"study_design_scores_gemma":[0.0000028823022,0.00006204953,0.99795425,0.000018818808,0.000028986584,0.00007187863,0.0011469852,0.00046497112,0.000037913804,0.000019377907,0.00018682431,0.0000050536364],"about_ca_topic_score_codex":0.081636,"about_ca_topic_score_gemma":0.13330448,"teacher_disagreement_score":0.081636,"about_ca_system_score_codex":0.0019510931,"about_ca_system_score_gemma":0.0017153829,"threshold_uncertainty_score":0.16232169},"labels":[],"label_agreement":null},{"id":"W2344056490","doi":"10.1016/j.jval.2015.03.1725","title":"Adherence to Iron Chelation Therapy and associated Healthcare resource Utilization and costs in Medicaid Patients with Thalassemia","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Thalassemia; Medicaid; Deferasirox; Incidence (geometry); Internal medicine; Pediatrics; Health care; Deferiprone","score_opus":0.061214443843849456,"score_gpt":0.3123881805425267,"score_spread":0.25117373669867726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344056490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998917,0.00024239915,0.000014940552,0.00024991418,0.0000060754664,0.0000031187537,0.0001138829,9.283769e-7,0.0004517783],"genre_scores_gemma":[0.9994491,0.00014741528,0.000026828528,0.00011080544,0.000011987925,0.0000036970741,0.0001320632,7.1893254e-7,0.00011735811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958366,0.00011120361,0.00006760502,0.000039827322,0.00007967459,0.00011806367],"domain_scores_gemma":[0.99828076,0.0004211607,0.00090688496,0.000047838952,0.000073913325,0.0002693723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041798063,0.00013690966,0.00028751724,0.00054786005,0.000588438,0.0007591499,0.0002798108,0.0006865413,0.0018614375],"category_scores_gemma":[0.0033396007,0.00021262384,0.00058219046,0.0011309868,0.00027209937,0.0004953801,0.0005376742,0.001113663,0.00007744861],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007999845,0.00015527787,0.99786794,0.0000061273186,0.00008057562,0.00006185895,0.000070837596,0.00007058445,0.00003924696,0.00004841534,0.00012663227,0.0013924643],"study_design_scores_gemma":[0.000007411671,0.000048431117,0.9988102,0.000013173764,0.000043282078,0.00011129255,0.00037790835,0.00040693153,0.00001431901,0.000058755493,0.00010464684,0.0000036593005],"about_ca_topic_score_codex":0.023268245,"about_ca_topic_score_gemma":0.03494402,"teacher_disagreement_score":0.023268245,"about_ca_system_score_codex":0.00069811527,"about_ca_system_score_gemma":0.0007362363,"threshold_uncertainty_score":0.04626566},"labels":[],"label_agreement":null},{"id":"W2344104450","doi":"10.1016/j.jval.2015.03.334","title":"Glycated Hemoglobin (Hba1c) Control In Patients with Type 2 Diabetes Mellitus (T2dm) Treated with Canagliflozin In a real-world setting","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Canagliflozin; Glycemic; Glycated hemoglobin; Internal medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Endocrinology; Insulin","score_opus":0.020484828497267325,"score_gpt":0.25867420052536416,"score_spread":0.23818937202809684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344104450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99853563,0.00057813263,0.000036322483,0.00018994954,0.000015087711,0.000007076798,0.0001312818,0.0000024828469,0.0005040391],"genre_scores_gemma":[0.9995454,0.00016833717,0.00005363043,0.000071780436,0.000014495489,0.000003352327,0.0001095908,9.0131107e-7,0.000032463297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992079,0.0003752742,0.00008604398,0.0001050755,0.00010112792,0.00012469328],"domain_scores_gemma":[0.9987839,0.00035676826,0.0004065548,0.000032423963,0.00009726276,0.0003230022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068904296,0.00019411929,0.00056671095,0.0004560528,0.00040377188,0.0010343805,0.00026739636,0.00063324644,0.00071808073],"category_scores_gemma":[0.0038622185,0.00017075568,0.0004625209,0.0011733404,0.00031017847,0.0006131641,0.00035209706,0.00082457485,0.00007362918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024473502,0.0005734913,0.98903406,0.000048960726,0.00015524513,0.00034400192,0.0001532506,0.00021228624,0.00012085455,0.000049995906,0.0005032915,0.006357155],"study_design_scores_gemma":[0.00021704503,0.0015593983,0.99410665,0.00003242823,0.00019226024,0.00051523984,0.00091377756,0.0018574728,0.00006869124,0.00011883971,0.0003968322,0.000021307416],"about_ca_topic_score_codex":0.01016071,"about_ca_topic_score_gemma":0.012410552,"teacher_disagreement_score":0.01016071,"about_ca_system_score_codex":0.0008317136,"about_ca_system_score_gemma":0.0005002398,"threshold_uncertainty_score":0.020203173},"labels":[],"label_agreement":null},{"id":"W2344111754","doi":"10.1016/j.jval.2015.03.855","title":"Drug Use Among Seniors On Public Drug Programs In Canada, 2012","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Drug; Medicine; Drug class; Medical prescription; Gerontology; Prescription drug; Antipsychotic drug; Family medicine; Antipsychotic; Psychiatry; Pharmacology","score_opus":0.32234881585246045,"score_gpt":0.3952171402858316,"score_spread":0.07286832443337116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344111754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96697646,0.0019092651,0.00010938233,0.0019913318,0.00007834981,0.00009207736,0.023475546,0.00002981567,0.0053378358],"genre_scores_gemma":[0.98963845,0.0011762129,0.0001714597,0.0006444264,0.00003260917,0.000028647972,0.004985398,0.000008002111,0.0033147878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889576,0.000045772038,0.00010554265,0.00011142954,0.00043037438,0.0004111834],"domain_scores_gemma":[0.99653566,0.000067453526,0.00063889707,0.00004179144,0.0014757132,0.0012405213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004824589,0.00032359007,0.0005651865,0.0017925142,0.0029487284,0.0016449201,0.0012879438,0.0009385796,0.00200202],"category_scores_gemma":[0.0021808862,0.00043307152,0.0009439443,0.005942852,0.00055916945,0.00076697586,0.00098458,0.0017748644,0.00032587763],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008346317,0.00011006133,0.9906254,0.000048483384,0.00005131993,0.00005056806,0.00041089105,0.000055609646,0.000044893924,0.000066841,0.003731937,0.004720511],"study_design_scores_gemma":[0.000008270138,0.000022501566,0.9973501,0.000044250803,0.000026289339,0.000037069985,0.0013350734,0.0001090896,0.00002845471,0.000014196338,0.0010162584,0.000008364202],"about_ca_topic_score_codex":0.9946142,"about_ca_topic_score_gemma":0.9979443,"teacher_disagreement_score":0.032108128,"about_ca_system_score_codex":0.032108128,"about_ca_system_score_gemma":0.048436705,"threshold_uncertainty_score":0.2329619},"labels":[],"label_agreement":null},{"id":"W2344132437","doi":"10.1016/j.jval.2015.03.1624","title":"Risk of Cardiovascular events Associated with Necessary Interventions for Parkinson Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Stroke (engine); Pharmacotherapy; Myocardial infarction; Heart failure; Disease; Confidence interval; Odds ratio","score_opus":0.07706753949940535,"score_gpt":0.3285573336009148,"score_spread":0.25148979410150946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344132437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96120983,0.02017314,0.0009869458,0.0016707239,0.00017433133,0.00007635127,0.0015289664,0.000036729594,0.014143029],"genre_scores_gemma":[0.99620193,0.0020717937,0.0003866899,0.00013654579,0.0001537841,0.000012627221,0.000505485,0.0000033366332,0.00052780024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945587,0.00017923347,0.000063320105,0.00007973189,0.00013202794,0.000089942296],"domain_scores_gemma":[0.9968395,0.0012596635,0.0010790189,0.00021790878,0.00022085791,0.00038301965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054879015,0.0002378971,0.00052971323,0.00047107105,0.00035081865,0.00061983836,0.00021131501,0.0006940531,0.0026488611],"category_scores_gemma":[0.0049876384,0.00019196556,0.0014312991,0.0005635448,0.00016108036,0.00031855304,0.00035626636,0.001665472,0.00013364003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00862233,0.00063719874,0.9395815,0.00037675552,0.0025058344,0.0007064857,0.0000817845,0.00031978165,0.0007533023,0.0010844951,0.0018590527,0.04347153],"study_design_scores_gemma":[0.00014423039,0.00086184376,0.9934674,0.00009637678,0.0012307138,0.00083175447,0.000078501704,0.00081856997,0.00015820697,0.0014214756,0.0008764621,0.000014406206],"about_ca_topic_score_codex":0.0022123912,"about_ca_topic_score_gemma":0.003507276,"teacher_disagreement_score":0.0026488611,"about_ca_system_score_codex":0.0004115082,"about_ca_system_score_gemma":0.00056453346,"threshold_uncertainty_score":0.008861303},"labels":[],"label_agreement":null},{"id":"W2344145331","doi":"10.1016/j.jval.2015.03.1231","title":"The Disconnect Between Funding Decisions of Cancer Drugs And Companion Diagnostic Tests in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Companion diagnostic; Diagnostic test; Medicine; Test (biology); Cancer; Cancer drugs; Family medicine; Intensive care medicine; Medical physics; Pediatrics; Internal medicine","score_opus":0.21203949751455525,"score_gpt":0.36278646560157163,"score_spread":0.15074696808701638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344145331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56886935,0.020068245,0.0010845345,0.33596775,0.0005217804,0.00010570916,0.008694287,0.000073231604,0.06461506],"genre_scores_gemma":[0.9833191,0.0026974252,0.0003265608,0.006159344,0.0001293483,0.000013378908,0.0006261828,0.00002471836,0.006704022],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.991542,0.0009523704,0.00035169403,0.00051763287,0.0028234036,0.0038129764],"domain_scores_gemma":[0.96473396,0.010701503,0.0039277407,0.00044752329,0.010314658,0.009874451],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0055343434,0.000244518,0.0008372375,0.0027156104,0.0041032736,0.008261747,0.0020829232,0.0038776542,0.00548566],"category_scores_gemma":[0.031699695,0.0006553546,0.00087124616,0.005217178,0.002584609,0.001619073,0.001729719,0.004542035,0.00019275463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001542783,0.00029877963,0.3366776,0.0006220093,0.000747798,0.0014011649,0.0034240999,0.028376969,0.0009334657,0.39354292,0.14433798,0.0880944],"study_design_scores_gemma":[0.0007087367,0.00015645362,0.74361306,0.0011322087,0.00068267796,0.00048050677,0.007995504,0.029692149,0.0013132059,0.05013039,0.16364197,0.00045323017],"about_ca_topic_score_codex":0.99657875,"about_ca_topic_score_gemma":0.9981192,"teacher_disagreement_score":0.99446565,"about_ca_system_score_codex":0.21406749,"about_ca_system_score_gemma":0.2258175,"threshold_uncertainty_score":0.9115703},"labels":[],"label_agreement":null},{"id":"W2344151845","doi":"10.1016/j.jval.2015.03.627","title":"Modelling The Cost Determinants For Older Persons’ Transitions In Care (Optic)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health care; Ordinary least squares; Emergency department; Estimation; Medicine; Medical emergency; Nursing; Statistics","score_opus":0.20624744831102487,"score_gpt":0.43444665632784274,"score_spread":0.22819920801681787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344151845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95822126,0.0009827635,0.023925066,0.0034809213,0.00015172375,0.000104793915,0.0032165209,0.00006797605,0.009849032],"genre_scores_gemma":[0.98749256,0.00030666523,0.0022884512,0.00007798458,0.000035583675,0.00006342085,0.0007404039,0.000024912419,0.008970006],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999343,0.00026120766,0.000026195868,0.000075806325,0.000046940386,0.00024688934],"domain_scores_gemma":[0.9960045,0.002963224,0.00031166378,0.00008088875,0.00025719043,0.00038255795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001472728,0.0006807671,0.0008340382,0.0009844867,0.00055051874,0.0020884352,0.0015340486,0.0023178293,0.010871765],"category_scores_gemma":[0.008806875,0.0007611463,0.0016090715,0.0014713913,0.0005405065,0.001339972,0.0010422565,0.0019846172,0.00045338427],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031341924,0.0003929121,0.045944575,0.00007885339,0.0001981595,0.00020557476,0.0002274431,0.9105013,0.00012921174,0.029140789,0.0037327358,0.009135014],"study_design_scores_gemma":[0.00006192817,0.00012515944,0.016004344,0.000050312403,0.00010866805,0.00008113868,0.00048896874,0.9667517,0.000063182975,0.014014561,0.0022184567,0.000031490697],"about_ca_topic_score_codex":0.13353705,"about_ca_topic_score_gemma":0.09877083,"teacher_disagreement_score":0.13353705,"about_ca_system_score_codex":0.004105858,"about_ca_system_score_gemma":0.0035151376,"threshold_uncertainty_score":0.26551956},"labels":[],"label_agreement":null},{"id":"W2344162046","doi":"10.1016/j.jval.2015.03.1522","title":"TUBERCULOSIS screening preferences of Healthcare workers in South Africa: a best-worst scaling study to analyze variation by Occupation","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of British Columbia","funders":"","keywords":"Tuberculosis; Variation (astronomy); Scaling; Health care; Environmental health; Medicine; Economic growth; Economics; Mathematics","score_opus":0.15148534458644577,"score_gpt":0.40164062202966927,"score_spread":0.2501552774432235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344162046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99976546,0.000013839172,0.000053042673,0.000016122594,9.270748e-7,0.0000032829564,0.000045978344,4.3657639e-7,0.000100794576],"genre_scores_gemma":[0.9998437,0.000008184072,0.000048575923,0.0000063930474,5.976923e-7,0.000003939916,0.000035989113,7.947263e-7,0.00005180663],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.998635,0.00076153,0.00007901811,0.0001405384,0.0001486994,0.00023521615],"domain_scores_gemma":[0.99763,0.00093695096,0.0005896019,0.00024392274,0.00025496757,0.0003444639],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015666934,0.00026030827,0.00035770782,0.0006428019,0.0008654704,0.00087476434,0.00042711385,0.0004013299,0.0015696991],"category_scores_gemma":[0.00649751,0.0002471591,0.0005310653,0.0009913712,0.0007823675,0.00070351304,0.0011291422,0.00054511864,0.00019029735],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020648935,0.00012019711,0.9886713,0.000013832511,0.00008407483,0.000107022424,0.0064550354,0.00018201933,0.00069047493,0.00011745507,0.00013639993,0.0032157353],"study_design_scores_gemma":[0.000004399347,0.00020160722,0.9848876,0.000009323379,0.000017762335,0.00012621252,0.013648814,0.00063526287,0.0001022733,0.00010989456,0.00024505207,0.0000118122425],"about_ca_topic_score_codex":0.015563389,"about_ca_topic_score_gemma":0.016993042,"teacher_disagreement_score":0.015563389,"about_ca_system_score_codex":0.00068099913,"about_ca_system_score_gemma":0.0004184138,"threshold_uncertainty_score":0.0309456},"labels":[],"label_agreement":null},{"id":"W2344218605","doi":"10.1016/j.jval.2015.03.1435","title":"HIV treatment strategies In europe (EU): Adoption of Single Tablet Regimen (STR)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Medicine; Dosing; Regimen; Family medicine; Quarter (Canadian coin); Human immunodeficiency virus (HIV); Demography; Pediatrics; Geography; Internal medicine; Adverse effect","score_opus":0.08063424318367501,"score_gpt":0.3113629764906792,"score_spread":0.23072873330700416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344218605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78357106,0.04536026,0.0042897877,0.07247812,0.0010005747,0.00022378427,0.000804326,0.00017742241,0.09209458],"genre_scores_gemma":[0.9598327,0.0071562133,0.005924799,0.021400882,0.00017800172,0.00004836971,0.00034263352,0.000042226166,0.0050741355],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977028,0.0011394703,0.00018425824,0.00019670572,0.00041401843,0.00036283274],"domain_scores_gemma":[0.99689746,0.0011109505,0.00065099605,0.0002036698,0.00045412494,0.0006828075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053282715,0.00013690065,0.00024027581,0.00049884774,0.00043704684,0.0020706228,0.0007038615,0.0014640744,0.004084532],"category_scores_gemma":[0.005848691,0.00011012999,0.00040183464,0.0007267309,0.00076178374,0.00096934784,0.0011729415,0.0013426815,0.00021384371],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013594996,0.0009238841,0.06440824,0.00081323594,0.00019167684,0.00083264045,0.0018000716,0.0013105882,0.0044685556,0.051832274,0.020900218,0.85115904],"study_design_scores_gemma":[0.0008370261,0.006205698,0.46986213,0.0037901064,0.00043964342,0.0053199674,0.008582599,0.0028392214,0.008688275,0.011052429,0.4822628,0.000120118944],"about_ca_topic_score_codex":0.006647319,"about_ca_topic_score_gemma":0.008825237,"teacher_disagreement_score":0.006647319,"about_ca_system_score_codex":0.0014611196,"about_ca_system_score_gemma":0.004758686,"threshold_uncertainty_score":0.02817893},"labels":[],"label_agreement":null},{"id":"W2344298048","doi":"10.1016/j.jval.2015.03.974","title":"Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / Biosimilars","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Infliximab; Biosimilar; Reimbursement; Formulary; Medicine; Family medicine; Health care; Internal medicine; Disease; Political science","score_opus":0.1314074851867528,"score_gpt":0.3296436078192548,"score_spread":0.19823612263250198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344298048","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.091175385,0.021268966,0.0045466013,0.29822263,0.010954937,0.0009342735,0.020661226,0.0021295515,0.55010635],"genre_scores_gemma":[0.687279,0.014146708,0.006878927,0.06060767,0.0027422302,0.00019509807,0.011160575,0.0004648878,0.21652491],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9827094,0.001168138,0.00040173667,0.0006855384,0.0115912,0.0034439769],"domain_scores_gemma":[0.96815586,0.0031017389,0.0012225738,0.00067483407,0.020054441,0.0067905425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050963527,0.0008022151,0.0007187079,0.00423996,0.003952786,0.0055659907,0.0024441052,0.004488821,0.034279108],"category_scores_gemma":[0.032236323,0.0006520678,0.0020358649,0.0031743904,0.0020030902,0.0007860025,0.0016529111,0.0043883617,0.0023581244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010041072,0.00020294348,0.013372765,0.0005133542,0.00022085871,0.00063704466,0.00033418808,0.0013578904,0.0016953693,0.060826536,0.8055824,0.1142525],"study_design_scores_gemma":[0.0005541752,0.00025170846,0.051277388,0.00056918483,0.00022455005,0.0007765391,0.0005018351,0.00252644,0.0014690155,0.002118166,0.9396121,0.00011887712],"about_ca_topic_score_codex":0.9654118,"about_ca_topic_score_gemma":0.9671407,"teacher_disagreement_score":0.8762117,"about_ca_system_score_codex":0.12378831,"about_ca_system_score_gemma":0.2740151,"threshold_uncertainty_score":0.8981513},"labels":[],"label_agreement":null},{"id":"W2344331325","doi":"10.1016/j.jval.2015.03.096","title":"Should decision makers embrace non-constant discounting?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Discounting; Constant (computer programming); Economics; Econometrics; Mathematical economics; Microeconomics; Computer science","score_opus":0.23457006303464598,"score_gpt":0.28773263669557353,"score_spread":0.05316257366092755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344331325","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1297726,0.015757248,0.33798385,0.4341224,0.003664359,0.0001035812,0.00019148712,0.00015024407,0.07825431],"genre_scores_gemma":[0.96332043,0.0025074866,0.022070227,0.00888929,0.0011092386,0.000025840767,0.000021725085,0.000048741284,0.002007049],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9926519,0.0042628874,0.00041717236,0.00077969313,0.001323186,0.00056522357],"domain_scores_gemma":[0.8860701,0.087201536,0.008741523,0.00790651,0.0074440576,0.0026362885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02693319,0.00050518155,0.0007807907,0.00056159974,0.0007371732,0.0067248046,0.0019193299,0.005358127,0.0026910743],"category_scores_gemma":[0.15298079,0.00059328903,0.00050508283,0.00070979726,0.0076132007,0.019444061,0.0016516069,0.007282863,0.00042368358],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017348214,0.00007635861,0.0028090202,0.00022621958,0.000134311,0.00018952542,0.00078670133,0.010219442,0.0004595055,0.914533,0.006587934,0.063804574],"study_design_scores_gemma":[0.000040421488,0.000017089553,0.00058554055,0.0001138306,0.000024244002,0.00007973964,0.00031243157,0.0074237464,0.0002753725,0.98159397,0.009509901,0.00002368738],"about_ca_topic_score_codex":0.0031382097,"about_ca_topic_score_gemma":0.002396634,"teacher_disagreement_score":0.02693319,"about_ca_system_score_codex":0.0025559296,"about_ca_system_score_gemma":0.0024625466,"threshold_uncertainty_score":0.14243805},"labels":[],"label_agreement":null},{"id":"W2344464066","doi":"10.1016/j.jval.2015.03.1329","title":"Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus Infection","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Tolerability; Pediatrics; Adverse effect; Observational study; Respiratory system; Internal medicine","score_opus":0.10080863401052034,"score_gpt":0.40178518505051664,"score_spread":0.3009765510399963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344464066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98710537,0.0034263344,0.00007550001,0.0013504183,0.000090357884,0.00007813494,0.0028127239,0.000010970293,0.005050112],"genre_scores_gemma":[0.99758184,0.0009626546,0.00008960806,0.00035572192,0.000030260797,0.000011816036,0.0006588706,0.0000024290837,0.00030687323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978715,0.00026675555,0.00017596358,0.00013916122,0.0007910146,0.0007555238],"domain_scores_gemma":[0.9960983,0.00034669167,0.0012175438,0.000051878997,0.0013109049,0.00097463164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009745734,0.00035504848,0.0005986622,0.0009061141,0.001693118,0.0011624724,0.000785752,0.0007973843,0.0022258551],"category_scores_gemma":[0.004688462,0.00032353518,0.0011594102,0.0019388387,0.0005306537,0.0002705697,0.000534338,0.0019463467,0.00010774625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002709533,0.00004795727,0.9933616,0.0000844616,0.00011652501,0.00035115398,0.00030176848,0.00010825131,0.00008154275,0.00007989209,0.0014998973,0.003695956],"study_design_scores_gemma":[0.000023142591,0.000103928396,0.9977366,0.00006169969,0.00006324157,0.00021800278,0.00070107833,0.00012613459,0.000033281183,0.000015260182,0.00090577797,0.000012041926],"about_ca_topic_score_codex":0.94752675,"about_ca_topic_score_gemma":0.9587202,"teacher_disagreement_score":0.052473247,"about_ca_system_score_codex":0.017864862,"about_ca_system_score_gemma":0.02159917,"threshold_uncertainty_score":0.12961924},"labels":[],"label_agreement":null},{"id":"W2344586242","doi":"10.1016/j.jval.2015.03.1240","title":"Pcodr – the pointless canadian oncology drug review?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Excellence; Agency (philosophy); Medicine; Family medicine; Health technology; Cancer drugs; Actuarial science; Health care; Business; Internal medicine; Political science; Cancer","score_opus":0.6382060207309973,"score_gpt":0.4735590873269704,"score_spread":0.16464693340402692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344586242","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023474511,0.35825068,0.00042645022,0.55704296,0.06542203,0.00005945914,0.00095785444,0.000095134295,0.017510671],"genre_scores_gemma":[0.013624541,0.3931705,0.002649635,0.51657456,0.04659886,0.00015286062,0.000992121,0.00018244912,0.026054442],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98258704,0.004158902,0.001213069,0.0010647816,0.008798017,0.002178175],"domain_scores_gemma":[0.8984431,0.018639844,0.0041570053,0.0035754412,0.061485834,0.013698764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024834637,0.0018355253,0.0032516583,0.007194251,0.0034332403,0.013951952,0.0049281167,0.011508854,0.024759306],"category_scores_gemma":[0.09674886,0.00075971254,0.0020348702,0.0097523695,0.008487743,0.010828215,0.0039524757,0.012524847,0.0053519276],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009952279,0.00001717853,0.00014424522,0.0007673115,0.000060474536,0.00002443714,0.000030677944,0.00006923404,0.000031997577,0.015447725,0.9282732,0.055034],"study_design_scores_gemma":[0.00007634532,0.00002299111,0.00045266788,0.0024819677,0.00007148297,0.000032119828,0.00008425678,0.00007298022,0.00002828009,0.0052953362,0.99134773,0.000033921868],"about_ca_topic_score_codex":0.6711576,"about_ca_topic_score_gemma":0.7837884,"teacher_disagreement_score":0.94504666,"about_ca_system_score_codex":0.054953363,"about_ca_system_score_gemma":0.17797954,"threshold_uncertainty_score":0.66155803},"labels":[],"label_agreement":null},{"id":"W2344591572","doi":"10.1016/j.jval.2015.03.101","title":"Assessing The Incremental Predictive Value Of Healthcare Utilization Pathways In Risk Prediction Modeling","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Quality Council; University of Manitoba","funders":"","keywords":"Medicine; Cohort; Emergency department; Health care; Proportional hazards model; Logistic regression; Statistic; Ambulatory; Hazard ratio; Population; Statistics; Akaike information criterion; COPD; Emergency medicine; Demography; Internal medicine; Environmental health; Mathematics; Confidence interval","score_opus":0.223990011396999,"score_gpt":0.39779283503377627,"score_spread":0.17380282363677726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344591572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8674409,0.003852892,0.11446387,0.004351155,0.00030992547,0.0004843611,0.0037064988,0.0005909187,0.0047995243],"genre_scores_gemma":[0.9843694,0.0005716911,0.013328019,0.00013079283,0.00010123981,0.00010287099,0.0009843345,0.00002366168,0.00038794772],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98922986,0.008161095,0.00051881484,0.00071541633,0.0009765284,0.00039824613],"domain_scores_gemma":[0.83056784,0.15743217,0.002706158,0.004158093,0.0039022076,0.0012334613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03441313,0.0018775004,0.0014323845,0.003422722,0.0005833052,0.0028961569,0.0019867811,0.0016782506,0.0021976922],"category_scores_gemma":[0.14139453,0.0005999274,0.0019665426,0.0027361976,0.0007280188,0.0032255582,0.0019393003,0.0033711274,0.00052693166],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025203764,0.00094763946,0.6226201,0.00029954527,0.002615319,0.00031607735,0.0002949828,0.2657869,0.00028332166,0.006058588,0.002381936,0.09587528],"study_design_scores_gemma":[0.00013690394,0.0008972007,0.031543456,0.00014410612,0.0011167142,0.0002956623,0.00018046125,0.9456609,0.0005662124,0.018555393,0.00084667647,0.000056284425],"about_ca_topic_score_codex":0.0077394154,"about_ca_topic_score_gemma":0.0052471883,"teacher_disagreement_score":0.03441313,"about_ca_system_score_codex":0.000868842,"about_ca_system_score_gemma":0.002864898,"threshold_uncertainty_score":0.18199623},"labels":[],"label_agreement":null},{"id":"W2344610150","doi":"10.1016/j.jval.2015.03.838","title":"Persistence And Compliance With Lipid- Lowering Drugs In Patients With Chronic Kidney Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Kidney disease; Persistence (discontinuity); Internal medicine; Poisson regression; Cohort; Nephrology; Diabetes mellitus; Disease; Cohort study; Population; Endocrinology; Environmental health","score_opus":0.07547145479782982,"score_gpt":0.3047942212543732,"score_spread":0.2293227664565434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344610150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975563,0.00089086604,0.00006656547,0.00034998133,0.000020623129,0.000007180082,0.0001536779,0.0000039872043,0.0009508658],"genre_scores_gemma":[0.99920243,0.00022897545,0.000076921024,0.000116568954,0.00003212808,0.000005603186,0.00016290612,0.0000022645222,0.00017229714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980338,0.00062869757,0.00042894343,0.00018247036,0.00044129646,0.00028486157],"domain_scores_gemma":[0.9865384,0.005042025,0.005620139,0.0005069014,0.00074950984,0.001543067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019801464,0.00026158907,0.0009055854,0.001379149,0.0009296312,0.001755429,0.00051386096,0.0014705411,0.0022460115],"category_scores_gemma":[0.017097725,0.00043751765,0.0013236867,0.0024256273,0.0005074034,0.0015835146,0.0008808698,0.0027523534,0.0002210989],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010554487,0.00013275613,0.99796754,0.000011314303,0.00010863922,0.000032789358,0.00008064808,0.000023870605,0.00002497201,0.000015549633,0.000040375202,0.0014560123],"study_design_scores_gemma":[0.000012470062,0.00015220272,0.9988776,0.00001585765,0.000067009736,0.00014664495,0.00026524332,0.00028072938,0.000021357224,0.00007067636,0.00008323804,0.000006885316],"about_ca_topic_score_codex":0.0050294087,"about_ca_topic_score_gemma":0.0062306416,"teacher_disagreement_score":0.0050294087,"about_ca_system_score_codex":0.00057590107,"about_ca_system_score_gemma":0.0007248869,"threshold_uncertainty_score":0.010472119},"labels":[],"label_agreement":null},{"id":"W2344625650","doi":"10.1016/j.jval.2015.03.086","title":"Comparing the predictive performance of two variants of the elixhauser comorbidity measures for all-cause in-hospital mortality in a large multi-payer u.s. Administrative database","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Insurance, Mortality, Demography, Risk Management","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Comorbidity; Medicine; Confounding; Logistic regression; Emergency medicine; Statistic; Demography; Health care; Medical diagnosis; Internal medicine; Statistics","score_opus":0.23330155053984405,"score_gpt":0.4206595807583505,"score_spread":0.18735803021850647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344625650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972324,0.00023489028,0.00020792193,0.00014810122,0.000016083815,0.000010425096,0.001917711,0.000010634241,0.00022187676],"genre_scores_gemma":[0.99667823,0.0001001504,0.00034749086,0.000045378372,0.000024081364,0.000015182132,0.0027264517,0.000004067918,0.00005895494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616647,0.002004705,0.0005245736,0.00061604794,0.0004375416,0.00025084274],"domain_scores_gemma":[0.97389966,0.017323721,0.0044950424,0.0022997786,0.0011592734,0.0008225055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054315086,0.00052347395,0.00070487533,0.0017089173,0.00036984886,0.0015700302,0.0011926203,0.00086096587,0.0011062729],"category_scores_gemma":[0.026048064,0.00032985696,0.0012574752,0.0021124883,0.0003862602,0.001193647,0.0011826177,0.0010327927,0.00019306951],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015390328,0.00014025907,0.9923463,0.000024051127,0.00071157474,0.000027203485,0.00007414304,0.0006660206,0.00007488257,0.00013060973,0.0005148599,0.0037510998],"study_design_scores_gemma":[0.00024579413,0.00027572512,0.98527783,0.00003055786,0.0006242314,0.00014711174,0.00028675332,0.012359064,0.0001772639,0.00026701877,0.0002821884,0.00002643171],"about_ca_topic_score_codex":0.011757414,"about_ca_topic_score_gemma":0.0141302105,"teacher_disagreement_score":0.011757414,"about_ca_system_score_codex":0.0007529035,"about_ca_system_score_gemma":0.0006970865,"threshold_uncertainty_score":0.02872485},"labels":[],"label_agreement":null},{"id":"W2344659104","doi":"10.1016/j.jval.2015.03.1128","title":"Overall survival in post-menopausal women with hr+/her2- metastatic breast cancer treated with 1st-line endocrine therapy vs. Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Metastatic breast cancer; Hazard ratio; Internal medicine; Proportional hazards model; Breast cancer; Chemotherapy; Oncology; Cancer; Medical record; Gynecology; Confidence interval","score_opus":0.041236051209525615,"score_gpt":0.3246524755579592,"score_spread":0.28341642434843356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344659104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509513,0.0032331878,0.000032111075,0.00028856235,0.00005329494,0.000014082215,0.00033348118,0.0000026540697,0.0009475294],"genre_scores_gemma":[0.99836093,0.00067791314,0.000018072898,0.00013020173,0.00004696121,0.000011849604,0.00034537437,9.384626e-7,0.00040765776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998901,0.000034812772,0.0000068634345,0.00002007641,0.000011720555,0.00003641861],"domain_scores_gemma":[0.9997632,0.00009738766,0.00005176453,0.000010374077,0.000011234973,0.00006607046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029573965,0.00012021027,0.00047210837,0.00017382701,0.00013599821,0.0002935351,0.00021583024,0.00036838028,0.0018389269],"category_scores_gemma":[0.0009617891,0.000068774025,0.0007308703,0.00020051507,0.00013115129,0.0002936188,0.00020086738,0.00043933612,0.00012262617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29026717,0.0026604936,0.5280088,0.0005105013,0.002282719,0.0007799197,0.00052877574,0.0051104715,0.006609444,0.0005841679,0.004702306,0.15795512],"study_design_scores_gemma":[0.006135819,0.041477315,0.94275767,0.00014650184,0.0018858998,0.0005491428,0.0004970151,0.0019138297,0.0007209024,0.0005548931,0.003332645,0.000028444723],"about_ca_topic_score_codex":0.0028881498,"about_ca_topic_score_gemma":0.0069790394,"teacher_disagreement_score":0.0028881498,"about_ca_system_score_codex":0.00047861124,"about_ca_system_score_gemma":0.0003391367,"threshold_uncertainty_score":0.0061517954},"labels":[],"label_agreement":null},{"id":"W2344728545","doi":"10.1016/j.jval.2015.03.835","title":"Cost Effectiveness of Drugs for Pulmonary Arterial Hypertension: A Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Tadalafil; Medicine; Sildenafil; Combination therapy; Riociguat; Placebo; Quality-adjusted life year; Cost-effectiveness analysis; Internal medicine; Pulmonary hypertension; Cost effectiveness; Chronic thromboembolic pulmonary hypertension","score_opus":0.16069031487988508,"score_gpt":0.3779929736393779,"score_spread":0.2173026587594928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344728545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95051795,0.0199927,0.00029900367,0.0039116913,0.000109868575,0.000520033,0.012709148,0.000017872444,0.011921618],"genre_scores_gemma":[0.97992754,0.012096929,0.00089173805,0.0011903433,0.00006916976,0.00014996585,0.004098208,0.000018689188,0.0015573939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961731,0.0007916324,0.00027875896,0.0003556055,0.001575967,0.0008249779],"domain_scores_gemma":[0.9894281,0.0028319538,0.0018595268,0.00043613845,0.00371752,0.0017266868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032191714,0.0011425056,0.002041652,0.0024099317,0.003542941,0.0024898292,0.0022710802,0.0017071993,0.0042501893],"category_scores_gemma":[0.012678174,0.00088646985,0.004213141,0.009796357,0.0015505686,0.0011047154,0.001123131,0.0029180436,0.00020160685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027720148,0.003438118,0.8405015,0.0045905043,0.009328712,0.0011560626,0.002170033,0.0039596558,0.00074841623,0.005427606,0.027968084,0.07299124],"study_design_scores_gemma":[0.008939031,0.0015049252,0.9619557,0.0015255281,0.0077157617,0.00062646676,0.002571794,0.0035529905,0.00022695572,0.0006489025,0.010422862,0.00030908154],"about_ca_topic_score_codex":0.99343264,"about_ca_topic_score_gemma":0.99502015,"teacher_disagreement_score":0.089383185,"about_ca_system_score_codex":0.089383185,"about_ca_system_score_gemma":0.08253016,"threshold_uncertainty_score":0.64852345},"labels":[],"label_agreement":null},{"id":"W2344781650","doi":"10.1016/j.jval.2015.03.945","title":"Biologic Discontinuation In Rheumatoid Arthritis: Experience From Canadian Clinics","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Discontinuation; Medicine; Rheumatoid arthritis; Hazard ratio; Proportional hazards model; Internal medicine; Confidence interval; Rheumatology; Cohort; Pharmacy; Prospective cohort study; Cohort study; Family medicine","score_opus":0.07325251117706211,"score_gpt":0.34661689109491295,"score_spread":0.27336437991785084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344781650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9497873,0.018076144,0.00024872855,0.01002465,0.00015847542,0.00018447379,0.0007205551,0.00001879837,0.020780858],"genre_scores_gemma":[0.98021185,0.012253657,0.00042921893,0.002576154,0.00009545219,0.000042911885,0.00037496685,0.000022140479,0.003993594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950315,0.00097059057,0.0002167846,0.00026180453,0.0022800083,0.0012392632],"domain_scores_gemma":[0.9845383,0.003071484,0.002804339,0.00022735096,0.003958137,0.0054003913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003538932,0.0003120215,0.00056072016,0.0007470591,0.0068426463,0.0029218225,0.0010508792,0.0011769679,0.0035054784],"category_scores_gemma":[0.013561379,0.00028640754,0.00042820355,0.0038801557,0.0015356271,0.0006681978,0.0014427298,0.0014604235,0.0002146369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019293947,0.001472656,0.5924058,0.0012294777,0.0001934666,0.0038778456,0.11005486,0.00043051987,0.0014381092,0.0018176994,0.03418394,0.2509662],"study_design_scores_gemma":[0.00028270145,0.0009769379,0.80728364,0.00093549624,0.0002294619,0.0030604447,0.09289925,0.000382351,0.00040236884,0.00024384151,0.093165085,0.00013837367],"about_ca_topic_score_codex":0.92204034,"about_ca_topic_score_gemma":0.9702355,"teacher_disagreement_score":0.07795966,"about_ca_system_score_codex":0.03513479,"about_ca_system_score_gemma":0.0617774,"threshold_uncertainty_score":0.25492197},"labels":[],"label_agreement":null},{"id":"W2344793782","doi":"10.1016/j.jval.2015.03.1599","title":"The Burden of Gout in a Canadian Primary Care Population","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Gout; Medicine; Dyslipidemia; Internal medicine; Comorbidity; Population; Cohort; Physical therapy; Retrospective cohort study; Obesity; Environmental health","score_opus":0.04199059418450885,"score_gpt":0.30378038739646335,"score_spread":0.2617897932119545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344793782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97607565,0.003115696,0.000091813854,0.0044131526,0.00005766017,0.000068677386,0.0075864824,0.00001539586,0.008575439],"genre_scores_gemma":[0.9956033,0.0020424135,0.00012534145,0.00031715215,0.000029915529,0.000011353733,0.0011999443,0.00000340104,0.0006672263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859256,0.00010213816,0.00006940359,0.00011686267,0.0005775092,0.0005415639],"domain_scores_gemma":[0.9983644,0.000075947915,0.00028797358,0.000042964628,0.0006462189,0.00058241317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004997503,0.00040051236,0.00056267367,0.0020503483,0.0042360183,0.0021806166,0.0012960833,0.0011211892,0.0034984797],"category_scores_gemma":[0.003085739,0.00040167663,0.0009761987,0.007103168,0.00082716317,0.0007275347,0.001353508,0.0014512803,0.00022594933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012411427,0.000086297645,0.9813859,0.0000894144,0.000119331875,0.00040955818,0.0015328268,0.00026123258,0.00019094146,0.0006401129,0.0050588716,0.010101382],"study_design_scores_gemma":[0.00000861577,0.000024471588,0.9959518,0.000048555652,0.00005616109,0.00016194684,0.0022109104,0.00030901333,0.000013864648,0.00007645181,0.0011206935,0.000017645196],"about_ca_topic_score_codex":0.9960769,"about_ca_topic_score_gemma":0.9973832,"teacher_disagreement_score":0.039854664,"about_ca_system_score_codex":0.039854664,"about_ca_system_score_gemma":0.0419036,"threshold_uncertainty_score":0.28916717},"labels":[],"label_agreement":null},{"id":"W2344795692","doi":"10.1016/j.jval.2015.03.1573","title":"The market for Hepatitis C services in Alberta","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Hepatitis C; Activity-based costing; Cirrhosis; Liver disease; Service (business); Medicine; Market segmentation; Business; Family medicine; Internal medicine; Marketing","score_opus":0.08335228341309626,"score_gpt":0.3811638095800761,"score_spread":0.29781152616697987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344795692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6223536,0.0070763514,0.0004491804,0.13257031,0.00097084057,0.00013537768,0.0045253183,0.00014224132,0.23177677],"genre_scores_gemma":[0.87415564,0.003185425,0.0004563809,0.007538901,0.0002834393,0.000028135277,0.0010233225,0.00003569562,0.11329304],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9983576,0.00012004856,0.000026429174,0.00006995922,0.0006997807,0.00072618295],"domain_scores_gemma":[0.9948244,0.0007812219,0.00025564324,0.000055886812,0.000985718,0.0030971088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008591883,0.00018450763,0.00024540318,0.0011747383,0.0025985837,0.0046284767,0.0011264371,0.0016779151,0.015947647],"category_scores_gemma":[0.00328507,0.0003079321,0.00027227946,0.0016398592,0.0014469795,0.00062573573,0.0012293748,0.00152621,0.0006201155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014856445,0.0004738735,0.32184,0.00041639275,0.00012783802,0.006133282,0.0033405824,0.004882,0.0029380391,0.13250326,0.35929844,0.1665607],"study_design_scores_gemma":[0.0003363667,0.00023499544,0.62214065,0.00044969478,0.000069216076,0.0012244678,0.013806352,0.007308406,0.0008033591,0.0063769645,0.34712735,0.00012214539],"about_ca_topic_score_codex":0.95771354,"about_ca_topic_score_gemma":0.98233515,"teacher_disagreement_score":0.058275193,"about_ca_system_score_codex":0.058275193,"about_ca_system_score_gemma":0.082802124,"threshold_uncertainty_score":0.42281812},"labels":[],"label_agreement":null},{"id":"W2344925427","doi":"10.1016/j.jval.2015.03.1665","title":"What are people willing to pay for whole genome sequencing information?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Bone and Joint Health Institute","funders":"","keywords":"Willingness to pay; Respondent; Contingent valuation; Harm; Medicine; Population; Actuarial science; Family medicine; Psychology; Business; Social psychology; Environmental health; Economics","score_opus":0.47968343518192064,"score_gpt":0.4236131884081372,"score_spread":0.056070246773783416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344925427","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16997117,0.029690836,0.0076315026,0.72873604,0.0032927308,0.00008841518,0.0013102987,0.00009096073,0.059188057],"genre_scores_gemma":[0.9125797,0.0065975254,0.00306709,0.07125455,0.0022112306,0.00009537329,0.00043277306,0.00006677804,0.0036949692],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9946396,0.0029604544,0.0003110432,0.00023569183,0.0011023412,0.0007508917],"domain_scores_gemma":[0.95181197,0.032522295,0.005275045,0.0014057312,0.0037152043,0.0052697104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008312779,0.00026862547,0.0007739991,0.0013381011,0.00090741087,0.004491795,0.00063379254,0.005339891,0.013975889],"category_scores_gemma":[0.09002423,0.00031734808,0.0006934501,0.0012525808,0.0029563985,0.005303676,0.0014627541,0.0042636483,0.0018819672],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001267334,0.00045355075,0.18012433,0.0009706364,0.0013551286,0.0010321385,0.0030583248,0.0020653766,0.0011012963,0.08366651,0.18837519,0.5365302],"study_design_scores_gemma":[0.00047818825,0.00062248716,0.20391686,0.0041398667,0.0011560568,0.0057686786,0.019965779,0.0067779454,0.001145229,0.5578956,0.19774729,0.00038603478],"about_ca_topic_score_codex":0.0025406347,"about_ca_topic_score_gemma":0.0021726296,"teacher_disagreement_score":0.013975889,"about_ca_system_score_codex":0.0013670751,"about_ca_system_score_gemma":0.0015893861,"threshold_uncertainty_score":0.046754003},"labels":[],"label_agreement":null},{"id":"W2344941622","doi":"10.1016/j.jval.2015.03.789","title":"Geographic Differences In Availability Of Antihypertensive Medications: A Comparison Of Australia, Canada, Saudi Arabia, Uk, And The Us","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Food and drug administration; Antihypertensive drug; Pharmaceutical Benefits Scheme; Environmental health; Family medicine; Internal medicine; Pharmacology; Blood pressure; Medical prescription","score_opus":0.12854499033636957,"score_gpt":0.33490604366982846,"score_spread":0.2063610533334589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344941622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99795353,0.00082641805,0.000022916856,0.00009162688,0.0000061947458,0.000007737667,0.00028289517,7.5242946e-7,0.00080792996],"genre_scores_gemma":[0.9991658,0.00043272905,0.000034755227,0.000041879925,0.00000438274,0.0000038231897,0.0001977103,9.0226536e-7,0.000117987984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917394,0.0001910948,0.00011040402,0.00009706089,0.0002116629,0.00021585857],"domain_scores_gemma":[0.99759173,0.00037555277,0.00071910484,0.00008087453,0.00081568834,0.0004170179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008027232,0.00026192598,0.00047603148,0.001921056,0.0010077558,0.0010372709,0.0005984406,0.0004286297,0.0013807459],"category_scores_gemma":[0.0029556775,0.00025458107,0.0007641245,0.0060105855,0.0006639039,0.0005225861,0.000939793,0.0004923818,0.00009920342],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017860578,0.000029928888,0.99557304,0.000050093404,0.00026405667,0.0001183039,0.0013428845,0.000037051926,0.00013426763,0.000107925865,0.00013793715,0.0020259833],"study_design_scores_gemma":[0.000004455003,0.000023647313,0.9971486,0.000018616174,0.000057527097,0.000059870483,0.0024188582,0.00003273275,0.000021568938,0.000010929782,0.00019931681,0.0000038876383],"about_ca_topic_score_codex":0.75926644,"about_ca_topic_score_gemma":0.79812235,"teacher_disagreement_score":0.24073356,"about_ca_system_score_codex":0.0028069988,"about_ca_system_score_gemma":0.002762585,"threshold_uncertainty_score":0.48430258},"labels":[],"label_agreement":null},{"id":"W2344995406","doi":"10.1016/j.jval.2015.03.1631","title":"Teriflunomide Shows Consistent Clinical Efficacy On Severe Relapses Across temso and tower: 2 Phase 3 trials","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Placebo; Tolerability; Internal medicine; Post-hoc analysis; Randomized controlled trial; Clinical endpoint; Clinical trial; Physical therapy; Adverse effect; Multiple sclerosis; Immunology; Pathology; Alternative medicine","score_opus":0.24609849403132955,"score_gpt":0.47822724840647296,"score_spread":0.2321287543751434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344995406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95820844,0.019394709,0.0016576347,0.0032773141,0.0005462177,0.0038441482,0.006618681,0.00041656045,0.006036193],"genre_scores_gemma":[0.95233506,0.017076418,0.0047984007,0.0043926067,0.0005103968,0.0043827756,0.008915819,0.00016949832,0.007419045],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993375,0.00028086614,0.000055961485,0.000108589134,0.00007414328,0.0001429163],"domain_scores_gemma":[0.9987042,0.000245441,0.00030946155,0.00014778705,0.0001471132,0.00044601745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025828972,0.0014540955,0.0032689716,0.00051106984,0.0007967527,0.0010286914,0.00090335123,0.00145182,0.0054997806],"category_scores_gemma":[0.0013933112,0.00046969525,0.0034726022,0.0005763123,0.0008542902,0.0012327477,0.00050008675,0.0038028462,0.001024042],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5899812,0.02766785,0.008135899,0.002898176,0.007425088,0.00018524652,0.00037238482,0.0018334625,0.036767643,0.00050538284,0.015530608,0.3086971],"study_design_scores_gemma":[0.6003262,0.3332901,0.038894083,0.00045299175,0.0039646467,0.00037940504,0.00020583003,0.0009915848,0.0067171613,0.0005948329,0.014053562,0.00012956474],"about_ca_topic_score_codex":0.0019910622,"about_ca_topic_score_gemma":0.010953304,"teacher_disagreement_score":0.0054997806,"about_ca_system_score_codex":0.0012645978,"about_ca_system_score_gemma":0.0014859035,"threshold_uncertainty_score":0.018398583},"labels":[],"label_agreement":null},{"id":"W2344998323","doi":"10.1016/j.jval.2015.03.973","title":"Analysis of Etanercept Treatment Patterns And Reimbursement Gaps In Patients When Transitioning from Private to Public Drug Plans","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Merck Canada Inc. (Canada)","funders":"","keywords":"Etanercept; Medicine; Reimbursement; Medical prescription; Family medicine; Retrospective cohort study; Internal medicine; Rheumatoid arthritis; Pharmacology; Economic growth","score_opus":0.06513608121172984,"score_gpt":0.332143952977266,"score_spread":0.2670078717655362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344998323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984561,0.00016813863,0.000041919804,0.00028349392,0.0000035638866,0.000012376625,0.0005441801,0.0000014820065,0.00048872887],"genre_scores_gemma":[0.9992156,0.00006184521,0.0000609127,0.00007179631,0.0000036633073,0.00001155452,0.0004533015,0.0000019958202,0.00011924399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974269,0.0007181164,0.00038176138,0.00030894318,0.00036039186,0.00080376456],"domain_scores_gemma":[0.98935366,0.0036788892,0.0046759075,0.00024752348,0.0008929276,0.0011511982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018059965,0.00011518111,0.0004906347,0.00090792024,0.0006978047,0.0016298472,0.0005311321,0.00067641767,0.0032976607],"category_scores_gemma":[0.0150977,0.00020996176,0.0009777276,0.002395126,0.00031766167,0.0016037913,0.0010249517,0.0011155838,0.00025041442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008992302,0.00014202496,0.99287194,0.000019627098,0.00007127815,0.00006853131,0.00034290014,0.00017020597,0.00005932356,0.00016554246,0.0003004983,0.004888948],"study_design_scores_gemma":[0.00003824337,0.0002884693,0.9931391,0.0000495151,0.00006738794,0.00021434805,0.003739161,0.0013791965,0.00011509291,0.00022976636,0.0007267636,0.00001290968],"about_ca_topic_score_codex":0.017060423,"about_ca_topic_score_gemma":0.018138306,"teacher_disagreement_score":0.017060423,"about_ca_system_score_codex":0.0018435831,"about_ca_system_score_gemma":0.002713056,"threshold_uncertainty_score":0.033922255},"labels":[],"label_agreement":null},{"id":"W2345038106","doi":"10.1016/j.jval.2015.03.492","title":"Impact of Clinical and Health Economic Publications on Commercial success of Pharmaceutical products in the U.S","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Casual; Asthma; Confounding; Internal medicine; Geography","score_opus":0.5591690276145322,"score_gpt":0.5192826927033346,"score_spread":0.03988633491119764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345038106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5654709,0.06314366,0.0003832492,0.17918397,0.0024788266,0.000063963766,0.018770583,0.00017174201,0.1703331],"genre_scores_gemma":[0.964056,0.016471997,0.0001562221,0.0036763668,0.0023886282,0.000019240117,0.0026461864,0.000053309876,0.010532063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908565,0.0033899294,0.0008397152,0.00046665524,0.0037068173,0.000740353],"domain_scores_gemma":[0.7323962,0.14961624,0.066593096,0.0032204736,0.03441999,0.013754092],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009761952,0.00024768186,0.0003700991,0.0064217555,0.0007756948,0.008919477,0.0006059172,0.0016064377,0.01166858],"category_scores_gemma":[0.10420369,0.00021100754,0.0004039114,0.010053123,0.0017522466,0.0031773036,0.0017850482,0.0025051094,0.0016227143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013932098,0.00055883656,0.58106244,0.0010667063,0.000590928,0.0011315987,0.0013456534,0.0023652804,0.0005039754,0.042526744,0.20795788,0.1594968],"study_design_scores_gemma":[0.00020859875,0.00036143724,0.8535068,0.0016369895,0.0003262907,0.001006794,0.0052330284,0.002537705,0.0018472217,0.00807669,0.12512751,0.00013097294],"about_ca_topic_score_codex":0.014332948,"about_ca_topic_score_gemma":0.014129288,"teacher_disagreement_score":0.9902381,"about_ca_system_score_codex":0.0038263407,"about_ca_system_score_gemma":0.0047807572,"threshold_uncertainty_score":0.051626742},"labels":[],"label_agreement":null},{"id":"W2345152158","doi":"10.1016/j.jval.2015.03.1666","title":"Estimating the value of Whole Exome Sequencing for parents of Children with Rare Genetic Diseases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; University of Calgary; Alberta Bone and Joint Health Institute","funders":"","keywords":"Exome sequencing; Genetic testing; Medicine; Diagnostic test; Exome; Genetic diagnosis; Test (biology); Pediatrics; Mutation; Genetics; Internal medicine; Biology","score_opus":0.028359158034846642,"score_gpt":0.2783447127836063,"score_spread":0.24998555474875964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345152158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860698,0.0026748013,0.0045992355,0.001885138,0.000039749957,0.000020535477,0.0024263996,0.000030041634,0.0022543285],"genre_scores_gemma":[0.99634093,0.00046998163,0.002376875,0.00011412541,0.000026308211,0.000011274724,0.0005221184,0.000008115777,0.00013025924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966974,0.0022735281,0.00015626925,0.0002749343,0.00044873773,0.00014913392],"domain_scores_gemma":[0.9443982,0.050943356,0.0018496773,0.0011190379,0.0012215668,0.0004680498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053356863,0.0005733641,0.0005627726,0.001427362,0.0002581942,0.00090154726,0.00055640936,0.0011512203,0.001698825],"category_scores_gemma":[0.054612424,0.00026649312,0.0006666327,0.0010377873,0.0004180295,0.0013219027,0.00070489454,0.0010905302,0.0002634462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007841767,0.000049564278,0.9609983,0.0000784453,0.00039693512,0.0006136253,0.00028955357,0.0039729453,0.0005897133,0.0007075654,0.0008135776,0.030705424],"study_design_scores_gemma":[0.000107595915,0.00078209606,0.92459404,0.00033391634,0.001176337,0.0041898056,0.0016518263,0.04885505,0.003704484,0.011020853,0.0035285284,0.00005541215],"about_ca_topic_score_codex":0.002938923,"about_ca_topic_score_gemma":0.0019378563,"teacher_disagreement_score":0.0053356863,"about_ca_system_score_codex":0.00040851074,"about_ca_system_score_gemma":0.00042016926,"threshold_uncertainty_score":0.02821815},"labels":[],"label_agreement":null},{"id":"W2345167039","doi":"10.1016/j.jval.2015.03.1656","title":"The Cost-Effectiveness of Lisdexamfetamine Dimesylate for The Treatment of Binge Eating Disorder","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cost effectiveness; Placebo; Binge-eating disorder; Cohort; Randomized controlled trial; Psychiatry; Physical therapy; Internal medicine; Eating disorders; Bulimia nervosa","score_opus":0.13392381945194728,"score_gpt":0.4112252914943482,"score_spread":0.27730147204240096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345167039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9746761,0.01823712,0.0004047997,0.002624268,0.00018312421,0.00016574324,0.0007108732,0.00003465722,0.0029632645],"genre_scores_gemma":[0.9967625,0.00231062,0.00024274336,0.00015101112,0.000072007344,0.000028432061,0.00015047002,0.0000020904822,0.00028012536],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993005,0.00039639167,0.00006498008,0.000046723304,0.00012199811,0.00006942988],"domain_scores_gemma":[0.9988827,0.00060672796,0.00023904405,0.000030195715,0.00004025372,0.00020112853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006853917,0.00042907408,0.0010822786,0.0008045696,0.00021900811,0.000609784,0.00036000766,0.00092818006,0.004989622],"category_scores_gemma":[0.0031869581,0.00026707308,0.0019518037,0.0005223951,0.0003987443,0.00080918515,0.0003587315,0.001183322,0.000263508],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.54558724,0.0044301427,0.02407674,0.0017756595,0.0049558003,0.000834048,0.00008487953,0.011303419,0.005208199,0.0016898996,0.00242134,0.39763266],"study_design_scores_gemma":[0.28482714,0.24325003,0.35717648,0.001829181,0.023383291,0.00449708,0.00082555285,0.05875159,0.009256254,0.0037055563,0.012115057,0.00038284605],"about_ca_topic_score_codex":0.0027724062,"about_ca_topic_score_gemma":0.005439319,"teacher_disagreement_score":0.004989622,"about_ca_system_score_codex":0.0023998842,"about_ca_system_score_gemma":0.001047205,"threshold_uncertainty_score":0.017412424},"labels":[],"label_agreement":null},{"id":"W2345185915","doi":"10.1016/j.jval.2015.03.1243","title":"Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Clinical trial; Crizotinib; Family medicine; Randomized controlled trial; Brentuximab vedotin; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Health care; Political science","score_opus":0.21594901015353493,"score_gpt":0.3568086925135758,"score_spread":0.14085968236004084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345185915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30816668,0.014968853,0.015733665,0.2478321,0.003672113,0.010471861,0.26909956,0.0023870855,0.12766798],"genre_scores_gemma":[0.8373752,0.00495641,0.01567044,0.037549615,0.0012566372,0.0022181524,0.0694281,0.0003198352,0.031225571],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.97880495,0.0076845777,0.0013034199,0.00092995795,0.00778527,0.0034917407],"domain_scores_gemma":[0.86687994,0.053403173,0.015202481,0.004717852,0.042674202,0.017122347],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028471516,0.0005101346,0.0010729306,0.002657473,0.0016070304,0.0054085953,0.0025671439,0.002385973,0.0062791402],"category_scores_gemma":[0.10882383,0.00085374864,0.0014041414,0.0057912264,0.0015372151,0.0012362425,0.0014042932,0.0029732764,0.00085568015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012601926,0.00051501155,0.10407083,0.0022197263,0.0010320885,0.00037335773,0.0003489012,0.022213362,0.0009027084,0.03756288,0.6832853,0.13487402],"study_design_scores_gemma":[0.012667199,0.0016889353,0.48883396,0.002079544,0.0016007752,0.0002545505,0.0004167076,0.045378827,0.002015273,0.007998657,0.43671006,0.00035554147],"about_ca_topic_score_codex":0.90980524,"about_ca_topic_score_gemma":0.9273525,"teacher_disagreement_score":0.9715285,"about_ca_system_score_codex":0.06146086,"about_ca_system_score_gemma":0.2622747,"threshold_uncertainty_score":0.44593185},"labels":[],"label_agreement":null},{"id":"W2345211209","doi":"10.1016/j.jval.2015.03.1507","title":"Expected costs and Health outcomes for a Cohort of Albertans diagnosed with Hepatitis C","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Medicine; Cohort; Hepatitis C; Liver disease; Health care; Demography; Cohort study; Population; Antiviral treatment; Internal medicine; Environmental health; Chronic hepatitis; Virology; Economic growth","score_opus":0.11152671704253161,"score_gpt":0.40058006416226816,"score_spread":0.2890533471197365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345211209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826056,0.00010277468,0.00003904344,0.00009794005,0.0000044805747,0.000006270354,0.0008295501,0.0000022383833,0.00065708143],"genre_scores_gemma":[0.99774724,0.000096419484,0.00005234932,0.000031854957,0.0000057358525,0.00000462077,0.0014357654,0.0000011266302,0.00062495255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997569,0.00003855354,0.000012301457,0.00003314438,0.000048987637,0.00011013224],"domain_scores_gemma":[0.99936455,0.0000917273,0.00016587015,0.00003234026,0.000120343495,0.00022517973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035313753,0.0002918588,0.00022158155,0.0007475206,0.0006953888,0.0009932366,0.0006724374,0.00050009554,0.001785059],"category_scores_gemma":[0.001747176,0.0002716095,0.00062013615,0.00081501063,0.00030308866,0.00037487978,0.00047362808,0.0007360332,0.00014261043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028195197,0.00007918553,0.9969482,0.000003910944,0.00008146193,0.00019019694,0.000052921456,0.0008252486,0.00007199583,0.000100932135,0.0003832298,0.0009807446],"study_design_scores_gemma":[0.000026989128,0.000088174835,0.9951485,0.000009324517,0.000056559693,0.00027949098,0.00052207423,0.0034088283,0.000035815192,0.00015859472,0.0002538589,0.000011804674],"about_ca_topic_score_codex":0.66977,"about_ca_topic_score_gemma":0.6244519,"teacher_disagreement_score":0.33023,"about_ca_system_score_codex":0.0058592805,"about_ca_system_score_gemma":0.0025606735,"threshold_uncertainty_score":0.66434956},"labels":[],"label_agreement":null},{"id":"W2345676570","doi":"10.1016/j.jval.2016.03.1832","title":"Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Galantamine; Hazard ratio; Discontinuation; Rivastigmine; Donepezil; Medicine; Population; Proportional hazards model; Internal medicine; Confidence interval; Cohort; Persistence (discontinuity); Cohort study; Propensity score matching; Dementia; Disease; Environmental health","score_opus":0.06013867219358992,"score_gpt":0.4119118203197864,"score_spread":0.3517731481261965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345676570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9028233,0.005198169,0.00048615184,0.06263953,0.00016070929,0.000067169836,0.0041575176,0.000021478436,0.024445968],"genre_scores_gemma":[0.9957216,0.0007877477,0.00010874759,0.0014434964,0.000043030424,0.000009545119,0.00025890325,0.0000058008363,0.0016210601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911327,0.002902586,0.00037162562,0.00028693487,0.0016591232,0.0036471135],"domain_scores_gemma":[0.96625715,0.01669618,0.0067336773,0.00081585103,0.0047395816,0.004757451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057776985,0.000124768,0.000660366,0.000890295,0.0014221171,0.0034001656,0.0013030494,0.0015665614,0.0046894546],"category_scores_gemma":[0.04819376,0.00026212932,0.0012974754,0.0031744703,0.001315022,0.0010859785,0.0016074566,0.0020503816,0.00014639359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040626815,0.0005737389,0.88559145,0.00031276394,0.0004615614,0.00031072221,0.0014212077,0.005345125,0.0005330459,0.031064725,0.011268784,0.05905427],"study_design_scores_gemma":[0.00026630293,0.00029981017,0.97366625,0.00028152825,0.000300498,0.00014272532,0.002220601,0.0051189363,0.00047718172,0.0054397234,0.011754908,0.00003152929],"about_ca_topic_score_codex":0.85272485,"about_ca_topic_score_gemma":0.8914472,"teacher_disagreement_score":0.85272485,"about_ca_system_score_codex":0.036439616,"about_ca_system_score_gemma":0.06155985,"threshold_uncertainty_score":0.2962849},"labels":[],"label_agreement":null},{"id":"W2346525997","doi":"10.1016/j.jval.2016.03.295","title":"Income Growth Trajectory For Parents Of Children With Down Syndrome In The United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Cohort; Medicine; Propensity score matching; Demography; Wilcoxon signed-rank test; Retrospective cohort study; Pediatrics; Internal medicine; Mann–Whitney U test","score_opus":0.02924142829214116,"score_gpt":0.2855053423278418,"score_spread":0.25626391403570065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346525997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99658525,0.00017945,0.000028358987,0.0003869326,0.000009528594,0.0000029569092,0.002085013,0.000004301621,0.0007181252],"genre_scores_gemma":[0.99737704,0.0002290896,0.00003581183,0.00005516512,0.0000038492094,0.0000051675643,0.0018444409,0.0000026888242,0.0004468537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985194,0.000025748843,0.00001454062,0.00002529912,0.000021737793,0.000060781702],"domain_scores_gemma":[0.99936754,0.00006346201,0.000244688,0.000015486647,0.00013254677,0.00017619965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020959011,0.0001825258,0.00018505663,0.0006602064,0.0006327638,0.00063626457,0.00030743456,0.00039438438,0.002002809],"category_scores_gemma":[0.001130514,0.00013946176,0.00041384718,0.0010954154,0.00017429802,0.00054335647,0.0007747211,0.00077677064,0.0002246461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046399946,0.00002981441,0.9977787,0.0000030262422,0.000018021496,0.000104041676,0.00021573834,0.000102321166,0.000036425918,0.00005607416,0.0005083408,0.0011009992],"study_design_scores_gemma":[0.0000016233294,0.000017761862,0.9982797,0.000008104605,0.000007900547,0.00007086467,0.0011965208,0.0001814722,0.000015406127,0.0000264377,0.00019185591,0.0000025556635],"about_ca_topic_score_codex":0.17503574,"about_ca_topic_score_gemma":0.20199464,"teacher_disagreement_score":0.17503574,"about_ca_system_score_codex":0.00088672875,"about_ca_system_score_gemma":0.00079541863,"threshold_uncertainty_score":0.34803385},"labels":[],"label_agreement":null},{"id":"W2346904063","doi":"10.1016/j.jval.2016.03.1855","title":"Regulatory Decision Making in Canada—Exploring New Frontiers in Patient Involvement","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta; Health Canada","funders":"Health Canada","keywords":"Transparency (behavior); Context (archaeology); Legislature; Process (computing); Health care; Business; Medicine; Public relations; Process management; Knowledge management; Political science; Computer science","score_opus":0.2721636936292732,"score_gpt":0.37906542746340494,"score_spread":0.10690173383413176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346904063","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2980639,0.008974167,0.0033689474,0.56721485,0.0009161714,0.00015398831,0.00033571798,0.000060927294,0.12091138],"genre_scores_gemma":[0.9659641,0.0019503036,0.0012306336,0.020065147,0.0001280097,0.000035970173,0.00007322683,0.000033544493,0.010519047],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.9646471,0.011444307,0.0007621563,0.0015980564,0.00780157,0.013746678],"domain_scores_gemma":[0.91507643,0.033361994,0.0035584306,0.0013161782,0.017878065,0.028808903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025950968,0.00034708428,0.0007758689,0.0021435125,0.023395767,0.022148313,0.00432968,0.008193833,0.010456142],"category_scores_gemma":[0.049372938,0.0005988602,0.00096198753,0.0043622083,0.017883293,0.0053135008,0.006591586,0.011016433,0.00030976473],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00068285264,0.00073724537,0.09699387,0.0006251,0.00016530631,0.0015596414,0.09114925,0.0037029455,0.00074438547,0.51709694,0.122298576,0.16424394],"study_design_scores_gemma":[0.00033655093,0.00031544385,0.19637622,0.0024983562,0.00014652485,0.00044243046,0.2424617,0.0077609024,0.0012823308,0.102471225,0.44536233,0.0005459626],"about_ca_topic_score_codex":0.98762333,"about_ca_topic_score_gemma":0.99532974,"teacher_disagreement_score":0.76204413,"about_ca_system_score_codex":0.23795587,"about_ca_system_score_gemma":0.54707867,"threshold_uncertainty_score":0.8838632},"labels":[],"label_agreement":null},{"id":"W2353253986","doi":"10.1016/j.jval.2016.02.012","title":"Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Health technology; Reimbursement; Medicine; Excellence; Health care; Family medicine; Medical physics; Political science","score_opus":0.429476778660788,"score_gpt":0.4731094845025803,"score_spread":0.043632705841792296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2353253986","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022588756,0.17243236,0.011870841,0.8066397,0.0015347073,0.000073866395,0.00029365413,0.000057533078,0.0048384736],"genre_scores_gemma":[0.1360086,0.64502984,0.0993034,0.10326477,0.012542319,0.0004219529,0.0008722958,0.00017772854,0.002379086],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9738947,0.014032115,0.0035348905,0.0012139962,0.0066302205,0.0006940785],"domain_scores_gemma":[0.7398692,0.17356037,0.007302883,0.004626707,0.06911111,0.005529754],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09750711,0.0012074043,0.0018473767,0.007809953,0.001208754,0.0098102195,0.0026744187,0.006784888,0.0034050923],"category_scores_gemma":[0.16103858,0.00055242813,0.0014475934,0.0070521026,0.004735618,0.0105343135,0.004469903,0.013226774,0.000977091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021932545,0.0002563998,0.016501853,0.0030629165,0.00019745134,0.0001945196,0.0011614006,0.0046810405,0.000468357,0.080266245,0.170351,0.72263956],"study_design_scores_gemma":[0.00022782589,0.00038049335,0.031344485,0.03990753,0.0005981726,0.0007729454,0.005006048,0.02311387,0.0021310358,0.41358057,0.48251566,0.0004213883],"about_ca_topic_score_codex":0.010093974,"about_ca_topic_score_gemma":0.0120252445,"teacher_disagreement_score":0.9024929,"about_ca_system_score_codex":0.0071093957,"about_ca_system_score_gemma":0.015788792,"threshold_uncertainty_score":0.51567304},"labels":[],"label_agreement":null},{"id":"W2359288261","doi":"10.1016/j.jval.2015.09.1311","title":"Assessing the Gap Between Evidence Based Indications for Radiotherapy and Actual Practice in European Countries","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Reimbursement; Radiation therapy; Medicine; Incidence (geometry); Cancer; Multidisciplinary approach; Population; Family medicine; Health care; Environmental health; Surgery; Economic growth; Political science; Internal medicine; Economics","score_opus":0.19147188405897955,"score_gpt":0.508198003752941,"score_spread":0.31672611969396147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2359288261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8008253,0.14345329,0.00782736,0.022064354,0.00052268815,0.00024648974,0.0040252297,0.000035333473,0.021000005],"genre_scores_gemma":[0.9899844,0.005027351,0.002821249,0.0011330892,0.000039021572,0.00012534208,0.0007677226,0.00001285795,0.00008903254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.91029227,0.052962158,0.02013827,0.0024862303,0.011810517,0.0023105727],"domain_scores_gemma":[0.7255419,0.20034292,0.041823044,0.0052058673,0.023833625,0.003252662],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09085184,0.00030608635,0.0013475438,0.0074244216,0.00049496285,0.0040312675,0.001570019,0.0017961945,0.0017709243],"category_scores_gemma":[0.26042777,0.00045277269,0.0013384981,0.013488394,0.0022005928,0.003095387,0.0042226175,0.001273349,0.00011747341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033448858,0.00030512438,0.67963916,0.014151648,0.0047548325,0.0005704866,0.011587133,0.006869504,0.000358533,0.039668072,0.008011168,0.23073943],"study_design_scores_gemma":[0.0005533421,0.00081322686,0.8985585,0.029709881,0.0020843968,0.001194029,0.015588401,0.0035393098,0.00086688745,0.014880743,0.03205106,0.00016013172],"about_ca_topic_score_codex":0.0090075815,"about_ca_topic_score_gemma":0.006574307,"teacher_disagreement_score":0.90914816,"about_ca_system_score_codex":0.006197305,"about_ca_system_score_gemma":0.009057284,"threshold_uncertainty_score":0.4804762},"labels":[],"label_agreement":null},{"id":"W2367707061","doi":"10.1016/j.jval.2016.04.004","title":"Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1312,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Conjoint analysis; Task force; Task (project management); Management science; Computer science; Econometrics; Economics; Microeconomics; Management; Preference; Political science","score_opus":0.3878825092848187,"score_gpt":0.4728920069229144,"score_spread":0.08500949763809568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2367707061","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007180144,0.0028199404,0.98750967,0.0025188217,0.00077692635,0.0023187604,0.001130481,0.0011089465,0.0010983953],"genre_scores_gemma":[0.005372618,0.0024107227,0.9799151,0.00076007773,0.00048331064,0.009051145,0.0007435908,0.0006925261,0.0005708714],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.4126261,0.51226336,0.02104697,0.0062330724,0.04658856,0.0012419467],"domain_scores_gemma":[0.1101675,0.7836396,0.015026303,0.06063417,0.028956488,0.0015759224],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.43339035,0.004026857,0.007293029,0.010210143,0.0027508603,0.0077726813,0.0074771303,0.00516481,0.014627418],"category_scores_gemma":[0.63869184,0.0048881257,0.010703392,0.011878801,0.0096817445,0.0041861976,0.0061707287,0.02611093,0.003651064],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016040604,0.001414333,0.0055268225,0.0068154824,0.003771083,0.00016554547,0.0017468327,0.014388835,0.0034181091,0.14483258,0.10698761,0.70932865],"study_design_scores_gemma":[0.0032951457,0.0019968417,0.02680156,0.009884466,0.0031634043,0.0008848518,0.00064071495,0.12694839,0.0138303,0.60889673,0.20252374,0.0011338688],"about_ca_topic_score_codex":0.0071137254,"about_ca_topic_score_gemma":0.007914222,"teacher_disagreement_score":0.5666096,"about_ca_system_score_codex":0.0052241883,"about_ca_system_score_gemma":0.018377626,"threshold_uncertainty_score":0.6987306},"labels":[],"label_agreement":null},{"id":"W2383450400","doi":"10.1016/j.jval.2015.03.952","title":"Preferences for New Treatments Diminish In The Face of Ambiguity","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ambiguity; Preference; Respondent; Confidence interval; Population; Point estimation; Medicine; Psychology; Statistics; Mathematics; Internal medicine; Computer science; Environmental health","score_opus":0.7659773916187583,"score_gpt":0.4927104789725335,"score_spread":0.2732669126462248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2383450400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84711635,0.003372061,0.04034804,0.027602619,0.00034286504,0.00007879742,0.00030652425,0.00006586333,0.08076682],"genre_scores_gemma":[0.99261206,0.00064736174,0.0029908707,0.0016155009,0.00022347,0.000019041667,0.000061830484,0.000022473296,0.0018074074],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99571145,0.002033542,0.00026611314,0.0004999417,0.0009713891,0.00051754626],"domain_scores_gemma":[0.95846826,0.028381186,0.0060162037,0.0032077376,0.0020213197,0.0019053117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008586999,0.00054944545,0.0012729634,0.00087954674,0.00081857527,0.00610156,0.0006750446,0.0037754744,0.009593686],"category_scores_gemma":[0.07330529,0.00043848966,0.00080755627,0.00072777015,0.0022106732,0.005892166,0.0018595329,0.0046196515,0.0006859972],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005609038,0.0015820565,0.11610051,0.00079132966,0.0017283264,0.0043511596,0.0067344466,0.031464886,0.021619078,0.3988233,0.016487824,0.39470795],"study_design_scores_gemma":[0.00030341916,0.00089978095,0.061873425,0.00012624545,0.00022764437,0.0016113571,0.004529844,0.01828431,0.0015478036,0.89979357,0.010692176,0.00011059775],"about_ca_topic_score_codex":0.00047235528,"about_ca_topic_score_gemma":0.0005186581,"teacher_disagreement_score":0.009593686,"about_ca_system_score_codex":0.00082959473,"about_ca_system_score_gemma":0.000596024,"threshold_uncertainty_score":0.045412958},"labels":[],"label_agreement":null},{"id":"W2394792307","doi":"10.1016/j.jval.2016.03.122","title":"Indirect Costs Associated with Cardiovascular Disease in Canada: A Literature Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Indirect costs; Myocardial infarction; Stroke (engine); Coronary artery disease; Disease; Unstable angina; Angina; Population; MEDLINE; Productivity; Cochrane Library; Demography; Emergency medicine; Environmental health; Meta-analysis; Internal medicine","score_opus":0.33434444075730774,"score_gpt":0.3970971816688013,"score_spread":0.06275274091149358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394792307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088505656,0.99669397,0.00006319616,0.00087872817,0.00007740592,0.000015124971,0.00059997616,0.0000025649615,0.00078406726],"genre_scores_gemma":[0.006521072,0.9926319,0.00022992997,0.00022609986,0.00006565395,0.000010706129,0.00018168292,0.000002348805,0.00013067921],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99743855,0.0003409234,0.00048493792,0.00019519101,0.0013543238,0.00018606153],"domain_scores_gemma":[0.98301536,0.009295478,0.0022106634,0.00013951902,0.0048816567,0.00045726637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047245515,0.0011658297,0.0027961645,0.015205376,0.0010391299,0.0045843557,0.0015845312,0.0012413285,0.0052059367],"category_scores_gemma":[0.021508187,0.00061628834,0.002735015,0.030316737,0.0015137699,0.0014412029,0.0011938984,0.0020594255,0.00017637461],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042443577,0.00014931614,0.021756193,0.18523163,0.005031408,0.0004146745,0.00048898545,0.0024060514,0.00011985744,0.008621497,0.043510225,0.73184574],"study_design_scores_gemma":[0.00025110258,0.00016152614,0.14394386,0.39973685,0.027371364,0.0016848729,0.0018780456,0.0015933873,0.00034506823,0.008189963,0.41450074,0.0003432219],"about_ca_topic_score_codex":0.8137859,"about_ca_topic_score_gemma":0.9051296,"teacher_disagreement_score":0.18621409,"about_ca_system_score_codex":0.030629996,"about_ca_system_score_gemma":0.0827349,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"split"},{"id":"W2395026299","doi":"10.1016/j.jval.2016.03.1617","title":"The Role of Cancer Care on Patient Productivity, Caregiver Burden, and Personal Financial Hardship","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Population; Family medicine; Quarter (Canadian coin); Health care; Bankruptcy; Gerontology; Demography; Finance; Environmental health; Internal medicine; Business","score_opus":0.02564414515165512,"score_gpt":0.24225326321653262,"score_spread":0.2166091180648775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395026299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98236763,0.004107651,0.0002970017,0.009041746,0.00009075385,0.000011791822,0.0006815861,0.0000043630744,0.003397564],"genre_scores_gemma":[0.9989311,0.00048941106,0.000032905482,0.000077920675,0.000047506695,0.0000036375093,0.000109594184,0.0000013037787,0.00030656648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973833,0.0015689775,0.000105582214,0.00009472292,0.00019784793,0.0006496235],"domain_scores_gemma":[0.96189785,0.023418093,0.0069762054,0.0006909853,0.0014671225,0.00554974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004257792,0.00034386254,0.00047664743,0.0012242432,0.0007035707,0.0021826106,0.00064990105,0.0011026815,0.0052778083],"category_scores_gemma":[0.031931,0.0002399361,0.0011994776,0.0017886118,0.0011640714,0.0015565938,0.0015736424,0.0021349,0.00026112955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043375048,0.0002694423,0.9827367,0.00004205343,0.00026964355,0.00022232288,0.00038936542,0.0031405594,0.000032406966,0.0024246823,0.0012694974,0.008769584],"study_design_scores_gemma":[0.00002788032,0.00013949175,0.98644036,0.000077455225,0.0001823521,0.00020040871,0.0025857035,0.005774488,0.000043568027,0.0036429923,0.0008626133,0.000022650613],"about_ca_topic_score_codex":0.023983605,"about_ca_topic_score_gemma":0.025472509,"teacher_disagreement_score":0.023983605,"about_ca_system_score_codex":0.0022963404,"about_ca_system_score_gemma":0.0019917968,"threshold_uncertainty_score":0.047688007},"labels":[],"label_agreement":null},{"id":"W2395194296","doi":"10.1016/j.jval.2016.03.1616","title":"Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment: Pharmacoeconomic Analysis of a Prospective Randomized Trial","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Randomized controlled trial; Population; Randomization; Internal medicine; Relative risk; Pediatrics; Confidence interval","score_opus":0.02439193084483897,"score_gpt":0.3324162105128729,"score_spread":0.3080242796680339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395194296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98269516,0.012165045,0.0008516467,0.00073653925,0.00048699407,0.0012569111,0.0007172173,0.00005027714,0.001040262],"genre_scores_gemma":[0.99378127,0.0031510124,0.00078688323,0.0003917383,0.0003168387,0.0005819456,0.00041698932,0.000010347628,0.0005631106],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963665,0.002397929,0.00030884877,0.0004358711,0.00022591787,0.000264978],"domain_scores_gemma":[0.99521565,0.0027939111,0.000967899,0.00034027264,0.0001600883,0.000522232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033736306,0.0014885794,0.004102611,0.0006001908,0.0005193306,0.0016953303,0.0009544525,0.0022680773,0.00382903],"category_scores_gemma":[0.007066114,0.0009968338,0.004907359,0.0008355591,0.0014530959,0.0014072667,0.0006833812,0.0034636573,0.00038970934],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98929465,0.00097630825,0.0011057537,0.00033333778,0.0032954332,0.000019861282,0.000017432998,0.00020699445,0.00030977651,0.000060280025,0.000088495945,0.004291793],"study_design_scores_gemma":[0.9638448,0.026775453,0.0028013494,0.000050985745,0.0053094556,0.000025781903,0.000025373962,0.0005929577,0.0001892133,0.00016510214,0.00019991962,0.000019594225],"about_ca_topic_score_codex":0.0018401982,"about_ca_topic_score_gemma":0.0026565606,"teacher_disagreement_score":0.004102611,"about_ca_system_score_codex":0.0010987394,"about_ca_system_score_gemma":0.0013798,"threshold_uncertainty_score":0.017841697},"labels":[],"label_agreement":null},{"id":"W2395341313","doi":"10.1016/j.jval.2016.03.520","title":"The Impact of Plaque Psoriasis Severity on Work Productivity and Daily Activities","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Vancouver Coastal Health; Novartis (Canada)","funders":"","keywords":"Psoriasis; Medicine; Presenteeism; Psoriasis Area and Severity Index; Interquartile range; Severity of illness; Activities of daily living; Depression (economics); Absenteeism; Physical therapy; Internal medicine; Psychology; Dermatology","score_opus":0.029818509174328312,"score_gpt":0.2788996319676803,"score_spread":0.24908112279335198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395341313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927043,0.0031693361,0.00017165316,0.00022394369,0.000022249431,0.000009032025,0.00014131336,0.0000052942924,0.003552863],"genre_scores_gemma":[0.9991973,0.00036196047,0.00005306564,0.0000143506895,0.000019299217,0.0000015592902,0.00004927974,0.00000163124,0.00030163128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928963,0.0002928631,0.000034973204,0.0000538959,0.00022505208,0.000103532395],"domain_scores_gemma":[0.99779737,0.0009037419,0.00053794717,0.00009757825,0.00021386573,0.0004494991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005514549,0.00024169924,0.0003043564,0.0005359951,0.00026012195,0.0009610155,0.00021547165,0.00035126458,0.0027217516],"category_scores_gemma":[0.0029287029,0.0001359842,0.00052065024,0.00048336782,0.00031488555,0.0002770807,0.0004003032,0.00078290177,0.000248697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004224631,0.0010488845,0.90848017,0.00012111235,0.0005928838,0.00036116666,0.00023253493,0.00047317412,0.010706404,0.0003061702,0.00053733826,0.072915435],"study_design_scores_gemma":[0.000009108387,0.0004145106,0.99845695,0.00000683042,0.00007002413,0.00019698945,0.0000829039,0.00018280678,0.00028433918,0.00010464695,0.00018607131,0.0000047501107],"about_ca_topic_score_codex":0.0018691436,"about_ca_topic_score_gemma":0.0018673214,"teacher_disagreement_score":0.0027217516,"about_ca_system_score_codex":0.0003123084,"about_ca_system_score_gemma":0.0002905049,"threshold_uncertainty_score":0.009105206},"labels":[],"label_agreement":null},{"id":"W2395669716","doi":"10.1016/j.jval.2016.03.1121","title":"CHANGES IN QUALITY OF CARE ASSOCIATED WITH CENTRALIZATION OF ELECTIVE ORTHOPAEDIC SURGERY PROCEDURES: A SCOPING REVIEW","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; Alberta Hip and Knee Clinic; University of Calgary","funders":"","keywords":"Medicine; Context (archaeology); CINAHL; Quality (philosophy); Health care; MEDLINE; Orthopedic surgery; Elective surgery; Psychological intervention; Nursing; Surgery","score_opus":0.53976794298189,"score_gpt":0.49305940082444877,"score_spread":0.046708542157441246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395669716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043030677,0.9991109,0.000047656376,0.00013110362,0.00004595854,0.000018383353,0.00007717952,0.0000016135389,0.00013695167],"genre_scores_gemma":[0.006200429,0.9932289,0.00020099891,0.0001791131,0.00007159193,0.0000294684,0.000059402926,0.00000173796,0.00002841114],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962275,0.0011080795,0.0012984632,0.00037619352,0.0008302492,0.00015945619],"domain_scores_gemma":[0.9678161,0.02540666,0.004874099,0.00026505554,0.0014075134,0.00023051274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073954393,0.0008005588,0.0033646675,0.0062580565,0.00028768723,0.00276202,0.001179329,0.001476921,0.0037736618],"category_scores_gemma":[0.039832026,0.0005807547,0.004777836,0.0091815,0.00095019833,0.0015580619,0.0012393615,0.0015126128,0.00019732551],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048264296,0.00007516801,0.0038406146,0.5989718,0.011608479,0.000078407094,0.00017635692,0.00059289153,0.00013671741,0.0014361084,0.00472808,0.37787268],"study_design_scores_gemma":[0.0003442549,0.00038266706,0.024271661,0.8300628,0.06907586,0.00056712853,0.0004854703,0.00035274366,0.00028378383,0.0023546673,0.07173084,0.00008807652],"about_ca_topic_score_codex":0.009153948,"about_ca_topic_score_gemma":0.018810766,"teacher_disagreement_score":0.009153948,"about_ca_system_score_codex":0.0029908107,"about_ca_system_score_gemma":0.0062845666,"threshold_uncertainty_score":0.039111316},"labels":[],"label_agreement":null},{"id":"W2395935292","doi":"10.1016/j.jval.2016.03.154","title":"A Comparison of Cardiovascular Drugs Approved by the Us Food and Drug Administration and Health Canada (1980-2014)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Food and drug administration; Drug; Medicine; Administration (probate law); Drug administration; Pharmacology; Business; Political science; Law","score_opus":0.07895263609743292,"score_gpt":0.3073892872669409,"score_spread":0.228436651169508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395935292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8523255,0.04871291,0.0005305461,0.012737478,0.0003197746,0.00013776911,0.039651047,0.00005423939,0.045530774],"genre_scores_gemma":[0.97547024,0.0054662717,0.0002612351,0.00093478005,0.000103380175,0.000020029047,0.010734742,0.000015699194,0.0069937115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715304,0.00025824766,0.00013593973,0.00020778229,0.001420896,0.0008240967],"domain_scores_gemma":[0.99140644,0.0016985745,0.0016343835,0.00013486133,0.004027162,0.0010986364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022173359,0.00028083174,0.0007299947,0.0042120763,0.0009241646,0.0026287807,0.0010105598,0.00096178864,0.003851366],"category_scores_gemma":[0.010826106,0.00026365378,0.0013405967,0.0068518072,0.00070725736,0.0010875252,0.0012613499,0.0013626037,0.00026598418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004118602,0.000476858,0.774009,0.0013142192,0.002279759,0.0010473748,0.0008900236,0.0130767,0.0008636154,0.02509451,0.0711711,0.10565829],"study_design_scores_gemma":[0.00011648242,0.00011891743,0.97240025,0.00014923826,0.0005298611,0.00016629926,0.0008622574,0.0013923104,0.00036002212,0.000712382,0.023160001,0.000032067328],"about_ca_topic_score_codex":0.9452269,"about_ca_topic_score_gemma":0.972462,"teacher_disagreement_score":0.054773092,"about_ca_system_score_codex":0.033855427,"about_ca_system_score_gemma":0.030500175,"threshold_uncertainty_score":0.24563944},"labels":[],"label_agreement":null},{"id":"W2396171252","doi":"10.1016/j.jval.2016.03.279","title":"Economic Surveillance For Chronic Obstructive Pulmonary Disease In Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health; Institute of Health Economics","funders":"","keywords":"COPD; Medicine; Smoking cessation; Pulmonary disease; Health care; Medical prescription; Emergency department; Pulmonary rehabilitation; Family medicine; Emergency medicine; Medical emergency; Nursing; Internal medicine; Economic growth","score_opus":0.035380711305421274,"score_gpt":0.25744907507388193,"score_spread":0.22206836376846065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396171252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321841,0.005453631,0.00085697434,0.004854188,0.00009409405,0.00021795515,0.04389709,0.00006460942,0.012377328],"genre_scores_gemma":[0.98279554,0.0023362178,0.0008130711,0.00032970027,0.00003960814,0.0000397673,0.00903116,0.0000129561395,0.0046020015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823064,0.00020969783,0.00013868207,0.00012272531,0.0009012436,0.00039701126],"domain_scores_gemma":[0.9927286,0.0007067778,0.0009989358,0.00013823292,0.0041234163,0.001304084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015236071,0.00039881998,0.00047991576,0.0041545173,0.0016511172,0.0019409512,0.0017900536,0.0005654134,0.0016331356],"category_scores_gemma":[0.0066089914,0.00028834955,0.00052413525,0.008152921,0.0006512288,0.00042479328,0.0008853872,0.00074540504,0.00015188495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019743452,0.00010776301,0.9543861,0.00017771148,0.00020367069,0.00032377374,0.0004977646,0.005005945,0.00013802052,0.0015821957,0.017055586,0.02032394],"study_design_scores_gemma":[0.000027273234,0.000024154635,0.98883116,0.00011607069,0.00005224791,0.00009624655,0.0010257172,0.0058005885,0.00007933993,0.0001633511,0.003761607,0.000022090877],"about_ca_topic_score_codex":0.9988104,"about_ca_topic_score_gemma":0.99916506,"teacher_disagreement_score":0.93568254,"about_ca_system_score_codex":0.064317495,"about_ca_system_score_gemma":0.08565295,"threshold_uncertainty_score":0.4666583},"labels":[],"label_agreement":null},{"id":"W2396704791","doi":"10.1016/j.jval.2016.03.1129","title":"COMPARISON OF DOSE ESCALATION AND COSTS OF DOSE ESCALATION BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGIC TREATMENT WITH ETANERCEPT, ADALIMUMAB, OR INFLIXIMAB","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Southlake Regional Health Center; Montreal Clinical Research Institute; Centre Hospitalier Universitaire de Sherbrooke; Amgen (Canada)","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Infliximab; Rheumatoid arthritis; Internal medicine; Gastroenterology; Tumor necrosis factor alpha","score_opus":0.06546985798292254,"score_gpt":0.33879417816226476,"score_spread":0.2733243201793422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396704791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957431,0.0014971639,0.0005030302,0.00054425764,0.000041626754,0.000102108424,0.00029360552,0.00001430224,0.0012607354],"genre_scores_gemma":[0.99893636,0.0001803034,0.00035918909,0.000112491354,0.00003557485,0.000051894745,0.00018964108,0.0000033203057,0.00013124333],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99461865,0.0032292416,0.00059125066,0.00045306998,0.0006489977,0.00045870105],"domain_scores_gemma":[0.9804621,0.013761106,0.003518837,0.0009426785,0.0005388706,0.000776564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047292532,0.00048819187,0.0011567915,0.00067596784,0.0002577313,0.0014352908,0.0007547353,0.0012470785,0.003805532],"category_scores_gemma":[0.02377024,0.00034009942,0.0034626205,0.00091463584,0.0004256705,0.0013520413,0.0007586158,0.0018722597,0.00023172399],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.49650884,0.006533307,0.18730903,0.0008494684,0.00832279,0.00044613783,0.0004715589,0.032592077,0.004006235,0.0028874574,0.0019163032,0.25815678],"study_design_scores_gemma":[0.052512363,0.15928707,0.7114168,0.00044745865,0.012088576,0.0014958481,0.00089227257,0.04844667,0.0043924158,0.004307662,0.0045057004,0.00020708608],"about_ca_topic_score_codex":0.0013225796,"about_ca_topic_score_gemma":0.0009076755,"teacher_disagreement_score":0.0047292532,"about_ca_system_score_codex":0.002426629,"about_ca_system_score_gemma":0.0010120079,"threshold_uncertainty_score":0.025011003},"labels":[],"label_agreement":null},{"id":"W2396922882","doi":"10.1016/j.jval.2016.03.1492","title":"Utilization of Radium-223 Dichloride (Ra-223) in Patients with Metastatic Castration-Resistant Prostate Cancer in Canada: A Real-World Retrospective Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada; Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Denosumab; Prostate cancer; Enzalutamide; Radium-223; Internal medicine; Oncology; Bone metastasis; Abiraterone acetate; Cancer; Retrospective cohort study; Osteoporosis; Androgen deprivation therapy; Androgen receptor","score_opus":0.05146567593889032,"score_gpt":0.34171162970323177,"score_spread":0.2902459537643414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396922882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996192,0.00082266435,0.000061987994,0.00017795234,0.0000053092313,0.000023289904,0.0016922554,0.000006953183,0.0010175309],"genre_scores_gemma":[0.99846077,0.00047631207,0.00006635912,0.00008629607,0.000006503129,0.0000052731284,0.0006983043,0.0000040873992,0.00019614343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903846,0.00008556521,0.00009388748,0.00014444122,0.00034130874,0.000296336],"domain_scores_gemma":[0.997488,0.00019240983,0.000818923,0.00009644317,0.00088578695,0.00051847263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003865829,0.00036134955,0.0004988009,0.0011615389,0.0013163646,0.0014479664,0.0011245034,0.0007815143,0.0013664126],"category_scores_gemma":[0.0019378362,0.00045462546,0.0007001037,0.0047621033,0.0009163316,0.0003885377,0.000598814,0.0007789417,0.0001974616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083659994,0.000022843335,0.9985233,0.000016810129,0.000045772693,0.0001230582,0.00012491996,0.00006460046,0.00011250179,0.000025426267,0.00014479253,0.0007125307],"study_design_scores_gemma":[0.000010698541,0.000052504663,0.997809,0.00001664687,0.0000761148,0.00032123734,0.0008384135,0.00026530598,0.00007635734,0.000013877063,0.0005062693,0.000013563903],"about_ca_topic_score_codex":0.9593706,"about_ca_topic_score_gemma":0.95805323,"teacher_disagreement_score":0.040629387,"about_ca_system_score_codex":0.019135453,"about_ca_system_score_gemma":0.016517987,"threshold_uncertainty_score":0.13883805},"labels":[],"label_agreement":null},{"id":"W2396967676","doi":"10.1016/j.jval.2016.03.495","title":"The Prevalence And Incidence Of Hidradenitis Suppurativa In Canada: Results From A Population-Based Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Université de Montréal","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Incidence (geometry); Epidemiology; Population; Prevalence; Demography; Pediatrics; Dermatology; Disease; Internal medicine; Environmental health","score_opus":0.03811131224112524,"score_gpt":0.2867204976295783,"score_spread":0.24860918538845306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396967676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99108315,0.0008529471,0.000082701525,0.00033793863,0.000009902925,0.000045473505,0.005638604,0.000010041795,0.0019391475],"genre_scores_gemma":[0.9972784,0.00062013685,0.000119332275,0.00010245123,0.00000542333,0.000011464887,0.001393627,0.0000035914495,0.0004655877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990693,0.0000689546,0.00008825738,0.0001091664,0.00040645504,0.0002578945],"domain_scores_gemma":[0.9976199,0.00011733541,0.0005196348,0.000052467887,0.0011161054,0.00057450816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046471975,0.0002452107,0.00039635602,0.0014659251,0.0016614975,0.0012289814,0.0010211217,0.00066704676,0.0015549437],"category_scores_gemma":[0.0023048325,0.00044644132,0.00068747334,0.005462981,0.00062300934,0.00046546786,0.0006436786,0.00085561693,0.00018712034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028072618,0.00002434764,0.99825627,0.000015386297,0.000030646323,0.00003123813,0.00021313052,0.000021145448,0.000053122654,0.000018953284,0.0002946499,0.0010130015],"study_design_scores_gemma":[0.000002769811,0.000009397381,0.99929607,0.000008402192,0.000010653017,0.000032329684,0.0003916986,0.000056781395,0.000012383281,0.000005443307,0.00017107232,0.0000030095073],"about_ca_topic_score_codex":0.99134254,"about_ca_topic_score_gemma":0.99162537,"teacher_disagreement_score":0.015122282,"about_ca_system_score_codex":0.015122282,"about_ca_system_score_gemma":0.015476343,"threshold_uncertainty_score":0.10972035},"labels":[],"label_agreement":null},{"id":"W2397168366","doi":"10.1016/j.jval.2016.03.451","title":"Estimation Of Direct And Indirect Costs Associated With Asthma And Copd: A Canadian Employers Perspective","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; COPD; Asthma; Absenteeism; Indirect costs; Population; Workforce; Physical therapy; Internal medicine; Environmental health","score_opus":0.03202428642657713,"score_gpt":0.29201430169615794,"score_spread":0.2599900152695808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397168366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53420526,0.07267689,0.048595402,0.056993,0.000821729,0.00086661486,0.03065521,0.00022895253,0.2549569],"genre_scores_gemma":[0.9538932,0.016719835,0.011786197,0.00060424884,0.0001537059,0.0000793505,0.0032091264,0.000048944086,0.013505374],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9972404,0.00057160755,0.000105568295,0.00016405842,0.0013299967,0.00058832153],"domain_scores_gemma":[0.997063,0.0009775703,0.000172737,0.00007985537,0.0014561686,0.00025073517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023395468,0.0015229848,0.0010772793,0.0049622073,0.0019256969,0.005716042,0.0023869993,0.0017927899,0.0050127665],"category_scores_gemma":[0.009525374,0.0007789655,0.0022533187,0.006423813,0.0011431146,0.0014322113,0.0012742656,0.0024226382,0.00021994079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007130576,0.00034217004,0.13553746,0.0014229525,0.0018901182,0.0013773156,0.0011402564,0.50531113,0.001468467,0.15323824,0.028087981,0.16947095],"study_design_scores_gemma":[0.00021728162,0.00028364066,0.41689104,0.0024480016,0.00246801,0.001020821,0.00900764,0.37722033,0.0020630555,0.07468333,0.113015,0.00068193057],"about_ca_topic_score_codex":0.98864216,"about_ca_topic_score_gemma":0.9883813,"teacher_disagreement_score":0.06751615,"about_ca_system_score_codex":0.06751615,"about_ca_system_score_gemma":0.067709744,"threshold_uncertainty_score":0.48986626},"labels":[],"label_agreement":null},{"id":"W2397649954","doi":"10.1016/j.jval.2016.03.655","title":"Evaluating The Cost Effectiveness of Personalised Medicine Co-Dependent Technologies: A Conceptual Framework","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Test (biology); Point (geometry); Personalized medicine; Medicine; Health care; Marginal cost; Actuarial science; Computer science; Mathematics; Economics","score_opus":0.2810152615169229,"score_gpt":0.43742987770943853,"score_spread":0.15641461619251562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397649954","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19478619,0.0327535,0.6177134,0.04839201,0.0006955344,0.0012609615,0.0013550305,0.00014777288,0.10289555],"genre_scores_gemma":[0.9547236,0.0069861216,0.03290019,0.00065783,0.00043920585,0.0005158337,0.0001824536,0.000030273484,0.003564553],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9811844,0.0140334405,0.00061891513,0.0010749458,0.0020091748,0.0010791797],"domain_scores_gemma":[0.9451022,0.049534958,0.0024675136,0.0009466238,0.0011629139,0.0007857796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019163791,0.0023612787,0.0032931045,0.0049281004,0.00088580145,0.011378771,0.0049174726,0.010000683,0.0073027327],"category_scores_gemma":[0.045344982,0.0013455118,0.0027947263,0.0040965057,0.007994432,0.010751897,0.0039828885,0.005321334,0.00029801243],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001814559,0.00027543103,0.0012283032,0.00040913094,0.00032678636,0.00013429024,0.000118356096,0.24197732,0.0002746115,0.7394334,0.00078959693,0.014851379],"study_design_scores_gemma":[0.0002226853,0.0008248189,0.0018947051,0.00077342085,0.00052627083,0.00023737957,0.00047265034,0.24817413,0.00065937644,0.7404974,0.005614265,0.00010283767],"about_ca_topic_score_codex":0.0038183413,"about_ca_topic_score_gemma":0.0023476477,"teacher_disagreement_score":0.019163791,"about_ca_system_score_codex":0.010467816,"about_ca_system_score_gemma":0.0059798453,"threshold_uncertainty_score":0.101348996},"labels":[],"label_agreement":null},{"id":"W2397714115","doi":"10.1016/j.jval.2016.03.1148","title":"ECONOMIC IMPACT OF A NEUROMUSCULAR TRAINING PREVENTION STRATEGY TO REDUCE INJURIES IN YOUTH SOCCER","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Health care; Cluster randomised controlled trial; Randomized controlled trial; Medicine; Bootstrapping (finance); Physical therapy; Rate ratio; Poisson regression; Cluster (spacecraft); Environmental health; Operations management; Business; Population; Surgery; Engineering; Computer science; Economics; Finance","score_opus":0.08566396184917122,"score_gpt":0.36674500053649467,"score_spread":0.2810810386873235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397714115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97366816,0.0022840234,0.00081842946,0.007911895,0.00024057225,0.00018610561,0.0008846037,0.000016188784,0.013990086],"genre_scores_gemma":[0.997957,0.0005328945,0.00030923766,0.00018790105,0.000049055117,0.000025701833,0.0001381719,0.0000021642254,0.0007978501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886847,0.00055604015,0.000046275003,0.000036916666,0.0001880393,0.00030426873],"domain_scores_gemma":[0.9985727,0.00043911074,0.00023003653,0.000029629291,0.00021483497,0.0005136738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012199491,0.0003124615,0.00027516394,0.0008850212,0.0005651383,0.0009996969,0.00037745002,0.0007919835,0.0049771448],"category_scores_gemma":[0.005963222,0.00020451685,0.0005879466,0.00053128984,0.00038154298,0.00047713835,0.0012646911,0.0008539785,0.00017788536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029745858,0.0189713,0.4516123,0.0006542521,0.0015603625,0.0011145858,0.0003769173,0.029662907,0.0025602258,0.015043062,0.0116070425,0.43709126],"study_design_scores_gemma":[0.0016263268,0.0076646493,0.93743193,0.0004562001,0.0012320033,0.00036504323,0.002194345,0.033470377,0.0011841046,0.0045004897,0.009806102,0.000068420064],"about_ca_topic_score_codex":0.020735962,"about_ca_topic_score_gemma":0.033425245,"teacher_disagreement_score":0.020735962,"about_ca_system_score_codex":0.0028297699,"about_ca_system_score_gemma":0.0040516453,"threshold_uncertainty_score":0.0412305},"labels":[],"label_agreement":null},{"id":"W2397716952","doi":"10.1016/j.jval.2016.03.1611","title":"Cost-Effectiveness of Pembrolizumab (Keytruda®) Versus Ipilimumab in Patients with Advanced Melanoma in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Université de Montréal","funders":"","keywords":"Ipilimumab; Pembrolizumab; Medicine; Clinical trial; Internal medicine; Oncology; Cancer; Immunotherapy","score_opus":0.028858743836033228,"score_gpt":0.2887272278546563,"score_spread":0.2598684840186231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397716952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812589,0.009338219,0.00006616558,0.003036185,0.000074631724,0.00008617069,0.0023191266,0.000009416755,0.0038111866],"genre_scores_gemma":[0.9968297,0.0016065238,0.00008994377,0.00027182227,0.00002651218,0.00001289198,0.00057581306,0.0000027608492,0.0005839183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929595,0.00012244165,0.000050808158,0.00007093654,0.00015470962,0.00030501996],"domain_scores_gemma":[0.9986003,0.00022003411,0.00025678685,0.000018661493,0.00028903858,0.00061522523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044346967,0.0002674252,0.0007048834,0.0005036137,0.0007996728,0.0012432182,0.0008358657,0.0005651865,0.0027278778],"category_scores_gemma":[0.0030802828,0.00021350959,0.0013741121,0.0014449286,0.00050326844,0.00037842718,0.000459563,0.0009969942,0.000091667614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05600564,0.0015921212,0.76522547,0.0017193368,0.004098774,0.0008946591,0.0005417607,0.018873284,0.0017139188,0.0030114253,0.016025329,0.13029829],"study_design_scores_gemma":[0.0054746405,0.002660612,0.9627534,0.0005648559,0.0037917877,0.00040538065,0.0015358248,0.015715653,0.0005377647,0.0005875824,0.005862243,0.00011020223],"about_ca_topic_score_codex":0.9704717,"about_ca_topic_score_gemma":0.9811999,"teacher_disagreement_score":0.05137947,"about_ca_system_score_codex":0.05137947,"about_ca_system_score_gemma":0.033173017,"threshold_uncertainty_score":0.37278593},"labels":[],"label_agreement":null},{"id":"W2397872810","doi":"10.1016/j.jval.2016.03.1535","title":"A Multi-Criteria Decision Making Approach for Selecting an Optimal Therapy for Metastatic Colorectal Cancer","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Multiple-criteria decision analysis; KRAS; Medicine; FOLFIRI; Cetuximab; Colorectal cancer; Computer science; Oxaliplatin; Cancer; Operations research; Mathematics; Internal medicine","score_opus":0.15329497171018916,"score_gpt":0.4508951441631486,"score_spread":0.29760017245295944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397872810","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.063934654,0.002496271,0.9210073,0.0040178057,0.00022302417,0.00069689576,0.00066163146,0.00022437758,0.006738036],"genre_scores_gemma":[0.7123324,0.0006557586,0.2831294,0.00059675425,0.00019338504,0.00058488024,0.0004003976,0.000049671882,0.0020573968],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9931218,0.004580271,0.00036537464,0.000663839,0.0009356405,0.00033314887],"domain_scores_gemma":[0.9852887,0.012499229,0.00063932454,0.00016103739,0.0008420312,0.0005697512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012170056,0.0019486331,0.003444668,0.0050270753,0.0011413639,0.003767144,0.0031314045,0.0033010335,0.0046137483],"category_scores_gemma":[0.017847927,0.0012336047,0.0021264297,0.0026839415,0.0014908406,0.0017761379,0.0021265137,0.0023321684,0.00032948298],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004621383,0.00030742472,0.0018476682,0.00030748398,0.0005067867,0.0002458338,0.00015784596,0.9373603,0.00041707,0.009194947,0.0017959782,0.04739649],"study_design_scores_gemma":[0.00008021256,0.00013840692,0.00024254575,0.000055970853,0.00008565505,0.000044122902,0.000050996514,0.987039,0.00014338436,0.011716325,0.0003816324,0.00002165302],"about_ca_topic_score_codex":0.007570066,"about_ca_topic_score_gemma":0.006812876,"teacher_disagreement_score":0.012170056,"about_ca_system_score_codex":0.003741823,"about_ca_system_score_gemma":0.003375292,"threshold_uncertainty_score":0.06436223},"labels":[],"label_agreement":null},{"id":"W2398081229","doi":"10.1016/j.jval.2016.03.1155","title":"SUBCUTANEOUS TOCILIZUMAB: A COST-MINIMIZATION ANALYSIS BASED ON THE POPULATION OF QUEBEC","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tocilizumab; Medicine; Population; Formulary; Cost-minimization analysis; Tofacitinib; Internal medicine; Pharmacology; Rheumatoid arthritis; Environmental health","score_opus":0.042142510521503945,"score_gpt":0.30883726459955646,"score_spread":0.26669475407805254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398081229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928845,0.0012180844,0.0006848814,0.00044331103,0.000008663812,0.00007082519,0.0029428657,0.000013973731,0.0017329791],"genre_scores_gemma":[0.9968604,0.000310195,0.0003917154,0.00008419379,0.0000043471023,0.000024944093,0.0012840799,0.000008173602,0.0010319253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993231,0.00022280637,0.000026365877,0.0000858837,0.00012489143,0.00021698624],"domain_scores_gemma":[0.99855,0.00051827583,0.00019800647,0.000042877477,0.0004971155,0.00019380187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010840168,0.00048125433,0.0008501144,0.0009616416,0.0007938751,0.0013170984,0.0010709735,0.0005854752,0.0046085482],"category_scores_gemma":[0.0032750475,0.00021951593,0.0016728473,0.0019538214,0.00032074412,0.00038753173,0.00042277682,0.00057598006,0.00017522051],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005688951,0.00035416125,0.8851163,0.00020525468,0.002600272,0.0009237386,0.00025423788,0.05868556,0.0015931611,0.002242371,0.006823477,0.03551252],"study_design_scores_gemma":[0.0004111262,0.00046683787,0.8968719,0.00006776577,0.0012504102,0.00030775432,0.0009323776,0.096741386,0.00034637074,0.00022086863,0.0023312687,0.00005192933],"about_ca_topic_score_codex":0.95118123,"about_ca_topic_score_gemma":0.9266567,"teacher_disagreement_score":0.048818767,"about_ca_system_score_codex":0.021504454,"about_ca_system_score_gemma":0.0074866232,"threshold_uncertainty_score":0.15602648},"labels":[],"label_agreement":null},{"id":"W2398115477","doi":"10.1016/j.jval.2016.03.538","title":"Comparison of Arteriovenous Fistula (AVF) Maintenance And Associated Costs Between Traditional Surgical AVF Creation and A New Endovascular Approach","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Arteriovenous fistula; Cohort; Propensity score matching; Psychological intervention; Angioplasty; Surgery; Fistula; Catheter; Internal medicine; Nursing","score_opus":0.14127674468636764,"score_gpt":0.3742748583450493,"score_spread":0.23299811365868167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398115477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99691296,0.001216319,0.00019920552,0.00018509931,0.000038167545,0.00002523852,0.00039778533,0.0000044728963,0.0010208994],"genre_scores_gemma":[0.9986333,0.00040439784,0.00026981102,0.000034376695,0.000043493037,0.00002182367,0.00037773227,0.0000036578156,0.00021146184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805224,0.0008692488,0.00019831983,0.0001683674,0.00042804412,0.0002837205],"domain_scores_gemma":[0.98860335,0.007736219,0.0017260703,0.00027117593,0.0008019175,0.0008612563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022121484,0.00036134868,0.00083770277,0.0019533434,0.00039977938,0.0011567991,0.0007004204,0.0008691061,0.004099291],"category_scores_gemma":[0.012053268,0.00016674974,0.0019317128,0.0017581683,0.00048467022,0.0013044768,0.0007660829,0.0010616624,0.00021843943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12770039,0.0072139897,0.62679315,0.0016405409,0.0034684471,0.0009480168,0.0006672104,0.009981749,0.0029107248,0.003967257,0.002459717,0.21224885],"study_design_scores_gemma":[0.0022180472,0.03668979,0.93986267,0.00026797692,0.0018008053,0.0016019512,0.0020628327,0.009734264,0.0016339933,0.0015602525,0.0024535533,0.00011378216],"about_ca_topic_score_codex":0.00313869,"about_ca_topic_score_gemma":0.003719674,"teacher_disagreement_score":0.004099291,"about_ca_system_score_codex":0.002679446,"about_ca_system_score_gemma":0.0011264731,"threshold_uncertainty_score":0.01944089},"labels":[],"label_agreement":null},{"id":"W2398216735","doi":"10.1016/j.jval.2016.03.1542","title":"Insights into the Pan-Canadian Pharmaceutical Alliance’s Decision not to Collectively Negotiate Pricing for Drug Products","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Negotiation; Reimbursement; Alliance; Business; List price; Product (mathematics); Actuarial science; Drug; Medicine; Marketing; Economics; Pharmacology; Political science; Finance; Health care","score_opus":0.3931898860967093,"score_gpt":0.44806228740831394,"score_spread":0.054872401311604646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398216735","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06715148,0.004328156,0.0042910757,0.47816372,0.0005063793,0.00013047662,0.00079157506,0.000032676722,0.44460455],"genre_scores_gemma":[0.9465255,0.0013808706,0.0024925245,0.028560031,0.0002786225,0.000034009106,0.00013831804,0.00003364271,0.020556452],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.9812821,0.0037317437,0.0004116744,0.00097411085,0.006872956,0.006727415],"domain_scores_gemma":[0.9792778,0.009539494,0.0010461938,0.0005540771,0.0059350864,0.0036473149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015949344,0.00042970997,0.00072844914,0.0019397904,0.009809716,0.014537799,0.002626183,0.011630116,0.011909722],"category_scores_gemma":[0.03614406,0.0005945148,0.0009677689,0.0028912865,0.0084553,0.004455007,0.002463062,0.009280675,0.00042988575],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008165604,0.00005119553,0.0044109556,0.0000483928,0.000048280694,0.0002932683,0.0019540763,0.0020805656,0.00023134897,0.91839904,0.061224815,0.011176332],"study_design_scores_gemma":[0.00022556371,0.000061512095,0.0424191,0.0005402546,0.0001532306,0.00035063064,0.01361173,0.012309873,0.00075347186,0.5169446,0.41225782,0.00037218316],"about_ca_topic_score_codex":0.9315346,"about_ca_topic_score_gemma":0.961713,"teacher_disagreement_score":0.9127836,"about_ca_system_score_codex":0.08721641,"about_ca_system_score_gemma":0.12910643,"threshold_uncertainty_score":0.63280225},"labels":[],"label_agreement":null},{"id":"W2398256166","doi":"10.1016/j.jval.2015.09.1266","title":"Cost-Utility Analysis Of Enzalutamide For Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (Mcrpc) After Failure Of Androgen Deprivation Therapy (Adt)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Alberta; University of Toronto","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Androgen deprivation therapy; Hazard ratio; Internal medicine; Oncology; Prednisone; Cancer; Confidence interval; Androgen receptor","score_opus":0.08888325761911012,"score_gpt":0.37325963935964823,"score_spread":0.28437638174053814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398256166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852786,0.0050692353,0.0029272875,0.0011671267,0.000060841325,0.00031602662,0.002019447,0.000042587537,0.0031188505],"genre_scores_gemma":[0.99808025,0.00043673723,0.0005536678,0.000082731276,0.0000107856395,0.00003145442,0.000508409,0.000004446803,0.00029149916],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99891686,0.0007357669,0.000044308017,0.000080747515,0.000085006475,0.00013731449],"domain_scores_gemma":[0.9979107,0.0014711014,0.00025818078,0.0000520828,0.000090057285,0.00021788181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017412058,0.0010510165,0.0014085365,0.0008624828,0.00020349312,0.0014287145,0.0009920048,0.00074257434,0.0036429618],"category_scores_gemma":[0.006284932,0.00040934244,0.0029848972,0.0010124838,0.00046784262,0.0009088525,0.0006571305,0.0010768765,0.00014380267],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13391018,0.002772717,0.10914075,0.0015346188,0.011318645,0.0015829178,0.00016580807,0.6259929,0.002926762,0.006849551,0.0046199034,0.09918522],"study_design_scores_gemma":[0.0117804175,0.024534645,0.14534366,0.00051343645,0.013541266,0.0015477912,0.0006991335,0.7908064,0.0017024672,0.005564569,0.0037862642,0.00017997045],"about_ca_topic_score_codex":0.019143004,"about_ca_topic_score_gemma":0.013465938,"teacher_disagreement_score":0.019143004,"about_ca_system_score_codex":0.004495481,"about_ca_system_score_gemma":0.0019517156,"threshold_uncertainty_score":0.03806317},"labels":[],"label_agreement":null},{"id":"W2398693187","doi":"10.1016/j.jval.2016.03.864","title":"HOW EFFECTIVE IS A WORKPLACE WELLNESS PROGRAM IN REDUCING PRESCRIPTION DRUG EXPENDITURES IN CANADA?","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medical prescription; Prescription drug; Logistic regression; Prescription costs; Intervention (counseling); Medicine; Baseline (sea); Health care; Drug; Business; Nursing; Internal medicine; Pharmacology; Economics","score_opus":0.06705906028951815,"score_gpt":0.3731771056248912,"score_spread":0.30611804533537307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398693187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80569655,0.015643422,0.000251835,0.15095179,0.0006166861,0.00013907105,0.0018589365,0.00004954458,0.024792146],"genre_scores_gemma":[0.9872269,0.0046432,0.0004590304,0.0053367596,0.00013788514,0.000024933686,0.00032850835,0.000009357823,0.0018333247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996612,0.00053176534,0.00012674299,0.000155999,0.001039062,0.0015344103],"domain_scores_gemma":[0.9856075,0.0012664811,0.001293739,0.00015033419,0.0040286826,0.0076532257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001595214,0.00023076334,0.00053164444,0.00096409227,0.004936549,0.0027954862,0.0016717638,0.0017857839,0.00320405],"category_scores_gemma":[0.012967944,0.00027220728,0.00066656916,0.0023666476,0.0015667978,0.0009148342,0.0011032888,0.0025887094,0.00012731322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011071295,0.0021180406,0.67801064,0.00086836994,0.000499762,0.00036261,0.002113445,0.0016241438,0.00043120672,0.005539313,0.04394298,0.26338246],"study_design_scores_gemma":[0.00020161334,0.0002625715,0.9776424,0.00070739776,0.00036034163,0.00009371198,0.0045871213,0.0012212216,0.00029516185,0.00069291936,0.013878272,0.000057219408],"about_ca_topic_score_codex":0.99440056,"about_ca_topic_score_gemma":0.99814236,"teacher_disagreement_score":0.08556552,"about_ca_system_score_codex":0.08556552,"about_ca_system_score_gemma":0.23672783,"threshold_uncertainty_score":0.6208242},"labels":[],"label_agreement":null},{"id":"W2398845959","doi":"10.1016/j.jval.2016.03.374","title":"Independent Factors Affecting Patient Compliance to Private Insurer-Funded Health Case Management in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Quality of life (healthcare); Body mass index; Disease; Physical therapy","score_opus":0.16512538375178124,"score_gpt":0.4094674109577054,"score_spread":0.24434202720592416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398845959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929067,0.00028994118,0.000070778624,0.0023239776,0.00001929958,0.00004630656,0.0005064777,0.000009280851,0.0038272913],"genre_scores_gemma":[0.99881494,0.00013716595,0.00012711706,0.00023762978,0.000010939176,0.000008748872,0.00019832607,0.000006058276,0.00045917532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944958,0.00095349195,0.00052213046,0.00041940666,0.002107731,0.0015013966],"domain_scores_gemma":[0.9618463,0.007886144,0.011587157,0.0010659986,0.009156466,0.008457911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002739984,0.00014620596,0.00032043847,0.0010247793,0.0027381931,0.0024515174,0.0021496427,0.0009618116,0.0039176582],"category_scores_gemma":[0.031049194,0.00038575658,0.00061020226,0.0023972895,0.0011208064,0.0004910759,0.0010969526,0.0019291871,0.00017228877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009832574,0.00017339122,0.9927118,0.000013358948,0.00004220388,0.00007926219,0.00083007937,0.00018030987,0.00004524509,0.00018188826,0.0012360229,0.004408178],"study_design_scores_gemma":[0.000012059832,0.00003822605,0.99633324,0.000037155194,0.000022863092,0.000058920148,0.001947026,0.0007094724,0.000033780572,0.000048128084,0.00074886245,0.000010334621],"about_ca_topic_score_codex":0.9660046,"about_ca_topic_score_gemma":0.9822466,"teacher_disagreement_score":0.03890639,"about_ca_system_score_codex":0.03890639,"about_ca_system_score_gemma":0.0711602,"threshold_uncertainty_score":0.282287},"labels":[],"label_agreement":null},{"id":"W2398865980","doi":"10.1016/j.jval.2016.03.1947","title":"HEALTH POLICY REVIEW: REGIONAL REFORMS IN HOSPITALS, MEDICAL PERSONNEL SYSTEM, AND MODE OF PAYMENT IN CHINA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Business; Health care; China; Health policy; Economic growth; Incentive; Health care reform; Public health; Public administration; Political science; Medicine; Economics; Nursing","score_opus":0.031602032778113694,"score_gpt":0.29597342528341936,"score_spread":0.26437139250530567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398865980","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031482518,0.7571539,0.00037809394,0.18605833,0.0048922487,0.00013905631,0.0037060701,0.000038377344,0.016151402],"genre_scores_gemma":[0.2503277,0.69964087,0.0006408932,0.03188715,0.007901513,0.00016586408,0.0029470883,0.000029849827,0.006459013],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966223,0.0016090864,0.00029100064,0.00018732718,0.0007940345,0.0004962912],"domain_scores_gemma":[0.9900603,0.0037074538,0.0011570142,0.00023164318,0.004079082,0.00076449686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007579052,0.00050796935,0.001479921,0.0048567518,0.0007902277,0.0029396468,0.00089347287,0.0016656773,0.004804362],"category_scores_gemma":[0.011714642,0.0003343978,0.00077938533,0.010172246,0.0010615223,0.0010930831,0.00089167967,0.0014006349,0.00040183886],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010230694,0.0002589458,0.043442927,0.025123175,0.0031237595,0.0003957322,0.0008242861,0.0057324716,0.0006031926,0.052374903,0.5905451,0.27655247],"study_design_scores_gemma":[0.0008658713,0.00047243963,0.3439623,0.017425051,0.0035203833,0.00017319052,0.0014141783,0.0023959628,0.0005364034,0.007801888,0.62132305,0.000109343084],"about_ca_topic_score_codex":0.18078512,"about_ca_topic_score_gemma":0.2197956,"teacher_disagreement_score":0.18078512,"about_ca_system_score_codex":0.011555536,"about_ca_system_score_gemma":0.05283712,"threshold_uncertainty_score":0.35946566},"labels":[],"label_agreement":null},{"id":"W2399143411","doi":"10.1016/j.jval.2016.03.1045","title":"BUDGET IMPACT ANALYSIS FOR THE FIRST-LINE AND SECOND-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Ibrutinib; Bendamustine; Chlorambucil; Obinutuzumab; Chronic lymphocytic leukemia; Medicine; Oncology; Rituximab; Incrementalism; Internal medicine; Ofatumumab; Leukemia; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.03223058491051058,"score_gpt":0.32911253656157347,"score_spread":0.2968819516510629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399143411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8770731,0.018139316,0.0154905105,0.017308746,0.00048746355,0.0017993469,0.016836878,0.00012564208,0.052739043],"genre_scores_gemma":[0.9895858,0.0019223139,0.0024053769,0.000537617,0.000058534297,0.00030655242,0.0026379502,0.000022469465,0.002523382],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99341774,0.004478653,0.00019117222,0.00019765945,0.00055473676,0.0011601181],"domain_scores_gemma":[0.98884344,0.008213708,0.0009479447,0.00020510599,0.00096031965,0.0008293953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066428776,0.0009514767,0.0019467811,0.0020562764,0.00053780514,0.002610381,0.0012049358,0.0012673078,0.009699857],"category_scores_gemma":[0.02578932,0.0006768216,0.003367123,0.0033552402,0.0005468294,0.0016887601,0.0013075629,0.0023800624,0.00024084141],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011426642,0.0010979004,0.07154958,0.001200766,0.0034427796,0.00042939614,0.00025394134,0.7785237,0.00063018897,0.04112907,0.01360434,0.07671179],"study_design_scores_gemma":[0.003402306,0.0048201033,0.18322007,0.0013812883,0.0060385237,0.00065445865,0.0031640804,0.727712,0.0011974598,0.040123213,0.028075779,0.00021071704],"about_ca_topic_score_codex":0.08284528,"about_ca_topic_score_gemma":0.06337032,"teacher_disagreement_score":0.08284528,"about_ca_system_score_codex":0.01343795,"about_ca_system_score_gemma":0.011082539,"threshold_uncertainty_score":0.16472614},"labels":[],"label_agreement":null},{"id":"W2399151328","doi":"10.1016/j.jval.2016.03.1438","title":"Cost-Effectiveness and Cost-Utility Analysis Comparing Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Uterine artery embolization; Hysterectomy; Uterine leiomyoma; Uterine artery; Cost-effectiveness analysis; Cost–utility analysis; Quality-adjusted life year; Cost effectiveness; Quality of life (healthcare); Surgery; Psychological intervention; Gynecology; Leiomyoma; Risk analysis (engineering)","score_opus":0.13106728717411492,"score_gpt":0.451548250599334,"score_spread":0.3204809634252191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399151328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629709,0.024288762,0.0049438146,0.0012694816,0.00012600703,0.00064026145,0.002227351,0.00004613467,0.0034872682],"genre_scores_gemma":[0.9963141,0.0014848461,0.0012662869,0.00010392175,0.00003962356,0.000115258204,0.00046976737,0.0000047458234,0.00020139995],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9939814,0.004813297,0.00027994064,0.00022532034,0.00040429452,0.00029563674],"domain_scores_gemma":[0.98240477,0.015766388,0.00086129876,0.00023777831,0.00034430795,0.0003853539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052890275,0.001140393,0.0026138145,0.002442478,0.00022509803,0.001449246,0.0010461325,0.0011900658,0.003741679],"category_scores_gemma":[0.020294132,0.0005541682,0.006310814,0.0022706403,0.0006954031,0.0012574921,0.00079721824,0.0015212056,0.00012801624],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34645784,0.0055898307,0.0849572,0.0066379826,0.050299622,0.0007010473,0.0003318332,0.31839404,0.0029225466,0.010007774,0.0030532107,0.17064711],"study_design_scores_gemma":[0.053984128,0.06563674,0.22179608,0.0017894153,0.07048613,0.0017646962,0.0012727977,0.56287694,0.0027911365,0.012931143,0.0041511753,0.00051963533],"about_ca_topic_score_codex":0.0077221617,"about_ca_topic_score_gemma":0.0042462097,"teacher_disagreement_score":0.0077221617,"about_ca_system_score_codex":0.004167665,"about_ca_system_score_gemma":0.001331187,"threshold_uncertainty_score":0.030238628},"labels":[],"label_agreement":null},{"id":"W2399165190","doi":"10.1016/j.jval.2016.03.812","title":"CAN THE ETHICAL DILEMMAS FOR HEALTH CARE DECISION MAKING ON DRUG REIMBURSMENT BE TACKLED THROUGH HOLISTIC MCDA: AN ADAPTATION OF THE EVIDEM FRAMEWORK IN REAL-WORLD SETTING - THE CATALAN EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Adaptation (eye); Catalan; Psychology; Medicine; Humanities; Operations research; Engineering; Philosophy","score_opus":0.4855523669470758,"score_gpt":0.5086104536596524,"score_spread":0.023058086712576586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399165190","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06012193,0.014958717,0.04165275,0.7903867,0.0014670935,0.00022283026,0.0001621822,0.00003452041,0.090993285],"genre_scores_gemma":[0.90883195,0.0049314457,0.04311232,0.038781855,0.0007410241,0.00021244571,0.00009066053,0.000039659946,0.0032585822],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9476463,0.04310234,0.0012390445,0.0014149339,0.0044521047,0.0021452769],"domain_scores_gemma":[0.9192678,0.059410784,0.0039037026,0.005840697,0.008209067,0.0033679442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.102547705,0.00055389013,0.0018894074,0.0020276092,0.003538463,0.0154989185,0.0028695986,0.008617246,0.0038264133],"category_scores_gemma":[0.10139805,0.00042479835,0.0011807942,0.0018321126,0.020155547,0.009546496,0.0079117445,0.0092620775,0.00040971878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023020334,0.00016349537,0.0042893104,0.0006280576,0.00023075286,0.00038546475,0.0067117056,0.005211939,0.00019716361,0.8985677,0.016862907,0.06652139],"study_design_scores_gemma":[0.00012853318,0.000073210154,0.0033729756,0.0015855754,0.00006179841,0.0002113398,0.0078113815,0.003910437,0.00013898266,0.93697,0.045675874,0.000059962404],"about_ca_topic_score_codex":0.020574804,"about_ca_topic_score_gemma":0.035174944,"teacher_disagreement_score":0.102547705,"about_ca_system_score_codex":0.013222773,"about_ca_system_score_gemma":0.02555691,"threshold_uncertainty_score":0.5423306},"labels":[],"label_agreement":null},{"id":"W2399173259","doi":"10.1016/j.jval.2016.03.1274","title":"ANALYSIS OF TRENDS IN UTILIZATION AND COST OF INSULIN IN THE UNITED STATES AND CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Unit (ring theory); Quarter (Canadian coin); Business; Medicine; Agricultural economics; Agricultural science; Geography; Economics; Internal medicine; Environmental science","score_opus":0.1408378403607111,"score_gpt":0.3340619785729026,"score_spread":0.1932241382121915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399173259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776139,0.0020198831,0.00017720879,0.0015055465,0.000019014728,0.000021013448,0.015776118,0.000028487022,0.0028387927],"genre_scores_gemma":[0.9891334,0.0013266667,0.00018077483,0.0001753823,0.000011087591,0.000007155888,0.007474064,0.000009872008,0.0016816129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989699,0.00006628591,0.00007863979,0.00011120287,0.00042351434,0.00035049833],"domain_scores_gemma":[0.9947672,0.0005874005,0.00079878775,0.000093577946,0.0030330408,0.00072000886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076189666,0.00023786513,0.00048893533,0.002785826,0.0011203346,0.0019815294,0.0014184031,0.0006781381,0.0015944282],"category_scores_gemma":[0.0051326524,0.00031028138,0.0009866478,0.010102921,0.0006100787,0.0005756513,0.0005863612,0.0010974057,0.00015769333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031933637,0.00006467844,0.98049027,0.000058606616,0.00022829059,0.00012508397,0.0002882648,0.004129693,0.00014495099,0.0011856545,0.004625142,0.008340034],"study_design_scores_gemma":[0.000010527533,0.000020708929,0.99261636,0.000020747932,0.00006191808,0.000057320976,0.0007923255,0.0043148273,0.00012849744,0.00008559187,0.0018772944,0.000013882278],"about_ca_topic_score_codex":0.9955456,"about_ca_topic_score_gemma":0.9962047,"teacher_disagreement_score":0.041084304,"about_ca_system_score_codex":0.041084304,"about_ca_system_score_gemma":0.034343008,"threshold_uncertainty_score":0.2980889},"labels":[],"label_agreement":null},{"id":"W2399195604","doi":"10.1016/j.jval.2016.03.1931","title":"SF6D VALUE SETS: A SYSTEMATIC REVIEW","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Checklist; Preference; Lottery; Scopus; Population; Index (typography); Actuarial science; Statistics; Demography; Medicine; Econometrics; MEDLINE; Geography; Psychology; Mathematics; Economics; Computer science; Political science; Sociology","score_opus":0.6244155366415018,"score_gpt":0.5045744746090518,"score_spread":0.11984106203245004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399195604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00065805955,0.99766266,0.00021914556,0.0002135601,0.00008536072,0.00015090148,0.00071469607,0.0000065974014,0.00028899862],"genre_scores_gemma":[0.019033968,0.97737086,0.0016645546,0.00060562976,0.0001344768,0.0004839212,0.0005724452,0.0000075268467,0.00012666584],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9918406,0.0030540903,0.0026624901,0.0005039893,0.0017723986,0.00016653487],"domain_scores_gemma":[0.9754969,0.019938353,0.0028158007,0.00036007861,0.00121591,0.00017292667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009760947,0.0015035907,0.007471523,0.0103667285,0.00047357343,0.002247011,0.0016127395,0.0013174089,0.0068124016],"category_scores_gemma":[0.051716685,0.0007246127,0.006681316,0.0091847805,0.0011270032,0.002057636,0.0018754873,0.0015174486,0.0002775254],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043549555,0.000033474167,0.0016988093,0.7722087,0.019239705,0.000053281037,0.00014475045,0.00035333502,0.0000661045,0.0013993095,0.005568068,0.19879904],"study_design_scores_gemma":[0.0016958702,0.00033095392,0.011687351,0.79758996,0.117170185,0.0005070604,0.0003804355,0.0003374386,0.00019294285,0.0068241186,0.063142225,0.00014143625],"about_ca_topic_score_codex":0.0072746035,"about_ca_topic_score_gemma":0.019426469,"teacher_disagreement_score":0.0103667285,"about_ca_system_score_codex":0.003323573,"about_ca_system_score_gemma":0.006229225,"threshold_uncertainty_score":0.051621437},"labels":[],"label_agreement":null},{"id":"W2399202503","doi":"10.1016/j.jval.2015.09.578","title":"First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology; Novartis (Canada)","funders":"","keywords":"Medicine; EQ-5D; Internal medicine; Health related quality of life; Disease","score_opus":0.20342684095568692,"score_gpt":0.3939097600164931,"score_spread":0.19048291906080617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399202503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99162966,0.001029851,0.0008702255,0.00036357075,0.000073920964,0.00032294463,0.0035097273,0.000018248451,0.0021817773],"genre_scores_gemma":[0.9940654,0.00023167569,0.0013820861,0.00034722895,0.00006463825,0.00023465868,0.0033215538,0.000012731607,0.00034001714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967849,0.0021111595,0.00022383682,0.00028693044,0.00039737122,0.00019581926],"domain_scores_gemma":[0.97571486,0.013962592,0.0030521764,0.0030845474,0.0030619316,0.0011237955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006001095,0.0007059439,0.0008960744,0.0010078911,0.000939848,0.0017230806,0.00069591356,0.0014477789,0.0033951132],"category_scores_gemma":[0.027437449,0.00036094518,0.0017156801,0.0012413107,0.00089869514,0.0016613164,0.0010554327,0.0023216002,0.0009205855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013247508,0.010722011,0.91655636,0.000816777,0.003820937,0.0006668505,0.0014733463,0.0010920094,0.0006001949,0.0016782967,0.011189424,0.038136195],"study_design_scores_gemma":[0.002704024,0.012410434,0.96605575,0.00038633338,0.0011865332,0.001453834,0.002178497,0.004332045,0.0003820241,0.00095139444,0.007803279,0.00015581766],"about_ca_topic_score_codex":0.0074844765,"about_ca_topic_score_gemma":0.0069469693,"teacher_disagreement_score":0.0074844765,"about_ca_system_score_codex":0.0014072707,"about_ca_system_score_gemma":0.0008031406,"threshold_uncertainty_score":0.03173721},"labels":[],"label_agreement":null},{"id":"W2399234573","doi":"10.1016/j.jval.2016.03.432","title":"Comparison Of First- And Second-Season Palivizumab Prophylaxis In Patients With Congenital Airway Anomalies (Caa) In The Caress Database (2005-2015)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Population; Demographics; Respiratory system; Airway; Internal medicine; Anesthesia; Pregnancy; Demography","score_opus":0.02883932831126311,"score_gpt":0.29917780399412974,"score_spread":0.2703384756828666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399234573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824782,0.0038691873,0.00006863277,0.00022703627,0.00004182302,0.000019127954,0.012334569,0.000007320968,0.0009542112],"genre_scores_gemma":[0.9941393,0.00051640347,0.000046633926,0.00008034829,0.000018554683,0.000011017278,0.0050563333,0.00000270839,0.00012869017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792683,0.0003495525,0.0005275265,0.0004946198,0.00030563795,0.000395897],"domain_scores_gemma":[0.9952512,0.0009132767,0.0025893191,0.00023542777,0.00055017805,0.00046073424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016186783,0.0002546233,0.00072789955,0.0015925281,0.00025503756,0.0009814659,0.0008824949,0.0007124396,0.0014261996],"category_scores_gemma":[0.00731246,0.00031410178,0.0017939311,0.0027066024,0.0002474857,0.00093100587,0.000951337,0.00078643183,0.00013285608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031857527,0.000013928724,0.9974468,0.00007363995,0.00035319413,0.000031094645,0.000047886268,0.00006186026,0.000044383327,0.000041051702,0.00046424032,0.0011034112],"study_design_scores_gemma":[0.000021818745,0.00007723548,0.9989176,0.00005021641,0.00013855164,0.000106368185,0.00020266029,0.00012917104,0.000033017695,0.000012667512,0.0003068967,0.0000038970175],"about_ca_topic_score_codex":0.05479616,"about_ca_topic_score_gemma":0.07302832,"teacher_disagreement_score":0.05479616,"about_ca_system_score_codex":0.001179783,"about_ca_system_score_gemma":0.0011771327,"threshold_uncertainty_score":0.10895443},"labels":[],"label_agreement":null},{"id":"W2399405744","doi":"10.1016/j.jval.2016.03.666","title":"SINGLE DOSE INTRAOPERATIVE RADIOTHERAPY FOR BREAST CANCER: NICE RECOMMENDATIONS REVISITED","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nice; Medicine; Radiation therapy; Breast cancer; Intraoperative radiotherapy; Medical physics; Cancer; Oncology; Radiology; Internal medicine; Computer science","score_opus":0.03304483866082563,"score_gpt":0.3322148039629425,"score_spread":0.29916996530211687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399405744","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015365526,0.13930134,0.0020500103,0.8241712,0.013767765,0.00029149902,0.0019090492,0.00018437163,0.016788209],"genre_scores_gemma":[0.026562303,0.07653904,0.019562177,0.85740745,0.012261757,0.0014385906,0.002120397,0.00023554821,0.0038726472],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9174905,0.041562945,0.016695729,0.0024977867,0.01881823,0.0029348645],"domain_scores_gemma":[0.70413643,0.20131174,0.017215448,0.007377506,0.058624055,0.011334868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07939685,0.0014700581,0.007112335,0.0045706807,0.0028195637,0.011883944,0.00892336,0.03123601,0.0068448274],"category_scores_gemma":[0.24597017,0.0020748521,0.008281304,0.008023641,0.007897314,0.0074901315,0.0059578847,0.0289128,0.0021190806],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078039354,0.00015850666,0.0027834256,0.008944662,0.001546001,0.0005337657,0.00063920475,0.0007810383,0.0004162325,0.032447383,0.8583721,0.09259724],"study_design_scores_gemma":[0.0016432842,0.00046901332,0.008224615,0.045245174,0.0027559884,0.000964881,0.0011660923,0.00058208447,0.0003445367,0.040289585,0.8979536,0.00036109443],"about_ca_topic_score_codex":0.030171571,"about_ca_topic_score_gemma":0.07699259,"teacher_disagreement_score":0.07939685,"about_ca_system_score_codex":0.008812967,"about_ca_system_score_gemma":0.027477156,"threshold_uncertainty_score":0.4198957},"labels":[],"label_agreement":null},{"id":"W2399424859","doi":"10.1016/j.jval.2016.03.1093","title":"MAPPING THE WESTERN ONTARIO AND MCMASTER UNIVERSITIES ARTHRITIS INDEX (WOMAC) TO THE EQ-5D","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"WOMAC; Categorical variable; Statistics; Osteoarthritis; Mathematics; Linear regression; Medicine; EQ-5D; Regression analysis; Physical therapy; Internal medicine; Health related quality of life","score_opus":0.42363948634078735,"score_gpt":0.3493824603878545,"score_spread":0.07425702595293288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399424859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8430681,0.005377342,0.022378618,0.005686385,0.00036206996,0.0003737322,0.06063611,0.0002793646,0.06183823],"genre_scores_gemma":[0.9626481,0.0013478084,0.010168801,0.00027874327,0.00003594375,0.0001268401,0.018960593,0.00006682174,0.006366326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864775,0.0003608436,0.000081412145,0.00022316749,0.00044081057,0.00024601462],"domain_scores_gemma":[0.99654466,0.00085611804,0.00043234284,0.00030883594,0.0016915078,0.00016654606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016437632,0.0004091505,0.0003989443,0.0038488626,0.00067983,0.0022388923,0.00080728583,0.0005683304,0.0054657175],"category_scores_gemma":[0.016287068,0.00023409275,0.0010073743,0.008567735,0.0005460542,0.0006694484,0.001541634,0.00077648385,0.0016347863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033633932,0.000114179806,0.81675386,0.00032101927,0.00041557717,0.00028816378,0.0013414593,0.012615896,0.0009756249,0.010613259,0.031619746,0.12460475],"study_design_scores_gemma":[0.00004905019,0.000057066707,0.9297535,0.00025158774,0.00017561261,0.00015615436,0.0027905104,0.024039503,0.00053150154,0.0076108896,0.034535043,0.00004965541],"about_ca_topic_score_codex":0.8400868,"about_ca_topic_score_gemma":0.78832805,"teacher_disagreement_score":0.8400868,"about_ca_system_score_codex":0.005671209,"about_ca_system_score_gemma":0.010199176,"threshold_uncertainty_score":0.32170987},"labels":[],"label_agreement":null},{"id":"W2399436709","doi":"10.1016/j.jval.2016.03.1315","title":"CHARACTERISTICS OF PATIENTS INITIATING TREATMENT WITH DULAGLUTIDE AND OTHER GLP-1 RECEPTOR AGONISTS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Dulaglutide; Exenatide; Medicine; Liraglutide; Internal medicine; Glucagon-like peptide 1 receptor; Type 2 diabetes; Diabetes mellitus; Endocrinology; Agonist; Receptor","score_opus":0.03022752582593738,"score_gpt":0.27330634948259236,"score_spread":0.24307882365665498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399436709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313873,0.00093437737,0.00010745365,0.00015527473,0.000027083657,0.00003388219,0.0018145933,0.000008041857,0.00378052],"genre_scores_gemma":[0.996029,0.0005022982,0.00008199425,0.0003186256,0.00006153168,0.000049647584,0.0018898846,0.000006579046,0.0010605695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955624,0.000043708365,0.00007358338,0.00009704378,0.00006497936,0.0001643582],"domain_scores_gemma":[0.9983096,0.0005348151,0.0005769334,0.000053417516,0.00009381863,0.00043136982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029384313,0.00021704119,0.0007002098,0.0007042013,0.00050347403,0.0007241571,0.00024361115,0.00067365647,0.0058446024],"category_scores_gemma":[0.002053425,0.00018326625,0.00096460915,0.0012172236,0.00025600716,0.0006453324,0.0003001796,0.0010217885,0.00052623724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034700634,0.0005235913,0.9875893,0.000050077033,0.00017559098,0.0007173694,0.00012616022,0.00018811699,0.0011304688,0.000111207286,0.00060993637,0.00530805],"study_design_scores_gemma":[0.00013171342,0.0013237642,0.99430203,0.000033348737,0.00009400314,0.0016048496,0.00053369964,0.00030943225,0.00013687866,0.000107557455,0.0014019189,0.000020673177],"about_ca_topic_score_codex":0.002410887,"about_ca_topic_score_gemma":0.0023233283,"teacher_disagreement_score":0.0058446024,"about_ca_system_score_codex":0.00043660257,"about_ca_system_score_gemma":0.00066662766,"threshold_uncertainty_score":0.019552112},"labels":[],"label_agreement":null},{"id":"W2399450583","doi":"10.1016/j.jval.2016.03.171","title":"Health-Related Quality of Life of Patients Suffering an Acute Coronary Syndrome: An Analysis Using Multinational Eq-5d Outcomes from the Pgrx-3 Real-World Dataset","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Acute coronary syndrome; Pharmacoepidemiology; Quality of life (healthcare); Population; Real world evidence; Pediatrics; Internal medicine; Environmental health","score_opus":0.15846213124894643,"score_gpt":0.4114763942298091,"score_spread":0.25301426298086266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399450583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8674061,0.00048316017,0.00029906404,0.00047658582,0.000032240718,0.00003357425,0.13068925,0.000035342466,0.00054460723],"genre_scores_gemma":[0.77185625,0.00022330391,0.00049434113,0.0002161518,0.000037011356,0.00013483393,0.22664945,0.000030195433,0.0003584764],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982663,0.0005495398,0.00021138675,0.00046035272,0.0002696987,0.00024279309],"domain_scores_gemma":[0.9956126,0.0010453061,0.0017753831,0.0006358064,0.00042559122,0.0005052645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430137,0.00080099364,0.0012175587,0.001389669,0.00039253544,0.0012998657,0.0013063978,0.0011955588,0.0016620813],"category_scores_gemma":[0.0070179803,0.00037111418,0.0025382228,0.0032145279,0.00041948052,0.001017436,0.0020176596,0.001647598,0.0006623971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012445312,0.00017987899,0.9816502,0.00010745758,0.001672817,0.000106790765,0.00013076731,0.0019486708,0.00012991288,0.00014174623,0.009538636,0.003148601],"study_design_scores_gemma":[0.000093765426,0.00009924791,0.9953371,0.00003702559,0.00024683645,0.00014645931,0.00018781838,0.0022473335,0.00005385466,0.00007014178,0.0014539767,0.000026411459],"about_ca_topic_score_codex":0.030637378,"about_ca_topic_score_gemma":0.023926606,"teacher_disagreement_score":0.030637378,"about_ca_system_score_codex":0.0009363457,"about_ca_system_score_gemma":0.0007627735,"threshold_uncertainty_score":0.060918093},"labels":[],"label_agreement":null},{"id":"W2399580742","doi":"10.1016/j.jval.2016.03.266","title":"A Budget Impact Analysis Establishing The Economic Benefit Of The Sandostatin® Lar® Mobile Administration Program In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acromegaly; Administration (probate law); Economic evaluation; Emergency medicine; Demography; Internal medicine; Political science","score_opus":0.014403776425862116,"score_gpt":0.30106372295989325,"score_spread":0.28665994653403115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399580742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90387315,0.0059472793,0.0014426125,0.011065573,0.00024322134,0.0020186203,0.01936617,0.00007630087,0.055967074],"genre_scores_gemma":[0.9876172,0.0020909098,0.001026806,0.00091140944,0.00003702395,0.00018889138,0.0025375583,0.000018271796,0.0055719297],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9923396,0.0016003012,0.0002479797,0.00024809185,0.0026396299,0.0029244353],"domain_scores_gemma":[0.9890969,0.003444734,0.00068583887,0.00015462804,0.005024145,0.0015937162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003924635,0.0006598407,0.0010893029,0.003387925,0.002236032,0.0041987235,0.0015169726,0.0011053586,0.0056395093],"category_scores_gemma":[0.017383343,0.0005864534,0.0017813653,0.006568016,0.0011325069,0.00083256204,0.0013431369,0.0019724502,0.00020440885],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022280483,0.0029485254,0.4106589,0.0034773012,0.004660731,0.0020978802,0.0015657806,0.18691902,0.00298645,0.07336594,0.07425718,0.2147818],"study_design_scores_gemma":[0.003486381,0.00322661,0.79497635,0.0016337127,0.0055894665,0.0003847573,0.008972679,0.109797075,0.002374865,0.0054305163,0.063759655,0.0003680205],"about_ca_topic_score_codex":0.9894873,"about_ca_topic_score_gemma":0.9885925,"teacher_disagreement_score":0.1569095,"about_ca_system_score_codex":0.1569095,"about_ca_system_score_gemma":0.2082757,"threshold_uncertainty_score":0.97786546},"labels":[],"label_agreement":null},{"id":"W2399606097","doi":"10.1016/j.jval.2016.03.1496","title":"Reimbursement Recommendations Based on Phase II Clinical Evidence for Oncology Drugs in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Formulary; Reimbursement; Medicine; Clinical trial; Oncology; Family medicine; Population; Listing (finance); Alternative medicine; Clinical Oncology; Internal medicine; Phases of clinical research; Intensive care medicine; Cancer; Pathology; Environmental health; Business; Health care","score_opus":0.8587800858823377,"score_gpt":0.69826068250283,"score_spread":0.16051940337950765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399606097","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.113867566,0.05802997,0.020295842,0.58128387,0.0066873934,0.00293223,0.028346468,0.00059093564,0.1879657],"genre_scores_gemma":[0.8286289,0.021085385,0.02591837,0.10148376,0.0025111435,0.00084209006,0.0076646884,0.00029956544,0.011566086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.955847,0.020474302,0.0044947793,0.0016104417,0.014489015,0.003084461],"domain_scores_gemma":[0.71906817,0.18058163,0.013749412,0.0028881095,0.07002202,0.013690635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046345487,0.0006493949,0.0016674576,0.00508003,0.0022321579,0.008794023,0.0024296714,0.0041096327,0.0065575233],"category_scores_gemma":[0.29761326,0.0007656545,0.0016669227,0.006255023,0.002745095,0.0017060676,0.0013635767,0.005675002,0.00048127363],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037381472,0.00021595518,0.062385667,0.0032032654,0.0017765107,0.00038563288,0.0013090752,0.02822159,0.00048278525,0.101721734,0.5868648,0.20969477],"study_design_scores_gemma":[0.007073229,0.00070231024,0.22770384,0.01827067,0.0053108395,0.00058719184,0.0025384654,0.067546256,0.0017787686,0.10635211,0.5615941,0.00054230134],"about_ca_topic_score_codex":0.86781913,"about_ca_topic_score_gemma":0.91159904,"teacher_disagreement_score":0.9421193,"about_ca_system_score_codex":0.0578807,"about_ca_system_score_gemma":0.22264259,"threshold_uncertainty_score":0.41995585},"labels":[],"label_agreement":null},{"id":"W2399610764","doi":"10.1016/j.jval.2016.03.1999","title":"CANADIAN PUBLIC REIMBURSEMENT OF BIOSIMILARS (REFERRED TO AS SUBSEQUENT ENTRY BIOLOGICS – SEBS – IN CANADA), AN UPDATE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Biosimilar; Orphan drug; Medicine; Public health; Alliance; Agency (philosophy); Family medicine; Business; Health care; Political science; Internal medicine; Nursing","score_opus":0.06628117005011978,"score_gpt":0.3140064158950997,"score_spread":0.2477252458449799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399610764","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009130777,0.5952065,0.001884537,0.2507811,0.015942188,0.00017977516,0.005588797,0.00028649083,0.12099985],"genre_scores_gemma":[0.07318689,0.79248416,0.0061844215,0.086744994,0.006064943,0.00013472985,0.00523834,0.00021686072,0.029744666],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99032277,0.00074202084,0.0008322664,0.0004663136,0.0064385254,0.0011980945],"domain_scores_gemma":[0.9522864,0.008024658,0.0026306221,0.0005218862,0.033132125,0.003404307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008921037,0.00085271656,0.0012691341,0.006168182,0.0029237682,0.008668799,0.0028836054,0.0046282657,0.011342854],"category_scores_gemma":[0.02588007,0.0005852986,0.0012566299,0.010666657,0.003660217,0.0022971467,0.0016027816,0.0059067053,0.0011607751],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001470203,0.00007852396,0.0044065583,0.0024495122,0.00011335047,0.00026816048,0.00054253824,0.00048163408,0.00023729242,0.015250305,0.7271526,0.24887256],"study_design_scores_gemma":[0.000051002444,0.0000195791,0.007599944,0.0024854722,0.0000931526,0.000228646,0.00033432513,0.00017788364,0.00014416027,0.00077709724,0.98804575,0.00004307232],"about_ca_topic_score_codex":0.95807374,"about_ca_topic_score_gemma":0.9806435,"teacher_disagreement_score":0.90220106,"about_ca_system_score_codex":0.097798936,"about_ca_system_score_gemma":0.23736846,"threshold_uncertainty_score":0.70958424},"labels":[],"label_agreement":null},{"id":"W2399640665","doi":"10.1016/j.jval.2016.03.754","title":"Prescription Factors Associated With A Do Not Substitute Prescription In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medical prescription; Medicine; Specialty; Generic drug; Family medicine; Pharmacist; Brand names; Pharmacy; Drug; Pharmacology; Business; Advertising","score_opus":0.126930399827186,"score_gpt":0.2746551098800359,"score_spread":0.14772471005284987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399640665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9364207,0.007058136,0.0002979215,0.02258265,0.00024927955,0.00009557005,0.019040229,0.000052292162,0.014203237],"genre_scores_gemma":[0.9916815,0.0016050291,0.00014003365,0.0009105762,0.000056514105,0.000010043431,0.0020281645,0.000015864463,0.003552157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968894,0.0002339119,0.0002499465,0.0003235452,0.0010246614,0.0012786567],"domain_scores_gemma":[0.976641,0.0030706525,0.0065805926,0.000556057,0.0064502233,0.0067014806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013681373,0.00027560815,0.00078292825,0.001776121,0.0029314402,0.0033754364,0.0016354121,0.001659233,0.0067535504],"category_scores_gemma":[0.013418663,0.00045852503,0.0014835374,0.005703343,0.0012705663,0.00075091625,0.0011905177,0.0038524088,0.00023209589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045684396,0.0001390285,0.96849334,0.00011242777,0.0003359059,0.00032478024,0.0005361049,0.0011509754,0.0001278939,0.005334895,0.013595162,0.009392689],"study_design_scores_gemma":[0.00006741462,0.00005013184,0.9848194,0.00015949774,0.00018844809,0.00020485735,0.0016886217,0.0019655693,0.0001418026,0.0007868784,0.009880437,0.00004690446],"about_ca_topic_score_codex":0.9968754,"about_ca_topic_score_gemma":0.9976793,"teacher_disagreement_score":0.057425503,"about_ca_system_score_codex":0.057425503,"about_ca_system_score_gemma":0.10869298,"threshold_uncertainty_score":0.4166531},"labels":[],"label_agreement":null},{"id":"W2399866507","doi":"10.1016/j.jval.2016.03.1524","title":"Pan-Canadian Oncology Drug Review Recommendations for Cancer Products without Statistically Significant Overall Survival Data","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Confounding; Internal medicine; Population; Oncology; Cancer; Environmental health","score_opus":0.6376866463596899,"score_gpt":0.5098763384596184,"score_spread":0.12781030790007142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399866507","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014975534,0.4244748,0.0042606336,0.40979117,0.022684768,0.0017999479,0.020891387,0.0006375278,0.11396225],"genre_scores_gemma":[0.033273026,0.39450675,0.03750551,0.44096604,0.015723083,0.0022208928,0.015637858,0.0005224469,0.059644405],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9656553,0.010325401,0.00578952,0.0012871891,0.015187166,0.0017554938],"domain_scores_gemma":[0.85677636,0.04130936,0.015769208,0.002987776,0.07826242,0.004894868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030596698,0.0017065607,0.0041789585,0.010504068,0.0018520154,0.0062366207,0.0061600376,0.010630507,0.017024087],"category_scores_gemma":[0.101607665,0.0011211401,0.0067995153,0.011602091,0.0026955954,0.002999913,0.0016516636,0.0072696498,0.0061181807],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045517777,0.000050202,0.00064604625,0.006649417,0.00034522568,0.00013245943,0.0000597247,0.000540611,0.00022393442,0.003999194,0.89776343,0.08913456],"study_design_scores_gemma":[0.00048788323,0.00007518146,0.0039973054,0.015324705,0.0014167598,0.00014455427,0.00007214055,0.0003607688,0.0002463044,0.0028749313,0.9749128,0.00008653597],"about_ca_topic_score_codex":0.49917275,"about_ca_topic_score_gemma":0.7394161,"teacher_disagreement_score":0.9742175,"about_ca_system_score_codex":0.025782516,"about_ca_system_score_gemma":0.10059375,"threshold_uncertainty_score":0.99253446},"labels":[],"label_agreement":null},{"id":"W2400148784","doi":"10.1016/j.jval.2016.03.1811","title":"CAN HOLISTIC MCDA TACKLE ISSUES RAISED BY EVALUATING TREATMENTS FOR RARE DISEASES: AN EXPLORATION FROM THE HTA PERSPECTIVE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Operationalization; Underpinning; Management science; Psychological intervention; Psychology; Weighting; Perspective (graphical); Medicine; Applied psychology; Computer science; Operations research; Psychiatry; Engineering","score_opus":0.6192007478366135,"score_gpt":0.5083943326665649,"score_spread":0.11080641517004863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400148784","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.074589,0.02320103,0.6498907,0.13898717,0.0013506006,0.0008109703,0.002126146,0.00014194875,0.10890239],"genre_scores_gemma":[0.7768874,0.005674946,0.20953634,0.0039788787,0.00074483757,0.0003563869,0.0004868171,0.000058807123,0.0022756043],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98496246,0.011130111,0.00053213054,0.0007670459,0.0019741522,0.0006341894],"domain_scores_gemma":[0.949426,0.037752442,0.003908106,0.002734928,0.004471774,0.0017067164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022042993,0.0011068739,0.0037790954,0.0053433627,0.0013449468,0.007765388,0.002531629,0.0031950588,0.00882048],"category_scores_gemma":[0.08243221,0.0007915515,0.0018601977,0.0058482722,0.0036138284,0.0075013526,0.004979422,0.0033021995,0.00041317113],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014128878,0.0002576936,0.010317467,0.0013411947,0.0010133524,0.00030522016,0.0009134974,0.050269637,0.00027531604,0.7897336,0.010271579,0.13516015],"study_design_scores_gemma":[0.000030861473,0.000047736452,0.001769995,0.00055938633,0.000105355604,0.00008725978,0.0008923704,0.026994176,0.000086540014,0.96124285,0.008158953,0.000024375282],"about_ca_topic_score_codex":0.013157578,"about_ca_topic_score_gemma":0.024092665,"teacher_disagreement_score":0.022042993,"about_ca_system_score_codex":0.0055959555,"about_ca_system_score_gemma":0.008782101,"threshold_uncertainty_score":0.11657584},"labels":[],"label_agreement":null},{"id":"W2400311525","doi":"10.1016/j.jval.2016.03.188","title":"Antiepileptic Drugs, Risk of Suicide Attempts, and the Impact of Underlying Medical Conditions: Results from the Pgrx Information System","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Depression (economics); Suicide attempt; Odds ratio; Confidence interval; Psychiatry; Telephone interview; Logistic regression; Major depressive episode; Suicidal ideation; History of depression; Poison control; Pediatrics; Suicide prevention; Emergency medicine; Internal medicine; Cognition","score_opus":0.057461349814338494,"score_gpt":0.37228434285311623,"score_spread":0.31482299303877775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400311525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9237563,0.0010194004,0.00024417078,0.0006750257,0.000013560949,0.00015946741,0.06981262,0.00008778336,0.0042316522],"genre_scores_gemma":[0.95580006,0.00093771756,0.00090439606,0.0003018778,0.00005886367,0.00019687616,0.039945982,0.00002858537,0.0018255048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761873,0.00087943405,0.00048236275,0.0002369275,0.00065733277,0.00012527256],"domain_scores_gemma":[0.9683915,0.017672075,0.009730645,0.0015009663,0.0018670575,0.00083780714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026496928,0.00036631845,0.0007506347,0.0036567943,0.00029520213,0.0013594015,0.0007081419,0.0007413392,0.005043155],"category_scores_gemma":[0.019357791,0.00022038246,0.0011988037,0.0043782936,0.0002707844,0.0014734209,0.0014893905,0.00064305984,0.001023332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021911142,0.00025723543,0.9797958,0.00033026503,0.0005280535,0.000054825752,0.00023883865,0.00038873538,0.000068337176,0.000109831155,0.002574729,0.013462199],"study_design_scores_gemma":[0.00016777503,0.00037978424,0.99566996,0.000091146474,0.0006367517,0.00010753177,0.00030376768,0.0006019297,0.00018893069,0.00010207171,0.0017323693,0.000018034916],"about_ca_topic_score_codex":0.010861694,"about_ca_topic_score_gemma":0.008142539,"teacher_disagreement_score":0.010861694,"about_ca_system_score_codex":0.0007464301,"about_ca_system_score_gemma":0.0011644994,"threshold_uncertainty_score":0.021596968},"labels":[],"label_agreement":null},{"id":"W2400513728","doi":"10.1016/j.jval.2016.03.062","title":"Does A Web-Based Decision Aid Help Parents in making a Decision to Vaccinate their Child against Hpv: Findings from Alberta","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Decision aids; Preference; Descriptive statistics; Sample (material); Family medicine; Psychology; Vaccination; Medicine; Session (web analytics); Demography; Alternative medicine; Computer science; Statistics","score_opus":0.02568770224073916,"score_gpt":0.3145284611527088,"score_spread":0.28884075891196964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400513728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986297,0.0004922946,0.00010278688,0.002111169,0.000028741604,0.000074562566,0.0002788035,0.00000954175,0.010605176],"genre_scores_gemma":[0.9942625,0.0009877586,0.0005760611,0.0009375177,0.000015807296,0.000066602304,0.00027617713,0.000011716764,0.0028659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970318,0.0012912857,0.00012838672,0.00016482305,0.00093554304,0.00044816968],"domain_scores_gemma":[0.977999,0.015506355,0.0014578026,0.0005861533,0.0029098538,0.0015408583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005370367,0.00021350959,0.00030635347,0.00066804874,0.0011901933,0.0020419299,0.0010151187,0.0008810947,0.004093225],"category_scores_gemma":[0.02943624,0.00030149694,0.00062560424,0.0011506671,0.00081833935,0.0010951135,0.0008545161,0.001123451,0.00039010428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021150978,0.003340498,0.87507,0.00031749273,0.00025891163,0.0003863512,0.009951992,0.00060574705,0.00032482538,0.0005673425,0.008836404,0.09822533],"study_design_scores_gemma":[0.00045693957,0.0010300837,0.95214736,0.0009736173,0.0004982252,0.00018957462,0.029357547,0.002695117,0.00054035435,0.0006040663,0.011439794,0.000067277855],"about_ca_topic_score_codex":0.6816216,"about_ca_topic_score_gemma":0.78339595,"teacher_disagreement_score":0.3183784,"about_ca_system_score_codex":0.006383135,"about_ca_system_score_gemma":0.013837239,"threshold_uncertainty_score":0.64050674},"labels":[],"label_agreement":null},{"id":"W2400637005","doi":"10.1016/j.jval.2016.03.747","title":"Chinese Health System Development From 1949 To 2015: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"EconLit; Political science; China; Government (linguistics); Politics; Context (archaeology); Health policy; Public relations; Health care; MEDLINE; Law; Geography","score_opus":0.11460281494638101,"score_gpt":0.35562115934816135,"score_spread":0.24101834440178033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400637005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0034256903,0.9937928,0.00015147617,0.00042643058,0.00007301663,0.00012905797,0.0015685569,0.000005664936,0.00042744706],"genre_scores_gemma":[0.05098788,0.9467785,0.00048444892,0.0005123905,0.00007813875,0.00025141364,0.0007382755,0.0000030270767,0.00016581839],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976926,0.0005524871,0.00082781643,0.00024797712,0.0005277178,0.00015153423],"domain_scores_gemma":[0.99508566,0.0027629668,0.0012217655,0.00012902907,0.0006552025,0.00014537071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004863684,0.001086126,0.0035485462,0.012090881,0.00047249848,0.0013771062,0.0010852262,0.00088051986,0.0041312245],"category_scores_gemma":[0.012623719,0.00064280553,0.0039759693,0.014768219,0.0008594151,0.0013879719,0.0015899136,0.00059405627,0.0001413829],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034368405,0.000055031367,0.019433249,0.7829849,0.02184956,0.00022936866,0.00050975766,0.00081455853,0.00019501941,0.0016441311,0.008564671,0.163376],"study_design_scores_gemma":[0.0007854729,0.00057281647,0.16387165,0.45194343,0.2550853,0.00082981546,0.0014529643,0.00059980893,0.0008085992,0.0025166338,0.121340625,0.00019290687],"about_ca_topic_score_codex":0.040822044,"about_ca_topic_score_gemma":0.09554422,"teacher_disagreement_score":0.040822044,"about_ca_system_score_codex":0.0053807436,"about_ca_system_score_gemma":0.020603497,"threshold_uncertainty_score":0.08116883},"labels":[],"label_agreement":null},{"id":"W2400663615","doi":"10.1016/j.jval.2016.03.1497","title":"Trends in Expenditures for Oral Chemotherapy after Market Entry (2007-2013)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Receipt; Quarter (Canadian coin); Drug prices; Medicare Part D; Prescription drug; Medicare Advantage; Cancer drugs; Medical prescription; Drug; Health care; Business; Public economics; Family medicine; Accounting; Pharmacology; Economics; Economic growth","score_opus":0.03689146752260034,"score_gpt":0.2778020703234234,"score_spread":0.24091060280082308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400663615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8204939,0.0037154038,0.00039528168,0.0021784494,0.000109388675,0.00003604099,0.16480172,0.00012348861,0.008146329],"genre_scores_gemma":[0.85792387,0.0033133114,0.00037996157,0.00051313185,0.0001715354,0.00006171907,0.12914865,0.000049091657,0.008438717],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993293,0.000048019403,0.00009228386,0.00010364775,0.00017716919,0.00024953263],"domain_scores_gemma":[0.99657565,0.00028774835,0.0019980401,0.00004550774,0.00081013713,0.00028300963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006490858,0.00024071103,0.00040528798,0.0019494522,0.00020270846,0.0011456918,0.00065001374,0.0007163522,0.005466962],"category_scores_gemma":[0.0026575753,0.00021251885,0.0013372292,0.004280862,0.0001949605,0.0011116813,0.00063947844,0.0014353974,0.0011428898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010276849,0.00012920999,0.94563264,0.00024940912,0.00031243017,0.00012875521,0.00018641812,0.00093820406,0.0003190499,0.0010917721,0.029722061,0.020262355],"study_design_scores_gemma":[0.0000085123065,0.000052137835,0.993111,0.000043041437,0.000047410915,0.00013602064,0.00016797363,0.00038944668,0.00017661953,0.00003125081,0.005829084,0.000007550452],"about_ca_topic_score_codex":0.16769056,"about_ca_topic_score_gemma":0.21637066,"teacher_disagreement_score":0.16769056,"about_ca_system_score_codex":0.002788576,"about_ca_system_score_gemma":0.0023077608,"threshold_uncertainty_score":0.33342904},"labels":[],"label_agreement":null},{"id":"W2401126186","doi":"10.1016/j.jval.2016.03.669","title":"NURSE-LED CARE FOR PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Nursing Roles and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"CINAHL; Medicine; MEDLINE; Inclusion (mineral); Randomized controlled trial; Rheumatoid arthritis; Family medicine; Health care; Systematic review; Nursing; Physical therapy; Psychological intervention; Internal medicine; Psychology","score_opus":0.07220387224143804,"score_gpt":0.4446594065409786,"score_spread":0.37245553429954054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401126186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018837973,0.99726045,0.00007294734,0.00015951759,0.00010593066,0.00018209907,0.00011489829,0.000004035939,0.00021620035],"genre_scores_gemma":[0.03264838,0.9654697,0.00073596434,0.0006657821,0.000065579115,0.0002214957,0.00008988075,0.0000032572045,0.000099975325],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957759,0.0013982946,0.0014572405,0.00037091685,0.0008211453,0.0001765963],"domain_scores_gemma":[0.98997504,0.007111154,0.0017603924,0.00013020297,0.0007544757,0.0002687166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038587293,0.0008661464,0.004970794,0.004138187,0.0006688525,0.0018787179,0.0014758306,0.0017850837,0.0040458636],"category_scores_gemma":[0.022879226,0.00071270874,0.005516558,0.004706585,0.0006280745,0.0018564228,0.0016565503,0.0018264315,0.00016520181],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053360354,0.00008223341,0.0018329333,0.9122842,0.0129979085,0.00011706834,0.0004416394,0.00009537905,0.000112854956,0.00013430632,0.0016882754,0.069679685],"study_design_scores_gemma":[0.0017054708,0.00056613167,0.012005702,0.8556556,0.108878925,0.0006117923,0.0012228421,0.00013786767,0.00013749216,0.0002960352,0.018703163,0.00007890128],"about_ca_topic_score_codex":0.010931892,"about_ca_topic_score_gemma":0.058787517,"teacher_disagreement_score":0.010931892,"about_ca_system_score_codex":0.0030752763,"about_ca_system_score_gemma":0.008016531,"threshold_uncertainty_score":0.02231276},"labels":[],"label_agreement":null},{"id":"W2401171230","doi":"10.1016/j.jval.2016.03.490","title":"Assessing Severity In Psoriasis: Correlation Of Different Measures (Pasi, Bsa, And Iga) In A Canadian Real-World Setting","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovaderm (Canada); Novartis (Canada)","funders":"","keywords":"Psoriasis; Psoriasis Area and Severity Index; Medicine; Rank correlation; Spearman's rank correlation coefficient; Severity of illness; Correlation; Observational study; Internal medicine; Body surface area; Dermatology","score_opus":0.039772160177721824,"score_gpt":0.28787270484287375,"score_spread":0.2481005446651519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401171230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943057,0.0008797754,0.00029027936,0.00076012115,0.000020077508,0.00007736026,0.00085857377,0.000010434476,0.002797833],"genre_scores_gemma":[0.99842155,0.0004984607,0.0005887261,0.000076269534,0.000005975795,0.000010289055,0.00021703789,0.000004148738,0.00017754333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971859,0.00066393544,0.0001702232,0.00024820506,0.0011464754,0.0005853287],"domain_scores_gemma":[0.99410605,0.0008032631,0.000706704,0.00012333653,0.0030201368,0.0012405383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003011729,0.0004183145,0.00044650625,0.0013285999,0.0022162832,0.0015002212,0.0010677376,0.00055977015,0.0013283368],"category_scores_gemma":[0.010684621,0.00028473206,0.00046631234,0.0035896522,0.0009911036,0.00046522124,0.0008738251,0.00096696935,0.00014350226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003100883,0.00016565021,0.9805022,0.000080879036,0.000059010577,0.00018870387,0.001644551,0.00031837504,0.00035286072,0.00018187842,0.0015029653,0.014692881],"study_design_scores_gemma":[0.000021950389,0.00012107478,0.99484915,0.000045736848,0.00004221798,0.00016784226,0.002784882,0.00072118494,0.00014156534,0.000056950725,0.001016754,0.00003075791],"about_ca_topic_score_codex":0.9791495,"about_ca_topic_score_gemma":0.9857756,"teacher_disagreement_score":0.020890944,"about_ca_system_score_codex":0.020890944,"about_ca_system_score_gemma":0.02658683,"threshold_uncertainty_score":0.15157509},"labels":[],"label_agreement":null},{"id":"W2401460285","doi":"10.1016/j.jval.2016.03.281","title":"The Service Utilization And Cost Of Hiv Treatment In Mbagathi District Hospital, Kenya","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Medicine; Per capita; Quarter (Canadian coin); Emergency medicine; Total cost; Unit cost; Unit (ring theory); Average cost; Environmental health; Pediatrics; Medical emergency; Business; Geography; Population","score_opus":0.056453288762448484,"score_gpt":0.3302134761228075,"score_spread":0.273760187360359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401460285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978536,0.00035882165,0.0000113002225,0.0005622331,0.0000063078724,0.000009436991,0.00042664065,0.0000012187061,0.0007703158],"genre_scores_gemma":[0.99912804,0.00028002827,0.000024167504,0.00007896097,0.000006217369,0.0000062410363,0.00013496842,7.050696e-7,0.00034071834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929976,0.00020629157,0.00006357885,0.000036528167,0.000054308282,0.00033942776],"domain_scores_gemma":[0.9983973,0.00026763833,0.00061972823,0.00002298493,0.000105700434,0.00058664056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003226016,0.00023548491,0.00019386866,0.0007137916,0.0014079965,0.000841438,0.00065431645,0.0008123546,0.0037663477],"category_scores_gemma":[0.0024771541,0.00047438557,0.00036362492,0.0013572463,0.0006395985,0.00066590915,0.0010413745,0.0010778772,0.00023432521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018590415,0.00015242193,0.9923328,0.00006756003,0.0000752399,0.0007546076,0.00083061756,0.0003383983,0.00018784119,0.00035895273,0.0011637458,0.0035518738],"study_design_scores_gemma":[0.000012222408,0.00010054009,0.99528307,0.000041906587,0.000024025052,0.00032636744,0.003380878,0.00036017652,0.00003284095,0.00006114323,0.0003665359,0.000010355243],"about_ca_topic_score_codex":0.24773836,"about_ca_topic_score_gemma":0.4329419,"teacher_disagreement_score":0.24773836,"about_ca_system_score_codex":0.0056678466,"about_ca_system_score_gemma":0.0034250566,"threshold_uncertainty_score":0.49259275},"labels":[],"label_agreement":null},{"id":"W2401695302","doi":"10.1016/j.jval.2016.03.1507","title":"Oncology Drugs Lag Between Europe and other Countries: Comparaison between EMA and others Agencies (FDA, Health Canada, TGA, and Swissmedic)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Food and drug administration; Drug approval; Agency (philosophy); Regulatory affairs; Drug; Regulatory agency; Family medicine; Internal medicine; Oncology; Pharmacology; Operations management; Political science","score_opus":0.1278358697310247,"score_gpt":0.3378959370583687,"score_spread":0.21006006732734397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401695302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79240984,0.09323433,0.002188002,0.03476204,0.00077994633,0.00005630704,0.011085057,0.0001001098,0.06538439],"genre_scores_gemma":[0.98587567,0.0067902743,0.0003168448,0.0028173574,0.00015138087,0.000009108449,0.002489614,0.000030622396,0.0015190851],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973802,0.00066241145,0.0002590557,0.00031569423,0.00053434673,0.00084828044],"domain_scores_gemma":[0.9806716,0.0061419522,0.007842016,0.0007225151,0.0030412541,0.0015806764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046459697,0.00024232431,0.0006073548,0.0034953856,0.00059916714,0.007905103,0.00041553893,0.0012973777,0.0060472297],"category_scores_gemma":[0.014194214,0.00023896717,0.0009864127,0.008954104,0.0011532486,0.0034998963,0.0020233875,0.0015825944,0.00064324803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025558402,0.00030150116,0.8184276,0.00055654923,0.0010230988,0.00057523383,0.0014116158,0.0031697582,0.0003157349,0.066422045,0.027991556,0.07724948],"study_design_scores_gemma":[0.00013992636,0.00022022118,0.91953796,0.00071282417,0.00040281235,0.00033949246,0.004359113,0.0007769533,0.00063094305,0.0056112795,0.0672319,0.000036547743],"about_ca_topic_score_codex":0.030948225,"about_ca_topic_score_gemma":0.0301321,"teacher_disagreement_score":0.9690518,"about_ca_system_score_codex":0.0031226852,"about_ca_system_score_gemma":0.0034805043,"threshold_uncertainty_score":0.061536193},"labels":[],"label_agreement":null},{"id":"W2401701380","doi":"10.1016/j.jval.2016.03.352","title":"Provider and Payer-Related Indicators of Commercial Price Variation in Professional Services in Vermont","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Copayment; Medicaid; Indemnity; Business; Service (business); Actuarial science; Preferred provider organization; Type of service; Medicine; Utilization management; Payment; Specialty; Deductible; Product (mathematics); Service provider; Health care; Fee-for-service; Quarter (Canadian coin); Family medicine; Managed care; Health insurance; Finance; Marketing","score_opus":0.036867823627027736,"score_gpt":0.28270046372601226,"score_spread":0.24583264009898453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401701380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967667,0.00011968409,0.00008305563,0.00032200696,0.0000040189884,0.000005325691,0.002160443,0.0000036408221,0.00053507456],"genre_scores_gemma":[0.99775887,0.000049912178,0.00009627478,0.000057991037,0.000006224714,0.0000065317363,0.0013727166,0.0000030643425,0.00064846716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819523,0.0006265876,0.00015577443,0.00022807678,0.00035005258,0.00044432285],"domain_scores_gemma":[0.9864829,0.0034588866,0.005679889,0.0003920946,0.0018514068,0.0021348067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018158245,0.00012286786,0.00029043318,0.0018631321,0.0008596691,0.001509042,0.0012808962,0.0008569709,0.0019716958],"category_scores_gemma":[0.009211136,0.00022659592,0.00033466984,0.0053469394,0.0005438871,0.0008231269,0.0014362896,0.0008696736,0.00017376867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077291195,0.000056271147,0.99496716,0.00000668808,0.0000741477,0.00006822349,0.0004046808,0.00056660915,0.00007887969,0.0003924538,0.0011978156,0.0021097455],"study_design_scores_gemma":[0.000003738731,0.000017859144,0.99707365,0.000008806122,0.000010730442,0.00004013294,0.0007968456,0.0013537909,0.000040131297,0.0000796773,0.0005702429,0.0000043365617],"about_ca_topic_score_codex":0.70164734,"about_ca_topic_score_gemma":0.8143805,"teacher_disagreement_score":0.70164734,"about_ca_system_score_codex":0.008555827,"about_ca_system_score_gemma":0.0040721544,"threshold_uncertainty_score":0.6002194},"labels":[],"label_agreement":null},{"id":"W2402007715","doi":"10.1016/j.jval.2016.03.1106","title":"IDENTIFYING FACTORS WHICH INFLUENCE THE SELECTION OF ANTI-TNF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ENGLAND","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rheumatoid arthritis; Medicine; Adalimumab; Etanercept; Infliximab; Imputation (statistics); Logistic regression; Internal medicine; Rheumatology; Multinomial logistic regression; Physical therapy; Demography; Tumor necrosis factor alpha; Missing data; Statistics","score_opus":0.021542608853551456,"score_gpt":0.2832496467589208,"score_spread":0.2617070379053693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402007715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997059,0.00083344016,0.000025464953,0.0008058631,0.000011841025,0.0000053248805,0.00013208101,8.748149e-7,0.0011261796],"genre_scores_gemma":[0.99962354,0.0001328498,0.000011832183,0.00006999591,0.000007156679,0.0000015489824,0.00003614045,6.468533e-7,0.0001161374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983235,0.0007290427,0.00027267833,0.000109817236,0.0002090837,0.00035581738],"domain_scores_gemma":[0.9917555,0.0025476967,0.003792923,0.00014697535,0.00061645446,0.0011405235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008106001,0.00009923076,0.00033886958,0.0005887285,0.0005097373,0.0012688,0.00043184365,0.0005116045,0.0024384754],"category_scores_gemma":[0.011263768,0.00019299996,0.0002648611,0.0012581887,0.00049682835,0.0006383929,0.00078606507,0.00075691665,0.00020702386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013832592,0.000024818406,0.9972218,0.000022285807,0.000019409868,0.00015452887,0.0005772412,0.000026682948,0.00006633047,0.000062783416,0.00017863816,0.0015070182],"study_design_scores_gemma":[0.000011077255,0.000045307643,0.9970094,0.000031162064,0.000016937254,0.00018223334,0.0022483221,0.000082105325,0.000030269832,0.000049231145,0.00028831707,0.000005679712],"about_ca_topic_score_codex":0.06647716,"about_ca_topic_score_gemma":0.08171372,"teacher_disagreement_score":0.06647716,"about_ca_system_score_codex":0.0015044464,"about_ca_system_score_gemma":0.0013221413,"threshold_uncertainty_score":0.1321804},"labels":[],"label_agreement":null},{"id":"W2402013895","doi":"10.1016/j.jval.2016.03.172","title":"Reported Psychological Symptoms and Quality of Life in Patients Suffering an Acute Coronary Syndrome: New Insights from the Pgrx-3 Real-World Dataset","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Anxiety; Acute coronary syndrome; Depression (economics); Myocardial infarction; Quality of life (healthcare); Medical record; Internal medicine; Psychiatry","score_opus":0.11267742304466523,"score_gpt":0.4093458487964976,"score_spread":0.2966684257518324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402013895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58687544,0.00072522764,0.00057237054,0.0015244535,0.00006181036,0.000056701872,0.40844923,0.00014289259,0.0015919923],"genre_scores_gemma":[0.4872016,0.00034968372,0.0014090897,0.00044131253,0.000063458494,0.00022845896,0.50947225,0.000041896405,0.00079227856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912125,0.00031920476,0.000106525404,0.00020990253,0.00013606134,0.0001072067],"domain_scores_gemma":[0.9960419,0.001538714,0.0009962217,0.00063299976,0.00032313264,0.0004671032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012371724,0.0005219984,0.00085593446,0.0010098456,0.00031706382,0.001133265,0.0011297012,0.001560768,0.0027622222],"category_scores_gemma":[0.008356292,0.00024212523,0.0013192646,0.0018516988,0.00032448102,0.0007640491,0.0016429307,0.001336679,0.0013970601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025174937,0.00042195845,0.8947608,0.00036934423,0.0015201279,0.00030348732,0.00040946496,0.0039712507,0.0003128885,0.00053987885,0.08077112,0.014102089],"study_design_scores_gemma":[0.00026163703,0.00018748852,0.9841754,0.00009832033,0.00019818188,0.0003201043,0.00047550345,0.0038538135,0.00013958366,0.00045645496,0.009782324,0.000051141473],"about_ca_topic_score_codex":0.017882708,"about_ca_topic_score_gemma":0.022888908,"teacher_disagreement_score":0.017882708,"about_ca_system_score_codex":0.0006573225,"about_ca_system_score_gemma":0.00053812924,"threshold_uncertainty_score":0.03555721},"labels":[],"label_agreement":null},{"id":"W2402014401","doi":"10.1016/j.jval.2015.09.1063","title":"Changes In Glucose Lowering Drug Use Before And After A Cancer Diagnosis Among Individuals With Diabetes","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer; Odds ratio; Colorectal cancer; Internal medicine; Diabetes mellitus; Prostate cancer; Odds; Pancreatic cancer; Breast cancer; Gastrointestinal cancer; Logistic regression; Gastroenterology; Oncology; Endocrinology","score_opus":0.020342466426591016,"score_gpt":0.26439479160198853,"score_spread":0.24405232517539752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402014401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983699,0.00032362234,0.000029641727,0.00006652035,0.000018792438,0.0000053690483,0.00045243476,0.000003608502,0.0007300051],"genre_scores_gemma":[0.998884,0.00013461373,0.00003130479,0.000049532064,0.000016827125,0.0000045567735,0.00045750165,0.0000016628347,0.00041997066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961275,0.000074270945,0.000041993106,0.00009728009,0.000067948786,0.000105897976],"domain_scores_gemma":[0.99827874,0.0004426538,0.00056862435,0.00008066331,0.00017211965,0.00045726038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033603582,0.00021892837,0.0005340585,0.00095787557,0.000491716,0.00083991955,0.00033386424,0.00092914107,0.0015264613],"category_scores_gemma":[0.0024861714,0.00025116524,0.00074568746,0.0014176348,0.00023004346,0.0006708944,0.00040836277,0.0014287457,0.00027024382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068392995,0.00011966088,0.99722373,0.000007400986,0.00007941034,0.0000656173,0.0000676926,0.000036659854,0.00018138452,0.000014146996,0.00007136166,0.0014491159],"study_design_scores_gemma":[0.0000057442817,0.00008283343,0.99955755,0.000002381321,0.000028087856,0.00004341405,0.000118882424,0.00006008218,0.000025753023,0.000011956137,0.00005966296,0.0000036129602],"about_ca_topic_score_codex":0.019527787,"about_ca_topic_score_gemma":0.022605209,"teacher_disagreement_score":0.019527787,"about_ca_system_score_codex":0.00054593914,"about_ca_system_score_gemma":0.00032463574,"threshold_uncertainty_score":0.038828254},"labels":[],"label_agreement":null},{"id":"W2402033264","doi":"10.1016/j.jval.2016.03.1491","title":"Real-World Comparison of Metastatic Melanoma Treatments between Academic and Community Hospitals in Canada: A Retrospective Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Ipilimumab; Medicine; Dabrafenib; Dacarbazine; Pembrolizumab; Trametinib; Internal medicine; Vemurafenib; Nivolumab; Oncology; Melanoma; Immunotherapy; Chemotherapy; Metastatic melanoma; Cancer","score_opus":0.08628646098148093,"score_gpt":0.38129555611284605,"score_spread":0.2950090951313651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402033264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918751,0.0010708899,0.00018722758,0.0003465437,0.000018325594,0.00010057053,0.0050330698,0.000009815441,0.0013584644],"genre_scores_gemma":[0.99673444,0.0003986507,0.00023149452,0.0002495873,0.000014108871,0.0000367016,0.00204504,0.00000942334,0.0002803858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99561644,0.00045749935,0.0005117989,0.00088604784,0.0012461034,0.0012821793],"domain_scores_gemma":[0.9893332,0.00088791264,0.0037543846,0.0005063365,0.0036342568,0.0018838459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015140256,0.0005901927,0.0010708068,0.0024548525,0.003067261,0.00277725,0.002107314,0.0011891706,0.0023571274],"category_scores_gemma":[0.006388926,0.0008085739,0.0010823286,0.009896274,0.0017128813,0.0008891243,0.0015459623,0.0014384962,0.00028712332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013929133,0.000044238142,0.9973139,0.000049878123,0.00016538982,0.000082575876,0.0003911264,0.00007713143,0.00005490488,0.00009167396,0.00052677304,0.0010629949],"study_design_scores_gemma":[0.000023160565,0.000065160835,0.996451,0.000056134184,0.000106172134,0.00014456839,0.0020277526,0.00028382533,0.00004361948,0.000033986635,0.00074103806,0.000023618988],"about_ca_topic_score_codex":0.972821,"about_ca_topic_score_gemma":0.9789478,"teacher_disagreement_score":0.037687395,"about_ca_system_score_codex":0.037687395,"about_ca_system_score_gemma":0.03694293,"threshold_uncertainty_score":0.27344245},"labels":[],"label_agreement":null},{"id":"W2402044355","doi":"10.1016/j.jval.2016.03.1637","title":"Castration-Resistant Prostate Cancer Patients In Quebec: Medication Use In The Last Year Of Life","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Abiraterone; Androgen deprivation therapy; Medical prescription; Cohort; Castration; Internal medicine; Abiraterone acetate; Cancer; Cohort study; Oncology; Pharmacology; Androgen receptor; Hormone","score_opus":0.06220926947193235,"score_gpt":0.3539470846249528,"score_spread":0.29173781515302044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402044355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99036866,0.0021899464,0.00007979508,0.0010952526,0.000030226776,0.000034312365,0.003343771,0.000007862651,0.0028502557],"genre_scores_gemma":[0.99682826,0.0007228454,0.00006571312,0.00019927806,0.000013076698,0.000010324366,0.00095743965,0.0000029656915,0.0012000757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958426,0.00006406777,0.00003569794,0.00005545005,0.00009806692,0.00016235809],"domain_scores_gemma":[0.998818,0.000079527206,0.00035647536,0.000021260827,0.00035419237,0.00037051877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036631583,0.00026628614,0.000470093,0.0009259149,0.0017906688,0.0013804651,0.0008332355,0.0008559198,0.0040821973],"category_scores_gemma":[0.001277211,0.0002374138,0.00070741476,0.0034174824,0.00043130535,0.0009758422,0.00064537575,0.001172646,0.00025809696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060552247,0.000047509922,0.99465454,0.000023644268,0.00006105138,0.00008786772,0.0004871585,0.000059805374,0.000080198195,0.00004643428,0.00086556206,0.0035256513],"study_design_scores_gemma":[0.0000038668913,0.000020475254,0.99843997,0.000022896627,0.000018167771,0.000042123746,0.0008378778,0.00017017561,0.000009751839,0.000009388919,0.00041907854,0.000006180454],"about_ca_topic_score_codex":0.9741002,"about_ca_topic_score_gemma":0.9863056,"teacher_disagreement_score":0.025899827,"about_ca_system_score_codex":0.013432122,"about_ca_system_score_gemma":0.008259785,"threshold_uncertainty_score":0.09745735},"labels":[],"label_agreement":null},{"id":"W2402389251","doi":"10.1016/j.jval.2016.03.1117","title":"RECENT EVOLUTION OF THE MARKET FOR BIOLOGIC AND NON-BIOLOGIC DRUGS MODIFYING RHEUMATOID ARTHRITIS AMONG ADULT PATIENTS IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Golimumab; Medicine; Medical prescription; Rheumatoid arthritis; Infliximab; Etanercept; Internal medicine; Population; Disease; Pharmacology; Environmental health","score_opus":0.014213958857748664,"score_gpt":0.24191585566944912,"score_spread":0.22770189681170044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402389251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70872545,0.03728379,0.0010810043,0.13874058,0.0012267048,0.00018210955,0.019577269,0.0001880497,0.09299495],"genre_scores_gemma":[0.9636294,0.0076539936,0.00089571375,0.012420814,0.00034424578,0.000034023047,0.002348542,0.000055070603,0.012618127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708384,0.00014630164,0.00015938639,0.00022464912,0.0014785964,0.00090720895],"domain_scores_gemma":[0.98066336,0.0016283615,0.002804926,0.00014668705,0.0073284833,0.0074281967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012942743,0.00016368914,0.0005034265,0.002550226,0.0025112794,0.0036884714,0.0014565436,0.0012833476,0.0097545935],"category_scores_gemma":[0.008583286,0.00027839065,0.00070394523,0.0046949172,0.0013538188,0.0008559055,0.0008291517,0.0019569593,0.00035108984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010611358,0.00024671698,0.7536035,0.00058475905,0.00021321399,0.0012920329,0.0028888818,0.0009795364,0.0014381757,0.018904366,0.1029382,0.115849406],"study_design_scores_gemma":[0.000097127,0.000073369374,0.8927585,0.00035064662,0.000087463784,0.0006934555,0.0033508737,0.0014949234,0.00036534978,0.0006110672,0.1000561,0.00006117404],"about_ca_topic_score_codex":0.98463124,"about_ca_topic_score_gemma":0.9924757,"teacher_disagreement_score":0.075434566,"about_ca_system_score_codex":0.075434566,"about_ca_system_score_gemma":0.07011672,"threshold_uncertainty_score":0.54731864},"labels":[],"label_agreement":null},{"id":"W2402469839","doi":"10.1016/j.jval.2016.03.175","title":"Clinical Outcomes and Quality of Life After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting in Armenia","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; EuroSCORE; Off-pump coronary artery bypass; Insulin pump; Hazard ratio; Coronary artery disease; Internal medicine; Cardiology; Myocardial infarction; Artery; Quality of life (healthcare); Diabetes mellitus; Surgery; Bypass grafting; Confidence interval; Type 1 diabetes","score_opus":0.10433066594796642,"score_gpt":0.3929993896336163,"score_spread":0.2886687236856499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402469839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99912995,0.00029981855,0.000018580124,0.000034855948,0.0000074800782,0.000005041653,0.00014265107,6.3224945e-7,0.00036086488],"genre_scores_gemma":[0.9993907,0.00016949356,0.000022735114,0.000050394905,0.000008735143,0.000007420195,0.00022397084,6.523078e-7,0.00012598348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995964,0.00012740848,0.00004153832,0.00003745366,0.000032821335,0.00016442296],"domain_scores_gemma":[0.9994099,0.00013627353,0.00022986346,0.00002598567,0.000030821542,0.00016715126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006532902,0.00020590333,0.0003361712,0.00079548004,0.00027511775,0.001108341,0.00022753507,0.00043469205,0.0010335663],"category_scores_gemma":[0.0016816437,0.00016736587,0.00071528595,0.0008850334,0.00032899677,0.00034341688,0.0006867743,0.00066406745,0.00011234149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006889502,0.0006482713,0.9783645,0.000074952004,0.0005730776,0.00030165937,0.00048664107,0.00042496648,0.0007143603,0.00018642492,0.00041810857,0.010917483],"study_design_scores_gemma":[0.00013655792,0.0011789731,0.9968533,0.000042116288,0.00019306946,0.00013929619,0.00049974566,0.0004788179,0.00006113437,0.00012631448,0.00027714748,0.000013644631],"about_ca_topic_score_codex":0.0056739314,"about_ca_topic_score_gemma":0.0081866905,"teacher_disagreement_score":0.0056739314,"about_ca_system_score_codex":0.0008259227,"about_ca_system_score_gemma":0.0004554917,"threshold_uncertainty_score":0.011281848},"labels":[],"label_agreement":null},{"id":"W2402649726","doi":"10.1016/j.jval.2016.03.723","title":"ECONOMIC EVALUATIONS OF MEDICAL DEVICES IN CANADA: LENSX® FEMTOSECOND LASER-ASSISTED CATARACT SURGERY","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spectacle; Phacoemulsification; Cataract surgery; Medicine; Optometry; Randomized controlled trial; Intraocular lens; Ophthalmology; Visual acuity; Surgery; Economics","score_opus":0.3946023341285425,"score_gpt":0.4280521667147428,"score_spread":0.03344983258620027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402649726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92231417,0.025638245,0.0012739111,0.012694578,0.00019790015,0.00055552094,0.017991513,0.000038905724,0.019295257],"genre_scores_gemma":[0.98941153,0.004058461,0.000705129,0.0004496434,0.000032778302,0.00006097662,0.0033910617,0.000011358286,0.0018789574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916255,0.0029282733,0.00056447927,0.00028005082,0.0033778853,0.0012238465],"domain_scores_gemma":[0.9745087,0.008835817,0.0029943238,0.00029198793,0.010300359,0.0030687926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008232465,0.00066807517,0.0008136476,0.0028700393,0.0017418748,0.0043035275,0.0011399194,0.0011467279,0.0022681884],"category_scores_gemma":[0.039374806,0.0003635764,0.0016072071,0.006524196,0.0013827177,0.00100337,0.0013413957,0.0021384137,0.000097571734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015974794,0.0020284643,0.6048763,0.0040714713,0.005238218,0.00075583823,0.0011479234,0.123203345,0.00083589496,0.0433784,0.04988781,0.1486016],"study_design_scores_gemma":[0.0016513836,0.0019363192,0.8375077,0.002413177,0.0021693096,0.00031470653,0.0033228332,0.11161194,0.0010740112,0.0050366297,0.032590996,0.00037103493],"about_ca_topic_score_codex":0.98417073,"about_ca_topic_score_gemma":0.9849194,"teacher_disagreement_score":0.14026704,"about_ca_system_score_codex":0.14026704,"about_ca_system_score_gemma":0.112188995,"threshold_uncertainty_score":0.99716836},"labels":[],"label_agreement":null},{"id":"W2402780690","doi":"10.1016/j.jval.2016.03.692","title":"BUDGET IMPACT ANALYSIS OF RETINAL PROSTHESIS IN RETINITIS PIGMENTOSA PATIENTS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Development and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Retinitis pigmentosa; Visual prosthesis; Retinal Prosthesis; Medicine; Prosthesis; Reimbursement; Population; Retinal; Surgery; Health care; Ophthalmology; Economics; Environmental health","score_opus":0.011752807292929528,"score_gpt":0.27794800092684885,"score_spread":0.2661951936339193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402780690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856976,0.0011246036,0.00059451454,0.0008164229,0.000018551995,0.00005690087,0.00677365,0.00001177625,0.0049059945],"genre_scores_gemma":[0.99774396,0.00020388923,0.00017975118,0.000033357977,0.000005591113,0.000019761612,0.0013999591,0.0000045238635,0.00040912582],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988518,0.0004902277,0.00012683606,0.000083669314,0.00020994982,0.00023754837],"domain_scores_gemma":[0.9967989,0.0010418225,0.0011367042,0.00010659185,0.00045517393,0.00046069705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010010464,0.0002778089,0.00037524736,0.001726888,0.00028977852,0.00095766294,0.0004509855,0.0003778149,0.0052391575],"category_scores_gemma":[0.008210819,0.00017282976,0.0013930578,0.0026000326,0.00020898668,0.00042438507,0.00077704305,0.00055893767,0.00024042706],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013447815,0.0002038044,0.9582067,0.00010625392,0.0006117279,0.000288209,0.00012261025,0.0160476,0.00026965706,0.001930454,0.0014353222,0.019432878],"study_design_scores_gemma":[0.000044186923,0.00033968437,0.98341066,0.00007067653,0.00035430625,0.00038373994,0.00076719234,0.011111129,0.00021268848,0.0009843764,0.0022997,0.00002167191],"about_ca_topic_score_codex":0.043775447,"about_ca_topic_score_gemma":0.036036562,"teacher_disagreement_score":0.043775447,"about_ca_system_score_codex":0.0033647139,"about_ca_system_score_gemma":0.0016361948,"threshold_uncertainty_score":0.08704126},"labels":[],"label_agreement":null},{"id":"W2403128845","doi":"10.1016/j.jval.2016.03.1350","title":"A Comparison Of Antidepressant Drugs Approved By The Us Food And Drug Adminstration And Health Canada (1959-2015)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Food and drug administration; Antidepressant; Drug; Pharmacology; Family medicine; Psychiatry","score_opus":0.37029370940055456,"score_gpt":0.5270848560558867,"score_spread":0.15679114665533217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403128845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91843563,0.0316509,0.00025462292,0.0009059741,0.00016698833,0.00013848732,0.020197017,0.000027615437,0.028222747],"genre_scores_gemma":[0.98760104,0.0028863717,0.0002277828,0.00030279232,0.0000360413,0.000015756332,0.005890866,0.000007523262,0.0030319658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835217,0.00020286979,0.00014987552,0.00014274461,0.00087091676,0.00028148707],"domain_scores_gemma":[0.996053,0.00084583816,0.000807586,0.00009782267,0.0018465936,0.00034918374],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0013857419,0.00022293144,0.00047746435,0.0027694097,0.00062672136,0.0011580961,0.00054441486,0.00046755615,0.0038660972],"category_scores_gemma":[0.0057594385,0.000116948555,0.0011747334,0.003777426,0.0004022664,0.0005878035,0.00074812776,0.0004915705,0.00042701632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014559688,0.0004341359,0.8033351,0.0011500313,0.002046119,0.000445703,0.0006703788,0.00094109663,0.0014273687,0.0026748786,0.011520017,0.16079554],"study_design_scores_gemma":[0.0000995569,0.0004433465,0.98548245,0.000090195645,0.0005506684,0.0001479281,0.000441167,0.00018007957,0.00032436804,0.00010125507,0.012125987,0.000012943663],"about_ca_topic_score_codex":0.6331429,"about_ca_topic_score_gemma":0.8327794,"teacher_disagreement_score":0.99861425,"about_ca_system_score_codex":0.010376145,"about_ca_system_score_gemma":0.008317662,"threshold_uncertainty_score":0.7380352},"labels":[],"label_agreement":null},{"id":"W2403287053","doi":"10.1016/j.jval.2016.03.128","title":"Identification and Management of Canadian Patients with Symptoms of Statin Intolerance: Results from a Real-World Clinical Practice Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Internal medicine","score_opus":0.04633829713438919,"score_gpt":0.3401803449154095,"score_spread":0.2938420477810203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403287053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901804,0.0006595688,0.00008668537,0.0015752068,0.000016422773,0.00007718175,0.0045233886,0.000010014628,0.0028711185],"genre_scores_gemma":[0.99627763,0.0006173239,0.00033004998,0.00062038726,0.0000168117,0.000027915068,0.0017336092,0.000005246507,0.00037087238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816895,0.00019518497,0.00020690961,0.0002224648,0.0007749242,0.00043153163],"domain_scores_gemma":[0.9949626,0.00041548634,0.0016220969,0.00009689026,0.0017005153,0.0012025277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010357818,0.00035811114,0.00050728396,0.0013550641,0.0022377828,0.0015204048,0.0012969039,0.0011968378,0.002017362],"category_scores_gemma":[0.0067884848,0.00044869457,0.00056497136,0.005422737,0.0006381828,0.0006414023,0.0008434099,0.0010712683,0.00024878926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000543704,0.00008379907,0.99587834,0.000030154633,0.0000313073,0.00007038073,0.0004929282,0.000041137213,0.00005748122,0.000030358087,0.0011013036,0.0021284285],"study_design_scores_gemma":[0.000012821032,0.000025937657,0.99812096,0.000023384857,0.000017453822,0.00008323266,0.0010739584,0.00016486342,0.000018280181,0.000012769549,0.00043509522,0.000011188538],"about_ca_topic_score_codex":0.95719343,"about_ca_topic_score_gemma":0.97120595,"teacher_disagreement_score":0.042806566,"about_ca_system_score_codex":0.016107354,"about_ca_system_score_gemma":0.022483941,"threshold_uncertainty_score":0.11686754},"labels":[],"label_agreement":null},{"id":"W2403383676","doi":"10.1016/j.jval.2016.03.119","title":"Development of a Pharmacoeconomic Model to Assess the Cost Effectiveness of Pharmacogenomics Tests in Chronic Heart Failure: The Case of Ivabradine","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; St. Joseph’s Healthcare Hamilton; Université de Montréal","funders":"","keywords":"Medicine; Ivabradine; Pharmacogenomics; Heart failure; Test (biology); Markov model; Internal medicine; Intensive care medicine; Statistics; Heart rate; Markov chain; Mathematics","score_opus":0.10136719221530832,"score_gpt":0.3854345694312964,"score_spread":0.28406737721598807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403383676","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15228277,0.0023742283,0.77850854,0.018319706,0.000369153,0.0018710787,0.0036223137,0.0004662692,0.042185996],"genre_scores_gemma":[0.86755383,0.0012138089,0.11610267,0.0012367868,0.0002023228,0.0012599902,0.0007735534,0.00008896691,0.011568094],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9949962,0.0037814532,0.00011984523,0.00037275843,0.00037401862,0.0003558416],"domain_scores_gemma":[0.97892374,0.018920936,0.00067905546,0.00034147708,0.0007689296,0.00036587653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01082491,0.0019482559,0.002762942,0.002130574,0.0006379301,0.004223604,0.0032010998,0.003991954,0.009313404],"category_scores_gemma":[0.028004501,0.0010632388,0.0018944461,0.0016212596,0.0016086586,0.0032534145,0.0015769837,0.004392351,0.0005225171],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004723205,0.00030612352,0.003728153,0.00015466726,0.0002788336,0.00025289328,0.00010549795,0.8824922,0.0003155558,0.092177115,0.0020103764,0.017706221],"study_design_scores_gemma":[0.00014438615,0.00015427553,0.0008386756,0.000043767333,0.00013563463,0.00010054182,0.000055385273,0.9640674,0.00010527412,0.033176236,0.0011518309,0.000026585096],"about_ca_topic_score_codex":0.024373347,"about_ca_topic_score_gemma":0.01431979,"teacher_disagreement_score":0.024373347,"about_ca_system_score_codex":0.005219972,"about_ca_system_score_gemma":0.0047407923,"threshold_uncertainty_score":0.057248235},"labels":[],"label_agreement":null},{"id":"W2403443918","doi":"10.1016/j.jval.2016.03.541","title":"Reimbursement-Based Economic Evaluation Of Drugs For The Treatment Of Overactive Bladder","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Oxybutynin; Tolterodine; Solifenacin; Overactive bladder; Medicine; Reimbursement; Cost effectiveness; Risk analysis (engineering)","score_opus":0.4871876779494038,"score_gpt":0.47216199904856404,"score_spread":0.015025678900839778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403443918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70696884,0.09889435,0.08820874,0.038123958,0.0019613567,0.0031543793,0.0060285204,0.00029554334,0.05636433],"genre_scores_gemma":[0.99090636,0.0030603919,0.003879351,0.0005036697,0.00020455867,0.0001784121,0.000723233,0.000014179321,0.00052975235],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9274144,0.06548933,0.0014305841,0.0006309033,0.003833948,0.0012007236],"domain_scores_gemma":[0.8897528,0.09755178,0.0046562767,0.001329254,0.0047580223,0.001951938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049563073,0.0015249723,0.0029416364,0.002472288,0.0005771814,0.0043277177,0.0012812171,0.0027413068,0.002429849],"category_scores_gemma":[0.15084729,0.00060663046,0.0020015447,0.002396178,0.0019692502,0.002496286,0.0017889701,0.003251686,0.00016188998],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022862269,0.0018944179,0.06527609,0.0047170883,0.0054653836,0.00043155687,0.00037063356,0.523386,0.00078561174,0.1880519,0.017828507,0.1689306],"study_design_scores_gemma":[0.004201328,0.004207892,0.0535398,0.002465949,0.003898512,0.0004677576,0.0006079687,0.81521815,0.0012117405,0.098974064,0.014967887,0.00023889582],"about_ca_topic_score_codex":0.008334029,"about_ca_topic_score_gemma":0.003923081,"teacher_disagreement_score":0.049563073,"about_ca_system_score_codex":0.008955788,"about_ca_system_score_gemma":0.0077191764,"threshold_uncertainty_score":0.26211768},"labels":[],"label_agreement":null},{"id":"W2403565867","doi":"10.1016/j.jval.2016.03.1994","title":"PCPA/CDR/PCODR CHANGES AND IMPACT TO MARKET ACCESS IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Listing (finance); Formulary; Prior authorization; Reimbursement; Market access; Business; Negotiation; Medicine; Accounting; Actuarial science; Geography; Finance; Political science; Health care; Family medicine; Economics; Economic growth","score_opus":0.44997579102469554,"score_gpt":0.45077479412457894,"score_spread":0.0007990030998833997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403565867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7951407,0.006209877,0.00040108376,0.05577758,0.0006262459,0.00017908143,0.06896168,0.00021506933,0.072488636],"genre_scores_gemma":[0.9590965,0.0019137982,0.00036620625,0.0030732262,0.00014149242,0.00004077368,0.007249661,0.00006668737,0.0280516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958859,0.00019409368,0.00015586884,0.00023019144,0.0016472242,0.0018866878],"domain_scores_gemma":[0.97861964,0.0017689737,0.0015801153,0.00029116657,0.010128373,0.0076117483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019084512,0.00024713765,0.000653424,0.0031685084,0.0026019155,0.0055643576,0.0017895389,0.0014219425,0.015531845],"category_scores_gemma":[0.01367837,0.00042213165,0.00128617,0.0054999576,0.0013108517,0.0011075626,0.0017112007,0.0026665917,0.00059748284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001353942,0.0007271179,0.64498544,0.00045272493,0.00048252768,0.0008600156,0.0019212938,0.0071102655,0.0005171807,0.038087178,0.21125247,0.092249855],"study_design_scores_gemma":[0.00017415975,0.000074816504,0.93065655,0.00015884927,0.00010104366,0.00013242895,0.002183387,0.0037282463,0.00026917495,0.0010090389,0.061427064,0.00008514729],"about_ca_topic_score_codex":0.9986173,"about_ca_topic_score_gemma":0.9988795,"teacher_disagreement_score":0.85547966,"about_ca_system_score_codex":0.14452036,"about_ca_system_score_gemma":0.18197553,"threshold_uncertainty_score":0.9922351},"labels":[],"label_agreement":null},{"id":"W2403568346","doi":"10.1016/j.jval.2016.03.130","title":"Identifying and Managing Patients with Symptoms of Statin Intolerance: Results from a Survey of Clinicians in the United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Ezetimibe; Asymptomatic; Internal medicine; Physical therapy","score_opus":0.045341564051060046,"score_gpt":0.31031842399619003,"score_spread":0.26497685994513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403568346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968154,0.0006482161,0.00007148321,0.000997732,0.000014768202,0.000020534046,0.00028102618,0.0000029961104,0.00114785],"genre_scores_gemma":[0.9983101,0.00044995788,0.00013491052,0.0007884075,0.000012022449,0.000011150102,0.00019136783,0.000002002729,0.00010008256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845946,0.0005015187,0.00029470873,0.0001852352,0.00037763338,0.00018139587],"domain_scores_gemma":[0.9949268,0.0011225389,0.0020946395,0.00011925339,0.00079806,0.0009386435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012844226,0.00017597026,0.00037137995,0.00069037796,0.0008279332,0.0011397158,0.00037001073,0.00097641593,0.0010453685],"category_scores_gemma":[0.007926084,0.00033928853,0.00032684777,0.001481386,0.00043459964,0.00070782076,0.00082591246,0.00085504237,0.00016050832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002564968,0.000057552777,0.9968585,0.000011475151,0.000023610017,0.00005210534,0.00051322964,0.00001675461,0.00007691108,0.000009013368,0.000322529,0.0020326194],"study_design_scores_gemma":[0.0000074632894,0.00004925005,0.9967153,0.000035292986,0.000020302188,0.0001333994,0.0025258001,0.00011136352,0.00003071333,0.00001565942,0.0003508944,0.0000046245295],"about_ca_topic_score_codex":0.039536532,"about_ca_topic_score_gemma":0.07946467,"teacher_disagreement_score":0.039536532,"about_ca_system_score_codex":0.0008497025,"about_ca_system_score_gemma":0.001620586,"threshold_uncertainty_score":0.078612804},"labels":[],"label_agreement":null},{"id":"W2403580599","doi":"10.1016/j.jval.2016.03.507","title":"Assure-Csu: Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Presenteeism; Absenteeism; Medicine; Angioedema; Productivity; Work productivity; Demography; Sick leave; Physical therapy; Gerontology; Internal medicine; Psychology","score_opus":0.03151715964130342,"score_gpt":0.33437554599371444,"score_spread":0.302858386352411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403580599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819087,0.00072865386,0.0013966825,0.00010081469,0.00004503048,0.00069537753,0.009767363,0.00024349097,0.0051139463],"genre_scores_gemma":[0.98672545,0.00031906756,0.0041440246,0.0000526741,0.00003998824,0.00073896564,0.0057556713,0.000037125556,0.0021870788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988539,0.00035582855,0.0001790543,0.000104923034,0.00039262534,0.00011367238],"domain_scores_gemma":[0.9968521,0.0010635754,0.0010125177,0.00016024329,0.00045295962,0.00045867168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016453821,0.0007733919,0.0011580735,0.001958543,0.00034361632,0.0007710257,0.00095166935,0.00064133387,0.0044591282],"category_scores_gemma":[0.004794735,0.00025379244,0.001747849,0.0015632593,0.0002520538,0.0005527965,0.001175635,0.00051198696,0.00089903345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00530809,0.0011713182,0.9100454,0.00052674726,0.0012455705,0.00010877822,0.0002141822,0.0015475955,0.0012412412,0.00019949836,0.0033927418,0.07499886],"study_design_scores_gemma":[0.0001874651,0.0021063185,0.9937616,0.000024974284,0.00020992354,0.00021146328,0.00010349026,0.0015965999,0.00041922714,0.000086609405,0.0012710784,0.000021221815],"about_ca_topic_score_codex":0.0032924192,"about_ca_topic_score_gemma":0.007873991,"teacher_disagreement_score":0.0044591282,"about_ca_system_score_codex":0.00050904055,"about_ca_system_score_gemma":0.00065642915,"threshold_uncertainty_score":0.014917314},"labels":[],"label_agreement":null},{"id":"W2403798239","doi":"10.1016/j.jval.2016.03.640","title":"The Diffusion of Indirect Comparison Meta-Analytic Methods in the Study of Drugs: A Systematic Review and Co-Authorship Network Analysis","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Scopus; Meta-analysis; Systematic review; Web of science; Empirical research; Citation; MEDLINE; Computer science; Medicine; Statistics; Library science; Mathematics; Political science; Pathology","score_opus":0.866564930708412,"score_gpt":0.6537149492497017,"score_spread":0.21284998145871026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403798239","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03847371,0.7200658,0.21734898,0.011096701,0.002291241,0.0039476743,0.0014615493,0.00029240554,0.005021904],"genre_scores_gemma":[0.6321634,0.119472,0.23322901,0.0037782267,0.0014204446,0.0076591517,0.00076500844,0.00032512486,0.0011876683],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.3101501,0.6072546,0.047827568,0.01366403,0.020032998,0.001070717],"domain_scores_gemma":[0.06738694,0.88003945,0.02149505,0.021711033,0.008899868,0.00046770304],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.41752818,0.0031417739,0.011653994,0.0147187365,0.0022341977,0.011925541,0.004697246,0.005593263,0.0028146598],"category_scores_gemma":[0.7748301,0.0029096387,0.015881496,0.015126856,0.0041283006,0.012751868,0.010031308,0.005621369,0.00031079297],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042745927,0.00017198357,0.053582706,0.11923886,0.49795702,0.0004463408,0.004859007,0.009804639,0.00048512252,0.038731124,0.004382209,0.26606643],"study_design_scores_gemma":[0.003257839,0.00096299616,0.02105763,0.07123441,0.6058342,0.0011271328,0.0015991199,0.058690064,0.0019380738,0.21493131,0.018788889,0.0005783581],"about_ca_topic_score_codex":0.0039443034,"about_ca_topic_score_gemma":0.0045545115,"teacher_disagreement_score":0.9852813,"about_ca_system_score_codex":0.0056310715,"about_ca_system_score_gemma":0.008137607,"threshold_uncertainty_score":0.71829146},"labels":[],"label_agreement":null},{"id":"W2403857619","doi":"10.1016/j.jval.2016.03.646","title":"Evidence Gaps In Economic Evaluations For Non-Drug Technologies: A Canadian Cost Perspective","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Health technology; Economic evaluation; Procurement; Activity-based costing; Business; Risk analysis (engineering); Medicine; Actuarial science; Health care; Economics; Marketing","score_opus":0.44077412387727744,"score_gpt":0.4703464327755811,"score_spread":0.029572308898303645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403857619","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004707348,0.57693464,0.002452899,0.3713636,0.0032518338,0.00015219333,0.005465855,0.000055291457,0.03561636],"genre_scores_gemma":[0.25090688,0.61425936,0.016265532,0.10392492,0.005923156,0.00048584884,0.0049276226,0.00019602999,0.0031106619],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.92948955,0.0229231,0.010489277,0.003300048,0.028712586,0.005085489],"domain_scores_gemma":[0.42808315,0.3404811,0.019774225,0.0064209956,0.19397803,0.011262402],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13467902,0.002218164,0.0065822564,0.025220318,0.004293028,0.018242039,0.007969271,0.006770495,0.017460087],"category_scores_gemma":[0.4340408,0.0014396014,0.004379772,0.034209624,0.010748241,0.011249667,0.005957767,0.012289968,0.0007013],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0016320783,0.0002381911,0.014582639,0.043402646,0.0034006706,0.00041235014,0.0019073625,0.0077930223,0.00022291213,0.26624045,0.230104,0.43006372],"study_design_scores_gemma":[0.0012972566,0.000306127,0.052261457,0.23680961,0.007786394,0.00045072808,0.0045764833,0.0049671624,0.00053211686,0.1734123,0.51691616,0.00068432494],"about_ca_topic_score_codex":0.94394046,"about_ca_topic_score_gemma":0.9510752,"teacher_disagreement_score":0.865321,"about_ca_system_score_codex":0.16785422,"about_ca_system_score_gemma":0.30187935,"threshold_uncertainty_score":0.96517116},"labels":[],"label_agreement":null},{"id":"W2403922878","doi":"10.1016/j.jval.2016.03.1095","title":"THE REAL-WORLD PAIN EXPERIENCE OF ADULTS WITH RHEUMATOID ARTHRITIS USING A MOBILE SURVEY","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; McGill Pain Questionnaire; Depression (economics); Anxiety; Rheumatoid arthritis; Physical therapy; Quality of life (healthcare); Pain catastrophizing; Demographics; Chronic pain; Visual analogue scale; Psychiatry; Internal medicine; Demography; Nursing","score_opus":0.0453238679859663,"score_gpt":0.3363598220800306,"score_spread":0.29103595409406435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403922878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984706,0.00014452926,0.000056080306,0.00014959113,0.000007952346,0.000019818748,0.00052453467,0.000002075277,0.0006247377],"genre_scores_gemma":[0.9988931,0.0002164874,0.0001487123,0.00010277823,0.00001349792,0.000034541103,0.00036241856,0.0000015184061,0.00022708206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988305,0.0006101306,0.00016096607,0.00009528033,0.00013778811,0.00016534794],"domain_scores_gemma":[0.99706346,0.00069602154,0.0012887911,0.00009990897,0.00032013003,0.000531674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095149665,0.00023792955,0.00034077273,0.0007667683,0.00042415518,0.0011532777,0.00025493544,0.0006774363,0.0017125322],"category_scores_gemma":[0.0066400752,0.00016371554,0.0005067562,0.0007745945,0.00024663276,0.00095642376,0.0012447147,0.00059747684,0.00031971955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019092807,0.00018368519,0.98398596,0.000086272084,0.00011671332,0.00015123919,0.0047031413,0.00007544437,0.00023889191,0.00003847593,0.00059298147,0.009636332],"study_design_scores_gemma":[0.000015449128,0.00048894837,0.9835179,0.0000584146,0.000051861705,0.00033631217,0.014122489,0.00029113056,0.000052366606,0.000035829395,0.0010074285,0.000021851227],"about_ca_topic_score_codex":0.0065486147,"about_ca_topic_score_gemma":0.0144248465,"teacher_disagreement_score":0.0065486147,"about_ca_system_score_codex":0.00034983826,"about_ca_system_score_gemma":0.000265045,"threshold_uncertainty_score":0.013020992},"labels":[],"label_agreement":null},{"id":"W2404165994","doi":"10.1016/j.jval.2016.03.1536","title":"Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Metastatic Breast Cancer: Systematic Review and Trial Level Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Surrogate endpoint; Progression-free survival; Rank correlation; Breast cancer; Spearman's rank correlation coefficient; Hazard ratio; Metastatic breast cancer; Clinical endpoint; Meta-analysis; Proportional hazards model; Randomized controlled trial; Cancer; Overall survival; Confidence interval; Statistics","score_opus":0.34436225851649654,"score_gpt":0.48731588217820454,"score_spread":0.142953623661708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404165994","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023704153,0.970289,0.0031477031,0.00036222534,0.00054008747,0.0004217014,0.00088544143,0.00010022994,0.0005494696],"genre_scores_gemma":[0.74584067,0.24257901,0.005897227,0.002088134,0.000581488,0.001029796,0.0011900569,0.00012903336,0.0006646254],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9781376,0.013912767,0.004049394,0.002136024,0.0013853842,0.00037879043],"domain_scores_gemma":[0.9728664,0.019971045,0.004066943,0.00176022,0.0010260949,0.00030910282],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.023457654,0.0032649857,0.01887788,0.0025531214,0.0005187196,0.0032803877,0.0024412828,0.0027368835,0.0028105152],"category_scores_gemma":[0.049088903,0.0017481111,0.044216137,0.0032249757,0.0010705832,0.002402326,0.0019606657,0.003747745,0.00034440932],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004252129,0.000014224026,0.002693379,0.051474296,0.9374207,0.000037469596,0.00003337602,0.00036042565,0.00012290027,0.00007444233,0.00020784397,0.0033087342],"study_design_scores_gemma":[0.0015852208,0.00030555623,0.0018312791,0.0021767528,0.9930335,0.000045887384,0.000017405795,0.00022897484,0.00007384046,0.00020377722,0.00048101702,0.000016786596],"about_ca_topic_score_codex":0.0037881306,"about_ca_topic_score_gemma":0.009991609,"teacher_disagreement_score":0.98112214,"about_ca_system_score_codex":0.002109981,"about_ca_system_score_gemma":0.001791067,"threshold_uncertainty_score":0.12405747},"labels":[],"label_agreement":null},{"id":"W2404392077","doi":"10.1016/j.jval.2016.03.1063","title":"ECONOMIC EVALUATION OF BENDAMUSTINE PLUS RITUXIMAB IN THE FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Bendamustine; Chlorambucil; Obinutuzumab; Medicine; Ofatumumab; Rituximab; Internal medicine; Oncology; Chronic lymphocytic leukemia; Clinical trial; Fludarabine; Combination therapy; Chemoimmunotherapy; Leukemia; Chemotherapy; Lymphoma","score_opus":0.05512079532798101,"score_gpt":0.33619575051494494,"score_spread":0.2810749551869639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404392077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91184664,0.06423159,0.0027940366,0.006578133,0.0006266201,0.0016791853,0.0019695703,0.000043928096,0.010230278],"genre_scores_gemma":[0.99529344,0.002901225,0.0006728017,0.0002878845,0.000049309136,0.0001714783,0.00031644866,0.0000034655197,0.00030383997],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9938537,0.0050971047,0.0002469921,0.00013963802,0.00038268502,0.00027991825],"domain_scores_gemma":[0.99329454,0.0046965275,0.00092808914,0.000110624154,0.00026956646,0.0007005926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053327084,0.00076459505,0.0017948458,0.00070425164,0.00028194266,0.0013707986,0.00065306266,0.0010677273,0.0037832104],"category_scores_gemma":[0.020571144,0.00032473385,0.003828779,0.0006340554,0.00047030073,0.00082492887,0.0008076533,0.0018531899,0.000107382126],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6239636,0.004288729,0.028880505,0.006306368,0.021528156,0.0004526158,0.00014942262,0.08596965,0.0015106116,0.0062976116,0.004277386,0.21637537],"study_design_scores_gemma":[0.3080452,0.22098266,0.13535196,0.0076507945,0.06307466,0.0018206516,0.0014162741,0.21468423,0.0036998007,0.0123742595,0.03049064,0.00040892372],"about_ca_topic_score_codex":0.0064983284,"about_ca_topic_score_gemma":0.005403027,"teacher_disagreement_score":0.0069341776,"about_ca_system_score_codex":0.0069341776,"about_ca_system_score_gemma":0.0036661043,"threshold_uncertainty_score":0.050311267},"labels":[],"label_agreement":null},{"id":"W2404402986","doi":"10.1016/j.jval.2016.03.615","title":"Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular Outcomes","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ezetimibe; Medicine; Cohort; Myocardial infarction; Cohort study; Population; Confidence interval; Internal medicine; Observational study; Prospective cohort study; Acute coronary syndrome; Statin; Cardiology","score_opus":0.117688988431826,"score_gpt":0.3257108274778754,"score_spread":0.20802183904604937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404402986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98556906,0.0013277306,0.0034537204,0.00094205805,0.0003677725,0.00035127264,0.0061646686,0.00010352715,0.0017203247],"genre_scores_gemma":[0.9912422,0.00023617204,0.001140336,0.00044792242,0.00019595209,0.00037815716,0.0044213687,0.000037157683,0.0019008573],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9950717,0.002980737,0.00020241887,0.00096147676,0.00027448146,0.0005092359],"domain_scores_gemma":[0.9874012,0.005234539,0.002017167,0.0035996072,0.00061935576,0.0011281298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008261156,0.0023933814,0.00376694,0.0007037853,0.00075439917,0.002097546,0.0028392882,0.002643529,0.007939331],"category_scores_gemma":[0.012120369,0.0013402177,0.0061306204,0.0006569586,0.0010591102,0.0014699762,0.0019896717,0.003536123,0.0012977893],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7675454,0.010796031,0.14314155,0.0008521191,0.042159915,0.00062271534,0.0004108877,0.006375243,0.0037904247,0.0029542246,0.009026527,0.012325047],"study_design_scores_gemma":[0.42910948,0.059427693,0.33306935,0.0005316959,0.07019187,0.0010576783,0.0009880977,0.08625383,0.0025736757,0.008866498,0.0074864854,0.00044366976],"about_ca_topic_score_codex":0.007363193,"about_ca_topic_score_gemma":0.0046999245,"teacher_disagreement_score":0.008261156,"about_ca_system_score_codex":0.0010604282,"about_ca_system_score_gemma":0.001749448,"threshold_uncertainty_score":0.043689728},"labels":[],"label_agreement":null},{"id":"W2404563259","doi":"10.1016/j.jval.2016.03.1271","title":"A COMPARISON OF ANTI-TYPE 2 DIABETES MELLITUS DRUGS IN CANADA, UNITED STATES, AND UNITED KINGDOM BETWEEN 1958–2015","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regulatory agency; Type 2 Diabetes Mellitus; Food and drug administration; Drug; Pharmacology; Diabetes mellitus; Family medicine","score_opus":0.12513342820040843,"score_gpt":0.3400936963470292,"score_spread":0.21496026814662075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404563259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537458,0.013880657,0.00019268946,0.00415713,0.0001504582,0.000036017587,0.020921428,0.000019356901,0.0068965703],"genre_scores_gemma":[0.9868507,0.0026809573,0.00010630622,0.00042623587,0.00003482834,0.000007668017,0.007702869,0.0000053652207,0.002185042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875104,0.0000762571,0.00013620588,0.00013652867,0.00041238038,0.00048753558],"domain_scores_gemma":[0.9959079,0.00039071057,0.0012320422,0.000063201674,0.0017702889,0.00063580513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086458353,0.00021072246,0.00047913415,0.002071349,0.0009193592,0.0021028186,0.0008231982,0.00094020355,0.0019412033],"category_scores_gemma":[0.004726213,0.000284214,0.00087456306,0.0058176424,0.00065529806,0.00092809525,0.0011969028,0.0012720496,0.0001174163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009953907,0.00011338966,0.9596524,0.00034246693,0.00056983344,0.00044705608,0.0010838704,0.0021604886,0.00019908688,0.0039325426,0.012237759,0.018265702],"study_design_scores_gemma":[0.000014328515,0.000025783851,0.98918086,0.00009321126,0.00008681659,0.000091935384,0.00088291045,0.00042889055,0.00011046595,0.00009664137,0.008972416,0.000015772208],"about_ca_topic_score_codex":0.9655525,"about_ca_topic_score_gemma":0.9806855,"teacher_disagreement_score":0.03444749,"about_ca_system_score_codex":0.024827005,"about_ca_system_score_gemma":0.016543321,"threshold_uncertainty_score":0.18013334},"labels":[],"label_agreement":null},{"id":"W2404571533","doi":"10.1016/j.jval.2016.03.526","title":"Comparative Effectiveness of Tacrolimus-Based Steroid Sparing Versus Steroid Maintenance Regimens in Patients with Kidney Transplantation: Results from a Discrete Event Simulation","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Tacrolimus; Adverse effect; Regimen; Population; Kidney transplantation; Internal medicine; Transplantation; Myocardial infarction","score_opus":0.03874152242494355,"score_gpt":0.32612742564687397,"score_spread":0.2873859032219304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404571533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99296784,0.0004969101,0.0041370913,0.00044772032,0.00005255086,0.000112669266,0.0006880215,0.000034497232,0.0010625871],"genre_scores_gemma":[0.99767345,0.00012370515,0.0012924193,0.0000695953,0.000017765486,0.00008773071,0.00045077867,0.0000074143786,0.0002772631],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978834,0.0015221207,0.00010065867,0.0001812767,0.000095984426,0.00021658829],"domain_scores_gemma":[0.92497915,0.07036913,0.0018330932,0.0010210789,0.00066313,0.0011344813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056744204,0.00091031234,0.002379373,0.00055520283,0.00033367393,0.0010671726,0.0013506808,0.0013928654,0.0046514175],"category_scores_gemma":[0.024354106,0.00045051868,0.0030835867,0.0005038845,0.00079719705,0.0008889858,0.0007582541,0.0019464494,0.00021327398],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05076034,0.004639439,0.018718671,0.00035089123,0.002634861,0.00017245277,0.00014288658,0.90678686,0.0004021097,0.0028864765,0.0010634838,0.011441567],"study_design_scores_gemma":[0.011167186,0.012101623,0.009830995,0.00007247062,0.0017000925,0.00012483312,0.00023008414,0.9592068,0.0006481357,0.0044007683,0.00044358382,0.00007340975],"about_ca_topic_score_codex":0.0096124755,"about_ca_topic_score_gemma":0.0043736133,"teacher_disagreement_score":0.0096124755,"about_ca_system_score_codex":0.0016406728,"about_ca_system_score_gemma":0.001706174,"threshold_uncertainty_score":0.030009568},"labels":[],"label_agreement":null},{"id":"W2405050116","doi":"10.1016/j.jval.2016.03.1777","title":"PROBABILISTIC RECORD MATCHING USING MACHINE LEARNING TECHNIQUES","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Data Quality and Management","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Computer science; Matching (statistics); Data mining; Weighting; Confusion matrix; Set (abstract data type); Metric (unit); Probabilistic logic; Levenshtein distance; Artificial intelligence; Algorithm; Mathematics; Statistics","score_opus":0.31160901547951836,"score_gpt":0.45121663754216795,"score_spread":0.1396076220626496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405050116","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012401585,0.00041606216,0.98377544,0.00044357008,0.00008036211,0.00022018325,0.00064244115,0.0010246242,0.000995733],"genre_scores_gemma":[0.2643044,0.00058151,0.7283452,0.00019607919,0.00016055019,0.00039611576,0.0025343734,0.00019431872,0.0032874907],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9808967,0.0069466494,0.0025806003,0.0030974532,0.0058730473,0.0006056132],"domain_scores_gemma":[0.9494806,0.0355022,0.0032808692,0.0069649788,0.0043632677,0.0004081657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012313659,0.0005183887,0.0019226867,0.0070964117,0.0015418004,0.0038199464,0.0038100863,0.002559528,0.0069547137],"category_scores_gemma":[0.07949434,0.0009177138,0.0027167704,0.011153165,0.0008383995,0.007273553,0.0033547461,0.0021177037,0.0019360929],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063930603,0.00049654295,0.017663993,0.0007101074,0.00044720396,0.00032923298,0.00040269917,0.08708625,0.0033436932,0.05449773,0.008507355,0.8258759],"study_design_scores_gemma":[0.00007371393,0.0001493021,0.0031029738,0.00010704549,0.00024195213,0.00058648485,0.00014703085,0.85983306,0.0066784234,0.12038057,0.008633477,0.00006595687],"about_ca_topic_score_codex":0.0038573034,"about_ca_topic_score_gemma":0.004099174,"teacher_disagreement_score":0.012313659,"about_ca_system_score_codex":0.0013375661,"about_ca_system_score_gemma":0.0036817486,"threshold_uncertainty_score":0.06512165},"labels":[],"label_agreement":null},{"id":"W2405143077","doi":"10.1016/j.jval.2016.03.055","title":"Early Impact Of Medicaid Expansion On Prescription Drug Utilization And Spending","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Quarter (Canadian coin); Medical prescription; Beneficiary; Prescription drug; Demography; Medicine; Tissue expansion; Demographic economics; Health care; Economics; Geography; Economic growth; Finance; Surgery","score_opus":0.15047289106444878,"score_gpt":0.33796745498184094,"score_spread":0.18749456391739217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405143077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672588,0.0010376046,0.00033254133,0.01266869,0.00010956922,0.000022544247,0.0025066335,0.000043307973,0.016020278],"genre_scores_gemma":[0.9945648,0.00025515127,0.0000937792,0.00042520734,0.00011532663,0.000007376312,0.00064835825,0.000008477089,0.003881489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988871,0.00021594051,0.000054152868,0.000075404256,0.0001866647,0.0005806113],"domain_scores_gemma":[0.9891579,0.006794862,0.0015858902,0.00020501512,0.0008289425,0.0014273842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002052033,0.00022145925,0.00044981256,0.0008466282,0.0007178988,0.0028650872,0.00046214188,0.0020298818,0.012342597],"category_scores_gemma":[0.013350349,0.0003213339,0.0006649652,0.0010175238,0.00064264814,0.001974043,0.0014968708,0.0033180271,0.000505079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030327311,0.0018703501,0.8577948,0.00018617688,0.00030662434,0.0015476451,0.00065829227,0.017969035,0.0027332988,0.04554901,0.01991078,0.048441235],"study_design_scores_gemma":[0.0000644327,0.0002576765,0.96349704,0.00006886117,0.00018482695,0.00019692973,0.001338681,0.014539777,0.0022485042,0.009140559,0.008417871,0.000044766657],"about_ca_topic_score_codex":0.057312764,"about_ca_topic_score_gemma":0.08402813,"teacher_disagreement_score":0.057312764,"about_ca_system_score_codex":0.003871097,"about_ca_system_score_gemma":0.0036493384,"threshold_uncertainty_score":0.1139583},"labels":[],"label_agreement":null},{"id":"W2405208786","doi":"10.1016/j.jval.2016.03.233","title":"Manager, Health Economics and Patient Access","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Novartis (Canada)","funders":"","keywords":"Fingolimod; Natalizumab; Teriflunomide; Discontinuation; Medicine; Glatiramer acetate; Internal medicine; Medical prescription; Multiple sclerosis; Brace; Physical therapy; Pharmacology; Immunology","score_opus":0.023061253990341028,"score_gpt":0.26396963519501826,"score_spread":0.24090838120467722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405208786","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017007746,0.0120500345,0.0024248909,0.8235801,0.005597671,0.000046921512,0.0004356081,0.00007454857,0.13878255],"genre_scores_gemma":[0.6610524,0.020640723,0.0039707134,0.14119463,0.026831202,0.00013621546,0.00029608826,0.0001707762,0.14570731],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944993,0.002420157,0.00029573438,0.0002571478,0.0019060742,0.00062142865],"domain_scores_gemma":[0.9606884,0.01877448,0.004763518,0.0007568489,0.0040221447,0.010994657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056932443,0.00022100785,0.0004239464,0.0008027029,0.0013284404,0.0077636503,0.0006037554,0.0045439694,0.050537776],"category_scores_gemma":[0.05272208,0.00023138772,0.00023177547,0.0008990591,0.0010622097,0.003731325,0.0011532904,0.0039253305,0.003179195],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015104901,0.0002448933,0.025948584,0.00022661373,0.000071683135,0.0007031889,0.0007177819,0.0007534703,0.00029096977,0.1313136,0.70769614,0.1318821],"study_design_scores_gemma":[0.00016187245,0.0002577011,0.025461659,0.00076474296,0.000077783036,0.0031927486,0.003293915,0.002893129,0.0005676373,0.122168146,0.8410514,0.00010928142],"about_ca_topic_score_codex":0.0027079517,"about_ca_topic_score_gemma":0.003949134,"teacher_disagreement_score":0.050537776,"about_ca_system_score_codex":0.0030882896,"about_ca_system_score_gemma":0.008346353,"threshold_uncertainty_score":0.16906571},"labels":[],"label_agreement":null},{"id":"W2405276630","doi":"10.1016/j.jval.2016.03.212","title":"A Life-Course Assessment Of Medication Use And Medical Costs Of Lennox-Gastaut Syndrome (Lgs)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Lennox–Gastaut syndrome; Medicine; Epilepsy; Pediatrics; Clobazam; Medicaid; Antipsychotic; Psychiatry; Health care; Schizophrenia (object-oriented programming)","score_opus":0.05953414159140488,"score_gpt":0.40038879073647815,"score_spread":0.34085464914507324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405276630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998075,0.00018823177,0.00007204195,0.000097968456,0.000004761362,0.000015955206,0.0006412933,0.000004193352,0.0009005043],"genre_scores_gemma":[0.9989417,0.00006347425,0.0001127308,0.00003541013,0.000006661353,0.000010981563,0.0005899851,0.000001212831,0.00023785472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996681,0.00009720526,0.00005386379,0.000055641594,0.00007011121,0.000055135977],"domain_scores_gemma":[0.9986181,0.0002429704,0.0005304262,0.000051592644,0.00016661745,0.00039014785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038292873,0.00033859783,0.00036134105,0.0012424523,0.00041989202,0.00053868804,0.00032128702,0.00066029513,0.0011598123],"category_scores_gemma":[0.0022371972,0.00014811303,0.0008728872,0.00078569853,0.0002747686,0.0007085442,0.0004767187,0.0007872746,0.00016685009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005011838,0.00021202251,0.99460196,0.000012969485,0.000092011775,0.00038810994,0.00005583756,0.00023427361,0.00021603322,0.000041706408,0.0001370425,0.0035068428],"study_design_scores_gemma":[0.000021940183,0.00069851556,0.99674314,0.000009527723,0.000048738486,0.001082334,0.00009818028,0.00086644996,0.00012578987,0.00008113098,0.00021443809,0.000009854636],"about_ca_topic_score_codex":0.007358664,"about_ca_topic_score_gemma":0.008119557,"teacher_disagreement_score":0.007358664,"about_ca_system_score_codex":0.0011583643,"about_ca_system_score_gemma":0.0004685826,"threshold_uncertainty_score":0.014631689},"labels":[],"label_agreement":null},{"id":"W2405377183","doi":"10.1016/j.jval.2016.03.246","title":"Health-Related Quality of Life and Work Productivity in Patients Treated with Onabotulinumtoxina for Cervical Dystonia in a Multicentre, Prospective, Observational Study: Posture","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Allergan (Canada)","funders":"","keywords":"Medicine; Cervical dystonia; Quality of life (healthcare); Observational study; Physical therapy; Work productivity; Rating scale; Prospective cohort study; Botulinum toxin; Internal medicine; Productivity; Surgery; Psychology","score_opus":0.07360094106801386,"score_gpt":0.32248248928804374,"score_spread":0.2488815482200299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405377183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933594,0.00028080438,0.000020871757,0.000029781537,0.000006733552,0.000008553607,0.00016592347,6.776484e-7,0.00015060478],"genre_scores_gemma":[0.99955314,0.00009748863,0.000020117668,0.000034221142,0.000009756066,0.000008933258,0.00019990478,7.1538653e-7,0.00007565888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994037,0.00018971515,0.00007182455,0.00010495376,0.00009014568,0.00013955725],"domain_scores_gemma":[0.9988833,0.00021112723,0.0004982042,0.00007147346,0.000097790435,0.00023809612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006126127,0.00040587393,0.0008077286,0.0007780162,0.00072633417,0.0009569305,0.00044745853,0.00096069,0.0011128617],"category_scores_gemma":[0.0019281271,0.00040978793,0.0012823811,0.0014088597,0.00047602123,0.0006478405,0.0005655109,0.0008694329,0.0001783866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000551615,0.00015668319,0.99804807,0.000017382434,0.00020571865,0.00008353783,0.00009472335,0.000020969697,0.0001991311,0.000006150117,0.00004329697,0.0005727291],"study_design_scores_gemma":[0.000032206804,0.000293622,0.9992417,0.000004865223,0.00006672508,0.00009893307,0.00014146732,0.00005852374,0.000015035903,0.000008074655,0.000033915643,0.00000486811],"about_ca_topic_score_codex":0.0083694365,"about_ca_topic_score_gemma":0.01044206,"teacher_disagreement_score":0.0083694365,"about_ca_system_score_codex":0.0006834457,"about_ca_system_score_gemma":0.00038651895,"threshold_uncertainty_score":0.016641438},"labels":[],"label_agreement":null},{"id":"W2405917246","doi":"10.1016/j.jval.2016.03.1242","title":"THE CHANGING EPIDEMIOLOGY OF CHILDHOOD INFECTIOUS DISEASES IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Measles; Rubella; Epidemiology; Pediatrics; Vaccination; Population; Meningitis; Poisson regression; Varicella vaccine; Measles-Mumps-Rubella Vaccine; Environmental health; Immunology; Immunization; Internal medicine","score_opus":0.07778729343505858,"score_gpt":0.37940557738568864,"score_spread":0.30161828395063006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405917246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8887168,0.037582602,0.0003688108,0.04259279,0.0005099804,0.00007378717,0.0148688825,0.00003419358,0.015252046],"genre_scores_gemma":[0.982177,0.012689917,0.0002614237,0.0012473677,0.00008367373,0.000017427355,0.0017325329,0.0000106759935,0.0017798711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646264,0.00038389492,0.0002497792,0.0002564518,0.0010623429,0.0015848621],"domain_scores_gemma":[0.9863559,0.0011098778,0.002353813,0.00026177242,0.006156839,0.003761754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017877145,0.00027375013,0.0006091438,0.0040432704,0.003717761,0.003401345,0.0018244078,0.0010141196,0.003617881],"category_scores_gemma":[0.008922159,0.00039988098,0.00073306967,0.014959713,0.0015201841,0.0011855012,0.0015545313,0.0023711957,0.00017225953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012670728,0.000061488165,0.96421427,0.00024087232,0.00014822697,0.00023190392,0.002436092,0.00038061955,0.00014983241,0.0028478613,0.008106069,0.02105611],"study_design_scores_gemma":[0.000012024139,0.000019835916,0.9862255,0.00025901632,0.000053846532,0.00008700744,0.005322984,0.00027284754,0.00007264109,0.00018732052,0.0074635204,0.000023497261],"about_ca_topic_score_codex":0.99844164,"about_ca_topic_score_gemma":0.99897975,"teacher_disagreement_score":0.08800385,"about_ca_system_score_codex":0.08800385,"about_ca_system_score_gemma":0.16309787,"threshold_uncertainty_score":0.6385156},"labels":[],"label_agreement":null},{"id":"W2406116237","doi":"10.1016/j.jval.2016.03.478","title":"Trends In Oral Glucocorticoid Utilization Among Older Adults With Respiratory Disease","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Asthma; COPD; Prednisone; Internal medicine; Concomitant; Respiratory system; Cumulative dose","score_opus":0.038429322898173385,"score_gpt":0.3164480924625336,"score_spread":0.2780187695643602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406116237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917464,0.0028140722,0.000057058834,0.00028142933,0.000018407922,0.000008758346,0.0034280503,0.0000077660015,0.00163792],"genre_scores_gemma":[0.99556965,0.0016731905,0.00009480621,0.00015015442,0.0000318548,0.000010750079,0.0019935633,0.0000026150083,0.00047354714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997118,0.00003076562,0.00006801153,0.000054295975,0.00006408144,0.00007095476],"domain_scores_gemma":[0.9987663,0.0001293725,0.00069513684,0.000030118346,0.00020445991,0.0001746578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030470596,0.00014383954,0.00032388236,0.00088267366,0.0002454942,0.00061562704,0.00020622535,0.00051038293,0.0016904154],"category_scores_gemma":[0.0014257712,0.00013280947,0.00073736004,0.0016900476,0.000108865555,0.0005532865,0.00031382672,0.0006214488,0.00020983267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015037348,0.000035990884,0.9947009,0.000047448157,0.00008260644,0.000041707215,0.00008922802,0.00003867387,0.00017891487,0.000030349505,0.0003094643,0.004294387],"study_design_scores_gemma":[0.00000388803,0.000056929734,0.9989767,0.000019692467,0.000034943685,0.000092322836,0.0002720453,0.000068339206,0.000032971882,0.000010335906,0.0004295713,0.0000023690723],"about_ca_topic_score_codex":0.030569894,"about_ca_topic_score_gemma":0.04692001,"teacher_disagreement_score":0.030569894,"about_ca_system_score_codex":0.00055452617,"about_ca_system_score_gemma":0.00051689026,"threshold_uncertainty_score":0.060783863},"labels":[],"label_agreement":null},{"id":"W2406117208","doi":"10.1016/j.jval.2016.03.710","title":"COST EFFECTIVENESS OF SCREENING FOR TYPE 2 DIABETES MELLITUS AND PRE-DIABETES: SYSTEMATIC LITERATURE REVIEW","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prediabetes; Type 2 diabetes; Psychological intervention; MEDLINE; Cost effectiveness; Type 2 Diabetes Mellitus; Diabetes mellitus; Scopus; Intensive care medicine; Risk analysis (engineering); Nursing","score_opus":0.05370381782965421,"score_gpt":0.327584085634383,"score_spread":0.2738802678047288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406117208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00813513,0.9899755,0.0001583564,0.00036927836,0.0001308139,0.00012621228,0.00085204386,0.000006873383,0.0002458904],"genre_scores_gemma":[0.20865835,0.7876557,0.0010850454,0.0010184144,0.0002226509,0.00037654053,0.0008373239,0.000010360287,0.00013561788],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98980683,0.004578812,0.003079536,0.0007002293,0.0014794993,0.00035505038],"domain_scores_gemma":[0.9366208,0.051595286,0.008039982,0.00069889013,0.0025869396,0.0004581506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010053707,0.001232672,0.008575616,0.0064736116,0.00036115406,0.0021173249,0.0016385652,0.002167001,0.00341084],"category_scores_gemma":[0.05996069,0.0013242913,0.0142383715,0.00767029,0.0007094949,0.0018668034,0.0015354559,0.0016887055,0.00016288839],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024539293,0.00009110772,0.020635622,0.7004178,0.23726687,0.00020064901,0.000156472,0.00071813865,0.0001074754,0.00037019688,0.0017669637,0.03581474],"study_design_scores_gemma":[0.0021429458,0.0004859787,0.03802593,0.20192972,0.74968594,0.00056254055,0.00034126872,0.000522105,0.00012732387,0.00079041405,0.0053041074,0.000081694336],"about_ca_topic_score_codex":0.016448254,"about_ca_topic_score_gemma":0.041518573,"teacher_disagreement_score":0.016448254,"about_ca_system_score_codex":0.004172667,"about_ca_system_score_gemma":0.0057195984,"threshold_uncertainty_score":0.053169727},"labels":[],"label_agreement":null},{"id":"W2406123041","doi":"10.1016/j.jval.2016.03.1919","title":"TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE: A CANADIAN COST-UTILITY ANALYSIS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tocilizumab; Adalimumab; Etanercept; Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Infliximab; Combination therapy; Tumor necrosis factor alpha","score_opus":0.04089977054338074,"score_gpt":0.31874141961241254,"score_spread":0.2778416490690318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406123041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86576927,0.0574103,0.0037117212,0.009398561,0.00027332897,0.0020424547,0.028735602,0.00011575949,0.032543097],"genre_scores_gemma":[0.97755027,0.009773105,0.0036253047,0.0008619608,0.00006125052,0.00022486942,0.0059235715,0.00004697436,0.0019327281],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99578875,0.0015619535,0.00023535397,0.00028052932,0.0015521642,0.0005811522],"domain_scores_gemma":[0.9903386,0.0050334656,0.00076647685,0.0002830304,0.0027038273,0.0008745963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043628956,0.0016818694,0.002552036,0.0037878898,0.0019546212,0.0032529042,0.0022440506,0.0012503893,0.0054420773],"category_scores_gemma":[0.021949051,0.00095042435,0.005958213,0.008794832,0.0010886017,0.0010709934,0.0011910615,0.0027680695,0.00018780243],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.065732874,0.0026598207,0.39030468,0.010941107,0.035242595,0.0027422602,0.0017164994,0.124095306,0.0022009518,0.024439003,0.0916184,0.24830651],"study_design_scores_gemma":[0.02372495,0.0034705505,0.6252804,0.0038456477,0.05301223,0.0024114854,0.0027047188,0.23489043,0.0007989441,0.0073163,0.04123441,0.0013099759],"about_ca_topic_score_codex":0.9699662,"about_ca_topic_score_gemma":0.97138464,"teacher_disagreement_score":0.08808868,"about_ca_system_score_codex":0.08808868,"about_ca_system_score_gemma":0.061897248,"threshold_uncertainty_score":0.63913107},"labels":[],"label_agreement":null},{"id":"W2406158193","doi":"10.1016/j.jval.2016.03.671","title":"BEYOND BUDGET SILOS: BUDGET IMPACT ANALYSIS OF TRANSARTERIAL RADIOEMBOLIZATION WITH YTTRIUM-90 GLASS MICROSPHERES FOR HEPATOCELLULAR CARCINOMA FROM A HOSPITAL PERSPECTIVE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; BC Cancer Agency; Toronto General Hospital","funders":"","keywords":"Hepatocellular carcinoma; Microsphere; Glass microsphere; Perspective (graphical); Yttrium; Medicine; Internal medicine; Materials science; Computer science; Engineering; Chemical engineering","score_opus":0.026591777081331015,"score_gpt":0.270853470834311,"score_spread":0.24426169375297999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406158193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7908507,0.022844123,0.024896566,0.0658236,0.00085560034,0.0011112893,0.009370845,0.00021115592,0.084036134],"genre_scores_gemma":[0.98776835,0.00384394,0.003150582,0.0014016255,0.00016293964,0.00014552548,0.0008669341,0.000054093234,0.00260599],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99506086,0.0028888104,0.00014904446,0.0001252046,0.0006098213,0.0011663181],"domain_scores_gemma":[0.9911782,0.0050897594,0.0011467211,0.00015942864,0.0014439728,0.0009818851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005315719,0.0013454598,0.0011930031,0.002644358,0.00050642615,0.004007253,0.00092187454,0.0016434862,0.0062158876],"category_scores_gemma":[0.015832562,0.0007407735,0.0018336873,0.004342341,0.0008008841,0.0027027659,0.0012995463,0.0024404887,0.00025544225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037616398,0.0010823732,0.0659596,0.0010411683,0.0022205648,0.0010781412,0.0004205088,0.7062755,0.002025405,0.075383104,0.027583005,0.113168985],"study_design_scores_gemma":[0.0014910398,0.0046703527,0.16425917,0.001952712,0.0049988683,0.00083108933,0.009662662,0.64153457,0.0039076963,0.09871926,0.06748165,0.00049089483],"about_ca_topic_score_codex":0.05142047,"about_ca_topic_score_gemma":0.05549125,"teacher_disagreement_score":0.05142047,"about_ca_system_score_codex":0.011375713,"about_ca_system_score_gemma":0.01437786,"threshold_uncertainty_score":0.10224235},"labels":[],"label_agreement":null},{"id":"W2406198421","doi":"10.1016/j.jval.2016.03.074","title":"Characterization of Statin Effectiveness using Real-World Data in a Canadian Population","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Statin; Framingham Risk Score; Internal medicine; Cohort; Atorvastatin; Hyperlipidemia; Population; Diagnosis code; Cohort study; Physical therapy; Disease; Diabetes mellitus; Endocrinology","score_opus":0.07271361172813516,"score_gpt":0.34943334336236187,"score_spread":0.2767197316342267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406198421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98281497,0.00083284144,0.0003593153,0.00065362186,0.000008215293,0.00004994638,0.014059744,0.000019563311,0.0012017532],"genre_scores_gemma":[0.9928128,0.0003555409,0.0005234033,0.00011860776,0.000007305348,0.000025191686,0.0059861415,0.000006030422,0.00016498101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973123,0.00047669027,0.00026269912,0.00042965938,0.0010029294,0.0005156438],"domain_scores_gemma":[0.9910603,0.0022044384,0.0021879226,0.00055101287,0.0031632443,0.00083307683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035191786,0.00048538644,0.0007217547,0.0029186904,0.0015444594,0.0019668664,0.0016360943,0.00083284103,0.0011080767],"category_scores_gemma":[0.014964718,0.00030491024,0.0010481322,0.008085534,0.0008208276,0.0006551382,0.00066168804,0.000981401,0.00017681137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019765875,0.00007001455,0.9917406,0.000049334685,0.0002589211,0.000059400634,0.00029710573,0.0009012817,0.00009020198,0.00027147718,0.0015966104,0.0044673756],"study_design_scores_gemma":[0.000017186352,0.000036216094,0.9954619,0.000024021532,0.00007963868,0.00007319955,0.00042577396,0.002870511,0.000058917034,0.000065935325,0.00086592726,0.000020872418],"about_ca_topic_score_codex":0.98250985,"about_ca_topic_score_gemma":0.98266107,"teacher_disagreement_score":0.022806896,"about_ca_system_score_codex":0.022806896,"about_ca_system_score_gemma":0.02266055,"threshold_uncertainty_score":0.16547638},"labels":[],"label_agreement":null},{"id":"W2406231314","doi":"10.1016/j.jval.2016.03.1654","title":"Impact Of Initial Local Primary Treatment On Late Regional Complications In Castration-Resistant Prostate Cancer Patients In Quebec","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"Sanofi","keywords":"Medicine; Prostate cancer; Prostatectomy; External beam radiotherapy; Cohort; Proportional hazards model; Logistic regression; Quality of life (healthcare); Radiation therapy; Complication; Surgery; Cancer; Internal medicine","score_opus":0.08621693277562745,"score_gpt":0.4200232491814673,"score_spread":0.3338063164058398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406231314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99144965,0.0022552977,0.00006995418,0.0012463363,0.00003803665,0.000034310793,0.0010229931,0.000008459763,0.0038749597],"genre_scores_gemma":[0.9980804,0.00041962435,0.00004540747,0.000203263,0.0000119938495,0.000006562392,0.00036747564,0.0000039924385,0.0008612716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994287,0.00012524624,0.00002739377,0.000047906567,0.00008945561,0.00028130758],"domain_scores_gemma":[0.99806994,0.00021053046,0.000433605,0.000025498892,0.00040664684,0.00085381354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041650623,0.00014983126,0.00042110335,0.0003694464,0.0016345786,0.0012427209,0.0006746497,0.0003636726,0.003624829],"category_scores_gemma":[0.0020570427,0.00012447852,0.000752137,0.0009098116,0.00051552383,0.00029706725,0.0005637409,0.0009672274,0.00012809024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043423445,0.00015791018,0.9823345,0.000049907914,0.00013229056,0.00018405773,0.00035070415,0.00039042116,0.0001931563,0.00010703626,0.0017211919,0.013944633],"study_design_scores_gemma":[0.000022526045,0.00012178034,0.99820375,0.000031176853,0.00005106889,0.00005278334,0.0007211917,0.00022572528,0.00003384018,0.000019299307,0.00050811906,0.000008641462],"about_ca_topic_score_codex":0.94708824,"about_ca_topic_score_gemma":0.98189616,"teacher_disagreement_score":0.05291176,"about_ca_system_score_codex":0.018808324,"about_ca_system_score_gemma":0.012978398,"threshold_uncertainty_score":0.13646454},"labels":[],"label_agreement":null},{"id":"W2406298188","doi":"10.1016/j.jval.2016.03.1279","title":"PREDICTING NON-INSULIN ANTIDIABETIC DRUG ADHERENCE USING A THEORETICAL FRAMEWORK BASED ON THE THEORY OF PLANNED BEHAVIOR IN ADULTS WITH TYPE 2 DIABETES: A PROSPECTIVE STUDY","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Theory of planned behavior; Medicine; Diabetes mellitus; Type 2 diabetes; Psychological intervention; Psychology; Clinical psychology; Control (management); Psychiatry; Endocrinology","score_opus":0.04699115807319104,"score_gpt":0.36286999317913055,"score_spread":0.3158788351059395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406298188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992698,0.00008536696,0.00026977705,0.000066318076,0.000010894839,0.000045725203,0.00006740228,0.0000024160943,0.00018239465],"genre_scores_gemma":[0.9990835,0.000083185194,0.00043448474,0.000043872365,0.000010034695,0.000047093767,0.000119120254,0.000001885877,0.00017688524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985404,0.0008614758,0.00012181642,0.00018509306,0.00014546115,0.00014578695],"domain_scores_gemma":[0.9960014,0.0020301784,0.0006678264,0.00043581802,0.0003641467,0.0005005241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050436817,0.0008853353,0.00067319855,0.0006637375,0.0015121303,0.0020339137,0.0008491384,0.0018434005,0.0014037082],"category_scores_gemma":[0.007974721,0.0015132481,0.001741729,0.00087661797,0.00071139203,0.0012429695,0.00095383025,0.003164563,0.00030416928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037415026,0.0025232516,0.994611,0.000011270476,0.00016995959,0.000030133355,0.0004628516,0.00013897875,0.00006495033,0.00008976464,0.000055646055,0.0014679922],"study_design_scores_gemma":[0.0001691455,0.0023637349,0.9899621,0.00003341652,0.00040466496,0.00013947871,0.0015646118,0.0047672978,0.00008774843,0.00031245308,0.0001764155,0.000018954737],"about_ca_topic_score_codex":0.018025478,"about_ca_topic_score_gemma":0.014779429,"teacher_disagreement_score":0.018025478,"about_ca_system_score_codex":0.0005971137,"about_ca_system_score_gemma":0.0009384579,"threshold_uncertainty_score":0.035841107},"labels":[],"label_agreement":null},{"id":"W2406399824","doi":"10.1016/j.jval.2016.03.219","title":"Impact Of New Entrants To The Market For Multiple-Sclerosis Disease-Modifying Drugs In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fingolimod; Medical prescription; Glatiramer acetate; Medicine; Teriflunomide; Dimethyl fumarate; Multiple sclerosis; Pediatrics; Family medicine; Pharmacology; Psychiatry","score_opus":0.16186943729508668,"score_gpt":0.32432642627937486,"score_spread":0.16245698898428818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406399824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387122,0.0032293994,0.00015042778,0.029025901,0.00026209513,0.00009186876,0.0036514895,0.000032707056,0.024843948],"genre_scores_gemma":[0.98545223,0.0013381547,0.000065278924,0.0016251124,0.00010526169,0.000010598659,0.000777871,0.000011115799,0.010614441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971577,0.0002003424,0.00009304782,0.00014919224,0.00078595144,0.001613723],"domain_scores_gemma":[0.9825829,0.0018036503,0.002340722,0.00013668246,0.0044317353,0.00870435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014220184,0.00023375417,0.00064688484,0.0016063964,0.0028151711,0.0059158173,0.0012961728,0.0022940342,0.009058389],"category_scores_gemma":[0.009006246,0.00034979192,0.0010226737,0.0018463974,0.0015563872,0.0010343997,0.0017886355,0.0031665282,0.00029796385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002882033,0.0010334805,0.8540657,0.00030887677,0.00036710332,0.0030684583,0.0018798225,0.008583804,0.0011972268,0.038688287,0.051637832,0.0362873],"study_design_scores_gemma":[0.00038582552,0.0001977464,0.9450249,0.00017663436,0.00018029672,0.00043286092,0.005198722,0.007912655,0.00074073445,0.0013770178,0.038264744,0.00010791224],"about_ca_topic_score_codex":0.9873032,"about_ca_topic_score_gemma":0.9926165,"teacher_disagreement_score":0.07898171,"about_ca_system_score_codex":0.07898171,"about_ca_system_score_gemma":0.083781175,"threshold_uncertainty_score":0.57305515},"labels":[],"label_agreement":null},{"id":"W2406430614","doi":"10.1016/j.jval.2016.03.807","title":"EARLY STAGE CLINICAL RESEARCH STUDIES IN CANADA: AN ANALYSIS OF THE ECONOMIC IMPACTS OF ATTRACTING MORE STUDIES: A CASE STUDY FOR MONTREAL","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"InterDigital (Canada); Montréal InVivo; Université de Montréal","funders":"","keywords":"Metropolitan area; Private sector; Business; Economic growth; Medicine; Economics","score_opus":0.8626377847964892,"score_gpt":0.6304865484119047,"score_spread":0.23215123638458457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406430614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9358837,0.00593472,0.0015050201,0.017666904,0.000059567796,0.00081875385,0.0019781794,0.000070512135,0.036082737],"genre_scores_gemma":[0.9841769,0.001862919,0.0015571448,0.0013608236,0.000024329573,0.00011896087,0.0004942417,0.000024378302,0.010380445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9932822,0.0017358876,0.00016922549,0.00026705753,0.0013661843,0.003179418],"domain_scores_gemma":[0.9671536,0.009372163,0.0022313048,0.00060587045,0.009036312,0.011600834],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0051879305,0.0005083658,0.0006002162,0.0036272372,0.009440088,0.005124957,0.0026239306,0.0023693554,0.007704092],"category_scores_gemma":[0.015234864,0.00045152535,0.0008953123,0.008082681,0.0026428755,0.001105159,0.002793541,0.002098192,0.00023676547],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0029305348,0.0020231414,0.7011355,0.00122979,0.0008254893,0.010042262,0.027184742,0.011296952,0.0047192606,0.07397314,0.035909284,0.1287299],"study_design_scores_gemma":[0.0004697729,0.0006848646,0.90050256,0.00056377717,0.00041037772,0.00066145416,0.04677204,0.0073561827,0.0007573303,0.0028040376,0.038811404,0.00020618191],"about_ca_topic_score_codex":0.99394196,"about_ca_topic_score_gemma":0.99756986,"teacher_disagreement_score":0.9948121,"about_ca_system_score_codex":0.14836916,"about_ca_system_score_gemma":0.1873444,"threshold_uncertainty_score":0.98777103},"labels":[],"label_agreement":null},{"id":"W2406441617","doi":"10.1016/j.jval.2016.03.508","title":"Resource Utilization and Quality of Life of Patients with Hidradenitis Suppurativa in Canada: Results from a Population-Based Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Quality of life (healthcare); Population; Likert scale; Physical therapy; Disease; Internal medicine; Environmental health","score_opus":0.09062995522749659,"score_gpt":0.30272240047354515,"score_spread":0.21209244524604856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406441617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938963,0.00047125653,0.000038763097,0.00031908212,0.000007648434,0.0000341374,0.0042537465,0.0000040837035,0.0009750271],"genre_scores_gemma":[0.9970901,0.00046656336,0.00009129781,0.00015272922,0.000005949125,0.000016861184,0.001846616,0.000002994459,0.00032688363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991295,0.000094183655,0.00009770517,0.00008421627,0.00028625547,0.00030827752],"domain_scores_gemma":[0.99769163,0.00015402258,0.00060601375,0.000054178192,0.0008458819,0.0006483792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053133286,0.00027474813,0.00052844844,0.00103435,0.0015642025,0.0013800432,0.0009406534,0.0006570873,0.0013364442],"category_scores_gemma":[0.0024458892,0.00038252395,0.0009502817,0.005627324,0.00056365144,0.00050163025,0.0007170216,0.0010664795,0.00018126697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039623657,0.000045988894,0.9981997,0.000017196073,0.000049673567,0.00003376374,0.00025323,0.000045343353,0.00003644052,0.000021787373,0.00034245275,0.0009146969],"study_design_scores_gemma":[0.000005483121,0.000014655651,0.9989843,0.000012919674,0.000015758842,0.000025169687,0.00062122225,0.00010347717,0.000010588334,0.0000071774184,0.00019408076,0.0000051961742],"about_ca_topic_score_codex":0.98199666,"about_ca_topic_score_gemma":0.9848679,"teacher_disagreement_score":0.018003345,"about_ca_system_score_codex":0.01665561,"about_ca_system_score_gemma":0.015149235,"threshold_uncertainty_score":0.1208455},"labels":[],"label_agreement":null},{"id":"W2406521578","doi":"10.1016/j.jval.2016.03.127","title":"Identification and Management of Patients with Symptoms of Statin Intolerance: Results from A Survey of Brazilian Clinicians","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Regimen; Informed consent; Internal medicine; Family medicine; Physical therapy; Alternative medicine","score_opus":0.02553132790576081,"score_gpt":0.2964966045555379,"score_spread":0.2709652766497771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406521578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99799865,0.0004266303,0.00006264857,0.0003063627,0.000005867923,0.000022960092,0.00018420992,0.0000014825006,0.0009911353],"genre_scores_gemma":[0.99890816,0.00049167266,0.00010381711,0.0001968555,0.000006506018,0.0000145116355,0.00016186963,0.0000016369788,0.00011486401],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991642,0.0002682353,0.000114694856,0.000118107244,0.0001839871,0.00015068232],"domain_scores_gemma":[0.9968892,0.00067941635,0.0012384171,0.000119956836,0.0006039329,0.0004690947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011563788,0.00024431036,0.0004449562,0.0009396519,0.00078724767,0.00094165193,0.00036725312,0.000774737,0.001343852],"category_scores_gemma":[0.00749605,0.00038034638,0.00031431208,0.0016055569,0.0004358588,0.00042453947,0.00063087896,0.0004640898,0.00018551773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002709336,0.00006456694,0.99588215,0.000023719056,0.00001584321,0.000103845894,0.0017946735,0.000009250556,0.00017404188,0.000022398273,0.000114707,0.0017677665],"study_design_scores_gemma":[0.000008997855,0.00007155482,0.9939627,0.000043708897,0.00002370185,0.00023082171,0.005012662,0.00007512947,0.000037034,0.000023655668,0.00050391414,0.000005956431],"about_ca_topic_score_codex":0.04682119,"about_ca_topic_score_gemma":0.060432296,"teacher_disagreement_score":0.04682119,"about_ca_system_score_codex":0.00092323864,"about_ca_system_score_gemma":0.0014065298,"threshold_uncertainty_score":0.09309727},"labels":[],"label_agreement":null},{"id":"W2406773265","doi":"10.1016/j.jval.2016.03.999","title":"TIME TRADE OFF STUDY FOR PARENTERAL SUPPORT IN SHORT BOWEL SYNDROME IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical Nutrition and Gastroenterology","field":"Nursing","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Short bowel syndrome; Medicine; Bowel function; Population; Quality of life (healthcare); Parenteral nutrition; Demography; Pediatrics; Gerontology; Environmental health; Surgery","score_opus":0.049338727622142635,"score_gpt":0.33365311912133405,"score_spread":0.2843143914991914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406773265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239564,0.0013704007,0.000053404154,0.0010892225,0.000045194505,0.00009300163,0.0022181317,0.0000037611928,0.002731215],"genre_scores_gemma":[0.9964508,0.0006574724,0.00007590536,0.0002655367,0.000019882918,0.000033184828,0.00087696017,0.000005622431,0.0016146526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836594,0.00018120356,0.00011765373,0.00011797451,0.00043950093,0.0007776967],"domain_scores_gemma":[0.99369967,0.00074435514,0.0012001065,0.00008328491,0.0020596306,0.0022129582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010582166,0.0002452329,0.0007859737,0.0011118916,0.002252428,0.0018340277,0.0011255752,0.00095787644,0.003252689],"category_scores_gemma":[0.0073061837,0.00026012445,0.0011864828,0.0035564678,0.00064735906,0.00068703026,0.0009371901,0.0020510978,0.00015268009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005442899,0.00081300683,0.9732861,0.00019309971,0.00027193353,0.0003967032,0.001164578,0.00034925083,0.00014805383,0.00090011564,0.002945909,0.014088466],"study_design_scores_gemma":[0.00023383881,0.00061686424,0.99297285,0.00014477555,0.00019654278,0.00009836642,0.0028669059,0.0007268718,0.000057034187,0.00012418967,0.0019309566,0.000030662097],"about_ca_topic_score_codex":0.9829274,"about_ca_topic_score_gemma":0.9862757,"teacher_disagreement_score":0.047340896,"about_ca_system_score_codex":0.047340896,"about_ca_system_score_gemma":0.06297271,"threshold_uncertainty_score":0.34348387},"labels":[],"label_agreement":null},{"id":"W2407069932","doi":"10.1016/j.jval.2015.09.1616","title":"Biosimilar Substitution Policies: An Overview","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Interchangeability; Legislation; European union; Medicine; Public economics; Business; International trade; Political science; Law; Economics; Engineering","score_opus":0.25185676392897954,"score_gpt":0.41127787069361604,"score_spread":0.1594211067646365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407069932","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003154653,0.9690267,0.0015587285,0.0064851767,0.0003007017,0.000060461458,0.00037890972,0.00004511405,0.018989615],"genre_scores_gemma":[0.020250473,0.97257406,0.0028051801,0.0021156203,0.00036223384,0.00008089176,0.00048212154,0.000022185786,0.0013072026],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99480575,0.0017639102,0.0010359224,0.0005577211,0.0014263275,0.00041041308],"domain_scores_gemma":[0.9865175,0.008840706,0.002206632,0.0002548364,0.0017774357,0.00040278296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056553963,0.00090612745,0.0008868162,0.011934102,0.000918236,0.004468692,0.0013185072,0.0035611636,0.00553337],"category_scores_gemma":[0.011343267,0.0007889114,0.0010699686,0.016703224,0.0012699842,0.005554693,0.001609256,0.0021578264,0.0015466558],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025195308,0.00027283496,0.0041679787,0.036188576,0.00018345524,0.00052591274,0.0013884022,0.002768396,0.0010501515,0.15396367,0.044710275,0.75452846],"study_design_scores_gemma":[0.000019471336,0.00012856207,0.0053129457,0.036603834,0.00013980911,0.0011618991,0.0007291606,0.0005025255,0.0006555412,0.013577527,0.9411295,0.00003930697],"about_ca_topic_score_codex":0.0067440695,"about_ca_topic_score_gemma":0.0037922626,"teacher_disagreement_score":0.011934102,"about_ca_system_score_codex":0.0065259202,"about_ca_system_score_gemma":0.010227781,"threshold_uncertainty_score":0.047349095},"labels":[],"label_agreement":null},{"id":"W2407236015","doi":"10.1016/j.jval.2016.03.048","title":"Economic Evaluation of A Mental Health Engagement Network","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Michael's Hospital","funders":"","keywords":"Medicine; Cost effectiveness; Economic evaluation; Mental health; Cost-effectiveness analysis; Activity-based costing; Health care; Randomized controlled trial; Demography; Gerontology; Psychiatry; Business; Surgery; Economics","score_opus":0.5272073915779727,"score_gpt":0.46577020942683395,"score_spread":0.06143718215113875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407236015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9105828,0.004857779,0.018559877,0.010465086,0.00056525914,0.0040568644,0.0034656809,0.00008228037,0.047364417],"genre_scores_gemma":[0.9931639,0.00061790476,0.0028620304,0.00020973386,0.00009813721,0.0008763247,0.00053012767,0.000009216249,0.0016326063],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.97246957,0.023689285,0.00055080716,0.00056347303,0.0016435309,0.0010833817],"domain_scores_gemma":[0.91956276,0.06660876,0.0033322333,0.002486953,0.0037319134,0.0042774323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029791461,0.0012469866,0.0013438265,0.0022938442,0.0010520814,0.0038508554,0.0016275118,0.0027161608,0.010080965],"category_scores_gemma":[0.09329451,0.000421109,0.0015762578,0.0019860184,0.0020593659,0.003473964,0.0033082722,0.0029536223,0.0003688691],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07141925,0.023976702,0.06829195,0.0035372963,0.0040628733,0.00067021506,0.00091180275,0.47660673,0.0008295458,0.14287168,0.018328449,0.18849349],"study_design_scores_gemma":[0.025889361,0.03962246,0.04807128,0.001594922,0.00478751,0.0004924128,0.0030320575,0.775549,0.0016971852,0.08097303,0.017970199,0.00032058722],"about_ca_topic_score_codex":0.010043821,"about_ca_topic_score_gemma":0.0066582696,"teacher_disagreement_score":0.029791461,"about_ca_system_score_codex":0.0103758015,"about_ca_system_score_gemma":0.00529048,"threshold_uncertainty_score":0.15755421},"labels":[],"label_agreement":null},{"id":"W2407250161","doi":"10.1016/j.jval.2016.03.834","title":"SINGLE-ENTRY MODELS FOR SCHEDULED SERVICES: TOWARDS A ROADMAP FOR THE IMPLEMENTATION OF BEST PRACTICES","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Research in Systems and Signal Processing","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; University of Manitoba; Alberta Bone and Joint Health Institute; Kingston General Hospital; University of Calgary","funders":"","keywords":"Triage; Stakeholder; Process management; Health care; Service (business); Best practice; Operations management; Medicine; Computer science; Knowledge management; Business; Engineering; Medical emergency; Public relations; Management; Political science; Marketing","score_opus":0.1561322101641723,"score_gpt":0.4087031227503152,"score_spread":0.25257091258614284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407250161","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021779593,0.0048314,0.8442859,0.074467145,0.0013553904,0.0020045761,0.0009557973,0.0051374296,0.045182712],"genre_scores_gemma":[0.20160034,0.0040483787,0.77972287,0.004340715,0.00046084396,0.001518289,0.0010113121,0.0010572193,0.0062400606],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9504627,0.030221565,0.0026271632,0.0036853065,0.010137261,0.0028659361],"domain_scores_gemma":[0.87059313,0.059060372,0.0068005193,0.024127668,0.029510543,0.009907865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057108693,0.0015641691,0.0021957334,0.0026575702,0.0027598788,0.020426787,0.013554702,0.007907366,0.024606198],"category_scores_gemma":[0.108983144,0.001109112,0.0028997506,0.0035521195,0.003607735,0.022904253,0.0076397983,0.00921333,0.0068558613],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068256777,0.0022061449,0.005483211,0.001619798,0.00021736525,0.00018213702,0.0028951988,0.052129317,0.001937724,0.36368424,0.04805181,0.52091056],"study_design_scores_gemma":[0.0006007764,0.001900464,0.0038269614,0.004219284,0.00024150238,0.00031459332,0.006453457,0.20214072,0.00405395,0.53597873,0.23983203,0.00043754085],"about_ca_topic_score_codex":0.028180221,"about_ca_topic_score_gemma":0.024998704,"teacher_disagreement_score":0.057108693,"about_ca_system_score_codex":0.012208518,"about_ca_system_score_gemma":0.049394004,"threshold_uncertainty_score":0.30202323},"labels":[],"label_agreement":null},{"id":"W2407650244","doi":"10.1016/j.jval.2016.03.1448","title":"Meta-Analysis Followed by Indirect Comparison of Treatments Comparing Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hysterectomy; Uterine artery embolization; Psychological intervention; Uterine fibroids; Uterine artery; Surgery; Pregnancy","score_opus":0.19269452744266832,"score_gpt":0.45384746215997207,"score_spread":0.2611529347173037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407650244","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19410983,0.77498597,0.015858233,0.0011103409,0.0051183687,0.0015369736,0.0037500607,0.00046402842,0.0030661544],"genre_scores_gemma":[0.93791157,0.046100922,0.008493242,0.0013747431,0.00087206956,0.001658448,0.0010941213,0.00013454385,0.0023602487],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9770905,0.016481467,0.002694002,0.0021779556,0.0009474132,0.00060860213],"domain_scores_gemma":[0.97398865,0.020951156,0.002186782,0.0018508701,0.0007295946,0.00029286402],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01615263,0.0040182127,0.018227335,0.002627056,0.0008513827,0.0029828204,0.0022030985,0.0036717574,0.0058109695],"category_scores_gemma":[0.039274503,0.0018724798,0.051528633,0.0026057232,0.0010858186,0.0018346878,0.0016918764,0.0043282663,0.0005401212],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026754113,0.00003881504,0.0026747128,0.012798445,0.95416963,0.00006903789,0.000037029764,0.00043957413,0.0002752161,0.00011597294,0.00023420411,0.0023933547],"study_design_scores_gemma":[0.009903821,0.00085674186,0.0032879203,0.00069929165,0.98343444,0.00006786728,0.000029516958,0.0005344665,0.00018652019,0.00040601092,0.0005660828,0.000027275823],"about_ca_topic_score_codex":0.0075783245,"about_ca_topic_score_gemma":0.008823619,"teacher_disagreement_score":0.9838474,"about_ca_system_score_codex":0.0016422903,"about_ca_system_score_gemma":0.0011380423,"threshold_uncertainty_score":0.085424304},"labels":[],"label_agreement":null},{"id":"W2407757632","doi":"10.1016/j.jval.2016.03.1791","title":"A NOVEL METHOD USING PRESCRIPTION TREATMENT PATTERNS TO ESTIMATE HEART FAILURE PREVALENCE IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Novartis (Canada)","funders":"","keywords":"Medicine; Medical prescription; Referral; Heart failure; Diagnosis code; Emergency medicine; Database; Internal medicine; Family medicine; Population; Environmental health","score_opus":0.2582645712173075,"score_gpt":0.5084803843387173,"score_spread":0.25021581312140984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407757632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8069143,0.0024598772,0.14095962,0.0028149276,0.00029313425,0.00062429626,0.030766577,0.0019657596,0.013201508],"genre_scores_gemma":[0.8743213,0.0005763727,0.1127948,0.00021714988,0.00006509695,0.00019278598,0.0060271053,0.00006350317,0.0057418835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992465,0.00011825447,0.000067620254,0.00017635516,0.00028262028,0.000108655586],"domain_scores_gemma":[0.9967114,0.000699697,0.00021207216,0.00011256516,0.0021177495,0.00014648931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011685698,0.00046689637,0.00069390755,0.00439901,0.0014261703,0.0019205359,0.001482575,0.00078400486,0.0021574898],"category_scores_gemma":[0.0077324607,0.00033881806,0.00076673983,0.005275871,0.00030070925,0.00053597614,0.0005561904,0.0007174361,0.00036327116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037942026,0.00030903815,0.6946941,0.0001940618,0.00076345936,0.00024434066,0.00032129153,0.043157496,0.0016290379,0.002711116,0.017661443,0.23793516],"study_design_scores_gemma":[0.00015972495,0.000059191243,0.32034266,0.0000908819,0.0002480703,0.00021114439,0.0006346725,0.66559535,0.0018799283,0.0018721643,0.0088048475,0.00010136376],"about_ca_topic_score_codex":0.9756359,"about_ca_topic_score_gemma":0.9739768,"teacher_disagreement_score":0.024364114,"about_ca_system_score_codex":0.009470756,"about_ca_system_score_gemma":0.019668123,"threshold_uncertainty_score":0.06871551},"labels":[],"label_agreement":null},{"id":"W2408318875","doi":"10.1016/j.jval.2016.03.1634","title":"Hypofractionated Radiotherapy For Low-Intermediate Risk Prostate Cancer: Clinical And Economic Evaluation In A Real-Life Setting","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Regimen; Radiation therapy; Internal medicine; Oncology; Proportional hazards model; Cohort; Cancer","score_opus":0.03385358057016979,"score_gpt":0.3974672351820683,"score_spread":0.3636136546118985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408318875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98587626,0.0063539986,0.0018810976,0.0014150225,0.000074028096,0.0005437398,0.0009836189,0.000018108642,0.0028541503],"genre_scores_gemma":[0.99719846,0.00102887,0.0010224712,0.00008777613,0.000022352333,0.00012045359,0.00034235502,0.0000055531427,0.00017178555],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9947232,0.0042709415,0.0001855812,0.00015494907,0.00039747922,0.00026782398],"domain_scores_gemma":[0.9826383,0.013180338,0.0019693738,0.00032623453,0.00071990304,0.0011658655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008032428,0.001066922,0.0011323694,0.00147923,0.00038814917,0.0018812751,0.00091533776,0.0013804401,0.0034651782],"category_scores_gemma":[0.03406448,0.00040310633,0.0024803623,0.0016960624,0.0010208845,0.0015260923,0.00095863285,0.0012507387,0.00015591335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21097073,0.016236385,0.12193641,0.0029660866,0.0059955805,0.001065913,0.00042714414,0.41954535,0.001424351,0.012323529,0.004489579,0.20261893],"study_design_scores_gemma":[0.037473615,0.1434896,0.22298928,0.001419951,0.008794627,0.0023040134,0.0024408423,0.5538484,0.0018520923,0.014460368,0.010312367,0.0006147476],"about_ca_topic_score_codex":0.00787395,"about_ca_topic_score_gemma":0.00487588,"teacher_disagreement_score":0.008032428,"about_ca_system_score_codex":0.0062220176,"about_ca_system_score_gemma":0.0030457897,"threshold_uncertainty_score":0.04514414},"labels":[],"label_agreement":null},{"id":"W2408418438","doi":"10.1016/j.jval.2016.03.1872","title":"INVESTIGATING STRUCTURAL INDEPENDENCE IN PREFERENCE-BASED UTILITY INSTRUMENTS USING GRAPHICAL MODELS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University Health Network; University of Toronto","funders":"","keywords":"Conditional independence; Independence (probability theory); Graphical model; Computer science; Multivariate statistics; Function (biology); Data mining; Preference; Bayesian probability; Bayesian network; Bayesian information criterion; Econometrics; Artificial intelligence; Machine learning; Statistics; Mathematics","score_opus":0.3769133944637185,"score_gpt":0.27740152763244696,"score_spread":0.09951186683127156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408418438","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13424304,0.00032293773,0.8594104,0.0010541655,0.00003036143,0.00010015589,0.00024345741,0.00017996831,0.0044155316],"genre_scores_gemma":[0.95132524,0.0005366963,0.04530304,0.00018866423,0.0000798687,0.00016895984,0.0003230419,0.00011294409,0.001961555],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.986324,0.009943224,0.00045178257,0.001471607,0.0009084288,0.00090099795],"domain_scores_gemma":[0.71741945,0.25845164,0.011475129,0.008532217,0.0025278472,0.001593676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019994231,0.001591701,0.0033662017,0.002148984,0.00096807,0.0048208763,0.0029964794,0.0031327503,0.009005892],"category_scores_gemma":[0.15314946,0.0022914405,0.0034547267,0.0032691176,0.0061089233,0.01288224,0.0041745915,0.005722813,0.00059366314],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029346618,0.00020622952,0.0050896253,0.00013442706,0.000273327,0.0002270596,0.00049067795,0.14085068,0.0004969451,0.83587795,0.00071653444,0.015343008],"study_design_scores_gemma":[0.00009193698,0.00007951545,0.0012161431,0.000032329626,0.00007777665,0.0000546413,0.00009781201,0.356977,0.00020563224,0.6407614,0.00036961297,0.00003612772],"about_ca_topic_score_codex":0.004337861,"about_ca_topic_score_gemma":0.0031494037,"teacher_disagreement_score":0.019994231,"about_ca_system_score_codex":0.0017943504,"about_ca_system_score_gemma":0.0016559339,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2408603834","doi":"10.1016/j.jval.2016.03.164","title":"Persistence and Compliance with Cardiovascular Drug Therapy Among Seniors","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Persistence (discontinuity); Medical prescription; Drug; Compliance (psychology); Drug class; Pharmacotherapy; Thiazide; Drug adherence; Intensive care medicine; Physical therapy; Emergency medicine; Pharmacology; Internal medicine; Blood pressure; Psychology","score_opus":0.0962179534138825,"score_gpt":0.29678072693088625,"score_spread":0.20056277351700375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408603834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989705,0.00019309518,0.00002373385,0.00013712636,0.0000110015235,0.0000034157986,0.00008830245,0.0000019175427,0.00057093776],"genre_scores_gemma":[0.99947613,0.000071828945,0.000035649173,0.000058329275,0.000017261995,0.0000020417967,0.00011460381,0.0000011478438,0.00022310097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988538,0.0002562389,0.00021116792,0.000113527305,0.00032811737,0.00023716608],"domain_scores_gemma":[0.9913339,0.0018043658,0.0036118575,0.00038918343,0.0008308714,0.0020297994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017010178,0.00025779102,0.00057016866,0.0015438462,0.0009689041,0.0017228846,0.0004518942,0.0012907523,0.0025037539],"category_scores_gemma":[0.011486439,0.00041763097,0.00095683476,0.0015781132,0.0005007679,0.0012500475,0.00086333015,0.001924898,0.0002878568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004872272,0.00015203179,0.9981851,0.000005453349,0.00004601134,0.000025518595,0.0001810091,0.000010965253,0.000026618098,0.000013745562,0.000047228954,0.0012575934],"study_design_scores_gemma":[0.0000041306853,0.00013745592,0.9989429,0.000009194212,0.00001968305,0.00007815021,0.0005702051,0.00011801613,0.000012889443,0.000042723415,0.00006054619,0.000004194158],"about_ca_topic_score_codex":0.010998592,"about_ca_topic_score_gemma":0.013424308,"teacher_disagreement_score":0.010998592,"about_ca_system_score_codex":0.0004928882,"about_ca_system_score_gemma":0.0006175201,"threshold_uncertainty_score":0.021869183},"labels":[],"label_agreement":null},{"id":"W2408640434","doi":"10.1016/j.jval.2016.03.1690","title":"Determining And Identifying Costs For Economic Evaluations: Guidance From Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Activity-based costing; Selection (genetic algorithm); Economic evaluation; Time horizon; Actuarial science; Computer science; Health care; Population; Perfect information; Risk analysis (engineering); Operations research; Data science; Economics; Business; Medicine; Marketing; Microeconomics; Engineering","score_opus":0.4308115233912238,"score_gpt":0.4545053054503063,"score_spread":0.023693782059082513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408640434","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013756735,0.070899166,0.12082565,0.28714618,0.0036346817,0.010321326,0.086422846,0.0040821712,0.40291128],"genre_scores_gemma":[0.10299116,0.0722905,0.66220284,0.0425071,0.0011305532,0.0089033,0.02509195,0.0021344244,0.08274822],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.96888644,0.0096656475,0.004961767,0.0007062679,0.013924918,0.0018549858],"domain_scores_gemma":[0.82684875,0.06568691,0.004932844,0.002071393,0.09611473,0.004345436],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036030542,0.002487489,0.0031981904,0.01253872,0.0028882076,0.009709747,0.004410509,0.0065381844,0.017023727],"category_scores_gemma":[0.18590297,0.0018377545,0.004231246,0.011906093,0.002172888,0.003777636,0.0032829954,0.0070050796,0.0045760944],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015127499,0.00012257739,0.006251104,0.0019751214,0.00017156322,0.00022962996,0.00055767765,0.009695358,0.00021755425,0.024603358,0.82725084,0.12877393],"study_design_scores_gemma":[0.0008894755,0.00012760368,0.048638653,0.02085145,0.0009731384,0.00055660843,0.0018658821,0.018129392,0.0016213305,0.056566898,0.8492444,0.0005350656],"about_ca_topic_score_codex":0.91506296,"about_ca_topic_score_gemma":0.94939226,"teacher_disagreement_score":0.96396947,"about_ca_system_score_codex":0.05320703,"about_ca_system_score_gemma":0.24287936,"threshold_uncertainty_score":0.3860458},"labels":[],"label_agreement":null},{"id":"W2408735958","doi":"10.1016/j.jval.2016.03.379","title":"Association between Neighborhood Socioeconomic Status, Stroke Center Admission, and Mortality after Ischemic and Ill-Define Stroke","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Alberta Health Services; Institute of Health Economics; University of Alberta","funders":"","keywords":"Socioeconomic status; Medicine; Stroke (engine); Emergency medicine; Demography; Neighbourhood (mathematics); Household income; Mortality rate; Pediatrics; Internal medicine; Environmental health; Population; Geography","score_opus":0.019119036118266212,"score_gpt":0.2839625645176131,"score_spread":0.2648435283993469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408735958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987465,0.00019577061,0.000041665993,0.000109377026,0.000012263899,0.0000020615355,0.00016161607,0.000002107696,0.0007286133],"genre_scores_gemma":[0.9995821,0.00004734203,0.000022158925,0.000015871648,0.000016658427,0.0000018351927,0.0001704044,7.5885083e-7,0.00014287877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995741,0.00014313892,0.000055271776,0.000058107904,0.00006200508,0.00010735477],"domain_scores_gemma":[0.9977254,0.0006465759,0.0007374733,0.00013130119,0.00014304926,0.0006162311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052935333,0.00019694207,0.000300161,0.0005869894,0.0004656565,0.0006756828,0.0003783027,0.00057305867,0.0024910802],"category_scores_gemma":[0.0039476976,0.00019131033,0.00052776485,0.00060694275,0.0002763304,0.00045193033,0.0005623005,0.0009527562,0.00015154482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018405101,0.00005980444,0.9988624,0.0000032191492,0.000071582,0.000027607664,0.00001860834,0.00003736535,0.00002977444,0.00002712703,0.00007694355,0.00060153357],"study_design_scores_gemma":[0.000005960201,0.000058218644,0.9992562,0.0000034837067,0.000038213795,0.00005982231,0.00011971145,0.00033392056,0.000014884149,0.00005801894,0.000048748032,0.000002789441],"about_ca_topic_score_codex":0.009616299,"about_ca_topic_score_gemma":0.014842186,"teacher_disagreement_score":0.009616299,"about_ca_system_score_codex":0.00041551556,"about_ca_system_score_gemma":0.00042188304,"threshold_uncertainty_score":0.019120634},"labels":[],"label_agreement":null},{"id":"W2409115721","doi":"10.1016/j.jval.2015.09.1199","title":"Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Medicine; Ceritinib; Pemetrexed; Internal medicine; Oncology; Lung cancer; Population; Anaplastic large-cell lymphoma; Lymphoma; Chemotherapy","score_opus":0.025349565040491275,"score_gpt":0.3133472650491722,"score_spread":0.2879977000086809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409115721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97059745,0.013954645,0.00013026543,0.005807752,0.00011550137,0.000090193425,0.003933527,0.000025270452,0.0053454433],"genre_scores_gemma":[0.99561054,0.0023571975,0.000096312506,0.00031539027,0.000039422823,0.000012456819,0.00097406283,0.0000046785613,0.0005898391],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998985,0.00015484625,0.00009470473,0.00012343324,0.0002822657,0.00035973862],"domain_scores_gemma":[0.9979686,0.00023843478,0.00045962422,0.00002247313,0.00035799068,0.00095296354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055212306,0.00034198991,0.0008447056,0.00065175875,0.00082266855,0.0017378086,0.0010950738,0.00073927455,0.0018524386],"category_scores_gemma":[0.0033150183,0.0002386684,0.001728881,0.0017260597,0.00053094205,0.0004248767,0.00046442906,0.0010216736,0.000099301855],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018021535,0.0010137856,0.8039168,0.0012801429,0.003812589,0.0017659437,0.00044741054,0.029550226,0.0015484842,0.0029457682,0.0208238,0.1148734],"study_design_scores_gemma":[0.0024956486,0.0018038283,0.96304476,0.00040737932,0.002298255,0.00094032177,0.0010516566,0.018930119,0.0005009552,0.0004968276,0.007922011,0.000108230626],"about_ca_topic_score_codex":0.9676779,"about_ca_topic_score_gemma":0.98178226,"teacher_disagreement_score":0.074766085,"about_ca_system_score_codex":0.074766085,"about_ca_system_score_gemma":0.043108813,"threshold_uncertainty_score":0.5424684},"labels":[],"label_agreement":null},{"id":"W2409305992","doi":"10.1016/j.jval.2015.09.924","title":"Managing Patients With Statin-Associated Symptoms: Does Real-World Clinical Practice Align With Clinical Guidelines And Hta Recommendations In Europe?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Ezetimibe; Medicine; Statin; Family medicine; Concomitant; Clinical Practice; Internal medicine","score_opus":0.12308576949465633,"score_gpt":0.4295672057527932,"score_spread":0.3064814362581369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409305992","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43422982,0.037599344,0.0044088415,0.4869483,0.0021528285,0.0001264067,0.0011378014,0.000101279875,0.033295274],"genre_scores_gemma":[0.94906765,0.010511965,0.0064565795,0.032198887,0.00077443715,0.00007287294,0.00050422066,0.000053060354,0.0003603475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9798355,0.009807558,0.0042076716,0.0012307175,0.003474333,0.0014442004],"domain_scores_gemma":[0.94783026,0.01706751,0.01398733,0.0018312257,0.01147299,0.0078106285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021866443,0.0001756506,0.00073053816,0.0013397402,0.0010932403,0.006303501,0.0016185829,0.0028588616,0.0019515909],"category_scores_gemma":[0.07897797,0.00026804776,0.00048347103,0.0027786712,0.00186366,0.0029788113,0.0016430699,0.0025409297,0.0003088912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005341451,0.0009749448,0.6570559,0.0014865862,0.000657715,0.0013277843,0.008675843,0.0014377383,0.0006472292,0.012243646,0.045832492,0.26912588],"study_design_scores_gemma":[0.0003646456,0.0005368023,0.8555765,0.013106164,0.00034009278,0.0025954572,0.030357776,0.0029374755,0.00064094167,0.013680197,0.079604425,0.0002593944],"about_ca_topic_score_codex":0.014553964,"about_ca_topic_score_gemma":0.024231842,"teacher_disagreement_score":0.021866443,"about_ca_system_score_codex":0.0035315729,"about_ca_system_score_gemma":0.013652494,"threshold_uncertainty_score":0.11564219},"labels":[],"label_agreement":null},{"id":"W2409911183","doi":"10.1016/j.jval.2015.09.1194","title":"Literature Review Of Economic Evaluations Of Screening Tests For Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Mammography; Breast cancer; Population; Gynecology; Demography; Cancer; Internal medicine; Environmental health","score_opus":0.24292221545576798,"score_gpt":0.4736622964160725,"score_spread":0.23074008096030452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409911183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013877575,0.99367636,0.00029799755,0.0021505726,0.00018781086,0.00005361585,0.00040894185,0.0000036853976,0.0018331987],"genre_scores_gemma":[0.030793332,0.96558416,0.00096983527,0.0016099191,0.00046388534,0.00012752372,0.00030133277,0.0000091372885,0.00014082323],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9855515,0.0075554103,0.0036196087,0.00058821484,0.0024269647,0.0002583239],"domain_scores_gemma":[0.78467417,0.19699638,0.010704943,0.0009960544,0.006021511,0.0006069545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018014366,0.0013295461,0.0041521722,0.010218015,0.00048415424,0.0034026415,0.0017605091,0.0021458871,0.007883208],"category_scores_gemma":[0.1316254,0.0007568827,0.004574309,0.011769621,0.0013117853,0.0022873974,0.0011691421,0.002335156,0.00032308456],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022689179,0.00027477506,0.0052081128,0.48941657,0.014074523,0.0003582661,0.00026603643,0.0031896832,0.0001827786,0.011086594,0.017044289,0.45662937],"study_design_scores_gemma":[0.00085310405,0.0007025421,0.020548206,0.782777,0.0405625,0.0014251566,0.00080856396,0.0015982284,0.0004020069,0.0142523,0.13594958,0.00012085604],"about_ca_topic_score_codex":0.008755443,"about_ca_topic_score_gemma":0.012268178,"teacher_disagreement_score":0.018014366,"about_ca_system_score_codex":0.0074597746,"about_ca_system_score_gemma":0.007990848,"threshold_uncertainty_score":0.09527022},"labels":[],"label_agreement":null},{"id":"W2409994208","doi":"10.1016/j.jval.2015.09.098","title":"Aretaeus: Retrospective Study Of Medication Usage Patterns Following The Diagnosis Of Type 2 Diabetes In Latin America","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Medical record; Medical prescription; Logistic regression; Diabetes mellitus; Statin; Retrospective cohort study; Type 2 diabetes; Pediatrics; Type 2 Diabetes Mellitus; Internal medicine; Family history; Medical history","score_opus":0.053595954010897985,"score_gpt":0.3121373045771011,"score_spread":0.2585413505662031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409994208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975132,0.00030590774,0.00007754183,0.000045750465,0.000005355312,0.000020605034,0.0008839755,0.0000036645094,0.0011440519],"genre_scores_gemma":[0.9981583,0.00030741093,0.00011798136,0.00010611272,0.000009417024,0.000045098073,0.0009416975,0.0000054686334,0.0003084867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996195,0.00012316169,0.00004898441,0.00008090996,0.000047420526,0.00007998395],"domain_scores_gemma":[0.9990275,0.00017352225,0.00043100293,0.0001002052,0.00014441926,0.00012329589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050519936,0.00030436018,0.00041570255,0.0011474863,0.00059801637,0.00078355597,0.00037798999,0.00049182004,0.0012051729],"category_scores_gemma":[0.0014535257,0.00032162567,0.00042192347,0.002168959,0.000327138,0.0004982846,0.0006213425,0.00053068757,0.00020362025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005133931,0.000031997002,0.99907684,0.0000075885328,0.000019312116,0.00004408795,0.00012326754,0.000007246431,0.00008345011,0.000013587084,0.00005516178,0.00048614663],"study_design_scores_gemma":[0.000008228181,0.00006293121,0.9979207,0.000018191186,0.000033769178,0.0001872579,0.001168153,0.00006322815,0.000043291937,0.000017634831,0.00047289787,0.0000037230309],"about_ca_topic_score_codex":0.04499712,"about_ca_topic_score_gemma":0.041880563,"teacher_disagreement_score":0.04499712,"about_ca_system_score_codex":0.0008048886,"about_ca_system_score_gemma":0.00071786076,"threshold_uncertainty_score":0.089470446},"labels":[],"label_agreement":null},{"id":"W2410634188","doi":"10.1016/j.jval.2015.09.2251","title":"Compliance With Allopurinol Among Hypertensive Patients With Gout Diagnosis and The Relationship to Onset of End-Stage Renal Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Allopurinol; Internal medicine; Gout; End stage renal disease; Kidney disease; Risk factor; Dyslipidemia; Diabetes mellitus; Hemodialysis; Aspirin; Cohort; Disease; Endocrinology","score_opus":0.087752376779564,"score_gpt":0.29836032800377094,"score_spread":0.21060795122420695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410634188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99794596,0.0005525439,0.000057446952,0.00016785091,0.000019411114,0.0000055921814,0.000116224575,0.00000544684,0.0011295677],"genre_scores_gemma":[0.9995466,0.00010166832,0.000038714454,0.000048878406,0.000024634679,0.0000025096115,0.000057124216,0.0000014380391,0.0001783768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99935824,0.00024324721,0.00007821879,0.00008120943,0.000120777804,0.000118251686],"domain_scores_gemma":[0.9948266,0.0018464751,0.002074035,0.00022019343,0.0002716315,0.0007611039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008424296,0.0001689175,0.0004650927,0.0008439956,0.0005632103,0.00084567844,0.00035241427,0.0008482275,0.0021182457],"category_scores_gemma":[0.0055466387,0.00033455246,0.00059437484,0.0014560457,0.00029420134,0.0006376147,0.00039224702,0.001552983,0.00018387432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111438996,0.00007988421,0.99890816,0.0000049256814,0.00005689153,0.00004652531,0.000039491963,0.000019714173,0.00004929669,0.00001094458,0.00002334129,0.0006492922],"study_design_scores_gemma":[0.0000059987915,0.00009525872,0.9994023,0.0000050105004,0.00003146681,0.00010195393,0.000111251,0.00016294865,0.000015740408,0.000021740849,0.000043090295,0.0000031824693],"about_ca_topic_score_codex":0.006823483,"about_ca_topic_score_gemma":0.008731292,"teacher_disagreement_score":0.006823483,"about_ca_system_score_codex":0.00039791822,"about_ca_system_score_gemma":0.0005161463,"threshold_uncertainty_score":0.013567507},"labels":[],"label_agreement":null},{"id":"W2411488224","doi":"10.1016/j.jval.2015.09.1246","title":"The Willingness Of Cancer Outpatients To Complete Patient-Reported Outcome Measures Outside Of The Clinic","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Family medicine; Outpatient clinic; Willingness to accept; Cancer; Willingness to pay; Internal medicine","score_opus":0.26775024784476514,"score_gpt":0.3436538099805708,"score_spread":0.07590356213580568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411488224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997769,0.000080218706,0.00017295971,0.0004953631,0.000008362163,0.000006603971,0.00034445434,0.0000034050172,0.0011196893],"genre_scores_gemma":[0.9991873,0.000036612568,0.000068446694,0.000075901,0.000011556838,0.000006567678,0.00030252244,0.0000014810508,0.0003096493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985489,0.0007982933,0.00010919032,0.00015635989,0.00017774558,0.00020957335],"domain_scores_gemma":[0.97548383,0.012876557,0.007648412,0.0010869149,0.00074325904,0.0021609475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028076675,0.00014684362,0.00038971638,0.00049329735,0.00022703406,0.0011517517,0.00045441595,0.0010315438,0.0044121007],"category_scores_gemma":[0.029169695,0.00016783908,0.0004946379,0.0005747859,0.00037196846,0.0007451195,0.0005170943,0.0011313014,0.00045239518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064188265,0.00035227154,0.989569,0.000020018864,0.00013251102,0.00012275983,0.00022913548,0.00059532485,0.0002594029,0.00051052734,0.00060005503,0.006967123],"study_design_scores_gemma":[0.000028870132,0.00048007525,0.99328834,0.000016529624,0.00003839948,0.00045129657,0.00083673483,0.0033216188,0.000119157405,0.0009845147,0.00042100024,0.000013681901],"about_ca_topic_score_codex":0.002492486,"about_ca_topic_score_gemma":0.0027917218,"teacher_disagreement_score":0.0044121007,"about_ca_system_score_codex":0.00044541477,"about_ca_system_score_gemma":0.0004016043,"threshold_uncertainty_score":0.01484853},"labels":[],"label_agreement":null},{"id":"W2411806854","doi":"10.1016/j.jval.2015.09.913","title":"The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom: Results From The Pgrx-3 Real World Dataset","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Acute coronary syndrome; Quality of life (healthcare); Disease; Coronary heart disease; Pediatrics; Internal medicine; Physical therapy; Myocardial infarction","score_opus":0.1108307801108801,"score_gpt":0.4003534970946386,"score_spread":0.2895227169837585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411806854","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29103065,0.0007312251,0.0003390563,0.0013701444,0.000073935786,0.000047410864,0.7050779,0.00018987418,0.0011398396],"genre_scores_gemma":[0.21931887,0.00028291214,0.00072374137,0.0003389522,0.000048498932,0.00014692315,0.7784019,0.000038433413,0.0006997236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917895,0.00023678872,0.00010785394,0.00022470548,0.000136248,0.00011543331],"domain_scores_gemma":[0.9969247,0.00094882166,0.0008701913,0.00044034346,0.0003772221,0.0004386991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010906684,0.0006818872,0.0009974279,0.0010502437,0.0003017218,0.0010779656,0.0012512458,0.0016712347,0.0029648028],"category_scores_gemma":[0.0075207814,0.00027148856,0.001782086,0.0018995826,0.0002927489,0.0008007277,0.0012765743,0.0014425493,0.0018581775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004611091,0.0006104498,0.73117924,0.0006471593,0.002800797,0.00038644823,0.0003021881,0.0089831995,0.0003317692,0.0007063849,0.2327343,0.01670702],"study_design_scores_gemma":[0.00065452524,0.00032951921,0.96528137,0.00022370889,0.00041507042,0.00044810426,0.000491868,0.0087081725,0.00026178226,0.0006552841,0.022432152,0.00009845468],"about_ca_topic_score_codex":0.034761023,"about_ca_topic_score_gemma":0.038869463,"teacher_disagreement_score":0.034761023,"about_ca_system_score_codex":0.0010953106,"about_ca_system_score_gemma":0.0007611165,"threshold_uncertainty_score":0.06911737},"labels":[],"label_agreement":null},{"id":"W2412493407","doi":"10.1016/j.jval.2015.09.2195","title":"Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Internal medicine; Cirrhosis; Antiviral therapy; Gastroenterology; Medical costs; Hepatitis C virus; Chronic hepatitis; Immunology; Virus; Health care","score_opus":0.04009649260743206,"score_gpt":0.35758776032102774,"score_spread":0.3174912677135957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412493407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914206,0.0026130995,0.00022874998,0.0020623421,0.000038614744,0.000017622575,0.004155196,0.0000068663717,0.0017354618],"genre_scores_gemma":[0.99806076,0.0004137917,0.00009720439,0.000075661505,0.00003132798,0.000006547048,0.0012142209,0.0000014818887,0.000099070545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860954,0.0006692525,0.00022734258,0.00010814277,0.00018276376,0.00020290853],"domain_scores_gemma":[0.99527764,0.0014640831,0.0022582437,0.00013290903,0.00023885848,0.0006282829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077625486,0.0002448026,0.00039929512,0.0008391012,0.0003580565,0.0011392056,0.0004149946,0.00089986983,0.0028077865],"category_scores_gemma":[0.008961432,0.0002963394,0.0012063023,0.0016295423,0.00033681808,0.0013361387,0.0007381556,0.0013828448,0.00015716553],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010351823,0.00015253744,0.9818325,0.00011853101,0.00066372706,0.00041264566,0.00009729466,0.0060926653,0.00012183947,0.001389311,0.0013388897,0.006744966],"study_design_scores_gemma":[0.000066656954,0.00025891446,0.9825037,0.00008744402,0.00022259154,0.0011977741,0.0008495431,0.012323466,0.00006376722,0.0012168318,0.0011746609,0.000034674264],"about_ca_topic_score_codex":0.017286863,"about_ca_topic_score_gemma":0.018540667,"teacher_disagreement_score":0.017286863,"about_ca_system_score_codex":0.0022761186,"about_ca_system_score_gemma":0.0007673205,"threshold_uncertainty_score":0.03437251},"labels":[],"label_agreement":null},{"id":"W2413468542","doi":"10.1016/j.jval.2015.09.1695","title":"Comparison of current and preferred status of hta implementation in central and eastern europen countries","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pharmacoeconomics; Agency (philosophy); Mandate; Health technology; Medicine; Transferability; Scope (computer science); Political science; Business; Economic growth; Health care; Economics","score_opus":0.6673983397566747,"score_gpt":0.5327567379794599,"score_spread":0.13464160177721485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413468542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99007446,0.0035134386,0.00017456102,0.0006844372,0.00002294884,0.000010836378,0.0008510358,0.0000067977626,0.0046614935],"genre_scores_gemma":[0.998486,0.0005687793,0.00011728695,0.000084094405,0.000007950119,0.0000047914423,0.00043171068,0.0000026816824,0.00029678823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696773,0.0009867646,0.00047578698,0.00021769918,0.0004756225,0.00087638444],"domain_scores_gemma":[0.99035245,0.0031010467,0.002872957,0.0004551026,0.0021456091,0.0010728112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006966233,0.00015794253,0.000427079,0.0025785754,0.000433125,0.0027962483,0.00080297026,0.0006448689,0.0018240666],"category_scores_gemma":[0.010018294,0.00021638762,0.0006016111,0.00351738,0.0008865791,0.0012681162,0.0014236172,0.0005927783,0.00009699999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016814409,0.00014726508,0.9335368,0.0004184252,0.00063596223,0.0004609952,0.0030255301,0.0029760909,0.000568299,0.011105875,0.0013755674,0.044067714],"study_design_scores_gemma":[0.000023285718,0.00008698297,0.9949668,0.00014043595,0.000070059075,0.00012776196,0.0016704025,0.00037209905,0.0001792481,0.00024651224,0.002106021,0.00001039919],"about_ca_topic_score_codex":0.034453694,"about_ca_topic_score_gemma":0.03379498,"teacher_disagreement_score":0.034453694,"about_ca_system_score_codex":0.0023695324,"about_ca_system_score_gemma":0.0023879465,"threshold_uncertainty_score":0.0685063},"labels":[],"label_agreement":null},{"id":"W2413529821","doi":"10.1016/j.jval.2015.09.284","title":"High-Cost Oncologic Medication Access: Why Is Latin America Falling Behind? Case Study In Non-Small Cell Lung Cancer (NSCLC)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Reimbursement; Medicine; Government (linguistics); Market access; Latin Americans; Health care; Family medicine; Business; Political science; Geography","score_opus":0.12955812101954917,"score_gpt":0.34338259185180825,"score_spread":0.21382447083225908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413529821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833051,0.0006383058,0.00031913054,0.0041818563,0.00001558453,0.000024672881,0.00023018336,0.000006142023,0.011279012],"genre_scores_gemma":[0.997771,0.00036609065,0.00024529285,0.00025221764,0.00001188265,0.000013774404,0.00008607903,0.0000041950348,0.0012495262],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99955636,0.00018067099,0.000015676704,0.00002842653,0.000041100335,0.0001776665],"domain_scores_gemma":[0.9987245,0.0006050834,0.00023924085,0.000043463253,0.0001761014,0.00021160464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007385531,0.00018478298,0.0002765895,0.0006370458,0.0017017007,0.0015715342,0.0004984596,0.0013882609,0.0044718725],"category_scores_gemma":[0.0027235122,0.000098774304,0.00037072168,0.0015495694,0.00089941605,0.0007102174,0.0010625381,0.00081977353,0.00021023981],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005537331,0.0017951342,0.85387117,0.00032421175,0.00013461542,0.046512377,0.016789855,0.005605476,0.0014790231,0.025188025,0.009233107,0.038513225],"study_design_scores_gemma":[0.00028317043,0.0007092246,0.5453662,0.00087903964,0.00032240938,0.031572394,0.31108668,0.02130931,0.0021891044,0.015751755,0.07041902,0.00011164816],"about_ca_topic_score_codex":0.1062074,"about_ca_topic_score_gemma":0.11824766,"teacher_disagreement_score":0.1062074,"about_ca_system_score_codex":0.0023053125,"about_ca_system_score_gemma":0.0015386912,"threshold_uncertainty_score":0.21117842},"labels":[],"label_agreement":null},{"id":"W2413612992","doi":"10.1016/j.jval.2015.09.2019","title":"Reversal of Neuromuscular Blockade: A Discrete Event Simulation Model of Clinical and Operating Room Efficiency Outcomes of Sugammadex Versus Neostigmine In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Sugammadex; Neostigmine; Neuromuscular Blockade; Medicine; Rocuronium; Anesthesia; Neuromuscular monitoring; Intubation","score_opus":0.15801954546230002,"score_gpt":0.3985121823993605,"score_spread":0.24049263693706047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413612992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850188,0.00031038956,0.0030909665,0.0022133982,0.00007229404,0.00012951207,0.003093293,0.000075247706,0.0059961104],"genre_scores_gemma":[0.9931323,0.00018557547,0.0011174318,0.0001580877,0.000020725662,0.00008553482,0.0011803835,0.00001639566,0.0041035716],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99893004,0.0002983232,0.000038116385,0.00017743076,0.00009807511,0.00045801234],"domain_scores_gemma":[0.9885959,0.007678363,0.0006601725,0.00021668416,0.0017082063,0.0011406144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022328119,0.0010118184,0.0018482826,0.0009932512,0.0015938431,0.002353132,0.0030576785,0.0035049506,0.0074746036],"category_scores_gemma":[0.010662702,0.0009862009,0.0021082629,0.0011931481,0.0018394891,0.0009101896,0.0009728187,0.0028653857,0.00041978154],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008693368,0.00035853425,0.0113872215,0.000031787098,0.000109235196,0.00010615646,0.000081096856,0.98103917,0.00009182687,0.0034518235,0.0013717571,0.0011020292],"study_design_scores_gemma":[0.00038557465,0.00013810243,0.00419613,0.000012638972,0.000081132595,0.000012394442,0.00016077343,0.99389356,0.00007105976,0.0006602846,0.0003541878,0.000034152217],"about_ca_topic_score_codex":0.9323302,"about_ca_topic_score_gemma":0.8456079,"teacher_disagreement_score":0.06766981,"about_ca_system_score_codex":0.020547755,"about_ca_system_score_gemma":0.021574795,"threshold_uncertainty_score":0.1490851},"labels":[],"label_agreement":null},{"id":"W2415373915","doi":"10.1016/j.jval.2015.09.1666","title":"Systematic Review Of Economic Evaluations In Personalized Medicine","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Economic evaluation; Psychological intervention; MEDLINE; Population; Systematic review; Quality-adjusted life year; Cost effectiveness; Cost–benefit analysis; Personalized medicine; Health care; Family medicine; Intensive care medicine; Environmental health; Pathology; Bioinformatics; Psychiatry","score_opus":0.5788776139443731,"score_gpt":0.5101132487640837,"score_spread":0.06876436518028939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415373915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018787171,0.9948789,0.00069135695,0.00065504067,0.00026583462,0.00048198167,0.0007036628,0.0000125740635,0.0004318919],"genre_scores_gemma":[0.09105721,0.9001551,0.0038154637,0.0018509416,0.00044356604,0.0016430502,0.0007518709,0.000027186798,0.00025554455],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.92668283,0.04859148,0.016172318,0.001994921,0.0059048925,0.00065354316],"domain_scores_gemma":[0.7790686,0.19208303,0.018968325,0.0030763147,0.0060104392,0.0007933436],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.050612696,0.0022351374,0.013958231,0.009939196,0.0006481882,0.0040773926,0.0021213081,0.0029920605,0.0054791863],"category_scores_gemma":[0.23726617,0.0015152661,0.012706971,0.009449908,0.0016526545,0.0025680158,0.0023439038,0.0030415417,0.0002652533],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020370183,0.000044633645,0.0016939156,0.8294882,0.11398948,0.00009182384,0.00012478814,0.0005997902,0.00008587842,0.0009338854,0.002847576,0.048063025],"study_design_scores_gemma":[0.005396232,0.0006497717,0.0095244255,0.54582775,0.41491488,0.0003283964,0.00020843638,0.00066180236,0.00024151953,0.003583572,0.018573543,0.00008971224],"about_ca_topic_score_codex":0.008461706,"about_ca_topic_score_gemma":0.020043207,"teacher_disagreement_score":0.9493873,"about_ca_system_score_codex":0.005716966,"about_ca_system_score_gemma":0.010644855,"threshold_uncertainty_score":0.26766878},"labels":[],"label_agreement":null},{"id":"W2415625112","doi":"10.1016/j.jval.2015.09.2325","title":"Economic Analysis of Ustekinumab for Psoriatic Arthritis in Russia","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Christian ministry; Adalimumab; Euros; Internal medicine; Arthritis; Humanities","score_opus":0.0691526633123643,"score_gpt":0.3625592694153222,"score_spread":0.2934066061029579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415625112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96371365,0.01379734,0.002534037,0.0049258345,0.00012757271,0.0001026774,0.001360193,0.000023578037,0.013415152],"genre_scores_gemma":[0.99807763,0.00087082264,0.00018163717,0.000065842556,0.00002290332,0.000014383111,0.00016194156,0.000003622546,0.00060119346],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973623,0.0016171904,0.00010966673,0.00010558925,0.0003240925,0.00048121292],"domain_scores_gemma":[0.99627113,0.0024652279,0.00059665204,0.000106953914,0.00025222715,0.0003076921],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002713354,0.00030887857,0.0009447302,0.0009758868,0.0003522742,0.0021853778,0.0005774857,0.00073050335,0.0025098145],"category_scores_gemma":[0.008214028,0.00026883272,0.0016307473,0.0007547749,0.0005480115,0.00070777314,0.0009036762,0.0011235741,0.00011397046],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033837073,0.0020462137,0.18479286,0.0028649813,0.006736711,0.0029150702,0.00053591724,0.43336943,0.0053867246,0.19040388,0.016196333,0.12091479],"study_design_scores_gemma":[0.004248998,0.0063263886,0.33394235,0.0012408063,0.009445915,0.0026296831,0.0035623868,0.52536774,0.0046110917,0.07022493,0.038126476,0.0002732454],"about_ca_topic_score_codex":0.015470211,"about_ca_topic_score_gemma":0.010049057,"teacher_disagreement_score":0.015470211,"about_ca_system_score_codex":0.0055925976,"about_ca_system_score_gemma":0.0036788324,"threshold_uncertainty_score":0.040577352},"labels":[],"label_agreement":null},{"id":"W2415727855","doi":"10.1016/j.jval.2015.09.1734","title":"The Clinical and Economic Burden of Medication Errors In The Canadian Acute Care Setting: A Review of Published Studies","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Harm; MEDLINE; Health care; Acute care; Adverse effect; Dosing; Emergency medicine; Patient safety; Chart; Intensive care medicine; Medical emergency; Internal medicine; Statistics","score_opus":0.33014109865665187,"score_gpt":0.5633862972637363,"score_spread":0.23324519860708448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415727855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000545469,0.9986009,0.00003154899,0.00025276226,0.00005330453,0.00001607066,0.0002562923,0.0000016632117,0.00024197399],"genre_scores_gemma":[0.003923486,0.9956214,0.00013820169,0.00014537937,0.000039663628,0.000009287341,0.0000856655,9.436659e-7,0.00003604567],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99647325,0.00039782553,0.00088423543,0.00029370483,0.0017905829,0.00016028584],"domain_scores_gemma":[0.98444414,0.0087515935,0.0031566068,0.00015122825,0.003180069,0.00031638594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054846196,0.0013051833,0.0037762565,0.013075694,0.000885232,0.0028650027,0.0019106452,0.0013530782,0.0032403092],"category_scores_gemma":[0.018836597,0.00060683786,0.004560588,0.02284696,0.00096644164,0.0013506481,0.0012694885,0.0012638151,0.00016003869],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037950985,0.00008165392,0.014891638,0.5320736,0.010562127,0.00031435673,0.0004965062,0.0005855818,0.0002029753,0.0012404401,0.014091576,0.42508],"study_design_scores_gemma":[0.00022519696,0.00027715924,0.117654614,0.5760413,0.06992209,0.0018170464,0.0020505444,0.00049428485,0.000481118,0.0016198665,0.2291479,0.00026900135],"about_ca_topic_score_codex":0.23718497,"about_ca_topic_score_gemma":0.44518754,"teacher_disagreement_score":0.762815,"about_ca_system_score_codex":0.0091200685,"about_ca_system_score_gemma":0.026351152,"threshold_uncertainty_score":0.47160882},"labels":[],"label_agreement":null},{"id":"W2416090704","doi":"10.1016/j.jval.2015.09.1283","title":"Quantifying Costs of Medical Personnel Involved with Radiation therapy Using Administrative Databases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ontario Institute for Cancer Research; Sunnybrook Hospital","funders":"","keywords":"Medicine; Cohort; Radiation oncologist; Radiation therapy; Total cost; Medical radiation; Radiation treatment planning; Diagnosis code; Cancer registry; Family medicine; Database; Emergency medicine; Cancer; Medical physics; Surgery; Population; Internal medicine; Environmental health","score_opus":0.43715603631681077,"score_gpt":0.39283065841495146,"score_spread":0.04432537790185931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416090704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96515656,0.0016465876,0.009106932,0.0010553885,0.000033228484,0.00018727484,0.01869707,0.0000720023,0.004044929],"genre_scores_gemma":[0.9883549,0.000556502,0.0045087244,0.000045540928,0.00002938751,0.000055151002,0.0062137553,0.000007384789,0.00022872059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426323,0.0028860625,0.0008088873,0.00046384352,0.0012010242,0.0003769069],"domain_scores_gemma":[0.94240755,0.039683454,0.0117765255,0.0022800749,0.0030120304,0.0008403471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005262724,0.0005726511,0.00069482444,0.0053075817,0.00038751363,0.0024045133,0.0012584751,0.0010460274,0.001274072],"category_scores_gemma":[0.05245402,0.000591985,0.0012685403,0.00886889,0.00035450768,0.001962445,0.00095106795,0.00079726,0.00018619398],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007732113,0.0005377828,0.7998347,0.00047394846,0.0014551186,0.00020530491,0.00023394742,0.13055375,0.00032820087,0.009745384,0.0036920512,0.052166514],"study_design_scores_gemma":[0.00014417332,0.0004583794,0.64184195,0.000324697,0.0011264025,0.0004984823,0.0014544536,0.33407637,0.0016176031,0.012301105,0.0060540684,0.00010233516],"about_ca_topic_score_codex":0.03555879,"about_ca_topic_score_gemma":0.026736071,"teacher_disagreement_score":0.03555879,"about_ca_system_score_codex":0.0032712298,"about_ca_system_score_gemma":0.00297375,"threshold_uncertainty_score":0.070703626},"labels":[],"label_agreement":null},{"id":"W2417736320","doi":"10.1016/j.jval.2015.09.2120","title":"Impact of Adherence to Oral Antidiabetics on All-Cause Mortality: A Population Based Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Nested case-control study; Confounding; Internal medicine; Cohort study; Proportional hazards model; Cohort; Population; Mortality rate; Risk of mortality; Logistic regression; Emergency medicine; Disease; Environmental health","score_opus":0.39578362843203835,"score_gpt":0.4934334644400016,"score_spread":0.09764983600796323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417736320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991911,0.00013436098,0.00006199687,0.000037353202,0.000007852809,0.000019543375,0.00017297563,0.0000028543755,0.00037192748],"genre_scores_gemma":[0.9991843,0.00009871835,0.00008251185,0.00006364121,0.000022608507,0.000023982866,0.00024511167,0.0000032000885,0.00027584255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788743,0.0008899383,0.00019392482,0.00038163943,0.00034148525,0.0003055507],"domain_scores_gemma":[0.99684757,0.0007879709,0.0009321087,0.00034444095,0.0003727379,0.0007150506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002044876,0.0008455004,0.0009978466,0.0013760449,0.0015422174,0.0018546458,0.0008627163,0.0021469165,0.0019405236],"category_scores_gemma":[0.0043183975,0.0013471126,0.0028253386,0.0028707967,0.00096672575,0.001763453,0.0011807543,0.002943641,0.0004708206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011163434,0.0011207683,0.9952567,0.000018730283,0.0006857342,0.0001362897,0.00033565686,0.000036463465,0.000205503,0.000021922848,0.000075598815,0.0009902618],"study_design_scores_gemma":[0.000066114706,0.0010510767,0.9978904,0.0000046878663,0.00026540883,0.00012536775,0.00035737237,0.00011255902,0.000021357086,0.00002259894,0.000070915376,0.000012277121],"about_ca_topic_score_codex":0.011742686,"about_ca_topic_score_gemma":0.014037924,"teacher_disagreement_score":0.011742686,"about_ca_system_score_codex":0.00075767946,"about_ca_system_score_gemma":0.00065082306,"threshold_uncertainty_score":0.02334869},"labels":[],"label_agreement":null},{"id":"W2417759952","doi":"10.1016/j.jval.2015.09.2018","title":"Hospitalizations In Hyperchylomicronemia Patients In Quebec, Canada; Results From A Real-World Observational Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université du Québec à Chicoutimi; Université de Montréal","funders":"","keywords":"Medicine; Abdominal pain; Acute pancreatitis; Observational study; Pancreatitis; Pediatrics; Emergency medicine; Internal medicine","score_opus":0.11462740945632892,"score_gpt":0.32779044191952234,"score_spread":0.2131630324631934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417759952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874637,0.0012317073,0.00018771943,0.0005017394,0.000028341074,0.00008851515,0.009161515,0.000014975357,0.0013216608],"genre_scores_gemma":[0.99602157,0.00047064805,0.00020191923,0.0002267439,0.0000143068255,0.000037945072,0.0025348961,0.0000071545282,0.00048491792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985537,0.00021198488,0.00015961252,0.00031885036,0.00032387185,0.00043192896],"domain_scores_gemma":[0.9955805,0.00030348764,0.0012857174,0.00021525135,0.0015220464,0.0010929217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011114934,0.0007984313,0.00088699994,0.0011944501,0.0028785272,0.0023437198,0.002387968,0.001523758,0.0020409848],"category_scores_gemma":[0.0035336006,0.0006787103,0.0011703371,0.0055124806,0.0012153647,0.0008979774,0.0011949821,0.0015079359,0.00029797124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010403386,0.00004826222,0.9979407,0.000022864302,0.00012396957,0.000074147836,0.00022103632,0.000089541434,0.00006462444,0.000054531396,0.00064805645,0.00060813344],"study_design_scores_gemma":[0.000019489098,0.000022317292,0.9985555,0.000029135872,0.000052138228,0.000039001454,0.00066508487,0.00027304774,0.000017594579,0.000014646077,0.0002991134,0.000012830101],"about_ca_topic_score_codex":0.98887026,"about_ca_topic_score_gemma":0.9914761,"teacher_disagreement_score":0.028977357,"about_ca_system_score_codex":0.028977357,"about_ca_system_score_gemma":0.023491856,"threshold_uncertainty_score":0.21024644},"labels":[],"label_agreement":null},{"id":"W2417885747","doi":"10.1016/j.jval.2015.09.788","title":"Association Between Adherence to Evidence-Based Heart Failure Drug Treatment and One-Year All-Cause Hospitalization and All-Cause Mortality","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Novartis (Canada); Université Laval","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Odds ratio; Cohort; Incidence (geometry); Isosorbide dinitrate; Logistic regression; Cohort study","score_opus":0.3104457396374599,"score_gpt":0.4142869778682186,"score_spread":0.10384123823075869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417885747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99602157,0.001446577,0.00023719629,0.00036765193,0.000037865975,0.000011177032,0.00034832463,0.000009388491,0.0015203352],"genre_scores_gemma":[0.9992459,0.00017856581,0.00012818986,0.000072398616,0.000029971625,0.000003969707,0.0001674611,0.0000012739013,0.00017226108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841094,0.00071456126,0.0002753755,0.0001814296,0.0002605652,0.00015715328],"domain_scores_gemma":[0.99012357,0.004185405,0.0041171447,0.0005101839,0.00046546565,0.00059819606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001958406,0.0002036026,0.00046026794,0.00055812846,0.00028664985,0.0006250419,0.00037505725,0.00089335156,0.001336737],"category_scores_gemma":[0.0103689395,0.00022441956,0.0009486832,0.00091474137,0.00020338353,0.00047334598,0.00038119106,0.001486977,0.00008756393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029346344,0.000165546,0.99578434,0.000029025907,0.00061527744,0.000018583118,0.00002445553,0.00010855052,0.00006248138,0.000033155233,0.00009022408,0.0027748523],"study_design_scores_gemma":[0.000014521799,0.0001207567,0.99890924,0.000013757685,0.00016552443,0.000039981802,0.000032140164,0.00054448214,0.000020977765,0.00005552104,0.00007962843,0.0000034842312],"about_ca_topic_score_codex":0.005204887,"about_ca_topic_score_gemma":0.006226486,"teacher_disagreement_score":0.005204887,"about_ca_system_score_codex":0.00029572187,"about_ca_system_score_gemma":0.00041183847,"threshold_uncertainty_score":0.0103571415},"labels":[],"label_agreement":null},{"id":"W2418647911","doi":"10.1016/j.jval.2015.09.594","title":"Real-World Treatment Patterns of Ranibizumab Among Patients With Retinal Diseases In Canada: 5 Years Of Data","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Cohort; Demography; Ophthalmology; Pediatrics; Surgery; Internal medicine; Bevacizumab; Chemotherapy","score_opus":0.06158111600708995,"score_gpt":0.3067277650903798,"score_spread":0.24514664908328984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418647911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94093543,0.007933644,0.00033328746,0.0019783375,0.00003224028,0.00010027003,0.045640446,0.00004179522,0.0030044944],"genre_scores_gemma":[0.98133403,0.002521649,0.0005139238,0.00052701955,0.000019355757,0.000038773418,0.01450859,0.00001710456,0.00051961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996786,0.00023886623,0.00050917565,0.00047566055,0.0012085236,0.00078178314],"domain_scores_gemma":[0.9878732,0.0011884468,0.0034283374,0.0004667125,0.0057143425,0.001328926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001528663,0.0003582981,0.0009280793,0.0018980579,0.0014271628,0.0019529781,0.0016242224,0.0009984695,0.0014434438],"category_scores_gemma":[0.0076738223,0.00049882865,0.0014650605,0.0083572725,0.0008790277,0.001002702,0.0009033853,0.0013512045,0.00021946443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003014856,0.00005177311,0.9907697,0.00015242845,0.0003671321,0.00007487841,0.00033352256,0.0002959663,0.00008677635,0.00013940039,0.0022946163,0.005132332],"study_design_scores_gemma":[0.000019254676,0.000029241173,0.99711466,0.00007759642,0.0001344954,0.000080269834,0.0004963536,0.00042780928,0.00005043107,0.000029724577,0.0015181027,0.00002201024],"about_ca_topic_score_codex":0.9857976,"about_ca_topic_score_gemma":0.9877801,"teacher_disagreement_score":0.036604065,"about_ca_system_score_codex":0.036604065,"about_ca_system_score_gemma":0.033522785,"threshold_uncertainty_score":0.26558232},"labels":[],"label_agreement":null},{"id":"W2419548009","doi":"10.1016/j.jval.2015.09.1785","title":"A Pitcure of Private Health Insurance Policyholders in Italy","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Management, Economics, and Public Policy","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Euros; Quarter (Canadian coin); Payment; Business; Health insurance; Private insurance; Geography; Private sector; Distribution (mathematics); Health care; Demographic economics; Actuarial science; Economic growth; Economics; Finance; Humanities","score_opus":0.08751209091308484,"score_gpt":0.2911826184889262,"score_spread":0.20367052757584134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419548009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89867055,0.0019801753,0.0003248977,0.042268824,0.000109446475,0.000034043773,0.00027107,0.00002198375,0.056318935],"genre_scores_gemma":[0.98388577,0.00033429734,0.00007532814,0.002121199,0.00009179896,0.000015937214,0.00008647885,0.0000068813833,0.013382222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867284,0.000296715,0.000029664297,0.00012532638,0.00021478461,0.00066075777],"domain_scores_gemma":[0.9970862,0.0008085105,0.0007290376,0.00012223244,0.00023836031,0.0010157807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020220869,0.00008275039,0.00020931511,0.0010700995,0.0024416323,0.0029254048,0.00047461488,0.0017586238,0.007224206],"category_scores_gemma":[0.0047499244,0.00018567631,0.00017922626,0.00088250043,0.0013764532,0.001166183,0.0016381525,0.0023056713,0.00037711373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000932105,0.00051803014,0.4971116,0.00019491398,0.00007471208,0.00357936,0.03915447,0.00069852197,0.002091429,0.26266903,0.10788518,0.08509066],"study_design_scores_gemma":[0.000080345846,0.00018132794,0.7918823,0.00024714888,0.000047955382,0.00078478316,0.024235036,0.0014631634,0.00044262173,0.00729635,0.17330414,0.00003482323],"about_ca_topic_score_codex":0.037779815,"about_ca_topic_score_gemma":0.0708769,"teacher_disagreement_score":0.037779815,"about_ca_system_score_codex":0.005067126,"about_ca_system_score_gemma":0.0040116212,"threshold_uncertainty_score":0.07511979},"labels":[],"label_agreement":null},{"id":"W2421102659","doi":"10.1016/j.jval.2015.09.2180","title":"Quality of Care For Patients With Diabetes Mellitus (Dm) In Canada: Findings From A National Population-Based Survey","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Health care; Population; Logistic regression; Family medicine; Odds; Demography; Receipt; Demographics; Cohort; Gerontology; Environmental health; Internal medicine","score_opus":0.33393288900011225,"score_gpt":0.47797611365129417,"score_spread":0.1440432246511819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421102659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98283064,0.001515896,0.00014965978,0.003065677,0.00004304812,0.00012250796,0.008564005,0.0000135803575,0.0036950447],"genre_scores_gemma":[0.99469876,0.0010076617,0.00042574672,0.0007303119,0.000017034676,0.00004728155,0.0025128785,0.0000052237056,0.00055507116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721646,0.0002831379,0.00033872176,0.00025122426,0.0012857305,0.00062469963],"domain_scores_gemma":[0.99160767,0.0005355276,0.0021061664,0.0001524595,0.0037086543,0.0018895386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014927896,0.00024756617,0.0005447156,0.001220836,0.0019974236,0.0016701961,0.0013872292,0.00089045364,0.0010634662],"category_scores_gemma":[0.008162346,0.00040529258,0.0009584005,0.0060086036,0.000629159,0.0006455477,0.0012005589,0.0014236192,0.00013173047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026690752,0.00006674263,0.99524623,0.000042719275,0.000062293264,0.000018459004,0.00042598977,0.000049476173,0.000024054127,0.000043564913,0.0013951978,0.0025984268],"study_design_scores_gemma":[0.0000054106226,0.0000111863565,0.9987318,0.000031761894,0.000021001199,0.000012713647,0.0006694327,0.000103896426,0.000011638194,0.000011372262,0.00038454754,0.000005206164],"about_ca_topic_score_codex":0.99117273,"about_ca_topic_score_gemma":0.99487793,"teacher_disagreement_score":0.032956727,"about_ca_system_score_codex":0.032956727,"about_ca_system_score_gemma":0.05038211,"threshold_uncertainty_score":0.23911893},"labels":[],"label_agreement":null},{"id":"W2424761896","doi":"10.1016/j.jval.2015.09.923","title":"Real-World Identification Of European Patients With Statin-Associated Symptoms: Clinical Practice Compared With Clinical Guidelines","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Clinical Practice; Internal medicine; Clinical trial; Physical therapy; Family medicine","score_opus":0.14872329184930203,"score_gpt":0.4334190002766845,"score_spread":0.28469570842738245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424761896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941043,0.0010126082,0.00032581776,0.0016414056,0.00003813795,0.00002830118,0.00077036273,0.0000104354185,0.0020686719],"genre_scores_gemma":[0.9984647,0.00028685507,0.00040012004,0.00038394218,0.00002887471,0.000011564692,0.00034568558,0.000004215865,0.00007408751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99381727,0.0031067242,0.0012064782,0.00092131185,0.00070520554,0.00024299217],"domain_scores_gemma":[0.97744,0.008415843,0.008505558,0.0012100214,0.002872158,0.001556326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005211632,0.00017930199,0.0005095561,0.0009866204,0.00038892293,0.0018909303,0.00049599435,0.0015416772,0.0011326234],"category_scores_gemma":[0.03692109,0.00021873976,0.0003776676,0.0016814923,0.0005194296,0.00126369,0.0008636724,0.00066559255,0.0002326083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006487343,0.00012606758,0.9877171,0.000057845235,0.00012981547,0.000120785844,0.0004632169,0.00015032371,0.00014300593,0.00010634123,0.0009184649,0.009418338],"study_design_scores_gemma":[0.00010383896,0.00023591965,0.99523646,0.00008242823,0.000095350886,0.00048638904,0.0013710796,0.0011147845,0.00012553087,0.00021282893,0.00091595924,0.000019622816],"about_ca_topic_score_codex":0.008213527,"about_ca_topic_score_gemma":0.008972348,"teacher_disagreement_score":0.008213527,"about_ca_system_score_codex":0.0007705659,"about_ca_system_score_gemma":0.00095157005,"threshold_uncertainty_score":0.027562082},"labels":[],"label_agreement":null},{"id":"W2427236216","doi":"10.1016/j.jval.2015.09.1754","title":"A Comparison of on-Patent Medicine Prices Using An Eks Method","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Order (exchange); Agricultural economics; Economics; Business; Econometrics; Geography; Finance","score_opus":0.7406702591304246,"score_gpt":0.42841221753622977,"score_spread":0.31225804159419485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427236216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80635023,0.0014667846,0.13580601,0.0004631276,0.00044787698,0.00024494698,0.0029405677,0.00053128996,0.051749203],"genre_scores_gemma":[0.9338553,0.0003142045,0.05957532,0.00004116244,0.00007171542,0.000053806645,0.0010761771,0.000083881,0.004928569],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976037,0.0010057228,0.00017503946,0.00021205119,0.0008987324,0.00010476074],"domain_scores_gemma":[0.9864407,0.010071864,0.0006838405,0.00097513554,0.0017136283,0.000114807415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030990634,0.00037477634,0.00065544643,0.002588484,0.00023502397,0.0017248498,0.0007810486,0.00077247963,0.0068473862],"category_scores_gemma":[0.018486537,0.0001836861,0.00075223553,0.0022613108,0.0003500426,0.0018067282,0.0005634269,0.00051868794,0.00072861643],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006797488,0.0012112639,0.092511214,0.0011980786,0.0008835603,0.00041371252,0.00058175804,0.10690195,0.01384566,0.08120282,0.0065978277,0.68785477],"study_design_scores_gemma":[0.0004413897,0.0012145803,0.2021219,0.00016112378,0.00036701362,0.0006020311,0.0007301231,0.741066,0.01807369,0.020787532,0.014184937,0.00024973266],"about_ca_topic_score_codex":0.004295544,"about_ca_topic_score_gemma":0.0033955695,"teacher_disagreement_score":0.0068473862,"about_ca_system_score_codex":0.0010162406,"about_ca_system_score_gemma":0.0007026879,"threshold_uncertainty_score":0.02290678},"labels":[],"label_agreement":null},{"id":"W2428310826","doi":"10.1016/j.jval.2015.09.1178","title":"Cost-Effectiveness Of Directly Mailed Fobt Kits To Previous Responders Being Recalled For Screening","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Psychological intervention; Family medicine; Cost–benefit analysis; Fecal occult blood; Cost effectiveness; Recall; Colorectal cancer; Internal medicine; Nursing; Cancer; Colonoscopy; Psychology","score_opus":0.16424523434306845,"score_gpt":0.3948749453357835,"score_spread":0.23062971099271504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2428310826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99601257,0.0017172907,0.00012447745,0.0005171116,0.000109445966,0.00008532354,0.000278902,0.000015494297,0.0011394172],"genre_scores_gemma":[0.99844486,0.0003513332,0.00020382764,0.00014013746,0.000046426765,0.00004049553,0.00015331525,0.0000023542336,0.0006172135],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9984112,0.0009837043,0.00011273617,0.00014941113,0.00013779398,0.00020513295],"domain_scores_gemma":[0.9928127,0.005116062,0.0008650963,0.00024823236,0.00022128243,0.00073664216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018658165,0.0005386596,0.00085566053,0.0007478024,0.0003523066,0.0008074062,0.0007434329,0.0020828212,0.008347399],"category_scores_gemma":[0.014294841,0.00042059066,0.0031502543,0.00046805383,0.00040989692,0.0008302151,0.00059084216,0.001190825,0.0005082263],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38001245,0.025846021,0.30424798,0.0018188041,0.00402901,0.00073206256,0.00076541357,0.015350257,0.0020202158,0.00091063825,0.0030807348,0.26118636],"study_design_scores_gemma":[0.029343104,0.20173785,0.7241323,0.00086279184,0.009570504,0.0012243072,0.0017962306,0.026329026,0.0021800185,0.0010431755,0.0016138046,0.00016693387],"about_ca_topic_score_codex":0.008608313,"about_ca_topic_score_gemma":0.0073627583,"teacher_disagreement_score":0.008608313,"about_ca_system_score_codex":0.0015891213,"about_ca_system_score_gemma":0.000984353,"threshold_uncertainty_score":0.027924836},"labels":[],"label_agreement":null},{"id":"W2430187105","doi":"10.1016/j.jval.2015.09.2768","title":"The Need to Revise Discount Rates in Belgium, The Netherlands, Poland and the Uk","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Discounting; Context (archaeology); Differential (mechanical device); Psychological intervention; Economics; Cost–benefit analysis; Public economics; Actuarial science; Work (physics); Medicine; Finance; Political science; Engineering; Geography","score_opus":0.3726395742421835,"score_gpt":0.4296086876783587,"score_spread":0.05696911343617517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430187105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6056228,0.08234823,0.017079279,0.24622722,0.0028004658,0.000103831655,0.0028992726,0.00011521451,0.04280361],"genre_scores_gemma":[0.98051125,0.009040381,0.004373294,0.0030109768,0.00033988262,0.000046948895,0.0005204392,0.00011137082,0.0020453504],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9900614,0.005784495,0.0015140881,0.0004355289,0.001287469,0.0009170705],"domain_scores_gemma":[0.9381091,0.043785196,0.005156827,0.0015129298,0.008697528,0.0027383135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030971114,0.0002538936,0.0011375345,0.0022611583,0.00058898533,0.0066307117,0.0011427129,0.0020302508,0.0020752205],"category_scores_gemma":[0.12241055,0.0004943082,0.00063700456,0.0037406853,0.0013975039,0.006045212,0.0017015687,0.0038099778,0.00009626622],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002737265,0.00019644985,0.09371778,0.0015741653,0.0006437866,0.0017113594,0.0089785075,0.067987636,0.0005259091,0.40170786,0.06835756,0.3518618],"study_design_scores_gemma":[0.0010091598,0.0003489869,0.2717677,0.010337103,0.00073476916,0.0022895338,0.027033847,0.07952621,0.0023169718,0.31955695,0.2843364,0.0007424487],"about_ca_topic_score_codex":0.22783981,"about_ca_topic_score_gemma":0.18164745,"teacher_disagreement_score":0.22783981,"about_ca_system_score_codex":0.0109116845,"about_ca_system_score_gemma":0.0069653983,"threshold_uncertainty_score":0.4530273},"labels":[],"label_agreement":null},{"id":"W2433516676","doi":"10.1016/j.jval.2015.09.1407","title":"Examining Health System And Resource Utilization And Medical Management Of Patients Idiopathic Pulmonary Fibrosis In Ontario: A Preliminary Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Boehringer Ingelheim (Canada); St. Michael's Hospital; Sunnybrook Hospital","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Cohort; Medical record; Health care; Retrospective cohort study; Emergency medicine; Internal medicine; Lung","score_opus":0.05449425924446007,"score_gpt":0.2874797715381301,"score_spread":0.23298551229367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433516676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946032,0.00025646342,0.000118285505,0.0003162877,0.000004702957,0.00011366742,0.0027843423,0.0000037952857,0.0017991832],"genre_scores_gemma":[0.9971396,0.00023813677,0.0002674052,0.00007602378,0.0000053593953,0.00006445326,0.00144906,0.000003222832,0.0007567776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978461,0.0004030768,0.00016102995,0.0001617873,0.00077835814,0.0006496703],"domain_scores_gemma":[0.9933615,0.0010054901,0.0017884743,0.00025237683,0.0024102863,0.001181841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016153413,0.00038332815,0.0005014954,0.001722073,0.0028661308,0.0014096058,0.0014743262,0.00050033466,0.0022356235],"category_scores_gemma":[0.00752748,0.0005034613,0.0015091577,0.00720508,0.000829747,0.00083883305,0.0017949458,0.0007407354,0.00016814728],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005723245,0.000034592482,0.99711007,0.00002568776,0.00005604348,0.000043755103,0.0009779541,0.000093674,0.000054207994,0.000076812525,0.00029644143,0.0011735674],"study_design_scores_gemma":[0.000007766103,0.000025534355,0.9977228,0.000012617575,0.000035306428,0.00001259979,0.0015832203,0.00022007844,0.000015350775,0.000018986328,0.00034118077,0.0000044972744],"about_ca_topic_score_codex":0.98985624,"about_ca_topic_score_gemma":0.99605644,"teacher_disagreement_score":0.037852433,"about_ca_system_score_codex":0.037852433,"about_ca_system_score_gemma":0.04668392,"threshold_uncertainty_score":0.2746399},"labels":[],"label_agreement":null},{"id":"W2435474959","doi":"10.1016/j.jval.2015.09.1447","title":"Cost And Resource Utilization Of Uncontrolled And Persistent Asthma In Canada: A Systematic Literature Review","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Asthma; Emergency department; MEDLINE; Emergency medicine; Intensive care medicine; Internal medicine","score_opus":0.6047163424795157,"score_gpt":0.49706156253122596,"score_spread":0.1076547799482897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435474959","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029916631,0.9570803,0.00012304432,0.0016037289,0.00014318833,0.00029695182,0.009591791,0.000014034738,0.0012302761],"genre_scores_gemma":[0.26036638,0.7321645,0.0012440201,0.0017799266,0.000110085646,0.0004033754,0.003646927,0.00001593922,0.0002687742],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9871695,0.0018278786,0.0044071944,0.0009268934,0.0048471624,0.00082144985],"domain_scores_gemma":[0.958033,0.016661633,0.01273545,0.0006380101,0.010531921,0.0013999206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007215709,0.0010247846,0.0051720794,0.018158685,0.0018650795,0.004637686,0.0023189797,0.001961724,0.0022268826],"category_scores_gemma":[0.061948646,0.0011469022,0.008302576,0.03934822,0.0014701715,0.001799518,0.0019967782,0.001657965,0.00010486027],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000873077,0.00019074992,0.31169605,0.51796234,0.053332172,0.00085863017,0.0017345517,0.0011692531,0.00014792228,0.001188543,0.016316287,0.09453038],"study_design_scores_gemma":[0.00064114627,0.0002267127,0.52160764,0.33877552,0.10420324,0.0014034405,0.0035627072,0.0010109963,0.00017327676,0.0007320148,0.02739614,0.00026714022],"about_ca_topic_score_codex":0.91635865,"about_ca_topic_score_gemma":0.9600932,"teacher_disagreement_score":0.08364135,"about_ca_system_score_codex":0.04956271,"about_ca_system_score_gemma":0.1386921,"threshold_uncertainty_score":0.3596043},"labels":[],"label_agreement":null},{"id":"W2436634292","doi":"10.1016/j.jval.2015.09.1707","title":"Association Between Depression And Discontinuation With Antidiabetic Drugs","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Discontinuation; Depression (economics); Medicine; Hazard ratio; Proportional hazards model; Cohort; Internal medicine; Confidence interval; Cohort study; Psychiatry","score_opus":0.06558384507194429,"score_gpt":0.332178813416621,"score_spread":0.26659496834467666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436634292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946508,0.0023573653,0.0001260391,0.00050645944,0.00005989727,0.00001602548,0.00054628024,0.000007877392,0.0017293274],"genre_scores_gemma":[0.99874854,0.00035326774,0.000100186204,0.00010403797,0.000055481727,0.000006279327,0.00018754251,0.000002277725,0.00044225436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844813,0.0005851244,0.0003066808,0.0001830035,0.00026372212,0.00021324796],"domain_scores_gemma":[0.9853558,0.005749979,0.006066552,0.00080686994,0.00075140875,0.001269343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015924695,0.00023405637,0.0005564635,0.0006715239,0.000546113,0.0008779997,0.00045788364,0.0010295567,0.0037358266],"category_scores_gemma":[0.011319916,0.00037311245,0.0019624683,0.001339489,0.00023712039,0.0005029399,0.00045644576,0.0026231871,0.00021235661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044373432,0.00012379531,0.99677086,0.000021269683,0.0003982731,0.000052345997,0.000028704639,0.00002582867,0.000071667724,0.00002156916,0.00008125301,0.0019607337],"study_design_scores_gemma":[0.000018540706,0.000098437355,0.9991767,0.000012349148,0.00016548697,0.00012277944,0.000038970116,0.00019059682,0.000019856949,0.000028869685,0.0001235191,0.000003860868],"about_ca_topic_score_codex":0.009468364,"about_ca_topic_score_gemma":0.013281785,"teacher_disagreement_score":0.009468364,"about_ca_system_score_codex":0.00051036687,"about_ca_system_score_gemma":0.00071864354,"threshold_uncertainty_score":0.018826544},"labels":[],"label_agreement":null},{"id":"W2440529192","doi":"10.1016/j.jval.2015.09.2825","title":"Review of Adherence Measures for use in Phase Iv Studies and Recommendations for a new Standardized Generic Measure","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Standardization; Reliability (semiconductor); Medicine; Content validity; Quarter (Canadian coin); Consistency (knowledge bases); Measure (data warehouse); Pharmacy; Evidence-based practice; Clinical psychology; Family medicine; Psychology; Psychometrics; Alternative medicine; Computer science; Data mining; Artificial intelligence; Pathology","score_opus":0.5534317867476899,"score_gpt":0.49880683336420484,"score_spread":0.05462495338348505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440529192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015522846,0.94920224,0.013435466,0.020222548,0.005167721,0.0050201844,0.0017714236,0.00029886817,0.0033292254],"genre_scores_gemma":[0.030206861,0.7860472,0.13353671,0.018582318,0.0026711815,0.022761974,0.004452222,0.000430822,0.0013107558],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.7984578,0.08407432,0.07610387,0.0045750714,0.035389658,0.0013993175],"domain_scores_gemma":[0.5573989,0.24392292,0.08613071,0.015835006,0.093641736,0.0030707952],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19644763,0.0017290999,0.00835568,0.016599054,0.0015017063,0.00816747,0.0051981686,0.0037150083,0.0047126],"category_scores_gemma":[0.426275,0.0018754757,0.012815536,0.0118353795,0.002417533,0.0062950356,0.0046640467,0.0069340337,0.0011801015],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057502586,0.00015965365,0.003177988,0.25074902,0.0042915787,0.000084796346,0.00072707934,0.00042130178,0.0004882658,0.0061071655,0.043143246,0.6900749],"study_design_scores_gemma":[0.0010508177,0.0011538091,0.012187188,0.67845935,0.011210758,0.00031179894,0.0007044099,0.00088292407,0.0011665557,0.00492479,0.28776327,0.00018429878],"about_ca_topic_score_codex":0.005937027,"about_ca_topic_score_gemma":0.007057824,"teacher_disagreement_score":0.8035524,"about_ca_system_score_codex":0.008762675,"about_ca_system_score_gemma":0.026207294,"threshold_uncertainty_score":0.9909231},"labels":[],"label_agreement":null},{"id":"W2442713704","doi":"10.1016/j.jval.2015.09.576","title":"Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients– Findings From The First International Burden of Illness Study (Assure-Csu)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology; Novartis (Canada)","funders":"","keywords":"Medicine; Medical record; Observational study; Health care; Retrospective cohort study; Emergency department; Family medicine; Disease burden; Cross-sectional study; Emergency medicine; Pediatrics; Disease; Internal medicine","score_opus":0.030402362027914055,"score_gpt":0.2819513700659319,"score_spread":0.25154900803801783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442713704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968123,0.00038504653,0.000021933067,0.00012245808,0.0000068848017,0.000009023133,0.0022313376,0.0000014812664,0.0004096552],"genre_scores_gemma":[0.99799335,0.00018159463,0.000030866802,0.00004385773,0.000009654969,0.000010709573,0.0016595011,0.0000012159999,0.0000693818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931026,0.00020675147,0.00015291083,0.00008187194,0.0001148583,0.00013335187],"domain_scores_gemma":[0.99865973,0.00017849187,0.00075003185,0.000059945494,0.00013823214,0.00021362923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008152385,0.00026226282,0.00041320897,0.0009958863,0.00032156587,0.00080463965,0.00043341023,0.000562135,0.0010302338],"category_scores_gemma":[0.0024672025,0.00025206918,0.0011223605,0.0023611102,0.0001997299,0.00077004806,0.00090191886,0.00067598396,0.00015834258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007417267,0.000032740954,0.99875486,0.000020466738,0.000088918205,0.000025176607,0.000095637246,0.00003549854,0.000039838844,0.000016370735,0.00019590132,0.00062059495],"study_design_scores_gemma":[0.000002279126,0.000017675233,0.9996395,0.0000060787766,0.000013611004,0.00003542399,0.00016351276,0.000049364782,0.0000053779427,0.0000071338222,0.000058522815,0.0000016021959],"about_ca_topic_score_codex":0.0213065,"about_ca_topic_score_gemma":0.027775362,"teacher_disagreement_score":0.0213065,"about_ca_system_score_codex":0.000628536,"about_ca_system_score_gemma":0.00048317248,"threshold_uncertainty_score":0.042365015},"labels":[],"label_agreement":null},{"id":"W2460051124","doi":"10.1016/j.jval.2015.09.2518","title":"How To Conduct Economic Evaluations Of New Treatments For Advanced Cancer When Overall Survival Data Are Not Available? Results From A Systematic Literature Review","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Surrogate endpoint; Medicine; Context (archaeology); Economic evaluation; Clinical trial; Population; Clinical endpoint; Cancer; Oncology; Cost effectiveness; Intensive care medicine; Lung cancer; Breast cancer; Internal medicine; Pathology; Environmental health; Risk analysis (engineering)","score_opus":0.7193642556993184,"score_gpt":0.49688215071113534,"score_spread":0.22248210498818305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460051124","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025746603,0.9851215,0.0023228286,0.005950514,0.00044077335,0.0009824821,0.0013875323,0.000018241064,0.0012015149],"genre_scores_gemma":[0.08475467,0.88919353,0.01553677,0.0055511,0.0005455254,0.0029261394,0.0012515676,0.00004337854,0.0001974173],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.88879657,0.0691271,0.029220516,0.002254287,0.009509512,0.0010920374],"domain_scores_gemma":[0.53813905,0.3985738,0.0361585,0.004266119,0.021451041,0.0014115964],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1237421,0.0021923785,0.011847955,0.013010213,0.00060967647,0.0068814536,0.0023271912,0.0036728615,0.0045676613],"category_scores_gemma":[0.42186472,0.0019015579,0.013198597,0.010805653,0.0018167322,0.007416506,0.0026764148,0.0031475124,0.0005333567],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013029185,0.000080241975,0.0036129472,0.733863,0.06788629,0.00013827649,0.00048608592,0.0013647453,0.00017556705,0.0031049505,0.0064650895,0.18151987],"study_design_scores_gemma":[0.0022097551,0.00038916696,0.0062572393,0.808817,0.13755785,0.00024113098,0.00075676176,0.0010449837,0.0003242472,0.009381461,0.032890767,0.00012954212],"about_ca_topic_score_codex":0.010239634,"about_ca_topic_score_gemma":0.029075332,"teacher_disagreement_score":0.8762579,"about_ca_system_score_codex":0.0075898375,"about_ca_system_score_gemma":0.019848473,"threshold_uncertainty_score":0.6544186},"labels":[],"label_agreement":null},{"id":"W2461634528","doi":"10.1016/j.jval.2015.09.2568","title":"Generating Costing Algorithms For Oncology Drugs Using Administrative Databases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute for Clinical Evaluative Sciences; Ontario Institute for Cancer Research; Sunnybrook Hospital","funders":"","keywords":"Activity-based costing; Formulary; Medicine; Database; Pharmacoeconomics; Drug; Nausea; Reimbursement; Cancer; Cost driver; Oncology; Internal medicine; Intensive care medicine; Family medicine; Pharmacology; Health care; Computer science; Business; Accounting","score_opus":0.6210175027478848,"score_gpt":0.5296016784073136,"score_spread":0.09141582434057116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461634528","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3984981,0.0013187337,0.5694779,0.002705693,0.00022460434,0.0016955524,0.014566555,0.0068255365,0.004687391],"genre_scores_gemma":[0.5600443,0.00040394271,0.42743793,0.0002227295,0.00009867118,0.0006049063,0.010275891,0.0001640437,0.00074762944],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977822,0.0008545399,0.0003392376,0.0004617249,0.00041760938,0.00014478278],"domain_scores_gemma":[0.97272563,0.022577778,0.0013908854,0.0011981649,0.0018253463,0.0002822195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035161632,0.00096611807,0.001292373,0.0036706794,0.0006754835,0.0025039478,0.0012868035,0.0013894778,0.002975856],"category_scores_gemma":[0.03267027,0.0008057952,0.0016339001,0.0033822174,0.00027930437,0.0016572343,0.00081031787,0.0012415112,0.00049340626],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085801544,0.0008639957,0.06194326,0.00033929842,0.0004192167,0.0003589769,0.00013848644,0.61206764,0.001086675,0.009718951,0.013036447,0.29916906],"study_design_scores_gemma":[0.0001102762,0.0000641703,0.00324026,0.000029662668,0.00007748644,0.00011018106,0.000058085487,0.9851377,0.00084364146,0.008978419,0.0013351843,0.000014910134],"about_ca_topic_score_codex":0.014169868,"about_ca_topic_score_gemma":0.0126982285,"teacher_disagreement_score":0.014169868,"about_ca_system_score_codex":0.0019108506,"about_ca_system_score_gemma":0.00393011,"threshold_uncertainty_score":0.028174818},"labels":[],"label_agreement":null},{"id":"W2462041422","doi":"10.1016/j.jval.2015.09.2521","title":"How Good Are Physicians And Chart Reviews At Capturing Health Resources And Drug Utilisation By Patients? Results Of The Pgrx-3 Prospective Real World Dataset Validation Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Family medicine; Pharmacy; Depression (economics); Medical record; Alternative medicine; Informed consent; Internal medicine","score_opus":0.12260972437845959,"score_gpt":0.31762735581036905,"score_spread":0.19501763143190948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462041422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8986331,0.0018526035,0.0063027847,0.00530815,0.00028113456,0.00041099745,0.0819733,0.000338783,0.0048991577],"genre_scores_gemma":[0.8815764,0.000400586,0.0057518706,0.0011891891,0.00013683854,0.00025221563,0.1088928,0.00014785069,0.001652288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96669436,0.024783175,0.001482268,0.003228971,0.0029031583,0.0009080242],"domain_scores_gemma":[0.8712795,0.07879664,0.015987182,0.019220695,0.012440988,0.002275031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046855528,0.0010151288,0.0009948997,0.0017546304,0.00085031975,0.0034841376,0.0027122367,0.0033038713,0.0019322904],"category_scores_gemma":[0.12976906,0.0007550951,0.002129533,0.0022771985,0.0013660177,0.0039897533,0.0024967515,0.0020819264,0.0015688676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027907752,0.00077438075,0.9353849,0.0002713948,0.0021078708,0.00007084139,0.0007213071,0.0060807066,0.00027690097,0.00074888964,0.032439146,0.018332765],"study_design_scores_gemma":[0.0010948261,0.0005376072,0.94687855,0.0004104498,0.0009665097,0.00024337323,0.0015573148,0.026365705,0.0010773026,0.0019153528,0.01881823,0.00013477956],"about_ca_topic_score_codex":0.04178191,"about_ca_topic_score_gemma":0.040601537,"teacher_disagreement_score":0.046855528,"about_ca_system_score_codex":0.0014021838,"about_ca_system_score_gemma":0.0027228387,"threshold_uncertainty_score":0.24779868},"labels":[],"label_agreement":null},{"id":"W2462481570","doi":"10.1016/j.jval.2015.09.700","title":"Examining The Economic Impact of Laboratory Developed Testing In Flow Cytometry Immunophenotyping for Hematologic Malignancies: An Analysis of Health Resource Utilization","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Becton Dickinson (Canada)","funders":"","keywords":"Immunophenotyping; Flow cytometry; Medicine; Immunology","score_opus":0.1469315015132018,"score_gpt":0.3584205553972972,"score_spread":0.21148905388409542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462481570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300694,0.0004991607,0.0009017817,0.0010545778,0.000013949915,0.000058864793,0.001538522,0.00000565751,0.0029204467],"genre_scores_gemma":[0.998885,0.00012950107,0.00032349702,0.000056441673,0.000008639324,0.00001621572,0.0003401263,0.0000027596193,0.00023785097],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956059,0.0026097335,0.00017881278,0.00018589084,0.0006509418,0.0007685968],"domain_scores_gemma":[0.98135144,0.012189504,0.0036073402,0.00043917444,0.0013980927,0.0010144286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004360796,0.00038016262,0.00035838896,0.0019192604,0.0003070248,0.0015912872,0.00079870486,0.0005939218,0.002741016],"category_scores_gemma":[0.021797713,0.00022838994,0.0012217282,0.0032105048,0.00068207015,0.0012655557,0.001351664,0.00085401797,0.00019322864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020704889,0.0005831011,0.934679,0.00010398972,0.0005706718,0.00031844422,0.00020620522,0.023059018,0.0007882349,0.0045205615,0.0011030609,0.031997275],"study_design_scores_gemma":[0.00006455026,0.0009907462,0.95098454,0.00008043299,0.00035834947,0.0002766188,0.002432931,0.03896469,0.0008817545,0.002247505,0.0026803263,0.0000375621],"about_ca_topic_score_codex":0.017495304,"about_ca_topic_score_gemma":0.015330111,"teacher_disagreement_score":0.017495304,"about_ca_system_score_codex":0.0038042865,"about_ca_system_score_gemma":0.0024093438,"threshold_uncertainty_score":0.03478694},"labels":[],"label_agreement":null},{"id":"W2462932418","doi":"10.1016/j.jval.2015.09.2730","title":"Alternatives To Winbugs for Network Meta–Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Computer science; Markov chain Monte Carlo; Software; Bayesian probability; Set (abstract data type); Bayesian network; Inference; Data mining; Machine learning; Artificial intelligence; Programming language","score_opus":0.9529848658246516,"score_gpt":0.6296324465257082,"score_spread":0.3233524192989434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462932418","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039130202,0.008147527,0.9678074,0.009182405,0.003206585,0.00223534,0.0014668613,0.0014699821,0.0025709732],"genre_scores_gemma":[0.10139066,0.002923007,0.8739076,0.005214768,0.0018400227,0.010629186,0.0006822664,0.0014503775,0.0019621416],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.56664795,0.4058339,0.010081529,0.007773685,0.008647536,0.0010154254],"domain_scores_gemma":[0.3620467,0.60364765,0.0066542285,0.02219407,0.004239993,0.0012172689],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.26942804,0.0057888026,0.015650406,0.0076789665,0.0019494996,0.008384635,0.0073196767,0.0077235056,0.02822572],"category_scores_gemma":[0.5763659,0.0034304908,0.013319319,0.009752259,0.0060848575,0.0139983725,0.0091972,0.015046579,0.002477364],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020413203,0.000407964,0.0019950091,0.015468944,0.041033797,0.0005435762,0.0017022054,0.046387475,0.00034589888,0.5177973,0.045083232,0.30882153],"study_design_scores_gemma":[0.003935143,0.0004600662,0.00029746143,0.0017124737,0.0050765784,0.0001078508,0.0001373477,0.06667097,0.00028857111,0.90642285,0.01473424,0.00015642054],"about_ca_topic_score_codex":0.004077005,"about_ca_topic_score_gemma":0.0043574017,"teacher_disagreement_score":0.730572,"about_ca_system_score_codex":0.002991432,"about_ca_system_score_gemma":0.0058348356,"threshold_uncertainty_score":0.9009253},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2463859463","doi":"10.1016/j.jval.2015.09.1784","title":"Ethical Requirements for the Conduct of Drug Utilisation Studies Involving AD Hoc Data Collection: An International Cross-Sectional Survey","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Data collection; Legislation; Medicine; Pharmacy; Family medicine; Informed consent; Data extraction; MEDLINE; Alternative medicine; Political science; Pathology; Law","score_opus":0.8808164289114158,"score_gpt":0.6266667740970572,"score_spread":0.2541496548143586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463859463","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1085034,0.0034785229,0.24258095,0.026251007,0.0067566014,0.5360065,0.008393387,0.000682413,0.067347206],"genre_scores_gemma":[0.24606991,0.0015786153,0.29745308,0.013017182,0.0014519957,0.4288023,0.0024248639,0.00017996109,0.009022197],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.66694224,0.22160915,0.06410287,0.008756896,0.030151982,0.008436838],"domain_scores_gemma":[0.40411103,0.3520852,0.02762399,0.09994541,0.10273978,0.013494648],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3336191,0.0018013032,0.003355499,0.0038564843,0.0048255203,0.008145936,0.004732799,0.012376525,0.008095924],"category_scores_gemma":[0.43533096,0.0034327165,0.0028951587,0.004448819,0.0082977805,0.0027322243,0.0033882451,0.010311496,0.004026291],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018923355,0.010732917,0.06260534,0.013824038,0.0012485263,0.009551522,0.1057674,0.0070271594,0.02190217,0.3716098,0.15964578,0.21716204],"study_design_scores_gemma":[0.010929828,0.009980995,0.110682525,0.03851066,0.0011556892,0.012014236,0.0418376,0.03731142,0.020678533,0.071409315,0.64450455,0.0009847863],"about_ca_topic_score_codex":0.004018169,"about_ca_topic_score_gemma":0.0057397517,"teacher_disagreement_score":0.98762345,"about_ca_system_score_codex":0.0036072258,"about_ca_system_score_gemma":0.030879851,"threshold_uncertainty_score":0.8217663},"labels":[],"label_agreement":null},{"id":"W2464779517","doi":"10.1016/j.jval.2015.09.2366","title":"Adherence and Persistence to Allopurinol among Hypertensive Patients with Gout","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Persistence (discontinuity); Cohort; Allopurinol; Internal medicine; Gout; Logistic regression; Proportional hazards model; Febuxostat; Aspirin; Uric acid; Hyperuricemia","score_opus":0.1316137125790434,"score_gpt":0.3285266063118007,"score_spread":0.1969128937327573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464779517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874145,0.0004017706,0.000030928673,0.00014776693,0.000013443192,0.00000480883,0.000075194424,0.0000017701972,0.00058295217],"genre_scores_gemma":[0.9994765,0.00011442191,0.00003346798,0.00008250215,0.000022620703,0.0000027601714,0.00007457942,0.0000010551128,0.00019211433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990651,0.0002625807,0.0001571204,0.00011159307,0.00019154543,0.00021217985],"domain_scores_gemma":[0.9957793,0.0011039529,0.0017466479,0.0002241516,0.00029832474,0.00084770226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008125752,0.00020412293,0.000570434,0.0008882365,0.0010552121,0.0013583999,0.00041338507,0.0010735921,0.0023479124],"category_scores_gemma":[0.0060674236,0.00035799117,0.00092725107,0.0013841498,0.00037238785,0.0010701035,0.0006453585,0.0021972458,0.00019567787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010951984,0.000153773,0.99790514,0.000008036507,0.00010083765,0.000051277784,0.00014598726,0.0000172084,0.000051152696,0.000016773769,0.00003690182,0.0014034699],"study_design_scores_gemma":[0.000009780521,0.00013725595,0.9988166,0.000012872005,0.00006361075,0.00014972019,0.0005023562,0.0001609778,0.000021942045,0.000041400795,0.00007762435,0.0000058500264],"about_ca_topic_score_codex":0.011976571,"about_ca_topic_score_gemma":0.015560811,"teacher_disagreement_score":0.011976571,"about_ca_system_score_codex":0.0005036132,"about_ca_system_score_gemma":0.00054715376,"threshold_uncertainty_score":0.023813725},"labels":[],"label_agreement":null},{"id":"W2467605331","doi":"10.1016/j.jval.2015.09.1435","title":"Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Quality Of Life In Asthma","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Eosinophil; Asthma; Quality of life (healthcare); Sputum; Correlation; Lung function; Pulmonary function testing; Internal medicine; Physical therapy; Lung; Pathology; Mathematics","score_opus":0.18632685399600232,"score_gpt":0.38028728565651776,"score_spread":0.19396043166051544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467605331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052492325,0.9928417,0.00014636447,0.00022623737,0.00016657439,0.00020941404,0.0008922511,0.000006950661,0.0002613704],"genre_scores_gemma":[0.122908264,0.873266,0.0009749405,0.0011200851,0.00022402576,0.0005424507,0.0007279054,0.000008581751,0.00022769085],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9917486,0.0032329261,0.0030899765,0.0007500817,0.0009458186,0.00023267702],"domain_scores_gemma":[0.96930546,0.023422033,0.00520999,0.0004914203,0.001249457,0.00032159695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007214985,0.0011701967,0.0100269895,0.004454736,0.0005027125,0.0019252782,0.0013627134,0.0014343938,0.0034620413],"category_scores_gemma":[0.037007578,0.000978592,0.012376922,0.0046795323,0.0008995159,0.0011449445,0.0013326787,0.001283973,0.00022755656],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007313017,0.000025668081,0.0058343704,0.8595277,0.11622988,0.00012189071,0.0001256669,0.00013702789,0.00016463465,0.00013444753,0.0010754274,0.015892018],"study_design_scores_gemma":[0.0015937809,0.00048747187,0.03377367,0.33353016,0.62087476,0.00042805434,0.00023058821,0.00013275993,0.00015663006,0.00038356674,0.008330011,0.00007851256],"about_ca_topic_score_codex":0.012568569,"about_ca_topic_score_gemma":0.03914465,"teacher_disagreement_score":0.012568569,"about_ca_system_score_codex":0.0021725076,"about_ca_system_score_gemma":0.0060049985,"threshold_uncertainty_score":0.038156927},"labels":[],"label_agreement":null},{"id":"W2470444713","doi":"10.1016/j.jval.2016.04.016","title":"Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates","keywords":"Association (psychology); Preference; Medicine; Obesity; Gerontology; Psychology; Internal medicine; Statistics; Mathematics; Psychotherapist","score_opus":0.07230966847754206,"score_gpt":0.3052448171826958,"score_spread":0.23293514870515375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470444713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99890673,0.0003238458,0.000053495307,0.00010069369,0.000007641579,0.0000033148604,0.00015900415,0.0000012057055,0.0004440569],"genre_scores_gemma":[0.9996178,0.000064267886,0.000043846623,0.00002894392,0.000007914147,0.0000014858662,0.0001410031,6.8541067e-7,0.00009412397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948955,0.00020391622,0.000073423704,0.00006337504,0.00008264513,0.00008709242],"domain_scores_gemma":[0.9969404,0.0008735392,0.0014560743,0.00013803074,0.00017113712,0.00042084654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010654483,0.00023072046,0.0003020528,0.0006277382,0.00025628094,0.00084761705,0.00027794033,0.0006498766,0.0021815216],"category_scores_gemma":[0.0055517177,0.00021627828,0.0010795164,0.00081166055,0.00029341227,0.000524948,0.00060396286,0.0011859394,0.000121851845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031076098,0.00009501592,0.99737996,0.00001636659,0.00028986362,0.000023963334,0.00006285484,0.00007642744,0.00006997362,0.00003739247,0.00006016917,0.0015772572],"study_design_scores_gemma":[0.0000122477,0.000115763054,0.9990552,0.0000069384473,0.00006012471,0.00005064075,0.00017428398,0.00036674418,0.000015520849,0.00007387021,0.000062458064,0.00000623948],"about_ca_topic_score_codex":0.0067565734,"about_ca_topic_score_gemma":0.010774332,"teacher_disagreement_score":0.0067565734,"about_ca_system_score_codex":0.00033836887,"about_ca_system_score_gemma":0.00021813075,"threshold_uncertainty_score":0.01343447},"labels":[],"label_agreement":null},{"id":"W2471462248","doi":"10.1016/j.jval.2015.09.906","title":"Quality Of Life Of Patients Experiencing Cancer-Associated Thrombosis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Quality of life (healthcare); Cancer; Internal medicine; Thrombosis; Prostate cancer; Venous thrombosis; Venous thromboembolism; Pulmonary embolism; Physical therapy","score_opus":0.1591948061942683,"score_gpt":0.3932760939144002,"score_spread":0.23408128772013193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471462248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966736,0.0008465812,0.00004451142,0.00037690616,0.000022919223,0.000009053286,0.00031815958,0.0000014745689,0.0017069146],"genre_scores_gemma":[0.9994351,0.00016323724,0.000023845621,0.00007236924,0.000011018235,0.0000024502192,0.00017109874,4.598446e-7,0.000120408935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994307,0.00022352359,0.00006522176,0.000040493556,0.00010221483,0.00013785157],"domain_scores_gemma":[0.9980294,0.0004240631,0.0008124974,0.000041489064,0.00021178187,0.00048077374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064027426,0.00016231458,0.00037269772,0.000566496,0.00040614486,0.0011049117,0.00021034929,0.00045129302,0.0024238254],"category_scores_gemma":[0.0056329994,0.000102726255,0.00065686373,0.0008007483,0.00024510946,0.00062357425,0.00056329294,0.00089686795,0.00014372055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020670913,0.00015657526,0.9919944,0.000026338475,0.00019777949,0.000087053806,0.00027321719,0.00010417248,0.00006570358,0.00007017059,0.00031378653,0.006504193],"study_design_scores_gemma":[0.000020801945,0.00039953526,0.9971271,0.000025815807,0.00008976808,0.0002730488,0.0009893696,0.00040525213,0.000034053443,0.00015052363,0.00047364068,0.000011032258],"about_ca_topic_score_codex":0.0037094003,"about_ca_topic_score_gemma":0.00475139,"teacher_disagreement_score":0.0037094003,"about_ca_system_score_codex":0.0005234628,"about_ca_system_score_gemma":0.00035253994,"threshold_uncertainty_score":0.008108497},"labels":[],"label_agreement":null},{"id":"W2474086326","doi":"10.1016/j.jval.2015.09.1777","title":"Methodological Gaps in the Assessment of the Utility and Burden of Risk Minimisation Interventions","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Risk analysis (engineering); Psychological intervention; Certification; Computer science; Medicine; Management science; Nursing; Engineering","score_opus":0.8483123480284182,"score_gpt":0.5652710809114766,"score_spread":0.28304126711694155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474086326","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017349456,0.67320424,0.12435998,0.1695669,0.0043469593,0.00064260286,0.0024463183,0.00010433742,0.007979255],"genre_scores_gemma":[0.53492606,0.28370142,0.11618374,0.046742313,0.011485286,0.0038025486,0.0022337087,0.0002664322,0.0006584808],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.61701566,0.26614198,0.06916273,0.01396292,0.031095814,0.002620881],"domain_scores_gemma":[0.105480224,0.8352776,0.022859883,0.015425381,0.019484406,0.0014725039],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.41887966,0.002056711,0.0087298015,0.010697269,0.0015096212,0.013419496,0.009886584,0.008403881,0.0071088234],"category_scores_gemma":[0.77098453,0.0023266897,0.005432529,0.010109776,0.01409463,0.0139869,0.010680332,0.010342819,0.0007993733],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019605965,0.00063177984,0.024216363,0.06018548,0.015923325,0.00013691033,0.0043978877,0.010365952,0.0002363571,0.26231048,0.014905904,0.604729],"study_design_scores_gemma":[0.00091344555,0.00055211125,0.01859498,0.11899271,0.0068048607,0.0006859334,0.0044035027,0.012561577,0.00052407885,0.7821361,0.053526204,0.0003044987],"about_ca_topic_score_codex":0.013707028,"about_ca_topic_score_gemma":0.011183977,"teacher_disagreement_score":0.5811204,"about_ca_system_score_codex":0.010301283,"about_ca_system_score_gemma":0.022781555,"threshold_uncertainty_score":0.71662486},"labels":[],"label_agreement":null},{"id":"W2474283084","doi":"10.1016/j.jval.2015.09.1914","title":"The Use of Single-Arm Evidence In The Comparative Efficacy of Interferon-Free Antivirals for Treatment-Naïve Hepatitis C Genotype 1","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ribavirin; Simeprevir; Sofosbuvir; Medicine; Boceprevir; Telaprevir; Interferon; Hepatitis C; Internal medicine; Clinical trial; Randomized controlled trial; Alpha interferon; Virology; Pharmacology; Gastroenterology; Hepatitis C virus; Virus","score_opus":0.6478963461135071,"score_gpt":0.46985399489420787,"score_spread":0.17804235121929923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474283084","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21826205,0.70187336,0.01730654,0.010833041,0.018857643,0.0048340242,0.0046299146,0.0003883577,0.023015063],"genre_scores_gemma":[0.93687207,0.04008492,0.008264973,0.0072391364,0.0031218387,0.0012406175,0.0014267353,0.00010017206,0.001649729],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.87036073,0.10190602,0.01588329,0.0039905664,0.0065900073,0.0012694917],"domain_scores_gemma":[0.7482233,0.21489836,0.016350457,0.0109974025,0.00681483,0.0027156256],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.108724214,0.00296087,0.011466981,0.003370985,0.0009126811,0.0059209317,0.0028229915,0.006259886,0.0075677847],"category_scores_gemma":[0.16772448,0.0014335035,0.024385696,0.0024717213,0.00326762,0.005907629,0.0025858704,0.007168444,0.0008362704],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48995262,0.00075519306,0.0060491166,0.05852535,0.3427163,0.00027140605,0.00048677408,0.0022485883,0.0020099406,0.004304128,0.0025498418,0.0901307],"study_design_scores_gemma":[0.4265944,0.056234073,0.025320452,0.031507373,0.39744428,0.000727963,0.0005970429,0.004974591,0.003594447,0.026619889,0.02599912,0.00038631508],"about_ca_topic_score_codex":0.0013284974,"about_ca_topic_score_gemma":0.0023432036,"teacher_disagreement_score":0.89127576,"about_ca_system_score_codex":0.0023629768,"about_ca_system_score_gemma":0.0021326686,"threshold_uncertainty_score":0.5749955},"labels":[],"label_agreement":null},{"id":"W2474456043","doi":"10.1016/j.jval.2015.09.801","title":"Association of Treatment with Carvedilol, Bisoprolol and Metoprolol on the Risk of Mortality and Hospital Admission Among Older Adults with Heart Failure","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université du Québec à Montréal; Montreal Heart Institute; Université de Sherbrooke; Université de Montréal","funders":"","keywords":"Bisoprolol; Metoprolol; Carvedilol; Metoprolol Tartrate; Medicine; Hazard ratio; Heart failure; Internal medicine; Proportional hazards model; Cardiology; Confidence interval; Propensity score matching","score_opus":0.02463452858014505,"score_gpt":0.277206121427177,"score_spread":0.25257159284703196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474456043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977149,0.0010736244,0.000036393347,0.00016855175,0.000021896805,0.000004983053,0.00014833447,0.000002534512,0.00082890654],"genre_scores_gemma":[0.99934584,0.00021981317,0.000028661892,0.00006556276,0.00004327078,0.0000034520472,0.00012064254,9.38187e-7,0.00017192021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994753,0.00018522714,0.00006475264,0.000063286265,0.000088689725,0.00012291314],"domain_scores_gemma":[0.9974922,0.0010867853,0.00069322187,0.00011472722,0.00017098806,0.00044209693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052865595,0.00021033586,0.00067025656,0.00031912327,0.0002869747,0.00069070404,0.00026145668,0.0008163985,0.0014861836],"category_scores_gemma":[0.0042674784,0.00019900942,0.00093388394,0.00049397635,0.00017861108,0.00042983697,0.00035245088,0.001352116,0.00010554344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032820203,0.00025915337,0.9921096,0.000031752057,0.00036801287,0.000088161134,0.000054546796,0.00009255965,0.00029217364,0.000036617734,0.00012034821,0.003264958],"study_design_scores_gemma":[0.000057533274,0.0004361076,0.9984652,0.0000124128965,0.00020375717,0.000092920476,0.00012260884,0.00039386435,0.00004455003,0.0000482897,0.00011627207,0.0000064396586],"about_ca_topic_score_codex":0.00372722,"about_ca_topic_score_gemma":0.004481425,"teacher_disagreement_score":0.00372722,"about_ca_system_score_codex":0.00032616887,"about_ca_system_score_gemma":0.00036119265,"threshold_uncertainty_score":0.0074110627},"labels":[],"label_agreement":null},{"id":"W2474811130","doi":"10.1016/j.jval.2015.09.1253","title":"The Finnish Versions Of The Lower-Limb Sections Of The Toronto Extremity Salvage Score And The Musculoskeletal Tumor Society Scale: A Pilot Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Knowledge translation; Physical therapy; Soft tissue sarcoma; Surgery; Soft tissue; Computer science","score_opus":0.053940665035936065,"score_gpt":0.31584261037075056,"score_spread":0.2619019453348145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474811130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961266,0.00028325088,0.00024922035,0.00008272618,0.0000553431,0.00023760846,0.0007654078,0.00000458556,0.0021953122],"genre_scores_gemma":[0.9926957,0.00044231123,0.0015922536,0.00011784616,0.00008046449,0.00069843215,0.0022230924,0.000015321264,0.0021346307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765956,0.0009677871,0.00024743765,0.00028351342,0.00059349707,0.0002481667],"domain_scores_gemma":[0.9953702,0.0023014434,0.00066669617,0.00024793987,0.0009870022,0.00042668753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004513264,0.0013032313,0.0009682762,0.0017623587,0.001574266,0.0013064258,0.0012118442,0.0010940905,0.0041003497],"category_scores_gemma":[0.013395005,0.0005990892,0.0016019944,0.0018610186,0.0011582451,0.001742836,0.0019112389,0.0011782893,0.00088231463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006087361,0.0025912344,0.9461243,0.00026048667,0.0006720734,0.00073265337,0.006723959,0.00059851597,0.0009862168,0.00049728923,0.0014504573,0.033275396],"study_design_scores_gemma":[0.0007001001,0.002671544,0.9886723,0.000080574486,0.0003128413,0.00060241326,0.004056769,0.00043081515,0.00035472255,0.0002818125,0.0017710666,0.00006494254],"about_ca_topic_score_codex":0.015830912,"about_ca_topic_score_gemma":0.015713941,"teacher_disagreement_score":0.015830912,"about_ca_system_score_codex":0.0012949778,"about_ca_system_score_gemma":0.0015166714,"threshold_uncertainty_score":0.03147751},"labels":[],"label_agreement":null},{"id":"W2527943338","doi":"10.1016/j.jval.2016.06.001","title":"Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Data collection; Observational study; Clinical trial; Health economics; Research design; Protocol (science); Management science; Outcomes research; Actuarial science; Task (project management); Computer science; Operations research; Risk analysis (engineering); Medicine; Public health; Economics; Statistics; Alternative medicine; Engineering; Nursing","score_opus":0.8850896686782405,"score_gpt":0.6448588139974663,"score_spread":0.2402308546807742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527943338","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029395144,0.031102363,0.8830426,0.030949801,0.00047029858,0.0045732455,0.008507814,0.000962761,0.010996015],"genre_scores_gemma":[0.20034237,0.021158144,0.75769424,0.0029098033,0.0007771824,0.0053765285,0.008521312,0.00069132313,0.0025291168],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8481831,0.12694645,0.007847149,0.0027255998,0.013344096,0.00095364905],"domain_scores_gemma":[0.41676816,0.5285842,0.014525858,0.017641168,0.02104581,0.0014347859],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25359973,0.0019980045,0.004065982,0.00829798,0.0010689497,0.00607019,0.0026005248,0.0032926353,0.0031460405],"category_scores_gemma":[0.49824274,0.002139639,0.0060473788,0.0069491505,0.0016640138,0.0034752637,0.00470345,0.0051309266,0.0009576839],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007059597,0.00058877264,0.07787196,0.0041305893,0.0071412707,0.0001682483,0.0010524237,0.08655132,0.0006927762,0.051754124,0.06440434,0.70493823],"study_design_scores_gemma":[0.0018856555,0.0011267798,0.085760325,0.015246859,0.008117729,0.00052428764,0.00087573205,0.44334197,0.0058193523,0.33951902,0.09721039,0.0005718957],"about_ca_topic_score_codex":0.02167849,"about_ca_topic_score_gemma":0.023799945,"teacher_disagreement_score":0.74640024,"about_ca_system_score_codex":0.003449025,"about_ca_system_score_gemma":0.012233984,"threshold_uncertainty_score":0.9204444},"labels":[],"label_agreement":null},{"id":"W2531737797","doi":"10.1016/j.jval.2016.08.003","title":"A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Prevention of Organ Failure; St. Paul's Hospital; Vancouver Coastal Health; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"COPD; Exacerbation; Medicine; Intensive care medicine; Comorbidity; Pulmonary disease; Systematic review; MEDLINE; Disease; Natural history; Physical therapy; Internal medicine","score_opus":0.08473290610881909,"score_gpt":0.38636510544835484,"score_spread":0.3016321993395358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531737797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009899085,0.9960218,0.0012356115,0.0003666983,0.00011482608,0.00020996561,0.00054097007,0.000017928583,0.0005023976],"genre_scores_gemma":[0.022301884,0.9739508,0.0025003045,0.00037216148,0.00008775957,0.0003207746,0.00030521778,0.000008811779,0.00015233863],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99230605,0.004456566,0.0017995768,0.00038781844,0.00093403563,0.000115901275],"domain_scores_gemma":[0.96185637,0.034031503,0.0023828028,0.00040501953,0.0011466763,0.00017771158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009504741,0.0021396433,0.0071349377,0.0049281893,0.00040339868,0.002498953,0.0025043897,0.001982017,0.007039386],"category_scores_gemma":[0.05387836,0.0009739548,0.010763563,0.005064636,0.00051255996,0.0019685922,0.0012453034,0.0018569848,0.0003959319],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054698694,0.000090244874,0.0014665201,0.8114202,0.035052504,0.0001427976,0.0001610396,0.007482045,0.000090337104,0.004068637,0.003919237,0.13555937],"study_design_scores_gemma":[0.0012113148,0.0005844183,0.004513036,0.7206635,0.18981071,0.0005547818,0.00024484194,0.005759971,0.00021223167,0.01031349,0.06599015,0.00014155809],"about_ca_topic_score_codex":0.014694455,"about_ca_topic_score_gemma":0.02673276,"teacher_disagreement_score":0.014694455,"about_ca_system_score_codex":0.0035883645,"about_ca_system_score_gemma":0.010097199,"threshold_uncertainty_score":0.050266445},"labels":[],"label_agreement":null},{"id":"W2539551211","doi":"10.1016/j.jval.2016.09.2181","title":"Real-World Treatment Patterns and Costs of Care Among Brentuximab Vendotin-Treated Patients with Hodgkin Lymphoma in The United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Discontinuation; Bendamustine; Pharmacy; Hodgkin lymphoma; Lymphoma; Rituximab; Family medicine","score_opus":0.018326210568359508,"score_gpt":0.2746963721163278,"score_spread":0.2563701615479683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539551211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978065,0.00043446064,0.000037548176,0.00039283372,0.0000062535364,0.0000040131717,0.0009691743,0.0000024458604,0.00034668166],"genre_scores_gemma":[0.9991716,0.00013357583,0.0000261905,0.00007740639,0.0000065243507,0.0000028545564,0.0005332976,0.0000011440719,0.00004735491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991941,0.00028632642,0.00015761242,0.00011429067,0.000097109696,0.00015065825],"domain_scores_gemma":[0.99702555,0.00061725464,0.0017097369,0.00008502283,0.00017194849,0.00039045693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044828292,0.0001548865,0.00028015327,0.00071410765,0.0002922634,0.0009334685,0.00038114053,0.00065637095,0.0013221721],"category_scores_gemma":[0.003493461,0.0002566203,0.0005007913,0.001813622,0.00035498146,0.00090845465,0.0005563951,0.00067930797,0.000115411116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013852205,0.00004234639,0.9977162,0.000008713449,0.00009354564,0.000060722126,0.000041950585,0.00045317155,0.000040030063,0.00006260731,0.00031018254,0.0010319779],"study_design_scores_gemma":[0.000015913783,0.00006465639,0.9970611,0.000014722982,0.000037945138,0.00020643156,0.0005190062,0.0016643986,0.00003615057,0.000095910174,0.0002750441,0.000008754681],"about_ca_topic_score_codex":0.026204593,"about_ca_topic_score_gemma":0.03556993,"teacher_disagreement_score":0.026204593,"about_ca_system_score_codex":0.0016143518,"about_ca_system_score_gemma":0.0005588676,"threshold_uncertainty_score":0.052104115},"labels":[],"label_agreement":null},{"id":"W2539783054","doi":"10.1016/j.jval.2016.09.1266","title":"Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Purchasing power parity; Medicine; Indirect costs; Health care; Purchasing power; Total cost; Environmental health; Demography; Emergency medicine; Medical emergency; Business; Exchange rate; Economic growth; Finance; Economics; Accounting","score_opus":0.03753408558041539,"score_gpt":0.3241156033441729,"score_spread":0.2865815177637575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539783054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99452645,0.0007335999,0.00005605035,0.000043177533,0.0000060122607,0.000013348569,0.0042416328,0.0000027646495,0.00037692275],"genre_scores_gemma":[0.9963916,0.00023763813,0.000060711878,0.000019765264,0.000005588905,0.0000146461225,0.0032024186,0.0000023128578,0.00006537573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979558,0.00090119394,0.00030744242,0.0002657223,0.0002456023,0.00032429403],"domain_scores_gemma":[0.9971226,0.00087997504,0.0012099617,0.00017220402,0.00037009522,0.00024508082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016417314,0.0006153795,0.000882136,0.0026036832,0.00034812832,0.0011080302,0.0007220674,0.0008029852,0.0011399183],"category_scores_gemma":[0.003488122,0.00040195513,0.0025212108,0.005271386,0.00048199645,0.0008043518,0.0013408675,0.000645116,0.0001522997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010598282,0.00007622711,0.9945011,0.00012870705,0.0011095904,0.0001498743,0.00014200942,0.0007237657,0.00008342834,0.00010192758,0.00035066577,0.0015728044],"study_design_scores_gemma":[0.00005620083,0.0001506967,0.9983765,0.000025387713,0.0002388885,0.0001494356,0.0004953209,0.0002425158,0.00004003822,0.000026985315,0.00019016232,0.000007824125],"about_ca_topic_score_codex":0.027305407,"about_ca_topic_score_gemma":0.021435104,"teacher_disagreement_score":0.027305407,"about_ca_system_score_codex":0.0011572273,"about_ca_system_score_gemma":0.0006573547,"threshold_uncertainty_score":0.054292917},"labels":[],"label_agreement":null},{"id":"W2539985417","doi":"10.1016/j.jval.2016.09.1549","title":"One-Year Patient-Reported Persistence To Antiresorptive Treatment In A Fracture Liaison Service: The Lucky Bone™ Program","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Discontinuation; Medicine; Osteoporosis; Regimen; Adverse effect; Persistence (discontinuity); Subgroup analysis; Internal medicine; Drug holiday; Pediatrics; Surgery; Family medicine","score_opus":0.08202172270453621,"score_gpt":0.367308252215629,"score_spread":0.2852865295110928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539985417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99808794,0.00012933064,0.00003983852,0.0003949355,0.000014998232,0.000067376575,0.0003118422,0.000010138164,0.000943491],"genre_scores_gemma":[0.9983895,0.00009686295,0.000110484325,0.00019239997,0.0000250519,0.0000455538,0.00046478413,0.000002131669,0.00067337346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938035,0.00015331173,0.000058460566,0.00007111825,0.00015181632,0.00018488958],"domain_scores_gemma":[0.9983145,0.00020068791,0.0005141708,0.000052669213,0.00025039187,0.0006675907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012700483,0.00024527076,0.00048101906,0.0008969461,0.0012930866,0.00078389136,0.0006828337,0.0007301769,0.001786364],"category_scores_gemma":[0.0036990845,0.00018781569,0.0005573175,0.0008329647,0.00038013377,0.0009726297,0.0010875076,0.0012116712,0.00029144617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001234512,0.0024653922,0.9638057,0.000046024743,0.00012161888,0.00012099371,0.0004293414,0.000092058566,0.00017736311,0.000032991393,0.00092430343,0.030549707],"study_design_scores_gemma":[0.000107436535,0.0020662565,0.99586934,0.00002005473,0.00011144592,0.00012579678,0.0007927497,0.00024638267,0.00010411726,0.000035933164,0.0005071225,0.000013205111],"about_ca_topic_score_codex":0.018504336,"about_ca_topic_score_gemma":0.040122595,"teacher_disagreement_score":0.018504336,"about_ca_system_score_codex":0.001017949,"about_ca_system_score_gemma":0.0015138887,"threshold_uncertainty_score":0.036793232},"labels":[],"label_agreement":null},{"id":"W2540051367","doi":"10.1016/j.jval.2016.09.1295","title":"Assessing Health-Utility Values for Chronic Spontaneous/Idiopathic Urticaria In Real-World Using The EQ-5D: Results From Assure-Csu Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Anxiety; EQ-5D; Observational study; Depression (economics); Quality of life (healthcare); Disease; Physical therapy; Internal medicine; Psychiatry; Health related quality of life","score_opus":0.1585019584030046,"score_gpt":0.38719095070230475,"score_spread":0.22868899229930015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540051367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953094,0.00037993974,0.00052773306,0.000051974635,0.000007976537,0.000050286406,0.0029470946,0.0000128759775,0.000712772],"genre_scores_gemma":[0.99722445,0.0000839912,0.00046826786,0.00002601906,0.000006775849,0.000040226194,0.0020675543,0.00000638734,0.00007635898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673885,0.002023842,0.00030030345,0.00023412607,0.0005598761,0.00014300556],"domain_scores_gemma":[0.99060625,0.0060459096,0.0013744006,0.0007334737,0.0009096665,0.00033028988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060652643,0.00044450472,0.00084281544,0.0010037659,0.0002746188,0.0009585447,0.00068962073,0.00063909363,0.001231092],"category_scores_gemma":[0.017566347,0.00016653427,0.0020908902,0.001656861,0.00041181254,0.0008166824,0.0010292067,0.00061266206,0.00030748383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070490297,0.0010608467,0.95684594,0.00026271673,0.0022131745,0.0001068241,0.0005973922,0.0020774184,0.0004256338,0.0004909534,0.001918996,0.026951062],"study_design_scores_gemma":[0.0003788597,0.0012898125,0.9919412,0.000035004694,0.00045799202,0.00018489055,0.0003331092,0.0039002511,0.00025520637,0.0002733167,0.00092098385,0.000029330977],"about_ca_topic_score_codex":0.0040128846,"about_ca_topic_score_gemma":0.0024570639,"teacher_disagreement_score":0.0060652643,"about_ca_system_score_codex":0.0005863402,"about_ca_system_score_gemma":0.00037499113,"threshold_uncertainty_score":0.032076538},"labels":[],"label_agreement":null},{"id":"W2540111953","doi":"10.1016/j.jval.2016.09.515","title":"The Burden of Parkinson's Disease(Pd) in Japan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Presenteeism; Medicine; Absenteeism; Quality of life (healthcare); Disease; Work productivity; Parkinson's disease; Gerontology; Health care; Disease burden; Population; Mental health; Quarter (Canadian coin); Productivity; Demography; Environmental health; Internal medicine; Psychology; Psychiatry","score_opus":0.031014052363993454,"score_gpt":0.2963841410564092,"score_spread":0.26537008869241574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540111953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890297,0.006086715,0.00008484235,0.0013521389,0.000050872724,0.000009928053,0.0014375261,0.0000041526237,0.0019441679],"genre_scores_gemma":[0.99610186,0.002875437,0.00009393488,0.0000862819,0.000051309158,0.0000046918685,0.00053976127,0.0000013827048,0.00024529456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995419,0.00009016286,0.00008666331,0.00007582865,0.00011367997,0.000091889895],"domain_scores_gemma":[0.99872214,0.000087952336,0.0005270094,0.000029995535,0.00026026956,0.00037259678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047650386,0.000250058,0.00036237238,0.0021494054,0.00057479,0.0010812588,0.00033764835,0.0004042542,0.0010348364],"category_scores_gemma":[0.0010313661,0.00027739286,0.00045875963,0.002561089,0.00051141996,0.000783497,0.0010480983,0.00047338344,0.000078522906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013300203,0.000038582006,0.9863949,0.00012898672,0.00017937005,0.00052881736,0.0007467867,0.00017173686,0.0005415959,0.00035627288,0.0012416629,0.009538408],"study_design_scores_gemma":[0.0000031119016,0.000021021138,0.9983633,0.000016762933,0.000039626793,0.0001470205,0.00052768545,0.00012055014,0.000015156966,0.000058990954,0.000681581,0.0000052235555],"about_ca_topic_score_codex":0.105429515,"about_ca_topic_score_gemma":0.14042293,"teacher_disagreement_score":0.105429515,"about_ca_system_score_codex":0.0026183808,"about_ca_system_score_gemma":0.0018105358,"threshold_uncertainty_score":0.20963174},"labels":[],"label_agreement":null},{"id":"W2540140777","doi":"10.1016/j.jval.2016.09.988","title":"The Risk of Falls and Fractures Among Those with Overactive Bladder: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overactive bladder; Odds ratio; Falls in older adults; CINAHL; Prospective cohort study; Odds; Poison control; Internal medicine; Injury prevention; Demography; Emergency medicine; Logistic regression; Psychological intervention","score_opus":0.03370604194456494,"score_gpt":0.3568974206333506,"score_spread":0.32319137868878567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540140777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015866605,0.9977717,0.000057673384,0.00010236681,0.00007490158,0.000052132982,0.0002379986,0.0000033116464,0.00011329892],"genre_scores_gemma":[0.029924072,0.96882933,0.00042268436,0.0003978189,0.0000962049,0.000088965826,0.0001529993,0.0000028923146,0.000084950334],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99727696,0.0006718951,0.0010697352,0.0003038729,0.0005528685,0.00012480152],"domain_scores_gemma":[0.9901816,0.006827149,0.0020063245,0.000126878,0.00071223406,0.00014577158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028133285,0.0011427973,0.0059679723,0.0047787493,0.00042030629,0.0016623219,0.0013532083,0.002254732,0.0037074236],"category_scores_gemma":[0.018668804,0.001180481,0.009282424,0.0061277715,0.0005676473,0.0015489189,0.0013187891,0.0017004067,0.00020480977],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068190764,0.000048620725,0.008103798,0.87332153,0.06392105,0.00020406685,0.000219991,0.0001437387,0.00011477032,0.0002010942,0.0021717884,0.050867606],"study_design_scores_gemma":[0.00091465283,0.0003963698,0.03448068,0.48176745,0.46334237,0.0009415206,0.0006477145,0.00022611259,0.00014404632,0.0006711818,0.016334334,0.00013370691],"about_ca_topic_score_codex":0.014392274,"about_ca_topic_score_gemma":0.043936756,"teacher_disagreement_score":0.014392274,"about_ca_system_score_codex":0.0014280009,"about_ca_system_score_gemma":0.004063361,"threshold_uncertainty_score":0.028617024},"labels":[],"label_agreement":null},{"id":"W2540214683","doi":"10.1016/j.jval.2016.09.1827","title":"Identification and Management of Patients with Statin Intolerance in Saudi Arabia and the United Arab Emirates: Comparison of Results from a Clinician Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Ezetimibe; Discontinuation; Concomitant; Fibrate; Family medicine; Internal medicine","score_opus":0.05091397687387444,"score_gpt":0.32305111330848535,"score_spread":0.2721371364346109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540214683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99940383,0.00014000692,0.000019215577,0.0000989144,0.0000033554054,0.000005622817,0.000096436735,7.052522e-7,0.00023182314],"genre_scores_gemma":[0.99952555,0.00015565899,0.000042476182,0.00007863679,0.000005082635,0.0000057916945,0.00011827216,5.741493e-7,0.0000678689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999166,0.00034476595,0.00013512938,0.000072077106,0.00014919009,0.00013282217],"domain_scores_gemma":[0.9981536,0.00038475948,0.00072847743,0.000050195045,0.00046698732,0.00021594457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010324346,0.00021720865,0.00032878638,0.0008393267,0.00048278784,0.00074439705,0.00035418337,0.00068238325,0.0008812547],"category_scores_gemma":[0.0047684875,0.00022157034,0.00033198018,0.0011976525,0.00022198733,0.00043560233,0.0005159781,0.00037736728,0.00016521204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008638253,0.000043271808,0.99809426,0.000010994086,0.000025792393,0.00006560766,0.00040372997,0.00001652895,0.00007745112,0.000009057868,0.00006202901,0.0011049485],"study_design_scores_gemma":[0.00001036478,0.0001190989,0.99705327,0.0000140637785,0.00002316568,0.00017110362,0.002273319,0.00015579727,0.000046950267,0.000008780851,0.00011971142,0.0000043957775],"about_ca_topic_score_codex":0.03391928,"about_ca_topic_score_gemma":0.029431842,"teacher_disagreement_score":0.03391928,"about_ca_system_score_codex":0.00069336785,"about_ca_system_score_gemma":0.0006882249,"threshold_uncertainty_score":0.06744367},"labels":[],"label_agreement":null},{"id":"W2540353830","doi":"10.1016/j.jval.2016.08.366","title":"Identification of Statin Intolerance: Results From A Survey of Clinicians in Taiwan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Internal medicine; Creatine kinase; Physical therapy","score_opus":0.06280279987977974,"score_gpt":0.34439576369363706,"score_spread":0.28159296381385734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540353830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99941325,0.00008729964,0.000024239183,0.00010557838,0.0000021857245,0.0000066453945,0.00010181144,9.852453e-7,0.00025805787],"genre_scores_gemma":[0.99957067,0.00007949595,0.000027964341,0.00011577187,0.0000040065456,0.000008273191,0.000119275326,0.0000010857314,0.00007335603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909675,0.00025322588,0.00021314832,0.00016655745,0.0001084987,0.00016177949],"domain_scores_gemma":[0.9967529,0.0005823282,0.0014353958,0.00014114038,0.00040720656,0.0006809678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081263104,0.00021848692,0.00040465366,0.0011184248,0.0007232033,0.0010359244,0.0003830496,0.0009874117,0.0016523249],"category_scores_gemma":[0.0047712764,0.000385734,0.00036880616,0.0020957682,0.00049602764,0.0007553844,0.0008882784,0.0006618312,0.0003227976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002464691,0.00003393174,0.9985896,0.000006169642,0.000014366808,0.00009354837,0.0006411309,0.000007137593,0.00010081005,0.0000063038738,0.000044398515,0.00043793628],"study_design_scores_gemma":[0.0000061369224,0.00006313156,0.99644655,0.000010660931,0.000015035713,0.00014955606,0.0030774893,0.00009165383,0.000026394338,0.000008577081,0.0001009542,0.000003885168],"about_ca_topic_score_codex":0.026102135,"about_ca_topic_score_gemma":0.0289714,"teacher_disagreement_score":0.026102135,"about_ca_system_score_codex":0.0006939529,"about_ca_system_score_gemma":0.000982408,"threshold_uncertainty_score":0.051900387},"labels":[],"label_agreement":null},{"id":"W2540560381","doi":"10.1016/j.jval.2016.09.223","title":"To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Watchful waiting; Lanreotide; Medicine; Actuarial science; Decision quality; Psychological intervention; Intensive care medicine; Surgery; Internal medicine; Economics; Patient satisfaction; Nursing","score_opus":0.14682131390380243,"score_gpt":0.4662197085444857,"score_spread":0.31939839464068326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540560381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9323627,0.002230057,0.048087087,0.010592594,0.0001679868,0.00055714644,0.0015141858,0.000084835105,0.0044034678],"genre_scores_gemma":[0.98922133,0.0001899914,0.009791832,0.00016155685,0.000041499698,0.00008067,0.0003622334,0.000011601747,0.00013919343],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.98673034,0.009850091,0.0008802946,0.0007990213,0.0011044716,0.0006357653],"domain_scores_gemma":[0.8572663,0.12872225,0.0070531354,0.00108536,0.0027486293,0.0031243658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025132127,0.0006811578,0.0015249061,0.0022938573,0.00071328063,0.004144958,0.0011768092,0.0008111858,0.0032929685],"category_scores_gemma":[0.13322037,0.00038181696,0.0022855124,0.0018773468,0.0005414421,0.0023706858,0.0015885865,0.00302054,0.00029666646],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006020941,0.0011463595,0.7321824,0.00071235915,0.002801766,0.00048325432,0.001448232,0.06507232,0.00029842267,0.013712496,0.0061389734,0.16998245],"study_design_scores_gemma":[0.0005740152,0.0019294303,0.08924616,0.00086644874,0.0014310809,0.0007788421,0.0031976542,0.7864644,0.0008883598,0.11054653,0.0038518726,0.00022526487],"about_ca_topic_score_codex":0.0024697443,"about_ca_topic_score_gemma":0.0034516647,"teacher_disagreement_score":0.025132127,"about_ca_system_score_codex":0.0017736128,"about_ca_system_score_gemma":0.0037835392,"threshold_uncertainty_score":0.132913},"labels":[],"label_agreement":null},{"id":"W2540798315","doi":"10.1016/j.jval.2016.09.1882","title":"Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Boehringer Ingelheim (Canada)","funders":"","keywords":"Empagliflozin; Medicine; Cost–benefit analysis; Quality-adjusted life year; Hazard ratio; Demography; Emergency medicine; Cost effectiveness; Confidence interval; Internal medicine; Type 2 diabetes; Diabetes mellitus; Risk analysis (engineering); Endocrinology","score_opus":0.013972489305047619,"score_gpt":0.24531437140533663,"score_spread":0.231341882100289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540798315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9727835,0.009836727,0.00010962003,0.0060258545,0.000102511105,0.000078639074,0.004405953,0.000016304863,0.0066408603],"genre_scores_gemma":[0.99558455,0.0022783515,0.00014742548,0.00041564854,0.000034795252,0.000012554622,0.0009389958,0.000004384019,0.00058332714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990804,0.00017610671,0.000074903335,0.00008327098,0.0002681798,0.00031704438],"domain_scores_gemma":[0.9970433,0.00060138915,0.00045486976,0.000045386252,0.0007396853,0.0011153406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065102684,0.0002357282,0.00077337236,0.0007295433,0.0010573454,0.0015961826,0.0008753881,0.000659542,0.0025920207],"category_scores_gemma":[0.006063413,0.00026761086,0.0015372371,0.002549018,0.0004974173,0.00050400797,0.0006783217,0.0012691589,0.00008580332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075006136,0.0007853352,0.89692175,0.00071530754,0.0018757195,0.00054135674,0.00032675418,0.0063871355,0.00018391144,0.001690141,0.012643623,0.070428304],"study_design_scores_gemma":[0.0013549199,0.00047192365,0.9828089,0.00040979037,0.0013758742,0.00028317078,0.0009848996,0.008491107,0.00010430244,0.00048088725,0.0031704041,0.00006389576],"about_ca_topic_score_codex":0.98147213,"about_ca_topic_score_gemma":0.9862206,"teacher_disagreement_score":0.046688102,"about_ca_system_score_codex":0.046688102,"about_ca_system_score_gemma":0.04021289,"threshold_uncertainty_score":0.3387475},"labels":[],"label_agreement":null},{"id":"W2540801981","doi":"10.1016/j.jval.2016.09.1539","title":"Health Care Resource Utilization and Costs Associated with the Management of Non-Infectious Intermediate, Posterior and Panuveitis in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Uveitis; Emergency medicine; Disease; Retrospective cohort study; Pediatrics; Infectious disease (medical specialty); Health care; Ophthalmology; Internal medicine","score_opus":0.011919829795575406,"score_gpt":0.2560002192787063,"score_spread":0.2440803894831309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540801981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730761,0.0037675148,0.0001076877,0.0041444716,0.00007490382,0.00007496086,0.0115470365,0.000018804196,0.0071884673],"genre_scores_gemma":[0.9951702,0.0015921808,0.00010945941,0.00034583543,0.000024540177,0.0000145693475,0.0019415055,0.0000061238384,0.00079552346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854445,0.00013346347,0.00013419593,0.00010474138,0.00038740295,0.0006958067],"domain_scores_gemma":[0.9957129,0.00035393462,0.00087943603,0.00005109326,0.0012734698,0.0017292186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031698708,0.0002474588,0.00046831334,0.0014913604,0.0019024931,0.001674263,0.0013248861,0.00068840175,0.0033586659],"category_scores_gemma":[0.004013809,0.00042927024,0.0010294552,0.0043825344,0.0006892551,0.0003877514,0.0009608174,0.0016996413,0.00014170427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023146904,0.00016185116,0.9788865,0.0001413062,0.0002939465,0.0004619319,0.00038195454,0.0011906412,0.00013984906,0.00084167987,0.0067432774,0.0105256],"study_design_scores_gemma":[0.00003483218,0.00003260101,0.99615085,0.000112607704,0.000074432486,0.00016200855,0.00094346487,0.0011049983,0.000037031168,0.000100821504,0.0012260647,0.000020291212],"about_ca_topic_score_codex":0.99574465,"about_ca_topic_score_gemma":0.9969317,"teacher_disagreement_score":0.06154596,"about_ca_system_score_codex":0.06154596,"about_ca_system_score_gemma":0.060271982,"threshold_uncertainty_score":0.4465493},"labels":[],"label_agreement":null},{"id":"W2540885017","doi":"10.1016/j.jval.2016.09.580","title":"Contrasting The Characteristics Of Hta Submissions For Rare Versus Ultra-Rare Diseases","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Reimbursement; Rare disease; Disease; Intensive care medicine; Internal medicine; Health care","score_opus":0.06843524395323793,"score_gpt":0.34015275991247335,"score_spread":0.27171751595923543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540885017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96826184,0.00413965,0.0017442944,0.0023949386,0.0007061483,0.00040602614,0.008673732,0.00006697032,0.013606373],"genre_scores_gemma":[0.9890736,0.0010660733,0.0016325262,0.00096644775,0.00051735394,0.00033337006,0.0032385206,0.000109614586,0.0030625458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96485823,0.016725756,0.008077398,0.0021308719,0.0054420047,0.0027656408],"domain_scores_gemma":[0.749119,0.12899885,0.05401538,0.015724342,0.03787391,0.014268529],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02270766,0.00036235718,0.00082133454,0.009937948,0.0023975188,0.0038736702,0.0014273906,0.0008762748,0.008881717],"category_scores_gemma":[0.1643791,0.00036010015,0.0007251999,0.008658622,0.0017105703,0.0019520946,0.004077681,0.00092213094,0.0019748143],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012908416,0.00018326892,0.93230987,0.0009357868,0.00033024355,0.0023068439,0.016598398,0.00012517704,0.0014593794,0.0032611326,0.013755124,0.027443925],"study_design_scores_gemma":[0.000069665126,0.00035297178,0.9360837,0.0012454538,0.00013131005,0.006768765,0.02479273,0.0003963107,0.0011147271,0.0022242607,0.026718365,0.00010165732],"about_ca_topic_score_codex":0.0036340852,"about_ca_topic_score_gemma":0.0053386735,"teacher_disagreement_score":0.97729236,"about_ca_system_score_codex":0.0009282752,"about_ca_system_score_gemma":0.002289273,"threshold_uncertainty_score":0.12009102},"labels":[],"label_agreement":null},{"id":"W2540898917","doi":"10.1016/j.jval.2016.09.1692","title":"Proton Pump Inhibitors and Major Adverse Cardiovascular Outcomes: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Clopidogrel; Observational study; Mace; Meta-analysis; Internal medicine; MEDLINE; Adverse effect; Stroke (engine); Population; Concomitant; Intensive care medicine; Systematic review; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.04688973419482255,"score_gpt":0.32791915394278925,"score_spread":0.2810294197479667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540898917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061482535,0.9988433,0.00005510546,0.00010963775,0.00006411247,0.00005576923,0.00014381639,0.000003827164,0.000109641],"genre_scores_gemma":[0.009913872,0.9891317,0.00026183607,0.0004135013,0.0000716009,0.00006388226,0.00006617248,0.000001734272,0.00007570407],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979177,0.00057146465,0.0008287063,0.00022776822,0.00034510318,0.00010922458],"domain_scores_gemma":[0.9931062,0.004245637,0.0020294334,0.000089619076,0.00039587825,0.0001332837],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0028978814,0.0015111141,0.007773939,0.004901229,0.00034663855,0.0019062936,0.0011194338,0.0018373198,0.0058171516],"category_scores_gemma":[0.011003769,0.0010051291,0.00741818,0.006015168,0.00059545727,0.0016740877,0.0015156904,0.0014942908,0.00027823463],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063315185,0.000045287165,0.0012895325,0.9047485,0.043913834,0.00017280661,0.00011213867,0.0001473505,0.00022592676,0.00019657932,0.00264605,0.045868844],"study_design_scores_gemma":[0.002042825,0.0005458928,0.0117766755,0.42835632,0.52229565,0.0007929789,0.00032844607,0.00019977956,0.00023004664,0.000641719,0.032679446,0.00011031581],"about_ca_topic_score_codex":0.005180833,"about_ca_topic_score_gemma":0.021511879,"teacher_disagreement_score":0.99222606,"about_ca_system_score_codex":0.0015173416,"about_ca_system_score_gemma":0.0041694366,"threshold_uncertainty_score":0.01946026},"labels":[],"label_agreement":null},{"id":"W2540988172","doi":"10.1016/j.jval.2016.09.1496","title":"Measuring the Relationship between Hospital Costs and Quality of Care: An Example of Acute Myocardial Infraction in Edmonton, Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Health care; Actuarial science; Proxy (statistics); Population; Quality (philosophy); Emergency medicine; Operations management; Medical emergency; Statistics; Business; Environmental health; Economics","score_opus":0.41427154196758803,"score_gpt":0.39648358298344977,"score_spread":0.017787958984138263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540988172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98404586,0.0015720904,0.0009958688,0.0030822586,0.000040244355,0.00014763795,0.0024062698,0.000024522786,0.0076852404],"genre_scores_gemma":[0.9941321,0.0007909597,0.0013624635,0.0002783415,0.000016737751,0.00002350163,0.0011113132,0.000008725627,0.0022758564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984012,0.00038273897,0.000077012104,0.000092118345,0.000543025,0.000503886],"domain_scores_gemma":[0.9965134,0.00070311193,0.0003113535,0.00008076108,0.0016705971,0.00072079455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018974401,0.0005852735,0.00054167974,0.0019595798,0.002748252,0.0018526545,0.0019478581,0.0009470612,0.0012239203],"category_scores_gemma":[0.00438309,0.00027519593,0.00047975316,0.006590543,0.0012995456,0.0004548459,0.0012692973,0.0014395947,0.000091067224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005209696,0.000597048,0.92408663,0.00025111967,0.0002841063,0.0018966655,0.003498894,0.017513527,0.0005299762,0.004690399,0.0116004385,0.034530245],"study_design_scores_gemma":[0.00008091687,0.00010234276,0.97627956,0.00012439855,0.00008962355,0.0001732877,0.00910902,0.010708495,0.00016382973,0.0005586127,0.002559255,0.0000505956],"about_ca_topic_score_codex":0.9977533,"about_ca_topic_score_gemma":0.9989741,"teacher_disagreement_score":0.054729234,"about_ca_system_score_codex":0.054729234,"about_ca_system_score_gemma":0.05315356,"threshold_uncertainty_score":0.39709026},"labels":[],"label_agreement":null},{"id":"W2541096280","doi":"10.1016/j.jval.2016.09.1826","title":"Identification of Statin Intolerance: Results from a Survey of Clinicians in Six European Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Discontinuation; European commission; myalgia; Family medicine; Internal medicine; Physical therapy; European union","score_opus":0.0547740678631304,"score_gpt":0.3296423393531061,"score_spread":0.2748682714899757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541096280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990565,0.00022920592,0.000046444708,0.00009231226,0.0000036648137,0.000008715067,0.00021367926,0.0000012665233,0.000348191],"genre_scores_gemma":[0.9993057,0.00018808233,0.00007231772,0.00011975495,0.0000034969014,0.000010500629,0.00022744054,0.0000014903785,0.00007127446],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979176,0.0008142268,0.00043180207,0.0003201575,0.0002690225,0.0002472499],"domain_scores_gemma":[0.9951325,0.001130147,0.0019426432,0.00018527835,0.0007828486,0.00082658016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017072756,0.00027163356,0.00058915094,0.0011967574,0.0007188308,0.0013593471,0.00034383603,0.0012388622,0.00097555586],"category_scores_gemma":[0.0057097175,0.0003713141,0.0003836643,0.0029354973,0.0006511314,0.0007708851,0.0010919138,0.00047866808,0.00023743689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005260728,0.000027464705,0.9977285,0.00001475338,0.000029658131,0.00008019251,0.0009790101,0.000015597305,0.00012822366,0.000010116947,0.000074199765,0.0008596499],"study_design_scores_gemma":[0.0000072194466,0.00005494275,0.9967301,0.000017230335,0.000015824944,0.00014390876,0.0027668506,0.000038906037,0.00003294879,0.0000057263337,0.00018207636,0.0000043526525],"about_ca_topic_score_codex":0.015688723,"about_ca_topic_score_gemma":0.016569098,"teacher_disagreement_score":0.015688723,"about_ca_system_score_codex":0.00057540997,"about_ca_system_score_gemma":0.000780482,"threshold_uncertainty_score":0.031194806},"labels":[],"label_agreement":null},{"id":"W2541115330","doi":"10.1016/j.jval.2016.09.996","title":"Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mirabegron; Tolterodine; Overactive bladder; Oxybutynin; Medicine; Solifenacin; Urology; Discontinuation; Persistence (discontinuity); Internal medicine","score_opus":0.23244306501809342,"score_gpt":0.45065249787508915,"score_spread":0.21820943285699573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541115330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644621,0.022965766,0.0014185929,0.0031011377,0.00012532315,0.00016284804,0.004717304,0.000022755343,0.0030240854],"genre_scores_gemma":[0.9959877,0.0019207612,0.0005559746,0.00020278209,0.000025854517,0.000040177798,0.00088153855,0.000004350979,0.00038083625],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954977,0.0030825548,0.00041135828,0.00029978913,0.00030317166,0.0004054443],"domain_scores_gemma":[0.9790558,0.017268855,0.0020978078,0.000307433,0.00064737303,0.000622653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004640584,0.00073283154,0.0014472214,0.0012676156,0.0002548635,0.002032096,0.00083178416,0.0020871677,0.0029379535],"category_scores_gemma":[0.02834622,0.0006900353,0.0024433276,0.0015160381,0.0008564542,0.0014756016,0.0015111795,0.0018567921,0.0002506779],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05828803,0.00075789064,0.33800697,0.005510715,0.006572782,0.0019821913,0.00070924603,0.46326172,0.0018610444,0.009410866,0.008739487,0.10489908],"study_design_scores_gemma":[0.008243028,0.015353484,0.68929136,0.002937859,0.008751404,0.0034265844,0.0035071678,0.2437935,0.0023595148,0.008278669,0.013547054,0.00051034143],"about_ca_topic_score_codex":0.0896553,"about_ca_topic_score_gemma":0.050076988,"teacher_disagreement_score":0.0896553,"about_ca_system_score_codex":0.007899312,"about_ca_system_score_gemma":0.0019430722,"threshold_uncertainty_score":0.17826694},"labels":[],"label_agreement":null},{"id":"W2541118887","doi":"10.1016/j.jval.2016.09.1003","title":"Assessing The Cost-Utility of Etelcalcetide: A Markov Model","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Cinacalcet; Calcimimetic; Medicine; Cost effectiveness; Secondary hyperparathyroidism; Internal medicine; Parathyroid hormone; Risk analysis (engineering)","score_opus":0.11327866254793244,"score_gpt":0.40679142997874657,"score_spread":0.2935127674308141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541118887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7289231,0.0036582702,0.22378385,0.013852719,0.00023532927,0.00089458347,0.009479172,0.0003811104,0.018791929],"genre_scores_gemma":[0.97918063,0.0010926985,0.010648491,0.00037539334,0.00009430742,0.0003306099,0.0013414472,0.000032759985,0.0069036703],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978613,0.0012259284,0.00006954087,0.00027919968,0.0001300243,0.00043395322],"domain_scores_gemma":[0.97757804,0.020241808,0.00088241574,0.000236613,0.0003409195,0.0007202044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051856944,0.0018495586,0.0039568692,0.0016964814,0.00074789755,0.003400487,0.0031431767,0.0045477585,0.011992516],"category_scores_gemma":[0.017657196,0.0017563099,0.002814993,0.001453658,0.0018637575,0.002436108,0.001502051,0.0037135705,0.0007619086],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019483697,0.00018720399,0.0035590099,0.00009570722,0.00018727897,0.00026199917,0.000040613544,0.97540647,0.00016650298,0.012340549,0.001028672,0.004777554],"study_design_scores_gemma":[0.0004129075,0.00020209684,0.00093314424,0.00004034712,0.0002117888,0.00010106688,0.000033573764,0.98834395,0.00007663126,0.009285968,0.000326542,0.00003196057],"about_ca_topic_score_codex":0.04011768,"about_ca_topic_score_gemma":0.017832588,"teacher_disagreement_score":0.04011768,"about_ca_system_score_codex":0.0051658093,"about_ca_system_score_gemma":0.00472957,"threshold_uncertainty_score":0.07976836},"labels":[],"label_agreement":null},{"id":"W2541171690","doi":"10.1016/j.jval.2016.08.233","title":"Influence of Cochrane Evidence on Medical Policies of Oncology Drugs in the United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Context (archaeology); Cochrane Library; Systematic review; Family medicine; Cochrane collaboration; Guideline; Quarter (Canadian coin); Business; MEDLINE; Internal medicine; Political science; Meta-analysis","score_opus":0.3885955164518271,"score_gpt":0.48894369645763275,"score_spread":0.10034818000580564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541171690","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.053214803,0.7465507,0.0011383911,0.117550395,0.0049598273,0.00023256475,0.007606849,0.00009767797,0.06864886],"genre_scores_gemma":[0.80368155,0.14535303,0.001602954,0.040255837,0.0044869375,0.00031062076,0.0016373341,0.00013577555,0.0025360084],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8980594,0.070547014,0.011379106,0.003110624,0.013610482,0.0032933],"domain_scores_gemma":[0.32690415,0.59059805,0.048570607,0.004966186,0.024148874,0.0048121973],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08330827,0.00093866006,0.0046051373,0.011744036,0.00080210424,0.010814424,0.0019203804,0.0073117437,0.0066998643],"category_scores_gemma":[0.51258343,0.0010439547,0.0042417846,0.0096667325,0.0036290474,0.004334096,0.0030849795,0.0053406716,0.00033039172],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03132122,0.0007145667,0.09607361,0.112466924,0.055084616,0.0009277177,0.0014633907,0.039859172,0.0010319025,0.21757418,0.16514844,0.27833435],"study_design_scores_gemma":[0.012105948,0.0017310476,0.22353877,0.2195501,0.12483155,0.0008347951,0.0019011168,0.013270992,0.007801563,0.08149147,0.31233597,0.00060670404],"about_ca_topic_score_codex":0.04652086,"about_ca_topic_score_gemma":0.042529624,"teacher_disagreement_score":0.9166917,"about_ca_system_score_codex":0.013322905,"about_ca_system_score_gemma":0.016939234,"threshold_uncertainty_score":0.4405815},"labels":[],"label_agreement":null},{"id":"W2541374879","doi":"10.1016/j.jval.2016.08.744","title":"A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Net-Benefit Regression Approach","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Nausea and vomiting management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Antiemetic; Breast cancer; Nausea; Vomiting; Randomized controlled trial; Willingness to pay; Cost effectiveness; Quality-adjusted life year; Chemotherapy-induced nausea and vomiting; Cancer; Emergency medicine; Internal medicine","score_opus":0.07089054980597101,"score_gpt":0.34369158779920556,"score_spread":0.2728010379932345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541374879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84730136,0.010637577,0.11777826,0.006197026,0.00029474028,0.0018424871,0.0032483814,0.00037270162,0.012327472],"genre_scores_gemma":[0.9860874,0.00086873,0.01001806,0.0002802326,0.00007898702,0.00023132698,0.00043558524,0.000037328977,0.001962248],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99192965,0.007191632,0.00009553057,0.00025260713,0.00022095915,0.00030954034],"domain_scores_gemma":[0.9710659,0.02734984,0.00058813556,0.00028157677,0.0003374162,0.00037702481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01156875,0.0022463377,0.0041495785,0.0020697904,0.00040092476,0.0024187947,0.0025142054,0.0019744122,0.0070914174],"category_scores_gemma":[0.0270055,0.0013951967,0.0037271425,0.0014352279,0.0010899786,0.0019138933,0.0014426229,0.002864093,0.00037819546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017364098,0.00093571976,0.00660572,0.0006125692,0.002597088,0.00022954633,0.000071912495,0.9394798,0.00036630576,0.0070716552,0.0012704462,0.023395203],"study_design_scores_gemma":[0.0016106296,0.001823214,0.002817713,0.0000835639,0.0020288397,0.00013582593,0.000071826944,0.98685247,0.00017339613,0.003946073,0.00041349637,0.000042957166],"about_ca_topic_score_codex":0.015466232,"about_ca_topic_score_gemma":0.0067775534,"teacher_disagreement_score":0.015466232,"about_ca_system_score_codex":0.0043381867,"about_ca_system_score_gemma":0.0029056296,"threshold_uncertainty_score":0.06118214},"labels":[],"label_agreement":null},{"id":"W2541447616","doi":"10.1016/j.jval.2016.09.1541","title":"Follow-Up Imaging After Nephrectomy in Canada: Urologists’ Compliance with Guidelines and Cost of Surveillance","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Guideline; Cohort; Renal cell carcinoma; Stage (stratigraphy); Population; Kidney cancer; Surgery; General surgery; Internal medicine; Kidney","score_opus":0.07945701525497316,"score_gpt":0.304048522511601,"score_spread":0.22459150725662785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541447616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9566711,0.003689442,0.0001378689,0.025987664,0.00009311754,0.000043497173,0.0026770218,0.00001840945,0.010681788],"genre_scores_gemma":[0.99648345,0.0010455297,0.00020742326,0.001080295,0.000034378736,0.000005747817,0.00051459874,0.000007377704,0.0006212917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971681,0.0004087086,0.0002529203,0.00017381416,0.0010424142,0.0009540371],"domain_scores_gemma":[0.9798723,0.0033249804,0.0063447747,0.00034011042,0.0055931546,0.004524693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001290619,0.00015219765,0.00035258496,0.0012228069,0.0020253768,0.0019578433,0.0015236347,0.001263847,0.0030437852],"category_scores_gemma":[0.020005386,0.00032703043,0.00059930014,0.004826929,0.0008501407,0.00073877414,0.00091486034,0.0019059079,0.00011756295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010184462,0.000088818764,0.98119074,0.000047952206,0.000069350266,0.00018955665,0.0006400741,0.00031403365,0.00004902826,0.0004375884,0.004436665,0.012434264],"study_design_scores_gemma":[0.000016893158,0.000024370176,0.9947325,0.00013149087,0.00005449015,0.00015184254,0.0017496682,0.0009587267,0.000051270203,0.00012690356,0.0019838803,0.000017962657],"about_ca_topic_score_codex":0.9882079,"about_ca_topic_score_gemma":0.99460703,"teacher_disagreement_score":0.95528495,"about_ca_system_score_codex":0.044715058,"about_ca_system_score_gemma":0.07370526,"threshold_uncertainty_score":0.32443202},"labels":[],"label_agreement":null},{"id":"W2541492109","doi":"10.1016/j.jval.2016.08.595","title":"The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Respondent; Life expectancy; Econometrics; Statistics; Quality of life (healthcare); Quality-adjusted life year; Censoring (clinical trials); Time-trade-off; Valuation (finance); Choice set; Mathematics; Psychology; Demography; Economics; Population; Cost effectiveness","score_opus":0.39091030224383405,"score_gpt":0.45037648218196175,"score_spread":0.059466179938127695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541492109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643537,0.00080125907,0.02354526,0.0012430064,0.00016556091,0.00027480678,0.0010379306,0.00006632983,0.0085122045],"genre_scores_gemma":[0.9935096,0.000112782574,0.0042508687,0.0002452533,0.000043939006,0.00021466208,0.00038970166,0.000022621765,0.0012105223],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.98093504,0.015699262,0.0005119691,0.0013066434,0.00092925585,0.00061789015],"domain_scores_gemma":[0.25979608,0.7245043,0.0054106154,0.0071738055,0.0013146498,0.001800543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.054792773,0.00078020024,0.0016501468,0.00061631657,0.00058532704,0.003865414,0.0013254484,0.0021558467,0.011873719],"category_scores_gemma":[0.21965933,0.00055962824,0.0023112558,0.00066858734,0.0023725969,0.0034631274,0.001766912,0.004432755,0.0005956832],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19437817,0.014566723,0.21170168,0.002389734,0.0077168955,0.0006841595,0.0030598047,0.28282505,0.008482138,0.13773507,0.0046742475,0.1317864],"study_design_scores_gemma":[0.011490569,0.022591565,0.23019998,0.0004979456,0.006266146,0.0004623685,0.0010494355,0.5259899,0.005065445,0.191389,0.0044963444,0.0005013459],"about_ca_topic_score_codex":0.002195653,"about_ca_topic_score_gemma":0.0011243948,"teacher_disagreement_score":0.054792773,"about_ca_system_score_codex":0.0015006707,"about_ca_system_score_gemma":0.0014789742,"threshold_uncertainty_score":0.28977537},"labels":[],"label_agreement":null},{"id":"W2541518521","doi":"10.1016/j.jval.2016.08.364","title":"Identification of Statin Intolerance: Results From A Survey of South Korean Clinicians","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Discontinuation; Internal medicine; Creatine kinase; Elevated transaminases; myalgia; Shoulders; Physical therapy; Surgery","score_opus":0.06689159316587932,"score_gpt":0.33439207756323075,"score_spread":0.2675004843973514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541518521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99918216,0.00012695415,0.000028289478,0.000106751875,0.000003912742,0.000011261044,0.0002261908,8.514443e-7,0.0003135913],"genre_scores_gemma":[0.9991359,0.00017425552,0.000062249914,0.00021387689,0.0000063534826,0.000014142163,0.00025164112,0.000001466686,0.00014018765],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991322,0.00019599982,0.0002207966,0.00017859827,0.0001249605,0.00014750195],"domain_scores_gemma":[0.99718946,0.00033974586,0.0013185727,0.00011115192,0.00047005698,0.0005711234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087446644,0.00028024142,0.0004204524,0.0011952446,0.00086870085,0.0010490293,0.00037465524,0.00081566133,0.001847427],"category_scores_gemma":[0.0033210642,0.00042364805,0.00044377378,0.0020417317,0.00039118144,0.0008074255,0.00088245544,0.0005982692,0.0004133291],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002313513,0.000033021897,0.99866843,0.00001048133,0.000016319967,0.000057555964,0.00058398815,0.0000037882096,0.00012690292,0.0000064531496,0.00005546189,0.00041452312],"study_design_scores_gemma":[0.000004603607,0.00004580312,0.99633247,0.000013383208,0.000020991285,0.00014838258,0.00318614,0.000038721166,0.000029506009,0.0000063035204,0.0001692405,0.0000044788007],"about_ca_topic_score_codex":0.017713428,"about_ca_topic_score_gemma":0.02414526,"teacher_disagreement_score":0.017713428,"about_ca_system_score_codex":0.00059805374,"about_ca_system_score_gemma":0.0009493613,"threshold_uncertainty_score":0.035220623},"labels":[],"label_agreement":null},{"id":"W2541589956","doi":"10.1016/j.jval.2016.09.1675","title":"Risk of Mortality and Hospital Readmission Among Older Adults with Heart Failure Treated with Carvedilol, Bisoprolol or Metoprolol Tartrate","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Bisoprolol; Carvedilol; Metoprolol Tartrate; Metoprolol; Medicine; Heart failure; Propensity score matching; Clinical endpoint; Internal medicine; Cardiology; Proportional hazards model; Randomized controlled trial","score_opus":0.018642567205404706,"score_gpt":0.27337619893152443,"score_spread":0.25473363172611974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541589956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841857,0.0007166123,0.00004416108,0.00013140595,0.000024034338,0.0000049443843,0.00016520015,0.0000027115116,0.0004923594],"genre_scores_gemma":[0.99918026,0.00024162099,0.00003896739,0.000081023936,0.000046304194,0.000004720366,0.00017598663,8.2818417e-7,0.00023019077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980897,0.00005223664,0.000025479336,0.000029400015,0.000035727902,0.000048104983],"domain_scores_gemma":[0.9993339,0.00015739203,0.0002549081,0.0000309712,0.00004498906,0.00017771829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028931172,0.00024314845,0.00043590536,0.00033957235,0.00021645571,0.00051992375,0.00020458044,0.0006471725,0.0016928198],"category_scores_gemma":[0.0016728123,0.00020584228,0.0010034479,0.0003303136,0.00011178678,0.00034926124,0.0003513118,0.00095488905,0.000120969664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014568013,0.00020572176,0.9933827,0.00003868846,0.0004067612,0.00012602714,0.000057399982,0.000116767325,0.00024939337,0.000045129356,0.00029584972,0.0036188115],"study_design_scores_gemma":[0.00007161388,0.00029286993,0.9984042,0.000019145715,0.00018966464,0.00014215145,0.00014066788,0.00050959334,0.000037637907,0.00005663115,0.00013034092,0.0000054259176],"about_ca_topic_score_codex":0.0038699056,"about_ca_topic_score_gemma":0.0055709872,"teacher_disagreement_score":0.0038699056,"about_ca_system_score_codex":0.00026890528,"about_ca_system_score_gemma":0.0002607621,"threshold_uncertainty_score":0.007694721},"labels":[],"label_agreement":null},{"id":"W2541597280","doi":"10.1016/j.jval.2016.09.1216","title":"Adding A Decision Aid to Asthma Education: Impact on Decisional Conflict and Appropriate Medication Usage","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Asthma; Medicine; Psychology; Internal medicine","score_opus":0.10144733140434008,"score_gpt":0.46872504972176654,"score_spread":0.36727771831742645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541597280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836977,0.00047281446,0.0016420558,0.0030908165,0.00034105682,0.0003099987,0.00019332698,0.00025556033,0.009996857],"genre_scores_gemma":[0.988069,0.00038051055,0.007956953,0.00063808996,0.00012901086,0.00015581417,0.00012558789,0.000022278358,0.0025227168],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.998104,0.001174129,0.00015396609,0.00015956012,0.00023110579,0.00017723147],"domain_scores_gemma":[0.9684336,0.026016638,0.0009788586,0.00045915908,0.0005124026,0.0035993902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022389095,0.00052844064,0.00065209216,0.0005986037,0.0007402135,0.0012839705,0.0007795844,0.0011185015,0.019628944],"category_scores_gemma":[0.022921152,0.00022227029,0.00058706687,0.00039042832,0.00032147116,0.0009791772,0.0011870611,0.0017278065,0.0010271667],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029682951,0.12952068,0.07493757,0.0010049045,0.00031295084,0.00091759226,0.002968466,0.0053456575,0.003122668,0.0015152869,0.012140556,0.7385307],"study_design_scores_gemma":[0.04126182,0.120651506,0.54535747,0.0047403434,0.0043590995,0.0037126853,0.014813165,0.13636097,0.02800803,0.0277633,0.071930714,0.0010408373],"about_ca_topic_score_codex":0.0012521507,"about_ca_topic_score_gemma":0.0017058727,"teacher_disagreement_score":0.019628944,"about_ca_system_score_codex":0.000560379,"about_ca_system_score_gemma":0.0016919724,"threshold_uncertainty_score":0.065665364},"labels":[],"label_agreement":null},{"id":"W2541610978","doi":"10.1016/j.jval.2016.09.465","title":"A Restrospective Non-Interventional Study Among Patients with Relapsing Multiple Sclerosis Switching to Fingolimod or to Other Disease Modifying Therapies","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Fingolimod; Glatiramer acetate; Brace; Cohort; Internal medicine; Multiple sclerosis; Physical therapy; Pediatrics; Disease; Immunology","score_opus":0.10963606316816456,"score_gpt":0.34606819753326173,"score_spread":0.2364321343650972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541610978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992046,0.00014872974,0.000045019333,0.000032936754,0.00001075161,0.00008242741,0.0000910998,0.0000017239923,0.00038273877],"genre_scores_gemma":[0.9985135,0.000108617205,0.0001753156,0.00022492233,0.00005442695,0.00016691392,0.00037926354,0.000002195769,0.0003748575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987526,0.0005953086,0.00012863652,0.0002625659,0.00009154978,0.00016943818],"domain_scores_gemma":[0.9978861,0.0008039011,0.00043202858,0.0003660573,0.00019492545,0.00031683425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015597058,0.0006873341,0.0008492776,0.00059347507,0.0012458753,0.0009646592,0.00046490564,0.0010579898,0.002786413],"category_scores_gemma":[0.0038681857,0.0004459475,0.0011414395,0.00082758494,0.00069846597,0.00096409646,0.0006571321,0.0011209794,0.00052711176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07611039,0.017546427,0.88154095,0.00028604036,0.0020822387,0.00066188327,0.0020326232,0.00010700144,0.0060876193,0.00025791096,0.00064135384,0.012645597],"study_design_scores_gemma":[0.012760304,0.038007166,0.9422445,0.000048550755,0.0017772465,0.00081306946,0.0014880637,0.00030059167,0.0005719202,0.00023498836,0.0017108123,0.000042830165],"about_ca_topic_score_codex":0.0030543923,"about_ca_topic_score_gemma":0.0033556102,"teacher_disagreement_score":0.0030543923,"about_ca_system_score_codex":0.00047908915,"about_ca_system_score_gemma":0.0006555988,"threshold_uncertainty_score":0.009321511},"labels":[],"label_agreement":null},{"id":"W2541695863","doi":"10.1016/j.jval.2016.09.2177","title":"Economic Evaluation of Targeted Therapies in Metastatic Clear Renal Cell Carcinoma in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Renal cell carcinoma; Cohort; Axitinib; Metastasectomy; Targeted therapy; Internal medicine; Kidney cancer; Cancer; Temsirolimus; Everolimus; Oncology; Nephrectomy; Metastasis; Kidney","score_opus":0.05884222490641769,"score_gpt":0.28982674212872045,"score_spread":0.23098451722230276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541695863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113227,0.024492461,0.0011502176,0.016504219,0.00021144716,0.00079732004,0.011565671,0.00003715707,0.033918917],"genre_scores_gemma":[0.9917001,0.0041331137,0.00048458105,0.00046845234,0.00003571737,0.000059883267,0.0013793374,0.000009057314,0.001729637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99616265,0.0013223786,0.00019232542,0.00015837814,0.0012849366,0.00087934465],"domain_scores_gemma":[0.99323225,0.0018095874,0.0007399547,0.000090150985,0.0024799502,0.0016482193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028996677,0.00039802198,0.0009150482,0.0014711076,0.001512679,0.0031126873,0.0010195848,0.0006831214,0.0028662973],"category_scores_gemma":[0.014767525,0.00026250997,0.0014090114,0.003626939,0.00093015167,0.0004917261,0.0008627775,0.0011994707,0.000084371095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.024271837,0.0023019894,0.4251341,0.00398023,0.0046507097,0.001198135,0.0009734617,0.1917727,0.0015801528,0.04469923,0.051664382,0.24777311],"study_design_scores_gemma":[0.004700754,0.0049298564,0.7204226,0.0023894368,0.0047127027,0.0011002509,0.0045507075,0.18025732,0.0017618214,0.008917657,0.065939434,0.00031752748],"about_ca_topic_score_codex":0.97756517,"about_ca_topic_score_gemma":0.9820986,"teacher_disagreement_score":0.85756886,"about_ca_system_score_codex":0.14243111,"about_ca_system_score_gemma":0.13020138,"threshold_uncertainty_score":0.99465835},"labels":[],"label_agreement":null},{"id":"W2541744580","doi":"10.1016/j.jval.2016.09.233","title":"What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Autonomy; Intervention (counseling); Quality (philosophy); Multiple-criteria decision analysis; Decision support system; Health care; Population; Family medicine; Nursing; Operations research; Computer science; Data mining; Environmental health; Engineering","score_opus":0.4453992910377964,"score_gpt":0.4562850092858128,"score_spread":0.010885718248016374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541744580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9259592,0.0058649885,0.039485797,0.012247076,0.00017702508,0.0008706233,0.00062132673,0.000025978416,0.014747941],"genre_scores_gemma":[0.9820753,0.0006484979,0.016411552,0.0003357635,0.000041467127,0.0001271194,0.00010258584,0.000010161355,0.0002475793],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9865101,0.010932778,0.0005542706,0.00039585817,0.0009656464,0.0006414389],"domain_scores_gemma":[0.9627923,0.032603864,0.0013033493,0.00016099517,0.0012347066,0.0019047774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015878597,0.00072738255,0.0014884886,0.0021209104,0.001274631,0.005570548,0.000900047,0.0014726361,0.0032821437],"category_scores_gemma":[0.045059443,0.00030759582,0.0017764347,0.0018108289,0.0012163689,0.0020876564,0.0020161825,0.0022433738,0.00014653032],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011236798,0.0032243175,0.18257459,0.0051913997,0.0034948837,0.0032235363,0.01668499,0.16910385,0.0030483657,0.1241888,0.013045255,0.46498328],"study_design_scores_gemma":[0.0008818126,0.005069366,0.05581216,0.0039991345,0.0019214444,0.0024217146,0.058194622,0.54700494,0.0022113496,0.30988207,0.01215538,0.00044605442],"about_ca_topic_score_codex":0.0028115113,"about_ca_topic_score_gemma":0.0038796624,"teacher_disagreement_score":0.015878597,"about_ca_system_score_codex":0.003051803,"about_ca_system_score_gemma":0.0044907397,"threshold_uncertainty_score":0.08397508},"labels":[],"label_agreement":null},{"id":"W2541890720","doi":"10.1016/j.jval.2016.09.1489","title":"Impact of Initiation of Long-Acting Injectable Antipsychotics on Resource Utilization In Patients with Schizophrenia","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Pediatrics; Psychiatry","score_opus":0.06129585616980711,"score_gpt":0.35225707465343087,"score_spread":0.2909612184836238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541890720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738675,0.0007327674,0.000019460236,0.00068926864,0.000021957992,0.0000060622674,0.00021346379,0.0000018828108,0.00092836807],"genre_scores_gemma":[0.99941325,0.00020749934,0.000030313719,0.00010835839,0.000015785678,0.0000029462365,0.0001309803,0.0000014459507,0.00008950867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987871,0.0005276004,0.00012940654,0.00007513328,0.00015491217,0.0003258093],"domain_scores_gemma":[0.99204224,0.0025569294,0.0031826813,0.00016346027,0.00040402848,0.001650725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093160843,0.00020364102,0.00046872356,0.0004516631,0.0007041546,0.001389974,0.00039473324,0.00073220185,0.0023993452],"category_scores_gemma":[0.0099266,0.0002724711,0.0014604277,0.0008944542,0.000386871,0.0007562815,0.00081438833,0.0017310212,0.0001367098],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014101688,0.00038539738,0.9916807,0.000023589724,0.00025717326,0.00013724255,0.00014756928,0.00029564803,0.00011355498,0.00008762724,0.00023948222,0.005221811],"study_design_scores_gemma":[0.000039784663,0.000241856,0.9981483,0.000031167805,0.00011790538,0.000064439875,0.0006312576,0.00043886926,0.000036015153,0.000120766366,0.0001196967,0.000009955903],"about_ca_topic_score_codex":0.03985506,"about_ca_topic_score_gemma":0.061691705,"teacher_disagreement_score":0.03985506,"about_ca_system_score_codex":0.0023172803,"about_ca_system_score_gemma":0.0030475338,"threshold_uncertainty_score":0.07924616},"labels":[],"label_agreement":null},{"id":"W2541931825","doi":"10.1016/j.jval.2016.09.169","title":"Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Investment (military); Transferability; Population; Econometrics; Computer science; Actuarial science; Business; Economics; Environmental health; Medicine; Political science","score_opus":0.7010600637857954,"score_gpt":0.43440576057104624,"score_spread":0.2666543032147492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541931825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63172436,0.0059544183,0.32184875,0.009661953,0.00019908373,0.0003024157,0.0029722035,0.00027223965,0.02706454],"genre_scores_gemma":[0.9840242,0.00090624235,0.010833058,0.0002999197,0.00006697539,0.00013690711,0.00072294194,0.00006367409,0.0029460255],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968821,0.0022070564,0.00012570944,0.000364066,0.0001332226,0.00028788514],"domain_scores_gemma":[0.9640253,0.032135367,0.0016545057,0.0009703457,0.00068978115,0.00052470755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01251891,0.001165616,0.0024631443,0.0014740132,0.00045271745,0.0041758283,0.0019566678,0.0032658174,0.005425477],"category_scores_gemma":[0.04304119,0.0007269699,0.0022721058,0.0015260217,0.001814722,0.0039119055,0.0023762612,0.003434588,0.00024616194],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003696282,0.00016227718,0.012523891,0.00034218645,0.0005850417,0.0002974665,0.00019602444,0.64461267,0.00044028318,0.32149425,0.004519921,0.014456369],"study_design_scores_gemma":[0.00013096494,0.00015559074,0.0072968025,0.0002170863,0.00038208306,0.00015358035,0.00025422257,0.8033767,0.00046325044,0.18525094,0.0022436776,0.00007508959],"about_ca_topic_score_codex":0.008452338,"about_ca_topic_score_gemma":0.0045552594,"teacher_disagreement_score":0.01251891,"about_ca_system_score_codex":0.0026862973,"about_ca_system_score_gemma":0.0019712762,"threshold_uncertainty_score":0.06620711},"labels":[],"label_agreement":null},{"id":"W2542010379","doi":"10.1016/j.jval.2016.09.1432","title":"Linguistic Validation of the Finnish Version of the Body-Q Pro Instrument","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Body Contouring and Surgery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Debriefing; Cognitive interview; Psychology; Multidisciplinary approach; Cognition; Linguistics; Applied psychology; Medical education; Medicine; Social psychology; Sociology; Social science","score_opus":0.037409939671038124,"score_gpt":0.2822359392181061,"score_spread":0.24482599954706796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542010379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9511876,0.00096657185,0.017183337,0.0015166231,0.0010914215,0.0008979295,0.003013086,0.00011771107,0.02402571],"genre_scores_gemma":[0.97111446,0.00039964006,0.018961778,0.00059610995,0.00018352008,0.0018199201,0.0027339186,0.00017845792,0.004012209],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98444045,0.0072505507,0.0025550406,0.001509601,0.0036519144,0.0005923737],"domain_scores_gemma":[0.95561266,0.025376862,0.0021621047,0.0027034376,0.013532563,0.0006123977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020667516,0.00076261,0.00062048674,0.002361727,0.0024358623,0.0022928994,0.0009814458,0.0012006344,0.006825591],"category_scores_gemma":[0.066959284,0.00038186286,0.0007962442,0.0012890907,0.002229148,0.0013867386,0.0029994864,0.0015709917,0.0018714196],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005521341,0.0025770382,0.34542486,0.0033619956,0.00052033307,0.0049840487,0.21714532,0.0022934538,0.045275245,0.018671423,0.020659184,0.33356577],"study_design_scores_gemma":[0.0010387797,0.0031019924,0.7761094,0.0031583733,0.00089150947,0.008455539,0.06520399,0.007856417,0.033198547,0.011622067,0.08874203,0.00062137045],"about_ca_topic_score_codex":0.0043318616,"about_ca_topic_score_gemma":0.0049065696,"teacher_disagreement_score":0.020667516,"about_ca_system_score_codex":0.0012763657,"about_ca_system_score_gemma":0.0033545133,"threshold_uncertainty_score":0.10930151},"labels":[],"label_agreement":null},{"id":"W2542038413","doi":"10.1016/j.jval.2016.09.765","title":"Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For Austria, Canada, Japan And Usa","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Climate Change Policy and Economics","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Per capita; Economics; Population; Value (mathematics); Human capital; Value of life; Present value; Demographic economics; Estimation; Unemployment; Demography; Geography; Socioeconomics; Economic growth; Statistics; Finance; Mathematics","score_opus":0.1586169172566441,"score_gpt":0.27608318737151843,"score_spread":0.11746627011487434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542038413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840464,0.00022200918,0.013024478,0.00025650818,0.000009532788,0.000015988777,0.00084855617,0.000042179407,0.0015344017],"genre_scores_gemma":[0.9964813,0.00008605315,0.002117092,0.000011354365,0.0000039260744,0.000010560001,0.0008123232,0.000009615137,0.0004677737],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998204,0.00007634457,0.0000059025383,0.0000388876,0.000017945391,0.000040468185],"domain_scores_gemma":[0.9984896,0.0010555492,0.00011612653,0.00007678116,0.0001730353,0.00008875093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010127622,0.0002978923,0.00044573628,0.00068965164,0.00032370887,0.00096024905,0.00063324586,0.00058325485,0.0011601461],"category_scores_gemma":[0.0042555444,0.00022756633,0.00079826504,0.0008453779,0.00027520146,0.0008430813,0.00030476492,0.0005751517,0.00009426151],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023589138,0.00010610718,0.0762301,0.00004687237,0.00020019994,0.000099473735,0.00011916421,0.89654243,0.00037459563,0.011011423,0.0020696844,0.012963976],"study_design_scores_gemma":[0.000020056023,0.000037336424,0.029969657,0.0000125066845,0.00007074601,0.00002795297,0.00016271994,0.9633542,0.00027029242,0.005431263,0.0006239567,0.000019357509],"about_ca_topic_score_codex":0.26368916,"about_ca_topic_score_gemma":0.18671751,"teacher_disagreement_score":0.73631084,"about_ca_system_score_codex":0.0027826605,"about_ca_system_score_gemma":0.0019492463,"threshold_uncertainty_score":0.5243087},"labels":[],"label_agreement":null},{"id":"W2542087192","doi":"10.1016/j.jval.2016.09.1673","title":"Effect of Spironolactone on The Risk of New Onset of Diabetes Among Patients with Heart Failure: A Population-Based Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Spironolactone; Medicine; Hazard ratio; Population; Cohort; Diabetes mellitus; Internal medicine; Heart failure; Proportional hazards model; Mineralocorticoid receptor; Cohort study; Endocrinology; Aldosterone; Confidence interval; Environmental health","score_opus":0.01607065464444648,"score_gpt":0.26807162203737805,"score_spread":0.2520009673929316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542087192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989692,0.0003822146,0.00006276771,0.000039818675,0.000018494213,0.000015111835,0.00016003445,0.0000045827883,0.000347806],"genre_scores_gemma":[0.99930763,0.0001521038,0.00006648156,0.000058628382,0.000037781705,0.000015952288,0.00017361692,0.0000026759944,0.00018520418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988109,0.0005436049,0.000094818344,0.00023770316,0.00016793022,0.00014519531],"domain_scores_gemma":[0.9972983,0.00090275856,0.00048492177,0.00031276015,0.00018768087,0.0008135128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012777225,0.0008202115,0.0014564915,0.0008066672,0.0009168735,0.0012778285,0.00057363464,0.0017363977,0.0013219406],"category_scores_gemma":[0.0031535714,0.00097168534,0.001936562,0.0013364817,0.0007583668,0.0010588816,0.0006330482,0.0020332509,0.00031825824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012368904,0.0019038792,0.98066807,0.000037265498,0.0010351964,0.00021469269,0.00020697834,0.00007762939,0.0011953595,0.000023024475,0.00007931254,0.0021898132],"study_design_scores_gemma":[0.00040902058,0.003271157,0.99519545,0.0000047906783,0.0004454213,0.00013467764,0.00014078029,0.00018336835,0.00007280588,0.000029140727,0.00009620857,0.000017116792],"about_ca_topic_score_codex":0.00498939,"about_ca_topic_score_gemma":0.00501658,"teacher_disagreement_score":0.00498939,"about_ca_system_score_codex":0.00048322266,"about_ca_system_score_gemma":0.00047285986,"threshold_uncertainty_score":0.009920716},"labels":[],"label_agreement":null},{"id":"W2542308039","doi":"10.1016/j.jval.2016.09.014","title":"Comparison of Oral Anti-Coagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation: Two Multi-Criteria Decision Analyses","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Dabigatran; Apixaban; Rivaroxaban; Medicine; Edoxaban; Atrial fibrillation; Warfarin; Stroke (engine); Internal medicine","score_opus":0.33158275307815427,"score_gpt":0.5367741989987577,"score_spread":0.2051914459206034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542308039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94913906,0.027667979,0.015032045,0.0013009597,0.00077053736,0.0020029235,0.0015961368,0.00008152871,0.0024088216],"genre_scores_gemma":[0.98473364,0.0025201929,0.009393986,0.0004443164,0.00021273507,0.0011236949,0.0010061739,0.000031080777,0.0005342154],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9661456,0.028589692,0.0017389597,0.0013028915,0.00149341,0.00072940066],"domain_scores_gemma":[0.84974104,0.13989763,0.0042512557,0.0013332708,0.0013712324,0.0034056166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030093908,0.0035649084,0.01159961,0.0022185082,0.00060539966,0.003616417,0.0025273967,0.0036385963,0.0049661407],"category_scores_gemma":[0.050135847,0.0016256077,0.015073535,0.0011117179,0.0013038724,0.003044856,0.0022479189,0.0062095583,0.00021876457],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8864199,0.0024345133,0.007896577,0.004298454,0.04177366,0.00012144772,0.00026240264,0.026356261,0.00061786216,0.0012452148,0.0006771898,0.027896464],"study_design_scores_gemma":[0.3637352,0.12920599,0.039000448,0.0026278473,0.10164148,0.00053936144,0.0009198567,0.3414426,0.0020579572,0.015531118,0.0025276977,0.00077047094],"about_ca_topic_score_codex":0.0022027693,"about_ca_topic_score_gemma":0.0021732026,"teacher_disagreement_score":0.030093908,"about_ca_system_score_codex":0.0028595345,"about_ca_system_score_gemma":0.00193721,"threshold_uncertainty_score":0.1591537},"labels":[],"label_agreement":null},{"id":"W2542411759","doi":"10.1016/j.jval.2016.08.365","title":"Management of Patients with Statin Intolerance in Japan, South Korea and Taiwan: Comparison of Results From A Clinician Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Statin; Medicine; Ezetimibe; Concomitant; Internal medicine","score_opus":0.04506475591994711,"score_gpt":0.3120484062235498,"score_spread":0.26698365030360266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542411759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99959844,0.0000777616,0.000016018175,0.000046070338,0.0000021044023,0.000005188753,0.00008340375,7.418995e-7,0.00017032254],"genre_scores_gemma":[0.9996062,0.00009144818,0.000031496264,0.000052927106,0.000004451767,0.000007299543,0.00015593335,8.59358e-7,0.000049478374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991394,0.00033468808,0.00018104968,0.0001111349,0.000119649296,0.00011398738],"domain_scores_gemma":[0.99786013,0.00043818142,0.00088947784,0.000082635765,0.0003628024,0.00036683842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008962029,0.00021581892,0.00048121173,0.0010450657,0.0005969731,0.00082089874,0.0003428908,0.00069752074,0.00080077583],"category_scores_gemma":[0.004101758,0.00030239052,0.0005508229,0.0018720449,0.00031195366,0.0006097331,0.0005589467,0.00046584563,0.00015447602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008648976,0.000041365758,0.99866724,0.000007933322,0.000030551066,0.00009412194,0.00035770822,0.000011110521,0.000077577955,0.0000051571888,0.00003653493,0.00058417267],"study_design_scores_gemma":[0.000013811493,0.000110139765,0.99779344,0.0000057270768,0.00003330899,0.00013926013,0.0016949718,0.00010589109,0.000027233102,0.000006277871,0.000065294065,0.0000046527607],"about_ca_topic_score_codex":0.019605618,"about_ca_topic_score_gemma":0.020969909,"teacher_disagreement_score":0.019605618,"about_ca_system_score_codex":0.0006989434,"about_ca_system_score_gemma":0.0007053474,"threshold_uncertainty_score":0.038982987},"labels":[],"label_agreement":null},{"id":"W2542428107","doi":"10.1016/j.jval.2016.09.027","title":"Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Acute coronary syndrome; Logistic regression; Pharmacoepidemiology; Internal medicine; Multivariate analysis; Bivariate analysis; Medication adherence; Emergency medicine","score_opus":0.12613340774085713,"score_gpt":0.36302375385771235,"score_spread":0.23689034611685522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542428107","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20450856,0.00061605556,0.00067994697,0.001069157,0.000066313805,0.00006953558,0.79095304,0.0001901502,0.0018473226],"genre_scores_gemma":[0.23807713,0.00034317875,0.0018310426,0.0005029637,0.000063441716,0.00029040704,0.75756574,0.000042040923,0.0012840321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973017,0.0009078443,0.00047724423,0.0006754992,0.00032299967,0.00031466878],"domain_scores_gemma":[0.98477596,0.0043970174,0.005916783,0.0031730647,0.0011002581,0.00063692266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024576166,0.0005873213,0.0010127992,0.0017171272,0.00044978748,0.0015386979,0.0015415649,0.0023239958,0.0054978374],"category_scores_gemma":[0.024743559,0.0004933837,0.0015076783,0.003819794,0.00036225183,0.0010383155,0.0012315793,0.0017408428,0.0021018442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002464687,0.0004071726,0.87347215,0.0006680566,0.0018632247,0.00020559183,0.000237198,0.0033115388,0.00025564973,0.0010231849,0.10422779,0.011863759],"study_design_scores_gemma":[0.0007806351,0.000355327,0.94999945,0.000415272,0.00074772415,0.00076517166,0.0004996522,0.0077586398,0.00051436655,0.0010980828,0.036956806,0.0001088627],"about_ca_topic_score_codex":0.023462527,"about_ca_topic_score_gemma":0.028831232,"teacher_disagreement_score":0.023462527,"about_ca_system_score_codex":0.00084326806,"about_ca_system_score_gemma":0.0011817991,"threshold_uncertainty_score":0.04665196},"labels":[],"label_agreement":null},{"id":"W2542475746","doi":"10.1016/j.jval.2016.09.824","title":"What are the Most Important Decision-Making Criteria For Innovative Health Technology Integration? A National Survey from French Hospitals Decision-Makers","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Likert scale; Context (archaeology); Multidisciplinary approach; Scale (ratio); Health care; Decision analysis; Operations management; Business; Psychology; Economics","score_opus":0.2974729309116838,"score_gpt":0.4656486341177557,"score_spread":0.1681757032060719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542475746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922421,0.0013900674,0.00039405114,0.0018548616,0.00001609713,0.00003618074,0.0008358212,0.0000055302444,0.0032252555],"genre_scores_gemma":[0.99868554,0.0002920829,0.00023392921,0.00013776378,0.000012613126,0.000018027024,0.00046617154,0.0000025934723,0.00015124014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99198335,0.0037870675,0.0011111269,0.0003805664,0.0014565052,0.0012813397],"domain_scores_gemma":[0.9538847,0.030256588,0.008621615,0.00067035767,0.0037868507,0.0027799255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014333628,0.00038609136,0.000722617,0.0031142368,0.0007852801,0.0030846803,0.00068764796,0.0012186801,0.0032124738],"category_scores_gemma":[0.03326753,0.00021391489,0.0011515481,0.0029124706,0.00063710957,0.001339706,0.00084185344,0.00111529,0.0003483365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028373662,0.00021279427,0.97648597,0.000132164,0.0003045371,0.000067269815,0.0021913762,0.0010505122,0.00010678203,0.00086953206,0.0020305347,0.016264826],"study_design_scores_gemma":[0.000031902397,0.0001315657,0.9872772,0.00020840784,0.00009142696,0.00009270947,0.005975303,0.0019525766,0.00012727473,0.00085562427,0.0032160631,0.00004004671],"about_ca_topic_score_codex":0.028348025,"about_ca_topic_score_gemma":0.02369626,"teacher_disagreement_score":0.028348025,"about_ca_system_score_codex":0.003369729,"about_ca_system_score_gemma":0.0024557342,"threshold_uncertainty_score":0.07580435},"labels":[],"label_agreement":null},{"id":"W2542703735","doi":"10.1016/j.jval.2016.09.1925","title":"The Mosaic Study: Regional Variation in Treatment Patterns Associated with Progression from Initial Insulin Regimen","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Insulin; Medicine; Regimen; Observational study; Internal medicine; Basal (medicine); Diabetes mellitus; Psychosocial; Demography; Endocrinology","score_opus":0.07460817757379205,"score_gpt":0.368022353641351,"score_spread":0.29341417606755893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542703735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886596,0.00017590208,0.00012793233,0.000062484054,0.00000640355,0.0000060194516,0.0004082596,0.0000042717575,0.00034278608],"genre_scores_gemma":[0.99914956,0.000048332156,0.00013195464,0.000025974641,0.000009243226,0.000006251142,0.00038819594,0.000011762885,0.00022870583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853563,0.000747544,0.00009897259,0.00036146923,0.00010319926,0.00015328238],"domain_scores_gemma":[0.99676466,0.0006100087,0.0013292183,0.00063024316,0.0002058911,0.00045998584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017305574,0.0002615883,0.00056142604,0.0007461349,0.00057219336,0.00097509485,0.0007803374,0.000512603,0.0019107033],"category_scores_gemma":[0.00565737,0.00040219183,0.00089231366,0.0014873594,0.00045530376,0.000538875,0.0010487066,0.00071847264,0.00017856323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018533748,0.00004624301,0.9940778,0.000010234693,0.00051735784,0.00006952691,0.0004097742,0.000059970534,0.000754692,0.00010974323,0.00034641338,0.0017448702],"study_design_scores_gemma":[0.00003629247,0.00006857399,0.9990959,0.00000532836,0.00010274792,0.00006659431,0.00028425295,0.00011631557,0.0000403476,0.000036496866,0.00014155448,0.0000054803622],"about_ca_topic_score_codex":0.033274792,"about_ca_topic_score_gemma":0.04052091,"teacher_disagreement_score":0.033274792,"about_ca_system_score_codex":0.00040350386,"about_ca_system_score_gemma":0.0005142601,"threshold_uncertainty_score":0.06616223},"labels":[],"label_agreement":null},{"id":"W2542761608","doi":"10.1016/j.jval.2016.09.1073","title":"Assessment of CTX-1 Bone Biomarker As An Indicator of Antiresorptive Therapy Efficacy And of Persistence In A Fracture Liaison Service","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Biomarker; Persistence (discontinuity); Internal medicine; Osteoporosis; Prospective cohort study; Cohort; Bone resorption; Fragility fracture; Urology; Gastroenterology; Bone mineral; Biology","score_opus":0.06347061313387148,"score_gpt":0.37608397767104207,"score_spread":0.3126133645371706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542761608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973483,0.0005229811,0.00008357516,0.00046126498,0.000020258569,0.00001987579,0.00016429037,0.000007963615,0.0013714845],"genre_scores_gemma":[0.9990631,0.00015175786,0.00015825547,0.00014707838,0.000028945407,0.0000071596005,0.00010688747,0.0000021981805,0.00033470686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987043,0.0003064495,0.00018994378,0.00012018408,0.0003824636,0.00029671585],"domain_scores_gemma":[0.99573684,0.0009064768,0.0018154633,0.000074151,0.0006491471,0.0008179407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011126142,0.00024615726,0.00047102777,0.0018050856,0.0009112704,0.0012650695,0.0007330666,0.0009811901,0.0024694214],"category_scores_gemma":[0.007200425,0.00024826537,0.0004049118,0.001240139,0.0003409068,0.00062212494,0.00050433376,0.0014448658,0.00037729085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009320254,0.00017320624,0.99728334,0.000010053344,0.0000170088,0.00020479398,0.000092152455,0.000024498113,0.00018546164,0.000016027356,0.000119887016,0.001780443],"study_design_scores_gemma":[0.000011701326,0.00067663396,0.995447,0.000033497043,0.00005870806,0.0011575914,0.0011882893,0.0006478185,0.00036944827,0.000052643794,0.00034780343,0.000008784866],"about_ca_topic_score_codex":0.011900766,"about_ca_topic_score_gemma":0.0144257685,"teacher_disagreement_score":0.011900766,"about_ca_system_score_codex":0.0007915391,"about_ca_system_score_gemma":0.001421998,"threshold_uncertainty_score":0.023662984},"labels":[],"label_agreement":null},{"id":"W2542767025","doi":"10.1016/j.jval.2016.09.939","title":"The European Social Preference Measurement (ESPM) Study: Conceptual Considerations and Implementation","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute","funders":"","keywords":"Valuation (finance); Actuarial science; Preference; Framing (construction); Health care; Social preferences; Resource allocation; Psychology; Public economics; Social psychology; Economics; Microeconomics; Engineering","score_opus":0.7162180975358698,"score_gpt":0.4617709975253506,"score_spread":0.25444710001051923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542767025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51578,0.025233382,0.24200682,0.090576954,0.0029177158,0.0016515717,0.0046510124,0.00018442167,0.11699808],"genre_scores_gemma":[0.92154557,0.0017226959,0.06540235,0.005108679,0.0005345686,0.0025999816,0.0007298396,0.00005233185,0.0023040075],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.834558,0.15170164,0.0034220966,0.0030391305,0.006252171,0.0010270617],"domain_scores_gemma":[0.78088343,0.18511628,0.005360165,0.018685741,0.008234002,0.0017204516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15877903,0.00080694247,0.001768435,0.0031252345,0.0016164897,0.0037418567,0.0032229223,0.0036787237,0.004838044],"category_scores_gemma":[0.18992525,0.0005236097,0.002402548,0.0071456335,0.0052349367,0.0056954636,0.006805478,0.00262641,0.00024584366],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010991946,0.0005122107,0.05868944,0.0008067047,0.00081894913,0.00014530915,0.0026435787,0.001589985,0.00022049769,0.7039887,0.010928938,0.21855657],"study_design_scores_gemma":[0.0010444002,0.0028058384,0.24863274,0.004407517,0.0010465682,0.00089608127,0.010375996,0.024912788,0.0021238874,0.6267283,0.07668944,0.00033647558],"about_ca_topic_score_codex":0.0058443504,"about_ca_topic_score_gemma":0.006209667,"teacher_disagreement_score":0.15877903,"about_ca_system_score_codex":0.003016224,"about_ca_system_score_gemma":0.0032896695,"threshold_uncertainty_score":0.8397138},"labels":[],"label_agreement":null},{"id":"W2542811946","doi":"10.1016/j.jval.2016.09.1306","title":"Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Presenteeism; Absenteeism; Purchasing power parity; Medicine; Indirect costs; Demography; Productivity; Observational study; Exchange rate; Business; Finance; Economics; Economic growth; Accounting; Internal medicine","score_opus":0.03406700829581941,"score_gpt":0.3057824574717473,"score_spread":0.2717154491759279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542811946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99721825,0.0007886741,0.00004263294,0.000020138124,0.0000029494847,0.0000074201116,0.0015616493,0.0000013943969,0.00035687324],"genre_scores_gemma":[0.9980457,0.00023859696,0.00005560854,0.000006560299,0.000003084448,0.000007750427,0.001580748,0.0000014352705,0.000060392555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985505,0.00075951614,0.00016992378,0.00016144912,0.00014901061,0.00020967441],"domain_scores_gemma":[0.9980233,0.0007741209,0.0006556625,0.00012038927,0.0002528226,0.00017378115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013619388,0.00052140566,0.00082571415,0.002897439,0.00036435467,0.0009893257,0.000545864,0.0005755512,0.0013328355],"category_scores_gemma":[0.0025033322,0.0003216343,0.001995438,0.0048322207,0.0005014369,0.00059236574,0.0010125653,0.00042309752,0.000111822716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018409361,0.000110865905,0.9898307,0.00018626168,0.0014387432,0.000318536,0.00021221906,0.0016620388,0.00017787084,0.0002694025,0.00025869347,0.0036937492],"study_design_scores_gemma":[0.000047336336,0.0002016082,0.99830925,0.000021903352,0.00025255955,0.0002017692,0.00040109092,0.00027648156,0.000051704388,0.00003344969,0.00019596599,0.0000069374205],"about_ca_topic_score_codex":0.017683217,"about_ca_topic_score_gemma":0.015800593,"teacher_disagreement_score":0.017683217,"about_ca_system_score_codex":0.0012626378,"about_ca_system_score_gemma":0.0005387404,"threshold_uncertainty_score":0.03516054},"labels":[],"label_agreement":null},{"id":"W2542885621","doi":"10.1016/j.jval.2016.09.2202","title":"Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Nivolumab; Value (mathematics); Willingness to pay; Productivity; Cost–benefit analysis; Actuarial science; Medicine; Incremental cost-effectiveness ratio; Quality-adjusted life year; Cost effectiveness; Economics; Risk analysis (engineering); Cancer; Internal medicine; Statistics; Mathematics; Microeconomics; Immunotherapy","score_opus":0.5343160658507669,"score_gpt":0.4181268274163777,"score_spread":0.11618923843438916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542885621","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071915425,0.01140654,0.86700654,0.009612055,0.00063905667,0.00030505704,0.0008349732,0.0002652207,0.038015164],"genre_scores_gemma":[0.87743926,0.0045462567,0.10726077,0.0008562603,0.0006676806,0.00034083906,0.00046057746,0.00011188313,0.008316495],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99582964,0.0029906954,0.0001776135,0.00025780383,0.0005907242,0.00015350277],"domain_scores_gemma":[0.96958625,0.027389953,0.001058326,0.00079340057,0.0008753505,0.00029678244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014171213,0.0014220218,0.0018253729,0.003183679,0.00049541314,0.003583027,0.0011431086,0.001559549,0.006322783],"category_scores_gemma":[0.04770415,0.000526459,0.0016365141,0.0016298665,0.0013635767,0.007290796,0.0016420323,0.0035529414,0.0002829174],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003088868,0.00024967678,0.0061554657,0.00046558725,0.00086254854,0.00025146734,0.00028805478,0.2173461,0.00052554393,0.6487619,0.0070795617,0.11770518],"study_design_scores_gemma":[0.000040671897,0.000094716714,0.0016883833,0.00013869844,0.00020088967,0.00013999105,0.00009886925,0.26969603,0.00025543803,0.72340995,0.004206827,0.000029612218],"about_ca_topic_score_codex":0.0022085253,"about_ca_topic_score_gemma":0.001900201,"teacher_disagreement_score":0.014171213,"about_ca_system_score_codex":0.002015162,"about_ca_system_score_gemma":0.002635019,"threshold_uncertainty_score":0.07494545},"labels":[],"label_agreement":null},{"id":"W2543035678","doi":"10.1016/j.jval.2016.08.243","title":"Risk Share Agreements (RSA), Product Listing Agreements (PLA) or Patient Access Schemes (PAS) - All the Same or Different ?","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Listing (finance); Reimbursement; Negotiation; Business; Government (linguistics); Product (mathematics); Market access; Finance; Accounting; Health care; Political science; Law","score_opus":0.5920221495791247,"score_gpt":0.45508822052241055,"score_spread":0.13693392905671414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543035678","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04203866,0.05138105,0.042537637,0.5189899,0.010802894,0.0001472692,0.0019658424,0.00034841005,0.33178836],"genre_scores_gemma":[0.81002456,0.02468527,0.012410068,0.099321455,0.009150287,0.00016894018,0.000718166,0.00024403534,0.043277256],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99064445,0.0041357167,0.0005506411,0.0010832226,0.0023569977,0.0012289166],"domain_scores_gemma":[0.9822543,0.008294088,0.0037512844,0.0017429162,0.0024716367,0.0014857495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0092262495,0.00051059335,0.0012131007,0.0018303196,0.0013672053,0.009906783,0.0019417375,0.008290657,0.018943658],"category_scores_gemma":[0.036169372,0.0003154249,0.0009600482,0.0035745064,0.0069646398,0.01748232,0.0019840326,0.0071147964,0.0021061592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004824845,0.000043664102,0.0009874881,0.00012318794,0.000049040093,0.000031129177,0.00018716823,0.0002789062,0.00008730801,0.95272106,0.017452994,0.027989797],"study_design_scores_gemma":[0.00006173985,0.00007543236,0.0022544852,0.00074937986,0.00007222512,0.00013352644,0.0007917195,0.00062950864,0.00023251073,0.85823643,0.13669787,0.00006525264],"about_ca_topic_score_codex":0.003929216,"about_ca_topic_score_gemma":0.0034995486,"teacher_disagreement_score":0.018943658,"about_ca_system_score_codex":0.0015998648,"about_ca_system_score_gemma":0.0038129198,"threshold_uncertainty_score":0.06337291},"labels":[],"label_agreement":null},{"id":"W2543134412","doi":"10.1016/j.jval.2016.09.1189","title":"The Cost of Remaining NTM Positive: Health Care Utilization and Costs In A Sample of Patients with Refractory Pulmonary Disease Due To Mycobacterium Avium Complex In Canada, Germany, United Kingdom And France","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Culture conversion; Medicine; Sputum; Sputum culture; Internal medicine; Retrospective cohort study; Cohort; Health care; Regimen; Disease; Pediatrics; Tuberculosis; Pathology","score_opus":0.03656199020766122,"score_gpt":0.3078445204524036,"score_spread":0.2712825302447424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543134412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985973,0.00019527713,0.000014516517,0.00008538847,0.0000026229886,0.0000064174333,0.0006775123,0.0000013618609,0.00041959193],"genre_scores_gemma":[0.9992255,0.00012682086,0.000024859071,0.00004709426,0.000004140939,0.0000043353025,0.00039366426,0.0000010237105,0.0001724859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994006,0.00011006266,0.000078737496,0.000068607456,0.0001267801,0.0002151768],"domain_scores_gemma":[0.99876815,0.00018904508,0.00036980436,0.000028913912,0.00025919042,0.00038486312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000328919,0.0003677725,0.00043711686,0.0015668006,0.0011413161,0.0014904843,0.00092660676,0.0009826692,0.0016426905],"category_scores_gemma":[0.0019189953,0.00032848216,0.00072004576,0.002746466,0.0007912581,0.000601922,0.0007506283,0.0006566713,0.00023148327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079276724,0.000032708915,0.99827814,0.000010887982,0.000059816786,0.00026936596,0.00022844033,0.00014631257,0.00006585565,0.000032126227,0.00016149656,0.0006355091],"study_design_scores_gemma":[0.000003594952,0.000040820276,0.9984566,0.000006447124,0.000016905075,0.00024236555,0.00089378434,0.00020415476,0.000016365924,0.000009173572,0.0001039917,0.0000057905354],"about_ca_topic_score_codex":0.7196198,"about_ca_topic_score_gemma":0.683592,"teacher_disagreement_score":0.2803802,"about_ca_system_score_codex":0.008588985,"about_ca_system_score_gemma":0.002682298,"threshold_uncertainty_score":0.5640628},"labels":[],"label_agreement":null},{"id":"W2543315468","doi":"10.1016/j.jval.2016.08.094","title":"Two New Cancer-Specific Multi-Attribute Utility Instruments: EORTC QLU-C10D and FACT-8D","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Quality of life (healthcare); Worry; Population; Medicine; Psychology; Actuarial science; Psychiatry; Anxiety; Economics; Environmental health","score_opus":0.5655679964228495,"score_gpt":0.45427419967107885,"score_spread":0.11129379675177065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543315468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5639236,0.015403283,0.15029018,0.00899814,0.0015101403,0.0036722072,0.21186645,0.0014339001,0.042902075],"genre_scores_gemma":[0.82341063,0.0034331158,0.09217156,0.0019379123,0.00043127537,0.0064812624,0.06459326,0.0002064553,0.0073344647],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99373627,0.0031261004,0.00067418854,0.0005116493,0.0016105251,0.0003412689],"domain_scores_gemma":[0.9742778,0.014284269,0.006078374,0.0011138225,0.0033780194,0.00086776895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007305329,0.00081936386,0.0011243167,0.0035542313,0.00028687352,0.0015636017,0.0010372576,0.0010821734,0.006660405],"category_scores_gemma":[0.041262865,0.000249128,0.0023570152,0.004533137,0.0005647374,0.0016964023,0.0017507792,0.002090764,0.00093757943],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004240251,0.001470777,0.43221813,0.0015472883,0.0021604707,0.00010399177,0.0005134735,0.020666745,0.0009392989,0.02395433,0.051140536,0.46104467],"study_design_scores_gemma":[0.0017291153,0.0025133023,0.7601298,0.0012542744,0.0017750966,0.00090898044,0.0005774148,0.060625862,0.003411296,0.039426286,0.12722495,0.00042360215],"about_ca_topic_score_codex":0.0030929071,"about_ca_topic_score_gemma":0.0039514583,"teacher_disagreement_score":0.007305329,"about_ca_system_score_codex":0.001831756,"about_ca_system_score_gemma":0.0015740898,"threshold_uncertainty_score":0.038634717},"labels":[],"label_agreement":null},{"id":"W2543358959","doi":"10.1016/j.jval.2016.09.1303","title":"Health Outcomes Related to Legal Blindness Caused By Retinal Disorders in Brazil","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Anxiety; Hospital Anxiety and Depression Scale; Depression (economics); Visual acuity; Observational study; Diabetic retinopathy; Quality of life (healthcare); Psychiatry; Ophthalmology; Internal medicine; Diabetes mellitus","score_opus":0.032924762263596016,"score_gpt":0.3908778715932861,"score_spread":0.35795310932969004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543358959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200636,0.0020953668,0.00013497897,0.0010110437,0.000018077355,0.00003792902,0.0009863884,0.000006369686,0.003703482],"genre_scores_gemma":[0.99928766,0.00040855134,0.000042862648,0.000038571106,0.000004377447,0.0000061317774,0.00014166646,0.0000012392113,0.000069020076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917907,0.0002254553,0.00009540307,0.00010318936,0.00014908637,0.00024770253],"domain_scores_gemma":[0.99714917,0.00052833586,0.0013501702,0.00011176254,0.00041563765,0.0004448862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007285061,0.00025797397,0.00039005277,0.0017235653,0.00063394173,0.00088229444,0.0004349181,0.00040475244,0.0012293444],"category_scores_gemma":[0.005412141,0.00023323347,0.00079521374,0.0016698661,0.00076205743,0.00043526487,0.0011318873,0.0007874172,0.00005423095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002897165,0.00006649878,0.9937836,0.00008573773,0.000107527514,0.00020901563,0.00089766766,0.000050929575,0.00014280663,0.0008075462,0.00023992987,0.0035798047],"study_design_scores_gemma":[0.0000067025935,0.000048228678,0.99582064,0.00014205999,0.0000980363,0.00029355,0.0023084101,0.00021574991,0.000055894463,0.00038943836,0.0006099157,0.000011324697],"about_ca_topic_score_codex":0.198551,"about_ca_topic_score_gemma":0.18869455,"teacher_disagreement_score":0.198551,"about_ca_system_score_codex":0.0033278198,"about_ca_system_score_gemma":0.002790846,"threshold_uncertainty_score":0.3947906},"labels":[],"label_agreement":null},{"id":"W2543659530","doi":"10.1016/j.jval.2016.09.1540","title":"Resource Utilization and Costs Associated with the Investigation of Pulmonary Nodules in Quebec, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cegep de Saint Jerome; Centre Hospitalier de l’Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Nodule (geology); Lung cancer; Watchful waiting; Solitary pulmonary nodule; Health care; Medical record; Radiology; Cancer; Computed tomography; Internal medicine","score_opus":0.030454115229304163,"score_gpt":0.26573616129985494,"score_spread":0.23528204607055078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543659530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535345,0.00645437,0.00022592304,0.0063334047,0.00011406326,0.0001046339,0.0217363,0.000042813066,0.011454072],"genre_scores_gemma":[0.9905657,0.0021308633,0.00022896915,0.00056088937,0.000033012504,0.000032342265,0.003463646,0.0000123188265,0.002972245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986498,0.00017995675,0.00011358955,0.00009675035,0.0004117338,0.0005482185],"domain_scores_gemma":[0.99535745,0.0004617138,0.0009019129,0.00006526399,0.0016415621,0.0015720831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048538085,0.00034491337,0.00045607783,0.0015649608,0.0021031168,0.0018065658,0.0016801705,0.00084933994,0.0049030785],"category_scores_gemma":[0.0043660807,0.000365994,0.0009972597,0.0043229777,0.000683055,0.0004044335,0.0008070517,0.0013438393,0.0002540762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002676122,0.00015016423,0.96026057,0.00017814426,0.0003346796,0.00052915915,0.00039907653,0.0031458803,0.00018610057,0.0010484938,0.016795175,0.016704954],"study_design_scores_gemma":[0.000040185892,0.00003446998,0.9934635,0.00015687237,0.00007902585,0.00013323365,0.000947963,0.0021979287,0.000049708444,0.000091744965,0.0027778847,0.0000276118],"about_ca_topic_score_codex":0.9987477,"about_ca_topic_score_gemma":0.9991304,"teacher_disagreement_score":0.09997963,"about_ca_system_score_codex":0.09997963,"about_ca_system_score_gemma":0.07051281,"threshold_uncertainty_score":0.7254064},"labels":[],"label_agreement":null},{"id":"W2543692165","doi":"10.1016/j.jval.2016.09.2115","title":"A Systematic Review On The Epidemiology of NRAS-Mutant Melanoma in Europe and Australia","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Medicine; Incidence (geometry); Epidemiology; Oncology; Stage (stratigraphy); Dermatology; Internal medicine; Disease; Cancer; Cancer research; Biology; Colorectal cancer","score_opus":0.2677690281873952,"score_gpt":0.46878631450449404,"score_spread":0.20101728631709886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543692165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012012576,0.9980282,0.000048593127,0.00015893993,0.00006157897,0.000043228316,0.00032110425,0.0000016329093,0.00013546346],"genre_scores_gemma":[0.013295358,0.98584276,0.00022506992,0.0002961873,0.000047858037,0.000060382597,0.00015978015,0.0000013650111,0.00007125817],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99516284,0.0013337318,0.0022070848,0.00044017434,0.0006843443,0.00017181181],"domain_scores_gemma":[0.98838204,0.007270454,0.0029000957,0.0001592168,0.0011057393,0.00018238983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043206676,0.00096522697,0.0055488776,0.008281793,0.00039060108,0.0017425996,0.0009977097,0.0013066131,0.0026067796],"category_scores_gemma":[0.0212507,0.00072092423,0.0075110113,0.010544094,0.00052666076,0.0014754637,0.0014523905,0.00097240723,0.00015111383],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003621815,0.000023843668,0.0060060825,0.9031074,0.030569822,0.00022957375,0.0002580793,0.00021399096,0.0002203948,0.00033055246,0.0024489034,0.056229074],"study_design_scores_gemma":[0.0002981733,0.00026294988,0.03239684,0.7265943,0.20356493,0.0010115405,0.0005125055,0.00010125215,0.00018227751,0.0005241056,0.03447863,0.00007244396],"about_ca_topic_score_codex":0.01980498,"about_ca_topic_score_gemma":0.05844265,"teacher_disagreement_score":0.01980498,"about_ca_system_score_codex":0.0025401348,"about_ca_system_score_gemma":0.00938553,"threshold_uncertainty_score":0.039379418},"labels":[],"label_agreement":null},{"id":"W2543939459","doi":"10.1016/j.jval.2016.09.1151","title":"Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Presenteeism; Randomized controlled trial; Placebo; Internal medicine; Bristol-Myers; Productivity; Physical therapy; Arthritis; Rheumatoid arthritis; Adalimumab; Alternative medicine","score_opus":0.13857463836310696,"score_gpt":0.348152258059836,"score_spread":0.20957761969672906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543939459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895966,0.000618276,0.00002308384,0.000048088557,0.000008463514,0.000004575784,0.00018058172,0.0000013735536,0.0001558533],"genre_scores_gemma":[0.9995222,0.00009813362,0.000013554902,0.00001609448,0.000010561925,0.000003866449,0.00022936851,3.079318e-7,0.00010585668],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923325,0.00024706055,0.00008575158,0.00012944682,0.00009784382,0.00020671345],"domain_scores_gemma":[0.9981725,0.00048128358,0.0007816933,0.000094422176,0.00013086462,0.00033920046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011508398,0.0003375394,0.00082252506,0.00049320667,0.00033075098,0.00074011687,0.00036043196,0.00085233443,0.0010279685],"category_scores_gemma":[0.0038092975,0.00021185062,0.0016878173,0.0007444705,0.0003192535,0.0008981494,0.0005714314,0.00095017266,0.00014375016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016657747,0.0008036196,0.9664106,0.000097768745,0.0011059601,0.00016620892,0.00022074021,0.0006245961,0.00043304902,0.000026826678,0.00016783664,0.013285033],"study_design_scores_gemma":[0.00012352457,0.001350398,0.997352,0.000009144741,0.00036036168,0.00006829909,0.00016744924,0.00035684602,0.00005448093,0.00003653295,0.00010967889,0.000011395955],"about_ca_topic_score_codex":0.006176738,"about_ca_topic_score_gemma":0.0071490244,"teacher_disagreement_score":0.006176738,"about_ca_system_score_codex":0.00058968045,"about_ca_system_score_gemma":0.00042563642,"threshold_uncertainty_score":0.012281597},"labels":[],"label_agreement":null},{"id":"W2544016569","doi":"10.1016/j.jval.2016.09.1552","title":"A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Santé Montérégie; Université de Montréal; Pfizer (Canada); Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; Kingston General Hospital","funders":"","keywords":"Medicine; Metastatic breast cancer; Quality of life (healthcare); Work productivity; Cohort; Breast cancer; Internal medicine; Cancer; Prospective cohort study; Disease; Cohort study; Physical therapy; Oncology; Productivity; Nursing","score_opus":0.35795054518969815,"score_gpt":0.5272409181921662,"score_spread":0.16929037300246808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544016569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99909425,0.00019836982,0.000043677624,0.00003834134,0.0000072003677,0.00006740381,0.00038747652,0.0000010948619,0.00016226566],"genre_scores_gemma":[0.99834406,0.00014713423,0.0001373519,0.00005141671,0.000014050354,0.00020186573,0.0009894662,0.0000019294648,0.0001127129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964933,0.0021200976,0.0004266039,0.00027710025,0.0003323044,0.00035069967],"domain_scores_gemma":[0.9893127,0.003877791,0.0035414572,0.00071138074,0.0012966973,0.0012599175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056677423,0.0007653838,0.0011906255,0.0014322625,0.0017291799,0.0015359026,0.0006769355,0.0010553483,0.0016444386],"category_scores_gemma":[0.012749419,0.00041850054,0.0022777922,0.0026462523,0.001030617,0.0015577815,0.0013433882,0.0013709781,0.0003789674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067462493,0.0025577843,0.9832413,0.00021343815,0.0012440705,0.00017233132,0.0010555716,0.00021110206,0.00013332603,0.00008866314,0.00041756974,0.0039184177],"study_design_scores_gemma":[0.0009460879,0.0048066727,0.98973745,0.00007591141,0.00053913327,0.0002002937,0.0025736766,0.00033156076,0.00009027962,0.00009418235,0.00055788615,0.000046964546],"about_ca_topic_score_codex":0.009848326,"about_ca_topic_score_gemma":0.011667288,"teacher_disagreement_score":0.009848326,"about_ca_system_score_codex":0.0020016504,"about_ca_system_score_gemma":0.0014008618,"threshold_uncertainty_score":0.029974282},"labels":[],"label_agreement":null},{"id":"W2544050541","doi":"10.1016/j.jval.2016.09.943","title":"Dose Escalation of Biologics in Crohn’s Disease: Summary of Observational Studies in the UK","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Observational study; Adalimumab; Infliximab; Audit; Family medicine; MEDLINE; Referral; Vedolizumab; Internal medicine; Crohn's disease; Disease; Pediatrics","score_opus":0.10781898280713792,"score_gpt":0.35012983698760963,"score_spread":0.2423108541804717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544050541","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5517179,0.43393528,0.0017861649,0.002532603,0.00035289887,0.0001555943,0.0060759145,0.000052932388,0.0033907706],"genre_scores_gemma":[0.95223224,0.042218953,0.0007847742,0.0014682557,0.00019597128,0.00008910296,0.0025965916,0.000047259447,0.00036689136],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.98396075,0.007827555,0.004001635,0.0016775423,0.0020759248,0.0004566301],"domain_scores_gemma":[0.94334257,0.031937573,0.016841894,0.0038102777,0.0035305019,0.0005372264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009545753,0.0005175109,0.003534564,0.00088386744,0.00028172688,0.0020257053,0.00068136066,0.0012234079,0.002275155],"category_scores_gemma":[0.038798753,0.00056558935,0.0043072705,0.0033482285,0.0008196325,0.0012560628,0.0009084702,0.0018921979,0.0003044751],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067362055,0.000334568,0.67574066,0.013970742,0.030072436,0.0003917428,0.0008169582,0.0023507753,0.0023877467,0.001005685,0.006476808,0.1990898],"study_design_scores_gemma":[0.0031173567,0.002852294,0.96225786,0.0033721435,0.0148425,0.0008898873,0.00032595877,0.0005970274,0.0005987814,0.00054730754,0.010510874,0.000088000685],"about_ca_topic_score_codex":0.008283784,"about_ca_topic_score_gemma":0.0069426317,"teacher_disagreement_score":0.009545753,"about_ca_system_score_codex":0.0022009704,"about_ca_system_score_gemma":0.0011616246,"threshold_uncertainty_score":0.050483406},"labels":[],"label_agreement":null},{"id":"W2544152081","doi":"10.1016/j.jval.2016.09.2251","title":"Development of a Global Model for the Economic Evaluation of Pharmacogenomics Tests for Early-Stage Breast Cancer Treatment","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; Breast cancer; Economic evaluation; Time horizon; Stage (stratigraphy); Christian ministry; Clinical trial; Oncology; Internal medicine; Cancer; Intensive care medicine; Economics; Pharmacology","score_opus":0.5941275241911437,"score_gpt":0.5022858520500565,"score_spread":0.09184167214108718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544152081","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055490553,0.0014967846,0.8854935,0.009764586,0.00024300691,0.00026574926,0.0024740794,0.00033379372,0.044437867],"genre_scores_gemma":[0.782204,0.0017683785,0.18719763,0.0010738274,0.00018335141,0.0008889362,0.0019447118,0.00031717314,0.02442211],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981463,0.0013145972,0.000047956655,0.00016994102,0.00014355301,0.0001777039],"domain_scores_gemma":[0.9943526,0.0044485633,0.00025033753,0.0001779544,0.00051736314,0.00025318313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005541428,0.001339158,0.0020879195,0.0013508312,0.00066966924,0.0033090774,0.0023284624,0.003307293,0.010129149],"category_scores_gemma":[0.01702119,0.00095046964,0.0018358144,0.002013036,0.0015644022,0.002731019,0.0022133188,0.0034310368,0.0007235663],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006162296,0.000024931567,0.0008368916,0.00003573517,0.00005970867,0.00011175811,0.000033570792,0.90212727,0.000073806135,0.08937281,0.0021941706,0.005067702],"study_design_scores_gemma":[0.00007529435,0.000029891415,0.00036994737,0.000025328722,0.000043326778,0.000054048982,0.000028432312,0.9373467,0.00006380295,0.059547797,0.0023983796,0.000017029599],"about_ca_topic_score_codex":0.022150096,"about_ca_topic_score_gemma":0.013530284,"teacher_disagreement_score":0.022150096,"about_ca_system_score_codex":0.004089837,"about_ca_system_score_gemma":0.0037854917,"threshold_uncertainty_score":0.04404235},"labels":[],"label_agreement":null},{"id":"W2544190873","doi":"10.1016/j.jval.2016.08.471","title":"Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cornerstone; MEDLINE; Medicine; China; Inclusion (mineral); Lung cancer; Family medicine; Clinical trial; Data science; Computer science; Internal medicine; Psychology; Geography; Political science","score_opus":0.29867573564660616,"score_gpt":0.5047160025495164,"score_spread":0.20604026690291027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544190873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65113705,0.004296031,0.020101627,0.0019139247,0.000096349155,0.0014805194,0.30887413,0.00033079003,0.011769593],"genre_scores_gemma":[0.8357873,0.0013459314,0.023886459,0.00021958613,0.000027308175,0.0015835288,0.13587093,0.000056148172,0.0012228239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956572,0.0012544338,0.0009872443,0.0007261178,0.00093452143,0.00044034343],"domain_scores_gemma":[0.9870439,0.0038751275,0.0028430303,0.002077547,0.0036045194,0.00055582053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057146708,0.0006202366,0.0008014208,0.01285526,0.0010612836,0.0018332204,0.0014665052,0.00048477814,0.0025123477],"category_scores_gemma":[0.018544476,0.00040023067,0.000969611,0.029158376,0.0004589593,0.00095688726,0.00232497,0.00049797783,0.00037260255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027086155,0.00017330576,0.8962974,0.0027242964,0.0012067895,0.0007075195,0.0025988873,0.0066704988,0.0020553765,0.00528267,0.012982119,0.0690303],"study_design_scores_gemma":[0.000070114904,0.000060017483,0.9484349,0.0007474672,0.00073932705,0.00018947406,0.0025768457,0.0070145666,0.0019058068,0.0023164633,0.03588164,0.00006339018],"about_ca_topic_score_codex":0.19422716,"about_ca_topic_score_gemma":0.15368739,"teacher_disagreement_score":0.19422716,"about_ca_system_score_codex":0.0038015496,"about_ca_system_score_gemma":0.014333197,"threshold_uncertainty_score":0.38619328},"labels":[],"label_agreement":null},{"id":"W2544318409","doi":"10.1016/j.jval.2016.09.2250","title":"Development of a Global Model for the Economic Evaluation of Personalized Medicine for the Treatment of Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Christian ministry; Personalized medicine; Economic evaluation; Medical physics; Precision medicine; Prostate; Gynecology; Oncology; Cancer; Internal medicine; Bioinformatics; Political science; Pathology","score_opus":0.23587646054394062,"score_gpt":0.4658859456792348,"score_spread":0.23000948513529418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544318409","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06951334,0.0025483146,0.8143176,0.013012657,0.00033877642,0.0003987124,0.0017725099,0.00024040403,0.09785766],"genre_scores_gemma":[0.84339243,0.0022827592,0.13349117,0.0010677599,0.00019922231,0.00069576415,0.0009132274,0.00019738487,0.017760267],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996974,0.0022950196,0.00005402225,0.00023292797,0.00021954863,0.00022448752],"domain_scores_gemma":[0.99577135,0.003313037,0.00018735563,0.00018167756,0.0003601318,0.00018647718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006555157,0.0014536926,0.0021360433,0.0013924649,0.00073916675,0.004343642,0.0025148224,0.003232282,0.009484146],"category_scores_gemma":[0.015206133,0.00076671975,0.0018390452,0.0021598777,0.0016858452,0.0041040513,0.002499915,0.0033561222,0.00050532696],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012482172,0.000058122438,0.0010441252,0.000089044486,0.00014455855,0.00014818607,0.00008157508,0.6599881,0.00013604233,0.32241228,0.003447546,0.012325608],"study_design_scores_gemma":[0.00010634056,0.000079339276,0.0006476527,0.000058578556,0.00009255713,0.00009223622,0.00009365049,0.70048743,0.00009890821,0.29238513,0.005823849,0.00003431087],"about_ca_topic_score_codex":0.012635837,"about_ca_topic_score_gemma":0.008462299,"teacher_disagreement_score":0.012635837,"about_ca_system_score_codex":0.0045672343,"about_ca_system_score_gemma":0.004060242,"threshold_uncertainty_score":0.034667373},"labels":[],"label_agreement":null},{"id":"W2544320374","doi":"10.1016/j.jval.2016.09.2059","title":"Perioperative Therapies Reducing Homologous Transfusions During Cardiovascular Surgery: A Network Meta-Analysis of Randomized Controlled Trials","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Continental (Canada)","funders":"","keywords":"Medicine; Perioperative; Randomized controlled trial; Blood transfusion; Odds ratio; Anesthesia; Placebo; Blood management; Meta-analysis; Surgery; Internal medicine","score_opus":0.12920722486443761,"score_gpt":0.3305678877174325,"score_spread":0.2013606628529949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544320374","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15073983,0.84058416,0.0040185996,0.00062911847,0.00093265506,0.0008205913,0.0010905142,0.00014169043,0.0010428758],"genre_scores_gemma":[0.8830724,0.107856326,0.0049957763,0.0012818144,0.0005209299,0.00069741573,0.00099348,0.00007805908,0.00050389237],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9842105,0.01013318,0.002537421,0.0017803212,0.000837036,0.0005015972],"domain_scores_gemma":[0.97709674,0.016982777,0.0035617482,0.0012751857,0.0006766159,0.0004069268],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01415127,0.0030705447,0.0131450845,0.0020050157,0.0007109999,0.003013343,0.0018485852,0.0024047534,0.0035839994],"category_scores_gemma":[0.03676185,0.0016900396,0.033272408,0.0023799583,0.0010880604,0.0021358216,0.0016463201,0.0036487714,0.0002863087],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037121825,0.000073876836,0.0053747953,0.029877627,0.92153835,0.000057596055,0.000052528347,0.00046358426,0.00029694894,0.00007520271,0.00027106647,0.004796608],"study_design_scores_gemma":[0.012842233,0.0007386316,0.0044713495,0.0015572221,0.9793888,0.000041881678,0.000029020635,0.0002312014,0.00010564861,0.00019901463,0.0003738037,0.00002125014],"about_ca_topic_score_codex":0.0032325876,"about_ca_topic_score_gemma":0.0064304513,"teacher_disagreement_score":0.9868549,"about_ca_system_score_codex":0.0014185423,"about_ca_system_score_gemma":0.0012944747,"threshold_uncertainty_score":0.07484001},"labels":[],"label_agreement":null},{"id":"W2544444843","doi":"10.1016/j.jval.2016.09.1074","title":"Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment (Sirround-D)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Rheumatology; Clinical endpoint; Adverse effect; Randomized controlled trial; Monoclonal antibody; Gastroenterology; Antibody; Immunology; Pathology","score_opus":0.028939958127314966,"score_gpt":0.3266549871393329,"score_spread":0.2977150290120179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544444843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96166193,0.011074995,0.0027750826,0.0013602569,0.0012838658,0.012709386,0.0039363154,0.00038245498,0.004815658],"genre_scores_gemma":[0.975114,0.0040226746,0.0040811426,0.003092313,0.00094909366,0.0071573337,0.002817427,0.00009717022,0.0026688783],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981925,0.0009222218,0.00017667608,0.0003189801,0.00016960272,0.00022008947],"domain_scores_gemma":[0.99652463,0.0014453676,0.0006222611,0.00030456067,0.0002961835,0.00080702396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055681346,0.0024528552,0.0050766277,0.0007336228,0.0011536436,0.0013248287,0.0012537702,0.0036725982,0.006044625],"category_scores_gemma":[0.0046614334,0.0011863878,0.0033493773,0.00059252896,0.0023173399,0.0019885234,0.000492329,0.0052912105,0.0011363719],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9805131,0.0083297705,0.00038739672,0.0004131024,0.0010310943,0.000033105393,0.000059448485,0.00014525493,0.0023382471,0.000055477332,0.000463685,0.0062304274],"study_design_scores_gemma":[0.9639385,0.033637084,0.001226418,0.000015314099,0.00049040787,0.000016631146,0.000010473818,0.000087084394,0.00027719743,0.00007126205,0.00021739678,0.000012298021],"about_ca_topic_score_codex":0.0011998757,"about_ca_topic_score_gemma":0.002439856,"teacher_disagreement_score":0.006044625,"about_ca_system_score_codex":0.0008543525,"about_ca_system_score_gemma":0.0020627032,"threshold_uncertainty_score":0.029447436},"labels":[],"label_agreement":null},{"id":"W2544452208","doi":"10.1016/j.jval.2016.09.1188","title":"The Economic Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Canada, France, United Kingdom And Germany","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Culture conversion; Health care; Exacerbation; Mycobacterium abscessus; Total cost; Indirect costs; Retrospective cohort study; Cohort; Family medicine; Emergency medicine; Pediatrics; Tuberculosis; Internal medicine; Sputum","score_opus":0.018953855520342264,"score_gpt":0.27625959904875586,"score_spread":0.25730574352841357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544452208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96913344,0.010010829,0.00008071614,0.005466238,0.00006887012,0.000021580505,0.0061111576,0.000012142394,0.009094918],"genre_scores_gemma":[0.99354047,0.0034310417,0.00007837096,0.00020214808,0.000022153474,0.000004992621,0.0011312686,0.0000034530872,0.0015861754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989207,0.00014875982,0.000079692545,0.00005493044,0.00034747116,0.00044852824],"domain_scores_gemma":[0.99785835,0.00016492396,0.0004684047,0.00002897642,0.0007493478,0.0007300281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005261866,0.00026712398,0.000349945,0.0025147998,0.0013296094,0.0024786086,0.0007514134,0.00068445504,0.0023891497],"category_scores_gemma":[0.0026856125,0.000181542,0.00051719556,0.0046931463,0.00083151355,0.00054750877,0.0011196533,0.00065846456,0.00012534062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041759794,0.0000696381,0.9542724,0.00017222154,0.00030760278,0.001448934,0.0011003016,0.0020834657,0.0002623637,0.0051704124,0.008004602,0.026690481],"study_design_scores_gemma":[0.000008171334,0.000016906759,0.99366283,0.0000856558,0.000038935217,0.00019516423,0.0016198497,0.00055723183,0.00004110555,0.00009559333,0.0036646763,0.00001382201],"about_ca_topic_score_codex":0.9870701,"about_ca_topic_score_gemma":0.98929405,"teacher_disagreement_score":0.039090175,"about_ca_system_score_codex":0.039090175,"about_ca_system_score_gemma":0.024206538,"threshold_uncertainty_score":0.28362036},"labels":[],"label_agreement":null},{"id":"W2544459228","doi":"10.1016/j.jval.2016.09.1275","title":"Direct and Indirect Costs Associated with Legal Blindness Caused by Retinal Disorders in Brazil","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Observational study; Indirect costs; Visual acuity; Visual impairment; Pediatrics; Family medicine; Demography; Ophthalmology; Psychiatry","score_opus":0.02628638315084306,"score_gpt":0.3318808093580622,"score_spread":0.3055944262072191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544459228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982077,0.0063422644,0.00019298804,0.0019352232,0.000031535634,0.00004203911,0.0020083892,0.000008182627,0.007362378],"genre_scores_gemma":[0.9981896,0.0013006248,0.00008122354,0.000038102666,0.000007763753,0.000006605968,0.00016953723,0.0000018619187,0.00020467887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990514,0.00029991966,0.000116477,0.000067563866,0.00019884865,0.00026579696],"domain_scores_gemma":[0.9973943,0.0005936551,0.0011120026,0.00008307212,0.00039530554,0.00042151188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005408551,0.00029682234,0.00032968252,0.0017266867,0.00041443878,0.0009579915,0.00046421724,0.0004324915,0.0020368746],"category_scores_gemma":[0.005627097,0.0002554325,0.0010849992,0.001805046,0.00052592135,0.00037312543,0.0010327474,0.00071420666,0.00007363318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090892005,0.00008354739,0.9804555,0.00022888806,0.00036298702,0.0008489128,0.00064102764,0.00034942894,0.00026846357,0.0032410647,0.0006759199,0.012753308],"study_design_scores_gemma":[0.000014415913,0.000060827468,0.9928965,0.0002552247,0.00028756584,0.0011209957,0.0016119395,0.00087745045,0.00006908665,0.00091312185,0.0018769397,0.000015861408],"about_ca_topic_score_codex":0.21520486,"about_ca_topic_score_gemma":0.23808306,"teacher_disagreement_score":0.21520486,"about_ca_system_score_codex":0.0053537074,"about_ca_system_score_gemma":0.0031925347,"threshold_uncertainty_score":0.4279045},"labels":[],"label_agreement":null},{"id":"W2544598042","doi":"10.1016/j.jval.2016.09.1444","title":"Comparison of Orphan Drug Market Access in A Sample of EU Countries, Ausralia, Canada and US","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Orphan drug; Revenue; Health technology; Business; Market access; Authorization; European union; Public economics; Cost–benefit analysis; Drug prices; Developed country; Marketing authorization; Health care; Actuarial science; Finance; International trade; Economic growth; Medicine; Economics; Political science; Environmental health; Population","score_opus":0.3440653529581487,"score_gpt":0.4416841600104544,"score_spread":0.09761880705230569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544598042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933971,0.0008150388,0.00003754216,0.00014125925,0.000005793568,0.00001530308,0.0038326068,0.0000029210007,0.0017523909],"genre_scores_gemma":[0.99634534,0.0004077075,0.00003953048,0.000057250876,0.000003631181,0.000008540086,0.0027224657,0.0000037587004,0.00041174897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987859,0.00020988713,0.0001245869,0.00017074984,0.00028210797,0.00042683125],"domain_scores_gemma":[0.9971762,0.00047337948,0.0008985974,0.0001043239,0.0008302841,0.0005172139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008606296,0.0002162919,0.00048528696,0.0033838602,0.00072512764,0.0016986277,0.00059732,0.00047229472,0.0024005475],"category_scores_gemma":[0.004301861,0.00018657483,0.00077829993,0.007658214,0.00059666735,0.00055947335,0.0014314122,0.0005462562,0.00018056248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031046208,0.000047424423,0.9936707,0.000057215853,0.00031475472,0.00015542547,0.0007554795,0.000182359,0.000121133475,0.00056461914,0.00085282396,0.0029674547],"study_design_scores_gemma":[0.000008684505,0.000029171335,0.99756795,0.00002183047,0.000038878145,0.000082784674,0.0013208363,0.000100941725,0.000026967162,0.00003205516,0.0007642617,0.000005599069],"about_ca_topic_score_codex":0.7073637,"about_ca_topic_score_gemma":0.74472106,"teacher_disagreement_score":0.996769,"about_ca_system_score_codex":0.00323097,"about_ca_system_score_gemma":0.0034218633,"threshold_uncertainty_score":0.5887193},"labels":[],"label_agreement":null},{"id":"W2544648193","doi":"10.1016/j.jval.2016.09.1631","title":"Risk of Motor-Vehicle Accidents Increases with Multimorbidity","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Autopsy Techniques and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information; Bruyère; University of Ottawa","funders":"","keywords":"Medicine; Confounding; Odds ratio; Logistic regression; Socioeconomic status; Demography; Environmental health; Internal medicine; Population","score_opus":0.03767953578546405,"score_gpt":0.3307678714438383,"score_spread":0.2930883356583742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544648193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98925203,0.0028031555,0.0013688041,0.0011278809,0.00006334962,0.000013375765,0.0008546622,0.00006854203,0.0044482513],"genre_scores_gemma":[0.9975809,0.0005723974,0.00065070536,0.00012553533,0.00012518445,0.000007696897,0.0002495642,0.00001087713,0.00067718164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988017,0.00039847265,0.00014900447,0.00024309807,0.00019887043,0.00020896511],"domain_scores_gemma":[0.9903936,0.0023295898,0.004801042,0.00078770425,0.00081193086,0.00087612966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010873864,0.0004988741,0.0007083896,0.0015347368,0.0008174762,0.0013941117,0.0005312002,0.0009775362,0.007369976],"category_scores_gemma":[0.013186083,0.0005904329,0.0011942049,0.0021951506,0.00036448773,0.0011053266,0.0014346228,0.0018883556,0.00069142884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036508896,0.000025294234,0.9964503,0.0000088723145,0.00009378743,0.000036261667,0.000032066033,0.000030100733,0.000046946316,0.000040600644,0.00011570725,0.0030835485],"study_design_scores_gemma":[0.0000016564468,0.000026403197,0.99865544,0.000013058395,0.000058246656,0.00035601037,0.00013138083,0.00026083263,0.00003038346,0.00029516322,0.00016647119,0.000004932642],"about_ca_topic_score_codex":0.004461356,"about_ca_topic_score_gemma":0.005347873,"teacher_disagreement_score":0.007369976,"about_ca_system_score_codex":0.00034411164,"about_ca_system_score_gemma":0.0005781915,"threshold_uncertainty_score":0.024654984},"labels":[],"label_agreement":null},{"id":"W2544861797","doi":"10.1016/j.jval.2016.09.1171","title":"Comparative Efficacy of Reslizumab and Mepolizumab For The Treatment of Asthma: A Network Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mepolizumab; Medicine; Internal medicine; Exacerbation; Population; Asthma; Gastroenterology; Eosinophil","score_opus":0.1694092795294351,"score_gpt":0.3925726666712042,"score_spread":0.22316338714176912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544861797","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26744026,0.71915823,0.007019872,0.00081435085,0.0012947031,0.0006593682,0.0018342072,0.00017716941,0.0016018248],"genre_scores_gemma":[0.95660293,0.037942346,0.002943147,0.0005210195,0.00031017585,0.00039228454,0.0007517693,0.000058875154,0.00047744322],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98137337,0.013505604,0.0017837549,0.0018201998,0.0011249476,0.00039214367],"domain_scores_gemma":[0.97558516,0.019108338,0.002488336,0.0016143858,0.0008264587,0.00037738698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018864514,0.00320902,0.013544663,0.0022903027,0.0005865283,0.002428413,0.002201909,0.0022065055,0.0026815007],"category_scores_gemma":[0.03233432,0.0016321477,0.03470269,0.0022273127,0.0008952535,0.0020598606,0.0015932703,0.0029624668,0.00028473747],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038103983,0.00005497885,0.0049207886,0.009517831,0.94299847,0.000052019037,0.000037459828,0.0008869803,0.00027398267,0.000085556414,0.00014614515,0.002921767],"study_design_scores_gemma":[0.007768632,0.00075425743,0.003792283,0.0004479627,0.9858871,0.000046737066,0.000023356513,0.0006132894,0.0001158899,0.00021003268,0.00031944353,0.0000210386],"about_ca_topic_score_codex":0.004304805,"about_ca_topic_score_gemma":0.00663772,"teacher_disagreement_score":0.018864514,"about_ca_system_score_codex":0.0019730981,"about_ca_system_score_gemma":0.00088841846,"threshold_uncertainty_score":0.099766254},"labels":[],"label_agreement":null},{"id":"W2544979968","doi":"10.1016/j.jval.2016.09.1067","title":"Gout Diagnosis and Possible Increased Risk of Joint Replacement: A Population-Based Cohort Study of Older Adults","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Gout; Internal medicine; Population; Cohort; Surgery; Physical therapy","score_opus":0.02108006549057902,"score_gpt":0.2851093319278378,"score_spread":0.26402926643725877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544979968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914205,0.00023877912,0.00006476613,0.00004513202,0.000013040123,0.00001020094,0.000255354,0.0000023754012,0.00022831206],"genre_scores_gemma":[0.9993218,0.00014336836,0.00005669439,0.00004696635,0.000016798607,0.0000079546335,0.0001841975,0.0000016596622,0.00022063788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954945,0.00010288912,0.000043629356,0.00012993607,0.0000670385,0.00010696592],"domain_scores_gemma":[0.9991947,0.00009876213,0.00022830121,0.00012957484,0.00009703597,0.0002515175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068776595,0.00050547824,0.00061962515,0.0008107086,0.0011626076,0.0011827237,0.00048825768,0.0012101976,0.0016490694],"category_scores_gemma":[0.0016760741,0.00095146307,0.0013323996,0.0012805344,0.00042884488,0.00082609785,0.0006418769,0.0015406557,0.00028316354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027105794,0.00013724437,0.9985056,0.000006263841,0.00018275119,0.00010112394,0.00010611442,0.000016445394,0.00024895885,0.0000130771705,0.0000651102,0.00034635924],"study_design_scores_gemma":[0.00002797839,0.0001627173,0.9989862,0.000005186307,0.00012126723,0.00019815286,0.00025772085,0.000114017734,0.000022831355,0.000020648042,0.00007781602,0.0000055545997],"about_ca_topic_score_codex":0.023243709,"about_ca_topic_score_gemma":0.028330773,"teacher_disagreement_score":0.023243709,"about_ca_system_score_codex":0.0003791226,"about_ca_system_score_gemma":0.0005181254,"threshold_uncertainty_score":0.046216786},"labels":[],"label_agreement":null},{"id":"W2545044819","doi":"10.1016/j.jval.2016.09.2218","title":"Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Everolimus; Medicine; Health economics; Reimbursement; Population; Health care; Actuarial science; Activity-based costing; Cost effectiveness; Hazard ratio; Indirect costs; Quality-adjusted life year; Internal medicine; Public health; Environmental health; Risk analysis (engineering); Accounting; Economics; Confidence interval","score_opus":0.03604510639432949,"score_gpt":0.3591619625200114,"score_spread":0.3231168561256819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545044819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38795352,0.22107768,0.002728892,0.22940929,0.0019103907,0.00038612582,0.041967157,0.00012062854,0.11444632],"genre_scores_gemma":[0.94191366,0.04352477,0.0014811407,0.004128683,0.0008051585,0.00005095465,0.005828726,0.00002071113,0.0022461363],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99763346,0.0006830947,0.0001343123,0.00012067058,0.0008438803,0.0005846425],"domain_scores_gemma":[0.99601775,0.000779476,0.00047827675,0.000048777572,0.0017653252,0.00091038557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019364983,0.0007984324,0.0010612372,0.0020839164,0.0009789001,0.0033886204,0.0014482257,0.0014834513,0.004777326],"category_scores_gemma":[0.00914392,0.0002735341,0.002646158,0.004248541,0.00087221625,0.00096460234,0.0008140121,0.0021656447,0.00018156589],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007876347,0.00097267743,0.27679807,0.0053280103,0.013773769,0.0019450468,0.0010177757,0.10825251,0.0022087232,0.08466406,0.14569269,0.35147038],"study_design_scores_gemma":[0.0027718048,0.0019373231,0.75394,0.006263783,0.012965636,0.002000927,0.00422543,0.06365965,0.0009458008,0.019292515,0.13139115,0.0006059761],"about_ca_topic_score_codex":0.92685634,"about_ca_topic_score_gemma":0.9423017,"teacher_disagreement_score":0.94218427,"about_ca_system_score_codex":0.057815716,"about_ca_system_score_gemma":0.05536724,"threshold_uncertainty_score":0.41948432},"labels":[],"label_agreement":null},{"id":"W2545094283","doi":"10.1016/j.jval.2016.09.1135","title":"Work Productivity/Interference and General Health Status Improvements with Sirukumab, an Anti-Il-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs: Results from the Phase 3 Sirround-D Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Placebo; Rheumatoid arthritis; Visual analogue scale; Internal medicine; Depression (economics); Physical therapy; Anxiety; Psychiatry","score_opus":0.02846267644605612,"score_gpt":0.31400816876233106,"score_spread":0.28554549231627496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545094283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99549305,0.003541137,0.00006734216,0.00010230167,0.000036040812,0.000051417115,0.00033815377,0.000010820342,0.0003596401],"genre_scores_gemma":[0.9977576,0.0010136501,0.00016403242,0.00014111958,0.00007023281,0.000053871812,0.0005229012,0.000003506072,0.0002731699],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99941087,0.0002658325,0.000054801272,0.000082315026,0.00010191903,0.00008428677],"domain_scores_gemma":[0.9989427,0.00029250074,0.00037230004,0.00007065131,0.00007816838,0.00024376085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015584053,0.00096627086,0.0014074657,0.00026765984,0.0002706845,0.0006885172,0.0005208937,0.00066785654,0.0008705379],"category_scores_gemma":[0.0014169228,0.00028839163,0.0019719442,0.00039391697,0.00043353127,0.00041183867,0.00035705316,0.001287389,0.00019879342],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6629116,0.014026731,0.18435153,0.00145321,0.014876368,0.00016465998,0.00034425635,0.0016989235,0.009197254,0.000092378206,0.0018419723,0.1090411],"study_design_scores_gemma":[0.14694898,0.115298025,0.7244854,0.00010757267,0.0085750725,0.00025240425,0.00020123669,0.0012738834,0.0013885782,0.00014960975,0.0012528272,0.00006640925],"about_ca_topic_score_codex":0.0012430069,"about_ca_topic_score_gemma":0.002108362,"teacher_disagreement_score":0.0015584053,"about_ca_system_score_codex":0.0003657624,"about_ca_system_score_gemma":0.00043345278,"threshold_uncertainty_score":0.008241773},"labels":[],"label_agreement":null},{"id":"W2545128212","doi":"10.1016/j.jval.2016.08.473","title":"Mapping of Existing Data Sources for the Conduct of Real-World Studies in Progressive Supranulcear Palsy (PSP) in North America, Europe and Japan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"MEDLINE; Medicine; Family medicine; Real world data; Progressive supranuclear palsy; Systematic review; Disease; Geography; Data science; Political science; Computer science; Pathology","score_opus":0.28916042285846794,"score_gpt":0.41770942456587595,"score_spread":0.12854900170740802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545128212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74360687,0.017018054,0.03950733,0.004435845,0.00029980415,0.002650265,0.17541425,0.0002935448,0.016774042],"genre_scores_gemma":[0.86265135,0.0046121934,0.065484434,0.0005000693,0.00006178215,0.0032515966,0.06241391,0.00009129347,0.0009333556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9898567,0.004182486,0.0030121424,0.0012277544,0.0011714398,0.0005494988],"domain_scores_gemma":[0.9457058,0.018253813,0.011950212,0.007024578,0.015336379,0.0017292245],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013379756,0.00056362484,0.0010146666,0.01680442,0.0016226564,0.0035170992,0.0018290891,0.000687153,0.0024477257],"category_scores_gemma":[0.03995816,0.00048537023,0.001074643,0.03225549,0.00079635956,0.0020409187,0.003433139,0.00070976274,0.0003170883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047568046,0.00026396778,0.88338333,0.0050018886,0.001657534,0.0007169164,0.0059810104,0.0020058192,0.0025998827,0.0044093,0.0072371536,0.08626759],"study_design_scores_gemma":[0.000072883115,0.000082359766,0.96116227,0.00184503,0.0014075644,0.00029214975,0.009241572,0.0019087694,0.0012362162,0.0017008977,0.0209791,0.00007130737],"about_ca_topic_score_codex":0.093709335,"about_ca_topic_score_gemma":0.109478034,"teacher_disagreement_score":0.98662025,"about_ca_system_score_codex":0.0028919561,"about_ca_system_score_gemma":0.01069463,"threshold_uncertainty_score":0.18632782},"labels":[],"label_agreement":null},{"id":"W2545168735","doi":"10.1016/j.jval.2016.09.1426","title":"Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes from the Rapid-Psa Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Internal medicine; Placebo; Randomized controlled trial; Psoriasis; Arthritis; Physical therapy; Etanercept; Dermatology; Rheumatoid arthritis","score_opus":0.03171754063272407,"score_gpt":0.3054579776833389,"score_spread":0.2737404370506148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545168735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651897,0.0021885717,0.00006768754,0.00010332099,0.00003027229,0.000021774204,0.00068252557,0.000006434079,0.00038045718],"genre_scores_gemma":[0.9982672,0.0005325408,0.00008826713,0.00007863394,0.00005889534,0.000017159146,0.0007897947,0.0000029588448,0.00016447373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985475,0.00064125494,0.00016229476,0.00022569492,0.00024386386,0.00017940304],"domain_scores_gemma":[0.9950864,0.0011532808,0.0024079962,0.0004025866,0.00038357786,0.0005661474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003135444,0.0007014454,0.0011588637,0.00050918246,0.0003512624,0.0011949372,0.0005228566,0.0010100444,0.0010405682],"category_scores_gemma":[0.004363366,0.000361719,0.002475412,0.0009843755,0.00045106804,0.000971977,0.0008702074,0.0016155298,0.00024975443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034792077,0.001283659,0.93532103,0.00039740012,0.00590833,0.000271047,0.00021832017,0.0004410357,0.000954081,0.000092922266,0.00091365894,0.019406585],"study_design_scores_gemma":[0.0017151316,0.0036884744,0.9908659,0.000049742765,0.0020778172,0.00024570516,0.00017629826,0.0003473219,0.00018800977,0.000102017446,0.000508727,0.00003478717],"about_ca_topic_score_codex":0.0013844708,"about_ca_topic_score_gemma":0.0015335483,"teacher_disagreement_score":0.003135444,"about_ca_system_score_codex":0.00034117093,"about_ca_system_score_gemma":0.00043871923,"threshold_uncertainty_score":0.016582012},"labels":[],"label_agreement":null},{"id":"W2545460684","doi":"10.1016/j.jval.2016.09.2308","title":"Castration-Resistant Prostate Cancer (CRPC): Evaluation of The Quality of Care and Disease Management in Real-Life Setting","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Enzalutamide; Docetaxel; Medicine; Cabazitaxel; Abiraterone acetate; Prostate cancer; Abiraterone; Internal medicine; Oncology; Quality of life (healthcare); Cancer; Androgen deprivation therapy; Nursing","score_opus":0.13060201330648763,"score_gpt":0.456727396626098,"score_spread":0.3261253833196104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545460684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836181,0.008064631,0.00056883343,0.0020532045,0.00007826657,0.00006698,0.0007967734,0.000011388092,0.0047419113],"genre_scores_gemma":[0.99828416,0.0008823181,0.00038804952,0.0000843899,0.000031012816,0.000012834702,0.0002366868,0.0000021510518,0.0000783196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99434537,0.0035098202,0.00043547133,0.00017549805,0.0012939352,0.00023979825],"domain_scores_gemma":[0.9888319,0.0033645295,0.0047670803,0.00028905214,0.0014006986,0.0013467085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005542424,0.00024467075,0.0005802523,0.0014806646,0.00040924785,0.0017227674,0.0006334088,0.0005025829,0.0010764853],"category_scores_gemma":[0.01829442,0.00009769612,0.0006221433,0.00220313,0.0008423569,0.0012112838,0.0009421845,0.00060092774,0.00011360404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000782222,0.00057111884,0.92061085,0.00041302055,0.00067687896,0.00006359769,0.00042725413,0.0007651049,0.00014900394,0.00076859375,0.0014372407,0.073335126],"study_design_scores_gemma":[0.000050437942,0.0019616727,0.98962015,0.00020189535,0.00017493911,0.00023411206,0.0017649741,0.002719867,0.0002460144,0.0008140578,0.002174286,0.000037508184],"about_ca_topic_score_codex":0.0058623143,"about_ca_topic_score_gemma":0.009236572,"teacher_disagreement_score":0.0058623143,"about_ca_system_score_codex":0.0024985846,"about_ca_system_score_gemma":0.0019334686,"threshold_uncertainty_score":0.029311478},"labels":[],"label_agreement":null},{"id":"W2545691744","doi":"10.1016/j.jval.2016.09.1212","title":"Development of A Global Model For The Economic Evaluation of A Biomarker For The Treatment of Uncontrolled Moderate To Severe Asthma","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Omalizumab; Medicine; Asthma; Context (archaeology); Christian ministry; Economic evaluation; Immunoglobulin E; Intensive care medicine; Internal medicine; Immunology","score_opus":0.2651210136055662,"score_gpt":0.4578383418120825,"score_spread":0.19271732820651627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545691744","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06035974,0.0015748441,0.9025051,0.0057210694,0.00021689356,0.00040216374,0.0015144637,0.00022529543,0.027480409],"genre_scores_gemma":[0.7741594,0.0016525369,0.20812196,0.0008200663,0.00016252279,0.0011907233,0.0013189234,0.00016553381,0.012408327],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970258,0.002221735,0.00006853051,0.0002499435,0.00019613182,0.00023790597],"domain_scores_gemma":[0.9923653,0.0063056676,0.00029684755,0.00019031897,0.00057514233,0.00026669196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008677491,0.0016589052,0.002626961,0.0015438962,0.00067384075,0.0035591521,0.0027758796,0.0033349174,0.006967289],"category_scores_gemma":[0.019092621,0.00088445167,0.002064518,0.0016987701,0.0018580944,0.0026889418,0.0025627827,0.0029559305,0.00040739655],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015486796,0.00005220504,0.0011888862,0.00007878803,0.00012574908,0.00012175146,0.00005040986,0.9049183,0.000118306765,0.08467625,0.0015925679,0.0069219936],"study_design_scores_gemma":[0.00009388535,0.00006537417,0.00042035143,0.000035211102,0.000071941904,0.000049177415,0.00004227283,0.94260377,0.000063460975,0.054949254,0.0015858951,0.00001943118],"about_ca_topic_score_codex":0.01718186,"about_ca_topic_score_gemma":0.009140322,"teacher_disagreement_score":0.01718186,"about_ca_system_score_codex":0.0038013652,"about_ca_system_score_gemma":0.004340461,"threshold_uncertainty_score":0.045891523},"labels":[],"label_agreement":null},{"id":"W2545830314","doi":"10.1016/j.jval.2016.09.1828","title":"Management of Patients with Statin Intolerance: Results from a Survey of Clinicians in Six European Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Ezetimibe; Statin; Medicine; Czech; Family medicine; Fenofibrate; Internal medicine","score_opus":0.03287162819912684,"score_gpt":0.28906069460862405,"score_spread":0.25618906640949723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545830314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99896884,0.00033913145,0.00003805405,0.0001360507,0.0000035995552,0.000009568433,0.0001243393,0.00000112959,0.00037926194],"genre_scores_gemma":[0.99933666,0.00026403766,0.000069352514,0.00013753136,0.0000035319977,0.000009283051,0.00012551546,0.000001190465,0.000052798867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812335,0.0007570186,0.00037377697,0.00021527142,0.0002879903,0.00024265626],"domain_scores_gemma":[0.9955069,0.0010553076,0.0019332903,0.00011773734,0.0006642724,0.0007225646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016740973,0.00023033097,0.00053371803,0.0009145706,0.0007635796,0.0012946227,0.00031129323,0.0010477748,0.0007832533],"category_scores_gemma":[0.0063926354,0.00034036525,0.00034654388,0.0025351632,0.00058184733,0.0007243303,0.0008711909,0.00046119155,0.0001467164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007567884,0.00004576115,0.99618965,0.000020806425,0.000035767694,0.00012932852,0.0015004074,0.000025065883,0.00010938079,0.000013192905,0.000100211815,0.0017547405],"study_design_scores_gemma":[0.000013947048,0.00010310428,0.99406,0.00003167168,0.000024949877,0.00024800815,0.005082051,0.00006802958,0.000040854997,0.000009628102,0.00031032524,0.000007387672],"about_ca_topic_score_codex":0.014626236,"about_ca_topic_score_gemma":0.017689124,"teacher_disagreement_score":0.014626236,"about_ca_system_score_codex":0.0007215199,"about_ca_system_score_gemma":0.0009181205,"threshold_uncertainty_score":0.02908218},"labels":[],"label_agreement":null},{"id":"W2546045155","doi":"10.1016/j.jval.2016.09.039","title":"HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain): Pilot Study Focused in Orphan Drugs","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Orphan drug; Weighting; Context (archaeology); Scope (computer science); Health care; Medicine; Decision analysis; Management science; Population; Operations research; Computer science; Statistics; Engineering; Mathematics; Geography; Environmental health","score_opus":0.32014109662810075,"score_gpt":0.4792208494398056,"score_spread":0.15907975281170483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546045155","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13746126,0.0006246715,0.8253261,0.002298302,0.00024237674,0.0019991049,0.0048925444,0.0013366876,0.025818946],"genre_scores_gemma":[0.3409874,0.00019613482,0.6528013,0.00018998294,0.000029618706,0.00076905865,0.0016357332,0.00010167784,0.0032891196],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99763477,0.001662225,0.00013092266,0.00016596343,0.00023688747,0.00016915883],"domain_scores_gemma":[0.99576354,0.0026142062,0.00016333608,0.00022586924,0.0010373801,0.00019569567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058447244,0.0008568525,0.00079000415,0.0014635497,0.00067548675,0.0024339862,0.0013880553,0.0013782805,0.012572163],"category_scores_gemma":[0.008101141,0.00049860834,0.0014533922,0.0009198385,0.000393188,0.0008367036,0.0016200854,0.0011401501,0.00071817246],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046060307,0.00055787456,0.005827521,0.00075001136,0.00029517867,0.00035871274,0.0005497131,0.8194199,0.0021248164,0.039081812,0.0090997815,0.121474095],"study_design_scores_gemma":[0.00017656415,0.00010673919,0.001506359,0.00019988247,0.000065284585,0.000029552622,0.00026743277,0.97833645,0.00079531275,0.010601966,0.007884318,0.000030163497],"about_ca_topic_score_codex":0.060110047,"about_ca_topic_score_gemma":0.044766568,"teacher_disagreement_score":0.060110047,"about_ca_system_score_codex":0.003141487,"about_ca_system_score_gemma":0.006438209,"threshold_uncertainty_score":0.11952031},"labels":[],"label_agreement":null},{"id":"W2546091019","doi":"10.1016/j.jval.2016.09.524","title":"The Impact of Treatment Adherence on Clinical and Economic Outcomes in Multiple Sclerosis: Real-World Evidence from Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Cégep de Lévis; Hôpital Notre-Dame; University of Calgary","funders":"","keywords":"Real world evidence; Multiple sclerosis; Medicine; Business; Psychiatry; Internal medicine","score_opus":0.619957445355035,"score_gpt":0.4789490194612332,"score_spread":0.14100842589380186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546091019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9245268,0.044319868,0.000394472,0.008287423,0.00016737566,0.00013507137,0.009971993,0.000023906241,0.012173094],"genre_scores_gemma":[0.98720413,0.00842737,0.00034572685,0.00046422644,0.00003853244,0.000030375053,0.0024909868,0.000008510096,0.0009902051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935342,0.0021060342,0.0005415696,0.00034330954,0.002418964,0.0010558706],"domain_scores_gemma":[0.9725878,0.009573452,0.004178086,0.0007819058,0.009992566,0.0028861966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007580082,0.00044026348,0.0012467746,0.0024320765,0.0023945724,0.0028739024,0.002020173,0.001015553,0.002687478],"category_scores_gemma":[0.026198382,0.00035802906,0.0013862613,0.008734623,0.0019398079,0.0006040775,0.0013494368,0.0019540333,0.00011935364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045516915,0.00063158,0.90710545,0.0014329322,0.0035818147,0.0004644908,0.0013343144,0.005744156,0.00011653162,0.0025683355,0.011314636,0.061154027],"study_design_scores_gemma":[0.00057236024,0.00013984944,0.9900143,0.0009924085,0.0014382575,0.00008632406,0.00132307,0.0018907161,0.00006235818,0.0005085575,0.0028989627,0.00007271246],"about_ca_topic_score_codex":0.99571544,"about_ca_topic_score_gemma":0.9968087,"teacher_disagreement_score":0.050929964,"about_ca_system_score_codex":0.050929964,"about_ca_system_score_gemma":0.06784976,"threshold_uncertainty_score":0.36952448},"labels":[],"label_agreement":null},{"id":"W2546103895","doi":"10.1016/j.jval.2016.09.2330","title":"The Declining Value of Economics in Canadian Cancer Reimbursement Reviews","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Value (mathematics); Listing (finance); Negotiation; Psychological intervention; Actuarial science; Economic evaluation; Public economics; Institution; Economics; Business; Political science; Medicine; Health care; Finance; Microeconomics; Law; Economic growth","score_opus":0.5256384406449428,"score_gpt":0.4636573011348084,"score_spread":0.0619811395101344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546103895","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030274237,0.17865267,0.00298079,0.7257016,0.0049548796,0.00009809623,0.0038592597,0.00022614382,0.053252365],"genre_scores_gemma":[0.75263786,0.11794064,0.007018206,0.094174616,0.009612875,0.00014362582,0.0031147553,0.00048604395,0.014871427],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.90695626,0.022621645,0.0047708773,0.002992142,0.057449177,0.005209942],"domain_scores_gemma":[0.49343622,0.18203709,0.028115358,0.007988213,0.26613435,0.022288784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0829929,0.00067853637,0.0015214743,0.023194721,0.0035579214,0.017331082,0.0034180295,0.00443578,0.006212101],"category_scores_gemma":[0.36448336,0.0012209307,0.0013840707,0.029972333,0.0057266424,0.0054676197,0.003009293,0.0065139276,0.00048302303],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003896399,0.00006649058,0.036558934,0.0024618767,0.00055250176,0.00019607511,0.0020040846,0.00633463,0.00022981236,0.13520539,0.52554315,0.29045746],"study_design_scores_gemma":[0.0002119343,0.000086819455,0.21317568,0.008192338,0.00049353373,0.0003310583,0.002985794,0.0077260523,0.00052155275,0.0336018,0.7322313,0.00044214833],"about_ca_topic_score_codex":0.95080024,"about_ca_topic_score_gemma":0.9714057,"teacher_disagreement_score":0.80539435,"about_ca_system_score_codex":0.19460566,"about_ca_system_score_gemma":0.1842109,"threshold_uncertainty_score":0.9341433},"labels":[],"label_agreement":null},{"id":"W2546256960","doi":"10.1016/j.jval.2016.09.778","title":"Good Enough For Policy Work? Study-Design Challenges In Implementing Stated-Preference Methods For Complex Health-Care Technologies","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Bone and Joint Health Institute","funders":"","keywords":"Respondent; Watchful waiting; Preference; Health care; Medicine; Valuation (finance); Actuarial science; Psychological intervention; Population; Sample (material); Contingent valuation; Willingness to pay; Family medicine; Nursing; Economics; Environmental health; Microeconomics","score_opus":0.6192934447782598,"score_gpt":0.4108913785004863,"score_spread":0.20840206627777347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546256960","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048044138,0.004199672,0.85924184,0.046217963,0.005094821,0.026985804,0.0016555251,0.000566237,0.007993973],"genre_scores_gemma":[0.29916704,0.0009777187,0.5795216,0.010892391,0.00075893605,0.10718089,0.00033196053,0.00025115378,0.00091841514],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.22912593,0.7369617,0.017306587,0.006452218,0.00835118,0.001802418],"domain_scores_gemma":[0.1599225,0.73773336,0.014527689,0.0602702,0.024205867,0.003340433],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6774208,0.0022949,0.006217891,0.0017473191,0.004412021,0.010100861,0.0062037287,0.007943482,0.013511122],"category_scores_gemma":[0.7327429,0.0037631982,0.006356917,0.003570811,0.009290603,0.014695388,0.0069106193,0.010808568,0.0023044006],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037683304,0.010366034,0.033346266,0.018590761,0.019161787,0.00068864156,0.026123302,0.030310243,0.0036595634,0.26332423,0.03728182,0.51946414],"study_design_scores_gemma":[0.03342292,0.013093932,0.017568149,0.007986558,0.0064809127,0.00030884915,0.008839883,0.07828812,0.0068351678,0.7558937,0.070501745,0.0007801303],"about_ca_topic_score_codex":0.0027261297,"about_ca_topic_score_gemma":0.003908013,"teacher_disagreement_score":0.3225792,"about_ca_system_score_codex":0.0040940517,"about_ca_system_score_gemma":0.013788048,"threshold_uncertainty_score":0.39779764},"labels":[],"label_agreement":null},{"id":"W2546306249","doi":"10.1016/j.jval.2016.09.432","title":"Seasonal Variations of Outpatient Antibiotic use in Austria","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Quarter (Canadian coin); Medicine; Population; Demography; Antibiotics; Defined daily dose; Lincosamides; Pediatrics; Environmental health; Geography; Antibiotic resistance; Biology","score_opus":0.04063148796038186,"score_gpt":0.271867072856534,"score_spread":0.23123558489615215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546306249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985085,0.00031541847,0.00010700453,0.00005942599,0.000011409256,0.000002178506,0.00037700313,0.000009356794,0.00060970103],"genre_scores_gemma":[0.99944216,0.0001056587,0.000056188273,0.000021145528,0.000008710593,0.0000022290772,0.00022023852,0.000004682983,0.00013904703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996244,0.00008001525,0.000045422403,0.000078846955,0.000047763748,0.00012354238],"domain_scores_gemma":[0.99897975,0.00018932133,0.0004623404,0.000050406234,0.00012255544,0.00019565095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004666572,0.00011874166,0.00022427432,0.00091547513,0.00015093324,0.0006170742,0.00018034672,0.0003795477,0.0013416735],"category_scores_gemma":[0.001321359,0.00014062914,0.00030832278,0.0008740695,0.00023079789,0.00028721313,0.00042424837,0.00034961203,0.00029116566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003235106,0.00005770432,0.9891466,0.000030149688,0.00006953987,0.00013853349,0.0006399206,0.00025023363,0.0013653182,0.00009317852,0.00054014986,0.00734519],"study_design_scores_gemma":[0.000001112085,0.00002707118,0.9990081,0.000005826825,0.0000064046685,0.00009665446,0.00032128987,0.00011584915,0.000073972966,0.000014321752,0.000326922,0.0000025739637],"about_ca_topic_score_codex":0.005051936,"about_ca_topic_score_gemma":0.008189049,"teacher_disagreement_score":0.005051936,"about_ca_system_score_codex":0.0005952269,"about_ca_system_score_gemma":0.00022628868,"threshold_uncertainty_score":0.010045052},"labels":[],"label_agreement":null},{"id":"W2546702107","doi":"10.1016/j.jval.2016.09.2399","title":"The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network","funders":"Fonds de Recherche du Québec - Santé; AstraZeneca Canada; Université Laval","keywords":"Depression (economics); Association (psychology); Medicine; Pharmacology; Psychiatry; Psychology; Psychotherapist; Economics","score_opus":0.025938143039643556,"score_gpt":0.2939749003113782,"score_spread":0.26803675727173465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546702107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983157,0.00068470166,0.000036789075,0.00018333817,0.000026852953,0.0000035371993,0.00012215228,0.0000015581016,0.00062531256],"genre_scores_gemma":[0.9992174,0.00027956392,0.000048792557,0.000058469654,0.00003497481,0.000002263304,0.0000804999,0.0000011704145,0.00027686873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943453,0.00019021868,0.000092814866,0.00007746768,0.00010378102,0.00010118925],"domain_scores_gemma":[0.9938975,0.0019494264,0.002561699,0.00022565998,0.00030218824,0.0010634988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005941347,0.0001830434,0.00035716145,0.0007062403,0.0005406672,0.0009530645,0.0004543837,0.0006815071,0.0025719136],"category_scores_gemma":[0.0049822414,0.00039376153,0.00085950934,0.0010454486,0.00027074388,0.00047481013,0.00045509613,0.0016509978,0.00018820236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001554811,0.00007010629,0.99832815,0.0000068506156,0.00010102067,0.000071450435,0.00003657094,0.000008053428,0.00009220309,0.000011230525,0.000040200997,0.0010787444],"study_design_scores_gemma":[0.000004280489,0.000032876836,0.9996275,0.0000035629805,0.00003259766,0.00010276917,0.000074504016,0.000053023312,0.000012799999,0.000011242353,0.000042872525,0.0000019970735],"about_ca_topic_score_codex":0.012658107,"about_ca_topic_score_gemma":0.02175366,"teacher_disagreement_score":0.012658107,"about_ca_system_score_codex":0.00035764612,"about_ca_system_score_gemma":0.00037529797,"threshold_uncertainty_score":0.025168896},"labels":[],"label_agreement":null},{"id":"W2549391882","doi":"10.1016/j.jval.2016.09.2403","title":"Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors’ Facility Residents","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta","funders":"","keywords":"Glycated hemoglobin; Medicine; Diabetes mellitus; Confidence interval; Risk assessment; Cross-sectional study; Receiver operating characteristic; Type 2 diabetes; Gerontology; Internal medicine; Endocrinology; Pathology","score_opus":0.06189749594463982,"score_gpt":0.3671160115294285,"score_spread":0.3052185155847887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549391882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633803,0.009099257,0.00096599146,0.00995366,0.00033176524,0.00029672188,0.0012957677,0.0000955883,0.014580905],"genre_scores_gemma":[0.99546695,0.0012967421,0.0016341667,0.00095461286,0.000087928085,0.00008318514,0.0002480917,0.000010997348,0.00021744195],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9801593,0.013022507,0.0018385706,0.00095233443,0.002933047,0.001094266],"domain_scores_gemma":[0.8402378,0.13459094,0.0088891,0.0036889506,0.008321809,0.0042714435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029564245,0.00046750205,0.0011472136,0.0011931345,0.0007298722,0.002730298,0.0013333128,0.0010797534,0.0035235058],"category_scores_gemma":[0.15076596,0.0004126065,0.0018179121,0.0013394419,0.00057337526,0.0029632235,0.0017502768,0.0014869863,0.0004542746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008179825,0.0038213048,0.39105597,0.0031259349,0.0021881268,0.0001973723,0.0031459227,0.0018194664,0.00042137023,0.0007875056,0.00895322,0.57630396],"study_design_scores_gemma":[0.0020994104,0.02023315,0.9214918,0.011885976,0.005443823,0.0006336422,0.007837856,0.0096636545,0.003407205,0.0033689071,0.013692376,0.00024221338],"about_ca_topic_score_codex":0.008087244,"about_ca_topic_score_gemma":0.010924084,"teacher_disagreement_score":0.029564245,"about_ca_system_score_codex":0.0022525599,"about_ca_system_score_gemma":0.0040435605,"threshold_uncertainty_score":0.15635252},"labels":[],"label_agreement":null},{"id":"W2554158039","doi":"10.1016/j.jval.2019.07.005","title":"A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network; SickKids Foundation; Hospital for Sick Children; University of Waterloo; Toronto Rehabilitation Institute","funders":"Canadian Institutes of Health Research; Public Health Agency of Canada","keywords":"Meta-analysis; Chronic hepatitis; Medicine; Environmental health; Intensive care medicine; Virology; Data science; Internal medicine; Computer science","score_opus":0.23622803842918885,"score_gpt":0.43879462226470733,"score_spread":0.20256658383551848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554158039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003818211,0.99492824,0.00032804252,0.00012267317,0.00013479257,0.00015400638,0.00031572944,0.00001352424,0.00018492894],"genre_scores_gemma":[0.17318594,0.82218087,0.0021247123,0.0009811695,0.00023058451,0.000501928,0.0005008913,0.0000230174,0.00027083477],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9876189,0.0064709606,0.0035218429,0.0009924306,0.0010480548,0.00034773],"domain_scores_gemma":[0.9826015,0.013554881,0.0022552097,0.00052620826,0.00086773786,0.00019441653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011493393,0.002471037,0.018883357,0.0052575073,0.00061257737,0.0031088842,0.0017075366,0.0020123904,0.0035991322],"category_scores_gemma":[0.03959263,0.0014413738,0.031329334,0.006952613,0.00079689926,0.0017967331,0.0021248893,0.0024792475,0.00024376615],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021491519,0.000025045421,0.0031205285,0.37340716,0.6071387,0.000089472225,0.00008912885,0.00029560013,0.000129919,0.0001327588,0.0005084578,0.012914128],"study_design_scores_gemma":[0.0010277713,0.0001818511,0.003457163,0.027870743,0.9653759,0.00008661226,0.000057177855,0.00012002019,0.00005257614,0.00022596237,0.0015162736,0.000027905568],"about_ca_topic_score_codex":0.008979096,"about_ca_topic_score_gemma":0.021464808,"teacher_disagreement_score":0.018883357,"about_ca_system_score_codex":0.0026518158,"about_ca_system_score_gemma":0.003674682,"threshold_uncertainty_score":0.060783625},"labels":[],"label_agreement":null},{"id":"W2554271301","doi":"10.1016/j.jval.2016.10.003","title":"Emerging Guidelines for Patient Engagement in Research","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":235,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of British Columbia","funders":"","keywords":"Reciprocity (cultural anthropology); Psychology; General partnership; Process (computing); Dissemination; Value (mathematics); Work (physics); Knowledge management; Public relations; Medical education; Medicine; Social psychology; Business; Political science; Computer science; Engineering","score_opus":0.8460801761068034,"score_gpt":0.6326473521940884,"score_spread":0.213432823912715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554271301","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018834976,0.014986752,0.03615961,0.9048035,0.0063978024,0.0007230844,0.00012715119,0.0003979772,0.0345206],"genre_scores_gemma":[0.10385939,0.021713208,0.23103938,0.60671157,0.011265004,0.00986408,0.00088806654,0.00090866705,0.013750578],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.4859831,0.36668336,0.07047091,0.011772809,0.050128505,0.014961311],"domain_scores_gemma":[0.20767696,0.6210749,0.022673234,0.026886925,0.08986111,0.031826816],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.42440665,0.0019146804,0.0039335256,0.0051183286,0.013289729,0.0333817,0.015119236,0.05470924,0.0109973],"category_scores_gemma":[0.5242612,0.0029860698,0.00612981,0.0051831515,0.03788158,0.02459212,0.037130237,0.0794923,0.005704066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019938857,0.0010520305,0.0054978817,0.00591246,0.00023474937,0.0007722406,0.026672032,0.00071403384,0.00047842375,0.36156505,0.32890213,0.26799956],"study_design_scores_gemma":[0.00041964807,0.00042429968,0.0050088903,0.04131182,0.00030227442,0.0011134237,0.019817568,0.0013044253,0.0009230708,0.40394178,0.5251621,0.00027077337],"about_ca_topic_score_codex":0.0071795527,"about_ca_topic_score_gemma":0.018135794,"teacher_disagreement_score":0.57559335,"about_ca_system_score_codex":0.014857994,"about_ca_system_score_gemma":0.08874154,"threshold_uncertainty_score":0.70980906},"labels":[],"label_agreement":null},{"id":"W2555523074","doi":"10.1016/j.jval.2016.09.2404","title":"Joint Utility Estimators in Substance Use Disorders","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver; Simon Fraser University","funders":"National Institute on Drug Abuse; National Institutes of Health","keywords":"Estimator; Mean squared error; Context (archaeology); Statistics; Mathematics; Multiplicative function; Econometrics; Medicine","score_opus":0.5234719838194661,"score_gpt":0.4170073309033911,"score_spread":0.10646465291607504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555523074","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.093497515,0.0047229235,0.8974604,0.00115464,0.00010185765,0.00011580165,0.0005196516,0.00023981003,0.0021874083],"genre_scores_gemma":[0.87411445,0.0026228006,0.11504407,0.00021054375,0.00029345934,0.00039523118,0.0014934337,0.00011279691,0.0057131904],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9895355,0.008783103,0.00033173125,0.00049313443,0.00054276746,0.00031383013],"domain_scores_gemma":[0.8777957,0.11180916,0.0030681714,0.0044456483,0.0022359185,0.0006454407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025883317,0.00075973466,0.0021451795,0.0026536123,0.0003672855,0.0025431786,0.0014522984,0.0012064294,0.0039199404],"category_scores_gemma":[0.11714892,0.0008666278,0.0013562895,0.0031155297,0.0014361994,0.0042409487,0.0023626674,0.0019291056,0.00039320788],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081794005,0.0006391751,0.06680681,0.0005059325,0.0016755454,0.00022623724,0.00047801703,0.25707832,0.0004845802,0.4106256,0.0067456355,0.2539161],"study_design_scores_gemma":[0.00011412385,0.00019154062,0.015285951,0.00015712097,0.00028792713,0.0001659661,0.0001880985,0.7187681,0.00051395106,0.26173955,0.0025355378,0.000052158648],"about_ca_topic_score_codex":0.0035308378,"about_ca_topic_score_gemma":0.0024800026,"teacher_disagreement_score":0.025883317,"about_ca_system_score_codex":0.0010457186,"about_ca_system_score_gemma":0.0011957552,"threshold_uncertainty_score":0.1368857},"labels":[],"label_agreement":null},{"id":"W2557677183","doi":"10.1016/j.jval.2016.10.010","title":"Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis: A Population-Based Study in Ontario, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of British Columbia; Hospital for Sick Children; Pediatric Oncology Group; University Health Network; University of Toronto; Centre for Addiction and Mental Health; Toronto Public Health; BC Cancer Agency; Institute for Work & Health; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Demography; Childhood cancer; Cancer; Sociology; Internal medicine","score_opus":0.03711258106478269,"score_gpt":0.3136323733191813,"score_spread":0.2765197922543986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557677183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889721,0.0009299507,0.000053336535,0.00037917713,0.000013902406,0.00004717174,0.007961098,0.000007903581,0.0016353597],"genre_scores_gemma":[0.9943289,0.0007792672,0.00011665694,0.00014039357,0.00000894244,0.00002812926,0.0031813406,0.0000059584777,0.0014105398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990803,0.00006562664,0.00008571523,0.0001254459,0.0002877124,0.00035508774],"domain_scores_gemma":[0.9979353,0.000096978845,0.00061534526,0.000051855204,0.00068633235,0.0006141621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036587627,0.00044840472,0.00064406334,0.0014238295,0.003048497,0.0016245261,0.0017256784,0.00086563453,0.0021422969],"category_scores_gemma":[0.001802015,0.00070653117,0.0013761511,0.005371269,0.0007352631,0.0006629599,0.0010469811,0.0012528027,0.00027129814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004572737,0.000035305053,0.9975089,0.000026800359,0.00005957129,0.00006942719,0.0004528858,0.000069488924,0.000042809865,0.000052070864,0.000708592,0.0009282949],"study_design_scores_gemma":[0.0000073189863,0.00001546757,0.9985946,0.000023017776,0.000024071976,0.00004082682,0.0008274593,0.00010699508,0.000011080582,0.000010208183,0.00033181792,0.000007117814],"about_ca_topic_score_codex":0.9953053,"about_ca_topic_score_gemma":0.9976707,"teacher_disagreement_score":0.03944774,"about_ca_system_score_codex":0.03944774,"about_ca_system_score_gemma":0.028697303,"threshold_uncertainty_score":0.2862147},"labels":[],"label_agreement":null},{"id":"W2562241265","doi":"10.1016/j.jval.2016.04.021","title":"Making Choices on the Journey to Universal Health Care Coverage: From Advocacy to Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Universal health care; Universal coverage; Health care; Public relations; Universal design; Political science; Business; Public administration; Internet privacy; Computer science; Law; Health policy; World Wide Web","score_opus":0.443176161521566,"score_gpt":0.4542985715634864,"score_spread":0.011122410041920383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562241265","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007757093,0.006656409,0.0054256674,0.97128785,0.00080655655,0.000019592417,0.00004879146,0.000016462289,0.007981624],"genre_scores_gemma":[0.8351662,0.024529777,0.01425,0.11559743,0.0062360954,0.00030193542,0.00015956754,0.00015350277,0.0036055888],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.93907464,0.043861132,0.0019108556,0.001677179,0.009396097,0.0040801363],"domain_scores_gemma":[0.7835962,0.17721002,0.007955155,0.0037786067,0.013143175,0.014316883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.085260525,0.00078758865,0.0021246083,0.003673512,0.0057560154,0.025348729,0.003252029,0.017648745,0.0077858465],"category_scores_gemma":[0.22165646,0.00082209334,0.000681337,0.002836739,0.032582574,0.03594079,0.013681253,0.025902763,0.00087130425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016857797,0.0003097975,0.0067491955,0.00066621765,0.00024982064,0.00040037016,0.014988053,0.0019133893,0.00023694083,0.7539016,0.09500233,0.12541364],"study_design_scores_gemma":[0.000026183725,0.000024071755,0.0008514392,0.0013736403,0.000029407049,0.000054359898,0.0102505805,0.0008142835,0.00015061545,0.9521329,0.03425112,0.000041413045],"about_ca_topic_score_codex":0.004843853,"about_ca_topic_score_gemma":0.0050717606,"teacher_disagreement_score":0.085260525,"about_ca_system_score_codex":0.007968174,"about_ca_system_score_gemma":0.021470336,"threshold_uncertainty_score":0.45090616},"labels":[],"label_agreement":null},{"id":"W2563317648","doi":"10.1016/j.jval.2016.09.2398","title":"Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Health and Medical Research Council; Department of Health, State Government of Victoria; Transport Accident Commission; National Institute for Health and Care Research; AGE-WELL; U.S. Department of Health and Human Services","keywords":"Traumatic brain injury; Glasgow Outcome Scale; Scale (ratio); Outcome (game theory); Glasgow Coma Scale; Preference; Psychology; Medicine; Psychiatry; Cartography; Geography; Statistics; Mathematics","score_opus":0.634080733168894,"score_gpt":0.5035893229815922,"score_spread":0.13049141018730182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563317648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018146994,0.96750087,0.0035225973,0.0008723648,0.00014808611,0.0024380337,0.0062377634,0.000046125435,0.0010870892],"genre_scores_gemma":[0.2893738,0.6916883,0.006633323,0.0012093649,0.00011713011,0.0070856027,0.003604548,0.000037103848,0.00025090558],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9701807,0.014052639,0.009859564,0.0019629376,0.0034404334,0.0005038717],"domain_scores_gemma":[0.8740017,0.103403464,0.014303302,0.0021904306,0.005726875,0.00037427078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032760803,0.0014452547,0.008065623,0.018406993,0.0005492514,0.0029767968,0.0021387017,0.001362923,0.0037215247],"category_scores_gemma":[0.15441722,0.0008985282,0.013819149,0.020397723,0.00095666526,0.0033483766,0.0025771814,0.0014016497,0.00025475855],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049691263,0.00003712216,0.0089142695,0.8798628,0.053262483,0.00014628416,0.00058585365,0.0006658056,0.00011250974,0.00091487874,0.0014946434,0.05350646],"study_design_scores_gemma":[0.0007048731,0.00047129276,0.023559066,0.73181266,0.22658339,0.00070582895,0.0012030052,0.00092477264,0.00026938098,0.0027484,0.010891903,0.00012553677],"about_ca_topic_score_codex":0.008500441,"about_ca_topic_score_gemma":0.014698239,"teacher_disagreement_score":0.032760803,"about_ca_system_score_codex":0.003712396,"about_ca_system_score_gemma":0.009226655,"threshold_uncertainty_score":0.17325771},"labels":[],"label_agreement":null},{"id":"W2564509916","doi":"10.1016/j.jval.2016.10.014","title":"Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Health technology; Medicine; Population; Jurisdiction; Economic evaluation; Family medicine; Health care; Actuarial science; Public economics; Business; Political science; Environmental health; Economics","score_opus":0.455087065970452,"score_gpt":0.4753060968876979,"score_spread":0.020219030917245917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564509916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933426,0.00056807435,0.00022525284,0.0026047372,0.000012795942,0.000051735373,0.00012275876,0.0000037892032,0.0030682788],"genre_scores_gemma":[0.99923766,0.00012679676,0.00021814843,0.00017634504,0.0000052029723,0.000013054474,0.000051480798,0.0000039172123,0.00016734652],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9798941,0.011078886,0.0018770673,0.00064590655,0.0038522396,0.0026517485],"domain_scores_gemma":[0.83652973,0.11033125,0.014285788,0.0029560765,0.025043547,0.010853683],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020940544,0.00021568272,0.00062203273,0.002766321,0.0037519915,0.0042643854,0.0014621259,0.0013795544,0.0022024969],"category_scores_gemma":[0.12767947,0.00038041399,0.0004888526,0.004423556,0.002609074,0.0018215021,0.0033367279,0.0023954965,0.00011259621],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096058653,0.0005945631,0.90347654,0.00027078364,0.00022646364,0.0033746685,0.0475012,0.0024799984,0.00040159654,0.010773952,0.0036002025,0.02633943],"study_design_scores_gemma":[0.00013076713,0.00031507623,0.9016092,0.0005586365,0.00017046113,0.0016996302,0.07772596,0.006478863,0.00045726213,0.0022763833,0.0084582055,0.00011961567],"about_ca_topic_score_codex":0.62146723,"about_ca_topic_score_gemma":0.6491955,"teacher_disagreement_score":0.9796271,"about_ca_system_score_codex":0.02037293,"about_ca_system_score_gemma":0.01639212,"threshold_uncertainty_score":0.761524},"labels":[],"label_agreement":null},{"id":"W2566793882","doi":"10.1016/j.jval.2016.10.017","title":"A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Shoulder Injury and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes; McMaster University","funders":"","keywords":"Medicine; Arthroplasty; Surgery","score_opus":0.11429479967215045,"score_gpt":0.40803130613426614,"score_spread":0.2937365064621157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566793882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96740204,0.023864996,0.002214273,0.0015759814,0.0003206913,0.00086319767,0.0011595887,0.00003885295,0.002560328],"genre_scores_gemma":[0.9961842,0.0020751706,0.0008001698,0.00022523529,0.0000983693,0.000119670396,0.00025544295,0.000004965993,0.00023685477],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9955721,0.003208671,0.0002808355,0.00024533574,0.0003249765,0.00036815778],"domain_scores_gemma":[0.9938624,0.004700954,0.0006826098,0.00011819324,0.00018506411,0.00045074336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038373254,0.0013645315,0.0026938566,0.0017318568,0.00034050774,0.0017942478,0.0010744798,0.0015785437,0.0046645645],"category_scores_gemma":[0.012378123,0.0006685214,0.007806395,0.0011301484,0.00065729587,0.0015522203,0.0009693727,0.0020259088,0.00017464206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.67190105,0.0063158274,0.04875822,0.0058706445,0.04454593,0.0007527062,0.00023528685,0.078112915,0.002608599,0.004071657,0.0020210887,0.1348061],"study_design_scores_gemma":[0.19732563,0.20337175,0.200799,0.0024951028,0.12832214,0.0024994768,0.002039886,0.24747808,0.0029712608,0.00660565,0.0054801903,0.0006117974],"about_ca_topic_score_codex":0.00813112,"about_ca_topic_score_gemma":0.006420262,"teacher_disagreement_score":0.00813112,"about_ca_system_score_codex":0.0041517345,"about_ca_system_score_gemma":0.0018586983,"threshold_uncertainty_score":0.030123055},"labels":[],"label_agreement":null},{"id":"W2568974466","doi":"10.1016/j.jval.2016.11.015","title":"Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":350,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; University of Alberta","funders":"","keywords":"EQ-5D; Index (typography); Valuation (finance); Statistics; China; Demography; Population; Preference; Quality of life (healthcare); Mean difference; Medicine; Mathematics; Geography; Health related quality of life; Computer science; Confidence interval; Environmental health; Economics","score_opus":0.435524157989484,"score_gpt":0.41001414243607087,"score_spread":0.025510015553413146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568974466","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42480752,0.003234196,0.5142795,0.0012374953,0.00034569143,0.0010628551,0.03402453,0.00071383093,0.020294404],"genre_scores_gemma":[0.8377097,0.00050608936,0.1390641,0.00033653455,0.00006223957,0.0012666185,0.019595642,0.000100055535,0.0013590361],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99173075,0.004929958,0.0007305714,0.0008029406,0.0014671001,0.00033862318],"domain_scores_gemma":[0.98021424,0.013824468,0.0020041966,0.0019109428,0.0018566414,0.00018951543],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015281529,0.00069396844,0.0007114096,0.0019631605,0.00018612883,0.0021019152,0.0011360829,0.00079042505,0.0031485988],"category_scores_gemma":[0.0696316,0.00020453928,0.0014919157,0.0015028121,0.0005292408,0.0013291403,0.001564785,0.0016062771,0.0007298625],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022498975,0.000828312,0.48671398,0.0012316644,0.00385747,0.00017634814,0.0011121321,0.040518835,0.0029401435,0.14881814,0.021045752,0.29050726],"study_design_scores_gemma":[0.000839516,0.0020100996,0.6299566,0.0013417,0.0013340809,0.0008860386,0.0013857312,0.17544594,0.013086582,0.13797604,0.035400856,0.00033680495],"about_ca_topic_score_codex":0.0011239996,"about_ca_topic_score_gemma":0.0009844899,"teacher_disagreement_score":0.98471844,"about_ca_system_score_codex":0.0007678717,"about_ca_system_score_gemma":0.0009261324,"threshold_uncertainty_score":0.0808174},"labels":[],"label_agreement":null},{"id":"W2571282247","doi":"10.1016/j.jval.2016.11.002","title":"Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Ottawa","funders":"Sanofi","keywords":"FOLFIRINOX; Gemcitabine; Medicine; Oxaliplatin; Quality-adjusted life year; Willingness to pay; Cost effectiveness; Cost-effectiveness analysis; Pancreatic cancer; Regimen; Capecitabine; Oncology; Health economics; Internal medicine; Public health; Cancer; Economics; Colorectal cancer","score_opus":0.10238186302510534,"score_gpt":0.4460894761690549,"score_spread":0.3437076131439496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571282247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9456707,0.022092162,0.0007351911,0.005519655,0.00011764481,0.00052398024,0.015810622,0.000039835995,0.009490205],"genre_scores_gemma":[0.99165803,0.0036425516,0.0006448073,0.00032380628,0.000031143012,0.00006158712,0.0031290199,0.0000065029512,0.00050261413],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948836,0.0014851135,0.0003283192,0.0003027998,0.0015840477,0.0014162122],"domain_scores_gemma":[0.99465513,0.0017215549,0.0007598802,0.00013408794,0.0018030766,0.0009261354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036034987,0.00091138016,0.0016947098,0.0034791764,0.0015418952,0.002794285,0.0023116022,0.00095344364,0.0030147731],"category_scores_gemma":[0.014583455,0.00047743798,0.0045168046,0.009307102,0.00097082386,0.0007883369,0.0012759422,0.0016446686,0.00008435919],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008394287,0.0013063363,0.6933076,0.004178186,0.01154988,0.00070434774,0.00070118735,0.16108857,0.0006898412,0.0119730495,0.018818429,0.08728831],"study_design_scores_gemma":[0.0014955672,0.0013833034,0.8808134,0.0009857151,0.0060791853,0.00037615982,0.0021258404,0.09789706,0.0003120956,0.0015754281,0.0067643877,0.00019181351],"about_ca_topic_score_codex":0.9898886,"about_ca_topic_score_gemma":0.99017817,"teacher_disagreement_score":0.14729893,"about_ca_system_score_codex":0.14729893,"about_ca_system_score_gemma":0.0943756,"threshold_uncertainty_score":0.98901236},"labels":[],"label_agreement":null},{"id":"W2587471491","doi":"10.1016/j.jval.2016.11.016","title":"Estimating an EQ-5D-5L Value Set for China","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":725,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Peking University","keywords":"China; Value (mathematics); Set (abstract data type); Statistics; Mathematics; Econometrics; Computer science; Geography; Archaeology","score_opus":0.5958439784398899,"score_gpt":0.47872628673502976,"score_spread":0.11711769170486014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587471491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81742543,0.0005619668,0.16730782,0.0007829622,0.00006273893,0.00083662133,0.007679835,0.00030714725,0.0050354158],"genre_scores_gemma":[0.9191872,0.00018993195,0.07040616,0.0001058967,0.000013126568,0.0009241959,0.008505534,0.0000329715,0.00063502643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972485,0.0013932424,0.00025165392,0.00037498664,0.0005837919,0.000147828],"domain_scores_gemma":[0.9951332,0.002129172,0.00084526587,0.0005486867,0.0012005055,0.00014318358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009098694,0.001095549,0.00093785464,0.004542889,0.000493966,0.0013482204,0.0014862112,0.0007468424,0.0020631156],"category_scores_gemma":[0.026587395,0.00037467238,0.0015257471,0.00398109,0.00061301806,0.001642173,0.0017353607,0.00073696626,0.00032492244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033110665,0.0002620971,0.51215976,0.0006027261,0.0010412496,0.00038887715,0.00079648336,0.27107248,0.0019339814,0.014718989,0.0083887195,0.18830363],"study_design_scores_gemma":[0.00011895892,0.00048063224,0.29088217,0.00038408634,0.00024119974,0.00015453604,0.0006817666,0.68510973,0.002083624,0.013114339,0.0066066585,0.00014237342],"about_ca_topic_score_codex":0.020195525,"about_ca_topic_score_gemma":0.007874013,"teacher_disagreement_score":0.020195525,"about_ca_system_score_codex":0.0033892067,"about_ca_system_score_gemma":0.002638686,"threshold_uncertainty_score":0.04811907},"labels":[],"label_agreement":null},{"id":"W2588398051","doi":"10.1016/j.jval.2016.08.737","title":"Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Human Genome Research Institute; National Institutes of Health; Canada Research Chairs","keywords":"Respondent; Value of information; Value (mathematics); Preference; Valuation (finance); Key (lock); Personalized medicine; Data science; Computer science; Risk analysis (engineering); Medicine; Artificial intelligence; Machine learning; Bioinformatics; Biology; Business; Economics; Microeconomics","score_opus":0.5955930544206002,"score_gpt":0.4086307409876269,"score_spread":0.18696231343297326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588398051","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19080986,0.004673837,0.7844864,0.009734371,0.00013036976,0.00008468312,0.00043243307,0.000085637956,0.009562465],"genre_scores_gemma":[0.8622182,0.0032705124,0.13099638,0.00052769226,0.00028680774,0.00007348683,0.0003782838,0.00005477503,0.0021939797],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99694,0.0022590256,0.0001184015,0.00029773542,0.0002564822,0.00012846565],"domain_scores_gemma":[0.94803905,0.048569784,0.000771908,0.001436332,0.00078241155,0.00040050127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009291599,0.00093613827,0.0017193281,0.0012774098,0.00029045285,0.0043585873,0.0015647798,0.0016547628,0.005364316],"category_scores_gemma":[0.060589068,0.0005851508,0.0010385484,0.0016923904,0.0011276465,0.005984657,0.0014608484,0.003114619,0.0003062381],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031366988,0.0005280388,0.050358556,0.00047959213,0.00075587374,0.0003136733,0.0006714019,0.38889968,0.0006225504,0.28110152,0.0045758677,0.27137962],"study_design_scores_gemma":[0.00003831497,0.000048912123,0.0041802,0.00009876337,0.000049548467,0.00008508082,0.00037976366,0.36667675,0.0002625994,0.6263001,0.0018377652,0.000042150732],"about_ca_topic_score_codex":0.0057839006,"about_ca_topic_score_gemma":0.004242745,"teacher_disagreement_score":0.009291599,"about_ca_system_score_codex":0.0011221573,"about_ca_system_score_gemma":0.000995848,"threshold_uncertainty_score":0.04913926},"labels":[],"label_agreement":null},{"id":"W2588514767","doi":"10.1016/j.jval.2016.08.736","title":"“What Goes Around Comes Around”: Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Human Genome Research Institute","keywords":"Personalized medicine; Digital health; Terminology; Precision medicine; Mainstream; Value (mathematics); Health care; Data science; Computer science; Big data; Medicine; Bioinformatics; Data mining; Political science","score_opus":0.24192065959935383,"score_gpt":0.49483608840447074,"score_spread":0.2529154288051169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588514767","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17933674,0.17628968,0.18116508,0.34102106,0.006906372,0.0024892709,0.001718589,0.00021570051,0.11085745],"genre_scores_gemma":[0.93786436,0.014218543,0.030038863,0.013539611,0.0016733297,0.001121437,0.00020026915,0.0001046828,0.0012388766],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.8677517,0.11653143,0.0039594723,0.0026488714,0.007534678,0.0015738949],"domain_scores_gemma":[0.44092646,0.53797066,0.0076093394,0.0055091307,0.0063054888,0.0016789391],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14534137,0.0018699539,0.0049072425,0.0028313326,0.0016386836,0.009272275,0.0029239461,0.0060037524,0.010301648],"category_scores_gemma":[0.38429487,0.00079060247,0.00298922,0.0031041896,0.011220194,0.018721895,0.003829419,0.008291002,0.0003623843],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071728034,0.0017927409,0.017682694,0.009812951,0.008907504,0.00029788027,0.002416774,0.019994406,0.00027538755,0.618755,0.013681394,0.2992105],"study_design_scores_gemma":[0.0019184246,0.0015231295,0.012402699,0.012997756,0.0038842896,0.00014466763,0.00315127,0.03485637,0.0009181898,0.9043001,0.023669815,0.00023328062],"about_ca_topic_score_codex":0.0053963712,"about_ca_topic_score_gemma":0.0060045407,"teacher_disagreement_score":0.8546586,"about_ca_system_score_codex":0.0070723253,"about_ca_system_score_gemma":0.0074016233,"threshold_uncertainty_score":0.7686478},"labels":[],"label_agreement":null},{"id":"W2591677998","doi":"10.1016/j.jval.2017.01.002","title":"A Practical ANOVA Approach for Uncertainty Analysis in Population-Based Disease Microsimulation Models","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"demographic modeling and climate adaptation","field":"Decision Sciences","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Microsimulation; Econometrics; Computer science; Statistics; Analysis of variance; Economics; Machine learning; Mathematics; Engineering; Transport engineering","score_opus":0.3697161496965331,"score_gpt":0.483039687209071,"score_spread":0.11332353751253788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591677998","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022914242,0.000045976754,0.99692315,0.00008688834,0.000031804462,0.000017890658,0.000059393235,0.00009353656,0.00044978957],"genre_scores_gemma":[0.3090446,0.00037973086,0.68355733,0.00029625362,0.00038394195,0.0007330897,0.0006085058,0.00041042228,0.004586119],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99723154,0.0018854969,0.000116935575,0.00023668901,0.0003787553,0.00015051354],"domain_scores_gemma":[0.98410296,0.013624348,0.00034533016,0.0006602163,0.0010498647,0.00021718307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067241164,0.0009308432,0.0019302013,0.0012847045,0.00082522415,0.0012650646,0.0017836094,0.0013695452,0.004616419],"category_scores_gemma":[0.023757689,0.00083427347,0.0025228735,0.0009799484,0.0009994122,0.0012094871,0.002247287,0.0029820818,0.00060061476],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006190317,0.00009089299,0.0008938702,0.000075954216,0.00017938415,0.00012098861,0.000082359904,0.8470358,0.00091420463,0.104749955,0.0018369505,0.043957707],"study_design_scores_gemma":[0.000005296385,0.00002176259,0.00007523909,0.000004436967,0.000013873849,0.000009909568,0.000007008491,0.9745285,0.00011745552,0.02475723,0.0004505836,0.000008607004],"about_ca_topic_score_codex":0.008674157,"about_ca_topic_score_gemma":0.0074584614,"teacher_disagreement_score":0.008674157,"about_ca_system_score_codex":0.0009075255,"about_ca_system_score_gemma":0.0022037276,"threshold_uncertainty_score":0.035560966},"labels":[],"label_agreement":null},{"id":"W2596640152","doi":"10.1016/j.jval.2017.01.013","title":"Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research; Alberta Bone and Joint Health Institute; University of Calgary","funders":"National Institutes of Health; National Institute for Health and Care Excellence","keywords":"Computer science; Set (abstract data type); Task (project management); Analytics; Health care; Optimization problem; Management science; Mathematical optimization; Budget constraint; Key (lock); Operations research; Data science; Engineering; Mathematics; Systems engineering","score_opus":0.24410267594782728,"score_gpt":0.6031738184923501,"score_spread":0.35907114254452277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596640152","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014622316,0.69969594,0.14581966,0.100275636,0.02126126,0.00040365057,0.0013689852,0.0002034423,0.029509217],"genre_scores_gemma":[0.013304353,0.6944963,0.19812436,0.024366565,0.03419488,0.0008653656,0.0015427117,0.0005929383,0.032512624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511826,0.0017171346,0.00046631595,0.0004383278,0.0020634264,0.00019661518],"domain_scores_gemma":[0.9853232,0.009857078,0.0006628704,0.0005320072,0.003250774,0.00037409112],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012754743,0.0013805612,0.001323691,0.0037631071,0.0008071439,0.0036103704,0.0014957557,0.0036526325,0.0056526004],"category_scores_gemma":[0.019191066,0.0010257331,0.0011556123,0.0057313386,0.0018722231,0.005179747,0.0026899634,0.0070035933,0.001830434],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060958002,0.0002535534,0.000980758,0.0023585984,0.000067541056,0.00006551987,0.00025125628,0.006432483,0.0006202791,0.088202626,0.5642923,0.33641416],"study_design_scores_gemma":[0.000027549495,0.00007351606,0.002096385,0.0039789774,0.00003478523,0.00015458415,0.00016818705,0.0065211277,0.0006526976,0.045911726,0.9402697,0.00011077815],"about_ca_topic_score_codex":0.010764818,"about_ca_topic_score_gemma":0.019164387,"teacher_disagreement_score":0.98724526,"about_ca_system_score_codex":0.0023141901,"about_ca_system_score_gemma":0.004725087,"threshold_uncertainty_score":0.06745434},"labels":[],"label_agreement":null},{"id":"W2613265403","doi":"10.1016/j.jval.2017.04.021","title":"Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ontario Institute for Cancer Research","funders":"Medical Research Council; National Institute for Health and Care Research; Health Technology Assessment Programme; Government of Ontario; University College London; Cancer Research UK","keywords":"Value (mathematics); Breast cancer; Oncology; Medicine; Internal medicine; Statistics; Chemotherapy; Cancer; Mathematics","score_opus":0.3272370129756914,"score_gpt":0.45522858774932023,"score_spread":0.12799157477362882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613265403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9408935,0.017502327,0.023329262,0.008877049,0.0008344797,0.0011840615,0.002477723,0.00052470405,0.004376992],"genre_scores_gemma":[0.9881996,0.0010547813,0.007316656,0.0008160331,0.00029517745,0.00051400263,0.0007556975,0.00009344545,0.0009546796],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.97404104,0.024009353,0.00037594725,0.0008085698,0.00047110996,0.0002939467],"domain_scores_gemma":[0.8813972,0.108511806,0.004110966,0.0041020485,0.00073637476,0.001141585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02824483,0.0025892707,0.004991708,0.0009773555,0.0004178217,0.0018708736,0.001767565,0.0028164552,0.00528166],"category_scores_gemma":[0.07172045,0.00075609947,0.0053680167,0.0006587759,0.0025273063,0.0031065738,0.0019171943,0.006252875,0.00038705784],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8762338,0.002442838,0.0052699815,0.0010698381,0.010230219,0.00011874835,0.00016083498,0.022522798,0.0005445535,0.004113084,0.0047070226,0.07258627],"study_design_scores_gemma":[0.60098803,0.10133548,0.013307969,0.0008509441,0.020499531,0.00034213244,0.00019942615,0.21102825,0.0019900373,0.04443775,0.004698706,0.00032173612],"about_ca_topic_score_codex":0.0015686398,"about_ca_topic_score_gemma":0.00085242896,"teacher_disagreement_score":0.02824483,"about_ca_system_score_codex":0.001640497,"about_ca_system_score_gemma":0.0017061732,"threshold_uncertainty_score":0.14937478},"labels":[],"label_agreement":null},{"id":"W2613948837","doi":"10.1016/j.jval.2017.03.010","title":"Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Center for Theoretical Sciences","keywords":"Akathisia; Tolerability; Aripiprazole; Medicine; Placebo; Positive and Negative Syndrome Scale; Olanzapine; Paliperidone Palmitate; Antipsychotic; Adverse effect; Internal medicine; Randomized controlled trial; Meta-analysis; Schizophrenia (object-oriented programming); Psychiatry; Psychosis","score_opus":0.17950323415263084,"score_gpt":0.40753957127611296,"score_spread":0.22803633712348212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613948837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055616237,0.94110817,0.00030038954,0.0002861852,0.0003886473,0.000302403,0.0005296947,0.000014534667,0.0014538536],"genre_scores_gemma":[0.37597907,0.6194371,0.001708523,0.00066868897,0.0003653046,0.00040389513,0.00039515647,0.00001169337,0.0010306047],"study_design_codex":"design_other","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998216,0.0009946025,0.00034303052,0.0001629439,0.00021455638,0.000068856956],"domain_scores_gemma":[0.9976019,0.0016125508,0.00052167906,0.000059641712,0.0001309613,0.00007328434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022546335,0.0012230187,0.0055883243,0.00097515254,0.00022124166,0.0008634264,0.0008815205,0.00089621195,0.0057099666],"category_scores_gemma":[0.0046593095,0.0005351107,0.0055830404,0.0010924637,0.00042354912,0.0008653331,0.00058856216,0.0018461646,0.0002534133],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2131243,0.0011408381,0.003722865,0.28352588,0.20439996,0.00030378238,0.0003578754,0.0007922919,0.0022026522,0.0010214223,0.0024378716,0.28697035],"study_design_scores_gemma":[0.20006102,0.038404893,0.032277815,0.036296632,0.66423434,0.00092471,0.00091123756,0.0012503954,0.0017428573,0.0014751416,0.022207854,0.00021314035],"about_ca_topic_score_codex":0.0027799495,"about_ca_topic_score_gemma":0.00907863,"teacher_disagreement_score":0.0057099666,"about_ca_system_score_codex":0.0011029441,"about_ca_system_score_gemma":0.00096218503,"threshold_uncertainty_score":0.019101799},"labels":[],"label_agreement":null},{"id":"W2615813500","doi":"10.1016/j.jval.2017.04.007","title":"Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; St. Paul's Hospital; Centre for Advancing Health Outcomes; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Latent tuberculosis; Tuberculosis; Medicine; Computer science; Mycobacterium tuberculosis; Pathology","score_opus":0.3093331670386622,"score_gpt":0.3579243593893773,"score_spread":0.04859119235071507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615813500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5765439,0.00065454456,0.40192,0.0038217898,0.0011684964,0.0059135626,0.00077455916,0.0002437812,0.008959388],"genre_scores_gemma":[0.86979026,0.00017423804,0.12083177,0.00086203136,0.00022188424,0.0064468817,0.00024303353,0.00006479853,0.0013651699],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.667686,0.31384665,0.0040555247,0.007597614,0.0060236007,0.00079066417],"domain_scores_gemma":[0.0860783,0.8881238,0.007978228,0.014469974,0.002866078,0.00048361497],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.26370245,0.0014484429,0.0022789845,0.0010431872,0.0017008843,0.0025858693,0.0032646535,0.0050531086,0.008742511],"category_scores_gemma":[0.5472845,0.0008391164,0.0025042552,0.0012145708,0.00780542,0.00411994,0.003556049,0.00506866,0.0006070741],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1378706,0.032750666,0.13274477,0.0033195752,0.010088322,0.0006884514,0.008317046,0.09308739,0.0071655107,0.24465865,0.00496163,0.3243474],"study_design_scores_gemma":[0.044598658,0.035739016,0.04920936,0.000678573,0.003113523,0.00045607684,0.0015686721,0.5366253,0.00836912,0.31146398,0.007753476,0.00042416336],"about_ca_topic_score_codex":0.0010585479,"about_ca_topic_score_gemma":0.00059717085,"teacher_disagreement_score":0.26370245,"about_ca_system_score_codex":0.001927984,"about_ca_system_score_gemma":0.0029401905,"threshold_uncertainty_score":0.907986},"labels":[],"label_agreement":null},{"id":"W2620608893","doi":"10.1016/j.jval.2017.04.015","title":"Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Ottawa; Health PEI; Public Health Ontario; University of Toronto; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Optometry; Diabetic retinopathy; Quality-adjusted life year; Public health; Eye care; Cost effectiveness; Retinopathy; Health care; Eye disease; Family medicine; Ophthalmology; Diabetes mellitus","score_opus":0.12586937650483118,"score_gpt":0.41313005615658904,"score_spread":0.28726067965175783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620608893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728545,0.0026625504,0.0117745595,0.0013504233,0.000080466845,0.0004543208,0.0033812155,0.00010888782,0.007333059],"genre_scores_gemma":[0.9965062,0.00020657244,0.0019484673,0.00007841524,0.000021157332,0.000060298593,0.00051166845,0.0000064805026,0.0006608282],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99726546,0.0018769358,0.00008290263,0.00020392578,0.00020257862,0.00036828138],"domain_scores_gemma":[0.9864682,0.011503777,0.000678059,0.00044417995,0.00047906468,0.0004266798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051404936,0.0013796863,0.0018030506,0.0017212926,0.00035576525,0.0021317797,0.0017745637,0.0013377144,0.0066725174],"category_scores_gemma":[0.016630325,0.00072314055,0.0030131885,0.0017988108,0.0008374853,0.001500952,0.0012023167,0.0016116956,0.00027756693],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022404218,0.0019743957,0.049462765,0.00049197004,0.0020241821,0.0004986473,0.00012741634,0.8763373,0.0011485065,0.0067886687,0.002344719,0.03639727],"study_design_scores_gemma":[0.0017267102,0.0033893199,0.04419402,0.00013115977,0.0028350945,0.00039674225,0.00035626002,0.94006395,0.0005883209,0.004846148,0.0013774715,0.00009471206],"about_ca_topic_score_codex":0.02089571,"about_ca_topic_score_gemma":0.008873443,"teacher_disagreement_score":0.02089571,"about_ca_system_score_codex":0.0036869943,"about_ca_system_score_gemma":0.0025625292,"threshold_uncertainty_score":0.041548193},"labels":[],"label_agreement":null},{"id":"W2621688581","doi":"10.1016/j.jval.2017.04.008","title":"Discordance in Utility Measurement in Persons with Neurological Conditions: A Comparison of the SF-6D and the HUI3","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"University of Manitoba","keywords":"Intraclass correlation; Statistics; Confidence interval; Psychology; Health Utilities Index; Regression analysis; Regression; Medicine; Psychometrics; Mathematics; Health related quality of life; Internal medicine; Disease","score_opus":0.6137064566419875,"score_gpt":0.4507835021211451,"score_spread":0.16292295452084243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621688581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946932,0.002086061,0.00055493857,0.00042426836,0.00003081148,0.00002036629,0.000556362,0.0000040867203,0.0016297802],"genre_scores_gemma":[0.99905425,0.00022557487,0.00025327402,0.00006332509,0.000012910379,0.000012737259,0.0003245655,0.0000039004876,0.00004956768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.977085,0.015451629,0.0022367816,0.0009329715,0.00358443,0.0007090302],"domain_scores_gemma":[0.9223301,0.06021921,0.009639864,0.002437079,0.004654706,0.00071896816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026113918,0.00035813623,0.0011391552,0.0026851182,0.0006074758,0.0023445506,0.0012285162,0.0011087169,0.00092839904],"category_scores_gemma":[0.11893042,0.00029380585,0.0016263445,0.004362034,0.0012434137,0.0014805653,0.0025587939,0.0010987363,0.00017194511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020300464,0.00008919766,0.96848196,0.00017656118,0.0006439692,0.00012180591,0.0029512262,0.0006010631,0.00011938539,0.0009982693,0.0006636679,0.02312298],"study_design_scores_gemma":[0.000052529067,0.00020151875,0.9939599,0.00012388114,0.00021814283,0.00022230575,0.0016814794,0.0016736592,0.00018318821,0.0009792238,0.000669842,0.000034362485],"about_ca_topic_score_codex":0.013814996,"about_ca_topic_score_gemma":0.0103271045,"teacher_disagreement_score":0.026113918,"about_ca_system_score_codex":0.0020483676,"about_ca_system_score_gemma":0.0009339053,"threshold_uncertainty_score":0.13810521},"labels":[],"label_agreement":null},{"id":"W2625079458","doi":"10.1016/j.jval.2016.11.020","title":"Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Amgen","keywords":"Psoriasis; Dermatology Life Quality Index; Intraclass correlation; Psoriasis Area and Severity Index; Cronbach's alpha; Medicine; Quality of life (healthcare); Convergent validity; Patient-reported outcome; Severity of illness; Construct validity; Internal medicine; Physical therapy; Dermatology; Psychometrics; Psychology; Clinical psychology; Internal consistency","score_opus":0.10255382474101048,"score_gpt":0.27751853022394274,"score_spread":0.17496470548293225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625079458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038281383,0.9945373,0.00037154293,0.00033169895,0.0001427376,0.000019672396,0.00011140348,0.000005877741,0.00065168284],"genre_scores_gemma":[0.04919277,0.9473389,0.0016918161,0.00050754286,0.00048784752,0.000061294886,0.00030346224,0.000005712927,0.00041069087],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982376,0.00057672063,0.00030372673,0.00020833686,0.00060704985,0.00006666203],"domain_scores_gemma":[0.9966133,0.0021700503,0.0005833494,0.000061118895,0.0005062503,0.0000658995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032945136,0.0008639095,0.0029463337,0.0016982453,0.00014853975,0.0015987296,0.001145299,0.0008590311,0.0007059618],"category_scores_gemma":[0.0054910784,0.00032493638,0.0013341595,0.0021333545,0.00056896784,0.0009613384,0.00069787947,0.0019526911,0.0002577173],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007107193,0.00016853186,0.027274096,0.011677826,0.0009845867,0.00017019044,0.0001764246,0.00036815394,0.0008205038,0.00075612863,0.004652176,0.95224065],"study_design_scores_gemma":[0.0007740618,0.0030907067,0.6215905,0.034830075,0.008850148,0.009470338,0.0020511113,0.0053172396,0.005864264,0.0060608103,0.30138534,0.00071538374],"about_ca_topic_score_codex":0.0016326056,"about_ca_topic_score_gemma":0.0023984383,"teacher_disagreement_score":0.0032945136,"about_ca_system_score_codex":0.0005916452,"about_ca_system_score_gemma":0.00072877685,"threshold_uncertainty_score":0.017423272},"labels":[],"label_agreement":null},{"id":"W2660824563","doi":"10.1016/j.jval.2017.05.004","title":"Market Exclusivity Time for Top Selling Originator Drugs in Canada: A Cohort Study","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"","keywords":"Biosimilar; Competition (biology); Notice; Liberian dollar; Marketing authorization; Business; Generic drug; Product (mathematics); Market share; Authorization; Marketing; Pharmaceutical industry; Interquartile range; Medicine; Advertising; Drug; Finance; Pharmacology; Law","score_opus":0.06924952983056451,"score_gpt":0.32369687843816025,"score_spread":0.25444734860759577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2660824563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894287,0.001277682,0.00007724549,0.000965148,0.00003384826,0.000041345585,0.0063623455,0.000013579191,0.0018001065],"genre_scores_gemma":[0.9934629,0.0006196755,0.00008910066,0.00020348675,0.000019217012,0.000015685888,0.002391971,0.000014416491,0.0031835085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788195,0.00010357999,0.00012057615,0.0004064508,0.00047416287,0.0010132014],"domain_scores_gemma":[0.98823977,0.0007331381,0.00370814,0.0006452667,0.0031243514,0.003549387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017002133,0.0004814452,0.0008996393,0.0021261263,0.0038392523,0.0036750468,0.00278095,0.0021549626,0.0069981036],"category_scores_gemma":[0.0058049066,0.0008232959,0.0018350212,0.0052875676,0.0011366112,0.0014698214,0.00136693,0.0034007877,0.0006183114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024418894,0.000114448834,0.9947378,0.00001752417,0.00014604247,0.000106750915,0.000860051,0.00006719008,0.00010239461,0.00027578342,0.0015182764,0.001809518],"study_design_scores_gemma":[0.000013709279,0.00003480119,0.9973863,0.000025221187,0.00006676659,0.000067216046,0.0010569894,0.00022885829,0.000036350288,0.00005549008,0.0010029178,0.00002540068],"about_ca_topic_score_codex":0.98741376,"about_ca_topic_score_gemma":0.9893768,"teacher_disagreement_score":0.97388244,"about_ca_system_score_codex":0.026117546,"about_ca_system_score_gemma":0.03797723,"threshold_uncertainty_score":0.18949693},"labels":[],"label_agreement":null},{"id":"W2734526364","doi":"10.1016/j.jval.2017.06.006","title":"Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Atrial fibrillation; Stroke (engine); Medicine; Internal medicine; Cardiology; Engineering","score_opus":0.4900080508987548,"score_gpt":0.5709273828429426,"score_spread":0.08091933194418782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734526364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032580152,0.9637348,0.0015316077,0.0005175258,0.00020387868,0.00031862306,0.00047951928,0.000011211456,0.0006227227],"genre_scores_gemma":[0.38137662,0.60611004,0.008364847,0.0013544923,0.0005508025,0.00056044,0.0012841319,0.000023672601,0.00037483012],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9899951,0.00609644,0.0017974176,0.0006142181,0.0012356428,0.00026115126],"domain_scores_gemma":[0.97794,0.019422581,0.0015889601,0.0002107794,0.0005651222,0.0002724405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010224446,0.001837012,0.010102553,0.0020373845,0.00027145466,0.0023085063,0.0014817768,0.0012860383,0.004306837],"category_scores_gemma":[0.024963096,0.0007166789,0.016259475,0.002355343,0.00038935288,0.0016196998,0.001168059,0.002527483,0.00015390805],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050166145,0.0006795753,0.014461072,0.18546076,0.5114003,0.00022110119,0.00020051897,0.006529696,0.00048272128,0.0016132379,0.0025925324,0.22619244],"study_design_scores_gemma":[0.029819049,0.007808583,0.020998714,0.042006124,0.86902034,0.00067723554,0.00038935212,0.010473266,0.00045796746,0.0058567165,0.012288978,0.00020370459],"about_ca_topic_score_codex":0.0025978524,"about_ca_topic_score_gemma":0.005506654,"teacher_disagreement_score":0.010224446,"about_ca_system_score_codex":0.0018517246,"about_ca_system_score_gemma":0.0023804686,"threshold_uncertainty_score":0.054072678},"labels":[],"label_agreement":null},{"id":"W2750070121","doi":"10.1016/j.jval.2017.05.025","title":"Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Etanercept; Adalimumab; Dermatology Life Quality Index; Placebo; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Randomized controlled trial; Erythema; Dermatology; Pathology; Disease; Tumor necrosis factor alpha","score_opus":0.3768532601695033,"score_gpt":0.4339955981307294,"score_spread":0.057142337961226086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750070121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8279782,0.14658353,0.008773962,0.001378717,0.003202614,0.0028719124,0.003838315,0.00018176758,0.0051910533],"genre_scores_gemma":[0.982239,0.009810963,0.0034946185,0.0006198256,0.00047253515,0.0012105271,0.0011174501,0.000042587133,0.0009924637],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9544926,0.03736121,0.0035837565,0.0021792022,0.0016997543,0.00068351737],"domain_scores_gemma":[0.9373051,0.05012558,0.007214157,0.003066211,0.0013145356,0.00097436825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027624052,0.0032487852,0.012601142,0.0017630401,0.00048455127,0.0028622402,0.0018622306,0.0033479438,0.006560777],"category_scores_gemma":[0.041498303,0.0016253925,0.016951228,0.0015953226,0.0018030703,0.0030344203,0.001663442,0.004924237,0.00052325847],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8640986,0.00036334136,0.0029689057,0.0055957865,0.11702017,0.000055936092,0.000074849195,0.000958773,0.00037790404,0.0003186105,0.0002606111,0.007906466],"study_design_scores_gemma":[0.74599606,0.033091653,0.010824953,0.0010201025,0.20183912,0.00020157897,0.00012712396,0.0027411901,0.00066816615,0.0019033493,0.0014685434,0.0001181902],"about_ca_topic_score_codex":0.0013298684,"about_ca_topic_score_gemma":0.0015570577,"teacher_disagreement_score":0.027624052,"about_ca_system_score_codex":0.0015385617,"about_ca_system_score_gemma":0.0008834527,"threshold_uncertainty_score":0.1460917},"labels":[],"label_agreement":null},{"id":"W2754746500","doi":"10.1016/j.jval.2017.06.015","title":"The Role of Noncomparative Evidence in Health Technology Assessment Decisions","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nice; Health technology; Medicine; Excellence; Health care; Randomized controlled trial; Agency (philosophy); Evidence-based medicine; Family medicine; Surgery; Alternative medicine; Political science","score_opus":0.6517531548830843,"score_gpt":0.547592138895979,"score_spread":0.10416101598710525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754746500","genre_codex":"review","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0536578,0.45435676,0.22433104,0.19926083,0.007454093,0.0014144317,0.003884442,0.00030752798,0.05533304],"genre_scores_gemma":[0.83573556,0.0561153,0.07612822,0.021578427,0.0060528438,0.0013673825,0.0011337809,0.00021515606,0.0016733425],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.4111824,0.5262178,0.022394855,0.009355414,0.029257733,0.0015917587],"domain_scores_gemma":[0.021391783,0.9523956,0.010232358,0.010229456,0.005104828,0.0006459942],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.552645,0.0027851397,0.01007296,0.01645384,0.0023972064,0.022322632,0.0071698045,0.014905921,0.007499826],"category_scores_gemma":[0.8453273,0.0022635972,0.0053250277,0.010466611,0.018144945,0.03530154,0.0082602855,0.012187896,0.000515818],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046318946,0.0008793392,0.041674275,0.020461362,0.023948837,0.001126849,0.0027069803,0.04100499,0.0003079122,0.5096691,0.019624902,0.33396348],"study_design_scores_gemma":[0.0011909171,0.0007103666,0.008433428,0.013473217,0.0035420065,0.00039724034,0.0007328423,0.018969752,0.0008450652,0.9306616,0.02080702,0.00023647552],"about_ca_topic_score_codex":0.0040122326,"about_ca_topic_score_gemma":0.004325093,"teacher_disagreement_score":0.44735497,"about_ca_system_score_codex":0.007747006,"about_ca_system_score_gemma":0.010594419,"threshold_uncertainty_score":0.5516684},"labels":[],"label_agreement":null},{"id":"W2765090282","doi":"10.1016/j.jval.2017.08.1664","title":"Applying The Institute For Clinical And Economic Review’s (ICER) Methodology To Canada: An Improved Way To Take Into Consideration Drug Affordability Challenges?","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Scrutiny; Economic evaluation; Public economics; Health care; Medicine; Actuarial science; Business; Economic growth; Political science; Economics","score_opus":0.7723680675271503,"score_gpt":0.5464587583068287,"score_spread":0.2259093092203216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765090282","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010056843,0.23086342,0.21730973,0.38165742,0.03070566,0.009632108,0.023446428,0.0011504502,0.09517794],"genre_scores_gemma":[0.34425738,0.095737346,0.40352172,0.11911761,0.0077618724,0.011568523,0.008701197,0.0010017199,0.008332639],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7026195,0.2259303,0.022323811,0.0057086307,0.03992502,0.0034927574],"domain_scores_gemma":[0.62495464,0.24276753,0.020582719,0.019314151,0.08816101,0.004219946],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2986503,0.0019079527,0.00793751,0.012389896,0.0020999329,0.010492863,0.0052017556,0.0043281037,0.0052326727],"category_scores_gemma":[0.50407594,0.0010471141,0.004605762,0.022820074,0.0039092456,0.0042466815,0.0038648944,0.007640984,0.00054698426],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009243718,0.00013116156,0.015352165,0.019337228,0.024091527,0.0002780578,0.000783515,0.013233993,0.00016620342,0.24555425,0.3704289,0.3097186],"study_design_scores_gemma":[0.003796795,0.0003943162,0.03830767,0.035433155,0.018852046,0.00039436467,0.000807012,0.049742214,0.0007549996,0.3485831,0.50213265,0.00080164947],"about_ca_topic_score_codex":0.64383644,"about_ca_topic_score_gemma":0.7056892,"teacher_disagreement_score":0.9644504,"about_ca_system_score_codex":0.035549577,"about_ca_system_score_gemma":0.149551,"threshold_uncertainty_score":0.864889},"labels":[],"label_agreement":null},{"id":"W2765147096","doi":"10.1016/j.jval.2017.08.751","title":"Cost Per Response for Abatacept Compared with Adalimumab In the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres In Italy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Université de Montréal","funders":"","keywords":"Abatacept; Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Cohort; Physical therapy; Rituximab","score_opus":0.04930851765117299,"score_gpt":0.3540597665934935,"score_spread":0.3047512489423205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765147096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809942,0.011565969,0.00035033803,0.0023855339,0.00015845287,0.00006845399,0.0012338299,0.000031897212,0.0032113756],"genre_scores_gemma":[0.99791795,0.0007990033,0.000178312,0.00015707641,0.000057937315,0.000039392056,0.00043790537,0.000007193118,0.00040522905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875546,0.0008282448,0.0000660288,0.0000952679,0.00009298775,0.00016197086],"domain_scores_gemma":[0.9989497,0.0005287818,0.0002276064,0.000053770334,0.00004531238,0.0001948301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012780372,0.00046458267,0.0007351699,0.00057371997,0.00011765491,0.00072185305,0.0004183181,0.00052091933,0.0027378662],"category_scores_gemma":[0.0028103322,0.0001980399,0.002320389,0.000583378,0.00035314474,0.00033286947,0.00039994752,0.00065569574,0.0002678784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26161566,0.003128014,0.30539635,0.002596704,0.0069455034,0.0012364736,0.00036949027,0.09019873,0.004418929,0.002897446,0.021353656,0.299843],"study_design_scores_gemma":[0.019608775,0.02155157,0.9015162,0.0005077222,0.0055647045,0.0013432798,0.00053979014,0.041627612,0.000915097,0.0012503623,0.0054787295,0.00009608465],"about_ca_topic_score_codex":0.012867078,"about_ca_topic_score_gemma":0.006660304,"teacher_disagreement_score":0.012867078,"about_ca_system_score_codex":0.0033871408,"about_ca_system_score_gemma":0.0010708475,"threshold_uncertainty_score":0.0255844},"labels":[],"label_agreement":null},{"id":"W2765153777","doi":"10.1016/j.jval.2017.08.3020","title":"Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Impact; Western University","funders":"","keywords":"Sevelamer; Hyperphosphatemia; Medicine; Kidney disease; Dialysis; Cohort; Cost effectiveness; Internal medicine; Phosphate binder; Intensive care medicine; Risk analysis (engineering)","score_opus":0.28332382501806846,"score_gpt":0.4652333992522647,"score_spread":0.18190957423419624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765153777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001326367,0.9982161,0.00003758706,0.00010196333,0.000043390115,0.000010003997,0.000050437066,0.0000017709337,0.00021239414],"genre_scores_gemma":[0.02409774,0.9748868,0.00033400836,0.00025956644,0.00010479204,0.00001950078,0.0001295356,0.0000024485073,0.00016556484],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9994696,0.00017211211,0.000121847006,0.000059437596,0.00013812304,0.00003896857],"domain_scores_gemma":[0.99885535,0.00084745145,0.00018673176,0.000011128151,0.00007346016,0.000025883992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012594284,0.0006519908,0.0036134922,0.0009902645,0.00010110988,0.00089269807,0.0010735344,0.00078763295,0.0044956086],"category_scores_gemma":[0.0026172602,0.00026356327,0.003839517,0.0012862956,0.00023585411,0.0006731052,0.00031922915,0.0012641016,0.00021973497],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008408318,0.00027253642,0.0013678682,0.23098888,0.019490512,0.00017910762,0.00006402566,0.0010897628,0.0008026901,0.001370517,0.0065393723,0.7294265],"study_design_scores_gemma":[0.023855215,0.010676932,0.05563781,0.24309213,0.32097048,0.004452297,0.000842374,0.0039672093,0.0032868544,0.007974708,0.324887,0.00035700077],"about_ca_topic_score_codex":0.0027776235,"about_ca_topic_score_gemma":0.006229402,"teacher_disagreement_score":0.0044956086,"about_ca_system_score_codex":0.0010706995,"about_ca_system_score_gemma":0.0011428909,"threshold_uncertainty_score":0.015039325},"labels":[],"label_agreement":null},{"id":"W2765163291","doi":"10.1016/j.jval.2017.08.298","title":"What Matters to Spanish Patients and Physicians when Facing Decisions for Gep-Net? An Exploration Using a Reflective Multicriteria Shared-Decisionmaking Framework","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Watchful waiting; Medicine; Lanreotide; Actuarial science; Quality of life (healthcare); Asymptomatic; Family medicine; Internal medicine; Cancer; Nursing; Economics","score_opus":0.22202642757610114,"score_gpt":0.47646787291575976,"score_spread":0.2544414453396586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765163291","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29497895,0.0024536706,0.26283666,0.322781,0.0017186466,0.0013512364,0.0005915842,0.00035227498,0.11293594],"genre_scores_gemma":[0.909717,0.00046972054,0.081220835,0.0058347695,0.00014726743,0.0003021547,0.00023253818,0.00007221098,0.0020034816],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.8672069,0.11838899,0.0026909811,0.0030426437,0.0045441957,0.0041262833],"domain_scores_gemma":[0.82084835,0.14016305,0.0068382947,0.007908586,0.011873325,0.012368366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11956727,0.00062708586,0.0010870239,0.0016216479,0.0077748657,0.021496514,0.0039630514,0.0038114549,0.0046369997],"category_scores_gemma":[0.19479111,0.00057463825,0.0015543818,0.0016971156,0.009621409,0.011168568,0.010293902,0.0073471996,0.0006087509],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010646924,0.0011439156,0.043460324,0.0007896869,0.00055597076,0.0019147648,0.19787711,0.013387383,0.0005957928,0.5226289,0.024174722,0.19240677],"study_design_scores_gemma":[0.00026157562,0.00023729469,0.0031153758,0.0009776851,0.00017462071,0.0005445806,0.13822968,0.027134808,0.0008109582,0.7723709,0.055982415,0.00016016199],"about_ca_topic_score_codex":0.011166721,"about_ca_topic_score_gemma":0.018694673,"teacher_disagreement_score":0.11956727,"about_ca_system_score_codex":0.011703175,"about_ca_system_score_gemma":0.04956194,"threshold_uncertainty_score":0.6323397},"labels":[],"label_agreement":null},{"id":"W2765212556","doi":"10.1016/j.jval.2017.08.1922","title":"A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Novartis (Canada)","funders":"","keywords":"Natalizumab; Discontinuation; Teriflunomide; Medicine; Fingolimod; Glatiramer acetate; Internal medicine; Medical prescription; Retrospective cohort study; Multiple sclerosis; Physical therapy; Disease; Pharmacology; Immunology","score_opus":0.07298604935886653,"score_gpt":0.3027775360402757,"score_spread":0.22979148668140914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765212556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98654115,0.000532066,0.000075651245,0.000111488,0.0000085621505,0.000072501534,0.011682623,0.000014158073,0.0009618216],"genre_scores_gemma":[0.99226135,0.00025313324,0.00014048576,0.00009096317,0.000013063435,0.00005227547,0.0067710746,0.0000059289932,0.00041180398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963905,0.0004197529,0.00053335953,0.00044408182,0.0013933202,0.0008189805],"domain_scores_gemma":[0.9859977,0.0018096785,0.0068188715,0.0006502202,0.0036083267,0.0011152455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022790213,0.0006205226,0.00084104796,0.0038058877,0.001778268,0.0016183185,0.0017670855,0.0011975573,0.0018647681],"category_scores_gemma":[0.01092396,0.000693133,0.00199031,0.009868541,0.0005784983,0.00080750283,0.0010099708,0.0011896669,0.0002132634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042108362,0.000058253634,0.9973712,0.000033477045,0.00017770652,0.000034674413,0.00019015263,0.00007977073,0.000045065266,0.000028693454,0.0003412414,0.0012187533],"study_design_scores_gemma":[0.000014147986,0.000039730767,0.9992213,0.000011877417,0.000056580233,0.000041600182,0.00016065464,0.00022013736,0.000020231335,0.000005451788,0.00020008726,0.000008091896],"about_ca_topic_score_codex":0.9262287,"about_ca_topic_score_gemma":0.88611287,"teacher_disagreement_score":0.0737713,"about_ca_system_score_codex":0.016168877,"about_ca_system_score_gemma":0.01597361,"threshold_uncertainty_score":0.14841145},"labels":[],"label_agreement":null},{"id":"W2765259856","doi":"10.1016/j.jval.2017.08.2978","title":"Secukinumab vs Adalimumab for The Treatment of Ankylosing Spondylitis: A Cost Per Responder Analysis at 52 Weeks from A Brazilian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Adalimumab; Secukinumab; Medicine; Ankylosing spondylitis; Internal medicine; Arthritis; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.056248322720849155,"score_gpt":0.367150004581591,"score_spread":0.31090168186074185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765259856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8794295,0.1022508,0.0023875032,0.004864952,0.00026260168,0.00032520897,0.0042339386,0.000026305222,0.006219188],"genre_scores_gemma":[0.9900311,0.007624604,0.0006621901,0.00041961207,0.00007003051,0.00006365657,0.0006776004,0.00001904363,0.00043216985],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99486697,0.003541415,0.00026695256,0.0003353688,0.0005236503,0.000465631],"domain_scores_gemma":[0.99131525,0.006054999,0.0015395422,0.00029542213,0.0004555407,0.00033914743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006384009,0.0011564284,0.0029030556,0.0015603943,0.00026973698,0.0022215862,0.0008433661,0.0014738995,0.004233338],"category_scores_gemma":[0.013441123,0.0006883148,0.008819875,0.0023234442,0.00062846916,0.0012298451,0.00087699643,0.0023093356,0.00021859193],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34759477,0.003449032,0.19885047,0.015406913,0.12713377,0.001657634,0.001563365,0.059893202,0.0049002166,0.014520378,0.0061768102,0.21885347],"study_design_scores_gemma":[0.070262335,0.03458318,0.52442783,0.008178772,0.23822595,0.0028086193,0.004309811,0.08043476,0.0020340215,0.012473232,0.02171196,0.00054946274],"about_ca_topic_score_codex":0.02813768,"about_ca_topic_score_gemma":0.02067405,"teacher_disagreement_score":0.02813768,"about_ca_system_score_codex":0.004938864,"about_ca_system_score_gemma":0.0022830246,"threshold_uncertainty_score":0.05594778},"labels":[],"label_agreement":null},{"id":"W2765275096","doi":"10.1016/j.jval.2017.08.1751","title":"Patients Acknowledge Adaptation: The Case Of Amputees","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Adaptation (eye); Ordered probit; Public health; Medicine; Test (biology); Perception; Quality of life (healthcare); Psychology; Gerontology; Actuarial science; Economics; Econometrics; Nursing","score_opus":0.1752474473640681,"score_gpt":0.485329844627453,"score_spread":0.3100823972633849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765275096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6982409,0.0018961997,0.0017263233,0.21018353,0.0016085596,0.00008255117,0.00009228784,0.000057015164,0.08611263],"genre_scores_gemma":[0.9760761,0.0011533377,0.0008547141,0.013803013,0.0005983833,0.0000299271,0.000034484565,0.00003963528,0.007410317],"study_design_codex":"case_report","study_design_gemma":"qualitative","domain_scores_codex":[0.9971505,0.0010475315,0.00009976144,0.0001637084,0.00031690067,0.0012216852],"domain_scores_gemma":[0.9940853,0.0022909695,0.00083826476,0.00023895397,0.00036730585,0.002179042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020810973,0.00061906263,0.00057571364,0.0009855293,0.013909317,0.0064459094,0.001564934,0.011625518,0.010359656],"category_scores_gemma":[0.016579714,0.00058167655,0.0007465788,0.0014802559,0.0077149407,0.003625452,0.006012039,0.012893572,0.0010173013],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016276036,0.000621078,0.045060765,0.00019957933,0.00007158128,0.6186709,0.229798,0.0007309218,0.0006722608,0.034046162,0.04369131,0.026274657],"study_design_scores_gemma":[0.00003325386,0.00018878281,0.014953025,0.00056304585,0.00003270167,0.34301645,0.5575564,0.0013350757,0.00030308272,0.022169579,0.059738375,0.000110184],"about_ca_topic_score_codex":0.004595979,"about_ca_topic_score_gemma":0.011829653,"teacher_disagreement_score":0.013909317,"about_ca_system_score_codex":0.003237474,"about_ca_system_score_gemma":0.0036037297,"threshold_uncertainty_score":0.034656465},"labels":[],"label_agreement":null},{"id":"W2765303786","doi":"10.1016/j.jval.2017.08.2440","title":"Cost-Utility Analysis (CUA) of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in the Brazilian Early Breast Cancer Patients","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Reimbursement; Breast cancer; Marginal cost; External beam radiotherapy; Incremental cost-effectiveness ratio; Quality-adjusted life year; Randomized controlled trial; Radiation therapy; Health care; Cancer; Medical physics; Surgery; Cost effectiveness; Brachytherapy; Internal medicine; Risk analysis (engineering)","score_opus":0.025575967159484576,"score_gpt":0.32753140166431627,"score_spread":0.3019554345048317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765303786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98497796,0.009276362,0.00084439403,0.0007955143,0.000022313197,0.00006043058,0.0016720159,0.000009332971,0.002341648],"genre_scores_gemma":[0.99845934,0.00081623736,0.00023376448,0.000038579514,0.000006124656,0.000019195788,0.0003030378,0.0000024036108,0.000121360696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985802,0.0010009604,0.000062433486,0.00008833406,0.00013475052,0.00013339837],"domain_scores_gemma":[0.9978484,0.0013306502,0.0003959848,0.00010276771,0.00017637314,0.00014576458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018902492,0.00046221018,0.00070634636,0.0012337862,0.00019737537,0.00081068504,0.000494205,0.0004247425,0.0014431869],"category_scores_gemma":[0.008746339,0.00021826745,0.0024891899,0.0019225741,0.00032692225,0.00031623364,0.0005507473,0.00052771025,0.00006550998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00677499,0.00052525924,0.88829184,0.00080285105,0.005746079,0.00035176234,0.00034816584,0.023467848,0.0010135978,0.0037382054,0.0014633579,0.06747608],"study_design_scores_gemma":[0.0004599,0.0024962896,0.9429848,0.00045097226,0.0055625276,0.00069644116,0.0010739766,0.03972441,0.0006833408,0.0020525167,0.003759719,0.00005507845],"about_ca_topic_score_codex":0.06035702,"about_ca_topic_score_gemma":0.044576522,"teacher_disagreement_score":0.06035702,"about_ca_system_score_codex":0.004406323,"about_ca_system_score_gemma":0.0016947364,"threshold_uncertainty_score":0.12001145},"labels":[],"label_agreement":null},{"id":"W2765315539","doi":"10.1016/j.jval.2017.08.2802","title":"Ethical Requirements for the Conduct of Drug Utilization Studies in Latin America: A Cross-Sectional Survey","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Observational study; Informed consent; Legislation; Medicine; Declaration of Helsinki; Family medicine; Political science; Latin Americans; Confidentiality; Health care; Legislature; Alternative medicine; Law; Pathology","score_opus":0.8620755115615225,"score_gpt":0.6410397730794198,"score_spread":0.22103573848210267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765315539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45598018,0.006103504,0.1109149,0.071215086,0.004835296,0.24192686,0.008675934,0.00035733212,0.09999091],"genre_scores_gemma":[0.62953323,0.0020836182,0.14136548,0.024155239,0.0012191487,0.19074973,0.0021029203,0.000104901424,0.008685859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.76862854,0.16758919,0.03500531,0.0052464064,0.017202452,0.0063280724],"domain_scores_gemma":[0.60768205,0.21661998,0.030154893,0.06529498,0.06825307,0.011994996],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23734385,0.0008164599,0.0013722308,0.003094313,0.0046807383,0.0054211044,0.0028258574,0.0056783934,0.0043386663],"category_scores_gemma":[0.269417,0.0014923221,0.0013614479,0.0032719744,0.0064075603,0.0017023731,0.0025356696,0.005187399,0.0010803605],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008618318,0.007115899,0.37306514,0.006186802,0.00090523064,0.0063796677,0.1464239,0.0036032065,0.01363354,0.17467433,0.09095031,0.1684436],"study_design_scores_gemma":[0.0033331655,0.0041321493,0.36230388,0.014243181,0.00058513967,0.0066175982,0.09977824,0.01279224,0.010685367,0.03238662,0.45267117,0.00047124803],"about_ca_topic_score_codex":0.008947861,"about_ca_topic_score_gemma":0.013439687,"teacher_disagreement_score":0.9943216,"about_ca_system_score_codex":0.0036782587,"about_ca_system_score_gemma":0.034393117,"threshold_uncertainty_score":0.94049084},"labels":[],"label_agreement":null},{"id":"W2765337144","doi":"10.1016/j.jval.2017.08.2244","title":"Network Meta-Analysis In The Evaluation of Vaccines","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; GlaxoSmithKline (Canada)","funders":"","keywords":"Vaccine efficacy; Medicine; Psychological intervention; Leverage (statistics); Intensive care medicine; Randomized controlled trial; Clinical trial; Meta-analysis; Epidemiology; Risk analysis (engineering); Vaccination; Computer science; Immunology; Surgery; Artificial intelligence; Internal medicine; Psychiatry","score_opus":0.5030887784739609,"score_gpt":0.5056242902308837,"score_spread":0.0025355117569227925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765337144","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05894349,0.87756693,0.048393477,0.0063418103,0.0031267966,0.0006249849,0.0022736415,0.00034364648,0.002385161],"genre_scores_gemma":[0.8825931,0.08228193,0.0268471,0.0025552206,0.001799584,0.0013895197,0.0012744773,0.00023629797,0.001022804],"study_design_codex":"meta_analysis","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.76622903,0.21776648,0.0066083428,0.004637069,0.0038672492,0.00089184137],"domain_scores_gemma":[0.601471,0.37480992,0.007993891,0.011527978,0.0030453461,0.001151828],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12281712,0.004032116,0.014294849,0.0045713033,0.0008721087,0.004341172,0.0028188587,0.0032166233,0.0034409035],"category_scores_gemma":[0.2946955,0.0017475487,0.022375247,0.004387114,0.0012673228,0.0037311725,0.0033857925,0.0045550754,0.0003125741],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013630891,0.000078838435,0.016433567,0.016077166,0.9127515,0.00013624996,0.00009206947,0.011587771,0.00013490027,0.0023907074,0.0017259249,0.024960482],"study_design_scores_gemma":[0.006530683,0.0011279415,0.009338763,0.0043280516,0.9303425,0.00020973186,0.00009832053,0.021085005,0.00033009477,0.022291154,0.0042187483,0.00009911757],"about_ca_topic_score_codex":0.008614127,"about_ca_topic_score_gemma":0.008978833,"teacher_disagreement_score":0.8771829,"about_ca_system_score_codex":0.0026502586,"about_ca_system_score_gemma":0.0029928205,"threshold_uncertainty_score":0.6495268},"labels":[],"label_agreement":null},{"id":"W2765388428","doi":"10.1016/j.jval.2017.08.2753","title":"Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Unit price; Unit (ring theory); Interrupted time series; Interrupted Time Series Analysis; Generic drug; Panel data; Public economics; Economics; Drug; Business; Econometrics; Medicine; Macroeconomics; Statistics; Pharmacology; Mathematics","score_opus":0.25661781000631123,"score_gpt":0.4364669964465159,"score_spread":0.17984918644020464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765388428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392736,0.0007500943,0.0010052491,0.0009984465,0.000056426863,0.0000144949345,0.0016994006,0.000038604896,0.0015098962],"genre_scores_gemma":[0.9949744,0.00058142334,0.000368125,0.000050907463,0.0000650007,0.000020247004,0.0025249522,0.000011949024,0.0014030548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865663,0.0005772927,0.0000884489,0.0001665276,0.00017543472,0.00033557473],"domain_scores_gemma":[0.9934062,0.0034998967,0.0016139748,0.00032621768,0.00076666503,0.0003870194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002465362,0.00042849,0.0009453745,0.00069166016,0.00032304172,0.0015393911,0.00080877426,0.0010856108,0.0022552651],"category_scores_gemma":[0.00794201,0.00027876886,0.00066868606,0.0013625713,0.00054178044,0.0006782935,0.000629093,0.0014710537,0.00025706037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007619788,0.0019174111,0.7239534,0.000390572,0.00144027,0.0028559396,0.0007574137,0.18593924,0.0035092698,0.02698821,0.014525145,0.030103324],"study_design_scores_gemma":[0.00047932324,0.001147227,0.67470413,0.00006885995,0.000657947,0.00036443432,0.0012220964,0.30627704,0.0015410039,0.0046705576,0.008772948,0.00009449327],"about_ca_topic_score_codex":0.10077718,"about_ca_topic_score_gemma":0.038971648,"teacher_disagreement_score":0.10077718,"about_ca_system_score_codex":0.0024612856,"about_ca_system_score_gemma":0.001144927,"threshold_uncertainty_score":0.20038116},"labels":[],"label_agreement":null},{"id":"W2765405386","doi":"10.1016/j.jval.2017.08.2074","title":"Probabilistic Sensitivity Analysis In Health Economic Models; How Many Simulations Should We Run?","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Probabilistic logic; Convergence (economics); Sensitivity (control systems); Econometrics; Statistics; Cohort; Mathematics; Computer science; Mathematical optimization; Economics","score_opus":0.5674748590167603,"score_gpt":0.4568098896202499,"score_spread":0.11066496939651044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765405386","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04899485,0.0045501785,0.92603046,0.013246264,0.00045660598,0.00021602114,0.0005231959,0.00043141752,0.005551042],"genre_scores_gemma":[0.82995546,0.002993184,0.16055766,0.0020936201,0.0005210474,0.00090242346,0.00046290128,0.00026382064,0.0022499922],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97955036,0.018496854,0.00036910735,0.0006500329,0.0006762455,0.0002573997],"domain_scores_gemma":[0.7822542,0.20747994,0.0029635145,0.00405235,0.0020214184,0.0012285272],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028066073,0.0014020844,0.0034445848,0.0013487667,0.0010441133,0.0029286416,0.0032215868,0.004189033,0.006033705],"category_scores_gemma":[0.19938417,0.0018204075,0.0021311368,0.001427133,0.003137886,0.0087922225,0.0027740216,0.007380448,0.00043697772],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000180013,0.00009553464,0.0015552514,0.00015739436,0.00025784713,0.00006550376,0.00009995191,0.9350387,0.00008379337,0.049913473,0.0017264907,0.010825979],"study_design_scores_gemma":[0.00004806421,0.000023974086,0.00021027324,0.000056560988,0.00006122663,0.000023822366,0.000040706844,0.80656475,0.0000930496,0.19208843,0.0007656187,0.0000236192],"about_ca_topic_score_codex":0.008903579,"about_ca_topic_score_gemma":0.005735748,"teacher_disagreement_score":0.9719339,"about_ca_system_score_codex":0.0025059767,"about_ca_system_score_gemma":0.0022372098,"threshold_uncertainty_score":0.14842933},"labels":[],"label_agreement":null},{"id":"W2765406418","doi":"10.1016/j.jval.2017.08.1213","title":"Modelling The Burden Of Cardiovascular Disease In Brazil And The Impact Of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Population; Disease; Obesity; Disease burden; Psychological intervention; Absenteeism; Internal medicine","score_opus":0.06896339803205377,"score_gpt":0.32759956384550865,"score_spread":0.2586361658134549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765406418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704052,0.0013937199,0.007887528,0.007245365,0.000076919394,0.000053685642,0.002698143,0.000056156845,0.01018318],"genre_scores_gemma":[0.9960884,0.00043231493,0.0014816865,0.000100917336,0.000015887284,0.000023432998,0.00036453377,0.000011043828,0.0014817981],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995567,0.00024715537,0.000014800923,0.000056016164,0.000023089024,0.000102205966],"domain_scores_gemma":[0.9981712,0.0012206042,0.00019613668,0.000064744796,0.00016760483,0.00017971825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011064147,0.000619953,0.00061168155,0.0004961331,0.00035482433,0.0016107638,0.001184566,0.0014870875,0.0026010147],"category_scores_gemma":[0.006645493,0.00041673754,0.0011324686,0.0008426961,0.00060119125,0.00078533846,0.00085861015,0.0011629631,0.0001392781],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016799207,0.00014256418,0.051680773,0.0000815239,0.00021907267,0.00032480893,0.000245727,0.91627204,0.00041544903,0.023496954,0.0017067443,0.0052462844],"study_design_scores_gemma":[0.0001450222,0.00014071004,0.026809815,0.0000920052,0.0002571773,0.00012479562,0.0007091175,0.95445734,0.00017745614,0.014062444,0.0029794748,0.000044638193],"about_ca_topic_score_codex":0.34179512,"about_ca_topic_score_gemma":0.22065692,"teacher_disagreement_score":0.34179512,"about_ca_system_score_codex":0.00371656,"about_ca_system_score_gemma":0.0040092934,"threshold_uncertainty_score":0.6796113},"labels":[],"label_agreement":null},{"id":"W2765420062","doi":"10.1016/j.jval.2017.08.545","title":"Persistence and Adherence to Oral Antiresorptive Therapy in a Fracture Liaison Service: 24-Month Results of a Prospective Cohort Study","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cohort; Persistence (discontinuity); Cumulative incidence; Osteoporosis; Internal medicine; Prospective cohort study; Pharmacy; Cohort study; Medical prescription; Incidence (geometry); Fragility fracture; Pediatrics; Family medicine","score_opus":0.2470111422459913,"score_gpt":0.45895994530630446,"score_spread":0.21194880306031316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765420062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99944776,0.00010386279,0.000032841624,0.000029784416,0.000008185092,0.000015169016,0.00021788906,0.0000020190528,0.00014251977],"genre_scores_gemma":[0.99898404,0.000104476276,0.000061339284,0.000038525166,0.000014778555,0.000018880583,0.00044181474,0.0000039705974,0.00033213955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850637,0.00041863645,0.00016940449,0.000289219,0.00022237346,0.00039402788],"domain_scores_gemma":[0.9957652,0.00058813964,0.001445922,0.0004898892,0.00062868325,0.0010821278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002136145,0.0006777052,0.00095463847,0.0014391403,0.0019574193,0.0022202844,0.0012174277,0.0019898564,0.0017049878],"category_scores_gemma":[0.0055538365,0.0010915092,0.0021162864,0.002159811,0.0008019178,0.0021111078,0.0014006617,0.0023883474,0.0005844702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003424944,0.00039329278,0.9982135,0.000005480971,0.0001721056,0.00006584235,0.00023150728,0.000015763602,0.00008205865,0.000006672552,0.000045830944,0.0004254963],"study_design_scores_gemma":[0.000027873513,0.00045267955,0.99841666,0.0000058044575,0.000096323376,0.000096576965,0.00069408014,0.00009253174,0.000032525622,0.000009009611,0.00006505177,0.000010749579],"about_ca_topic_score_codex":0.033620942,"about_ca_topic_score_gemma":0.02886992,"teacher_disagreement_score":0.033620942,"about_ca_system_score_codex":0.0009596477,"about_ca_system_score_gemma":0.00095858675,"threshold_uncertainty_score":0.06685054},"labels":[],"label_agreement":null},{"id":"W2765421581","doi":"10.1016/j.jval.2017.08.2182","title":"Translation And Cultural Adaptation Of The Body-Q Chest Module Into Finnish For Use In Gynecomastia, Weight Loss And FTM Chest Surgery","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Multidisciplinary approach; Medicine; Gynecomastia; Knowledge translation; Test (biology); Medical physics; Physical therapy; Psychology; Linguistics; Computer science; Internal medicine; Sociology; Knowledge management","score_opus":0.0866865391187612,"score_gpt":0.3016297536377145,"score_spread":0.2149432145189533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765421581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93100715,0.00079690875,0.012117297,0.0027047948,0.0012935612,0.003772537,0.0074476656,0.0003150965,0.040545058],"genre_scores_gemma":[0.85406244,0.0023121648,0.100609675,0.0015981301,0.00023646723,0.009003756,0.009035501,0.0006002071,0.02254166],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99788,0.0007740877,0.0004468169,0.000207349,0.00038797932,0.00030372248],"domain_scores_gemma":[0.9937961,0.00288521,0.00040561045,0.00048061323,0.0021085532,0.00032390398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075086155,0.0007194274,0.0005206314,0.0013262503,0.0015577044,0.0015402671,0.00068636663,0.00055504806,0.012275779],"category_scores_gemma":[0.01613247,0.00045442398,0.0012665174,0.0013523985,0.0008793737,0.00094621966,0.0022489447,0.0018834423,0.0026320356],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016746027,0.0035703979,0.1512999,0.003210753,0.00019486992,0.005385426,0.21820468,0.0012351233,0.015712002,0.0038083536,0.039007906,0.556696],"study_design_scores_gemma":[0.0007840523,0.0017520576,0.63978124,0.004476418,0.00052397366,0.0036549743,0.12420949,0.0019744532,0.012794921,0.004234571,0.20529702,0.0005168908],"about_ca_topic_score_codex":0.02043649,"about_ca_topic_score_gemma":0.03628192,"teacher_disagreement_score":0.02043649,"about_ca_system_score_codex":0.0019862195,"about_ca_system_score_gemma":0.005362296,"threshold_uncertainty_score":0.041066587},"labels":[],"label_agreement":null},{"id":"W2765427898","doi":"10.1016/j.jval.2017.08.435","title":"Prevalence of Cardiovascular Disease In Type 2 Diabetes: A Global Systematic Review","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Myocardial infarction; Angina; Internal medicine; Coronary artery disease; Stroke (engine); Diabetes mellitus; Heart failure; Cardiology; Disease; Type 2 diabetes; Cause of death; Checklist","score_opus":0.04519239517489385,"score_gpt":0.3158561704397169,"score_spread":0.27066377526482305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765427898","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052804905,0.9932187,0.00010137009,0.00035269588,0.00011566641,0.000053938384,0.0007345477,0.0000064821465,0.00013603177],"genre_scores_gemma":[0.1097825,0.88707495,0.0007882928,0.0012686496,0.00019210344,0.00018040753,0.00063534704,0.0000089153955,0.00006886759],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9912608,0.0027519753,0.0033672727,0.0010197031,0.0013387298,0.00026152554],"domain_scores_gemma":[0.968322,0.021705128,0.0069085434,0.0006022325,0.002009067,0.00045298992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008802272,0.0011831191,0.006413222,0.00776821,0.0004351172,0.0019109971,0.0013049205,0.0019420831,0.001876106],"category_scores_gemma":[0.03461025,0.0011637566,0.012044012,0.008681077,0.0007520431,0.0020972048,0.002002467,0.0013404627,0.00014357097],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010547044,0.00005224921,0.06497335,0.706347,0.16869918,0.00025617526,0.0004173681,0.0002419388,0.00026608078,0.00027910143,0.004473014,0.052939918],"study_design_scores_gemma":[0.0010148413,0.00038597244,0.15076996,0.26585853,0.5663447,0.0011945956,0.00070756994,0.00020447979,0.00019378442,0.00056041597,0.012636119,0.00012901865],"about_ca_topic_score_codex":0.010389736,"about_ca_topic_score_gemma":0.030958308,"teacher_disagreement_score":0.010389736,"about_ca_system_score_codex":0.001706126,"about_ca_system_score_gemma":0.0045689256,"threshold_uncertainty_score":0.046551466},"labels":[],"label_agreement":null},{"id":"W2765441049","doi":"10.1016/j.jval.2017.08.585","title":"Cost-Utility Analysis Of Antihypertensive Dosage Adjustments By A Pharmacist In A Community Setting","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pharmacy; Pharmacist; Blood pressure; Pharmacoeconomics; Cohort; Intervention (counseling); Cost effectiveness; Cost–benefit analysis; Emergency medicine; Intensive care medicine; Internal medicine; Family medicine; Nursing; Risk analysis (engineering)","score_opus":0.6086480717448937,"score_gpt":0.502880051012615,"score_spread":0.10576802073227864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765441049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800575,0.003049193,0.010845867,0.0015176088,0.000057306737,0.00041256915,0.0009810686,0.000052700478,0.0030261436],"genre_scores_gemma":[0.9977952,0.00023958719,0.0013272803,0.000046136494,0.000022210184,0.00004451594,0.00019612582,0.000003760159,0.0003252431],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9938321,0.004956362,0.00014185975,0.0002509193,0.0003404759,0.00047832806],"domain_scores_gemma":[0.97478104,0.02191715,0.0011161055,0.00040560865,0.00071898627,0.0010611204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007900953,0.0014335376,0.0017792865,0.002537564,0.0004906712,0.002156989,0.0018743807,0.001844386,0.004746096],"category_scores_gemma":[0.02750622,0.0007535029,0.0021369837,0.0024729124,0.0011870395,0.0015631022,0.0013364945,0.0018878155,0.00016387047],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029109647,0.005608204,0.10989951,0.001081666,0.005457557,0.0010581268,0.00027912285,0.78159875,0.0011510926,0.012343799,0.0029982703,0.049414195],"study_design_scores_gemma":[0.0021545568,0.0045261653,0.03614384,0.0001188028,0.00269009,0.00041857452,0.00060059177,0.94742084,0.00031140543,0.004967409,0.00054200686,0.00010573264],"about_ca_topic_score_codex":0.038426593,"about_ca_topic_score_gemma":0.021020144,"teacher_disagreement_score":0.038426593,"about_ca_system_score_codex":0.0054007648,"about_ca_system_score_gemma":0.003007488,"threshold_uncertainty_score":0.07640582},"labels":[],"label_agreement":null},{"id":"W2765460113","doi":"10.1016/j.jval.2017.08.2973","title":"Secukinumab Shows Higher Symptomatic Improvement and Lower Cost Per Response vs. Adalimumab After One Year Treatment of Active Ankylosing Spondylitis: A Cost Per Responder Analysis from A Chilean Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Adalimumab; Secukinumab; Medicine; Ankylosing spondylitis; Internal medicine; Psoriatic arthritis; Tumor necrosis factor alpha; Arthritis","score_opus":0.03133953096601857,"score_gpt":0.3190984669833122,"score_spread":0.28775893601729363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765460113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97284806,0.016381519,0.00083887164,0.003123188,0.00006115054,0.000111381945,0.0022402317,0.000017709477,0.004377918],"genre_scores_gemma":[0.9950427,0.0020253703,0.00037324877,0.0003076379,0.000037991307,0.000043127537,0.0009357384,0.000012954151,0.0012212637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846005,0.001031179,0.00007163011,0.00010073029,0.00016318019,0.00017326663],"domain_scores_gemma":[0.9971922,0.001882352,0.000479905,0.00013411608,0.00016447878,0.0001469611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002757166,0.00062396727,0.0013655683,0.0012783781,0.00021898787,0.00191409,0.0005528908,0.00073386694,0.0056661],"category_scores_gemma":[0.004574707,0.00029296393,0.0035524063,0.0013676839,0.0005006844,0.0009579289,0.0006410992,0.001187592,0.00023929047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13588303,0.0027770454,0.47730386,0.006296995,0.040479437,0.0025722838,0.0010929016,0.08151471,0.008221388,0.013659719,0.010440556,0.219758],"study_design_scores_gemma":[0.011414465,0.011443032,0.88346726,0.0014418772,0.021792646,0.0016876612,0.0030417182,0.04145387,0.0022993532,0.0066798795,0.015021834,0.00025646624],"about_ca_topic_score_codex":0.015286388,"about_ca_topic_score_gemma":0.010189736,"teacher_disagreement_score":0.015286388,"about_ca_system_score_codex":0.0038738265,"about_ca_system_score_gemma":0.0013723276,"threshold_uncertainty_score":0.030394793},"labels":[],"label_agreement":null},{"id":"W2765482791","doi":"10.1016/j.jval.2017.08.1592","title":"Trends In Fda Drug Promotion Enforcement Letters Over A Ten-Year Period","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Enforcement; Revenue; Promotion (chess); Business; Advertising; Product (mathematics); Prescription drug; Medical prescription; Marketing; Public relations; Medicine; Finance; Political science; Law; Pharmacology","score_opus":0.4513791833501678,"score_gpt":0.5552794849824366,"score_spread":0.10390030163226882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765482791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95938903,0.0032347864,0.0003881325,0.0036328759,0.00018552586,0.000060345214,0.01930386,0.00017367184,0.013631804],"genre_scores_gemma":[0.9760365,0.0028047294,0.0005380131,0.001210742,0.00026601495,0.000073825875,0.011974584,0.000040172206,0.0070555047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974381,0.00025907223,0.00061653764,0.00034807995,0.00086255063,0.0004756981],"domain_scores_gemma":[0.9707502,0.0029501833,0.018231554,0.00024476257,0.0063425424,0.0014806985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001408142,0.00022592672,0.0003240365,0.005115874,0.00067436014,0.0022959525,0.0007181297,0.0012310763,0.004271543],"category_scores_gemma":[0.010355204,0.00022520838,0.00047292275,0.007735406,0.00036188713,0.00184195,0.00080342224,0.0013765588,0.0016997843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043320277,0.00017750924,0.96527696,0.00022604545,0.000057859655,0.00027963726,0.0007821039,0.0001484607,0.00051876955,0.0002892478,0.009223556,0.02258666],"study_design_scores_gemma":[0.000005127849,0.00010839233,0.9891483,0.00006900291,0.000014661307,0.0005395657,0.001586948,0.00025466626,0.00027676972,0.000030157706,0.007955219,0.000011186758],"about_ca_topic_score_codex":0.025803424,"about_ca_topic_score_gemma":0.03129923,"teacher_disagreement_score":0.025803424,"about_ca_system_score_codex":0.0018919196,"about_ca_system_score_gemma":0.001796598,"threshold_uncertainty_score":0.051306427},"labels":[],"label_agreement":null},{"id":"W2765484440","doi":"10.1016/j.jval.2017.08.1223","title":"Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Statin; Cohort; Quality-adjusted life year; Cost effectiveness; Primary prevention; Disease; Physical therapy; Internal medicine; Demography; Risk analysis (engineering)","score_opus":0.42949032231917544,"score_gpt":0.44771150180298447,"score_spread":0.018221179483809025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765484440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650517,0.013477524,0.0068345917,0.005270018,0.0006404931,0.0005161309,0.0007787096,0.00016047765,0.0072703706],"genre_scores_gemma":[0.998128,0.0005113041,0.0008078801,0.00021085476,0.00006938043,0.000029013676,0.00009375568,0.0000043507875,0.00014544003],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9941585,0.004293015,0.00032403384,0.00045012968,0.00038801474,0.00038630783],"domain_scores_gemma":[0.98557127,0.0121806525,0.0009985891,0.00033337768,0.0002170293,0.00069916487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005797267,0.0015313508,0.0031278296,0.0011097235,0.00029874523,0.0016665395,0.0010360606,0.0020958798,0.0067017716],"category_scores_gemma":[0.02329489,0.0006247164,0.003894521,0.00069656444,0.000895105,0.0016280233,0.0010263881,0.0024490396,0.00028481026],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42809382,0.008373615,0.03764247,0.0026646885,0.01809554,0.00035573068,0.00026572138,0.2633275,0.0022782988,0.009379314,0.0038620017,0.22566123],"study_design_scores_gemma":[0.11413215,0.07830302,0.12315552,0.0012944415,0.047723755,0.00090604415,0.0007267103,0.59492046,0.0032272404,0.032487173,0.0027457138,0.00037778652],"about_ca_topic_score_codex":0.0069507044,"about_ca_topic_score_gemma":0.0033166143,"teacher_disagreement_score":0.0069507044,"about_ca_system_score_codex":0.0020992693,"about_ca_system_score_gemma":0.001942965,"threshold_uncertainty_score":0.030659258},"labels":[],"label_agreement":null},{"id":"W2765553628","doi":"10.1016/j.jval.2017.08.2707","title":"Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Itching; Ixekizumab; Visual analogue scale; Internal medicine; Anesthesia; Dermatology; Psoriasis","score_opus":0.0614360303973777,"score_gpt":0.34248773775626107,"score_spread":0.28105170735888335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765553628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790318,0.013773261,0.00034575353,0.0013578199,0.0006207109,0.000080275524,0.00014858654,0.00005345285,0.004588296],"genre_scores_gemma":[0.99558204,0.0020384283,0.0003049169,0.0003135462,0.0003114588,0.000019756568,0.00019090749,0.0000062720387,0.001232679],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99965954,0.00009063784,0.000029290513,0.000035619756,0.000037904738,0.00014703587],"domain_scores_gemma":[0.9994074,0.00028751855,0.000079843994,0.000045538185,0.000024393274,0.00015535053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005298084,0.0003424679,0.0016177299,0.00017238244,0.00022240024,0.00060497253,0.0002718061,0.00070169615,0.0049963547],"category_scores_gemma":[0.00090831355,0.00015768822,0.00083847303,0.00013516279,0.0003263916,0.0006708484,0.00022121973,0.0017837461,0.00051510363],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5027243,0.014857431,0.006260228,0.001133042,0.0010826297,0.0015391717,0.00018559414,0.0014856517,0.06820054,0.0012248582,0.0061732726,0.39513335],"study_design_scores_gemma":[0.17435484,0.45183578,0.23511355,0.00073685206,0.004468686,0.009891501,0.00074942934,0.0075419154,0.08276485,0.0033850872,0.028907062,0.00025033596],"about_ca_topic_score_codex":0.00041273533,"about_ca_topic_score_gemma":0.0011255473,"teacher_disagreement_score":0.0049963547,"about_ca_system_score_codex":0.00026237738,"about_ca_system_score_gemma":0.00039247744,"threshold_uncertainty_score":0.016714513},"labels":[],"label_agreement":null},{"id":"W2765562164","doi":"10.1016/j.jval.2017.08.2974","title":"Secukinumab vs Adalimumab for The Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis At 48 Weeks from A Chilean Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Secukinumab; Adalimumab; Medicine; Psoriatic arthritis; Internal medicine; Rheumatology; Arthritis; Rheumatoid arthritis","score_opus":0.31348197192613836,"score_gpt":0.43554577432095204,"score_spread":0.12206380239481368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765562164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96393794,0.019158458,0.0019195264,0.005281115,0.00012904177,0.00031006747,0.0024257784,0.00002210497,0.0068159183],"genre_scores_gemma":[0.9925964,0.0027045116,0.0006294385,0.00047049407,0.00009080958,0.00014957384,0.0008546108,0.000020795294,0.0024834366],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963337,0.002902805,0.00010087511,0.00012951558,0.00020186292,0.00033120185],"domain_scores_gemma":[0.9926158,0.0057414724,0.00077916385,0.00023352366,0.000304145,0.00032585993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007774531,0.00090176595,0.001894036,0.0015895526,0.00027305805,0.002108335,0.00094761414,0.0010420101,0.007513617],"category_scores_gemma":[0.01146169,0.00049595674,0.0041251103,0.0014508463,0.0006498072,0.0012195905,0.0011749666,0.0024189374,0.00024901092],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30552313,0.004907256,0.13349703,0.007937331,0.04419646,0.001981603,0.0014690983,0.26700357,0.0056736665,0.035105187,0.012751739,0.17995392],"study_design_scores_gemma":[0.057756606,0.029328993,0.44029343,0.0040727044,0.054228567,0.0013302462,0.0069104168,0.3502745,0.003526318,0.02428128,0.027418954,0.0005780495],"about_ca_topic_score_codex":0.01961083,"about_ca_topic_score_gemma":0.010233479,"teacher_disagreement_score":0.01961083,"about_ca_system_score_codex":0.004724132,"about_ca_system_score_gemma":0.0024569281,"threshold_uncertainty_score":0.04111612},"labels":[],"label_agreement":null},{"id":"W2765589002","doi":"10.1016/j.jval.2017.08.2990","title":"Assessing the Burden of Disease in Peripheral and Axial Spondyloarthritis in Mexico and Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Ankylosing spondylitis; Cohort; Psoriatic arthritis; Quality of life (healthcare); Axial spondyloarthritis; Internal medicine; Physical therapy; Disease; Sacroiliitis","score_opus":0.03705310933083487,"score_gpt":0.3578899243783942,"score_spread":0.3208368150475593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765589002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556434,0.0018225198,0.00012400883,0.00061712135,0.0000066818134,0.000022488219,0.00050699036,0.0000017800447,0.0013341332],"genre_scores_gemma":[0.99891853,0.00066805707,0.0001558781,0.000032507945,0.000004941532,0.00001221719,0.00013354314,6.094589e-7,0.00007384806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937135,0.00030086868,0.00005756468,0.00006814457,0.00009788599,0.000104142666],"domain_scores_gemma":[0.998359,0.0004887426,0.0007002948,0.00006513218,0.00023539123,0.00015140972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016869064,0.00025652832,0.00028390312,0.0014532668,0.00039203206,0.0006402404,0.00034949742,0.00029739027,0.00047481872],"category_scores_gemma":[0.0045161103,0.00018742248,0.0003472887,0.001487154,0.0004860494,0.00035000854,0.00082428736,0.00033610675,0.00002196415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062271494,0.000030787927,0.9926438,0.000079673344,0.00017362887,0.000062676685,0.0010272366,0.00009962825,0.00019566594,0.00036548584,0.00013990884,0.005119312],"study_design_scores_gemma":[0.000008815521,0.000041745494,0.9974584,0.00008203607,0.00010187243,0.000057163463,0.0013392571,0.00014254992,0.00004773285,0.00009323775,0.00062224845,0.0000050268236],"about_ca_topic_score_codex":0.1982301,"about_ca_topic_score_gemma":0.22572215,"teacher_disagreement_score":0.1982301,"about_ca_system_score_codex":0.0021679117,"about_ca_system_score_gemma":0.0018319888,"threshold_uncertainty_score":0.39415252},"labels":[],"label_agreement":null},{"id":"W2765635337","doi":"10.1016/j.jval.2017.08.2679","title":"Treatment Patterns and Satisfaction For Rheumatoid Arthritis Patients In Latin America Undergoing Advanced Therapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Antirheumatic drugs; Biologic Agents; Rheumatology; Combination therapy; Physical therapy; Antirheumatic Agents","score_opus":0.049543698073820856,"score_gpt":0.3535058204042228,"score_spread":0.30396212233040193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765635337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748236,0.00037666236,0.0000292391,0.00040722176,0.000008211448,0.0000063610196,0.00022085664,0.0000015588765,0.0014675279],"genre_scores_gemma":[0.9993432,0.00012594217,0.000027594811,0.00012949022,0.0000069561524,0.0000036809854,0.00013296945,0.000001130702,0.00022891579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99951684,0.0001908904,0.000053714994,0.000028850029,0.000054103406,0.00015558802],"domain_scores_gemma":[0.9980508,0.0004366579,0.0008886282,0.00003471793,0.00016939535,0.00041975942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054894155,0.00013246975,0.00024810588,0.00066254707,0.0006163163,0.0009740814,0.00021704944,0.0004651113,0.003652046],"category_scores_gemma":[0.0030886228,0.00011413806,0.0006122342,0.0012101653,0.00034782794,0.00040932666,0.00053006323,0.00057798985,0.00016926625],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007959632,0.000057960373,0.99699163,0.000010311198,0.000039378654,0.000029398783,0.00035214657,0.000029789242,0.000046919078,0.000031558764,0.00017213772,0.0021591382],"study_design_scores_gemma":[0.000014705543,0.00010046608,0.99491936,0.00002495947,0.000028588815,0.00008283524,0.00412688,0.00015814397,0.00002086379,0.000037709575,0.00048015398,0.0000052710684],"about_ca_topic_score_codex":0.032487333,"about_ca_topic_score_gemma":0.048880883,"teacher_disagreement_score":0.032487333,"about_ca_system_score_codex":0.0008286135,"about_ca_system_score_gemma":0.0007641482,"threshold_uncertainty_score":0.064596474},"labels":[],"label_agreement":null},{"id":"W2765645961","doi":"10.1016/j.jval.2017.08.2425","title":"Epidemiology of Psoriasis In Colombia: A Governmental Database Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Epidemiology; Medicine; Psoriasis; Database; Demography; Population; Prevalence; Health care; Pediatrics; Environmental health; Pathology; Dermatology","score_opus":0.07505115506693723,"score_gpt":0.3351063444301166,"score_spread":0.2600551893631794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765645961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96607023,0.0018402549,0.00016985774,0.00021502071,0.000009896038,0.000068265275,0.030060466,0.000020052315,0.0015459252],"genre_scores_gemma":[0.9853087,0.0014952341,0.00034612758,0.000056777015,0.000015264592,0.00006332322,0.012487069,0.00000949903,0.00021796035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988206,0.00027977128,0.0002878901,0.00023763023,0.00018597317,0.00018810705],"domain_scores_gemma":[0.99572265,0.0011154169,0.0017382377,0.0003318176,0.0006741319,0.00041778258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006592847,0.00032478187,0.00060694275,0.0060029635,0.0005843602,0.001158983,0.00044210616,0.00038432397,0.0026019437],"category_scores_gemma":[0.0038321614,0.000261272,0.00068413164,0.008060882,0.00025073622,0.00043668682,0.00087863876,0.0003542217,0.0002480794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008920045,0.00003274877,0.9963082,0.0001698037,0.000107915366,0.00010264002,0.00014171794,0.000059536425,0.000060857852,0.00007074982,0.00058817025,0.0022685102],"study_design_scores_gemma":[0.0000079964475,0.000022846856,0.99759585,0.000080902944,0.00011849928,0.00022742174,0.00087398477,0.00016907869,0.00003481066,0.000023297314,0.00083754794,0.000007845919],"about_ca_topic_score_codex":0.1612708,"about_ca_topic_score_gemma":0.14990985,"teacher_disagreement_score":0.1612708,"about_ca_system_score_codex":0.002527216,"about_ca_system_score_gemma":0.0020431099,"threshold_uncertainty_score":0.32066417},"labels":[],"label_agreement":null},{"id":"W2765688979","doi":"10.1016/j.jval.2017.08.941","title":"Time to Access: Too Fast, Too Slow, or Just Right? An Evolving Public Reimbursement Landscape of Drugs For Rare Diseases In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Negotiation; Orphan drug; Alliance; Market access; Public economics; Actuarial science; Business; Economic growth; Political science; Health care; Law; Bioinformatics; Economics","score_opus":0.35014217316110186,"score_gpt":0.424691304518594,"score_spread":0.07454913135749214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765688979","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.260523,0.02567172,0.0011998267,0.6689966,0.0008423102,0.00009159056,0.0039505153,0.00005045883,0.038674094],"genre_scores_gemma":[0.9572376,0.012551853,0.0014703693,0.022959031,0.00049748993,0.00003157329,0.00082033995,0.00007248791,0.0043592406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9880641,0.0016016576,0.0006584116,0.0007159351,0.005237928,0.003721878],"domain_scores_gemma":[0.9324461,0.012405129,0.0061442647,0.00063303846,0.026928907,0.021442505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007790095,0.00021772805,0.00096151745,0.0029126853,0.0052982196,0.00992937,0.002281116,0.0023467345,0.0062731565],"category_scores_gemma":[0.034387812,0.00038247998,0.00081794796,0.006557915,0.004100013,0.0026333404,0.0019751028,0.0048116087,0.00018280586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011276586,0.0003534771,0.31355837,0.0010533438,0.00037499916,0.0017684378,0.008648665,0.0067939884,0.0013114976,0.20472905,0.20824121,0.2520394],"study_design_scores_gemma":[0.00034653198,0.00019954349,0.71520954,0.0030089982,0.00043609334,0.001155414,0.021950906,0.01285614,0.0007102035,0.029773174,0.213759,0.00059451687],"about_ca_topic_score_codex":0.9941573,"about_ca_topic_score_gemma":0.9970847,"teacher_disagreement_score":0.8076881,"about_ca_system_score_codex":0.1923119,"about_ca_system_score_gemma":0.28426257,"threshold_uncertainty_score":0.9368037},"labels":[],"label_agreement":null},{"id":"W2765738011","doi":"10.1016/j.jval.2017.08.2323","title":"Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada); Université de Montréal","funders":"","keywords":"Comorbidity; Medicine; Internal medicine; Human immunodeficiency virus (HIV); Intensive care medicine; Immunology","score_opus":0.04251783146444847,"score_gpt":0.32151836482720975,"score_spread":0.27900053336276126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765738011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990513,0.00032109607,0.0000149537655,0.000043621298,0.000005712039,0.000003839639,0.00017536,4.356982e-7,0.00038376602],"genre_scores_gemma":[0.9995517,0.00009726618,0.000018187047,0.000022061025,0.000009264873,0.0000029435382,0.000235196,4.5000365e-7,0.00006285818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946576,0.00012513436,0.000084520245,0.00005771167,0.00007030509,0.00019662232],"domain_scores_gemma":[0.9981804,0.00038733202,0.0008873559,0.000038311755,0.00008447145,0.00042212175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031274906,0.00022952289,0.0004332503,0.00084844005,0.00043221432,0.0009849027,0.00023337558,0.00039153066,0.0033101912],"category_scores_gemma":[0.0038727487,0.00018240226,0.00094774546,0.0012868728,0.00029339717,0.0006114067,0.0008624278,0.0006568973,0.0001145038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063236075,0.00008104626,0.9965031,0.000022381675,0.00022157501,0.00010247884,0.00007709592,0.00022021729,0.00012238623,0.00013006419,0.00009802755,0.0017892453],"study_design_scores_gemma":[0.000023635035,0.00017905919,0.9976826,0.000020969395,0.00009048992,0.00033908244,0.00064104237,0.0007184145,0.00003485348,0.00014709606,0.00011542763,0.000007201764],"about_ca_topic_score_codex":0.007922583,"about_ca_topic_score_gemma":0.012985675,"teacher_disagreement_score":0.007922583,"about_ca_system_score_codex":0.00078585575,"about_ca_system_score_gemma":0.0005120338,"threshold_uncertainty_score":0.015752971},"labels":[],"label_agreement":null},{"id":"W2765801098","doi":"10.1016/j.jval.2017.08.2858","title":"Treatment Patterns of Chronic Heart Failure (CHF) In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Myocardial infarction; Disease; Blood pressure; Internal medicine; Cardiology; Vital signs; Emergency medicine; Surgery","score_opus":0.04395410500466229,"score_gpt":0.3473847502943221,"score_spread":0.3034306452896598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765801098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99067444,0.0021449847,0.00021785348,0.0016817708,0.0000155818,0.000044608452,0.00084861804,0.000011046916,0.0043610977],"genre_scores_gemma":[0.9987668,0.00064697646,0.00013503482,0.000090909765,0.0000055650385,0.000011984255,0.00015399238,0.000003902692,0.00018476196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993118,0.0001600225,0.00010894846,0.00010824401,0.000131963,0.0001789325],"domain_scores_gemma":[0.9976477,0.00056881417,0.0009629941,0.00006884394,0.0003500488,0.00040160204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005902987,0.00015737473,0.000362127,0.0017686364,0.00069302594,0.000782998,0.00043887313,0.0003413857,0.0016804569],"category_scores_gemma":[0.004547795,0.00023964276,0.00043203533,0.002123535,0.0006257023,0.00037616908,0.00081264036,0.00048650714,0.00008383871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040200277,0.000062422565,0.9805431,0.00015815813,0.00006337379,0.00027489307,0.003864086,0.000093512586,0.0006237898,0.0018516437,0.00059447956,0.011830246],"study_design_scores_gemma":[0.000007512694,0.000041605508,0.99162334,0.00016891645,0.00003758483,0.00039509512,0.004984844,0.00030024094,0.00008798777,0.00031718568,0.0020207544,0.000014800166],"about_ca_topic_score_codex":0.13149145,"about_ca_topic_score_gemma":0.2170967,"teacher_disagreement_score":0.13149145,"about_ca_system_score_codex":0.0029576805,"about_ca_system_score_gemma":0.0030731966,"threshold_uncertainty_score":0.2614522},"labels":[],"label_agreement":null},{"id":"W2765829869","doi":"10.1016/j.jval.2017.08.2373","title":"The Early Bird Catches The Worm: Measuring The Potential Value Of Mesenchymal Stem Cells Therapy For Septic Shock Using The Early Health Economic Evaluation","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Ottawa Hospital","funders":"","keywords":"Medicine; Septic shock; Quality-adjusted life year; Cost–benefit analysis; Willingness to pay; Sepsis; Economic evaluation; Health care; Cost-effectiveness analysis; Intensive care medicine; Emergency medicine; Cost effectiveness; Surgery; Risk analysis (engineering); Pathology","score_opus":0.1269467254872112,"score_gpt":0.35639127866096726,"score_spread":0.22944455317375606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765829869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.949073,0.017108738,0.00790026,0.006756465,0.00036629138,0.001308439,0.0057337186,0.00002839745,0.011724617],"genre_scores_gemma":[0.9887384,0.002250654,0.006307196,0.0004425883,0.00008198836,0.00037589003,0.001043561,0.000007609903,0.00075196824],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99445736,0.0040702326,0.0003330692,0.00015237142,0.00070695305,0.00027997236],"domain_scores_gemma":[0.98343444,0.010861712,0.0027231406,0.0004340736,0.0015378189,0.0010089553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008783729,0.000581961,0.000981537,0.0018026894,0.00031392544,0.0015950887,0.000535355,0.0009367963,0.0023198912],"category_scores_gemma":[0.038628157,0.00016444898,0.0017579567,0.0015284198,0.00039761563,0.0014624853,0.0010324243,0.0012766272,0.00021593706],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022547388,0.0031839341,0.5480729,0.0028719464,0.00619203,0.00041987267,0.00036497632,0.021315524,0.0010972512,0.013647833,0.009562265,0.37072414],"study_design_scores_gemma":[0.0017909901,0.023825955,0.84029293,0.0034447236,0.006139637,0.0009689376,0.0012748475,0.075233735,0.0033795887,0.019171366,0.024095431,0.00038184127],"about_ca_topic_score_codex":0.0028039226,"about_ca_topic_score_gemma":0.0035965901,"teacher_disagreement_score":0.008783729,"about_ca_system_score_codex":0.0017052817,"about_ca_system_score_gemma":0.0017053434,"threshold_uncertainty_score":0.046453357},"labels":[],"label_agreement":null},{"id":"W2765869121","doi":"10.1016/j.jval.2017.08.1358","title":"Assessing the Burden of Chronic Heart Failure on Caregivers of Patients in Colombia","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Nursing care and research","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Spouse; Medicine; Caregiver burden; Demographics; Depression (economics); Caregiver stress; Heart failure; Medical prescription; Family medicine; Disease; Nursing; Internal medicine; Demography","score_opus":0.119511744836538,"score_gpt":0.49750044767202883,"score_spread":0.37798870283549085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765869121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759394,0.0004414098,0.000056498426,0.00033922473,0.00001248242,0.000022962538,0.00023533357,0.0000014543016,0.0012965987],"genre_scores_gemma":[0.99907744,0.00046264892,0.000099574136,0.000039184844,0.0000062630666,0.000015889193,0.00014741078,8.012017e-7,0.00015064339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996105,0.00016325264,0.00003940588,0.000027191238,0.00005100011,0.0001086535],"domain_scores_gemma":[0.99908805,0.00019480877,0.0002479205,0.00002847867,0.00019180575,0.00024896825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005539371,0.00034325273,0.00025448157,0.00084874814,0.0008478432,0.00083558814,0.00031806293,0.00028727666,0.0011254991],"category_scores_gemma":[0.0028028148,0.00015545406,0.0002747094,0.00070790405,0.00029554317,0.00027462718,0.0010241561,0.00046827205,0.000088368455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008299375,0.00008648094,0.9882824,0.00007499098,0.0000348785,0.0001989833,0.0025815808,0.000058098776,0.000120945835,0.000077666715,0.0005923439,0.0078086234],"study_design_scores_gemma":[0.000011187088,0.000055889155,0.9820957,0.000092689,0.00003178361,0.0001742117,0.016047515,0.0002255923,0.000052502302,0.000067503715,0.0011362766,0.00000913505],"about_ca_topic_score_codex":0.13966753,"about_ca_topic_score_gemma":0.21228728,"teacher_disagreement_score":0.13966753,"about_ca_system_score_codex":0.0026906775,"about_ca_system_score_gemma":0.0017560943,"threshold_uncertainty_score":0.27770913},"labels":[],"label_agreement":null},{"id":"W2765882061","doi":"10.1016/j.jval.2017.08.2143","title":"Predicting EQ-5D Index Scores From Promis Profile 29 In The United Kingdom, France, And Germany","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"EQ-5D; Mean squared error; Statistics; Linear regression; Population; Index (typography); Medicine; Mathematics; Regression analysis; Psychological intervention; Demography; Econometrics; Health related quality of life; Computer science; Environmental health; Internal medicine; Psychiatry","score_opus":0.4971491260232522,"score_gpt":0.4171712345850391,"score_spread":0.0799778914382131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765882061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967679,0.00055314676,0.00008738267,0.00030127406,0.000017650698,0.0000059543586,0.0015542061,0.0000069282487,0.0007056039],"genre_scores_gemma":[0.9978308,0.00013173524,0.00005697702,0.000058182188,0.000006419746,0.0000062615663,0.001646646,0.000004112581,0.00025889557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781656,0.0010237161,0.0001658878,0.000311337,0.0002292168,0.00045321474],"domain_scores_gemma":[0.99510705,0.0017425681,0.0011199015,0.00028643187,0.001106284,0.0006377643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038246287,0.00048815648,0.00077532005,0.0017569019,0.0004174622,0.00213911,0.00079858874,0.0011546996,0.0013603747],"category_scores_gemma":[0.010058601,0.00029380698,0.0011452024,0.0021462515,0.00053875253,0.00089941645,0.001377232,0.00075035763,0.0003609035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037065332,0.000046944755,0.9922733,0.000024324165,0.00022275401,0.000157388,0.0001942717,0.0019072812,0.000056858826,0.00026966218,0.0012629861,0.0032136529],"study_design_scores_gemma":[0.000020792895,0.000058303103,0.99659157,0.00003259622,0.00007544889,0.000057414632,0.00042751982,0.0022198844,0.000053579595,0.000064282525,0.00038605265,0.000012499859],"about_ca_topic_score_codex":0.30838907,"about_ca_topic_score_gemma":0.21590836,"teacher_disagreement_score":0.30838907,"about_ca_system_score_codex":0.0032969366,"about_ca_system_score_gemma":0.001390129,"threshold_uncertainty_score":0.6131881},"labels":[],"label_agreement":null},{"id":"W2765933349","doi":"10.1016/j.jval.2017.08.2847","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Heart failure; Cohort; Physical therapy; Household income; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.08690891637536316,"score_gpt":0.41364413340729894,"score_spread":0.32673521703193575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765933349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941507,0.0011917077,0.00017275408,0.001189654,0.000011310688,0.000029554429,0.00042190595,0.000004604197,0.0028278448],"genre_scores_gemma":[0.9991978,0.00047240496,0.00015109045,0.000040740557,0.0000047126405,0.0000074328977,0.000064972664,8.999036e-7,0.000059916845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991553,0.00037634574,0.00009343877,0.00007272315,0.00017611403,0.00012606737],"domain_scores_gemma":[0.9972146,0.0010004255,0.0009678912,0.00010814692,0.0003240408,0.0003849133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001312924,0.00021887179,0.00032825803,0.0009406722,0.0004750315,0.0006415809,0.0003806101,0.00033912054,0.0007980422],"category_scores_gemma":[0.0070239105,0.00021514278,0.000485665,0.0010925567,0.0005128351,0.00035325487,0.0007840501,0.0005473431,0.000042787604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024674362,0.000053936186,0.98792213,0.00008873352,0.00007151308,0.00008221667,0.0016344502,0.000071119626,0.00017166453,0.00045124526,0.00021565401,0.009212714],"study_design_scores_gemma":[0.0000069995303,0.00006366211,0.9961798,0.00013342121,0.000054815933,0.00013371049,0.0019155254,0.00045062695,0.000052370517,0.00023316209,0.00076644425,0.000009448469],"about_ca_topic_score_codex":0.12122692,"about_ca_topic_score_gemma":0.14825022,"teacher_disagreement_score":0.12122692,"about_ca_system_score_codex":0.0020616013,"about_ca_system_score_gemma":0.0023742171,"threshold_uncertainty_score":0.24104255},"labels":[],"label_agreement":null},{"id":"W2765943310","doi":"10.1016/j.jval.2017.08.1924","title":"Epidemiology of Multiple Sclerosis: Literature Review for Prevalence and Trend Over Time in 5 European Countries and Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Demography; Observational study; Internal medicine","score_opus":0.13014247802225137,"score_gpt":0.3735685823921938,"score_spread":0.24342610436994244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765943310","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029437818,0.9603525,0.00014411015,0.0011056481,0.00010973698,0.00010170754,0.006861948,0.000013788004,0.0018728373],"genre_scores_gemma":[0.13489667,0.85922635,0.0011444414,0.00075197837,0.00008841335,0.000092961935,0.0034470574,0.000009793668,0.0003422645],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956928,0.00036552938,0.0015943468,0.00046717867,0.0014909296,0.00038922593],"domain_scores_gemma":[0.9808754,0.0046551996,0.004572728,0.00026714185,0.00898034,0.0006492269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00475254,0.0005667693,0.0022070957,0.021595981,0.0014107393,0.0034435845,0.0013504506,0.0008670945,0.0018917758],"category_scores_gemma":[0.01685061,0.00052033394,0.0026548128,0.056482792,0.0010515738,0.0015219519,0.0012306003,0.0007411647,0.00014415536],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080677884,0.00012477607,0.53042835,0.17000197,0.007156668,0.0013497655,0.0047767097,0.0005780921,0.0005579554,0.0012134257,0.01777835,0.26522708],"study_design_scores_gemma":[0.00007039501,0.00008918398,0.86298585,0.08057547,0.010740927,0.0015056761,0.0050246217,0.00019319172,0.00026194684,0.00018247397,0.038273603,0.000096588075],"about_ca_topic_score_codex":0.8835207,"about_ca_topic_score_gemma":0.933671,"teacher_disagreement_score":0.11647928,"about_ca_system_score_codex":0.016259832,"about_ca_system_score_gemma":0.06710227,"threshold_uncertainty_score":0.23433048},"labels":[],"label_agreement":null},{"id":"W2765951590","doi":"10.1016/j.jval.2017.08.2856","title":"Treatment Patterns of Chronic Heart Failure (CHF) In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Myocardial infarction; Internal medicine; Disease; Blood pressure; Cardiology","score_opus":0.05287494600055623,"score_gpt":0.337469004248144,"score_spread":0.28459405824758777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765951590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939659,0.0010688746,0.000105628846,0.0006889019,0.000016974756,0.000013912119,0.0009214127,0.0000061396877,0.0032122855],"genre_scores_gemma":[0.9974463,0.0008635577,0.00017459675,0.00007939096,0.000015930731,0.0000145264285,0.0006429358,0.0000048512784,0.00075787137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995665,0.00011675075,0.00004839001,0.000055077246,0.00006311814,0.00015014816],"domain_scores_gemma":[0.9991032,0.0001548123,0.0003216445,0.000024890114,0.00016736325,0.00022807815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032781955,0.00014777025,0.00025086274,0.001099331,0.00040914933,0.0005339669,0.0002321344,0.00028755725,0.0021093306],"category_scores_gemma":[0.0013403951,0.00015347968,0.00021775714,0.0014868737,0.00036874955,0.00018752097,0.00045527684,0.00035444798,0.00013849832],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016649746,0.00011312,0.9854091,0.000059287286,0.000035720605,0.00043586345,0.0008479494,0.0001653993,0.0004647964,0.00083589903,0.001247815,0.010218755],"study_design_scores_gemma":[0.000008859667,0.000035608464,0.99655414,0.000029454623,0.000008605842,0.00024530248,0.0009989166,0.00018014104,0.000038484897,0.00006842412,0.0018281415,0.0000039225065],"about_ca_topic_score_codex":0.08821238,"about_ca_topic_score_gemma":0.13243218,"teacher_disagreement_score":0.08821238,"about_ca_system_score_codex":0.0020306604,"about_ca_system_score_gemma":0.0010962558,"threshold_uncertainty_score":0.17539781},"labels":[],"label_agreement":null},{"id":"W2765975035","doi":"10.1016/j.jval.2017.08.2015","title":"Conceptualization, Development, And Internal And External Validation of A ‘Whole Disease’ Model for Chronic Obstructive Pulmonary Disease","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"COPD; Exacerbation; Medicine; Population; Cohort; Tiotropium bromide; Disease; Internal medicine; Lung; Lung function; Environmental health","score_opus":0.05886674890457673,"score_gpt":0.35175803275238937,"score_spread":0.29289128384781266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765975035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.555503,0.0018738759,0.3032337,0.04416295,0.0006837313,0.0024567458,0.00073064235,0.00028317736,0.09107217],"genre_scores_gemma":[0.9300249,0.0002516504,0.06708363,0.0008681508,0.00004363588,0.0006412861,0.00040950798,0.00006295635,0.00061428425],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.974518,0.018748505,0.0012182314,0.001449221,0.003250427,0.0008155912],"domain_scores_gemma":[0.92115605,0.04873909,0.0042147534,0.009391889,0.01378951,0.002708679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039375253,0.0007448228,0.0007066588,0.0036745213,0.0027903586,0.006592641,0.0028718463,0.0019382493,0.0024774806],"category_scores_gemma":[0.07317588,0.000568181,0.0017291197,0.002837033,0.011179253,0.008170144,0.0064714807,0.0040756967,0.00026823595],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019826305,0.0005248558,0.09499774,0.00073121086,0.0002653908,0.00033809556,0.080650605,0.004170937,0.0010950927,0.70339286,0.0062479307,0.107387014],"study_design_scores_gemma":[0.00017166793,0.00057891535,0.1347656,0.0022855573,0.0004380806,0.0012201339,0.05004006,0.051721424,0.002086977,0.6961911,0.060272623,0.00022784984],"about_ca_topic_score_codex":0.010721514,"about_ca_topic_score_gemma":0.008463347,"teacher_disagreement_score":0.039375253,"about_ca_system_score_codex":0.0096240025,"about_ca_system_score_gemma":0.012222781,"threshold_uncertainty_score":0.20823878},"labels":[],"label_agreement":null},{"id":"W2766006797","doi":"10.1016/j.jval.2017.08.2708","title":"Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Ixekizumab; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Ustekinumab; Internal medicine; Physical therapy; Placebo; Secukinumab; Disease","score_opus":0.10933141652726085,"score_gpt":0.34734586787121413,"score_spread":0.23801445134395327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766006797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871535,0.007969533,0.00030795086,0.0008228282,0.00037886336,0.000039910472,0.00020601922,0.000046259705,0.00307518],"genre_scores_gemma":[0.99682057,0.001179595,0.00023216764,0.00019735105,0.00011269739,0.000015566253,0.00021351053,0.000004862307,0.0012236739],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99980456,0.000048497186,0.000012855745,0.000025374613,0.00002161612,0.00008718486],"domain_scores_gemma":[0.9997086,0.00010867888,0.00004875471,0.000030221316,0.000016706055,0.00008704789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035310414,0.00023520848,0.00097507396,0.000091458845,0.0001298815,0.0004855148,0.00015244835,0.00036623832,0.004250101],"category_scores_gemma":[0.00050600735,0.00008455086,0.00071680837,0.00008953416,0.00022160035,0.0003960627,0.00016576702,0.00135437,0.00033964225],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.45088115,0.014911344,0.010486109,0.0006319842,0.0010078527,0.00038087924,0.00010615545,0.0011168149,0.06957866,0.00075460534,0.005086128,0.44505823],"study_design_scores_gemma":[0.08620268,0.36749125,0.41132662,0.00045228555,0.00410533,0.0024349582,0.00070053164,0.004682401,0.09722769,0.0032471805,0.021993116,0.00013601214],"about_ca_topic_score_codex":0.00039280902,"about_ca_topic_score_gemma":0.00066208193,"teacher_disagreement_score":0.004250101,"about_ca_system_score_codex":0.00023363052,"about_ca_system_score_gemma":0.00037632207,"threshold_uncertainty_score":0.014218032},"labels":[],"label_agreement":null},{"id":"W2766053761","doi":"10.1016/j.jval.2017.08.2265","title":"Vaccines for Herpes Zoster: A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Randomized controlled trial; Pediatrics; Internal medicine","score_opus":0.1616777751833053,"score_gpt":0.45811497600048945,"score_spread":0.29643720081718417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766053761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091689173,0.9982287,0.00011215339,0.000086932305,0.00007098456,0.00026100178,0.00019915726,0.000008622317,0.00011559098],"genre_scores_gemma":[0.018390022,0.9796276,0.0008286467,0.000482575,0.000056427314,0.0003432795,0.0001630981,0.000006420391,0.0001019282],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9942801,0.0020721594,0.0021716561,0.0005007343,0.00072943105,0.00024596887],"domain_scores_gemma":[0.9881017,0.008138932,0.0027184743,0.00018380675,0.0006621756,0.00019484735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075069666,0.0023477483,0.016283471,0.005382436,0.000587939,0.0026999114,0.0021403,0.0024081601,0.0057368656],"category_scores_gemma":[0.02641721,0.0013473282,0.014254122,0.005696595,0.0009802744,0.0023744158,0.0018550775,0.002181371,0.00027971025],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011559888,0.000023315042,0.00049209676,0.93494123,0.041874975,0.000059321785,0.00008933087,0.00010336899,0.00015188158,0.0001095667,0.0007106561,0.020288244],"study_design_scores_gemma":[0.004296448,0.00060239236,0.0046487167,0.44783765,0.528812,0.00030625678,0.00025570247,0.00012381778,0.0002006134,0.0004501361,0.012397813,0.00006853183],"about_ca_topic_score_codex":0.008606377,"about_ca_topic_score_gemma":0.028610157,"teacher_disagreement_score":0.016283471,"about_ca_system_score_codex":0.0029112662,"about_ca_system_score_gemma":0.005972132,"threshold_uncertainty_score":0.039701104},"labels":[],"label_agreement":null},{"id":"W2766088226","doi":"10.1016/j.jval.2017.08.1362","title":"Assessing the Burden of Chronic Heart Failure on Patients in Colombia","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Spouse; Anxiety; Depression (economics); Heart failure; Chronic pain; Body mass index; Physical therapy; Demography; Internal medicine; Psychiatry","score_opus":0.04908035033122704,"score_gpt":0.36159973473367746,"score_spread":0.3125193844024504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766088226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920546,0.0011624662,0.00016238897,0.0012131679,0.000019349038,0.00003481256,0.0013186974,0.000005381064,0.0040291226],"genre_scores_gemma":[0.99861133,0.00060025166,0.00014964417,0.00005205737,0.000010454676,0.000011743818,0.0003484342,0.0000013336373,0.00021473062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999681,0.00013253247,0.000026320791,0.000025781294,0.000044102497,0.00009028762],"domain_scores_gemma":[0.9992706,0.0001683148,0.00019963396,0.000020274263,0.0001296397,0.00021155685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037044735,0.00030861597,0.00021501502,0.0011351206,0.0004677505,0.00087079674,0.00026925007,0.0002611251,0.0014134578],"category_scores_gemma":[0.0017766317,0.00012382574,0.00024018009,0.0009756297,0.00025268277,0.0002803213,0.0007963368,0.00044938587,0.00007557217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010564031,0.00006117818,0.9868205,0.0000980809,0.00006530737,0.00018518858,0.0007537895,0.00019598895,0.00015423377,0.00033068197,0.0010255667,0.010203753],"study_design_scores_gemma":[0.000012895932,0.00003514103,0.99497414,0.00006151137,0.0000357294,0.000120333316,0.0027416402,0.00044182007,0.00005548706,0.00013691909,0.0013752315,0.0000090240865],"about_ca_topic_score_codex":0.23651339,"about_ca_topic_score_gemma":0.27593508,"teacher_disagreement_score":0.23651339,"about_ca_system_score_codex":0.003154459,"about_ca_system_score_gemma":0.0016080737,"threshold_uncertainty_score":0.47027344},"labels":[],"label_agreement":null},{"id":"W2766091521","doi":"10.1016/j.jval.2017.08.1030","title":"A Critical Quality Appraisal Of Studies Estimating The Cost Of Radiotherapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Critical appraisal; Activity-based costing; Concordance; Medicine; Statistics; MEDLINE; Coefficient of variation; Quality (philosophy); Medical physics; Actuarial science; Mathematics; Accounting; Alternative medicine; Pathology; Business","score_opus":0.21329798082026463,"score_gpt":0.5412433320517112,"score_spread":0.3279453512314465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766091521","genre_codex":"review","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017531695,0.9107706,0.021404648,0.025051061,0.0065609505,0.011185283,0.003219646,0.00014769736,0.004128316],"genre_scores_gemma":[0.5869042,0.2675854,0.0959248,0.01792789,0.00958772,0.017931914,0.0029483824,0.000285289,0.0009044125],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.3145197,0.43108928,0.17258254,0.009983805,0.06999482,0.0018297901],"domain_scores_gemma":[0.0637322,0.7514794,0.08804331,0.019061008,0.0757517,0.0019325184],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4734886,0.0039588637,0.01278211,0.025202164,0.0032056342,0.013884766,0.006009802,0.007369435,0.0033302056],"category_scores_gemma":[0.8255099,0.0032232027,0.019718032,0.015113365,0.006469608,0.005650304,0.0046588033,0.0069334423,0.00039711955],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014866492,0.00021136965,0.037377246,0.42440936,0.24089526,0.0005491902,0.0030161568,0.003956373,0.0012251755,0.010272425,0.016173115,0.24704789],"study_design_scores_gemma":[0.009725896,0.005029768,0.06372537,0.42200276,0.3996056,0.0011929031,0.002177823,0.0073466455,0.0025931601,0.021481622,0.06441923,0.0006992634],"about_ca_topic_score_codex":0.011351076,"about_ca_topic_score_gemma":0.0151376575,"teacher_disagreement_score":0.52651143,"about_ca_system_score_codex":0.024859615,"about_ca_system_score_gemma":0.026953401,"threshold_uncertainty_score":0.64928234},"labels":[],"label_agreement":null},{"id":"W2766091900","doi":"10.1016/j.jval.2017.08.2857","title":"Treatment Patterns of Chronic Heart Failure (CHF) In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Myocardial infarction; Internal medicine; Disease; Blood pressure; Cardiology; Emergency medicine","score_opus":0.049971201523338754,"score_gpt":0.33920951256411314,"score_spread":0.28923831104077435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766091900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978346,0.00036407905,0.00005338451,0.00043899356,0.000005054182,0.000007457212,0.00045842025,0.000002720252,0.0008353044],"genre_scores_gemma":[0.9986332,0.00046676985,0.00011340669,0.00007435648,0.000008578835,0.000013868447,0.00040650996,0.0000024391459,0.00028090412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970406,0.00006532813,0.000035281428,0.000045877237,0.000033546166,0.00011591593],"domain_scores_gemma":[0.998919,0.0001756814,0.00061649655,0.000027257245,0.000112239395,0.00014928228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034846953,0.00012719212,0.00021988754,0.0012726743,0.0006485865,0.00058207696,0.0003439447,0.0002854733,0.0018162592],"category_scores_gemma":[0.0016291164,0.00016918621,0.00029264373,0.0017611169,0.00029290863,0.0003435557,0.00063755055,0.00041004288,0.00006443023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006754742,0.0000766509,0.9936341,0.000030408948,0.000028374036,0.00010735038,0.00076552643,0.000054421776,0.00015048432,0.00028224857,0.00043003942,0.004372759],"study_design_scores_gemma":[0.0000053005233,0.00002763205,0.99706906,0.000029428249,0.000014362138,0.00009497336,0.001998061,0.000105698935,0.00002730747,0.000037911002,0.0005867774,0.0000035673356],"about_ca_topic_score_codex":0.0990844,"about_ca_topic_score_gemma":0.14609319,"teacher_disagreement_score":0.0990844,"about_ca_system_score_codex":0.0015905927,"about_ca_system_score_gemma":0.0010827519,"threshold_uncertainty_score":0.19701535},"labels":[],"label_agreement":null},{"id":"W2766123849","doi":"10.1016/j.jval.2017.08.2416","title":"Patient Characteristics and Disease Burden of Psoriasis In Mexico: A Real-World Physician and Patient Survey","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Psoriasis; Dermatology Life Quality Index; Psoriatic arthritis; Body surface area; Medical prescription; Quality of life (healthcare); Disease burden; Concomitant; Body mass index; Disease; Internal medicine; Dermatology","score_opus":0.03611941783254451,"score_gpt":0.28237981687616465,"score_spread":0.24626039904362013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766123849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986065,0.00009846087,0.000026870512,0.00011164306,0.0000021602543,0.0000055647665,0.00088166754,0.0000021615858,0.00026504544],"genre_scores_gemma":[0.99902356,0.00012585314,0.00005073931,0.00004757516,0.000008164665,0.000007281387,0.0006413212,0.0000013269993,0.000094035546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99954236,0.00014952707,0.000055502216,0.00009080319,0.00007043497,0.00009137601],"domain_scores_gemma":[0.9982792,0.00022655586,0.001076281,0.00007936524,0.00011133846,0.00022724982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060474855,0.00021355478,0.00031402934,0.0008505313,0.00051532313,0.00067317096,0.00034969437,0.0006501135,0.0014358446],"category_scores_gemma":[0.0019851406,0.00028039215,0.00034846787,0.00177136,0.00027351818,0.00056380563,0.00049570296,0.0005713565,0.00016218107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003958646,0.000037707905,0.99930847,0.0000039967294,0.000024530147,0.000026716963,0.000081230864,0.00001996894,0.000026612955,0.000005909071,0.000097987235,0.00032718063],"study_design_scores_gemma":[0.000004919477,0.000034143246,0.9994211,0.000002742638,0.000012657374,0.000062749416,0.00029445463,0.00006152523,0.000007740279,0.000004041471,0.00009194777,0.0000021253902],"about_ca_topic_score_codex":0.04156102,"about_ca_topic_score_gemma":0.038835,"teacher_disagreement_score":0.04156102,"about_ca_system_score_codex":0.0008212771,"about_ca_system_score_gemma":0.00044890746,"threshold_uncertainty_score":0.082638204},"labels":[],"label_agreement":null},{"id":"W2766129054","doi":"10.1016/j.jval.2017.08.2845","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Spouse; Medicine; Caregiver burden; Anxiety; Heart failure; Rehabilitation; Family medicine; Disease; Gerontology; Physical therapy; Psychiatry; Internal medicine","score_opus":0.04604751906998376,"score_gpt":0.34404556662153285,"score_spread":0.2979980475515491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766129054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983367,0.00025192177,0.000036601672,0.00054745114,0.000005819983,0.000006884843,0.00015454194,7.412012e-7,0.0006593742],"genre_scores_gemma":[0.9990841,0.00046739235,0.0001232005,0.000057812835,0.000006804599,0.0000147995,0.00012835884,5.351103e-7,0.000116996496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997594,0.00012268772,0.00001883908,0.000017596163,0.000025212481,0.000056205146],"domain_scores_gemma":[0.99917966,0.00020484808,0.00034468845,0.00002439909,0.00012229156,0.00012404785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070967956,0.00016894247,0.00017583778,0.0005395709,0.00071792165,0.00054683286,0.00027576456,0.00020365637,0.0008938655],"category_scores_gemma":[0.002815084,0.000116773044,0.00020547441,0.0006704454,0.0002349122,0.0002781089,0.0007363594,0.00044743888,0.000032437576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006486531,0.00007521959,0.99043816,0.000037285656,0.00004316463,0.00008697703,0.0017438226,0.000058295016,0.00005751413,0.00017286498,0.0005998683,0.0066219517],"study_design_scores_gemma":[0.00001489196,0.00006208434,0.9904801,0.00009051379,0.00005452325,0.00007929629,0.0077013113,0.00023954362,0.00003786763,0.00008526712,0.0011498476,0.0000047793515],"about_ca_topic_score_codex":0.1384014,"about_ca_topic_score_gemma":0.17935835,"teacher_disagreement_score":0.1384014,"about_ca_system_score_codex":0.0017888236,"about_ca_system_score_gemma":0.0014841972,"threshold_uncertainty_score":0.2751916},"labels":[],"label_agreement":null},{"id":"W2766143852","doi":"10.1016/j.jval.2017.08.717","title":"Very Low Compliance for Vulvovaginal Atrophy (VVA) Treatment: A Retrospective U.S. Healthcare Claims Database Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada); Statistics Canada","funders":"","keywords":"Discontinuation; Medicine; Genitourinary system; Internal medicine; Vagina; Menopause; Gynecology; Surgery","score_opus":0.1540388719938162,"score_gpt":0.42050147547177463,"score_spread":0.26646260347795847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766143852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99060327,0.0014088248,0.0002937614,0.00027735558,0.000019335681,0.000033623986,0.0062310575,0.000010480495,0.0011223564],"genre_scores_gemma":[0.99622923,0.00027372336,0.00016240371,0.00019799951,0.000018429051,0.000024859997,0.0029762266,0.0000064145415,0.00011079651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997029,0.00089970033,0.0006781865,0.00051372376,0.0006264739,0.00025294704],"domain_scores_gemma":[0.9902597,0.0028157092,0.0048654117,0.0009841969,0.0007249714,0.00035011736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002145099,0.00017781921,0.0004065545,0.0011845485,0.0005858816,0.0009758952,0.0005997882,0.00061893754,0.0015589412],"category_scores_gemma":[0.008471927,0.0003895049,0.000947114,0.0031636637,0.00031703332,0.0006083052,0.00065712765,0.0010982801,0.00016838136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012003139,0.000040449504,0.9975649,0.000037110905,0.00022626856,0.0000408484,0.0000503921,0.000031487445,0.00004875476,0.00007215801,0.0005023838,0.0012651699],"study_design_scores_gemma":[0.000015628462,0.00005775601,0.9983601,0.000044366217,0.00014507277,0.0002553623,0.00017874489,0.00032376117,0.00004853466,0.00006510599,0.0004981582,0.0000073708115],"about_ca_topic_score_codex":0.01398619,"about_ca_topic_score_gemma":0.017448174,"teacher_disagreement_score":0.01398619,"about_ca_system_score_codex":0.00063746097,"about_ca_system_score_gemma":0.0009079955,"threshold_uncertainty_score":0.02780956},"labels":[],"label_agreement":null},{"id":"W2766144097","doi":"10.1016/j.jval.2017.08.852","title":"A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Discontinuation; Carcinoid syndrome; Medicine; Diarrhea; Neuroendocrine tumors; Orphan drug; Incidence (geometry); Internal medicine; Pediatrics","score_opus":0.03307720752923835,"score_gpt":0.3404542266968829,"score_spread":0.30737701916764454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766144097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5753263,0.007984358,0.14370744,0.047871772,0.0013857358,0.0038631377,0.021138292,0.0007575145,0.19796543],"genre_scores_gemma":[0.96273,0.0013712614,0.0061585126,0.0012088398,0.00010739709,0.0006308419,0.0010188735,0.000053864802,0.026720522],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99530256,0.002641931,0.00012256482,0.0003952924,0.00034142743,0.0011961941],"domain_scores_gemma":[0.9916272,0.0061806673,0.0008128677,0.00016848979,0.00039558965,0.00081524765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055030934,0.0019471148,0.0030917635,0.0015483688,0.00071570155,0.004132898,0.002596602,0.004451667,0.024945298],"category_scores_gemma":[0.017899968,0.0015449624,0.002218921,0.0016726301,0.002255498,0.0033783638,0.0023727382,0.004385036,0.0009973045],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004088354,0.000587661,0.004195871,0.00031531442,0.00046393104,0.00040143565,0.00011125894,0.9018451,0.00060527056,0.0678641,0.003940515,0.0155812055],"study_design_scores_gemma":[0.003036092,0.0033968699,0.009942386,0.00030200245,0.0014210294,0.0003504516,0.00076830894,0.8791473,0.0006575556,0.08927003,0.011507145,0.00020084783],"about_ca_topic_score_codex":0.053187456,"about_ca_topic_score_gemma":0.028771132,"teacher_disagreement_score":0.053187456,"about_ca_system_score_codex":0.0076032034,"about_ca_system_score_gemma":0.008637038,"threshold_uncertainty_score":0.10575575},"labels":[],"label_agreement":null},{"id":"W2766150197","doi":"10.1016/j.jval.2017.08.1170","title":"Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Novartis (Canada)","funders":"","keywords":"Sacubitril, Valsartan; Valsartan; Sacubitril; Medicine; Enalapril; Heart failure; Ejection fraction; Number needed to treat; Internal medicine; Population; Cardiology; Emergency medicine; Angiotensin-converting enzyme; Relative risk; Confidence interval; Blood pressure","score_opus":0.04549424147602688,"score_gpt":0.334384230025348,"score_spread":0.28888998854932113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766150197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93498397,0.013896253,0.0006781852,0.020829553,0.0003586149,0.00022454563,0.0036793307,0.00017688287,0.025172701],"genre_scores_gemma":[0.9940367,0.0017380181,0.0009396533,0.001522284,0.000089390494,0.000017665869,0.00056852115,0.000018954011,0.0010688835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990138,0.00017368028,0.00007906255,0.0000870561,0.00030127144,0.00034506276],"domain_scores_gemma":[0.9975376,0.00020987605,0.00047807055,0.000036366862,0.0007053704,0.0010326483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054077903,0.0001781989,0.00048396437,0.00048688456,0.00093044195,0.0011958168,0.000658287,0.00038409192,0.0044017863],"category_scores_gemma":[0.003703968,0.00014553872,0.0005041127,0.000906726,0.0004013475,0.0003357484,0.00035553353,0.0010995158,0.00020201692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073591103,0.0030487282,0.5352987,0.00069628493,0.0007879121,0.00053957547,0.00039085431,0.0035413366,0.0028001887,0.002434955,0.052187867,0.39091447],"study_design_scores_gemma":[0.001190842,0.0008290563,0.97607476,0.0004455779,0.0005988232,0.0003038598,0.0007670853,0.0045159925,0.00081933226,0.00084896415,0.013548049,0.00005761317],"about_ca_topic_score_codex":0.900807,"about_ca_topic_score_gemma":0.97086966,"teacher_disagreement_score":0.09919298,"about_ca_system_score_codex":0.018466853,"about_ca_system_score_gemma":0.05012007,"threshold_uncertainty_score":0.19955426},"labels":[],"label_agreement":null},{"id":"W2766152205","doi":"10.1016/j.jval.2017.08.1171","title":"Preliminary Results of Restarting Oral Anticoagulant Treatment In Patients with Non-Valvular Atrial Fibrillation Following Intracranial Hemorrhage: A Population-Based Cohort Study","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Cohort; Internal medicine; Intracerebral hemorrhage; Population; Cardiology; Cohort study; Oral anticoagulant; Warfarin; Subarachnoid hemorrhage","score_opus":0.049837315282472594,"score_gpt":0.34869094795167527,"score_spread":0.2988536326692027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766152205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986853,0.00014967368,0.00011722203,0.000062741434,0.000018403338,0.000034542973,0.00054076547,0.0000032174462,0.00038815325],"genre_scores_gemma":[0.998432,0.00012725216,0.00017402798,0.00006675422,0.00004075447,0.000043746102,0.0008406901,0.00000536583,0.00026951387],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979468,0.0008542995,0.00020270851,0.00043644835,0.00026965945,0.000290092],"domain_scores_gemma":[0.9952532,0.0013767533,0.001173457,0.0009188558,0.0006115397,0.0006661615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025169824,0.0007684511,0.00093535683,0.0006772514,0.0010479749,0.0022138413,0.000950917,0.001176511,0.001964009],"category_scores_gemma":[0.009958994,0.00063011824,0.0022861408,0.0013866541,0.00062966463,0.0014938157,0.00080978405,0.0016511927,0.00042160967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033356133,0.0005722423,0.9927471,0.00001857927,0.00061298325,0.0002073572,0.00029066973,0.00004618732,0.00050113373,0.000037984068,0.00016895152,0.0014611011],"study_design_scores_gemma":[0.0003065007,0.0014112417,0.9961361,0.000008249642,0.0006046098,0.00027554654,0.0005964215,0.00024845195,0.000107527034,0.000069930815,0.0002095714,0.000025687938],"about_ca_topic_score_codex":0.011333336,"about_ca_topic_score_gemma":0.012275552,"teacher_disagreement_score":0.011333336,"about_ca_system_score_codex":0.0006182221,"about_ca_system_score_gemma":0.0009073379,"threshold_uncertainty_score":0.022534788},"labels":[],"label_agreement":null},{"id":"W2766154081","doi":"10.1016/j.jval.2017.08.2992","title":"Long-Term work Productivity improvement from Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Work productivity; Placebo; Presenteeism; Rheumatoid arthritis; Methotrexate; Subgroup analysis; Internal medicine; Adalimumab; Randomized controlled trial; Productivity; Physical therapy; Confidence interval","score_opus":0.17553996103029543,"score_gpt":0.49089193898083794,"score_spread":0.3153519779505425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766154081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780788,0.014688834,0.0007516559,0.00038097572,0.00016690503,0.00017192944,0.0038238184,0.000033867702,0.0019032671],"genre_scores_gemma":[0.9950328,0.0009911731,0.0001721482,0.00042952993,0.00008735334,0.00017736816,0.0023802838,0.00002146987,0.0007079222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988689,0.0003402512,0.00016064254,0.00024966992,0.00012027968,0.00026032768],"domain_scores_gemma":[0.9993254,0.00017758938,0.00020192142,0.0001299968,0.0000994194,0.000065646374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018197654,0.00077630556,0.0021460617,0.0008551903,0.00043264034,0.0011799324,0.0006376219,0.0006466922,0.0019828018],"category_scores_gemma":[0.0021114233,0.00032044732,0.005935932,0.0014738439,0.00027049799,0.0004587417,0.0008129156,0.00085886667,0.00025494638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08614925,0.0005369895,0.74197096,0.0026571935,0.12125563,0.0005715313,0.00046394987,0.0010302714,0.003918583,0.0004028543,0.005766815,0.035275944],"study_design_scores_gemma":[0.01227923,0.002592389,0.8883542,0.0004178929,0.086751394,0.0002994934,0.0011349627,0.00113458,0.0006157564,0.00061477616,0.0057222922,0.000083021936],"about_ca_topic_score_codex":0.0073927753,"about_ca_topic_score_gemma":0.01470695,"teacher_disagreement_score":0.0073927753,"about_ca_system_score_codex":0.0006009097,"about_ca_system_score_gemma":0.00079884793,"threshold_uncertainty_score":0.014699459},"labels":[],"label_agreement":null},{"id":"W2766166596","doi":"10.1016/j.jval.2017.12.019","title":"Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Type 2 Diabetes Mellitus; Indirect costs; Disease burden; Population; Coronary artery disease; MEDLINE; Type 2 diabetes; Disease; Intensive care medicine; Diabetes mellitus; Emergency medicine; Comorbidity; Environmental health; Internal medicine","score_opus":0.06739378503097723,"score_gpt":0.33144060148306953,"score_spread":0.26404681645209227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766166596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008196358,0.9984401,0.000056664732,0.00017203159,0.00008216295,0.000038212056,0.00025755,0.0000027130368,0.000130946],"genre_scores_gemma":[0.012057181,0.98718613,0.00020888445,0.00026355401,0.000078059325,0.000048846974,0.00010985917,0.0000018883396,0.00004555019],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99704486,0.0009315342,0.0010097991,0.00026546358,0.00061118806,0.0001372123],"domain_scores_gemma":[0.98887527,0.00843877,0.0018827799,0.00011043878,0.00054327113,0.0001493866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003781362,0.00131069,0.006676042,0.005585951,0.00039162155,0.0021198865,0.0012907978,0.0016333184,0.0048390287],"category_scores_gemma":[0.020515768,0.0009400652,0.007763698,0.0074232165,0.00051091035,0.0017657963,0.0016156313,0.0017269242,0.0002039008],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047225849,0.00003954077,0.0038406039,0.8842135,0.049702663,0.00016143662,0.00013847796,0.00023409008,0.000083585765,0.00045847127,0.0031960246,0.05745923],"study_design_scores_gemma":[0.00073710113,0.00022956547,0.022778485,0.5891655,0.3594371,0.0007548015,0.00045632516,0.00026781677,0.00011802252,0.0013676244,0.024576727,0.00011096922],"about_ca_topic_score_codex":0.010920885,"about_ca_topic_score_gemma":0.030402398,"teacher_disagreement_score":0.010920885,"about_ca_system_score_codex":0.0021441,"about_ca_system_score_gemma":0.0047866637,"threshold_uncertainty_score":0.021714628},"labels":[],"label_agreement":null},{"id":"W2766182174","doi":"10.1016/j.jval.2017.08.2594","title":"Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Decision quality; Lanreotide; Watchful waiting; Population; Actuarial science; Family medicine; Psychology; Nursing; Patient satisfaction; Internal medicine; Business","score_opus":0.1712701435847904,"score_gpt":0.5248776480838744,"score_spread":0.35360750449908396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766182174","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09729196,0.00047003917,0.87298954,0.008713467,0.00024626276,0.0017481581,0.00027924337,0.0014001171,0.016861262],"genre_scores_gemma":[0.46502134,0.00015742703,0.53205997,0.0006138973,0.00006175859,0.00074535946,0.000223948,0.00016523106,0.00095106126],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8985829,0.085888796,0.003882855,0.0031687852,0.006492322,0.0019844018],"domain_scores_gemma":[0.74917525,0.21833701,0.0080905855,0.009945429,0.010100683,0.004351037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06261105,0.0016526128,0.001701423,0.0025466539,0.0021335597,0.008757885,0.0033982105,0.002639543,0.008356055],"category_scores_gemma":[0.19366828,0.0009917595,0.0023068246,0.0013812016,0.0025728643,0.006533812,0.009630286,0.004639903,0.0013802679],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031747737,0.002284548,0.021844905,0.0017593163,0.001330114,0.0016688975,0.028014507,0.15519157,0.0053865686,0.06491965,0.016631579,0.69779354],"study_design_scores_gemma":[0.00069946214,0.0008994074,0.0033359863,0.0015106603,0.00041519714,0.0005839083,0.010109975,0.6848047,0.008625212,0.2692798,0.019390147,0.00034559512],"about_ca_topic_score_codex":0.0016819262,"about_ca_topic_score_gemma":0.0036427751,"teacher_disagreement_score":0.06261105,"about_ca_system_score_codex":0.003148828,"about_ca_system_score_gemma":0.010379225,"threshold_uncertainty_score":0.33112288},"labels":[],"label_agreement":null},{"id":"W2766207394","doi":"10.1016/j.jval.2017.08.1628","title":"Evaluating The Cost-Utility Of Immunosuppressive Regimens In Liver Transplant Recipients In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tacrolimus; Medicine; Immunosuppression; Liver transplantation; Quality-adjusted life year; Cost effectiveness; Regimen; Transplantation; Internal medicine","score_opus":0.15095178776877424,"score_gpt":0.40144201143883523,"score_spread":0.250490223670061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766207394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.979224,0.0040609944,0.0002567888,0.0050135083,0.000045472043,0.000106865584,0.004379684,0.0000122305955,0.006900277],"genre_scores_gemma":[0.996338,0.0016496247,0.0003152982,0.00026961192,0.000017852044,0.0000133170515,0.0008969961,0.000004757842,0.0004945538],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99822503,0.00034817806,0.00013805921,0.00009042288,0.0005580978,0.0006402005],"domain_scores_gemma":[0.9932539,0.0010987803,0.0011079019,0.000094903284,0.0028005403,0.0016440589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011649749,0.00031712517,0.000489466,0.0019075213,0.001556857,0.002237359,0.0011722378,0.0005229391,0.0021895315],"category_scores_gemma":[0.009659317,0.0002561871,0.0009412065,0.0051893657,0.0008426211,0.00044462213,0.0008800086,0.0009783566,0.00008589632],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009628578,0.00029442128,0.94774765,0.0003434639,0.00055988046,0.0003460932,0.00040919913,0.007749023,0.00022742913,0.0031569174,0.005922744,0.032280292],"study_design_scores_gemma":[0.00029732377,0.0002537348,0.9732872,0.00048240906,0.00072923955,0.00025532374,0.0027321682,0.01593836,0.00042248945,0.00080519874,0.0047286465,0.00006794833],"about_ca_topic_score_codex":0.9942697,"about_ca_topic_score_gemma":0.99657696,"teacher_disagreement_score":0.116458185,"about_ca_system_score_codex":0.116458185,"about_ca_system_score_gemma":0.112684846,"threshold_uncertainty_score":0.84496725},"labels":[],"label_agreement":null},{"id":"W2766277025","doi":"10.1016/j.jval.2017.08.1386","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Costa Rica","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Medicine; Enalapril; Heart failure; Ejection fraction; Internal medicine; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","score_opus":0.05966566235948348,"score_gpt":0.3549479626983868,"score_spread":0.29528230033890335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766277025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9547054,0.018697387,0.0010011033,0.012923785,0.000103705235,0.00010280344,0.000744274,0.000068527326,0.011652962],"genre_scores_gemma":[0.9947679,0.003051539,0.00082755566,0.00068527716,0.00005912212,0.000029092811,0.000132954,0.0000067504743,0.00043974165],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999703,0.00018788346,0.000019459649,0.000014264367,0.00002455226,0.000050836803],"domain_scores_gemma":[0.99970406,0.000050640592,0.000095596406,0.000027726748,0.000059481597,0.00006254757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008656238,0.00018634104,0.00024261257,0.00025285195,0.00021328332,0.0005572559,0.00035144045,0.0001768387,0.0011943852],"category_scores_gemma":[0.0011153022,0.00006102543,0.00028478092,0.00032096464,0.000315027,0.00015255391,0.00034065644,0.00036696825,0.00009361128],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011816942,0.0020633773,0.3654518,0.0019024002,0.0013620519,0.0016455215,0.0012251484,0.0066816965,0.023267077,0.011088631,0.016448727,0.55704665],"study_design_scores_gemma":[0.0017408185,0.001745906,0.94803005,0.0006178504,0.0012096225,0.0007864336,0.0014865542,0.004830376,0.0030699198,0.0017528296,0.03468474,0.00004485241],"about_ca_topic_score_codex":0.040969666,"about_ca_topic_score_gemma":0.06725975,"teacher_disagreement_score":0.040969666,"about_ca_system_score_codex":0.0014053053,"about_ca_system_score_gemma":0.0027239448,"threshold_uncertainty_score":0.08146238},"labels":[],"label_agreement":null},{"id":"W2766296243","doi":"10.1016/j.jval.2017.08.2676","title":"Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Demographics; Morning stiffness; Physical therapy; Demography; Psoriatic arthritis","score_opus":0.025266128976147648,"score_gpt":0.2989488968504094,"score_spread":0.2736827678742617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766296243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959972,0.00030046233,0.000034699664,0.00017871782,0.000010764012,0.000013228476,0.0005816559,0.0000024530432,0.0028808438],"genre_scores_gemma":[0.99836737,0.00022338373,0.000034234603,0.00021614949,0.000024295074,0.000018755936,0.00058562186,0.0000030764454,0.0005271094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996737,0.00006183445,0.000045341418,0.000050161198,0.000045679215,0.00012333013],"domain_scores_gemma":[0.9987313,0.00026224827,0.00057023595,0.000039602553,0.00011214011,0.0002844214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030362402,0.0002530842,0.00044842716,0.0010451897,0.00066965836,0.0008740836,0.00022136551,0.00053827104,0.005989237],"category_scores_gemma":[0.0019402169,0.00017496859,0.0004141996,0.0017101876,0.0003839936,0.000533112,0.00039795335,0.00062668143,0.00048467718],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023139043,0.00014248578,0.99771154,0.000010971241,0.000037910297,0.00020424572,0.00019353961,0.000030028978,0.00023848956,0.000051548363,0.00021442915,0.00093352667],"study_design_scores_gemma":[0.000028516604,0.00017030229,0.9965395,0.000017265444,0.000031134045,0.00049128814,0.001872599,0.000097099924,0.000031043495,0.000059891685,0.0006538834,0.0000075644757],"about_ca_topic_score_codex":0.011795349,"about_ca_topic_score_gemma":0.011179243,"teacher_disagreement_score":0.011795349,"about_ca_system_score_codex":0.00048583146,"about_ca_system_score_gemma":0.0005860868,"threshold_uncertainty_score":0.023453355},"labels":[],"label_agreement":null},{"id":"W2766309622","doi":"10.1016/j.jval.2017.08.2433","title":"Comparison of the Assessments and Recommendations Issued by Brazil’s Conitec and Canada’s Cadth for Select Oncology Drugs","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cetuximab; Bevacizumab; Medicine; Everolimus; Oncology; Internal medicine; Biosimilar; Clinical trial; Breast cancer; Cancer; Colorectal cancer; Medical physics; Family medicine; Chemotherapy","score_opus":0.422258233729823,"score_gpt":0.5403794349603194,"score_spread":0.11812120123049635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766309622","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16396971,0.056664016,0.015206134,0.33452287,0.006249197,0.0024651573,0.056959957,0.0006608693,0.36330214],"genre_scores_gemma":[0.8586956,0.016432796,0.039374128,0.050237957,0.0011663192,0.00081794383,0.01217884,0.00027544872,0.0208208],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.94363165,0.012041517,0.00385398,0.0014178772,0.035938345,0.0031165835],"domain_scores_gemma":[0.8034789,0.07043879,0.009236861,0.0034177883,0.10600621,0.007421438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05306766,0.0007067093,0.0010668255,0.009115308,0.0019651009,0.006837088,0.0028133192,0.0035505602,0.0033008137],"category_scores_gemma":[0.18144281,0.00048479156,0.002350408,0.007336781,0.0017630073,0.0016208097,0.0017819478,0.0054286425,0.00047458865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016111288,0.0003826507,0.100990266,0.0039789323,0.0018899287,0.00028779617,0.0030518342,0.011897444,0.0011771948,0.11232721,0.4543473,0.30805826],"study_design_scores_gemma":[0.0006259317,0.00049842085,0.279329,0.009690623,0.0024448875,0.00024644283,0.0027698935,0.012845524,0.003457129,0.013763068,0.6738861,0.0004428806],"about_ca_topic_score_codex":0.7090111,"about_ca_topic_score_gemma":0.80530334,"teacher_disagreement_score":0.9596252,"about_ca_system_score_codex":0.040374804,"about_ca_system_score_gemma":0.099308744,"threshold_uncertainty_score":0.58540523},"labels":[],"label_agreement":null},{"id":"W2766317520","doi":"10.1016/j.jval.2017.08.512","title":"Comparison Of Post-Creation Procedures And Related Costs Between Traditional Surgical Versus A New Endovascular Approach To Creating An Arteriovenous Fistula: A Usrds Comparison","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Arteriovenous fistula; Cohort; Propensity score matching; Emergency medicine; Fistula; Catheter; Hemodialysis; Surgery; Internal medicine","score_opus":0.1734764795781764,"score_gpt":0.42967908214419115,"score_spread":0.25620260256601474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766317520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786516,0.0051285783,0.001183013,0.00038689916,0.00024156478,0.00024134418,0.0073227007,0.000033016117,0.0068112575],"genre_scores_gemma":[0.9925567,0.00096559984,0.000855618,0.00018997646,0.00013010032,0.00019307052,0.0038978246,0.00002369183,0.001187327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99123174,0.005030544,0.0009654551,0.00048526045,0.0015838316,0.00070321525],"domain_scores_gemma":[0.9846734,0.0096253455,0.0024091112,0.0008550442,0.0016279967,0.000809085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005822827,0.00083567813,0.0022176302,0.005863117,0.00045088105,0.0017860697,0.001447972,0.0012750353,0.0097037],"category_scores_gemma":[0.018388435,0.00045068856,0.0053759636,0.0054656705,0.00074072473,0.0020263428,0.0014737613,0.0016758714,0.00058326096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36767307,0.008474418,0.3930936,0.004631619,0.024644995,0.00063869695,0.0011335845,0.016568584,0.004884459,0.011239928,0.013629261,0.1533877],"study_design_scores_gemma":[0.015952345,0.071424074,0.85754156,0.0009781758,0.01091452,0.0014070936,0.004705132,0.012501082,0.0047450773,0.004520327,0.014954846,0.00035578795],"about_ca_topic_score_codex":0.0060357847,"about_ca_topic_score_gemma":0.005836274,"teacher_disagreement_score":0.0097037,"about_ca_system_score_codex":0.0033624314,"about_ca_system_score_gemma":0.0011184552,"threshold_uncertainty_score":0.03246212},"labels":[],"label_agreement":null},{"id":"W2766319621","doi":"10.1016/j.jval.2017.08.137","title":"Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Carboplatin; Gemcitabine; Medicine; Regimen; Cisplatin; Internal medicine; Oncology; Chemotherapy; Cancer","score_opus":0.05453436083096245,"score_gpt":0.337921771874297,"score_spread":0.28338741104333454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766319621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98947656,0.006188706,0.00010752173,0.00047453574,0.00006242513,0.000011188549,0.0010343711,0.0000085459205,0.0026361549],"genre_scores_gemma":[0.9976278,0.00071742444,0.000026113375,0.00009873975,0.000037239886,0.000004781147,0.0010581653,0.0000018267691,0.0004279915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998215,0.00004248535,0.000009595743,0.000025486337,0.000026672975,0.000074218195],"domain_scores_gemma":[0.9995215,0.00013796367,0.000119867305,0.000024059396,0.00004691341,0.00014962195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003316531,0.0001708068,0.0005834422,0.00031553436,0.00024136691,0.00056884147,0.00026282252,0.00045187888,0.0018100007],"category_scores_gemma":[0.0014557089,0.00007997116,0.0011570073,0.0004619047,0.00015959934,0.0004544151,0.0003945777,0.0006034226,0.0001518696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005591177,0.00025031305,0.9493605,0.00013913405,0.0006941861,0.000470629,0.00014678214,0.0011263798,0.0009177227,0.00017643867,0.0019874373,0.03913938],"study_design_scores_gemma":[0.00011663681,0.001451975,0.99539727,0.00004096087,0.0003785847,0.0005304465,0.00014343699,0.0005859718,0.00015221392,0.00022166563,0.0009718539,0.000009017289],"about_ca_topic_score_codex":0.0033989553,"about_ca_topic_score_gemma":0.0067177597,"teacher_disagreement_score":0.0033989553,"about_ca_system_score_codex":0.00067102263,"about_ca_system_score_gemma":0.0004145496,"threshold_uncertainty_score":0.0067583323},"labels":[],"label_agreement":null},{"id":"W2766387740","doi":"10.1016/j.jval.2017.08.1218","title":"Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Sacubitril, Valsartan; Sacubitril; Valsartan; Cohort; Cost effectiveness; Quality-adjusted life year; Heart failure; Clinical trial; Cost-effectiveness analysis; Ejection fraction; Internal medicine; Intensive care medicine; Emergency medicine; Blood pressure","score_opus":0.5222522496897127,"score_gpt":0.48047281140990933,"score_spread":0.041779438279803405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766387740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765977,0.016731437,0.00021908327,0.0021605503,0.00009716664,0.000084145584,0.0014353596,0.000012854068,0.0026617476],"genre_scores_gemma":[0.9976457,0.0016757773,0.00009536518,0.000058445814,0.000021407814,0.000014735451,0.0003248348,0.0000015987532,0.0001621802],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999092,0.000548182,0.000065943044,0.00005664147,0.00009436469,0.00014287137],"domain_scores_gemma":[0.99874383,0.00041894094,0.00029343288,0.000033065295,0.00012444628,0.00038625943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009110755,0.00027504851,0.0005553365,0.0005200927,0.00017341065,0.00086233823,0.00035740907,0.00033694587,0.0015223678],"category_scores_gemma":[0.0026177336,0.000110714805,0.00083040464,0.00056084356,0.00033313202,0.00027374647,0.00042814537,0.0007489467,0.000050893468],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1458239,0.0073644477,0.3634688,0.008069676,0.010108706,0.0023711582,0.00057164236,0.04314106,0.003542273,0.008490311,0.013631546,0.39341652],"study_design_scores_gemma":[0.023088899,0.014828905,0.9033808,0.001573502,0.008623037,0.001055508,0.0020227726,0.028144954,0.0016755984,0.0019087052,0.013518428,0.00017889496],"about_ca_topic_score_codex":0.06881451,"about_ca_topic_score_gemma":0.09316843,"teacher_disagreement_score":0.06881451,"about_ca_system_score_codex":0.004935219,"about_ca_system_score_gemma":0.0023118341,"threshold_uncertainty_score":0.13682795},"labels":[],"label_agreement":null},{"id":"W2766400217","doi":"10.1016/j.jval.2017.08.2988","title":"Reliability, Validity and Responsiveness of A New Measure of Neck Disability (ND10)","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Practices and Rehabilitation","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Construct validity; Intraclass correlation; Readability; Clinical psychology; Psychology; Reliability (semiconductor); Dash; Medicine; Physical therapy; Psychometrics","score_opus":0.2556462446960754,"score_gpt":0.5001857133928145,"score_spread":0.2445394686967391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766400217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912965,0.00046535645,0.0017492373,0.00020771043,0.00014084164,0.00018639241,0.00064604095,0.000027115528,0.0052808216],"genre_scores_gemma":[0.9943457,0.00025623033,0.0025663788,0.000111228524,0.00005134194,0.00035137168,0.0007453571,0.000020368167,0.0015519501],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921789,0.0022910135,0.0008661793,0.00073800667,0.0035689492,0.00035686124],"domain_scores_gemma":[0.9672678,0.0199168,0.003386337,0.001569118,0.0068968902,0.000963057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077907066,0.00052073214,0.00054048846,0.0020445317,0.0005052925,0.001019364,0.00086496223,0.00086648494,0.0016321471],"category_scores_gemma":[0.039363902,0.00039521314,0.0011470595,0.00094062067,0.00095765194,0.0010743589,0.0019469163,0.001149438,0.0006372884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007684228,0.0004920571,0.9545525,0.000112022004,0.00030065823,0.000063195504,0.0014581339,0.000614338,0.0013114621,0.0003530832,0.00087047566,0.039103683],"study_design_scores_gemma":[0.00010040345,0.0009350802,0.99228716,0.000058692684,0.00008822175,0.00021186541,0.00075101526,0.0022177189,0.0007807633,0.00043022714,0.00210643,0.000032443422],"about_ca_topic_score_codex":0.007537365,"about_ca_topic_score_gemma":0.008659265,"teacher_disagreement_score":0.0077907066,"about_ca_system_score_codex":0.0015780389,"about_ca_system_score_gemma":0.0012303764,"threshold_uncertainty_score":0.04120165},"labels":[],"label_agreement":null},{"id":"W2766414735","doi":"10.1016/j.jval.2017.08.1081","title":"A Cost-Utility Analysis of Artificial Urinary Sphincter Versus Advance Male Sling In Post Prostatectomy Stress Urinary Incontinence: A Canadian Healthcare Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Artificial urinary sphincter; Sling (weapon); Urinary incontinence; Medicine; Prostatectomy; Stress incontinence; Urology; Surgery; Internal medicine; Prostate cancer; Cancer","score_opus":0.06907056302338273,"score_gpt":0.3787156711099319,"score_spread":0.30964510808654916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766414735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72398466,0.12529588,0.010050696,0.040056206,0.0009406182,0.0018522438,0.031165602,0.0001536278,0.06650044],"genre_scores_gemma":[0.97292984,0.013943235,0.004996611,0.0014552244,0.00019853954,0.00012269811,0.0034634862,0.00003408445,0.0028563382],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99576604,0.001799712,0.00017516714,0.00026091715,0.0012289649,0.0007692199],"domain_scores_gemma":[0.9957337,0.002020005,0.00030514778,0.000074260744,0.0013754488,0.00049143523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042565083,0.0014141344,0.0021479852,0.0030358182,0.001348318,0.004043178,0.0018868446,0.0016817302,0.007272297],"category_scores_gemma":[0.014623081,0.0007002141,0.004730493,0.005461155,0.0009830967,0.0009796027,0.0010869431,0.0028355198,0.00022364355],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032717746,0.0017821811,0.1505367,0.00817095,0.018242238,0.0018621864,0.0013049176,0.35540304,0.003067423,0.0760105,0.06713338,0.28376877],"study_design_scores_gemma":[0.0091359,0.0057590376,0.43868646,0.005677776,0.029484717,0.001819962,0.004971556,0.42573532,0.0013336479,0.02008378,0.05619619,0.0011156506],"about_ca_topic_score_codex":0.94688076,"about_ca_topic_score_gemma":0.94761616,"teacher_disagreement_score":0.07799466,"about_ca_system_score_codex":0.07799466,"about_ca_system_score_gemma":0.049856395,"threshold_uncertainty_score":0.56589353},"labels":[],"label_agreement":null},{"id":"W2766497866","doi":"10.1016/j.jval.2017.08.012","title":"Utilization and Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Predictive Molecular Biomarker (BMX) Tests","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Internal medicine; Lung cancer; Medicine; Oncology; Stage (stratigraphy); Biology","score_opus":0.024863729510475538,"score_gpt":0.3383560817909946,"score_spread":0.313492352280519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766497866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979723,0.0003455825,0.000050457216,0.00018617832,0.0000076097826,0.00000481246,0.0006592294,0.00000289155,0.0007708779],"genre_scores_gemma":[0.99899715,0.00013088407,0.000030377107,0.00008326594,0.0000111492245,0.0000041626618,0.0005079282,0.0000017328792,0.00023325824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995372,0.00008159088,0.000064287284,0.00009284052,0.00006959358,0.00015444796],"domain_scores_gemma":[0.99852496,0.0003466761,0.00067601947,0.00005726564,0.000114750976,0.0002803604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003120191,0.00013838004,0.00027005502,0.00066119217,0.00031169475,0.00061897293,0.0002536294,0.0005315783,0.0027090067],"category_scores_gemma":[0.002294712,0.00016584195,0.0005703937,0.0013560059,0.00024169161,0.0006579323,0.00044573503,0.00073799276,0.0002515842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001025807,0.000039223552,0.99836916,0.000004508083,0.00003071284,0.000032725035,0.00003110251,0.000058414003,0.00008760471,0.000027095486,0.000115025374,0.0011020206],"study_design_scores_gemma":[0.0000046152954,0.00008768292,0.99870217,0.000008702866,0.000023683298,0.0001283931,0.000315749,0.00039934806,0.00005114417,0.000060963783,0.00021329467,0.0000041990143],"about_ca_topic_score_codex":0.009100565,"about_ca_topic_score_gemma":0.009235927,"teacher_disagreement_score":0.009100565,"about_ca_system_score_codex":0.00048060316,"about_ca_system_score_gemma":0.00044605762,"threshold_uncertainty_score":0.018095195},"labels":[],"label_agreement":null},{"id":"W2766513204","doi":"10.1016/j.jval.2017.08.958","title":"Biosimilar Discounts are Not Similar: A Comparison of The Prices and Discounts of Anti-Tnf Biosimilars Between Canada and Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Infliximab; Drug prices; Reimbursement; Agency (philosophy); Medicine; Business; Economics; Public economics; Economic growth; Health care; Tumor necrosis factor alpha; Internal medicine","score_opus":0.06781305736739056,"score_gpt":0.3392838893712127,"score_spread":0.2714708320038221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766513204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8869845,0.030954834,0.0010177413,0.018494295,0.0003719861,0.000106486645,0.004828721,0.000054473294,0.05718686],"genre_scores_gemma":[0.99095917,0.003210237,0.00041243358,0.0016869542,0.00004408691,0.0000071888685,0.0009240538,0.000031142205,0.0027246932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99364775,0.00071727287,0.00021917955,0.0003373352,0.003991819,0.0010866884],"domain_scores_gemma":[0.98247117,0.0044674813,0.0019872321,0.00030045694,0.0089504495,0.0018232276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004307162,0.00020903788,0.0005278579,0.0022741896,0.0012491726,0.0053891796,0.0008213624,0.0011953276,0.002730716],"category_scores_gemma":[0.023358995,0.00021370489,0.0010442212,0.00463703,0.0013913235,0.0011366897,0.00088254415,0.0020469958,0.00018758069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030082017,0.00060620694,0.39417708,0.0020737972,0.0029972298,0.0017601524,0.0068731136,0.017260067,0.0059784106,0.11278964,0.0820418,0.34336045],"study_design_scores_gemma":[0.000899384,0.00071427366,0.87652016,0.00062248413,0.0012103862,0.00071473635,0.007995474,0.004730212,0.0023836978,0.0034701258,0.100482404,0.00025669456],"about_ca_topic_score_codex":0.9158228,"about_ca_topic_score_gemma":0.9249777,"teacher_disagreement_score":0.084177196,"about_ca_system_score_codex":0.045622952,"about_ca_system_score_gemma":0.035578858,"threshold_uncertainty_score":0.33101922},"labels":[],"label_agreement":null},{"id":"W2766539369","doi":"10.1016/j.jval.2017.08.2989","title":"Assessing the Economic and Humanistic Burden of Psoriatic Arthritis in Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Presenteeism; Psoriatic arthritis; Internal medicine; Psoriasis; Absenteeism; Anxiety; Depression (economics); Arthritis; Physical therapy; Dermatology; Psychiatry","score_opus":0.04398812082373241,"score_gpt":0.323395261109215,"score_spread":0.27940714028548264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766539369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881848,0.0022229154,0.00036319648,0.0018131359,0.000011240819,0.000037616155,0.00044444017,0.0000033075503,0.0069194357],"genre_scores_gemma":[0.99915004,0.0005098982,0.00017130998,0.000025733982,0.0000029374962,0.0000044436415,0.00003467099,9.152473e-7,0.00009999219],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908674,0.00043469627,0.00006714634,0.00005112411,0.00022997087,0.0001302299],"domain_scores_gemma":[0.99792373,0.00069244293,0.00071097846,0.00008114105,0.00034238078,0.00024930024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014903226,0.0002251354,0.00023596139,0.0012973006,0.00036401284,0.0008504798,0.00031765623,0.00030100555,0.0008433243],"category_scores_gemma":[0.0068197097,0.00016226985,0.00035017842,0.0015205026,0.00068955205,0.0003854963,0.0008862671,0.00032433379,0.00005491006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007786911,0.000079916834,0.95538,0.00019431232,0.00015733579,0.00031008583,0.0030246293,0.00045946747,0.0006067412,0.0046405587,0.0004756053,0.0345935],"study_design_scores_gemma":[0.00001006258,0.00008195771,0.9871273,0.00021485261,0.00009478101,0.0004611016,0.0051094084,0.001391079,0.00019304942,0.0016351495,0.0036665923,0.000014645144],"about_ca_topic_score_codex":0.103559084,"about_ca_topic_score_gemma":0.13518542,"teacher_disagreement_score":0.103559084,"about_ca_system_score_codex":0.003459379,"about_ca_system_score_gemma":0.002707107,"threshold_uncertainty_score":0.20591259},"labels":[],"label_agreement":null},{"id":"W2766560421","doi":"10.1016/j.jval.2017.08.1780","title":"Early Scientific Advice At Cadth – Options and Recommendations For Future Development","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Interdisciplinary Research and Collaboration","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Institute of Health Economics","funders":"","keywords":"Advice (programming); Engineering ethics; Medical education; Computer science; Medicine; Engineering","score_opus":0.21430480673009605,"score_gpt":0.4826950680277159,"score_spread":0.26839026129761984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766560421","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013523354,0.040058475,0.008687686,0.9277734,0.011927373,0.00020525056,0.0003474375,0.00015802888,0.009489934],"genre_scores_gemma":[0.096709825,0.14103243,0.23109941,0.47225893,0.027111212,0.0027035698,0.0017856641,0.00037377153,0.026925236],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9431505,0.036461182,0.0051131016,0.002218662,0.01008276,0.0029738457],"domain_scores_gemma":[0.618982,0.20648386,0.011043952,0.014731654,0.11543558,0.033322882],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13285246,0.0015412074,0.003497346,0.0056499424,0.004377334,0.017152263,0.0067738504,0.021579381,0.05094596],"category_scores_gemma":[0.2553078,0.0011891513,0.0029557422,0.0040977784,0.008398388,0.02396112,0.008602862,0.021537997,0.010967064],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001005537,0.00094345096,0.0040344717,0.0052011902,0.00037570158,0.00043946382,0.0016942929,0.0011887009,0.0006301239,0.11621801,0.46703905,0.40123007],"study_design_scores_gemma":[0.0005698423,0.00041376156,0.0038868636,0.038062505,0.0006118686,0.0004714781,0.009199021,0.002463437,0.0011167126,0.43348488,0.50939,0.00032961846],"about_ca_topic_score_codex":0.011454464,"about_ca_topic_score_gemma":0.028110547,"teacher_disagreement_score":0.9896639,"about_ca_system_score_codex":0.010336085,"about_ca_system_score_gemma":0.06741889,"threshold_uncertainty_score":0.7025994},"labels":[],"label_agreement":null},{"id":"W2766601188","doi":"10.1016/j.jval.2017.08.2343","title":"Burden Of Respiratory Syncytial Virus (RSV) Disease In Adults: Final Analysis From A Retrospective Chart Review","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Retrospective cohort study; Asthma; Mechanical ventilation; Intensive care unit; Pediatrics; Internal medicine; Young adult; Disease; Emergency medicine","score_opus":0.11751060484294505,"score_gpt":0.42398235418095936,"score_spread":0.3064717493380143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766601188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911668,0.00053154357,0.00022077152,0.00003492736,0.000004742483,0.00004471745,0.0075306604,0.000012086342,0.00045384475],"genre_scores_gemma":[0.99405956,0.00032762115,0.0002480026,0.000023715464,0.000007700239,0.000028662127,0.0052044946,0.000005125362,0.00009517385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986506,0.00024920885,0.00034419168,0.00030197267,0.00028611987,0.00016800403],"domain_scores_gemma":[0.9947254,0.0008523673,0.00266518,0.0004243357,0.0010272069,0.00030536662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001212033,0.00025118774,0.0004836093,0.0030892985,0.0004750184,0.00085836434,0.00039004776,0.00031172298,0.0010048891],"category_scores_gemma":[0.004390825,0.0003241029,0.00067842385,0.0037875636,0.00028952333,0.00094634824,0.0006838813,0.00029653386,0.00021142767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030310672,0.0000058999685,0.9990393,0.000014487335,0.00003410281,0.000050239727,0.000053862514,0.000021926688,0.00006872984,0.000010342609,0.00011869642,0.00055212755],"study_design_scores_gemma":[0.0000025136983,0.000031781055,0.9991074,0.000011991636,0.00003525883,0.00020767139,0.00021957574,0.00008851971,0.000074396754,0.000005588565,0.00021173502,0.000003400301],"about_ca_topic_score_codex":0.0146891065,"about_ca_topic_score_gemma":0.015661582,"teacher_disagreement_score":0.0146891065,"about_ca_system_score_codex":0.00074094144,"about_ca_system_score_gemma":0.0010468429,"threshold_uncertainty_score":0.02920723},"labels":[],"label_agreement":null},{"id":"W2766605928","doi":"10.1016/j.jval.2017.08.229","title":"Health-Economics Evaluations in France, England, Canada and Autralia: Comparison of Methodologies and Impact on Drugs’ Access To Patients","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Health technology; Negotiation; Economic evaluation; Medicine; Agency (philosophy); Public health; Access to medicines; Family medicine; Actuarial science; Political science; Business; Public economics; Health care; Economics; Economic growth; Computer science; Sociology; Nursing","score_opus":0.5601480199139278,"score_gpt":0.539275883837461,"score_spread":0.020872136076466874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766605928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90705717,0.0459733,0.0021689152,0.013262522,0.00036052993,0.0006903406,0.01041843,0.00011408029,0.019954655],"genre_scores_gemma":[0.988974,0.0042777364,0.0017848462,0.00052648224,0.00007106138,0.00013748938,0.003078801,0.000025950729,0.0011236034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95206136,0.03611411,0.0021893962,0.0008948739,0.0060791797,0.0026610324],"domain_scores_gemma":[0.861852,0.09361871,0.009310868,0.0024199751,0.028091501,0.0047069965],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0357569,0.0011847543,0.0018947411,0.007543588,0.0016918515,0.005741015,0.001549869,0.0014865439,0.0025239068],"category_scores_gemma":[0.11192521,0.0004322351,0.0026283693,0.0101823425,0.002001038,0.0024147572,0.00350918,0.0015627496,0.00013387011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019887736,0.0026474155,0.64050335,0.0051072505,0.010870808,0.00077123503,0.0026749105,0.081142366,0.0004981197,0.039766215,0.027274976,0.16885561],"study_design_scores_gemma":[0.0028008036,0.0017512979,0.9102957,0.0033454099,0.003248549,0.0003838812,0.0060078707,0.04517516,0.001489777,0.005088072,0.020002415,0.00041112155],"about_ca_topic_score_codex":0.80831474,"about_ca_topic_score_gemma":0.74462575,"teacher_disagreement_score":0.9642431,"about_ca_system_score_codex":0.06892366,"about_ca_system_score_gemma":0.044496667,"threshold_uncertainty_score":0.5000785},"labels":[],"label_agreement":null},{"id":"W2766608852","doi":"10.1016/j.jval.2017.08.999","title":"Estimating the Comparative Accuracy of Diagnostic Tests: AN Example using Typhoid Fever","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Typhoid fever; Salmonella typhi; Widal test; Medicine; Blood culture; Internal medicine; Incidence (geometry); Salmonella; Population; Immunology; Diagnostic test; Veterinary medicine; Virology; Biology; Environmental health; Microbiology; Mathematics; Antibiotics","score_opus":0.9348896130216434,"score_gpt":0.6298666315882766,"score_spread":0.3050229814333668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766608852","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.071568444,0.78477544,0.1264059,0.009105542,0.0018511983,0.0009145081,0.001745603,0.0002897344,0.0033436804],"genre_scores_gemma":[0.812369,0.07200375,0.11056384,0.002473147,0.0008402651,0.00059323723,0.00064620975,0.00011543578,0.00039514218],"study_design_codex":"meta_analysis","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.58520347,0.38713944,0.012523971,0.0069567133,0.0074587963,0.0007176615],"domain_scores_gemma":[0.21293814,0.76333994,0.006722527,0.010660833,0.005959138,0.00037943682],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.23928654,0.003405317,0.013489713,0.008495439,0.00093223836,0.004451191,0.0033165086,0.00600033,0.0016362859],"category_scores_gemma":[0.54714096,0.0011702641,0.025571806,0.008562778,0.0026313874,0.0032051513,0.0029281557,0.005224468,0.00016290673],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016030155,0.00036955357,0.048399597,0.07802232,0.6207582,0.0012296444,0.0014084235,0.029976333,0.0013377146,0.013779964,0.0045882924,0.18409987],"study_design_scores_gemma":[0.0066048102,0.004288884,0.033886813,0.020647634,0.8044297,0.0023168344,0.0010002885,0.041640747,0.0027622986,0.06664608,0.015238823,0.0005371463],"about_ca_topic_score_codex":0.011110816,"about_ca_topic_score_gemma":0.009516236,"teacher_disagreement_score":0.23928654,"about_ca_system_score_codex":0.003054395,"about_ca_system_score_gemma":0.003111155,"threshold_uncertainty_score":0.93809515},"labels":[],"label_agreement":null},{"id":"W2766612740","doi":"10.1016/j.jval.2017.08.2686","title":"Burden of Disease for Rheumatoid Arthritis In Argentina, Brazil, Colombia, Mexico and Venezuela","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Latin Americans; Medicine; Rheumatoid arthritis; Portuguese; Burden of disease; Diabetes mellitus; Disease; Quality of life (healthcare); Gerontology; Internal medicine; Political science","score_opus":0.032003469156457055,"score_gpt":0.3369848384008826,"score_spread":0.30498136924442554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766612740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900455,0.005098446,0.000042276708,0.0005908925,0.00001511528,0.000012843523,0.001619518,0.0000041904223,0.0025712512],"genre_scores_gemma":[0.9974184,0.0017905164,0.00008775413,0.000025403631,0.000012461908,0.0000074271943,0.0003897752,0.0000011184293,0.0002671506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997571,0.000076017684,0.000024994137,0.000028993152,0.000046293295,0.00006662338],"domain_scores_gemma":[0.9995653,0.000083657644,0.00018354369,0.000015641093,0.00006120559,0.000090673566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036979953,0.00020930315,0.00026905967,0.0015787437,0.00043157206,0.00079551723,0.0001956094,0.0002605444,0.0012793733],"category_scores_gemma":[0.00087144127,0.00015124357,0.0002793097,0.001501752,0.0003028651,0.0002281679,0.0004621789,0.0003349223,0.000053308773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017469103,0.00003596444,0.9886485,0.00009008822,0.00014701455,0.00017203373,0.0005483248,0.00013483419,0.00043285027,0.00033813427,0.000670114,0.008607566],"study_design_scores_gemma":[0.0000071756367,0.000014213494,0.9985421,0.000035573084,0.000035814563,0.000083978586,0.0006495724,0.000060893995,0.00001767881,0.000029793006,0.0005206635,0.000002595725],"about_ca_topic_score_codex":0.21475725,"about_ca_topic_score_gemma":0.36466,"teacher_disagreement_score":0.21475725,"about_ca_system_score_codex":0.0015450331,"about_ca_system_score_gemma":0.0009108264,"threshold_uncertainty_score":0.42701447},"labels":[],"label_agreement":null},{"id":"W2766631407","doi":"10.1016/j.jval.2017.08.2410","title":"Assessing The Disease Course And Treatment of Psoriatic Arthritis (PSA) In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Apremilast; Psoriatic arthritis; Disease; Internal medicine; Physical therapy","score_opus":0.051585399396294744,"score_gpt":0.35965043286646015,"score_spread":0.3080650334701654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766631407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651026,0.006773815,0.00034244417,0.005830593,0.00008939913,0.00015373656,0.00737165,0.000029036662,0.014306829],"genre_scores_gemma":[0.99486333,0.0019395978,0.0003273068,0.000400566,0.000015004496,0.000012979364,0.0009039886,0.000006580132,0.0015306249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979867,0.00020636464,0.00014527822,0.00015189579,0.00096426666,0.0005455828],"domain_scores_gemma":[0.99562526,0.00032363975,0.0005821254,0.000050613122,0.0020605372,0.0013577747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008549218,0.00020544739,0.00038101393,0.0012691711,0.0025081257,0.0014261941,0.0013822129,0.00047717654,0.0021968859],"category_scores_gemma":[0.004362985,0.00029130117,0.00046862903,0.0043553873,0.00064852095,0.00039015638,0.0007473436,0.0011979275,0.00016923591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016104296,0.00014613473,0.9646693,0.00013121401,0.00008000943,0.0001678925,0.0009324484,0.000418412,0.00018411901,0.0003936208,0.004559211,0.02815664],"study_design_scores_gemma":[0.000022045944,0.000043526426,0.9945311,0.000085342035,0.00003992507,0.00010201371,0.0014739054,0.0005954866,0.000088454566,0.00007588234,0.0029234109,0.000018990442],"about_ca_topic_score_codex":0.9982547,"about_ca_topic_score_gemma":0.9990458,"teacher_disagreement_score":0.05350703,"about_ca_system_score_codex":0.05350703,"about_ca_system_score_gemma":0.08383397,"threshold_uncertainty_score":0.38822252},"labels":[],"label_agreement":null},{"id":"W2766636502","doi":"10.1016/j.jval.2017.08.1150","title":"The Effect Of Nsaids On Myocardial, Vascular And Renal Risk Categories:Systematic Review Of Randomized Controlled Trial And Observational Studies","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Meloxicam; Rofecoxib; Observational study; Randomized controlled trial; Internal medicine; Relative risk; Confidence interval","score_opus":0.07332535881470767,"score_gpt":0.3601853610210842,"score_spread":0.28686000220637653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766636502","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008182752,0.9899957,0.000370756,0.00018066257,0.00017734471,0.00036419398,0.00054109556,0.000015218602,0.00017223414],"genre_scores_gemma":[0.18924412,0.80447954,0.0025415933,0.0012981566,0.00034240363,0.0009257629,0.00093596964,0.000025343272,0.00020708684],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98695767,0.005331195,0.004847611,0.0012705713,0.0012943732,0.00029866103],"domain_scores_gemma":[0.9542239,0.033640888,0.008634759,0.0012690723,0.0018215326,0.00040990682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015889464,0.0019760102,0.017019035,0.0029178995,0.00058693875,0.0025406494,0.0022874516,0.002385402,0.0033743186],"category_scores_gemma":[0.05257925,0.0014500438,0.016553052,0.0045949803,0.0014353729,0.0018668425,0.0015806238,0.0021320689,0.00023239682],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008176441,0.00005131747,0.0047019715,0.62780166,0.34448275,0.00009085354,0.00011910864,0.00019838636,0.0003191196,0.00013630748,0.0006362316,0.01328577],"study_design_scores_gemma":[0.0058174,0.00053772505,0.008871348,0.043783057,0.9375902,0.00013852955,0.000108215536,0.000109483626,0.00018403748,0.00031398187,0.0025015755,0.00004442347],"about_ca_topic_score_codex":0.005846503,"about_ca_topic_score_gemma":0.01413514,"teacher_disagreement_score":0.017019035,"about_ca_system_score_codex":0.0019981975,"about_ca_system_score_gemma":0.0036593026,"threshold_uncertainty_score":0.084032536},"labels":[],"label_agreement":null},{"id":"W2766775047","doi":"10.1016/j.jval.2017.08.2848","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Heart failure; Cohort; Health insurance; Physical therapy; Emergency medicine; Health care; Internal medicine; Psychiatry","score_opus":0.05811089744045684,"score_gpt":0.362352868378118,"score_spread":0.30424197093766114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766775047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901454,0.0011012456,0.0002484067,0.0013085451,0.000023406134,0.000025402078,0.00092923193,0.0000062936824,0.0062120394],"genre_scores_gemma":[0.99804735,0.00062808004,0.0003082851,0.000073597206,0.000032812943,0.000013924555,0.00047068018,0.000001802981,0.00042346513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854434,0.0008941724,0.0001130072,0.00006926351,0.00025783447,0.00012140112],"domain_scores_gemma":[0.99787855,0.00061513396,0.00073248794,0.000099095254,0.0003215203,0.00035313575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015154422,0.00029588546,0.0002737436,0.0010630778,0.00035670222,0.0008364984,0.00026757363,0.00033145462,0.0016751505],"category_scores_gemma":[0.0058605974,0.00011658502,0.00042257775,0.0010653218,0.00032181246,0.0004924627,0.0008664106,0.00041408575,0.00015868327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017395141,0.00009305879,0.9858635,0.000023210248,0.00009848005,0.00004626204,0.0001851396,0.00015139084,0.000090878566,0.00026888502,0.0007179244,0.012287417],"study_design_scores_gemma":[0.000019726438,0.00018497012,0.99696976,0.000032367385,0.000050084807,0.000119762146,0.00039862582,0.00078610313,0.00007123824,0.00029312124,0.00106981,0.000004528029],"about_ca_topic_score_codex":0.015262676,"about_ca_topic_score_gemma":0.020457301,"teacher_disagreement_score":0.015262676,"about_ca_system_score_codex":0.0010234524,"about_ca_system_score_gemma":0.0009171666,"threshold_uncertainty_score":0.030347645},"labels":[],"label_agreement":null},{"id":"W2766806935","doi":"10.1016/j.jval.2017.08.1726","title":"Minimally Important Difference: Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Confidence interval; Statistics; Medicine; Sample size determination; Observational study; Estimation; Otorhinolaryngology; Mathematics; Surgery; Economics","score_opus":0.4339353703206813,"score_gpt":0.6171888009541954,"score_spread":0.18325343063351407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766806935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65070546,0.0032595422,0.33659366,0.0006623697,0.0003651597,0.002121309,0.00056509813,0.00021236193,0.0055150934],"genre_scores_gemma":[0.8666389,0.00044817236,0.12996672,0.00014226955,0.000057766934,0.0017945821,0.00025394603,0.00007593537,0.00062158244],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.81548333,0.16582857,0.006746173,0.0036980717,0.00747352,0.00077026116],"domain_scores_gemma":[0.13108131,0.8540559,0.0043582874,0.0062008086,0.0038282273,0.00047545673],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14541045,0.0009631852,0.0018897213,0.004450754,0.00087093195,0.0021495537,0.003217169,0.0020583174,0.0060938587],"category_scores_gemma":[0.50926346,0.0008098134,0.0030221187,0.002623071,0.003786853,0.005186302,0.0037449722,0.0027232443,0.00036321802],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038474746,0.0041177594,0.1749977,0.0121176215,0.010365946,0.00034568447,0.03553282,0.031225154,0.00361067,0.0864694,0.0048517035,0.59789085],"study_design_scores_gemma":[0.0068254876,0.03667863,0.32934627,0.004702368,0.0069650393,0.0021482748,0.039167766,0.41131338,0.009703122,0.14133309,0.010353976,0.0014626251],"about_ca_topic_score_codex":0.0015451668,"about_ca_topic_score_gemma":0.001519135,"teacher_disagreement_score":0.8545896,"about_ca_system_score_codex":0.0015223345,"about_ca_system_score_gemma":0.0012547517,"threshold_uncertainty_score":0.76901317},"labels":[],"label_agreement":null},{"id":"W2766867540","doi":"10.1016/j.jval.2017.08.390","title":"The Difference Between Regulatory And Market Access Decisions On Treatment Availability For New Drugs In Six Common Cancers Across Australia, Canada, And Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Population; European union; Market access; Family medicine; Health care; Environmental health; Business; Geography; Economic growth","score_opus":0.5115265019704277,"score_gpt":0.47998978577437584,"score_spread":0.03153671619605186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766867540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99171704,0.0009483062,0.00019778304,0.0022878624,0.000014432442,0.000014497582,0.0007149928,0.0000043053283,0.0041007143],"genre_scores_gemma":[0.9990941,0.0001162414,0.000050128147,0.00017038768,0.00000815539,0.0000032174926,0.00022383222,0.0000019642757,0.00033207893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996197,0.0014699993,0.0002317336,0.0003002029,0.00089737005,0.00090387196],"domain_scores_gemma":[0.9679244,0.017560892,0.0069524357,0.00045770782,0.0048024147,0.0023021218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054306225,0.00008871099,0.0003580794,0.0015588914,0.0005752696,0.0019177545,0.000814879,0.0007159799,0.0017014213],"category_scores_gemma":[0.025507446,0.00018233688,0.0006322047,0.0022030438,0.0013371501,0.00094695523,0.0013408344,0.001341199,0.00006511324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068894855,0.0001315131,0.96525306,0.0000782927,0.000556926,0.0001681746,0.0015371618,0.005206506,0.00030530998,0.007503502,0.0028180026,0.015752519],"study_design_scores_gemma":[0.000015910446,0.000036759946,0.99527884,0.000026739526,0.0000622053,0.00003601032,0.0010016236,0.0018309172,0.00007482897,0.0004673732,0.0011543096,0.000014562061],"about_ca_topic_score_codex":0.69913745,"about_ca_topic_score_gemma":0.759575,"teacher_disagreement_score":0.9919845,"about_ca_system_score_codex":0.008015542,"about_ca_system_score_gemma":0.004752811,"threshold_uncertainty_score":0.6052687},"labels":[],"label_agreement":null},{"id":"W2766879304","doi":"10.1016/j.jval.2017.08.2407","title":"The Patient-Reported Disease Burden In Adults With Atopic Dermatitis: A Cross-Sectional Study In Canada and Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; SCORAD; Atopic dermatitis; Visual analogue scale; Quality of life (healthcare); Anxiety; Depression (economics); Cross-sectional study; Pittsburgh Sleep Quality Index; Internal medicine; Hospital Anxiety and Depression Scale; Dermatology Life Quality Index; Physical therapy; Disease; Sleep quality; Psychiatry; Dermatology; Insomnia","score_opus":0.022317231205276646,"score_gpt":0.2961147211057402,"score_spread":0.2737974899004636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766879304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99616575,0.0010615855,0.00004391063,0.00019728988,0.0000121641215,0.000015279984,0.0015696258,0.0000046669147,0.0009297867],"genre_scores_gemma":[0.9984675,0.0005027391,0.000048882903,0.00007247736,0.000006160898,0.0000049582686,0.00066831993,0.000002705729,0.00022610836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864334,0.00016652285,0.00015189374,0.00020475042,0.00044765725,0.000385922],"domain_scores_gemma":[0.9978684,0.00014369027,0.0004805589,0.00006870771,0.0008311394,0.0006074759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088167336,0.00039388728,0.00066172774,0.0015643531,0.001866799,0.0020753143,0.0012945561,0.0009018772,0.0013323411],"category_scores_gemma":[0.002483806,0.00043564467,0.0009770688,0.0053404514,0.00083081383,0.0007047605,0.0009811705,0.0010484903,0.00016548322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032175485,0.000021689704,0.99877757,0.000009189211,0.000071847084,0.000048303704,0.00022674073,0.000027566228,0.00003681536,0.00002537617,0.00015428687,0.0005684819],"study_design_scores_gemma":[0.0000019610916,0.000008668244,0.99915016,0.000010059032,0.000018313418,0.000052092117,0.00056892453,0.000051103518,0.0000098622995,0.0000055234505,0.00011876577,0.000004572821],"about_ca_topic_score_codex":0.9647244,"about_ca_topic_score_gemma":0.96528214,"teacher_disagreement_score":0.03527558,"about_ca_system_score_codex":0.011250882,"about_ca_system_score_gemma":0.010049844,"threshold_uncertainty_score":0.08163124},"labels":[],"label_agreement":null},{"id":"W2766879860","doi":"10.1016/j.jval.2017.08.793","title":"Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Quality of life (healthcare); Presenteeism; Internal medicine; Axial spondyloarthritis; Disease burden; Disease; Physical therapy; Productivity","score_opus":0.04581180184827871,"score_gpt":0.35745504306898074,"score_spread":0.311643241220702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766879860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663454,0.0012670881,0.000097011995,0.0005656807,0.0000070663427,0.00001083244,0.00055408746,0.0000012197587,0.0008625987],"genre_scores_gemma":[0.99862695,0.00078000606,0.0001460303,0.000038431965,0.000009730402,0.0000123271075,0.00026977996,5.3189376e-7,0.000116225165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936014,0.00033838814,0.000047913698,0.000059726546,0.00007849244,0.000115343195],"domain_scores_gemma":[0.99857044,0.00039307057,0.0006940533,0.000051500814,0.00017108378,0.00011985403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001610779,0.0002459773,0.00023152477,0.0012445232,0.0004032466,0.0006241219,0.00034080294,0.00029446345,0.000572902],"category_scores_gemma":[0.0032627955,0.00014520937,0.00028821215,0.0015126106,0.00032182812,0.00035166935,0.0007839219,0.00034529087,0.0000288369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014660334,0.00004942805,0.99360985,0.00006134834,0.00015604997,0.00003864383,0.0004299303,0.00013476759,0.000100506026,0.0001945753,0.00022149242,0.0048566908],"study_design_scores_gemma":[0.000015599526,0.00006870733,0.9978173,0.00006193903,0.00011101473,0.000031088668,0.0009800179,0.00017019002,0.000040864736,0.0000758864,0.0006237332,0.0000036066183],"about_ca_topic_score_codex":0.12412112,"about_ca_topic_score_gemma":0.12474229,"teacher_disagreement_score":0.12412112,"about_ca_system_score_codex":0.0017141055,"about_ca_system_score_gemma":0.0013206751,"threshold_uncertainty_score":0.24679732},"labels":[],"label_agreement":null},{"id":"W2766900682","doi":"10.1016/j.jval.2017.08.1084","title":"Cost-Utility Of Novel Tests After A Negative Prostate Biopsy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Overdiagnosis; Medicine; Prostate cancer; Prostate; Biopsy; Prostate biopsy; Gynecology; Radiology; Internal medicine; Cancer","score_opus":0.11422681531541032,"score_gpt":0.38765849657896384,"score_spread":0.27343168126355355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766900682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.911507,0.045042515,0.00870874,0.00798976,0.0005755834,0.00015719325,0.006891276,0.000114999784,0.019012967],"genre_scores_gemma":[0.9930369,0.0025604125,0.0017034217,0.00023570107,0.00020831136,0.000017652614,0.0012456159,0.00001089537,0.0009810567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983157,0.00080219615,0.00009747172,0.00016756229,0.00041851142,0.00019857661],"domain_scores_gemma":[0.9925823,0.004946342,0.00090537034,0.0002903472,0.0007592098,0.00051643077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018399374,0.00067875814,0.0010335093,0.0012914864,0.00023715249,0.0015061084,0.0008375515,0.0010437608,0.0044244234],"category_scores_gemma":[0.014129698,0.00021623395,0.0018079095,0.001091489,0.00039116392,0.0011400067,0.00060155604,0.0010318294,0.00047673375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013034915,0.0009656801,0.57697153,0.00084498327,0.0025270062,0.0013979431,0.00016601737,0.026876211,0.002009526,0.005625137,0.007965016,0.361616],"study_design_scores_gemma":[0.00061271124,0.005681423,0.8822762,0.0008686029,0.0034654639,0.005355949,0.00063360995,0.07275905,0.0038590406,0.012979388,0.011334905,0.00017374477],"about_ca_topic_score_codex":0.009587164,"about_ca_topic_score_gemma":0.009790729,"teacher_disagreement_score":0.009587164,"about_ca_system_score_codex":0.0023338278,"about_ca_system_score_gemma":0.0013183439,"threshold_uncertainty_score":0.019062757},"labels":[],"label_agreement":null},{"id":"W2766904337","doi":"10.1016/j.jval.2017.08.2446","title":"The Economic Burden of Varicella in Peru","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Chickenpox; Indirect costs; Varicella vaccine; Pediatrics; Public health; Medical prescription; Varicella zoster virus; Immunization; Environmental health; Virology; Virus; Immunology; Business","score_opus":0.051010488479955915,"score_gpt":0.35147208771698607,"score_spread":0.30046159923703014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766904337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907963,0.001462058,0.00005458489,0.0025618898,0.0000058388805,0.000007844359,0.00048976357,0.0000026451835,0.0046190363],"genre_scores_gemma":[0.99853194,0.0009496415,0.000027627235,0.000047870246,0.0000107376945,0.0000050080566,0.0001379641,0.000001025573,0.00028823348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994696,0.00031086104,0.000020989091,0.000018089759,0.000054114935,0.00012637742],"domain_scores_gemma":[0.9982692,0.00055657583,0.0007224495,0.000054617954,0.00020989761,0.00018715508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006659412,0.00015475377,0.00015595647,0.0012089129,0.0004449541,0.001030015,0.00026075836,0.0004530356,0.0022555399],"category_scores_gemma":[0.0044047046,0.0001720304,0.00026556052,0.001954451,0.00064149156,0.0006302233,0.0016105958,0.00055265694,0.00011217589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020065169,0.00012501748,0.97812325,0.00012279811,0.0001957277,0.0009148687,0.0022450513,0.000774717,0.00022495253,0.0043262015,0.0013401929,0.011406467],"study_design_scores_gemma":[0.000013381289,0.00007539624,0.9908959,0.00007326753,0.000052306696,0.00028906635,0.003526232,0.00084348273,0.000059355647,0.0008271995,0.0033371719,0.000007234943],"about_ca_topic_score_codex":0.03783441,"about_ca_topic_score_gemma":0.03853289,"teacher_disagreement_score":0.03783441,"about_ca_system_score_codex":0.0017526661,"about_ca_system_score_gemma":0.0007370299,"threshold_uncertainty_score":0.07522839},"labels":[],"label_agreement":null},{"id":"W2766908455","doi":"10.1016/j.jval.2017.08.046","title":"Cost-Effectiveness of Diagnosis: from Tests to Long-Term Outcomes and Costs","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Watchful waiting; Context (archaeology); Cost effectiveness; Medicine; Decision tree; Cost–benefit analysis; Incremental cost-effectiveness ratio; Cost database; Prostate cancer; Computer science; Cost-effectiveness analysis; Machine learning; Risk analysis (engineering); Cancer","score_opus":0.14750244572191867,"score_gpt":0.4600771578112557,"score_spread":0.312574712089337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766908455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7567958,0.16208911,0.016651154,0.039154228,0.0009835141,0.00022666086,0.0054156072,0.000104587205,0.0185793],"genre_scores_gemma":[0.9923409,0.0043599517,0.0016083266,0.0005942633,0.00027238554,0.000022874607,0.00055697554,0.000013244641,0.00023102778],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97983325,0.01348313,0.0017362923,0.0010490478,0.003028055,0.0008702229],"domain_scores_gemma":[0.7620307,0.21109357,0.0152208945,0.0033758676,0.0055327094,0.0027462563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020067062,0.0011359812,0.002022829,0.0034204181,0.00053258706,0.00459254,0.0019204261,0.0026653886,0.003947512],"category_scores_gemma":[0.17433807,0.0006061779,0.003284152,0.0030973284,0.002651918,0.006239482,0.0018687956,0.0036724042,0.00031837693],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004702147,0.0010638774,0.8351406,0.0015930713,0.011365061,0.00032698535,0.00038737556,0.01900769,0.0002531595,0.012354463,0.0038798454,0.10992575],"study_design_scores_gemma":[0.00040978045,0.002014733,0.8301843,0.002435554,0.010202644,0.0015406504,0.0013313072,0.04850806,0.0010619183,0.09865239,0.0033984273,0.00026029485],"about_ca_topic_score_codex":0.009170957,"about_ca_topic_score_gemma":0.0068849707,"teacher_disagreement_score":0.020067062,"about_ca_system_score_codex":0.0044592787,"about_ca_system_score_gemma":0.002465362,"threshold_uncertainty_score":0.10612607},"labels":[],"label_agreement":null},{"id":"W2766911482","doi":"10.1016/j.jval.2017.08.2844","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Spouse; Caregiver burden; Heart failure; Anxiety; Family medicine; Disease; Gerontology; Psychiatry; Internal medicine","score_opus":0.04856459005445351,"score_gpt":0.3426876044657896,"score_spread":0.2941230144113361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766911482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958334,0.00072327285,0.00009740662,0.00074464595,0.000017998493,0.00001512962,0.0003313656,0.0000017687432,0.002234837],"genre_scores_gemma":[0.9984138,0.0007797288,0.00018804819,0.000050153525,0.000012681583,0.00001545768,0.00022256564,0.0000012827563,0.00031619926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999553,0.00025897712,0.000028579036,0.000024261213,0.000049057257,0.00008604612],"domain_scores_gemma":[0.99922705,0.000184283,0.00019832466,0.000024886795,0.00019939788,0.00016599653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006984433,0.00020422494,0.00018885199,0.00045438585,0.00039058874,0.0004219456,0.00019558478,0.00019526876,0.0008624434],"category_scores_gemma":[0.0024107173,0.00010952195,0.00016210423,0.0005818612,0.0002734058,0.00016700354,0.00052060164,0.00039038796,0.00006057528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013020734,0.00010557431,0.9831549,0.00005158153,0.000033781187,0.00032853964,0.0017583206,0.00014978157,0.00017545225,0.000381331,0.0012746401,0.012455762],"study_design_scores_gemma":[0.000014752898,0.00007433935,0.99319226,0.00006916361,0.000020555692,0.0002379011,0.003146737,0.00042609146,0.000052642703,0.00013120429,0.0026295595,0.000004635697],"about_ca_topic_score_codex":0.14385471,"about_ca_topic_score_gemma":0.13864729,"teacher_disagreement_score":0.14385471,"about_ca_system_score_codex":0.0021251887,"about_ca_system_score_gemma":0.0012460123,"threshold_uncertainty_score":0.28603476},"labels":[],"label_agreement":null},{"id":"W2766920003","doi":"10.1016/j.jval.2017.08.1523","title":"Observed Reduction of Healthcare Utilization after Omalizumab Initiation Among Patients with Persistent Asthma Followed in Canadian Clinical Settings","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GDI Integrated Facility Services (Canada); Novartis (Canada); Université Laval; Ottawa Allergy Research Corporation","funders":"","keywords":"Omalizumab; Medicine; Asthma; Emergency department; Pediatrics; Receipt; Observational study; Population; Retrospective cohort study; Clinical endpoint; Emergency medicine; Internal medicine; Clinical trial; Environmental health; Immunoglobulin E","score_opus":0.08250806495527803,"score_gpt":0.3408665259369044,"score_spread":0.2583584609816264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766920003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878683,0.0021439146,0.00008263588,0.00093851716,0.000031269647,0.000049304526,0.0049167867,0.000020842932,0.003948361],"genre_scores_gemma":[0.9980945,0.0003092399,0.00008501729,0.00015732355,0.000010483861,0.000008127952,0.00093996676,0.0000027933283,0.00039251303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988135,0.00008202571,0.00007567532,0.00016197967,0.00028883325,0.0005779054],"domain_scores_gemma":[0.9978175,0.00017888933,0.00054883416,0.000059765924,0.00083870895,0.00055631285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052460557,0.00028515776,0.00055307645,0.00065020646,0.0017308309,0.001190795,0.0010455606,0.000615961,0.002062348],"category_scores_gemma":[0.0031255258,0.00026749683,0.0010052631,0.0020884066,0.00034387634,0.0003780828,0.00042460443,0.0015044127,0.000111795845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039194748,0.000073498144,0.9928343,0.0000471141,0.00010347478,0.00008792911,0.00028305608,0.00011705241,0.00022166112,0.00009364978,0.001285223,0.0044609522],"study_design_scores_gemma":[0.000009258855,0.000024596131,0.99920255,0.000016932474,0.000033556782,0.000029338586,0.00019262076,0.000115144336,0.000037498972,0.000008337917,0.0003248974,0.000005288987],"about_ca_topic_score_codex":0.9773368,"about_ca_topic_score_gemma":0.9852997,"teacher_disagreement_score":0.022663176,"about_ca_system_score_codex":0.021115212,"about_ca_system_score_gemma":0.02232475,"threshold_uncertainty_score":0.1532023},"labels":[],"label_agreement":null},{"id":"W2766924311","doi":"10.1016/j.jval.2017.08.548","title":"Health Care Use Among Incident Cases of Heart Failure: A Population-Based Cohort Study from 1997 To 2010","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Heart failure; Atrial fibrillation; Incidence (geometry); Cohort; Mortality rate; Emergency medicine; Population; Diabetes mellitus; Cohort study; Internal medicine","score_opus":0.051261072957602634,"score_gpt":0.348788307715528,"score_spread":0.29752723475792536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766924311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957224,0.00018805692,0.00006644101,0.000052111023,0.000012498179,0.00001945563,0.0034412323,0.0000050473427,0.0004927655],"genre_scores_gemma":[0.996416,0.00016828674,0.000064279346,0.000052064734,0.000011052012,0.000025440377,0.0028846879,0.000004097767,0.00037407255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992669,0.00009645203,0.00010263486,0.0002107136,0.0001617111,0.00016148515],"domain_scores_gemma":[0.99855834,0.00012366913,0.0005529099,0.00015249618,0.00029570304,0.00031689715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074292766,0.00036907103,0.0005165666,0.0012634346,0.0007905614,0.0012631887,0.00082703435,0.00097079104,0.0010729557],"category_scores_gemma":[0.0017589629,0.0007634127,0.0011538585,0.0023093743,0.0003565192,0.0013282963,0.0009216118,0.0014045413,0.00042037122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006809365,0.000046237205,0.99917537,0.000005718788,0.00009073947,0.00003451141,0.00007625997,0.000020213354,0.00007706763,0.000006548037,0.0001374322,0.00026175455],"study_design_scores_gemma":[0.0000047237418,0.00002969725,0.9994753,0.0000041538174,0.00003267143,0.000072727446,0.00019067797,0.00006839295,0.000020046144,0.0000043725104,0.000093782095,0.0000035235212],"about_ca_topic_score_codex":0.092014484,"about_ca_topic_score_gemma":0.1141571,"teacher_disagreement_score":0.092014484,"about_ca_system_score_codex":0.0011814439,"about_ca_system_score_gemma":0.0010187747,"threshold_uncertainty_score":0.18295783},"labels":[],"label_agreement":null},{"id":"W2766988545","doi":"10.1016/j.jval.2017.08.1819","title":"Characteristics And Approvals Of Regulatory Submissions Based On Non-Randomized Studies In The United States And Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Randomized controlled trial; Orphan drug; Placebo; Food and drug administration; Drug approval; Population; MEDLINE; European union; Alternative medicine; Family medicine; Intensive care medicine; Drug; Internal medicine; Pharmacology; Environmental health; Bioinformatics; Business; Law; Political science; Pathology","score_opus":0.6477175901327824,"score_gpt":0.576844853450072,"score_spread":0.07087273668271044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766988545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59488434,0.14521652,0.038543776,0.024689168,0.009364039,0.0073158196,0.020620793,0.0012734757,0.15809204],"genre_scores_gemma":[0.9364695,0.014893159,0.016549058,0.010893549,0.0022811482,0.0030608915,0.0075725904,0.0009713629,0.007308786],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.6678831,0.18167406,0.07920192,0.014708348,0.04996856,0.0065640286],"domain_scores_gemma":[0.18140015,0.56747276,0.12330056,0.04515732,0.073128216,0.009540978],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.25563475,0.001058799,0.0026925425,0.010835302,0.0024360279,0.01117166,0.0026973074,0.005085484,0.0069133393],"category_scores_gemma":[0.5659644,0.0012353902,0.0050992304,0.008375062,0.0035896779,0.0033722443,0.0032853195,0.005452721,0.00151998],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033047497,0.0012444736,0.33701843,0.02034946,0.010650909,0.0028430566,0.0054720505,0.006197453,0.0048627253,0.0718011,0.1405611,0.36595175],"study_design_scores_gemma":[0.005598338,0.0046970714,0.58282334,0.014981871,0.005632953,0.008030985,0.002611304,0.005637609,0.0065329745,0.023908596,0.33883217,0.0007128247],"about_ca_topic_score_codex":0.00097646704,"about_ca_topic_score_gemma":0.0010987954,"teacher_disagreement_score":0.7443652,"about_ca_system_score_codex":0.002598575,"about_ca_system_score_gemma":0.00837644,"threshold_uncertainty_score":0.9179349},"labels":[],"label_agreement":null},{"id":"W2767001703","doi":"10.1016/j.jval.2017.08.2959","title":"Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Secukinumab; Adalimumab; BASFI; Ankylosing spondylitis; Placebo; Odds ratio; Internal medicine; BASDAI; Logistic regression; Tumor necrosis factor alpha; Disease; Pathology","score_opus":0.27024685298879236,"score_gpt":0.5160331448616927,"score_spread":0.24578629187290035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767001703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95869327,0.028436838,0.00681669,0.00028564106,0.0005668799,0.0011314995,0.0017567754,0.00008049849,0.0022319658],"genre_scores_gemma":[0.9950905,0.0013430658,0.0019178683,0.00016936388,0.000087378576,0.00038808509,0.0006245535,0.00002086087,0.00035822447],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9457513,0.04670534,0.0025855028,0.0023592156,0.0017059959,0.0008926111],"domain_scores_gemma":[0.95662516,0.03508403,0.003798143,0.003336993,0.0006496191,0.00050604006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03542393,0.0019519969,0.0069806525,0.0014298244,0.0004036541,0.0015627964,0.0016614302,0.0017058247,0.004363855],"category_scores_gemma":[0.039519634,0.00095164625,0.011654774,0.0014394966,0.0012164105,0.0021158212,0.0014869134,0.0025139782,0.00028593937],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8030072,0.00051792985,0.017344208,0.0027345403,0.15027027,0.0001019835,0.00012765786,0.0034485576,0.000853969,0.0006336151,0.00038145742,0.02057857],"study_design_scores_gemma":[0.39622444,0.088138826,0.09226034,0.00076255214,0.38691676,0.00053171854,0.00031200136,0.02131968,0.0030174942,0.0069560236,0.0032846243,0.0002755249],"about_ca_topic_score_codex":0.00077567186,"about_ca_topic_score_gemma":0.0010464112,"teacher_disagreement_score":0.03542393,"about_ca_system_score_codex":0.00081500446,"about_ca_system_score_gemma":0.0006619381,"threshold_uncertainty_score":0.18734193},"labels":[],"label_agreement":null},{"id":"W2767003101","doi":"10.1016/j.jval.2017.08.2979","title":"Secukinumab vs. Adalimumab for the Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis at 48 Weeks from a Brazilian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Secukinumab; Adalimumab; Medicine; Psoriatic arthritis; Internal medicine; Arthritis; Rheumatoid arthritis","score_opus":0.2898852686510517,"score_gpt":0.43815052363955315,"score_spread":0.14826525498850146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767003101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90713906,0.07426152,0.0044400264,0.003920006,0.0002475751,0.0002829619,0.002062334,0.000034339126,0.007612266],"genre_scores_gemma":[0.9933681,0.004479495,0.0008018397,0.00025806355,0.0000668382,0.00005763841,0.00039980342,0.00002213149,0.00054623355],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99400055,0.004553153,0.00021997241,0.0002786536,0.00046765403,0.00048006544],"domain_scores_gemma":[0.98750883,0.009995303,0.0011984153,0.00040781902,0.00056393136,0.0003257239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010051794,0.0012714912,0.0033939325,0.0018205557,0.00026912303,0.0022671171,0.0009780262,0.001662154,0.0045023146],"category_scores_gemma":[0.019758673,0.0005928922,0.0074884165,0.0019723854,0.0007576297,0.0012679386,0.0009181922,0.0019902447,0.00021784166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29310313,0.0043274146,0.10027249,0.01152716,0.06125193,0.0014842958,0.0015037435,0.20292257,0.007424339,0.03629667,0.0060063726,0.27387992],"study_design_scores_gemma":[0.048594885,0.04057513,0.36216772,0.005995535,0.14192675,0.002668606,0.0042319205,0.33218414,0.0040834243,0.03201004,0.025014276,0.00054764777],"about_ca_topic_score_codex":0.019653961,"about_ca_topic_score_gemma":0.010664905,"teacher_disagreement_score":0.019653961,"about_ca_system_score_codex":0.0038453776,"about_ca_system_score_gemma":0.0019659626,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2767037589","doi":"10.1016/j.jval.2017.08.273","title":"Characterizing The Utilization of The Trillium Drug Program by An Oncology Patient Population","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Sunnybrook Hospital; Princess Margaret Cancer Centre; Cancer Care Ontario; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Cancer; Cancer registry; Cohort; Population; Incidence (geometry); Prostate cancer; Cancer drugs; Breast cancer; Internal medicine; Environmental health","score_opus":0.0976468212976088,"score_gpt":0.3281997216850771,"score_spread":0.2305529003874683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767037589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99673635,0.00013750892,0.0009443241,0.00074972905,0.0000054298453,0.000016239243,0.00062542816,0.0000058031164,0.0007791414],"genre_scores_gemma":[0.9990061,0.0000879886,0.00015749127,0.00003915545,0.000011558929,0.0000063942193,0.00033840345,0.0000018779905,0.00035103355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899906,0.0004519934,0.00005975139,0.00013182861,0.000082581566,0.00027486685],"domain_scores_gemma":[0.9894084,0.0060234284,0.0031383038,0.0003251879,0.00029284766,0.00081184134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022114958,0.00023619908,0.00043594855,0.0010589452,0.00028492976,0.0015390195,0.00069686165,0.0009160339,0.003207158],"category_scores_gemma":[0.011786553,0.00023995072,0.000837238,0.0016559022,0.00055858324,0.0009802786,0.0007371451,0.000990204,0.00024888842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029944966,0.00037666227,0.9575079,0.000016241183,0.00025574723,0.00021423779,0.00012644262,0.030523274,0.00027460605,0.0035113574,0.00080825936,0.006085831],"study_design_scores_gemma":[0.00004607897,0.00053797715,0.73633087,0.000019862708,0.00019049976,0.0005503036,0.0019508598,0.25254643,0.00040761754,0.006227235,0.001155342,0.00003697172],"about_ca_topic_score_codex":0.01961375,"about_ca_topic_score_gemma":0.016275415,"teacher_disagreement_score":0.01961375,"about_ca_system_score_codex":0.0013996849,"about_ca_system_score_gemma":0.0007941933,"threshold_uncertainty_score":0.03899914},"labels":[],"label_agreement":null},{"id":"W2767057806","doi":"10.1016/j.jval.2017.08.2675","title":"Treatment Patterns and Impact of Not Achieving Skin Clearance for Psoriasis Patients In Latin America","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Eli Lilly (Canada)","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Quality of life (healthcare); Incidence (geometry); Systemic therapy; Groin; Surgery; Internal medicine","score_opus":0.04440911577702839,"score_gpt":0.3167958107092912,"score_spread":0.2723866949322628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767057806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912668,0.0021147656,0.000054761946,0.001939039,0.000016996426,0.000009793998,0.000319588,0.0000042135357,0.0042740605],"genre_scores_gemma":[0.9989779,0.00048232442,0.000028266008,0.00024996567,0.000009685873,0.0000039678816,0.00008768472,0.000002875101,0.00015736553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920374,0.00035109126,0.00006237513,0.00006366606,0.00008201121,0.00023698932],"domain_scores_gemma":[0.9979139,0.00039401272,0.0010653735,0.000052658117,0.0001885188,0.000385493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006722734,0.000109467655,0.00024325468,0.00053573685,0.0005381746,0.001125734,0.00028517272,0.0003690594,0.0019809862],"category_scores_gemma":[0.0035538427,0.00009507623,0.0003741047,0.0012419542,0.00037002785,0.00039314435,0.0004856289,0.0006599963,0.000097685304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022404459,0.000119524746,0.9894929,0.000025538293,0.00007607323,0.00010904191,0.0003959009,0.00006697784,0.00020467697,0.00016220337,0.00047887157,0.008644306],"study_design_scores_gemma":[0.00002253491,0.000091759655,0.9943932,0.00008659142,0.00006466049,0.00023765532,0.0033660694,0.00014251102,0.000069670525,0.00012783562,0.0013904065,0.0000070627534],"about_ca_topic_score_codex":0.056014847,"about_ca_topic_score_gemma":0.06489482,"teacher_disagreement_score":0.056014847,"about_ca_system_score_codex":0.0014774173,"about_ca_system_score_gemma":0.0012382611,"threshold_uncertainty_score":0.1113776},"labels":[],"label_agreement":null},{"id":"W2767102936","doi":"10.1016/j.jval.2017.08.771","title":"Secukinumab Vs. Adalimumab for Treatment of Ankylosing Spondylitis: A Cost Per Responder Analysis at 52 Weeks from an Argentinian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Adalimumab; Secukinumab; Medicine; Ankylosing spondylitis; Internal medicine; Tumor necrosis factor alpha; Arthritis; Psoriatic arthritis","score_opus":0.0735229516493286,"score_gpt":0.3888190182910509,"score_spread":0.31529606664172233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767102936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91821855,0.06548809,0.0019025716,0.004237043,0.0003811605,0.00028899126,0.003614674,0.00004004053,0.0058288947],"genre_scores_gemma":[0.9908607,0.005877388,0.0006228256,0.00048237684,0.00017525532,0.000086953245,0.00078935217,0.000024252318,0.0010808604],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9962935,0.0027625398,0.00014305035,0.00020717736,0.00027943708,0.00031431203],"domain_scores_gemma":[0.9953666,0.0035247768,0.00062081317,0.00011671422,0.00015076269,0.00022033774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004643972,0.0010621945,0.0023546237,0.0010342697,0.00018930633,0.0017687214,0.00065123785,0.0012441789,0.005971453],"category_scores_gemma":[0.006292442,0.0004612733,0.005497538,0.0012285355,0.00039481302,0.001105553,0.000697229,0.0024196233,0.00026846596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71836466,0.0015631923,0.037477497,0.0052112974,0.04208771,0.0006130652,0.00026690835,0.052389707,0.0024059513,0.0038542736,0.004246852,0.1315189],"study_design_scores_gemma":[0.18515861,0.090070024,0.34919742,0.0037049942,0.1981539,0.0014846763,0.0018225797,0.14089873,0.0022040033,0.009468221,0.01744459,0.00039235243],"about_ca_topic_score_codex":0.007045261,"about_ca_topic_score_gemma":0.0061595384,"teacher_disagreement_score":0.007045261,"about_ca_system_score_codex":0.0028228718,"about_ca_system_score_gemma":0.0010174046,"threshold_uncertainty_score":0.024559975},"labels":[],"label_agreement":null},{"id":"W2767117194","doi":"10.1016/j.jval.2017.08.2241","title":"Revisiting Indirect Health Preference Elicitation As A Base Case","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Quality-adjusted life year; Preference; Context (archaeology); Actuarial science; Population; Relative value; Value of life; Quality (philosophy); Value (mathematics); Quality of life (healthcare); Psychological intervention; Resource (disambiguation); Preference elicitation; Resource allocation; Public economics; Economics; Medicine; Microeconomics; Risk analysis (engineering); Cost effectiveness; Computer science; Environmental health","score_opus":0.6696764267156496,"score_gpt":0.4853605800244246,"score_spread":0.18431584669122503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767117194","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023906758,0.0014070576,0.8715313,0.009253048,0.00025044728,0.0016398355,0.0018938426,0.00020205622,0.0899158],"genre_scores_gemma":[0.49656737,0.0013750319,0.4881463,0.0026487298,0.00023239451,0.0037587138,0.0009854713,0.0001663334,0.0061196014],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9188034,0.065885104,0.0025745397,0.0035782584,0.007627265,0.0015314819],"domain_scores_gemma":[0.75226814,0.22222996,0.0045676404,0.013047603,0.0069565023,0.00093016226],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.055444863,0.0024857197,0.002686089,0.0024835663,0.0015702074,0.009168176,0.0055157854,0.0058578,0.026265545],"category_scores_gemma":[0.16358005,0.0018031261,0.0039151045,0.0037338093,0.0046828315,0.0108775245,0.008811713,0.008451843,0.0019505547],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005765765,0.00039322118,0.0031873875,0.0014832881,0.00044976352,0.001269773,0.0019998637,0.054339614,0.0008704911,0.8632111,0.0051910495,0.067027844],"study_design_scores_gemma":[0.00024872855,0.0001942333,0.0007292003,0.00080322876,0.00020738154,0.000524017,0.0008164066,0.16233261,0.0014630436,0.8133139,0.019256756,0.000110529145],"about_ca_topic_score_codex":0.004636883,"about_ca_topic_score_gemma":0.0049261604,"teacher_disagreement_score":0.94455516,"about_ca_system_score_codex":0.004904805,"about_ca_system_score_gemma":0.0042160447,"threshold_uncertainty_score":0.29322398},"labels":[],"label_agreement":null},{"id":"W2767133819","doi":"10.1016/j.jval.2017.08.2157","title":"Qualitative Interviews To Inform Development Of A Patient Reported Outcome (PRO) Strategy In RLBP1 Retinitis Pigmentosa (RLBP1 RP)","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Development and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Retinitis pigmentosa; Thematic analysis; Medicine; Quality of life (healthcare); Debriefing; Qualitative research; International Classification of Functioning, Disability and Health; Clinical psychology; Family medicine; Psychology; Physical therapy; Ophthalmology; Nursing; Medical education; Rehabilitation","score_opus":0.1604376732304067,"score_gpt":0.42156493867428174,"score_spread":0.26112726544387505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767133819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85632503,0.0009343263,0.07703212,0.030113516,0.000853567,0.008299805,0.0024250231,0.00031825388,0.023698322],"genre_scores_gemma":[0.93068093,0.00066518807,0.037959337,0.0058358856,0.00008241656,0.016563963,0.0005245669,0.00012867534,0.007559111],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9630359,0.0312872,0.0011728003,0.00089479156,0.0010574836,0.0025518853],"domain_scores_gemma":[0.9310552,0.052853342,0.003783945,0.001458066,0.0059840907,0.0048653586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03547335,0.0012617337,0.00068079535,0.0013886767,0.0081346175,0.004086284,0.0018220614,0.0026023523,0.006884472],"category_scores_gemma":[0.050638605,0.00072946196,0.0006002071,0.0010631826,0.005922998,0.0037888885,0.0077195964,0.00662895,0.0011207232],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014248816,0.00024224627,0.0031583663,0.0005326443,0.0000094516645,0.00062407146,0.9731011,0.00015756501,0.0013368563,0.0048072427,0.0027747792,0.013113212],"study_design_scores_gemma":[0.00006936119,0.00014666047,0.0012803738,0.00042720456,0.000011930093,0.0002873171,0.9695516,0.00034673983,0.0011333859,0.004215628,0.022471098,0.000058782603],"about_ca_topic_score_codex":0.004872684,"about_ca_topic_score_gemma":0.009558239,"teacher_disagreement_score":0.03547335,"about_ca_system_score_codex":0.007813682,"about_ca_system_score_gemma":0.010635994,"threshold_uncertainty_score":0.18760324},"labels":[],"label_agreement":null},{"id":"W2767141524","doi":"10.1016/j.jval.2017.08.1197","title":"The Economic Impact of Dietary Sodium Reduction In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Sodium Intake and Health","field":"Nursing","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Environmental health; Blood pressure; Myocardial infarction; Sodium; Demography; Internal medicine; Chemistry","score_opus":0.06030507970031484,"score_gpt":0.34636784873385446,"score_spread":0.2860627690335396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767141524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82032657,0.013491911,0.00022740387,0.089213096,0.0005188396,0.00009730558,0.0058975387,0.000033264514,0.07019402],"genre_scores_gemma":[0.9848986,0.005297409,0.00024887902,0.0023842272,0.00006838595,0.0000151902605,0.0006752447,0.000011407455,0.00640073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997079,0.00029931383,0.00007793317,0.00008424494,0.0011563024,0.0013031728],"domain_scores_gemma":[0.99305844,0.0007246106,0.0004739889,0.00006453417,0.0028645128,0.0028139467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012904007,0.00021050859,0.0003905968,0.0013901892,0.0034248699,0.0033379397,0.0009866576,0.0010260381,0.0042559123],"category_scores_gemma":[0.007692396,0.00023634935,0.00064416334,0.0035627796,0.0013464668,0.0004963997,0.0013696899,0.0017646789,0.00014303178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049209283,0.0012524128,0.613367,0.0011683911,0.00074843987,0.0023684234,0.0026372436,0.008952865,0.0009554796,0.04883798,0.10292855,0.21186225],"study_design_scores_gemma":[0.00032042773,0.0002728405,0.9242183,0.00057861937,0.00029746737,0.0002421164,0.0061815623,0.0036933646,0.0003830036,0.002015819,0.061695702,0.00010076034],"about_ca_topic_score_codex":0.9966009,"about_ca_topic_score_gemma":0.9982797,"teacher_disagreement_score":0.13390662,"about_ca_system_score_codex":0.13390662,"about_ca_system_score_gemma":0.20195943,"threshold_uncertainty_score":0.97156507},"labels":[],"label_agreement":null},{"id":"W2767145646","doi":"10.1016/j.jval.2017.08.1082","title":"Integrating Novel Screening Methods For Prostate Cancer, Cost-Utility Interventions","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Biopsy; Quality-adjusted life year; Prostate biopsy; Prostate-specific antigen; Cancer; Cost effectiveness; Gynecology; Radiology; Internal medicine; Risk analysis (engineering)","score_opus":0.7768964640079218,"score_gpt":0.5994020993364176,"score_spread":0.17749436467150415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767145646","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08336561,0.03537661,0.8275352,0.026439648,0.001316539,0.0009908364,0.0031595356,0.0004697973,0.021346135],"genre_scores_gemma":[0.77324486,0.013544478,0.20191741,0.0014439619,0.0012985554,0.0005437352,0.00087685644,0.00009433961,0.007035859],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9935406,0.0048336517,0.0002638694,0.00033353228,0.00088487694,0.00014354417],"domain_scores_gemma":[0.97867143,0.017448183,0.0013000655,0.0009347318,0.0013853466,0.00026029893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012618472,0.0009930548,0.0013392849,0.0022393153,0.0002637757,0.003432749,0.0010172814,0.0012555884,0.006465998],"category_scores_gemma":[0.057812724,0.0004125141,0.0011503575,0.002122554,0.00072967197,0.003319213,0.0012411736,0.0021186613,0.0004498584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069719565,0.0010826187,0.028422674,0.0016482574,0.001735713,0.00015745379,0.00014096577,0.22914624,0.0009919312,0.1163903,0.01359732,0.6059893],"study_design_scores_gemma":[0.00035038264,0.0006141185,0.021481765,0.00073488307,0.0011253306,0.00030257227,0.00019269549,0.6848215,0.0011511697,0.27514347,0.013957683,0.00012443065],"about_ca_topic_score_codex":0.0056653074,"about_ca_topic_score_gemma":0.00783186,"teacher_disagreement_score":0.012618472,"about_ca_system_score_codex":0.002448364,"about_ca_system_score_gemma":0.003162912,"threshold_uncertainty_score":0.06673366},"labels":[],"label_agreement":null},{"id":"W2767153714","doi":"10.1016/j.jval.2017.08.2677","title":"Characteristics of Psoriasis Patients In Latin America","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Demographics; Psoriasis; Scalp; Groin; Dermatology; Surgery; Pediatrics; Demography","score_opus":0.036731974026227215,"score_gpt":0.27956688195942864,"score_spread":0.24283490793320142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767153714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592507,0.00047587173,0.00003955396,0.00020742134,0.000008569192,0.000014370143,0.00049618573,0.0000038144433,0.0028292877],"genre_scores_gemma":[0.99884605,0.0002476195,0.00003438399,0.0001513747,0.000013418265,0.000012881127,0.00037465311,0.0000031221778,0.0003164985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964666,0.00008107915,0.00004506103,0.00005174162,0.000046443918,0.00012896671],"domain_scores_gemma":[0.99910575,0.00012974371,0.00035833707,0.000024050996,0.000109180066,0.00027280586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029663762,0.00022444055,0.00042122402,0.0013403428,0.00072976964,0.0009021874,0.0002005889,0.00044937007,0.003160895],"category_scores_gemma":[0.0013513622,0.00015635433,0.00033187037,0.0021090664,0.00031342695,0.0003999616,0.00043302387,0.0005189595,0.00033747137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008879074,0.00007869882,0.9975942,0.000010965703,0.000023829723,0.00016171606,0.00025754937,0.000015574218,0.00024054846,0.000038776263,0.00018906668,0.0013002544],"study_design_scores_gemma":[0.000008154655,0.00007954764,0.9966689,0.000013261581,0.000016129581,0.00045393614,0.0019715333,0.000039694223,0.000025043311,0.000035959612,0.00068383204,0.000004030461],"about_ca_topic_score_codex":0.013193686,"about_ca_topic_score_gemma":0.012345044,"teacher_disagreement_score":0.013193686,"about_ca_system_score_codex":0.00060904864,"about_ca_system_score_gemma":0.0005436054,"threshold_uncertainty_score":0.026233792},"labels":[],"label_agreement":null},{"id":"W2767174961","doi":"10.1016/j.jval.2017.08.2986","title":"Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Visual analogue scale; Rheumatoid arthritis; Internal medicine; Methotrexate; Combination therapy; Physical therapy; Subgroup analysis; Confidence interval","score_opus":0.06600752135216663,"score_gpt":0.3868284313646635,"score_spread":0.32082091001249685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767174961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97476566,0.014953775,0.00090359926,0.0004668511,0.00017648567,0.0002389637,0.0060099363,0.00003802293,0.002446685],"genre_scores_gemma":[0.99342304,0.001385842,0.0002352182,0.00051095564,0.000118756965,0.00027439932,0.003390387,0.000024549108,0.00063692214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827933,0.0006267166,0.0002515621,0.00033241304,0.00019465758,0.00031532437],"domain_scores_gemma":[0.9989353,0.00039246806,0.0003263596,0.00015032217,0.00011417241,0.000081357655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002395763,0.00097631506,0.0024224457,0.0010922046,0.0003424813,0.0012013876,0.0005971501,0.0006643451,0.0020780128],"category_scores_gemma":[0.0032485565,0.00031800682,0.006472452,0.0017250074,0.0002971607,0.0005419576,0.0009255564,0.0011111717,0.00022238221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07388378,0.0005017242,0.72133595,0.0028607303,0.158269,0.0005802614,0.0004032038,0.001350299,0.002804547,0.0006104218,0.0071637486,0.030236382],"study_design_scores_gemma":[0.018402955,0.0028623105,0.8431683,0.0005610918,0.121581316,0.000488428,0.0013807623,0.0024258152,0.00074250513,0.0012765934,0.006983606,0.00012642855],"about_ca_topic_score_codex":0.005405495,"about_ca_topic_score_gemma":0.012977904,"teacher_disagreement_score":0.005405495,"about_ca_system_score_codex":0.0006224126,"about_ca_system_score_gemma":0.0008151248,"threshold_uncertainty_score":0.012670159},"labels":[],"label_agreement":null},{"id":"W2767191336","doi":"10.1016/j.jval.2017.08.881","title":"Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nontuberculous mycobacteria; Internal medicine; Cystic fibrosis; Tuberculosis; Asthma; Comorbidity; Ethambutol; Ivacaftor; Pharmacy; Rifampicin; Family medicine; Pathology; Mycobacterium","score_opus":0.06283266517973207,"score_gpt":0.36302721634824064,"score_spread":0.30019455116850857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767191336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939786,0.00048470736,0.000046509853,0.000528849,0.000029439725,0.0000091937045,0.0040524956,0.000008296637,0.00086196786],"genre_scores_gemma":[0.99526656,0.00017822042,0.000025030478,0.00014290835,0.00002161923,0.000009635432,0.0038137583,0.0000019732713,0.0005404101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900585,0.00016543565,0.0000906739,0.00015090953,0.00010008213,0.00048719396],"domain_scores_gemma":[0.9975836,0.00030753706,0.001350796,0.00006133181,0.000118751464,0.00057782885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004559461,0.0002865351,0.00043255583,0.0011279162,0.00043284806,0.0008139648,0.00061185966,0.0010036114,0.003464788],"category_scores_gemma":[0.0028375955,0.00029623546,0.0015107543,0.0014971273,0.00035151216,0.0010431132,0.0011171354,0.0012627803,0.00022012499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088630174,0.00017281066,0.9936278,0.000023276347,0.00025526414,0.000092472146,0.000092487935,0.0004615193,0.00011364727,0.00020366616,0.0015127523,0.0025580686],"study_design_scores_gemma":[0.000023749346,0.00013371033,0.9983339,0.000013156136,0.0000627336,0.00007483794,0.0003562188,0.00058661285,0.00003587707,0.00009519119,0.00027657722,0.0000075753874],"about_ca_topic_score_codex":0.079926565,"about_ca_topic_score_gemma":0.09368915,"teacher_disagreement_score":0.079926565,"about_ca_system_score_codex":0.0013433018,"about_ca_system_score_gemma":0.0012216216,"threshold_uncertainty_score":0.15892267},"labels":[],"label_agreement":null},{"id":"W2767198133","doi":"10.1016/j.jval.2017.08.2401","title":"Development of A New Patient-Reported Outcome Instrument To Evaluate Treatments For Stretchmarks: The Body-Q Stretchmark Scale","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Patient-reported outcome; Scale (ratio); Cronbach's alpha; Body contouring; Clinical psychology; Psychology; Item response theory; Operationalization; Distress; Psychosocial; Medicine; Physical therapy; Psychometrics; Quality of life (healthcare); Developmental psychology; Psychiatry; Weight loss; Internal medicine; Obesity; Psychotherapist; Geography","score_opus":0.18237214870573912,"score_gpt":0.4297200905538024,"score_spread":0.24734794184806327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767198133","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90540713,0.001813491,0.043057114,0.0023960406,0.000763494,0.0095271645,0.012525368,0.00058638153,0.02392392],"genre_scores_gemma":[0.8880388,0.0013801922,0.08294507,0.0012858814,0.00022972873,0.011548898,0.009970918,0.00013175991,0.0044687763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943269,0.0017800854,0.0011080246,0.00029037386,0.0022228637,0.00027171784],"domain_scores_gemma":[0.98332477,0.006447789,0.0047420096,0.00045777883,0.004249287,0.0007784478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006637585,0.0005673273,0.0009313586,0.0021173833,0.00045396335,0.0010378046,0.0008681518,0.0007112517,0.0033668587],"category_scores_gemma":[0.020684725,0.00026104643,0.0019990432,0.0009860754,0.00038329436,0.0015384341,0.0016713055,0.0016760287,0.0007518274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001668715,0.0025111432,0.67582744,0.00084923045,0.0014650289,0.00014112395,0.0013039187,0.0031447632,0.0034289903,0.0024113113,0.017587839,0.28966045],"study_design_scores_gemma":[0.0005705628,0.0020494875,0.9683279,0.00032468975,0.00031802428,0.00034514852,0.0009822624,0.008816927,0.001833307,0.0015756028,0.014694345,0.00016170631],"about_ca_topic_score_codex":0.0015613367,"about_ca_topic_score_gemma":0.0034176381,"teacher_disagreement_score":0.006637585,"about_ca_system_score_codex":0.00079404796,"about_ca_system_score_gemma":0.0015444763,"threshold_uncertainty_score":0.03510332},"labels":[],"label_agreement":null},{"id":"W2767203323","doi":"10.1016/j.jval.2017.08.1060","title":"Cost-Effectiveness Of A Supraciliary Micro-Stent Glaucoma Implant Combined With Cataract Surgery In Management Of Primary Open-Angle Glaucoma (POAG) From The Canadian Payer Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Alcon (Canada); Prism Eye Institute","funders":"","keywords":"Medicine; Trabeculectomy; Cataract surgery; Glaucoma; Intraocular pressure; Open angle glaucoma; Incremental cost-effectiveness ratio; Randomized controlled trial; Adverse effect; Glaucoma surgery; Ophthalmology; Clinical trial; Surgery; Quality-adjusted life year; Cost effectiveness; Internal medicine","score_opus":0.05640213813470263,"score_gpt":0.3147829040293632,"score_spread":0.2583807658946606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767203323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8535835,0.07745099,0.00074634445,0.021048259,0.0007037766,0.00033177037,0.005928324,0.000062857885,0.04014435],"genre_scores_gemma":[0.9921672,0.0053592934,0.0003727205,0.0006403605,0.00021602206,0.000018493309,0.00071171403,0.000005293876,0.0005088882],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9976426,0.0004664605,0.00016032571,0.0001348135,0.0009104083,0.0006853855],"domain_scores_gemma":[0.997424,0.00074870983,0.00043397117,0.000043947734,0.00048875395,0.0008605632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001189144,0.000641849,0.0011149277,0.0018424165,0.00095595146,0.0025534944,0.0010905577,0.0015974339,0.005300819],"category_scores_gemma":[0.0068859165,0.0003097975,0.003537012,0.0025266598,0.00082537514,0.0007627633,0.0008929095,0.0018509156,0.00017199431],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.082138956,0.0036581345,0.28084108,0.005503831,0.01297594,0.0034844633,0.0007991034,0.0474688,0.004400099,0.020813914,0.032265678,0.5056499],"study_design_scores_gemma":[0.00826056,0.011456533,0.8769763,0.0030626354,0.019938786,0.0041166893,0.0026168055,0.042661835,0.0013056219,0.0070781084,0.021929247,0.0005969175],"about_ca_topic_score_codex":0.6741728,"about_ca_topic_score_gemma":0.7949909,"teacher_disagreement_score":0.32582718,"about_ca_system_score_codex":0.03499035,"about_ca_system_score_gemma":0.027470022,"threshold_uncertainty_score":0.65549207},"labels":[],"label_agreement":null},{"id":"W2767725047","doi":"10.1016/j.jval.2017.09.015","title":"What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Marie Curie","keywords":"Medicine; Quality of life (healthcare); Venous thromboembolism; Cancer; Hemostasis; EQ-5D; Major bleeding; Analysis of variance; Repeated measures design; Internal medicine; Thrombosis; Disease; Health related quality of life; Statistics","score_opus":0.07389960248074597,"score_gpt":0.3948794624123354,"score_spread":0.32097985993158945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767725047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7840804,0.0768494,0.0005003834,0.10655809,0.0010468389,0.000033006367,0.0020032926,0.000010801692,0.028917782],"genre_scores_gemma":[0.9874676,0.009508109,0.00014670807,0.0019914173,0.0003594189,0.00000742908,0.0002282774,0.000003600103,0.00028749893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986199,0.00065909594,0.00010338677,0.00006539135,0.0003360072,0.00021623612],"domain_scores_gemma":[0.9908471,0.0038774328,0.0024661273,0.00012897668,0.0010742856,0.0016060785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022367993,0.00017029779,0.0005591681,0.0009332404,0.00049177156,0.0023222,0.0004292719,0.000926008,0.0035175723],"category_scores_gemma":[0.015967024,0.00016300104,0.0009090075,0.0014735003,0.0010331057,0.0016213229,0.0005923796,0.0013032381,0.00033595637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043498664,0.0003394116,0.83631456,0.0006550833,0.001003164,0.00027819595,0.0008852836,0.0005133532,0.00017683378,0.0034545264,0.010838103,0.14510645],"study_design_scores_gemma":[0.000072458155,0.00038669436,0.9680065,0.0013857668,0.00045607466,0.00072384917,0.0051063695,0.0010141626,0.00019493546,0.007851055,0.014738405,0.0000637281],"about_ca_topic_score_codex":0.0049136383,"about_ca_topic_score_gemma":0.010738187,"teacher_disagreement_score":0.0049136383,"about_ca_system_score_codex":0.0018463184,"about_ca_system_score_gemma":0.0012394405,"threshold_uncertainty_score":0.013396025},"labels":[],"label_agreement":null},{"id":"W2768023721","doi":"10.1016/j.jval.2017.09.009","title":"Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Tolerability; Clinical trial; Food and drug administration; Drug development; Medicine; Terminology; Adverse effect; Common Terminology Criteria for Adverse Events; Alternative medicine; Patient-reported outcome; Regulatory science; Drug; Medical physics; Pharmacology; Internal medicine; Pathology; Nursing; Quality of life (healthcare)","score_opus":0.6308552548625395,"score_gpt":0.5046292452090074,"score_spread":0.12622600965353203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768023721","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017200457,0.18028194,0.030230243,0.74702793,0.0077980026,0.0014228296,0.0024246234,0.00015687349,0.013457072],"genre_scores_gemma":[0.24343874,0.31494296,0.17915685,0.22034498,0.024157472,0.0034423296,0.0028655988,0.0002141054,0.01143697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9785824,0.013699593,0.0018256927,0.000893796,0.0043417118,0.0006568784],"domain_scores_gemma":[0.8016983,0.1378545,0.007810348,0.004149457,0.044577587,0.0039097723],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1437051,0.0014406774,0.0013533932,0.0017388255,0.0006586823,0.0055453447,0.002132282,0.0056932415,0.002570176],"category_scores_gemma":[0.10970528,0.0006638197,0.002559909,0.001499136,0.0016344851,0.0041342746,0.001910456,0.011228122,0.00055020425],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027840002,0.0010982398,0.005656123,0.0020229823,0.0007926244,0.00022169604,0.0009984454,0.0021415344,0.0018406374,0.01362233,0.19010353,0.77871794],"study_design_scores_gemma":[0.0027757382,0.0053746114,0.033286594,0.03259569,0.0033838963,0.0005350865,0.002467991,0.01167574,0.014855976,0.064520314,0.8279388,0.0005896931],"about_ca_topic_score_codex":0.006997067,"about_ca_topic_score_gemma":0.010850311,"teacher_disagreement_score":0.8562949,"about_ca_system_score_codex":0.0050429706,"about_ca_system_score_gemma":0.0143575035,"threshold_uncertainty_score":0.75999427},"labels":[],"label_agreement":null},{"id":"W2768414951","doi":"10.1046/j.1524-4733.2001.40202-290.x","title":"PQP7: IS COMPLIANCE WITH DRUG TREATMENT CORRELATED WITH HEALTH RELATED QUALITY OF LIFE?","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Compliance (psychology); Drug; Drug treatment; Quality of life (healthcare); Quality (philosophy); Medicine; Intensive care medicine; Pharmacology; Psychology; Internal medicine; Nursing; Social psychology; Philosophy","score_opus":0.3780971992205958,"score_gpt":0.4672445697107085,"score_spread":0.08914737049011268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768414951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98901063,0.0013626372,0.00048793625,0.0018574584,0.000064909276,0.000057303434,0.0026659963,0.000023788825,0.0044693514],"genre_scores_gemma":[0.9975204,0.00020622356,0.000342582,0.00016667128,0.000063217434,0.000038213973,0.001215623,0.000008544037,0.0004384098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966552,0.0015735558,0.0003285844,0.0002812145,0.00077389734,0.0003874411],"domain_scores_gemma":[0.9596906,0.018711843,0.015462739,0.0008413851,0.0025113886,0.0027820761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041666934,0.00041962494,0.0008882449,0.0010281345,0.00046925104,0.0016693018,0.0011370075,0.0018536354,0.00835171],"category_scores_gemma":[0.027611002,0.00024640077,0.0018446136,0.0016908073,0.00083629513,0.0011293514,0.0012052498,0.002239422,0.0009915248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043240414,0.0000957749,0.9920814,0.00005614509,0.00051493436,0.000030994383,0.000053932035,0.000098079894,0.000056443907,0.00011119559,0.00042725296,0.0060413494],"study_design_scores_gemma":[0.00003369655,0.00028546923,0.9977488,0.00003496366,0.00020814786,0.00010699748,0.000094658826,0.00068863103,0.00008225074,0.0002653403,0.00044203145,0.000009038055],"about_ca_topic_score_codex":0.0034787033,"about_ca_topic_score_gemma":0.0031000976,"teacher_disagreement_score":0.00835171,"about_ca_system_score_codex":0.0008115376,"about_ca_system_score_gemma":0.0011027887,"threshold_uncertainty_score":0.02793926},"labels":[],"label_agreement":null},{"id":"W2770033375","doi":"10.1016/j.jval.2017.10.001","title":"The Use of MCDA in HTA: Great Potential, but More Effort Needed","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Multiple-criteria decision analysis; Decision analysis; Health technology; Management science; Risk analysis (engineering); Health care; Medicine; Operations research; Political science; Engineering; Economics","score_opus":0.5732722177594017,"score_gpt":0.4426717322215603,"score_spread":0.13060048553784143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770033375","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010517155,0.06782047,0.44405267,0.41050825,0.008759367,0.0012581957,0.001609491,0.00073281606,0.05474151],"genre_scores_gemma":[0.16200227,0.04499484,0.75194794,0.025303552,0.007766667,0.0009908295,0.0009455985,0.00039596474,0.0056523187],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.91751796,0.06853608,0.0021121786,0.001724223,0.00924676,0.0008627765],"domain_scores_gemma":[0.6161966,0.27327165,0.008764372,0.03368309,0.060397238,0.007687108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09968728,0.0017731442,0.0036916968,0.005802328,0.0017308664,0.011527134,0.007472177,0.005473805,0.02041794],"category_scores_gemma":[0.20055795,0.0010801891,0.0024969368,0.007702685,0.0051358896,0.016918918,0.0076309606,0.0103210285,0.0034491317],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046646662,0.00068692723,0.015321649,0.003723292,0.0010819444,0.00019794508,0.0011074424,0.019224929,0.0009599556,0.23389623,0.08510548,0.6382277],"study_design_scores_gemma":[0.00027829988,0.0003195476,0.0085020475,0.010191001,0.00031656402,0.0003334796,0.0032557584,0.070847616,0.0010508102,0.6174669,0.28698298,0.00045502343],"about_ca_topic_score_codex":0.03838857,"about_ca_topic_score_gemma":0.053807802,"teacher_disagreement_score":0.09968728,"about_ca_system_score_codex":0.0055714673,"about_ca_system_score_gemma":0.012741775,"threshold_uncertainty_score":0.527203},"labels":[],"label_agreement":null},{"id":"W2770573141","doi":"10.1016/j.jval.2014.03.1121","title":"Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitus","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psychological intervention; Diabetes mellitus; Intensive care medicine; Type 2 diabetes; MEDLINE; Time horizon; Type 2 Diabetes Mellitus; Health care; Nursing; Endocrinology","score_opus":0.7243221584177844,"score_gpt":0.5205481949066872,"score_spread":0.2037739635110971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770573141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007374205,0.9753048,0.01871723,0.0020227763,0.00049505447,0.00003384968,0.00035608505,0.00004471517,0.00228806],"genre_scores_gemma":[0.013772023,0.97209567,0.0116067985,0.00061902835,0.0007433386,0.00012996902,0.0003099497,0.00005012334,0.00067308475],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.995464,0.003073684,0.00047591396,0.00021590231,0.0006467659,0.0001238518],"domain_scores_gemma":[0.9782658,0.019419776,0.00074744626,0.00035121522,0.0011103787,0.00010543462],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010381978,0.0021930607,0.0036646137,0.0041745496,0.00035432822,0.0028958693,0.0031813658,0.0022164434,0.0039419904],"category_scores_gemma":[0.024684003,0.00095096463,0.0035004965,0.006661197,0.0008065704,0.0022222553,0.001007858,0.0028346546,0.0010590067],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032585047,0.00023993115,0.0017357166,0.03977153,0.0025786296,0.0003357977,0.00013460612,0.106823005,0.00035085,0.16891529,0.06391773,0.61487114],"study_design_scores_gemma":[0.00025955742,0.000310317,0.004522436,0.060284916,0.004313995,0.0011269253,0.00021869373,0.11723532,0.000812428,0.23107184,0.5795759,0.00026778286],"about_ca_topic_score_codex":0.011210116,"about_ca_topic_score_gemma":0.009056869,"teacher_disagreement_score":0.989618,"about_ca_system_score_codex":0.0029003033,"about_ca_system_score_gemma":0.0030786726,"threshold_uncertainty_score":0.05490583},"labels":[],"label_agreement":null},{"id":"W2772793015","doi":"10.1016/j.jval.2017.10.018","title":"ISPOR Code of Ethics 2017 (4th Edition)","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"European Organisation for Rare Diseases; Agency for Healthcare Research and Quality; European Federation of Pharmaceutical Industries and Associations; Patient-Centered Outcomes Research Institute","keywords":"Transparency (behavior); Beneficence; Research ethics; Scientific misconduct; Ethical code; Conflict of interest; Political science; Incentive; Medicine; Public relations; Engineering ethics; Alternative medicine; Engineering; Autonomy; Law","score_opus":0.7120559726715702,"score_gpt":0.5139610946457226,"score_spread":0.19809487802584758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772793015","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014066406,0.0064653037,0.021952545,0.05932926,0.012094425,0.00095944037,0.0130099375,0.0024771646,0.8823053],"genre_scores_gemma":[0.017856559,0.006742345,0.022827143,0.03603724,0.005003814,0.0036867848,0.0120122135,0.0025341813,0.89329964],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97131485,0.009107018,0.0041166,0.00097625563,0.011966651,0.002518679],"domain_scores_gemma":[0.95070505,0.015632667,0.002732943,0.005027466,0.024415499,0.0014863146],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015765741,0.0008859235,0.0012809748,0.0047878157,0.0037173706,0.013420102,0.002142607,0.011687264,0.08663637],"category_scores_gemma":[0.062228817,0.0012949649,0.0011901883,0.004786575,0.0037634661,0.0053848433,0.0037842458,0.012218418,0.086693965],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026746948,0.000034957997,0.00016695287,0.00028251996,0.000005423628,0.00005347107,0.00039860798,0.00016457059,0.00012308432,0.14239678,0.81980586,0.036541022],"study_design_scores_gemma":[0.000008604237,0.000009212083,0.00041045254,0.0005990728,0.000004505519,0.00008269317,0.000113134716,0.00013014054,0.00012345148,0.023891369,0.9746018,0.000025577603],"about_ca_topic_score_codex":0.015640484,"about_ca_topic_score_gemma":0.015182715,"teacher_disagreement_score":0.9883127,"about_ca_system_score_codex":0.005362485,"about_ca_system_score_gemma":0.02348161,"threshold_uncertainty_score":0.28982753},"labels":[],"label_agreement":null},{"id":"W2772813269","doi":"10.1016/j.jval.2017.10.014","title":"Agreement among the Productivity Components of Eight Presenteeism Tests in a Sample of Health Care Workers","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"University of Alberta","keywords":"Presenteeism; Context (archaeology); Variance (accounting); Construct validity; Productivity; Sample (material); Test (biology); Psychology; Health care; Construct (python library); Medicine; Statistics; Absenteeism; Psychometrics; Clinical psychology; Social psychology; Mathematics; Computer science; Economics","score_opus":0.08888480415211664,"score_gpt":0.4093968860784344,"score_spread":0.32051208192631775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772813269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99969935,0.000015859347,0.000035570054,0.000011179939,0.0000021042174,0.0000029791386,0.00001928398,5.976665e-7,0.00021314103],"genre_scores_gemma":[0.9997445,0.000009684563,0.00003210862,0.0000070959277,0.0000018409236,0.000004218761,0.000050001683,7.6038975e-7,0.00014981328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983651,0.00050120166,0.0001551959,0.00019134334,0.00047122082,0.00031600718],"domain_scores_gemma":[0.9940387,0.0027244983,0.001210395,0.00027806673,0.0011442453,0.00060421653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001952833,0.00022187922,0.0002897611,0.0012607985,0.0006389097,0.0007914132,0.0005423142,0.0005427131,0.0010760111],"category_scores_gemma":[0.011011395,0.00023672146,0.00032068448,0.0007053555,0.0006406136,0.0004244976,0.00094857794,0.0005301741,0.00023110508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011945593,0.00010819005,0.9963097,0.0000047783647,0.000021913542,0.00003195811,0.0012888544,0.00003830412,0.00045783515,0.000013611073,0.000043346092,0.0015619765],"study_design_scores_gemma":[0.0000038063627,0.0000747267,0.9983683,0.0000018933703,0.000004946059,0.000033022305,0.0011820171,0.00015886541,0.000100931524,0.000016845985,0.00005202619,0.0000025478228],"about_ca_topic_score_codex":0.011589024,"about_ca_topic_score_gemma":0.011756816,"teacher_disagreement_score":0.011589024,"about_ca_system_score_codex":0.00051276694,"about_ca_system_score_gemma":0.00037705427,"threshold_uncertainty_score":0.023043156},"labels":[],"label_agreement":null},{"id":"W2795706072","doi":"10.1016/j.jval.2018.02.007","title":"Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Index (typography); EQ-5D; Medicine; Baseline (sea); Population; Quality of life (healthcare); Type 2 diabetes; Distress; Demography; Statistics; Diabetes mellitus; Health related quality of life; Mathematics; Clinical psychology; Environmental health; Internal medicine; Computer science","score_opus":0.25439126907890175,"score_gpt":0.3565012307887493,"score_spread":0.10210996170984754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795706072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944054,0.002706756,0.00019192317,0.00048505957,0.00006627731,0.000008821009,0.00094486465,0.0000048561774,0.001186032],"genre_scores_gemma":[0.9989655,0.00018098432,0.0000926455,0.00007280398,0.000029028273,0.0000059785657,0.0005204713,0.0000012495094,0.00013120649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985617,0.00072530145,0.00018905936,0.000178497,0.00020763616,0.00013789232],"domain_scores_gemma":[0.9961079,0.0021430776,0.000949348,0.00019796935,0.00023288325,0.00036887458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022328312,0.00033186976,0.00079876615,0.00071889145,0.00018450005,0.00097427174,0.0005017634,0.0009748149,0.0014839902],"category_scores_gemma":[0.013660022,0.00024142861,0.0011953874,0.0008417118,0.0003001204,0.0008387019,0.00074108696,0.0017569059,0.000137501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024335491,0.00020859075,0.9888715,0.000055770244,0.00052906293,0.00011532732,0.00009289249,0.000574245,0.00011750532,0.000462199,0.00056242617,0.005976898],"study_design_scores_gemma":[0.000071538154,0.00038887945,0.9952486,0.000026499227,0.00022735038,0.00015547464,0.00021926798,0.0025555426,0.000054072134,0.0007972093,0.00023899098,0.000016677935],"about_ca_topic_score_codex":0.0055609546,"about_ca_topic_score_gemma":0.0038649053,"teacher_disagreement_score":0.0055609546,"about_ca_system_score_codex":0.0006265622,"about_ca_system_score_gemma":0.0003080742,"threshold_uncertainty_score":0.011808515},"labels":[],"label_agreement":null},{"id":"W2795808606","doi":"10.1016/j.jval.2018.03.010","title":"Can Severity Outweigh Smaller Numbers? A Deliberative Perspective from Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Deliberation; Perspective (graphical); Differential treatment; Thematic analysis; Disease; Psychology; Medicine; Social psychology; Actuarial science; Business; Political science; Sociology; Qualitative research; Internal medicine; Law; Computer science","score_opus":0.30751391417731505,"score_gpt":0.39811182688057445,"score_spread":0.0905979127032594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795808606","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023021929,0.0077303457,0.0014414523,0.9142865,0.00068644556,0.000058426613,0.00016296958,0.000014831777,0.052597117],"genre_scores_gemma":[0.7293915,0.00689492,0.0037047716,0.24518555,0.0008680388,0.00012400953,0.00008958595,0.00009554608,0.013646041],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.9523416,0.020465782,0.0016616298,0.0030093726,0.012070689,0.010451019],"domain_scores_gemma":[0.8208924,0.12824279,0.0040744217,0.0023123182,0.029930755,0.014547367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05564479,0.0008068586,0.0016794995,0.0030361488,0.027348418,0.02041375,0.0040540975,0.019670859,0.005461924],"category_scores_gemma":[0.12535769,0.0008294142,0.001211232,0.0049902825,0.033075508,0.0075697363,0.006652443,0.024243204,0.00027269954],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036407265,0.00011312193,0.012441229,0.0005044386,0.00022193787,0.00096743135,0.037392166,0.0018700771,0.00039759002,0.7434612,0.15575613,0.046510633],"study_design_scores_gemma":[0.0004912337,0.00020579598,0.022742257,0.0043842876,0.0005319193,0.0005290326,0.0961231,0.003201623,0.0012966542,0.37205657,0.49772516,0.0007123469],"about_ca_topic_score_codex":0.9816996,"about_ca_topic_score_gemma":0.9865524,"teacher_disagreement_score":0.168527,"about_ca_system_score_codex":0.168527,"about_ca_system_score_gemma":0.2862251,"threshold_uncertainty_score":0.9643908},"labels":[],"label_agreement":null},{"id":"W2803518159","doi":"10.1016/j.jval.2018.03.014","title":"Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; World Health Organization","keywords":"Vaccination; Systematic review; Medicine; MEDLINE; Cost effectiveness; Meta-analysis; Computer science; Management science; Risk analysis (engineering); Immunology; Pathology","score_opus":0.1512715677482712,"score_gpt":0.4631866427257164,"score_spread":0.3119150749774452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803518159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011372975,0.98228365,0.0030160525,0.00047743894,0.00024118413,0.0005979538,0.0014020825,0.000040268376,0.00056846655],"genre_scores_gemma":[0.3488104,0.6380156,0.008653215,0.00076773384,0.0002465056,0.001589272,0.0015190834,0.000048851165,0.0003492496],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97795516,0.016016236,0.0031023037,0.001195536,0.0013879322,0.00034279213],"domain_scores_gemma":[0.93160343,0.0631544,0.0033620757,0.0006491903,0.0010036494,0.00022727807],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024952265,0.003777667,0.016218856,0.0044438588,0.00034720413,0.0033610305,0.0034231138,0.002670471,0.0072248867],"category_scores_gemma":[0.08353807,0.0018285059,0.02323588,0.00439267,0.00081562676,0.0027547039,0.0015927774,0.0034719985,0.00040880917],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009826553,0.00023772333,0.0048856763,0.461703,0.4482915,0.00015601871,0.0001823015,0.02018157,0.00023201462,0.0029541561,0.0011703552,0.05017903],"study_design_scores_gemma":[0.0062565287,0.0019271326,0.005435606,0.07145522,0.892552,0.00027200545,0.0001892295,0.008657587,0.0002748734,0.0066743013,0.0061908597,0.00011473211],"about_ca_topic_score_codex":0.012256448,"about_ca_topic_score_gemma":0.0126614915,"teacher_disagreement_score":0.9750477,"about_ca_system_score_codex":0.005486443,"about_ca_system_score_gemma":0.0061894604,"threshold_uncertainty_score":0.13196176},"labels":[],"label_agreement":null},{"id":"W2806908842","doi":"10.1016/j.jval.2018.01.013","title":"Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ultragenyx Pharmaceutical","keywords":"Debriefing; Physical therapy; Cognitive interview; Population; Psychology; Medicine; WOMAC; Cognition; Clinical psychology; Psychiatry; Osteoarthritis; Alternative medicine; Pathology","score_opus":0.5080128962114483,"score_gpt":0.5933957270194816,"score_spread":0.08538283080803333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806908842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.916205,0.004066301,0.025012163,0.02313718,0.000672421,0.007176148,0.001528906,0.0000777306,0.022124149],"genre_scores_gemma":[0.9674296,0.0019154334,0.012456745,0.0062872213,0.000088929,0.008151076,0.00027017406,0.000038945804,0.0033619986],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9460072,0.04842684,0.0012331277,0.00095523003,0.0015484913,0.001829054],"domain_scores_gemma":[0.9111752,0.07419815,0.004133479,0.0015500665,0.0062700934,0.0026730045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05225744,0.000512037,0.0007829372,0.0014255343,0.0052940445,0.003716848,0.0017659981,0.0017576363,0.0045792037],"category_scores_gemma":[0.068150684,0.00038745394,0.0006441069,0.0017087018,0.0061405767,0.0035760168,0.004932152,0.0030548135,0.0005962205],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117402895,0.000100686804,0.0031777858,0.0010520858,0.000015222164,0.0006077431,0.97696006,0.00011594495,0.00066576415,0.0034915048,0.0020794903,0.011616384],"study_design_scores_gemma":[0.000059826343,0.00018380563,0.001233955,0.001210248,0.000014223073,0.00033698516,0.9725772,0.0002991189,0.00052502257,0.00222907,0.021302072,0.000028423272],"about_ca_topic_score_codex":0.0038732064,"about_ca_topic_score_gemma":0.0056011667,"teacher_disagreement_score":0.05225744,"about_ca_system_score_codex":0.007254892,"about_ca_system_score_gemma":0.009012623,"threshold_uncertainty_score":0.276367},"labels":[],"label_agreement":null},{"id":"W2809722184","doi":"10.1016/j.jval.2018.04.387","title":"Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Business; Actuarial science; Accrual; Cash flow; Revenue; Public economics; Economics; Finance; Earnings","score_opus":0.185399073756288,"score_gpt":0.3928800009505027,"score_spread":0.20748092719421468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809722184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6709553,0.0031318495,0.15403666,0.029077087,0.00093081454,0.0004057239,0.0012611503,0.00051958347,0.1396819],"genre_scores_gemma":[0.9829678,0.00021197018,0.006065014,0.00023123513,0.0001639543,0.000033127842,0.000051082134,0.000028147484,0.010247666],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9962606,0.001559605,0.00012219891,0.0003352995,0.0004481323,0.0012741885],"domain_scores_gemma":[0.98612833,0.009255529,0.0009919356,0.0010292619,0.0009415297,0.001653497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005452604,0.0010875567,0.0031387783,0.0012767415,0.0015190663,0.0060620164,0.0032777712,0.008127976,0.017900018],"category_scores_gemma":[0.019470278,0.0006683873,0.002507199,0.0013979545,0.0025535892,0.0041790875,0.0026425086,0.0049716434,0.0008957496],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001426848,0.001184175,0.008579432,0.00025027755,0.0002956733,0.0048396494,0.0003341567,0.21200302,0.0025637697,0.7107213,0.018238727,0.039563008],"study_design_scores_gemma":[0.0006068134,0.0003585943,0.004383286,0.000046999132,0.00020515794,0.0012171254,0.00040781798,0.7232385,0.0010057861,0.26271045,0.0056842878,0.00013517916],"about_ca_topic_score_codex":0.010107395,"about_ca_topic_score_gemma":0.0057922886,"teacher_disagreement_score":0.017900018,"about_ca_system_score_codex":0.002917339,"about_ca_system_score_gemma":0.0021328889,"threshold_uncertainty_score":0.05988151},"labels":[],"label_agreement":null},{"id":"W2809820498","doi":"10.1016/j.jval.2018.04.765","title":"Drivers of Genomic Precision Medicine Adoption in the US: Payer Preferences","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Life expectancy; Actuarial science; Willingness to pay; Health care; Quality (philosophy); Medical Expenditure Panel Survey; Medicine; Business; Health insurance; Economics; Environmental health","score_opus":0.48699798991361704,"score_gpt":0.442559034847695,"score_spread":0.04443895506592205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809820498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.948592,0.0023273274,0.0017170318,0.036944915,0.000057947444,0.000025504087,0.0009132259,0.000013810796,0.009408186],"genre_scores_gemma":[0.99743843,0.00032801757,0.00021194854,0.0014862247,0.000039056442,0.0000043224018,0.00013962381,0.0000072249286,0.00034513816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971731,0.0013470772,0.00018921969,0.00025732917,0.00049328693,0.0005399281],"domain_scores_gemma":[0.97293526,0.017345097,0.005598852,0.00072287954,0.0011863633,0.002211521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005796486,0.0001195288,0.00032158458,0.0010432081,0.000515586,0.0027901107,0.00038490124,0.0012450526,0.0069921617],"category_scores_gemma":[0.031965733,0.00019494673,0.00044910645,0.0015262426,0.0007237442,0.0015287778,0.0009915621,0.0025083881,0.0002807739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053880486,0.00027256442,0.9137528,0.00006327442,0.00027806248,0.00022092863,0.0021794064,0.0015039633,0.00042465955,0.016285192,0.0071128933,0.05736747],"study_design_scores_gemma":[0.0000996411,0.00023850311,0.92778367,0.00026944515,0.00018946682,0.00094914105,0.008770083,0.007015146,0.00057344476,0.03754118,0.016478632,0.00009173296],"about_ca_topic_score_codex":0.013028986,"about_ca_topic_score_gemma":0.017891597,"teacher_disagreement_score":0.013028986,"about_ca_system_score_codex":0.0012867483,"about_ca_system_score_gemma":0.0013032461,"threshold_uncertainty_score":0.030655146},"labels":[],"label_agreement":null},{"id":"W2809845542","doi":"10.1016/j.jval.2018.04.1716","title":"Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus: A Cost-Effectiveness Analysis in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Belimumab; Medicine; Quality-adjusted life year; Population; Quality of life (healthcare); Cost–benefit analysis; Incremental cost-effectiveness ratio; Cohort; Cost-effectiveness analysis; Economic evaluation; Cost effectiveness; Internal medicine; Environmental health; Immunology; Risk analysis (engineering)","score_opus":0.03828282117421825,"score_gpt":0.3294544794386287,"score_spread":0.29117165826441044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809845542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86535317,0.09913081,0.00071891095,0.00827054,0.00024864063,0.0011414085,0.016598603,0.000045219113,0.008492847],"genre_scores_gemma":[0.9700806,0.023877693,0.0010340619,0.00091269694,0.000061112456,0.00014447473,0.0030317819,0.000012454659,0.0008450624],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99661946,0.0010147432,0.00029234108,0.00019072554,0.0012130499,0.00066966825],"domain_scores_gemma":[0.99393713,0.0018654083,0.000924613,0.00008866922,0.0019396316,0.0012445101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025863661,0.0007029092,0.0020048965,0.0020540848,0.0012096115,0.0023440633,0.0011725387,0.00085750886,0.002560537],"category_scores_gemma":[0.011207421,0.00056065037,0.0040613776,0.005624688,0.00081106595,0.00062532315,0.00075786543,0.0018352257,0.00007747757],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07682365,0.002437006,0.5404307,0.020867897,0.03675929,0.0017055265,0.0010069874,0.03898053,0.0014525164,0.0065722438,0.0355717,0.23739195],"study_design_scores_gemma":[0.0342655,0.0050336067,0.8238646,0.008017098,0.05365869,0.0011517002,0.0027548017,0.047161907,0.000768922,0.0017970252,0.021066707,0.0004595618],"about_ca_topic_score_codex":0.979341,"about_ca_topic_score_gemma":0.98692024,"teacher_disagreement_score":0.9181775,"about_ca_system_score_codex":0.081822544,"about_ca_system_score_gemma":0.080924205,"threshold_uncertainty_score":0.5936669},"labels":[],"label_agreement":null},{"id":"W2809867426","doi":"10.1016/j.jval.2018.04.525","title":"The Cost of New Oral Anti-Diabetic Drugs in Canada and Internationally","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Canagliflozin; Sitagliptin; Metformin; Business; Market share; Public economics; International economics; Economics; Medicine; Diabetes mellitus; Type 2 diabetes; Health care; Finance; Economic growth; Endocrinology","score_opus":0.07862818365720377,"score_gpt":0.3103516778663703,"score_spread":0.23172349420916655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809867426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7122159,0.053957682,0.0011607242,0.09861284,0.0007616025,0.00012810632,0.021104984,0.000105497646,0.11195259],"genre_scores_gemma":[0.97451854,0.01098518,0.00067381514,0.0012823718,0.00014969677,0.000014391099,0.0017601817,0.000022345941,0.010593324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967578,0.00023104405,0.00013922881,0.00015727087,0.0018214282,0.00089319],"domain_scores_gemma":[0.9909889,0.0010173038,0.0012696735,0.000107437525,0.0045729037,0.0020437848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013598884,0.00037886138,0.0006654705,0.0034929947,0.0023583905,0.0058341995,0.0014241087,0.0014846736,0.004150294],"category_scores_gemma":[0.010856869,0.00039820417,0.0009979511,0.0076445392,0.0018372228,0.0012728956,0.0012130608,0.0024721716,0.00015521633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017881222,0.00038922258,0.45203808,0.0010506015,0.0009200488,0.0020747592,0.001660094,0.04594825,0.00078513933,0.18527086,0.101672225,0.2064026],"study_design_scores_gemma":[0.00029985054,0.00020123125,0.7867512,0.0012269216,0.0007916855,0.001360221,0.0062912484,0.026913103,0.0010282813,0.01407006,0.1608097,0.00025649584],"about_ca_topic_score_codex":0.99524504,"about_ca_topic_score_gemma":0.99620193,"teacher_disagreement_score":0.2091009,"about_ca_system_score_codex":0.2091009,"about_ca_system_score_gemma":0.123674825,"threshold_uncertainty_score":0.91733086},"labels":[],"label_agreement":null},{"id":"W2809894823","doi":"10.1016/j.jval.2018.04.726","title":"Potential Impact of Changes to Basket of Comparator Countries from PMPRB7 to Pmprb12 has on Canadian Product List Prices","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sample (material); Product (mathematics); Formulary; Comparator; Economics; Business; Database transaction; Agricultural economics; Actuarial science; Medicine; Computer science; Mathematics; Engineering","score_opus":0.1348878784726197,"score_gpt":0.34733144081204054,"score_spread":0.21244356233942083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809894823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7055648,0.0068514277,0.0018271238,0.04373751,0.0016900285,0.00056883506,0.052290574,0.00031660352,0.18715301],"genre_scores_gemma":[0.9670788,0.001372808,0.0023907777,0.0061134486,0.00018688258,0.00007522772,0.009820161,0.00005984324,0.012902002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942061,0.0015239482,0.00026911127,0.00044340774,0.0022719193,0.0012855057],"domain_scores_gemma":[0.98941004,0.0024489542,0.0012110161,0.00043066338,0.0049924273,0.0015069724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059601,0.00038554813,0.00047680916,0.0015694908,0.0014462286,0.003630139,0.001533133,0.0013974586,0.0134242],"category_scores_gemma":[0.022241708,0.000374935,0.0011085607,0.0024264432,0.0007401119,0.0010751565,0.0009936724,0.001536411,0.00078839285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040481467,0.002371435,0.3348514,0.0023794353,0.00276347,0.001454057,0.0008700658,0.04754297,0.014129998,0.09559161,0.18282674,0.27473736],"study_design_scores_gemma":[0.0026333153,0.003056768,0.7539099,0.0006093365,0.0015785005,0.0004639499,0.0019748085,0.016648864,0.009675022,0.0044011795,0.20473842,0.00031003557],"about_ca_topic_score_codex":0.7939355,"about_ca_topic_score_gemma":0.77915156,"teacher_disagreement_score":0.9820736,"about_ca_system_score_codex":0.017926393,"about_ca_system_score_gemma":0.016418096,"threshold_uncertainty_score":0.41455615},"labels":[],"label_agreement":null},{"id":"W2809912489","doi":"10.1016/j.jval.2018.04.1051","title":"The Economic Burden of Varicella in Mexico","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Medical prescription; Public health; Epidemiology; Health care; Incidence (geometry); Emergency medicine; Indirect costs; Intensive care unit; Varicella vaccine; Pediatrics; Intensive care medicine; Internal medicine; Immunization","score_opus":0.03425352522956795,"score_gpt":0.33063706826115524,"score_spread":0.2963835430315873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809912489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9635463,0.008730449,0.00008598134,0.01516737,0.00008192121,0.000011504153,0.0013641653,0.0000039226707,0.011008435],"genre_scores_gemma":[0.9927026,0.005454381,0.000082550396,0.00022033435,0.0000879353,0.000008984305,0.000346178,0.0000013992686,0.0010956252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997626,0.000086487154,0.000010306992,0.000011725835,0.000044596305,0.00008436284],"domain_scores_gemma":[0.9993211,0.00014626107,0.00033095691,0.00001646856,0.00006930509,0.000115898714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039443062,0.000103928316,0.00011436401,0.0009139137,0.0005174902,0.0010636593,0.00021194213,0.00034404243,0.0025036703],"category_scores_gemma":[0.0017298935,0.00008632858,0.00017506104,0.0012642792,0.00032484255,0.00049552176,0.0007475074,0.00044655983,0.00005557917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059073063,0.00018904795,0.90821165,0.00027399755,0.00024403687,0.0009445161,0.0014653108,0.0011856704,0.0003299914,0.015267427,0.013641947,0.0576556],"study_design_scores_gemma":[0.00003862729,0.00006661531,0.9735327,0.00027127474,0.00008751508,0.00030348578,0.0035505064,0.0006817277,0.00007830391,0.0011152077,0.02026446,0.00000955378],"about_ca_topic_score_codex":0.09819356,"about_ca_topic_score_gemma":0.098821305,"teacher_disagreement_score":0.09819356,"about_ca_system_score_codex":0.0032645045,"about_ca_system_score_gemma":0.0014175153,"threshold_uncertainty_score":0.19524401},"labels":[],"label_agreement":null},{"id":"W2809913281","doi":"10.1016/j.jval.2018.04.1668","title":"Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Liraglutide; Weight loss; Prediabetes; Cohort; Weight management; Weight change; Body weight; Internal medicine; Weight gain; Type 2 diabetes; Diabetes mellitus; Obesity; Gastroenterology; Endocrinology","score_opus":0.047210574591376675,"score_gpt":0.3647974245499249,"score_spread":0.31758684995854825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809913281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97478026,0.008232104,0.00017780469,0.0037897807,0.00007343795,0.00031407102,0.0065257386,0.00005935333,0.0060474384],"genre_scores_gemma":[0.99561214,0.0015130371,0.00037481272,0.00056171266,0.000037244943,0.000046306217,0.0013323071,0.000011702351,0.0005107316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983156,0.00048362353,0.0001660162,0.00022916788,0.00047473508,0.00033093366],"domain_scores_gemma":[0.993594,0.0016163057,0.0013739769,0.00014915482,0.0014840331,0.0017825406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013915515,0.00034523872,0.0010707843,0.0004420952,0.0011407775,0.0015557901,0.00075755385,0.0007645251,0.0026379153],"category_scores_gemma":[0.010209498,0.00025494202,0.000959859,0.0016405572,0.0009619595,0.00050818437,0.00048362173,0.0012462569,0.00021947743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1574833,0.005363642,0.5311174,0.0029133789,0.0042160717,0.00093236746,0.0013101381,0.02046194,0.0019269955,0.0016394573,0.044787344,0.22784801],"study_design_scores_gemma":[0.021314785,0.012032307,0.92592454,0.0008105311,0.0034714583,0.00046685094,0.0018262264,0.019036483,0.00083264714,0.0005527447,0.013439251,0.0002920718],"about_ca_topic_score_codex":0.9405449,"about_ca_topic_score_gemma":0.96018046,"teacher_disagreement_score":0.059455097,"about_ca_system_score_codex":0.04996928,"about_ca_system_score_gemma":0.03265143,"threshold_uncertainty_score":0.3625542},"labels":[],"label_agreement":null},{"id":"W2809943359","doi":"10.1016/j.jval.2018.04.068","title":"Cost-Utility Analysis Comparing Abobotulinumtoxina with Onabotulinumtoxina for the Treatment of Pediatric Lower Limb Spasticity","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Spasticity; Medicine; Cerebral palsy; Tolerability; Botulinum toxin; Dosing; Physical therapy; Physical medicine and rehabilitation; Adverse effect; Surgery; Internal medicine","score_opus":0.11082874778539213,"score_gpt":0.3457163393041222,"score_spread":0.23488759151873007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809943359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96970177,0.015864015,0.004989942,0.0014812893,0.0002022333,0.00092033437,0.002782711,0.000066703775,0.0039909943],"genre_scores_gemma":[0.99643826,0.0010715621,0.0011139885,0.00016751725,0.000025929514,0.00013505304,0.0006422735,0.000008097118,0.0003974458],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965724,0.0025141675,0.00016291798,0.00022135406,0.00024090486,0.00028831104],"domain_scores_gemma":[0.99443877,0.0044537606,0.00046952118,0.00011289677,0.00017635513,0.00034863545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035138002,0.001377358,0.0028018593,0.0012537702,0.00022064148,0.0017840643,0.0011514785,0.0011210729,0.0057692435],"category_scores_gemma":[0.011598477,0.00060162315,0.005725999,0.0012512906,0.0005750654,0.001234605,0.0008752609,0.0017991386,0.00018641923],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50327307,0.0036792594,0.027519522,0.0033042077,0.035096165,0.0008391275,0.00014218304,0.30708703,0.0035517584,0.005428233,0.0032724028,0.10680706],"study_design_scores_gemma":[0.10126622,0.096312545,0.11263712,0.0016741941,0.06715533,0.0016253624,0.00094826357,0.59848094,0.0036138461,0.010264743,0.0056247707,0.0003966636],"about_ca_topic_score_codex":0.009725748,"about_ca_topic_score_gemma":0.004492023,"teacher_disagreement_score":0.009725748,"about_ca_system_score_codex":0.0048546107,"about_ca_system_score_gemma":0.0018236717,"threshold_uncertainty_score":0.03522277},"labels":[],"label_agreement":null},{"id":"W2810063204","doi":"10.1016/j.jval.2018.04.044","title":"Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1: A Canadian Cost-Utility Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Rilpivirine; Dolutegravir; Human immunodeficiency virus (HIV); Medicine; Virology; Antiretroviral therapy; Viral load","score_opus":0.021294070653612593,"score_gpt":0.2763232802801294,"score_spread":0.2550292096265168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810063204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82768834,0.07548939,0.004591905,0.0074980417,0.00027311532,0.002603545,0.04047458,0.00013030108,0.041250788],"genre_scores_gemma":[0.9700252,0.015302193,0.0032898355,0.0006603027,0.000050024977,0.00021505721,0.006695822,0.00004803946,0.0037134981],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99675447,0.0012766038,0.00015615096,0.0001630774,0.0011340226,0.00051565433],"domain_scores_gemma":[0.9960879,0.002023924,0.00028613186,0.00011019978,0.0010874134,0.00040440608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004106176,0.0013878365,0.0018935332,0.0030031863,0.0010000365,0.0024218801,0.0017664422,0.0008158673,0.004405606],"category_scores_gemma":[0.0120579535,0.0006560041,0.0055610365,0.0066376342,0.00068408693,0.00083136774,0.00087677076,0.0021824962,0.0001585151],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06541803,0.0020465576,0.19154383,0.009711298,0.025201896,0.0015654411,0.0009970092,0.2759889,0.002128361,0.026462855,0.054878768,0.344057],"study_design_scores_gemma":[0.015693929,0.00474934,0.5268587,0.0031693669,0.047167964,0.0014518745,0.0028913198,0.32554364,0.0011196497,0.007866065,0.06264201,0.0008461887],"about_ca_topic_score_codex":0.9695417,"about_ca_topic_score_gemma":0.97381693,"teacher_disagreement_score":0.07685245,"about_ca_system_score_codex":0.07685245,"about_ca_system_score_gemma":0.055868067,"threshold_uncertainty_score":0.55760616},"labels":[],"label_agreement":null},{"id":"W2810075563","doi":"10.1016/j.jval.2018.04.688","title":"Budget Impact Model of Low Chloride Balanced Intravenous Solutions in Patients with Systemic Inflammatory Response Syndrome from a Hospital Perspective in Colombia","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Systemic inflammatory response syndrome; Observational study; Emergency medicine; Adverse effect; Surgery; Internal medicine","score_opus":0.02703627245170822,"score_gpt":0.29549363244693333,"score_spread":0.26845735999522513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810075563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85040677,0.0054598385,0.012700256,0.015986815,0.00038275545,0.0004658837,0.008538401,0.00011703343,0.10594221],"genre_scores_gemma":[0.9916803,0.0007879412,0.0011240343,0.00016087318,0.000028719349,0.000103946804,0.00062157767,0.000016479744,0.0054761027],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99890196,0.0004334639,0.000033219287,0.00009687506,0.000102714956,0.00043168422],"domain_scores_gemma":[0.99823713,0.00078581384,0.00020592743,0.00003441468,0.0003890454,0.0003477036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008957356,0.00075717893,0.00089242763,0.0013477921,0.000792108,0.0034407238,0.0012117852,0.0013408739,0.009160118],"category_scores_gemma":[0.0036393392,0.00046873227,0.0010520899,0.0013974459,0.00061677024,0.0011350266,0.0015321596,0.0014917018,0.00029216395],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012198465,0.0005045973,0.045008793,0.0003899399,0.0003392263,0.0013296976,0.00036768994,0.859796,0.00046619694,0.06585764,0.010098392,0.014622008],"study_design_scores_gemma":[0.00041316834,0.00061793416,0.052753214,0.0004454435,0.00055059354,0.00040898772,0.0049929833,0.8922799,0.0003250687,0.023046043,0.02398408,0.0001825262],"about_ca_topic_score_codex":0.3123512,"about_ca_topic_score_gemma":0.23455474,"teacher_disagreement_score":0.3123512,"about_ca_system_score_codex":0.014928583,"about_ca_system_score_gemma":0.0078224335,"threshold_uncertainty_score":0.6210662},"labels":[],"label_agreement":null},{"id":"W2810086625","doi":"10.1016/j.jval.2018.04.1526","title":"Quality of Life of Adults with a History of Juvenile Idiopathic Arthritis: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Quality of life (healthcare); Arthritis; Physical therapy; MEDLINE; Disease; Juvenile; Gerontology; Family medicine; Internal medicine","score_opus":0.2443058714598039,"score_gpt":0.4535697120265673,"score_spread":0.20926384056676342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810086625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0039955317,0.9952508,0.000046177327,0.000108819295,0.000059371007,0.000050008417,0.00036315082,0.000002624285,0.00012344254],"genre_scores_gemma":[0.07011459,0.92832845,0.0004364346,0.0005035824,0.00007900831,0.00012361542,0.00031719136,0.0000026597593,0.000094417104],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99811614,0.00044954728,0.0007508696,0.00022809829,0.0003488551,0.00010651084],"domain_scores_gemma":[0.9936783,0.0043180306,0.0013839082,0.00006783072,0.00040491676,0.00014713086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018875943,0.0009035819,0.004822265,0.0047046263,0.00039500467,0.0016051457,0.0010272514,0.0013871355,0.0028212764],"category_scores_gemma":[0.0126510635,0.0006891257,0.0076021133,0.005549638,0.0004813264,0.001445234,0.0012457963,0.0013170833,0.00012024134],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056931755,0.00007655914,0.021543948,0.85970795,0.048736073,0.00023664307,0.0003875563,0.00017862876,0.0001669487,0.00021532773,0.0023618462,0.0658193],"study_design_scores_gemma":[0.0007610634,0.00047445705,0.09418082,0.58161646,0.29928255,0.0013809365,0.0014210206,0.00026665122,0.00016117952,0.00057141687,0.019706741,0.00017664534],"about_ca_topic_score_codex":0.011846169,"about_ca_topic_score_gemma":0.040043667,"teacher_disagreement_score":0.011846169,"about_ca_system_score_codex":0.0015057756,"about_ca_system_score_gemma":0.00282741,"threshold_uncertainty_score":0.023554385},"labels":[],"label_agreement":null},{"id":"W2810087808","doi":"10.1016/j.jval.2018.04.1042","title":"Respiratory Illness (RI) and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH) in Infants with Congenital Diaphragmatic Hernia (CDH) in the Caress Registry (2005-2017)","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Hazard ratio; Proportional hazards model; Respiratory system; Confounding; Internal medicine; Confidence interval; Pregnancy","score_opus":0.026615641306224708,"score_gpt":0.29491242927136857,"score_spread":0.2682967879651439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810087808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854999,0.0010655391,0.00006287985,0.00013668627,0.000022297105,0.000017233795,0.011878386,0.000006536116,0.0013104687],"genre_scores_gemma":[0.99086577,0.0005874641,0.00007513139,0.00006634528,0.000022755701,0.00002482582,0.00802061,0.0000033149174,0.00033385184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987847,0.00021713566,0.0002870447,0.00021487854,0.00022618989,0.0002699922],"domain_scores_gemma":[0.9972995,0.00030635073,0.00143344,0.00016296067,0.00037727092,0.00042054473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011390727,0.00027868542,0.0003992483,0.0020371713,0.00044634793,0.00081462896,0.00074417534,0.0005735286,0.0012568837],"category_scores_gemma":[0.0040290514,0.00031567187,0.0008831254,0.0033415111,0.000296336,0.0009786483,0.0012916507,0.0006381518,0.00020495999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022210595,0.000005580642,0.999186,0.000014512626,0.000038025642,0.000025896363,0.000038089518,0.000020148747,0.000027557677,0.000023085502,0.00026017698,0.0003387361],"study_design_scores_gemma":[0.0000013814081,0.000013105498,0.9994715,0.000016311657,0.000016491536,0.00007532937,0.00018579043,0.000029787394,0.000020749945,0.0000050172885,0.00016307527,0.0000015232633],"about_ca_topic_score_codex":0.0832053,"about_ca_topic_score_gemma":0.12866765,"teacher_disagreement_score":0.0832053,"about_ca_system_score_codex":0.0010977748,"about_ca_system_score_gemma":0.0017534406,"threshold_uncertainty_score":0.16544193},"labels":[],"label_agreement":null},{"id":"W2810120321","doi":"10.1016/j.jval.2018.04.213","title":"Cost Effectiveness Analysis of Azacitidine in Patients with Acute Myeloid Leukemia With >30% Blasts and who are Not Candidate for Curative-Intend Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Azacitidine; Medicine; Myeloid leukemia; Hypomethylating agent; Oncology; Internal medicine; Chemotherapy; Leukemia; Cost effectiveness; DNA methylation","score_opus":0.02851383953554438,"score_gpt":0.33395888648280764,"score_spread":0.30544504694726327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810120321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800774,0.010358097,0.0010328746,0.0019631963,0.00012224997,0.00028539545,0.001952735,0.000024245519,0.0041838605],"genre_scores_gemma":[0.99770075,0.000894258,0.00034346708,0.00015173764,0.000032048974,0.000047611768,0.0005816687,0.0000022295476,0.00024633392],"study_design_codex":"simulation_or_modeling","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99849844,0.0009589702,0.00007323584,0.00011400229,0.00011601133,0.00023934961],"domain_scores_gemma":[0.9979705,0.0014171789,0.00023328868,0.000050443363,0.00008221976,0.00024635662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015614533,0.0006955698,0.0019643332,0.00090748956,0.00029857893,0.0015257471,0.00079139724,0.0011986198,0.004567152],"category_scores_gemma":[0.006263637,0.00040924977,0.0046683787,0.001069241,0.00042969707,0.0008848314,0.00059834274,0.0013430453,0.00014633106],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23219009,0.006128809,0.2141361,0.0044622663,0.032734588,0.0015852525,0.00025018718,0.35259467,0.0029218383,0.010846989,0.0059559704,0.13619335],"study_design_scores_gemma":[0.04320089,0.058285344,0.36528552,0.0016900675,0.0536258,0.0022327814,0.0018998153,0.4531439,0.0021527226,0.010169299,0.008026665,0.00028719023],"about_ca_topic_score_codex":0.019906998,"about_ca_topic_score_gemma":0.013785293,"teacher_disagreement_score":0.019906998,"about_ca_system_score_codex":0.0046077524,"about_ca_system_score_gemma":0.0021734217,"threshold_uncertainty_score":0.039582253},"labels":[],"label_agreement":null},{"id":"W2810121650","doi":"10.1016/j.jval.2018.04.1439","title":"First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Delphi method; Medicine; Voting; Delphi; Set (abstract data type); Outcome (game theory); Stakeholder; Medical physics; Family medicine; Psychology; Computer science; Artificial intelligence; Mathematics","score_opus":0.7198303027161496,"score_gpt":0.5305209853273261,"score_spread":0.1893093173888235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810121650","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20154212,0.0030475536,0.6458351,0.029925687,0.00036829922,0.004121366,0.00045098568,0.00066112017,0.114047736],"genre_scores_gemma":[0.2427324,0.0008355635,0.74419767,0.0027672148,0.000028091545,0.0015187225,0.00023568231,0.000304706,0.0073799505],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9503058,0.038148377,0.0023059726,0.0012262337,0.0059864963,0.0020271686],"domain_scores_gemma":[0.93865114,0.045204658,0.0012269422,0.0039711883,0.008973894,0.0019721265],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06999257,0.0008292991,0.0013353938,0.002574146,0.0072931885,0.006874129,0.0018069898,0.0028015145,0.0040008193],"category_scores_gemma":[0.07225801,0.0009076811,0.0010629128,0.0030667898,0.00454343,0.0063328124,0.00873632,0.005585082,0.0012341553],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050420564,0.00071413396,0.01670952,0.0029426955,0.00010221319,0.001936587,0.12737826,0.0020891286,0.007940775,0.31574523,0.023382964,0.5005542],"study_design_scores_gemma":[0.000152235,0.0012170888,0.027101336,0.0055210115,0.0002105131,0.0041363165,0.11842878,0.009869684,0.021827321,0.5491286,0.26195183,0.00045529017],"about_ca_topic_score_codex":0.008624496,"about_ca_topic_score_gemma":0.017086376,"teacher_disagreement_score":0.93000746,"about_ca_system_score_codex":0.0060256035,"about_ca_system_score_gemma":0.015384868,"threshold_uncertainty_score":0.37016052},"labels":[],"label_agreement":null},{"id":"W2810155319","doi":"10.1016/j.jval.2018.04.940","title":"Study of Prevalence of Tobacco Use Among Children and Youth in India","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health and Nutrition","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Environmental health; Population; Tobacco use; Tobacco product; Quarter (Canadian coin); Cross-sectional study; Demography; Geography","score_opus":0.05420497193470426,"score_gpt":0.33210564974297846,"score_spread":0.2779006778082742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810155319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990914,0.000064133594,0.00002504576,0.000031479503,0.0000031605855,0.000009717008,0.00028542543,0.0000031608297,0.0004863768],"genre_scores_gemma":[0.9991447,0.00011392842,0.000057363017,0.0000378854,0.0000035613584,0.000012316903,0.00023132932,0.0000019478082,0.00039693544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995585,0.0000628718,0.00005730223,0.000058641086,0.00010726896,0.00015536572],"domain_scores_gemma":[0.99913687,0.0001230466,0.00024374733,0.000048530565,0.00014679818,0.0003011115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035647856,0.00023116854,0.00032692318,0.0013542759,0.0010994253,0.0009493302,0.00054510933,0.00050169503,0.0011657443],"category_scores_gemma":[0.0006531367,0.00049564976,0.00060012814,0.0013466182,0.0005368763,0.0003403914,0.0006281763,0.0010532767,0.00036007684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014785421,0.00007053931,0.9976113,0.000011817265,0.0000131701045,0.00010619838,0.0011912778,0.000007873377,0.00020271033,0.000025609068,0.00006328853,0.0006814584],"study_design_scores_gemma":[8.5033264e-7,0.00006240949,0.9964264,0.000005650945,0.000011577363,0.00019697842,0.0030493725,0.000023576142,0.00006107848,0.0000049426008,0.00015418901,0.00000297989],"about_ca_topic_score_codex":0.049397867,"about_ca_topic_score_gemma":0.07466664,"teacher_disagreement_score":0.049397867,"about_ca_system_score_codex":0.00076520693,"about_ca_system_score_gemma":0.0011817602,"threshold_uncertainty_score":0.09822065},"labels":[],"label_agreement":null},{"id":"W2810191405","doi":"10.1016/j.jval.2018.04.520","title":"Real-World Comparison of Healthcare Costs Among Patients with Type 2 Diabetes Treated with Dulaglutide Vs. Liraglutide in the United States","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Liraglutide; Dulaglutide; Medicine; Exenatide; Type 2 diabetes; Propensity score matching; Pharmacy; Health care; Internal medicine; Demography; Diabetes mellitus; Emergency medicine; Family medicine; Endocrinology; Economics","score_opus":0.028896201102718882,"score_gpt":0.3041923772416751,"score_spread":0.2752961761389562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810191405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993964,0.0014686506,0.00009030849,0.00056889263,0.000032572007,0.000011710521,0.003206025,0.0000064095702,0.00065129006],"genre_scores_gemma":[0.9976635,0.0002675391,0.000075631884,0.0001095955,0.000014716082,0.0000099821855,0.0017914416,0.0000021670664,0.00006538295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904734,0.00044405335,0.00013210785,0.00014251689,0.000107377935,0.00012657123],"domain_scores_gemma":[0.9976375,0.00097080274,0.00091001735,0.00006970299,0.00018463809,0.00022727036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007571991,0.00022580633,0.00057893095,0.0005790347,0.00020862871,0.0010584197,0.00037378637,0.00055874855,0.0013645724],"category_scores_gemma":[0.004455176,0.00018514982,0.0011223145,0.0013606967,0.00025225861,0.0007526998,0.0004266483,0.0008329081,0.000093739014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013782626,0.00062621094,0.9470982,0.00037242382,0.0031933284,0.0003842841,0.00014433039,0.013976013,0.00032851275,0.0009747171,0.0059103738,0.013208974],"study_design_scores_gemma":[0.0009886121,0.0014607752,0.9708801,0.00015580154,0.0012004967,0.00053302385,0.0011107047,0.021013469,0.00025106597,0.0006436726,0.0016989212,0.00006324098],"about_ca_topic_score_codex":0.026969558,"about_ca_topic_score_gemma":0.022947367,"teacher_disagreement_score":0.026969558,"about_ca_system_score_codex":0.001635219,"about_ca_system_score_gemma":0.0005911906,"threshold_uncertainty_score":0.053625166},"labels":[],"label_agreement":null},{"id":"W2810215276","doi":"10.1016/j.jval.2018.04.115","title":"Long-Term Epidemiological Impact of Pertuzumab+Trastuzmab on Metastatic Breast Cancer Incidence in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pertuzumab; Breast cancer; Incidence (geometry); Population; Internal medicine; Trastuzumab; Epidemiology; Cancer registry; Oncology; Cancer; Demography; Environmental health","score_opus":0.15389497500984478,"score_gpt":0.4715576909005265,"score_spread":0.31766271589068173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810215276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534607,0.010136588,0.00023735128,0.0058808993,0.00013278365,0.000051864856,0.025420971,0.00005548184,0.0046234494],"genre_scores_gemma":[0.9903447,0.00312947,0.0001409452,0.00036725472,0.00004915599,0.000013747545,0.004102768,0.000012742563,0.0018392566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982279,0.00015775897,0.00017564108,0.0002299707,0.0005218481,0.0006869538],"domain_scores_gemma":[0.9928964,0.0003737882,0.0015667484,0.00021776189,0.0029970433,0.0019483246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081944425,0.0003450051,0.0007358659,0.001872684,0.0017628873,0.0018077975,0.0016841375,0.0010957286,0.0036993886],"category_scores_gemma":[0.00464479,0.00048423893,0.0015396065,0.006615346,0.00078864757,0.0005974532,0.0011273093,0.0019082525,0.00029339662],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029814016,0.000046994992,0.9930073,0.00005816127,0.00028711397,0.000103165454,0.0001506037,0.00027061682,0.000111983856,0.00024842122,0.0017616468,0.0036558],"study_design_scores_gemma":[0.000019217345,0.000037604856,0.9972154,0.000051027913,0.00017259772,0.00006031228,0.00043287216,0.0003540388,0.000067525296,0.000041164014,0.0015287899,0.000019432044],"about_ca_topic_score_codex":0.99610364,"about_ca_topic_score_gemma":0.9955872,"teacher_disagreement_score":0.04486014,"about_ca_system_score_codex":0.04486014,"about_ca_system_score_gemma":0.06271233,"threshold_uncertainty_score":0.32548463},"labels":[],"label_agreement":null},{"id":"W2810252118","doi":"10.1016/j.jval.2018.04.1033","title":"The Comparative Efficacy, Safety, And Reactogenicity, of Herpes Zoster Vaccines: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; GlaxoSmithKline (Canada)","funders":"","keywords":"Reactogenicity; Medicine; Postherpetic neuralgia; Confidence interval; Adverse effect; Randomized controlled trial; Meta-analysis; Internal medicine; Anesthesia; Immunology; Immunization","score_opus":0.16900403461462918,"score_gpt":0.3933269815970516,"score_spread":0.22432294698242242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810252118","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24865024,0.72962093,0.012499441,0.0010995391,0.0012600791,0.0006148844,0.0037880973,0.00024320948,0.002223593],"genre_scores_gemma":[0.9687063,0.02546785,0.003027904,0.0006180695,0.00028527546,0.00035102098,0.000954078,0.00007739301,0.00051221903],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96430635,0.027248701,0.00282324,0.003621135,0.0013519055,0.000648704],"domain_scores_gemma":[0.94270355,0.04800022,0.0037124853,0.003961447,0.0010430353,0.00057937566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03314946,0.0031969415,0.011703953,0.0024648472,0.0006751659,0.0030963684,0.0024132149,0.0028350614,0.0036363131],"category_scores_gemma":[0.06524389,0.0019378795,0.041029617,0.0025890565,0.0012628242,0.0024705776,0.0023694513,0.0036229745,0.00035577355],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014748923,0.00002457631,0.010837513,0.0072796373,0.9634458,0.000047442332,0.00003167347,0.0009932804,0.00017192891,0.00012418913,0.00017534784,0.0021197777],"study_design_scores_gemma":[0.0031314872,0.00041586772,0.005637491,0.00044039352,0.98852694,0.000058201782,0.000026813332,0.0007793702,0.00010311088,0.00048182093,0.000379172,0.000019247387],"about_ca_topic_score_codex":0.0049559977,"about_ca_topic_score_gemma":0.0051707495,"teacher_disagreement_score":0.03314946,"about_ca_system_score_codex":0.0015362749,"about_ca_system_score_gemma":0.00087967626,"threshold_uncertainty_score":0.17531323},"labels":[],"label_agreement":null},{"id":"W2810253561","doi":"10.1016/j.jval.2018.04.1410","title":"Resource Use Related to Pediatric Lower Limb Spasticity in Canada: Physician Questionnaire","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Spasticity; Medicine; Physical therapy; Cerebral palsy; Population; Orthopedic surgery; Lower limb; Ankle; Outpatient clinic; Surgery; Internal medicine","score_opus":0.02473211436890637,"score_gpt":0.26514577416735985,"score_spread":0.24041365979845347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810253561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96213126,0.0010011243,0.00012767626,0.0020240853,0.000039126822,0.0002001541,0.020074612,0.000026562895,0.014375401],"genre_scores_gemma":[0.9878715,0.0011997459,0.00043231482,0.0008296452,0.000023766592,0.000107722975,0.005975428,0.000015239862,0.0035445082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879164,0.00010336737,0.00017029482,0.00008432207,0.000547356,0.0003030459],"domain_scores_gemma":[0.9938903,0.00063544966,0.0019039515,0.000054294163,0.001949175,0.0015668389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006123871,0.00019691503,0.0004035425,0.0017771401,0.0013014984,0.0010030221,0.0008629642,0.00052200933,0.0056080683],"category_scores_gemma":[0.00602722,0.00024930836,0.0006752708,0.0051396457,0.0004394052,0.0005005567,0.0006823806,0.0009385076,0.0004536847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024636634,0.000077128345,0.9916142,0.000044385673,0.00003944985,0.00008961041,0.0005799867,0.00016218289,0.00003879226,0.00008463866,0.0039086593,0.003336417],"study_design_scores_gemma":[0.0000049645605,0.000016018723,0.99740237,0.000039798175,0.00001023521,0.00004988706,0.0008073963,0.0001853411,0.000016860144,0.000011222679,0.0014485803,0.000007235631],"about_ca_topic_score_codex":0.9809544,"about_ca_topic_score_gemma":0.9902857,"teacher_disagreement_score":0.019045591,"about_ca_system_score_codex":0.018966587,"about_ca_system_score_gemma":0.02494393,"threshold_uncertainty_score":0.13761288},"labels":[],"label_agreement":null},{"id":"W2810254284","doi":"10.1016/j.jval.2018.04.1510","title":"1. Indirect Treatment Comparison of Pembrolizumab Versus Standard-of-Care for Relapsed and Refractory Classical Hodgkin’s Lymphoma Using Time-Varying Hazard Ratios","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Pembrolizumab; Medicine; Hazard ratio; Internal medicine; Population; Oncology; Brentuximab vedotin; Proportional hazards model; Refractory (planetary science); Confidence interval; Lymphoma; Cancer; Hodgkin lymphoma","score_opus":0.08550170059292984,"score_gpt":0.37566668849101037,"score_spread":0.29016498789808054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810254284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92436016,0.03215193,0.011143499,0.0021233847,0.0025837882,0.002105323,0.014595215,0.00037061173,0.010566152],"genre_scores_gemma":[0.9872831,0.0017781748,0.0038930876,0.0005909825,0.00028946268,0.00054925604,0.0026162202,0.00006240115,0.0029373846],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9837737,0.012866857,0.0007837729,0.0012132566,0.00080350053,0.0005589657],"domain_scores_gemma":[0.96265197,0.033006925,0.0020946742,0.0011869407,0.00049223576,0.00056729873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015973236,0.002526781,0.0052445256,0.0013751894,0.0002938134,0.0015951678,0.0021175938,0.0028145434,0.017712323],"category_scores_gemma":[0.038359817,0.0009567336,0.01292246,0.0008441709,0.0012995148,0.0026070608,0.0017280821,0.003883565,0.00077826437],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85601115,0.000991635,0.014980654,0.0061608106,0.06144959,0.00012359458,0.00014082715,0.008569801,0.0018237089,0.0024283177,0.003583296,0.043736663],"study_design_scores_gemma":[0.27867106,0.1613364,0.19212203,0.0029876614,0.26366684,0.0009500202,0.00075741205,0.07248917,0.006763621,0.0087117385,0.011074473,0.00046952645],"about_ca_topic_score_codex":0.004352095,"about_ca_topic_score_gemma":0.0034095256,"teacher_disagreement_score":0.017712323,"about_ca_system_score_codex":0.0014712197,"about_ca_system_score_gemma":0.0011118212,"threshold_uncertainty_score":0.08447558},"labels":[],"label_agreement":null},{"id":"W2810356983","doi":"10.1016/j.jval.2018.04.286","title":"Clinical Characteristics, Treatment Patterns, And Health Care Resource Utilization In Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: A Medical Record Review Study In The United States And Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Carboplatin; Lung cancer; Medical record; Internal medicine; Etoposide; Stage (stratigraphy); Cisplatin; Cancer; Retrospective cohort study; Oncology; Chemotherapy","score_opus":0.05425463639825754,"score_gpt":0.41486277107407804,"score_spread":0.3606081346758205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810356983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9504723,0.014240626,0.00008845832,0.0010917084,0.000030290505,0.00009689707,0.030881748,0.000012302715,0.0030856563],"genre_scores_gemma":[0.98806304,0.005384548,0.0001449628,0.00031766592,0.000016787257,0.000035331406,0.005626002,0.0000068711306,0.00040470975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974974,0.00017397075,0.0006110574,0.00036850828,0.00095994305,0.00038903026],"domain_scores_gemma":[0.9881881,0.001330925,0.0045175306,0.00023632914,0.004704783,0.0010224102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010387612,0.0002163051,0.00066229264,0.004433079,0.0016291947,0.002148159,0.0012711836,0.00059468334,0.001291051],"category_scores_gemma":[0.008168223,0.00032644262,0.00096569565,0.019742351,0.0007517744,0.00079993455,0.0007968036,0.0006225428,0.000129994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003888022,0.000013811361,0.9961467,0.00016513074,0.00012642973,0.00006646463,0.00041247328,0.000032056963,0.000048151942,0.000048040663,0.0009864476,0.0019153922],"study_design_scores_gemma":[0.0000060870652,0.000009619327,0.997743,0.00011108769,0.00009102364,0.00008827187,0.0010436494,0.000081018574,0.000038485825,0.000012498629,0.0007650343,0.000010138354],"about_ca_topic_score_codex":0.96955544,"about_ca_topic_score_gemma":0.98224133,"teacher_disagreement_score":0.030444562,"about_ca_system_score_codex":0.019714631,"about_ca_system_score_gemma":0.035055306,"threshold_uncertainty_score":0.14304036},"labels":[],"label_agreement":null},{"id":"W2810391398","doi":"10.1016/j.jval.2018.04.833","title":"The Economic Burden of Overactive Bladder (OAB) in Brazil: A Retrospective Observational Study Using Data from the Sistema Unico De Saude (SUS)","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Overactive bladder; Population; Observational study; Healthcare system; Health care; Government (linguistics); Public health; Outpatient visits; Medical prescription; Family medicine; Emergency medicine; Demography; Environmental health; Internal medicine; Alternative medicine; Nursing","score_opus":0.19977847580645897,"score_gpt":0.4170202940239363,"score_spread":0.21724181821747734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810391398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99780816,0.00063682906,0.000079961705,0.000079353515,0.000004674587,0.000020621372,0.0010142603,0.0000018891146,0.00035432863],"genre_scores_gemma":[0.9988564,0.00038241025,0.0000916602,0.000038456197,0.0000053099693,0.00001644584,0.0005538213,0.0000021399842,0.000053176645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989924,0.00030769687,0.00020337269,0.00016348812,0.00016941213,0.0001636062],"domain_scores_gemma":[0.9967248,0.0005344369,0.001891111,0.00025691788,0.00028415333,0.00030870273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011012182,0.00037224055,0.0006542257,0.0017127222,0.00054874696,0.0011047054,0.0004595724,0.00074192963,0.0006701991],"category_scores_gemma":[0.004333028,0.00064531644,0.0011538491,0.0026232507,0.0005417361,0.00069680915,0.0011138195,0.00066527416,0.000117520816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020944412,0.00002178269,0.9992223,0.00001847802,0.00008401112,0.000052292642,0.0001352649,0.00001646698,0.000044878114,0.000028696883,0.000035418318,0.00031946122],"study_design_scores_gemma":[0.000005069974,0.00005371965,0.998464,0.00003332397,0.00007946718,0.00026670046,0.00069741113,0.00014036821,0.00001942882,0.000025416852,0.00020867246,0.000006589729],"about_ca_topic_score_codex":0.048415862,"about_ca_topic_score_gemma":0.051283926,"teacher_disagreement_score":0.048415862,"about_ca_system_score_codex":0.0012366169,"about_ca_system_score_gemma":0.0012727513,"threshold_uncertainty_score":0.09626812},"labels":[],"label_agreement":null},{"id":"W2810401299","doi":"10.1016/j.jval.2018.04.048","title":"Graphical Probabilistic Models for Risk Prediction and Decision Making Using Real-World Data: A Developing Tool for the Era of Precision Medicine","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bayesian Modeling and Causal Inference","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Graphical model; Bayesian network; Probabilistic logic; Computer science; Machine learning; Artificial intelligence; Data mining; Representation (politics)","score_opus":0.1946416373609757,"score_gpt":0.3984558518297552,"score_spread":0.20381421446877948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810401299","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010524897,0.0011563771,0.9947931,0.0019113215,0.00005167468,0.000024523208,0.00019699098,0.00031385783,0.0004996433],"genre_scores_gemma":[0.16527836,0.006040945,0.82322115,0.001521563,0.00074117485,0.0005658992,0.0009105767,0.00027150352,0.001448757],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9863797,0.009544353,0.00067794457,0.0012092437,0.0020126717,0.00017601582],"domain_scores_gemma":[0.860967,0.12688825,0.004287227,0.0047680195,0.0022219836,0.0008676727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021443054,0.0023348215,0.0040040133,0.0057130344,0.0009985341,0.007066143,0.004799702,0.004075474,0.0045561763],"category_scores_gemma":[0.11741902,0.001938252,0.003297565,0.005009783,0.0044114552,0.008722093,0.0033349635,0.009219766,0.0011026384],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001050204,0.0001303118,0.002516679,0.0005064238,0.0006224001,0.00014727222,0.0002973938,0.3579818,0.0002780738,0.54926807,0.0061850157,0.0819616],"study_design_scores_gemma":[0.000028861827,0.000015797174,0.0001961197,0.00009291033,0.00005797575,0.00005235046,0.000022814387,0.3248404,0.00009937584,0.67213565,0.002419104,0.00003862073],"about_ca_topic_score_codex":0.010567806,"about_ca_topic_score_gemma":0.00977298,"teacher_disagreement_score":0.021443054,"about_ca_system_score_codex":0.0038410053,"about_ca_system_score_gemma":0.0040293443,"threshold_uncertainty_score":0.11340308},"labels":[],"label_agreement":null},{"id":"W2810481689","doi":"10.1016/j.jval.2018.04.180","title":"Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Incremental cost-effectiveness ratio; Cost effectiveness; Quality-adjusted life year; Economic evaluation; Demography","score_opus":0.039087229412345915,"score_gpt":0.35913062030158643,"score_spread":0.3200433908892405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810481689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616885,0.018932851,0.00072190695,0.0032835552,0.00012364158,0.0009160017,0.008451062,0.00005851594,0.005823936],"genre_scores_gemma":[0.9937909,0.0027759857,0.0007794601,0.00034586815,0.000024756737,0.000087343644,0.0016726446,0.000007552855,0.0005154742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961014,0.0012269693,0.00030804894,0.00030993987,0.0010179308,0.001035856],"domain_scores_gemma":[0.9958406,0.00096844113,0.00071646506,0.0000896108,0.001020368,0.00136455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00257174,0.00074841443,0.0016678007,0.0015914714,0.00081342395,0.0022453237,0.0015501878,0.00085985544,0.003061146],"category_scores_gemma":[0.0088287005,0.00049463834,0.0044286386,0.003417094,0.0009212295,0.0007410125,0.0011018793,0.0015238676,0.000098176795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17088382,0.0055697868,0.40062082,0.0089010885,0.022919947,0.0009622301,0.0006283998,0.124850415,0.00245713,0.012527426,0.020258037,0.22942092],"study_design_scores_gemma":[0.030709922,0.019832287,0.78906757,0.0026607735,0.025727363,0.0007238987,0.0022242696,0.11004811,0.0013293981,0.0023004534,0.014966148,0.0004098409],"about_ca_topic_score_codex":0.96453965,"about_ca_topic_score_gemma":0.968513,"teacher_disagreement_score":0.11946292,"about_ca_system_score_codex":0.11946292,"about_ca_system_score_gemma":0.074629866,"threshold_uncertainty_score":0.86676824},"labels":[],"label_agreement":null},{"id":"W2810515776","doi":"10.1016/j.jval.2018.04.626","title":"Policies and Processes Applicable to Drugs for Very Rare Diseases in Australia, Canada, England, France and Germany","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Reimbursement; CLARITY; Government (linguistics); Medicine; Population; Grey literature; Health technology; Public economics; Business; Economic growth; Political science; Environmental health; MEDLINE; Health care; Economics","score_opus":0.19976115118742885,"score_gpt":0.39614496461826704,"score_spread":0.1963838134308382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810515776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65219504,0.009953998,0.00927955,0.12708968,0.0005474939,0.0007299654,0.0057356055,0.0002542218,0.19421436],"genre_scores_gemma":[0.9675903,0.0018678367,0.0029752003,0.0061136903,0.00017231089,0.00017834593,0.00056495925,0.00002521612,0.020512126],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9925956,0.002213646,0.00044256455,0.00042881,0.0018261404,0.0024932995],"domain_scores_gemma":[0.98318684,0.008785746,0.0018276041,0.0004511854,0.002919601,0.0028290593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007312723,0.00017258374,0.00041458913,0.0020172007,0.0022842567,0.0056283916,0.00096033374,0.002892861,0.0046907994],"category_scores_gemma":[0.02376244,0.0003871455,0.00080488354,0.0020770768,0.0022818008,0.0018335022,0.0016426774,0.0021264905,0.00018950626],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036265852,0.00021061691,0.05425607,0.00022634737,0.00017540182,0.0006998073,0.002300926,0.023783868,0.001050071,0.842604,0.03143625,0.042893954],"study_design_scores_gemma":[0.00043473364,0.0003679094,0.5380089,0.0010965227,0.00035606144,0.00083454605,0.004359372,0.041729674,0.0029278747,0.12224242,0.28728944,0.00035262443],"about_ca_topic_score_codex":0.673834,"about_ca_topic_score_gemma":0.6127378,"teacher_disagreement_score":0.32616597,"about_ca_system_score_codex":0.033869125,"about_ca_system_score_gemma":0.052662246,"threshold_uncertainty_score":0.65617365},"labels":[],"label_agreement":null},{"id":"W2810674445","doi":"10.1016/j.jval.2018.04.015","title":"United States Valuation of EQ-5D-5L Health States: An Initial Model Using a Standardized Protocol","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Time-trade-off; Respondent; Population; Logistic regression; Heteroscedasticity; EQ-5D; Medicine; Valuation (finance); Tobit model; Demography; Statistics; Mathematics; Environmental health; Economics; Quality of life (healthcare); Finance","score_opus":0.6670629596829336,"score_gpt":0.5101795922979174,"score_spread":0.15688336738501618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810674445","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19555165,0.0011691082,0.59756905,0.0052553806,0.00032128373,0.02137341,0.097496025,0.001168761,0.08009534],"genre_scores_gemma":[0.6731853,0.0014359414,0.20721437,0.00075244764,0.00012477381,0.038777214,0.039700735,0.00022975872,0.03857949],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9953146,0.0032819468,0.00021656975,0.00042834645,0.00051228754,0.00024618933],"domain_scores_gemma":[0.9876143,0.008652417,0.0006974736,0.00089000457,0.0020148393,0.00013096644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011851657,0.0010203054,0.0013225293,0.0015294543,0.0005566526,0.002707434,0.0029690359,0.0023305502,0.013042218],"category_scores_gemma":[0.026190378,0.0010583572,0.0024168508,0.0026985519,0.0008249875,0.0026604421,0.0012711267,0.0028199165,0.0025684347],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010501534,0.0006981041,0.011660028,0.00044477996,0.0004273709,0.0003255961,0.00029751987,0.67906904,0.00048934756,0.23588444,0.029913133,0.03974042],"study_design_scores_gemma":[0.00072401686,0.0005535776,0.009230462,0.00025273793,0.00044085845,0.0001720662,0.00021586959,0.8609069,0.0010927976,0.09714191,0.029095339,0.00017339588],"about_ca_topic_score_codex":0.020450506,"about_ca_topic_score_gemma":0.009717993,"teacher_disagreement_score":0.020450506,"about_ca_system_score_codex":0.0035781972,"about_ca_system_score_gemma":0.004286089,"threshold_uncertainty_score":0.06267828},"labels":[],"label_agreement":null},{"id":"W2810748550","doi":"10.1016/j.jval.2018.04.573","title":"Cost-Effectiveness Analysis of Sofosbuvir/Velpatasvir in Genotype 1 Hepatitis C Infected Patients in Mexico","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sofosbuvir; Medicine; Hepatocellular carcinoma; Internal medicine; Hepatitis C virus; Hepatitis C; Cirrhosis; Cost effectiveness; Clinical trial; Ribavirin; Virology; Virus","score_opus":0.0928255286419245,"score_gpt":0.4034928285793031,"score_spread":0.31066729993737857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810748550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950964,0.0028689671,0.00020379879,0.0005684373,0.000016693792,0.00006784905,0.00054238696,0.000006627919,0.0006288239],"genre_scores_gemma":[0.99848926,0.0006651089,0.00026679802,0.00006137595,0.000012479049,0.00003895014,0.0003382861,0.0000016713221,0.00012601049],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989667,0.00066689256,0.000060582406,0.00007362223,0.00006994245,0.00016232],"domain_scores_gemma":[0.99876803,0.0006165266,0.00035903952,0.000032222284,0.000065661276,0.00015844792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015482125,0.00046924793,0.00095932913,0.0007879227,0.00025302728,0.0010131192,0.0005693126,0.00060327887,0.0022917665],"category_scores_gemma":[0.0037732976,0.00030341337,0.002399463,0.00080621184,0.00028356444,0.00043954115,0.0005888683,0.00068007427,0.000052458872],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11377599,0.0037160576,0.6626972,0.0024882967,0.018059967,0.0012569828,0.0003891471,0.096674204,0.0022157747,0.0031084123,0.0032443667,0.092373595],"study_design_scores_gemma":[0.017430343,0.018267034,0.84139746,0.0010545262,0.021162195,0.00086008344,0.0019373576,0.091389306,0.00095213734,0.0012208587,0.0042055645,0.00012316021],"about_ca_topic_score_codex":0.044699978,"about_ca_topic_score_gemma":0.037172504,"teacher_disagreement_score":0.044699978,"about_ca_system_score_codex":0.0061734985,"about_ca_system_score_gemma":0.002160514,"threshold_uncertainty_score":0.088879585},"labels":[],"label_agreement":null},{"id":"W2810762849","doi":"10.1016/j.jval.2018.04.241","title":"Evidence Driven Cancer Drug Approvals In Phase II Versus Phase III Clinical Trials Within A Single-Payer Public Healthcare System","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clinical trial; Disadvantaged; Health care; Population; Logistic regression; Cancer; Oncology; Internal medicine; Family medicine; Intensive care medicine; Environmental health","score_opus":0.734505048864647,"score_gpt":0.6096282853595097,"score_spread":0.12487676350513721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810762849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75451136,0.025008537,0.025985252,0.123215176,0.0013989784,0.0030362306,0.004246786,0.00025083064,0.062346876],"genre_scores_gemma":[0.9863647,0.0008146694,0.0035753888,0.0075922357,0.00038388238,0.00038437362,0.00029887925,0.000028790682,0.00055704254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.7294739,0.2085101,0.016270615,0.011748597,0.024334868,0.009661986],"domain_scores_gemma":[0.4518317,0.38663173,0.099058285,0.016175188,0.024693804,0.021609226],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18885231,0.00038370307,0.0018184694,0.0023331572,0.0015180815,0.012446377,0.0017016691,0.0034629514,0.005871653],"category_scores_gemma":[0.34859008,0.0007978733,0.0020187402,0.0028883244,0.0031748354,0.0064953645,0.0050421073,0.005500161,0.00060640735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036432914,0.0033630547,0.45384473,0.0032217442,0.006814039,0.0006594489,0.003172953,0.016340246,0.002959985,0.08933485,0.029430144,0.35442582],"study_design_scores_gemma":[0.010494338,0.016362993,0.721219,0.004483684,0.004792399,0.0012361355,0.005176802,0.039882693,0.0068460763,0.10352131,0.08552914,0.00045549803],"about_ca_topic_score_codex":0.004066849,"about_ca_topic_score_gemma":0.0067939595,"teacher_disagreement_score":0.8111477,"about_ca_system_score_codex":0.010718095,"about_ca_system_score_gemma":0.02723025,"threshold_uncertainty_score":0.99875844},"labels":[],"label_agreement":null},{"id":"W2810775937","doi":"10.1016/j.jval.2018.04.317","title":"Benefit Of Abiraterone Acetate Plus Prednisone (AA+P) Added To Androgen Deprivation Therapy (ADT) In Patients With High-Risk, Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): Post Hoc Analysis Of EQ-5D-5L From The Latitude Study","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Visual analogue scale; Androgen deprivation therapy; Post-hoc analysis; Internal medicine; Oncology; Urology; Cancer; Surgery","score_opus":0.04130192865995992,"score_gpt":0.315470123305977,"score_spread":0.2741681946460171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810775937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957924,0.0026109917,0.00011580146,0.00020601558,0.00014606908,0.000058183727,0.00048626564,0.000013940582,0.00057033764],"genre_scores_gemma":[0.99835986,0.00055978127,0.00010093538,0.00010527246,0.00012209245,0.000028182218,0.00042953272,0.000004170978,0.00029019875],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99869823,0.00074822176,0.00008177015,0.00020189499,0.000078795165,0.00019102823],"domain_scores_gemma":[0.9979424,0.0011376741,0.0002953536,0.00016953792,0.000060116585,0.00039497693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017909849,0.000985687,0.0023135792,0.00031305247,0.00030926513,0.0011395154,0.0006091151,0.00062720984,0.00216182],"category_scores_gemma":[0.0035187723,0.00039525196,0.0047488064,0.00041229572,0.0006954335,0.00091459835,0.0007041415,0.0018724486,0.00022677984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95640343,0.001071125,0.02007489,0.0002447213,0.00502081,0.00007008389,0.000060620565,0.001420389,0.0011072122,0.00008163179,0.00047393818,0.013971281],"study_design_scores_gemma":[0.30249757,0.31044015,0.33292407,0.00022920483,0.03866359,0.0003619511,0.0006323086,0.0073435768,0.0021972756,0.0015625234,0.0029718676,0.0001759479],"about_ca_topic_score_codex":0.0030248654,"about_ca_topic_score_gemma":0.0056897365,"teacher_disagreement_score":0.0030248654,"about_ca_system_score_codex":0.0006466685,"about_ca_system_score_gemma":0.0011515691,"threshold_uncertainty_score":0.009471774},"labels":[],"label_agreement":null},{"id":"W2810788589","doi":"10.1016/j.jval.2018.04.370","title":"A Discrete Event Simulation Model For A Pharmacogenomics Test For Statin-Induced Myopathy In Patients Initiating A Statin In Secondary Cardiovascular Prevention","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Université Laval; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Statin; Pharmacogenomics; Dyslipidemia; Myopathy; Rhabdomyolysis; Internal medicine; Physical therapy; Cardiology; Pharmacology","score_opus":0.06368450406815251,"score_gpt":0.35470105840453175,"score_spread":0.29101655433637924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810788589","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45969954,0.00073585124,0.49799973,0.008778346,0.0004931633,0.0008179372,0.009085544,0.0011812712,0.02120878],"genre_scores_gemma":[0.97013503,0.00022163363,0.016760485,0.00036959976,0.00008470135,0.00056294334,0.0016267842,0.000048524857,0.01019034],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983944,0.0008019248,0.00006392124,0.0003279133,0.00014302919,0.00026879273],"domain_scores_gemma":[0.981764,0.015577032,0.0008081717,0.00035321934,0.0008213547,0.00067627156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038677976,0.0013395075,0.002578931,0.0015921603,0.000864766,0.0025315075,0.0028865407,0.0048133875,0.012549049],"category_scores_gemma":[0.016051952,0.0012052418,0.0017666875,0.0009875816,0.0018847308,0.0014793215,0.0020426423,0.0036046081,0.0010309132],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019328682,0.00006777491,0.002743373,0.000021412567,0.000056002114,0.00014087232,0.00004232655,0.98685503,0.00011480778,0.008522759,0.00037547792,0.0008669052],"study_design_scores_gemma":[0.00006379132,0.00003143953,0.00033696997,0.000006140115,0.000020286327,0.000017364033,0.00001467606,0.9972711,0.00003937745,0.002068017,0.0001198828,0.000010814815],"about_ca_topic_score_codex":0.052689612,"about_ca_topic_score_gemma":0.020989267,"teacher_disagreement_score":0.052689612,"about_ca_system_score_codex":0.0023536033,"about_ca_system_score_gemma":0.003271045,"threshold_uncertainty_score":0.10476583},"labels":[],"label_agreement":null},{"id":"W2810813567","doi":"10.1016/j.jval.2018.04.059","title":"Consumer Preferences for Precision Medicine Technologies: Evidence from A Discrete Choice Experiment","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Respondent; Medical Expenditure Panel Survey; Context (archaeology); Mixed logit; Willingness to pay; Health care; Actuarial science; Population; Econometrics; Life expectancy; Medicine; Statistics; Logistic regression; Environmental health; Economics; Mathematics; Geography","score_opus":0.6293071375630176,"score_gpt":0.5050231840894309,"score_spread":0.12428395347358667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810813567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089843,0.0008830832,0.0026641323,0.0011922698,0.000064993925,0.00016931855,0.00024920824,0.000011430905,0.0038673058],"genre_scores_gemma":[0.99587727,0.00047376033,0.0018997152,0.0005412595,0.000044555116,0.00012797341,0.00022449586,0.0000081941935,0.00080277945],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9885437,0.009088123,0.00041592054,0.0005976743,0.0011353,0.00021927946],"domain_scores_gemma":[0.7393388,0.2449158,0.009084555,0.004486318,0.0010845009,0.0010900015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018384093,0.00067743467,0.001033176,0.000469682,0.0005077544,0.002314886,0.00063410733,0.0034607255,0.011207669],"category_scores_gemma":[0.07987869,0.0005143522,0.0013886873,0.00062305597,0.0020355037,0.0021790534,0.000667194,0.0024474557,0.0005728681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39918137,0.062187787,0.25276142,0.004262543,0.010009968,0.0008664953,0.0057488936,0.015216354,0.01311504,0.032512736,0.006909467,0.19722797],"study_design_scores_gemma":[0.111919716,0.11244345,0.50175214,0.002026504,0.012110828,0.0021453039,0.005744332,0.077028185,0.015646646,0.13641253,0.021858834,0.0009115172],"about_ca_topic_score_codex":0.001157278,"about_ca_topic_score_gemma":0.00053577416,"teacher_disagreement_score":0.018384093,"about_ca_system_score_codex":0.00070707744,"about_ca_system_score_gemma":0.00046236833,"threshold_uncertainty_score":0.09722555},"labels":[],"label_agreement":null},{"id":"W2810822711","doi":"10.1016/j.jval.2018.04.684","title":"Cost Drivers in Public Drug Plans in Canada, 2016/17","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Stakeholder; Business; Public health; Public economics; Medicine; Operations management; Environmental health; Economics; Pharmacology; Public relations; Political science","score_opus":0.44441971562021837,"score_gpt":0.3999781983258125,"score_spread":0.044441517294405875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810822711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8084464,0.011862732,0.0004941714,0.05406303,0.00038289293,0.00034105062,0.08728591,0.000105169805,0.037018664],"genre_scores_gemma":[0.97433305,0.0039298567,0.00044113217,0.0023099943,0.000111532376,0.000044435485,0.010540508,0.00003773932,0.0082518505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638474,0.0001997965,0.00023228844,0.00016991376,0.0019973097,0.0010159197],"domain_scores_gemma":[0.98794544,0.00089422154,0.002053931,0.00013432736,0.006214262,0.0027578499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016990904,0.00027677682,0.00045299673,0.0026388727,0.0021807172,0.004741724,0.00094276416,0.00081088673,0.003328103],"category_scores_gemma":[0.014167942,0.0004093358,0.0010838675,0.0069388654,0.00068884593,0.0010796491,0.0014362993,0.0025446473,0.00019518685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005879254,0.00021857006,0.8171373,0.0003189199,0.0004191096,0.0002938762,0.0011496933,0.004296678,0.00017478151,0.014239442,0.10843145,0.0527323],"study_design_scores_gemma":[0.000054579647,0.000046403562,0.9454184,0.00025701878,0.00016067817,0.00014598778,0.0024280453,0.0033155193,0.00019232897,0.0010363637,0.046882078,0.00006265267],"about_ca_topic_score_codex":0.99465984,"about_ca_topic_score_gemma":0.99734664,"teacher_disagreement_score":0.86065346,"about_ca_system_score_codex":0.13934655,"about_ca_system_score_gemma":0.12883966,"threshold_uncertainty_score":0.998236},"labels":[],"label_agreement":null},{"id":"W2810830875","doi":"10.1016/j.jval.2018.04.094","title":"Approaches for Estimating the Comparative Efficacy of Treatments for Patients with Recurrent Small Cell Lung Cancer (SCLC) within Connected and Disconnected Networks of Evidence","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Topotecan; Medicine; Nivolumab; Internal medicine; Oncology; Ipilimumab; Randomized controlled trial; Hazard ratio; Chemotherapy; Cancer; Confidence interval; Immunotherapy","score_opus":0.2681648071868797,"score_gpt":0.4290487568621788,"score_spread":0.16088394967529912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810830875","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21510303,0.028005255,0.7273815,0.012035962,0.0003502663,0.0028298975,0.0043563773,0.00034904885,0.009588697],"genre_scores_gemma":[0.71701366,0.005787458,0.2703039,0.0008657883,0.0003608222,0.002757886,0.0017057132,0.00006383882,0.0011409605],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9064054,0.08137971,0.0033727176,0.0054515093,0.0026570156,0.000733613],"domain_scores_gemma":[0.439812,0.5407859,0.0116600655,0.004621618,0.0018776605,0.0012428209],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10260767,0.0023663412,0.0061783423,0.013328954,0.0011776743,0.00740979,0.006218212,0.004344267,0.0054078056],"category_scores_gemma":[0.3593447,0.0021285303,0.0056386217,0.011087495,0.0046556317,0.008466593,0.006920168,0.0047480334,0.00025852647],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030236007,0.0005951728,0.069886714,0.0052155573,0.019476844,0.000883666,0.0018492879,0.47960758,0.0005398428,0.21252331,0.002912924,0.20348555],"study_design_scores_gemma":[0.0006361691,0.00067050743,0.010748442,0.0011299185,0.004502223,0.00040331538,0.00068834913,0.39140058,0.00035455826,0.5858618,0.0034829306,0.00012119059],"about_ca_topic_score_codex":0.005680927,"about_ca_topic_score_gemma":0.0036224218,"teacher_disagreement_score":0.89739233,"about_ca_system_score_codex":0.0043970495,"about_ca_system_score_gemma":0.002831524,"threshold_uncertainty_score":0.5426477},"labels":[],"label_agreement":null},{"id":"W2810837006","doi":"10.1016/j.jval.2018.04.234","title":"Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Cisplatin; Internal medicine; Chemotherapy; Oncology; Cancer; Performance status; Urothelial cancer; Bladder cancer; Urology","score_opus":0.07991176340706468,"score_gpt":0.35837939078157655,"score_spread":0.27846762737451186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810837006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93779993,0.0072000287,0.000357912,0.008619004,0.00010629896,0.00014702955,0.026084593,0.0000993711,0.019585809],"genre_scores_gemma":[0.99039173,0.0020550324,0.00026708355,0.00076758774,0.000017129598,0.000021645357,0.0031412998,0.000032125015,0.0033064063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981357,0.00010966776,0.00016321929,0.00023014055,0.00054683903,0.0008143092],"domain_scores_gemma":[0.9929126,0.00033282404,0.001833366,0.000094735864,0.002639765,0.0021867428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004474579,0.00023384622,0.0005207093,0.0021100352,0.002166,0.0017272722,0.0015496992,0.0006308438,0.006664091],"category_scores_gemma":[0.0037050114,0.00033277745,0.001049687,0.005895742,0.0007610669,0.00041559,0.0011066493,0.0012663093,0.0002975633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019458421,0.000054380034,0.97374696,0.0001565211,0.00010109569,0.00030336677,0.00075881166,0.0003928985,0.00043241392,0.0011157882,0.0075580576,0.0151852155],"study_design_scores_gemma":[0.00001575499,0.000050442315,0.9886475,0.00020872854,0.000047437898,0.00040929552,0.002316949,0.0005862655,0.00023114524,0.000107742424,0.007350609,0.000028174565],"about_ca_topic_score_codex":0.99275136,"about_ca_topic_score_gemma":0.99660623,"teacher_disagreement_score":0.055008426,"about_ca_system_score_codex":0.055008426,"about_ca_system_score_gemma":0.06303037,"threshold_uncertainty_score":0.39911592},"labels":[],"label_agreement":null},{"id":"W2810839909","doi":"10.1016/j.jval.2018.04.1027","title":"Risk of Cardiovascular Disease Among Patients with Hepatitis C Virus (HCV) Infection","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Framingham Risk Score; Hepatitis C virus; Obesity; Metabolic syndrome; Hepatitis C; Confounding; Fibrinogen; Disease; Immunology; Virus","score_opus":0.02552159919997815,"score_gpt":0.2956715168264515,"score_spread":0.27014991762647333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810839909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997232,0.0006477005,0.00006503224,0.00022908731,0.000025487303,0.000004729791,0.00019236248,0.0000027722606,0.0016007705],"genre_scores_gemma":[0.99929476,0.00021183491,0.000041067007,0.00005188817,0.00003738449,0.0000023126236,0.00011634615,0.0000011624112,0.00024321297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997584,0.000078027755,0.00001976225,0.000028621707,0.000052367173,0.000062876396],"domain_scores_gemma":[0.99933547,0.00017180269,0.00021063923,0.000040231735,0.000052729916,0.00018909657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024649478,0.0002011006,0.0002481818,0.00040861708,0.0004317404,0.0006813928,0.00017639899,0.0005170829,0.0024066898],"category_scores_gemma":[0.0018155203,0.00021118649,0.0004062192,0.00061219366,0.00018028343,0.00038717812,0.00035148568,0.0010452011,0.00020052482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015516877,0.000055669032,0.9979925,0.00000611591,0.000044004035,0.000057448648,0.000038120143,0.000023173929,0.00010426483,0.000037198723,0.000104975006,0.0013814479],"study_design_scores_gemma":[0.000008319091,0.00006271646,0.9991678,0.0000067343453,0.000042477743,0.0001572403,0.00014347823,0.00016592165,0.0000263199,0.00008833894,0.00012715433,0.0000034839636],"about_ca_topic_score_codex":0.004185671,"about_ca_topic_score_gemma":0.0044850684,"teacher_disagreement_score":0.004185671,"about_ca_system_score_codex":0.00018184932,"about_ca_system_score_gemma":0.00025985052,"threshold_uncertainty_score":0.008322656},"labels":[],"label_agreement":null},{"id":"W2810851952","doi":"10.1016/j.jval.2018.04.273","title":"Positive Cancer Drug Recommendations By The Pan-Canadian Oncology Drug Review Are Not Without Conditions Placed On Cost-Effectiveness","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Cost effectiveness; MEDLINE; Oncology; Internal medicine; Health care; Risk analysis (engineering)","score_opus":0.38887776849728567,"score_gpt":0.4938660210535424,"score_spread":0.10498825255625671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810851952","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001986801,0.11622911,0.0015998115,0.7778385,0.03408322,0.00032798288,0.0045194416,0.00016290926,0.06325224],"genre_scores_gemma":[0.08523721,0.14136265,0.020967182,0.69893265,0.027210291,0.00049370754,0.0036768408,0.00025728566,0.021862192],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.94663864,0.01876453,0.0050641405,0.001830734,0.02535114,0.0023508568],"domain_scores_gemma":[0.80122894,0.0723707,0.013480373,0.0053513763,0.09902011,0.00854851],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.049448058,0.0011924936,0.002807697,0.005279095,0.0019203888,0.0071762064,0.0033513296,0.008948246,0.011525868],"category_scores_gemma":[0.19192198,0.0006561036,0.003045758,0.006405011,0.004225893,0.004563128,0.0015245867,0.008616525,0.003108571],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040511577,0.000060799164,0.0019316138,0.0040747956,0.0010067394,0.00007648312,0.000080783044,0.00053684786,0.00021381964,0.025985569,0.859882,0.105745465],"study_design_scores_gemma":[0.0007358117,0.00015093865,0.006287987,0.013173431,0.0022589029,0.00011398055,0.00023194605,0.0007398873,0.00039547382,0.018094417,0.9576449,0.00017232969],"about_ca_topic_score_codex":0.41279626,"about_ca_topic_score_gemma":0.71434236,"teacher_disagreement_score":0.97934395,"about_ca_system_score_codex":0.020656055,"about_ca_system_score_gemma":0.07874783,"threshold_uncertainty_score":0.820787},"labels":[],"label_agreement":null},{"id":"W2810861643","doi":"10.1016/j.jval.2019.08.012","title":"Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"Medical Research Council; Imperial College London; Public Health England; University of Bristol; National Institute for Health and Care Research; National Institute for Health Research Health Protection Research Unit; Wellcome Trust","keywords":"Genotype; Baseline (sea); Medicine; Chronic hepatitis; Internal medicine; Hepatitis C virus; Hepatitis a virus; Virology; Outcome (game theory); Virus; Genetics; Biology; Gene","score_opus":0.11046850236747514,"score_gpt":0.37932636186120294,"score_spread":0.2688578594937278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810861643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95630914,0.007517958,0.020216214,0.0033866563,0.0001279097,0.0013159937,0.0016655786,0.00011669303,0.009343878],"genre_scores_gemma":[0.9956958,0.00047240904,0.0027752048,0.00017562548,0.000014387196,0.00020127592,0.00021256926,0.00000678715,0.00044586294],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9946372,0.0045186398,0.00010182105,0.00020214649,0.00018100502,0.0003591177],"domain_scores_gemma":[0.98593235,0.011958251,0.0008912746,0.00014732816,0.0003448395,0.0007260105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006270425,0.0015771609,0.0021555761,0.0013766079,0.00036633678,0.0018913444,0.0014470271,0.001734161,0.0050413585],"category_scores_gemma":[0.018917166,0.00086022867,0.0033279655,0.00089217984,0.00074287946,0.0013212991,0.0011407291,0.0016411102,0.00019806557],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007909666,0.0005184343,0.0051619476,0.00046498794,0.0012069374,0.0001372033,0.000052333053,0.97149783,0.000255365,0.0016783292,0.00055497437,0.010561989],"study_design_scores_gemma":[0.0026055234,0.004084752,0.0053954683,0.00029423618,0.0019818677,0.00017193216,0.00011993736,0.9815516,0.00028534865,0.0027674208,0.00067710126,0.00006480479],"about_ca_topic_score_codex":0.017235976,"about_ca_topic_score_gemma":0.008192709,"teacher_disagreement_score":0.017235976,"about_ca_system_score_codex":0.008318496,"about_ca_system_score_gemma":0.00441712,"threshold_uncertainty_score":0.060355186},"labels":[],"label_agreement":null},{"id":"W2810896877","doi":"10.1016/j.jval.2018.04.1796","title":"The Efficacy and Safety of Mirabegron Relative to Onabotulinumtoxina in Patients with Overactive Bladder Not Appropriately Managed with An Antimuscarinic: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Mirabegron; Overactive bladder; Medicine; Population; Relative risk; Meta-analysis; Internal medicine; Confidence interval; Odds ratio; Urology; Alternative medicine","score_opus":0.08105085702441846,"score_gpt":0.34967670686357183,"score_spread":0.2686258498391534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810896877","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45216691,0.53746784,0.0040899487,0.0007587509,0.0011749903,0.00048819432,0.0015593766,0.00015850597,0.0021354414],"genre_scores_gemma":[0.9765535,0.020394992,0.0012546327,0.0005222521,0.00020036941,0.00014378777,0.00043670356,0.000037808157,0.00045600976],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9930391,0.0043437965,0.00088292937,0.0010114951,0.00046101588,0.00026184806],"domain_scores_gemma":[0.9906336,0.0065598157,0.0013932218,0.00082999474,0.00035275985,0.0002306294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009753383,0.002360358,0.008339996,0.0010888376,0.00054650486,0.002450693,0.0013591988,0.0017885239,0.0028771576],"category_scores_gemma":[0.020292828,0.0014489548,0.026533943,0.0015879945,0.0010206131,0.0016067941,0.0013550067,0.0032987124,0.0002986655],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.069776915,0.00008892703,0.011471858,0.011636773,0.8993411,0.00008059242,0.000068515015,0.0008696207,0.00053020724,0.00011611096,0.00023973711,0.005779566],"study_design_scores_gemma":[0.012961981,0.0016973596,0.007696994,0.00056588824,0.9753353,0.000070056594,0.000039668706,0.0005563637,0.00018627853,0.00029358736,0.0005674831,0.000029056833],"about_ca_topic_score_codex":0.0037776774,"about_ca_topic_score_gemma":0.0067307726,"teacher_disagreement_score":0.009753383,"about_ca_system_score_codex":0.0014447304,"about_ca_system_score_gemma":0.00072559394,"threshold_uncertainty_score":0.051581383},"labels":[],"label_agreement":null},{"id":"W2810900685","doi":"10.1016/j.jval.2018.04.1437","title":"Assessment of Anticholinergic Burden scales and Measures for Estimating Anticholinergic Exposure in Retrospective u.s. Database Analyses","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver Coastal Health","funders":"","keywords":"Anticholinergic; Medicine; Scale (ratio); Internal medicine","score_opus":0.256364972110458,"score_gpt":0.5112095692867041,"score_spread":0.25484459717624613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810900685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98408854,0.0011421364,0.005252292,0.00028338327,0.000030430441,0.00016651729,0.0076802946,0.000028675551,0.0013278783],"genre_scores_gemma":[0.9903978,0.00036361362,0.004158293,0.00008791205,0.000024961917,0.00018716494,0.0046429876,0.000009518417,0.00012785883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98231333,0.010772458,0.0031870897,0.001063488,0.0023259067,0.0003376956],"domain_scores_gemma":[0.95075387,0.02229218,0.016709466,0.00554188,0.004141112,0.0005615974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019558897,0.0005059145,0.0005699152,0.00250856,0.00040094674,0.0017784991,0.00072844565,0.0005050171,0.0005454568],"category_scores_gemma":[0.057916474,0.0004588578,0.0013881398,0.0036780494,0.00031364814,0.0010985975,0.0012372419,0.0007736544,0.00012330424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019529452,0.000032316242,0.994826,0.00003462249,0.0004910893,0.000008540883,0.000093436254,0.00016322901,0.00007947677,0.00015260257,0.00028437522,0.003638958],"study_design_scores_gemma":[0.000029980367,0.00015019176,0.99459475,0.000050075974,0.00039271568,0.00008991379,0.00033157514,0.003233566,0.00027141077,0.00018117897,0.00066261325,0.000011913931],"about_ca_topic_score_codex":0.009252482,"about_ca_topic_score_gemma":0.01234851,"teacher_disagreement_score":0.019558897,"about_ca_system_score_codex":0.00058158726,"about_ca_system_score_gemma":0.0010534644,"threshold_uncertainty_score":0.103438556},"labels":[],"label_agreement":null},{"id":"W2810932342","doi":"10.1016/j.jval.2018.04.530","title":"Assessing the Benefits of Co-Pay Card Usage Among Diabetic Patients in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Dapagliflozin; Medicine; Cohort; Glycemic; Diabetes mellitus; Emergency medicine; Environmental health; Internal medicine; Type 2 diabetes","score_opus":0.07325382569998956,"score_gpt":0.34670810640418975,"score_spread":0.2734542807042002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810932342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374384,0.001025445,0.0000585646,0.0014139491,0.000020668213,0.000040707113,0.0009690966,0.000004376051,0.0027233744],"genre_scores_gemma":[0.998429,0.0005137325,0.00017120823,0.00024109831,0.0000091011925,0.000007785042,0.00022852824,0.0000022525337,0.00039725192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795973,0.00031208686,0.00019054065,0.00015199691,0.0007538046,0.00063187315],"domain_scores_gemma":[0.99317616,0.001032709,0.0012944819,0.00011959966,0.0021988,0.002178181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329108,0.00018959281,0.0005363004,0.0010776083,0.0027606217,0.002139627,0.0009745627,0.0006711112,0.0014883463],"category_scores_gemma":[0.008064577,0.0002953187,0.0007468392,0.0044777673,0.00068405597,0.00043787612,0.0007979106,0.0016561268,0.000088005756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015329137,0.00018064567,0.9882401,0.000040339954,0.00006637571,0.00007269222,0.00044512763,0.00013287751,0.00004003828,0.00012347498,0.0007996316,0.009705463],"study_design_scores_gemma":[0.00003208623,0.00006973787,0.99601537,0.00006971207,0.000081687875,0.00005947149,0.0018390925,0.0007792694,0.00004579841,0.000058313257,0.000934415,0.00001500934],"about_ca_topic_score_codex":0.9898599,"about_ca_topic_score_gemma":0.9949092,"teacher_disagreement_score":0.039987147,"about_ca_system_score_codex":0.039987147,"about_ca_system_score_gemma":0.04677803,"threshold_uncertainty_score":0.2901284},"labels":[],"label_agreement":null},{"id":"W2810938347","doi":"10.1016/j.jval.2018.04.1190","title":"Demographic Variation of Hepatitis C Virus (HCV) Prevalence in the US: Results from the National Health and Nutrition Examination Survey 2009 – 2016","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"National Health and Nutrition Examination Survey; Medicine; Demography; Marital status; Hepatitis C virus; Logistic regression; Cross-sectional study; Hepatitis C; Odds ratio; Multivariate analysis; Sexual orientation; Odds; Internal medicine; Environmental health; Population; Immunology; Virus; Pathology","score_opus":0.09297881753801358,"score_gpt":0.3665450905113663,"score_spread":0.27356627297335273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810938347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913897,0.00036906512,0.00014028446,0.00015357752,0.000018580638,0.00000871226,0.007156623,0.000010269526,0.00075321604],"genre_scores_gemma":[0.99530005,0.00018330928,0.000084386265,0.00006657561,0.000009898337,0.000010085193,0.0041158185,0.0000041481785,0.00022575722],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993224,0.00015954251,0.00012305209,0.00015246405,0.00014039942,0.000102143626],"domain_scores_gemma":[0.9984475,0.00018887989,0.0007545201,0.00011646322,0.000311125,0.00018155186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083400914,0.00019276988,0.00021560297,0.00094363454,0.0002256703,0.00043101108,0.00044695014,0.00040777112,0.00089946017],"category_scores_gemma":[0.0023871616,0.00025839242,0.0006112089,0.0020152635,0.00024133862,0.0007046329,0.00064607826,0.0005218392,0.00021117259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047641694,0.000014776594,0.9984144,0.0000078004605,0.000059293194,0.0000108964705,0.00006504306,0.000053734657,0.00006452699,0.000019283067,0.00043160564,0.0008110141],"study_design_scores_gemma":[7.850671e-7,0.0000066942825,0.9996648,0.0000031155362,0.0000073352758,0.000020641426,0.000080129976,0.0000629113,0.000014340271,0.0000047445405,0.00013325727,0.0000013943377],"about_ca_topic_score_codex":0.05783451,"about_ca_topic_score_gemma":0.07127225,"teacher_disagreement_score":0.05783451,"about_ca_system_score_codex":0.00058945117,"about_ca_system_score_gemma":0.00043361788,"threshold_uncertainty_score":0.11499572},"labels":[],"label_agreement":null},{"id":"W2810942974","doi":"10.1016/j.jval.2018.04.110","title":"A Systematic Review and Network Meta-Analysis of Panitumumab with Chemotherapy in the First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer (MCRC) with Left-Sided Tumors","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Panitumumab; Medicine; Bevacizumab; Internal medicine; Cetuximab; Oncology; Hazard ratio; Colorectal cancer; Meta-analysis; Chemotherapy; Subgroup analysis; Progression-free survival; Randomized controlled trial; Cancer; Confidence interval","score_opus":0.10571835447578684,"score_gpt":0.3709600085857512,"score_spread":0.26524165410996436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810942974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038755562,0.99491864,0.00023067558,0.00015034586,0.00013270481,0.00011727019,0.00034669117,0.00000962235,0.00021840175],"genre_scores_gemma":[0.16037081,0.8358253,0.001278824,0.0009875905,0.00020988488,0.00034074698,0.00061733444,0.000017548107,0.000351893],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9945148,0.0025102478,0.0015853237,0.00059493224,0.0005772303,0.00021748562],"domain_scores_gemma":[0.99115527,0.006443219,0.0014771161,0.0002185099,0.0005609337,0.00014497727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058352817,0.0020272667,0.01311484,0.003600028,0.0005144878,0.002262102,0.0014986878,0.0016519009,0.0037882046],"category_scores_gemma":[0.022285542,0.0009682162,0.024663886,0.005148594,0.00055067067,0.0013511993,0.0013393391,0.0019549457,0.00028042798],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026831424,0.00003642995,0.003384683,0.37541908,0.6014883,0.00013509668,0.00008786482,0.0004366792,0.00021932987,0.00016271652,0.0007662505,0.0151804],"study_design_scores_gemma":[0.0007413114,0.00017573316,0.0031571737,0.021223944,0.9723094,0.00008665003,0.000039803603,0.00010946697,0.00006331246,0.00017044635,0.0019013258,0.000021427695],"about_ca_topic_score_codex":0.011495843,"about_ca_topic_score_gemma":0.030703781,"teacher_disagreement_score":0.01311484,"about_ca_system_score_codex":0.0025379998,"about_ca_system_score_gemma":0.003253688,"threshold_uncertainty_score":0.030860305},"labels":[],"label_agreement":null},{"id":"W2810976272","doi":"10.1016/j.jval.2018.04.1680","title":"Real World Incidence and Prevalence of Systematic Lupus Erythematosus in Alberta, Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Population; Demography; Confidence interval; Odds ratio; Pediatrics; Internal medicine; Environmental health","score_opus":0.03722122577952359,"score_gpt":0.32218528800459756,"score_spread":0.284964062225074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810976272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708354,0.0037690625,0.00022713192,0.0016406814,0.000046080575,0.00004656954,0.018944014,0.00004634523,0.0044448352],"genre_scores_gemma":[0.99395293,0.0012978624,0.00022441235,0.00015575321,0.000015715012,0.000010381888,0.0030531227,0.0000069166663,0.0012828942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850297,0.00015645844,0.00013807687,0.00016291616,0.00060886354,0.0004307222],"domain_scores_gemma":[0.9960974,0.0003146928,0.000761088,0.00011813637,0.0018220259,0.00088676164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007167879,0.0003195845,0.00046669185,0.002175903,0.0016467551,0.0016931768,0.001533095,0.00066162867,0.0023987566],"category_scores_gemma":[0.0036641697,0.00043832816,0.0006405975,0.006026006,0.0008524757,0.0004343056,0.00087716104,0.00083663507,0.00024495574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009496092,0.000031159878,0.9914062,0.000067160305,0.0000995028,0.00015584457,0.00037235333,0.00047709473,0.00007815199,0.00023068913,0.0028437122,0.0041430756],"study_design_scores_gemma":[0.000012601842,0.000014510802,0.9971414,0.000049818682,0.00003964433,0.00010332668,0.0010479441,0.0006453762,0.000028978997,0.000048196533,0.0008544425,0.000013809748],"about_ca_topic_score_codex":0.9982191,"about_ca_topic_score_gemma":0.99861753,"teacher_disagreement_score":0.039705183,"about_ca_system_score_codex":0.039705183,"about_ca_system_score_gemma":0.04153706,"threshold_uncertainty_score":0.28808266},"labels":[],"label_agreement":null},{"id":"W2810977826","doi":"10.1016/j.jval.2018.04.469","title":"Characteristics & Glycemic Response of Patients With Uncontrolled Type 2 Diabetes Initiating Dulaglutide Alone or In Combination with Insulin In US Real World Practice","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Dulaglutide; Type 2 diabetes; Internal medicine; Glycemic; Medical prescription; Diabetes mellitus; Retrospective cohort study; Glucagon-like peptide 1 receptor; Insulin; Exenatide; Agonist; Endocrinology; Pharmacology","score_opus":0.024793714633708025,"score_gpt":0.29655450761118235,"score_spread":0.27176079297747435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810977826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679935,0.00048960315,0.000058551486,0.00018877503,0.000011197051,0.000009414648,0.0010087863,0.0000061232263,0.0014282418],"genre_scores_gemma":[0.99895227,0.00014695158,0.00005148539,0.00014962548,0.000015135867,0.000008968166,0.0004898713,0.0000032186192,0.00018240417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994814,0.0001114955,0.00010007191,0.00011110468,0.00009411193,0.00010181206],"domain_scores_gemma":[0.99742967,0.0007174308,0.0011741859,0.0000642413,0.000102016784,0.00051244476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043070505,0.00015996104,0.00037318503,0.0006279519,0.00031740408,0.0007253561,0.00023801236,0.00057187246,0.0032654142],"category_scores_gemma":[0.0038897162,0.00016509599,0.0006725143,0.0014647488,0.0002111243,0.00066688086,0.00031811022,0.0008586916,0.00029319865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036277605,0.00008262715,0.9973928,0.000014527213,0.00007267765,0.0000958563,0.000058918038,0.000082530445,0.00011591626,0.000025199617,0.00022409938,0.0014719856],"study_design_scores_gemma":[0.000031369487,0.00028301144,0.99814,0.0000128906695,0.000051914634,0.00044922568,0.00033624872,0.00029837564,0.00004265765,0.000040349576,0.00030550564,0.000008447718],"about_ca_topic_score_codex":0.0054979315,"about_ca_topic_score_gemma":0.0060759066,"teacher_disagreement_score":0.0054979315,"about_ca_system_score_codex":0.00045875568,"about_ca_system_score_gemma":0.0004184922,"threshold_uncertainty_score":0.0109318495},"labels":[],"label_agreement":null},{"id":"W2810985327","doi":"10.1016/j.jval.2018.04.1692","title":"Evaluation of Subcutaneous Rituximab Administration Impacts on Canadian Systemic Therapy Suites","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Roche (Canada); Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Rituximab; Medicine; Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Population; Oncology; Internal medicine","score_opus":0.08634858034312419,"score_gpt":0.3644915796989373,"score_spread":0.2781429993558131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810985327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7837157,0.003223013,0.0013480766,0.053585976,0.00044697055,0.00064470404,0.006336592,0.00025464263,0.15044431],"genre_scores_gemma":[0.9856755,0.0012606228,0.0025291024,0.0039455127,0.00008125965,0.00010487737,0.0009395487,0.00007299143,0.005390535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98346776,0.004078563,0.00078329013,0.0008099422,0.0074789235,0.00338166],"domain_scores_gemma":[0.943928,0.0116056735,0.0067890803,0.0008007295,0.027918605,0.008957976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005785963,0.0002775426,0.00031826613,0.0015970455,0.003524274,0.0039141485,0.0020979194,0.0007637478,0.012043108],"category_scores_gemma":[0.05226081,0.00025729698,0.0006822652,0.0022507482,0.0010683959,0.0011167427,0.0019837946,0.0016069907,0.00069985486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018598227,0.00067982555,0.6899222,0.00052130304,0.0002184976,0.00047458115,0.0043059704,0.0018757829,0.0010402577,0.0060408833,0.069534056,0.22352684],"study_design_scores_gemma":[0.0002078865,0.00093538756,0.87921005,0.0013062034,0.00029318934,0.0005462922,0.01491534,0.0039115106,0.0018954249,0.0012515216,0.09539202,0.00013529987],"about_ca_topic_score_codex":0.9153292,"about_ca_topic_score_gemma":0.9511582,"teacher_disagreement_score":0.90439695,"about_ca_system_score_codex":0.095603034,"about_ca_system_score_gemma":0.1548881,"threshold_uncertainty_score":0.6936518},"labels":[],"label_agreement":null},{"id":"W2811002132","doi":"10.1016/j.jval.2018.04.271","title":"Cancer Drug Recommendations Without Statistically Significant Overall Survival By The Pan-Canadian Oncology Drug Review","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Confounding; Internal medicine; Clinical Oncology; Oncology; Cancer; Drug; Cancer drugs; Health care; Pharmacology","score_opus":0.38546653095419053,"score_gpt":0.4691142313822293,"score_spread":0.08364770042803876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811002132","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012315203,0.6994053,0.0014016681,0.14480768,0.0067264927,0.0005150089,0.03242348,0.00017765096,0.10222747],"genre_scores_gemma":[0.34894636,0.5182428,0.007961335,0.07259839,0.004222767,0.00038144094,0.024441283,0.00024054725,0.022965092],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98461413,0.004267288,0.0018501743,0.0008645148,0.0073599517,0.0010438581],"domain_scores_gemma":[0.9264074,0.020795668,0.0056278626,0.0018471599,0.042582966,0.0027389901],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014969338,0.0007399854,0.001663571,0.004614636,0.0009701761,0.0032353958,0.0021539296,0.0019466293,0.0093274405],"category_scores_gemma":[0.09108433,0.00039241588,0.002194856,0.0077066263,0.0011152262,0.0016077461,0.00081419665,0.0026814267,0.0012856427],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010458711,0.000043873493,0.01344335,0.012409005,0.0030993682,0.000126688,0.00012204516,0.0019582035,0.0001713698,0.013651553,0.69475746,0.25917122],"study_design_scores_gemma":[0.0009310352,0.00016422819,0.056393757,0.023574933,0.007128361,0.00025918233,0.00031443528,0.0018400783,0.000504883,0.0073266937,0.9014056,0.0001569327],"about_ca_topic_score_codex":0.77165794,"about_ca_topic_score_gemma":0.90652764,"teacher_disagreement_score":0.98503065,"about_ca_system_score_codex":0.027558098,"about_ca_system_score_gemma":0.081815794,"threshold_uncertainty_score":0.4593736},"labels":[],"label_agreement":null},{"id":"W2811010124","doi":"10.1016/j.jval.2018.04.571","title":"Cost-Effectiveness Analysis of Hepatitis C Treatments in Mexico: Genotype 2 and 3","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sofosbuvir; Medicine; Ribavirin; Daclatasvir; Hepatocellular carcinoma; Internal medicine; Hepatitis C; Cirrhosis; Cost effectiveness; Cost-effectiveness analysis; Gastroenterology; Hepatitis C virus; Virology; Virus","score_opus":0.13113047439261022,"score_gpt":0.4354932396254479,"score_spread":0.3043627652328377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811010124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98201364,0.00787501,0.0011040595,0.0012173355,0.00006293882,0.00028756596,0.004834686,0.000021899981,0.0025827803],"genre_scores_gemma":[0.99607927,0.0012052287,0.00072116865,0.000103068574,0.000022560807,0.00011430541,0.0013660437,0.0000042913425,0.00038405822],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982987,0.0011870627,0.000080252874,0.00009986032,0.000121091936,0.00021309],"domain_scores_gemma":[0.9965963,0.0022939325,0.0006409199,0.00009780101,0.00017700426,0.00019403957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026168805,0.0007296921,0.0013449499,0.0012305335,0.00024522797,0.0010806415,0.00069226755,0.0008216673,0.004099573],"category_scores_gemma":[0.007838518,0.00038554007,0.0041281576,0.0013866667,0.00035249523,0.00063644384,0.00072962325,0.0010320285,0.00008446786],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15772103,0.004154963,0.4396488,0.00547296,0.04612623,0.0009044347,0.00039297287,0.21992572,0.0022294023,0.010367066,0.007560738,0.10549571],"study_design_scores_gemma":[0.027212096,0.017262938,0.724802,0.0016918647,0.061141916,0.0009864683,0.0017883274,0.15004818,0.0015897645,0.004502224,0.008775386,0.00019890191],"about_ca_topic_score_codex":0.057647925,"about_ca_topic_score_gemma":0.0403052,"teacher_disagreement_score":0.057647925,"about_ca_system_score_codex":0.0053480477,"about_ca_system_score_gemma":0.002585246,"threshold_uncertainty_score":0.11462474},"labels":[],"label_agreement":null},{"id":"W2811028687","doi":"10.1016/j.jval.2018.04.816","title":"The Out-Of-Pocket Cost Burden of Prescription Drugs: A Pan-Canadian Comparison","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Cost sharing; Medical prescription; Reimbursement; Prescription costs; Jurisdiction; Prescription drug; Business; Residence; Public health; Medicine; Public economics; Family medicine; Environmental health; Health care; Economic growth; Demographic economics; Economics; Political science; Pharmacology; Nursing","score_opus":0.42228210617666756,"score_gpt":0.4391225608255413,"score_spread":0.016840454648873737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811028687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8655008,0.05281011,0.00073169736,0.004344115,0.00029745116,0.00041405988,0.03671535,0.000041743137,0.039144676],"genre_scores_gemma":[0.9815849,0.007863293,0.00071645755,0.0003782477,0.00004005912,0.00007023926,0.007248269,0.000022184353,0.002076434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99486613,0.0008404832,0.0004684183,0.0004200767,0.0023980865,0.0010068198],"domain_scores_gemma":[0.99280655,0.0011658303,0.0008189969,0.00019931758,0.0038617377,0.0011475887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003737756,0.001330756,0.0019756097,0.0052848044,0.0029097064,0.0026568803,0.0028295387,0.0015065573,0.006769511],"category_scores_gemma":[0.011200211,0.000504414,0.0044392347,0.011626094,0.0010010293,0.0016803434,0.002398801,0.0020370705,0.0002284753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036232892,0.0015009705,0.6869415,0.0097054485,0.023172785,0.0012138083,0.003697281,0.015609877,0.0012251445,0.025772922,0.044534937,0.15039255],"study_design_scores_gemma":[0.0013469714,0.00077194045,0.96721387,0.00093314965,0.0057850997,0.00049134577,0.0036699844,0.0041615595,0.00021806476,0.0012014685,0.013959,0.00024757718],"about_ca_topic_score_codex":0.9900765,"about_ca_topic_score_gemma":0.99432486,"teacher_disagreement_score":0.06540507,"about_ca_system_score_codex":0.06540507,"about_ca_system_score_gemma":0.042235274,"threshold_uncertainty_score":0.47454923},"labels":[],"label_agreement":null},{"id":"W2811118039","doi":"10.1016/j.jval.2018.04.062","title":"Long-Term Health Benefit of Ibalizumab In The Treatment of Adults with Multidrug-Resistant HIV-1 Infection","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Medicine; Cohort; Population; Human immunodeficiency virus (HIV); Internal medicine; Antiretroviral therapy; Viral load; Pediatrics; Immunology; Environmental health","score_opus":0.028074962668648597,"score_gpt":0.30990236135482774,"score_spread":0.2818273986861791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811118039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93025374,0.062711254,0.00010951745,0.0029312905,0.00020983448,0.000037214133,0.0004296281,0.000015940828,0.0033015567],"genre_scores_gemma":[0.9912437,0.0070568635,0.00010313339,0.00070775516,0.00022021712,0.00001512036,0.0002937212,0.0000013007414,0.00035815706],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9998,0.000070433045,0.000019971563,0.000018146791,0.000026295524,0.00006500668],"domain_scores_gemma":[0.99962294,0.00009166442,0.00011384716,0.000012221351,0.000025350993,0.00013391428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048640234,0.00020154557,0.0007426656,0.00018551314,0.00027376576,0.00039799258,0.00014707372,0.00055581785,0.0013400434],"category_scores_gemma":[0.0012395208,0.00009127083,0.00062526745,0.00020933468,0.00017909115,0.0003654459,0.0001997636,0.0010033739,0.00012761867],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24875,0.005174989,0.19031762,0.0017589985,0.0040242206,0.0016796539,0.00031035958,0.0011971077,0.009216088,0.0008643388,0.0062023182,0.5305044],"study_design_scores_gemma":[0.016107896,0.03861242,0.9184667,0.0011216179,0.007413025,0.0014604748,0.00048104953,0.0015688135,0.0015192953,0.0010172757,0.012175116,0.000056274883],"about_ca_topic_score_codex":0.0018376898,"about_ca_topic_score_gemma":0.0047712177,"teacher_disagreement_score":0.0018376898,"about_ca_system_score_codex":0.0004081458,"about_ca_system_score_gemma":0.0003775481,"threshold_uncertainty_score":0.0044828653},"labels":[],"label_agreement":null},{"id":"W2811199668","doi":"10.1016/j.jval.2018.04.344","title":"Contemporary Natural History Of Heart Failure In Nova Scotia, Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of British Columbia; Vancouver Coastal Health; Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Nova scotia; Incidence (geometry); Epidemiology; Population; Natural history; Cohort; Demography; Cohort study; Retrospective cohort study; Heart failure; Pediatrics; Gerontology; Internal medicine; Environmental health; Geography","score_opus":0.043329415506171046,"score_gpt":0.29331401961323705,"score_spread":0.24998460410706602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811199668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595845,0.012257187,0.00014332768,0.010554285,0.00014426788,0.000050376028,0.008650994,0.000015161211,0.008599907],"genre_scores_gemma":[0.99272823,0.0040428666,0.00010022665,0.000489776,0.00003992273,0.000020741623,0.0011787763,0.0000064234823,0.0013929891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867886,0.00015722573,0.0000983884,0.0001415337,0.00028498858,0.00063896447],"domain_scores_gemma":[0.9933509,0.0005521013,0.0011111057,0.0001448836,0.0018549229,0.0029861634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008505864,0.00018702244,0.0004219687,0.0028485619,0.0041112434,0.002212601,0.0013661114,0.0007779018,0.0034493706],"category_scores_gemma":[0.0042561186,0.00028189938,0.0004920151,0.006722973,0.0016834418,0.0005709327,0.0017008609,0.0016924049,0.00019088067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011895236,0.000075695425,0.97865295,0.000114753435,0.00007214729,0.00053464714,0.0036835687,0.00018716992,0.00011609061,0.001784408,0.0054783723,0.009181238],"study_design_scores_gemma":[0.000009004002,0.000019044828,0.9904164,0.00019209499,0.000019774934,0.00015821449,0.0062232576,0.00013924787,0.00001915386,0.00015110745,0.0026332543,0.000019392564],"about_ca_topic_score_codex":0.9969302,"about_ca_topic_score_gemma":0.9982515,"teacher_disagreement_score":0.060255647,"about_ca_system_score_codex":0.060255647,"about_ca_system_score_gemma":0.076971404,"threshold_uncertainty_score":0.43718737},"labels":[],"label_agreement":null},{"id":"W2811312889","doi":"10.1016/j.jval.2018.04.020","title":"Economic Guidance Panel Changes to Minimize Post-Progression Treatment Effects by the Pan-Canadian Oncology Drug Review in Economic Evaluations Assessing Cancer Drugs","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Time horizon; Hazard ratio; Life expectancy; Clinical trial; Economic evaluation; Oncology; Cancer; Internal medicine; Intensive care medicine; Actuarial science; Confidence interval; Health care; Environmental health; Economics; Finance","score_opus":0.33241591969907847,"score_gpt":0.5035252615666249,"score_spread":0.17110934186754645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811312889","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005489723,0.06255295,0.019770449,0.64837855,0.04102747,0.0056972755,0.02134661,0.000995668,0.19474128],"genre_scores_gemma":[0.08831811,0.037807576,0.13868599,0.5997637,0.01650737,0.0077322866,0.01192197,0.0010336055,0.09822947],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.90351576,0.04116125,0.008937587,0.0021957473,0.03841637,0.005773383],"domain_scores_gemma":[0.77548957,0.06519545,0.008685915,0.005620778,0.13668153,0.008326788],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12950058,0.0026687598,0.0031161562,0.0069218297,0.0026942806,0.00957796,0.0073183253,0.018395485,0.011280594],"category_scores_gemma":[0.2462054,0.0016347357,0.0060352236,0.007212027,0.0031311065,0.004151062,0.0030345616,0.0182265,0.002615348],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038380767,0.00007453142,0.00081293855,0.0011686282,0.000321928,0.000067864734,0.00022067141,0.0021207135,0.0002547197,0.029562348,0.9258583,0.039153505],"study_design_scores_gemma":[0.0010561857,0.0001227403,0.012561992,0.007953655,0.0010258296,0.00009847751,0.00014845148,0.0029293702,0.0006503212,0.0118352575,0.9613523,0.00026549835],"about_ca_topic_score_codex":0.6096294,"about_ca_topic_score_gemma":0.75391215,"teacher_disagreement_score":0.9696152,"about_ca_system_score_codex":0.030384785,"about_ca_system_score_gemma":0.11623868,"threshold_uncertainty_score":0.7853391},"labels":[],"label_agreement":null},{"id":"W2811318987","doi":"10.1016/j.jval.2018.05.008","title":"Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"EuroQol Research Foundation; Chongqing University of Arts and Sciences","keywords":"Medicine; Schema crosswalk; Quality-adjusted life year; Statistics; EQ-5D; Econometrics; Mathematics; Cost effectiveness; Internal medicine; Disease; Geography; Health related quality of life","score_opus":0.7114669972652248,"score_gpt":0.4543631785699398,"score_spread":0.257103818695285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811318987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6836165,0.020280506,0.24494405,0.025420066,0.0004347629,0.00048356006,0.008642817,0.00032169063,0.015855988],"genre_scores_gemma":[0.98105055,0.0013050387,0.015236554,0.00089353556,0.00007903933,0.00009564325,0.0010494849,0.00006622677,0.00022390985],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96341187,0.031266604,0.0009217348,0.0012054229,0.0027373906,0.000456996],"domain_scores_gemma":[0.891914,0.094313495,0.0055264756,0.003281343,0.004618838,0.00034589373],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.037045818,0.0007335603,0.0016833624,0.0017598413,0.0002843978,0.0044816528,0.0016416447,0.0009773653,0.0020611295],"category_scores_gemma":[0.17919384,0.00061032875,0.0021798904,0.0036334533,0.001312002,0.0048421365,0.0013871917,0.00270502,0.00039688568],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012219619,0.00045774455,0.31573322,0.0025912614,0.008279011,0.00033300326,0.000915064,0.40323696,0.00079384865,0.050263114,0.009212662,0.20696218],"study_design_scores_gemma":[0.00042719053,0.0013795793,0.16752072,0.00428965,0.001630856,0.0005925656,0.0016056807,0.7002158,0.0025383774,0.10827081,0.011109356,0.00041945884],"about_ca_topic_score_codex":0.013503243,"about_ca_topic_score_gemma":0.009628172,"teacher_disagreement_score":0.96295416,"about_ca_system_score_codex":0.0041118446,"about_ca_system_score_gemma":0.0019625148,"threshold_uncertainty_score":0.1959194},"labels":[],"label_agreement":null},{"id":"W2811322614","doi":"10.1016/j.jval.2018.04.748","title":"What US Healthcare Providers Value in Genomic Precision Medicine: A Discrete Choice Experiment","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Life expectancy; Genetic testing; Willingness to pay; Health care; Test (biology); Mixed logit; Family medicine; Medicine; Preference; Expectancy theory; Actuarial science; Logistic regression; Statistics; Psychology; Environmental health; Business; Social psychology; Mathematics","score_opus":0.03418635957216529,"score_gpt":0.35688717178857926,"score_spread":0.322700812216414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811322614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95476073,0.0012126998,0.010488894,0.014468228,0.00050947594,0.002070465,0.0012521703,0.000072101204,0.015165184],"genre_scores_gemma":[0.99023587,0.0002104008,0.0036771514,0.002029267,0.00022349232,0.0010673978,0.0001791171,0.000014582454,0.002362733],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9734282,0.020922916,0.000849152,0.0016001463,0.0012941726,0.0019053933],"domain_scores_gemma":[0.69291884,0.2827701,0.010147618,0.0053998954,0.0018432213,0.006920311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030230226,0.0014123787,0.0020592932,0.00093093683,0.0017197005,0.0076028644,0.0018108159,0.008471282,0.020267596],"category_scores_gemma":[0.11145412,0.0012210627,0.001811591,0.00077729864,0.005875195,0.005125251,0.0026574477,0.0072676754,0.0015195791],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3199754,0.120822385,0.1371984,0.003549883,0.0058511295,0.0013225091,0.011335735,0.08681282,0.009809634,0.18447183,0.018113893,0.10073648],"study_design_scores_gemma":[0.121212676,0.084525816,0.08225968,0.0012936769,0.005777432,0.00092210434,0.011531214,0.29105175,0.00783505,0.3694584,0.022673115,0.0014591814],"about_ca_topic_score_codex":0.0022352415,"about_ca_topic_score_gemma":0.0012548078,"teacher_disagreement_score":0.030230226,"about_ca_system_score_codex":0.0029766879,"about_ca_system_score_gemma":0.0029925401,"threshold_uncertainty_score":0.15987462},"labels":[],"label_agreement":null},{"id":"W2811367147","doi":"10.1016/j.jval.2018.04.1624","title":"Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Ixekizumab; Medicine; Secukinumab; Ustekinumab; Etanercept; Psoriasis Area and Severity Index; Adalimumab; Infliximab; Internal medicine; Randomized controlled trial; Psoriasis; Dermatology; Psoriatic arthritis; Disease; Tumor necrosis factor alpha","score_opus":0.10257215354349344,"score_gpt":0.31986341823037634,"score_spread":0.2172912646868829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811367147","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21468222,0.77232856,0.006689302,0.0009197541,0.0011424941,0.00037708814,0.0020049599,0.00024199394,0.0016136122],"genre_scores_gemma":[0.9566699,0.038460314,0.0023312813,0.0006669151,0.00031196154,0.00021094328,0.0007240341,0.00007342951,0.00055116735],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98706484,0.008486071,0.001213425,0.001981251,0.0007875958,0.00046691688],"domain_scores_gemma":[0.9837997,0.011860987,0.0017550739,0.0014189137,0.0007289913,0.0004363307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015077265,0.003253226,0.01369463,0.001961582,0.00072511384,0.0028910143,0.0021019222,0.002223901,0.0028198562],"category_scores_gemma":[0.02137578,0.0017295312,0.037657145,0.0023892121,0.0008840502,0.0016800353,0.0018263768,0.0033879925,0.00031419404],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020419147,0.000035657795,0.008786271,0.007943598,0.95814794,0.000060445407,0.000029780304,0.0007957503,0.0003060595,0.000072637915,0.00019879789,0.003203971],"study_design_scores_gemma":[0.002986543,0.00041082184,0.006008101,0.0003825685,0.98895407,0.000048849546,0.000019183322,0.00051567634,0.00008802349,0.00019605915,0.00037214326,0.000018007267],"about_ca_topic_score_codex":0.0048423684,"about_ca_topic_score_gemma":0.007577194,"teacher_disagreement_score":0.015077265,"about_ca_system_score_codex":0.0014172487,"about_ca_system_score_gemma":0.0008479628,"threshold_uncertainty_score":0.07973713},"labels":[],"label_agreement":null},{"id":"W2811394421","doi":"10.1016/j.jval.2018.04.1643","title":"The Cost of Drugs for Age-Related Macular Degeneration in Canada and Internationally","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aflibercept; Macular degeneration; Ranibizumab; Reimbursement; Drug prices; Generic drug; Drug; Business; Medicine; International economics; Economics; Ophthalmology; Monetary economics; Pharmacology; Internal medicine; Economic growth; Bevacizumab; Health care","score_opus":0.06700896132124044,"score_gpt":0.3012974722135881,"score_spread":0.23428851089234765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811394421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70516455,0.066344574,0.0010473041,0.11208497,0.0008750236,0.00015875296,0.026264017,0.000094718,0.08796606],"genre_scores_gemma":[0.97049576,0.014187871,0.00073347695,0.0016255123,0.00016043673,0.000019563038,0.0022347383,0.000023811112,0.010518825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970139,0.00024453306,0.00014932903,0.00013449133,0.0015492329,0.00090849155],"domain_scores_gemma":[0.9913043,0.0008988111,0.0010693502,0.00009339424,0.0046059494,0.0020282767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001277565,0.00036716403,0.0006151027,0.003676842,0.0021160375,0.0042243865,0.00140631,0.0013678728,0.0033707253],"category_scores_gemma":[0.0106563615,0.00033997252,0.0010361786,0.007213454,0.0015746325,0.000995874,0.0011692935,0.0022422567,0.00014094112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013018693,0.00030559377,0.5342095,0.0010447578,0.0009719699,0.0021543212,0.0017127573,0.02818703,0.0006784939,0.13208443,0.11090942,0.18643999],"study_design_scores_gemma":[0.00021539876,0.00015187054,0.84262943,0.0011146987,0.0006706143,0.001365883,0.004700916,0.01547653,0.00061795994,0.008105149,0.12476482,0.00018671223],"about_ca_topic_score_codex":0.99596906,"about_ca_topic_score_gemma":0.9968514,"teacher_disagreement_score":0.17267743,"about_ca_system_score_codex":0.17267743,"about_ca_system_score_gemma":0.13057387,"threshold_uncertainty_score":0.9595769},"labels":[],"label_agreement":null},{"id":"W2811422218","doi":"10.1016/j.jval.2018.04.1127","title":"Cost Effectiveness of Ultra-Violet Germicidal Irradiation in Canadian Health Region","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Effects and Dosimetry","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Emergency medicine","score_opus":0.04774474030455195,"score_gpt":0.29883493373651565,"score_spread":0.2510901934319637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811422218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711546,0.0057610925,0.0004526332,0.0036502893,0.00005042022,0.00007074002,0.0031361524,0.000033169476,0.015690854],"genre_scores_gemma":[0.995884,0.0012609824,0.00031181812,0.00016281103,0.000008116195,0.000012032308,0.00038808724,0.0000069370467,0.0019652746],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861765,0.0003522422,0.00004227755,0.00007248259,0.0004570101,0.000458382],"domain_scores_gemma":[0.99797326,0.00047667604,0.0002565855,0.000043346477,0.0008527283,0.0003973217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010016885,0.00021333236,0.00034616367,0.00075276074,0.00090027676,0.0012418524,0.0009948072,0.00047529538,0.0033823617],"category_scores_gemma":[0.0042549507,0.00015451359,0.0010421461,0.0019027512,0.00042710223,0.00026470106,0.0005937537,0.00048555556,0.00009055595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073784026,0.00061236345,0.5846232,0.00111893,0.0014675806,0.00086636725,0.0012525023,0.109515026,0.0053744204,0.015827106,0.019783657,0.25218037],"study_design_scores_gemma":[0.0002274196,0.0010320062,0.9580639,0.00022787595,0.00096486224,0.0004632085,0.0030719088,0.018467188,0.0018682771,0.00093074027,0.014599416,0.00008326057],"about_ca_topic_score_codex":0.9810463,"about_ca_topic_score_gemma":0.98791677,"teacher_disagreement_score":0.074290365,"about_ca_system_score_codex":0.074290365,"about_ca_system_score_gemma":0.047788613,"threshold_uncertainty_score":0.53901684},"labels":[],"label_agreement":null},{"id":"W2811436997","doi":"10.1016/j.jval.2018.04.1634","title":"Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Medicine; Ixekizumab; Ustekinumab; Adalimumab; Infliximab; Formulary; Secukinumab; Etanercept; Psoriasis Area and Severity Index; Discontinuation; Psoriasis; Internal medicine; Pharmacology; Psoriatic arthritis; Dermatology","score_opus":0.34018676712369283,"score_gpt":0.4183694531234424,"score_spread":0.07818268599974959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811436997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95491356,0.015300602,0.0010480167,0.003982855,0.00010001366,0.0005115982,0.01686702,0.00005680224,0.00721955],"genre_scores_gemma":[0.9925211,0.002334957,0.00054168416,0.0002077755,0.000020366322,0.000045416225,0.0030041218,0.000012356757,0.0013121313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762577,0.0005304479,0.00014701967,0.0001791554,0.0006906216,0.00082699955],"domain_scores_gemma":[0.9959941,0.0012009506,0.00043765217,0.00010017992,0.001450622,0.0008164404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019951826,0.00061949494,0.0015441579,0.001984468,0.00096242526,0.0024681392,0.0017553128,0.00068717205,0.0030563446],"category_scores_gemma":[0.007665004,0.0005029622,0.0032405176,0.0036737812,0.00066157954,0.00049978774,0.0008421571,0.0014909728,0.000120109326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034991194,0.002570386,0.5031027,0.0050873314,0.013479726,0.0017912812,0.000729522,0.26003537,0.0018933833,0.015474261,0.027492333,0.13335249],"study_design_scores_gemma":[0.005917341,0.002454715,0.74198765,0.0014534664,0.011321952,0.0006059542,0.0022666738,0.21375433,0.0011676303,0.0028565547,0.01593574,0.00027807342],"about_ca_topic_score_codex":0.9868088,"about_ca_topic_score_gemma":0.98852766,"teacher_disagreement_score":0.07951365,"about_ca_system_score_codex":0.07951365,"about_ca_system_score_gemma":0.071197174,"threshold_uncertainty_score":0.57691455},"labels":[],"label_agreement":null},{"id":"W2811450988","doi":"10.1016/j.jval.2018.04.1003","title":"Drug Use Among Seniors in Canada, 2016","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Polypharmacy; Medicine; Beers Criteria; Drug class; Drug; Quarter (Canadian coin); Neighbourhood (mathematics); Public health; Gerontology; Environmental health; Family medicine; Psychiatry; Geography; Pharmacology; Nursing","score_opus":0.13779944569602773,"score_gpt":0.3939402055017065,"score_spread":0.25614075980567874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811450988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93414074,0.004170516,0.00015891796,0.0035483749,0.00016584991,0.00011000559,0.049027048,0.000046818226,0.008631836],"genre_scores_gemma":[0.98379195,0.0021414107,0.00024028757,0.00088084274,0.000051103223,0.000033317145,0.0085578365,0.000011842459,0.00429144],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882907,0.00003816949,0.00012492602,0.0001289965,0.00047704886,0.0004019185],"domain_scores_gemma":[0.99641633,0.000068862064,0.0006191005,0.000043908945,0.0015596473,0.0012922202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053543923,0.00034261897,0.0005399231,0.0019985666,0.0027916753,0.0019063734,0.0011516344,0.00093614054,0.002035864],"category_scores_gemma":[0.0026174856,0.00037921534,0.0008929792,0.0071201776,0.0005877886,0.000878684,0.001172637,0.0016491455,0.00033568693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093950235,0.00007106101,0.9852101,0.00008096499,0.00006508239,0.00007610673,0.0005290654,0.00007092641,0.00005185585,0.00011292568,0.006870106,0.006767698],"study_design_scores_gemma":[0.000009110834,0.000020193578,0.99553776,0.00008381204,0.000030622792,0.00006193677,0.0018227423,0.00011920798,0.000031773503,0.000026832937,0.0022450057,0.000010902192],"about_ca_topic_score_codex":0.9943118,"about_ca_topic_score_gemma":0.99808514,"teacher_disagreement_score":0.033424117,"about_ca_system_score_codex":0.033424117,"about_ca_system_score_gemma":0.056434806,"threshold_uncertainty_score":0.24251008},"labels":[],"label_agreement":null},{"id":"W2811459770","doi":"10.1016/j.jval.2018.04.1145","title":"The Cost-Effectiveness of a Public Health Nurse Program to Screen for Amblyopia in Ontario","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Ophthalmology and Visual Impairment Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; University of Toronto","funders":"","keywords":"Medicine; Public health; Public health nurse; Health care; Christian ministry; Cost–benefit analysis; Family medicine; Cost effectiveness; Cohort; Pediatrics; Environmental health; Nursing","score_opus":0.2236896677052986,"score_gpt":0.4786570780213815,"score_spread":0.25496741031608294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811459770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191064,0.0022646075,0.000056302757,0.0017527556,0.000039842784,0.00015468833,0.0008707191,0.0000056887143,0.002944751],"genre_scores_gemma":[0.99828714,0.0007515234,0.00009984811,0.0001638911,0.000015938991,0.00003754703,0.00024632976,0.0000014343792,0.00039624167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968381,0.001063535,0.00022839682,0.00014828285,0.0008218315,0.0008998593],"domain_scores_gemma":[0.995024,0.0013091298,0.0011758707,0.00013556103,0.000890998,0.0014643187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016843564,0.00038627986,0.0005938259,0.0006169663,0.0014861369,0.001076025,0.0011699359,0.001018992,0.0015529593],"category_scores_gemma":[0.01032213,0.00044036334,0.0015643553,0.0018006731,0.0009788101,0.0006761998,0.0008874667,0.0010352313,0.000060922397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017235713,0.004240365,0.89224946,0.0019808663,0.0024451339,0.0005725912,0.0020252534,0.0067620273,0.0006666852,0.0016014366,0.006277453,0.0639431],"study_design_scores_gemma":[0.0021573864,0.003389441,0.9851804,0.00033970777,0.001277274,0.00009462935,0.0016993588,0.0036713118,0.00013355649,0.00026540647,0.0017421251,0.000049381088],"about_ca_topic_score_codex":0.96548426,"about_ca_topic_score_gemma":0.9806116,"teacher_disagreement_score":0.06542781,"about_ca_system_score_codex":0.06542781,"about_ca_system_score_gemma":0.04958237,"threshold_uncertainty_score":0.47471422},"labels":[],"label_agreement":null},{"id":"W2811480812","doi":"10.1016/j.jval.2018.04.923","title":"How Values Inform the Health Policy Decision-Making Processes About Health-System Financing in Latin America? A Critical Interpretive Synthesis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Corporate governance; Scope (computer science); Situational ethics; Health policy; Process (computing); Inclusion (mineral); Political science; Business; Health care; Public relations; Sociology; Computer science; Finance; Social science","score_opus":0.041496451469458275,"score_gpt":0.3302488597120274,"score_spread":0.2887524082425691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811480812","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021954592,0.21376655,0.046944622,0.625691,0.004611281,0.00020470838,0.0008768535,0.00008901693,0.085861415],"genre_scores_gemma":[0.8699557,0.07547686,0.01250953,0.033027884,0.005648872,0.000622537,0.00030245158,0.00016139522,0.002294732],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.97233754,0.02328912,0.00077636837,0.0010465902,0.0013786338,0.001171657],"domain_scores_gemma":[0.7393357,0.24529749,0.004028448,0.004390169,0.0063004675,0.0006477393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06673068,0.0020288243,0.002785712,0.010892342,0.0046637654,0.022651887,0.0041352287,0.0068048337,0.006880473],"category_scores_gemma":[0.1138045,0.00073621556,0.001294746,0.009339199,0.03455574,0.02112051,0.0057206643,0.012458057,0.00032438702],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051909956,0.000020579351,0.00054412737,0.0015554619,0.00011028929,0.000091635644,0.017483886,0.0008322814,0.00006683172,0.96275073,0.0042755404,0.01221684],"study_design_scores_gemma":[0.000030086816,0.000019295967,0.0011541796,0.012293221,0.00019567029,0.000042745432,0.02607409,0.0014445349,0.00033891713,0.8643138,0.09405364,0.000039859427],"about_ca_topic_score_codex":0.018180994,"about_ca_topic_score_gemma":0.016016982,"teacher_disagreement_score":0.06673068,"about_ca_system_score_codex":0.022825358,"about_ca_system_score_gemma":0.013971513,"threshold_uncertainty_score":0.3529098},"labels":[],"label_agreement":null},{"id":"W2811495265","doi":"10.1016/j.jval.2018.04.741","title":"The Frequency and Availability of Population-Specific Patient Reported Outcome Measures and Minimal Clinically Important Differences Among Approved Drugs in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Minimal clinically important difference; Patient-reported outcome; Population; Quality of life (healthcare); Prom; Internal medicine; Randomized controlled trial; Environmental health","score_opus":0.3490020649427621,"score_gpt":0.3809580061455704,"score_spread":0.03195594120280831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811495265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475819,0.011298496,0.00087295606,0.0069073904,0.000079949314,0.00008059865,0.023196673,0.000047776717,0.00993419],"genre_scores_gemma":[0.9962437,0.0010248891,0.00019960065,0.00024134503,0.000014766152,0.000007599094,0.0018560486,0.0000059783783,0.00040610816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953316,0.0008290779,0.00056862424,0.0006502569,0.0018667236,0.00075370277],"domain_scores_gemma":[0.95860857,0.012888371,0.010363096,0.0012424737,0.013072026,0.003825388],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0039720587,0.00016591598,0.00058934354,0.0020068046,0.0012735389,0.0020131087,0.0016749128,0.00063916616,0.002663199],"category_scores_gemma":[0.031223733,0.00034806415,0.000723297,0.0059162127,0.0011548118,0.00081560726,0.0007399395,0.0015985651,0.00009091737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006849015,0.000065702894,0.9660789,0.00021082672,0.00038875945,0.00010492177,0.00035108696,0.0015774306,0.00012706533,0.0016439516,0.0061222133,0.02264421],"study_design_scores_gemma":[0.00004859185,0.000044495195,0.99465936,0.00008379089,0.00012971144,0.00007815617,0.00034543368,0.0019336562,0.00010425519,0.00031525185,0.002232886,0.00002446565],"about_ca_topic_score_codex":0.9916883,"about_ca_topic_score_gemma":0.992316,"teacher_disagreement_score":0.99602795,"about_ca_system_score_codex":0.040534627,"about_ca_system_score_gemma":0.042068824,"threshold_uncertainty_score":0.2941007},"labels":[],"label_agreement":null},{"id":"W2811504378","doi":"10.1016/j.jval.2018.04.1212","title":"A Canadian Cost-Utility Analysis of two Trabecular Micro-Bypass Stents in Patients with Mild-to-Moderate Open-Angle Glaucoma","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Prism Eye Institute","funders":"","keywords":"Medicine; Glaucoma; Quality-adjusted life year; Quality of life (healthcare); Intraocular pressure; Population ageing; Health care; Population; Cost effectiveness; Surgery; Ophthalmology; Economics; Risk analysis (engineering)","score_opus":0.025335773030799993,"score_gpt":0.2982317992226022,"score_spread":0.2728960261918022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811504378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767089,0.0062668906,0.00064251584,0.0027309645,0.000073564166,0.00036477819,0.0072857356,0.000027079808,0.00589958],"genre_scores_gemma":[0.9936045,0.0012823588,0.0008727169,0.00043654305,0.00004147615,0.00006183602,0.002976721,0.000011857793,0.00071206084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764305,0.00068560615,0.00014376405,0.00024171652,0.0007136441,0.0005721553],"domain_scores_gemma":[0.9954965,0.0017037594,0.000674454,0.00017380732,0.0011465509,0.000805017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020894404,0.0011685097,0.0014865324,0.0018188304,0.0012631738,0.002405433,0.0015649415,0.0011429834,0.0035997494],"category_scores_gemma":[0.010067032,0.0005561726,0.0052424637,0.00428279,0.00083238597,0.0007315215,0.00103208,0.0020692379,0.0001665481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050658133,0.0020667887,0.7468482,0.0019174007,0.01307065,0.0017492028,0.00068113126,0.060715597,0.0015174182,0.008747859,0.024956029,0.08707169],"study_design_scores_gemma":[0.006114013,0.0031973044,0.8791159,0.00061709573,0.008877975,0.001139272,0.0014628228,0.089009196,0.00033621717,0.0015547059,0.008171738,0.00040375468],"about_ca_topic_score_codex":0.9300149,"about_ca_topic_score_gemma":0.92666435,"teacher_disagreement_score":0.06998509,"about_ca_system_score_codex":0.0667641,"about_ca_system_score_gemma":0.031872347,"threshold_uncertainty_score":0.48440975},"labels":[],"label_agreement":null},{"id":"W2884004329","doi":"10.1016/j.jval.2018.06.007","title":"Performance of a Bayesian Approach for Imputing Missing Data on the SF-12 Health-Related Quality-of-Life Measure","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods and Bayesian Inference","field":"Mathematics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Missing data; Imputation (statistics); Statistics; Cohort; Categorical variable; SF-36; Bayesian probability; Medicine; Computer science; Mathematics; Health related quality of life","score_opus":0.4348050802861287,"score_gpt":0.45449927568290693,"score_spread":0.019694195396778247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884004329","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13915502,0.0015083832,0.85089874,0.0021091902,0.00017315325,0.00020656327,0.0006479091,0.0010987723,0.0042023147],"genre_scores_gemma":[0.54579216,0.0006185115,0.44886753,0.0005577447,0.0001281838,0.0002899046,0.0016454348,0.000272768,0.001827688],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9812615,0.014779235,0.0007397013,0.0011294868,0.0017816103,0.00030836574],"domain_scores_gemma":[0.8643273,0.12467159,0.002051582,0.0034662555,0.0045718043,0.0009114243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04345988,0.0011022971,0.0018468386,0.0019154823,0.000999287,0.0025010388,0.0023479494,0.0037303362,0.004173939],"category_scores_gemma":[0.1545302,0.0010008429,0.0015996919,0.0017193216,0.0010578673,0.0033581546,0.003101389,0.0031716211,0.0007709199],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005409365,0.00083012757,0.015286125,0.0005080284,0.0011276187,0.00014401606,0.00047675672,0.63587826,0.002080389,0.029973328,0.0043766247,0.3039094],"study_design_scores_gemma":[0.00018713913,0.00017023279,0.0020374858,0.000054295164,0.00008370186,0.00005706621,0.00003786923,0.9836031,0.000595052,0.012551988,0.0005823029,0.000039906052],"about_ca_topic_score_codex":0.017132435,"about_ca_topic_score_gemma":0.01146148,"teacher_disagreement_score":0.04345988,"about_ca_system_score_codex":0.0015268995,"about_ca_system_score_gemma":0.005124857,"threshold_uncertainty_score":0.22984052},"labels":[],"label_agreement":null},{"id":"W2884520592","doi":"10.1016/j.jval.2018.06.004","title":"Realizing the “Great Potential” of MCDA in HTA","year":2018,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Multiple-criteria decision analysis; Computer science; Operations research; Engineering","score_opus":0.458412775041121,"score_gpt":0.42257971729625765,"score_spread":0.03583305774486334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884520592","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001476608,0.0006390957,0.00038317396,0.99575585,0.00163686,0.0000037159678,0.000015399646,0.0000057609004,0.0014124495],"genre_scores_gemma":[0.007898519,0.0008166014,0.001590978,0.9727463,0.01505604,0.00004228728,0.000016465607,0.000018975961,0.0018137943],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97227174,0.014383803,0.002069227,0.0019284006,0.007724,0.0016228466],"domain_scores_gemma":[0.83374244,0.13817619,0.0038534119,0.0043028644,0.011357938,0.008567041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.039399285,0.00061749754,0.0014020676,0.000785955,0.00430286,0.00815741,0.002637455,0.06170786,0.008290724],"category_scores_gemma":[0.14438568,0.00073847006,0.0014316046,0.0010214515,0.014731478,0.013325493,0.007110759,0.071232215,0.002750876],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005844399,0.0000564739,0.0012045346,0.00013358188,0.000038421607,0.00072396937,0.00062850135,0.00032453964,0.00016866393,0.10392167,0.8632424,0.029498875],"study_design_scores_gemma":[0.00017995894,0.000043928274,0.0010599393,0.00093024137,0.000029763069,0.00073095504,0.0008065284,0.001704836,0.00026650057,0.21790974,0.77623445,0.00010313841],"about_ca_topic_score_codex":0.011199708,"about_ca_topic_score_gemma":0.024405947,"teacher_disagreement_score":0.06170786,"about_ca_system_score_codex":0.0077398247,"about_ca_system_score_gemma":0.011017492,"threshold_uncertainty_score":0.2083658},"labels":[],"label_agreement":null},{"id":"W2885318744","doi":"10.1016/j.jval.2018.06.010","title":"Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Canadian Centre for Applied Research in Cancer Control; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control; Cancer Research Institute","keywords":"Valuation (finance); MEDLINE; Health care; Preference; Actuarial science; Computer science; Data science; Management science; Medicine; Economics; Biology; Accounting; Microeconomics","score_opus":0.9440262427380309,"score_gpt":0.4852302784682474,"score_spread":0.45879596426978353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885318744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013019594,0.9826095,0.009822879,0.0041295546,0.00026204588,0.000031206433,0.00021273726,0.000013840958,0.0016163575],"genre_scores_gemma":[0.030060645,0.9570922,0.010299772,0.00100057,0.00078406057,0.00011037935,0.0002616408,0.000014711662,0.00037606095],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922105,0.00492079,0.0005045806,0.0004971983,0.0017083852,0.00015857184],"domain_scores_gemma":[0.928922,0.06574709,0.0021203049,0.0009005295,0.0020716623,0.00023842957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024940474,0.001896271,0.004630764,0.004504889,0.0003154784,0.0047110436,0.0028058258,0.0023389682,0.003710939],"category_scores_gemma":[0.05606315,0.00049757096,0.0024877517,0.0063326624,0.0019984029,0.005636149,0.002095528,0.0035196117,0.00038072473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015987345,0.000104735445,0.004101708,0.01836678,0.0018564021,0.00011738878,0.00019798355,0.010299402,0.00019003247,0.12379902,0.009569537,0.83123714],"study_design_scores_gemma":[0.00014851533,0.00026615264,0.008567069,0.07042096,0.0029031676,0.0009763845,0.0008339596,0.02111234,0.0006828966,0.67316914,0.22066833,0.00025108652],"about_ca_topic_score_codex":0.0036824427,"about_ca_topic_score_gemma":0.004870058,"teacher_disagreement_score":0.024940474,"about_ca_system_score_codex":0.0025816606,"about_ca_system_score_gemma":0.004672322,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2886206370","doi":"10.1016/j.jval.2018.07.003","title":"Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled “Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis”","year":2018,"lang":"en","type":"letter","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Psychological intervention; Scopus; Medicine; Alternative medicine; Systematic review; Meta-analysis; MEDLINE; Content analysis; Family medicine; Nursing; Political science; Internal medicine","score_opus":0.16185768923630062,"score_gpt":0.429318066127496,"score_spread":0.2674603768911954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886206370","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001685458,0.00089622184,0.00012021119,0.91163814,0.08603933,0.00005105288,0.0002615482,0.000052851803,0.0007720435],"genre_scores_gemma":[0.0010655914,0.00069608825,0.0002427069,0.92153686,0.073424205,0.0001252335,0.00006338559,0.000041609386,0.0028043566],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98286575,0.0051497514,0.0041812677,0.0016094086,0.0048278673,0.0013659858],"domain_scores_gemma":[0.9215009,0.043313462,0.009426377,0.001881961,0.018950183,0.0049272147],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.020412974,0.0013537182,0.0043232692,0.0021922344,0.0047519826,0.0056231846,0.003476086,0.05866399,0.010972165],"category_scores_gemma":[0.15009068,0.0016203955,0.0038255232,0.0018405513,0.0025897068,0.003312473,0.002548784,0.04250225,0.009804964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012972385,0.00002384114,0.00022151766,0.00023664914,0.00006219703,0.0003741704,0.00006229427,0.00003559203,0.0000876908,0.00039715512,0.9950099,0.003359223],"study_design_scores_gemma":[0.0011622816,0.0002578316,0.002419787,0.0030139557,0.00051902974,0.001080183,0.00042714016,0.0008902272,0.0006337239,0.0041760136,0.98523915,0.00018058348],"about_ca_topic_score_codex":0.007861276,"about_ca_topic_score_gemma":0.0117959,"teacher_disagreement_score":0.979587,"about_ca_system_score_codex":0.008866392,"about_ca_system_score_gemma":0.010527839,"threshold_uncertainty_score":0.107955396},"labels":[{"model":"gemma","categories":["metaresearch","research_integrity"],"domain":"evaluation","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2887553020","doi":"10.1016/j.jval.2018.06.017","title":"Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; University of British Columbia; University of Calgary","funders":"National Human Genome Research Institute","keywords":"Economic evaluation; Management science; Delphi method; Value (mathematics); Computer science; Data science; Medicine; Artificial intelligence; Engineering; Machine learning","score_opus":0.5199318264038608,"score_gpt":0.451017848571655,"score_spread":0.06891397783220582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887553020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003899425,0.95357114,0.0038786738,0.038311552,0.0017674619,0.000022251035,0.00016848688,0.000018089688,0.0018723469],"genre_scores_gemma":[0.012787821,0.9551112,0.00983232,0.016086366,0.0049958834,0.00010078847,0.00020290322,0.000042532203,0.0008402304],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98786384,0.0056035044,0.0012056222,0.0010675329,0.0039117145,0.00034770012],"domain_scores_gemma":[0.83909625,0.14147563,0.0040860795,0.0018977711,0.012262511,0.0011817239],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04044466,0.0013574648,0.0045407177,0.0030426218,0.00068358023,0.006238057,0.0043698587,0.006213108,0.0050084875],"category_scores_gemma":[0.092098586,0.0006041428,0.0014380825,0.0035042027,0.0056406166,0.009014511,0.002888474,0.00823489,0.0011573595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020787523,0.000072357645,0.0016689264,0.014626903,0.0006552788,0.00028823293,0.0002274767,0.001821365,0.00041390318,0.064696774,0.047504157,0.86781675],"study_design_scores_gemma":[0.000107591004,0.00016288497,0.003384399,0.04752239,0.0008885016,0.0012031961,0.0008998095,0.0019478787,0.0008811905,0.23259643,0.7101716,0.00023406387],"about_ca_topic_score_codex":0.0045697973,"about_ca_topic_score_gemma":0.006659235,"teacher_disagreement_score":0.9595553,"about_ca_system_score_codex":0.0035988654,"about_ca_system_score_gemma":0.0076813605,"threshold_uncertainty_score":0.21389437},"labels":[],"label_agreement":null},{"id":"W2887815625","doi":"10.1016/j.jval.2018.06.016","title":"Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institute of Health Economics; Canadian Centre for Applied Research in Cancer Control; University of Alberta; University of Calgary","funders":"","keywords":"Big data; Data science; Key (lock); Computer science; DNA sequencing; Health care; Data mining; Biology; Political science; Computer security","score_opus":0.8757959084535702,"score_gpt":0.48642022198103374,"score_spread":0.3893756864725365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887815625","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030733595,0.07896221,0.49067733,0.3720638,0.00720066,0.0007175721,0.005291916,0.00062296464,0.013730079],"genre_scores_gemma":[0.52438045,0.058299404,0.3456713,0.05093469,0.012460358,0.0019606363,0.0039113564,0.00044885575,0.0019330443],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8932094,0.08975912,0.004089851,0.0036232206,0.008310174,0.001008245],"domain_scores_gemma":[0.41195387,0.5343886,0.016565008,0.019433754,0.013976326,0.0036823505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14607398,0.0028128736,0.007092461,0.004493958,0.0016804113,0.013800646,0.005958411,0.008400623,0.006838481],"category_scores_gemma":[0.32532105,0.0021586048,0.0040434026,0.009766803,0.008008944,0.026706459,0.0072089005,0.014422711,0.0008864082],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019207054,0.0009645454,0.0374063,0.00871216,0.0065093595,0.000604122,0.001072712,0.10994156,0.0011414409,0.438165,0.049985293,0.34357676],"study_design_scores_gemma":[0.00012185653,0.00014939361,0.002443835,0.0016415216,0.00029619568,0.00010304341,0.00048560783,0.048403684,0.0003480074,0.9295252,0.016352363,0.00012931961],"about_ca_topic_score_codex":0.007113934,"about_ca_topic_score_gemma":0.010332559,"teacher_disagreement_score":0.14607398,"about_ca_system_score_codex":0.0056958417,"about_ca_system_score_gemma":0.01343879,"threshold_uncertainty_score":0.7725223},"labels":[],"label_agreement":null},{"id":"W2892210399","doi":"10.1016/j.jval.2018.05.003","title":"Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary; Alberta Health Services; Tellabs (Canada)","funders":"","keywords":"Task force; Task (project management); Management science; Computer science; Medicine; Engineering; Political science; Systems engineering; Public administration","score_opus":0.2221371570409141,"score_gpt":0.5923094517570339,"score_spread":0.3701722947161198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892210399","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03251667,0.044861294,0.7243843,0.09706338,0.0034221534,0.0036862998,0.0069414396,0.0007395698,0.08638489],"genre_scores_gemma":[0.12824178,0.060893152,0.7604121,0.0066274963,0.002203397,0.003850744,0.007204938,0.0012499307,0.029316464],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9676223,0.020022346,0.0012092941,0.0010057049,0.009093516,0.0010469002],"domain_scores_gemma":[0.90611815,0.06266724,0.0035799555,0.004871828,0.02059312,0.002169674],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0716404,0.0014331458,0.001427833,0.0038385885,0.0012793434,0.004087854,0.0018813019,0.0023738027,0.0057553165],"category_scores_gemma":[0.07855044,0.00091485115,0.0019207406,0.0054926984,0.001235525,0.0026650273,0.003991738,0.003701002,0.0012926303],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003206076,0.0012001118,0.010740752,0.0019967263,0.00042573691,0.00011728675,0.000619849,0.07881166,0.0015423221,0.067852125,0.19844396,0.63792896],"study_design_scores_gemma":[0.00046835016,0.0006740635,0.028827496,0.005389099,0.0003423457,0.0002068754,0.0010355386,0.32273144,0.012725869,0.103870034,0.52343726,0.0002916245],"about_ca_topic_score_codex":0.044722177,"about_ca_topic_score_gemma":0.06382379,"teacher_disagreement_score":0.9283596,"about_ca_system_score_codex":0.004257622,"about_ca_system_score_gemma":0.022457974,"threshold_uncertainty_score":0.3788752},"labels":[],"label_agreement":null},{"id":"W2899561579","doi":"10.1016/j.jval.2018.07.249","title":"Burden of Ischemic Heart Disease And Stroke And Impact of Lipid Control And Modifiable Risk Factors In China","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Stroke (engine); Environmental health; Disease; Population; Obesity; Risk factor; Diabetes mellitus; Disease burden; Public health; Demography; Gerontology; Internal medicine","score_opus":0.01394295970635822,"score_gpt":0.28171289580616343,"score_spread":0.2677699360998052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899561579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984444,0.00033124478,0.000053325002,0.00020005224,0.000008652519,0.0000075947737,0.00048435043,0.000005303271,0.0004650908],"genre_scores_gemma":[0.9989574,0.00017855034,0.00003615596,0.000036756555,0.0000112187045,0.00000589466,0.0004607837,0.0000016499558,0.00031169978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992969,0.00010535951,0.000105796185,0.00013915336,0.00010664457,0.0002462107],"domain_scores_gemma":[0.9988783,0.00009467764,0.0002833621,0.00010102651,0.00017572385,0.0004667974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008757018,0.00051802513,0.0006287253,0.0022048266,0.00094726105,0.00087643554,0.00070771185,0.000512421,0.0017069287],"category_scores_gemma":[0.0010121327,0.00062155037,0.0011363968,0.0033512486,0.0007679379,0.00074635574,0.0011773205,0.00057211396,0.00014301528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010972666,0.00005137324,0.9963458,0.000025760548,0.00022990823,0.0002122681,0.00024065998,0.00023703059,0.00021691821,0.00021208599,0.00024705878,0.0018714052],"study_design_scores_gemma":[0.000008665025,0.00002477067,0.9990583,0.0000046950627,0.000050870298,0.00004514412,0.00021219056,0.00036401572,0.000016352378,0.00007032993,0.00013672629,0.000007931162],"about_ca_topic_score_codex":0.15428226,"about_ca_topic_score_gemma":0.15682934,"teacher_disagreement_score":0.15428226,"about_ca_system_score_codex":0.0023978187,"about_ca_system_score_gemma":0.0044170716,"threshold_uncertainty_score":0.30676848},"labels":[],"label_agreement":null},{"id":"W2899799073","doi":"10.1016/j.jval.2018.07.056","title":"Towards a More Accurate Budget Impact Analysis: Population-Level Screening for Hepatitis C Virus (HCV) in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; Toronto Public Health; University of Waterloo","funders":"","keywords":"Medicine; Population; Cohort; Hepatitis C; Hepatitis C virus; Demography; Environmental health; Pediatrics; Virology; Internal medicine; Virus","score_opus":0.12368826849587636,"score_gpt":0.40830744627403137,"score_spread":0.28461917777815504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899799073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8300756,0.0110726245,0.009063524,0.040087268,0.00036737113,0.0013620125,0.061683692,0.00014684472,0.04614101],"genre_scores_gemma":[0.9748439,0.004540913,0.007629329,0.0013295999,0.00005750185,0.0002458789,0.0075176833,0.00004112561,0.0037940764],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99523914,0.0014717272,0.00035718014,0.0002114558,0.001577051,0.0011433156],"domain_scores_gemma":[0.9868313,0.0021484024,0.0012681214,0.00030833427,0.007977598,0.0014661964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004461644,0.0005282721,0.0008865601,0.0027815439,0.001654617,0.0028479402,0.0017200165,0.0007130723,0.0024572425],"category_scores_gemma":[0.019028371,0.00044388458,0.0010676165,0.00793389,0.00071670825,0.0010319793,0.0012828832,0.001279756,0.00014201457],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041886867,0.0002669017,0.7745943,0.0015841639,0.0015768572,0.00043447255,0.0017419519,0.08786136,0.00042085725,0.01318348,0.047821887,0.0700948],"study_design_scores_gemma":[0.0001713421,0.00011286378,0.91427356,0.0011055174,0.0007130585,0.00009663533,0.004597087,0.047243558,0.00034071965,0.0033138427,0.027929587,0.00010226621],"about_ca_topic_score_codex":0.9986046,"about_ca_topic_score_gemma":0.9990397,"teacher_disagreement_score":0.13236284,"about_ca_system_score_codex":0.13236284,"about_ca_system_score_gemma":0.17951511,"threshold_uncertainty_score":0.9603641},"labels":[],"label_agreement":null},{"id":"W2899921812","doi":"10.1016/j.jval.2018.07.635","title":"The Relationship Between Socio Economic Status and Traumatic Brain Injuries for Pediatric Populations","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Traumatic brain injury; Medicine; Demography; Incidence (geometry); Injury prevention; Pediatrics; Poison control; Emergency medicine; Psychiatry","score_opus":0.20128737208470174,"score_gpt":0.4164966929250285,"score_spread":0.21520932084032676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899921812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843305,0.00045843804,0.000026970325,0.00022429504,0.000010313882,0.0000024710575,0.00015143554,8.007765e-7,0.00069209276],"genre_scores_gemma":[0.99954104,0.00020634058,0.000018412205,0.000022198665,0.0000110671745,0.000002210003,0.000105485095,0.000001059319,0.00009217752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911994,0.0002784508,0.00008699033,0.00006669564,0.00012041011,0.00032755252],"domain_scores_gemma":[0.9957676,0.0012711535,0.0016186185,0.00017202889,0.00029168397,0.0008788635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010562984,0.00022810593,0.0002326296,0.0016702597,0.00077165867,0.0011086853,0.00048834237,0.00044323623,0.002962088],"category_scores_gemma":[0.008797023,0.00021602603,0.00068509264,0.0022950089,0.0006910797,0.0009990742,0.0013806709,0.0010091527,0.00021845756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030079253,0.000028112905,0.99868923,0.000004749548,0.000029746176,0.00004612986,0.0001530718,0.000011850674,0.000016325772,0.00007977064,0.000049687456,0.00086123793],"study_design_scores_gemma":[9.639315e-7,0.000031370742,0.9987961,0.0000060185025,0.000011904573,0.00007736136,0.00088056974,0.000034903736,0.000013701621,0.000041565505,0.00010398063,0.0000016061628],"about_ca_topic_score_codex":0.016284944,"about_ca_topic_score_gemma":0.02300829,"teacher_disagreement_score":0.016284944,"about_ca_system_score_codex":0.0006645493,"about_ca_system_score_gemma":0.00086464896,"threshold_uncertainty_score":0.032380283},"labels":[],"label_agreement":null},{"id":"W2900040219","doi":"10.1016/j.jval.2018.07.019","title":"Cross-Country Comparison Of Cancer-Specific Multi-Attribute Utility Instruments (Mauis): Relative Weighting And Ranking Of Health-Related Quality Of Life (Hrql) Domains In Country-Specific Utility Algorithms","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Life expectancy; Quality of life (healthcare); Demography; Medicine; Representativeness heuristic; Ranking (information retrieval); Population; Valuation (finance); Statistics; Actuarial science; Gerontology; Econometrics; Mathematics; Computer science; Machine learning; Economics; Accounting; Environmental health","score_opus":0.44500466645428105,"score_gpt":0.46851434396187175,"score_spread":0.0235096775075907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900040219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9357801,0.001882174,0.053605665,0.00025375592,0.000089169014,0.00035150748,0.0052786674,0.00012362478,0.0026354818],"genre_scores_gemma":[0.9695117,0.00034443176,0.022220125,0.000054117594,0.000011883115,0.0002632597,0.0072817425,0.00006277954,0.00024994768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98497635,0.012488251,0.00064721674,0.0007306467,0.0007535553,0.000403928],"domain_scores_gemma":[0.9657119,0.025450809,0.0022082406,0.0036219235,0.0024755378,0.0005314857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035983935,0.00081547635,0.0013285271,0.0037172325,0.00037359237,0.0022243084,0.0012555819,0.0010177395,0.0022162895],"category_scores_gemma":[0.070191294,0.0003878828,0.0035732617,0.004109293,0.0006374606,0.0017522575,0.0028958651,0.0015139054,0.0003885277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014239758,0.0013590276,0.58688647,0.0013243641,0.016758302,0.0001477702,0.0010809249,0.17812736,0.0016293842,0.02111962,0.0077652927,0.16956176],"study_design_scores_gemma":[0.0017491693,0.005292444,0.6268822,0.0007155457,0.0069435663,0.00071193476,0.0021466352,0.3228311,0.005061988,0.01822831,0.009111083,0.0003260757],"about_ca_topic_score_codex":0.003512982,"about_ca_topic_score_gemma":0.002683343,"teacher_disagreement_score":0.035983935,"about_ca_system_score_codex":0.0009795374,"about_ca_system_score_gemma":0.0007232671,"threshold_uncertainty_score":0.1903035},"labels":[],"label_agreement":null},{"id":"W2900118984","doi":"10.1016/j.jval.2018.07.622","title":"The Health and Economic Burden of Osteoporosis and Impact of Effective Treatment In Singapore","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Osteoporosis; Medicine; Incidence (geometry); Population; Status quo; Total cost; Indirect costs; Health care; Environmental health; Cost–benefit analysis; Demography; Business; Economics; Economic growth; Internal medicine","score_opus":0.38431139445152424,"score_gpt":0.5455991089242566,"score_spread":0.16128771447273232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900118984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041724,0.001956801,0.000027182445,0.0038173513,0.000027470172,0.000007583242,0.00071904314,0.0000017070768,0.0030257378],"genre_scores_gemma":[0.9980556,0.0010540846,0.000031598862,0.0001333068,0.00001868767,0.000003817492,0.00022212665,8.072368e-7,0.00047992833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992399,0.00018367109,0.00016327744,0.000040225736,0.00018624333,0.00018653236],"domain_scores_gemma":[0.99789965,0.00017559303,0.0009358842,0.00003676631,0.00024711536,0.0007050633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073777017,0.00014874086,0.00029115097,0.0010623499,0.0005976643,0.0013539599,0.00033806515,0.00046505834,0.0039158575],"category_scores_gemma":[0.0019095106,0.00025364658,0.000576094,0.0023956457,0.00064043695,0.00091333356,0.001398085,0.00087476603,0.00026083694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111268266,0.00008856919,0.98613876,0.000079977304,0.000075484066,0.0006641896,0.0008588774,0.00013871628,0.000097950724,0.0007630891,0.00091199693,0.010071087],"study_design_scores_gemma":[0.00000760783,0.000069258094,0.9959357,0.00004678391,0.000019797051,0.00021394074,0.0022020547,0.00021013337,0.000014033874,0.00017888055,0.0010939458,0.000007882388],"about_ca_topic_score_codex":0.120179735,"about_ca_topic_score_gemma":0.21939501,"teacher_disagreement_score":0.120179735,"about_ca_system_score_codex":0.0036863813,"about_ca_system_score_gemma":0.0051219426,"threshold_uncertainty_score":0.23896044},"labels":[],"label_agreement":null},{"id":"W2900137235","doi":"10.1016/j.jval.2018.07.873","title":"Costs and Survival for Dialysis Patients: Real World Evidence Supporting Home Dialysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Stroke Network; London Health Sciences Centre; St. Michael's Hospital; Western University; Toronto Public Health; Centre for Addiction and Mental Health; Toronto General Hospital","funders":"","keywords":"Medicine; Home hemodialysis; Dialysis; Hemodialysis; Hazard ratio; Proportional hazards model; Peritoneal dialysis; Population; Cohort; Survival analysis; Internal medicine; Retrospective cohort study; Emergency medicine; Confidence interval; Environmental health","score_opus":0.05310273921355673,"score_gpt":0.3517320114645391,"score_spread":0.29862927225098235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900137235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47019017,0.46635094,0.0014546805,0.035771605,0.0015644324,0.00015836289,0.008533406,0.000028877263,0.015947472],"genre_scores_gemma":[0.9380241,0.05334261,0.0011133065,0.0037906067,0.0011578671,0.000047198122,0.0021664083,0.00001556043,0.0003423228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99145764,0.0053558415,0.0011210989,0.00053364673,0.0011437858,0.0003881272],"domain_scores_gemma":[0.81893814,0.14633484,0.023133004,0.0039076554,0.0052301083,0.0024561838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012654834,0.00073330867,0.002006332,0.0018282458,0.00067979173,0.0054872865,0.002108666,0.002387951,0.008884883],"category_scores_gemma":[0.09023387,0.0005233712,0.0037183631,0.003511682,0.001884588,0.0022077595,0.0017616717,0.004414464,0.00038991784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036837794,0.001717753,0.6392979,0.030612001,0.053234287,0.00048069214,0.00090614485,0.0049582967,0.00032609268,0.011341333,0.013192512,0.20709522],"study_design_scores_gemma":[0.0072064777,0.0041341903,0.82411945,0.036589175,0.05716167,0.00095156126,0.0028592192,0.0034893574,0.00061846746,0.024455598,0.038086336,0.00032837508],"about_ca_topic_score_codex":0.008548695,"about_ca_topic_score_gemma":0.010137927,"teacher_disagreement_score":0.012654834,"about_ca_system_score_codex":0.0029894814,"about_ca_system_score_gemma":0.002783784,"threshold_uncertainty_score":0.066926},"labels":[],"label_agreement":null},{"id":"W2900203095","doi":"10.1016/j.jval.2018.07.248","title":"Burden of Ischemic Heart Disease And Stroke And The Impact Of Modifiable Risk Factors In Taiwan","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Stroke (engine); Disease; Environmental health; Disease burden; Risk factor; Obesity; Population; Diabetes mellitus; Public health; Population ageing; Emergency medicine; Demography; Gerontology; Internal medicine","score_opus":0.03738710247321565,"score_gpt":0.32173634977274773,"score_spread":0.2843492472995321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900203095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99892443,0.00019587515,0.00002590801,0.0001317881,0.0000036134484,0.0000027391634,0.00030880945,0.0000016366014,0.00040522192],"genre_scores_gemma":[0.9992762,0.0001293454,0.000015119969,0.000018685098,0.0000058524893,0.0000032643763,0.00034599245,8.069841e-7,0.00020477608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99966216,0.00006579067,0.00006311707,0.00006645848,0.000032054242,0.00011034921],"domain_scores_gemma":[0.99905294,0.00011222844,0.00031736237,0.00008189411,0.00012539726,0.00031009555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005060085,0.00024226101,0.00029445504,0.001260978,0.00040923653,0.00083704095,0.00044313355,0.00055481266,0.0014464154],"category_scores_gemma":[0.0011482725,0.00036548008,0.0006475673,0.0020744868,0.00042919273,0.00063811743,0.00080280314,0.0008218208,0.00017157776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007333848,0.000040559837,0.9984932,0.0000063841626,0.00006420349,0.00013674685,0.00019682701,0.00010670513,0.0000780111,0.000093962415,0.000100479374,0.00060948764],"study_design_scores_gemma":[0.0000043083887,0.000028373226,0.99868065,0.000004725129,0.00003096135,0.00005844081,0.00067909266,0.0003242935,0.000014883977,0.00005522079,0.00011434705,0.000004785736],"about_ca_topic_score_codex":0.10084003,"about_ca_topic_score_gemma":0.0863711,"teacher_disagreement_score":0.10084003,"about_ca_system_score_codex":0.0011607988,"about_ca_system_score_gemma":0.0013905618,"threshold_uncertainty_score":0.20050615},"labels":[],"label_agreement":null},{"id":"W2900324617","doi":"10.1016/j.jval.2018.07.277","title":"Non-Severe Hypoglycemia Episodes (Nshes) Clinical And Economic Outcomes: A Comparison Between Sulfonylurea (Su) And Sodium-Glucose Co-Transporter 2 Inhibitor (Sglt2i) As Add On To Metformin From A Canadian Perspective","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Hypoglycemia; Metformin; Sulfonylurea; Type 2 Diabetes Mellitus; Adverse effect; Reimbursement; Health economics; Environmental health; Demography; Diabetes mellitus; Internal medicine; Health care; Insulin; Economics; Endocrinology; Public health","score_opus":0.04709727888063146,"score_gpt":0.3620011550741379,"score_spread":0.3149038761935064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900324617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91490877,0.060924727,0.0002445181,0.0029713814,0.0005140198,0.0003408603,0.007888314,0.000016888684,0.012190577],"genre_scores_gemma":[0.98560494,0.009036265,0.000557937,0.0006312585,0.00017841635,0.000054414177,0.0030754097,0.0000064900514,0.000854796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715376,0.0006170756,0.00024542576,0.00024362314,0.000991196,0.0007488915],"domain_scores_gemma":[0.99685574,0.000631014,0.00069135136,0.000061873856,0.0005873754,0.0011726225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021371322,0.0009564392,0.002153631,0.0012202227,0.001100548,0.0019266567,0.0011261029,0.0010221939,0.0038606965],"category_scores_gemma":[0.005372642,0.0003983775,0.004715936,0.0026100234,0.00071529,0.0008233626,0.0010237396,0.002759816,0.00009201696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2866989,0.0046615046,0.4457269,0.00955891,0.040739544,0.00068477215,0.0010922333,0.005054659,0.0013790022,0.005490503,0.016562356,0.18235067],"study_design_scores_gemma":[0.023534784,0.01463074,0.9183581,0.0021858872,0.02397234,0.000304492,0.0021154578,0.003054601,0.00045019586,0.0015400493,0.009494232,0.00035914383],"about_ca_topic_score_codex":0.8022471,"about_ca_topic_score_gemma":0.90520275,"teacher_disagreement_score":0.1977529,"about_ca_system_score_codex":0.018467693,"about_ca_system_score_gemma":0.027406087,"threshold_uncertainty_score":0.39783496},"labels":[],"label_agreement":null},{"id":"W2900443357","doi":"10.1016/j.jval.2018.07.409","title":"A Study of Determinants of Hospitalizations in India","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Demography; Logistic regression; Christian ministry; Quarter (Canadian coin); Poverty; Population; Environmental health; Geography; Internal medicine","score_opus":0.07561749740671518,"score_gpt":0.31558603299138577,"score_spread":0.23996853558467057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900443357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99730504,0.00015697455,0.00009654076,0.00071995886,0.000005997466,0.0000069538787,0.00058982737,0.000006269426,0.0011125294],"genre_scores_gemma":[0.9993855,0.00007098743,0.000027747295,0.000028861403,0.000008054841,0.0000026437758,0.00020995823,0.0000017672552,0.00026450548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988733,0.0003071208,0.000060860828,0.000078448364,0.00010055933,0.00057970366],"domain_scores_gemma":[0.9914799,0.003967627,0.0021506536,0.00030854868,0.0006086108,0.0014847162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006060555,0.00024189404,0.00034881866,0.0016097134,0.00094777386,0.0015851008,0.00093993807,0.0004787963,0.0037893998],"category_scores_gemma":[0.0041068294,0.00037208144,0.0009890222,0.0039214785,0.00085800205,0.00067630544,0.0011883989,0.0018702291,0.00035330505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008023087,0.0001624044,0.99416816,0.00001930104,0.000105346495,0.00041717273,0.0007284925,0.000580463,0.000070452035,0.0010954622,0.0007484897,0.0018239829],"study_design_scores_gemma":[0.0000051279158,0.000048896,0.99576485,0.000010697292,0.00004191324,0.00015164944,0.002463211,0.00087386445,0.000054739405,0.00015201287,0.0004237565,0.000009217923],"about_ca_topic_score_codex":0.20992345,"about_ca_topic_score_gemma":0.18058938,"teacher_disagreement_score":0.20992345,"about_ca_system_score_codex":0.0030078357,"about_ca_system_score_gemma":0.0032643944,"threshold_uncertainty_score":0.4174031},"labels":[],"label_agreement":null},{"id":"W2902615909","doi":"10.1016/j.jval.2018.08.008","title":"Evaluating Canadians’ Values for Drug Coverage Decision Making","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Centre for Advancing Health Outcomes; York University; University of British Columbia; Providence Health Care Research Institute; Providence Health Care; Ministry of Health","funders":"Canadian Institutes of Health Research","keywords":"Drug; Computer science; Medicine; Pharmacology","score_opus":0.4991278213945099,"score_gpt":0.5029373610944847,"score_spread":0.0038095396999748288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902615909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7812291,0.0052866247,0.0039472193,0.045275595,0.00028626627,0.000298508,0.006490948,0.00007107908,0.15711464],"genre_scores_gemma":[0.9960134,0.00045610985,0.0012904343,0.0004617432,0.000029951207,0.000022982154,0.0006097214,0.00000737073,0.0011084316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98807853,0.0045659966,0.00045620484,0.00043992916,0.004612593,0.001846712],"domain_scores_gemma":[0.9466631,0.02357732,0.0030555434,0.001061284,0.02196088,0.0036817787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013902183,0.00043909828,0.0006081744,0.0031016322,0.0036109677,0.0060998946,0.0012000963,0.0015259149,0.005176436],"category_scores_gemma":[0.0916925,0.0002697398,0.00088097807,0.0054527647,0.0019871849,0.0014026152,0.0011478345,0.0017623822,0.00017818871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027746838,0.0005706667,0.53598374,0.00062781427,0.0013049094,0.00043762336,0.004192805,0.044027314,0.00033845694,0.13460387,0.09504672,0.18009137],"study_design_scores_gemma":[0.0008708116,0.000641631,0.6818495,0.0015061724,0.0011427265,0.0003435206,0.01851187,0.11942565,0.0013188795,0.060200866,0.11368511,0.00050324656],"about_ca_topic_score_codex":0.97271574,"about_ca_topic_score_gemma":0.9757126,"teacher_disagreement_score":0.09061451,"about_ca_system_score_codex":0.09061451,"about_ca_system_score_gemma":0.07369708,"threshold_uncertainty_score":0.65745735},"labels":[],"label_agreement":null},{"id":"W2904484213","doi":"10.1016/j.jval.2018.08.010","title":"Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; Institute of Health Economics; Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Health technology; Reimbursement; Pharmacoeconomics; Scope (computer science); Health care; Best practice; Medicine; Management science; Health economics; Process management; Business; Political science; Nursing; Computer science; Engineering; Management; Economics; Public health; Intensive care medicine","score_opus":0.7828634860829735,"score_gpt":0.5493517150779043,"score_spread":0.23351177100506926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904484213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000911374,0.9253352,0.0077620796,0.059660017,0.0016369296,0.00060550804,0.0009513306,0.00010532925,0.0030322259],"genre_scores_gemma":[0.019388935,0.90318704,0.0500646,0.02300065,0.0011472498,0.0012380399,0.0013685889,0.00010409645,0.0005007257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.87641996,0.0558295,0.029129794,0.0038993582,0.032851774,0.001869708],"domain_scores_gemma":[0.5392209,0.33881354,0.041544642,0.013717096,0.06328684,0.003416974],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19862646,0.0014484621,0.0038630646,0.009418656,0.0012013207,0.008012434,0.0051791873,0.0074296882,0.0031588327],"category_scores_gemma":[0.33063397,0.0015142455,0.0048016887,0.0117494995,0.004249634,0.008317567,0.0058511337,0.011604814,0.0011477568],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012609406,0.00014421697,0.0028894548,0.11782732,0.0012844348,0.000119297874,0.0016521082,0.0012378829,0.00040247102,0.021556364,0.063031696,0.78972864],"study_design_scores_gemma":[0.00018820401,0.00018986769,0.013187169,0.4603375,0.0028814275,0.00035826172,0.0011984368,0.000886246,0.0018173977,0.031139206,0.48760834,0.00020801224],"about_ca_topic_score_codex":0.016647303,"about_ca_topic_score_gemma":0.027402619,"teacher_disagreement_score":0.80137354,"about_ca_system_score_codex":0.009110537,"about_ca_system_score_gemma":0.05080652,"threshold_uncertainty_score":0.98823625},"labels":[],"label_agreement":null},{"id":"W2905594795","doi":"10.1016/j.jval.2018.09.882","title":"PGI40 - THE ROLE OF PERFORMANCE-BASED RISK-SHARING AGREEMENTS IN MINIMISING PAYER UNCERTAINTY WHEN STANDARD OF CARE IS NOT CLEARLY DEFINED; THE EXAMPLE OF CROHN’S DISEASE RELATED COMPLEX PERIANAL FISTULAS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Reimbursement; Medicine; MEDLINE; Cochrane Library; Disease; Systematic review; Health care; Intensive care medicine; Family medicine; Randomized controlled trial; Surgery; Pathology","score_opus":0.0485758511796468,"score_gpt":0.3004503757805898,"score_spread":0.251874524600943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905594795","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013022964,0.0071274666,0.04077902,0.4376451,0.0063043768,0.0007049687,0.0012738593,0.0009380925,0.49220416],"genre_scores_gemma":[0.5653843,0.006728677,0.07956997,0.21331659,0.011185142,0.0016562396,0.001782689,0.0008456627,0.11953078],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.943776,0.032502312,0.0017122339,0.0026931607,0.015065322,0.0042509465],"domain_scores_gemma":[0.9003815,0.062227845,0.0061405245,0.009317587,0.012429411,0.009503081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06304117,0.0009871047,0.00093595055,0.001449475,0.00229508,0.012178193,0.0039140573,0.016039988,0.022558108],"category_scores_gemma":[0.12852965,0.00059499807,0.0018464511,0.0018031371,0.0054370365,0.00564315,0.00956279,0.0143769225,0.004490767],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034774822,0.0003197978,0.0035528291,0.0004395761,0.00016246072,0.0003594046,0.0010672886,0.0056098434,0.00061472063,0.5760159,0.23919445,0.17231598],"study_design_scores_gemma":[0.0003405828,0.00045105885,0.009065921,0.002039235,0.000117518364,0.0005197285,0.00066630146,0.0078049228,0.0013329358,0.44999024,0.52747434,0.00019729277],"about_ca_topic_score_codex":0.0056237364,"about_ca_topic_score_gemma":0.004966193,"teacher_disagreement_score":0.06304117,"about_ca_system_score_codex":0.0064682774,"about_ca_system_score_gemma":0.02430202,"threshold_uncertainty_score":0.3333975},"labels":[],"label_agreement":null},{"id":"W2905613400","doi":"10.1016/j.jval.2018.09.933","title":"PHP37 - SPEEDING TO MARKET? AN EVALUATION OF ACCELERATED DRUG APPROVAL PATHWAYS IN AUSTRALIA, CANADA, AND SAUDI ARABIA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Drug; Medicine; Pharmacology","score_opus":0.407439286169447,"score_gpt":0.4595118803334806,"score_spread":0.05207259416403359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905613400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99017346,0.0012351708,0.00025317533,0.0014900041,0.000040652987,0.0015714206,0.00055086083,0.000033989945,0.004651228],"genre_scores_gemma":[0.9952231,0.0010540434,0.00141579,0.0005880672,0.000018040235,0.00041214432,0.00028296592,0.000009902001,0.0009959056],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99056846,0.004100194,0.000494935,0.00053492654,0.0024882432,0.0018132721],"domain_scores_gemma":[0.9606918,0.011159464,0.0054064137,0.0012504469,0.012899705,0.008592209],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015720574,0.00040992387,0.0009518036,0.0010300865,0.002663612,0.0028560166,0.0013699699,0.0010657843,0.0045295046],"category_scores_gemma":[0.03449029,0.00043592323,0.0012045967,0.0019914755,0.0018416457,0.0017431248,0.001962825,0.0018709627,0.0003538833],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10251375,0.021408984,0.3470968,0.003213564,0.0016383533,0.00054650207,0.010521088,0.008653658,0.0022785624,0.008362303,0.009982259,0.48378426],"study_design_scores_gemma":[0.0356883,0.096793175,0.76924217,0.0022875736,0.0033823287,0.0005300981,0.019524999,0.02362325,0.004136468,0.0025503782,0.04175816,0.00048303555],"about_ca_topic_score_codex":0.7391659,"about_ca_topic_score_gemma":0.80814886,"teacher_disagreement_score":0.9606078,"about_ca_system_score_codex":0.039392147,"about_ca_system_score_gemma":0.10838981,"threshold_uncertainty_score":0.52474034},"labels":[],"label_agreement":null},{"id":"W2905617446","doi":"10.1016/j.jval.2018.09.311","title":"PCN229 - COMPARISON OF SICKNESS BENEFIT AND SICK LEAVE DURATION IN ONCOLOGY ACROSS COUNTRIES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sick leave; Absenteeism; Duration (music); Productivity; Medicine; Presenteeism; Workforce; Indirect costs; Economic impact analysis; Family medicine; Demographic economics; Business; Economic growth; Psychology; Economics; Physical therapy; Accounting","score_opus":0.05015643137826087,"score_gpt":0.46488467894569724,"score_spread":0.41472824756743637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905617446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.804964,0.036128663,0.0016609832,0.0008658655,0.0007781992,0.0015102266,0.13477652,0.00010946473,0.019205997],"genre_scores_gemma":[0.95261514,0.0034227208,0.0006655257,0.0002550869,0.00011161439,0.0014775742,0.039504062,0.000050391525,0.0018979344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900711,0.005507194,0.0015867216,0.0006775928,0.0015681908,0.00058918697],"domain_scores_gemma":[0.98236704,0.010273206,0.0037685977,0.00044007925,0.0023042008,0.00084687374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007930281,0.00061677257,0.0021308458,0.0061726617,0.0003984286,0.0021553708,0.0010234695,0.00081470667,0.009603795],"category_scores_gemma":[0.026752926,0.00030433346,0.007282763,0.008201935,0.00042429287,0.0015682994,0.002052744,0.001274878,0.00087179587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.078339264,0.0014856004,0.62251586,0.04122098,0.07699355,0.0004613768,0.0016279671,0.018182758,0.0004578027,0.004531659,0.0384246,0.11575861],"study_design_scores_gemma":[0.0053467574,0.0065360013,0.9473222,0.004454091,0.007694131,0.000351643,0.0023252105,0.0028996982,0.00027095908,0.0008931453,0.021745598,0.00016059505],"about_ca_topic_score_codex":0.022021659,"about_ca_topic_score_gemma":0.015576969,"teacher_disagreement_score":0.022021659,"about_ca_system_score_codex":0.002521604,"about_ca_system_score_gemma":0.0019039849,"threshold_uncertainty_score":0.043786943},"labels":[],"label_agreement":null},{"id":"W2905623501","doi":"10.1016/j.jval.2018.09.154","title":"PCN72 - BUDGET IMPACT ANALYSIS OF TISAGENLECLEUCEL FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN ENGLAND","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Cytokine release syndrome; Diffuse large B-cell lymphoma; Gemcitabine; Rituximab; Hematopoietic stem cell transplantation; Oncology; Salvage therapy; Internal medicine; Lymphoma; Immunotherapy; Transplantation; Chemotherapy; Cancer; Chimeric antigen receptor","score_opus":0.03206869418140544,"score_gpt":0.34377035954052426,"score_spread":0.3117016653591188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905623501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9159272,0.015257744,0.0022720958,0.009326476,0.000278746,0.001667367,0.03364946,0.00011948492,0.021501431],"genre_scores_gemma":[0.9884935,0.002116709,0.000907535,0.0007286927,0.000043468513,0.00038698842,0.005003358,0.00002321367,0.0022964973],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99445903,0.0034150102,0.00025775243,0.00019199285,0.00070778397,0.0009685384],"domain_scores_gemma":[0.9948549,0.0021529263,0.0011117882,0.00013829613,0.00062128156,0.0011206609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004594718,0.0006732582,0.001433851,0.001216771,0.00024372361,0.0014519148,0.0010537605,0.0008612128,0.005051133],"category_scores_gemma":[0.013028606,0.00046668676,0.0025555964,0.0017939311,0.0005217427,0.0007501385,0.00139148,0.0013936881,0.0002774341],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09984998,0.0021985462,0.09345225,0.0050326856,0.008585611,0.0010623685,0.00033555584,0.52671677,0.002478655,0.0107712485,0.02963517,0.21988119],"study_design_scores_gemma":[0.035787184,0.037526794,0.6501165,0.0032013417,0.012613635,0.0011740654,0.0022845643,0.17008124,0.003132838,0.006394076,0.07733492,0.0003528857],"about_ca_topic_score_codex":0.17840157,"about_ca_topic_score_gemma":0.16300309,"teacher_disagreement_score":0.17840157,"about_ca_system_score_codex":0.015766082,"about_ca_system_score_gemma":0.012170645,"threshold_uncertainty_score":0.35472637},"labels":[],"label_agreement":null},{"id":"W2905623651","doi":"10.1016/j.jval.2018.09.1928","title":"PMU92 - CAN THE EQ-5D-3L PREDICT POST-HOSPITALIZATION HEALTHCARE USE AND OUTCOMES?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Emergency department; Logistic regression; Depression (economics); Observational study; Anxiety; EQ-5D; Emergency medicine; Health care; Physical therapy; Internal medicine; Psychiatry; Health related quality of life","score_opus":0.45160265575515557,"score_gpt":0.4077404640815757,"score_spread":0.04386219167357985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905623651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69271713,0.026422491,0.010182679,0.07144086,0.0019921674,0.0002317294,0.15458389,0.00023734507,0.042191684],"genre_scores_gemma":[0.97285664,0.0016470712,0.0019288211,0.0017103342,0.0005360988,0.0001580476,0.019553991,0.00004301535,0.0015659372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971215,0.0016584704,0.0002240288,0.00021936848,0.0004606403,0.0003159819],"domain_scores_gemma":[0.9910994,0.0047204033,0.0018973672,0.00054195407,0.001118072,0.00062279735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052071176,0.0007006717,0.0012101734,0.0015511845,0.00033301325,0.0029791556,0.0012680847,0.0015486866,0.009289439],"category_scores_gemma":[0.034260344,0.00032393303,0.0023505131,0.0030409317,0.00059623644,0.0024506152,0.0015497421,0.0021089811,0.0021979222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012667426,0.00025534298,0.86905676,0.00040429205,0.0018385414,0.00010195982,0.00013063439,0.005484402,0.000085602056,0.007973775,0.034417547,0.07898442],"study_design_scores_gemma":[0.000350844,0.0007145562,0.9222074,0.0011126669,0.00085651485,0.00039223477,0.00057980564,0.027508914,0.00030238472,0.024096003,0.021762831,0.0001157762],"about_ca_topic_score_codex":0.014611364,"about_ca_topic_score_gemma":0.009163234,"teacher_disagreement_score":0.014611364,"about_ca_system_score_codex":0.0012628885,"about_ca_system_score_gemma":0.0012844605,"threshold_uncertainty_score":0.031076312},"labels":[],"label_agreement":null},{"id":"W2905627404","doi":"10.1016/j.jval.2017.08.769","title":"Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Secukinumab; Adalimumab; Medicine; Psoriatic arthritis; Internal medicine; Arthritis; Rheumatoid arthritis","score_opus":0.34400279589064076,"score_gpt":0.4548185456381139,"score_spread":0.11081574974747316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905627404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95371073,0.03439591,0.002429902,0.002945021,0.00020321332,0.00014873446,0.0016868818,0.00002828675,0.0044513275],"genre_scores_gemma":[0.9941738,0.0032180077,0.0005504808,0.00023572822,0.00012498233,0.000064006876,0.00054784754,0.000021918842,0.0010631772],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99646854,0.0028013354,0.000092087,0.00014581448,0.0002105785,0.00028165162],"domain_scores_gemma":[0.99426055,0.0046872823,0.0005196011,0.00014816245,0.00019487753,0.00018955272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067234477,0.00097324746,0.002370244,0.0011333207,0.00017686079,0.0015698972,0.00061186025,0.001121247,0.004907473],"category_scores_gemma":[0.0075469585,0.00036504425,0.0036528718,0.0011764348,0.0004277623,0.0009084269,0.00063045614,0.0018086676,0.00018454315],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5294264,0.0023447021,0.044832204,0.0050387485,0.027654096,0.0008448336,0.0004219475,0.20341495,0.0037872312,0.011269057,0.006618293,0.1643475],"study_design_scores_gemma":[0.063840196,0.051708005,0.35249928,0.0022779354,0.08715732,0.0011005006,0.001935465,0.40391144,0.0028655962,0.015543973,0.016825907,0.00033439073],"about_ca_topic_score_codex":0.0067520086,"about_ca_topic_score_gemma":0.0037625635,"teacher_disagreement_score":0.0067520086,"about_ca_system_score_codex":0.0021445958,"about_ca_system_score_gemma":0.0008471145,"threshold_uncertainty_score":0.03555745},"labels":[],"label_agreement":null},{"id":"W2905632992","doi":"10.1016/j.jval.2018.09.1558","title":"PMD109 - A CANADIAN COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IMPLANTED AT TIME OF CATARACT SURGERY IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Prism Eye Institute","funders":"","keywords":"Medicine; Glaucoma; Quality-adjusted life year; Randomized controlled trial; Cataract surgery; Intraocular pressure; Quality of life (healthcare); Population; Surgery; Emergency medicine; Cost effectiveness; Ophthalmology","score_opus":0.026112480431253242,"score_gpt":0.2848861269923436,"score_spread":0.25877364656109036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905632992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775339,0.0034711056,0.0004962465,0.0010520216,0.000044914235,0.00028327396,0.012453438,0.00002673392,0.004638507],"genre_scores_gemma":[0.9916346,0.00072154327,0.00054069806,0.00023494817,0.000024153522,0.000057564066,0.0059376624,0.000012198167,0.0008367514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984952,0.00039564582,0.00008584037,0.00018256412,0.0004906653,0.0003500811],"domain_scores_gemma":[0.9975553,0.00081470306,0.00043896865,0.00012478231,0.0005747561,0.00049162906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001648017,0.0010813675,0.0014573198,0.0014731601,0.0007649686,0.00206357,0.0015992549,0.00090435235,0.0035883645],"category_scores_gemma":[0.0069988226,0.00054086203,0.004988318,0.00371378,0.00064501516,0.0006092765,0.0010040437,0.0015378132,0.00023134559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05023058,0.0013791649,0.7834877,0.0017470419,0.012038662,0.0014658421,0.00039625986,0.06287867,0.0017054963,0.0051010544,0.015304971,0.06426447],"study_design_scores_gemma":[0.0037997542,0.0025114783,0.92202455,0.00036385775,0.0053835195,0.00070233445,0.00069290027,0.05725649,0.00030481652,0.0006632576,0.00606576,0.0002312877],"about_ca_topic_score_codex":0.9028719,"about_ca_topic_score_gemma":0.8787335,"teacher_disagreement_score":0.09712809,"about_ca_system_score_codex":0.03957717,"about_ca_system_score_gemma":0.020442205,"threshold_uncertainty_score":0.28715384},"labels":[],"label_agreement":null},{"id":"W2905645767","doi":"10.1016/j.jval.2018.09.090","title":"PCN7 - A TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF NIRAPARIB COMPARED WITH ROUTINE SURVEILLANCE IN THE MAINTENANCE TREATMENT OF PATIENTS WITH RECURRENT OVARIAN CANCER","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Nausea; Cohort; Internal medicine; Ovarian cancer; Vomiting; Adverse effect; Toxicity; Oncology; Cancer; Gastroenterology; Surgery","score_opus":0.041604897005488584,"score_gpt":0.3369448825303392,"score_spread":0.29533998552485063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905645767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996851,0.0021293964,0.0001161511,0.00007248462,0.000028982413,0.000030477766,0.00015035155,0.000010905201,0.00061023736],"genre_scores_gemma":[0.9990258,0.00032961636,0.00013307067,0.000042941585,0.00002192468,0.000024706827,0.00019150336,0.0000038002452,0.00022665266],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9993036,0.00031707197,0.000046861605,0.00013061632,0.00012936584,0.000072532166],"domain_scores_gemma":[0.9985239,0.0005936655,0.0003754938,0.00014203906,0.000103472696,0.00026147914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012633,0.0002630737,0.0013174252,0.00027197148,0.000150752,0.00056146696,0.00041755612,0.00033928108,0.0011918957],"category_scores_gemma":[0.0026651034,0.00013022216,0.0009712138,0.000349347,0.0002790116,0.0005819352,0.00027198473,0.0011067806,0.00013808846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.48736146,0.0039363904,0.17448656,0.00067327486,0.003059907,0.000235357,0.00028883756,0.0034077244,0.01862629,0.0003598859,0.0015341314,0.30603018],"study_design_scores_gemma":[0.019178888,0.22238699,0.72238994,0.00015549206,0.005325479,0.0013611004,0.00036978102,0.012037355,0.010134339,0.0007596808,0.005797304,0.0001036334],"about_ca_topic_score_codex":0.00070789224,"about_ca_topic_score_gemma":0.0011484425,"teacher_disagreement_score":0.0013174252,"about_ca_system_score_codex":0.0005410309,"about_ca_system_score_gemma":0.0007041465,"threshold_uncertainty_score":0.0066810846},"labels":[],"label_agreement":null},{"id":"W2905661534","doi":"10.1016/j.jval.2018.09.1985","title":"PND18 - PROGRESSION OF DISABILITY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS: A RETROSPECTIVE COHORT STUDY USING DATA FROM THE MSBASE REGISTRY AND A CONTEXTUALISATION WITH AN EXISTING NATURAL HISTORY DATASET","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame","funders":"","keywords":"Natural history; Expanded Disability Status Scale; Medicine; Akaike information criterion; Cohort; Retrospective cohort study; Multiple sclerosis; Pediatrics; Demography; Internal medicine; Statistics; Psychiatry; Mathematics","score_opus":0.29451073122915267,"score_gpt":0.41892886080129244,"score_spread":0.12441812957213977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905661534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748516,0.0005675585,0.0003460601,0.00008960238,0.000021731968,0.00006058407,0.023504427,0.000015652384,0.00054276484],"genre_scores_gemma":[0.97177345,0.00033841838,0.00071236165,0.000054482123,0.000022964608,0.00017666118,0.026511589,0.000023788041,0.0003863444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767417,0.00063808274,0.0003621348,0.0008141384,0.00026155877,0.00024987763],"domain_scores_gemma":[0.99382895,0.0010192258,0.0024875188,0.0014147041,0.0007707996,0.0004788697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024765935,0.00045049225,0.00073884387,0.0017364302,0.0008242823,0.0015102639,0.001076168,0.0006615669,0.0019098823],"category_scores_gemma":[0.00862762,0.0004945141,0.0014281573,0.0039816895,0.0003912137,0.001167584,0.0017693856,0.00119869,0.00050358416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052599877,0.000059816608,0.9958305,0.00007266242,0.0005378599,0.00010155526,0.00025406582,0.00012504765,0.00008432453,0.00009088634,0.001060493,0.0012568226],"study_design_scores_gemma":[0.000035687113,0.0001060599,0.9971602,0.00005746537,0.0002919103,0.00025072473,0.00036204988,0.00023423934,0.00005850189,0.000064672924,0.0013642032,0.0000142794825],"about_ca_topic_score_codex":0.02975869,"about_ca_topic_score_gemma":0.034592196,"teacher_disagreement_score":0.02975869,"about_ca_system_score_codex":0.0008549063,"about_ca_system_score_gemma":0.0012808822,"threshold_uncertainty_score":0.05917096},"labels":[],"label_agreement":null},{"id":"W2905662036","doi":"10.1016/j.jval.2018.09.253","title":"PCN170 - COST-EFFECTIVENESS OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A CANADIAN SOCIETAL PERSPECTIVE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Salvage therapy; Oncology; Refractory (planetary science); Young adult; Pediatrics; Chemotherapy; Internal medicine","score_opus":0.024353770187356884,"score_gpt":0.31183947846377785,"score_spread":0.28748570827642095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905662036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6680303,0.1599821,0.0016011096,0.058115393,0.0008439448,0.0005482253,0.027745493,0.000108016786,0.08302536],"genre_scores_gemma":[0.9689849,0.02061095,0.0010860972,0.0018474404,0.0001881671,0.00006286708,0.004694435,0.000017099353,0.0025080263],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99873406,0.00035403497,0.00006251031,0.00008097285,0.0003601645,0.00040823058],"domain_scores_gemma":[0.9986827,0.00029451807,0.00020428181,0.000019392532,0.00031569856,0.00048335083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014355704,0.0005324523,0.00093752984,0.0009354602,0.0005493459,0.0022464637,0.00096359226,0.0008644933,0.006134905],"category_scores_gemma":[0.0043147984,0.0001910562,0.002209651,0.0019912082,0.0005582631,0.0006397274,0.00057363464,0.0014930648,0.00027242512],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02506843,0.0013316536,0.19561477,0.004029257,0.009261008,0.0015197514,0.00048346748,0.0678112,0.0017035259,0.033106945,0.07162381,0.5884462],"study_design_scores_gemma":[0.00930253,0.008138824,0.7515778,0.0054133954,0.01767705,0.00217147,0.0035089676,0.044875376,0.0015896331,0.013121355,0.14220282,0.00042071982],"about_ca_topic_score_codex":0.8296653,"about_ca_topic_score_gemma":0.9001409,"teacher_disagreement_score":0.1703347,"about_ca_system_score_codex":0.037736196,"about_ca_system_score_gemma":0.03976057,"threshold_uncertainty_score":0.34267563},"labels":[],"label_agreement":null},{"id":"W2905683464","doi":"10.1016/j.jval.2018.09.2294","title":"PRM175 - EQ-5D-3L VS. EQ-5D-5L: A CROSS-SECTIONAL COMPARISON OF MEASUREMENT PROPERTIES AMONG TOTAL HIP AND KNEE REPLACEMENT PATIENTS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"EQ-5D; WOMAC; Medicine; Physical therapy; Body mass index; Knee replacement; Spearman's rank correlation coefficient; Arthroplasty; Statistics; Health related quality of life; Mathematics; Osteoarthritis; Internal medicine; Surgery","score_opus":0.6275389110596924,"score_gpt":0.40456614060292706,"score_spread":0.22297277045676533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905683464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603623,0.00043323907,0.0004206201,0.00012012895,0.000024717372,0.00002503768,0.0024823651,0.000012405677,0.0004452357],"genre_scores_gemma":[0.99589705,0.00010185789,0.00021889234,0.000065571825,0.00001999698,0.000033982484,0.0034941053,0.000010553506,0.00015814291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967693,0.0018209204,0.00030891207,0.00042280613,0.00046228184,0.00021582944],"domain_scores_gemma":[0.9808264,0.010208924,0.005421195,0.0016798547,0.001167954,0.00069570664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008978447,0.00067246245,0.000879947,0.0018029193,0.000350393,0.0015707809,0.0012984364,0.0014202225,0.0026743347],"category_scores_gemma":[0.03233961,0.00042403408,0.0021269042,0.0026142523,0.00057082553,0.0018711194,0.0016442515,0.0013389374,0.00079308345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017080351,0.00016524048,0.9925702,0.000035087403,0.0009075853,0.00002005034,0.00013834299,0.00045990173,0.000102874874,0.00026032692,0.00049135805,0.0031409238],"study_design_scores_gemma":[0.000121619065,0.0006846059,0.9957749,0.000019026817,0.00028664025,0.000092803486,0.00026365442,0.002024202,0.000108448614,0.00024742523,0.00035460605,0.00002204789],"about_ca_topic_score_codex":0.004213559,"about_ca_topic_score_gemma":0.0023812493,"teacher_disagreement_score":0.008978447,"about_ca_system_score_codex":0.00061571354,"about_ca_system_score_gemma":0.0004174755,"threshold_uncertainty_score":0.047483087},"labels":[],"label_agreement":null},{"id":"W2905687536","doi":"10.1016/j.jval.2018.09.578","title":"PCV31 - ANTICOAGULANTS IN OLDER PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AFTER INTRACRANIAL HEMORRHAGE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Hazard ratio; Confidence interval; Cohort; Internal medicine; Intracerebral hemorrhage; Stroke (engine); Proportional hazards model; Cardiology","score_opus":0.030059225787707207,"score_gpt":0.31224019076357296,"score_spread":0.28218096497586576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905687536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98607093,0.008615574,0.000087575405,0.00091544056,0.000118169926,0.000016838643,0.00029308657,0.000004860521,0.0038775464],"genre_scores_gemma":[0.9964011,0.002280296,0.00009846675,0.0003431211,0.00026698786,0.000008423227,0.00027931642,0.0000013400636,0.00032090372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995426,0.00010260504,0.000089441826,0.000046568228,0.00011362597,0.00010512994],"domain_scores_gemma":[0.9984297,0.0004707027,0.000662628,0.000042344032,0.000099390745,0.00029517757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034146672,0.00017276815,0.0005238913,0.0005344926,0.0002795692,0.00084029906,0.00017776106,0.0006371919,0.0018167633],"category_scores_gemma":[0.0046063834,0.000110609384,0.0005737208,0.0010060545,0.00019282963,0.0006471306,0.00034895356,0.00095332734,0.00013983487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016120096,0.00022504192,0.97083044,0.0001180271,0.0003193955,0.00058616966,0.00011955535,0.00008138183,0.00020344826,0.00015725988,0.000734686,0.025012525],"study_design_scores_gemma":[0.00018691474,0.0007435323,0.99490803,0.00013874318,0.0003770898,0.0011595897,0.00034138648,0.00034699708,0.00010052042,0.00046146242,0.0012202702,0.000015486843],"about_ca_topic_score_codex":0.0024406663,"about_ca_topic_score_gemma":0.00487706,"teacher_disagreement_score":0.0024406663,"about_ca_system_score_codex":0.00029843178,"about_ca_system_score_gemma":0.0005095022,"threshold_uncertainty_score":0.006077647},"labels":[],"label_agreement":null},{"id":"W2905693631","doi":"10.1016/j.jval.2018.09.2476","title":"PRS83 - PATIENT PERSPECTIVE ON MEDICATION ADHERENCE IN ASTHMA: A SYSTEMATIC REVIEW OF THE LITERATURE","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Asthma; Discontinuation; Observational study; Inhaler; MEDLINE; Intensive care medicine; Family medicine; Systematic review; Disease; Physical therapy; Pediatrics; Psychiatry; Internal medicine","score_opus":0.04470704873582795,"score_gpt":0.3780196122531596,"score_spread":0.33331256351733163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905693631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011473846,0.99797195,0.000048579772,0.00034320337,0.00007243745,0.000037538754,0.00017368938,0.0000015474925,0.00020356312],"genre_scores_gemma":[0.022263624,0.97634435,0.0003911031,0.00058980926,0.0001353556,0.00008513324,0.00013466625,0.0000014583892,0.000054608765],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99132407,0.0034873926,0.0028324248,0.00063875865,0.0015157334,0.00020160346],"domain_scores_gemma":[0.9686161,0.02511274,0.0045069554,0.00026607423,0.0012286217,0.00026950528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007295132,0.0009094415,0.005017547,0.005316654,0.0005275116,0.0025218714,0.001196974,0.0022560786,0.004488423],"category_scores_gemma":[0.04174879,0.00058369973,0.0059801,0.0072125257,0.0007387284,0.0021843808,0.0016176237,0.0018353777,0.0001745019],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041538116,0.000056884244,0.0062540993,0.8468708,0.017535208,0.00017792074,0.00057609007,0.000113371374,0.000114070775,0.0006140824,0.0027807157,0.124491416],"study_design_scores_gemma":[0.00039883613,0.00027961234,0.022313423,0.85671747,0.08905302,0.00093868864,0.0009958477,0.000170336,0.00013271565,0.00075344334,0.028173964,0.00007276262],"about_ca_topic_score_codex":0.0063495925,"about_ca_topic_score_gemma":0.020025738,"teacher_disagreement_score":0.007295132,"about_ca_system_score_codex":0.0019150766,"about_ca_system_score_gemma":0.0064251306,"threshold_uncertainty_score":0.038580775},"labels":[],"label_agreement":null},{"id":"W2905731813","doi":"10.1016/j.jval.2018.09.170","title":"PCN88 - NET IMPACT ANALYSIS OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF ADULTS WITH MULTIPLE MYELOMA FOR QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Ixazomib; Lenalidomide; Carfilzomib; Multiple myeloma; Medicine; Dexamethasone; Intensive care medicine; Oncology; Internal medicine","score_opus":0.04407377388686907,"score_gpt":0.3565733311433827,"score_spread":0.3124995572565136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905731813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8773481,0.027293352,0.0011675665,0.0056704003,0.0002225722,0.0011234157,0.06756751,0.00012419627,0.01948284],"genre_scores_gemma":[0.9822649,0.003238183,0.00085064815,0.0007309195,0.00005464353,0.00016760305,0.010210733,0.000022048524,0.002460289],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985751,0.00057652296,0.00006217665,0.000109358254,0.0003810695,0.00029586544],"domain_scores_gemma":[0.9980247,0.0005084246,0.00038197017,0.000053115702,0.00062191923,0.00040984884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023099962,0.00049691735,0.001313471,0.00055811676,0.00034919716,0.0009786577,0.0009317088,0.00036875132,0.0054395],"category_scores_gemma":[0.0039788727,0.00017510445,0.0027399175,0.0012730962,0.00025394082,0.00028478715,0.0005792654,0.0008215256,0.0002552582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11231561,0.0019761848,0.45182794,0.004806076,0.03430147,0.00056889676,0.00021136564,0.11522773,0.0031537104,0.0030557832,0.04690584,0.22564936],"study_design_scores_gemma":[0.014678864,0.011152287,0.8823053,0.0011526638,0.019559355,0.00016800791,0.00042387636,0.040951587,0.00089778414,0.0006605939,0.027952008,0.00009759319],"about_ca_topic_score_codex":0.909427,"about_ca_topic_score_gemma":0.94193137,"teacher_disagreement_score":0.09057301,"about_ca_system_score_codex":0.025838904,"about_ca_system_score_gemma":0.021473015,"threshold_uncertainty_score":0.18747526},"labels":[],"label_agreement":null},{"id":"W2905747065","doi":"10.1016/j.jval.2018.09.2288","title":"PRM169 - RESPONSIVENESS OF THE EQ-5D-5L AND EQ-5D-3L IN PATIENTS FOLLOWING TOTAL HIP OR KNEE REPLACEMENT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"WOMAC; EQ-5D; Medicine; Physical therapy; Osteoarthritis; Total hip replacement; Health related quality of life; Surgery; Internal medicine","score_opus":0.3531582670757215,"score_gpt":0.39037770457500764,"score_spread":0.037219437499286134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905747065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914171,0.0011708961,0.00016542923,0.0014622676,0.00010809661,0.00001852867,0.0020121401,0.000009147164,0.0036363935],"genre_scores_gemma":[0.9983991,0.000120072196,0.000032396823,0.00017961877,0.000040604933,0.0000062525737,0.0009860955,0.0000027389815,0.00023310236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848855,0.00061692274,0.00018404039,0.00015613111,0.00021362664,0.00034066866],"domain_scores_gemma":[0.9941632,0.0028044812,0.0016931931,0.00030838163,0.00044601847,0.0005847647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00175304,0.00022831373,0.0006199016,0.00055266486,0.0003194164,0.0014430996,0.00052748015,0.0010435688,0.0060591414],"category_scores_gemma":[0.018563507,0.00020909491,0.0015325228,0.001177035,0.0004361319,0.001012614,0.0009909775,0.0022156758,0.001078971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014768941,0.00014304333,0.98582286,0.00006219208,0.00036125618,0.00035517482,0.00018754232,0.0005807588,0.0002507799,0.0004230501,0.0013495889,0.008986916],"study_design_scores_gemma":[0.000028260669,0.00019177911,0.9976802,0.00001969497,0.000080364705,0.00017162284,0.00028312966,0.0005727676,0.00005530791,0.0003946023,0.00050938927,0.000012805938],"about_ca_topic_score_codex":0.006065347,"about_ca_topic_score_gemma":0.0033803436,"teacher_disagreement_score":0.006065347,"about_ca_system_score_codex":0.0006438562,"about_ca_system_score_gemma":0.00073511177,"threshold_uncertainty_score":0.02026987},"labels":[],"label_agreement":null},{"id":"W2905766015","doi":"10.1016/j.jval.2018.09.2303","title":"PRM185 - COMPARISON OF THE MEASUREMENT PROPERTIES OF THE EQ-5D-5L AND EQ-5D-3L IN PATIENTS WITH CROHN’S DISEASE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"EQ-5D; Ceiling effect; Medicine; Crohn's disease; Physical therapy; Internal medicine; Quality of life (healthcare); Gastroenterology; Disease; Health related quality of life","score_opus":0.0674422719778096,"score_gpt":0.25286739843575806,"score_spread":0.18542512645794845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905766015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98678386,0.0017857586,0.0010785315,0.000413978,0.00007532743,0.000055959055,0.005377575,0.00003145353,0.0043975995],"genre_scores_gemma":[0.99610424,0.00016644625,0.00038490735,0.000094481176,0.000028825656,0.000034143577,0.0028312744,0.0000118411435,0.00034377322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978986,0.0009250936,0.00024644175,0.00029757724,0.00043219965,0.00020002869],"domain_scores_gemma":[0.9929011,0.0042023794,0.0013524677,0.000387224,0.0009340829,0.00022285689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039695613,0.0004761245,0.0009237187,0.0010259701,0.00027100343,0.00167344,0.0006177697,0.0008137612,0.003077979],"category_scores_gemma":[0.01824587,0.00021253183,0.0018192676,0.001685038,0.0003210684,0.0011176303,0.0010955548,0.000936339,0.0009990418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002892254,0.00009601036,0.97410405,0.00014220974,0.00073299254,0.00008526286,0.00015400608,0.00079317176,0.0005343575,0.00032396233,0.00076768186,0.019374015],"study_design_scores_gemma":[0.000115547744,0.0007085908,0.99460137,0.00003799438,0.00028520418,0.00021679197,0.00021764087,0.00213414,0.00031135592,0.00025638126,0.0010937395,0.000021161019],"about_ca_topic_score_codex":0.0026110688,"about_ca_topic_score_gemma":0.0012860469,"teacher_disagreement_score":0.0039695613,"about_ca_system_score_codex":0.00062892336,"about_ca_system_score_gemma":0.00037277787,"threshold_uncertainty_score":0.020993292},"labels":[],"label_agreement":null},{"id":"W2905768002","doi":"10.1016/j.jval.2018.09.1276","title":"PIH11 - ANTIEMETIC USE IN PREGNANCY AND THE RISK OF MAJOR CONGENITAL MALFORMATIONS: A POPULATION-BASED COHORT STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ondansetron; Medicine; Metoclopramide; Pregnancy; Antiemetic; Pyridoxine; Nausea; Cohort; Vomiting; Obstetrics; Anesthesia; Internal medicine","score_opus":0.038751097454649906,"score_gpt":0.3251436682894239,"score_spread":0.28639257083477404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905768002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99827254,0.00033023403,0.0001343968,0.00006128923,0.000011885833,0.000014332596,0.000803365,0.000004300755,0.00036757623],"genre_scores_gemma":[0.99872106,0.00024756038,0.00012253808,0.000048777532,0.000014192567,0.000018917495,0.00044577432,0.00000509188,0.00037606884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999271,0.00016389295,0.000068108355,0.0002537768,0.000101504374,0.0001417475],"domain_scores_gemma":[0.9986527,0.00020994461,0.00043550474,0.00028734995,0.00014140332,0.00027310924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070714456,0.00058805535,0.00054616143,0.00071637233,0.00094870804,0.0011864495,0.0006974177,0.0011558463,0.0024192964],"category_scores_gemma":[0.0021874292,0.0010251723,0.001446343,0.0017219097,0.00042481214,0.0008448412,0.0007656457,0.0016483229,0.00039802009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035023506,0.0000915704,0.9975496,0.0000115024095,0.0004214812,0.00017359121,0.00011682705,0.000030194265,0.00036896608,0.00003100046,0.00014011921,0.0007149975],"study_design_scores_gemma":[0.00004406758,0.00025879339,0.99798405,0.000011693428,0.00029539719,0.0005735387,0.00031195013,0.00018667067,0.00006921777,0.000033498734,0.00021807972,0.0000130354365],"about_ca_topic_score_codex":0.01725559,"about_ca_topic_score_gemma":0.014020407,"teacher_disagreement_score":0.01725559,"about_ca_system_score_codex":0.00047829814,"about_ca_system_score_gemma":0.00064089854,"threshold_uncertainty_score":0.03431034},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2905771584","doi":"10.1016/j.jval.2018.09.428","title":"PCN346 - DISEASE SPECIFIC COST ANALYSIS OF THE NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER HEALTH STATES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Prostate cancer; Medicine; Disease; Oncology; Cancer; Radiation therapy; Prostate; Internal medicine; Cohort; Medical prescription; Metastasis; Castration; Pharmacology","score_opus":0.08198804906189198,"score_gpt":0.38275112796108274,"score_spread":0.30076307889919074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905771584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9495132,0.003978657,0.005248064,0.0015891126,0.00012584511,0.0003807125,0.022349603,0.000101447804,0.016713463],"genre_scores_gemma":[0.9888313,0.0004256671,0.0012314871,0.00011431175,0.000023957478,0.000060215196,0.0063368953,0.00001658562,0.0029596873],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99867743,0.0006225723,0.00004454166,0.00013897374,0.00021690664,0.00029953703],"domain_scores_gemma":[0.9980787,0.0011264958,0.00020116298,0.000094236806,0.00030952203,0.00018994685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020749369,0.0007910858,0.0015153468,0.0015508123,0.00029399613,0.0014403386,0.001266594,0.0006521418,0.006623401],"category_scores_gemma":[0.0052122623,0.0005663602,0.0027474142,0.002548623,0.00037553417,0.0011484141,0.00081128784,0.0011328392,0.0002552594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048536016,0.00046795764,0.05565619,0.00048467136,0.0022745323,0.0003918107,0.0000652154,0.88730687,0.00048663327,0.017371122,0.007872325,0.022769067],"study_design_scores_gemma":[0.0008173083,0.0014550476,0.11943362,0.00015547543,0.0019889667,0.0004674574,0.00046472842,0.85774213,0.0005382534,0.00889706,0.0079419445,0.00009799429],"about_ca_topic_score_codex":0.09572822,"about_ca_topic_score_gemma":0.07432611,"teacher_disagreement_score":0.09572822,"about_ca_system_score_codex":0.004665864,"about_ca_system_score_gemma":0.003691069,"threshold_uncertainty_score":0.19034201},"labels":[],"label_agreement":null},{"id":"W2905838767","doi":"10.1016/j.jval.2018.09.2310","title":"PRM192 - TYPE 2 DIABETES MELLITUS: LACK OF GOOD PRACTICES FOR REAL-WORLD EVIDENCE STUDIES.","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Psychological intervention; Sample size determination; Protocol (science); Randomized controlled trial; Intervention (counseling); Population; Productivity; Research design; Type 2 Diabetes Mellitus; Clinical study design; Clinical trial; MEDLINE; Family medicine; Environmental health; Intensive care medicine; Alternative medicine; Diabetes mellitus; Surgery; Internal medicine; Nursing","score_opus":0.7956857768788268,"score_gpt":0.5618158084824325,"score_spread":0.2338699683963943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905838767","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008167055,0.8630118,0.008550194,0.09850011,0.0041675144,0.0008708473,0.00625587,0.00013586637,0.010340748],"genre_scores_gemma":[0.33424088,0.5295976,0.07056396,0.047708955,0.006888972,0.003087576,0.006329017,0.00034595653,0.0012370921],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.78168005,0.14495519,0.041669413,0.00743487,0.022892004,0.0013684641],"domain_scores_gemma":[0.3604975,0.5061423,0.06240825,0.027479455,0.03930597,0.0041664867],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20533274,0.0010125219,0.0039139274,0.00797021,0.00106016,0.007906727,0.0053946874,0.003432906,0.006610093],"category_scores_gemma":[0.48772836,0.0012993799,0.0044388636,0.010029968,0.0033628244,0.006072345,0.0041391007,0.0067946413,0.0015861486],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003455063,0.00022440837,0.02667274,0.10214823,0.017173002,0.00024099027,0.00092127884,0.00080024014,0.00023145217,0.018707486,0.077125676,0.7522994],"study_design_scores_gemma":[0.0032275694,0.0011680556,0.062856965,0.4980737,0.028845115,0.0014551305,0.0023175976,0.0025088438,0.0016577306,0.058131,0.33947387,0.0002844906],"about_ca_topic_score_codex":0.0073391395,"about_ca_topic_score_gemma":0.011453017,"teacher_disagreement_score":0.79466724,"about_ca_system_score_codex":0.0035626919,"about_ca_system_score_gemma":0.009011567,"threshold_uncertainty_score":0.9799662},"labels":[],"label_agreement":null},{"id":"W2905843948","doi":"10.1016/j.jval.2018.09.382","title":"PCN300 - MODERN TRENDS OF ORCHIECTOMY FOR PROSTATE CANCER","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Orchiectomy; Medicine; Androgen deprivation therapy; Prostate cancer; Odds ratio; Urology; Logistic regression; Confidence interval; Cohort; Internal medicine; Cancer","score_opus":0.061809588052491475,"score_gpt":0.3756561472565735,"score_spread":0.313846559204082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905843948","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35569566,0.38597623,0.006082626,0.061988745,0.005451568,0.00023109048,0.029336521,0.00064065214,0.154597],"genre_scores_gemma":[0.743377,0.19372348,0.0062197293,0.008184229,0.0048316834,0.000104221166,0.016803274,0.00022524121,0.026531156],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993463,0.00007882862,0.00007084371,0.00012850936,0.00023878261,0.00013670088],"domain_scores_gemma":[0.9971494,0.00037479762,0.0007498015,0.00007264827,0.0008761839,0.0007771685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076922,0.00019922396,0.00018924948,0.0019015453,0.00033664712,0.00120902,0.00046003697,0.00043902715,0.010226912],"category_scores_gemma":[0.002626485,0.00010186357,0.00038163192,0.004441166,0.0004561648,0.0011021023,0.0007240453,0.0016192404,0.0019051905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007102253,0.00026902603,0.27171588,0.0019382717,0.00013773226,0.00037849686,0.00029124957,0.0012113361,0.0023297288,0.022138366,0.08663407,0.6122456],"study_design_scores_gemma":[0.000032567757,0.000309819,0.52901834,0.0009880761,0.00009219557,0.0024169458,0.00057467964,0.0009908692,0.0013156957,0.0031965969,0.4610143,0.000049927534],"about_ca_topic_score_codex":0.011425764,"about_ca_topic_score_gemma":0.021445686,"teacher_disagreement_score":0.011425764,"about_ca_system_score_codex":0.0022760394,"about_ca_system_score_gemma":0.003449866,"threshold_uncertainty_score":0.03421241},"labels":[],"label_agreement":null},{"id":"W2905855316","doi":"10.1016/j.jval.2018.09.2292","title":"PRM173 - DISCRIMINATIVE VALIDITY OF THE EQ-5D-5L AND SF-12 IN OLDER ADULTS WITH ARTHRITIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; EQ-5D; Body mass index; Quality of life (healthcare); Arthritis; Physical therapy; Discriminative model; SF-36; Internal medicine; Health related quality of life; Disease","score_opus":0.35857795981761786,"score_gpt":0.3813336790564049,"score_spread":0.022755719238787053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905855316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99374396,0.0010002236,0.00019601792,0.00039568826,0.000056014207,0.000020925072,0.0019354164,0.0000070470237,0.0026447533],"genre_scores_gemma":[0.99766684,0.00016003524,0.00012602803,0.00009898196,0.00004071217,0.0000141891915,0.0014980214,0.000004581207,0.00039062946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975763,0.0009046164,0.00040759853,0.00029383905,0.0004601835,0.00035746145],"domain_scores_gemma":[0.9938823,0.0025813254,0.0019306113,0.00039990584,0.00079645007,0.00040945222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045308936,0.00058537954,0.00081323757,0.0013298849,0.00039625436,0.0014839458,0.0006417659,0.0010881268,0.003723721],"category_scores_gemma":[0.019596267,0.00034494247,0.0022968003,0.0014035224,0.0005143179,0.0011086102,0.0014891742,0.0013940798,0.0008694846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003632298,0.00006803295,0.992477,0.00003704514,0.00023693035,0.00004751264,0.00013482747,0.00014449544,0.000106502805,0.000150759,0.00035962305,0.0058738943],"study_design_scores_gemma":[0.000022418517,0.00010833017,0.9983443,0.000022470958,0.00010361572,0.00009782447,0.00017353229,0.000445597,0.000059694463,0.00024100521,0.00037333512,0.000007873896],"about_ca_topic_score_codex":0.0067061023,"about_ca_topic_score_gemma":0.0075672967,"teacher_disagreement_score":0.0067061023,"about_ca_system_score_codex":0.00046306817,"about_ca_system_score_gemma":0.0005543851,"threshold_uncertainty_score":0.023961961},"labels":[],"label_agreement":null},{"id":"W2905885911","doi":"10.1016/j.jval.2018.09.2137","title":"PRM13 - THE FLAWED RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health technology; Panel discussion; Equity (law); Actuarial science; Empirical evidence; Discounting; Health economics; Economics; Positive economics; Management science; Health care; Political science; Business; Law","score_opus":0.6070789669914266,"score_gpt":0.48456448744048564,"score_spread":0.12251447955094097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905885911","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057630957,0.008984246,0.015623673,0.8972115,0.049142644,0.00072479557,0.005477105,0.0005109604,0.021748867],"genre_scores_gemma":[0.009124901,0.0049540596,0.06331793,0.87116534,0.03322329,0.0025577475,0.0021069376,0.0007208265,0.012828933],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.7275279,0.097179264,0.040848557,0.0150814885,0.10925631,0.010106389],"domain_scores_gemma":[0.45309964,0.30776653,0.020177962,0.039743967,0.16650003,0.012711883],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22183014,0.004685993,0.0100111365,0.0107163,0.005421665,0.024793593,0.01798231,0.08731698,0.012954536],"category_scores_gemma":[0.54672426,0.005550954,0.016184716,0.01078357,0.014571009,0.012418047,0.015324814,0.111053735,0.017934822],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015898736,0.000102271115,0.00052798894,0.0011817957,0.0003877144,0.00010819149,0.0003970943,0.0006007384,0.00023475576,0.046775002,0.9264044,0.023121012],"study_design_scores_gemma":[0.0007340993,0.00017184003,0.005057837,0.015246633,0.0013719378,0.00037635467,0.0003552417,0.0023952203,0.0013414861,0.12873127,0.8436397,0.0005783672],"about_ca_topic_score_codex":0.042508394,"about_ca_topic_score_gemma":0.036815234,"teacher_disagreement_score":0.7781699,"about_ca_system_score_codex":0.010815989,"about_ca_system_score_gemma":0.041008085,"threshold_uncertainty_score":0.95962197},"labels":[],"label_agreement":null},{"id":"W2905886417","doi":"10.1016/j.jval.2018.09.2530","title":"PSS30 - COST EFFECTIVENESS OF DIMETHYL FUMARATE (DMF) IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS: A UK PERSPECTIVE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Ustekinumab; Cohort; Cost effectiveness; Dimethyl fumarate; Cost-effectiveness analysis; Psoriasis; Internal medicine; Physical therapy; Disease","score_opus":0.3661798865923854,"score_gpt":0.4509577385647107,"score_spread":0.08477785197232535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905886417","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3753012,0.41843027,0.0035692852,0.09621648,0.0021534197,0.00032422773,0.024674932,0.00013322283,0.07919697],"genre_scores_gemma":[0.95953244,0.0306594,0.00084930955,0.002753509,0.0007251717,0.00010811113,0.0027002434,0.000027337122,0.0026443594],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9910522,0.0063826754,0.00055683526,0.00030529257,0.0011472073,0.00055584416],"domain_scores_gemma":[0.99029434,0.0060463953,0.0016483525,0.00014981485,0.0010802842,0.0007807577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005269843,0.00072162604,0.0018737002,0.001359173,0.00024393933,0.0024080148,0.0005704288,0.0025300786,0.00899087],"category_scores_gemma":[0.016872196,0.00033287582,0.0031789066,0.0015387726,0.000792051,0.0011023155,0.0010758825,0.0026350177,0.00064955576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.097528696,0.0010602846,0.05150339,0.020526323,0.012958602,0.0018763477,0.00054168736,0.108201794,0.00481606,0.06757658,0.07762517,0.55578506],"study_design_scores_gemma":[0.034131482,0.042462148,0.53442854,0.028196404,0.024194088,0.007381628,0.002681791,0.071534194,0.0037090513,0.048211273,0.20224142,0.0008279564],"about_ca_topic_score_codex":0.024643144,"about_ca_topic_score_gemma":0.020985072,"teacher_disagreement_score":0.024643144,"about_ca_system_score_codex":0.006552984,"about_ca_system_score_gemma":0.0036206276,"threshold_uncertainty_score":0.04899943},"labels":[],"label_agreement":null},{"id":"W2905890547","doi":"10.1016/j.jval.2018.09.1917","title":"PMU81 - PHYSICIANS' PREFERENCES WITH RESPECT TO ADHERENCE PROGRAMS: A DISCRETE CHOICE EXPERIMENT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Certificate; Medicine; Family medicine; Quarter (Canadian coin); Compensation (psychology); Nursing; Psychology; Social psychology; Computer science","score_opus":0.3218619123561217,"score_gpt":0.47068049493074166,"score_spread":0.14881858257461994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905890547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363434,0.000028018427,0.0012284761,0.0004513765,0.00012110778,0.0011531378,0.00028957592,0.000023967807,0.0030700143],"genre_scores_gemma":[0.9855334,0.000043877233,0.0044313907,0.000430625,0.00011225898,0.004423908,0.00020315926,0.000013120394,0.004808163],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.992074,0.0051697157,0.0006703019,0.0006982814,0.00058971153,0.0007979413],"domain_scores_gemma":[0.95333725,0.039083313,0.0024670877,0.002310689,0.0005259661,0.0022757745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009007561,0.00095991656,0.0010985777,0.0004349036,0.0013895815,0.002907111,0.001057424,0.004835193,0.023718614],"category_scores_gemma":[0.030163402,0.0010116878,0.00082511717,0.00039169154,0.0017017396,0.0013604006,0.0010884011,0.003665451,0.0026461768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.62275547,0.22775939,0.022408308,0.00073094387,0.0005811678,0.0005578312,0.0060892566,0.016038235,0.03813509,0.015471987,0.0034158935,0.046056505],"study_design_scores_gemma":[0.3030759,0.4400008,0.085492164,0.0002487044,0.0014427694,0.00040980653,0.0052782367,0.09319099,0.026313161,0.027155593,0.016739914,0.00065196946],"about_ca_topic_score_codex":0.0011501148,"about_ca_topic_score_gemma":0.0007093587,"teacher_disagreement_score":0.023718614,"about_ca_system_score_codex":0.00074550876,"about_ca_system_score_gemma":0.0019177018,"threshold_uncertainty_score":0.07934672},"labels":[],"label_agreement":null},{"id":"W2905900238","doi":"10.1016/j.jval.2018.09.1179","title":"PHP285 - EXPERTS IN HEALTH TECHNOLOGY ASSESSMENT ARE CONCERNED ABOUT THE TRANSLATION FROM EVIDENCE TO DECISION-MAKING","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Reimbursement; Health technology; Knowledge translation; Relevance (law); Government (linguistics); Evidence-based practice; Evidence-based medicine; Psychology; Management science; Medical education; Medicine; Public relations; MEDLINE; Political science; Knowledge management; Health care; Computer science; Alternative medicine; Economics","score_opus":0.19430038570837205,"score_gpt":0.48765147036599216,"score_spread":0.2933510846576201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905900238","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037289085,0.0025748787,0.0021177607,0.96384597,0.00847582,0.00009362408,0.00018157795,0.00007162243,0.022265797],"genre_scores_gemma":[0.012472629,0.0061023543,0.009503749,0.89482903,0.04288088,0.00039618765,0.00038242788,0.00029002439,0.03314264],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9341131,0.029361418,0.009214643,0.0027074872,0.020616865,0.0039865742],"domain_scores_gemma":[0.45657238,0.41347173,0.01856689,0.020658828,0.06786683,0.022863276],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09831973,0.00092193106,0.0024128018,0.0024036407,0.0034144416,0.0127660725,0.005407326,0.07173819,0.040672895],"category_scores_gemma":[0.34176952,0.001638626,0.001993603,0.003610412,0.013507937,0.014883506,0.011515817,0.057795193,0.024419142],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012010327,0.00012332136,0.0006861609,0.0012326299,0.00003929892,0.00038827703,0.0009059467,0.00032965987,0.00059264124,0.03828641,0.87966883,0.077626735],"study_design_scores_gemma":[0.00020610866,0.00008618723,0.001536499,0.0028950123,0.000028494756,0.0006965142,0.0005626031,0.0006411015,0.0006076212,0.101650886,0.8910207,0.00006821906],"about_ca_topic_score_codex":0.0047150026,"about_ca_topic_score_gemma":0.007462377,"teacher_disagreement_score":0.9016803,"about_ca_system_score_codex":0.004969318,"about_ca_system_score_gemma":0.02680288,"threshold_uncertainty_score":0.51997066},"labels":[],"label_agreement":null},{"id":"W2905902014","doi":"10.1016/j.jval.2018.09.168","title":"PCN86 - VALIDATION OF THE IMPACT OF TREATMENT EVOLUTION IN NON-SMALL CELL LUNG CANCER (NSCLC) MODEL (ITEN): A DISCRETE EVENT PATIENT SIMULATION","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Cancer registry; Lung cancer; Medical record; Oncology; Internal medicine; Survival analysis; Cancer","score_opus":0.23811520941958197,"score_gpt":0.43236938186880974,"score_spread":0.19425417244922777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905902014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589535,0.00034986515,0.02466141,0.0011577212,0.00016748976,0.00022020354,0.0041478095,0.0004076195,0.009934319],"genre_scores_gemma":[0.9884116,0.000068745285,0.0073839175,0.00013366512,0.000020751368,0.00012133425,0.0021902418,0.000035490186,0.0016343035],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990388,0.000589017,0.000037086993,0.00013211906,0.00008888464,0.00011419872],"domain_scores_gemma":[0.98643535,0.011333521,0.0004043439,0.0005165998,0.00092288444,0.00038728048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037759156,0.0007540589,0.001206496,0.0004728772,0.0004384485,0.0008164568,0.0016626781,0.0021470718,0.0047786776],"category_scores_gemma":[0.010899881,0.0004707432,0.0011828132,0.00039771476,0.0006947162,0.00046274712,0.00085276493,0.0020565386,0.000419881],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023890102,0.00016865467,0.002058622,0.000040216124,0.000039286282,0.00002898104,0.000010760695,0.99458367,0.00008549342,0.00070425513,0.00060990383,0.0014312834],"study_design_scores_gemma":[0.00014278841,0.000107516455,0.00054151245,0.000007893218,0.000015106963,0.000008753109,0.000007682751,0.99858236,0.00015077494,0.00026357628,0.00016703737,0.00000492138],"about_ca_topic_score_codex":0.047417235,"about_ca_topic_score_gemma":0.02431313,"teacher_disagreement_score":0.047417235,"about_ca_system_score_codex":0.0015102258,"about_ca_system_score_gemma":0.0025282153,"threshold_uncertainty_score":0.09428245},"labels":[],"label_agreement":null},{"id":"W2905902881","doi":"10.1016/j.jval.2018.09.2554","title":"PSS54 - ETHICAL VALIDATION PROCESS FOR VIDEO RECORDED QUALITATIVE INTERVIEWS: EXPERIENCE FROM A RESEARCH PROJECT IN DERMATOLOGY IN FRANCE AND CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Big Data and Business Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Research ethics; Ethics committee; Informed consent; Qualitative research; Institutional review board; Medical education; Psychology; European commission; Medicine; Family medicine; Political science; Alternative medicine; Sociology; Pathology; Business; Social science; Surgery","score_opus":0.395727625209408,"score_gpt":0.5115420759320097,"score_spread":0.11581445072260171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905902881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5334907,0.00071835925,0.23276332,0.017335976,0.0017534982,0.13641337,0.0035040579,0.0012284099,0.07279225],"genre_scores_gemma":[0.6405039,0.00047637228,0.14714889,0.0045028427,0.00024456525,0.17161414,0.001696967,0.0009473352,0.032865006],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.8488128,0.12440749,0.0055859513,0.0052403365,0.009070137,0.006883203],"domain_scores_gemma":[0.65492207,0.17311893,0.007531053,0.027468937,0.12705179,0.009907227],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.1530088,0.0012623167,0.0009927427,0.0028173903,0.020530745,0.008427103,0.003304457,0.0031310709,0.012385183],"category_scores_gemma":[0.21222217,0.0016386703,0.0010696383,0.0026232107,0.013186567,0.0030003067,0.008373201,0.0062721637,0.0038690325],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003374051,0.0002443537,0.0027967198,0.0006102015,0.000011805646,0.0006605627,0.934583,0.00040769117,0.00885861,0.0064541837,0.010177187,0.03485832],"study_design_scores_gemma":[0.00025431902,0.0003919959,0.009285709,0.00173942,0.000028793846,0.00031697983,0.8306239,0.0016651334,0.00900915,0.0057256087,0.14080347,0.00015551221],"about_ca_topic_score_codex":0.085215524,"about_ca_topic_score_gemma":0.1515033,"teacher_disagreement_score":0.9968689,"about_ca_system_score_codex":0.028206637,"about_ca_system_score_gemma":0.09430169,"threshold_uncertainty_score":0.80919755},"labels":[],"label_agreement":null},{"id":"W2905912394","doi":"10.1016/j.jval.2018.09.535","title":"PCP60 - EVOLVING STRATEGIES FOR GENERATING, SYNTHESIZING, AND VISUALIZING REAL WORLD EVIDENCE IN RARE DISEASES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Alkaline Phosphatase Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Computer science; Checklist; Data science; Presentation (obstetrics); Data collection; Medicine; Psychology","score_opus":0.16128416007011498,"score_gpt":0.4472253362674338,"score_spread":0.28594117619731885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905912394","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047199237,0.00090343243,0.9684004,0.0028419832,0.00018453965,0.0004817291,0.0028340763,0.015879553,0.0037542528],"genre_scores_gemma":[0.027654987,0.0005843084,0.9672869,0.0002588786,0.000054153268,0.00029356754,0.0015547224,0.0013754047,0.0009371622],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9883669,0.00585751,0.0016624125,0.0013177877,0.0025681052,0.00022740358],"domain_scores_gemma":[0.90736544,0.06810539,0.0028543456,0.009809957,0.009811595,0.0020533805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02834986,0.0016122452,0.0017181099,0.007748942,0.0010191129,0.012283163,0.0036835212,0.002352549,0.019592755],"category_scores_gemma":[0.15187703,0.0015588062,0.0031536585,0.0053377724,0.0013660996,0.007254758,0.0066886456,0.0032273922,0.005342615],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058849924,0.00027466752,0.0075319507,0.0040478725,0.00086813996,0.0008243791,0.0031182866,0.02773561,0.013062394,0.09789098,0.04603601,0.7980212],"study_design_scores_gemma":[0.0003541234,0.0001901486,0.002341297,0.001478726,0.00054096413,0.0010528757,0.001470659,0.37412292,0.040877312,0.3486112,0.22869068,0.0002690655],"about_ca_topic_score_codex":0.0072680637,"about_ca_topic_score_gemma":0.013969109,"teacher_disagreement_score":0.02834986,"about_ca_system_score_codex":0.0022673719,"about_ca_system_score_gemma":0.007342013,"threshold_uncertainty_score":0.14993018},"labels":[],"label_agreement":null},{"id":"W2905933638","doi":"10.1016/j.jval.2018.09.1005","title":"PHP111 - EXPLORING THE LEVELS OF UNDERSTANDING OF PERSONALIZED MEDICINE AMONGST MEDICAL STUDENTS IN SARAJEVO","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Personalized medicine; Medical education; Alternative medicine; Family medicine; Medicine; Population; Subject (documents); Psychology; Environmental health; Computer science; World Wide Web; Bioinformatics; Pathology","score_opus":0.17233357574726696,"score_gpt":0.34127491408433375,"score_spread":0.1689413383370668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905933638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99678445,0.00005379443,0.00004401826,0.0009237823,0.000013568946,0.00001331809,0.000030866096,0.0000020523041,0.0021342433],"genre_scores_gemma":[0.9964408,0.00010606327,0.000121739286,0.0004936466,0.000008251818,0.000022882206,0.000052771684,0.0000053997555,0.0027484521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987676,0.0004109727,0.000057398378,0.00011774642,0.0002198935,0.000426357],"domain_scores_gemma":[0.99538463,0.0010588181,0.00059671147,0.00010109592,0.0006197174,0.0022390098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025972566,0.00019563832,0.00041375015,0.0006842577,0.0038803238,0.0032092456,0.00061249506,0.00084920396,0.004280364],"category_scores_gemma":[0.004992222,0.00034875734,0.00029142923,0.00057650206,0.0018602746,0.0013731557,0.003613746,0.0027024369,0.0006471457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023854867,0.001162472,0.5533551,0.00018041354,0.00002853547,0.00087411393,0.4129572,0.00006379326,0.0031387687,0.0018861622,0.002125771,0.023989173],"study_design_scores_gemma":[0.000025031073,0.00050601666,0.39335835,0.00021001788,0.00002412091,0.00046020732,0.58495694,0.00030066335,0.0010737288,0.00068597373,0.01835178,0.000047184945],"about_ca_topic_score_codex":0.018864673,"about_ca_topic_score_gemma":0.03038954,"teacher_disagreement_score":0.018864673,"about_ca_system_score_codex":0.0021812047,"about_ca_system_score_gemma":0.0056395954,"threshold_uncertainty_score":0.03750974},"labels":[],"label_agreement":null},{"id":"W2905953069","doi":"10.1016/j.jval.2018.09.1804","title":"PMS90 - A BONE RESORPTION MARKER TO MONITOR DRUG PROFILE IN PATIENTS WITH OSTEOPOROTIC FRACTURES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cohort; Internal medicine; Bone resorption; Bisphosphonate; N-terminal telopeptide; Resorption; Cohort study; Osteoporosis; Urology; Gastroenterology","score_opus":0.014429686661716326,"score_gpt":0.3007155358357491,"score_spread":0.28628584917403277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905953069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94382435,0.03754202,0.0027682316,0.0019861234,0.00036011852,0.00023349447,0.001813643,0.0003927959,0.01107928],"genre_scores_gemma":[0.9904265,0.003349328,0.0023823066,0.0007022722,0.00018515409,0.00008026914,0.001074416,0.000026796204,0.0017729901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991899,0.00027479907,0.000091752554,0.000098998724,0.00028846055,0.000056129058],"domain_scores_gemma":[0.9990563,0.00024161843,0.00031971288,0.000044740587,0.00018848099,0.00014912988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072926807,0.0006070594,0.0011748681,0.0010087519,0.00025401806,0.0007133795,0.00034786094,0.00071904866,0.0011593319],"category_scores_gemma":[0.0025445337,0.00025322856,0.00047757925,0.0008382817,0.00021278384,0.00034321263,0.00033756418,0.00091833045,0.00060697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012905649,0.0008514561,0.73095304,0.000579854,0.000905369,0.0012423977,0.00020601858,0.0010803407,0.031964723,0.0004127913,0.0076003093,0.21129812],"study_design_scores_gemma":[0.0019366454,0.01160251,0.922812,0.0002025451,0.0009831894,0.010873438,0.00029614553,0.008688415,0.024979822,0.0007850044,0.016763914,0.00007653603],"about_ca_topic_score_codex":0.0008461432,"about_ca_topic_score_gemma":0.0013904527,"teacher_disagreement_score":0.0011748681,"about_ca_system_score_codex":0.00032616762,"about_ca_system_score_gemma":0.00041857577,"threshold_uncertainty_score":0.003878355},"labels":[],"label_agreement":null},{"id":"W2905976337","doi":"10.1016/j.jval.2018.09.462","title":"PCN380 - THE PROGNOSTIC SIGNIFICANCE OF HEALTH-RELATED QUALITY OF LIFE FROM CANCER RANDOMIZED CONTROLLED TRIALS: A SYSTEMATIC EVALUATION OF THE STATISTICAL METHODS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Univariate; Sample size determination; Randomized controlled trial; Missing data; Multivariate analysis; Quality of life (healthcare); Multivariate statistics; Systematic review; MEDLINE; Internal medicine; Statistics; Mathematics","score_opus":0.6685403982685437,"score_gpt":0.5508959488733488,"score_spread":0.11764444939519492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905976337","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06466788,0.79388547,0.10014728,0.004361702,0.005297369,0.020517217,0.005197475,0.0015505389,0.0043750163],"genre_scores_gemma":[0.8335199,0.0668571,0.069200896,0.0030157843,0.0016335848,0.022401646,0.0015204573,0.00048975216,0.0013608354],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.5721094,0.36212644,0.035449725,0.014340816,0.014792693,0.0011809126],"domain_scores_gemma":[0.46089238,0.48368406,0.03161443,0.017352581,0.0049564275,0.0015002098],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19799912,0.003260019,0.013943872,0.004528928,0.00081555604,0.004045535,0.003494967,0.0044200146,0.0058011347],"category_scores_gemma":[0.3822959,0.0017144849,0.032671053,0.0047200825,0.0053349575,0.0052082143,0.0038580382,0.0071977526,0.00045739417],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06724292,0.00011351206,0.0066635897,0.18880102,0.6496246,0.00018270672,0.00034141252,0.0019369796,0.00037097407,0.0036845065,0.002886669,0.078151174],"study_design_scores_gemma":[0.11069059,0.006846217,0.012702347,0.03998557,0.783278,0.00048109674,0.00029077916,0.010425823,0.001091887,0.019502278,0.014433543,0.0002719095],"about_ca_topic_score_codex":0.0026475287,"about_ca_topic_score_gemma":0.0039645424,"teacher_disagreement_score":0.8020009,"about_ca_system_score_codex":0.003672596,"about_ca_system_score_gemma":0.0040664803,"threshold_uncertainty_score":0.98900986},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2905980782","doi":"10.1016/j.jval.2018.09.2088","title":"PND123 - PATIENT AND CAREGIVER WEB-BASED SURVEY: HEALTH UTILITIES IN TUBEROUS SCLEROSIS COMPLEX (TSC) PATIENT POPULATION","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Tuberous sclerosis; Medicine; Psychology; Psychiatry","score_opus":0.17796121247498944,"score_gpt":0.3458422233776498,"score_spread":0.16788101090266036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905980782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92443126,0.00029361105,0.00071253924,0.00044611597,0.000041682157,0.00069029105,0.06755407,0.00010106461,0.0057293624],"genre_scores_gemma":[0.94906026,0.0003863808,0.0018924266,0.0003732765,0.000047257523,0.0017855199,0.043570615,0.000037295038,0.002846974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852294,0.00051436445,0.0003446919,0.00015557522,0.00032348867,0.00013887449],"domain_scores_gemma":[0.9967579,0.00062044756,0.0014385988,0.00015018375,0.00063015777,0.00040270717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014415199,0.00037937678,0.00076605444,0.0012666066,0.00041630853,0.0007982566,0.00050114346,0.000622668,0.004387324],"category_scores_gemma":[0.007286497,0.00021702111,0.0009321341,0.0021862825,0.00017058302,0.0008317263,0.0010509738,0.00087197404,0.00155441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057572307,0.00041307154,0.9797468,0.0001180669,0.00018920137,0.000074022464,0.000167475,0.00019103459,0.0001174293,0.000073873736,0.0076493453,0.010683921],"study_design_scores_gemma":[0.000063715655,0.0001803722,0.99710613,0.000020962518,0.000050848084,0.00014980958,0.00015416314,0.00032932108,0.00009288945,0.00004214759,0.0017967139,0.000012974715],"about_ca_topic_score_codex":0.009719945,"about_ca_topic_score_gemma":0.010596719,"teacher_disagreement_score":0.009719945,"about_ca_system_score_codex":0.0008029557,"about_ca_system_score_gemma":0.00067246176,"threshold_uncertainty_score":0.019326746},"labels":[],"label_agreement":null},{"id":"W2905991609","doi":"10.1016/j.jval.2018.09.1746","title":"PMS32 - ASSESSING DIRECT AND INDIRECT HEALTH SYSTEM COSTS OF THE BUILD BETTER BONES WITH EXERCISE PILOT TRIAL","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Joseph’s Healthcare Hamilton; McMaster University; University of Waterloo; Sunnybrook Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Physical therapy; Adverse effect; Quality of life (healthcare); Intervention (counseling); Indirect costs; Total cost; Clinical trial; Surgery; Nursing; Internal medicine","score_opus":0.06709747475268046,"score_gpt":0.35007321997119073,"score_spread":0.28297574521851027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905991609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9468845,0.0018191625,0.002507695,0.005181585,0.0010407462,0.009733776,0.025282448,0.00026966893,0.0072803604],"genre_scores_gemma":[0.9735763,0.00049624237,0.0034347752,0.00074463687,0.00043398762,0.010423563,0.0064898795,0.000053163712,0.004347523],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99403375,0.0043731746,0.00028467196,0.0005105053,0.00036898642,0.00042899005],"domain_scores_gemma":[0.9904998,0.0043671024,0.0018746076,0.0010571679,0.00077928,0.0014220133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008659699,0.002538631,0.003167573,0.00058025704,0.00057285797,0.0011285308,0.0014950153,0.0026821576,0.020168219],"category_scores_gemma":[0.019603282,0.0010591309,0.006112966,0.0008387339,0.0016489963,0.0016185528,0.0024622115,0.0044874474,0.0024160843],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94177854,0.0053928485,0.008575465,0.0009936823,0.004955346,0.000090596375,0.00007039595,0.005154539,0.0005959209,0.0010063289,0.0063995565,0.024986822],"study_design_scores_gemma":[0.66011727,0.25734806,0.05589094,0.0006185129,0.0069160294,0.00017078592,0.00019433531,0.005377953,0.0010983124,0.0031299486,0.009020753,0.00011710216],"about_ca_topic_score_codex":0.005825414,"about_ca_topic_score_gemma":0.004398851,"teacher_disagreement_score":0.020168219,"about_ca_system_score_codex":0.0021544492,"about_ca_system_score_gemma":0.0051104287,"threshold_uncertainty_score":0.06746942},"labels":[],"label_agreement":null},{"id":"W2906002519","doi":"10.1016/j.jval.2018.09.260","title":"PCN177 - COST-EFFECTIVENESS OF TISAGENLECLEUCEL FOR ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA : A CANADIAN SOCIETAL PERSPECTIVE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Oncology; Salvage therapy; Refractory (planetary science); Quality-adjusted life year; Internal medicine; Cost effectiveness; Chemotherapy; Biology","score_opus":0.05165991619322524,"score_gpt":0.3583497100789593,"score_spread":0.3066897938857341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906002519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4700578,0.289247,0.0017295928,0.10439184,0.0015778963,0.0006343918,0.03528892,0.00012538087,0.09694727],"genre_scores_gemma":[0.9523441,0.033956062,0.0012285175,0.003324814,0.00043693662,0.0000778123,0.005820737,0.000025691214,0.0027851628],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981527,0.00053322315,0.000108447464,0.00012316303,0.00056121964,0.00052121846],"domain_scores_gemma":[0.9976642,0.00055828877,0.0003416095,0.000037496306,0.00069299503,0.00070545217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023280005,0.0006719909,0.0012732933,0.0012898828,0.0006459311,0.0027057119,0.0011391297,0.0011962405,0.0067433],"category_scores_gemma":[0.0072392784,0.00023680273,0.0028628812,0.002552365,0.0007407548,0.0008330342,0.0006942843,0.0020274373,0.00035354847],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030582871,0.0012117327,0.1738154,0.006565325,0.0153246075,0.0013841403,0.0006159702,0.049966965,0.0015721611,0.033541065,0.10021536,0.58520436],"study_design_scores_gemma":[0.014182581,0.006602282,0.7003078,0.009775908,0.031303186,0.0017454795,0.0032973527,0.03986443,0.0012493558,0.016632853,0.17446652,0.00057230453],"about_ca_topic_score_codex":0.8537583,"about_ca_topic_score_gemma":0.91075903,"teacher_disagreement_score":0.14624172,"about_ca_system_score_codex":0.044723127,"about_ca_system_score_gemma":0.048334073,"threshold_uncertainty_score":0.3244905},"labels":[],"label_agreement":null},{"id":"W2906016239","doi":"10.1016/j.jval.2018.09.2375","title":"PRM258 - METHODOLOGICAL APPROACHES FOR CONDUCTING MATCHING-ADJUSTED INDIRECT COMPARISONS INVOLVING MULTIPLE RANDOMIZED CONTROLLED TRIALS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University","funders":"","keywords":"Randomized controlled trial; Pooling; Matching (statistics); Meta-analysis; Computer science; Medicine; Consistency (knowledge bases); Set (abstract data type); Statistics; Data mining; Medical physics; Artificial intelligence; Mathematics; Internal medicine","score_opus":0.9602785610421709,"score_gpt":0.637073148182864,"score_spread":0.32320541285930693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906016239","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005701013,0.0012148975,0.99095565,0.0008008213,0.00037879904,0.00450383,0.0003806944,0.00033386715,0.0008612897],"genre_scores_gemma":[0.014184903,0.0005119523,0.9639573,0.0005729647,0.00017628758,0.019659456,0.00020677969,0.00015639467,0.00057395955],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.3828675,0.56687534,0.023255918,0.01038977,0.015589881,0.0010215775],"domain_scores_gemma":[0.42912692,0.48683888,0.014831435,0.058116514,0.010185381,0.00090089627],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.41846976,0.003601419,0.0068943934,0.0060019,0.0019378877,0.005740849,0.0088420035,0.0064209066,0.024158593],"category_scores_gemma":[0.6753212,0.004347886,0.016499251,0.008240622,0.004369006,0.0056319046,0.007139945,0.012857258,0.0028801484],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004638163,0.00046202127,0.0027990756,0.021035865,0.031492487,0.0003046239,0.0018351027,0.015867336,0.000932958,0.38203293,0.017293034,0.5213065],"study_design_scores_gemma":[0.0063764383,0.0018348657,0.002845405,0.0055898237,0.012532444,0.00058851566,0.00030337885,0.09565725,0.0027125988,0.8289858,0.042280927,0.00029262004],"about_ca_topic_score_codex":0.0029389593,"about_ca_topic_score_gemma":0.0034304142,"teacher_disagreement_score":0.5815302,"about_ca_system_score_codex":0.0039329277,"about_ca_system_score_gemma":0.0113760885,"threshold_uncertainty_score":0.7171303},"labels":[],"label_agreement":null},{"id":"W2906035745","doi":"10.1016/j.jval.2018.09.2817","title":"PUK19 - COST-UTILITY OF SUCROFERRIC OXYHYDROXIDE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING DIALYSIS IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperphosphatemia; Medicine; Dialysis; Kidney disease; Context (archaeology); Intensive care medicine; Renal replacement therapy; Sevelamer; Phosphate binder; Internal medicine; Emergency medicine","score_opus":0.03226915132111558,"score_gpt":0.30377775689931125,"score_spread":0.27150860557819567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906035745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93539244,0.02444847,0.0008357993,0.00996239,0.00014220286,0.00039515132,0.006561275,0.0000925494,0.02216967],"genre_scores_gemma":[0.99332184,0.0033463582,0.0008157842,0.00027949005,0.000046372334,0.000021590284,0.0008997771,0.000010011242,0.001258691],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993142,0.00012850891,0.000046345835,0.000051528263,0.00030179316,0.00015770295],"domain_scores_gemma":[0.99848986,0.0001950084,0.00024667013,0.000024405605,0.00048450436,0.00055966224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055089063,0.00020743326,0.00045684254,0.00064680836,0.00045619954,0.0011342652,0.0006127126,0.0002847766,0.0039743907],"category_scores_gemma":[0.0027371035,0.00013379176,0.00082764326,0.0008954027,0.0004064708,0.00022811179,0.0004773929,0.0005591551,0.00016893666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0151848,0.000861523,0.5099872,0.0015835786,0.0016899601,0.0014880757,0.0003843321,0.009001373,0.0055018207,0.00371072,0.021581749,0.42902476],"study_design_scores_gemma":[0.001881301,0.002478914,0.93509454,0.0008345254,0.0020371184,0.0017423616,0.00081281696,0.014833107,0.0029635206,0.00069504324,0.03655003,0.00007670377],"about_ca_topic_score_codex":0.8010868,"about_ca_topic_score_gemma":0.8775547,"teacher_disagreement_score":0.19891322,"about_ca_system_score_codex":0.026123118,"about_ca_system_score_gemma":0.027833184,"threshold_uncertainty_score":0.40016925},"labels":[],"label_agreement":null},{"id":"W2906074521","doi":"10.1016/j.jval.2018.09.179","title":"PCN97 - ASSESSING THE IMPACT OF ACTIVE IDENTIFICATION OF PATIENTS APPROPRIATE FOR PALLIATIVE CARE ON RESOURCE UTILIZATION AND COSTS IN THE FINAL MONTH OF LIFE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Stroke Network; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Palliative care; Propensity score matching; Intervention (counseling); Emergency medicine; Demographics; Emergency department; Intensive care unit; Cancer; Health care; Intensive care medicine; Internal medicine; Nursing; Demography","score_opus":0.29629929727656923,"score_gpt":0.4993572707063406,"score_spread":0.2030579734297714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906074521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92591894,0.00038425912,0.0010920644,0.0012852841,0.00014991382,0.0023767138,0.057360336,0.00012025298,0.011312167],"genre_scores_gemma":[0.9313698,0.0003834654,0.0061701187,0.00056175067,0.00009942035,0.005093106,0.052305017,0.00013740525,0.003879967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950859,0.0023219592,0.0005415672,0.00026020734,0.0011959155,0.00059440115],"domain_scores_gemma":[0.9762565,0.009696938,0.005482886,0.0012511631,0.0035777143,0.0037348696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0079507455,0.000832641,0.001281017,0.0015077126,0.0006846736,0.0023376567,0.0025058554,0.000987999,0.010115065],"category_scores_gemma":[0.021429267,0.0005991543,0.003669009,0.002481461,0.00059182313,0.0016601415,0.0027553719,0.0020402467,0.0019676809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016236909,0.004907271,0.8840923,0.00067417155,0.0022571208,0.00013665704,0.00048568318,0.0045515,0.000120423225,0.0009166572,0.026943082,0.058678307],"study_design_scores_gemma":[0.0015970767,0.0057627107,0.9770974,0.00033209202,0.0005010331,0.00014217304,0.0008705841,0.0055790176,0.0004060614,0.0003674723,0.007292044,0.00005229685],"about_ca_topic_score_codex":0.036745045,"about_ca_topic_score_gemma":0.039967008,"teacher_disagreement_score":0.036745045,"about_ca_system_score_codex":0.0027244526,"about_ca_system_score_gemma":0.0061471597,"threshold_uncertainty_score":0.0730623},"labels":[],"label_agreement":null},{"id":"W2906110772","doi":"10.1016/j.jval.2018.09.103","title":"PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Population; Internal medicine; Lung cancer; Hazard ratio; Regimen; Cancer; Immunotherapy; Confidence interval","score_opus":0.146381492280194,"score_gpt":0.4403910053062912,"score_spread":0.29400951302609724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906110772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826345,0.011723595,0.00057950744,0.00026336912,0.00043962031,0.00035890826,0.0018883174,0.000029551902,0.002082758],"genre_scores_gemma":[0.99732345,0.00084433565,0.00029074753,0.00010989447,0.000055404307,0.00014502445,0.0008107485,0.0000047772,0.00041559496],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920231,0.005846392,0.00051800034,0.0007649681,0.00042835306,0.0004192503],"domain_scores_gemma":[0.9948731,0.0032275303,0.000848759,0.00036596274,0.00027560742,0.00040896435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00652626,0.0015337054,0.0039634653,0.0008360625,0.00029233363,0.001405029,0.0013821464,0.001674051,0.0046074986],"category_scores_gemma":[0.009377304,0.00063034496,0.010162139,0.0009242284,0.00075683265,0.0013887025,0.0010805725,0.0025007722,0.00034947824],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9006904,0.0011140765,0.018344754,0.0017472287,0.05919019,0.00007422977,0.00009431827,0.0022666357,0.0006081448,0.00027319556,0.0004860194,0.015110855],"study_design_scores_gemma":[0.4344028,0.18732797,0.16888475,0.00077050185,0.18661748,0.0003216827,0.00035505145,0.01310745,0.0028692996,0.0018368885,0.0033182565,0.00018786332],"about_ca_topic_score_codex":0.007273905,"about_ca_topic_score_gemma":0.0073086563,"teacher_disagreement_score":0.007273905,"about_ca_system_score_codex":0.0018632272,"about_ca_system_score_gemma":0.0011196769,"threshold_uncertainty_score":0.034514606},"labels":[],"label_agreement":null},{"id":"W2906111461","doi":"10.1016/j.jval.2018.09.892","title":"PGI50 - HAPPY TOMORROW BUT GLOOMING ELDERLY? SELF-ESTIMATION OF FUTURE HEALTH IN CROHN’S DISEASE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Life expectancy; Medicine; Demography; Disease; Crohn's disease; Descriptive statistics; Gerontology; Expectancy theory; Multivariate analysis; Psychology; Internal medicine; Statistics; Environmental health; Population","score_opus":0.01079699156998785,"score_gpt":0.2748808890924737,"score_spread":0.26408389752248584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906111461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986844,0.0041134846,0.00010822246,0.0022868523,0.00012394946,0.000016364223,0.00060098397,0.000005870532,0.005900139],"genre_scores_gemma":[0.99749005,0.0009971423,0.00016775502,0.00031205898,0.00007903522,0.000010776095,0.00027374484,0.000002038871,0.0006673149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994748,0.00022736583,0.000052173833,0.000043922413,0.00010971084,0.000091984635],"domain_scores_gemma":[0.9984573,0.00046000653,0.000530466,0.000050146336,0.00014517811,0.00035681282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009896142,0.00023373656,0.00042788323,0.00050911744,0.00037212632,0.0010123618,0.00023091918,0.0006776087,0.0017904608],"category_scores_gemma":[0.0044130725,0.00013511175,0.00039360728,0.0008225008,0.00027047787,0.00056068355,0.00047113368,0.0011006602,0.0003549148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002661182,0.00008476254,0.9847794,0.000038294587,0.00008687738,0.00017636876,0.00028800566,0.000038872164,0.000085711734,0.00006015026,0.0008049815,0.013290521],"study_design_scores_gemma":[0.000010757987,0.0001290836,0.9976731,0.000043229753,0.00005956786,0.0002731897,0.0006848962,0.00014291563,0.000049470123,0.00014193427,0.0007834641,0.000008344455],"about_ca_topic_score_codex":0.0053476016,"about_ca_topic_score_gemma":0.008783869,"teacher_disagreement_score":0.0053476016,"about_ca_system_score_codex":0.00035321244,"about_ca_system_score_gemma":0.00026345323,"threshold_uncertainty_score":0.010632992},"labels":[],"label_agreement":null},{"id":"W2906179342","doi":"10.1016/j.jval.2018.09.2751","title":"PSY177 - HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH BETA-THALASSEMIA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Thalassemia; Beta thalassemia; Medicine; Chelation therapy; Deferasirox; Quality of life (healthcare); Blood transfusion; Population; Pediatrics; Internal medicine; Environmental health","score_opus":0.03674726007807153,"score_gpt":0.31280917885811466,"score_spread":0.2760619187800431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906179342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964361,0.00069809763,0.00002962593,0.00019973403,0.000023752447,0.000007467976,0.00046693662,0.0000022376894,0.0021361317],"genre_scores_gemma":[0.99898773,0.00016884987,0.000026495283,0.00005011067,0.0000125727165,0.0000035928326,0.0003464011,5.9797793e-7,0.00040353506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997925,0.000055583914,0.00002600916,0.00001925898,0.000048809514,0.000057859124],"domain_scores_gemma":[0.9994795,0.00009806291,0.00020810406,0.000013168131,0.00006170134,0.00013947788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033054198,0.00018717942,0.00028930785,0.00044668588,0.00030218528,0.0005530996,0.00014016662,0.00026417538,0.0030746155],"category_scores_gemma":[0.0018158236,0.00006805221,0.0005354541,0.00064145034,0.00013963661,0.00036524792,0.00035639395,0.0005663359,0.00026114026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004165128,0.0001674183,0.9880019,0.00003829782,0.0001836643,0.00018624462,0.00011222228,0.00010224388,0.0002176515,0.00006156849,0.0004852587,0.010027033],"study_design_scores_gemma":[0.00002695096,0.00027223062,0.9983063,0.000012626674,0.0000792884,0.00027765206,0.0002219353,0.00016344442,0.00007228771,0.000087096974,0.00047580074,0.0000043837626],"about_ca_topic_score_codex":0.0027361405,"about_ca_topic_score_gemma":0.0030932438,"teacher_disagreement_score":0.0030746155,"about_ca_system_score_codex":0.00035073239,"about_ca_system_score_gemma":0.00037455183,"threshold_uncertainty_score":0.010285616},"labels":[],"label_agreement":null},{"id":"W2906189161","doi":"10.1016/j.jval.2018.09.1789","title":"PMS75 - SEEKING THE STATE OF THE ART IN STANDARDIZED MEASUREMENT OF HEALTH CARE RESOURCE USE AND COSTS IN JUVENILE IDIOPATHIC ARTHRITIS: A SCOPING REVIEW","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Activity-based costing; Reimbursement; Health care; Productivity; Unit (ring theory); Resource (disambiguation); Medicine; Indirect costs; Unit cost; Cost driver; Resource use; Business; Operations management; Psychology; Marketing; Environmental resource management; Economics; Computer science; Accounting","score_opus":0.23778470500484308,"score_gpt":0.45086921298212745,"score_spread":0.21308450797728437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906189161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025754867,0.9991235,0.00008356016,0.00022127213,0.000068990375,0.000025815865,0.00010280154,0.000002232393,0.0001141839],"genre_scores_gemma":[0.0038386344,0.99496704,0.00053006073,0.0003346812,0.00008890189,0.00006932045,0.00012776857,0.0000035719827,0.00004008598],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98830557,0.0035926828,0.0041923015,0.0010808232,0.0025410773,0.00028757227],"domain_scores_gemma":[0.94098127,0.050574206,0.0048338342,0.0006747804,0.0026920459,0.00024386159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020248247,0.0016295173,0.010274056,0.008589305,0.0005875248,0.006251239,0.00332084,0.0030752367,0.0036648698],"category_scores_gemma":[0.0645899,0.0011538898,0.009654534,0.0124670705,0.0015654213,0.004526863,0.0027811485,0.0028426677,0.00045228354],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027188426,0.0000653019,0.0045681205,0.52566624,0.0105316015,0.0000684499,0.00038746203,0.0003920736,0.00011788918,0.0018049952,0.004506239,0.45161974],"study_design_scores_gemma":[0.00016975694,0.0002233595,0.013927584,0.8561312,0.040248077,0.0004919667,0.00077120424,0.0004397226,0.00027411478,0.0023413615,0.084873155,0.00010853001],"about_ca_topic_score_codex":0.013321813,"about_ca_topic_score_gemma":0.023887178,"teacher_disagreement_score":0.020248247,"about_ca_system_score_codex":0.0029978086,"about_ca_system_score_gemma":0.011773986,"threshold_uncertainty_score":0.107084274},"labels":[],"label_agreement":null},{"id":"W2906229801","doi":"10.1016/j.jval.2018.09.881","title":"PGI39 - DARVADSTROCEL IN THE MANAGEMENT OF COMPLEX PERIANAL FISTULAS: THE ROLE OF PATIENT REGISTRY DATA COLLECTION TO SUPPORT PERFORMANCE-BASED RISK SHARING AGREEMENTS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Daratumumab; Medicine; Intensive care medicine; Family medicine; Multiple myeloma; Internal medicine","score_opus":0.4197929599770777,"score_gpt":0.4112457840577802,"score_spread":0.008547175919297545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906229801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44216418,0.08870679,0.021406792,0.18282482,0.004574204,0.0010997123,0.007188848,0.0011200635,0.25091466],"genre_scores_gemma":[0.9444377,0.016460441,0.015592609,0.008889015,0.0010843148,0.00043717478,0.0023679987,0.00016922072,0.01056159],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99478686,0.003451144,0.000287884,0.00030586493,0.0008651008,0.0003031107],"domain_scores_gemma":[0.9924394,0.0035202848,0.0014138711,0.0008323495,0.0005733713,0.0012207566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0087565975,0.00017985197,0.0004402133,0.00048742275,0.00027602442,0.0022352703,0.00065057306,0.0007525402,0.01256541],"category_scores_gemma":[0.017282464,0.00010420558,0.00047084817,0.0009642986,0.00069590425,0.0013426886,0.0015002142,0.002084853,0.0019397101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003051297,0.00048927375,0.01964405,0.00041137927,0.00021259327,0.00045664518,0.00027416978,0.0029739446,0.0005259993,0.021242905,0.054843742,0.895874],"study_design_scores_gemma":[0.0041919188,0.00408189,0.094005495,0.003525994,0.00027149008,0.0035915608,0.00072741526,0.0092461165,0.003289098,0.050518487,0.8264299,0.0001206358],"about_ca_topic_score_codex":0.00088037224,"about_ca_topic_score_gemma":0.0011579699,"teacher_disagreement_score":0.01256541,"about_ca_system_score_codex":0.0012354479,"about_ca_system_score_gemma":0.002791674,"threshold_uncertainty_score":0.04630983},"labels":[],"label_agreement":null},{"id":"W2906235082","doi":"10.1016/j.jval.2018.09.721","title":"PDB15 - CARDIOVASCULAR SAFETY OF EMPAGLIFLOZIN VERSUS DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS: SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISONS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Saxagliptin; Empagliflozin; Sitagliptin; Medicine; Sitagliptin Phosphate; Internal medicine; Hazard ratio; Myocardial infarction; Type 2 diabetes; Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Diabetes mellitus; Endocrinology; Confidence interval","score_opus":0.03487364832103898,"score_gpt":0.295668107964375,"score_spread":0.26079445964333603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906235082","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01906692,0.9762406,0.0004409218,0.00047287316,0.0003473875,0.00039026345,0.002089501,0.000017753142,0.00093378674],"genre_scores_gemma":[0.41736004,0.5723316,0.0024022977,0.0026611814,0.00070374814,0.0010483583,0.002667339,0.000032092703,0.00079324795],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9855655,0.006541993,0.004796341,0.001416145,0.0012865249,0.00039352744],"domain_scores_gemma":[0.973865,0.017740447,0.0059804274,0.00063604023,0.0014773903,0.0003006829],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.012582455,0.0014798484,0.008487165,0.0044547445,0.00036652596,0.0026238633,0.0012708427,0.0022357246,0.0072854487],"category_scores_gemma":[0.03690991,0.0010892831,0.018937642,0.0043868558,0.0008698169,0.0018375673,0.00216789,0.0019416339,0.0005378443],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016077057,0.000079203666,0.00811085,0.46821913,0.47157404,0.00012006045,0.00015169798,0.00026269947,0.0003979651,0.00029584183,0.0010546193,0.033656843],"study_design_scores_gemma":[0.011329604,0.00119826,0.015443678,0.042461798,0.9234521,0.0001662375,0.00012803973,0.00015304078,0.00016007364,0.00037600394,0.0050836573,0.0000475472],"about_ca_topic_score_codex":0.004267292,"about_ca_topic_score_gemma":0.010733036,"teacher_disagreement_score":0.99151284,"about_ca_system_score_codex":0.0019839543,"about_ca_system_score_gemma":0.002974252,"threshold_uncertainty_score":0.06654316},"labels":[],"label_agreement":null},{"id":"W2906254779","doi":"10.1016/j.jval.2018.09.1178","title":"PHP284 - TIME TO HTA DECISION FOR INTERNATIONALISED MEDICINES IN AUSTRALIA, CANADA AND EUROPE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Internal medicine","score_opus":0.12341032519558928,"score_gpt":0.3578184141197676,"score_spread":0.23440808892417833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906254779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49162486,0.0066279247,0.0035700796,0.09845541,0.0012195043,0.000691624,0.025780894,0.0004038426,0.37162584],"genre_scores_gemma":[0.9286051,0.0006292574,0.001240606,0.009775386,0.00036030807,0.000078927085,0.0024365964,0.00010076912,0.056773063],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9916047,0.0012867376,0.00031360134,0.00058886677,0.002638992,0.0035670572],"domain_scores_gemma":[0.9814913,0.0087562855,0.0009990078,0.00027737362,0.0037306142,0.0047454364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009872921,0.00035400141,0.00129245,0.0017304049,0.0016373543,0.008993513,0.0017421527,0.0067162076,0.020545341],"category_scores_gemma":[0.026531424,0.0007508089,0.001760184,0.0013348706,0.0013089391,0.0021833864,0.0012363573,0.0065463497,0.0011406204],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077870926,0.00081377686,0.09029298,0.0008317814,0.0011489156,0.0025517729,0.0012856892,0.09116463,0.002274404,0.40120056,0.31791416,0.082734294],"study_design_scores_gemma":[0.0020549272,0.0014372353,0.34550568,0.00088112353,0.0012823762,0.0009143446,0.00434017,0.14564866,0.0062502567,0.09114327,0.399955,0.0005870886],"about_ca_topic_score_codex":0.74368834,"about_ca_topic_score_gemma":0.7626322,"teacher_disagreement_score":0.9663957,"about_ca_system_score_codex":0.03360434,"about_ca_system_score_gemma":0.0480064,"threshold_uncertainty_score":0.5156422},"labels":[],"label_agreement":null},{"id":"W2906258950","doi":"10.1016/j.jval.2018.09.2517","title":"PSS17 - COST PER RESPONDER ANALYSIS OF BRODALUMAB COMPARED WITH USTEKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Dalhousie University","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Plaque psoriasis; Dosing; Placebo; Dermatology; Internal medicine; Adalimumab","score_opus":0.308804429168465,"score_gpt":0.39591576199725853,"score_spread":0.08711133282879352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906258950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95427114,0.013118781,0.0005969884,0.0020612834,0.00015136626,0.00063494174,0.02420902,0.000058978487,0.0048975605],"genre_scores_gemma":[0.9908075,0.0017094923,0.00030565617,0.00024436758,0.00003483684,0.000082798,0.004867691,0.00001678685,0.001930936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99626166,0.001336544,0.00026966562,0.0003227795,0.00094220525,0.00086708093],"domain_scores_gemma":[0.99435884,0.0018010602,0.0008950773,0.00018698463,0.0017331168,0.0010249534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035562566,0.0008636263,0.0031385573,0.0014988105,0.00081507035,0.0020099462,0.0022405365,0.00096675847,0.004723998],"category_scores_gemma":[0.009227134,0.0006788989,0.0068436903,0.0032865626,0.0006548436,0.0004993748,0.0008175958,0.0020875013,0.00022050393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3061465,0.0026870565,0.3077889,0.00615859,0.040884614,0.0011102066,0.00054981204,0.21724188,0.0020130316,0.006717273,0.027952239,0.08074995],"study_design_scores_gemma":[0.04621098,0.010236813,0.73870575,0.0012853489,0.038551837,0.0005265777,0.0017772373,0.1489656,0.0016285549,0.0012052944,0.010527403,0.0003786487],"about_ca_topic_score_codex":0.9721361,"about_ca_topic_score_gemma":0.9642437,"teacher_disagreement_score":0.05369126,"about_ca_system_score_codex":0.05369126,"about_ca_system_score_gemma":0.047540776,"threshold_uncertainty_score":0.3895592},"labels":[],"label_agreement":null},{"id":"W2906270512","doi":"10.1016/j.jval.2018.09.258","title":"PCN175 - BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN’S LYMPHOMA: A COST-EFFECTIVENESS ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Hodgkin's lymphoma; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Chemotherapy; Vincristine","score_opus":0.044222356736891504,"score_gpt":0.3657062456429737,"score_spread":0.3214838889060822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906270512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955222,0.035909504,0.0020863772,0.00082922954,0.00031620523,0.00095385406,0.0016775132,0.000054892393,0.0029504052],"genre_scores_gemma":[0.99542326,0.0028156596,0.00074023666,0.00016155462,0.000056604884,0.00013194006,0.00039632805,0.000005091477,0.00026932821],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997491,0.0017036046,0.00013499899,0.0002008508,0.00022027925,0.0002493802],"domain_scores_gemma":[0.99795496,0.0014161934,0.00029953252,0.000058040398,0.000054070457,0.00021708568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002869323,0.0015688826,0.002920785,0.0012335865,0.00021761289,0.0015102689,0.001095297,0.0012154503,0.004170104],"category_scores_gemma":[0.004698615,0.0005743073,0.007596905,0.0011762545,0.00075447216,0.0017748541,0.00073896354,0.0022115475,0.00016426892],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7638793,0.0035132896,0.013952668,0.005240675,0.032586273,0.00041031287,0.00011963567,0.045454267,0.0018334726,0.0014870785,0.0012084446,0.13031463],"study_design_scores_gemma":[0.35964373,0.29824126,0.0866379,0.0024449017,0.12978978,0.0014952541,0.00085503137,0.106898375,0.0029869466,0.0048377924,0.005829154,0.00033996336],"about_ca_topic_score_codex":0.0049959305,"about_ca_topic_score_gemma":0.00542159,"teacher_disagreement_score":0.0049959305,"about_ca_system_score_codex":0.00359658,"about_ca_system_score_gemma":0.0013446765,"threshold_uncertainty_score":0.026095092},"labels":[],"label_agreement":null},{"id":"W2906277950","doi":"10.1016/j.jval.2018.09.2215","title":"PRM94 - ALIGNING TEXT MINING AND MACHINE LEARNING ALGORITHMS WITH BEST PRACTICES FOR STUDY SELECTION IN SYSTEMATIC LITERATURE REVIEWS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Machine learning; Artificial intelligence; Computer science; Algorithm; Systematic review; Support vector machine; Bootstrapping (finance); Population; Naive Bayes classifier; Data mining; Medicine; MEDLINE; Mathematics","score_opus":0.7225400825203923,"score_gpt":0.5514569078851442,"score_spread":0.17108317463524803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906277950","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014586395,0.013030977,0.7924546,0.0049649826,0.0021247275,0.019350024,0.062614664,0.08412437,0.006749231],"genre_scores_gemma":[0.014432022,0.0010362895,0.95797414,0.000513208,0.00016031544,0.011594383,0.010109729,0.0035482058,0.0006317029],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.79410654,0.119126104,0.060661837,0.014693598,0.0101897335,0.0012221903],"domain_scores_gemma":[0.5150891,0.40381822,0.018683163,0.04362976,0.017325293,0.0014544612],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17141472,0.0032846392,0.006671579,0.017204357,0.0029612798,0.009142351,0.0060161175,0.004233475,0.030682176],"category_scores_gemma":[0.5017857,0.00451781,0.01613851,0.01899652,0.0016971827,0.0054725227,0.012059317,0.0053710956,0.009360899],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041935565,0.00052993227,0.009697264,0.09443333,0.023073142,0.0007892173,0.004691746,0.008826825,0.006343224,0.016894817,0.10899755,0.7215294],"study_design_scores_gemma":[0.011648439,0.0020192002,0.018279416,0.041070383,0.04672146,0.0016487833,0.0018549195,0.1236885,0.025627432,0.14919543,0.57687116,0.0013750151],"about_ca_topic_score_codex":0.0027252885,"about_ca_topic_score_gemma":0.009804779,"teacher_disagreement_score":0.82858527,"about_ca_system_score_codex":0.0020771923,"about_ca_system_score_gemma":0.018277567,"threshold_uncertainty_score":0.9065385},"labels":[],"label_agreement":null},{"id":"W2906289752","doi":"10.1016/j.jval.2018.09.2814","title":"PUK16 - COST-EFFECTIVENESS OF TOLVAPTAN IN CANADIAN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: AN ADAPTATION OF THE ADPKD OUTCOMES MODEL","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolvaptan; Autosomal dominant polycystic kidney disease; Medicine; Renal function; Population; Placebo; Cost effectiveness; Quality of life (healthcare); Internal medicine; Intensive care medicine; Disease; Heart failure; Nursing; Environmental health","score_opus":0.26199461690141296,"score_gpt":0.39140897932462515,"score_spread":0.1294143624232122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906289752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9308378,0.006753349,0.0056274966,0.009061715,0.00028717596,0.00072927686,0.027555242,0.00018521116,0.018962778],"genre_scores_gemma":[0.9870036,0.0011513423,0.0015218778,0.0003090712,0.000035171353,0.00015156301,0.0060351803,0.000026959404,0.0037652294],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99808,0.0006988703,0.0000915088,0.0002703387,0.0002374212,0.0006218967],"domain_scores_gemma":[0.9955967,0.0023433499,0.0005249017,0.00022851936,0.0006697078,0.00063677743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059781955,0.0013212557,0.0025363849,0.0008303429,0.00080798427,0.002515289,0.0034290499,0.0015997025,0.0068373405],"category_scores_gemma":[0.012851739,0.00067563646,0.0041441354,0.00187122,0.0010140206,0.00096878415,0.0012491014,0.0028744026,0.00042654035],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021672063,0.0010891593,0.08874979,0.0009824713,0.0061202324,0.000597555,0.00027223566,0.791196,0.0005664072,0.023653194,0.017980408,0.047120452],"study_design_scores_gemma":[0.008358689,0.001614163,0.11341906,0.00050514954,0.005644898,0.00034033105,0.0004942538,0.84705263,0.0004969628,0.011670549,0.010133492,0.00026977612],"about_ca_topic_score_codex":0.9166656,"about_ca_topic_score_gemma":0.8693029,"teacher_disagreement_score":0.08333439,"about_ca_system_score_codex":0.037027813,"about_ca_system_score_gemma":0.03105466,"threshold_uncertainty_score":0.26865685},"labels":[],"label_agreement":null},{"id":"W2906311050","doi":"10.1016/j.jval.2018.09.303","title":"PCN221 - STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER TREATMENT PATTERNS AND COSTS: AN ONTARIO, CANADA ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); McMaster University; Sunnybrook Hospital","funders":"","keywords":"Medicine; Lung cancer; Activity-based costing; Cohort; Stage (stratigraphy); Cancer registry; Population; Cancer; Radiation therapy; Total cost; Emergency medicine; Internal medicine; Environmental health","score_opus":0.034121309097623266,"score_gpt":0.26013806268134393,"score_spread":0.22601675358372067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906311050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9312983,0.0040650093,0.0007075692,0.0021086223,0.000052396565,0.00035579596,0.052151445,0.00004338607,0.009217483],"genre_scores_gemma":[0.9662317,0.0023755345,0.0006990666,0.00038840788,0.00003136799,0.00012177324,0.019514978,0.0000430158,0.010594125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976903,0.0002061016,0.00014348389,0.00021612117,0.00069165044,0.0010524556],"domain_scores_gemma":[0.9936068,0.00056599505,0.0011488884,0.00022064486,0.003000634,0.0014569312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015622594,0.00087659626,0.0012221345,0.0023834896,0.0033454117,0.0021875168,0.0024732982,0.0008291857,0.0060023526],"category_scores_gemma":[0.004063687,0.0010425851,0.003474646,0.010977745,0.0011006047,0.0006755917,0.0014511696,0.0016397764,0.0005021991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082306314,0.00019968892,0.9620727,0.00033101032,0.0010936944,0.0004658794,0.0009783275,0.0042224466,0.00018291223,0.0022293688,0.01773062,0.009670232],"study_design_scores_gemma":[0.00017696626,0.000082533305,0.98470104,0.0001551843,0.0005745608,0.00018026157,0.0022230886,0.005250573,0.00008852868,0.00025985454,0.0062475703,0.000059856273],"about_ca_topic_score_codex":0.9991008,"about_ca_topic_score_gemma":0.99946445,"teacher_disagreement_score":0.103666164,"about_ca_system_score_codex":0.103666164,"about_ca_system_score_gemma":0.12032175,"threshold_uncertainty_score":0.7521542},"labels":[],"label_agreement":null},{"id":"W2906312333","doi":"10.1016/j.jval.2018.09.2050","title":"PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A INJECTIONS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Spasticity; Botulinum toxin; Caregiver burden; Stroke (engine); Physical therapy; Etiology; Modified Ashworth scale; Internal medicine; Surgery; Disease","score_opus":0.028652847744912342,"score_gpt":0.2864307632228324,"score_spread":0.25777791547792006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906312333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98552656,0.00083668024,0.0001015752,0.00089305395,0.00004382432,0.000026495882,0.00091038964,0.0000054963157,0.011655909],"genre_scores_gemma":[0.998692,0.00026620275,0.00007969801,0.00005819415,0.000019048844,0.000010683121,0.0003356221,0.000001622424,0.0005369168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987489,0.0004718576,0.00014689071,0.00006136809,0.00032235944,0.00024857203],"domain_scores_gemma":[0.99577326,0.0009773362,0.0017848342,0.000112446345,0.00058118696,0.00077087706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009811452,0.00020452542,0.0003860119,0.00068582786,0.000812789,0.00086790207,0.00029355133,0.00043204974,0.0072989627],"category_scores_gemma":[0.011515404,0.00013545231,0.0006163944,0.0008337403,0.00022321664,0.0007004257,0.0008619666,0.0008087781,0.00042287516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033217465,0.00022201234,0.9779344,0.00006237798,0.00015098516,0.00063909986,0.00040785965,0.00016849782,0.000102326754,0.00018293475,0.0015512521,0.018246127],"study_design_scores_gemma":[0.000011268997,0.00011241095,0.99701786,0.000069489106,0.00004379619,0.0009263866,0.00059998664,0.00021127929,0.000039910174,0.0001145944,0.00084547873,0.0000075141047],"about_ca_topic_score_codex":0.0069654644,"about_ca_topic_score_gemma":0.011102762,"teacher_disagreement_score":0.0072989627,"about_ca_system_score_codex":0.0010321395,"about_ca_system_score_gemma":0.0009197403,"threshold_uncertainty_score":0.02441752},"labels":[],"label_agreement":null},{"id":"W2906351675","doi":"10.1016/j.jval.2018.09.2189","title":"PRM68 - IMPUTATION METHODS FOR MISSING DATA IN COST-UTILITY ANALYSES ALONGSIDE RANDOMIZED CONTROLLED TRIALS: AGGREGATE OR NON-AGGREGATE?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Missing data; Imputation (statistics); Statistics; Quantile; Econometrics; Aggregate data; Aggregate (composite); Medicine; Mathematics; Computer science","score_opus":0.767217208767292,"score_gpt":0.61259766830442,"score_spread":0.15461954046287207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906351675","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052705887,0.014265001,0.9575878,0.010614287,0.0017094737,0.0014799905,0.004611373,0.0015058101,0.002955712],"genre_scores_gemma":[0.17945278,0.0064753746,0.78546315,0.0065102084,0.0029454837,0.008988329,0.0060137743,0.0012270958,0.0029237939],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.48393664,0.4760842,0.019688068,0.01001369,0.00904336,0.0012339775],"domain_scores_gemma":[0.36263812,0.53619117,0.02841681,0.06141054,0.010116508,0.0012268521],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.33312967,0.0023021344,0.008705045,0.0034595812,0.0008070205,0.006192717,0.006547715,0.005319696,0.019390894],"category_scores_gemma":[0.6352362,0.0028442834,0.01084454,0.008326663,0.0018005462,0.009525013,0.005477599,0.008918908,0.003919542],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006141409,0.00055239134,0.021886878,0.01781824,0.045531314,0.00044177988,0.0013905312,0.030366383,0.00037539707,0.12248172,0.07536217,0.6776518],"study_design_scores_gemma":[0.005394096,0.0022603662,0.015783064,0.012307179,0.017590933,0.00092793955,0.00042530097,0.1897087,0.0014326447,0.6745779,0.079099946,0.0004919926],"about_ca_topic_score_codex":0.0016012837,"about_ca_topic_score_gemma":0.0023894724,"teacher_disagreement_score":0.66687036,"about_ca_system_score_codex":0.001240413,"about_ca_system_score_gemma":0.0052893683,"threshold_uncertainty_score":0.8223698},"labels":[],"label_agreement":null},{"id":"W2906359407","doi":"10.1016/j.jval.2018.09.2173","title":"PRM51 - A NEW CONCEPTUAL MODEL OF THE COST-EFFECTIVENESS THRESHOLD","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Economic surplus; Economics; Welfare; Microeconomics; Work (physics); Threshold model; Econometrics; Engineering","score_opus":0.6398081143046667,"score_gpt":0.46051423451423984,"score_spread":0.17929387979042682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906359407","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013213626,0.004379938,0.78790337,0.017918278,0.0004054736,0.00055687106,0.0011245875,0.00021692968,0.17428087],"genre_scores_gemma":[0.73347133,0.0057964167,0.2267303,0.0033544127,0.0006305102,0.0019490301,0.00057340047,0.0001683558,0.02732627],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9927933,0.0035781513,0.00031758597,0.0011195685,0.001675388,0.0005161176],"domain_scores_gemma":[0.993948,0.004142903,0.00049934885,0.00037743113,0.00076675846,0.0002656573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0079027405,0.0013419547,0.0013419917,0.003284973,0.00083823455,0.0080858935,0.00385283,0.004497861,0.013180605],"category_scores_gemma":[0.013419452,0.00086051686,0.0027039908,0.0026135745,0.004060315,0.009800863,0.0021303026,0.004917088,0.001654866],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014912478,0.000019869496,0.00014459233,0.000103323844,0.000022110431,0.00004597789,0.00009087592,0.018819885,0.00012009884,0.9726988,0.0012760429,0.006643535],"study_design_scores_gemma":[0.000044834833,0.00011230724,0.0004945243,0.00026793775,0.00006360815,0.0003045007,0.00015952702,0.08013249,0.00022050303,0.89045936,0.027695423,0.000044970155],"about_ca_topic_score_codex":0.0035296902,"about_ca_topic_score_gemma":0.0023291814,"teacher_disagreement_score":0.013180605,"about_ca_system_score_codex":0.008302827,"about_ca_system_score_gemma":0.0052990317,"threshold_uncertainty_score":0.06024146},"labels":[],"label_agreement":null},{"id":"W2906360693","doi":"10.1016/j.jval.2018.09.2482","title":"PRS89 - MEASUREMENT OF MAINTENANCE AND RELIEVER USE IN ASTHMA: A SYSTEMATIC REVIEW OF THE LITERATURE","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Asthma; Medicine; Medical prescription; Systematic review; Inhaled corticosteroids; MEDLINE; Population; Intensive care medicine; Emergency medicine; Pediatrics; Internal medicine; Environmental health; Pharmacology","score_opus":0.07593275818547308,"score_gpt":0.33788342186508674,"score_spread":0.26195066367961367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906360693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010066188,0.99856925,0.000029213566,0.00008152625,0.000037855385,0.0000310455,0.00015391744,0.000001494737,0.00008905001],"genre_scores_gemma":[0.020442724,0.97856927,0.00036547246,0.00026896756,0.000072446404,0.00007201313,0.00016304967,0.0000017413414,0.00004429388],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949739,0.0014109481,0.0018633843,0.0005344001,0.0010787738,0.00013866795],"domain_scores_gemma":[0.9848246,0.011362583,0.002756225,0.00019282864,0.00072086893,0.00014293884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004665262,0.0011011657,0.006942605,0.0044044955,0.00043005153,0.0021335627,0.0014850252,0.0017023329,0.002932409],"category_scores_gemma":[0.023872772,0.00074680825,0.00896344,0.006148081,0.00075213914,0.001503305,0.001384246,0.0013923575,0.00018682565],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006940272,0.000061818544,0.006617965,0.86214596,0.03182156,0.000114055314,0.00020057804,0.00011516559,0.00016367534,0.00024222542,0.0015121566,0.09631071],"study_design_scores_gemma":[0.0008927871,0.00059345964,0.049638588,0.6490491,0.27079242,0.001108692,0.0005749677,0.00024017092,0.00027233028,0.00050370395,0.026212644,0.00012114434],"about_ca_topic_score_codex":0.007996054,"about_ca_topic_score_gemma":0.02177793,"teacher_disagreement_score":0.007996054,"about_ca_system_score_codex":0.001586808,"about_ca_system_score_gemma":0.004639694,"threshold_uncertainty_score":0.024672508},"labels":[],"label_agreement":null},{"id":"W2906366100","doi":"10.1016/j.jval.2018.09.2149","title":"PRM25 - INCORPORATING EXPERT OPINION TO IMPROVE ESTIMATES OF LONG-TERM SURVIVAL WHEN FOLLOW-UP OF EMPIRICAL STUDIES IS SHORT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Clinical trial; Survival analysis; Medicine; Bayesian probability; Term (time); Statistics; Expert opinion; Econometrics; Actuarial science; Intensive care medicine; Internal medicine; Mathematics","score_opus":0.31266622312522485,"score_gpt":0.5190184818313346,"score_spread":0.20635225870610974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906366100","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056069758,0.0107460115,0.8823528,0.008740284,0.0023500207,0.0029333392,0.013913323,0.0060788435,0.016815564],"genre_scores_gemma":[0.49193606,0.0012429191,0.48646024,0.0040571894,0.0017459366,0.0016325939,0.007945857,0.0005928561,0.004386278],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9266603,0.055080727,0.00530669,0.007333275,0.004604719,0.0010142929],"domain_scores_gemma":[0.6841859,0.25788492,0.015628561,0.022874499,0.016709102,0.0027169778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10603825,0.0023566263,0.0036610344,0.0044158977,0.0008429314,0.0042858124,0.0040244386,0.0037800132,0.013787278],"category_scores_gemma":[0.3440975,0.0014138691,0.00544455,0.002331922,0.0009574034,0.0039555067,0.002922038,0.0037604193,0.0036766971],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004659766,0.0006861543,0.0742836,0.0082328115,0.021522043,0.00072875316,0.0008831578,0.08150016,0.0027775764,0.0150987245,0.07152944,0.71809787],"study_design_scores_gemma":[0.0029263624,0.002685335,0.058144856,0.004683281,0.013534276,0.0011875641,0.0005091195,0.7035274,0.007657424,0.13232541,0.072202876,0.0006160775],"about_ca_topic_score_codex":0.0043212296,"about_ca_topic_score_gemma":0.006471189,"teacher_disagreement_score":0.10603825,"about_ca_system_score_codex":0.0011079542,"about_ca_system_score_gemma":0.002681668,"threshold_uncertainty_score":0.56079054},"labels":[],"label_agreement":null},{"id":"W2906374771","doi":"10.1016/j.jval.2018.09.2617","title":"PSY40 - ALL-CAUSE MORTALITY INCREASED WITH NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN US MEDICARE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Cohort; Comorbidity; Proportional hazards model; Lung cancer; Charlson comorbidity index; Nontuberculous mycobacteria; Hazard ratio; Mortality rate; Confidence interval; Tuberculosis; Pathology","score_opus":0.04982570034092148,"score_gpt":0.3604555803989629,"score_spread":0.31062988005804143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906374771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948691,0.00093753927,0.00009188432,0.00065852585,0.000028270922,0.000004715929,0.0019066412,0.000010754528,0.0014926115],"genre_scores_gemma":[0.99841857,0.00015624751,0.00003980481,0.00010586562,0.000036956702,0.0000027918168,0.000720141,0.0000026494522,0.0005169585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925596,0.00017830197,0.00007271543,0.000118611606,0.00013361346,0.00024081547],"domain_scores_gemma":[0.99705386,0.0004320562,0.001588296,0.00013028833,0.00025778473,0.00053768733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063588447,0.00023142148,0.00026686257,0.00086800166,0.0003785253,0.0009374088,0.0004725683,0.0007239128,0.0059627504],"category_scores_gemma":[0.0043552653,0.00022305879,0.00090612745,0.0013085402,0.00022668538,0.00067071733,0.00077973935,0.00085615675,0.00030078407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013617292,0.000019795882,0.9976012,0.000008906567,0.00008037658,0.000058939007,0.00003760893,0.000039494415,0.00010530337,0.000068504705,0.0004015142,0.0014423172],"study_design_scores_gemma":[0.000004074874,0.000023842804,0.9991742,0.000008295123,0.00003006936,0.000097855016,0.00010648554,0.0001625804,0.00004020802,0.00006450697,0.00028565468,0.0000023332225],"about_ca_topic_score_codex":0.021605361,"about_ca_topic_score_gemma":0.021049082,"teacher_disagreement_score":0.021605361,"about_ca_system_score_codex":0.0006788866,"about_ca_system_score_gemma":0.0006169854,"threshold_uncertainty_score":0.042959213},"labels":[],"label_agreement":null},{"id":"W2906374798","doi":"10.1016/j.jval.2018.09.675","title":"PCV130 - VALUE OF IMPLEMENTATION OF PHARMACEUTICAL CARE FOR CARDIOVASCULAR DISEASES IN LMICS: A HYPOTHETICAL SIMULATION FOR DECISION MAKING","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Net present value; Health care; Return on investment; Epidemiology; Cash flow; Equity (law); Public health; Investment (military); Actuarial science; Emergency medicine; Medical emergency; Business; Finance; Internal medicine; Nursing; Economics","score_opus":0.05476266835415367,"score_gpt":0.4272374999583958,"score_spread":0.37247483160424216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906374798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8962358,0.00024951313,0.012040224,0.012312205,0.00020709408,0.0010241562,0.0076942733,0.00019129486,0.0700455],"genre_scores_gemma":[0.9905723,0.00007310027,0.0025999562,0.00030035805,0.000020797665,0.00041864635,0.0005974535,0.00001202512,0.0054053674],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970168,0.001806896,0.00006200448,0.0002228077,0.0001130753,0.00077849376],"domain_scores_gemma":[0.98063594,0.015283323,0.00097156304,0.00039772794,0.00085298903,0.0018584429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030173354,0.00091655954,0.001145952,0.0009764782,0.0009448202,0.0032029005,0.0022641972,0.0053640925,0.031101814],"category_scores_gemma":[0.017886342,0.00070912787,0.0014646302,0.0011699944,0.0016528246,0.0020474186,0.0017171508,0.0041577974,0.0013706563],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002695168,0.0012931426,0.018658584,0.00018156592,0.00020300547,0.0006576205,0.00032449604,0.9166036,0.00041598245,0.04579682,0.0057408586,0.007429142],"study_design_scores_gemma":[0.0015333253,0.0016091563,0.008031338,0.00010810315,0.00019027853,0.00015011184,0.0012845852,0.9589987,0.00036137956,0.023706337,0.0039113034,0.00011537178],"about_ca_topic_score_codex":0.049806025,"about_ca_topic_score_gemma":0.025001023,"teacher_disagreement_score":0.049806025,"about_ca_system_score_codex":0.0060962643,"about_ca_system_score_gemma":0.005522991,"threshold_uncertainty_score":0.10404599},"labels":[],"label_agreement":null},{"id":"W2906378256","doi":"10.1016/j.jval.2018.09.2225","title":"PRM104 - EVALUATION OF DATA COLLECTION DURATION IN RETROSPECTIVE NONINTERVENTIONAL MEDICAL RECORD REVIEW ONCOLOGY STUDIES CONDUCTED IN THE UNITED STATES (US), CANADA, UNITED KINGDOM (UK), GERMANY, FRANCE AND SPAIN","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical record; Demography; Retrospective cohort study; Data collection; Family medicine; Emergency medicine; Pediatrics; Internal medicine; Statistics","score_opus":0.22762195149862566,"score_gpt":0.39984836686461217,"score_spread":0.1722264153659865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906378256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93046904,0.0062086475,0.013148114,0.002330019,0.00035861277,0.008469338,0.03240317,0.0002958316,0.0063172127],"genre_scores_gemma":[0.9497014,0.0009475702,0.013696888,0.0006261498,0.00019456782,0.018247593,0.014919136,0.00008576563,0.0015809616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.68306684,0.23931244,0.044837598,0.010847777,0.019357597,0.0025777107],"domain_scores_gemma":[0.31894356,0.4716887,0.10979303,0.03991234,0.054044902,0.005617567],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2160962,0.00061493274,0.0018469073,0.004158388,0.0018013152,0.003317923,0.0039402233,0.0022946259,0.0050593717],"category_scores_gemma":[0.43181604,0.0012016217,0.0049830806,0.0077467533,0.0014130971,0.0043298076,0.004187291,0.0015956166,0.0009859947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016554639,0.00097618875,0.915274,0.0040541855,0.0039359676,0.00017421317,0.0029560043,0.0017167124,0.00026683827,0.00067386474,0.003689477,0.049727827],"study_design_scores_gemma":[0.0016938118,0.008901382,0.97135586,0.0012514184,0.0021635515,0.00033420522,0.00304116,0.0032942167,0.0006765817,0.000254373,0.006918296,0.00011521083],"about_ca_topic_score_codex":0.013861589,"about_ca_topic_score_gemma":0.013179123,"teacher_disagreement_score":0.78390384,"about_ca_system_score_codex":0.004681636,"about_ca_system_score_gemma":0.006772836,"threshold_uncertainty_score":0.9666929},"labels":[],"label_agreement":null},{"id":"W2906404816","doi":"10.1016/j.jval.2018.09.219","title":"PCN136 - A COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Sunitinib; Ipilimumab; Nivolumab; Cost-effectiveness analysis; Oncology; Internal medicine; Renal cell carcinoma; Population; Clinical trial; Discontinuation; Cancer; Cost effectiveness; Immunotherapy","score_opus":0.22874216180549872,"score_gpt":0.3873366656431198,"score_spread":0.15859450383762108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906404816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9739603,0.0117126,0.00073039765,0.001655984,0.00011047639,0.00086862146,0.00653577,0.000038967562,0.0043867473],"genre_scores_gemma":[0.99503493,0.001770511,0.0005318812,0.0001426019,0.000023351271,0.00008373233,0.0017788626,0.0000072236558,0.0006268959],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99648106,0.0015703802,0.00020523569,0.00026375763,0.00080535485,0.00067409646],"domain_scores_gemma":[0.9967062,0.0012369094,0.0004876967,0.00010553529,0.0008012948,0.0006623029],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037690522,0.0010463239,0.0023391352,0.0013231712,0.0007027016,0.0021103434,0.0015254036,0.00097444066,0.002655329],"category_scores_gemma":[0.008885445,0.000608206,0.0047619953,0.0026285306,0.0008058022,0.000666614,0.0007773978,0.0017348703,0.00013934878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22621188,0.005833056,0.13890968,0.009071983,0.045203324,0.0015963935,0.0004352754,0.38755816,0.004367988,0.006493739,0.013661869,0.16065657],"study_design_scores_gemma":[0.07379931,0.032099366,0.42904213,0.002397396,0.06734671,0.0012296728,0.0016651282,0.36675647,0.002661234,0.002502048,0.019938633,0.00056187174],"about_ca_topic_score_codex":0.902244,"about_ca_topic_score_gemma":0.8964954,"teacher_disagreement_score":0.09775603,"about_ca_system_score_codex":0.064030014,"about_ca_system_score_gemma":0.043444976,"threshold_uncertainty_score":0.46457243},"labels":[],"label_agreement":null},{"id":"W2906421864","doi":"10.1016/j.jval.2018.09.2433","title":"PRS39 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY (SITT) VERSUS MULTIPLE INHALER TRIPLE THERAPIES (MITT) TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fluticasone propionate; Medicine; Inhaler; COPD; Exacerbation; Salmeterol; Dry-powder inhaler; Internal medicine; Asthma","score_opus":0.07153174223992449,"score_gpt":0.3123967742672741,"score_spread":0.2408650320273496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906421864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95126665,0.014556958,0.00034584515,0.0056166355,0.0002746327,0.0005050189,0.01670512,0.000069978356,0.010659223],"genre_scores_gemma":[0.991189,0.002806652,0.0004556856,0.0005149515,0.000049112907,0.000069509435,0.0027340965,0.000014064939,0.0021667536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979225,0.00043625338,0.00017773049,0.00023890514,0.00063840934,0.00058623916],"domain_scores_gemma":[0.9971872,0.0004514814,0.0003892386,0.00004889272,0.000743982,0.0011792425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014655867,0.0004331227,0.0014009905,0.000801304,0.0009329586,0.0016439823,0.0012963939,0.00095468934,0.006137874],"category_scores_gemma":[0.0054410733,0.00039230348,0.0034710404,0.0018656461,0.00066232774,0.0005712726,0.0006940441,0.001510776,0.00022749322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16045426,0.0037393502,0.40289608,0.0056220205,0.009786453,0.0008593217,0.0007752885,0.05033209,0.0031473895,0.00945956,0.049809802,0.30311844],"study_design_scores_gemma":[0.028110659,0.011438462,0.8888389,0.001611946,0.008047951,0.00057206355,0.0016850996,0.038262155,0.0012095869,0.0011253379,0.018847438,0.00025049565],"about_ca_topic_score_codex":0.97633106,"about_ca_topic_score_gemma":0.98189294,"teacher_disagreement_score":0.059182286,"about_ca_system_score_codex":0.059182286,"about_ca_system_score_gemma":0.07345337,"threshold_uncertainty_score":0.42939955},"labels":[],"label_agreement":null},{"id":"W2906423725","doi":"10.1016/j.jval.2018.09.150","title":"PCN68 - BUDGET IMPACT ANALYSIS OF TISAGENLECLEUCEL FOR THE TREATMENT OF PAEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA IN ENGLAND","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Blinatumomab; Medicine; Fludarabine; Population; Leukapheresis; Pediatrics; Internal medicine; Chemotherapy; CD19; Cyclophosphamide; Stem cell","score_opus":0.022785619237043562,"score_gpt":0.32269402317777024,"score_spread":0.29990840394072665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906423725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9029527,0.017324623,0.0021431097,0.014014856,0.00036375245,0.0018540568,0.036447827,0.00011726165,0.02478196],"genre_scores_gemma":[0.9867736,0.0027554065,0.000973389,0.0010204888,0.000047996058,0.0004770084,0.0052579828,0.000024126546,0.0026700369],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99268407,0.0043875044,0.00035159817,0.00021486923,0.0008925298,0.0014694924],"domain_scores_gemma":[0.9931804,0.00290177,0.0013766144,0.00015604471,0.0008082391,0.0015769775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004850123,0.00064023153,0.0014753325,0.0012533715,0.00027718322,0.0016305883,0.0011064754,0.0010812058,0.0057115615],"category_scores_gemma":[0.018267425,0.000584729,0.0024537144,0.0019806742,0.0005464056,0.00092013256,0.00170081,0.0016399184,0.00028640236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0658298,0.0020808938,0.11348339,0.007096206,0.008660458,0.0016932621,0.00057245215,0.51908,0.0020739972,0.016592918,0.04309151,0.21974505],"study_design_scores_gemma":[0.02684185,0.028619744,0.631864,0.0052561355,0.01024394,0.0018272701,0.003918617,0.16912188,0.0025500813,0.009112873,0.11022653,0.0004171151],"about_ca_topic_score_codex":0.22561069,"about_ca_topic_score_gemma":0.21213923,"teacher_disagreement_score":0.22561069,"about_ca_system_score_codex":0.01866228,"about_ca_system_score_gemma":0.015719792,"threshold_uncertainty_score":0.44859493},"labels":[],"label_agreement":null},{"id":"W2906437870","doi":"10.1016/j.jval.2018.09.1691","title":"PMH56 - ACCESS TO DEMENTIA TREATMENTS IN ENGLAND; IS THIS REALLY A PRIORITY AREA FOR PRIMARY CARE?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Dementia; Medicine; Quarter (Canadian coin); Emergency medicine; Family medicine; Pediatrics; Geography; Disease; Internal medicine; Business; Accounting","score_opus":0.40859598737393177,"score_gpt":0.45211445595484256,"score_spread":0.043518468580910796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906437870","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22141665,0.054687068,0.0008922306,0.57956696,0.0048457724,0.00030077485,0.063699216,0.00010360352,0.07448773],"genre_scores_gemma":[0.90229106,0.019884927,0.0015159402,0.039417554,0.0032939685,0.00049025717,0.011709721,0.000057547157,0.02133904],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9959974,0.001388712,0.00059591775,0.00019695729,0.00089297775,0.0009279639],"domain_scores_gemma":[0.977789,0.006890336,0.0050827884,0.0005723039,0.003012495,0.006653023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041310894,0.00023020605,0.0007467353,0.001241147,0.0005177554,0.0033378096,0.0006421403,0.002933671,0.020239918],"category_scores_gemma":[0.035653148,0.00037472325,0.00056976586,0.0024781323,0.0007401243,0.004131642,0.0019024559,0.0023431748,0.0011285368],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020350595,0.00032642376,0.2335899,0.007980938,0.00041893998,0.0019771839,0.0034200503,0.0011213479,0.0006453539,0.04833363,0.54185826,0.15829305],"study_design_scores_gemma":[0.0010500395,0.00050930795,0.7987516,0.0054957783,0.0001832361,0.0013762763,0.004936896,0.0012104707,0.00021772904,0.011112809,0.17502935,0.00012652922],"about_ca_topic_score_codex":0.11890903,"about_ca_topic_score_gemma":0.19544712,"teacher_disagreement_score":0.11890903,"about_ca_system_score_codex":0.0061443755,"about_ca_system_score_gemma":0.010852195,"threshold_uncertainty_score":0.2364338},"labels":[],"label_agreement":null},{"id":"W2906439904","doi":"10.1016/j.jval.2018.09.330","title":"PCN248 - USE OF CANCER DRUGS IN THE END-OF-LIFE IN MEN DYING OF CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Prostate cancer; Abiraterone acetate; Internal medicine; Cancer; Oncology; Abiraterone; Cohort; Odds ratio; Confidence interval; Population; Drug; Enzalutamide; Androgen deprivation therapy; Pharmacology; Androgen receptor","score_opus":0.12536312144343623,"score_gpt":0.421221625974369,"score_spread":0.29585850453093276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906439904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803525,0.0004520966,0.000066312816,0.00004351759,0.000010137049,0.000014462772,0.00059002027,0.0000030238407,0.0007851711],"genre_scores_gemma":[0.999113,0.00016957436,0.00003230173,0.000042324715,0.000015763982,0.000009906623,0.0003761468,0.0000020502007,0.00023888152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945945,0.00013766269,0.0000578002,0.00013574262,0.00011615544,0.00009318064],"domain_scores_gemma":[0.99856,0.00021940857,0.0007339611,0.000111067384,0.00013275023,0.00024283119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004959823,0.0003264249,0.00046787248,0.00069639954,0.000526592,0.0010449045,0.00049454643,0.00091740786,0.0019471825],"category_scores_gemma":[0.0021313275,0.00040034592,0.001248996,0.0013839456,0.0003074844,0.00084782345,0.0005282618,0.001353586,0.0003833769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038137013,0.00010904847,0.99788254,0.000018156468,0.0002400853,0.000068881556,0.00007540375,0.000032687036,0.0001103497,0.00001855753,0.00008478502,0.0009780362],"study_design_scores_gemma":[0.000019052293,0.0002425947,0.99886703,0.000007658004,0.0001288536,0.00017763069,0.00019659281,0.00011634061,0.0000222619,0.000026093054,0.00018856321,0.0000072570792],"about_ca_topic_score_codex":0.0062887305,"about_ca_topic_score_gemma":0.006679041,"teacher_disagreement_score":0.0062887305,"about_ca_system_score_codex":0.00042630924,"about_ca_system_score_gemma":0.00034127245,"threshold_uncertainty_score":0.01250428},"labels":[],"label_agreement":null},{"id":"W2906444991","doi":"10.1016/j.jval.2018.09.2438","title":"PRS44 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS UMEC/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Cost effectiveness; Quality-adjusted life year; Inhaler; Exacerbation; Internal medicine; Asthma","score_opus":0.30460778890449236,"score_gpt":0.4269383488251285,"score_spread":0.12233055992063613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906444991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9561471,0.00855772,0.001475983,0.0069105597,0.00021506824,0.0024032658,0.012265999,0.00009370141,0.011930644],"genre_scores_gemma":[0.99196106,0.0013690019,0.0017306863,0.0006032409,0.000041359046,0.00041380708,0.002547151,0.000009257318,0.0013243519],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945504,0.0039167246,0.00020659922,0.00026060757,0.00049392646,0.0005717235],"domain_scores_gemma":[0.9939361,0.0030423533,0.00082147185,0.0001823618,0.0009924569,0.0010253236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075718965,0.0007157312,0.00125356,0.00058894657,0.00061204314,0.0017156915,0.0010141423,0.0011144365,0.007094765],"category_scores_gemma":[0.014506729,0.0002779843,0.003542014,0.0012507322,0.0005859332,0.0009093483,0.0010633214,0.0016415258,0.00024238438],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21535939,0.010904134,0.17366798,0.004822375,0.013479655,0.0003161036,0.0005837759,0.11666857,0.0013609768,0.005684113,0.026431505,0.4307215],"study_design_scores_gemma":[0.10723321,0.04439323,0.64832246,0.0029038715,0.014332812,0.0001609754,0.0013286134,0.16385317,0.0011398727,0.0023620988,0.013661886,0.0003077809],"about_ca_topic_score_codex":0.8512408,"about_ca_topic_score_gemma":0.83801204,"teacher_disagreement_score":0.14875919,"about_ca_system_score_codex":0.0257399,"about_ca_system_score_gemma":0.036046132,"threshold_uncertainty_score":0.29927045},"labels":[],"label_agreement":null},{"id":"W2906465468","doi":"10.1016/j.jval.2018.09.011","title":"AD4 - ARE PATIENT-REPORTED PERSISTENCE AND ADHERENCE TO TREATMENT FOR A CHRONIC DISEASE VALID OUTCOMES? AN EXAMPLE WITH OSTEOPOROSIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Persistence (discontinuity); Osteoporosis; Medical prescription; Pharmacy; Internal medicine; Cohort; Predictive value; Disease; Bisphosphonate; Physical therapy; Pediatrics; Family medicine","score_opus":0.24395644706288575,"score_gpt":0.3833767179431372,"score_spread":0.13942027088025147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906465468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42341492,0.021225868,0.010375307,0.30840912,0.0018469676,0.00022234628,0.0024253041,0.0000657098,0.23201446],"genre_scores_gemma":[0.97263837,0.0051128943,0.0055596908,0.007489692,0.00072158774,0.000109792825,0.0004102238,0.00001903477,0.007938851],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99406475,0.003965607,0.0003539523,0.00024341521,0.0010956178,0.0002766726],"domain_scores_gemma":[0.97855777,0.01477106,0.0015652337,0.0010273892,0.003358093,0.00072047353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010372683,0.00026847285,0.0006055289,0.0012970793,0.0015493378,0.0025762965,0.0006320375,0.0019342325,0.0051828343],"category_scores_gemma":[0.032742854,0.00016606222,0.0010417998,0.0025866884,0.002911806,0.0026025937,0.0017880533,0.0028559854,0.0004374072],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011065163,0.0011573306,0.28619015,0.0011889492,0.0004745831,0.002185259,0.011408073,0.000746869,0.0004995179,0.15345766,0.038374353,0.50321084],"study_design_scores_gemma":[0.00054734404,0.0014290283,0.33899695,0.002573208,0.00091767614,0.0069359797,0.031062089,0.005587298,0.0015937198,0.3806241,0.22955625,0.00017634839],"about_ca_topic_score_codex":0.014237189,"about_ca_topic_score_gemma":0.018982746,"teacher_disagreement_score":0.014237189,"about_ca_system_score_codex":0.001784552,"about_ca_system_score_gemma":0.002483806,"threshold_uncertainty_score":0.054856658},"labels":[],"label_agreement":null},{"id":"W2906504932","doi":"10.1016/j.jval.2018.09.857","title":"PGI15 - HEALTHCARE RESOURCE UTILIZATION (HCRU) IN METASTATIC OR UNRESECTABLE GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER PATIENTS RECEIVING SECOND-LINE TREATMENT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Concomitant; Cancer; Cohort; Retrospective cohort study; Internal medicine; Emergency department; Medical prescription; Intensive care unit; Emergency medicine; Pediatrics","score_opus":0.12950185169841275,"score_gpt":0.37501043576867993,"score_spread":0.24550858407026718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906504932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9692122,0.003169478,0.00020904912,0.0010757885,0.00009265102,0.00005162908,0.01904589,0.00003123442,0.0071120807],"genre_scores_gemma":[0.9909141,0.00043217387,0.00022587997,0.00026921218,0.000040751114,0.000038908576,0.007355337,0.000008517267,0.0007151802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991116,0.00022432292,0.00014638065,0.0001131496,0.00018256866,0.0002219151],"domain_scores_gemma":[0.99726665,0.0004393265,0.0013857979,0.00006962805,0.00026751557,0.000571146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083530997,0.00024935516,0.00054130406,0.0012117883,0.00024322589,0.0011099761,0.00041194214,0.00051606,0.0046115965],"category_scores_gemma":[0.004678655,0.0001412328,0.001403894,0.0026687318,0.00021267716,0.0006193742,0.001104151,0.0008853716,0.0005182785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014189893,0.000046703954,0.99266464,0.000056592202,0.00025687815,0.00002886125,0.000041190513,0.00026906864,0.00003731997,0.00009737737,0.001535471,0.0048239655],"study_design_scores_gemma":[0.000009567876,0.00007273052,0.99804604,0.00004304717,0.00006299292,0.000068715155,0.00013577864,0.00041809483,0.000041735482,0.0000736466,0.001022497,0.000005192834],"about_ca_topic_score_codex":0.017740993,"about_ca_topic_score_gemma":0.02100565,"teacher_disagreement_score":0.017740993,"about_ca_system_score_codex":0.0013783337,"about_ca_system_score_gemma":0.0013263418,"threshold_uncertainty_score":0.03527546},"labels":[],"label_agreement":null},{"id":"W2906508065","doi":"10.1016/j.jval.2018.09.2728","title":"PSY154 - ECONOMIC BURDEN OF BETA-THALASSEMIA: LITERATURE REVIEW","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Observational study; Thalassemia; Beta thalassemia; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.022354379021380447,"score_gpt":0.3077341515956701,"score_spread":0.28537977257428965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906508065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013329845,0.9963934,0.000037665377,0.0011438655,0.00014930555,0.000010945372,0.00026188674,0.000001270294,0.00066873274],"genre_scores_gemma":[0.0066196956,0.99249774,0.00009562139,0.00037332554,0.0002388362,0.000010011554,0.000118605065,0.0000010382186,0.000045096167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902356,0.00020638468,0.00039359654,0.00011020512,0.00020636558,0.000059886635],"domain_scores_gemma":[0.99074966,0.0061885477,0.0020237702,0.00008131454,0.0007952818,0.00016135524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002174247,0.0005949144,0.0015969184,0.0075414144,0.00036272837,0.0020352877,0.0008175997,0.0011903526,0.0059158397],"category_scores_gemma":[0.010138476,0.000408961,0.0015239989,0.012512009,0.0007274259,0.0018921681,0.0008902925,0.0010153654,0.00038970157],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005933395,0.0001878929,0.032480013,0.362834,0.0048607257,0.0017369648,0.00074848015,0.00056954834,0.00020751101,0.0071996464,0.037428938,0.5511529],"study_design_scores_gemma":[0.00017133408,0.00025341017,0.09480942,0.54207206,0.018263413,0.00860974,0.0037899425,0.0003827126,0.00020439914,0.0047508483,0.32654607,0.0001466604],"about_ca_topic_score_codex":0.0059482884,"about_ca_topic_score_gemma":0.01219716,"teacher_disagreement_score":0.0075414144,"about_ca_system_score_codex":0.0014443775,"about_ca_system_score_gemma":0.0051132804,"threshold_uncertainty_score":0.01979047},"labels":[],"label_agreement":null},{"id":"W2906536618","doi":"10.1016/j.jval.2018.09.1679","title":"PMH44 - CANADIAN ECONOMIC IMPACT OF IMPROVED WORKPLACE PRODUCTIVITY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH VORTIOXETINE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Perfectionism, Procrastination, Anxiety Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Grey Nuns Community Hospital; Université de Montréal","funders":"","keywords":"Presenteeism; Vortioxetine; Absenteeism; Productivity; Major depressive disorder; Medicine; Mental health; Psychiatry; Psychology; Cognition; Physical therapy; Economics","score_opus":0.010973306690792654,"score_gpt":0.2818942331976553,"score_spread":0.2709209265068626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906536618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736771,0.003891648,0.00003307875,0.002478017,0.00016903527,0.00007955639,0.0061243786,0.000007103149,0.013540119],"genre_scores_gemma":[0.99580693,0.0010823924,0.00006023514,0.00018642606,0.00004586461,0.000017057575,0.00169815,0.0000016542223,0.0011013224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995066,0.00010163517,0.000029328348,0.000020245334,0.00019633709,0.00014580699],"domain_scores_gemma":[0.9989503,0.00010099738,0.0002277922,0.000014472858,0.0003637718,0.00034266696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045435727,0.0001383427,0.0003261129,0.00057626946,0.00095922215,0.0008260963,0.00041422114,0.0002833477,0.003855743],"category_scores_gemma":[0.0026302875,0.0000962934,0.00069439417,0.0014041167,0.00019854073,0.00018750507,0.00039888217,0.0007077766,0.00015167451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013502182,0.0009501498,0.8852884,0.00042635747,0.0014985373,0.00056258874,0.00027495096,0.0015140926,0.0006557131,0.0007639504,0.014040744,0.0805223],"study_design_scores_gemma":[0.00031399526,0.00025197645,0.9968131,0.000042344956,0.00016620054,0.00005963606,0.00020944879,0.00025434952,0.000051916966,0.00003431633,0.0017909987,0.0000116118945],"about_ca_topic_score_codex":0.8269989,"about_ca_topic_score_gemma":0.9014857,"teacher_disagreement_score":0.17300111,"about_ca_system_score_codex":0.009192495,"about_ca_system_score_gemma":0.011119444,"threshold_uncertainty_score":0.34803987},"labels":[],"label_agreement":null},{"id":"W2906546777","doi":"10.1016/j.jval.2018.09.718","title":"PDB12 - CARDIOVASCULAR SAFETY OF EMPAGLIFLOZIN VERSUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISONS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Empagliflozin; Semaglutide; Lixisenatide; Liraglutide; Medicine; Dulaglutide; Exenatide; Internal medicine; Glucagon-like peptide 1 receptor; Type 2 diabetes; Hazard ratio; Myocardial infarction; Diabetes mellitus; Cardiology; Pharmacology; Endocrinology; Confidence interval; Agonist; Receptor","score_opus":0.03565310845774038,"score_gpt":0.2958013506025581,"score_spread":0.2601482421448177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906546777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013719633,0.9830945,0.00033095546,0.00035819065,0.00024565088,0.00026645913,0.00121332,0.000014001525,0.000757194],"genre_scores_gemma":[0.32510477,0.66665745,0.0018289698,0.0024474976,0.00059218373,0.00072742795,0.0019496465,0.00003155948,0.0006605524],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895467,0.0043950244,0.0036362892,0.0011340919,0.000978144,0.0003097491],"domain_scores_gemma":[0.978964,0.014538209,0.004566062,0.0005017462,0.001189394,0.0002406236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0104390355,0.0013860574,0.008615048,0.0039125374,0.00034585706,0.0025972358,0.0012613408,0.0021294886,0.006714216],"category_scores_gemma":[0.029985147,0.00091265456,0.017421005,0.0041399067,0.0009090451,0.0018166604,0.0018232152,0.0019348024,0.0005034416],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017333481,0.00008120434,0.0058146426,0.5250183,0.4101821,0.00012687416,0.00015367185,0.0002640958,0.00045344786,0.0002871861,0.0010554317,0.03922962],"study_design_scores_gemma":[0.009993987,0.0011714988,0.01213385,0.045685407,0.9245061,0.0001675738,0.00013812115,0.00014771041,0.00017051001,0.00038653103,0.00544983,0.000048769914],"about_ca_topic_score_codex":0.0038765583,"about_ca_topic_score_gemma":0.010564811,"teacher_disagreement_score":0.0104390355,"about_ca_system_score_codex":0.001784253,"about_ca_system_score_gemma":0.0027014716,"threshold_uncertainty_score":0.05520755},"labels":[],"label_agreement":null},{"id":"W2906550505","doi":"10.1016/j.jval.2018.09.015","title":"CE3 - COST-EFFECTIVENESS OF DEMENTIA CARE MANAGEMENT ALONGSIDE A CLUSTER-RANDOMIZED CONTROLLED INTERVENTIONAL DELPHI TRIAL","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dementia; Randomized controlled trial; Health care; Cost–utility analysis; Cost effectiveness; Quality-adjusted life year; Cluster randomised controlled trial; Willingness to pay; Delphi; Cost–benefit analysis; Emergency medicine; Surgery; Disease; Internal medicine","score_opus":0.28504094599139745,"score_gpt":0.4460323135968182,"score_spread":0.16099136760542077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906550505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9260392,0.0030919455,0.011522149,0.004286648,0.0016152387,0.039291784,0.003674617,0.0004397651,0.01003868],"genre_scores_gemma":[0.9550529,0.00046300993,0.009723489,0.0010214082,0.00028744678,0.0306409,0.00086255494,0.000046259593,0.0019020328],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.966132,0.027689818,0.0015575665,0.0018436152,0.0009734099,0.0018035205],"domain_scores_gemma":[0.979565,0.013252033,0.0021416855,0.001996214,0.0010564167,0.0019885397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017997634,0.0029979981,0.0055373567,0.0009873976,0.0010822554,0.0018243047,0.002122459,0.0050327433,0.021981955],"category_scores_gemma":[0.03690422,0.00120276,0.006807081,0.00095773826,0.0026018957,0.0031980886,0.002963233,0.00450014,0.001549688],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97682494,0.0039835377,0.0004874796,0.000890478,0.0027474468,0.000019635565,0.000108372195,0.0013585915,0.00030675,0.000677199,0.00062972534,0.011965842],"study_design_scores_gemma":[0.9401834,0.049158987,0.0021520401,0.0003063151,0.002444794,0.000021404612,0.000111215835,0.0027921193,0.0003743407,0.0013842242,0.0010051107,0.000066052],"about_ca_topic_score_codex":0.0054976135,"about_ca_topic_score_gemma":0.0041176146,"teacher_disagreement_score":0.021981955,"about_ca_system_score_codex":0.003822188,"about_ca_system_score_gemma":0.0060269027,"threshold_uncertainty_score":0.09518176},"labels":[],"label_agreement":null},{"id":"W2906554289","doi":"10.1016/j.jval.2018.09.1959","title":"PMU123 - THE RELATIONSHIP BETWEEN INDIVIDUAL-LEVEL DEPRIVATION WITH HEALTH-RELATED QUALITY OF LIFE IN THE GENERAL POPULATION","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; EQ-5D; Logistic regression; Quality of life (healthcare); Visual analogue scale; Population; Demography; Anxiety; Depression (economics); Social deprivation; Multivariate statistics; Index (typography); Gerontology; Health related quality of life; Physical therapy; Statistics; Environmental health; Psychiatry; Internal medicine","score_opus":0.7260924564620357,"score_gpt":0.4691966552861604,"score_spread":0.2568958011758753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906554289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9605423,0.0024505658,0.00057821133,0.0029716971,0.00016474293,0.000041959698,0.024568584,0.000039415267,0.0086424975],"genre_scores_gemma":[0.99464816,0.0003091096,0.00016424689,0.00010690919,0.00007400801,0.000025769585,0.0039524804,0.000007929975,0.0007114627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984577,0.0008500853,0.00011459168,0.00012189452,0.00027121144,0.00018445341],"domain_scores_gemma":[0.9922881,0.0033102504,0.0021005142,0.0004559938,0.00084309326,0.0010021848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016111847,0.00022130832,0.00045387333,0.0014073524,0.0003101962,0.0008881243,0.0005083445,0.00050489535,0.0068303985],"category_scores_gemma":[0.013431187,0.00019284029,0.0007561554,0.0034725582,0.00036418586,0.0004346133,0.0009978942,0.00085103227,0.0005906234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015432473,0.000035243633,0.9881015,0.000051786406,0.00021243667,0.000039031944,0.000054852702,0.00024126444,0.000026632051,0.00039702628,0.0032244797,0.007461319],"study_design_scores_gemma":[0.0000066058014,0.00004774947,0.9982235,0.0000121910625,0.00003541411,0.00008571355,0.00008497104,0.0003651185,0.000031459655,0.0002353182,0.0008685341,0.0000034745285],"about_ca_topic_score_codex":0.025958603,"about_ca_topic_score_gemma":0.015729135,"teacher_disagreement_score":0.025958603,"about_ca_system_score_codex":0.0006449401,"about_ca_system_score_gemma":0.0005814149,"threshold_uncertainty_score":0.051615},"labels":[],"label_agreement":null},{"id":"W2906554411","doi":"10.1016/j.jval.2018.09.304","title":"PCN222 - TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILISATION (HCRU) IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) IN CANADA AND EUROPE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Sorafenib; Internal medicine; Hepatitis C; Cancer; Liver disease; Liver cancer; Adverse effect; Medical record; Hepatitis; Pediatrics","score_opus":0.0511909730936406,"score_gpt":0.23822773814185386,"score_spread":0.18703676504821326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906554411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792635,0.0052343784,0.00011585017,0.0013157725,0.000033997836,0.000017187547,0.010992254,0.0000130520375,0.0030140702],"genre_scores_gemma":[0.991932,0.0016816074,0.000072908275,0.00015123523,0.000012332511,0.0000067546625,0.0047669704,0.0000123152695,0.0013639901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893135,0.00009727526,0.000107842025,0.00013711602,0.00024133352,0.00048496088],"domain_scores_gemma":[0.9967871,0.00022663355,0.0007466397,0.00009147222,0.0010887102,0.0010595173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077001756,0.00027689507,0.00051016477,0.0020071713,0.0011511067,0.0022268316,0.0011469639,0.0007104015,0.0032604327],"category_scores_gemma":[0.0028874166,0.00028850356,0.001434751,0.0068985377,0.0006874756,0.00051462854,0.0010073963,0.0011383833,0.0002473281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021829252,0.00004275707,0.99141085,0.000044964716,0.00025811477,0.00013234481,0.00021466303,0.0008112826,0.000086549924,0.0005568833,0.0017794723,0.004443866],"study_design_scores_gemma":[0.000008370178,0.000014392242,0.99653625,0.00005831622,0.00005840972,0.000079756115,0.00080118305,0.00060787064,0.00005230015,0.00008294645,0.0016839062,0.000016356973],"about_ca_topic_score_codex":0.99006325,"about_ca_topic_score_gemma":0.9906961,"teacher_disagreement_score":0.027089303,"about_ca_system_score_codex":0.027089303,"about_ca_system_score_gemma":0.02336884,"threshold_uncertainty_score":0.19654757},"labels":[],"label_agreement":null},{"id":"W2906558033","doi":"10.1016/j.jval.2018.09.2236","title":"PRM116 - GENERAL PERCEPTIONS OF INNOVATIVE METHODS FOR SURVIVAL EXTRAPOLATION IN ONCOLOGY AMONG HTA IN EUROPE, CANADA AND AUSTRALIA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Extrapolation; Medicine; Telephone survey; Perception; Psychology; Geography; Marketing; Business; Statistics; Mathematics","score_opus":0.5452247698468845,"score_gpt":0.5335008043305957,"score_spread":0.011723965516288848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906558033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9465954,0.001763416,0.00086282426,0.027440134,0.00011324616,0.00016347792,0.00037224562,0.000020730615,0.02266846],"genre_scores_gemma":[0.99317366,0.0008626418,0.0010625833,0.002161203,0.000036135672,0.000027868997,0.00011874719,0.000023509401,0.0025336563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9817749,0.0072413385,0.0013567525,0.0007517875,0.0065692654,0.0023058904],"domain_scores_gemma":[0.9079888,0.032221045,0.0072277617,0.0016991488,0.032125425,0.018737825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037636887,0.000168343,0.00046260626,0.0017155298,0.0037339951,0.007686888,0.0011489771,0.0012556566,0.004953203],"category_scores_gemma":[0.094932675,0.00037159937,0.0008677474,0.0020902527,0.002827044,0.0020497045,0.0034231935,0.0031220482,0.00030365473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006912912,0.00038576894,0.74443185,0.00038506655,0.0001861453,0.0005519076,0.11551751,0.0021541081,0.0010257876,0.010349284,0.012441457,0.11187987],"study_design_scores_gemma":[0.000046827277,0.0004707967,0.84679645,0.0010264128,0.00009415916,0.00038410618,0.10125792,0.003916015,0.00058985286,0.0022413807,0.042994916,0.00018111302],"about_ca_topic_score_codex":0.6888498,"about_ca_topic_score_gemma":0.6556272,"teacher_disagreement_score":0.3111502,"about_ca_system_score_codex":0.02579664,"about_ca_system_score_gemma":0.03249594,"threshold_uncertainty_score":0.62596524},"labels":[],"label_agreement":null},{"id":"W2906577617","doi":"10.1016/j.jval.2018.09.094","title":"PCN11 - GLOBAL LONGITUDINAL ASSESSMENT OF TREATMENT OUTCOMES IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (GLANCE-H&N) STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cetuximab; Head and neck squamous-cell carcinoma; Interquartile range; Head and neck cancer; Taxane; Internal medicine; Regimen; Oncology; Cancer; Retrospective cohort study; Confidence interval; Colorectal cancer; Breast cancer","score_opus":0.09713192143538302,"score_gpt":0.40555071226183603,"score_spread":0.308418790826453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906577617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757092,0.001226096,0.00026976204,0.00062787393,0.00008893782,0.00021978047,0.019716242,0.000014635265,0.0021273186],"genre_scores_gemma":[0.9793131,0.00089908123,0.0006263303,0.0004271006,0.00006207948,0.00052451465,0.015853934,0.000023147417,0.002270653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976203,0.0012461175,0.00016399889,0.00035921362,0.00029306812,0.00031732282],"domain_scores_gemma":[0.9954383,0.00048231706,0.0015348673,0.00097424217,0.00071300677,0.000857251],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040963097,0.00088808965,0.00092014665,0.00061988534,0.0012651755,0.0012571837,0.0018035871,0.0012898989,0.001916646],"category_scores_gemma":[0.0062563783,0.0007854878,0.0022956324,0.0023899465,0.00061749393,0.001523763,0.003539149,0.0023085778,0.00070357707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006019771,0.00033744596,0.9823415,0.00013389229,0.0019835203,0.000087849075,0.00027232378,0.00024988168,0.00019256838,0.00020989176,0.0033108257,0.0048605683],"study_design_scores_gemma":[0.00051678804,0.000573599,0.99592775,0.000061163766,0.0007990915,0.00006866381,0.0003944285,0.0001314929,0.00006786851,0.00008262965,0.0013520977,0.000024412933],"about_ca_topic_score_codex":0.07820189,"about_ca_topic_score_gemma":0.12635112,"teacher_disagreement_score":0.07820189,"about_ca_system_score_codex":0.001960869,"about_ca_system_score_gemma":0.0029083635,"threshold_uncertainty_score":0.15549344},"labels":[],"label_agreement":null},{"id":"W2906604963","doi":"10.1016/j.jval.2018.09.963","title":"PHP69 - A REVIEW OF FUNDING PATHS FOR E-HEALTH SOLUTIONS IN THE EU5, US AND CANADA","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"eHealth; Business; Payment; Telemedicine; Health care; Sustainability; Economic growth; Finance; Economics","score_opus":0.29494746443194264,"score_gpt":0.46699937985137785,"score_spread":0.1720519154194352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906604963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003802115,0.9882939,0.0001269804,0.0042023896,0.00041355728,0.000052908883,0.0005749669,0.00001129991,0.005943716],"genre_scores_gemma":[0.0030868037,0.99390006,0.0005182643,0.0011951546,0.00007671508,0.00003855428,0.00020038155,0.000009178839,0.00097493554],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99492395,0.00074894837,0.00069726096,0.0002804325,0.0026302536,0.00071910874],"domain_scores_gemma":[0.98408604,0.006450224,0.0014148697,0.00020481787,0.006816863,0.0010271983],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010696502,0.001114278,0.0020888448,0.012275547,0.00203105,0.007144159,0.0026910256,0.002651353,0.010048668],"category_scores_gemma":[0.022667736,0.0005772108,0.0022845708,0.021715662,0.0018051681,0.0026243737,0.0028358246,0.0030447473,0.00091204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022707978,0.00005989295,0.0013071343,0.09394483,0.00061614503,0.00019603246,0.0004434531,0.0009929435,0.00029423524,0.04274262,0.11010284,0.74907273],"study_design_scores_gemma":[0.00005197141,0.000038000475,0.0031917896,0.115400136,0.0007177918,0.00014666768,0.00040362257,0.00010778783,0.0002130226,0.0026351206,0.8770566,0.000037452526],"about_ca_topic_score_codex":0.52515024,"about_ca_topic_score_gemma":0.6820388,"teacher_disagreement_score":0.98930347,"about_ca_system_score_codex":0.03902028,"about_ca_system_score_gemma":0.14881323,"threshold_uncertainty_score":0.95529246},"labels":[],"label_agreement":null},{"id":"W2906629470","doi":"10.1016/j.jval.2018.09.1353","title":"PIN34 - COMPARING THE ESTIMATED PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PHID-CV AND PCV-13 IN THE ROUTINE IMMUNISATION PROGRAMME IN GAVI-ELIGIBLE COUNTRIES (SUB-SAHARAN AFRICA AND ASIA/OCEANIA): A MODELLING STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Vaccination; Pneumococcal conjugate vaccine; Conjugate vaccine; Cohort; Disease burden; Environmental health; Pediatrics; Immunization; Population; Immunology; Internal medicine; Streptococcus pneumoniae","score_opus":0.2750409052276595,"score_gpt":0.4456546928419141,"score_spread":0.1706137876142546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906629470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9123647,0.0032886246,0.014518578,0.0023024792,0.00021300076,0.0015148057,0.03470681,0.00035318552,0.030737756],"genre_scores_gemma":[0.985914,0.0005958951,0.0040641245,0.00022518366,0.00002908741,0.000690686,0.0043198806,0.00005771657,0.0041034496],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971252,0.0020653878,0.00008642047,0.00022897215,0.00012685216,0.00036719578],"domain_scores_gemma":[0.9836812,0.0143757025,0.00066137686,0.00042917524,0.0005207771,0.00033183076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076800743,0.0015092245,0.0024059115,0.001350102,0.0003248701,0.0018586383,0.002578936,0.0022194753,0.02173051],"category_scores_gemma":[0.01788744,0.0014496559,0.005950708,0.0020782056,0.00055981125,0.0016830862,0.0011863636,0.0026849539,0.0013105888],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005857522,0.0005636883,0.011685069,0.0011998595,0.002908148,0.00017484036,0.000070897004,0.9572746,0.00027430808,0.0040443526,0.0029429845,0.013003818],"study_design_scores_gemma":[0.011045103,0.011536008,0.04788293,0.0010993709,0.008578461,0.00071689073,0.00069652515,0.89370525,0.0014609495,0.014174386,0.008864053,0.00023997256],"about_ca_topic_score_codex":0.041629754,"about_ca_topic_score_gemma":0.014330731,"teacher_disagreement_score":0.041629754,"about_ca_system_score_codex":0.0037187838,"about_ca_system_score_gemma":0.003474968,"threshold_uncertainty_score":0.08277488},"labels":[],"label_agreement":null},{"id":"W2906629779","doi":"10.1016/j.jval.2018.09.611","title":"PCV64 - THE DIRECT RESOURCE USE AND MEDICAL COSTS OF HEART FAILURE IN NOVA SCOTIA, CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of British Columbia; Vancouver Coastal Health; Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Nova scotia; Confidence interval; Emergency medicine; Population; Inpatient care; Cohort; Health care; Retrospective cohort study; Cohort study; Indirect costs; Demography; Environmental health; Pediatrics; Internal medicine; Business; Geography","score_opus":0.1324443529553812,"score_gpt":0.3977724597865986,"score_spread":0.2653281068312174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906629779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91709065,0.008100191,0.00021081205,0.00821589,0.00022983471,0.00015379189,0.051847078,0.00003647395,0.0141154025],"genre_scores_gemma":[0.98373806,0.0026895641,0.00027127546,0.0007565392,0.000060383754,0.00004672427,0.0071276114,0.000015902166,0.0052939528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858993,0.00015541083,0.00016177146,0.00011087651,0.0004614522,0.0005205549],"domain_scores_gemma":[0.9936841,0.0004971496,0.0013228602,0.000098011886,0.0024164743,0.0019813746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007092641,0.00035641418,0.0005866231,0.0018019738,0.0015837378,0.0019787485,0.0013506898,0.0007874475,0.003605742],"category_scores_gemma":[0.0057408297,0.0004019377,0.0010481263,0.004563167,0.00063504296,0.00042020614,0.001130136,0.0012204975,0.00035276366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024436298,0.000085017826,0.9741657,0.00022716436,0.00022151518,0.00034706414,0.00033484004,0.0011099232,0.0001054683,0.0006295797,0.012728787,0.0098006325],"study_design_scores_gemma":[0.00004578989,0.00003231993,0.9950051,0.00021799412,0.000062113984,0.0001086992,0.00072929217,0.0008006813,0.000036046313,0.00006505741,0.0028781663,0.000018814171],"about_ca_topic_score_codex":0.99828726,"about_ca_topic_score_gemma":0.99865997,"teacher_disagreement_score":0.051500503,"about_ca_system_score_codex":0.051500503,"about_ca_system_score_gemma":0.09254491,"threshold_uncertainty_score":0.37366402},"labels":[],"label_agreement":null},{"id":"W2906638584","doi":"10.1016/j.jval.2018.09.375","title":"PCN293 - WHAT IS THE VALUE OF REAL WORLD EVIDENCE IN ONCOLOGY IN HTA APPRAISALS IN ENGLAND, FRANCE, CANADA AND AUSTRALIA?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Reimbursement; Medicine; Observational study; Excellence; Health technology; Real world evidence; Family medicine; Agency (philosophy); Economic evaluation; Health care; Political science; Internal medicine","score_opus":0.4504710151510692,"score_gpt":0.46695492943462263,"score_spread":0.016483914283553447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906638584","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043261264,0.19181213,0.002088465,0.68015486,0.007131996,0.0007666825,0.0126976725,0.00007264867,0.062014226],"genre_scores_gemma":[0.767568,0.083802804,0.012071057,0.112528585,0.008328713,0.0010966889,0.0077647204,0.0003106371,0.0065287175],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.83076936,0.10903013,0.020281719,0.0032775658,0.03203825,0.0046029007],"domain_scores_gemma":[0.2777073,0.53046334,0.035486788,0.010112186,0.12769295,0.018537434],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.19382834,0.00063412456,0.004063353,0.010436436,0.00230361,0.021107662,0.0033352217,0.00628548,0.014376909],"category_scores_gemma":[0.621425,0.0009711074,0.0030461345,0.012222199,0.0069029196,0.01046236,0.0051633203,0.0061363354,0.0011886315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042848988,0.00028578416,0.10568373,0.05085437,0.011037786,0.0005626005,0.0072027617,0.0043124063,0.00048849615,0.10653881,0.2568558,0.45189264],"study_design_scores_gemma":[0.0027063012,0.0010539981,0.28324115,0.20109715,0.009797259,0.0007350588,0.008850072,0.00649921,0.0012102013,0.071870714,0.41204315,0.0008956451],"about_ca_topic_score_codex":0.2302758,"about_ca_topic_score_gemma":0.37981322,"teacher_disagreement_score":0.7697242,"about_ca_system_score_codex":0.039208103,"about_ca_system_score_gemma":0.080814935,"threshold_uncertainty_score":0.9941532},"labels":[],"label_agreement":null},{"id":"W2906646251","doi":"10.1016/j.jval.2018.09.292","title":"PCN210 - USING REAL WORLD DATA TO DETERMINE HEALTH SYSTEM COSTS OF A 5-YEAR NON-SMALL CELL LUNG CANCER COHORT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); McMaster University; Sunnybrook Hospital","funders":"","keywords":"Medicine; Cohort; Activity-based costing; Lung cancer; Total cost; Cancer; Cancer registry; Health care; Emergency medicine; Cohort study; Family medicine; Internal medicine; Business","score_opus":0.12407475187079188,"score_gpt":0.32821576885284254,"score_spread":0.20414101698205067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906646251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93068117,0.00007374421,0.00048134432,0.00017236592,0.00002014709,0.000063599255,0.067212366,0.000043259144,0.0012520475],"genre_scores_gemma":[0.88397014,0.00009732567,0.0013504197,0.00006825854,0.000029622444,0.00012546983,0.112495214,0.000026932474,0.001836532],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993801,0.0002021255,0.00004672613,0.00015442517,0.00013041371,0.00008613731],"domain_scores_gemma":[0.9956436,0.0014852335,0.00093279063,0.0007328288,0.00069570215,0.0005097332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047788,0.0004438791,0.0003717384,0.0014951719,0.0003662989,0.00094160886,0.0008938467,0.0006842574,0.0028166012],"category_scores_gemma":[0.007821093,0.0004326255,0.0008993025,0.0018307953,0.00020978106,0.00059161754,0.00079366553,0.00078956195,0.0010244055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001023514,0.00038059702,0.9708067,0.000045903987,0.0005960745,0.00017855762,0.0000548716,0.012259131,0.00021454415,0.00037128586,0.00799348,0.0060752975],"study_design_scores_gemma":[0.00019259988,0.00037495856,0.9695566,0.00001987255,0.000115210496,0.00026957382,0.00017899253,0.024786925,0.00035117738,0.0002730953,0.003855061,0.0000257726],"about_ca_topic_score_codex":0.12411473,"about_ca_topic_score_gemma":0.11470523,"teacher_disagreement_score":0.12411473,"about_ca_system_score_codex":0.0013453759,"about_ca_system_score_gemma":0.0014934039,"threshold_uncertainty_score":0.24678457},"labels":[],"label_agreement":null},{"id":"W2914185992","doi":"10.1016/j.jval.2013.02.010","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":681,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"","keywords":"Checklist; Statement (logic); Government (linguistics); Delphi method; Psychological intervention; Economic evaluation; Systematic review; Consolidated Standards of Reporting Trials; Delphi; Public relations; Political science; Medicine; MEDLINE; Medical education; Psychology; Nursing; Computer science; Law","score_opus":0.5301534469288427,"score_gpt":0.5052983449688688,"score_spread":0.02485510195997387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914185992","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008911544,0.044333044,0.1718709,0.19988723,0.044852056,0.051973913,0.35448086,0.006558126,0.117132284],"genre_scores_gemma":[0.06670046,0.036351573,0.3290201,0.059405953,0.011088758,0.10275924,0.3711779,0.0024069168,0.021089109],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.78748107,0.10662151,0.05165113,0.0027835795,0.047530077,0.0039326968],"domain_scores_gemma":[0.3984341,0.26367596,0.060516443,0.04235791,0.22769305,0.007322497],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2054076,0.0028489626,0.0060320813,0.013201014,0.0014533221,0.010089054,0.0065841996,0.009018732,0.013154742],"category_scores_gemma":[0.55560076,0.0021529049,0.006609855,0.022343377,0.004143762,0.0045633013,0.0060060066,0.016476434,0.008120349],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001406763,0.00037918377,0.0059022023,0.009131224,0.0013655954,0.00013801952,0.00024791845,0.0027130072,0.00019193735,0.035836037,0.82803947,0.11464866],"study_design_scores_gemma":[0.0031009945,0.00040267096,0.03109047,0.0272114,0.00278639,0.0005981184,0.0004952014,0.006821876,0.0018546886,0.06709772,0.85828507,0.00025537197],"about_ca_topic_score_codex":0.0105438605,"about_ca_topic_score_gemma":0.005775784,"teacher_disagreement_score":0.7945924,"about_ca_system_score_codex":0.0068444167,"about_ca_system_score_gemma":0.036393635,"threshold_uncertainty_score":0.9798739},"labels":[],"label_agreement":null},{"id":"W2921518676","doi":"10.1016/j.jval.2019.01.006","title":"Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Bayesian Modeling and Causal Inference","field":"Computer Science","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; University of Toronto","funders":"","keywords":"Bayesian network; Machine learning; Computer science; Artificial intelligence; Graphical model; Bayes' theorem; Estimation; Naive Bayes classifier; Bayesian probability; Data mining; Data science; Support vector machine; Risk analysis (engineering); Engineering; Medicine","score_opus":0.3173173099108415,"score_gpt":0.4416796139974549,"score_spread":0.12436230408661342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921518676","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002063183,0.9675425,0.027913522,0.0026070634,0.00032009708,0.000020946052,0.00015052636,0.00006310471,0.0011759805],"genre_scores_gemma":[0.006475995,0.97047204,0.020301003,0.0010143414,0.000990426,0.00007417103,0.00015754595,0.000023269253,0.0004912555],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9974445,0.0012116748,0.00022778356,0.00030942186,0.00076620193,0.000040360315],"domain_scores_gemma":[0.9778751,0.019667836,0.00079289987,0.00048400866,0.0010058202,0.00017432171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075709685,0.0017567364,0.004399415,0.0040997285,0.00029193895,0.0026501503,0.0029955776,0.0034689922,0.0035856685],"category_scores_gemma":[0.021008534,0.00083380775,0.0017476876,0.0046443297,0.001999087,0.0030507268,0.0011841564,0.00629271,0.001181951],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000088492714,0.00009967775,0.00066195766,0.013859095,0.0009668381,0.00011696778,0.00007595736,0.011078243,0.00024182424,0.08552839,0.019876735,0.86740583],"study_design_scores_gemma":[0.00013123335,0.00016906695,0.0020319528,0.02086122,0.0017178188,0.001027073,0.00012243427,0.028780783,0.00086699374,0.48446587,0.45956105,0.00026454328],"about_ca_topic_score_codex":0.0044904943,"about_ca_topic_score_gemma":0.0039223596,"teacher_disagreement_score":0.0075709685,"about_ca_system_score_codex":0.002329905,"about_ca_system_score_gemma":0.0028823153,"threshold_uncertainty_score":0.0400396},"labels":[],"label_agreement":null},{"id":"W2924788313","doi":"10.1016/j.jval.2018.12.005","title":"Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides","funders":"","keywords":"Medicine; Opioid; Chronic pain; Opioid abuse; Opioid overdose; Substance abuse; Psychiatry; Internal medicine","score_opus":0.034042281318582605,"score_gpt":0.3396351064168651,"score_spread":0.3055928250982825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924788313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8677716,0.041236717,0.03032887,0.010363337,0.0005433146,0.004368409,0.008543257,0.0001698107,0.036674593],"genre_scores_gemma":[0.9872765,0.0046602776,0.0043731355,0.00070820196,0.000076084165,0.00042475166,0.00091698073,0.000013747759,0.0015503068],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99266255,0.0056407023,0.00026226646,0.00034868965,0.00050421414,0.0005816002],"domain_scores_gemma":[0.982261,0.01554885,0.001054287,0.00019688664,0.0005012452,0.00043766858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0091467155,0.0019768989,0.0034147045,0.0031852394,0.00045518854,0.0043335324,0.0023091205,0.0026931341,0.008053652],"category_scores_gemma":[0.028513543,0.0014857131,0.0070391726,0.0028293543,0.0011908807,0.003593302,0.0015700175,0.0026972212,0.00032943903],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022804933,0.0030045344,0.055222522,0.003700412,0.017642312,0.0006472031,0.00025152578,0.79651475,0.0007417096,0.027331578,0.0037021842,0.068436414],"study_design_scores_gemma":[0.00830766,0.011995447,0.05771281,0.0024159695,0.040922977,0.0012435426,0.0013521584,0.84033257,0.00077914813,0.026889354,0.007772883,0.00027549156],"about_ca_topic_score_codex":0.022248713,"about_ca_topic_score_gemma":0.01377181,"teacher_disagreement_score":0.022248713,"about_ca_system_score_codex":0.008776752,"about_ca_system_score_gemma":0.0046064467,"threshold_uncertainty_score":0.06368011},"labels":[],"label_agreement":null},{"id":"W2945144952","doi":"10.1016/j.jval.2018.12.012","title":"Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Social Sciences and Humanities Research Council of Canada; University of Sheffield","keywords":"SF-36; Consistency (knowledge bases); Ceiling effect; Dimension (graph theory); Quality of life (healthcare); Statistics; Mean difference; Significant difference; Medicine; Demography; Mathematics; Psychology; Health related quality of life; Combinatorics; Confidence interval; Alternative medicine; Internal medicine; Nursing; Discrete mathematics; Sociology","score_opus":0.5010494795401929,"score_gpt":0.40114926710934196,"score_spread":0.0999002124308509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945144952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8140825,0.0024439853,0.13442378,0.0031097087,0.002267472,0.007681073,0.00886032,0.0009907169,0.026140485],"genre_scores_gemma":[0.84666646,0.0011644388,0.12166625,0.0020461492,0.0002777007,0.012977959,0.009216526,0.00089412776,0.00509048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.75672454,0.15052988,0.04222985,0.011551045,0.03606599,0.0028985909],"domain_scores_gemma":[0.5582532,0.31572935,0.02645631,0.03733383,0.060504783,0.0017224557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12942474,0.001239571,0.0012486802,0.0030581306,0.0012065903,0.0061706523,0.0017539004,0.002631261,0.0032945715],"category_scores_gemma":[0.43617046,0.0014236356,0.0034925682,0.0036764054,0.002932964,0.0030643197,0.0044853175,0.003655528,0.0022711784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065088742,0.0015478709,0.78498954,0.0010992878,0.0027150419,0.00014404331,0.016923029,0.0034328792,0.0038345158,0.01028316,0.016288891,0.15223289],"study_design_scores_gemma":[0.0012971947,0.0029978212,0.9165827,0.0016483332,0.0012926649,0.00070862233,0.0055950913,0.010046842,0.0123663265,0.012525743,0.034427818,0.0005107655],"about_ca_topic_score_codex":0.0036616116,"about_ca_topic_score_gemma":0.0045161913,"teacher_disagreement_score":0.12942474,"about_ca_system_score_codex":0.0024475234,"about_ca_system_score_gemma":0.0032996407,"threshold_uncertainty_score":0.6844716},"labels":[],"label_agreement":null},{"id":"W2945409099","doi":"10.1016/j.jval.2019.02.009","title":"United States Valuation of EQ-5D-5L Health States Using an International Protocol","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":391,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto","funders":"University of Illinois at Chicago; Universitetet i Oslo; National Pharmaceutical Council; Johns Hopkins University; Eli Lilly and Company; Bristol-Myers Squibb; EuroQol Research Foundation; Bristol-Myers Squibb Foundation","keywords":"Respondent; Tobit model; Valuation (finance); Protocol (science); Statistics; Population; Actuarial science; EQ-5D; Willingness to pay; Medicine; Demography; Econometrics; Mathematics; Economics; Environmental health; Accounting; Health related quality of life","score_opus":0.5921958787152075,"score_gpt":0.48178246599350655,"score_spread":0.11041341272170097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945409099","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04905383,0.0016631018,0.23967327,0.0029404988,0.0011556848,0.22258288,0.13705714,0.00091581105,0.34495786],"genre_scores_gemma":[0.15945907,0.0020779145,0.26486638,0.0016923471,0.00018227044,0.46827316,0.08052455,0.00026002832,0.022664258],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9684208,0.022696441,0.0035266127,0.00089917466,0.0037204414,0.0007365961],"domain_scores_gemma":[0.972749,0.008630015,0.0021676165,0.0038206764,0.012124691,0.0005079763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03920841,0.001202106,0.00072565343,0.0037270624,0.0011489508,0.0022560412,0.0018070121,0.0013267783,0.031167306],"category_scores_gemma":[0.0691589,0.0004919279,0.0016815917,0.0049612913,0.0007097868,0.0016991381,0.0021962193,0.0018727508,0.006737535],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037106832,0.0021544024,0.041298278,0.0037294577,0.0004530835,0.0004813067,0.0028465383,0.011617395,0.0018125866,0.18596357,0.30712074,0.43881193],"study_design_scores_gemma":[0.0013543781,0.0034314033,0.07222234,0.006449178,0.00036169277,0.00045932946,0.002599,0.021341458,0.004371471,0.028979184,0.8581664,0.00026428566],"about_ca_topic_score_codex":0.0038571693,"about_ca_topic_score_gemma":0.0034487154,"teacher_disagreement_score":0.03920841,"about_ca_system_score_codex":0.0029352366,"about_ca_system_score_gemma":0.0069459127,"threshold_uncertainty_score":0.2073564},"labels":[],"label_agreement":null},{"id":"W2946124699","doi":"10.1016/j.jval.2019.04.001","title":"Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual Model","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Leeds; Rijksuniversiteit Groningen; University of Aberdeen; University of Oxford","keywords":"Equity (law); Economics; Health technology; Health care; Productivity; Marginal cost; Public economics; Microeconomics; Macroeconomics","score_opus":0.35735526573300347,"score_gpt":0.4565311403333935,"score_spread":0.09917587460039001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946124699","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22843838,0.009209671,0.40433183,0.091421455,0.00086241605,0.00043353613,0.0010996738,0.00013918948,0.26406375],"genre_scores_gemma":[0.9682283,0.0020876313,0.016286897,0.00081971963,0.00031024427,0.00020438751,0.00011173758,0.00004547724,0.011905486],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9960349,0.0022965805,0.00017692901,0.0002999795,0.00069664296,0.0004949398],"domain_scores_gemma":[0.977413,0.018413382,0.001198299,0.00056847074,0.0016717511,0.0007351358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008740714,0.0013678143,0.0011557147,0.0024868432,0.001667414,0.008303138,0.0032957804,0.0042111427,0.012704213],"category_scores_gemma":[0.026727509,0.001178255,0.0014198669,0.0042078667,0.006740356,0.011572104,0.0033175114,0.0047087637,0.00041949732],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029618162,0.00007998276,0.0007228519,0.000057193713,0.000027081816,0.00009176508,0.00020915782,0.03269464,0.00005347227,0.9609511,0.00072628964,0.0043569296],"study_design_scores_gemma":[0.000053203992,0.000050511066,0.0014047255,0.00009350691,0.000055391396,0.000101192665,0.00049307843,0.057645325,0.00012159981,0.9343597,0.0055896025,0.000032191103],"about_ca_topic_score_codex":0.012338343,"about_ca_topic_score_gemma":0.0126454905,"teacher_disagreement_score":0.012704213,"about_ca_system_score_codex":0.0077684303,"about_ca_system_score_gemma":0.0057947384,"threshold_uncertainty_score":0.05636424},"labels":[],"label_agreement":null},{"id":"W2946511627","doi":"10.1016/j.jval.2019.01.019","title":"Parent Proxy Discrepancy Groups of Quality of Life in Childhood Epilepsy","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hamilton Health Sciences; Queen's University; McMaster University; University of Waterloo; St. Joseph’s Healthcare Hamilton; Toronto Western Hospital","funders":"Canadian Institutes of Health Research; Kids Brain Health Network","keywords":"Proxy (statistics); Epilepsy; Psychology; Cohort; Quality of life (healthcare); Latent class model; Developmental psychology; Clinical psychology; Medicine; Psychiatry; Statistics; Mathematics","score_opus":0.059918623898900465,"score_gpt":0.37121868201895963,"score_spread":0.3113000581200592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946511627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990695,0.000081110666,0.00008193688,0.000061236286,0.000005494509,0.0000045632783,0.00013372913,0.0000015232345,0.00056091364],"genre_scores_gemma":[0.99949276,0.000028859324,0.00006743486,0.000008676138,0.0000021520996,0.000010417136,0.0002369112,0.0000018913154,0.00015099272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998103,0.0011515049,0.00015173614,0.00012557565,0.000274799,0.00019333824],"domain_scores_gemma":[0.98565185,0.0072940877,0.0040711076,0.0011799107,0.0008785562,0.0009245135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003193263,0.00024925676,0.00035205946,0.0011200081,0.00048035354,0.0010420132,0.00047312764,0.00070877216,0.0023229027],"category_scores_gemma":[0.028629562,0.00020477969,0.00041888334,0.0010269505,0.00049739645,0.0010676028,0.0015386392,0.0009205241,0.00018417471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043415691,0.000070350456,0.9945978,0.000008590332,0.0000660293,0.00008032305,0.001363174,0.00016214873,0.00005747819,0.00026869174,0.0001646295,0.0027266284],"study_design_scores_gemma":[0.000019958337,0.0001918155,0.99554646,0.000014869393,0.000019378129,0.00020204148,0.002473891,0.00078664377,0.00008740803,0.00037328445,0.00027374196,0.00001053635],"about_ca_topic_score_codex":0.005848621,"about_ca_topic_score_gemma":0.004807261,"teacher_disagreement_score":0.005848621,"about_ca_system_score_codex":0.0008998257,"about_ca_system_score_gemma":0.00037424988,"threshold_uncertainty_score":0.016887784},"labels":[],"label_agreement":null},{"id":"W2946583077","doi":"10.1016/j.jval.2019.03.016","title":"A Systematic Review of Decision-Analytic Models for Evaluating Cost-Effectiveness of Asthma Interventions","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Vancouver General Hospital; Centre for Advancing Health Outcomes","funders":"Genome British Columbia; Canadian Institutes of Health Research; Genome Canada; Novartis; Sanofi; Merck; Michael Smith Health Research BC; GlaxoSmithKline; AstraZeneca; Boehringer Ingelheim","keywords":"Asthma; Psychological intervention; Medicine; MEDLINE; Systematic review; Comorbidity; Economic evaluation; Intensive care medicine; Psychiatry","score_opus":0.3321268090656154,"score_gpt":0.5268106722280252,"score_spread":0.19468386316240982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946583077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020529204,0.9920244,0.0033481603,0.00034334205,0.00021867357,0.000951513,0.00061524176,0.000050816394,0.00039496238],"genre_scores_gemma":[0.093045644,0.8877001,0.0147696445,0.0006938762,0.0002481722,0.0025625562,0.0006650246,0.000056626177,0.0002583614],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9393291,0.042272344,0.010320032,0.001784119,0.005815453,0.00047903304],"domain_scores_gemma":[0.8845227,0.10445368,0.006363611,0.001313605,0.0028535845,0.0004927691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044062473,0.004515253,0.023091683,0.009990558,0.0006260906,0.004884263,0.0036789249,0.0028767951,0.0058548045],"category_scores_gemma":[0.14612566,0.0021956854,0.027325792,0.0083544785,0.0012015096,0.0030056685,0.0022938205,0.00458734,0.0003926898],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037661123,0.000104435094,0.0012253554,0.6661676,0.23483668,0.000079632155,0.00013321666,0.0054476056,0.00011913357,0.0015896404,0.0015875025,0.0849431],"study_design_scores_gemma":[0.0047631,0.0012501394,0.0026241846,0.26056185,0.7097341,0.00021290606,0.00015824779,0.0069421027,0.00022381009,0.0039028036,0.00950202,0.0001248757],"about_ca_topic_score_codex":0.01030456,"about_ca_topic_score_gemma":0.017545294,"teacher_disagreement_score":0.044062473,"about_ca_system_score_codex":0.008108339,"about_ca_system_score_gemma":0.010122009,"threshold_uncertainty_score":0.23302746},"labels":[],"label_agreement":null},{"id":"W2946796215","doi":"10.1016/j.jval.2019.02.001","title":"Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"Medtronic","keywords":"Medicine; Radiofrequency ablation; Paroxysmal atrial fibrillation; Propensity score matching; Atrial fibrillation; Cost effectiveness; Ablation; Cost-effectiveness analysis; Retrospective cohort study; Emergency medicine; Surgery; Internal medicine","score_opus":0.21033455062870782,"score_gpt":0.4212953856727369,"score_spread":0.21096083504402907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946796215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957878,0.0023941402,0.00013600876,0.00020342835,0.000018690498,0.000033244192,0.0011077584,0.000006832134,0.00031212656],"genre_scores_gemma":[0.99849117,0.00039225057,0.00008482362,0.000044694854,0.000012924014,0.000023652317,0.0008864161,0.0000022570373,0.00006161141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979475,0.000983362,0.00019442927,0.0002909938,0.00023304805,0.0003507489],"domain_scores_gemma":[0.9949019,0.002706454,0.0013582025,0.00020675937,0.000334889,0.0004916817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003571829,0.00079562154,0.001550872,0.0017048548,0.00027097113,0.0011382657,0.0010863137,0.0008921862,0.0020717967],"category_scores_gemma":[0.010778486,0.00035401506,0.004388237,0.002003235,0.00080414454,0.0018224812,0.0008934256,0.0008375631,0.00011116059],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04514714,0.001561993,0.85707265,0.0017062349,0.013471639,0.00034626134,0.00026517175,0.040451974,0.00036108747,0.0009316823,0.0016542743,0.037029944],"study_design_scores_gemma":[0.0056248913,0.0061634816,0.92129487,0.00029321492,0.009528242,0.00028944228,0.0005617823,0.053531155,0.0004847935,0.0012672461,0.000827029,0.0001338958],"about_ca_topic_score_codex":0.028652715,"about_ca_topic_score_gemma":0.021199515,"teacher_disagreement_score":0.028652715,"about_ca_system_score_codex":0.0043671564,"about_ca_system_score_gemma":0.0023623437,"threshold_uncertainty_score":0.056971908},"labels":[],"label_agreement":null},{"id":"W2949511939","doi":"10.1016/j.jval.2019.04.1604","title":"PNS249 WHAT ARE THE PRIORITY PATIENT ENGAGEMENT ACTIVITIES IN MEDICINES DEVELOPMENT? RESULTS OF A GLOBAL MULTI-STAKEHOLDER CONSULTATION","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Outreach; Stakeholder; Public involvement; Stakeholder engagement; Medicine; Relevance (law); Family medicine; Clinical trial; Public engagement; Medical education; Public relations; Political science","score_opus":0.3587521875131387,"score_gpt":0.43136637303915515,"score_spread":0.07261418552601645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949511939","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30968633,0.004399574,0.0056113503,0.5419181,0.002469637,0.0027488328,0.0026218493,0.00020523732,0.13033904],"genre_scores_gemma":[0.8766279,0.0046193367,0.010232625,0.08348364,0.00038728458,0.002603711,0.0012478984,0.00023275056,0.020564789],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9408064,0.045892905,0.0015457269,0.0008852878,0.0053621274,0.005507592],"domain_scores_gemma":[0.9000117,0.0711551,0.0024869,0.001370343,0.014067369,0.010908518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.080649726,0.0008505718,0.00068791374,0.0011848316,0.006110522,0.005510267,0.0016323258,0.007261028,0.011543293],"category_scores_gemma":[0.0590483,0.0004151404,0.0013329871,0.0019095298,0.0034115985,0.004381829,0.013592989,0.0049790815,0.00096896186],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025513172,0.0014933222,0.039275587,0.011924261,0.00034170266,0.006277141,0.36303818,0.0024566967,0.006674488,0.022405477,0.21209243,0.33146942],"study_design_scores_gemma":[0.0004502692,0.0011284563,0.050678723,0.006587503,0.0002943395,0.0006859456,0.43212563,0.0009674187,0.0025956968,0.008035388,0.49625152,0.0001991196],"about_ca_topic_score_codex":0.017329823,"about_ca_topic_score_gemma":0.04393162,"teacher_disagreement_score":0.080649726,"about_ca_system_score_codex":0.009853121,"about_ca_system_score_gemma":0.047759574,"threshold_uncertainty_score":0.4265216},"labels":[],"label_agreement":null},{"id":"W2950419520","doi":"10.1016/j.jval.2019.05.001","title":"Choosing Video Instead of In-Clinic Consultations in Primary Care in Israel: Discrete Choice Experiment Among Key Stakeholders—Patients, Primary Care Physicians, and Policy Makers","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Israel National Institute for Health Policy Research; McMaster University","keywords":"Stakeholder; Mixed logit; Primary care; Preference; Key (lock); Family medicine; Logistic regression; Service (business); Business; Medicine; Nursing; Psychology; Marketing; Public relations; Computer science; Political science; Economics","score_opus":0.12869048864886293,"score_gpt":0.3965134190292427,"score_spread":0.26782293038037974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950419520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963238,0.000019345547,0.000552617,0.00042097454,0.000036317346,0.0008688378,0.00006576536,0.000007239804,0.0017050738],"genre_scores_gemma":[0.99403507,0.000038117334,0.0020350534,0.0005979065,0.00004051425,0.0021847545,0.00004459501,0.0000048454235,0.0010192544],"study_design_codex":"nonrandomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9866036,0.010250389,0.00044992307,0.0008501611,0.0006163285,0.0012296988],"domain_scores_gemma":[0.9301698,0.060698025,0.0031250953,0.0009349521,0.00079345336,0.004278666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015341696,0.00059878547,0.00081717747,0.00033489006,0.0022664864,0.0029059062,0.0013773253,0.0041081733,0.009303005],"category_scores_gemma":[0.03155633,0.00075675664,0.0006095657,0.00037052063,0.001736874,0.0017295437,0.0010401723,0.0035903296,0.00076297414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27667087,0.49519527,0.06764163,0.0014547748,0.0008344183,0.0006958276,0.03305199,0.011379294,0.01743577,0.010449226,0.0035120142,0.08167891],"study_design_scores_gemma":[0.17833026,0.45750183,0.1456217,0.00060779223,0.0015643896,0.0002532783,0.058493353,0.10995519,0.017057931,0.020630889,0.009289458,0.00069400296],"about_ca_topic_score_codex":0.0052963677,"about_ca_topic_score_gemma":0.0056373524,"teacher_disagreement_score":0.015341696,"about_ca_system_score_codex":0.0021183083,"about_ca_system_score_gemma":0.0050512007,"threshold_uncertainty_score":0.08113563},"labels":[],"label_agreement":null},{"id":"W2952018160","doi":"10.1016/j.jval.2019.04.1910","title":"A Beginner's Guide to Understanding Curative Therapies","year":2019,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.4661862497926434,"score_gpt":0.46943729054409455,"score_spread":0.003251040751451162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952018160","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000075216276,0.040503968,0.0004937511,0.0763233,0.8803128,0.000026190317,0.00007525549,0.0000487115,0.0022085274],"genre_scores_gemma":[0.00016143516,0.014641284,0.0003967037,0.03972249,0.93902194,0.000059629994,0.000027199378,0.000054052714,0.005915281],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9849294,0.0059412597,0.0023830992,0.000944053,0.0052953064,0.00050692726],"domain_scores_gemma":[0.86646855,0.09709476,0.0040836823,0.0022483023,0.023654321,0.0064503895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023596745,0.0056506256,0.006438319,0.014018357,0.00431563,0.016099762,0.0045683817,0.024604456,0.019504229],"category_scores_gemma":[0.104048,0.0018259673,0.0036038596,0.0050915675,0.007826327,0.011090586,0.0041116863,0.04537118,0.013960364],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007853939,0.000006827579,0.000006309897,0.00021086143,0.000011789261,0.000022876822,0.000017160864,0.000014328379,0.000009497206,0.0014409847,0.9932939,0.0049577304],"study_design_scores_gemma":[0.00005141423,0.0000146095335,0.00007724604,0.0016675775,0.00004328472,0.00009965692,0.000053449137,0.00012572826,0.000021020802,0.009235773,0.98858774,0.00002252097],"about_ca_topic_score_codex":0.0046265596,"about_ca_topic_score_gemma":0.0127324555,"teacher_disagreement_score":0.024604456,"about_ca_system_score_codex":0.0067542987,"about_ca_system_score_gemma":0.008553117,"threshold_uncertainty_score":0.12479305},"labels":[],"label_agreement":null},{"id":"W2953312545","doi":"10.1016/j.jval.2019.01.014","title":"Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Governo Brasil; International Network of Agencies for Health Technology Assessment; Novartis Pharmaceuticals Corporation","keywords":"Real world evidence; Latin Americans; Health care; Political science; Data science; Computer science; Medicine; Economics; Economic growth","score_opus":0.5635607403954428,"score_gpt":0.616140320756119,"score_spread":0.052579580360676226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953312545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00032230152,0.9982229,0.00006775486,0.0008918163,0.00003861093,0.00000809909,0.00005507969,0.0000015078131,0.0003918973],"genre_scores_gemma":[0.0052655186,0.99344105,0.00054391153,0.0005585481,0.00007060389,0.000017362761,0.00006348605,0.000002511123,0.000036944733],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936858,0.0024352893,0.0018367931,0.00046666941,0.0013478465,0.00022768174],"domain_scores_gemma":[0.9156551,0.07368795,0.0050527016,0.0007604247,0.0043439367,0.00050006725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020207984,0.0010014767,0.0034730893,0.009030204,0.00047800032,0.0051650084,0.0018136019,0.0024619915,0.0043055858],"category_scores_gemma":[0.052494332,0.000566906,0.002384128,0.014487484,0.0015007443,0.0029120345,0.0018384719,0.0028583058,0.0003295901],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046110348,0.00010852407,0.003789113,0.25170484,0.003484448,0.00048989675,0.0008455003,0.0008242274,0.00022945687,0.0071955766,0.011054692,0.7198127],"study_design_scores_gemma":[0.00024493353,0.00024434025,0.014703594,0.6582397,0.010180427,0.0016402727,0.0019613518,0.00047774936,0.00039631338,0.008865526,0.30293489,0.00011090377],"about_ca_topic_score_codex":0.009960258,"about_ca_topic_score_gemma":0.022047728,"teacher_disagreement_score":0.020207984,"about_ca_system_score_codex":0.0053326506,"about_ca_system_score_gemma":0.010807468,"threshold_uncertainty_score":0.10687131},"labels":[],"label_agreement":null},{"id":"W2953408360","doi":"10.1016/j.jval.2019.04.056","title":"MT3 THE EFFECTIVENESS OF CAPNOGRAPHY ON CLINICALLY IMPORTANT OUTCOMES FROM OPIOID-INDUCED RESPIRATORY DEPRESSION: A LITERATURE REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Capnography; Medicine; Adverse effect; Depression (economics); Intensive care medicine; Emergency medicine; Respiratory arrest; Hazard ratio; Incidence (geometry); Anesthesia; Internal medicine; Confidence interval","score_opus":0.14976732494740577,"score_gpt":0.42732657591205025,"score_spread":0.2775592509646445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953408360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009964115,0.99968016,0.000012374285,0.00006288971,0.00003851137,0.0000051545676,0.000024204995,7.488706e-7,0.00007640072],"genre_scores_gemma":[0.0016347402,0.9979487,0.000085624124,0.00018403758,0.000077599514,0.000008105124,0.000026526961,6.5863185e-7,0.00003394682],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990716,0.00018218656,0.00036567746,0.00013875336,0.00019884242,0.000042918906],"domain_scores_gemma":[0.9941863,0.0043742564,0.000879919,0.000055626642,0.00042078123,0.00008316533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021843517,0.00089596,0.0040463014,0.00345374,0.0002779965,0.0016605131,0.0013586973,0.0014507793,0.004823103],"category_scores_gemma":[0.007787957,0.00048209913,0.0031217146,0.0035497337,0.000549575,0.0011023249,0.0009155035,0.0013959941,0.0004186939],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005898468,0.000111325426,0.0013465685,0.51264507,0.0056561357,0.00016972575,0.00011135049,0.00023755597,0.0004679838,0.00072147994,0.006585886,0.47135708],"study_design_scores_gemma":[0.0007867073,0.0011033207,0.01973955,0.6561071,0.0673143,0.0017012969,0.00058073114,0.00039666737,0.0007328476,0.001661537,0.24970655,0.00016936682],"about_ca_topic_score_codex":0.0036565526,"about_ca_topic_score_gemma":0.010077073,"teacher_disagreement_score":0.004823103,"about_ca_system_score_codex":0.00093047833,"about_ca_system_score_gemma":0.0031139515,"threshold_uncertainty_score":0.016134858},"labels":[],"label_agreement":null},{"id":"W2953433507","doi":"10.1016/j.jval.2019.04.117","title":"PBI35 QUALITY-OF-LIFE OUTCOMES COMPARING THE PROPOSED BIOSIMILAR MSB11022 TO REFERENCE ADALIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE-TYPE PSORIASIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Biosimilar; Psoriatic arthritis; Visual analogue scale; Psoriasis; Bioequivalence; Internal medicine; Quality of life (healthcare); Clinical endpoint; Randomized controlled trial; Physical therapy; Rheumatoid arthritis; Dermatology","score_opus":0.10881923235388875,"score_gpt":0.3679393811453456,"score_spread":0.25912014879145684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953433507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453616,0.003941716,0.00014464674,0.00013270466,0.00005325906,0.000066976034,0.00029410952,0.0000053097106,0.0008251471],"genre_scores_gemma":[0.99904376,0.00032031804,0.00010370354,0.00007850951,0.00003398653,0.000031135904,0.00025322766,9.3579484e-7,0.0001344242],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99926287,0.00037564037,0.00007714828,0.00010723898,0.000088359215,0.0000886954],"domain_scores_gemma":[0.9989737,0.00039766464,0.00031454716,0.000061023413,0.000103922095,0.00014914118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013160093,0.00031431628,0.0010054508,0.00021307175,0.00015525245,0.0007255864,0.00021445913,0.0004634581,0.0023445073],"category_scores_gemma":[0.0022647746,0.00012276621,0.0019011535,0.00027084895,0.00029544515,0.00039866354,0.00036184178,0.0011061656,0.0001781121],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8158892,0.003744202,0.051937412,0.0021358565,0.009243498,0.00012591816,0.00029503347,0.0022243054,0.006083569,0.0005442215,0.001808663,0.105968],"study_design_scores_gemma":[0.13064934,0.4022796,0.42551783,0.00073939917,0.01888667,0.00069383456,0.0007480197,0.007365017,0.0049783494,0.0013803109,0.00661322,0.00014846986],"about_ca_topic_score_codex":0.00097233173,"about_ca_topic_score_gemma":0.0010249584,"teacher_disagreement_score":0.0023445073,"about_ca_system_score_codex":0.000711085,"about_ca_system_score_gemma":0.00047745,"threshold_uncertainty_score":0.007843196},"labels":[],"label_agreement":null},{"id":"W2953436115","doi":"10.1016/j.jval.2019.04.1774","title":"PSS2 THE EFFICACY OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada; Vancouver Coastal Health","funders":"","keywords":"Tazarotene; Medicine; Psoriasis; Internal medicine; Randomized controlled trial; Plaque psoriasis; Combination therapy; Meta-analysis; Dermatology; Oncology; Pharmacology","score_opus":0.03505089356395533,"score_gpt":0.2565548362702506,"score_spread":0.22150394270629528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953436115","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24989185,0.7247956,0.007787668,0.001574476,0.0031202629,0.000585229,0.008101979,0.00043349178,0.0037094841],"genre_scores_gemma":[0.96295047,0.03000268,0.0019435562,0.0009051168,0.00048109164,0.00038766983,0.0016725238,0.0000960746,0.0015608381],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9930207,0.0044458555,0.0006980352,0.0011535735,0.0004297893,0.00025192552],"domain_scores_gemma":[0.99248075,0.005118899,0.000998245,0.0006154157,0.00051524263,0.00027153478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009571466,0.0029986338,0.009576624,0.0017327525,0.00055169803,0.0023898988,0.0016186668,0.0024566783,0.004745668],"category_scores_gemma":[0.015831463,0.0015338185,0.040381916,0.0020472014,0.0006331719,0.0013247228,0.0013804757,0.0034845995,0.0005120731],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035633035,0.000037807884,0.009117786,0.013882076,0.93491143,0.000082190236,0.00003643596,0.0012926043,0.0005732069,0.00010194597,0.0006860012,0.0036454347],"study_design_scores_gemma":[0.006366586,0.00074200117,0.0071898936,0.00048205775,0.98306364,0.000067257984,0.000024616063,0.0008084521,0.00015184961,0.00026832166,0.0008110034,0.000024267521],"about_ca_topic_score_codex":0.0070204795,"about_ca_topic_score_gemma":0.00900897,"teacher_disagreement_score":0.009576624,"about_ca_system_score_codex":0.0011062983,"about_ca_system_score_gemma":0.0007747618,"threshold_uncertainty_score":0.050619364},"labels":[],"label_agreement":null},{"id":"W2953535203","doi":"10.1016/j.jval.2019.04.1175","title":"PMU12 SCALABLE DECISION-ANALYTIC MODELLING WITH INFLUENCE DIAGRAMS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Influence diagram; Computer science; Decision tree; Bayesian network; Graphical model; Decision engineering; Decision analysis; Machine learning; Scalability; Artificial intelligence; Evidential reasoning approach; Decision problem; Representation (politics); Data mining; Decision support system; Business decision mapping; Mathematics; Algorithm","score_opus":0.09826136734443984,"score_gpt":0.4127631678258993,"score_spread":0.3145018004814594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953535203","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075078337,0.00012302762,0.97762144,0.00028818383,0.00007077101,0.00023055388,0.0017161364,0.0073884013,0.0050535845],"genre_scores_gemma":[0.21822508,0.00023407888,0.7719266,0.00016800602,0.00006312736,0.0011872733,0.003060583,0.0016073936,0.0035278834],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972011,0.0013105528,0.00019250497,0.00038371913,0.00072556594,0.00018653685],"domain_scores_gemma":[0.9870957,0.010323341,0.00029877742,0.001169234,0.000879693,0.00023318993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003755084,0.0015388298,0.0015908564,0.001396437,0.0011973799,0.0032381373,0.0024490908,0.0018561435,0.022909718],"category_scores_gemma":[0.028938176,0.001618374,0.002980643,0.001252137,0.0006265601,0.002510212,0.003167495,0.0022018976,0.0033004642],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004108011,0.00021059366,0.0027001065,0.0005941047,0.0002866287,0.00018845404,0.0004173391,0.754169,0.0012791248,0.07001377,0.0123917395,0.15733832],"study_design_scores_gemma":[0.00004127455,0.00001826607,0.00005777904,0.000027537028,0.00001921848,0.000017169747,0.000014186775,0.97056156,0.0005846763,0.023266915,0.0053806244,0.000010833855],"about_ca_topic_score_codex":0.01639195,"about_ca_topic_score_gemma":0.014293653,"teacher_disagreement_score":0.022909718,"about_ca_system_score_codex":0.0012419471,"about_ca_system_score_gemma":0.003121943,"threshold_uncertainty_score":0.076640666},"labels":[],"label_agreement":null},{"id":"W2953537532","doi":"10.1016/j.jval.2019.04.904","title":"PIN33 COST-EFFECTIVENESS ANALYSIS OF EFINACONAZOLE FOR THE TREATMENT OF MILD TO MODERATE TOENAIL ONYCHOMYCOSIS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Terbinafine; Medicine; Itraconazole; Formulary; Dermatology; Antifungal; Clinical trial; Internal medicine; Family medicine","score_opus":0.05960679403513741,"score_gpt":0.3476716298323949,"score_spread":0.2880648357972575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953537532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9193864,0.029758243,0.0009778019,0.0030641167,0.00017767849,0.0018708183,0.031683724,0.00008576768,0.012995519],"genre_scores_gemma":[0.9867726,0.0059705316,0.00070428324,0.00053197664,0.00003414128,0.00016790142,0.0043805074,0.000012267721,0.0014258036],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974904,0.00081633544,0.00015981708,0.00015401325,0.0007837141,0.0005957102],"domain_scores_gemma":[0.9977718,0.0006357995,0.00034053516,0.000038819097,0.0007369863,0.00047603744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015724623,0.00074604317,0.0016738136,0.0017211082,0.0006235193,0.0018062004,0.0010423085,0.0006966302,0.003664962],"category_scores_gemma":[0.0061108177,0.00044553148,0.003983369,0.0037326477,0.00042950953,0.0003625999,0.0005876623,0.001203854,0.000119116914],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15239228,0.0037955209,0.35101563,0.015516662,0.034392808,0.0018494803,0.00041726828,0.14925615,0.0029479284,0.008641124,0.0358218,0.24395335],"study_design_scores_gemma":[0.026222724,0.008960124,0.8270616,0.0029232234,0.026821962,0.00086379587,0.0011399735,0.08774318,0.0009822642,0.0010959517,0.015901508,0.00028373318],"about_ca_topic_score_codex":0.9697492,"about_ca_topic_score_gemma":0.972492,"teacher_disagreement_score":0.059057735,"about_ca_system_score_codex":0.059057735,"about_ca_system_score_gemma":0.06239918,"threshold_uncertainty_score":0.42849588},"labels":[],"label_agreement":null},{"id":"W2953666721","doi":"10.1016/j.jval.2019.04.1682","title":"PRO49 A COMPARISON OF THE NICE HST PROGRAM WITH HEALTH TECHNOLOGY ASSESSMENTS FROM FRANCE, GERMANY, AUSTRALIA, AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Health technology; Orphan drug; Medicine; Economic evaluation; Family medicine; Operations research; Health care; Computer science; Economic growth; Engineering; Economics","score_opus":0.297970523444058,"score_gpt":0.4592387894789624,"score_spread":0.1612682660349044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953666721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7431702,0.008160512,0.003915783,0.010408285,0.00041912598,0.001406003,0.13728127,0.0004349592,0.0948039],"genre_scores_gemma":[0.94536144,0.0013757135,0.0029338354,0.0008170017,0.00008131031,0.00044735434,0.03925949,0.00011910868,0.009604703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98225385,0.007363271,0.0006782732,0.0006951379,0.0075795664,0.0014297767],"domain_scores_gemma":[0.9586185,0.012495809,0.0025347103,0.0015233823,0.022278763,0.0025487558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015155155,0.0004454343,0.0011292794,0.0045026313,0.0009882391,0.0024341654,0.0013941003,0.0008535388,0.0048361523],"category_scores_gemma":[0.05323915,0.00037507783,0.0014760478,0.0079326825,0.0005652975,0.0012375914,0.0021136357,0.0012785505,0.0006314405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008663227,0.00096799916,0.6492853,0.001805848,0.0027366327,0.00022782743,0.0011422178,0.01567767,0.00030385813,0.009044201,0.13660277,0.1735425],"study_design_scores_gemma":[0.00037763503,0.00044638582,0.9739886,0.0002549805,0.00043057947,0.00008941315,0.00067353674,0.0049326154,0.00023825867,0.0003174113,0.018200196,0.000050313276],"about_ca_topic_score_codex":0.91139764,"about_ca_topic_score_gemma":0.9016719,"teacher_disagreement_score":0.97920066,"about_ca_system_score_codex":0.020799313,"about_ca_system_score_gemma":0.036617454,"threshold_uncertainty_score":0.17824829},"labels":[],"label_agreement":null},{"id":"W2953684232","doi":"10.1016/j.jval.2019.04.373","title":"PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Scope (computer science); Medicine; Quality (philosophy); Economic evaluation; Actuarial science; Medical physics; Family medicine; Computer science; Pathology; Business","score_opus":0.9294760374727394,"score_gpt":0.6743938392265685,"score_spread":0.25508219824617095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953684232","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2582221,0.3685283,0.050996173,0.11595116,0.0042225346,0.0034557106,0.030437859,0.00021188433,0.1679743],"genre_scores_gemma":[0.9508649,0.018534753,0.01576405,0.0035066502,0.0014622369,0.0011820692,0.0057982854,0.000113924034,0.0027731739],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8257785,0.14018884,0.010992736,0.002340328,0.01901675,0.0016828824],"domain_scores_gemma":[0.7059531,0.16872457,0.03498923,0.016051989,0.06692308,0.0073580197],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13791533,0.0005273897,0.0019783983,0.0057348693,0.0010139472,0.006732877,0.0012887327,0.0010203302,0.0043702032],"category_scores_gemma":[0.25075996,0.00031484713,0.0015339004,0.00939879,0.0019401966,0.0020178612,0.0031174081,0.0013031593,0.00030923064],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007991769,0.0003734501,0.1925625,0.013485404,0.008026691,0.00019137445,0.0016095554,0.013441641,0.00089462055,0.08757197,0.03903744,0.6348135],"study_design_scores_gemma":[0.0019491761,0.003020629,0.6370988,0.022344165,0.009104229,0.0006326247,0.0025275974,0.022117965,0.005182051,0.06412631,0.23158123,0.0003151959],"about_ca_topic_score_codex":0.020494163,"about_ca_topic_score_gemma":0.014065267,"teacher_disagreement_score":0.8620847,"about_ca_system_score_codex":0.010906689,"about_ca_system_score_gemma":0.01958412,"threshold_uncertainty_score":0.72937465},"labels":[],"label_agreement":null},{"id":"W2953688847","doi":"10.1016/j.jval.2019.04.146","title":"PCN22 CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) CATEGORIZED AS INTERMEDIATE RISK (IR) GROUP ACCORDING TO THE INTERNATIONAL MRCC DATABASE CONSORTIUM (IMDC) RISK MODEL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Discontinuation; Renal cell carcinoma; Internal medicine; Oncology; Gastroenterology","score_opus":0.05839267446960073,"score_gpt":0.31812552893717355,"score_spread":0.2597328544675728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953688847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939349,0.00086135557,0.0010175669,0.00024023569,0.000035641846,0.000035255205,0.0025739248,0.000023297755,0.0012778493],"genre_scores_gemma":[0.9983292,0.000058086862,0.00009574795,0.00003107162,0.000011835856,0.000010709051,0.0012787058,0.000004004505,0.00018062428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989262,0.00031139862,0.00010659342,0.0003222353,0.00014649176,0.00018710797],"domain_scores_gemma":[0.99771166,0.00090912735,0.00066134427,0.0002809708,0.00016333647,0.00027365715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015327133,0.00033235006,0.00079779205,0.000748754,0.00026660622,0.0012787398,0.0007092076,0.000404356,0.0028098552],"category_scores_gemma":[0.0052084117,0.00017915723,0.00263709,0.0009376916,0.00023709801,0.0005309415,0.0006446488,0.00080779026,0.00024236822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002369424,0.000042589356,0.9867858,0.000038258127,0.0018177517,0.00010713735,0.000050469196,0.0019453906,0.0002628659,0.00030367958,0.0009420888,0.0053344136],"study_design_scores_gemma":[0.00021546929,0.00055397203,0.96603453,0.000037838097,0.0018275022,0.00075875106,0.00027825835,0.026518568,0.00034324097,0.001756174,0.0016350183,0.000040693467],"about_ca_topic_score_codex":0.009439753,"about_ca_topic_score_gemma":0.007860759,"teacher_disagreement_score":0.009439753,"about_ca_system_score_codex":0.0007271189,"about_ca_system_score_gemma":0.0008254998,"threshold_uncertainty_score":0.018769622},"labels":[],"label_agreement":null},{"id":"W2953738724","doi":"10.1016/j.jval.2019.04.228","title":"PCN104 OBINUTUZUMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: AN IMPORTANT CLINICAL AND COST-EFFECTIVE OPTION FOR HIGH-RISK (INTERMEDIATE/HIGH FLIPI) PATIENTS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Follicular lymphoma; Obinutuzumab; Hazard ratio; Internal medicine; Rituximab; Population; Regimen; Oncology; Confidence interval; Surgery; Progression-free survival; Chemotherapy; Lymphoma","score_opus":0.01568608151706712,"score_gpt":0.28868285891160483,"score_spread":0.2729967773945377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953738724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7337131,0.06611599,0.0011495056,0.083906084,0.0007605417,0.00044463103,0.0033708976,0.00022994257,0.1103093],"genre_scores_gemma":[0.95705944,0.018752972,0.001823351,0.0055283317,0.00031944385,0.000042300126,0.0012119339,0.000040657098,0.015221613],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977595,0.000022517524,0.000009229432,0.0000191416,0.000057689234,0.000115584146],"domain_scores_gemma":[0.9994111,0.000035852165,0.000047419726,0.000007081557,0.00011787894,0.0003807818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019576408,0.00017931891,0.0002853095,0.00037688875,0.0010095701,0.0013043483,0.00052872277,0.0004744127,0.008909523],"category_scores_gemma":[0.0007345789,0.00011400036,0.00026984425,0.0007430193,0.00052324374,0.0003327394,0.00036433697,0.00084854953,0.0005486842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004857176,0.0008242125,0.18002623,0.0006139167,0.00016383124,0.004402227,0.00036259711,0.0024934416,0.00653372,0.0045602648,0.092174575,0.70298773],"study_design_scores_gemma":[0.002761776,0.0022263592,0.65764475,0.0017274319,0.0006899932,0.008192754,0.0036408647,0.0066847582,0.004363431,0.005380193,0.3065293,0.00015840794],"about_ca_topic_score_codex":0.8298068,"about_ca_topic_score_gemma":0.9423425,"teacher_disagreement_score":0.1701932,"about_ca_system_score_codex":0.017310588,"about_ca_system_score_gemma":0.028537687,"threshold_uncertainty_score":0.34239095},"labels":[],"label_agreement":null},{"id":"W2953886592","doi":"10.1016/j.jval.2019.04.301","title":"PCN179 DISPARITY IN COLORECTAL CANCER SCREENING AMONG US VETERANS: RESULTS FROM BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM 2014-2016","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Behavioral Risk Factor Surveillance System; Medicine; Colorectal cancer; Logistic regression; Odds; Odds ratio; Demography; Cross-sectional study; Ethnic group; Risk factor; Behavioral risk; Cancer; Gerontology; Internal medicine; Environmental health; Population; Pathology","score_opus":0.0364951497337882,"score_gpt":0.30943125088308787,"score_spread":0.27293610114929967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953886592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98071986,0.0005416475,0.00014885976,0.00061331526,0.00005869289,0.000021102678,0.015075976,0.000015302316,0.0028053347],"genre_scores_gemma":[0.9919641,0.00018057556,0.00009068478,0.00018347151,0.000022946508,0.000016495027,0.0069665764,0.0000072312855,0.0005679686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892765,0.00015540098,0.00015149856,0.00021800466,0.0002472921,0.00030009882],"domain_scores_gemma":[0.99855524,0.00013225753,0.0006963028,0.000089080786,0.00027246008,0.0002546864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006787524,0.0001986941,0.00025383165,0.0011504797,0.00039877644,0.0006349292,0.000582987,0.00049650116,0.0019212589],"category_scores_gemma":[0.0031967044,0.00026177644,0.00078612356,0.0025625683,0.00022420741,0.00073453085,0.0012699831,0.0006792157,0.00027753835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046986195,0.000020588937,0.99732345,0.000010871358,0.00006183427,0.000015855792,0.000047340898,0.00004670069,0.0000503265,0.00006879925,0.00091329543,0.0013939213],"study_design_scores_gemma":[0.0000021892588,0.000010824525,0.99922085,0.000008003624,0.000015448384,0.000025466872,0.00016578322,0.000094205556,0.000028174181,0.000027973567,0.00039884695,0.000002232902],"about_ca_topic_score_codex":0.10344512,"about_ca_topic_score_gemma":0.17751563,"teacher_disagreement_score":0.10344512,"about_ca_system_score_codex":0.00077955174,"about_ca_system_score_gemma":0.0012474634,"threshold_uncertainty_score":0.20568597},"labels":[],"label_agreement":null},{"id":"W2953956356","doi":"10.1016/j.jval.2019.04.1826","title":"PSY1 CONCEPTUALIZING A FRAMEWORK FOR MODELING SYSTEMIC LUPUS ERYTHEMATOSUS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Disease; Conceptual model; Conceptual framework; Intensive care medicine; Internal medicine; Computer science","score_opus":0.08770676315568394,"score_gpt":0.36965341817216457,"score_spread":0.28194665501648064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953956356","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038160253,0.0013407221,0.78551143,0.027178925,0.0002182846,0.0003145034,0.0011434109,0.00041280573,0.14571966],"genre_scores_gemma":[0.6719115,0.0012992682,0.29962435,0.0011906927,0.00017262144,0.00060780684,0.0010088166,0.000121022495,0.024063854],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9985446,0.0008526618,0.00006834575,0.00017090111,0.00020512262,0.00015851161],"domain_scores_gemma":[0.9979504,0.0011153816,0.00018132188,0.0001591505,0.00031951588,0.00027425407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025509694,0.0006987869,0.0003374493,0.0014468362,0.0014731298,0.0048485356,0.0018187716,0.0017747715,0.007883405],"category_scores_gemma":[0.0047963457,0.00036729424,0.00119326,0.0016119519,0.003492452,0.005349212,0.0026268922,0.0022828053,0.00077648496],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000690737,0.000014068126,0.0004898048,0.000019527859,0.0000063428643,0.00006740842,0.00048598423,0.0057514175,0.000062194194,0.989081,0.00094631966,0.0030689281],"study_design_scores_gemma":[0.000022674732,0.000028354743,0.00036969903,0.00007976537,0.000023228991,0.00015920222,0.0007366967,0.047210645,0.00018708278,0.9102242,0.040944863,0.000013635448],"about_ca_topic_score_codex":0.018277086,"about_ca_topic_score_gemma":0.011611747,"teacher_disagreement_score":0.018277086,"about_ca_system_score_codex":0.0036433584,"about_ca_system_score_gemma":0.0045623356,"threshold_uncertainty_score":0.03634137},"labels":[],"label_agreement":null},{"id":"W2953968008","doi":"10.1016/j.jval.2019.04.1567","title":"PNS210 REVIEW OF CANADIAN VERSUS OTHER GUIDELINES FOR CONDUCTING BUDGET IMPACT ANALYSIS: DO CANADIAN GUIDELINES DIFFER AND WHY?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Public economics; Actuarial science; Accounting; Health economics; Medicine; Political science; Business; Public health; Environmental health; Economics","score_opus":0.7124043694265298,"score_gpt":0.5210945753044769,"score_spread":0.19130979412205296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953968008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045139967,0.45448822,0.010758791,0.2748254,0.019767206,0.0034686076,0.0455745,0.0005991976,0.18600409],"genre_scores_gemma":[0.097480975,0.5044064,0.10846131,0.2011325,0.007432183,0.0074108285,0.03391272,0.0017407098,0.038022473],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.90427166,0.023131683,0.01753956,0.0023279248,0.048211202,0.0045180493],"domain_scores_gemma":[0.6300303,0.07148087,0.015771028,0.0056687007,0.27091432,0.006134825],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09707297,0.0016333028,0.0028902339,0.024477035,0.004177268,0.008586228,0.007921691,0.0046036444,0.010089644],"category_scores_gemma":[0.3076603,0.0016527922,0.005492891,0.04787461,0.0040625427,0.0026407058,0.0031418845,0.0059707966,0.0018656834],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001786593,0.00002901964,0.0029845268,0.01611179,0.00069785304,0.000083082625,0.00079376687,0.00060739846,0.00011866594,0.01736473,0.85541373,0.10561677],"study_design_scores_gemma":[0.00026046828,0.00003226371,0.01916629,0.06539782,0.0015772625,0.00010564325,0.0007478694,0.00040196188,0.00026999007,0.004147138,0.90772605,0.00016732662],"about_ca_topic_score_codex":0.92046994,"about_ca_topic_score_gemma":0.95095015,"teacher_disagreement_score":0.91881263,"about_ca_system_score_codex":0.08118736,"about_ca_system_score_gemma":0.28046128,"threshold_uncertainty_score":0.5890583},"labels":[],"label_agreement":null},{"id":"W2953974800","doi":"10.1016/j.jval.2019.04.739","title":"PDG60 DID CITIZEN PETITIONS PROLONG THE NUMBER OF APPROVAL DAYS OF GENERIC DRUGS?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Value (mathematics); Food and drug administration; Pharmacology; Geography; Statistics; Mathematics","score_opus":0.07224846029655808,"score_gpt":0.3052642194823649,"score_spread":0.2330157591858068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953974800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7634386,0.00245104,0.0015523548,0.15293768,0.0015881748,0.000099802346,0.0053776368,0.000107126834,0.0724476],"genre_scores_gemma":[0.98341656,0.00023335888,0.00013021988,0.008965208,0.00047371024,0.000033163426,0.00042083746,0.000019138664,0.006307679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698144,0.0010393662,0.000103926424,0.0003165464,0.0004435617,0.0011151565],"domain_scores_gemma":[0.95600724,0.025731381,0.009860672,0.0011791935,0.0034989817,0.0037225373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005777775,0.00015789585,0.00045162413,0.000459342,0.00078806723,0.0027918718,0.00062040694,0.0047016307,0.012106161],"category_scores_gemma":[0.047079317,0.00027137366,0.00084325037,0.0006070449,0.0011175829,0.0019025964,0.0009294048,0.004944125,0.0011660579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013337997,0.0015475976,0.52557117,0.00061316986,0.0009321462,0.00084181275,0.0022055241,0.0059413672,0.0018304415,0.1253859,0.17802387,0.14376898],"study_design_scores_gemma":[0.0013681033,0.0020467662,0.6980632,0.0005045292,0.00082407234,0.00044453482,0.0038180053,0.011760805,0.0030528274,0.050303087,0.22765565,0.00015841099],"about_ca_topic_score_codex":0.021307224,"about_ca_topic_score_gemma":0.026217932,"teacher_disagreement_score":0.021307224,"about_ca_system_score_codex":0.003292812,"about_ca_system_score_gemma":0.004350632,"threshold_uncertainty_score":0.042366445},"labels":[],"label_agreement":null},{"id":"W2954103814","doi":"10.1016/j.jval.2019.04.025","title":"CP2 ESTIMATING THE SURVIVAL AND COST IMPACT OF INTRODUCING FIRST-LINE ALECTINIB AND OSIMERTINIB FOR PATIENTS WITH ADVANCED NSCLC: AN ITEN MODEL ASSESSMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Alectinib; Osimertinib; Medicine; Oncology; Lung cancer; Internal medicine; Erlotinib; Crizotinib; Cancer","score_opus":0.04173580079861362,"score_gpt":0.31266619281454017,"score_spread":0.27093039201592656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954103814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7978995,0.0022811121,0.14009942,0.008989668,0.0004147611,0.0008303288,0.013809939,0.0007502597,0.034925],"genre_scores_gemma":[0.9675647,0.00038847091,0.015212639,0.0004766318,0.00010323764,0.00034637825,0.003277869,0.000079156176,0.012550913],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99888045,0.00065885246,0.000029298266,0.00015715176,0.0000892337,0.00018508863],"domain_scores_gemma":[0.9861466,0.012041786,0.0005147296,0.00026532315,0.0006813436,0.00035008887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005014082,0.0014895848,0.0015881252,0.0009603945,0.00045000447,0.0021268022,0.0019745287,0.0025958463,0.009269992],"category_scores_gemma":[0.015239159,0.000919336,0.002779036,0.0008744706,0.0005840317,0.0012340177,0.0011650454,0.0027849586,0.00056333747],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039768973,0.0001145224,0.0031931964,0.00008213369,0.00016398008,0.00005329617,0.000012318601,0.9869984,0.00008279863,0.0021086938,0.0014227169,0.0053703324],"study_design_scores_gemma":[0.0001096187,0.00013956596,0.0008894073,0.000015828438,0.000084309686,0.00002163753,0.000019562518,0.996491,0.00007902076,0.001744657,0.00039651766,0.000008709499],"about_ca_topic_score_codex":0.062297482,"about_ca_topic_score_gemma":0.032897636,"teacher_disagreement_score":0.062297482,"about_ca_system_score_codex":0.0030302643,"about_ca_system_score_gemma":0.0043753954,"threshold_uncertainty_score":0.12386978},"labels":[],"label_agreement":null},{"id":"W2954105574","doi":"10.1016/j.jval.2019.04.357","title":"PCN236 COST-EFFECTIVENESS OF LENALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN THE CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA BUT INELIGIBLE FOR STEM CELL TRANSPLANT THERAPY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Quality-adjusted life year; Cost effectiveness; Cost-effectiveness analysis; Relative risk; Per capita; Cost–benefit analysis; Internal medicine; Confidence interval; Environmental health; Population; Risk analysis (engineering)","score_opus":0.041184977474890576,"score_gpt":0.32130413625237836,"score_spread":0.2801191587774878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954105574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973495,0.0018023737,0.000020703717,0.0002833369,0.000021431362,0.000026833462,0.0001163083,0.0000024497087,0.0003771499],"genre_scores_gemma":[0.9990841,0.00047133383,0.000039915994,0.000089603265,0.000018749544,0.00001659151,0.00016375375,7.306331e-7,0.000115338175],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99969435,0.000090073474,0.000024350136,0.00005328479,0.00003284337,0.00010512695],"domain_scores_gemma":[0.99955565,0.000093453215,0.00010735883,0.000013328663,0.000022491402,0.00020766945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038969578,0.00041376965,0.0011087729,0.00039221335,0.00043075497,0.000639572,0.0005408716,0.00050443807,0.0026944038],"category_scores_gemma":[0.0011266341,0.00021295516,0.0022970275,0.0007819642,0.0004032274,0.00053294125,0.00044198078,0.00076388643,0.000095463605],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20976299,0.005801255,0.63455856,0.0014743186,0.0062432326,0.0019489321,0.00050272606,0.013575524,0.0023273502,0.0010896239,0.0027768004,0.11993865],"study_design_scores_gemma":[0.024191381,0.034266375,0.89316124,0.00034080722,0.017107839,0.00096140866,0.0018750263,0.02260352,0.00093125534,0.0013068563,0.0030755955,0.00017880904],"about_ca_topic_score_codex":0.034568038,"about_ca_topic_score_gemma":0.038287923,"teacher_disagreement_score":0.034568038,"about_ca_system_score_codex":0.0029883147,"about_ca_system_score_gemma":0.0034702718,"threshold_uncertainty_score":0.06873369},"labels":[],"label_agreement":null},{"id":"W2954156255","doi":"10.1016/j.jval.2019.04.412","title":"PCN293 REAL-WORLD PRODUCTIVITY, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND QUALITY OF LIFE (QOL) IN PATIENTS RECEIVING FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (GC) IN CANADA AND EUROPE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Visual analogue scale; Work productivity; Cancer; Productivity; Population; Disease; Health care; Gerontology; Family medicine; Internal medicine; Physical therapy; Environmental health; Nursing","score_opus":0.10974837712851088,"score_gpt":0.3052322435279914,"score_spread":0.1954838663994805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954156255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873783,0.0006849489,0.000060091294,0.00034745896,0.000013683668,0.000011353033,0.010244241,0.000007049501,0.0012528462],"genre_scores_gemma":[0.9937366,0.00027477718,0.000042698106,0.000058645324,0.0000063920397,0.000005541824,0.0051918915,0.0000032208393,0.00068007974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934214,0.0000843539,0.000054177744,0.00007982142,0.0001372809,0.00030227285],"domain_scores_gemma":[0.9975351,0.00029332886,0.00051070447,0.000073670846,0.0007362432,0.00085096195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000710812,0.0002473397,0.0004588154,0.0010024188,0.00071504776,0.0016092208,0.000722855,0.00049096526,0.0024754733],"category_scores_gemma":[0.0031763737,0.00021104177,0.0010005783,0.003996993,0.00052415853,0.00043793785,0.0007395652,0.0010553232,0.00023291988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013849024,0.000032458793,0.9962494,0.000017508404,0.00012784726,0.000044607823,0.00010180049,0.00054856425,0.00002380963,0.00009721062,0.0009943257,0.0016240646],"study_design_scores_gemma":[0.000007423277,0.000015768099,0.99851364,0.000012359739,0.000027655593,0.000026298732,0.0003962732,0.0004412868,0.000013978624,0.000023429579,0.0005150771,0.0000068124364],"about_ca_topic_score_codex":0.9696829,"about_ca_topic_score_gemma":0.9586852,"teacher_disagreement_score":0.030317128,"about_ca_system_score_codex":0.013864992,"about_ca_system_score_gemma":0.012088313,"threshold_uncertainty_score":0.10059804},"labels":[],"label_agreement":null},{"id":"W2954218874","doi":"10.1016/j.jval.2019.04.429","title":"PCN311 CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA AFTER PROGRESSION ON PLATINUM-BASED THERAPY: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; Medical record; Internal medicine; Retrospective cohort study; Disease; Regimen; Cisplatin; Cancer; Oncology; Chemotherapy","score_opus":0.048399791486402555,"score_gpt":0.3538531635827382,"score_spread":0.30545337209633566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954218874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94788116,0.017499315,0.000071514405,0.0008475531,0.000029461653,0.0000879258,0.030290175,0.000009298713,0.0032836571],"genre_scores_gemma":[0.9881523,0.0053353296,0.00012868822,0.00026749712,0.000017082997,0.00003237492,0.005735038,0.0000040221726,0.00032766492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978504,0.00019116662,0.0005053005,0.00031300104,0.00084357295,0.0002964978],"domain_scores_gemma":[0.9897911,0.0013081479,0.004628614,0.00020720025,0.0032850911,0.00077987206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010054656,0.0001685444,0.0006583601,0.0033224155,0.0010787741,0.0017204464,0.0008686685,0.00049531355,0.0011345564],"category_scores_gemma":[0.007873517,0.00022041104,0.0009047627,0.017386757,0.00053342356,0.0006949943,0.00060290407,0.0005490805,0.0000969777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051489955,0.000013694502,0.9963995,0.00019781137,0.0001821754,0.000057024958,0.000196876,0.00003625622,0.000039730796,0.00003898333,0.00073919183,0.0020472757],"study_design_scores_gemma":[0.0000070703827,0.000010539241,0.9985214,0.00010708677,0.000080640384,0.000080135935,0.0004123133,0.00007651686,0.000028075441,0.000010482596,0.00065922766,0.000006543751],"about_ca_topic_score_codex":0.901869,"about_ca_topic_score_gemma":0.93338364,"teacher_disagreement_score":0.901869,"about_ca_system_score_codex":0.011182891,"about_ca_system_score_gemma":0.020505643,"threshold_uncertainty_score":0.1974178},"labels":[],"label_agreement":null},{"id":"W2954222820","doi":"10.1016/j.jval.2019.04.1552","title":"PNS195 MODELLING HETEROGENEOUS PUBLIC PREFERENCES IN DISCRETE CHOICE EXPERIMENTS: AN APPLICATION TO PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES FOR CHROMOSOMAL ABNORMALITIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes","funders":"","keywords":"Population; Miscarriage; Prenatal screening; Medicine; Bayes' theorem; Prenatal diagnosis; Sample (material); Pregnancy; Psychology; Environmental health; Statistics; Bayesian probability; Biology; Genetics","score_opus":0.149757639033529,"score_gpt":0.28136582638758395,"score_spread":0.13160818735405494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954222820","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1347993,0.00068670063,0.8524022,0.0029354044,0.00020824159,0.00037191503,0.001336683,0.00042360197,0.006835987],"genre_scores_gemma":[0.8157835,0.0009521165,0.15562129,0.0005802581,0.00024577923,0.0010356632,0.0007975948,0.00013671027,0.024847131],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9937655,0.0050403834,0.00014398049,0.0004940221,0.00026182152,0.00029440052],"domain_scores_gemma":[0.92046255,0.07493376,0.0017507223,0.0014038193,0.0006461671,0.0008030073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016419457,0.001302248,0.0032327655,0.0016362423,0.00073614967,0.0031082872,0.0024423897,0.003959146,0.017679276],"category_scores_gemma":[0.04283097,0.0015250085,0.0027378884,0.0020890564,0.0023656096,0.0034615283,0.0021162007,0.0037532912,0.00069562346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006643907,0.00035423657,0.0040799435,0.00020275758,0.00034883348,0.0003274229,0.00026272336,0.692387,0.00046442714,0.27696645,0.0016213757,0.022320466],"study_design_scores_gemma":[0.00019442823,0.000099584744,0.0005658594,0.000020982552,0.000056238936,0.000030303585,0.000045591307,0.88964486,0.00008875397,0.10848252,0.0007465395,0.000024416166],"about_ca_topic_score_codex":0.01350708,"about_ca_topic_score_gemma":0.008526136,"teacher_disagreement_score":0.017679276,"about_ca_system_score_codex":0.0027547784,"about_ca_system_score_gemma":0.0018412828,"threshold_uncertainty_score":0.086835444},"labels":[],"label_agreement":null},{"id":"W2954288090","doi":"10.1016/j.jval.2019.04.958","title":"PIN88 INTERRUPTED TIME SERIES ANALYSIS OF UVGI TECHNOLOGY TO REDUCE INFECTION RATES IN A CANADIAN HEALTH REGION - AN ECONOMIC ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Device Sterilization and Disinfection","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Northern British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Context (archaeology); Interrupted Time Series Analysis; Infection control; Environmental health; Emergency medicine; Intensive care medicine; Geography; Statistics","score_opus":0.018881734878317978,"score_gpt":0.32016355207449304,"score_spread":0.3012818171961751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954288090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719743,0.002782,0.0027153867,0.001401258,0.000050765237,0.00027116743,0.016657755,0.000051118663,0.004096139],"genre_scores_gemma":[0.990651,0.0009824311,0.00087617896,0.0001366888,0.000021881957,0.00007664777,0.0043029143,0.000006309748,0.0029459645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682367,0.00069973845,0.00016510434,0.000279323,0.0009604591,0.0010717353],"domain_scores_gemma":[0.99519855,0.0018752299,0.0009983686,0.0002251874,0.0012484739,0.00045425855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003984817,0.0006010475,0.0009251261,0.0021584928,0.0007317607,0.0017989126,0.0017145592,0.00088501733,0.0026592088],"category_scores_gemma":[0.009038968,0.00044179734,0.0024122566,0.0045367256,0.00058702665,0.00040379804,0.00070839433,0.0014742356,0.00012438431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038853167,0.0006261739,0.81625074,0.00077975803,0.005200901,0.00087928405,0.00047833959,0.11947741,0.0011739724,0.013061573,0.0077964165,0.030390086],"study_design_scores_gemma":[0.00021835991,0.00056164805,0.86945105,0.00010061731,0.0017027903,0.000101847145,0.0011874111,0.121324,0.0003273375,0.000638528,0.004298665,0.00008777638],"about_ca_topic_score_codex":0.9758749,"about_ca_topic_score_gemma":0.94890845,"teacher_disagreement_score":0.02449395,"about_ca_system_score_codex":0.02449395,"about_ca_system_score_gemma":0.022818888,"threshold_uncertainty_score":0.17771685},"labels":[],"label_agreement":null},{"id":"W2954426845","doi":"10.1016/j.jval.2019.04.663","title":"PDB116 REAL-WORLD ADHERENCE AND PERSISTENCE AMONG ELDERLY PATIENTS WITH T2DM INITIATING DULAGLUTIDE VS. LIRAGLUTIDE OR EXENATIDE ONCE-WEEKLY IN THE US","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Liraglutide; Medicine; Dulaglutide; Discontinuation; Lira; Exenatide; Internal medicine; Hazard ratio; Type 2 diabetes; Diabetes mellitus; Endocrinology; Confidence interval","score_opus":0.03829917965234857,"score_gpt":0.2758031372049166,"score_spread":0.23750395755256803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954426845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481034,0.00056412397,0.000052796393,0.00016336112,0.000026134963,0.000012610015,0.003420474,0.000009709683,0.0009403676],"genre_scores_gemma":[0.9973304,0.00015932595,0.00006249465,0.00009978116,0.00002142468,0.000012978177,0.002027069,0.0000035781802,0.0002829416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924916,0.00023680241,0.00015617524,0.00013305436,0.00013146635,0.00009333711],"domain_scores_gemma":[0.99755186,0.0004537213,0.001208765,0.0001738993,0.00026062143,0.00035101295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008930929,0.00020003176,0.0005260996,0.0005469757,0.0003869053,0.001046486,0.00035886353,0.00064835534,0.0018303599],"category_scores_gemma":[0.0046227667,0.0002037026,0.0010597268,0.0015752751,0.00015286407,0.0005065268,0.00044258917,0.0010305429,0.00026924492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017436106,0.00016209808,0.9925524,0.00004194154,0.0003963127,0.000023179466,0.000060752005,0.0001043787,0.000053168293,0.000026637834,0.00074820773,0.0040873336],"study_design_scores_gemma":[0.00011915381,0.00032727997,0.99803156,0.000028350514,0.00022679145,0.00007273092,0.00017288368,0.00047716964,0.000033899487,0.000034085373,0.00046467155,0.000011311371],"about_ca_topic_score_codex":0.030799681,"about_ca_topic_score_gemma":0.023026016,"teacher_disagreement_score":0.030799681,"about_ca_system_score_codex":0.00055206806,"about_ca_system_score_gemma":0.00049129623,"threshold_uncertainty_score":0.061240852},"labels":[],"label_agreement":null},{"id":"W2954431181","doi":"10.1016/j.jval.2019.04.534","title":"PCV99 BAYESIAN NETWORKS AS AN EMERGING TOOL FOR DISEASE RISK ESTIMATION AND CLINICAL DECISION-MAKING: A REAL-WORLD EXAMPLE IN CORONARY ARTERY DISEASE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Toronto Public Health","funders":"","keywords":"Interpretability; Coronary artery disease; Logistic regression; Machine learning; CAD; Bayesian network; Disease; Artificial intelligence; Receiver operating characteristic; Computer science; Missing data; Medicine; Bayesian probability; Risk assessment; Data mining; Internal medicine; Engineering","score_opus":0.1502559212390691,"score_gpt":0.508387657659241,"score_spread":0.3581317364201719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954431181","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052178193,0.002226647,0.9166557,0.006489631,0.00021744496,0.00021719294,0.002094496,0.001699886,0.018220818],"genre_scores_gemma":[0.46595165,0.0013771477,0.52590126,0.00053522445,0.00011950322,0.0001865481,0.0011791209,0.00023489112,0.00451469],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964307,0.002321075,0.0001505455,0.0003086437,0.00070626143,0.000082770544],"domain_scores_gemma":[0.96467286,0.030907106,0.0008130609,0.001182903,0.0020220948,0.00040196534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007478588,0.00086483435,0.0008383668,0.002450918,0.00094651047,0.0033908484,0.0015795896,0.0023264496,0.0073309005],"category_scores_gemma":[0.04163921,0.0004891006,0.000697934,0.0024530957,0.000772691,0.0025016991,0.0013016125,0.002620738,0.001061936],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059996545,0.00032141167,0.011499084,0.00030447426,0.00025330155,0.00042031112,0.0003889267,0.52062297,0.0006701178,0.08108224,0.014795111,0.36904204],"study_design_scores_gemma":[0.00005476441,0.00005086042,0.0011434044,0.00011410683,0.000049842023,0.00013261691,0.000067711364,0.9070553,0.0005723377,0.082412586,0.008312548,0.000033966142],"about_ca_topic_score_codex":0.026461642,"about_ca_topic_score_gemma":0.029131183,"teacher_disagreement_score":0.026461642,"about_ca_system_score_codex":0.0017572221,"about_ca_system_score_gemma":0.0025821456,"threshold_uncertainty_score":0.052615225},"labels":[],"label_agreement":null},{"id":"W2954455586","doi":"10.1016/j.jval.2019.04.1777","title":"PSS5 THE COST-EFFECTIVENESS OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: A CANADIAN ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Vancouver Coastal Health","funders":"","keywords":"Medicine; Tazarotene; Plaque psoriasis; Reimbursement; Psoriasis; Relative risk; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Dermatology; Health care; Confidence interval","score_opus":0.20773328661019286,"score_gpt":0.38207586315887165,"score_spread":0.1743425765486788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954455586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74703205,0.08739502,0.003693401,0.0052421545,0.00048770884,0.002181164,0.1180356,0.00022600226,0.03570683],"genre_scores_gemma":[0.97035575,0.010855675,0.0015992166,0.00034073455,0.00006143703,0.00015212558,0.012088866,0.000039242866,0.0045068935],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99724305,0.0012298033,0.00023249342,0.0002033258,0.00071015133,0.0003811034],"domain_scores_gemma":[0.9951154,0.0022710264,0.00078328326,0.00016894129,0.0010889204,0.00057243434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036705153,0.0010726321,0.0018074353,0.0022120494,0.0005769317,0.0016802802,0.0017417478,0.0008670453,0.007740968],"category_scores_gemma":[0.01545144,0.00060015643,0.0068596415,0.0039371666,0.0006043303,0.0005927526,0.00069920556,0.0017632919,0.00024965347],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17095241,0.0011130067,0.16070576,0.021043397,0.05746202,0.0009848381,0.00053301285,0.25682345,0.0023209297,0.022370309,0.08799333,0.21769756],"study_design_scores_gemma":[0.074698016,0.012114305,0.5771243,0.00610011,0.08471238,0.0012601819,0.0017193757,0.18184063,0.0025311972,0.008232451,0.048905168,0.0007618821],"about_ca_topic_score_codex":0.9533285,"about_ca_topic_score_gemma":0.9395751,"teacher_disagreement_score":0.04667151,"about_ca_system_score_codex":0.037949484,"about_ca_system_score_gemma":0.03292286,"threshold_uncertainty_score":0.27534407},"labels":[],"label_agreement":null},{"id":"W2954511636","doi":"10.1016/j.jval.2019.04.1412","title":"PNS52 CAN COST-EFFECTIVENESS ANALYSIS INFORM THE EXTENT OF COVERAGE UNDER PUBLIC HEALTHCARE? A MICROSIMULATION MODEL OF ALTERNATIVE PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Prenatal screening; Cost-effectiveness analysis; Microsimulation; Population; Cost effectiveness; Quality-adjusted life year; Gynecology; Obstetrics; Pregnancy; Statistics; Prenatal diagnosis; Risk analysis (engineering); Fetus; Environmental health; Mathematics; Biology","score_opus":0.07238440788601408,"score_gpt":0.3416837077488114,"score_spread":0.2692992998627973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954511636","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38682473,0.0032310162,0.52219445,0.019733276,0.00038745542,0.0016801007,0.00782536,0.0006200115,0.057503674],"genre_scores_gemma":[0.96316,0.00094490626,0.021886792,0.00085707166,0.000095168805,0.00063963636,0.0007235316,0.000054018474,0.011638807],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9965912,0.002459597,0.00007245826,0.00031010297,0.00019770986,0.0003689918],"domain_scores_gemma":[0.9898829,0.008766572,0.0006023318,0.00025923466,0.00032589663,0.00016310293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006792409,0.0012420333,0.0028320584,0.0012902914,0.0003198183,0.0025339238,0.0019118504,0.0018970555,0.01577144],"category_scores_gemma":[0.025163515,0.00090079807,0.002479835,0.0013235008,0.000979704,0.0030769343,0.0009428783,0.0019715051,0.0006635219],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004281495,0.00017290424,0.0028713911,0.00013602975,0.00032541034,0.00006911689,0.000058376147,0.9256047,0.00021251183,0.04934689,0.001281344,0.019493245],"study_design_scores_gemma":[0.00013747238,0.0003922615,0.0023912971,0.00008801554,0.0003101556,0.000062997926,0.000090576454,0.94296074,0.00020150878,0.05110017,0.0022367777,0.000027974656],"about_ca_topic_score_codex":0.020753048,"about_ca_topic_score_gemma":0.0104345735,"teacher_disagreement_score":0.020753048,"about_ca_system_score_codex":0.004045481,"about_ca_system_score_gemma":0.004008182,"threshold_uncertainty_score":0.05276078},"labels":[],"label_agreement":null},{"id":"W2954516837","doi":"10.1016/j.jval.2019.04.1375","title":"PNS9 PROPENSITY SCORE MATCHING AND REWEIGHTING TO ASSESS COMPARATIVE EFFICACY OF SINGLE-ARM TRIALS: A GENERAL FRAMEWORK AND SIMULATION STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Propensity score matching; Replicate; Observational study; Computer science; Inverse probability weighting; Matching (statistics); Weighting; Sample size determination; Flexibility (engineering); Comparative effectiveness research; Average treatment effect; Data mining; Statistics; Mathematics; Medicine","score_opus":0.6619148956200791,"score_gpt":0.5295113976503267,"score_spread":0.13240349796975237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954516837","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018427186,0.0012793134,0.97524524,0.0013041656,0.00008922218,0.0005458723,0.0002901294,0.0001881014,0.002630791],"genre_scores_gemma":[0.5216419,0.0016328886,0.4688739,0.0006402303,0.00023927847,0.001980537,0.00045103993,0.00014203257,0.0043981853],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9544431,0.041915357,0.0007441418,0.0011500835,0.0013456471,0.00040167186],"domain_scores_gemma":[0.8417604,0.14671457,0.0040452746,0.005279893,0.0015043906,0.0006955399],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08198539,0.0012022445,0.003565796,0.0023921041,0.0005314261,0.0019538966,0.0027709643,0.0024154957,0.009646263],"category_scores_gemma":[0.16891691,0.00096929976,0.003982669,0.0023847134,0.0019642247,0.002962623,0.0022605076,0.003081185,0.0004967935],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002241846,0.00029500521,0.005850068,0.0006333943,0.0018159862,0.00028170986,0.00025053357,0.36239225,0.0003605721,0.51576334,0.0033909508,0.10672438],"study_design_scores_gemma":[0.00086786074,0.00039197048,0.00087067636,0.0001438183,0.0004010787,0.00012963085,0.000026256206,0.74096805,0.00028831424,0.25379184,0.0020901035,0.000030348592],"about_ca_topic_score_codex":0.0038856112,"about_ca_topic_score_gemma":0.0019642473,"teacher_disagreement_score":0.9180146,"about_ca_system_score_codex":0.0015630368,"about_ca_system_score_gemma":0.0036692063,"threshold_uncertainty_score":0.43358535},"labels":[],"label_agreement":null},{"id":"W2954519816","doi":"10.1016/j.jval.2019.04.1162","title":"PMS52 REAL-WORLD OUTCOMES AND COST OF MANAGEMENT OF OSTEOPOROTIC FRACTURES IN ONTARIO, CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); Western University; Université Laval; McMaster University","funders":"","keywords":"Medicine; Incidence (geometry); Primary care; Emergency medicine; Cohort; Ambulatory; Medical prescription; Emergency department; Pediatrics; Demography; Family medicine; Internal medicine","score_opus":0.021773941302268247,"score_gpt":0.30148378690816907,"score_spread":0.27970984560590084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954519816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89405006,0.0036487621,0.0002520746,0.0049159033,0.00009864297,0.00018650525,0.08364542,0.00004862237,0.013154008],"genre_scores_gemma":[0.9823837,0.0015059968,0.00034469404,0.00034792337,0.000033057077,0.000054622837,0.011899251,0.000013842767,0.003417053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982358,0.00014761748,0.00017369902,0.00013128105,0.0007958021,0.0005157263],"domain_scores_gemma":[0.9946866,0.000308466,0.0012032625,0.00011415365,0.0023801527,0.0013073422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005953852,0.00031858584,0.0005723548,0.0014219419,0.001708496,0.0016724278,0.0013461038,0.0007518865,0.004612295],"category_scores_gemma":[0.0062748804,0.0005135821,0.0010857494,0.0054696016,0.00063255907,0.00049860054,0.0008781361,0.0011174434,0.000265639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047094884,0.00011486761,0.9655424,0.0003130837,0.00038247052,0.00018961455,0.00038976214,0.0024031482,0.00009586753,0.0008842194,0.01706374,0.012150003],"study_design_scores_gemma":[0.00007587052,0.00004124167,0.99410313,0.00011678326,0.00008208732,0.000067501685,0.0005706337,0.0012609886,0.000038445567,0.00007125704,0.003549417,0.00002277655],"about_ca_topic_score_codex":0.9983506,"about_ca_topic_score_gemma":0.9988776,"teacher_disagreement_score":0.08038739,"about_ca_system_score_codex":0.08038739,"about_ca_system_score_gemma":0.08180219,"threshold_uncertainty_score":0.5832541},"labels":[],"label_agreement":null},{"id":"W2954562872","doi":"10.1016/j.jval.2019.04.1028","title":"PMD31 SWIPING RIGHT ON MEDICAL TECHNOLOGY; AN ANALYSIS OF DRUG VS. DEVICE HTA APPROVALS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Medicine; Medical device; Drug approval; Medical record; Family medicine; Health care; Drug; Pharmacology; Internal medicine; Political science","score_opus":0.1941737618440383,"score_gpt":0.39292715575708087,"score_spread":0.19875339391304256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954562872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83576596,0.018491017,0.0018152671,0.015810125,0.0002594048,0.000921482,0.045384195,0.00018973196,0.0813628],"genre_scores_gemma":[0.9815196,0.002253266,0.00041093997,0.0012496376,0.00009424427,0.000065952416,0.0036461488,0.000050219245,0.010710042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9882572,0.0011080094,0.00052980485,0.00084353547,0.005291101,0.0039703306],"domain_scores_gemma":[0.9575125,0.014859604,0.008844966,0.0008936532,0.0104292445,0.0074600796],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004642148,0.0005522991,0.0015796474,0.0046088593,0.0031432677,0.0055271965,0.0020819928,0.0021951087,0.00781255],"category_scores_gemma":[0.038049612,0.00070140493,0.002613284,0.008666309,0.0021948018,0.00091873185,0.0015172159,0.0050395527,0.0003769716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047494303,0.0005024933,0.6937716,0.0014720142,0.002312854,0.0014627017,0.0016839349,0.03673346,0.0007608853,0.08252986,0.117833875,0.05618697],"study_design_scores_gemma":[0.00086813746,0.00035040185,0.91877913,0.00043642166,0.0013414072,0.00038816922,0.0024714172,0.029091017,0.0007031994,0.0034024178,0.041984096,0.00018422313],"about_ca_topic_score_codex":0.99344134,"about_ca_topic_score_gemma":0.994848,"teacher_disagreement_score":0.9953579,"about_ca_system_score_codex":0.08332135,"about_ca_system_score_gemma":0.11347005,"threshold_uncertainty_score":0.60454154},"labels":[],"label_agreement":null},{"id":"W2954589792","doi":"10.1016/j.jval.2019.04.1500","title":"PNS143 PREFERENCES IN THE PRESCRIPTION OF INSULINS IN PATIENTS WITH TYPE II DIABETES MELLITUS IN COLOMBIA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Lifestyle Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); NPH insulin; Diabetes mellitus; Medical prescription; Population; Internal medicine; Pediatrics; Type 2 Diabetes Mellitus; Insulin; Type 2 diabetes; Endocrinology; Insulin glargine; Pharmacology","score_opus":0.0583429957406808,"score_gpt":0.3547013782813226,"score_spread":0.2963583825406418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954589792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806494,0.00030901167,0.000019173409,0.0001682344,0.000006914048,0.0000052452633,0.00014063952,6.0286624e-7,0.001285292],"genre_scores_gemma":[0.9994307,0.00018098643,0.000027397275,0.000045081986,0.000003656075,0.000002657004,0.000079509766,8.8225755e-7,0.00022913306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995932,0.0001248061,0.00004321702,0.000048757454,0.00006538084,0.00012455758],"domain_scores_gemma":[0.9990054,0.00023644614,0.0003458657,0.000025908008,0.00011571534,0.00027069362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035345578,0.00017045406,0.00023564078,0.0008865564,0.00062946934,0.000926994,0.00023572956,0.00037100664,0.0024979466],"category_scores_gemma":[0.001968986,0.00016748722,0.00033974086,0.0011556359,0.00026943162,0.00023569787,0.00042408702,0.0006504221,0.00015612952],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010644047,0.000093217765,0.9958865,0.000021263948,0.000020252695,0.0001465832,0.0006751472,0.00002222254,0.00007717205,0.000050591654,0.00016518084,0.0027355251],"study_design_scores_gemma":[0.0000069158423,0.000037894046,0.9952459,0.000025371299,0.00001663546,0.00013218253,0.003890219,0.00010877217,0.00002339082,0.000021813143,0.00048535175,0.000005608461],"about_ca_topic_score_codex":0.15137416,"about_ca_topic_score_gemma":0.2237215,"teacher_disagreement_score":0.15137416,"about_ca_system_score_codex":0.0018309071,"about_ca_system_score_gemma":0.00096290634,"threshold_uncertainty_score":0.3009861},"labels":[],"label_agreement":null},{"id":"W2954628789","doi":"10.1016/j.jval.2019.04.639","title":"PDB91 ADJUSTING THE COMMERCIAL VALUE OF EARLY-STAGE BIOMEDICAL TECHNOLOGIES FOR COST-EFFECTIVENESS: A VALUE-BASED APPROACH USING REAL OPTIONS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University of British Columbia","funders":"","keywords":"Actuarial science; Willingness to pay; Reimbursement; Econometrics; Economics; Microeconomics; Health care","score_opus":0.5067783142808269,"score_gpt":0.458966353943776,"score_spread":0.047811960337050874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954628789","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11505147,0.004635962,0.758932,0.010293477,0.0011838316,0.0016225361,0.011231699,0.001024388,0.09602457],"genre_scores_gemma":[0.85122615,0.0013481807,0.11910451,0.00066352595,0.00022952874,0.000740247,0.002780652,0.0002476317,0.023659622],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9908261,0.0066293324,0.00025086344,0.0005997945,0.0014224817,0.00027146132],"domain_scores_gemma":[0.980646,0.015985476,0.0008168227,0.00084065157,0.0014286184,0.000282379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010999842,0.001091295,0.0015691844,0.0030222149,0.00052500307,0.0046735127,0.0027939274,0.00352102,0.020278797],"category_scores_gemma":[0.046825543,0.00093353656,0.0020707755,0.0034480386,0.0008837273,0.0030851832,0.0015627384,0.0034635717,0.0013591341],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010121195,0.00055402215,0.009276337,0.0007385335,0.0008789028,0.0002697095,0.00011075445,0.56589866,0.00087851397,0.15466289,0.016736858,0.24898267],"study_design_scores_gemma":[0.00030200154,0.00034400212,0.005405027,0.0002465958,0.00034361798,0.00018543687,0.00015211898,0.7936043,0.0015647245,0.1741493,0.023560641,0.0001420891],"about_ca_topic_score_codex":0.0086052455,"about_ca_topic_score_gemma":0.004551456,"teacher_disagreement_score":0.020278797,"about_ca_system_score_codex":0.0032561712,"about_ca_system_score_gemma":0.0031199846,"threshold_uncertainty_score":0.067839265},"labels":[],"label_agreement":null},{"id":"W2954710002","doi":"10.1016/j.jval.2019.04.1061","title":"PMH16 ECONOMIC BURDEN ASSOCIATED WITH NON-COMMUNICABLE DISEASES AMONG ADULTS WITH DEPRESSION AND ANXIETY IN THE UNITED STATES.","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Medical Expenditure Panel Survey; Diabetes mellitus; Cohort; Obesity; Medical prescription; Health care; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.015725878820998754,"score_gpt":0.2549591850394295,"score_spread":0.23923330621843075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954710002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.922326,0.003958632,0.00013270363,0.0027571078,0.00019941397,0.000074265554,0.06419848,0.000022065045,0.0063312897],"genre_scores_gemma":[0.97639114,0.0024968113,0.00012559223,0.00042648002,0.00018141871,0.00008591306,0.018089145,0.0000073096608,0.0021961853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996131,0.000101606354,0.0000655736,0.00005096358,0.00007627323,0.00009256995],"domain_scores_gemma":[0.9985623,0.00016349053,0.00079690205,0.00005406829,0.00015441272,0.00026888793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036307104,0.00023008973,0.00022550728,0.0011430962,0.00029662065,0.0005458645,0.00035930172,0.00046532234,0.006941264],"category_scores_gemma":[0.002331961,0.00021318717,0.0007223454,0.0021165581,0.0001451147,0.00042922053,0.0008814982,0.0008967428,0.00047495027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017917862,0.000036702408,0.98866767,0.00008228766,0.00014223796,0.00009103611,0.000053202424,0.00010173988,0.000039656086,0.00012039675,0.005989039,0.004496766],"study_design_scores_gemma":[0.000008580915,0.000018731364,0.9988771,0.000039578277,0.00002400661,0.00007469942,0.000104167535,0.000098160395,0.000009640406,0.000032353473,0.00071093184,0.0000019997237],"about_ca_topic_score_codex":0.042211138,"about_ca_topic_score_gemma":0.040039558,"teacher_disagreement_score":0.042211138,"about_ca_system_score_codex":0.00042672642,"about_ca_system_score_gemma":0.000667001,"threshold_uncertainty_score":0.08393091},"labels":[],"label_agreement":null},{"id":"W2954822769","doi":"10.1016/j.jval.2019.04.166","title":"PCN42 THE HEALTH UTILITY BOOK (HUB): TOWARD A CENTRALIZED, SYSTEMATIC APPROACH TO THE IDENTIFICATION, APPRAISAL, AND USE OF HEALTH STATE UTILITY VALUES FOR REIMBURSEMENT DECISION MAKING","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Canadian Institutes of Health Research; Institute of Health Economics; McMaster University","funders":"","keywords":"Reimbursement; Identification (biology); Health care; Jurisdiction; Quality (philosophy); Actuarial science; Checklist; Risk analysis (engineering); Business; Medicine; Operations management; Management science; Economics; Psychology; Political science","score_opus":0.4701570964053416,"score_gpt":0.4568015764234166,"score_spread":0.013355519981924968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954822769","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020788251,0.0032169481,0.88201785,0.014868004,0.0008256506,0.00060874195,0.0037862372,0.0041366704,0.08846102],"genre_scores_gemma":[0.0616233,0.004871242,0.8647459,0.0038143732,0.0017145978,0.0012009132,0.0052486286,0.0028779113,0.053903054],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9855601,0.007929513,0.0008877241,0.0006639134,0.004679831,0.0002789219],"domain_scores_gemma":[0.9619778,0.022680297,0.0010530126,0.0048718397,0.008628068,0.00078906456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01981771,0.0012671213,0.0016410868,0.00378694,0.0011715022,0.009465462,0.0021285354,0.0032417467,0.015800629],"category_scores_gemma":[0.07725089,0.0016588697,0.0008180057,0.0053840927,0.002830747,0.008571584,0.0036491842,0.0055793645,0.008842655],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004554813,0.00005316789,0.00079333637,0.00019129956,0.000027011429,0.00007783466,0.00021034727,0.00920578,0.00020118199,0.49946907,0.26978734,0.21993804],"study_design_scores_gemma":[0.000039602466,0.00005309954,0.0016963397,0.00060398993,0.000030269633,0.00026714377,0.00013138766,0.060318567,0.0012803911,0.5119275,0.42354476,0.0001068712],"about_ca_topic_score_codex":0.010193493,"about_ca_topic_score_gemma":0.00869015,"teacher_disagreement_score":0.01981771,"about_ca_system_score_codex":0.0033472725,"about_ca_system_score_gemma":0.015347345,"threshold_uncertainty_score":0.10480732},"labels":[],"label_agreement":null},{"id":"W2954830939","doi":"10.1016/j.jval.2019.04.036","title":"CV3 VARIATIONS IN HEALTHCARE RESOURCE USE AND EXPENDITURES BY AGE IN PATIENTS UNDER AGE 65 NEWLY DIAGNOSED WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) IN THE UNITED STATES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Pediatrics; Age groups; Medical diagnosis; Health care; Internal medicine; Demography","score_opus":0.019393040594343967,"score_gpt":0.2667663555864715,"score_spread":0.24737331499212753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954830939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939114,0.0003252712,0.00005623267,0.00016073753,0.000011215248,0.0000054612533,0.0044437554,0.0000071329664,0.0010787667],"genre_scores_gemma":[0.99750584,0.0001731864,0.00003259502,0.00007131237,0.000012404849,0.0000054109732,0.0019463906,0.0000029531561,0.00025005644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963987,0.00005762585,0.000058103356,0.00008457423,0.00004902102,0.00011081074],"domain_scores_gemma":[0.99873894,0.00017133342,0.00068503374,0.00004656111,0.000112965856,0.00024508536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024124958,0.00021525213,0.00028135726,0.00095283246,0.00028619054,0.0006477818,0.0002879177,0.00046807615,0.0023349228],"category_scores_gemma":[0.0014833559,0.00020359714,0.00088325585,0.0021272982,0.0001681168,0.0005220984,0.0005368287,0.0006702103,0.00022928623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057115107,0.000018743374,0.99858594,0.000005734053,0.00007039234,0.000035037345,0.000034889068,0.000120189434,0.000039938303,0.000030967032,0.00030774862,0.00069333275],"study_design_scores_gemma":[0.0000020109094,0.00001308528,0.99942976,0.0000045221777,0.000015205169,0.00005608388,0.00014197877,0.00018790075,0.000010303109,0.000016742713,0.00011999184,0.000002409782],"about_ca_topic_score_codex":0.07344824,"about_ca_topic_score_gemma":0.090433,"teacher_disagreement_score":0.07344824,"about_ca_system_score_codex":0.0007389541,"about_ca_system_score_gemma":0.0005306615,"threshold_uncertainty_score":0.14604145},"labels":[],"label_agreement":null},{"id":"W2954838902","doi":"10.1016/j.jval.2019.04.1576","title":"PNS220 CHARACTERISTICS AND METHODS OF INCORPORATING RANDOMIZED AND NON-RANDOMIZED EVIDENCE IN NETWORK META-ANALYSES: A SCOPING REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Randomized controlled trial; Observational study; Pooling; Medicine; Statistics; Artificial intelligence; Computer science; Mathematics; Internal medicine","score_opus":0.9324885607285037,"score_gpt":0.6726216544897671,"score_spread":0.25986690623873665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954838902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033430918,0.8527243,0.098838665,0.008134439,0.002046327,0.019803973,0.008983547,0.0003555607,0.0057700654],"genre_scores_gemma":[0.064441405,0.54654115,0.3070207,0.005442478,0.0018705897,0.066599034,0.0052682715,0.00057452486,0.0022417724],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.5081079,0.31743196,0.13639809,0.0069377287,0.02998522,0.0011390755],"domain_scores_gemma":[0.2664918,0.6501111,0.03444263,0.024160963,0.02383055,0.00096305984],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.30225405,0.002934289,0.01114248,0.01835259,0.0013811508,0.01099993,0.004359906,0.005606412,0.011309488],"category_scores_gemma":[0.7404643,0.0038530019,0.027637735,0.019834276,0.0022499657,0.008623257,0.006806319,0.005619258,0.0017113847],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003136506,0.00016646979,0.006409768,0.44386852,0.093931474,0.00017432214,0.0006754119,0.0026690688,0.000238488,0.012683963,0.012300341,0.42374572],"study_design_scores_gemma":[0.004425039,0.0011389847,0.013937413,0.59464157,0.21691692,0.0010715378,0.0003561128,0.0073554646,0.0017322458,0.054383643,0.10356457,0.00047652432],"about_ca_topic_score_codex":0.0052422294,"about_ca_topic_score_gemma":0.009215738,"teacher_disagreement_score":0.6977459,"about_ca_system_score_codex":0.006472452,"about_ca_system_score_gemma":0.018244384,"threshold_uncertainty_score":0.86044496},"labels":[],"label_agreement":null},{"id":"W2954881004","doi":"10.1016/j.jval.2019.04.1447","title":"PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Health care; Randomized controlled trial; Medicine; Systematic review; Psychological intervention; Incentive; MEDLINE; EconLit; Cochrane Library; Health economics; Family medicine; Business; Nursing; Public health; Political science; Economics","score_opus":0.14979100340319898,"score_gpt":0.39850446512372395,"score_spread":0.24871346172052497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954881004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017280923,0.9963039,0.00031777087,0.0002837312,0.00017637377,0.0003890453,0.00048614555,0.000017061611,0.00029776234],"genre_scores_gemma":[0.044975076,0.9504835,0.0017597028,0.0011846189,0.00020228092,0.0006666965,0.00039766153,0.00001968179,0.00031073947],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9893902,0.005080137,0.003092112,0.0008767946,0.0013093002,0.0002514621],"domain_scores_gemma":[0.9712821,0.022106713,0.0048565324,0.00047305023,0.0010089389,0.0002726382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012675102,0.0015170692,0.010504399,0.0035896231,0.00037396493,0.002590387,0.0015754265,0.0022478558,0.007647035],"category_scores_gemma":[0.049391564,0.00078916556,0.013768151,0.0039841654,0.0009852481,0.0016730808,0.001411461,0.0023198845,0.00036629837],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050187893,0.000052842737,0.00081562885,0.8482093,0.07784547,0.000058143043,0.000053831758,0.00024740162,0.00022520995,0.00039973666,0.0020986572,0.0649749],"study_design_scores_gemma":[0.014090433,0.0012570302,0.008262648,0.4120255,0.54154927,0.00028996644,0.0001375985,0.00030286124,0.00038059364,0.0013433998,0.020270478,0.00009028716],"about_ca_topic_score_codex":0.0042043775,"about_ca_topic_score_gemma":0.010418658,"teacher_disagreement_score":0.012675102,"about_ca_system_score_codex":0.0025261596,"about_ca_system_score_gemma":0.0051182243,"threshold_uncertainty_score":0.06703317},"labels":[],"label_agreement":null},{"id":"W2954897982","doi":"10.1016/j.jval.2019.04.606","title":"PDB57 REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPELTM STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Type 2 diabetes; Pharmacy; Diabetes mellitus; Basal (medicine); Basal insulin; Dulaglutide; Propensity score matching; Internal medicine; Retrospective cohort study; Exenatide; Insulin; Surgery; Endocrinology; Family medicine","score_opus":0.013326857875443965,"score_gpt":0.2506861155821586,"score_spread":0.23735925770671462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954897982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845138,0.0018036477,0.00007620707,0.0005184726,0.00006223614,0.000028704912,0.01186808,0.000004977127,0.001123831],"genre_scores_gemma":[0.9882302,0.00065943884,0.00010297215,0.00023563321,0.000076331446,0.000046072204,0.010142455,0.000004446613,0.0005023854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991233,0.00039899803,0.00012110368,0.00011750607,0.00012345126,0.000115698436],"domain_scores_gemma":[0.9979023,0.00046827836,0.0010107907,0.00014677376,0.00013931145,0.0003325855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011125745,0.00040407816,0.0007090495,0.00060862326,0.0003437064,0.0013306774,0.00073923863,0.0007507428,0.0028312262],"category_scores_gemma":[0.004031067,0.00032165973,0.002026037,0.0021018211,0.00022096653,0.00067188166,0.0008829117,0.0015069426,0.00030798608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017143272,0.00045190437,0.9699062,0.00023716998,0.003116484,0.00012333281,0.000063534266,0.00041353836,0.00012659287,0.00027966677,0.0032750692,0.004863144],"study_design_scores_gemma":[0.0027823038,0.00097136444,0.99115807,0.000115468385,0.0015650633,0.000157025,0.00032839907,0.0012358992,0.00008670215,0.00022802403,0.0013368599,0.000034997443],"about_ca_topic_score_codex":0.0150912795,"about_ca_topic_score_gemma":0.012747186,"teacher_disagreement_score":0.0150912795,"about_ca_system_score_codex":0.0010264707,"about_ca_system_score_gemma":0.0006490292,"threshold_uncertainty_score":0.030006886},"labels":[],"label_agreement":null},{"id":"W2954918223","doi":"10.1016/j.jval.2019.04.397","title":"PCN278 REAL WORLD TREATMENT PATTERNS FOR FIRST LINE (1L) RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) PATIENTS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Cetuximab; Internal medicine; Stage (stratigraphy); Dysphagia; Radiation therapy; Oncology; Cancer; Surgery; Colorectal cancer","score_opus":0.05830342842827169,"score_gpt":0.32448883679989876,"score_spread":0.2661854083716271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954918223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99285156,0.0003902414,0.000060613234,0.00012724876,0.000008280167,0.000013176816,0.0046029277,0.0000050941844,0.0019408336],"genre_scores_gemma":[0.99749124,0.00010657732,0.000038467635,0.00003740142,0.0000043683153,0.0000098115715,0.0018536592,0.0000032844157,0.0004551887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999635,0.00009747012,0.000036942,0.00008137443,0.000057432557,0.00009174031],"domain_scores_gemma":[0.99897873,0.00022089074,0.00046512164,0.00006515198,0.00012844373,0.00014161672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030227663,0.0001049353,0.00022233771,0.0005159429,0.00030821844,0.0005041408,0.0002662907,0.00022621556,0.005004606],"category_scores_gemma":[0.0021648048,0.00008337939,0.00039795178,0.0013602691,0.00019155383,0.000471995,0.00032022197,0.00038055747,0.00048466725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007907961,0.000063557796,0.9878824,0.00003626398,0.0000861633,0.000064240245,0.00012239456,0.00021734621,0.00029689126,0.00007856248,0.0011695138,0.0091919135],"study_design_scores_gemma":[0.000022046232,0.000270691,0.99719006,0.000014724382,0.00005015099,0.00016128976,0.0004393085,0.00026521273,0.00019163132,0.0000752676,0.0013133571,0.000006336297],"about_ca_topic_score_codex":0.023967601,"about_ca_topic_score_gemma":0.035620134,"teacher_disagreement_score":0.023967601,"about_ca_system_score_codex":0.0008651224,"about_ca_system_score_gemma":0.0005269156,"threshold_uncertainty_score":0.04765618},"labels":[],"label_agreement":null},{"id":"W2954946792","doi":"10.1016/j.jval.2019.04.184","title":"PCN60 FITTING DISTRIBUTIONS OF PARAMETRIC MODELS INTO NON-PARAMETRIC KAPLAN-MEIER CURVE: APPLICATION IN EXCEL AND COMPARISON OF DIFFERENT DATA RECREATION METHODS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Weibull distribution; Parametric statistics; Statistics; Goodness of fit; Mathematics; Distribution fitting; Parametric model; Survival analysis; Computer science; Exponential distribution","score_opus":0.49807697278271973,"score_gpt":0.5119474165045507,"score_spread":0.013870443721830938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954946792","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033623073,0.00013968043,0.9443973,0.00011747485,0.00006757636,0.00039653137,0.002691343,0.015338058,0.0032288737],"genre_scores_gemma":[0.23779613,0.000345063,0.74338865,0.00008476956,0.000040868144,0.0018243807,0.005100338,0.0067555094,0.004664285],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99622923,0.0019066504,0.0004505513,0.00050330174,0.00073586724,0.0001743847],"domain_scores_gemma":[0.96367866,0.02924168,0.0013616309,0.0028201756,0.0026945206,0.00020335456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010935456,0.0010945622,0.0009631398,0.0032601773,0.00049653003,0.0018685786,0.001637383,0.0008428362,0.017338447],"category_scores_gemma":[0.05953311,0.00068874133,0.0012828734,0.0023823006,0.00037243738,0.0020346562,0.0017576431,0.0015349194,0.003265833],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013744023,0.0008661541,0.02427893,0.0012190426,0.0004733555,0.00047905455,0.0016821937,0.16202915,0.004212989,0.040317487,0.031088226,0.7319791],"study_design_scores_gemma":[0.00012354513,0.00028310416,0.010072398,0.00020265601,0.000086597196,0.000546706,0.00037520824,0.9387031,0.00928312,0.019613354,0.020571537,0.0001386411],"about_ca_topic_score_codex":0.0045178877,"about_ca_topic_score_gemma":0.002893605,"teacher_disagreement_score":0.017338447,"about_ca_system_score_codex":0.0007009386,"about_ca_system_score_gemma":0.0018479924,"threshold_uncertainty_score":0.05800289},"labels":[],"label_agreement":null},{"id":"W2955043329","doi":"10.1016/j.jval.2019.04.235","title":"PCN111 OUT-OF-POCKET COSTS IN CANADIAN PROSTATE CANCER PATIENTS : A REMOTE REGION PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec en Abitibi-Témiscamingue; McGill University","funders":"","keywords":"Medicine; Context (archaeology); Medical prescription; Prostate cancer; Demography; Medical costs; Average cost; Total cost; Family medicine; Cancer; Health care; Internal medicine; Geography; Nursing","score_opus":0.03911328808554823,"score_gpt":0.271962246680821,"score_spread":0.23284895859527274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955043329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80058324,0.031731654,0.0005748503,0.056394897,0.00029316984,0.00010682165,0.025742963,0.000031955213,0.08454046],"genre_scores_gemma":[0.98566914,0.006979465,0.0003256996,0.0014589446,0.00013049178,0.0000172624,0.0028422428,0.0000116189085,0.0025651737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875796,0.00014081599,0.000041135943,0.00006775331,0.00040612035,0.00058613316],"domain_scores_gemma":[0.9970675,0.00026919175,0.0005367955,0.00003516456,0.0011680841,0.00092330907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068580563,0.0004255157,0.00059018057,0.0018149128,0.002324759,0.002933717,0.0012127819,0.00081872,0.0074989353],"category_scores_gemma":[0.004447763,0.00026235636,0.0014344252,0.005431498,0.00080014986,0.0008316352,0.0011942675,0.0022463207,0.00027264937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010101098,0.00034110816,0.81535923,0.00089016196,0.0011819239,0.0012842375,0.002168355,0.0095905075,0.00039118427,0.022719875,0.06224228,0.08282102],"study_design_scores_gemma":[0.00007843318,0.00011408227,0.95908654,0.0007386055,0.0005315993,0.00071733224,0.007273474,0.0037230966,0.00010690202,0.0025424275,0.024954429,0.00013307827],"about_ca_topic_score_codex":0.9926293,"about_ca_topic_score_gemma":0.9962214,"teacher_disagreement_score":0.06838565,"about_ca_system_score_codex":0.06838565,"about_ca_system_score_gemma":0.049300075,"threshold_uncertainty_score":0.496175},"labels":[],"label_agreement":null},{"id":"W2955100594","doi":"10.1016/j.jval.2019.04.1384","title":"PNS19 AN APPROACH TO EXAMINING GEOGRAPHIC VARIATION IN HEALTHCARE SPENDING AND UTILIZATION IN THE CANADIAN WORKERS COMPENSATION SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Work & Health; University of British Columbia","funders":"","keywords":"Health care; Incentive; Compensation (psychology); Business; Context (archaeology); Variation (astronomy); Work (physics); Economics; Economic growth; Geography; Psychology","score_opus":0.4016367580259676,"score_gpt":0.42661815371161355,"score_spread":0.024981395685645946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955100594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6424615,0.0014059779,0.032206707,0.005148389,0.0005134671,0.0040490716,0.23048738,0.0005826538,0.08314484],"genre_scores_gemma":[0.87154543,0.0009381636,0.048105873,0.0009266383,0.00014254592,0.00502704,0.04497114,0.00012349398,0.028219748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923798,0.0019068958,0.0005968098,0.0006555161,0.0031269493,0.0013340682],"domain_scores_gemma":[0.992002,0.0011237023,0.00085942185,0.0004953233,0.0049353363,0.0005843421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004442861,0.0007197847,0.00068665744,0.009949764,0.0047033895,0.0024494857,0.002517078,0.00044462338,0.006538751],"category_scores_gemma":[0.016372303,0.00048215452,0.0020872601,0.021754012,0.0009898283,0.0006640567,0.0028004728,0.0009993984,0.00042072078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014124702,0.00016216583,0.88809067,0.00032901057,0.0008193138,0.00025717242,0.0032879554,0.0033621495,0.00046934353,0.018958844,0.033417434,0.05070465],"study_design_scores_gemma":[0.00003081141,0.00008762718,0.9513965,0.00009864241,0.00016579611,0.0000634237,0.0066815647,0.0042070313,0.00037489727,0.0013907189,0.03546439,0.000038566275],"about_ca_topic_score_codex":0.9926127,"about_ca_topic_score_gemma":0.989165,"teacher_disagreement_score":0.97545004,"about_ca_system_score_codex":0.02454994,"about_ca_system_score_gemma":0.08083307,"threshold_uncertainty_score":0.17812312},"labels":[],"label_agreement":null},{"id":"W2955137575","doi":"10.1016/j.jval.2019.04.1837","title":"PSY12 COST BURDEN OF BREAKTHROUGH HEMOLYSIS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA ON ECULIZUMAB TREATMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Medicine; Hemoglobinuria; Dosing; Internal medicine; Hemolysis; Anemia; Gastroenterology; Surgery; Immunology; Complement system","score_opus":0.017046406412129688,"score_gpt":0.26013103467897464,"score_spread":0.24308462826684496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955137575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99191415,0.0042356146,0.00010180972,0.0009483671,0.000036982918,0.00000874803,0.001182552,0.0000075768207,0.0015641411],"genre_scores_gemma":[0.99839383,0.00062739546,0.000061362654,0.000074056545,0.000042962656,0.0000048416264,0.0005002558,0.0000017527617,0.00029354106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996326,0.00010890021,0.00003392073,0.000044394983,0.000080223275,0.000099891186],"domain_scores_gemma":[0.99942625,0.00012288414,0.00025450316,0.000020364125,0.000069006215,0.00010706121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027275234,0.000203971,0.00046914845,0.0003979275,0.00026740888,0.000669501,0.00024387284,0.0003829565,0.0034887898],"category_scores_gemma":[0.0015568295,0.00015204883,0.00071675784,0.0007815679,0.00011132257,0.0003512053,0.0002927844,0.0007974777,0.00017142062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064867437,0.00019223224,0.9105654,0.00024572227,0.001849578,0.0014049889,0.00010081634,0.0016461174,0.0009463505,0.0006843279,0.0046461103,0.07123165],"study_design_scores_gemma":[0.00011007648,0.00037320732,0.9928483,0.0000789105,0.00054182525,0.0014472986,0.00021474027,0.0024874262,0.000110258974,0.00027308048,0.0015032081,0.000011641143],"about_ca_topic_score_codex":0.013067673,"about_ca_topic_score_gemma":0.0129454415,"teacher_disagreement_score":0.013067673,"about_ca_system_score_codex":0.0013186799,"about_ca_system_score_gemma":0.0005972696,"threshold_uncertainty_score":0.025983214},"labels":[],"label_agreement":null},{"id":"W2955141130","doi":"10.1016/j.jval.2019.04.1775","title":"PSS3 LATANOPROSTENE BUNOD FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION: SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Dorzolamide; Travoprost; Bimatoprost; Brimonidine; Latanoprost; Medicine; Ocular hypertension; Timolol; Glaucoma; Intraocular pressure; Betaxolol; Ophthalmology; Meta-analysis; Cochrane Library; Placebo; Internal medicine","score_opus":0.06604684013103458,"score_gpt":0.32285602673916414,"score_spread":0.25680918660812957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955141130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015781524,0.98098975,0.0006816294,0.0003031156,0.0003774481,0.00021439782,0.0011206303,0.000036005946,0.00049552514],"genre_scores_gemma":[0.47662213,0.51431715,0.0027553835,0.0022063996,0.0006150496,0.0008215143,0.0016466804,0.00005672604,0.00095896155],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99352056,0.0025628088,0.001978608,0.0009212014,0.0006896803,0.00032713573],"domain_scores_gemma":[0.9929128,0.004391647,0.0016070068,0.0003528079,0.0005809024,0.00015471355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064936383,0.0019321662,0.010909683,0.004084633,0.0006351828,0.0027375007,0.0013496085,0.002030907,0.004875804],"category_scores_gemma":[0.015872808,0.0011484459,0.03360722,0.0047434033,0.00063650083,0.0015886689,0.0018568682,0.0019609923,0.00041984936],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004396364,0.000042293792,0.007293829,0.13495003,0.842161,0.00010037561,0.00005998298,0.00025342347,0.00033086885,0.00008946802,0.00057957065,0.009742814],"study_design_scores_gemma":[0.0012718597,0.00017919093,0.0047847475,0.005993928,0.98637265,0.000056160716,0.00003010826,0.00010753235,0.00007490627,0.00012745558,0.0009814847,0.00001996096],"about_ca_topic_score_codex":0.007826468,"about_ca_topic_score_gemma":0.022629565,"teacher_disagreement_score":0.010909683,"about_ca_system_score_codex":0.0015760567,"about_ca_system_score_gemma":0.0024486063,"threshold_uncertainty_score":0.03434205},"labels":[],"label_agreement":null},{"id":"W2955235983","doi":"10.1016/j.jval.2019.04.1569","title":"PNS212 AUTOMATING VARIABLE SELECTION IN META-REGRESSION","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Confidence interval; Covariate; Ranking (information retrieval); Statistics; Bayesian probability; Computer science; Meta-regression; Meta-analysis; Regression analysis; Regression; Feature selection; Machine learning; Artificial intelligence; Medicine; Mathematics; Internal medicine","score_opus":0.7890056633125838,"score_gpt":0.5528310360976231,"score_spread":0.23617462721496074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955235983","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069502364,0.00123781,0.8522238,0.0009576989,0.00044346604,0.0006401242,0.014849195,0.11898086,0.0037167019],"genre_scores_gemma":[0.049834777,0.0005822689,0.9220187,0.00038818206,0.00017849283,0.0013963211,0.011723051,0.008452039,0.0054262513],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9925855,0.0045852996,0.0009591834,0.00076813,0.000904245,0.00019770303],"domain_scores_gemma":[0.9530262,0.039255027,0.000886574,0.00433491,0.002236444,0.0002608067],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014573174,0.0023242293,0.0018644814,0.003794791,0.00083563867,0.0036699746,0.0021115036,0.0012287614,0.049049057],"category_scores_gemma":[0.08829428,0.0022107593,0.0039346446,0.0040628803,0.00040442153,0.0019286558,0.0032818534,0.0016928874,0.01954759],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019700418,0.00021846745,0.009189148,0.0030856445,0.0030514468,0.00040341893,0.0004080642,0.019407842,0.0029389672,0.013106693,0.1408207,0.80539966],"study_design_scores_gemma":[0.0033501931,0.00040003902,0.007926399,0.0009354212,0.0021103306,0.0006774712,0.0002579427,0.61250824,0.020987695,0.08224347,0.26837623,0.00022648834],"about_ca_topic_score_codex":0.0069774836,"about_ca_topic_score_gemma":0.017124472,"teacher_disagreement_score":0.98542684,"about_ca_system_score_codex":0.0008381599,"about_ca_system_score_gemma":0.0054477034,"threshold_uncertainty_score":0.16408539},"labels":[],"label_agreement":null},{"id":"W2955253476","doi":"10.1016/j.jval.2019.04.361","title":"PCN240 EVALUATING PARTITIONED SURVIVAL MODEL AND RESPONSE-BASED MODELING APPROACHES FOR USE IN COST-EFFECTIVENESS ANALYSIS: ESTIMATING AND VALIDATING SURVIVAL OUTCOMES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Sunitinib; Medicine; Survival analysis; Oncology; Progression-free survival; Internal medicine; Overall survival; Renal cell carcinoma; Statistics; Mathematics","score_opus":0.756340347782525,"score_gpt":0.4887053661435728,"score_spread":0.2676349816389522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955253476","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38815442,0.0012076063,0.57364535,0.0011744865,0.00026817262,0.002833593,0.013517174,0.0024487716,0.016750416],"genre_scores_gemma":[0.7487418,0.0004050536,0.23633915,0.00031451014,0.00004712964,0.0022813196,0.0087765595,0.00044233623,0.0026521625],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97874874,0.017954368,0.00057054,0.00095116853,0.0015038826,0.00027137104],"domain_scores_gemma":[0.8716761,0.11312964,0.0027017016,0.005138613,0.0068427473,0.0005112318],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.047323037,0.0012274933,0.0010157726,0.0013656105,0.00041218096,0.0012586946,0.001732378,0.0010468623,0.00958347],"category_scores_gemma":[0.13544008,0.000579678,0.0021322172,0.0012823849,0.00048450186,0.0010814834,0.001492381,0.001259408,0.00077397545],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046625636,0.0010905724,0.020987045,0.0010592177,0.0023313463,0.00012615926,0.00019676062,0.7643444,0.0007290374,0.013680799,0.011490877,0.17930128],"study_design_scores_gemma":[0.00043317818,0.00083862816,0.0036819791,0.0001164763,0.00027871644,0.000040506715,0.000046883557,0.9878583,0.0009549717,0.0036396503,0.0020877775,0.000023002178],"about_ca_topic_score_codex":0.027675629,"about_ca_topic_score_gemma":0.019323798,"teacher_disagreement_score":0.95267695,"about_ca_system_score_codex":0.0020222063,"about_ca_system_score_gemma":0.00451943,"threshold_uncertainty_score":0.25027108},"labels":[],"label_agreement":null},{"id":"W2955276946","doi":"10.1016/j.jval.2019.04.173","title":"PCN49 COST-EFFECTIVENESS MODEL COMPARING EXPANDED UMBILICAL CORD BLOOD TRANSPLANTS WITH OTHER HSCT STRATEGIES FOR PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège de Maisonneuve","funders":"","keywords":"Medicine; Umbilical cord; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Intensive care medicine; Immunology","score_opus":0.09297863822422445,"score_gpt":0.28282580944271085,"score_spread":0.1898471712184864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955276946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7403114,0.019389614,0.08233932,0.014698364,0.0011304871,0.0048203557,0.0338724,0.0004658457,0.102972284],"genre_scores_gemma":[0.97644186,0.001654963,0.005488822,0.00074658514,0.00009101941,0.0010371101,0.0026600682,0.000026988084,0.011852696],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99807465,0.0012710469,0.000054648568,0.00017881328,0.00011862808,0.00030217867],"domain_scores_gemma":[0.993299,0.005670146,0.0002967038,0.000083982566,0.00031428732,0.00033585532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041577737,0.0015309505,0.003284127,0.0014488146,0.0003763592,0.00191149,0.0022816218,0.0025874402,0.02688537],"category_scores_gemma":[0.010243569,0.0010048959,0.0031567959,0.0011321272,0.00078860245,0.0012173743,0.0009602037,0.0026772602,0.0008678094],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002852503,0.00026657194,0.0012234725,0.00040163586,0.0005576986,0.00013193185,0.000016922004,0.9805468,0.00015379993,0.003949448,0.0016735968,0.008225654],"study_design_scores_gemma":[0.0030932734,0.0024534545,0.0031392972,0.00034349613,0.0018283735,0.00020712812,0.00008506952,0.9800356,0.00027731745,0.0055923685,0.0029002149,0.000044343335],"about_ca_topic_score_codex":0.03723515,"about_ca_topic_score_gemma":0.014911231,"teacher_disagreement_score":0.03723515,"about_ca_system_score_codex":0.00452202,"about_ca_system_score_gemma":0.004346464,"threshold_uncertainty_score":0.08994049},"labels":[],"label_agreement":null},{"id":"W2955303878","doi":"10.1016/j.jval.2019.04.1379","title":"PNS13 DYNAMIC APPROACHES TO VISUALIZING HEOR DATA: TELLING A COMPLICATED NMA STORY, MORE SIMPLY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Diffusion and Forecasting","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Visualization; Computer science; Creative visualization; Data visualization; Field (mathematics); Data science; Data mining; Variety (cybernetics); Exploratory data analysis; Sample (material); Human–computer interaction; Artificial intelligence","score_opus":0.5844017364243129,"score_gpt":0.4599355204810647,"score_spread":0.12446621594324825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955303878","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034228344,0.0018481556,0.778122,0.10299797,0.0020952953,0.0001819304,0.014717718,0.009983996,0.055824548],"genre_scores_gemma":[0.3643052,0.002345135,0.60191965,0.004807184,0.00077359786,0.00041017157,0.005698338,0.0036726994,0.01606809],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99574786,0.002550078,0.00023782389,0.00047933307,0.0008012638,0.00018363503],"domain_scores_gemma":[0.9779137,0.014567826,0.0008565751,0.0031367524,0.0027482961,0.00077687996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009034267,0.0009658686,0.000726669,0.0031951137,0.001754444,0.01138317,0.002019529,0.0025914807,0.018914731],"category_scores_gemma":[0.045691576,0.0007953971,0.0011998134,0.0046462896,0.0034098446,0.01749042,0.005024808,0.006125625,0.0031409573],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034355838,0.0001024966,0.014838926,0.00094667973,0.00019340713,0.00042556488,0.011979283,0.021796675,0.0040547145,0.5220129,0.19395393,0.22935191],"study_design_scores_gemma":[0.00005109178,0.00006527799,0.0049137115,0.00063819636,0.000052733918,0.00033215678,0.0076183146,0.10009549,0.0038869062,0.52630836,0.35583752,0.00020025381],"about_ca_topic_score_codex":0.016721787,"about_ca_topic_score_gemma":0.018443536,"teacher_disagreement_score":0.018914731,"about_ca_system_score_codex":0.0019867008,"about_ca_system_score_gemma":0.002252053,"threshold_uncertainty_score":0.06327605},"labels":[],"label_agreement":null},{"id":"W2955315974","doi":"10.1016/j.jval.2019.04.1342","title":"PND69 MIGRAINE PROPHYLAXIS WITH VITAMINS AND MINERALS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Migraine; Medicine; Placebo; Randomized controlled trial; Meta-analysis; Adverse effect; Clinical trial; Internal medicine; Physical therapy; Crossover study; Alternative medicine","score_opus":0.2477587662814493,"score_gpt":0.43353778030669543,"score_spread":0.18577901402524613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955315974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044334135,0.9941467,0.00035190303,0.0001145532,0.000125034,0.00027161365,0.00034291888,0.00002086159,0.00019298056],"genre_scores_gemma":[0.12901849,0.86564696,0.0026783377,0.0009542009,0.0002087135,0.0005839904,0.00050364324,0.000024754598,0.00038090275],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9947924,0.002030732,0.0017720099,0.0005745927,0.0006145069,0.00021567394],"domain_scores_gemma":[0.991943,0.005515008,0.001709696,0.00025023153,0.00043225085,0.0001499697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072665745,0.002469439,0.016814813,0.003933434,0.00059091847,0.0027051433,0.0018441614,0.002358434,0.0059509957],"category_scores_gemma":[0.021075204,0.0014130642,0.02586994,0.0048346813,0.00089438807,0.0017521415,0.0018458264,0.0023688066,0.00034165004],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004552462,0.00004753746,0.0019247918,0.5354092,0.43889004,0.00010641151,0.00008078802,0.00026802454,0.00028389285,0.000121717254,0.0005850111,0.01773021],"study_design_scores_gemma":[0.0026519606,0.0002705762,0.0028946607,0.029074831,0.96284,0.00008529987,0.0000489615,0.00010688955,0.00008986918,0.00016763296,0.0017436165,0.000025604118],"about_ca_topic_score_codex":0.00664448,"about_ca_topic_score_gemma":0.021662097,"teacher_disagreement_score":0.016814813,"about_ca_system_score_codex":0.0019186009,"about_ca_system_score_gemma":0.003240077,"threshold_uncertainty_score":0.038429797},"labels":[],"label_agreement":null},{"id":"W2955317597","doi":"10.1016/j.jval.2019.04.459","title":"PCV23 HEALTHCARE RESOURCE USE AND COSTS FOLLOWING CATHETER ABLATION IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) PATIENTS AGE <65","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Ablation; Catheter ablation; Tachycardia; Catheter; Cardiology; Emergency medicine; Internal medicine; Surgery","score_opus":0.020741366614907712,"score_gpt":0.27031944291054566,"score_spread":0.24957807629563794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955317597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521035,0.000979735,0.0000423185,0.00039276545,0.000021963679,0.000010149914,0.0015382852,0.0000028245754,0.0018016202],"genre_scores_gemma":[0.9983303,0.00035477953,0.00003225064,0.00007209138,0.000029773706,0.000009000304,0.0008443445,0.0000014733241,0.000325994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995665,0.000101499936,0.0000613568,0.000049189373,0.00007902817,0.0001423905],"domain_scores_gemma":[0.9987515,0.00030495872,0.00054138905,0.000034906738,0.00008535981,0.00028186594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025179127,0.00016225934,0.00031078586,0.00071763236,0.0003119647,0.0010821095,0.0003269126,0.0005306724,0.003970018],"category_scores_gemma":[0.0033812886,0.00012619763,0.0011315488,0.0011514226,0.00015896859,0.00072404015,0.00058405317,0.00085888227,0.00026827736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005207268,0.00015474629,0.98696136,0.00005998154,0.00034082943,0.00033411942,0.00009867484,0.0006480391,0.00008720607,0.000222878,0.0009595829,0.009611775],"study_design_scores_gemma":[0.000016454815,0.00016625336,0.9974657,0.000044905344,0.000086232445,0.00030250536,0.0004202662,0.00079463364,0.000030663316,0.00018411383,0.00047869192,0.000009605416],"about_ca_topic_score_codex":0.021650288,"about_ca_topic_score_gemma":0.0262488,"teacher_disagreement_score":0.021650288,"about_ca_system_score_codex":0.0011396805,"about_ca_system_score_gemma":0.0007589788,"threshold_uncertainty_score":0.04304856},"labels":[],"label_agreement":null},{"id":"W2955329712","doi":"10.1016/j.jval.2019.04.165","title":"PCN41 THE HEALTH UTILITY BOOK (HUB): A REGISTRY OF HEALTH STATE UTILITY VALUES IN ONCOLOGY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Institute of Health Economics; Toronto Public Health; McMaster University","funders":"","keywords":"Systematic review; Health technology; Medicine; Actuarial science; MEDLINE; Operations research; Health care; Business; Engineering; Economics","score_opus":0.42942051057808245,"score_gpt":0.4589360608112073,"score_spread":0.029515550233124854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955329712","genre_codex":"dataset","genre_gemma":"dataset","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"dataset","genre_consensus":"dataset","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015798029,0.0015916263,0.008473012,0.00072181283,0.00014277679,0.00050722924,0.89910996,0.0040562632,0.0695993],"genre_scores_gemma":[0.06407092,0.0024853542,0.011386549,0.00038570518,0.0001949554,0.0011512263,0.88085747,0.0018607245,0.037607115],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976866,0.00059070106,0.0003974463,0.00022370668,0.0009406051,0.0001608087],"domain_scores_gemma":[0.97380644,0.010937783,0.0039002155,0.00362283,0.0060619684,0.0016708518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003668556,0.00072164944,0.0010173556,0.009769847,0.00059579476,0.0026617027,0.001213036,0.0007620495,0.057542082],"category_scores_gemma":[0.035218038,0.00055723306,0.00037815777,0.020999406,0.00043665915,0.0024386146,0.0015900226,0.0016426968,0.027530886],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046946213,0.00011709454,0.027445173,0.00042233322,0.00005762372,0.00008332899,0.000103623635,0.0025532783,0.00013959278,0.009565486,0.8332376,0.12580536],"study_design_scores_gemma":[0.00025350956,0.000118297896,0.060527194,0.0004407874,0.00006190199,0.0004273833,0.00010612349,0.0042786226,0.0014815645,0.0072439467,0.9249674,0.00009338689],"about_ca_topic_score_codex":0.015957812,"about_ca_topic_score_gemma":0.010490671,"teacher_disagreement_score":0.057542082,"about_ca_system_score_codex":0.0016071881,"about_ca_system_score_gemma":0.0059556686,"threshold_uncertainty_score":0.19249743},"labels":[],"label_agreement":null},{"id":"W2955338367","doi":"10.1016/j.jval.2019.04.803","title":"PIH2 DEVELOPMENT AND VALIDATION OF A PATIENT CENTERED OUTCOME MEASURE FOR USE IN DEMENTIA DRUG TRIALS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Dementia; Clinical trial; Donepezil; Clinical Dementia Rating; Vascular dementia; Drug trial; Medicine; Construct validity; Content validity; Psychology; Clinical Global Impression; Clinical psychology; Physical therapy; Disease; Psychiatry; Psychometrics; Internal medicine; Alternative medicine; Pathology","score_opus":0.6179477531647908,"score_gpt":0.4426310976051971,"score_spread":0.1753166555595937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955338367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6568649,0.0064234985,0.19990304,0.014068772,0.0021950267,0.032928012,0.039312486,0.0023190752,0.045985222],"genre_scores_gemma":[0.726906,0.0016392556,0.20418379,0.0024473357,0.0008363392,0.039123114,0.01947027,0.00036365684,0.005030242],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96520776,0.022495301,0.002808866,0.0011912126,0.0075246617,0.0007722058],"domain_scores_gemma":[0.9329157,0.03988033,0.008002657,0.00398143,0.0135377785,0.0016822284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0762569,0.0007448863,0.0013716285,0.001656108,0.0005492158,0.0032425325,0.0013541618,0.0011410698,0.0058052395],"category_scores_gemma":[0.09508762,0.00040382674,0.0018775755,0.0018833786,0.00064109615,0.0014713269,0.0019418353,0.0017912767,0.001218137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03320827,0.003074239,0.20082065,0.0029543312,0.0051009115,0.0002930896,0.0008331652,0.009273018,0.004850956,0.016486049,0.051349185,0.6717561],"study_design_scores_gemma":[0.025404643,0.032537784,0.61231303,0.002315144,0.006792054,0.0013630611,0.0006360137,0.089903355,0.0315044,0.027263667,0.16948019,0.00048667163],"about_ca_topic_score_codex":0.0012590201,"about_ca_topic_score_gemma":0.0017035389,"teacher_disagreement_score":0.0762569,"about_ca_system_score_codex":0.0015650026,"about_ca_system_score_gemma":0.005406618,"threshold_uncertainty_score":0.40328985},"labels":[],"label_agreement":null},{"id":"W2955368946","doi":"10.1016/j.jval.2019.04.340","title":"PCN218 PHYSICIAN ATTITUDES AND TREATMENT PATTERNS IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) IN CANADA AND EUROPE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sorafenib; Medicine; Family medicine; CHAID; Hepatocellular carcinoma; Guideline; Internal medicine; Oncology","score_opus":0.030896579803201953,"score_gpt":0.22386614706433408,"score_spread":0.19296956726113212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955368946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99332386,0.0008363859,0.00004392899,0.0005862544,0.000012950781,0.000008780118,0.002724174,0.0000054697393,0.0024580962],"genre_scores_gemma":[0.99680495,0.00047414264,0.00004047547,0.00008820789,0.000007538818,0.00000309242,0.0013257449,0.0000051065244,0.0012509542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990957,0.000087534296,0.00006948506,0.000107434345,0.00023413199,0.00040578956],"domain_scores_gemma":[0.9964212,0.00025044577,0.00068929855,0.000061795305,0.001292181,0.0012850016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005505736,0.00019614861,0.00029417808,0.0019912603,0.0014214484,0.001367568,0.00074875547,0.00061550323,0.0035193309],"category_scores_gemma":[0.002964459,0.00021849523,0.00068147335,0.004772735,0.0006645819,0.0004153239,0.00077824795,0.0007759077,0.0002795183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008340227,0.00003145326,0.9960665,0.000012162458,0.000035283705,0.000069138034,0.00029242784,0.0001682354,0.000047858008,0.0001461086,0.0005916093,0.002455803],"study_design_scores_gemma":[0.000003407162,0.000008973603,0.9981852,0.0000131536635,0.000009440802,0.00004257704,0.0008955839,0.00016733489,0.000023620054,0.000021553342,0.00062361703,0.000005565799],"about_ca_topic_score_codex":0.990004,"about_ca_topic_score_gemma":0.9905511,"teacher_disagreement_score":0.020857614,"about_ca_system_score_codex":0.020857614,"about_ca_system_score_gemma":0.020330586,"threshold_uncertainty_score":0.15133333},"labels":[],"label_agreement":null},{"id":"W2955447147","doi":"10.1016/j.jval.2019.04.424","title":"PCN306 REAL-WORLD STUDY OF HEALTHCARE UTILIZATION AND LONG-TERM PRODUCTIVITY LOSS IN CHRONIC GRAFT VERSUS HOST DISEASE IN SWEDEN","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Internal medicine; Disease; Incidence (geometry); Population; Extracorporeal Photopheresis","score_opus":0.12275267947926925,"score_gpt":0.42146343937160263,"score_spread":0.29871075989233337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955447147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960795,0.000280838,0.00007012237,0.00005631053,0.000014838304,0.00001991148,0.003011448,0.0000040342484,0.00046302492],"genre_scores_gemma":[0.9935713,0.0002618515,0.0001034226,0.00005182062,0.000021962791,0.00007629854,0.004791562,0.00000739368,0.0011144147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987589,0.0006099915,0.00013991178,0.00014142525,0.00011427403,0.0002354925],"domain_scores_gemma":[0.9982401,0.000433405,0.00045461254,0.00020152428,0.0002689168,0.00040148353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011121273,0.00061658595,0.00076504983,0.0017040077,0.001024877,0.0017927769,0.0007575127,0.0011048533,0.0026325278],"category_scores_gemma":[0.0026466125,0.0006620134,0.0013459687,0.0028167446,0.0004362768,0.0006168458,0.0013388463,0.0011462261,0.00085574127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000987633,0.0002600815,0.9943561,0.00007790184,0.00051999284,0.0003227239,0.00044149006,0.0002760304,0.00010310165,0.000052994696,0.0009597491,0.0016420962],"study_design_scores_gemma":[0.000061482104,0.00022913562,0.9967272,0.000051592775,0.0001395675,0.00017932979,0.0012485541,0.0002998561,0.000042589723,0.000024468836,0.0009786807,0.000017409813],"about_ca_topic_score_codex":0.106559485,"about_ca_topic_score_gemma":0.07259037,"teacher_disagreement_score":0.106559485,"about_ca_system_score_codex":0.0013389386,"about_ca_system_score_gemma":0.0016629953,"threshold_uncertainty_score":0.21187848},"labels":[],"label_agreement":null},{"id":"W2955516289","doi":"10.1016/j.jval.2019.04.1395","title":"PNS33 BUGSNET: A NEW COMPREHENSIVE R PACKAGE FOR NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Waterloo","funders":"","keywords":"Computer science; Systematic review; Best practice; Completeness (order theory); Data science; MEDLINE; Mathematics","score_opus":0.8786727326830011,"score_gpt":0.5574297508011428,"score_spread":0.3212429818818583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955516289","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004081794,0.0034299768,0.4641463,0.0020334725,0.0016022882,0.0012282967,0.18112406,0.33441412,0.007939674],"genre_scores_gemma":[0.04458829,0.0032763602,0.6669506,0.0024087403,0.00071847404,0.012555008,0.073582426,0.18178174,0.014138367],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99340534,0.003986574,0.0008227615,0.0008549069,0.00067715376,0.0002532171],"domain_scores_gemma":[0.94372135,0.047636934,0.0018479446,0.004070479,0.0020695522,0.0006537424],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011119385,0.004935617,0.004237046,0.0051547545,0.0009626605,0.004113116,0.004125959,0.0018335468,0.13118856],"category_scores_gemma":[0.07896852,0.0035304807,0.007120893,0.0038464644,0.0008718868,0.0024988533,0.0052390904,0.0038311349,0.04377735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023859565,0.00023790049,0.008477873,0.017645925,0.014941682,0.00088179886,0.0007550713,0.028378759,0.0025534476,0.027438793,0.7549321,0.1413707],"study_design_scores_gemma":[0.0063519115,0.0004370595,0.006798189,0.003649504,0.0104268035,0.0013638084,0.00019527262,0.13516067,0.0062002707,0.1333583,0.69538355,0.0006746421],"about_ca_topic_score_codex":0.0059140003,"about_ca_topic_score_gemma":0.009640984,"teacher_disagreement_score":0.98888063,"about_ca_system_score_codex":0.0014357844,"about_ca_system_score_gemma":0.0055381134,"threshold_uncertainty_score":0.43886942},"labels":[],"label_agreement":null},{"id":"W2955532382","doi":"10.1016/j.jval.2019.04.552","title":"PDB2 COMPARATIVE EFFICACY AND SAFETY OF PHARMACOTHERAPIES FOR THE TREATMENT OF OBESITY AMONG ADULTS: A SYSTEMATLIC LITERATURE AND NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Phentermine; Orlistat; Liraglutide; Bupropion; Placebo; Topiramate; Overweight; Internal medicine; Meta-analysis; Subgroup analysis; Adverse effect; Obesity; Weight loss; Type 2 diabetes; Diabetes mellitus; Smoking cessation; Endocrinology; Epilepsy; Psychiatry","score_opus":0.08286185006423652,"score_gpt":0.3746949147785509,"score_spread":0.29183306471431436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955532382","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19410735,0.7835118,0.0074647143,0.0015657715,0.0014128485,0.00068430405,0.006978826,0.00021357692,0.0040609012],"genre_scores_gemma":[0.9419545,0.048591368,0.003399341,0.0012917599,0.00050148024,0.0005921546,0.0021245272,0.00009106786,0.0014537713],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9869731,0.008156683,0.001859081,0.0015959956,0.001003373,0.00041178658],"domain_scores_gemma":[0.9810627,0.014095722,0.0022974508,0.0013350513,0.00093047734,0.00027862046],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.012516004,0.0018803093,0.0070616254,0.003164771,0.00069803005,0.0030397926,0.0014689105,0.0021864478,0.0064390544],"category_scores_gemma":[0.03204432,0.0010753747,0.029415315,0.0035881428,0.00080094254,0.0013398647,0.0021842779,0.0026326429,0.0005083416],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013575771,0.000046179583,0.015305425,0.017746938,0.94676334,0.00006533329,0.00005962579,0.00043753255,0.0002962524,0.0001948116,0.0005130517,0.0049958187],"study_design_scores_gemma":[0.003496471,0.00033085266,0.009756865,0.0010441391,0.9832622,0.00005937023,0.000039540915,0.00037192664,0.00012452518,0.0003472982,0.0011464164,0.000020339814],"about_ca_topic_score_codex":0.007059459,"about_ca_topic_score_gemma":0.010584637,"teacher_disagreement_score":0.9929384,"about_ca_system_score_codex":0.0012749915,"about_ca_system_score_gemma":0.0011308813,"threshold_uncertainty_score":0.06619173},"labels":[],"label_agreement":null},{"id":"W2955595457","doi":"10.1016/j.jval.2019.04.158","title":"PCN34 MAKING WORDS COUNT: OPPORTUNITIES FOR INNOVATION IN HEALTH TECHNOLOGY ASSESSMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Takeda (Canada); St. Michael's Hospital","funders":"","keywords":"Qualitative research; Multidisciplinary approach; Health technology; Health care; Management science; Qualitative property; Medicine; Knowledge management; Engineering ethics; Psychology; Sociology; Computer science; Social science; Economic growth; Engineering; Economics","score_opus":0.6319355951142256,"score_gpt":0.4943120994513966,"score_spread":0.137623495662829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955595457","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009633758,0.014430234,0.00369017,0.09645953,0.091980755,0.00017486615,0.00304492,0.0006191348,0.788637],"genre_scores_gemma":[0.019052608,0.015404699,0.0034726898,0.013692655,0.062649414,0.00024768006,0.0017343267,0.00072129414,0.8830246],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9949315,0.0013449531,0.000536064,0.00072930707,0.0021282937,0.00032986188],"domain_scores_gemma":[0.944372,0.01915805,0.0024839074,0.0022996962,0.0239034,0.0077828923],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0047220318,0.0009849233,0.0016313306,0.0042651044,0.0017843685,0.011392876,0.0020195232,0.005972469,0.52674395],"category_scores_gemma":[0.043756366,0.00050045055,0.00044611123,0.0045894133,0.002118767,0.005983653,0.0031149122,0.0042910553,0.33152917],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043623415,0.000017269864,0.00025793287,0.00033422056,0.0000051727293,0.00003432555,0.000019965893,0.000080290774,0.00008235472,0.0064056227,0.8890466,0.103672676],"study_design_scores_gemma":[0.000021266394,0.00002519486,0.0014859618,0.00083360035,0.000010140662,0.00009587605,0.00007915196,0.00040453827,0.00015898133,0.010005737,0.9868564,0.000023144832],"about_ca_topic_score_codex":0.0033164078,"about_ca_topic_score_gemma":0.006270455,"teacher_disagreement_score":0.99527794,"about_ca_system_score_codex":0.003623787,"about_ca_system_score_gemma":0.004326625,"threshold_uncertainty_score":0.6750423},"labels":[],"label_agreement":null},{"id":"W2955606396","doi":"10.1016/j.jval.2019.04.913","title":"PIN43 THE ECONOMIC BURDEN OF ANTIMICROBIAL RESISTANCE: RESULTS FROM A TARGETED LITERATURE REVIEW","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Antimicrobial stewardship; Medicine; Acinetobacter; Antibiotic resistance; Economic cost; Economic impact analysis; Health care; Intensive care medicine; Indirect costs; Environmental health; Business; Economic growth; Biology; Economics; Microbiology","score_opus":0.012498447355532323,"score_gpt":0.24706080147555648,"score_spread":0.23456235412002416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955606396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013508819,0.9617478,0.00043008997,0.00754358,0.0005161956,0.0001456866,0.005638716,0.000024480596,0.010444468],"genre_scores_gemma":[0.044278648,0.9500064,0.0008357468,0.0022515035,0.00037255167,0.00010502881,0.0015423299,0.000020695114,0.00058703043],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99699956,0.00078247424,0.0007608494,0.00023138434,0.0010018246,0.00022387969],"domain_scores_gemma":[0.9715486,0.019796697,0.0041673672,0.00033156603,0.0037235552,0.0004322824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047166185,0.0005972785,0.0013098713,0.022497699,0.00048745266,0.003535888,0.00065399567,0.0013204337,0.00931523],"category_scores_gemma":[0.02220856,0.00042281067,0.0025219577,0.028148213,0.000698085,0.0024954397,0.0020474663,0.00087843987,0.0013857002],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000924557,0.0001636995,0.024960896,0.29390475,0.004536473,0.0018230522,0.0024131187,0.00079434994,0.0009779327,0.008493259,0.056448333,0.60455954],"study_design_scores_gemma":[0.00015232216,0.00026292517,0.08516829,0.48096335,0.022086354,0.00296139,0.005271322,0.0003294058,0.0008035396,0.0037084476,0.39818484,0.00010784204],"about_ca_topic_score_codex":0.0064300247,"about_ca_topic_score_gemma":0.013291393,"teacher_disagreement_score":0.022497699,"about_ca_system_score_codex":0.0024895214,"about_ca_system_score_gemma":0.011495827,"threshold_uncertainty_score":0.0311625},"labels":[],"label_agreement":null},{"id":"W2955796504","doi":"10.1016/j.jval.2019.04.196","title":"PCN72 COST OF MANAGING METASTATIC BLADDER CANCER WITH THE INTRODUCTION OF IMMUNOTHERAPIES FROM A CANADIAN HEALTHCARE PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Docetaxel; Pembrolizumab; Gemcitabine; Medicine; Atezolizumab; Oncology; Adverse effect; Internal medicine; Paclitaxel; Carboplatin; Prostate cancer; Metastatic Urothelial Carcinoma; Cisplatin; Bladder cancer; Cancer; Immunotherapy; Chemotherapy; Urothelial carcinoma","score_opus":0.02545748039092295,"score_gpt":0.30961575421447696,"score_spread":0.284158273823554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955796504","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23114063,0.105525956,0.0030574126,0.38145822,0.0030757082,0.00031594586,0.036844935,0.00018284122,0.23839836],"genre_scores_gemma":[0.9184728,0.045675658,0.003031535,0.011597662,0.0013602844,0.00008249326,0.006404547,0.00005724078,0.013317624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960508,0.00063625246,0.00014218812,0.00016655338,0.0020231055,0.000981199],"domain_scores_gemma":[0.99335206,0.0006613428,0.00064786355,0.000055055792,0.0033973441,0.0018862366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014457123,0.0005341351,0.0006458686,0.0017738213,0.0016585885,0.0030591586,0.0012524179,0.001570971,0.011707169],"category_scores_gemma":[0.009143324,0.00028920168,0.0021907685,0.0033085318,0.0007416575,0.00082377344,0.0009680027,0.00295279,0.00047078583],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038998711,0.000495566,0.1173633,0.0031974462,0.0032946942,0.0018054373,0.0011919235,0.036646694,0.0015842897,0.091405004,0.3315267,0.40758908],"study_design_scores_gemma":[0.0009962121,0.0011226197,0.42825323,0.0059379307,0.0044153533,0.0031973673,0.00476918,0.021636846,0.00112645,0.012574754,0.5154914,0.00047870947],"about_ca_topic_score_codex":0.9699573,"about_ca_topic_score_gemma":0.9783448,"teacher_disagreement_score":0.9070517,"about_ca_system_score_codex":0.09294832,"about_ca_system_score_gemma":0.11318806,"threshold_uncertainty_score":0.67439044},"labels":[],"label_agreement":null},{"id":"W2955805426","doi":"10.1016/j.jval.2019.04.1562","title":"PNS205 GENERATING A REALISTIC SIMULATED ADMINISTRATIVE CLAIMS DATASET FOR DRUG SAFETY AND EFFECTIVENESS RESEARCH AND TRAINING","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Manitoba","funders":"","keywords":"Interquartile range; Observational study; Concordance; Medicine; Confidence interval; Population; Medical record; Drug; Statistics; Drug-drug interaction; Internal medicine; Environmental health; Mathematics; Pharmacology","score_opus":0.6980787133271151,"score_gpt":0.5421506316945964,"score_spread":0.1559280816325187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955805426","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8008085,0.0005125953,0.027318276,0.00466457,0.00046885866,0.0006268206,0.15193003,0.002262864,0.011407563],"genre_scores_gemma":[0.8603026,0.0002393666,0.024880601,0.0007059883,0.00010276225,0.00081415183,0.1081838,0.00020101498,0.0045695812],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998993,0.0006038168,0.000046395402,0.00015777364,0.00009931014,0.000099663375],"domain_scores_gemma":[0.98650485,0.0109017305,0.0004455046,0.0009095247,0.00089494063,0.00034347895],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002904428,0.0007061374,0.0007048005,0.0011502572,0.00058849575,0.0010318687,0.0020190524,0.0027762346,0.0101589495],"category_scores_gemma":[0.014647052,0.00074226025,0.0016237653,0.0015049723,0.0006564069,0.0006284868,0.0005980531,0.0016409977,0.0015348105],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089152146,0.0005516323,0.021015551,0.00024575926,0.00025950023,0.00047372194,0.0000968397,0.9275509,0.0003388164,0.006428076,0.034731347,0.007416217],"study_design_scores_gemma":[0.000816257,0.00019772342,0.008240991,0.00006047253,0.0000650972,0.00017816667,0.000082941755,0.9768336,0.00042140545,0.006484168,0.0065755905,0.000043575965],"about_ca_topic_score_codex":0.040022675,"about_ca_topic_score_gemma":0.04154453,"teacher_disagreement_score":0.9970956,"about_ca_system_score_codex":0.0020297447,"about_ca_system_score_gemma":0.0022135845,"threshold_uncertainty_score":0.07957941},"labels":[],"label_agreement":null},{"id":"W2956015350","doi":"10.1016/j.jval.2019.04.766","title":"PDG87 DRUG UTILIZATION IN PERSISTENT NAMD PATIENTS TREATED WITH LICENSED ANTI-VEGFS IN CANADA: A REAL WORLD STUDY USING THE ONTARIO PUBLIC CLAIMS DATABASE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Aflibercept; Ranibizumab; Medicine; Cohort; Macular degeneration; Retrospective cohort study; Dosing; Cohort study; Medical prescription; Bevacizumab; Pediatrics; Internal medicine; Pro re nata; Ophthalmology; Pharmacology; Chemotherapy","score_opus":0.20157718155231333,"score_gpt":0.2979772143020565,"score_spread":0.09640003274974315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956015350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.970746,0.0019663067,0.0001555723,0.0011173056,0.00002256411,0.00010292649,0.023545455,0.000018776529,0.0023252228],"genre_scores_gemma":[0.99093294,0.0011217677,0.00023910339,0.00036561963,0.00002079534,0.000035400488,0.006450567,0.000010695318,0.0008232171],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788386,0.00018234274,0.00021664397,0.0002786519,0.00080734474,0.00063110364],"domain_scores_gemma":[0.9921272,0.0006870602,0.0029468325,0.00025750016,0.0024450445,0.0015363689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009994084,0.0004577442,0.0008367307,0.0019366052,0.0020691592,0.002596322,0.0016162021,0.00096171716,0.0023837457],"category_scores_gemma":[0.005689353,0.0006418723,0.0014443975,0.008908928,0.0010491662,0.00085173437,0.0012409112,0.0015885873,0.00027009752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002770746,0.00009689987,0.99202347,0.00011269003,0.00025511096,0.00012587209,0.00046764835,0.0002789967,0.000075687036,0.00026057838,0.002923802,0.0031022779],"study_design_scores_gemma":[0.000046373694,0.00004310455,0.9958675,0.00008316388,0.00012987814,0.00009736937,0.0009567477,0.0010894582,0.00004424557,0.000044483986,0.0015714568,0.000026337773],"about_ca_topic_score_codex":0.99406993,"about_ca_topic_score_gemma":0.9950481,"teacher_disagreement_score":0.053493198,"about_ca_system_score_codex":0.053493198,"about_ca_system_score_gemma":0.047785662,"threshold_uncertainty_score":0.38812214},"labels":[],"label_agreement":null},{"id":"W2956079173","doi":"10.1016/j.jval.2019.04.919","title":"PIN49 EXAMINING THE CLINICAL AND ECONOMIC IMPACT OF ANTIMICROBIAL RESISTANCE AT ACUTE CARE FACILITIES: A PRACTICAL TOOL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network; Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Antibiotic resistance; Klebsiella pneumonia; Intensive care medicine; Enterococcus faecalis; Pseudomonas aeruginosa; Pneumonia; Antimicrobial stewardship; Enterococcus faecium; Emergency medicine; Staphylococcus aureus; Internal medicine; Antibiotics; Microbiology; Biology","score_opus":0.04440263655330046,"score_gpt":0.3484250662317067,"score_spread":0.30402242967840626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956079173","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27263486,0.017576374,0.07991842,0.08450776,0.0034561313,0.0028637077,0.013486018,0.0014357393,0.524121],"genre_scores_gemma":[0.89393955,0.00888819,0.063653566,0.005725945,0.0012677567,0.0016938504,0.0023618755,0.0001542094,0.022315081],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950429,0.0023414,0.0003446368,0.00024129447,0.001665961,0.00036383304],"domain_scores_gemma":[0.98717284,0.0066298493,0.0016842211,0.00053164153,0.0031705268,0.000810834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065843584,0.0012218416,0.0009638389,0.004190048,0.0010010827,0.004765585,0.0015632757,0.0011637837,0.028365813],"category_scores_gemma":[0.026706891,0.0004949659,0.0008354823,0.0032762883,0.00078167365,0.0031259153,0.0038303302,0.0018013974,0.0030720937],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083585223,0.0010989931,0.25920638,0.0024122,0.0006837943,0.0017951205,0.00087785727,0.0019968073,0.0019689302,0.01775084,0.070521876,0.6408513],"study_design_scores_gemma":[0.000323459,0.0046295356,0.6494327,0.00449411,0.00093149126,0.005418218,0.011034538,0.014795096,0.008521868,0.090428956,0.20965102,0.00033904676],"about_ca_topic_score_codex":0.0024512678,"about_ca_topic_score_gemma":0.004543236,"teacher_disagreement_score":0.028365813,"about_ca_system_score_codex":0.0014089945,"about_ca_system_score_gemma":0.0028214224,"threshold_uncertainty_score":0.0948931},"labels":[],"label_agreement":null},{"id":"W2956090666","doi":"10.1016/j.jval.2019.04.1079","title":"PMH34 LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Medical prescription; Polypharmacy; Antidepressant; Defined daily dose; Logistic regression; Cohort; Retrospective cohort study; Population; Pharmacoepidemiology; Cohort study; Psychiatry; Internal medicine; Environmental health; Pharmacology","score_opus":0.05257813352891314,"score_gpt":0.33475845587792147,"score_spread":0.2821803223490083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956090666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952427,0.0010903681,0.000104157676,0.00019303126,0.000020448773,0.00001958084,0.0019236528,0.000009030793,0.0013969669],"genre_scores_gemma":[0.99799,0.00036613733,0.000102843675,0.000059867143,0.000043249715,0.000017121205,0.0008418837,0.0000026121697,0.0005761758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996655,0.000059966675,0.000039901224,0.000041946492,0.00010411373,0.000088513676],"domain_scores_gemma":[0.9984394,0.00018934997,0.00085698284,0.000042001615,0.00014507503,0.0003272055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000297078,0.00025956726,0.00024931095,0.00090351136,0.0005004878,0.0007004687,0.00044569996,0.00052796054,0.0045232824],"category_scores_gemma":[0.001928965,0.00020173915,0.00052857056,0.0017656889,0.00019203148,0.0004152653,0.0004923912,0.0007972665,0.00044501052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057899488,0.000041434065,0.9975775,0.000011775666,0.000033081025,0.000055626573,0.000028827437,0.0000093628805,0.000081783386,0.000015444406,0.00021512066,0.0018721699],"study_design_scores_gemma":[0.0000014310643,0.000026127744,0.9995827,0.0000049397745,0.000008652814,0.00013374821,0.00005977119,0.000032136355,0.00001141589,0.00000877401,0.00012899685,0.0000012347374],"about_ca_topic_score_codex":0.009042111,"about_ca_topic_score_gemma":0.0078000235,"teacher_disagreement_score":0.009042111,"about_ca_system_score_codex":0.0003815037,"about_ca_system_score_gemma":0.00041240265,"threshold_uncertainty_score":0.017978966},"labels":[],"label_agreement":null},{"id":"W2957978461","doi":"10.1016/j.jval.2019.09.1207","title":"PIH26 JUVENILE IDIOPATHIC ARTHRITIS IS ASSOCIATED WITH CONSIDERABLE FINANCIAL BURDEN TO SOCIETY: RESULTS OF A DUTCH COST ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Formulary; Indirect costs; Cohort; Emergency medicine; Health care; Arthritis; Total cost; Pediatrics; Productivity; Family medicine; Accounting; Internal medicine","score_opus":0.06174097908282342,"score_gpt":0.3675661191720163,"score_spread":0.30582514008919287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957978461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97609144,0.0070935837,0.00066003046,0.00066690694,0.000025065083,0.00015094629,0.010513549,0.000004508681,0.0047939536],"genre_scores_gemma":[0.9853816,0.0043113325,0.0008363976,0.0001137102,0.00002129905,0.00014588877,0.007528167,0.000020558482,0.001641053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835277,0.0007987849,0.00019507165,0.00012582287,0.0003280826,0.00019951489],"domain_scores_gemma":[0.99775404,0.0011705527,0.00055651355,0.000079756996,0.0003107465,0.00012833804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001529945,0.0004977166,0.00085428497,0.001181928,0.00028757562,0.001107931,0.00046142464,0.00055561657,0.0048793266],"category_scores_gemma":[0.006252816,0.00032755744,0.0030924352,0.004089627,0.00026087402,0.00064826105,0.0005119018,0.00036015885,0.00027183772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011119822,0.0008095836,0.8366535,0.0043234588,0.012468393,0.003980128,0.00090767763,0.022096772,0.0010158144,0.0021731548,0.008611227,0.095840596],"study_design_scores_gemma":[0.0015768629,0.0008912025,0.9627123,0.0008896056,0.0070459927,0.0020402095,0.0016170236,0.01303369,0.0004408536,0.0007619646,0.008889637,0.000100646495],"about_ca_topic_score_codex":0.14915194,"about_ca_topic_score_gemma":0.14276628,"teacher_disagreement_score":0.14915194,"about_ca_system_score_codex":0.0053092483,"about_ca_system_score_gemma":0.0030659356,"threshold_uncertainty_score":0.2965675},"labels":[],"label_agreement":null},{"id":"W2967556947","doi":"10.1016/j.jval.2019.05.012","title":"A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist–Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia; University of Alberta; University of Calgary","funders":"Alberta Innovates; Alberta Health; Alberta Health Services; Sanofi","keywords":"Medicine; Pharmacy; Pharmacist; Intervention (counseling); Health care; Emergency medicine; Randomized controlled trial; Relative risk; Emergency department; Cost–benefit analysis; Health economics; Confidence interval; Family medicine; Public health; Internal medicine; Nursing","score_opus":0.24082409729051427,"score_gpt":0.45692213633212886,"score_spread":0.2160980390416146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967556947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9798631,0.0027849004,0.00666815,0.0011172423,0.00009893165,0.0024895275,0.003070362,0.00010275203,0.0038050213],"genre_scores_gemma":[0.99435693,0.0003676239,0.002820293,0.00016050407,0.000024247955,0.000369541,0.001249839,0.00000988021,0.0006410001],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9948716,0.0035976644,0.00011589382,0.00025661677,0.0006284178,0.00052983],"domain_scores_gemma":[0.99252945,0.0054931804,0.0004234874,0.00028816413,0.00071245106,0.0005532996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006978862,0.0021445723,0.0027397743,0.0020593305,0.0007497536,0.0021717676,0.0021320821,0.0017663857,0.0043814257],"category_scores_gemma":[0.013427523,0.0012214275,0.005160847,0.0021625545,0.001049577,0.0010097682,0.0015428176,0.0027763161,0.0001964522],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1528206,0.0098849,0.060422968,0.0025058934,0.012709147,0.00086852873,0.0002872925,0.6526142,0.0026348333,0.006043328,0.005809462,0.093398854],"study_design_scores_gemma":[0.034776635,0.029865388,0.10850363,0.0004500158,0.018162446,0.0005458715,0.0007770235,0.797972,0.0014307654,0.0041135973,0.003101253,0.00030148047],"about_ca_topic_score_codex":0.1902677,"about_ca_topic_score_gemma":0.10825184,"teacher_disagreement_score":0.8097323,"about_ca_system_score_codex":0.015188914,"about_ca_system_score_gemma":0.014108599,"threshold_uncertainty_score":0.3783204},"labels":[],"label_agreement":null},{"id":"W2971395672","doi":"10.1016/j.jval.2019.07.010","title":"The Joint Committee on Vaccination and Immunisation’s Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision?","year":2019,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Vaccination; Advice (programming); Human papillomavirus; Bent molecular geometry; Medicine; Joint (building); Virology; Family medicine; Operations research; Computer science; Engineering; Internal medicine","score_opus":0.44464417776986664,"score_gpt":0.5723809910731553,"score_spread":0.12773681330328868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971395672","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026021627,0.0067668636,0.00017533764,0.16325143,0.8285581,0.000047789177,0.00012936085,0.00003932635,0.0010057893],"genre_scores_gemma":[0.000467,0.0043267966,0.00031987973,0.13120878,0.8595461,0.00010757756,0.000055574208,0.00006432724,0.0039039638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95145655,0.014289831,0.007980666,0.0031790538,0.020487158,0.0026067717],"domain_scores_gemma":[0.7612907,0.15659906,0.010428194,0.0043160147,0.055210855,0.012155155],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.061780386,0.0057783066,0.012123823,0.008971936,0.0065783756,0.0169127,0.009774853,0.08255902,0.011315334],"category_scores_gemma":[0.19806303,0.003957905,0.00911185,0.0057786573,0.006757649,0.009147904,0.0030915826,0.08013541,0.009555654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005870224,0.000016559025,0.000022135144,0.00032283677,0.000057657882,0.000034081473,0.000018169643,0.000020807058,0.00001605666,0.00035382676,0.9962476,0.0028316278],"study_design_scores_gemma":[0.00062917423,0.0000641261,0.0005504303,0.0043396843,0.0006746072,0.00014811466,0.00011279064,0.0004086544,0.00016791483,0.004257639,0.9885384,0.000108458014],"about_ca_topic_score_codex":0.013839771,"about_ca_topic_score_gemma":0.02724553,"teacher_disagreement_score":0.9382196,"about_ca_system_score_codex":0.012484085,"about_ca_system_score_gemma":0.017768618,"threshold_uncertainty_score":0.32672977},"labels":[],"label_agreement":null},{"id":"W2978965473","doi":"10.1016/j.jval.2019.08.008","title":"Quebec Health-Related Quality-of-Life Population Norms Using the EQ-5D-5L: Decomposition by Sociodemographic Data and Health Problems","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"Social Sciences and Humanities Research Council of Canada","keywords":"Medicine; Demography; Confidence interval; Quality of life (healthcare); Disadvantaged; Population; Interquartile range; Gerontology; Environmental health","score_opus":0.5531132612288412,"score_gpt":0.457097136029606,"score_spread":0.09601612519923519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978965473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45199066,0.0031211197,0.03212669,0.002657364,0.00039962237,0.0016057118,0.44567215,0.0009940636,0.06143256],"genre_scores_gemma":[0.76423335,0.0011456772,0.026748395,0.00049703073,0.000062473664,0.0022444022,0.17422329,0.00024856243,0.030596787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978435,0.00058607484,0.0001798576,0.00026495708,0.00092756544,0.00019800152],"domain_scores_gemma":[0.99586993,0.00040243435,0.000343743,0.00020743597,0.0030008848,0.00017557848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028359825,0.00046321427,0.00065987813,0.0031195679,0.00094683794,0.0015196819,0.0014120787,0.0003029867,0.007928657],"category_scores_gemma":[0.00842566,0.00021879356,0.0008290704,0.0044678263,0.00039773487,0.0005823219,0.00070931204,0.0009321359,0.0007464113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043971435,0.00024240273,0.710028,0.0003388106,0.00094958005,0.00014832386,0.0011043159,0.007671011,0.0004647056,0.01267582,0.1467133,0.11922396],"study_design_scores_gemma":[0.00007146673,0.00005505919,0.95277226,0.00013773801,0.000097646654,0.00007846024,0.0005402502,0.008815282,0.0003170103,0.00075247197,0.036304697,0.000057593672],"about_ca_topic_score_codex":0.9749952,"about_ca_topic_score_gemma":0.9782939,"teacher_disagreement_score":0.025004804,"about_ca_system_score_codex":0.017277306,"about_ca_system_score_gemma":0.010047046,"threshold_uncertainty_score":0.12535626},"labels":[],"label_agreement":null},{"id":"W2979237484","doi":"10.1016/j.jval.2018.09.2607","title":"PSY30 - INCIDENCE AND PREVALENCE OF NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN US MEDICARE, 2008-2015","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Incidence (geometry); Nontuberculous mycobacteria; Demography; Lung disease; Pediatrics; Internal medicine; Tuberculosis; Lung; Pathology","score_opus":0.022459743634765186,"score_gpt":0.3404490655037625,"score_spread":0.31798932186899737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979237484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9747362,0.0011815635,0.00013009208,0.00043470337,0.000029534707,0.00002145127,0.021622553,0.000025083022,0.0018188094],"genre_scores_gemma":[0.9899809,0.00033721593,0.000068428664,0.00010074991,0.00001744469,0.000014948368,0.008732509,0.000003166959,0.00074450206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991309,0.00013937327,0.00014024312,0.00017158188,0.00019381421,0.00022418417],"domain_scores_gemma":[0.9968015,0.00023421449,0.0019855385,0.00007648114,0.00040783972,0.00049445295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078194414,0.00023531143,0.00028290742,0.0014439746,0.0003438549,0.000724755,0.0006844566,0.00064251403,0.003092703],"category_scores_gemma":[0.0038098542,0.00024208923,0.00074493885,0.001884747,0.00024678846,0.00079179025,0.00113228,0.0005795648,0.000440685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006049911,0.000017416283,0.9977502,0.000019148561,0.000056075343,0.000020983261,0.00004165588,0.00006497501,0.000056456374,0.00004351985,0.00091219007,0.0009569069],"study_design_scores_gemma":[0.0000020699397,0.00001853992,0.99939823,0.000010889965,0.000009531699,0.00004899524,0.00008675099,0.00010230834,0.000016041857,0.0000114029035,0.00029378786,0.0000014329605],"about_ca_topic_score_codex":0.07981645,"about_ca_topic_score_gemma":0.09704603,"teacher_disagreement_score":0.07981645,"about_ca_system_score_codex":0.0009996507,"about_ca_system_score_gemma":0.0010108959,"threshold_uncertainty_score":0.15870374},"labels":[],"label_agreement":null},{"id":"W2979346316","doi":"10.1016/j.jval.2019.08.004","title":"Development of System Performance Indicators for Adolescent and Young Adult Cancer Care and Control in Canada","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; CancerCare Manitoba; Ottawa Hospital; Izaak Walton Killam Health Centre; BC Children's Hospital; University of Toronto; Pediatric Oncology Group; SickKids Foundation; Canadian Hospice Palliative Care Association; Hospital for Sick Children; McMaster University","funders":"","keywords":"Ranking (information retrieval); Psychosocial; Delphi method; Benchmarking; Medicine; Multidisciplinary approach; Family medicine; Performance indicator; Computer science; Business; Artificial intelligence","score_opus":0.01719475353412628,"score_gpt":0.27802148955567296,"score_spread":0.26082673602154666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979346316","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85382843,0.0028806569,0.009930316,0.0045162193,0.00029429432,0.0029738238,0.08727629,0.0005284499,0.037771493],"genre_scores_gemma":[0.9629986,0.0010656611,0.011810128,0.00019487938,0.000019870151,0.0010168193,0.019760938,0.00005164016,0.00308142],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952762,0.00065780245,0.0005240524,0.00025868876,0.0022255485,0.001057639],"domain_scores_gemma":[0.96803623,0.0016927401,0.0024012523,0.0003183672,0.024683896,0.002867489],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0064428565,0.00061532727,0.0008935883,0.0064489027,0.002435202,0.0029166094,0.0017410286,0.0004334042,0.0015766518],"category_scores_gemma":[0.023466984,0.00035927788,0.001237931,0.010325974,0.00044414954,0.0011340377,0.001744575,0.0013620639,0.00021697683],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011683058,0.00017972777,0.93270016,0.00020772574,0.00015300675,0.000041359584,0.00093757646,0.004255956,0.00008265817,0.0020025831,0.015887845,0.043434687],"study_design_scores_gemma":[0.000022151411,0.000077946795,0.9842412,0.00015596564,0.000059571605,0.000011943648,0.0009208518,0.007241244,0.00020806021,0.00020247517,0.0068328953,0.000025768479],"about_ca_topic_score_codex":0.9932227,"about_ca_topic_score_gemma":0.99308276,"teacher_disagreement_score":0.99355716,"about_ca_system_score_codex":0.08946602,"about_ca_system_score_gemma":0.16055554,"threshold_uncertainty_score":0.64912444},"labels":[],"label_agreement":null},{"id":"W2980040069","doi":"10.1016/j.jval.2020.02.010","title":"Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; Medical Research Council; Norges Forskningsråd; University College London; National Center for Advancing Translational Sciences; University of Bristol; Canadian Institutes of Health Research; National Institute for Health and Care Research; National Cancer Institute; National Institutes of Health; University Hospitals Bristol NHS Foundation Trust","keywords":"Computer science; Value of information; Sample (material); Value (mathematics); Simple (philosophy); Software; Management science; Data science; Operations research; Machine learning; Artificial intelligence; Mathematics; Engineering","score_opus":0.6075820547132345,"score_gpt":0.5162253699919509,"score_spread":0.09135668472128355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980040069","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005976652,0.00024026351,0.9972053,0.00090679,0.00004805834,0.00010638685,0.00009013114,0.00034618741,0.00045917695],"genre_scores_gemma":[0.017928584,0.00044555563,0.97934145,0.00039205077,0.00011920713,0.0005122092,0.0002696446,0.00035637565,0.00063494913],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97015834,0.02177093,0.001976299,0.0019624927,0.0036580944,0.00047388376],"domain_scores_gemma":[0.76725274,0.20164026,0.0026588824,0.015231029,0.011732977,0.0014842045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04124161,0.0034572869,0.0050374805,0.0043513654,0.0015368601,0.007663496,0.009147986,0.004585592,0.018329084],"category_scores_gemma":[0.28614137,0.0021363157,0.00422198,0.005315043,0.0029552379,0.01443928,0.0057804217,0.012781502,0.0043515144],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005942838,0.0008038041,0.0046484997,0.0011034582,0.00051056023,0.0002146336,0.00045274562,0.22819388,0.0015175872,0.23127212,0.022243993,0.5084445],"study_design_scores_gemma":[0.000247937,0.00007088328,0.00064299844,0.0003249942,0.00012560916,0.00013802943,0.000117418764,0.7165588,0.0013349857,0.27567706,0.0046612495,0.000099972225],"about_ca_topic_score_codex":0.017238157,"about_ca_topic_score_gemma":0.019216424,"teacher_disagreement_score":0.04124161,"about_ca_system_score_codex":0.0045680497,"about_ca_system_score_gemma":0.007960959,"threshold_uncertainty_score":0.21810901},"labels":[],"label_agreement":null},{"id":"W2984821753","doi":"10.1016/j.jval.2019.08.013","title":"Community-Based Services by Pharmacists: A Systematic Review of Cost-Utility Analyses","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Pharmacists Association","funders":"","keywords":"Generalizability theory; Observational study; Context (archaeology); MEDLINE; Systematic review; Medicine; Quality (philosophy); Health care; Family medicine; Actuarial science; Psychology; Business; Political science; Geography","score_opus":0.6363299863112107,"score_gpt":0.594137732421894,"score_spread":0.04219225388931669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984821753","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002634351,0.9960568,0.00022688515,0.00014068905,0.0000544407,0.00015722262,0.0005732252,0.0000072885114,0.00014910502],"genre_scores_gemma":[0.06896361,0.92817426,0.0014928828,0.00042156325,0.00007987165,0.00032426565,0.00045429272,0.000012288132,0.00007687498],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9806637,0.007940808,0.0066389134,0.0012393728,0.0031639726,0.00035319699],"domain_scores_gemma":[0.9441201,0.043912165,0.008584349,0.000838768,0.0021543717,0.00039018464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014992993,0.0015844671,0.012568705,0.009010558,0.00046860517,0.003135727,0.0019215004,0.001526896,0.0038513113],"category_scores_gemma":[0.06732488,0.00096480123,0.015733352,0.013286353,0.0008888969,0.0022595495,0.0020782473,0.0020127285,0.00018422074],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014222913,0.000038065427,0.004070394,0.7919669,0.14703627,0.00007846586,0.0001298245,0.00033652392,0.000102378894,0.00028628207,0.0012815256,0.053251013],"study_design_scores_gemma":[0.0016767515,0.00045819647,0.01706137,0.34766006,0.62152845,0.0004090976,0.00029064875,0.00049225846,0.00019428847,0.00086160784,0.009281302,0.000085952524],"about_ca_topic_score_codex":0.0076769316,"about_ca_topic_score_gemma":0.02831475,"teacher_disagreement_score":0.014992993,"about_ca_system_score_codex":0.004121265,"about_ca_system_score_gemma":0.0066844276,"threshold_uncertainty_score":0.07929152},"labels":[],"label_agreement":null},{"id":"W2994620391","doi":"10.1016/j.jval.2019.09.2150","title":"PNS250 CADTH PARALLEL SCIENTIFIC ADVICE PROGRAMS WITH NICE AND HEALTH CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Nice; Excellence; Advice (programming); Timeline; Agency (philosophy); Computer science; Public relations; Medicine; Operations research; Medical education; Political science; Engineering; Sociology; Mathematics","score_opus":0.32392215033784855,"score_gpt":0.38768589662501723,"score_spread":0.06376374628716869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994620391","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026933178,0.007901714,0.0035449718,0.4525305,0.023814034,0.0019129525,0.02599337,0.004184067,0.47742504],"genre_scores_gemma":[0.016592765,0.0030223362,0.009787873,0.06099601,0.0076104407,0.00068203284,0.008324474,0.0016909986,0.89129305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9814286,0.0026524595,0.00056975574,0.0011601361,0.011820677,0.002368407],"domain_scores_gemma":[0.89072514,0.015419487,0.0025076142,0.0035827046,0.054068834,0.03369617],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017162088,0.0008507322,0.0016547643,0.004127809,0.0033024256,0.007832646,0.0030825255,0.010848351,0.31163174],"category_scores_gemma":[0.075327516,0.00091220863,0.0020334588,0.0022673383,0.0017766816,0.0013378629,0.003740703,0.0059582777,0.059417065],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066490575,0.000023922457,0.00023229478,0.0000431372,0.000012243882,0.000031484753,0.000014671908,0.00007486216,0.000026854528,0.001151749,0.98443997,0.01388239],"study_design_scores_gemma":[0.00020671914,0.000034421726,0.0025928302,0.00013217462,0.000018498533,0.00004667161,0.000046685276,0.000417164,0.0000752567,0.0011101498,0.9953004,0.000019075404],"about_ca_topic_score_codex":0.5487641,"about_ca_topic_score_gemma":0.76956856,"teacher_disagreement_score":0.96138334,"about_ca_system_score_codex":0.03861663,"about_ca_system_score_gemma":0.1529339,"threshold_uncertainty_score":0.98187375},"labels":[],"label_agreement":null},{"id":"W2994627824","doi":"10.1016/j.jval.2019.09.510","title":"PCN315 USE OF NOVEL HORMONAL AGENTS IN THE MONTH BEFORE DYING IN MEN DYING OF PROSTATE CANCER","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Odds ratio; Cohort; Androgen deprivation therapy; Internal medicine; Cancer; Hormonal therapy; Abiraterone; Logistic regression; Medical prescription; Cohort study; Cause of death; Androgen receptor; Pharmacology; Disease","score_opus":0.16702729598851532,"score_gpt":0.4021691145844173,"score_spread":0.23514181859590197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994627824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810214,0.011465172,0.00014075401,0.0010812425,0.00014591894,0.000031272182,0.0004926159,0.0000073946744,0.005614183],"genre_scores_gemma":[0.9970862,0.0017915801,0.00012928885,0.00023026436,0.00007918818,0.000006410515,0.0002200169,0.0000013531779,0.00045577256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996711,0.000103071754,0.0000281682,0.000031319785,0.00008623045,0.00008013559],"domain_scores_gemma":[0.9991339,0.00026809803,0.00030054542,0.00001533639,0.00006593141,0.00021624447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003475033,0.000101733,0.00035663132,0.00030105174,0.00044447294,0.0004219981,0.00017107722,0.00033471355,0.0018188129],"category_scores_gemma":[0.0021640274,0.00008759282,0.00051131076,0.00043562497,0.00017636098,0.00030682085,0.0002191326,0.00073824986,0.000089789115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038017645,0.00032278945,0.9377299,0.00024200135,0.00023311761,0.0007752985,0.00023642223,0.00018268336,0.0005642434,0.00013869841,0.0012958479,0.054477282],"study_design_scores_gemma":[0.00011045369,0.0018937902,0.9905172,0.00021523012,0.00023908129,0.0018261058,0.001031019,0.0003596455,0.0003439223,0.00020977284,0.0032329257,0.000020776883],"about_ca_topic_score_codex":0.004118436,"about_ca_topic_score_gemma":0.015936268,"teacher_disagreement_score":0.004118436,"about_ca_system_score_codex":0.00040034804,"about_ca_system_score_gemma":0.0007031842,"threshold_uncertainty_score":0.008188963},"labels":[],"label_agreement":null},{"id":"W2994659526","doi":"10.1016/j.jval.2019.09.2211","title":"PNS311 PREDICTIVE-ADJUSTED INDIRECT COMPARISON (PAIC): A NOVEL METHOD FOR POPULATION-ADJUSTED INDIRECT COMPARISON","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Covariate; Statistics; Population; Econometrics; Aggregate (composite); Standard error; Computer science; Mathematics; Medicine","score_opus":0.4801097598572617,"score_gpt":0.4623911089460939,"score_spread":0.017718650911167755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994659526","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048658654,0.0014397317,0.91961735,0.0007951208,0.0009406495,0.0030946594,0.010403748,0.0017349113,0.013315196],"genre_scores_gemma":[0.32518232,0.00038637733,0.6561019,0.00043818587,0.00032373617,0.0064651626,0.0052247047,0.0007439802,0.005133738],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9665257,0.024578713,0.0016097563,0.002929065,0.003992953,0.00036393662],"domain_scores_gemma":[0.9329331,0.053430863,0.0022652096,0.006524326,0.004390985,0.000455535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030389138,0.0012648634,0.0019576196,0.0048632845,0.0011836834,0.0025680133,0.0024294297,0.0010167897,0.02250639],"category_scores_gemma":[0.14574938,0.0007118359,0.0029482758,0.005816824,0.0011510525,0.0022860852,0.00324707,0.0026211469,0.0014908031],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004558808,0.0006002123,0.06054676,0.002201908,0.008772249,0.00032781044,0.0009650863,0.0120545635,0.001037717,0.0740684,0.03595277,0.79891366],"study_design_scores_gemma":[0.0032166156,0.0035038483,0.10593648,0.0014769229,0.008997568,0.0029144709,0.0013505577,0.29621577,0.0067398213,0.43081805,0.13819282,0.0006370572],"about_ca_topic_score_codex":0.004404282,"about_ca_topic_score_gemma":0.005527278,"teacher_disagreement_score":0.030389138,"about_ca_system_score_codex":0.0011550692,"about_ca_system_score_gemma":0.0035909535,"threshold_uncertainty_score":0.1607151},"labels":[],"label_agreement":null},{"id":"W2994662905","doi":"10.1016/j.jval.2019.09.631","title":"PCN438 ECONOMIC EVALUATION METHODS IN ONCOLOGY: ONWARDS AND UPWARDS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Economic evaluation; MEDLINE; Actuarial science; Time horizon; Sophistication; Sample size determination; Statistics; Pathology; Mathematics; Economics","score_opus":0.5460106175539866,"score_gpt":0.5567845640533401,"score_spread":0.010773946499353482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994662905","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031018395,0.12698966,0.37576318,0.18870099,0.017399503,0.00072411343,0.0015608382,0.000850676,0.28490925],"genre_scores_gemma":[0.09584015,0.15101102,0.52151114,0.044802092,0.026341831,0.0037614221,0.001509241,0.0037061172,0.15151706],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9393515,0.046687797,0.0022468364,0.0014952377,0.009720433,0.0004981505],"domain_scores_gemma":[0.7846262,0.15307108,0.0040679323,0.011668895,0.043330386,0.003235561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06290974,0.0016908644,0.0021353166,0.006416209,0.0019640548,0.011704626,0.002386175,0.003084302,0.029449016],"category_scores_gemma":[0.22425857,0.0013958652,0.0011955036,0.00790829,0.0061632353,0.012599053,0.0057292604,0.010694187,0.008054776],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008884701,0.000053437318,0.00087047124,0.0011329598,0.000060945906,0.000028728142,0.00031908593,0.0024551929,0.00005778117,0.47574127,0.16427772,0.3549136],"study_design_scores_gemma":[0.00007470561,0.000047316433,0.0019810589,0.005731567,0.000044387914,0.00009802744,0.00019127509,0.013179887,0.00023607654,0.51642853,0.46189448,0.00009271091],"about_ca_topic_score_codex":0.01970895,"about_ca_topic_score_gemma":0.025418501,"teacher_disagreement_score":0.06290974,"about_ca_system_score_codex":0.007946906,"about_ca_system_score_gemma":0.012382502,"threshold_uncertainty_score":0.33270246},"labels":[],"label_agreement":null},{"id":"W2994673562","doi":"10.1016/j.jval.2019.09.1192","title":"PIH10 ANALYSING PRESCRIBING PATTERNS AND COSTS OF DRUG TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS IN THE NETHERLANDS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Formulary; Cohort; Arthritis; Methotrexate; Juvenile; Pediatrics; Drug; Internal medicine; Family medicine; Pharmacology","score_opus":0.06680391592013195,"score_gpt":0.3743388889725187,"score_spread":0.30753497305238675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994673562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782671,0.0012661543,0.00043209948,0.000252026,0.000016681659,0.000052739226,0.018072966,0.000009179189,0.0016311579],"genre_scores_gemma":[0.9840163,0.0006294871,0.0008783849,0.000069652735,0.000020622085,0.00012012277,0.012206623,0.000028962731,0.0020298199],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792296,0.0006907431,0.00041091634,0.00030584962,0.00035904034,0.00031054576],"domain_scores_gemma":[0.9952259,0.0020842415,0.0016042946,0.00017636448,0.0005193938,0.00038979674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014413513,0.0002635369,0.0005659752,0.00209394,0.00020905124,0.0012939668,0.00067978073,0.0005601384,0.0032082896],"category_scores_gemma":[0.01024899,0.0004765384,0.0016666268,0.004428239,0.00022600364,0.0006896483,0.0007552987,0.00048210536,0.00033780644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063533295,0.00011238318,0.9773776,0.00038995486,0.0012177151,0.0004973729,0.0004964879,0.0035750929,0.00017729371,0.00033706677,0.0025142517,0.012669487],"study_design_scores_gemma":[0.000090982525,0.00012711564,0.986343,0.0001527797,0.00040336134,0.00033468127,0.001216854,0.007511731,0.00018783804,0.00013480037,0.0034737652,0.000022936863],"about_ca_topic_score_codex":0.37147403,"about_ca_topic_score_gemma":0.28999096,"teacher_disagreement_score":0.37147403,"about_ca_system_score_codex":0.0032088386,"about_ca_system_score_gemma":0.0028462291,"threshold_uncertainty_score":0.7386236},"labels":[],"label_agreement":null},{"id":"W2994776872","doi":"10.1016/j.jval.2019.09.649","title":"PCN457 THE SISAQOL INITIATIVE: ESTABLISHING INTERNATIONAL STANDARDS AND RECOMMENDATIONS FOR THE ANALYSIS OF PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE DATA IN ONCOLOGY RANDOMIZED CLINICAL TRIALS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of British Columbia","funders":"","keywords":"Missing data; Terminology; Comparability; Standardization; Clinical trial; Data quality; Medicine; Descriptive statistics; Data science; Management science; Computer science; Business; Service (business); Statistics; Pathology; Engineering","score_opus":0.7850245816451625,"score_gpt":0.6153870542944893,"score_spread":0.16963752735067328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994776872","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033143535,0.013273671,0.73111284,0.07707149,0.008900353,0.06995637,0.05666319,0.013043577,0.026664238],"genre_scores_gemma":[0.009281806,0.0033865366,0.8455293,0.016890103,0.0017910721,0.085874654,0.028529,0.0047332016,0.0039842348],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.21214971,0.5922597,0.10563205,0.008100133,0.07797626,0.0038821225],"domain_scores_gemma":[0.08050049,0.6395215,0.0508882,0.07324476,0.14405465,0.011790485],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.72788244,0.0043253326,0.01237233,0.020445917,0.0033472374,0.024288105,0.016913326,0.015558519,0.016968232],"category_scores_gemma":[0.82610106,0.0069168685,0.013515171,0.03420761,0.0094354255,0.010356363,0.017371131,0.03275294,0.014634312],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054549444,0.00071156974,0.0076377685,0.018249132,0.0049151955,0.000163793,0.0015872695,0.006240808,0.00091752876,0.059909914,0.58295023,0.31126177],"study_design_scores_gemma":[0.013466042,0.0015394527,0.027678495,0.0434787,0.0044430057,0.00042026458,0.0005891482,0.020378698,0.0048295157,0.08120524,0.8012374,0.0007340365],"about_ca_topic_score_codex":0.011027753,"about_ca_topic_score_gemma":0.011781823,"teacher_disagreement_score":0.27211756,"about_ca_system_score_codex":0.012477906,"about_ca_system_score_gemma":0.070601135,"threshold_uncertainty_score":0.33556944},"labels":[],"label_agreement":null},{"id":"W2994840958","doi":"10.1016/j.jval.2019.09.839","title":"PCV115 SOME APPROACHES FOR THE ESTIMATION OF CENSORED PATIENT REPORTED OUTCOMES: RESULTS USING THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE (KCCQ)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Censoring (clinical trials); Medicine; Hazard ratio; Population; Demography; Statistics; Internal medicine; Confidence interval; Mathematics","score_opus":0.49171937253535586,"score_gpt":0.41389337964587286,"score_spread":0.077825992889483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994840958","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26157382,0.0022591155,0.7087649,0.0012810001,0.00022441904,0.0014021584,0.012546113,0.0006721498,0.011276264],"genre_scores_gemma":[0.7554839,0.00066937896,0.22858691,0.0002542529,0.000071771494,0.0013125848,0.0080343755,0.00020065586,0.00538617],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9665971,0.029134683,0.0008612666,0.0011537542,0.0018935268,0.00035973932],"domain_scores_gemma":[0.9249266,0.062375613,0.0017943842,0.006084222,0.0044998797,0.00031924038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026695281,0.0008446154,0.0007371307,0.002827306,0.0007167387,0.0021212194,0.0027075282,0.00084179884,0.00960146],"category_scores_gemma":[0.09722942,0.0004563298,0.0018272548,0.004499926,0.0006984743,0.0012548107,0.0017859498,0.001414197,0.0008776092],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001529105,0.0004012256,0.41213402,0.0008319156,0.0037170846,0.00020539557,0.0013639388,0.058731202,0.0005486372,0.025661511,0.012781486,0.48209456],"study_design_scores_gemma":[0.0005233336,0.0013353715,0.5574385,0.0006021862,0.0012347637,0.0002859049,0.0016300528,0.37082162,0.0029738087,0.036916442,0.026003344,0.00023465116],"about_ca_topic_score_codex":0.0780014,"about_ca_topic_score_gemma":0.041185405,"teacher_disagreement_score":0.0780014,"about_ca_system_score_codex":0.0013615957,"about_ca_system_score_gemma":0.002063309,"threshold_uncertainty_score":0.1550948},"labels":[],"label_agreement":null},{"id":"W2994847507","doi":"10.1016/j.jval.2019.09.2632","title":"PSY4 THE USE OF EQ-5D VISUAL ANALOG SCALE (EQ-VAS) IN DISEASES AREAS WHERE EQ-5D IS INSENSITIVE TO CHANGES IN THE DISEASE STATUS: THE CASE OF LIPODYSTROPHY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"EQ-5D; Visual analogue scale; Medicine; Placebo; Minimal clinically important difference; Statistical significance; Physical therapy; Statistics; Disease; Internal medicine; Randomized controlled trial; Mathematics; Pathology; Alternative medicine","score_opus":0.45032909295852713,"score_gpt":0.3982563434239082,"score_spread":0.052072749534618934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994847507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43223482,0.08073599,0.06217205,0.06033022,0.003841326,0.0006383606,0.053052634,0.0003629298,0.30663168],"genre_scores_gemma":[0.96915543,0.007286085,0.007850899,0.0017071894,0.0008657829,0.00019634858,0.004696965,0.000052564676,0.0081886845],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9971879,0.0015708618,0.00028681246,0.00015093917,0.00067931873,0.00012412605],"domain_scores_gemma":[0.99541557,0.0023630485,0.00104086,0.00024016442,0.0007282229,0.00021204544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035412044,0.00033479845,0.000460271,0.0017392708,0.00030099376,0.0014281077,0.00056369655,0.0006719115,0.0128420275],"category_scores_gemma":[0.019027807,0.00011842357,0.00086026394,0.0030313965,0.0007276201,0.0011760981,0.0010641194,0.0012035903,0.0013102925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012633796,0.00015382662,0.40560797,0.0013643206,0.001002999,0.0010293694,0.00046203696,0.004968324,0.00091698323,0.050665263,0.073029876,0.45953575],"study_design_scores_gemma":[0.00022905682,0.0009912207,0.73111194,0.0015613714,0.0005399092,0.004515759,0.001026534,0.015756555,0.001869517,0.08001886,0.16225117,0.00012813693],"about_ca_topic_score_codex":0.007260777,"about_ca_topic_score_gemma":0.003852455,"teacher_disagreement_score":0.0128420275,"about_ca_system_score_codex":0.00095933554,"about_ca_system_score_gemma":0.0012561148,"threshold_uncertainty_score":0.042960882},"labels":[],"label_agreement":null},{"id":"W2994881204","doi":"10.1016/j.jval.2019.09.2451","title":"PRO121 THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Nice; Observational study; Tolerability; Health technology; Real world data; Medicine; Randomized controlled trial; Clinical trial; Data extraction; MEDLINE; Family medicine; Health care; Data science; Adverse effect; Computer science; Internal medicine; Political science","score_opus":0.633768669566204,"score_gpt":0.5191857200238837,"score_spread":0.11458294954232029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994881204","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39420432,0.030373927,0.13740009,0.031730462,0.0023333533,0.0008056198,0.33720794,0.0011550842,0.06478926],"genre_scores_gemma":[0.90195626,0.0047163647,0.02902931,0.0010840126,0.00044882504,0.0003686435,0.05879185,0.00013721654,0.0034675715],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9655037,0.028014857,0.0019858351,0.0009490325,0.003337528,0.00020890984],"domain_scores_gemma":[0.736895,0.21019283,0.02605841,0.015283315,0.010211195,0.001359254],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024847815,0.00051744626,0.00046982957,0.0044696485,0.0003610114,0.0041525885,0.0007813598,0.0016494902,0.0053671356],"category_scores_gemma":[0.18524408,0.00044112362,0.0006868568,0.008322249,0.000753742,0.0026363216,0.0013864449,0.001861301,0.0017918693],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002503148,0.0006613714,0.49200475,0.0030869658,0.0024013063,0.00043657218,0.00050356606,0.060703535,0.00090109673,0.03383541,0.076212294,0.32675],"study_design_scores_gemma":[0.0007485325,0.0013991771,0.47385094,0.0031522962,0.0009989155,0.0014120741,0.0010117594,0.24138297,0.0050587566,0.06839256,0.20220876,0.0003832199],"about_ca_topic_score_codex":0.00475895,"about_ca_topic_score_gemma":0.0038258827,"teacher_disagreement_score":0.9751522,"about_ca_system_score_codex":0.0010730681,"about_ca_system_score_gemma":0.0012426701,"threshold_uncertainty_score":0.1314094},"labels":[],"label_agreement":null},{"id":"W2994893487","doi":"10.1016/j.jval.2019.09.597","title":"PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN REIMBURSEMENT FOR SELECT NOVEL CANCER THERAPEUTICS IN CANADA, ITALY, AND AUSTRALIA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Reimbursement; Crizotinib; Ipilimumab; Medicine; Trastuzumab; Family medicine; Cancer; Oncology; Health care; Internal medicine; Breast cancer; Lung cancer; Economic growth","score_opus":0.60011601143961,"score_gpt":0.4933354986417834,"score_spread":0.10678051279782663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994893487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9540702,0.004806316,0.00022104867,0.02604433,0.00012483975,0.00006912806,0.003610975,0.000016729678,0.0110364035],"genre_scores_gemma":[0.9933854,0.0016963097,0.00020566212,0.0012453789,0.000056472945,0.00003435713,0.0010243024,0.0000131778925,0.0023390306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959722,0.0007485736,0.00023309016,0.00024585135,0.0014876589,0.0013125653],"domain_scores_gemma":[0.9764721,0.0037062464,0.0053742053,0.000366163,0.0064247735,0.0076566134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034068532,0.00018602682,0.00040070468,0.0016075108,0.0011286379,0.0024398782,0.0009431743,0.0010438777,0.0021976607],"category_scores_gemma":[0.02271338,0.0003363358,0.0006378587,0.0032512208,0.0012599851,0.00064101885,0.001735603,0.0023520521,0.0001066772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002134488,0.0002498728,0.87336594,0.00032979785,0.00043480957,0.00095242326,0.0022709635,0.00515599,0.00044090522,0.011836365,0.03456941,0.068259105],"study_design_scores_gemma":[0.00008885933,0.00013633473,0.98344827,0.00015854642,0.00009290308,0.00021648026,0.0017615984,0.0034733512,0.000101696394,0.00047866418,0.010004893,0.000038363625],"about_ca_topic_score_codex":0.9646559,"about_ca_topic_score_gemma":0.9708482,"teacher_disagreement_score":0.9333745,"about_ca_system_score_codex":0.06662549,"about_ca_system_score_gemma":0.06291673,"threshold_uncertainty_score":0.48340404},"labels":[],"label_agreement":null},{"id":"W2994908759","doi":"10.1016/j.jval.2019.09.2296","title":"PNS396 VALUING HEALTH RELATED QUALITY OF LIFE IN MOROCCO: AN EQ-5D-3L VALUE SET","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Representativeness heuristic; Logistic regression; Sample (material); Population; Statistics; EQ-5D; Econometrics; Computer science; Mathematics; Medicine; Environmental health; Health related quality of life","score_opus":0.6290592087948895,"score_gpt":0.4562251904492626,"score_spread":0.17283401834562695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994908759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77151835,0.003279767,0.022187518,0.006916596,0.00026127519,0.0005650071,0.06554562,0.00017050472,0.12955528],"genre_scores_gemma":[0.98008907,0.00046860456,0.007719682,0.00011401129,0.000046453566,0.0002555392,0.008081656,0.00001135073,0.0032135341],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99901164,0.00048710802,0.00005234922,0.0000487421,0.0002829454,0.00011710912],"domain_scores_gemma":[0.9986462,0.0004368413,0.00016678429,0.000107741864,0.00055823586,0.00008420035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022720601,0.00039778146,0.0004470874,0.0016709523,0.00046225908,0.0012730265,0.0004897059,0.00037504817,0.0034040438],"category_scores_gemma":[0.0073783738,0.000118927375,0.0005544907,0.002068983,0.00032769179,0.0005954241,0.0010196787,0.00045758128,0.0004438334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012901818,0.00043397376,0.33229533,0.0009400932,0.00058363145,0.0009907834,0.0011848302,0.08473143,0.0018133549,0.11997279,0.08008257,0.37568107],"study_design_scores_gemma":[0.00020650314,0.0005762419,0.6115142,0.0015661024,0.0003467438,0.00067051355,0.0029881566,0.1891454,0.002610142,0.05531946,0.13490719,0.00014926157],"about_ca_topic_score_codex":0.054927923,"about_ca_topic_score_gemma":0.026483454,"teacher_disagreement_score":0.054927923,"about_ca_system_score_codex":0.0036268928,"about_ca_system_score_gemma":0.0019662243,"threshold_uncertainty_score":0.10921639},"labels":[],"label_agreement":null},{"id":"W2994926825","doi":"10.1016/j.jval.2019.09.637","title":"PCN445 INDIRECT TREATMENT COMPARISON OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VERSUS TISAGENLECLEUCEL (TISA-CEL) IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA (RR-LBCL)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Leukapheresis; Population; Internal medicine; Adverse effect; Oncology; Refractory (planetary science); Clinical trial; Surgery; Gastroenterology; Stem cell","score_opus":0.08268486209824036,"score_gpt":0.36535704509718864,"score_spread":0.28267218299894825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994926825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875886,0.007738826,0.00025556458,0.0002709751,0.00023042559,0.00016192147,0.0005583417,0.000053948115,0.0031415273],"genre_scores_gemma":[0.9936306,0.002008965,0.0003862874,0.00017579754,0.00012769361,0.00014022648,0.00056043593,0.000010189797,0.002959813],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99962986,0.00016099,0.000022882525,0.0000672574,0.00004032503,0.00007866307],"domain_scores_gemma":[0.9996605,0.00008825471,0.000061826264,0.00002768023,0.000016874028,0.00014479826],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0005859955,0.00065416086,0.0018941783,0.00040263336,0.00014615495,0.000633824,0.0006068904,0.0006161771,0.009682838],"category_scores_gemma":[0.0005287696,0.0002610305,0.0010285631,0.00033279776,0.0005221382,0.0005981979,0.00033857106,0.0017468052,0.0008469594],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9010169,0.007447477,0.0011095909,0.0006357483,0.0015635643,0.00003960198,0.000046298606,0.0008983235,0.010401226,0.0002492974,0.000835062,0.0757569],"study_design_scores_gemma":[0.3923373,0.5617599,0.023149969,0.00019401137,0.0044622743,0.00018353813,0.00013035299,0.0028683937,0.009413607,0.0004235545,0.0050147427,0.00006227312],"about_ca_topic_score_codex":0.0012215362,"about_ca_topic_score_gemma":0.003375446,"teacher_disagreement_score":0.9981058,"about_ca_system_score_codex":0.00057769846,"about_ca_system_score_gemma":0.0006616628,"threshold_uncertainty_score":0.032392323},"labels":[],"label_agreement":null},{"id":"W2994945806","doi":"10.1016/j.jval.2019.09.1643","title":"PMU24 ECONOMIC EVALUATION OF BIOCELLULOSE WOUND DRESSINGS FOR THE MANAGEMENT OF CHRONIC LEG ULCERS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Agricultural and Food Sciences","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Venous leg ulcer; Wound care; Clinical trial; Wound healing; Physical therapy; Intensive care medicine; Surgery; Internal medicine","score_opus":0.05270500171359643,"score_gpt":0.2601330335013135,"score_spread":0.20742803178771707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994945806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96829426,0.006459411,0.00052136305,0.0016140897,0.00008339276,0.0010874304,0.004681808,0.000026395957,0.017231971],"genre_scores_gemma":[0.98862106,0.0028042612,0.00091939495,0.00022434344,0.000024215022,0.0001584947,0.001302034,0.0000090753265,0.00593713],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9975204,0.0006694642,0.00008299962,0.00008056761,0.0010649738,0.000581599],"domain_scores_gemma":[0.99613696,0.00068021833,0.00025323796,0.000043344608,0.0020175215,0.0008685916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002469512,0.0005017302,0.0005926314,0.0022017644,0.0015309361,0.0025593087,0.0008365996,0.0005543148,0.0039193206],"category_scores_gemma":[0.006007945,0.00029833624,0.0009693704,0.0019803103,0.00048180312,0.0002735834,0.0006369991,0.0006520409,0.00015841053],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06417389,0.0104660345,0.3457101,0.004702424,0.001978699,0.0018701723,0.0007859035,0.0757859,0.01427721,0.011022577,0.03410607,0.43512103],"study_design_scores_gemma":[0.004130261,0.021479074,0.81994486,0.0009928303,0.001408075,0.0005038033,0.0039297827,0.098068416,0.007423407,0.00072779646,0.041180633,0.00021108497],"about_ca_topic_score_codex":0.9645988,"about_ca_topic_score_gemma":0.9650266,"teacher_disagreement_score":0.07202066,"about_ca_system_score_codex":0.07202066,"about_ca_system_score_gemma":0.070177525,"threshold_uncertainty_score":0.5225489},"labels":[],"label_agreement":null},{"id":"W2994953762","doi":"10.1016/j.jval.2019.09.776","title":"PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Rivaroxaban; Medicine; Stroke (engine); Myocardial infarction; Coronary artery disease; Cost effectiveness; Quality-adjusted life year; Internal medicine; Emergency medicine; Warfarin; Atrial fibrillation","score_opus":0.32924311323728783,"score_gpt":0.41870843693616056,"score_spread":0.08946532369887272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994953762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7306661,0.22246405,0.00083966344,0.01709594,0.0016398029,0.00031564152,0.011267508,0.000067502384,0.015643822],"genre_scores_gemma":[0.9799716,0.014896857,0.00025444257,0.00073027675,0.00024621584,0.0000947203,0.0030465033,0.000014470398,0.00074486306],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99361706,0.003856301,0.00083156134,0.0003617876,0.0008569839,0.00047636492],"domain_scores_gemma":[0.99225146,0.004041559,0.0017632184,0.00018322964,0.00073268375,0.0010278795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029432254,0.0005090907,0.0018398006,0.0016300473,0.00024000426,0.002522788,0.000553569,0.0017500153,0.0049365913],"category_scores_gemma":[0.0246924,0.00038153064,0.0027648953,0.0019896869,0.00051691587,0.0014144004,0.001231204,0.0024626546,0.0003236734],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18028903,0.0009581741,0.16518295,0.017572181,0.019799855,0.0022549015,0.0005665684,0.057389792,0.0014441089,0.01064629,0.050825216,0.49307087],"study_design_scores_gemma":[0.05971868,0.025786502,0.75740933,0.017681215,0.01869075,0.0055716773,0.0012553951,0.051368278,0.0011021516,0.0057616807,0.055054117,0.0006002475],"about_ca_topic_score_codex":0.027623182,"about_ca_topic_score_gemma":0.015779102,"teacher_disagreement_score":0.027623182,"about_ca_system_score_codex":0.0058405446,"about_ca_system_score_gemma":0.0026069258,"threshold_uncertainty_score":0.054924786},"labels":[],"label_agreement":null},{"id":"W2994956998","doi":"10.1016/j.jval.2019.09.2592","title":"PSU5 ECONOMIC IMPACT OF PULMONARY ARTERY CATHETER UTILIZATION AMONG CARDIAC SURGERY PATIENTS: PERSPECTIVES FOR AN ACUTE CARE HOSPITAL AND AN INTEGRATED PAYER-PROVIDER HEALTH SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pulmonary artery catheter; Perioperative; Cardiac surgery; Emergency medicine; Acute care; Health care; Catheter; Intensive care medicine; Surgery; Cardiac output; Cardiology; Hemodynamics","score_opus":0.04665708739467265,"score_gpt":0.29946249176459333,"score_spread":0.25280540436992066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994956998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9048692,0.003532025,0.0007088523,0.046716064,0.00023089103,0.000044236564,0.0054264786,0.00002184233,0.038450353],"genre_scores_gemma":[0.9964665,0.000505647,0.00013177074,0.00048591156,0.000115386705,0.000008386171,0.00089345453,0.000005380823,0.0013875308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981768,0.000625997,0.00007404884,0.000085052765,0.00026256626,0.000775558],"domain_scores_gemma":[0.99312556,0.0026901665,0.0012220376,0.00014276913,0.0010339967,0.0017854525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012677738,0.00028174996,0.00056492264,0.0015529632,0.0008942318,0.0042607263,0.00067718426,0.0011274581,0.010459142],"category_scores_gemma":[0.008154744,0.00023964846,0.0015015396,0.0024422004,0.000685107,0.0018872306,0.0016725216,0.0021835451,0.00030772339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018047949,0.0011557644,0.7941269,0.00028398688,0.0010756238,0.0010164924,0.00045346972,0.027330616,0.00066000596,0.091980614,0.023818398,0.05629331],"study_design_scores_gemma":[0.000080804726,0.0003932591,0.9275528,0.00023487558,0.00045508286,0.00032069045,0.005435877,0.02854123,0.0004967027,0.02706348,0.009360667,0.00006445073],"about_ca_topic_score_codex":0.057202946,"about_ca_topic_score_gemma":0.06806163,"teacher_disagreement_score":0.057202946,"about_ca_system_score_codex":0.004305475,"about_ca_system_score_gemma":0.0036782657,"threshold_uncertainty_score":0.11373997},"labels":[],"label_agreement":null},{"id":"W2994982266","doi":"10.1016/j.jval.2019.09.432","title":"PCN237 IMPACT OF ORAL TARGETED THERAPY ON THE ECONOMIC BURDEN OF CLL IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; CancerCare Manitoba; Ottawa Hospital; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"IGHV@; Chemoimmunotherapy; Medicine; Chronic lymphocytic leukemia; Fludarabine; Watchful waiting; Adverse effect; Incidence (geometry); Internal medicine; Leukemia; Cancer; Chemotherapy","score_opus":0.04563556119087507,"score_gpt":0.33886766914407607,"score_spread":0.293232107953201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994982266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85367924,0.017610261,0.00021617234,0.048856445,0.00029231276,0.00010688486,0.030363329,0.00003962098,0.04883576],"genre_scores_gemma":[0.98241764,0.0073687183,0.00017372455,0.0013085757,0.000079667385,0.000021884392,0.0033055937,0.00001802989,0.0053061727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857414,0.00016163442,0.000061132545,0.000060579336,0.0004900069,0.0006524854],"domain_scores_gemma":[0.99603516,0.00025183384,0.00053333875,0.000040822844,0.0019021049,0.0012366367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006237455,0.00021855399,0.00042265555,0.0011207071,0.0015771061,0.002630479,0.0008381831,0.00047735946,0.0066062026],"category_scores_gemma":[0.0040641157,0.00017967937,0.0006898176,0.0035611263,0.00061965524,0.0003654879,0.0008940277,0.0011517939,0.00030223254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023855022,0.00024210959,0.770801,0.0006187865,0.00058390916,0.00089620164,0.0009999215,0.005181774,0.0007078199,0.013524138,0.07452263,0.12953621],"study_design_scores_gemma":[0.00023356164,0.00015134593,0.944475,0.0005199305,0.00038298135,0.00034517024,0.0034514158,0.003273229,0.0003383843,0.0009257942,0.045841426,0.00006178406],"about_ca_topic_score_codex":0.9962626,"about_ca_topic_score_gemma":0.9973678,"teacher_disagreement_score":0.101446286,"about_ca_system_score_codex":0.101446286,"about_ca_system_score_gemma":0.12469924,"threshold_uncertainty_score":0.73604774},"labels":[],"label_agreement":null},{"id":"W2995016183","doi":"10.1016/j.jval.2019.09.2651","title":"PSY23 DIRECT COSTS OF SYSTEMIC LUPUS ERYTHEMATOSUS IN ALBERTA IN REAL WORLD","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ambulatory; Indirect costs; Health care; Ambulatory care; Disease; Systemic lupus erythematosus; Emergency medicine; Internal medicine; Business","score_opus":0.03757876475180175,"score_gpt":0.33459525469702217,"score_spread":0.2970164899452204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995016183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700163,0.0017678132,0.00020784498,0.003361203,0.00005372368,0.000026480982,0.015030869,0.000031745316,0.009503921],"genre_scores_gemma":[0.99138534,0.0012013518,0.00016481765,0.00018412164,0.000026918575,0.000008829313,0.0029728594,0.000006124209,0.004049641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991289,0.00017829749,0.000056372977,0.000059801743,0.00029004668,0.00028668885],"domain_scores_gemma":[0.99835616,0.0002486381,0.00040441053,0.00003471011,0.0004437999,0.0005122027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005109985,0.00025238612,0.00023268195,0.0011634278,0.000564172,0.0014980136,0.00080489926,0.00053030276,0.004234124],"category_scores_gemma":[0.0031431767,0.0002331503,0.00047769127,0.0025851757,0.00048737257,0.00037528705,0.00083095115,0.00096908375,0.00023424813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080019387,0.00018841546,0.95288837,0.00014809349,0.00037167378,0.000997212,0.00045600286,0.01025199,0.0002623432,0.0029337408,0.010721363,0.01998064],"study_design_scores_gemma":[0.000078023375,0.000090980175,0.98577684,0.000080788435,0.00016794536,0.00046102618,0.0021458562,0.0048645223,0.00012330379,0.00066211174,0.0055210884,0.000027645352],"about_ca_topic_score_codex":0.9715376,"about_ca_topic_score_gemma":0.9772979,"teacher_disagreement_score":0.030499812,"about_ca_system_score_codex":0.030499812,"about_ca_system_score_gemma":0.01784959,"threshold_uncertainty_score":0.22129267},"labels":[],"label_agreement":null},{"id":"W2995067257","doi":"10.1016/j.jval.2019.09.2663","title":"PSY35 A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENTS EVALUATING RECENTLY APPROVED BIOLOGICAL THERAPIES FOR ADULT PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS IN THE US, CANADA AND UK","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ixekizumab; Discontinuation; Psoriasis; Pharmacoeconomics; Population; Clinical trial; Regimen; Intensive care medicine; Internal medicine; Psoriatic arthritis; Dermatology; Secukinumab; Environmental health","score_opus":0.3489291710632158,"score_gpt":0.44264316494841577,"score_spread":0.09371399388519996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995067257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9232196,0.046502862,0.00088229706,0.0012949473,0.00013092469,0.00030281593,0.021664111,0.000029896268,0.005972515],"genre_scores_gemma":[0.9923447,0.0017369884,0.00025796026,0.000106732725,0.000031071686,0.000053132888,0.0051006456,0.0000051536063,0.00036370076],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9883306,0.006308152,0.001453128,0.00065738655,0.002569728,0.0006809647],"domain_scores_gemma":[0.9691956,0.019320657,0.004582541,0.0007187549,0.0050270795,0.0011552759],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009305673,0.0005091383,0.001825651,0.0022228071,0.00039733676,0.0017605987,0.00065232423,0.0007845594,0.003472979],"category_scores_gemma":[0.044922955,0.00024554195,0.0056217182,0.004628257,0.00047674507,0.001133074,0.0011928134,0.0015868851,0.00018018342],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10994894,0.00042808888,0.68703705,0.0058495146,0.050165854,0.0003641718,0.0009581034,0.014167679,0.000679795,0.0030729682,0.010550593,0.11677731],"study_design_scores_gemma":[0.0020399105,0.0026520926,0.9793785,0.00055303646,0.006479877,0.00017757638,0.000496678,0.0041675847,0.00016739209,0.00028964385,0.0035147541,0.00008295507],"about_ca_topic_score_codex":0.31313765,"about_ca_topic_score_gemma":0.27412382,"teacher_disagreement_score":0.9909452,"about_ca_system_score_codex":0.009054798,"about_ca_system_score_gemma":0.0057075606,"threshold_uncertainty_score":0.62263},"labels":[],"label_agreement":null},{"id":"W2995082013","doi":"10.1016/j.jval.2019.09.1595","title":"PMS51 TRAJECTORIES OF FOLLOW-UP COMPLIANCE AND THEIR PREDICTORS IN A FRACTURE LIAISON SERVICE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Polypharmacy; Medicine; Fragility fracture; Osteoporosis; Logistic regression; Orthopedic surgery; Multinomial logistic regression; Physical therapy; Internal medicine; Bone mineral; Demography; Surgery","score_opus":0.038601018447865704,"score_gpt":0.3012766790900169,"score_spread":0.2626756606421512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995082013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99774075,0.0001435552,0.000069428555,0.00042713754,0.000017253315,0.000019980575,0.0007365372,0.000011950909,0.0008334133],"genre_scores_gemma":[0.9981509,0.000073570176,0.00006046012,0.0000686775,0.000013299514,0.000016547834,0.0006223494,0.000005074246,0.0009891139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985091,0.00029600985,0.00014462252,0.00020240614,0.00022929058,0.0006185871],"domain_scores_gemma":[0.9913735,0.0016915636,0.0028073697,0.00040058006,0.0010739597,0.0026531043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016484791,0.0003082731,0.00050471583,0.0012253649,0.0016829611,0.002103508,0.0010791215,0.0016317936,0.0070794676],"category_scores_gemma":[0.013470139,0.00056824135,0.0011365126,0.0018037201,0.0003573423,0.0013640969,0.001760287,0.0027219625,0.0011464052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009636355,0.00016429977,0.9977963,0.0000046884343,0.000027897375,0.000034224286,0.00019664688,0.000058969148,0.000024883433,0.00003178072,0.00020403725,0.0013600297],"study_design_scores_gemma":[0.000004798949,0.00013446482,0.9982797,0.000018238768,0.000015140903,0.000046858924,0.0008094366,0.00041144234,0.000024137455,0.000044882538,0.0002042496,0.0000067364103],"about_ca_topic_score_codex":0.06020197,"about_ca_topic_score_gemma":0.04739921,"teacher_disagreement_score":0.06020197,"about_ca_system_score_codex":0.0013713327,"about_ca_system_score_gemma":0.0029883673,"threshold_uncertainty_score":0.119703114},"labels":[],"label_agreement":null},{"id":"W2995099757","doi":"10.1016/j.jval.2019.09.2178","title":"PNS278 A REVIEW OF HEALTH TECHNOLOGY ASSESSMENT GUIDELINES ON THE APPROVAL OF BIOSIMILARS","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biosimilar; Medicine; Drug approval; Health technology; Pharmacology; Political science; Health care; Drug; Internal medicine; Law","score_opus":0.34093109077958933,"score_gpt":0.49828318519403947,"score_spread":0.15735209441445014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995099757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000085025546,0.993913,0.0002949321,0.001876298,0.00075126503,0.000033582983,0.0001550769,0.000012147313,0.0028787383],"genre_scores_gemma":[0.0007253117,0.99465334,0.0006215136,0.0022579802,0.00031595965,0.000041856354,0.00016309238,0.0000045548722,0.0012163006],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980562,0.0004996161,0.00041451518,0.00017943417,0.00073048903,0.00011973702],"domain_scores_gemma":[0.9948896,0.0029264484,0.0008034559,0.000090003945,0.0011372071,0.00015330524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003908839,0.0010993168,0.0018714045,0.0053775115,0.0004451944,0.002027914,0.0014424914,0.002783338,0.008435482],"category_scores_gemma":[0.0077549247,0.00044176975,0.0017294473,0.004687272,0.0007390727,0.0016425177,0.0012563398,0.0029415719,0.002896493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016687253,0.00006195206,0.000118478274,0.052738465,0.00023395092,0.00018209676,0.000067738336,0.00026122044,0.0010016955,0.0073559117,0.0924095,0.8454021],"study_design_scores_gemma":[0.00004564349,0.000067765235,0.00049974123,0.027209187,0.00035706413,0.00039455915,0.0000328695,0.000057510624,0.0003542152,0.0016843282,0.9692798,0.00001737425],"about_ca_topic_score_codex":0.003620529,"about_ca_topic_score_gemma":0.0055150012,"teacher_disagreement_score":0.008435482,"about_ca_system_score_codex":0.0024886548,"about_ca_system_score_gemma":0.007355697,"threshold_uncertainty_score":0.028219521},"labels":[],"label_agreement":null},{"id":"W2995221331","doi":"10.1016/j.jval.2019.09.2520","title":"PRS30 PRAGMATIC META-ANALYSIS OF PROPORTIONAL ASSIST VENTILATION+ VERSUS PRESSURE SUPPORT VENTILATION AND ITS IMPACT ON COST EFFECTIVENESS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Meta-analysis; Mechanical ventilation; Intensive care unit; Emergency medicine; Pressure support ventilation; Intensive care medicine; Internal medicine","score_opus":0.11156407113994983,"score_gpt":0.40559102009987,"score_spread":0.2940269489599202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995221331","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14133586,0.7372203,0.046362855,0.007759954,0.012407811,0.013068749,0.024939563,0.0021898656,0.01471508],"genre_scores_gemma":[0.92084086,0.04102246,0.015791204,0.006074852,0.0018442952,0.0058896216,0.004177909,0.00052108115,0.0038377675],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96447885,0.027445737,0.004089936,0.0020355505,0.0013915704,0.00055846287],"domain_scores_gemma":[0.9739422,0.020102996,0.002707484,0.0015441166,0.0012177428,0.00048551214],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.027530553,0.004536185,0.013927203,0.002118885,0.0006463129,0.0030681258,0.0021940887,0.0030244587,0.018340576],"category_scores_gemma":[0.066365995,0.0023938175,0.060129434,0.0020472042,0.001256625,0.0023672925,0.0025392445,0.005142928,0.0013556574],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08824359,0.000079705576,0.00092180684,0.0690461,0.826492,0.00012124835,0.000063333806,0.0015143338,0.000425555,0.00060403603,0.0020999722,0.010388284],"study_design_scores_gemma":[0.07211782,0.0024261104,0.0020157923,0.004426164,0.9115181,0.00014726305,0.000046342713,0.0013423027,0.0002515721,0.0020525404,0.0035842939,0.00007171329],"about_ca_topic_score_codex":0.0052731563,"about_ca_topic_score_gemma":0.007065749,"teacher_disagreement_score":0.97246945,"about_ca_system_score_codex":0.0022022128,"about_ca_system_score_gemma":0.0023335556,"threshold_uncertainty_score":0.14559722},"labels":[],"label_agreement":null},{"id":"W2995229498","doi":"10.1016/j.jval.2019.09.1393","title":"PIN153 HEALTH OUTCOMES AND HEALTH SYSTEM COSTS ASSOCIATED WITH SEPSIS: A POPULATION-BASED, RETROSPECTIVE COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Institute for Clinical Evaluative Sciences; Ottawa Hospital; Ottawa Public Health","funders":"","keywords":"Sepsis; Medicine; Propensity score matching; Organ dysfunction; Retrospective cohort study; Population; Confounding; Cohort; Cohort study; Internal medicine; Emergency medicine; Intensive care medicine","score_opus":0.06678578242228349,"score_gpt":0.36549910260453317,"score_spread":0.29871332018224966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995229498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984592,0.00010990332,0.00006321239,0.000027404989,0.000006783049,0.000009777293,0.0010002527,0.0000019574977,0.0003214663],"genre_scores_gemma":[0.99856013,0.00008671337,0.00005846832,0.00003728845,0.000012239903,0.00001933291,0.0010004903,0.000002806878,0.00022242256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894184,0.00028999543,0.00010728338,0.00028475333,0.00015547553,0.00022060637],"domain_scores_gemma":[0.9984413,0.00020381564,0.0006989863,0.00027187227,0.00016134512,0.00022258492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008004947,0.0004792922,0.00046675839,0.0009952054,0.00071416784,0.0013956273,0.0005910303,0.0009455853,0.0021933496],"category_scores_gemma":[0.0027685435,0.0008195134,0.0013760088,0.002182755,0.00043908533,0.0011717303,0.0009366411,0.0014921381,0.00055043714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027718488,0.00007535488,0.99875784,0.000006833026,0.00015938883,0.00008018755,0.000045478002,0.000030414118,0.00010217495,0.000019568632,0.00011361279,0.00033193865],"study_design_scores_gemma":[0.000021223068,0.00013825235,0.99906677,0.000005031924,0.00007410652,0.0002123148,0.0001972604,0.000109095454,0.000027471893,0.00002412248,0.00011795941,0.000006490491],"about_ca_topic_score_codex":0.007883663,"about_ca_topic_score_gemma":0.0066853133,"teacher_disagreement_score":0.007883663,"about_ca_system_score_codex":0.00058955094,"about_ca_system_score_gemma":0.0006169401,"threshold_uncertainty_score":0.015675545},"labels":[],"label_agreement":null},{"id":"W2995253338","doi":"10.1016/j.jval.2019.09.2180","title":"PNS280 AN ASSESSMENT OF THE LIKELIHOOD OF RECEIVING A POSITIVE RECOMMENDATION THROUGH NICE'S STA PROCESS WITHOUT A PATIENT ACCESS SCHEME OF COMMERCIAL ACCESS AGREEMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Authorization; Medicine; Quarter (Canadian coin); Order (exchange); Family medicine; Business; Computer science; Finance; Computer security","score_opus":0.4463815778078915,"score_gpt":0.617376192932067,"score_spread":0.17099461512417552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995253338","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44748008,0.002040125,0.010607075,0.040317945,0.00077616505,0.0031622192,0.038059544,0.0015263206,0.4560306],"genre_scores_gemma":[0.9484496,0.00086627074,0.018795537,0.00475717,0.00036750518,0.0010790778,0.008026026,0.00019738654,0.017461384],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9569516,0.019143647,0.005619991,0.0012213534,0.015511183,0.0015521076],"domain_scores_gemma":[0.85148484,0.086357765,0.026747307,0.0037646254,0.02338014,0.008265266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018765876,0.0003059285,0.0007423975,0.003401497,0.00081598037,0.0023986036,0.0013220041,0.0027178081,0.048279226],"category_scores_gemma":[0.16187501,0.00034453394,0.0019510866,0.002459041,0.0010106417,0.002007391,0.0019348745,0.0020297552,0.009905066],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055515077,0.00081644725,0.75065,0.0010642201,0.0007324032,0.0010407335,0.0005732881,0.0012934251,0.00054340967,0.0047903084,0.14289117,0.09005312],"study_design_scores_gemma":[0.00082252506,0.0063008587,0.845947,0.0014946795,0.000672763,0.0047741537,0.0020849146,0.009111649,0.0018188045,0.006257158,0.1204893,0.00022623022],"about_ca_topic_score_codex":0.010323957,"about_ca_topic_score_gemma":0.010203178,"teacher_disagreement_score":0.048279226,"about_ca_system_score_codex":0.001928867,"about_ca_system_score_gemma":0.005459715,"threshold_uncertainty_score":0.16151011},"labels":[],"label_agreement":null},{"id":"W2995421171","doi":"10.1016/j.jval.2019.09.2137","title":"PNS237 CLINICAL OUTCOME ASSESSMENTS AS A CONDITION IN HTA RECOMMENDATIONS: THE CANADIAN PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Health technology; Family medicine; Internal medicine; Inclusion (mineral); Oncology; Health care; Psychology","score_opus":0.6467678325215246,"score_gpt":0.5822884350383812,"score_spread":0.06447939748314335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995421171","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00461025,0.027780892,0.002341395,0.8827293,0.0034008361,0.00016477465,0.0033536395,0.00006294986,0.07555594],"genre_scores_gemma":[0.45691606,0.10021875,0.041563913,0.33766058,0.023590945,0.0006595635,0.009406864,0.00033482068,0.02964852],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.96741843,0.0122714825,0.0024543162,0.0015535287,0.01273755,0.0035646192],"domain_scores_gemma":[0.81171465,0.051408853,0.007362731,0.0026693426,0.104363464,0.022480968],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04284143,0.0010180227,0.0022859254,0.0066685113,0.0047345734,0.01213567,0.0055923588,0.011116912,0.012377045],"category_scores_gemma":[0.15866533,0.00092763506,0.0018268932,0.009057588,0.008549968,0.0042896336,0.0039458903,0.014143296,0.0010607122],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003673048,0.00016446732,0.012380148,0.0016349984,0.00032187966,0.00037397956,0.0016285613,0.0047147023,0.00016502476,0.26416847,0.5578584,0.15622216],"study_design_scores_gemma":[0.0007425908,0.00020458421,0.05180429,0.019785753,0.00078074035,0.00047109506,0.0034591397,0.008949491,0.0002698923,0.13762796,0.77530736,0.00059711456],"about_ca_topic_score_codex":0.9724955,"about_ca_topic_score_gemma":0.9751865,"teacher_disagreement_score":0.9724955,"about_ca_system_score_codex":0.10576448,"about_ca_system_score_gemma":0.27648863,"threshold_uncertainty_score":0.76737857},"labels":[],"label_agreement":null},{"id":"W2995421271","doi":"10.1016/j.jval.2019.09.2328","title":"PPM11 TUMOUR-SPECIFIC RANDOMIZED CONTROLLED TRIALS IN RARE ONCOGENE-DRIVEN CANCERS: ASKING FOR THE IMPOSSIBLE?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Memorial University of Newfoundland","funders":"","keywords":"Medicine; Randomized controlled trial; Sample size determination; Clinical trial; Internal medicine; Oncology; Hazard ratio; Confidence interval; Statistics","score_opus":0.04023934404654731,"score_gpt":0.3192069739619339,"score_spread":0.2789676299153866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995421271","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.095534585,0.44416615,0.035439286,0.3704528,0.030904852,0.004781959,0.0030759857,0.0005671084,0.015077247],"genre_scores_gemma":[0.72218144,0.070193514,0.040774345,0.13738175,0.014993986,0.009137297,0.0012371042,0.00022675096,0.0038738693],"study_design_codex":"randomized_trial","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.93311805,0.057637278,0.004047688,0.0021035767,0.0019759382,0.0011175076],"domain_scores_gemma":[0.8445779,0.13357173,0.010092032,0.0055724033,0.0034410725,0.0027448402],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07708823,0.0009938058,0.007025158,0.00054369244,0.00070688204,0.004057761,0.0018782135,0.0057535465,0.0074226437],"category_scores_gemma":[0.12022144,0.0007083612,0.006732393,0.0012765373,0.004513521,0.0058870376,0.0015855295,0.00876159,0.0009929285],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36558914,0.0013186133,0.007994672,0.057520665,0.07261451,0.00031326918,0.0011437654,0.003978747,0.0023984448,0.05410852,0.068819635,0.36420012],"study_design_scores_gemma":[0.54176635,0.032476958,0.016656866,0.043171793,0.04685876,0.00040981648,0.0013549466,0.0058870628,0.0016701323,0.15247776,0.1568608,0.00040880876],"about_ca_topic_score_codex":0.0014506661,"about_ca_topic_score_gemma":0.003149985,"teacher_disagreement_score":0.92291176,"about_ca_system_score_codex":0.00221525,"about_ca_system_score_gemma":0.0035488398,"threshold_uncertainty_score":0.4076864},"labels":[],"label_agreement":null},{"id":"W2995451028","doi":"10.1016/j.jval.2019.09.2395","title":"PRO65 VARIABILITY IN AGE AT LOSS OF AMBULATION BY GENOTYPE AMONG BOYS WITH DUCHENNE MUSCULAR DYSTROPHY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Genotype; Exon; Medicine; Confidence interval; Duchenne muscular dystrophy; Dystrophin; Pediatrics; Internal medicine; Genetics; Biology; Gene","score_opus":0.006206016705310842,"score_gpt":0.2251929632491145,"score_spread":0.21898694654380366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995451028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99948657,0.00008689005,0.000083665975,0.000012697327,0.000003725926,0.0000018220086,0.00012027258,0.0000045653264,0.00019980836],"genre_scores_gemma":[0.99953854,0.000022394126,0.000040138148,0.000007219539,0.000003267872,0.0000021995431,0.000095606745,0.0000045339325,0.00028619467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99932814,0.00018063937,0.000062107814,0.00020013195,0.00011445709,0.000114558],"domain_scores_gemma":[0.9988071,0.00038394422,0.00040512177,0.00006507001,0.00010776981,0.00023110898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004479339,0.0005311698,0.00044684025,0.0015067296,0.00040542183,0.0006526231,0.0003404993,0.00065253756,0.0023656155],"category_scores_gemma":[0.0014792201,0.000261619,0.00039945426,0.0008427054,0.00033480165,0.0002959633,0.0005087725,0.0004790083,0.00048447715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062791584,0.0000737492,0.98746103,0.0000129346445,0.000098132674,0.0008771468,0.00057002256,0.00016788066,0.0071483315,0.00006759041,0.00007921995,0.0028160017],"study_design_scores_gemma":[0.000004480508,0.00016562112,0.998044,0.0000046072428,0.000017274895,0.00086632697,0.00032138597,0.00015876051,0.00026684493,0.000021372334,0.00012370921,0.000005584438],"about_ca_topic_score_codex":0.0039516855,"about_ca_topic_score_gemma":0.0024767772,"teacher_disagreement_score":0.0039516855,"about_ca_system_score_codex":0.00022242252,"about_ca_system_score_gemma":0.00010136823,"threshold_uncertainty_score":0.007913768},"labels":[],"label_agreement":null},{"id":"W2995453878","doi":"10.1016/j.jval.2019.10.012","title":"Ranking the Criteria Used in the Appraisal of Drugs for Reimbursement: A Stated Preferences Elicitation With Health Technology Assessment Stakeholders Across Jurisdictional Contexts","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Reimbursement; Health technology; Actuarial science; Ranking (information retrieval); Gatekeeping; Multidisciplinary approach; Economic evaluation; Medicine; Public economics; Business; Health care; Economics; Political science; Computer science","score_opus":0.4215895903042945,"score_gpt":0.4946185477543377,"score_spread":0.07302895745004323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995453878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94444376,0.00042808728,0.03314637,0.0034162807,0.000039617382,0.0013963963,0.0006917335,0.000033349566,0.016404403],"genre_scores_gemma":[0.9593663,0.00013969668,0.0390027,0.00029495233,0.000013041401,0.00058649434,0.00027416676,0.000011850144,0.00031081773],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9283625,0.05913379,0.00364419,0.0011206542,0.0059602354,0.0017786995],"domain_scores_gemma":[0.7924223,0.17426604,0.0072972393,0.003860554,0.019623507,0.002530336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.062048722,0.00059695117,0.0010034355,0.00392586,0.0031203479,0.00647949,0.0012567214,0.0025002954,0.0038176663],"category_scores_gemma":[0.1872079,0.00043433747,0.0014914789,0.0034749415,0.0016801019,0.0038359966,0.0054509547,0.0026224996,0.000396554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008806849,0.0051998296,0.20975633,0.004375475,0.0016290967,0.0031782237,0.15735503,0.047590733,0.021663675,0.08719629,0.017933922,0.4353146],"study_design_scores_gemma":[0.0022868966,0.0057986504,0.20069867,0.0036965443,0.0014411026,0.0013663837,0.27964067,0.2499412,0.020987934,0.17966668,0.053444486,0.0010308425],"about_ca_topic_score_codex":0.008644578,"about_ca_topic_score_gemma":0.0125936745,"teacher_disagreement_score":0.062048722,"about_ca_system_score_codex":0.0052233064,"about_ca_system_score_gemma":0.0060653356,"threshold_uncertainty_score":0.3281489},"labels":[],"label_agreement":null},{"id":"W2995466058","doi":"10.1016/j.jval.2019.09.2736","title":"SP2 DISCREPANCY IN HEALTH STATE UTILITY VALUES BETWEEN COST-UTILITY ANALYSIS AND REFERENCED ORIGINAL HEALTH UTILITY STUDIES IN CARDIOVASCULAR DISEASE: A REGISTRY-BASED ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cost–utility analysis; Quality-adjusted life year; Disease; Environmental health; Cost effectiveness; Risk analysis (engineering); Internal medicine","score_opus":0.4555989122277066,"score_gpt":0.4638549586848619,"score_spread":0.008256046457155275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995466058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9139264,0.0028252169,0.05471852,0.0010692031,0.0001974011,0.00032392092,0.016966585,0.00029105548,0.009681667],"genre_scores_gemma":[0.99149007,0.00012783089,0.0034215879,0.00012163811,0.000034199515,0.000085999476,0.004150422,0.000057239395,0.00051095797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.95326793,0.034273773,0.0038708842,0.003383283,0.004637136,0.00056706223],"domain_scores_gemma":[0.6901571,0.26361355,0.015192311,0.018469155,0.011890933,0.0006769156],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06725383,0.0006194533,0.0010056386,0.005099932,0.0005303447,0.0026454383,0.0014427918,0.0008119839,0.0049683186],"category_scores_gemma":[0.21739171,0.00043369638,0.003559939,0.0056893025,0.0011746639,0.001509379,0.0025614386,0.0022630815,0.0006541811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043050586,0.00026099887,0.88879377,0.0008996019,0.009686476,0.0007855355,0.0010331185,0.024374513,0.0009671402,0.00901705,0.009464777,0.050411977],"study_design_scores_gemma":[0.00048634093,0.0012028699,0.82594156,0.00054221065,0.0057229465,0.0042850156,0.0018880779,0.120031595,0.0044837105,0.02365135,0.011585674,0.00017860661],"about_ca_topic_score_codex":0.0037818842,"about_ca_topic_score_gemma":0.002024102,"teacher_disagreement_score":0.9327462,"about_ca_system_score_codex":0.0010748708,"about_ca_system_score_gemma":0.0009328386,"threshold_uncertainty_score":0.35567647},"labels":[],"label_agreement":null},{"id":"W2995535198","doi":"10.1016/j.jval.2019.09.1260","title":"PIN15 THE VALUE OF ACHIEVING OPTIMAL ADHERENCE WITH LONG-ACTING DIRECTLY OBSERVED ANTIRETROVIRAL THERAPY (LA DOT ART) AMONGST PATIENTS LIVING WITH HIV-1 INFECTION: A MODELLING STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Dosing; Antiretroviral therapy; Viral load; Cohort; Transmission (telecommunications); Human immunodeficiency virus (HIV); Quality of life (healthcare); Medication adherence; Health care; Intensive care medicine; Internal medicine; Family medicine","score_opus":0.06000358241910445,"score_gpt":0.3252636823510242,"score_spread":0.26526009993191974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995535198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823735,0.0012463821,0.006294508,0.0014543916,0.000052495718,0.000310131,0.0015296675,0.000057981364,0.00668088],"genre_scores_gemma":[0.9965496,0.0002706018,0.0012363648,0.000109664565,0.000013557419,0.00016923642,0.0002593841,0.0000098755445,0.0013816006],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972072,0.0020465674,0.000082736195,0.00019362582,0.000092251554,0.00037755436],"domain_scores_gemma":[0.9585562,0.037651937,0.0018371535,0.00058895786,0.00056137255,0.00080436683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004964223,0.0014655272,0.0016235467,0.00084483396,0.00068349065,0.0025540749,0.0024775572,0.0028818494,0.008749171],"category_scores_gemma":[0.023455776,0.00092261564,0.003734171,0.0009695556,0.0009251447,0.0017353725,0.0015711227,0.0029606884,0.00058686105],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00865159,0.0031477506,0.07495462,0.0008883687,0.0028773318,0.00068443007,0.001125439,0.8764842,0.00037415823,0.010829452,0.001695158,0.018287482],"study_design_scores_gemma":[0.0013620589,0.005355054,0.019780181,0.00028049553,0.001479137,0.00030264855,0.0009332151,0.9606663,0.00023834538,0.008198154,0.0012857089,0.00011867779],"about_ca_topic_score_codex":0.030442031,"about_ca_topic_score_gemma":0.01457112,"teacher_disagreement_score":0.030442031,"about_ca_system_score_codex":0.0025943,"about_ca_system_score_gemma":0.0022282423,"threshold_uncertainty_score":0.06052965},"labels":[],"label_agreement":null},{"id":"W2995561666","doi":"10.1016/j.jval.2019.09.1541","title":"PMH67 ANALYSIS OF PSYCHOTROPIC MEDICATIONS PRESCRIPTIONS IN TURKEY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Psychological Treatments and Assessments","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polypharmacy; Medical prescription; Medicine; Psychotropic drug; Family medicine; Psychiatry; Quarter (Canadian coin); Health care; Drug; Pharmacology","score_opus":0.08424708840107599,"score_gpt":0.43444519281258115,"score_spread":0.3501981044115052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995561666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980361,0.00044729802,0.00004289802,0.000051344803,0.000007564812,0.000005219269,0.0007459604,0.0000034700686,0.00066017435],"genre_scores_gemma":[0.9988531,0.00015535929,0.00007938133,0.000023728073,0.000006782069,0.000004038986,0.00063594274,0.0000022865036,0.00023948739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968755,0.000051872987,0.000048162714,0.000050462928,0.000085182546,0.00007672591],"domain_scores_gemma":[0.9995091,0.00009793712,0.00020845783,0.000015894937,0.00011246776,0.000056113262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018776536,0.00018245827,0.00025317667,0.0011020257,0.00023392719,0.00035195766,0.00021949396,0.00020343358,0.0015067253],"category_scores_gemma":[0.0005351558,0.00014096223,0.00042774825,0.0013464444,0.00012320951,0.00012266381,0.00022687913,0.000276308,0.00020316568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021734207,0.000059094265,0.9877543,0.00006435541,0.000069122994,0.00043921891,0.00012078118,0.000118045864,0.000611337,0.00006753599,0.00047591454,0.010002871],"study_design_scores_gemma":[0.0000027825215,0.00005382607,0.9985613,0.000010246555,0.000024128954,0.00032701928,0.0002280373,0.00014005174,0.00014683245,0.000011734141,0.0004913619,0.0000025691127],"about_ca_topic_score_codex":0.012719786,"about_ca_topic_score_gemma":0.010160786,"teacher_disagreement_score":0.012719786,"about_ca_system_score_codex":0.0005679942,"about_ca_system_score_gemma":0.0007473963,"threshold_uncertainty_score":0.025291502},"labels":[],"label_agreement":null},{"id":"W2995580028","doi":"10.1016/j.jval.2019.09.2460","title":"PRO131 WHAT DO WE KNOW ABOUT PATIENT'S AND CAREGIVERS' EXPERIENCE WHEN LIVING WITH THE HEREDITARY RETINAL CONDITION RETINITIS PIGMENTOSA?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Retinitis pigmentosa; Thematic analysis; Medicine; Quality of life (healthcare); International Classification of Functioning, Disability and Health; RPE65; Qualitative research; Psychology; Clinical psychology; Physical therapy; Ophthalmology; Rehabilitation; Retinal; Nursing","score_opus":0.0152273162949261,"score_gpt":0.26572605024777374,"score_spread":0.25049873395284766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995580028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.583254,0.06378409,0.0004681848,0.27388608,0.002027018,0.000084993415,0.0016960647,0.0000252683,0.07477441],"genre_scores_gemma":[0.94057304,0.03369628,0.0005780745,0.016991576,0.0016552835,0.000105943036,0.0007002337,0.000012902615,0.00568662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999244,0.00043641927,0.000058986818,0.000025999401,0.00012095198,0.000113730224],"domain_scores_gemma":[0.99349666,0.0029172108,0.0011892972,0.00007654892,0.0010954458,0.001224875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010919174,0.00010456083,0.0003214825,0.00059290574,0.0009516829,0.0014330538,0.00023119412,0.0011832797,0.008018431],"category_scores_gemma":[0.0151586365,0.00011172114,0.00024128016,0.0007171206,0.0007269969,0.0017769971,0.0004902196,0.0011814923,0.0009072912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044337238,0.00063651294,0.5566108,0.00174768,0.000111807676,0.002664791,0.021266121,0.00007754484,0.00050276646,0.0021735507,0.08100016,0.3327649],"study_design_scores_gemma":[0.00007227773,0.00058260746,0.7132752,0.0049418337,0.0001355682,0.0063087414,0.11804935,0.00015943096,0.00031161855,0.002590594,0.15347351,0.000099299854],"about_ca_topic_score_codex":0.0071707107,"about_ca_topic_score_gemma":0.015610165,"teacher_disagreement_score":0.008018431,"about_ca_system_score_codex":0.000656579,"about_ca_system_score_gemma":0.0015844014,"threshold_uncertainty_score":0.026824355},"labels":[],"label_agreement":null},{"id":"W2995599161","doi":"10.1016/j.jval.2019.09.1565","title":"PMS21 PRELIMINARY RESULTS OF A COST-UTILITY ANALYSIS OF A FRACTURE LIAISON SERVICE BASED ON HEALTH SERVICES INDICATORS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Attendance; Medicine; Health care; Fragility; Actuarial science; Demography; Gerontology; Economics","score_opus":0.2005420108421545,"score_gpt":0.4076456322731381,"score_spread":0.2071036214309836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995599161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9535256,0.0005744407,0.011703971,0.0023547814,0.00010568212,0.0009177795,0.0123520745,0.00022888114,0.018236812],"genre_scores_gemma":[0.9865377,0.00016978962,0.00413607,0.00012377965,0.00004916548,0.00022150339,0.0040315073,0.000034488046,0.004695924],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9965497,0.002523789,0.000104315055,0.00012973083,0.0004975364,0.00019488246],"domain_scores_gemma":[0.9746338,0.022145195,0.00043770619,0.000613063,0.0018982074,0.0002720287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047067953,0.0008713939,0.0011388357,0.002320909,0.00048600748,0.0010750772,0.00083797664,0.0007200331,0.011609563],"category_scores_gemma":[0.026121905,0.000320243,0.0022627949,0.0029384452,0.00041808025,0.00074287417,0.00062786357,0.0010655767,0.0005690904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015906394,0.0028290101,0.17387125,0.0010751223,0.0017801154,0.0018544868,0.0005338017,0.6646648,0.0026628633,0.015193687,0.028201306,0.09142715],"study_design_scores_gemma":[0.0020587908,0.0045742095,0.24961577,0.000069131725,0.0012129553,0.000385126,0.0013087575,0.708874,0.0049374895,0.016891612,0.009954513,0.00011762159],"about_ca_topic_score_codex":0.07076462,"about_ca_topic_score_gemma":0.034873866,"teacher_disagreement_score":0.07076462,"about_ca_system_score_codex":0.0037343255,"about_ca_system_score_gemma":0.00248696,"threshold_uncertainty_score":0.14070547},"labels":[],"label_agreement":null},{"id":"W2995618478","doi":"10.1016/j.jval.2019.09.1168","title":"PGI46 DISEASE BURDEN, SYMPTOMS ASSOCIATED WITH TREATMENT-SEEKING AND REMISSION DEFINITION: A QUALITATIVE STUDY IN ADULT AND ADOLESCENT PATIENTS WITH CROHN'S DISEASE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Abdominal pain; Disease; Diarrhea; Internal medicine; Thematic analysis; Crohn's disease; Young adult; Physical therapy; Qualitative research","score_opus":0.01550078949732708,"score_gpt":0.2756693564290811,"score_spread":0.260168566931754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995618478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99821556,0.00017709465,0.0001593278,0.0007739279,0.0000124245,0.00005200801,0.00012722822,0.0000015214436,0.000481029],"genre_scores_gemma":[0.99885976,0.00015568011,0.00024376316,0.00033624354,0.00000405636,0.00008691917,0.00006960659,0.0000026632927,0.00024129207],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9954039,0.003003502,0.0003049333,0.00022460068,0.00033382207,0.00072930765],"domain_scores_gemma":[0.9895844,0.006106937,0.0017400678,0.0001980289,0.00079514075,0.0015755526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076344423,0.00025546586,0.0006220357,0.0009387781,0.0035800182,0.0024743185,0.0007391548,0.0007988471,0.0016273042],"category_scores_gemma":[0.012898707,0.00044911267,0.00059783115,0.0010323407,0.0026946664,0.0017662755,0.0037264798,0.002399962,0.00011485033],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000805862,0.0001877266,0.23552851,0.0001909564,0.000036434307,0.00037164835,0.756919,0.000044604712,0.0004551749,0.00052054407,0.0005344081,0.005130403],"study_design_scores_gemma":[0.000010775361,0.00009972868,0.06574612,0.0001556468,0.000012412754,0.000257625,0.93150294,0.000085743864,0.00011537306,0.00012834575,0.0018615475,0.00002365743],"about_ca_topic_score_codex":0.025076,"about_ca_topic_score_gemma":0.0429548,"teacher_disagreement_score":0.025076,"about_ca_system_score_codex":0.004753837,"about_ca_system_score_gemma":0.005396947,"threshold_uncertainty_score":0.04986006},"labels":[],"label_agreement":null},{"id":"W2995624503","doi":"10.1016/j.jval.2019.09.249","title":"PCN52 ABIRATERONE VERSUS ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Enzalutamide; Abiraterone; Prostate cancer; Medicine; Oncology; Chemotherapy; Internal medicine; Docetaxel; Cancer; Urology; Androgen receptor","score_opus":0.059171874472310246,"score_gpt":0.38392891040404814,"score_spread":0.3247570359317379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995624503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981164,0.00096904824,0.00006960011,0.000051485447,0.000026548729,0.000047494214,0.0002751289,0.0000059547488,0.00043841978],"genre_scores_gemma":[0.99887604,0.00035438966,0.000055051638,0.00008441231,0.000044496886,0.00003855588,0.00025819283,0.000003169795,0.000285704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986539,0.0005417723,0.00010771701,0.00031425784,0.00019333448,0.00018893875],"domain_scores_gemma":[0.9984999,0.00038639386,0.00048880087,0.00012182901,0.00014830711,0.0003548021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013154536,0.00072736974,0.0013679699,0.00052167533,0.00050723826,0.0011318248,0.00059068284,0.001318703,0.0024131013],"category_scores_gemma":[0.0035770517,0.00056397787,0.0017623814,0.0011863422,0.00056556833,0.00095147215,0.00050274964,0.0015912564,0.00039430434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3069162,0.007385676,0.6471026,0.00040680415,0.007950757,0.00038906583,0.0004454733,0.00055408257,0.0023907518,0.00012697933,0.001135135,0.025196418],"study_design_scores_gemma":[0.013026092,0.05693796,0.9202049,0.0000750002,0.005621184,0.0004589117,0.0005795575,0.0010156473,0.00031917077,0.00022814739,0.0014445442,0.000088963156],"about_ca_topic_score_codex":0.004025184,"about_ca_topic_score_gemma":0.006109425,"teacher_disagreement_score":0.004025184,"about_ca_system_score_codex":0.00071134424,"about_ca_system_score_gemma":0.000737889,"threshold_uncertainty_score":0.008072615},"labels":[],"label_agreement":null},{"id":"W2995627578","doi":"10.1016/j.jval.2019.09.2397","title":"PRO67 UTILITY VALUES FOR HEALTH STATES ASSOCIATED WITH DUCHENNE MUSCULAR DYSTROPHY: A SYSTEMATIC REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; EQ-5D; Respondent; Quality of life (healthcare); Ambulatory; Health related quality of life; MEDLINE; Physical therapy; Pediatrics; Gerontology; Disease; Internal medicine","score_opus":0.15159876406443257,"score_gpt":0.42624683226003407,"score_spread":0.2746480681956015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995627578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010447805,0.99806064,0.00010268768,0.00011168157,0.00005742929,0.00006209522,0.000427227,0.0000053439367,0.00012805246],"genre_scores_gemma":[0.053975742,0.9436087,0.0009491696,0.0006821889,0.00010142227,0.00020196366,0.00036242531,0.000008820484,0.0001095407],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9933288,0.0025432496,0.0021424543,0.0006487529,0.0011248842,0.00021185007],"domain_scores_gemma":[0.96725804,0.026852373,0.0043184627,0.0003333107,0.0010143003,0.00022346155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071217087,0.0014323763,0.008533273,0.007927164,0.0003925504,0.002996881,0.0014490403,0.0017917746,0.006143607],"category_scores_gemma":[0.04400452,0.0010971475,0.013447435,0.008471426,0.0010873413,0.0019745661,0.0023139734,0.0025054098,0.00025339978],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008284851,0.000028536871,0.0054702586,0.8477029,0.081644386,0.000103900056,0.00016396343,0.00027608164,0.00010413903,0.0005936632,0.0022457219,0.060838033],"study_design_scores_gemma":[0.0015219024,0.00031181236,0.0178317,0.5134154,0.44821134,0.0005205206,0.00037267467,0.00035855893,0.00016686135,0.0015506062,0.015608396,0.00013031128],"about_ca_topic_score_codex":0.008413105,"about_ca_topic_score_gemma":0.02331794,"teacher_disagreement_score":0.008533273,"about_ca_system_score_codex":0.0029479254,"about_ca_system_score_gemma":0.0043595913,"threshold_uncertainty_score":0.03766364},"labels":[],"label_agreement":null},{"id":"W2995676398","doi":"10.1016/j.jval.2019.09.085","title":"ON5 DEVELOPMENT AND TESTING OF PATIENT-REPORTED OUTCOME PERFORMANCE MEASURES (PRO-PMS) FOR COMPARING ONCOLOGY PRACTICES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nausea; Internal medicine; Constipation; Vomiting; Anxiety; Quality of life (healthcare); Physical therapy; Psychiatry","score_opus":0.2590660895548335,"score_gpt":0.39554645827610435,"score_spread":0.13648036872127084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995676398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9133195,0.0010474051,0.03221495,0.0016534963,0.0004054338,0.009334755,0.013399261,0.0003292245,0.028295947],"genre_scores_gemma":[0.9093981,0.0003206351,0.06816608,0.0006032529,0.00010346433,0.0075321198,0.010444432,0.00007851344,0.0033534705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9531843,0.030337738,0.005077059,0.0017008532,0.008448989,0.0012510993],"domain_scores_gemma":[0.87927604,0.07529973,0.017180337,0.006334141,0.019770563,0.002139192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04861422,0.00075396296,0.0006946182,0.0024551374,0.0006310648,0.0030362802,0.0017606156,0.0011510712,0.0060973656],"category_scores_gemma":[0.1090693,0.00032223063,0.0023051482,0.0022488956,0.0007047373,0.0015309964,0.0023570466,0.0009345359,0.0015190482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024804485,0.0016032972,0.8452153,0.00058088213,0.0006682502,0.00006837688,0.0008497051,0.0011734052,0.0010037422,0.0023912436,0.0033509822,0.14061439],"study_design_scores_gemma":[0.0006770732,0.009289066,0.9465077,0.00061771506,0.00049099623,0.00022721174,0.0022551066,0.010048719,0.006845704,0.0025598304,0.020404948,0.00007586176],"about_ca_topic_score_codex":0.003408369,"about_ca_topic_score_gemma":0.0045941058,"teacher_disagreement_score":0.04861422,"about_ca_system_score_codex":0.0018994858,"about_ca_system_score_gemma":0.0047133467,"threshold_uncertainty_score":0.25709963},"labels":[],"label_agreement":null},{"id":"W2995697325","doi":"10.1016/j.jval.2019.09.1316","title":"PIN75 WHAT WE KNOW NOW: REVISITING THE COST-EFFECTIVENESS OF CHICKENPOX VACCINATION USING AN AGENT-BASED MODEL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Animal Disease Management and Epidemiology","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"","keywords":"Chickenpox; Shingles; Medicine; Vaccination; Chickenpox Vaccine; Cost effectiveness; Varicella zoster virus; Pediatrics; Immunology; Immunization; Varicella vaccine; Risk analysis (engineering); Virus","score_opus":0.1413402650637444,"score_gpt":0.34276130102507063,"score_spread":0.20142103596132624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995697325","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35623074,0.029063879,0.44488662,0.05844163,0.0020262096,0.0005532414,0.0023478689,0.0002415437,0.106208295],"genre_scores_gemma":[0.95338094,0.008656157,0.024503369,0.0022519783,0.00030059728,0.0001803593,0.00021838758,0.00007026009,0.010437944],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990694,0.00063398026,0.000030190704,0.000087397195,0.00010654487,0.00007251773],"domain_scores_gemma":[0.9942213,0.005162821,0.00018964884,0.00011954138,0.00021313054,0.00009362066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002505959,0.00079714536,0.0015263371,0.0004919872,0.00025970192,0.0021007163,0.001975667,0.0016801842,0.009540442],"category_scores_gemma":[0.010710721,0.0003802398,0.00094799016,0.00066082244,0.0009889798,0.0032498473,0.00066779513,0.0024528075,0.0004959844],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037647114,0.0002158363,0.002976055,0.00070029864,0.00032506714,0.00016413962,0.00006907654,0.7878429,0.0007847192,0.15328716,0.0046234922,0.048634768],"study_design_scores_gemma":[0.00013362209,0.00032349836,0.0015408648,0.0002770642,0.00027433896,0.000091400674,0.00010431875,0.8395962,0.00047405448,0.14905857,0.008087617,0.000038548504],"about_ca_topic_score_codex":0.011535732,"about_ca_topic_score_gemma":0.0061571724,"teacher_disagreement_score":0.011535732,"about_ca_system_score_codex":0.0016540099,"about_ca_system_score_gemma":0.0018003561,"threshold_uncertainty_score":0.031915963},"labels":[],"label_agreement":null},{"id":"W2995728682","doi":"10.1016/j.jval.2019.09.571","title":"PCN376 ACCESS TO ONCOLOGY THERAPIES IN RUSSIA AND VISEGRAD GROUP COUNTRIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Orphan drug; Czech; Medicine; Family medicine; Oncology; Quarter (Canadian coin); Business; Internal medicine; Economic growth; Health care; Economics; Geography; Bioinformatics","score_opus":0.37961848078322585,"score_gpt":0.4638089895472058,"score_spread":0.08419050876397993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995728682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864943,0.0009706226,0.000114669645,0.0007076858,0.00002244062,0.0000074567624,0.0022633444,0.000006024945,0.0094134845],"genre_scores_gemma":[0.99758554,0.00031949897,0.000043180473,0.000049462487,0.0000099602385,0.000008178845,0.0011315388,0.000003326997,0.0008493035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947244,0.00014337341,0.00003080422,0.000048783186,0.00006661185,0.00023794977],"domain_scores_gemma":[0.9989675,0.0002141202,0.0003946268,0.0000403233,0.000119233024,0.00026422192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055364973,0.000082273335,0.00021125899,0.0010433507,0.00030934537,0.0012308958,0.00025452208,0.0002481539,0.0027658304],"category_scores_gemma":[0.0017185949,0.00008862069,0.00030842217,0.0014491715,0.00029431918,0.00031736988,0.0011438385,0.00047115775,0.00022631868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007904773,0.00014544379,0.9343473,0.00015207111,0.000315218,0.00067543145,0.0009855679,0.002597226,0.0006882177,0.021309545,0.006059404,0.03193416],"study_design_scores_gemma":[0.000029040804,0.00007288725,0.98192835,0.00008723635,0.00006008477,0.00030996892,0.001375669,0.0008112589,0.00020161619,0.0011198731,0.01399604,0.0000080094305],"about_ca_topic_score_codex":0.031602077,"about_ca_topic_score_gemma":0.022514,"teacher_disagreement_score":0.031602077,"about_ca_system_score_codex":0.0013254377,"about_ca_system_score_gemma":0.002167391,"threshold_uncertainty_score":0.06283629},"labels":[],"label_agreement":null},{"id":"W2995755707","doi":"10.1016/j.jval.2019.09.888","title":"PDB6 LONG-TERM ASSOCIATION OF OBSERVED VERSUS PREDICTED MICRO- AND MACROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES MELLITUS: EXTERNAL VALIDATION OF THE CORNERSTONE DIABETES SIMULATION MODEL (CDSM)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Macrovascular disease; Type 1 diabetes; Diabetes mellitus; Incidence (geometry); Term (time); Internal medicine; Physical therapy; Type 2 diabetes; Endocrinology; Mathematics","score_opus":0.07182885755864084,"score_gpt":0.32474521389005545,"score_spread":0.2529163563314146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995755707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97868437,0.00012119496,0.010285688,0.00040268846,0.00011941503,0.00006392089,0.0076791765,0.00033521996,0.0023082634],"genre_scores_gemma":[0.9856802,0.00005569193,0.005296961,0.0000961177,0.000020255038,0.00007872899,0.0078037507,0.000045097688,0.00092316954],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991897,0.0004332498,0.000041033643,0.0001767332,0.00009538061,0.00006392678],"domain_scores_gemma":[0.9893042,0.008196375,0.00043527217,0.0008132513,0.0008978765,0.00035304218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037606964,0.0005326282,0.0006797078,0.00055151107,0.00036836395,0.0008703172,0.0011563479,0.0011784206,0.0035337529],"category_scores_gemma":[0.012896625,0.00033704937,0.00095345406,0.00059396226,0.00037212917,0.00034541963,0.00068381935,0.0011336381,0.0006847173],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025959776,0.0008704197,0.15267451,0.00014810765,0.00058636506,0.00020598627,0.00011238781,0.8186181,0.0008350397,0.002045901,0.005896602,0.0154107],"study_design_scores_gemma":[0.00032023407,0.00037342808,0.020045368,0.000026121457,0.000091411915,0.00009035331,0.000056767396,0.97563034,0.00093438884,0.001189738,0.0012114485,0.000030392295],"about_ca_topic_score_codex":0.029970884,"about_ca_topic_score_gemma":0.012800071,"teacher_disagreement_score":0.029970884,"about_ca_system_score_codex":0.00090409565,"about_ca_system_score_gemma":0.0014992037,"threshold_uncertainty_score":0.059592843},"labels":[],"label_agreement":null},{"id":"W2995767116","doi":"10.1016/j.jval.2019.09.2565","title":"PSS3 INDUCTION COST PER RESPONDER OF BRODALUMAB COMPARED WITH OTHER BIOLOGICS APPROVED FOR PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Ixekizumab; Ustekinumab; Medicine; Secukinumab; Etanercept; Infliximab; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Dermatology; Psoriatic arthritis; Internal medicine; Tumor necrosis factor alpha","score_opus":0.2527293837330802,"score_gpt":0.35371938499942923,"score_spread":0.10099000126634905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995767116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94796705,0.015358184,0.00038178006,0.0074835857,0.00019660714,0.00031222685,0.014476711,0.0000678833,0.013755872],"genre_scores_gemma":[0.99227774,0.0027380083,0.00024788055,0.00053252396,0.000043108223,0.000038985723,0.0021504762,0.000013780029,0.0019575483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985858,0.00029310345,0.00010212004,0.00015372665,0.0004415157,0.00042366554],"domain_scores_gemma":[0.9965397,0.0007012377,0.00061904377,0.00006407341,0.0009096899,0.0011661937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096036616,0.0003028966,0.0010230142,0.00072398945,0.0008931137,0.0017782568,0.001145431,0.0006228108,0.0048129396],"category_scores_gemma":[0.004930746,0.00036743993,0.002814514,0.0019952264,0.00060069293,0.00035011617,0.00048744484,0.0016035303,0.000200985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09613223,0.001896854,0.50898963,0.0040142997,0.008634464,0.0012694848,0.00084684556,0.072430484,0.002935267,0.008931865,0.07385137,0.22006726],"study_design_scores_gemma":[0.013104568,0.0032331524,0.92999035,0.00099959,0.0050684833,0.00055855524,0.0013525143,0.029620923,0.0008297477,0.0009494892,0.0141006885,0.00019186591],"about_ca_topic_score_codex":0.98772323,"about_ca_topic_score_gemma":0.9894243,"teacher_disagreement_score":0.085236095,"about_ca_system_score_codex":0.085236095,"about_ca_system_score_gemma":0.072778575,"threshold_uncertainty_score":0.6184341},"labels":[],"label_agreement":null},{"id":"W2995792315","doi":"10.1016/j.jval.2019.09.039","title":"AD3 ORAL ANTICOAGULANT PRESCRIPTION TRENDS, PROFILE USE AND DETERMINANTS OF ADHERENCE IN PATIENTS WITH ATRIAL FIBRILLATION","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Apixaban; Medicine; Rivaroxaban; Atrial fibrillation; Cohort; Warfarin; Logistic regression; Internal medicine; Medical prescription; Persistence (discontinuity); Oral anticoagulant; Cohort study; Pharmacology","score_opus":0.08758697975023697,"score_gpt":0.3378493194199908,"score_spread":0.25026233966975386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995792315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982152,0.00032349015,0.000046303743,0.00011162112,0.000009616411,0.0000042878046,0.00053158123,0.0000030235929,0.0007549196],"genre_scores_gemma":[0.99911565,0.00013609602,0.00005297474,0.00005024874,0.0000149079515,0.0000041519543,0.00035990714,0.0000015157405,0.00026457306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994721,0.00009622732,0.00012192997,0.00010000096,0.000092615424,0.00011730453],"domain_scores_gemma":[0.9978765,0.00061306794,0.0009438747,0.00014224972,0.0001699228,0.00025434856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006204087,0.0001543235,0.00036637226,0.000603531,0.0004674385,0.0011417354,0.00028908867,0.0007192001,0.0023041691],"category_scores_gemma":[0.004292445,0.00021142968,0.0007735301,0.0015836458,0.00016212788,0.00077852176,0.00040750418,0.0011116734,0.0002449018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100226905,0.00006290357,0.9980591,0.000007328454,0.000059440612,0.000020958832,0.000052357194,0.000033899647,0.000039569597,0.000017061297,0.00007133179,0.0014756911],"study_design_scores_gemma":[0.000006889715,0.00007873417,0.9989888,0.000009214017,0.000039555456,0.0001027967,0.00021301169,0.00034077256,0.000022183185,0.000043939675,0.00014991504,0.0000040937753],"about_ca_topic_score_codex":0.014410164,"about_ca_topic_score_gemma":0.018109608,"teacher_disagreement_score":0.014410164,"about_ca_system_score_codex":0.000364042,"about_ca_system_score_gemma":0.00056786963,"threshold_uncertainty_score":0.028652608},"labels":[],"label_agreement":null},{"id":"W2995845770","doi":"10.1016/j.jval.2019.09.311","title":"PCN114 ASSESSMENT OF THE SURVIVAL BENEFIT AND COST IMPACT OF NEW TREATMENTS FOR KEY ANSCLC BIOMARKERS USING THE ITEN MODEL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Dabrafenib; Alectinib; Medicine; Trametinib; Oncology; Pembrolizumab; Osimertinib; Lung cancer; Internal medicine; Erlotinib; Vemurafenib; Crizotinib; Cancer; Immunotherapy","score_opus":0.11917166889007196,"score_gpt":0.3461158137998317,"score_spread":0.22694414490975973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995845770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7222096,0.002469511,0.1623548,0.0057986844,0.00040072115,0.00039803408,0.014141217,0.00047503907,0.091752455],"genre_scores_gemma":[0.9731367,0.0003618476,0.0066512404,0.00028561568,0.000055106942,0.00014634265,0.0028124272,0.00004761996,0.016503107],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994147,0.00031769476,0.000014536507,0.00007644011,0.00007420915,0.000102417696],"domain_scores_gemma":[0.99682117,0.0024850443,0.00015632501,0.00012844309,0.00028442426,0.00012442961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00243654,0.00064051844,0.00103813,0.0009354273,0.00025985794,0.0012139428,0.0013238305,0.0010627446,0.013609169],"category_scores_gemma":[0.0071320096,0.000354049,0.0016046881,0.00084177405,0.0004085201,0.00075336546,0.00066434726,0.0013030482,0.0007856259],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033172578,0.0000732927,0.0038881144,0.00006225695,0.0001235722,0.000067400215,0.000009133266,0.9735242,0.000115587005,0.009220878,0.003088121,0.009495758],"study_design_scores_gemma":[0.00008413379,0.00013141756,0.0020531185,0.00002391293,0.000057037214,0.00005459575,0.00001732274,0.98822826,0.00012730286,0.0077613974,0.001452144,0.000009349812],"about_ca_topic_score_codex":0.027525032,"about_ca_topic_score_gemma":0.017489102,"teacher_disagreement_score":0.027525032,"about_ca_system_score_codex":0.0019997004,"about_ca_system_score_gemma":0.0015207264,"threshold_uncertainty_score":0.05472964},"labels":[],"label_agreement":null},{"id":"W2995883695","doi":"10.1016/j.jval.2019.09.633","title":"PCN440 NETWORK META-ANALYSIS USING FRACTIONAL POLYNOMIALS: HEURISTIC FOR MODEL SELECTION INCORPORATING BEYOND-TRIAL EXTRAPOLATIONS (A MELANOMA EXAMPLE)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Model selection; Gompertz function; Weibull distribution; Mathematics; Extrapolation; Deviance (statistics); Boolean model; Statistics; Parametric statistics; Computer science; Econometrics","score_opus":0.796887340975208,"score_gpt":0.5686788188507079,"score_spread":0.22820852212450005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995883695","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022006115,0.0026645993,0.9703241,0.0016145406,0.00013779133,0.00022157557,0.0004969736,0.00047919786,0.0020552063],"genre_scores_gemma":[0.32356095,0.0012285872,0.6711383,0.00058391213,0.0001601878,0.0005346266,0.00045829255,0.00024313862,0.0020920062],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99236125,0.006729954,0.00014525127,0.00033739404,0.00030213982,0.00012399322],"domain_scores_gemma":[0.9632805,0.033694346,0.00051408494,0.0012975112,0.00093367405,0.00027977012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019155588,0.0012385754,0.0029342514,0.0023766693,0.0012447964,0.0014232058,0.001987549,0.0016059338,0.0051056985],"category_scores_gemma":[0.061893754,0.0006923381,0.0031129138,0.0026174732,0.00070305064,0.0015020202,0.0016008324,0.003405678,0.00039164993],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012311614,0.00017834005,0.0029654286,0.0007095667,0.0020873512,0.00036941995,0.00021006401,0.8410246,0.00041617668,0.034289427,0.0061219158,0.11039645],"study_design_scores_gemma":[0.00023371729,0.000124121,0.0003119021,0.00009231845,0.00042881593,0.00006276101,0.00002970807,0.9441207,0.00016986343,0.052837413,0.0015649882,0.00002369695],"about_ca_topic_score_codex":0.017354866,"about_ca_topic_score_gemma":0.022742972,"teacher_disagreement_score":0.019155588,"about_ca_system_score_codex":0.0012880095,"about_ca_system_score_gemma":0.0031556545,"threshold_uncertainty_score":0.10130566},"labels":[],"label_agreement":null},{"id":"W2995887845","doi":"10.1016/j.jval.2019.09.2337","title":"PRO5 COMPARING PRODUCTIVITY LOSSES FROM TREATING ATYPICAL HEMOLYTIC UREMIC SYNDROME PATIENTS IN THE UNITED STATES WITH ECULIZUMAB OR RAVULIZUMAB IN AN INFUSION CLINIC OR AT HOME","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Eculizumab; Medicine; Pediatrics; Immunology; Complement system; Immune system","score_opus":0.052469791764286074,"score_gpt":0.30749270376951143,"score_spread":0.25502291200522537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995887845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899969,0.002081821,0.00034698684,0.000665481,0.000109338165,0.000058399168,0.0035851118,0.000014949408,0.003141126],"genre_scores_gemma":[0.9974426,0.0003496749,0.00015413547,0.00018367848,0.000025656951,0.000027354406,0.0012412086,0.0000026532718,0.0005729901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876463,0.0006338488,0.000119264296,0.0001093104,0.000179792,0.00019312296],"domain_scores_gemma":[0.99776614,0.00083147007,0.00081094477,0.000072274786,0.00022407639,0.00029512713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010620042,0.00032283852,0.00030111172,0.0004427464,0.00026089765,0.0006864337,0.0003180071,0.00035820503,0.003613183],"category_scores_gemma":[0.00453243,0.00012352149,0.0015300107,0.000553972,0.00016814038,0.00038287343,0.00053896283,0.0006230774,0.00020055925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058800414,0.002916033,0.7197051,0.00087028224,0.009985851,0.00045796362,0.00023513121,0.011483487,0.0017374309,0.0009009083,0.012651415,0.18025592],"study_design_scores_gemma":[0.0025358459,0.013562543,0.9667686,0.00020728564,0.0027928536,0.00039972356,0.00075506425,0.005942635,0.0011536442,0.00038330664,0.0054612965,0.000037216265],"about_ca_topic_score_codex":0.015545488,"about_ca_topic_score_gemma":0.016567614,"teacher_disagreement_score":0.015545488,"about_ca_system_score_codex":0.0015389844,"about_ca_system_score_gemma":0.0011499927,"threshold_uncertainty_score":0.030910015},"labels":[],"label_agreement":null},{"id":"W2995889671","doi":"10.1016/j.jval.2019.09.2661","title":"PSY33 HTA REVIEW OF DECISIONS FOR PRODUCTS INDICATED IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND LUPUS NEPHRITIS (N) IN UK, GERMANY, FRANCE, ITALY, SPAIN, CANADA AND TURKEY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Belimumab; Medicine; Lupus nephritis; Rituximab; Systemic lupus erythematosus; European union; Reimbursement; Disease; Dermatology; Immunology; Internal medicine; Lymphoma","score_opus":0.04953274642682193,"score_gpt":0.28781476204506123,"score_spread":0.2382820156182393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995889671","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005423272,0.9668674,0.00046482004,0.008785311,0.0010731557,0.000059003214,0.0023521755,0.00002636189,0.014948458],"genre_scores_gemma":[0.08367438,0.89736426,0.0019086406,0.004915073,0.0012370114,0.00007986011,0.002399716,0.000033242522,0.008387718],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981218,0.00073650264,0.00028557377,0.00012969656,0.00058953743,0.00013684075],"domain_scores_gemma":[0.9914315,0.0045724576,0.0013247922,0.00010210412,0.0023153268,0.00025388578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034940506,0.00036467437,0.00077573804,0.0029696007,0.000216975,0.001641597,0.0006181696,0.0009620682,0.009852456],"category_scores_gemma":[0.010752861,0.00024329178,0.0014142353,0.0044396077,0.0002925207,0.0007293456,0.0003454519,0.0009040914,0.0008571882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013045745,0.000067628076,0.0045199296,0.020589557,0.0008182892,0.0002860121,0.00010692282,0.0030744593,0.00033984444,0.0064931745,0.18735689,0.7750427],"study_design_scores_gemma":[0.0003147723,0.00037324673,0.05572686,0.038545005,0.0017433242,0.0005194402,0.00028632997,0.0010425791,0.0006660871,0.0018843081,0.8988456,0.000052392],"about_ca_topic_score_codex":0.028256245,"about_ca_topic_score_gemma":0.044047624,"teacher_disagreement_score":0.97174376,"about_ca_system_score_codex":0.005412352,"about_ca_system_score_gemma":0.0067329793,"threshold_uncertainty_score":0.056183517},"labels":[],"label_agreement":null},{"id":"W2995913988","doi":"10.1016/j.jval.2019.09.2637","title":"PSY9 PREFERENCE WEIGHTS FOR QUALITY-ADJUSTED LIFE-YEARS ESTIMATION FOR TREATMENTS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE UNITED KINGDOM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Censoring (clinical trials); Primaquine; Life expectancy; Demography; Pediatrics; Environmental health; Internal medicine; Population","score_opus":0.19069914004973343,"score_gpt":0.42360172912124805,"score_spread":0.23290258907151462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995913988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9313124,0.008339683,0.02558459,0.001744957,0.0002692488,0.00026689016,0.021291446,0.00008274079,0.011108067],"genre_scores_gemma":[0.9924501,0.0006179378,0.0035307405,0.00008187247,0.000010485303,0.000069388385,0.0024653184,0.000017004648,0.00075717893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954863,0.003484774,0.00034445515,0.0001737429,0.00036701866,0.00014356808],"domain_scores_gemma":[0.99332035,0.004841832,0.0007174538,0.00031233605,0.0006206718,0.0001873674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00444809,0.0002941377,0.0007430812,0.0012711018,0.00018488396,0.001181435,0.00038047764,0.00044254275,0.0061480254],"category_scores_gemma":[0.029457016,0.00023380521,0.0012997888,0.0018304267,0.00020545795,0.00072060694,0.0007938289,0.0006537445,0.00039672927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013327422,0.00021854888,0.53098476,0.0017294214,0.0036393686,0.0004922192,0.0006474581,0.09232936,0.00095282594,0.017208245,0.023256533,0.31521374],"study_design_scores_gemma":[0.0014636753,0.0022175957,0.69375163,0.0012984441,0.0011804369,0.0017610765,0.0017066627,0.25411245,0.00077358773,0.017107561,0.024385424,0.0002414758],"about_ca_topic_score_codex":0.036521886,"about_ca_topic_score_gemma":0.024710527,"teacher_disagreement_score":0.036521886,"about_ca_system_score_codex":0.0018061693,"about_ca_system_score_gemma":0.0006281018,"threshold_uncertainty_score":0.0726186},"labels":[],"label_agreement":null},{"id":"W2996043655","doi":"10.1016/j.jval.2019.09.2125","title":"PNS225 CURRENT STATUS OF OUTCOMES-BASED AGREEMENTS IN SELECTED EUROPEAN COUNTRIES AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Demography; Database; Geography; Computer science","score_opus":0.24033668744919628,"score_gpt":0.39441947964327345,"score_spread":0.15408279219407717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996043655","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27030596,0.039789334,0.004756594,0.03668833,0.0012427951,0.0006767407,0.061378427,0.00083233154,0.5843295],"genre_scores_gemma":[0.8778004,0.011300718,0.0070613534,0.0048681274,0.0002936884,0.00041075004,0.03395106,0.00020003587,0.06411377],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9863864,0.0016156543,0.00089769484,0.0007630395,0.0067706434,0.0035666348],"domain_scores_gemma":[0.9364973,0.008868183,0.003907879,0.0016515478,0.039637875,0.009437198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013257828,0.00031981527,0.00083773833,0.0049666213,0.0036262998,0.006488761,0.0035720565,0.002010189,0.011568864],"category_scores_gemma":[0.029853456,0.00039351612,0.00074875867,0.010830503,0.0017222344,0.0017155175,0.0021801495,0.0016638016,0.00084311905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001231547,0.00043880072,0.15202636,0.0020191034,0.0002881286,0.00046738904,0.0019634622,0.009138378,0.00067331846,0.32007775,0.25083783,0.26083785],"study_design_scores_gemma":[0.00018811368,0.000109922235,0.4309687,0.0013725278,0.00010622202,0.00016500228,0.002564607,0.003200894,0.00086181547,0.0067010266,0.5536439,0.00011727292],"about_ca_topic_score_codex":0.95416355,"about_ca_topic_score_gemma":0.9325191,"teacher_disagreement_score":0.9556536,"about_ca_system_score_codex":0.04434637,"about_ca_system_score_gemma":0.15216629,"threshold_uncertainty_score":0.32175696},"labels":[],"label_agreement":null},{"id":"W2996090251","doi":"10.1016/j.jval.2019.09.084","title":"ON4 THE ECONOMIC BURDEN OF RENAL CELL CARCINOMA (RCC) IN CANADA USING REAL-WORLD EVIDENCE; A SOCIETAL PERSPECTIVE.","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Kidney cancer; Microsimulation; Cancer; Urology; Oncology; Internal medicine; Intensive care medicine; Kidney","score_opus":0.07003359689348444,"score_gpt":0.2786211863205374,"score_spread":0.20858758942705297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996090251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38982582,0.274458,0.0032656072,0.11310077,0.001014462,0.00025776724,0.14466599,0.00011435161,0.07329733],"genre_scores_gemma":[0.9375649,0.04813731,0.0014502098,0.0018055324,0.00016900695,0.000029005732,0.007854627,0.000020621093,0.0029687935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987172,0.00026939297,0.00009582636,0.00007061974,0.0005921558,0.0002547897],"domain_scores_gemma":[0.99453473,0.000968438,0.0008452125,0.00011439907,0.0030067991,0.00053046393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020371268,0.00043694768,0.0004145911,0.004049631,0.0007994133,0.0023673454,0.0007454789,0.0006102389,0.0042646853],"category_scores_gemma":[0.011727898,0.00017496292,0.0012139254,0.008987114,0.0006689522,0.00070206437,0.0010351071,0.0010207396,0.00019755424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066844677,0.00007849218,0.7149768,0.0033585404,0.0038363342,0.0008340064,0.0008675645,0.023232203,0.00029714766,0.050200775,0.096790776,0.10485892],"study_design_scores_gemma":[0.00014589762,0.000063875836,0.84884924,0.004380687,0.0042354045,0.0004474419,0.0040712054,0.016037887,0.0004260975,0.012154251,0.10905046,0.00013754601],"about_ca_topic_score_codex":0.99225545,"about_ca_topic_score_gemma":0.9952011,"teacher_disagreement_score":0.036478292,"about_ca_system_score_codex":0.036478292,"about_ca_system_score_gemma":0.06273388,"threshold_uncertainty_score":0.26466978},"labels":[],"label_agreement":null},{"id":"W2996136710","doi":"10.1016/j.jval.2019.09.349","title":"PCN153 OVERVIEW OF ECONOMIC EVALUATIONS OF ONCOLOGY PRODUCTS WITH A FOCUS ON THE KEY CHALLENGES ACROSS, UNITED KINGDOM, FRANCE AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic evaluation; Agency (philosophy); Key (lock); Strengths and weaknesses; Nice; Funding Agency; Economic impact analysis; Economic model; Operations research; Actuarial science; Computer science; Medicine; Political science; Business; Economics; Public relations; Engineering; Psychology; Sociology; Pathology","score_opus":0.4889677482856861,"score_gpt":0.44810181189483794,"score_spread":0.04086593639084818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996136710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052328263,0.6539023,0.0060779904,0.018021364,0.0016498979,0.001494574,0.02354782,0.00051552674,0.2895577],"genre_scores_gemma":[0.054267034,0.83653337,0.025756951,0.006241275,0.0016471201,0.00091535033,0.018311338,0.0004954001,0.05583222],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918607,0.0017313679,0.0009650934,0.0003351877,0.0043913843,0.0007163492],"domain_scores_gemma":[0.9658572,0.010405235,0.001794316,0.0005702509,0.02008323,0.0012896602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013825596,0.0013568158,0.0017163329,0.015869636,0.0013669599,0.00787519,0.0015288033,0.0015690731,0.014915027],"category_scores_gemma":[0.03066229,0.00064887275,0.0015456195,0.02670658,0.0009156718,0.0019430019,0.0013532167,0.0017294968,0.0016295958],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029401312,0.00011728038,0.0024516133,0.009099407,0.0002742513,0.000117408854,0.00012816887,0.0048079407,0.00025500002,0.023134219,0.4630925,0.49622816],"study_design_scores_gemma":[0.000060533013,0.00009611922,0.017732525,0.013440932,0.00026355524,0.00015404916,0.00014332666,0.0013052549,0.00029724665,0.0038059745,0.9626455,0.000055106],"about_ca_topic_score_codex":0.6690224,"about_ca_topic_score_gemma":0.7364084,"teacher_disagreement_score":0.95859575,"about_ca_system_score_codex":0.04140423,"about_ca_system_score_gemma":0.06706204,"threshold_uncertainty_score":0.6658536},"labels":[],"label_agreement":null},{"id":"W2996143033","doi":"10.1016/j.jval.2019.09.1083","title":"PDG70 KNOWLEDGE, ATTITUDES AND PRACTICES OF MOROCCAN COMMUNITY PHARMACISTS TOWARDS THE THIRD-PARTY PAYER SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Profit margin; Medical prescription; Pharmacy; Family medicine; Pharmacist; Observational study; Business; Medicine; Marketing; Nursing; Geography","score_opus":0.3107613983466334,"score_gpt":0.4927608822237867,"score_spread":0.1819994838771533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996143033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99810517,0.0001129561,0.0000102880995,0.00025084268,0.0000030685737,0.000008414779,0.000077761186,6.510203e-7,0.0014307766],"genre_scores_gemma":[0.9992449,0.00011349109,0.000024482873,0.00012447003,0.0000045205957,0.0000052820233,0.00003611119,4.4475593e-7,0.00044621617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992505,0.00016758952,0.00006084805,0.000054371005,0.00022057754,0.00024606122],"domain_scores_gemma":[0.99726164,0.0005897151,0.0011373567,0.000057418674,0.0004072988,0.00054651545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087493024,0.00011192256,0.0002136992,0.0005436528,0.00077393046,0.0010862314,0.00021339033,0.00050368137,0.0037327681],"category_scores_gemma":[0.003978487,0.00012725084,0.00025907374,0.0005308277,0.0002715409,0.0004567043,0.00064166647,0.00051142264,0.00030288906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008050215,0.0003044007,0.98303705,0.00005326787,0.000031741154,0.0001780887,0.005583304,0.000027990081,0.00030160724,0.00008907156,0.00035500893,0.009958001],"study_design_scores_gemma":[0.000007669293,0.00024091803,0.98534644,0.00008699897,0.000019171268,0.0002424156,0.012028224,0.00012207699,0.00009612035,0.000040272575,0.0017604973,0.0000091467755],"about_ca_topic_score_codex":0.03935795,"about_ca_topic_score_gemma":0.04636997,"teacher_disagreement_score":0.03935795,"about_ca_system_score_codex":0.0010935736,"about_ca_system_score_gemma":0.0015395334,"threshold_uncertainty_score":0.07825774},"labels":[],"label_agreement":null},{"id":"W2996151803","doi":"10.1016/j.jval.2019.09.570","title":"PCN375 WHEN EARLY MODELS MAY BE TOO EARLY - PREDICTING SURVIVAL FROM INTERIM ANALYSES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Censoring (clinical trials); Interim; Survival analysis; Interim analysis; Statistics; Medicine; Sample size determination; Clinical trial; Econometrics; Computer science; Mathematics; Internal medicine","score_opus":0.660567735543121,"score_gpt":0.4661269712448579,"score_spread":0.19444076429826307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996151803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43809465,0.020690093,0.37548092,0.045086935,0.006933597,0.0011031361,0.03036236,0.0056408113,0.07660758],"genre_scores_gemma":[0.9219975,0.0014377461,0.05050456,0.003223917,0.0007676097,0.00033430848,0.009044899,0.0010216656,0.011667733],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99566156,0.0027693775,0.00025990017,0.00045477014,0.00055647356,0.00029793155],"domain_scores_gemma":[0.9756202,0.017674757,0.0010246745,0.0021119353,0.00253418,0.0010343083],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012999097,0.0009755898,0.0013609676,0.0011790481,0.00059923733,0.0030018003,0.0015369949,0.0011070294,0.017207116],"category_scores_gemma":[0.07870131,0.00048379024,0.0016705252,0.0007970398,0.00050327537,0.0026110103,0.0013154943,0.004173448,0.0028551097],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0085702995,0.00047026956,0.15780354,0.0009311879,0.0024101108,0.0007042307,0.00034463024,0.094529204,0.0012735303,0.016999913,0.15062499,0.56533813],"study_design_scores_gemma":[0.0011122078,0.0020293526,0.07704626,0.002490962,0.0021108873,0.0012006918,0.00037442567,0.62528443,0.010680229,0.16008037,0.11730891,0.00028124073],"about_ca_topic_score_codex":0.014666562,"about_ca_topic_score_gemma":0.02427625,"teacher_disagreement_score":0.9870009,"about_ca_system_score_codex":0.0014621427,"about_ca_system_score_gemma":0.003108033,"threshold_uncertainty_score":0.06874663},"labels":[],"label_agreement":null},{"id":"W2996166277","doi":"10.1016/j.jval.2019.09.332","title":"PCN136 ECONOMIC VIABILITY OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULTS WITH ADVANCED LEUKEMIA: EVIDENCE FROM AN EARLY ECONOMIC MODELLING","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Blinatumomab; Chimeric antigen receptor; Oncology; Immunotherapy; Salvage therapy; Internal medicine; Leukemia; Chemotherapy; Cancer; Lymphoblastic Leukemia","score_opus":0.04991998451427404,"score_gpt":0.33051687973485416,"score_spread":0.2805968952205801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996166277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85689867,0.029059064,0.029099742,0.0096127875,0.0005490181,0.0012681052,0.010674297,0.00015206535,0.062686145],"genre_scores_gemma":[0.9900746,0.0035864413,0.0016133739,0.00022848597,0.00004652815,0.00018677118,0.0007049242,0.000020498008,0.0035383909],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968442,0.0023496302,0.00007589435,0.00012709378,0.0002743896,0.00032881284],"domain_scores_gemma":[0.9750811,0.023066582,0.00078324514,0.00034440428,0.0004248135,0.00029988497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075040185,0.0011950817,0.0015739421,0.0007640273,0.0002636299,0.0018763703,0.0014686862,0.0012820514,0.007166503],"category_scores_gemma":[0.02041693,0.0005160681,0.0026943947,0.0009265049,0.0008675638,0.0012281348,0.00086991105,0.002731202,0.00039547094],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030288542,0.0012024055,0.009571586,0.0022113028,0.0028241044,0.0003031316,0.00016480082,0.80719197,0.00048250332,0.04754155,0.007879164,0.090338804],"study_design_scores_gemma":[0.013441343,0.010992213,0.016763546,0.0017006539,0.009431546,0.0002856041,0.00041158576,0.8251567,0.0026514106,0.089131854,0.029820863,0.00021270101],"about_ca_topic_score_codex":0.024949526,"about_ca_topic_score_gemma":0.011231383,"teacher_disagreement_score":0.024949526,"about_ca_system_score_codex":0.0053724563,"about_ca_system_score_gemma":0.0041555176,"threshold_uncertainty_score":0.04960859},"labels":[],"label_agreement":null},{"id":"W2996166460","doi":"10.1016/j.jval.2019.09.1910","title":"PNS7 PATIENT INPUT TO COST-UTILITY ANALYSES: A REVIEW FROM THE UK, CANADA AND AUSTRALIA","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nice; CLARITY; Documentation; Health technology; Patient participation; Grey literature; Process (computing); Medicine; Critical appraisal; Psychology; MEDLINE; Health care; Political science; Alternative medicine; Computer science","score_opus":0.7871575636325829,"score_gpt":0.5374722777608169,"score_spread":0.24968528587176608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996166460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028746316,0.99686867,0.0003455246,0.00075922965,0.00010705184,0.000058930338,0.0006184266,0.000010497271,0.00094427436],"genre_scores_gemma":[0.006359576,0.9904879,0.0015742208,0.00061640324,0.000097374876,0.000088112516,0.00046969036,0.000018638315,0.0002882331],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98888004,0.0045262957,0.0020525123,0.0004763111,0.0037628263,0.00030208108],"domain_scores_gemma":[0.9654156,0.025459286,0.0023406274,0.00049980736,0.0059404396,0.00034427166],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021209603,0.0016691493,0.007175553,0.0071830004,0.00051700725,0.0045653246,0.0026958596,0.0015640596,0.010501322],"category_scores_gemma":[0.06292817,0.00073895615,0.0075852447,0.013437132,0.0010832992,0.0016403774,0.0020055778,0.0030936657,0.00077054574],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008280353,0.00006494682,0.0012983414,0.1733832,0.005757862,0.00006338331,0.000106843676,0.0016643639,0.00007392183,0.0039950013,0.026471011,0.7862931],"study_design_scores_gemma":[0.0012225334,0.00044161634,0.016990075,0.46814293,0.03618518,0.00060899305,0.00025375665,0.0020629426,0.00049156515,0.0070147673,0.46639162,0.00019403259],"about_ca_topic_score_codex":0.12149095,"about_ca_topic_score_gemma":0.20051888,"teacher_disagreement_score":0.985749,"about_ca_system_score_codex":0.014250987,"about_ca_system_score_gemma":0.024208624,"threshold_uncertainty_score":0.24156761},"labels":[],"label_agreement":null},{"id":"W2996286890","doi":"10.1016/j.jval.2019.09.2321","title":"PPM4 COMPREHENSIVE GENOMIC PROFILING FOR NON-SMALL CELL LUNG CANCER (NSCLC): A HEALTH AND BUDGET IMPACT ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; William Osler Health System; Vancouver Coastal Health; Roche (Canada)","funders":"","keywords":"Medicine; Turnaround time; Genetic testing; Hotspot (geology); Profiling (computer programming); Oncology; Bioinformatics; Internal medicine; Computer science; Biology","score_opus":0.01608610984209335,"score_gpt":0.30957089460392595,"score_spread":0.2934847847618326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996286890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8342029,0.0058807433,0.010160562,0.010620871,0.000094118084,0.00031065472,0.1171251,0.00021262573,0.021392465],"genre_scores_gemma":[0.9602478,0.002094722,0.0069045024,0.0005206521,0.00006987602,0.00016970233,0.026973609,0.000042354757,0.0029768017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981908,0.00075495656,0.00006670909,0.00015160613,0.00057364715,0.0002621896],"domain_scores_gemma":[0.99711883,0.0008526738,0.0006096874,0.00017971001,0.00096239866,0.00027662737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002614849,0.00041318175,0.00040620042,0.0023817238,0.00021571008,0.000956135,0.0004872808,0.00033855636,0.003335634],"category_scores_gemma":[0.0047573624,0.00021032341,0.0009288329,0.0059521357,0.00020152885,0.0005632336,0.0011552734,0.00044716476,0.00033081375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002042931,0.00017731925,0.721746,0.00079545326,0.0017224924,0.0003533575,0.00019824735,0.032259032,0.0073456042,0.0053887833,0.020500066,0.2074707],"study_design_scores_gemma":[0.000054823664,0.00044136937,0.9403107,0.00019550041,0.00081505446,0.00027483844,0.00047734444,0.013314461,0.004091987,0.0023265344,0.037661657,0.00003572258],"about_ca_topic_score_codex":0.02861071,"about_ca_topic_score_gemma":0.042977422,"teacher_disagreement_score":0.02861071,"about_ca_system_score_codex":0.0026665856,"about_ca_system_score_gemma":0.0032989695,"threshold_uncertainty_score":0.056888342},"labels":[],"label_agreement":null},{"id":"W2996343063","doi":"10.1016/j.jval.2019.09.605","title":"PCN411 HOW ARE SINGLE-ARM TRIALS PERCEIVED IN HEATH TECHNOLOGY ASSESSMENTS FOR CHRONIC LEUKAEMIA ACROSS THE EU5, AUSTRALIA AND CANADA?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Psychological intervention; Medicine; Ponatinib; Nice; Clinical trial; Family medicine; Internal medicine; Psychiatry; Leukemia; Computer science","score_opus":0.5688357697135255,"score_gpt":0.4873895302611391,"score_spread":0.08144623945238633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996343063","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33236492,0.085116506,0.009826244,0.44089252,0.0062099686,0.00433714,0.013814523,0.00021101086,0.10722711],"genre_scores_gemma":[0.9444397,0.008194743,0.0058820173,0.034325693,0.0016885571,0.0017295335,0.0015595631,0.00010830355,0.0020718004],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.7408935,0.18476677,0.025338553,0.0073707397,0.035065193,0.00656526],"domain_scores_gemma":[0.47149935,0.33205342,0.06937271,0.0131270075,0.0820227,0.03192481],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23667227,0.00045347287,0.002916453,0.0021276423,0.0030389475,0.011477958,0.002277813,0.0036609473,0.011528514],"category_scores_gemma":[0.51943773,0.00069385266,0.0029401751,0.004709955,0.0044050873,0.007423473,0.004472153,0.006457087,0.0007993101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03147411,0.000517327,0.19510461,0.0108937295,0.010242206,0.00016839511,0.015224813,0.0057071005,0.0006890405,0.035735685,0.09911514,0.5951279],"study_design_scores_gemma":[0.009851577,0.008209824,0.6888673,0.029898573,0.0055250353,0.00034756862,0.015038474,0.00813952,0.0011479307,0.044206098,0.1879215,0.00084672257],"about_ca_topic_score_codex":0.14738724,"about_ca_topic_score_gemma":0.17418635,"teacher_disagreement_score":0.9785179,"about_ca_system_score_codex":0.021482104,"about_ca_system_score_gemma":0.04014586,"threshold_uncertainty_score":0.941319},"labels":[],"label_agreement":null},{"id":"W2996366298","doi":"10.1016/j.jval.2019.09.739","title":"PCV14 COMPARATIVE EFFECTIVENESS AND SAFETY OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROPENSITY SCORE-MATCHED COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Montreal General Hospital; Université de Montréal","funders":"","keywords":"Apixaban; Rivaroxaban; Medicine; Dabigatran; Warfarin; Atrial fibrillation; Hazard ratio; Internal medicine; Cohort; Stroke (engine); Propensity score matching; Anticoagulant; Proportional hazards model; Cardiology; Anesthesia; Confidence interval","score_opus":0.09799204310040462,"score_gpt":0.35245286258703734,"score_spread":0.25446081948663274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996366298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978644,0.0010107312,0.0002607225,0.000032885175,0.000035127883,0.000029380888,0.00041750976,0.0000039531724,0.0003453643],"genre_scores_gemma":[0.9988625,0.00022788168,0.000117006246,0.00004285516,0.000048585673,0.000022094076,0.00053070503,0.0000036678568,0.00014468253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975534,0.0008193017,0.0003555919,0.00063313567,0.00033114874,0.0003073706],"domain_scores_gemma":[0.99549,0.0012327478,0.0016783383,0.000896178,0.00030030272,0.0004023756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020489322,0.00050072634,0.0010654605,0.00079661113,0.00047135452,0.0015018622,0.0007139337,0.0010859175,0.0022386569],"category_scores_gemma":[0.006031261,0.0004952196,0.0033062275,0.0014778198,0.0004952531,0.0008337021,0.00067789934,0.001071048,0.0003202198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037298944,0.00040959707,0.9417586,0.00013721426,0.011839725,0.00018038004,0.00009905498,0.00036283355,0.0008267565,0.0002887037,0.0004096754,0.00638867],"study_design_scores_gemma":[0.0038826182,0.0052878535,0.98025733,0.00004595354,0.0062649045,0.0005034326,0.00020591532,0.001867521,0.00036168224,0.0005096419,0.0007615718,0.00005159802],"about_ca_topic_score_codex":0.0018820113,"about_ca_topic_score_gemma":0.0018512716,"teacher_disagreement_score":0.0022386569,"about_ca_system_score_codex":0.0004911696,"about_ca_system_score_gemma":0.000527448,"threshold_uncertainty_score":0.010835946},"labels":[],"label_agreement":null},{"id":"W2996421917","doi":"10.1016/j.jval.2019.09.2320","title":"PPM3 GENOMIC SCREENING COSTS IN MODELLING: A PENALTY FOR INNOVATION?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Memorial University of Newfoundland","funders":"","keywords":"Medicine; Oncology; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Risk analysis (engineering)","score_opus":0.5644246595470902,"score_gpt":0.44695344151287586,"score_spread":0.11747121803421434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996421917","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21625105,0.0034181832,0.6135176,0.06722559,0.0018272902,0.0002060295,0.002937615,0.0008147191,0.09380194],"genre_scores_gemma":[0.9563449,0.00051843526,0.02854004,0.0018252664,0.0003040863,0.0001452191,0.00043025255,0.00025850677,0.011633277],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995884,0.002520057,0.00019832903,0.00041687212,0.00063973415,0.00034090615],"domain_scores_gemma":[0.9487126,0.04320076,0.0016250032,0.003689739,0.0019011452,0.0008707664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008588738,0.00071700104,0.0011120511,0.0007148924,0.0006378307,0.0038203164,0.002622108,0.00442911,0.017587237],"category_scores_gemma":[0.100413814,0.00076851225,0.001038048,0.0011736075,0.0019746001,0.0071710097,0.0018659177,0.005620468,0.00096495525],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048455351,0.00011620559,0.009925695,0.00030870465,0.00015709606,0.0003667499,0.00036599557,0.5560886,0.000447075,0.36321318,0.012036831,0.05648927],"study_design_scores_gemma":[0.00008434587,0.000099767654,0.0029020829,0.00022088252,0.00008003769,0.00024932105,0.00019767878,0.54255474,0.0007553206,0.44088545,0.011901336,0.00006904498],"about_ca_topic_score_codex":0.009468498,"about_ca_topic_score_gemma":0.0067114816,"teacher_disagreement_score":0.017587237,"about_ca_system_score_codex":0.0020600224,"about_ca_system_score_gemma":0.0018645818,"threshold_uncertainty_score":0.05883521},"labels":[],"label_agreement":null},{"id":"W2996439492","doi":"10.1016/j.jval.2019.09.1880","title":"PND110 SYMPTOM SEVERITY IN MULTIPLE SCLEROSIS FROM THE PATIENT'S PERSPECTIVE: REVISITING THE PSYCHOMETRIC PROPERTIES OF THE SYMPTOMSCREEN QUESTIONNAIRE (PERCEPTIONS-MS STUDY)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Cronbach's alpha; Item response theory; Physical therapy; Construct validity; Medicine; Anxiety; Hospital Anxiety and Depression Scale; Multiple sclerosis; Clinical psychology; Psychometrics; Psychology; Psychiatry","score_opus":0.10268659292913154,"score_gpt":0.3248727864658438,"score_spread":0.22218619353671223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996439492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965063,0.00055555505,0.00030489216,0.00024535484,0.000036836598,0.000115417606,0.00027468585,0.0000044213,0.0019565534],"genre_scores_gemma":[0.9986733,0.00018518638,0.00048620504,0.000118221586,0.000021174365,0.000089073554,0.00022344133,0.000003713749,0.00019959324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950499,0.0026131787,0.0005870589,0.0001954432,0.0013814542,0.0001730131],"domain_scores_gemma":[0.9869336,0.007836001,0.0026210381,0.0004939269,0.0014402505,0.0006750891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009914226,0.0002894803,0.000547388,0.0010095317,0.00041640416,0.0012251339,0.00055438216,0.0004472515,0.0010953128],"category_scores_gemma":[0.024696413,0.00021274877,0.0011348499,0.0011308113,0.0006383519,0.0009891358,0.0014684687,0.0011117777,0.00017747603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041280268,0.00032660054,0.9683184,0.00017644587,0.0003512055,0.000072175375,0.001885732,0.0001584596,0.00042249128,0.00020912543,0.00045518402,0.027211418],"study_design_scores_gemma":[0.00007327455,0.0010019941,0.9954254,0.00006772161,0.000085741645,0.00015155337,0.0013094117,0.00035656523,0.00023988912,0.00013769013,0.0011358988,0.000014798779],"about_ca_topic_score_codex":0.003396527,"about_ca_topic_score_gemma":0.003705469,"teacher_disagreement_score":0.009914226,"about_ca_system_score_codex":0.00055888464,"about_ca_system_score_gemma":0.00095302094,"threshold_uncertainty_score":0.052432},"labels":[],"label_agreement":null},{"id":"W2996469325","doi":"10.1016/j.jval.2019.09.1619","title":"PMS78 CANADIAN REAL-WORLD EVIDENCE ON EPIDEMIOLOGY, OUTCOMES AND ECONOMICS OF MODERATE-TO-SEVERE OSTEOARTHRITIS: A SYSTEMATIC LITERATURE REVIEW","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Osteoarthritis; MEDLINE; Cochrane Library; Systematic review; Comorbidity; Epidemiology; Population; Physical therapy; Health economics; Evidence-based medicine; Public health; Family medicine; Alternative medicine; Internal medicine; Meta-analysis; Environmental health; Pathology","score_opus":0.06106474913122725,"score_gpt":0.3292774540070096,"score_spread":0.2682127048757823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996469325","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003976606,0.9666422,0.00035061425,0.0022885196,0.0005621932,0.0017863081,0.021347342,0.000030636827,0.0030155207],"genre_scores_gemma":[0.07247883,0.90998566,0.0028869458,0.0035163374,0.00031531518,0.0026469263,0.0071054325,0.00003832693,0.0010263672],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97653776,0.0064826403,0.007922782,0.0014485812,0.006366741,0.001241475],"domain_scores_gemma":[0.92358106,0.0386918,0.015097785,0.0022317944,0.018694445,0.0017030034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022817543,0.0019559602,0.0070346114,0.024513433,0.001899775,0.0045692855,0.0028501928,0.0031962486,0.015539191],"category_scores_gemma":[0.14980936,0.0015317795,0.012317541,0.03088281,0.0017103261,0.002067488,0.0029913438,0.0018020296,0.0009907425],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013848174,0.000045871293,0.007396855,0.87674457,0.045311786,0.0002137028,0.00035398448,0.0002832909,0.0001641009,0.00084650045,0.019791827,0.047462646],"study_design_scores_gemma":[0.002846872,0.00018033496,0.038960855,0.74856174,0.16585337,0.0002460577,0.00036688335,0.00010925139,0.00013981291,0.0006212073,0.041970264,0.00014340378],"about_ca_topic_score_codex":0.56529224,"about_ca_topic_score_gemma":0.76301676,"teacher_disagreement_score":0.43470776,"about_ca_system_score_codex":0.027952306,"about_ca_system_score_gemma":0.12499797,"threshold_uncertainty_score":0.8745357},"labels":[],"label_agreement":null},{"id":"W2996471497","doi":"10.1016/j.jval.2019.09.226","title":"PCN29 COMPARATIVE EFFICACY OF NIVOLUMAB VERSUS RELEVANT TREATMENTS IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW AND INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS (RCTS)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Medicine; Docetaxel; Internal medicine; Oncology; Hazard ratio; Atezolizumab; Lung cancer; Erlotinib; Randomized controlled trial; Population; Cancer; Confidence interval; Immunotherapy; Epidermal growth factor receptor","score_opus":0.050520128968875665,"score_gpt":0.3839835827175796,"score_spread":0.33346345374870395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996471497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018303817,0.97688985,0.0008462261,0.00036568055,0.00044567027,0.0015676152,0.0008497995,0.000033186192,0.00069822214],"genre_scores_gemma":[0.4509899,0.53708196,0.004850312,0.0018882226,0.00046014707,0.0029365022,0.0011924668,0.000039900508,0.0005605904],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98429847,0.00815383,0.0046520373,0.0012941319,0.0012680648,0.00033335778],"domain_scores_gemma":[0.98113555,0.013351072,0.0038389452,0.00057259825,0.00085859356,0.00024317818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014587273,0.0018115668,0.012877057,0.0028995671,0.0005081427,0.0029628526,0.0014208711,0.0025217433,0.004411736],"category_scores_gemma":[0.03585511,0.0011451637,0.021236235,0.0031226554,0.0013618934,0.0019067643,0.0014622242,0.0023738085,0.00032426455],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02734461,0.00010520143,0.0020926225,0.5511192,0.39378804,0.00007539848,0.00013662499,0.00034000108,0.000533507,0.00029784426,0.0005147097,0.023652267],"study_design_scores_gemma":[0.029493108,0.0019412227,0.005408815,0.052026443,0.9062262,0.000115011004,0.00012139755,0.00026317945,0.00027868856,0.00056765426,0.0035032819,0.000054915192],"about_ca_topic_score_codex":0.00470648,"about_ca_topic_score_gemma":0.01101304,"teacher_disagreement_score":0.014587273,"about_ca_system_score_codex":0.0028157684,"about_ca_system_score_gemma":0.003371023,"threshold_uncertainty_score":0.077145755},"labels":[],"label_agreement":null},{"id":"W2996554616","doi":"10.1016/j.jval.2019.09.2224","title":"PNS324 A NOVEL APPROACH OF USING GRAPHICAL REPRESENTATION OF EQ-5D-3L DIMENSIONS, LEVELS, AND HEALTH STATES FOR ILLITERATE RESPONDENTS IN VALUATION STUDIES - AN EXAMPLE FROM MOROCCO","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Valuation (finance); Functional illiteracy; Respondent; Time-trade-off; Graphics; Population; EQ-5D; Mathematics; Psychology; Statistics; Medicine; Demography; Computer science; Quality of life (healthcare); Health related quality of life; Nursing; Environmental health; Sociology; Economics","score_opus":0.8553870662258464,"score_gpt":0.505834811641362,"score_spread":0.34955225458448436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996554616","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026441187,0.00020062404,0.953382,0.0010156225,0.00007986615,0.00015641314,0.0051679877,0.0017361545,0.011820085],"genre_scores_gemma":[0.47394264,0.0003173534,0.5141043,0.00014732037,0.000054830693,0.00026984522,0.004520505,0.00027576598,0.006367369],"study_design_codex":"design_other","study_design_gemma":"design_other","domain_scores_codex":[0.99895006,0.00075171125,0.00004642563,0.000101602505,0.000117687894,0.000032532884],"domain_scores_gemma":[0.99761873,0.0016702601,0.00010502,0.00027868015,0.00028901346,0.00003832095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016789592,0.0006130648,0.0003972784,0.0016966002,0.00039111788,0.0019323537,0.0006594653,0.0004558666,0.010247983],"category_scores_gemma":[0.007778994,0.00022156,0.0009750814,0.0019427976,0.0002917514,0.0010449382,0.0010248945,0.00057025725,0.0010513158],"study_design_candidate":"design_other","study_design_consensus":"design_other","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033199432,0.00023275187,0.020919831,0.0005896875,0.00039558212,0.0010892997,0.0017775039,0.13092183,0.006093591,0.2744516,0.02945536,0.53374094],"study_design_scores_gemma":[0.000054034354,0.00007541251,0.007592356,0.000115911556,0.00013454969,0.00038631217,0.0005161354,0.741583,0.0020828156,0.20982124,0.037584353,0.000053951713],"about_ca_topic_score_codex":0.01152552,"about_ca_topic_score_gemma":0.012552465,"teacher_disagreement_score":0.01152552,"about_ca_system_score_codex":0.00066041754,"about_ca_system_score_gemma":0.000831848,"threshold_uncertainty_score":0.034282923},"labels":[],"label_agreement":null},{"id":"W2996558002","doi":"10.1016/j.jval.2019.09.2481","title":"PRO152 CONFIRMATORY PSYCHOMETRIC VALIDATION OF THE WESTERN ONTARIO MCMASTER UNIVERSITIES OSTEOARTHRITIS INVENTORY (WOMAC) IN ADULT X-LINKED HYPOPHOSPHATEMIA (XLH)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"WOMAC; Physical therapy; Osteoarthritis; Confirmatory factor analysis; Construct validity; Psychology; Rating scale; Medicine; Clinical psychology; Psychometrics; Structural equation modeling; Statistics; Developmental psychology; Mathematics; Pathology","score_opus":0.06352130796399402,"score_gpt":0.326215959190256,"score_spread":0.26269465122626195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996558002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901198,0.0001699718,0.0013137336,0.00016603805,0.000053581512,0.0005627373,0.0015348953,0.00003098621,0.0060482915],"genre_scores_gemma":[0.9891544,0.00012863433,0.0030373952,0.0001719349,0.000027136006,0.00074857037,0.002932183,0.000030346662,0.0037693484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950654,0.0015048161,0.00067565514,0.00039479113,0.002038701,0.00032058056],"domain_scores_gemma":[0.9866671,0.0025404235,0.0021242455,0.0009951099,0.0070640445,0.000609107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008981735,0.0006609799,0.00044487606,0.0011571215,0.0009949465,0.0011483605,0.00075209216,0.0005544162,0.0035821097],"category_scores_gemma":[0.020211624,0.0003862891,0.001222533,0.0011733437,0.0007317568,0.0005527815,0.0012790754,0.0007817601,0.0014005577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096349994,0.0006141451,0.96428144,0.00010877953,0.00028383348,0.00011849035,0.0016395572,0.0003125052,0.002932101,0.00037278654,0.0019519834,0.026420994],"study_design_scores_gemma":[0.000106826104,0.00065726566,0.9940866,0.000044210363,0.000090774265,0.000096054915,0.0005177904,0.00067275023,0.0011702325,0.00014147315,0.002399488,0.00001661469],"about_ca_topic_score_codex":0.0301887,"about_ca_topic_score_gemma":0.05120082,"teacher_disagreement_score":0.0301887,"about_ca_system_score_codex":0.0012588815,"about_ca_system_score_gemma":0.0030873942,"threshold_uncertainty_score":0.06002599},"labels":[],"label_agreement":null},{"id":"W2996565854","doi":"10.1016/j.jval.2019.09.1510","title":"PMH36 ST. JOHN'S WORT THERAPY IS ASSOCIATED WITH A REDUCED INCIDENCE OF DEMENTIA IN PATIENTS TREATED IN GENERAL PRACTICES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Medicine; Incidence (geometry); Odds ratio; Internal medicine; Disease; Psychiatry","score_opus":0.07058589676998091,"score_gpt":0.3660012362672071,"score_spread":0.2954153394972262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996565854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99239737,0.0061261076,0.000022511736,0.00021706437,0.000027130627,0.000005235516,0.00014833667,0.0000036093154,0.0010526617],"genre_scores_gemma":[0.99841416,0.0011876326,0.000042201187,0.00006109448,0.000023180093,0.0000019432102,0.000059902923,6.697328e-7,0.00020917327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975556,0.00009290012,0.000027900409,0.000034918106,0.000054780085,0.000033953642],"domain_scores_gemma":[0.9986602,0.00033133882,0.0007486711,0.00004956717,0.00006475811,0.0001453843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025283362,0.00014775306,0.00046297896,0.0003676945,0.0002463815,0.00047597662,0.00017080795,0.00048611566,0.002550158],"category_scores_gemma":[0.0027044346,0.00016650966,0.00053351355,0.00083899096,0.00016774885,0.00019424224,0.00017501731,0.0004684776,0.00012933686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003610682,0.00035376148,0.9658104,0.00036966486,0.0008023022,0.00029235816,0.00035439833,0.00005180487,0.0010050411,0.00005077352,0.000568583,0.026730245],"study_design_scores_gemma":[0.000044396205,0.0003138862,0.9990293,0.000035104556,0.00014899834,0.000110417095,0.000101402824,0.000033972425,0.00001955311,0.00002017916,0.00014055098,0.0000023381583],"about_ca_topic_score_codex":0.010832925,"about_ca_topic_score_gemma":0.013734031,"teacher_disagreement_score":0.010832925,"about_ca_system_score_codex":0.00026480985,"about_ca_system_score_gemma":0.00029831176,"threshold_uncertainty_score":0.021539748},"labels":[],"label_agreement":null},{"id":"W2996570620","doi":"10.1016/j.jval.2019.09.2408","title":"PRO78 THE CURRENT AND FUTURE COSTS OF ORPHAN DRUGS IN CANADA - A PUBLIC PAYER BUDGET IMPACT ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Medicine; Drug; Population; Public health; Environmental health; Pharmacology; Bioinformatics","score_opus":0.04297398827064129,"score_gpt":0.306910077215501,"score_spread":0.2639360889448597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996570620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68943304,0.022248043,0.0021148748,0.044391673,0.0004395279,0.0007016035,0.104280785,0.00015381486,0.13623665],"genre_scores_gemma":[0.93634486,0.010066063,0.00230745,0.0019361984,0.00016071677,0.00014535789,0.011776847,0.000060830927,0.037201565],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9963565,0.00036050464,0.00010798567,0.00013542331,0.0016934825,0.0013461936],"domain_scores_gemma":[0.9942946,0.0009881523,0.00049567514,0.00009790548,0.003285289,0.00083835726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00216282,0.0005501413,0.0007058807,0.00405163,0.0021789023,0.003996334,0.0010818976,0.0013088444,0.008821743],"category_scores_gemma":[0.009582551,0.0005702165,0.001464248,0.0071913097,0.00082501024,0.0011095533,0.0008855311,0.0017542636,0.0002863715],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028016542,0.00066761905,0.33341682,0.0013761261,0.0016765344,0.0011342084,0.0012882035,0.13067362,0.00079750555,0.20304619,0.19505763,0.12806387],"study_design_scores_gemma":[0.00090750086,0.00033840374,0.6657506,0.001185422,0.001999794,0.00048972626,0.004324291,0.092312045,0.001456761,0.021152308,0.2097593,0.0003238551],"about_ca_topic_score_codex":0.99593544,"about_ca_topic_score_gemma":0.997482,"teacher_disagreement_score":0.15646146,"about_ca_system_score_codex":0.15646146,"about_ca_system_score_gemma":0.16953582,"threshold_uncertainty_score":0.97838515},"labels":[],"label_agreement":null},{"id":"W2996581514","doi":"10.1016/j.jval.2019.09.2322","title":"PPM5 COSTS OF IN-HOUSE MUTATIONAL-TESTING AND IMPLICATIONS FOR ECONOMIC EVALUATION: A CASE EXAMPLE OF NON-SMALL CELL LUNG CANCER (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; William Osler Health System; Vancouver Coastal Health; Roche (Canada)","funders":"","keywords":"Activity-based costing; Profiling (computer programming); Medicine; Test (biology); Operations management; Business; Computer science; Accounting; Engineering","score_opus":0.39202791417122157,"score_gpt":0.4476798572754144,"score_spread":0.0556519431041928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996581514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86385936,0.0031527423,0.018071065,0.018319521,0.00019047843,0.0004617342,0.0030477855,0.00019206338,0.0927052],"genre_scores_gemma":[0.99249035,0.00026965173,0.0044845883,0.00020478506,0.000026902999,0.000057923688,0.00028895494,0.000012004636,0.002164952],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9955363,0.0030674438,0.00015561009,0.0001518796,0.0006983445,0.00039049963],"domain_scores_gemma":[0.9739656,0.02136519,0.0010239492,0.00065797765,0.0020907058,0.0008965824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071800053,0.00040415753,0.00045192149,0.0012619074,0.0008142925,0.0025829708,0.0010142578,0.00159718,0.011697176],"category_scores_gemma":[0.034342397,0.00019812827,0.00095846114,0.0013064009,0.00078304287,0.0014997507,0.0014034737,0.0014608888,0.00041642837],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048661754,0.0021258625,0.19698215,0.0009447502,0.00044805647,0.0076832892,0.00095383957,0.16356258,0.0022825727,0.15089542,0.026751565,0.4425037],"study_design_scores_gemma":[0.00104794,0.0044952803,0.324844,0.0013593821,0.0010171214,0.010794981,0.0064822165,0.47235653,0.005745555,0.11423026,0.0573314,0.00029541034],"about_ca_topic_score_codex":0.022783153,"about_ca_topic_score_gemma":0.01453978,"teacher_disagreement_score":0.022783153,"about_ca_system_score_codex":0.0066739684,"about_ca_system_score_gemma":0.004105603,"threshold_uncertainty_score":0.04842323},"labels":[],"label_agreement":null},{"id":"W2996622117","doi":"10.1016/j.jval.2019.09.885","title":"PDB3 HETEROGENEITY IN RENAL COMPOSITE ENDPOINTS IN CARDIOVASCULAR OUTCOMES TRIALS IN TYPE 2 DIABETES (T2D)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Renal replacement therapy; Creatinine; Internal medicine; Clinical endpoint; Renal function; Randomized controlled trial; Clinical trial; Intensive care medicine","score_opus":0.0794590413743681,"score_gpt":0.3468020962248144,"score_spread":0.2673430548504463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996622117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72418463,0.22318695,0.012985746,0.006271426,0.0030533492,0.0017172322,0.011722311,0.00034806103,0.01653027],"genre_scores_gemma":[0.988181,0.003216106,0.0021233242,0.0021468173,0.00054049067,0.0005024403,0.0022610473,0.00008607049,0.00094275206],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.91868645,0.06522231,0.008020402,0.0035146906,0.00289504,0.0016611011],"domain_scores_gemma":[0.919919,0.063377306,0.007153081,0.0065839323,0.0018598163,0.0011068749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05898011,0.0012569369,0.005081669,0.00091009686,0.00075665815,0.0040951367,0.0014934785,0.0023628226,0.007005129],"category_scores_gemma":[0.082611255,0.00075532607,0.017090932,0.002017077,0.0011578519,0.002531913,0.0022551967,0.0034917337,0.0006746488],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5291784,0.00033963713,0.07418874,0.00896625,0.32949197,0.00022482194,0.00030838375,0.0018105535,0.001410632,0.0025533543,0.0055011488,0.046026126],"study_design_scores_gemma":[0.23935387,0.020237615,0.20753165,0.0036018642,0.47598445,0.00074698863,0.00060543895,0.0062512215,0.0022093067,0.018090704,0.025011038,0.0003758578],"about_ca_topic_score_codex":0.001961431,"about_ca_topic_score_gemma":0.004375946,"teacher_disagreement_score":0.05898011,"about_ca_system_score_codex":0.0014744455,"about_ca_system_score_gemma":0.0016407039,"threshold_uncertainty_score":0.31192034},"labels":[],"label_agreement":null},{"id":"W2996636335","doi":"10.1016/j.jval.2019.09.2393","title":"PRO63 THE NATURAL HISTORY OF DUCHENNE MUSCULAR DYSTROPHY IN THE CORTICOSTEROID ERA: A SYSTEMATIC REVIEW OF STUDIES FROM CANADA AND THE US","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Vancouver Coastal Health","funders":"","keywords":"Medicine; Natural history; Life expectancy; Pediatrics; Ambulatory; Cause of death; Disease; Internal medicine; Population","score_opus":0.03416032635633043,"score_gpt":0.29450400967540474,"score_spread":0.2603436833190743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996636335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041633993,0.9989773,0.0000119843235,0.00011109176,0.000025032512,0.000006810246,0.00036144827,8.562234e-7,0.000089238776],"genre_scores_gemma":[0.0043660137,0.9950388,0.00008679891,0.00023191185,0.000027930284,0.000013258035,0.00018962729,9.68645e-7,0.00004464677],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99817777,0.00032097477,0.00060531416,0.00029303957,0.00049720943,0.000105667925],"domain_scores_gemma":[0.99069643,0.005615126,0.0020229013,0.00011667367,0.0013176206,0.00023121068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031273018,0.0006786657,0.0036756948,0.007263321,0.0004735974,0.002030623,0.0010514626,0.0011592082,0.0029722194],"category_scores_gemma":[0.010617626,0.0004362849,0.0031073608,0.014020366,0.0008136484,0.00084068306,0.001001697,0.00093891507,0.0001931395],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085593853,0.00004334321,0.025716117,0.6471561,0.017365858,0.00044662342,0.00047454986,0.000330841,0.0004188988,0.0007973454,0.015438638,0.29095572],"study_design_scores_gemma":[0.00034784543,0.00021146296,0.12721181,0.6283049,0.080979005,0.001706131,0.0009973774,0.00012825095,0.00029720383,0.0006412187,0.15901263,0.00016224287],"about_ca_topic_score_codex":0.1506527,"about_ca_topic_score_gemma":0.3499742,"teacher_disagreement_score":0.8493473,"about_ca_system_score_codex":0.004166094,"about_ca_system_score_gemma":0.015951935,"threshold_uncertainty_score":0.2995516},"labels":[],"label_agreement":null},{"id":"W2996655326","doi":"10.1016/j.jval.2019.09.489","title":"PCN294 THE IMPACT OF VALUE-BASED CARE ON ONCOLOGY SPECIALTY PHYSICIANS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Status quo; Specialty; Medicine; Workload; Family medicine; Health care; Quarter (Canadian coin); Quality (philosophy); Index (typography); Political science","score_opus":0.045495818099755496,"score_gpt":0.3041986340361171,"score_spread":0.2587028159363616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996655326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.468088,0.007301873,0.0017906566,0.21386099,0.0011667443,0.0001429242,0.010673147,0.00006530909,0.29691038],"genre_scores_gemma":[0.979592,0.0021733372,0.00031330858,0.003214819,0.00086030184,0.00003080929,0.0010004027,0.000021557227,0.01279346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99704605,0.0015568729,0.00007749813,0.00011452159,0.00068628904,0.0005187701],"domain_scores_gemma":[0.9644078,0.020950316,0.004458,0.0005453215,0.0039055997,0.0057328744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026960378,0.00015829141,0.00025253007,0.0009685322,0.00069413247,0.0026043653,0.0005123009,0.0010044695,0.0386173],"category_scores_gemma":[0.039419916,0.00018126282,0.0004649369,0.0018597355,0.00067490217,0.0011450105,0.0011755947,0.0017064608,0.0010992236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012586357,0.0011068919,0.4951813,0.00032776472,0.00031649944,0.00078875636,0.00043712635,0.027708923,0.00024524695,0.11291574,0.21449429,0.14521885],"study_design_scores_gemma":[0.000457486,0.000767369,0.72692513,0.00069589046,0.0003069351,0.0006840082,0.0033182367,0.051689286,0.00066604203,0.086406894,0.12798512,0.000097652905],"about_ca_topic_score_codex":0.0751626,"about_ca_topic_score_gemma":0.091936894,"teacher_disagreement_score":0.0751626,"about_ca_system_score_codex":0.007815567,"about_ca_system_score_gemma":0.0077540367,"threshold_uncertainty_score":0.14945018},"labels":[],"label_agreement":null},{"id":"W2996669353","doi":"10.1016/j.jval.2019.09.1786","title":"PND16 A SEMI-STANDARDIZED SYMPTOM MENU TO FACILITATE GOAL ATTAINMENT SCALING IN DEMENTIA DRUG TRIALS: COMPARISON WITH TRADITIONAL APPROACHES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Donepezil; Dementia; Galantamine; Psychology; Vascular dementia; Disease; Medicine; Psychiatry; Gerontology; Internal medicine","score_opus":0.23451725043372423,"score_gpt":0.3714425484613226,"score_spread":0.13692529802759834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996669353","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31191924,0.008074749,0.31123134,0.004609948,0.0034457985,0.14797859,0.11944287,0.033018555,0.060278818],"genre_scores_gemma":[0.22772795,0.0031132277,0.53632504,0.0012245817,0.00029899913,0.19010611,0.021013375,0.0016763216,0.018514369],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.97553265,0.013235363,0.0072554382,0.0007022893,0.0028911931,0.00038309733],"domain_scores_gemma":[0.939972,0.043607578,0.006090538,0.0035519323,0.005400834,0.0013771129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031195337,0.0014722687,0.0029076487,0.0031038225,0.000543035,0.0014374459,0.0014022699,0.00084218197,0.037545286],"category_scores_gemma":[0.06577056,0.0010910346,0.0034434814,0.002163562,0.00061252626,0.0019192703,0.003970161,0.0017114679,0.005912358],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039903138,0.0026981053,0.012923004,0.007851339,0.00127298,0.0001435929,0.00071849435,0.0022296316,0.0025528285,0.002513122,0.072574496,0.8546193],"study_design_scores_gemma":[0.121189505,0.048740163,0.34333465,0.008769594,0.003998768,0.0017080877,0.0019663225,0.047114786,0.021958863,0.018775452,0.38102078,0.0014229878],"about_ca_topic_score_codex":0.00053933135,"about_ca_topic_score_gemma":0.0017861819,"teacher_disagreement_score":0.037545286,"about_ca_system_score_codex":0.0010710766,"about_ca_system_score_gemma":0.0030280005,"threshold_uncertainty_score":0.16497868},"labels":[],"label_agreement":null},{"id":"W2996686534","doi":"10.1016/j.jval.2019.09.284","title":"PCN87 COST-EFFECTIVNESS ANALYSIS OF DABRAFENIB PLUS TRAMETINIB AS ADJUVANT TREATMENT FOR BRAF V600 MUTATION-POSITIVE MELANOMA AFTER SURGICAL RESECTION IN CANADA- A SOCIETAL PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Oncology; Internal medicine; Cohort; Placebo; Adverse effect; Adjuvant; Melanoma; Surgery; Metastatic melanoma; Cancer; Pathology; Vemurafenib; Cancer research","score_opus":0.1878447953967277,"score_gpt":0.4213764691044462,"score_spread":0.23353167370771852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996686534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9431768,0.014728889,0.00216931,0.005651911,0.00011363783,0.0006215371,0.017751556,0.000074352145,0.015711982],"genre_scores_gemma":[0.99185354,0.0020691124,0.0007704216,0.0003348696,0.000034448338,0.000062363775,0.0032961462,0.0000133397,0.0015658791],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99754673,0.00086273544,0.0000961181,0.00013386,0.000602912,0.0007576818],"domain_scores_gemma":[0.9970554,0.0012327592,0.00029146907,0.000079799036,0.0008676353,0.00047296027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003294927,0.00091075746,0.0019761727,0.0015798383,0.0005386049,0.0021726484,0.0012424049,0.00067929534,0.0033009474],"category_scores_gemma":[0.0074138422,0.00050704996,0.0036121977,0.002651251,0.00071848324,0.0005796144,0.00084538275,0.0015431349,0.00017020933],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031014217,0.0012101254,0.15891491,0.0028823745,0.015815496,0.0011539006,0.00028358272,0.62718284,0.0021605452,0.01876044,0.021787653,0.11883393],"study_design_scores_gemma":[0.007595779,0.004965648,0.42232972,0.0015216888,0.02508982,0.00080120936,0.0019565665,0.49815574,0.0021988526,0.010793544,0.02427053,0.00032091758],"about_ca_topic_score_codex":0.92172873,"about_ca_topic_score_gemma":0.9233469,"teacher_disagreement_score":0.07827127,"about_ca_system_score_codex":0.044210877,"about_ca_system_score_gemma":0.049323436,"threshold_uncertainty_score":0.3207739},"labels":[],"label_agreement":null},{"id":"W2996709796","doi":"10.1016/j.jval.2019.09.896","title":"PDB14 COST-EFFECTIVENESS OF CONTRAVE® IN OBESITY MANAGEMENT IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Overweight; Economic evaluation; Obesity; Demography; Time horizon; Weight management; Gerontology; Internal medicine; Finance; Economics","score_opus":0.28969815379271635,"score_gpt":0.3963640760027804,"score_spread":0.10666592221006405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996709796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95530766,0.0073597226,0.0006000424,0.006060461,0.00031812076,0.0004979443,0.01321148,0.00013300142,0.016511612],"genre_scores_gemma":[0.990917,0.0015358425,0.00066541636,0.00038731046,0.00004830757,0.000062262305,0.0029682748,0.00001741087,0.0033981411],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984768,0.00039927865,0.000115680705,0.00012494285,0.00052592665,0.00035732583],"domain_scores_gemma":[0.994115,0.0015128771,0.0005798299,0.00010892589,0.0017843421,0.0018989125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017544323,0.00040270915,0.00082926796,0.0011302625,0.00081411755,0.0015195705,0.0010084809,0.00075998803,0.006943779],"category_scores_gemma":[0.01048082,0.00022572777,0.0015948208,0.0014303555,0.0006400155,0.00043672614,0.0007981076,0.0012093092,0.00023420548],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.081006594,0.006009082,0.21994771,0.0022519256,0.0026767792,0.0003739684,0.0003695553,0.07064818,0.0008966661,0.009831186,0.066943996,0.5390443],"study_design_scores_gemma":[0.021209065,0.01431694,0.80603486,0.0015309707,0.0034100846,0.00033886527,0.0017161109,0.11146664,0.0018269682,0.002602397,0.035267167,0.00028004564],"about_ca_topic_score_codex":0.9604816,"about_ca_topic_score_gemma":0.96536803,"teacher_disagreement_score":0.05545957,"about_ca_system_score_codex":0.05545957,"about_ca_system_score_gemma":0.06842026,"threshold_uncertainty_score":0.40238923},"labels":[],"label_agreement":null},{"id":"W2996712851","doi":"10.1016/j.jval.2019.09.2194","title":"PNS294 REVIEW OF ANALYTICAL METHODS FOR ANALYSIS OF PATIENT REPORTED OUTCOME (PRO) DATA IN THE PRESENCE OF CENSORING DUE TO DEATH","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Censoring (clinical trials); Interpretability; Computer science; Statistics; Continuation; Econometrics; Data mining; Mathematics; Machine learning","score_opus":0.6611683677528487,"score_gpt":0.6394010307986849,"score_spread":0.021767336954163774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996712851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002399854,0.54901993,0.41012686,0.011772891,0.0040350826,0.0014780657,0.0091910595,0.00091243285,0.011063798],"genre_scores_gemma":[0.018354649,0.58212453,0.3656058,0.0072325785,0.0052699605,0.0038337589,0.009421978,0.0010619482,0.007094778],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.91427535,0.058436222,0.010078544,0.0040913513,0.0126892,0.0004293984],"domain_scores_gemma":[0.7666688,0.18770672,0.009435484,0.009360267,0.026080472,0.00074815104],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09765188,0.0019410951,0.0031878643,0.009586322,0.0008065231,0.0040405425,0.0037026817,0.0019581674,0.0088989055],"category_scores_gemma":[0.1997601,0.0013195637,0.0040887413,0.01048545,0.0023217725,0.0018521256,0.0023161299,0.0036692165,0.005541896],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037655988,0.00013662224,0.00925924,0.020432228,0.002172352,0.00023311368,0.0002805577,0.0014233303,0.00077011535,0.017293192,0.061206155,0.8864165],"study_design_scores_gemma":[0.000244942,0.0010052357,0.056635123,0.051778518,0.003299631,0.0036174234,0.0003907896,0.011339967,0.0053937524,0.04646923,0.81943184,0.00039343486],"about_ca_topic_score_codex":0.0062634232,"about_ca_topic_score_gemma":0.0069229174,"teacher_disagreement_score":0.9023481,"about_ca_system_score_codex":0.0024719317,"about_ca_system_score_gemma":0.009302776,"threshold_uncertainty_score":0.51643866},"labels":[],"label_agreement":null},{"id":"W2996713596","doi":"10.1016/j.jval.2019.09.509","title":"PCN314 POPULATION BASED STUDY OF BASELINE BONE DENSITY SCREENING IN PROSTATE CANCER PATIENTS TREATED WITH LONG-TERM ANDROGEN DEPRIVATION THERAPY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Cohort; Internal medicine; Logistic regression; Bone mineral; Odds ratio; Population; Osteoporosis; Oncology; Cancer","score_opus":0.03952232571577525,"score_gpt":0.32195357712049316,"score_spread":0.2824312514047179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996713596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99796295,0.00014429344,0.00006926756,0.000051798615,0.000012799909,0.000033751996,0.0009057476,0.000004287539,0.0008149859],"genre_scores_gemma":[0.9982779,0.00005142488,0.000045239434,0.00006663453,0.000012791121,0.000028535882,0.0008104312,0.000003759378,0.0007034483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885285,0.00037461368,0.00007721627,0.00026503194,0.0002279247,0.000202409],"domain_scores_gemma":[0.9990151,0.00014035476,0.00023628862,0.000099631085,0.00018121905,0.00032739324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058740354,0.0005236469,0.00073844055,0.0009434498,0.0013653082,0.0010969834,0.00088565936,0.000942537,0.0026921034],"category_scores_gemma":[0.0017995378,0.0006348808,0.0009220866,0.002745924,0.0004980813,0.00068442407,0.00074610364,0.001549872,0.00053788844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000995423,0.00023400463,0.99688905,0.00000967344,0.00017375093,0.00013813676,0.00009279911,0.00003537243,0.00032410497,0.000023376473,0.00023601252,0.00084824726],"study_design_scores_gemma":[0.000055367123,0.0002460577,0.9989874,0.0000028480677,0.00005658177,0.00014279307,0.00015101515,0.000093952905,0.000025955866,0.00001530647,0.0002171495,0.000005638986],"about_ca_topic_score_codex":0.051623717,"about_ca_topic_score_gemma":0.051195342,"teacher_disagreement_score":0.051623717,"about_ca_system_score_codex":0.0011029694,"about_ca_system_score_gemma":0.0011931749,"threshold_uncertainty_score":0.10264641},"labels":[],"label_agreement":null},{"id":"W2996718802","doi":"10.1016/j.jval.2019.09.632","title":"PCN439 DEVELOPING A DISCRETE-EVENT SIMULATION TO STUDY THE INFLUENCE OF WAITING TIMES ON THE EFFECTIVENESS AND COST-EFFECTIVENESS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Guelph; University of Waterloo","funders":"","keywords":"Medicine; Chimeric antigen receptor; Cost-effectiveness analysis; Cost effectiveness; Oncology; Lymphoma; Internal medicine; Immunotherapy; Cancer","score_opus":0.04619662143292034,"score_gpt":0.37127889652554735,"score_spread":0.325082275092627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996718802","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35577685,0.00050224,0.61322236,0.0013694548,0.0003361163,0.0005694803,0.0015417485,0.0019986362,0.024683146],"genre_scores_gemma":[0.8871943,0.00022048727,0.10627868,0.00021913582,0.000043646054,0.00039566398,0.00073671754,0.00015890026,0.0047525004],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99950254,0.0002688071,0.000018151119,0.000056920824,0.00008498722,0.0000686942],"domain_scores_gemma":[0.9925011,0.006649003,0.00016457756,0.0001289507,0.00039758306,0.00015887035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018600638,0.00062258524,0.00093638897,0.00048361946,0.00038494787,0.00086495024,0.0011854232,0.0012794702,0.0062982705],"category_scores_gemma":[0.0065251044,0.0005863947,0.001032556,0.00041250917,0.0004271983,0.00045706445,0.0005992068,0.0011911812,0.000295641],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004925944,0.000044136174,0.00034165056,0.00001796262,0.000022062795,0.000013379297,0.000005924579,0.99671894,0.000108149055,0.0010450041,0.00017133163,0.0014621009],"study_design_scores_gemma":[0.000022179,0.000010969406,0.000031327498,0.0000012429864,0.0000038819758,0.0000012375974,0.0000017960546,0.99958175,0.00005794576,0.00020067628,0.00008571362,0.0000013082722],"about_ca_topic_score_codex":0.04703997,"about_ca_topic_score_gemma":0.019739648,"teacher_disagreement_score":0.04703997,"about_ca_system_score_codex":0.0011095089,"about_ca_system_score_gemma":0.0026223212,"threshold_uncertainty_score":0.09353238},"labels":[],"label_agreement":null},{"id":"W2996732096","doi":"10.1016/j.jval.2019.09.936","title":"PDB54 ECONOMIC EVALUATION OF A NEW POLYGENIC RISK SCORE TO PREVENT NEPHROPATHIES IN TYPE-2 DIABETIC PATIENTS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Diabetic nephropathy; Time horizon; Disease; Type 2 diabetes; Diabetes mellitus; Demography; Internal medicine; Finance; Endocrinology","score_opus":0.290316852410596,"score_gpt":0.4066461255172055,"score_spread":0.11632927310660951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996732096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95101345,0.0070995972,0.010806665,0.004860391,0.00083597476,0.0026278284,0.010170238,0.00015717316,0.012428666],"genre_scores_gemma":[0.9914895,0.000635811,0.0041150823,0.00031298384,0.0000931386,0.00056766067,0.0019903327,0.0000087201515,0.00078669837],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99028814,0.007913118,0.00037721737,0.00028657855,0.00081609515,0.00031895048],"domain_scores_gemma":[0.98807496,0.00870298,0.0008740281,0.00048074618,0.0009923077,0.00087501435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011826142,0.0008590189,0.0018217318,0.0011823633,0.00030332687,0.0015366955,0.0007678241,0.0011491554,0.0045098825],"category_scores_gemma":[0.03180256,0.00027676337,0.003027615,0.0010302279,0.0003843965,0.00062950957,0.0011330724,0.0012600241,0.00024189841],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32035086,0.011122252,0.1645549,0.0026542693,0.017643942,0.00036609865,0.00014328757,0.19039145,0.0009398449,0.013945485,0.015496155,0.26239148],"study_design_scores_gemma":[0.13973203,0.07955167,0.20614542,0.0011195578,0.015343247,0.0003637491,0.00036222287,0.53209746,0.0015576018,0.009882116,0.013556845,0.00028802681],"about_ca_topic_score_codex":0.010922405,"about_ca_topic_score_gemma":0.0049181706,"teacher_disagreement_score":0.011826142,"about_ca_system_score_codex":0.0033254689,"about_ca_system_score_gemma":0.0033687796,"threshold_uncertainty_score":0.06254339},"labels":[],"label_agreement":null},{"id":"W2996735042","doi":"10.1016/j.jval.2019.09.742","title":"PCV17 HEALTHCARE UTILIZATION PRIOR TO AN INITIAL DIAGNOSIS OF PAROXYSMAL SUPRVENTRICULAR TACHYCARDIA IN A LARGE HEALTHCARE SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Medical diagnosis; Emergency department; Paroxysmal supraventricular tachycardia; Pediatrics; Demographics; Health care; Ventricular tachycardia; Tachycardia; Internal medicine; Emergency medicine; Cardiology; Demography; Radiology","score_opus":0.05408101590404009,"score_gpt":0.3605485894862076,"score_spread":0.30646757358216753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996735042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924695,0.0007745611,0.00016542441,0.0017085053,0.000057891655,0.00002768622,0.0017490404,0.000014459297,0.0030329733],"genre_scores_gemma":[0.99823344,0.0002676521,0.00007983923,0.0003415348,0.00006998896,0.000011085114,0.00073800853,0.0000053348804,0.0002530978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986964,0.00022017346,0.00014994336,0.00023903798,0.00016258076,0.0005319067],"domain_scores_gemma":[0.99524885,0.0008493732,0.0018995415,0.00014686662,0.00037231226,0.0014830327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038296563,0.00022821927,0.0004141268,0.0011416189,0.0011842325,0.0016502709,0.0006310434,0.000702315,0.0048402483],"category_scores_gemma":[0.0038441063,0.00039816773,0.0005905919,0.0018082606,0.0005106866,0.0010536159,0.00125514,0.0016629029,0.00036329505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051741066,0.0000603969,0.9958983,0.000016407539,0.00004531792,0.00051001285,0.00012475598,0.000067347675,0.00009856717,0.000082336,0.0011058724,0.0019388815],"study_design_scores_gemma":[0.0000075904813,0.000068054695,0.9969318,0.000053987875,0.000021316351,0.000759587,0.0012644286,0.00033456075,0.00004803613,0.00010706148,0.00039354686,0.000010208316],"about_ca_topic_score_codex":0.061577562,"about_ca_topic_score_gemma":0.08312204,"teacher_disagreement_score":0.061577562,"about_ca_system_score_codex":0.0015532892,"about_ca_system_score_gemma":0.0029588242,"threshold_uncertainty_score":0.12243825},"labels":[],"label_agreement":null},{"id":"W2996753060","doi":"10.1016/j.jval.2019.09.1323","title":"PIN82 CHOICE OF INFLUENZA IMMUNIZATION PROVIDER AND IMPACT ON IMMUNIZATION COVERAGE IN ALBERTA, CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health","funders":"","keywords":"Immunization; Medicine; Multinomial logistic regression; Public health; Pharmacy; Health care; Logistic regression; Family medicine; Population; Demography; Environmental health; Pediatrics; Immunology; Nursing; Internal medicine; Statistics","score_opus":0.051392981099729874,"score_gpt":0.37792022575970946,"score_spread":0.32652724465997957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996753060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740927,0.0021419278,0.00012473432,0.0027374572,0.0000608807,0.000073232346,0.0061227838,0.000018171657,0.014628099],"genre_scores_gemma":[0.98726547,0.0012959294,0.00023626663,0.00049813336,0.00001651832,0.000028277209,0.0016317758,0.000013304346,0.009014388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977412,0.00030704698,0.00009226232,0.00015622535,0.00070103613,0.0010022155],"domain_scores_gemma":[0.9938398,0.000845764,0.000812557,0.00013435856,0.0024750235,0.0018925912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015692576,0.00029253718,0.0003831336,0.0019290524,0.0031357151,0.0020035554,0.0016676711,0.0007168866,0.0059641944],"category_scores_gemma":[0.0056694564,0.00038368258,0.0007950603,0.00469637,0.00091895193,0.00045710106,0.0010994435,0.0013450832,0.00035245373],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005857515,0.00023773494,0.9746953,0.00007907185,0.00014226921,0.0002293897,0.00101765,0.0005342144,0.00012325321,0.0010312072,0.0068220096,0.01450219],"study_design_scores_gemma":[0.000058476708,0.000053271175,0.9929085,0.00009884206,0.000084216175,0.00005787276,0.0032175998,0.00057176023,0.00010214843,0.00011241933,0.0027117357,0.000023118846],"about_ca_topic_score_codex":0.99862635,"about_ca_topic_score_gemma":0.9992061,"teacher_disagreement_score":0.062299434,"about_ca_system_score_codex":0.062299434,"about_ca_system_score_gemma":0.08246203,"threshold_uncertainty_score":0.45201612},"labels":[],"label_agreement":null},{"id":"W2999858676","doi":"10.1016/j.jval.2019.10.010","title":"Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nice; Medicine; Surrogate endpoint; Orphan drug; Cancer drugs; Cancer; Excellence; Cost effectiveness; Quality-adjusted life year; Family medicine; Internal medicine; Risk analysis (engineering); Bioinformatics; Computer science","score_opus":0.7453347584734222,"score_gpt":0.5305209856817386,"score_spread":0.21481377279168368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999858676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6406581,0.29636484,0.0067025223,0.0060655843,0.00035230137,0.00065059913,0.041994296,0.0000957886,0.0071158935],"genre_scores_gemma":[0.9748482,0.012786743,0.0022398124,0.0014509998,0.00023150796,0.00028843852,0.007818362,0.000059413647,0.00027643316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.87331945,0.08159713,0.024508454,0.005357201,0.014025336,0.0011924724],"domain_scores_gemma":[0.43959105,0.3223598,0.19816522,0.021448495,0.016717907,0.0017175612],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06572932,0.0005193982,0.0022913783,0.0033843203,0.0003858318,0.003138584,0.001001231,0.0015202289,0.0010866936],"category_scores_gemma":[0.2568172,0.000918997,0.005517682,0.007156769,0.00086332444,0.0021651923,0.0013973116,0.0027222305,0.00023021722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016929762,0.00014930434,0.88187253,0.008205317,0.04110831,0.00016448965,0.0005476077,0.0027416903,0.00042190545,0.0039106864,0.012223099,0.03172527],"study_design_scores_gemma":[0.00167001,0.0016873559,0.9466768,0.003981283,0.023772595,0.0010336717,0.00023141735,0.0030343586,0.00087973813,0.0019558063,0.014891227,0.00018576933],"about_ca_topic_score_codex":0.0029430534,"about_ca_topic_score_gemma":0.0049856487,"teacher_disagreement_score":0.9982258,"about_ca_system_score_codex":0.00177417,"about_ca_system_score_gemma":0.0021810855,"threshold_uncertainty_score":0.34761405},"labels":[],"label_agreement":null},{"id":"W3005936722","doi":"10.1016/j.jval.2019.12.003","title":"Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rheumatoid arthritis; Methotrexate; Medicine; Internal medicine; Physical therapy","score_opus":0.09013654746989737,"score_gpt":0.34934846832493693,"score_spread":0.2592119208550396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005936722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717173,0.014089924,0.0037539748,0.0027225087,0.00012938464,0.0007249378,0.0013218225,0.00004618991,0.00549397],"genre_scores_gemma":[0.99627644,0.0008718052,0.0012914276,0.00019708386,0.000030440164,0.00018890537,0.0005790618,0.0000069626644,0.0005579481],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9890142,0.0088970745,0.0003351121,0.0003810944,0.0008617581,0.00051076955],"domain_scores_gemma":[0.98754954,0.009042445,0.0013660007,0.00023066778,0.00076024065,0.001051085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0113105485,0.0007787339,0.0012239044,0.0013486911,0.00042603785,0.0019118085,0.0009978979,0.0012250358,0.0047982284],"category_scores_gemma":[0.022258015,0.00036097318,0.002242265,0.0007073949,0.0007693685,0.0008602869,0.0010279655,0.001054244,0.00016171132],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.24266128,0.007320423,0.08447728,0.0034495206,0.005408472,0.00068745634,0.00042308928,0.39131275,0.0033360359,0.017219769,0.0055698277,0.23813419],"study_design_scores_gemma":[0.05436832,0.12740137,0.27860108,0.002132961,0.0077586034,0.0024251994,0.0017599203,0.4778274,0.0032263775,0.008405715,0.035779722,0.00031336636],"about_ca_topic_score_codex":0.028924597,"about_ca_topic_score_gemma":0.0123434635,"teacher_disagreement_score":0.028924597,"about_ca_system_score_codex":0.014293243,"about_ca_system_score_gemma":0.0078788195,"threshold_uncertainty_score":0.10370523},"labels":[],"label_agreement":null},{"id":"W3010732428","doi":"10.1016/j.jval.2019.11.004","title":"Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"Arnold Ventures","keywords":"Sitagliptin; Medicine; Dulaglutide; Exenatide; Glipizide; Canagliflozin; Hypoglycemia; Diabetes mellitus; Internal medicine; Type 2 diabetes; Endocrinology","score_opus":0.16055804221929282,"score_gpt":0.4034613075485288,"score_spread":0.242903265329236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010732428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96028006,0.0018170051,0.007354816,0.0017712229,0.000091305265,0.00074220356,0.020687725,0.00005614371,0.0071994793],"genre_scores_gemma":[0.9796274,0.00037840224,0.005496723,0.00070818193,0.00009356801,0.0007514107,0.012338811,0.0000202653,0.0005853539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.92238337,0.055428695,0.0060835504,0.0034763187,0.010509337,0.0021186932],"domain_scores_gemma":[0.51901275,0.3663548,0.08340204,0.014960493,0.013827508,0.002442358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.051106248,0.0008614164,0.0014172136,0.0033125437,0.00072817324,0.0026436776,0.002492263,0.0019085883,0.0020938783],"category_scores_gemma":[0.2546412,0.00078395143,0.0021294379,0.006166981,0.0009867286,0.0032640717,0.0021549165,0.0023939335,0.00047228573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012315152,0.00064158207,0.97224265,0.00031426598,0.0014993579,0.00004036774,0.0003249607,0.004675928,0.00008119424,0.0015416373,0.0025664594,0.014839936],"study_design_scores_gemma":[0.000706971,0.0019529135,0.9533067,0.00042588788,0.0013710952,0.00022199289,0.0007378872,0.0320235,0.00069983554,0.0027027356,0.005774489,0.000075929885],"about_ca_topic_score_codex":0.035049483,"about_ca_topic_score_gemma":0.021257386,"teacher_disagreement_score":0.051106248,"about_ca_system_score_codex":0.0029870635,"about_ca_system_score_gemma":0.003926074,"threshold_uncertainty_score":0.27027887},"labels":[],"label_agreement":null},{"id":"W3012421263","doi":"10.1016/j.jval.2017.08.248","title":"Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Ipilimumab; Nivolumab; Medicine; Pembrolizumab; Internal medicine; Oncology; Discontinuation; Clinical trial; Population; Cost effectiveness; Cancer; Immunotherapy","score_opus":0.26104725874053547,"score_gpt":0.4041042178493367,"score_spread":0.14305695910880123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012421263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94925994,0.023240766,0.00060579664,0.0076964144,0.00021509771,0.0008714927,0.0067680664,0.00002535533,0.011317053],"genre_scores_gemma":[0.99513066,0.0024926176,0.00039002232,0.0002605717,0.000027574675,0.000064191896,0.0009306564,0.000004764733,0.00069893984],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970673,0.0013422035,0.00015310137,0.00013681996,0.0007191114,0.0005814851],"domain_scores_gemma":[0.9945003,0.0016439694,0.0006867907,0.00007563355,0.0014577581,0.0016355937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033613818,0.00051270827,0.0010624243,0.0010096066,0.0011405847,0.002468604,0.0009121708,0.0007072564,0.0021320141],"category_scores_gemma":[0.012952574,0.0002633149,0.0019459622,0.0019325598,0.00079821405,0.00047594978,0.0007280022,0.0014706418,0.00006242458],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13274956,0.005029206,0.30374792,0.00788248,0.01607084,0.0012446584,0.0007398936,0.2409013,0.0025624463,0.01365392,0.033854887,0.2415629],"study_design_scores_gemma":[0.032148965,0.016922385,0.5649497,0.00449665,0.019214662,0.0010280033,0.0033240872,0.31476176,0.002160888,0.004076602,0.036425192,0.00049123686],"about_ca_topic_score_codex":0.94428813,"about_ca_topic_score_gemma":0.9566864,"teacher_disagreement_score":0.09564012,"about_ca_system_score_codex":0.09564012,"about_ca_system_score_gemma":0.072327994,"threshold_uncertainty_score":0.6939209},"labels":[],"label_agreement":null},{"id":"W3013595319","doi":"10.1016/j.jval.2020.01.016","title":"Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Bone and Joint Health Institute; University of Calgary","funders":"National Cancer Institute; National Human Genome Research Institute; Arthritis Society; ZonMw; National Institute for Health and Care Research; Genome Canada","keywords":"Computer science; Psychological intervention; Context (archaeology); Risk analysis (engineering); Management science; Discrete event simulation; Precision medicine; Health care; Data science; Simulation; Medicine; Engineering","score_opus":0.637103806670257,"score_gpt":0.563617939581778,"score_spread":0.07348586708847904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013595319","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04054614,0.00596794,0.88499945,0.04271134,0.0007027397,0.0002691714,0.00032959448,0.00017887983,0.024294756],"genre_scores_gemma":[0.8868398,0.0035408235,0.10428293,0.0016766639,0.00052893354,0.00027475302,0.00014364193,0.00010508166,0.002607412],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9876552,0.009769947,0.0002771601,0.00058316597,0.0013057273,0.00040876848],"domain_scores_gemma":[0.9356377,0.058113817,0.0018567984,0.0011857355,0.0023581772,0.00084776984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020962862,0.0011186949,0.002887874,0.0013454157,0.0009808616,0.006882402,0.0025916288,0.003178621,0.0030462313],"category_scores_gemma":[0.06580198,0.0010246568,0.00114072,0.0016153335,0.0029622049,0.0050313277,0.0028621913,0.0052380166,0.00021274896],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071014285,0.00008738714,0.001096644,0.00016357502,0.00015480105,0.00005797963,0.00011079339,0.8188973,0.00015257661,0.15827698,0.002216299,0.018714653],"study_design_scores_gemma":[0.000025904741,0.000037533995,0.0002058949,0.00009356391,0.000022187209,0.000015806267,0.000092434886,0.82985914,0.00009129302,0.16723254,0.002303374,0.000020319081],"about_ca_topic_score_codex":0.020661576,"about_ca_topic_score_gemma":0.013480622,"teacher_disagreement_score":0.020962862,"about_ca_system_score_codex":0.0058208564,"about_ca_system_score_gemma":0.010458688,"threshold_uncertainty_score":0.11086357},"labels":[],"label_agreement":null},{"id":"W3014922133","doi":"10.1016/j.jval.2020.01.011","title":"How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Benefits Viewed in Health Technology Assessment Recommendations in the United States?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Health technology; Risk analysis (engineering); Actuarial science; Computer science; Business; Economics; Health care; Economic growth","score_opus":0.5350898077037821,"score_gpt":0.46058443854014264,"score_spread":0.07450536916363948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014922133","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09184759,0.13704073,0.017409325,0.6880264,0.0056558056,0.0003845383,0.0037398746,0.0001219183,0.055773802],"genre_scores_gemma":[0.89694625,0.03714507,0.015604671,0.044921704,0.0032142156,0.00038262983,0.0008656994,0.00006870163,0.00085101865],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.95801485,0.029822886,0.0028601186,0.0012752404,0.006621873,0.0014049562],"domain_scores_gemma":[0.85872406,0.11906597,0.006327762,0.0017262624,0.012279748,0.001876274],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.055606678,0.0009451642,0.001833023,0.0053445054,0.0010784823,0.009431236,0.0020667128,0.006208578,0.0044545587],"category_scores_gemma":[0.22737782,0.000725144,0.0023199606,0.0047963527,0.0033373495,0.009588563,0.0025112126,0.009404013,0.00041584723],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021314735,0.00075981114,0.06904441,0.007221101,0.005730222,0.00048462258,0.0036530544,0.03880417,0.00046580815,0.22711608,0.09341001,0.5511792],"study_design_scores_gemma":[0.0016481506,0.0018867544,0.12796168,0.04567718,0.011735186,0.00074037455,0.015722126,0.03811162,0.0024754133,0.6025398,0.1505632,0.00093848276],"about_ca_topic_score_codex":0.02664984,"about_ca_topic_score_gemma":0.05941392,"teacher_disagreement_score":0.94439334,"about_ca_system_score_codex":0.00817073,"about_ca_system_score_gemma":0.009019124,"threshold_uncertainty_score":0.29407972},"labels":[],"label_agreement":null},{"id":"W3015554102","doi":"10.1016/j.jval.2019.11.003","title":"Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Health Evaluation and Outcome Sciences","funders":"National Cancer Institute; Amgen","keywords":"Medicine; Credibility; Randomized controlled trial; Psychological intervention; Pharmacoeconomics; Checklist; Outcomes research; Meta-analysis; Relevance (law); Alternative medicine; Family medicine; Medical physics; Psychology; Intensive care medicine; Psychiatry; Internal medicine; Pathology","score_opus":0.5210599431721261,"score_gpt":0.5482646029242919,"score_spread":0.027204659752165794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015554102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022668554,0.99056256,0.002441391,0.00063162233,0.0011764823,0.0014584991,0.00088578573,0.000059625378,0.0005171785],"genre_scores_gemma":[0.17290258,0.798286,0.013056738,0.0036062086,0.0016730332,0.0076422296,0.0015561507,0.00015723327,0.0011198447],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9285632,0.048155874,0.014268121,0.002913328,0.005275234,0.00082423026],"domain_scores_gemma":[0.8544337,0.121081784,0.014146444,0.0042279502,0.005561385,0.0005487404],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07181648,0.004333314,0.019595338,0.0058118263,0.000789457,0.0051397868,0.004415927,0.0036872204,0.008647619],"category_scores_gemma":[0.22164024,0.002518024,0.03757155,0.005275743,0.0017334826,0.0027647782,0.0027911668,0.004999238,0.00060188584],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043462566,0.000027238084,0.00072241947,0.4400312,0.53482336,0.00008740001,0.00012535256,0.00048822345,0.00013896014,0.0005101624,0.0013838254,0.017315686],"study_design_scores_gemma":[0.00480671,0.0003319699,0.0018444005,0.06909465,0.91637516,0.000074118434,0.00007498289,0.00033181245,0.00017424121,0.0016042647,0.0052369414,0.000050736493],"about_ca_topic_score_codex":0.008706045,"about_ca_topic_score_gemma":0.015066845,"teacher_disagreement_score":0.9281835,"about_ca_system_score_codex":0.0059259185,"about_ca_system_score_gemma":0.0072431974,"threshold_uncertainty_score":0.3798064},"labels":[],"label_agreement":null},{"id":"W3017315152","doi":"10.1016/j.jval.2020.03.001","title":"Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Stakeholder; Outcomes research; Pharmacoeconomics; Relevance (law); Task force; Task (project management); Health care; Transparency (behavior); Health economics; Process (computing); Medicine; Management science; Health technology; Best practice; Process management; Engineering ethics; Computer science; Public relations; Business; Political science; Alternative medicine; Engineering; Management; Economics","score_opus":0.6836882030997739,"score_gpt":0.5277028102109224,"score_spread":0.1559853928888515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017315152","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019855248,0.0037106583,0.44686925,0.11736765,0.005628266,0.21973114,0.012450794,0.00455528,0.16983175],"genre_scores_gemma":[0.036430694,0.0016459159,0.8395938,0.009958639,0.0007924419,0.06837504,0.0072821407,0.0011354281,0.03478582],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.665293,0.12273636,0.06797774,0.009377571,0.115918405,0.01869695],"domain_scores_gemma":[0.38058004,0.15113068,0.04710775,0.047516763,0.33955237,0.03411235],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3357812,0.0021864427,0.002937276,0.022226222,0.013178796,0.024270156,0.008088647,0.01425823,0.014277027],"category_scores_gemma":[0.42045125,0.0026850814,0.0049712025,0.011877887,0.006813883,0.009224981,0.0151762655,0.016043285,0.01013674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003815969,0.0022340096,0.01581081,0.004657262,0.00028539324,0.0011177049,0.016543683,0.0036071683,0.004976293,0.14837661,0.46670708,0.33530235],"study_design_scores_gemma":[0.00040507718,0.00084369676,0.023550164,0.015286519,0.00035953638,0.0003874642,0.012548078,0.0041863336,0.0075288606,0.06689379,0.8674552,0.0005553351],"about_ca_topic_score_codex":0.035477977,"about_ca_topic_score_gemma":0.053814135,"teacher_disagreement_score":0.3357812,"about_ca_system_score_codex":0.017953174,"about_ca_system_score_gemma":0.2149717,"threshold_uncertainty_score":0.8191},"labels":[],"label_agreement":null},{"id":"W3020992630","doi":"10.1016/j.jval.2012.03.236","title":"PMS47 Parents' Willingness-to-Pay for Biologic Treatments in Juvenile Idiopathic Arthritis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Willingness to pay; Medicine; Etanercept; Confidence interval; Juvenile; Arthritis; Internal medicine; Economics","score_opus":0.14802877914566942,"score_gpt":0.43588684877928724,"score_spread":0.2878580696336178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020992630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964355,0.00021701556,0.00003433472,0.00093687035,0.000015170332,0.0000028090888,0.00007849819,0.0000014962345,0.0022782828],"genre_scores_gemma":[0.99953294,0.000039810984,0.000018439065,0.000061712235,0.0000051439533,0.0000019432146,0.000024693825,8.409311e-7,0.0003145594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991486,0.00046880194,0.000062339284,0.000043417356,0.00013708635,0.0001397792],"domain_scores_gemma":[0.9924091,0.0045266324,0.0018552995,0.00016204407,0.000289489,0.00075744523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011892,0.00008566565,0.00016274091,0.0003389935,0.00042340416,0.000669082,0.00019254649,0.0006564839,0.009341194],"category_scores_gemma":[0.012596005,0.00015256002,0.00039945124,0.0003854945,0.00028095624,0.0004957183,0.00032464348,0.0008580352,0.00043579837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034270412,0.00024875172,0.9823627,0.000020682362,0.000044862143,0.0007810137,0.001541726,0.00014941429,0.00020792449,0.00043458102,0.0010166472,0.012849107],"study_design_scores_gemma":[0.000030754007,0.00023092487,0.9925547,0.000039670405,0.00003940969,0.0013219038,0.003246149,0.0006948692,0.000172446,0.00039860955,0.0012606003,0.000009942498],"about_ca_topic_score_codex":0.0058655776,"about_ca_topic_score_gemma":0.0043238937,"teacher_disagreement_score":0.009341194,"about_ca_system_score_codex":0.0005675772,"about_ca_system_score_gemma":0.0004897476,"threshold_uncertainty_score":0.031249344},"labels":[],"label_agreement":null},{"id":"W3022659013","doi":"10.1016/j.jval.2020.01.021","title":"Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Federal Office of Rural Health Policy; Office of the Vice President for Research, University of South Carolina; U.S. Department of Health and Human Services","keywords":"Medicine; COPD; Dementia; Reimbursement; Intensive care unit; Emergency medicine; Disease; Gerontology; Demography; Health care; Intensive care medicine; Internal medicine","score_opus":0.21075281912268728,"score_gpt":0.45832047393969183,"score_spread":0.24756765481700455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022659013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99714595,0.0005430228,0.000107841835,0.0002344521,0.000011554981,0.0000040739274,0.0007859013,0.0000055062915,0.001161755],"genre_scores_gemma":[0.99856406,0.00010942589,0.00006275584,0.00003775193,0.000016506414,0.0000026950195,0.0006286252,0.000004982958,0.00057311147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915016,0.00021698404,0.0001293662,0.00014019874,0.00008966048,0.00027357985],"domain_scores_gemma":[0.98863065,0.0037407898,0.0053829188,0.0005132468,0.0004966448,0.0012358193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001136235,0.00029475498,0.00037426862,0.0009331631,0.0003434319,0.0009519826,0.0006852262,0.00076164294,0.009134899],"category_scores_gemma":[0.007924187,0.00040683657,0.0017269859,0.0014742322,0.00036220122,0.0010848638,0.0012783713,0.0010511406,0.000575769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009580636,0.000018207322,0.9990507,0.0000055973574,0.00010376966,0.00003224564,0.000028339166,0.000060262606,0.000041635976,0.000022386483,0.00005283145,0.0004882002],"study_design_scores_gemma":[0.0000019227668,0.000020395526,0.9994783,0.0000065306494,0.000024037508,0.00008388251,0.0001255767,0.00014256247,0.0000102895465,0.00002378587,0.00008037238,0.0000023470125],"about_ca_topic_score_codex":0.0102924,"about_ca_topic_score_gemma":0.014096002,"teacher_disagreement_score":0.0102924,"about_ca_system_score_codex":0.00044950543,"about_ca_system_score_gemma":0.0005573924,"threshold_uncertainty_score":0.030559242},"labels":[],"label_agreement":null},{"id":"W3024185595","doi":"10.1016/j.jval.2020.03.003","title":"Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Queen's University; Queen's University Belfast; Health Research Board","keywords":"Valuation (finance); Statistics; EQ-5D; Index (typography); Mathematics; Standard deviation; Algorithm; Population; Consistency (knowledge bases); Consistency index; Econometrics; Medicine; Computer science; Economics; Finance; Internal medicine; Physics","score_opus":0.4940096939819453,"score_gpt":0.41816122914842163,"score_spread":0.07584846483352364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024185595","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32036787,0.00047980458,0.6665625,0.00034595828,0.000108032196,0.0029586905,0.0019584156,0.00030265425,0.0069161076],"genre_scores_gemma":[0.6802598,0.00018069847,0.31298992,0.00015762664,0.000017019487,0.0039513744,0.0018982311,0.000069265196,0.00047612833],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9718545,0.021490673,0.0015071774,0.0012695012,0.0035499712,0.0003281238],"domain_scores_gemma":[0.9578023,0.030582897,0.00406327,0.0030894342,0.0042139976,0.00024810064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045230314,0.0009187015,0.0008300102,0.0016194044,0.00032534587,0.0018982992,0.0014593634,0.0006784665,0.0026280717],"category_scores_gemma":[0.12981337,0.00046592846,0.0018094195,0.0013774682,0.00070963963,0.0012386339,0.0019074713,0.001543398,0.00040999794],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044198725,0.00090157526,0.3734817,0.00094524963,0.002695547,0.00022475739,0.0012806705,0.2645595,0.007129555,0.04206524,0.0059932866,0.29630306],"study_design_scores_gemma":[0.0008922602,0.00496078,0.21845734,0.0007118788,0.0006614149,0.0006591927,0.0007021795,0.71275765,0.018116945,0.032413792,0.009354334,0.00031222354],"about_ca_topic_score_codex":0.0017179758,"about_ca_topic_score_gemma":0.0012869781,"teacher_disagreement_score":0.045230314,"about_ca_system_score_codex":0.0014745158,"about_ca_system_score_gemma":0.0023258307,"threshold_uncertainty_score":0.23920363},"labels":[],"label_agreement":null},{"id":"W3024460317","doi":"10.1016/j.jval.2020.04.046","title":"MS3 PREDICTING OPTIMAL TREATMENT REGIMENS FOR HR+/HER2- BREAST CANCER BASED ON ELECTRONIC HEALTH RECORDS USING RANDOM FOREST","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Regimen; Medicine; Cohort; Proportional hazards model; Breast cancer; Oncology; Random forest; Internal medicine; Cancer; Machine learning; Computer science","score_opus":0.03991685157468309,"score_gpt":0.35201333159086773,"score_spread":0.3120964800161846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024460317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87687,0.0030990613,0.07328885,0.0017139487,0.00016292528,0.00022047742,0.038268566,0.0020653305,0.0043108864],"genre_scores_gemma":[0.9593709,0.00036270276,0.02217018,0.00020347335,0.00010266038,0.00009266282,0.016814133,0.00006197874,0.0008211581],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99928904,0.0002647482,0.00008537838,0.00016840188,0.00010149034,0.00009089279],"domain_scores_gemma":[0.9955733,0.0033862367,0.00044374488,0.00016659393,0.00031289193,0.00011733034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015845635,0.00044186745,0.0007475943,0.0017415456,0.00021585946,0.0007298413,0.0004183755,0.00045697775,0.004886662],"category_scores_gemma":[0.009114184,0.00018458944,0.0015798212,0.0011732968,0.000106615465,0.00048013704,0.00026487396,0.0005087444,0.0009273929],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033972138,0.00072337134,0.66547287,0.000411787,0.0013726862,0.00019325982,0.00007361919,0.07773608,0.0016607658,0.00081127987,0.016012646,0.23213443],"study_design_scores_gemma":[0.0003982673,0.0007560201,0.16054678,0.00019709438,0.0012256008,0.00046937205,0.0001384074,0.8222342,0.0030916373,0.0052907136,0.0055878893,0.00006394265],"about_ca_topic_score_codex":0.0088313045,"about_ca_topic_score_gemma":0.010483139,"teacher_disagreement_score":0.0088313045,"about_ca_system_score_codex":0.00043663918,"about_ca_system_score_gemma":0.001026745,"threshold_uncertainty_score":0.017559767},"labels":[],"label_agreement":null},{"id":"W3024870800","doi":"10.1016/j.jval.2020.04.014","title":"CE2 APPLICATION OF PROPENSITY SCORE MATCHING AND BAYESIAN HIERARCHICAL DESIGN METHODS TO INTEGRATE SINGLE-ARM STUDIES INTO NETWORK META-ANALYSES (NMAS): OPPORTUNITIES AND PITFALLS ILLUSTRATED IN A CASE STUDY ASSESSING ABLATION/RADIATION THERAPIES IN LUNG CANCER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Observational study; Propensity score matching; Comparative effectiveness research; Covariate; Meta-analysis; Matching (statistics); Medicine; Bayesian probability; Statistics; Randomized controlled trial; Weighting; Mathematics; Internal medicine; Pathology; Radiology","score_opus":0.927848190614603,"score_gpt":0.6171876414016051,"score_spread":0.3106605492129979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024870800","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0069737574,0.0036883787,0.9800229,0.0024197155,0.00036579324,0.0018137436,0.0010923897,0.0008388612,0.0027845618],"genre_scores_gemma":[0.14254647,0.0016337676,0.8489795,0.0009729888,0.00022805025,0.0030741338,0.0007533877,0.00036985052,0.0014419743],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8062616,0.17828748,0.0060782377,0.002721959,0.006145641,0.00050504645],"domain_scores_gemma":[0.7819395,0.18113557,0.006951192,0.02040417,0.00898667,0.0005828196],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15647168,0.0017285354,0.002616052,0.004511908,0.0006663793,0.0047058035,0.0022668606,0.0018756891,0.0092233475],"category_scores_gemma":[0.338796,0.0012643557,0.0088584805,0.005837002,0.0008314209,0.0027475515,0.004190778,0.0026758104,0.001070467],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004288623,0.0003497634,0.022297056,0.008266147,0.06293095,0.00030304567,0.0006419816,0.069407225,0.0017417069,0.08692127,0.0153150465,0.7275373],"study_design_scores_gemma":[0.0055379956,0.0014984986,0.014243143,0.0027310918,0.029827142,0.00056784455,0.00030675536,0.5571189,0.005104923,0.3214455,0.06127431,0.00034395888],"about_ca_topic_score_codex":0.008467441,"about_ca_topic_score_gemma":0.010304107,"teacher_disagreement_score":0.84352833,"about_ca_system_score_codex":0.001458498,"about_ca_system_score_gemma":0.0069612605,"threshold_uncertainty_score":0.82751125},"labels":[],"label_agreement":null},{"id":"W3025089949","doi":"10.1016/j.jval.2020.04.093","title":"PBI27 TRENDS IN AVERAGE SALES PRICES OF BIOLOGICS REIMBURSED BY THE MEDICARE PART B PROGRAM (FIRST QUARTER 2010-FIRST QUARTER 2020)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Biosimilar; Medicine; Medicaid; Family medicine; Actuarial science; Business; Internal medicine; Health care; Economics","score_opus":0.048426148946019404,"score_gpt":0.3161614695657245,"score_spread":0.26773532061970506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025089949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.699654,0.0046603084,0.0008264187,0.0023998583,0.00031936844,0.00003211691,0.26118615,0.00065032346,0.030271528],"genre_scores_gemma":[0.8499707,0.0021820986,0.00062923145,0.0007550759,0.00014507808,0.00003689979,0.13284144,0.000071652415,0.013367864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995517,0.00002934657,0.000041616673,0.00010414478,0.0001302868,0.00014295046],"domain_scores_gemma":[0.9983612,0.00018793321,0.0006758931,0.00003103586,0.0005535773,0.00019040366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004982767,0.00031590968,0.0002884744,0.0015899106,0.00020846646,0.0010778285,0.0004096815,0.0005596739,0.008357683],"category_scores_gemma":[0.0017562447,0.00019723109,0.0008731921,0.0025858127,0.00013758022,0.0005880018,0.00044941483,0.00078515214,0.002953527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016125673,0.00016445982,0.80524224,0.0005018705,0.00051254197,0.00022714358,0.0001996526,0.0041172616,0.001490997,0.0019833338,0.13659415,0.047353696],"study_design_scores_gemma":[0.00002172494,0.00014541858,0.977692,0.00007356338,0.000059792696,0.00031203596,0.000259822,0.00187341,0.00048969884,0.00010612076,0.01895006,0.00001638898],"about_ca_topic_score_codex":0.0980201,"about_ca_topic_score_gemma":0.091841474,"teacher_disagreement_score":0.0980201,"about_ca_system_score_codex":0.0015569006,"about_ca_system_score_gemma":0.0011164587,"threshold_uncertainty_score":0.19489914},"labels":[],"label_agreement":null},{"id":"W3025490551","doi":"10.1016/j.jval.2020.04.013","title":"CE1 METHODOLOGICAL CHALLENGES WITH CONDUCTING NETWORK META-ANALYSES ASSESSING LONG-TERM COMPARATIVE EFFICACY IN PSORIASIS: A CRITIQUE OF ASSUMPTIONS UNDERPINNING RECENT INDIRECT TREATMENT COMPARISONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; EVERSANA (Canada)","funders":"","keywords":"Psoriasis; Term (time); Randomized controlled trial; Placebo; Medicine; Underpinning; Surgery; Alternative medicine; Physics; Engineering","score_opus":0.9900690591832846,"score_gpt":0.6957327199012941,"score_spread":0.29433633928199043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025490551","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006537033,0.14045987,0.5210143,0.3003262,0.012243625,0.0028603973,0.002039465,0.000592664,0.01392657],"genre_scores_gemma":[0.2916632,0.035574462,0.51892024,0.124782756,0.014895938,0.010963694,0.0007855501,0.0007266086,0.0016875124],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.22285922,0.66795236,0.055287436,0.013265871,0.039552618,0.0010824801],"domain_scores_gemma":[0.044908393,0.9146088,0.009667948,0.018443825,0.011885713,0.00048527567],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.69417125,0.0026700904,0.0067953914,0.00793352,0.002901807,0.0137613285,0.010136314,0.009700755,0.004368917],"category_scores_gemma":[0.8955342,0.0027457478,0.01160593,0.0115967225,0.017514234,0.011183461,0.009488612,0.021717267,0.0011487287],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044504814,0.00016962667,0.008998205,0.061017483,0.06665943,0.0007386345,0.008351308,0.012252134,0.0008571355,0.35902268,0.05816837,0.41931453],"study_design_scores_gemma":[0.0030726753,0.0006935791,0.004150219,0.034022115,0.023560688,0.00093796424,0.0011864037,0.017495405,0.0015938382,0.83396876,0.07887672,0.00044173156],"about_ca_topic_score_codex":0.008545034,"about_ca_topic_score_gemma":0.010034272,"teacher_disagreement_score":0.30582875,"about_ca_system_score_codex":0.007751289,"about_ca_system_score_gemma":0.017716423,"threshold_uncertainty_score":0.37714136},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W3025523126","doi":"10.1016/j.jval.2020.04.057","title":"PAM4 SOCIOECONOMIC DIFFERENTIALS OF CHILD STUNTING IN RURAL AND URBAN AREAS OF ZAMBIA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Child Nutrition and Water Access","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Socioeconomic status; Residence; Geography; Socioeconomics; Malnutrition; Odds; Rural area; Logistic regression; Environmental health; Demography; Quarter (Canadian coin); Household income; Disadvantaged; Medicine; Population; Economic growth; Economics; Sociology","score_opus":0.026606704307170163,"score_gpt":0.27854364178570673,"score_spread":0.25193693747853657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025523126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871135,0.0000805873,0.000020034735,0.0000524272,0.000001533598,0.0000066041725,0.0003413475,0.0000013041944,0.00078481704],"genre_scores_gemma":[0.99947125,0.00005622963,0.00003079505,0.000009495856,0.0000011393251,0.000008331169,0.00012783516,6.917616e-7,0.00029427823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999729,0.00004980555,0.000016785334,0.000022296968,0.000022603212,0.00015941924],"domain_scores_gemma":[0.9997191,0.000035819696,0.00012800752,0.000012737277,0.00003654099,0.00006777429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019805311,0.00015583726,0.00017966633,0.0011074772,0.00075867295,0.00053580606,0.00024691958,0.00019306566,0.0033761247],"category_scores_gemma":[0.0009702825,0.00023441415,0.000302462,0.0016537533,0.00037027555,0.00031517236,0.00084401126,0.00036497557,0.00018848573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000872734,0.000040224346,0.99330336,0.00003025725,0.00003405832,0.00019036159,0.0025949662,0.00005293036,0.0004027344,0.00026130624,0.00027485105,0.0027275945],"study_design_scores_gemma":[0.0000013148637,0.00001656179,0.99770725,0.000008100877,0.000005304776,0.000043451295,0.0019679116,0.00004082553,0.00002727202,0.000018380353,0.00016212881,0.0000015248263],"about_ca_topic_score_codex":0.1565102,"about_ca_topic_score_gemma":0.25975308,"teacher_disagreement_score":0.1565102,"about_ca_system_score_codex":0.0008615304,"about_ca_system_score_gemma":0.0005867492,"threshold_uncertainty_score":0.3111984},"labels":[],"label_agreement":null},{"id":"W3025552441","doi":"10.1016/j.jval.2020.04.042","title":"MD4 ERROR PROPAGATION FOR SIMULATED TREATMENT COMPARISONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Waterloo; McMaster University","funders":"","keywords":"Covariate; Bootstrapping (finance); Statistics; Bayesian probability; Parametric statistics; Econometrics; Survival analysis; Term (time); Mathematics; Computer science","score_opus":0.7038675797499268,"score_gpt":0.48029601840201597,"score_spread":0.22357156134791079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025552441","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06663739,0.001378469,0.9089247,0.0025667707,0.0008569788,0.0007728776,0.0060997233,0.0049813963,0.0077817584],"genre_scores_gemma":[0.5767513,0.00025066934,0.40594333,0.0010063632,0.00018696631,0.0022305192,0.004710472,0.000893308,0.008027143],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98673034,0.010754079,0.000598405,0.00080145843,0.0007872238,0.00032852226],"domain_scores_gemma":[0.75029546,0.2288978,0.0028571552,0.008842259,0.008233497,0.0008738143],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039015222,0.00083571556,0.0014894819,0.001617047,0.0008740174,0.0015959282,0.0029265052,0.003452826,0.027120568],"category_scores_gemma":[0.21551825,0.0011363849,0.0017394098,0.0014819836,0.0010793883,0.0017361431,0.0017006601,0.0033556728,0.0020676435],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002305314,0.00016989066,0.0051653115,0.0003176328,0.00042562664,0.00009519302,0.000109074404,0.8951911,0.00015440746,0.022837564,0.01419073,0.059038103],"study_design_scores_gemma":[0.0002758838,0.0000730652,0.00042984248,0.00009923315,0.000045475983,0.000026576929,0.000015483656,0.9843502,0.00035926313,0.012700057,0.001609599,0.000015251573],"about_ca_topic_score_codex":0.01992904,"about_ca_topic_score_gemma":0.012584973,"teacher_disagreement_score":0.96098477,"about_ca_system_score_codex":0.0022933783,"about_ca_system_score_gemma":0.0038473636,"threshold_uncertainty_score":0.20633465},"labels":[],"label_agreement":null},{"id":"W3026036024","doi":"10.1016/j.jval.2020.04.1082","title":"PNS79 MONOPSONY BUYER: A CRITIQUE OF THE NATIONAL PHARMACEUTICAL PROGRAM PROPOSED FOR CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Monopsony; Government (linguistics); Agency (philosophy); Prescription drug; Medical prescription; Investment (military); Business; Public economics; Political science; Public administration; Economic growth; Economics; Politics; Medicine; Law; Labour economics; Sociology","score_opus":0.1793486899776441,"score_gpt":0.37779381546604734,"score_spread":0.19844512548840323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026036024","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021340314,0.0035930814,0.003392969,0.6310742,0.0011971827,0.00018339985,0.0010950423,0.000111029265,0.33801275],"genre_scores_gemma":[0.5891744,0.003514058,0.004556487,0.24167931,0.0025702743,0.00030435168,0.00023216827,0.0002690596,0.15769996],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9833889,0.0019361136,0.00036450033,0.0019020784,0.008773964,0.0036344358],"domain_scores_gemma":[0.971412,0.010757565,0.0007542156,0.00083705044,0.013176109,0.0030630825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011308145,0.0007518303,0.0016824924,0.002926718,0.012703711,0.012214068,0.0052067935,0.02309458,0.014451403],"category_scores_gemma":[0.047037166,0.00091726886,0.0015506905,0.0030782234,0.015064552,0.0039630267,0.003124492,0.018700514,0.0011740951],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047126443,0.000017972556,0.0007403488,0.000054720676,0.00002266497,0.00006468877,0.00051392865,0.0005691079,0.00007612124,0.91049546,0.08174886,0.005648848],"study_design_scores_gemma":[0.0004104031,0.00005872446,0.008361423,0.000575511,0.00020485283,0.00013264907,0.002061686,0.0058928286,0.00076945085,0.3684998,0.6127865,0.00024614148],"about_ca_topic_score_codex":0.9765902,"about_ca_topic_score_gemma":0.97280294,"teacher_disagreement_score":0.8847091,"about_ca_system_score_codex":0.11529086,"about_ca_system_score_gemma":0.20391469,"threshold_uncertainty_score":0.83649766},"labels":[],"label_agreement":null},{"id":"W3026074587","doi":"10.1016/j.jval.2020.04.1700","title":"PCN229 POPULATION BASED ANALYSIS OF RATES OF USE OF NOVEL HORMONAL AGENTS AT THE END-OF-LIFE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Odds ratio; Cohort; Abiraterone acetate; Internal medicine; Cancer; Hormonal therapy; Population; Cause of death; Logistic regression; Cohort study; Oncology; Disease; Androgen deprivation therapy","score_opus":0.1936823565217613,"score_gpt":0.40062361726868073,"score_spread":0.20694126074691943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026074587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970421,0.00023565648,0.00010895154,0.000024354744,0.000005162057,0.0000070605006,0.0019699107,0.000006192743,0.00060072035],"genre_scores_gemma":[0.9982697,0.00007964501,0.00004915822,0.000019116225,0.0000066695616,0.0000061983455,0.0012788199,0.0000032469438,0.0002874749],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999298,0.0002342703,0.00005452334,0.00020465578,0.00012147004,0.000086968335],"domain_scores_gemma":[0.9987594,0.00023419339,0.0005912192,0.00012985444,0.00012478884,0.00016052814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005218079,0.00026453,0.00033969764,0.00082862854,0.00026495632,0.00069761084,0.0005002376,0.00054172106,0.0018085127],"category_scores_gemma":[0.0016005733,0.00031034384,0.0007579514,0.0015596375,0.00022383171,0.0004991129,0.00048576412,0.0005973049,0.00031575974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004487836,0.000034639244,0.99771464,0.00000973827,0.00022042762,0.00003793837,0.000028651482,0.00008870336,0.00026226128,0.000019498928,0.000119594726,0.001014994],"study_design_scores_gemma":[0.0000069760094,0.00008463756,0.99934894,0.0000015060946,0.000034125613,0.00008231503,0.00005765591,0.00021822433,0.000037114292,0.000010142999,0.00011495174,0.0000033788674],"about_ca_topic_score_codex":0.012422322,"about_ca_topic_score_gemma":0.012067376,"teacher_disagreement_score":0.012422322,"about_ca_system_score_codex":0.00037535338,"about_ca_system_score_gemma":0.00025750312,"threshold_uncertainty_score":0.024700046},"labels":[],"label_agreement":null},{"id":"W3026097555","doi":"10.1016/j.jval.2020.04.1618","title":"PCN128 COST-EFFECTIVENESS OF RIBOCILIB PLUS FULVESTRANT (R+F) VS FULVESTRANT (FUL) IN HORMONE RECEPTOR–POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–NEGATIVE (HR+/HER2-) ADVANCED BREAST CANCER (ABC): A CANADIAN HEALTHCARE PERSPECTIVE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Discontinuation; Fulvestrant; Adverse effect; Internal medicine; Breast cancer; Placebo; Oncology; Cancer; Estrogen receptor","score_opus":0.23368470631295493,"score_gpt":0.3999543408166003,"score_spread":0.16626963450364537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026097555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.720605,0.14079362,0.002832504,0.03883333,0.0012283606,0.001129112,0.014445578,0.0001632414,0.07996927],"genre_scores_gemma":[0.9760114,0.0148490295,0.0016005499,0.0011792972,0.00018510807,0.00009304056,0.0028023953,0.000016936061,0.0032623669],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990559,0.0003673013,0.00003738293,0.00006430586,0.00025262556,0.00022249606],"domain_scores_gemma":[0.9988613,0.00037846132,0.00013752704,0.000027184284,0.00021049353,0.00038499595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017504193,0.0006040205,0.0011991377,0.00059605687,0.0003308872,0.0015916342,0.00091642025,0.00073537376,0.0068763294],"category_scores_gemma":[0.0045506717,0.00021674256,0.0019204993,0.0010762361,0.00056444225,0.0005667069,0.00048365656,0.00155431,0.00024896723],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12619212,0.0018180998,0.018658932,0.003921407,0.00632312,0.00045878932,0.00018070718,0.09811927,0.003156965,0.020516768,0.052745804,0.66790813],"study_design_scores_gemma":[0.113144174,0.051756404,0.41017893,0.0101892315,0.033534095,0.001623112,0.0021937545,0.16615985,0.005460179,0.030020533,0.17491241,0.0008273353],"about_ca_topic_score_codex":0.5777519,"about_ca_topic_score_gemma":0.7278813,"teacher_disagreement_score":0.9770998,"about_ca_system_score_codex":0.022900252,"about_ca_system_score_gemma":0.023927711,"threshold_uncertainty_score":0.84946966},"labels":[],"label_agreement":null},{"id":"W3026112452","doi":"10.1016/j.jval.2020.04.1031","title":"PNS20 BEST-WORST SCALING IN HEALTH ECONOMICS IN CHINA: PAST, PRESENT AND FUTURE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Identification (biology); Internal validity; External validity; Data extraction; Quality (philosophy); Management science; Psychology; MEDLINE; Statistics; Economics; Social psychology; Political science; Mathematics","score_opus":0.081840291478429,"score_gpt":0.4115494818644264,"score_spread":0.32970919038599744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026112452","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63238984,0.04432217,0.010960765,0.18801673,0.0027366905,0.00020095712,0.005108268,0.0005348451,0.11572964],"genre_scores_gemma":[0.9816093,0.0050071566,0.003540347,0.0025571932,0.0006558089,0.0000674809,0.0007873814,0.000047590256,0.0057276906],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970401,0.0010057682,0.00018856923,0.0003028132,0.0007852302,0.00067738537],"domain_scores_gemma":[0.99197704,0.0014359102,0.000899295,0.0005595924,0.0026644848,0.0024637002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009032456,0.0005533899,0.00083087117,0.003307499,0.0013173837,0.0040466823,0.0013924019,0.0008255363,0.0074526817],"category_scores_gemma":[0.013124761,0.0002571143,0.00073741446,0.006746009,0.0029881955,0.0039802617,0.0025768566,0.0011029519,0.0003673424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004427789,0.00034203022,0.31032726,0.001046512,0.0002767792,0.00032391958,0.0019875045,0.009404535,0.00047774016,0.17803724,0.071923986,0.4254097],"study_design_scores_gemma":[0.00009027869,0.0003458011,0.68030363,0.00106419,0.00011687733,0.0002614307,0.00655701,0.029556824,0.0007858594,0.14316387,0.137543,0.0002112012],"about_ca_topic_score_codex":0.102733485,"about_ca_topic_score_gemma":0.10393631,"teacher_disagreement_score":0.102733485,"about_ca_system_score_codex":0.015185895,"about_ca_system_score_gemma":0.019483557,"threshold_uncertainty_score":0.20427102},"labels":[],"label_agreement":null},{"id":"W3026135127","doi":"10.1016/j.jval.2020.04.964","title":"PND72 MICROCOSTING OF CEREBRAL VENOUS THROMBOSIS IN A CANADIAN URBAN TERTIARY HOSPITAL","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Northern British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Activity-based costing; Venous thrombosis; Stroke (engine); Emergency medicine; Randomized controlled trial; Thrombosis; Medical emergency; Surgery","score_opus":0.02665056615424881,"score_gpt":0.26694232537910084,"score_spread":0.24029175922485202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026135127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992781,0.0003467139,0.00006615541,0.0011949171,0.000025301946,0.000058519963,0.00069202186,0.000009251832,0.0048261643],"genre_scores_gemma":[0.9980096,0.00029172827,0.00008508013,0.0003912587,0.000034826393,0.000010957681,0.00025926516,0.0000053278127,0.00091189606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855214,0.00008194203,0.00008048259,0.00012745344,0.00032551153,0.00083244935],"domain_scores_gemma":[0.99772483,0.00015550277,0.00043604846,0.00003847312,0.0006782774,0.0009669177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030177992,0.0005780691,0.00056340033,0.0017439696,0.0065031946,0.0019600508,0.0018288672,0.0011629941,0.005958111],"category_scores_gemma":[0.001970195,0.0006697301,0.0005308585,0.0036679667,0.0013720635,0.00063217,0.0012005178,0.0020160011,0.00043491708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013818707,0.0003132403,0.9828029,0.0000613223,0.000040902552,0.0070613865,0.0019326787,0.00015901578,0.00030556854,0.00029984958,0.0021674833,0.0047174916],"study_design_scores_gemma":[0.00002068063,0.00014282993,0.9822636,0.000079002544,0.000044904697,0.0036594055,0.012113291,0.00045959416,0.00010385867,0.00011813878,0.0009419797,0.00005267012],"about_ca_topic_score_codex":0.94866806,"about_ca_topic_score_gemma":0.97296405,"teacher_disagreement_score":0.051331937,"about_ca_system_score_codex":0.026225572,"about_ca_system_score_gemma":0.032284316,"threshold_uncertainty_score":0.19028074},"labels":[],"label_agreement":null},{"id":"W3026143491","doi":"10.1016/j.jval.2020.04.775","title":"PMS93 CHARACTERIZING THE NATURAL HISTORY OF DUCHENNE MUSCULAR DYSTROPHY IN THE UNITED STATES IN REAL-WORLD COMMERCIAL AND MEDICAID DATA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicaid; Medicine; Interquartile range; Natural history; Duchenne muscular dystrophy; Pediatrics; Natural history study; Scoliosis; Demography; Physical therapy; Internal medicine; Surgery; Health care","score_opus":0.06040704485812555,"score_gpt":0.2980984236882663,"score_spread":0.23769137883014074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026143491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785583,0.00016483912,0.00014113507,0.00040829793,0.000005923834,0.000017508277,0.019507412,0.0000095524965,0.0011871213],"genre_scores_gemma":[0.98738563,0.00011542769,0.00018418011,0.00010464575,0.0000081927055,0.00003222515,0.0118328165,0.0000079302445,0.00032887966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832004,0.00055960764,0.00026297057,0.0002820902,0.00031133136,0.0002638508],"domain_scores_gemma":[0.9901355,0.002522514,0.0048483494,0.00069890136,0.0010126113,0.0007821676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017752707,0.00016145634,0.00021852128,0.0022258647,0.00060726714,0.0011035474,0.00065720757,0.0004599587,0.0023620552],"category_scores_gemma":[0.009228604,0.00020515453,0.0003814346,0.0051967753,0.00044303684,0.00069685664,0.0010683306,0.00054757844,0.00028310818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038351165,0.000016687283,0.99777895,0.0000051584375,0.00002664861,0.00004002666,0.000053788357,0.000124179,0.000043179047,0.00013460286,0.0008422244,0.0008962218],"study_design_scores_gemma":[0.000003569147,0.00001573597,0.9974232,0.000015489806,0.00001286771,0.00018668306,0.0004342225,0.0007063348,0.00006676798,0.000097174074,0.0010335069,0.000004482857],"about_ca_topic_score_codex":0.088283606,"about_ca_topic_score_gemma":0.09850039,"teacher_disagreement_score":0.088283606,"about_ca_system_score_codex":0.0011131385,"about_ca_system_score_gemma":0.001340409,"threshold_uncertainty_score":0.17553943},"labels":[],"label_agreement":null},{"id":"W3026164881","doi":"10.1016/j.jval.2020.04.1209","title":"PNS218 THE PROFILE OF PHYSICAL VIOLENCE AGAINST PREGNANT WOMEN IN BRAZIL: A DESCRIPTIVE ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Intimate Partner and Family Violence","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Descriptive statistics; Medicine; Physical abuse; Public health; Domestic violence; Demography; Poison control; Injury prevention; Environmental health; Geography; Nursing","score_opus":0.050045634199469564,"score_gpt":0.3438313369798677,"score_spread":0.2937857027803981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026164881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937704,0.00023859528,0.00020114321,0.00014435106,0.0000061072055,0.00014200674,0.0026160395,0.0000049012724,0.0028764145],"genre_scores_gemma":[0.9973224,0.00030450872,0.0003621435,0.00004596149,0.000004508951,0.00016872745,0.0012598182,0.000003837537,0.00052814995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894255,0.0002903781,0.00022873456,0.00010422563,0.00024874145,0.00018527235],"domain_scores_gemma":[0.9972485,0.00075063156,0.0010447111,0.00017045367,0.0005325009,0.00025327766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013647199,0.00024116563,0.0003828877,0.002386453,0.0008663594,0.0009362538,0.00062496803,0.00037240065,0.0017037424],"category_scores_gemma":[0.0073790224,0.00034318023,0.00084381824,0.0032602623,0.0005118833,0.0006310034,0.0011628561,0.0004752222,0.00025232672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017160826,0.00003278187,0.99221236,0.00005549629,0.000028913542,0.00007990384,0.0033792125,0.000023645922,0.00015936578,0.00017474337,0.00014740022,0.003689067],"study_design_scores_gemma":[0.0000014130778,0.00005623989,0.9884266,0.00007583806,0.000020520682,0.00021482685,0.009827741,0.000097252145,0.000097064054,0.00006854797,0.0011080893,0.0000059011923],"about_ca_topic_score_codex":0.031353563,"about_ca_topic_score_gemma":0.047299873,"teacher_disagreement_score":0.031353563,"about_ca_system_score_codex":0.0015997627,"about_ca_system_score_gemma":0.002308154,"threshold_uncertainty_score":0.062342107},"labels":[],"label_agreement":null},{"id":"W3026258989","doi":"10.1016/j.jval.2020.04.225","title":"PDB38 BURDEN OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR (CV) RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): AN ANALYSIS OF A US HEALTH INSURANCE DATABASE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Cohort; Type 2 Diabetes Mellitus; Cohort study; Population; Internal medicine; Diabetes mellitus; Environmental health; Endocrinology","score_opus":0.028990527003234512,"score_gpt":0.2586314884798779,"score_spread":0.22964096147664337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026258989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88857424,0.00051805185,0.00011837766,0.00023364012,0.000018328685,0.000035954334,0.10946803,0.000020921718,0.0010125083],"genre_scores_gemma":[0.91430134,0.00045961747,0.00031610532,0.00014196862,0.000041694017,0.00006527196,0.08409874,0.000010555157,0.0005646881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840313,0.00037170458,0.00037661963,0.00034262173,0.00033057405,0.00017546129],"domain_scores_gemma":[0.99470925,0.0010390517,0.002718796,0.0005063516,0.00054278306,0.00048384833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013684344,0.00034764197,0.00066852616,0.0029805538,0.00039359884,0.0011145312,0.0008635828,0.00061815523,0.0027051729],"category_scores_gemma":[0.0061767874,0.00036794457,0.0013624928,0.0082976585,0.00021155471,0.0007753467,0.0011153638,0.0006234587,0.0005551719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002008422,0.000036095666,0.9960776,0.000036546095,0.00029055495,0.00004730431,0.000035355504,0.00017997833,0.000040120616,0.00006567441,0.0015801071,0.0014098028],"study_design_scores_gemma":[0.000028637269,0.000032660373,0.9981055,0.000012686872,0.00009776807,0.000151491,0.000103454884,0.0005787933,0.0000316426,0.00003214844,0.0008188788,0.000006435479],"about_ca_topic_score_codex":0.05913806,"about_ca_topic_score_gemma":0.04143612,"teacher_disagreement_score":0.05913806,"about_ca_system_score_codex":0.0011137553,"about_ca_system_score_gemma":0.0013974274,"threshold_uncertainty_score":0.117587686},"labels":[],"label_agreement":null},{"id":"W3026466697","doi":"10.1016/j.jval.2020.04.743","title":"PMS57 EPIDEMIOLOGIC MODELING TO GUIDE PAYER DECISIONS IN RARE DISEASES: A CASE STUDY OF DUCHENNE MUSCULAR DYSTROPHY IN THE UNITED STATES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Population; Duchenne muscular dystrophy; Medicine; Epidemiology; Incidence (geometry); Sample size determination; Estimation; Demography; Pediatrics; Statistics; Environmental health; Mathematics; Pathology","score_opus":0.6033858586141566,"score_gpt":0.4710968884644692,"score_spread":0.13228897014968743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026466697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88786435,0.001098435,0.061543416,0.022761986,0.00013854713,0.00028227727,0.0036040484,0.00022877964,0.022478106],"genre_scores_gemma":[0.98156595,0.00046365333,0.013390835,0.000388774,0.000051690262,0.00007547999,0.0007704012,0.000040143015,0.0032530578],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99787605,0.0016707826,0.000074439115,0.00011829767,0.0001252652,0.00013513626],"domain_scores_gemma":[0.985858,0.0123662,0.000537207,0.00037528464,0.0006010615,0.00026230238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005262317,0.00034693728,0.00042920664,0.0010256466,0.0007877271,0.0016263841,0.00075657124,0.0014429973,0.006163805],"category_scores_gemma":[0.021849465,0.00036224196,0.0008858459,0.0013942869,0.00037455827,0.00074658834,0.0007687426,0.0012528355,0.00037523985],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039965205,0.0010917136,0.4157085,0.00013984858,0.00035034606,0.003579519,0.0008854762,0.42177674,0.00033520025,0.040130686,0.02572477,0.08987751],"study_design_scores_gemma":[0.00013120647,0.00015498075,0.041659992,0.00015883798,0.0001323448,0.00083643047,0.001559469,0.92060167,0.00028406188,0.025282163,0.009158169,0.000040623778],"about_ca_topic_score_codex":0.04908661,"about_ca_topic_score_gemma":0.045613267,"teacher_disagreement_score":0.04908661,"about_ca_system_score_codex":0.0017479705,"about_ca_system_score_gemma":0.0030485464,"threshold_uncertainty_score":0.09760177},"labels":[],"label_agreement":null},{"id":"W3026476137","doi":"10.1016/j.jval.2020.04.714","title":"PMS27 CONCEPTUAL FRAMEWORK FOR ECONOMIC EVALUATION OF KNEE KINESIOGRAPHY FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Osteoarthritis; Medicine; Physical therapy; Grading (engineering); Clinical trial; Health care; Randomized controlled trial; Knee pain; Alternative medicine; Surgery; Internal medicine","score_opus":0.07688610364192276,"score_gpt":0.3318201377192933,"score_spread":0.25493403407737053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026476137","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015242717,0.003776788,0.8170936,0.01730604,0.0003718211,0.0018508337,0.0017339828,0.00016054431,0.14246373],"genre_scores_gemma":[0.5840255,0.0038343736,0.3856709,0.0018510624,0.0006747798,0.004482369,0.001189193,0.00017163822,0.01810016],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97398835,0.018703418,0.0012071821,0.0010945377,0.004111257,0.00089529733],"domain_scores_gemma":[0.97526896,0.019382078,0.0013269772,0.0007278054,0.002658543,0.00063558767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031140378,0.001771301,0.0016340245,0.0062540546,0.0012678867,0.0086160535,0.003580236,0.0036607627,0.01925631],"category_scores_gemma":[0.054527275,0.0009891937,0.002881614,0.0043998016,0.00444028,0.0059117693,0.0037398126,0.003915143,0.0014895947],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048153946,0.000073309355,0.00053702627,0.00017230338,0.00009333186,0.00005245343,0.000094441384,0.017040452,0.00008176636,0.9638514,0.002106074,0.015849266],"study_design_scores_gemma":[0.0001551502,0.00024204151,0.001219626,0.000635587,0.0001510075,0.00011997555,0.00031020516,0.07989864,0.0003983396,0.88150734,0.035316475,0.000045664132],"about_ca_topic_score_codex":0.0074549215,"about_ca_topic_score_gemma":0.0038172363,"teacher_disagreement_score":0.031140378,"about_ca_system_score_codex":0.009058863,"about_ca_system_score_gemma":0.011991731,"threshold_uncertainty_score":0.16468799},"labels":[],"label_agreement":null},{"id":"W3026479502","doi":"10.1016/j.jval.2020.04.188","title":"PCV87 HEART FAILURE RISK FACTORS ANALYSIS ON STABLE CORONARY ARTERY DISEASE PATIENTS IN CHINA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Internal medicine; Logistic regression; Propensity score matching; Heart failure; Coronary artery disease; Observational study; Retrospective cohort study","score_opus":0.019546882460897728,"score_gpt":0.265733087006147,"score_spread":0.24618620454524928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026479502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989772,0.0001868739,0.000057204874,0.000060796498,0.000005934271,0.000010410264,0.00035259122,0.0000022637569,0.00034680899],"genre_scores_gemma":[0.9988871,0.000092550974,0.000038124595,0.000040551273,0.000013820607,0.000012071642,0.00070394407,0.0000021633628,0.00020969911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991302,0.00016653445,0.00010839828,0.00015782012,0.00017335663,0.00026383786],"domain_scores_gemma":[0.99909174,0.00012355125,0.0002015245,0.000097392534,0.00017471689,0.00031112038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006299843,0.00046796593,0.0007364489,0.0016712721,0.0009337501,0.0009688788,0.0005563497,0.00045725753,0.0014542976],"category_scores_gemma":[0.0012708609,0.00041414276,0.0011156321,0.0032307059,0.0005246211,0.0004989371,0.0008234305,0.00071039784,0.00018966985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011044061,0.00003436536,0.99792695,0.000009588528,0.00008975719,0.000090619615,0.000077060715,0.000050971055,0.00010483347,0.000037920763,0.00015446643,0.0013130654],"study_design_scores_gemma":[0.000012680032,0.000041944775,0.9991709,0.0000034170541,0.00006591601,0.000067279376,0.0001540149,0.0002583434,0.000028479784,0.000029758932,0.00016332892,0.000003999008],"about_ca_topic_score_codex":0.048835635,"about_ca_topic_score_gemma":0.04303519,"teacher_disagreement_score":0.048835635,"about_ca_system_score_codex":0.0010954761,"about_ca_system_score_gemma":0.002086408,"threshold_uncertainty_score":0.09710276},"labels":[],"label_agreement":null},{"id":"W3026733513","doi":"10.1016/j.jval.2020.04.1588","title":"PCN87 COST-EFFECTIVENESS OF RIBOCILIB PLUS NONSTEROIDAL AROMATASE INHIBITOR (NSAI) IN HORMONE RECEPTOR–POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–NEGATIVE (HR+/HER2-) ADVANCED BREAST CANCER (ABC): A CANADIAN HEALTHCARE PERSPECTIVE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Discontinuation; Breast cancer; Internal medicine; Quality-adjusted life year; Population; Placebo; Oncology; Exemestane; Adverse effect; Hazard ratio; Cohort; Cancer; Cost effectiveness; Confidence interval; Pathology; Aromatase; Environmental health","score_opus":0.038519867999389855,"score_gpt":0.33232328371295655,"score_spread":0.2938034157135667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026733513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5805543,0.24685015,0.0012555927,0.055009387,0.0013410226,0.0008373269,0.014404829,0.00014475943,0.099602625],"genre_scores_gemma":[0.95384413,0.034854714,0.0013550568,0.0027844082,0.00046325524,0.00007344317,0.0027614227,0.000017802375,0.0038458009],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986626,0.0004120078,0.00006770893,0.00008624358,0.00044739744,0.0003239751],"domain_scores_gemma":[0.99875474,0.00028247692,0.00019195453,0.000018012428,0.00029769796,0.0004552336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012184712,0.00058161526,0.0012286631,0.00076381036,0.00046670478,0.0018407537,0.0008711975,0.00095377973,0.0065702847],"category_scores_gemma":[0.0032724582,0.00025849443,0.0021978752,0.0014846821,0.00059177546,0.00046915936,0.000417845,0.0016077467,0.00032263945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0900519,0.0020614283,0.041076053,0.00558997,0.00807228,0.0008992415,0.00034022794,0.0444148,0.0034601798,0.014962542,0.0746615,0.7144099],"study_design_scores_gemma":[0.054424874,0.038922258,0.5650091,0.011201164,0.039453838,0.0025058142,0.0028723162,0.057557486,0.0034739836,0.010090749,0.2138498,0.00063867704],"about_ca_topic_score_codex":0.73749673,"about_ca_topic_score_gemma":0.88473135,"teacher_disagreement_score":0.26250327,"about_ca_system_score_codex":0.039390985,"about_ca_system_score_gemma":0.034085713,"threshold_uncertainty_score":0.52809834},"labels":[],"label_agreement":null},{"id":"W3026734581","doi":"10.1016/j.jval.2020.04.796","title":"PMU20 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A UNITED STATES ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Electrosurgery; Medicine; Operations management; Activity-based costing; Surgery; Engineering; Business","score_opus":0.5098418878074189,"score_gpt":0.4212594018386066,"score_spread":0.0885824859688123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026734581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92100424,0.0027226452,0.024618741,0.0037473359,0.00020313622,0.00029134713,0.022238104,0.00039116232,0.024783324],"genre_scores_gemma":[0.9775624,0.00063854223,0.0040890537,0.0003397348,0.000059323935,0.00022268646,0.0084843235,0.00005580296,0.008548193],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99865806,0.00081675063,0.00003341453,0.00014937826,0.00009501854,0.0002472996],"domain_scores_gemma":[0.9951067,0.0038539767,0.00031687904,0.00019022638,0.00034911558,0.00018316429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032696738,0.0010089667,0.0017034212,0.001989718,0.0006509232,0.0026001846,0.0017913219,0.0015858972,0.011810932],"category_scores_gemma":[0.0072333934,0.0008264112,0.0029936456,0.0026347295,0.00059759215,0.0015513942,0.0011071085,0.0022858928,0.00076756475],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013558281,0.0007393402,0.038885973,0.0002552724,0.0014354794,0.00028886704,0.000088178145,0.8844548,0.0002682068,0.032269254,0.023937883,0.016020829],"study_design_scores_gemma":[0.00038502214,0.0005102145,0.023652375,0.000107857544,0.0009002571,0.00011497801,0.0002624401,0.95831746,0.00026761985,0.010150897,0.005261632,0.00006917433],"about_ca_topic_score_codex":0.08951132,"about_ca_topic_score_gemma":0.046042256,"teacher_disagreement_score":0.08951132,"about_ca_system_score_codex":0.0029255687,"about_ca_system_score_gemma":0.0018060869,"threshold_uncertainty_score":0.17798066},"labels":[],"label_agreement":null},{"id":"W3026749736","doi":"10.1016/j.jval.2020.04.1146","title":"PNS146 BEYOND DEFAULTS - ADAPTING PRINCIPLED PRIOR SELECTION IN BAYESIAN NETWORK META-ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; EVERSANA (Canada)","funders":"","keywords":"Prior probability; Computer science; Bayesian probability; Inference; Machine learning; Artificial intelligence; Bayesian inference; Selection (genetic algorithm); Frequentist inference; Data mining","score_opus":0.8066889316083695,"score_gpt":0.5199534122958824,"score_spread":0.2867355193124871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026749736","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002933676,0.000879955,0.991172,0.00086393725,0.0001711339,0.0004044048,0.00068747834,0.0013539866,0.0015334836],"genre_scores_gemma":[0.11236054,0.0008450512,0.8790073,0.0010959575,0.00026084314,0.0014908261,0.0016904997,0.0014130353,0.0018359653],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.92648876,0.06409595,0.0028269498,0.0030668215,0.003168373,0.00035317673],"domain_scores_gemma":[0.8205383,0.1528521,0.0024767865,0.018659905,0.004705577,0.00076733704],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07885714,0.0016938219,0.0035165243,0.0027308085,0.0011454877,0.004161426,0.004401839,0.0028681199,0.015113535],"category_scores_gemma":[0.27394566,0.0024505788,0.005967987,0.0037035702,0.001942365,0.0050366484,0.0063103414,0.0053895526,0.0028643284],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029454406,0.00023740125,0.007949289,0.0048466907,0.0082359295,0.00048699172,0.00085984444,0.16287509,0.0011991044,0.20437369,0.02786072,0.5781299],"study_design_scores_gemma":[0.0009223609,0.00021738757,0.0011971167,0.000841571,0.0014525035,0.00025641324,0.000057597634,0.45235583,0.0014011719,0.52089256,0.020290423,0.000115084855],"about_ca_topic_score_codex":0.0037204993,"about_ca_topic_score_gemma":0.005083446,"teacher_disagreement_score":0.9211429,"about_ca_system_score_codex":0.0012850717,"about_ca_system_score_gemma":0.005053089,"threshold_uncertainty_score":0.41704142},"labels":[],"label_agreement":null},{"id":"W3026818610","doi":"10.1016/j.jval.2020.04.1223","title":"PPM7 A NOVEL APPROACH TO QUANTITATIVELY SYNTHESIZE SUBGROUP FINDINGS FROM MULTIPLE TRIALS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Subgroup analysis; Meta-analysis; Statistics; Mathematics; Standard error; Treatment effect; Econometrics; Medicine; Confidence interval; Internal medicine; Traditional medicine","score_opus":0.9348229604684398,"score_gpt":0.5632636626395024,"score_spread":0.3715592978289374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026818610","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030067528,0.0042115212,0.95761555,0.0035730242,0.0017547302,0.0052499697,0.015171204,0.006476004,0.0029412908],"genre_scores_gemma":[0.033056967,0.0008206751,0.9456933,0.0016377952,0.00064696383,0.011952459,0.0037138793,0.00093187316,0.0015460219],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.80433303,0.1450845,0.020843854,0.012537667,0.01639719,0.0008037693],"domain_scores_gemma":[0.587978,0.35148945,0.011135694,0.03415681,0.0140847005,0.0011552382],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13274236,0.0031330513,0.005559581,0.011852288,0.0014059815,0.00743935,0.0038612979,0.004175039,0.031570155],"category_scores_gemma":[0.4982959,0.003017764,0.015129067,0.0093313055,0.0014983824,0.003799822,0.009177849,0.0048469687,0.0038646797],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006880728,0.00035395252,0.008141063,0.047677506,0.11572709,0.00039375844,0.0014546345,0.012391779,0.004107023,0.05252096,0.069735244,0.68061626],"study_design_scores_gemma":[0.017005682,0.0026669684,0.009551571,0.010301946,0.095664494,0.001183727,0.00068082934,0.14323722,0.011244942,0.40116817,0.30652755,0.00076694024],"about_ca_topic_score_codex":0.002929934,"about_ca_topic_score_gemma":0.006019572,"teacher_disagreement_score":0.86725765,"about_ca_system_score_codex":0.002018526,"about_ca_system_score_gemma":0.009965267,"threshold_uncertainty_score":0.70201707},"labels":[],"label_agreement":null},{"id":"W3026823264","doi":"10.1016/j.jval.2020.04.1566","title":"PCN63 A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN AMONG PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE EARLY BREAST CANCER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Breast cancer; Indirect costs; Population; Economic evaluation; Activity-based costing; Systematic review; Disease burden; Cancer; MEDLINE; Health economics; Economic cost; Disease; Intensive care medicine; Gynecology; Family medicine; Internal medicine; Environmental health; Public health; Pathology","score_opus":0.01557663739878143,"score_gpt":0.22116586987455097,"score_spread":0.20558923247576955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026823264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003047123,0.9928558,0.00011955811,0.0005430041,0.00014099403,0.00014894808,0.0025814925,0.000003957977,0.0005591637],"genre_scores_gemma":[0.041324813,0.95565844,0.00041552042,0.000943119,0.00017007912,0.00027952582,0.0010079045,0.0000055117403,0.0001950346],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9920432,0.0024317575,0.003365209,0.00071182364,0.001198435,0.00024955827],"domain_scores_gemma":[0.9718472,0.019920321,0.005549736,0.00041616548,0.0019400328,0.00032646998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006072055,0.00091436144,0.0051483936,0.011116471,0.00045079188,0.0024931817,0.000989642,0.001513986,0.0058299694],"category_scores_gemma":[0.05163734,0.0006658473,0.008573711,0.014064454,0.00066258624,0.0015976203,0.0016006175,0.0010983804,0.0003636055],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005697166,0.000028315597,0.009305513,0.8924872,0.048027225,0.00019173339,0.00013130163,0.00025180657,0.00013280731,0.0004542579,0.0040680137,0.04435208],"study_design_scores_gemma":[0.000690732,0.00020605768,0.035936065,0.75944567,0.17612717,0.0005422419,0.0002829864,0.00013706676,0.000101787504,0.0006933753,0.025773007,0.00006387224],"about_ca_topic_score_codex":0.020611376,"about_ca_topic_score_gemma":0.049158677,"teacher_disagreement_score":0.020611376,"about_ca_system_score_codex":0.0031149078,"about_ca_system_score_gemma":0.010506164,"threshold_uncertainty_score":0.040982783},"labels":[],"label_agreement":null},{"id":"W3026889703","doi":"10.1016/j.jval.2020.04.220","title":"PDB32 COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE 1 MG VS. CANAGLIFLOZIN 300 MG IN PATIENTS WITH TYPE 2 DIABETES IN A CANADIAN SETTING","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Semaglutide; Medicine; Type 2 diabetes; Cost effectiveness; Quality-adjusted life year; Metformin; Dapagliflozin; Type 2 Diabetes Mellitus; Internal medicine; Diabetes mellitus; Endocrinology; Insulin; Liraglutide; Risk analysis (engineering)","score_opus":0.024046204953987165,"score_gpt":0.26741884943052635,"score_spread":0.2433726444765392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026889703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95817876,0.016276883,0.000266976,0.004405052,0.0003796014,0.00039175697,0.0061736144,0.000078126584,0.013849231],"genre_scores_gemma":[0.99478865,0.0017168646,0.00039156733,0.00037265473,0.00006086892,0.00004383759,0.0014586141,0.0000090134245,0.001157933],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99914825,0.0001924968,0.000049940136,0.000117265634,0.00018955274,0.0003025141],"domain_scores_gemma":[0.99866295,0.00026249682,0.00017752581,0.000033398286,0.00020958307,0.00065408857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080517813,0.00059338374,0.0014994157,0.0005630747,0.0008097975,0.0014707987,0.00091425644,0.0009861458,0.006365992],"category_scores_gemma":[0.0036588416,0.00030137078,0.0032352372,0.0011787433,0.00045410186,0.0005975247,0.00058851787,0.0015372195,0.00024390564],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5252443,0.006154487,0.09344416,0.002962441,0.0071257968,0.00054966984,0.00029888964,0.02995807,0.0020165541,0.004278591,0.036134314,0.29183277],"study_design_scores_gemma":[0.14628902,0.043228075,0.68154603,0.002804087,0.022975242,0.00097036915,0.0021085618,0.075653985,0.0017254542,0.0032629813,0.018757848,0.0006783927],"about_ca_topic_score_codex":0.8480564,"about_ca_topic_score_gemma":0.876064,"teacher_disagreement_score":0.15194362,"about_ca_system_score_codex":0.029373035,"about_ca_system_score_gemma":0.028334087,"threshold_uncertainty_score":0.30567688},"labels":[],"label_agreement":null},{"id":"W3027016823","doi":"10.1016/j.jval.2020.04.1267","title":"PRO41 A MULTI-CRITERIA DECISION ANALYSIS CONTRIBUTION TO THE CANADIAN INTRAVENOUS IMMUNOGLOBULIN COST-EFFECTIVENESS ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prednisone; Medicine; Methylprednisolone; Prom; Internal medicine","score_opus":0.05088097463456857,"score_gpt":0.35548980166092736,"score_spread":0.3046088270263588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027016823","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.096880406,0.040459607,0.6580366,0.04743271,0.0029394838,0.0038789087,0.012700569,0.00086031575,0.13681148],"genre_scores_gemma":[0.66771096,0.010329338,0.29762927,0.0025995567,0.0009564028,0.00091769936,0.0037125451,0.00038029146,0.015763944],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98861015,0.007670251,0.00032013675,0.00037408853,0.0025926568,0.0004328865],"domain_scores_gemma":[0.98185754,0.012694957,0.0001965263,0.0003225237,0.004414035,0.0005143716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014424867,0.002177362,0.0019342942,0.004424661,0.0012599858,0.0037537245,0.001590323,0.0014608986,0.00781563],"category_scores_gemma":[0.04376218,0.0007332775,0.0027597935,0.0031848715,0.0006379067,0.0007337267,0.0012489241,0.002882177,0.00042912606],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024289757,0.00039670093,0.0054843933,0.0018847194,0.002934143,0.00035369015,0.00024239946,0.5061127,0.000977477,0.047675442,0.06298004,0.36852932],"study_design_scores_gemma":[0.00081986183,0.00030873614,0.0045758383,0.0011892989,0.0017297523,0.00017702453,0.00018740201,0.9033162,0.0007984328,0.041480467,0.04520464,0.00021226016],"about_ca_topic_score_codex":0.58783805,"about_ca_topic_score_gemma":0.5510934,"teacher_disagreement_score":0.41216195,"about_ca_system_score_codex":0.02232276,"about_ca_system_score_gemma":0.041326635,"threshold_uncertainty_score":0.8291785},"labels":[],"label_agreement":null},{"id":"W3027025576","doi":"10.1016/j.jval.2020.04.958","title":"PND66 RECENT EVOLUTION OF THE MARKET FOR DISEASE-MODIFYING DRUGS FOR MULTIPLE SCLEROSIS IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Teriflunomide; Fingolimod; Glatiramer acetate; Medical prescription; Dimethyl fumarate; Medicine; Multiple sclerosis; Ocrelizumab; Pediatrics; Family medicine; Internal medicine; Pharmacology; Psychiatry","score_opus":0.10127915638511291,"score_gpt":0.28736479265838666,"score_spread":0.18608563627327374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027025576","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2414404,0.06243101,0.009434863,0.24473804,0.008022796,0.00071944104,0.014926573,0.0010319852,0.41725492],"genre_scores_gemma":[0.708761,0.030823356,0.009675342,0.041081633,0.0015071303,0.000117148586,0.0055664503,0.00037477392,0.20209306],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99692446,0.00017829289,0.000094143084,0.00025377457,0.0019212215,0.00062815205],"domain_scores_gemma":[0.99089384,0.00061866635,0.00045379033,0.0000925339,0.0053886697,0.002552433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002666257,0.0002791947,0.00039376153,0.0017412406,0.0018086549,0.0036904134,0.000986817,0.0016841152,0.01687003],"category_scores_gemma":[0.0072128912,0.00026252327,0.0007786241,0.0018182339,0.0016109362,0.00066418643,0.0010298152,0.0023921088,0.0012172341],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029297885,0.00048184698,0.047676302,0.0013197836,0.00021775329,0.002934892,0.00110269,0.004933682,0.021311574,0.09054983,0.31906292,0.5074789],"study_design_scores_gemma":[0.00022835107,0.00023013174,0.063662976,0.00037524308,0.000059821254,0.00059291424,0.0005530267,0.0016091033,0.0028850376,0.0015665242,0.92817837,0.00005843438],"about_ca_topic_score_codex":0.9241122,"about_ca_topic_score_gemma":0.93807024,"teacher_disagreement_score":0.0758878,"about_ca_system_score_codex":0.064354844,"about_ca_system_score_gemma":0.098763354,"threshold_uncertainty_score":0.46692926},"labels":[],"label_agreement":null},{"id":"W3027027909","doi":"10.1016/j.jval.2020.04.1720","title":"PCN252 TIME-TO-TREATMENT INITIATION (TTI) IN COMMUNITY INFUSION CLINICS: DECREASING WAIT TIMES FOR CANADIAN ONCOLOGY PATIENTS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Dr. Georges-L.-Dumont University Hospital Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Interquartile range; Medical prescription; Distress; Breast cancer; Internal medicine; Cancer; Emergency medicine","score_opus":0.09796139484102039,"score_gpt":0.3101762630144521,"score_spread":0.21221486817343171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027027909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9359425,0.008999316,0.0010050895,0.026403513,0.0003187961,0.000262768,0.0053286143,0.00015371505,0.021585807],"genre_scores_gemma":[0.9937263,0.0013240398,0.00080460234,0.0014422039,0.0000651284,0.000057925732,0.0008062934,0.00003067805,0.0017429163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988564,0.00016834533,0.00003278941,0.00011357189,0.00019316668,0.0006358339],"domain_scores_gemma":[0.99236405,0.0010879586,0.0011596788,0.00006264762,0.00074643665,0.004579158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011905143,0.00028375862,0.00036222918,0.0006352951,0.0020727885,0.001596419,0.0017107097,0.000690031,0.013821157],"category_scores_gemma":[0.010599492,0.00024129375,0.0009112365,0.0014791321,0.00046856116,0.0005950295,0.0009978081,0.0018303912,0.0003431603],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0072115744,0.0020664837,0.503391,0.001021969,0.00038141623,0.00038267433,0.00218429,0.009641202,0.0006608256,0.0053725275,0.12946709,0.3382189],"study_design_scores_gemma":[0.0015244479,0.0019509004,0.9356174,0.001084694,0.00052841107,0.00036062434,0.0050953184,0.015797896,0.00056153955,0.0027794195,0.03454858,0.00015077497],"about_ca_topic_score_codex":0.95988053,"about_ca_topic_score_gemma":0.9795815,"teacher_disagreement_score":0.046678636,"about_ca_system_score_codex":0.046678636,"about_ca_system_score_gemma":0.072893314,"threshold_uncertainty_score":0.33867878},"labels":[],"label_agreement":null},{"id":"W3027084788","doi":"10.1016/j.jval.2020.04.1260","title":"PRO32 PREFERENCE WEIGHTS FOR QUALITY-ADJUSTED LIFE-YEARS ESTIMATION FOR TREATMENTS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN FIVE COUNTRIES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Western University","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Life expectancy; Demography; Estimation; Censoring (clinical trials); Primaquine; Environmental health; Internal medicine","score_opus":0.1414315463800529,"score_gpt":0.39823204591984507,"score_spread":0.25680049953979217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027084788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8152939,0.003437355,0.14341852,0.0013290261,0.0002839723,0.0008501756,0.019974839,0.00023260845,0.015179619],"genre_scores_gemma":[0.9643619,0.00031947411,0.02981977,0.00008822633,0.000015509719,0.000335561,0.0037990934,0.000032744425,0.0012277262],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.98996806,0.008565109,0.00028169464,0.00034191404,0.0005471438,0.00029613383],"domain_scores_gemma":[0.9890113,0.008221024,0.00054812257,0.0008211417,0.0011134156,0.00028496466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01405335,0.00074708904,0.0010721878,0.0022620244,0.00032809906,0.0019748933,0.0007872356,0.00088195736,0.005727875],"category_scores_gemma":[0.04034472,0.00044639068,0.0020774384,0.003902057,0.00041983457,0.0011448762,0.0011824336,0.0014859826,0.00038729777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010553714,0.0005552677,0.20952216,0.0015003842,0.006461487,0.00032716425,0.00073018426,0.38523635,0.001099989,0.06609491,0.01647343,0.30144492],"study_design_scores_gemma":[0.0017724647,0.0026027516,0.18264839,0.00094085524,0.0018395877,0.00066226354,0.0018390527,0.7072403,0.001126024,0.07885107,0.02019198,0.0002853489],"about_ca_topic_score_codex":0.0139095,"about_ca_topic_score_gemma":0.007986665,"teacher_disagreement_score":0.01405335,"about_ca_system_score_codex":0.0017058873,"about_ca_system_score_gemma":0.00090695365,"threshold_uncertainty_score":0.074322104},"labels":[],"label_agreement":null},{"id":"W3027141167","doi":"10.1016/j.jval.2020.01.022","title":"Acceptability and Validity of the EQ-5D in Patients Living With Dementia","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Hamilton Health Sciences","funders":"Bundesministerium für Gesundheit","keywords":"Dementia; Multivariate statistics; EQ-5D; Quality of life (healthcare); Ceiling effect; Clinical Dementia Rating; Rating scale; Proxy (statistics); Bayesian multivariate linear regression; Convergent validity; Medicine; Multivariate analysis; Clinical psychology; Activities of daily living; Psychology; Linear regression; Gerontology; Psychometrics; Statistics; Physical therapy; Health related quality of life; Internal medicine; Developmental psychology; Mathematics; Disease","score_opus":0.4723344697446466,"score_gpt":0.3779385357160594,"score_spread":0.0943959340285872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027141167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915155,0.0021786136,0.0003276236,0.00093486736,0.00005921698,0.000034224635,0.0005781145,0.0000040355194,0.00436778],"genre_scores_gemma":[0.9992077,0.00021798322,0.00012384636,0.00013450565,0.000011401337,0.000010404387,0.00022506002,0.0000017404564,0.000067441164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98988414,0.006180837,0.001339645,0.00057214114,0.0015383873,0.0004847088],"domain_scores_gemma":[0.95643854,0.032066707,0.0056427983,0.0011053664,0.0038167213,0.0009298864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014749817,0.00032531176,0.00096870295,0.0014596302,0.0005807982,0.0028936383,0.000696529,0.0013957097,0.0014506702],"category_scores_gemma":[0.105467275,0.00023955802,0.0021629445,0.0017837521,0.0013314519,0.0019888217,0.0017006302,0.0015701483,0.00019430132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000841981,0.00014448774,0.98031676,0.00011323108,0.0004818826,0.00008489841,0.001175467,0.0005171925,0.000044322434,0.00065708725,0.0005531913,0.015069327],"study_design_scores_gemma":[0.000086077824,0.0005670117,0.9880363,0.00021515138,0.00027237606,0.00042256972,0.002772504,0.0043955157,0.000090624926,0.00213619,0.00094206666,0.00006366113],"about_ca_topic_score_codex":0.008734481,"about_ca_topic_score_gemma":0.005457359,"teacher_disagreement_score":0.014749817,"about_ca_system_score_codex":0.0015614578,"about_ca_system_score_gemma":0.00088983576,"threshold_uncertainty_score":0.07800537},"labels":[],"label_agreement":null},{"id":"W3027152066","doi":"10.1016/j.jval.2020.04.470","title":"PIH76 ITCH REPORTED OUTCOME TOOL FOR CAREGIVERS OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE: AN ANALYSIS OF VALIDATION AND SCORING FROM THE ICONIC MARALIXIBAT STUDY","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Evening; Placebo; Concurrent validity; Convergent validity; Randomization; Internal medicine; Randomized controlled trial; Clinical psychology; Psychometrics; Pathology","score_opus":0.07093263383090202,"score_gpt":0.32692815986518725,"score_spread":0.2559955260342852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027152066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962352,0.00065517664,0.0004227922,0.00009543929,0.000029447303,0.00017068173,0.0010993411,0.000010534422,0.0012814824],"genre_scores_gemma":[0.9956001,0.00039465915,0.0008930225,0.000081283215,0.000022476655,0.00028805947,0.002312884,0.000009714592,0.00039784363],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715817,0.001130074,0.00036412416,0.00024811484,0.0008791827,0.00022036667],"domain_scores_gemma":[0.9956552,0.0012554018,0.0016964135,0.00030752682,0.00079857116,0.00028693367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004661236,0.0007586473,0.0009489562,0.0013442002,0.00057390373,0.001143918,0.00076830277,0.0005176658,0.0010762116],"category_scores_gemma":[0.011335655,0.00024195077,0.0011561634,0.0011862997,0.00042611157,0.0007701416,0.0013792338,0.00092351844,0.00037769572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040576587,0.000119929115,0.9904261,0.00004991186,0.00016708951,0.00010602649,0.00021941772,0.00014926773,0.00012829856,0.000052892476,0.0004975399,0.007677792],"study_design_scores_gemma":[0.000060686598,0.00035811632,0.9973416,0.000049193288,0.00010502566,0.00030458282,0.00033463494,0.00051243475,0.00021419431,0.00005064379,0.0006576994,0.000011156976],"about_ca_topic_score_codex":0.0036294903,"about_ca_topic_score_gemma":0.004933367,"teacher_disagreement_score":0.004661236,"about_ca_system_score_codex":0.0008087507,"about_ca_system_score_gemma":0.0008648525,"threshold_uncertainty_score":0.02465123},"labels":[],"label_agreement":null},{"id":"W3027243897","doi":"10.1016/j.jval.2020.04.1816","title":"PCN361 POOR PROGNOSTIC FACTORS AND THEIR IMPACT ON TREATMENT PATTERNS AND OUTCOMES FOR WOMEN WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-NEGATIVE (HR+/HER2-) ADVANCED BREAST CANCER (ABC) IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Chemotherapy; Cancer; Hormone receptor; Metastatic breast cancer; Endocrine system; Disease; Hormone","score_opus":0.026102601444537375,"score_gpt":0.29660249050752663,"score_spread":0.2704998890629893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027243897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790861,0.0026763696,0.00008366559,0.0023898724,0.000063872285,0.000031547657,0.009293199,0.000013875271,0.006361544],"genre_scores_gemma":[0.9946457,0.0011717185,0.000083673636,0.00020138778,0.000018320108,0.0000094475145,0.002162505,0.000009967929,0.0016971665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925524,0.000054985423,0.00004623085,0.00010113734,0.00016331949,0.00037907643],"domain_scores_gemma":[0.998014,0.00010265487,0.00040465881,0.000051491457,0.0006770468,0.00075017184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036192389,0.00030754303,0.00043230478,0.001010981,0.0019707708,0.0013174978,0.0012936988,0.00059759617,0.0035843465],"category_scores_gemma":[0.00244444,0.0002814968,0.00088912254,0.004163703,0.0008521362,0.0003392455,0.0009282863,0.0011212187,0.00033030636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025248068,0.00003056524,0.9922397,0.000025103946,0.00006789853,0.00009212562,0.00021661428,0.00014378042,0.000095502764,0.00015443638,0.0019300159,0.0047517456],"study_design_scores_gemma":[0.00002124272,0.000024367399,0.99714166,0.000044957374,0.00006122972,0.000082045306,0.0010581748,0.00020671086,0.00004097966,0.00008011867,0.0012255106,0.000012892841],"about_ca_topic_score_codex":0.9868041,"about_ca_topic_score_gemma":0.99344265,"teacher_disagreement_score":0.020267338,"about_ca_system_score_codex":0.020267338,"about_ca_system_score_gemma":0.032029115,"threshold_uncertainty_score":0.1470505},"labels":[],"label_agreement":null},{"id":"W3027261873","doi":"10.1016/j.jval.2020.04.137","title":"PCV32 ECONOMIC BURDEN OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND SPECIFIC EVENTS IN ONTARIO, CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Toronto Rehabilitation Institute; St. Michael's Hospital; Amgen (Canada)","funders":"","keywords":"Medicine; Cohort; Atherosclerosis Risk in Communities; Myocardial infarction; Atherosclerotic cardiovascular disease; Emergency medicine; Demography; Cardiovascular event; Liberian dollar; Total cost; Disease; Internal medicine; Finance; Business","score_opus":0.06000550234280399,"score_gpt":0.24517587991442055,"score_spread":0.18517037757161656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027261873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7832785,0.009044241,0.0004085267,0.013634821,0.00027949875,0.00025744652,0.15305898,0.00010927034,0.0399288],"genre_scores_gemma":[0.959848,0.00566314,0.00050578837,0.0007668968,0.00007903659,0.00009177835,0.016029907,0.00003686439,0.016978497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998473,0.00010151719,0.00012575598,0.00011239308,0.00054168864,0.00064561644],"domain_scores_gemma":[0.99446964,0.00020529819,0.0008202445,0.000108556706,0.0025380782,0.0018581819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066868926,0.00042486194,0.0006557104,0.002733979,0.0037900817,0.0027551674,0.0014105667,0.0008294383,0.007197303],"category_scores_gemma":[0.0040165125,0.00057405117,0.001439102,0.007846678,0.000656922,0.0005736981,0.0014362077,0.0013363333,0.00054963713],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003637722,0.00008438069,0.9248329,0.00029467742,0.00039847387,0.00041459154,0.0010630222,0.0013503995,0.00015203322,0.0030691805,0.04666934,0.021307154],"study_design_scores_gemma":[0.000042739717,0.000023378909,0.9868607,0.00018777323,0.00009613192,0.00011673625,0.0016721368,0.0008555223,0.000038735823,0.0002133266,0.009859818,0.00003295999],"about_ca_topic_score_codex":0.99941313,"about_ca_topic_score_gemma":0.99965,"teacher_disagreement_score":0.086150385,"about_ca_system_score_codex":0.086150385,"about_ca_system_score_gemma":0.1654923,"threshold_uncertainty_score":0.6250677},"labels":[],"label_agreement":null},{"id":"W3027285142","doi":"10.1016/j.jval.2020.04.1806","title":"PCN350 USING REAL WORLD DATA TO DETERMINE HEALTH SYSTEM COSTS OF CANADIANS DIAGNOSED WITH CHRONIC LYMPHOCYTIC LEUKEMIA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; AstraZeneca (Canada); Sunnybrook Hospital","funders":"","keywords":"Medicine; Activity-based costing; Chronic lymphocytic leukemia; Cohort; Total cost; Cancer; Cancer registry; Health care; Cost driver; Emergency medicine; Family medicine; Pediatrics; Leukemia; Internal medicine","score_opus":0.1461978433614025,"score_gpt":0.36675676022454073,"score_spread":0.22055891686313822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027285142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9163499,0.00074993446,0.00038969397,0.0008131011,0.000031648273,0.00012318269,0.07642747,0.000055317556,0.005059647],"genre_scores_gemma":[0.9576965,0.00032342554,0.0011243739,0.00016712351,0.000015956764,0.000059399186,0.039897773,0.0000120225795,0.0007035163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986528,0.00016181466,0.00010142572,0.00017557481,0.0005196635,0.0003887341],"domain_scores_gemma":[0.99546945,0.0006018346,0.00067615067,0.00012320314,0.0025360305,0.00059326284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014143364,0.0006175546,0.0005542836,0.0028699602,0.0013440672,0.0015030884,0.0011652042,0.0005668201,0.002391334],"category_scores_gemma":[0.009179961,0.00032180635,0.0010972772,0.007135684,0.00037339088,0.0004700186,0.000753294,0.00075932103,0.00026551646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006078156,0.00012528893,0.9661456,0.00016873174,0.00053813873,0.00010449203,0.00017802836,0.008541358,0.00011493345,0.0007412093,0.013003052,0.009731293],"study_design_scores_gemma":[0.00008857927,0.00005824143,0.9769031,0.00006066497,0.0001381746,0.000087822584,0.0005695328,0.016200824,0.000104029554,0.00014114825,0.005620549,0.000027430036],"about_ca_topic_score_codex":0.9941275,"about_ca_topic_score_gemma":0.9927988,"teacher_disagreement_score":0.035871673,"about_ca_system_score_codex":0.035871673,"about_ca_system_score_gemma":0.02889122,"threshold_uncertainty_score":0.2602684},"labels":[],"label_agreement":null},{"id":"W3027312170","doi":"10.1016/j.jval.2020.04.1391","title":"PSS2 A CANADIAN NETWORK META-ANALYSIS OF THE EFFICACY OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Vancouver Coastal Health","funders":"","keywords":"Tazarotene; Medicine; Psoriasis; Plaque psoriasis; Randomized controlled trial; Psoriasis Area and Severity Index; Dermatology; Internal medicine; Combination therapy","score_opus":0.04641643822411487,"score_gpt":0.24942889753249692,"score_spread":0.20301245930838205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027312170","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31203264,0.6486478,0.0057603903,0.0025491198,0.00315499,0.0011136364,0.021243054,0.00036134405,0.005137094],"genre_scores_gemma":[0.9596039,0.029102698,0.0027390467,0.0012790232,0.00044086867,0.000490742,0.004293204,0.00009682632,0.0019537394],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99264354,0.0041562095,0.00076112454,0.0013655233,0.0007360477,0.00033760926],"domain_scores_gemma":[0.9932713,0.0034729904,0.0008670991,0.00078298454,0.0012589246,0.00034677016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00787683,0.0028293624,0.006255782,0.0016739612,0.0011583269,0.0019603306,0.0017494689,0.002012671,0.0047876337],"category_scores_gemma":[0.018046793,0.0011761928,0.03203366,0.00259225,0.00056069606,0.00065518473,0.0011934248,0.0027527746,0.0003981833],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050621245,0.00005166655,0.017421033,0.013259297,0.907729,0.00014055143,0.000073623916,0.001479875,0.00081995444,0.00020216624,0.0023030802,0.005898562],"study_design_scores_gemma":[0.011556534,0.00060344115,0.019958789,0.00071269105,0.9639387,0.000073693984,0.000026885931,0.00081130594,0.00013449775,0.00026321,0.0018812782,0.000038927326],"about_ca_topic_score_codex":0.19095643,"about_ca_topic_score_gemma":0.2456142,"teacher_disagreement_score":0.8090436,"about_ca_system_score_codex":0.0040546227,"about_ca_system_score_gemma":0.0044150758,"threshold_uncertainty_score":0.37968987},"labels":[],"label_agreement":null},{"id":"W3027314007","doi":"10.1016/j.jval.2020.04.1073","title":"PNS70 US “IMPORT-FROM-CANADA” DRUG LEGISLATION: WILL IT LOWER DRUG COSTS FOR AMERICAN CONSUMERS?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Legislation; European union; Business; Medical prescription; CINAHL; MEDLINE; Public economics; Medicine; International trade; Economics; Political science; Pharmacology; Law","score_opus":0.07922509688112722,"score_gpt":0.30170426512868065,"score_spread":0.22247916824755343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027314007","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04507577,0.0039506485,0.0006707969,0.41831043,0.0037952473,0.00023495291,0.0095055,0.00036062495,0.518096],"genre_scores_gemma":[0.2700585,0.0037685898,0.0024435127,0.3728365,0.0020055356,0.00017191643,0.0036258716,0.00020390071,0.3448857],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99382824,0.0004977839,0.00013117817,0.00029619507,0.0033082028,0.0019383873],"domain_scores_gemma":[0.9878513,0.0023873555,0.0006452878,0.00024572178,0.006132409,0.0027378346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037883986,0.00047367797,0.00049500534,0.0016397062,0.003652131,0.006122433,0.0019397083,0.010044964,0.02698281],"category_scores_gemma":[0.01528061,0.00037947064,0.0011453567,0.0014952844,0.0024258732,0.0014531964,0.0011970327,0.004324885,0.002399705],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000258699,0.00021174447,0.009066945,0.00014680474,0.00006107343,0.00016367635,0.00020178476,0.00055673654,0.0007232815,0.11474522,0.8473436,0.02652037],"study_design_scores_gemma":[0.00019659115,0.00013367183,0.060628023,0.0004053695,0.00017621391,0.000113976974,0.0006205561,0.0014214922,0.0021113683,0.009425272,0.92463666,0.00013089438],"about_ca_topic_score_codex":0.9339193,"about_ca_topic_score_gemma":0.9588794,"teacher_disagreement_score":0.06608069,"about_ca_system_score_codex":0.04228833,"about_ca_system_score_gemma":0.11908426,"threshold_uncertainty_score":0.30682474},"labels":[],"label_agreement":null},{"id":"W3027324875","doi":"10.1016/j.jval.2020.04.960","title":"PND68 EVOLUTION OF THE CANADIAN MARKET FOR PSYCHOSTIMULANTS FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methylphenidate; Medical prescription; Attention deficit hyperactivity disorder; Dextroamphetamine; Psychiatry; Amphetamine; Medicine; Stimulant; Psychology; Pharmacology; Internal medicine","score_opus":0.07377258964137429,"score_gpt":0.34609899088351115,"score_spread":0.27232640124213686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027324875","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08452118,0.01707498,0.002603593,0.32189217,0.0061719036,0.00040942535,0.018806584,0.000569276,0.5479509],"genre_scores_gemma":[0.509199,0.019302273,0.008700387,0.09764222,0.002829308,0.00020049485,0.008258504,0.00051960285,0.35334823],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9957854,0.00018597687,0.00008035372,0.00025840898,0.0026842789,0.0010054811],"domain_scores_gemma":[0.984781,0.000849561,0.00047227528,0.00017659322,0.009194898,0.0045256587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030154136,0.00046648554,0.00042705456,0.003960351,0.003875192,0.0049076197,0.0017530092,0.0025898817,0.026860787],"category_scores_gemma":[0.009179726,0.00038848587,0.0009935129,0.0026132218,0.001728937,0.00087781704,0.0015343057,0.003185821,0.0023551928],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007469109,0.00025458273,0.028320597,0.00044087734,0.00008604282,0.00090474414,0.0006497772,0.0012770564,0.0031201649,0.111076824,0.6403211,0.21280149],"study_design_scores_gemma":[0.00009738923,0.00011138386,0.03924807,0.0003328046,0.00003149706,0.00026988247,0.0005179856,0.00086852297,0.00069576356,0.0018620469,0.9559059,0.000058567744],"about_ca_topic_score_codex":0.9598443,"about_ca_topic_score_gemma":0.9800468,"teacher_disagreement_score":0.08679906,"about_ca_system_score_codex":0.08679906,"about_ca_system_score_gemma":0.15774177,"threshold_uncertainty_score":0.6297742},"labels":[],"label_agreement":null},{"id":"W3027354369","doi":"10.1016/j.jval.2020.04.452","title":"PIH58 GEOGRAPHICAL DISPARITIES IN NON-UTILIZATION OF HEALTH FACILITY DELIVERY AND POSTNATAL SERVICES IN GHANA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Maternal and Child Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Health facility; Environmental health; Poverty; Business; Poisson regression; Community health; Geography; Socioeconomics; Medicine; Health services; Public health; Economic growth; Population; Nursing","score_opus":0.03470844041434358,"score_gpt":0.2910844536127891,"score_spread":0.25637601319844555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027354369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961373,0.0003067429,0.00006603287,0.0006470534,0.000011425926,0.000010543437,0.0007956476,0.0000019687075,0.0020233518],"genre_scores_gemma":[0.9994186,0.00012184823,0.00004830208,0.00004012962,0.0000052500136,0.000008378256,0.0001376677,0.0000017713229,0.0002180706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995889,0.00011994447,0.00003550871,0.00003643911,0.000047756133,0.00017146108],"domain_scores_gemma":[0.99842596,0.00032952087,0.0007726587,0.00005718798,0.0001322756,0.00028244208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000404678,0.00012353373,0.00018395322,0.0005875119,0.0004007994,0.0004888424,0.0002921748,0.00020299199,0.006154065],"category_scores_gemma":[0.003403415,0.00015997766,0.00025140386,0.002261029,0.0003361861,0.0004704709,0.00060116145,0.00049069483,0.00026918077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007738371,0.000029612353,0.9931312,0.000037155285,0.000042207783,0.00014373443,0.0009391878,0.00004149876,0.00010955877,0.00033935436,0.00064762746,0.004461425],"study_design_scores_gemma":[0.0000072022976,0.00002193697,0.9969394,0.000041802912,0.000012719559,0.0001057473,0.002043241,0.00006138544,0.000030478841,0.00009970324,0.0006341254,0.0000021829026],"about_ca_topic_score_codex":0.081300706,"about_ca_topic_score_gemma":0.08040694,"teacher_disagreement_score":0.081300706,"about_ca_system_score_codex":0.0007449889,"about_ca_system_score_gemma":0.0009741399,"threshold_uncertainty_score":0.16165495},"labels":[],"label_agreement":null},{"id":"W3027400885","doi":"10.1016/j.jval.2020.04.821","title":"PMU47 NOSOCOMIAL INFLUENZA HOSPITALIZATIONS AMONG END-STAGE RENAL DISEASE PATIENTS DURING THE 2013-2014 THROUGH 2015-2016 INFLUENZA SEASONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Healthcare and Medical Tourism","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; End stage renal disease; Internal medicine; Emergency medicine; Influenza season; Disease; Intensive care medicine; Pediatrics; Influenza vaccine; Virus; Immunology","score_opus":0.06450895319907456,"score_gpt":0.3984255884052816,"score_spread":0.333916635206207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027400885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927624,0.00033622494,0.000075617754,0.000091148606,0.00003381145,0.000013361617,0.0052806777,0.000009757024,0.0013969409],"genre_scores_gemma":[0.9973247,0.00017339607,0.00004215116,0.000073303185,0.000027958162,0.000017369917,0.0019430942,0.0000035980238,0.00039446904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992054,0.00011520475,0.0001129655,0.00014376019,0.0001442993,0.00027851792],"domain_scores_gemma":[0.9985837,0.00016058242,0.0007851157,0.00005109749,0.00016622698,0.00025339262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005277482,0.00028433165,0.00034217042,0.00083013956,0.00056870404,0.00076727226,0.00046418558,0.00049608795,0.003429493],"category_scores_gemma":[0.00229216,0.0002904836,0.00094765425,0.0014254493,0.00025713095,0.00075537537,0.0011136656,0.00066010235,0.00039663663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010000011,0.000014872111,0.99735355,0.000021308435,0.000059766116,0.000046339013,0.000093426956,0.000040288494,0.000081313396,0.000022441123,0.0005974227,0.0015691626],"study_design_scores_gemma":[0.000002029342,0.000027446356,0.99916947,0.000018056893,0.0000133843,0.000094511524,0.00032343122,0.000085068285,0.000032033524,0.000010120907,0.00022217253,0.000002383545],"about_ca_topic_score_codex":0.030957745,"about_ca_topic_score_gemma":0.037694048,"teacher_disagreement_score":0.030957745,"about_ca_system_score_codex":0.0006895301,"about_ca_system_score_gemma":0.00088371796,"threshold_uncertainty_score":0.061555147},"labels":[],"label_agreement":null},{"id":"W3027445498","doi":"10.1016/j.jval.2020.04.1157","title":"PNS159 THE UTILITY OF UMBRELLA REVIEWS: A CASE-STUDY ON THE SAFETY OF PROTON PUMP INHIBITORS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Generalizability theory; Observational study; Sample size determination; Systematic review; Population; Scale (ratio); Sample (material); Computer science; Quality (philosophy); Meta-analysis; Medicine; Data science; Risk analysis (engineering); Medical physics; MEDLINE; Statistics; Pathology; Mathematics; Environmental health; Geography; Chemistry","score_opus":0.8534689212612868,"score_gpt":0.5460346040034282,"score_spread":0.30743431725785864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027445498","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13896999,0.73613375,0.028598046,0.04497342,0.002413795,0.0024359676,0.0049255434,0.00020305869,0.041346405],"genre_scores_gemma":[0.83004457,0.12127769,0.032344956,0.009600777,0.001498833,0.0013862654,0.0014583489,0.00018984781,0.0021987152],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.77628136,0.18450746,0.023205139,0.0039886963,0.011015833,0.001001532],"domain_scores_gemma":[0.50009334,0.4405624,0.028756188,0.013445345,0.016074652,0.0010680433],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10007717,0.001274895,0.0027778298,0.006510108,0.0013400574,0.0050035305,0.0012830996,0.0044576065,0.005190902],"category_scores_gemma":[0.3934837,0.001010488,0.0076892916,0.0065895566,0.001535138,0.0037504323,0.00313281,0.0024650746,0.0005143856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022972913,0.00039791316,0.07871621,0.13550782,0.10558255,0.0061832657,0.0048779077,0.003315478,0.0023289092,0.022859948,0.026902271,0.5903548],"study_design_scores_gemma":[0.010170955,0.0049224705,0.08699928,0.2996572,0.2714703,0.015728503,0.004932506,0.015615899,0.006721708,0.054713454,0.22834517,0.00072271255],"about_ca_topic_score_codex":0.0049987305,"about_ca_topic_score_gemma":0.007051258,"teacher_disagreement_score":0.89992285,"about_ca_system_score_codex":0.003673912,"about_ca_system_score_gemma":0.004772429,"threshold_uncertainty_score":0.529265},"labels":[],"label_agreement":null},{"id":"W3027511647","doi":"10.1016/j.jval.2020.04.1492","title":"RW2 THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES IN CANADA AND THE UK","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Nice; Observational study; Medicine; Health technology; Family medicine; Real world data; Disease; Rare disease; Data extraction; MEDLINE; Data science; Health care; Political science; Computer science; Internal medicine","score_opus":0.5814513806912681,"score_gpt":0.47190512632206744,"score_spread":0.10954625436920068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027511647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44998792,0.022848587,0.0048964415,0.028301755,0.00085526676,0.0004996018,0.4432414,0.00035678042,0.04901226],"genre_scores_gemma":[0.888462,0.008075354,0.004864636,0.0014259013,0.00016019147,0.00020664056,0.08363635,0.00019602322,0.0129729435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99208975,0.001911463,0.00094818947,0.0005842206,0.0036194858,0.0008468564],"domain_scores_gemma":[0.9327104,0.026267326,0.006285662,0.002681974,0.02841626,0.0036383874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006565173,0.00045668797,0.0006377991,0.0055256765,0.0009977316,0.0039708363,0.0012038506,0.0009792056,0.0044409824],"category_scores_gemma":[0.08529505,0.0004586588,0.00087528996,0.013426202,0.0008153232,0.0010279528,0.0014968336,0.0014829158,0.0007642781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00096698554,0.00013409965,0.7168918,0.0015024373,0.0012490413,0.00081819185,0.0014264799,0.014990143,0.00028948873,0.0066959667,0.13048469,0.12455062],"study_design_scores_gemma":[0.00012065407,0.00007104036,0.9091577,0.00080558035,0.00021424773,0.0002806185,0.0013873128,0.013152537,0.0006022294,0.001007682,0.073035315,0.00016507883],"about_ca_topic_score_codex":0.9892306,"about_ca_topic_score_gemma":0.98564535,"teacher_disagreement_score":0.966986,"about_ca_system_score_codex":0.033013973,"about_ca_system_score_gemma":0.04424732,"threshold_uncertainty_score":0.23953426},"labels":[],"label_agreement":null},{"id":"W3027591386","doi":"10.1016/j.jval.2020.04.1342","title":"PRS17 COST-EFFECTIVENESS OF CASE DETECTION STRATEGIES FOR THE EARLY DETECTION OF COPD","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; COPD; Guideline; Cost effectiveness; Cost-effectiveness analysis; Spirometry; Population; Willingness to pay; Emergency medicine; Inhaler; Economic evaluation; Health care; Physical therapy; Pediatrics; Asthma; Internal medicine; Environmental health","score_opus":0.17538076928570642,"score_gpt":0.3306669253024309,"score_spread":0.1552861560167245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027591386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8757952,0.017111484,0.020187285,0.015524705,0.0022107866,0.0037063411,0.01510078,0.0014478407,0.048915472],"genre_scores_gemma":[0.98883456,0.0013954238,0.0037479592,0.0005713274,0.00025728325,0.00037604186,0.0022009069,0.00004628672,0.0025702429],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9924589,0.0050284257,0.00044397012,0.0005342567,0.0010619048,0.00047239804],"domain_scores_gemma":[0.966131,0.027151955,0.0023763643,0.0010235979,0.0016233424,0.001693748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008442113,0.0008735936,0.002227724,0.0020291468,0.00029051874,0.0015085485,0.001452932,0.0020720244,0.032293823],"category_scores_gemma":[0.052647557,0.00048440904,0.0044893543,0.0011049823,0.0005413113,0.0012305916,0.0010155864,0.0018869091,0.0020484095],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10833107,0.0059919227,0.03019498,0.003929436,0.004554258,0.000351178,0.00015923825,0.14099684,0.0013611136,0.011044963,0.040131208,0.6529538],"study_design_scores_gemma":[0.0682985,0.085575715,0.1928971,0.003502614,0.01206327,0.0016067058,0.00089572434,0.57171935,0.006443294,0.027382886,0.029212665,0.00040218743],"about_ca_topic_score_codex":0.00912672,"about_ca_topic_score_gemma":0.003401473,"teacher_disagreement_score":0.032293823,"about_ca_system_score_codex":0.0025460324,"about_ca_system_score_gemma":0.0040315413,"threshold_uncertainty_score":0.1080336},"labels":[],"label_agreement":null},{"id":"W3027623322","doi":"10.1016/j.jval.2020.04.1029","title":"PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Relevance (law); Health economics; Context (archaeology); Cost–utility analysis; Population; Reimbursement; Medicine; Population health; Actuarial science; Health care; Public health; Environmental health; Cost effectiveness; Risk analysis (engineering); Business; Economics; Nursing; Political science; Geography","score_opus":0.4635269331228747,"score_gpt":0.44454746574912946,"score_spread":0.01897946737374523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027623322","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029064259,0.0021085953,0.8545735,0.005144522,0.00087101996,0.00159912,0.0383005,0.02061887,0.04771964],"genre_scores_gemma":[0.20862584,0.0025149174,0.72558326,0.0013910419,0.00059329526,0.003004934,0.036333684,0.0051766247,0.016776433],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9843106,0.008909485,0.001805627,0.00060600304,0.004056254,0.00031196533],"domain_scores_gemma":[0.9178168,0.056414053,0.0033937723,0.0055622333,0.016271824,0.0005413141],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021578597,0.0010839424,0.0010500366,0.0049068606,0.000405401,0.0034517236,0.0013639845,0.00077578827,0.033666387],"category_scores_gemma":[0.15887299,0.00076839875,0.0024305324,0.005962948,0.00037027872,0.0032175146,0.0028177144,0.001997764,0.007971948],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050665805,0.00033596254,0.017611738,0.001721555,0.0006131174,0.00016105553,0.00036338405,0.016450439,0.0006613688,0.037997726,0.18206225,0.7415147],"study_design_scores_gemma":[0.000744491,0.0006487218,0.040983576,0.002240148,0.0007224689,0.00094645366,0.00028408412,0.2813132,0.00954868,0.08479341,0.5774471,0.00032756585],"about_ca_topic_score_codex":0.0062725293,"about_ca_topic_score_gemma":0.004762081,"teacher_disagreement_score":0.9784214,"about_ca_system_score_codex":0.0012719398,"about_ca_system_score_gemma":0.0043177353,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W3027712008","doi":"10.1016/j.jval.2020.04.1268","title":"PRO42 ASSESSING GLOBAL PEDIATRIC MULTIPLE SCLEROSIS EPIDEMIOLOGY: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epidemiology; Incidence (geometry); Medicine; Meta-analysis; Population; Systematic review; Demography; Disease; Multiple sclerosis; MEDLINE; Pediatrics; Environmental health; Internal medicine; Immunology; Biology","score_opus":0.43310155539118017,"score_gpt":0.44271438963547255,"score_spread":0.009612834244292379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027712008","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0137657495,0.9802879,0.002103506,0.0004906492,0.0003356208,0.0008498287,0.0017063707,0.00006470291,0.0003956945],"genre_scores_gemma":[0.48685047,0.48661277,0.016024277,0.0025361425,0.0006069184,0.003784756,0.0025833605,0.00013483764,0.00086649455],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9688164,0.01630604,0.008442819,0.002608118,0.0030995717,0.00072705164],"domain_scores_gemma":[0.952952,0.03308412,0.007855697,0.0023972006,0.0032142273,0.00049668347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03455438,0.0032083124,0.014460548,0.01102869,0.0009192387,0.0047838003,0.0022908824,0.003123846,0.0050896816],"category_scores_gemma":[0.078812055,0.0024102253,0.042665903,0.010674197,0.0010013927,0.0029625273,0.0034109126,0.0020859246,0.0005639169],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014707879,0.00003125631,0.01105713,0.17733553,0.7992183,0.00009841591,0.00010682997,0.00025072423,0.00017755288,0.00009884653,0.0005708125,0.009583824],"study_design_scores_gemma":[0.0007827041,0.00012199057,0.00682141,0.01344693,0.9771289,0.0000748248,0.00005725413,0.00015264696,0.0000805589,0.00013212484,0.0011689833,0.00003157185],"about_ca_topic_score_codex":0.006658626,"about_ca_topic_score_gemma":0.023044465,"teacher_disagreement_score":0.03455438,"about_ca_system_score_codex":0.002379503,"about_ca_system_score_gemma":0.00564803,"threshold_uncertainty_score":0.18274319},"labels":[],"label_agreement":null},{"id":"W3027747692","doi":"10.1016/j.jval.2020.04.1152","title":"PNS152 MODELS USING ARM-BASED DATA ENTRY MAY GIVE MISLEADING INCONSISTENCY RESULTS IN NETWORK META-ANALYSES INVOLVING MULTI-ARM TRIALS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Placebo; Leverage (statistics); Randomization; Inference; Meta-analysis; Clinical trial; Causal inference; Statistics; Contrast (vision); Bayesian probability; Econometrics; Medicine; Computer science; Physical medicine and rehabilitation; Mathematics; Artificial intelligence; Internal medicine","score_opus":0.984981316700297,"score_gpt":0.6454214011592782,"score_spread":0.33955991554101883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027747692","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022272412,0.05981317,0.84302694,0.010969043,0.0092609795,0.0058485214,0.029716613,0.0055232686,0.013569008],"genre_scores_gemma":[0.47480473,0.005533412,0.47227654,0.013061649,0.0017804343,0.01483882,0.009907474,0.0026311472,0.0051657804],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.42995533,0.49946722,0.040415924,0.018413061,0.010453375,0.0012950283],"domain_scores_gemma":[0.17953506,0.76036686,0.015593978,0.036781386,0.006970228,0.0007524961],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35189104,0.006408799,0.010809599,0.0064060637,0.0019345059,0.008322005,0.0054391874,0.0060395305,0.023174142],"category_scores_gemma":[0.75886524,0.0045969216,0.024384145,0.010220398,0.003097729,0.009039967,0.005224255,0.01025677,0.003808586],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01722123,0.00032126706,0.040936586,0.06754916,0.4414119,0.001215924,0.0017818008,0.043385655,0.0008046062,0.035637576,0.062669605,0.28706464],"study_design_scores_gemma":[0.018873788,0.0024052227,0.024888817,0.018425178,0.20500064,0.0016266878,0.00057985965,0.14670633,0.0030050739,0.5026686,0.07480629,0.0010134734],"about_ca_topic_score_codex":0.007191551,"about_ca_topic_score_gemma":0.010618953,"teacher_disagreement_score":0.64810896,"about_ca_system_score_codex":0.0020581353,"about_ca_system_score_gemma":0.0045450027,"threshold_uncertainty_score":0.79923373},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W3027757439","doi":"10.1016/j.jval.2020.04.1575","title":"PCN73 COST-EFFECTIVENESS OF BLINATUMOMAB VERSUS STANDARD OF CARE IN ADULT PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA FROM A CANADIAN HEALTHCARE SECTOR PERSPECTIVE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Blinatumomab; Medicine; Population; Internal medicine; Oncology; Lymphoblastic Leukemia; Leukemia","score_opus":0.02414033120568015,"score_gpt":0.30001612231371944,"score_spread":0.2758757911080393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027757439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7380435,0.14879642,0.00112605,0.03228402,0.0008261402,0.0007505196,0.016934687,0.000113469505,0.0611252],"genre_scores_gemma":[0.9808975,0.012307757,0.0007763418,0.0016277666,0.00016933102,0.0000628779,0.0027571577,0.000010849878,0.0013904893],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99854505,0.00040440567,0.0000766859,0.00010842493,0.00036444634,0.0005009642],"domain_scores_gemma":[0.99872714,0.0003090681,0.00021442542,0.000022144195,0.00024487314,0.00048233717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012751968,0.0005946755,0.0014242979,0.0007426483,0.00053114403,0.0021657313,0.0009869199,0.0008535498,0.0061510154],"category_scores_gemma":[0.004571854,0.000246127,0.002574578,0.002004183,0.000665265,0.0006630632,0.00060981885,0.0018636999,0.0002119773],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16095136,0.0019152091,0.08384672,0.0057929475,0.012482095,0.0009897931,0.00047522076,0.07814318,0.0024874983,0.020847183,0.05050003,0.5815688],"study_design_scores_gemma":[0.053041536,0.028732939,0.7086372,0.008090002,0.031656846,0.0018889573,0.0035898143,0.060142685,0.0023783,0.011732511,0.08957843,0.000530837],"about_ca_topic_score_codex":0.80076563,"about_ca_topic_score_gemma":0.8949588,"teacher_disagreement_score":0.19923437,"about_ca_system_score_codex":0.04618945,"about_ca_system_score_gemma":0.037259806,"threshold_uncertainty_score":0.40081537},"labels":[],"label_agreement":null},{"id":"W3027820444","doi":"10.1016/j.jval.2020.04.1312","title":"PRO91 REDUCTION IN HRQOL WITH INCREASING VOC FREQUENCY AMONG PATIENTS WITH SCD","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Discontinuation; Observational study; Quality of life (healthcare); EQ-5D; Cohort; Cohort study; Pediatrics; Demography; Disease; Internal medicine; Health related quality of life","score_opus":0.015133686863505271,"score_gpt":0.2370791572203594,"score_spread":0.22194547035685414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027820444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782735,0.000455649,0.00009417283,0.00010508063,0.000015659201,0.00000540517,0.00023275058,0.0000047856893,0.0012591009],"genre_scores_gemma":[0.9990746,0.00010555237,0.00007861623,0.00004280315,0.000015984016,0.0000045880743,0.00022847415,0.0000011719693,0.00044827812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997899,0.00005349141,0.000023362207,0.00003251127,0.000045353347,0.000055360575],"domain_scores_gemma":[0.99934775,0.00012134711,0.00030057278,0.00003241011,0.00008348866,0.00011438819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023647107,0.00017289208,0.000276757,0.00026841552,0.00022929478,0.0006506735,0.00012878662,0.00030040118,0.0020601922],"category_scores_gemma":[0.0013290744,0.000085493935,0.0004340788,0.00044646044,0.00011925831,0.00024786283,0.00030212078,0.00073817,0.0002196851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068374164,0.00022254032,0.9856521,0.00003509406,0.00013264015,0.00007705022,0.00008936499,0.000104275896,0.0008013366,0.00005343943,0.00026714263,0.011881212],"study_design_scores_gemma":[0.000009239208,0.00021408842,0.99890494,0.000007252471,0.00005701301,0.000121085184,0.0001277727,0.00016423543,0.000092535425,0.000041969375,0.00025737323,0.0000026376504],"about_ca_topic_score_codex":0.0014697298,"about_ca_topic_score_gemma":0.0018413985,"teacher_disagreement_score":0.0020601922,"about_ca_system_score_codex":0.0002081068,"about_ca_system_score_gemma":0.00023287014,"threshold_uncertainty_score":0.006892085},"labels":[],"label_agreement":null},{"id":"W3027822766","doi":"10.1016/j.jval.2020.04.1799","title":"PCN341 REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Regimen; Ambulatory; Incidence (geometry); Renal cell carcinoma; Retrospective cohort study; Oncology; Emergency medicine","score_opus":0.08793599950874943,"score_gpt":0.29811222298814666,"score_spread":0.21017622347939724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027822766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671715,0.00035058384,0.000062007784,0.0001595504,0.0000086060345,0.000005744342,0.0020763855,0.000003825714,0.0006162113],"genre_scores_gemma":[0.9987464,0.0000722789,0.00003713247,0.000035685098,0.000006678228,0.0000047465965,0.0009630995,0.000001879084,0.00013211656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99948907,0.000106561776,0.000070858696,0.00010729108,0.000077545825,0.00014865366],"domain_scores_gemma":[0.99823856,0.00034326426,0.0008746174,0.000079707876,0.00013318268,0.00033061038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040857363,0.0001594848,0.00029614734,0.0006124005,0.00037469383,0.0009447432,0.00040348253,0.00049390434,0.0031145494],"category_scores_gemma":[0.0033616056,0.00017494873,0.00072584633,0.0019599006,0.00024094613,0.0007685533,0.00071307196,0.00075896323,0.00032609922],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013152306,0.000026183,0.9981036,0.000010114779,0.000067759436,0.000026782729,0.000035608846,0.00014492932,0.000038535472,0.000032121592,0.00019583295,0.0011869824],"study_design_scores_gemma":[0.000004417783,0.00005576967,0.9985588,0.000009440283,0.000024013725,0.00009751052,0.0002388795,0.0006154908,0.00003008548,0.00006263449,0.00029670008,0.000006186261],"about_ca_topic_score_codex":0.023078619,"about_ca_topic_score_gemma":0.02710029,"teacher_disagreement_score":0.023078619,"about_ca_system_score_codex":0.0010116358,"about_ca_system_score_gemma":0.0006372872,"threshold_uncertainty_score":0.045888603},"labels":[],"label_agreement":null},{"id":"W3027934943","doi":"10.1016/j.jval.2020.04.927","title":"PND34 RESOURCE USE RELATED TO CERVICAL DYSTONIA, PEDIATRIC LOWER LIMB SPASTICITY AND ADULT UPPER LIMB SPASTICITY IN THE UNITED KINGDOM: A PHYSICIAN QUESTIONNAIRE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Spasticity; Cervical dystonia; Gabapentin; Dystonia; Physical therapy; Internal medicine; Psychiatry","score_opus":0.0491245793622048,"score_gpt":0.2890550414252006,"score_spread":0.23993046206299581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027934943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991355,0.00032883792,0.000043024866,0.00023609961,0.000009366835,0.00003866048,0.005805594,0.0000050855356,0.0021782296],"genre_scores_gemma":[0.9955421,0.00034407026,0.00015155754,0.00016488532,0.000009509666,0.00004616394,0.0027333968,0.0000026521363,0.001005687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999403,0.00015422735,0.00018239443,0.000059511964,0.00012016669,0.00008060534],"domain_scores_gemma":[0.99765044,0.0003854392,0.0013006397,0.000034923298,0.00027642428,0.00035219968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004170197,0.00019808786,0.00031692602,0.0012090656,0.00025950515,0.00057153596,0.00031917894,0.00043143547,0.00363703],"category_scores_gemma":[0.0029641222,0.00020728732,0.0005298177,0.0017385589,0.00021505929,0.00043281296,0.0006964785,0.0004953286,0.0005149701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003661862,0.000031789637,0.9972837,0.00003209404,0.000038806695,0.00009619279,0.00022382861,0.0000680183,0.00010032187,0.000017646396,0.0007644947,0.0013064309],"study_design_scores_gemma":[0.0000026198152,0.000029849507,0.9992887,0.0000109791035,0.0000054044053,0.00008637693,0.00021916135,0.00004405043,0.000011881537,0.0000025432425,0.00029615482,0.0000022476593],"about_ca_topic_score_codex":0.070966356,"about_ca_topic_score_gemma":0.09459788,"teacher_disagreement_score":0.070966356,"about_ca_system_score_codex":0.0012180738,"about_ca_system_score_gemma":0.00058631727,"threshold_uncertainty_score":0.1411066},"labels":[],"label_agreement":null},{"id":"W3028020071","doi":"10.1016/j.jval.2020.04.1540","title":"PCN34 COMPATIBILITY OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY STUDIES IN THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (LBCL) FOR INDIRECT TREATMENT COMPARISON (ITC) ANALYSES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Clinical trial; Population; Refractory (planetary science); Chimeric antigen receptor; Transplantation; Salvage therapy; Immunotherapy; Cancer; Chemotherapy","score_opus":0.2432661122207745,"score_gpt":0.42804879365365917,"score_spread":0.18478268143288468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028020071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880547,0.0072109383,0.0005996258,0.0001428062,0.00007713984,0.00026605593,0.00036772294,0.00001158959,0.0032693374],"genre_scores_gemma":[0.9981988,0.0005223417,0.00034038798,0.00007037137,0.000056083543,0.00012499707,0.00030209147,0.00000520092,0.00037984195],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9952217,0.0038992062,0.00018517481,0.0002202355,0.00022961314,0.00024415957],"domain_scores_gemma":[0.9979055,0.001249012,0.00026844238,0.0002122074,0.0001432624,0.00022155125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049922625,0.0006072396,0.001188087,0.0005473408,0.00024652554,0.0007746392,0.000455508,0.00051853847,0.0027786489],"category_scores_gemma":[0.0037866246,0.0001570611,0.0012025011,0.0005567876,0.00059646944,0.00066335587,0.00048205187,0.0012058635,0.00022304771],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81054115,0.0030942743,0.054289393,0.001002422,0.0057735736,0.000111347086,0.00026120554,0.0011592353,0.010200506,0.0012216502,0.000585237,0.11176006],"study_design_scores_gemma":[0.1347491,0.61055374,0.20846124,0.00023550335,0.016796546,0.0003933457,0.0004978854,0.003162432,0.014185827,0.0015962872,0.009297937,0.00007009919],"about_ca_topic_score_codex":0.00081935484,"about_ca_topic_score_gemma":0.0013699327,"teacher_disagreement_score":0.0049922625,"about_ca_system_score_codex":0.00090552674,"about_ca_system_score_gemma":0.00067208795,"threshold_uncertainty_score":0.026401937},"labels":[],"label_agreement":null},{"id":"W3028026700","doi":"10.1016/j.jval.2020.04.1519","title":"PCN13 FACTORS THAT MODIFY THE EFFECT OF MONO- OR COMBINATION PD-1/PD-L1 INHIBITOR THERAPIES ON SURVIVAL OUTCOMES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Medicine; Meta-analysis; Hazard ratio; Subgroup analysis; Internal medicine; Renal cell carcinoma; Oncology; Randomized controlled trial; Relative risk; Cochrane Library; Confidence interval","score_opus":0.12982187583047608,"score_gpt":0.3417928850839819,"score_spread":0.21197100925350584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028026700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077590407,0.99083436,0.0003394324,0.0001406293,0.00014010216,0.0000901628,0.0004302832,0.000015972688,0.00025005252],"genre_scores_gemma":[0.2664444,0.7286302,0.0015235383,0.0012651432,0.00027973496,0.0003402834,0.0009165729,0.000023433986,0.0005766668],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9978849,0.0008537945,0.00055368664,0.00034247164,0.00023173165,0.00013335179],"domain_scores_gemma":[0.9962387,0.0027254706,0.0005879823,0.0001326941,0.00023354263,0.00008167745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036360542,0.0017818579,0.010671146,0.0017597886,0.0003850512,0.0018907028,0.0013670438,0.00187452,0.0036349434],"category_scores_gemma":[0.009722895,0.0009992636,0.023215592,0.0031726677,0.0005398049,0.0010028481,0.0009942529,0.002156681,0.00033956664],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059602777,0.000073523166,0.006991056,0.22357695,0.7354022,0.000108742504,0.00007060526,0.00064290164,0.00042359845,0.0001546041,0.00096741016,0.0256281],"study_design_scores_gemma":[0.0012037839,0.00024498312,0.005370358,0.007726117,0.9832592,0.000053612388,0.000033136246,0.00016579818,0.00010292778,0.00020954177,0.0016053346,0.000025276682],"about_ca_topic_score_codex":0.0070851413,"about_ca_topic_score_gemma":0.01807906,"teacher_disagreement_score":0.010671146,"about_ca_system_score_codex":0.0012790285,"about_ca_system_score_gemma":0.0016898336,"threshold_uncertainty_score":0.019229472},"labels":[],"label_agreement":null},{"id":"W3028028781","doi":"10.1016/j.jval.2020.04.346","title":"PDG60 OPIOID PRESCRIBING IN CANADA: HOW ARE PRACTICES CHANGING?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medical prescription; Medicine; Opioid; Addiction; Chronic pain; Population; Health care; Psychiatry; Environmental health; Pharmacology; Internal medicine","score_opus":0.07838127476695059,"score_gpt":0.30163685747627517,"score_spread":0.22325558270932458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028028781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5210697,0.020897659,0.000684102,0.39895532,0.0018440931,0.00018541633,0.009319012,0.00015803515,0.046886686],"genre_scores_gemma":[0.953513,0.010008093,0.0013347281,0.025124166,0.00036609935,0.000059401547,0.0021687017,0.00006536988,0.007360304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99165946,0.00085698726,0.000418797,0.00058209256,0.0035332309,0.002949474],"domain_scores_gemma":[0.9639964,0.0025720776,0.003857513,0.00040255842,0.017624663,0.011546732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003658676,0.00023098325,0.00065933366,0.0017438981,0.004331011,0.005203088,0.0024448608,0.0023759673,0.0069726943],"category_scores_gemma":[0.019193005,0.00037224783,0.0008627817,0.006317839,0.0018953561,0.001988145,0.0012577669,0.0036970538,0.00045943796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027915853,0.0004728934,0.70643497,0.00067106663,0.00016385895,0.00038293898,0.0067388145,0.00057047704,0.00034090545,0.0052137026,0.11278173,0.1659495],"study_design_scores_gemma":[0.000047788475,0.00005631954,0.9331117,0.0011077,0.000074886004,0.0001511813,0.012654754,0.0009318848,0.00016715677,0.0007187689,0.050911803,0.00006614543],"about_ca_topic_score_codex":0.9944041,"about_ca_topic_score_gemma":0.9969669,"teacher_disagreement_score":0.12393001,"about_ca_system_score_codex":0.12393001,"about_ca_system_score_gemma":0.23513345,"threshold_uncertainty_score":0.89917934},"labels":[],"label_agreement":null},{"id":"W3028033786","doi":"10.1016/j.jval.2020.04.1147","title":"PNS147 VISUALIZATION AND COMMUNICATION OF RESULTS FROM BAYESIAN NETWORK META-ANALYSIS: PAST, PRESENT, AND FUTURE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Computer science; Bayesian probability; Visualization; Bayesian network; Data science; Bayesian statistics; Bayesian inference; Data mining; Artificial intelligence","score_opus":0.7322393485829635,"score_gpt":0.5182469085323363,"score_spread":0.21399244005062712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028033786","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010170061,0.011564086,0.6391786,0.056719393,0.007590172,0.0013282469,0.05678409,0.18376154,0.032903768],"genre_scores_gemma":[0.09897635,0.010031242,0.8166041,0.005749873,0.003742267,0.0028320807,0.02450697,0.025396567,0.012160496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98185754,0.012077697,0.0022160949,0.0010478658,0.0024888038,0.00031211067],"domain_scores_gemma":[0.8024977,0.16155481,0.006349277,0.0130633535,0.0135294255,0.0030053835],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0317608,0.0026600498,0.002764802,0.008151921,0.00092842116,0.0103292875,0.0036876565,0.0035527032,0.12279786],"category_scores_gemma":[0.2506162,0.0016934106,0.0035497507,0.008104479,0.0011822202,0.0064087296,0.0068650395,0.0037911586,0.016001284],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025480783,0.00015154325,0.0037916505,0.008618237,0.0012516661,0.0006352678,0.0017448346,0.007948075,0.0014166688,0.03984369,0.56073695,0.37131327],"study_design_scores_gemma":[0.0028731346,0.00029617985,0.004335609,0.008633277,0.0012312813,0.00093550864,0.0006079743,0.10754701,0.0053962437,0.24064325,0.62703824,0.00046232028],"about_ca_topic_score_codex":0.006086423,"about_ca_topic_score_gemma":0.0067249606,"teacher_disagreement_score":0.9682392,"about_ca_system_score_codex":0.002019479,"about_ca_system_score_gemma":0.007959627,"threshold_uncertainty_score":0.4107998},"labels":[],"label_agreement":null},{"id":"W3028075797","doi":"10.1016/j.jval.2020.04.1028","title":"PNS15 IMPROVING UNDERSTANDING OF UNCERTAINTY IN ECONOMIC MODELS THROUGH MACHINE LEARNING : POSSIBILITIES AND RECOMMENDATIONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cart; Interpretability; Machine learning; Computer science; Artificial intelligence; Parametric statistics; Sensitivity (control systems); Probabilistic logic; Regression; Selection (genetic algorithm); Parametric model; Econometrics; Data mining; Statistics; Mathematics; Engineering","score_opus":0.5789832477018952,"score_gpt":0.4220951941486235,"score_spread":0.15688805355327173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028075797","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008083322,0.017649684,0.31208977,0.57406545,0.008782341,0.00029151692,0.0072160796,0.004770611,0.06705121],"genre_scores_gemma":[0.23795956,0.054456234,0.56929076,0.03670542,0.015606317,0.0013703193,0.017904902,0.0025744468,0.0641321],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99396294,0.0034595162,0.00035779536,0.00048166767,0.0014775501,0.00026046654],"domain_scores_gemma":[0.9188538,0.049504474,0.0013719483,0.005466247,0.021827675,0.0029759123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018578067,0.0013725804,0.001766469,0.002476022,0.0008680199,0.0066654766,0.0036105197,0.0036648177,0.05247022],"category_scores_gemma":[0.09344329,0.00057863607,0.0014593231,0.0027709445,0.0019007402,0.011772362,0.0044338685,0.0052286657,0.013085094],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024371008,0.0004051517,0.0046495385,0.0009609216,0.00018041334,0.00011245963,0.00022618545,0.04165708,0.00028386657,0.21302937,0.4136974,0.32455394],"study_design_scores_gemma":[0.00010593418,0.00005415999,0.0010441582,0.0017553351,0.000045479417,0.00004737593,0.00028197342,0.1220034,0.0008229829,0.66364676,0.21012095,0.000071398725],"about_ca_topic_score_codex":0.017145874,"about_ca_topic_score_gemma":0.011890179,"teacher_disagreement_score":0.05247022,"about_ca_system_score_codex":0.0028799362,"about_ca_system_score_gemma":0.0075946194,"threshold_uncertainty_score":0.17553037},"labels":[],"label_agreement":null},{"id":"W3028101882","doi":"10.1016/j.jval.2020.04.1748","title":"PCN282 VALIDATION AND CALIBRATION OF A DISCRETE EVENT SIMULATION TREATMENT SEQUENCING MODEL TO ESTIMATE LONG-TERM SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Survival analysis; Proportional hazards model; Calibration; Population; Event (particle physics); Cancer registry; Overall survival; Oncology; Multiple myeloma; Progression-free survival; Term (time); Covariate; Internal medicine; Statistics; Cancer; Mathematics","score_opus":0.5010529218027832,"score_gpt":0.5316223444785074,"score_spread":0.030569422675724267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028101882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76638407,0.00046358007,0.22724852,0.0012233736,0.0001137882,0.0003403519,0.0010563905,0.00048672044,0.0026832721],"genre_scores_gemma":[0.97282946,0.00009147954,0.02506476,0.00016320126,0.000019862822,0.00020308961,0.0009856027,0.00003549654,0.00060709123],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99720603,0.0021795805,0.0000816824,0.00024260163,0.00017195042,0.0001182365],"domain_scores_gemma":[0.96617746,0.02986866,0.0009536396,0.0011914142,0.0013664394,0.000442368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012765237,0.00065057306,0.0010967009,0.00054976624,0.00040392007,0.00095212547,0.0013651645,0.0013291776,0.0018498132],"category_scores_gemma":[0.036872134,0.0005640768,0.0009926528,0.00050662964,0.00067372096,0.0005412591,0.0008673536,0.0020928064,0.00030783346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005513607,0.00015211548,0.0056497953,0.00003767895,0.00012026843,0.000031665437,0.000037166537,0.98373264,0.00023657913,0.0017962274,0.00040454837,0.007249951],"study_design_scores_gemma":[0.00009149558,0.00008562447,0.00073825056,0.0000075566973,0.000018258133,0.000011206418,0.0000054275006,0.9975932,0.00016519762,0.0011546651,0.00012412948,0.000004925121],"about_ca_topic_score_codex":0.016119633,"about_ca_topic_score_gemma":0.006298297,"teacher_disagreement_score":0.016119633,"about_ca_system_score_codex":0.001343243,"about_ca_system_score_gemma":0.0029166609,"threshold_uncertainty_score":0.06750989},"labels":[],"label_agreement":null},{"id":"W3028105516","doi":"10.1016/j.jval.2020.04.1035","title":"PNS25 METHODS FOR DETECTING TREATMENT EFFECT MODIFIERS IN ANCHORED INDIRECT TREATMENT COMPARISONS: AN OVERVIEW AND SIMULATION STUDY OF MACHINE LEARNING ALGORITHMS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Feature selection; Machine learning; Computer science; Leverage (statistics); Collinearity; Artificial intelligence; Propensity score matching; Selection bias; Random forest; Matching (statistics); Bayesian probability; Statistics; Mathematics","score_opus":0.6766310166177457,"score_gpt":0.5460223350871631,"score_spread":0.13060868153058258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028105516","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005078565,0.0019093683,0.98998755,0.00055190944,0.000104462735,0.000398824,0.00033966423,0.00036755245,0.0012622218],"genre_scores_gemma":[0.120431915,0.0020990614,0.86960644,0.00067951466,0.00022354037,0.0030156448,0.0008158556,0.00025913463,0.0028689266],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9606271,0.034035172,0.00094694766,0.0016932455,0.0024180196,0.0002795705],"domain_scores_gemma":[0.84154093,0.14669043,0.0022208404,0.0062295347,0.0028662556,0.0004519622],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06314413,0.0023412458,0.004200931,0.0035085247,0.00092243945,0.0022710012,0.004829158,0.0025686875,0.007873674],"category_scores_gemma":[0.13998565,0.0014378978,0.004477761,0.0034362485,0.002865639,0.0033530102,0.0036563862,0.006124334,0.0009828939],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012192011,0.00036471276,0.007127642,0.001142601,0.0019902247,0.00013153508,0.0003227391,0.4060171,0.00043772,0.21706548,0.007483122,0.35669786],"study_design_scores_gemma":[0.00039656105,0.0003323934,0.0010864431,0.00023142123,0.00027127247,0.00010570126,0.00003519116,0.78088194,0.00072280085,0.2107366,0.0051477146,0.000051953288],"about_ca_topic_score_codex":0.006390743,"about_ca_topic_score_gemma":0.0048875134,"teacher_disagreement_score":0.93685585,"about_ca_system_score_codex":0.002116091,"about_ca_system_score_gemma":0.0042952974,"threshold_uncertainty_score":0.33394206},"labels":[],"label_agreement":null},{"id":"W3028188420","doi":"10.1016/j.jval.2020.04.1534","title":"PCN28 CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) IN HORMONE RECEPTOR-POSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC): A SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE (RWE) STUDIES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Palbociclib; Letrozole; Medicine; Fulvestrant; Metastatic breast cancer; Internal medicine; Oncology; Progression-free survival; Cyclin-dependent kinase 4; Cancer; Breast cancer; Aromatase; Gynecology; Estrogen receptor; Overall survival; Cyclin-dependent kinase 2; Cell cycle","score_opus":0.06409227364805688,"score_gpt":0.3774474890229369,"score_spread":0.31335521537488004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028188420","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031353696,0.99563867,0.0000854978,0.00019511287,0.000062883424,0.00014167161,0.00044149897,0.000004692528,0.0002946712],"genre_scores_gemma":[0.068706766,0.9290503,0.0007094919,0.00074089086,0.00007795235,0.00026076214,0.00033803607,0.000005166139,0.0001107208],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959288,0.00147493,0.0014282225,0.00042751554,0.00057381403,0.00016673417],"domain_scores_gemma":[0.98762554,0.008818574,0.0025004894,0.00019089809,0.00070065295,0.00016384879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006614281,0.0008633951,0.0055522597,0.0035657708,0.00035977075,0.0017433704,0.0012103958,0.0012337909,0.0036756368],"category_scores_gemma":[0.021274054,0.0006354183,0.00790758,0.004275309,0.0007844716,0.0012034362,0.0011292864,0.0012543937,0.0001973383],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022359146,0.00005221339,0.0030684047,0.8806521,0.05123688,0.00008128822,0.00014608067,0.00018130774,0.00034760442,0.00026765,0.001224087,0.06050646],"study_design_scores_gemma":[0.0031598853,0.0008190743,0.016823305,0.46218777,0.49588186,0.00033946687,0.00035629014,0.00017250645,0.00044121064,0.0007231515,0.01902853,0.00006699299],"about_ca_topic_score_codex":0.006026877,"about_ca_topic_score_gemma":0.021369765,"teacher_disagreement_score":0.006614281,"about_ca_system_score_codex":0.0017254082,"about_ca_system_score_gemma":0.003788496,"threshold_uncertainty_score":0.03498012},"labels":[],"label_agreement":null},{"id":"W3028188475","doi":"10.1016/j.jval.2020.04.581","title":"PMD12 THE BURDEN OF READMISSIONS IN THE POST-OPERATIVE POPULATION IN THE US: THE INFLUENCE OF MANAGEMENT WITH AN OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trudell Medical International (Canada)","funders":"","keywords":"Medicine; Emergency medicine; Health care; Population; Medical emergency; Environmental health","score_opus":0.04013387572327031,"score_gpt":0.33901425033959276,"score_spread":0.29888037461632244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028188475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236405,0.002289286,0.00006935544,0.0015632337,0.00008444457,0.000007949748,0.002033917,0.0000061153937,0.0015816839],"genre_scores_gemma":[0.99821556,0.0005358741,0.000028824672,0.00014563477,0.00008637293,0.0000064032747,0.0007481127,0.0000027895326,0.00023047173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859446,0.0005319651,0.00018828717,0.00016104901,0.00023241295,0.00029181907],"domain_scores_gemma":[0.9943756,0.0013427589,0.0023347428,0.00032550193,0.0005871676,0.001034328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011514231,0.00031174524,0.00050519116,0.00077678356,0.00047342904,0.0010130603,0.0006906198,0.0009898697,0.0028610197],"category_scores_gemma":[0.010339964,0.00028716275,0.0017143363,0.001625678,0.00029826994,0.0007910474,0.00094397715,0.0016297098,0.00021684096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014640739,0.000046762092,0.9970028,0.000027090136,0.0001672033,0.000043046653,0.000048736583,0.000060771545,0.000023113487,0.000050291754,0.00048820034,0.0018955932],"study_design_scores_gemma":[0.0000050856916,0.000044015702,0.99940205,0.000016228987,0.000046465688,0.00004207312,0.00017577206,0.00010755588,0.000008998322,0.000022252189,0.00012633768,0.0000033185192],"about_ca_topic_score_codex":0.04115686,"about_ca_topic_score_gemma":0.046356075,"teacher_disagreement_score":0.04115686,"about_ca_system_score_codex":0.00068914634,"about_ca_system_score_gemma":0.001079124,"threshold_uncertainty_score":0.081834614},"labels":[],"label_agreement":null},{"id":"W3028192330","doi":"10.1016/j.jval.2020.04.1239","title":"PRO8 MEDICATIONS FOR ACROMEGALY: COST-UTILITY AND VALUE OF INFORMATION ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Pegvisomant; Medicine; Lanreotide; Acromegaly; Cost–utility analysis; Per capita; Actuarial science; Cohort; Cost effectiveness; Internal medicine; Economics; Environmental health; Risk analysis (engineering)","score_opus":0.39396429871304967,"score_gpt":0.4385871465986704,"score_spread":0.04462284788562071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028192330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58923537,0.08665327,0.23039013,0.018119255,0.00045579427,0.001423744,0.014659507,0.00056938815,0.058493495],"genre_scores_gemma":[0.97210836,0.0049373237,0.018082384,0.00018477831,0.0001481608,0.00015095931,0.001374183,0.000049810682,0.0029639923],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99462634,0.004205989,0.00013972392,0.00016192484,0.00070181966,0.00016421273],"domain_scores_gemma":[0.98102736,0.016823307,0.0007721544,0.00048946176,0.0006961247,0.00019160267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006482091,0.0010219017,0.0010906106,0.0030926836,0.00022857054,0.0022632633,0.0007874381,0.0009952541,0.0070247552],"category_scores_gemma":[0.030917488,0.0002879224,0.0014322291,0.0033584917,0.00061580015,0.0023423042,0.0009531326,0.0015555078,0.0003315494],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006991181,0.0007069501,0.054253675,0.0017983327,0.002605119,0.0005297847,0.00021360576,0.32975703,0.00092067826,0.12641719,0.021500243,0.45430622],"study_design_scores_gemma":[0.00048682033,0.0012493433,0.029127184,0.00084002624,0.0017967438,0.00101485,0.00031466063,0.8106682,0.0011869784,0.1383247,0.014855344,0.0001350479],"about_ca_topic_score_codex":0.00562976,"about_ca_topic_score_gemma":0.003808047,"teacher_disagreement_score":0.0070247552,"about_ca_system_score_codex":0.0034150355,"about_ca_system_score_gemma":0.0016933382,"threshold_uncertainty_score":0.034281015},"labels":[],"label_agreement":null},{"id":"W3028249995","doi":"10.1016/j.jval.2020.04.1151","title":"PNS151 USING INSTANT MESSENGER TO RECRUIT RESEARCH PARTICIPANTS IN MEDICAL DECISION MAKING: DOES WECHAT PROVIDE AN ALTERNATIVE SOLUTION?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"China; Socioeconomic status; Family medicine; Population; Pharmacist; Instant messaging; Medicine; Systematic sampling; Medical education; Psychology; Environmental health; Geography; Computer science; World Wide Web","score_opus":0.6845484196820977,"score_gpt":0.6039650139845262,"score_spread":0.0805834056975715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028249995","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07055216,0.002675627,0.20278925,0.41097358,0.011117417,0.0020235027,0.0011289421,0.008684878,0.29005462],"genre_scores_gemma":[0.54758245,0.0032304095,0.23739843,0.07581851,0.00395963,0.004601121,0.0010067639,0.0013033445,0.12509927],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9784678,0.015813716,0.00069907756,0.0012436535,0.0022803545,0.0014954666],"domain_scores_gemma":[0.92302465,0.054210488,0.003919524,0.006270183,0.0065651787,0.0060100136],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.030275676,0.00059679535,0.0007522646,0.0011588268,0.0028029068,0.0074624936,0.0031503579,0.0058760666,0.08012589],"category_scores_gemma":[0.06953769,0.00046568803,0.0010080318,0.0013341963,0.002634761,0.008515968,0.00626372,0.0045411293,0.025675671],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018418818,0.0015065213,0.0058271238,0.0015875689,0.00015605705,0.0004910621,0.006859949,0.0008216159,0.004849046,0.055365726,0.16582325,0.75487024],"study_design_scores_gemma":[0.0024518012,0.0037846523,0.009860468,0.0032102517,0.00039036767,0.0012275835,0.018031279,0.0140797775,0.00862,0.23380513,0.7040508,0.00048789725],"about_ca_topic_score_codex":0.0012762485,"about_ca_topic_score_gemma":0.0028194485,"teacher_disagreement_score":0.9697243,"about_ca_system_score_codex":0.001421713,"about_ca_system_score_gemma":0.0060089445,"threshold_uncertainty_score":0.2680478},"labels":[],"label_agreement":null},{"id":"W3028345760","doi":"10.1016/j.jval.2020.04.136","title":"PCV31 COST-EFFECTIVENESS OF EVOLOCUMAB FOR THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA IN THE KINGDOM OF SAUDI ARABIA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Familial hypercholesterolemia; Ezetimibe; PCSK9; Statin; Internal medicine; Population; Atherosclerotic cardiovascular disease; Cohort; Observational study; Gastroenterology; Cholesterol; Lipoprotein; Disease; LDL receptor","score_opus":0.17483326838493118,"score_gpt":0.3406081854431775,"score_spread":0.16577491705824632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028345760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846485,0.011518949,0.00008630976,0.0019667374,0.000053985674,0.000028197252,0.00052068674,0.00000497563,0.0011717067],"genre_scores_gemma":[0.99843234,0.0010828234,0.000060601644,0.00009504564,0.000023251985,0.0000057818856,0.00018262926,8.8955636e-7,0.000116643634],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99920267,0.00042233287,0.00007908942,0.000053379605,0.00009900812,0.00014353046],"domain_scores_gemma":[0.9976701,0.00101594,0.00053255237,0.000050283536,0.00025334946,0.00047776577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011986317,0.00022742621,0.0006502471,0.00039374258,0.00016002114,0.0009256904,0.00031089495,0.00058355124,0.0022973663],"category_scores_gemma":[0.005461644,0.00014778631,0.0011435318,0.0004777072,0.00030315717,0.00051275594,0.00043909202,0.00083912845,0.00009642223],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13705869,0.001736003,0.46627522,0.0039736517,0.007453429,0.0018918563,0.00066948374,0.051327106,0.0024311745,0.005804543,0.009473372,0.31190556],"study_design_scores_gemma":[0.01915079,0.020895839,0.8779175,0.0021464531,0.008081516,0.0025570644,0.002182486,0.052187376,0.0014363372,0.0019643311,0.011327967,0.00015238125],"about_ca_topic_score_codex":0.027632244,"about_ca_topic_score_gemma":0.023267254,"teacher_disagreement_score":0.027632244,"about_ca_system_score_codex":0.0031667405,"about_ca_system_score_gemma":0.0021458655,"threshold_uncertainty_score":0.054942787},"labels":[],"label_agreement":null},{"id":"W3028360824","doi":"10.1016/j.jval.2020.04.809","title":"PMU35 MODELING POTENTIAL HEALTH GAINS AND HEALTH SYSTEM SAVINGS ASSOCIATED WITH VAPORIZED NICOTINE PRODUCTS IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Life expectancy; Environmental health; Context (archaeology); Population; Demography; Public health; Medicine; Geography","score_opus":0.13127850040993652,"score_gpt":0.3739760863222083,"score_spread":0.24269758591227178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028360824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92192477,0.00093783485,0.006704046,0.0026514041,0.00011364571,0.00016574636,0.009454595,0.0002140287,0.057834003],"genre_scores_gemma":[0.97671336,0.00037441312,0.0025651946,0.00022044056,0.000016224212,0.0000586749,0.001313609,0.000041934378,0.01869614],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994142,0.000116362164,0.000012370331,0.000072146046,0.000092225964,0.00029268934],"domain_scores_gemma":[0.9978713,0.0010035409,0.0000987307,0.00004481154,0.00077463547,0.00020697499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008449527,0.00061532843,0.0008122714,0.000938297,0.0012509932,0.0018108444,0.0019204527,0.0017119747,0.011160615],"category_scores_gemma":[0.0032090277,0.0007116619,0.0013229267,0.0014492804,0.0009084564,0.00054542895,0.00050913275,0.0012545993,0.00044649004],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014812569,0.00007543798,0.006557373,0.0000512798,0.000048031212,0.00007755982,0.000042948603,0.98040515,0.00015147189,0.005609458,0.003494192,0.00333904],"study_design_scores_gemma":[0.000072966075,0.000060012702,0.005919526,0.0000246695,0.000058328842,0.00001749493,0.00017414356,0.9895216,0.00017617967,0.0010917025,0.0028556655,0.000027657],"about_ca_topic_score_codex":0.986464,"about_ca_topic_score_gemma":0.97651184,"teacher_disagreement_score":0.027469233,"about_ca_system_score_codex":0.027469233,"about_ca_system_score_gemma":0.025613807,"threshold_uncertainty_score":0.19930416},"labels":[],"label_agreement":null},{"id":"W3028376624","doi":"10.1016/j.jval.2020.04.177","title":"PCV75 IDENTIFYING APPROPIATE HOSPITALS FOR PATIENT RECRUITMENT IN CLINICAL TRIALS FOR CANADA USING MACHINE LEARNING ALGORITHMS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oversampling; Pharmacy; Machine learning; Artificial intelligence; Computer science; Medicine; Support vector machine; Data mining; Algorithm; Family medicine","score_opus":0.8227583973736148,"score_gpt":0.6122533430454646,"score_spread":0.21050505432815014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028376624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.575226,0.013534676,0.09275959,0.077397004,0.0017488741,0.015466892,0.049212687,0.0062177894,0.16843657],"genre_scores_gemma":[0.85909075,0.0020906914,0.10546397,0.0068627787,0.00028776328,0.0029676298,0.011823942,0.0003208967,0.011091635],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98501486,0.006232096,0.0014597535,0.0014052525,0.003540673,0.0023474128],"domain_scores_gemma":[0.9002871,0.04626701,0.010193603,0.0025732748,0.031254556,0.009424404],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014674676,0.0005290875,0.0008075128,0.0051787766,0.0024291154,0.005033116,0.0026007153,0.00160177,0.010186539],"category_scores_gemma":[0.11834663,0.0004839734,0.0010724125,0.0045462907,0.0007976183,0.0009847437,0.0020932436,0.001917135,0.0014761538],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001404967,0.0004524741,0.3527201,0.0010580407,0.0004310906,0.00035716657,0.0010770914,0.009276241,0.0005509517,0.010832093,0.20497978,0.41686004],"study_design_scores_gemma":[0.0020498096,0.0009111338,0.55764186,0.0026453966,0.0009149315,0.000711712,0.004141166,0.1823433,0.0045482675,0.019182513,0.22459793,0.00031199012],"about_ca_topic_score_codex":0.7889072,"about_ca_topic_score_gemma":0.87086403,"teacher_disagreement_score":0.98532534,"about_ca_system_score_codex":0.024117876,"about_ca_system_score_gemma":0.14352664,"threshold_uncertainty_score":0.42467195},"labels":[],"label_agreement":null},{"id":"W3028378442","doi":"10.1016/j.jval.2020.04.264","title":"PDB79 INSULIN PRICES IN CANADA, SAUDI ARABIA, AND THE US.","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Pharmacy; Insulin degludec; Insulin detemir; Insulin lispro; Insulin glargine; Medicine; Vial; Insulin pen; Business; Traditional medicine; Human insulin; Family medicine; Hypoglycemia; Internal medicine; Chemistry","score_opus":0.10052263533040784,"score_gpt":0.3564280143713151,"score_spread":0.25590537904090727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028378442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8909343,0.0059414925,0.00016574099,0.012513829,0.00023542688,0.000035772424,0.043210506,0.000057616362,0.046905197],"genre_scores_gemma":[0.9756374,0.002403047,0.00017114248,0.00087479036,0.00006074449,0.000010454025,0.008509237,0.000021261834,0.012311957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993358,0.000058606835,0.000037187776,0.00005204965,0.00030695018,0.00020938394],"domain_scores_gemma":[0.99761766,0.00027909505,0.00038275716,0.000033572902,0.0010165949,0.00067033875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041265076,0.00015955628,0.00015897403,0.0011346461,0.0009047717,0.001833496,0.00049828837,0.00053066324,0.0048276093],"category_scores_gemma":[0.0031511635,0.00014072708,0.0003235392,0.003052717,0.00041843095,0.00047025434,0.00051792,0.0009150303,0.00045893193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031416707,0.00024429895,0.72322583,0.00028043173,0.00024376022,0.0010875178,0.0012621444,0.002559544,0.0006530629,0.015784632,0.15185611,0.09966113],"study_design_scores_gemma":[0.00008025791,0.000056858054,0.93988645,0.000110236295,0.000043449556,0.00039022832,0.0045683486,0.0018023225,0.00046105147,0.0004274672,0.05214118,0.00003210048],"about_ca_topic_score_codex":0.9300679,"about_ca_topic_score_gemma":0.9309601,"teacher_disagreement_score":0.0699321,"about_ca_system_score_codex":0.021824311,"about_ca_system_score_gemma":0.011323706,"threshold_uncertainty_score":0.15834725},"labels":[],"label_agreement":null},{"id":"W3028464929","doi":"10.1016/j.jval.2020.04.1154","title":"PNS154 THE PRISMA 2020 STATEMENT: DEVELOPMENT OF AND KEY CHANGES IN AN UPDATED GUIDELINE FOR REPORTING SYSTEMATIC REVIEWS AND META-ANALYSES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Systematic review; Checklist; Guideline; Stakeholder; MEDLINE; Statement (logic); Management science; Medicine; Medical education; Computer science; Psychology; Political science; Public relations; Engineering; Pathology","score_opus":0.9380358184741009,"score_gpt":0.6234064317895016,"score_spread":0.3146293866845993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028464929","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00143046,0.0639524,0.3139204,0.16966772,0.09603164,0.08218632,0.23639132,0.018511757,0.017907988],"genre_scores_gemma":[0.008620878,0.029776515,0.5982977,0.07300839,0.009482137,0.17716356,0.08042848,0.00849142,0.014730989],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.43984404,0.32158443,0.1788503,0.0073284158,0.048007626,0.004385148],"domain_scores_gemma":[0.4089759,0.31694812,0.07657109,0.04605093,0.146375,0.00507892],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.34774312,0.005210349,0.012634052,0.016914532,0.0029417106,0.017456064,0.014300286,0.018562132,0.04011145],"category_scores_gemma":[0.6817233,0.011331123,0.03231927,0.023600854,0.005882084,0.00828624,0.0143302055,0.031135488,0.04619297],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013641586,0.00011391103,0.0011752612,0.10130059,0.005777674,0.00014302286,0.00065803126,0.0007033802,0.00047126997,0.005687768,0.82022333,0.062381484],"study_design_scores_gemma":[0.006856766,0.00031806043,0.007558281,0.164323,0.010969026,0.0006726383,0.00050661765,0.0030477333,0.0020662777,0.035006847,0.7678369,0.00083771395],"about_ca_topic_score_codex":0.012496558,"about_ca_topic_score_gemma":0.01701887,"teacher_disagreement_score":0.65225685,"about_ca_system_score_codex":0.010034661,"about_ca_system_score_gemma":0.05800945,"threshold_uncertainty_score":0.8043488},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"reporting","study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch"],"domain":"reporting","study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W3028524412","doi":"10.1016/j.jval.2020.04.510","title":"PIN38 COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF LIPOHYPERTROPHY IN THE US","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Cost effectiveness; Internal medicine","score_opus":0.09075011246359468,"score_gpt":0.36815019954233863,"score_spread":0.277400087078744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028524412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91030073,0.06875829,0.0008867217,0.003536836,0.00035870896,0.00029102573,0.0034026236,0.000058499303,0.012406598],"genre_scores_gemma":[0.99090636,0.007115543,0.0002959575,0.00031686504,0.00006840693,0.000063467356,0.0006411236,0.000005252812,0.0005870958],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903715,0.00057353923,0.00006271268,0.000074610005,0.0001417396,0.00011021859],"domain_scores_gemma":[0.999311,0.0003877948,0.0001333161,0.00001888723,0.000032735203,0.000116343486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010420558,0.00034996567,0.000795822,0.0007218011,0.00012673848,0.00086730765,0.00030511236,0.00054851244,0.004813321],"category_scores_gemma":[0.0031614134,0.00018680838,0.002159709,0.0008472836,0.00029270203,0.0006257142,0.0004361909,0.0008842693,0.00019708296],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20389272,0.0023906336,0.05126436,0.005634859,0.009379229,0.0009339111,0.00015641561,0.030247226,0.0030622047,0.0038479632,0.008606327,0.68058413],"study_design_scores_gemma":[0.08868436,0.12144235,0.59110004,0.006802195,0.039022718,0.0056373733,0.0017343388,0.07529173,0.008244998,0.0102936905,0.05133487,0.0004113323],"about_ca_topic_score_codex":0.005119841,"about_ca_topic_score_gemma":0.005217343,"teacher_disagreement_score":0.005119841,"about_ca_system_score_codex":0.00201481,"about_ca_system_score_gemma":0.0013580532,"threshold_uncertainty_score":0.016102135},"labels":[],"label_agreement":null},{"id":"W3030589008","doi":"10.1016/j.jval.2020.03.011","title":"Let’s Make Sure We Are Doing Authorship Right","year":2020,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"History; Computer science","score_opus":0.14263317791247473,"score_gpt":0.42021720386083117,"score_spread":0.2775840259483564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030589008","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009523465,0.0015199266,0.00008809097,0.04508998,0.9523999,0.000011451047,0.000030945437,0.000029449124,0.00082071655],"genre_scores_gemma":[0.00023238391,0.0018137861,0.0001404586,0.02735631,0.9639293,0.000038596547,0.000024459727,0.000047059762,0.0064176503],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9725336,0.0065748882,0.0036166252,0.0020008541,0.013757232,0.0015168086],"domain_scores_gemma":[0.8381113,0.07452204,0.0074526547,0.0041495245,0.058886383,0.016878163],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.028497308,0.004555863,0.006424543,0.007972563,0.007899283,0.023722192,0.0056474432,0.041794844,0.040635977],"category_scores_gemma":[0.14259903,0.0023802482,0.004218734,0.003748765,0.0058467695,0.010620531,0.004381269,0.03688787,0.022506353],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013308212,0.0000091287875,0.00001809972,0.00017582033,0.000018185225,0.000037931786,0.000019228375,0.000010981511,0.000016955652,0.0004342947,0.9956339,0.0036122105],"study_design_scores_gemma":[0.000106811196,0.000022536999,0.0002077823,0.0012301775,0.0001018535,0.00015797735,0.00012597226,0.00019729832,0.00007224609,0.0041219625,0.9936133,0.000041956548],"about_ca_topic_score_codex":0.0038554661,"about_ca_topic_score_gemma":0.01284398,"teacher_disagreement_score":0.97150266,"about_ca_system_score_codex":0.007545909,"about_ca_system_score_gemma":0.0115779685,"threshold_uncertainty_score":0.15070999},"labels":[],"label_agreement":null},{"id":"W3035049698","doi":"10.1016/j.jval.2020.05.001","title":"Announcing the New Definition of Health Technology Assessment","year":2020,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Data science; Computer science","score_opus":0.5571480633302464,"score_gpt":0.4431271181544711,"score_spread":0.11402094517577527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035049698","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016309912,0.0011613875,0.0005926877,0.98198617,0.009728887,0.00002229797,0.000098095355,0.000022715045,0.0062245964],"genre_scores_gemma":[0.0015314731,0.00032443632,0.00068007334,0.97210974,0.016710129,0.00008147337,0.000037336387,0.00003934756,0.008485956],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.93755496,0.022500468,0.0074050073,0.0055400734,0.02206335,0.004936097],"domain_scores_gemma":[0.8411175,0.12261435,0.006696967,0.0038877502,0.016377486,0.009305926],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.044581123,0.0019150102,0.0042144014,0.0024216832,0.008944377,0.020070944,0.005671363,0.16241844,0.007955949],"category_scores_gemma":[0.1392576,0.0025162115,0.0032747455,0.0026311295,0.01894926,0.017753968,0.009095629,0.13445573,0.006405354],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045044686,0.000040784267,0.00029954466,0.00006182391,0.000014123905,0.00016676988,0.0004132512,0.00008169329,0.0000918442,0.07917246,0.91372794,0.0058847927],"study_design_scores_gemma":[0.00017813472,0.000052498126,0.0012932015,0.00063997327,0.000033645454,0.00028753668,0.0005452531,0.0008625895,0.00018426792,0.08495705,0.91078436,0.00018145212],"about_ca_topic_score_codex":0.035540972,"about_ca_topic_score_gemma":0.0571358,"teacher_disagreement_score":0.9554189,"about_ca_system_score_codex":0.011172066,"about_ca_system_score_gemma":0.025222305,"threshold_uncertainty_score":0.23577034},"labels":[],"label_agreement":null},{"id":"W3038928679","doi":"10.1016/j.jval.2019.09.1573","title":"PMS29 HEALTH STATE UTILITY VALUES FOR JUVENILE IDIOPATHIC ARTHRITIS: A SYSTEMATIC REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; EconLit; CINAHL; Etanercept; MEDLINE; Psychological intervention; Population; Quality of life (healthcare); Quality-adjusted life year; Gerontology; Physical therapy; Pediatrics; Family medicine; Cost effectiveness; Psychiatry; Internal medicine; Environmental health","score_opus":0.09139433784859055,"score_gpt":0.39604055883944567,"score_spread":0.30464622099085514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038928679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010487663,0.9973678,0.00015591376,0.00014384244,0.00007682828,0.00016838904,0.0007892217,0.000010975633,0.00023831033],"genre_scores_gemma":[0.04626365,0.9509412,0.0010825163,0.00058472104,0.000093965245,0.0003598139,0.0004921488,0.000013112745,0.00016885233],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9926571,0.0029617958,0.0023563812,0.0005451689,0.001265727,0.0002138209],"domain_scores_gemma":[0.9698501,0.024359366,0.004016611,0.00035187078,0.0011752947,0.00024674562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008090213,0.0015550813,0.010599288,0.009108316,0.0005040274,0.0029480387,0.0015964297,0.0018390616,0.009359767],"category_scores_gemma":[0.047017567,0.0011209564,0.0137841655,0.009919269,0.00097503216,0.0021431984,0.0022229964,0.002444291,0.0003813917],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066766964,0.00002860112,0.0019773026,0.8930529,0.050411224,0.00006346906,0.00011857185,0.00018926058,0.00008138133,0.0003659076,0.0023484644,0.050695296],"study_design_scores_gemma":[0.0023176412,0.0003522745,0.0147541845,0.5692984,0.3952558,0.00038986374,0.0002978039,0.00035979078,0.00013582097,0.0011567783,0.015562381,0.00011931575],"about_ca_topic_score_codex":0.0102769025,"about_ca_topic_score_gemma":0.031572524,"teacher_disagreement_score":0.010599288,"about_ca_system_score_codex":0.0032816322,"about_ca_system_score_gemma":0.0057542087,"threshold_uncertainty_score":0.042785645},"labels":[],"label_agreement":null},{"id":"W3039168663","doi":"10.1016/j.jval.2020.03.004","title":"Health-Related Quality of Life in Neurological Disorders Most Commonly Associated With Zika-Virus Infection: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Toronto Public Health; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Zika virus; Medicine; Virology; Virus","score_opus":0.09814051525275887,"score_gpt":0.3744254804555154,"score_spread":0.2762849652027565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039168663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012030094,0.99801743,0.000054927106,0.0000967352,0.00006647784,0.000065670276,0.00037065826,0.0000044057138,0.00012065396],"genre_scores_gemma":[0.02518765,0.97364205,0.00034154957,0.0003817346,0.00005922243,0.000113736176,0.00019724287,0.0000033289703,0.00007340083],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99783665,0.0005608515,0.000879538,0.00025401742,0.00033372646,0.00013523444],"domain_scores_gemma":[0.99305576,0.004741454,0.0015823232,0.00007406668,0.00041734587,0.00012915758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028793188,0.0012667219,0.0071861255,0.0059629004,0.00034750713,0.0020192377,0.0010923825,0.0013099393,0.0049149836],"category_scores_gemma":[0.013355431,0.00081439613,0.009550514,0.007319899,0.00059495127,0.0015042365,0.0016314547,0.0014572511,0.00022733254],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035643033,0.000024806515,0.0028071308,0.9196784,0.036837727,0.00007764189,0.00014137018,0.00013228749,0.00013912177,0.0001564664,0.0013136083,0.038334884],"study_design_scores_gemma":[0.0008526828,0.0003410237,0.025372861,0.5974258,0.35698563,0.00041293903,0.0004867779,0.00018799165,0.00015049102,0.00045478,0.01722658,0.00010238079],"about_ca_topic_score_codex":0.014829489,"about_ca_topic_score_gemma":0.047208354,"teacher_disagreement_score":0.014829489,"about_ca_system_score_codex":0.0022752394,"about_ca_system_score_gemma":0.0044294777,"threshold_uncertainty_score":0.029486358},"labels":[],"label_agreement":null},{"id":"W3040479255","doi":"10.1016/j.jval.2019.11.009","title":"Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions—Report of the ISPOR Stated Preference Research Special Interest Group","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"Agency for Healthcare Research and Quality","keywords":"Reimbursement; Preference; Authorization; Marketing; Health economics; Business; Actuarial science; Economics; Health care; Microeconomics; Computer science","score_opus":0.780389263494015,"score_gpt":0.4427709155179167,"score_spread":0.33761834797609835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040479255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003907706,0.9705198,0.004013922,0.013152015,0.00095992244,0.00029130603,0.0004907968,0.000025525771,0.0066389996],"genre_scores_gemma":[0.071766086,0.9062832,0.011787441,0.007251298,0.0010478104,0.0007250323,0.000592156,0.000047394013,0.0004996346],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.8779705,0.07873426,0.020709079,0.0027288564,0.018548867,0.0013083916],"domain_scores_gemma":[0.5812551,0.3345165,0.024190646,0.007131159,0.05054208,0.0023644855],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19784638,0.0008530924,0.002869413,0.012685238,0.0008880748,0.007631091,0.0018393989,0.0024822955,0.003468399],"category_scores_gemma":[0.18789096,0.000800002,0.0045134444,0.01841666,0.0033930342,0.0050254352,0.0032882316,0.0033365884,0.00052819686],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000461726,0.00015146814,0.0052593383,0.037609518,0.0009816455,0.000104256025,0.0011163028,0.0004557357,0.00016266997,0.008186452,0.015769523,0.92974126],"study_design_scores_gemma":[0.00045904485,0.001338063,0.055765953,0.47881046,0.0038030236,0.0018926928,0.006344245,0.0020371343,0.0020666742,0.011963855,0.43507782,0.00044094663],"about_ca_topic_score_codex":0.00658438,"about_ca_topic_score_gemma":0.006277563,"teacher_disagreement_score":0.8021536,"about_ca_system_score_codex":0.0059650713,"about_ca_system_score_gemma":0.018828794,"threshold_uncertainty_score":0.9891982},"labels":[],"label_agreement":null},{"id":"W3042405756","doi":"10.1016/j.jval.2020.03.017","title":"Patient-Centered Care for Women: Delphi Consensus on Evidence-Derived Recommendations","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Ottawa; University Health Network; St. Michael's Hospital; Toronto General Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Likert scale; Concordance; Delphi method; Residence; Delphi; Medicine; Health professionals; Family medicine; Health care; Nursing; Representativeness heuristic; Medical education; Psychology; Social psychology; Political science","score_opus":0.4705739344627006,"score_gpt":0.45940311900739167,"score_spread":0.011170815455308958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042405756","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2159181,0.050759893,0.29049027,0.2617227,0.0060123717,0.10349619,0.0023636732,0.0006664087,0.06857045],"genre_scores_gemma":[0.4951029,0.020783382,0.41703704,0.019727595,0.00051146664,0.04386209,0.0009314566,0.0001436765,0.0019003274],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.605728,0.33326134,0.031648487,0.0049442216,0.018118624,0.006299309],"domain_scores_gemma":[0.78398037,0.14961843,0.013282086,0.005509639,0.04332978,0.0042796563],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.28878936,0.0025471093,0.0026701868,0.0094846785,0.0042388653,0.006361792,0.004582241,0.0049858023,0.004018801],"category_scores_gemma":[0.24583428,0.0018375937,0.0039037627,0.005262327,0.005840343,0.0077673686,0.019335007,0.0066045537,0.0009735043],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011890503,0.0007478809,0.010847398,0.05533108,0.0013859775,0.0018340365,0.28340334,0.006860595,0.005196092,0.023072027,0.045473985,0.56465864],"study_design_scores_gemma":[0.0012502152,0.0019114661,0.013824355,0.22911301,0.0018438539,0.0021960088,0.38213634,0.016134657,0.0066762287,0.10952208,0.23436806,0.0010237197],"about_ca_topic_score_codex":0.004404345,"about_ca_topic_score_gemma":0.005948438,"teacher_disagreement_score":0.28878936,"about_ca_system_score_codex":0.012894646,"about_ca_system_score_gemma":0.05013015,"threshold_uncertainty_score":0.8770493},"labels":[],"label_agreement":null},{"id":"W3043807864","doi":"10.1016/j.jval.2020.03.007","title":"Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Center for AIDS Research, Duke University; University of South Carolina; Center for AIDS Research, University of Washington; Robert Wood Johnson Foundation","keywords":"Interquartile range; Medicine; Pill; Latent class model; Dosing; Mixed logit; Logistic regression; Internal medicine","score_opus":0.20786424438569817,"score_gpt":0.27657637800375756,"score_spread":0.06871213361805939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043807864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635446,0.00007716989,0.0015760376,0.00046619694,0.000023307632,0.000097463904,0.00021083368,0.000008842581,0.0011857245],"genre_scores_gemma":[0.99753475,0.000047508922,0.0013936636,0.00019297734,0.00002267712,0.000075016746,0.00013606313,0.000006190015,0.00059114513],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9898538,0.008775665,0.00023373248,0.00046308985,0.00033584595,0.00033781122],"domain_scores_gemma":[0.7952305,0.19430968,0.0037636997,0.0046787537,0.00037665488,0.0016407752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018888896,0.00074356573,0.0010186392,0.0002838068,0.00060322735,0.0022828758,0.0008862114,0.0022602333,0.0118012875],"category_scores_gemma":[0.054264344,0.00048114706,0.0012198915,0.00032918973,0.0023348017,0.001674353,0.00073601387,0.0030463764,0.0006080669],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5386674,0.13077115,0.12649783,0.0009035233,0.006339393,0.0016376271,0.0051454143,0.05851997,0.013083357,0.03591217,0.0047697346,0.07775243],"study_design_scores_gemma":[0.17990167,0.1923598,0.17611864,0.00026051677,0.005367241,0.00283799,0.0046843095,0.30291057,0.008779048,0.12092504,0.0051738257,0.00068131863],"about_ca_topic_score_codex":0.0009969063,"about_ca_topic_score_gemma":0.00040464484,"teacher_disagreement_score":0.018888896,"about_ca_system_score_codex":0.00057647383,"about_ca_system_score_gemma":0.00090401387,"threshold_uncertainty_score":0.09989518},"labels":[],"label_agreement":null},{"id":"W3046026348","doi":"10.1016/j.jval.2020.03.021","title":"Spending on Hepatitis C Antivirals in the United States and Canada, 2014 to 2018","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Women's College Hospital; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Health Canada; U.S. Department of Veterans Affairs","keywords":"Reimbursement; Medical prescription; Prescription drug; Population; Medicine; Environmental health; Pharmacy; Business; Economic growth; Family medicine; Health care; Economics","score_opus":0.10160303295357649,"score_gpt":0.36168720156351963,"score_spread":0.26008416860994316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046026348","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3743014,0.04373474,0.00060779386,0.05986688,0.0018156798,0.0001630275,0.4415405,0.0003954451,0.07757445],"genre_scores_gemma":[0.79339087,0.04303994,0.00087691133,0.008199891,0.00068143214,0.00015186387,0.106664926,0.000101834434,0.04689226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99745363,0.00012810585,0.00016636921,0.00015689392,0.001114652,0.000980372],"domain_scores_gemma":[0.9939243,0.00022896111,0.00098846,0.000054358556,0.0031601093,0.0016438497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006471817,0.0005308889,0.00080177566,0.0032874986,0.0020051168,0.0027006033,0.0013704795,0.0009784204,0.004869686],"category_scores_gemma":[0.0069753863,0.00039302217,0.0014542679,0.0070723826,0.0008115991,0.0010282588,0.0014940191,0.0017191604,0.00046129923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093325647,0.0001386318,0.48967937,0.0012973212,0.0012641768,0.00037544422,0.0006399733,0.002956754,0.00026851628,0.0081714075,0.42421797,0.070057236],"study_design_scores_gemma":[0.00011485077,0.000073171635,0.81263196,0.0010039972,0.00065252074,0.00041683932,0.0023519283,0.0017377874,0.00040014472,0.000797095,0.17975658,0.00006313525],"about_ca_topic_score_codex":0.9933669,"about_ca_topic_score_gemma":0.99612623,"teacher_disagreement_score":0.07039735,"about_ca_system_score_codex":0.07039735,"about_ca_system_score_gemma":0.12165465,"threshold_uncertainty_score":0.5107709},"labels":[],"label_agreement":null},{"id":"W3046551175","doi":"10.1016/j.jval.2020.05.010","title":"Improving Academic Biobank Value and Sustainability Through an Outputs Focus","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Agency; NSW Ministry of Health; Cancer Institute NSW","keywords":"Biobank; Sustainability; Business; Risk analysis (engineering); Computer science; Knowledge management; Bioinformatics; Biology","score_opus":0.4558728335814894,"score_gpt":0.5645469740327095,"score_spread":0.10867414045122009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046551175","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024498582,0.004189081,0.05913391,0.7226428,0.0032956966,0.000328418,0.00026040766,0.00041223303,0.18523896],"genre_scores_gemma":[0.7413303,0.0064287116,0.061685316,0.10928156,0.0096062785,0.0009477486,0.00044312232,0.0009648379,0.069312096],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.88380307,0.07897111,0.0032206571,0.0033584142,0.025673226,0.0049735685],"domain_scores_gemma":[0.7162604,0.13345993,0.020628778,0.018152926,0.045652058,0.06584586],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14099503,0.0011157161,0.0010654153,0.0036009504,0.0073145577,0.040112395,0.0030616145,0.007516292,0.018207839],"category_scores_gemma":[0.18460825,0.0008120156,0.0007560246,0.004486985,0.016053706,0.017914886,0.032698847,0.010828005,0.0051176683],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024791693,0.0005669752,0.0125538,0.0011644538,0.00015811887,0.00035981374,0.011742791,0.0011911208,0.002542049,0.7006601,0.08998751,0.17882535],"study_design_scores_gemma":[0.00011941249,0.00029283238,0.0054310253,0.0014765958,0.000117707015,0.00031307427,0.011298025,0.0013024613,0.0059153936,0.66933393,0.30431718,0.00008242704],"about_ca_topic_score_codex":0.0007519872,"about_ca_topic_score_gemma":0.0012639072,"teacher_disagreement_score":0.859005,"about_ca_system_score_codex":0.011952491,"about_ca_system_score_gemma":0.06580488,"threshold_uncertainty_score":0.74566185},"labels":[],"label_agreement":null},{"id":"W3047819746","doi":"10.1016/j.jval.2020.06.003","title":"Are We Making a Difference? A Qualitative Study of Patient Engagement at the pan-Canadian Oncology Drug Review: Perspectives of Patient Groups","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Canadian Agency for Drugs and Technologies in Health; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Canadian Cancer Society; Canadian Centre for Applied Research in Cancer Control","keywords":"Transparency (behavior); Agency (philosophy); Qualitative research; Process (computing); Patient participation; Grounded theory; Resource (disambiguation); Medical education; Psychology; Public relations; Medicine; Knowledge management; Health care; Political science; Sociology; Computer science; Social science","score_opus":0.4094212928421418,"score_gpt":0.49856360630401103,"score_spread":0.08914231346186924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047819746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550353,0.0014843325,0.0012092243,0.031723507,0.00040905405,0.00036101163,0.00033789,0.00002557524,0.00941406],"genre_scores_gemma":[0.9853815,0.00080854486,0.0006334599,0.008637076,0.00008603349,0.000351175,0.00009311394,0.000045818626,0.0039633457],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.94846106,0.03748237,0.0012781677,0.0017019415,0.0033221983,0.0077542127],"domain_scores_gemma":[0.89109427,0.07481821,0.006508153,0.0016874311,0.010799055,0.015092922],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036884632,0.00080856885,0.0012948187,0.0027138493,0.039658356,0.011353201,0.0041319546,0.0057160202,0.005345398],"category_scores_gemma":[0.064222805,0.0012042818,0.0007370095,0.003608143,0.02042593,0.0080837635,0.013237782,0.012815168,0.00051646866],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027602593,0.00003216893,0.0012759872,0.000044171036,0.0000041266253,0.00018680599,0.9959435,0.0000082672605,0.00012093628,0.0005370915,0.0007579003,0.0010614665],"study_design_scores_gemma":[0.000004237813,0.000017491311,0.00052309624,0.0000495637,0.0000022932952,0.000047801826,0.9954847,0.000011248814,0.000048352154,0.000078438025,0.0037235806,0.000009314946],"about_ca_topic_score_codex":0.18210949,"about_ca_topic_score_gemma":0.3228312,"teacher_disagreement_score":0.967855,"about_ca_system_score_codex":0.032145042,"about_ca_system_score_gemma":0.04338646,"threshold_uncertainty_score":0.36209893},"labels":[],"label_agreement":null},{"id":"W3080701258","doi":"10.1016/j.jval.2020.02.016","title":"Is Multicriteria Decision Analysis a Resource Allocation Framework?","year":2020,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Multiple-criteria decision analysis; Reimbursement; Resource allocation; Decision analysis; Health technology; Value (mathematics); Cost–benefit analysis; Resource (disambiguation); Health care; Management science; Computer science; Risk analysis (engineering); Actuarial science; Operations research; Medicine; Business; Economics; Engineering; Mathematics; Political science; Statistics","score_opus":0.43422251882991036,"score_gpt":0.4493405050899699,"score_spread":0.015117986260059557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080701258","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008402309,0.0031497122,0.024202101,0.95745873,0.002928943,0.000035256573,0.00014789213,0.00004352738,0.011193586],"genre_scores_gemma":[0.17687543,0.007896576,0.054813635,0.6920283,0.049218424,0.00070878206,0.00020390916,0.00020930251,0.018045632],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.93899274,0.047854006,0.0017873145,0.0020520655,0.007359246,0.0019545823],"domain_scores_gemma":[0.81833905,0.16171218,0.0041822656,0.0045267395,0.0087067755,0.0025330198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.062344946,0.0009776591,0.00321122,0.0020953834,0.0023233383,0.011911031,0.0037169417,0.017744966,0.011195585],"category_scores_gemma":[0.13165028,0.001148663,0.002027278,0.0022630482,0.009535663,0.012590235,0.0034704534,0.022537773,0.0022567648],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002038744,0.00013063151,0.0012207833,0.00023828512,0.00019498175,0.00025115654,0.00033385705,0.007446372,0.00006326295,0.57740736,0.33751604,0.07499339],"study_design_scores_gemma":[0.00011085092,0.000023531962,0.00035751358,0.00030590285,0.000028772056,0.00011327596,0.00024255214,0.014050123,0.000049671,0.9201108,0.06455757,0.000049347105],"about_ca_topic_score_codex":0.01515589,"about_ca_topic_score_gemma":0.022764264,"teacher_disagreement_score":0.062344946,"about_ca_system_score_codex":0.010481913,"about_ca_system_score_gemma":0.012321183,"threshold_uncertainty_score":0.32971555},"labels":[],"label_agreement":null},{"id":"W3083800969","doi":"10.1016/j.jval.2020.06.009","title":"How Good Is Machine Learning in Predicting All-Cause 30-Day Hospital Readmission? Evidence From Administrative Data","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université Laval","funders":"Xinjiang University","keywords":"Computer science; Medicine; Emergency medicine","score_opus":0.22221323422341235,"score_gpt":0.38450535892164184,"score_spread":0.16229212469822948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083800969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72667813,0.16902153,0.021192608,0.057042688,0.0017737257,0.0003836278,0.0077055464,0.00038587154,0.015816325],"genre_scores_gemma":[0.9814922,0.0108045805,0.002876103,0.0018934702,0.0005148127,0.000043775308,0.0017974983,0.000051098054,0.00052649487],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96787775,0.023518983,0.0015948893,0.002469968,0.0035786754,0.0009597737],"domain_scores_gemma":[0.72498107,0.22577702,0.010229908,0.011181621,0.024943337,0.0028871377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06888274,0.0015014154,0.0016807618,0.0026248293,0.0009048769,0.0034329484,0.0030424541,0.002765111,0.002419614],"category_scores_gemma":[0.18010385,0.0005172971,0.0035094833,0.002861927,0.0019799354,0.0042229304,0.0012035823,0.0028973017,0.00096775324],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031422987,0.0005162051,0.81363,0.0024829104,0.007355716,0.00014659925,0.0005659348,0.021648923,0.000074881784,0.0016953079,0.011167654,0.1375735],"study_design_scores_gemma":[0.000544795,0.0026824817,0.80239505,0.01037517,0.006877675,0.00035676587,0.001734308,0.14031233,0.0009786237,0.014709638,0.01876213,0.0002710077],"about_ca_topic_score_codex":0.05449824,"about_ca_topic_score_gemma":0.035783526,"teacher_disagreement_score":0.06888274,"about_ca_system_score_codex":0.003077733,"about_ca_system_score_gemma":0.003625876,"threshold_uncertainty_score":0.36429113},"labels":[],"label_agreement":null},{"id":"W3090606661","doi":"10.1016/j.jval.2020.06.013","title":"Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; AIDS Vancouver","funders":"National Institute on Drug Abuse; National Institute of Development Administration","keywords":"Human immunodeficiency virus (HIV); Decision aids; Value (mathematics); Data collection; Value of information; Data science; Actuarial science; Computer science; Psychology; Medicine; Statistics; Econometrics; Environmental health; Business; Economics; Family medicine; Mathematics; Alternative medicine; Artificial intelligence","score_opus":0.3479087323139526,"score_gpt":0.42412682563229603,"score_spread":0.07621809331834345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090606661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.911899,0.003498135,0.03811269,0.027973372,0.00022643985,0.0022547713,0.0032705595,0.00021814233,0.012546869],"genre_scores_gemma":[0.9802935,0.0004419938,0.017455298,0.0006573315,0.000051731284,0.0002607975,0.0005697424,0.000022811191,0.0002466717],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9151778,0.07435412,0.0022029958,0.0011744963,0.0042352895,0.0028552266],"domain_scores_gemma":[0.6789862,0.29331076,0.010583632,0.0037838635,0.010272986,0.0030625542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06269925,0.0012293257,0.0017362136,0.0062646074,0.0015477373,0.0082889525,0.002289211,0.002525869,0.0030570508],"category_scores_gemma":[0.19731377,0.0008331533,0.0026163529,0.007823506,0.0014312466,0.006113413,0.0037710383,0.0034134586,0.00016685009],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008546342,0.0038806668,0.2899226,0.0025841128,0.0039612213,0.00036997843,0.004063504,0.1947311,0.0010027909,0.026112666,0.016557243,0.44826788],"study_design_scores_gemma":[0.002018679,0.0039799474,0.18588017,0.0017007593,0.0048125875,0.00017606534,0.013876545,0.7089837,0.004506243,0.06235035,0.011272524,0.00044242604],"about_ca_topic_score_codex":0.0467826,"about_ca_topic_score_gemma":0.047225013,"teacher_disagreement_score":0.06269925,"about_ca_system_score_codex":0.009921324,"about_ca_system_score_gemma":0.020136068,"threshold_uncertainty_score":0.33158928},"labels":[],"label_agreement":null},{"id":"W3093380260","doi":"10.1016/j.jval.2011.08.907","title":"PIH2 Caress: The Canadian Registry of Synagis (2005-2010)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Observational study; Gestational age; Cystic fibrosis; Adverse effect; Respiratory system; Internal medicine; Pregnancy","score_opus":0.15323497291199784,"score_gpt":0.37451556645950496,"score_spread":0.22128059354750712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093380260","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11967134,0.004228801,0.0006818413,0.002029774,0.0003400253,0.0009641858,0.8359798,0.00035053576,0.035753675],"genre_scores_gemma":[0.4662054,0.0077308826,0.0029861596,0.0018703814,0.00027329556,0.0010440052,0.4928194,0.00018418298,0.02688626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638957,0.00009873276,0.00032666518,0.00041274424,0.0018678934,0.0009043442],"domain_scores_gemma":[0.9872792,0.0002027661,0.0018088778,0.00034764054,0.008979947,0.0013815828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014856241,0.0011757112,0.0009552035,0.009924023,0.0031447352,0.0022460832,0.0030270321,0.0008937338,0.011224597],"category_scores_gemma":[0.007513141,0.0007887392,0.0011431348,0.02128599,0.00051781733,0.0010057018,0.0018217805,0.0012954891,0.0026483461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033428083,0.00006873668,0.58790135,0.0007332122,0.00027949232,0.0003096093,0.00057024806,0.0003349075,0.00022035735,0.0015380958,0.38552955,0.022180192],"study_design_scores_gemma":[0.00008998957,0.00003070007,0.9381589,0.00044063368,0.0001433847,0.00031194364,0.0008210086,0.00063636986,0.0002287639,0.00016883879,0.05889706,0.00007243751],"about_ca_topic_score_codex":0.99443793,"about_ca_topic_score_gemma":0.99643326,"teacher_disagreement_score":0.043459807,"about_ca_system_score_codex":0.043459807,"about_ca_system_score_gemma":0.11457504,"threshold_uncertainty_score":0.31532443},"labels":[],"label_agreement":null},{"id":"W3099175750","doi":"10.1016/j.jval.2020.10.004","title":"What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"Alberta Health; University of Alberta","keywords":"Chickenpox; Vaccination; Medicine; Actuarial science; Virology; Economics; Virus","score_opus":0.24138141308185504,"score_gpt":0.41371211326094587,"score_spread":0.17233070017909083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099175750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72082126,0.026900528,0.17257787,0.024809979,0.001313014,0.002051501,0.0037954894,0.00025094274,0.047479466],"genre_scores_gemma":[0.971872,0.004134532,0.01657661,0.00095298816,0.00020130682,0.00032192367,0.0003795359,0.00003987622,0.0055212937],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996073,0.00305814,0.00008644265,0.00022636798,0.00023876163,0.00031729083],"domain_scores_gemma":[0.9669524,0.03040807,0.0010216357,0.00036464565,0.0006517843,0.00060145615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009741645,0.0020556492,0.0042954152,0.0011281655,0.000597186,0.0037500262,0.0025422038,0.004002511,0.0101740835],"category_scores_gemma":[0.027580857,0.0011806379,0.0024680698,0.0011479778,0.00162693,0.0044175456,0.0010506936,0.0038122225,0.00041139094],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023708774,0.00051550864,0.0016567018,0.0006184405,0.00050925167,0.00011825769,0.000040084444,0.9574792,0.0003010499,0.020370949,0.0016660204,0.014353737],"study_design_scores_gemma":[0.001472545,0.0016139232,0.0015888712,0.00028911966,0.0010425057,0.000086755754,0.00014686369,0.96273893,0.00032182867,0.028231261,0.002386227,0.00008127168],"about_ca_topic_score_codex":0.019730205,"about_ca_topic_score_gemma":0.008656793,"teacher_disagreement_score":0.019730205,"about_ca_system_score_codex":0.0054040467,"about_ca_system_score_gemma":0.0044362685,"threshold_uncertainty_score":0.051519394},"labels":[],"label_agreement":null},{"id":"W3100474061","doi":"10.1016/j.jval.2020.06.017","title":"Childhood Nutrition in Rural China: What Impact Does Public Health Insurance Have?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Office for Philosophy and Social Sciences","keywords":"Environmental health; Propensity score matching; Calorie; Medicine; China; Public health; Consumption (sociology); Health insurance; Health care; Economic growth; Geography; Economics","score_opus":0.05972141688948395,"score_gpt":0.2773414359053089,"score_spread":0.21762001901582495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100474061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98326117,0.0023110681,0.00008229771,0.011487634,0.000026443751,0.000009381585,0.0005963694,0.000004584126,0.0022209124],"genre_scores_gemma":[0.99808383,0.0007784486,0.000029527588,0.00025996583,0.000022288528,0.0000033873455,0.0001879337,0.0000014217428,0.0006332032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99939597,0.000123476,0.000020865707,0.000056577275,0.00006544703,0.00033777667],"domain_scores_gemma":[0.9980862,0.00031339106,0.00063728733,0.000041229127,0.0002589164,0.0006630397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007802745,0.0002400464,0.00041063846,0.0009862046,0.0005205969,0.0013169748,0.00065511884,0.0006563181,0.0041074045],"category_scores_gemma":[0.0019302977,0.00018419299,0.0003948458,0.0022177515,0.0008827123,0.0011141532,0.0009488156,0.0008096984,0.00014608096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011264181,0.00016437106,0.9764658,0.00014158055,0.00013584954,0.0007987634,0.0016284673,0.00062661467,0.00023423367,0.006119252,0.0020830035,0.01148929],"study_design_scores_gemma":[0.000009068104,0.000043109165,0.9910227,0.00006180346,0.00004569108,0.000068187175,0.005113582,0.0007815678,0.00006111594,0.00094046316,0.0018442898,0.000008495955],"about_ca_topic_score_codex":0.24012817,"about_ca_topic_score_gemma":0.3396563,"teacher_disagreement_score":0.24012817,"about_ca_system_score_codex":0.005183926,"about_ca_system_score_gemma":0.0053293076,"threshold_uncertainty_score":0.47746092},"labels":[],"label_agreement":null},{"id":"W3101964747","doi":"10.1016/j.jval.2020.10.006","title":"Independent Registries Are Cost-Effective Tools to Provide Mandatory Postauthorization Surveillance for Orphan Medicinal Products","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Dalhousie University; University of Toronto; Nova Scotia Health Authority; University of Manitoba; Université de Montréal; University of British Columbia","funders":"","keywords":"Authorization; Medicine; Business; Data quality; Disease registry; Family medicine; Disease; Computer science; Marketing; Pathology","score_opus":0.4344236756413911,"score_gpt":0.42444105680058314,"score_spread":0.009982618840807977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101964747","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25989988,0.014081296,0.29030037,0.031935215,0.0034605842,0.015933715,0.18502341,0.011390719,0.18797487],"genre_scores_gemma":[0.65302414,0.0088348,0.20861606,0.0064968206,0.0030368266,0.007835914,0.096273825,0.0008734623,0.015008222],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.95312095,0.028257016,0.008458641,0.0022117628,0.006947923,0.001003801],"domain_scores_gemma":[0.58783066,0.1900215,0.1227542,0.04748737,0.045608785,0.006297507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058143135,0.0010179451,0.0012830488,0.012525891,0.0006099691,0.0036798532,0.001910616,0.00149333,0.013176866],"category_scores_gemma":[0.21314424,0.00096730527,0.0015819233,0.010650113,0.0004925599,0.005310787,0.002881592,0.0018326577,0.004993046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017894597,0.0009805234,0.26175177,0.0013724477,0.0009329124,0.00018010667,0.00034171884,0.003287565,0.00057088904,0.010546975,0.13960467,0.57864106],"study_design_scores_gemma":[0.0029136993,0.0027818403,0.5665259,0.003931846,0.0024896879,0.0013008227,0.0010168636,0.040260125,0.008987708,0.027681151,0.34161577,0.000494605],"about_ca_topic_score_codex":0.004419316,"about_ca_topic_score_gemma":0.005590203,"teacher_disagreement_score":0.058143135,"about_ca_system_score_codex":0.0014364539,"about_ca_system_score_gemma":0.0075187427,"threshold_uncertainty_score":0.30749398},"labels":[],"label_agreement":null},{"id":"W3103710866","doi":"10.1016/j.jval.2020.10.005","title":"Economic Consequences of Adult Living Kidney Donation: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Public Health Ontario","funders":"","keywords":"Donation; Kidney donation; Indirect costs; Payment; Mandate; Actuarial science; Health economics; Direct Payments; Medicine; Demographic economics; Business; Finance; Public economics; Health care; Economics; Accounting; Economic growth; Kidney transplantation; Transplantation; Political science; Surgery","score_opus":0.07338687701028504,"score_gpt":0.3607495151924245,"score_spread":0.2873626381821395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103710866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010213979,0.9977937,0.00007376286,0.00021970841,0.00011144075,0.000057663983,0.0005060148,0.0000032992298,0.00021297894],"genre_scores_gemma":[0.016064873,0.98285204,0.00022697305,0.00043580483,0.00007382678,0.00008402048,0.00017018279,0.0000034600903,0.000088763045],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966742,0.0011267465,0.001056541,0.00027253487,0.0006896728,0.0001803164],"domain_scores_gemma":[0.98596686,0.010014805,0.0030268407,0.00013377302,0.00066263037,0.00019509856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004534874,0.0010905738,0.0057869693,0.0049452703,0.0003407781,0.0026076003,0.0011910469,0.0017324885,0.007342677],"category_scores_gemma":[0.025329297,0.0008277104,0.0062542176,0.008124348,0.00063194626,0.001933847,0.001937186,0.0019964962,0.00028624377],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049001636,0.000025966683,0.0022928626,0.91844356,0.027124558,0.00014621472,0.00010085886,0.0002274624,0.00006545204,0.00063299265,0.0032365331,0.047213368],"study_design_scores_gemma":[0.00078164676,0.00016799007,0.014519046,0.75276273,0.19848658,0.0006268061,0.00045646605,0.0002533434,0.0001223936,0.0016351425,0.0301088,0.000079090125],"about_ca_topic_score_codex":0.010208033,"about_ca_topic_score_gemma":0.032174356,"teacher_disagreement_score":0.010208033,"about_ca_system_score_codex":0.0029033525,"about_ca_system_score_gemma":0.005658017,"threshold_uncertainty_score":0.02456367},"labels":[],"label_agreement":null},{"id":"W3105325131","doi":"10.1016/j.jval.2020.07.015","title":"Incidence and Variables Associated With Inconsistencies in Opioid Prescribing at Hospital Discharge and Its Associated Adverse Drug Outcomes","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Medicine; Confidence interval; Medical prescription; Odds ratio; Opioid; Logistic regression; Emergency medicine; Incidence (geometry); Emergency department; Rate ratio; Cohort study; Internal medicine; Adverse effect; Psychiatry; Pharmacology","score_opus":0.025132959170162592,"score_gpt":0.2601186465083062,"score_spread":0.2349856873381436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105325131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863535,0.00023216614,0.00008253049,0.00008721971,0.000008460701,0.000009507734,0.00057761057,0.0000036835982,0.0003634262],"genre_scores_gemma":[0.99921274,0.00006628356,0.00011148169,0.000022751732,0.000010011407,0.000006282377,0.00048527587,0.0000025432284,0.00008251869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973328,0.00065812375,0.0007388551,0.00035885573,0.00049960957,0.00041171195],"domain_scores_gemma":[0.970968,0.00865441,0.016189458,0.0011525115,0.0017301302,0.0013054846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002298956,0.0002151992,0.00043477738,0.0013921964,0.0005889003,0.0014432782,0.0006586557,0.00074885745,0.0016965865],"category_scores_gemma":[0.021676125,0.00026841759,0.00095252116,0.0024129648,0.00042750203,0.0009296418,0.0010378071,0.0017577058,0.00014625936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000064915876,0.000020893687,0.99941707,0.0000037660052,0.000039807892,0.000014393901,0.00002518984,0.0000264345,0.000012451858,0.000011548366,0.000018903904,0.00034459334],"study_design_scores_gemma":[0.0000029119228,0.000060446593,0.9991036,0.000009528816,0.000027751827,0.00011195853,0.00027087366,0.00027983694,0.000026361016,0.000046686167,0.000055653894,0.0000043661726],"about_ca_topic_score_codex":0.0076856473,"about_ca_topic_score_gemma":0.008883396,"teacher_disagreement_score":0.0076856473,"about_ca_system_score_codex":0.00091127434,"about_ca_system_score_gemma":0.0014104894,"threshold_uncertainty_score":0.015281856},"labels":[],"label_agreement":null},{"id":"W3110688360","doi":"10.1016/j.jval.2020.08.1388","title":"PND63 Knowledge and Understanding of Alzheimer'S Disease: Revisiting the Psychometric Properties of the Adks Questionnaire","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Item response theory; Psychology; Scale (ratio); Nonparametric statistics; Logistic regression; Clinical psychology; Depression (economics); Psychometrics; Statistics; Medicine; Internal medicine; Mathematics","score_opus":0.16588021300344877,"score_gpt":0.36432523585094856,"score_spread":0.1984450228474998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110688360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99466175,0.00036657936,0.0004104402,0.00020856092,0.000033361688,0.000110184286,0.00042795896,0.000010080937,0.003771076],"genre_scores_gemma":[0.99794155,0.00025579406,0.0006177413,0.00007922702,0.00001915037,0.0001043153,0.00040865128,0.000005366141,0.00056812423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996669,0.0008387276,0.00063555664,0.0002124834,0.0014596747,0.0001846102],"domain_scores_gemma":[0.981428,0.0100025,0.0041568517,0.0008965956,0.0026158995,0.0009001336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006140094,0.00033519827,0.0007439818,0.0016551369,0.00052734115,0.0014250829,0.0007187151,0.00065510673,0.0019772528],"category_scores_gemma":[0.023402415,0.00026678038,0.0014467336,0.0010802072,0.0007501824,0.0013453695,0.0016482334,0.0012266716,0.00031850353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021349294,0.00031660238,0.9762506,0.00008869546,0.00027069205,0.000053352724,0.0008813449,0.00031532175,0.00016553576,0.00017518846,0.00035445276,0.020914664],"study_design_scores_gemma":[0.000046324163,0.0003419897,0.99552226,0.00006667818,0.00009011418,0.00012683497,0.00093856687,0.000888535,0.00022601768,0.00041408034,0.0013222452,0.000016341935],"about_ca_topic_score_codex":0.0075019062,"about_ca_topic_score_gemma":0.006799222,"teacher_disagreement_score":0.0075019062,"about_ca_system_score_codex":0.0010788676,"about_ca_system_score_gemma":0.0014520958,"threshold_uncertainty_score":0.032472312},"labels":[],"label_agreement":null},{"id":"W3110734664","doi":"10.1016/j.jval.2020.08.2023","title":"PSY15 Utilizing Administrative DATA to Determine the Healthcare Burden for Atopic Dermatitis Patients","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Prednisone; Rash; Health care; Potency; Population; Pediatrics; Dermatology; Internal medicine; Environmental health","score_opus":0.25558768654296843,"score_gpt":0.40771020100773453,"score_spread":0.1521225144647661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110734664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97956043,0.0003570196,0.00030695787,0.0002321399,0.000018655215,0.000037189347,0.01756186,0.000013919616,0.0019118385],"genre_scores_gemma":[0.990266,0.00015187326,0.0003965684,0.00009083577,0.00002138041,0.00004143021,0.008687401,0.0000059691115,0.00033848328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979633,0.0005268672,0.00040524456,0.00035577023,0.00043506944,0.0003138187],"domain_scores_gemma":[0.9959474,0.0009003732,0.002020235,0.00033883477,0.00049321965,0.000299954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013997976,0.0003023366,0.00049064757,0.0015205975,0.00038516958,0.0012653623,0.00056961324,0.0003563377,0.0025900775],"category_scores_gemma":[0.0075868317,0.00026877763,0.0014620313,0.0030567502,0.00015779636,0.000687668,0.0011548563,0.00067833427,0.0004081723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001088919,0.000037664886,0.99652195,0.000023307995,0.00021062151,0.00002270475,0.000032187956,0.00015157108,0.000042462783,0.00009651972,0.0008277548,0.0019243545],"study_design_scores_gemma":[0.000019168845,0.00004718277,0.9972395,0.000023712839,0.00010326384,0.00010231748,0.00016034898,0.0010874711,0.00009341618,0.000118650394,0.0010004336,0.000004538775],"about_ca_topic_score_codex":0.025925338,"about_ca_topic_score_gemma":0.021916488,"teacher_disagreement_score":0.025925338,"about_ca_system_score_codex":0.0009339058,"about_ca_system_score_gemma":0.0014173567,"threshold_uncertainty_score":0.0515489},"labels":[],"label_agreement":null},{"id":"W3110753338","doi":"10.1016/j.jval.2020.08.601","title":"PDB4 Evaluation of Quality of Life in PRE-Pubertal Children Using the Quality of Life in Short Stature Youth (QOLISSY) Questionnaire, Following 12 Months of Growth Hormone Treatment with Either a Weekly Somatrogon or a Daily Genotropin Injection Schedule","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"OPKO Health (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Short stature; Idiopathic short stature; Pediatrics; Confidence interval; Growth hormone deficiency; Growth hormone; Internal medicine; Hormone","score_opus":0.08308775449079076,"score_gpt":0.35384864155282025,"score_spread":0.2707608870620295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110753338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946248,0.00028952392,0.00019011322,0.000040180792,0.000012514202,0.00017610876,0.0022445004,0.000017225864,0.002405007],"genre_scores_gemma":[0.9937395,0.00019893303,0.00069384906,0.000024568544,0.000007639559,0.00020247066,0.0027316147,0.0000059884496,0.0023956175],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996,0.00011359814,0.000059480397,0.000033671644,0.000116503616,0.000076790275],"domain_scores_gemma":[0.99908125,0.00010757715,0.00035131915,0.000031595333,0.00022352385,0.00020463012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008298489,0.00039708495,0.00051746255,0.0010503929,0.00033129283,0.00046638105,0.00034342866,0.00025749844,0.0022897306],"category_scores_gemma":[0.0013287378,0.00014052715,0.0009332124,0.000739942,0.0002057787,0.00022853544,0.00045478065,0.0005936448,0.00034512012],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081795856,0.00069730537,0.9783781,0.00009906445,0.0002068494,0.00016359094,0.00029381068,0.00039284202,0.0015569101,0.00004760795,0.0005656208,0.01678031],"study_design_scores_gemma":[0.0000277458,0.0007492577,0.99771464,0.000005697318,0.000032298936,0.00014755574,0.00012275281,0.00026239888,0.0004189053,0.000011782791,0.0005011286,0.0000059393437],"about_ca_topic_score_codex":0.005311674,"about_ca_topic_score_gemma":0.008605185,"teacher_disagreement_score":0.005311674,"about_ca_system_score_codex":0.00044594094,"about_ca_system_score_gemma":0.0003192657,"threshold_uncertainty_score":0.010561526},"labels":[],"label_agreement":null},{"id":"W3110774437","doi":"10.1016/j.jval.2020.08.610","title":"PDB13 Examining Self-Monitoring of Blood Glucose in the NOVA Scotia Public Pharmacare Program","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Nova scotia; Test (biology); Medicine; Diabetes mellitus; Hypoglycemia; Population; Environmental health; Blood test; Emergency medicine; Gerontology; Internal medicine; Endocrinology; Geography; Biology","score_opus":0.3963706619794468,"score_gpt":0.46195742878241347,"score_spread":0.06558676680296666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110774437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99441236,0.00014876788,0.00004573718,0.00091421115,0.000021100135,0.00014582368,0.0016433696,0.0000038641174,0.0026646806],"genre_scores_gemma":[0.9961837,0.00018491154,0.00023231377,0.0008480158,0.000016550384,0.00015992294,0.0008729298,0.000005137656,0.0014965907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965553,0.0009319696,0.00030869615,0.00027140896,0.00076048536,0.0011721959],"domain_scores_gemma":[0.9865818,0.001797547,0.0041218684,0.00036539638,0.0040067825,0.0031266266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020781187,0.00027284492,0.0004255222,0.0011193462,0.0026336347,0.0015523555,0.001404845,0.0009517967,0.0024979655],"category_scores_gemma":[0.010731097,0.00047184608,0.00062160875,0.0020963387,0.0005208764,0.0004962284,0.0019979342,0.0014547318,0.00035219174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079679674,0.0002878911,0.995359,0.000026359496,0.000043115626,0.0000791213,0.00039121165,0.000040580744,0.000041961255,0.000028844088,0.0010674533,0.002554772],"study_design_scores_gemma":[0.000019010098,0.00010124597,0.9979007,0.00004906644,0.000021042782,0.00003776757,0.001357313,0.00012798153,0.000027743883,0.000008837969,0.00034516313,0.000004036505],"about_ca_topic_score_codex":0.8871055,"about_ca_topic_score_gemma":0.93418276,"teacher_disagreement_score":0.112894475,"about_ca_system_score_codex":0.017685786,"about_ca_system_score_gemma":0.02564863,"threshold_uncertainty_score":0.22711861},"labels":[],"label_agreement":null},{"id":"W3110799233","doi":"10.1016/j.jval.2020.08.1768","title":"PRO32 A Treatment Cost MODEL to Estimate TOTAL Annual Costs for Management of Patients with Transthyretin Amyloid Polyneuropathy in Spain","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Context (archaeology); Total cost; Adverse effect; Polyneuropathy; Concomitant; Emergency medicine; Surgery; Internal medicine; Business","score_opus":0.2398097921726874,"score_gpt":0.39360278506548524,"score_spread":0.15379299289279783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110799233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9064576,0.0032456396,0.06085122,0.00279504,0.0003374598,0.0004896558,0.013466428,0.00050916726,0.011847864],"genre_scores_gemma":[0.98011804,0.00053118233,0.009539237,0.00019122237,0.000050832718,0.00046602546,0.004441514,0.000077147364,0.0045847916],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.999046,0.00061323185,0.000047152625,0.00010592477,0.00005264802,0.00013504576],"domain_scores_gemma":[0.9953033,0.0036837722,0.00019051143,0.00011296431,0.00052138866,0.00018808946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003312761,0.0014294942,0.0019930152,0.001657441,0.00041874798,0.0020684386,0.0016047057,0.002930136,0.0058940016],"category_scores_gemma":[0.009186416,0.0009130129,0.0017888467,0.0015486025,0.00036538916,0.0007832443,0.0007313629,0.0015894754,0.0005668141],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038284765,0.00008686528,0.002913653,0.000043725573,0.000088250454,0.00006234192,0.0000076184065,0.99208575,0.000038482613,0.0005478067,0.0007975536,0.0029450727],"study_design_scores_gemma":[0.00027849225,0.00009415302,0.0018221526,0.00003172954,0.00006190425,0.00003779774,0.000029563624,0.9962161,0.000046289213,0.0008190324,0.0005495426,0.000013161863],"about_ca_topic_score_codex":0.13443765,"about_ca_topic_score_gemma":0.03692803,"teacher_disagreement_score":0.13443765,"about_ca_system_score_codex":0.006113062,"about_ca_system_score_gemma":0.003714225,"threshold_uncertainty_score":0.26731026},"labels":[],"label_agreement":null},{"id":"W3110821288","doi":"10.1016/j.jval.2020.08.289","title":"PCN152 The Burden of Skeletal-Related Events in FOUR LATIN American Countries: Argentina, Brazil, Colombia, and Mexico","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Amgen (Canada)","funders":"","keywords":"Latin Americans; Medicine; Demography; Geography; Environmental health; Political science","score_opus":0.041234432112897665,"score_gpt":0.34084631647731306,"score_spread":0.2996118843644154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110821288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993964,0.0013092868,0.000071380644,0.00030878978,0.000010902172,0.00001023067,0.0021817347,0.0000041173084,0.0021395278],"genre_scores_gemma":[0.99779606,0.0006595018,0.000084263804,0.000037738515,0.000009056544,0.000010565406,0.00093453756,0.0000026400444,0.00046566775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998411,0.00004943005,0.000013276173,0.000031413692,0.000023755641,0.0000411013],"domain_scores_gemma":[0.999647,0.0000431479,0.00016198549,0.000015098556,0.000074440264,0.000058332407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003296137,0.00023902231,0.00021316807,0.0009923422,0.0003699769,0.0006445926,0.00026129818,0.00022620866,0.0012161598],"category_scores_gemma":[0.00084376114,0.0001350305,0.00022827368,0.0013618396,0.00024128292,0.00015711458,0.00041791334,0.0002753114,0.000073820964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007719264,0.000015806208,0.99630034,0.00001867656,0.00007335531,0.000058108795,0.00014985818,0.00006443329,0.00010208278,0.00013876955,0.0004145008,0.0025868122],"study_design_scores_gemma":[0.000007924515,0.000014178142,0.997922,0.000024140036,0.000047099482,0.00007208506,0.0005851466,0.00011907666,0.000040194718,0.000035313984,0.0011306388,0.000002294326],"about_ca_topic_score_codex":0.17408954,"about_ca_topic_score_gemma":0.2167362,"teacher_disagreement_score":0.17408954,"about_ca_system_score_codex":0.000850101,"about_ca_system_score_gemma":0.00061000977,"threshold_uncertainty_score":0.34615248},"labels":[],"label_agreement":null},{"id":"W3110836949","doi":"10.1016/j.jval.2020.08.885","title":"PIN44 Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis: A Canadian Cost-Utility Analysis","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Voriconazole; Medicine; Aspergillosis; Internal medicine; Case fatality rate; Population; Intensive care medicine; Mucormycosis; Economic evaluation; Emergency medicine; Surgery; Epidemiology; Antifungal; Environmental health; Immunology; Pathology","score_opus":0.09615228891756904,"score_gpt":0.3281833001406183,"score_spread":0.23203101122304925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110836949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8735998,0.04617601,0.0071087764,0.006934364,0.00020829088,0.0022069667,0.024646804,0.00015431049,0.03896467],"genre_scores_gemma":[0.97699386,0.011168599,0.003825353,0.0006339023,0.000036779184,0.00019230158,0.0043361005,0.00003781763,0.0027753317],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971232,0.001189282,0.0001110046,0.00016023705,0.0010279978,0.0003882549],"domain_scores_gemma":[0.9970155,0.0014733442,0.00023477088,0.00007822782,0.0009363962,0.00026175825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035097653,0.0012189402,0.0015042982,0.0028227228,0.0007898186,0.002174663,0.0012507562,0.0007890881,0.0041986196],"category_scores_gemma":[0.010136467,0.00051531557,0.004389518,0.005205613,0.00057667855,0.00061072357,0.00069928286,0.0015120483,0.00015527302],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033542518,0.001668488,0.17750072,0.0066111926,0.017112855,0.0018207226,0.00067792356,0.30233085,0.0026326743,0.025687182,0.053579584,0.37683535],"study_design_scores_gemma":[0.007874056,0.004299468,0.49581578,0.0024689792,0.032063514,0.0017000881,0.0017344852,0.39447695,0.0011583588,0.0060467934,0.051696233,0.0006654134],"about_ca_topic_score_codex":0.95301014,"about_ca_topic_score_gemma":0.9518833,"teacher_disagreement_score":0.0577719,"about_ca_system_score_codex":0.0577719,"about_ca_system_score_gemma":0.047041193,"threshold_uncertainty_score":0.41916645},"labels":[],"label_agreement":null},{"id":"W3110868324","doi":"10.1016/j.jval.2020.08.1985","title":"PSS23 Burden of Dry Eye Disease and Treatment Experience with Lifitegrast: A CROSS-Sectional Patient Survey in US and Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Cross-sectional study; Mood; Disease; Affect (linguistics); Demographics; Physical therapy; Demography; Psychiatry; Internal medicine; Psychology; Nursing","score_opus":0.04031627114512207,"score_gpt":0.29550984013359965,"score_spread":0.25519356898847756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110868324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836516,0.0009329332,0.00005597428,0.00045595932,0.000012578111,0.000028490203,0.011964684,0.000018922792,0.0028788866],"genre_scores_gemma":[0.99697304,0.00048474374,0.00004927143,0.00011087268,0.000004751952,0.000008031215,0.0017759348,0.0000044895855,0.00058895187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998884,0.000081986065,0.000110342204,0.00016104963,0.00036449532,0.00039807288],"domain_scores_gemma":[0.9977937,0.000113562994,0.00059452606,0.00006055237,0.00077200594,0.00066577166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042792258,0.00023421108,0.00048640626,0.0011401485,0.0013124488,0.0013188475,0.0011143936,0.00057920883,0.0033199023],"category_scores_gemma":[0.0021770017,0.00036744977,0.0009626696,0.0036967814,0.00048471303,0.0004628883,0.0008035937,0.0008378533,0.0002688117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037856997,0.000019321658,0.9976305,0.000013722526,0.00006503,0.000044756736,0.00015360845,0.00006571578,0.000044545697,0.000044066674,0.000692749,0.0011880302],"study_design_scores_gemma":[0.0000028905004,0.000012710951,0.99912673,0.000010835382,0.000016175403,0.000051415274,0.00038959456,0.00010128184,0.00001243449,0.0000064821083,0.00026501637,0.0000045358133],"about_ca_topic_score_codex":0.98176974,"about_ca_topic_score_gemma":0.98462766,"teacher_disagreement_score":0.01823026,"about_ca_system_score_codex":0.012962581,"about_ca_system_score_gemma":0.014701065,"threshold_uncertainty_score":0.09405053},"labels":[],"label_agreement":null},{"id":"W3111112701","doi":"10.1016/j.jval.2020.08.079","title":"PBI1 The Psoriasis Study of Health Outcomes (PSOHO) in Biologic-Naive and -Experienced Patients: Results from the First 217 Patients","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Internal medicine; Psoriasis; Psoriatic arthritis; Plaque psoriasis; Cohort; Ustekinumab; Population; Observational study; Psoriasis Area and Severity Index; Interleukin 17; Arthritis; Dermatology; Adalimumab; Disease","score_opus":0.055678992256940826,"score_gpt":0.2791351838719384,"score_spread":0.22345619161499758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111112701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964271,0.0004699526,0.000071962735,0.00003505525,0.000008235651,0.000056922265,0.002074876,0.0000050351396,0.0008508362],"genre_scores_gemma":[0.9918297,0.0005221684,0.00017140349,0.00010381762,0.000061030998,0.00010804274,0.006350449,0.000010582742,0.00084281305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992111,0.0003258736,0.000049453767,0.00012695033,0.00013451239,0.00015214772],"domain_scores_gemma":[0.9986303,0.0002530145,0.0004897789,0.0001285619,0.00014948411,0.00034885976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011777714,0.00059683283,0.00093399425,0.00080319063,0.0007036753,0.0012015884,0.0004310088,0.00064820884,0.0017940251],"category_scores_gemma":[0.001953985,0.000437339,0.0011858083,0.00123419,0.00029292452,0.0006819187,0.00077808456,0.000949227,0.00058517366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0097240275,0.0008147715,0.9801697,0.000093962655,0.00058657816,0.00016725114,0.00024609052,0.00012464114,0.000627263,0.000043518492,0.00066458475,0.00673758],"study_design_scores_gemma":[0.00071738625,0.0015258087,0.99619234,0.00001653292,0.0003111262,0.00023963225,0.00019838891,0.000102388476,0.00016969976,0.00002853055,0.0004833342,0.000014803008],"about_ca_topic_score_codex":0.0034845632,"about_ca_topic_score_gemma":0.0034264028,"teacher_disagreement_score":0.0034845632,"about_ca_system_score_codex":0.00050081423,"about_ca_system_score_gemma":0.00051896664,"threshold_uncertainty_score":0.006928563},"labels":[],"label_agreement":null},{"id":"W3111116262","doi":"10.1016/j.jval.2020.08.546","title":"PCV55 Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada.","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; St. Michael's Hospital; Robarts Clinical Trials; Université de Montréal","funders":"","keywords":"Medicine; Placebo; Unstable angina; Internal medicine; Emergency medicine; Revascularization; Cardiology; Myocardial infarction; Alternative medicine","score_opus":0.3390108444763588,"score_gpt":0.38144706280034824,"score_spread":0.042436218323989416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111116262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8992214,0.052046485,0.00071554567,0.007842744,0.0003880842,0.0012251313,0.017816786,0.00009709704,0.020646848],"genre_scores_gemma":[0.9877275,0.006507925,0.000543248,0.0004903219,0.00006159461,0.00008518494,0.003018751,0.000007693319,0.0015577546],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987031,0.00050077116,0.000081383274,0.00008417111,0.0003247409,0.0003056937],"domain_scores_gemma":[0.9987841,0.0003178133,0.00018107957,0.000030164932,0.00021702913,0.0004697608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011411047,0.00044387425,0.0007103893,0.00054309703,0.00033686848,0.00090409047,0.0007437383,0.0008248861,0.004605297],"category_scores_gemma":[0.004634471,0.00022319662,0.0020358912,0.0010107394,0.0004836335,0.00031552083,0.00040822598,0.0013922958,0.00015945682],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39754772,0.004165938,0.07579766,0.005538451,0.01004836,0.00053345115,0.0002221254,0.04448865,0.0018305787,0.008523598,0.037667975,0.41363546],"study_design_scores_gemma":[0.110643156,0.04358187,0.7087226,0.0043696556,0.02347643,0.00079378946,0.0011478524,0.06756292,0.0023286666,0.0027047107,0.03437892,0.00028943643],"about_ca_topic_score_codex":0.86989474,"about_ca_topic_score_gemma":0.8731621,"teacher_disagreement_score":0.13010526,"about_ca_system_score_codex":0.02498287,"about_ca_system_score_gemma":0.029774498,"threshold_uncertainty_score":0.2617429},"labels":[],"label_agreement":null},{"id":"W3111185175","doi":"10.1016/j.jval.2020.08.743","title":"PDG60 The IMPACT of International Reference Pricing (IRP) in France, Italy, Spain, United Kingdom, and Canada to New and Existing Marketed Medications","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Negotiation; Publication; International economics; Developing country; Confidentiality; Price index; Business; Economics; International trade; Public economics; Political science; Economic growth; Advertising; Macroeconomics; Law","score_opus":0.17518797701970895,"score_gpt":0.3549262249663573,"score_spread":0.17973824794664833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111185175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58447284,0.018789696,0.0014185795,0.08923323,0.0018111769,0.00017284157,0.029637503,0.00048432735,0.27397978],"genre_scores_gemma":[0.97161597,0.002080721,0.0004790835,0.0058132424,0.0004988999,0.000022246351,0.00547363,0.00012412196,0.013891968],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9901703,0.0019358721,0.00038369308,0.0008058064,0.0043070093,0.0023973135],"domain_scores_gemma":[0.9699985,0.009739388,0.0028096635,0.0009324958,0.012544035,0.003975914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009215211,0.0003654872,0.000923291,0.0026547962,0.00085293717,0.011820148,0.0015630599,0.0031247695,0.006493374],"category_scores_gemma":[0.04468928,0.00032022226,0.0014168256,0.0038209227,0.0017765022,0.0017532177,0.0019156083,0.0033007748,0.0006854022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010274869,0.0010495479,0.2573982,0.0007564774,0.0013777345,0.0016081777,0.00096299953,0.08166114,0.0010358321,0.18601751,0.27929902,0.17855859],"study_design_scores_gemma":[0.0016654405,0.0008707052,0.6731431,0.0006415348,0.00096699677,0.0004942798,0.001994566,0.045516778,0.00251258,0.019731598,0.25205877,0.000403751],"about_ca_topic_score_codex":0.77416444,"about_ca_topic_score_gemma":0.64345556,"teacher_disagreement_score":0.22583556,"about_ca_system_score_codex":0.036412418,"about_ca_system_score_gemma":0.023866229,"threshold_uncertainty_score":0.4543311},"labels":[],"label_agreement":null},{"id":"W3111189188","doi":"10.1016/j.jval.2020.08.261","title":"PCN124 Health Utilities for Patients with HR-Positive, HER2-Negative EARLY Breast Cancer: A Systematic Literature Review","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Breast cancer; Disease; Generalizability theory; Cancer; Oncology; Systematic review; MEDLINE; Internal medicine; Family medicine; Meta-analysis; Gynecology; Psychology","score_opus":0.2340163735266508,"score_gpt":0.3874628003376505,"score_spread":0.1534464268109997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111189188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028186254,0.9939135,0.00015452306,0.00029021635,0.000077921984,0.00016508548,0.0022303616,0.000006471376,0.0003433302],"genre_scores_gemma":[0.080169186,0.91539264,0.00096679403,0.0007672166,0.00014762804,0.00063951395,0.0017492746,0.00001012832,0.0001576545],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99263316,0.0025659394,0.0027142565,0.0006686539,0.0011405589,0.00027730703],"domain_scores_gemma":[0.97269917,0.020869352,0.004671712,0.00031399884,0.0012007197,0.0002450585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073396433,0.0011737926,0.0064814864,0.010827576,0.00042457567,0.0025554686,0.0011415739,0.001396058,0.0054446226],"category_scores_gemma":[0.048748277,0.00082691805,0.015071658,0.011957486,0.0007249954,0.0020387464,0.0019903877,0.0017053076,0.0002782638],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083680457,0.000048762056,0.011170042,0.83348143,0.06218894,0.00007958802,0.00012560024,0.0004141493,0.00006481614,0.000545669,0.0039153975,0.08712873],"study_design_scores_gemma":[0.0014343946,0.00041886524,0.05924097,0.652131,0.26176134,0.0005603609,0.0003870997,0.00041825091,0.0001276013,0.0015930075,0.021775551,0.00015154605],"about_ca_topic_score_codex":0.013778715,"about_ca_topic_score_gemma":0.03317965,"teacher_disagreement_score":0.013778715,"about_ca_system_score_codex":0.0038937037,"about_ca_system_score_gemma":0.006516168,"threshold_uncertainty_score":0.038816214},"labels":[],"label_agreement":null},{"id":"W3111193106","doi":"10.1016/j.jval.2020.08.810","title":"PIH11 Quality of Life and Economic Burden of Erectile Dysfunction","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Erectile dysfunction; Quality of life (healthcare); Medicine; Psychosocial; Depression (economics); Anxiety; Sexual dysfunction; Observational study; Gerontology; Human sexuality; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.14883802938699991,"score_gpt":0.3558114739756161,"score_spread":0.20697344458861616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111193106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98368156,0.005224372,0.00014098985,0.00077961746,0.00007573066,0.000037936523,0.0028643487,0.000003741516,0.0071917344],"genre_scores_gemma":[0.9964527,0.0010450543,0.00010255197,0.00009601451,0.00005208443,0.000022999133,0.001109379,0.0000018977343,0.0011173332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876773,0.0005663526,0.00011542036,0.00009137626,0.000239416,0.00021973944],"domain_scores_gemma":[0.9953216,0.0016060687,0.001968855,0.00021380658,0.0002818546,0.00060786953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001790299,0.00039303585,0.0004721849,0.0012130073,0.0005260056,0.0016952269,0.0005800527,0.00063019176,0.007292899],"category_scores_gemma":[0.007923813,0.0002512361,0.0016128633,0.002541557,0.00051758194,0.0008663442,0.001216355,0.0015626,0.00029121176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004917016,0.00016001149,0.98917013,0.0001263652,0.00093638216,0.00007867449,0.00011241521,0.00018404938,0.00003855137,0.00044189565,0.00044936678,0.007810403],"study_design_scores_gemma":[0.000020675894,0.00017101852,0.9980572,0.000046172732,0.00020480478,0.00012341882,0.0002107437,0.00014748651,0.000022760014,0.00015418838,0.00083285203,0.000008719461],"about_ca_topic_score_codex":0.0073439213,"about_ca_topic_score_gemma":0.005850446,"teacher_disagreement_score":0.0073439213,"about_ca_system_score_codex":0.00083552004,"about_ca_system_score_gemma":0.0008729513,"threshold_uncertainty_score":0.024397194},"labels":[],"label_agreement":null},{"id":"W3111219757","doi":"10.1016/j.jval.2020.08.144","title":"PCN7 Systematic Differences between Embraca and Olympiad Phase III Physician's Choice Chemotherapy (PCT) Arms: A FOCUS on the First-LINE (1L) Treatment of Metastatic Breast Cancer (MBC) Subpopulations","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Olympiad; Medicine; Internal medicine; Propensity score matching; Hazard ratio; Subgroup analysis; Oncology; Confidence interval","score_opus":0.42864673254123686,"score_gpt":0.43219481286707206,"score_spread":0.003548080325835201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111219757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76465416,0.11133172,0.012708898,0.012488982,0.0030755443,0.0034121182,0.05343653,0.00027535486,0.038616627],"genre_scores_gemma":[0.98074234,0.0033992822,0.0015810649,0.00409925,0.000478495,0.0009600835,0.005610587,0.000054640426,0.0030741603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9693969,0.024618076,0.001334156,0.0021676007,0.0018156543,0.000667633],"domain_scores_gemma":[0.9525408,0.034434617,0.007720666,0.00264398,0.0016879373,0.0009718541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018860659,0.000533269,0.0012568526,0.0006150951,0.00029600394,0.0011022971,0.0009471727,0.0012048124,0.007551103],"category_scores_gemma":[0.06392387,0.00032373326,0.0063660704,0.0011748429,0.00078980497,0.00095795543,0.001352709,0.0016910165,0.00043680883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20960471,0.0006625972,0.28648427,0.012811338,0.14696506,0.00025914036,0.00056060916,0.0050738864,0.001328098,0.008983559,0.05146163,0.27580523],"study_design_scores_gemma":[0.049238414,0.017084971,0.6205661,0.011022158,0.1711985,0.0005943624,0.001062433,0.01208131,0.0034150798,0.01631749,0.09718612,0.00023299996],"about_ca_topic_score_codex":0.011862921,"about_ca_topic_score_gemma":0.022972291,"teacher_disagreement_score":0.018860659,"about_ca_system_score_codex":0.0013106526,"about_ca_system_score_gemma":0.0028542571,"threshold_uncertainty_score":0.09974587},"labels":[],"label_agreement":null},{"id":"W3111286950","doi":"10.1016/j.jval.2020.08.1941","title":"PRS61 Targeted Literature Review of Economic Models USED in Health Technology Agency Assessments in Severe Asthma","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Mepolizumab; Omalizumab; Medicine; Asthma; Nice; Health technology; Benralizumab; Exacerbation; Intensive care medicine; Health care; Immunology; Economic growth","score_opus":0.3697345047300995,"score_gpt":0.4512277504731536,"score_spread":0.08149324574305411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111286950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028781388,0.9552673,0.009479489,0.014251178,0.0012648271,0.00019935335,0.0041188924,0.000095716845,0.012445085],"genre_scores_gemma":[0.041312065,0.9401736,0.010111692,0.003155357,0.001296605,0.00026607484,0.0020529588,0.00007545419,0.0015561054],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98879063,0.0069988007,0.00164528,0.0004856968,0.001867489,0.00021219795],"domain_scores_gemma":[0.8731917,0.1126747,0.003947349,0.001442733,0.00841079,0.00033266732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019818153,0.000841238,0.0014910622,0.011498011,0.00043101888,0.0029492723,0.0011611903,0.0018244506,0.011515268],"category_scores_gemma":[0.101636656,0.00052211434,0.004077625,0.013482463,0.0005112462,0.002487553,0.001171462,0.0019886883,0.0014450612],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035800398,0.00017967423,0.0045513604,0.15065283,0.0037331781,0.00031238128,0.00034958113,0.011083258,0.0003550539,0.065644875,0.095141746,0.66763806],"study_design_scores_gemma":[0.00018371899,0.0003521816,0.016279263,0.371204,0.008299471,0.000651816,0.0007181353,0.013506573,0.00093373813,0.043955103,0.5437772,0.00013874848],"about_ca_topic_score_codex":0.013741002,"about_ca_topic_score_gemma":0.018547965,"teacher_disagreement_score":0.019818153,"about_ca_system_score_codex":0.0035373415,"about_ca_system_score_gemma":0.008846841,"threshold_uncertainty_score":0.1048097},"labels":[],"label_agreement":null},{"id":"W3111320730","doi":"10.1016/j.jval.2020.08.1439","title":"PND114 Registries As a Source of Real World DATA (RWD) to Demonstrate the Effectiveness of Therapies for Multiple Sclerosis: A Global Perspective","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Clinical trial; Real world evidence; MEDLINE; Quarter (Canadian coin); Internal medicine; Geography; Political science","score_opus":0.5872572653081088,"score_gpt":0.45002986459435024,"score_spread":0.1372274007137586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111320730","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052887674,0.10292527,0.11997902,0.48117253,0.0057203514,0.0016548123,0.109977335,0.0009090889,0.12477393],"genre_scores_gemma":[0.62344694,0.081973195,0.17740358,0.04258536,0.0048172404,0.002607324,0.060464285,0.0006442173,0.0060578524],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.89981806,0.0796002,0.006344933,0.0026562952,0.010296604,0.0012839107],"domain_scores_gemma":[0.638186,0.23421313,0.039565407,0.0409232,0.040410284,0.006702053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1346508,0.0008091835,0.0016003463,0.0087481085,0.0005465379,0.009141358,0.0025942717,0.0027097834,0.0070944806],"category_scores_gemma":[0.20579642,0.0007569834,0.0013158739,0.014869096,0.0025137113,0.009069395,0.007082787,0.0045089577,0.0013927958],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000916903,0.0004539194,0.12706773,0.0066240453,0.0028867293,0.00030405383,0.0010294368,0.0058029774,0.00075896364,0.26711574,0.14333536,0.44370413],"study_design_scores_gemma":[0.0008915682,0.00090273604,0.13629967,0.031387813,0.002051623,0.0010873473,0.0024965298,0.012690853,0.0023253555,0.14086488,0.6687251,0.00027652425],"about_ca_topic_score_codex":0.0064844037,"about_ca_topic_score_gemma":0.0062008156,"teacher_disagreement_score":0.1346508,"about_ca_system_score_codex":0.0025861878,"about_ca_system_score_gemma":0.012291382,"threshold_uncertainty_score":0.71211},"labels":[],"label_agreement":null},{"id":"W3111325356","doi":"10.1016/j.jval.2020.08.153","title":"PCN16 External Control Analysis of Overall Survival in BRAFV600 Mutated Metastatic NSCLC: Comparing Single-Arm Dabrafenib+Trametinib Clinical Trial Outcomes with Real-World Standards of Care","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Dabrafenib; Trametinib; Medicine; Oncology; Internal medicine; Pemetrexed; Cohort; Carboplatin; Vemurafenib; Progression-free survival; Chemotherapy; Cancer; Metastatic melanoma; Biology","score_opus":0.14629362356321837,"score_gpt":0.4254324990872466,"score_spread":0.2791388755240283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111325356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808852,0.006007546,0.0023981065,0.00054239586,0.0005942652,0.001067129,0.0048928233,0.00010562291,0.0035068202],"genre_scores_gemma":[0.99473166,0.00033154935,0.00067949103,0.00017985363,0.00013932155,0.0006806435,0.0024457572,0.00002942244,0.00078226434],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9871711,0.008147544,0.0008706039,0.0021022656,0.0011099946,0.0005985667],"domain_scores_gemma":[0.9864763,0.005299032,0.0043481044,0.002078599,0.0008266227,0.00097124063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017345924,0.0016958872,0.0027164202,0.00078368705,0.00044488773,0.0017710001,0.0018042378,0.0015305673,0.002900844],"category_scores_gemma":[0.020379506,0.00047496904,0.006590911,0.00096966553,0.0013369413,0.0015769228,0.001300677,0.0023260952,0.00045481639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9155831,0.00078207743,0.02954973,0.0009571756,0.032674856,0.00004410057,0.00007451065,0.0029402638,0.00096932845,0.00044309947,0.0018814495,0.014100439],"study_design_scores_gemma":[0.4517371,0.096376345,0.351299,0.0008778611,0.06644344,0.0003563559,0.00031455632,0.015095018,0.004221822,0.0033094606,0.0097452905,0.00022378338],"about_ca_topic_score_codex":0.0024142058,"about_ca_topic_score_gemma":0.0031454067,"teacher_disagreement_score":0.017345924,"about_ca_system_score_codex":0.0022569364,"about_ca_system_score_gemma":0.0015812622,"threshold_uncertainty_score":0.091735065},"labels":[],"label_agreement":null},{"id":"W3111345396","doi":"10.1016/j.jval.2020.08.347","title":"PCN210 Estimating the IMPACT of Delayed Access to Oncology Drugs on Patient Outcomes in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Reimbursement; Medicine; Process (computing); Intensive care medicine; Oncology; Computer science; Economics; Health care; Economic growth","score_opus":0.43150778939808093,"score_gpt":0.47636811682202057,"score_spread":0.04486032742393964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111345396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95394284,0.002360906,0.003328863,0.0058640596,0.0001659033,0.00016390637,0.026873037,0.00015648411,0.0071439785],"genre_scores_gemma":[0.986754,0.00066,0.0017111265,0.0002364207,0.000037003338,0.000040918512,0.0071174856,0.000026287209,0.0034167268],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99838245,0.00041103284,0.00007208991,0.00023091777,0.0002827893,0.0006206867],"domain_scores_gemma":[0.9876831,0.006124349,0.000978099,0.00035789437,0.003389153,0.0014673857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031459806,0.0006725506,0.001160061,0.0016048485,0.0011628352,0.002106934,0.001964624,0.0011536622,0.005708792],"category_scores_gemma":[0.020647224,0.0006573801,0.0017373792,0.0033226253,0.00094029633,0.0006345442,0.0009158188,0.0024389974,0.00029265266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016693291,0.0005995414,0.5156565,0.00030936787,0.001394955,0.0004445291,0.00018928201,0.3996141,0.00018139216,0.009739314,0.037552502,0.032649323],"study_design_scores_gemma":[0.0007874301,0.00025597864,0.29263213,0.00016189969,0.00057573064,0.00013576738,0.0008280703,0.6918329,0.00041745024,0.004121002,0.008137851,0.000113793605],"about_ca_topic_score_codex":0.99467695,"about_ca_topic_score_gemma":0.99249625,"teacher_disagreement_score":0.9497603,"about_ca_system_score_codex":0.050239656,"about_ca_system_score_gemma":0.0516714,"threshold_uncertainty_score":0.3645159},"labels":[],"label_agreement":null},{"id":"W3111458010","doi":"10.1016/j.jval.2020.08.034","title":"HTA4 Clinical Development and HTA Approval of MULTI-Indication Oncology Products: Evidence from Germany, France, England, Scotland, the US, Canada, and Australia","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Timeline; Clinical trial; Orphan drug; Family medicine; Agency (philosophy); Drug approval; Health care; Internal medicine; Political science; Geography; Pharmacology","score_opus":0.5630408906124301,"score_gpt":0.4574362463879819,"score_spread":0.10560464422444821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111458010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47132125,0.4428252,0.0016253022,0.019453362,0.00055878796,0.00043845552,0.0062595555,0.00006896791,0.05744914],"genre_scores_gemma":[0.94192034,0.050014105,0.0008840074,0.0026539818,0.00024985298,0.000078544115,0.0018960153,0.000020975109,0.0022821606],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99486536,0.0031836187,0.00028011046,0.00023327273,0.0011396791,0.00029789182],"domain_scores_gemma":[0.9676366,0.021219468,0.007018334,0.00050780876,0.0022166988,0.0014010736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008280893,0.00019123062,0.0007480183,0.001055193,0.00030413826,0.0017614303,0.0005384252,0.0009680686,0.0061133583],"category_scores_gemma":[0.027071036,0.00022022324,0.0021005813,0.0015637506,0.0010207765,0.00088161416,0.0005739382,0.0018745885,0.0002523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07330018,0.00078462897,0.09163572,0.012553398,0.008254249,0.0005110834,0.0005334423,0.004705361,0.0011887352,0.009705812,0.030087642,0.7667397],"study_design_scores_gemma":[0.029739475,0.025807338,0.6628076,0.019617844,0.018499317,0.0021884623,0.0012556118,0.0055039246,0.0038894755,0.0061911503,0.22429802,0.00020184406],"about_ca_topic_score_codex":0.019399269,"about_ca_topic_score_gemma":0.025708178,"teacher_disagreement_score":0.9806007,"about_ca_system_score_codex":0.003627899,"about_ca_system_score_gemma":0.0042545446,"threshold_uncertainty_score":0.043794036},"labels":[],"label_agreement":null},{"id":"W3111651503","doi":"10.1016/j.jval.2020.08.567","title":"PCV76 NEWLY Introduced Drugs for Second-LINE Treatment of Stable Angina: Approvals and Reimbursement Decisions in the UK, Canada, Australia and Scotland","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ranolazine; Reimbursement; Trimetazidine; Ivabradine; Medicine; Nicorandil; Angina; Formulary; Health care; Intensive care medicine; Pharmacology; Internal medicine; Political science","score_opus":0.18607472664411934,"score_gpt":0.33849278440518543,"score_spread":0.1524180577610661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111651503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9035056,0.031839307,0.0003149919,0.027755262,0.00037378434,0.00007979524,0.0061920676,0.00003181903,0.02990731],"genre_scores_gemma":[0.98175347,0.007864921,0.0003123429,0.002484889,0.00023857686,0.00001397003,0.0013792735,0.000022106846,0.0059304982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961486,0.000560547,0.0003438884,0.00025996682,0.0016597242,0.0010272027],"domain_scores_gemma":[0.988366,0.002736962,0.0025089618,0.00012086359,0.002947904,0.0033193235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002235061,0.0001498224,0.00059108355,0.001924438,0.00076948834,0.003355301,0.0007539371,0.0012695139,0.003101032],"category_scores_gemma":[0.009595685,0.00027860224,0.00080885325,0.0034451527,0.0012077402,0.00068616786,0.0007793044,0.0019708532,0.00021343367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009842107,0.0003604631,0.5550057,0.0019626694,0.0007773813,0.0067077344,0.0044070845,0.0064036236,0.004725502,0.039968174,0.07569082,0.2941487],"study_design_scores_gemma":[0.00031959044,0.00033707387,0.9593295,0.0003656457,0.00015425142,0.0011046083,0.0013726297,0.0015309599,0.00058122515,0.00039588223,0.03441549,0.000093119816],"about_ca_topic_score_codex":0.7367076,"about_ca_topic_score_gemma":0.8370143,"teacher_disagreement_score":0.26329237,"about_ca_system_score_codex":0.023397954,"about_ca_system_score_gemma":0.018761452,"threshold_uncertainty_score":0.52968585},"labels":[],"label_agreement":null},{"id":"W3111690689","doi":"10.1016/j.jval.2020.08.540","title":"PCV49 Cost-Effectiveness of Evolocumab in Patients with Prior Myocardial Infarction in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Evolocumab; Ezetimibe; Statin; Atherosclerotic cardiovascular disease; Internal medicine; Cardiology; Myocardial infarction; Cholesterol; Disease; Total cholesterol","score_opus":0.2259214883881992,"score_gpt":0.3570972620746227,"score_spread":0.13117577368642352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111690689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579873,0.023383142,0.00012490147,0.0053567034,0.00018610814,0.00014678876,0.0050991545,0.000017440054,0.007698498],"genre_scores_gemma":[0.9926057,0.0044623157,0.00012081062,0.00043889633,0.00006119932,0.000022996412,0.001534369,0.0000062048734,0.00074760633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998638,0.00025005537,0.00009792196,0.00013317665,0.0003813274,0.0004994989],"domain_scores_gemma":[0.9971775,0.0004913716,0.00046684395,0.00005004506,0.0007399654,0.0010743479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008850827,0.00040461702,0.0011385455,0.0009370673,0.0010630733,0.0020645198,0.001138044,0.00071838434,0.0025118864],"category_scores_gemma":[0.006176463,0.00029130338,0.0018733141,0.0024781192,0.00074612495,0.0004687653,0.00062640785,0.0017179407,0.000115801784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027338343,0.0012560384,0.806076,0.0018501267,0.0052697337,0.0011745846,0.0005245336,0.01344105,0.00060044485,0.00374772,0.021415096,0.117306285],"study_design_scores_gemma":[0.0044914996,0.0013644557,0.96909595,0.0009736146,0.0032922463,0.00041852583,0.0012536135,0.010849162,0.0002017813,0.00061551883,0.0073269918,0.00011672282],"about_ca_topic_score_codex":0.9798181,"about_ca_topic_score_gemma":0.98864055,"teacher_disagreement_score":0.056870766,"about_ca_system_score_codex":0.056870766,"about_ca_system_score_gemma":0.04907545,"threshold_uncertainty_score":0.41262823},"labels":[],"label_agreement":null},{"id":"W3111705182","doi":"10.1016/j.jval.2020.08.180","title":"PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Meta-analysis; Hazard ratio; Anastrozole; Randomized controlled trial; Tamoxifen; Subgroup analysis; Adjuvant therapy; Adjuvant; Gynecology; Cancer; Confidence interval","score_opus":0.03763970652950111,"score_gpt":0.3181948405284842,"score_spread":0.2805551339989831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111705182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004370027,0.9946597,0.00023176579,0.00009160804,0.00008745527,0.000042846532,0.0003634384,0.000010665823,0.00014242638],"genre_scores_gemma":[0.15495157,0.841733,0.0010891238,0.00074729626,0.00022041216,0.0001785817,0.00067434926,0.000018548326,0.00038722143],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9980045,0.00067510543,0.0006186236,0.0003468318,0.00024137809,0.00011352991],"domain_scores_gemma":[0.99652857,0.0023780968,0.0005929173,0.00015607121,0.00026707244,0.00007732506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034731172,0.0016704728,0.009194906,0.0022790963,0.00037561724,0.0017853065,0.0013517631,0.0015968104,0.0029437447],"category_scores_gemma":[0.009518331,0.0010218365,0.022036195,0.0040651676,0.00041798584,0.0009491285,0.0010711735,0.0016170779,0.00028315998],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027625912,0.0000427045,0.011866181,0.3006624,0.6562031,0.00017525951,0.000101899655,0.0004882841,0.00040048303,0.00014467924,0.0013448639,0.025807576],"study_design_scores_gemma":[0.0004931048,0.00013629072,0.008664189,0.011156021,0.9769033,0.000103627666,0.000051908766,0.00011882999,0.00008652298,0.0001803036,0.002076628,0.000029320036],"about_ca_topic_score_codex":0.008222819,"about_ca_topic_score_gemma":0.02305654,"teacher_disagreement_score":0.009194906,"about_ca_system_score_codex":0.0010080477,"about_ca_system_score_gemma":0.0016162752,"threshold_uncertainty_score":0.018367827},"labels":[],"label_agreement":null},{"id":"W3111895883","doi":"10.1016/j.jval.2020.08.1892","title":"PRS12 Comparison of Healthcare Costs Associated with the Use of Two Different Dosing Strategies in Asthma Patients in Indonesia, Thailand and Vietnam.","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Formoterol; Salmeterol; Medicine; Fluticasone propionate; Budesonide; Health care; Fluticasone; Asthma; Pediatrics; Internal medicine; Economic growth","score_opus":0.3932886221204399,"score_gpt":0.4055459358805237,"score_spread":0.012257313760083766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111895883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898033,0.0019720502,0.00017755038,0.00063800626,0.00003979307,0.00006625531,0.005094907,0.000008732145,0.0021993928],"genre_scores_gemma":[0.99758136,0.00030057738,0.00008548679,0.000058930247,0.000012611598,0.00003208807,0.001483038,0.0000023590223,0.00044344342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986307,0.00063721644,0.00018108092,0.00013038503,0.00015770935,0.00026281143],"domain_scores_gemma":[0.99700683,0.0012245761,0.00095117575,0.00008030464,0.0003036359,0.00043348878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012437684,0.00026226582,0.0006188892,0.00068496563,0.00023500694,0.00082640134,0.00044970514,0.0005398238,0.005770064],"category_scores_gemma":[0.0042168694,0.00019936459,0.002343342,0.0013069061,0.00022361669,0.00060027716,0.00065168145,0.0011584901,0.00019543529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027005589,0.0012437482,0.8760587,0.0017293692,0.0045497846,0.001022813,0.0005052424,0.017162248,0.00049439893,0.0020384383,0.00603764,0.062152],"study_design_scores_gemma":[0.00052274176,0.0029482425,0.9815661,0.00025274017,0.0012001757,0.0005614815,0.0016577785,0.008801339,0.00025000586,0.0004079916,0.001789328,0.000042048185],"about_ca_topic_score_codex":0.034453247,"about_ca_topic_score_gemma":0.023188196,"teacher_disagreement_score":0.034453247,"about_ca_system_score_codex":0.0025819011,"about_ca_system_score_gemma":0.0016862017,"threshold_uncertainty_score":0.06850541},"labels":[],"label_agreement":null},{"id":"W3111918987","doi":"10.1016/j.jval.2020.08.1243","title":"PMU31 Defining Clinically Relevant Threshold for Chronic Opioid Use Using NOVEL Modelling Techniques","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Opioid; Emergency department; Proportional hazards model; Cohort study; Prospective cohort study; Emergency medicine; Cohort; Internal medicine; Intensive care medicine; Psychiatry","score_opus":0.71166119968764,"score_gpt":0.4717105230265069,"score_spread":0.23995067666113307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111918987","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11958216,0.001303424,0.8589316,0.004056106,0.00027801446,0.00025464667,0.0013745655,0.00051930925,0.013700196],"genre_scores_gemma":[0.92873865,0.00041393653,0.06498364,0.00028355586,0.00012981812,0.00032752068,0.00089654914,0.00008794679,0.0041382606],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99831307,0.00094436423,0.0001049881,0.00021314528,0.00021816349,0.00020633331],"domain_scores_gemma":[0.9906256,0.007662823,0.00048927893,0.00038165887,0.000651288,0.00018931234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003877245,0.0006713328,0.0011596605,0.0011502419,0.0005325876,0.0026775722,0.0014428227,0.0017500076,0.004524588],"category_scores_gemma":[0.024351805,0.0004997222,0.0017596964,0.0009128163,0.00051147456,0.0012622109,0.0013714914,0.0021783288,0.0005244996],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003845732,0.00024468958,0.027901292,0.0002850121,0.00032209288,0.00055659236,0.00027558327,0.7636495,0.0012761984,0.11353035,0.009353858,0.08222022],"study_design_scores_gemma":[0.000013684721,0.00003511517,0.0025361576,0.000046986643,0.000021989248,0.00010136879,0.000032269993,0.9630064,0.00021378514,0.032915924,0.0010615232,0.000014726786],"about_ca_topic_score_codex":0.014363556,"about_ca_topic_score_gemma":0.007037153,"teacher_disagreement_score":0.014363556,"about_ca_system_score_codex":0.0013529332,"about_ca_system_score_gemma":0.0020428405,"threshold_uncertainty_score":0.028559923},"labels":[],"label_agreement":null},{"id":"W3111989140","doi":"10.1016/j.jval.2020.08.1948","title":"PRS68 The Humanistic Burden of Mild Asthma: Evidence from the Novelty Study","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Asthma; Quality of life (healthcare); Internal medicine; Bronchodilator; Physical therapy","score_opus":0.19503699521300255,"score_gpt":0.3912421078211199,"score_spread":0.19620511260811735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111989140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917504,0.003400521,0.000048442304,0.0009308954,0.00003449472,0.000010591479,0.0004108727,0.0000014587574,0.0034122253],"genre_scores_gemma":[0.9985563,0.00091422687,0.000031548512,0.000099666955,0.000045553068,0.000004168812,0.00012472218,9.041753e-7,0.00022278132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988115,0.0007247596,0.000047639693,0.00009125278,0.00020598127,0.000118888325],"domain_scores_gemma":[0.9946898,0.0017484223,0.0022844938,0.0003691585,0.00025673685,0.0006513804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015917245,0.00017741884,0.0003280412,0.00051289744,0.00049224007,0.0008142665,0.00040347865,0.000557112,0.0036465775],"category_scores_gemma":[0.0076399245,0.0001253417,0.0005471355,0.0008789858,0.0007181417,0.0004907725,0.000851777,0.0007051209,0.0001446814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018431831,0.00022400923,0.9689557,0.00018734191,0.0006494545,0.00023891959,0.0005653714,0.00007110263,0.00024293977,0.0007544027,0.0007256301,0.025541874],"study_design_scores_gemma":[0.000052130767,0.00024188544,0.99780434,0.000042526673,0.00012395912,0.00013573086,0.00043564115,0.0000366521,0.00003312701,0.0002618952,0.0008251102,0.00000697752],"about_ca_topic_score_codex":0.008058407,"about_ca_topic_score_gemma":0.0081955,"teacher_disagreement_score":0.008058407,"about_ca_system_score_codex":0.00035891912,"about_ca_system_score_gemma":0.00044175965,"threshold_uncertainty_score":0.01602298},"labels":[],"label_agreement":null},{"id":"W3112058853","doi":"10.1016/j.jval.2020.08.393","title":"PCN256 Health Technology Assessment for Chimeric Antigen Receptor (CAR) T-CELL Therapies for Cancer in Europe, US, and Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Nice; Medicine; Clinical trial; Lymphoma; Cancer; Oncology; Immunotherapy; Intensive care medicine; Internal medicine","score_opus":0.06356303064571747,"score_gpt":0.37776048199218754,"score_spread":0.31419745134647004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112058853","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17787927,0.063372016,0.011744845,0.08772066,0.0039458266,0.005471693,0.15004249,0.0008643071,0.49895892],"genre_scores_gemma":[0.6488966,0.060508456,0.026712958,0.019356357,0.0008254519,0.0024947464,0.07254766,0.00037766955,0.16828015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98844856,0.0013354506,0.0003311789,0.0004173315,0.007976244,0.0014911012],"domain_scores_gemma":[0.9832903,0.0012599125,0.0007285527,0.00015905368,0.011935064,0.0026270968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011325858,0.0007116327,0.0007403684,0.0036751148,0.0016796867,0.0043649506,0.0015757775,0.0017404841,0.0058679027],"category_scores_gemma":[0.013179651,0.00031699036,0.001653355,0.0037553012,0.00078725367,0.00068271987,0.00113155,0.0014899501,0.0010327538],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059750434,0.00073153776,0.10060061,0.0026119405,0.00088899815,0.0005550389,0.0004085343,0.01332241,0.0075947065,0.03608696,0.3905024,0.44072175],"study_design_scores_gemma":[0.0006064654,0.0018132953,0.19617978,0.0018467904,0.00076654536,0.0002414629,0.00077797397,0.0055903336,0.006505006,0.0022230407,0.78332055,0.00012880993],"about_ca_topic_score_codex":0.9414508,"about_ca_topic_score_gemma":0.9376905,"teacher_disagreement_score":0.06188728,"about_ca_system_score_codex":0.06188728,"about_ca_system_score_gemma":0.23955463,"threshold_uncertainty_score":0.44902575},"labels":[],"label_agreement":null},{"id":"W3112066415","doi":"10.1016/j.jval.2020.08.260","title":"PCN123 5-Year Health Care Costs of Sepsis in Cancer Patients: Results from a Population-Based Case-Control Matched Cohort","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Sepsis; Cohort; Population; Cancer; Cancer registry; Health care; Emergency medicine; Cohort study; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.2273304204467554,"score_gpt":0.39825146497253205,"score_spread":0.17092104452577667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112066415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997113,0.00014601988,0.00011240806,0.000019929137,0.00001095638,0.000016407022,0.0022055896,0.0000044791045,0.00037122724],"genre_scores_gemma":[0.9962902,0.000111575035,0.000067937515,0.000017549408,0.000014539455,0.00002238889,0.0031038737,0.0000031209468,0.0003688853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933654,0.00018588053,0.00005655072,0.00017609156,0.00013322814,0.00011173075],"domain_scores_gemma":[0.9991436,0.00018190002,0.00026309342,0.0001340932,0.00014529134,0.00013200911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074000895,0.00048818023,0.0005154435,0.0018636439,0.000591802,0.00086173165,0.0006763738,0.00075703824,0.002314983],"category_scores_gemma":[0.0023493827,0.0005451893,0.001563886,0.002023864,0.00025239625,0.00061251054,0.0005453138,0.0007521244,0.00032895914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028413362,0.0002754264,0.9931451,0.00002326109,0.00071376504,0.00019048832,0.000044222357,0.00024972163,0.0002544935,0.000039706687,0.0004491762,0.0017732376],"study_design_scores_gemma":[0.00008213082,0.00021581029,0.9986399,0.0000033126223,0.00020549993,0.00017267029,0.000084098865,0.00036907478,0.000055270957,0.000017802395,0.00014676267,0.000007798949],"about_ca_topic_score_codex":0.036365893,"about_ca_topic_score_gemma":0.019794492,"teacher_disagreement_score":0.036365893,"about_ca_system_score_codex":0.00071562827,"about_ca_system_score_gemma":0.0004813695,"threshold_uncertainty_score":0.07230842},"labels":[],"label_agreement":null},{"id":"W3112088125","doi":"10.1016/j.jval.2020.08.066","title":"PA1 Different Levels of Care for Follow-up of Adults with Congenital Heart Disease","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Disease; Heart disease; Population; Internal medicine; Medical care; Emergency medicine; Pediatrics; Cardiology","score_opus":0.05046567629784095,"score_gpt":0.3103802315755243,"score_spread":0.25991455527768337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112088125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909691,0.00187903,0.00017048401,0.00079693104,0.00005146519,0.000038346006,0.0017923871,0.0000043534906,0.004297823],"genre_scores_gemma":[0.99799335,0.00029064383,0.000116256255,0.00020983182,0.000029185889,0.000037849863,0.0008180562,0.0000021711471,0.0005027793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965449,0.0015225302,0.00039881334,0.00042072596,0.00042249452,0.00069054286],"domain_scores_gemma":[0.9952976,0.0015220334,0.0015295774,0.00027604232,0.00055843825,0.0008162236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00169716,0.0002611582,0.00037970368,0.0012758505,0.00096857554,0.0011835248,0.0007615613,0.0009370115,0.0035451103],"category_scores_gemma":[0.01603038,0.0001984864,0.0013992365,0.0018487031,0.00033121326,0.0012041935,0.001256919,0.0013442272,0.0002500477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041432393,0.00020201338,0.9898824,0.000060298815,0.00026240037,0.00006734329,0.00037972996,0.000056403187,0.00007547063,0.0002602777,0.0005484296,0.007790847],"study_design_scores_gemma":[0.000029100614,0.00025535733,0.99782383,0.00006729942,0.00013609022,0.000063217485,0.0008330584,0.000088867266,0.000055571207,0.0000856094,0.00055663317,0.000005345151],"about_ca_topic_score_codex":0.049602162,"about_ca_topic_score_gemma":0.06932978,"teacher_disagreement_score":0.049602162,"about_ca_system_score_codex":0.0012815697,"about_ca_system_score_gemma":0.0014726095,"threshold_uncertainty_score":0.09862685},"labels":[],"label_agreement":null},{"id":"W3112194058","doi":"10.1016/j.jval.2020.08.1858","title":"PRO122 Challenges in Defining the Burden of RARE Diseases: A Literature Review of Dravet Syndrome","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Dravet syndrome; Medicine; Disease burden; MEDLINE; Burden of disease; Caregiver burden; Cohort; Disease; Pediatrics; Psychiatry; Gerontology; Intensive care medicine; Epilepsy; Pathology","score_opus":0.11650596238733464,"score_gpt":0.4054315794879144,"score_spread":0.2889256171005798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112194058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000079993515,0.99887556,0.000055235516,0.0006382537,0.00011554251,0.00000205181,0.000024773533,0.0000022715387,0.00020639779],"genre_scores_gemma":[0.000672875,0.9985447,0.00013724895,0.0003515854,0.00021099068,0.000003077843,0.000023715384,7.8089175e-7,0.00005501942],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99897987,0.00024596904,0.00031255485,0.00012514558,0.00029399135,0.000042376094],"domain_scores_gemma":[0.99450994,0.003968034,0.00068908476,0.0000565193,0.00064882566,0.00012754204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021567098,0.0007242747,0.002186836,0.005677559,0.0003470941,0.0020622588,0.00095725927,0.0014344634,0.0035104158],"category_scores_gemma":[0.0064594736,0.0003230799,0.0011656953,0.0054537295,0.00063938764,0.0023549462,0.0011729018,0.0015013776,0.0006041402],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107752916,0.00003652275,0.0011166943,0.089993276,0.00055714743,0.0004299892,0.00018823975,0.00023432622,0.00044801965,0.0040371907,0.026483085,0.87636775],"study_design_scores_gemma":[0.000061309154,0.00014218014,0.006629734,0.14132361,0.002625143,0.0050713005,0.0006367333,0.00029069823,0.00030442985,0.0054378924,0.8373835,0.000093468545],"about_ca_topic_score_codex":0.0029634626,"about_ca_topic_score_gemma":0.006431853,"teacher_disagreement_score":0.005677559,"about_ca_system_score_codex":0.0009632279,"about_ca_system_score_gemma":0.0035019272,"threshold_uncertainty_score":0.011743486},"labels":[],"label_agreement":null},{"id":"W3112223458","doi":"10.1016/j.jval.2020.08.643","title":"PDB46 The Utilisation and Switching Rates of Neutral Protamine Hagedorn (NPH) Insulin and Long-acting Insulin Analogs in Patients with Type 2 Diabetes in the United Kingdom","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"NPH insulin; Medicine; Insulin detemir; Insulin glargine; Insulin; Type 2 diabetes; Internal medicine; Hazard ratio; Cohort; Diabetes mellitus; Protamine; Retrospective cohort study; Endocrinology; Pediatrics; Confidence interval","score_opus":0.07732936425646522,"score_gpt":0.3193085223512552,"score_spread":0.24197915809478995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112223458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975848,0.00120416,0.000031836527,0.000091366805,0.0000098962455,0.0000032321154,0.0005394411,0.0000028400414,0.0005324344],"genre_scores_gemma":[0.9989065,0.00037437078,0.000035224915,0.000073068026,0.0000060789725,0.0000024720784,0.00031629647,0.0000025221464,0.00028350303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992756,0.00020908083,0.0001380903,0.00012350635,0.0001288365,0.00012480382],"domain_scores_gemma":[0.9977197,0.00061007024,0.0010357514,0.00007242543,0.00028824084,0.00027382487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003511283,0.00021401852,0.00049085316,0.0005665681,0.00024627981,0.0009884608,0.00029488347,0.00063681515,0.0022125063],"category_scores_gemma":[0.0030048972,0.00025290163,0.0006418151,0.0012168011,0.00026616277,0.00048270109,0.00042721015,0.00064970844,0.0003319514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001208505,0.000026094098,0.9927321,0.000047062014,0.00007158997,0.00030296182,0.00027409213,0.00008358939,0.0004319104,0.000031198753,0.00019878974,0.004592165],"study_design_scores_gemma":[0.00001611612,0.00018201131,0.99833715,0.000019942227,0.000034377874,0.00045600178,0.0003930108,0.00013707837,0.000099816265,0.000009406791,0.00030688188,0.000008220005],"about_ca_topic_score_codex":0.046663232,"about_ca_topic_score_gemma":0.033417784,"teacher_disagreement_score":0.046663232,"about_ca_system_score_codex":0.0015105229,"about_ca_system_score_gemma":0.00045128656,"threshold_uncertainty_score":0.09278321},"labels":[],"label_agreement":null},{"id":"W3112228448","doi":"10.1016/j.jval.2020.08.580","title":"PCV89 Risk-Based Treatment Improves Survival in Higher-Risk NON-ST Elevation ACUTE Coronary Syndrome (NSTE-ACS) Patients","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; Kwantlen Polytechnic University","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Cardiac catheterization; Odds ratio; Population; Retrospective cohort study; Revascularization; Cardiology; Myocardial infarction","score_opus":0.047892617782398235,"score_gpt":0.30106399890336355,"score_spread":0.2531713811209653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112228448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97795814,0.009786871,0.0005476188,0.0017777814,0.00039680908,0.00010188879,0.0007013073,0.000106210304,0.008623336],"genre_scores_gemma":[0.9953815,0.0018286341,0.0003213219,0.0005918779,0.0002606334,0.000024997536,0.00074833614,0.000010877188,0.0008319288],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9997441,0.00006311274,0.000020454134,0.00004572109,0.00005850572,0.0000680175],"domain_scores_gemma":[0.9995912,0.00010478091,0.00009878775,0.000024590334,0.000045044224,0.00013569852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020766181,0.00024631128,0.00065330823,0.00022837818,0.00017246742,0.0007578676,0.00030429923,0.00037648404,0.003306757],"category_scores_gemma":[0.0017671536,0.00010289488,0.00055987685,0.00025429673,0.00015032281,0.0003390006,0.0002698661,0.0010204469,0.00046847676],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043032,0.0048750034,0.23518299,0.00052332284,0.0016936816,0.0003152605,0.00013242346,0.001909574,0.00480011,0.0011703176,0.024208223,0.68215716],"study_design_scores_gemma":[0.008644906,0.016603498,0.9423193,0.0004862173,0.001957711,0.0011466305,0.0003861156,0.006588387,0.0023330853,0.003286068,0.016175319,0.00007277693],"about_ca_topic_score_codex":0.0015975458,"about_ca_topic_score_gemma":0.0028400375,"teacher_disagreement_score":0.003306757,"about_ca_system_score_codex":0.0003448683,"about_ca_system_score_gemma":0.0005376347,"threshold_uncertainty_score":0.011062145},"labels":[],"label_agreement":null},{"id":"W3112327018","doi":"10.1016/j.jval.2020.08.462","title":"PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Adverse effect; Refractory (planetary science); Population; Progressive disease; Oncology; Disease; Diffuse large B-cell lymphoma; Lymphoma; Environmental health","score_opus":0.05595646326215171,"score_gpt":0.3238289691381307,"score_spread":0.267872505875979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112327018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363965,0.0030011395,0.00017464945,0.00076790265,0.000054246626,0.00039058283,0.0005936456,0.000037896552,0.0013402875],"genre_scores_gemma":[0.9943709,0.001906936,0.00046977308,0.0005767115,0.00008962758,0.00037059543,0.0010915288,0.00001266963,0.0011112421],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99951077,0.00028342064,0.000017820877,0.000055166325,0.000038523176,0.0000943085],"domain_scores_gemma":[0.99944264,0.00014390323,0.000099223325,0.00003245445,0.000023419976,0.00025825304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017908888,0.0009828855,0.0012326755,0.0003082393,0.00022714319,0.0009504818,0.000596956,0.0009998879,0.0029343867],"category_scores_gemma":[0.0009631554,0.00028560642,0.0013451403,0.00026911483,0.0011674233,0.0009613603,0.00039645008,0.0027254426,0.00050484744],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.76967466,0.031534873,0.011089626,0.0007504535,0.0023986532,0.0002536294,0.00023147724,0.0032402454,0.01611818,0.00055729254,0.0037145645,0.1604364],"study_design_scores_gemma":[0.5965683,0.36550856,0.026446918,0.00010602176,0.0014112684,0.0003113723,0.00016057202,0.0024917992,0.002622324,0.0005834847,0.0037436336,0.00004580123],"about_ca_topic_score_codex":0.0010144323,"about_ca_topic_score_gemma":0.002705084,"teacher_disagreement_score":0.0029343867,"about_ca_system_score_codex":0.0010507075,"about_ca_system_score_gemma":0.0007821729,"threshold_uncertainty_score":0.009816527},"labels":[],"label_agreement":null},{"id":"W3112338649","doi":"10.1016/j.jval.2020.08.793","title":"PGI27 Systematic Review and Network Meta-Analysis: Topical Corticosteroids for Inducing Histological Remission in Eosinophilic Oesophagitis","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Eosinophilic esophagitis; Medicine; Budesonide; Fluticasone; Placebo; Internal medicine; Corticosteroid; Meta-analysis; Gastroenterology; Odds ratio; Randomized controlled trial; Eosinophil; Asthma; Pathology; Disease","score_opus":0.1818737944557659,"score_gpt":0.3575367436261121,"score_spread":0.1756629491703462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112338649","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012488918,0.98095953,0.0010440575,0.00090829574,0.0007540208,0.00034152326,0.0024828096,0.00007656341,0.0009442439],"genre_scores_gemma":[0.6619291,0.32383603,0.0033925392,0.0047115167,0.0014046988,0.0010615344,0.002203114,0.00012943412,0.0013319488],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9805608,0.012301495,0.003081883,0.002188684,0.0012572871,0.00060988124],"domain_scores_gemma":[0.9720491,0.021247955,0.0036294563,0.0012911226,0.001342409,0.00043987823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013277092,0.0028830266,0.014315684,0.0036422438,0.00072791864,0.0032977723,0.0022035502,0.003245644,0.008925537],"category_scores_gemma":[0.052286413,0.0015636716,0.037875168,0.0049189357,0.0011192961,0.0019000852,0.0028340842,0.0033753836,0.00077049655],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005985196,0.000022579277,0.0045028105,0.12735759,0.85239166,0.00009296138,0.00005963696,0.00027092252,0.00019797501,0.00010735114,0.00131043,0.0077008335],"study_design_scores_gemma":[0.0031085743,0.0001873947,0.0046318327,0.0064323256,0.9838208,0.000058807876,0.000027199994,0.00013035047,0.000049109585,0.00020692084,0.0013248295,0.000021831915],"about_ca_topic_score_codex":0.01042236,"about_ca_topic_score_gemma":0.020455876,"teacher_disagreement_score":0.014315684,"about_ca_system_score_codex":0.0021108466,"about_ca_system_score_gemma":0.0029291292,"threshold_uncertainty_score":0.070216835},"labels":[],"label_agreement":null},{"id":"W3112404269","doi":"10.1016/j.jval.2020.08.173","title":"PCN36 Systematic Review of Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC) with DNA Damage Repair Gene Mutation (DDRm)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Olaparib; Oncology; Internal medicine; Clinical trial; Taxane; Pembrolizumab; Prostate cancer; Cancer; Breast cancer; Immunotherapy","score_opus":0.08304421118659776,"score_gpt":0.3717929691983274,"score_spread":0.2887487580117296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112404269","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011476456,0.9968233,0.00012978143,0.00021186571,0.00013162107,0.00017192723,0.00090125616,0.000009602325,0.00047299222],"genre_scores_gemma":[0.030903367,0.96614355,0.0006240035,0.0010255057,0.000097414995,0.00027496676,0.0005866423,0.000010997559,0.00033349832],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961384,0.0014227977,0.001392868,0.0003906974,0.0005198115,0.00013539444],"domain_scores_gemma":[0.99401516,0.0035731324,0.0016220706,0.00012994107,0.0005312571,0.00012850278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034238135,0.0009980648,0.0065736626,0.004422006,0.0004023753,0.0015716143,0.0010381542,0.0010044455,0.0058593415],"category_scores_gemma":[0.015172026,0.00070596987,0.00988627,0.0053084623,0.00057487574,0.0009344549,0.0011330276,0.0011897399,0.0003767756],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011501138,0.00002131356,0.0010589996,0.8977883,0.05076013,0.000075004566,0.00010289511,0.00024730567,0.0004568752,0.00019353056,0.003054212,0.04509129],"study_design_scores_gemma":[0.0023756537,0.0007478686,0.012003852,0.5573064,0.37586015,0.00040562084,0.00015360948,0.0001555345,0.0003452884,0.0004969001,0.05007017,0.00007898381],"about_ca_topic_score_codex":0.020485295,"about_ca_topic_score_gemma":0.071705714,"teacher_disagreement_score":0.020485295,"about_ca_system_score_codex":0.00287717,"about_ca_system_score_gemma":0.0058802688,"threshold_uncertainty_score":0.040732086},"labels":[],"label_agreement":null},{"id":"W3112452857","doi":"10.1016/j.jval.2020.08.988","title":"PIN147 Geography Variations in Antibiotic Use RATE: Evidence from 8,026 Primary Clinics in Taiwan","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Medicine; Antibiotics; Urbanization; Quarter (Canadian coin); Population; Medical insurance; Demography; Family medicine; Geography; Environmental health; Business; Nursing; Actuarial science","score_opus":0.057126501757598945,"score_gpt":0.2906207310753689,"score_spread":0.23349422931776995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112452857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997813,0.0005480781,0.000075210046,0.00011622073,0.0000060439565,0.000013662495,0.00065334304,0.0000028451427,0.00077144644],"genre_scores_gemma":[0.9992723,0.00018448371,0.000049650796,0.000066391774,0.000005913085,0.000014653824,0.00029118732,0.0000022769857,0.000113179245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980519,0.0006408957,0.00033292858,0.00039208453,0.00022085001,0.00036139108],"domain_scores_gemma":[0.994068,0.0014376845,0.0028809758,0.00038417403,0.0006055823,0.0006235073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001015505,0.00029045864,0.0004065549,0.001983322,0.00055167964,0.0011695755,0.00069044146,0.00058286224,0.0026128874],"category_scores_gemma":[0.0054702004,0.0004101252,0.0009890364,0.0044502574,0.0006557629,0.0006999116,0.0012405862,0.00051993685,0.00031187726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003421058,0.000020651198,0.99856454,0.000027410859,0.00010029402,0.00007588618,0.00025313153,0.000019868663,0.000038839124,0.000016831244,0.000059433973,0.0007890052],"study_design_scores_gemma":[0.0000063214834,0.00003799573,0.99857056,0.000024822575,0.000072805604,0.000082226295,0.0009659951,0.000070327515,0.000022373506,0.000015927331,0.00012726836,0.0000033596173],"about_ca_topic_score_codex":0.068920076,"about_ca_topic_score_gemma":0.07849623,"teacher_disagreement_score":0.068920076,"about_ca_system_score_codex":0.0009991346,"about_ca_system_score_gemma":0.0014838227,"threshold_uncertainty_score":0.13703781},"labels":[],"label_agreement":null},{"id":"W3112465969","doi":"10.1016/j.jval.2020.08.1967","title":"PSS5 Cost per Responder Analysis of Latanoprostene Bunod Compared to Prostaglandin Analogs for OPEN-Angle Glaucoma in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Bausch Health (Canada); Health Canada","funders":"","keywords":"Travoprost; Bimatoprost; Latanoprost; Medicine; Glaucoma; Ophthalmology; Intraocular pressure","score_opus":0.4487912280949728,"score_gpt":0.42915609732484056,"score_spread":0.019635130770132236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112465969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.927185,0.009944993,0.0008903725,0.0032656258,0.00020523465,0.0012230346,0.04200607,0.00011590794,0.015163717],"genre_scores_gemma":[0.9877373,0.0018761439,0.00046225023,0.00045618674,0.000041185536,0.00012881438,0.0048758998,0.00002273952,0.0043993415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99682486,0.00088660733,0.00024309031,0.00022059112,0.0010000645,0.00082478696],"domain_scores_gemma":[0.99538356,0.0012255609,0.0006508802,0.00008959172,0.0017925268,0.0008577906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019249226,0.00060397125,0.0017091394,0.0017211926,0.0008446094,0.0014880083,0.0014721362,0.00071592326,0.008649263],"category_scores_gemma":[0.008721792,0.00046246863,0.004748419,0.0035314101,0.0005941466,0.0004013163,0.00067763997,0.001161088,0.00029618575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19780761,0.0021794296,0.32287174,0.007283326,0.016454969,0.0011492796,0.00069594214,0.1610353,0.0022506933,0.010970023,0.061533347,0.21576832],"study_design_scores_gemma":[0.028120244,0.013975827,0.8092328,0.0014923871,0.014826074,0.0005241782,0.0027910857,0.104139216,0.0020864583,0.0015127744,0.020960247,0.00033871373],"about_ca_topic_score_codex":0.9857922,"about_ca_topic_score_gemma":0.98166335,"teacher_disagreement_score":0.07709917,"about_ca_system_score_codex":0.07709917,"about_ca_system_score_gemma":0.07633042,"threshold_uncertainty_score":0.55939627},"labels":[],"label_agreement":null},{"id":"W3112507268","doi":"10.1016/j.jval.2020.08.1234","title":"PMU22 Cost of Inotersen and Patisiran for the Treatment of Adults with Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Canada, Germany, and Italy","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Polyneuropathy; Amyloidosis; Medicine; Amyloid polyneuropathy; Pediatrics; Internal medicine; Disease; Age of onset","score_opus":0.015310756377109052,"score_gpt":0.23101841232887085,"score_spread":0.2157076559517618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112507268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90378636,0.026559886,0.0003311046,0.016850818,0.00066645176,0.00039645663,0.008631155,0.00016682665,0.042610995],"genre_scores_gemma":[0.97748524,0.007154367,0.00054667343,0.0027811497,0.00059533445,0.00017513687,0.0038003733,0.000028089244,0.0074336412],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996617,0.00007351168,0.000020090094,0.000032850847,0.00008388278,0.00012787741],"domain_scores_gemma":[0.999199,0.000058638558,0.00008261818,0.000015678423,0.000054113392,0.0005899879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024008917,0.00025734212,0.000353625,0.0004624539,0.0003686009,0.00051142776,0.00031333222,0.0005017347,0.0061608083],"category_scores_gemma":[0.00090935174,0.00011401122,0.00051612785,0.0006439065,0.00036140464,0.00016477295,0.00042125952,0.000787371,0.0006005533],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04383677,0.00362712,0.25542173,0.0010670794,0.0015926404,0.004976107,0.00024316301,0.003437645,0.005316852,0.0031478636,0.13217586,0.54515725],"study_design_scores_gemma":[0.008547808,0.006975546,0.9003995,0.00066214136,0.00088603894,0.004568741,0.00027039702,0.0020734814,0.00072933495,0.00046901926,0.07435592,0.00006201901],"about_ca_topic_score_codex":0.09837044,"about_ca_topic_score_gemma":0.1502615,"teacher_disagreement_score":0.90162957,"about_ca_system_score_codex":0.003994207,"about_ca_system_score_gemma":0.0050695087,"threshold_uncertainty_score":0.19559568},"labels":[],"label_agreement":null},{"id":"W3112510814","doi":"10.1016/j.jval.2020.08.259","title":"PCN122 Cost-Effectiveness of Brentuximab Vedotin for the Frontline Treatment of Peripheral T-Cell Lymphomas in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Medicine; CHOP; Vincristine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; Population; Prednisone; Lymphoma; CD30; Cyclophosphamide; Chemotherapy; Environmental health","score_opus":0.09055864429809313,"score_gpt":0.34746410205941075,"score_spread":0.2569054577613176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112510814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94067484,0.018830417,0.00043405106,0.00844406,0.00022178232,0.00026847745,0.010255008,0.000086910695,0.02078451],"genre_scores_gemma":[0.99175406,0.0030068785,0.0003204689,0.0005022912,0.000042963442,0.000025085319,0.0019067669,0.00001372173,0.0024277682],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992587,0.0001289211,0.000035755744,0.00006707802,0.00025651083,0.0002530933],"domain_scores_gemma":[0.9983504,0.00020410908,0.0001902796,0.000022021213,0.000605718,0.0006274295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005076668,0.00028347634,0.00056496036,0.00055890036,0.0005253209,0.0013680141,0.0007779044,0.00043294195,0.004476994],"category_scores_gemma":[0.00258237,0.0001633653,0.00078450073,0.0010476685,0.0003576603,0.00029634338,0.0003211618,0.0008346201,0.00020061032],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055962782,0.0018722499,0.26808152,0.0018554357,0.0023796894,0.0012851198,0.0003981968,0.04728764,0.005541482,0.0070214164,0.07473371,0.53358084],"study_design_scores_gemma":[0.007078694,0.0062053176,0.88996375,0.00078498013,0.0036438133,0.0010840488,0.0013399229,0.039257705,0.0025484683,0.0009536494,0.046977345,0.00016234613],"about_ca_topic_score_codex":0.96354616,"about_ca_topic_score_gemma":0.9779733,"teacher_disagreement_score":0.054118533,"about_ca_system_score_codex":0.054118533,"about_ca_system_score_gemma":0.03936168,"threshold_uncertainty_score":0.39265925},"labels":[],"label_agreement":null},{"id":"W3112950326","doi":"10.1016/j.jval.2020.08.1390","title":"PND65 Assessing Knowledge and Perceptions Towards People with Alzheimer'S Disease Among Employees of a Pharmaceutical Company (CONOCE STUDY)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Checklist; Psychology; Beck Depression Inventory; Bachelor; Perception; Disease; Dementia; Scale (ratio); Intervention (counseling); Medicine; Depression (economics); Gerontology; Clinical psychology; Family medicine; Psychiatry; Anxiety","score_opus":0.2837333545752284,"score_gpt":0.5065411783051593,"score_spread":0.2228078237299309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112950326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828976,0.00006007451,0.000035419296,0.000053810352,0.000007720465,0.000082229126,0.00030913847,0.0000018047318,0.0011601236],"genre_scores_gemma":[0.99717194,0.00011880211,0.00017897625,0.000146891,0.000013652051,0.0001216345,0.00054051116,0.000002099382,0.0017054206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982797,0.00043459123,0.00030119825,0.00013477744,0.00054376514,0.00030602285],"domain_scores_gemma":[0.99387664,0.0009863682,0.001979334,0.0002796171,0.0013044757,0.0015735851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029766369,0.00042881872,0.00055586867,0.0014754892,0.0014461605,0.0018075119,0.0006948993,0.0010788424,0.0019069823],"category_scores_gemma":[0.005730888,0.00064154173,0.001259492,0.0013276101,0.00045416286,0.0011105674,0.0019798279,0.0014521726,0.0008197044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016822467,0.0011853328,0.99280035,0.000037156333,0.000064748114,0.00007212113,0.0018629078,0.000022865739,0.0001970076,0.000015126812,0.00013969372,0.0034345088],"study_design_scores_gemma":[0.000028849792,0.0008689239,0.99466753,0.000023024892,0.000047071047,0.00008178719,0.0036139605,0.00005863508,0.00010681517,0.0000165113,0.0004785649,0.000008268598],"about_ca_topic_score_codex":0.033706464,"about_ca_topic_score_gemma":0.044543877,"teacher_disagreement_score":0.033706464,"about_ca_system_score_codex":0.0010107644,"about_ca_system_score_gemma":0.0016566851,"threshold_uncertainty_score":0.067020535},"labels":[],"label_agreement":null},{"id":"W3112951039","doi":"10.1016/j.jval.2020.08.1027","title":"PIT6 Risk Factors and Incidence Following an INDEX HIP Fracture in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hip fracture; Incidence (geometry); Arthroplasty; Observational study; Population; Cohort; Retrospective cohort study; Cohort study; Multivariate analysis; Surgery; Internal medicine; Osteoporosis","score_opus":0.03170036156280356,"score_gpt":0.2801966250568596,"score_spread":0.24849626349405604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112951039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688766,0.002920369,0.00018774369,0.0020423026,0.00008668468,0.000088327564,0.014427368,0.00003256099,0.011337926],"genre_scores_gemma":[0.990936,0.0015864683,0.0002043768,0.00023071785,0.000026413249,0.00002225583,0.002710886,0.0000110734,0.0042717583],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912804,0.00004437097,0.00007808333,0.00008524715,0.00034519468,0.00031901003],"domain_scores_gemma":[0.9969752,0.000102789665,0.0006803897,0.000056990953,0.0012717275,0.0009129255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034746536,0.00028273647,0.00047234737,0.0014540019,0.0029164182,0.0014605159,0.0014052225,0.00080654386,0.0044263685],"category_scores_gemma":[0.002322694,0.00050808775,0.00096989097,0.004405832,0.00062388874,0.00036514035,0.0008515461,0.0012223485,0.00036976655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000103388964,0.00004724927,0.9929281,0.000058839465,0.00006736591,0.00014365106,0.00040948356,0.0001203126,0.00008873452,0.00016069449,0.0025546562,0.0033176239],"study_design_scores_gemma":[0.000016013177,0.000020747726,0.9969439,0.00006484397,0.000032394553,0.00008432282,0.0010184672,0.00021234651,0.000025551017,0.000032044947,0.0015378839,0.000011532088],"about_ca_topic_score_codex":0.99707484,"about_ca_topic_score_gemma":0.9984365,"teacher_disagreement_score":0.028739769,"about_ca_system_score_codex":0.028739769,"about_ca_system_score_gemma":0.04113231,"threshold_uncertainty_score":0.20852256},"labels":[],"label_agreement":null},{"id":"W3112969174","doi":"10.1016/j.jval.2020.08.501","title":"PCV10 Comparative Effectiveness and Safety of Low Dose of ORAL Anticoagulant in Patients with NON-Valvular Atrial Fibrillation","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Apixaban; Atrial fibrillation; Warfarin; Internal medicine; Rivaroxaban; Dabigatran; Hazard ratio; Cohort; Propensity score matching; Stroke (engine); Population; Myocardial infarction; Proportional hazards model; Cardiology; Confidence interval","score_opus":0.06871258715731554,"score_gpt":0.3451663734047593,"score_spread":0.27645378624744377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112969174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846407,0.011507553,0.00019743592,0.00041196184,0.00028104582,0.000100437115,0.00051177246,0.000009591415,0.0023395708],"genre_scores_gemma":[0.9963953,0.0017159923,0.00017645203,0.00032057977,0.00028365117,0.000048332455,0.000570588,0.0000032717458,0.00048587171],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979804,0.0012102765,0.00017618194,0.00025017592,0.00016176757,0.00022121615],"domain_scores_gemma":[0.9942648,0.0038788994,0.0007313465,0.0002565591,0.0001858711,0.00068255956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020722463,0.00054692826,0.0016996129,0.0004508873,0.00016781651,0.0014240838,0.00063499814,0.0010773476,0.0052790577],"category_scores_gemma":[0.0058967625,0.00025794294,0.0027179385,0.00048896443,0.00069851486,0.0012467917,0.00044116715,0.001895467,0.00031552112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9129928,0.0021988587,0.026741585,0.0009883113,0.006034421,0.00011730303,0.00008644889,0.0007418533,0.0013560831,0.00039186256,0.0005643071,0.047786154],"study_design_scores_gemma":[0.37016082,0.3391706,0.25591484,0.0008513551,0.018414535,0.0006986593,0.0006631264,0.0051951,0.0023665528,0.0019226556,0.004452816,0.00018894635],"about_ca_topic_score_codex":0.0012402849,"about_ca_topic_score_gemma":0.0023334469,"teacher_disagreement_score":0.0052790577,"about_ca_system_score_codex":0.00095253566,"about_ca_system_score_gemma":0.0008143775,"threshold_uncertainty_score":0.0176602},"labels":[],"label_agreement":null},{"id":"W3112969951","doi":"10.1016/j.jval.2020.08.1721","title":"PPM4 Health and Budget IMPACT of Liquid-Based Comprehensive Genomic Profile Testing (CGP) in Advance NON-SMALL CELL LUNG Cancer (ANSCLC) Patients with Insufficient Tissue, Exhausted Tissue Samples and or Insufficient DNA in Tissue Samples","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University Health Network; Princess Margaret Cancer Centre; University of Ottawa; Roche (Canada)","funders":"","keywords":"Medicine; Population; Biopsy; Liquid biopsy; Biomarker; Lung cancer; Health care; Cancer; Oncology; Intensive care medicine; Internal medicine; Pathology; Environmental health; Biology","score_opus":0.03154745500702,"score_gpt":0.29905586956367863,"score_spread":0.26750841455665864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112969951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92527175,0.0023205567,0.0018634251,0.018739892,0.00022022582,0.00012321463,0.024836611,0.00017125346,0.026453001],"genre_scores_gemma":[0.9923523,0.00030096638,0.00072062906,0.0006008591,0.000060910887,0.0000615111,0.0038475392,0.000022174532,0.002033028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976051,0.001184069,0.00012206416,0.00017399748,0.00039603177,0.00051879615],"domain_scores_gemma":[0.9951799,0.0013912318,0.0013153383,0.00014572902,0.00085205596,0.00111588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002160805,0.00026410611,0.00024884217,0.00077051966,0.000359443,0.0013163529,0.0006583498,0.00051790394,0.0136961695],"category_scores_gemma":[0.009276384,0.00018347082,0.0009196054,0.0011353872,0.00040189995,0.00064754573,0.0018476845,0.0006054917,0.0007741975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060030427,0.00036388962,0.8148729,0.00029977164,0.00048636633,0.00045552925,0.00015948607,0.0151585685,0.0014992536,0.0033709537,0.018513532,0.13881674],"study_design_scores_gemma":[0.00033246793,0.0017842306,0.9535916,0.00028148232,0.0004848254,0.00052569463,0.001016071,0.015230974,0.0016973199,0.0026645113,0.022344131,0.00004666793],"about_ca_topic_score_codex":0.047865387,"about_ca_topic_score_gemma":0.03726379,"teacher_disagreement_score":0.047865387,"about_ca_system_score_codex":0.0051649273,"about_ca_system_score_gemma":0.0056122877,"threshold_uncertainty_score":0.09517354},"labels":[],"label_agreement":null},{"id":"W3113059643","doi":"10.1016/j.jval.2020.08.691","title":"PDG8 A Chart Review Study of Dry Eye Disease Symptoms and Treatment Patterns Among Patients Receiving Lifitegrast in the United States and Canada","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Blurred vision; Medical prescription; Depression (economics); Demographics; Internal medicine; Pediatrics; Surgery; Demography","score_opus":0.037948362591216575,"score_gpt":0.3171088141172968,"score_spread":0.2791604515260802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113059643","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048046596,0.89641005,0.0001724045,0.0009387475,0.0002505678,0.0008251427,0.048156828,0.000040191757,0.0051594125],"genre_scores_gemma":[0.22199447,0.74812657,0.0014819849,0.001233669,0.00011927569,0.0006257949,0.02435624,0.00001998232,0.002041971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702746,0.00034457442,0.0008503902,0.00035245623,0.0012327898,0.0001924087],"domain_scores_gemma":[0.98761255,0.002136641,0.0031173043,0.00024062934,0.006513184,0.0003796198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021469307,0.000419095,0.001784885,0.008821168,0.00092818233,0.00155784,0.00094553665,0.0004475705,0.002179603],"category_scores_gemma":[0.010841159,0.00030755418,0.0019479934,0.020945966,0.00045266325,0.00051774376,0.00062362006,0.0005023027,0.00022773714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010622019,0.00015870343,0.44124994,0.17892744,0.010236151,0.0008309081,0.0013708721,0.0002779766,0.00066236703,0.00073765434,0.08603951,0.2784464],"study_design_scores_gemma":[0.00035125442,0.00015243818,0.84209114,0.06953025,0.011404573,0.0007671173,0.0011467054,0.00017660607,0.00031032405,0.00006542101,0.073914275,0.00008989961],"about_ca_topic_score_codex":0.72598153,"about_ca_topic_score_gemma":0.8384922,"teacher_disagreement_score":0.27401847,"about_ca_system_score_codex":0.0085694315,"about_ca_system_score_gemma":0.035443332,"threshold_uncertainty_score":0.5512644},"labels":[],"label_agreement":null},{"id":"W3113091013","doi":"10.1016/j.jval.2020.08.1918","title":"PRS38 Cost-Effectiveness of Once-Daily Single-Inhaler Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Novartis (Canada)","funders":"","keywords":"Indacaterol; Medicine; Mometasone furoate; Fluticasone propionate; Asthma; Exacerbation; Inhaler; Salmeterol; Fluticasone; Internal medicine; Corticosteroid; Bronchodilator","score_opus":0.0341880804048101,"score_gpt":0.2796605259224613,"score_spread":0.24547244551765124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113091013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856858,0.009488548,0.00016621497,0.0008136391,0.00017281316,0.00017714867,0.001201032,0.000030817017,0.0022638803],"genre_scores_gemma":[0.99771994,0.0009765782,0.00015811554,0.00011555708,0.00008612587,0.00003953929,0.0005721396,0.0000028172842,0.00032908004],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9994036,0.00028639712,0.00006150385,0.00007537852,0.00009678285,0.00007639633],"domain_scores_gemma":[0.99935776,0.00026158695,0.0001620004,0.000026013868,0.000032640964,0.00015996881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090609037,0.0005493909,0.0016726094,0.00041279063,0.00014411812,0.0007680228,0.00038660056,0.0006399616,0.004357998],"category_scores_gemma":[0.0022193643,0.0002532143,0.004429484,0.00048297722,0.00022903453,0.00071290444,0.00036816997,0.001084839,0.00027518964],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71518195,0.0026976513,0.045640543,0.00230237,0.008756718,0.0005476408,0.000087271466,0.010515531,0.0029199654,0.00051879167,0.0026560042,0.20817558],"study_design_scores_gemma":[0.2477143,0.16998382,0.51791227,0.00090036733,0.022838715,0.0015066139,0.00045889616,0.030743131,0.0020279607,0.0010013893,0.0047401907,0.00017228739],"about_ca_topic_score_codex":0.0035947005,"about_ca_topic_score_gemma":0.0037420024,"teacher_disagreement_score":0.004357998,"about_ca_system_score_codex":0.001231471,"about_ca_system_score_gemma":0.0008798988,"threshold_uncertainty_score":0.0145789385},"labels":[],"label_agreement":null},{"id":"W3113101217","doi":"10.1016/j.jval.2020.08.1102","title":"PMH24 Factors Associated with Receiving Integrated Care Among People with Concurrent Opioid Use Disorder and Mental Illness in a Canadian Setting","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; British Columbia Centre on Substance Use","funders":"","keywords":"Medicine; Opioid use disorder; Mental illness; Odds ratio; Mental health; Psychiatry; Confidence interval; Population; Medical prescription; Proxy (statistics); Opioid; Internal medicine; Environmental health; Nursing","score_opus":0.020906964772381593,"score_gpt":0.2651394919507443,"score_spread":0.24423252717836272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113101217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859677,0.0012981556,0.0000794058,0.0019659405,0.000072838855,0.000121507386,0.003990228,0.00000984781,0.0064945053],"genre_scores_gemma":[0.996976,0.0005350474,0.00017944914,0.00045776882,0.000035708064,0.00003508978,0.00095992367,0.000004930944,0.00081610354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750596,0.00020524331,0.00017461235,0.00023500132,0.00070141174,0.0011777778],"domain_scores_gemma":[0.99501365,0.00025387583,0.0011416685,0.00008176971,0.0015677925,0.0019411141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007998846,0.00046184857,0.00057809177,0.001665844,0.004268988,0.0024093038,0.0023327887,0.0009823982,0.006234738],"category_scores_gemma":[0.004851569,0.0005132254,0.0016536319,0.0049232603,0.0008329457,0.0007010224,0.001812852,0.002565402,0.00021020552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053478394,0.00010473088,0.995195,0.000034353445,0.00007675395,0.00009561462,0.00053093734,0.000055419518,0.000036448513,0.000116624,0.0013726807,0.00232809],"study_design_scores_gemma":[0.000009791022,0.000028658851,0.99622166,0.000080753445,0.00004150731,0.00008011837,0.0025951907,0.00014560123,0.000012513441,0.000027348007,0.00074408745,0.000012734195],"about_ca_topic_score_codex":0.98628914,"about_ca_topic_score_gemma":0.9916971,"teacher_disagreement_score":0.027474219,"about_ca_system_score_codex":0.027474219,"about_ca_system_score_gemma":0.044239096,"threshold_uncertainty_score":0.19934034},"labels":[],"label_agreement":null},{"id":"W3113127196","doi":"10.1016/j.jval.2020.08.1769","title":"PRO33 Ravulizumab Reduces Productivity Losses Versus Eculizumab for Treating Atypical Hemolytic Uremic Syndrome: A 'cost Consequence' Analysis in 4 Countries","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Eculizumab; Medicine; Dosing; Population; Atypical hemolytic uremic syndrome; Productivity; Pediatrics; Internal medicine; Immunology; Complement system; Environmental health; Economics; Antibody","score_opus":0.07000402329229,"score_gpt":0.32721898669838995,"score_spread":0.25721496340609995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113127196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723681,0.019941857,0.00098124,0.001228501,0.00008315676,0.00014021553,0.0016092826,0.00003644763,0.0036113486],"genre_scores_gemma":[0.99690056,0.0017622485,0.0003802772,0.0001872621,0.000017063789,0.000034577297,0.00037231148,0.000007131483,0.00033852342],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973015,0.0019228684,0.000094334566,0.00014798708,0.00022653329,0.00030694794],"domain_scores_gemma":[0.9979722,0.0010225545,0.00061833346,0.00009254394,0.00014083556,0.00015361139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023077533,0.0007205328,0.0010407175,0.0012285893,0.00021886636,0.0014190151,0.00045401245,0.0009149135,0.002974078],"category_scores_gemma":[0.004381688,0.00043780764,0.0033559387,0.0012577801,0.0006903941,0.00093948544,0.0007315163,0.0011041872,0.00022555029],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26138732,0.0022990932,0.20817134,0.003428402,0.030021545,0.0018652257,0.00039799904,0.05969516,0.0050876555,0.0037280435,0.008475251,0.41544306],"study_design_scores_gemma":[0.033175584,0.077411644,0.78916985,0.0016694603,0.03897927,0.002976451,0.0021498716,0.025384294,0.0054623643,0.0042241253,0.019103063,0.0002939995],"about_ca_topic_score_codex":0.0047688405,"about_ca_topic_score_gemma":0.003779659,"teacher_disagreement_score":0.0047688405,"about_ca_system_score_codex":0.0019075542,"about_ca_system_score_gemma":0.0010430232,"threshold_uncertainty_score":0.013840377},"labels":[],"label_agreement":null},{"id":"W3113130970","doi":"10.1016/j.jval.2020.08.513","title":"PCV22 Trends in Diagnostic Testing Utilization and Expenditures in Patients with NEWLY Diagnosed Paroxysmal Supraventricular Tachycardia in the United States","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Diagnostic test; Stress testing (software); Cohort; Pediatrics; Internal medicine","score_opus":0.04718057191234119,"score_gpt":0.28990666732547565,"score_spread":0.24272609541313445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113130970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98813534,0.0011674812,0.00011786345,0.00071656296,0.000026960373,0.000008075788,0.0070836064,0.000018209692,0.0027259008],"genre_scores_gemma":[0.9950394,0.00073512364,0.00007499284,0.00022887789,0.00003530956,0.000008315667,0.003349409,0.000004344648,0.00052415754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996867,0.00004971655,0.00004820417,0.000071236864,0.000063903586,0.00008033136],"domain_scores_gemma":[0.9984641,0.00024903734,0.0008427549,0.000034401895,0.0001779839,0.00023186284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023212575,0.00016660322,0.0002153363,0.0009536416,0.00019282154,0.0006495503,0.00030073416,0.00049145054,0.0019543003],"category_scores_gemma":[0.0017083926,0.00017716274,0.00054250757,0.0017421982,0.00015705812,0.00056175655,0.00036930645,0.00071241474,0.00020300264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061421386,0.000034646466,0.9956222,0.00001711675,0.000082907434,0.00006484588,0.00003208763,0.00020956897,0.000085672276,0.00008243062,0.0012505918,0.0024565272],"study_design_scores_gemma":[0.000004048978,0.000026310458,0.9985683,0.000014774813,0.000025946412,0.0001648343,0.00015750965,0.00054818945,0.000036107358,0.000031213054,0.00041938352,0.0000033966776],"about_ca_topic_score_codex":0.047283694,"about_ca_topic_score_gemma":0.067912325,"teacher_disagreement_score":0.047283694,"about_ca_system_score_codex":0.00075937127,"about_ca_system_score_gemma":0.00061271194,"threshold_uncertainty_score":0.09401697},"labels":[],"label_agreement":null},{"id":"W3113155387","doi":"10.1016/j.jval.2020.08.225","title":"PCN88 Systematic Literature Review (SLR) of Economic and Healthcare Resource Utilization Evidence in the Treatment of Relapsed or Refractory Large B-Cell Lymphoma (LBCL)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Cochrane Library; Health care; Systematic review; MEDLINE; Database; Family medicine; Internal medicine; Meta-analysis; Political science","score_opus":0.48915247073500495,"score_gpt":0.43620843639404155,"score_spread":0.0529440343409634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113155387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023756127,0.98464453,0.0005225027,0.0018233667,0.0004949673,0.0018873799,0.0064550787,0.000030329396,0.0017663518],"genre_scores_gemma":[0.03367879,0.95265216,0.0027822123,0.003780802,0.00044496678,0.0033910985,0.002567385,0.00003228044,0.0006704093],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9750822,0.009800745,0.010072196,0.0014559403,0.0030517075,0.00053710944],"domain_scores_gemma":[0.9316458,0.04827181,0.012471576,0.0013074563,0.005497947,0.0008053165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019847566,0.0012957661,0.006945009,0.017068774,0.0008158626,0.003500673,0.0017256474,0.002227407,0.01072758],"category_scores_gemma":[0.11328902,0.0009702085,0.011199951,0.013610282,0.00088022836,0.0019890745,0.002994275,0.0016502911,0.0007808324],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008366472,0.00002700457,0.0014178398,0.91498905,0.026101995,0.00010883558,0.00011006516,0.00014958087,0.0001568638,0.0002832678,0.0052445866,0.05057435],"study_design_scores_gemma":[0.0012766873,0.00023578163,0.006353113,0.85767776,0.108314596,0.00024095467,0.0001081944,0.00009300197,0.00014730512,0.00039905784,0.025113812,0.00003963802],"about_ca_topic_score_codex":0.018162623,"about_ca_topic_score_gemma":0.0498971,"teacher_disagreement_score":0.019847566,"about_ca_system_score_codex":0.005873519,"about_ca_system_score_gemma":0.022706358,"threshold_uncertainty_score":0.10496527},"labels":[],"label_agreement":null},{"id":"W3113272092","doi":"10.1016/j.jval.2020.08.500","title":"PCV9 Health IMPACT of Tafamidis in Transthyretin Amyloid Cardiomyopathy Patients: An Analysis from the Attr-ACT and the OPEN-Label Extension Studies","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Cohort; Life expectancy; Population; Environmental health","score_opus":0.07246697400830371,"score_gpt":0.3661639939859637,"score_spread":0.29369701997766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113272092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909484,0.0061792703,0.00016565168,0.00014998188,0.000028615286,0.00007965485,0.0016078036,0.000004783755,0.0008358993],"genre_scores_gemma":[0.99724126,0.0011629007,0.00013088899,0.00009272899,0.000048067956,0.000051190036,0.0010778737,0.0000032652838,0.00019185037],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9970208,0.0017860208,0.000208539,0.00033549967,0.0004003916,0.00024868187],"domain_scores_gemma":[0.9902097,0.0053076986,0.002729026,0.00061234954,0.0005103952,0.00063077774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052752676,0.0006451759,0.001245927,0.0006711339,0.0002956931,0.001069538,0.00037862707,0.0008541706,0.0019440269],"category_scores_gemma":[0.0057727844,0.00023973166,0.0027971696,0.0009967667,0.00063070224,0.0009034631,0.0008700449,0.0012365475,0.00018864505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44712597,0.0023322257,0.43633083,0.0017482138,0.022421898,0.0005002034,0.00050045486,0.0013658709,0.0033080992,0.0005251077,0.001202651,0.08263843],"study_design_scores_gemma":[0.017976856,0.03049678,0.9226097,0.00046038118,0.021754896,0.000501611,0.00041948995,0.0010265803,0.00084137684,0.0006751974,0.0031342406,0.00010298343],"about_ca_topic_score_codex":0.0013503548,"about_ca_topic_score_gemma":0.002258968,"teacher_disagreement_score":0.0052752676,"about_ca_system_score_codex":0.00067451986,"about_ca_system_score_gemma":0.00064412376,"threshold_uncertainty_score":0.02789861},"labels":[],"label_agreement":null},{"id":"W3113325231","doi":"10.1016/j.jval.2020.08.1800","title":"PRO64 Preferences for Hemophilia Treatments in Canada: A General Population Preference-Based Utility Study","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Manitoba; Roche (Canada); Vancouver Coastal Health","funders":"","keywords":"Medicine; Bleed; Clotting factor; Population; Vignette; Pediatrics; Internal medicine; Surgery; Environmental health","score_opus":0.260018410057465,"score_gpt":0.3719096248838227,"score_spread":0.11189121482635767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113325231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99583733,0.00034283177,0.00009117597,0.00021416682,0.000007801398,0.00007423406,0.0018230743,0.000003954589,0.0016053026],"genre_scores_gemma":[0.9968928,0.00032220222,0.00019916729,0.00017151749,0.0000056639137,0.000025571084,0.0013195282,0.000005987171,0.001057536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980337,0.00044533858,0.00013675992,0.0002357141,0.00065508997,0.0004934383],"domain_scores_gemma":[0.99369484,0.0010465059,0.0011081866,0.00027809254,0.0021488043,0.0017235265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016941839,0.00063155335,0.0009574855,0.0013509349,0.0035789574,0.0023176991,0.001514358,0.0010488774,0.0056526726],"category_scores_gemma":[0.00834066,0.0005624863,0.0015711017,0.005350801,0.001424273,0.0008697747,0.0012693482,0.0016781689,0.00039602644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007686474,0.00041088424,0.987793,0.00006396333,0.00026901305,0.00016073127,0.00190119,0.0002672994,0.000117433476,0.00042442387,0.0023232792,0.005500245],"study_design_scores_gemma":[0.00018734389,0.00017972941,0.9931322,0.000050866736,0.00017640463,0.00014723481,0.003549579,0.0011733614,0.000043365377,0.00019358855,0.0011079515,0.00005841864],"about_ca_topic_score_codex":0.9890659,"about_ca_topic_score_gemma":0.9918406,"teacher_disagreement_score":0.031588092,"about_ca_system_score_codex":0.031588092,"about_ca_system_score_gemma":0.022828016,"threshold_uncertainty_score":0.22918874},"labels":[],"label_agreement":null},{"id":"W3113356610","doi":"10.1016/j.jval.2020.08.1327","title":"PND2 Indirect Treatment Comparisons of Apomorphine Sublingual Film Versus Apomorphine Subcutaneous Injection for the on-Demand Treatment of \"Off\" Episodes in Patients with Parkinson's Disease","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Apomorphine; Parkinson's disease; Medicine; Placebo; Rating scale; Internal medicine; Anesthesia; Disease; Psychology; Dopamine; Dopaminergic","score_opus":0.061515354360156434,"score_gpt":0.29896833249471916,"score_spread":0.23745297813456273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113356610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933236,0.0020609843,0.00021506837,0.00012760608,0.00015299929,0.00027694393,0.0004804422,0.000025420117,0.0033368482],"genre_scores_gemma":[0.9964143,0.0007548192,0.00034928124,0.000074624266,0.00009747227,0.0001357709,0.00030072432,0.000006090687,0.0018669409],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9993247,0.00042327322,0.00004108391,0.00007353414,0.000070886366,0.0000666112],"domain_scores_gemma":[0.99910814,0.00030108503,0.00017845097,0.00005773929,0.00005379133,0.00030075846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064514275,0.00077491935,0.0017677416,0.00034749068,0.00019716001,0.0006751547,0.0005183724,0.000613571,0.0074927476],"category_scores_gemma":[0.0011253073,0.0002749177,0.0008396303,0.0002447328,0.0005763252,0.000613881,0.00034334796,0.0012877206,0.00066489866],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9537548,0.0044991574,0.0010978522,0.00031254193,0.00062825065,0.000030850486,0.00003907182,0.00018460701,0.005964674,0.00010701999,0.00031688358,0.033064317],"study_design_scores_gemma":[0.30165195,0.63596416,0.04867835,0.00014094819,0.002482972,0.00015904811,0.0001993885,0.0018222568,0.0065483176,0.00022826694,0.0020657878,0.000058609436],"about_ca_topic_score_codex":0.00181335,"about_ca_topic_score_gemma":0.0045829765,"teacher_disagreement_score":0.0074927476,"about_ca_system_score_codex":0.000696772,"about_ca_system_score_gemma":0.00074661756,"threshold_uncertainty_score":0.02506572},"labels":[],"label_agreement":null},{"id":"W3115006642","doi":"10.1016/j.jval.2020.10.027","title":"Cost-Effectiveness Analysis of Transcatheter Arterial Embolization Techniques for the Treatment of Gastrointestinal Bleeding in the United States","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health; University of Alberta","funders":"","keywords":"Medicine; Confidence interval; Cyanoacrylate; Cost-effectiveness analysis; Surgery; Embolization; Gastrointestinal bleeding; Cost effectiveness; Internal medicine","score_opus":0.17060380702533615,"score_gpt":0.41513460310074934,"score_spread":0.2445307960754132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115006642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00049588014,0.9989134,0.000047570138,0.00012621113,0.000038776143,0.000009491888,0.00011252182,0.000002135136,0.0002539857],"genre_scores_gemma":[0.0083125,0.991084,0.00020266349,0.00013262572,0.000049372506,0.000015344283,0.000118071395,0.0000013254464,0.00008413385],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9993019,0.00022519697,0.00013428109,0.00005781761,0.00024016807,0.000040678606],"domain_scores_gemma":[0.9979456,0.0014709606,0.00033615742,0.000015292419,0.00018681092,0.000045207602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001600703,0.00072878174,0.002835404,0.0033082252,0.000105854786,0.00094776705,0.0008052683,0.0005860315,0.0037554617],"category_scores_gemma":[0.004201623,0.0003033052,0.0036185223,0.0039423103,0.00021803573,0.0005580149,0.00038261857,0.0008162541,0.00022505406],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013994792,0.00011867997,0.0014792755,0.2663149,0.017143643,0.00012275174,0.000044675515,0.0020856287,0.00031371415,0.0021857452,0.0120565705,0.6967349],"study_design_scores_gemma":[0.0036941478,0.002737567,0.05651494,0.36703253,0.20614313,0.002280911,0.000402328,0.0052602408,0.0010426791,0.007334913,0.34733713,0.0002194888],"about_ca_topic_score_codex":0.006130705,"about_ca_topic_score_gemma":0.0108982865,"teacher_disagreement_score":0.006130705,"about_ca_system_score_codex":0.0019089028,"about_ca_system_score_gemma":0.0018406503,"threshold_uncertainty_score":0.013850093},"labels":[],"label_agreement":null},{"id":"W3116189451","doi":"10.1016/j.jval.2020.10.019","title":"Rasch Analysis of Patient- and Parent-Reported Outcome Measures in the International Consortium for Health Outcomes Measurement Standard Set for Cleft Lip and Palate","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cleft Lip and Palate Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Rasch model; Medicine; Patient-reported outcome; Context (archaeology); Nose; Psychosocial; Distress; Polytomous Rasch model; Quality of life (healthcare); Psychometrics; Item response theory; Clinical psychology; Psychology; Psychiatry; Developmental psychology; Nursing; Surgery","score_opus":0.1775950929461954,"score_gpt":0.3945738047265021,"score_spread":0.2169787117803067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116189451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837625,0.00015871538,0.010744282,0.00015011818,0.000059726837,0.00024373815,0.0035349813,0.00017172867,0.0011742723],"genre_scores_gemma":[0.99275804,0.000036927857,0.003016854,0.000021876589,0.00001028066,0.00051692704,0.0031972209,0.000048881724,0.0003929001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97557384,0.015555888,0.0018207153,0.0017736366,0.00427477,0.0010011238],"domain_scores_gemma":[0.943748,0.035173636,0.0065249796,0.006997825,0.006984697,0.00057083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019907057,0.00076580775,0.0012449945,0.0020670178,0.0007901633,0.0012899148,0.0011361701,0.00080064416,0.0014803417],"category_scores_gemma":[0.058996484,0.00029056863,0.002833261,0.0024008215,0.00070173293,0.0008920654,0.0016940073,0.0017355557,0.00042789525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014846992,0.0003159383,0.9679693,0.00008601868,0.0021214425,0.000052580708,0.0007560384,0.0029619231,0.000543848,0.0010288116,0.001949409,0.020729944],"study_design_scores_gemma":[0.00007553666,0.00066596724,0.98824036,0.000024883326,0.00036643364,0.00006783899,0.00038141987,0.008128802,0.00058516127,0.0006670752,0.0007688727,0.000027544644],"about_ca_topic_score_codex":0.014569374,"about_ca_topic_score_gemma":0.0136241475,"teacher_disagreement_score":0.019907057,"about_ca_system_score_codex":0.0014343878,"about_ca_system_score_gemma":0.0021450745,"threshold_uncertainty_score":0.10527986},"labels":[],"label_agreement":null},{"id":"W3120257392","doi":"10.1016/j.jval.2020.10.023","title":"A Patient-Centric Tool to Facilitate Goal Attainment Scaling in Neurogenic Bladder and Bowel Dysfunction: Path to Individualization","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"","keywords":"Goal Attainment Scaling; Thematic analysis; Medicine; Stakeholder; Neurogenic bladder dysfunction; Bowel management; Psychology; MEDLINE; Physical therapy; Rehabilitation; Qualitative research; Internal medicine; Constipation; Urinary bladder","score_opus":0.03472075627906216,"score_gpt":0.2743503460624292,"score_spread":0.23962958978336704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120257392","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46484768,0.0014252987,0.4493305,0.017736055,0.00070790236,0.014406056,0.0039667957,0.005895056,0.04168468],"genre_scores_gemma":[0.35624784,0.0005810745,0.6253361,0.001134295,0.00007053252,0.012790708,0.0012551408,0.00026128427,0.0023229986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97617483,0.017850267,0.002668306,0.0006498587,0.002139077,0.00051765813],"domain_scores_gemma":[0.93909836,0.042573195,0.004653846,0.002869304,0.008889719,0.0019155995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04340919,0.0009951039,0.00068546296,0.003903685,0.00101434,0.002759707,0.001448145,0.0011223177,0.0041136844],"category_scores_gemma":[0.07754922,0.00045384845,0.0013031164,0.0018868211,0.0012464711,0.004508384,0.005191796,0.0022410292,0.0011727214],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006250734,0.0014264053,0.06200944,0.0042026043,0.00016837988,0.00067245215,0.08289372,0.002493393,0.0050487192,0.015316945,0.04382371,0.7813192],"study_design_scores_gemma":[0.0011188872,0.005372741,0.22049883,0.013093999,0.0005848366,0.005442713,0.13633204,0.038258597,0.026397709,0.09646541,0.45498157,0.0014527008],"about_ca_topic_score_codex":0.00049594755,"about_ca_topic_score_gemma":0.0013535518,"teacher_disagreement_score":0.04340919,"about_ca_system_score_codex":0.0018089637,"about_ca_system_score_gemma":0.003813684,"threshold_uncertainty_score":0.22957247},"labels":[],"label_agreement":null},{"id":"W3120408758","doi":"10.1016/j.jval.2020.11.011","title":"Development and Validation of a Hospital Indicator of Activity-Based Costs for Injury Admissions","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; Institut National d'Excellence en Santé et en Services Sociaux; The Quebec Population Health Research Network","funders":"Fonds de Recherche du Québec - Santé; Australian Research Council; Canadian Institutes of Health Research","keywords":"Medical emergency; Computer science; Medicine","score_opus":0.05218566131556476,"score_gpt":0.35302608824998466,"score_spread":0.3008404269344199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120408758","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764483,0.0002070793,0.013578643,0.00025134496,0.00009132197,0.0016942471,0.0027191949,0.00008303533,0.004926684],"genre_scores_gemma":[0.96815914,0.00011267981,0.02460879,0.00011227113,0.000040818722,0.0021889128,0.003665367,0.000045251025,0.0010667599],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9884566,0.005656779,0.0014674513,0.00096139056,0.002983477,0.0004743609],"domain_scores_gemma":[0.95800555,0.019991776,0.0057582483,0.0026044229,0.012650352,0.0009895697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017078783,0.0007674697,0.0007116368,0.0032620868,0.0007515802,0.0025141109,0.0018156153,0.0012009168,0.0015126603],"category_scores_gemma":[0.037591785,0.0004216589,0.0014092046,0.0028713713,0.00076959433,0.0014237739,0.0014705706,0.0012279535,0.00053939706],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083463686,0.0013485992,0.9573802,0.00011615982,0.00031622435,0.000043388285,0.0006615363,0.0014807299,0.001276853,0.00084852055,0.0011291112,0.034564182],"study_design_scores_gemma":[0.00021134154,0.0026719985,0.97693956,0.000092808616,0.00025200823,0.00015017547,0.00082986645,0.01224978,0.002937055,0.0005284458,0.0030979088,0.000038968512],"about_ca_topic_score_codex":0.006817062,"about_ca_topic_score_gemma":0.0067151254,"teacher_disagreement_score":0.017078783,"about_ca_system_score_codex":0.0017587953,"about_ca_system_score_gemma":0.0032233298,"threshold_uncertainty_score":0.090322316},"labels":[],"label_agreement":null},{"id":"W3123064527","doi":"10.1016/s1098-3015(10)70027-9","title":"CA3 A COST-EFFECTIVENESS ANALYSIS OF HEPATITIS C SCREENING AMONG IMMIGRANTS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immigration; Medicine; Virology; Demographic economics; Environmental health; Demography; Political science; Economics; Sociology","score_opus":0.0936129543675355,"score_gpt":0.35785491326516716,"score_spread":0.2642419588976317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123064527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750616,0.006925816,0.0004176399,0.0017389271,0.00008567842,0.0009274296,0.009490594,0.000039471408,0.0053128037],"genre_scores_gemma":[0.9945456,0.001486221,0.00057118665,0.0002990654,0.000019912182,0.00013794535,0.0019214393,0.00000722591,0.0010114006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738675,0.0010454461,0.00015252134,0.00017308994,0.00059475115,0.0006475018],"domain_scores_gemma":[0.9966204,0.0010834828,0.00037521124,0.000086591666,0.0010703913,0.00076389586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023237716,0.00081944035,0.0016216133,0.0014520087,0.0014239949,0.0019436002,0.0012571556,0.0008673803,0.0037132776],"category_scores_gemma":[0.0085870605,0.00043255085,0.003678839,0.0034440218,0.0006501005,0.00039269467,0.0007463102,0.0011324141,0.00012875997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13040163,0.0041969134,0.5190263,0.007128992,0.021188924,0.001372137,0.0007544073,0.13827337,0.0026967896,0.0047241226,0.020408152,0.14982826],"study_design_scores_gemma":[0.02270645,0.010790425,0.8317907,0.0015019195,0.019003252,0.00047911136,0.0023586622,0.09935743,0.0011611641,0.001233865,0.00928523,0.0003317628],"about_ca_topic_score_codex":0.9837421,"about_ca_topic_score_gemma":0.9815198,"teacher_disagreement_score":0.084727384,"about_ca_system_score_codex":0.084727384,"about_ca_system_score_gemma":0.08125176,"threshold_uncertainty_score":0.6147431},"labels":[],"label_agreement":null},{"id":"W3129801150","doi":"10.1016/j.jval.2017.08.764","title":"Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Golimumab; Adalimumab; Secukinumab; BASDAI; Certolizumab pegol; BASFI; Infliximab; Population; Ankylosing spondylitis; Etanercept; Cost effectiveness; Adverse effect; Internal medicine; Disease; Tumor necrosis factor alpha; Environmental health","score_opus":0.08393438153360656,"score_gpt":0.3907806412306049,"score_spread":0.30684625969699836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129801150","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24336068,0.47908315,0.005025313,0.14033522,0.0022422182,0.0010869431,0.035489835,0.00012326498,0.09325327],"genre_scores_gemma":[0.8817942,0.097578086,0.0045813997,0.006046704,0.00070227194,0.00021211602,0.005098687,0.000049192113,0.0039373175],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9921854,0.00303379,0.00043987556,0.00032617123,0.0028206615,0.0011941411],"domain_scores_gemma":[0.99138343,0.0030549162,0.0006447927,0.00011270307,0.0038267476,0.000977417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059190462,0.00151837,0.0025590237,0.004210047,0.00134456,0.004486363,0.0019959954,0.0020444852,0.0065155416],"category_scores_gemma":[0.021316702,0.00061326905,0.0045956476,0.0076228585,0.001150042,0.0011426171,0.0010331445,0.003429847,0.00020535495],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03435083,0.0012361198,0.08640594,0.027367353,0.03995691,0.0016672116,0.0014216428,0.16322634,0.0029418902,0.13047738,0.12398563,0.38696283],"study_design_scores_gemma":[0.019478774,0.005947979,0.4106461,0.035951775,0.086816564,0.0024752503,0.005872041,0.1278754,0.0023022988,0.050437532,0.25057703,0.0016192842],"about_ca_topic_score_codex":0.9557791,"about_ca_topic_score_gemma":0.9594419,"teacher_disagreement_score":0.11350571,"about_ca_system_score_codex":0.11350571,"about_ca_system_score_gemma":0.114875905,"threshold_uncertainty_score":0.82354546},"labels":[],"label_agreement":null},{"id":"W3131215855","doi":"10.1016/j.jval.2018.09.2182","title":"PRM60 - THE BURDEN OF OSTEOPOROSIS IN FOUR LATIN AMERICAN COUNTRIES: BRAZIL, MEXICO, COLOMBIA, AND ARGENTINA.","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Latin Americans; Medicine; Osteoporosis; Environmental health; Demography; Geography; Political science","score_opus":0.04729401005202691,"score_gpt":0.3283814925033479,"score_spread":0.281087482451321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131215855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9537945,0.014716529,0.00017502805,0.00161282,0.00005002591,0.000057538135,0.019768666,0.000029640132,0.009795298],"genre_scores_gemma":[0.99124604,0.003517477,0.00027368602,0.000080075195,0.000019732774,0.000028826244,0.0041103205,0.0000042217735,0.0007196301],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982315,0.000051820385,0.000021232268,0.000026822296,0.000040605613,0.000036333084],"domain_scores_gemma":[0.99959344,0.000048467064,0.00019631725,0.000018149374,0.00008201284,0.00006167401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003816354,0.00021216556,0.00027866018,0.0010470538,0.0002999559,0.0005897352,0.00025789943,0.0002584592,0.0016631078],"category_scores_gemma":[0.0011037535,0.000109475186,0.00026186605,0.002200129,0.00019494638,0.00019242849,0.0005437497,0.00026472125,0.00014329977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016648618,0.000026872018,0.9787248,0.00020075902,0.00011070705,0.00015472363,0.00035897814,0.000107774555,0.00025352457,0.0004176429,0.002014185,0.017463557],"study_design_scores_gemma":[0.000010715434,0.000021804519,0.99590045,0.000071288174,0.0000461024,0.00015260739,0.00064277777,0.000085379215,0.000044012748,0.000064387226,0.0029578903,0.0000026458013],"about_ca_topic_score_codex":0.18394548,"about_ca_topic_score_gemma":0.20727557,"teacher_disagreement_score":0.18394548,"about_ca_system_score_codex":0.0006624341,"about_ca_system_score_gemma":0.000862088,"threshold_uncertainty_score":0.3657496},"labels":[],"label_agreement":null},{"id":"W3131565960","doi":"10.1016/j.jval.2016.03.1598","title":"A Global Economic Model to Assess the Cost Effectiveness of New Treatments for Advanced Breast Cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Lapatinib; Letrozole; Anastrozole; Breast cancer; Context (archaeology); Cost effectiveness; Quality-adjusted life year; Pharmacoeconomics; Oncology; Tamoxifen; Internal medicine; Quality of life (healthcare); Economic evaluation; Cancer; Trastuzumab; Intensive care medicine; Risk analysis (engineering)","score_opus":0.07840256884304636,"score_gpt":0.322367131382007,"score_spread":0.24396456253896065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131565960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87759733,0.004510432,0.024816789,0.015143612,0.00040892552,0.00033207683,0.013651079,0.0002570154,0.063282765],"genre_scores_gemma":[0.9833149,0.0011333075,0.0032994922,0.00029588403,0.000039420513,0.000077211436,0.0017862906,0.000036116835,0.010017388],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992576,0.00024831874,0.00002369464,0.00009075551,0.00008167228,0.00029790692],"domain_scores_gemma":[0.997755,0.0011458942,0.00014105988,0.000050551407,0.0005567768,0.0003507404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019092808,0.0011354559,0.001268475,0.0016843316,0.0015313602,0.0031188694,0.0019618948,0.0021056733,0.005811025],"category_scores_gemma":[0.007047563,0.00069011847,0.0013633969,0.0028767895,0.0017034895,0.0011243407,0.0012130608,0.0021407919,0.00024277711],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017379156,0.00004642278,0.0054426766,0.000037269467,0.00007928119,0.00011921997,0.00003896041,0.97589093,0.00005147907,0.01277107,0.0028796701,0.0024692393],"study_design_scores_gemma":[0.00019704354,0.00007113423,0.0050100978,0.00003634429,0.0001282693,0.000052539708,0.0002796593,0.9849037,0.00007124625,0.006110007,0.0030958692,0.00004420757],"about_ca_topic_score_codex":0.96088976,"about_ca_topic_score_gemma":0.93032867,"teacher_disagreement_score":0.042643297,"about_ca_system_score_codex":0.042643297,"about_ca_system_score_gemma":0.026053268,"threshold_uncertainty_score":0.3094002},"labels":[],"label_agreement":null},{"id":"W3131646276","doi":"10.1016/j.jval.2012.03.483","title":"PMH38 Cost-Effectiveness of Asenapine in the Treatment of Schizophrenia in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Asenapine; Olanzapine; Quetiapine; Medicine; Schizophrenia (object-oriented programming); Psychiatry; Lurasidone; Antipsychotic; Clozapine","score_opus":0.4165838611011524,"score_gpt":0.42392985867867783,"score_spread":0.007345997577525409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131646276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93887806,0.019992597,0.00042958118,0.010592169,0.00026987915,0.0005624737,0.0090645,0.000052640364,0.02015812],"genre_scores_gemma":[0.99266195,0.0039880606,0.00035176944,0.00038422522,0.000059176487,0.000063171,0.0011139056,0.0000056459944,0.0013721351],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986518,0.00055340765,0.000074155825,0.000058534442,0.00041436878,0.00024765823],"domain_scores_gemma":[0.9979455,0.0004551231,0.00025942933,0.000028576836,0.0006463637,0.0006650463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009190448,0.00025922596,0.00079078326,0.000763269,0.00065340905,0.0008224805,0.00067145185,0.00062466285,0.0039023238],"category_scores_gemma":[0.00563437,0.00014634948,0.0013463458,0.0011604545,0.00039342945,0.00031130124,0.00045805037,0.0008770796,0.0000949454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.122170836,0.0026580193,0.1711369,0.0049052704,0.0062569403,0.0011128478,0.0003840687,0.06834919,0.0024245824,0.009671748,0.052588783,0.5583408],"study_design_scores_gemma":[0.023836829,0.011072957,0.86509264,0.0020036972,0.0051202076,0.00065890164,0.0012353029,0.06447358,0.0013091959,0.0023313833,0.022652972,0.00021228236],"about_ca_topic_score_codex":0.94098717,"about_ca_topic_score_gemma":0.965968,"teacher_disagreement_score":0.05901283,"about_ca_system_score_codex":0.036007263,"about_ca_system_score_gemma":0.03981219,"threshold_uncertainty_score":0.26125222},"labels":[],"label_agreement":null},{"id":"W3132387454","doi":"10.1016/j.jval.2015.09.978","title":"Economic Analysis of Paliperidone Long-Acting Acting Injectable for Chronic Schizophrenia in Portugal","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Medicine; Paliperidone; Risperidone; Cost effectiveness; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.16933871207313145,"score_gpt":0.4292288433559895,"score_spread":0.25989013128285804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132387454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.952695,0.022515796,0.0019181776,0.0056028934,0.0001406274,0.00027577527,0.005091638,0.000025787394,0.011734412],"genre_scores_gemma":[0.995643,0.0022427614,0.00043262902,0.0001568351,0.00003589315,0.00004537142,0.0006256054,0.000008555139,0.0008093747],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.996259,0.0025847454,0.00016745007,0.00013388164,0.00035024993,0.0005047448],"domain_scores_gemma":[0.99317086,0.0045609097,0.0010809649,0.00015906643,0.0003749102,0.00065331766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033862477,0.00043739902,0.001051976,0.0012545818,0.00037683596,0.0022014931,0.0006730106,0.0009706028,0.0031555267],"category_scores_gemma":[0.013095586,0.0003935343,0.002029169,0.0017146498,0.0005427915,0.0006819603,0.00092248636,0.00096498604,0.00009321719],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06752967,0.0049524526,0.36535373,0.014455306,0.013077322,0.009013691,0.0012759205,0.2730268,0.0049175695,0.08105059,0.013633208,0.15171373],"study_design_scores_gemma":[0.00896532,0.008679093,0.70137966,0.0060715205,0.010762504,0.005569718,0.0057370085,0.19211587,0.002386227,0.018770328,0.039260432,0.00030240256],"about_ca_topic_score_codex":0.04241164,"about_ca_topic_score_gemma":0.038127255,"teacher_disagreement_score":0.04241164,"about_ca_system_score_codex":0.008366723,"about_ca_system_score_gemma":0.0046035745,"threshold_uncertainty_score":0.084329545},"labels":[],"label_agreement":null},{"id":"W3132455626","doi":"10.1016/j.jval.2015.09.736","title":"Budget Impact Analysis Of Bioabsorbable Drug-Eluting Sinus Implants For Endoscopic Sinus Surgery","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Otorhinolaryngology; Chronic rhinosinusitis; Endoscopic sinus surgery; Surgery; Emergency medicine; Environmental health","score_opus":0.4296458436844888,"score_gpt":0.4445677761171849,"score_spread":0.014921932432696072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132455626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.912668,0.01019795,0.029807981,0.0068707415,0.00028565282,0.0010850837,0.004534125,0.00009913399,0.034451265],"genre_scores_gemma":[0.9934942,0.0012614265,0.0024543467,0.00013859491,0.000034395915,0.00017043077,0.00074798055,0.00001912607,0.0016794802],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9941519,0.004070408,0.00020320032,0.00014744517,0.0005408757,0.00088616443],"domain_scores_gemma":[0.98708713,0.010220395,0.0009741576,0.00023519709,0.00096550427,0.00051763625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009222806,0.0011251663,0.0016239678,0.002542198,0.00042068245,0.0032741714,0.0010304418,0.0014248963,0.0060009668],"category_scores_gemma":[0.032104418,0.0008699106,0.0020745876,0.0025400296,0.00072285015,0.0018691682,0.0011722813,0.0020882247,0.00020384675],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006030361,0.0010123253,0.021913156,0.00091301254,0.0011908484,0.00036417186,0.0001499724,0.8737126,0.0010308294,0.042542845,0.004631237,0.046508692],"study_design_scores_gemma":[0.0016203548,0.00281161,0.037228357,0.0007322586,0.0027615656,0.00022854206,0.0010780088,0.9106526,0.0016740997,0.031636186,0.009448454,0.0001281187],"about_ca_topic_score_codex":0.024580272,"about_ca_topic_score_gemma":0.017912067,"teacher_disagreement_score":0.024580272,"about_ca_system_score_codex":0.008376733,"about_ca_system_score_gemma":0.0064019156,"threshold_uncertainty_score":0.060777724},"labels":[],"label_agreement":null},{"id":"W3140219234","doi":"10.1016/j.jval.2017.08.637","title":"Resource Utilization And Disaggregated Cost Analysis For Initial Treatment Of Melanoma","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Melanoma; Resource (disambiguation); Computer science; Resource use; Natural resource economics; Economics; Medicine; Cancer research; Computer network","score_opus":0.22265516802860844,"score_gpt":0.4504007556636089,"score_spread":0.22774558763500044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140219234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981979,0.0009765938,0.0018408373,0.000492468,0.000021912414,0.000059135313,0.012414667,0.00004192226,0.0021734657],"genre_scores_gemma":[0.9950664,0.00014645355,0.000666987,0.00004206277,0.000008253523,0.000032381504,0.0034952268,0.000009850122,0.00053236994],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99916625,0.00043131897,0.000054844997,0.00008035917,0.000105622574,0.00016159075],"domain_scores_gemma":[0.9982023,0.0010042812,0.00031993137,0.0001366855,0.00022064394,0.00011610353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009656634,0.00038183515,0.00078752526,0.0014084097,0.00016995147,0.000992649,0.0006322655,0.00048811088,0.004002492],"category_scores_gemma":[0.005188123,0.0003526359,0.001973825,0.0028311952,0.00018726011,0.00062225125,0.00048010747,0.0006382664,0.00024989853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003643666,0.00049160316,0.18469058,0.00027716308,0.0025147588,0.00025088387,0.00012436314,0.7698327,0.0008898703,0.005579026,0.0052374527,0.026468018],"study_design_scores_gemma":[0.00020005171,0.0006785945,0.3951833,0.00009362286,0.0010682615,0.00037003303,0.00060172455,0.5923458,0.0009208163,0.0039943582,0.004480298,0.00006316627],"about_ca_topic_score_codex":0.052271817,"about_ca_topic_score_gemma":0.037838947,"teacher_disagreement_score":0.052271817,"about_ca_system_score_codex":0.0028588548,"about_ca_system_score_gemma":0.0013307724,"threshold_uncertainty_score":0.10393512},"labels":[],"label_agreement":null},{"id":"W3143265745","doi":"10.1016/j.jval.2012.06.014","title":"State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":491,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Context (archaeology); Computer science; Guideline; Health care; Management science; Decision model; Risk analysis (engineering); Medicine; Engineering; Machine learning; Political science","score_opus":0.7140652159236576,"score_gpt":0.5232955978891705,"score_spread":0.1907696180344871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143265745","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007944071,0.0058724373,0.92168397,0.02266935,0.0007046058,0.0011704905,0.014420186,0.0031121415,0.022422709],"genre_scores_gemma":[0.0648577,0.010290518,0.87655723,0.002648093,0.00093061343,0.002825822,0.029275065,0.00301667,0.009598288],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97566843,0.01595017,0.0011281999,0.0011963153,0.005505874,0.0005510684],"domain_scores_gemma":[0.9258703,0.04126255,0.0030751093,0.010639421,0.017708005,0.0014446393],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.072343454,0.002165926,0.0027627833,0.0035047086,0.001213607,0.0049868175,0.006163425,0.0033239077,0.008516544],"category_scores_gemma":[0.097543426,0.0023667556,0.0042538396,0.004854466,0.0010114199,0.0047935946,0.005775149,0.0051286826,0.0042266473],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038388692,0.00049495767,0.009619775,0.001455587,0.0010097213,0.0001417533,0.00048587035,0.24890839,0.0013862393,0.14003514,0.24602148,0.35005715],"study_design_scores_gemma":[0.00027290368,0.00013196237,0.0034646029,0.002316722,0.00058904703,0.00008779203,0.00021217963,0.5984677,0.004535889,0.18262002,0.20709294,0.0002082659],"about_ca_topic_score_codex":0.054025397,"about_ca_topic_score_gemma":0.05906189,"teacher_disagreement_score":0.92765653,"about_ca_system_score_codex":0.004288839,"about_ca_system_score_gemma":0.015625032,"threshold_uncertainty_score":0.38259333},"labels":[],"label_agreement":null},{"id":"W3146682687","doi":"10.1016/j.jval.2021.01.003","title":"Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Regional Development Fund; Instituto de Salud Carlos III","keywords":"Osteoarthritis; Medicine; Physical therapy; Physical medicine and rehabilitation; Alternative medicine; Pathology","score_opus":0.24094120553758566,"score_gpt":0.3887095910785677,"score_spread":0.147768385540982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146682687","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30214784,0.0038644609,0.66582984,0.0059479466,0.0004110307,0.0025883117,0.008879106,0.00070888386,0.0096225925],"genre_scores_gemma":[0.8900188,0.00066075474,0.09327792,0.00080957444,0.000087896784,0.0032027687,0.0050654775,0.00012227912,0.006754614],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.98167694,0.01621234,0.00041130543,0.0006747278,0.00073180784,0.00029285718],"domain_scores_gemma":[0.97704667,0.019662796,0.0008266586,0.0010234306,0.0012706458,0.00016990938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023914417,0.00075765094,0.001279987,0.0018463578,0.0007705662,0.0012221454,0.0017969017,0.0011110208,0.008862944],"category_scores_gemma":[0.080844045,0.00041484888,0.0027813653,0.0021998638,0.0006713303,0.0008131953,0.0022822558,0.0020145138,0.0009862366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003793502,0.00086794427,0.19972281,0.0017544715,0.0047062435,0.00041937392,0.0020775557,0.16244479,0.00094960135,0.055363107,0.02382923,0.5440714],"study_design_scores_gemma":[0.0015295958,0.0011465168,0.15591043,0.0008171705,0.0014109001,0.00039664825,0.002156388,0.72053254,0.0010296911,0.09929834,0.015539901,0.00023181432],"about_ca_topic_score_codex":0.07465576,"about_ca_topic_score_gemma":0.04034953,"teacher_disagreement_score":0.07465576,"about_ca_system_score_codex":0.0021710806,"about_ca_system_score_gemma":0.003131327,"threshold_uncertainty_score":0.14844245},"labels":[],"label_agreement":null},{"id":"W3153029604","doi":"10.1016/j.jval.2021.01.002","title":"Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"University of Sheffield; Pfizer","keywords":"Systematic review; Critical appraisal; Cost effectiveness; Task force; Psychological intervention; Outcomes research; Cost–benefit analysis; Management science; Task (project management); Comparative effectiveness research; Computer science; Health economics; Health care; Risk analysis (engineering); Medicine; MEDLINE; Alternative medicine; Economics; Nursing; Management; Political science","score_opus":0.5460033851608647,"score_gpt":0.5349296484122177,"score_spread":0.011073736748646978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153029604","genre_codex":"review","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00259855,0.40756136,0.14424187,0.07164723,0.017783042,0.32522777,0.014635156,0.0026446264,0.013660404],"genre_scores_gemma":[0.016242854,0.21691826,0.42606297,0.007781176,0.0036981981,0.32217932,0.0043205325,0.0005846274,0.002212032],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.3440566,0.36436513,0.20790942,0.012601808,0.06786192,0.0032050458],"domain_scores_gemma":[0.15513706,0.4817084,0.11261303,0.034457114,0.21062253,0.0054618423],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.51030993,0.0061435457,0.01546226,0.04003506,0.0068543646,0.015750544,0.009259207,0.011941588,0.010371435],"category_scores_gemma":[0.73224235,0.0069980146,0.02096243,0.032911777,0.009708325,0.009283123,0.010870257,0.013338451,0.0051530846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005727731,0.000119832475,0.0018848942,0.5876384,0.008139743,0.0003422534,0.005036571,0.0012734398,0.0008386428,0.008069419,0.11100284,0.2750813],"study_design_scores_gemma":[0.0012440175,0.00028271994,0.0026021735,0.8380884,0.008932531,0.00033527173,0.0009843964,0.0020511402,0.0010530328,0.013139037,0.13094126,0.0003461233],"about_ca_topic_score_codex":0.011128597,"about_ca_topic_score_gemma":0.014133625,"teacher_disagreement_score":0.48969007,"about_ca_system_score_codex":0.018481743,"about_ca_system_score_gemma":0.109976985,"threshold_uncertainty_score":0.60387504},"labels":[],"label_agreement":null},{"id":"W3160886066","doi":"10.1016/j.jval.2021.03.003","title":"“Looking Under the Hood” of Anchor-Based Assessment of Clinically Important Change: A Machine Learning Approach","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Attribution; Quality of life (healthcare); Psychology; Baseline (sea); Clinical psychology; Medicine; Gerontology; Social psychology","score_opus":0.10079346617120334,"score_gpt":0.38964103719680804,"score_spread":0.2888475710256047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160886066","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19148208,0.0028642197,0.79025453,0.0056778737,0.00071479887,0.00039406557,0.000903836,0.0008105798,0.006898028],"genre_scores_gemma":[0.8646455,0.00038307984,0.13264488,0.0005999802,0.00034579445,0.00014851797,0.00036471695,0.00006572055,0.0008018029],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.988014,0.0077572353,0.000929898,0.0018231192,0.0012114609,0.00026428016],"domain_scores_gemma":[0.92864066,0.057675354,0.0043770093,0.00442124,0.0040557114,0.0008300343],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022371402,0.0010914104,0.0021713586,0.0041458183,0.0011054071,0.0039750063,0.002699313,0.002404065,0.0029707244],"category_scores_gemma":[0.1011812,0.0004370791,0.00138151,0.0036135796,0.003067675,0.005208254,0.0027472551,0.004249239,0.0005456018],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00202076,0.0008076668,0.14704505,0.0008651318,0.0013628209,0.00038384905,0.0023360443,0.033370353,0.002866392,0.03995102,0.011312003,0.757679],"study_design_scores_gemma":[0.00018443522,0.0014911718,0.048394,0.0006137858,0.00047519428,0.0005551993,0.0018378996,0.70943564,0.0031169902,0.22869404,0.0049329028,0.00026877644],"about_ca_topic_score_codex":0.0026685493,"about_ca_topic_score_gemma":0.003751154,"teacher_disagreement_score":0.9776286,"about_ca_system_score_codex":0.0007905162,"about_ca_system_score_gemma":0.0012065971,"threshold_uncertainty_score":0.11831266},"labels":[],"label_agreement":null},{"id":"W3161848643","doi":"10.1016/j.jval.2021.02.011","title":"Bias Assessment in Outcomes Research: The Role of Relative Versus Absolute Approaches","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Qatar National Research Fund; Fonds National de la Recherche Luxembourg; Australian National University; Qatar Foundation","keywords":"Consistency (knowledge bases); Independence (probability theory); Statistics; Scale (ratio); Relative value; Intraclass correlation; Econometrics; Quality (philosophy); Psychology; Mathematics; Computer science; Artificial intelligence; Psychometrics; Geography","score_opus":0.8214349676296412,"score_gpt":0.5378024960010247,"score_spread":0.2836324716286165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161848643","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010369431,0.17927851,0.7775844,0.021053677,0.004128065,0.00094475184,0.0003997227,0.00024415806,0.0059973244],"genre_scores_gemma":[0.35707602,0.039852098,0.5815216,0.010147042,0.0060278634,0.00381284,0.00023894446,0.00039975636,0.00092381105],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.13928504,0.75818837,0.046314035,0.016814373,0.038573798,0.0008243876],"domain_scores_gemma":[0.048093446,0.90348834,0.018072212,0.021693805,0.008091247,0.00056103006],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.66885173,0.0039428985,0.01614906,0.016022531,0.0034078392,0.018814405,0.009624821,0.011178943,0.0031520594],"category_scores_gemma":[0.83763033,0.0033516546,0.008714165,0.013255407,0.030323748,0.02613908,0.013858942,0.014832018,0.0005952757],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015518876,0.00022262041,0.01988079,0.024007972,0.02226312,0.0002106042,0.005923738,0.008720265,0.00056243874,0.54664755,0.004893037,0.365116],"study_design_scores_gemma":[0.00044496206,0.00082985056,0.00496237,0.012539756,0.0040651807,0.0009781187,0.0010934131,0.022174865,0.0010992619,0.9414173,0.009939711,0.00045523283],"about_ca_topic_score_codex":0.002427519,"about_ca_topic_score_gemma":0.0026513063,"teacher_disagreement_score":0.33114827,"about_ca_system_score_codex":0.0075134216,"about_ca_system_score_gemma":0.009563852,"threshold_uncertainty_score":0.40836483},"labels":[],"label_agreement":null},{"id":"W3163746986","doi":"10.1016/j.jval.2021.01.007","title":"The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"National Health and Medical Research Council; EuroQol Research Foundation; Australian Government","keywords":"Quality of life (healthcare); Worry; Logit; Valuation (finance); EQ-5D; Descriptive statistics; Medicine; Population; Psychology; Actuarial science; Statistics; Econometrics; Psychiatry; Nursing; Health related quality of life; Disease; Anxiety; Economics","score_opus":0.5490412816647725,"score_gpt":0.455468135442835,"score_spread":0.09357314622193752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163746986","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71068925,0.01569377,0.040316384,0.006796059,0.00079840905,0.011313237,0.1545829,0.00057180517,0.059238218],"genre_scores_gemma":[0.86290896,0.006204852,0.053432733,0.0013759804,0.00014470446,0.009611197,0.05768981,0.00010341227,0.008528349],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953296,0.0019527425,0.00055715826,0.00020515754,0.0017205189,0.00023482316],"domain_scores_gemma":[0.9903876,0.0025307164,0.0035565328,0.00040884604,0.0023977323,0.00071846816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056005083,0.00046743185,0.001056091,0.0037370583,0.00045519724,0.0010544116,0.0008760535,0.00069687824,0.002375321],"category_scores_gemma":[0.025597116,0.00021862112,0.0016646208,0.0037557688,0.0005225831,0.0010827406,0.0020621861,0.0018075145,0.00041584068],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018120416,0.0008212434,0.53635246,0.001898501,0.0015798655,0.00030118533,0.0020139616,0.0074465293,0.0013214075,0.01643552,0.08396063,0.34605655],"study_design_scores_gemma":[0.00019165533,0.00090412464,0.91031307,0.0007086567,0.0003234409,0.0005731164,0.00039754747,0.005270917,0.00070485927,0.0067906813,0.073682174,0.00013981905],"about_ca_topic_score_codex":0.010500104,"about_ca_topic_score_gemma":0.01288443,"teacher_disagreement_score":0.010500104,"about_ca_system_score_codex":0.0019323225,"about_ca_system_score_gemma":0.0024220897,"threshold_uncertainty_score":0.02961868},"labels":[],"label_agreement":null},{"id":"W3165898648","doi":"10.1016/j.jval.2021.04.1053","title":"PRO68 Patient-Reported Outcomes in Patients with Pemphigus Vulgaris Treated with Rituximab in the Phase 3 PEMPHIX Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Pemphigus vulgaris; Dermatology Life Quality Index; Prednisone; Quality of life (healthcare); Gastroenterology; Adverse effect; Dermatology; Disease; Lymphoma","score_opus":0.024645869739995482,"score_gpt":0.3074965499189303,"score_spread":0.2828506801789348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165898648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959716,0.0025173316,0.0000623304,0.00015316141,0.000028592563,0.00003723228,0.00060201914,0.000003720032,0.00062386657],"genre_scores_gemma":[0.9977348,0.0006410594,0.00008527299,0.0001243993,0.00006143032,0.00006122678,0.0010516682,0.00000201151,0.00023828413],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989831,0.00057776377,0.000076981116,0.00009919085,0.000117658215,0.00014530818],"domain_scores_gemma":[0.9981621,0.00040226633,0.0009548442,0.000067242734,0.00012900801,0.00028451724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015748559,0.00048264174,0.00089920044,0.00036037868,0.00030999427,0.000932636,0.0004042826,0.00079098216,0.0008393884],"category_scores_gemma":[0.0024774054,0.00020199709,0.001272172,0.00061795436,0.00025213815,0.0006885949,0.00055628555,0.0009965778,0.00016133583],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07039826,0.001487601,0.89104474,0.00056756847,0.006744106,0.00033624173,0.00022542084,0.0007892757,0.0017739298,0.00022159227,0.001630249,0.024780974],"study_design_scores_gemma":[0.007880729,0.011340157,0.9735835,0.00012306155,0.0031775094,0.00052949163,0.0002276439,0.00066254823,0.00035307845,0.00020288104,0.0018759171,0.000043585544],"about_ca_topic_score_codex":0.0007418095,"about_ca_topic_score_gemma":0.0010390161,"teacher_disagreement_score":0.0015748559,"about_ca_system_score_codex":0.00042801604,"about_ca_system_score_gemma":0.0003017707,"threshold_uncertainty_score":0.008328736},"labels":[],"label_agreement":null},{"id":"W3165914463","doi":"10.1016/j.jval.2021.04.1210","title":"SM1 The Random Effects Warfarin Days' Supply (REWARDS) Model: Development and Validation of a NOVEL Method to Estimate Exposure to Warfarin Using Administrative Data","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Intraclass correlation; Warfarin; Medical prescription; Medicine; Statistics; Dosing; Mean squared error; Population; Correlation coefficient; Random effects model; Linear regression; Mathematics; Pearson product-moment correlation coefficient; Econometrics; Internal medicine; Pharmacology","score_opus":0.2910005260188193,"score_gpt":0.47007499112169027,"score_spread":0.17907446510287095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165914463","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13363338,0.00052263803,0.85057104,0.0018231982,0.0002567747,0.0007684154,0.007543662,0.0018804045,0.0030005225],"genre_scores_gemma":[0.6595072,0.00054250273,0.31841654,0.00050729304,0.00026607988,0.0018037058,0.006366698,0.00027796224,0.012312035],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99292654,0.0048969304,0.00028599563,0.0010475692,0.00060942443,0.00023353951],"domain_scores_gemma":[0.9725281,0.022236785,0.0017865705,0.0016257038,0.0016033213,0.00021951689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016864708,0.0010231506,0.0012463115,0.0016897549,0.000488226,0.0014662539,0.0028187325,0.0015246934,0.006811053],"category_scores_gemma":[0.04593948,0.0008114927,0.0024516154,0.001337452,0.0005817267,0.00132464,0.0015631261,0.0022331083,0.0016234609],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021407676,0.0010059138,0.15858522,0.00062564336,0.0030354944,0.00031915965,0.00047475463,0.43478677,0.0012078992,0.03471746,0.016493972,0.34660694],"study_design_scores_gemma":[0.00016950836,0.00034366045,0.01263486,0.000094490584,0.00024767878,0.00010497367,0.00005506585,0.9738264,0.0004456909,0.008219324,0.0038173718,0.000041014453],"about_ca_topic_score_codex":0.024033988,"about_ca_topic_score_gemma":0.017810443,"teacher_disagreement_score":0.024033988,"about_ca_system_score_codex":0.0013129702,"about_ca_system_score_gemma":0.0028910472,"threshold_uncertainty_score":0.089190125},"labels":[],"label_agreement":null},{"id":"W3166447425","doi":"10.1016/j.jval.2021.04.081","title":"PBI10 Economic Impact of Originator-to-Biosimilar Non-Medical Switching on Health Care Resource Utilization in Rheumatic Patients in Quebec, Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Biosimilar; Medicine; Psoriatic arthritis; Productivity; Health care; Rheumatoid arthritis; Indirect costs; Emergency medicine; Family medicine; Business; Accounting; Internal medicine","score_opus":0.021976219381300247,"score_gpt":0.3289181174072616,"score_spread":0.3069418980259614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166447425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9088153,0.006920231,0.0005797831,0.014983509,0.00026435155,0.00027821015,0.03986188,0.000113931936,0.028182782],"genre_scores_gemma":[0.98165405,0.0018259282,0.0005040124,0.0015923158,0.00007808832,0.000053487052,0.0056997878,0.000032930053,0.008559386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764615,0.00039285354,0.00012845946,0.00015388695,0.0007160242,0.0009625505],"domain_scores_gemma":[0.9902464,0.0012604501,0.0014241646,0.00012257903,0.00318382,0.0037626626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001529988,0.00037591706,0.00048078943,0.0012225518,0.0016019631,0.0032316628,0.0011438609,0.00083719887,0.010529886],"category_scores_gemma":[0.006490772,0.00030328784,0.0015280326,0.0022444916,0.00069155404,0.00043523542,0.000882664,0.001782305,0.00043028116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003631883,0.00048159694,0.84835964,0.0004650899,0.0010455576,0.0006468567,0.00044352407,0.011033809,0.0009647627,0.004490619,0.061941948,0.06649471],"study_design_scores_gemma":[0.00033936097,0.0003271165,0.97480357,0.00026364406,0.00026068263,0.00020375167,0.0012287025,0.00837752,0.00029719717,0.0001810367,0.013655643,0.00006169851],"about_ca_topic_score_codex":0.9954072,"about_ca_topic_score_gemma":0.99579924,"teacher_disagreement_score":0.12326472,"about_ca_system_score_codex":0.12326472,"about_ca_system_score_gemma":0.11049465,"threshold_uncertainty_score":0.8943523},"labels":[],"label_agreement":null},{"id":"W3166552977","doi":"10.1016/j.jval.2021.04.1112","title":"PSS11 Comparing Patient's Compliance and Persistence on Prostaglandin Analogs Using Real-World Utilization Databases for the Treatment of OPEN-Angle Glaucoma or Ocular Hypertension.","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Latanoprost; Travoprost; Bimatoprost; Medicine; Glaucoma; Intraocular pressure; Prostaglandin analogue; Persistence (discontinuity); Ophthalmology; Database","score_opus":0.3786091611457831,"score_gpt":0.4009362327950256,"score_spread":0.022327071649242525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166552977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131168,0.001228151,0.00077843823,0.0004641872,0.000054515116,0.00019970053,0.081594095,0.000052891606,0.0025110792],"genre_scores_gemma":[0.9625055,0.00043202617,0.000723182,0.0001695025,0.00004823331,0.0003338565,0.035243582,0.000013126943,0.00053106225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936848,0.0027611293,0.0017789163,0.0007330826,0.0007265243,0.0003155304],"domain_scores_gemma":[0.9703352,0.01341805,0.011328641,0.001773204,0.0022964543,0.0008483983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004343477,0.0004287441,0.00085739733,0.0026506102,0.00038227352,0.0012858529,0.0006927021,0.0008687774,0.00444729],"category_scores_gemma":[0.032049514,0.0003219386,0.0025711663,0.0074526607,0.00020196741,0.0011371732,0.0011298879,0.0008357259,0.00059956615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024191923,0.000121389035,0.9863273,0.00038810947,0.0025263883,0.00003481541,0.00010099945,0.00035725415,0.000048752005,0.00013522273,0.0022754143,0.005265179],"study_design_scores_gemma":[0.00032696646,0.00059636973,0.9941322,0.00013429495,0.0009187088,0.00012759211,0.00028717812,0.0015891064,0.000121741476,0.00013619348,0.0016081227,0.000021564461],"about_ca_topic_score_codex":0.014573947,"about_ca_topic_score_gemma":0.010717777,"teacher_disagreement_score":0.014573947,"about_ca_system_score_codex":0.0007049153,"about_ca_system_score_gemma":0.0013255898,"threshold_uncertainty_score":0.028978229},"labels":[],"label_agreement":null},{"id":"W3166565630","doi":"10.1016/j.jval.2021.04.802","title":"PND18 BoNT-As for Adult Spasticity and Cervical Dystonia: Cost-Effectiveness Analysis and the Cost of Response in the United Kingdom","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Cervical dystonia; Spasticity; Medicine; Observational study; Dosing; Cost effectiveness; Physical therapy; Emergency medicine; Internal medicine; Botulinum toxin; Surgery","score_opus":0.06328015375340351,"score_gpt":0.3558874872140535,"score_spread":0.29260733346065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166565630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8330003,0.13979165,0.001528608,0.005911488,0.00040194512,0.0003605723,0.010862215,0.00004300014,0.008100202],"genre_scores_gemma":[0.9848786,0.012118244,0.0004748169,0.00043472406,0.00005066119,0.00011320249,0.0014038781,0.00000945251,0.00051637884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943182,0.0038956497,0.00048823404,0.00030163766,0.0005791617,0.0004172142],"domain_scores_gemma":[0.9936992,0.0043551847,0.0010764356,0.000100836514,0.00046133908,0.00030699614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036727425,0.0007323142,0.0020719436,0.002181209,0.00022546815,0.0018825532,0.0005606613,0.0015242682,0.0031592473],"category_scores_gemma":[0.014537779,0.00060873234,0.0049666944,0.0025988705,0.0005909759,0.00122199,0.0010534342,0.0013309004,0.00014791093],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12925416,0.0009870527,0.31116527,0.022396527,0.031296406,0.0026733994,0.0007801731,0.16222925,0.0027139524,0.013460801,0.021167828,0.30187523],"study_design_scores_gemma":[0.020404918,0.01623709,0.7949399,0.010734296,0.03448726,0.004895329,0.0021054167,0.08307702,0.0018184304,0.004731295,0.026068322,0.0005007957],"about_ca_topic_score_codex":0.074460074,"about_ca_topic_score_gemma":0.050689887,"teacher_disagreement_score":0.074460074,"about_ca_system_score_codex":0.01306059,"about_ca_system_score_gemma":0.0030351977,"threshold_uncertainty_score":0.14805335},"labels":[],"label_agreement":null},{"id":"W3166773323","doi":"10.1016/j.jval.2021.04.567","title":"PIN7 Qualitative Research Methods to Evaluate Healthcare Provider and Adult Vaccine Recipient Attitudes, Barriers, and Facilitators to Completing the Recombinant Zoster Vaccine Regimen in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; GlaxoSmithKline (Canada)","funders":"","keywords":"Regimen; Thematic analysis; Qualitative research; Medicine; Family medicine; Health care; Vaccination; Modalities; Immunology; Surgery; Political science","score_opus":0.15326142826965736,"score_gpt":0.5099195613806192,"score_spread":0.35665813311096184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166773323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93223596,0.0017567686,0.0070103602,0.0040096603,0.00013106097,0.021164263,0.0045565283,0.000048058235,0.02908737],"genre_scores_gemma":[0.9347197,0.001919674,0.013680826,0.0022773962,0.000027712935,0.032146152,0.0009841406,0.000033031483,0.014211436],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9847874,0.00751489,0.00080064655,0.0009057515,0.0021316556,0.0038596352],"domain_scores_gemma":[0.96562326,0.017945863,0.0020767634,0.0008010157,0.011257508,0.002295569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023959558,0.0006540122,0.0008982311,0.0041123247,0.01955326,0.0046076886,0.0025541612,0.0011927465,0.008249593],"category_scores_gemma":[0.031246796,0.0009972136,0.0007861703,0.007039999,0.0049998267,0.0017372237,0.0048667453,0.0021985676,0.000360316],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002619663,0.00062381127,0.04842029,0.0018706782,0.000056705543,0.00028967313,0.8990035,0.00042038487,0.00079325156,0.0063834176,0.004765014,0.037111435],"study_design_scores_gemma":[0.00010908841,0.00017045098,0.031426933,0.0015362309,0.000053761116,0.00004336474,0.9471127,0.0004931546,0.0006776274,0.00089985464,0.017425863,0.00005099543],"about_ca_topic_score_codex":0.941702,"about_ca_topic_score_gemma":0.95994854,"teacher_disagreement_score":0.10588974,"about_ca_system_score_codex":0.10588974,"about_ca_system_score_gemma":0.2508245,"threshold_uncertainty_score":0.7682874},"labels":[],"label_agreement":null},{"id":"W3166908400","doi":"10.1016/j.jval.2021.04.919","title":"PNS64 Canadian Pricing and Reimbursement: Understanding the Biggest Hurdles in the Payer Landscape","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Negotiation; Alliance; Agency (philosophy); Medicine; Health technology; Orphan drug; Public economics; Business; Actuarial science; Health care; Economics; Political science; Economic growth","score_opus":0.5076952837433918,"score_gpt":0.4032474981015994,"score_spread":0.10444778564179241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166908400","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023083488,0.021571932,0.0019887972,0.78675354,0.0019352082,0.00006142019,0.0031231665,0.00013843208,0.16134402],"genre_scores_gemma":[0.75644237,0.041910727,0.009726639,0.12046759,0.005731907,0.00015942553,0.004081492,0.0005083545,0.06097153],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.97689235,0.003448108,0.00048170512,0.0008212183,0.014001645,0.0043549254],"domain_scores_gemma":[0.94020325,0.010881732,0.0018339935,0.0012680655,0.036068298,0.009744665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018693576,0.00056906603,0.0010821125,0.004660825,0.0056285593,0.014100403,0.0028712105,0.004116938,0.017714389],"category_scores_gemma":[0.0830867,0.00046152007,0.0009004724,0.008777068,0.0049525285,0.0048702103,0.0024199456,0.005670427,0.0014446079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016405027,0.00006526129,0.018511066,0.0002526934,0.00006164494,0.00013372676,0.0009718128,0.0022537787,0.0001632126,0.32601076,0.49233353,0.15907852],"study_design_scores_gemma":[0.00010550714,0.00006573943,0.13073343,0.0022072399,0.00010162549,0.00024715834,0.0044610095,0.008003811,0.00028761133,0.16938229,0.68403137,0.00037324562],"about_ca_topic_score_codex":0.9725935,"about_ca_topic_score_gemma":0.9814502,"teacher_disagreement_score":0.106448926,"about_ca_system_score_codex":0.106448926,"about_ca_system_score_gemma":0.21385902,"threshold_uncertainty_score":0.77234465},"labels":[],"label_agreement":null},{"id":"W3167334836","doi":"10.1016/j.jval.2021.04.1062","title":"PRO77 Preliminary Characterization of Eculizumab Treatment Patterns, Preceding Disease Triggers and Supportive Therapies in Atypical Hemolytic Uremic Syndrome: A US Claims Database Analysis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Medicine; Internal medicine; Dialysis; Pediatrics; Intensive care medicine; Immunology; Complement system; Antibody","score_opus":0.02884418536160672,"score_gpt":0.28661492116014775,"score_spread":0.25777073579854104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167334836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9499245,0.0010111897,0.00041297238,0.00014226936,0.000010300299,0.000079951526,0.045585435,0.00001990223,0.0028134997],"genre_scores_gemma":[0.9719935,0.000355377,0.00049471867,0.000074722586,0.000019049416,0.00006439291,0.026527157,0.000009228922,0.00046196327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980233,0.00031659898,0.0006489731,0.0002929456,0.0004985178,0.00021974952],"domain_scores_gemma":[0.9918298,0.0021031355,0.004299007,0.0005587231,0.0009069287,0.00030234488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014898855,0.0003094191,0.0005462523,0.0052600265,0.0004951346,0.0014519478,0.0005708389,0.00049673027,0.0040996294],"category_scores_gemma":[0.007082606,0.00022480058,0.0013394661,0.007609872,0.00024148318,0.0007809139,0.0006826385,0.00045534217,0.0006879249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007304092,0.00006728573,0.9916402,0.00013235309,0.00033734625,0.00017548757,0.00008679108,0.00022444474,0.00045635737,0.00018737097,0.0007632653,0.00519861],"study_design_scores_gemma":[0.000024388026,0.00010150558,0.99557495,0.00006460165,0.00023253412,0.0005445941,0.00027406117,0.0008104428,0.00032009569,0.0001096011,0.0019323129,0.000011015631],"about_ca_topic_score_codex":0.009160282,"about_ca_topic_score_gemma":0.008938757,"teacher_disagreement_score":0.009160282,"about_ca_system_score_codex":0.0007990508,"about_ca_system_score_gemma":0.0010208343,"threshold_uncertainty_score":0.018213928},"labels":[],"label_agreement":null},{"id":"W3167365590","doi":"10.1016/j.jval.2021.04.1115","title":"PSS14 Qualitative Exploration of Patient Experiences of Visual Function Impairments and Health-Related Quality of Life Impacts Associated with RLBP1 Retinitis Pigmentosa in a Sample of Canadian Patients","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Retinitis pigmentosa; Quality of life (healthcare); Thematic analysis; Activities of daily living; Visual impairment; Qualitative research; Medicine; Psychology; International Classification of Functioning, Disability and Health; Gerontology; Clinical psychology; Physical therapy; Psychiatry; Rehabilitation; Nursing; Ophthalmology","score_opus":0.11024301667418432,"score_gpt":0.3724507974459393,"score_spread":0.262207780771755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167365590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98916245,0.0005994085,0.00039407195,0.0023684988,0.000055896675,0.00032937535,0.00094808417,0.000010513336,0.0061316444],"genre_scores_gemma":[0.9940976,0.00063908496,0.0006495102,0.0012032986,0.000016286987,0.00044064136,0.00030650097,0.000015645472,0.0026315863],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99524915,0.002144091,0.00022864052,0.00024463437,0.0005187451,0.0016148016],"domain_scores_gemma":[0.9895784,0.0050856676,0.0008521648,0.00019440486,0.0021492618,0.0021400314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062360237,0.000576792,0.0007948894,0.0018014276,0.014801628,0.0040239245,0.0017493974,0.0010806435,0.004508029],"category_scores_gemma":[0.011148345,0.0005508791,0.00079086993,0.0032742491,0.0049119038,0.0013421407,0.004552188,0.0027544298,0.0002445371],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007716463,0.000056894918,0.014805399,0.00020994234,0.000015554235,0.00041270867,0.97824174,0.000049769897,0.00026658445,0.00042076895,0.0015795729,0.0038639081],"study_design_scores_gemma":[0.0000085637,0.000028854158,0.008147632,0.00014560367,0.000008105545,0.00010786562,0.98655313,0.000028935396,0.00007786374,0.00007699324,0.004795132,0.000021250415],"about_ca_topic_score_codex":0.7238709,"about_ca_topic_score_gemma":0.8410708,"teacher_disagreement_score":0.27612913,"about_ca_system_score_codex":0.03675496,"about_ca_system_score_gemma":0.053516813,"threshold_uncertainty_score":0.5555106},"labels":[],"label_agreement":null},{"id":"W3167366760","doi":"10.1016/j.jval.2021.04.1207","title":"SC3 The Drivers of Health State Utilities in Duchenne Muscular Dystrophy (DMD): A Study Using the Health Utilities Index Mark 3 (HUI3)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Centre for Advancing Health Outcomes","funders":"","keywords":"Health Utilities Index; Quality of life (healthcare); Physical therapy; Medicine; Proxy (statistics); Physical medicine and rehabilitation; Ambulatory; Psychology; Audiology; Health related quality of life; Disease; Statistics; Internal medicine","score_opus":0.05910006206190667,"score_gpt":0.32651615608504336,"score_spread":0.2674160940231367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167366760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942714,0.0002001206,0.00037068772,0.00016098555,0.000010056858,0.000019436044,0.004084359,0.00001211722,0.0008708272],"genre_scores_gemma":[0.99801934,0.00005847958,0.00011249982,0.000027960778,0.000007718241,0.000018628878,0.001300478,0.000007009486,0.00044798595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988531,0.0004904136,0.00013620162,0.0001418733,0.00019335348,0.00018507773],"domain_scores_gemma":[0.9924118,0.0031815146,0.0027864117,0.00047557388,0.000569078,0.0005755777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021967618,0.0003184689,0.00033701526,0.0012152207,0.00042855006,0.0013488078,0.00047590488,0.00056171184,0.003488715],"category_scores_gemma":[0.012803784,0.00021180093,0.001985799,0.0026373698,0.00023920879,0.00082989957,0.0008742294,0.0009453312,0.00046633725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010451842,0.000031286523,0.997203,0.000010922658,0.00015436069,0.000027758588,0.000060922215,0.0001608941,0.000024467074,0.00012632734,0.00030807214,0.0017874489],"study_design_scores_gemma":[0.000008137104,0.00008517814,0.9964796,0.00001943942,0.00011054315,0.00009130623,0.00024735462,0.0020912627,0.00006354077,0.0002050194,0.00058731454,0.000011409094],"about_ca_topic_score_codex":0.030933475,"about_ca_topic_score_gemma":0.02080297,"teacher_disagreement_score":0.030933475,"about_ca_system_score_codex":0.0007911733,"about_ca_system_score_gemma":0.0010433045,"threshold_uncertainty_score":0.061506808},"labels":[],"label_agreement":null},{"id":"W3167413681","doi":"10.1016/j.jval.2021.04.023","title":"CO3 Comparison of Goal Attainment and Measures of Function in Two Dementia Clinical Trials.","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Dementia; Activities of daily living; Clinical trial; Psychology; Physical therapy; Gerontology; Medicine; Disease; Clinical psychology; Internal medicine; Rehabilitation","score_opus":0.7950828561245876,"score_gpt":0.5748109284433855,"score_spread":0.22027192768120207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167413681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86736226,0.08036103,0.010458873,0.0043065366,0.0024556823,0.006301606,0.011462132,0.00024238676,0.01704943],"genre_scores_gemma":[0.9882514,0.0029723379,0.001989689,0.0005699627,0.000268645,0.0021926388,0.002313697,0.00002841542,0.0014132055],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9541577,0.039640263,0.0021653757,0.0012014348,0.0019192348,0.00091605063],"domain_scores_gemma":[0.9390978,0.046016913,0.0071915896,0.0027066886,0.002825536,0.0021614083],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025726259,0.0011213933,0.003027626,0.0011450786,0.00037583857,0.0017532436,0.0009658645,0.0026374124,0.006455934],"category_scores_gemma":[0.07417771,0.0003821294,0.004661798,0.0015496416,0.0008279028,0.0016423184,0.0011639905,0.0025791544,0.00067483337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.944949,0.0009917992,0.0046349154,0.0023057547,0.01694133,0.000025169367,0.00008451383,0.0010762295,0.00035970242,0.0011131723,0.0014176442,0.026100835],"study_design_scores_gemma":[0.7046813,0.11911023,0.09254202,0.0021359983,0.049259674,0.00017014322,0.00028149958,0.012228789,0.0029818537,0.005744355,0.010639192,0.00022500602],"about_ca_topic_score_codex":0.005128325,"about_ca_topic_score_gemma":0.0038992227,"teacher_disagreement_score":0.97427374,"about_ca_system_score_codex":0.002299408,"about_ca_system_score_gemma":0.0027800922,"threshold_uncertainty_score":0.13605511},"labels":[],"label_agreement":null},{"id":"W3167593734","doi":"10.1016/j.jval.2021.04.047","title":"HT3 What is Value? A Systematic Review of Value Assessment Frameworks","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Context (archaeology); Health care; Value (mathematics); Weighting; Actuarial science; Systematic review; Medicine; Psychology; MEDLINE; Computer science; Business; Political science","score_opus":0.49565166486407897,"score_gpt":0.5230396104214051,"score_spread":0.027387945557326154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167593734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018313246,0.9948921,0.0005388721,0.0022231552,0.00032880486,0.00025188955,0.0009170038,0.000015140119,0.00064978324],"genre_scores_gemma":[0.0058162836,0.9876671,0.0024676726,0.0022738317,0.00034270418,0.0007436607,0.00041466617,0.00001655305,0.0002576111],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9777475,0.009606831,0.0071151527,0.0010722311,0.004055142,0.0004031564],"domain_scores_gemma":[0.8823566,0.091360085,0.015794432,0.0016192835,0.008103129,0.00076650694],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0270005,0.0015348515,0.0078074955,0.016465835,0.00070156273,0.004558848,0.0023700846,0.0025594863,0.014918986],"category_scores_gemma":[0.14163584,0.0011275315,0.006280196,0.017045086,0.0017896079,0.004747673,0.0031771888,0.002634018,0.0009292955],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030366785,0.00002082872,0.00056931697,0.7691221,0.007212122,0.00004988513,0.00023338888,0.00019048844,0.000117392454,0.0044799214,0.014493374,0.20320745],"study_design_scores_gemma":[0.0002820889,0.00005983209,0.0012751209,0.92229474,0.015723981,0.00009852845,0.0001329019,0.00011413651,0.00007416784,0.004747883,0.055157587,0.00003906813],"about_ca_topic_score_codex":0.010282758,"about_ca_topic_score_gemma":0.02571013,"teacher_disagreement_score":0.9729995,"about_ca_system_score_codex":0.005290616,"about_ca_system_score_gemma":0.020932365,"threshold_uncertainty_score":0.14279401},"labels":[],"label_agreement":null},{"id":"W3167827777","doi":"10.1016/j.jval.2021.04.1222","title":"PIN34 COVID-19 Related Knowledge, Attitude and Practices in a Southeastern City in Nigeria: A Cross-Sectional Survey","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Cross-sectional study; Bachelor; Quarter (Canadian coin); Medicine; Psychological intervention; Population; Positive attitude; Family medicine; Demography; Environmental health; Psychology; Geography; Nursing; Social psychology; Disease; Internal medicine; Pathology; Infectious disease (medical specialty)","score_opus":0.26725566002035955,"score_gpt":0.5195720081422702,"score_spread":0.25231634812191067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167827777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891806,0.000048013007,0.000019618976,0.00005626243,0.0000033654658,0.000016803499,0.00021948807,8.0428435e-7,0.0007175875],"genre_scores_gemma":[0.9984944,0.00014934382,0.00008724898,0.000115536975,0.0000037624209,0.00002796331,0.00021595445,0.0000010850869,0.00090478815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968505,0.00006303112,0.00004329422,0.000038321672,0.000056982874,0.0001133644],"domain_scores_gemma":[0.99927956,0.00009697048,0.00027011283,0.000030959185,0.00010997347,0.0002124151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004364405,0.00023926173,0.00030093922,0.00088184094,0.0014851353,0.00087408663,0.0002716235,0.0005840387,0.0024025354],"category_scores_gemma":[0.0010712066,0.00052734016,0.00033842,0.0012253077,0.0004604178,0.00062229164,0.000749249,0.0009466764,0.0005619898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014484651,0.0001649754,0.99713814,0.000017478207,0.00000872565,0.00010729464,0.0013893363,0.00000676541,0.00013057176,0.000017784187,0.000099670535,0.0009047841],"study_design_scores_gemma":[0.0000023428727,0.00011546808,0.9887207,0.000031648786,0.000013241644,0.00019731506,0.010460379,0.000037519727,0.000055608372,0.000014464176,0.00034640607,0.0000049255264],"about_ca_topic_score_codex":0.035784908,"about_ca_topic_score_gemma":0.07758114,"teacher_disagreement_score":0.035784908,"about_ca_system_score_codex":0.0007598262,"about_ca_system_score_gemma":0.001144487,"threshold_uncertainty_score":0.07115322},"labels":[],"label_agreement":null},{"id":"W3168057438","doi":"10.1016/j.jval.2021.04.234","title":"PCN142 Patient and Caregiver Preferences in Treatment Decision Making in Multiple Myeloma — Results of a Targeted Literature Review","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CINAHL; Medicine; Family medicine; Psychology; Nursing; Psychological intervention","score_opus":0.321312210181872,"score_gpt":0.4074328189622541,"score_spread":0.08612060878038208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168057438","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019418148,0.97389436,0.0003121911,0.0033395758,0.000110078545,0.00008231264,0.00056891295,0.000002122718,0.0022722264],"genre_scores_gemma":[0.18088067,0.8155871,0.0010724425,0.0013680079,0.00020032759,0.00017195758,0.000486106,0.000005869432,0.00022742822],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937644,0.0032393106,0.0012299545,0.00026235386,0.0012901895,0.00021379051],"domain_scores_gemma":[0.9378766,0.053725924,0.004939736,0.0003074199,0.0028475937,0.0003027447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0114279995,0.00038179077,0.0017521591,0.004931151,0.00036637782,0.0027859772,0.0006105004,0.001125514,0.0040854635],"category_scores_gemma":[0.051077515,0.00028668347,0.0024236701,0.0092023285,0.00071795966,0.0015402898,0.0010212662,0.0010883139,0.00023020165],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015411917,0.0003401611,0.03260241,0.20361304,0.009363856,0.00045227094,0.0019425023,0.0013048976,0.00016689138,0.0055209124,0.007576151,0.7355758],"study_design_scores_gemma":[0.0007880248,0.00079964544,0.16270392,0.6497481,0.037953574,0.0019240081,0.009056881,0.0015538504,0.0004915182,0.010473344,0.12432565,0.00018140773],"about_ca_topic_score_codex":0.008253999,"about_ca_topic_score_gemma":0.014279578,"teacher_disagreement_score":0.0114279995,"about_ca_system_score_codex":0.0033504842,"about_ca_system_score_gemma":0.008139605,"threshold_uncertainty_score":0.06043774},"labels":[],"label_agreement":null},{"id":"W3168253197","doi":"10.1016/j.jval.2021.04.282","title":"PCN191 Cost Associated with Implementation of CAR T-Cell Therapy for the Management of Hematologic Cancers in Canada.","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Health care; Leukapheresis; Audit; Chimeric antigen receptor; Medicine; Cost driver; Unit (ring theory); Business; Operations management; Medical emergency; Immunotherapy; Cancer; Internal medicine; Stem cell; CD34","score_opus":0.07457973308357888,"score_gpt":0.3793339968645089,"score_spread":0.30475426378093007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168253197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8185087,0.012341167,0.00109231,0.061317377,0.00068460597,0.000570385,0.048495665,0.00017416527,0.05681565],"genre_scores_gemma":[0.9697304,0.005318226,0.00081720273,0.0039738864,0.00018001861,0.000098605575,0.008798948,0.00004045819,0.011042331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970204,0.00031728932,0.00012399197,0.00014347755,0.001170894,0.0012238853],"domain_scores_gemma":[0.99414647,0.0005384872,0.0011145995,0.000076659046,0.0019787985,0.0021449307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006322342,0.00022557222,0.00031358117,0.00092340796,0.0013208519,0.0015547541,0.0012608285,0.00088384637,0.007921624],"category_scores_gemma":[0.007022484,0.00024401028,0.0009000782,0.0020881363,0.00054790004,0.00043485453,0.0010242859,0.002017822,0.00034468132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025293543,0.0006190179,0.7025302,0.000641234,0.0006260358,0.0009738431,0.0005352274,0.00738349,0.0007516271,0.009734889,0.12132726,0.15234788],"study_design_scores_gemma":[0.00019901695,0.00042263523,0.9420372,0.00043805095,0.00039159268,0.00062911236,0.002094405,0.007542531,0.00051275356,0.00079012854,0.04488069,0.000061900486],"about_ca_topic_score_codex":0.9885141,"about_ca_topic_score_gemma":0.99202853,"teacher_disagreement_score":0.08393676,"about_ca_system_score_codex":0.08393676,"about_ca_system_score_gemma":0.10028286,"threshold_uncertainty_score":0.60900664},"labels":[],"label_agreement":null},{"id":"W3168706338","doi":"10.1016/j.jval.2021.04.424","title":"PDB26 Applying the Stages of Implementation Completion (SIC) Framework Retrospectively to a Community Pharmacy Clinical Intervention Implementation Project for Scaling up Future Success","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Documentation; Pharmacy; Intervention (counseling); Qualitative property; Medicine; Qualitative research; Pharmacy practice; Nursing; Medical education; Family medicine; Psychology; Computer science","score_opus":0.44011216483301235,"score_gpt":0.6095084148125154,"score_spread":0.16939624997950303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168706338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4408705,0.0009173827,0.3346519,0.013670182,0.00076680066,0.06762318,0.012485183,0.002663155,0.12635162],"genre_scores_gemma":[0.5558699,0.00029509308,0.40192217,0.0010059513,0.00003629782,0.029146438,0.0042673824,0.00022367183,0.007233044],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.92928207,0.046330128,0.0064341063,0.0025913725,0.011705974,0.003656277],"domain_scores_gemma":[0.86079293,0.043754786,0.013114662,0.01147634,0.06308966,0.0077716247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08929818,0.0010961174,0.0010193484,0.009088733,0.0044338536,0.0060222857,0.0028775297,0.0011366458,0.0055777086],"category_scores_gemma":[0.13459848,0.0012871718,0.0020936162,0.007937814,0.00230551,0.0037279867,0.0088121705,0.0033092413,0.0011818903],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010511859,0.0025776739,0.45233873,0.0019939167,0.0002956331,0.00015662998,0.01950892,0.0040430934,0.0010288588,0.028175604,0.022879634,0.46595016],"study_design_scores_gemma":[0.0012605025,0.0052667726,0.70408595,0.003907889,0.0010126279,0.00037557096,0.05334541,0.04967111,0.0113897445,0.036876872,0.13223077,0.0005767672],"about_ca_topic_score_codex":0.11036642,"about_ca_topic_score_gemma":0.20360936,"teacher_disagreement_score":0.11036642,"about_ca_system_score_codex":0.017074816,"about_ca_system_score_gemma":0.0934317,"threshold_uncertainty_score":0.47225958},"labels":[],"label_agreement":null},{"id":"W3168865188","doi":"10.1016/j.jval.2021.04.463","title":"PDG15 Trends in Utilization of Amphetamine-Containing Medications Following State Level Restriction Laws for Acute Pain Opioid Prescriptions","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Medical prescription; Amphetamine; Medicine; Opioid; Quarter (Canadian coin); Stimulant; Emergency medicine; Demography; Psychiatry; Health care; Pharmacology; Internal medicine; Law; Political science","score_opus":0.10912976396203877,"score_gpt":0.3836722561471581,"score_spread":0.27454249218511934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168865188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8813874,0.00040561796,0.0004311481,0.0013806439,0.00007843169,0.00009959775,0.10515871,0.00014509489,0.010913417],"genre_scores_gemma":[0.9291246,0.00032471315,0.00055553194,0.00095753203,0.000047843874,0.00012861362,0.05820862,0.000033947006,0.0106186075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991327,0.00009092226,0.00012422624,0.00018667997,0.00020672636,0.00025868017],"domain_scores_gemma":[0.9943341,0.0008085397,0.002694608,0.00018109038,0.001244216,0.000737361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006038132,0.00014316237,0.0002436137,0.0015785106,0.00044330128,0.0012302364,0.00089570053,0.00069209794,0.006917137],"category_scores_gemma":[0.003881769,0.0003310955,0.0007336288,0.002421378,0.00022788832,0.00066054845,0.0009275811,0.0010242601,0.00090244407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012347254,0.00011159602,0.985635,0.000063587984,0.0001318862,0.000035649766,0.000111331334,0.000281387,0.00022700265,0.0003454047,0.007872395,0.005061254],"study_design_scores_gemma":[0.000007646061,0.000036012516,0.99633104,0.000023228113,0.00001944572,0.00003260809,0.00014973123,0.00025760938,0.00014201003,0.000029983566,0.002966411,0.000004178359],"about_ca_topic_score_codex":0.1923872,"about_ca_topic_score_gemma":0.24211437,"teacher_disagreement_score":0.1923872,"about_ca_system_score_codex":0.0017576439,"about_ca_system_score_gemma":0.002640526,"threshold_uncertainty_score":0.38253474},"labels":[],"label_agreement":null},{"id":"W3168954433","doi":"10.1016/j.jval.2021.04.800","title":"PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Socioeconomic status; Expanded Disability Status Scale; Pharmacy; Family medicine; Expanded access; Environmental health; Multiple sclerosis; Internal medicine; Population; Psychiatry","score_opus":0.2693607032521882,"score_gpt":0.36455428980768195,"score_spread":0.09519358655549376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168954433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97418106,0.0098112095,0.00021695152,0.005021751,0.00013303898,0.000042576186,0.0023743953,0.000005522253,0.008213434],"genre_scores_gemma":[0.99870646,0.0005588299,0.00007345929,0.00008335063,0.000039936993,0.000007576516,0.00039590258,7.5743014e-7,0.00013386809],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983038,0.0010989214,0.00013228235,0.00006419938,0.00025860607,0.00014217036],"domain_scores_gemma":[0.9955438,0.0020765201,0.0012636872,0.00012997976,0.00036820906,0.00061776786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002284436,0.00020418581,0.000541303,0.0005530914,0.00027392348,0.00089170894,0.00024030216,0.00040017042,0.0026433545],"category_scores_gemma":[0.0135604525,0.00008476406,0.0010895852,0.000789498,0.00026982187,0.00057171664,0.0007480604,0.0010498535,0.00012309138],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015995992,0.0010630927,0.8101372,0.000794953,0.0033596675,0.00038849175,0.00021050383,0.0066700527,0.00025076288,0.003895848,0.004808659,0.15242463],"study_design_scores_gemma":[0.0009879607,0.0037447086,0.97024035,0.0006022537,0.0014713231,0.0004987363,0.00048147043,0.01228205,0.000240995,0.0042674146,0.005138188,0.000044602515],"about_ca_topic_score_codex":0.00506547,"about_ca_topic_score_gemma":0.005649605,"teacher_disagreement_score":0.00506547,"about_ca_system_score_codex":0.0017037434,"about_ca_system_score_gemma":0.0009419632,"threshold_uncertainty_score":0.0123615265},"labels":[],"label_agreement":null},{"id":"W3168988530","doi":"10.1016/j.jval.2021.04.019","title":"CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Chronic lymphocytic leukemia; Randomized controlled trial; Quality of life (healthcare); Oncology; Gastroenterology; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.11065497743286437,"score_gpt":0.3871581889329666,"score_spread":0.27650321150010226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168988530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619177,0.010207029,0.0008115897,0.0009251866,0.00046273385,0.0013918371,0.018770184,0.000084096835,0.0054296767],"genre_scores_gemma":[0.97245556,0.0024419834,0.0009781397,0.0012806753,0.000305405,0.0019214068,0.016621653,0.000033960918,0.0039612013],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99825233,0.0010359872,0.00008631402,0.00022372424,0.00017305755,0.00022865304],"domain_scores_gemma":[0.99730754,0.0009170704,0.00080850377,0.0001932879,0.00023326026,0.0005403087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029299064,0.0014011827,0.0021655746,0.00048614465,0.0005284205,0.0010412604,0.0012866135,0.0010760706,0.0076823165],"category_scores_gemma":[0.0034784868,0.0003814068,0.0051312624,0.00070575834,0.000655886,0.0010230347,0.0007535532,0.0028482203,0.0005913427],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95284855,0.0016501358,0.009404227,0.0010999852,0.011274557,0.000057565114,0.000039613948,0.001325857,0.0011024647,0.00022816569,0.0044317083,0.0165372],"study_design_scores_gemma":[0.8715861,0.048370488,0.05790792,0.00024994285,0.013614571,0.00013892312,0.000089025336,0.0015150242,0.0008110573,0.00073997315,0.0049078427,0.00006920438],"about_ca_topic_score_codex":0.0044086836,"about_ca_topic_score_gemma":0.0102043,"teacher_disagreement_score":0.0076823165,"about_ca_system_score_codex":0.0016600548,"about_ca_system_score_gemma":0.0020523984,"threshold_uncertainty_score":0.025699914},"labels":[],"label_agreement":null},{"id":"W3169082367","doi":"10.1016/j.jval.2021.04.1238","title":"PIN50 Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19: A Comparison of Two Methods","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Vancouver Coastal Health","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Reproduction; Computer science; Data science; Statistics; Biology; Mathematics; Medicine; Virology; Infectious disease (medical specialty)","score_opus":0.24816327956777595,"score_gpt":0.4887703199853104,"score_spread":0.24060704041753445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169082367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4158987,0.0089271,0.30291674,0.0013866244,0.001930361,0.0013330719,0.21327455,0.02739084,0.02694197],"genre_scores_gemma":[0.6072421,0.0014702197,0.2045271,0.0007241939,0.0003907789,0.0014696869,0.1709879,0.0019364756,0.011251524],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973476,0.00082941534,0.00014923973,0.00091578625,0.000571537,0.00018641932],"domain_scores_gemma":[0.9903154,0.0063106106,0.00061468757,0.0017634404,0.0008063512,0.0001895379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005474872,0.0016628703,0.0013637533,0.0030859883,0.0005720235,0.0023365684,0.0031181388,0.0017936409,0.012653179],"category_scores_gemma":[0.02632661,0.0006810646,0.0014649978,0.0022842567,0.00044117452,0.0018146676,0.0019944108,0.0013116166,0.007566169],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063324487,0.0011703188,0.31867734,0.0030735899,0.0037375183,0.00038796724,0.0005777696,0.16623752,0.008762193,0.011116292,0.0880618,0.3918652],"study_design_scores_gemma":[0.0007878431,0.001144519,0.14993256,0.0006968613,0.00087204535,0.0008443951,0.00077785173,0.7436666,0.015330284,0.017450545,0.06795316,0.00054337515],"about_ca_topic_score_codex":0.0146132605,"about_ca_topic_score_gemma":0.014282659,"teacher_disagreement_score":0.0146132605,"about_ca_system_score_codex":0.00077635807,"about_ca_system_score_gemma":0.0013339822,"threshold_uncertainty_score":0.042329073},"labels":[],"label_agreement":null},{"id":"W3169107845","doi":"10.1016/j.jval.2021.04.604","title":"PMD6 Procedure Cost-Comparison Analysis of Liquid Embolic System Techniques Using EVOH and n-BCA in the Embolization of Brain Arteriovenous Malformations","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Balloon; Embolization; Medicine; Balloon catheter; Surgery; Cyanoacrylate; Arteriovenous malformation; Biomedical engineering; Materials science; Nanotechnology","score_opus":0.044871895607436145,"score_gpt":0.34379141436094046,"score_spread":0.2989195187535043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169107845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946737,0.0022766045,0.0011708332,0.00014495896,0.000035966706,0.00006330904,0.00063792017,0.000012446582,0.0009842489],"genre_scores_gemma":[0.9978544,0.0005131174,0.0006072707,0.000028989269,0.00003011206,0.000034023597,0.00050939096,0.000008006335,0.00041465633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982284,0.0008548348,0.00016071355,0.00018500275,0.0004138926,0.00015713142],"domain_scores_gemma":[0.996725,0.0020750917,0.0005323301,0.00016055632,0.00031211806,0.00019495357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016130912,0.00039705867,0.00086668314,0.0015163175,0.0001537967,0.0007783092,0.000587478,0.00041829975,0.0047007077],"category_scores_gemma":[0.0060544102,0.0001845481,0.0023524875,0.00137818,0.00026930092,0.0008191035,0.0004882628,0.0004536088,0.0002962558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17202064,0.0030620592,0.40213564,0.0023441557,0.0064275125,0.00078827445,0.00028143564,0.036625665,0.0059829694,0.0029051495,0.0026049889,0.36482152],"study_design_scores_gemma":[0.002887592,0.03660293,0.8850058,0.00028102708,0.0064118034,0.0021326784,0.00061233196,0.05336356,0.0056869257,0.0012828443,0.0055932608,0.00013931221],"about_ca_topic_score_codex":0.002231303,"about_ca_topic_score_gemma":0.0021584344,"teacher_disagreement_score":0.0047007077,"about_ca_system_score_codex":0.0017455958,"about_ca_system_score_gemma":0.00063699874,"threshold_uncertainty_score":0.015725493},"labels":[],"label_agreement":null},{"id":"W3169421399","doi":"10.1016/j.jval.2021.04.1109","title":"PSS8 The Economic Burden of Macular Edema (ME) Associated with Non-infectious Uveitis (NIU) – A US Commercial Payer’s Perspective","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Pharmacy; Health plan; Health care; Medical costs; Macular edema; Indirect costs; Emergency medicine; Surgery; Family medicine","score_opus":0.017764460271561255,"score_gpt":0.28811739745547454,"score_spread":0.2703529371839133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169421399","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06344237,0.14593886,0.0010582105,0.7245806,0.0069063674,0.000025624146,0.0022938843,0.000033393742,0.05572064],"genre_scores_gemma":[0.72844267,0.15324663,0.001309998,0.06904754,0.04209813,0.00003154332,0.0013424283,0.000043929176,0.0044371276],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9986223,0.00056131935,0.00012584148,0.00007192387,0.00039662616,0.00022200175],"domain_scores_gemma":[0.9935069,0.0021655671,0.0015868192,0.00013979033,0.00152488,0.0010760862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021270248,0.00031336,0.0004209089,0.0014742757,0.00056479505,0.0038383591,0.00035903804,0.002549063,0.0074358755],"category_scores_gemma":[0.009078635,0.00015738612,0.00088392687,0.0017232365,0.0008655665,0.0014842984,0.0010264614,0.0038174014,0.0005395099],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012250697,0.00046551554,0.123848274,0.0013237348,0.0015939934,0.0023887882,0.0005838422,0.003847131,0.0012144116,0.10441246,0.39320666,0.36589006],"study_design_scores_gemma":[0.00033386308,0.000966156,0.26071864,0.010387567,0.0012549745,0.0069319173,0.004691982,0.0062137446,0.00074135565,0.08608931,0.62139,0.00028047434],"about_ca_topic_score_codex":0.010610871,"about_ca_topic_score_gemma":0.017035764,"teacher_disagreement_score":0.010610871,"about_ca_system_score_codex":0.0022879438,"about_ca_system_score_gemma":0.003092363,"threshold_uncertainty_score":0.024875522},"labels":[],"label_agreement":null},{"id":"W3169494821","doi":"10.1016/j.jval.2021.04.1221","title":"PIN33 How Does Mortality Differ In Early Vs. Late Diagnosed Nontuberculous Mycobacterial Lung Disease Among Patients With Chronic Obstructive Pulmonary Disease (COPD)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Internal medicine; Disease; Obstructive lung disease; Nontuberculous mycobacteria; Pediatrics; Tuberculosis; Pathology; Mycobacterium","score_opus":0.01430568836790284,"score_gpt":0.26565550981760727,"score_spread":0.2513498214497044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169494821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921061,0.0017002863,0.0002665585,0.0010387662,0.000198063,0.000020054882,0.001582786,0.0000087102935,0.003078662],"genre_scores_gemma":[0.9983296,0.00019381416,0.00004435725,0.00023421833,0.00010446678,0.000011365569,0.00062753493,0.0000041443377,0.0004505107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983942,0.0004302001,0.0001331015,0.0003704474,0.00019532286,0.00047676158],"domain_scores_gemma":[0.9966101,0.0011209884,0.0010586405,0.0002285143,0.00031979074,0.0006619025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012776569,0.0004426223,0.00063132134,0.00072533987,0.00055975653,0.00215735,0.0008544771,0.0015186375,0.0050228536],"category_scores_gemma":[0.008053767,0.00034974088,0.0022784348,0.0009014025,0.00049365766,0.0017114719,0.0013082736,0.0018408861,0.0011476639],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079067,0.000060129612,0.99378467,0.00005215062,0.00043241328,0.00009460176,0.0001247936,0.00009372244,0.000152308,0.0001080489,0.0004983047,0.0038082267],"study_design_scores_gemma":[0.000028223574,0.00028145075,0.99708253,0.00004901326,0.0002456555,0.00021459378,0.00066831964,0.0003812771,0.00009259441,0.0003595336,0.0005811265,0.000015694228],"about_ca_topic_score_codex":0.0035717664,"about_ca_topic_score_gemma":0.0043886304,"teacher_disagreement_score":0.0050228536,"about_ca_system_score_codex":0.00050572574,"about_ca_system_score_gemma":0.0004558679,"threshold_uncertainty_score":0.016803145},"labels":[],"label_agreement":null},{"id":"W3169681939","doi":"10.1016/j.jval.2021.04.111","title":"PCN19 Beyond a Binary Endpoint: Longitudinal and Individual Symptom Analyses from the Simplify-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor Naive Myelofibrosis Patients","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sierra Wireless (Canada); St. Paul's Hospital; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Ruxolitinib; Repeated measures design; Myelofibrosis; Medicine; Population; Clinical endpoint; Random effects model; Clinical trial; Internal medicine; Statistics; Mathematics; Meta-analysis","score_opus":0.0983970036572504,"score_gpt":0.3711097913004383,"score_spread":0.2727127876431879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169681939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423164,0.002340158,0.00033133905,0.00028134626,0.000033999404,0.00004372589,0.00155109,0.000028152754,0.0011584153],"genre_scores_gemma":[0.9958619,0.00041849606,0.0002980239,0.00020710715,0.00008415318,0.000028377615,0.0026932063,0.000008931457,0.00039976725],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991924,0.00039146864,0.000050290622,0.00015055673,0.00011585793,0.00009938816],"domain_scores_gemma":[0.9979133,0.00072030356,0.00061201164,0.0003494641,0.00012195838,0.00028293152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027437743,0.0004922865,0.0012739956,0.0002636603,0.00026940645,0.001000522,0.0003904298,0.00049947243,0.001586431],"category_scores_gemma":[0.003821382,0.00020039755,0.0016239632,0.00036995203,0.0003600394,0.0007344686,0.0005079483,0.0013363925,0.00019780023],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2762256,0.003005097,0.5207485,0.00063661416,0.009668444,0.00034148258,0.00029108932,0.0034278722,0.011551069,0.0007455813,0.005812117,0.16754657],"study_design_scores_gemma":[0.010077443,0.016833782,0.96124065,0.00006178997,0.0034985663,0.000252228,0.00010492221,0.0022218726,0.0016663871,0.00069060305,0.0032983362,0.000053407595],"about_ca_topic_score_codex":0.0010062534,"about_ca_topic_score_gemma":0.0028599275,"teacher_disagreement_score":0.0027437743,"about_ca_system_score_codex":0.0003533382,"about_ca_system_score_gemma":0.0005089173,"threshold_uncertainty_score":0.014510691},"labels":[],"label_agreement":null},{"id":"W3169869292","doi":"10.1016/j.jval.2021.04.210","title":"PCN118 Estimated Prevalence of Treated Locally Advanced or Metastatic Urothelial Carcinoma in Canada Using Simulation Modeling","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Incidence (geometry); Population; Disease; Metastatic Urothelial Carcinoma; Cancer; Stage (stratigraphy); Clinical trial; Internal medicine; Oncology; Demography; Urothelial carcinoma; Environmental health","score_opus":0.12021920660365858,"score_gpt":0.36470048855537374,"score_spread":0.24448128195171515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169869292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9294103,0.0007918949,0.005857223,0.0024131194,0.000080884354,0.00014435181,0.047903534,0.00036916972,0.013029502],"genre_scores_gemma":[0.9831165,0.0004359402,0.0024009296,0.0001631026,0.00001319087,0.000056607976,0.010267688,0.000042284355,0.0035037166],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99943024,0.00011720815,0.000028092316,0.0001017427,0.0001161022,0.00020657288],"domain_scores_gemma":[0.9970636,0.0009866231,0.00020637597,0.00008884445,0.0013524597,0.00030214328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075495115,0.0004389244,0.0006431812,0.0013884268,0.0011010073,0.0015657247,0.0018012285,0.000817747,0.005173441],"category_scores_gemma":[0.0050479737,0.00054590794,0.0015228137,0.0024918872,0.00049511454,0.0004574825,0.0004496321,0.0010862227,0.0003820429],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026666946,0.0001566793,0.27397978,0.00016127972,0.00040556781,0.00026765317,0.00021434299,0.69472945,0.00019335008,0.0056690527,0.015182433,0.008773688],"study_design_scores_gemma":[0.00014134544,0.00004749023,0.08979201,0.000116790354,0.0001662749,0.00011075662,0.00062853645,0.9008042,0.0002218952,0.0012727286,0.006630863,0.00006699955],"about_ca_topic_score_codex":0.99671316,"about_ca_topic_score_gemma":0.99277014,"teacher_disagreement_score":0.03446648,"about_ca_system_score_codex":0.03446648,"about_ca_system_score_gemma":0.03574603,"threshold_uncertainty_score":0.25007296},"labels":[],"label_agreement":null},{"id":"W3169975841","doi":"10.1016/j.jval.2021.04.818","title":"PND34 Healthcare Utilization and Costs at End-of-Life Among US Medicaid Beneficiaries with Huntington's Disease","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Medicine; Cohort; Emergency department; Health care; Quarter (Canadian coin); Emergency medicine; Demography; Gerontology; Family medicine; Internal medicine; Psychiatry","score_opus":0.06893559540573628,"score_gpt":0.308476524921593,"score_spread":0.2395409295158567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169975841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671715,0.00020126805,0.000022497881,0.00010373986,0.0000055752053,0.000004825739,0.0023580051,0.0000016029114,0.0005852413],"genre_scores_gemma":[0.99718946,0.00013215501,0.000029384795,0.000054030734,0.000009780562,0.000008571925,0.0021815426,0.0000012055305,0.00039390827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971825,0.0000450732,0.000043367683,0.000043199394,0.00006609081,0.000083901854],"domain_scores_gemma":[0.99924016,0.00010258846,0.00041554793,0.000021390399,0.000074705196,0.00014554046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027187166,0.00020983946,0.00020811394,0.0010528152,0.00040037397,0.00056600105,0.00031800772,0.0004938728,0.0020161893],"category_scores_gemma":[0.0017672081,0.00016247298,0.0006929434,0.001393501,0.00017237653,0.0006731726,0.00068243983,0.000638424,0.00014952284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008772561,0.000040430416,0.9984901,0.00000561848,0.0000625681,0.000050859646,0.000028287659,0.00007775439,0.00005430932,0.000046543333,0.00022260558,0.00083314884],"study_design_scores_gemma":[0.000003692441,0.000026827915,0.99916804,0.0000100619645,0.0000263301,0.00011270506,0.00015100054,0.00026330893,0.000018530365,0.000044503184,0.00017148389,0.000003404914],"about_ca_topic_score_codex":0.04109199,"about_ca_topic_score_gemma":0.048727218,"teacher_disagreement_score":0.04109199,"about_ca_system_score_codex":0.00090280996,"about_ca_system_score_gemma":0.0005899205,"threshold_uncertainty_score":0.08170557},"labels":[],"label_agreement":null},{"id":"W3170184488","doi":"10.1016/j.jval.2021.04.537","title":"PIH19 Dosing and Safety of Medical Cannabis in Children: Preliminary Findings from a Living Systematic Review","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Dosing; Cannabis; Cannabidiol; MEDLINE; Adverse effect; Population; Psychiatry; Internal medicine; Environmental health","score_opus":0.02391460586121771,"score_gpt":0.3241359134724661,"score_spread":0.30022130761124843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170184488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016141294,0.9806161,0.00022515943,0.00057486165,0.00014942286,0.00013900538,0.0014127753,0.000010879689,0.00073041563],"genre_scores_gemma":[0.32183683,0.6727807,0.0013343096,0.0021824164,0.00025072802,0.0002699314,0.001016713,0.000020077483,0.0003081858],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9932841,0.0024677373,0.002122129,0.00086187257,0.0010069745,0.00025721596],"domain_scores_gemma":[0.9570589,0.033854198,0.006631521,0.00065873074,0.0014810907,0.0003155619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006467334,0.0006369994,0.0037178847,0.0019355014,0.00035299073,0.0019383333,0.0010157562,0.0015975297,0.0031287575],"category_scores_gemma":[0.05101136,0.0006649766,0.00798863,0.0031961026,0.00074825325,0.0014002763,0.0011446025,0.0014217212,0.0002178319],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059418087,0.000083551466,0.03390083,0.6632438,0.2136703,0.00035085686,0.000722032,0.00032896816,0.00057078444,0.00042241055,0.002933874,0.07783074],"study_design_scores_gemma":[0.0033607902,0.0010941697,0.08243412,0.20552862,0.6864676,0.00067216647,0.000604285,0.00018089078,0.00052738877,0.0007682168,0.018247137,0.00011463016],"about_ca_topic_score_codex":0.012125138,"about_ca_topic_score_gemma":0.033881404,"teacher_disagreement_score":0.012125138,"about_ca_system_score_codex":0.0016512171,"about_ca_system_score_gemma":0.0045313304,"threshold_uncertainty_score":0.034202933},"labels":[],"label_agreement":null},{"id":"W3170379224","doi":"10.1016/j.jval.2021.04.829","title":"PND45 Epidemiology, Treatment Landscape, and Healthcare Utilization for Patients with Migraine in Canada: A Literature Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Migraine; Medicine; Epidemiology; MEDLINE; Chronic Migraine; Health care; Disease burden; Disease; Burden of disease; Pediatrics; Emergency medicine; Psychiatry; Internal medicine","score_opus":0.18950456692383275,"score_gpt":0.41593242209848463,"score_spread":0.2264278551746519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170379224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007576425,0.9977842,0.000018034129,0.0003189728,0.000046846788,0.000015448313,0.0006737345,0.0000025999414,0.0003824709],"genre_scores_gemma":[0.0055569126,0.9937125,0.00014394891,0.00023674953,0.000031297302,0.000013144044,0.0002365823,0.0000010257069,0.00006782503],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99874085,0.00014433198,0.00037649865,0.00015157442,0.0004601266,0.0001266598],"domain_scores_gemma":[0.99462247,0.0026133766,0.0011093755,0.00006129244,0.0013368409,0.00025665923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00218104,0.0006277981,0.002281788,0.009778241,0.00088130037,0.002530211,0.0011630856,0.0010101873,0.004488653],"category_scores_gemma":[0.009258911,0.00042818132,0.003265684,0.02446456,0.00072342454,0.0008487675,0.0010024422,0.0010809498,0.00022301626],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042215074,0.0001268357,0.037660062,0.4616281,0.007259551,0.000364967,0.0006711279,0.0005161779,0.0002211938,0.0020395508,0.033346627,0.45574373],"study_design_scores_gemma":[0.00021485383,0.00015136156,0.17306463,0.5613073,0.040048134,0.0014032092,0.0017928159,0.0003782439,0.00019795432,0.0011459445,0.22011971,0.00017577868],"about_ca_topic_score_codex":0.6723151,"about_ca_topic_score_gemma":0.8249917,"teacher_disagreement_score":0.32768488,"about_ca_system_score_codex":0.012489564,"about_ca_system_score_gemma":0.049253028,"threshold_uncertainty_score":0.65922934},"labels":[],"label_agreement":null},{"id":"W3170496984","doi":"10.1016/j.jval.2021.04.1249","title":"PIN61 Switch Patterns Among Patients Claiming Antifungal Therapies for Onychomycosis in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Terbinafine; Itraconazole; Medicine; Dermatology; Onycholysis; Antifungal; Nail (fastener)","score_opus":0.02905417858433395,"score_gpt":0.28241707516934383,"score_spread":0.2533628965850099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170496984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98867315,0.0008812333,0.0000742272,0.00086455425,0.00002142654,0.000041087493,0.0035324728,0.000011541678,0.0059002223],"genre_scores_gemma":[0.9971848,0.0005229138,0.000064513864,0.0002995509,0.000006870797,0.000008208873,0.0007854625,0.0000073431534,0.0011202071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857783,0.000054919125,0.0001032679,0.00021667618,0.00041051192,0.00063663936],"domain_scores_gemma":[0.9970197,0.00020742665,0.0008150675,0.000051855674,0.0010493017,0.0008566275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031737715,0.00020354765,0.000365681,0.0015698172,0.0019702043,0.0016976884,0.0010573464,0.0006453192,0.005674722],"category_scores_gemma":[0.002213896,0.00028398813,0.0006340046,0.004422273,0.0007383476,0.00044871747,0.00076945353,0.0010772521,0.00037235412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093875526,0.00004519149,0.9931758,0.00002695634,0.000033852575,0.0003043323,0.0006400074,0.00007641786,0.00023896746,0.0002191561,0.0013083783,0.003837079],"study_design_scores_gemma":[0.000007674625,0.000026376407,0.9949457,0.00006544237,0.000024030312,0.00035409792,0.0028552043,0.0002433546,0.00007936521,0.000051712927,0.0013320282,0.000015008342],"about_ca_topic_score_codex":0.9797106,"about_ca_topic_score_gemma":0.9876035,"teacher_disagreement_score":0.020289421,"about_ca_system_score_codex":0.019651916,"about_ca_system_score_gemma":0.020694314,"threshold_uncertainty_score":0.14258534},"labels":[],"label_agreement":null},{"id":"W3170732077","doi":"10.1016/j.jval.2021.04.079","title":"PBI8 Economic Impact of an Originator-to-Biosimilar Non-Medical Switch in the Real-World Setting: A Systematic Literature Review","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Biosimilar; Medicine; MEDLINE; Systematic review; Health care; Actuarial science; Business; Political science; Internal medicine","score_opus":0.02852181198879856,"score_gpt":0.3766476230798687,"score_spread":0.34812581109107016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170732077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0060677095,0.988706,0.0002572596,0.0010544657,0.00024324583,0.00027659844,0.0024634292,0.000008466238,0.00092277426],"genre_scores_gemma":[0.08227584,0.91252524,0.0010565073,0.0018073961,0.0002763308,0.00043844458,0.0013291888,0.000019164263,0.0002718395],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98854697,0.004175596,0.0037532242,0.0009778996,0.0020347007,0.00051167246],"domain_scores_gemma":[0.92421013,0.0575146,0.01290194,0.00074935006,0.0039972616,0.0006266658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014611234,0.0010560603,0.005217059,0.0075927903,0.00040624337,0.003709173,0.0014272024,0.0022554144,0.009052287],"category_scores_gemma":[0.068821244,0.0006901277,0.010777647,0.008963714,0.00094290165,0.0021303936,0.0017293023,0.0023326045,0.0004999085],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029183254,0.00008978044,0.008351205,0.84294057,0.06138573,0.00026989996,0.0001918184,0.00049337087,0.00024302314,0.0010247466,0.0041919174,0.07789958],"study_design_scores_gemma":[0.0015529935,0.0007266545,0.023518939,0.6688223,0.26878196,0.00082740077,0.0006080016,0.0003834894,0.00038163492,0.0013168602,0.03298789,0.00009181942],"about_ca_topic_score_codex":0.00920682,"about_ca_topic_score_gemma":0.018654674,"teacher_disagreement_score":0.014611234,"about_ca_system_score_codex":0.0049621295,"about_ca_system_score_gemma":0.011796389,"threshold_uncertainty_score":0.077272475},"labels":[],"label_agreement":null},{"id":"W3170763689","doi":"10.1016/j.jval.2021.04.327","title":"PCN237 Patterns of Healthcare Resource Utilization (HRU) in Unfit Patients with Acute Myeloid Leukemia (AML) Receiving First-line Systemic Treatment or Best Supportive Care (BSC): A Multicenter International Study (CURRENT)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Retrospective cohort study; Pediatrics; Myeloid leukemia","score_opus":0.06428564752719745,"score_gpt":0.3636105994002395,"score_spread":0.29932495187304203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170763689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99852884,0.00014707896,0.000021610005,0.0000477378,0.0000038064918,0.0000066883977,0.0008724364,0.0000013150681,0.00037047232],"genre_scores_gemma":[0.9986694,0.00008640091,0.00003559958,0.000044750737,0.000009853654,0.000011139467,0.0010392745,0.0000017295275,0.00010178554],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994641,0.00017195038,0.000056832334,0.0000926229,0.0000852524,0.00012919391],"domain_scores_gemma":[0.99884135,0.00014623672,0.0005741705,0.000048828788,0.00010894318,0.00028049923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005344641,0.0002754332,0.00031308288,0.0008089631,0.0003747831,0.00096188753,0.0005287205,0.00042647062,0.0015356928],"category_scores_gemma":[0.0015766601,0.00018400568,0.00050297467,0.0024108652,0.0003168227,0.0005794827,0.0006141716,0.0005234136,0.00028354634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016610944,0.000040238494,0.9986259,0.000004711641,0.000060439706,0.000018190782,0.000038182225,0.000026055652,0.00006249454,0.000014984135,0.00012937664,0.0008132811],"study_design_scores_gemma":[0.000011679852,0.00007452815,0.9993144,0.000003602116,0.000023897122,0.000058690428,0.00020575782,0.000100709425,0.00003041447,0.000011885107,0.00016139584,0.0000030128078],"about_ca_topic_score_codex":0.01696075,"about_ca_topic_score_gemma":0.016387984,"teacher_disagreement_score":0.01696075,"about_ca_system_score_codex":0.0007398137,"about_ca_system_score_gemma":0.0005144324,"threshold_uncertainty_score":0.03372401},"labels":[],"label_agreement":null},{"id":"W3170829278","doi":"10.1016/j.jval.2021.04.821","title":"PND37 Cost-Effectiveness of BoNT-A Products for Treatment of Pediatric Spasticity in the United Kingdom","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Spasticity; Physical therapy; Clinical trial; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.1719244336872071,"score_gpt":0.3721468767769931,"score_spread":0.20022244308978598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170829278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9496216,0.0359179,0.00018408347,0.0018933943,0.00016756356,0.0000708894,0.005135363,0.000017092574,0.006992147],"genre_scores_gemma":[0.99465454,0.0034986183,0.0001210444,0.00023039276,0.000021633234,0.000024729878,0.00079937285,0.0000042901033,0.0006453494],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979442,0.0009907073,0.0002818915,0.00014914683,0.00037475774,0.0002593298],"domain_scores_gemma":[0.99720335,0.0011661506,0.00075160904,0.00004653294,0.0004751323,0.00035713345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010334388,0.00031716752,0.0008020759,0.0008818493,0.00017678407,0.0011388643,0.00035239125,0.0008498621,0.0037810865],"category_scores_gemma":[0.0071713524,0.0002775918,0.0019434319,0.00091549865,0.00029428495,0.000540919,0.0007380219,0.00061475456,0.00021100213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044332698,0.00063996314,0.5991977,0.00787318,0.006383634,0.003090149,0.00088167057,0.035151344,0.0036741653,0.0048704944,0.019743646,0.27416137],"study_design_scores_gemma":[0.0022544372,0.0056874794,0.9611771,0.0023884824,0.002863003,0.0019973796,0.0011240587,0.008830751,0.0012324555,0.00028144798,0.012077148,0.00008633009],"about_ca_topic_score_codex":0.13061097,"about_ca_topic_score_gemma":0.12379479,"teacher_disagreement_score":0.13061097,"about_ca_system_score_codex":0.010283185,"about_ca_system_score_gemma":0.0026039258,"threshold_uncertainty_score":0.2597015},"labels":[],"label_agreement":null},{"id":"W3170955787","doi":"10.1016/j.jval.2021.04.1019","title":"PRO34 Challenges in the Estimation of Birth Prevalence for Rare Diseases: A Case Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Epidemiology; Medicine; Population; Prevalence; Estimation; Pediatrics; Demography; Environmental health; Pathology","score_opus":0.1521987731504998,"score_gpt":0.4141682704890762,"score_spread":0.2619694973385764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170955787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9640567,0.0032575969,0.010083137,0.0116709,0.00022388707,0.0001833926,0.0006368519,0.00005022375,0.009837349],"genre_scores_gemma":[0.98996395,0.0024547982,0.005160228,0.0008387667,0.00017175918,0.000050164806,0.0001559261,0.000043942615,0.0011605796],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99646395,0.0018668317,0.00043364568,0.0003810207,0.0005440744,0.0003104637],"domain_scores_gemma":[0.9859475,0.009980447,0.0012574797,0.0008706246,0.0014364683,0.00050741114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004359682,0.00054836454,0.0005798825,0.0024037287,0.001908453,0.0020994763,0.0012818128,0.0027888955,0.005267017],"category_scores_gemma":[0.033868678,0.0004583974,0.0005338755,0.0012908126,0.0011620601,0.0015313441,0.0014276521,0.0019933025,0.00061106886],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003023941,0.00057636254,0.587486,0.00030496862,0.000079009194,0.33527112,0.008424048,0.0006575682,0.0012102571,0.005559569,0.0051010274,0.05502763],"study_design_scores_gemma":[0.00003582131,0.0005423648,0.14369142,0.0010552892,0.00019834026,0.8054181,0.016773226,0.005440425,0.0023974767,0.008767569,0.015552212,0.00012777254],"about_ca_topic_score_codex":0.009231281,"about_ca_topic_score_gemma":0.0061862874,"teacher_disagreement_score":0.009231281,"about_ca_system_score_codex":0.0012631328,"about_ca_system_score_gemma":0.0010875423,"threshold_uncertainty_score":0.023056448},"labels":[],"label_agreement":null},{"id":"W3171123541","doi":"10.1016/j.jval.2021.04.096","title":"PCN4 Carfilzomib in Combination with Dexamethasone (Kd) Versus Pomalidomide in Combination with Bortezomib and Dexamethasone (PVd): A Matching Adjusted Indirect Treatment Comparison (MAIC)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Carfilzomib; Hazard ratio; Internal medicine; Oncology; Multiple myeloma; Dexamethasone; Surgery; Confidence interval","score_opus":0.08798981438038964,"score_gpt":0.35239230713077546,"score_spread":0.26440249275038585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171123541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97176623,0.0100759715,0.002660323,0.00077995064,0.002044766,0.0021663974,0.0033667197,0.00012870935,0.0070110126],"genre_scores_gemma":[0.9920541,0.0011441084,0.0017625601,0.000362383,0.00024044195,0.0010585274,0.00072072004,0.000016439733,0.0026408252],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99385273,0.0041475184,0.00038127627,0.00059709174,0.00037364473,0.00064772385],"domain_scores_gemma":[0.9978333,0.0011590349,0.00041612322,0.00021270769,0.00009063739,0.00028816206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032166569,0.0021956647,0.004145159,0.00080474507,0.00035311174,0.0013232362,0.0017113741,0.0019883276,0.014200561],"category_scores_gemma":[0.0056878403,0.00084292307,0.00647459,0.00060827244,0.00096341845,0.001455065,0.0012908224,0.0038366183,0.0008081225],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9789893,0.0013010585,0.0010222838,0.00060416386,0.0075338525,0.000022632463,0.000032221993,0.0006704736,0.0004600749,0.00029731393,0.00045077366,0.008615881],"study_design_scores_gemma":[0.7854931,0.15603329,0.014391291,0.00033353583,0.028215917,0.00010974431,0.00019364602,0.007170851,0.0017637517,0.0024837353,0.0037011376,0.00010994167],"about_ca_topic_score_codex":0.0037820784,"about_ca_topic_score_gemma":0.0048282756,"teacher_disagreement_score":0.014200561,"about_ca_system_score_codex":0.0015787685,"about_ca_system_score_gemma":0.0014546424,"threshold_uncertainty_score":0.047505617},"labels":[],"label_agreement":null},{"id":"W3171180990","doi":"10.1016/j.jval.2021.04.481","title":"PDG33 Awareness and Consideration of Confidential Listing Agreements in Cost-Effectiveness Evaluation By Health Technology Assessment (HTA) Bodies","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Listing (finance); Confidentiality; Jurisdiction; Business; Health technology; Cost–benefit analysis; Actuarial science; Accounting; Health care; Finance; Political science; Law","score_opus":0.4948930189948507,"score_gpt":0.5157849277552804,"score_spread":0.020891908760429678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171180990","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007187864,0.0026826113,0.038507257,0.74323237,0.014475613,0.0015283586,0.0013314851,0.0012924139,0.18976198],"genre_scores_gemma":[0.13251737,0.0021547303,0.07224331,0.65672404,0.01247066,0.0028703911,0.0017977633,0.0012893112,0.11793243],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.75994045,0.13578643,0.0296869,0.00800827,0.055931844,0.0106461095],"domain_scores_gemma":[0.33200178,0.4646867,0.02573058,0.044330444,0.11834002,0.014910507],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.246784,0.0008303935,0.0014073149,0.0031222769,0.0049950867,0.017594628,0.006750851,0.05563637,0.026058575],"category_scores_gemma":[0.48104197,0.0020574988,0.0025219915,0.003012276,0.006167691,0.012930779,0.009803326,0.030400747,0.011222967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002962422,0.00033285448,0.0061798166,0.0006842274,0.000069957976,0.00069560506,0.0015529258,0.001049041,0.0008904225,0.12448934,0.77054036,0.09321922],"study_design_scores_gemma":[0.00017982941,0.00013868802,0.004701587,0.0020976625,0.00006989917,0.0006581529,0.0007025277,0.0025708573,0.0012352372,0.03743525,0.95006335,0.00014694518],"about_ca_topic_score_codex":0.0071060206,"about_ca_topic_score_gemma":0.0074793063,"teacher_disagreement_score":0.246784,"about_ca_system_score_codex":0.0069834003,"about_ca_system_score_gemma":0.035584025,"threshold_uncertainty_score":0.92884946},"labels":[],"label_agreement":null},{"id":"W3171367633","doi":"10.1016/j.jval.2021.04.268","title":"PCN177 Trends in Canadian Oncology Health Technology Assessment","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Internal medicine; Categorical variable; Oncology; Family medicine; Health care; Statistics; Mathematics","score_opus":0.46681475869174616,"score_gpt":0.5055276278036891,"score_spread":0.03871286911194294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171367633","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2064912,0.047030687,0.0029477456,0.050581973,0.0021805007,0.0002360677,0.48678878,0.00093773863,0.20280536],"genre_scores_gemma":[0.66262776,0.03905261,0.0039102193,0.00660367,0.0010798505,0.00020163828,0.22192052,0.0003720375,0.06423177],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9946144,0.00025973134,0.00042483135,0.00041671091,0.0034020736,0.0008822822],"domain_scores_gemma":[0.95761293,0.0023206961,0.0026722122,0.0005745153,0.034105048,0.0027146698],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.003511375,0.00062940904,0.0007262601,0.011918935,0.0015902354,0.003585888,0.0018470417,0.0010248862,0.013878599],"category_scores_gemma":[0.023846103,0.00037437244,0.0014401068,0.023519306,0.00067672424,0.0012103671,0.0010738233,0.0020245556,0.0023968345],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005252949,0.00009703686,0.27480632,0.001154167,0.0002832581,0.00016944295,0.0004998613,0.0042385617,0.0003497222,0.018147182,0.50850403,0.19122514],"study_design_scores_gemma":[0.00003682851,0.000051200663,0.67788935,0.0004955851,0.00012623423,0.00022080234,0.0005468669,0.002708391,0.00046395132,0.0006923461,0.31670877,0.000059682305],"about_ca_topic_score_codex":0.99244046,"about_ca_topic_score_gemma":0.9916441,"teacher_disagreement_score":0.99648863,"about_ca_system_score_codex":0.09059861,"about_ca_system_score_gemma":0.10288447,"threshold_uncertainty_score":0.657342},"labels":[],"label_agreement":null},{"id":"W3171413946","doi":"10.1016/j.jval.2021.04.276","title":"PCN185 Identification of Gaps and Opportunities for Provincial Reimbursement of Oncology Companion Diagnostics in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Health technology; Family medicine; Stakeholder; Agency (philosophy); Health care; Oncology; Political science; Public relations","score_opus":0.5090590351128075,"score_gpt":0.4255924511664017,"score_spread":0.08346658394640577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171413946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8576175,0.0049322005,0.0014544976,0.050821137,0.0002747932,0.00021479678,0.04322774,0.000116032075,0.041341245],"genre_scores_gemma":[0.9873705,0.0009599166,0.0008797684,0.0011804169,0.00002948723,0.000050057537,0.0053947214,0.000026945774,0.0041082227],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99395764,0.00058524293,0.00030090666,0.00030926167,0.0017900033,0.0030568345],"domain_scores_gemma":[0.9665787,0.00564162,0.0030222898,0.00060127367,0.017959341,0.006196805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035127734,0.00020646479,0.0007357211,0.0030639863,0.002664277,0.00399515,0.0018030772,0.0008786659,0.006080784],"category_scores_gemma":[0.028910358,0.00041012792,0.00081746257,0.008162774,0.00086486567,0.0008917009,0.0018674281,0.001510609,0.00029393416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060299656,0.0001828316,0.81465364,0.00046936612,0.00023260452,0.0003109065,0.0020392975,0.0049800198,0.0001831651,0.028194856,0.08810099,0.060049355],"study_design_scores_gemma":[0.00010742941,0.00005719376,0.9418209,0.0006306732,0.00013971288,0.00012709906,0.0067937286,0.015290054,0.0002749228,0.0030900969,0.031610463,0.000057751284],"about_ca_topic_score_codex":0.997488,"about_ca_topic_score_gemma":0.99800366,"teacher_disagreement_score":0.87929,"about_ca_system_score_codex":0.120709985,"about_ca_system_score_gemma":0.30494747,"threshold_uncertainty_score":0.87581635},"labels":[],"label_agreement":null},{"id":"W3171432099","doi":"10.1016/j.jval.2021.04.453","title":"PDG5 Changes in Canadian Guidelines for Conducting Budget IMPACT Analysis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transparency (behavior); Best practice; Consistency (knowledge bases); Flexibility (engineering); Population; Presentation (obstetrics); Resource (disambiguation); Cornerstone; Pharmaceutical policy; Risk analysis (engineering); Computer science; Operations research; Actuarial science; Medicine; Accounting; Business; Political science; Engineering; Health policy; Public health; Economics; Environmental health; Geography","score_opus":0.7389327488570064,"score_gpt":0.5343481174377673,"score_spread":0.2045846314192391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171432099","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003512518,0.010726341,0.03686736,0.27445054,0.047567878,0.007636998,0.18851876,0.0071865325,0.42353308],"genre_scores_gemma":[0.032135088,0.01128158,0.2480259,0.18882458,0.0060936944,0.008481244,0.1287894,0.007224977,0.36914355],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.88221544,0.018839898,0.014544683,0.0030097873,0.06987024,0.011519965],"domain_scores_gemma":[0.61741745,0.04147247,0.0063922172,0.013740214,0.30477217,0.016205426],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.084935136,0.0023588382,0.0026467093,0.018442763,0.0061582224,0.014627267,0.012922041,0.01270007,0.069919944],"category_scores_gemma":[0.27953294,0.002943763,0.0073949136,0.021225007,0.0037701228,0.0040059644,0.0064666932,0.012291266,0.018250158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054238666,0.000048139525,0.00082129496,0.00039405393,0.000049245282,0.00003530771,0.00014741559,0.00043626258,0.00006918744,0.007076006,0.9712461,0.019622864],"study_design_scores_gemma":[0.00010507526,0.000021004073,0.0075070714,0.0014248193,0.00008819657,0.00004462493,0.00028501495,0.00050638645,0.00022142482,0.0037707626,0.9859244,0.00010123886],"about_ca_topic_score_codex":0.96928316,"about_ca_topic_score_gemma":0.9747035,"teacher_disagreement_score":0.9150649,"about_ca_system_score_codex":0.09313583,"about_ca_system_score_gemma":0.4097863,"threshold_uncertainty_score":0.67575085},"labels":[],"label_agreement":null},{"id":"W3171555601","doi":"10.1016/j.jval.2021.04.1074","title":"PRS10 Economic Evaluation of Umeclidinium/Vilanterol Versus Umeclidinium or Salmeterol in a UK COPD Population at Low Risk of Exacerbations Using the GALAXY Model","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Salmeterol; COPD; Exacerbation; Discontinuation; Population; Internal medicine; Environmental health","score_opus":0.13333645138141373,"score_gpt":0.39433921915454717,"score_spread":0.26100276777313347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171555601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90379906,0.018278485,0.022261007,0.0073593273,0.0008625726,0.0025789556,0.0092254365,0.0004954027,0.035139777],"genre_scores_gemma":[0.9893021,0.0013308824,0.0030889884,0.00058015884,0.000062871026,0.00050944445,0.0016698029,0.000036225505,0.0034195555],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99216264,0.006664489,0.00014944118,0.00025819545,0.0002905005,0.00047468857],"domain_scores_gemma":[0.9883243,0.009955965,0.0005827974,0.00026263276,0.00032220295,0.0005520478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00977089,0.0014468398,0.0034598953,0.0007961846,0.00021771104,0.0018097742,0.0021162028,0.0018564846,0.012596461],"category_scores_gemma":[0.019787133,0.0006531551,0.0055827755,0.0007819642,0.00096892717,0.0012352084,0.001684767,0.0027240952,0.00074607274],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19674198,0.0017427576,0.010788308,0.0057691517,0.008665194,0.00062740647,0.00015736373,0.6736867,0.0010284815,0.018307816,0.015387788,0.06709709],"study_design_scores_gemma":[0.05668689,0.04551043,0.01705933,0.0015287189,0.011299043,0.00057773956,0.00060447695,0.8388973,0.0011171286,0.0131518515,0.013318382,0.00024878158],"about_ca_topic_score_codex":0.013708735,"about_ca_topic_score_gemma":0.0075911414,"teacher_disagreement_score":0.013708735,"about_ca_system_score_codex":0.0037680834,"about_ca_system_score_gemma":0.0031053158,"threshold_uncertainty_score":0.05167401},"labels":[],"label_agreement":null},{"id":"W3171594441","doi":"10.1016/j.jval.2021.04.565","title":"PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunogenicity; Adverse effect; Vaccination; Seroconversion; Placebo; Randomized controlled trial; Chills; Internal medicine; Neutralizing antibody; Immunization; Immunology; Antibody; Pathology; Alternative medicine","score_opus":0.1385991307620825,"score_gpt":0.4436223027155003,"score_spread":0.30502317195341777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171594441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018671297,0.99717206,0.00007896844,0.00009331272,0.00009967088,0.00013043555,0.00037528275,0.000005645076,0.00017765512],"genre_scores_gemma":[0.026655283,0.9719355,0.00032732694,0.0004223449,0.00008084389,0.00019161598,0.00024820754,0.0000042682195,0.00013455613],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997233,0.00078354025,0.0010699211,0.0003334228,0.00044603602,0.0001340675],"domain_scores_gemma":[0.9927389,0.004912054,0.0016463624,0.00010714489,0.0004867237,0.00010870273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003600608,0.0013146076,0.008299938,0.0030206696,0.00029932597,0.0020158428,0.0012502333,0.0017831407,0.004642817],"category_scores_gemma":[0.018545015,0.0007980482,0.010685433,0.003578651,0.0005715286,0.0011924958,0.0010556359,0.0014201108,0.0003048187],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015415504,0.00003082992,0.0012783406,0.9112948,0.048053917,0.00006368265,0.000099672354,0.00013267456,0.00023727298,0.00014434851,0.0011832644,0.03593963],"study_design_scores_gemma":[0.0025013192,0.0009984958,0.009999951,0.45065075,0.51557183,0.00029998572,0.0002687984,0.00014522653,0.00030751494,0.00044843895,0.018724982,0.00008272494],"about_ca_topic_score_codex":0.008935852,"about_ca_topic_score_gemma":0.01714429,"teacher_disagreement_score":0.008935852,"about_ca_system_score_codex":0.0021304586,"about_ca_system_score_gemma":0.0040679327,"threshold_uncertainty_score":0.019042075},"labels":[],"label_agreement":null},{"id":"W3171647414","doi":"10.1016/j.jval.2021.04.471","title":"PDG23 Comparing Average Time to Listing and Drug Coverage Rates between Provinces in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Dalhousie University","funders":"","keywords":"Listing (finance); Formulary; Reimbursement; Medicine; Family medicine; Business; Health care; Political science; Finance","score_opus":0.2749427207777276,"score_gpt":0.37667107664398813,"score_spread":0.10172835586626056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171647414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8024662,0.0051161363,0.00090672873,0.005257514,0.00023382275,0.0002508832,0.1709234,0.00018132119,0.014663994],"genre_scores_gemma":[0.9545442,0.0012305556,0.0011090379,0.00078510446,0.00003512918,0.00008058352,0.032886483,0.000051700208,0.009277257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977349,0.00026119754,0.00019079247,0.00023550828,0.0006353947,0.00094220886],"domain_scores_gemma":[0.98975265,0.0011253876,0.0009732548,0.00026842853,0.0063126814,0.0015675549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019233733,0.00039916762,0.00073406764,0.0028340912,0.0015633985,0.0017873734,0.0014307194,0.0005869142,0.0046707387],"category_scores_gemma":[0.01016047,0.00039734071,0.0017386418,0.008267656,0.00044863817,0.00046442705,0.00078514277,0.0010646229,0.00023608652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013119853,0.00013636486,0.9315014,0.00036069757,0.0011509281,0.00011611241,0.0003963867,0.0033201524,0.0001521939,0.0011393966,0.037188917,0.02322538],"study_design_scores_gemma":[0.00019593503,0.00007470521,0.98815745,0.00010720282,0.0003584325,0.000043591368,0.0009273022,0.0020927899,0.0002938796,0.00013271885,0.0075809457,0.00003500394],"about_ca_topic_score_codex":0.9987973,"about_ca_topic_score_gemma":0.99869114,"teacher_disagreement_score":0.95462453,"about_ca_system_score_codex":0.045375463,"about_ca_system_score_gemma":0.06895524,"threshold_uncertainty_score":0.32922357},"labels":[],"label_agreement":null},{"id":"W3171719546","doi":"10.1016/j.jval.2021.04.882","title":"PNS27 Amphetamine-Related Hospitalizations in the United States, 2003-2014: Examining Trends and Factors Associated with Admission Outcomes","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; University of Sudbury; University of British Columbia","funders":"","keywords":"Medicine; Amphetamine; Demography; Odds; Odds ratio; Logistic regression; Population; Pediatrics; Environmental health; Internal medicine","score_opus":0.06584952268862525,"score_gpt":0.3350995346757501,"score_spread":0.26925001198712484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171719546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911068,0.000438767,0.00007158908,0.00017788561,0.000020306952,0.000012074483,0.0071625616,0.0000103089005,0.0009997172],"genre_scores_gemma":[0.9926024,0.00060222344,0.00007690803,0.0000731959,0.000018835732,0.000017309812,0.0061194743,0.0000049491623,0.00048479647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996693,0.000041006388,0.00006171954,0.000063784115,0.000074497686,0.00008966387],"domain_scores_gemma":[0.998793,0.00009518467,0.0006366633,0.000039746134,0.00022758698,0.00020788102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032464592,0.00023253047,0.00024066238,0.0011768215,0.00040142096,0.0006908446,0.00050398416,0.00036713795,0.0014242254],"category_scores_gemma":[0.0014327563,0.00020751475,0.00065737515,0.002178018,0.00021631047,0.0006088252,0.0008610446,0.00078415463,0.00022781402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006309243,0.00002477814,0.997912,0.00001375923,0.00005298505,0.000024166744,0.000042239095,0.000044241166,0.0000581002,0.000023923722,0.00046549848,0.0012752683],"study_design_scores_gemma":[0.0000019448119,0.000017341925,0.99911696,0.000012535908,0.000016392076,0.000056995425,0.00035145186,0.00013131365,0.000026769145,0.000010330262,0.0002555174,0.000002441021],"about_ca_topic_score_codex":0.094621085,"about_ca_topic_score_gemma":0.15843943,"teacher_disagreement_score":0.094621085,"about_ca_system_score_codex":0.0010243362,"about_ca_system_score_gemma":0.0013927415,"threshold_uncertainty_score":0.18814069},"labels":[],"label_agreement":null},{"id":"W3171955094","doi":"10.1016/j.jval.2021.04.872","title":"PNS17 Value of a Comprehensive Ophthalmology Custom Pack in a Canadian Setting","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Healthcare and Medical Tourism","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cataract surgery; Operations management; Commodity; Supply chain; Business; Surgery; Engineering; Marketing; Finance","score_opus":0.11033175135646203,"score_gpt":0.4529946908160473,"score_spread":0.34266293945958526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171955094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9108971,0.0009282813,0.00024945548,0.014487048,0.00026090528,0.00019816436,0.0014393528,0.000042155752,0.071497396],"genre_scores_gemma":[0.9841287,0.0007893797,0.0008110838,0.0018845301,0.000048728394,0.000023232333,0.00032956994,0.000029201467,0.011955611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978417,0.0002689318,0.0000648026,0.000097844444,0.00078157213,0.00094514963],"domain_scores_gemma":[0.993024,0.00035448358,0.00037535882,0.00008743869,0.0028188408,0.0033398527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011122391,0.0002211478,0.00022081783,0.0009188452,0.0062168306,0.0023111724,0.0011028249,0.00069643673,0.014549068],"category_scores_gemma":[0.0057255756,0.00019704293,0.0005697813,0.0017882789,0.0010735972,0.0004931347,0.0013118733,0.0014297767,0.00065350876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009757751,0.0017236337,0.6662483,0.0004372328,0.00008157152,0.0057071047,0.011256028,0.00087705516,0.0010320407,0.005387848,0.09609401,0.2101793],"study_design_scores_gemma":[0.00007900735,0.0010398482,0.80174905,0.0009115524,0.00015788042,0.0030023523,0.07574171,0.0018173077,0.0007071763,0.0008098694,0.113818154,0.00016605052],"about_ca_topic_score_codex":0.9714479,"about_ca_topic_score_gemma":0.99026906,"teacher_disagreement_score":0.058238156,"about_ca_system_score_codex":0.058238156,"about_ca_system_score_gemma":0.09195575,"threshold_uncertainty_score":0.42254937},"labels":[],"label_agreement":null},{"id":"W3172087558","doi":"10.1016/j.jval.2021.04.1197","title":"RE3 Expectations Versus Reality: How Real-World Data Fits into Budget Impact Analyses","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Bevacizumab; Medicine; Actuarial science; Population; Surgery; Economics; Environmental health","score_opus":0.7657741920010389,"score_gpt":0.5634521673753913,"score_spread":0.20232202462564763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172087558","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20335495,0.01126312,0.51253873,0.1016094,0.0013945185,0.00026960188,0.005685017,0.0013684045,0.16251625],"genre_scores_gemma":[0.9531606,0.0013936558,0.039085932,0.0019396706,0.0002609455,0.00012582965,0.0011938612,0.0005981658,0.0022412369],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.98026466,0.015372124,0.00097033783,0.0010999145,0.0017742096,0.0005186922],"domain_scores_gemma":[0.8616447,0.11787154,0.0054542823,0.0065862834,0.0073160236,0.00112713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033155367,0.0010638351,0.0011062725,0.0039803055,0.00075766066,0.0103635825,0.0022563043,0.0020007847,0.009488765],"category_scores_gemma":[0.24633381,0.00071287114,0.001063408,0.0046045273,0.003115115,0.016653292,0.0025025716,0.0039600274,0.0010986207],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041126646,0.0001319678,0.034951817,0.00079095166,0.00061878643,0.00042339298,0.004768978,0.07747204,0.00032475608,0.7250299,0.024368329,0.13070779],"study_design_scores_gemma":[0.000021025424,0.00005280254,0.0076003866,0.00065629027,0.00007836479,0.000107460466,0.0027820952,0.08178644,0.0004004389,0.8833905,0.02303323,0.00009110237],"about_ca_topic_score_codex":0.022430653,"about_ca_topic_score_gemma":0.017568562,"teacher_disagreement_score":0.033155367,"about_ca_system_score_codex":0.0046900935,"about_ca_system_score_gemma":0.0029705367,"threshold_uncertainty_score":0.17534441},"labels":[],"label_agreement":null},{"id":"W3172282266","doi":"10.1016/j.jval.2021.04.994","title":"PRO9 ADV7103 Treatment Adherence in Patients with Distal Renal Tubular Acidosis (DRTA)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Distal renal tubular acidosis; Internal medicine; Regimen; Renal function; Acidosis; Pediatrics","score_opus":0.012793272988322026,"score_gpt":0.2352269332976978,"score_spread":0.22243366030937578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172282266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99271774,0.002374146,0.00018283578,0.0006633402,0.000042405944,0.000013267107,0.00034499518,0.000008985128,0.0036523277],"genre_scores_gemma":[0.998451,0.00045955373,0.00014408877,0.00020603107,0.000028041462,0.0000068254435,0.00021393808,0.0000021825751,0.00048825904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99920964,0.00020575998,0.00012819866,0.0001014934,0.00022382307,0.00013107795],"domain_scores_gemma":[0.9982298,0.00048258985,0.0007673831,0.000058427464,0.00017195076,0.00028980282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004840239,0.00011847372,0.00043655574,0.00037266238,0.00046698158,0.00079195737,0.00024549515,0.0005825715,0.0019051661],"category_scores_gemma":[0.0029402648,0.00010505925,0.00049367937,0.0009355039,0.00016688669,0.00041020435,0.00036671417,0.0011774332,0.00019873485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007777087,0.00022878902,0.97306687,0.00006107779,0.00015102806,0.00046576734,0.00014272466,0.00007851306,0.00028153663,0.000115956245,0.00045827875,0.024171675],"study_design_scores_gemma":[0.00003958285,0.0005999066,0.9936232,0.00009185751,0.0001613914,0.0023423075,0.0004894673,0.00066603266,0.0001878162,0.00023650962,0.0015484763,0.000013601843],"about_ca_topic_score_codex":0.005191993,"about_ca_topic_score_gemma":0.0069023576,"teacher_disagreement_score":0.005191993,"about_ca_system_score_codex":0.00048149665,"about_ca_system_score_gemma":0.0005206711,"threshold_uncertainty_score":0.0103235245},"labels":[],"label_agreement":null},{"id":"W3172504610","doi":"10.1016/j.jval.2021.04.1121","title":"PSU1 An Umbrella Review Comparing the Safety and Effectiveness of Femtosecond Laser-Assisted Cataract Surgery with Manual Cataract Surgery","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Phacoemulsification; Cataract surgery; Randomized controlled trial; Ophthalmology; Capsulorhexis; Visual acuity; Meta-analysis; Capsulotomy; Clinical trial; Surgery; Intraocular lens; Internal medicine","score_opus":0.07538350795345872,"score_gpt":0.33184569055049123,"score_spread":0.2564621825970325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172504610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008186793,0.9965257,0.00006464614,0.00083345524,0.00058760843,0.000048392332,0.00028900558,0.000005335815,0.00082719605],"genre_scores_gemma":[0.01660779,0.97675484,0.0005028494,0.0036607592,0.0013757467,0.00015801853,0.00045420646,0.000012196928,0.00047367986],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99489355,0.0019453069,0.0017251284,0.0003970089,0.00084500393,0.00019393503],"domain_scores_gemma":[0.97925115,0.013951019,0.0039776084,0.00036948244,0.0020833355,0.00036737515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005828372,0.0009503098,0.0034111107,0.0073752375,0.00058577606,0.002079549,0.0009856353,0.0014782891,0.0063857846],"category_scores_gemma":[0.033343226,0.00046710757,0.004849345,0.0053285244,0.00065655145,0.0013251058,0.0014338715,0.0010264062,0.00067748607],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004067661,0.00009495963,0.0016849393,0.5827876,0.013957501,0.00020537776,0.00022658733,0.00014777175,0.0015343418,0.0010373385,0.021005215,0.37325072],"study_design_scores_gemma":[0.0018645538,0.0030042236,0.015634,0.6615558,0.07659912,0.0010647663,0.00032205772,0.000103473016,0.0018050034,0.0012782125,0.23667268,0.000096102696],"about_ca_topic_score_codex":0.004820483,"about_ca_topic_score_gemma":0.00919518,"teacher_disagreement_score":0.0073752375,"about_ca_system_score_codex":0.0023248894,"about_ca_system_score_gemma":0.0058880677,"threshold_uncertainty_score":0.030823708},"labels":[],"label_agreement":null},{"id":"W3172762747","doi":"10.1016/j.jval.2021.04.1050","title":"PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Quality of life (healthcare); Reimbursement; Dermatology Life Quality Index; Disease; Physical therapy; Health care; Internal medicine; Nursing","score_opus":0.040126077484995304,"score_gpt":0.30613077415160156,"score_spread":0.26600469666660626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172762747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97255623,0.0010302952,0.00059987337,0.007302102,0.00007997038,0.00006169256,0.00005746158,0.000012847409,0.018299324],"genre_scores_gemma":[0.9947515,0.000782011,0.0005111776,0.0019500699,0.00009431832,0.000013396281,0.000026956555,0.0000134646525,0.0018571176],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.998615,0.0006612418,0.000072597024,0.0000892774,0.00014865135,0.00041314965],"domain_scores_gemma":[0.9967675,0.0014549377,0.000628597,0.0000776224,0.00013986055,0.00093143986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093534304,0.00037967908,0.00031366636,0.00050704344,0.005201013,0.002413239,0.00047058996,0.00301328,0.0049966862],"category_scores_gemma":[0.0052757207,0.00034750858,0.0005779463,0.0007086361,0.0016254134,0.0011358671,0.0014964745,0.0030826472,0.0004086132],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004297182,0.0026975544,0.2358986,0.00023741432,0.00007022814,0.68549794,0.036054622,0.0003601323,0.0014496724,0.0065241545,0.005955859,0.024824182],"study_design_scores_gemma":[0.0000801091,0.0012657657,0.045660447,0.000487396,0.00008950796,0.8218932,0.105108954,0.001837261,0.0009513278,0.002563392,0.01996033,0.00010234176],"about_ca_topic_score_codex":0.0048520635,"about_ca_topic_score_gemma":0.009723699,"teacher_disagreement_score":0.005201013,"about_ca_system_score_codex":0.0012019612,"about_ca_system_score_gemma":0.0015097851,"threshold_uncertainty_score":0.016715586},"labels":[],"label_agreement":null},{"id":"W3172780154","doi":"10.1016/j.jval.2021.04.1202","title":"RW3 Quantitative Bias Analysis (QBA) for Comparative Effectiveness of Alectinib versus Ceritinib in Non-Small Cell Lung Cancer (NSCLC)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Alectinib; Ceritinib; Medicine; Lung cancer; Hazard ratio; Internal medicine; Oncology; Crizotinib; Confidence interval","score_opus":0.12709427324781572,"score_gpt":0.45329962642739347,"score_spread":0.3262053531795778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172780154","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16157804,0.050948735,0.71489227,0.0053649675,0.0067234165,0.016952902,0.02445782,0.0061925747,0.0128892455],"genre_scores_gemma":[0.73908746,0.0017620673,0.22931254,0.0043655857,0.0006948326,0.013268311,0.0025273988,0.0016748284,0.0073069967],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6432305,0.31176966,0.011073124,0.020011747,0.010714511,0.0032004116],"domain_scores_gemma":[0.5899376,0.37329477,0.012174122,0.018064002,0.0047471304,0.0017823306],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19378501,0.003945868,0.011376008,0.0033517918,0.0010264511,0.0032453171,0.0051383777,0.0051514595,0.0530841],"category_scores_gemma":[0.3099931,0.002176777,0.043482177,0.0030968308,0.0034288887,0.0055053513,0.004158115,0.007927967,0.0025945862],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.120440386,0.0005802534,0.036102645,0.025581269,0.6146698,0.00072829454,0.00076359813,0.020926684,0.003646152,0.020085571,0.017175447,0.13929991],"study_design_scores_gemma":[0.093560696,0.02933578,0.04648906,0.0083784945,0.36733934,0.0020924076,0.0010224124,0.2927159,0.009440304,0.099561274,0.048898168,0.0011662123],"about_ca_topic_score_codex":0.0043302933,"about_ca_topic_score_gemma":0.004010489,"teacher_disagreement_score":0.806215,"about_ca_system_score_codex":0.002983904,"about_ca_system_score_gemma":0.003939628,"threshold_uncertainty_score":0.9942066},"labels":[],"label_agreement":null},{"id":"W3172903954","doi":"10.1016/j.jval.2021.04.1193","title":"PVM1 Dog Owners Preferences for Preventive Antiparasitic Treatment for Their Dogs: A Discrete Choice Experiment (DCE) in the UK","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zoetis (Canada)","funders":"","keywords":"Lungworm; Multinomial logistic regression; Veterinary medicine; Animal welfare; Medicine; Mange; Environmental health; Biology; Statistics; Immunology","score_opus":0.10977495508433478,"score_gpt":0.41134380818190197,"score_spread":0.3015688530975672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172903954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993967,0.000011772955,0.00007743741,0.000055475448,0.000004513726,0.000017940454,0.000055451696,0.0000011685476,0.0003795599],"genre_scores_gemma":[0.9966018,0.00003085226,0.0003708284,0.00010406563,0.000004103964,0.00010138716,0.00009466406,0.000002838071,0.0026894226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988205,0.00073904457,0.000049023736,0.0001476124,0.00010410919,0.00013971211],"domain_scores_gemma":[0.9976871,0.0013751735,0.00032812002,0.00016820265,0.00011439137,0.00032701137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012957606,0.00021205675,0.00047785338,0.00015358378,0.0004972346,0.0009461494,0.000303838,0.00091977447,0.007731795],"category_scores_gemma":[0.0040797014,0.00030230227,0.0002791481,0.0001462128,0.00082790677,0.0005125468,0.00053413917,0.0010846158,0.00069870666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21502736,0.06346206,0.3817887,0.0011501394,0.00042973223,0.0027640287,0.032612503,0.005903358,0.15885869,0.010145172,0.0124085955,0.11544959],"study_design_scores_gemma":[0.005796342,0.108746774,0.836097,0.00017981102,0.00021690568,0.00095541094,0.014876331,0.013819524,0.0070564584,0.0020160775,0.009981145,0.00025829207],"about_ca_topic_score_codex":0.020410713,"about_ca_topic_score_gemma":0.030694092,"teacher_disagreement_score":0.020410713,"about_ca_system_score_codex":0.0013326019,"about_ca_system_score_gemma":0.00053970667,"threshold_uncertainty_score":0.04058385},"labels":[],"label_agreement":null},{"id":"W3173427485","doi":"10.1016/j.jval.2021.04.1274","title":"Opioid Prescribing in United States Health Systems, 2015 to 2019","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; St. Michael's Hospital","funders":"U.S. Department of Veterans Affairs","keywords":"Oxycodone; Hydrocodone; Fentanyl; Medicine; Opioid; Medical prescription; Pharmacy; Health care; Emergency medicine; Family medicine; Anesthesia; Pharmacology; Internal medicine","score_opus":0.04718630774174696,"score_gpt":0.3448121681259759,"score_spread":0.29762586038422895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173427485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.738981,0.025323756,0.0011778878,0.032980286,0.0021147013,0.00018337982,0.16193779,0.00026509754,0.03703615],"genre_scores_gemma":[0.94145966,0.0072393054,0.0008353283,0.006411783,0.00069821987,0.00011846706,0.035775784,0.000032363132,0.0074291215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985446,0.00017993538,0.00031866264,0.00015488135,0.0004897639,0.00031226053],"domain_scores_gemma":[0.99539655,0.0005346186,0.0023692688,0.00007629181,0.0010065974,0.00061665825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009158489,0.00020964787,0.0002772797,0.0016400495,0.0005959237,0.0016143941,0.0005846254,0.00077510625,0.0029319266],"category_scores_gemma":[0.0070683956,0.00025124356,0.0010212322,0.003229441,0.00026175272,0.0012757885,0.0012132811,0.0017451905,0.00041534746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033869644,0.00017619599,0.8713432,0.00086682296,0.0005289223,0.00024997286,0.00056453224,0.0014875891,0.0002887676,0.0022259322,0.07392013,0.04800921],"study_design_scores_gemma":[0.000026949194,0.00006293226,0.9682778,0.0005845311,0.000101648475,0.00022602902,0.00090716843,0.0011054808,0.00020931957,0.00028147854,0.028200835,0.000015780099],"about_ca_topic_score_codex":0.18427923,"about_ca_topic_score_gemma":0.39343715,"teacher_disagreement_score":0.18427923,"about_ca_system_score_codex":0.0055323937,"about_ca_system_score_gemma":0.005787167,"threshold_uncertainty_score":0.36641324},"labels":[],"label_agreement":null},{"id":"W3188740930","doi":"10.1016/j.jval.2021.03.016","title":"Development and Validation of an Instrument to Measure Health-Related Out-of-Pocket Costs: The Cost for Patients Questionnaire","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Louis-H Lafontaine; McGill University; Institut Universitaire en Santé Mentale de Québec; Université Laval; Université de Montréal; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; Ministère de la Santé; Fonds de Recherche du Québec - Santé; Ministère de la Santé et des Services sociaux","keywords":"Intraclass correlation; Delphi method; Delphi; Test (biology); Kappa; Medicine; Health care; Content validity; Face validity; Sample (material); Indirect costs; Statistics; Computer science; Psychometrics; Clinical psychology; Business; Mathematics","score_opus":0.35456415368130634,"score_gpt":0.4036578623536867,"score_spread":0.04909370867238039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188740930","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9121699,0.0011405095,0.033208005,0.0025620582,0.00045587827,0.022598771,0.018574003,0.0002715497,0.009019369],"genre_scores_gemma":[0.8356417,0.0011375888,0.094860114,0.0016263853,0.00017145793,0.03920969,0.022204362,0.00022509217,0.0049237492],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.988356,0.0053899856,0.0019073252,0.00056401774,0.0031939356,0.00058878737],"domain_scores_gemma":[0.9642045,0.01863672,0.004492174,0.0018028446,0.009754427,0.001109339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022041688,0.0006022465,0.00087831105,0.0022652186,0.0006805988,0.0013919565,0.0013612042,0.0010243434,0.0026387726],"category_scores_gemma":[0.033949375,0.0005119735,0.0018268088,0.0016316368,0.0007075881,0.0011269652,0.0022236991,0.0023743412,0.0010557174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002217561,0.0071733887,0.6581894,0.0006989247,0.0009560578,0.00019499105,0.0032088675,0.0040199826,0.00426901,0.0034818412,0.027223686,0.2883663],"study_design_scores_gemma":[0.0011654376,0.003131819,0.9589195,0.00036232301,0.00033987273,0.0003827667,0.0011847795,0.0071307234,0.0024467572,0.0013545279,0.023441097,0.00014041895],"about_ca_topic_score_codex":0.004582733,"about_ca_topic_score_gemma":0.0048103915,"teacher_disagreement_score":0.022041688,"about_ca_system_score_codex":0.001773926,"about_ca_system_score_gemma":0.0054512704,"threshold_uncertainty_score":0.11656898},"labels":[],"label_agreement":null},{"id":"W3190464317","doi":"10.1016/j.jval.2021.04.1277","title":"Reimagining Pharmaceutical Market Exclusivities: Should the Duration of Guaranteed Monopoly Periods Be Value Based?","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Fonden","keywords":"Tying; Monopoly; Duration (music); Product (mathematics); Competition (biology); Business; Value (mathematics); New product development; Prescription drug; Generic drug; Pharmaceutical industry; Industrial organization; Medical prescription; Marketing; Economics; Drug; Microeconomics; Computer science; Medicine; Pharmacology","score_opus":0.1694680259873237,"score_gpt":0.36037445588318173,"score_spread":0.19090642989585804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190464317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50828147,0.015449241,0.36409017,0.036597196,0.0015708642,0.00033641982,0.0009914641,0.0008962485,0.071786955],"genre_scores_gemma":[0.98837554,0.00076591375,0.00674876,0.0008950597,0.0003984395,0.00006359602,0.000058313424,0.00007278487,0.0026215492],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99627006,0.001445713,0.0002405038,0.0007308575,0.0006185105,0.0006943477],"domain_scores_gemma":[0.93902427,0.0425865,0.009694651,0.0043135765,0.0021958451,0.0021852723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015707828,0.00068334246,0.0020265402,0.0007063171,0.00088047585,0.0057017314,0.0030761594,0.0047077867,0.008399237],"category_scores_gemma":[0.09424713,0.00088968105,0.001012345,0.0008460331,0.002772269,0.012641104,0.0018344965,0.0077892807,0.0005862011],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002213206,0.0005348919,0.008236981,0.0008160547,0.00033657893,0.0004506388,0.0012476846,0.0938222,0.0068030804,0.62751687,0.011025174,0.24699666],"study_design_scores_gemma":[0.00038599517,0.0009097436,0.010370227,0.0004983705,0.0002386244,0.00029724344,0.0007627847,0.08056444,0.0034674164,0.8807433,0.02163455,0.00012731417],"about_ca_topic_score_codex":0.0018245861,"about_ca_topic_score_gemma":0.0016166045,"teacher_disagreement_score":0.015707828,"about_ca_system_score_codex":0.0021729884,"about_ca_system_score_gemma":0.003343641,"threshold_uncertainty_score":0.08307195},"labels":[],"label_agreement":null},{"id":"W3195770982","doi":"10.1016/j.jval.2021.06.008","title":"Adherence to Clinical Practice Guideline Recommendations on Low-Value Injury Care: A Multicenter Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; Université de Sherbrooke; Alberta Health Services; Institut National d'Excellence en Santé et en Services Sociaux; Université Laval; Calgary Laboratory Services; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Guideline; Retrospective cohort study; Emergency medicine; Decompressive craniectomy; Health care; Psychological intervention; Blunt; Physical therapy; Traumatic brain injury; Surgery; Nursing","score_opus":0.5737211830408306,"score_gpt":0.6405620772311604,"score_spread":0.06684089419032979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195770982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983369,0.00022312037,0.00012285983,0.000095592215,0.000020438125,0.000047036767,0.0007653338,0.0000042856004,0.00038439035],"genre_scores_gemma":[0.9983125,0.00012062519,0.00014534198,0.00014960581,0.000020707961,0.00006397289,0.00089516817,0.000007658403,0.00028438185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617434,0.0010096509,0.000517463,0.0010829029,0.000529249,0.0006863501],"domain_scores_gemma":[0.9894009,0.0013767834,0.0053222263,0.0011733619,0.0016539026,0.0010727457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029907892,0.00065796904,0.0009964615,0.0013448962,0.0018254165,0.0025633483,0.0012734279,0.0016448153,0.0027517749],"category_scores_gemma":[0.010393826,0.0011835496,0.0019143505,0.0029524039,0.00076206145,0.0018633106,0.001513132,0.0023222475,0.0006003581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015423751,0.00014216968,0.998638,0.000009600192,0.00019910785,0.000037483078,0.0001913239,0.000010372544,0.00003655756,0.000018307941,0.00021767929,0.00034513627],"study_design_scores_gemma":[0.000058885158,0.00024560344,0.99782526,0.000029394447,0.00019602383,0.0001672396,0.0009970232,0.00016025171,0.000026254524,0.00003416446,0.0002420682,0.000017818129],"about_ca_topic_score_codex":0.025215894,"about_ca_topic_score_gemma":0.02768445,"teacher_disagreement_score":0.025215894,"about_ca_system_score_codex":0.0013968273,"about_ca_system_score_gemma":0.0019300523,"threshold_uncertainty_score":0.050138235},"labels":[],"label_agreement":null},{"id":"W3199103380","doi":"10.1016/j.jval.2021.07.005","title":"What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Health care; Weighting; Context (archaeology); Systematic review; Computer science; Actuarial science; Medicine; MEDLINE; Business; Economics; Political science","score_opus":0.38132054323708087,"score_gpt":0.5037583313132762,"score_spread":0.12243778807619532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199103380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001536103,0.9982145,0.00023018176,0.00104524,0.00007836538,0.000029978915,0.000060413484,0.0000022455301,0.00018547078],"genre_scores_gemma":[0.005295614,0.9925944,0.0010605376,0.0007113143,0.00013365186,0.000117385716,0.000050185165,0.0000033938738,0.000033515124],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97443306,0.012583814,0.0065101953,0.0012722601,0.004781101,0.00041964528],"domain_scores_gemma":[0.8453776,0.13608651,0.011246354,0.0013420817,0.0051348335,0.0008124541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.037153643,0.0016176654,0.0073156483,0.02228869,0.0010517401,0.0073905084,0.0021523978,0.0030667463,0.0042263004],"category_scores_gemma":[0.1243368,0.0011627953,0.005346032,0.021632776,0.004117689,0.008152539,0.0040180124,0.003696748,0.00025572785],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020936155,0.000054823122,0.0014518911,0.5374861,0.0054112924,0.000071961644,0.00065970037,0.00059074705,0.000106176594,0.017483715,0.007717204,0.4287571],"study_design_scores_gemma":[0.00012453727,0.00009299201,0.002483812,0.90796995,0.011198637,0.00021549242,0.0006047993,0.00030243152,0.000097756194,0.017751025,0.059092484,0.000066176195],"about_ca_topic_score_codex":0.010965346,"about_ca_topic_score_gemma":0.02087749,"teacher_disagreement_score":0.037153643,"about_ca_system_score_codex":0.009139351,"about_ca_system_score_gemma":0.024946412,"threshold_uncertainty_score":0.19648963},"labels":[],"label_agreement":null},{"id":"W3199180667","doi":"10.1016/j.jval.2021.07.012","title":"The Health Value of Kidney Exchange and Altruistic Donation","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Donation; Actuarial science; Robustness (evolution); Value (mathematics); Markov decision process; Quality-adjusted life year; Kidney transplant; Public economics; Kidney transplantation; Transplantation; Economics; Cost effectiveness; Internal medicine; Markov process; Risk analysis (engineering); Statistics; Mathematics; Economic growth","score_opus":0.03347727442108214,"score_gpt":0.31631947376211783,"score_spread":0.2828421993410357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199180667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79295766,0.0071358387,0.09575826,0.01488885,0.00020831166,0.00029443207,0.00072677096,0.000030336048,0.08799955],"genre_scores_gemma":[0.99561465,0.0004906123,0.0028693392,0.00014934216,0.000018755809,0.00003286471,0.00003423652,0.000003001645,0.0007872106],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99488586,0.004154589,0.00011249453,0.00018731137,0.00040944666,0.0002503285],"domain_scores_gemma":[0.9879958,0.009595701,0.0013861991,0.0002854286,0.0004265844,0.00031025294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006614609,0.00027859348,0.00031300023,0.00041655247,0.00023930095,0.0013285499,0.00047980328,0.0006530866,0.0033151016],"category_scores_gemma":[0.020649334,0.00013512901,0.0005354903,0.00048282882,0.0015219721,0.0010673831,0.0011883926,0.0008055976,0.00009169454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022965323,0.0005340397,0.06997296,0.0013997393,0.00082167075,0.0008650701,0.0010647197,0.35040188,0.0025781938,0.37889323,0.0027685277,0.18840343],"study_design_scores_gemma":[0.0005188904,0.0018855815,0.07082033,0.0012164853,0.000565455,0.0013923909,0.0016008143,0.25116202,0.004134259,0.6451455,0.02142762,0.00013064897],"about_ca_topic_score_codex":0.0033731323,"about_ca_topic_score_gemma":0.0020526894,"teacher_disagreement_score":0.006614609,"about_ca_system_score_codex":0.002980225,"about_ca_system_score_gemma":0.0025115076,"threshold_uncertainty_score":0.034981847},"labels":[],"label_agreement":null},{"id":"W3199242555","doi":"10.1016/j.jval.2021.05.019","title":"Patient Self-Reported Health, Clinical Quality, and Patient Satisfaction in English Primary Care: Practice-Level Longitudinal Observational Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"EuroQol Research Foundation","keywords":"Bivariate analysis; Medicine; Observational study; Patient satisfaction; Random effects model; Family medicine; Clinical Practice; Quality (philosophy); Health care; Nursing; Statistics; Meta-analysis; Internal medicine","score_opus":0.5043776651335483,"score_gpt":0.5361471046057397,"score_spread":0.03176943947219135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199242555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994735,0.000046814093,0.00004360833,0.000033659293,0.0000023399257,0.000019291043,0.00021561998,0.0000016460135,0.00016348014],"genre_scores_gemma":[0.99928856,0.000032665954,0.00007730006,0.00006786925,0.0000056440977,0.000037121106,0.00033628702,0.0000017039952,0.00015278434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720985,0.0012946955,0.00035107922,0.00035216284,0.00041166905,0.00038057988],"domain_scores_gemma":[0.9916829,0.0021368093,0.0027828468,0.00059084164,0.0011812918,0.0016252517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031456726,0.00034577842,0.0007558953,0.0010467436,0.0010319528,0.0015513122,0.00066567725,0.0012073013,0.0017251002],"category_scores_gemma":[0.008478249,0.0006770216,0.0008889651,0.002251408,0.0007988685,0.0015896548,0.0013428433,0.001234163,0.0004868279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014137008,0.00023998786,0.99841976,0.000009308419,0.000072211515,0.00003431308,0.0005664486,0.000015378548,0.000048150792,0.0000073377823,0.00006481153,0.0003808836],"study_design_scores_gemma":[0.000029068755,0.0003354879,0.99810874,0.0000066230627,0.00004171972,0.000053428772,0.0011739174,0.000113644244,0.000021241434,0.000010164525,0.0000985664,0.00000754806],"about_ca_topic_score_codex":0.02217502,"about_ca_topic_score_gemma":0.03087137,"teacher_disagreement_score":0.02217502,"about_ca_system_score_codex":0.0013741141,"about_ca_system_score_gemma":0.0014633413,"threshold_uncertainty_score":0.04409188},"labels":[],"label_agreement":null},{"id":"W3200895382","doi":"10.1016/j.jval.2021.08.006","title":"Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Toronto Liver Centre; University of Guelph; Toronto East General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Confidence interval; Health care; Emergency medicine; Total cost; Household income; Indirect costs; Family medicine; Pediatrics; Demography; Environmental health; Internal medicine; Geography; Business","score_opus":0.026278283875487755,"score_gpt":0.23635915929628795,"score_spread":0.2100808754208002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200895382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987562,0.00021297022,0.000060632807,0.00010879612,0.0000029792843,0.000014238943,0.00058785494,0.0000011936376,0.00025510503],"genre_scores_gemma":[0.9993888,0.00007421168,0.00008052323,0.000020786907,0.0000072260823,0.000011235265,0.00035686587,6.428834e-7,0.00005971174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986455,0.0005168223,0.0001792443,0.00011164837,0.00023846592,0.00030834632],"domain_scores_gemma":[0.99448425,0.0014511661,0.0030343186,0.000117028765,0.00045634652,0.00045694335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015808097,0.00033811235,0.00040414618,0.0010750019,0.00063813105,0.0012120117,0.00051045325,0.00044483342,0.00164466],"category_scores_gemma":[0.0070161293,0.00028821817,0.0013039707,0.0019784255,0.0003052779,0.000761398,0.0009477901,0.00075544446,0.00008583319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091705006,0.000043041444,0.9977496,0.000020360501,0.00011053899,0.00002733995,0.00005976112,0.0006534355,0.00001576116,0.000040982126,0.00011376349,0.0010737181],"study_design_scores_gemma":[0.000012785476,0.00006386389,0.9968947,0.000031885582,0.000062241794,0.00008230464,0.00026448563,0.0023656967,0.000019795414,0.00003911669,0.00015626171,0.000006710508],"about_ca_topic_score_codex":0.16357906,"about_ca_topic_score_gemma":0.16795689,"teacher_disagreement_score":0.16357906,"about_ca_system_score_codex":0.0057395184,"about_ca_system_score_gemma":0.0026604913,"threshold_uncertainty_score":0.32525384},"labels":[],"label_agreement":null},{"id":"W3205845182","doi":"10.1016/j.jval.2021.08.011","title":"Do You Recall?: Results From a Within-Person Recall Study of the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 – Physical Function 8c","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; Janssen Pharmaceuticals; Pfizer UK; Merck; AstraZeneca Korea; Genentech; Pfizer; Novartis Pharmaceuticals Corporation; Amgen; Bristol-Myers Squibb; Bayer Corporation; AbbVie; U.S. Food and Drug Administration","keywords":"Recall; Raw score; Free recall; Medicine; Recall test; Population; Demography; Physical therapy; Statistics; Psychology; Mathematics; Raw data; Cognitive psychology","score_opus":0.08351097887655864,"score_gpt":0.29320404685958756,"score_spread":0.20969306798302892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205845182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98946863,0.0009164354,0.00025147508,0.00026227493,0.00004698014,0.00031821732,0.007145957,0.000017466155,0.001572514],"genre_scores_gemma":[0.99163634,0.00051902945,0.00040619,0.00053924223,0.00005150613,0.00036834317,0.0043521887,0.00001930539,0.0021076829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962178,0.0012953554,0.0006768209,0.00061933557,0.0008947257,0.00029599405],"domain_scores_gemma":[0.99069124,0.0023098746,0.0035668008,0.0008847833,0.0020262802,0.0005209537],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005069831,0.00044673932,0.0007454214,0.0010363687,0.00095118664,0.0016337849,0.0009714553,0.001633152,0.0017148398],"category_scores_gemma":[0.01782519,0.0006191567,0.0014655621,0.0012980556,0.00032695156,0.0011355446,0.0011188351,0.00144032,0.0012699673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001015829,0.0008649204,0.9873253,0.00015422954,0.00060205976,0.00008719614,0.0012084328,0.000062087944,0.00012583827,0.00002973588,0.0015078426,0.0070166313],"study_design_scores_gemma":[0.000086429594,0.00047932466,0.99715626,0.000037757643,0.00022270651,0.00015683846,0.0005647464,0.00009141722,0.0000784887,0.000019474264,0.0010868682,0.000019702753],"about_ca_topic_score_codex":0.027303698,"about_ca_topic_score_gemma":0.023776602,"teacher_disagreement_score":0.99493015,"about_ca_system_score_codex":0.000685426,"about_ca_system_score_gemma":0.00082527683,"threshold_uncertainty_score":0.05428952},"labels":[],"label_agreement":null},{"id":"W3208421062","doi":"10.1016/j.jval.2021.09.015","title":"Rasch Analysis of the Michigan Hand Questionnaire","year":2021,"lang":"fr","type":"article","venue":"Value in Health","topic":"Orthopedic Surgery and Rehabilitation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Rasch model; Polytomous Rasch model; Psychology; Construct validity; Differential item functioning; Scale (ratio); Reliability (semiconductor); Construct (python library); Thumb; Clinical psychology; Psychometrics; Item response theory; Medicine; Developmental psychology; Computer science","score_opus":0.025148740710454386,"score_gpt":0.31346259356938366,"score_spread":0.2883138528589293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208421062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98485655,0.000112203925,0.009457201,0.000099821846,0.000027976792,0.00025600783,0.0013467117,0.00013971317,0.0037038813],"genre_scores_gemma":[0.9917641,0.00005788517,0.005174381,0.000020215617,0.000020143718,0.0004195872,0.0008662599,0.000032360553,0.0016451655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937797,0.003954196,0.0003165613,0.00044798537,0.0012648704,0.00023666013],"domain_scores_gemma":[0.9694546,0.023772916,0.0019177258,0.0015710525,0.0030758085,0.0002079121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043352977,0.0003367179,0.00049045443,0.0024544494,0.00044142356,0.0005257371,0.0003535739,0.00021161926,0.005008492],"category_scores_gemma":[0.0314876,0.00015040612,0.00081689877,0.0017640374,0.00027284308,0.0004275102,0.0005982487,0.0005110401,0.00070133276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013898717,0.00044409794,0.8657295,0.000088836656,0.00055465335,0.00012514937,0.0024345808,0.0021533347,0.0012373658,0.001717696,0.0030934396,0.121031575],"study_design_scores_gemma":[0.0000306176,0.000418676,0.9899917,0.000017999639,0.00007964407,0.00008664209,0.0006709068,0.006443614,0.00047081537,0.0006550956,0.0011177302,0.00001646129],"about_ca_topic_score_codex":0.008095074,"about_ca_topic_score_gemma":0.010834652,"teacher_disagreement_score":0.008095074,"about_ca_system_score_codex":0.00056595256,"about_ca_system_score_gemma":0.00069082517,"threshold_uncertainty_score":0.022927523},"labels":[],"label_agreement":null},{"id":"W3216773004","doi":"10.1016/j.jval.2021.10.004","title":"Parametric Survival Extrapolation of Early Survival Data in Economic Analyses: A Comparison of Projected Versus Observed Updated Survival","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Survival analysis; Medicine; Statistics; Randomized controlled trial; Extrapolation; Parametric statistics; Mathematics; Surgery","score_opus":0.8939621023731137,"score_gpt":0.5850169261698159,"score_spread":0.30894517620329776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216773004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007619547,0.9936073,0.004278565,0.0004008407,0.000143125,0.000027438255,0.00023575661,0.000016581927,0.00052839215],"genre_scores_gemma":[0.014774753,0.9789331,0.005001071,0.00025494225,0.00030425625,0.00009895913,0.00038929514,0.000022765635,0.00022083201],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99089885,0.0059561436,0.0007711333,0.000551521,0.001722681,0.00009959074],"domain_scores_gemma":[0.9331214,0.06180968,0.0018987925,0.0011041608,0.0019271239,0.00013883656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023620311,0.0012011571,0.0048494833,0.003182924,0.00012014117,0.0021202464,0.002669803,0.0014805653,0.0036205398],"category_scores_gemma":[0.061593,0.0005496581,0.0034446814,0.0048420145,0.00074491865,0.002426921,0.0012288088,0.0033679807,0.0006442751],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006947713,0.00006937744,0.0012688541,0.027110493,0.002593743,0.000064679596,0.00006896568,0.005545881,0.00009687609,0.008932026,0.0063453084,0.9472091],"study_design_scores_gemma":[0.0025321639,0.0025549524,0.03660767,0.21280082,0.030589035,0.0033226265,0.0005314362,0.042357504,0.002392292,0.14153932,0.5240778,0.0006944838],"about_ca_topic_score_codex":0.0025117644,"about_ca_topic_score_gemma":0.0021762622,"teacher_disagreement_score":0.023620311,"about_ca_system_score_codex":0.0013539238,"about_ca_system_score_gemma":0.0017031125,"threshold_uncertainty_score":0.12491763},"labels":[],"label_agreement":null},{"id":"W4200113032","doi":"10.1016/j.jval.2021.10.018","title":"Economic Evaluation of In-Hospital Clinical Practices in Acute Injury Care: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; University of Calgary; Université Laval; Hôpital de l'Enfant-Jésus","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Medicine; Psychological intervention; Economic evaluation; MEDLINE; Health care; Randomized controlled trial; Cost effectiveness; Acute care; Protocol (science); Emergency department; Systematic review; Evidence-based medicine; Family medicine; Emergency medicine; Intensive care medicine; Medical emergency; Alternative medicine; Nursing; Internal medicine","score_opus":0.8123009844441162,"score_gpt":0.692925247875254,"score_spread":0.11937573656886225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200113032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005060911,0.99301684,0.0002378736,0.00029240514,0.00014086651,0.00036554338,0.0005834438,0.0000087311355,0.00029335113],"genre_scores_gemma":[0.13716924,0.8588805,0.0016560745,0.0007446957,0.00017390013,0.0007382591,0.00046117726,0.000014132351,0.00016197423],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9802832,0.010565744,0.005014549,0.0009044335,0.0027787508,0.00045328905],"domain_scores_gemma":[0.9525591,0.036481887,0.007909925,0.00056767795,0.0020144857,0.0004669066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014327364,0.0016453688,0.011973231,0.006065169,0.00047586928,0.00345206,0.0018956438,0.0022020086,0.005578404],"category_scores_gemma":[0.07646223,0.0011016577,0.012566948,0.008981905,0.0010280262,0.002166242,0.0018513175,0.0024144426,0.00019533599],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002836077,0.00011337753,0.0038591966,0.8188091,0.12638982,0.000106926615,0.00013364504,0.00046294904,0.000067127476,0.00044997316,0.0014654613,0.045306403],"study_design_scores_gemma":[0.0048623993,0.0009419155,0.017295,0.47217095,0.49145067,0.000404342,0.00048480197,0.0008618776,0.00016469863,0.0011723205,0.010087299,0.000103753635],"about_ca_topic_score_codex":0.010538872,"about_ca_topic_score_gemma":0.027318856,"teacher_disagreement_score":0.014327364,"about_ca_system_score_codex":0.0065572504,"about_ca_system_score_gemma":0.007685869,"threshold_uncertainty_score":0.07577121},"labels":[],"label_agreement":null},{"id":"W4205090700","doi":"10.1016/j.jval.2021.11.1253","title":"POSB390 Characterisation of the Management Pathway for Muscle-Invasive Urothelial Carcinoma (MIUC) from Physician Perspectives in France, Germany, Italy, Spain, UK (EU5), US, Canada, China, and Japan","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neoadjuvant therapy; Adjuvant therapy; Adjuvant; Workload; Family medicine; Demographics; China; Adjuvant chemotherapy; Disease; Internal medicine; General surgery; Chemotherapy; Cancer; Demography","score_opus":0.014646910119070398,"score_gpt":0.24073067759258132,"score_spread":0.22608376747351092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205090700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89842033,0.023295864,0.00072486384,0.045798905,0.00019779716,0.000041998537,0.0020359296,0.00002963738,0.029454665],"genre_scores_gemma":[0.9894202,0.003951823,0.000905143,0.0035185583,0.000115297145,0.000014837373,0.0008375309,0.000024365088,0.0012121997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983442,0.00059839315,0.00010545599,0.00016280935,0.00039747052,0.00039167012],"domain_scores_gemma":[0.9957183,0.0009886692,0.0011177585,0.00006412234,0.001232636,0.00087842613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026237345,0.00012244306,0.00025667856,0.0010569526,0.000623599,0.0018849676,0.00034218497,0.0005743084,0.0029662636],"category_scores_gemma":[0.005038857,0.00011915441,0.000359068,0.0020398155,0.000490692,0.00082541246,0.0005634202,0.00079430453,0.00035125506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018187112,0.00019412018,0.71356,0.000654056,0.00023823943,0.0018138265,0.005666778,0.0011739223,0.0047745323,0.008935011,0.026540639,0.23463012],"study_design_scores_gemma":[0.00009469721,0.0005045061,0.9035668,0.0007741531,0.00016343604,0.0019310613,0.00838586,0.0013267585,0.001284741,0.0018721905,0.080033705,0.00006206683],"about_ca_topic_score_codex":0.05086739,"about_ca_topic_score_gemma":0.102244094,"teacher_disagreement_score":0.9491326,"about_ca_system_score_codex":0.0061955466,"about_ca_system_score_gemma":0.006226646,"threshold_uncertainty_score":0.101142585},"labels":[],"label_agreement":null},{"id":"W4205130677","doi":"10.1016/j.jval.2021.11.295","title":"POSA154 A Comparison of the Costs of Atrial Fibrillation Ablation Using Radiofrequency and Cryobaloon Technologies in the United Kingdom and Italy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Atrial fibrillation; Guideline; Catheter ablation; Emergency medicine; Radiofrequency ablation; Ablation; Health care; Cardiology","score_opus":0.16069491005307293,"score_gpt":0.3878266112819413,"score_spread":0.22713170122886836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205130677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97947925,0.006430522,0.00031825836,0.0015283949,0.00007793405,0.000042033884,0.005001092,0.0000131724455,0.0071093095],"genre_scores_gemma":[0.9967006,0.0006632783,0.00011066144,0.00016605487,0.000038809165,0.000025821086,0.0016490758,0.0000064609744,0.0006390728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980636,0.00097245706,0.00015149215,0.0001849179,0.00034454753,0.00028303568],"domain_scores_gemma":[0.9945011,0.0025254365,0.0017445198,0.00024201233,0.00062214426,0.0003647213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014947128,0.00030352618,0.0005694892,0.0016826118,0.00017769226,0.0015062963,0.00043372036,0.00069385336,0.0029825594],"category_scores_gemma":[0.008698786,0.000203311,0.00136886,0.0024049731,0.00034315095,0.0006526777,0.0007602684,0.00061651453,0.0003180499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013299901,0.00025665594,0.91175866,0.001226308,0.0027070823,0.0006581103,0.0003904611,0.0063441377,0.0011323678,0.0025680568,0.007462169,0.05219623],"study_design_scores_gemma":[0.0002840437,0.00052619475,0.9937505,0.00013171104,0.000521019,0.00031786427,0.00038093852,0.0010810615,0.00020115166,0.00016099532,0.0026236724,0.000020817011],"about_ca_topic_score_codex":0.027803374,"about_ca_topic_score_gemma":0.024812112,"teacher_disagreement_score":0.027803374,"about_ca_system_score_codex":0.0037256165,"about_ca_system_score_gemma":0.0009861966,"threshold_uncertainty_score":0.05528307},"labels":[],"label_agreement":null},{"id":"W4205164366","doi":"10.1016/j.jval.2021.11.639","title":"POSB201 Effectiveness and Safety of Low Versus High Dose Rivaroxaban and Apixaban for Atrial Fibrillation: Propensity Score-Matched Cohort Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Atrial fibrillation; Propensity score matching; Internal medicine; Hazard ratio; Cohort; Stroke (engine); Myocardial infarction; Cardiology; Warfarin; Confidence interval","score_opus":0.09249093714176072,"score_gpt":0.3493307644094097,"score_spread":0.256839827267649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205164366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605536,0.00078740105,0.00076803355,0.00009936111,0.00011579637,0.00005470146,0.0012605464,0.000015707574,0.0008431073],"genre_scores_gemma":[0.9977253,0.00018057958,0.00022730207,0.00012732214,0.00007823166,0.00004670913,0.0011001211,0.000012133075,0.0005023089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976549,0.00071600446,0.0003169258,0.0006973439,0.00032722726,0.00028755437],"domain_scores_gemma":[0.99692196,0.0006052608,0.0011031146,0.00088051526,0.00019177924,0.0002973359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020931282,0.00051545526,0.00090003194,0.000515559,0.0005948554,0.0015406734,0.00068591547,0.0011047613,0.004149208],"category_scores_gemma":[0.005214879,0.00063655176,0.0034217916,0.0010260635,0.0005442345,0.0010326599,0.0006461642,0.0014591938,0.00091600773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13265543,0.0013197705,0.8285061,0.00025326473,0.012792233,0.00035606013,0.00021178463,0.0008025772,0.0038743,0.0008050855,0.002156093,0.016267367],"study_design_scores_gemma":[0.008524728,0.009646055,0.96451557,0.000068305344,0.0070359693,0.0006719396,0.00025850398,0.0034704825,0.0010137493,0.0016243131,0.003063245,0.00010710222],"about_ca_topic_score_codex":0.0014051716,"about_ca_topic_score_gemma":0.0013979232,"teacher_disagreement_score":0.004149208,"about_ca_system_score_codex":0.00049672625,"about_ca_system_score_gemma":0.00051910983,"threshold_uncertainty_score":0.013880432},"labels":[],"label_agreement":null},{"id":"W4205192480","doi":"10.1016/j.jval.2021.11.1364","title":"Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Extracorporeal Photopheresis; Cutaneous T-cell lymphoma; Quality of life (healthcare); Lymphoma; Intensive care medicine; Disease; Mycosis fungoides; Internal medicine; Graft-versus-host disease","score_opus":0.06604903885238529,"score_gpt":0.34829919069375,"score_spread":0.2822501518413647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205192480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914453,0.0041325106,0.00013809846,0.0014802074,0.000041388663,0.000074702075,0.00018427541,0.0000062870463,0.0024971787],"genre_scores_gemma":[0.9989372,0.00060200045,0.000111448186,0.00009067053,0.00001669732,0.000017408525,0.00005157046,9.1803383e-7,0.00017212659],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985671,0.0009050206,0.000096301424,0.00007473245,0.00019401396,0.0001627836],"domain_scores_gemma":[0.99814796,0.0007502801,0.00051417697,0.000040711144,0.00011926206,0.0004276992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001009332,0.00029757209,0.0005272864,0.0006145311,0.0003697526,0.0009140566,0.00054349634,0.0006833496,0.002856196],"category_scores_gemma":[0.007098283,0.00021398178,0.0014793581,0.0006997699,0.00041828954,0.0006846919,0.00096275995,0.0008584801,0.000084625724],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05938242,0.006336756,0.44592968,0.0029949406,0.0047286083,0.0021565752,0.0012266561,0.038908325,0.0020747948,0.003931099,0.0066682473,0.42566183],"study_design_scores_gemma":[0.004197708,0.015128856,0.9384804,0.00058497034,0.0026950086,0.0015662652,0.0012155276,0.0315393,0.00041875456,0.0015079413,0.0025649576,0.000100281366],"about_ca_topic_score_codex":0.038505442,"about_ca_topic_score_gemma":0.040987078,"teacher_disagreement_score":0.038505442,"about_ca_system_score_codex":0.004797252,"about_ca_system_score_gemma":0.002113342,"threshold_uncertainty_score":0.07656264},"labels":[],"label_agreement":null},{"id":"W4205213502","doi":"10.1016/j.jval.2021.11.1323","title":"POSA421 Two Sensitization Methods: to Enhance Participant Engagement During the Conduct on Online Discrete Choice Experiments: A Case Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Sensitization; Respondent; Context (archaeology); McNemar's test; Phone; Medicine; Wilcoxon signed-rank test; Psychology; Statistics; Mathematics; Internal medicine; Immunology; Mann–Whitney U test","score_opus":0.39329200089804156,"score_gpt":0.4288814689573522,"score_spread":0.035589468059310625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205213502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.668735,0.0002485416,0.27842653,0.0044318317,0.00035319544,0.0098467395,0.0007025282,0.0018105822,0.035445128],"genre_scores_gemma":[0.7260808,0.00017572787,0.24242681,0.0015896762,0.000098196084,0.018423608,0.0002735101,0.0003198602,0.010611829],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97379535,0.021723673,0.0005910195,0.0016918554,0.0015318729,0.00066627783],"domain_scores_gemma":[0.8893072,0.0873258,0.0035111846,0.012079209,0.003755403,0.0040211766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027088309,0.0009703957,0.0007782336,0.0007988217,0.0015739452,0.0022911732,0.002482036,0.0028417015,0.022352941],"category_scores_gemma":[0.059104674,0.0006596665,0.00085511606,0.0006072625,0.0015647665,0.002872591,0.004909471,0.0027284329,0.0054540113],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008720374,0.045291346,0.028700879,0.0038596527,0.0002523455,0.0012173636,0.04388358,0.0037998743,0.07739671,0.019327613,0.012681428,0.7548688],"study_design_scores_gemma":[0.013968022,0.09892775,0.13218322,0.0032199267,0.0013837722,0.0048301043,0.04540894,0.08339767,0.19165732,0.1476989,0.27601475,0.0013097519],"about_ca_topic_score_codex":0.00030901463,"about_ca_topic_score_gemma":0.000683152,"teacher_disagreement_score":0.027088309,"about_ca_system_score_codex":0.0006978365,"about_ca_system_score_gemma":0.0024563146,"threshold_uncertainty_score":0.1432584},"labels":[],"label_agreement":null},{"id":"W4205227233","doi":"10.1016/j.jval.2021.11.185","title":"POSA39 Cost-Effectiveness Analysis of Nivolumab for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada); Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Medicine; Esophageal cancer; Population; Internal medicine; Oncology; Cancer; Esophagectomy; Clinical endpoint; Clinical trial; Immunotherapy","score_opus":0.05022544396001486,"score_gpt":0.3513786160326748,"score_spread":0.3011531720726599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205227233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9563085,0.016120583,0.00054204086,0.002475419,0.00017057243,0.0005740037,0.01710454,0.000041772477,0.0066626174],"genre_scores_gemma":[0.9912334,0.0027412241,0.00041159242,0.00036210028,0.000035999168,0.00008803473,0.004111226,0.000010991656,0.0010053642],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998696,0.00042235997,0.00009586464,0.00013154629,0.00030134054,0.0003529195],"domain_scores_gemma":[0.9985323,0.00031488796,0.00023393925,0.00004258758,0.00042411656,0.00045216133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001364785,0.0006506965,0.0014303236,0.0008705105,0.000513163,0.0015352205,0.0010646974,0.0005590351,0.0027603174],"category_scores_gemma":[0.004455379,0.0004054114,0.004449142,0.0020283367,0.00043635562,0.00043296194,0.00059433264,0.0011682977,0.00013782235],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12880524,0.0018561527,0.47183037,0.0082492875,0.029845277,0.0010591729,0.0003787723,0.14523879,0.0037816288,0.0065397792,0.027658803,0.17475678],"study_design_scores_gemma":[0.017131025,0.008555826,0.8391963,0.0017907376,0.023895271,0.0006376437,0.0011072652,0.08634978,0.0012465261,0.0014382362,0.01839535,0.0002560213],"about_ca_topic_score_codex":0.92088133,"about_ca_topic_score_gemma":0.94757277,"teacher_disagreement_score":0.07911867,"about_ca_system_score_codex":0.044724222,"about_ca_system_score_gemma":0.03998261,"threshold_uncertainty_score":0.32449847},"labels":[],"label_agreement":null},{"id":"W4205278684","doi":"10.1016/j.jval.2021.11.1124","title":"POSB357 Health State Utilities for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Clinical trial; Quality of life (healthcare); Population; Internal medicine; Demography; Pediatrics; Environmental health","score_opus":0.22660836271440996,"score_gpt":0.3902736951606705,"score_spread":0.16366533244626055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205278684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93999577,0.0033857403,0.0011163092,0.0034464567,0.00021761046,0.00013803145,0.025075098,0.000096134034,0.026528895],"genre_scores_gemma":[0.9888657,0.00035840218,0.00023833987,0.0003240371,0.000048063008,0.000060693576,0.008383658,0.000009445224,0.0017116292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995357,0.00023156601,0.000038944057,0.00004425626,0.000064922584,0.00008457099],"domain_scores_gemma":[0.9983254,0.0006970078,0.00042085166,0.00008490115,0.000105549596,0.0003663393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009616118,0.00020015596,0.00057107967,0.0005370478,0.00015349886,0.0007423734,0.00020579343,0.00038706153,0.010266795],"category_scores_gemma":[0.004877322,0.000096607495,0.0010249853,0.0010711954,0.00022876218,0.00055552943,0.00044062076,0.0011434435,0.0011478716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.060103253,0.0012389116,0.58760375,0.00063239736,0.0013917129,0.00044738973,0.00012844827,0.02300212,0.001334102,0.009057638,0.050600793,0.2644595],"study_design_scores_gemma":[0.0035734465,0.007936714,0.92866623,0.00029610549,0.0007582845,0.00046941458,0.00026104267,0.023162773,0.0011573186,0.011343059,0.022307532,0.00006815227],"about_ca_topic_score_codex":0.0023619428,"about_ca_topic_score_gemma":0.0029120606,"teacher_disagreement_score":0.010266795,"about_ca_system_score_codex":0.0008286656,"about_ca_system_score_gemma":0.0006766591,"threshold_uncertainty_score":0.034345806},"labels":[],"label_agreement":null},{"id":"W4205288848","doi":"10.1016/j.jval.2021.11.612","title":"POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Psychological intervention; Economic impact analysis; Gross domestic product; Quarter (Canadian coin); Index (typography); Health care; Econometrics; Healthcare system; Economic cost; Economics; Development economics; Medicine; Geography; Economic growth; Disease; Infectious disease (medical specialty); Computer science","score_opus":0.7274146615997276,"score_gpt":0.5643975778910673,"score_spread":0.1630170837086603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205288848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8662427,0.006547097,0.042242482,0.022861183,0.00084073126,0.00036234048,0.012676661,0.00042380727,0.047802947],"genre_scores_gemma":[0.9798147,0.0014640639,0.0019042746,0.00034538432,0.0001803752,0.0001418959,0.002704929,0.000051724364,0.013392706],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99895227,0.0005108285,0.000028299377,0.00013096309,0.00005984308,0.00031770134],"domain_scores_gemma":[0.99495727,0.0038317516,0.0003417881,0.00016709497,0.00039694083,0.00030511522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041140225,0.0011296872,0.0019801483,0.0017211337,0.0005801293,0.00313652,0.0017212942,0.0030835602,0.015678788],"category_scores_gemma":[0.00923368,0.0006474504,0.0021123425,0.0013759761,0.0011436805,0.0011053439,0.0011543069,0.0030991326,0.0013595639],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016396312,0.00067145197,0.04175015,0.00017153675,0.0004969079,0.00097318715,0.00016356165,0.8703206,0.00019165328,0.046273813,0.017488377,0.019859085],"study_design_scores_gemma":[0.00036276618,0.00026318058,0.012290998,0.00016155849,0.00034956422,0.00016268918,0.00030007595,0.9537009,0.00009078414,0.027831048,0.004432063,0.0000543423],"about_ca_topic_score_codex":0.098015204,"about_ca_topic_score_gemma":0.033380836,"teacher_disagreement_score":0.098015204,"about_ca_system_score_codex":0.0038176645,"about_ca_system_score_gemma":0.002541371,"threshold_uncertainty_score":0.19488937},"labels":[],"label_agreement":null},{"id":"W4205289006","doi":"10.1016/j.jval.2021.11.103","title":"POSA30 Canadian Real-World Experience with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Systemic Anticancer Therapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Nivolumab; Medicine; Lung cancer; Regimen; Internal medicine; Stage (stratigraphy); Oncology; Population; Cancer; Database; Immunotherapy","score_opus":0.012919443884347018,"score_gpt":0.26732898897647517,"score_spread":0.25440954509212815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205289006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9604821,0.004963235,0.0002764678,0.0037681411,0.00019781056,0.00015526981,0.0025837044,0.000026529508,0.027546667],"genre_scores_gemma":[0.9901765,0.002685083,0.00035448672,0.0012046273,0.00015128234,0.000047260994,0.002264326,0.000026811114,0.0030896643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993297,0.000117022464,0.00003375628,0.00007590682,0.00020730101,0.00023636143],"domain_scores_gemma":[0.99849546,0.00014070784,0.00020972047,0.00003590886,0.00044510106,0.0006731801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007071546,0.00028839876,0.0004788949,0.0002597819,0.0022829226,0.0014471628,0.0004530311,0.0005630487,0.0028597058],"category_scores_gemma":[0.0018557397,0.00013717375,0.0006268301,0.00090881303,0.0006124647,0.00033702413,0.0005045925,0.00096741994,0.0004564658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014976631,0.0027220247,0.76023155,0.0006028798,0.0008804553,0.0075297803,0.003111257,0.004568504,0.005297122,0.0018619056,0.042761583,0.15545641],"study_design_scores_gemma":[0.0015009796,0.004777948,0.86259234,0.00038330723,0.00067094003,0.0056601907,0.003918866,0.0022728422,0.0012084342,0.0005198516,0.11628213,0.00021201973],"about_ca_topic_score_codex":0.6518741,"about_ca_topic_score_gemma":0.8109398,"teacher_disagreement_score":0.34812587,"about_ca_system_score_codex":0.014834666,"about_ca_system_score_gemma":0.01130639,"threshold_uncertainty_score":0.7003521},"labels":[],"label_agreement":null},{"id":"W4205351508","doi":"10.1016/j.jval.2021.04.274","title":"PCN183 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet-Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Ipilimumab; Nivolumab; Medicine; Oncology; Internal medicine; Chemotherapy; Progression-free survival; Quality of life (healthcare); Lung cancer; Cancer; Immunotherapy","score_opus":0.2546435512431814,"score_gpt":0.4184204429304267,"score_spread":0.1637768916872453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205351508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97706544,0.011211123,0.0007319315,0.0013090947,0.00014081526,0.00090892625,0.0041578473,0.000037060254,0.004437806],"genre_scores_gemma":[0.9961582,0.0012455913,0.00054581725,0.0001414688,0.00002322931,0.00009628163,0.0011308314,0.0000058521214,0.0006528227],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99761224,0.0011671835,0.0001241592,0.00019511963,0.000406039,0.0004953242],"domain_scores_gemma":[0.9972728,0.0011145361,0.00033107706,0.00006318048,0.0005091023,0.00070927845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027940935,0.0010542083,0.0019614766,0.00093576155,0.00059775455,0.0015530223,0.001396419,0.0008603898,0.0036906078],"category_scores_gemma":[0.0077444483,0.0004994386,0.0037673907,0.0015376117,0.00069960713,0.00060810783,0.00073509774,0.0016204827,0.00013617755],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3689846,0.0063657085,0.08022789,0.007253085,0.023178818,0.00083160587,0.00035936837,0.31400275,0.0026765617,0.0058032814,0.011862189,0.1784541],"study_design_scores_gemma":[0.102068804,0.049987298,0.33287165,0.0024287226,0.043953728,0.0008775128,0.0015461415,0.44812328,0.0021693064,0.0032025264,0.012322258,0.000448702],"about_ca_topic_score_codex":0.83569205,"about_ca_topic_score_gemma":0.81386286,"teacher_disagreement_score":0.16430795,"about_ca_system_score_codex":0.051743105,"about_ca_system_score_gemma":0.03609177,"threshold_uncertainty_score":0.37542427},"labels":[],"label_agreement":null},{"id":"W4205417271","doi":"10.1016/j.jval.2021.12.002","title":"Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Government of Canada; Bill and Melinda Gates Foundation; United States Agency for International Development","keywords":"Cost effectiveness; Marginal cost; Medicine; Cost–benefit analysis; Time horizon; Randomized controlled trial; Total cost; Operations management; Physical therapy; Risk analysis (engineering); Business; Economics; Surgery; Finance","score_opus":0.1194410942274034,"score_gpt":0.4133505954305272,"score_spread":0.2939095012031238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205417271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921693,0.0033097104,0.00043069123,0.0010898462,0.00004108446,0.00014532197,0.00029718823,0.00001749423,0.002499375],"genre_scores_gemma":[0.9985343,0.00063881476,0.00045918638,0.00005238562,0.00001047223,0.000054924483,0.000045637986,0.0000017728216,0.00020248578],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9940925,0.0043906462,0.000418673,0.00020172352,0.00052724493,0.00036920744],"domain_scores_gemma":[0.98431855,0.011680568,0.002144145,0.00041753775,0.0006349827,0.00080425385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00358764,0.00048434097,0.00052397244,0.0016382157,0.0005163803,0.0017911318,0.00069313135,0.0012610735,0.0038259407],"category_scores_gemma":[0.028338203,0.00039550636,0.0012909496,0.0015859538,0.0008479588,0.0014698704,0.0017049562,0.0011877702,0.00019756008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036608502,0.00706673,0.305997,0.0036921247,0.002057742,0.0013576236,0.001318981,0.04449729,0.0013221926,0.0045899507,0.0033267252,0.58816516],"study_design_scores_gemma":[0.006521856,0.07374879,0.7341072,0.005090399,0.009604874,0.005618721,0.009528728,0.1310235,0.0047514485,0.007854038,0.011710106,0.00044034244],"about_ca_topic_score_codex":0.008183171,"about_ca_topic_score_gemma":0.0061451704,"teacher_disagreement_score":0.008183171,"about_ca_system_score_codex":0.0039532175,"about_ca_system_score_gemma":0.0017269875,"threshold_uncertainty_score":0.028682768},"labels":[],"label_agreement":null},{"id":"W4205445180","doi":"10.1016/j.jval.2021.11.181","title":"POSC35 Venetoclax Combination Therapies Show Significant Improvements in Overall Survival and Remission in Treatment-Naïve Patients with AML Who Are Ineligible for Intensive Chemotherapy: A Network Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Venetoclax; Azacitidine; Decitabine; Cytarabine; Medicine; Myeloid leukemia; Oncology; Internal medicine; Ven; Chemotherapy; Meta-analysis; Lorazepam; Leukemia; Psychiatry; Chronic lymphocytic leukemia; Computer science","score_opus":0.07826583072483097,"score_gpt":0.33380613268509246,"score_spread":0.2555403019602615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205445180","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44925708,0.5377396,0.0032463986,0.0013139498,0.0011518014,0.0002777458,0.0035101806,0.00018590772,0.0033173715],"genre_scores_gemma":[0.9802698,0.016283097,0.00077617704,0.00080196076,0.00020854104,0.000089577574,0.0009074839,0.000030299583,0.00063296483],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9963904,0.002286131,0.00027817333,0.00062847685,0.0002310318,0.00018581071],"domain_scores_gemma":[0.9956338,0.0029363253,0.0006862701,0.00041036864,0.00016708218,0.00016610131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044796704,0.0015932627,0.005289331,0.0007376433,0.00040098265,0.0017673816,0.0010108015,0.0014689141,0.0034558102],"category_scores_gemma":[0.008876497,0.0008748156,0.019005178,0.0014776749,0.0005890435,0.0009177125,0.0008211245,0.0025639394,0.00035000138],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09156987,0.0001241963,0.032758042,0.009650604,0.8420511,0.00013572612,0.00007605381,0.0019809706,0.00093835586,0.00020787069,0.0012903926,0.019216904],"study_design_scores_gemma":[0.014122423,0.002331846,0.03069235,0.00069081946,0.94810313,0.00011323329,0.000057044126,0.0010060422,0.00022224491,0.000696488,0.0019253542,0.000039111077],"about_ca_topic_score_codex":0.004938435,"about_ca_topic_score_gemma":0.0107502695,"teacher_disagreement_score":0.005289331,"about_ca_system_score_codex":0.0008889701,"about_ca_system_score_gemma":0.0005922997,"threshold_uncertainty_score":0.023691058},"labels":[],"label_agreement":null},{"id":"W4205481831","doi":"10.1016/j.jval.2021.11.1147","title":"POSB380 General Population Reference Values for the Promis Global Health in Hungary","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Mental health; Population; Demography; Patient-Reported Outcomes Measurement Information System; Gerontology; Environmental health; Psychometrics; Clinical psychology; Psychiatry; Computerized adaptive testing","score_opus":0.08872762529206583,"score_gpt":0.36976151017928055,"score_spread":0.2810338848872147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205481831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43626875,0.0038332634,0.012344782,0.0018626337,0.0008440798,0.00067813374,0.4123613,0.000857288,0.13094977],"genre_scores_gemma":[0.753685,0.0011763193,0.010425047,0.0005459555,0.0001534577,0.0008778099,0.21377845,0.0002153812,0.019142669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983735,0.0004435888,0.00024927396,0.00021863283,0.0004606747,0.00025436992],"domain_scores_gemma":[0.99781066,0.00042333905,0.0003236966,0.0002244517,0.0010536904,0.00016426625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002142612,0.0003760126,0.0004888258,0.0035330008,0.00033443669,0.0011109307,0.0009727825,0.000480783,0.004706156],"category_scores_gemma":[0.004457465,0.00019244959,0.0004671238,0.0042852,0.00019556911,0.0004079274,0.00096807,0.0006015939,0.001848711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023823709,0.00043026725,0.5272583,0.00095057336,0.0003249919,0.0010927669,0.0018181492,0.0072365375,0.00166481,0.023349386,0.2285758,0.20491605],"study_design_scores_gemma":[0.000106482854,0.00022753504,0.9093773,0.0001847273,0.00008180878,0.00041388848,0.0009839346,0.0015401379,0.0008079205,0.0028262439,0.083420396,0.000029626435],"about_ca_topic_score_codex":0.07241494,"about_ca_topic_score_gemma":0.031033598,"teacher_disagreement_score":0.07241494,"about_ca_system_score_codex":0.0025079446,"about_ca_system_score_gemma":0.0021887848,"threshold_uncertainty_score":0.14398688},"labels":[],"label_agreement":null},{"id":"W4205492501","doi":"10.1016/j.jval.2021.11.127","title":"POSB17 Ozanimod for the Treatment of Biologic-Experienced Patients with Moderate-to-Severe Ulcerative Colitis: Results from a Systematic Literature Review and Network Meta-Analyses","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Tofacitinib; Vedolizumab; Ulcerative colitis; Adalimumab; Infliximab; Ustekinumab; Placebo; Golimumab; Clinical trial; Disease; Pathology; Rheumatoid arthritis","score_opus":0.05959311009066321,"score_gpt":0.3249714604986568,"score_spread":0.26537835040799357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205492501","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034139283,0.96393347,0.00039672613,0.00023676566,0.00019290039,0.00010910177,0.000586743,0.000017062433,0.00038797714],"genre_scores_gemma":[0.6317584,0.36424485,0.001248046,0.0010777705,0.00027254695,0.00020849644,0.0008810267,0.000021331776,0.00028751304],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99597484,0.0019945158,0.00093274727,0.0005160391,0.00042614233,0.00015570388],"domain_scores_gemma":[0.9939063,0.0040020244,0.001451643,0.00020337461,0.00030240748,0.00013432732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005562566,0.0013433108,0.0083566,0.0020570133,0.00034764415,0.0018584976,0.001023039,0.0012615944,0.0018974121],"category_scores_gemma":[0.010762004,0.00068606157,0.01902716,0.0033576936,0.0005951548,0.0010942353,0.0010370031,0.0017763256,0.00015543301],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02163993,0.00010057922,0.014672978,0.12763059,0.8023237,0.000146869,0.00009789026,0.00068641943,0.000575905,0.00012463493,0.00067469635,0.031325884],"study_design_scores_gemma":[0.0035901102,0.00069419143,0.0133876875,0.005789416,0.97424966,0.00009507856,0.00007052827,0.00023582247,0.00014160019,0.00020005215,0.0015144283,0.000031549775],"about_ca_topic_score_codex":0.0031839558,"about_ca_topic_score_gemma":0.009316797,"teacher_disagreement_score":0.0083566,"about_ca_system_score_codex":0.0010131188,"about_ca_system_score_gemma":0.0010994336,"threshold_uncertainty_score":0.029417992},"labels":[],"label_agreement":null},{"id":"W4205496798","doi":"10.1016/j.jval.2021.11.1090","title":"POSA379 Differences in Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Discrete Choice Experiment","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Respondent; Mixed logit; Family member; Family medicine; Preference; Lung cancer; Ordered logit; Logistic regression; Demography; Internal medicine","score_opus":0.19245673646556236,"score_gpt":0.2903950607173132,"score_spread":0.09793832425175084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205496798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998309,0.00001563765,0.0002463753,0.00016088449,0.000023996157,0.000090883004,0.000097077354,0.0000032721705,0.0010529074],"genre_scores_gemma":[0.99760133,0.00001996525,0.0005857795,0.00013092514,0.000015632737,0.00023905477,0.000074179545,0.0000025691556,0.0013306912],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9978332,0.0013986549,0.00010275644,0.00025095308,0.00016207136,0.00025233632],"domain_scores_gemma":[0.9869773,0.009867705,0.0009766546,0.00070341193,0.00014407099,0.0013308387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043824054,0.00043544144,0.0006452965,0.0002453124,0.00075629266,0.0018249524,0.00048161895,0.0017123154,0.017365718],"category_scores_gemma":[0.010046909,0.0004271391,0.0007437574,0.00025115686,0.001233671,0.0006733035,0.0006022238,0.0018819934,0.0011350228],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5928154,0.19642255,0.09446319,0.00035224567,0.000988205,0.0006110529,0.0037082364,0.011348305,0.028214248,0.013735003,0.002194848,0.055146843],"study_design_scores_gemma":[0.15074916,0.46543005,0.2352275,0.00017647333,0.0014903563,0.00086469424,0.0067134122,0.072875015,0.016316673,0.04229437,0.0073653627,0.0004969399],"about_ca_topic_score_codex":0.0009371544,"about_ca_topic_score_gemma":0.0005865775,"teacher_disagreement_score":0.017365718,"about_ca_system_score_codex":0.00058049546,"about_ca_system_score_gemma":0.0010415254,"threshold_uncertainty_score":0.058094144},"labels":[],"label_agreement":null},{"id":"W4205499854","doi":"10.1016/j.jval.2021.11.1242","title":"POSA417 Trends of Oral Anticoagulant Use and the Predictors of Initiation Choice between Men and Women with Atrial Fibrillation and Discharged from Hospital to the Community","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Warfarin; Cohort; Internal medicine; Apixaban; Odds ratio; Rivaroxaban; Comorbidity; Logistic regression; Confidence interval; Anticoagulant; Cardiology","score_opus":0.06247951852073041,"score_gpt":0.32155720498746077,"score_spread":0.25907768646673035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205499854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973774,0.00030515753,0.00005881995,0.00013478743,0.000020559834,0.0000050009303,0.00097621034,0.000005697967,0.0011164056],"genre_scores_gemma":[0.99842536,0.000118989796,0.000029003613,0.000048528575,0.000023080713,0.000004788612,0.00062793517,0.0000043417986,0.0007180412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995542,0.000082323386,0.000047744277,0.000121693694,0.00005354305,0.00014043145],"domain_scores_gemma":[0.99792504,0.0005976607,0.0006378976,0.00012768645,0.00017032566,0.00054130366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050820614,0.0002040852,0.00038719754,0.00061965786,0.0004622798,0.0011247713,0.00043344966,0.0007578174,0.008660325],"category_scores_gemma":[0.003006825,0.000311485,0.0012467959,0.0009141036,0.00029801868,0.0008407331,0.00050526723,0.0012922667,0.0007269886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047843857,0.000054746273,0.9978415,0.000008454136,0.00011540826,0.000063629195,0.00007930955,0.000033280176,0.00015540012,0.000052699004,0.00017688079,0.000940213],"study_design_scores_gemma":[0.000018986924,0.00017543975,0.99821967,0.000011497058,0.000059840724,0.00018517341,0.0005200639,0.00044416977,0.000053945452,0.0000769115,0.0002256402,0.000008640217],"about_ca_topic_score_codex":0.013241799,"about_ca_topic_score_gemma":0.0119101275,"teacher_disagreement_score":0.013241799,"about_ca_system_score_codex":0.00029583665,"about_ca_system_score_gemma":0.0006319914,"threshold_uncertainty_score":0.028971672},"labels":[],"label_agreement":null},{"id":"W4205514480","doi":"10.1016/j.jval.2021.11.751","title":"POSA236 Real-World Treatment (Tx) Characteristics for Advanced Non-Small Cell Lung Cancer (aNSCLC) Without Actionable Mutations After Introduction of Immune Checkpoint Inhibitors (ICIs) in EU4 and UK","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Pemetrexed; Pembrolizumab; Carboplatin; Lung cancer; Nivolumab; Oncology; Medicine; Internal medicine; Atezolizumab; Cancer; Chemotherapy; Immunotherapy; Cisplatin","score_opus":0.017029739607347674,"score_gpt":0.3016004906995064,"score_spread":0.28457075109215874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205514480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95300096,0.0035646441,0.000726259,0.001422874,0.0001950175,0.00008079941,0.024750665,0.00006137464,0.016197389],"genre_scores_gemma":[0.98499286,0.0003063996,0.00020122307,0.00036620066,0.000043249645,0.000044884255,0.010871634,0.00003249983,0.0031411091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995585,0.00006809885,0.000084377156,0.00009209873,0.00007487689,0.00012209795],"domain_scores_gemma":[0.9988998,0.00021704102,0.0004526505,0.00004764327,0.00013527826,0.0002476071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004116183,0.00012236697,0.00031860618,0.00030607323,0.00018970584,0.0007194857,0.00025959918,0.00036342928,0.007902666],"category_scores_gemma":[0.0018302283,0.00007215725,0.0005300695,0.0007240984,0.0001815839,0.00060589286,0.000368355,0.00059412676,0.0010178112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019451514,0.00012748785,0.86819035,0.0004339022,0.0005790102,0.0016373019,0.0002225776,0.0042488007,0.0058912043,0.0021612819,0.0159406,0.081116006],"study_design_scores_gemma":[0.00023060378,0.0015824133,0.96196645,0.00009748755,0.0001861723,0.0017628339,0.0002374497,0.00086479343,0.0011810556,0.00064975437,0.031209707,0.00003118107],"about_ca_topic_score_codex":0.0049994155,"about_ca_topic_score_gemma":0.0068425657,"teacher_disagreement_score":0.007902666,"about_ca_system_score_codex":0.0009019072,"about_ca_system_score_gemma":0.00056521664,"threshold_uncertainty_score":0.026436985},"labels":[],"label_agreement":null},{"id":"W4205536822","doi":"10.1016/j.jval.2021.11.081","title":"POSA6 Use of Real-World Evidence to Evaluate Infliximab Biosimilars: A Scoping Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Biosimilar; Medicine; Infliximab; Tolerability; Rheumatoid arthritis; Observational study; Adverse effect; Clinical trial; Internal medicine; Intensive care medicine; Disease","score_opus":0.4610570349245248,"score_gpt":0.4993665742394198,"score_spread":0.038309539314895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205536822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013484614,0.99908864,0.00008614414,0.00020935053,0.00009697119,0.000042446154,0.00009678179,0.0000038878616,0.00024108282],"genre_scores_gemma":[0.0022814178,0.99642545,0.000422404,0.000501721,0.00007021051,0.00006363082,0.00013142619,0.0000042358183,0.00009948623],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99330926,0.001679117,0.0026846353,0.0006744517,0.0014461103,0.00020634788],"domain_scores_gemma":[0.96236813,0.02945662,0.00492105,0.0004738981,0.002478466,0.00030177413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014163721,0.001607305,0.0070660366,0.009745147,0.000528563,0.005171039,0.0025560933,0.003705976,0.006839893],"category_scores_gemma":[0.04203952,0.0009736434,0.0068830084,0.007138147,0.0012173356,0.00334915,0.00218689,0.002406755,0.0008482158],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043934368,0.000039456758,0.00060537213,0.73355186,0.008043727,0.00013287694,0.0001716246,0.00026581192,0.00046729395,0.0014831352,0.0047445884,0.25005493],"study_design_scores_gemma":[0.00026548802,0.00016765227,0.0016245472,0.8620714,0.031759202,0.00038695714,0.00019259502,0.00012701305,0.00036026965,0.001232517,0.10176204,0.000050336275],"about_ca_topic_score_codex":0.0043687345,"about_ca_topic_score_gemma":0.00858592,"teacher_disagreement_score":0.014163721,"about_ca_system_score_codex":0.0032692233,"about_ca_system_score_gemma":0.009963681,"threshold_uncertainty_score":0.07490581},"labels":[],"label_agreement":null},{"id":"W4205539415","doi":"10.1016/j.jval.2021.11.329","title":"POSB56 Cost-Effectiveness of Satralizumab Compared to Eculizumab for the Treatment Neuromyelitis Optica Spectrum Disorders (NMOSD) in Adult and Adolescent Patients Who Are Anti-Aquaporin 4 (AQP4) Seropositive in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"","keywords":"Medicine; Eculizumab; Neuromyelitis optica; Cost effectiveness; Quality of life (healthcare); Clinical trial; Quality-adjusted life year; Pediatrics; Internal medicine; Psychiatry; Immunology; Multiple sclerosis","score_opus":0.15332191501015396,"score_gpt":0.35527819416933787,"score_spread":0.2019562791591839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205539415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98896724,0.0060381573,0.000057882942,0.0010644699,0.00009184866,0.00012110422,0.0017518847,0.000009374202,0.0018979531],"genre_scores_gemma":[0.99818605,0.0008027394,0.00006234323,0.000102069615,0.000016377428,0.000023663139,0.00052118907,0.0000017193452,0.00028376776],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99908936,0.0003094386,0.000088111476,0.00010215614,0.00013500502,0.00027585553],"domain_scores_gemma":[0.99808455,0.00050711853,0.00033741197,0.00004614829,0.00020527579,0.0008195792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009564629,0.0003947948,0.0012247033,0.00052048475,0.00046620594,0.0013246584,0.00079073734,0.0009205565,0.004146661],"category_scores_gemma":[0.0046386085,0.00034316388,0.0026086422,0.0008387975,0.00060041563,0.0006878738,0.00053805613,0.0013688072,0.00014762308],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5481177,0.0049236068,0.19383743,0.0026971046,0.010915585,0.00071252167,0.000440578,0.054366816,0.0016473335,0.004202195,0.010182709,0.16795653],"study_design_scores_gemma":[0.09792598,0.048300363,0.7524167,0.0021097667,0.016862873,0.0007518054,0.0020085012,0.06921787,0.0013857124,0.0020173432,0.0067080166,0.00029503816],"about_ca_topic_score_codex":0.55851084,"about_ca_topic_score_gemma":0.5621955,"teacher_disagreement_score":0.44148916,"about_ca_system_score_codex":0.017075447,"about_ca_system_score_gemma":0.011157637,"threshold_uncertainty_score":0.88817835},"labels":[],"label_agreement":null},{"id":"W4205566294","doi":"10.1016/j.jval.2021.11.1188","title":"POSC363 Engaging Patients and Caregivers in Health Economic Evaluations: Generating Stakeholder Input to Inform the Conduct of an Early Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Economic evaluation; Stakeholder; Medicine; Psychology; Political science; Public relations","score_opus":0.4604869906156747,"score_gpt":0.4311957501962077,"score_spread":0.029291240419467013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205566294","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20033543,0.0052970275,0.04314144,0.4582124,0.002956578,0.016144872,0.005364194,0.0005340123,0.26801404],"genre_scores_gemma":[0.8020218,0.0024857405,0.11536642,0.05215998,0.0011568099,0.014845162,0.0019360388,0.00019331145,0.009834769],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9122638,0.07882725,0.0022114986,0.00061483466,0.0042539667,0.0018285861],"domain_scores_gemma":[0.6942221,0.23887695,0.0109345475,0.006371411,0.03629152,0.013303495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.13106841,0.00058616727,0.0008050761,0.0013502577,0.0020545481,0.0040265894,0.00081242237,0.0042163427,0.01737043],"category_scores_gemma":[0.28897133,0.00037582588,0.0006489386,0.0011929566,0.0014910515,0.002266068,0.0042825458,0.004076378,0.0027695415],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006128251,0.0021191682,0.026518589,0.0016662445,0.00030738895,0.00091796566,0.0031785157,0.0046764375,0.0013799734,0.023936508,0.41336787,0.5158031],"study_design_scores_gemma":[0.007908224,0.005627759,0.06740061,0.013924204,0.00088982703,0.0010618179,0.011207991,0.03516231,0.008203951,0.13129517,0.7168093,0.00050884014],"about_ca_topic_score_codex":0.002132282,"about_ca_topic_score_gemma":0.0065518264,"teacher_disagreement_score":0.13106841,"about_ca_system_score_codex":0.0052159033,"about_ca_system_score_gemma":0.021640602,"threshold_uncertainty_score":0.6931643},"labels":[],"label_agreement":null},{"id":"W4205579936","doi":"10.1016/j.jval.2021.11.955","title":"POSC295 Delay in Shock Wave Lithotripsy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Shock wave lithotripsy; Stent; Lithotripsy; Medicine; Health care; Shock (circulatory); Surgery; Radiology; Political science","score_opus":0.04196312070066311,"score_gpt":0.29061631122286186,"score_spread":0.24865319052219875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205579936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663216,0.0007885774,0.000054759035,0.0002665559,0.000045497516,0.0000058029523,0.00053626334,0.000003987447,0.0016664392],"genre_scores_gemma":[0.99868566,0.00020099049,0.00004212913,0.00011616772,0.000036711146,0.0000036149831,0.00037884014,0.0000025244715,0.00053335074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995646,0.00006127488,0.000058025944,0.00006598934,0.000091803595,0.0001583162],"domain_scores_gemma":[0.99780434,0.00052594877,0.0008373136,0.000088349385,0.0001872911,0.0005567152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033272893,0.00016167031,0.0003666039,0.00050884014,0.0004357327,0.0009284884,0.0003207334,0.00069075375,0.0057447637],"category_scores_gemma":[0.0036287056,0.00019130632,0.00084541575,0.0010248238,0.00021628077,0.0005949339,0.0004610489,0.0013398111,0.00037502096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005345817,0.0001264191,0.9964342,0.000023071576,0.00012069231,0.00018633102,0.000053215466,0.000059528396,0.0001738949,0.00009438007,0.00025713068,0.0019365986],"study_design_scores_gemma":[0.000016634258,0.00019666048,0.998326,0.000022255572,0.00006334818,0.000271942,0.000260632,0.00024314965,0.00006383858,0.00009231393,0.000434211,0.000008993881],"about_ca_topic_score_codex":0.011219306,"about_ca_topic_score_gemma":0.01026272,"teacher_disagreement_score":0.011219306,"about_ca_system_score_codex":0.0005503907,"about_ca_system_score_gemma":0.0009911078,"threshold_uncertainty_score":0.022307992},"labels":[],"label_agreement":null},{"id":"W4205606847","doi":"10.1016/j.jval.2021.11.934","title":"POSA297 Preferences for Hemophilia Treatments in Canada: A Discrete Choice Experiment (DCE)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Manitoba; Roche (Canada); Vancouver Coastal Health","funders":"","keywords":"Medicine; Mixed logit; Odds ratio; Subcutaneous injection; Odds; Preference; Logistic regression; Internal medicine","score_opus":0.09231612351512183,"score_gpt":0.368783246722976,"score_spread":0.27646712320785416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205606847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885316,0.00012748824,0.00047703684,0.0006739209,0.00004375981,0.0006025022,0.001198964,0.000015272544,0.008329582],"genre_scores_gemma":[0.9796718,0.0001853192,0.0021780469,0.0006585143,0.000015343021,0.0004130066,0.00080259435,0.000012906105,0.01606263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977991,0.000906498,0.00005904438,0.00025700597,0.00044288312,0.0005355443],"domain_scores_gemma":[0.99578625,0.0018606189,0.00034646608,0.00026416988,0.0008681322,0.00087437965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025447046,0.0004475413,0.0008579252,0.0004021876,0.003891792,0.0019369104,0.001066793,0.0015435427,0.012646495],"category_scores_gemma":[0.0066049094,0.00043217192,0.0007720653,0.00082349015,0.0019683328,0.0006593541,0.00060889334,0.001841048,0.00081560767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15781114,0.08009149,0.40965566,0.0010797069,0.00139081,0.0010124226,0.011670374,0.023813864,0.023199879,0.042052764,0.05566609,0.19255583],"study_design_scores_gemma":[0.024997786,0.033374753,0.76311165,0.00032346105,0.0010222006,0.0002356099,0.01820252,0.07621966,0.007261059,0.010856485,0.06341429,0.0009805693],"about_ca_topic_score_codex":0.9810111,"about_ca_topic_score_gemma":0.9904447,"teacher_disagreement_score":0.03574609,"about_ca_system_score_codex":0.03574609,"about_ca_system_score_gemma":0.052138913,"threshold_uncertainty_score":0.25935727},"labels":[],"label_agreement":null},{"id":"W4205695850","doi":"10.1016/j.jval.2021.11.442","title":"POSC37 Economic Cost of Treatment in Canada: A Multi-Centre, Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Alberta Health Services; Takeda (Canada); McMaster University","funders":"","keywords":"Medicine; Retrospective cohort study; Medical record; Health care; Emergency medicine; Clotting factor; Pediatrics; Emergency department; Internal medicine","score_opus":0.07644320912488124,"score_gpt":0.35097409444697025,"score_spread":0.274530885322089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205695850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719234,0.0036831023,0.00016602997,0.00071768166,0.000029884326,0.0001762919,0.018894644,0.000016440856,0.0043926053],"genre_scores_gemma":[0.98982716,0.0025793232,0.00021784658,0.00033006474,0.000027843518,0.00006300874,0.0056369877,0.00001894552,0.0012988058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966198,0.0002935671,0.0002924466,0.00028821154,0.0013554951,0.0011504551],"domain_scores_gemma":[0.9908914,0.0007238903,0.0026988531,0.0003406928,0.0037093346,0.0016358151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009057382,0.00076585653,0.0012835885,0.004425404,0.0031883414,0.003732972,0.0018798198,0.0011048291,0.0038866983],"category_scores_gemma":[0.006476133,0.0010513559,0.0018303894,0.01585736,0.0012237332,0.00073018076,0.0013032387,0.001782545,0.00037990845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044705404,0.00011387578,0.990571,0.00016780611,0.0005254233,0.0003163023,0.00034852285,0.00041564528,0.00006945232,0.00050638034,0.0021432803,0.0043752748],"study_design_scores_gemma":[0.000065988876,0.000075339456,0.9944318,0.0002099842,0.00033883803,0.00037515175,0.0013462277,0.00064934255,0.000063954954,0.00008929061,0.0023083277,0.00004578468],"about_ca_topic_score_codex":0.99268687,"about_ca_topic_score_gemma":0.99228865,"teacher_disagreement_score":0.08827134,"about_ca_system_score_codex":0.08827134,"about_ca_system_score_gemma":0.075756386,"threshold_uncertainty_score":0.64045644},"labels":[],"label_agreement":null},{"id":"W4205703018","doi":"10.1016/j.jval.2021.11.311","title":"POSB38 Developing a Cost-Effectiveness Analysis for Nivolumab for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in the Absence of Overall Survival Data","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Nivolumab; Esophageal cancer; Internal medicine; Clinical trial; Cancer; Oncology; Cancer registry; Population; Clinical endpoint; Adjuvant; Surgery; Immunotherapy","score_opus":0.14257649278531676,"score_gpt":0.40980165906960714,"score_spread":0.2672251662842904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205703018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7905659,0.03282641,0.09655452,0.018374063,0.0012924724,0.004720083,0.018517515,0.0004687243,0.03668036],"genre_scores_gemma":[0.97163206,0.0028002032,0.015916947,0.0015112347,0.0002325688,0.00068987417,0.004125692,0.00006590793,0.0030254612],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9961993,0.0030047786,0.00012778013,0.00021800362,0.00027415642,0.00017594201],"domain_scores_gemma":[0.9939983,0.004974716,0.00031075525,0.00015120338,0.0003565469,0.00020847446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073171095,0.001075486,0.0016572974,0.001311468,0.00018636539,0.002323232,0.00073637697,0.0010339578,0.0070064887],"category_scores_gemma":[0.016851785,0.0006261566,0.0050920094,0.0011106674,0.00025578783,0.0013692225,0.0006889753,0.0017732016,0.00042779435],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03941251,0.0014228743,0.041316275,0.0038465997,0.026033815,0.00058216596,0.00008866467,0.61755884,0.0035086207,0.019846559,0.017052002,0.22933103],"study_design_scores_gemma":[0.01398264,0.008665694,0.03062176,0.0016919154,0.020216187,0.00044672683,0.0002213924,0.8787733,0.0028267775,0.022744816,0.019663772,0.0001449695],"about_ca_topic_score_codex":0.008791358,"about_ca_topic_score_gemma":0.0066107064,"teacher_disagreement_score":0.008791358,"about_ca_system_score_codex":0.0033923488,"about_ca_system_score_gemma":0.003737115,"threshold_uncertainty_score":0.038697064},"labels":[],"label_agreement":null},{"id":"W4205710120","doi":"10.1016/j.jval.2021.11.1117","title":"POSB350 Real-World (RW) Patient-Reported Outcomes (PROs) in Frontline Maintenance Therapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) in France, Germany, and the UK","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Lung cancer; Visual analogue scale; Family medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.025007975140934766,"score_gpt":0.33300384644181724,"score_spread":0.30799587130088246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205710120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875866,0.0024506508,0.000093622,0.0009956824,0.00005377121,0.000018884833,0.006488673,0.00001813141,0.002293935],"genre_scores_gemma":[0.99467826,0.00028784267,0.00006731676,0.00022474345,0.000027892962,0.000021724676,0.004337277,0.000003699489,0.00035137436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985091,0.0006281283,0.00016842986,0.00019440423,0.00023168715,0.00026821363],"domain_scores_gemma":[0.9968622,0.000846027,0.0012830986,0.0000799827,0.00038020202,0.00054863247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022389947,0.00018298792,0.0003832567,0.0005390992,0.0001653542,0.0010101118,0.0002937238,0.0005365655,0.0019580268],"category_scores_gemma":[0.0049843076,0.00009641965,0.0006932922,0.0011094819,0.00031207563,0.0009679962,0.00080693245,0.0006899787,0.00026040856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008747178,0.00015448236,0.92939883,0.000347736,0.000605333,0.0001807019,0.00037342825,0.0012364081,0.00050694356,0.00076656014,0.009730749,0.047951587],"study_design_scores_gemma":[0.00024483755,0.0011928102,0.9941788,0.0000880654,0.00014037851,0.00010140906,0.00027921385,0.0005253818,0.00010702784,0.0000746103,0.0030514756,0.000016067203],"about_ca_topic_score_codex":0.016834226,"about_ca_topic_score_gemma":0.016167512,"teacher_disagreement_score":0.016834226,"about_ca_system_score_codex":0.0017776324,"about_ca_system_score_gemma":0.00083977275,"threshold_uncertainty_score":0.03347248},"labels":[],"label_agreement":null},{"id":"W4205878845","doi":"10.1016/j.jval.2021.11.1094","title":"POSB327 Assessing the Benefits of Improving Health-Related Quality of Life in Heart Failure: A Preliminary Analysis in EU, UK, and Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of life (healthcare); Medicine; Perspective (graphical); Heart failure; Health related quality of life; Health care; Physical therapy; Disease; Family medicine; Gerontology; Nursing; Pathology; Internal medicine","score_opus":0.14784828911360437,"score_gpt":0.4426767060232651,"score_spread":0.2948284169096607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205878845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97619116,0.0025441116,0.00046613434,0.0012429769,0.00002793635,0.00029167478,0.010862586,0.000018411363,0.008354922],"genre_scores_gemma":[0.9907803,0.0009320393,0.0008607977,0.00030751489,0.000010916978,0.00012005166,0.0047552097,0.00002034996,0.0022128534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957847,0.0011532127,0.00024861103,0.00023036392,0.0016044792,0.0009786598],"domain_scores_gemma":[0.9861166,0.0026567632,0.00090470375,0.00035090614,0.007491444,0.0024795774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058014127,0.00044879428,0.0009834105,0.0019656508,0.0020767832,0.002158883,0.0013364969,0.00070564967,0.0028579282],"category_scores_gemma":[0.015535288,0.00034198668,0.0018273226,0.0047922414,0.0011259103,0.0007243666,0.0020320602,0.0012428873,0.000232339],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049429797,0.0003199305,0.9379552,0.00041946562,0.0007253241,0.00011554264,0.0013739564,0.0019881728,0.00030702492,0.0012381709,0.00501681,0.045597445],"study_design_scores_gemma":[0.000103750186,0.0002181653,0.99491876,0.000101670244,0.00019410464,0.00001714372,0.0013261514,0.00082636083,0.000106013926,0.00012849945,0.0020376903,0.000021709591],"about_ca_topic_score_codex":0.9866007,"about_ca_topic_score_gemma":0.99165875,"teacher_disagreement_score":0.029191498,"about_ca_system_score_codex":0.029191498,"about_ca_system_score_gemma":0.05224957,"threshold_uncertainty_score":0.2118001},"labels":[],"label_agreement":null},{"id":"W4205905722","doi":"10.1016/j.jval.2021.11.1061","title":"POSA350 Effect of Filgotinib on EQ-5D-5L and Work Productivity and Activity Impairment Among Patients with Ulcerative Colitis: Results from the Phase 2B/3 Selection Trial","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Work productivity; Placebo; Medicine; Randomized controlled trial; Ulcerative colitis; Physical therapy; Internal medicine; Productivity; Disease","score_opus":0.16785296529215923,"score_gpt":0.36649082633534463,"score_spread":0.1986378610431854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205905722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98266923,0.010882188,0.00028602438,0.0012676718,0.00034258375,0.000379304,0.0020894248,0.00007637751,0.0020073],"genre_scores_gemma":[0.9928925,0.002102337,0.000320259,0.0009592376,0.00021637119,0.00034845588,0.0021916027,0.00001405288,0.0009552059],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994349,0.0002931362,0.000033134467,0.000092301874,0.000053290572,0.00009325613],"domain_scores_gemma":[0.9991979,0.00026141448,0.00020683667,0.00005915761,0.000057585214,0.00021717309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014999406,0.0013831866,0.002240073,0.00023073761,0.0002952793,0.0011404185,0.00064860535,0.0011850602,0.00459858],"category_scores_gemma":[0.0015924666,0.0004052712,0.0040576993,0.0004094053,0.0007508837,0.00089443877,0.00041107245,0.003235534,0.0007417151],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95266265,0.0019201578,0.004277423,0.000835902,0.0046179765,0.000050822277,0.000046782763,0.0007607586,0.0016163815,0.00020894961,0.002540352,0.03046195],"study_design_scores_gemma":[0.8968285,0.059254397,0.033221684,0.00022007937,0.005363566,0.00011253908,0.000094731084,0.0015903721,0.0005681204,0.0006848323,0.0020027966,0.0000583751],"about_ca_topic_score_codex":0.0017027071,"about_ca_topic_score_gemma":0.0029073667,"teacher_disagreement_score":0.00459858,"about_ca_system_score_codex":0.0010065947,"about_ca_system_score_gemma":0.00080925453,"threshold_uncertainty_score":0.01538378},"labels":[],"label_agreement":null},{"id":"W4205906208","doi":"10.1016/j.jval.2021.11.015","title":"P16 Recent Estimates of Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in the US (2010-2020)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Nivolumab; Stage (stratigraphy); Lung cancer; Internal medicine; Oncology; Ipilimumab; Cancer; Disease; Database; Immunotherapy","score_opus":0.020252863955841333,"score_gpt":0.2807579044830403,"score_spread":0.2605050405271989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205906208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47232345,0.06293469,0.006447355,0.013965362,0.0011281115,0.00008780075,0.4149624,0.00031664237,0.027834132],"genre_scores_gemma":[0.8158953,0.020193845,0.0018152155,0.0013550795,0.0005160564,0.000117382726,0.15144321,0.000036675945,0.008627133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961627,0.000056818713,0.00005519109,0.00007627354,0.00013826259,0.000057187455],"domain_scores_gemma":[0.99749607,0.00035253144,0.0008931247,0.00005450112,0.00094571296,0.00025805627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010072667,0.00038043794,0.0002430386,0.0016636066,0.00014911506,0.00077826064,0.00042071418,0.00038573012,0.0020552785],"category_scores_gemma":[0.0044142795,0.00016243038,0.0009850913,0.0028939587,0.00013349611,0.00068296713,0.000760734,0.00082358974,0.0005532032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038619866,0.000042704898,0.84627116,0.0009608919,0.0010017633,0.00011395958,0.00014344657,0.0062341676,0.00031076462,0.001535246,0.06681926,0.07618036],"study_design_scores_gemma":[0.000033240914,0.00010172252,0.9336909,0.00033275055,0.00034397357,0.0004217323,0.00021567645,0.0021281254,0.00042728914,0.00052219944,0.0617538,0.000028467784],"about_ca_topic_score_codex":0.077667326,"about_ca_topic_score_gemma":0.10688226,"teacher_disagreement_score":0.077667326,"about_ca_system_score_codex":0.0015173149,"about_ca_system_score_gemma":0.0012683746,"threshold_uncertainty_score":0.15443051},"labels":[],"label_agreement":null},{"id":"W4205947264","doi":"10.1016/j.jval.2021.11.810","title":"POSC243 Systemic Challenges in Tele-Health and Structural Solutions to Enhance Access","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Socioeconomic status; Psychological intervention; Health care; Telemedicine; Thematic analysis; Health equity; Ethnic group; Digital divide; Medicine; Qualitative research; Nursing; Political science; Computer science; Population; World Wide Web; Sociology; Environmental health; The Internet","score_opus":0.14941626398079044,"score_gpt":0.43867488101201285,"score_spread":0.2892586170312224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205947264","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027802115,0.002098275,0.010652632,0.752577,0.0010426964,0.00016966715,0.00019588611,0.00007251341,0.20538917],"genre_scores_gemma":[0.8578343,0.004394415,0.015631383,0.06619036,0.0018092456,0.00056840107,0.00027268566,0.00014006074,0.053159215],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9838806,0.0083011035,0.0004928975,0.0009465329,0.0032208445,0.003158144],"domain_scores_gemma":[0.9497381,0.030717142,0.0022409894,0.0021018225,0.008139941,0.007062014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0238918,0.00039673154,0.00047242126,0.0012098817,0.0050893095,0.021399472,0.002313533,0.011338129,0.044519097],"category_scores_gemma":[0.031864665,0.0004226797,0.00060496014,0.0026276158,0.009591481,0.011701775,0.009044496,0.009715466,0.0026091882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003910798,0.00029505632,0.0026004394,0.0003833743,0.000018737945,0.0002509571,0.00362574,0.0011503878,0.00072735635,0.8446689,0.06747253,0.07876752],"study_design_scores_gemma":[0.00009132077,0.00030759128,0.008098976,0.0016752763,0.000024106455,0.00031622898,0.03173819,0.004058604,0.0013195347,0.5241552,0.42814,0.000074870244],"about_ca_topic_score_codex":0.011287638,"about_ca_topic_score_gemma":0.013602813,"teacher_disagreement_score":0.044519097,"about_ca_system_score_codex":0.011255254,"about_ca_system_score_gemma":0.051204454,"threshold_uncertainty_score":0.1489312},"labels":[],"label_agreement":null},{"id":"W4205958817","doi":"10.1016/j.jval.2021.11.594","title":"POSA193 Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Driver Mutations: Projections by Line of Therapy (LOT) in Western Europe (WE), 2021-2026","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Lung cancer; Medicine; Incidence (geometry); Stage (stratigraphy); Oncology; Internal medicine; Epidemiology; Population; Cancer; Environmental health; Biology","score_opus":0.037267381836158894,"score_gpt":0.36435690747723504,"score_spread":0.32708952564107613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205958817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78847796,0.016131274,0.0041164444,0.012235213,0.0004589242,0.00006271012,0.14953272,0.00035824146,0.02862664],"genre_scores_gemma":[0.9105702,0.009738853,0.0019494428,0.0016631684,0.00018300967,0.00007088903,0.0687692,0.00006284278,0.006992378],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996897,0.000060043494,0.000040604336,0.000040923187,0.00009130872,0.000077378674],"domain_scores_gemma":[0.99922633,0.00007436263,0.0002885269,0.000020299522,0.00022405873,0.00016642567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048564278,0.00028710772,0.00024486327,0.00079534366,0.00017443154,0.0009688838,0.00026164245,0.00045303043,0.0026129496],"category_scores_gemma":[0.0012886102,0.000178521,0.0007832312,0.0020484524,0.00015409956,0.0007170458,0.00057158887,0.00085107883,0.0010885881],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018373664,0.00018140813,0.83477324,0.0003935009,0.0004986971,0.00040134526,0.00019424499,0.004109859,0.0014843149,0.003976478,0.06362416,0.08852536],"study_design_scores_gemma":[0.000054809647,0.00027509668,0.95264393,0.00019030746,0.0002933893,0.0007463476,0.00067130814,0.0036044733,0.00066067424,0.0012494329,0.039576564,0.00003368709],"about_ca_topic_score_codex":0.03543198,"about_ca_topic_score_gemma":0.053137586,"teacher_disagreement_score":0.03543198,"about_ca_system_score_codex":0.0013128782,"about_ca_system_score_gemma":0.0013561544,"threshold_uncertainty_score":0.0704515},"labels":[],"label_agreement":null},{"id":"W4205978338","doi":"10.1016/j.jval.2021.11.526","title":"POSC122 Cost-Effectiveness of ALPHA-2 Adrenergic Agonist (LOFEXIDINE) and Long-Acting Injectables for Treatment of Opioid Use Disorder","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Buprenorphine; Naltrexone; Opioid use disorder; Medicine; Methadone; Opioid; Cost effectiveness; Detoxification (alternative medicine); (+)-Naloxone; Clonidine; Quality-adjusted life year; Pharmacology; Anesthesia; Internal medicine","score_opus":0.06262431295225769,"score_gpt":0.34519507232196955,"score_spread":0.2825707593697119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205978338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97450465,0.012026469,0.0003480203,0.0019234039,0.0002828176,0.00029126418,0.002316946,0.00003909486,0.008267347],"genre_scores_gemma":[0.9972602,0.0009048707,0.0002530735,0.00020816442,0.00007038301,0.00004197422,0.00067770586,0.000003282077,0.0005803736],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99896646,0.00055962213,0.000089249035,0.00007077357,0.0001632259,0.00015072538],"domain_scores_gemma":[0.9982687,0.0007584196,0.00038181586,0.000037605463,0.0001548229,0.0003986058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001055393,0.00038162374,0.0011189576,0.0006044227,0.0001951526,0.0008963801,0.0003419389,0.00069422374,0.007731327],"category_scores_gemma":[0.0040536947,0.00019652338,0.0028070507,0.0006178357,0.0002057681,0.0007245713,0.0003649251,0.0010321563,0.0002590424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4099324,0.0065565114,0.12035299,0.0021469432,0.010486047,0.0007275272,0.00012540362,0.017534493,0.0030641695,0.002704306,0.0068984986,0.41947076],"study_design_scores_gemma":[0.06285745,0.109966405,0.741995,0.0016386121,0.019576857,0.0014543419,0.00082094304,0.046196572,0.0026999777,0.0018019612,0.010803223,0.00018864975],"about_ca_topic_score_codex":0.009582859,"about_ca_topic_score_gemma":0.014590516,"teacher_disagreement_score":0.009582859,"about_ca_system_score_codex":0.0024977801,"about_ca_system_score_gemma":0.0016879959,"threshold_uncertainty_score":0.025863826},"labels":[],"label_agreement":null},{"id":"W4206006624","doi":"10.1016/j.jval.2021.10.008","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":830,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Checklist; Context (archaeology); Health care; Stakeholder; Economic evaluation; Public health; Guideline; Public relations; Political science; Psychology; Medicine; Nursing; Law","score_opus":0.3403059080011961,"score_gpt":0.4691500656672357,"score_spread":0.12884415766603963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206006624","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018181364,0.016490228,0.27817184,0.1169485,0.056520823,0.24187472,0.22728336,0.011681559,0.04921083],"genre_scores_gemma":[0.008311144,0.014385505,0.33307758,0.02996315,0.005580306,0.46071422,0.13092898,0.0029154387,0.014123683],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.39044613,0.3498247,0.16343546,0.008479673,0.081060134,0.006753873],"domain_scores_gemma":[0.2081718,0.3688207,0.0921175,0.04850022,0.27856395,0.003825809],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4830866,0.00569016,0.011727932,0.02819397,0.0033984575,0.021327734,0.012754485,0.017972847,0.04758968],"category_scores_gemma":[0.7893426,0.007253154,0.0175412,0.035150077,0.0077990415,0.012035327,0.010179103,0.029262852,0.038167946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008662209,0.00015481317,0.0007898774,0.027887985,0.0004762909,0.00013312018,0.00069642445,0.0019746239,0.00022169408,0.015756022,0.8844121,0.066630855],"study_design_scores_gemma":[0.0021198129,0.0002423456,0.0040452476,0.06512928,0.00063487096,0.00023888594,0.00066600373,0.004293186,0.001219179,0.030925067,0.8899521,0.0005339819],"about_ca_topic_score_codex":0.012695126,"about_ca_topic_score_gemma":0.006613998,"teacher_disagreement_score":0.5169134,"about_ca_system_score_codex":0.015481805,"about_ca_system_score_gemma":0.057791326,"threshold_uncertainty_score":0.6374463},"labels":[],"label_agreement":null},{"id":"W4206084158","doi":"10.1016/j.jval.2021.11.1136","title":"POSB369 Development of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Patient-reported outcome; Delphi method; Dermatological diseases; Medicine; Psychology; Family medicine; Dermatology; Quality of life (healthcare); Nursing","score_opus":0.4002255298422964,"score_gpt":0.4141431859737437,"score_spread":0.013917656131447298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206084158","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14835781,0.0064257453,0.4713149,0.012713649,0.0023286673,0.0043037417,0.09899936,0.0020164547,0.25353965],"genre_scores_gemma":[0.6036651,0.0035308618,0.310299,0.0012890124,0.000694633,0.004652553,0.046465725,0.00040866784,0.028994469],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99486524,0.0024933042,0.00031890042,0.00034749758,0.0018033751,0.00017163713],"domain_scores_gemma":[0.9922409,0.002333846,0.0007145509,0.0005992872,0.0035872601,0.0005242222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007275575,0.00070052955,0.0007500806,0.003229275,0.0002932386,0.0017955875,0.0010314205,0.00056374975,0.017135736],"category_scores_gemma":[0.017131496,0.00030335464,0.0010178385,0.002615655,0.0004013182,0.0011248763,0.0017459275,0.0018906578,0.005222766],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008629481,0.000662382,0.04193368,0.0008775844,0.0004938065,0.00015288405,0.0001410586,0.017133228,0.0022146313,0.124900825,0.05547866,0.75514835],"study_design_scores_gemma":[0.000858924,0.006052883,0.20593992,0.0021432173,0.00048259585,0.0009044255,0.00047980933,0.13753867,0.012988935,0.1702335,0.46211147,0.00026564082],"about_ca_topic_score_codex":0.0033990457,"about_ca_topic_score_gemma":0.0018198999,"teacher_disagreement_score":0.017135736,"about_ca_system_score_codex":0.0015657442,"about_ca_system_score_gemma":0.002311082,"threshold_uncertainty_score":0.057324767},"labels":[],"label_agreement":null},{"id":"W4206156660","doi":"10.1016/j.jval.2021.11.928","title":"POSA291 Impact of Intrepid® Hybrid Tip on Incidence and Cost of Posterior Capsule Ruptures in Cataract Surgery","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Phacoemulsification; Cataract surgery; Incidence (geometry); Posterior capsule opacification; Surgery; Vitrectomy; Ophthalmology; Visual acuity","score_opus":0.03675749743531352,"score_gpt":0.3243977628798562,"score_spread":0.2876402654445427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206156660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887149,0.0018901668,0.00018273368,0.0003879765,0.00011747415,0.000043757194,0.002029718,0.00003152651,0.006601847],"genre_scores_gemma":[0.99696726,0.00044476346,0.00022724507,0.000092972405,0.000054031265,0.000028489614,0.0009043138,0.000008932864,0.001271988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910456,0.00021087777,0.00010061475,0.000116513635,0.00032438568,0.00014294063],"domain_scores_gemma":[0.9966348,0.0010513813,0.0012067165,0.00017269919,0.00037653043,0.00055794895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086219155,0.0002519351,0.00037656428,0.0009530349,0.00022959754,0.0013894698,0.0004659136,0.00044204062,0.012279132],"category_scores_gemma":[0.005788358,0.00015965245,0.0017519622,0.0010529235,0.00024902137,0.00067977613,0.0009797217,0.0006602678,0.0012006619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027752344,0.0024455613,0.66718,0.0011549309,0.002261095,0.0005115165,0.00017855784,0.0025608507,0.0018046931,0.0012532407,0.0063725407,0.28652468],"study_design_scores_gemma":[0.00042948712,0.0073636845,0.98338544,0.0002671505,0.0008180884,0.0005607381,0.0004116374,0.0018363297,0.0007465703,0.00047913732,0.0036496152,0.000052235664],"about_ca_topic_score_codex":0.0033906247,"about_ca_topic_score_gemma":0.0030454944,"teacher_disagreement_score":0.012279132,"about_ca_system_score_codex":0.0009057222,"about_ca_system_score_gemma":0.00084851886,"threshold_uncertainty_score":0.041077733},"labels":[],"label_agreement":null},{"id":"W4206171792","doi":"10.1016/j.jval.2021.11.484","title":"POSC79 Hospital Costs Associated with Cataract, Glaucoma, Vitreoretinal, and Laser Refractive Surgeries in Europe: A Comprehensive Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Vitrectomy; Cataract surgery; Ophthalmology; Glaucoma; Optometry; Intraocular lens; Glaucoma surgery; Surgery; Visual acuity","score_opus":0.01550587302368212,"score_gpt":0.26438034799005744,"score_spread":0.24887447496637533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206171792","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01437873,0.977778,0.000088937384,0.0008410351,0.00022317232,0.000032652155,0.0040920605,0.0000066354714,0.0025588102],"genre_scores_gemma":[0.05542886,0.9400728,0.0003892522,0.000858014,0.00033873206,0.00005503491,0.0026014696,0.000006401339,0.00024952536],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998324,0.00023833118,0.00073375896,0.000168358,0.0003947822,0.00014069898],"domain_scores_gemma":[0.9957249,0.00196352,0.0016241596,0.00005360187,0.0005137843,0.000120096105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019082143,0.00061249186,0.001427646,0.014677275,0.00033588894,0.0017846896,0.00066521554,0.0009865547,0.004260886],"category_scores_gemma":[0.0052290997,0.00031460228,0.0032399045,0.023298487,0.00046503617,0.0012155465,0.00083734083,0.00056003296,0.0003022778],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008767292,0.00022102823,0.16023931,0.24164669,0.010596464,0.0016577346,0.0005177416,0.0010182853,0.0003404985,0.0036920162,0.03994279,0.53925073],"study_design_scores_gemma":[0.00022026624,0.00035342647,0.5011887,0.2253211,0.01949596,0.0064563914,0.0026734495,0.0004112328,0.00041113395,0.0014081654,0.24191523,0.0001449778],"about_ca_topic_score_codex":0.010319592,"about_ca_topic_score_gemma":0.013580317,"teacher_disagreement_score":0.014677275,"about_ca_system_score_codex":0.0014836638,"about_ca_system_score_gemma":0.0035596834,"threshold_uncertainty_score":0.020519018},"labels":[],"label_agreement":null},{"id":"W4206200900","doi":"10.1016/j.jval.2021.11.290","title":"POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; University of British Columbia; Queen's University; EVERSANA (Canada); Novartis (Canada)","funders":"","keywords":"Relapsing remitting; Ofatumumab; Multiple sclerosis; Medicine; Natalizumab; Physical therapy; Intensive care medicine; Physical medicine and rehabilitation; Internal medicine; Psychiatry; Rituximab","score_opus":0.3750685980621716,"score_gpt":0.390211152634659,"score_spread":0.015142554572487421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206200900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646618,0.012733005,0.00016188879,0.0038130789,0.00019316585,0.00023155863,0.011319943,0.000029404751,0.0068561593],"genre_scores_gemma":[0.9932247,0.0026962464,0.00019097928,0.00025984552,0.000040955158,0.00004118134,0.0024152498,0.000009538516,0.0011212487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826485,0.00052513246,0.00012952676,0.00015148586,0.0004916851,0.00043734256],"domain_scores_gemma":[0.9959739,0.0010164134,0.0005032514,0.000074873664,0.0013257493,0.0011057956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013615706,0.0004976775,0.0013638312,0.0011907705,0.0009762355,0.002059946,0.0013435219,0.0008654444,0.003100211],"category_scores_gemma":[0.0075499313,0.00032710837,0.0020830848,0.0023348192,0.00087198743,0.0006827944,0.0006723009,0.0014114066,0.00012982788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19534506,0.0029006242,0.444515,0.004521797,0.009869745,0.0013068153,0.0008072079,0.06941218,0.0022927427,0.01157408,0.044114236,0.21334057],"study_design_scores_gemma":[0.019324234,0.004402615,0.917909,0.0010322143,0.0058434377,0.0004257791,0.0014863829,0.038108297,0.0007152804,0.0015777478,0.0088979,0.0002771258],"about_ca_topic_score_codex":0.9818232,"about_ca_topic_score_gemma":0.9841669,"teacher_disagreement_score":0.056710094,"about_ca_system_score_codex":0.056710094,"about_ca_system_score_gemma":0.062647216,"threshold_uncertainty_score":0.4114625},"labels":[],"label_agreement":null},{"id":"W4206207684","doi":"10.1016/j.jval.2021.11.430","title":"POSB157 Demographics and Treatment Patterns of Onychomycosis Patients Claiming Efinaconazole: A Canadian Retrospective Claims Analysis Stratified By Diabetes Status","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Terbinafine; Dermatology; Nail matrix; Diabetes mellitus; Population; Type 2 diabetes; Itraconazole; Internal medicine; Antifungal; Nail plate; Psoriasis","score_opus":0.015025666350614591,"score_gpt":0.2602608489948207,"score_spread":0.24523518264420613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206207684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98175055,0.0006824948,0.00008563428,0.00020897419,0.000015653855,0.000053535896,0.014684941,0.000015631267,0.0025025648],"genre_scores_gemma":[0.99123514,0.00054973084,0.0001752054,0.00017708834,0.000014706831,0.000026120728,0.0067322,0.000016623326,0.001073167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980292,0.000094660325,0.000157988,0.00032176977,0.0006565843,0.0007398217],"domain_scores_gemma":[0.9960926,0.00017677885,0.0012864303,0.00019213592,0.0015813513,0.00067072455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075054885,0.00078382,0.0007259339,0.0032102528,0.0024850906,0.0019825452,0.0020610658,0.001182344,0.0050470517],"category_scores_gemma":[0.002919447,0.001115181,0.0020759662,0.008047381,0.00087731273,0.000856218,0.0011810422,0.0016122606,0.00072032405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015463347,0.000051642917,0.997072,0.000018004594,0.00013314013,0.00012299343,0.00020329887,0.00006184633,0.00013516625,0.00008595132,0.00096730795,0.0009940687],"study_design_scores_gemma":[0.000011910058,0.000025712798,0.9984504,0.000021054533,0.000046700254,0.00013696546,0.00048943964,0.0001947045,0.000035026875,0.000019353403,0.0005512575,0.00001747359],"about_ca_topic_score_codex":0.97266406,"about_ca_topic_score_gemma":0.9744168,"teacher_disagreement_score":0.027335942,"about_ca_system_score_codex":0.0153251095,"about_ca_system_score_gemma":0.017379973,"threshold_uncertainty_score":0.11119193},"labels":[],"label_agreement":null},{"id":"W4206232750","doi":"10.1016/j.jval.2021.11.1129","title":"POSB362 Measuring Patient Preferences: Comparison of Five Discrete Choice Modeling Methods","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Mixed logit; Logit; Akaike information criterion; Statistics; Bayesian information criterion; Bayes' theorem; Ordered logit; Scale (ratio); Logistic regression; Latent class model; Class (philosophy); Econometrics; Bayesian probability; Mathematics; Computer science; Artificial intelligence","score_opus":0.3751476121542434,"score_gpt":0.3393561957265101,"score_spread":0.035791416427733314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206232750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62047255,0.0028667504,0.35561147,0.0030991079,0.00023468833,0.0024330071,0.003728614,0.00046605204,0.0110877855],"genre_scores_gemma":[0.8591549,0.0011185412,0.13443841,0.00040817398,0.000042973163,0.0021481942,0.0012230868,0.00008157977,0.0013840939],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96553236,0.02992867,0.0010853333,0.00073669857,0.0023399207,0.00037709897],"domain_scores_gemma":[0.85353535,0.13653135,0.0030534617,0.0028247794,0.0030630205,0.000991964],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036028963,0.0011460568,0.0016509168,0.0030922778,0.00044311772,0.0023071559,0.0015308419,0.0020666134,0.007389323],"category_scores_gemma":[0.083920375,0.0007457237,0.0030755175,0.0022294999,0.0005892099,0.0019652478,0.0018503459,0.0019288723,0.0006798559],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036302,0.0047583566,0.15346402,0.0022069833,0.0048317434,0.00009186244,0.0020122966,0.09931896,0.0016076778,0.034513604,0.004087427,0.65680516],"study_design_scores_gemma":[0.003699003,0.0070352145,0.07465434,0.000755277,0.0011946986,0.00024336396,0.0012636295,0.86747056,0.0024158193,0.036547504,0.004378668,0.00034192033],"about_ca_topic_score_codex":0.0038644723,"about_ca_topic_score_gemma":0.0026303963,"teacher_disagreement_score":0.963971,"about_ca_system_score_codex":0.0019929078,"about_ca_system_score_gemma":0.0018880797,"threshold_uncertainty_score":0.19054168},"labels":[],"label_agreement":null},{"id":"W4206245401","doi":"10.1016/j.jval.2021.11.194","title":"POSA49 Projecting the Long-Term Benefits of Venetoclax Combination Therapies for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy: An Assessment of Net Health Benefit","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Myeloid leukemia; Medicine; Term (time); Oncology; Intensive care medicine; Internal medicine; Leukemia","score_opus":0.03830778710592713,"score_gpt":0.3585435742328819,"score_spread":0.3202357871269548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206245401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7864985,0.0112569025,0.022229325,0.019248977,0.001111543,0.001128754,0.09301251,0.00037400232,0.06513958],"genre_scores_gemma":[0.97784585,0.0016806875,0.0060226778,0.0009709502,0.00019522932,0.00025229136,0.010175427,0.000026885858,0.0028300611],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954476,0.003441001,0.0001128843,0.00023894804,0.0005215035,0.0002381184],"domain_scores_gemma":[0.9930952,0.004162892,0.0007855938,0.0005575156,0.00088288455,0.00051579764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006111382,0.00076001923,0.00096735597,0.0009261223,0.0002692791,0.0018881299,0.0009580129,0.0010459716,0.006816448],"category_scores_gemma":[0.014487578,0.00035428567,0.002552914,0.0019221781,0.0005279731,0.0012242864,0.0016668387,0.0016822026,0.00070391776],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01582736,0.00088677014,0.3302156,0.0017471192,0.00920643,0.00047163558,0.00019755047,0.29215437,0.0014203098,0.036965102,0.033664975,0.27724284],"study_design_scores_gemma":[0.004578426,0.011859264,0.33498842,0.0021847095,0.010250564,0.00073875947,0.0010760333,0.40926683,0.0039297966,0.12613292,0.0947193,0.00027502418],"about_ca_topic_score_codex":0.010363265,"about_ca_topic_score_gemma":0.010199129,"teacher_disagreement_score":0.010363265,"about_ca_system_score_codex":0.0016605787,"about_ca_system_score_gemma":0.0024874725,"threshold_uncertainty_score":0.0323205},"labels":[],"label_agreement":null},{"id":"W4206298574","doi":"10.1016/j.jval.2021.11.153","title":"POSC7 Work Productivity and Activity Impairment for Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 AND CIMPASI-2)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Presenteeism; Absenteeism; Placebo; Psoriatic arthritis; Work productivity; Physical therapy; Internal medicine; Productivity; Arthritis; Disease; Adalimumab; Psychology","score_opus":0.04380790334745937,"score_gpt":0.289780443493676,"score_spread":0.2459725401462166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206298574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99041104,0.006248397,0.00022668048,0.0006256754,0.00012766644,0.00026784991,0.0011321169,0.000046727688,0.00091383304],"genre_scores_gemma":[0.9945844,0.001839102,0.00030170288,0.000490978,0.00016741478,0.00021971216,0.0017631629,0.000009959732,0.00062347524],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990386,0.0004905827,0.000052273706,0.0001312152,0.00012846527,0.00015883264],"domain_scores_gemma":[0.9981261,0.00048215679,0.00044504096,0.00012843548,0.00014723136,0.0006710965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026203054,0.0013652452,0.0021666402,0.00041245215,0.0005238341,0.001258938,0.00080364774,0.0018011052,0.0019753594],"category_scores_gemma":[0.0018034085,0.0003689716,0.0035711366,0.0006169298,0.0007548019,0.0007765083,0.00047513456,0.0027188356,0.00045200853],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8638634,0.006808195,0.043324787,0.00048942375,0.0042139576,0.00015662545,0.00012104,0.0011122631,0.004135003,0.00009745818,0.002041271,0.07363652],"study_design_scores_gemma":[0.4092051,0.2559642,0.32331604,0.00013326557,0.004640515,0.00036727442,0.00022860689,0.00201214,0.0015210982,0.00030227017,0.0022065612,0.00010293791],"about_ca_topic_score_codex":0.003059691,"about_ca_topic_score_gemma":0.00349465,"teacher_disagreement_score":0.003059691,"about_ca_system_score_codex":0.0007967379,"about_ca_system_score_gemma":0.0014040465,"threshold_uncertainty_score":0.013857663},"labels":[],"label_agreement":null},{"id":"W4206322108","doi":"10.1016/j.jval.2021.11.849","title":"POSA282 Oncology Drugs without Phase III Data: Comparison of Reimbursement Recommendations Issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); EVERSANA (Canada)","funders":"","keywords":"Nice; Reimbursement; Excellence; Medicine; Agency (philosophy); Family medicine; Clinical trial; Health care; Internal medicine; Oncology; Political science; Computer science","score_opus":0.43561174244064815,"score_gpt":0.5090414548938318,"score_spread":0.07342971245318364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206322108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5123661,0.18850598,0.013874604,0.04434329,0.0046596434,0.0035573968,0.10783747,0.0007928444,0.12406263],"genre_scores_gemma":[0.926691,0.014392517,0.005878492,0.013406379,0.00070441427,0.0007674735,0.03330881,0.0003754358,0.004475525],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.97981834,0.012415255,0.0018470911,0.00111291,0.00405567,0.00075067434],"domain_scores_gemma":[0.9483518,0.03747513,0.0071389675,0.0015213051,0.0026953502,0.0028174787],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.027401438,0.00068052456,0.0029358072,0.001999672,0.00037691052,0.0027526086,0.0015371104,0.0020998768,0.0111352],"category_scores_gemma":[0.058721185,0.00044511893,0.0062750205,0.003205037,0.0006780412,0.0018222651,0.0013363098,0.00399895,0.0011269904],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3786053,0.0012268898,0.024221687,0.0109853195,0.024093105,0.00028060295,0.00029658075,0.02048214,0.0017760659,0.018376892,0.17007697,0.34957844],"study_design_scores_gemma":[0.14119361,0.02992248,0.33807626,0.009486661,0.049924873,0.0015961658,0.0013367152,0.02597066,0.0037143833,0.01856919,0.37954575,0.0006632199],"about_ca_topic_score_codex":0.009090418,"about_ca_topic_score_gemma":0.011099391,"teacher_disagreement_score":0.9949145,"about_ca_system_score_codex":0.005085525,"about_ca_system_score_gemma":0.005186713,"threshold_uncertainty_score":0.14491433},"labels":[],"label_agreement":null},{"id":"W4206332072","doi":"10.1016/j.jval.2021.11.785","title":"POSB244 Regional Variation in Uptake of Recommended Cancer Treatments in England (2018-2020) - An Osimertinib Case Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Nice; Medicine; Excellence; Quarter (Canadian coin); Family medicine; Cancer; Internal medicine; Political science; Erlotinib; Geography","score_opus":0.1113062868943185,"score_gpt":0.31834692378330126,"score_spread":0.20704063688898278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206332072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98064077,0.0007506663,0.00027892724,0.0011829386,0.000021384614,0.000018036335,0.014236533,0.000017858485,0.0028528366],"genre_scores_gemma":[0.99425596,0.00015557292,0.00010282851,0.00007928666,0.000010948402,0.000017256758,0.0034930715,0.000009000303,0.001876142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998882,0.00035124275,0.00011612121,0.00019765433,0.00015836976,0.00029460128],"domain_scores_gemma":[0.9930948,0.0023206603,0.0025655346,0.00031628032,0.0011116082,0.0005911296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012925811,0.00015674694,0.00046563763,0.00086664635,0.00023281264,0.0009794981,0.0008314981,0.0007090154,0.0049037393],"category_scores_gemma":[0.0087356465,0.0002485626,0.00066042604,0.0017172964,0.0003442314,0.00064226944,0.001030245,0.00090039003,0.0007155809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013025192,0.00015573371,0.9535423,0.00018439945,0.00041453927,0.0014289409,0.00156368,0.009680176,0.00043294983,0.0022788823,0.013471712,0.01554426],"study_design_scores_gemma":[0.00003744522,0.00012003539,0.9864319,0.000046678106,0.000077283825,0.0003672144,0.0024463912,0.0041803177,0.00013747919,0.00023374001,0.005896767,0.000024727839],"about_ca_topic_score_codex":0.28157172,"about_ca_topic_score_gemma":0.24002552,"teacher_disagreement_score":0.28157172,"about_ca_system_score_codex":0.0022910207,"about_ca_system_score_gemma":0.0010233525,"threshold_uncertainty_score":0.5598656},"labels":[],"label_agreement":null},{"id":"W4206379445","doi":"10.1016/j.jval.2021.11.064","title":"P66 Epidemiology of Non-Small Cell Lung Cancer (NSCLC) by Histology and Disease Stage in Western Europe (WE): Population-Level Projections 2021-2026","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Lung cancer; Incidence (geometry); Stage (stratigraphy); Epidemiology; Medicine; Histology; Population; Cancer; Oncology; Internal medicine; Demography; Environmental health; Biology","score_opus":0.14929005134298978,"score_gpt":0.3981975554432942,"score_spread":0.24890750410030443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206379445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9407705,0.0046905275,0.0032666652,0.0011293045,0.000086575965,0.00004085236,0.046677105,0.00009835335,0.0032400815],"genre_scores_gemma":[0.96145046,0.0037407205,0.0014977478,0.00023894131,0.00006931899,0.000039354378,0.030774431,0.000016878992,0.0021721555],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982256,0.000040118895,0.000026301359,0.000036899808,0.000032489057,0.000041577485],"domain_scores_gemma":[0.999653,0.000028555465,0.00012381733,0.000022740016,0.000112602436,0.000059232887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000514644,0.00041722567,0.00025429818,0.000977139,0.00014685259,0.0005262518,0.00024438027,0.00063137914,0.0011945991],"category_scores_gemma":[0.0006826086,0.00025565078,0.0011844002,0.001953057,0.00011800874,0.00057933474,0.0004210245,0.00043122767,0.0005277638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065666344,0.00008117698,0.9628356,0.00022355637,0.000439476,0.00018432789,0.00012606855,0.0049520847,0.00095185085,0.00074768084,0.0063935514,0.022408012],"study_design_scores_gemma":[0.000020919213,0.00009142732,0.9926805,0.000052647996,0.00013135484,0.00023753804,0.00015387197,0.0023240787,0.0001732674,0.000362727,0.003760904,0.0000108507875],"about_ca_topic_score_codex":0.038560756,"about_ca_topic_score_gemma":0.037291855,"teacher_disagreement_score":0.038560756,"about_ca_system_score_codex":0.0005896113,"about_ca_system_score_gemma":0.0005857375,"threshold_uncertainty_score":0.07667261},"labels":[],"label_agreement":null},{"id":"W4206389358","doi":"10.1016/j.jval.2021.11.1087","title":"POSA376 Health State Utilities and Willingness to Pay in Patients with Coeliac Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Willingness to pay; Visual analogue scale; Medicine; Coeliac disease; Disease; Cross-sectional study; Environmental health; Internal medicine; Physical therapy; Pathology","score_opus":0.02094277590584004,"score_gpt":0.30247436219227647,"score_spread":0.28153158628643643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206389358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99742496,0.0002943588,0.00008089001,0.00016381704,0.0000064511837,0.0000045829192,0.00033983294,0.00000216115,0.0016830878],"genre_scores_gemma":[0.9996183,0.000029314819,0.000026805164,0.000016302714,0.000004715226,0.0000022799472,0.00015227942,5.476509e-7,0.00014930645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994771,0.0002626797,0.000054240638,0.000046061403,0.00005412742,0.000105894105],"domain_scores_gemma":[0.9961985,0.00207063,0.00094671285,0.00014930511,0.00015021287,0.0004846661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001164525,0.00018570658,0.00036901227,0.0005897974,0.00024798315,0.0011497363,0.00023106938,0.00058286724,0.0047979825],"category_scores_gemma":[0.007938798,0.00016695273,0.0008364716,0.00089705555,0.00033716857,0.0007651526,0.00053728354,0.0010419566,0.00033038793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010307444,0.00014573279,0.99313885,0.000022810862,0.00018298872,0.00009638341,0.00010196965,0.00077927706,0.000088516594,0.00038778814,0.00015345388,0.0038714374],"study_design_scores_gemma":[0.000051502448,0.0003953857,0.993848,0.000019299923,0.000089688074,0.00024033476,0.00031223238,0.0036373367,0.0000559425,0.0009825937,0.0003531136,0.000014694836],"about_ca_topic_score_codex":0.0026177336,"about_ca_topic_score_gemma":0.0020745657,"teacher_disagreement_score":0.0047979825,"about_ca_system_score_codex":0.0005579136,"about_ca_system_score_gemma":0.00030343764,"threshold_uncertainty_score":0.016050875},"labels":[],"label_agreement":null},{"id":"W4206406549","doi":"10.1016/j.jval.2021.11.592","title":"POSA191 Transmission Control Outcomes for Tuberculosis in Polar Regions: A Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tuberculosis; Arctic; Environmental health; Epidemiology; Family medicine; Intensive care medicine; Pathology; Ecology","score_opus":0.19195609831026914,"score_gpt":0.45823556044205205,"score_spread":0.2662794621317829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206406549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000066979825,0.99967885,0.000015279074,0.0000903149,0.00003083745,0.0000035704804,0.00004056233,0.0000011143035,0.00007250241],"genre_scores_gemma":[0.0014237352,0.9982369,0.00008077702,0.00013679078,0.00005104838,0.0000064397336,0.000036337562,8.1488537e-7,0.00002715035],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9990196,0.00023553598,0.00030173123,0.00015912058,0.00021458438,0.00006934209],"domain_scores_gemma":[0.9964767,0.0024935277,0.00063318433,0.000035731147,0.0002870437,0.00007394768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024390914,0.0009350917,0.0037853224,0.0032158927,0.0002756526,0.0017353023,0.001327803,0.0014421366,0.005982587],"category_scores_gemma":[0.007356105,0.00046461253,0.0032954453,0.0042630737,0.0005081536,0.0013001331,0.0010183943,0.0015123824,0.00050291524],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040302126,0.00007085142,0.0022561243,0.38690153,0.0055999337,0.000114383125,0.00013545547,0.0003719559,0.00021000442,0.0015573413,0.013308538,0.5890709],"study_design_scores_gemma":[0.0005659991,0.00067918043,0.020910477,0.5402234,0.05023597,0.0013857196,0.0006108656,0.0003800832,0.0004140006,0.003875534,0.3805793,0.00013946813],"about_ca_topic_score_codex":0.0068650395,"about_ca_topic_score_gemma":0.013518337,"teacher_disagreement_score":0.0068650395,"about_ca_system_score_codex":0.0012618275,"about_ca_system_score_gemma":0.0035061964,"threshold_uncertainty_score":0.02001369},"labels":[],"label_agreement":null},{"id":"W4206423678","doi":"10.1016/j.jval.2021.11.987","title":"POSB303 Systematic Review of Probabilistic Sensitivity Analysis Methods in Microsimulation of Chronic Diseases","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Microsimulation; Probabilistic logic; Sensitivity (control systems); Medicine; Computer science; Operations research; Data mining; Artificial intelligence; Engineering; Transport engineering","score_opus":0.32109451891293583,"score_gpt":0.4845840533272075,"score_spread":0.16348953441427166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206423678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020534804,0.97793627,0.013319053,0.00095264026,0.00041006343,0.0013520232,0.0026309537,0.00008920095,0.0012563589],"genre_scores_gemma":[0.084947646,0.88271207,0.021640422,0.0024071,0.00065753754,0.0045564086,0.0020147867,0.00016444648,0.00089952495],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9518937,0.03553375,0.0073687118,0.0018406116,0.003073443,0.00028972822],"domain_scores_gemma":[0.8512765,0.13466033,0.0068946024,0.0034380737,0.0034229232,0.0003076645],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04849563,0.002552858,0.009061843,0.005201405,0.00043760712,0.002633721,0.0026169268,0.002890664,0.013240921],"category_scores_gemma":[0.16275024,0.0015189904,0.025889387,0.0050570155,0.00071568345,0.001994426,0.002381188,0.002704382,0.00085490546],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028756282,0.00011057623,0.0015167897,0.65983844,0.16845322,0.0001303324,0.00010666229,0.008545346,0.00024805756,0.0031976586,0.004540176,0.15043707],"study_design_scores_gemma":[0.0037720075,0.0018768118,0.008074824,0.49700633,0.4111111,0.00041068843,0.000118668504,0.008722848,0.00068899966,0.014514138,0.053476296,0.00022729705],"about_ca_topic_score_codex":0.009238515,"about_ca_topic_score_gemma":0.013747026,"teacher_disagreement_score":0.95150435,"about_ca_system_score_codex":0.0029800863,"about_ca_system_score_gemma":0.0077294274,"threshold_uncertainty_score":0.25647253},"labels":[],"label_agreement":null},{"id":"W4206436356","doi":"10.1016/j.jval.2021.11.943","title":"POSB294 Delay in Percutaneous Nephrolithotomy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Percutaneous nephrolithotomy; Medicine; Stent; Surgery; Retrospective cohort study; Logistic regression; Cohort; Percutaneous; Internal medicine","score_opus":0.025920826517402566,"score_gpt":0.28040161292705085,"score_spread":0.2544807864096483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206436356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946221,0.0014398413,0.00006334828,0.0005648892,0.00006764303,0.0000068254126,0.00080542517,0.000004880266,0.0024250387],"genre_scores_gemma":[0.99824667,0.0003587674,0.000054149845,0.0001652609,0.00004711503,0.000004437228,0.0004827474,0.000003165376,0.0006377223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942756,0.0000861575,0.00007726232,0.00008931732,0.00012027007,0.00019962611],"domain_scores_gemma":[0.9969795,0.0007768289,0.001140196,0.00009461074,0.00023509041,0.00077375356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043579945,0.00017942906,0.00043727813,0.0005996424,0.0005053248,0.0010774204,0.00038021567,0.0007709941,0.0067112246],"category_scores_gemma":[0.0047905413,0.00023764344,0.0009071148,0.0013093232,0.00024323378,0.0008325018,0.0005656236,0.0016792917,0.0004098991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033613318,0.00010334576,0.9970023,0.000023883433,0.00009662262,0.0001279373,0.000049651993,0.00005205266,0.00009550394,0.000091734946,0.00028078337,0.0017400135],"study_design_scores_gemma":[0.00001655283,0.00016103731,0.9978345,0.000035075882,0.00006739147,0.00033413494,0.0004023054,0.0003099691,0.00005573517,0.00014098652,0.0006326422,0.0000096513795],"about_ca_topic_score_codex":0.015816024,"about_ca_topic_score_gemma":0.014328685,"teacher_disagreement_score":0.015816024,"about_ca_system_score_codex":0.00068832724,"about_ca_system_score_gemma":0.0013370235,"threshold_uncertainty_score":0.031447947},"labels":[],"label_agreement":null},{"id":"W4206483067","doi":"10.1016/j.jval.2021.11.759","title":"POSA244 First-Line Maintenance (1L MT) Treatment of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Western Europe (WE): Results of the CancerMPact® Survey 2020","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Pembrolizumab; Pemetrexed; Carboplatin; Internal medicine; Oncology; Medicine; Lung cancer; Chemotherapy; Cancer; Immunotherapy; Cisplatin","score_opus":0.04938723913475337,"score_gpt":0.3179807771920575,"score_spread":0.2685935380573041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206483067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97724104,0.0018128663,0.00013018705,0.0003196311,0.000030196235,0.00002396296,0.018686952,0.000014057278,0.0017410183],"genre_scores_gemma":[0.97101134,0.0012814042,0.00018002381,0.00040033247,0.00003856751,0.000038577768,0.025572395,0.0000067992323,0.001470567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99958104,0.000095847354,0.00005640059,0.0000741376,0.00011976384,0.000072872324],"domain_scores_gemma":[0.999388,0.00006550609,0.00028820697,0.000026414753,0.000101495345,0.0001304278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006331942,0.0002515741,0.00031344368,0.00066975405,0.00013580084,0.0006011334,0.00030022653,0.00044461727,0.00090126466],"category_scores_gemma":[0.001102052,0.00014749813,0.0005319628,0.0019771522,0.00011421666,0.0004803302,0.00049091753,0.00034914206,0.00040857928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003323868,0.000078395904,0.99141055,0.000051411917,0.00015020889,0.00003373123,0.000026753009,0.00009200993,0.00015025187,0.00002434872,0.0016954499,0.0059545296],"study_design_scores_gemma":[0.000014048529,0.00009546196,0.99851805,0.000014088296,0.000061007846,0.000048409056,0.00005633867,0.00008518845,0.000047829562,0.000011230894,0.0010465425,0.0000018585283],"about_ca_topic_score_codex":0.017650977,"about_ca_topic_score_gemma":0.021626959,"teacher_disagreement_score":0.017650977,"about_ca_system_score_codex":0.00042853513,"about_ca_system_score_gemma":0.00046416942,"threshold_uncertainty_score":0.035096467},"labels":[],"label_agreement":null},{"id":"W4206518892","doi":"10.1016/j.jval.2021.11.040","title":"P42 Comparison of Estimation Methods for Single-Arm Trials in Rare Diseases with Historical Control Groups","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Propensity score matching; Confidence interval; Confounding; Statistics; Estimator; Sample size determination; Randomization; Weighting; Medicine; Inverse probability weighting; Standard error; Coverage probability; Placebo; Type I and type II errors; Population; Mean squared error; Mathematics; Average treatment effect; Randomized controlled trial; Internal medicine","score_opus":0.7588654549010957,"score_gpt":0.6388849453975496,"score_spread":0.1199805095035461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206518892","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027761316,0.006883868,0.95589644,0.0016034431,0.0006863497,0.0021463244,0.0008712699,0.0008195164,0.0033314445],"genre_scores_gemma":[0.43600512,0.0038111818,0.54207903,0.001386737,0.00054042944,0.00842964,0.0014116162,0.00087274605,0.0054634428],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.692592,0.28991988,0.005090102,0.005919314,0.0057020686,0.0007765925],"domain_scores_gemma":[0.26065722,0.71177715,0.007444009,0.014532754,0.004563443,0.001025392],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23192939,0.002118646,0.0052700955,0.002637623,0.0007103748,0.0035952744,0.0032961753,0.0037012785,0.0152486],"category_scores_gemma":[0.5184837,0.0013728623,0.008507271,0.002343577,0.0026106504,0.004993738,0.0026682585,0.005738626,0.0011628103],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059602045,0.001070139,0.014267494,0.010448884,0.039532494,0.0003872818,0.0015523505,0.086591095,0.0014563047,0.15574965,0.01330271,0.61603963],"study_design_scores_gemma":[0.018278135,0.0155001,0.019482115,0.0041228533,0.017504146,0.000990393,0.0006082386,0.5984138,0.0048500253,0.29543072,0.024349805,0.00046967188],"about_ca_topic_score_codex":0.001464416,"about_ca_topic_score_gemma":0.0008311693,"teacher_disagreement_score":0.7680706,"about_ca_system_score_codex":0.0019111881,"about_ca_system_score_gemma":0.0040211393,"threshold_uncertainty_score":0.9471678},"labels":[],"label_agreement":null},{"id":"W4206535356","doi":"10.1016/j.jval.2021.11.896","title":"POSC258 Acceptance of Progression-Free Survival 2 (PFS2) By EU5 and Canadian Health Authorities for Cancer Drug Reimbursement","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Overall survival; Business; Cancer; Oncology; Medicine; Internal medicine; Health care; Economic growth; Economics","score_opus":0.05005467635728975,"score_gpt":0.30122836691425137,"score_spread":0.2511736905569616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206535356","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0689418,0.009208224,0.007771544,0.20147194,0.0064567863,0.0012983583,0.029392948,0.00087928644,0.6745792],"genre_scores_gemma":[0.7697105,0.002256549,0.0061560855,0.066955484,0.0024220946,0.00048097954,0.0119512575,0.00034190118,0.1397252],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9732154,0.0037562428,0.0010842633,0.0012002463,0.014372159,0.0063716914],"domain_scores_gemma":[0.92831594,0.01509446,0.0026386706,0.0026951092,0.041235805,0.010020019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021164464,0.0006668882,0.001002563,0.0026755114,0.0023347093,0.005672527,0.0030840775,0.0075824964,0.022422967],"category_scores_gemma":[0.07019995,0.00061474345,0.0021619939,0.001996879,0.0016457911,0.0013625713,0.002482925,0.0067532784,0.002427212],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024592122,0.00019238815,0.02608939,0.00046427333,0.00030155893,0.0004812909,0.00045428166,0.004914022,0.0012182915,0.21915787,0.6450678,0.099199615],"study_design_scores_gemma":[0.0006302767,0.00034750038,0.105380535,0.00072686793,0.00023454354,0.00030385423,0.00028475714,0.0047012456,0.0015158224,0.010632544,0.87507236,0.00016965384],"about_ca_topic_score_codex":0.7482756,"about_ca_topic_score_gemma":0.76378804,"teacher_disagreement_score":0.9644606,"about_ca_system_score_codex":0.035539363,"about_ca_system_score_gemma":0.11152864,"threshold_uncertainty_score":0.5064137},"labels":[],"label_agreement":null},{"id":"W4206561547","doi":"10.1016/j.jval.2021.11.1006","title":"POSC299 Transportability Analysis: A Principled Method for Transporting Treatment Effects Observed in One Real-World Dataset to Another","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Real world data; Population; Sample (material); Sample size determination; Computer science; Statistics; Data science; Medicine; Environmental health; Mathematics","score_opus":0.5469523301601773,"score_gpt":0.47580667639863894,"score_spread":0.07114565376153836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206561547","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007074425,0.00026383184,0.9732092,0.0006810584,0.00024223504,0.00093216024,0.011803067,0.0042350134,0.0015589383],"genre_scores_gemma":[0.133191,0.00020664166,0.825788,0.000763398,0.00046567046,0.004335758,0.028696718,0.00290754,0.0036452552],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98695636,0.00838542,0.00071446336,0.0024088386,0.0011734879,0.00036132493],"domain_scores_gemma":[0.9460523,0.038872067,0.0014225477,0.010747558,0.0023883062,0.0005172181],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.032392506,0.001707782,0.00231024,0.0058339313,0.0019501203,0.0033804707,0.004715081,0.0038694665,0.024625918],"category_scores_gemma":[0.110337324,0.001535782,0.009039186,0.005010838,0.0020744158,0.0027393247,0.0050360416,0.0056112655,0.0038138544],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033210227,0.00091940776,0.027130492,0.0024516238,0.006343574,0.00078017067,0.0010358692,0.10411041,0.002735732,0.15921384,0.11453728,0.5774206],"study_design_scores_gemma":[0.0012996976,0.00044389308,0.008312458,0.00041179996,0.00085557165,0.0003345835,0.00022391694,0.5346179,0.0018651854,0.3966917,0.054791845,0.00015148176],"about_ca_topic_score_codex":0.009288772,"about_ca_topic_score_gemma":0.010742112,"teacher_disagreement_score":0.9676075,"about_ca_system_score_codex":0.0016867452,"about_ca_system_score_gemma":0.00706788,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4206594807","doi":"10.1016/j.jval.2021.11.537","title":"POSC133 Use of Expert Elicitation to Extrapolate Observed Intermediate Clinical Trial Outcomes to Clinically Meaningful Long-Term Outcomes for Use in Health Technology Assessments: A Case Study in a Rare, Lifelong Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Physical therapy; Hypophosphatemia; Clinical trial; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.6183386954103173,"score_gpt":0.5973015759163192,"score_spread":0.021037119493998113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206594807","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30839193,0.0014205101,0.40844834,0.03088719,0.00073139725,0.010440143,0.028039476,0.0049366634,0.20670438],"genre_scores_gemma":[0.6587125,0.0005459582,0.31254625,0.0045131375,0.00025908404,0.0055163093,0.008863416,0.00058392115,0.008459567],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.93737006,0.04693643,0.0058976146,0.0023841292,0.006262365,0.0011495202],"domain_scores_gemma":[0.58003753,0.3407916,0.011135328,0.027489666,0.037964243,0.0025817265],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07868921,0.0006952918,0.0006512375,0.0036397355,0.0014335029,0.0035197542,0.0014987676,0.002484898,0.015620008],"category_scores_gemma":[0.22697207,0.00035641144,0.00076668465,0.0025072575,0.0011009973,0.0023937274,0.0044742953,0.0018276906,0.003247301],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004472386,0.0011276668,0.09851622,0.0036850153,0.00034746542,0.0037593786,0.023847638,0.011755328,0.01063553,0.04211469,0.07867093,0.7210677],"study_design_scores_gemma":[0.0019155941,0.0028776953,0.11022236,0.009040838,0.0008493088,0.0074748266,0.014354747,0.17268957,0.033598747,0.15278593,0.49325985,0.0009305575],"about_ca_topic_score_codex":0.0055398177,"about_ca_topic_score_gemma":0.006541431,"teacher_disagreement_score":0.9213108,"about_ca_system_score_codex":0.002771792,"about_ca_system_score_gemma":0.008212054,"threshold_uncertainty_score":0.4161533},"labels":[],"label_agreement":null},{"id":"W4206608028","doi":"10.1016/j.jval.2021.11.1351","title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":997,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"National Institute for Health and Care Research; National Institute for Health Research Health Protection Research Unit","keywords":"Checklist; Economic evaluation; Context (archaeology); Health care; Public health; Stakeholder; Statement (logic); Public relations; Medicine; Political science; Psychology; Nursing; Law","score_opus":0.6187632095078116,"score_gpt":0.5762228648688769,"score_spread":0.042540344638934746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206608028","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026101389,0.06900628,0.23027176,0.11374205,0.040827394,0.1286421,0.3208454,0.011253949,0.082800925],"genre_scores_gemma":[0.019064704,0.072167434,0.3079341,0.029700467,0.007695898,0.3183704,0.22131234,0.0047604316,0.01899415],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.48531243,0.31377336,0.1119766,0.008167418,0.07529483,0.005475287],"domain_scores_gemma":[0.2670116,0.3763275,0.09263197,0.040356193,0.21943974,0.0042330036],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35525686,0.0049135988,0.01158999,0.021256408,0.002628722,0.01905913,0.010345016,0.012894646,0.050401516],"category_scores_gemma":[0.72282916,0.004589986,0.0146547,0.03951825,0.005036842,0.010683548,0.008238486,0.022889776,0.029076176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012964626,0.00015623536,0.0011729292,0.04572259,0.0014568481,0.00013970165,0.0006835286,0.002375066,0.00020627986,0.023286175,0.8003899,0.123114355],"study_design_scores_gemma":[0.0020586853,0.00024829182,0.0034484847,0.0876812,0.0016839181,0.00027241788,0.0004582882,0.0036220998,0.0010300562,0.03775299,0.8612835,0.00046006986],"about_ca_topic_score_codex":0.010802657,"about_ca_topic_score_gemma":0.0056097256,"teacher_disagreement_score":0.64474314,"about_ca_system_score_codex":0.013931755,"about_ca_system_score_gemma":0.05262755,"threshold_uncertainty_score":0.7950831},"labels":[],"label_agreement":null},{"id":"W4206610800","doi":"10.1016/j.jval.2021.11.1131","title":"POSB364 Systematic Literature Reviews (SLRS) of Economic Evaluations and Health Utility Studies of AML Treatments for Adults Receiving High Intensity Induction Therapy, with or without Maintenance Therapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Systematic review; Gemtuzumab ozogamicin; MEDLINE; Quality-adjusted life year; Induction chemotherapy; Economic evaluation; Cochrane Library; Cost effectiveness; Intensive care medicine; Internal medicine; Meta-analysis; Chemotherapy; Pathology","score_opus":0.17890931844490274,"score_gpt":0.43546477481830104,"score_spread":0.25655545637339827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206610800","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015061242,0.92266405,0.002368447,0.0023567576,0.0010364765,0.0113809705,0.03897771,0.00026689662,0.0058873673],"genre_scores_gemma":[0.32247534,0.6029777,0.0147732515,0.007830883,0.0010895104,0.030721592,0.01675172,0.0002979698,0.0030820647],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9216073,0.042635486,0.026184538,0.0035205162,0.0048568756,0.0011951936],"domain_scores_gemma":[0.8994528,0.064491905,0.025252583,0.0034135107,0.0062502394,0.0011390208],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.034526624,0.002613018,0.013354062,0.014295286,0.0010272528,0.0045465324,0.001962161,0.002890316,0.021114387],"category_scores_gemma":[0.1600999,0.0019903253,0.028935757,0.01381777,0.0013874479,0.002871157,0.004543536,0.0028838904,0.0014780606],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007262482,0.00003348173,0.0014639178,0.78772825,0.17842267,0.00008578789,0.00015817648,0.0002132325,0.0003124815,0.00034136223,0.0033396073,0.020638542],"study_design_scores_gemma":[0.018367678,0.0009951092,0.01127584,0.36099276,0.5812498,0.00022169852,0.00022827703,0.00022535217,0.00036224973,0.0010859427,0.02489924,0.00009613008],"about_ca_topic_score_codex":0.009900503,"about_ca_topic_score_gemma":0.023052607,"teacher_disagreement_score":0.98664594,"about_ca_system_score_codex":0.005123445,"about_ca_system_score_gemma":0.009900283,"threshold_uncertainty_score":0.18259645},"labels":[],"label_agreement":null},{"id":"W4206649529","doi":"10.1016/j.jval.2021.11.638","title":"POSB200 Type of Polypharmacy and the Risk of Mortality Among Patients with Chronic Heart Failure Newly Diagnosed? A Nested Case-Control Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Polypharmacy; Medicine; Internal medicine; Odds ratio; Incidence (geometry); Cohort; Nested case-control study; Logistic regression; Heart failure; Cohort study; Pediatrics","score_opus":0.07061029806713807,"score_gpt":0.38459458133017627,"score_spread":0.3139842832630382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206649529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988751,0.00031338047,0.0001521247,0.000047909496,0.00002563112,0.000018569752,0.00030917607,0.000003342844,0.00025486204],"genre_scores_gemma":[0.99914443,0.00008020903,0.00012750033,0.00005639811,0.00003573747,0.000017820974,0.0002824672,0.0000032493365,0.00025209726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983834,0.0005678355,0.00014802106,0.0004916464,0.00019252417,0.00021650906],"domain_scores_gemma":[0.99690264,0.00064525794,0.0010716055,0.00064538594,0.00022854476,0.0005066219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016292862,0.0006779178,0.0010238385,0.0006861541,0.0010634799,0.0018288296,0.0010764992,0.0016535919,0.0025364596],"category_scores_gemma":[0.0032660053,0.0012658125,0.0022375549,0.0011025659,0.0007925829,0.00089148723,0.0007080009,0.0018793215,0.00041990462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004105618,0.0006438911,0.99152327,0.000037254522,0.0013008174,0.00023400458,0.00019285348,0.000052813844,0.0009830506,0.000091260576,0.00018935834,0.0006457646],"study_design_scores_gemma":[0.00043930352,0.0010095268,0.9958402,0.000016944,0.0007898004,0.0005242416,0.0003017222,0.00057204365,0.0001097329,0.00010215686,0.00026796907,0.000026372289],"about_ca_topic_score_codex":0.010175544,"about_ca_topic_score_gemma":0.011315808,"teacher_disagreement_score":0.010175544,"about_ca_system_score_codex":0.0005954405,"about_ca_system_score_gemma":0.000525247,"threshold_uncertainty_score":0.020232677},"labels":[],"label_agreement":null},{"id":"W4206668685","doi":"10.1016/j.jval.2021.11.469","title":"POSC64 Healthcare Costs and Resource Utilization in 1L Maintenance (1L MT) Treatment (Tx) of Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Pemetrexed; Pembrolizumab; Bevacizumab; Gemcitabine; Internal medicine; Oncology; Lenalidomide; Lung cancer; Indirect costs; Emergency medicine; Cancer; Chemotherapy; Multiple myeloma; Immunotherapy","score_opus":0.039606330470159865,"score_gpt":0.28104352964096635,"score_spread":0.24143719917080647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206668685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008446689,0.98757553,0.000087111,0.00043388532,0.00009834034,0.00009607283,0.0027402907,0.000003803107,0.00051817764],"genre_scores_gemma":[0.12870988,0.86728585,0.00051847665,0.00095030357,0.00016236487,0.00035470378,0.001791026,0.000006858521,0.00022047826],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99606884,0.0011803333,0.0014458772,0.00036427742,0.0007246094,0.00021608747],"domain_scores_gemma":[0.98491734,0.01014453,0.0037564232,0.00019315067,0.0007897193,0.00019879999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038220373,0.0005510364,0.0033363993,0.0055247513,0.0002788994,0.001636829,0.0008412208,0.0013354714,0.0047817305],"category_scores_gemma":[0.025681486,0.00054522854,0.010310539,0.00974102,0.00040914988,0.001289534,0.0010966193,0.0011615433,0.0002485439],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001474464,0.000094656,0.057573613,0.7394258,0.06881077,0.00021942185,0.00019506925,0.0008815243,0.00014420795,0.0009721527,0.0065530324,0.123655334],"study_design_scores_gemma":[0.0012088015,0.0006307503,0.16594039,0.5517179,0.23780519,0.00088756514,0.0007696191,0.0005613579,0.00019244754,0.0016236104,0.038529795,0.0001326469],"about_ca_topic_score_codex":0.017447487,"about_ca_topic_score_gemma":0.039321017,"teacher_disagreement_score":0.017447487,"about_ca_system_score_codex":0.0026709882,"about_ca_system_score_gemma":0.005185596,"threshold_uncertainty_score":0.03469181},"labels":[],"label_agreement":null},{"id":"W4206717734","doi":"10.1016/j.jval.2021.11.871","title":"POSB268 Landscape Review Exploring Acceptability of Oncology Surrogate Endpoints By NICE (England), CADTH (Canada), and PBAC (Australia) from 2010 to 2021","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Medicine; Clinical endpoint; Surrogate endpoint; Health technology; Oncology; Clinical trial; Maturity (psychological); Internal medicine; Family medicine; Psychology; Political science; Health care; Computer science","score_opus":0.465133554621386,"score_gpt":0.4235940712446222,"score_spread":0.04153948337676383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206717734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005885889,0.9595777,0.00057847035,0.016435415,0.0003814852,0.0002281072,0.0047744974,0.000018939782,0.012119524],"genre_scores_gemma":[0.12329122,0.84937674,0.0021276926,0.016577566,0.00059967977,0.0006564268,0.0053819274,0.000056500063,0.0019322626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9837615,0.0097384015,0.0023081845,0.0006236406,0.002999247,0.0005690341],"domain_scores_gemma":[0.9514737,0.031504404,0.008715015,0.0006131624,0.006871764,0.0008220355],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021846993,0.00041217744,0.0024511712,0.0022127768,0.00030729888,0.002740577,0.00124384,0.0011510063,0.0070683085],"category_scores_gemma":[0.06778444,0.00041425074,0.0045951656,0.005298378,0.0005598852,0.0014110343,0.0014994186,0.0022700182,0.0005189068],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070440257,0.000067300156,0.011747115,0.19562574,0.013669496,0.00019563462,0.0004088929,0.002692435,0.00032807217,0.009613234,0.100386575,0.65822154],"study_design_scores_gemma":[0.002532656,0.0018281805,0.068750806,0.36633956,0.030079978,0.0006560253,0.00075204496,0.0007703143,0.00039414954,0.006364186,0.52139884,0.00013328053],"about_ca_topic_score_codex":0.029627439,"about_ca_topic_score_gemma":0.07048297,"teacher_disagreement_score":0.9919067,"about_ca_system_score_codex":0.008093312,"about_ca_system_score_gemma":0.012440605,"threshold_uncertainty_score":0.11553931},"labels":[],"label_agreement":null},{"id":"W4206739434","doi":"10.1016/j.jval.2021.11.1201","title":"POSC376 Speak up Your Pain: Patient Care Course in Chronic Pain","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Medicine; McGill Pain Questionnaire; Nociception; Discontinuation; Population; Physical therapy; Chronic pain; Visual analogue scale; Anesthesia; Internal medicine","score_opus":0.05314602458588587,"score_gpt":0.3058556171375494,"score_spread":0.25270959255166353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206739434","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.901024,0.010130662,0.0013288783,0.012082965,0.0010540215,0.0007676094,0.000910533,0.00018808288,0.07251328],"genre_scores_gemma":[0.9818856,0.0035308625,0.0022497617,0.0022725288,0.00044454166,0.00042498857,0.00037695552,0.000028753655,0.008785974],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996338,0.00016272019,0.000024475707,0.000035386507,0.000078134704,0.00006545748],"domain_scores_gemma":[0.9989247,0.00041254002,0.00013562459,0.000047607893,0.000103847546,0.00037571814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008763636,0.00019060243,0.0006104317,0.00015418831,0.0005018806,0.00050076743,0.00020984888,0.00065891596,0.023265986],"category_scores_gemma":[0.0036195524,0.00009009446,0.0003627946,0.0002334506,0.00026944728,0.00044556044,0.00026476313,0.0013210324,0.0013609359],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09198593,0.010125164,0.008188492,0.0012016972,0.00027460334,0.00021123371,0.00038356622,0.00031974018,0.0062665376,0.00277682,0.018984094,0.85928214],"study_design_scores_gemma":[0.091540426,0.2798932,0.418236,0.0037312617,0.002302093,0.003075681,0.0028681024,0.006081152,0.018185854,0.013537081,0.16025718,0.00029202222],"about_ca_topic_score_codex":0.0009650614,"about_ca_topic_score_gemma":0.002617737,"teacher_disagreement_score":0.023265986,"about_ca_system_score_codex":0.00051676045,"about_ca_system_score_gemma":0.0010087639,"threshold_uncertainty_score":0.07783246},"labels":[],"label_agreement":null},{"id":"W4206764530","doi":"10.1016/j.jval.2021.11.1003","title":"POSB320 Matching-Adjusted Indirect Comparison of Guselkumab Versus Risankizumab in Patients with Moderate-to-Severe Plaque Psoriasis: Change in Baseline PASI from Week 4-40","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Plaque psoriasis; Baseline (sea); Psoriasis; Matching (statistics); Internal medicine; Propensity score matching; Dermatology; Pathology","score_opus":0.36272036851086087,"score_gpt":0.39018630177853797,"score_spread":0.0274659332676771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206764530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98416173,0.006630467,0.0010848137,0.000440105,0.00063101534,0.00043632998,0.0030095917,0.000079163656,0.0035267295],"genre_scores_gemma":[0.99534684,0.0007219928,0.000617134,0.00025390077,0.00011710044,0.00021611337,0.0013541305,0.0000129059545,0.0013598641],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99749005,0.0014650292,0.00018749064,0.0004004229,0.00020229329,0.00025470142],"domain_scores_gemma":[0.998494,0.0005951559,0.00040839432,0.00019426303,0.00010117099,0.00020694936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002592329,0.0015528433,0.0033312934,0.00039123572,0.00025671232,0.0012101872,0.001055738,0.0013948121,0.010335154],"category_scores_gemma":[0.0038699165,0.0012050327,0.00633256,0.00049209676,0.0005730756,0.001186475,0.0010414019,0.0025364573,0.0012693414],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96272236,0.0008045867,0.005356532,0.00062896806,0.010999122,0.000041621857,0.000036576897,0.0015876563,0.00089202507,0.00024722784,0.0007604173,0.01592289],"study_design_scores_gemma":[0.658908,0.13764426,0.12387145,0.0005578711,0.052856907,0.00032531944,0.00022970569,0.015569036,0.002858566,0.0025534665,0.0044575417,0.0001678375],"about_ca_topic_score_codex":0.0035389808,"about_ca_topic_score_gemma":0.0036835717,"teacher_disagreement_score":0.010335154,"about_ca_system_score_codex":0.0011518932,"about_ca_system_score_gemma":0.0009216383,"threshold_uncertainty_score":0.03457451},"labels":[],"label_agreement":null},{"id":"W4210349448","doi":"10.1016/j.jval.2021.11.1373","title":"A Conceptual Framework for Life-Cycle Health Technology Assessment","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Health technology; Procurement; Certainty; Business; Risk analysis (engineering); Economic evaluation; Net present value; Value (mathematics); Sustainability; Actuarial science; Economics; Health care; Computer science; Marketing; Production (economics); Microeconomics","score_opus":0.42759688667811124,"score_gpt":0.4784584415503076,"score_spread":0.050861554872196346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210349448","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015241295,0.0042142225,0.93264157,0.012352723,0.00032042078,0.0020114349,0.0009140222,0.00028087583,0.04574066],"genre_scores_gemma":[0.13882734,0.006155891,0.83744955,0.0023496696,0.0005451245,0.008157085,0.0012913764,0.00018607786,0.0050378987],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9352341,0.05113642,0.0029175046,0.0031425878,0.006179698,0.0013895789],"domain_scores_gemma":[0.91328084,0.06871826,0.004437349,0.0038575465,0.008044939,0.0016610266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.061972767,0.0034046455,0.0021307536,0.0091094,0.0027384653,0.014010606,0.007374529,0.006716722,0.017718215],"category_scores_gemma":[0.078552194,0.0013643021,0.004938365,0.008830791,0.010526956,0.011906508,0.0067281816,0.00691326,0.0026466162],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001711032,0.000029592104,0.00026857323,0.00053950265,0.00006793211,0.00004400645,0.0002878434,0.01887834,0.000044801534,0.9621497,0.00203143,0.015641158],"study_design_scores_gemma":[0.000041903793,0.000078650206,0.00014077309,0.00080668874,0.000056736022,0.000062387306,0.00031015582,0.024793433,0.000137277,0.92606795,0.047464937,0.000039101866],"about_ca_topic_score_codex":0.01055745,"about_ca_topic_score_gemma":0.0048632617,"teacher_disagreement_score":0.061972767,"about_ca_system_score_codex":0.016570287,"about_ca_system_score_gemma":0.02921066,"threshold_uncertainty_score":0.32774723},"labels":[],"label_agreement":null},{"id":"W4210604834","doi":"10.1016/j.jval.2021.12.004","title":"Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; University of Toronto; Cancer Care Ontario; Queen's University; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Survival analysis; Standard deviation; Medicine; Clinical trial; Absolute deviation; Randomized controlled trial; Statistics; Surgery; Mathematics; Internal medicine","score_opus":0.3505452425193095,"score_gpt":0.355994801969507,"score_spread":0.005449559450197483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210604834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57959324,0.0047733216,0.3421621,0.00182099,0.00024555155,0.0006189589,0.06292865,0.002878367,0.004978811],"genre_scores_gemma":[0.8942986,0.00051375595,0.06405734,0.00031077093,0.000045376197,0.00032935172,0.039225865,0.0004052297,0.0008135624],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9863294,0.008828789,0.0010728851,0.0015310629,0.0019098575,0.00032806105],"domain_scores_gemma":[0.7383922,0.20890567,0.012370058,0.027651176,0.01204349,0.00063731056],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.056922056,0.0005841639,0.0008636284,0.0020964525,0.00034056342,0.0021005755,0.0019846682,0.0010849563,0.003391119],"category_scores_gemma":[0.2599404,0.0005469147,0.0016325356,0.002430618,0.0009170757,0.001193535,0.00094016467,0.0017040077,0.0010375679],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005631652,0.00021141689,0.19259115,0.00146724,0.0046598203,0.00032340043,0.00092051795,0.6332288,0.0023623076,0.014134859,0.021150185,0.123318695],"study_design_scores_gemma":[0.0015491018,0.00077822886,0.1465413,0.00092001853,0.001235637,0.0006070658,0.00034444034,0.78783405,0.0065369844,0.02257813,0.030833539,0.00024156022],"about_ca_topic_score_codex":0.08492841,"about_ca_topic_score_gemma":0.052593738,"teacher_disagreement_score":0.9430779,"about_ca_system_score_codex":0.0025756387,"about_ca_system_score_gemma":0.0044276,"threshold_uncertainty_score":0.30103624},"labels":[],"label_agreement":null},{"id":"W4211209444","doi":"10.1016/j.jval.2020.11.007","title":"Engaging the Voices of Children: A Scoping Review of How Children and Adolescents Are Involved in the Development of Quality-of-Life–Related Measures","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University; Western University","funders":"McMaster University","keywords":"Psychology; Developmental psychology; Quality (philosophy); Quality of life (healthcare); Psychotherapist","score_opus":0.530326870832528,"score_gpt":0.4627843983045805,"score_spread":0.06754247252794754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211209444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015491611,0.99913836,0.000083222134,0.0003306929,0.00006494946,0.000038057893,0.000042174324,0.0000012706851,0.0001463434],"genre_scores_gemma":[0.0018992138,0.9970906,0.00045238473,0.00034995776,0.000033353845,0.000101041514,0.00003414911,0.0000020937364,0.000037205213],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9842555,0.00788416,0.0040555354,0.0007251559,0.00269561,0.00038406192],"domain_scores_gemma":[0.93587345,0.05695219,0.0039968994,0.0004713576,0.0023780628,0.00032803416],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022549834,0.001146859,0.004631538,0.008304359,0.000685202,0.0051143337,0.00166195,0.0033361681,0.0027122677],"category_scores_gemma":[0.06269799,0.0010320225,0.004806604,0.009628699,0.0017241768,0.004227533,0.0030025141,0.0030731177,0.0003140904],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014837991,0.000039034134,0.00087526924,0.68068635,0.002971902,0.00008429065,0.0011604781,0.00019759427,0.00021090185,0.0031866117,0.004781545,0.30565766],"study_design_scores_gemma":[0.000048534002,0.00004947228,0.001559534,0.92719954,0.0047226753,0.00015913458,0.0005940378,0.000041194595,0.00010582649,0.0009970928,0.06449897,0.000023952933],"about_ca_topic_score_codex":0.012368095,"about_ca_topic_score_gemma":0.042732738,"teacher_disagreement_score":0.9774502,"about_ca_system_score_codex":0.0046660616,"about_ca_system_score_gemma":0.017573887,"threshold_uncertainty_score":0.11925638},"labels":[],"label_agreement":null},{"id":"W4212830678","doi":"10.1016/j.jval.2022.01.005","title":"Defining a Core Data Set for the Economic Evaluation of Precision Oncology","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; BC Cancer Agency; University of British Columbia; Queen's University; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Core (optical fiber); Set (abstract data type); Data set; Precision oncology; Medical physics; Medicine; Computer science; Internal medicine; Artificial intelligence; Telecommunications; Cancer","score_opus":0.9090435443040895,"score_gpt":0.6118206883164435,"score_spread":0.297222855987646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212830678","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056222253,0.011027857,0.7027471,0.020257665,0.0014736187,0.14108488,0.023080919,0.0004982393,0.04360748],"genre_scores_gemma":[0.122379325,0.0024171737,0.68512136,0.0029804576,0.00020320059,0.17607604,0.01018269,0.000141134,0.0004985787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.3952623,0.41655272,0.12474691,0.0074324007,0.05273295,0.0032726664],"domain_scores_gemma":[0.18081445,0.6311483,0.038982466,0.04483004,0.10149465,0.0027302133],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.539153,0.0025151467,0.005633745,0.025148634,0.0038663468,0.014677088,0.0061893486,0.005089104,0.006613175],"category_scores_gemma":[0.73217565,0.0021716913,0.008131244,0.016297845,0.0052256184,0.015452964,0.014070141,0.008704999,0.0013709337],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027392388,0.0017911583,0.030510385,0.07131498,0.0043416386,0.0005789199,0.023650732,0.019101748,0.0031609794,0.21813445,0.041165438,0.58351034],"study_design_scores_gemma":[0.003468757,0.0042199777,0.057719633,0.19866739,0.0057723396,0.000995038,0.022449568,0.040399976,0.018417995,0.34061974,0.30598956,0.0012800053],"about_ca_topic_score_codex":0.003538964,"about_ca_topic_score_gemma":0.0031599577,"teacher_disagreement_score":0.46084702,"about_ca_system_score_codex":0.016477138,"about_ca_system_score_gemma":0.043185454,"threshold_uncertainty_score":0.56830645},"labels":[],"label_agreement":null},{"id":"W4220982152","doi":"10.1016/j.jval.2021.12.016","title":"The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Biosimilar; Insulin; Checklist; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 1 diabetes; Intensive care medicine; Cost effectiveness; Meta-analysis; Internal medicine; Endocrinology; Risk analysis (engineering)","score_opus":0.19056836850277048,"score_gpt":0.43366563132549774,"score_spread":0.24309726282272726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220982152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014380567,0.997999,0.00007114163,0.000078813624,0.000062531595,0.00005574829,0.00018694179,0.0000042750726,0.0001035071],"genre_scores_gemma":[0.027660916,0.97118574,0.000410554,0.0003214467,0.00006946869,0.00008950864,0.00017302773,0.0000043138343,0.00008506467],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996965,0.0010830277,0.0009355107,0.00029518956,0.00058538624,0.00013581691],"domain_scores_gemma":[0.9902436,0.0076765786,0.0014297666,0.00010306196,0.00041752955,0.00012944704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004410511,0.0013695883,0.009497517,0.004025125,0.0003153383,0.0022844991,0.0015287503,0.0017663141,0.0039895335],"category_scores_gemma":[0.016554395,0.0007928839,0.0123873595,0.0051295436,0.0006312299,0.0016141835,0.0010753998,0.0019824358,0.0002163416],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002396182,0.00004366667,0.0012762755,0.8571318,0.08327549,0.0000855761,0.00009229039,0.00030480482,0.00024359609,0.0002747654,0.001322285,0.053553224],"study_design_scores_gemma":[0.0031071506,0.00067485776,0.008778789,0.3090847,0.6643657,0.00036987162,0.00030341186,0.00034976384,0.00027795703,0.00072333036,0.011876993,0.0000875011],"about_ca_topic_score_codex":0.008542784,"about_ca_topic_score_gemma":0.023097463,"teacher_disagreement_score":0.009497517,"about_ca_system_score_codex":0.0024201297,"about_ca_system_score_gemma":0.0034054837,"threshold_uncertainty_score":0.023325264},"labels":[],"label_agreement":null},{"id":"W4221058544","doi":"10.1016/j.jval.2022.01.014","title":"The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment","year":2022,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"F. Hoffmann-La Roche; Roche","keywords":"Real world data; Computer science; Data science","score_opus":0.6585661098041051,"score_gpt":0.533671017920227,"score_spread":0.12489509188387815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221058544","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005724853,0.0005738683,0.0009085541,0.9846095,0.0049812915,0.00003263841,0.0001676302,0.000023862383,0.0081302775],"genre_scores_gemma":[0.0057758703,0.00022729073,0.0012870979,0.9800531,0.0071991147,0.00013647729,0.000050900366,0.000033752156,0.005236264],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8612069,0.0800224,0.012624271,0.009769618,0.030689394,0.0056873756],"domain_scores_gemma":[0.5602134,0.38522455,0.010940931,0.009791538,0.025263669,0.008565956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.12791362,0.0010795066,0.0033523536,0.001972133,0.008649868,0.017076392,0.0055298465,0.120860554,0.0074269976],"category_scores_gemma":[0.3160923,0.0019789764,0.0026368243,0.002539306,0.018576672,0.017251378,0.009947566,0.07915282,0.0047460734],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013539229,0.000050163177,0.001438281,0.00015347911,0.000043996242,0.00071613875,0.00096676796,0.00013140615,0.00018745371,0.121366136,0.8633367,0.01147419],"study_design_scores_gemma":[0.00043056067,0.00011587709,0.0032126748,0.0015831204,0.00010997987,0.0010443957,0.0014845656,0.0016758904,0.00056486804,0.14660828,0.84293956,0.00023028192],"about_ca_topic_score_codex":0.01637062,"about_ca_topic_score_gemma":0.035005573,"teacher_disagreement_score":0.12791362,"about_ca_system_score_codex":0.009979032,"about_ca_system_score_gemma":0.01795605,"threshold_uncertainty_score":0.67648},"labels":[],"label_agreement":null},{"id":"W4223462176","doi":"10.1016/j.jval.2021.11.1379","title":"Economic Evaluation of Cognitive Behavioral Therapy for Depression: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"National Office for Philosophy and Social Sciences","keywords":"Medicine; Depression (economics); Economic evaluation; Quality-adjusted life year; Cognitive behavioral therapy; Systematic review; Cost effectiveness; Cognition; MEDLINE; Psychiatry; Clinical psychology","score_opus":0.47844142313795274,"score_gpt":0.5805198222754698,"score_spread":0.1020783991375171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223462176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031286366,0.9942058,0.00040928877,0.00036557936,0.00024305655,0.0007508663,0.00045781498,0.000017407323,0.00042168493],"genre_scores_gemma":[0.08773602,0.9073278,0.0018058755,0.0008584963,0.00019071554,0.0014075707,0.0003538897,0.000016831687,0.0003027383],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99029213,0.0055797817,0.001863984,0.00040619474,0.0015787972,0.00027899147],"domain_scores_gemma":[0.98293346,0.01305449,0.0027179327,0.00023189683,0.0007895481,0.00027267038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011124321,0.0016433195,0.012182932,0.0045421147,0.00046747574,0.0028224625,0.0014817014,0.002180824,0.0062834085],"category_scores_gemma":[0.042579472,0.0009329075,0.010522774,0.0048262645,0.00085194584,0.0015307233,0.0015102705,0.002508498,0.00024497628],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00636514,0.0001394249,0.000986612,0.8334499,0.08541224,0.00010400343,0.000079931626,0.0004876728,0.00016064644,0.0005430123,0.001785644,0.070485905],"study_design_scores_gemma":[0.015894985,0.001577617,0.0076815197,0.47115886,0.48557252,0.00037707642,0.00029725762,0.0011292109,0.0003285942,0.001532574,0.014353682,0.00009608239],"about_ca_topic_score_codex":0.008692134,"about_ca_topic_score_gemma":0.018197447,"teacher_disagreement_score":0.012182932,"about_ca_system_score_codex":0.0044756955,"about_ca_system_score_gemma":0.0058128703,"threshold_uncertainty_score":0.05883175},"labels":[],"label_agreement":null},{"id":"W4224860695","doi":"10.1016/j.jval.2022.03.017","title":"Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; University of British Columbia","funders":"Pfizer","keywords":"Pneumococcal conjugate vaccine; Pneumococcal disease; Medicine; Immunization; Streptococcus pneumoniae; Pediatrics; Immunology; Biology; Microbiology; Antibody","score_opus":0.02402005044632292,"score_gpt":0.316356643054663,"score_spread":0.29233659260834005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224860695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973562,0.00054961856,0.000052470125,0.0001140525,0.000009521625,0.000010701266,0.0014143459,0.0000028300503,0.0004903595],"genre_scores_gemma":[0.9983998,0.00030000348,0.00003875687,0.000060286442,0.00002434515,0.000016375265,0.0010082108,0.0000020348923,0.00015012645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894494,0.00033141213,0.00012942009,0.00021178681,0.00015537255,0.0002269765],"domain_scores_gemma":[0.9980134,0.00043187645,0.0008674003,0.000117886855,0.00023570504,0.00033373176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008003959,0.0005386208,0.00068906334,0.0012899092,0.0005339073,0.0011969222,0.00068858935,0.0017353782,0.001331774],"category_scores_gemma":[0.0034015889,0.00069762213,0.0025827866,0.002424039,0.00037681096,0.0018564395,0.00084997516,0.001963835,0.00025130415],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004411663,0.00015927332,0.9974745,0.000022987879,0.00054431014,0.000109268454,0.00006263944,0.00020500403,0.000060154678,0.00003814533,0.00023880656,0.00064369116],"study_design_scores_gemma":[0.00002131018,0.00016248808,0.9987135,0.000008630602,0.00015867759,0.00017211135,0.00020876838,0.00036856966,0.000012383416,0.00003634673,0.00012761305,0.0000095396945],"about_ca_topic_score_codex":0.015820574,"about_ca_topic_score_gemma":0.014516815,"teacher_disagreement_score":0.015820574,"about_ca_system_score_codex":0.0010775898,"about_ca_system_score_gemma":0.0005458843,"threshold_uncertainty_score":0.031456947},"labels":[],"label_agreement":null},{"id":"W4225128199","doi":"10.1016/j.jval.2022.01.012","title":"Accounting for Preference Heterogeneity in Discrete-Choice Experiments: An ISPOR Special Interest Group Report","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Preference; Mixed logit; Preference elicitation; Portfolio; Selection (genetic algorithm); Discrete choice; Econometrics; Actuarial science; Accounting; Psychology; Logistic regression; Economics; Computer science; Statistics; Microeconomics; Mathematics; Financial economics","score_opus":0.5665849309178793,"score_gpt":0.3834187387557521,"score_spread":0.1831661921621272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225128199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018233208,0.97641104,0.01672922,0.002325704,0.00054398517,0.00010078792,0.00020774509,0.000045273107,0.0018128959],"genre_scores_gemma":[0.04777553,0.9074745,0.037067413,0.0028791782,0.0012876181,0.00036863706,0.0004408614,0.00004063573,0.002665607],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99316555,0.0047284286,0.00034992376,0.0006678087,0.0009807558,0.00010748093],"domain_scores_gemma":[0.92001384,0.0741454,0.0019346888,0.0020868843,0.0016428232,0.00017644318],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022248218,0.00086989475,0.0031957198,0.0014962379,0.00018273894,0.0018437086,0.0013894711,0.0016422176,0.0063000615],"category_scores_gemma":[0.032344136,0.00050015014,0.0034803285,0.0022430206,0.0009938717,0.0021204513,0.0007638427,0.0021847675,0.0005677046],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005902498,0.00032079892,0.0014282302,0.013857002,0.0031057042,0.000045288143,0.000033399687,0.0018958936,0.00032340505,0.022584533,0.012442338,0.94337314],"study_design_scores_gemma":[0.0025781982,0.0022862426,0.03897697,0.048486948,0.025733456,0.0012668396,0.00022992537,0.036802225,0.0060480544,0.34893546,0.48821348,0.00044215083],"about_ca_topic_score_codex":0.0031289628,"about_ca_topic_score_gemma":0.0037418993,"teacher_disagreement_score":0.9777518,"about_ca_system_score_codex":0.0017088271,"about_ca_system_score_gemma":0.0024110556,"threshold_uncertainty_score":0.11766124},"labels":[],"label_agreement":null},{"id":"W4229033896","doi":"10.1016/j.jval.2022.03.019","title":"“Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; Simon Fraser University; Public Health Ontario; University of British Columbia; University of Waterloo; Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network; Toronto General Hospital; Canadian Centre for Applied Research in Cancer Control","funders":"Canadian Institutes of Health Research","keywords":"Socioeconomic status; Comorbidity; Demography; Health care; Medicine; Cohort; Ethnic group; Population; Health equity; Gerontology; Environmental health; Sociology; Psychiatry; Economics; Economic growth; Pathology","score_opus":0.19914484187713516,"score_gpt":0.4368686704032987,"score_spread":0.23772382852616353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229033896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894832,0.0011670945,0.00029740637,0.0052940995,0.000086880325,0.000018404766,0.0009082687,0.000004146018,0.002740484],"genre_scores_gemma":[0.9985196,0.00016728115,0.00012760739,0.0004172919,0.00003776127,0.000011134323,0.00031349814,0.000005949699,0.00039980427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920604,0.0050612474,0.0002807471,0.00057173,0.00050438085,0.0015214941],"domain_scores_gemma":[0.9826232,0.0060085966,0.0055377334,0.0020389275,0.001370661,0.0024209956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071064853,0.00031952877,0.00053702627,0.0009166783,0.001071201,0.0018058951,0.0019539814,0.0013961551,0.0073512173],"category_scores_gemma":[0.041516773,0.00047485743,0.0016497729,0.0018470435,0.0020667985,0.0027440563,0.0032345438,0.0023764318,0.00054168364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012264979,0.00033676208,0.9816155,0.000053241085,0.00085418887,0.00011340412,0.0023500032,0.00016127739,0.00007433543,0.0023134076,0.0026244095,0.008277121],"study_design_scores_gemma":[0.00003160466,0.00021679254,0.991702,0.00009902313,0.00023122651,0.000076614866,0.004902136,0.00036147688,0.00007382751,0.0010420228,0.0012429414,0.000020307214],"about_ca_topic_score_codex":0.053351443,"about_ca_topic_score_gemma":0.054782566,"teacher_disagreement_score":0.053351443,"about_ca_system_score_codex":0.0009768631,"about_ca_system_score_gemma":0.0015076344,"threshold_uncertainty_score":0.106081784},"labels":[],"label_agreement":null},{"id":"W4229035098","doi":"10.1016/j.jval.2021.09.003","title":"Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Immunogenicity; Adverse effect; Seroconversion; Vaccination; Placebo; Pandemic; Randomized controlled trial; Neutralizing antibody; Immunology; Coronavirus disease 2019 (COVID-19); Internal medicine; Antibody; Disease; Infectious disease (medical specialty); Pathology","score_opus":0.1421119319798012,"score_gpt":0.4645748723840944,"score_spread":0.3224629404042932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229035098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011484491,0.9830972,0.0004002043,0.0009987848,0.0002112306,0.0016653073,0.0015504705,0.000012611993,0.0005796659],"genre_scores_gemma":[0.104392186,0.8882451,0.0021089138,0.0014913237,0.000088646615,0.0029118543,0.000497398,0.000010791923,0.0002537697],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98546904,0.0064267875,0.004999121,0.0007958499,0.0018485129,0.00046072886],"domain_scores_gemma":[0.9460942,0.043832064,0.0066247736,0.0004622733,0.0025317473,0.00045486432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018758941,0.0011202103,0.006099033,0.005405331,0.00069480325,0.0028230757,0.0012773206,0.0016277784,0.0037979647],"category_scores_gemma":[0.0859248,0.0009067009,0.007070558,0.006469979,0.0009476868,0.0023527816,0.002066243,0.0018288984,0.00017249209],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007747694,0.000056670855,0.0018968142,0.9402827,0.01706411,0.0000747638,0.0017882132,0.00010287605,0.0001657384,0.0002633132,0.0009061061,0.036623824],"study_design_scores_gemma":[0.0008230357,0.00052961067,0.0062773908,0.8771019,0.10015879,0.00018093399,0.0027684933,0.00010075335,0.00024526357,0.0004475542,0.011290439,0.00007583476],"about_ca_topic_score_codex":0.018911555,"about_ca_topic_score_gemma":0.037962448,"teacher_disagreement_score":0.018911555,"about_ca_system_score_codex":0.007778836,"about_ca_system_score_gemma":0.016283907,"threshold_uncertainty_score":0.09920794},"labels":[],"label_agreement":null},{"id":"W4229065899","doi":"10.1016/j.jval.2022.03.014","title":"Value of Nonpharmacological Interventions for People With an Acquired Brain Injury: A Systematic Review of Economic Evaluations","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Irish Research Council; Enterprise Ireland","keywords":"Psychological intervention; Checklist; Medicine; Health care; Acquired brain injury; Rehabilitation; Economic evaluation; Systematic review; Population; Multidisciplinary approach; Cost effectiveness; MEDLINE; Nursing; Psychology; Physical therapy; Environmental health","score_opus":0.36394547423926177,"score_gpt":0.5507474374556581,"score_spread":0.18680196321639636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229065899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023414614,0.99501544,0.00027945254,0.00057594344,0.00016453474,0.00054870447,0.00051821664,0.0000092815735,0.00054693833],"genre_scores_gemma":[0.06767069,0.9278269,0.0016453292,0.000651495,0.0001635641,0.0014251159,0.00044323443,0.000013984569,0.00015962025],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9713775,0.015027349,0.007500963,0.0008936283,0.004683086,0.00051753526],"domain_scores_gemma":[0.9053198,0.07829173,0.010758958,0.0007712923,0.0043159192,0.0005423191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026247196,0.0021730794,0.012207092,0.012873832,0.00078711257,0.0049216887,0.0020805062,0.002135399,0.0054407045],"category_scores_gemma":[0.111825876,0.0012326151,0.015381813,0.010039551,0.0011208155,0.0029609755,0.0020413334,0.002581717,0.00022984394],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018984168,0.00006549809,0.0011397569,0.8849968,0.04773897,0.00011155571,0.0001222471,0.0004127853,0.00008254733,0.00074132934,0.001162832,0.061527252],"study_design_scores_gemma":[0.0021566662,0.0006671362,0.005231613,0.78058535,0.19794326,0.00033932016,0.0003153687,0.0006179862,0.0002511768,0.0013444411,0.010476231,0.0000714885],"about_ca_topic_score_codex":0.0063771103,"about_ca_topic_score_gemma":0.013758126,"teacher_disagreement_score":0.026247196,"about_ca_system_score_codex":0.009133898,"about_ca_system_score_gemma":0.010755849,"threshold_uncertainty_score":0.13881004},"labels":[],"label_agreement":null},{"id":"W4230183862","doi":"10.1016/j.jval.2016.03.719","title":"COST EFFECTIVENESS OF DRUG-COATED BALLOON VERSUS PERCUTANEOUS TRANSLUMINAL BALLOON ANGIOPLASTY, BARE METAL STENT, AND DRUG-ELUTING STENT IN THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE IN LOWER LIMBS CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Medicine; Restenosis; Balloon; Percutaneous; Stent; Angioplasty; Internal medicine; Cardiology; Surgery; Radiology","score_opus":0.027091795592356107,"score_gpt":0.27225588382449806,"score_spread":0.24516408823214195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230183862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98279786,0.0063046697,0.00017716864,0.0026778495,0.000112700225,0.00009683094,0.0014558272,0.00001445667,0.006362622],"genre_scores_gemma":[0.997262,0.0012505263,0.00012835501,0.00021321837,0.000044257446,0.000011437539,0.00043187244,0.0000027467115,0.00065559393],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.999025,0.00042957012,0.000056831806,0.0000668782,0.00019468059,0.00022698818],"domain_scores_gemma":[0.998444,0.0005775847,0.00019485984,0.00002456832,0.0002444908,0.0005145789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005567468,0.00026873918,0.0006766172,0.0005753507,0.00046018523,0.00085271086,0.0006208438,0.0006634561,0.0026871022],"category_scores_gemma":[0.0045004324,0.00017278989,0.0013325848,0.0008907294,0.0004231169,0.00035551115,0.0005433459,0.00075785926,0.000067591085],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15680811,0.0048970664,0.5042413,0.0026159177,0.0076422263,0.001188609,0.00053439126,0.06719466,0.0021126608,0.00807563,0.023823725,0.22086577],"study_design_scores_gemma":[0.010050173,0.008043382,0.8921828,0.0005213575,0.0066683157,0.0005700988,0.0011842336,0.073007576,0.0008858983,0.0020327403,0.004666058,0.0001873945],"about_ca_topic_score_codex":0.722415,"about_ca_topic_score_gemma":0.7886167,"teacher_disagreement_score":0.27758503,"about_ca_system_score_codex":0.015188077,"about_ca_system_score_gemma":0.011475551,"threshold_uncertainty_score":0.55843955},"labels":[],"label_agreement":null},{"id":"W4230554561","doi":"10.1016/j.jval.2021.04.823","title":"PND39 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Remitting Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Ocrelizumab; Medicine; Expanded Disability Status Scale; Teriflunomide; Cladribine; Multiple sclerosis; Socioeconomic status; Family medicine; Internal medicine; Environmental health; Population; Psychiatry; Fingolimod","score_opus":0.3144445585958653,"score_gpt":0.36695481173962446,"score_spread":0.05251025314375918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230554561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718658,0.0093644345,0.0002519448,0.006219234,0.00016328202,0.00004593185,0.0024416184,0.0000073793162,0.0096404],"genre_scores_gemma":[0.9988231,0.00051557017,0.00007375725,0.00009397804,0.00004130015,0.000007684399,0.00032046693,8.7153524e-7,0.0001232173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836737,0.0010650916,0.00011296962,0.000058999183,0.0002570312,0.00013849618],"domain_scores_gemma":[0.9961985,0.0018094118,0.0009875568,0.000117610994,0.00030792475,0.0005790192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019684837,0.00017901516,0.0005174113,0.00048613167,0.00027273464,0.00086061115,0.00021516698,0.00036717468,0.0028399955],"category_scores_gemma":[0.012929409,0.000077150224,0.0009207267,0.00074022904,0.00024963348,0.00053690013,0.0007440591,0.0009966381,0.00012873075],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024569197,0.0015092136,0.6960143,0.0009889418,0.0035170137,0.00052420417,0.00026905767,0.009243661,0.0004502481,0.0060760207,0.0071895295,0.24964865],"study_design_scores_gemma":[0.0016734613,0.00526139,0.9593989,0.0007328664,0.001644705,0.00060492597,0.0005675645,0.015601715,0.00035332819,0.0060109827,0.00809279,0.000057299952],"about_ca_topic_score_codex":0.0046773627,"about_ca_topic_score_gemma":0.0048721638,"teacher_disagreement_score":0.0046773627,"about_ca_system_score_codex":0.0016747764,"about_ca_system_score_gemma":0.0009929725,"threshold_uncertainty_score":0.0121513605},"labels":[],"label_agreement":null},{"id":"W4230911392","doi":"10.1016/j.jval.2020.05.003","title":"A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Ministry of Research, Innovation and Science; Canadian Institutes of Health Research; Canadian Liver Foundation; Merck; AbbVie; Public Health Agency of Canada; Gilead Sciences","keywords":"Chronic hepatitis; Medicine; Meta-analysis; Internal medicine; Intensive care medicine; Virology","score_opus":0.20106905520628113,"score_gpt":0.4271879401206643,"score_spread":0.22611888491438317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230911392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035502163,0.99519026,0.0003303214,0.0001245797,0.00013598264,0.00014789,0.00031469777,0.000013686441,0.00019236174],"genre_scores_gemma":[0.16406517,0.83122903,0.002139905,0.0010085307,0.00022401611,0.0005165548,0.0005273682,0.000023030565,0.00026643675],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98863155,0.0060821613,0.0030834272,0.00092349714,0.0009506772,0.0003286233],"domain_scores_gemma":[0.983706,0.012779661,0.0020372162,0.0004891704,0.00080257916,0.00018549018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011088927,0.0023922191,0.01793295,0.004741544,0.0005769372,0.0029802464,0.0016604641,0.0019726895,0.0037832425],"category_scores_gemma":[0.037784427,0.0013888082,0.03016384,0.0065962714,0.0007534946,0.0018048863,0.0020370677,0.0025138035,0.0002520235],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022766218,0.000025654312,0.0030168681,0.38680986,0.5919348,0.000089455105,0.000088113266,0.00031407404,0.00013161406,0.00014656855,0.00056755537,0.014598905],"study_design_scores_gemma":[0.0011825983,0.0001943767,0.0036678833,0.030310541,0.9623172,0.000091392474,0.000058418653,0.000128223,0.000055790217,0.00025312946,0.0017113807,0.000029041796],"about_ca_topic_score_codex":0.008926587,"about_ca_topic_score_gemma":0.020980028,"teacher_disagreement_score":0.01793295,"about_ca_system_score_codex":0.0026049365,"about_ca_system_score_gemma":0.0036730184,"threshold_uncertainty_score":0.058644533},"labels":[],"label_agreement":null},{"id":"W4230986977","doi":"10.1016/j.jval.2016.08.367","title":"Identification of Statin Intolerance: Results From a Survey of Clinicians in Japan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Creatine kinase; Internal medicine; Physical therapy; Family medicine","score_opus":0.06476042054602767,"score_gpt":0.3441394531380865,"score_spread":0.2793790325920589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230986977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992543,0.00014398209,0.000035952842,0.00011822969,0.0000045483534,0.0000069541534,0.0001331021,0.0000010908274,0.00030183376],"genre_scores_gemma":[0.9992805,0.00017067546,0.00006152877,0.0001824516,0.000010564428,0.000011295185,0.00017697799,0.0000017222712,0.00010424976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878234,0.00030132665,0.0002930264,0.00024258709,0.00017248161,0.00020826177],"domain_scores_gemma":[0.99590814,0.0005154563,0.0016137502,0.00015572314,0.00075969915,0.0010471636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088838756,0.00029142006,0.0005813046,0.0014566878,0.001167816,0.0010443422,0.00041841037,0.00089598953,0.0013179253],"category_scores_gemma":[0.0040416173,0.00052372454,0.00050053647,0.0024263714,0.0005469006,0.0007937922,0.0009904881,0.00058289606,0.00025884932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017362072,0.000023483133,0.99870884,0.000007695422,0.000014828405,0.00006698538,0.0006268296,0.000003910035,0.00010861525,0.0000036544377,0.00005837072,0.00035946516],"study_design_scores_gemma":[0.000003969742,0.000027396,0.99756455,0.0000066749963,0.000020517795,0.000102568534,0.0020859276,0.00004742465,0.000020406465,0.0000037668694,0.000112746224,0.0000039599217],"about_ca_topic_score_codex":0.040536474,"about_ca_topic_score_gemma":0.052065533,"teacher_disagreement_score":0.040536474,"about_ca_system_score_codex":0.0008738639,"about_ca_system_score_gemma":0.0012836282,"threshold_uncertainty_score":0.08060104},"labels":[],"label_agreement":null},{"id":"W4231347798","doi":"10.1016/j.jval.2018.09.2440","title":"PRS46 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Exacerbation; Internal medicine; Incremental cost-effectiveness ratio; Cost effectiveness; Quality-adjusted life year; Corticosteroid","score_opus":0.060863748677646975,"score_gpt":0.34872056230772047,"score_spread":0.2878568136300735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231347798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96372485,0.010448784,0.0012990775,0.004898746,0.0001498941,0.001623363,0.008412493,0.000067095825,0.00937564],"genre_scores_gemma":[0.9937756,0.0016481745,0.0015052996,0.00043035566,0.000028560144,0.00020069302,0.0015690301,0.0000061709006,0.0008360925],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99582374,0.0027949705,0.00015537738,0.000270946,0.00042569626,0.0005292379],"domain_scores_gemma":[0.9961482,0.0017569221,0.0006146658,0.00011887124,0.0006049938,0.0007563577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005542918,0.000764461,0.0014221816,0.0005006713,0.00059556426,0.0020359938,0.0009512741,0.0011463724,0.006096577],"category_scores_gemma":[0.008898809,0.00028243984,0.0042357706,0.0011366528,0.00061283115,0.0008926321,0.000964074,0.0015237238,0.00021784559],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20181748,0.008950645,0.1967009,0.0056898305,0.015787965,0.0004513548,0.00053482375,0.14520466,0.002211199,0.0053489483,0.015141031,0.40216124],"study_design_scores_gemma":[0.091571435,0.06559469,0.5923942,0.003582245,0.022191128,0.00039857515,0.0018745955,0.20193367,0.0019388681,0.0023813723,0.015773179,0.0003662072],"about_ca_topic_score_codex":0.77571326,"about_ca_topic_score_gemma":0.7756491,"teacher_disagreement_score":0.22428674,"about_ca_system_score_codex":0.025492746,"about_ca_system_score_gemma":0.03085065,"threshold_uncertainty_score":0.4512152},"labels":[],"label_agreement":null},{"id":"W4231757079","doi":"10.1016/j.jval.2013.03.1501","title":"Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy for the treatment of atrial fibrillation in canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atrial fibrillation; Catheter ablation; Ablation; Internal medicine; Cardiology; Quality of life (healthcare); Cohort; Randomized controlled trial; Clinical trial; Cost-effectiveness analysis; Cardiac Ablation; Atrial flutter; Quality-adjusted life year; Cost effectiveness; Surgery","score_opus":0.37408275044730444,"score_gpt":0.41802445470097255,"score_spread":0.04394170425366811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231757079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94643986,0.01967447,0.0003960319,0.013077132,0.00021118156,0.00015643905,0.009052397,0.00003027713,0.01096209],"genre_scores_gemma":[0.99448365,0.0029742063,0.00022260984,0.0003780028,0.00003677263,0.000016950169,0.0011015757,0.0000063860193,0.00077984197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977271,0.00062746165,0.00017510953,0.00014778588,0.00068889913,0.00063371286],"domain_scores_gemma":[0.99284595,0.0022730532,0.0009550654,0.00007736878,0.0021137756,0.0017348969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015124694,0.00032397162,0.0009283627,0.0014523525,0.001248908,0.0020721524,0.0014565103,0.0010384792,0.0029267278],"category_scores_gemma":[0.015073662,0.00031377494,0.0015135485,0.0032904325,0.00095241494,0.0005531787,0.000697216,0.0015336922,0.00006107655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013209067,0.0011273392,0.73602957,0.0024790477,0.004558241,0.0009967908,0.0007487758,0.07242567,0.00065035967,0.0227223,0.03637466,0.10867815],"study_design_scores_gemma":[0.0040739365,0.00094745227,0.8890625,0.0010319452,0.003512737,0.0006451457,0.0018913845,0.08588562,0.00054179935,0.0035914346,0.008611929,0.00020409537],"about_ca_topic_score_codex":0.9929638,"about_ca_topic_score_gemma":0.99478453,"teacher_disagreement_score":0.09649357,"about_ca_system_score_codex":0.09649357,"about_ca_system_score_gemma":0.08939291,"threshold_uncertainty_score":0.7001132},"labels":[],"label_agreement":null},{"id":"W4233315542","doi":"10.1016/j.jval.2020.10.007","title":"Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Genentech; University of North Carolina at Chapel Hill; Agency for Healthcare Research and Quality; Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill; National Institutes of Health; Arnold Ventures; Leukemia and Lymphoma Society; American Foundation for Pharmaceutical Education; GlaxoSmithKline; Pfizer; Commonwealth Fund","keywords":"Myeloid leukemia; Tyrosine-kinase inhibitor; Tyrosine kinase; Medicine; Cancer research; Oncology; Pharmacology; Internal medicine; Receptor; Cancer","score_opus":0.10672761659228684,"score_gpt":0.3530499165824488,"score_spread":0.24632229999016192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233315542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92648095,0.04434113,0.002274498,0.008497951,0.0003977684,0.0005419877,0.0027118116,0.00008711985,0.014666746],"genre_scores_gemma":[0.99559766,0.0027195755,0.00046992468,0.00031214734,0.000070783826,0.000054198445,0.00035171458,0.0000053197746,0.0004187167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99832803,0.00088333775,0.00009147028,0.00012522038,0.00023190002,0.00033990812],"domain_scores_gemma":[0.9969921,0.0017836528,0.0005589648,0.00005028877,0.00012994796,0.00048511487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001791176,0.00061571976,0.0011209404,0.00084732956,0.00024329987,0.0015678201,0.0006890748,0.0010153591,0.008002397],"category_scores_gemma":[0.0088318465,0.00024027422,0.0027773476,0.000788489,0.00033503823,0.0011486198,0.0007580247,0.0015037168,0.00022931553],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06997715,0.0053799367,0.07354449,0.002811879,0.0056452546,0.00033677972,0.00022167439,0.11443669,0.0017341236,0.010285494,0.009416185,0.7062103],"study_design_scores_gemma":[0.029382017,0.06651239,0.5970292,0.0054455074,0.025233984,0.0016012549,0.0024740424,0.21501736,0.0057568923,0.025895093,0.02535302,0.000299194],"about_ca_topic_score_codex":0.009220001,"about_ca_topic_score_gemma":0.010141224,"teacher_disagreement_score":0.009220001,"about_ca_system_score_codex":0.005327349,"about_ca_system_score_gemma":0.0036393413,"threshold_uncertainty_score":0.038652778},"labels":[],"label_agreement":null},{"id":"W4233609854","doi":"10.1016/j.jval.2017.08.2462","title":"Economic Burden Of Herpes Zoster (“CULEBRILLA”) In Latin America","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Indirect costs; Rash; Postherpetic neuralgia; Latin Americans; Presenteeism; Incidence (geometry); Pediatrics; Demography; Emergency medicine; Surgery; Absenteeism; Alternative medicine","score_opus":0.04773359073251996,"score_gpt":0.3462902319375404,"score_spread":0.2985566412050204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233609854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97046214,0.011090828,0.00008096999,0.008410463,0.00006160495,0.000012172673,0.0014589974,0.0000042399233,0.00841856],"genre_scores_gemma":[0.991829,0.006428611,0.00006441918,0.0004402467,0.00005097299,0.000009391749,0.0005142057,0.0000021687529,0.0006608816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972326,0.0001276118,0.00001808431,0.000011005057,0.00003696902,0.00008309039],"domain_scores_gemma":[0.99942386,0.000093668765,0.0002681254,0.000014551204,0.00008223873,0.00011771013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041274694,0.0001415958,0.00014214014,0.0007345512,0.00030105346,0.000957741,0.00021673554,0.0003703861,0.0019075995],"category_scores_gemma":[0.001609968,0.00008413648,0.00026383254,0.0014350947,0.0003928819,0.00042663852,0.00077730673,0.0004410273,0.00006592931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043992928,0.0001729224,0.9580918,0.00022747525,0.00027244625,0.0006786767,0.0009428843,0.00068308203,0.00044107702,0.0045454893,0.0048263064,0.028678037],"study_design_scores_gemma":[0.00003738046,0.000052245246,0.9850471,0.00023677011,0.00007542323,0.00028149557,0.003596912,0.00041062103,0.00006790879,0.00075105944,0.009435253,0.000007894745],"about_ca_topic_score_codex":0.0914445,"about_ca_topic_score_gemma":0.08726362,"teacher_disagreement_score":0.0914445,"about_ca_system_score_codex":0.0024810631,"about_ca_system_score_gemma":0.0012168237,"threshold_uncertainty_score":0.18182445},"labels":[],"label_agreement":null},{"id":"W4233770435","doi":"10.1016/j.jval.2013.08.1524","title":"Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol: 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Placebo; Double blind; Internal medicine; Randomized controlled trial; Psoriasis Area and Severity Index; Psoriasis; Surgery; Arthritis; Etanercept; Rheumatoid arthritis; Dermatology","score_opus":0.04774889429504628,"score_gpt":0.2914950134532094,"score_spread":0.2437461191581631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233770435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751854,0.0012048817,0.00009204954,0.000059189053,0.00002026765,0.00007417799,0.0006055927,0.000018459854,0.00040696806],"genre_scores_gemma":[0.99837875,0.00029596133,0.000112054775,0.000065806475,0.000044784458,0.000057494675,0.0007359834,0.0000046070695,0.00030464877],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9983728,0.0006816453,0.00017607296,0.00023719027,0.00031056846,0.00022181994],"domain_scores_gemma":[0.99562126,0.0010951535,0.001628958,0.0005510673,0.0003664614,0.0007370702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045373915,0.0011921017,0.0022030207,0.0005915964,0.00047525731,0.00094607554,0.00064274523,0.0015416141,0.0011723567],"category_scores_gemma":[0.0039720265,0.00044394596,0.0025016575,0.00063812407,0.0006170369,0.0014494936,0.00067210133,0.0019891595,0.00047776755],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3753008,0.013745041,0.4966142,0.0008352605,0.011249138,0.00054017565,0.0009383279,0.0025268847,0.007818461,0.0001174407,0.0016415295,0.08867289],"study_design_scores_gemma":[0.03226748,0.07686643,0.88153595,0.00006683347,0.0043053413,0.0005883345,0.0002704034,0.0012762948,0.0017279016,0.000126155,0.0008439656,0.00012486172],"about_ca_topic_score_codex":0.0013823694,"about_ca_topic_score_gemma":0.0012275944,"teacher_disagreement_score":0.0045373915,"about_ca_system_score_codex":0.00048177943,"about_ca_system_score_gemma":0.00039376452,"threshold_uncertainty_score":0.023996294},"labels":[],"label_agreement":null},{"id":"W4234084467","doi":"10.1016/j.jval.2017.08.1212","title":"Modelling The Burden Of Cardiovascular Disease In Turkey And The Impact Of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Population; Disease; Disease burden; Obesity; Psychological intervention; Gerontology; Demography; Internal medicine","score_opus":0.0755433532259023,"score_gpt":0.31907866696298776,"score_spread":0.24353531373708545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234084467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9829555,0.00095007586,0.004932065,0.0026174248,0.0001179534,0.000042626656,0.0036566562,0.00005966999,0.004667974],"genre_scores_gemma":[0.99547654,0.00034485373,0.0011556657,0.000060712315,0.000021930513,0.000038030714,0.0010104689,0.0000139007325,0.0018779276],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99932873,0.00030260714,0.000028943223,0.00010786456,0.000025166028,0.00020668432],"domain_scores_gemma":[0.99817777,0.0011060996,0.00020265143,0.000062339386,0.000247472,0.00020368434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095225754,0.0012711012,0.0010733523,0.0006364186,0.0004239955,0.001772362,0.0016506889,0.0023407224,0.004339095],"category_scores_gemma":[0.0037883862,0.0006439019,0.001468368,0.00090107106,0.0005355633,0.0010138381,0.000931897,0.0017417845,0.00033147354],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024741027,0.00009350349,0.013185202,0.000041465184,0.00009604456,0.00016458725,0.000042744196,0.9803038,0.00011334324,0.0028653317,0.0009985627,0.0018479798],"study_design_scores_gemma":[0.00012147256,0.0001546811,0.01229334,0.000035659672,0.00016384016,0.000086019136,0.000348747,0.9825017,0.00013632826,0.0028990584,0.0012131713,0.00004608424],"about_ca_topic_score_codex":0.21416137,"about_ca_topic_score_gemma":0.08450266,"teacher_disagreement_score":0.21416137,"about_ca_system_score_codex":0.0031833746,"about_ca_system_score_gemma":0.004008431,"threshold_uncertainty_score":0.4258296},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4235166966","doi":"10.1016/j.jval.2011.08.910","title":"PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special Populations","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Observational study; Respiratory system; Internal medicine; Pregnancy; Biology","score_opus":0.2800302140486858,"score_gpt":0.41816500035010795,"score_spread":0.13813478630142217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235166966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940683,0.0032029946,0.0001484944,0.00380494,0.0001721166,0.000035935507,0.0002640761,0.000012125001,0.012952357],"genre_scores_gemma":[0.9985973,0.0005007069,0.00010193857,0.00021091325,0.00008797432,0.000011418359,0.000085183834,0.0000010628175,0.00040341797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995553,0.00017154134,0.000027184551,0.000026554517,0.00006664394,0.00015278913],"domain_scores_gemma":[0.99885714,0.00022588616,0.00021225447,0.000030133266,0.00009970677,0.00057491596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045756754,0.00010512429,0.00018362343,0.00032721413,0.00046325356,0.00043736424,0.00016983548,0.000313343,0.0044559017],"category_scores_gemma":[0.0032210478,0.00004776657,0.00016946845,0.00035702187,0.00021230802,0.00020693071,0.0004203842,0.00037138507,0.0002368811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013811964,0.0005691353,0.80677855,0.00015139651,0.000058135014,0.0009715452,0.00026419584,0.00016487388,0.0013255944,0.0007212258,0.007727771,0.17988636],"study_design_scores_gemma":[0.00012946129,0.0021117234,0.9867757,0.00015071633,0.00007379852,0.0013955376,0.0008647758,0.0003614156,0.0008770317,0.0005501383,0.006704505,0.000005255687],"about_ca_topic_score_codex":0.0036418717,"about_ca_topic_score_gemma":0.0069668097,"teacher_disagreement_score":0.0044559017,"about_ca_system_score_codex":0.0006511292,"about_ca_system_score_gemma":0.0010861787,"threshold_uncertainty_score":0.014906466},"labels":[],"label_agreement":null},{"id":"W4235301199","doi":"10.1016/j.jval.2017.08.1389","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Medicine; Heart failure; Ejection fraction; Internal medicine; Population; Cardiology; Blood pressure; Angiotensin-converting enzyme","score_opus":0.06002917433916491,"score_gpt":0.3546279566412262,"score_spread":0.29459878230206127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235301199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9597961,0.015346223,0.0011141521,0.01663917,0.0002347262,0.00006519329,0.0015998374,0.00006632581,0.005138373],"genre_scores_gemma":[0.9914169,0.0046748524,0.0015271193,0.00079281646,0.00020619985,0.00004996999,0.00062823796,0.000008167044,0.00069570815],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9997547,0.000114551505,0.000017882061,0.000026154177,0.000022011678,0.000064588654],"domain_scores_gemma":[0.9996,0.000074926065,0.00015509356,0.000015312175,0.00006003421,0.00009461007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006216665,0.0001565605,0.00032352592,0.00028148017,0.00024285099,0.00057640707,0.00041395033,0.0002814053,0.0022259823],"category_scores_gemma":[0.001024669,0.000083701154,0.0003485526,0.00032471714,0.00021262445,0.0002036249,0.00026910944,0.0007616059,0.000075559125],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025223449,0.0043356842,0.5347876,0.002442532,0.0016764469,0.0017975942,0.0006120844,0.0040382817,0.009977981,0.009758398,0.026984472,0.37836537],"study_design_scores_gemma":[0.005025431,0.004717886,0.9451877,0.00069909403,0.002182956,0.00077245367,0.0012864752,0.0043877442,0.0021300504,0.0018936987,0.03165834,0.0000581356],"about_ca_topic_score_codex":0.025685469,"about_ca_topic_score_gemma":0.042085633,"teacher_disagreement_score":0.025685469,"about_ca_system_score_codex":0.0013081097,"about_ca_system_score_gemma":0.0023623842,"threshold_uncertainty_score":0.051071882},"labels":[],"label_agreement":null},{"id":"W4235888460","doi":"10.1016/j.jval.2017.08.1392","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Medicine; Heart failure; Ejection fraction; Internal medicine; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","score_opus":0.05498248345565799,"score_gpt":0.34901841988879123,"score_spread":0.29403593643313325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235888460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587764,0.018220974,0.00069899054,0.013406854,0.0001722645,0.000075022035,0.00092992006,0.00004540433,0.007674102],"genre_scores_gemma":[0.9909729,0.0055736825,0.00082741916,0.00071097625,0.00013442017,0.000047067628,0.00035210646,0.000008190867,0.0013731703],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999765,0.00011809939,0.000021115333,0.00001654339,0.000022964829,0.000056242294],"domain_scores_gemma":[0.9996395,0.00006786978,0.00008717412,0.000017494101,0.000070137554,0.00011764933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005654376,0.00014220942,0.00024091628,0.0003034709,0.00019228378,0.0005319374,0.00032709714,0.00020994234,0.0023494612],"category_scores_gemma":[0.0010096922,0.00006396514,0.00033125115,0.0002918132,0.0002497618,0.00019444237,0.0003830496,0.00065810606,0.00013317318],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023873758,0.006374664,0.36995307,0.0044494225,0.0011991195,0.0036842797,0.0012766308,0.0026076569,0.02101734,0.01097141,0.019366184,0.53522646],"study_design_scores_gemma":[0.004768967,0.0049838056,0.9210459,0.0011439672,0.0013570896,0.0014015777,0.0029775447,0.0030964683,0.0050549586,0.0036807326,0.050392218,0.00009672666],"about_ca_topic_score_codex":0.016331576,"about_ca_topic_score_gemma":0.02372251,"teacher_disagreement_score":0.016331576,"about_ca_system_score_codex":0.0014754259,"about_ca_system_score_gemma":0.003014081,"threshold_uncertainty_score":0.032473028},"labels":[],"label_agreement":null},{"id":"W4236892631","doi":"10.1016/j.jval.2012.08.1987","title":"PND63 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis: Findings From the Phase 3 Define Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Relapsing remitting; Expanded Disability Status Scale; Quality of life (healthcare); Multiple sclerosis; Internal medicine; Physical therapy; Randomized controlled trial; Psychiatry","score_opus":0.5634492335473503,"score_gpt":0.4438502054138887,"score_spread":0.11959902813346163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236892631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99833655,0.00084017863,0.00006519914,0.00010563526,0.000013461266,0.000024504745,0.00029221037,0.000007123464,0.00031512452],"genre_scores_gemma":[0.99883205,0.00038901044,0.00011435555,0.00007043763,0.0000152067305,0.000037158927,0.00024648957,0.0000055487453,0.00028964464],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990194,0.0006330851,0.000040933715,0.00007494162,0.00012371007,0.000107918204],"domain_scores_gemma":[0.9981591,0.00080182333,0.00044271728,0.00017949683,0.0001124613,0.00030438424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018979504,0.0004806565,0.0012195267,0.00025796756,0.0003182443,0.00073791464,0.00038474772,0.0007494811,0.0013647531],"category_scores_gemma":[0.0031800536,0.00020458121,0.0012326486,0.00057713763,0.00062596565,0.00056592847,0.0005404078,0.0013138095,0.00023456439],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69989115,0.015408911,0.15119724,0.00044795522,0.0031272362,0.00022663322,0.00050712365,0.0021002279,0.006563087,0.0002559343,0.0011414016,0.11913314],"study_design_scores_gemma":[0.025194207,0.09591401,0.8699246,0.0001428061,0.00240622,0.0001500883,0.0003442372,0.0012487866,0.0020608506,0.0007248924,0.0018387055,0.000050669125],"about_ca_topic_score_codex":0.0037498053,"about_ca_topic_score_gemma":0.0027731643,"teacher_disagreement_score":0.0037498053,"about_ca_system_score_codex":0.00044218978,"about_ca_system_score_gemma":0.0006989337,"threshold_uncertainty_score":0.010037422},"labels":[],"label_agreement":null},{"id":"W4237025882","doi":"10.1016/j.jval.2014.03.228","title":"Economic evaluations of treatments for inflammatory bowel diseases","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Azathioprine; Economic evaluation; Inflammatory Bowel Diseases; MEDLINE; Cost effectiveness; Inflammatory bowel disease; Family medicine; Internal medicine; Pathology; Disease","score_opus":0.01603525369785998,"score_gpt":0.30236244143259344,"score_spread":0.2863271877347335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237025882","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46036905,0.33554065,0.024295593,0.042802524,0.003072153,0.0027527506,0.007123972,0.00013231284,0.123910986],"genre_scores_gemma":[0.98130345,0.01355382,0.0023535066,0.0006592819,0.00028097135,0.0003366008,0.0003874436,0.000010584347,0.0011142595],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9694351,0.02662409,0.00075078086,0.0002925983,0.0024185262,0.00047889765],"domain_scores_gemma":[0.95133775,0.042000562,0.00309243,0.00073866383,0.0016278852,0.0012027348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01640945,0.0007765264,0.0017895942,0.0016204333,0.00032654256,0.002143136,0.0005658153,0.0013478184,0.0060842945],"category_scores_gemma":[0.07111511,0.0002405215,0.0019663405,0.0014596442,0.0010920584,0.001225411,0.00080178556,0.001995376,0.00021115245],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10278682,0.0030076941,0.030961046,0.01030757,0.014542312,0.0003839421,0.0003353267,0.09684753,0.0010748849,0.082810216,0.018135324,0.6388073],"study_design_scores_gemma":[0.04265986,0.058425907,0.15112746,0.026255209,0.034952935,0.002253634,0.0031991461,0.21712938,0.0045855246,0.31127897,0.1475766,0.0005554688],"about_ca_topic_score_codex":0.00199058,"about_ca_topic_score_gemma":0.0017260473,"teacher_disagreement_score":0.01640945,"about_ca_system_score_codex":0.0033809063,"about_ca_system_score_gemma":0.0023434479,"threshold_uncertainty_score":0.086782455},"labels":[],"label_agreement":null},{"id":"W4237085286","doi":"10.1016/j.jval.2017.08.2987","title":"Patient-Reported Outcomes from Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Visual analogue scale; Continuous variable; Rheumatoid arthritis; Placebo; Internal medicine; Physical therapy; Imputation (statistics); Categorical variable; Methotrexate; Missing data","score_opus":0.06214276786185622,"score_gpt":0.38303694143057254,"score_spread":0.3208941735687163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237085286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97076887,0.018292714,0.00093879714,0.00054327556,0.00018855506,0.00022476984,0.0064215655,0.000041046682,0.0025804641],"genre_scores_gemma":[0.99341416,0.0015323258,0.00022295908,0.00053676264,0.00012258886,0.00023659045,0.003306301,0.00002522705,0.0006030278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823207,0.0006567816,0.00026212868,0.00033129472,0.00020552555,0.000312175],"domain_scores_gemma":[0.9989795,0.00036847132,0.00031560904,0.00014833407,0.00011490727,0.00007319835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023826123,0.0009533987,0.00248301,0.0011357194,0.00033998955,0.0012025743,0.0006260763,0.0006528209,0.0020402903],"category_scores_gemma":[0.0032611084,0.0003169121,0.0064191306,0.001932855,0.0003032404,0.0005295767,0.0009288976,0.0010451563,0.00022385283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06992275,0.00041127967,0.71258116,0.0030384457,0.16811995,0.0005827796,0.00036964973,0.0014504034,0.0028136238,0.000616057,0.0077330465,0.03236084],"study_design_scores_gemma":[0.017817589,0.0023814014,0.8326594,0.00057876133,0.13215038,0.0005569688,0.0012836312,0.0026234528,0.0007648883,0.001388936,0.0076659787,0.00012855686],"about_ca_topic_score_codex":0.0054806154,"about_ca_topic_score_gemma":0.012574105,"teacher_disagreement_score":0.0054806154,"about_ca_system_score_codex":0.00065128406,"about_ca_system_score_gemma":0.00079897314,"threshold_uncertainty_score":0.012600601},"labels":[],"label_agreement":null},{"id":"W4237096206","doi":"10.1016/j.jval.2013.03.201","title":"Examination of preferences elicited from the general public: Subgroup comparisons of results from the time trade-off and standard gamble instruments","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Rank correlation; Correlation; Demography; Medicine; Spearman's rank correlation coefficient; Statistics; Mathematics","score_opus":0.3222879764111123,"score_gpt":0.3765451523510831,"score_spread":0.054257175939970814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237096206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99751806,0.00022664558,0.0007038822,0.00008545708,0.000012151455,0.000049944218,0.00055946107,0.000007721194,0.00083667436],"genre_scores_gemma":[0.99847955,0.00007514217,0.0002923487,0.000058426147,0.0000108056065,0.00004586183,0.00071021565,0.0000076121983,0.00032008247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927086,0.005626939,0.00043447808,0.00040895544,0.00052733306,0.0002937295],"domain_scores_gemma":[0.9153917,0.07176282,0.0039316188,0.0063649113,0.0018881545,0.00066081615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016421705,0.00067903736,0.0015372911,0.0010686258,0.0003058314,0.0011401452,0.0006923655,0.0010289522,0.00529233],"category_scores_gemma":[0.060716283,0.00021836655,0.0032747064,0.0011110842,0.00047896837,0.0013253012,0.0014468617,0.0012820257,0.00046604217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16433834,0.0038058374,0.69437647,0.0015013748,0.024324259,0.00062771054,0.00971408,0.0063411486,0.008753714,0.0042838072,0.0037002834,0.07823301],"study_design_scores_gemma":[0.0028922292,0.0131620895,0.9412858,0.00013595475,0.009751965,0.0004750834,0.010203507,0.008299647,0.0038520636,0.006868068,0.0029357108,0.00013798538],"about_ca_topic_score_codex":0.0022564814,"about_ca_topic_score_gemma":0.0016483631,"teacher_disagreement_score":0.016421705,"about_ca_system_score_codex":0.00037027328,"about_ca_system_score_gemma":0.0003844258,"threshold_uncertainty_score":0.086847305},"labels":[],"label_agreement":null},{"id":"W4239324238","doi":"10.1016/s1098-3015(10)70031-0","title":"DH3 THE IMPACT OF DRUG VINTAGE ON PATIENT SURVIVAL: A PATIENT-LEVEL APPROACH USING QUEBEC'S PROVINCIAL HEALTH PLAN DATA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vintage; Health plan; Plan (archaeology); Medicine; Gerontology; Geography; Economic growth; Health care; Economics; Archaeology","score_opus":0.5182127301852874,"score_gpt":0.465950194362394,"score_spread":0.05226253582289336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239324238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.920267,0.0006545224,0.004223362,0.0016338034,0.00005602531,0.00018670777,0.067059375,0.00017732686,0.005741896],"genre_scores_gemma":[0.9871952,0.000070130765,0.0019867618,0.00011923151,0.000013781176,0.00006187602,0.008268048,0.000028658302,0.002256487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995385,0.0027846221,0.0002006256,0.0003778838,0.0007013121,0.0005505502],"domain_scores_gemma":[0.9831201,0.011181628,0.0010542726,0.00070939254,0.003123833,0.00081072364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072786068,0.00034743207,0.00085378165,0.0022138804,0.00078725733,0.0016478483,0.0013532599,0.0004757804,0.0051583312],"category_scores_gemma":[0.016127884,0.00020146505,0.0024092875,0.0058033955,0.0004678457,0.00043751288,0.0008904282,0.0015314915,0.00020595007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005487892,0.00007314964,0.94982356,0.00012029701,0.002862884,0.00016904357,0.00024388423,0.02407858,0.00019754434,0.0012768204,0.008177704,0.012427763],"study_design_scores_gemma":[0.000110024856,0.00017637493,0.9104714,0.000037719754,0.0008372066,0.000071778995,0.00073127093,0.08113717,0.0003018379,0.0005060236,0.0055836854,0.000035492638],"about_ca_topic_score_codex":0.9669583,"about_ca_topic_score_gemma":0.96263486,"teacher_disagreement_score":0.033041716,"about_ca_system_score_codex":0.012087317,"about_ca_system_score_gemma":0.0147339,"threshold_uncertainty_score":0.08770001},"labels":[],"label_agreement":null},{"id":"W4239427141","doi":"10.1016/j.jval.2017.08.2849","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Depression (economics); Heart failure; Anxiety; Cohort; Physical therapy; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.05323294192521293,"score_gpt":0.3640354118462159,"score_spread":0.31080246992100297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239427141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676824,0.0003938818,0.00007814081,0.0010120068,0.000009071993,0.000008941462,0.0006018956,0.0000018531813,0.0011259575],"genre_scores_gemma":[0.99872094,0.00052881247,0.000171913,0.00006902495,0.000015508216,0.000012346128,0.00032344856,8.231792e-7,0.00015720566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997309,0.0001272301,0.00002094964,0.000024328743,0.00003220672,0.00006438792],"domain_scores_gemma":[0.9990227,0.00024201201,0.00044197263,0.000028333374,0.000103409824,0.00016158186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006298837,0.00019328245,0.00018110458,0.00070832786,0.00045846935,0.0006028179,0.0003172643,0.0002798871,0.0011395378],"category_scores_gemma":[0.0022704548,0.0001148477,0.00024786234,0.0008745548,0.00022180962,0.00029187134,0.0007063342,0.00043095517,0.000042612508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006949474,0.000053764245,0.99451363,0.000025744877,0.000052776166,0.000044827684,0.0002905725,0.00009165452,0.000057824363,0.00018007454,0.0004564314,0.0041631656],"study_design_scores_gemma":[0.000012625222,0.000055234017,0.9975376,0.000037897255,0.00004879622,0.00004086513,0.0012579852,0.00028114291,0.000024526153,0.00008117381,0.00061878614,0.000003275753],"about_ca_topic_score_codex":0.11960087,"about_ca_topic_score_gemma":0.14398135,"teacher_disagreement_score":0.11960087,"about_ca_system_score_codex":0.00149849,"about_ca_system_score_gemma":0.0011813737,"threshold_uncertainty_score":0.23780942},"labels":[],"label_agreement":null},{"id":"W4239543405","doi":"10.1016/j.jval.2017.08.2852","title":"Modelling The Burden of Cardiovascular Disease In Colombia And The Impact of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Disease; Population; Obesity; Disease burden; Psychological intervention; Absenteeism; Internal medicine","score_opus":0.07365659251281628,"score_gpt":0.3187881141388855,"score_spread":0.24513152162606924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239543405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685582,0.0019475159,0.004245581,0.006567713,0.00014801232,0.00006333503,0.0052444334,0.00008586449,0.013139328],"genre_scores_gemma":[0.99491704,0.00048670472,0.001011146,0.00008711417,0.000027784792,0.000030161604,0.00074704067,0.00001179385,0.0026813026],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99960726,0.00019932486,0.000013439841,0.000052008356,0.000019293811,0.000108665794],"domain_scores_gemma":[0.99835193,0.0010595708,0.00015323564,0.00004443869,0.00018454525,0.00020615429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006496118,0.00076923065,0.0006313328,0.00074035954,0.00050199014,0.002072343,0.0009412644,0.0014855101,0.0051269387],"category_scores_gemma":[0.0036948605,0.00035815535,0.00074186205,0.00094212615,0.0005029267,0.00068576355,0.0007574026,0.0012093979,0.0002191999],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045811903,0.00018747793,0.059434615,0.00012520037,0.00019792648,0.00031284368,0.00018238589,0.9181617,0.0003105887,0.010694087,0.004142068,0.0057929624],"study_design_scores_gemma":[0.00024994573,0.00018544529,0.045419328,0.00009456293,0.00024424028,0.000105243766,0.0012270882,0.93972665,0.00020147736,0.0067670853,0.0056913425,0.000087633416],"about_ca_topic_score_codex":0.45822912,"about_ca_topic_score_gemma":0.33489463,"teacher_disagreement_score":0.45822912,"about_ca_system_score_codex":0.00496071,"about_ca_system_score_gemma":0.0035920541,"threshold_uncertainty_score":0.9111239},"labels":[],"label_agreement":null},{"id":"W4240963739","doi":"10.1016/j.jval.2011.08.908","title":"PIH3 Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Bronchopulmonary dysplasia; Pediatrics; Gestational age; Respiratory system; Intubation; Internal medicine; Pregnancy; Anesthesia","score_opus":0.1840139763475343,"score_gpt":0.3977114718368939,"score_spread":0.21369749548935962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240963739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92212206,0.0012671174,0.00023460148,0.0014184893,0.000089865964,0.00018484953,0.06189088,0.000048488808,0.012743548],"genre_scores_gemma":[0.9860092,0.00045912596,0.00021524998,0.00025188996,0.00002405219,0.00004385795,0.011875393,0.000009300808,0.0011119196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975393,0.0001451098,0.0001390316,0.00028119617,0.0010282688,0.0008671065],"domain_scores_gemma":[0.9964066,0.00013652787,0.0007060844,0.00015151335,0.0017823979,0.0008169172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011168997,0.000525241,0.0005131931,0.0023145291,0.0028232757,0.0014078752,0.0020191406,0.0008089218,0.0038280713],"category_scores_gemma":[0.004542919,0.00044963378,0.001051706,0.005285574,0.0005884862,0.000624988,0.0012651092,0.0012047522,0.00030794353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008287473,0.000020622581,0.99153566,0.000027844642,0.000076197575,0.00007334897,0.00017572896,0.00011207294,0.000107066175,0.00029027511,0.005379068,0.0021191],"study_design_scores_gemma":[0.000008746022,0.000009869164,0.9982079,0.000023122255,0.000022351926,0.00006561081,0.0004243105,0.00022644033,0.00003805463,0.000035552534,0.00092860364,0.000009353469],"about_ca_topic_score_codex":0.9926295,"about_ca_topic_score_gemma":0.9958332,"teacher_disagreement_score":0.027535347,"about_ca_system_score_codex":0.027535347,"about_ca_system_score_gemma":0.050172288,"threshold_uncertainty_score":0.19978386},"labels":[],"label_agreement":null},{"id":"W4241084954","doi":"10.1016/j.jval.2017.08.957","title":"Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Internal medicine; Pediatrics","score_opus":0.09008481767277333,"score_gpt":0.39372915698477035,"score_spread":0.303644339311997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241084954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937593,0.00062665826,0.00007126833,0.0013366536,0.000016816128,0.0000070471865,0.0032745362,0.0000045831034,0.0009032196],"genre_scores_gemma":[0.9981559,0.00025497572,0.000041233296,0.00009186211,0.000014176624,0.0000073826195,0.0012847559,0.0000017542451,0.00014789564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998874,0.0005187318,0.00015293069,0.00008736544,0.00011132896,0.00025564144],"domain_scores_gemma":[0.9968528,0.00064780534,0.001543971,0.00006212531,0.00022115003,0.0006720511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054501556,0.00023246842,0.0003314906,0.00072394527,0.00027721518,0.0010546669,0.00033708953,0.0010963249,0.0019752486],"category_scores_gemma":[0.0039187064,0.00021981416,0.0009698998,0.0018640822,0.00037066193,0.0009560283,0.0007968522,0.0011185884,0.00021396873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013266971,0.00021747965,0.9883475,0.00007010477,0.00028180378,0.00031386493,0.00015974094,0.0028057252,0.0001561187,0.00074281415,0.001824412,0.0037537266],"study_design_scores_gemma":[0.000033764318,0.0002231982,0.9933838,0.00003544502,0.00008125897,0.0004056814,0.0011793196,0.0035219602,0.000074873984,0.00018219877,0.00085510325,0.000023274913],"about_ca_topic_score_codex":0.025572382,"about_ca_topic_score_gemma":0.025350202,"teacher_disagreement_score":0.025572382,"about_ca_system_score_codex":0.0019655807,"about_ca_system_score_gemma":0.00061484246,"threshold_uncertainty_score":0.050847054},"labels":[],"label_agreement":null},{"id":"W4241389844","doi":"10.1016/s1098-3015(10)70320-x","title":"PIN22 PHARMACOECONOMIC ANALYSIS BASED ON GUIDELINES FOR TREATING MILD DIABETIC FOOT INFECTIONS: A DECISION TREE MODEL FOR CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diabetic foot; Medicine; Decision tree; Intensive care medicine; Tree (set theory); Foot (prosody); Decision tree model; Diabetes mellitus; Traditional medicine; Computer science; Data mining; Mathematics; Endocrinology","score_opus":0.14024203312818365,"score_gpt":0.3908647622137405,"score_spread":0.25062272908555683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241389844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8751081,0.001743784,0.08486064,0.0063099805,0.00016585834,0.001213982,0.015036954,0.0009455998,0.014615049],"genre_scores_gemma":[0.9598814,0.0006457478,0.030477624,0.0003166066,0.000034332385,0.00037002645,0.004019605,0.0000687862,0.004185845],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998701,0.0006954879,0.000054875953,0.0001739821,0.00016834066,0.00020627672],"domain_scores_gemma":[0.98818237,0.009278032,0.00034086787,0.00013373062,0.0016266389,0.0004383813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046056556,0.0010647933,0.0017923743,0.0029580265,0.0011378521,0.0023917083,0.0014786609,0.0012910302,0.0059735845],"category_scores_gemma":[0.012820319,0.00066363,0.0020540906,0.0027953323,0.0006127914,0.00076687866,0.00058961497,0.0015546298,0.00034195388],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009719507,0.00027274803,0.018961292,0.00011979273,0.00029644492,0.00017881623,0.000083347506,0.9496825,0.00009278103,0.0036786327,0.004545939,0.021115815],"study_design_scores_gemma":[0.000104954845,0.00004377197,0.001927502,0.000013460252,0.00008278165,0.000018754195,0.00003666424,0.9958139,0.000029203948,0.0015657932,0.00034922978,0.000013993751],"about_ca_topic_score_codex":0.8107397,"about_ca_topic_score_gemma":0.70821214,"teacher_disagreement_score":0.1892603,"about_ca_system_score_codex":0.014538612,"about_ca_system_score_gemma":0.018468177,"threshold_uncertainty_score":0.38074976},"labels":[],"label_agreement":null},{"id":"W4241968959","doi":"10.1016/j.jval.2014.08.2267","title":"Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Ofatumumab; Chlorambucil; Medicine; Fludarabine; Population; Time horizon; Quality-adjusted life year; Cost effectiveness; Chronic lymphocytic leukemia; Internal medicine; Oncology; Leukemia; Chemotherapy; Mathematics; Risk analysis (engineering); Environmental health","score_opus":0.05877112671093143,"score_gpt":0.329355149885676,"score_spread":0.27058402317474456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241968959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95575345,0.01997874,0.00021703308,0.009217007,0.0002331587,0.00029969536,0.005802379,0.00003633717,0.008462226],"genre_scores_gemma":[0.99299943,0.0041192053,0.00028318254,0.00047939993,0.00004515611,0.000033805627,0.0010371271,0.0000070206825,0.0009956734],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99829286,0.00038806954,0.00011066355,0.000132738,0.00042517134,0.0006504783],"domain_scores_gemma":[0.9959487,0.00068648095,0.00055896933,0.000045806613,0.0011394994,0.0016204901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009190864,0.0004420113,0.0010688254,0.0010350025,0.0012718721,0.002149439,0.0015154862,0.00086778833,0.0035958875],"category_scores_gemma":[0.006929875,0.00029738262,0.001814209,0.0023182174,0.00080293324,0.0005905832,0.00078657386,0.001411955,0.00010155194],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06348305,0.0024400556,0.55692834,0.004442267,0.0055155545,0.001484286,0.0010063804,0.054949082,0.0015530171,0.009176131,0.042418614,0.2566033],"study_design_scores_gemma":[0.016076125,0.0055234446,0.8928125,0.0024373436,0.008020569,0.0011379748,0.004089886,0.044045422,0.0011277302,0.0018840918,0.022567667,0.00027742426],"about_ca_topic_score_codex":0.9889609,"about_ca_topic_score_gemma":0.9933164,"teacher_disagreement_score":0.12471476,"about_ca_system_score_codex":0.12471476,"about_ca_system_score_gemma":0.113868676,"threshold_uncertainty_score":0.9048732},"labels":[],"label_agreement":null},{"id":"W4242632056","doi":"10.1016/j.jval.2014.03.922","title":"Psychiatric Health Care Utilisation And Related Costs In Newly Diagnosed Patients With Autism Spectrum Disorder (Asd) In Quebec (Canada)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hôpital Rivière-des-Prairies; Université de Montréal","funders":"","keywords":"Medicine; Cohort; Psychiatry; Cohort study; Pediatrics; Public health; Autism spectrum disorder; Autism; Internal medicine","score_opus":0.011603267159437824,"score_gpt":0.2606169778665502,"score_spread":0.24901371070711237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242632056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852384,0.001914779,0.000070754824,0.0014240276,0.000035198962,0.00004730192,0.008481439,0.000011564493,0.0027764994],"genre_scores_gemma":[0.9948559,0.0009938888,0.00012852982,0.00036066506,0.000016451299,0.00002182825,0.0022010973,0.000004798653,0.0014168705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992976,0.00007590923,0.0000857271,0.00008229361,0.000164682,0.0002937138],"domain_scores_gemma":[0.9973584,0.00020559256,0.0007090762,0.000037406637,0.00083436054,0.00085507025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032806437,0.00032094843,0.00044469014,0.0010837085,0.0021222127,0.0016399926,0.0014570443,0.0010711032,0.004217774],"category_scores_gemma":[0.002408095,0.00037408082,0.0010682325,0.0038585456,0.0005779061,0.00070280075,0.00089147664,0.0014380298,0.00028095735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000069213,0.000055051325,0.99385697,0.00004554936,0.00008391747,0.0001909868,0.00031296766,0.00028551876,0.00005179703,0.0001216792,0.0018839441,0.0030423517],"study_design_scores_gemma":[0.000012313782,0.000024837616,0.99731535,0.000062497165,0.000032012285,0.000103980274,0.0013431341,0.0004757062,0.00001875219,0.000023106804,0.000575674,0.000012571125],"about_ca_topic_score_codex":0.99610436,"about_ca_topic_score_gemma":0.9977962,"teacher_disagreement_score":0.04555463,"about_ca_system_score_codex":0.04555463,"about_ca_system_score_gemma":0.025789272,"threshold_uncertainty_score":0.33052355},"labels":[],"label_agreement":null},{"id":"W4244538003","doi":"10.1016/j.jval.2017.08.2846","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Spouse; Caregiver burden; Medicine; Anxiety; Daughter; Family caregivers; Heart failure; Disease; Family medicine; Psychiatry; Gerontology; Internal medicine","score_opus":0.04086998790194693,"score_gpt":0.3513212728027999,"score_spread":0.31045128490085294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244538003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99258476,0.0014655906,0.00015123219,0.0018417404,0.000021652133,0.00003433583,0.00030035552,0.0000029563237,0.003597489],"genre_scores_gemma":[0.9989833,0.0006780428,0.00013342754,0.000054029886,0.0000049487053,0.000010650373,0.00005494761,8.270612e-7,0.00007971213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992649,0.00037294364,0.00007891171,0.000045734578,0.00012293205,0.00011465086],"domain_scores_gemma":[0.9975057,0.00079509837,0.00076061307,0.000086787106,0.00046779908,0.00038404798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001468096,0.00021692966,0.00028286348,0.0008023037,0.0006552069,0.0006829193,0.00035239055,0.00024862803,0.00087697426],"category_scores_gemma":[0.009200702,0.00019285241,0.00037769138,0.00090968725,0.00055784814,0.00037454168,0.0010043819,0.0005272582,0.000048540358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035465102,0.00006510737,0.97161746,0.00017012666,0.00007874769,0.00020759545,0.007899374,0.000082542305,0.00017913058,0.0007711298,0.0007437655,0.018149566],"study_design_scores_gemma":[0.000013403121,0.000075038246,0.98020685,0.0004930721,0.00008413925,0.00032433792,0.01440432,0.0004499582,0.00009272766,0.0005043552,0.0033352126,0.000016693215],"about_ca_topic_score_codex":0.122171074,"about_ca_topic_score_gemma":0.16245581,"teacher_disagreement_score":0.122171074,"about_ca_system_score_codex":0.0026266326,"about_ca_system_score_gemma":0.0032924628,"threshold_uncertainty_score":0.24291992},"labels":[],"label_agreement":null},{"id":"W4246859680","doi":"10.1016/j.jval.2019.04.414","title":"PCN295 PATIENT-CENTERED OUTCOMES IN ARIEL3, A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH RECURRENT OVARIAN CARCINOMA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Confidence interval; Nausea; Adverse effect; Vomiting","score_opus":0.0278019643634444,"score_gpt":0.31318732152585166,"score_spread":0.28538535716240726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246859680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98672754,0.007526633,0.0005652789,0.0005891628,0.0002840378,0.0010421952,0.0011210999,0.00014114348,0.0020028928],"genre_scores_gemma":[0.99388313,0.0018664297,0.000662281,0.0006453412,0.00019252265,0.0007944943,0.000831874,0.000017367902,0.0011065825],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993771,0.00033779733,0.000031825482,0.00009503383,0.00006496536,0.000093332674],"domain_scores_gemma":[0.99917346,0.00026823292,0.00022657895,0.00006520783,0.0000534303,0.0002130596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016056518,0.0009389029,0.0021577494,0.0003303958,0.0003669959,0.00080362556,0.0006817127,0.0010586098,0.0043098764],"category_scores_gemma":[0.0015640766,0.0003256447,0.0019879295,0.0003970668,0.0006783223,0.0007563016,0.00030739442,0.0034366813,0.0004813782],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9323715,0.0076618562,0.0021898528,0.0009690316,0.0027705007,0.00004931931,0.000053486358,0.0008489746,0.0033379951,0.00017875504,0.0016871926,0.047881637],"study_design_scores_gemma":[0.8497001,0.1327943,0.011489524,0.00007536782,0.001794105,0.00007467632,0.000055290606,0.0014114152,0.0009141413,0.00029318617,0.0013607437,0.000037191014],"about_ca_topic_score_codex":0.0010718992,"about_ca_topic_score_gemma":0.0032096943,"teacher_disagreement_score":0.0043098764,"about_ca_system_score_codex":0.00059173827,"about_ca_system_score_gemma":0.0009078481,"threshold_uncertainty_score":0.014417946},"labels":[],"label_agreement":null},{"id":"W4248792744","doi":"10.1016/j.jval.2014.08.253","title":"Antithrombotic Therapy and Direct Medical Costs in Patients with Acute Coronary Syndrome in Shanghai, China","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Antithrombotic; Acute coronary syndrome; Medical record; Emergency medicine; Comorbidity; Emergency department; Retrospective cohort study; Internal medicine; Cohort; Hyperlipidemia; Diabetes mellitus; Myocardial infarction","score_opus":0.011740001394551919,"score_gpt":0.25301597810182797,"score_spread":0.24127597670727605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248792744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99917525,0.00026939576,0.000018321494,0.00011143669,0.0000063251846,0.000003033239,0.00017912283,0.0000015557666,0.00023542356],"genre_scores_gemma":[0.9995245,0.000110118825,0.000014317107,0.000028195995,0.000010036482,0.0000027882588,0.0002011432,5.3931956e-7,0.000108404354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996118,0.00009272267,0.00006307815,0.000046638477,0.000053299296,0.00013255741],"domain_scores_gemma":[0.9989248,0.00012650972,0.00033935253,0.00003591601,0.00013178664,0.000441511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037203674,0.0004576321,0.0004252483,0.0015022033,0.0008157961,0.0009045114,0.0003698535,0.0005416741,0.0011517253],"category_scores_gemma":[0.0010424481,0.0003778567,0.0006451704,0.0026593818,0.0005159402,0.0004018873,0.0005348993,0.00069399923,0.00009509663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047334703,0.000023313858,0.99909484,0.000008611129,0.000057065794,0.00013740697,0.00009311361,0.00006657391,0.00003868028,0.000024803774,0.00008661778,0.00032168385],"study_design_scores_gemma":[0.000009164146,0.000031824904,0.99908435,0.0000047991034,0.00005366605,0.00008963388,0.00037430442,0.00022931397,0.00000956288,0.000027069967,0.00008128487,0.000005066278],"about_ca_topic_score_codex":0.14492804,"about_ca_topic_score_gemma":0.1435956,"teacher_disagreement_score":0.14492804,"about_ca_system_score_codex":0.0022152797,"about_ca_system_score_gemma":0.0025014766,"threshold_uncertainty_score":0.2881689},"labels":[],"label_agreement":null},{"id":"W4249181773","doi":"10.1016/j.jval.2017.08.443","title":"Economic Burden of Cardiovascular Disease In Type 2 Diabetes: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Indirect costs; Disease burden; Disease; Type 2 diabetes; Population; Burden of disease; MEDLINE; Coronary artery disease; Environmental health; Diabetes mellitus; Demography; Internal medicine; Accounting; Business","score_opus":0.10946144812439924,"score_gpt":0.3608086619003093,"score_spread":0.25134721377591007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249181773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007808359,0.99850595,0.000057577727,0.00016708722,0.00007924658,0.000037696922,0.00023868993,0.000002771049,0.00013010208],"genre_scores_gemma":[0.011398489,0.9878805,0.00020425091,0.00025099822,0.000074091906,0.000045434845,0.000100033954,0.0000018184373,0.000044340886],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99714345,0.00089876936,0.00096385996,0.00025533733,0.0006077815,0.00013070102],"domain_scores_gemma":[0.9900067,0.0074426667,0.0017842556,0.000101629936,0.00052242813,0.0001422723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037157005,0.0013323018,0.0067515764,0.0055205193,0.00037949253,0.0020360267,0.0012709844,0.0015513772,0.004619163],"category_scores_gemma":[0.018828904,0.00091628754,0.007605531,0.0073525924,0.0005056717,0.0016888035,0.0015919753,0.0016558967,0.00019960252],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048307687,0.000039288538,0.0036119132,0.8778461,0.051424924,0.00016581967,0.00013089448,0.00024763084,0.00009039988,0.00044905135,0.0033481168,0.062162776],"study_design_scores_gemma":[0.0007944025,0.00024441694,0.022615666,0.568011,0.3782762,0.0007886189,0.00044896093,0.00029043615,0.00013210805,0.001422984,0.02685895,0.00011636723],"about_ca_topic_score_codex":0.0102213295,"about_ca_topic_score_gemma":0.02917665,"teacher_disagreement_score":0.0102213295,"about_ca_system_score_codex":0.0020788952,"about_ca_system_score_gemma":0.004649983,"threshold_uncertainty_score":0.020323694},"labels":[],"label_agreement":null},{"id":"W4249416452","doi":"10.1016/j.jval.2013.03.1149","title":"Empirical Comparison Of Discrete Choice Experiment And Best-Worst Scaling To Estimate Stakeholders' Risk Tolerance For Hip Replacement Surgery","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Logit; Mixed logit; Medicine; Population; Hip replacement; Arthroplasty; Physical therapy; Logistic regression; Statistics; Surgery; Mathematics; Environmental health","score_opus":0.3436284322013221,"score_gpt":0.3635771169670837,"score_spread":0.019948684765761615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249416452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98719317,0.00008503126,0.011677965,0.00015128336,0.00004103358,0.00006744236,0.000105043866,0.000024077854,0.0006548877],"genre_scores_gemma":[0.9954491,0.000019153471,0.004130797,0.00003228866,0.000012102787,0.00007619499,0.000115276045,0.000005163727,0.00015991983],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9820113,0.015573663,0.00049170793,0.0009257715,0.0006702257,0.00032733267],"domain_scores_gemma":[0.4496001,0.52915883,0.008272554,0.00928054,0.0024830897,0.0012048341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.046658184,0.0007064689,0.00088534923,0.00089544756,0.00045775925,0.0015170852,0.0012497439,0.0016885245,0.002521976],"category_scores_gemma":[0.1419873,0.00043216057,0.0012638675,0.0007789454,0.0019557357,0.0025565068,0.0009570582,0.0020403748,0.0002469212],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045959756,0.019506536,0.5199683,0.00085073814,0.0029623844,0.0003133911,0.0038042427,0.26753592,0.0037895672,0.035672717,0.0025260854,0.09711036],"study_design_scores_gemma":[0.001770571,0.009636302,0.16976725,0.000098773955,0.00046553178,0.00014067988,0.002132872,0.7864186,0.0026974035,0.025468986,0.0012249436,0.00017807176],"about_ca_topic_score_codex":0.0022967095,"about_ca_topic_score_gemma":0.0013349564,"teacher_disagreement_score":0.046658184,"about_ca_system_score_codex":0.0011542641,"about_ca_system_score_gemma":0.0008216462,"threshold_uncertainty_score":0.246755},"labels":[],"label_agreement":null},{"id":"W4249427946","doi":"10.1016/j.jval.2013.08.696","title":"The Impact of Memory Problems on Diabetes Treatment in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cognitive Functions and Memory","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Forgetting; Diabetes mellitus; Medicine; Insulin; Internal medicine; Demography; Endocrinology; Psychology","score_opus":0.043670895939709235,"score_gpt":0.31678220050994527,"score_spread":0.273111304570236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249427946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9237664,0.010135984,0.000066130444,0.0353095,0.0003647832,0.00007171652,0.0069092833,0.000017243457,0.023358818],"genre_scores_gemma":[0.99133646,0.0034478845,0.0000855019,0.0017944687,0.00006807139,0.000012967514,0.00086874573,0.0000075463176,0.0023783224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829155,0.00013843959,0.000100786216,0.00007704566,0.00044180418,0.00095043523],"domain_scores_gemma":[0.99309784,0.00039895697,0.000998595,0.00006307139,0.0020182142,0.003423259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000490004,0.000154774,0.00041741267,0.0011865427,0.0037734606,0.0023830181,0.0012675618,0.0009699451,0.0063456227],"category_scores_gemma":[0.0047497195,0.00029623884,0.00088022003,0.004164652,0.00093551766,0.00051338214,0.0013952983,0.0023902932,0.00018271942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048737368,0.00038098719,0.9388845,0.00018394405,0.00019958618,0.0006816168,0.0011547967,0.00042984786,0.00015590149,0.0016102471,0.014677487,0.041153733],"study_design_scores_gemma":[0.000051646366,0.00004143922,0.9917101,0.00017230614,0.0000726438,0.0001459309,0.003210788,0.00025190634,0.000052216095,0.00014241306,0.004125842,0.000022861659],"about_ca_topic_score_codex":0.9971414,"about_ca_topic_score_gemma":0.99852055,"teacher_disagreement_score":0.05504838,"about_ca_system_score_codex":0.05504838,"about_ca_system_score_gemma":0.10316424,"threshold_uncertainty_score":0.39940578},"labels":[],"label_agreement":null},{"id":"W4249486415","doi":"10.1016/j.jval.2020.08.505","title":"PCV14 Comparative Effectiveness and Safety of High Dose of ORAL Anticoagulant in Patients with NON-Valvular Atrial Fibrillation","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Apixaban; Warfarin; Atrial fibrillation; Rivaroxaban; Internal medicine; Hazard ratio; Dabigatran; Cohort; Propensity score matching; Stroke (engine); Population; Censoring (clinical trials); Confidence interval","score_opus":0.06981529492529387,"score_gpt":0.34197775896764976,"score_spread":0.2721624640423559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249486415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99021226,0.0073487884,0.00014650906,0.0002192323,0.00015711428,0.00009101101,0.00034966765,0.0000063295256,0.0014692028],"genre_scores_gemma":[0.99734783,0.0011692952,0.00017297527,0.00019773356,0.00021960666,0.000053358723,0.00049916725,0.0000031081493,0.00033698688],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99729484,0.0016221945,0.00026361327,0.00031752922,0.00023834493,0.0002635351],"domain_scores_gemma":[0.9944747,0.0035359126,0.0008303518,0.00030932136,0.00022521663,0.000624521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021917745,0.00053644663,0.0018573295,0.0006107265,0.00019820705,0.0014385236,0.00066443847,0.00116963,0.0039379257],"category_scores_gemma":[0.0070451377,0.00030368712,0.003469556,0.0006399991,0.00069398165,0.0012393679,0.0005857599,0.0016182015,0.00025976184],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8870509,0.002024573,0.04682628,0.0008154841,0.011261706,0.00013797682,0.000088566274,0.0010409572,0.0012893035,0.00044506683,0.0005099238,0.048509188],"study_design_scores_gemma":[0.30547297,0.3301783,0.3266572,0.0006598311,0.021992333,0.00077247864,0.0005250455,0.0050888993,0.0026159484,0.0020311482,0.003803519,0.00020239288],"about_ca_topic_score_codex":0.0008783667,"about_ca_topic_score_gemma":0.0013549177,"teacher_disagreement_score":0.0039379257,"about_ca_system_score_codex":0.0008218509,"about_ca_system_score_gemma":0.000900623,"threshold_uncertainty_score":0.013173699},"labels":[],"label_agreement":null},{"id":"W4249632297","doi":"10.1016/j.jval.2017.08.1381","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Heart failure; Medicine; Internal medicine; Ejection fraction; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","score_opus":0.05380732864162632,"score_gpt":0.36163250280887577,"score_spread":0.3078251741672494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249632297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8834587,0.061550498,0.0022347984,0.033299524,0.00031950703,0.00016557804,0.001848435,0.00010466585,0.017018346],"genre_scores_gemma":[0.99087596,0.0065059583,0.0012050117,0.0006906288,0.000110389425,0.000029061293,0.00017111265,0.00000967798,0.0004022329],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994128,0.0002836097,0.000056782774,0.000053557844,0.00008622922,0.00010702751],"domain_scores_gemma":[0.9989779,0.00022967646,0.0003295198,0.00004699731,0.0001979125,0.00021796988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009807022,0.00018632735,0.0004007482,0.00048571083,0.00024089354,0.00060318084,0.00045967186,0.0003028183,0.0017771171],"category_scores_gemma":[0.0024963217,0.00010509272,0.00045012566,0.0004858396,0.00041811494,0.00024664123,0.0003456792,0.0007004644,0.000091799084],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053547085,0.00209511,0.341129,0.005289708,0.0015507349,0.0025197656,0.0021707818,0.0021507666,0.0149645815,0.023094647,0.013218942,0.58646125],"study_design_scores_gemma":[0.0020834426,0.003489832,0.9151732,0.0025824415,0.0025162145,0.002514466,0.0026098278,0.004516738,0.0036676123,0.007345012,0.053379662,0.00012155041],"about_ca_topic_score_codex":0.039019488,"about_ca_topic_score_gemma":0.07005921,"teacher_disagreement_score":0.039019488,"about_ca_system_score_codex":0.0017038146,"about_ca_system_score_gemma":0.004375337,"threshold_uncertainty_score":0.07758474},"labels":[],"label_agreement":null},{"id":"W4250343618","doi":"10.1016/j.jval.2017.08.796","title":"Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Quality of life (healthcare); Presenteeism; Internal medicine; Axial spondyloarthritis; Psoriasis; Physical therapy; Disease; Absenteeism; Dermatology","score_opus":0.0407107101428829,"score_gpt":0.36507900828323436,"score_spread":0.32436829814035145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250343618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851172,0.007508551,0.0003714649,0.001471798,0.000018762277,0.00005972843,0.00093335385,0.000004355743,0.004514736],"genre_scores_gemma":[0.9986236,0.0010277515,0.00015855968,0.000031449763,0.000004084586,0.000008025874,0.00009263914,8.358536e-7,0.000053119198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849963,0.0007382395,0.00017747715,0.00011606503,0.00029936692,0.00016926366],"domain_scores_gemma":[0.9968184,0.0011484785,0.0010639797,0.00014058918,0.00051917124,0.00030928457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026257345,0.00029282543,0.0003701889,0.0016534786,0.00034242173,0.0007121246,0.00043023808,0.00029341815,0.0004860719],"category_scores_gemma":[0.009692957,0.00024279539,0.0004870851,0.0020143795,0.00070257304,0.00048243772,0.00095773995,0.00038981042,0.000039169183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051838797,0.000036008303,0.9836452,0.00023162364,0.00020443268,0.000079311205,0.0017764741,0.00013678365,0.00029650412,0.000690274,0.00019752618,0.012653932],"study_design_scores_gemma":[0.000009132615,0.00006183165,0.9956819,0.00024621934,0.00012925963,0.00013470724,0.0017069858,0.0003245109,0.00009376481,0.00040563243,0.0011963145,0.000009724586],"about_ca_topic_score_codex":0.12830958,"about_ca_topic_score_gemma":0.14582643,"teacher_disagreement_score":0.12830958,"about_ca_system_score_codex":0.0026231036,"about_ca_system_score_gemma":0.0029348026,"threshold_uncertainty_score":0.25512546},"labels":[],"label_agreement":null},{"id":"W4250372619","doi":"10.1016/j.jval.2017.08.2853","title":"Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for The Treatment of Heart Failure In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Valsartan; Sacubitril; Sacubitril, Valsartan; Ejection fraction; Medicine; Heart failure; Internal medicine; Cardiology; Number needed to treat; Population; Blood pressure; Relative risk; Confidence interval","score_opus":0.063597866338838,"score_gpt":0.35326783955731994,"score_spread":0.2896699732184819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250372619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9045839,0.04520066,0.0020238287,0.023545314,0.00079239917,0.0001039351,0.0025092482,0.000103789986,0.02113704],"genre_scores_gemma":[0.9836374,0.009814848,0.0019591227,0.0009829701,0.00043271412,0.00004169314,0.00085513934,0.00002061611,0.0022555923],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99961686,0.0001871984,0.000029934637,0.000031166066,0.0000461838,0.00008859695],"domain_scores_gemma":[0.9995951,0.00007504755,0.00009467331,0.000018548542,0.000096520525,0.00012015541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055925926,0.00016031147,0.00028669744,0.0002847581,0.00020253591,0.00050615973,0.0002595675,0.00025880788,0.0022158057],"category_scores_gemma":[0.0010935907,0.00006466314,0.00023958863,0.0002810621,0.00027494575,0.00013696136,0.0002421617,0.00072397734,0.00015000996],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02339261,0.002443989,0.32827744,0.002445015,0.0008514455,0.0048772544,0.0006401331,0.003662952,0.017633747,0.01913614,0.03695131,0.559688],"study_design_scores_gemma":[0.0027809085,0.0032192585,0.88932586,0.0006242641,0.000769459,0.0024627056,0.0007585529,0.003943541,0.0033304584,0.0033418469,0.089384876,0.00005824364],"about_ca_topic_score_codex":0.020639969,"about_ca_topic_score_gemma":0.033150744,"teacher_disagreement_score":0.020639969,"about_ca_system_score_codex":0.0013200961,"about_ca_system_score_gemma":0.0021715052,"threshold_uncertainty_score":0.041039646},"labels":[],"label_agreement":null},{"id":"W4251588635","doi":"10.1016/j.jval.2013.03.304","title":"Nice's selective application of differential discounting: Ambiguous, inconsistent and unjustified","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Discounting; Nice; Differential (mechanical device); Life expectancy; Actuarial science; Psychological intervention; Medicine; Economics; Computer science; Psychiatry; Environmental health; Engineering; Finance","score_opus":0.2286926043882996,"score_gpt":0.38317678095816954,"score_spread":0.15448417656986993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251588635","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021632036,0.014331184,0.20107241,0.61997044,0.0111302845,0.00037858018,0.0014090181,0.001175681,0.1289003],"genre_scores_gemma":[0.62779826,0.0042237947,0.16757971,0.18063144,0.007905089,0.00046614883,0.00045273642,0.0009806111,0.009962168],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8564941,0.09535974,0.009032401,0.005415938,0.030782716,0.00291505],"domain_scores_gemma":[0.64674187,0.29840806,0.007390529,0.026411263,0.017047837,0.0040005394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11033807,0.0010723706,0.0026048834,0.0021901128,0.0014963512,0.010731451,0.0047660307,0.01404722,0.0053296923],"category_scores_gemma":[0.46602985,0.0013401577,0.0034319907,0.0019501472,0.009465926,0.009506649,0.0061687664,0.022951448,0.00083811034],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011516331,0.0000795849,0.003557562,0.00083093083,0.00079947413,0.00031301202,0.0011281706,0.005045542,0.0003387819,0.6576224,0.18311939,0.14601357],"study_design_scores_gemma":[0.00054401276,0.00017345279,0.0024731795,0.0014400018,0.0006574061,0.00067065493,0.00022243167,0.013593644,0.0011461452,0.8417745,0.13704655,0.00025796692],"about_ca_topic_score_codex":0.007545073,"about_ca_topic_score_gemma":0.008735882,"teacher_disagreement_score":0.11033807,"about_ca_system_score_codex":0.0042315978,"about_ca_system_score_gemma":0.008261051,"threshold_uncertainty_score":0.5835304},"labels":[],"label_agreement":null},{"id":"W4252345673","doi":"10.1016/j.jval.2014.08.2528","title":"Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Vaccination; Influenza vaccine; Cost effectiveness; Demography; Virology","score_opus":0.2795574574424417,"score_gpt":0.4684477307636322,"score_spread":0.18889027332119052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252345673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97596765,0.019541029,0.00019914596,0.0010379291,0.00018354304,0.00009245563,0.0011766842,0.000007692136,0.0017938877],"genre_scores_gemma":[0.996999,0.0019785576,0.00014522886,0.00027681474,0.000024078365,0.00003775234,0.00034290424,0.0000019032419,0.00019372335],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9965784,0.002630373,0.0001914181,0.00014884985,0.00023079744,0.00022014657],"domain_scores_gemma":[0.9960074,0.002626647,0.0005388309,0.00014177733,0.00028603995,0.00039933407],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042522466,0.0004784548,0.001461929,0.00082319474,0.00022620843,0.0009303949,0.00058829976,0.00078351266,0.0027350632],"category_scores_gemma":[0.009484486,0.00029930542,0.002866045,0.0010281751,0.0004636987,0.0010111217,0.00049034134,0.0010237249,0.000098206096],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5219835,0.010393577,0.17870902,0.003733533,0.029930973,0.00035165754,0.00033923748,0.045702104,0.0022275762,0.003992541,0.006069463,0.19656675],"study_design_scores_gemma":[0.07966973,0.1237597,0.65050346,0.0027866107,0.07534767,0.0007397362,0.0027717007,0.048809722,0.00430245,0.004915875,0.006110552,0.0002828084],"about_ca_topic_score_codex":0.024871912,"about_ca_topic_score_gemma":0.026585907,"teacher_disagreement_score":0.024871912,"about_ca_system_score_codex":0.0035067645,"about_ca_system_score_gemma":0.0018586305,"threshold_uncertainty_score":0.04945427},"labels":[],"label_agreement":null},{"id":"W4252898622","doi":"10.1016/j.jval.2018.09.1922","title":"PMU86 - VALUING HEALTH-STATE: AN EQ-5D-5L VALUE SET FOR ETHIOPIANS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"EQ-5D; Population; Valuation (finance); Context (archaeology); Medicine; Statistics; Psychology; Mathematics; Geography; Environmental health; Economics","score_opus":0.5698953724552035,"score_gpt":0.46620168362564907,"score_spread":0.10369368882955443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252898622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82619154,0.0011236337,0.07489098,0.0027551495,0.00017732086,0.000535127,0.04125844,0.00027584608,0.052791923],"genre_scores_gemma":[0.96381277,0.00021769996,0.027466968,0.00009470285,0.000018677072,0.00024367243,0.0063140867,0.000022562155,0.0018088453],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9987005,0.000744753,0.00006616598,0.00008583084,0.00025308007,0.0001495598],"domain_scores_gemma":[0.9976803,0.0012817505,0.00018996594,0.0002017671,0.0005138143,0.00013243736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039409813,0.00052105583,0.0005295678,0.0017534731,0.00046786582,0.0021456766,0.00075865415,0.0006805751,0.00319111],"category_scores_gemma":[0.011533905,0.00024104219,0.0007693985,0.0018835461,0.00036602208,0.0011842054,0.0011955433,0.0008088891,0.000512506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018922713,0.00092431455,0.17332031,0.00077456963,0.0006022645,0.00057868694,0.00089480093,0.323803,0.0017892146,0.14272091,0.050984647,0.301715],"study_design_scores_gemma":[0.00032869726,0.00093588,0.14106576,0.0012917292,0.0003255162,0.00061618135,0.0030613816,0.67354006,0.007038801,0.10377734,0.06777724,0.0002414009],"about_ca_topic_score_codex":0.009070652,"about_ca_topic_score_gemma":0.004130905,"teacher_disagreement_score":0.009070652,"about_ca_system_score_codex":0.002315137,"about_ca_system_score_gemma":0.0013143703,"threshold_uncertainty_score":0.020842195},"labels":[],"label_agreement":null},{"id":"W4252916761","doi":"10.1016/j.jval.2017.08.2678","title":"Burden of Disease for Psoriasis In Argentina, Brazil, Colombia and Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Latin Americans; Population; Epidemiology; Depression (economics); Disease; MEDLINE; Anxiety; Psychological intervention; Family medicine; Environmental health; Dermatology; Psychiatry; Internal medicine","score_opus":0.039352777556383604,"score_gpt":0.3087343521731895,"score_spread":0.2693815746168059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252916761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892418,0.003983482,0.00006856368,0.00071352115,0.000013705453,0.000019167908,0.0024001747,0.000007016937,0.003552606],"genre_scores_gemma":[0.99755883,0.0014648773,0.00011183341,0.000028798431,0.000013331525,0.000009429903,0.0004765324,0.0000016848956,0.00033459676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977964,0.00006397013,0.000022367702,0.000031096795,0.000044708126,0.000058171365],"domain_scores_gemma":[0.99948055,0.00007136142,0.00027041358,0.000018723347,0.00006962189,0.00008940557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030079525,0.00017149189,0.00023885533,0.0012033478,0.00039680852,0.00072765193,0.0001738686,0.00022844109,0.0015766263],"category_scores_gemma":[0.0008340485,0.0001321445,0.00025889225,0.00106301,0.0002183915,0.00018847028,0.00039903825,0.0002751988,0.0000615966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010336497,0.000031173222,0.99149984,0.000060487895,0.0000827633,0.00011433616,0.0003577056,0.00006215259,0.00032167323,0.00031151008,0.0005759984,0.006479105],"study_design_scores_gemma":[0.0000040372,0.000014653967,0.99847525,0.00002604951,0.000025391315,0.00009201831,0.0005163018,0.00004515738,0.000020798569,0.000024377241,0.0007540128,0.0000019091838],"about_ca_topic_score_codex":0.15147965,"about_ca_topic_score_gemma":0.24642554,"teacher_disagreement_score":0.15147965,"about_ca_system_score_codex":0.0014375192,"about_ca_system_score_gemma":0.00080500817,"threshold_uncertainty_score":0.30119592},"labels":[],"label_agreement":null},{"id":"W4253038084","doi":"10.1016/j.jval.2017.08.1209","title":"Modelling The Burden Of Cardiovascular Disease In Mexico And The Impact Of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Population; Disease; Disease burden; Obesity; Psychological intervention; Absenteeism; Internal medicine","score_opus":0.07655966887107223,"score_gpt":0.3211138911252003,"score_spread":0.24455422225412804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253038084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97828525,0.0007713087,0.004033718,0.005714573,0.000107618136,0.00003546846,0.0041845483,0.000055167202,0.00681238],"genre_scores_gemma":[0.99321365,0.0005148099,0.0017549979,0.00010862214,0.000044860422,0.00004392202,0.0010498397,0.000013170752,0.0032561217],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996824,0.00015567124,0.000009791763,0.000047965554,0.000012336231,0.00009182142],"domain_scores_gemma":[0.9985909,0.00088233297,0.0001978781,0.00004807979,0.00012894042,0.00015185794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084753305,0.00060906605,0.0006680879,0.00054003706,0.0004575551,0.0017460454,0.0011734504,0.0017745144,0.005018259],"category_scores_gemma":[0.0034133645,0.000418977,0.0010230376,0.0009950574,0.00046441643,0.0007238642,0.0008200997,0.0012876176,0.0001895742],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004566347,0.0002198767,0.046024907,0.00005227582,0.00024395855,0.00019057363,0.00013062544,0.935804,0.00019166483,0.010631994,0.0025591566,0.0034943367],"study_design_scores_gemma":[0.00033163198,0.00023511842,0.033978745,0.00006124593,0.00033677972,0.000065181404,0.0008678551,0.95396554,0.00015425636,0.006387103,0.0035647913,0.00005182061],"about_ca_topic_score_codex":0.29164627,"about_ca_topic_score_gemma":0.18285082,"teacher_disagreement_score":0.29164627,"about_ca_system_score_codex":0.0031054206,"about_ca_system_score_gemma":0.002917085,"threshold_uncertainty_score":0.5798974},"labels":[],"label_agreement":null},{"id":"W4254935015","doi":"10.1016/s1098-3015(10)66761-7","title":"PHC7 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Total hip replacement; Medicine; Enoxaparin sodium; Surgery; Low molecular weight heparin; Thrombosis","score_opus":0.03896411178915887,"score_gpt":0.2812575138109857,"score_spread":0.2422934020218268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254935015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742848,0.0075098933,0.0001534921,0.0043292143,0.0001271941,0.0001705187,0.005034802,0.000027770393,0.008362338],"genre_scores_gemma":[0.9943836,0.0019025891,0.00020852167,0.00045492031,0.00004240263,0.000023855779,0.0013012826,0.000007738924,0.0016750817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981635,0.00032850404,0.00012002933,0.00013482705,0.00056561345,0.0006875042],"domain_scores_gemma":[0.99650097,0.00058985985,0.00046688042,0.000045541317,0.0013223095,0.0010745421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089872297,0.00037241558,0.00084313186,0.0010303289,0.0011801679,0.0015989953,0.0010680433,0.00084703526,0.0052556796],"category_scores_gemma":[0.006405839,0.00035254078,0.0015394819,0.001998402,0.0006871183,0.00048617015,0.00062337704,0.00093531626,0.00013964926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07288187,0.0025321266,0.64586514,0.0020255418,0.0037743656,0.0011006958,0.00071331795,0.030369993,0.0014856631,0.0074462136,0.0358736,0.19593145],"study_design_scores_gemma":[0.007107316,0.003514584,0.9487387,0.00051512726,0.0024341778,0.00048262632,0.0018020547,0.025663432,0.00095833355,0.0007431258,0.007884071,0.00015638204],"about_ca_topic_score_codex":0.98391867,"about_ca_topic_score_gemma":0.9883111,"teacher_disagreement_score":0.068600014,"about_ca_system_score_codex":0.068600014,"about_ca_system_score_gemma":0.06431368,"threshold_uncertainty_score":0.49773026},"labels":[],"label_agreement":null},{"id":"W4255419074","doi":"10.1016/s1098-3015(10)73566-x","title":"PDB22 ECONOMIC EVALUATION OF LONG-ACTING INSULIN ANALOGUES FOR THE TREATMENT OF PATIENTS WITH TYPE-1 AND TYPE-2 DIABETES MELLITUS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Type 2 Diabetes Mellitus; Medicine; Insulin; Type (biology); Internal medicine; Diabetes mellitus; Endocrinology; Biology","score_opus":0.05875028572945534,"score_gpt":0.3254283673808369,"score_spread":0.26667808165138157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255419074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.920947,0.025602294,0.000541836,0.011358302,0.0005205238,0.0015656492,0.013399941,0.00005281783,0.026011715],"genre_scores_gemma":[0.9890609,0.0049806973,0.00058911514,0.00090321846,0.00010506529,0.00011971539,0.0019852805,0.000008239118,0.002247905],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979777,0.001014218,0.0001298205,0.00008082739,0.00049865624,0.000298777],"domain_scores_gemma":[0.9944602,0.0013801089,0.0006250857,0.00006426603,0.0015457554,0.0019245881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021585606,0.0003639643,0.001012342,0.00061534985,0.000805786,0.0016658701,0.00071607233,0.00069843204,0.0042941165],"category_scores_gemma":[0.010481018,0.00023478543,0.0014308337,0.0012472508,0.0004510431,0.0003208389,0.0004699469,0.0010807748,0.000117004325],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41507265,0.0059680226,0.19706261,0.0032691464,0.004267359,0.0009851903,0.00032217748,0.030916944,0.0014985325,0.006011456,0.040466804,0.2941591],"study_design_scores_gemma":[0.14843053,0.033373635,0.69575876,0.0021084812,0.006762729,0.0007579417,0.0014830364,0.06267321,0.0011781031,0.0013831969,0.045820072,0.00027026597],"about_ca_topic_score_codex":0.89438343,"about_ca_topic_score_gemma":0.92701256,"teacher_disagreement_score":0.10561657,"about_ca_system_score_codex":0.043242123,"about_ca_system_score_gemma":0.060877644,"threshold_uncertainty_score":0.31374508},"labels":[],"label_agreement":null},{"id":"W4255505380","doi":"10.1016/j.jval.2020.04.807","title":"PMU32 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A CHINESE ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid and Parathyroid Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Electrosurgery; Medicine; Operations management; Surgery; Engineering","score_opus":0.0915492600715045,"score_gpt":0.3285721655058998,"score_spread":0.2370229054343953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255505380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97188187,0.0010079448,0.013997619,0.0011009518,0.000042294007,0.000238284,0.004743666,0.00012749729,0.006859776],"genre_scores_gemma":[0.99063,0.0003417161,0.002001278,0.00007631289,0.000021465632,0.0001545527,0.0018649959,0.00002289985,0.0048868298],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99879265,0.00065794186,0.00003757704,0.00013947499,0.000081343554,0.00029093793],"domain_scores_gemma":[0.9947747,0.004226105,0.00026887667,0.00018799317,0.0003174977,0.0002248795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027706388,0.0011060096,0.0018172979,0.0021829926,0.00077698124,0.0018506119,0.0017356782,0.0009235797,0.012498276],"category_scores_gemma":[0.005485733,0.0007393122,0.0036005154,0.002664727,0.0007621951,0.0014046096,0.0010677553,0.0016605242,0.0004980835],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001925798,0.00081049756,0.1735679,0.0007226138,0.0039632088,0.0012357268,0.000434225,0.7232424,0.000863189,0.049703497,0.011224006,0.03230697],"study_design_scores_gemma":[0.00033881416,0.000571825,0.061545253,0.00007743557,0.0016842348,0.00012959907,0.00061745965,0.9223739,0.00034385512,0.009851004,0.0023695668,0.00009705957],"about_ca_topic_score_codex":0.14342593,"about_ca_topic_score_gemma":0.06425514,"teacher_disagreement_score":0.14342593,"about_ca_system_score_codex":0.0041383463,"about_ca_system_score_gemma":0.0038617766,"threshold_uncertainty_score":0.28518224},"labels":[],"label_agreement":null},{"id":"W4256022211","doi":"10.1016/j.jval.2014.03.226","title":"Comparison costs of ERCP and MRCP in patients with suspected biliary obstruction based on a randomized trial","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Magnetic resonance cholangiopancreatography; Endoscopic retrograde cholangiopancreatography; Randomized controlled trial; Indirect costs; Medical costs; Cost analysis; Surgery; General surgery; Pancreatitis","score_opus":0.018268988718558605,"score_gpt":0.288296914815033,"score_spread":0.2700279260964744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256022211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753645,0.0106659,0.0021877482,0.002227564,0.0021942328,0.002636053,0.0011619009,0.00009010198,0.0034720604],"genre_scores_gemma":[0.99510634,0.0011529048,0.0008688195,0.00065719924,0.00044789087,0.0007286385,0.0005124183,0.000016547547,0.00050918566],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9863208,0.0101572415,0.0009825024,0.0011496607,0.0005794192,0.00081044674],"domain_scores_gemma":[0.9661795,0.025215637,0.0037373467,0.0016891905,0.0007778609,0.0024004118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008971898,0.0029133873,0.0065859086,0.0010379169,0.00064387795,0.002896109,0.0021408305,0.0042927326,0.01067382],"category_scores_gemma":[0.026037423,0.0017963517,0.010639166,0.00092998333,0.0029395015,0.0038076744,0.0018442256,0.006367519,0.00073123747],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9884793,0.0008391349,0.0016189311,0.00054363755,0.004141301,0.000033312357,0.000028215261,0.00078773906,0.00014558983,0.00022825689,0.0001841729,0.0029702887],"study_design_scores_gemma":[0.9470955,0.035837576,0.0034280624,0.0002168723,0.008826864,0.00006042312,0.000062105624,0.002790487,0.00024973517,0.0010205056,0.0003591174,0.000052743562],"about_ca_topic_score_codex":0.0020549577,"about_ca_topic_score_gemma":0.0016928626,"teacher_disagreement_score":0.01067382,"about_ca_system_score_codex":0.0032176569,"about_ca_system_score_gemma":0.0018544914,"threshold_uncertainty_score":0.047448516},"labels":[],"label_agreement":null},{"id":"W4256251854","doi":"10.1016/j.jval.2012.08.2054","title":"PSS7 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study): 6-Month Findings","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Care; Novartis (Canada)","funders":"","keywords":"Medicine; Visual acuity; Observational study; Quality of life (healthcare); Macular edema; Diabetes mellitus; Diabetic macular edema; Diabetic retinopathy; Ophthalmology; Visual analogue scale; Telephone interview; Surgery; Internal medicine","score_opus":0.13751446866177175,"score_gpt":0.37339115689902935,"score_spread":0.2358766882372576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256251854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8726429,0.0024278169,0.00015982108,0.0017693647,0.000104946266,0.00017761803,0.11421524,0.00003967093,0.008462623],"genre_scores_gemma":[0.9438625,0.0010145734,0.00032132535,0.0003939359,0.00008024761,0.00008697672,0.053062674,0.000012561603,0.0011651815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814737,0.00019547749,0.00015223875,0.00017097249,0.0008706704,0.00046336572],"domain_scores_gemma":[0.9952201,0.00027693657,0.0015163255,0.00018949425,0.0018415091,0.00095563487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018143643,0.0006731199,0.0008145226,0.0017231208,0.001385761,0.0012929406,0.0015956016,0.0011407384,0.0021164545],"category_scores_gemma":[0.0062507065,0.00039108784,0.0012903012,0.0050784973,0.00039738222,0.0009128133,0.0013993804,0.0013751436,0.0002663486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047450096,0.000070000875,0.9917058,0.000058946312,0.00021681839,0.00005275756,0.00010562169,0.00006814099,0.00005275092,0.000091100665,0.0046710107,0.0024326781],"study_design_scores_gemma":[0.000020416235,0.000020336214,0.99920976,0.000013297266,0.000052875956,0.000020445796,0.000114099166,0.000046760157,0.0000073338947,0.000013893325,0.00047457925,0.0000061850183],"about_ca_topic_score_codex":0.91429657,"about_ca_topic_score_gemma":0.92253286,"teacher_disagreement_score":0.08570343,"about_ca_system_score_codex":0.0077220732,"about_ca_system_score_gemma":0.013864972,"threshold_uncertainty_score":0.17241627},"labels":[],"label_agreement":null},{"id":"W4256475711","doi":"10.1016/j.jval.2016.09.1386","title":"Cost-Effectiveness of Apremilast In Moderate-To-Severe Psoriasis In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Apremilast; Medicine; Adalimumab; Infliximab; Ustekinumab; Psoriasis; Etanercept; Quality-adjusted life year; Cost effectiveness; Internal medicine; Psoriatic arthritis; Dermatology; Disease","score_opus":0.38534836230586117,"score_gpt":0.4053830465265382,"score_spread":0.020034684220677057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256475711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94880146,0.025137244,0.00029507713,0.009246977,0.00014755623,0.00024849814,0.0059146686,0.000033039934,0.010175411],"genre_scores_gemma":[0.9942397,0.0036024083,0.00021155653,0.0002782251,0.000029243385,0.000023420715,0.00083073246,0.0000048909765,0.00077981915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845123,0.00044694755,0.00011654276,0.000111766516,0.00046398796,0.00040956168],"domain_scores_gemma":[0.99678373,0.0006719453,0.00039033504,0.0000353304,0.0008477275,0.0012708795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010250405,0.0002958612,0.00083619583,0.0007892245,0.0011403478,0.0017036744,0.0007978502,0.0005573887,0.0029427567],"category_scores_gemma":[0.0054209395,0.000199704,0.0014652915,0.0018245659,0.000635072,0.00037272315,0.0005114643,0.0011493525,0.0000782071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05352204,0.0034643835,0.5000814,0.0047446596,0.0057756077,0.0015882982,0.0008850845,0.03942923,0.001914146,0.010003954,0.044233445,0.33435777],"study_design_scores_gemma":[0.008969123,0.0032918253,0.9394287,0.0015929899,0.0037141251,0.0007279033,0.0019076149,0.026773093,0.0005479505,0.001551926,0.011310316,0.0001844161],"about_ca_topic_score_codex":0.98454213,"about_ca_topic_score_gemma":0.99128145,"teacher_disagreement_score":0.06507856,"about_ca_system_score_codex":0.06507856,"about_ca_system_score_gemma":0.0659082,"threshold_uncertainty_score":0.4721802},"labels":[],"label_agreement":null},{"id":"W4280647474","doi":"10.1016/j.jval.2022.04.1729","title":"Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Impact","funders":"Innovative Medicines Initiative; European Commission; European Federation of Pharmaceutical Industries and Associations","keywords":"Offensive; Medicine; Harmony (color); Health care; Alliance; Clinical trial; Family medicine; Political science; Internal medicine; Operations research; Engineering","score_opus":0.2321244757652726,"score_gpt":0.3742485561811349,"score_spread":0.1421240804158623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280647474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4443999,0.048224635,0.24484432,0.10441358,0.0012075553,0.01746688,0.0051113535,0.0008737375,0.13345805],"genre_scores_gemma":[0.5706674,0.004865959,0.41493776,0.0024347506,0.00010142864,0.004450855,0.0017279075,0.00010975902,0.0007042021],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.7818627,0.1695516,0.015181554,0.0037875057,0.025383392,0.004233218],"domain_scores_gemma":[0.67476815,0.25176635,0.02166799,0.014271818,0.030630656,0.0068949685],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.24066857,0.0011177016,0.001743597,0.023271246,0.003807897,0.017906481,0.003537338,0.0022582577,0.0034561208],"category_scores_gemma":[0.23576412,0.0006355564,0.0040958677,0.01767507,0.0056344797,0.015266397,0.014578961,0.0035583375,0.0002457155],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060680596,0.0011189528,0.05304398,0.012436956,0.0014055105,0.00029784365,0.02729818,0.005901113,0.0007764387,0.25796178,0.011639196,0.62751323],"study_design_scores_gemma":[0.0012316216,0.0045494684,0.15120746,0.08990389,0.0034530943,0.0009236237,0.14574765,0.039245557,0.0032935943,0.3017708,0.2579475,0.000725764],"about_ca_topic_score_codex":0.0113108,"about_ca_topic_score_gemma":0.014569339,"teacher_disagreement_score":0.24066857,"about_ca_system_score_codex":0.03257288,"about_ca_system_score_gemma":0.069628425,"threshold_uncertainty_score":0.9363909},"labels":[],"label_agreement":null},{"id":"W4281251623","doi":"10.1016/j.jval.2022.04.003","title":"Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple myeloma; Decision aids; Medicine; Intensive care medicine; Management science; Alternative medicine; Internal medicine; Engineering; Pathology","score_opus":0.12025877929423238,"score_gpt":0.41947872882124226,"score_spread":0.29921994952700987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281251623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038872112,0.9948985,0.000108153086,0.00031488287,0.00005442772,0.00015376607,0.0003074942,0.000002693806,0.00027286625],"genre_scores_gemma":[0.055336524,0.9421025,0.0012738276,0.0005870411,0.0000576112,0.00031462734,0.00024444712,0.0000044360972,0.0000789903],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9886325,0.004899208,0.003970228,0.00063685665,0.0016010851,0.0002601281],"domain_scores_gemma":[0.92919457,0.060886785,0.006996284,0.00039637968,0.0021296456,0.00039638876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0120509565,0.00095507875,0.005620231,0.0059619783,0.00066515565,0.0036317466,0.001340402,0.0015448756,0.0034561455],"category_scores_gemma":[0.062482167,0.0007296146,0.0071061994,0.009182989,0.00088291505,0.0024931203,0.0019706385,0.0020523465,0.00014982754],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076487375,0.00009077272,0.006565566,0.8465833,0.024899026,0.00014073307,0.0010043754,0.00016703128,0.00009544304,0.00039329,0.001496114,0.1177995],"study_design_scores_gemma":[0.00088959624,0.0003150802,0.021117818,0.81946975,0.13596472,0.00050443853,0.0018143946,0.00018205782,0.00016217686,0.00065615645,0.018811282,0.00011240424],"about_ca_topic_score_codex":0.010007976,"about_ca_topic_score_gemma":0.031351,"teacher_disagreement_score":0.0120509565,"about_ca_system_score_codex":0.0037128946,"about_ca_system_score_gemma":0.010254693,"threshold_uncertainty_score":0.063732326},"labels":[],"label_agreement":null},{"id":"W4281488265","doi":"10.1016/j.jval.2022.04.002","title":"A Data-Driven Approach to Support the Understanding and Improvement of Patients’ Journeys: A Case Study Using Electronic Health Records of an Emergency Department","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Business Process Modeling and Analysis","field":"Business, Management and Accounting","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Research Foundation of Korea","keywords":"Emergency department; Health records; Medical emergency; Electronic health record; Data science; Medicine; Computer science; Nursing; Health care; Political science","score_opus":0.16079424607813764,"score_gpt":0.3331459692628482,"score_spread":0.17235172318471054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281488265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8562193,0.0005496847,0.1101232,0.010268669,0.00014603026,0.0014061845,0.0026151438,0.000986125,0.01768567],"genre_scores_gemma":[0.8505008,0.0003769058,0.1455276,0.0004486872,0.000017212951,0.0002614894,0.0009857427,0.00008748246,0.0017939197],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99669635,0.002292305,0.0002020828,0.0002175403,0.0004358861,0.00015578487],"domain_scores_gemma":[0.9822842,0.012937611,0.0008608298,0.0012248546,0.0019214011,0.0007710525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005314887,0.00046374602,0.00027324609,0.0017747824,0.0015630868,0.004304629,0.0017652116,0.0015440403,0.0017399464],"category_scores_gemma":[0.019003239,0.00035024772,0.00048576016,0.0021968859,0.0007048633,0.0030771655,0.0018767205,0.0014477734,0.00037348946],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013980523,0.0059467196,0.22769223,0.0023569218,0.0004067552,0.010320846,0.12543236,0.042822182,0.00978786,0.041304406,0.022644691,0.509887],"study_design_scores_gemma":[0.00037909686,0.0019748283,0.070442356,0.002239029,0.0005548749,0.0068608164,0.23513046,0.42005587,0.02241194,0.043362204,0.19601943,0.00056910154],"about_ca_topic_score_codex":0.010060154,"about_ca_topic_score_gemma":0.01881633,"teacher_disagreement_score":0.010060154,"about_ca_system_score_codex":0.0023333447,"about_ca_system_score_gemma":0.0046697413,"threshold_uncertainty_score":0.02810812},"labels":[],"label_agreement":null},{"id":"W4281655166","doi":"10.1016/j.jval.2022.03.018","title":"Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; University of Ottawa","funders":"Wellcome Trust","keywords":"Deliberation; Scrutiny; Checklist; Management science; Political science; Citizen journalism; Health technology; Process management; Engineering ethics; Psychology; Health care; Engineering","score_opus":0.44967659264047266,"score_gpt":0.49790826696571755,"score_spread":0.04823167432524489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281655166","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027084583,0.0061495714,0.812968,0.10392254,0.0011704259,0.0226207,0.00070492644,0.0034292846,0.021949997],"genre_scores_gemma":[0.05915329,0.0031333896,0.91987926,0.0057158796,0.00022925012,0.008552697,0.000654334,0.0007894126,0.0018924233],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.4098274,0.45290682,0.04108634,0.009875144,0.07554425,0.010759958],"domain_scores_gemma":[0.202699,0.59618413,0.03615305,0.06482833,0.09043769,0.009697735],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5438595,0.0040442515,0.003210335,0.012058624,0.013396409,0.0235396,0.010632503,0.01121058,0.0028036158],"category_scores_gemma":[0.5758225,0.004207599,0.005440263,0.007653649,0.016885862,0.015828371,0.021357339,0.020245487,0.0025463097],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040082715,0.0022436704,0.013289752,0.007452978,0.0007970058,0.00036848744,0.09746069,0.014111416,0.004297093,0.03701123,0.046945963,0.7756208],"study_design_scores_gemma":[0.0015157729,0.002394698,0.028780246,0.047583364,0.002049167,0.0010232141,0.08017505,0.042013533,0.04857704,0.23618066,0.50792116,0.0017861499],"about_ca_topic_score_codex":0.025908178,"about_ca_topic_score_gemma":0.027198518,"teacher_disagreement_score":0.45614052,"about_ca_system_score_codex":0.01836329,"about_ca_system_score_gemma":0.12569463,"threshold_uncertainty_score":0.5625025},"labels":[],"label_agreement":null},{"id":"W4281695053","doi":"10.1016/j.jval.2022.03.011","title":"Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; Toronto Rehabilitation Institute; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Checklist; Medicine; Trivalent influenza vaccine; Cost effectiveness; Purchasing power parity; Influenza vaccine; Demography; Vaccination; Immunology; Economics; Psychology; Finance","score_opus":0.23675180593529893,"score_gpt":0.4794656861400883,"score_spread":0.24271388020478935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281695053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011696075,0.99777776,0.00010115861,0.00013526839,0.00015172937,0.00013497173,0.00033315725,0.000006133704,0.00019013911],"genre_scores_gemma":[0.021109296,0.9774399,0.00044291498,0.00039358827,0.00010624518,0.00019399059,0.00018642074,0.000004101372,0.0001236031],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99464625,0.0020183732,0.0018698634,0.00035220277,0.000914571,0.00019871847],"domain_scores_gemma":[0.9841928,0.012486143,0.0021736734,0.00019677667,0.0007799215,0.00017062212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069706314,0.0017575402,0.010609694,0.005098638,0.00039491543,0.0023224675,0.0014010479,0.0017689588,0.005420513],"category_scores_gemma":[0.03170912,0.0010647811,0.013041022,0.0059408695,0.0006776665,0.0015179008,0.0012982072,0.0018967123,0.00027411393],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008785797,0.000023609671,0.0008021924,0.8982618,0.068588346,0.00007828137,0.000060895396,0.0002085392,0.0001433403,0.00020072605,0.0011452552,0.029608456],"study_design_scores_gemma":[0.0018122247,0.00046480683,0.0071048397,0.44474715,0.5315936,0.00027288008,0.000154715,0.00018426907,0.00020874728,0.0005065576,0.012898227,0.000051992927],"about_ca_topic_score_codex":0.014714877,"about_ca_topic_score_gemma":0.033142537,"teacher_disagreement_score":0.014714877,"about_ca_system_score_codex":0.0034935905,"about_ca_system_score_gemma":0.0061835265,"threshold_uncertainty_score":0.03686464},"labels":[],"label_agreement":null},{"id":"W4281763642","doi":"10.1016/j.jval.2022.05.001","title":"Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"AOSpine; Medtronic","keywords":"Medicine; Qualitative research; Palliative treatment; Palliative care; General surgery; Intensive care medicine; Physical therapy; Internal medicine; Nursing; Sociology; Social science","score_opus":0.11867797464171849,"score_gpt":0.4408110104406888,"score_spread":0.32213303579897035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281763642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99104476,0.000735991,0.0020610113,0.0022877697,0.000054070457,0.00020816328,0.00020957377,0.000014461306,0.003384114],"genre_scores_gemma":[0.99587137,0.00073689164,0.00087430136,0.0007946905,0.000017423754,0.00030009076,0.00008748618,0.00001543631,0.0013021829],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98923105,0.008331653,0.00034177175,0.0004112635,0.00075532496,0.0009289646],"domain_scores_gemma":[0.97040063,0.024389282,0.0019175956,0.00030853206,0.0013900285,0.0015939112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0126655465,0.0004828829,0.0006112241,0.000868578,0.0046302653,0.002845133,0.0012766538,0.0014897309,0.0028565542],"category_scores_gemma":[0.023067247,0.00051738415,0.00041069838,0.0010192329,0.0043995804,0.003069373,0.0030984697,0.0027524543,0.00032359746],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059138983,0.000069411086,0.0038915935,0.0002212377,0.0000063606903,0.0006102385,0.98995554,0.000045663863,0.0006315201,0.0006596216,0.00046644552,0.00338327],"study_design_scores_gemma":[0.000009096471,0.00009271634,0.0022067486,0.00020186594,0.0000058921305,0.00038481495,0.9912005,0.00010393239,0.00025483686,0.0002409422,0.0052812924,0.000017294202],"about_ca_topic_score_codex":0.0039012583,"about_ca_topic_score_gemma":0.0060452754,"teacher_disagreement_score":0.0126655465,"about_ca_system_score_codex":0.0041660126,"about_ca_system_score_gemma":0.0042160666,"threshold_uncertainty_score":0.06698257},"labels":[],"label_agreement":null},{"id":"W4282832845","doi":"10.1016/j.jval.2022.05.003","title":"How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"National Natural Science Foundation of China","keywords":"Medicine; Latent class model; Mixed logit; Family history; Quality of life (healthcare); Logistic regression; Preference; Lung cancer; Family member; Family medicine; Internal medicine","score_opus":0.17010140186982514,"score_gpt":0.29178897737570464,"score_spread":0.1216875755058795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282832845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99880433,0.00021606805,0.00012866661,0.00029887995,0.000011931711,0.000028922517,0.00006928933,0.0000010811816,0.00044074157],"genre_scores_gemma":[0.99933076,0.00010425898,0.000079494755,0.00014708229,0.000008365074,0.000024860932,0.000073472904,7.0809705e-7,0.00023114194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940333,0.004350954,0.00019650628,0.00042737683,0.00034039904,0.0006515253],"domain_scores_gemma":[0.98706543,0.007915953,0.0028047536,0.00076568715,0.00031867655,0.001129569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007787847,0.00045837602,0.0010013273,0.00065950176,0.0009643827,0.0014283104,0.00088242267,0.0015141251,0.0038281514],"category_scores_gemma":[0.013610672,0.0002881558,0.0012617721,0.0011723517,0.0024435136,0.0009814112,0.0006479464,0.0011040043,0.0002693515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02743754,0.0084711695,0.91630185,0.00029186148,0.0028962307,0.0006786475,0.0033730627,0.0040440923,0.0013836685,0.0039994963,0.0011047623,0.030017648],"study_design_scores_gemma":[0.008946935,0.010133357,0.95204353,0.000099900295,0.0016322286,0.00029810163,0.0042093624,0.01365765,0.0011337517,0.0059320214,0.0017774989,0.00013570525],"about_ca_topic_score_codex":0.03083964,"about_ca_topic_score_gemma":0.020968914,"teacher_disagreement_score":0.03083964,"about_ca_system_score_codex":0.0018330608,"about_ca_system_score_gemma":0.0024575302,"threshold_uncertainty_score":0.061320305},"labels":[],"label_agreement":null},{"id":"W4282927626","doi":"10.1016/j.jval.2022.05.004","title":"No Time to Waste: An Appraisal of Value at the End of Life","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Sinai Health System; McMaster University; University of Toronto","funders":"","keywords":"Quality of life (healthcare); CINAHL; Psychological intervention; PsycINFO; Value of life; Quality-adjusted life year; Medicine; End-of-life care; MEDLINE; Economic appraisal; EQ-5D; Gerontology; Psychology; Health related quality of life; Cost effectiveness; Nursing; Palliative care; Public economics; Economics","score_opus":0.5088164664211489,"score_gpt":0.4764487851588149,"score_spread":0.03236768126233397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282927626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000093322524,0.9981415,0.00007952414,0.0012544206,0.00009079915,0.000005098238,0.000014304472,9.126247e-7,0.00032010995],"genre_scores_gemma":[0.0030108595,0.9953056,0.00040530515,0.00092955417,0.00019564635,0.000019223464,0.000021410564,0.0000022066424,0.000110192326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99516195,0.0023343433,0.00055479095,0.0001869983,0.0016355849,0.00012630825],"domain_scores_gemma":[0.984512,0.012258841,0.0015336964,0.00019015511,0.0012511931,0.00025408078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009819817,0.0008367479,0.0029414669,0.00441828,0.0004018115,0.0029050275,0.0012511666,0.0022713556,0.0028777174],"category_scores_gemma":[0.022998532,0.00035535288,0.001299719,0.00587066,0.0024056574,0.003829039,0.0015970012,0.0036226697,0.00045867127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025445168,0.00005734335,0.00039900935,0.04230307,0.00058743055,0.00004002558,0.00016876505,0.00035338962,0.000083685416,0.023809453,0.022262678,0.9096807],"study_design_scores_gemma":[0.0002812501,0.00043092392,0.0062990757,0.2526206,0.0021471204,0.0008503157,0.0007997165,0.0005518354,0.0002585858,0.06380116,0.6718496,0.00010987171],"about_ca_topic_score_codex":0.004466664,"about_ca_topic_score_gemma":0.0093375845,"teacher_disagreement_score":0.009819817,"about_ca_system_score_codex":0.0041218107,"about_ca_system_score_gemma":0.0066980743,"threshold_uncertainty_score":0.05193281},"labels":[],"label_agreement":null},{"id":"W4283511755","doi":"10.1016/j.jval.2022.04.219","title":"CO123 Characterizing Key Clinical Outcomes Among Patients with Duchenne Muscular Dystrophy (DMD): Results from a 20-Year Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Population; Weakness; Key (lock); Physical medicine and rehabilitation; Pediatrics; Physical therapy; Internal medicine; Surgery; Computer science; Environmental health","score_opus":0.021409717025830253,"score_gpt":0.2878411933165251,"score_spread":0.2664314762906948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283511755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988581,0.00010344249,0.00006369201,0.00003434504,0.0000051319385,0.000012348249,0.0006109889,0.0000028942989,0.0003091375],"genre_scores_gemma":[0.9984913,0.00007813142,0.00005736997,0.00004418435,0.000012036895,0.000023563929,0.0010133666,0.0000037020934,0.0002762723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988795,0.00034173415,0.00012044682,0.000300401,0.00016233478,0.00019559418],"domain_scores_gemma":[0.99771404,0.0003143108,0.000833178,0.00016856704,0.00049295573,0.00047695643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012325206,0.00060927967,0.0006619847,0.0015193187,0.0011346245,0.0014036755,0.0005923875,0.0012853942,0.0011786928],"category_scores_gemma":[0.0029867184,0.00040877314,0.000979325,0.002757873,0.00058862224,0.001341687,0.0011577338,0.0008837437,0.0004940776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017500916,0.00007722601,0.9989027,0.0000044271337,0.00006658543,0.000048982856,0.00006771138,0.000018760285,0.00011730548,0.0000051060388,0.00006299217,0.00045311265],"study_design_scores_gemma":[0.000011134384,0.00013784559,0.99938345,0.0000017362428,0.0000364589,0.00006803694,0.00021784967,0.000045197805,0.000021804059,0.0000072459316,0.000064909356,0.0000041692865],"about_ca_topic_score_codex":0.015941346,"about_ca_topic_score_gemma":0.013422742,"teacher_disagreement_score":0.015941346,"about_ca_system_score_codex":0.0007253136,"about_ca_system_score_gemma":0.000584424,"threshold_uncertainty_score":0.031697154},"labels":[],"label_agreement":null},{"id":"W4283511847","doi":"10.1016/j.jval.2022.04.1440","title":"PCR97 Discrete Choice Experiment Vs. Best-Worst Scaling: An Empirical Comparison in Measuring Treatment Preference of Lung Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Mixed logit; Multinomial logistic regression; Preference; Lung cancer; Medicine; Statistics; Ordered logit; Random effects model; Demography; Logistic regression; Mathematics; Internal medicine; Meta-analysis","score_opus":0.3568688916061442,"score_gpt":0.3480348468592822,"score_spread":0.008834044746862002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283511847","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766367,0.00030238132,0.01756071,0.00038500724,0.00012257246,0.0006290755,0.000842441,0.00007671054,0.0034443566],"genre_scores_gemma":[0.9878641,0.00010116994,0.009545959,0.00018934751,0.00004327164,0.0007638576,0.00052511226,0.000021597796,0.00094568956],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97535396,0.022176769,0.0005708588,0.00073348044,0.00092113885,0.00024377415],"domain_scores_gemma":[0.71201515,0.2736494,0.005617206,0.0058937897,0.0015081776,0.0013162942],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021417605,0.0005616433,0.0009550515,0.0007363205,0.00041323,0.0012960241,0.000995321,0.0015268764,0.01109916],"category_scores_gemma":[0.08679166,0.00039240034,0.0014411501,0.0010568324,0.0015568421,0.0015104293,0.0008473057,0.0019450105,0.00091903424],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25530258,0.039880596,0.19934869,0.0027128062,0.0037789005,0.00043655265,0.0034226822,0.078581244,0.009028359,0.03239735,0.0078091254,0.36730114],"study_design_scores_gemma":[0.032157686,0.13986091,0.22105323,0.00054048747,0.0018310166,0.00089404563,0.0036916633,0.5373199,0.016942447,0.035227418,0.009825836,0.0006553871],"about_ca_topic_score_codex":0.0010146821,"about_ca_topic_score_gemma":0.0005552055,"teacher_disagreement_score":0.9785824,"about_ca_system_score_codex":0.00096948125,"about_ca_system_score_gemma":0.00097475364,"threshold_uncertainty_score":0.113268435},"labels":[],"label_agreement":null},{"id":"W4283512297","doi":"10.1016/j.jval.2022.04.982","title":"HPR56 Challenges of Funding Orphan Medicinal Products in Canada: Quantification of Approval Rate and Reimbursement","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Medicine; Reimbursement; Drug approval; European union; Family medicine; Business; Health care; Drug; Political science; Pharmacology","score_opus":0.5454051307329327,"score_gpt":0.40045133446491277,"score_spread":0.14495379626801996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283512297","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21946186,0.031516,0.009422841,0.5707445,0.0012428627,0.00073504786,0.0145390285,0.00030435927,0.15203354],"genre_scores_gemma":[0.9397061,0.008578115,0.010051141,0.024552165,0.00077139,0.00018821229,0.0019835918,0.00012113715,0.01404819],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9570374,0.01025629,0.0016677382,0.0018417044,0.023409944,0.0057870145],"domain_scores_gemma":[0.7949426,0.08839588,0.010607839,0.0027370502,0.09217652,0.011140082],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03949062,0.0005372679,0.0013301078,0.004633552,0.00327755,0.012955006,0.002827325,0.004418894,0.0040740944],"category_scores_gemma":[0.12857987,0.0006501052,0.0013643652,0.005253025,0.0037840067,0.0024475022,0.00203041,0.00565215,0.00025540887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010652845,0.0002176806,0.082875945,0.0013382537,0.0009483026,0.0005777886,0.0016909741,0.03175316,0.0011028597,0.47486144,0.21195117,0.1916171],"study_design_scores_gemma":[0.0009563516,0.00063104666,0.30879825,0.006311932,0.0013446828,0.0006441757,0.0058023334,0.10743914,0.0031105315,0.13100874,0.43303698,0.00091583957],"about_ca_topic_score_codex":0.9851591,"about_ca_topic_score_gemma":0.986297,"teacher_disagreement_score":0.96050936,"about_ca_system_score_codex":0.17559212,"about_ca_system_score_gemma":0.33519626,"threshold_uncertainty_score":0.9561963},"labels":[],"label_agreement":null},{"id":"W4283512920","doi":"10.1016/j.jval.2022.04.733","title":"EE486 A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Azithromycin; Medicine; Exacerbation; COPD; Guideline; Intensive care medicine; Cost effectiveness; Adverse effect; Internal medicine; Quality of life (healthcare); Quality-adjusted life year; Antibiotics; Pathology","score_opus":0.04916303242893981,"score_gpt":0.37226190545767857,"score_spread":0.32309887302873874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283512920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9200721,0.04734244,0.006898444,0.0023031498,0.0005106115,0.0015273816,0.0077152736,0.00020216474,0.0134286005],"genre_scores_gemma":[0.9915827,0.0033652482,0.0019650203,0.00026637848,0.00009404101,0.00022829408,0.0013363685,0.000017823879,0.0011441733],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9939038,0.00504646,0.00020424582,0.00022366927,0.0003839714,0.00023781536],"domain_scores_gemma":[0.9942935,0.004956094,0.00029299868,0.00011670019,0.00015800577,0.00018271466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042054337,0.0011622632,0.0030775152,0.0015743768,0.00022023312,0.0014429071,0.000984075,0.001807954,0.00868838],"category_scores_gemma":[0.012839211,0.00056177954,0.0076384465,0.0013398181,0.00036782442,0.0011865613,0.0006897558,0.0019626587,0.00034280794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.59985656,0.003343662,0.014106674,0.011525603,0.057976026,0.00070761767,0.00012894647,0.14322543,0.004732727,0.0054443185,0.003994368,0.15495805],"study_design_scores_gemma":[0.26062933,0.124925196,0.10078277,0.0043559815,0.17843902,0.0018331944,0.0005392939,0.29941624,0.004236108,0.0058817957,0.018512515,0.00044867714],"about_ca_topic_score_codex":0.0087277265,"about_ca_topic_score_gemma":0.005153393,"teacher_disagreement_score":0.0087277265,"about_ca_system_score_codex":0.0024276518,"about_ca_system_score_gemma":0.0014265208,"threshold_uncertainty_score":0.02906555},"labels":[],"label_agreement":null},{"id":"W4283512986","doi":"10.1016/j.jval.2022.04.781","title":"EPH28 Impact of COVID19 on Mental Health - Focus on Depression & Anxiety","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anxiety; Pandemic; Mental health; Population; Depression (economics); Psychiatry; Inclusion and exclusion criteria; Medicine; Demography; Psychology; Coronavirus disease 2019 (COVID-19); Disease; Environmental health; Internal medicine; Alternative medicine; Pathology","score_opus":0.10393384563019542,"score_gpt":0.4633761492619452,"score_spread":0.3594423036317498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283512986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53295815,0.010386328,0.0010492256,0.07044814,0.0038423094,0.00085141236,0.022876685,0.0003618261,0.3572259],"genre_scores_gemma":[0.92285186,0.0042956653,0.002491672,0.010444662,0.0014720592,0.00044793313,0.012005246,0.00018609432,0.04580477],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9953725,0.001345666,0.00029396603,0.00018896702,0.001401313,0.001397692],"domain_scores_gemma":[0.9830776,0.0036171745,0.0018655113,0.00076541596,0.0033132036,0.00736107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004587107,0.0002724698,0.00041885857,0.0009256904,0.0017577049,0.002754997,0.0008380669,0.0007438471,0.044227917],"category_scores_gemma":[0.019489115,0.00016395548,0.0010687684,0.0008879462,0.00067416416,0.00094608316,0.006077058,0.0017991661,0.0040451237],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042618415,0.002410208,0.4008984,0.0009829726,0.0003818079,0.00031293888,0.0010740038,0.00035937142,0.00074705546,0.0070846574,0.14176705,0.43971968],"study_design_scores_gemma":[0.000489332,0.0011572954,0.74787027,0.0011507218,0.0001968863,0.00044877297,0.003222073,0.00028760143,0.0010428221,0.0022531748,0.24180445,0.00007660377],"about_ca_topic_score_codex":0.020974094,"about_ca_topic_score_gemma":0.04536776,"teacher_disagreement_score":0.044227917,"about_ca_system_score_codex":0.0039450806,"about_ca_system_score_gemma":0.007615586,"threshold_uncertainty_score":0.14795715},"labels":[],"label_agreement":null},{"id":"W4283513648","doi":"10.1016/j.jval.2022.04.586","title":"EE341 Hospital Costs Associated with Cataract, Glaucoma, Vitreoretinal, and Laser Refractive Surgeries: A Targeted Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Imaging and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Trabeculectomy; Cataract surgery; Vitrectomy; Glaucoma; Optometry; Ophthalmology; Phacoemulsification; Indirect costs; Glaucoma surgery; Surgery; Visual acuity","score_opus":0.010789554767928424,"score_gpt":0.27172226699308294,"score_spread":0.2609327122251545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283513648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0057677445,0.9880453,0.000103931576,0.0013492887,0.00022683194,0.000039814437,0.002464656,0.000005971018,0.0019965188],"genre_scores_gemma":[0.02038801,0.9768833,0.00033505983,0.00071067555,0.00029648995,0.00004200328,0.0010615161,0.000005033186,0.00027784336],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984666,0.00027796903,0.0006412066,0.00012598059,0.0003662961,0.000122023775],"domain_scores_gemma":[0.99122953,0.005361807,0.0021415455,0.00008415527,0.0010438089,0.00013899743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016888542,0.00059714465,0.0011037156,0.01833929,0.00040045148,0.0018090636,0.00061763666,0.0009422002,0.006325936],"category_scores_gemma":[0.008852918,0.0004017107,0.002768732,0.020470027,0.0004058221,0.0015786295,0.0009452776,0.0007756009,0.000496249],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056047714,0.00015433539,0.040569406,0.37842938,0.0052248044,0.0009876895,0.000542261,0.0006269891,0.00052860193,0.0037676936,0.038748264,0.5298601],"study_design_scores_gemma":[0.0001412699,0.00032544378,0.16962793,0.50845295,0.019224359,0.004895114,0.0027645647,0.00052043574,0.0005908952,0.0020429743,0.29129526,0.00011887251],"about_ca_topic_score_codex":0.009892135,"about_ca_topic_score_gemma":0.02414868,"teacher_disagreement_score":0.01833929,"about_ca_system_score_codex":0.0017896497,"about_ca_system_score_gemma":0.004841367,"threshold_uncertainty_score":0.021162331},"labels":[],"label_agreement":null},{"id":"W4283513966","doi":"10.1016/j.jval.2022.04.523","title":"EE277 Cost-Effectiveness Analysis of National Smoking Cessation Service Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Thailand","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Smoking cessation; COPD; Psychological intervention; Cost effectiveness; Quality-adjusted life year; Economic evaluation; Cost-effectiveness analysis; Cost–utility analysis; Cost–benefit analysis; Multidisciplinary approach; Health economics; Willingness to pay; Physical therapy; Family medicine; Emergency medicine; Public health; Internal medicine; Psychiatry; Nursing","score_opus":0.22750096609301,"score_gpt":0.3906097163570932,"score_spread":0.1631087502640832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283513966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915208,0.004053949,0.0005776433,0.00044692296,0.000027010308,0.00020892233,0.0010891651,0.000010277527,0.0020653156],"genre_scores_gemma":[0.99853265,0.0005784301,0.00017081255,0.000033102882,0.000010918182,0.00006041044,0.00037564593,0.0000016631029,0.00023627137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663997,0.0020472035,0.00026061968,0.00014229339,0.0003193956,0.00059052184],"domain_scores_gemma":[0.99549365,0.0027822861,0.0005867164,0.000079618745,0.00045707924,0.00060061424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034476896,0.00063474104,0.0013300945,0.0015210812,0.0004756559,0.0016155934,0.0006065481,0.00072929304,0.004002743],"category_scores_gemma":[0.006541384,0.0004351875,0.0034316825,0.0017753526,0.0004813984,0.0010340766,0.0009916773,0.0010285097,0.00011279501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.078619726,0.00794129,0.38267595,0.009350955,0.016820606,0.0023423294,0.00069994247,0.36632237,0.0022126785,0.004658211,0.0031213618,0.1252346],"study_design_scores_gemma":[0.0082490975,0.035097152,0.54708743,0.0017799232,0.022901783,0.0014832001,0.0038281209,0.37102124,0.0022527596,0.0025269839,0.0035184433,0.00025391445],"about_ca_topic_score_codex":0.056279235,"about_ca_topic_score_gemma":0.032116443,"teacher_disagreement_score":0.056279235,"about_ca_system_score_codex":0.007959619,"about_ca_system_score_gemma":0.0057387995,"threshold_uncertainty_score":0.11190331},"labels":[],"label_agreement":null},{"id":"W4283514070","doi":"10.1016/j.jval.2022.04.751","title":"EE505 Canada's Evolving Market for Biosimilars and What It Means for Payers","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Public economics; Medicine; Economics","score_opus":0.03955446445295664,"score_gpt":0.3009156528136979,"score_spread":0.2613611883607413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283514070","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01158482,0.011724285,0.00062891666,0.8900376,0.003837026,0.000038718856,0.0008247448,0.00014940217,0.08117459],"genre_scores_gemma":[0.20916185,0.02448832,0.0054159155,0.6191562,0.004304873,0.000056970068,0.0010182211,0.00031086407,0.13608682],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98543096,0.0010606034,0.00026165572,0.0008054269,0.009414069,0.0030273688],"domain_scores_gemma":[0.9654317,0.004974419,0.0011111731,0.00038799102,0.014684491,0.013410236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009498687,0.00045621302,0.0005725239,0.002326828,0.0071470714,0.020828944,0.002482036,0.012951811,0.022334645],"category_scores_gemma":[0.017270474,0.0005018526,0.0012746492,0.0028183856,0.007410681,0.0044225333,0.0016329468,0.008989531,0.0017443176],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018631777,0.000117396696,0.006740735,0.00025452612,0.000043463675,0.00044427117,0.0007031794,0.00044535843,0.001370698,0.10691923,0.8146317,0.06814314],"study_design_scores_gemma":[0.000052949803,0.00005452823,0.012034759,0.00047824826,0.000026283467,0.00016582446,0.0016535788,0.0005126937,0.0004025772,0.010632926,0.97386736,0.000118371136],"about_ca_topic_score_codex":0.9243133,"about_ca_topic_score_gemma":0.9654868,"teacher_disagreement_score":0.11175725,"about_ca_system_score_codex":0.11175725,"about_ca_system_score_gemma":0.2510422,"threshold_uncertainty_score":0.8108594},"labels":[],"label_agreement":null},{"id":"W4283514695","doi":"10.1016/j.jval.2022.04.300","title":"EE46 Venetoclax in Combination with Azacitidine Is Cost-Effective Vs. AZA for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; ABB (Canada)","funders":"","keywords":"Azacitidine; Venetoclax; Myeloid leukemia; Medicine; Perspective (graphical); Oncology; Internal medicine; Leukemia; Intensive care medicine; Computer science","score_opus":0.03141783833154448,"score_gpt":0.32722244076908236,"score_spread":0.29580460243753787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283514695","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.052951384,0.53547776,0.0009931467,0.29101115,0.0032148536,0.00023033837,0.0073209726,0.00010553481,0.108694926],"genre_scores_gemma":[0.5550091,0.36974493,0.0046939016,0.045080658,0.006264061,0.0001291486,0.0039232536,0.00009940847,0.015055557],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977666,0.0006030083,0.00012814287,0.0001728823,0.0008243609,0.0005050369],"domain_scores_gemma":[0.9941028,0.0016123734,0.0006783165,0.00006799068,0.0020609032,0.0014775424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029869457,0.00052796485,0.0015680813,0.0011254401,0.0010722231,0.0039112866,0.0013376845,0.0019632024,0.0132144075],"category_scores_gemma":[0.00833499,0.00024917882,0.0018754542,0.002109765,0.001264077,0.0007904035,0.0005889763,0.003936538,0.0006315789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02123401,0.00050759723,0.013445794,0.005497938,0.0025253133,0.0006992637,0.00043609494,0.0060752505,0.0033382045,0.041483093,0.15963326,0.7451242],"study_design_scores_gemma":[0.014335721,0.005900503,0.12836523,0.018799506,0.012594517,0.0016705676,0.00241923,0.004784159,0.0017538004,0.019526165,0.7893902,0.00046051477],"about_ca_topic_score_codex":0.7892478,"about_ca_topic_score_gemma":0.91984546,"teacher_disagreement_score":0.21075219,"about_ca_system_score_codex":0.038314205,"about_ca_system_score_gemma":0.06876979,"threshold_uncertainty_score":0.42398667},"labels":[],"label_agreement":null},{"id":"W4283514875","doi":"10.1016/j.jval.2022.04.1609","title":"RWD85 Uptake and Utilization Trends of Direct-Acting Antivirals (DAA) for Hepatitis-C in Manitoba, Canada between 1999 and 2019","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"","keywords":"Sofosbuvir; Medicine; Medical prescription; Ledipasvir; Internal medicine; Population; Hepatitis C; Chronic hepatitis; Pediatrics; Demography; Virology; Ribavirin; Environmental health; Pharmacology; Virus","score_opus":0.14514847872305828,"score_gpt":0.36510712310036464,"score_spread":0.21995864437730636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283514875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91647613,0.004249835,0.00029843234,0.0027753715,0.00007781339,0.00014540658,0.066704705,0.00009684892,0.009175472],"genre_scores_gemma":[0.9761731,0.0032609664,0.00048918667,0.0009620589,0.000030562507,0.000071703194,0.013509087,0.000026710966,0.005476529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984322,0.00009550793,0.000166893,0.00020140818,0.0005305802,0.00057333085],"domain_scores_gemma":[0.9949109,0.00022558609,0.0010775431,0.000088587294,0.0027374832,0.00095991883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082563626,0.00042242857,0.00053562375,0.0031632385,0.001682253,0.0018810764,0.0024011973,0.00085155707,0.0036660556],"category_scores_gemma":[0.0035754677,0.00058938627,0.0013272054,0.009238685,0.0007858535,0.00080102234,0.0011413243,0.0013702896,0.00047490632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018142573,0.000083610175,0.98314625,0.00022456114,0.00021282787,0.00010742181,0.0007084784,0.0005982115,0.00025771462,0.00039035603,0.005950423,0.00813875],"study_design_scores_gemma":[0.00001453821,0.000028872344,0.99506927,0.00012216026,0.00007157582,0.00006192173,0.0013675502,0.000531755,0.000094618226,0.000026004855,0.0025946393,0.000017032198],"about_ca_topic_score_codex":0.9979513,"about_ca_topic_score_gemma":0.9983448,"teacher_disagreement_score":0.050334193,"about_ca_system_score_codex":0.050334193,"about_ca_system_score_gemma":0.067036286,"threshold_uncertainty_score":0.36520183},"labels":[],"label_agreement":null},{"id":"W4283515283","doi":"10.1016/j.jval.2022.04.1714","title":"SA48 Patient Impact and Economic Burden of Waiting for Cataract Surgery in Canada: A Targeted Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cataract surgery; Medicine; Optometry; Surgery","score_opus":0.061970840104955294,"score_gpt":0.39238078665227666,"score_spread":0.33040994654732136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515283","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02694509,0.92898804,0.00011155309,0.019713469,0.0007596154,0.0001679738,0.008270709,0.000020383932,0.01502314],"genre_scores_gemma":[0.13507111,0.8565179,0.0005325107,0.0042581377,0.0003373627,0.00008846256,0.0018818761,0.000015881684,0.0012967397],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959572,0.0003901933,0.000653708,0.00023843556,0.0021706256,0.00058986305],"domain_scores_gemma":[0.9746456,0.007130298,0.0034217695,0.00018944278,0.0129856095,0.0016272349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041090883,0.00061753014,0.001414236,0.014563187,0.0029534202,0.007105553,0.0013079952,0.0016059086,0.0074043525],"category_scores_gemma":[0.024479682,0.00050635205,0.0022402902,0.037446205,0.0018233714,0.0015295015,0.0015814286,0.0018095444,0.00042268354],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007458111,0.0003105317,0.16993606,0.20690784,0.0049036774,0.001770749,0.0073858933,0.0012213712,0.00043597762,0.013396279,0.14554083,0.44744492],"study_design_scores_gemma":[0.00016046163,0.00016213709,0.3728304,0.32324758,0.0092594735,0.0016887044,0.025476785,0.0006538015,0.0003191669,0.0019186519,0.26397488,0.00030791137],"about_ca_topic_score_codex":0.9688873,"about_ca_topic_score_gemma":0.9855812,"teacher_disagreement_score":0.06182035,"about_ca_system_score_codex":0.06182035,"about_ca_system_score_gemma":0.2732739,"threshold_uncertainty_score":0.44854015},"labels":[],"label_agreement":null},{"id":"W4283515389","doi":"10.1016/j.jval.2022.04.1172","title":"HTA40 Challenges in Evaluating and Paying for Combination Therapies in Oncology - a Canadian Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Amgen (Canada)","funders":"","keywords":"Perspective (graphical); Medicine; Oncology; Medical physics; Internal medicine; Computer science; Artificial intelligence","score_opus":0.6811056705381711,"score_gpt":0.4993283717805609,"score_spread":0.18177729875761017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515389","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025021788,0.024147322,0.0011153317,0.9420944,0.0015379316,0.0000326265,0.00049241417,0.000027366688,0.028050413],"genre_scores_gemma":[0.4283118,0.16297741,0.021242158,0.33958638,0.016023966,0.00019967784,0.0015464551,0.00031760123,0.029794581],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97119194,0.009025211,0.0015882857,0.0013409164,0.012348025,0.004505637],"domain_scores_gemma":[0.8234548,0.060470182,0.005576701,0.0023228023,0.07920136,0.02897426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04252375,0.0010070212,0.0021673206,0.006277959,0.007242309,0.020478595,0.0050022625,0.012475181,0.013006845],"category_scores_gemma":[0.114475235,0.0008669565,0.0020982348,0.008043643,0.012560441,0.0069727805,0.0045042215,0.01629543,0.0007827045],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00022378715,0.00017436058,0.008264748,0.0008029017,0.000313715,0.0005281548,0.0016397799,0.009139199,0.00023774155,0.4178584,0.41814435,0.1426729],"study_design_scores_gemma":[0.0002888968,0.00016234553,0.027046457,0.006792511,0.0004609686,0.00057544134,0.0059011574,0.012270939,0.00027703505,0.28819188,0.65740013,0.0006321994],"about_ca_topic_score_codex":0.97998923,"about_ca_topic_score_gemma":0.9830308,"teacher_disagreement_score":0.8272039,"about_ca_system_score_codex":0.17279607,"about_ca_system_score_gemma":0.3582136,"threshold_uncertainty_score":0.9594393},"labels":[],"label_agreement":null},{"id":"W4283515565","doi":"10.1016/j.jval.2022.04.712","title":"EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Obesity; Core (optical fiber); Medicine; Management of obesity; Internal medicine; Computer science; Endocrinology; Diabetes mellitus; Weight loss; Type 2 diabetes; Telecommunications","score_opus":0.06628811665079676,"score_gpt":0.30435177880656766,"score_spread":0.2380636621557709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9435132,0.013048245,0.004839206,0.004882834,0.000330381,0.0013276861,0.011608968,0.00019779701,0.020251725],"genre_scores_gemma":[0.99112153,0.002553129,0.0022004072,0.00028923032,0.000023649813,0.000098109645,0.001889096,0.000016013975,0.0018088226],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984931,0.0008582182,0.000058561884,0.00009032536,0.00024800646,0.00025171676],"domain_scores_gemma":[0.9976714,0.0013036089,0.00021529054,0.0000816797,0.0003803006,0.00034763318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028363343,0.0008405108,0.0012371853,0.00082734245,0.00048716587,0.0012725925,0.0011243327,0.0006173892,0.005245857],"category_scores_gemma":[0.0073593576,0.0002825384,0.0027014562,0.0015369559,0.0004723208,0.00060305005,0.0008345036,0.0010645736,0.00023852897],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.084361024,0.004172915,0.19936238,0.0035844855,0.00870127,0.00065073464,0.00027941528,0.3322647,0.0012476481,0.016986001,0.030600883,0.31778854],"study_design_scores_gemma":[0.014572701,0.01248852,0.23649381,0.0015449893,0.010522376,0.00053385587,0.0011201449,0.7008008,0.0009092798,0.0074676224,0.01328387,0.00026203805],"about_ca_topic_score_codex":0.8860203,"about_ca_topic_score_gemma":0.866175,"teacher_disagreement_score":0.1139797,"about_ca_system_score_codex":0.02713442,"about_ca_system_score_gemma":0.032842394,"threshold_uncertainty_score":0.22930187},"labels":[],"label_agreement":null},{"id":"W4283515634","doi":"10.1016/j.jval.2022.04.949","title":"HPR23 Analysis of Patient Turnover Data and Patient and Medical Delay Data of Lung Cancer Patients between 2016-2020","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Lung cancer; Medical record; Medical care; Internal medicine; Pediatrics; Emergency medicine","score_opus":0.05772208341555722,"score_gpt":0.3025960606320201,"score_spread":0.24487397721646287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57275856,0.0009979234,0.0009214438,0.00096844585,0.00008969139,0.00004942744,0.4213023,0.0003175066,0.0025946854],"genre_scores_gemma":[0.6184942,0.00028361898,0.0009716661,0.000161936,0.000082769024,0.00007883216,0.37741154,0.000052735213,0.002462676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987356,0.0002722316,0.000107692336,0.00024548644,0.00032159244,0.00031730306],"domain_scores_gemma":[0.9947895,0.0018549369,0.0013932108,0.00042094343,0.00095941545,0.0005821297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020434328,0.00034244655,0.00051016745,0.0023111592,0.00022712714,0.0010786066,0.00073035684,0.0005718708,0.0057951454],"category_scores_gemma":[0.008580211,0.00024714874,0.001179942,0.003108125,0.00018888117,0.00052847463,0.0008458464,0.00077813043,0.0020971748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013043277,0.0002561803,0.8635527,0.00040287946,0.0011478894,0.00042425233,0.00018749935,0.020261208,0.0005075801,0.0014608181,0.08578257,0.024712026],"study_design_scores_gemma":[0.0001486304,0.0002490088,0.9441526,0.00012508918,0.00019035387,0.00035858323,0.0005698004,0.023288123,0.0005805712,0.00051944336,0.029772902,0.0000448909],"about_ca_topic_score_codex":0.08325768,"about_ca_topic_score_gemma":0.048921734,"teacher_disagreement_score":0.08325768,"about_ca_system_score_codex":0.0009905122,"about_ca_system_score_gemma":0.0020692775,"threshold_uncertainty_score":0.16554612},"labels":[],"label_agreement":null},{"id":"W4283516150","doi":"10.1016/j.jval.2022.04.1560","title":"RWD36 Challenges with Identification of Cancer Chemotherapy Regimens and Patient Cohorts in Administrative Claims","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Identification (biology); Medicine; Cancer chemotherapy; Chemotherapy; Oncology; Family medicine; Internal medicine","score_opus":0.0666314164350095,"score_gpt":0.29037583119194266,"score_spread":0.22374441475693316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3820135,0.012734516,0.21817066,0.29313955,0.0020799788,0.0010759498,0.047925286,0.00085274904,0.04200773],"genre_scores_gemma":[0.92507595,0.0014841354,0.050226085,0.007854004,0.0011946582,0.00045549282,0.010496276,0.00011807675,0.0030952725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9472608,0.03840023,0.0048717386,0.003857026,0.003969139,0.0016411296],"domain_scores_gemma":[0.51052403,0.4314191,0.02230463,0.018993191,0.013376378,0.0033825992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09506476,0.0005612931,0.002374948,0.003378797,0.0016139915,0.0059963125,0.0047358316,0.0031664802,0.004836157],"category_scores_gemma":[0.3589711,0.0014474468,0.0021372826,0.0043179444,0.0017575393,0.00358212,0.0046064206,0.005453566,0.0019598447],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004950153,0.00051183486,0.7463857,0.0006044337,0.0012589733,0.0006049342,0.0021790357,0.01883424,0.00018014853,0.049610943,0.06472113,0.114613585],"study_design_scores_gemma":[0.0003391642,0.00023288283,0.31660545,0.0026119936,0.0006434189,0.0015311395,0.008730042,0.21882138,0.00082373794,0.3845601,0.06488918,0.00021153626],"about_ca_topic_score_codex":0.03645627,"about_ca_topic_score_gemma":0.026803093,"teacher_disagreement_score":0.09506476,"about_ca_system_score_codex":0.001976914,"about_ca_system_score_gemma":0.0053584957,"threshold_uncertainty_score":0.5027565},"labels":[],"label_agreement":null},{"id":"W4283516214","doi":"10.1016/j.jval.2022.04.1025","title":"HSD23 Using Natural Language Processing of Unstructured EMR Data to Describe Canadian Patients with ASCVD","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Aortic Thrombus and Embolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; St. Michael's Hospital; University of Regina; Novartis (Canada)","funders":"","keywords":"Electronic medical record; Computer science; Medical record; Natural language processing; Epidemiology; Artificial intelligence; Data science; Medicine; Internal medicine; Internet privacy","score_opus":0.06000136648612014,"score_gpt":0.32111070762740707,"score_spread":0.2611093411412869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74293226,0.0011562766,0.024872007,0.0024579314,0.00014875806,0.0009770008,0.21085714,0.0028547465,0.013743834],"genre_scores_gemma":[0.8083003,0.0005857594,0.054954253,0.00044848194,0.000058533387,0.00032700694,0.13156721,0.00018002045,0.0035784976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993673,0.000109397835,0.0000885652,0.0001390488,0.0001691847,0.00012661528],"domain_scores_gemma":[0.9966356,0.0014076986,0.0002597833,0.0001874825,0.0013499564,0.00015952637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007767992,0.00048588566,0.0002273577,0.002942933,0.0009537408,0.0013072117,0.00047957076,0.00040251418,0.0024999934],"category_scores_gemma":[0.0062949113,0.000121128716,0.0004924984,0.0024090332,0.00033132156,0.00035039586,0.0005394264,0.00044465583,0.00069596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020250515,0.000454093,0.49967417,0.0017897028,0.00045455748,0.0066387965,0.014627883,0.023120483,0.027165568,0.00571309,0.11108183,0.30725473],"study_design_scores_gemma":[0.00020844972,0.00029775288,0.6044282,0.0006854105,0.0004671137,0.0035926541,0.025094043,0.11264918,0.016648954,0.0055132355,0.23001865,0.00039634274],"about_ca_topic_score_codex":0.8463507,"about_ca_topic_score_gemma":0.8597787,"teacher_disagreement_score":0.15364927,"about_ca_system_score_codex":0.005883595,"about_ca_system_score_gemma":0.010453883,"threshold_uncertainty_score":0.30910826},"labels":[],"label_agreement":null},{"id":"W4283516257","doi":"10.1016/j.jval.2022.04.601","title":"EE353 The Economic Burden of Anticholinergic Use in Adults with Overactive Bladder in the United States: A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Anticholinergic; Overactive bladder; Medicine; Urology; Intensive care medicine; Internal medicine; Alternative medicine; Pathology","score_opus":0.04646744997891307,"score_gpt":0.3342320079571843,"score_spread":0.2877645579782712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009144284,0.98399067,0.00013135865,0.0007159243,0.00019801888,0.00020417944,0.0049284548,0.0000078172325,0.00067928113],"genre_scores_gemma":[0.089612536,0.9061301,0.0007117177,0.0013492061,0.00021658027,0.00037149692,0.0013782114,0.000008722534,0.00022143085],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99195194,0.0023437503,0.0036503824,0.00053350633,0.0012032364,0.00031729683],"domain_scores_gemma":[0.96995443,0.019852683,0.007714429,0.0003473778,0.0018108027,0.00032026647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064748293,0.0010469914,0.0044746697,0.013886705,0.00048642856,0.0028163665,0.0009562064,0.0019012666,0.004459518],"category_scores_gemma":[0.043118156,0.000931691,0.011512435,0.0143302325,0.0005889208,0.0019310216,0.002049129,0.001179801,0.00027594],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066844595,0.000051546216,0.0346369,0.8132052,0.108461484,0.0002986211,0.00029488603,0.00027251805,0.00013725943,0.00039833068,0.0029639658,0.03861096],"study_design_scores_gemma":[0.00069802115,0.0002528804,0.071097024,0.6354274,0.2739564,0.00069630647,0.0007170912,0.0002604079,0.00013074603,0.0005216676,0.016145606,0.00009640627],"about_ca_topic_score_codex":0.022480277,"about_ca_topic_score_gemma":0.056480385,"teacher_disagreement_score":0.022480277,"about_ca_system_score_codex":0.003003893,"about_ca_system_score_gemma":0.0088343555,"threshold_uncertainty_score":0.044698834},"labels":[],"label_agreement":null},{"id":"W4283516308","doi":"10.1016/j.jval.2022.04.177","title":"CO80 Canada National and Provincial Cataract Surgery Wait Times (2017-2021): A Targeted Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alcon (Canada)","funders":"","keywords":"Medicine; Percentile; Cataract surgery; Coronavirus disease 2019 (COVID-19); Government (linguistics); Family medicine; Demography; Surgery; Internal medicine","score_opus":0.026196942901740235,"score_gpt":0.2794340714533809,"score_spread":0.25323712855164066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00571258,0.9331399,0.0002375074,0.014268156,0.0013006459,0.00034721437,0.032504525,0.00005556219,0.012433952],"genre_scores_gemma":[0.048540354,0.9317077,0.0014545115,0.00670478,0.0004129783,0.00033995268,0.008185627,0.000028303235,0.002625802],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99455416,0.0004263369,0.0011038719,0.0003249927,0.0028206802,0.00076993986],"domain_scores_gemma":[0.95838326,0.011010469,0.005706847,0.00034889235,0.022464687,0.002085875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005829044,0.0008521301,0.0015331571,0.028020363,0.0022282624,0.004825076,0.0014933363,0.001459852,0.009405425],"category_scores_gemma":[0.031287152,0.0005946627,0.0025647713,0.046458114,0.0011807064,0.0021204604,0.0020115545,0.00165888,0.0008889303],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004036895,0.00012237408,0.03421672,0.24949534,0.0019956368,0.0006958466,0.0019988026,0.0007401988,0.0002861793,0.008424879,0.3538708,0.34774953],"study_design_scores_gemma":[0.00013688274,0.00006787292,0.0930751,0.3978396,0.005583013,0.000588229,0.006035572,0.00032415657,0.00027446766,0.0014730582,0.49444252,0.00015962594],"about_ca_topic_score_codex":0.9337087,"about_ca_topic_score_gemma":0.9732141,"teacher_disagreement_score":0.06629127,"about_ca_system_score_codex":0.053366993,"about_ca_system_score_gemma":0.2648563,"threshold_uncertainty_score":0.38720644},"labels":[],"label_agreement":null},{"id":"W4283516611","doi":"10.1016/j.jval.2022.04.416","title":"EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Confidence interval; Internal medicine; Multiple myeloma; Hazard ratio; Adverse effect; Oncology; Pembrolizumab; Immunotherapy","score_opus":0.19992756430541408,"score_gpt":0.38641269888520613,"score_spread":0.18648513457979204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5136211,0.010927997,0.33931017,0.007897815,0.001182989,0.0022956624,0.024519723,0.0017375839,0.09850693],"genre_scores_gemma":[0.9374598,0.0015269859,0.03942024,0.0005462748,0.00012138967,0.00076750125,0.0033970338,0.0003707463,0.016390098],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964616,0.0028074752,0.000087076514,0.00018444595,0.000289151,0.00017028929],"domain_scores_gemma":[0.9858623,0.01239767,0.00043802118,0.0004822761,0.0006370278,0.00018268096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008594894,0.0010269681,0.001568887,0.0012961457,0.0003371231,0.0023839297,0.0018917162,0.0013099862,0.015459799],"category_scores_gemma":[0.022124954,0.00058163994,0.0031686106,0.0013228568,0.00031987653,0.0015605564,0.00074279204,0.0018804577,0.00090121786],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023764384,0.00044427384,0.0060457955,0.0004766967,0.0009032812,0.00015364063,0.00007041255,0.8946137,0.00028445377,0.023145765,0.0065154014,0.064970195],"study_design_scores_gemma":[0.00022479388,0.00038977384,0.0020620045,0.00016248887,0.00039713897,0.00006169818,0.000074867545,0.9783409,0.00036193518,0.012708181,0.0051856735,0.000030582305],"about_ca_topic_score_codex":0.023704512,"about_ca_topic_score_gemma":0.01598488,"teacher_disagreement_score":0.023704512,"about_ca_system_score_codex":0.00367479,"about_ca_system_score_gemma":0.0025636116,"threshold_uncertainty_score":0.051718175},"labels":[],"label_agreement":null},{"id":"W4283518065","doi":"10.1016/j.jval.2022.04.264","title":"EE12 A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab As a First-Line, 12-Month, Fixed Duration Therapy in Chronic Lymphocytic Leukemia (CLL) in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Foothills Medical Centre","funders":"","keywords":"Obinutuzumab; Venetoclax; Medicine; Bendamustine; Fludarabine; Rituximab; Chlorambucil; Internal medicine; Ibrutinib; Population; Oncology; Chronic lymphocytic leukemia; Alemtuzumab; Cyclophosphamide; Leukemia; Chemotherapy; Lymphoma; Transplantation","score_opus":0.046311378443070615,"score_gpt":0.3219957015005659,"score_spread":0.2756843230574953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91442764,0.01621442,0.0067862584,0.004178425,0.00019263217,0.0026642133,0.037753984,0.00029243433,0.017490078],"genre_scores_gemma":[0.9847024,0.0024244427,0.0030201294,0.00044045897,0.000040796927,0.0003074597,0.0054910313,0.00003865214,0.0035346067],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99577004,0.0023683975,0.00014765319,0.00029552318,0.00053050247,0.00088781625],"domain_scores_gemma":[0.9892567,0.0075007775,0.00069492654,0.0002715498,0.0014830438,0.00079297466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005887216,0.0015609775,0.002994201,0.0018692226,0.0009570911,0.0028240923,0.0025225433,0.001573542,0.007187695],"category_scores_gemma":[0.018632619,0.0012428873,0.004903828,0.0032053401,0.0010180853,0.0009210123,0.0009831613,0.0023751548,0.00027442197],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030954804,0.0011712767,0.034405407,0.0017667797,0.007326566,0.00037607562,0.00014319878,0.8754177,0.0005165212,0.007077563,0.010308744,0.030535392],"study_design_scores_gemma":[0.017366484,0.004479752,0.08204094,0.00089950336,0.011718273,0.0003786052,0.000593,0.8675155,0.0005485711,0.004452374,0.009703117,0.00030382266],"about_ca_topic_score_codex":0.9315313,"about_ca_topic_score_gemma":0.8869869,"teacher_disagreement_score":0.06846869,"about_ca_system_score_codex":0.05448339,"about_ca_system_score_gemma":0.042151473,"threshold_uncertainty_score":0.39530653},"labels":[],"label_agreement":null},{"id":"W4283518363","doi":"10.1016/j.jval.2022.04.285","title":"EE33 Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre; Princess Margaret Cancer Centre; University of Manitoba; McMaster University; ABB (Canada)","funders":"","keywords":"Medicine; Myeloid leukemia; Total cost; Incidence (geometry); Health care; Productivity; Economic cost; Hematopoietic stem cell transplantation; Intensive care medicine; Transplantation; Emergency medicine; Internal medicine","score_opus":0.309785688474981,"score_gpt":0.4123878680048094,"score_spread":0.10260217952982842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93615043,0.0036134478,0.0008185765,0.008400012,0.00013336858,0.00031423432,0.029060012,0.000037963673,0.021471933],"genre_scores_gemma":[0.9862829,0.0016131363,0.00087994576,0.00034458018,0.000029617218,0.000039651495,0.0064952965,0.000014603939,0.0043004435],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99827456,0.00036452868,0.00010065031,0.00008459181,0.00071148004,0.00046416165],"domain_scores_gemma":[0.9912277,0.0013077455,0.00058625377,0.000109103996,0.0055762534,0.0011930009],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002256797,0.00040485605,0.00054766715,0.0023665922,0.0014565284,0.0024649748,0.00079831714,0.00053695816,0.0028371774],"category_scores_gemma":[0.014875501,0.0002337642,0.0007236728,0.0052444804,0.0005975062,0.00049956597,0.0008104055,0.0010606565,0.00015285474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017375528,0.0004851562,0.7857078,0.000489325,0.000998928,0.000579284,0.00053518324,0.08448966,0.0003587904,0.012800242,0.050978698,0.060839396],"study_design_scores_gemma":[0.0005130226,0.0002975193,0.86033976,0.0003555495,0.0004401044,0.00016087184,0.003247473,0.109294,0.00062425464,0.0021831298,0.022416184,0.00012815038],"about_ca_topic_score_codex":0.99737537,"about_ca_topic_score_gemma":0.9977539,"teacher_disagreement_score":0.09354796,"about_ca_system_score_codex":0.09354796,"about_ca_system_score_gemma":0.09870117,"threshold_uncertainty_score":0.67874116},"labels":[],"label_agreement":null},{"id":"W4283518383","doi":"10.1016/j.jval.2022.04.242","title":"CO148 Opioid Prescribing Among Commercially Insured Men Undergoing a Procedure for the Treatment Benign Prostatic Hyperplasia","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; Canadian Institute of Mining, Metallurgy and Petroleum","funders":"","keywords":"Medicine; Opioid; Opioid epidemic; Incidence (geometry); Hyperplasia; Benign prostatic hyperplasia (BPH); Prostate; Internal medicine","score_opus":0.07299414170132784,"score_gpt":0.34096830118201066,"score_spread":0.2679741594806828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987061,0.00019119104,0.000016764116,0.000105023726,0.000008678872,0.00000570817,0.0003159707,0.0000014053567,0.0006491323],"genre_scores_gemma":[0.99924266,0.00012586886,0.00002229252,0.00006943791,0.000017498583,0.0000037588609,0.00011871119,9.1613384e-7,0.00039886154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996736,0.00007731216,0.00003702282,0.000047153186,0.00009929984,0.000065560176],"domain_scores_gemma":[0.99836,0.00038508978,0.00085205474,0.000052009833,0.00009056561,0.00026034028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018747913,0.00012778123,0.00019162105,0.0005369014,0.00050768326,0.0006145454,0.00023221964,0.0005274163,0.0031580057],"category_scores_gemma":[0.0019705785,0.00027901802,0.00037174037,0.00083511183,0.0002411093,0.00036965925,0.00038792574,0.00064042414,0.00024780704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009641419,0.000092934504,0.9980227,0.000010224857,0.00003730052,0.00009012745,0.00012874849,0.000025056695,0.0001915307,0.000025802277,0.000120744604,0.0011584254],"study_design_scores_gemma":[0.000004868193,0.000054164186,0.999114,0.000007631882,0.000013759482,0.00013843543,0.00037291896,0.00011338947,0.00003313792,0.000012340367,0.00013220287,0.0000030661172],"about_ca_topic_score_codex":0.026384246,"about_ca_topic_score_gemma":0.04114244,"teacher_disagreement_score":0.026384246,"about_ca_system_score_codex":0.00054724474,"about_ca_system_score_gemma":0.0005723008,"threshold_uncertainty_score":0.052461326},"labels":[],"label_agreement":null},{"id":"W4283518453","doi":"10.1016/j.jval.2022.04.724","title":"EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bleed; Clotting factor; Reimbursement; Population; Intensive care medicine; Pediatrics; Internal medicine; Surgery; Health care","score_opus":0.0339048881023621,"score_gpt":0.31997298410178954,"score_spread":0.28606809599942745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98323166,0.011557417,0.00019400076,0.00073658617,0.00007376645,0.00003725365,0.0007091024,0.000011791865,0.0034484058],"genre_scores_gemma":[0.9977526,0.0012499267,0.00011990832,0.000105419036,0.000049715854,0.000012490765,0.00037315884,0.0000019329839,0.00033495043],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994924,0.00028075892,0.00003834594,0.00003540999,0.000064902255,0.00008805006],"domain_scores_gemma":[0.99952376,0.00027590676,0.000099688754,0.00001560433,0.000018254099,0.00006680249],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005488076,0.00026070568,0.0008670094,0.00028769847,0.00012198741,0.00060604163,0.0001688072,0.00043886458,0.0040258514],"category_scores_gemma":[0.0021882867,0.00013811323,0.0019624627,0.00040912942,0.00014957089,0.0004001832,0.00022651858,0.00060849654,0.00022556641],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42240047,0.0029130622,0.17553937,0.0014898025,0.008228834,0.0008245898,0.00010479095,0.013091961,0.0047569172,0.002470517,0.0045057097,0.36367404],"study_design_scores_gemma":[0.043440603,0.068925634,0.8283246,0.0007884109,0.015101269,0.0024824438,0.0004034262,0.026314627,0.0038750859,0.0016910852,0.008557454,0.00009531838],"about_ca_topic_score_codex":0.0019065901,"about_ca_topic_score_gemma":0.001724047,"teacher_disagreement_score":0.0040258514,"about_ca_system_score_codex":0.0006856312,"about_ca_system_score_gemma":0.00045832206,"threshold_uncertainty_score":0.013467789},"labels":[],"label_agreement":null},{"id":"W4283520061","doi":"10.1016/j.jval.2022.04.286","title":"EE34 Comparing the Cost-Effectiveness of the Otago Exercise Programme Among Older Women and Men: A Secondary Analysis of a Randomized Controlled Trial","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Medicine; Randomized controlled trial; Demography; Rate ratio; Incidence (geometry); Health care; Confidence interval; Physical therapy; Gerontology; Internal medicine","score_opus":0.20346855827437949,"score_gpt":0.3857099857577455,"score_spread":0.18224142748336603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283520061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9521513,0.021078922,0.0031223719,0.0013182593,0.0011971769,0.010306766,0.005779185,0.00021108365,0.004834996],"genre_scores_gemma":[0.98375976,0.0041957255,0.0021108761,0.0009428937,0.0004965586,0.0045396206,0.0014726006,0.000025235511,0.0024567093],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9936047,0.0044726874,0.00069076364,0.00044955898,0.00038377236,0.00039847067],"domain_scores_gemma":[0.9935934,0.0044189207,0.0009108538,0.00031657857,0.00033535273,0.00042492617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004681385,0.0016396577,0.004939846,0.0012503522,0.00053618336,0.0014287266,0.00078214897,0.0032518483,0.011366611],"category_scores_gemma":[0.012946783,0.0007234987,0.010059978,0.0015821808,0.000925843,0.0011372832,0.00096835184,0.0033246328,0.00060966477],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96341306,0.0021977103,0.0010912302,0.003821717,0.014477224,0.000050153092,0.000054524633,0.00036465673,0.0005052845,0.00016620045,0.00038153824,0.013476656],"study_design_scores_gemma":[0.9183035,0.045296215,0.007936657,0.0005984382,0.02515948,0.000040051033,0.000078358695,0.00083990284,0.0004009523,0.00026914736,0.0010390904,0.000038176855],"about_ca_topic_score_codex":0.0061417115,"about_ca_topic_score_gemma":0.0058900355,"teacher_disagreement_score":0.011366611,"about_ca_system_score_codex":0.0011563501,"about_ca_system_score_gemma":0.0016962942,"threshold_uncertainty_score":0.03802508},"labels":[],"label_agreement":null},{"id":"W4283520789","doi":"10.1016/j.jval.2022.04.610","title":"EE362 Microcosting of Cataract Surgery Complications from a US Provider Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Cataract surgery; Perspective (graphical); Intensive care medicine; Surgery; General surgery","score_opus":0.4938335676468563,"score_gpt":0.43453481711336384,"score_spread":0.059298750533492484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283520789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8836864,0.017166596,0.0026231008,0.02672052,0.0002566062,0.00006987814,0.011011806,0.000030032725,0.05843493],"genre_scores_gemma":[0.99650574,0.0011293864,0.00028570066,0.0004379497,0.00013935324,0.000007998496,0.0007282484,0.0000054290344,0.0007602561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984799,0.0006001978,0.00012306083,0.00010754204,0.00042294664,0.00026642103],"domain_scores_gemma":[0.98797053,0.0044114287,0.0046975766,0.00030180818,0.0015747279,0.0010439007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015766788,0.00014931582,0.00024515504,0.00216084,0.00037032535,0.0017568568,0.0002548691,0.00060085097,0.0064144703],"category_scores_gemma":[0.015086891,0.00014593477,0.00102527,0.0028340858,0.00040898554,0.0008132046,0.00060020626,0.0012755241,0.00016950496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069764926,0.0002840535,0.8914647,0.00020172246,0.0006028187,0.00031844326,0.00020220995,0.0038098134,0.00025307745,0.01791059,0.011704834,0.07255001],"study_design_scores_gemma":[0.000045309505,0.0002513468,0.97063136,0.00035439702,0.00042250002,0.001033027,0.0011118231,0.0062896363,0.00049197616,0.008040348,0.011287014,0.000041207433],"about_ca_topic_score_codex":0.037524883,"about_ca_topic_score_gemma":0.044400115,"teacher_disagreement_score":0.037524883,"about_ca_system_score_codex":0.0028536099,"about_ca_system_score_gemma":0.0018366344,"threshold_uncertainty_score":0.074612916},"labels":[],"label_agreement":null},{"id":"W4283521197","doi":"10.1016/j.jval.2022.04.034","title":"P25 Income and Equity Effect of Modelled Sugar Tax and Fruit and Vegetable Subsidy Program across Different Income Groups in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Food Security and Health in Diverse Populations","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Subsidy; Equity (law); Sugar; Economics; Income tax; Gross income; Agricultural economics; Public economics; Business; State income tax; Food science; Chemistry; Tax reform; Political science","score_opus":0.10202356290991975,"score_gpt":0.42831701411650436,"score_spread":0.3262934512065846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95915234,0.0024705762,0.00020904903,0.0041437033,0.0001330299,0.00019947483,0.019207181,0.00006157723,0.014423022],"genre_scores_gemma":[0.9851313,0.00047241262,0.00012706268,0.00033531964,0.000020662512,0.000032616153,0.0029702121,0.000014106568,0.010896284],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9961617,0.00040519252,0.00013945745,0.00035193615,0.0005559243,0.0023858382],"domain_scores_gemma":[0.99251115,0.0010479072,0.00086871494,0.00018269489,0.0023525243,0.0030370706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015562894,0.000415219,0.0012578603,0.0011855423,0.0023140174,0.0022495184,0.0023101312,0.0010129759,0.017155696],"category_scores_gemma":[0.0059257443,0.0004108515,0.0028272779,0.0023381072,0.0010977492,0.00084380136,0.002165796,0.0028420126,0.00043372886],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033834146,0.00073788734,0.94444054,0.00016055423,0.001102241,0.00028970046,0.0008408892,0.004599046,0.00020977297,0.0055948347,0.01831482,0.02032632],"study_design_scores_gemma":[0.00024730893,0.00022618887,0.9884752,0.00009893615,0.0006313534,0.000040636824,0.002551304,0.0027337568,0.00020917995,0.00043974828,0.004306884,0.00003956776],"about_ca_topic_score_codex":0.9974343,"about_ca_topic_score_gemma":0.9977608,"teacher_disagreement_score":0.04735666,"about_ca_system_score_codex":0.04735666,"about_ca_system_score_gemma":0.06945415,"threshold_uncertainty_score":0.34359825},"labels":[],"label_agreement":null},{"id":"W4283521513","doi":"10.1016/j.jval.2022.04.944","title":"HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers?","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jurisdiction; Pandemic; Coronavirus disease 2019 (COVID-19); Business; Prescription drug; Public health; Demographic economics; Actuarial science; Medical prescription; Political science; Economics; Medicine; Law","score_opus":0.07219326008814375,"score_gpt":0.26731051966740016,"score_spread":0.1951172595792564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521513","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28458607,0.016024625,0.00030476338,0.6229626,0.0019448819,0.00008258754,0.042899627,0.000050066945,0.031144852],"genre_scores_gemma":[0.9254028,0.008753682,0.00043905972,0.037300345,0.0011132736,0.00006536822,0.010783994,0.00006264304,0.01607874],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9965616,0.00022273655,0.00010819779,0.0002164735,0.0009836853,0.001907291],"domain_scores_gemma":[0.98257875,0.001859721,0.0022622813,0.00025040534,0.0061063017,0.006942454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035465239,0.0003683234,0.00071615016,0.0016142488,0.0055474755,0.0061025983,0.0024495253,0.004391577,0.0073100994],"category_scores_gemma":[0.019348757,0.0003152965,0.00078807474,0.004200656,0.002541453,0.003140042,0.0020526533,0.0077594277,0.0005833041],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044647194,0.0001913427,0.4055891,0.00030326075,0.00024786394,0.00080686144,0.0073127984,0.001105152,0.00013751155,0.043060403,0.5053238,0.03547542],"study_design_scores_gemma":[0.00014108859,0.00011445463,0.72280025,0.0022077989,0.00032957608,0.0004163267,0.04871971,0.005235305,0.00037357278,0.02064762,0.19869852,0.00031572478],"about_ca_topic_score_codex":0.9938933,"about_ca_topic_score_gemma":0.9965372,"teacher_disagreement_score":0.056536384,"about_ca_system_score_codex":0.056536384,"about_ca_system_score_gemma":0.12449618,"threshold_uncertainty_score":0.4102021},"labels":[],"label_agreement":null},{"id":"W4283521763","doi":"10.1016/j.jval.2022.04.1448","title":"PCR105 The Impact of Key Health State Transitions on Health-Related Quality of Life (HRQOL) in Duchenne Muscular Dystrophy (DMD): A Qualitative Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Health related quality of life; Quality of life (healthcare); Key (lock); Medicine; Gerontology; Physical medicine and rehabilitation; Physical therapy; Environmental health; Computer science; Nursing; Internal medicine; Disease; Computer security","score_opus":0.05509591619869709,"score_gpt":0.383970738274185,"score_spread":0.3288748220754879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940696,0.00011366918,0.00085593393,0.001241243,0.000029017043,0.00012476917,0.00020097842,0.000009064472,0.0033557764],"genre_scores_gemma":[0.9978903,0.00009277899,0.0005262374,0.00025896187,0.0000046776568,0.00022826644,0.00005382905,0.000008951885,0.00093602267],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9893139,0.008041097,0.00024519072,0.0003645945,0.00062613253,0.001409122],"domain_scores_gemma":[0.9741372,0.019111887,0.001489918,0.0005101115,0.0018353537,0.002915542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014539788,0.00040398803,0.00055083656,0.0010775231,0.0055693733,0.0031569912,0.0011474529,0.0011482282,0.00296304],"category_scores_gemma":[0.020891003,0.0005073521,0.0006835079,0.000948624,0.00478795,0.002009227,0.0044731996,0.0037100685,0.00025698144],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007084593,0.00020846757,0.022136165,0.00017425146,0.000018848146,0.00027487217,0.9684572,0.000110902285,0.00066221517,0.0011135233,0.0004989744,0.006273645],"study_design_scores_gemma":[0.000012323364,0.00013763638,0.014669885,0.00011422466,0.000010567323,0.00010831976,0.9812764,0.00015782633,0.000339536,0.0003136208,0.0028300548,0.00002967823],"about_ca_topic_score_codex":0.013965616,"about_ca_topic_score_gemma":0.024344139,"teacher_disagreement_score":0.014539788,"about_ca_system_score_codex":0.006327246,"about_ca_system_score_gemma":0.0052491915,"threshold_uncertainty_score":0.0768947},"labels":[],"label_agreement":null},{"id":"W4283521784","doi":"10.1016/j.jval.2022.04.1194","title":"HTA62 Evaluating the Gaps in Health Technology Assessment (HTA) Requirements: A Comparative Analysis of HTA Systems of Europe, Canada, and United States with Asia Pacific Region","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Asia pacific; Health technology; Geography; Political science; International trade; Business; Health care","score_opus":0.4248246450838225,"score_gpt":0.4568233006471045,"score_spread":0.03199865556328202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83461744,0.010454439,0.008639117,0.011076519,0.00015950223,0.0003495647,0.037064325,0.0002376982,0.09740137],"genre_scores_gemma":[0.9861421,0.0009870194,0.0031398323,0.0003899839,0.00004376095,0.00007083283,0.0072651827,0.00004046875,0.0019209424],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.986392,0.0036420233,0.0005598783,0.00034895734,0.0074207517,0.001636347],"domain_scores_gemma":[0.91462564,0.046786606,0.004848214,0.0023276473,0.027878547,0.0035333184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019555794,0.00028414413,0.00092577474,0.0065128873,0.0013626569,0.00432698,0.0009955633,0.00096630404,0.004056389],"category_scores_gemma":[0.06989699,0.00027465963,0.0013572476,0.0122243995,0.001227553,0.0022213547,0.00220533,0.0013375342,0.0003131874],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026448986,0.0005091259,0.5768419,0.0015018098,0.001510252,0.00039854538,0.0033354412,0.04497925,0.0008663224,0.13222745,0.05142822,0.18375671],"study_design_scores_gemma":[0.00020921059,0.00040823352,0.9222846,0.00073294534,0.00057100266,0.00018209843,0.004422309,0.020201366,0.0015760951,0.012031404,0.03727832,0.00010238026],"about_ca_topic_score_codex":0.5691947,"about_ca_topic_score_gemma":0.50436544,"teacher_disagreement_score":0.98516864,"about_ca_system_score_codex":0.014831348,"about_ca_system_score_gemma":0.036564182,"threshold_uncertainty_score":0.86668485},"labels":[],"label_agreement":null},{"id":"W4283521874","doi":"10.1016/j.jval.2022.04.1010","title":"HSD8 Real-World Patient Persistence: A Comparison of Prostaglandin Analogs Used for the Treatment of Open-Angle Glaucoma or Ocular Hypertension","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Travoprost; Bimatoprost; Latanoprost; Medicine; Persistence (discontinuity); Glaucoma; Intraocular pressure; Ophthalmology; Prostaglandin analogue; Internal medicine","score_opus":0.10695162705707968,"score_gpt":0.35653611630490095,"score_spread":0.24958448924782128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99723166,0.0013133305,0.0000858309,0.00006787725,0.000022130656,0.000027784863,0.0006207208,0.000004154485,0.00062658155],"genre_scores_gemma":[0.9985166,0.00043560012,0.000121081874,0.00005383778,0.000031264823,0.000029974553,0.0006405414,0.000002869195,0.00016817448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998103,0.0008962662,0.0002917856,0.0002412017,0.0002962071,0.0001715928],"domain_scores_gemma":[0.99238306,0.0039392114,0.0022781517,0.00040058515,0.0004045967,0.0005944017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018975963,0.00030282035,0.00096133014,0.000717339,0.00037165353,0.0011532952,0.00035218924,0.0006594386,0.0042311396],"category_scores_gemma":[0.00867064,0.00012731444,0.0014605772,0.0008670366,0.00041491116,0.0011132535,0.0007518378,0.0007545459,0.0003289391],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19117926,0.0028371797,0.7268052,0.0010386675,0.0038083515,0.0003697034,0.00093545485,0.0006122569,0.0011213133,0.0004981127,0.0008521367,0.069942355],"study_design_scores_gemma":[0.0048892344,0.05847812,0.92266774,0.00022817041,0.0022613865,0.0015016289,0.0030120148,0.0017173312,0.0007353815,0.0004081718,0.003970901,0.00013000658],"about_ca_topic_score_codex":0.0012289808,"about_ca_topic_score_gemma":0.001326772,"teacher_disagreement_score":0.0042311396,"about_ca_system_score_codex":0.0006561367,"about_ca_system_score_gemma":0.0005215916,"threshold_uncertainty_score":0.014154553},"labels":[],"label_agreement":null},{"id":"W4283522130","doi":"10.1016/j.jval.2022.04.801","title":"EPH48 Operationalizing the 2019 GINA Asthma Treatment Steps for Application to Real-World Data from the UK","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Operationalization; Real world data; Asthma; Real world evidence; Proxy (statistics); Asthma management; Medicine; Computer science; Data science; Internal medicine","score_opus":0.10503792245288969,"score_gpt":0.38474080539840766,"score_spread":0.279702882945518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55890167,0.0020357065,0.06817311,0.030845571,0.0010018724,0.0026434048,0.21984623,0.005129322,0.11142312],"genre_scores_gemma":[0.8122384,0.00065786217,0.099883005,0.0015612533,0.00012052947,0.0007987239,0.07829673,0.00033430144,0.00610927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99526113,0.0021142196,0.00058623566,0.0005302098,0.0009991062,0.000509192],"domain_scores_gemma":[0.98583835,0.0066011185,0.0012892348,0.0015125169,0.004016845,0.00074195047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0081181135,0.00055918546,0.00057405117,0.0015943698,0.000557262,0.0035434128,0.00076876755,0.0009134023,0.009133246],"category_scores_gemma":[0.041696113,0.00030253697,0.00093042507,0.0024559163,0.00050746143,0.0016497971,0.0025609196,0.0010063406,0.0026870884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026743459,0.00051254546,0.49174094,0.0021710608,0.0006570359,0.0005554579,0.002436189,0.058251128,0.0023124444,0.032139454,0.18254115,0.22400826],"study_design_scores_gemma":[0.0007176981,0.000969576,0.5129224,0.0017212398,0.00034053012,0.00046371183,0.006423978,0.21712768,0.00663611,0.02779109,0.22462514,0.0002608424],"about_ca_topic_score_codex":0.08908215,"about_ca_topic_score_gemma":0.07652792,"teacher_disagreement_score":0.08908215,"about_ca_system_score_codex":0.0025388543,"about_ca_system_score_gemma":0.005963168,"threshold_uncertainty_score":0.17712724},"labels":[],"label_agreement":null},{"id":"W4283522197","doi":"10.1016/j.jval.2022.04.1519","title":"PCR176 Time Trade-Off Utility Values for Health States Characterizing Progressive Muscular Degeneration in Duchenne Muscular Dystrophy (DMD)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Ambulatory; Medicine; Cardiorespiratory fitness; Physical therapy; Duchenne muscular dystrophy; Physical medicine and rehabilitation; Gerontology; Surgery; Internal medicine","score_opus":0.017378348042804168,"score_gpt":0.2821608258928954,"score_spread":0.2647824778500912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7306575,0.0024685087,0.24773341,0.0009506409,0.00015952876,0.00034758326,0.004039193,0.0012557971,0.012387803],"genre_scores_gemma":[0.9623157,0.00020481876,0.033485353,0.00021987449,0.000023915305,0.00016541533,0.0014522079,0.0001374464,0.001995442],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961701,0.0017404747,0.00018723575,0.0007154729,0.00083183154,0.00035479767],"domain_scores_gemma":[0.96704906,0.028677445,0.0012625975,0.0012226152,0.0014605533,0.00032782144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007829341,0.0007024431,0.00059715094,0.0017575007,0.00042376757,0.0020587621,0.0005791868,0.0011096906,0.005090384],"category_scores_gemma":[0.031718977,0.00030949787,0.0007781876,0.0011553114,0.0010194522,0.0010418781,0.00062556786,0.0011461065,0.0008682023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009427668,0.000976872,0.20580567,0.0008311651,0.000590885,0.0011705522,0.00077805185,0.286968,0.096872,0.045598768,0.0038000038,0.3471803],"study_design_scores_gemma":[0.0002486311,0.0022910456,0.10173692,0.00020004903,0.00033696217,0.0017723205,0.00075042614,0.69981956,0.11239817,0.07357273,0.0066070235,0.00026611818],"about_ca_topic_score_codex":0.0014995115,"about_ca_topic_score_gemma":0.0016171756,"teacher_disagreement_score":0.007829341,"about_ca_system_score_codex":0.0014922227,"about_ca_system_score_gemma":0.000799352,"threshold_uncertainty_score":0.041405976},"labels":[],"label_agreement":null},{"id":"W4283522293","doi":"10.1016/j.jval.2022.04.997","title":"HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Normative; Vaccination; Pillar; Coronavirus disease 2019 (COVID-19); Business; Political science; Medicine; Geography; Virology; Engineering; Law","score_opus":0.10357791320472587,"score_gpt":0.4248794316950125,"score_spread":0.32130151849028665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522293","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26401109,0.025110492,0.0021106463,0.58709365,0.0019213458,0.00031148962,0.0014120538,0.00012380764,0.117905416],"genre_scores_gemma":[0.94356704,0.007357107,0.0013681164,0.033724632,0.00040654995,0.00012829107,0.000410169,0.000053767944,0.012984344],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.99356186,0.0017512888,0.00028692768,0.00038892316,0.0013442639,0.0026666045],"domain_scores_gemma":[0.9894021,0.0032191835,0.0013353092,0.0003781511,0.003041117,0.0026241606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010523508,0.00022928405,0.00040399592,0.0007572994,0.001652292,0.0034318748,0.0010376134,0.002286913,0.0050860485],"category_scores_gemma":[0.015821368,0.00034954838,0.0005745608,0.0006977365,0.0017952815,0.0013475469,0.0024249535,0.0038462982,0.0003574469],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065993844,0.00042669257,0.12886232,0.0032796422,0.00026787294,0.003219805,0.03293452,0.0013291516,0.018106403,0.4282044,0.10267213,0.28003713],"study_design_scores_gemma":[0.00011590603,0.0004759521,0.20643045,0.0038052448,0.00014385174,0.0006976339,0.014828774,0.0007603678,0.0031165234,0.012377578,0.7571489,0.00009880536],"about_ca_topic_score_codex":0.21751049,"about_ca_topic_score_gemma":0.20786947,"teacher_disagreement_score":0.21751049,"about_ca_system_score_codex":0.014584703,"about_ca_system_score_gemma":0.052498855,"threshold_uncertainty_score":0.43248886},"labels":[],"label_agreement":null},{"id":"W4283522453","doi":"10.1016/j.jval.2022.04.241","title":"CO147 Driving Outcomes in Mild Cognitive Impairment/Alzheimer's Disease - a Review of Association between Driving Simulator Measures and Clinical Outcomes Assessments","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognition; Montreal Cognitive Assessment; Cognitive impairment; Psychology; Association (psychology); Driving simulator; Dementia; Physical medicine and rehabilitation; Audiology; Disease; Clinical psychology; Medicine; Psychiatry; Simulation; Computer science; Internal medicine","score_opus":0.3129230384004081,"score_gpt":0.5638753659952257,"score_spread":0.2509523275948176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00059824064,0.9991054,0.000023299368,0.000035811267,0.000032644894,0.000016478389,0.000119339245,0.0000012211979,0.000067580724],"genre_scores_gemma":[0.0076525975,0.9918122,0.00016694625,0.000105473584,0.00004782237,0.00003861315,0.00013143572,0.0000012132689,0.000043708642],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99715924,0.00070832035,0.0011556327,0.00031492673,0.00057998794,0.000081950726],"domain_scores_gemma":[0.989846,0.0076519856,0.0015814183,0.00010387354,0.00071690994,0.00009981593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043512373,0.0009747912,0.0058179796,0.005001219,0.00029818353,0.001612867,0.001113173,0.0011858982,0.0027034392],"category_scores_gemma":[0.015323354,0.0005647729,0.006472719,0.0057904683,0.0004947654,0.00098879,0.0010586814,0.0010837049,0.00023335402],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093879225,0.00009118776,0.007430192,0.68322676,0.032829463,0.00008115049,0.00015687791,0.00020322818,0.00020920693,0.00033397926,0.0028239088,0.27167526],"study_design_scores_gemma":[0.0009232683,0.0010296227,0.063579544,0.64653224,0.22485514,0.00081184023,0.000473731,0.00030341838,0.00036317576,0.000812766,0.060172748,0.00014260059],"about_ca_topic_score_codex":0.0091364095,"about_ca_topic_score_gemma":0.026094398,"teacher_disagreement_score":0.0091364095,"about_ca_system_score_codex":0.0011886265,"about_ca_system_score_gemma":0.0032081127,"threshold_uncertainty_score":0.023011863},"labels":[],"label_agreement":null},{"id":"W4283522792","doi":"10.1016/j.jval.2022.04.353","title":"EE100 Treatment-Related Lost Productivity in Paroxysmal Nocturnal Hemoglobinuria: A Comparison of Investigational Subcutaneous Ravulizumab and Pegcetacoplan in the United States","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine","score_opus":0.04406080065395183,"score_gpt":0.2992194460803861,"score_spread":0.25515864542643424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964765,0.0026186774,0.00004086817,0.00012576558,0.000024651536,0.0000112666585,0.00024255502,0.0000031344737,0.00045652062],"genre_scores_gemma":[0.9989913,0.0006245142,0.000029147086,0.00008476306,0.000013080376,0.0000054082307,0.00017160781,0.0000010751669,0.00007908958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999225,0.00035924732,0.00006358078,0.00010959486,0.000142427,0.000100012476],"domain_scores_gemma":[0.9988765,0.0004012,0.00042826205,0.000040623152,0.00006774177,0.0001855607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009875562,0.00023157026,0.00054127,0.00038938978,0.00018879511,0.0005711461,0.00034165167,0.00043436768,0.0009022438],"category_scores_gemma":[0.0019768237,0.00012606292,0.00094636035,0.00064521004,0.00028634994,0.00035821664,0.00029332642,0.00064806774,0.000085949825],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.089740865,0.0024718186,0.7917511,0.0005078708,0.0045203655,0.00039281274,0.00029330445,0.0009335964,0.002245532,0.00026974693,0.0020603212,0.10481267],"study_design_scores_gemma":[0.0020804878,0.005470379,0.9888305,0.00006631733,0.0011692453,0.0002579556,0.00032561785,0.00086057064,0.00022149751,0.000051579264,0.0006472226,0.000018617136],"about_ca_topic_score_codex":0.00999835,"about_ca_topic_score_gemma":0.01564979,"teacher_disagreement_score":0.00999835,"about_ca_system_score_codex":0.00091723306,"about_ca_system_score_gemma":0.00061711913,"threshold_uncertainty_score":0.019880295},"labels":[],"label_agreement":null},{"id":"W4283523166","doi":"10.1016/j.jval.2022.04.485","title":"EE237 The Risk-Based Price: Incorporating Uncertainty and Risk Attitues in Health Technology Pricing","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Value (mathematics); Actuarial science; Value of information; Net present value; Present value; Economics; Risk aversion (psychology); Optimal decision; Risk management; Expected utility hypothesis; Risk analysis (engineering); Microeconomics; Production (economics); Business; Computer science; Financial economics; Decision tree; Statistics; Mathematics; Finance","score_opus":0.2385129450787944,"score_gpt":0.3979705544848342,"score_spread":0.1594576094060398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523166","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11280037,0.0022802898,0.8485765,0.009105293,0.0009753878,0.00011714206,0.00041232846,0.00020398146,0.025528722],"genre_scores_gemma":[0.940946,0.0009326484,0.04468004,0.00041845703,0.00068704935,0.000070632515,0.00017262514,0.00012051304,0.01197208],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9976096,0.001546094,0.00009551611,0.00018661327,0.00040061856,0.00016156826],"domain_scores_gemma":[0.9879638,0.010114022,0.00042639446,0.00042851342,0.0007151258,0.00035222844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060493024,0.0006717335,0.00119215,0.0008705354,0.0004966316,0.004387768,0.0015579195,0.003064719,0.0067975866],"category_scores_gemma":[0.037256803,0.0007746159,0.00093548157,0.0014221092,0.001259366,0.008581485,0.0015972158,0.00314632,0.0004457354],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013277197,0.00018120694,0.003676013,0.000086749395,0.00014157082,0.00020501032,0.0001762311,0.6139932,0.00022526139,0.3334851,0.003865648,0.043831218],"study_design_scores_gemma":[0.000010538193,0.000025619767,0.00042333157,0.000018876228,0.000021834687,0.000021691396,0.000022251137,0.8782714,0.000048403857,0.120182924,0.00093384244,0.000019253963],"about_ca_topic_score_codex":0.011263678,"about_ca_topic_score_gemma":0.008615392,"teacher_disagreement_score":0.011263678,"about_ca_system_score_codex":0.0016168794,"about_ca_system_score_gemma":0.0015984365,"threshold_uncertainty_score":0.031992137},"labels":[],"label_agreement":null},{"id":"W4283523329","doi":"10.1016/j.jval.2022.04.191","title":"CO95 A Matching-Adjusted Indirect Comparison of Filgotinib Versus Tofacitinib for Moderately to Severely Active Ulcerative Colitis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tofacitinib; Ulcerative colitis; Medicine; Matching (statistics); Internal medicine; Pathology","score_opus":0.06464436844036901,"score_gpt":0.3386565124043133,"score_spread":0.2740121439639443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9465407,0.024512306,0.0048342394,0.0012683416,0.0018583043,0.0004712168,0.012207704,0.00016975448,0.008137464],"genre_scores_gemma":[0.9938685,0.0006743406,0.00089607685,0.0004202971,0.00016138154,0.00014186402,0.0016547673,0.00002162191,0.002161222],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98969114,0.006712806,0.00062990445,0.0015325557,0.00064052304,0.0007931127],"domain_scores_gemma":[0.9911851,0.00520911,0.0015284872,0.0010674081,0.000541834,0.00046797117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005058539,0.0013338977,0.0025573133,0.0009164835,0.00054383214,0.0016502686,0.0017387534,0.0022629232,0.012208104],"category_scores_gemma":[0.018574933,0.0008110676,0.008999558,0.0011350834,0.00061631977,0.0010884487,0.0013471236,0.0023447424,0.0009190527],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.61163723,0.00081782544,0.12982076,0.0039085653,0.19640109,0.0004968164,0.000231692,0.004056133,0.0026105053,0.0017193151,0.0072107203,0.041089427],"study_design_scores_gemma":[0.14518236,0.04372498,0.42279798,0.0014263764,0.335796,0.0012782218,0.0009828176,0.0195242,0.0037227513,0.0063448395,0.01890697,0.00031258506],"about_ca_topic_score_codex":0.016745638,"about_ca_topic_score_gemma":0.01136014,"teacher_disagreement_score":0.016745638,"about_ca_system_score_codex":0.0011810333,"about_ca_system_score_gemma":0.000849433,"threshold_uncertainty_score":0.04084015},"labels":[],"label_agreement":null},{"id":"W4283523373","doi":"10.1016/j.jval.2022.04.356","title":"EE103 Cost-Effectiveness Analysis of the Smart Quit Clinic Program in Cardiovascular Disease Patients in Thailand","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverse Scientific Research Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Disease; Multidisciplinary approach; Cost-effectiveness analysis; Perspective (graphical); Multidisciplinary team; Gerontology; Population; Health care; Cost effectiveness; Family medicine; Physical therapy; Environmental health; Nursing; Risk analysis (engineering); Computer science; Internal medicine","score_opus":0.16486912780196544,"score_gpt":0.46542616875867265,"score_spread":0.3005570409567072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919578,0.0031637922,0.00049435574,0.00041067257,0.000043093416,0.00064384466,0.0012317159,0.0000151835075,0.0020395773],"genre_scores_gemma":[0.9979685,0.00071426,0.0002930924,0.000080274396,0.000019182657,0.00017394355,0.0004489057,0.0000024931783,0.00029935007],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99625254,0.0025076708,0.00025023744,0.00019515348,0.00028735428,0.0005069805],"domain_scores_gemma":[0.9970746,0.0016221773,0.00048422386,0.0000845509,0.00019701636,0.0005373878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032238124,0.00071165443,0.0013266723,0.0010595492,0.00046775365,0.0013333998,0.0006008633,0.0008779287,0.005617841],"category_scores_gemma":[0.0052939593,0.00038626624,0.0050962362,0.0014376704,0.0004867623,0.00078068394,0.0009155035,0.0012880684,0.0001770079],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3589911,0.02104277,0.22054994,0.008718239,0.022775283,0.0013427621,0.0006150744,0.09198832,0.0022705598,0.0018840925,0.002526745,0.2672951],"study_design_scores_gemma":[0.066886336,0.27405614,0.5058787,0.0029342747,0.04348023,0.0010641416,0.004159171,0.09199747,0.0030891155,0.0015267028,0.004560358,0.00036736944],"about_ca_topic_score_codex":0.02971247,"about_ca_topic_score_gemma":0.020765377,"teacher_disagreement_score":0.02971247,"about_ca_system_score_codex":0.004968932,"about_ca_system_score_gemma":0.0046805185,"threshold_uncertainty_score":0.05907905},"labels":[],"label_agreement":null},{"id":"W4283523834","doi":"10.1016/j.jval.2022.04.1092","title":"HSD92 Natural Language Processing (NLP) of Unstructured EMR Data to Describe Treatment Patterns and Achievement of Guideline Recommended LDL-C Targets of Canadian Patients with Ascvd and Hypercholesterolemia","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of British Columbia; University of Regina; St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Statin; Medicine; Guideline; Internal medicine; Medical record; Electronic medical record; Family medicine; Pathology","score_opus":0.03963855517563155,"score_gpt":0.29906989038568843,"score_spread":0.2594313352100569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523834","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19921006,0.00066575664,0.0468448,0.0013045901,0.000101263446,0.0012991057,0.72469467,0.013449303,0.012430467],"genre_scores_gemma":[0.30077398,0.0005739716,0.12345828,0.0003854299,0.000038420487,0.0006772513,0.5679687,0.00054123765,0.005582722],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99934727,0.00009428705,0.00010712312,0.00018738776,0.000188822,0.000075087],"domain_scores_gemma":[0.99681866,0.0018122676,0.00021320714,0.0002482448,0.0008157973,0.000091876245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009540107,0.0006313121,0.00033104562,0.002691046,0.00062853174,0.0010665425,0.00054893503,0.0003706973,0.0047745514],"category_scores_gemma":[0.006566492,0.0002288213,0.0008180907,0.0025937003,0.0003528027,0.00039040955,0.0005377516,0.0005444494,0.0014677137],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028103953,0.00056077936,0.20175739,0.0046847807,0.00073078234,0.0034840857,0.004735659,0.04127975,0.041422877,0.010945512,0.22981222,0.4577758],"study_design_scores_gemma":[0.0005384641,0.0003855801,0.33849552,0.00054591504,0.00069589925,0.0019021216,0.003989997,0.20644219,0.050638244,0.01072043,0.38538402,0.00026157667],"about_ca_topic_score_codex":0.46628997,"about_ca_topic_score_gemma":0.52558374,"teacher_disagreement_score":0.53371,"about_ca_system_score_codex":0.0031721096,"about_ca_system_score_gemma":0.008978527,"threshold_uncertainty_score":0.92715174},"labels":[],"label_agreement":null},{"id":"W4283524809","doi":"10.1016/j.jval.2022.04.1033","title":"HSD32 Using Natural Language Processing (NLP) of Unstructured EMR Data to Describe Canadian Patients with Familial Hypercholesterolemia (FH) and Their Management","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); St. Michael's Hospital; University of Regina; University of British Columbia","funders":"","keywords":"Medicine; Ezetimibe; Statin; Medical record; Diabetes mellitus; Electronic medical record; Internal medicine; Familial hypercholesterolemia; Natural history; Pediatrics; Cholesterol; Family medicine","score_opus":0.03412514860987251,"score_gpt":0.27114720835118716,"score_spread":0.23702205974131466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283524809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79705966,0.0008588398,0.02289998,0.0028658973,0.00007787047,0.0015626524,0.15431301,0.001819885,0.018542154],"genre_scores_gemma":[0.8471906,0.000676758,0.07418319,0.00046951347,0.000032723085,0.000576698,0.07114935,0.0001937349,0.005527303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994886,0.0000880934,0.00008318448,0.0001028858,0.00013594558,0.00010129707],"domain_scores_gemma":[0.99748355,0.0009857039,0.00021806995,0.00012992154,0.0010357533,0.00014713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009513638,0.0004193174,0.0002435712,0.0027933856,0.0010886374,0.0011530926,0.00039342893,0.00034788402,0.003590377],"category_scores_gemma":[0.006060322,0.00013873677,0.00046207185,0.002665869,0.00028953853,0.00027474813,0.00062310137,0.0004380623,0.0005420357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014630293,0.00042963482,0.6170509,0.0015435482,0.00028373033,0.008279517,0.021394381,0.0105123,0.02257366,0.005780189,0.072460614,0.23822854],"study_design_scores_gemma":[0.00021929135,0.000216652,0.69273764,0.0005916599,0.0003903282,0.004987061,0.026082005,0.05087241,0.0119276,0.0040586223,0.20759377,0.0003229956],"about_ca_topic_score_codex":0.8894833,"about_ca_topic_score_gemma":0.9002614,"teacher_disagreement_score":0.11051673,"about_ca_system_score_codex":0.006791405,"about_ca_system_score_gemma":0.015731623,"threshold_uncertainty_score":0.2223351},"labels":[],"label_agreement":null},{"id":"W4283524965","doi":"10.1016/j.jval.2022.04.1726","title":"P8 Patient Prioritisation of Items for the New Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure: A Delphi Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Delphi method; Likert scale; Patient-reported outcome; Qualitative research; Medicine; Psychology; Delphi; Qualitative property; Family medicine; Quality of life (healthcare); Nursing; Computer science","score_opus":0.4281103753495668,"score_gpt":0.4375998081650893,"score_spread":0.009489432815522503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283524965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8722892,0.000298134,0.030610636,0.015962895,0.0006260585,0.011929317,0.0020546257,0.00017430987,0.06605475],"genre_scores_gemma":[0.948834,0.0002146697,0.030373132,0.0031812428,0.00008189293,0.010076616,0.0005281194,0.000062308995,0.006648084],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.97540593,0.017381791,0.0020517576,0.0005660081,0.0031195707,0.0014749398],"domain_scores_gemma":[0.9493668,0.034506872,0.0020283975,0.001569632,0.011139144,0.0013890469],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04041524,0.00041149452,0.00035634672,0.0012954774,0.0015241222,0.0012987215,0.00086922245,0.0012206633,0.015046904],"category_scores_gemma":[0.07510824,0.00030303813,0.0009439214,0.00083058304,0.0008339198,0.0012177327,0.0032370845,0.0017936886,0.0024130933],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030089398,0.0019214323,0.211737,0.0030038792,0.00027518958,0.0018944354,0.11857742,0.0023339137,0.012718024,0.011980686,0.0716003,0.5609487],"study_design_scores_gemma":[0.0011427462,0.009667996,0.36865798,0.0045320233,0.0003961345,0.0059257206,0.24668996,0.0175713,0.040955264,0.028347038,0.275627,0.00048681113],"about_ca_topic_score_codex":0.0011800291,"about_ca_topic_score_gemma":0.0018032154,"teacher_disagreement_score":0.04041524,"about_ca_system_score_codex":0.0017132065,"about_ca_system_score_gemma":0.0039876583,"threshold_uncertainty_score":0.2137388},"labels":[],"label_agreement":null},{"id":"W4283525681","doi":"10.1016/j.jval.2022.04.366","title":"EE115 Comparing the Cost-Effectiveness of Multimodal Versus Unimodal Interventions That Include Exercise to Prevent Falls Among Community Dwelling Older Adults: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Psychological intervention; Falls in older adults; Medicine; Gerontology; Physical medicine and rehabilitation; Multimodal therapy; Physical therapy; Human factors and ergonomics; Poison control; Environmental health; Psychiatry; Surgery","score_opus":0.25219543217542306,"score_gpt":0.46470774190866826,"score_spread":0.2125123097332452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283525681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038867714,0.992671,0.0004024076,0.00021085666,0.0003210146,0.0009232014,0.0010021854,0.000028015376,0.0005544459],"genre_scores_gemma":[0.060453404,0.9351009,0.0014765194,0.00072715135,0.00018653253,0.0010223088,0.0005110153,0.000019747895,0.0005023896],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954249,0.0017664555,0.0014645065,0.00035452776,0.00080343673,0.00018603544],"domain_scores_gemma":[0.99214196,0.005459237,0.0014386376,0.00015012817,0.0006573802,0.00015264904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00597853,0.0021696286,0.012109617,0.0051780865,0.0005739152,0.002772613,0.0013176932,0.002237866,0.008445475],"category_scores_gemma":[0.025819816,0.0012934197,0.02080159,0.0051723863,0.00068940455,0.0014977625,0.0015732582,0.0024204913,0.0005091587],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035424132,0.000063754494,0.00064127106,0.83426225,0.12565504,0.00008171513,0.00006315745,0.00021943059,0.00030665495,0.00017527997,0.00084179733,0.034147244],"study_design_scores_gemma":[0.005776748,0.0007478697,0.0049264436,0.2671134,0.7126125,0.00019374248,0.0001316309,0.0002178378,0.00031438484,0.00033209202,0.0075761005,0.000057263016],"about_ca_topic_score_codex":0.015223909,"about_ca_topic_score_gemma":0.038789667,"teacher_disagreement_score":0.015223909,"about_ca_system_score_codex":0.003824573,"about_ca_system_score_gemma":0.005663962,"threshold_uncertainty_score":0.03161782},"labels":[],"label_agreement":null},{"id":"W4283526695","doi":"10.1016/j.jval.2022.04.464","title":"EE215 Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn's Perianal Fistula: Results from a Global Burden of Illness Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverticular Disease and Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Crohn's and Colitis Canada","funders":"","keywords":"Medicine; Work productivity; Crohn's disease; Disease; Internal medicine; Physical therapy; Productivity","score_opus":0.030334855686088343,"score_gpt":0.2866943060435277,"score_spread":0.25635945035743934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283526695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974349,0.0004835604,0.00003567619,0.00012785177,0.00001642416,0.000007991079,0.001068721,0.0000023533669,0.0008225844],"genre_scores_gemma":[0.9984232,0.00022918735,0.000034145214,0.00008371234,0.000030726605,0.00000921778,0.0009164671,0.0000016165176,0.0002717489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994404,0.00019880259,0.00006273398,0.00007021392,0.000073486575,0.0001542983],"domain_scores_gemma":[0.9988405,0.0001578284,0.0004914528,0.00007320548,0.00010963703,0.00032740002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006811166,0.00046730557,0.0005310524,0.0011678739,0.0006544905,0.0015311147,0.0003220583,0.0007727624,0.0022352918],"category_scores_gemma":[0.0022271897,0.00029723128,0.001483072,0.0024295799,0.0002516288,0.0006726137,0.0009992941,0.0007516988,0.00031851354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013604472,0.000051742736,0.998801,0.000013858019,0.00016006765,0.000048339214,0.000045077606,0.000017893546,0.00003171379,0.0000064816704,0.000101159254,0.00058651017],"study_design_scores_gemma":[0.000011765721,0.000050075443,0.9994678,0.0000056566314,0.00006165615,0.000058803205,0.00018572809,0.00003169298,0.000008831612,0.000010074405,0.00010490745,0.0000031321013],"about_ca_topic_score_codex":0.008555891,"about_ca_topic_score_gemma":0.010547706,"teacher_disagreement_score":0.008555891,"about_ca_system_score_codex":0.00037276544,"about_ca_system_score_gemma":0.0004396166,"threshold_uncertainty_score":0.017012179},"labels":[],"label_agreement":null},{"id":"W4283526754","doi":"10.1016/j.jval.2022.04.1419","title":"PCR74 Out-of-Pocket Costs and Time/Productivity Losses from Pediatric Emergency Resulting in Resuscitation in Five Niagara Hospitals in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster Children's Hospital; Brock University","funders":"","keywords":"Productivity; Resuscitation; Emergency department; Medical emergency; Health care; Medicine; Emergency medicine; Operations management; Business; Nursing; Engineering; Economics; Economic growth","score_opus":0.025294904343497248,"score_gpt":0.2909096790845052,"score_spread":0.265614774741008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283526754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98967147,0.00050615886,0.00008009544,0.00087444816,0.000013562641,0.00006177731,0.004089449,0.0000116631845,0.0046913098],"genre_scores_gemma":[0.9935818,0.0006948267,0.00021722066,0.0002953781,0.000010202422,0.000027637245,0.0019038817,0.000009220909,0.0032598984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822587,0.00016340616,0.00012726533,0.00010813194,0.00045117325,0.00092430774],"domain_scores_gemma":[0.9954796,0.00032288372,0.0008208814,0.000063017804,0.0015838288,0.001729836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044480967,0.00046772376,0.00042075285,0.0016869843,0.0033538805,0.0018455663,0.0016017464,0.00066409307,0.0029176108],"category_scores_gemma":[0.0027949214,0.0005375468,0.00079801213,0.004555956,0.00089714624,0.0005309165,0.0014138839,0.0014608986,0.0002795868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095144256,0.00009658811,0.9887658,0.00006461248,0.00007354633,0.00052594783,0.0012335561,0.0005874856,0.00009940346,0.0002676877,0.0030209331,0.005169405],"study_design_scores_gemma":[0.0000068295462,0.00002498087,0.9936086,0.000038406,0.000019616538,0.000105306586,0.0047697956,0.00044080132,0.00004100871,0.000022596334,0.000908901,0.0000133868],"about_ca_topic_score_codex":0.99724185,"about_ca_topic_score_gemma":0.9987148,"teacher_disagreement_score":0.06615245,"about_ca_system_score_codex":0.06615245,"about_ca_system_score_gemma":0.06069456,"threshold_uncertainty_score":0.4799719},"labels":[],"label_agreement":null},{"id":"W4283526908","doi":"10.1016/j.jval.2022.04.1184","title":"HTA52 Comparing the Change from Base Case to Re-Analyzed ICER Values for CADTH Oncology Evaluations","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Medicine; Oncology; Internal medicine; Actuarial science; Family medicine; Business; Economics; Health care","score_opus":0.7810870673887269,"score_gpt":0.528524047256737,"score_spread":0.25256302013198995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283526908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47957128,0.014804094,0.07127214,0.011372579,0.0063865515,0.0016416983,0.2882392,0.004221257,0.12249121],"genre_scores_gemma":[0.89824003,0.0007090559,0.025767948,0.002284715,0.0006039714,0.00068789604,0.055299204,0.0009811,0.0154261235],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.988571,0.0064562154,0.0007024314,0.0011886728,0.0025134247,0.0005682482],"domain_scores_gemma":[0.90677613,0.072489485,0.0049797283,0.0056731957,0.00946386,0.00061758456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020641834,0.0005339447,0.0012190482,0.0022007255,0.00024776193,0.0015640634,0.0015475397,0.0010248838,0.021767607],"category_scores_gemma":[0.11265321,0.00036220884,0.0041018263,0.0020235549,0.0004002784,0.001688707,0.00078622537,0.0023193385,0.0026384285],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01710996,0.0009386637,0.1344111,0.0046058223,0.02625053,0.00060799916,0.000404244,0.091928,0.0021975045,0.015662938,0.48282188,0.22306146],"study_design_scores_gemma":[0.0064826375,0.004695801,0.54637986,0.0022769354,0.0155951185,0.0014973219,0.001101056,0.16475044,0.01498344,0.023138676,0.21861196,0.0004867452],"about_ca_topic_score_codex":0.01153022,"about_ca_topic_score_gemma":0.011703513,"teacher_disagreement_score":0.99778086,"about_ca_system_score_codex":0.002219133,"about_ca_system_score_gemma":0.0010163472,"threshold_uncertainty_score":0.10916573},"labels":[],"label_agreement":null},{"id":"W4283527250","doi":"10.1016/j.jval.2022.04.1749","title":"MSR5 Visualizing Network Meta-Analyses is not Trivial - A Novel Take on the Network Diagram","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Outcome (game theory); Pairwise comparison; Computer science; Visualization; Data mining; Diagram; Data science; Information retrieval; Artificial intelligence; Mathematics; Database","score_opus":0.7312387314201398,"score_gpt":0.5629214554371543,"score_spread":0.16831727598298551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283527250","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009038327,0.0032134205,0.9095233,0.02007026,0.002459995,0.00028929597,0.014388874,0.027268339,0.013748145],"genre_scores_gemma":[0.15924399,0.002432281,0.8072034,0.0033743607,0.0013401775,0.0009761904,0.0075891553,0.008183904,0.009656537],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9891566,0.007953794,0.0007693848,0.0011695769,0.00080248265,0.00014811376],"domain_scores_gemma":[0.8905734,0.09408664,0.003253792,0.0071131093,0.003927522,0.001045468],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015783502,0.0017145176,0.0013927275,0.006523463,0.0013178054,0.0075770225,0.0024774547,0.0023601905,0.046476346],"category_scores_gemma":[0.15459837,0.0009798887,0.0040316563,0.0044638873,0.0013736483,0.008925655,0.0045630224,0.0037568056,0.0039262087],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089209643,0.0001031676,0.0077080033,0.0043851663,0.002002108,0.0005909847,0.0031495113,0.016565572,0.0028065841,0.48027664,0.22043245,0.26108775],"study_design_scores_gemma":[0.00036586725,0.00019395386,0.0018184511,0.00179694,0.0011310155,0.0006808889,0.00046281944,0.07477303,0.002600547,0.6667732,0.24923478,0.00016857818],"about_ca_topic_score_codex":0.004599421,"about_ca_topic_score_gemma":0.007854521,"teacher_disagreement_score":0.9842165,"about_ca_system_score_codex":0.0013295772,"about_ca_system_score_gemma":0.0028454412,"threshold_uncertainty_score":0.15547884},"labels":[],"label_agreement":null},{"id":"W4283527881","doi":"10.1016/j.jval.2022.04.904","title":"EPH153 A Population-Based Study of the Epidemiology, Healthcare Resource Utilization and Costs of Duchenne Muscular Dystrophy in Alberta, Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Roche (Canada); Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Duchenne muscular dystrophy; Diagnosis code; Health care; Medical prescription; Ambulatory; Pediatrics; Epidemiology; Population; Retrospective cohort study; Medical costs; Emergency medicine; Internal medicine; Environmental health","score_opus":0.029643526493535154,"score_gpt":0.288809186208019,"score_spread":0.25916565971448385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283527881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878664,0.0010449592,0.00021668829,0.00036562263,0.00002789957,0.00008202384,0.0077330745,0.000015641914,0.00264766],"genre_scores_gemma":[0.99446315,0.0005448877,0.0002777372,0.0001591624,0.000010563347,0.000032933687,0.0024595407,0.000008469186,0.0020435122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983859,0.00022493003,0.00014334531,0.0002495944,0.0005279667,0.0004682681],"domain_scores_gemma":[0.9975821,0.00017225856,0.00034897818,0.000118123055,0.0012577155,0.0005208146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009886181,0.00057977,0.0007773282,0.0023229271,0.0029409889,0.0018333461,0.0018514856,0.00095761457,0.0021751255],"category_scores_gemma":[0.0022429854,0.0007448061,0.0010239313,0.007095061,0.00084056926,0.0004834081,0.0011030445,0.0009718497,0.0003212411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012994451,0.00006198422,0.99583495,0.000027331866,0.0001396459,0.000150407,0.0004074633,0.00019315958,0.0001486608,0.00014565438,0.0010332887,0.0017276363],"study_design_scores_gemma":[0.000018106412,0.000018868508,0.99832326,0.000025274585,0.000036935067,0.00005900704,0.0007759126,0.00025330315,0.000020055008,0.00001904708,0.00043915515,0.000011048716],"about_ca_topic_score_codex":0.9960141,"about_ca_topic_score_gemma":0.9961104,"teacher_disagreement_score":0.028570576,"about_ca_system_score_codex":0.028570576,"about_ca_system_score_gemma":0.031212494,"threshold_uncertainty_score":0.207295},"labels":[],"label_agreement":null},{"id":"W4283528865","doi":"10.1016/j.jval.2022.04.443","title":"EE194 Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test for Postmenopausal Women with HR+/HER2- Node-Positive Early Breast Cancer in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.02652207861705762,"score_gpt":0.2546484479736108,"score_spread":0.22812636935655317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283528865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715307,0.009817418,0.00080950605,0.002639266,0.00010952856,0.0006593221,0.008925858,0.000047716014,0.0054607047],"genre_scores_gemma":[0.994477,0.0016306073,0.0004400044,0.00028385146,0.000030158673,0.000059797436,0.0019488345,0.0000069977355,0.0011229179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998184,0.0007379316,0.00011320272,0.00015154901,0.0003927877,0.00042047197],"domain_scores_gemma":[0.99650985,0.0016992417,0.00042656704,0.00008618366,0.00062548695,0.0006526871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024290541,0.00069979887,0.0012700841,0.0009103509,0.00044132338,0.0013034639,0.0011199825,0.00075527927,0.0028783097],"category_scores_gemma":[0.00978304,0.00034759476,0.0031583016,0.0015008678,0.0005586801,0.0004296053,0.00064171175,0.0011969918,0.00014407675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10970701,0.003189372,0.45512053,0.0044824933,0.016476635,0.0010143279,0.0003262007,0.20598906,0.0015874663,0.0047639096,0.020032588,0.17731039],"study_design_scores_gemma":[0.017042153,0.013500072,0.7458287,0.0010171402,0.017867152,0.00058834336,0.0011494628,0.19241245,0.00088001223,0.0014244965,0.008055475,0.00023451455],"about_ca_topic_score_codex":0.9364683,"about_ca_topic_score_gemma":0.9322428,"teacher_disagreement_score":0.0635317,"about_ca_system_score_codex":0.041756336,"about_ca_system_score_gemma":0.032883108,"threshold_uncertainty_score":0.3029648},"labels":[],"label_agreement":null},{"id":"W4289528638","doi":"10.1016/j.jval.2022.02.006","title":"Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Health technology; Health care; Transparency (behavior); Comparative effectiveness research; Medicine; Health economics; Business; Political science","score_opus":0.8340480531300055,"score_gpt":0.5396893270750756,"score_spread":0.29435872605492996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289528638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002626048,0.90758485,0.0007706866,0.08727535,0.0013236782,0.000027570435,0.000094159994,0.000011154558,0.0026499454],"genre_scores_gemma":[0.005350012,0.9700579,0.0032730913,0.018116197,0.0018796948,0.00006765794,0.000113580514,0.000016214615,0.0011256199],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864672,0.006090821,0.0015616602,0.0006166113,0.004638231,0.00062550785],"domain_scores_gemma":[0.9261964,0.0505013,0.0030349307,0.0015622468,0.01715984,0.001545145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.058529187,0.0008500083,0.0021529847,0.0040418743,0.0010236513,0.008107991,0.0016014049,0.0060762465,0.003584229],"category_scores_gemma":[0.044538636,0.0006484372,0.0016600697,0.007919057,0.0025693413,0.009251993,0.00458038,0.0077946745,0.00079909386],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006169607,0.000080825164,0.0006033431,0.00917707,0.00024788192,0.0001263245,0.00033275026,0.000795902,0.00016671162,0.07272497,0.18015094,0.73553157],"study_design_scores_gemma":[0.00004381914,0.000059330392,0.0025688885,0.03417965,0.00031656292,0.00017840115,0.0004466469,0.00061451946,0.00022237093,0.028878238,0.93243027,0.00006126688],"about_ca_topic_score_codex":0.024985267,"about_ca_topic_score_gemma":0.044375557,"teacher_disagreement_score":0.058529187,"about_ca_system_score_codex":0.009002846,"about_ca_system_score_gemma":0.038230803,"threshold_uncertainty_score":0.30953562},"labels":[],"label_agreement":null},{"id":"W4290694631","doi":"10.1016/j.jval.2022.06.017","title":"Revising the Suspected-Cancer Guidelines: Impacts on Patients’ Primary Care Contacts and Costs","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Cancer Research UK","keywords":"Interquartile range; Medicine; Nice; Guideline; Referral; Colorectal cancer; Confidence interval; Cancer; Primary care; Internal medicine; Family medicine; Pathology","score_opus":0.13012044976738527,"score_gpt":0.3930884307887857,"score_spread":0.2629679810214004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290694631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98390096,0.0027150754,0.00048837945,0.005389239,0.00008610723,0.00010314634,0.001589978,0.00002438802,0.0057026576],"genre_scores_gemma":[0.9983413,0.0003303264,0.00034816164,0.00041041232,0.000048715618,0.000027805541,0.0002889986,0.000006403886,0.00019777808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9774735,0.014689106,0.0018765214,0.0014598414,0.0031154926,0.0013855193],"domain_scores_gemma":[0.91340685,0.046387903,0.028580945,0.0038721026,0.00483403,0.0029180788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077127474,0.00036727378,0.0007905843,0.0008331009,0.0007702561,0.0024638635,0.0010182036,0.0012131064,0.005518771],"category_scores_gemma":[0.1105747,0.00044466383,0.0025371416,0.0013751194,0.0005065372,0.0014598089,0.0018985766,0.0019298015,0.0003672144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005546936,0.00040814994,0.968652,0.0002496263,0.0010304919,0.0002812387,0.0006661981,0.0013609228,0.00008026769,0.00041872045,0.0019596692,0.024338022],"study_design_scores_gemma":[0.00006492175,0.00041551402,0.9921795,0.0003575545,0.0006669256,0.00047090865,0.0010088092,0.002482815,0.00012077614,0.00059266645,0.0016109813,0.000028591092],"about_ca_topic_score_codex":0.02765138,"about_ca_topic_score_gemma":0.032077596,"teacher_disagreement_score":0.02765138,"about_ca_system_score_codex":0.0032904262,"about_ca_system_score_gemma":0.0023198724,"threshold_uncertainty_score":0.054980814},"labels":[],"label_agreement":null},{"id":"W4291129604","doi":"10.1016/j.jval.2022.07.009","title":"A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Medicine","score_opus":0.08805298515709291,"score_gpt":0.40495892514454024,"score_spread":0.3169059399874473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291129604","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00161852,0.0022824954,0.9510168,0.011038733,0.0008996401,0.0041530044,0.00402929,0.0060954746,0.018866034],"genre_scores_gemma":[0.0026277949,0.00089489383,0.9899284,0.000806869,0.00010798702,0.00175027,0.00081702933,0.00045206078,0.002614747],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98480266,0.010750786,0.0017976006,0.00053542294,0.0018655173,0.0002479602],"domain_scores_gemma":[0.9009754,0.077662736,0.0032482254,0.0030758537,0.0136840455,0.001353819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026391419,0.003487414,0.0017429581,0.006013053,0.0011792504,0.0048683574,0.0040157516,0.0047105937,0.035964206],"category_scores_gemma":[0.12135872,0.0021021573,0.0027214265,0.0032843985,0.0013576988,0.0034926329,0.0029775386,0.007346112,0.017859064],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003439221,0.00041021634,0.0017937518,0.0025529095,0.00024316223,0.0008107928,0.0010977591,0.031880487,0.0015258744,0.086036265,0.4137859,0.45951897],"study_design_scores_gemma":[0.0006517443,0.00027256904,0.0012294269,0.0055324878,0.00015321288,0.00089808286,0.00062004366,0.119412765,0.0021409334,0.23371613,0.63512284,0.0002497829],"about_ca_topic_score_codex":0.003531036,"about_ca_topic_score_gemma":0.0077534863,"teacher_disagreement_score":0.035964206,"about_ca_system_score_codex":0.002380359,"about_ca_system_score_gemma":0.009000783,"threshold_uncertainty_score":0.1395728},"labels":[],"label_agreement":null},{"id":"W4291710093","doi":"10.1016/j.jval.2022.06.015","title":"Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Presenteeism; Absenteeism; Randomized controlled trial; Productivity; Medicine; Physical therapy; Psychology; Economics","score_opus":0.2966418737397171,"score_gpt":0.4938031018404098,"score_spread":0.1971612281006927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291710093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009694227,0.98845065,0.0023084732,0.0017554455,0.0007073636,0.004672642,0.00042334283,0.000041847838,0.00067082996],"genre_scores_gemma":[0.018749742,0.94743365,0.013304011,0.0024149155,0.00068404,0.016536595,0.000565532,0.000045916804,0.00026551238],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.7549205,0.11306432,0.0999783,0.0058037573,0.024444133,0.0017889322],"domain_scores_gemma":[0.4560254,0.45143068,0.05581872,0.008433606,0.027147109,0.0011444697],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16466787,0.0036438655,0.01647848,0.03259323,0.002458481,0.011141959,0.005406238,0.008012036,0.004892247],"category_scores_gemma":[0.4877456,0.0034327002,0.01728525,0.025644759,0.0037658948,0.012117543,0.004510632,0.0048060953,0.0009512219],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017769818,0.000029408007,0.00060106406,0.9498601,0.0065244767,0.000069265036,0.00052594853,0.00018258514,0.00014910325,0.0008210136,0.0018275735,0.0392318],"study_design_scores_gemma":[0.00015450934,0.000088328416,0.0006882715,0.97161186,0.019309528,0.00010294347,0.00027512552,0.000121766105,0.0001568729,0.00074691576,0.006715149,0.00002880409],"about_ca_topic_score_codex":0.005377552,"about_ca_topic_score_gemma":0.011984106,"teacher_disagreement_score":0.83533216,"about_ca_system_score_codex":0.0111960545,"about_ca_system_score_gemma":0.039842006,"threshold_uncertainty_score":0.87085736},"labels":[],"label_agreement":null},{"id":"W4293161987","doi":"10.1016/j.jval.2022.07.015","title":"Generic Health-Related Quality of Life Utility Measure for Preschool Children (Health Utilities Preschool): Design, Development, and Properties","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Dalhousie University; Public Health Ontario; University of Toronto; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Health Utilities Index; Intraclass correlation; Interpretability; Quality of life (healthcare); Reliability (semiconductor); Psychology; Quality (philosophy); Index (typography); Test (biology); Statistics; Developmental psychology; Health related quality of life; Applied psychology; Psychometrics; Mathematics; Artificial intelligence; Computer science","score_opus":0.573156690105205,"score_gpt":0.39172589689531795,"score_spread":0.18143079320988703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293161987","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77006483,0.002307277,0.1359261,0.0009231004,0.00021759515,0.043150026,0.031431142,0.00090733415,0.015072629],"genre_scores_gemma":[0.72862065,0.001107698,0.20056568,0.00026137658,0.000036676913,0.05141973,0.015813757,0.00013513962,0.0020393883],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953544,0.0023899826,0.0007713829,0.00028492245,0.0009815673,0.0002177554],"domain_scores_gemma":[0.99498135,0.0019126534,0.000912328,0.0003881787,0.0015615565,0.00024393098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010372849,0.00054032746,0.0005604567,0.0017753198,0.00033593315,0.0008068887,0.0008320101,0.0004243762,0.0033563182],"category_scores_gemma":[0.015339578,0.00030350708,0.0013626958,0.002182275,0.0004573604,0.00084423885,0.0010902019,0.0009889841,0.00044430877],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031155061,0.0014743287,0.5659312,0.0017413985,0.00050102506,0.0003435475,0.0014659872,0.006595102,0.0031321987,0.009297907,0.017375726,0.38902605],"study_design_scores_gemma":[0.0005584538,0.0055765575,0.93827075,0.0007906906,0.00041604246,0.0008079166,0.0014939605,0.013117095,0.006515299,0.0032532425,0.02902301,0.00017687235],"about_ca_topic_score_codex":0.0049512996,"about_ca_topic_score_gemma":0.007959321,"teacher_disagreement_score":0.010372849,"about_ca_system_score_codex":0.001998652,"about_ca_system_score_gemma":0.0041116043,"threshold_uncertainty_score":0.054857492},"labels":[],"label_agreement":null},{"id":"W4293558719","doi":"10.1016/j.jval.2022.07.016","title":"The Use of Generic Patient-Reported Outcome Measures in Emergency Department Surveys: Discriminant Validity Evidence for the Veterans RAND 12-Item Health Survey and the EQ-5D","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Trinity Western University; Ministry of Health; Western University","funders":"Canada Research Chairs; Trinity Western University","keywords":"Mental health; Discriminant validity; Patient Health Questionnaire; Medicine; Comorbidity; Logistic regression; Anxiety; Patient-reported outcome; EQ-5D; Psychiatry; Clinical psychology; Psychology; Psychometrics; Quality of life (healthcare)","score_opus":0.7689206212697642,"score_gpt":0.4870731421387547,"score_spread":0.28184747913100955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293558719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648371,0.010809047,0.012997714,0.0020574755,0.00035175096,0.0004600991,0.002506197,0.00005972645,0.0059210197],"genre_scores_gemma":[0.9924555,0.0010383626,0.0037879539,0.00055550167,0.0002316844,0.00027453812,0.0013624104,0.000027201651,0.00026689965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.91093725,0.06347348,0.0079907,0.0054586814,0.010978478,0.0011614907],"domain_scores_gemma":[0.72892785,0.20519716,0.03565898,0.016112946,0.0129691,0.0011340068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.103640676,0.0010842951,0.0010312564,0.0035960106,0.0006635601,0.0022677362,0.00111752,0.0016071314,0.0010768509],"category_scores_gemma":[0.2380257,0.00050466583,0.003083097,0.0036714522,0.0025796648,0.0017363292,0.0025573082,0.0015999273,0.0003028622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050218607,0.00013822471,0.96984833,0.0003341934,0.0018674952,0.000034196444,0.000538049,0.0008801805,0.000109724766,0.000715567,0.00035703465,0.0246749],"study_design_scores_gemma":[0.00015063724,0.0009084562,0.9859926,0.00069991656,0.0008059144,0.00025147936,0.000697384,0.0060572843,0.00037940594,0.0018925196,0.0021003275,0.00006414188],"about_ca_topic_score_codex":0.0016358825,"about_ca_topic_score_gemma":0.002481108,"teacher_disagreement_score":0.103640676,"about_ca_system_score_codex":0.0007916386,"about_ca_system_score_gemma":0.0011492042,"threshold_uncertainty_score":0.54811084},"labels":[],"label_agreement":null},{"id":"W4304183885","doi":"10.1016/j.jval.2022.09.001","title":"HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health; Wellcome Trust","keywords":"Protocol (science); Reproducibility; Task force; Task (project management); Computer science; Joint (building); Medical physics; Data mining; Medicine; Engineering; Alternative medicine; Mathematics; Statistics; Pathology; Systems engineering; Political science","score_opus":0.8858172267355363,"score_gpt":0.6478881162136745,"score_spread":0.23792911052186183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304183885","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":"methods","domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020375254,0.0010887899,0.42706472,0.026725026,0.011193133,0.5177601,0.003024365,0.004009295,0.0070970915],"genre_scores_gemma":[0.005048239,0.0009053843,0.46029547,0.00930987,0.0014363147,0.51762027,0.0011946446,0.00086994306,0.0033197773],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.2893206,0.5054927,0.1466767,0.013229925,0.039776668,0.005503416],"domain_scores_gemma":[0.13792998,0.43486065,0.049932826,0.16323678,0.2053935,0.008646294],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7110911,0.0049327114,0.008462679,0.018631972,0.009654438,0.017759183,0.011772306,0.021876806,0.024156934],"category_scores_gemma":[0.7869448,0.008544007,0.013166813,0.0137062855,0.013223115,0.01523742,0.012177666,0.035534367,0.025825165],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032701723,0.0020462798,0.001840666,0.027761023,0.0010367777,0.0026575183,0.035968672,0.0047276253,0.008292604,0.07632208,0.4779236,0.3581529],"study_design_scores_gemma":[0.0071215755,0.0017967345,0.0040688147,0.051257994,0.0010418107,0.001844158,0.005668304,0.01619381,0.009226165,0.08142286,0.81893367,0.0014241141],"about_ca_topic_score_codex":0.0039327038,"about_ca_topic_score_gemma":0.0055807773,"teacher_disagreement_score":0.2889089,"about_ca_system_score_codex":0.020120043,"about_ca_system_score_gemma":0.09861302,"threshold_uncertainty_score":0.35627615},"labels":[],"label_agreement":null},{"id":"W4307955800","doi":"10.1016/j.jval.2022.09.2479","title":"Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses","year":2022,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Government of Canada; Bill and Melinda Gates Foundation; United States Agency for International Development","keywords":"Premise; Psychological intervention; Protocol (science); Context (archaeology); Selection (genetic algorithm); Scale (ratio); Psychology; Computer science; Medicine; Epistemology; Alternative medicine; Artificial intelligence; Psychiatry","score_opus":0.7339025097111027,"score_gpt":0.5443817416088326,"score_spread":0.18952076810227014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307955800","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0066473,0.08014681,0.07789507,0.7650906,0.023665814,0.0072077527,0.0049730623,0.0005466976,0.033826914],"genre_scores_gemma":[0.15282707,0.020843623,0.23688687,0.5158006,0.0407116,0.02510755,0.0022193592,0.00068767724,0.0049157096],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.25572172,0.69870174,0.023999335,0.0036101264,0.016533732,0.0014333657],"domain_scores_gemma":[0.04981303,0.9198341,0.010711762,0.009292474,0.008806685,0.0015418995],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.46579462,0.0029217587,0.009017288,0.007646587,0.0018504629,0.013479831,0.004593545,0.021001188,0.014117336],"category_scores_gemma":[0.8426946,0.0026976254,0.006050945,0.006405445,0.00797758,0.013272571,0.0049138595,0.021175211,0.003586011],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014188226,0.0007005595,0.00847688,0.020810489,0.017046036,0.0006759586,0.0014141006,0.009541601,0.0005394068,0.14117345,0.5056152,0.27981806],"study_design_scores_gemma":[0.017581597,0.0014049716,0.004559657,0.02503642,0.010010007,0.00034565953,0.0007509757,0.031906817,0.0008576142,0.7198715,0.18735714,0.0003175667],"about_ca_topic_score_codex":0.0027212494,"about_ca_topic_score_gemma":0.0061769425,"teacher_disagreement_score":0.46579462,"about_ca_system_score_codex":0.010008991,"about_ca_system_score_gemma":0.01989692,"threshold_uncertainty_score":0.6587704},"labels":[],"label_agreement":null},{"id":"W4308949677","doi":"10.1016/j.jval.2022.11.003","title":"Modeling Tiered Pricing Frameworks: A Simulation Approach","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre for Advancing Health Outcomes; University of British Columbia; St. Paul's Hospital; University of Toronto","funders":"Institute of Population and Public Health; Canadian Institutes of Health Research","keywords":"Computer science","score_opus":0.1747292760358831,"score_gpt":0.3388581767082557,"score_spread":0.1641289006723726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308949677","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17898715,0.00087977,0.78317773,0.0030082725,0.00018796396,0.00018619465,0.0010457565,0.00056487764,0.031962268],"genre_scores_gemma":[0.9284353,0.00048436396,0.06389884,0.00022964158,0.000075787146,0.00018808067,0.00033093704,0.00010795394,0.0062490124],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985355,0.0008618719,0.000055371907,0.00015043365,0.00016574234,0.00023116315],"domain_scores_gemma":[0.9913236,0.0069508366,0.00046456038,0.00034125624,0.0005346557,0.00038513646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030942028,0.0007617108,0.0015433369,0.0011818481,0.0008995445,0.0034778574,0.002781999,0.003553868,0.008809327],"category_scores_gemma":[0.012390709,0.0009453565,0.0014981213,0.0017969743,0.0013329764,0.0034869171,0.0015895942,0.0025206916,0.00056417036],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022581122,0.000042154108,0.00043965384,0.000010755682,0.000022882974,0.000025379,0.00003073121,0.9436894,0.000054640608,0.05403019,0.00035220876,0.0012794388],"study_design_scores_gemma":[0.000009919064,0.0000051475827,0.00003869574,0.0000026389548,0.0000046549435,0.0000038694684,0.000009834518,0.98491293,0.000014852058,0.014813442,0.00018029471,0.0000037243096],"about_ca_topic_score_codex":0.03156377,"about_ca_topic_score_gemma":0.021122988,"teacher_disagreement_score":0.03156377,"about_ca_system_score_codex":0.0027075754,"about_ca_system_score_gemma":0.0030213818,"threshold_uncertainty_score":0.062760055},"labels":[],"label_agreement":null},{"id":"W4310927699","doi":"10.1016/j.jval.2022.12.002","title":"Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Cystic fibrosis; Physical therapy; Clinical psychology; Internal medicine","score_opus":0.03474663053389354,"score_gpt":0.3214268659082409,"score_spread":0.28668023537434734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310927699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76067626,0.00393602,0.16181575,0.0017260978,0.00020218758,0.015740588,0.043361187,0.00043140506,0.012110455],"genre_scores_gemma":[0.7811811,0.0011807022,0.17819442,0.00036319575,0.00004186799,0.020068966,0.017262496,0.000054864333,0.0016523334],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99335057,0.0039932067,0.0008003896,0.0003232408,0.0013819737,0.0001506546],"domain_scores_gemma":[0.99124205,0.003842401,0.0018782277,0.0004493951,0.0024281095,0.00015985304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010854784,0.00045150513,0.0006018139,0.0013547105,0.00016222484,0.00054795435,0.0005433078,0.00040733075,0.0015993844],"category_scores_gemma":[0.027192393,0.00023612073,0.0017615117,0.001144722,0.00023171536,0.0005739986,0.00072818605,0.0010668631,0.0003973023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001450269,0.00060119433,0.44685328,0.001317852,0.0012305104,0.00015093425,0.0011328271,0.016675979,0.0024946667,0.004064123,0.021461476,0.5025669],"study_design_scores_gemma":[0.0006341677,0.0021546355,0.9144561,0.0008018279,0.00047685747,0.0007297499,0.0005322097,0.0361541,0.002738587,0.00495205,0.036181137,0.00018842767],"about_ca_topic_score_codex":0.0015414644,"about_ca_topic_score_gemma":0.0025024,"teacher_disagreement_score":0.010854784,"about_ca_system_score_codex":0.0006636822,"about_ca_system_score_gemma":0.00090958015,"threshold_uncertainty_score":0.057406247},"labels":[],"label_agreement":null},{"id":"W4311200002","doi":"10.1016/j.jval.2022.11.017","title":"A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Bristol-Myers Squibb","keywords":"Hazard ratio; Proportional hazards model; Hazard; Medicine; Survival analysis; Event (particle physics); Randomized controlled trial; Meta-analysis; Internal medicine; Statistics; Oncology; Mathematics; Confidence interval; Chemistry; Physics","score_opus":0.8342556377342246,"score_gpt":0.6213187337870495,"score_spread":0.21293690394717513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311200002","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22110878,0.4696587,0.28669167,0.008450751,0.0011825573,0.0042738034,0.002639591,0.00040502337,0.005588984],"genre_scores_gemma":[0.84529793,0.038233038,0.110315084,0.001529437,0.0003247318,0.0026144008,0.00083943224,0.00011997398,0.0007260414],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.90278757,0.09048208,0.0024920187,0.0021753637,0.0017231496,0.00033986822],"domain_scores_gemma":[0.792234,0.19629182,0.004306188,0.0043677394,0.0024794429,0.00032081464],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09190842,0.0020862254,0.0049301893,0.0029227133,0.0006461953,0.0026846514,0.0019205969,0.0023093403,0.0022174348],"category_scores_gemma":[0.17950279,0.0007328507,0.019307995,0.002190021,0.000601585,0.002173007,0.0012874128,0.0021925108,0.00016192904],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028110562,0.0003998192,0.042202696,0.053560697,0.6137708,0.0019708592,0.000572002,0.077877626,0.0013069926,0.012325422,0.0037168646,0.16418564],"study_design_scores_gemma":[0.011265291,0.0046140114,0.022139788,0.012019707,0.69627595,0.0018444423,0.00050842075,0.18998815,0.001608239,0.04723227,0.012125266,0.00037846965],"about_ca_topic_score_codex":0.0050503835,"about_ca_topic_score_gemma":0.007130774,"teacher_disagreement_score":0.9080916,"about_ca_system_score_codex":0.0020954541,"about_ca_system_score_gemma":0.0018046577,"threshold_uncertainty_score":0.48606396},"labels":[],"label_agreement":null},{"id":"W4311331782","doi":"10.1016/j.jval.2022.09.992","title":"EPH70 Transcription Errors in Ophthalmology: Current Burden and the Opportunity for Digital Technologies","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Software; Human error; Computer science; Risk analysis (engineering)","score_opus":0.48562994880418014,"score_gpt":0.43237557081016076,"score_spread":0.053254377994019386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311331782","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06562875,0.16884743,0.013775587,0.6188114,0.015801614,0.000118512275,0.012651779,0.00088133564,0.10348365],"genre_scores_gemma":[0.48123112,0.3176673,0.022959312,0.072943605,0.034044642,0.00017214334,0.0123425275,0.0012238638,0.057415523],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9734412,0.010886843,0.0036036612,0.00171141,0.009132901,0.0012240418],"domain_scores_gemma":[0.7301977,0.15696841,0.03548087,0.012310961,0.05833634,0.0067056306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021266002,0.0004733627,0.0008200809,0.005921308,0.0013524817,0.00867034,0.0012244496,0.0035264466,0.044506084],"category_scores_gemma":[0.16638231,0.00037430075,0.0010866703,0.008521393,0.0045277546,0.008121013,0.0037496379,0.0035218117,0.009308653],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005053971,0.00011288047,0.05135102,0.0017495955,0.00010460736,0.0011426762,0.0018407736,0.0010817697,0.00048232637,0.034112744,0.22935003,0.6781662],"study_design_scores_gemma":[0.00012020006,0.0002402366,0.08217122,0.018209968,0.00026433286,0.0070774737,0.012928702,0.00272986,0.0021692838,0.08135038,0.7924763,0.00026211675],"about_ca_topic_score_codex":0.015083138,"about_ca_topic_score_gemma":0.012077032,"teacher_disagreement_score":0.044506084,"about_ca_system_score_codex":0.0041880826,"about_ca_system_score_gemma":0.00964684,"threshold_uncertainty_score":0.14888763},"labels":[],"label_agreement":null},{"id":"W4311332319","doi":"10.1016/j.jval.2022.09.760","title":"EE519 Cost Effectiveness Analysis of Avacopan in Antineutrophil Cytoplasm Antibody-Associated Vasculitis - A Canadian Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Anti-neutrophil cytoplasmic antibody; Vasculitis; Cyclophosphamide; Medicine; Perspective (graphical); Antibody; Cytoplasm; Immunology; Internal medicine; Chemotherapy; Chemistry; Biochemistry; Disease; Computer science","score_opus":0.021229862549495562,"score_gpt":0.31598453716034847,"score_spread":0.2947546746108529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36533698,0.29691273,0.011402835,0.06812103,0.0023454402,0.0024340109,0.08535076,0.00025870826,0.16783749],"genre_scores_gemma":[0.91252214,0.054344352,0.00683477,0.004921187,0.0006535369,0.00040380986,0.011572547,0.00007602616,0.008671634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.994334,0.002402612,0.00023517874,0.0002882528,0.0016681768,0.0010718153],"domain_scores_gemma":[0.9953994,0.0016868759,0.00037794985,0.000072343595,0.0017220022,0.00074149034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004657804,0.0015820634,0.0025901848,0.0026326254,0.00090258376,0.003879813,0.0018935916,0.0017142335,0.008274716],"category_scores_gemma":[0.011817436,0.00059071044,0.0058612884,0.0049536703,0.00066846627,0.000758459,0.00092653406,0.0026097626,0.00031576338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.051112767,0.0013901461,0.048643067,0.02268965,0.041814882,0.001809451,0.0005135135,0.30862832,0.0026798078,0.07531776,0.11806994,0.32733074],"study_design_scores_gemma":[0.03321725,0.010043153,0.3332319,0.026317641,0.085095026,0.0025440163,0.003136886,0.24087635,0.0021824136,0.029642284,0.23247686,0.0012362924],"about_ca_topic_score_codex":0.9363915,"about_ca_topic_score_gemma":0.934553,"teacher_disagreement_score":0.0819181,"about_ca_system_score_codex":0.0819181,"about_ca_system_score_gemma":0.07675722,"threshold_uncertainty_score":0.5943602},"labels":[],"label_agreement":null},{"id":"W4311332939","doi":"10.1016/j.jval.2022.09.660","title":"EE414 Cost-Effectiveness of Mobile Intermittent Pneumatic Compression Devices (IPCD) Compared to Traditional IPCD for Early Postoperative Total Knee Replacement: The Hospital’s Perspectives","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Reimbursement; Economic evaluation; Cost effectiveness; Quality of life (healthcare); Physical therapy; Health care; Emergency medicine","score_opus":0.050186844731795154,"score_gpt":0.3261354727008441,"score_spread":0.27594862796904895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65627456,0.16102968,0.002025638,0.10060807,0.0036671346,0.00041113258,0.0075942953,0.000051810028,0.06833764],"genre_scores_gemma":[0.9648941,0.021447012,0.0014285301,0.0064291186,0.0022509838,0.00009086981,0.0014752054,0.000016357431,0.0019677256],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958519,0.0027650995,0.00029768486,0.00015248485,0.0005118965,0.00042094773],"domain_scores_gemma":[0.9889681,0.007291292,0.0015593058,0.00018010625,0.001210133,0.0007910411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004213317,0.00046224697,0.0009430966,0.0010471955,0.00033101786,0.0029475386,0.0007038859,0.0014168277,0.011521946],"category_scores_gemma":[0.017385617,0.00015072484,0.0025628167,0.0016184804,0.0006136131,0.0010718681,0.0007405155,0.0015887378,0.000384619],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06658638,0.0039550937,0.12656176,0.007944272,0.0119996695,0.00071389566,0.0003288886,0.014604361,0.0023441056,0.021438746,0.03618478,0.7073381],"study_design_scores_gemma":[0.022661423,0.073035724,0.6818114,0.01651775,0.027378866,0.0020212887,0.006233508,0.02232222,0.007185981,0.0304163,0.10971022,0.0007053376],"about_ca_topic_score_codex":0.008979465,"about_ca_topic_score_gemma":0.01643119,"teacher_disagreement_score":0.011521946,"about_ca_system_score_codex":0.003675705,"about_ca_system_score_gemma":0.002779607,"threshold_uncertainty_score":0.038544714},"labels":[],"label_agreement":null},{"id":"W4311332949","doi":"10.1016/j.jval.2022.09.846","title":"EE607 Healthcare Utilisation of Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA): A European Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Pediatrics; Granulomatosis with polyangiitis; Cohort; Asthma; Retrospective cohort study; Internal medicine; Vasculitis; Disease","score_opus":0.0168169861265941,"score_gpt":0.24770740156910745,"score_spread":0.23089041544251335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332949","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30472064,0.46922943,0.0007469355,0.16840252,0.0042765276,0.00002542504,0.008125999,0.000026263056,0.04444613],"genre_scores_gemma":[0.75777334,0.20614284,0.00055853993,0.02584641,0.004928844,0.000033763125,0.002319998,0.000014814372,0.0023814167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998857,0.00051463593,0.000103704726,0.00008536296,0.00014649809,0.00029279938],"domain_scores_gemma":[0.9975579,0.0005293918,0.00096244423,0.000028460447,0.0003008103,0.00062099315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009690874,0.00020144161,0.00043814039,0.0009534636,0.00028122828,0.0019943605,0.0002696403,0.001915025,0.004237871],"category_scores_gemma":[0.0026913187,0.00009292564,0.00086721004,0.0019271555,0.000348755,0.00092098425,0.00071335473,0.0013073307,0.00038633935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026066916,0.0009703196,0.4924315,0.0069706016,0.0043841098,0.0039071953,0.001893583,0.0020410044,0.0014143632,0.030918647,0.100915514,0.35154635],"study_design_scores_gemma":[0.00021047815,0.0007868591,0.78195083,0.012946899,0.0012003055,0.00325278,0.005265207,0.0008387382,0.00023354778,0.0052626915,0.18791656,0.00013514118],"about_ca_topic_score_codex":0.013406794,"about_ca_topic_score_gemma":0.01350593,"teacher_disagreement_score":0.013406794,"about_ca_system_score_codex":0.0010906819,"about_ca_system_score_gemma":0.0016396983,"threshold_uncertainty_score":0.026657522},"labels":[],"label_agreement":null},{"id":"W4311332979","doi":"10.1016/j.jval.2022.09.1209","title":"HPR79 A Qualitative Exploration of Drivers of Cannabis Purchase Decisions in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Legalization; Cannabis; Business; Product (mathematics); Advertising; Marketing; Environmental health; Medicine; Psychiatry","score_opus":0.09933753477325599,"score_gpt":0.39082510555118755,"score_spread":0.2914875707779315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9576638,0.00062877475,0.0005053104,0.009328223,0.000066932495,0.00023315442,0.00106849,0.000012049556,0.03049329],"genre_scores_gemma":[0.99177,0.0004321773,0.00034754633,0.0010106458,0.00000750144,0.00010428389,0.00016969115,0.000020405016,0.006137779],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9935823,0.0025079586,0.00018451911,0.00046921434,0.0012849903,0.0019709028],"domain_scores_gemma":[0.9730119,0.016561545,0.0013764633,0.00038467874,0.0054032556,0.0032621322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006266822,0.00031705084,0.00056949083,0.0023436395,0.020936953,0.008489115,0.0023219935,0.0018037227,0.009350209],"category_scores_gemma":[0.021515885,0.00067341345,0.00040873105,0.0056112306,0.008194321,0.0024604849,0.004393594,0.0035976788,0.0003001693],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010116596,0.00008295853,0.027555242,0.00017045718,0.000017349827,0.00085160957,0.94783115,0.00016630415,0.00033851678,0.011175172,0.004338365,0.007371704],"study_design_scores_gemma":[0.0000069016182,0.000013744644,0.011104184,0.00016953467,0.0000060877646,0.0000428471,0.970869,0.0001736034,0.00009300681,0.0005335035,0.016955765,0.000031835825],"about_ca_topic_score_codex":0.98699933,"about_ca_topic_score_gemma":0.9909079,"teacher_disagreement_score":0.12055178,"about_ca_system_score_codex":0.12055178,"about_ca_system_score_gemma":0.19508381,"threshold_uncertainty_score":0.8746685},"labels":[],"label_agreement":null},{"id":"W4311333153","doi":"10.1016/j.jval.2022.09.1265","title":"HPR136 The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health – A Systematic Review of Canadian Studies","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Cost sharing; Drug; Medical prescription; Prescription drug; Medicine; Actuarial science; Specialty; Environmental health; Business; Family medicine; Pharmacology; Nursing","score_opus":0.33129663583526237,"score_gpt":0.36781962359721515,"score_spread":0.036522987761952785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051440956,0.99783933,0.00005263897,0.00020961765,0.000050152015,0.000052731168,0.0010812569,0.000004020264,0.00019579846],"genre_scores_gemma":[0.010341845,0.9881599,0.0003782821,0.0003047054,0.00006585476,0.00007778636,0.00055576354,0.0000047959343,0.0001111289],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941995,0.0013157399,0.0017479896,0.00061585294,0.0018740372,0.00024686963],"domain_scores_gemma":[0.97316337,0.017469766,0.0048011746,0.00056543184,0.0035783506,0.00042190604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010104094,0.0014482387,0.0057640905,0.013438006,0.0008670304,0.003030274,0.0017020184,0.0016841311,0.0055279904],"category_scores_gemma":[0.040240318,0.00091996684,0.011771712,0.020988261,0.0011144753,0.0013058305,0.001768931,0.0012956052,0.00033541647],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005810002,0.000037789116,0.009289457,0.7924518,0.056870397,0.00010286498,0.00019029043,0.00025881545,0.00015407,0.000890199,0.009470729,0.12970251],"study_design_scores_gemma":[0.0006344063,0.0001839066,0.069808595,0.591738,0.27025217,0.00042362398,0.00035814877,0.00021816883,0.00020778202,0.001077176,0.064917065,0.00018101378],"about_ca_topic_score_codex":0.35082236,"about_ca_topic_score_gemma":0.5489315,"teacher_disagreement_score":0.6491777,"about_ca_system_score_codex":0.008741137,"about_ca_system_score_gemma":0.033439927,"threshold_uncertainty_score":0.69756067},"labels":[],"label_agreement":null},{"id":"W4311333205","doi":"10.1016/j.jval.2022.09.1193","title":"HPR61 Cannabis Edibles: Using a Discrete Choice Experiment to Explore Patterns of Purchase Preferences Among Canadians","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Cannabis; Consumption (sociology); Advertising; Accidental; Business; Psychology; Sociology; Psychiatry; Social science","score_opus":0.1049600704807775,"score_gpt":0.3759209959704342,"score_spread":0.2709609254896567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99802667,0.000025703503,0.00013331375,0.000081665006,0.000006492706,0.00013111393,0.00017145519,0.000003298015,0.0014202],"genre_scores_gemma":[0.99055403,0.0001166421,0.0025007343,0.00023509873,0.000007603982,0.0002275567,0.00038056858,0.000008258942,0.005969465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999079,0.0001997547,0.00002362768,0.00013605274,0.00029898493,0.00026271987],"domain_scores_gemma":[0.9984524,0.00045027767,0.00017212595,0.00009866806,0.00042448565,0.00040208088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015374625,0.00039359077,0.00048715938,0.0004629448,0.005025883,0.0015389784,0.00090049644,0.0009941335,0.005953275],"category_scores_gemma":[0.003554076,0.00043078678,0.00064718357,0.0009084225,0.0012456398,0.000562541,0.00049830996,0.0012667719,0.0004262558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06052576,0.05426662,0.6344295,0.00055714714,0.0006573863,0.00077694596,0.056190703,0.0037683204,0.046358354,0.01039121,0.00996636,0.12211166],"study_design_scores_gemma":[0.0026663733,0.012998484,0.92590016,0.0001139048,0.0003167082,0.00012707242,0.026799101,0.0079832645,0.004318886,0.0014059942,0.016941372,0.00042878886],"about_ca_topic_score_codex":0.95713186,"about_ca_topic_score_gemma":0.9749415,"teacher_disagreement_score":0.042868137,"about_ca_system_score_codex":0.013109131,"about_ca_system_score_gemma":0.013909611,"threshold_uncertainty_score":0.09511387},"labels":[],"label_agreement":null},{"id":"W4311333331","doi":"10.1016/j.jval.2022.09.931","title":"EPH8 Factors Associated With Oral Anticoagulant Switching in Patients With Atrial Fibrillation","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atrial fibrillation; Medicine; Internal medicine; Vitamin k; Stroke (engine); Cardiology","score_opus":0.08897633262924041,"score_gpt":0.3236349419093532,"score_spread":0.23465860928011278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965178,0.000932705,0.000089199726,0.0003397561,0.00004597559,0.0000057087036,0.0002218673,0.0000025414733,0.001844364],"genre_scores_gemma":[0.9988551,0.00023596728,0.000087619774,0.00014792742,0.00008173411,0.0000037088926,0.00022781176,0.00000218707,0.0003578791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994838,0.00011773505,0.00008616514,0.00008232339,0.000092713104,0.0001372298],"domain_scores_gemma":[0.9976701,0.0008511615,0.00091709243,0.00011289997,0.00012993987,0.00031870315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040190876,0.0001693657,0.0003116457,0.0003775204,0.00030395042,0.0009892376,0.00027204774,0.000633608,0.0037033802],"category_scores_gemma":[0.0042542354,0.00014454736,0.00074015674,0.00079776236,0.0002270646,0.00054354296,0.0003652237,0.0014104822,0.00017948895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002609307,0.000074128184,0.99598867,0.0000149527195,0.00016668235,0.00016536565,0.00004916583,0.000051072668,0.00013315385,0.00008856875,0.0001867329,0.0028205763],"study_design_scores_gemma":[0.000025977622,0.00011621741,0.99764556,0.000032924778,0.00012359074,0.00057495426,0.0002953629,0.00042167437,0.0000627486,0.00024312206,0.0004491327,0.000008774227],"about_ca_topic_score_codex":0.0029305862,"about_ca_topic_score_gemma":0.0039732736,"teacher_disagreement_score":0.0037033802,"about_ca_system_score_codex":0.00024772435,"about_ca_system_score_gemma":0.00047987298,"threshold_uncertainty_score":0.012389064},"labels":[],"label_agreement":null},{"id":"W4311333885","doi":"10.1016/j.jval.2022.09.682","title":"EE436 General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Sample (material); Computer science; Value (mathematics); Term (time); Parametric statistics; Sampling (signal processing); Statistics; Value of information; Sample size determination; Econometrics; Data mining; Mathematics; Machine learning; Artificial intelligence","score_opus":0.6352303352871447,"score_gpt":0.5342563891131628,"score_spread":0.10097394617398192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333885","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0059507573,0.00009978548,0.97831774,0.00008437148,0.000076543656,0.0001024279,0.001986468,0.008787377,0.0045945225],"genre_scores_gemma":[0.13361445,0.00022311787,0.84258074,0.00018274684,0.00008511803,0.0009855896,0.0064641233,0.0041447394,0.011719362],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989592,0.0005522879,0.00007196082,0.000089675494,0.000249167,0.00007777867],"domain_scores_gemma":[0.9931051,0.0049556303,0.00018749625,0.0006798638,0.00094497635,0.00012686558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033617269,0.00081470585,0.00063837017,0.0011084789,0.00049398013,0.0010583652,0.0026932838,0.0014607211,0.04144991],"category_scores_gemma":[0.018014155,0.0007913479,0.0010945086,0.0014424209,0.00026691347,0.00083162886,0.0007878439,0.0015190532,0.0070280596],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004424542,0.00016974637,0.002667356,0.00026291033,0.00016584345,0.00016865347,0.00013032729,0.77165145,0.001743542,0.032378316,0.031276662,0.15894279],"study_design_scores_gemma":[0.00006625096,0.000019711835,0.00019769266,0.000017733031,0.000013043535,0.00004381774,0.000005493888,0.9843812,0.0015587837,0.0067264554,0.006958556,0.000011378813],"about_ca_topic_score_codex":0.009834549,"about_ca_topic_score_gemma":0.009489159,"teacher_disagreement_score":0.04144991,"about_ca_system_score_codex":0.0007069373,"about_ca_system_score_gemma":0.001203035,"threshold_uncertainty_score":0.13866377},"labels":[],"label_agreement":null},{"id":"W4311334188","doi":"10.1016/j.jval.2022.09.979","title":"EPH57 Epidemiology of Alopecia Areata Across Global Regions – A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Alopecia areata; Medicine; Epidemiology; Incidence (geometry); Systematic review; Prevalence; Dermatology; MEDLINE; Pediatrics; Internal medicine","score_opus":0.08656780890402353,"score_gpt":0.3959142111902736,"score_spread":0.30934640228625004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334188","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027190045,0.969314,0.00015857277,0.00031461945,0.000103700724,0.000097812066,0.0022644014,0.0000040184864,0.0005529004],"genre_scores_gemma":[0.2524207,0.74375427,0.0007704333,0.0008686929,0.0001878828,0.0002320791,0.0015404515,0.000007027637,0.00021848665],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962823,0.0009504401,0.0015632673,0.00055028766,0.0004815379,0.0001720986],"domain_scores_gemma":[0.9881792,0.007234932,0.0033846167,0.00023978893,0.0008130923,0.0001483653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002756837,0.00057803333,0.0024733078,0.0057867477,0.00035267675,0.0016047369,0.00066918816,0.0010347797,0.0030667228],"category_scores_gemma":[0.014539432,0.000491896,0.0066925623,0.008260622,0.000479252,0.0013404826,0.0011656964,0.0006474041,0.00016594367],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001149194,0.00009909388,0.24008685,0.57836473,0.07963255,0.00067768514,0.00086870516,0.00028739197,0.0004937087,0.000684316,0.0037601073,0.09389565],"study_design_scores_gemma":[0.00049880845,0.00041546702,0.3961599,0.37770244,0.19850665,0.0023885798,0.0019037637,0.00021845393,0.00024611308,0.00070473994,0.021135824,0.00011929381],"about_ca_topic_score_codex":0.01089529,"about_ca_topic_score_gemma":0.026145363,"teacher_disagreement_score":0.01089529,"about_ca_system_score_codex":0.0009085806,"about_ca_system_score_gemma":0.002901996,"threshold_uncertainty_score":0.021663725},"labels":[],"label_agreement":null},{"id":"W4311334508","doi":"10.1016/j.jval.2022.09.475","title":"EE227 Healthcare Resource Utilization and Costs Among Patients with Moderately-to-Severely Active Crohn’s Disease Treated with Ustekinumab: Real-World Evidence","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; University of Calgary; McGill University Health Centre","funders":"","keywords":"Ustekinumab; Crohn's disease; Medicine; Disease; Crohn disease; Health care; Resource (disambiguation); Disease control; Internal medicine; Environmental health; Computer science; Infliximab","score_opus":0.028703573641365374,"score_gpt":0.2765764417257364,"score_spread":0.24787286808437103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.71391815,0.25904635,0.00042646317,0.0051120073,0.00041145016,0.00012042984,0.011568594,0.000014646684,0.009381904],"genre_scores_gemma":[0.97456646,0.021405715,0.00031080598,0.00085502345,0.00027309408,0.00004343111,0.002322185,0.0000027879842,0.00022036585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972465,0.0015695493,0.0003619319,0.00020583237,0.0003920724,0.0002241627],"domain_scores_gemma":[0.98908734,0.0066844104,0.0031475811,0.00026909032,0.0004580979,0.00035356247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023312788,0.00043184758,0.0009107921,0.0011214494,0.00023290812,0.0018163137,0.0005205999,0.0010758281,0.003535965],"category_scores_gemma":[0.0119634485,0.0002783888,0.0032129684,0.0022179298,0.00049275527,0.0007864895,0.0006326938,0.0011099888,0.00025912613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020241652,0.0007290031,0.82565975,0.010351569,0.03597812,0.0003152241,0.00013789769,0.0014036166,0.00029070757,0.0012469947,0.004909018,0.09873645],"study_design_scores_gemma":[0.004325788,0.0024137518,0.94542366,0.0065337857,0.02410611,0.00063098146,0.00062458025,0.0016390312,0.00029752034,0.0023300762,0.011576366,0.000098379394],"about_ca_topic_score_codex":0.005917842,"about_ca_topic_score_gemma":0.008874676,"teacher_disagreement_score":0.005917842,"about_ca_system_score_codex":0.0010246817,"about_ca_system_score_gemma":0.00083214056,"threshold_uncertainty_score":0.012329102},"labels":[],"label_agreement":null},{"id":"W4311334543","doi":"10.1016/j.jval.2022.09.930","title":"EPH7 A Survey of the Occurrence and Transmission of COVID-19 in Outdoor Education Settings in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Island University","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Transmission (telecommunications); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Family medicine; Psychology; Medical education; Pediatrics; Computer science; Telecommunications; Virology; Disease","score_opus":0.09890239423765883,"score_gpt":0.41777431697071,"score_spread":0.31887192273305115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98665684,0.00051411585,0.00011936121,0.0005066097,0.000020171827,0.00012636391,0.0063378057,0.000010944528,0.0057076686],"genre_scores_gemma":[0.9938146,0.0006121805,0.00020140226,0.00038250905,0.000006868452,0.000039489983,0.0016843741,0.000006594223,0.0032520073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844533,0.00012752344,0.00008763304,0.00012547504,0.0004461741,0.00076788047],"domain_scores_gemma":[0.9975414,0.00009178823,0.0003740168,0.00003804431,0.0010734432,0.0008813481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043662917,0.00023127721,0.00028969205,0.0014970403,0.0030868878,0.001170214,0.00095925404,0.00053920713,0.0026964033],"category_scores_gemma":[0.0016935855,0.00036306272,0.00042471127,0.0038707166,0.0006280554,0.00033013354,0.001079301,0.0009278949,0.0003537312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020244688,0.000057946414,0.9935522,0.000042386982,0.000018794515,0.00013196009,0.0016599243,0.000028485674,0.00013706507,0.000072342234,0.0013303432,0.002948249],"study_design_scores_gemma":[0.0000014540294,0.000018133253,0.9945169,0.000035318564,0.00000440017,0.000046648613,0.0041975747,0.000043498665,0.000032652093,0.0000071730483,0.0010916312,0.000004480507],"about_ca_topic_score_codex":0.9931694,"about_ca_topic_score_gemma":0.9961514,"teacher_disagreement_score":0.017468376,"about_ca_system_score_codex":0.017468376,"about_ca_system_score_gemma":0.030954024,"threshold_uncertainty_score":0.12674254},"labels":[],"label_agreement":null},{"id":"W4311334641","doi":"10.1016/j.jval.2022.09.1213","title":"HPR83 Unequal Access of Innovative Dermatology Products Across Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Listing (finance); Dermatology; Formulary; Atopic dermatitis; Family medicine; Summary of Product Characteristics; Public health; Psoriasis; Agency (philosophy); Regulatory agency; Actinic keratosis; Drug; Business; Internal medicine; Political science; Pathology; Pharmacology; Finance","score_opus":0.08229528690575083,"score_gpt":0.3893846440052599,"score_spread":0.3070893570995091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.706205,0.0052372874,0.0013107436,0.03603398,0.00012034255,0.00018552155,0.0014387091,0.00006464667,0.24940377],"genre_scores_gemma":[0.9698712,0.001034937,0.0004565503,0.004070949,0.000019619763,0.000029569128,0.00015480045,0.000023977116,0.0243383],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.98601323,0.0013765176,0.00031312098,0.0009446674,0.0062859473,0.0050665727],"domain_scores_gemma":[0.97259426,0.007678591,0.0023024045,0.00096997316,0.01060595,0.005848861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050693406,0.00016330626,0.00040966744,0.0035067364,0.009701098,0.009583968,0.0014286512,0.0020878084,0.014709348],"category_scores_gemma":[0.017758802,0.0004547182,0.0006932704,0.004175103,0.0049507055,0.0015030905,0.0034471375,0.0027768393,0.00044460577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009928623,0.00039525022,0.24870697,0.0007359787,0.00028322573,0.0022127265,0.044836193,0.0013794529,0.0064996704,0.38300332,0.06627475,0.24467951],"study_design_scores_gemma":[0.000089760615,0.0001361366,0.6897134,0.000967167,0.00012473774,0.00062987895,0.043352284,0.0019132337,0.0022425274,0.0104370145,0.25019237,0.00020141686],"about_ca_topic_score_codex":0.98272,"about_ca_topic_score_gemma":0.99092484,"teacher_disagreement_score":0.10302712,"about_ca_system_score_codex":0.10302712,"about_ca_system_score_gemma":0.11448756,"threshold_uncertainty_score":0.7475176},"labels":[],"label_agreement":null},{"id":"W4311334862","doi":"10.1016/j.jval.2022.09.769","title":"EE528 Resource Use and Costs Associated With Computerized Decision Support System for Managing Patients With Atrial Fibrillation","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada); Nova Scotia Health Authority; Dalhousie University; Queen Elizabeth II Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Activity-based costing; Atrial fibrillation; Nova scotia; Health care; Emergency medicine; Resource use; Emergency department; Randomized controlled trial; Indirect costs; Medical emergency; Nursing; Internal medicine; Business","score_opus":0.09971890078041812,"score_gpt":0.380445567567029,"score_spread":0.2807266667866109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659854,0.00033696613,0.00008063252,0.0002683325,0.000019741354,0.000032233587,0.0008181553,0.000007906635,0.0018375538],"genre_scores_gemma":[0.99879503,0.00012493882,0.000101872545,0.00007149933,0.000022849594,0.000022900338,0.00047250692,0.0000025747283,0.00038571638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990006,0.0003774844,0.00019208659,0.00007793954,0.00019657091,0.00015530121],"domain_scores_gemma":[0.99384755,0.0033185575,0.0018358923,0.00012277972,0.0003394188,0.00053573033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006754349,0.00023429058,0.00031716723,0.00086251734,0.00041700678,0.00094486616,0.00032040823,0.0003429276,0.0057002017],"category_scores_gemma":[0.011034126,0.00014365505,0.0009861186,0.0009869711,0.00022335097,0.0006142852,0.00060761184,0.00070829614,0.0002447774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049388674,0.001028372,0.94942904,0.00019579656,0.000682023,0.0006498398,0.00014562192,0.0029539894,0.00034249213,0.00036170965,0.0015893772,0.037682854],"study_design_scores_gemma":[0.0001605135,0.0014849734,0.9857824,0.00009809983,0.00033153655,0.00058884965,0.00053983036,0.009299587,0.00030902046,0.00027452863,0.0011034033,0.000027111933],"about_ca_topic_score_codex":0.009051465,"about_ca_topic_score_gemma":0.010115231,"teacher_disagreement_score":0.009051465,"about_ca_system_score_codex":0.0020245856,"about_ca_system_score_gemma":0.001101894,"threshold_uncertainty_score":0.019069076},"labels":[],"label_agreement":null},{"id":"W4311335052","doi":"10.1016/j.jval.2022.09.968","title":"EPH46 Three-Year Epidemiology, Economic Burden and All-Cause Mortality Among Palmoplantar Pustolosis Patients: A Canadian Incidence Study of Inpatient Care, Emergency Departments, and Hospital- or Community-Based Outpatient Clinics","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Epidemiology; Incidence (geometry); Inpatient care; Emergency medicine; Medical emergency; Family medicine; Health care; Internal medicine","score_opus":0.0815685335182627,"score_gpt":0.3247590854359011,"score_spread":0.2431905519176384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311335052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944752,0.00044730573,0.00003917063,0.00011554356,0.000006158248,0.000018151628,0.003882346,0.0000069328908,0.001009209],"genre_scores_gemma":[0.9967269,0.0003448742,0.00006784819,0.00005615642,0.000008944032,0.000008654539,0.00228302,0.0000038807357,0.0004997481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928766,0.000054520027,0.00005200467,0.00010050026,0.00021900256,0.0002862959],"domain_scores_gemma":[0.99874675,0.00005770949,0.00040445494,0.00006592572,0.00037566,0.00034955022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044762337,0.00047515443,0.0004944536,0.0019838542,0.0015080458,0.0014846949,0.001033274,0.0007619783,0.0022997304],"category_scores_gemma":[0.0012534586,0.0005441041,0.0014617007,0.0041022315,0.00050997786,0.0005696762,0.0009349265,0.0011904326,0.00026535752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010152089,0.000029647566,0.99854565,0.00000823178,0.000081328784,0.00005473874,0.000067719266,0.000032252246,0.00007700239,0.000024358902,0.00026811246,0.00070944213],"study_design_scores_gemma":[0.000005665485,0.000012567858,0.99950385,0.0000045682145,0.000019712668,0.000089685884,0.00015832137,0.00007758055,0.000011046148,0.0000054195057,0.00010680498,0.0000047964186],"about_ca_topic_score_codex":0.8663927,"about_ca_topic_score_gemma":0.85525537,"teacher_disagreement_score":0.13360733,"about_ca_system_score_codex":0.0066737565,"about_ca_system_score_gemma":0.006543408,"threshold_uncertainty_score":0.26878828},"labels":[],"label_agreement":null},{"id":"W4311336401","doi":"10.1016/j.jval.2022.09.2338","title":"RWD113 Differences in Adverse Events Reporting Between Natural Products Versus Prescription Products in the United States and Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Adverse effect; Adverse Event Reporting System; Medicine; Pharmacovigilance; Pharmacy; Natural experiment; Environmental health; Business; Family medicine; Pharmacology","score_opus":0.19805873725713635,"score_gpt":0.3804346809967236,"score_spread":0.18237594373958727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311336401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92998224,0.004370491,0.00032035692,0.0024763304,0.000091356495,0.00012035356,0.03908335,0.000059971015,0.02349549],"genre_scores_gemma":[0.98800105,0.0015221292,0.00023508191,0.00052497705,0.000019057867,0.000017516291,0.0063942955,0.000023260396,0.0032626407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975247,0.00020664674,0.00027620577,0.00033086425,0.0011725604,0.00048901106],"domain_scores_gemma":[0.9891777,0.0011306263,0.0024478456,0.0002126792,0.005628386,0.0014026404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012718593,0.00021368962,0.00039876864,0.0025330107,0.0011260525,0.0016650084,0.0010460807,0.00042424776,0.003691355],"category_scores_gemma":[0.007254545,0.0002753022,0.0011703427,0.0050799767,0.0006268274,0.00039293527,0.0006238983,0.00087529334,0.0002591795],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003191858,0.00003712614,0.9829972,0.00010786169,0.00023864661,0.0000779499,0.00035599465,0.00020038628,0.00018559922,0.00037539765,0.0043679797,0.010736701],"study_design_scores_gemma":[0.00001432903,0.000020709564,0.997439,0.000044500383,0.000052144336,0.0000433179,0.00044282337,0.00017430581,0.00010397452,0.000027848424,0.0016244183,0.000012646978],"about_ca_topic_score_codex":0.99459994,"about_ca_topic_score_gemma":0.9951143,"teacher_disagreement_score":0.018682074,"about_ca_system_score_codex":0.018682074,"about_ca_system_score_gemma":0.026016457,"threshold_uncertainty_score":0.13554859},"labels":[],"label_agreement":null},{"id":"W4311336419","doi":"10.1016/j.jval.2022.09.2301","title":"RWD76 Real-World Patient Persistence and Compliance: A Comparison of Prostaglandin Analogs Used for the Treatment of Open-Angle Glaucoma or Ocular Hypertension","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Latanoprost; Bimatoprost; Medicine; Persistence (discontinuity); Glaucoma; Intraocular pressure; Travoprost; Ocular hypertension; Ophthalmology","score_opus":0.14980671950648414,"score_gpt":0.36872816248461615,"score_spread":0.218921442978132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311336419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771994,0.00076144456,0.000053054788,0.0000429118,0.000021598242,0.000045061122,0.00039651422,0.00000677039,0.0009525262],"genre_scores_gemma":[0.9985045,0.00030390185,0.00016191443,0.00005054391,0.000034884324,0.0000629741,0.00044121037,0.0000039769516,0.00043608632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972626,0.0013233073,0.00039934096,0.0003197189,0.0004873518,0.00020773576],"domain_scores_gemma":[0.9937471,0.002770714,0.0022316722,0.00040600396,0.00024242437,0.0006021091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025703313,0.0004400113,0.0012658964,0.00075674395,0.0004231455,0.000979514,0.00042899454,0.00090890523,0.003693681],"category_scores_gemma":[0.007890069,0.00023454559,0.0020727757,0.0010236948,0.00048785596,0.001153366,0.00067434704,0.00095470075,0.00045620976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.404302,0.0092960335,0.48708025,0.0011175084,0.0064076087,0.00026696065,0.00086737203,0.0009726379,0.0022385302,0.0003946162,0.00060186913,0.08645458],"study_design_scores_gemma":[0.012327834,0.07906145,0.90087503,0.00014751052,0.0021279887,0.00041822417,0.00075724546,0.0013214293,0.0008493256,0.00017501562,0.0018109039,0.00012801045],"about_ca_topic_score_codex":0.0012777597,"about_ca_topic_score_gemma":0.0014773415,"teacher_disagreement_score":0.003693681,"about_ca_system_score_codex":0.0007677744,"about_ca_system_score_gemma":0.00062804646,"threshold_uncertainty_score":0.013593376},"labels":[],"label_agreement":null},{"id":"W4311336870","doi":"10.1016/j.jval.2022.09.2470","title":"SA77 Considerations for Patient Identification and Enrolment for Retrospective Studies for the Collection of Long-Term Follow-up Data","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Identification (biology); Outreach; Leverage (statistics); Medicine; Data collection; Retrospective cohort study; Computer science; Political science; Surgery; Artificial intelligence","score_opus":0.6847738698547348,"score_gpt":0.5956522814703781,"score_spread":0.08912158838435669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311336870","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08662906,0.011452174,0.16386716,0.5379786,0.024112618,0.019296601,0.0024569852,0.0011573083,0.15304957],"genre_scores_gemma":[0.41485706,0.005827388,0.3032975,0.17911662,0.01645004,0.04849699,0.00128413,0.0006880932,0.029982235],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.5851069,0.33680803,0.041491248,0.005599381,0.026535857,0.0044586416],"domain_scores_gemma":[0.34656072,0.5156682,0.020908842,0.046588402,0.058530416,0.011743394],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.30650747,0.00065789564,0.0016572854,0.0038068427,0.003285688,0.008527902,0.003230357,0.011848162,0.016205616],"category_scores_gemma":[0.4408065,0.001557654,0.0025748585,0.0022366343,0.0049922387,0.004566645,0.0041270303,0.009830227,0.0069107665],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005231075,0.0012348787,0.052795306,0.004391448,0.0011640346,0.0054068635,0.02088635,0.002305954,0.00825348,0.124735154,0.34115475,0.43244067],"study_design_scores_gemma":[0.001206425,0.0030420537,0.070026994,0.019261416,0.0007028829,0.011604975,0.011660478,0.008881024,0.005871952,0.05498541,0.8123056,0.0004507077],"about_ca_topic_score_codex":0.0030960492,"about_ca_topic_score_gemma":0.0072486443,"teacher_disagreement_score":0.69349253,"about_ca_system_score_codex":0.0023117706,"about_ca_system_score_gemma":0.014474975,"threshold_uncertainty_score":0.85519975},"labels":[],"label_agreement":null},{"id":"W4311337115","doi":"10.1016/j.jval.2022.09.1675","title":"HTA217 Reimbursement of Drugs for Rare Diseases in Canada: Do Treatment Cost and Cost-Effectiveness Ratio Correlate With Epidemiologic Factors?","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reimbursement; Population; Orphan drug; Incidence (geometry); Emergency medicine; Pediatrics; Family medicine; Environmental health; Health care; Bioinformatics","score_opus":0.38810860723138335,"score_gpt":0.4132467128701277,"score_spread":0.025138105638744357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311337115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80298996,0.04412974,0.0014562159,0.08497022,0.00042516537,0.00023686596,0.038319413,0.00009125397,0.027381117],"genre_scores_gemma":[0.98567027,0.005403445,0.0006634971,0.002195381,0.0001518539,0.000022138514,0.00465268,0.000022694423,0.0012180425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99543804,0.0009920767,0.0003610386,0.00030973527,0.0018528866,0.0010463899],"domain_scores_gemma":[0.96713436,0.010534116,0.007634691,0.0007283358,0.009749087,0.004219423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050355257,0.00032865413,0.00084182975,0.0022968627,0.0011168331,0.0036445444,0.0016297696,0.0013398795,0.00518101],"category_scores_gemma":[0.05025582,0.00037502096,0.0014313796,0.0073289573,0.0012065144,0.0010524372,0.0006600778,0.0021537666,0.000312623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004700997,0.00009956515,0.95756364,0.00018243735,0.0007710696,0.00012737916,0.00014227965,0.0016278531,0.00005246244,0.0042586247,0.01360658,0.021097993],"study_design_scores_gemma":[0.00009442722,0.0000392771,0.9869048,0.00023421565,0.00051940524,0.00011869109,0.0004128437,0.004918392,0.00007116649,0.0011693685,0.005480621,0.000036837926],"about_ca_topic_score_codex":0.98409355,"about_ca_topic_score_gemma":0.9856732,"teacher_disagreement_score":0.042671327,"about_ca_system_score_codex":0.042671327,"about_ca_system_score_gemma":0.07462167,"threshold_uncertainty_score":0.30960357},"labels":[],"label_agreement":null},{"id":"W4311337941","doi":"10.1016/j.jval.2022.09.1483","title":"HTA23 Restrictions and Real-World Evidence Requirements in the Health Technology Assessment of Gene Therapy Medicinal Products in Europe, Canada, Australia, and the United States","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Real world evidence; Business; Medicine; International trade; Economic growth; Health care; Economics","score_opus":0.5626067800328953,"score_gpt":0.4797600705352616,"score_spread":0.08284670949763373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311337941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2749206,0.107695006,0.118505694,0.2703011,0.0021830138,0.0023782046,0.05486517,0.0007389863,0.16841212],"genre_scores_gemma":[0.9349496,0.006887596,0.026009336,0.019842308,0.00078065705,0.001455107,0.00749041,0.00017439424,0.002410697],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.76785165,0.15772916,0.030389903,0.008007468,0.028997594,0.0070242854],"domain_scores_gemma":[0.102229424,0.85200363,0.017853074,0.0097255,0.015006041,0.0031823232],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.33437967,0.00087054697,0.00442119,0.0075347787,0.0015676372,0.019256143,0.0055139447,0.00908952,0.0077056237],"category_scores_gemma":[0.6242987,0.0019954352,0.00661954,0.00955028,0.009214366,0.009875476,0.0040976712,0.012443012,0.0007521843],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048190663,0.0002611279,0.057542264,0.0040699732,0.004027272,0.0014979886,0.0017429317,0.07293379,0.0008420627,0.74113506,0.034442294,0.07668615],"study_design_scores_gemma":[0.002419805,0.0010869766,0.1467206,0.015234576,0.0040855245,0.0029310219,0.0018172914,0.05760414,0.0036869003,0.6677064,0.09604959,0.0006572394],"about_ca_topic_score_codex":0.060608547,"about_ca_topic_score_gemma":0.029171241,"teacher_disagreement_score":0.6656203,"about_ca_system_score_codex":0.010045794,"about_ca_system_score_gemma":0.023438148,"threshold_uncertainty_score":0.8208284},"labels":[],"label_agreement":null},{"id":"W4311338332","doi":"10.1016/j.jval.2022.09.1495","title":"HTA35 Should Health Technology Assessment (HTA) Bodies Utilize Living HTA Tools? Validation of LiveSLR® and LiveNMA™ Tools Using ICER’S Class Review in Relapsed Refractory Multiple Myeloma (RRMM)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Daratumumab; Ixazomib; Dexamethasone; Carfilzomib; Oncology; Medical physics; Internal medicine; Lenalidomide","score_opus":0.5787481936986596,"score_gpt":0.46973739952004934,"score_spread":0.10901079417861026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311338332","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26056594,0.40905795,0.047886763,0.060701266,0.0055705477,0.008270777,0.107578866,0.0010076859,0.09936015],"genre_scores_gemma":[0.8818089,0.028328428,0.033683922,0.012928792,0.0017638733,0.0052165207,0.03178372,0.00031383813,0.0041720006],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.93075716,0.045871917,0.007875485,0.0024572876,0.011535988,0.0015021642],"domain_scores_gemma":[0.7822069,0.13577326,0.040771782,0.010656482,0.027932046,0.0026595586],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11389028,0.0006140589,0.0023902378,0.002245048,0.00046154516,0.004526259,0.0019326286,0.0015713583,0.005803011],"category_scores_gemma":[0.2248985,0.00047299484,0.0077495025,0.0026446874,0.00088112406,0.003399115,0.002177875,0.0023087931,0.0015166238],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008497472,0.00033571568,0.14753404,0.027333375,0.03280098,0.00010854634,0.0012319875,0.0050032726,0.0005489214,0.012598786,0.10641673,0.65759015],"study_design_scores_gemma":[0.0058703437,0.0053668884,0.45050958,0.07536419,0.0355308,0.0005889853,0.0011347207,0.01219378,0.0045799757,0.018704196,0.38960215,0.00055434945],"about_ca_topic_score_codex":0.005312916,"about_ca_topic_score_gemma":0.0049419417,"teacher_disagreement_score":0.8861097,"about_ca_system_score_codex":0.0026654126,"about_ca_system_score_gemma":0.005288777,"threshold_uncertainty_score":0.6023166},"labels":[],"label_agreement":null},{"id":"W4311338536","doi":"10.1016/j.jval.2022.09.2412","title":"SA18 Development and Application of a Taxonomy on the Beneficial Effects of Oral Anticoagulant Switching in Atrial Fibrillation","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atrial fibrillation; Medicine; Taxonomy (biology); Stroke (engine); Delphi method; Adverse effect; Rivaroxaban; Intensive care medicine; Medical emergency; Warfarin; Internal medicine; Computer science; Artificial intelligence","score_opus":0.0802103012756382,"score_gpt":0.32527594924359643,"score_spread":0.2450656479679582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311338536","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08892656,0.022723312,0.60768116,0.07105198,0.0077540465,0.0055930386,0.027212063,0.004519459,0.16453844],"genre_scores_gemma":[0.18651497,0.012646766,0.7500316,0.0063012303,0.0020711848,0.0040592607,0.019150974,0.0006716478,0.018552396],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.983113,0.006849555,0.0040280377,0.00086629676,0.0045349444,0.00060819346],"domain_scores_gemma":[0.9206986,0.025898807,0.0057211975,0.0045565446,0.04006668,0.0030581015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021225255,0.0011466662,0.0014457832,0.008321144,0.0014621768,0.006204681,0.0016613906,0.0016326654,0.008513053],"category_scores_gemma":[0.071515046,0.0005016819,0.0036916516,0.005795332,0.001389139,0.004071427,0.005281116,0.0029274346,0.0039590574],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006356561,0.000371666,0.04464815,0.0031981412,0.00056884886,0.00016465878,0.0025096803,0.006138244,0.0022138094,0.09534883,0.09186484,0.7523375],"study_design_scores_gemma":[0.00021697288,0.0013022271,0.030572938,0.00705052,0.0005779661,0.0007397617,0.0032251677,0.022011684,0.0038760817,0.13595894,0.7942888,0.0001789056],"about_ca_topic_score_codex":0.007237713,"about_ca_topic_score_gemma":0.0077829957,"teacher_disagreement_score":0.021225255,"about_ca_system_score_codex":0.0038571951,"about_ca_system_score_gemma":0.015415264,"threshold_uncertainty_score":0.11225122},"labels":[],"label_agreement":null},{"id":"W4311338564","doi":"10.1016/j.jval.2022.09.2165","title":"PCR232 The Use of EuroQol EQ-5D in the Middle East and North Africa Region: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CINAHL; PsycINFO; Data extraction; Systematic review; Medicine; EQ-5D; MEDLINE; Population; Inclusion (mineral); Family medicine; Psychology; Health related quality of life; Environmental health; Psychiatry; Psychological intervention; Political science; Pathology","score_opus":0.9323004053396625,"score_gpt":0.4378622853480493,"score_spread":0.49443811999161325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311338564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045748087,0.99854726,0.00010362592,0.0001452362,0.00007458287,0.000120695324,0.0004026905,0.0000036851527,0.00014466915],"genre_scores_gemma":[0.009161806,0.9893818,0.00054747076,0.0003732456,0.000048217873,0.00020522978,0.00020370532,0.0000048439633,0.00007370579],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9925759,0.0024616169,0.0027728947,0.0005850991,0.0013825733,0.00022184657],"domain_scores_gemma":[0.9833872,0.012010954,0.003038548,0.00021762366,0.0011846926,0.00016098004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00946134,0.0015181683,0.00790602,0.009458727,0.00048447074,0.003081582,0.0016186968,0.0017744385,0.005907758],"category_scores_gemma":[0.041716125,0.0009346646,0.008844224,0.010904266,0.00091646734,0.0023931614,0.002115944,0.001537639,0.00032796586],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026441956,0.000017912067,0.0015534131,0.90167636,0.017659556,0.00006249923,0.00011999903,0.0001289734,0.00010997184,0.00040423273,0.001965245,0.07603732],"study_design_scores_gemma":[0.0005163278,0.00016825733,0.009390666,0.8470467,0.11377988,0.00030728988,0.0003162285,0.00012134295,0.00016815965,0.0005465883,0.02756966,0.00006890394],"about_ca_topic_score_codex":0.013898052,"about_ca_topic_score_gemma":0.03359387,"teacher_disagreement_score":0.013898052,"about_ca_system_score_codex":0.0033605527,"about_ca_system_score_gemma":0.01007316,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"opus","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4311339045","doi":"10.1016/j.jval.2022.09.2177","title":"PCR244 Burden of Myelodysplastic Syndromes Part I: Systematic Literature Review of Epidemiologic and Humanistic Burden","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Disease burden; Incidence (geometry); Quality of life (healthcare); Myelodysplastic syndromes; Disease; Epidemiology; Anemia; MEDLINE; Cancer; Systematic review; Gerontology; Internal medicine; Family medicine; Bone marrow","score_opus":0.06700767727458984,"score_gpt":0.3471173889155005,"score_spread":0.28010971164091064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339045","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014309821,0.9790037,0.00024370008,0.0006226555,0.000120773824,0.000087171,0.005171471,0.000007678232,0.0004329745],"genre_scores_gemma":[0.22389269,0.7692941,0.0015336042,0.0012176636,0.00026752794,0.00035621284,0.003284425,0.000013276199,0.0001405263],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.991032,0.00354432,0.0030749992,0.0010487932,0.0010585199,0.00024137681],"domain_scores_gemma":[0.96260965,0.025095113,0.008859356,0.00092280604,0.002195321,0.00031775824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009622345,0.0006455191,0.0033405072,0.009030395,0.0003964493,0.0018371581,0.0010779728,0.001181709,0.0027567793],"category_scores_gemma":[0.045698293,0.0007032453,0.007317716,0.015334927,0.00092310633,0.001594001,0.0015060676,0.001097159,0.00020180034],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009668946,0.000049666607,0.22121331,0.54920703,0.1414533,0.0002452437,0.00079951214,0.0004743709,0.00031019273,0.0010762004,0.0067728357,0.077431485],"study_design_scores_gemma":[0.0005913967,0.00029872608,0.37783417,0.32171595,0.27262157,0.0010069765,0.0013761432,0.00036235494,0.00026423234,0.0014547083,0.022338586,0.00013518984],"about_ca_topic_score_codex":0.014193034,"about_ca_topic_score_gemma":0.02897816,"teacher_disagreement_score":0.014193034,"about_ca_system_score_codex":0.0014783314,"about_ca_system_score_gemma":0.004477342,"threshold_uncertainty_score":0.05088848},"labels":[],"label_agreement":null},{"id":"W4311339051","doi":"10.1016/j.jval.2022.09.1458","title":"HSD115 Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Enzalutamide; Medicine; Abiraterone acetate; Prostate cancer; Taxane; Cohort; Internal medicine; Tolerability; Cabazitaxel; Oncology; Specialty; Population; Retrospective cohort study; Chemotherapy; Cancer; Gynecology; Androgen deprivation therapy; Family medicine; Adverse effect; Breast cancer; Androgen receptor; Environmental health","score_opus":0.20298439713475921,"score_gpt":0.4291731003992639,"score_spread":0.22618870326450466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587052,0.007617437,0.00031208427,0.0014346119,0.000034855,0.00004508314,0.02255724,0.000060670973,0.009232922],"genre_scores_gemma":[0.98623,0.0030581316,0.00031703667,0.0003340927,0.000014537403,0.000016753718,0.0050018346,0.000015153487,0.0050123637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99963915,0.000038779268,0.00002981638,0.000059487265,0.00011645453,0.000116309464],"domain_scores_gemma":[0.9984413,0.00013566243,0.00035549284,0.000023372737,0.0007848136,0.0002593872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003905916,0.00017646713,0.00028152094,0.0013149232,0.00061313546,0.0010444387,0.00048825628,0.00029164826,0.0041472795],"category_scores_gemma":[0.0010904975,0.0001303735,0.00062010577,0.0032340395,0.0002727903,0.00028737748,0.00024204653,0.0005216944,0.00028389474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034691027,0.00005276637,0.9640723,0.000120748184,0.00018149437,0.00015388869,0.00041111623,0.00064712303,0.000875034,0.00045096685,0.004124408,0.028563315],"study_design_scores_gemma":[0.000008698082,0.00005754498,0.9929323,0.00005603217,0.000055611556,0.00008239802,0.0005531237,0.00054467557,0.00019475703,0.000017560438,0.0054858145,0.000011354763],"about_ca_topic_score_codex":0.98286426,"about_ca_topic_score_gemma":0.98847383,"teacher_disagreement_score":0.01913604,"about_ca_system_score_codex":0.01913604,"about_ca_system_score_gemma":0.011817775,"threshold_uncertainty_score":0.13884234},"labels":[],"label_agreement":null},{"id":"W4311339315","doi":"10.1016/j.jval.2022.09.1992","title":"PCR57 An Empirical Comparison of Data From Forced vs Non-Forced Choices in a Dual Response Discrete Choice Experiment, With Breast Cancer Patients in Six European Countries","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Two-alternative forced choice; Multinomial logistic regression; Medicine; Task (project management); Payment; Breast cancer; Econometrics; Demography; Physical therapy; Actuarial science; Cancer; Statistics; Mathematics; Computer science; Economics; Internal medicine","score_opus":0.17818193928497023,"score_gpt":0.34239335676456256,"score_spread":0.16421141747959234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998218,0.0000984405,0.00071715435,0.00004802079,0.000009540783,0.000094534786,0.0004027591,0.0000041664857,0.00040750302],"genre_scores_gemma":[0.9976574,0.000040397623,0.00068262534,0.00007748044,0.0000073216984,0.0001353527,0.0009081494,0.000004067187,0.0004871139],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.987621,0.010408023,0.0004076169,0.00078129285,0.00042765122,0.00035449714],"domain_scores_gemma":[0.9102555,0.077237636,0.0050683445,0.0047045173,0.0017189906,0.0010149598],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018023128,0.0005014882,0.0007927011,0.0005246029,0.00061569596,0.0013141081,0.00060713955,0.0014143445,0.0045963344],"category_scores_gemma":[0.046367172,0.0003715317,0.0012485887,0.0008977216,0.0012784476,0.0008971864,0.0008038836,0.00112566,0.00068512396],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1417316,0.017064767,0.7651542,0.0007587837,0.0030160274,0.00057851867,0.0062313434,0.013776885,0.0053415396,0.0027925663,0.001839587,0.041714188],"study_design_scores_gemma":[0.008463593,0.03831314,0.91080767,0.00015900526,0.0015291199,0.0006746423,0.0047919303,0.019570408,0.008634783,0.0028807006,0.0038949351,0.0002799778],"about_ca_topic_score_codex":0.0038075026,"about_ca_topic_score_gemma":0.0019026661,"teacher_disagreement_score":0.98197687,"about_ca_system_score_codex":0.0005726743,"about_ca_system_score_gemma":0.00070893054,"threshold_uncertainty_score":0.09531659},"labels":[],"label_agreement":null},{"id":"W4311339322","doi":"10.1016/j.jval.2022.09.1369","title":"HSD25 Occupational Burnout Among Pediatric Neurologists Is Associated with Therapeutic Inertia in the Management of Spinal Muscular Atrophy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Spinal muscular atrophy; SMA*; Burnout; Medicine; Atrophy; Health care; Physical medicine and rehabilitation; Physical therapy; Clinical psychology; Internal medicine","score_opus":0.04637529546752485,"score_gpt":0.32557207515289815,"score_spread":0.2791967796853733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979259,0.00038597625,0.00004708983,0.00038465852,0.000024503124,0.0000049901846,0.000046151647,0.000001925547,0.0011787614],"genre_scores_gemma":[0.99950194,0.00014606531,0.000056255652,0.000050195304,0.000016503067,0.0000032285207,0.000048090995,0.0000014990881,0.00017615734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987909,0.000383242,0.00011994693,0.00011282811,0.0002989629,0.00029417803],"domain_scores_gemma":[0.9928396,0.001996171,0.0030773513,0.00016113806,0.0006291365,0.0012965113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085514534,0.00020693227,0.00023105813,0.0007242769,0.0010094873,0.0010149925,0.0004035146,0.0005989696,0.0028612602],"category_scores_gemma":[0.009093597,0.00024110104,0.00032832404,0.0007407696,0.00047856907,0.00030165794,0.0008373273,0.0010289733,0.00022321513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031905634,0.00006327958,0.99659353,0.00001117959,0.000018642952,0.00023298322,0.0005759644,0.000020976931,0.000067109926,0.000043348515,0.00014061324,0.0022004445],"study_design_scores_gemma":[0.0000015180656,0.000022178161,0.99751174,0.000026269865,0.0000098892,0.00033799442,0.0017033567,0.00007357981,0.00002402435,0.000041877996,0.00024440372,0.000003261631],"about_ca_topic_score_codex":0.013766831,"about_ca_topic_score_gemma":0.019735279,"teacher_disagreement_score":0.013766831,"about_ca_system_score_codex":0.0010425498,"about_ca_system_score_gemma":0.0017482267,"threshold_uncertainty_score":0.027373374},"labels":[],"label_agreement":null},{"id":"W4311339500","doi":"10.1016/j.jval.2022.09.2113","title":"PCR180 Real-World Impact of Patient-Reported Outcome Measurement on Overall Survival and Healthcare Resource Utilization in Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cohort; Propensity score matching; Colorectal cancer; Internal medicine; Breast cancer; Logistic regression; Retrospective cohort study; Cancer; Lung cancer; Cohort study; Proportional hazards model; Cancer registry; Population; Health care","score_opus":0.17113242961639882,"score_gpt":0.3820315933152187,"score_spread":0.21089916369881986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99234277,0.0005108105,0.00050288736,0.000685205,0.00006438903,0.000016201324,0.0039664092,0.000040882594,0.0018705337],"genre_scores_gemma":[0.9981122,0.00006585966,0.00021843724,0.000084710846,0.000023359285,0.000017513443,0.0012786725,0.0000063385164,0.00019302774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669963,0.0018589507,0.0002355461,0.00039108793,0.00043080028,0.00038393275],"domain_scores_gemma":[0.9897211,0.0055062766,0.002979931,0.00043430805,0.00074739737,0.0006108946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031207232,0.00031029558,0.00046316572,0.0005548949,0.00029465609,0.0019250216,0.00035857197,0.00049521204,0.002453525],"category_scores_gemma":[0.017918251,0.0001838887,0.0013428873,0.0013588009,0.00036636123,0.00093428354,0.0008463241,0.0011666424,0.00051626394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097416836,0.0001956171,0.9837299,0.00006660655,0.0004894095,0.00003729667,0.00009410764,0.0013240017,0.0001424189,0.00016811032,0.001133501,0.011644874],"study_design_scores_gemma":[0.000045510955,0.00074206863,0.9918833,0.00002651129,0.00024980566,0.000084561405,0.00031312637,0.004826281,0.00045062852,0.00027998662,0.0010706158,0.000027584789],"about_ca_topic_score_codex":0.0048607583,"about_ca_topic_score_gemma":0.003765283,"teacher_disagreement_score":0.0048607583,"about_ca_system_score_codex":0.0008234653,"about_ca_system_score_gemma":0.00076357496,"threshold_uncertainty_score":0.016504169},"labels":[],"label_agreement":null},{"id":"W4311339610","doi":"10.1016/j.jval.2022.09.1401","title":"HSD58 Country Differences in the Clinical Manifestations and Treatment Patterns of Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA): A European Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Granulomatosis with polyangiitis; Eosinophilic; Hypereosinophilia; Medicine; Asthma; Cohort; Disease; Dermatology; Churg-strauss syndrome; Vasculitis; Perspective (graphical); Pathology; Internal medicine; Eosinophilia","score_opus":0.036711804050618996,"score_gpt":0.2950755711097987,"score_spread":0.25836376705917974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98191386,0.00912585,0.00023606607,0.0022400082,0.000083541374,0.000005743793,0.0008621098,0.0000040790387,0.005528611],"genre_scores_gemma":[0.9969964,0.001974532,0.00011380821,0.00037316736,0.000052873875,0.0000021685066,0.00026459232,0.0000027308486,0.00021971737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992518,0.00030791064,0.00006982909,0.00010903972,0.00006135941,0.00020014375],"domain_scores_gemma":[0.9987582,0.0002976967,0.00053833734,0.000055735978,0.00014889029,0.0002010812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086003524,0.00012427749,0.00027592684,0.0006463351,0.0002481035,0.0009678837,0.0001820084,0.00038933582,0.002473597],"category_scores_gemma":[0.0017874177,0.00009045248,0.0003535884,0.0017281462,0.00041593448,0.0004931211,0.0004116846,0.00041011366,0.00018199679],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048093344,0.00008995792,0.9773786,0.000090172485,0.00032302414,0.00081255875,0.0006197662,0.00018827553,0.00069407345,0.0009920298,0.0008115934,0.017519027],"study_design_scores_gemma":[0.000014267975,0.000055077835,0.9960259,0.00007129974,0.000054593427,0.0006278679,0.0010479504,0.00005547393,0.000069326285,0.00015850992,0.0018108919,0.000008803448],"about_ca_topic_score_codex":0.0099028405,"about_ca_topic_score_gemma":0.00854284,"teacher_disagreement_score":0.0099028405,"about_ca_system_score_codex":0.00045554645,"about_ca_system_score_gemma":0.0004351263,"threshold_uncertainty_score":0.019690394},"labels":[],"label_agreement":null},{"id":"W4311340638","doi":"10.1016/j.jval.2022.09.2468","title":"SA75 Exploring the Relationship Between Comorbidities and Alzheimer's Disease Progression Assessed Using the Clinical Dementia Rating Scale: A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Clinical Dementia Rating; Medicine; Dementia; Internal medicine; Disease; Comorbidity; Cochrane Library; Meta-analysis; MEDLINE","score_opus":0.35663442671034135,"score_gpt":0.4784197933380734,"score_spread":0.12178536662773204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311340638","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029338365,0.9951025,0.00018043617,0.00022014341,0.00012961832,0.00032055096,0.0008606281,0.0000069098032,0.00024530498],"genre_scores_gemma":[0.03410399,0.9628928,0.00093760085,0.00064152357,0.00010918289,0.00064625364,0.0005366772,0.0000056073104,0.00012636541],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9914875,0.0025509002,0.0038086823,0.00077479234,0.0011205004,0.00025756075],"domain_scores_gemma":[0.9612157,0.029169377,0.005894285,0.0005527385,0.0028292204,0.00033871297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010774494,0.0013100379,0.00717692,0.009836997,0.00073446083,0.003383592,0.00163069,0.0023780004,0.0041108606],"category_scores_gemma":[0.058818184,0.00111383,0.013264767,0.009536757,0.0008722745,0.0020874657,0.0019435207,0.0016331263,0.00037606314],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046036008,0.00003828766,0.0046934364,0.9176172,0.045884833,0.00009895857,0.00020217044,0.00012167666,0.0001791633,0.00018954102,0.00085051736,0.02966385],"study_design_scores_gemma":[0.00050761394,0.00029776708,0.015869178,0.71554744,0.2584727,0.0003264109,0.00033985949,0.000119980505,0.00014353405,0.00029566616,0.008004607,0.00007511067],"about_ca_topic_score_codex":0.01792556,"about_ca_topic_score_gemma":0.059153926,"teacher_disagreement_score":0.01792556,"about_ca_system_score_codex":0.0034153196,"about_ca_system_score_gemma":0.015715234,"threshold_uncertainty_score":0.056981623},"labels":[],"label_agreement":null},{"id":"W4311340667","doi":"10.1016/j.jval.2022.09.1539","title":"HTA79 Time-Driven Activity-Based Costing to Compare the Cost of Administering Bronchodilators by Metered Dose Inhalers and by Nebulization in the Emergency Department","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Salbutamol; Ipratropium; Medicine; Emergency department; Asthma; Activity-based costing; Anesthesia; Emergency medicine; Bronchodilator; Business; Internal medicine; Nursing","score_opus":0.0482354415398309,"score_gpt":0.3180764359581671,"score_spread":0.2698409944183362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311340667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9441053,0.002841089,0.009637907,0.0010508582,0.0004502227,0.0011379619,0.028358148,0.00035552835,0.012062997],"genre_scores_gemma":[0.9852541,0.00025957788,0.004631027,0.00030141263,0.000075973214,0.00046344002,0.007137442,0.00006892101,0.0018080741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957481,0.0021537077,0.00028765312,0.0004337817,0.0010774173,0.0002993191],"domain_scores_gemma":[0.9908688,0.005863244,0.0015258312,0.00043742778,0.00080956105,0.0004949932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038588978,0.00075959857,0.0011964343,0.0016296222,0.0002158216,0.0011186054,0.001676371,0.0008615091,0.00891258],"category_scores_gemma":[0.019452982,0.0002615227,0.0036429188,0.002372553,0.00028084457,0.0012125855,0.00084613066,0.0012933088,0.0008873444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11181152,0.0053606927,0.43104544,0.0032033413,0.025637034,0.00034126,0.00048301846,0.1043888,0.002215835,0.015950102,0.028506678,0.27105635],"study_design_scores_gemma":[0.009773217,0.023015043,0.5641555,0.000916164,0.00861311,0.0009003222,0.00074131053,0.34425852,0.004413229,0.010160422,0.032767322,0.00028577232],"about_ca_topic_score_codex":0.015289899,"about_ca_topic_score_gemma":0.0066591497,"teacher_disagreement_score":0.015289899,"about_ca_system_score_codex":0.002692928,"about_ca_system_score_gemma":0.0017404195,"threshold_uncertainty_score":0.030401826},"labels":[],"label_agreement":null},{"id":"W4311341467","doi":"10.1016/j.jval.2022.09.2469","title":"SA76 Burden of Illness in Patients with Alzheimer’s Disease: A Systematic Review of Incidence, Prevalence, Comorbidities, Disability and Mortality","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Dementia; Medicine; Comorbidity; Incidence (geometry); Disease; Diabetes mellitus; Gerontology; Pediatrics; Internal medicine","score_opus":0.08060692880070522,"score_gpt":0.3664804199279967,"score_spread":0.28587349112729143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311341467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009523385,0.99807334,0.000056349687,0.00006798172,0.000055203793,0.000056933935,0.00060885324,0.0000062925865,0.00012264011],"genre_scores_gemma":[0.01100335,0.9881017,0.00028811707,0.00017239815,0.000036669855,0.00007802271,0.0002481021,0.000003293882,0.00006833338],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975617,0.0005490519,0.0010526,0.00026585968,0.00047004395,0.00010077132],"domain_scores_gemma":[0.99489355,0.003153025,0.0012608027,0.00008199518,0.00049413455,0.000116542215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032753868,0.001257955,0.008025368,0.007193386,0.00040140623,0.0017140377,0.0011361495,0.0012151946,0.0041313227],"category_scores_gemma":[0.012592382,0.0009355039,0.010577418,0.008774372,0.00046736345,0.0014243231,0.0015680566,0.0012708675,0.00030374012],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039541206,0.000019910734,0.0032976076,0.89059794,0.047091432,0.00006489013,0.0001361733,0.00015358329,0.00015599845,0.00018533209,0.002414647,0.055487134],"study_design_scores_gemma":[0.00075960654,0.00035352755,0.033962995,0.52542984,0.4055236,0.00052743213,0.00038378075,0.00021624129,0.0001753662,0.000579472,0.03196506,0.00012313691],"about_ca_topic_score_codex":0.017047634,"about_ca_topic_score_gemma":0.057876665,"teacher_disagreement_score":0.017047634,"about_ca_system_score_codex":0.0017559129,"about_ca_system_score_gemma":0.00515002,"threshold_uncertainty_score":0.033896804},"labels":[],"label_agreement":null},{"id":"W4311342278","doi":"10.1016/j.jval.2022.09.2105","title":"PCR170 Mapping IWQOL-Lite Onto EQ-5D-5L and SF-6DV2 in Chinese Overweight and Obese Population","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Akaike information criterion; Statistics; Mathematics; Overweight; Population; Bayesian information criterion; Mean squared error; Mean absolute percentage error; Linear regression; EQ-5D; Demography; Medicine; Body mass index; Internal medicine; Health related quality of life","score_opus":0.3244837192577949,"score_gpt":0.3800896128161344,"score_spread":0.0556058935583395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311342278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962291,0.00011367725,0.000627417,0.00016384329,0.00002121729,0.00002275647,0.0014319151,0.000013603121,0.00137646],"genre_scores_gemma":[0.99715555,0.000054655444,0.00032416164,0.000047274192,0.000011093967,0.000044226814,0.0013323532,0.000012175871,0.0010186433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933773,0.00017165618,0.00004393382,0.00017634033,0.00008904989,0.00018129071],"domain_scores_gemma":[0.9991025,0.00031029317,0.00014849317,0.00010241305,0.00021118746,0.00012513995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014458838,0.00047595776,0.0003390562,0.0014075434,0.00068590365,0.0010411895,0.000548295,0.0003200733,0.0051517524],"category_scores_gemma":[0.0042492873,0.000344951,0.0017698001,0.0027294245,0.00040503033,0.00044089742,0.0008471548,0.0007350728,0.00075478206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030576027,0.000067569395,0.98571825,0.000038829374,0.00023196064,0.0001536155,0.00055524166,0.0004670091,0.0008535187,0.00040869464,0.0009156993,0.010283876],"study_design_scores_gemma":[0.00001655425,0.00005542788,0.99637944,0.000012701231,0.00019298025,0.00006564251,0.0007013152,0.0014680086,0.00024097126,0.00026419593,0.0005904351,0.000012328983],"about_ca_topic_score_codex":0.098758884,"about_ca_topic_score_gemma":0.04174273,"teacher_disagreement_score":0.098758884,"about_ca_system_score_codex":0.00069194,"about_ca_system_score_gemma":0.0018276749,"threshold_uncertainty_score":0.1963681},"labels":[],"label_agreement":null},{"id":"W4311342469","doi":"10.1016/j.jval.2022.09.057","title":"P45 Internal, External, and Cross-Validation of the DEDUCE Model, a Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Western University","funders":"","keywords":"Mean absolute percentage error; Continuous glucose monitoring; Type 2 diabetes; Computer science; Type 1 diabetes; Statistics; Medicine; Diabetes mellitus; Mean squared error; Mathematics","score_opus":0.15984441964134768,"score_gpt":0.40083696094883586,"score_spread":0.24099254130748818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311342469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8811575,0.00018729236,0.11043335,0.00011250092,0.000076404125,0.00019884684,0.0022557392,0.0021733858,0.0034049875],"genre_scores_gemma":[0.9768059,0.000032054642,0.020483974,0.00003145963,0.000005806851,0.00010377556,0.0019221115,0.00012316485,0.00049170427],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974879,0.001256739,0.0001495337,0.00047886602,0.0005003236,0.00012651537],"domain_scores_gemma":[0.9862672,0.010128942,0.0005810824,0.0011387075,0.0017563307,0.00012774568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009007288,0.0012832223,0.0006087686,0.001171135,0.00028917522,0.0010969243,0.00088459195,0.0006603886,0.002695616],"category_scores_gemma":[0.023440653,0.00038582753,0.0010749327,0.0006983548,0.00050461653,0.0007541375,0.000863414,0.00063194596,0.0004969737],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033176944,0.00089322345,0.080828615,0.0003712875,0.00095591805,0.00017608769,0.00014788655,0.83542454,0.0052457517,0.0019407229,0.0042420784,0.06645626],"study_design_scores_gemma":[0.00011818494,0.00055442506,0.0134248445,0.000028253695,0.00011752216,0.000053864504,0.00004133899,0.980113,0.00440092,0.000554562,0.00057593005,0.00001705445],"about_ca_topic_score_codex":0.009361845,"about_ca_topic_score_gemma":0.004430927,"teacher_disagreement_score":0.009361845,"about_ca_system_score_codex":0.0007804214,"about_ca_system_score_gemma":0.001229889,"threshold_uncertainty_score":0.047635674},"labels":[],"label_agreement":null},{"id":"W4311342894","doi":"10.1016/j.jval.2022.09.2432","title":"SA38 Mortality Estimates in Patients With Anti-Aquaporin-4 Autoantibody Positive Neuromyelitis Optica Spectrum Disorder","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Autoantibody; Medicine; Aquaporin 4; Multiple sclerosis; Disease; Pediatrics; Immunology; Pathology; Antibody; Psychiatry","score_opus":0.036218474785306,"score_gpt":0.3299394272878361,"score_spread":0.2937209525025301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311342894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851142,0.000782013,0.00027899467,0.00015144264,0.000026314827,0.0000073174333,0.011642391,0.000016956816,0.0019803664],"genre_scores_gemma":[0.9939733,0.00018978424,0.00011804184,0.000024134664,0.000020775364,0.0000144900205,0.005180122,0.0000042272973,0.00047508953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931574,0.00022283322,0.00011944123,0.00010983082,0.00013277495,0.00009932991],"domain_scores_gemma":[0.99842525,0.00031647983,0.00065706414,0.0001285213,0.000352772,0.00011991777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010875071,0.0003065454,0.00029442838,0.0021362964,0.00027242355,0.0006247974,0.0003415483,0.00030974374,0.0017607496],"category_scores_gemma":[0.0034236116,0.00016793369,0.0010529947,0.0013855307,0.00012563163,0.0004597939,0.0006710325,0.00044889443,0.00045547262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003075051,0.000014070642,0.9942015,0.00003632355,0.00039594577,0.00005409117,0.000093976865,0.00036198986,0.00015210634,0.00013207113,0.0009886706,0.0032617606],"study_design_scores_gemma":[0.000013579385,0.000077560246,0.99709666,0.000020354611,0.00010148027,0.00019316043,0.00024345824,0.0007074516,0.00012409869,0.00013025281,0.0012843494,0.000007655666],"about_ca_topic_score_codex":0.010546518,"about_ca_topic_score_gemma":0.009769431,"teacher_disagreement_score":0.010546518,"about_ca_system_score_codex":0.0006036691,"about_ca_system_score_gemma":0.00034869814,"threshold_uncertainty_score":0.020970225},"labels":[],"label_agreement":null},{"id":"W4311351195","doi":"10.1016/j.jval.2022.09.1658","title":"HTA200 Do Pharmacoeconomic Analyses Impact Price Negotiation Outcomes in Canada? Comparison of Rare Disease and Oncology Drugs","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Negotiation; Medicine; Internal medicine; Alliance; Family medicine; Oncology; Political science","score_opus":0.41548483295136796,"score_gpt":0.516473419995901,"score_spread":0.10098858704453306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311351195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7325775,0.023831978,0.0014048982,0.07635057,0.0011979743,0.0006787084,0.06838433,0.00015976488,0.095414296],"genre_scores_gemma":[0.98163086,0.0021710335,0.00077281985,0.0044316845,0.0001249539,0.000057909638,0.005814996,0.0000487436,0.0049470356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99459213,0.0013449317,0.00036972342,0.00035891685,0.0020644786,0.0012699085],"domain_scores_gemma":[0.96743786,0.010927685,0.005569261,0.0010226899,0.011317566,0.0037249313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058905296,0.00034406557,0.0007183878,0.001615445,0.0017864616,0.004386306,0.0016578339,0.0014820463,0.016676435],"category_scores_gemma":[0.05744049,0.0003652415,0.0023325146,0.004250407,0.001538289,0.0013988675,0.0012793258,0.0020151744,0.0005857356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013907487,0.00076754513,0.6642047,0.0015777627,0.0064716493,0.00029049028,0.0010068823,0.010678481,0.0004659965,0.025962036,0.14293997,0.131727],"study_design_scores_gemma":[0.0031447716,0.0005530935,0.9246737,0.0011771655,0.0040645944,0.00011854883,0.0020929135,0.009464928,0.00085602974,0.005008033,0.048631433,0.00021477457],"about_ca_topic_score_codex":0.9898499,"about_ca_topic_score_gemma":0.9932528,"teacher_disagreement_score":0.94755375,"about_ca_system_score_codex":0.052446242,"about_ca_system_score_gemma":0.09467324,"threshold_uncertainty_score":0.38052595},"labels":[],"label_agreement":null},{"id":"W4311351375","doi":"10.1016/j.jval.2022.09.034","title":"P22 Value of Information - Consolidated Health Economic Evaluation Reporting Standards: A Checklist Extension","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Checklist; Delphi; Likert scale; Delphi method; Psychology; Medical education; Medicine; Computer science; Applied psychology","score_opus":0.34194073805082653,"score_gpt":0.45688222302516546,"score_spread":0.11494148497433893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311351375","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015422406,0.008255964,0.27977353,0.042063285,0.0064462945,0.0831289,0.386763,0.017308826,0.16083775],"genre_scores_gemma":[0.069063745,0.0046551824,0.5302335,0.01448818,0.0013141029,0.16426067,0.19181353,0.0036783947,0.02049267],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8314397,0.07801445,0.049159534,0.002231512,0.035555746,0.0035990966],"domain_scores_gemma":[0.48745793,0.28391963,0.03370342,0.025498351,0.16466637,0.0047542807],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10255273,0.002473543,0.0024781113,0.016837966,0.0021935795,0.0072671827,0.0047402433,0.005738832,0.03146695],"category_scores_gemma":[0.42884037,0.0020025983,0.005878613,0.016338572,0.002277519,0.0051166825,0.006791434,0.0066756755,0.015617244],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012147493,0.00057544466,0.012627401,0.011791918,0.0005135343,0.0002901297,0.0006009106,0.0018358582,0.00046173457,0.018285302,0.72994184,0.22186114],"study_design_scores_gemma":[0.0021334325,0.000688751,0.063541666,0.018487044,0.00092849496,0.00080162956,0.0010809086,0.005151857,0.004708548,0.04169138,0.8603443,0.00044204883],"about_ca_topic_score_codex":0.0078771245,"about_ca_topic_score_gemma":0.007667816,"teacher_disagreement_score":0.8974473,"about_ca_system_score_codex":0.0058881403,"about_ca_system_score_gemma":0.023912596,"threshold_uncertainty_score":0.54235715},"labels":[],"label_agreement":null},{"id":"W4311352505","doi":"10.1016/j.jval.2022.09.2427","title":"SA33 Demographic Characteristics of Patients Initiating Topical Combination Therapies for Plaque Psoriasis in Canada: A Claims-Based Analysis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Tazarotene; Dermatology; Calcipotriol; Lotion; Betamethasone dipropionate; Clobetasol propionate; Pharmacology","score_opus":0.02600185905838446,"score_gpt":0.24841278352575952,"score_spread":0.22241092446737507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311352505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96754307,0.0005182157,0.00013206758,0.00041288696,0.000016619757,0.000072384726,0.026356572,0.00002073788,0.0049274806],"genre_scores_gemma":[0.9925661,0.00033081206,0.00013951324,0.00014757756,0.000009743259,0.00002753303,0.0055560176,0.000007507139,0.0012152435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998667,0.000083347884,0.00013813694,0.00016850373,0.0005699152,0.00037314714],"domain_scores_gemma":[0.9959176,0.00029829537,0.0012408609,0.00012159557,0.0016404118,0.0007812794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047365672,0.0002906368,0.00046453686,0.0023147308,0.0017630417,0.0013724818,0.000974598,0.0006482077,0.0058523184],"category_scores_gemma":[0.003115768,0.00041446544,0.0011707966,0.0068959147,0.00043965495,0.00040774196,0.0005034563,0.0010254849,0.0005023367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011175852,0.00005746919,0.9960821,0.00002053993,0.00008501143,0.000049104747,0.00011627134,0.00007342126,0.000096463315,0.00007171909,0.0012633641,0.0019727785],"study_design_scores_gemma":[0.000011739369,0.000022932962,0.9985129,0.000016644577,0.000038676186,0.000058956877,0.00036579886,0.00025352844,0.000037063615,0.000019525009,0.00065350276,0.00000870398],"about_ca_topic_score_codex":0.97530943,"about_ca_topic_score_gemma":0.9749485,"teacher_disagreement_score":0.024690568,"about_ca_system_score_codex":0.013558196,"about_ca_system_score_gemma":0.021375023,"threshold_uncertainty_score":0.09837204},"labels":[],"label_agreement":null},{"id":"W4311359183","doi":"10.1016/j.jval.2022.09.128","title":"CO49 3D Visualisation Systems: Advantages for Cataract Surgery","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Imaging and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Cataract surgery; Cataracts; Optometry; Visual acuity; Ophthalmology; Surgery","score_opus":0.0762933706307163,"score_gpt":0.3751060343998624,"score_spread":0.2988126637691461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359183","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06537452,0.05816958,0.6666796,0.01634639,0.004308879,0.0007784809,0.008314791,0.020047277,0.15998048],"genre_scores_gemma":[0.42706552,0.024050964,0.47227702,0.006285935,0.0031637524,0.00082817214,0.00410401,0.015215815,0.04700876],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980015,0.00057522603,0.00010678908,0.0001817212,0.0010315778,0.00010312311],"domain_scores_gemma":[0.9884983,0.00693109,0.0004633614,0.0013121605,0.0022345162,0.00056058116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031127762,0.001063173,0.000735908,0.0031210452,0.00054424955,0.0045699407,0.0010466455,0.002416767,0.07864224],"category_scores_gemma":[0.014077334,0.0010082744,0.0010147764,0.0021218522,0.00049826864,0.0021500846,0.002434324,0.0014966697,0.008923854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003323825,0.00017112939,0.008987008,0.0017409378,0.0001930312,0.0007624178,0.00043987844,0.0030335377,0.07558878,0.013512852,0.091350116,0.80089647],"study_design_scores_gemma":[0.0007212733,0.0013048535,0.046623122,0.002270424,0.0009491372,0.021454252,0.00051719625,0.048355997,0.10771694,0.013269569,0.75583947,0.0009778593],"about_ca_topic_score_codex":0.0031996944,"about_ca_topic_score_gemma":0.0042989287,"teacher_disagreement_score":0.07864224,"about_ca_system_score_codex":0.0007840736,"about_ca_system_score_gemma":0.0014948052,"threshold_uncertainty_score":0.26308453},"labels":[],"label_agreement":null},{"id":"W4311359312","doi":"10.1016/j.jval.2022.09.077","title":"P65 Impact of COVID-19 on Hospital Screening, Diagnosis and Treatment Activities Among Prostate and Colorectal Cancer Patients in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Colorectal cancer; Cancer; Pandemic; Medical diagnosis; Prostate; Internal medicine; Oncology; Emergency medicine; Gynecology; Coronavirus disease 2019 (COVID-19); Disease; Pathology","score_opus":0.04621478754045466,"score_gpt":0.36221524361490054,"score_spread":0.3160004560744459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94512266,0.0029539587,0.00012306482,0.010815483,0.00019263128,0.000083720835,0.016746586,0.000026845613,0.023935003],"genre_scores_gemma":[0.99312085,0.0010433266,0.000119925695,0.0007348228,0.000043051794,0.000014897186,0.0025387907,0.000008433614,0.0023758563],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968489,0.0003098845,0.00018249304,0.00014424772,0.0009149626,0.0015994238],"domain_scores_gemma":[0.99293447,0.00040273537,0.0013455678,0.000105678955,0.0021301683,0.0030813853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092047144,0.00020042543,0.0003805074,0.0011572889,0.0017527498,0.002037156,0.000901263,0.0005306534,0.0046667326],"category_scores_gemma":[0.005776053,0.00023282554,0.0010898177,0.0038791662,0.00070429494,0.0005494564,0.0021761288,0.0017221401,0.0002987102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001737551,0.0001159394,0.97760105,0.00007569313,0.00011845035,0.00007430191,0.0004323556,0.00024776376,0.00005676192,0.0004801141,0.007062041,0.01356175],"study_design_scores_gemma":[0.000012507767,0.00003403428,0.9943199,0.00009420173,0.000051772106,0.000034470984,0.0015903458,0.00023592569,0.000038947477,0.00007705066,0.0034956438,0.0000151739105],"about_ca_topic_score_codex":0.98165107,"about_ca_topic_score_gemma":0.9902986,"teacher_disagreement_score":0.031525575,"about_ca_system_score_codex":0.031525575,"about_ca_system_score_gemma":0.0500465,"threshold_uncertainty_score":0.22873515},"labels":[],"label_agreement":null},{"id":"W4311359314","doi":"10.1016/j.jval.2022.09.143","title":"CO64 Comparison of Propensity Score Matching to Inverse Probability Weighting in Obstructive Sleep Apnea Patients With Cardiovascular Diseases","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Propensity score matching; Medicine; Confounding; Atrial fibrillation; Obstructive sleep apnea; Heart failure; Internal medicine; Cardiology; Sleep apnea; Inverse probability weighting; Matching (statistics); Intensive care medicine; Physical therapy","score_opus":0.15405656193558057,"score_gpt":0.35047196049547574,"score_spread":0.19641539855989518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8829172,0.008694161,0.09587083,0.0024275568,0.000885763,0.00086266914,0.001431904,0.00023352275,0.006676271],"genre_scores_gemma":[0.9867513,0.00074008666,0.010367335,0.00019631788,0.00011344283,0.00019560194,0.00046358292,0.000031346193,0.0011410449],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98028564,0.017156499,0.0006736597,0.00075889885,0.0007471019,0.00037818664],"domain_scores_gemma":[0.94480246,0.04663254,0.0026424946,0.003808788,0.0014638904,0.0006499277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027323429,0.0006565418,0.0018174932,0.00088255375,0.00038806145,0.0013819936,0.0011158076,0.0011874388,0.0067780055],"category_scores_gemma":[0.100642055,0.0004607502,0.003426465,0.0013950273,0.00056178815,0.0012982399,0.0014186719,0.0013481715,0.00045935778],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21187775,0.0024087778,0.1548018,0.0027624294,0.023694387,0.00021553415,0.00070500746,0.072594464,0.001066023,0.034571268,0.009792395,0.48551023],"study_design_scores_gemma":[0.03613139,0.031467825,0.15493721,0.0010339456,0.023722023,0.0006742304,0.0009226339,0.6262846,0.0029960182,0.10867818,0.01286533,0.00028671874],"about_ca_topic_score_codex":0.003319109,"about_ca_topic_score_gemma":0.0015847499,"teacher_disagreement_score":0.027323429,"about_ca_system_score_codex":0.0008812455,"about_ca_system_score_gemma":0.0017185328,"threshold_uncertainty_score":0.1445018},"labels":[],"label_agreement":null},{"id":"W4311359463","doi":"10.1016/j.jval.2022.09.207","title":"CO129 Effectiveness of a Prescription Digital Therapeutic of Cognitive-Behavioral Therapy for Insomnia in 2 Clinical Trials and in Real-World Clinical Settings: A Number Needed to Treat Analysis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec","funders":"","keywords":"Number needed to treat; Medicine; Insomnia; Randomized controlled trial; Medical prescription; Clinical trial; Population; Psychiatry; Physical therapy; Internal medicine; Relative risk; Confidence interval; Pharmacology","score_opus":0.20241365686122118,"score_gpt":0.5206924393650006,"score_spread":0.3182787825037795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.953561,0.016438534,0.003601786,0.0015483896,0.001421475,0.009370139,0.0037755824,0.0002069321,0.010076068],"genre_scores_gemma":[0.9893728,0.0021053792,0.0024262664,0.0003847339,0.00042925306,0.0031678134,0.0004617912,0.000025712383,0.0016261765],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9729893,0.02020705,0.0023569951,0.0015653115,0.0019103052,0.0009709651],"domain_scores_gemma":[0.96227235,0.02808011,0.0058913324,0.001508089,0.0011571283,0.0010910415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012796197,0.0012645309,0.005368381,0.002037435,0.0006904967,0.0019588124,0.0010207945,0.0027783753,0.0135794105],"category_scores_gemma":[0.041520532,0.00076536194,0.0075187963,0.0017313467,0.0016166646,0.0032691609,0.0017419611,0.0026066268,0.0007240232],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9261065,0.0030599453,0.0055588405,0.002435447,0.013330026,0.000049858023,0.00012784448,0.0006481238,0.0005799176,0.00044399762,0.0006319675,0.047027536],"study_design_scores_gemma":[0.66768813,0.20213039,0.068189666,0.000980696,0.044457708,0.00012466015,0.00046496434,0.007269865,0.0020619135,0.0017469836,0.004674493,0.00021050981],"about_ca_topic_score_codex":0.0014213828,"about_ca_topic_score_gemma":0.003012382,"teacher_disagreement_score":0.0135794105,"about_ca_system_score_codex":0.0021117106,"about_ca_system_score_gemma":0.001750661,"threshold_uncertainty_score":0.067673564},"labels":[],"label_agreement":null},{"id":"W4311481312","doi":"10.1016/j.jval.2022.09.2081","title":"PCR146 Preferences for Toenail Onychomycosis Treatments Among Canadians With and Without Diabetes Mellitus: A Discrete Choice Experiment","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Diabetes mellitus; Medicine; Dermatology; Gerontology; Endocrinology","score_opus":0.03652971868480791,"score_gpt":0.3082840769449951,"score_spread":0.2717543582601872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311481312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843496,0.000022805812,0.00007317855,0.00008600974,0.000009169123,0.000085916276,0.00014719956,0.0000014925902,0.0011391304],"genre_scores_gemma":[0.99502265,0.00005728086,0.0006411033,0.00027162,0.0000065763106,0.00012765477,0.0002097236,0.0000024357892,0.0036609054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985858,0.0003212625,0.000034544046,0.0001837076,0.00031482617,0.0005598954],"domain_scores_gemma":[0.99822575,0.0005259234,0.00023984857,0.0000885139,0.0003696481,0.0005502887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012622644,0.00040131592,0.0005756883,0.0002963041,0.0030725643,0.0013286485,0.00074453326,0.0011570458,0.006086238],"category_scores_gemma":[0.003300188,0.00038227934,0.0008116497,0.0006415702,0.0011068227,0.00037028207,0.00039955974,0.0014416717,0.000436604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0880894,0.056575947,0.71836394,0.00030681948,0.0007274783,0.0004639313,0.019661978,0.0030241332,0.026889743,0.0043477532,0.00824969,0.073299244],"study_design_scores_gemma":[0.0032948693,0.016056035,0.9488415,0.00006900723,0.00033929205,0.00011614298,0.014840747,0.0060727233,0.0022008107,0.0009590391,0.0069632456,0.00024677019],"about_ca_topic_score_codex":0.8981156,"about_ca_topic_score_gemma":0.93363357,"teacher_disagreement_score":0.101884425,"about_ca_system_score_codex":0.008890099,"about_ca_system_score_gemma":0.011874049,"threshold_uncertainty_score":0.20496881},"labels":[],"label_agreement":null},{"id":"W4311481338","doi":"10.1016/j.jval.2022.09.1805","title":"MSR74 Can Artificial Intelligence (AI) Replace a Human Reviewer in Systematic Literature Review (SLR)? Validation of the LIVESTARTTM Tool","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Inclusion and exclusion criteria; Inclusion (mineral); Computer science; Artificial intelligence; Systematic review; Machine learning; Medical physics; Population; Medicine; Natural language processing; Information retrieval; MEDLINE; Alternative medicine; Psychology; Pathology","score_opus":0.1691173899103994,"score_gpt":0.42817319533023207,"score_spread":0.25905580541983264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311481338","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12581481,0.052324206,0.27909732,0.23106308,0.034487095,0.17134729,0.039451655,0.0057991273,0.060615398],"genre_scores_gemma":[0.36400485,0.0029447635,0.32396576,0.044988316,0.0023104686,0.24999869,0.0059003257,0.0011852403,0.0047016186],"study_design_codex":"systematic_review","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.23735064,0.5240303,0.16339305,0.025499769,0.04571572,0.004010531],"domain_scores_gemma":[0.058277316,0.7550566,0.057274327,0.053017005,0.072995536,0.0033792376],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.67414355,0.0016426438,0.0065771258,0.013913615,0.0045947144,0.010849462,0.0070786634,0.008168166,0.022268748],"category_scores_gemma":[0.89298695,0.0032394917,0.009095896,0.012224433,0.010750852,0.011314207,0.0105696665,0.0045418884,0.0040557785],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013599911,0.0008313909,0.06775897,0.30956632,0.03021648,0.0011478381,0.048813097,0.0018074879,0.0030510337,0.045379713,0.1725214,0.30530646],"study_design_scores_gemma":[0.03175498,0.0039441953,0.06559188,0.22350828,0.041999936,0.001725451,0.015889931,0.015572647,0.0070966305,0.06821383,0.52295876,0.0017434407],"about_ca_topic_score_codex":0.0058354773,"about_ca_topic_score_gemma":0.020751305,"teacher_disagreement_score":0.32585645,"about_ca_system_score_codex":0.008009111,"about_ca_system_score_gemma":0.052355513,"threshold_uncertainty_score":0.40183908},"labels":[],"label_agreement":null},{"id":"W4311481774","doi":"10.1016/j.jval.2022.09.2265","title":"RWD40 Persistence and Switching Patterns of Migraine Prophylactic Medications in Canada: A Retrospective Claims Analysis Comparing Adherence and Evaluating the Economic Burden of Illness","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Persistence (discontinuity); Migraine; Medicine; Prophylactic treatment; Intensive care medicine; Psychiatry; Pediatrics; Internal medicine","score_opus":0.06985849963981648,"score_gpt":0.32918318267924,"score_spread":0.2593246830394235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311481774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894056,0.001195287,0.00007358494,0.00024311847,0.000013403804,0.000049878312,0.0076177297,0.000008124989,0.0013933192],"genre_scores_gemma":[0.9945727,0.00056441134,0.00014095541,0.00013624487,0.000014067025,0.000021707296,0.0040678056,0.000006349582,0.0004757865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969131,0.00034304606,0.0003858895,0.00041691866,0.0011829972,0.00075812463],"domain_scores_gemma":[0.9916938,0.00081465923,0.0033644957,0.000615879,0.0023686613,0.0011425056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020056292,0.0005404508,0.00089463615,0.0024307927,0.0023296787,0.00215703,0.0021515838,0.0012411033,0.002228907],"category_scores_gemma":[0.008556818,0.0007623724,0.002109735,0.009800627,0.0010376693,0.0008487393,0.0013353468,0.0019939202,0.00023510623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018252475,0.00005016158,0.99781066,0.000024292112,0.00028360693,0.000036439105,0.000124153,0.0000664552,0.000037704533,0.000071022056,0.0002802817,0.0010327254],"study_design_scores_gemma":[0.000019243706,0.000026777567,0.9989396,0.000024588438,0.000103812155,0.000043219417,0.00025232165,0.00026311772,0.000020417958,0.000023439528,0.000273428,0.000010002353],"about_ca_topic_score_codex":0.97629595,"about_ca_topic_score_gemma":0.9739127,"teacher_disagreement_score":0.023704052,"about_ca_system_score_codex":0.017018542,"about_ca_system_score_gemma":0.022834932,"threshold_uncertainty_score":0.12347871},"labels":[],"label_agreement":null},{"id":"W4311483258","doi":"10.1016/j.jval.2022.09.269","title":"EE15 Cost-Consequence Analysis of Ofatumumab in Comparison With Other Disease-Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada); Queen's University; Memorial University of Newfoundland; University of British Columbia; Novartis (Canada); Innovative Medicines Canada","funders":"","keywords":"Relapsing remitting; Ofatumumab; Medicine; Multiple sclerosis; Natalizumab; Physical therapy; Internal medicine; Psychiatry; Rituximab","score_opus":0.4139563000556837,"score_gpt":0.39781964934160297,"score_spread":0.016136650714080714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311483258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9380655,0.00984698,0.0009620797,0.0022358368,0.00017901011,0.0005929536,0.041376226,0.000052798943,0.0066885394],"genre_scores_gemma":[0.98478204,0.0016809612,0.000677756,0.0002747765,0.00003574339,0.00009240826,0.010087801,0.000018508408,0.0023500326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99679655,0.001120655,0.00024416333,0.00024586788,0.0008183569,0.00077440287],"domain_scores_gemma":[0.99372816,0.0021697253,0.0006186259,0.00019562859,0.0025226013,0.000765192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035523893,0.00080014457,0.0019885178,0.0017287041,0.0008080239,0.002122948,0.0019724653,0.0008381735,0.0030632422],"category_scores_gemma":[0.013225598,0.0005080645,0.004302122,0.0035952982,0.0005796968,0.0005789252,0.0009579066,0.0017602912,0.00012576395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.083384916,0.002173338,0.4874163,0.004583581,0.027244577,0.0013094381,0.00046166236,0.26071846,0.0011005442,0.013404842,0.04134317,0.076859124],"study_design_scores_gemma":[0.013949589,0.0029416834,0.7683394,0.0009920502,0.014526274,0.00049863104,0.0013444588,0.1804661,0.0009913436,0.0024889314,0.013139097,0.00032239174],"about_ca_topic_score_codex":0.98020977,"about_ca_topic_score_gemma":0.9785727,"teacher_disagreement_score":0.04778408,"about_ca_system_score_codex":0.04778408,"about_ca_system_score_gemma":0.051042605,"threshold_uncertainty_score":0.34669936},"labels":[],"label_agreement":null},{"id":"W4311496568","doi":"10.1016/j.jval.2022.09.1963","title":"PCR28 Utility Values Derived From Canadian Adults With Toenail Onychomycosis With and Without Comorbid Diabetes Mellitus: A Study Using the Health Utilities Index®","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Diabetes mellitus; Nail (fastener); Comorbidity; Gerontology; Pediatrics; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.043164892350169876,"score_gpt":0.2976046667651237,"score_spread":0.2544397744149538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311496568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913235,0.0007014243,0.00017339893,0.00009354785,0.000010386952,0.00006120636,0.005315047,0.000011765537,0.0023097422],"genre_scores_gemma":[0.9968972,0.00023192105,0.00016930544,0.00007891642,0.0000043205714,0.00002347754,0.0022766378,0.000005590611,0.000312626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978703,0.00024740899,0.00016069606,0.0002663983,0.0009904905,0.00046462263],"domain_scores_gemma":[0.99667823,0.00053199823,0.0008981187,0.00011537666,0.0013072898,0.00046895343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001537434,0.0006521362,0.0008242197,0.0019262433,0.001295021,0.002000246,0.0011314012,0.0006576189,0.0013427928],"category_scores_gemma":[0.00855374,0.00031540712,0.0015179383,0.006513594,0.00062888436,0.00065921526,0.0008314133,0.0012744064,0.00018254563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006248308,0.000093126815,0.9909869,0.000068356334,0.00032849205,0.000064876804,0.0005635916,0.00031692855,0.00010512873,0.00019390775,0.0010447564,0.005609026],"study_design_scores_gemma":[0.000022100852,0.00005034779,0.9980204,0.000019511934,0.00010784978,0.000051627405,0.00044246376,0.0006936489,0.0000455871,0.000038222155,0.00048814507,0.000020139394],"about_ca_topic_score_codex":0.9578642,"about_ca_topic_score_gemma":0.9505492,"teacher_disagreement_score":0.042135775,"about_ca_system_score_codex":0.021941934,"about_ca_system_score_gemma":0.010860715,"threshold_uncertainty_score":0.15920061},"labels":[],"label_agreement":null},{"id":"W4311496671","doi":"10.1016/j.jval.2022.09.400","title":"EE148 Canadian Cost-Effectiveness Analysis of Deferiprone Compared to Deferoxamine and Deferasirox for the Treatment of Iron Overload in Patients With Sickle Cell Disease and Other Anemias","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferasirox; Deferiprone; Deferoxamine; Medicine; Thalassemia; Disease; Anemia; Beta thalassemia; Internal medicine; Intensive care medicine","score_opus":0.022562213554775005,"score_gpt":0.27061245405231676,"score_spread":0.24805024049754176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311496671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.763146,0.10745401,0.0014754763,0.013897032,0.00132149,0.004090556,0.06700292,0.00017185886,0.041440696],"genre_scores_gemma":[0.9629361,0.015410655,0.0022583518,0.0025357527,0.00028186463,0.0005851164,0.011772079,0.000038835064,0.004181365],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.996557,0.0016190691,0.00018088144,0.0002198064,0.00085930404,0.00056393835],"domain_scores_gemma":[0.9958691,0.0015829531,0.000560611,0.00011038065,0.0011007123,0.00077625056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028184324,0.0012973617,0.0027185383,0.0016831197,0.0008385956,0.0018426515,0.001713151,0.0012909429,0.0067268307],"category_scores_gemma":[0.011385138,0.0006579364,0.0064242603,0.0031434875,0.00065864157,0.00057624804,0.00071125675,0.0020446845,0.00020812545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5289113,0.0027547262,0.07492825,0.019598711,0.049977895,0.0010027208,0.0004332121,0.06859339,0.0024125285,0.010600206,0.08822167,0.15256539],"study_design_scores_gemma":[0.27008852,0.019192854,0.52109075,0.007687671,0.06968453,0.0008628673,0.0010942155,0.06103823,0.0010542878,0.0026429987,0.044810925,0.000752152],"about_ca_topic_score_codex":0.93603915,"about_ca_topic_score_gemma":0.94334304,"teacher_disagreement_score":0.06396085,"about_ca_system_score_codex":0.059664126,"about_ca_system_score_gemma":0.051580932,"threshold_uncertainty_score":0.4328956},"labels":[],"label_agreement":null},{"id":"W4311497573","doi":"10.1016/j.jval.2022.09.265","title":"EE11 Burden of Myelodysplastic Syndromes Part II: Systematic Literature Review of Economic Burden","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cytopenia; Myelodysplastic syndromes; Medicine; Disease burden; Disease; Haematopoiesis; Dysfunctional family; Burden of disease; Bone marrow; Intensive care medicine; Oncology; Internal medicine; Stem cell; Psychiatry; Biology; Genetics","score_opus":0.035555775977325975,"score_gpt":0.32383861803766656,"score_spread":0.2882828420603406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311497573","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008686565,0.9825602,0.00016340097,0.000601487,0.00012312527,0.00011801091,0.007270206,0.0000067277374,0.0004701437],"genre_scores_gemma":[0.11513627,0.8783074,0.00093003095,0.0009457586,0.00023809835,0.00043310307,0.0037623069,0.000012485757,0.00023447226],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9928925,0.0024685706,0.0027089368,0.00068265677,0.0009118294,0.00033548055],"domain_scores_gemma":[0.973828,0.017394781,0.006781494,0.0004793362,0.0012706858,0.0002456824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075993002,0.0010244874,0.004933648,0.009502143,0.00033328257,0.0024057443,0.0011166843,0.0013296688,0.0048932703],"category_scores_gemma":[0.040930267,0.00082941767,0.011823825,0.013508732,0.00060975895,0.0016147869,0.0019388507,0.001256521,0.00027319972],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013501873,0.0000428233,0.054852925,0.69881636,0.1831268,0.00017388583,0.00023685487,0.00059223635,0.0001783542,0.00080447947,0.006229292,0.053595904],"study_design_scores_gemma":[0.0011702693,0.0002700141,0.15679337,0.41412595,0.40107512,0.00074237207,0.00057668256,0.0003986655,0.00017796773,0.0013558213,0.023202067,0.000111754074],"about_ca_topic_score_codex":0.015238743,"about_ca_topic_score_gemma":0.032220162,"teacher_disagreement_score":0.015238743,"about_ca_system_score_codex":0.002065434,"about_ca_system_score_gemma":0.004999459,"threshold_uncertainty_score":0.040189385},"labels":[],"label_agreement":null},{"id":"W4311497732","doi":"10.1016/j.jval.2022.09.242","title":"CO166 Clinical Outcomes of Patients With Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion Cancer Treated With Non-Tropomyosin Recepter Kinase Inhibitors: A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Trk receptor; Medicine; Fusion gene; Tropomyosin receptor kinase B; Tropomyosin receptor kinase C; Tyrosine kinase; Oncology; Receptor tyrosine kinase; Clinical trial; Internal medicine; Kinase; Tropomyosin receptor kinase A; Neurotrophin; Bioinformatics; Cancer research; Gene; Receptor; Biology; Neurotrophic factors; Genetics; Platelet-derived growth factor receptor","score_opus":0.050287907902456706,"score_gpt":0.3700510836361082,"score_spread":0.31976317573365154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311497732","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0090909265,0.98857516,0.00008631711,0.00018949158,0.00008385095,0.00008317938,0.001581462,0.0000037569102,0.0003058617],"genre_scores_gemma":[0.19633998,0.7992868,0.0005986669,0.0014084197,0.00018953723,0.00035819664,0.0015698241,0.000008685939,0.00023989749],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961747,0.00082473335,0.0018423563,0.00054940867,0.000442373,0.00016647135],"domain_scores_gemma":[0.9912169,0.0051099476,0.0027993196,0.000128389,0.0006046305,0.00014082402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027959782,0.00075158133,0.0056345006,0.004102097,0.00035172905,0.0016675418,0.0009319445,0.001282805,0.0030072809],"category_scores_gemma":[0.0122024985,0.0005890493,0.009679541,0.0065628286,0.0005247006,0.0012020796,0.0009640565,0.0009365969,0.00020101298],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024660088,0.000075505064,0.044033058,0.7581347,0.14674757,0.00024542885,0.0002994938,0.00027059834,0.00047149736,0.00028248416,0.002646488,0.044327192],"study_design_scores_gemma":[0.0017947069,0.00076354446,0.09408394,0.27472368,0.6087099,0.0008766206,0.0007524104,0.00024870387,0.00029715343,0.0005255001,0.017070852,0.00015292618],"about_ca_topic_score_codex":0.006603743,"about_ca_topic_score_gemma":0.02265018,"teacher_disagreement_score":0.006603743,"about_ca_system_score_codex":0.0015673065,"about_ca_system_score_gemma":0.0029124233,"threshold_uncertainty_score":0.01478672},"labels":[],"label_agreement":null},{"id":"W4312204106","doi":"10.1016/j.jval.2022.12.009","title":"The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Representativeness heuristic; Demography; Population; Quality of life (healthcare); Medicine; Psychology; Sociology","score_opus":0.5791804608984477,"score_gpt":0.4599164838745568,"score_spread":0.11926397702389085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312204106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2864893,0.06794149,0.2547116,0.017546875,0.0024446335,0.056669496,0.13177717,0.0018264456,0.18059303],"genre_scores_gemma":[0.4405045,0.016632056,0.37889123,0.0021509088,0.00019284309,0.051739633,0.10078879,0.00072030345,0.008379671],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9679598,0.013612849,0.004297065,0.0010804195,0.012072273,0.0009774554],"domain_scores_gemma":[0.93022025,0.017327785,0.0066221254,0.003292106,0.040550727,0.0019871122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05428821,0.0006001301,0.001353691,0.005737587,0.0010280395,0.003028775,0.0025781903,0.00080809556,0.0021866788],"category_scores_gemma":[0.09918675,0.000314581,0.0018408344,0.010578556,0.001187631,0.0013072765,0.0031526063,0.0022509752,0.00066067034],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014032653,0.00046615617,0.20765293,0.0030727529,0.00078900106,0.00016559573,0.0033704522,0.0057152053,0.0006598433,0.02926946,0.15626414,0.5911711],"study_design_scores_gemma":[0.0004638971,0.00061809225,0.72478724,0.004532,0.00037861493,0.0003920502,0.0024575992,0.009213664,0.0012132594,0.0078785755,0.24783587,0.00022919],"about_ca_topic_score_codex":0.15340845,"about_ca_topic_score_gemma":0.1952237,"teacher_disagreement_score":0.84659153,"about_ca_system_score_codex":0.01695729,"about_ca_system_score_gemma":0.02564387,"threshold_uncertainty_score":0.30503106},"labels":[],"label_agreement":null},{"id":"W4316035311","doi":"10.1016/j.jval.2022.12.016","title":"Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Vancouver Infectious Diseases Centre; University Health Network; Toronto East General Hospital; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Sanofi Pasteur; Seqirus; University of New South Wales; Department of Health and Ageing, Australian Government; Moderna; Sanofi; Indivior; Eisai; AbbVie; Australian Government; Gilead Sciences; ViiV Healthcare; AstraZeneca","keywords":"Medicine; Confidence interval; Odds ratio; Quality of life (healthcare); Hepatitis C; Distress; Hepatitis C virus; Generalized estimating equation; Odds; Internal medicine; Logistic regression; Clinical psychology; Immunology; Virus","score_opus":0.034601238215164254,"score_gpt":0.33547102626649616,"score_spread":0.3008697880513319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316035311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970169,0.000582026,0.00004189784,0.00020085779,0.000026716827,0.000017862027,0.0012058129,0.0000032119701,0.0009047246],"genre_scores_gemma":[0.99865013,0.0002280878,0.00003385954,0.0000823358,0.00002627074,0.000012251261,0.0007835014,0.0000014268388,0.0001821552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998628,0.00039664848,0.00021806837,0.00015468082,0.00023807591,0.00036448528],"domain_scores_gemma":[0.99279493,0.0016737027,0.0038844342,0.00017884781,0.00044098296,0.001027179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012943022,0.00023558822,0.0005712735,0.00081672793,0.0005919278,0.0013212815,0.0003924924,0.0008809268,0.0016032478],"category_scores_gemma":[0.009026889,0.0002471266,0.0018058814,0.001235552,0.00035801623,0.0011998484,0.0009034089,0.0019096668,0.00017649421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038104958,0.00013400306,0.99693054,0.000034869452,0.00026972985,0.00003929971,0.00017765883,0.00007589701,0.000036833906,0.000027452868,0.00014998043,0.0017426938],"study_design_scores_gemma":[0.000016006079,0.00023819042,0.99873585,0.000021858717,0.00010608889,0.00006759169,0.00043434973,0.00014753657,0.000028928449,0.000038123773,0.00015273086,0.000012836468],"about_ca_topic_score_codex":0.0117977895,"about_ca_topic_score_gemma":0.017633334,"teacher_disagreement_score":0.0117977895,"about_ca_system_score_codex":0.00083863485,"about_ca_system_score_gemma":0.0006940693,"threshold_uncertainty_score":0.023458242},"labels":[],"label_agreement":null},{"id":"W4317936571","doi":"10.1016/j.jval.2023.01.008","title":"Generic Price Regulation and Drug Expenditures: Evidence From Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Nottingham Ningbo China","keywords":"Copayment; Per capita; Incentive; Public economics; Government (linguistics); Prescription drug; Medical prescription; Cost sharing; Price elasticity of demand; Economics; Business; Health care; Health insurance; Economic growth; Microeconomics; Environmental health","score_opus":0.1379334060196279,"score_gpt":0.31495871854030644,"score_spread":0.17702531252067855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317936571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86171484,0.04261272,0.00043571007,0.02050114,0.0001349593,0.00011644296,0.031434238,0.000036177255,0.043013666],"genre_scores_gemma":[0.9718327,0.01617003,0.00026373597,0.0014903627,0.00008241294,0.000017871964,0.0063535706,0.000016656422,0.0037727328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727374,0.0003201701,0.00015451378,0.0002285945,0.0013611505,0.000661857],"domain_scores_gemma":[0.96973586,0.008681664,0.009138914,0.0007404737,0.009477164,0.002226006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00196076,0.00033256496,0.0007757457,0.0026836365,0.0018418755,0.0028493921,0.0012160612,0.0011541157,0.005782206],"category_scores_gemma":[0.017382002,0.0003960174,0.0010459671,0.0113435285,0.0019639165,0.00063824694,0.0008340195,0.001602674,0.00023069758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016872026,0.00024971802,0.92459863,0.00088156294,0.0009313344,0.0003340897,0.0008266257,0.002335691,0.00019763573,0.008075578,0.02497603,0.034905914],"study_design_scores_gemma":[0.00023167793,0.000073958305,0.9821348,0.00030888783,0.00067487196,0.000078033634,0.0008921989,0.000750416,0.00020583528,0.00068024796,0.013925567,0.000043549757],"about_ca_topic_score_codex":0.9955308,"about_ca_topic_score_gemma":0.9968509,"teacher_disagreement_score":0.041759185,"about_ca_system_score_codex":0.041759185,"about_ca_system_score_gemma":0.059560556,"threshold_uncertainty_score":0.3029855},"labels":[],"label_agreement":null},{"id":"W4319311385","doi":"10.1016/j.jval.2022.12.004","title":"A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Task force; Preference; Task (project management); Outcomes research; Comparative effectiveness research; Medicine; Management science; Psychology; Medical physics; Alternative medicine; Political science; Engineering; Economics; Systems engineering","score_opus":0.6683350970802836,"score_gpt":0.532583760693091,"score_spread":0.1357513363871926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319311385","genre_codex":"commentary","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002464938,0.12122524,0.06611734,0.7911918,0.005997667,0.002837248,0.00075662934,0.0007960305,0.008613096],"genre_scores_gemma":[0.045587838,0.09651296,0.62749755,0.21055527,0.010491031,0.006412736,0.0008167221,0.0006930161,0.0014328542],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.42399782,0.45838702,0.045648906,0.009036448,0.058751687,0.004178181],"domain_scores_gemma":[0.040525604,0.8340352,0.012371817,0.020962887,0.086003274,0.0061012413],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7374221,0.0044660345,0.010578651,0.021844802,0.004276194,0.029869739,0.0138366325,0.037877895,0.014167602],"category_scores_gemma":[0.7296872,0.0047094943,0.013519756,0.011039696,0.018729176,0.042955726,0.022265898,0.03763941,0.0029019297],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001570878,0.0019942645,0.0076614902,0.020066172,0.0021336083,0.00028007381,0.0049342616,0.0032809924,0.0006933481,0.039921094,0.14385673,0.7736072],"study_design_scores_gemma":[0.00570602,0.004435182,0.033024758,0.17115025,0.0037230516,0.0012613308,0.009097472,0.011159427,0.0025541375,0.32236722,0.43347234,0.0020488838],"about_ca_topic_score_codex":0.024982851,"about_ca_topic_score_gemma":0.026394255,"teacher_disagreement_score":0.2625779,"about_ca_system_score_codex":0.016114416,"about_ca_system_score_gemma":0.06867157,"threshold_uncertainty_score":0.32380533},"labels":[],"label_agreement":null},{"id":"W4319786977","doi":"10.1016/j.jval.2023.01.021","title":"Author Reply","year":2023,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"Novartis Pharmaceuticals Canada; Government of Alberta; F. Hoffmann-La Roche; AstraZeneca","keywords":"Health technology; Context (archaeology); Conceptual framework; Scopus; Sustainability; Psychological intervention; Health care; Risk analysis (engineering); Computer science; Knowledge management; Management science; Engineering ethics; Medicine; Political science; MEDLINE; Engineering; Sociology; Economics; Social science; Nursing; Economic growth","score_opus":0.6345184384418253,"score_gpt":0.46674389545876654,"score_spread":0.16777454298305877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319786977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016321937,0.000689535,0.00006926616,0.9658098,0.028511692,0.00002111111,0.00007875615,0.000021206453,0.0046353913],"genre_scores_gemma":[0.0008949528,0.00017706712,0.00006258867,0.9757589,0.010394147,0.00004260287,0.000014936655,0.000014440093,0.0126403645],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99050456,0.0024035813,0.0010168018,0.0013957012,0.002863001,0.0018163023],"domain_scores_gemma":[0.9788633,0.012039385,0.0011203851,0.0007818063,0.004458538,0.002736542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009863268,0.0009359278,0.0025194294,0.0015853988,0.0077175763,0.011523689,0.0027436765,0.10054326,0.01711104],"category_scores_gemma":[0.056550678,0.001397617,0.0019673663,0.0013569361,0.005344797,0.005761989,0.003844377,0.07042468,0.014555387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002514693,0.000009607483,0.00018421756,0.000025284193,0.000009163872,0.00020993392,0.00011563065,0.000019131816,0.000035624955,0.0024710172,0.99520016,0.0016950384],"study_design_scores_gemma":[0.00009889483,0.000023959792,0.0010868689,0.00030930626,0.000030205632,0.00033545302,0.00062686356,0.00019028294,0.000121211466,0.00952679,0.9875715,0.000078685145],"about_ca_topic_score_codex":0.02263161,"about_ca_topic_score_gemma":0.03575596,"teacher_disagreement_score":0.10054326,"about_ca_system_score_codex":0.010663663,"about_ca_system_score_gemma":0.012398133,"threshold_uncertainty_score":0.07737064},"labels":[],"label_agreement":null},{"id":"W4321254002","doi":"10.1016/j.jval.2023.02.007","title":"Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Merck KGaA","keywords":"Lung cancer; EQ-5D; Medicine; Quality of life (healthcare); Cancer; Baseline (sea); Internal medicine; Oncology; Health related quality of life; Political science","score_opus":0.031775053334926036,"score_gpt":0.3563054454033183,"score_spread":0.3245303920683923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321254002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764735,0.00064572704,0.000431388,0.00007312954,0.000004125387,0.000030085119,0.0008313469,0.0000065992754,0.00033015094],"genre_scores_gemma":[0.9990846,0.0000610012,0.0001522225,0.000020572177,0.0000026335924,0.000016455308,0.0006063476,0.0000011179326,0.00005518773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990375,0.0005422787,0.00006894117,0.0001296834,0.0001298356,0.00009177488],"domain_scores_gemma":[0.9982362,0.00081698236,0.0006353554,0.000056235716,0.0001236685,0.00013165838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032535815,0.00034659443,0.0006506478,0.0005839802,0.00012276048,0.00060961396,0.00028153893,0.00022670484,0.0007841352],"category_scores_gemma":[0.00433308,0.00010563606,0.001278654,0.00076618185,0.00017611579,0.00036699852,0.00032912067,0.0005002176,0.000089714325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028253797,0.0005858626,0.9011015,0.00044470045,0.0032940635,0.00024536956,0.00016665607,0.015918108,0.0017245689,0.0003702303,0.0013775094,0.04651771],"study_design_scores_gemma":[0.001034929,0.007220319,0.949727,0.00006307916,0.0011967822,0.00048472965,0.00013254184,0.037134912,0.0015414993,0.00050507503,0.00091749144,0.000041691987],"about_ca_topic_score_codex":0.0016419181,"about_ca_topic_score_gemma":0.0019328026,"teacher_disagreement_score":0.0032535815,"about_ca_system_score_codex":0.00088802236,"about_ca_system_score_gemma":0.00035717472,"threshold_uncertainty_score":0.017206788},"labels":[],"label_agreement":null},{"id":"W4321766341","doi":"10.1016/j.jval.2023.02.010","title":"The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health: A Systematic Review of Canadian Studies","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Cost sharing; Drug; Prescription drug; Underinsured; Medicine; Medical prescription; Public health; Actuarial science; Environmental health; Business; Family medicine; Health insurance; Health care; Pharmacology; Nursing; Economic growth","score_opus":0.3750769150385265,"score_gpt":0.4369751328649851,"score_spread":0.0618982178264586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321766341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001342712,0.99753594,0.00006402807,0.000121861456,0.00003614365,0.00005557012,0.0007287859,0.0000033927809,0.00011160944],"genre_scores_gemma":[0.019582372,0.9792047,0.00041824498,0.00024085866,0.000039956034,0.000093082985,0.0003552169,0.0000041839658,0.000061404346],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99358493,0.001533799,0.0023474442,0.00073579216,0.0015270691,0.00027090026],"domain_scores_gemma":[0.9662075,0.024687234,0.005573281,0.0004921868,0.0025988112,0.0004410062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009226533,0.001566099,0.0081596365,0.011466024,0.0010233984,0.0032942302,0.0020039272,0.001782803,0.0033065183],"category_scores_gemma":[0.037494365,0.0011190585,0.012002966,0.021926872,0.0011805738,0.001434361,0.0019996339,0.0015185615,0.00015853051],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053647475,0.000030165726,0.011340681,0.86179894,0.07409109,0.00011973428,0.0003193689,0.00017442915,0.00013581576,0.00029424872,0.0023525087,0.048806597],"study_design_scores_gemma":[0.00048260333,0.00014752282,0.06417643,0.46955845,0.44388497,0.0004155542,0.0005492571,0.00018138626,0.00015960331,0.00051772373,0.019781802,0.00014477492],"about_ca_topic_score_codex":0.21137257,"about_ca_topic_score_gemma":0.44708598,"teacher_disagreement_score":0.78862745,"about_ca_system_score_codex":0.006879629,"about_ca_system_score_gemma":0.021166181,"threshold_uncertainty_score":0.42028445},"labels":[],"label_agreement":null},{"id":"W4323307189","doi":"10.1016/j.jval.2023.02.013","title":"Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Reimbursement; Transparency (behavior); Agency (philosophy); Health technology; Medicine; Business; Public economics; Family medicine; Political science; Economic growth; Health care; Economics","score_opus":0.2429961041087212,"score_gpt":0.41485228067937063,"score_spread":0.17185617657064944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323307189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8879857,0.008485683,0.0012594302,0.0484837,0.00022108102,0.0003349406,0.013837854,0.000048381582,0.03934318],"genre_scores_gemma":[0.9949239,0.001396086,0.0008117969,0.0009611515,0.00003120606,0.00004106793,0.0010722645,0.0000081627195,0.0007544618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9877944,0.0024285961,0.001082971,0.00078595505,0.0063099866,0.0015981008],"domain_scores_gemma":[0.9475487,0.013882509,0.020121558,0.0011871253,0.014733092,0.0025271347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009391969,0.00016747028,0.0002936759,0.0016426421,0.0016148023,0.0019830652,0.0011096431,0.0006549927,0.0024844832],"category_scores_gemma":[0.07481373,0.0002805189,0.00063423184,0.00438191,0.0012933279,0.0008366043,0.0008919329,0.00088429364,0.00019866967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011372786,0.000021524129,0.9675802,0.000238082,0.00008665303,0.00009295627,0.0021223081,0.00046353595,0.000089485664,0.0010962988,0.0063009453,0.021794306],"study_design_scores_gemma":[0.000021460504,0.00001979451,0.98930115,0.00023343985,0.00008281352,0.00006124664,0.0014515222,0.0010217258,0.00012459377,0.00018308336,0.0074805794,0.000018607003],"about_ca_topic_score_codex":0.9855445,"about_ca_topic_score_gemma":0.9892013,"teacher_disagreement_score":0.9360752,"about_ca_system_score_codex":0.06392482,"about_ca_system_score_gemma":0.08890637,"threshold_uncertainty_score":0.4638092},"labels":[],"label_agreement":null},{"id":"W4324067497","doi":"10.1016/j.jval.2023.02.017","title":"A Rapid Review on the Value of Biobanks Containing Genetic Information","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; Genome British Columbia","keywords":"Biobank; Data sharing; Data science; Computer science; MEDLINE; Medicine; Risk analysis (engineering); Knowledge management; Bioinformatics; Alternative medicine; Biology; Pathology","score_opus":0.08505933344486308,"score_gpt":0.34281268738137427,"score_spread":0.2577533539365112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324067497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005374241,0.9943961,0.00024207126,0.0020786342,0.000546777,0.00012369735,0.0006224821,0.000015095973,0.0014378855],"genre_scores_gemma":[0.0036214544,0.9934869,0.00095642323,0.0011238633,0.00017448943,0.00018780405,0.000293844,0.0000075607186,0.00014766109],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98124105,0.0057385033,0.0066998466,0.0009681333,0.0049216575,0.00043084356],"domain_scores_gemma":[0.82942164,0.12942377,0.017771505,0.0020661338,0.020083338,0.0012335213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02604668,0.0012543907,0.0034190156,0.03838784,0.0008114661,0.0053292573,0.0020709864,0.002555329,0.0054624495],"category_scores_gemma":[0.088249244,0.0008905793,0.003926768,0.036384773,0.001476028,0.006125611,0.0023229094,0.0017862796,0.0011233253],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020389922,0.00002757048,0.0011069339,0.7023029,0.0014950634,0.00025294354,0.00065524835,0.00023146778,0.0005796576,0.0037935998,0.018623738,0.27072698],"study_design_scores_gemma":[0.000041824696,0.00011774409,0.004646327,0.82022446,0.0049975114,0.0003869172,0.0005842975,0.00008417037,0.00031512565,0.0012030501,0.167358,0.000040562325],"about_ca_topic_score_codex":0.004627005,"about_ca_topic_score_gemma":0.009503404,"teacher_disagreement_score":0.03838784,"about_ca_system_score_codex":0.00781743,"about_ca_system_score_gemma":0.026057394,"threshold_uncertainty_score":0.13774967},"labels":[],"label_agreement":null},{"id":"W4328103233","doi":"10.1016/j.jval.2023.03.004","title":"EUreccA 2025: A Multistakeholder Effort to Further Real-World Evidence in Healthcare Decision Making","year":2023,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health care; Clinical decision making; Data science; Computer science; Medicine; Political science; Intensive care medicine; Law","score_opus":0.5745583756137145,"score_gpt":0.5052156346191224,"score_spread":0.06934274099459203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328103233","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013914647,0.090773486,0.04552288,0.667886,0.08888829,0.006840511,0.0115006305,0.002571668,0.08462506],"genre_scores_gemma":[0.017016795,0.07042475,0.3103526,0.4637635,0.019641278,0.01190729,0.020125024,0.0027698495,0.083998926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8840143,0.047084324,0.012990003,0.0053668227,0.042834893,0.007709678],"domain_scores_gemma":[0.63319004,0.123568736,0.026390186,0.02318017,0.12953286,0.06413794],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.28564125,0.0031645857,0.0056535676,0.014332854,0.002916679,0.022696001,0.014738492,0.03388319,0.05444093],"category_scores_gemma":[0.32274663,0.0018121981,0.008238891,0.010272383,0.006144556,0.015548232,0.022566179,0.021591397,0.02575946],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061231025,0.0003032934,0.00044993203,0.005159446,0.00036169056,0.00026531058,0.00023813061,0.00071714655,0.0007494903,0.072138056,0.7417642,0.17724112],"study_design_scores_gemma":[0.00027930408,0.0001635193,0.00091130845,0.01144866,0.00012776817,0.00019988106,0.00011226606,0.0006062197,0.00058750383,0.024856707,0.9606401,0.00006676381],"about_ca_topic_score_codex":0.011305053,"about_ca_topic_score_gemma":0.00704372,"teacher_disagreement_score":0.28564125,"about_ca_system_score_codex":0.016984545,"about_ca_system_score_gemma":0.17089613,"threshold_uncertainty_score":0.8809315},"labels":[],"label_agreement":null},{"id":"W4360999208","doi":"10.1016/j.jval.2023.03.009","title":"Frameworks for Health Technology Assessment at an Early Stage of Product Development: A Review and Roadmap to Guide Applications","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"NanoMedicines Innovation Network","keywords":"Terminology; Scope (computer science); Health technology; Multidisciplinary approach; Stakeholder; Computer science; New product development; Process (computing); Management science; Relevance (law); Process management; Product (mathematics); Knowledge management; Data science; Health care; Engineering; Business; Political science","score_opus":0.5853200366028672,"score_gpt":0.5640251301456641,"score_spread":0.02129490645720311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360999208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004894609,0.9935174,0.0020756964,0.0027441361,0.00023871796,0.00008558292,0.000121122175,0.000028341658,0.0011400399],"genre_scores_gemma":[0.00086455577,0.9899901,0.007216731,0.0011996296,0.00021782947,0.00014958627,0.00012098693,0.000009593019,0.00023090662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921836,0.0031443632,0.0016281944,0.00050332624,0.002311213,0.00022921193],"domain_scores_gemma":[0.95325696,0.035441678,0.003663616,0.0009758273,0.006058419,0.000603419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024098823,0.0022988336,0.005996648,0.011315813,0.0006983941,0.005651148,0.0036967923,0.004151435,0.0075219427],"category_scores_gemma":[0.03520406,0.0010544825,0.0033321828,0.010473271,0.0021443518,0.0057133785,0.002820461,0.0059178257,0.0024448563],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086148866,0.00010851609,0.0003189547,0.09373016,0.0004863362,0.000097107826,0.00015802676,0.0011509482,0.00038617195,0.036819212,0.03873037,0.82792807],"study_design_scores_gemma":[0.000094533556,0.00015414286,0.0012184975,0.16978541,0.0017755962,0.00037618226,0.00017870317,0.0007879108,0.00041808552,0.03094833,0.79416674,0.00009579751],"about_ca_topic_score_codex":0.008915411,"about_ca_topic_score_gemma":0.012754173,"teacher_disagreement_score":0.024098823,"about_ca_system_score_codex":0.0067124544,"about_ca_system_score_gemma":0.019369157,"threshold_uncertainty_score":0.12744832},"labels":[],"label_agreement":null},{"id":"W4365452602","doi":"10.1016/j.jval.2023.04.001","title":"Resurrecting Multiattribute Utility Function: Developing a Value Set for Health Utility for Glaucoma","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Glaucoma Research Society of Canada; Glaucoma Research Foundation","keywords":"Glaucoma; Population; Medicine; Scale (ratio); Statistics; Quality of life (healthcare); Set (abstract data type); Quality-adjusted life year; Standard error; Optometry; Actuarial science; Computer science; Environmental health; Mathematics; Cost effectiveness; Risk analysis (engineering); Economics; Geography","score_opus":0.6489430105830064,"score_gpt":0.48852018688162996,"score_spread":0.16042282370137645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365452602","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013101089,0.00021096124,0.9841085,0.00033051465,0.000038411647,0.00009208114,0.00014417156,0.00009470361,0.0018794471],"genre_scores_gemma":[0.33977938,0.00048594954,0.6553373,0.00020802135,0.00009226921,0.0005070521,0.00060906576,0.00014659067,0.0028344335],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99633116,0.00209698,0.0002708954,0.00031339301,0.0008091833,0.0001784187],"domain_scores_gemma":[0.9910279,0.0058942633,0.0004014719,0.00089535135,0.0015969822,0.00018408631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009626145,0.00076641294,0.0013649213,0.0029812483,0.0006368488,0.0028864187,0.0019050154,0.0012632861,0.0031046132],"category_scores_gemma":[0.03508108,0.0005582543,0.002212824,0.0017713669,0.0009819181,0.0044971416,0.0027376425,0.002800056,0.00059105933],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012033428,0.00033071707,0.005844829,0.00027321678,0.00024373725,0.00026908165,0.00054660486,0.35851267,0.0023850459,0.26360995,0.0057951612,0.36206865],"study_design_scores_gemma":[0.00001049467,0.000051964358,0.0007868891,0.00009482435,0.000035417725,0.00007797717,0.00006546203,0.8928285,0.00088507554,0.10270785,0.0024260485,0.000029467916],"about_ca_topic_score_codex":0.0026483121,"about_ca_topic_score_gemma":0.0019143022,"teacher_disagreement_score":0.009626145,"about_ca_system_score_codex":0.0014209726,"about_ca_system_score_gemma":0.0014532635,"threshold_uncertainty_score":0.050908566},"labels":[],"label_agreement":null},{"id":"W4365816846","doi":"10.1016/j.jval.2023.04.002","title":"“What’s Sex and Gender Got to Do With It?” A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Centre for Advancing Health Outcomes; Research Canada; University of British Columbia","funders":"Canadian Institutes of Health Research; Institute of Gender and Health; Michael Smith Health Research BC","keywords":"Medicine","score_opus":0.6250718421632692,"score_gpt":0.56661426865861,"score_spread":0.05845757350465919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365816846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028824582,0.99850416,0.00019137928,0.00053831434,0.00016506975,0.00006750947,0.000074341486,0.0000018901204,0.00016915162],"genre_scores_gemma":[0.008116796,0.9885111,0.0012076813,0.0015479665,0.0001438069,0.00026255017,0.00008673175,0.000006387631,0.00011701413],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9726236,0.014030001,0.008347677,0.0015629722,0.0030224735,0.00041332806],"domain_scores_gemma":[0.9318073,0.057954486,0.006098083,0.000813864,0.003090955,0.0002353423],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03708731,0.0012905482,0.010312747,0.008962584,0.0009644447,0.005633769,0.0020573873,0.0034220128,0.004557585],"category_scores_gemma":[0.091447785,0.0014388348,0.01049998,0.010082902,0.002406367,0.006059196,0.0028128494,0.0027861798,0.00036846352],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029708707,0.000025085914,0.0013479562,0.83038974,0.016987659,0.00010124761,0.0009454251,0.000088172405,0.00018333645,0.0018025327,0.0023862354,0.14544557],"study_design_scores_gemma":[0.0001462669,0.00010131458,0.0030408814,0.9270067,0.0403241,0.00023966422,0.0005743125,0.000055275596,0.000125729,0.0011433768,0.027199501,0.000042852393],"about_ca_topic_score_codex":0.011800186,"about_ca_topic_score_gemma":0.039800864,"teacher_disagreement_score":0.9629127,"about_ca_system_score_codex":0.003385218,"about_ca_system_score_gemma":0.013092535,"threshold_uncertainty_score":0.19613874},"labels":[],"label_agreement":null},{"id":"W4376613432","doi":"10.1016/j.jval.2023.04.013","title":"Impacts of Chronic Obstructive Pulmonary Disease Care Pathway on Healthcare Utilization and Costs: A Matched Multiple Control Cohort Study in Saskatchewan, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Regina; Saskatchewan Health Quality Council; Saskatchewan Health Authority; University of Saskatchewan; Saskatchewan Health","funders":"Ministry of Health, Saskatchewan","keywords":"Medicine; COPD; Health care; Spirometry; Pulmonary disease; Cohort; Emergency medicine; Clinical pathway; Internal medicine; Physical therapy; Family medicine; Nursing","score_opus":0.028972792278288268,"score_gpt":0.313842896047916,"score_spread":0.28487010376962774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376613432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947068,0.0004112622,0.00025142747,0.00019883898,0.000026973188,0.00016436892,0.003340055,0.000008530744,0.00089187163],"genre_scores_gemma":[0.99621224,0.00037503004,0.0003310983,0.0002450888,0.000011930609,0.00010448639,0.001774243,0.000005291445,0.00094071974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978611,0.0003229239,0.00017593557,0.00050707656,0.0005501173,0.0005828434],"domain_scores_gemma":[0.9977696,0.00014851912,0.00055912044,0.00017322048,0.00083113555,0.0005183154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001170661,0.00083990925,0.000702325,0.001333516,0.00323664,0.001534283,0.001768734,0.0007218661,0.0018764302],"category_scores_gemma":[0.0016725241,0.000635454,0.0010741394,0.0040550544,0.0010782444,0.00061146065,0.0010343589,0.000987807,0.00031960005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013200474,0.00010762391,0.9969927,0.000022885188,0.0001951272,0.000105059844,0.00026572877,0.00008065349,0.0001861773,0.00007418925,0.00061664183,0.0012212583],"study_design_scores_gemma":[0.000058667716,0.00007625407,0.9974075,0.00003052196,0.000100970734,0.000060573973,0.0012006608,0.00037229873,0.000070727176,0.000028031636,0.00057800754,0.000015923686],"about_ca_topic_score_codex":0.9854774,"about_ca_topic_score_gemma":0.99101603,"teacher_disagreement_score":0.026305623,"about_ca_system_score_codex":0.026305623,"about_ca_system_score_gemma":0.029752577,"threshold_uncertainty_score":0.19086152},"labels":[],"label_agreement":null},{"id":"W4379390644","doi":"10.1016/j.jval.2023.05.019","title":"Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University","funders":"National Natural Science Foundation of China","keywords":"Intraclass correlation; Statistics; Anchoring; Mean difference; Valuation (finance); Mathematics; Sample (material); Econometrics; Sample size determination; Psychology; Confidence interval; Social psychology; Economics; Psychometrics","score_opus":0.5658238044292196,"score_gpt":0.4622320659100591,"score_spread":0.10359173851916054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379390644","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13521402,0.0046000527,0.83625096,0.013318598,0.0012536778,0.0002926637,0.0007283476,0.0005105748,0.007831195],"genre_scores_gemma":[0.8997599,0.0012340829,0.09500475,0.0009860628,0.00036221158,0.00046262445,0.00032178,0.00015201331,0.0017166059],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.96254337,0.03260858,0.00111525,0.0019172721,0.0012988622,0.00051660335],"domain_scores_gemma":[0.65081793,0.31863144,0.00933987,0.017303035,0.0022722196,0.0016355193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.094238676,0.0011346682,0.0026235024,0.0010716125,0.0006779252,0.005293952,0.0022727188,0.004768304,0.009763838],"category_scores_gemma":[0.33440354,0.0011083327,0.0017724583,0.0023025812,0.0055090208,0.019796796,0.0038574645,0.008254842,0.0009876889],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011511689,0.0012112854,0.016175484,0.0011819504,0.0013622548,0.0002654836,0.002495357,0.104762204,0.002215614,0.5713717,0.0050225104,0.28242445],"study_design_scores_gemma":[0.000622524,0.0005324771,0.0040838546,0.00037979518,0.00023119859,0.000059622176,0.00035206904,0.14384733,0.00073183805,0.8463724,0.002649593,0.00013724044],"about_ca_topic_score_codex":0.0017697293,"about_ca_topic_score_gemma":0.0011843335,"teacher_disagreement_score":0.094238676,"about_ca_system_score_codex":0.0015793623,"about_ca_system_score_gemma":0.0010510184,"threshold_uncertainty_score":0.4983877},"labels":[],"label_agreement":null},{"id":"W4380091268","doi":"10.1016/j.jval.2023.03.028","title":"P15 Indirect Treatment Comparisons of Time-to-Event Outcomes with Mis-Matched \"Time Zero\": Methodology and Application in Resectable Non-Small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver Coastal Health","funders":"","keywords":"Atezolizumab; Medicine; Nivolumab; Oncology; Adjuvant; Lung cancer; Internal medicine; Adjuvant chemotherapy; Cancer; Immunotherapy","score_opus":0.06422358985551754,"score_gpt":0.40355901932712707,"score_spread":0.33933542947160955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380091268","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4824313,0.0059621013,0.48466048,0.001397812,0.003476638,0.007266153,0.0059915357,0.0011539139,0.0076600104],"genre_scores_gemma":[0.8384008,0.00045268214,0.14377774,0.0009353426,0.00033210023,0.009480697,0.0011929396,0.0002654859,0.005162291],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.78712165,0.18975663,0.004878952,0.011407129,0.0050918427,0.00174377],"domain_scores_gemma":[0.7391728,0.22955032,0.009259709,0.01813532,0.002549815,0.0013319976],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10838024,0.0024329938,0.0053445078,0.0016531352,0.0010040127,0.0023960536,0.0041386234,0.002703982,0.01721302],"category_scores_gemma":[0.22461884,0.0010683439,0.010316847,0.0021227894,0.0031617123,0.0024187036,0.0037072755,0.005668806,0.00065748725],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22306097,0.0039813705,0.1064527,0.00984619,0.16738479,0.001265391,0.0021967264,0.039930377,0.004050417,0.052757733,0.011763646,0.37730974],"study_design_scores_gemma":[0.060103342,0.092910945,0.20790581,0.00248615,0.100604616,0.0018530553,0.0020878827,0.28825414,0.028945634,0.18129277,0.03265716,0.0008985414],"about_ca_topic_score_codex":0.0026915555,"about_ca_topic_score_gemma":0.0023056506,"teacher_disagreement_score":0.89161974,"about_ca_system_score_codex":0.0019606769,"about_ca_system_score_gemma":0.0026488423,"threshold_uncertainty_score":0.5731764},"labels":[],"label_agreement":null},{"id":"W4380091322","doi":"10.1016/j.jval.2023.03.043","title":"P31 The Association between Patient- and Caregiver-Reported Utility Values in Duchenne Muscular Dystrophy (DMD)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Association (psychology); Physical medicine and rehabilitation; Psychology; Internal medicine; Psychotherapist","score_opus":0.05538977007114077,"score_gpt":0.32189522714853497,"score_spread":0.2665054570773942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380091322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226165,0.0006665837,0.0002277632,0.0014285492,0.000037450576,0.000012214297,0.0013002842,0.0000051952516,0.0040602908],"genre_scores_gemma":[0.9990264,0.00008830395,0.00012593201,0.000054339896,0.00001326294,0.00000798899,0.00023757019,0.0000015509992,0.00044465298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882275,0.0005352579,0.000141672,0.00011744865,0.00022563123,0.00015722078],"domain_scores_gemma":[0.98235095,0.009583673,0.0047034267,0.00043789152,0.0016290938,0.0012950539],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014879629,0.0002087256,0.00023522126,0.0005459439,0.00056207203,0.0008620454,0.00042181832,0.00074255175,0.01156712],"category_scores_gemma":[0.027314374,0.00011886547,0.0005299051,0.0011378266,0.0005267883,0.0006884942,0.00072096236,0.0012389873,0.0004767742],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032691367,0.000070241025,0.9855445,0.000056758712,0.00008836604,0.00016345145,0.0003943358,0.00013075181,0.000057942245,0.00035310397,0.0012252572,0.011588455],"study_design_scores_gemma":[0.0000109873245,0.00010091218,0.9969907,0.00006058505,0.000029296876,0.00036359578,0.00040593173,0.00040007307,0.000056660072,0.0007271968,0.0008439992,0.000010072234],"about_ca_topic_score_codex":0.007054654,"about_ca_topic_score_gemma":0.0061613778,"teacher_disagreement_score":0.01156712,"about_ca_system_score_codex":0.000713642,"about_ca_system_score_gemma":0.00059604045,"threshold_uncertainty_score":0.03869587},"labels":[],"label_agreement":null},{"id":"W4380148858","doi":"10.1016/j.jval.2023.03.2771","title":"PCR229 Impact of Fibrodysplasia Ossificans Progressiva on Living Adaptations and Employment: Burden of Illness Survey Results from the United States and Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Medicine; Surgery; Heterotopic ossification","score_opus":0.09229519149242431,"score_gpt":0.3544175803240869,"score_spread":0.26212238883166256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380148858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98297817,0.000688918,0.000047303573,0.00033534446,0.000013893809,0.000023697901,0.012535869,0.000006759063,0.0033700115],"genre_scores_gemma":[0.99506664,0.0005179895,0.00004308771,0.000063826774,0.000005584231,0.000007754253,0.0034467673,0.0000041565895,0.0008442269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900717,0.00008034675,0.000089881345,0.000093212046,0.00039293504,0.00033649828],"domain_scores_gemma":[0.99803203,0.000074248106,0.0005305218,0.000043456486,0.00083466293,0.00048512145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004375909,0.00026135848,0.0003261185,0.0019661728,0.0009927904,0.0010451105,0.00082537386,0.00035486813,0.002049606],"category_scores_gemma":[0.0018955582,0.00021588478,0.00067870354,0.004385823,0.0005285267,0.00033086518,0.000809568,0.00061249564,0.00027616316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020624026,0.000010435832,0.9982784,0.00000927644,0.00002993347,0.000050470764,0.00013032561,0.00004147136,0.000049294842,0.000026745885,0.00035717324,0.0009958881],"study_design_scores_gemma":[8.816033e-7,0.0000041874673,0.9993469,0.0000074181644,0.000007503403,0.00003372848,0.000359576,0.000035714827,0.00001281051,0.0000040471496,0.00018498233,0.0000022236018],"about_ca_topic_score_codex":0.9738168,"about_ca_topic_score_gemma":0.9809038,"teacher_disagreement_score":0.026183188,"about_ca_system_score_codex":0.007021118,"about_ca_system_score_gemma":0.009572826,"threshold_uncertainty_score":0.05267471},"labels":[],"label_agreement":null},{"id":"W4380148911","doi":"10.1016/j.jval.2023.03.2673","title":"MSR87 Reviewing Elements to Inform Re-Running Searches: Refreshing Systematic Literature Reviews","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Citation; Systematic review; Information retrieval; Computer science; Data science; World Wide Web; MEDLINE; Political science","score_opus":0.8685452736614624,"score_gpt":0.5913280332634462,"score_spread":0.2772172403980162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380148911","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019709611,0.27277592,0.11087593,0.25547656,0.06519017,0.13659748,0.059383627,0.012964452,0.06702619],"genre_scores_gemma":[0.05883879,0.09808631,0.61658543,0.05638768,0.011998616,0.111469075,0.02128853,0.0040386976,0.021306872],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.5141476,0.20133574,0.22862159,0.007936479,0.04508576,0.002872843],"domain_scores_gemma":[0.18963401,0.46148944,0.07932642,0.06253147,0.20198742,0.005031247],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3023187,0.0040534157,0.0091107525,0.07073259,0.004800973,0.013849059,0.0069065196,0.009207826,0.035836283],"category_scores_gemma":[0.7584088,0.006734721,0.010366401,0.030428588,0.003626929,0.016221816,0.012668712,0.008715627,0.01481527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014920384,0.00018527015,0.0028986463,0.34556875,0.004559384,0.0006272237,0.012038572,0.00035314725,0.0039354498,0.0030778504,0.32338628,0.30187738],"study_design_scores_gemma":[0.0018920343,0.0003906741,0.005873467,0.4622071,0.01203645,0.0004274387,0.004029238,0.0009860264,0.00304431,0.007824003,0.5007654,0.0005239504],"about_ca_topic_score_codex":0.0073667327,"about_ca_topic_score_gemma":0.0243275,"teacher_disagreement_score":0.6976813,"about_ca_system_score_codex":0.0072093406,"about_ca_system_score_gemma":0.049891893,"threshold_uncertainty_score":0.8603653},"labels":[],"label_agreement":null},{"id":"W4380148927","doi":"10.1016/j.jval.2023.03.2661","title":"HTA95 Building a Lifecycle Ethics Framework for the Assessment of Artificial Intelligence Technologies in Health: A Scoping Review of Reviews","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sociotechnical system; Engineering ethics; Health technology; Knowledge management; Value (mathematics); Management science; Health care; Computer science; Engineering; Political science","score_opus":0.7557564526278353,"score_gpt":0.6519334106088249,"score_spread":0.10382304201901038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380148927","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007449577,0.96093357,0.0076959655,0.011760854,0.00088669476,0.0013535537,0.0010503829,0.00007729981,0.015496755],"genre_scores_gemma":[0.015748546,0.94063044,0.028806869,0.0062406096,0.00043319195,0.0027379359,0.0012136963,0.00007721882,0.0041114576],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.97753006,0.011660443,0.004475136,0.00067366794,0.0050379355,0.0006226674],"domain_scores_gemma":[0.94027984,0.04273209,0.0050181616,0.0014610844,0.009906917,0.00060181314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03530346,0.0012153832,0.0030983917,0.015541897,0.0014761061,0.007355478,0.0024085166,0.004257717,0.009789911],"category_scores_gemma":[0.06325542,0.0008907973,0.0047220723,0.012155555,0.0022085935,0.006784982,0.0049852184,0.0032850448,0.0019417087],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018652009,0.000095347394,0.0007218161,0.23581724,0.0012237426,0.0002299069,0.0017862921,0.0007626377,0.00068355293,0.09266612,0.054666247,0.6111605],"study_design_scores_gemma":[0.00008194209,0.00009116141,0.0015092493,0.49436623,0.0024706866,0.00030978612,0.0008609967,0.00033968102,0.00061998033,0.025408171,0.47387695,0.00006503366],"about_ca_topic_score_codex":0.010197054,"about_ca_topic_score_gemma":0.0156242475,"teacher_disagreement_score":0.03530346,"about_ca_system_score_codex":0.008527293,"about_ca_system_score_gemma":0.037307024,"threshold_uncertainty_score":0.18670475},"labels":[],"label_agreement":null},{"id":"W4380149017","doi":"10.1016/j.jval.2023.03.2772","title":"PCR230 Estimating Utility Values Using the Duchenne Muscular Dystrophy-Quality of Life Measure (DMD-QOL): A New Preference-Based Measure for Duchenne Muscular Dystrophy","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Measure (data warehouse); Medicine; Preference; Physical medicine and rehabilitation; Muscular dystrophy; Quality of life (healthcare); Physical therapy; Computer science; Statistics; Internal medicine; Mathematics; Data mining","score_opus":0.3225282216474105,"score_gpt":0.3865191215701263,"score_spread":0.06399089992271578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74696106,0.0005920728,0.22808579,0.00040115096,0.00007151238,0.0012126229,0.005701429,0.00020465159,0.016769743],"genre_scores_gemma":[0.9117841,0.00013805668,0.08297019,0.00009457158,0.000015058711,0.0008829617,0.0020264802,0.000030324658,0.0020582208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941175,0.0034816258,0.00042295275,0.00034445536,0.00143964,0.00019388691],"domain_scores_gemma":[0.9892292,0.0079754945,0.0011413005,0.000351024,0.0011413217,0.00016172878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005183579,0.0003785834,0.0004901628,0.0018520755,0.00024843373,0.0013660815,0.0004503523,0.0004370108,0.0058245],"category_scores_gemma":[0.029316247,0.00017156484,0.0011671737,0.0021169118,0.0003126802,0.0007545074,0.0007678069,0.0006936646,0.0007481813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011573302,0.00081955857,0.5014587,0.00047234382,0.0008868034,0.0001964777,0.0011580986,0.01679133,0.0031733096,0.010598734,0.005658615,0.4576287],"study_design_scores_gemma":[0.00039300535,0.0032678596,0.66331625,0.00046916833,0.0005640725,0.0012128945,0.0025113118,0.2770177,0.010088613,0.02589472,0.01499206,0.00027225463],"about_ca_topic_score_codex":0.0029921376,"about_ca_topic_score_gemma":0.0034632573,"teacher_disagreement_score":0.0058245,"about_ca_system_score_codex":0.00081479,"about_ca_system_score_gemma":0.0008215028,"threshold_uncertainty_score":0.027413726},"labels":[],"label_agreement":null},{"id":"W4380149081","doi":"10.1016/j.jval.2023.03.2755","title":"MSR100 Validation of a Mixed Model for Repeated Measures Approach to Including Trials with Varying Follow-up in Indirect Treatment Comparisons of Long-Term Outcomes","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Repeated measures design; Term (time); Clinical trial; Medicine; Statistics; Mathematics; Internal medicine","score_opus":0.8189508191169114,"score_gpt":0.5024172141915285,"score_spread":0.31653360492538285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149081","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07175521,0.003333989,0.9062689,0.0015481404,0.0013270157,0.0051818164,0.0045826687,0.0028361902,0.0031660602],"genre_scores_gemma":[0.43761164,0.0005453792,0.53655565,0.0011873003,0.000340138,0.0152710555,0.002822952,0.0016921366,0.003973627],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.47878402,0.48780414,0.010990997,0.013727729,0.0077201365,0.00097302685],"domain_scores_gemma":[0.253036,0.6891573,0.010648966,0.037376117,0.00899658,0.0007850497],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.33850965,0.003156577,0.0048213475,0.0021499812,0.0015211058,0.004201897,0.005201901,0.004136845,0.013502702],"category_scores_gemma":[0.53134525,0.0018699595,0.01776851,0.0024283645,0.0019491137,0.003282852,0.003540318,0.0056347223,0.0024110863],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09742294,0.0029897883,0.053494245,0.012303324,0.18205416,0.000857826,0.0034929242,0.13342254,0.0042329873,0.06521257,0.023974933,0.42054173],"study_design_scores_gemma":[0.03617799,0.024754185,0.043716714,0.002884686,0.069963954,0.0011017662,0.00079661456,0.6848919,0.005687666,0.0840301,0.045176685,0.0008176972],"about_ca_topic_score_codex":0.0053065843,"about_ca_topic_score_gemma":0.005006746,"teacher_disagreement_score":0.33850965,"about_ca_system_score_codex":0.0016856422,"about_ca_system_score_gemma":0.004013994,"threshold_uncertainty_score":0.8157354},"labels":[],"label_agreement":null},{"id":"W4380149104","doi":"10.1016/j.jval.2023.03.1894","title":"PCR118 Quantifying Patient Preferences for Targeted Therapies in Metastatic Melanoma: A Discrete-Choice Experiment","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"University of Illinois at Chicago; University of Illinois at Urbana-Champaign; University of Pennsylvania","keywords":"Metastatic melanoma; Melanoma; Medicine; Targeted therapy; MEK inhibitor; Oncology; V600E; Internal medicine; Mutation; Cancer research; Cancer; MAPK/ERK pathway; Biology; Genetics","score_opus":0.1896000257103892,"score_gpt":0.40708443497224944,"score_spread":0.21748440926186025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911987,0.000073409334,0.0056118146,0.00048784295,0.000035250512,0.00019989027,0.00062736217,0.000026156937,0.0017395056],"genre_scores_gemma":[0.9942372,0.000035413206,0.003980913,0.00014349764,0.000014843127,0.00027286154,0.00023673139,0.0000074663126,0.0010711071],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.996062,0.0029117079,0.00009224294,0.00045904325,0.00024754068,0.00022737002],"domain_scores_gemma":[0.9399248,0.056187123,0.00168433,0.0010267163,0.00043520215,0.0007418718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006991112,0.00053989806,0.000659333,0.00024892617,0.00038298406,0.0012811993,0.00064612326,0.0015265797,0.011096392],"category_scores_gemma":[0.034624673,0.00031531815,0.00090562424,0.0003633896,0.0010126468,0.0007607522,0.0005181681,0.001992466,0.00082035054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2498575,0.043343168,0.20625253,0.0015346425,0.0022285655,0.0006148674,0.00244731,0.16331668,0.03606472,0.04068292,0.0074888896,0.2461682],"study_design_scores_gemma":[0.021804994,0.11587778,0.13688028,0.00021111473,0.0019267999,0.0007845745,0.0017069688,0.6280052,0.03228485,0.053057697,0.007016662,0.00044310902],"about_ca_topic_score_codex":0.0011220766,"about_ca_topic_score_gemma":0.000751793,"teacher_disagreement_score":0.011096392,"about_ca_system_score_codex":0.00085140736,"about_ca_system_score_gemma":0.0009733291,"threshold_uncertainty_score":0.037121117},"labels":[],"label_agreement":null},{"id":"W4380149107","doi":"10.1016/j.jval.2023.03.1885","title":"PCR107 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures Part I: Instrument Development and Content Validity","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Content validity; Medicine; Patient-reported outcome; Quality of life (healthcare); Health related quality of life; Disease; Content (measure theory); Physical therapy; Intensive care medicine; Psychometrics; Clinical psychology; Pathology; Nursing","score_opus":0.9256591917202315,"score_gpt":0.49881490904595216,"score_spread":0.4268442826742793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001768558,0.99208504,0.0008404532,0.0005168003,0.00030327064,0.0020793008,0.0017490158,0.000024989233,0.0006324586],"genre_scores_gemma":[0.045119826,0.93924916,0.006617227,0.0015244709,0.00020514731,0.0054011196,0.0013898944,0.00003624589,0.0004569441],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9593253,0.015051093,0.016018055,0.0021457393,0.006995462,0.0004643953],"domain_scores_gemma":[0.9430874,0.03491357,0.014346153,0.001555878,0.0057114568,0.00038550442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028394805,0.0018606466,0.0109047135,0.0100275725,0.00093436637,0.0040264614,0.0021782937,0.0020575204,0.006441226],"category_scores_gemma":[0.13141318,0.0012132522,0.014440909,0.0108118225,0.0016638055,0.0027863637,0.0030683824,0.0020185048,0.00056550116],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039219565,0.000023013145,0.0021172003,0.9056973,0.036300488,0.000048349102,0.00018207075,0.0001110651,0.0001638325,0.00053556607,0.0025207824,0.051908184],"study_design_scores_gemma":[0.0014147824,0.0002855374,0.013121504,0.7525245,0.20429616,0.00029171247,0.00020652456,0.00022091527,0.00029687962,0.0009144954,0.026328655,0.00009832952],"about_ca_topic_score_codex":0.010047093,"about_ca_topic_score_gemma":0.02572284,"teacher_disagreement_score":0.028394805,"about_ca_system_score_codex":0.005728427,"about_ca_system_score_gemma":0.015993817,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4380149109","doi":"10.1016/j.jval.2023.03.2773","title":"PCR231 The Mosaic Study: A Clinical and Humanistic Burden of Illness Study Among Patients with Geographic Atrophy (GA) and Their Caregivers in the United States (US) and Canada (CA)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Morinda citrifolia extract uses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geographic atrophy; Humanism; Medicine; Mosaic; Atrophy; Gerontology; Family medicine; Geography; Pathology; Psychiatry; Political science; Archaeology","score_opus":0.03209713117121181,"score_gpt":0.29571615598813783,"score_spread":0.263619024816926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994363,0.00005474181,0.000011431429,0.000023251672,0.0000016992145,0.0000071858653,0.0002551787,6.004384e-7,0.00020954164],"genre_scores_gemma":[0.99931574,0.00007480331,0.000026707272,0.000032717566,0.000003626054,0.000008735911,0.000296197,8.7778045e-7,0.00024069095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976546,0.000057484882,0.000018558569,0.00004156797,0.000050538765,0.00006637515],"domain_scores_gemma":[0.9996643,0.000018535378,0.000113345726,0.000017416878,0.000062284256,0.0001241066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026312514,0.00046236682,0.00033702253,0.0009427036,0.0014986394,0.00078660715,0.000360506,0.0004345576,0.0012686665],"category_scores_gemma":[0.0005976585,0.00034936413,0.0004150253,0.0015653722,0.0004184545,0.00052280776,0.0008583385,0.00058626704,0.00019817702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094896,0.00006482612,0.99828845,0.000004628438,0.000036648908,0.00015150635,0.0005319664,0.000009974541,0.00025364457,0.000014989676,0.00013137865,0.00041710804],"study_design_scores_gemma":[0.000005852242,0.000049061753,0.99827945,0.000003210846,0.000013508682,0.00017151562,0.0013376109,0.00002772465,0.000020315128,0.000007504537,0.000081040496,0.000003303774],"about_ca_topic_score_codex":0.18311754,"about_ca_topic_score_gemma":0.2648032,"teacher_disagreement_score":0.8168825,"about_ca_system_score_codex":0.0010146004,"about_ca_system_score_gemma":0.00086164835,"threshold_uncertainty_score":0.36410338},"labels":[],"label_agreement":null},{"id":"W4380149112","doi":"10.1016/j.jval.2023.03.1783","title":"PCR3 Pain-Free Injections for Growth Hormone Deficiency (GHD) Improve Quality of Life: A Time Trade-Off (TTO) Study in the UK and Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Markham Stouffville Hospital; Hospital for Sick Children","funders":"","keywords":"Quality of life (healthcare); Growth hormone; Medicine; Growth hormone deficiency; Hormone; Internal medicine; Pediatrics; Endocrinology; Nursing","score_opus":0.059696646969894254,"score_gpt":0.3358211887015872,"score_spread":0.276124541731693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925275,0.0021523696,0.00005025999,0.0010508416,0.000038800525,0.00017085961,0.0010072795,0.000004489071,0.0029975674],"genre_scores_gemma":[0.99630827,0.0012338464,0.00013368769,0.00042951017,0.000017154278,0.000058465626,0.00044026197,0.000007981208,0.0013709444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969783,0.0006086683,0.00014184504,0.00019160763,0.00093510654,0.001144525],"domain_scores_gemma":[0.99538463,0.0006964345,0.00087115105,0.00013154068,0.0011481935,0.0017680769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020487742,0.00035990917,0.00095454114,0.0005665578,0.0026089486,0.002184674,0.0011822303,0.0010130748,0.0032129942],"category_scores_gemma":[0.0050485507,0.00041685655,0.0017549912,0.0027260818,0.0017486138,0.0006272105,0.00092598685,0.0019398801,0.00019504137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029740503,0.0052644107,0.85466623,0.0007549224,0.0018459924,0.0003577997,0.0043470114,0.0006916549,0.001031134,0.0014640297,0.007969563,0.09186678],"study_design_scores_gemma":[0.0023908154,0.002932623,0.9858096,0.00024922946,0.0006945587,0.0000912397,0.004222135,0.00043371026,0.0001606518,0.00015677339,0.0027884396,0.00007006613],"about_ca_topic_score_codex":0.9759774,"about_ca_topic_score_gemma":0.9875436,"teacher_disagreement_score":0.03148591,"about_ca_system_score_codex":0.03148591,"about_ca_system_score_gemma":0.04335594,"threshold_uncertainty_score":0.22844738},"labels":[],"label_agreement":null},{"id":"W4380149121","doi":"10.1016/j.jval.2023.03.1488","title":"HTA59 Anticipating Market Access Challenges in Canada for Lecanemab: Learnings from Previous Health Technology Assessments of Disease-Modifying Therapies in Neurodegenerative Diseases","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Commercialization; Medicine; Disease; Health technology; Intensive care medicine; Health care; Business; Political science; Internal medicine; Marketing","score_opus":0.5703338503532178,"score_gpt":0.48509432609956143,"score_spread":0.08523952425365638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149121","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31895292,0.013249111,0.0032799707,0.5858931,0.0011992349,0.00031204877,0.02632168,0.00015406971,0.050637826],"genre_scores_gemma":[0.9631159,0.003403074,0.0027533611,0.017202782,0.0004593033,0.000078448,0.0045516756,0.000061372804,0.008374141],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961837,0.0005517155,0.00018869495,0.00028447888,0.0015213869,0.001269985],"domain_scores_gemma":[0.9802665,0.0049596014,0.0023860808,0.00025321974,0.007079594,0.005055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064238855,0.00025663816,0.00049518415,0.001127175,0.0013729458,0.0047025457,0.0012831808,0.0019477968,0.005691177],"category_scores_gemma":[0.029839363,0.00021498693,0.000676555,0.0019136091,0.00083017355,0.0017684848,0.0011937727,0.0037661362,0.00041185966],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024989753,0.0005489902,0.35013247,0.0006199027,0.00059288373,0.0012159002,0.001784017,0.016372567,0.00089852675,0.04347852,0.37765303,0.20420429],"study_design_scores_gemma":[0.0009618515,0.00053076306,0.6185,0.0015656077,0.0005251977,0.00037023282,0.004558941,0.07298313,0.0012947628,0.028598635,0.26976645,0.00034438577],"about_ca_topic_score_codex":0.9789261,"about_ca_topic_score_gemma":0.98753417,"teacher_disagreement_score":0.94898957,"about_ca_system_score_codex":0.05101043,"about_ca_system_score_gemma":0.10555867,"threshold_uncertainty_score":0.3701083},"labels":[],"label_agreement":null},{"id":"W4380149137","doi":"10.1016/j.jval.2023.03.1687","title":"MT42 HTA Landscape of Medical Devices in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Business; Environmental planning; Environmental resource management; Health care; Political science; Geography; Economics","score_opus":0.4165548739745294,"score_gpt":0.4320107335899042,"score_spread":0.015455859615374823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149137","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30825356,0.024644166,0.0038639538,0.21225703,0.001232272,0.0005200393,0.05004762,0.0007512164,0.39843023],"genre_scores_gemma":[0.80889857,0.012265719,0.004649838,0.022132283,0.0005364769,0.00017237403,0.010911567,0.0003325465,0.14010066],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9947954,0.00027863213,0.00014352729,0.00031837026,0.002886437,0.0015777247],"domain_scores_gemma":[0.97837174,0.0014225044,0.0008943347,0.00026578896,0.012162835,0.006882785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019901376,0.00031635395,0.0004761844,0.004266439,0.0045828284,0.007851133,0.0018941433,0.001870011,0.017547159],"category_scores_gemma":[0.009901971,0.0004910146,0.00095349224,0.006790942,0.0021274085,0.0011534843,0.0018471148,0.002511442,0.0010811028],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0006967426,0.00031907143,0.12424453,0.0006385227,0.00022918773,0.0014514579,0.0021486331,0.008715394,0.0022815547,0.2483895,0.41238478,0.19850063],"study_design_scores_gemma":[0.000098927594,0.00015682225,0.31929597,0.00067482545,0.00008020307,0.0005537327,0.0029527154,0.006988025,0.0005353553,0.0063215857,0.66215867,0.00018308815],"about_ca_topic_score_codex":0.9940002,"about_ca_topic_score_gemma":0.99680316,"teacher_disagreement_score":0.8351528,"about_ca_system_score_codex":0.1648472,"about_ca_system_score_gemma":0.21084902,"threshold_uncertainty_score":0.96865886},"labels":[],"label_agreement":null},{"id":"W4380149197","doi":"10.1016/j.jval.2023.03.2280","title":"SA64 Comparative Effectiveness of Bimekizumab in Patients with Psoriatic Arthritis: Results from a Systematic Literature Review and Network Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Psoriatic arthritis; Medicine; Meta-analysis; Systematic review; Internal medicine; Arthritis; Oncology; MEDLINE; Biology","score_opus":0.049348241419072084,"score_gpt":0.28872810596136006,"score_spread":0.239379864542288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149197","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044059526,0.9527431,0.00081959984,0.00031544178,0.0003442854,0.00020336,0.00094315165,0.000035556,0.0005359177],"genre_scores_gemma":[0.7834731,0.21054086,0.00208699,0.00137928,0.0004837752,0.00038485962,0.0011889156,0.00005237338,0.00040985015],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9859635,0.007311293,0.0031804817,0.0018929394,0.0011656646,0.00048607524],"domain_scores_gemma":[0.98305595,0.011486068,0.0033925243,0.0008143669,0.0009472912,0.0003038418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01348649,0.0022050824,0.014372275,0.0032104664,0.00052831165,0.0032943368,0.0016510206,0.0025070345,0.0029356661],"category_scores_gemma":[0.02553764,0.0013921307,0.037571967,0.0038205343,0.00088548043,0.0020144228,0.0018650104,0.002433296,0.0003065837],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013884618,0.000041316023,0.0074115405,0.06193778,0.90894794,0.00007178447,0.00006428425,0.00031908375,0.00031532499,0.00006648774,0.00025481885,0.00668512],"study_design_scores_gemma":[0.0031229253,0.00041013898,0.0057630795,0.0025477465,0.98717,0.000049202245,0.000037826983,0.00012763272,0.000084555475,0.000112543355,0.00055318937,0.000021135422],"about_ca_topic_score_codex":0.0043995865,"about_ca_topic_score_gemma":0.010155497,"teacher_disagreement_score":0.014372275,"about_ca_system_score_codex":0.0018180384,"about_ca_system_score_gemma":0.0017634371,"threshold_uncertainty_score":0.07132423},"labels":[],"label_agreement":null},{"id":"W4380149209","doi":"10.1016/j.jval.2023.03.1585","title":"MSR50 A Practical Method for Determining the Optimal Allocation between Computation Time and Accuracy in Probabilistic Patient-Level Microsimulation Models","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Probabilistic logic; Microsimulation; Computation; Computer science; Software; Statistical model; Operations research; Machine learning; Artificial intelligence; Algorithm; Engineering; Transport engineering","score_opus":0.6480269135571526,"score_gpt":0.5125421770265757,"score_spread":0.1354847365305769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149209","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033491321,0.00012371321,0.992195,0.00014449889,0.00004397156,0.00008189734,0.00009408616,0.0014666639,0.0025011245],"genre_scores_gemma":[0.12167377,0.00012932418,0.8737014,0.0001806114,0.00006608402,0.0003967629,0.0002351406,0.00069498515,0.0029218714],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99692816,0.0017550108,0.0001566107,0.00030321148,0.0007016021,0.00015535964],"domain_scores_gemma":[0.9882212,0.008408459,0.0005000136,0.0012207809,0.0014776661,0.0001719015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005410391,0.0013208241,0.0012550695,0.0013694611,0.0007591264,0.0009224846,0.0015493378,0.0016292878,0.013092905],"category_scores_gemma":[0.028570423,0.0008956975,0.001119728,0.00089228305,0.00076894334,0.0012631039,0.0018157891,0.0024407383,0.0024476792],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004999222,0.00019173913,0.00096127565,0.0003025007,0.00017647319,0.00011569046,0.00015371274,0.6535372,0.013254175,0.07028391,0.0077848514,0.25273862],"study_design_scores_gemma":[0.000042024432,0.00005335798,0.00013693019,0.000022088643,0.000015843927,0.000032342024,0.000008147795,0.9874007,0.0026785927,0.0073712072,0.0022217655,0.00001696288],"about_ca_topic_score_codex":0.003465366,"about_ca_topic_score_gemma":0.00481149,"teacher_disagreement_score":0.013092905,"about_ca_system_score_codex":0.0009978571,"about_ca_system_score_gemma":0.0022191743,"threshold_uncertainty_score":0.043800116},"labels":[],"label_agreement":null},{"id":"W4380149217","doi":"10.1016/j.jval.2023.03.995","title":"EPH113 Healthcare Utilization Remains Elevated Among People Living with Post-COVID-19 Condition More Than One Year after Acute COVID-19 Illness","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Centre for Disease Control","funders":"","keywords":"Medicine; Poisson regression; Health care; Coronavirus disease 2019 (COVID-19); Emergency department; Cohort; Healthcare system; Acute care; Emergency medicine; Cohort study; Demography; Internal medicine; Population; Environmental health; Disease","score_opus":0.06722746693682904,"score_gpt":0.37034355241222755,"score_spread":0.3031160854753985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873376,0.0018402606,0.00014298441,0.0011350245,0.000089009685,0.000014941207,0.0039077257,0.0000106587695,0.0055217245],"genre_scores_gemma":[0.9958473,0.00079077046,0.0001326072,0.00032699964,0.00006600012,0.000011912609,0.002007048,0.0000037313703,0.0008136669],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993771,0.00009522099,0.00007998911,0.00008326473,0.0001344161,0.00023010134],"domain_scores_gemma":[0.9985065,0.00019739773,0.00074675237,0.000063057334,0.00018149058,0.00030472927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034703038,0.00014587495,0.00029069526,0.0005119445,0.00048092255,0.0010502322,0.00027119805,0.00047062745,0.0039164545],"category_scores_gemma":[0.002917575,0.00012899691,0.0007253741,0.0010751954,0.00018056903,0.0007223017,0.00081685954,0.0008793196,0.00044477958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001006307,0.000030120793,0.99325633,0.00002758562,0.00007010699,0.000093130686,0.00007415261,0.000016076452,0.00007501259,0.00006799092,0.0006579507,0.005531006],"study_design_scores_gemma":[0.0000023244568,0.000023434486,0.99856746,0.000041895582,0.000023617653,0.00013420364,0.00034078525,0.00004755974,0.000022669834,0.000065351946,0.0007269184,0.0000037740306],"about_ca_topic_score_codex":0.020271327,"about_ca_topic_score_gemma":0.029410658,"teacher_disagreement_score":0.020271327,"about_ca_system_score_codex":0.00046375525,"about_ca_system_score_gemma":0.0008294047,"threshold_uncertainty_score":0.040306687},"labels":[],"label_agreement":null},{"id":"W4380149232","doi":"10.1016/j.jval.2023.03.1463","title":"HTA34 A Review of Real-World Evidence in Health Technology Assessment Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health technology; Clinical decision making; Medicine; Economic growth; Family medicine; Health care; Economics","score_opus":0.5663168932045964,"score_gpt":0.531492625671388,"score_spread":0.03482426753320844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000105194784,0.9989666,0.00007040696,0.00034465521,0.00006343207,0.000023351027,0.00018157923,0.0000021721205,0.00024266283],"genre_scores_gemma":[0.0027740619,0.9960483,0.00036487856,0.00048303072,0.00006511991,0.00004940581,0.00013122094,0.0000026905072,0.00008127492],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99348795,0.002696579,0.0017197455,0.00043820587,0.0014465083,0.00021092998],"domain_scores_gemma":[0.95742506,0.035194155,0.003623035,0.00040266637,0.0030480658,0.00030697903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014948967,0.0010395453,0.004973821,0.0070379595,0.0004474276,0.0033184746,0.001402805,0.0018686007,0.0073980824],"category_scores_gemma":[0.048659403,0.0005396149,0.005802048,0.009521222,0.0007476584,0.0015536974,0.001387016,0.0021443304,0.000596422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007046018,0.000050726347,0.00092579314,0.51755416,0.010524784,0.00008823643,0.000111601206,0.0008623726,0.0002241196,0.0030571576,0.013675102,0.45222148],"study_design_scores_gemma":[0.00048189802,0.00029709833,0.0074642813,0.7701294,0.044722874,0.00026742692,0.00015010363,0.0003195307,0.00029306635,0.0028000707,0.17299555,0.00007874995],"about_ca_topic_score_codex":0.023057027,"about_ca_topic_score_gemma":0.047889255,"teacher_disagreement_score":0.9944421,"about_ca_system_score_codex":0.0055579157,"about_ca_system_score_gemma":0.013090243,"threshold_uncertainty_score":0.07905865},"labels":[],"label_agreement":null},{"id":"W4380149263","doi":"10.1016/j.jval.2023.03.1472","title":"HTA43 Do Complexities of Combination Oncology Submissions Impact Reimbursement Outcomes: An Evaluation of Multi-Therapy Oncology Regimens in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Oncology; Regimen; Alliance; Internal medicine; Agency (philosophy); Health care; Political science","score_opus":0.718435995987888,"score_gpt":0.5454551394674425,"score_spread":0.17298085652044548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9213874,0.0022607492,0.00067759235,0.018196866,0.00022678761,0.0013513588,0.0124429045,0.000091471054,0.04336495],"genre_scores_gemma":[0.9871679,0.00085129455,0.0010751395,0.0018867136,0.000064655505,0.0002572168,0.0026978247,0.000049992836,0.0059494018],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874451,0.0033749205,0.00063679164,0.0006168107,0.0048580132,0.00306832],"domain_scores_gemma":[0.92285436,0.025421543,0.009735564,0.0016558082,0.02572326,0.014609369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0092776725,0.0004508744,0.0009751191,0.0015512701,0.0043855417,0.007111405,0.002136939,0.0016445772,0.0122037],"category_scores_gemma":[0.06930064,0.0005766549,0.002412104,0.004180433,0.0022334792,0.0019801888,0.002015184,0.0025399898,0.0006025789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017965095,0.004667261,0.6668412,0.0010844507,0.0030272536,0.0003245066,0.002509788,0.030192534,0.0005855112,0.012689896,0.116965696,0.14314678],"study_design_scores_gemma":[0.008822923,0.005102312,0.877773,0.0011092554,0.003244339,0.00023005994,0.010372271,0.041408524,0.00151912,0.0041905725,0.04575147,0.0004761142],"about_ca_topic_score_codex":0.9850788,"about_ca_topic_score_gemma":0.9931131,"teacher_disagreement_score":0.8750008,"about_ca_system_score_codex":0.124999225,"about_ca_system_score_gemma":0.18908809,"threshold_uncertainty_score":0.9069371},"labels":[],"label_agreement":null},{"id":"W4380149284","doi":"10.1016/j.jval.2023.03.1855","title":"PCR77 “It Shocks Me That There Is Not Something like This Already in Place”: Patient Perspectives for Enhancing Pan-Canadian Data Sharing for Precision Oncology","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Data sharing; Precision oncology; Qualitative property; Patient data; Limit (mathematics); Qualitative research; Medicine; Internet privacy; Cancer; Computer science; Alternative medicine; Internal medicine; Sociology; Pathology","score_opus":0.6926131779362804,"score_gpt":0.5897458583175645,"score_spread":0.10286731961871587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149284","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0051068338,0.0007690316,0.0009885152,0.97461694,0.001473021,0.000032804015,0.00011432433,0.000027064129,0.016871462],"genre_scores_gemma":[0.19971776,0.0019322471,0.0059761433,0.769892,0.0011819657,0.0001382082,0.00019982998,0.00019004915,0.020771872],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9108328,0.04834177,0.0036099395,0.0037710539,0.019754171,0.0136902975],"domain_scores_gemma":[0.8066696,0.06646554,0.0063954093,0.005502915,0.07138438,0.043582186],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.07409752,0.0004572074,0.0006457548,0.0010151525,0.029686904,0.022684867,0.0041473308,0.013720629,0.013701445],"category_scores_gemma":[0.16319302,0.00079839816,0.0012579431,0.0023868901,0.017268734,0.008150399,0.012499396,0.0315076,0.0016524777],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013176781,0.000055758363,0.009993054,0.00034937263,0.00010715487,0.0018078213,0.14402097,0.0002765795,0.0008908049,0.09594627,0.70912653,0.037293896],"study_design_scores_gemma":[0.000054968437,0.0000399245,0.0040669143,0.0008165075,0.00007792603,0.0012369114,0.13724214,0.00027801274,0.00045094817,0.021764152,0.83375365,0.00021797548],"about_ca_topic_score_codex":0.7517141,"about_ca_topic_score_gemma":0.8487542,"teacher_disagreement_score":0.99585265,"about_ca_system_score_codex":0.06269978,"about_ca_system_score_gemma":0.252644,"threshold_uncertainty_score":0.49949616},"labels":[],"label_agreement":null},{"id":"W4380149295","doi":"10.1016/j.jval.2023.03.2270","title":"SA54 A Scoping Review of Economic Evaluation of Breast Cancer Screening in China","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Mammography; Medicine; China; Mammography screening; Breast cancer screening; Genetic testing; Population; Oncology; Gynecology; Cancer; Internal medicine; Environmental health; Political science","score_opus":0.7405862422499305,"score_gpt":0.5755986582167099,"score_spread":0.16498758403322067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005210157,0.9983966,0.0001000146,0.00028396293,0.000074436975,0.000114624,0.00018431799,0.0000031739412,0.00032178598],"genre_scores_gemma":[0.007288362,0.99153495,0.0003812835,0.0002971025,0.00006986838,0.00019178391,0.00014184076,0.0000031977747,0.00009146615],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9905195,0.0036045858,0.0032279622,0.00047709644,0.0018823869,0.00028846343],"domain_scores_gemma":[0.9782136,0.0153004015,0.0032147618,0.00034090847,0.0026761596,0.00025422865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02218619,0.0016646747,0.007868755,0.0120364325,0.00072044693,0.0037269653,0.0013176384,0.0017277424,0.0048767985],"category_scores_gemma":[0.05475961,0.0007708531,0.0074493526,0.01505977,0.00096043665,0.0018917855,0.0019663104,0.0013628762,0.00025018747],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005812623,0.000073287905,0.0016367534,0.74286795,0.015121205,0.00010146781,0.00014949447,0.0004702521,0.00018552708,0.0015810303,0.0046201698,0.2326116],"study_design_scores_gemma":[0.0005317778,0.00039648323,0.0111270305,0.8454177,0.089393646,0.00027391186,0.00021748144,0.00043663508,0.0003012551,0.0015855405,0.050236117,0.00008251422],"about_ca_topic_score_codex":0.020162245,"about_ca_topic_score_gemma":0.038459178,"teacher_disagreement_score":0.02218619,"about_ca_system_score_codex":0.0067168716,"about_ca_system_score_gemma":0.020470476,"threshold_uncertainty_score":0.117333174},"labels":[],"label_agreement":null},{"id":"W4380149336","doi":"10.1016/j.jval.2023.03.1270","title":"HPR124 A Review of Managed Entry Agreements and Innovative Payment Models Established for Gene Therapies in the UK, EU4, US, Canada, and Japan","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Payment; Business; Transformative learning; Process (computing); Actuarial science; Finance; Computer science","score_opus":0.14002874336732274,"score_gpt":0.3846746761567369,"score_spread":0.24464593278941416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008351623,0.9971384,0.00006978674,0.0011537661,0.00022514444,0.000022657994,0.00006417748,0.000002419853,0.0012401174],"genre_scores_gemma":[0.001450327,0.995624,0.00038631263,0.0018941654,0.000110851026,0.00004741028,0.00005177775,0.0000031785332,0.0004320281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9943032,0.0023422646,0.000973401,0.00037110623,0.0017120243,0.00029805134],"domain_scores_gemma":[0.9819759,0.01364468,0.0016773626,0.0002500723,0.00222572,0.0002262855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013746011,0.0007948626,0.002355567,0.005300924,0.00079157867,0.0036519591,0.0016653873,0.0034448777,0.0058394596],"category_scores_gemma":[0.02249913,0.00044102606,0.0020536643,0.008100356,0.00123804,0.0021517558,0.001476028,0.003263149,0.0007579326],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002701644,0.000060296654,0.00022716798,0.12553981,0.00053932157,0.00012841799,0.00024021036,0.00033373482,0.0003444328,0.028934585,0.06747203,0.77590984],"study_design_scores_gemma":[0.000103902836,0.0001050727,0.0017685607,0.14505592,0.0010532,0.00024637431,0.00017548336,0.000069225374,0.0002497163,0.0025336796,0.84860003,0.00003878576],"about_ca_topic_score_codex":0.017967606,"about_ca_topic_score_gemma":0.027759675,"teacher_disagreement_score":0.9925949,"about_ca_system_score_codex":0.00740512,"about_ca_system_score_gemma":0.0173689,"threshold_uncertainty_score":0.072696686},"labels":[],"label_agreement":null},{"id":"W4380149351","doi":"10.1016/j.jval.2023.03.1018","title":"EPH136 Available Screening Programs for the Early Identification of Cancers: A Targeted Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Identification (biology); Medicine; Incidence (geometry); Cancer; Environmental health; Internal medicine; Biology","score_opus":0.17926116964922653,"score_gpt":0.3911789751035352,"score_spread":0.2119178054543087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008872229,0.9955824,0.00018446046,0.0017590248,0.0001844821,0.00003313565,0.00030422513,0.0000060269786,0.0010590501],"genre_scores_gemma":[0.0051093544,0.9933662,0.0003690721,0.0006867999,0.00014517295,0.000023432875,0.00016391963,0.0000022417785,0.00013370528],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99867415,0.00034511884,0.0004849493,0.00013566171,0.00027589238,0.000084361374],"domain_scores_gemma":[0.98810774,0.008783656,0.0015629652,0.00012398197,0.0012449701,0.0001767368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027588527,0.00055659,0.0015315346,0.009019495,0.0003498646,0.0018640432,0.0007516329,0.0010962653,0.0050767506],"category_scores_gemma":[0.01231254,0.0004207567,0.0017363582,0.007551189,0.0005433723,0.0019164664,0.0012525439,0.0011397641,0.0005650446],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030090433,0.00009557254,0.0049516866,0.28039315,0.0014330113,0.00046657276,0.0004241178,0.00028925287,0.0007934611,0.0030985817,0.013809765,0.69394386],"study_design_scores_gemma":[0.000091356465,0.0002481338,0.01998324,0.6196564,0.014390244,0.0018218608,0.0014331548,0.00029202932,0.0010282133,0.003290226,0.33769047,0.000074773045],"about_ca_topic_score_codex":0.004013689,"about_ca_topic_score_gemma":0.010228814,"teacher_disagreement_score":0.009019495,"about_ca_system_score_codex":0.0012005183,"about_ca_system_score_gemma":0.006795472,"threshold_uncertainty_score":0.01698339},"labels":[],"label_agreement":null},{"id":"W4380149416","doi":"10.1016/j.jval.2023.03.1671","title":"MT25 Assessing the Impact of a Patient Portal Application for Cancer Patients on Missed Appointments","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Patient portal; Medicine; Electronic health record; Health records; Family medicine; Medical physics; Medical emergency; Health care","score_opus":0.31713300889339857,"score_gpt":0.577605929251769,"score_spread":0.26047292035837044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961234,0.00048610303,0.0016243965,0.0074118297,0.00032138044,0.0017424306,0.006727372,0.0004919902,0.019960549],"genre_scores_gemma":[0.9844195,0.00024444907,0.006002206,0.0011667341,0.00020040236,0.0020580094,0.0021201768,0.000059074315,0.0037293145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98386127,0.00865733,0.0014997534,0.00067941146,0.0040943907,0.001207831],"domain_scores_gemma":[0.87986165,0.071443826,0.018439718,0.0034016017,0.012869805,0.013983464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015749406,0.0005163914,0.00075427844,0.0017830016,0.0016917911,0.002775448,0.0012097608,0.0017071473,0.015463573],"category_scores_gemma":[0.124673806,0.00042658162,0.0022459978,0.001966346,0.0005021421,0.0014594801,0.002309909,0.0025406266,0.0023814011],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019016841,0.018829836,0.5356284,0.001969745,0.0016995183,0.0003526301,0.004179832,0.0029561168,0.00076974096,0.0016858793,0.03832984,0.37458163],"study_design_scores_gemma":[0.003015886,0.036839794,0.9080651,0.0010380634,0.002416005,0.00020185225,0.0048372364,0.0107924845,0.001709002,0.001391421,0.029496726,0.00019641493],"about_ca_topic_score_codex":0.027998872,"about_ca_topic_score_gemma":0.03312376,"teacher_disagreement_score":0.027998872,"about_ca_system_score_codex":0.00428086,"about_ca_system_score_gemma":0.012744792,"threshold_uncertainty_score":0.08329183},"labels":[],"label_agreement":null},{"id":"W4380149429","doi":"10.1016/j.jval.2023.03.1432","title":"HTA3 Analysis of Canadian and International Health Technology Assessment Uncertainty for Spinal Muscular Atrophy Therapies","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Spinal muscular atrophy; SMA*; Medicine; Physical medicine and rehabilitation; Computer science","score_opus":0.08823189869798545,"score_gpt":0.42165982530605,"score_spread":0.33342792660806453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45188197,0.07958161,0.0824314,0.018178886,0.0009724274,0.0015484536,0.2714556,0.0011420173,0.09280759],"genre_scores_gemma":[0.9587739,0.0024315228,0.011848255,0.0012344787,0.00014311378,0.00023556573,0.022945946,0.00009778125,0.0022893967],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9656795,0.01684003,0.0018470644,0.002628175,0.011092182,0.001912978],"domain_scores_gemma":[0.7169466,0.24131724,0.008152945,0.0060591325,0.025646253,0.0018778285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06036322,0.00091411575,0.0019791743,0.0040555377,0.0010270933,0.0048079086,0.0022424092,0.0013413018,0.0049751597],"category_scores_gemma":[0.18698022,0.0004995869,0.0072653606,0.0062057427,0.0012489752,0.0012665831,0.0015473762,0.0028516462,0.0003293831],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076360903,0.00014103357,0.2774004,0.0030965162,0.02665599,0.00030650193,0.00074536883,0.4578097,0.00042029604,0.080535635,0.049734637,0.0955178],"study_design_scores_gemma":[0.0011396765,0.0009780623,0.34580216,0.002623433,0.01733576,0.00049566827,0.0010254494,0.4650056,0.0020736041,0.07467597,0.0882923,0.00055236334],"about_ca_topic_score_codex":0.67869437,"about_ca_topic_score_gemma":0.46603295,"teacher_disagreement_score":0.32130563,"about_ca_system_score_codex":0.020426903,"about_ca_system_score_gemma":0.0314823,"threshold_uncertainty_score":0.6463957},"labels":[],"label_agreement":null},{"id":"W4380149462","doi":"10.1016/j.jval.2023.03.2536","title":"EE558 Key Methodological Considerations for Developing Cost-Offset Budget Impact Models for a Range of Medical Technologies and Cost Perspectives in Ophthalmology","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Activity-based costing; Offset (computer science); Key (lock); Health technology; Computer science; Management science; Risk analysis (engineering); Operations research; Business; Engineering; Economics; Marketing; Health care; Computer security","score_opus":0.8183538183289807,"score_gpt":0.5655483587990042,"score_spread":0.25280545952997646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149462","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041064313,0.00086136156,0.97260296,0.009069499,0.00036565328,0.0005458305,0.00083908276,0.00007309559,0.011536129],"genre_scores_gemma":[0.18021002,0.001868405,0.795303,0.0036659036,0.0006366013,0.0037920738,0.001235953,0.00026121628,0.01302688],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9678573,0.02766826,0.0013228591,0.0007441771,0.0020143413,0.00039310558],"domain_scores_gemma":[0.9278326,0.06012228,0.0023291195,0.0033280728,0.006073977,0.0003139092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05214296,0.0011140126,0.0013336906,0.0024697199,0.00089281163,0.0067041237,0.0034702618,0.0026517818,0.014432495],"category_scores_gemma":[0.19937046,0.0010019568,0.0023276971,0.003603377,0.0014705214,0.0052564275,0.0022014847,0.00669391,0.0013705721],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012650821,0.00012959154,0.0016045491,0.0003087643,0.00036576425,0.00012346669,0.00017462161,0.123773724,0.00031220887,0.8120607,0.010595783,0.05042435],"study_design_scores_gemma":[0.00016033761,0.00006577971,0.0011360839,0.0006162739,0.00022373794,0.0001000059,0.00026163878,0.19472827,0.0008030279,0.7696159,0.032225855,0.00006303961],"about_ca_topic_score_codex":0.011076218,"about_ca_topic_score_gemma":0.01283848,"teacher_disagreement_score":0.05214296,"about_ca_system_score_codex":0.0031410095,"about_ca_system_score_gemma":0.004635301,"threshold_uncertainty_score":0.27576166},"labels":[],"label_agreement":null},{"id":"W4380149464","doi":"10.1016/j.jval.2023.03.1843","title":"PCR65 Psychometric Assessment of the Psoriatic Arthritis Impact of Disease-12 (PsAID-12) Questionnaire Using Pooled Data from the Phase 3 BE OPTIMAL and BE COMPLETE Trials of Bimekizumab in Patients with Psoriatic Arthritis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Psoriatic arthritis; Medicine; Disease; Pooled analysis; Arthritis; Physical therapy; Internal medicine; Dermatology","score_opus":0.17268626101470816,"score_gpt":0.4282699343671551,"score_spread":0.2555836733524469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98476404,0.002158766,0.0028407364,0.00018205227,0.00009822642,0.0018696509,0.0041422974,0.00010106331,0.0038432707],"genre_scores_gemma":[0.9896666,0.0005544523,0.0022047586,0.00022141181,0.000071132505,0.0021810725,0.004093005,0.000029205616,0.0009784346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910109,0.0045641894,0.0013717886,0.0006010033,0.001934743,0.0005173776],"domain_scores_gemma":[0.99170834,0.003066367,0.0031860627,0.00065547624,0.00106011,0.0003236884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013608369,0.0010866217,0.002190287,0.0014202888,0.00045781466,0.0010416827,0.00056834886,0.000582461,0.002690698],"category_scores_gemma":[0.014278739,0.0004972661,0.0046751145,0.0017463762,0.00044317852,0.00094398705,0.0011463091,0.0012653978,0.000622725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06908218,0.0055025797,0.7450446,0.002012875,0.024816893,0.00012419747,0.0009069024,0.0042611877,0.003693095,0.0003312179,0.0058130794,0.13841121],"study_design_scores_gemma":[0.0066146334,0.014788627,0.96588224,0.0001358569,0.0044905567,0.00028566332,0.00028847987,0.0021053741,0.0012957667,0.0002517191,0.0037692601,0.00009193107],"about_ca_topic_score_codex":0.0012172143,"about_ca_topic_score_gemma":0.0018398025,"teacher_disagreement_score":0.013608369,"about_ca_system_score_codex":0.00054095924,"about_ca_system_score_gemma":0.00073206896,"threshold_uncertainty_score":0.071968794},"labels":[],"label_agreement":null},{"id":"W4380149473","doi":"10.1016/j.jval.2023.03.1261","title":"HPR114 Formulary Management of Biologics in Plaque Psoriasis in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Biosimilar; Formulary; Plaque psoriasis; Medicine; Psoriasis; Dermatology; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.05714793715616513,"score_gpt":0.3078940492575455,"score_spread":0.25074611210138037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8881074,0.016785057,0.0010970077,0.03312002,0.00030488215,0.00045285304,0.0033196637,0.00016664436,0.056646418],"genre_scores_gemma":[0.9726448,0.006063197,0.0016920464,0.0041206013,0.00010238102,0.000056766814,0.00077316153,0.000058273556,0.014488777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980806,0.00017807119,0.000079753736,0.00014129227,0.0009924463,0.00052795507],"domain_scores_gemma":[0.99570787,0.00029658832,0.00053481036,0.000048145786,0.0017178325,0.0016947245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009185978,0.00017485283,0.00029641966,0.0010302042,0.0029294132,0.0021764268,0.0012624862,0.0006915184,0.004405842],"category_scores_gemma":[0.003196341,0.00025426474,0.0004813782,0.0019235451,0.0007903667,0.00033054926,0.00072962017,0.0016476733,0.00030750316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019294821,0.0014512418,0.46262643,0.00096935546,0.00020527618,0.0050694104,0.0038348027,0.0022099218,0.007780828,0.013956337,0.07249974,0.42746714],"study_design_scores_gemma":[0.00036645576,0.00068446883,0.8584849,0.0008276752,0.00018388756,0.0027648832,0.00639896,0.0029559075,0.001845711,0.00074785954,0.124648415,0.0000908243],"about_ca_topic_score_codex":0.9882835,"about_ca_topic_score_gemma":0.9933868,"teacher_disagreement_score":0.07878049,"about_ca_system_score_codex":0.07878049,"about_ca_system_score_gemma":0.13520747,"threshold_uncertainty_score":0.5715951},"labels":[],"label_agreement":null},{"id":"W4380149491","doi":"10.1016/j.jval.2023.03.1066","title":"EPH185 Clinical, Humanistic, and Economic Benefits of Early Cancer Diagnosis: A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Narrative review; Quality of life (healthcare); Cancer; Intensive care medicine; Humanism; Narrative; Nursing; Internal medicine; Political science","score_opus":0.1341357470523731,"score_gpt":0.42168135602369583,"score_spread":0.28754560897132275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149491","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007225067,0.990272,0.00010645709,0.00063029333,0.000117740754,0.00015194024,0.0010450047,0.0000027586623,0.0004486589],"genre_scores_gemma":[0.1531232,0.84324443,0.0007972526,0.0013218301,0.00020050872,0.0005314652,0.0005792964,0.000005554717,0.00019645096],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9917746,0.0035769385,0.0025290595,0.0005739389,0.0012400728,0.00030535317],"domain_scores_gemma":[0.9380238,0.052010175,0.0069334493,0.0006173657,0.0019604815,0.00045470148],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010808737,0.0007507971,0.0036444385,0.0066179503,0.0005859265,0.0026034836,0.001099176,0.001941561,0.005342346],"category_scores_gemma":[0.0629251,0.0006237764,0.0071333842,0.008431116,0.0010301758,0.0015783018,0.0017720212,0.001402833,0.00021492298],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095529825,0.00007599175,0.028503528,0.84560806,0.068174094,0.00021849223,0.00045586354,0.00020567104,0.00010181542,0.000856238,0.0023551488,0.052489836],"study_design_scores_gemma":[0.00093501736,0.00027687152,0.06342074,0.6995215,0.2200543,0.00048352298,0.0010370748,0.00017803173,0.00012601007,0.0011544145,0.012729594,0.000082954786],"about_ca_topic_score_codex":0.013924093,"about_ca_topic_score_gemma":0.049394153,"teacher_disagreement_score":0.013924093,"about_ca_system_score_codex":0.0032399506,"about_ca_system_score_gemma":0.009991571,"threshold_uncertainty_score":0.05716276},"labels":[],"label_agreement":null},{"id":"W4380149493","doi":"10.1016/j.jval.2023.03.1454","title":"HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Real world evidence; Oncology; Real world data; Medicine; Drug; Anticancer drug; Precision oncology; Internal medicine; Drug trial; Clinical trial; Pharmacology; Data science; Computer science; Cancer","score_opus":0.830896354530937,"score_gpt":0.5539287354849298,"score_spread":0.2769676190460072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149493","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056260023,0.035669077,0.041172672,0.6779399,0.08324319,0.005582609,0.03397075,0.0021775595,0.114618324],"genre_scores_gemma":[0.08367044,0.014518663,0.13218115,0.6732055,0.05749262,0.0057233563,0.009602641,0.0016650357,0.021940468],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.8065928,0.08093098,0.044456434,0.0060432376,0.054671235,0.0073052677],"domain_scores_gemma":[0.2405118,0.59471494,0.04813784,0.026268478,0.07537255,0.014994339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16955239,0.0016604679,0.006345388,0.0091444645,0.0027971019,0.016606223,0.0070069437,0.03839127,0.031154675],"category_scores_gemma":[0.6493407,0.0039089504,0.012198062,0.009001621,0.005997796,0.007622895,0.0053188936,0.033338778,0.01211021],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002115339,0.0002459492,0.0050179902,0.00912273,0.0040913224,0.000766463,0.000582663,0.0031468181,0.0009789169,0.038217884,0.82047564,0.115238324],"study_design_scores_gemma":[0.0028642288,0.0005971524,0.021265838,0.03807468,0.0059534186,0.0010712944,0.00026812914,0.0074257688,0.0025218364,0.08329769,0.8358391,0.00082087907],"about_ca_topic_score_codex":0.015975537,"about_ca_topic_score_gemma":0.023902498,"teacher_disagreement_score":0.16955239,"about_ca_system_score_codex":0.0071151736,"about_ca_system_score_gemma":0.02002717,"threshold_uncertainty_score":0.8966894},"labels":[],"label_agreement":null},{"id":"W4380149502","doi":"10.1016/j.jval.2023.03.1275","title":"HPR129 Is Cost-Effectiveness Analysis a Tool to Exercise Value-Based Pricing or Monopsony Power? Evidence from Canada and Other Countries","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incentive; Monopsony; Value (mathematics); Health care; Economics; Population; Business; Actuarial science; Cost-effectiveness analysis; Public economics; Microeconomics; Operations management; Cost effectiveness; Computer science; Medicine; Economic growth; Environmental health","score_opus":0.34254730141015777,"score_gpt":0.4281455441476438,"score_spread":0.08559824273748601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149502","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06554266,0.38154942,0.0068173576,0.23085961,0.0033263478,0.00093685096,0.016624484,0.00023558493,0.29410776],"genre_scores_gemma":[0.86780596,0.073351964,0.008384233,0.03471489,0.0020113287,0.0003407533,0.004097868,0.00020663258,0.009086326],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9542252,0.027152566,0.0020377834,0.0012460374,0.013649806,0.0016886385],"domain_scores_gemma":[0.7454466,0.19241084,0.015814776,0.0060887598,0.036772102,0.0034668667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041648135,0.000520457,0.0017998932,0.0035457755,0.0008874561,0.005313699,0.0018169994,0.0023835013,0.016792731],"category_scores_gemma":[0.21547417,0.00061074714,0.0032569896,0.006280557,0.0035112447,0.002857284,0.001032476,0.0033636715,0.0008827497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006861829,0.00042340066,0.042044394,0.015529761,0.008480758,0.00018038736,0.0006509344,0.00427051,0.00022111494,0.0548308,0.14988549,0.7166206],"study_design_scores_gemma":[0.008108757,0.0017392375,0.3493099,0.07443558,0.018414592,0.0006557594,0.0020777618,0.0075958543,0.0014251554,0.057984702,0.47765952,0.0005932004],"about_ca_topic_score_codex":0.6225359,"about_ca_topic_score_gemma":0.60116905,"teacher_disagreement_score":0.37746412,"about_ca_system_score_codex":0.024188964,"about_ca_system_score_gemma":0.04213643,"threshold_uncertainty_score":0.75937414},"labels":[],"label_agreement":null},{"id":"W4380149523","doi":"10.1016/j.jval.2023.03.2388","title":"PCR209 Comparing the Value of Daily Measurement of Wellbeing for Individuals with Alcohol Use Disorder Versus Reimbursement-Based Timing","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicaid; Reimbursement; Alcohol use disorder; Payment; Medicine; Quality assurance; Skilled Nursing Facility; Nursing homes; Nursing; Family medicine; Psychiatry; Psychology; Alcohol; Business; Health care","score_opus":0.2578126394764068,"score_gpt":0.4159053060127521,"score_spread":0.1580926665363453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862022,0.0006948376,0.0018769072,0.00063898636,0.00023559973,0.00032451426,0.0030632073,0.00002838415,0.0069354866],"genre_scores_gemma":[0.995606,0.00016070095,0.0015145566,0.00018901513,0.00006198859,0.00030071518,0.00090509054,0.000012469789,0.001249536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99302906,0.004537475,0.00037588624,0.00052306365,0.0010793097,0.0004552993],"domain_scores_gemma":[0.97435886,0.018900996,0.003309076,0.0006814648,0.0018029858,0.0009466427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006323524,0.00036821474,0.00067389756,0.0006490289,0.00042206206,0.0011968019,0.0006739499,0.00062468514,0.006861857],"category_scores_gemma":[0.03379082,0.00022310897,0.0021756068,0.0011640425,0.0004956356,0.0008880842,0.0008827119,0.0011075848,0.00080943963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09745585,0.004436902,0.74063593,0.0013007633,0.00506083,0.0001624399,0.0008737803,0.003041216,0.0014927041,0.0030974313,0.0060953144,0.13634673],"study_design_scores_gemma":[0.0038155273,0.043745633,0.9242688,0.00043283257,0.0040597566,0.00035383628,0.0016664545,0.009189787,0.002941861,0.002581325,0.0068385806,0.00010545266],"about_ca_topic_score_codex":0.0037399032,"about_ca_topic_score_gemma":0.0033095793,"teacher_disagreement_score":0.006861857,"about_ca_system_score_codex":0.0012916661,"about_ca_system_score_gemma":0.0014364333,"threshold_uncertainty_score":0.033442438},"labels":[],"label_agreement":null},{"id":"W4380149544","doi":"10.1016/j.jval.2023.03.2468","title":"EE489 The Economic Burden of Caring for a Child with Duchene Muscular Dystrophy in Canada: A Caregiver Survey","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Social Policies and Family","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; Muscular dystrophy; Medicine; Disease; Child health; Neuromuscular disease; Psychology; Physical therapy; Gerontology; Pediatrics; Pathology; Internal medicine","score_opus":0.0447936984588629,"score_gpt":0.2921372469343314,"score_spread":0.24734354847546852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860225,0.0006437483,0.000054791028,0.0008960791,0.0000203988,0.00007717995,0.00913201,0.000004702071,0.0031485653],"genre_scores_gemma":[0.99094474,0.0015712078,0.00016764546,0.0005195628,0.000013107896,0.00006602902,0.0038010688,0.000006522936,0.0029101006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992712,0.00008652573,0.0000816484,0.00005465067,0.00022008937,0.00028581815],"domain_scores_gemma":[0.997013,0.00012061762,0.0006566756,0.000048282047,0.0012545902,0.000906782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005587374,0.00031932292,0.00034756574,0.0012446548,0.002554165,0.0012291202,0.0009404536,0.00068970554,0.0024560322],"category_scores_gemma":[0.0027743883,0.00038780965,0.00066484034,0.0044771214,0.0004312026,0.00045062604,0.0011080127,0.001235935,0.0003092684],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037391612,0.000065133754,0.99452484,0.000038102706,0.00003928943,0.00017426525,0.0010392288,0.0000707464,0.0000367003,0.00008438908,0.0017376854,0.002152265],"study_design_scores_gemma":[0.000007098752,0.000021047636,0.9937628,0.000078036144,0.000019685629,0.00008838404,0.0043373555,0.00014979731,0.000019554334,0.000013334593,0.0014931652,0.0000098195205],"about_ca_topic_score_codex":0.993119,"about_ca_topic_score_gemma":0.99611783,"teacher_disagreement_score":0.023232587,"about_ca_system_score_codex":0.023232587,"about_ca_system_score_gemma":0.033828042,"threshold_uncertainty_score":0.16856498},"labels":[],"label_agreement":null},{"id":"W4380149549","doi":"10.1016/j.jval.2023.03.1267","title":"HPR120 The Pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A Comparative Study Using Donabedian's Structure-Process-Outcome Framework","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Procurement; Pooling; Purchasing; Business; Process (computing); Outcome (game theory); Purchasing power; Process management; Economics; Marketing; Computer science; Microeconomics","score_opus":0.18835347595039248,"score_gpt":0.4017387286497625,"score_spread":0.21338525269937003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58561057,0.012298175,0.021106716,0.005826794,0.00015830553,0.000480965,0.002694777,0.00019759641,0.37162608],"genre_scores_gemma":[0.98431385,0.00196139,0.0037130043,0.00022908993,0.000023281998,0.000045543573,0.00037866065,0.000028860524,0.0093063675],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99567944,0.0011438627,0.00011684157,0.00027381952,0.0017797524,0.0010064197],"domain_scores_gemma":[0.99492043,0.0018672687,0.0003850825,0.0003643052,0.0020110335,0.00045184736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004844642,0.000471923,0.00082063285,0.00284646,0.0019509651,0.0051351683,0.0017912315,0.00079174916,0.0069945124],"category_scores_gemma":[0.00863607,0.0002796377,0.001187871,0.0071599237,0.0023961482,0.002186167,0.0012049077,0.0010241942,0.0003178192],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037343783,0.00019579986,0.033505004,0.00037428926,0.00022080267,0.0002695097,0.0009934538,0.040970545,0.0004670146,0.8355746,0.009623983,0.0774314],"study_design_scores_gemma":[0.00031952388,0.0006526074,0.37089133,0.0005297991,0.001169204,0.00047485402,0.011306099,0.24483702,0.0013640048,0.25982967,0.10802305,0.00060289016],"about_ca_topic_score_codex":0.889362,"about_ca_topic_score_gemma":0.88489443,"teacher_disagreement_score":0.11063802,"about_ca_system_score_codex":0.043538503,"about_ca_system_score_gemma":0.044459008,"threshold_uncertainty_score":0.31589544},"labels":[],"label_agreement":null},{"id":"W4380149593","doi":"10.1016/j.jval.2023.03.719","title":"EE418 Cost-Effectiveness Analysis of Halobetasol and Tazarotene (DUOBRIITM) Compared to Standard of Care for Adult Patients with Moderate-to-Severe Plaque Psoriasis in Québec","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health; Bausch Health (Canada); Health Canada","funders":"","keywords":"Tazarotene; Plaque psoriasis; Psoriasis; Medicine; Dermatology","score_opus":0.026973085544685683,"score_gpt":0.28754943763129465,"score_spread":0.26057635208660895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9719273,0.014174178,0.00044385984,0.0011898797,0.00008782438,0.00067087245,0.0068647526,0.0000324945,0.0046088803],"genre_scores_gemma":[0.995611,0.001286364,0.00033433826,0.00022552814,0.000024161269,0.00009622222,0.0015236071,0.0000039780402,0.0008947309],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99817073,0.0010551749,0.0000941844,0.00012744048,0.00026228282,0.00029014907],"domain_scores_gemma":[0.9984621,0.0005564774,0.00029272298,0.000040046998,0.00027479357,0.00037387997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015850073,0.00050409517,0.0012894333,0.00051502266,0.00033074152,0.0009551115,0.00089829316,0.00071557815,0.0047731767],"category_scores_gemma":[0.0038692805,0.00024448885,0.0028055815,0.0011012313,0.00036034727,0.00036195823,0.00045370613,0.0007424219,0.00015298015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47430244,0.0043165768,0.21395694,0.0050051403,0.019227648,0.00076337904,0.00025013494,0.066923544,0.004124642,0.0019636266,0.01078598,0.19837995],"study_design_scores_gemma":[0.071478546,0.04679443,0.8170498,0.00096822897,0.0097790975,0.00033990887,0.0005173502,0.045752853,0.0007986805,0.00026504995,0.0061163944,0.00013962438],"about_ca_topic_score_codex":0.78935707,"about_ca_topic_score_gemma":0.79198736,"teacher_disagreement_score":0.21064293,"about_ca_system_score_codex":0.02543758,"about_ca_system_score_gemma":0.011273761,"threshold_uncertainty_score":0.42376685},"labels":[],"label_agreement":null},{"id":"W4380149641","doi":"10.1016/j.jval.2023.03.2157","title":"RWD128 A Retrospective Claims Analysis Characterizing Health Care Resource Use Among Patients with Friedreich Ataxia in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Medicine; Scoliosis; Resource use; Health care; Physical medicine and rehabilitation; Retrospective cohort study; Resource (disambiguation); Pediatrics; Physical therapy; Surgery; Psychiatry; Economics; Computer science; Natural resource economics; Economic growth","score_opus":0.04581371773125673,"score_gpt":0.29166533557567764,"score_spread":0.24585161784442092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909672,0.00022986637,0.00011806435,0.000091663365,0.000010023159,0.000017736653,0.007881631,0.0000074233762,0.0006762628],"genre_scores_gemma":[0.9935835,0.00008265123,0.00010484788,0.00006756762,0.000011915071,0.000020031914,0.0059206355,0.0000032662304,0.00020548255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837756,0.00036509722,0.00042570446,0.0002925584,0.0003301545,0.00020889372],"domain_scores_gemma":[0.9951224,0.001014638,0.0025342302,0.0004898242,0.00055276527,0.0002860986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012423256,0.00035374096,0.0005335359,0.002353197,0.0005218635,0.0012184178,0.0005807821,0.00056876504,0.0012400475],"category_scores_gemma":[0.00532793,0.00037561113,0.0010786852,0.004224619,0.00029144727,0.0006700918,0.0008237306,0.0007575506,0.00028627296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007398578,0.000037461145,0.99848586,0.000012054728,0.00015348042,0.000053775006,0.000040235842,0.000052413063,0.000051005438,0.000040712348,0.00033867813,0.0006603053],"study_design_scores_gemma":[0.000014391051,0.000041087915,0.9983181,0.000018750094,0.00008904018,0.00021263068,0.00018968734,0.0005441023,0.00007144618,0.000044624972,0.00044810207,0.000008118894],"about_ca_topic_score_codex":0.034165107,"about_ca_topic_score_gemma":0.029060198,"teacher_disagreement_score":0.034165107,"about_ca_system_score_codex":0.0010202854,"about_ca_system_score_gemma":0.0010985469,"threshold_uncertainty_score":0.06793249},"labels":[],"label_agreement":null},{"id":"W4380149657","doi":"10.1016/j.jval.2023.03.1016","title":"EPH134 Accurately Counting Cancer Patients: An Epidemiologic Model to Estimate the Prevalence of Epithelial Ovarian Cancer (EOC) While Accounting for Cure","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Disease; Epithelial ovarian cancer; Ovarian cancer; Cancer; Internal medicine; Estimation; Oncology; Cure rate","score_opus":0.1665433368578929,"score_gpt":0.43834770719090455,"score_spread":0.27180437033301164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149657","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76522654,0.0010512893,0.21640177,0.0066770725,0.00019397549,0.00020752464,0.005392702,0.00031153602,0.004537541],"genre_scores_gemma":[0.97326374,0.00045291812,0.018627807,0.00033913009,0.00014245586,0.00012829619,0.0014954952,0.000028002281,0.0055221072],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989698,0.00053685723,0.000045684457,0.00023970024,0.00006826754,0.00013971688],"domain_scores_gemma":[0.99387556,0.0048409794,0.0005368757,0.00027330598,0.00029679702,0.00017648636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003099567,0.0007309717,0.0013090838,0.0011098958,0.00047264126,0.0016957144,0.0017765395,0.0020518086,0.002765504],"category_scores_gemma":[0.011485449,0.0009840436,0.0012441024,0.0011550902,0.0007580161,0.0013970874,0.0009939938,0.0020149164,0.00044667185],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042324344,0.00028305477,0.10461814,0.00005291593,0.0002967226,0.0002463476,0.000113920454,0.856794,0.00041103674,0.014939873,0.0021084184,0.01971232],"study_design_scores_gemma":[0.00004246091,0.00005156266,0.006269059,0.000012597434,0.000055622044,0.00009213742,0.000030122275,0.9882727,0.00008479626,0.004563912,0.00050973485,0.000015323249],"about_ca_topic_score_codex":0.030449774,"about_ca_topic_score_gemma":0.019148238,"teacher_disagreement_score":0.030449774,"about_ca_system_score_codex":0.0011839111,"about_ca_system_score_gemma":0.0014899805,"threshold_uncertainty_score":0.060545087},"labels":[],"label_agreement":null},{"id":"W4380149693","doi":"10.1016/j.jval.2023.03.1650","title":"MT3 Delphi Panel on the Recommended Use of the Cue COVID-19 at Home Diagnostic Test","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Test (biology); Medicine; Delphi method; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Family medicine; Population; Internal medicine; Disease; Computer science; Artificial intelligence; Environmental health","score_opus":0.4396154849915233,"score_gpt":0.4449518178797979,"score_spread":0.005336332888274564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149693","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047947906,0.0028939755,0.024901077,0.7734197,0.011508827,0.009553066,0.002546338,0.00054369215,0.12668552],"genre_scores_gemma":[0.34762523,0.0037242677,0.07438699,0.5161451,0.005007308,0.014490155,0.0016173957,0.00038730688,0.036616188],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.95825607,0.0252565,0.0043363506,0.0014898689,0.005485311,0.005175816],"domain_scores_gemma":[0.86930203,0.07038962,0.0031695892,0.003438198,0.04506872,0.008631821],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.067265585,0.0004067809,0.00054497865,0.0014067742,0.0032219375,0.0024842268,0.0020040008,0.009126857,0.013996827],"category_scores_gemma":[0.1290589,0.0006293611,0.0015383777,0.0005619973,0.0021097641,0.0017842522,0.004994923,0.008675273,0.0050771097],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009990131,0.00037782243,0.015883284,0.0016400975,0.00011540849,0.0013872145,0.012701463,0.00089720037,0.010016427,0.015826467,0.7651461,0.17500955],"study_design_scores_gemma":[0.00018854541,0.0005665765,0.020119272,0.0067975917,0.000089833775,0.0013117434,0.01440029,0.0017574809,0.0034395799,0.009263597,0.94175994,0.00030551248],"about_ca_topic_score_codex":0.007764951,"about_ca_topic_score_gemma":0.011434924,"teacher_disagreement_score":0.067265585,"about_ca_system_score_codex":0.003976279,"about_ca_system_score_gemma":0.018266227,"threshold_uncertainty_score":0.35573864},"labels":[],"label_agreement":null},{"id":"W4380149697","doi":"10.1016/j.jval.2023.03.994","title":"EPH112 Economic Impact of Rapid Treatment Initiation of HIV with Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from a Canadian Healthcare Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tenofovir alafenamide; Emtricitabine; Medicine; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral load","score_opus":0.03494687805753612,"score_gpt":0.3124821156191319,"score_spread":0.2775352375615958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149697","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11523928,0.05438852,0.0016035102,0.33868632,0.0019899344,0.00019845541,0.0246362,0.00009289406,0.46316484],"genre_scores_gemma":[0.91929203,0.03403293,0.00234513,0.013554088,0.0009528313,0.00005029431,0.0039331615,0.000042963904,0.025796507],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99623847,0.0006420746,0.00008386608,0.000110263216,0.0015983423,0.0013269958],"domain_scores_gemma":[0.9936212,0.0009050383,0.000381402,0.0000529159,0.0034400737,0.0015993695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018047815,0.0005684155,0.00043713953,0.002085607,0.0017475521,0.004551933,0.00089982356,0.0016269712,0.010796101],"category_scores_gemma":[0.007411512,0.00027827866,0.0011046903,0.0025410315,0.0009858739,0.0008511656,0.0010082403,0.0026204414,0.00031841788],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023915744,0.00040959855,0.049402986,0.0015075915,0.0011910016,0.001501046,0.0008363846,0.038352206,0.0013861748,0.3205021,0.3682979,0.21422134],"study_design_scores_gemma":[0.00085007644,0.00067185337,0.20796554,0.0045902706,0.0019660213,0.001115555,0.0049477085,0.02717007,0.0012423155,0.039393585,0.7096478,0.00043919982],"about_ca_topic_score_codex":0.97652394,"about_ca_topic_score_gemma":0.9839335,"teacher_disagreement_score":0.0729803,"about_ca_system_score_codex":0.0729803,"about_ca_system_score_gemma":0.13823123,"threshold_uncertainty_score":0.5295116},"labels":[],"label_agreement":null},{"id":"W4380149702","doi":"10.1016/j.jval.2023.03.1164","title":"HPR17 PDCI's Biopharmaceutical Ecosystem Index: Where Does Canada Rank on Its Attractiveness for New Medicine Launch?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Attractiveness; Rank (graph theory); Index (typography); Biopharmaceutical; Comparator; Business; Marketing; Psychology; Computer science; Engineering; Biotechnology; Biology; Mathematics; World Wide Web","score_opus":0.07971240240055555,"score_gpt":0.3611136865954009,"score_spread":0.28140128419484534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149702","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13860592,0.009894133,0.0016481592,0.29113147,0.0028459693,0.00024882273,0.019850403,0.0005482974,0.5352268],"genre_scores_gemma":[0.8617561,0.0072600353,0.004726629,0.022621263,0.0005670956,0.00010522316,0.007351364,0.00030548635,0.09530687],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9951283,0.0002381047,0.0000971531,0.00012135628,0.0030879565,0.0013272399],"domain_scores_gemma":[0.9723335,0.0011061155,0.000976652,0.0001904615,0.016444877,0.008948315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033434997,0.00038666563,0.00044484975,0.004103402,0.004362065,0.010904991,0.0011089193,0.0012265905,0.01724112],"category_scores_gemma":[0.01361575,0.00021472081,0.0004997732,0.005217207,0.0023211397,0.0023322217,0.0020982777,0.002679609,0.0025331264],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003066504,0.000104381514,0.14360645,0.00020546463,0.00008852562,0.00017532837,0.0008221058,0.0003028142,0.00063069205,0.04092877,0.6788985,0.13393036],"study_design_scores_gemma":[0.00009564091,0.000121364224,0.2741755,0.00070728804,0.00012460421,0.00016904446,0.008757651,0.0013719862,0.00128393,0.0064235576,0.70657057,0.00019887064],"about_ca_topic_score_codex":0.96231943,"about_ca_topic_score_gemma":0.98776567,"teacher_disagreement_score":0.93642986,"about_ca_system_score_codex":0.06357016,"about_ca_system_score_gemma":0.13332693,"threshold_uncertainty_score":0.46123594},"labels":[],"label_agreement":null},{"id":"W4380149737","doi":"10.1016/j.jval.2023.03.951","title":"EPH69 Economic Impact of Clozapine Treatment Persistence: A Canadian Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Douglas Mental Health University Institute","funders":"","keywords":"Clozapine; Persistence (discontinuity); Schizophrenia (object-oriented programming); Perspective (graphical); Psychiatry; Medicine; Psychology; Computer science; Engineering; Artificial intelligence","score_opus":0.18758604027506046,"score_gpt":0.3728724681580302,"score_spread":0.18528642788296976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149737","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12152706,0.066278026,0.001829893,0.48864397,0.00087850983,0.00007187252,0.011073429,0.000050483013,0.3096466],"genre_scores_gemma":[0.9067747,0.056888428,0.0011810029,0.012128709,0.0012976527,0.000027898208,0.0018869133,0.000051624982,0.019763093],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9971529,0.00034776842,0.000093191775,0.00014683147,0.0011757563,0.0010835666],"domain_scores_gemma":[0.99000096,0.0019819266,0.0010460396,0.00017640863,0.0051979073,0.0015967048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021768203,0.0005421338,0.0009299283,0.0037722352,0.0027524503,0.007217161,0.0013848856,0.0026657928,0.009799596],"category_scores_gemma":[0.012812333,0.00029672787,0.0013628899,0.0062908707,0.002728673,0.0016963045,0.0013993031,0.0045376867,0.00031090353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009250296,0.00023271471,0.04338448,0.0006846836,0.0006089388,0.0014030272,0.0010790555,0.018561436,0.00084364635,0.7584676,0.088511705,0.08529764],"study_design_scores_gemma":[0.00046026305,0.00025290085,0.28483963,0.0036449374,0.001406049,0.0009880401,0.007247518,0.026404407,0.0008972423,0.22951014,0.4437457,0.0006031424],"about_ca_topic_score_codex":0.9888924,"about_ca_topic_score_gemma":0.9842992,"teacher_disagreement_score":0.08609396,"about_ca_system_score_codex":0.08609396,"about_ca_system_score_gemma":0.114949964,"threshold_uncertainty_score":0.62465835},"labels":[],"label_agreement":null},{"id":"W4380149798","doi":"10.1016/j.jval.2023.03.1433","title":"HTA4 Pembrolizumab Vs. Standard of Care Chemotherapy As First-Line Treatment for Advanced Non-Small Cell Lung Cancer with High Pd-L1 Expression Levels: A Cost-Utility Analysis from the Ontario, Canada Public Payer Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Sunnybrook Health Science Centre; York University; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Intensive care medicine; Immunotherapy","score_opus":0.0349656346771366,"score_gpt":0.3159447320730994,"score_spread":0.28097909739596283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9335945,0.031012887,0.0012496458,0.0052209725,0.00024306266,0.0006276126,0.010024339,0.0000694314,0.01795743],"genre_scores_gemma":[0.9945018,0.002410252,0.00040836868,0.000379164,0.00003936015,0.000044887984,0.0010800479,0.000008711931,0.001127313],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982514,0.000812343,0.000071197835,0.00014027396,0.00033222119,0.00039255654],"domain_scores_gemma":[0.998069,0.0009424802,0.00037034883,0.000056938792,0.0002026104,0.00035860762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023670504,0.00070283655,0.0015867045,0.00071945274,0.00043395755,0.0019903725,0.0011941304,0.0009965284,0.0047504273],"category_scores_gemma":[0.0056206123,0.00044580342,0.003575407,0.0015235374,0.00060013414,0.000708145,0.00050877983,0.0015246121,0.00018949993],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36686164,0.0019564945,0.13070413,0.005565561,0.0289562,0.0011822616,0.0005260678,0.16365223,0.00390834,0.01374944,0.029562926,0.25337467],"study_design_scores_gemma":[0.060947638,0.025480337,0.5517007,0.0028718123,0.054358892,0.0016029831,0.0018663926,0.25224397,0.0024268453,0.009662289,0.036391947,0.00044620276],"about_ca_topic_score_codex":0.61160624,"about_ca_topic_score_gemma":0.68100494,"teacher_disagreement_score":0.38839376,"about_ca_system_score_codex":0.031132812,"about_ca_system_score_gemma":0.01580244,"threshold_uncertainty_score":0.7813622},"labels":[],"label_agreement":null},{"id":"W4380149799","doi":"10.1016/j.jval.2023.03.759","title":"EE458 Economic Evaluation of Lifestyle Interventions to Promote Cognition in Older Adults with Chronic Stroke","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Vancouver Coastal Health Research Institute; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Cognition; Stroke (engine); Cognitive training; Perspective (graphical); Psychological intervention; Physical medicine and rehabilitation; Physical therapy; Medicine; Gerontology; Health care; Chronic stroke; Psychology; Rehabilitation; Psychiatry; Computer science","score_opus":0.20140413197429213,"score_gpt":0.5073952337859001,"score_spread":0.305991101811608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93397045,0.028688187,0.0022434362,0.0025089257,0.0012466745,0.0114708645,0.008500657,0.000108909415,0.011261852],"genre_scores_gemma":[0.98468786,0.0053468454,0.0013703034,0.0007153,0.00025125753,0.0036599927,0.0019340747,0.000011559046,0.0020228357],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9942789,0.004187617,0.00055460224,0.00019644466,0.00037883507,0.00040361407],"domain_scores_gemma":[0.9968569,0.0016946815,0.00063265976,0.00015746585,0.00024983802,0.00040847895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050530317,0.0012859275,0.0019193444,0.0013707529,0.00048830704,0.0014530136,0.00062438636,0.0018338575,0.011441545],"category_scores_gemma":[0.012045333,0.0006053812,0.007729538,0.0009278927,0.000578729,0.0007762641,0.0011848278,0.0018851372,0.0004885056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8678808,0.011749903,0.008578878,0.007909295,0.027671725,0.000118374795,0.00011677318,0.0037380378,0.0005047881,0.0009613657,0.0021462992,0.06862383],"study_design_scores_gemma":[0.76688427,0.120618336,0.044964865,0.004669773,0.04362989,0.0001271966,0.0003760326,0.008238152,0.0009324198,0.0013505556,0.008083246,0.00012536703],"about_ca_topic_score_codex":0.010382217,"about_ca_topic_score_gemma":0.010449493,"teacher_disagreement_score":0.011441545,"about_ca_system_score_codex":0.0028849354,"about_ca_system_score_gemma":0.003291246,"threshold_uncertainty_score":0.038275838},"labels":[],"label_agreement":null},{"id":"W4380149805","doi":"10.1016/j.jval.2023.03.2254","title":"SA38 Approaches to Comparing Treatments from Meta-Analyses of Single-Arm Studies from a Systematic Literature Review: Case Example of Non-Surgical Technologies for Treatment of Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Microwave ablation; Radiofrequency ablation; Lung cancer; Meta-analysis; Ablation; Radiology; Systematic review; Medical physics; Surgery; Oncology; MEDLINE; Internal medicine","score_opus":0.48189212663009995,"score_gpt":0.4685687475370384,"score_spread":0.013323379093061527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149805","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025573457,0.18983738,0.73586553,0.0053788926,0.0024033275,0.012093798,0.018822327,0.0029349625,0.0070902663],"genre_scores_gemma":[0.3482633,0.019414928,0.6022695,0.0032930132,0.0008836932,0.015704881,0.0066285343,0.0011133678,0.0024289137],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.6866184,0.27167732,0.02070313,0.011162419,0.009080136,0.0007585106],"domain_scores_gemma":[0.5951031,0.3637487,0.011108348,0.022145204,0.0067495834,0.0011449631],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17488062,0.004640328,0.01081276,0.020410975,0.0014397694,0.006140248,0.005066337,0.003965921,0.016139746],"category_scores_gemma":[0.39443296,0.002461454,0.06334671,0.013591098,0.0020900308,0.0031237702,0.0055851,0.0060361847,0.0023166807],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00461304,0.00017190073,0.008805998,0.0589033,0.7754709,0.00041910162,0.00090987433,0.010722091,0.0013311657,0.0068765962,0.0053913905,0.12638462],"study_design_scores_gemma":[0.007630674,0.0038702623,0.018855589,0.01996041,0.7076574,0.001364591,0.0012125041,0.044571176,0.0030496279,0.1332068,0.057958897,0.0006621301],"about_ca_topic_score_codex":0.0040826546,"about_ca_topic_score_gemma":0.0066578058,"teacher_disagreement_score":0.8251194,"about_ca_system_score_codex":0.0016325589,"about_ca_system_score_gemma":0.0045086173,"threshold_uncertainty_score":0.92486817},"labels":[],"label_agreement":null},{"id":"W4380149838","doi":"10.1016/j.jval.2023.03.2185","title":"RWD157 Healthcare Resource Utilization and Cost of Care in Patients with BRAF-Mutated Unresectable/Metastatic Melanoma in the US","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Metastatic melanoma; Melanoma; Medicine; Health care; Oncology; Mutant; Internal medicine; Cancer research; Biology; Gene; Genetics; Political science","score_opus":0.05831661155919933,"score_gpt":0.27630889138393905,"score_spread":0.21799227982473973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919287,0.0008118039,0.00004563321,0.00087445066,0.000028655973,0.0000063982516,0.0049825027,0.0000054264915,0.0013165327],"genre_scores_gemma":[0.9970342,0.00031952342,0.000030668005,0.00017336241,0.000020296427,0.000006398186,0.0021156585,0.0000024383824,0.00029749022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996408,0.000088020315,0.000064628,0.00004224905,0.000059398815,0.00010493592],"domain_scores_gemma":[0.9988802,0.0002031812,0.00054768886,0.000043574706,0.000119250806,0.00020620771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036964248,0.00016819859,0.0002796537,0.0008949818,0.0002226213,0.00070630765,0.0003273433,0.000490382,0.002483408],"category_scores_gemma":[0.0026364054,0.00020368355,0.000910688,0.0020769157,0.00018871052,0.00050169096,0.00047667537,0.0008020916,0.00022950277],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013101308,0.00006406293,0.9953843,0.000018180788,0.00013654109,0.000080353995,0.00003157939,0.00044523017,0.00003987504,0.00011690099,0.0014470653,0.0021049737],"study_design_scores_gemma":[0.000015099294,0.00004303334,0.9975426,0.000025763098,0.000063343716,0.0001840169,0.00031535683,0.0009233342,0.000029806304,0.00015916863,0.0006910631,0.0000074869927],"about_ca_topic_score_codex":0.074764915,"about_ca_topic_score_gemma":0.06970243,"teacher_disagreement_score":0.074764915,"about_ca_system_score_codex":0.0016302677,"about_ca_system_score_gemma":0.0010123049,"threshold_uncertainty_score":0.14865947},"labels":[],"label_agreement":null},{"id":"W4380149871","doi":"10.1016/j.jval.2023.03.100","title":"CO26 Impact in Health Outcomes of Anti-PD(L)1 Inhibitors to Treat Early-Stage Cancers in Belgium","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Adjuvant; Stage (stratigraphy); Internal medicine; Cancer; Oncology; Incidence (geometry); Overall survival","score_opus":0.06355808240718473,"score_gpt":0.3210031120379493,"score_spread":0.25744502963076454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665834,0.012537358,0.0005287292,0.004878675,0.0001360685,0.000016482883,0.009455295,0.000033193042,0.005830783],"genre_scores_gemma":[0.9947495,0.00125221,0.00012219742,0.00019158593,0.000047005302,0.00001446545,0.0022456401,0.000017379942,0.001360071],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979235,0.0009363619,0.000121326804,0.00018121467,0.00020996525,0.00062758516],"domain_scores_gemma":[0.9974831,0.00065499014,0.00087062304,0.000056235855,0.00033414693,0.00060088426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015279293,0.00022238371,0.00057536416,0.0011189347,0.00018148159,0.0017847822,0.00030615728,0.00055990194,0.002934631],"category_scores_gemma":[0.0053906823,0.0001601428,0.0017227869,0.0018422698,0.0002505004,0.00040447747,0.0007129184,0.0011796223,0.0002083971],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009689698,0.0007617505,0.8494235,0.00053900055,0.0037883988,0.00093779335,0.00039353687,0.03927001,0.00064780656,0.009411442,0.013114339,0.0720227],"study_design_scores_gemma":[0.00022596151,0.0004606578,0.9750495,0.00024887122,0.0006838371,0.00042692464,0.0005692464,0.0080191335,0.0003439707,0.0014978328,0.012433059,0.000040951614],"about_ca_topic_score_codex":0.14619094,"about_ca_topic_score_gemma":0.09525986,"teacher_disagreement_score":0.14619094,"about_ca_system_score_codex":0.005801853,"about_ca_system_score_gemma":0.002542123,"threshold_uncertainty_score":0.29068005},"labels":[],"label_agreement":null},{"id":"W4380149964","doi":"10.1016/j.jval.2023.03.2074","title":"RWD44 Use of Real-World Data for Hard-to-Identify Patient Population: Methodology and a Case Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Real world data; Real world evidence; Medicine; Matching (statistics); Psychological intervention; Computer science; Intensive care medicine; Data science; Internal medicine; Psychiatry","score_opus":0.8950720303877125,"score_gpt":0.6683719799046978,"score_spread":0.22670005048301478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149964","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83516276,0.0014494692,0.11976902,0.0035138463,0.00019335639,0.01809289,0.0056393053,0.00028278513,0.015896656],"genre_scores_gemma":[0.8148197,0.001094901,0.16140242,0.0012644351,0.0000816063,0.016285535,0.00225371,0.00014294665,0.0026546535],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9362944,0.05027074,0.004641172,0.0024006567,0.0054296926,0.00096331025],"domain_scores_gemma":[0.8780797,0.08830135,0.006456136,0.013741874,0.012161358,0.0012595608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045536283,0.00060319406,0.00060667616,0.0032525023,0.0018233515,0.002763393,0.0024367233,0.0025079635,0.0042927344],"category_scores_gemma":[0.11861581,0.0007536932,0.0012050782,0.0031571442,0.0017328556,0.0017690975,0.003253835,0.0012959975,0.0010851941],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003559154,0.010501561,0.5676605,0.0047554267,0.0010405758,0.010962764,0.04875028,0.0057395124,0.0064678513,0.0155909415,0.013176968,0.31179437],"study_design_scores_gemma":[0.004253792,0.01929321,0.43026423,0.010541433,0.0030549269,0.03366561,0.11943163,0.06726044,0.056550417,0.02230449,0.23212832,0.0012514824],"about_ca_topic_score_codex":0.008585314,"about_ca_topic_score_gemma":0.010723036,"teacher_disagreement_score":0.045536283,"about_ca_system_score_codex":0.0022525438,"about_ca_system_score_gemma":0.0061219106,"threshold_uncertainty_score":0.24082172},"labels":[],"label_agreement":null},{"id":"W4380149975","doi":"10.1016/j.jval.2023.03.1596","title":"MSR61 AI Support Reduced Screening Burden in a Systematic Review with Costs and Cost-Effectiveness Outcomes (SR-CCEO) for Cost-Effectiveness Modeling","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Impact of AI and Big Data on Business and Society","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Critical appraisal; Cost effectiveness; Computer science; Process (computing); Resource (disambiguation); Medicine; Risk analysis (engineering); Alternative medicine; Pathology","score_opus":0.4568049397514221,"score_gpt":0.5197233834991778,"score_spread":0.06291844374775568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149975","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063803582,0.9529328,0.009770474,0.005989015,0.0016754076,0.0043510515,0.01199865,0.0004012746,0.006501086],"genre_scores_gemma":[0.3743498,0.54474735,0.049479615,0.008785895,0.0021325082,0.009419824,0.0071517504,0.00029726297,0.0036360184],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.94847697,0.036381464,0.008504046,0.0021093157,0.0039303056,0.00059796206],"domain_scores_gemma":[0.9276031,0.059131138,0.0072772326,0.0019091704,0.0034762758,0.00060308346],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.035274465,0.0023511827,0.010885393,0.0063461727,0.00037451027,0.0037063123,0.001995081,0.00271587,0.021831576],"category_scores_gemma":[0.13960318,0.0012657824,0.026714379,0.005804615,0.00067841733,0.0034775152,0.0018813915,0.0030061603,0.0016106265],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045998553,0.00009723699,0.0021170757,0.5910465,0.26737022,0.00014334684,0.00014275286,0.003430286,0.0003542768,0.0065123397,0.009226522,0.11495957],"study_design_scores_gemma":[0.009535747,0.0014198442,0.006693403,0.19058204,0.7190424,0.0003143482,0.00017103698,0.004927688,0.00035916542,0.012592212,0.054207683,0.00015435378],"about_ca_topic_score_codex":0.0063588475,"about_ca_topic_score_gemma":0.014207064,"teacher_disagreement_score":0.96472555,"about_ca_system_score_codex":0.0028507512,"about_ca_system_score_gemma":0.0072592474,"threshold_uncertainty_score":0.18655139},"labels":[],"label_agreement":null},{"id":"W4380150010","doi":"10.1016/j.jval.2023.03.1557","title":"MSR21 Impact of Correlated Outcomes in Probabilistic Sensitivity Analyses When Treatment Effects Are Derived from a Network Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Meta-analysis; Econometrics; Probabilistic logic; Sensitivity (control systems); Regression; Meta-regression; Correlation; Regression analysis; Statistics; Computer science; Mathematics; Medicine; Internal medicine; Engineering","score_opus":0.8169312145311791,"score_gpt":0.6222054501852085,"score_spread":0.19472576434597066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150010","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20449567,0.12090363,0.57774484,0.013453772,0.006559398,0.0060710325,0.038122717,0.0039597335,0.028689235],"genre_scores_gemma":[0.93050605,0.0043727043,0.050290633,0.0030629921,0.00108696,0.0028388826,0.0039675618,0.00078205834,0.0030921719],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.57010436,0.37647796,0.017479187,0.023470268,0.010295976,0.0021722228],"domain_scores_gemma":[0.20239332,0.7517396,0.0124577,0.028214324,0.0041545657,0.0010405007],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.283667,0.0046306215,0.010606651,0.007510641,0.0015579727,0.0077623245,0.004794068,0.005510413,0.017944079],"category_scores_gemma":[0.61743265,0.0036044952,0.046171233,0.0071022473,0.0033357814,0.007904128,0.005980979,0.010079832,0.0016015833],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030029153,0.00029309365,0.05771196,0.022619678,0.66970634,0.0022646678,0.00082180323,0.11838538,0.0014162646,0.015071998,0.010128563,0.07155107],"study_design_scores_gemma":[0.005470272,0.002424751,0.035244364,0.0057259663,0.62637997,0.0024611496,0.00053793704,0.18336397,0.0040454795,0.11455245,0.01910824,0.0006855333],"about_ca_topic_score_codex":0.00710182,"about_ca_topic_score_gemma":0.004619023,"teacher_disagreement_score":0.71633303,"about_ca_system_score_codex":0.0024846203,"about_ca_system_score_gemma":0.0030838242,"threshold_uncertainty_score":0.8833661},"labels":[],"label_agreement":null},{"id":"W4380150026","doi":"10.1016/j.jval.2023.03.381","title":"EE76 Budget Impact of Faricimab in Patients with Diabetic Macular Edema and Neovascular Age Related Degeneration in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Aflibercept; Macular degeneration; Diabetic macular edema; Medicine; Pro re nata; Clinical trial; Ophthalmology; Ranibizumab; Bevacizumab; Clinical Practice; Optometry; Internal medicine; Diabetic retinopathy; Physical therapy; Diabetes mellitus; Chemotherapy","score_opus":0.12314040411303451,"score_gpt":0.33776208573596267,"score_spread":0.21462168162292816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93854773,0.011047847,0.00012428328,0.015899904,0.00019940997,0.00018563315,0.018683236,0.0000150450405,0.015296905],"genre_scores_gemma":[0.98763394,0.0036495158,0.00020051673,0.0010302456,0.00006347882,0.000049681807,0.004339677,0.0000074190593,0.0030256126],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99777454,0.00039796854,0.00015767485,0.000102845595,0.000549051,0.0010178268],"domain_scores_gemma":[0.9948054,0.00062854285,0.00097077043,0.00006860586,0.001464543,0.0020620814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010982283,0.00023188507,0.0005757081,0.0013210903,0.0012273781,0.0021326605,0.00077532674,0.0008569367,0.0034125748],"category_scores_gemma":[0.007500195,0.00027861237,0.0013168381,0.0034179287,0.00054581976,0.00041934758,0.0008993538,0.001540485,0.00014078371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054744943,0.00095721526,0.88285524,0.00060312235,0.0017279917,0.0007369123,0.00038463387,0.0091520455,0.0003107561,0.004610272,0.029069297,0.06411801],"study_design_scores_gemma":[0.00084409455,0.00031581632,0.97754025,0.00048630717,0.0006988506,0.00025224837,0.0011184413,0.0068027372,0.000119886696,0.00054292736,0.011214807,0.00006366097],"about_ca_topic_score_codex":0.98939824,"about_ca_topic_score_gemma":0.9940526,"teacher_disagreement_score":0.082350425,"about_ca_system_score_codex":0.082350425,"about_ca_system_score_gemma":0.08628095,"threshold_uncertainty_score":0.597497},"labels":[],"label_agreement":null},{"id":"W4380150158","doi":"10.1016/j.jval.2023.03.216","title":"CO143 Impact of Investigational, at-Home, Self-Administered, Intranasal Etripamil on the Need for Additional Medical Intervention in Patients with Supraventricular Tachycardia","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Intervention (counseling); Paroxysmal supraventricular tachycardia; Emergency department; Supraventricular tachycardia; Psychological intervention; Tachycardia; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.026004385502460314,"score_gpt":0.30779506948395896,"score_spread":0.28179068398149865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99564207,0.00123253,0.00010552422,0.0003335754,0.00005909084,0.00001890246,0.00009757607,0.0000068426557,0.0025038908],"genre_scores_gemma":[0.9991264,0.00029847864,0.00009940064,0.00013365629,0.000060295686,0.000008652519,0.00006193341,0.0000018825006,0.00020925784],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997329,0.00009681188,0.000029363146,0.000040077404,0.00005381039,0.000047024536],"domain_scores_gemma":[0.99863607,0.0007580695,0.00027910218,0.00004014243,0.00008625264,0.00020030868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027727362,0.00014634809,0.00040978089,0.0000974121,0.00016316431,0.00043878867,0.00013477002,0.0003067755,0.001631287],"category_scores_gemma":[0.002579633,0.000070893,0.0005507914,0.00013492843,0.00013600418,0.0003549583,0.00015098651,0.00070976245,0.00015120217],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09559962,0.0043772543,0.5314935,0.0005879906,0.002088536,0.002594923,0.00039000888,0.0013598382,0.010399568,0.0003174429,0.0026555024,0.34813586],"study_design_scores_gemma":[0.0013480091,0.015171047,0.9748268,0.000111288246,0.0010793877,0.0011276961,0.00053478224,0.0028137623,0.0011224108,0.00022117415,0.0016114527,0.000032171887],"about_ca_topic_score_codex":0.0012045371,"about_ca_topic_score_gemma":0.003394889,"teacher_disagreement_score":0.001631287,"about_ca_system_score_codex":0.00033591266,"about_ca_system_score_gemma":0.00045398367,"threshold_uncertainty_score":0.0054572225},"labels":[],"label_agreement":null},{"id":"W4380150175","doi":"10.1016/j.jval.2023.03.482","title":"EE181 The Economic Burden of Preterm Labor (PTL): A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Preterm Birth and Chorioamnionitis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Preterm labor; Medicine; Obstetrics; Preterm labour; Economics; Pregnancy; Fetus; Gestation; Biology","score_opus":0.028214016319805975,"score_gpt":0.3070589685119456,"score_spread":0.2788449521921396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150175","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036881913,0.9926156,0.00014499022,0.0006695392,0.00017698083,0.000278216,0.001949131,0.0000056679846,0.0004717954],"genre_scores_gemma":[0.051509295,0.9449373,0.00073347805,0.0012676144,0.00015665314,0.000600084,0.0006085846,0.000008188319,0.00017886324],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9891418,0.003923884,0.00429274,0.00067808916,0.00149832,0.000465182],"domain_scores_gemma":[0.9491262,0.037505288,0.009373007,0.0007277101,0.0027249171,0.0005428996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009887858,0.0012663931,0.006029949,0.012985181,0.00062191987,0.0032534916,0.0014311894,0.0027260024,0.00721673],"category_scores_gemma":[0.068889745,0.0012076285,0.010128073,0.013033561,0.0008912185,0.0024784612,0.0027525744,0.0014796555,0.00041735457],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034196372,0.000027616556,0.0061036637,0.9301241,0.0383192,0.00016940989,0.00022565752,0.00011921794,0.00008523242,0.00032688727,0.0015463852,0.022610674],"study_design_scores_gemma":[0.0004499714,0.00015749704,0.016660001,0.82546604,0.14516172,0.00037830317,0.00044374433,0.00009373283,0.00007455563,0.00041543524,0.010643123,0.000055821918],"about_ca_topic_score_codex":0.01657299,"about_ca_topic_score_gemma":0.04653791,"teacher_disagreement_score":0.01657299,"about_ca_system_score_codex":0.003998272,"about_ca_system_score_gemma":0.014409548,"threshold_uncertainty_score":0.052292645},"labels":[],"label_agreement":null},{"id":"W4380150183","doi":"10.1016/j.jval.2023.03.512","title":"EE211 Guidelines for the Economic Evaluation of Vaccination Programs in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; Canadian Agency for Drugs and Technologies in Health; University of British Columbia; BC Centre for Disease Control; University of Toronto","funders":"","keywords":"Mandate; Vaccination; Immunization program; Context (archaeology); Advisory committee; Immunization; Health care; Medicine; Political science; Public administration; Business; Economic growth; Virology; Economics; Immunology; Geography","score_opus":0.78773921110202,"score_gpt":0.5120014130453933,"score_spread":0.2757377980566268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150183","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004649723,0.051300384,0.048120767,0.052599162,0.0064183003,0.023927113,0.19534706,0.0028693222,0.6147682],"genre_scores_gemma":[0.048398525,0.07484395,0.3074523,0.03952743,0.002672241,0.030014671,0.12506653,0.0035169336,0.3685074],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9463076,0.013350548,0.011218753,0.0010905828,0.0238142,0.0042183315],"domain_scores_gemma":[0.78870016,0.05002649,0.0057364646,0.0053623393,0.14542754,0.004746974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.043234393,0.0026774653,0.0039741113,0.017438661,0.004437341,0.0101226065,0.009294873,0.010664735,0.0384839],"category_scores_gemma":[0.1810462,0.003341371,0.0065780235,0.022846734,0.0028187488,0.0020423585,0.0027326935,0.007928927,0.012000728],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001521266,0.0001702238,0.0020463073,0.0023508735,0.00021425053,0.00023375147,0.00029917134,0.0055672005,0.000134471,0.021032562,0.88723,0.08056912],"study_design_scores_gemma":[0.0005025022,0.000085904314,0.03207505,0.014596068,0.00042403842,0.00032468556,0.0003356113,0.0044371258,0.00052864366,0.014030551,0.9323991,0.00026079267],"about_ca_topic_score_codex":0.962958,"about_ca_topic_score_gemma":0.9667919,"teacher_disagreement_score":0.9271836,"about_ca_system_score_codex":0.07281638,"about_ca_system_score_gemma":0.254547,"threshold_uncertainty_score":0.5283223},"labels":[],"label_agreement":null},{"id":"W4380150191","doi":"10.1016/j.jval.2023.03.513","title":"EE212 Comprehensive Review of Methods to Estimate Market Share Uptakes in Budget Impact Models","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Market share; Intervention (counseling); Business; Environmental economics; Econometrics; Economics; Marketing; Medicine","score_opus":0.5983251675744082,"score_gpt":0.5634925773266871,"score_spread":0.03483259024772112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150191","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005941681,0.1878598,0.7587665,0.004150653,0.00091893645,0.00066678436,0.011599114,0.001139813,0.028956773],"genre_scores_gemma":[0.0721354,0.22993037,0.6649641,0.0019922226,0.0013483318,0.0017320784,0.01128736,0.001344272,0.015265916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9890448,0.006867714,0.00093857443,0.0006006418,0.0023101517,0.00023800846],"domain_scores_gemma":[0.96375144,0.02950875,0.0012613186,0.0018075895,0.0035554126,0.00011545796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020994488,0.001985564,0.0018704747,0.005297672,0.00042891377,0.0023658178,0.0025970307,0.0013386441,0.013294451],"category_scores_gemma":[0.06888446,0.0012563361,0.0030328785,0.007669666,0.00050313486,0.0023813546,0.0012877157,0.0019096815,0.0037624866],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011042287,0.00019596897,0.006266998,0.0076899626,0.0017968953,0.00007421378,0.0001242579,0.06436764,0.00044981972,0.06269981,0.060420904,0.79580307],"study_design_scores_gemma":[0.00016061439,0.00030910526,0.027291806,0.016063808,0.002696145,0.00042549835,0.00023730117,0.20600693,0.0045957984,0.11519732,0.6266449,0.000370822],"about_ca_topic_score_codex":0.030275913,"about_ca_topic_score_gemma":0.037437484,"teacher_disagreement_score":0.030275913,"about_ca_system_score_codex":0.0026994003,"about_ca_system_score_gemma":0.0038972008,"threshold_uncertainty_score":0.11103076},"labels":[],"label_agreement":null},{"id":"W4380150199","doi":"10.1016/j.jval.2023.03.1945","title":"PCR169 A Systematic Literature Review (SLR) of Health State Utility Values (HSUV) in Metastatic Castration-Resistant Prostate Cancer (MCRPC)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Systematic review; Cancer; Internal medicine; Gynecology; MEDLINE; Biology","score_opus":0.4235380140617159,"score_gpt":0.46106455717523254,"score_spread":0.037526543113516664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023853246,0.9911991,0.0004460644,0.0010098066,0.00026850848,0.0007825524,0.003011848,0.000014174991,0.0008826042],"genre_scores_gemma":[0.050278656,0.9408357,0.002761057,0.0024649927,0.00027342106,0.0016551806,0.0013360949,0.000021248195,0.0003735826],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97119695,0.012036168,0.011576704,0.0015887816,0.0029880153,0.00061322725],"domain_scores_gemma":[0.92074245,0.06019845,0.012270694,0.0013025892,0.0048093298,0.00067656656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022912001,0.0011497863,0.006827721,0.017144907,0.0006885595,0.0038410728,0.0015701357,0.0019538621,0.007845906],"category_scores_gemma":[0.1086027,0.0010793853,0.013433102,0.015532482,0.0011168226,0.0025209542,0.0030983414,0.001843649,0.0005142878],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039008382,0.0000183501,0.001881341,0.9288803,0.02190328,0.00009258289,0.00021430754,0.00013578702,0.00013427481,0.00045921243,0.002743924,0.043146595],"study_design_scores_gemma":[0.00055350584,0.00024192828,0.006568035,0.8762206,0.0906744,0.0002683058,0.00025178306,0.00010957091,0.00015002771,0.0005068378,0.024403378,0.000051659154],"about_ca_topic_score_codex":0.019102124,"about_ca_topic_score_gemma":0.051311713,"teacher_disagreement_score":0.022912001,"about_ca_system_score_codex":0.005448939,"about_ca_system_score_gemma":0.019760104,"threshold_uncertainty_score":0.12117165},"labels":[],"label_agreement":null},{"id":"W4380150200","doi":"10.1016/j.jval.2023.03.1833","title":"PCR54 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures (PROMS): Part II Psychometric Properties","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Patient-reported outcome; Medicine; Quality of life (healthcare); Disease; Health related quality of life; Physical therapy; Systematic review; Psychometric testing; Psychometrics; MEDLINE; Intensive care medicine; Clinical psychology; Pathology; Nursing","score_opus":0.851519320718531,"score_gpt":0.4987643617179948,"score_spread":0.35275495900053616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018883178,0.99348783,0.0007823024,0.0003640003,0.00020541162,0.0014769862,0.0012702654,0.000021399994,0.0005034541],"genre_scores_gemma":[0.03862735,0.9519753,0.0045227376,0.00083878776,0.0001240542,0.002744198,0.0008007162,0.000020091202,0.00034689764],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97786593,0.008164716,0.008139942,0.0012528648,0.004285588,0.0002909537],"domain_scores_gemma":[0.96713424,0.020774623,0.007904811,0.00081601704,0.0031152598,0.0002550388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01935638,0.0016680371,0.008840897,0.0071766134,0.0006643514,0.002915768,0.0016224455,0.0016763964,0.00615681],"category_scores_gemma":[0.082878925,0.0008842739,0.012896679,0.008950069,0.0010602449,0.0021882588,0.0022411987,0.0017129905,0.00048830075],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055254635,0.000027299682,0.0021982382,0.8836811,0.037490427,0.00006191461,0.00013604006,0.00017975108,0.00017808558,0.0005147968,0.0024105664,0.0725692],"study_design_scores_gemma":[0.0016692409,0.00045754344,0.017261377,0.66697794,0.2814003,0.00043291113,0.0002161645,0.00033875962,0.00034347075,0.0009619762,0.029833533,0.00010677941],"about_ca_topic_score_codex":0.007069038,"about_ca_topic_score_gemma":0.01929236,"teacher_disagreement_score":0.01935638,"about_ca_system_score_codex":0.0035934679,"about_ca_system_score_gemma":0.010601569,"threshold_uncertainty_score":0.10236758},"labels":[],"label_agreement":null},{"id":"W4380150210","doi":"10.1016/j.jval.2023.03.754","title":"EE453 Baseline Cognitive Performance Is a Determinant of Prospective Health Resource Utilization Among Adults with Chronic Stroke: A Secondary Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Vancouver Coastal Health Research Institute; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Stroke (engine); Chronic stroke; Prospective cohort study; Medicine; Public health; Cognition; Gerontology; Cognitive impairment; Baseline (sea); Resource (disambiguation); Health care; Physical therapy; Psychiatry; Nursing; Political science; Internal medicine; Computer science","score_opus":0.04158020078950074,"score_gpt":0.2708718675230642,"score_spread":0.22929166673356344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99280965,0.00026740643,0.00016855015,0.0001018115,0.000023017617,0.0000300008,0.005827349,0.000010075744,0.0007621534],"genre_scores_gemma":[0.99367225,0.0000986195,0.00009446962,0.00009997421,0.00004757666,0.00005062515,0.0046880036,0.0000064017026,0.0012419497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848443,0.0004322068,0.00021024782,0.00022625476,0.00016419856,0.00048278962],"domain_scores_gemma":[0.99737227,0.0007032775,0.00072979147,0.00038548576,0.00034515673,0.0004639972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014226997,0.00060427265,0.0008796427,0.001072652,0.00069570396,0.001926974,0.0007761406,0.0011636369,0.005314826],"category_scores_gemma":[0.004447387,0.00055221777,0.0045902585,0.002206407,0.00029843493,0.00091345015,0.0013175168,0.0015051893,0.0007479378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016832306,0.00042526747,0.99304044,0.00005952769,0.0017115395,0.00006923671,0.00008788792,0.00022495959,0.00011181589,0.00009334712,0.0008944192,0.0015982114],"study_design_scores_gemma":[0.00007922103,0.0003163358,0.997614,0.00001632234,0.00050095934,0.00006579666,0.00019922054,0.00055774854,0.00006767732,0.00008689583,0.00048373072,0.000011996068],"about_ca_topic_score_codex":0.03797654,"about_ca_topic_score_gemma":0.032608375,"teacher_disagreement_score":0.03797654,"about_ca_system_score_codex":0.0007186623,"about_ca_system_score_gemma":0.0016742185,"threshold_uncertainty_score":0.07551098},"labels":[],"label_agreement":null},{"id":"W4380150246","doi":"10.1016/j.jval.2023.03.605","title":"EE304 Induction Cost per Responder of Biologic Therapies for Plaque Psoriasis in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Plaque psoriasis; Psoriasis; Medicine; Psoriasis Area and Severity Index; Induction therapy; Biologic Agents; Internal medicine; Dermatology; Chemotherapy","score_opus":0.5355696792310978,"score_gpt":0.43386758548700805,"score_spread":0.10170209374408973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8602932,0.01770162,0.0016435869,0.024482626,0.00039220793,0.000536336,0.053321168,0.00024361964,0.041385777],"genre_scores_gemma":[0.9776779,0.004263584,0.00068415666,0.0011504439,0.00008619915,0.00006733529,0.005774067,0.00003225441,0.010264005],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99731123,0.0005162475,0.0001645262,0.00017972547,0.0010385473,0.00078976713],"domain_scores_gemma":[0.99388313,0.0014088624,0.0008154414,0.00010459652,0.002078196,0.0017097726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013944396,0.0002991146,0.00082306843,0.0015812605,0.0011381366,0.0021071264,0.0015239175,0.00095845934,0.0054902816],"category_scores_gemma":[0.0076014684,0.00044748708,0.0016901909,0.0027422365,0.00057923066,0.00038096766,0.00055988086,0.0018312068,0.00032088175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011433767,0.0013943055,0.5565502,0.0018233485,0.002741312,0.0015778276,0.00066021,0.067828394,0.0018825773,0.02308415,0.12431946,0.20670448],"study_design_scores_gemma":[0.0024383208,0.0008007495,0.9029369,0.00059990416,0.0017103056,0.0006843451,0.0013101536,0.05418401,0.0009814596,0.0015610508,0.032628667,0.00016410495],"about_ca_topic_score_codex":0.9953011,"about_ca_topic_score_gemma":0.9952571,"teacher_disagreement_score":0.12668161,"about_ca_system_score_codex":0.12668161,"about_ca_system_score_gemma":0.11478387,"threshold_uncertainty_score":0.91914374},"labels":[],"label_agreement":null},{"id":"W4380150287","doi":"10.1016/j.jval.2023.03.2385","title":"PCR206 Effectiveness and Cost-Effectiveness of a Comprehensive Package Based on Electronic Medication Monitors at Improving Treatment Outcomes Among Tuberculosis Patients in Tibet: A Multi-Centre Randomised Controlled Trial","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tuberculosis; Complement (music); Real world evidence; Physical therapy; Internal medicine","score_opus":0.042868138807674136,"score_gpt":0.3606872950935974,"score_spread":0.3178191562859233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99510574,0.0023069223,0.00030296386,0.00016430709,0.00023247175,0.0010996242,0.00031213593,0.000023287015,0.00045256273],"genre_scores_gemma":[0.99688727,0.0005787027,0.00054425723,0.00018427346,0.00012881277,0.0010079592,0.00025704622,0.000004064629,0.00040763643],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956428,0.0025930468,0.00035223755,0.00067604816,0.0002715913,0.00046434448],"domain_scores_gemma":[0.99693143,0.001350898,0.0007037239,0.0002467904,0.00018675605,0.0005805011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004115843,0.00250697,0.004957955,0.0008893044,0.0008125788,0.0018039948,0.0014873963,0.003780807,0.004524895],"category_scores_gemma":[0.0054824925,0.0016658914,0.0051369513,0.0012425967,0.0021802492,0.0017720374,0.0011636025,0.0034546265,0.00048733447],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9773811,0.0074612466,0.0027635803,0.00090657343,0.0035514138,0.000030774514,0.00007959612,0.0005240109,0.00038841303,0.000053430453,0.00011144468,0.006748275],"study_design_scores_gemma":[0.8261853,0.14819114,0.015516137,0.00018016601,0.0077182367,0.00002702494,0.00009581566,0.0013852349,0.0002744729,0.0001865338,0.000176274,0.00006351676],"about_ca_topic_score_codex":0.0054493756,"about_ca_topic_score_gemma":0.004437903,"teacher_disagreement_score":0.0054493756,"about_ca_system_score_codex":0.002277945,"about_ca_system_score_gemma":0.001787582,"threshold_uncertainty_score":0.02176696},"labels":[],"label_agreement":null},{"id":"W4380150317","doi":"10.1016/j.jval.2023.03.2446","title":"CO221 Efficacy and Safety of Personalized Topography-Guided-Lasik Laser Refractive Correction: A Targeted Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Corneal surgery and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"LASIK; Keratomileusis; Medicine; Refractive surgery; Optometry; Visual acuity; Ophthalmology; Laser; Patient safety; Optics; Cornea","score_opus":0.03878480766650315,"score_gpt":0.3296877372726271,"score_spread":0.29090292960612396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150317","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015508834,0.9968438,0.00014430918,0.0005331698,0.000101973594,0.000021897498,0.000098433025,0.000003808958,0.0007017294],"genre_scores_gemma":[0.019153932,0.97894764,0.00036312782,0.0008242215,0.00029566925,0.000028062432,0.00014789744,0.000005224287,0.00023419227],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9987947,0.00022710342,0.00046526306,0.00017294576,0.0002878774,0.000052086496],"domain_scores_gemma":[0.9936435,0.004349111,0.0011195195,0.00010247666,0.000714485,0.00007086521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023433988,0.0004069056,0.0019515435,0.002527192,0.0003346957,0.0017996295,0.000979836,0.0011241308,0.004394224],"category_scores_gemma":[0.006821008,0.00029964605,0.0017065624,0.002745945,0.0006962539,0.0014119672,0.000621272,0.0008315013,0.0006627116],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012044808,0.0001561432,0.0041399742,0.26527226,0.00343913,0.0004159229,0.00035541365,0.00025247925,0.001926276,0.0019145403,0.0075472225,0.71337616],"study_design_scores_gemma":[0.00063251395,0.0024346916,0.040087063,0.3800518,0.06321015,0.006641044,0.0021442387,0.0010016175,0.006296402,0.0060943267,0.491134,0.00027209276],"about_ca_topic_score_codex":0.002013357,"about_ca_topic_score_gemma":0.003981317,"teacher_disagreement_score":0.004394224,"about_ca_system_score_codex":0.00077102426,"about_ca_system_score_gemma":0.0036776052,"threshold_uncertainty_score":0.014700174},"labels":[],"label_agreement":null},{"id":"W4380150346","doi":"10.1016/j.jval.2023.03.356","title":"EE51 A Cost-Consequence Analysis of Adopting Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma in Saudi Arabia: a Multi-Center Comparison","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Chimeric antigen receptor; Refractory (planetary science); Lymphoma; Medicine; Referral; Oncology; Immunotherapy; Internal medicine; Family medicine; Cancer; Biology","score_opus":0.08135585999482925,"score_gpt":0.36770681570183034,"score_spread":0.2863509557070011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976041,0.0008585071,0.0001937666,0.00012260934,0.000019915235,0.00007560719,0.00053706305,0.0000033303447,0.00058521825],"genre_scores_gemma":[0.9989195,0.00019624029,0.000106442974,0.000083536885,0.000015941028,0.000032727898,0.00044858397,0.0000018289041,0.0001952308],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979711,0.0012727563,0.00013343302,0.00016722913,0.00015923595,0.0002962352],"domain_scores_gemma":[0.9956867,0.0023691785,0.00087555475,0.00021031094,0.00034805312,0.0005101866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003442199,0.00071691355,0.001150955,0.00065391464,0.00031137042,0.0011710058,0.00072640204,0.0010253472,0.0044047004],"category_scores_gemma":[0.0058549987,0.00028022274,0.00387575,0.00090122945,0.00044519125,0.0009392993,0.00082258385,0.0010541119,0.00024197201],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5136086,0.004481369,0.3248053,0.0015487588,0.020133913,0.0006154967,0.0005067143,0.039959926,0.003644399,0.0022980357,0.0021277836,0.086269654],"study_design_scores_gemma":[0.038164932,0.19364288,0.6900181,0.00037889296,0.02731351,0.00091124995,0.0023639542,0.037783995,0.0030224305,0.0013329186,0.0048324657,0.00023458283],"about_ca_topic_score_codex":0.007816141,"about_ca_topic_score_gemma":0.006392048,"teacher_disagreement_score":0.007816141,"about_ca_system_score_codex":0.003363956,"about_ca_system_score_gemma":0.001105235,"threshold_uncertainty_score":0.024407268},"labels":[],"label_agreement":null},{"id":"W4380150563","doi":"10.1016/j.jval.2023.03.2452","title":"CO227 An Updated Umbrella Review Comparing the Safety and Effectiveness of Femtosecond Laser-Assisted Cataract Surgery with Manual Cataract Surgery","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Cataract surgery; Medicine; Surgery; Narrative review; Ophthalmology; Optometry; Intensive care medicine","score_opus":0.07885190400231591,"score_gpt":0.33674010799105175,"score_spread":0.25788820398873585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150563","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043016757,0.9924441,0.00009556271,0.0020997827,0.0023936792,0.00005843988,0.0007988368,0.00001119709,0.0016681707],"genre_scores_gemma":[0.005796637,0.9801983,0.00071616634,0.00818962,0.0027625198,0.00015822469,0.0009190243,0.000018751169,0.0012407018],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99316823,0.0018378018,0.002561144,0.0005246033,0.0016264222,0.00028187045],"domain_scores_gemma":[0.96879154,0.019368444,0.0055427877,0.00049630407,0.0053140447,0.00048698933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006366327,0.0011076281,0.004344574,0.012085932,0.0005178018,0.003017843,0.0013878755,0.0017340702,0.010852405],"category_scores_gemma":[0.035962224,0.0007527791,0.005403596,0.007851724,0.0006577308,0.0025124014,0.0015928282,0.0017337144,0.0014859961],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002553884,0.00007896484,0.001493775,0.4670141,0.014696579,0.0002576433,0.00023982437,0.00016311812,0.0015688046,0.0013366758,0.09595694,0.4146397],"study_design_scores_gemma":[0.001087474,0.0008425445,0.0129436115,0.46366212,0.049930394,0.0008313614,0.00023520914,0.00007887436,0.0007138478,0.0009395584,0.46861073,0.00012426973],"about_ca_topic_score_codex":0.011039164,"about_ca_topic_score_gemma":0.027033817,"teacher_disagreement_score":0.012085932,"about_ca_system_score_codex":0.003657036,"about_ca_system_score_gemma":0.007750221,"threshold_uncertainty_score":0.03630489},"labels":[],"label_agreement":null},{"id":"W4380150585","doi":"10.1016/j.jval.2023.03.209","title":"CO136 Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged 6 and Older with Mild to Moderate Atopic Dermatitis in Two Phase 3 Integument Trials","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Probity Medical Research; Queen's University","funders":"","keywords":"Roflumilast; Atopic dermatitis; Medicine; Dermatology; Internal medicine","score_opus":0.030405791412619995,"score_gpt":0.3500039181887003,"score_spread":0.3195981267760803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833921,0.011565463,0.00030497767,0.0004458277,0.00019588628,0.0011767634,0.0007585513,0.000051036775,0.0021094535],"genre_scores_gemma":[0.9916558,0.003937757,0.00064531923,0.000434303,0.00015325761,0.0009198421,0.00067724695,0.000014660675,0.0015618522],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990288,0.0005355537,0.00007983217,0.00012251893,0.00009780076,0.00013553127],"domain_scores_gemma":[0.9992035,0.0002984968,0.00018591748,0.00005304007,0.000085380445,0.00017358956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018293599,0.0007961357,0.0019798186,0.00029927606,0.00031838755,0.00082313706,0.00049281423,0.0010619102,0.0030651242],"category_scores_gemma":[0.0015806111,0.00040254876,0.0021605357,0.00026250273,0.0005068601,0.0006891201,0.00032976017,0.0017930765,0.0005310959],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8751765,0.00884549,0.0053650946,0.0020717783,0.0030203145,0.00014586403,0.0002731781,0.00042874154,0.014089053,0.00020657471,0.0015926696,0.0887847],"study_design_scores_gemma":[0.71993905,0.23777004,0.032644127,0.00018377324,0.0023623984,0.0002762889,0.00014371457,0.0004807328,0.0026154602,0.00015457028,0.0033767065,0.000053192198],"about_ca_topic_score_codex":0.0011118673,"about_ca_topic_score_gemma":0.0032779921,"teacher_disagreement_score":0.0030651242,"about_ca_system_score_codex":0.0006495728,"about_ca_system_score_gemma":0.00077072904,"threshold_uncertainty_score":0.010253906},"labels":[],"label_agreement":null},{"id":"W4380150610","doi":"10.1016/j.jval.2023.03.106","title":"CO32 Heterotopic Ossification in Palovarotene-Treated and Untreated Individuals with Fibrodysplasia Ossificans Progressiva: Matched and Weighted Analyses","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Heterotopic ossification; Medicine; Ossification; Heterotopic bone; Myositis ossificans; Surgery","score_opus":0.06962022869461355,"score_gpt":0.35814500665615673,"score_spread":0.2885247779615432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99937445,0.00015185193,0.00013766254,0.0000036184463,0.0000039751126,0.0000075768708,0.00012152997,0.0000016447333,0.00019780592],"genre_scores_gemma":[0.99941206,0.000035606656,0.000070261034,0.000005467091,0.0000043863215,0.00000934737,0.00014684464,0.0000023318826,0.00031372422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989316,0.00034638363,0.00011195997,0.00032228898,0.00013506302,0.00015273165],"domain_scores_gemma":[0.99899644,0.0002809436,0.00037156456,0.00017422106,0.000090059104,0.00008683014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008769922,0.00037478938,0.00050254195,0.0010505375,0.0003602547,0.00053716986,0.000547329,0.0005446697,0.0018755622],"category_scores_gemma":[0.0021227722,0.0003222257,0.00083865115,0.000789052,0.00034996553,0.00038629185,0.0005999543,0.00036679232,0.00018387643],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019854942,0.00031769602,0.96525407,0.000057604586,0.0015556035,0.00029166104,0.00026524175,0.00017001556,0.005177308,0.00015727138,0.00012567738,0.006772911],"study_design_scores_gemma":[0.0001696041,0.0015004589,0.9955396,0.0000067052342,0.0005460495,0.0003545576,0.0003565701,0.0005028845,0.00053786766,0.00009500627,0.00037701914,0.000013681625],"about_ca_topic_score_codex":0.0041095917,"about_ca_topic_score_gemma":0.004164727,"teacher_disagreement_score":0.0041095917,"about_ca_system_score_codex":0.00029586966,"about_ca_system_score_gemma":0.00016401395,"threshold_uncertainty_score":0.00817132},"labels":[],"label_agreement":null},{"id":"W4380150642","doi":"10.1016/j.jval.2023.03.2490","title":"EE511 Modeling Approaches in the Cost-Effectiveness Analysis of Cancer Treatments: A Review of Submissions Made to the Canadian Agency for Drugs and Technologies in Health","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Cancer drugs; Health technology; Medicine; Cancer; Risk analysis (engineering); Medical physics; Health care; Internal medicine; Political science; Sociology","score_opus":0.7904782343008674,"score_gpt":0.5436824659390989,"score_spread":0.24679576836176853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004033052,0.99660647,0.0006610107,0.0011459371,0.00023325192,0.000035759054,0.00019515507,0.000007566298,0.0010745076],"genre_scores_gemma":[0.00072543387,0.9964964,0.0015662679,0.0005176708,0.00013766225,0.000038214886,0.00011831326,0.000008509282,0.00039162394],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99522346,0.0017710592,0.00065812405,0.00024190858,0.001956583,0.00014893524],"domain_scores_gemma":[0.97833997,0.014282326,0.0014214133,0.0003635805,0.005301573,0.00029114416],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014066272,0.001555134,0.0031051033,0.008160454,0.00042860027,0.0025871645,0.0022147696,0.0022505631,0.005760083],"category_scores_gemma":[0.025918981,0.00075130136,0.0027607766,0.01350074,0.0007220037,0.0015871034,0.0011430281,0.0025833962,0.0017506785],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014211085,0.0000760671,0.00026119692,0.08351066,0.0013366914,0.00007658588,0.000072517454,0.0025075183,0.00027965556,0.01517634,0.11765758,0.7789031],"study_design_scores_gemma":[0.00011731114,0.00007886337,0.0020657917,0.11892154,0.0025987774,0.00020316904,0.0000489291,0.0010138095,0.0002743699,0.006102874,0.8685022,0.000072369854],"about_ca_topic_score_codex":0.074655734,"about_ca_topic_score_gemma":0.13971637,"teacher_disagreement_score":0.99109334,"about_ca_system_score_codex":0.0089066345,"about_ca_system_score_gemma":0.020264354,"threshold_uncertainty_score":0.14844239},"labels":[],"label_agreement":null},{"id":"W4380150697","doi":"10.1016/j.jval.2023.03.347","title":"EE41 Cost-Utility of Nivolumab Versus Observation for the Adjuvant Treatment of Urothelial Carcinoma (UC) for Patients Who Are at High-Risk of Recurrence: A Canada Public Payer Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada); McGill University Health Centre","funders":"","keywords":"Nivolumab; Medicine; Urothelial carcinoma; Adjuvant; Perspective (graphical); Oncology; Internal medicine; Cancer; Immunotherapy; Bladder cancer; Computer science","score_opus":0.46517240906319957,"score_gpt":0.4034397641697604,"score_spread":0.06173264489343916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51331735,0.1125059,0.007051856,0.15017723,0.002059421,0.0009178195,0.041509584,0.00023090796,0.17222999],"genre_scores_gemma":[0.9719635,0.010126372,0.0021015601,0.004189128,0.0005328783,0.00007129193,0.003801879,0.00004465898,0.007168753],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99670094,0.0014933036,0.00013538488,0.00013652781,0.00091353746,0.00062032475],"domain_scores_gemma":[0.99453247,0.002340414,0.00046506466,0.00013129292,0.0016915555,0.0008391595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034781992,0.00061856984,0.0010415943,0.0013193287,0.00055040675,0.0040427037,0.0010084641,0.0016037083,0.005593958],"category_scores_gemma":[0.017766047,0.00033448293,0.0018833086,0.0019653216,0.0008168599,0.0007571649,0.00078258885,0.0025334589,0.00024513423],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030158222,0.0013715549,0.12747283,0.0032287242,0.0115096215,0.0010623925,0.0004749383,0.17072855,0.0022139074,0.09654462,0.14223234,0.4130023],"study_design_scores_gemma":[0.008200019,0.004201105,0.45163664,0.0066190492,0.01703776,0.001452255,0.0023779303,0.2556137,0.002773326,0.06305508,0.1863843,0.0006488441],"about_ca_topic_score_codex":0.68967384,"about_ca_topic_score_gemma":0.759582,"teacher_disagreement_score":0.31032616,"about_ca_system_score_codex":0.03345109,"about_ca_system_score_gemma":0.03416331,"threshold_uncertainty_score":0.62430745},"labels":[],"label_agreement":null},{"id":"W4380150699","doi":"10.1016/j.jval.2023.03.374","title":"EE69 Extended Cost-Effectiveness Analysis of Varenicline for Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease in Thailand","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Varenicline; Medicine; COPD; Pulmonary disease; Smoking cessation; Disease; Internal medicine; Physical therapy; Intensive care medicine; Environmental health; Pathology","score_opus":0.04764366028635881,"score_gpt":0.33184384341611556,"score_spread":0.28420018312975676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823615,0.009728402,0.0017119505,0.00046960125,0.000051892053,0.000414343,0.0022141642,0.000022967699,0.003025163],"genre_scores_gemma":[0.99734664,0.0010988628,0.00036808345,0.000058782585,0.000023728373,0.00007521247,0.0006721039,0.0000027978074,0.0003536588],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9973572,0.0018552076,0.00016278696,0.00012331606,0.00020078075,0.00030067636],"domain_scores_gemma":[0.9961624,0.0026142434,0.00051622564,0.00010338966,0.0002456686,0.00035805572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003858749,0.00061368884,0.0015699974,0.0010052617,0.00024378122,0.0014918597,0.00052938535,0.0005911886,0.0040628994],"category_scores_gemma":[0.006109364,0.00039279577,0.0054726186,0.0012280471,0.00028218632,0.0007920804,0.0007090826,0.0011815227,0.00013628328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26468813,0.005090174,0.17768458,0.009105431,0.04445001,0.0021776808,0.00033731895,0.29557785,0.0026461107,0.0030700427,0.0021421441,0.19303054],"study_design_scores_gemma":[0.032265224,0.09899465,0.43097597,0.003130803,0.08312089,0.0021624297,0.0016064894,0.3324655,0.002899308,0.003407868,0.008622647,0.0003481949],"about_ca_topic_score_codex":0.017795695,"about_ca_topic_score_gemma":0.012579351,"teacher_disagreement_score":0.017795695,"about_ca_system_score_codex":0.0034236345,"about_ca_system_score_gemma":0.0025668202,"threshold_uncertainty_score":0.03538418},"labels":[],"label_agreement":null},{"id":"W4380150724","doi":"10.1016/j.jval.2023.03.166","title":"CO93 A Qualitative Investigation of the Impact of the Sars-Cov-2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Resilience and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Goal Attainment Scaling; Medicine; Virology; Disease; Physical therapy; Internal medicine; Infectious disease (medical specialty)","score_opus":0.48801306908659803,"score_gpt":0.6483330795490284,"score_spread":0.16032001046243038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9413259,0.0010327438,0.008698839,0.017925115,0.00038947922,0.0010998995,0.00038437065,0.000049024507,0.029094579],"genre_scores_gemma":[0.98941606,0.0003922594,0.0023871362,0.0024621817,0.000028539369,0.00088149856,0.000052964362,0.000037839218,0.004341562],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9592051,0.035960358,0.00058415195,0.0008676482,0.0011553229,0.0022273732],"domain_scores_gemma":[0.89992434,0.08576734,0.0029781396,0.0017809707,0.005238829,0.0043102433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0372857,0.00044337794,0.0005748533,0.0015118712,0.011485189,0.0060062166,0.0018059029,0.0023500882,0.0067940233],"category_scores_gemma":[0.06533522,0.00066602597,0.0005082117,0.0014740911,0.011049654,0.0046552736,0.0071503576,0.005327036,0.00055724714],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007338064,0.00014569354,0.0036143663,0.0003527464,0.000010102484,0.00043622966,0.9807053,0.00008232432,0.00037948322,0.004575761,0.0018297739,0.0077949124],"study_design_scores_gemma":[0.000015496267,0.00007735833,0.0013933347,0.00035115963,0.000006437788,0.00010098313,0.9866411,0.00011706666,0.00027871729,0.0010303806,0.009968728,0.000019270525],"about_ca_topic_score_codex":0.012583622,"about_ca_topic_score_gemma":0.028750898,"teacher_disagreement_score":0.0372857,"about_ca_system_score_codex":0.009652915,"about_ca_system_score_gemma":0.015871178,"threshold_uncertainty_score":0.19718796},"labels":[],"label_agreement":null},{"id":"W4380150835","doi":"10.1016/j.jval.2023.03.2238","title":"SA22 The Complexity Of Finding Fit-For-Purpose Real-World Data on Oncology Patients with Rare NTRK Gene Fusions and a Novel Solution","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Thermo Fisher Scientific (Canada)","funders":"","keywords":"Real world data; Fusion gene; Gene; Solid tumor; Oncology; Internal medicine; Clinical trial; Bioinformatics; Medicine; Cancer research; Computational biology; Biology; Computer science; Data science; Genetics; Cancer","score_opus":0.18076789470356933,"score_gpt":0.36776784074736274,"score_spread":0.1869999460437934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150835","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20955399,0.010461591,0.6466441,0.098323196,0.00103002,0.00083899265,0.020801451,0.0051006586,0.007246035],"genre_scores_gemma":[0.6494964,0.0018933072,0.32995707,0.004508294,0.00094661565,0.00035701282,0.010616339,0.00054124923,0.0016838177],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98489016,0.0077167023,0.0015848229,0.0035908213,0.0017051919,0.0005122913],"domain_scores_gemma":[0.91510856,0.06584329,0.0035767672,0.008199678,0.0051873573,0.0020844245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014941632,0.001751185,0.0037798209,0.0034314233,0.0012785583,0.008486459,0.003641043,0.004323563,0.004521904],"category_scores_gemma":[0.08669755,0.0013886217,0.0023886303,0.0043802485,0.002103683,0.007738236,0.0038879688,0.005321892,0.0019747645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022090892,0.0011252448,0.2559537,0.002797023,0.0025167936,0.0034751894,0.0019034424,0.11389591,0.012092525,0.03243052,0.063123375,0.50847715],"study_design_scores_gemma":[0.0003845545,0.0005542641,0.030483568,0.000636049,0.0004068823,0.004663997,0.0044228598,0.5844343,0.004540198,0.33815143,0.03106221,0.00025972832],"about_ca_topic_score_codex":0.00553459,"about_ca_topic_score_gemma":0.007882294,"teacher_disagreement_score":0.014941632,"about_ca_system_score_codex":0.0015503427,"about_ca_system_score_gemma":0.0035075396,"threshold_uncertainty_score":0.079019845},"labels":[],"label_agreement":null},{"id":"W4380150846","doi":"10.1016/j.jval.2023.03.646","title":"EE345 Strengths and Limitations of Different Costing Approaches Used for Hospital Budget Impact Models: Application to Imaging Guidance in Left Atrial Appendage Occlusion Procedures","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Activity-based costing; Strengths and weaknesses; Reimbursement; Left atrial appendage occlusion; Occlusion; Medicine; Medical physics; Computer science; Operations management; Business; Surgery; Atrial fibrillation; Engineering; Economics; Psychology; Accounting; Cardiology","score_opus":0.3384203410352223,"score_gpt":0.4207580905936663,"score_spread":0.08233774955844403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150846","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2785898,0.007945479,0.6245627,0.01011231,0.00077203655,0.0017766792,0.0139692575,0.000787443,0.06148442],"genre_scores_gemma":[0.8180882,0.002381017,0.16632284,0.001480491,0.00023860783,0.0008876446,0.002753348,0.0004105314,0.007437334],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.98610944,0.011014754,0.00084563333,0.0005538912,0.0011442569,0.00033203233],"domain_scores_gemma":[0.9677099,0.02650588,0.0011290225,0.0014667233,0.0029415386,0.0002469093],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022310209,0.0010961143,0.0015063508,0.0018561224,0.0007106074,0.0054027117,0.0029217727,0.0020258422,0.0069804643],"category_scores_gemma":[0.07441958,0.00072064815,0.0026298335,0.004613477,0.0004132956,0.002744248,0.0019692848,0.003037301,0.00062501],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084894267,0.0005061713,0.03030865,0.0011557098,0.0032272022,0.0003649064,0.000507025,0.6701101,0.0005008996,0.09365397,0.010053318,0.1887631],"study_design_scores_gemma":[0.00018367011,0.0002616498,0.013282376,0.0009050506,0.0009096103,0.00017626378,0.00056638377,0.9282668,0.00076358765,0.03620776,0.018340774,0.00013613688],"about_ca_topic_score_codex":0.042508353,"about_ca_topic_score_gemma":0.03178714,"teacher_disagreement_score":0.9776898,"about_ca_system_score_codex":0.002976934,"about_ca_system_score_gemma":0.0034701447,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4380150848","doi":"10.1016/j.jval.2023.03.178","title":"CO105 The Association of Sars-Cov-2 Infection and Tuberculosis Disease with Unfavorable Treatment Outcomes: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Coinfection; Medicine; Tuberculosis; Disease; Disease management; Intensive care medicine; MEDLINE; Internal medicine; Human immunodeficiency virus (HIV); Immunology; Pathology","score_opus":0.18618067222810938,"score_gpt":0.44812224148817265,"score_spread":0.2619415692600633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001342427,0.99754107,0.000095323645,0.00014187681,0.00011677849,0.00009940119,0.00048312807,0.0000068983627,0.00017307414],"genre_scores_gemma":[0.030513113,0.96769094,0.00044753545,0.00061147514,0.00013975098,0.00016749626,0.0002765347,0.0000069493362,0.00014623695],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964539,0.0010691362,0.0013338348,0.00039838706,0.0005798823,0.0001648614],"domain_scores_gemma":[0.9865682,0.009328843,0.0028024549,0.00019833301,0.0009043653,0.00019770097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004183529,0.001267,0.008364227,0.004874365,0.0003812243,0.0024792843,0.0014225799,0.0020645228,0.0061573116],"category_scores_gemma":[0.021300513,0.0010848608,0.010350641,0.0069419183,0.00061934436,0.0016725592,0.0013954798,0.0016074321,0.0004843631],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006545199,0.000025232786,0.0046651512,0.8750205,0.09071499,0.00011676516,0.00011392463,0.00013080731,0.00016317143,0.00018702149,0.002118918,0.026089005],"study_design_scores_gemma":[0.0012566418,0.00027229553,0.01635105,0.35825124,0.6087597,0.0003013804,0.00023702421,0.00017748169,0.0001454319,0.00041032824,0.013752629,0.000084745654],"about_ca_topic_score_codex":0.0104311425,"about_ca_topic_score_gemma":0.028635202,"teacher_disagreement_score":0.0104311425,"about_ca_system_score_codex":0.0017231551,"about_ca_system_score_gemma":0.005443107,"threshold_uncertainty_score":0.022124887},"labels":[],"label_agreement":null},{"id":"W4380150957","doi":"10.1016/j.jval.2023.03.472","title":"EE171 Time to Diagnosis and Cost Effectiveness of Whole Exome Sequencing (WES) Position in the Diagnostic Pathways of Patients with Suspected Rare Genetic Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Calgary; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Exome sequencing; Diagnostic test; Genetic diagnosis; Medicine; Genetic testing; Exome; Rare disease; Disease; Diagnostic accuracy; DNA sequencing; Bioinformatics; Pediatrics; Pathology; Genetics; Mutation; Biology; Internal medicine; Gene","score_opus":0.014862761692949356,"score_gpt":0.24222299703425193,"score_spread":0.22736023534130256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651398,0.009848142,0.0044603776,0.006383812,0.0003662574,0.00006627142,0.0044299043,0.0001321258,0.009173303],"genre_scores_gemma":[0.9930996,0.0011960259,0.0021463677,0.00053204125,0.00012908029,0.000027380907,0.0015243281,0.00004219014,0.0013030655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982122,0.00072308106,0.00015751236,0.00031656201,0.00038091157,0.00020965257],"domain_scores_gemma":[0.9935974,0.004539754,0.00055234885,0.00018640861,0.000648239,0.00047582312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022847871,0.00053768855,0.00060934125,0.0009435032,0.00025961353,0.0015098699,0.0005767277,0.0008577372,0.007862433],"category_scores_gemma":[0.016600415,0.00023232859,0.0012761859,0.00069104804,0.00019861969,0.001127145,0.0007153964,0.00097597146,0.0009167359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014143819,0.00072705623,0.6051865,0.00043968164,0.0014120765,0.0034816146,0.00033027676,0.025622163,0.003539686,0.0031501872,0.01252715,0.32943976],"study_design_scores_gemma":[0.00071670813,0.0031918494,0.86215794,0.00092938886,0.0029900298,0.009355083,0.0015881459,0.083929025,0.007119473,0.009189669,0.018685358,0.00014735475],"about_ca_topic_score_codex":0.010333096,"about_ca_topic_score_gemma":0.009385308,"teacher_disagreement_score":0.010333096,"about_ca_system_score_codex":0.0018163465,"about_ca_system_score_gemma":0.0013662772,"threshold_uncertainty_score":0.026302397},"labels":[],"label_agreement":null},{"id":"W4380150987","doi":"10.1016/j.jval.2023.03.1581","title":"MSR45 Identifying Longitudinal Treatment Effect Trajectories Using Flexible Outcome Modeling and Clustering","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Outcome (game theory); Cluster analysis; Interpretation (philosophy); Computer science; Longitudinal data; Treatment effect; Longitudinal study; Statistical power; Econometrics; Data mining; Artificial intelligence; Statistics; Medicine; Mathematics","score_opus":0.5678470637420231,"score_gpt":0.5187338618576554,"score_spread":0.04911320188436774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150987","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03834882,0.0004967313,0.95599264,0.0008066483,0.000066144865,0.0001538928,0.001804197,0.0010373623,0.0012935742],"genre_scores_gemma":[0.6149059,0.00053633674,0.37068188,0.0003397013,0.00014028135,0.000657057,0.0056057423,0.00045558764,0.0066774106],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99354964,0.0039858753,0.00027517098,0.0012589166,0.00058173144,0.00034862052],"domain_scores_gemma":[0.96394956,0.027361862,0.0018551581,0.005129373,0.0012519835,0.00045213473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01263936,0.00086197717,0.0019553031,0.0024190259,0.0011012041,0.0019100831,0.0030023984,0.001742223,0.007166696],"category_scores_gemma":[0.06265412,0.0010130212,0.0035839295,0.0026981952,0.0008333514,0.0016238883,0.0021850711,0.0031830175,0.0011220387],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008332064,0.00038784833,0.03347418,0.00042797736,0.0014511878,0.0003059233,0.0006641561,0.47274464,0.001154422,0.23671435,0.013472002,0.23837009],"study_design_scores_gemma":[0.000062047184,0.00006092547,0.0027423298,0.000059192957,0.00011479583,0.00005114845,0.000043658813,0.8562913,0.0004181211,0.13781017,0.0023165734,0.000029804596],"about_ca_topic_score_codex":0.018412,"about_ca_topic_score_gemma":0.016113576,"teacher_disagreement_score":0.018412,"about_ca_system_score_codex":0.0012384387,"about_ca_system_score_gemma":0.0031112307,"threshold_uncertainty_score":0.066844106},"labels":[],"label_agreement":null},{"id":"W4380151004","doi":"10.1016/j.jval.2023.03.1434","title":"HTA5 Variation in Health Technology Assessments for Nivolumab Plus Chemotherapy Vs Chemotherapy in First-Line Gastric Cancer","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Chemotherapy; Cancer; Oncology; First line; Internal medicine; Political science; Health care","score_opus":0.33470217407681796,"score_gpt":0.46869174006400766,"score_spread":0.1339895659871897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98395175,0.0040468536,0.001250415,0.0013839334,0.00013230291,0.000030201127,0.0074338997,0.00003428152,0.0017363123],"genre_scores_gemma":[0.9973959,0.0001173367,0.00014655244,0.00012529176,0.00002443398,0.000011170286,0.001974904,0.00000674066,0.00019765751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907381,0.0057065305,0.0008315394,0.0011365899,0.0008896328,0.0006974991],"domain_scores_gemma":[0.9492565,0.035800952,0.009744326,0.0022071407,0.0018461948,0.0011448901],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009551294,0.00023862564,0.00077037286,0.0007927291,0.00023618265,0.0016560205,0.00072942616,0.0009432628,0.0028912826],"category_scores_gemma":[0.059138868,0.00022707388,0.0025869985,0.0017280154,0.00038106114,0.0010522607,0.00085335376,0.0019191935,0.00031915004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0055900184,0.000143943,0.9536228,0.00018215635,0.005086286,0.00013956119,0.00020040752,0.011679261,0.00029658337,0.0019293152,0.0023669817,0.0187627],"study_design_scores_gemma":[0.0001242492,0.00066002156,0.9779106,0.00011234403,0.0011012951,0.00014750735,0.00019343857,0.016042463,0.000295471,0.001814419,0.0015600518,0.000038282007],"about_ca_topic_score_codex":0.012557869,"about_ca_topic_score_gemma":0.008888351,"teacher_disagreement_score":0.9904487,"about_ca_system_score_codex":0.0018710179,"about_ca_system_score_gemma":0.0006845519,"threshold_uncertainty_score":0.05051273},"labels":[],"label_agreement":null},{"id":"W4380151031","doi":"10.1016/j.jval.2023.03.761","title":"EE460 A Budget Impact Model to Evaluate the Economic Impact of Treating Walking Impairment in Chronic Stroke, A US Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Perspective (graphical); Chronic stroke; Rehabilitation; Stroke (engine); Physical medicine and rehabilitation; Economic impact analysis; Medicine; Physical therapy; Economics; Economic growth; Computer science; Engineering; Health care","score_opus":0.29192499509371406,"score_gpt":0.476929972208334,"score_spread":0.18500497711461994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151031","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26982516,0.008524211,0.44760785,0.025442941,0.0011881347,0.001101824,0.020056363,0.00073467474,0.22551881],"genre_scores_gemma":[0.9044103,0.00295529,0.030441727,0.001466183,0.00027818794,0.0008312868,0.0039850767,0.00013489944,0.05549705],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979826,0.0014097478,0.000049143477,0.00012108627,0.00016010039,0.00027723372],"domain_scores_gemma":[0.9970029,0.0022777154,0.00014733156,0.00006291268,0.00030212375,0.00020700559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051253606,0.0013930936,0.0017825756,0.0019537897,0.00052656716,0.0030776088,0.0014006237,0.0033352724,0.013151499],"category_scores_gemma":[0.01271384,0.0010480604,0.0015536227,0.0026301837,0.0008223401,0.0023449499,0.001031854,0.0028677424,0.00076984585],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023464276,0.00010656139,0.0009216686,0.00009110386,0.00011453681,0.000083519044,0.00002790088,0.9312854,0.00009575898,0.053111058,0.0055712215,0.008356697],"study_design_scores_gemma":[0.00021962303,0.00016592648,0.0011284146,0.00011633198,0.0001286233,0.00006607771,0.000060457947,0.9580825,0.00009594465,0.033139147,0.0067684706,0.000028446404],"about_ca_topic_score_codex":0.046168994,"about_ca_topic_score_gemma":0.019699167,"teacher_disagreement_score":0.046168994,"about_ca_system_score_codex":0.00469903,"about_ca_system_score_gemma":0.0044716117,"threshold_uncertainty_score":0.09180051},"labels":[],"label_agreement":null},{"id":"W4380151052","doi":"10.1016/j.jval.2023.03.145","title":"CO71 The Impact of Socioeconomic Status (SES), Insurance Type, and Treatment Facility on Survival in Metastatic Prostate Cancer (MPC): A Systematic Literature Review (SLR) of Social Determinants of Health (SDOH)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Melanoma; Nevus; Medicine; Blue nevus; Dermatology; Malignancy; Pathology; Cancer research","score_opus":0.05854703843497897,"score_gpt":0.37991226960415453,"score_spread":0.32136523116917554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151052","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015397999,0.97905904,0.00017928428,0.0005011617,0.0001189375,0.00022678555,0.003884418,0.000008835629,0.00062355114],"genre_scores_gemma":[0.2757377,0.7180536,0.0013031975,0.0013340454,0.00017421787,0.00080029364,0.0020791055,0.000012984975,0.0005047988],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99326175,0.002107335,0.0026299744,0.0007133007,0.00092526595,0.00036243993],"domain_scores_gemma":[0.97829354,0.015106388,0.0046268194,0.00045068105,0.001270508,0.00025200399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006400142,0.0008209649,0.0034731736,0.009162711,0.0005635682,0.0021055408,0.0008527767,0.0014829088,0.003856598],"category_scores_gemma":[0.034280486,0.0007909973,0.013657947,0.010165967,0.00072068145,0.0014943349,0.0018680353,0.00086279685,0.00034180935],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008850888,0.00006904095,0.08816322,0.70622844,0.1345798,0.0002233972,0.0005660556,0.0002851387,0.0002604334,0.00042830931,0.0025053911,0.06580571],"study_design_scores_gemma":[0.00062482443,0.00045155507,0.14872634,0.42113802,0.40965682,0.00049809983,0.00083532964,0.00024548144,0.00032244576,0.00052984,0.01684719,0.00012402487],"about_ca_topic_score_codex":0.033667002,"about_ca_topic_score_gemma":0.08831866,"teacher_disagreement_score":0.033667002,"about_ca_system_score_codex":0.0019081325,"about_ca_system_score_gemma":0.007084813,"threshold_uncertainty_score":0.066942096},"labels":[],"label_agreement":null},{"id":"W4380151155","doi":"10.1016/j.jval.2023.03.727","title":"EE426 A Comparison of the Cost-Saving Impact of Biosimilar Switching Policies across Canadian Provinces: A Case-Study for a Ranibizumab Biosimilar","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Ranibizumab; Business; Plan (archaeology); Medicine; Public economics; Economics; Internal medicine; Geography","score_opus":0.5020097557805653,"score_gpt":0.5113061537833411,"score_spread":0.009296398002775819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675868,0.0025086016,0.00095771346,0.0021034863,0.000042805972,0.0002779214,0.0048424196,0.00004472554,0.02163552],"genre_scores_gemma":[0.99350727,0.0005994621,0.00077969,0.00018180846,0.000007264491,0.000035260302,0.001312369,0.000011532893,0.0035653412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657744,0.000849401,0.00009869075,0.0001841266,0.0008994224,0.0013908086],"domain_scores_gemma":[0.9940189,0.0024612183,0.00040786393,0.00023428704,0.0024258748,0.00045182797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003318945,0.00047358093,0.00072340766,0.0015241056,0.0016224387,0.0023312964,0.0011615565,0.0010066801,0.004627543],"category_scores_gemma":[0.011147745,0.00026540257,0.0015269339,0.003059877,0.00071270874,0.00065817154,0.00070072646,0.0013629632,0.00018275376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028477447,0.0041219527,0.37910938,0.0026469906,0.0053631044,0.002802151,0.0021877154,0.2577708,0.0070781303,0.050924692,0.041421413,0.21809608],"study_design_scores_gemma":[0.0030668047,0.002797874,0.8025648,0.00041139833,0.003511784,0.0005362791,0.01035887,0.1206435,0.004889475,0.0034291546,0.0474598,0.00033019856],"about_ca_topic_score_codex":0.9874018,"about_ca_topic_score_gemma":0.98316956,"teacher_disagreement_score":0.94324845,"about_ca_system_score_codex":0.056751534,"about_ca_system_score_gemma":0.06339105,"threshold_uncertainty_score":0.41176313},"labels":[],"label_agreement":null},{"id":"W4380151340","doi":"10.1016/j.jval.2023.03.1155","title":"HPR8 Accelerating Access to Promising New Pediatric Medicines in Canada: Comparing International Approaches to Regulation and Reimbursement","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Reimbursement; Relevance (law); Public economics; Access to medicines; Business; Risk analysis (engineering); Medicine; Economic growth; Health care; Political science; Economics; Public health; Nursing","score_opus":0.5678122409767149,"score_gpt":0.4430175279265617,"score_spread":0.12479471305015322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44295558,0.01703324,0.0034991126,0.20778862,0.0006494906,0.00043384128,0.0039284066,0.00025147808,0.32346022],"genre_scores_gemma":[0.9547487,0.0059830425,0.0038759357,0.01761996,0.00022246908,0.00009747674,0.0010861759,0.00011024314,0.016255958],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9808733,0.0024208685,0.00045753928,0.0007511465,0.0098089045,0.0056882114],"domain_scores_gemma":[0.9436961,0.01775881,0.004509377,0.0013208458,0.022235846,0.010478972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013493439,0.00028025798,0.00042606852,0.0025309331,0.0032363725,0.008018765,0.0017146033,0.002149517,0.0077061076],"category_scores_gemma":[0.040943462,0.0002975128,0.0010586446,0.0036300595,0.0041151396,0.0020037815,0.0027304774,0.0040335045,0.00026863135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024045045,0.0005932294,0.24765398,0.0013282077,0.00047422902,0.0007653164,0.008099523,0.004621294,0.0023021577,0.30173975,0.10337333,0.32664454],"study_design_scores_gemma":[0.00050586916,0.00078998576,0.6033168,0.0019927325,0.0006277229,0.0005331316,0.012850041,0.0040090526,0.004349717,0.010505711,0.36024845,0.0002707214],"about_ca_topic_score_codex":0.96174884,"about_ca_topic_score_gemma":0.9764459,"teacher_disagreement_score":0.9015478,"about_ca_system_score_codex":0.09845218,"about_ca_system_score_gemma":0.23909819,"threshold_uncertainty_score":0.7143239},"labels":[],"label_agreement":null},{"id":"W4380151393","doi":"10.1016/j.jval.2023.03.119","title":"CO45 Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults with Chronic Plaque Psoriasis from a 52-Week, Phase 2 Open-Label Safety Trial","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; University of British Columbia; Queen's University","funders":"","keywords":"Roflumilast; Open label; Medicine; Psoriasis; Dermatology Life Quality Index; Plaque psoriasis; Safety profile; Adverse effect; Psoriasis Area and Severity Index; Body surface area; Dermatology; Internal medicine","score_opus":0.136141081805109,"score_gpt":0.428183312101855,"score_spread":0.29204223029674603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133194,0.008642014,0.00070752914,0.0007915446,0.00026174838,0.001775182,0.0021394729,0.000111679394,0.0042389547],"genre_scores_gemma":[0.991381,0.0020080393,0.00069650746,0.00082530687,0.00034973866,0.0008013083,0.0015766504,0.000023252656,0.0023382325],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989417,0.000460052,0.00010307733,0.00017287344,0.00015400408,0.00016826276],"domain_scores_gemma":[0.9986539,0.0004271855,0.00032656555,0.00013433919,0.00014678964,0.000311176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002306638,0.00071918,0.0016282063,0.00030010348,0.0003806538,0.000897021,0.0003869016,0.0012450537,0.0050254134],"category_scores_gemma":[0.00208063,0.0003418185,0.0014057765,0.00024710066,0.0006075783,0.0008890018,0.0003060131,0.0021424335,0.0013967755],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8285782,0.010801291,0.004667326,0.0010815659,0.00206477,0.00012810205,0.0001697682,0.00048906694,0.02493837,0.00017787295,0.0031969948,0.12370662],"study_design_scores_gemma":[0.6291907,0.323165,0.033891454,0.00011666676,0.0018232034,0.00027600635,0.00007498778,0.0007560716,0.005482706,0.0002207021,0.0049428823,0.000059532736],"about_ca_topic_score_codex":0.00048729707,"about_ca_topic_score_gemma":0.0009780593,"teacher_disagreement_score":0.0050254134,"about_ca_system_score_codex":0.00044091046,"about_ca_system_score_gemma":0.00061849173,"threshold_uncertainty_score":0.016811669},"labels":[],"label_agreement":null},{"id":"W4380151448","doi":"10.1016/j.jval.2023.03.1648","title":"MT1 Challenges and Opportunities with Quantifying Comprehensive Health Economics of Diagnostic Imaging Modalities Using Radiopharmaceuticals: A Case Study in Coronary Artery Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Coronary artery disease; Modalities; Positron emission tomography; Myocardial perfusion imaging; Medicine; Medical physics; Single-photon emission computed tomography; Emission computed tomography; CAD; Radiology; Internal medicine; Engineering","score_opus":0.3610492235762827,"score_gpt":0.4122719971330515,"score_spread":0.0512227735567688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7509543,0.006937498,0.14493649,0.05360193,0.00016386164,0.000313177,0.0014195204,0.00012098715,0.041552313],"genre_scores_gemma":[0.96523404,0.0011473614,0.032199524,0.00039317686,0.00011133107,0.00004245492,0.00009870641,0.00004404033,0.00072927837],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99431914,0.003993667,0.00034196477,0.00039359543,0.00070717913,0.00024449435],"domain_scores_gemma":[0.9213017,0.06515194,0.0060155443,0.0021505738,0.004483993,0.0008960984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01589039,0.000660102,0.00072302483,0.0027991002,0.0010516784,0.005288305,0.0014827056,0.0020116149,0.0033772832],"category_scores_gemma":[0.061378475,0.00036905147,0.0009133261,0.0026047397,0.002394978,0.004615921,0.0022296093,0.0022686978,0.00022397046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052691845,0.00051516807,0.5084882,0.0011147993,0.00062333146,0.005647856,0.0043226248,0.03916454,0.0023518137,0.19853577,0.005311965,0.23339714],"study_design_scores_gemma":[0.00006765703,0.0007090006,0.21812522,0.0022671756,0.0005802632,0.014592004,0.015972178,0.22281215,0.0050574914,0.48153415,0.037982594,0.00030021978],"about_ca_topic_score_codex":0.01354746,"about_ca_topic_score_gemma":0.016046071,"teacher_disagreement_score":0.01589039,"about_ca_system_score_codex":0.0038590024,"about_ca_system_score_gemma":0.0036294044,"threshold_uncertainty_score":0.08403742},"labels":[],"label_agreement":null},{"id":"W4380151573","doi":"10.1016/j.jval.2023.03.1559","title":"MSR23 Improving the Interpretability of Ordinal Endpoints in NMAs","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Interpretability; Ordinal data; Odds; Medicine; Ordinal regression; Statistics; Mathematics; Computer science; Machine learning; Logistic regression","score_opus":0.44049555592682,"score_gpt":0.4383808703812958,"score_spread":0.0021146855455241864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151573","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06821385,0.004747893,0.8701074,0.009570267,0.0016816192,0.0007241002,0.012111752,0.0060923533,0.026750822],"genre_scores_gemma":[0.5239166,0.0012119424,0.45274517,0.0019473908,0.0015943344,0.0010549048,0.008759253,0.0022552437,0.006515224],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.894819,0.08512912,0.0070002596,0.0041253804,0.008026959,0.0008992558],"domain_scores_gemma":[0.7218549,0.20833147,0.012640658,0.03216641,0.023927197,0.0010793181],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07138407,0.0016593585,0.0025852555,0.004455893,0.00074530806,0.0072212685,0.0021401534,0.001996459,0.021352407],"category_scores_gemma":[0.37618753,0.0007381186,0.0036224786,0.0034546396,0.0012141567,0.0043636765,0.0042912164,0.004460395,0.0056436104],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042985273,0.0003526135,0.03096742,0.0022170402,0.001699009,0.0003987743,0.0011256107,0.048154008,0.00307422,0.09899865,0.059625037,0.7490891],"study_design_scores_gemma":[0.0010009905,0.0010955174,0.021542428,0.0021359883,0.0008871469,0.0007956715,0.00047984693,0.5047634,0.008396183,0.35850254,0.100066274,0.00033402885],"about_ca_topic_score_codex":0.0035879896,"about_ca_topic_score_gemma":0.0029403388,"teacher_disagreement_score":0.9286159,"about_ca_system_score_codex":0.0014172966,"about_ca_system_score_gemma":0.002194618,"threshold_uncertainty_score":0.37751955},"labels":[],"label_agreement":null},{"id":"W4380151862","doi":"10.1016/j.jval.2023.03.1263","title":"HPR116 US List Prices for Maine’S High-Cost Highly Prescribed Drugs Were over 7-Fold Higher Than the Lowest Canadian Prices","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transparency (behavior); Legislation; Medical prescription; Drug prices; Business; Economics; Public economics; Medicine; Political science; Pharmacology; Law","score_opus":0.2831185888249872,"score_gpt":0.3922508095959677,"score_spread":0.1091322207709805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151862","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13716017,0.011657502,0.0020341885,0.06933943,0.0048559722,0.00020931587,0.19322184,0.0015204566,0.5800012],"genre_scores_gemma":[0.48672035,0.005681975,0.0045780037,0.01851891,0.0014185442,0.000107385196,0.08538491,0.0005788256,0.39701113],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99809307,0.00018889696,0.00009495989,0.00015143582,0.0011337838,0.0003378985],"domain_scores_gemma":[0.9943258,0.000918971,0.00039028114,0.00012624727,0.003653682,0.000584972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013043203,0.000470727,0.00035068122,0.0025544807,0.0011798604,0.00290778,0.00046753616,0.00085113605,0.035811074],"category_scores_gemma":[0.007949068,0.0003400897,0.00065330573,0.0028987443,0.0005237884,0.0006410003,0.000693819,0.0015206669,0.0037570929],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051811675,0.000054744676,0.04205366,0.00029378978,0.0002260516,0.00018154942,0.00011804242,0.00066183606,0.0013322751,0.011537014,0.8711993,0.0718236],"study_design_scores_gemma":[0.00013894758,0.00008151739,0.2619335,0.00021917575,0.00010594584,0.00021411183,0.00021149749,0.0013091408,0.0018497109,0.0008813636,0.73298144,0.00007364426],"about_ca_topic_score_codex":0.82263976,"about_ca_topic_score_gemma":0.88434607,"teacher_disagreement_score":0.17736024,"about_ca_system_score_codex":0.019221844,"about_ca_system_score_gemma":0.014832359,"threshold_uncertainty_score":0.35680944},"labels":[],"label_agreement":null},{"id":"W4380151866","doi":"10.1016/j.jval.2023.03.2128","title":"RWD99 The Clinical Burden of Friedreich Ataxia: A Retrospective Claims Analysis in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Medicine; Retrospective cohort study; Cohort; Scoliosis; Pediatrics; Cardiomyopathy; Diabetes mellitus; Internal medicine; Physical medicine and rehabilitation; Physical therapy; Surgery; Heart failure; Psychiatry; Endocrinology","score_opus":0.1333431285981183,"score_gpt":0.39916298336723555,"score_spread":0.26581985476911724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918441,0.00059289933,0.000115707095,0.00019838665,0.000011784162,0.000009008232,0.006033229,0.000006762591,0.0011880439],"genre_scores_gemma":[0.9958949,0.00021305466,0.00005960863,0.000061742394,0.000015229227,0.000006082603,0.0034796242,0.0000029666041,0.00026670977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988123,0.00028865694,0.00023711663,0.00023768129,0.00028160072,0.0001426642],"domain_scores_gemma":[0.9949302,0.00082059775,0.002904703,0.0005379474,0.00053047447,0.0002759773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001254956,0.0002762764,0.00037886773,0.0017826639,0.0005044448,0.0012141821,0.00060425396,0.00065541425,0.0017214894],"category_scores_gemma":[0.005643225,0.00038755406,0.00073744263,0.0039410223,0.00038908998,0.0007816032,0.0008669639,0.0008296082,0.0003501382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000095667456,0.000034383742,0.99796283,0.000010075374,0.00011986177,0.000091862654,0.000041535346,0.000063325206,0.00006254687,0.000093203984,0.00040462476,0.0010202349],"study_design_scores_gemma":[0.000007517441,0.000027204995,0.99837327,0.000018391396,0.00007679477,0.00029478504,0.000155374,0.00041840982,0.000055544835,0.00008717919,0.00047936052,0.0000061669703],"about_ca_topic_score_codex":0.028191416,"about_ca_topic_score_gemma":0.02530967,"teacher_disagreement_score":0.028191416,"about_ca_system_score_codex":0.00076299807,"about_ca_system_score_gemma":0.00070347387,"threshold_uncertainty_score":0.05605465},"labels":[],"label_agreement":null},{"id":"W4380151925","doi":"10.1016/j.jval.2023.03.2759","title":"MSR107 Assessment of the Power of ITCs to Detect Minimally Important Treatment Effects in Subsequent Head-to-Head Trials","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Placebo; Medicine; Leverage (statistics); Head (geology); Randomization; Clinical trial; Internal medicine; Computer science; Artificial intelligence; Alternative medicine; Pathology","score_opus":0.48481004003162703,"score_gpt":0.5006952098182541,"score_spread":0.015885169786627074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67219126,0.03733661,0.14097263,0.016627148,0.0040100412,0.01744819,0.02493684,0.002562425,0.08391493],"genre_scores_gemma":[0.96105874,0.0011424326,0.022863396,0.0025517785,0.00068629254,0.004082581,0.003460804,0.0002958756,0.0038581376],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8631007,0.1208471,0.0061590257,0.0037979342,0.0048292014,0.0012659653],"domain_scores_gemma":[0.3727142,0.5863339,0.013496389,0.018608944,0.0066169086,0.0022297325],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18628895,0.001863784,0.0060141706,0.0017987979,0.00067722716,0.0029601776,0.0018125612,0.003984665,0.025075732],"category_scores_gemma":[0.32918042,0.0010838612,0.014060356,0.0020015931,0.0032100528,0.0031977238,0.0018930933,0.0045680716,0.0027476926],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6149213,0.0011972127,0.0581259,0.008442042,0.09221676,0.00073770806,0.0006784021,0.02308797,0.0033848623,0.014028648,0.022945384,0.16023384],"study_design_scores_gemma":[0.22709373,0.15300567,0.16659823,0.0037757396,0.12841743,0.0025497912,0.0009075102,0.17512311,0.013186297,0.058181085,0.07042835,0.0007330003],"about_ca_topic_score_codex":0.0012475888,"about_ca_topic_score_gemma":0.001328512,"teacher_disagreement_score":0.81371105,"about_ca_system_score_codex":0.0010995938,"about_ca_system_score_gemma":0.0021597382,"threshold_uncertainty_score":0.9852019},"labels":[],"label_agreement":null},{"id":"W4380152124","doi":"10.1016/j.jval.2023.03.2433","title":"CO208 Recurrence Rates and Survival Among Patients with Early-Stage Cancers: A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Stage (stratigraphy); Medicine; Oncology; Internal medicine; Biology","score_opus":0.03182598772810142,"score_gpt":0.34936151797824433,"score_spread":0.3175355302501429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380152124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012114581,0.98396456,0.000092089016,0.00030338977,0.00010125146,0.00007301847,0.0030815715,0.000005917963,0.0002635818],"genre_scores_gemma":[0.23398143,0.7607022,0.0007383535,0.0014143087,0.00019433435,0.00037029522,0.0023721315,0.000012074475,0.0002149012],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99442106,0.0011947711,0.0026600983,0.0008180784,0.0006402649,0.0002656897],"domain_scores_gemma":[0.974895,0.0167015,0.006308032,0.00047061458,0.0012480058,0.00037680057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038548417,0.0007796506,0.004621906,0.008875457,0.00045563874,0.0017990968,0.0011591773,0.0017092419,0.003440668],"category_scores_gemma":[0.027315669,0.0008679781,0.012182702,0.012415551,0.00072218507,0.0017637206,0.001436828,0.0012428268,0.0002720057],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008573123,0.000061035855,0.15585613,0.6607947,0.14497736,0.00036909187,0.0005147179,0.00025730496,0.00028205183,0.00033601964,0.0038283959,0.031865902],"study_design_scores_gemma":[0.0006169659,0.00035744216,0.22457041,0.3515503,0.40397906,0.0012304201,0.0012673422,0.00021527482,0.00020269208,0.0005326736,0.01532409,0.00015337371],"about_ca_topic_score_codex":0.016938647,"about_ca_topic_score_gemma":0.05538864,"teacher_disagreement_score":0.016938647,"about_ca_system_score_codex":0.0019305979,"about_ca_system_score_gemma":0.0049291602,"threshold_uncertainty_score":0.03368014},"labels":[],"label_agreement":null},{"id":"W4380154583","doi":"10.1016/j.jval.2023.03.1183","title":"HPR36 Utilization of Glucagon-like Peptide-1 Receptor Agonists in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Medicine; Diabetes mellitus; Receptor; Business; Internal medicine; Type 2 diabetes; Endocrinology; Economics; Agonist; Health care; Economic growth","score_opus":0.058496546352470515,"score_gpt":0.30340409613507235,"score_spread":0.24490754978260185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380154583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8990192,0.016957473,0.0004652292,0.015512399,0.00031953005,0.00020797948,0.032676734,0.00009054214,0.034750935],"genre_scores_gemma":[0.9654487,0.0119083235,0.0009629138,0.0034079645,0.0000773978,0.000062098894,0.0042681475,0.00006508461,0.013799295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984242,0.00013220195,0.00011957584,0.00017878518,0.0005668277,0.0005785159],"domain_scores_gemma":[0.995609,0.00024786408,0.00056129234,0.00005460014,0.0019808148,0.0015463851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007326297,0.00028243716,0.0005514286,0.0018735541,0.0024777846,0.0021716252,0.0009824267,0.00062107784,0.0066487296],"category_scores_gemma":[0.0025048556,0.00039089666,0.0008752959,0.005862406,0.0005478345,0.00035164587,0.00078842515,0.0012484863,0.00045456694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013569129,0.00031763603,0.84764296,0.00074163673,0.00041409815,0.0014171512,0.0023857797,0.0009015907,0.0014850377,0.0047900775,0.043014947,0.09553209],"study_design_scores_gemma":[0.000121101155,0.00015743199,0.94634444,0.0004973163,0.00020543323,0.0006356173,0.0039674556,0.0009973849,0.0005060928,0.0002342517,0.046251714,0.00008169193],"about_ca_topic_score_codex":0.99770784,"about_ca_topic_score_gemma":0.99854064,"teacher_disagreement_score":0.07743228,"about_ca_system_score_codex":0.07743228,"about_ca_system_score_gemma":0.12208349,"threshold_uncertainty_score":0.5618131},"labels":[],"label_agreement":null},{"id":"W4380184426","doi":"10.1016/j.jval.2023.03.2607","title":"EPH262 Preventing COVID-19 Outbreaks Using Wastewater Surveillance at Long-Term Care Facilities: A Pilot Modelling Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Outbreak; Wastewater; Coronavirus disease 2019 (COVID-19); Long-term care; Medicine; Infection control; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Environmental science; Environmental health; Virology; Environmental engineering; Intensive care medicine; Infectious disease (medical specialty); Disease; Internal medicine","score_opus":0.21380927732753016,"score_gpt":0.388897964553323,"score_spread":0.17508868722579282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380184426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504435,0.00011815776,0.0024645964,0.00016472166,0.000015825986,0.00014659353,0.000698001,0.000031830008,0.0013159376],"genre_scores_gemma":[0.99644023,0.00012947114,0.0019204632,0.000028619032,0.0000031438196,0.0001406671,0.0004234971,0.000008141441,0.0009057155],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99922895,0.0003263204,0.00002919325,0.00013582992,0.000062019986,0.00021760816],"domain_scores_gemma":[0.9981358,0.0011226927,0.00019207576,0.00008433987,0.0002858219,0.0001792634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016797187,0.0010644342,0.0010881828,0.00041401488,0.0005299195,0.0016154227,0.0017400715,0.0016289916,0.0025502208],"category_scores_gemma":[0.0026905905,0.0005113963,0.0020394905,0.00049555034,0.0005680128,0.00096290954,0.0007235073,0.00094610616,0.00025427685],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002994928,0.0028611373,0.031282246,0.0004509581,0.0005324458,0.00049987395,0.00018974958,0.94196254,0.004398627,0.00093962194,0.001016976,0.012870827],"study_design_scores_gemma":[0.0007990193,0.0096674245,0.032057427,0.00008667364,0.0005854258,0.00012215986,0.00087205064,0.9497929,0.0033648743,0.0011840535,0.0013531249,0.00011487189],"about_ca_topic_score_codex":0.0873655,"about_ca_topic_score_gemma":0.047606774,"teacher_disagreement_score":0.0873655,"about_ca_system_score_codex":0.003544999,"about_ca_system_score_gemma":0.0038654765,"threshold_uncertainty_score":0.17371398},"labels":[],"label_agreement":null},{"id":"W4380184439","doi":"10.1016/j.jval.2023.03.2621","title":"HPR144 Coverage of Biologics for Rheumatoid Arthritis in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Guideline; Rheumatoid arthritis; Antirheumatic drugs; Equity (law); Actuarial science; Antirheumatic Agents; Business; Internal medicine","score_opus":0.05111866706465138,"score_gpt":0.30295467291690203,"score_spread":0.25183600585225063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380184439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7173952,0.02886701,0.0013425577,0.043448348,0.0006556975,0.00034075286,0.049598787,0.0004457044,0.15790598],"genre_scores_gemma":[0.9409492,0.007524779,0.0011343276,0.008704157,0.00016680398,0.00006532212,0.0056622475,0.00006599632,0.03572719],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968238,0.00016618171,0.000103678954,0.0002173027,0.0019016296,0.0007874935],"domain_scores_gemma":[0.9928437,0.00066075503,0.00073529093,0.00007939877,0.003511346,0.0021694228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011849959,0.00018563434,0.0003606918,0.0017103147,0.00132932,0.0016703035,0.0010131346,0.0008084009,0.008712867],"category_scores_gemma":[0.0046011913,0.0002806928,0.00070810615,0.002501962,0.0006509651,0.00030281112,0.000574061,0.0010864064,0.0005260587],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002344419,0.000355675,0.3997763,0.0018061901,0.00056976615,0.002658116,0.0024438158,0.0049380464,0.017030073,0.031646244,0.23305711,0.30337426],"study_design_scores_gemma":[0.000134879,0.0002553371,0.75700337,0.0004519542,0.00013406825,0.0008498284,0.0010314697,0.0020602231,0.0015372629,0.0003830608,0.23610291,0.000055617907],"about_ca_topic_score_codex":0.99061954,"about_ca_topic_score_gemma":0.99010956,"teacher_disagreement_score":0.05434333,"about_ca_system_score_codex":0.05434333,"about_ca_system_score_gemma":0.09935241,"threshold_uncertainty_score":0.39429027},"labels":[],"label_agreement":null},{"id":"W4380201856","doi":"10.1016/j.jval.2023.03.2592","title":"EPH246 Real-World Evaluation of Health Disparities in Treatment Patterns for Systemic Lupus Erythematosus","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Systemic lupus; Biologic Agents; Ethnic group; Race (biology); Systemic therapy; Systemic lupus erythematosus; Lupus erythematosus; Internal medicine; Immunology; Disease; Antibody","score_opus":0.1702458433476343,"score_gpt":0.42013165861879,"score_spread":0.2498858152711557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380201856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911117,0.00041437743,0.0002047377,0.000627276,0.000023073708,0.000057518457,0.006196852,0.0000059894865,0.0013584768],"genre_scores_gemma":[0.99531883,0.00016506338,0.00043077965,0.00014157625,0.00003056818,0.000099318895,0.0034658462,0.000003715524,0.00034423103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99540126,0.003030504,0.00040760796,0.00037702103,0.00038868192,0.00039485286],"domain_scores_gemma":[0.98896676,0.0041044587,0.0041479645,0.00085848535,0.0010991357,0.0008231684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004333347,0.00023874194,0.0004519521,0.0008627549,0.00052428094,0.0010374943,0.0005536906,0.00075261516,0.0036251233],"category_scores_gemma":[0.01889808,0.00016754902,0.0012183163,0.002206846,0.00043408934,0.0009913014,0.0011557714,0.00086504087,0.0004664764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00321358,0.0009133864,0.97210634,0.0002935078,0.0011840712,0.00005932875,0.00031469547,0.00077697285,0.00012426906,0.00061620784,0.0031705557,0.01722697],"study_design_scores_gemma":[0.0005314499,0.0014838239,0.9897035,0.00016770631,0.0004957411,0.000106150605,0.0008728435,0.002144017,0.0003121529,0.0005728201,0.0035713585,0.000038537597],"about_ca_topic_score_codex":0.014881639,"about_ca_topic_score_gemma":0.013566558,"teacher_disagreement_score":0.014881639,"about_ca_system_score_codex":0.0011209276,"about_ca_system_score_gemma":0.0012892048,"threshold_uncertainty_score":0.02959001},"labels":[],"label_agreement":null},{"id":"W4380261239","doi":"10.1016/j.jval.2023.03.064","title":"P53 Budget Impact Analysis of Adopting Primary Care-Based COPD Case Detection in the Canadian General Population","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"COPD; Primary care; Population; Medicine; Primary (astronomy); Business; Environmental health; Family medicine; Internal medicine","score_opus":0.03970856907619333,"score_gpt":0.35398832634081673,"score_spread":0.3142797572646234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380261239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93410504,0.0039128615,0.0009951715,0.009747024,0.00015381734,0.0006739359,0.022896336,0.000076709824,0.027439073],"genre_scores_gemma":[0.9938991,0.0008638368,0.00061999547,0.0004361231,0.000025040108,0.00007847757,0.0025304449,0.000008643049,0.0015383211],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9945511,0.001223598,0.00018323651,0.00033143887,0.0016158395,0.0020946723],"domain_scores_gemma":[0.9910226,0.0023270613,0.0009266669,0.00022816904,0.003747268,0.0017481811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027470042,0.00056938233,0.00067530654,0.0021645362,0.0014873,0.002229343,0.0019637193,0.0009836672,0.0054409057],"category_scores_gemma":[0.018842349,0.00037984218,0.002036926,0.004205719,0.0008468654,0.0006212984,0.0013754482,0.0012676802,0.00026082128],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042661764,0.00089235516,0.80172783,0.0009027892,0.0016010335,0.0006090989,0.0006830662,0.043194238,0.00074553804,0.008158459,0.025829453,0.11139],"study_design_scores_gemma":[0.00028162036,0.0006466173,0.96112394,0.00025092709,0.0011512244,0.00021313582,0.0020519223,0.0255412,0.000365829,0.00073807687,0.0075761345,0.00005934586],"about_ca_topic_score_codex":0.9819764,"about_ca_topic_score_gemma":0.9820672,"teacher_disagreement_score":0.08452821,"about_ca_system_score_codex":0.08452821,"about_ca_system_score_gemma":0.0906648,"threshold_uncertainty_score":0.61329794},"labels":[],"label_agreement":null},{"id":"W4383100478","doi":"10.1016/j.jval.2023.06.014","title":"Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; SickKids Foundation; Institute of Health Economics; University of Ottawa; Public Health Ontario; Hospital for Sick Children","funders":"Hospital for Sick Children; Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Checklist; Delphi; Delphi method; Transparency (behavior); Medicine; Computer science; Psychology","score_opus":0.5949654745968979,"score_gpt":0.5350122596358549,"score_spread":0.059953214961043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383100478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005629921,0.90370655,0.0160715,0.024493167,0.004902669,0.005049633,0.029069427,0.0004782118,0.015665956],"genre_scores_gemma":[0.008458563,0.87831056,0.058260925,0.011706032,0.0021196096,0.009484988,0.028351722,0.0002824003,0.003025141],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9279291,0.026517976,0.024114776,0.0013835386,0.018935297,0.0011192762],"domain_scores_gemma":[0.86264795,0.08471542,0.018292088,0.0049697184,0.02826909,0.0011056676],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07057132,0.002553871,0.0067627267,0.02366988,0.00063448155,0.0063046333,0.005885252,0.004139067,0.009523187],"category_scores_gemma":[0.18013181,0.0014278521,0.0064766943,0.028751917,0.0025369232,0.0044419602,0.00395586,0.007205533,0.0044568917],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045535451,0.00015009855,0.00093562144,0.112228304,0.0017020889,0.00006395995,0.00023169044,0.0013264866,0.00022495746,0.053259745,0.2927793,0.53664243],"study_design_scores_gemma":[0.00035008008,0.00010664241,0.0038192482,0.11802556,0.0019204232,0.00022654187,0.00014339635,0.0007059774,0.00067178044,0.030083891,0.84382993,0.00011634183],"about_ca_topic_score_codex":0.008412636,"about_ca_topic_score_gemma":0.006085275,"teacher_disagreement_score":0.9294287,"about_ca_system_score_codex":0.008192957,"about_ca_system_score_gemma":0.020448875,"threshold_uncertainty_score":0.37322128},"labels":[],"label_agreement":null},{"id":"W4383466085","doi":"10.1016/j.jval.2023.06.019","title":"Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; National Institute for Health and Care Research","keywords":"Discontinuation; Clinical trial; Excellence; Medicine; Data collection; Intensive care medicine; Family medicine; Internal medicine; Political science","score_opus":0.5425764741298827,"score_gpt":0.4782558540473472,"score_spread":0.06432062008253553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383466085","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02224277,0.0928202,0.07865108,0.765002,0.008513756,0.00033943175,0.0129534025,0.00020132541,0.019276014],"genre_scores_gemma":[0.6137562,0.06885273,0.06280112,0.19306675,0.042954337,0.0020303905,0.010325274,0.00046805677,0.005745243],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.59412307,0.35412213,0.021983711,0.008114644,0.019323038,0.0023334573],"domain_scores_gemma":[0.07602019,0.86811185,0.025087217,0.014530221,0.013615024,0.0026355544],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.40505397,0.0013262276,0.0061676586,0.0042618006,0.0013763753,0.016342334,0.006940784,0.014186264,0.0076398444],"category_scores_gemma":[0.72007453,0.0017880193,0.005013894,0.009636337,0.0084095895,0.019693526,0.0049313614,0.01771336,0.0010597683],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006816176,0.0005537933,0.070338264,0.006461201,0.0045158938,0.0016178245,0.0039848653,0.028772205,0.0005381936,0.47503808,0.11727986,0.2840836],"study_design_scores_gemma":[0.0010153429,0.0012796307,0.03484798,0.007852804,0.0014772546,0.0014507709,0.002005869,0.023306048,0.00079345267,0.7650946,0.16037245,0.00050390686],"about_ca_topic_score_codex":0.0055667693,"about_ca_topic_score_gemma":0.0051065604,"teacher_disagreement_score":0.40505397,"about_ca_system_score_codex":0.0058325985,"about_ca_system_score_gemma":0.0061258576,"threshold_uncertainty_score":0.7336744},"labels":[],"label_agreement":null},{"id":"W4383874821","doi":"10.1016/j.jval.2023.06.010","title":"Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report","year":2023,"lang":"en","type":"erratum","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Health care; Outcomes research; Healthcare system; Health technology; Medicine; Political science; Alternative medicine","score_opus":0.6781235203538044,"score_gpt":0.4868992296090297,"score_spread":0.1912242907447747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874821","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081092835,0.008657784,0.00168955,0.89898586,0.056113824,0.0000872223,0.0012126693,0.0001363678,0.032305915],"genre_scores_gemma":[0.03173985,0.03406369,0.024623519,0.5666869,0.07317726,0.0004767401,0.0022736571,0.0009185489,0.26603988],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9606434,0.010217669,0.004169596,0.0016202818,0.021084683,0.002264398],"domain_scores_gemma":[0.8488844,0.090933025,0.0037857706,0.004619291,0.046947446,0.004829947],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.059848383,0.0013284505,0.0014312398,0.003176159,0.006624791,0.019986318,0.0035280844,0.02327286,0.013929764],"category_scores_gemma":[0.09793082,0.0009813991,0.0018586445,0.004388451,0.005603946,0.012310089,0.005295112,0.021168996,0.0038393582],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001720195,0.000023992505,0.0002725687,0.00010647753,0.000009325809,0.00015470434,0.00023341643,0.00019588249,0.000032107175,0.029602844,0.9560346,0.013316891],"study_design_scores_gemma":[0.00004133954,0.000023887758,0.0022977246,0.0010241396,0.000028872035,0.00015548944,0.0012556107,0.00077350804,0.00020595371,0.02378866,0.97032434,0.00008062041],"about_ca_topic_score_codex":0.11432548,"about_ca_topic_score_gemma":0.20015219,"teacher_disagreement_score":0.94015163,"about_ca_system_score_codex":0.011157179,"about_ca_system_score_gemma":0.054802086,"threshold_uncertainty_score":0.3165123},"labels":[],"label_agreement":null},{"id":"W4385552805","doi":"10.1016/j.jval.2023.07.004","title":"Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Health Innovation Network South London; Terry Fox Research Institute; Genome British Columbia; Genome Canada; Roche; AstraZeneca; Roche Canada","keywords":"Current (fluid); Intensive care medicine; Management science; Medicine; Risk analysis (engineering); Engineering ethics; Psychology; Economics; Engineering","score_opus":0.813869672095695,"score_gpt":0.5795392842646053,"score_spread":0.23433038783108973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385552805","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006582436,0.9065369,0.020769553,0.06514459,0.0017287603,0.0015448219,0.00047657915,0.0001304589,0.0030102178],"genre_scores_gemma":[0.017151562,0.8340664,0.1237097,0.016856033,0.0013527152,0.005899901,0.00045542052,0.0001608944,0.000347356],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.5452403,0.28604248,0.115778975,0.007919848,0.042229794,0.002788596],"domain_scores_gemma":[0.08806176,0.8301189,0.02497335,0.009322441,0.046289954,0.0012335966],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.49392855,0.0041182013,0.011844735,0.051133014,0.0035382695,0.025802538,0.011772683,0.011650737,0.0052064876],"category_scores_gemma":[0.7366913,0.0050009293,0.014277296,0.044159155,0.010352331,0.026220879,0.010491952,0.0158719,0.0015500586],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026035018,0.0001235788,0.0013431293,0.394669,0.003328904,0.00028296045,0.0048633628,0.0025051355,0.00024244451,0.057662643,0.027372172,0.5073464],"study_design_scores_gemma":[0.000117670956,0.0000792621,0.0008517059,0.86112094,0.0023293395,0.0001545993,0.0018124072,0.0011966663,0.00029632196,0.051473487,0.080449596,0.000118001786],"about_ca_topic_score_codex":0.011981379,"about_ca_topic_score_gemma":0.018612614,"teacher_disagreement_score":0.49392855,"about_ca_system_score_codex":0.033600297,"about_ca_system_score_gemma":0.080952905,"threshold_uncertainty_score":0.62407625},"labels":[],"label_agreement":null},{"id":"W4386935853","doi":"10.1016/j.jval.2023.09.001","title":"Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Impact","funders":"","keywords":"Ven; Medicine; Internal medicine; Cytarabine; Hazard ratio; Myeloid leukemia; Oncology; Confidence interval","score_opus":0.20436581651139224,"score_gpt":0.42398445399190704,"score_spread":0.2196186374805148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386935853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03649891,0.96086806,0.00093654037,0.00019088738,0.0003056653,0.00014033604,0.00049672206,0.000029162016,0.0005337068],"genre_scores_gemma":[0.6238043,0.37068975,0.0022760096,0.0009273251,0.00033967223,0.00028510077,0.00095861463,0.000038342754,0.00068081124],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969127,0.0019245528,0.00045424644,0.00036008755,0.00022279973,0.0001255858],"domain_scores_gemma":[0.9947206,0.0041468097,0.0006320304,0.00020625065,0.00018797863,0.000106396794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052314913,0.0016383663,0.009459455,0.0013332594,0.00027804502,0.0015646927,0.0012118581,0.001329313,0.0032453942],"category_scores_gemma":[0.010840126,0.0008192241,0.020829013,0.0021091145,0.00045960987,0.00095074717,0.0008052664,0.0024141541,0.00022915116],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033890657,0.00009529307,0.0050096605,0.065692976,0.8706756,0.000077528886,0.00005898475,0.0010912529,0.0003807127,0.0001687982,0.00055128813,0.022307187],"study_design_scores_gemma":[0.0066890735,0.0010169965,0.0048684794,0.002799437,0.98253286,0.000051778894,0.00003743241,0.00039631806,0.00012005921,0.00029492922,0.0011686105,0.000024002524],"about_ca_topic_score_codex":0.004471537,"about_ca_topic_score_gemma":0.01028383,"teacher_disagreement_score":0.009459455,"about_ca_system_score_codex":0.001296946,"about_ca_system_score_gemma":0.0008769229,"threshold_uncertainty_score":0.027667046},"labels":[],"label_agreement":null},{"id":"W4386968516","doi":"10.1016/j.jval.2023.08.008","title":"Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Servier; Schweizerische Herzstiftung; Universität Basel; Biosense Webster; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Foundation for Cardiovascular Research; Daiichi Sankyo Europe; European Commission; Sanofi; AstraZeneca; Amgen; Pfizer; Boston Scientific Corporation; National Science Foundation","keywords":"Medicine; Context (archaeology); Cost effectiveness; Atrial fibrillation; Randomized controlled trial; Hazard ratio; Quality-adjusted life year; Observational study; Cohort; Incremental cost-effectiveness ratio; Internal medicine; Emergency medicine; Confidence interval; Intensive care medicine","score_opus":0.1724954474430679,"score_gpt":0.4085436308525736,"score_spread":0.2360481834095057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386968516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89890265,0.015924223,0.050793253,0.006534297,0.0020503537,0.007241887,0.008334177,0.00039268154,0.0098265475],"genre_scores_gemma":[0.9857217,0.0009929455,0.006085844,0.0006799221,0.0004230216,0.0029587287,0.0020026607,0.00006162502,0.0010735876],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.96767586,0.028044628,0.0011371801,0.0016093596,0.0006518845,0.0008811245],"domain_scores_gemma":[0.9620088,0.03280867,0.00183708,0.0017599439,0.00075494125,0.0008306358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.034185443,0.0030382872,0.006662213,0.001498386,0.0005814911,0.0038616003,0.002443589,0.0034779515,0.009123481],"category_scores_gemma":[0.0554754,0.0012126658,0.010850972,0.0014745726,0.0016049562,0.004210507,0.0030060376,0.006297781,0.00082188105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6359276,0.008424755,0.030755188,0.0083260005,0.14270893,0.00097321684,0.0004702248,0.098333076,0.0025694997,0.022569444,0.0061926977,0.04274928],"study_design_scores_gemma":[0.34818733,0.14929368,0.040162828,0.0017393623,0.17681444,0.0014476975,0.00092276547,0.20219663,0.0033149808,0.06493814,0.010450321,0.0005318706],"about_ca_topic_score_codex":0.0012430856,"about_ca_topic_score_gemma":0.0009245719,"teacher_disagreement_score":0.034185443,"about_ca_system_score_codex":0.0015622735,"about_ca_system_score_gemma":0.001604643,"threshold_uncertainty_score":0.18079203},"labels":[],"label_agreement":null},{"id":"W4388486850","doi":"10.1016/j.jval.2023.10.015","title":"Microsimulation Models on Mental Health: A Critical Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"demographic modeling and climate adaptation","field":"Decision Sciences","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Economic and Social Research Council; UK Research and Innovation","keywords":"Microsimulation; Mental health; EconLit; PsycINFO; Checklist; Psychological intervention; Quality (philosophy); Psychology; MEDLINE; Applied psychology; Psychiatry; Engineering; Political science; Transport engineering","score_opus":0.5414938261332398,"score_gpt":0.5376371266359655,"score_spread":0.0038566994972742963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388486850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001745625,0.99710244,0.0010032684,0.0010848829,0.00016901857,0.0000068815802,0.000048477406,0.0000062384534,0.0004042092],"genre_scores_gemma":[0.0030897246,0.99535346,0.00085544423,0.00030614453,0.00025541644,0.000022363316,0.000038276663,0.0000039452525,0.00007529833],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99883705,0.0005947784,0.00016208393,0.0001300296,0.00023015209,0.000045976056],"domain_scores_gemma":[0.9748583,0.022949759,0.00068610866,0.00023685608,0.0011349116,0.000134077],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005420757,0.001992374,0.003998979,0.0034867565,0.00037959547,0.002465132,0.0025734324,0.0023497506,0.0050825295],"category_scores_gemma":[0.019718371,0.0007842604,0.0020624776,0.0045657624,0.0011707748,0.0028040665,0.0016330493,0.0028025964,0.00079918443],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019196093,0.00015831424,0.0011275051,0.09979132,0.0016265021,0.00017690021,0.00023635749,0.020623235,0.00016589276,0.070303045,0.026758676,0.7788404],"study_design_scores_gemma":[0.00013799712,0.00038065994,0.004639748,0.2391195,0.005281222,0.0006767995,0.0007032441,0.020259578,0.0006188174,0.158664,0.5692377,0.00028071008],"about_ca_topic_score_codex":0.011885261,"about_ca_topic_score_gemma":0.011806549,"teacher_disagreement_score":0.99457926,"about_ca_system_score_codex":0.002845555,"about_ca_system_score_gemma":0.005739711,"threshold_uncertainty_score":0.028668046},"labels":[],"label_agreement":null},{"id":"W4389279525","doi":"10.1016/j.jval.2023.11.009","title":"Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Calgary; University of Alberta","funders":"Medical Research Council; Queen's University; Canadian Institutes of Health Research; Queen's University Belfast","keywords":"Counterfactual thinking; Consistency (knowledge bases); Value (mathematics); Medicine; Quality of life (healthcare); Actuarial science; Value of life; Regret; Axiom independence; Ranking (information retrieval); Quality-adjusted life year; Quality (philosophy); Axiom; Computer science; Economics; Risk analysis (engineering); Psychology; Mathematics; Microeconomics; Social psychology; Artificial intelligence; Statistics; Epistemology; Cost effectiveness","score_opus":0.4485692626853146,"score_gpt":0.42085538631396635,"score_spread":0.027713876371348256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389279525","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12549837,0.009672219,0.7374975,0.057973325,0.002305195,0.0011077869,0.0016807996,0.00016424504,0.06410047],"genre_scores_gemma":[0.7283258,0.0015187735,0.2614614,0.0054704603,0.0004728202,0.0010826318,0.00039237482,0.000054701446,0.0012210055],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8351111,0.13003044,0.0073374216,0.007786347,0.018025042,0.0017096441],"domain_scores_gemma":[0.76005054,0.19640179,0.020620653,0.01130303,0.010682967,0.00094104785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.11797307,0.0010014662,0.0016247551,0.003038963,0.0015363868,0.0076892483,0.004139103,0.0034382606,0.0054474636],"category_scores_gemma":[0.28207803,0.00074165565,0.0032744454,0.003661203,0.0108204745,0.009286184,0.00475764,0.0075439597,0.0003566072],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029882486,0.00007897227,0.0024537744,0.00073842803,0.00038719026,0.00018071708,0.0012104156,0.011983944,0.00025570233,0.93845785,0.002372657,0.041581623],"study_design_scores_gemma":[0.0001795031,0.00017872606,0.0018719821,0.0005198738,0.00017889692,0.0001937252,0.00067991886,0.015552682,0.0007369895,0.97145563,0.008362223,0.000089821806],"about_ca_topic_score_codex":0.0015526133,"about_ca_topic_score_gemma":0.0021084766,"teacher_disagreement_score":0.11797307,"about_ca_system_score_codex":0.0054490087,"about_ca_system_score_gemma":0.006936211,"threshold_uncertainty_score":0.62390864},"labels":[],"label_agreement":null},{"id":"W4389989768","doi":"10.1016/j.jval.2023.11.011","title":"Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); Precision Nanosystems (Canada); University of British Columbia","funders":"Medical Research Council; Bristol-Myers Squibb","keywords":"Inverse probability weighting; Statistics; Propensity score matching; Weighting; Confidence interval; Regression; Population; Hazard ratio; Proportional hazards model; Standard error; Medicine; Econometrics; Mathematics","score_opus":0.5243210205611497,"score_gpt":0.5456246118675028,"score_spread":0.021303591306353065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389989768","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031848887,0.0005061607,0.9947954,0.00023221623,0.00013000771,0.00016414466,0.0002350006,0.00015393032,0.000598236],"genre_scores_gemma":[0.0926023,0.0007791751,0.89931875,0.0003333595,0.00027270667,0.0017713938,0.00067176775,0.0003265705,0.0039239344],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9627656,0.030584712,0.001379997,0.0020364113,0.002907978,0.00032533426],"domain_scores_gemma":[0.9504257,0.037953548,0.002311169,0.007359818,0.0017135671,0.00023622194],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.049971245,0.0010549171,0.0017979121,0.002106967,0.00045114435,0.001854735,0.004029698,0.0011116852,0.008554064],"category_scores_gemma":[0.14639564,0.0006758045,0.0030864843,0.0022404972,0.0010414326,0.0024380113,0.0030232498,0.0036075707,0.00077626377],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017286967,0.00047486395,0.0064906795,0.0012669798,0.0053671324,0.0001534828,0.0005111643,0.03306499,0.0010987888,0.4143351,0.008355033,0.5271532],"study_design_scores_gemma":[0.0007684648,0.00064313906,0.0057380856,0.0006098576,0.0020659964,0.00031975136,0.00013723786,0.2994877,0.0024698637,0.66664964,0.020983664,0.00012651592],"about_ca_topic_score_codex":0.0022938247,"about_ca_topic_score_gemma":0.00297078,"teacher_disagreement_score":0.9500288,"about_ca_system_score_codex":0.00078367506,"about_ca_system_score_gemma":0.002421129,"threshold_uncertainty_score":0.26427633},"labels":[],"label_agreement":null},{"id":"W4390009972","doi":"10.1016/j.jval.2023.12.002","title":"Scoring the Value Assessment Framework for China: A Factorial Survey","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Factorial analysis; Factorial; Value (mathematics); China; Statistics; Mathematics; Geography; Archaeology","score_opus":0.6268504498657739,"score_gpt":0.5128430012630208,"score_spread":0.11400744860275303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390009972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940655,0.00007453162,0.0026190132,0.0002443975,0.000008314852,0.0003280702,0.00038523995,0.000012545859,0.0022623173],"genre_scores_gemma":[0.9953501,0.00004671932,0.0031947556,0.000040512252,0.000004832808,0.00023030929,0.0005380942,0.0000041181847,0.0005903685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99268883,0.0036695031,0.0006635126,0.0005641484,0.0017079371,0.00070604996],"domain_scores_gemma":[0.98220426,0.0053042513,0.0020610355,0.002369942,0.0063254954,0.0017351041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016863443,0.0005368635,0.0006759263,0.0030224218,0.0019197043,0.0015180896,0.0009582461,0.00067831395,0.0028414652],"category_scores_gemma":[0.020657992,0.00031718446,0.0009008582,0.0049797194,0.0013676396,0.00170027,0.001460388,0.0009761783,0.00038501923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014971357,0.00082110986,0.93151516,0.000053036554,0.00009035495,0.00009269459,0.0032423595,0.0023711522,0.0004672323,0.0036724736,0.0026120376,0.05491272],"study_design_scores_gemma":[0.00004213204,0.0005151717,0.9785444,0.000033646313,0.00004750324,0.00005207641,0.0032333762,0.012814848,0.0003198746,0.0017930683,0.0025616696,0.000042202253],"about_ca_topic_score_codex":0.060473923,"about_ca_topic_score_gemma":0.05809901,"teacher_disagreement_score":0.060473923,"about_ca_system_score_codex":0.007245985,"about_ca_system_score_gemma":0.010306651,"threshold_uncertainty_score":0.12024385},"labels":[],"label_agreement":null},{"id":"W4390124513","doi":"10.1016/j.jval.2023.09.2695","title":"PCR258 Baseline Demographic and Clinical Characteristics of Patients with Plaque Psoriasis Treated with Brodalumab in the Canadian Real-World Setting: Results from the Care Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Covenant Health; University of Toronto; SKiN Health; University of British Columbia","funders":"","keywords":"Plaque psoriasis; Baseline (sea); Medicine; Psoriasis; Dermatology; Political science","score_opus":0.034849143537404266,"score_gpt":0.282796456769974,"score_spread":0.24794731323256974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460703,0.00027819577,0.000054067274,0.0000842386,0.000006734523,0.000043218315,0.0030576838,0.0000053017247,0.001863455],"genre_scores_gemma":[0.9975304,0.00017489128,0.000092646165,0.00009198648,0.000007029202,0.00001762395,0.0015052556,0.0000029509538,0.0005773427],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928707,0.000054137778,0.000032655968,0.00010961358,0.0002478744,0.00026872611],"domain_scores_gemma":[0.99935585,0.000046898396,0.00015525008,0.000022331817,0.00025698214,0.00016273299],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035125224,0.0002965791,0.00034043565,0.0008482448,0.0010655274,0.0008666459,0.00054425816,0.0004362001,0.002588361],"category_scores_gemma":[0.0012522903,0.00025490264,0.0005681956,0.0018429233,0.00038164048,0.00029456988,0.00026665884,0.0005652364,0.0003392151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031069937,0.00009799684,0.996305,0.000016032842,0.00004324584,0.000063898406,0.00016800326,0.000037752117,0.0003592133,0.00002514042,0.0006478666,0.0019250147],"study_design_scores_gemma":[0.000011856194,0.000045966983,0.99934584,0.0000034450716,0.00001629869,0.000039541606,0.00021062075,0.000039102553,0.00003119428,0.0000049094792,0.00024716122,0.000004041302],"about_ca_topic_score_codex":0.81964934,"about_ca_topic_score_gemma":0.8384898,"teacher_disagreement_score":0.18035066,"about_ca_system_score_codex":0.0052386704,"about_ca_system_score_gemma":0.0045917993,"threshold_uncertainty_score":0.3628255},"labels":[],"label_agreement":null},{"id":"W4390124534","doi":"10.1016/j.jval.2023.09.2578","title":"PCR139 'We Have Conversations That Other Couples Don′t Have to Have:' A Qualitative Study of the Impact of Caregiving in Friedreich Ataxia (FA)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Psychology; Gerontology; Medicine; Psychiatry","score_opus":0.19821881146564405,"score_gpt":0.42535055676750094,"score_spread":0.2271317453018569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8899928,0.0025880127,0.0069782017,0.056037743,0.0018536154,0.00058521057,0.0006841136,0.000101014935,0.041179296],"genre_scores_gemma":[0.9682943,0.0007755885,0.0015481422,0.015487581,0.00008636564,0.00065446465,0.00008950425,0.000067663874,0.012996402],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98519784,0.011402105,0.0003229199,0.0005635154,0.0009935948,0.0015200224],"domain_scores_gemma":[0.9756673,0.014176581,0.0021522173,0.0007992275,0.0032285214,0.0039762254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015825868,0.00067588506,0.0007640451,0.00076545746,0.015437918,0.005162064,0.0017429173,0.0035065261,0.0076304157],"category_scores_gemma":[0.032928538,0.0006438709,0.0005991657,0.0008788058,0.0130031295,0.0056259823,0.007895326,0.010425715,0.0009097149],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013707202,0.000025433017,0.0012635159,0.00009978124,0.000004700715,0.00020296888,0.99271375,0.000009375282,0.00020943736,0.0013777922,0.0019139845,0.0021656365],"study_design_scores_gemma":[0.0000047638173,0.000018392857,0.000869018,0.000129332,0.0000040335717,0.00012664727,0.98518974,0.000015419733,0.0000922913,0.0005043107,0.013029653,0.000016368074],"about_ca_topic_score_codex":0.024771208,"about_ca_topic_score_gemma":0.037136126,"teacher_disagreement_score":0.024771208,"about_ca_system_score_codex":0.0064890566,"about_ca_system_score_gemma":0.009113443,"threshold_uncertainty_score":0.08369619},"labels":[],"label_agreement":null},{"id":"W4390124642","doi":"10.1016/j.jval.2023.09.2523","title":"PCR84 The Daily Life and Psychosocial Impacts of Friedreich Ataxia: A Qualitative Study of Patient Lived Experiences","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Psychosocial; Ataxia; Qualitative research; Psychology; Gerontology; Medicine; Psychiatry; Sociology; Social science","score_opus":0.13606213559689534,"score_gpt":0.4065440204105064,"score_spread":0.2704818848136111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932273,0.0003928428,0.0006888625,0.0020674765,0.0000622642,0.000099228884,0.00018787642,0.000012999981,0.0032611138],"genre_scores_gemma":[0.9966717,0.00035660094,0.00031527478,0.00069152465,0.000017209339,0.00017045974,0.0000627693,0.000018848668,0.0016955287],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9910671,0.006350715,0.00024961724,0.00040540186,0.0004149767,0.0015121833],"domain_scores_gemma":[0.9845793,0.010287013,0.0010343172,0.0003793685,0.0011978785,0.0025220914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0093777655,0.00069976284,0.0010893849,0.0015328637,0.0100026,0.0054160855,0.0018066724,0.002548047,0.004048287],"category_scores_gemma":[0.017632946,0.00079770235,0.0006194141,0.0017455834,0.007946613,0.0045030927,0.007080873,0.005783867,0.00048628973],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002217059,0.000043257936,0.0027902084,0.000050755134,0.0000037351872,0.00034355925,0.9947596,0.000018615869,0.00021772263,0.0002955622,0.00023594474,0.0012188822],"study_design_scores_gemma":[0.0000024994545,0.000030411573,0.0013224613,0.000042393363,0.0000020575999,0.00014530637,0.99662304,0.000021137424,0.000075488475,0.000108948654,0.0016135946,0.000012574192],"about_ca_topic_score_codex":0.011968386,"about_ca_topic_score_gemma":0.021985129,"teacher_disagreement_score":0.011968386,"about_ca_system_score_codex":0.0046453658,"about_ca_system_score_gemma":0.0048087346,"threshold_uncertainty_score":0.04959494},"labels":[],"label_agreement":null},{"id":"W4390124644","doi":"10.1016/j.jval.2023.09.2629","title":"PCR192 Content Validity of the EQ-5D and Health Utilities Index (HUI) to Assess Health-Related Quality-of-Life (HRQoL) Impact in Duchenne Muscular Dystrophy (DMD)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Health related quality of life; EQ-5D; Index (typography); Muscular dystrophy; Content validity; Gerontology; Quality of life (healthcare); Health Utilities Index; Medicine; Physical medicine and rehabilitation; Physical therapy; Computer science; Clinical psychology; Psychometrics; Internal medicine; World Wide Web; Nursing","score_opus":0.8408987447331119,"score_gpt":0.47673210207243377,"score_spread":0.3641666426606781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98366,0.001039529,0.0013853008,0.00034227045,0.000104574916,0.00015413853,0.0026154004,0.000015012178,0.010683832],"genre_scores_gemma":[0.9965405,0.00017768708,0.0006588913,0.00014170476,0.00003674657,0.00011300641,0.0015674125,0.000016760596,0.0007473436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917979,0.0034651114,0.00095197826,0.00058168516,0.0027664744,0.0004367851],"domain_scores_gemma":[0.96874905,0.020931758,0.004512802,0.0010483331,0.0042482,0.00050997146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01035195,0.00046259872,0.00060489244,0.0025717681,0.00049613573,0.0016918265,0.00083719013,0.0009606063,0.003076019],"category_scores_gemma":[0.050080027,0.0003447421,0.002001556,0.0024222455,0.00077634293,0.0011116534,0.0012695936,0.0009708266,0.0010024776],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003705194,0.00016821525,0.98062515,0.000064337575,0.0004812673,0.000040413608,0.00037150976,0.00054786826,0.00025215428,0.000595163,0.000754252,0.015729178],"study_design_scores_gemma":[0.00006557694,0.00030623132,0.991234,0.00011770519,0.00023731048,0.00014175821,0.00042453915,0.003966126,0.00054024055,0.0010835086,0.001855928,0.00002711785],"about_ca_topic_score_codex":0.0037440436,"about_ca_topic_score_gemma":0.0033396026,"teacher_disagreement_score":0.01035195,"about_ca_system_score_codex":0.0011268819,"about_ca_system_score_gemma":0.00080023607,"threshold_uncertainty_score":0.054747045},"labels":[],"label_agreement":null},{"id":"W4390124666","doi":"10.1016/j.jval.2023.09.2662","title":"PCR225 The Added Value of the Cognition, Dining, Gastrointestinal Problems, Sleep, and Tiredness Bolt-Ons for the EQ-5D-5L in Patients With Coeliac Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cognition; Coeliac disease; Medicine; Disease; Value (mathematics); Sleep (system call); Physical medicine and rehabilitation; Psychiatry; Internal medicine; Computer science; Machine learning","score_opus":0.05487262209103292,"score_gpt":0.29920280237462277,"score_spread":0.24433018028358985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555589,0.01871899,0.0008054285,0.0042929607,0.0007608384,0.00014689499,0.006423932,0.00005758666,0.013234516],"genre_scores_gemma":[0.9936573,0.0014003994,0.001198389,0.00061678217,0.00030107461,0.000050285304,0.001577576,0.000009609436,0.0011885971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998511,0.0006992125,0.00012618605,0.00012690773,0.000416273,0.000120461766],"domain_scores_gemma":[0.9970702,0.00160963,0.0004318485,0.00011821003,0.0004868425,0.00028321976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001717038,0.00053590594,0.0010157315,0.000729511,0.0003071914,0.0016137763,0.00045487666,0.00066098996,0.0058792345],"category_scores_gemma":[0.009079506,0.00018796492,0.0016455037,0.0013390962,0.00029862818,0.0007590707,0.0006158348,0.0010066609,0.000665754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013367169,0.00044531564,0.7830467,0.0011394428,0.0028250313,0.000278398,0.00030009286,0.0013901159,0.0010500293,0.00058599457,0.006367921,0.18920377],"study_design_scores_gemma":[0.0017573499,0.0036291934,0.97566766,0.0004949613,0.002965087,0.0004844796,0.00054044975,0.0058726952,0.0010661846,0.0014265723,0.0059769643,0.00011840937],"about_ca_topic_score_codex":0.004723316,"about_ca_topic_score_gemma":0.007760815,"teacher_disagreement_score":0.0058792345,"about_ca_system_score_codex":0.00079034973,"about_ca_system_score_gemma":0.00062583445,"threshold_uncertainty_score":0.019667983},"labels":[],"label_agreement":null},{"id":"W4390124680","doi":"10.1016/j.jval.2023.09.2762","title":"RWD45 Describing Medication Switching Patterns Among Adults With Rheumatoid Arthritis From 2016-2022 Using Real-World Data","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Rheumatoid arthritis; Medicine; Real world data; Computer science; Internal medicine; Data science","score_opus":0.09259842473848416,"score_gpt":0.3330869123943982,"score_spread":0.24048848765591402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124680","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22370589,0.0024780931,0.0018026455,0.00057923514,0.00007916353,0.00010125449,0.7673328,0.00036715533,0.0035536976],"genre_scores_gemma":[0.43549162,0.0014832861,0.003946349,0.00033897496,0.000050341794,0.00031697893,0.55675066,0.00006756679,0.0015541696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794537,0.00047734234,0.00063117023,0.00043845442,0.00033642785,0.00017122374],"domain_scores_gemma":[0.9896097,0.004879994,0.0029767654,0.00089882134,0.0012376026,0.00039705687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021459933,0.0004623534,0.00057462865,0.0029461372,0.0002199689,0.0012971708,0.0005713437,0.0006752081,0.0050066295],"category_scores_gemma":[0.021115791,0.00029187775,0.0021110526,0.0045073056,0.00016508088,0.0008180268,0.00088243815,0.0006932344,0.0015475457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010761435,0.00014650723,0.88107246,0.0020623822,0.0023026003,0.00021067444,0.0003967893,0.009564647,0.00056126056,0.0010293478,0.054181334,0.047395967],"study_design_scores_gemma":[0.0002241372,0.00030026014,0.90648896,0.0011720693,0.0009111661,0.00059387845,0.00070229155,0.010979546,0.00086993957,0.00089994364,0.07675741,0.000100400226],"about_ca_topic_score_codex":0.052189037,"about_ca_topic_score_gemma":0.044550493,"teacher_disagreement_score":0.052189037,"about_ca_system_score_codex":0.0007443027,"about_ca_system_score_gemma":0.0012110837,"threshold_uncertainty_score":0.103770554},"labels":[],"label_agreement":null},{"id":"W4390124693","doi":"10.1016/j.jval.2023.09.2540","title":"PCR101 Patient-Centric-Approach and Personalized Clinical Trials to Increase Patients Participation in Drug Development: Insight from a Targeted Literature Review (TLR)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes","funders":"","keywords":"Drug development; Clinical trial; Drug; Medicine; Personalized medicine; Intensive care medicine; Pharmacology; Bioinformatics; Internal medicine; Biology","score_opus":0.5070844340435421,"score_gpt":0.4871521168423514,"score_spread":0.019932317201190708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0073048035,0.91260135,0.009263125,0.038681936,0.0006822443,0.0006767136,0.0025175458,0.00012134218,0.028150948],"genre_scores_gemma":[0.19021426,0.75198823,0.021962758,0.02778587,0.0012888173,0.0009770864,0.0022591571,0.00009403221,0.0034296638],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9884742,0.008095902,0.0012864933,0.00043560186,0.0014294405,0.00027838504],"domain_scores_gemma":[0.95549905,0.03668688,0.0038299006,0.00061736343,0.002929368,0.00043744696],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018558104,0.0005355847,0.0012024656,0.003683225,0.00021623354,0.003310438,0.0008500411,0.0014837317,0.0100695845],"category_scores_gemma":[0.033385124,0.0002557366,0.0020287307,0.0044063255,0.00045119753,0.0016709467,0.0011054792,0.0013694866,0.0013790026],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008947046,0.00020520293,0.0023073137,0.06104494,0.0030632282,0.00015944958,0.00024731815,0.0013471085,0.0009214661,0.024380645,0.029320447,0.87610817],"study_design_scores_gemma":[0.0020616725,0.0028436186,0.021015245,0.16265826,0.024168024,0.0013789688,0.0008717067,0.003089393,0.0057675755,0.044244062,0.7317425,0.000158987],"about_ca_topic_score_codex":0.0011813078,"about_ca_topic_score_gemma":0.0032606127,"teacher_disagreement_score":0.9814419,"about_ca_system_score_codex":0.0021089572,"about_ca_system_score_gemma":0.0063017,"threshold_uncertainty_score":0.09814578},"labels":[],"label_agreement":null},{"id":"W4390124712","doi":"10.1016/j.jval.2023.09.2743","title":"RWD25 Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of British Columbia","funders":"","keywords":"Exacerbation; COPD; Copd exacerbation; Resource use; Health care; Medicine; Resource (disambiguation); Emergency medicine; Business; Medical emergency; Natural resource economics; Internal medicine; Economics; Economic growth; Computer science; Acute exacerbation of chronic obstructive pulmonary disease","score_opus":0.06440937331467148,"score_gpt":0.323999661133497,"score_spread":0.25959028781882554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97933257,0.0040796157,0.000063419415,0.00017399745,0.000027835156,0.000053906628,0.01447786,0.0000063351376,0.0017845212],"genre_scores_gemma":[0.9889215,0.0014100724,0.000088998466,0.00010257786,0.000019956944,0.000048547787,0.008884336,0.0000059758745,0.00051798945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834085,0.0003708762,0.00027519837,0.00020313793,0.00042807116,0.00038193268],"domain_scores_gemma":[0.9968555,0.0004923392,0.0011181779,0.00014568344,0.0007382374,0.00064997736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019497585,0.00061495206,0.0011943551,0.0025944877,0.0004987845,0.0021566984,0.0013957561,0.0007556331,0.0012095413],"category_scores_gemma":[0.0052419365,0.0003645939,0.0029472862,0.006700584,0.0004737247,0.0006113199,0.0013897701,0.00079257984,0.00015102091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075006235,0.000060194096,0.9939798,0.00014952241,0.001543405,0.000068791494,0.000113766815,0.00025750196,0.000036090238,0.0000640389,0.00077681994,0.0022000023],"study_design_scores_gemma":[0.000051295123,0.000031804062,0.99887973,0.000051924035,0.0002813027,0.000024999723,0.00028094294,0.000105414394,0.000015077503,0.000011894925,0.00025690478,0.000008766435],"about_ca_topic_score_codex":0.7117678,"about_ca_topic_score_gemma":0.7348036,"teacher_disagreement_score":0.2882322,"about_ca_system_score_codex":0.0056360583,"about_ca_system_score_gemma":0.0045561115,"threshold_uncertainty_score":0.5798593},"labels":[],"label_agreement":null},{"id":"W4390124723","doi":"10.1016/j.jval.2023.09.2583","title":"PCR145 Dupilumab Reduces Systemic Corticosteroid Use in Children with Uncontrolled Moderate-to-Severe Asthma Regardless of Prior Exacerbation History","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dupilumab; Exacerbation; Medicine; Asthma; Asthma exacerbations; Corticosteroid; Copd exacerbation; Immunology; Internal medicine","score_opus":0.033270086964335414,"score_gpt":0.266753867250361,"score_spread":0.23348378028602557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280245,0.009103212,0.0002600391,0.00049182936,0.00015865761,0.00004382614,0.00047908124,0.00013883466,0.0065220473],"genre_scores_gemma":[0.9974431,0.00080075086,0.0003563627,0.0002948423,0.00006562653,0.000014079344,0.00026960025,0.000009145838,0.0007465463],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.999721,0.00006386691,0.000018176946,0.000047784633,0.00008125316,0.000067860296],"domain_scores_gemma":[0.99945265,0.00018665499,0.00014178001,0.000018184552,0.000040644332,0.00016012123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025009565,0.00021003764,0.0005263993,0.00012918648,0.00013443155,0.000370052,0.00020992412,0.00023637009,0.0025842204],"category_scores_gemma":[0.0013004427,0.00012450392,0.00039811456,0.000111933674,0.00012857655,0.00021740633,0.00011004706,0.00068568933,0.00040199384],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033737443,0.0030968108,0.39455494,0.0009899333,0.0010442017,0.0009960707,0.00026234647,0.0008517496,0.024414666,0.00034809991,0.019622523,0.52008134],"study_design_scores_gemma":[0.0035557742,0.014733118,0.9560172,0.000256978,0.0007582074,0.0038002278,0.000263241,0.0020299722,0.008146295,0.00011862565,0.010287973,0.000032485794],"about_ca_topic_score_codex":0.0022682077,"about_ca_topic_score_gemma":0.0073943534,"teacher_disagreement_score":0.0025842204,"about_ca_system_score_codex":0.00030289253,"about_ca_system_score_gemma":0.00035731605,"threshold_uncertainty_score":0.008645058},"labels":[],"label_agreement":null},{"id":"W4390124743","doi":"10.1016/j.jval.2023.09.2546","title":"PCR107 (How) Should Cost-Effectiveness Analysis Accommodate Heterogeneity in Patient Preferences?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science; Risk analysis (engineering); Business","score_opus":0.6588872030235842,"score_gpt":0.4794505031011653,"score_spread":0.17943669992241884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124743","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051442813,0.018891359,0.30902654,0.55411804,0.0043542106,0.00046367306,0.0035207525,0.0003694595,0.05781315],"genre_scores_gemma":[0.7831806,0.009232162,0.12169285,0.07046743,0.006645423,0.00071984297,0.0012796524,0.00047187164,0.006310135],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97104776,0.024093091,0.0011520236,0.0012438183,0.0019010314,0.0005622517],"domain_scores_gemma":[0.8910718,0.092804305,0.004089143,0.0049236994,0.006275867,0.00083522673],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04473373,0.0005485009,0.0015353046,0.001071297,0.00039410984,0.003987429,0.0013481594,0.0030556356,0.008415734],"category_scores_gemma":[0.23946893,0.0006635358,0.0024627997,0.0015597102,0.0014338379,0.006298742,0.001008149,0.0036146718,0.0017259003],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010006148,0.00035523332,0.030286863,0.002055988,0.0035062097,0.0003530112,0.0004916573,0.041214768,0.00068095257,0.1747815,0.10312915,0.64214414],"study_design_scores_gemma":[0.0006049581,0.00025362446,0.023935573,0.0017725285,0.001403251,0.0008510328,0.0007838796,0.104834825,0.0013510043,0.7886806,0.07534267,0.00018596908],"about_ca_topic_score_codex":0.0063355677,"about_ca_topic_score_gemma":0.004199888,"teacher_disagreement_score":0.9552663,"about_ca_system_score_codex":0.0019154304,"about_ca_system_score_gemma":0.0034157059,"threshold_uncertainty_score":0.23657739},"labels":[],"label_agreement":null},{"id":"W4390124903","doi":"10.1016/j.jval.2023.09.2673","title":"PCR236 Treatment Preferences Among Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in France, Germany, Italy, Japan, Spain, the United States, and the United Kingdom","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Lymphoma; Demography; Internal medicine; Sociology; Biology","score_opus":0.027145006543339806,"score_gpt":0.26055075679010387,"score_spread":0.23340575024676405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998458,0.00040449502,0.000013708314,0.00018759635,0.0000042203783,0.0000019977297,0.0002119284,0.0000011471997,0.00071693904],"genre_scores_gemma":[0.9996207,0.00008712228,0.000009043173,0.00007131631,0.0000041036765,0.0000013829799,0.00010411274,9.4844455e-7,0.00010126313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994562,0.00021327584,0.000060277984,0.000070148104,0.000065701,0.00013444315],"domain_scores_gemma":[0.99865913,0.00033170203,0.0005739935,0.000023028879,0.00011986776,0.0002922524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004019216,0.00009356202,0.00026390576,0.0005368533,0.00030988082,0.00075665093,0.00017543735,0.00043927348,0.0019884005],"category_scores_gemma":[0.0021298442,0.0000888661,0.00034091636,0.0010630843,0.00028725283,0.00035216572,0.0003527176,0.00037013087,0.00021545829],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030275725,0.00002277272,0.9956493,0.000012136697,0.000065250875,0.00016669437,0.00029266768,0.00012592894,0.00012782839,0.000051945248,0.00028812533,0.0028944635],"study_design_scores_gemma":[0.000012820963,0.00011290138,0.99788815,0.000011581284,0.000023945975,0.00029493027,0.00092413824,0.00015923409,0.000030465135,0.000022146343,0.0005126711,0.0000069554367],"about_ca_topic_score_codex":0.024551773,"about_ca_topic_score_gemma":0.027165517,"teacher_disagreement_score":0.024551773,"about_ca_system_score_codex":0.0011384344,"about_ca_system_score_gemma":0.00039353938,"threshold_uncertainty_score":0.048817754},"labels":[],"label_agreement":null},{"id":"W4390124954","doi":"10.1016/j.jval.2023.09.2693","title":"PCR256 Correlation of Patient-Reported Vitiligo Noticeability Scale With Physician-Assessed Facial Vitiligo Area Scoring Index Responses: Post Hoc Analyses From the True-V Trials of Ruxolitinib Cream in Vitiligo","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Vitiligo; Medicine; Post-hoc analysis; Dermatology; Post hoc; Correlation; Internal medicine; Mathematics","score_opus":0.08675642530319132,"score_gpt":0.3663956141107383,"score_spread":0.27963918880754696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711967,0.00016514723,0.000568454,0.000045421202,0.00002924793,0.000044690158,0.0006141268,0.000019753861,0.0013934185],"genre_scores_gemma":[0.99809283,0.000022838147,0.00021729442,0.00002536719,0.000015344362,0.00004770449,0.00047078604,0.0000116160945,0.0010961511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974241,0.0012300495,0.00013162731,0.00052779773,0.00039134084,0.00029514253],"domain_scores_gemma":[0.9935116,0.004996695,0.000654631,0.00032489854,0.00025235387,0.0002597578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034175017,0.00035206135,0.0007660376,0.00036425272,0.0002278201,0.00074811315,0.00043084446,0.00035123562,0.0057403506],"category_scores_gemma":[0.005768314,0.00025118727,0.0009553336,0.00036130802,0.00034346743,0.00076417875,0.00039641286,0.0011062415,0.00055758475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14935742,0.0022262356,0.7802257,0.00018587355,0.006066551,0.00021951777,0.00047780527,0.0031038097,0.016052604,0.0003202534,0.00268492,0.039079376],"study_design_scores_gemma":[0.0020732349,0.016330333,0.9677315,0.000012148439,0.0013730829,0.00021370042,0.0002450952,0.0058807004,0.00427652,0.00019348359,0.00163595,0.000034200773],"about_ca_topic_score_codex":0.0010490868,"about_ca_topic_score_gemma":0.0012367012,"teacher_disagreement_score":0.0057403506,"about_ca_system_score_codex":0.00029883097,"about_ca_system_score_gemma":0.0003322221,"threshold_uncertainty_score":0.019203365},"labels":[],"label_agreement":null},{"id":"W4390125005","doi":"10.1016/j.jval.2023.09.2290","title":"MT64 The Role of Digital Health Technologies in Out-of-Hospital Management of Mental Health Disorders in the UK","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Mental health; Digital health; Health management system; Medicine; Psychiatry; Psychology; Alternative medicine; Political science; Health care; Pathology","score_opus":0.03966932086109155,"score_gpt":0.37933598816397296,"score_spread":0.3396666673028814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56866753,0.0441148,0.00048887247,0.29281205,0.0023892,0.00015980491,0.0006520261,0.000067351735,0.0906483],"genre_scores_gemma":[0.9460949,0.029071763,0.00064601353,0.012500736,0.0007822701,0.00009345784,0.00014688884,0.0000329531,0.010631027],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99832815,0.00087807345,0.000114784714,0.00007205817,0.0002644437,0.0003425378],"domain_scores_gemma":[0.98383784,0.0077095814,0.0019701615,0.00022138162,0.0013571632,0.004903804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001814639,0.00014470734,0.00020294863,0.0010137309,0.001037899,0.0031558657,0.00034615342,0.0012490936,0.01970723],"category_scores_gemma":[0.019114248,0.00021401464,0.00034505,0.0009819331,0.0012697411,0.001419155,0.0019479248,0.0019901262,0.00062452175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017990442,0.0011123166,0.13577382,0.003301277,0.00014778203,0.0018063457,0.009235325,0.00083610363,0.001353655,0.012734428,0.08637869,0.7455211],"study_design_scores_gemma":[0.000595486,0.0023245662,0.8029539,0.011169475,0.00014155624,0.0014616265,0.01869284,0.0013504912,0.00061624456,0.004590494,0.15592161,0.00018163012],"about_ca_topic_score_codex":0.05117246,"about_ca_topic_score_gemma":0.10298344,"teacher_disagreement_score":0.05117246,"about_ca_system_score_codex":0.0059741535,"about_ca_system_score_gemma":0.007184068,"threshold_uncertainty_score":0.10174924},"labels":[],"label_agreement":null},{"id":"W4390125246","doi":"10.1016/j.jval.2023.09.2687","title":"PCR250 Management of Osteogenesis Imperfecta: Self-Reported Funding Sources for Healthcare, Consumables and Services Across the EU5 and Nordics","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Consumables; Osteogenesis imperfecta; Business; Medicine; Marketing; Pathology","score_opus":0.05284334681061882,"score_gpt":0.3669621924580889,"score_spread":0.3141188456474701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87355673,0.0324048,0.0029637783,0.007661715,0.00036526122,0.0002741444,0.017353674,0.0001239271,0.06529593],"genre_scores_gemma":[0.97674507,0.006149347,0.0037509257,0.00067182473,0.000073370844,0.00016532783,0.0052529303,0.00005774722,0.0071335346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973055,0.0009144647,0.00035829382,0.00024199797,0.00090222544,0.0002773991],"domain_scores_gemma":[0.99492705,0.0013339786,0.002146323,0.00019403295,0.00069644104,0.0007022327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029946705,0.00016560018,0.00026832803,0.0018749153,0.0005650575,0.0012550798,0.00045084904,0.00045670648,0.004819493],"category_scores_gemma":[0.007366189,0.00014184971,0.00025019917,0.002769161,0.00040743558,0.00029723297,0.0010473666,0.00035439545,0.00052493747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038097732,0.0002218888,0.73932165,0.00087585323,0.00037056537,0.002126186,0.0014520708,0.000892708,0.0017251022,0.0035997203,0.024277193,0.22475609],"study_design_scores_gemma":[0.000044914486,0.00016538575,0.9259959,0.001580207,0.000146851,0.005105068,0.0019773017,0.00054595707,0.0008165492,0.0007531721,0.06283323,0.000035545738],"about_ca_topic_score_codex":0.025394632,"about_ca_topic_score_gemma":0.02819996,"teacher_disagreement_score":0.025394632,"about_ca_system_score_codex":0.0012586076,"about_ca_system_score_gemma":0.0040791533,"threshold_uncertainty_score":0.050493598},"labels":[],"label_agreement":null},{"id":"W4390125469","doi":"10.1016/j.jval.2023.09.1344","title":"HPR25 Germany: Leading the Way for Digital Health Technology Assessment in Europe","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Health technology; Political science; Health care; Law","score_opus":0.45876416220943367,"score_gpt":0.476087155703371,"score_spread":0.017322993493937344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125469","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13628578,0.07073279,0.05117804,0.18308869,0.011543546,0.0006769359,0.017786613,0.0034987195,0.52520883],"genre_scores_gemma":[0.54337555,0.030477965,0.0753352,0.02110945,0.0029766469,0.0006139194,0.01460219,0.0013137014,0.3101955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977151,0.0006637489,0.0001399141,0.0003218428,0.00063425,0.00052515167],"domain_scores_gemma":[0.9970937,0.00060789695,0.00024169311,0.00028393284,0.0006048494,0.0011679131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007031687,0.00073387,0.0005553455,0.0018819763,0.0007220681,0.0058790534,0.0010276071,0.0032538287,0.02971575],"category_scores_gemma":[0.0052989433,0.0002907662,0.00055928965,0.001983523,0.0009464979,0.0035024118,0.0034004431,0.0028511824,0.007250772],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004312021,0.00029184704,0.005706856,0.0006393064,0.00010861541,0.0007571807,0.0003241587,0.004102814,0.0025325783,0.3231485,0.3125216,0.34943536],"study_design_scores_gemma":[0.0001369799,0.00017947363,0.02146807,0.0006299772,0.00005532547,0.00039256876,0.00024204266,0.0024919312,0.0032567868,0.016499,0.95459753,0.000050212293],"about_ca_topic_score_codex":0.012300074,"about_ca_topic_score_gemma":0.0033770152,"teacher_disagreement_score":0.02971575,"about_ca_system_score_codex":0.0033980506,"about_ca_system_score_gemma":0.009998488,"threshold_uncertainty_score":0.0994091},"labels":[],"label_agreement":null},{"id":"W4390125519","doi":"10.1016/j.jval.2023.09.1316","title":"PT8 Five-Year Healthcare Resource Consumption and Direct Costs of Women with a New Diagnosis of Hr+/HER2- Breast Cancer Primary or Advanced: Analysis of a Large Italian Administrative Database","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Breast cancer; Consumption (sociology); Resource consumption; Medicine; Database; Health care; Resource (disambiguation); Cancer; Business; Computer science; Internal medicine; Economics; Economic growth","score_opus":0.06180095294210449,"score_gpt":0.3222798541341488,"score_spread":0.2604789011920443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8432161,0.0007888341,0.0003397574,0.00035511266,0.000022657694,0.00004042959,0.1532582,0.000059579907,0.0019194023],"genre_scores_gemma":[0.8595268,0.00043682926,0.00036135467,0.00011508101,0.000055002412,0.000120055556,0.13680859,0.000028487968,0.0025477938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917346,0.00022337143,0.00010323012,0.00023315438,0.00010785531,0.00015878717],"domain_scores_gemma":[0.99571604,0.0012324664,0.0018380508,0.000644555,0.00028543317,0.0002834232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090158376,0.00046135992,0.00063444587,0.0027055216,0.0002696578,0.0010375744,0.00087878696,0.00074032677,0.0060895337],"category_scores_gemma":[0.005340722,0.00043639657,0.0018199334,0.004553556,0.0002599546,0.00048634253,0.00085658237,0.00068353035,0.0013503548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008089692,0.000109444954,0.98468786,0.000112579764,0.00082964025,0.00016984469,0.00007621437,0.0019071756,0.00009419327,0.00017482952,0.007401459,0.0036278137],"study_design_scores_gemma":[0.00006688846,0.0000738381,0.9951186,0.000028155091,0.0001992492,0.00021654568,0.000102989594,0.0019310017,0.00005969472,0.00005467228,0.0021359273,0.000012407943],"about_ca_topic_score_codex":0.08781891,"about_ca_topic_score_gemma":0.04460339,"teacher_disagreement_score":0.08781891,"about_ca_system_score_codex":0.0012604443,"about_ca_system_score_gemma":0.0011388378,"threshold_uncertainty_score":0.1746155},"labels":[],"label_agreement":null},{"id":"W4390125524","doi":"10.1016/j.jval.2023.09.1372","title":"HPR54 Policy Approaches to the Regulation and Reimbursement of Pediatric Medicines: Comparing Canadian, European, and UK Health Systems","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Reimbursement; Business; Public economics; Family medicine; Medicine; Political science; Health care; Economics; Law","score_opus":0.3992960127610062,"score_gpt":0.4098861714505228,"score_spread":0.010590158689516627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125524","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51554984,0.013198802,0.0029995048,0.15163432,0.0005092476,0.00048323616,0.003855604,0.00013852121,0.31163096],"genre_scores_gemma":[0.9763698,0.0028696167,0.0022526404,0.0111760795,0.00009451483,0.000085137246,0.00065139774,0.00003226678,0.0064685917],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9624803,0.0072901743,0.0010862031,0.0010752546,0.015159782,0.012908188],"domain_scores_gemma":[0.95283115,0.015555377,0.004321274,0.0013304224,0.0195961,0.0063656205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015598225,0.00022250332,0.0004272287,0.0039582658,0.005031543,0.010980681,0.0020478005,0.0033476,0.0065396987],"category_scores_gemma":[0.056120485,0.00033680204,0.001076109,0.006849248,0.003968361,0.002421438,0.0029601285,0.0028338633,0.0002866217],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010332514,0.0003263981,0.19949202,0.0011417925,0.00041991338,0.00077375036,0.017208077,0.008261322,0.0016161037,0.5529872,0.07476684,0.14197336],"study_design_scores_gemma":[0.00023756316,0.00038644168,0.7318373,0.0021801621,0.00037688654,0.00036709718,0.030084064,0.003876683,0.0019681284,0.012074047,0.21633697,0.00027467863],"about_ca_topic_score_codex":0.95910406,"about_ca_topic_score_gemma":0.9653805,"teacher_disagreement_score":0.891294,"about_ca_system_score_codex":0.10870601,"about_ca_system_score_gemma":0.17957613,"threshold_uncertainty_score":0.788721},"labels":[],"label_agreement":null},{"id":"W4390125527","doi":"10.1016/j.jval.2023.09.1396","title":"HPR78 From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Coronavirus disease 2019 (COVID-19); Ripple; Business; Internet privacy; Medicine; Computer science; Economics; Internal medicine; Engineering; Economic growth; Health care","score_opus":0.17823753359767747,"score_gpt":0.47125299226925815,"score_spread":0.2930154586715807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125527","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08276774,0.0062628933,0.0011306402,0.7211985,0.00422207,0.00032728404,0.010035361,0.00040950693,0.17364599],"genre_scores_gemma":[0.71845156,0.007979084,0.0035200296,0.16563721,0.002160394,0.00022219315,0.0042441157,0.0008815484,0.09690386],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9598107,0.0036173419,0.0013358254,0.0016235651,0.019909823,0.013702745],"domain_scores_gemma":[0.84381807,0.022473475,0.006287672,0.0023799753,0.06149157,0.06354935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017686574,0.00037046729,0.00085815205,0.0032347098,0.011142569,0.017618645,0.0034659887,0.0056030424,0.03454715],"category_scores_gemma":[0.08080174,0.0010277032,0.0013530557,0.0050517325,0.0053472742,0.0030711477,0.006306656,0.009435197,0.0027692348],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00045664498,0.00019255996,0.066874385,0.00039184463,0.00012927185,0.000554602,0.0029686925,0.0009635172,0.00040652047,0.03271131,0.81547785,0.078872845],"study_design_scores_gemma":[0.00028438304,0.00022342693,0.22663532,0.0020421133,0.00018084867,0.0003406919,0.012647711,0.002775304,0.00079590303,0.007970682,0.74574345,0.0003601273],"about_ca_topic_score_codex":0.9871569,"about_ca_topic_score_gemma":0.99307126,"teacher_disagreement_score":0.8152438,"about_ca_system_score_codex":0.1847562,"about_ca_system_score_gemma":0.46380782,"threshold_uncertainty_score":0.94556725},"labels":[],"label_agreement":null},{"id":"W4390125633","doi":"10.1016/j.jval.2023.09.1434","title":"HPR116 Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Payment; Business; Finance","score_opus":0.18683578292174954,"score_gpt":0.4635676073281766,"score_spread":0.2767318244064271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125633","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034459576,0.016070677,0.33166054,0.3223944,0.0041164174,0.0015370739,0.0009463273,0.0013594825,0.2874555],"genre_scores_gemma":[0.43307167,0.012937214,0.50092745,0.018705394,0.002571835,0.0015921374,0.0010356562,0.00031111075,0.028847527],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9724195,0.013146937,0.003379502,0.0014537289,0.007879234,0.001721138],"domain_scores_gemma":[0.95205694,0.021104654,0.0057587437,0.0047398536,0.013829529,0.00251039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023387631,0.001056151,0.0012133219,0.008889998,0.004094713,0.017600482,0.0027769606,0.007077514,0.0124858],"category_scores_gemma":[0.049700744,0.00058072153,0.0020371636,0.0069986805,0.013137502,0.027931934,0.007128901,0.008306582,0.0027094898],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005539056,0.00016265633,0.005355166,0.00043630085,0.000033030014,0.00007850664,0.002817549,0.0005513829,0.00020889212,0.8182387,0.021657607,0.15040489],"study_design_scores_gemma":[0.00011837788,0.00048580265,0.0077433405,0.0028042647,0.000118170006,0.0007456177,0.0063711745,0.012467655,0.0008750712,0.7598385,0.20825356,0.00017850082],"about_ca_topic_score_codex":0.006356197,"about_ca_topic_score_gemma":0.006566548,"teacher_disagreement_score":0.023387631,"about_ca_system_score_codex":0.007772096,"about_ca_system_score_gemma":0.01991066,"threshold_uncertainty_score":0.12368709},"labels":[],"label_agreement":null},{"id":"W4390125642","doi":"10.1016/j.jval.2023.09.1296","title":"EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Pulmonary disease; Medicine; Intensive care medicine; Disease; Resource consumption; Health care; Internal medicine; Cardiology; Economic growth; Economics","score_opus":0.055644098638278794,"score_gpt":0.36136678470511346,"score_spread":0.30572268606683467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99432445,0.00065105606,0.00004005841,0.00014887947,0.000018424433,0.0000133701515,0.0036489307,0.000004970284,0.0011499852],"genre_scores_gemma":[0.9950884,0.00029808225,0.000058177757,0.00007714279,0.000047785026,0.00002452955,0.0039725807,0.000005806476,0.00042756865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993912,0.0002272989,0.00006164296,0.00013698044,0.000075937336,0.00010702296],"domain_scores_gemma":[0.99898237,0.00024756236,0.00041521018,0.00010867588,0.00007647972,0.00016967818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006934296,0.0005151498,0.00051100773,0.0010266664,0.00023720585,0.00089904753,0.0005163003,0.00086868886,0.0018964839],"category_scores_gemma":[0.0021179798,0.00030249197,0.0013311603,0.0015935509,0.00024231969,0.0004779718,0.0008968927,0.00067863497,0.00045632198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006438352,0.00012355924,0.99642545,0.0000486276,0.0003873222,0.00007624921,0.00007954718,0.00014211875,0.000075937176,0.000034920053,0.0006006695,0.0013617888],"study_design_scores_gemma":[0.000025177222,0.000047853166,0.99949014,0.000008234742,0.000066201,0.000034968318,0.00007496808,0.00008590362,0.000007955466,0.000011744741,0.00014363737,0.0000030674853],"about_ca_topic_score_codex":0.017058048,"about_ca_topic_score_gemma":0.014369653,"teacher_disagreement_score":0.017058048,"about_ca_system_score_codex":0.0006379149,"about_ca_system_score_gemma":0.00038627014,"threshold_uncertainty_score":0.033917487},"labels":[],"label_agreement":null},{"id":"W4390125944","doi":"10.1016/j.jval.2023.09.1818","title":"HTA134 The Impact of Non-Comparative Data for Non-Orphan Drugs on HTA and Pricing Outcomes in Germany: Can an Added Benefit Ever be Proven?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Orphan drug; Economics; Actuarial science; Public economics; Medicine; Bioinformatics; Biology","score_opus":0.5317275469605763,"score_gpt":0.5061777442554654,"score_spread":0.02554980270511098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125944","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.70661163,0.040678453,0.008633427,0.06840794,0.00407913,0.0002892011,0.13476461,0.00029310724,0.036242347],"genre_scores_gemma":[0.9631314,0.002374341,0.0027200403,0.00356661,0.0006434738,0.000110741494,0.023475656,0.0000691777,0.0039086225],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.98489976,0.009722141,0.00096483546,0.00107078,0.0024349696,0.0009075397],"domain_scores_gemma":[0.94267917,0.03329406,0.009735996,0.007293906,0.0052501047,0.0017467369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023335822,0.00045202792,0.00093636446,0.0017760127,0.00032520725,0.0029564772,0.001289991,0.0013447156,0.010380043],"category_scores_gemma":[0.054706864,0.00032525996,0.0018768535,0.0027702092,0.0011074767,0.0026235112,0.0014591389,0.0017480904,0.0008691281],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018610574,0.0010319082,0.38845184,0.004284816,0.011817822,0.0007830357,0.0006595407,0.014224199,0.0015362795,0.10273395,0.1466447,0.30922148],"study_design_scores_gemma":[0.00157456,0.002238427,0.852895,0.002562318,0.0044452907,0.00040406914,0.0006159512,0.009300998,0.0037852016,0.018606566,0.1033007,0.0002709693],"about_ca_topic_score_codex":0.03135963,"about_ca_topic_score_gemma":0.020566735,"teacher_disagreement_score":0.03135963,"about_ca_system_score_codex":0.0031474913,"about_ca_system_score_gemma":0.0031469543,"threshold_uncertainty_score":0.123413146},"labels":[],"label_agreement":null},{"id":"W4390125958","doi":"10.1016/j.jval.2023.09.391","title":"EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Biosimilar; Tocilizumab; Adalimumab; Perspective (graphical); Medicine; Internal medicine; Computer science; Rheumatoid arthritis; Artificial intelligence","score_opus":0.15026313276785994,"score_gpt":0.3781046183827965,"score_spread":0.22784148561493658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125958","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.034059595,0.24874122,0.01621639,0.54775625,0.007022943,0.00009285419,0.0018535787,0.00026603843,0.1439911],"genre_scores_gemma":[0.6304574,0.13430995,0.016956089,0.1692997,0.021860084,0.00016437186,0.0013214889,0.00032301075,0.025307864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932902,0.0035908443,0.00039113287,0.00048002484,0.0016176323,0.00063021044],"domain_scores_gemma":[0.9872458,0.0070117414,0.0016130473,0.00045666256,0.0026958436,0.0009768324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011436654,0.00055063,0.00084598473,0.0009849089,0.00033609683,0.008031444,0.0010203837,0.006595181,0.015747594],"category_scores_gemma":[0.023057122,0.0002372027,0.0016781595,0.0011359319,0.0017763383,0.0036199135,0.0014131368,0.0044958116,0.0014897663],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004853532,0.00034473278,0.0030999673,0.0018122493,0.0009580478,0.00055584364,0.00021691367,0.00768477,0.0045846347,0.30789903,0.09096283,0.57702744],"study_design_scores_gemma":[0.0011966077,0.0019422204,0.01402285,0.0064944536,0.0010192529,0.0016598067,0.00056917546,0.0043821367,0.00367133,0.13392289,0.8309529,0.00016643995],"about_ca_topic_score_codex":0.0031785076,"about_ca_topic_score_gemma":0.002990772,"teacher_disagreement_score":0.015747594,"about_ca_system_score_codex":0.0044423863,"about_ca_system_score_gemma":0.0057392376,"threshold_uncertainty_score":0.060483515},"labels":[],"label_agreement":null},{"id":"W4390125967","doi":"10.1016/j.jval.2023.09.654","title":"EE388 Cost of Illness for Advanced Hepatocellular Carcinoma (aHCC) in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; AstraZeneca (Canada); Sunnybrook Hospital","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Oncology; Internal medicine","score_opus":0.059121993882623965,"score_gpt":0.2473479164425411,"score_spread":0.18822592255991713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74893296,0.0075695934,0.0004952167,0.0144246975,0.00035551278,0.00036178052,0.18322986,0.00009035526,0.044539977],"genre_scores_gemma":[0.9485208,0.0036675252,0.0005249247,0.00083689607,0.00009184578,0.00008802752,0.021660822,0.000027116725,0.02458212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989668,0.000078145,0.00008999153,0.000071447546,0.00040004725,0.00039359013],"domain_scores_gemma":[0.99693066,0.00012799547,0.00046409946,0.00004192983,0.0014402147,0.0009951451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046965404,0.00034129666,0.0005091844,0.0018643654,0.0018063568,0.0015899243,0.0010634146,0.00062955037,0.0067765294],"category_scores_gemma":[0.0031372225,0.00044624857,0.0011245298,0.0045375186,0.000472927,0.00045127343,0.00094231433,0.0011352786,0.000422054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042852445,0.00010486982,0.9014251,0.0005155881,0.0004143485,0.00075425446,0.00055445614,0.0034900364,0.00022001634,0.0034416986,0.06863467,0.020016437],"study_design_scores_gemma":[0.00009002215,0.000041836247,0.9776177,0.0001717265,0.000116157076,0.00022305571,0.0011676511,0.0023583118,0.00005901669,0.00022239068,0.017901799,0.000030340625],"about_ca_topic_score_codex":0.9988366,"about_ca_topic_score_gemma":0.9993968,"teacher_disagreement_score":0.89952445,"about_ca_system_score_codex":0.10047554,"about_ca_system_score_gemma":0.09713584,"threshold_uncertainty_score":0.7290045},"labels":[],"label_agreement":null},{"id":"W4390125989","doi":"10.1016/j.jval.2023.09.620","title":"EE354 Value for Money: Evaluating the Economic Benefit of a Hypothetical Disease Modifying Therapy for Alzheimer's Disease From Canadian Payer and Societal Perspectives","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Value for money; Value (mathematics); Medicine; Economics; Intensive care medicine; Psychology; Public economics; Computer science; Internal medicine","score_opus":0.4749751899164508,"score_gpt":0.45748576411303055,"score_spread":0.017489425803420278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5188687,0.018311631,0.030618038,0.025967369,0.0010717206,0.001992498,0.059943736,0.0005077808,0.34271848],"genre_scores_gemma":[0.9611486,0.002624951,0.012424522,0.00081404566,0.0001216522,0.00034598983,0.0065607107,0.000073857176,0.015885683],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956273,0.0022850002,0.00014658977,0.00014656727,0.0012503674,0.00054423325],"domain_scores_gemma":[0.9889249,0.00774932,0.00027919174,0.00025794384,0.0021937252,0.00059492665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068911426,0.0009598626,0.0009640455,0.0020013074,0.0011805868,0.0036553096,0.001190851,0.0018531485,0.009809515],"category_scores_gemma":[0.03354591,0.00036441477,0.0012847444,0.0029679819,0.0010382042,0.0009924169,0.0010076171,0.0019482475,0.00038896743],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010904928,0.0012974339,0.04863763,0.0023851832,0.0024904683,0.0008257679,0.00058685354,0.4069487,0.0014325622,0.17713629,0.14265613,0.20469809],"study_design_scores_gemma":[0.00283205,0.0019385164,0.109603934,0.0013800763,0.0029409314,0.0005087484,0.0020086437,0.68639004,0.0025018519,0.07005151,0.119335495,0.00050823286],"about_ca_topic_score_codex":0.83602023,"about_ca_topic_score_gemma":0.84438,"teacher_disagreement_score":0.9716873,"about_ca_system_score_codex":0.02831269,"about_ca_system_score_gemma":0.03037568,"threshold_uncertainty_score":0.3298909},"labels":[],"label_agreement":null},{"id":"W4390126012","doi":"10.1016/j.jval.2023.09.349","title":"EE77 The Cost-Effectiveness of Tradition Chinese Medicine Icaritin Versus Cinobufotalin in Patients with Unresectable Advanced Hepatocellular Carcinoma in China","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Medicinal Plant Pharmacodynamics Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centennial College","funders":"","keywords":"Hepatocellular carcinoma; China; Medicine; Traditional Chinese medicine; Oncology; Traditional medicine; Internal medicine; Alternative medicine; History; Pathology","score_opus":0.14768610125522946,"score_gpt":0.4517254448553063,"score_spread":0.30403934360007684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934969,0.0051132804,0.000045762405,0.0003754742,0.000031837146,0.000039006794,0.0001700925,0.0000028984,0.0007246951],"genre_scores_gemma":[0.9985796,0.0007555619,0.000060585273,0.00009733268,0.000035852514,0.000018144217,0.00021374434,7.322182e-7,0.00023848453],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99956924,0.00017188977,0.00004089489,0.000049924023,0.000050347844,0.00011762176],"domain_scores_gemma":[0.9995684,0.0001199864,0.00012684127,0.000015212094,0.000035228768,0.00013434046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006078615,0.00034942242,0.0008392364,0.00046215157,0.00030075826,0.00056359393,0.00032252228,0.0003905385,0.0018888445],"category_scores_gemma":[0.0012735127,0.00014822226,0.0021903745,0.00080480153,0.00034630692,0.00047934998,0.00038544228,0.00053779414,0.0000731876],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1975105,0.0030316892,0.5610044,0.0019996262,0.0077165617,0.0009980912,0.00032910384,0.008091215,0.0027300979,0.00096096226,0.0017880485,0.21383974],"study_design_scores_gemma":[0.023203993,0.034700237,0.9086396,0.00041640297,0.012765308,0.00060236914,0.0010781967,0.011582584,0.0014688323,0.0010372205,0.0043937173,0.00011156882],"about_ca_topic_score_codex":0.015211582,"about_ca_topic_score_gemma":0.021390378,"teacher_disagreement_score":0.015211582,"about_ca_system_score_codex":0.0031839632,"about_ca_system_score_gemma":0.0018766624,"threshold_uncertainty_score":0.030246079},"labels":[],"label_agreement":null},{"id":"W4390126073","doi":"10.1016/j.jval.2023.09.1034","title":"PT44 Cost-Effectiveness of Olaparib Vs. Rucaparib for Patients with Metastatic Castration-Resistant Prostate Cancer – the Canadian Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University","funders":"","keywords":"Olaparib; Prostate cancer; Medicine; Oncology; Perspective (graphical); Internal medicine; Gynecology; Cancer; Poly ADP ribose polymerase; Computer science; Biology; Artificial intelligence","score_opus":0.07375261166157042,"score_gpt":0.37935217719536884,"score_spread":0.3055995655337984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126073","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24904072,0.36404338,0.0026255688,0.21564169,0.0038344664,0.000798592,0.03246279,0.0002480011,0.13130482],"genre_scores_gemma":[0.8974296,0.0667907,0.0024320013,0.015773993,0.002416818,0.00014922228,0.0071931966,0.00010123322,0.0077133295],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976545,0.00081351114,0.00012658068,0.00018578509,0.00060238136,0.00061736314],"domain_scores_gemma":[0.9961218,0.0010311175,0.0005857553,0.00006526847,0.00087560574,0.0013203789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002320526,0.00095948315,0.0022402327,0.0010325576,0.0007860864,0.003953302,0.0015860829,0.0016594296,0.013812579],"category_scores_gemma":[0.008088346,0.00041179097,0.0043384316,0.002666338,0.0010016881,0.0010077558,0.00077146856,0.0037752197,0.00069232757],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.091315985,0.0009409283,0.028493684,0.0078020836,0.013090363,0.0007769188,0.00037683875,0.06626094,0.0027709408,0.03038518,0.1568108,0.60097533],"study_design_scores_gemma":[0.06256903,0.022068694,0.39767691,0.017205654,0.050842654,0.0029884046,0.0028269547,0.07260078,0.0025739372,0.036237545,0.33122113,0.0011882519],"about_ca_topic_score_codex":0.74114996,"about_ca_topic_score_gemma":0.8497098,"teacher_disagreement_score":0.94940794,"about_ca_system_score_codex":0.050592035,"about_ca_system_score_gemma":0.049420383,"threshold_uncertainty_score":0.52074885},"labels":[],"label_agreement":null},{"id":"W4390126123","doi":"10.1016/j.jval.2023.09.656","title":"EE390 Optimizing the Use of Risk Factors to Guide the Cost-Effective Use of Palivizumab Prophylaxis Against Severe Respiratory Syncytial Virus Infection in Korean Infants Born 32–35 Weeks’ Gestational Age","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Virus; Virology; Biology; Pregnancy","score_opus":0.16633067683303307,"score_gpt":0.3960097912728213,"score_spread":0.22967911443978825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955618,0.016618982,0.005270306,0.008180501,0.0005081641,0.00030982247,0.001929686,0.00015107737,0.011413396],"genre_scores_gemma":[0.9914135,0.0019743205,0.004460386,0.00068512047,0.00011399317,0.00008072379,0.00058509764,0.000022745146,0.000664127],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989303,0.0004927642,0.00016573817,0.0000901603,0.00017407682,0.00014687216],"domain_scores_gemma":[0.99892634,0.00032407584,0.00031779613,0.000039048584,0.0002140481,0.00017874532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012064489,0.00037697481,0.00060915254,0.0004953943,0.00019159657,0.00086045207,0.00045779636,0.0004823805,0.001912077],"category_scores_gemma":[0.0054577813,0.0001691188,0.00079169637,0.00045306413,0.00011550524,0.0006111251,0.00040032092,0.0007796933,0.0002999885],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00370323,0.00090435427,0.6294549,0.0007096415,0.00069202366,0.0006232274,0.00021615802,0.0034249965,0.0025026465,0.0010578783,0.009398072,0.34731278],"study_design_scores_gemma":[0.00088045694,0.0037697994,0.914841,0.0020340183,0.0021947848,0.0016979913,0.0009789892,0.036131274,0.0049910354,0.002174172,0.030193971,0.00011250772],"about_ca_topic_score_codex":0.0066338317,"about_ca_topic_score_gemma":0.0074753785,"teacher_disagreement_score":0.0066338317,"about_ca_system_score_codex":0.0008791073,"about_ca_system_score_gemma":0.0023010077,"threshold_uncertainty_score":0.013190389},"labels":[],"label_agreement":null},{"id":"W4390126168","doi":"10.1016/j.jval.2023.09.319","title":"EE46 BoNT-As for Cervical Dystonia: Cost of Treatment and Response to Therapy in Canadian Patients","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Cervical dystonia; Medicine; Dystonia; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.0537677110640155,"score_gpt":0.34135118690507277,"score_spread":0.28758347584105726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97448957,0.004162922,0.00008930835,0.0036366065,0.00005553013,0.00005894225,0.006554903,0.000011484486,0.010940703],"genre_scores_gemma":[0.9928625,0.0024343324,0.00023579568,0.0004724856,0.000031655043,0.000018561665,0.0019059376,0.000008611535,0.002030155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990828,0.00009786856,0.00005020111,0.00006722065,0.0003117404,0.00039009715],"domain_scores_gemma":[0.9981912,0.00022572502,0.00038056297,0.000024968842,0.0006511177,0.0005264556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065696833,0.00039948855,0.0005717692,0.0010225651,0.0021426291,0.0014696759,0.00084547576,0.0008457603,0.0060891933],"category_scores_gemma":[0.0042238953,0.000313632,0.0011467296,0.003904378,0.0005265368,0.00058219046,0.00060587906,0.001191814,0.00026999504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031141983,0.0003253789,0.9322317,0.00027400383,0.00036886454,0.00080553023,0.00080199615,0.0012689417,0.00038535817,0.0020826324,0.011683964,0.046657354],"study_design_scores_gemma":[0.00014599398,0.00024797567,0.9902237,0.00017454838,0.00023821421,0.00066586235,0.0018446044,0.001705815,0.00009662588,0.00020190889,0.0043953224,0.00005943027],"about_ca_topic_score_codex":0.9858379,"about_ca_topic_score_gemma":0.9898307,"teacher_disagreement_score":0.9396177,"about_ca_system_score_codex":0.060382325,"about_ca_system_score_gemma":0.034551572,"threshold_uncertainty_score":0.43810648},"labels":[],"label_agreement":null},{"id":"W4390126243","doi":"10.1016/j.jval.2023.09.598","title":"EE332 Evaluation of Hospital Pandemic Control Strategies of a Chinese Tertiary Care Hospital During the Late Phase of COVID-19 Pandemic","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Disaster Response and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Tertiary care; 2019-20 coronavirus outbreak; Phase (matter); Medicine; Control (management); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medical emergency; Emergency medicine; Virology; Computer science; Infectious disease (medical specialty); Disease; Artificial intelligence; Internal medicine; Outbreak","score_opus":0.09191689034729571,"score_gpt":0.4647197002811461,"score_spread":0.3728028099338504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507254,0.000076581324,0.0002935349,0.00036098761,0.000021748094,0.00046761447,0.00017661163,0.000019864054,0.003510644],"genre_scores_gemma":[0.99821293,0.000074079144,0.00046341916,0.00012219703,0.000009919962,0.00014785078,0.00015368596,0.0000024958947,0.0008134342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858403,0.0006699205,0.00007193421,0.00007931924,0.00018792211,0.0004068714],"domain_scores_gemma":[0.9975496,0.00051441125,0.00025610699,0.0000684142,0.00096614874,0.00064526114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003281855,0.0006472582,0.00034592187,0.0007075803,0.001450539,0.0010366377,0.000892721,0.00069851585,0.0029828248],"category_scores_gemma":[0.0039267456,0.0001814918,0.00052066863,0.0004727537,0.00043372926,0.00060246437,0.0009481149,0.00038845788,0.00017919295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024606315,0.017228581,0.5637901,0.0028952009,0.00087590853,0.004001333,0.009617914,0.068011135,0.031127144,0.0045908093,0.011144363,0.26211122],"study_design_scores_gemma":[0.0019376369,0.053730242,0.78674835,0.00029210537,0.0008322347,0.0002627438,0.060832772,0.07138531,0.013710295,0.00072930363,0.00934657,0.00019238886],"about_ca_topic_score_codex":0.063725024,"about_ca_topic_score_gemma":0.059670094,"teacher_disagreement_score":0.063725024,"about_ca_system_score_codex":0.0052886712,"about_ca_system_score_gemma":0.012196879,"threshold_uncertainty_score":0.12670821},"labels":[],"label_agreement":null},{"id":"W4390126259","doi":"10.1016/j.jval.2023.09.476","title":"EE208 A Total Cost of Care Analysis of Immune-Oncology (IO) Treatments for Unresectable Hepatocellular Carcinoma (uHCC): A Canadian Payer Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatocellular carcinoma; Perspective (graphical); Oncology; Medicine; Internal medicine; Computer science","score_opus":0.06253045675848833,"score_gpt":0.30213991439623,"score_spread":0.23960945763774166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42116496,0.057399623,0.033437673,0.06767055,0.0019984336,0.002011874,0.09750398,0.00040781614,0.31840506],"genre_scores_gemma":[0.9222576,0.012897775,0.009633835,0.002901677,0.0004356579,0.00025200145,0.012727753,0.00013121129,0.038762476],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9976109,0.00051611685,0.00006851177,0.00010805039,0.0008925676,0.0008038565],"domain_scores_gemma":[0.9976404,0.0006314601,0.0001353726,0.00007098847,0.0012270873,0.00029479235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022170118,0.0012297801,0.0011931304,0.004381076,0.0012611961,0.003674467,0.0015141936,0.0012411394,0.010152201],"category_scores_gemma":[0.00740246,0.00068644155,0.0031449252,0.0063290596,0.00070236984,0.0010192717,0.00086195493,0.002513116,0.00039422052],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013756119,0.00056509644,0.05097549,0.0014223326,0.0028239186,0.0009752586,0.0003549169,0.42202255,0.0011848839,0.26316732,0.13288958,0.12224309],"study_design_scores_gemma":[0.00073533773,0.00066820014,0.17122078,0.0021491214,0.004109023,0.00083598815,0.0029245897,0.540459,0.0018333084,0.07440811,0.20015341,0.0005031929],"about_ca_topic_score_codex":0.9624779,"about_ca_topic_score_gemma":0.9642905,"teacher_disagreement_score":0.06718371,"about_ca_system_score_codex":0.06718371,"about_ca_system_score_gemma":0.07395021,"threshold_uncertainty_score":0.48745424},"labels":[],"label_agreement":null},{"id":"W4390126269","doi":"10.1016/j.jval.2023.09.502","title":"EE234 Economic Analysis of the Pronto Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TD Bank Group; Sunnybrook Hospital; Health Sciences Centre; Queen's University; Ontario Institute for Cancer Research; Sunnybrook Health Science Centre","funders":"","keywords":"Computer science","score_opus":0.19176115659049378,"score_gpt":0.2778787533060494,"score_spread":0.0861175967155556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126269","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20184453,0.01265071,0.08223629,0.036690995,0.00091430004,0.00014880415,0.0013365094,0.000060886436,0.664117],"genre_scores_gemma":[0.89535236,0.0028057112,0.0036592155,0.00096447475,0.0005219598,0.00008578396,0.00020141236,0.00003646726,0.09637278],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99947065,0.0003223943,0.000012208691,0.000057487778,0.00006529332,0.000072051516],"domain_scores_gemma":[0.9982993,0.0013178749,0.00008830238,0.000093682655,0.00012716526,0.00007365139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008651534,0.00026644234,0.00037616157,0.0009083482,0.0005765518,0.0015282044,0.00030904173,0.0007180794,0.022402827],"category_scores_gemma":[0.004899683,0.00011758953,0.0004831243,0.0009576009,0.001159894,0.0018516354,0.0007707947,0.001163075,0.00032885975],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045190514,0.000029221299,0.0013342759,0.00004698846,0.000022241355,0.00013459538,0.00011836715,0.0038149743,0.00007973804,0.978381,0.0072174203,0.0087759895],"study_design_scores_gemma":[0.000031219268,0.00004044677,0.0035100419,0.00006798948,0.000032113596,0.00012842426,0.00041896652,0.020872101,0.00018492618,0.9305753,0.04412841,0.000010001086],"about_ca_topic_score_codex":0.010582934,"about_ca_topic_score_gemma":0.0093946,"teacher_disagreement_score":0.022402827,"about_ca_system_score_codex":0.0018902104,"about_ca_system_score_gemma":0.0008610524,"threshold_uncertainty_score":0.07494491},"labels":[],"label_agreement":null},{"id":"W4390126273","doi":"10.1016/j.jval.2023.09.317","title":"EE44 Health Care Resource Utilization and Cost in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Disease; Parkinson's disease; Medicine; Resource (disambiguation); Health care; Resource use; Gerontology; Business; Environmental health; Natural resource economics; Economic growth; Economics; Computer science; Internal medicine","score_opus":0.2552703499515529,"score_gpt":0.39745832381049645,"score_spread":0.14218797385894355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672986,0.0028725355,0.00015864713,0.0022654384,0.000049084665,0.00012097828,0.023045339,0.000021766818,0.004167568],"genre_scores_gemma":[0.9930976,0.0008282069,0.00020974285,0.00035937826,0.000016669606,0.000040293526,0.0039766636,0.000008013786,0.0014634392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985669,0.00025300108,0.00016095798,0.0001505209,0.00032660566,0.0005420282],"domain_scores_gemma":[0.9959836,0.0004105404,0.0007966959,0.00007542667,0.0015331635,0.0012005509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008588364,0.00041402396,0.00079616904,0.0014414048,0.0024978325,0.002369078,0.0015679409,0.0009887114,0.004017476],"category_scores_gemma":[0.0035708805,0.0004483938,0.0012866522,0.0063645593,0.0009386967,0.0007048421,0.0010034211,0.0015622579,0.00028978268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000197749,0.00011992528,0.9862153,0.000121552264,0.00026893147,0.00025401067,0.0003508066,0.0012575058,0.00006629014,0.00036475956,0.006289568,0.0044936533],"study_design_scores_gemma":[0.000044922734,0.000031606127,0.9963505,0.00007301435,0.000053212163,0.00007126104,0.0009880961,0.0013467462,0.000019793913,0.000040587132,0.0009551996,0.000025047826],"about_ca_topic_score_codex":0.9982703,"about_ca_topic_score_gemma":0.9988323,"teacher_disagreement_score":0.08049326,"about_ca_system_score_codex":0.08049326,"about_ca_system_score_gemma":0.048607018,"threshold_uncertainty_score":0.58402216},"labels":[],"label_agreement":null},{"id":"W4390126283","doi":"10.1016/j.jval.2023.09.569","title":"EE303 Cost-Utility Analysis of Roflumilast Cream for Plaque Psoriasis, Including Intertriginous, From the Canadian Societal Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Intertriginous; Roflumilast; Medicine; Psoriasis; Tolerability; Plaque psoriasis; Dermatology; Perspective (graphical); Intensive care medicine; Adverse effect; Pharmacology; Internal medicine; COPD; Disease; Computer science","score_opus":0.49500513229894355,"score_gpt":0.46462465527978847,"score_spread":0.030380477019155083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83101666,0.041673124,0.017212031,0.008506412,0.0002198635,0.0014310564,0.027329896,0.0001891252,0.072421744],"genre_scores_gemma":[0.9865508,0.0034659996,0.003040796,0.00027918554,0.000034461053,0.000100405996,0.0027382944,0.000022483766,0.0037675959],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981976,0.0007797897,0.000060750328,0.00009037928,0.00045879744,0.00041254237],"domain_scores_gemma":[0.9980052,0.0010937634,0.000111012974,0.000058494767,0.00057212496,0.00015938737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033421365,0.0010739481,0.0013751129,0.0021640377,0.00060130074,0.0022549115,0.0013466503,0.00083723,0.005933521],"category_scores_gemma":[0.0077007175,0.0005076148,0.003137947,0.0028964572,0.0005494082,0.00052441534,0.0006676717,0.0013116053,0.00022200937],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013540955,0.0008437981,0.037829276,0.0028152769,0.0065639056,0.0008999032,0.00029403358,0.74968314,0.0025659753,0.042088855,0.020504974,0.12236988],"study_design_scores_gemma":[0.0035639857,0.0020067696,0.1248563,0.0012647741,0.010175397,0.000758524,0.0011209092,0.8168953,0.0014401989,0.011710838,0.02582711,0.00037976058],"about_ca_topic_score_codex":0.9034632,"about_ca_topic_score_gemma":0.8818262,"teacher_disagreement_score":0.096536815,"about_ca_system_score_codex":0.033306457,"about_ca_system_score_gemma":0.026796851,"threshold_uncertainty_score":0.24165636},"labels":[],"label_agreement":null},{"id":"W4390126285","doi":"10.1016/j.jval.2023.09.326","title":"EE53 An Investigation of Value for Money of Oncology Drugs in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Value for money; Value (mathematics); Medicine; Internal medicine; Oncology; Family medicine; Economics; Computer science; Public economics","score_opus":0.0767024081748256,"score_gpt":0.28984539239443036,"score_spread":0.21314298421960476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89588344,0.00319711,0.00042591398,0.014349321,0.00007208709,0.00013775479,0.007539998,0.000034632092,0.07835979],"genre_scores_gemma":[0.9799581,0.0012145088,0.000211744,0.0005246305,0.000024992272,0.000015325902,0.0011395738,0.000011763482,0.016899318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808145,0.00017786647,0.00005201546,0.00009281499,0.0008956171,0.00070028676],"domain_scores_gemma":[0.9901844,0.0028989036,0.00094530097,0.00014472424,0.0047688507,0.0010578143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012763384,0.00020093595,0.00049562054,0.0022964727,0.0033653826,0.00390934,0.0009652334,0.0009861374,0.004391934],"category_scores_gemma":[0.012130594,0.0002623541,0.00050967775,0.005173817,0.001002129,0.00076888327,0.0008248279,0.0016111701,0.00017821131],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010924768,0.00051872927,0.685804,0.00043228388,0.00039269947,0.0023326273,0.00374717,0.02564593,0.00067283306,0.12893048,0.084518306,0.06591241],"study_design_scores_gemma":[0.00013103207,0.00018618352,0.8392591,0.00021021439,0.00024299124,0.00032126627,0.01891039,0.03268179,0.0011580619,0.0076066647,0.09916653,0.00012566465],"about_ca_topic_score_codex":0.9962096,"about_ca_topic_score_gemma":0.9975394,"teacher_disagreement_score":0.09848029,"about_ca_system_score_codex":0.09848029,"about_ca_system_score_gemma":0.07590172,"threshold_uncertainty_score":0.71452785},"labels":[],"label_agreement":null},{"id":"W4390126297","doi":"10.1016/j.jval.2023.09.972","title":"EE707 Modelling the Cost Effectiveness and Budget Impact of Uterine Botulinum Toxin Injections in Severe Dysmenorrhoea: A France Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Perspective (graphical); Botulinum toxin; Medicine; Toxin; Gynecology; Surgery; Biology; Computer science","score_opus":0.18882333438025434,"score_gpt":0.5097049883689522,"score_spread":0.32088165398869783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6129432,0.011048611,0.093481205,0.033602033,0.0009405463,0.0005663439,0.019860549,0.0006228174,0.22693466],"genre_scores_gemma":[0.9430951,0.0027041107,0.017504072,0.0011939035,0.00018477267,0.0004057938,0.0028168343,0.00017190576,0.031923536],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99793917,0.0014181943,0.000043122767,0.000108105836,0.00014290957,0.00034855417],"domain_scores_gemma":[0.9913492,0.0072769057,0.0003056559,0.00011645474,0.0006559873,0.00029572175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029120287,0.0012357202,0.0013765437,0.0018006191,0.00058487395,0.004194415,0.0015755722,0.005160835,0.018903501],"category_scores_gemma":[0.011772073,0.0011466995,0.0022135056,0.002428249,0.00080741243,0.0013521834,0.00095851184,0.00258211,0.000945565],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001458937,0.000092679365,0.0014505568,0.00009815383,0.0001532544,0.00007804638,0.0000515982,0.9792012,0.000069345486,0.011545855,0.0024775972,0.00463592],"study_design_scores_gemma":[0.00025536213,0.00023054497,0.0021712913,0.00019700233,0.00021520347,0.000052002462,0.00023703762,0.97659874,0.0001025091,0.009854045,0.01004369,0.0000426136],"about_ca_topic_score_codex":0.29320815,"about_ca_topic_score_gemma":0.17696439,"teacher_disagreement_score":0.29320815,"about_ca_system_score_codex":0.010453793,"about_ca_system_score_gemma":0.0071907807,"threshold_uncertainty_score":0.583003},"labels":[],"label_agreement":null},{"id":"W4390126302","doi":"10.1016/j.jval.2023.09.214","title":"CO142 A Retrospective Study Characterizing Age at Key Clinical Disease Indicators Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Key (lock); Retrospective cohort study; Medicine; Disease; Gerontology; Environmental health; Demography; Family medicine; Computer science; Psychiatry; Internal medicine; Sociology; Computer security","score_opus":0.22687381343874513,"score_gpt":0.4176494520205479,"score_spread":0.19077563858180274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936372,0.00018682897,0.00013041047,0.000077781406,0.000011418344,0.000011322432,0.005277922,0.00000502634,0.0006621884],"genre_scores_gemma":[0.9958853,0.0000705343,0.00009099186,0.00007677747,0.000012369116,0.000014392199,0.003602316,0.0000036541044,0.00024359535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840444,0.00037875658,0.00025115395,0.00044053045,0.00026327738,0.00026187656],"domain_scores_gemma":[0.9940491,0.0009511092,0.0027495679,0.00063208706,0.0010974419,0.0005208227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010226726,0.00040525862,0.0004995246,0.0017503076,0.000947517,0.0012201786,0.0006590132,0.000652629,0.0012026614],"category_scores_gemma":[0.0042834585,0.00049463956,0.0007581132,0.0049930015,0.00037535556,0.0007378015,0.0006971054,0.000856515,0.00037862165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041740255,0.000017041299,0.9994137,0.000002967146,0.00004965844,0.00002171648,0.000030380615,0.000015892252,0.000041077226,0.000014607561,0.00015936958,0.00019181355],"study_design_scores_gemma":[0.000007497443,0.000028844432,0.99907035,0.0000062294375,0.000040124207,0.0000887818,0.00016308586,0.0002458473,0.00006229007,0.000022144497,0.0002598991,0.000004968606],"about_ca_topic_score_codex":0.09220115,"about_ca_topic_score_gemma":0.08620773,"teacher_disagreement_score":0.09220115,"about_ca_system_score_codex":0.0013140417,"about_ca_system_score_gemma":0.001641578,"threshold_uncertainty_score":0.18332893},"labels":[],"label_agreement":null},{"id":"W4390126313","doi":"10.1016/j.jval.2023.09.292","title":"EE19 Cost Utility Analysis of the Flash Glucose Monitoring System in the Management of People With Type 2 Diabetes Mellitus on Basal Insulin Therapy—An Italian Healthcare System Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Perspective (graphical); Flash (photography); Basal insulin; Basal (medicine); Medicine; Type 2 Diabetes Mellitus; Health care; Diabetes mellitus; Continuous glucose monitoring; Diabetes management; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology; Computer science; Type 1 diabetes; Economics; Artificial intelligence; Economic growth; Art","score_opus":0.06278408498487052,"score_gpt":0.34595576695782315,"score_spread":0.2831716819729526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8080844,0.026954748,0.022012768,0.016852342,0.00045717126,0.00049279357,0.026625142,0.0001768398,0.09834386],"genre_scores_gemma":[0.98754615,0.0020904704,0.0024597594,0.00067355414,0.00021918087,0.000076945515,0.0041631875,0.000031061478,0.002739672],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976767,0.0015224376,0.000056113895,0.00013004686,0.0003394467,0.00027530658],"domain_scores_gemma":[0.9974643,0.0016628326,0.00025176117,0.00012157134,0.0003877316,0.000111784844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031655936,0.0006983811,0.0005955952,0.0017345794,0.00017237355,0.0017112226,0.0005565348,0.0006894975,0.0061185546],"category_scores_gemma":[0.00664754,0.00020909074,0.0019270336,0.002168956,0.00030051378,0.00055787293,0.000692681,0.0007229628,0.00038460142],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012261822,0.00094533496,0.25159156,0.0016423472,0.0056147734,0.0015891236,0.00027587742,0.42528135,0.0022453447,0.056704383,0.050022136,0.19182594],"study_design_scores_gemma":[0.001261679,0.0035977277,0.4584235,0.0011974324,0.0047925855,0.0013026331,0.0010959122,0.45455527,0.0017394631,0.0169267,0.05494543,0.00016175902],"about_ca_topic_score_codex":0.035357665,"about_ca_topic_score_gemma":0.014313715,"teacher_disagreement_score":0.035357665,"about_ca_system_score_codex":0.0052581057,"about_ca_system_score_gemma":0.0021258986,"threshold_uncertainty_score":0.07030368},"labels":[],"label_agreement":null},{"id":"W4390126321","doi":"10.1016/j.jval.2023.09.524","title":"EE257 Real-World, Longitudinal, Retrospective Study of Healthcare Resource Utilization of Patients With Atopic Dermatitis Under the Public Health Insurance Plan of Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; McGill University Health Centre; ABB (Canada)","funders":"","keywords":"Atopic dermatitis; Plan (archaeology); Health care; Health insurance; Health plan; Public health; Environmental health; Business; Family medicine; Resource (disambiguation); Medicine; Economic growth; Geography; Dermatology; Nursing; Economics; Computer science; Archaeology","score_opus":0.06004624865925035,"score_gpt":0.3109220224604371,"score_spread":0.25087577380118675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9685416,0.0012185565,0.00019256806,0.0004063527,0.000034122695,0.0001015409,0.027215224,0.000020155347,0.0022698555],"genre_scores_gemma":[0.99209845,0.0003544664,0.00017537086,0.0001962847,0.0000128094935,0.000045722492,0.0060754926,0.0000070371066,0.0010343856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986507,0.0001842294,0.00013257883,0.0002436227,0.00030209887,0.00048664608],"domain_scores_gemma":[0.99637586,0.00025594034,0.00078897,0.0002041422,0.0016435583,0.0007315844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078114646,0.00054762256,0.0007104686,0.0012307509,0.0022618435,0.0015290296,0.0016387197,0.00089495664,0.0031365396],"category_scores_gemma":[0.0023372588,0.0005525611,0.0010535612,0.0053973515,0.00056257285,0.000589495,0.0008733806,0.0012701101,0.0005488393],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000075544915,0.000041900927,0.9973043,0.000019500892,0.00011387854,0.00004848791,0.00013518588,0.0000812634,0.000057589772,0.00004218303,0.0012628435,0.0008172233],"study_design_scores_gemma":[0.000013678991,0.000021455115,0.99835396,0.000024805433,0.00004142904,0.000033817138,0.00047977405,0.0003358855,0.000020472224,0.000010074836,0.00065497216,0.000009747131],"about_ca_topic_score_codex":0.99307257,"about_ca_topic_score_gemma":0.99409497,"teacher_disagreement_score":0.025706846,"about_ca_system_score_codex":0.025706846,"about_ca_system_score_gemma":0.023562612,"threshold_uncertainty_score":0.18651706},"labels":[],"label_agreement":null},{"id":"W4390126357","doi":"10.1016/j.jval.2023.09.807","title":"EE542 Assessment of the Cost-Effectiveness of Risk Factor Guided Prophylaxis with Palivizumab for the Prevention of Severe Respiratory Syncytial Virus Infection in Colombian Infants Born at 32–35 Weeks’ Gestational Age","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Risk factor; Respiratory system; Intensive care medicine; Pregnancy; Internal medicine; Biology","score_opus":0.12902002488907793,"score_gpt":0.4397569434015834,"score_spread":0.31073691851250546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782171,0.009052522,0.0012649696,0.0010147827,0.00013913095,0.0005851548,0.004893609,0.000035646317,0.004797132],"genre_scores_gemma":[0.99662066,0.0007964361,0.0007601382,0.00006581193,0.000020782241,0.00010301785,0.001129264,0.0000043737823,0.0004995187],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99826884,0.0011317558,0.00011948145,0.000120561715,0.00019130278,0.00016802135],"domain_scores_gemma":[0.99811435,0.0011470625,0.00030871178,0.00007713372,0.00016703697,0.00018563212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021749714,0.00065620773,0.0009353685,0.00058965455,0.00015144242,0.0010566697,0.00052731275,0.00069121836,0.0037475722],"category_scores_gemma":[0.008105479,0.00026738312,0.002309295,0.0004986112,0.0001932913,0.0004280807,0.00050487247,0.0006946053,0.0001592942],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22865269,0.004765019,0.37474078,0.0077939876,0.024926854,0.0009848318,0.0002676656,0.08120736,0.004583483,0.0038093654,0.005372379,0.26289555],"study_design_scores_gemma":[0.021599991,0.055516694,0.76451874,0.0020087452,0.021012943,0.00094779284,0.0007723212,0.11619682,0.0030775932,0.0014825888,0.012679851,0.00018591847],"about_ca_topic_score_codex":0.035033543,"about_ca_topic_score_gemma":0.024630487,"teacher_disagreement_score":0.035033543,"about_ca_system_score_codex":0.003923994,"about_ca_system_score_gemma":0.00196552,"threshold_uncertainty_score":0.06965929},"labels":[],"label_agreement":null},{"id":"W4390126372","doi":"10.1016/j.jval.2023.09.357","title":"EE85 Health System Costs and Resources for Stage-Specific Breast Cancer: A Population-Based Approach (Updated)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; TD Bank Group; University of Ottawa; Public Health Ontario; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Stage (stratigraphy); Computer science; Medicine; Actuarial science; Cancer; Business; Internal medicine; Biology","score_opus":0.06274836336562925,"score_gpt":0.27583831508370776,"score_spread":0.2130899517180785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126372","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044397168,0.043000028,0.014616643,0.010705505,0.0060367337,0.00086226274,0.8300811,0.00060140295,0.049699243],"genre_scores_gemma":[0.37589893,0.050190464,0.029082961,0.014847056,0.009220175,0.0028803335,0.44038376,0.00039522373,0.07710098],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99798334,0.00047599827,0.00031330975,0.00014976929,0.0009185679,0.0001590036],"domain_scores_gemma":[0.9958366,0.0016311879,0.0006833923,0.0001737606,0.0014609349,0.0002140962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029038065,0.00089054107,0.0011788129,0.0069254884,0.00020376086,0.0015239228,0.002064174,0.0016844759,0.01609622],"category_scores_gemma":[0.01043038,0.00081833627,0.0035459036,0.011878224,0.0001989347,0.0020449394,0.0010143119,0.0025806758,0.0025713756],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004477138,0.0005370893,0.07741468,0.0024775604,0.003954244,0.00028150083,0.00018586701,0.010896481,0.00013279633,0.0044556,0.7735356,0.12568077],"study_design_scores_gemma":[0.0005943267,0.00019864032,0.6582577,0.001996546,0.0025442503,0.00096601364,0.00042785137,0.00585749,0.000418787,0.0027986742,0.32584012,0.00009951088],"about_ca_topic_score_codex":0.12324282,"about_ca_topic_score_gemma":0.15014473,"teacher_disagreement_score":0.12324282,"about_ca_system_score_codex":0.0022912833,"about_ca_system_score_gemma":0.00222039,"threshold_uncertainty_score":0.24505097},"labels":[],"label_agreement":null},{"id":"W4390126459","doi":"10.1016/j.jval.2023.09.676","title":"EE410 Retrospective Database Analysis of Healthcare Resource Utilization and Costs in Patients With Vitiligo in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; University of British Columbia","funders":"","keywords":"Vitiligo; Health care; Resource (disambiguation); Business; Medicine; Database; Computer science; Economic growth; Economics; Dermatology","score_opus":0.016446085424430507,"score_gpt":0.27406209967042905,"score_spread":0.25761601424599856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93609965,0.001932412,0.00019940014,0.00034272228,0.0000312351,0.00018635941,0.058103457,0.000029163943,0.0030756297],"genre_scores_gemma":[0.97942185,0.0008739344,0.00029173028,0.00032015776,0.00001784539,0.000121507524,0.01748124,0.000014987807,0.0014567763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847144,0.00016999866,0.00019964026,0.00026101444,0.00038475613,0.0005131557],"domain_scores_gemma":[0.9956197,0.0003814009,0.00096167467,0.00019537858,0.002184248,0.0006575208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007653018,0.00062023813,0.0009735433,0.0027475173,0.0020247425,0.0019306642,0.0017773558,0.0007656738,0.0036464196],"category_scores_gemma":[0.003329791,0.0006455194,0.0011773951,0.0110569615,0.0005153885,0.00059821474,0.00096416957,0.0009109695,0.00047312316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016457813,0.000047142257,0.9944068,0.000063828804,0.00025732504,0.00012351018,0.000125595,0.0002795033,0.000072299714,0.00009468464,0.0025628018,0.0018020207],"study_design_scores_gemma":[0.00003882048,0.000029463099,0.99731064,0.00006692593,0.0000883424,0.0000808954,0.00044805906,0.0006159602,0.000040057086,0.00001609619,0.0012470619,0.000017594191],"about_ca_topic_score_codex":0.9931785,"about_ca_topic_score_gemma":0.99332035,"teacher_disagreement_score":0.03603137,"about_ca_system_score_codex":0.03603137,"about_ca_system_score_gemma":0.03380607,"threshold_uncertainty_score":0.2614271},"labels":[],"label_agreement":null},{"id":"W4390126460","doi":"10.1016/j.jval.2023.09.182","title":"CO110 Systematic Literature Review and Network Meta-Analysis to Assess the Comparative Efficacy of Topical Fixed-Dose Combinations for Moderate to Severe Acne Vulgaris as Measured By Lesion Counts","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Meta-analysis; Acne; Medicine; Dermatology; Lesion; Systematic review; Internal medicine; Surgery; MEDLINE; Biology","score_opus":0.23064222845716525,"score_gpt":0.4289315749864708,"score_spread":0.19828934652930552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126460","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023420656,0.9686046,0.0020810876,0.0004636025,0.00058897235,0.0012551922,0.0024766233,0.000080557926,0.0010285868],"genre_scores_gemma":[0.66320443,0.3198544,0.0066265147,0.0023032376,0.00056028384,0.0033857855,0.002590206,0.00008957447,0.0013855459],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98253655,0.009526222,0.003951551,0.0020099701,0.0014661315,0.00050966075],"domain_scores_gemma":[0.9794032,0.014469752,0.0034564745,0.001031255,0.0012976504,0.000341737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015408724,0.002534845,0.016299885,0.0062720566,0.0007724676,0.002978426,0.0019106452,0.0024064013,0.007190151],"category_scores_gemma":[0.038087912,0.0012919534,0.038093686,0.006087629,0.00093551824,0.0020820077,0.0021146294,0.0022389914,0.0006628825],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006848834,0.000034534543,0.0029291916,0.1202323,0.86390036,0.00006654371,0.00005420749,0.00025200064,0.00021699937,0.00009551129,0.0003231606,0.0050464505],"study_design_scores_gemma":[0.0032776834,0.00031329796,0.0029897986,0.0062464317,0.9857778,0.000052329244,0.000027628827,0.00013036063,0.000057315723,0.0001604289,0.0009465739,0.00002033753],"about_ca_topic_score_codex":0.009138162,"about_ca_topic_score_gemma":0.018478781,"teacher_disagreement_score":0.016299885,"about_ca_system_score_codex":0.0027281763,"about_ca_system_score_gemma":0.0032163605,"threshold_uncertainty_score":0.0814901},"labels":[],"label_agreement":null},{"id":"W4390126533","doi":"10.1016/j.jval.2023.09.142","title":"CO70 COPD Exacerbations Pre, During, and Post COVID-19 Pandemic in the US","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; COPD; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Intensive care medicine; Virology; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.06418947601148334,"score_gpt":0.3799944225302698,"score_spread":0.3158049465187865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845137,0.0012967396,0.000069891066,0.0018829764,0.00008458368,0.00004334043,0.0088041155,0.000018625775,0.00328588],"genre_scores_gemma":[0.99342257,0.00046175244,0.000036364767,0.00060364633,0.00007014487,0.000035188503,0.0045062294,0.0000057586267,0.0008584389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990029,0.00012981055,0.00012027081,0.0001586606,0.00017902379,0.00040942707],"domain_scores_gemma":[0.9987521,0.000093864866,0.0004524628,0.000045976925,0.0002283893,0.000427188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037105827,0.000272867,0.00034263803,0.000824756,0.0010431748,0.00089466205,0.00056138245,0.0010334428,0.002781802],"category_scores_gemma":[0.0019333481,0.00025418692,0.00057415076,0.0014222934,0.00031807233,0.00089018303,0.0014287375,0.0013326425,0.00036020472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029268957,0.00011238448,0.98932517,0.000042589145,0.00006895295,0.00013897219,0.0003033036,0.00009181306,0.00013760997,0.0000951468,0.0042754044,0.005115874],"study_design_scores_gemma":[0.0000048994402,0.00003255507,0.9978903,0.000027716856,0.000014016725,0.000071159935,0.00096779404,0.00013298065,0.00002502603,0.0000418631,0.0007861738,0.0000055119312],"about_ca_topic_score_codex":0.21993224,"about_ca_topic_score_gemma":0.35996103,"teacher_disagreement_score":0.21993224,"about_ca_system_score_codex":0.0018723506,"about_ca_system_score_gemma":0.0028252862,"threshold_uncertainty_score":0.4373042},"labels":[],"label_agreement":null},{"id":"W4390126566","doi":"10.1016/j.jval.2023.09.1704","title":"HTA19 Insights Into NICE Technology Appraisal Outcomes in Oncology","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Nice; Oncology; Medicine; Medical physics; Internal medicine; Computer science","score_opus":0.4071762311421113,"score_gpt":0.4930174094996413,"score_spread":0.08584117835752997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126566","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005776208,0.0994204,0.05062459,0.38276032,0.0068685813,0.0014794561,0.04796217,0.0018201707,0.40328822],"genre_scores_gemma":[0.30985808,0.12786604,0.20047541,0.16290638,0.03331457,0.0068280566,0.07147317,0.0050925897,0.08218575],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.85985327,0.08978797,0.012327979,0.0018716934,0.031705603,0.0044535054],"domain_scores_gemma":[0.6544253,0.2553769,0.0143208,0.009925037,0.059876587,0.0060753846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.069840215,0.0013607265,0.0033674878,0.008309332,0.001157418,0.012913269,0.0029043963,0.008035764,0.025052287],"category_scores_gemma":[0.42366803,0.0012017322,0.005753257,0.010604996,0.002609512,0.0069219014,0.0054005007,0.009129825,0.005973536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034692624,0.000080634956,0.0036491938,0.0038502957,0.000604704,0.00019634595,0.00059744355,0.0054172087,0.00007819985,0.189144,0.68093145,0.11510355],"study_design_scores_gemma":[0.00061817595,0.0004498012,0.021302916,0.014269249,0.00085033855,0.00072280806,0.00041002032,0.005991867,0.0003669893,0.22043678,0.73427063,0.00031043726],"about_ca_topic_score_codex":0.03750517,"about_ca_topic_score_gemma":0.037937693,"teacher_disagreement_score":0.069840215,"about_ca_system_score_codex":0.010759949,"about_ca_system_score_gemma":0.021261686,"threshold_uncertainty_score":0.36935478},"labels":[],"label_agreement":null},{"id":"W4390126595","doi":"10.1016/j.jval.2023.09.121","title":"CO49 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Ixekizumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ixekizumab; Axial spondyloarthritis; Medicine; Matching (statistics); Internal medicine; Pathology; Arthritis; Secukinumab","score_opus":0.06100829648213404,"score_gpt":0.3312366531993723,"score_spread":0.27022835671723827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675839,0.016594771,0.0041763876,0.00051850005,0.0012863589,0.00078047323,0.0052365554,0.0001013554,0.0037217026],"genre_scores_gemma":[0.99497765,0.0006818547,0.0010757722,0.00025842772,0.00015057104,0.00021537574,0.0010259855,0.000015561318,0.001598822],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9871875,0.008924961,0.0007812442,0.0015456772,0.0008135675,0.0007470725],"domain_scores_gemma":[0.9914027,0.0050999676,0.0012994814,0.0012728301,0.0005754668,0.00034966177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063291406,0.0014382517,0.002960345,0.0006810913,0.0004424738,0.0013250835,0.0014535796,0.0018530956,0.006261693],"category_scores_gemma":[0.016200751,0.0010267607,0.010350582,0.0009832291,0.00056154723,0.0008339706,0.0009318232,0.002414416,0.00065369095],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7897615,0.0009794082,0.045566216,0.002667213,0.13033108,0.00013147664,0.00015348679,0.0020461753,0.0018857173,0.0005965816,0.0020882713,0.023792878],"study_design_scores_gemma":[0.33300263,0.075153776,0.28725147,0.0007492215,0.2740941,0.00041932773,0.00041331747,0.015275739,0.0047758087,0.0018400587,0.0067629423,0.00026162548],"about_ca_topic_score_codex":0.01178325,"about_ca_topic_score_gemma":0.0068891193,"teacher_disagreement_score":0.01178325,"about_ca_system_score_codex":0.0010455183,"about_ca_system_score_gemma":0.0008472044,"threshold_uncertainty_score":0.03347206},"labels":[],"label_agreement":null},{"id":"W4390126613","doi":"10.1016/j.jval.2023.09.099","title":"CO26 Efficacy of the Dupilumab 200 Mg Dose Every 2 Weeks in Children with Moderate-to-Severe Asthma during Voyage and Excursion","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Travel-related health issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Dupilumab; Excursion; Asthma; Medicine; Pediatrics; Internal medicine; Political science; Law","score_opus":0.02223058562201335,"score_gpt":0.291016622937088,"score_spread":0.26878603731507467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172735,0.004872959,0.00006984356,0.0003382041,0.00017434626,0.000087869026,0.00033342798,0.00002918585,0.0023667894],"genre_scores_gemma":[0.9979665,0.00060887425,0.00014683655,0.0001642963,0.000066189976,0.000049279442,0.00018372046,0.0000046218033,0.0008097026],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9996556,0.00009314499,0.000022872206,0.00006601184,0.000049639533,0.000112672446],"domain_scores_gemma":[0.9995448,0.00011536814,0.0000888498,0.000016141403,0.000035750563,0.0001990146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004394226,0.00035039167,0.001230422,0.00019183621,0.00034755396,0.0005167848,0.00031442445,0.0006689111,0.0022053104],"category_scores_gemma":[0.0008750128,0.00018329806,0.0011089895,0.00013401086,0.0001993722,0.00034990913,0.00017598555,0.0013102476,0.00034643404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4443677,0.014394701,0.09810369,0.0017876286,0.0024268152,0.001143983,0.0005086255,0.0031000036,0.015990349,0.00031027943,0.0075398255,0.41032645],"study_design_scores_gemma":[0.077560484,0.29018217,0.5973985,0.00079515897,0.0034850477,0.0016831525,0.0008198182,0.006383365,0.0077850306,0.00019209586,0.013593296,0.00012174811],"about_ca_topic_score_codex":0.0052924277,"about_ca_topic_score_gemma":0.009324264,"teacher_disagreement_score":0.0052924277,"about_ca_system_score_codex":0.0007986679,"about_ca_system_score_gemma":0.0007704719,"threshold_uncertainty_score":0.0105232},"labels":[],"label_agreement":null},{"id":"W4390126617","doi":"10.1016/j.jval.2023.09.124","title":"CO52 Comparative Analysis of Tabelecleucel Versus Standard of Care in Patients with EBV+ PTLD Following Hematopoietic Cell Transplant (HCT) or Solid Organ Transplant (SOT)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Hematopoietic cell; Solid organ; Medicine; Haematopoiesis; Standard of care; Internal medicine; Organ transplantation; Oncology; Transplantation; Biology; Stem cell; Genetics","score_opus":0.04066198766973922,"score_gpt":0.3452641387185456,"score_spread":0.3046021510488064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743646,0.0015173159,0.000096629024,0.00005968416,0.000037071924,0.000018907222,0.0002588547,0.0000040778905,0.0005709288],"genre_scores_gemma":[0.9991835,0.0002014183,0.000063769105,0.00005052515,0.000025812735,0.0000102105705,0.0003258932,0.0000017232574,0.00013717102],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99934644,0.00026352174,0.00006351583,0.00012698994,0.000061960345,0.00013761692],"domain_scores_gemma":[0.9987851,0.00059674564,0.00024809866,0.000057288642,0.00009489025,0.00021791575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007232681,0.00022719451,0.0008710834,0.000467638,0.00019251346,0.0007918895,0.00030893803,0.00048216354,0.0039513665],"category_scores_gemma":[0.0023844969,0.00009077296,0.0014598187,0.000647539,0.00027130044,0.0005332309,0.00030334017,0.0006020565,0.0003095935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5623431,0.0019619635,0.3462642,0.00065708486,0.004185216,0.0002874152,0.00018131426,0.00079746405,0.0042458265,0.00038042248,0.0009344805,0.077761486],"study_design_scores_gemma":[0.013975075,0.122578785,0.84946954,0.0001668725,0.0049198978,0.00047707686,0.0007563022,0.0026999363,0.002330836,0.00050739886,0.0020604003,0.00005778279],"about_ca_topic_score_codex":0.0015316586,"about_ca_topic_score_gemma":0.0021737432,"teacher_disagreement_score":0.0039513665,"about_ca_system_score_codex":0.0008562278,"about_ca_system_score_gemma":0.00045867127,"threshold_uncertainty_score":0.013218641},"labels":[],"label_agreement":null},{"id":"W4390126628","doi":"10.1016/j.jval.2023.09.207","title":"CO135 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Pharmaceutical Interventions for First-Line (1L) Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (MCRPC)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Asymptomatic; Oncology; Internal medicine; First line; Psychological intervention; Cancer; Psychiatry","score_opus":0.17517301786223566,"score_gpt":0.4448476951343678,"score_spread":0.2696746772721321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126628","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016677424,0.9643979,0.00248468,0.0012964543,0.0009276093,0.0020101892,0.010038331,0.00020470518,0.0019626908],"genre_scores_gemma":[0.56513935,0.4010104,0.012681576,0.0057896837,0.0008528365,0.006854368,0.005151588,0.00019967045,0.002320557],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9687312,0.017126989,0.0075023253,0.0034279462,0.002425668,0.0007858434],"domain_scores_gemma":[0.95993894,0.027008826,0.0071453257,0.0021391266,0.0032064507,0.000561315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017080514,0.0020567137,0.011750486,0.010688311,0.0009309705,0.0033867839,0.0017325256,0.0026770453,0.011900586],"category_scores_gemma":[0.07112191,0.0015125314,0.036694765,0.008632177,0.0008340553,0.0024337904,0.002608883,0.0020846128,0.0013620971],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003552828,0.000032645858,0.0051756953,0.29469305,0.68383425,0.000116779825,0.00009876903,0.00020877543,0.0002830316,0.000173548,0.0016037546,0.010226779],"study_design_scores_gemma":[0.0029115025,0.0002682469,0.0055333315,0.033562288,0.95315766,0.0000966884,0.000046793146,0.0001859308,0.0001293186,0.0002400208,0.0038316133,0.00003664604],"about_ca_topic_score_codex":0.014030534,"about_ca_topic_score_gemma":0.034589067,"teacher_disagreement_score":0.017080514,"about_ca_system_score_codex":0.002935051,"about_ca_system_score_gemma":0.005774878,"threshold_uncertainty_score":0.090331495},"labels":[],"label_agreement":null},{"id":"W4390126634","doi":"10.1016/j.jval.2023.09.028","title":"P20 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Vs Belantamab Mafodotin for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Matching (statistics); Class (philosophy); Refractory (planetary science); Oncology; Internal medicine; Computer science; Physics; Artificial intelligence; Pathology","score_opus":0.0862507112215568,"score_gpt":0.3333338324338619,"score_spread":0.24708312121230508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96980506,0.016013797,0.00234822,0.0009600827,0.0021018174,0.00090243,0.0024119571,0.00012644443,0.0053301514],"genre_scores_gemma":[0.9954352,0.0008259296,0.00080360787,0.00041217238,0.00017068736,0.00036045958,0.0005028334,0.000011385361,0.0014778743],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99616516,0.002469225,0.00023746905,0.0005007315,0.00022555406,0.00040191974],"domain_scores_gemma":[0.998314,0.0009852651,0.00030065302,0.00014396985,0.000076335105,0.00017987995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026591797,0.0011823874,0.0032511558,0.00042983104,0.00024358397,0.0010148436,0.0010832828,0.0013680306,0.010124322],"category_scores_gemma":[0.0052684983,0.0004729022,0.0058510117,0.0003558794,0.00051897654,0.0011503559,0.00086588453,0.002892044,0.00045341664],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96516687,0.00064528955,0.002594177,0.00086122175,0.014757343,0.000042901367,0.000043397926,0.0008469129,0.00079875725,0.00038911987,0.0009617009,0.012892346],"study_design_scores_gemma":[0.7064959,0.15108763,0.050444555,0.00061868853,0.06514085,0.00024428638,0.00029511293,0.01295536,0.0028624283,0.0041137245,0.0056043463,0.0001371223],"about_ca_topic_score_codex":0.0026955083,"about_ca_topic_score_gemma":0.0035218268,"teacher_disagreement_score":0.010124322,"about_ca_system_score_codex":0.00090553577,"about_ca_system_score_gemma":0.00091687834,"threshold_uncertainty_score":0.033869267},"labels":[],"label_agreement":null},{"id":"W4390127024","doi":"10.1016/j.jval.2023.09.033","title":"P24 Improving Efficiency of Living Systematic Literature Reviews (SLR) with Artificial Intelligence (AI): Assisted Extraction of Population, Intervention/Comparator, Outcome, and Study Design (P-I/C-O-S)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Outcome (game theory); Intervention (counseling); Medicine; Extraction (chemistry); Comparator; Population; Engineering; Environmental health; Psychiatry; Mathematics; Chemistry; Chromatography; Electrical engineering","score_opus":0.31446627410944494,"score_gpt":0.4808376401205651,"score_spread":0.16637136601112018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127024","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019072378,0.0824606,0.12619331,0.047223736,0.0104184495,0.34091562,0.3110343,0.013549551,0.0491321],"genre_scores_gemma":[0.092538476,0.01843313,0.5261668,0.0101785185,0.0016236631,0.31743526,0.023302939,0.0018973876,0.008423835],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.68789995,0.18200931,0.092852555,0.011055727,0.023917666,0.0022649046],"domain_scores_gemma":[0.35106686,0.47194165,0.07730208,0.040014364,0.055867936,0.0038071333],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19328167,0.0022009066,0.007767968,0.023034098,0.0016660366,0.008269404,0.0033799664,0.0034021372,0.08986896],"category_scores_gemma":[0.63201636,0.002990326,0.014647272,0.024262382,0.0022989702,0.0043829856,0.0075416504,0.002966736,0.009623726],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040016538,0.00021211589,0.0071290233,0.6039737,0.021405786,0.0003024847,0.0011179524,0.00075026427,0.0011536815,0.005261557,0.12863818,0.22605364],"study_design_scores_gemma":[0.024628831,0.0018055167,0.03588651,0.36065602,0.075841144,0.0008290044,0.0012914587,0.0064366474,0.004897817,0.02789856,0.45910326,0.0007252985],"about_ca_topic_score_codex":0.0040028095,"about_ca_topic_score_gemma":0.012730179,"teacher_disagreement_score":0.80671835,"about_ca_system_score_codex":0.0039597135,"about_ca_system_score_gemma":0.025877113,"threshold_uncertainty_score":0.99482733},"labels":[],"label_agreement":null},{"id":"W4390127055","doi":"10.1016/j.jval.2023.09.100","title":"CO27 The Feasibility of Systematic Goal Quality Assurance During Goal Attainment Scaling in a Rare Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Quality assurance; Goal setting; Quality (philosophy); Goal orientation; Disease; Computer science; Medicine; Risk analysis (engineering); Psychology; Physical therapy; Internal medicine; Pathology; Social psychology; Physics","score_opus":0.4857534074856333,"score_gpt":0.4654239281577498,"score_spread":0.020329479327883482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40928423,0.0032668312,0.4038965,0.04892436,0.0016655977,0.009415769,0.0041982043,0.0020089487,0.11733959],"genre_scores_gemma":[0.8153447,0.0004162822,0.17421763,0.0019064015,0.00019963345,0.002955501,0.0007146415,0.00032898676,0.0039161476],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.95035505,0.035224017,0.0025689271,0.0022437694,0.00837907,0.0012292849],"domain_scores_gemma":[0.64860296,0.23914726,0.015598981,0.031443182,0.060629394,0.0045781727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07695784,0.00054750795,0.00079021376,0.0025146024,0.0019816274,0.00467061,0.0015722855,0.0014400848,0.006993632],"category_scores_gemma":[0.2693448,0.000496686,0.0009292955,0.0025117667,0.0015437324,0.002674728,0.0034090544,0.0028398253,0.00094184215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003035375,0.0022259203,0.06912742,0.0008190453,0.00036811546,0.00015153705,0.002604691,0.014123198,0.0016655339,0.033213843,0.026693646,0.84597164],"study_design_scores_gemma":[0.004038694,0.0071850335,0.3424756,0.0031650937,0.0011942609,0.00071757473,0.006953202,0.29771447,0.042113774,0.15739885,0.13630755,0.0007359389],"about_ca_topic_score_codex":0.026616646,"about_ca_topic_score_gemma":0.02571341,"teacher_disagreement_score":0.07695784,"about_ca_system_score_codex":0.0060479976,"about_ca_system_score_gemma":0.025558686,"threshold_uncertainty_score":0.4069968},"labels":[],"label_agreement":null},{"id":"W4390127084","doi":"10.1016/j.jval.2023.09.110","title":"CO37 Inventory-Facilitated Goal Setting Interview Conducted by Disease Experts Yields a Broader Range of Goal Areas","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Goal setting; Goal orientation; Goal programming; Psychology; Range (aeronautics); Applied psychology; Operations research; Engineering; Social psychology","score_opus":0.40282029590413954,"score_gpt":0.41973673308607024,"score_spread":0.0169164371819307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8506264,0.00032931316,0.0439389,0.0050880336,0.00026410056,0.007873518,0.0030912694,0.00035829234,0.08843017],"genre_scores_gemma":[0.83937895,0.00037142087,0.11255822,0.0027440204,0.00010128192,0.019171018,0.002454789,0.00012786944,0.023092432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954722,0.0028338747,0.00032308922,0.0002699985,0.00047198054,0.0006288574],"domain_scores_gemma":[0.9798432,0.009994981,0.001878533,0.001344147,0.0054624397,0.0014768003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008813962,0.0005518684,0.00062419183,0.0022408618,0.0030166653,0.0019446921,0.0007191193,0.0015296042,0.0066193803],"category_scores_gemma":[0.01704162,0.00045790002,0.00043984063,0.0011224737,0.0007157749,0.0008920956,0.0023560387,0.0020526357,0.0026815862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012498174,0.0046420083,0.29712072,0.0012820889,0.00008925677,0.0028441714,0.28272295,0.0030104565,0.04033955,0.0114838965,0.084277295,0.2709378],"study_design_scores_gemma":[0.0004605262,0.0017627941,0.33198234,0.000849734,0.00011427645,0.0020503632,0.32939935,0.011440386,0.027229039,0.015163262,0.2789514,0.0005965139],"about_ca_topic_score_codex":0.0069459,"about_ca_topic_score_gemma":0.017653821,"teacher_disagreement_score":0.008813962,"about_ca_system_score_codex":0.0022291087,"about_ca_system_score_gemma":0.0040543033,"threshold_uncertainty_score":0.046613216},"labels":[],"label_agreement":null},{"id":"W4390127085","doi":"10.1016/j.jval.2023.09.813","title":"EE548 Data Availability and Modelling Approaches in Health Economic Evaluation of Cystic Fibrosis: A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Efficiency Analysis Using DEA","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Cystic fibrosis; Systematic review; Data science; Field (mathematics); Computer science; Medicine; Intensive care medicine; Management science; MEDLINE; Economics; Political science; Internal medicine; Mathematics","score_opus":0.493393444492352,"score_gpt":0.44966258476300053,"score_spread":0.04373085972935148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044153733,0.97997904,0.0066850935,0.0028468454,0.00031505874,0.0012020855,0.0031515914,0.000035166137,0.0013696719],"genre_scores_gemma":[0.15571916,0.8162171,0.018214086,0.0021167332,0.00036007824,0.004565142,0.002414313,0.00007924577,0.00031411732],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.80259275,0.13162954,0.04364086,0.004567047,0.016280616,0.0012891802],"domain_scores_gemma":[0.38499802,0.56367844,0.03109812,0.0063729407,0.013027892,0.0008245629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16169272,0.00187731,0.009752995,0.016250439,0.00083624094,0.0073249172,0.0031628653,0.0033057844,0.009057977],"category_scores_gemma":[0.43684152,0.0021184382,0.020356426,0.016512085,0.0020114675,0.006543337,0.0042799413,0.0039687115,0.00047210342],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000989189,0.0000902225,0.0032541817,0.8161458,0.055428065,0.000110898545,0.000277126,0.0021774026,0.00008828636,0.0038567437,0.0018094821,0.11577271],"study_design_scores_gemma":[0.00076117157,0.00027890055,0.0037234507,0.8690786,0.10140042,0.00020549585,0.00027631002,0.0017114795,0.0002227437,0.0047201454,0.017527804,0.000093456605],"about_ca_topic_score_codex":0.009116131,"about_ca_topic_score_gemma":0.016480684,"teacher_disagreement_score":0.16169272,"about_ca_system_score_codex":0.0074610594,"about_ca_system_score_gemma":0.026407192,"threshold_uncertainty_score":0.85512304},"labels":[],"label_agreement":null},{"id":"W4390127095","doi":"10.1016/j.jval.2023.09.036","title":"P26 Drug Utilization, Adherence, and Persistence in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Persistence (discontinuity); Medicine; Disease; Drug; Parkinson's disease; Intensive care medicine; Gerontology; Psychiatry; Internal medicine; Engineering","score_opus":0.04709858550269786,"score_gpt":0.296608719596008,"score_spread":0.24951013409331013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843345,0.0014327179,0.00014679524,0.0020454784,0.000050176586,0.00012650316,0.008300673,0.000015678359,0.0035474685],"genre_scores_gemma":[0.9961759,0.00050034054,0.00021716602,0.00039489413,0.000017080876,0.000046866386,0.0015659292,0.000006333307,0.0010754297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881685,0.0001741836,0.00012638465,0.00014760117,0.00030755185,0.00042745675],"domain_scores_gemma":[0.9952195,0.000366655,0.0007804652,0.00008147827,0.0019849641,0.0015669418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009868771,0.00036546268,0.0007385204,0.0011119102,0.0042366097,0.0024810196,0.0018017893,0.0009477545,0.0037601227],"category_scores_gemma":[0.003201832,0.0004307806,0.001046639,0.0050242026,0.0010257337,0.0008186767,0.0009980367,0.0018821016,0.00028841966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052521973,0.00008997923,0.994624,0.00004527988,0.00006789806,0.00008297928,0.0005903053,0.00010861436,0.000035280285,0.00008698741,0.0020526065,0.0021634975],"study_design_scores_gemma":[0.000017160524,0.000032954315,0.9966378,0.00007328603,0.00002912935,0.00004382716,0.0020736074,0.00038683586,0.000015055417,0.000020646528,0.0006545207,0.00001525958],"about_ca_topic_score_codex":0.9969348,"about_ca_topic_score_gemma":0.9981475,"teacher_disagreement_score":0.041568562,"about_ca_system_score_codex":0.041568562,"about_ca_system_score_gemma":0.040456317,"threshold_uncertainty_score":0.30160242},"labels":[],"label_agreement":null},{"id":"W4390127102","doi":"10.1016/j.jval.2023.09.062","title":"P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Medicine; Political science; Physics","score_opus":0.322493166513005,"score_gpt":0.4149761842089676,"score_spread":0.09248301769596257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81526095,0.014674821,0.005464155,0.11358809,0.00018074195,0.00017413338,0.0054854234,0.00006790782,0.04510372],"genre_scores_gemma":[0.9929638,0.0013903324,0.00076359994,0.0024655068,0.00011113211,0.000033453143,0.0004984397,0.000015695301,0.0017579739],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937011,0.0023426877,0.00031084518,0.0003522972,0.0017976181,0.0014955299],"domain_scores_gemma":[0.9333612,0.04763513,0.009444878,0.0008566926,0.0061148703,0.0025872232],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012179656,0.00016652205,0.0008600631,0.0025008712,0.0010754105,0.0076216864,0.0009104516,0.0019202699,0.0049673193],"category_scores_gemma":[0.064927444,0.0004380642,0.0011810894,0.0054041697,0.0019205523,0.0028169171,0.0013986476,0.0028125914,0.00022811657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001418313,0.00033650236,0.590096,0.00039720783,0.0014546431,0.001029358,0.0037401153,0.045197334,0.00048325164,0.19568126,0.03972601,0.12044005],"study_design_scores_gemma":[0.0003839985,0.00039861916,0.79135615,0.0009931595,0.00087073783,0.00055452995,0.013309818,0.047158856,0.001004182,0.06848802,0.075266704,0.00021530742],"about_ca_topic_score_codex":0.33976415,"about_ca_topic_score_gemma":0.32846153,"teacher_disagreement_score":0.9878203,"about_ca_system_score_codex":0.012759668,"about_ca_system_score_gemma":0.009904378,"threshold_uncertainty_score":0.675573},"labels":[],"label_agreement":null},{"id":"W4390127158","doi":"10.1016/j.jval.2023.09.132","title":"CO60 Predicting Treatment Effects from Surrogate Endpoints in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (MCRPC)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Internal medicine; Surrogate endpoint; Cancer","score_opus":0.09172677733241291,"score_gpt":0.3858182695491741,"score_spread":0.2940914922167612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98322254,0.005632935,0.0034277092,0.0005392978,0.00011071526,0.00008154418,0.0026489662,0.0000860673,0.0042501],"genre_scores_gemma":[0.9963451,0.00060706004,0.0010460677,0.00010107907,0.000047478792,0.000030259214,0.0012940072,0.000012672155,0.0005162317],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989002,0.0005708638,0.000049329683,0.00013167385,0.00024639218,0.00010164065],"domain_scores_gemma":[0.99552345,0.0027641586,0.00089670776,0.00019949363,0.0002822437,0.00033400246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022830649,0.00044479102,0.0008689719,0.000541701,0.00016298518,0.0011796542,0.00026859037,0.0004301544,0.002225584],"category_scores_gemma":[0.007839787,0.00012206525,0.0008630842,0.00053095346,0.00023171426,0.00036054192,0.00048560137,0.00085495965,0.00042193936],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.033033904,0.002401974,0.59556633,0.0009269779,0.0021358142,0.00020924422,0.00016683136,0.043172125,0.011630071,0.0020311102,0.00673676,0.3019888],"study_design_scores_gemma":[0.0013271194,0.027671669,0.74377716,0.0004072879,0.0016692488,0.00091512536,0.00019226702,0.18912041,0.016710699,0.0065982877,0.011482344,0.00012846633],"about_ca_topic_score_codex":0.001495921,"about_ca_topic_score_gemma":0.0021792755,"teacher_disagreement_score":0.0022830649,"about_ca_system_score_codex":0.0006771936,"about_ca_system_score_gemma":0.00056496705,"threshold_uncertainty_score":0.0120741725},"labels":[],"label_agreement":null},{"id":"W4390127191","doi":"10.1016/j.jval.2023.09.1717","title":"HTA32 When Should the Conduct of RWE Studies Be Prioritized for Reimbursement: Insights from Canadian and Global Stakeholders","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Reimbursement; Business; Public economics; Actuarial science; Accounting; Public relations; Political science; Economics; Law","score_opus":0.5122569694828171,"score_gpt":0.37295231799855466,"score_spread":0.1393046514842624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127191","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007911009,0.0036370414,0.0013804138,0.8954707,0.0032712852,0.00053386274,0.0029369118,0.00014971044,0.08470916],"genre_scores_gemma":[0.16995473,0.004612359,0.017001893,0.7400154,0.0035487462,0.0012502469,0.0020388495,0.0003469791,0.061230794],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.95518917,0.014690149,0.0031861048,0.0015308756,0.01256605,0.012837548],"domain_scores_gemma":[0.6443764,0.128187,0.011720547,0.007851214,0.13702023,0.070844635],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07606063,0.0004989692,0.0010784535,0.0026501415,0.008123468,0.014867894,0.004492814,0.02614977,0.028870761],"category_scores_gemma":[0.20890272,0.00073734,0.0014279854,0.002827477,0.0074922303,0.00579747,0.0053076292,0.0101779075,0.0033258765],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004967779,0.00015142954,0.010928859,0.0009936424,0.000145209,0.0007140512,0.0037999668,0.00049497944,0.0017937152,0.082146905,0.83812904,0.06020544],"study_design_scores_gemma":[0.0004297516,0.00015724819,0.044503056,0.0041397605,0.0002293026,0.00029333623,0.0075596445,0.0006770572,0.0009768917,0.036682848,0.90403193,0.0003191778],"about_ca_topic_score_codex":0.6239472,"about_ca_topic_score_gemma":0.8089467,"teacher_disagreement_score":0.9632964,"about_ca_system_score_codex":0.036703583,"about_ca_system_score_gemma":0.3031366,"threshold_uncertainty_score":0.7565349},"labels":[],"label_agreement":null},{"id":"W4390127197","doi":"10.1016/j.jval.2023.09.1196","title":"EPH154 Modeled Head-to-Head Comparison of Nirsevimab and Rsvpref Maternal Vaccine in the US","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Head (geology); Computer science; Medicine; Geology; Geomorphology","score_opus":0.24723519965376098,"score_gpt":0.4945282484013186,"score_spread":0.24729304874755761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557906,0.0005637547,0.0007328047,0.00009968614,0.00004674549,0.00003655293,0.00081557035,0.000036407157,0.0020894527],"genre_scores_gemma":[0.9971771,0.00022744123,0.00049192074,0.0001065211,0.000007622959,0.000029336048,0.0005722099,0.000011025364,0.0013767914],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99979323,0.000081390426,0.000007290271,0.000034643388,0.000031805717,0.000051638086],"domain_scores_gemma":[0.9996718,0.00016312601,0.000041342813,0.000024342855,0.00007900967,0.000020382828],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004929425,0.00016674513,0.000384143,0.00015448942,0.00014141864,0.00032247187,0.0003241474,0.0003334733,0.0043270374],"category_scores_gemma":[0.0011502792,0.00016791462,0.00043346226,0.00017188773,0.00018114844,0.00026452774,0.00019900051,0.00030207785,0.0004271409],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096197516,0.00495734,0.11430694,0.0011021718,0.0020956337,0.0016689709,0.0003232197,0.41567895,0.18178093,0.0052389516,0.017706117,0.15894328],"study_design_scores_gemma":[0.0035023568,0.08375278,0.13975693,0.00015836564,0.003804707,0.00081615365,0.0017394929,0.54149383,0.19824095,0.0028613536,0.023708949,0.00016416743],"about_ca_topic_score_codex":0.01665102,"about_ca_topic_score_gemma":0.012722234,"teacher_disagreement_score":0.01665102,"about_ca_system_score_codex":0.0006394854,"about_ca_system_score_gemma":0.0011502655,"threshold_uncertainty_score":0.033108234},"labels":[],"label_agreement":null},{"id":"W4390127244","doi":"10.1016/j.jval.2023.09.1144","title":"EPH102 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) Among Canadian Infants","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Respiratory system; Virus; Lower respiratory tract infection; Respiratory illness; Virology; Respiratory tract infections; Respiratory tract; Pediatrics; Immunology; Internal medicine","score_opus":0.10860903853609306,"score_gpt":0.4102578771591319,"score_spread":0.3016488386230389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94492155,0.007155871,0.00029127064,0.011026409,0.00022405451,0.00015344244,0.008102712,0.00004494786,0.028079774],"genre_scores_gemma":[0.9918107,0.0022316566,0.00040861982,0.0007624739,0.000035798766,0.000020733325,0.0010202143,0.0000037498598,0.0037060543],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991316,0.00012343275,0.00002246476,0.000046705427,0.0002926088,0.00038309206],"domain_scores_gemma":[0.9992192,0.00008076163,0.00008957591,0.000015559695,0.00043522305,0.00015971798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008614624,0.00030775333,0.00019587387,0.00040974887,0.000708233,0.00091529754,0.0006795751,0.0005704448,0.0048361314],"category_scores_gemma":[0.002063516,0.00013121584,0.00044125417,0.00050138927,0.00028306473,0.0002247607,0.00035341165,0.0005194316,0.00017712187],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027783052,0.00054947054,0.8173631,0.00073660107,0.00042183217,0.0007520298,0.0006552443,0.0024570161,0.0069958074,0.0038874887,0.02143347,0.1419696],"study_design_scores_gemma":[0.00020414007,0.00076588604,0.97191477,0.00043253542,0.0004722721,0.00023115738,0.0021384426,0.0025044908,0.0024676407,0.00038540727,0.018455232,0.000028112352],"about_ca_topic_score_codex":0.95562446,"about_ca_topic_score_gemma":0.96542156,"teacher_disagreement_score":0.04437554,"about_ca_system_score_codex":0.015155932,"about_ca_system_score_gemma":0.033505373,"threshold_uncertainty_score":0.10996449},"labels":[],"label_agreement":null},{"id":"W4390127502","doi":"10.1016/j.jval.2023.09.1093","title":"EPH51 Artificial Intelligence (AI) Tools for Outbreak Detection and Response: A Transnational Platform for Surveillance, Monitoring and Decision Support","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Risk and Safety Analysis","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Outbreak; Computer science; Artificial intelligence; Data science; Medicine; Virology","score_opus":0.22684601517586042,"score_gpt":0.4382117484402083,"score_spread":0.2113657332643479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127502","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047428694,0.0014251687,0.5401174,0.004964934,0.00057477667,0.00071883656,0.010370511,0.03720684,0.35719293],"genre_scores_gemma":[0.3432213,0.0021623466,0.512109,0.0013143205,0.00034433487,0.00059693085,0.018768549,0.0032596558,0.11822366],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984341,0.00053142384,0.000120493976,0.00016129889,0.0006348475,0.00011787898],"domain_scores_gemma":[0.996546,0.0011729436,0.00023757614,0.0009996064,0.00074537145,0.00029861138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002770502,0.0005485263,0.00040235117,0.0017229683,0.00050731655,0.003852876,0.00095933,0.0010004296,0.042581134],"category_scores_gemma":[0.006730598,0.0002898937,0.00052620715,0.0015240968,0.00064471737,0.002438547,0.0033880104,0.00095280434,0.011600976],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087892485,0.00034308076,0.006420069,0.00053961214,0.00014452942,0.00067073765,0.00055506383,0.01388116,0.023768751,0.15180868,0.13711411,0.6638752],"study_design_scores_gemma":[0.00031619493,0.00034835155,0.010809478,0.00038298612,0.0001500811,0.00059647067,0.00036522455,0.17788999,0.0432702,0.08296515,0.6828024,0.00010356668],"about_ca_topic_score_codex":0.0024322616,"about_ca_topic_score_gemma":0.0019112598,"teacher_disagreement_score":0.042581134,"about_ca_system_score_codex":0.000641358,"about_ca_system_score_gemma":0.0017651366,"threshold_uncertainty_score":0.14244813},"labels":[],"label_agreement":null},{"id":"W4390127584","doi":"10.1016/j.jval.2023.09.1846","title":"HTA162 Canadian HTA and Early-Phase Evidence in Oncology: Current Trends and the Path Ahead","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Current (fluid); Path (computing); Oncology; Medicine; Intensive care medicine; Computer science; Engineering; Electrical engineering","score_opus":0.5850161206492978,"score_gpt":0.5025133678377591,"score_spread":0.08250275281153863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127584","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042353165,0.3379421,0.00093852426,0.586932,0.014371742,0.0001690982,0.017198462,0.00013714103,0.038075604],"genre_scores_gemma":[0.22711818,0.44374236,0.02143422,0.22446841,0.025620978,0.0005589112,0.021953758,0.00049409474,0.03460909],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.974164,0.008220471,0.0017942161,0.00097415916,0.011921457,0.0029256581],"domain_scores_gemma":[0.6570131,0.11213022,0.014924689,0.005942069,0.17610122,0.03388874],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.049166318,0.0008390813,0.0025747763,0.006021815,0.0025184015,0.009261833,0.004006147,0.004907098,0.03352431],"category_scores_gemma":[0.18770808,0.0006376083,0.002023114,0.015543335,0.0037836507,0.0045906357,0.0026585408,0.006068085,0.0019354057],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010993575,0.00009175118,0.008903059,0.004700589,0.0005595086,0.000070165755,0.00023324434,0.0006002165,0.00012048463,0.041171875,0.75189424,0.1905555],"study_design_scores_gemma":[0.0009755797,0.00022937497,0.045770176,0.029453909,0.0008464973,0.000111875794,0.0007430541,0.0011251451,0.00029717403,0.028581211,0.89163196,0.00023403735],"about_ca_topic_score_codex":0.91880864,"about_ca_topic_score_gemma":0.9424391,"teacher_disagreement_score":0.9508337,"about_ca_system_score_codex":0.07716551,"about_ca_system_score_gemma":0.30199656,"threshold_uncertainty_score":0.5598775},"labels":[],"label_agreement":null},{"id":"W4390127626","doi":"10.1016/j.jval.2023.09.1192","title":"EPH150 Impact CKD: The Growing Burden of CKD in Spain","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Energy, Environment, and Transportation Policies","field":"Energy","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Environmental health","score_opus":0.03430081154451731,"score_gpt":0.30114747536467523,"score_spread":0.2668466638201579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8137686,0.03608265,0.002882542,0.04792777,0.0010671307,0.00007516896,0.03984386,0.0003734264,0.057978775],"genre_scores_gemma":[0.9738535,0.0082129985,0.0010106025,0.0024353557,0.00026611064,0.000038547056,0.008353732,0.000052831627,0.00577631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936825,0.00019405299,0.000042805157,0.00006774798,0.00010298668,0.00022423145],"domain_scores_gemma":[0.998923,0.00017804683,0.0002588672,0.000061281804,0.0002803312,0.00029839794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010220702,0.00023584891,0.00044987001,0.0008342186,0.00024600475,0.0019356434,0.00042716882,0.0009121026,0.005875312],"category_scores_gemma":[0.0028160736,0.00011913327,0.0011741996,0.0011916108,0.00024553284,0.00050507294,0.0012298047,0.00088716147,0.00046364524],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024731385,0.0003753834,0.80052096,0.0016746266,0.0008468989,0.0008193628,0.00043176682,0.00511104,0.0011763411,0.01303504,0.053172026,0.12036353],"study_design_scores_gemma":[0.00030686255,0.00015589764,0.90498793,0.0013673218,0.0005431315,0.0005468828,0.0015491074,0.0021075746,0.0005015888,0.0059895758,0.08189323,0.000050980525],"about_ca_topic_score_codex":0.12161067,"about_ca_topic_score_gemma":0.08449786,"teacher_disagreement_score":0.12161067,"about_ca_system_score_codex":0.003167531,"about_ca_system_score_gemma":0.0059704822,"threshold_uncertainty_score":0.24180561},"labels":[],"label_agreement":null},{"id":"W4390127706","doi":"10.1016/j.jval.2023.09.1797","title":"HTA113 How Have Manufacturers Maximised Their Digital Health Technologies’ Chances of Successful Reimbursement in Germany?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Reimbursement; Business; Health technology; Actuarial science; Economics; Health care; Economic growth","score_opus":0.11329061689698565,"score_gpt":0.41084237333234436,"score_spread":0.2975517564353587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127706","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30453637,0.008919335,0.003456855,0.37856382,0.0024808263,0.00010405099,0.0027896815,0.00035630175,0.2987928],"genre_scores_gemma":[0.9514953,0.0011535386,0.0016599592,0.010107294,0.00040046166,0.000067370805,0.00049614423,0.000052517942,0.034567304],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99464226,0.0021469223,0.0002322908,0.00037531866,0.0011922884,0.0014109049],"domain_scores_gemma":[0.98964673,0.0057252073,0.0009081443,0.0006424366,0.0019108702,0.0011665954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008696455,0.00023761873,0.00030189648,0.0017183045,0.0021954859,0.0077871205,0.000683477,0.004041844,0.022841483],"category_scores_gemma":[0.02210244,0.00030829455,0.00050481834,0.001223957,0.0021283894,0.003984213,0.0020179027,0.0018339361,0.0025604337],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006864481,0.00026989123,0.052547045,0.0006078445,0.00020532789,0.00077749754,0.0044358075,0.0018180213,0.0018272346,0.43466532,0.2568664,0.2452931],"study_design_scores_gemma":[0.00021167911,0.0005952834,0.18536773,0.002159165,0.00033813488,0.0008948355,0.013250579,0.0068714265,0.007890757,0.05838686,0.72370595,0.0003276622],"about_ca_topic_score_codex":0.02551591,"about_ca_topic_score_gemma":0.024428304,"teacher_disagreement_score":0.02551591,"about_ca_system_score_codex":0.006854602,"about_ca_system_score_gemma":0.0066925944,"threshold_uncertainty_score":0.07641238},"labels":[],"label_agreement":null},{"id":"W4390127717","doi":"10.1016/j.jval.2023.09.1101","title":"EPH59 An Evidence Gap Analysis of the Epidemiology and Burden of Obstructive Hypertrophic Cardiomyopathy","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Epidemiology; Obstructive cardiomyopathy; Hypertrophic cardiomyopathy; Cardiology; Internal medicine; Cardiomyopathy; Heart failure","score_opus":0.14508085559372463,"score_gpt":0.3766464503121173,"score_spread":0.23156559471839266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127717","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89318675,0.087735794,0.0011708688,0.0060367454,0.0002729064,0.000034043638,0.005194031,0.000008857402,0.006359986],"genre_scores_gemma":[0.9922484,0.0053211222,0.0002984415,0.00071825663,0.00017236696,0.000016354828,0.0010115596,0.0000063634798,0.00020713625],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9921957,0.0045459047,0.0011575237,0.0008715344,0.0007533501,0.00047599844],"domain_scores_gemma":[0.9726714,0.016304687,0.005469111,0.0022807496,0.0022788234,0.0009952442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008712361,0.00034106788,0.0010377725,0.0021251754,0.0005149578,0.0021958975,0.000780957,0.0011479143,0.003083022],"category_scores_gemma":[0.032415673,0.00029531616,0.0018908512,0.0038275388,0.00066929375,0.0012066058,0.0023905514,0.001059636,0.0002991816],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017285772,0.000070246264,0.96149796,0.0014376224,0.00859032,0.00030622963,0.000488504,0.00019593707,0.00036504696,0.0025655522,0.0015978259,0.021156214],"study_design_scores_gemma":[0.00012838085,0.0002461824,0.9826251,0.001489182,0.0063951057,0.00044158852,0.00094687735,0.00034834153,0.00017606754,0.0015484674,0.0056351256,0.00001956666],"about_ca_topic_score_codex":0.005854899,"about_ca_topic_score_gemma":0.0053599193,"teacher_disagreement_score":0.008712361,"about_ca_system_score_codex":0.00053296745,"about_ca_system_score_gemma":0.0012266156,"threshold_uncertainty_score":0.04607594},"labels":[],"label_agreement":null},{"id":"W4390127723","doi":"10.1016/j.jval.2023.09.1705","title":"HTA20 Predicting Post-AMNOG Price for a New Product Launch in Germany","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Product (mathematics); Business; Economics; Mathematics","score_opus":0.11154586051683021,"score_gpt":0.30773938563539766,"score_spread":0.19619352511856744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98186237,0.001071039,0.0045590717,0.0006985208,0.00003409788,0.000029080422,0.009414235,0.00009597917,0.0022356159],"genre_scores_gemma":[0.99455476,0.0003269573,0.00075847935,0.000031014868,0.00001925893,0.000013138961,0.003685361,0.000007963241,0.000603057],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99957615,0.00011391416,0.000031555082,0.00009202608,0.000100395904,0.000085925436],"domain_scores_gemma":[0.9965366,0.0018837635,0.0010926628,0.00013455878,0.00019779634,0.00015463935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017032234,0.00044812632,0.000407328,0.0013156252,0.00013087445,0.0016431169,0.00047354726,0.00061398454,0.0018101654],"category_scores_gemma":[0.005579499,0.0002200675,0.00068817084,0.0011919002,0.0002278488,0.0009040509,0.00041513905,0.00056308816,0.00041887155],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001007876,0.00021252428,0.5604,0.00021769386,0.0005034041,0.00048485366,0.000115875286,0.38759407,0.0011495178,0.0059331935,0.007417794,0.03496318],"study_design_scores_gemma":[0.0000560385,0.00034292112,0.3810337,0.00006788351,0.00022354398,0.00019919508,0.00016467551,0.6087281,0.0018324837,0.00236923,0.004924985,0.000057305355],"about_ca_topic_score_codex":0.036314085,"about_ca_topic_score_gemma":0.014909859,"teacher_disagreement_score":0.036314085,"about_ca_system_score_codex":0.0022508318,"about_ca_system_score_gemma":0.00066623895,"threshold_uncertainty_score":0.072205424},"labels":[],"label_agreement":null},{"id":"W4390127855","doi":"10.1016/j.jval.2023.09.2194","title":"MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Disease; Medicine; Gerontology; Computer science; Internal medicine","score_opus":0.6457526558320349,"score_gpt":0.4940366541097025,"score_spread":0.1517160017223324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127855","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020991724,0.012701979,0.34607893,0.3833452,0.011508418,0.0009771655,0.036065836,0.00236491,0.1859659],"genre_scores_gemma":[0.3331761,0.009069182,0.39832568,0.05015044,0.009519186,0.003147845,0.028729336,0.004888458,0.16299385],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9802408,0.015863098,0.0006470104,0.000731834,0.0021464725,0.00037075943],"domain_scores_gemma":[0.9351546,0.050234728,0.0010942821,0.0036449367,0.008427892,0.0014434926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06188781,0.0013163596,0.0022845557,0.0011376559,0.00075057533,0.0054217083,0.0042279325,0.0040945783,0.04251311],"category_scores_gemma":[0.08534203,0.0016709563,0.003959838,0.0012466499,0.00082747894,0.0030970103,0.0036844995,0.005819921,0.0076559237],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010275912,0.00032903053,0.0013752978,0.0008214009,0.0011073045,0.00018533757,0.00016421157,0.17644751,0.00042951465,0.18693355,0.4976994,0.13347988],"study_design_scores_gemma":[0.000934953,0.00034940257,0.0013505691,0.0014091086,0.0004898881,0.00012320542,0.0001911155,0.36514956,0.0010287529,0.23710021,0.39169753,0.00017584939],"about_ca_topic_score_codex":0.022582065,"about_ca_topic_score_gemma":0.021537254,"teacher_disagreement_score":0.06188781,"about_ca_system_score_codex":0.00456295,"about_ca_system_score_gemma":0.007635049,"threshold_uncertainty_score":0.327298},"labels":[],"label_agreement":null},{"id":"W4390127895","doi":"10.1016/j.jval.2023.09.155","title":"CO83 Disease Burden of Moderate to Severe Ulcerative Colitis in Chinese Patients Under Current Care: A Model Simulation Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Ulcerative colitis; Medicine; Disease; Current (fluid); Burden of disease; Internal medicine; Intensive care medicine; Engineering","score_opus":0.02596179047694591,"score_gpt":0.33175967105117693,"score_spread":0.305797880574231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747723,0.000088387074,0.00059986766,0.00030533306,0.000016007602,0.000024159051,0.0006035945,0.000014585821,0.00087082176],"genre_scores_gemma":[0.99843174,0.00005930378,0.0002075052,0.000047275098,0.000009030444,0.00004059348,0.0005296936,0.000005100031,0.00066968653],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99943763,0.00020673701,0.00002168,0.00010332982,0.0000254923,0.00020509979],"domain_scores_gemma":[0.99639124,0.002249191,0.0003834068,0.00018497212,0.00024405635,0.00054709084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012762498,0.00074209116,0.0014950514,0.00074266497,0.0009130813,0.0015351189,0.0015653766,0.0018730932,0.0061450857],"category_scores_gemma":[0.0041411454,0.0006748256,0.0024498738,0.0009903867,0.00078774255,0.0009453353,0.0009313626,0.0013639475,0.00036257037],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027518952,0.002265415,0.32226193,0.00012966272,0.0016191981,0.0011334363,0.0004118378,0.658629,0.00038822045,0.0040150997,0.0023930266,0.0040012565],"study_design_scores_gemma":[0.0006958966,0.0008927423,0.059663028,0.00003239686,0.000565253,0.00020301637,0.0007034737,0.9353002,0.00011044885,0.0013637585,0.00040536205,0.00006444538],"about_ca_topic_score_codex":0.17112349,"about_ca_topic_score_gemma":0.071766324,"teacher_disagreement_score":0.17112349,"about_ca_system_score_codex":0.0031125438,"about_ca_system_score_gemma":0.0031796834,"threshold_uncertainty_score":0.3402549},"labels":[],"label_agreement":null},{"id":"W4390127909","doi":"10.1016/j.jval.2023.09.2170","title":"MSR111 Causal Inference and Statistical Considerations for Indirectly Comparing Time-to-Event Endpoints for Treatments with Different Starting Points for Outcome Assessment in Resectable NSCLC","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Outcome (game theory); Causal inference; Inference; Event (particle physics); Statistical inference; Medicine; Internal medicine; Computer science; Statistics; Artificial intelligence; Mathematics; Pathology","score_opus":0.31694711317792057,"score_gpt":0.49713635470914014,"score_spread":0.18018924153121957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127909","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01922392,0.0021547417,0.9684598,0.006144985,0.0002625491,0.0002471952,0.0005666303,0.00022185476,0.0027184081],"genre_scores_gemma":[0.552328,0.0021464957,0.4326825,0.002626029,0.0011687842,0.0016057647,0.00088360667,0.00021382669,0.006344984],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9291144,0.063358426,0.0015098447,0.002853557,0.0027072825,0.00045645895],"domain_scores_gemma":[0.49996835,0.48324484,0.0049420474,0.008545776,0.0025888956,0.0007101663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0922029,0.0014334981,0.0033136304,0.002332357,0.0007362801,0.0031930567,0.0035090416,0.0024503225,0.008675223],"category_scores_gemma":[0.30920354,0.001271307,0.00451054,0.002090933,0.004029495,0.0040607164,0.0026479117,0.0077211815,0.00041546722],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018831299,0.00029095518,0.0076070935,0.0011009942,0.0022886293,0.0005305385,0.00038981478,0.11756567,0.0006325641,0.75041205,0.0045433515,0.11275527],"study_design_scores_gemma":[0.00036834046,0.00026706845,0.0011261859,0.00012082701,0.0005256666,0.0001381336,0.00004731735,0.18671449,0.00048199232,0.80810577,0.002077693,0.000026578771],"about_ca_topic_score_codex":0.0029084962,"about_ca_topic_score_gemma":0.0019770353,"teacher_disagreement_score":0.0922029,"about_ca_system_score_codex":0.0020319074,"about_ca_system_score_gemma":0.003734485,"threshold_uncertainty_score":0.48762137},"labels":[],"label_agreement":null},{"id":"W4390128002","doi":"10.1016/j.jval.2023.09.451","title":"EE182 Costs and Health Impact of Wastewater Surveillance to Guide Respiratory Syncytial Virus Prophylaxis in Canada, Compared to Clinical Surveillance","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Environmental health; Respiratory system; Intensive care medicine; Internal medicine","score_opus":0.15133295131608016,"score_gpt":0.4667479452092924,"score_spread":0.31541499389321226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9522786,0.0052143424,0.00049784646,0.009397235,0.00017720494,0.00016849357,0.013793191,0.000041557552,0.018431505],"genre_scores_gemma":[0.9930247,0.0011774383,0.00044864102,0.00066452275,0.00003517723,0.000017653441,0.0019582403,0.000011428546,0.0026622366],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99716467,0.00057744514,0.00014345124,0.00017604599,0.0010475003,0.00089089177],"domain_scores_gemma":[0.9949403,0.00073250954,0.0006915513,0.000081828344,0.0024002101,0.0011535614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013035608,0.00042510458,0.00041795996,0.0013192382,0.0012498654,0.0027791155,0.0008394375,0.00089229376,0.004419958],"category_scores_gemma":[0.008740408,0.00031137426,0.001345956,0.0020742083,0.0006665686,0.0005425665,0.0010854567,0.0012799351,0.00017726971],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034976332,0.0004412427,0.89549583,0.00047854165,0.00086137664,0.0004145756,0.00033131335,0.010519783,0.0006838456,0.004090103,0.013269057,0.06991667],"study_design_scores_gemma":[0.00023456388,0.00040875404,0.9754646,0.00033952648,0.0005674842,0.00023937669,0.0016377354,0.01315793,0.0004994127,0.0005539507,0.006845329,0.00005140547],"about_ca_topic_score_codex":0.9908189,"about_ca_topic_score_gemma":0.9914408,"teacher_disagreement_score":0.08125356,"about_ca_system_score_codex":0.08125356,"about_ca_system_score_gemma":0.076152824,"threshold_uncertainty_score":0.5895386},"labels":[],"label_agreement":null},{"id":"W4390128004","doi":"10.1016/j.jval.2023.09.1839","title":"HTA155 The Impact of Phase 2 Clinical Trials on Reimbursement Recommendations in Oncology By Canadian Health Technology Assessment Agencies","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Reimbursement; Clinical trial; Health technology; Medicine; Family medicine; Business; Internal medicine; Health care; Economic growth; Economics","score_opus":0.8350915822005727,"score_gpt":0.6717757189770044,"score_spread":0.16331586322356828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128004","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018509604,0.053614944,0.0024561088,0.69284445,0.015301628,0.0020780533,0.049684647,0.0005521237,0.16495848],"genre_scores_gemma":[0.49959716,0.047871273,0.019469727,0.30256006,0.013554692,0.002538266,0.040640883,0.00073289336,0.07303503],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9203002,0.03790328,0.005084522,0.002219654,0.028012522,0.0064798268],"domain_scores_gemma":[0.55747235,0.21832027,0.020426936,0.0076376614,0.16400644,0.03213632],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.093171336,0.00085138873,0.0018367348,0.004083475,0.0023849108,0.010834529,0.0039921324,0.009009532,0.021549555],"category_scores_gemma":[0.35483834,0.0008581746,0.0032959261,0.0051341304,0.002134898,0.0021279377,0.001976818,0.0069809733,0.0022439172],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002127866,0.00014389335,0.008372564,0.0012914019,0.00068264717,0.000082523504,0.0002056106,0.003431283,0.00018211816,0.01546444,0.8536246,0.1143909],"study_design_scores_gemma":[0.0066442112,0.001066948,0.12259223,0.015130933,0.002257269,0.000119127144,0.00056478597,0.012125994,0.0008845415,0.011940799,0.8262463,0.00042686798],"about_ca_topic_score_codex":0.8536959,"about_ca_topic_score_gemma":0.8959145,"teacher_disagreement_score":0.93114674,"about_ca_system_score_codex":0.06885323,"about_ca_system_score_gemma":0.25725934,"threshold_uncertainty_score":0.4995675},"labels":[],"label_agreement":null},{"id":"W4390128058","doi":"10.1016/j.jval.2023.09.177","title":"CO105 A Retrospective Study Characterizing Age at Loss of Ambulation Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Medicine; Retrospective cohort study; Gerontology; Demography; Psychiatry; Surgery; Sociology","score_opus":0.18487250582154063,"score_gpt":0.3781800547029752,"score_spread":0.1933075488814346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945582,0.0002687223,0.00011492074,0.00006258366,0.000009696526,0.000013391405,0.004283828,0.0000053854537,0.0006832134],"genre_scores_gemma":[0.9974164,0.000081107,0.000063035244,0.0000537482,0.000009417485,0.000011988602,0.002202783,0.0000021212218,0.00015946358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987319,0.0002840326,0.00024942865,0.00033197974,0.00021152468,0.00019107548],"domain_scores_gemma":[0.9954137,0.0006936794,0.0024025275,0.00042315506,0.0007300023,0.00033687026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007992979,0.0003437259,0.00049248856,0.0015174529,0.00072320714,0.0011091057,0.00051035715,0.0005552907,0.0011417004],"category_scores_gemma":[0.004081389,0.00041074457,0.0007681286,0.003941292,0.0003300344,0.0006844929,0.00053715013,0.0006917792,0.0003246175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042885156,0.000017102797,0.9993863,0.0000040206296,0.00005953816,0.00003056388,0.000026128091,0.000017288467,0.000035141486,0.000013084313,0.00011838082,0.00024950376],"study_design_scores_gemma":[0.000008305948,0.000037333608,0.9991203,0.000008121653,0.000046792724,0.00014050053,0.00014481872,0.00024890056,0.000042928812,0.000021026968,0.00017606774,0.0000049309438],"about_ca_topic_score_codex":0.06025263,"about_ca_topic_score_gemma":0.047655053,"teacher_disagreement_score":0.06025263,"about_ca_system_score_codex":0.0009964615,"about_ca_system_score_gemma":0.0010757314,"threshold_uncertainty_score":0.119803846},"labels":[],"label_agreement":null},{"id":"W4390128074","doi":"10.1016/j.jval.2023.09.1852","title":"HTA168 Widening the Value Lens for Child Health Technologies: Development of a Child-Tailored HTA Value Assessment Framework Using Multi-Criteria Decision Analysis Incorporating Patient, Public, and Expert Perspectives","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Respiratory Research Network; Sunnybrook Health Science Centre; Pediatric Oncology Group; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Value (mathematics); Health technology; Medicine; Psychology; Knowledge management; Management science; Political science; Computer science; Engineering; Health care; Machine learning","score_opus":0.41169293837486043,"score_gpt":0.46800534590760956,"score_spread":0.05631240753274913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128074","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01607289,0.0012280473,0.930694,0.008658549,0.00014912496,0.0004977696,0.00062314025,0.0001942811,0.041882243],"genre_scores_gemma":[0.4075985,0.0007483355,0.5828283,0.0010995294,0.00025586374,0.0005892216,0.000480388,0.00011876253,0.0062811184],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9890448,0.0072598453,0.0003771978,0.0004971955,0.0023284662,0.0004924988],"domain_scores_gemma":[0.984213,0.010087561,0.0009224633,0.0006549537,0.0032923047,0.0008297104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015882159,0.001069783,0.0012108975,0.0040350873,0.0012137903,0.007644163,0.0022142658,0.003003242,0.009803501],"category_scores_gemma":[0.028236842,0.00071674923,0.002362807,0.002635706,0.0024870832,0.0060496577,0.0039010528,0.0052499534,0.0008818737],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006639286,0.00019433255,0.0044592344,0.0002987894,0.00025213868,0.00022443713,0.0007407814,0.092796326,0.0008739949,0.789285,0.01066767,0.10014097],"study_design_scores_gemma":[0.00003526384,0.000114917944,0.002133131,0.00072879356,0.00009693613,0.0001519071,0.00054030784,0.31736994,0.0011789019,0.6439567,0.033603474,0.00008969506],"about_ca_topic_score_codex":0.0075915908,"about_ca_topic_score_gemma":0.009279216,"teacher_disagreement_score":0.015882159,"about_ca_system_score_codex":0.0060820663,"about_ca_system_score_gemma":0.006563438,"threshold_uncertainty_score":0.08399391},"labels":[],"label_agreement":null},{"id":"W4390128212","doi":"10.1016/j.jval.2023.09.1693","title":"HTA8 Health Technology Assessment (HTA) Case Studies: Comparing Acceptability of Real-World Evidence (RWE) in Appraisals for Oncology Medicines","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital","funders":"","keywords":"Real world evidence; Health technology; Medicine; Medical physics; Oncology; Intensive care medicine; Internal medicine; Health care; Economics; Economic growth","score_opus":0.7638739125985797,"score_gpt":0.6161334100116591,"score_spread":0.14774050258692062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28445166,0.055209152,0.1759638,0.08318807,0.006211555,0.08538113,0.08793443,0.0014337683,0.22022642],"genre_scores_gemma":[0.7617197,0.005205808,0.17853673,0.005288723,0.00080689753,0.035478648,0.006943371,0.00022316344,0.005796938],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.7809148,0.19343348,0.01150681,0.0019993004,0.010421041,0.0017246312],"domain_scores_gemma":[0.42582104,0.5312449,0.015332239,0.010511672,0.014485911,0.0026043411],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12734465,0.0009914865,0.0016102018,0.0032475668,0.0015644961,0.004090031,0.0020489506,0.0064274417,0.034595914],"category_scores_gemma":[0.42063695,0.0010035952,0.0059900917,0.0036883452,0.0021331862,0.003876851,0.0037300687,0.003912485,0.0014757912],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057959538,0.0033171324,0.038034387,0.093937755,0.039012916,0.0038290753,0.007090268,0.048902035,0.0038971936,0.18946938,0.21072477,0.30382556],"study_design_scores_gemma":[0.07497643,0.03472439,0.0916038,0.08193438,0.040709384,0.0034543108,0.0053758235,0.09453664,0.012982971,0.25365797,0.30477417,0.0012697347],"about_ca_topic_score_codex":0.005239478,"about_ca_topic_score_gemma":0.0048456145,"teacher_disagreement_score":0.87265533,"about_ca_system_score_codex":0.0053316364,"about_ca_system_score_gemma":0.0085074855,"threshold_uncertainty_score":0.673471},"labels":[],"label_agreement":null},{"id":"W4390128256","doi":"10.1016/j.jval.2023.09.1767","title":"HTA83 Economic Evaluations in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Challenges for Health Technology Assessment (HTA) Submissions","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Health technology; Follicular phase; Medicine; Oncology; Lymphoma; Medical physics; Internal medicine; Health care; Economics; Biology; Economic growth","score_opus":0.49528498971328,"score_gpt":0.508883211188328,"score_spread":0.013598221475048022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128256","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01172909,0.039557733,0.028438771,0.5674822,0.09430676,0.0048288098,0.05940317,0.0026420148,0.19161147],"genre_scores_gemma":[0.2455381,0.06582724,0.13133216,0.20097375,0.10843072,0.015207502,0.056407373,0.0061589736,0.17012419],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.8896825,0.07855123,0.0091105765,0.0011477075,0.019456195,0.0020518717],"domain_scores_gemma":[0.32597914,0.47750244,0.019004807,0.020084308,0.1431513,0.014278016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15443547,0.00072502025,0.0035402284,0.0031504058,0.0017820335,0.01630868,0.0033525515,0.0065241554,0.072457716],"category_scores_gemma":[0.5395499,0.0009261871,0.0030559741,0.0052722036,0.0017881817,0.0050668567,0.0046152966,0.00781336,0.01624502],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005053378,0.00014518625,0.0007361692,0.0015906717,0.0002732204,0.00010521326,0.00012462608,0.0010823712,0.00007138883,0.00958494,0.90031284,0.08546812],"study_design_scores_gemma":[0.0018183666,0.0006994071,0.01274385,0.0144383125,0.00041109277,0.00026539713,0.0005379525,0.008325717,0.0008334865,0.107751235,0.85194594,0.00022927263],"about_ca_topic_score_codex":0.005277853,"about_ca_topic_score_gemma":0.005264252,"teacher_disagreement_score":0.15443547,"about_ca_system_score_codex":0.005975989,"about_ca_system_score_gemma":0.018475156,"threshold_uncertainty_score":0.8167426},"labels":[],"label_agreement":null},{"id":"W4390128316","doi":"10.1016/j.jval.2023.09.1080","title":"EPH38 Exploring the Relationship Between Hemochromatosis and Fracture Risk: A Population-Based Matched Cohort Study Stratified on Ferritin Levels","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hemochromatosis; Ferritin; Cohort; Medicine; Internal medicine; Demography; Pediatrics; Sociology","score_opus":0.15622680918982387,"score_gpt":0.3576634433343067,"score_spread":0.20143663414448285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99884486,0.000106971085,0.00017981432,0.000030597963,0.000010463815,0.000009547686,0.00045631963,0.0000035801704,0.0003577599],"genre_scores_gemma":[0.9988073,0.000050341907,0.000114640985,0.000032375097,0.000009679962,0.000009742717,0.0002626905,0.0000031299178,0.00071007217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994128,0.00015175683,0.000048083723,0.00018214624,0.000075512675,0.00012972097],"domain_scores_gemma":[0.99935025,0.000093546885,0.0001469182,0.00017820335,0.000091675436,0.00013942792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007668615,0.00040035893,0.0003738687,0.00053205277,0.0008289408,0.0008294888,0.00047273497,0.000730249,0.0025906367],"category_scores_gemma":[0.001540699,0.0005987187,0.001215601,0.0011289063,0.00027264885,0.0004375936,0.00055098074,0.0008355942,0.00040295726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020530755,0.00016458049,0.9929883,0.00001859311,0.0006106088,0.0003155222,0.00018966869,0.00004571944,0.0016715457,0.000071939736,0.00022579997,0.001644694],"study_design_scores_gemma":[0.000078680685,0.0004225363,0.9976877,0.000005499734,0.000346854,0.0003296376,0.00023329376,0.00021236068,0.00019254364,0.00008214403,0.00040208496,0.0000065236013],"about_ca_topic_score_codex":0.010079129,"about_ca_topic_score_gemma":0.010334754,"teacher_disagreement_score":0.010079129,"about_ca_system_score_codex":0.00027176258,"about_ca_system_score_gemma":0.00045971587,"threshold_uncertainty_score":0.02004087},"labels":[],"label_agreement":null},{"id":"W4390128371","doi":"10.1016/j.jval.2023.09.825","title":"EE560 A Comparison of Time-Driven Activity-Based Costs for Patients and Caregivers Receiving Intravitreal Treatments for Neovascular Age-Related Macular Degeneration","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of Windsor; Ottawa Hospital","funders":"","keywords":"Macular degeneration; Medicine; Ophthalmology; Optometry; Gerontology","score_opus":0.24911130776865745,"score_gpt":0.4091125458603099,"score_spread":0.16000123809165243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867524,0.0017064465,0.0005554871,0.00025915276,0.00007787843,0.00013994116,0.0051955804,0.000013346053,0.005299813],"genre_scores_gemma":[0.99520564,0.00032128196,0.00040077858,0.000051717507,0.000020975665,0.00008998773,0.0028126612,0.0000051260818,0.0010917812],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9976295,0.0014960517,0.00022454967,0.00014400785,0.00033415933,0.00017167733],"domain_scores_gemma":[0.9944107,0.0041471347,0.00048130273,0.00022637502,0.00042427672,0.0003101959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037989123,0.000427841,0.0007799207,0.0011129434,0.000238759,0.0011314205,0.00049183954,0.0006083139,0.0070686736],"category_scores_gemma":[0.017617978,0.0001826553,0.002375113,0.0012308734,0.00021646418,0.00089460285,0.00083272706,0.0006884765,0.00037893292],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34260416,0.0078066904,0.3007501,0.004532335,0.01702809,0.0004956647,0.00091901526,0.050279148,0.0029299785,0.013932199,0.00983967,0.24888298],"study_design_scores_gemma":[0.017348664,0.03736154,0.86603564,0.000885317,0.007237454,0.0007701838,0.0017627801,0.045811288,0.0023927928,0.0034420139,0.016753059,0.00019923346],"about_ca_topic_score_codex":0.009581918,"about_ca_topic_score_gemma":0.0061078495,"teacher_disagreement_score":0.009581918,"about_ca_system_score_codex":0.0020563214,"about_ca_system_score_gemma":0.0011183837,"threshold_uncertainty_score":0.02364701},"labels":[],"label_agreement":null},{"id":"W4390128438","doi":"10.1016/j.jval.2023.09.160","title":"CO88 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Secukinumab; Axial spondyloarthritis; Medicine; Matching (statistics); Radiography; Nuclear medicine; Orthodontics; Radiology; Internal medicine; Ankylosing spondylitis; Pathology; Arthritis","score_opus":0.05772239883084474,"score_gpt":0.32962091304604074,"score_spread":0.271898514215196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863614,0.0063466122,0.0016933121,0.0002590834,0.00053942495,0.0003535089,0.0024805774,0.000052728934,0.0019133133],"genre_scores_gemma":[0.99697566,0.0003745951,0.000625072,0.0001439497,0.00008790536,0.00014099434,0.0006498245,0.000010058432,0.0009919367],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98800755,0.008665769,0.00066147215,0.0012891386,0.00066844403,0.000707662],"domain_scores_gemma":[0.9918869,0.0043680137,0.0016797921,0.0012205762,0.000479853,0.00036492743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064084437,0.001401734,0.002772529,0.0006281048,0.0003600988,0.0012066966,0.0013404749,0.0016824428,0.005175616],"category_scores_gemma":[0.014116593,0.0010763264,0.007753108,0.00080860005,0.0005816455,0.00081842864,0.0010256569,0.0020526699,0.00047990205],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86717975,0.0010448324,0.039177302,0.0016353679,0.06684037,0.000084449006,0.00012607597,0.0019225988,0.0015291537,0.00043754306,0.0012365696,0.01878593],"study_design_scores_gemma":[0.36466184,0.09613521,0.3370237,0.0006279917,0.17386647,0.0003640497,0.00040791524,0.015798371,0.004215978,0.0014329178,0.0052247695,0.00024080282],"about_ca_topic_score_codex":0.009285815,"about_ca_topic_score_gemma":0.0059666573,"teacher_disagreement_score":0.009285815,"about_ca_system_score_codex":0.001099186,"about_ca_system_score_gemma":0.0008334372,"threshold_uncertainty_score":0.03389144},"labels":[],"label_agreement":null},{"id":"W4390128441","doi":"10.1016/j.jval.2023.09.1763","title":"HTA79 CADTH Reimbursement Recommendations for Mental Illness Health Products: 10-Year Trends in Relation to Non-Mental Illness Health Products and Recommendations From Other HTA Bodies","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Mental illness; Mental health; Medicine; Psychiatry; Environmental health; Health care; Political science; Law","score_opus":0.339166958989266,"score_gpt":0.44347530709181965,"score_spread":0.10430834810255363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128441","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.040493958,0.09089439,0.0075800573,0.35689783,0.01955757,0.0015571738,0.26285204,0.0022362173,0.21793081],"genre_scores_gemma":[0.20463797,0.08882047,0.0408817,0.2360864,0.019576903,0.0028928604,0.24279644,0.0011970494,0.16311021],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9924434,0.00091912696,0.0009966168,0.0003033087,0.0046368716,0.0007006585],"domain_scores_gemma":[0.9555133,0.015047105,0.0063987346,0.0007636188,0.018848186,0.0034290599],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0075368187,0.00056751305,0.0009345827,0.0056205643,0.0008489717,0.0037169855,0.0017861455,0.0051322803,0.022798419],"category_scores_gemma":[0.032054715,0.0005070427,0.0031468526,0.007199637,0.00046862592,0.0015832417,0.0010702382,0.0043514213,0.00892315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031069203,0.00027422162,0.016426733,0.00073029596,0.0001284125,0.00010301882,0.000073901545,0.0007049673,0.00025207776,0.0021572348,0.89358485,0.08525359],"study_design_scores_gemma":[0.00046128468,0.00026919102,0.29851717,0.0048692,0.0004991569,0.00027302912,0.00039468886,0.0031241968,0.0009222277,0.0027491886,0.68776965,0.00015103286],"about_ca_topic_score_codex":0.10695951,"about_ca_topic_score_gemma":0.12345754,"teacher_disagreement_score":0.9957753,"about_ca_system_score_codex":0.0042247437,"about_ca_system_score_gemma":0.0110682715,"threshold_uncertainty_score":0.2126739},"labels":[],"label_agreement":null},{"id":"W4390128467","doi":"10.1016/j.jval.2023.09.1179","title":"EPH137 Healthcare Resource Consumption and Direct Costs of Patients Newly Diagnosed with Acute Myeloid Leukemia from a Large Italian Administrative Database","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Myeloid leukemia; Resource consumption; Consumption (sociology); Health care; Medicine; Resource (disambiguation); Database; Business; Operations management; Intensive care medicine; Computer science; Internal medicine; Economics; Computer network; Economic growth; Biology","score_opus":0.05861001445377408,"score_gpt":0.29106940854868874,"score_spread":0.23245939409491465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.800602,0.0009980613,0.00029062058,0.0003966895,0.000026013855,0.00005385957,0.1952059,0.00003698778,0.0023898445],"genre_scores_gemma":[0.82341766,0.00052108284,0.00033408907,0.00021313346,0.000074441166,0.00015057778,0.17364322,0.000022356897,0.0016234438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884063,0.0002558922,0.00019499025,0.00027902043,0.00018423703,0.00024527631],"domain_scores_gemma":[0.99635726,0.0009215416,0.0017071884,0.0004045947,0.00029161465,0.00031780938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007519857,0.00039980322,0.00066623226,0.00250097,0.00025169287,0.0011545264,0.00066280924,0.00062746817,0.0051250616],"category_scores_gemma":[0.0055898665,0.00034565764,0.0013695061,0.0049770977,0.00021419387,0.00044851884,0.00079460244,0.00071581954,0.0010585014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071707455,0.000115022674,0.98343796,0.00019692958,0.00078260596,0.00017679523,0.000066713015,0.0010903898,0.00010875888,0.00025371695,0.009515584,0.0035383643],"study_design_scores_gemma":[0.000094021074,0.00006289508,0.9944131,0.00005024112,0.0002021603,0.0002750298,0.00010937165,0.001119664,0.00007094769,0.00007145226,0.0035186997,0.000012432538],"about_ca_topic_score_codex":0.050101813,"about_ca_topic_score_gemma":0.031122062,"teacher_disagreement_score":0.050101813,"about_ca_system_score_codex":0.001671241,"about_ca_system_score_gemma":0.0013927115,"threshold_uncertainty_score":0.0996204},"labels":[],"label_agreement":null},{"id":"W4390128515","doi":"10.1016/j.jval.2023.09.163","title":"CO91 Association Between Progression-Free Survival (PFS) and Overall Survival (OS) in Patients with Relapsed/Refractory (RR) Multiple Myeloma (MM)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Progression-free survival; Multiple myeloma; Medicine; Refractory (planetary science); Oncology; Internal medicine; Overall survival; Biology","score_opus":0.04410244819865129,"score_gpt":0.3251122891990199,"score_spread":0.28100984100036863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975235,0.00079749146,0.00007251311,0.00023007179,0.000021351716,0.0000033394288,0.00043911394,0.000006255365,0.0009063076],"genre_scores_gemma":[0.99910825,0.00010063653,0.000034893466,0.000056987537,0.000032090025,0.0000029517794,0.00027282684,0.0000019249774,0.00038942462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970835,0.00008179434,0.00003159618,0.00005797311,0.000035209112,0.000085073174],"domain_scores_gemma":[0.9987496,0.00045291902,0.00042259615,0.000061186045,0.00008230546,0.00023139824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052777235,0.00021148167,0.00029460472,0.00051171595,0.00038486675,0.0008017451,0.00025987803,0.0005516357,0.0038641419],"category_scores_gemma":[0.002120075,0.00017021355,0.0005626549,0.0007891264,0.00024905198,0.00049305503,0.00043035296,0.0008082157,0.00048817557],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012092969,0.000056008506,0.99439454,0.0000170352,0.00011307902,0.00008235999,0.000037652142,0.00008057053,0.00025885302,0.000036040103,0.00023903491,0.0034755354],"study_design_scores_gemma":[0.00004048893,0.000315284,0.99798113,0.00000819606,0.000120905956,0.0002621675,0.000117659314,0.00047123776,0.000085361185,0.00012604886,0.00046512778,0.0000063963644],"about_ca_topic_score_codex":0.0022708748,"about_ca_topic_score_gemma":0.00292248,"teacher_disagreement_score":0.0038641419,"about_ca_system_score_codex":0.0003447891,"about_ca_system_score_gemma":0.00035282018,"threshold_uncertainty_score":0.012926817},"labels":[],"label_agreement":null},{"id":"W4390128516","doi":"10.1016/j.jval.2023.09.2269","title":"MT40 Trends of Use of Knotless Tissue Control Devices and Smooth Sutures in Robotic Ventral Hernia Repair: A Retrospective Database Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Hernia repair and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Custom Security Industries (Canada)","funders":"","keywords":"Ventral hernia; Medicine; Surgery; Hernia","score_opus":0.0455359024825187,"score_gpt":0.33510054316516696,"score_spread":0.28956464068264826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903458,0.0012312168,0.00020137224,0.00008375907,0.000016253178,0.000015171647,0.0070610116,0.00001132255,0.0010340374],"genre_scores_gemma":[0.9947556,0.00048295484,0.00013764133,0.0000808439,0.000022725999,0.000022421296,0.004225322,0.000009548563,0.00026294836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984126,0.00018888066,0.00039617243,0.00042291792,0.0003159499,0.00026335136],"domain_scores_gemma":[0.99453676,0.0006408767,0.0035483653,0.00041853226,0.0004494956,0.00040612108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078512554,0.00021496131,0.0004609733,0.002033034,0.00033960113,0.0011793554,0.0004909299,0.0005698313,0.0027643708],"category_scores_gemma":[0.003361738,0.00036741156,0.0013903208,0.0038686688,0.00028443412,0.00085787696,0.00068235915,0.00079791364,0.0004630028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018662553,0.000022230035,0.9978911,0.00003928749,0.00019728097,0.000055912908,0.00004339014,0.000051125837,0.000122063764,0.000045219145,0.00024167403,0.0011040764],"study_design_scores_gemma":[0.000008004531,0.00010266359,0.99813205,0.00002829799,0.00011322953,0.0003624821,0.00027142622,0.00020964093,0.000085904794,0.000028665792,0.0006478481,0.000009731647],"about_ca_topic_score_codex":0.006427746,"about_ca_topic_score_gemma":0.0073375273,"teacher_disagreement_score":0.006427746,"about_ca_system_score_codex":0.0006721036,"about_ca_system_score_gemma":0.00079201325,"threshold_uncertainty_score":0.012780666},"labels":[],"label_agreement":null},{"id":"W4390128568","doi":"10.1016/j.jval.2023.09.1881","title":"HTA198 Comparisons of Economic Evaluation Guidelines Between Japan and Six Countries (England, France, Germany, Sweden, Canada and Australia)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography; Political science; Demography; Sociology","score_opus":0.20151999857550057,"score_gpt":0.3665210341295877,"score_spread":0.16500103555408713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128568","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09312314,0.029736236,0.049130496,0.040264074,0.0063488907,0.015593476,0.23026517,0.004463349,0.5310752],"genre_scores_gemma":[0.47118065,0.010228274,0.23255554,0.03532586,0.002284029,0.024599317,0.09879462,0.0031780207,0.12185378],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9548312,0.01974178,0.0091934865,0.0008614616,0.013020536,0.0023515602],"domain_scores_gemma":[0.8188473,0.11192291,0.009873354,0.005663111,0.050859526,0.0028338097],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.057958063,0.0005923073,0.0012252074,0.010200549,0.0018769698,0.005869424,0.0023952925,0.0044656256,0.022997478],"category_scores_gemma":[0.18437521,0.0011029987,0.0035633217,0.015060628,0.001267216,0.0020780822,0.001867453,0.0024276797,0.00434601],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033699756,0.0005691367,0.020909252,0.0078947395,0.001533273,0.00064643857,0.0023801283,0.0046006287,0.0011795217,0.04039365,0.7526608,0.16386247],"study_design_scores_gemma":[0.0029369483,0.0007672846,0.35022905,0.011759646,0.0025699262,0.00053329486,0.002484149,0.0056400537,0.0033072005,0.013057343,0.6063124,0.0004027366],"about_ca_topic_score_codex":0.074714035,"about_ca_topic_score_gemma":0.110888846,"teacher_disagreement_score":0.9937646,"about_ca_system_score_codex":0.006235441,"about_ca_system_score_gemma":0.014128602,"threshold_uncertainty_score":0.30651522},"labels":[],"label_agreement":null},{"id":"W4390128709","doi":"10.1016/j.jval.2023.09.204","title":"CO132 A Real-World Evidence Analysis of the Impact of Patient-Physician Sex Concordance on Cancer Treatment Practices and Outcomes","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Concordance; Cancer; Medicine; Real world evidence; Family medicine; Internal medicine","score_opus":0.21637236000319132,"score_gpt":0.4932190053436516,"score_spread":0.2768466453404603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43474993,0.39515156,0.008934794,0.037241563,0.0026956107,0.0050640474,0.055577133,0.00019155593,0.060393825],"genre_scores_gemma":[0.92473704,0.049777202,0.008885547,0.0057010357,0.00068865303,0.0013890871,0.005738992,0.00007850835,0.0030039626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9517696,0.031727422,0.007088056,0.0024898932,0.005965588,0.00095944514],"domain_scores_gemma":[0.7924148,0.15802075,0.024854213,0.0044510057,0.01774642,0.002512875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024585066,0.00063428265,0.001880557,0.004496642,0.0010235255,0.0039726095,0.0010711664,0.0022196549,0.013194879],"category_scores_gemma":[0.1758376,0.0005724249,0.008100041,0.0066305795,0.00094429695,0.001733957,0.0017485981,0.0027312085,0.0010378768],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036513522,0.0014574595,0.23273514,0.12850854,0.2218686,0.0008180817,0.0016387551,0.0034343437,0.0011635988,0.0069467984,0.029869033,0.3350462],"study_design_scores_gemma":[0.023586337,0.010819723,0.31922114,0.13003571,0.36318502,0.0016458519,0.0029243173,0.004916728,0.0033879268,0.00722693,0.13250233,0.0005479807],"about_ca_topic_score_codex":0.021578532,"about_ca_topic_score_gemma":0.037301853,"teacher_disagreement_score":0.024585066,"about_ca_system_score_codex":0.004971766,"about_ca_system_score_gemma":0.009816651,"threshold_uncertainty_score":0.13001984},"labels":[],"label_agreement":null},{"id":"W4390128716","doi":"10.1016/j.jval.2023.09.165","title":"CO93 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Versus Selinexor-Dexamethasone for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Dexamethasone; Medicine; Matching (statistics); Refractory (planetary science); Class (philosophy); Oncology; Multiple myeloma; Internal medicine; Computer science; Physics; Pathology; Artificial intelligence","score_opus":0.13386070313518275,"score_gpt":0.35811897525514064,"score_spread":0.22425827211995789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9659091,0.016036898,0.0031017796,0.00092022977,0.0024659857,0.0014494695,0.0037098136,0.00018926787,0.006217493],"genre_scores_gemma":[0.9944922,0.00085505575,0.001006058,0.00046201862,0.00017905585,0.000488584,0.0006431163,0.0000135705495,0.001860502],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99485636,0.0033570812,0.0003368896,0.00064874906,0.00030081818,0.000500168],"domain_scores_gemma":[0.9981198,0.0010318673,0.00035521723,0.00019299901,0.00010250882,0.00019765463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028393595,0.001316117,0.0035316213,0.00054940116,0.00031572513,0.0010335309,0.0010712531,0.0015993104,0.009947806],"category_scores_gemma":[0.0053408537,0.000567433,0.006823053,0.00045074723,0.00056351366,0.0010177196,0.000862245,0.0029949653,0.0005748483],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96458954,0.0006455589,0.002323703,0.000882983,0.018210724,0.00003565361,0.000042111584,0.000775891,0.00072427077,0.00036021613,0.0009247592,0.010484468],"study_design_scores_gemma":[0.7273558,0.12887439,0.046525106,0.000601877,0.069589995,0.00019853012,0.00026477638,0.014451386,0.0027476675,0.0033038247,0.005940522,0.00014612707],"about_ca_topic_score_codex":0.0044455635,"about_ca_topic_score_gemma":0.005460994,"teacher_disagreement_score":0.009947806,"about_ca_system_score_codex":0.001112112,"about_ca_system_score_gemma":0.0011431278,"threshold_uncertainty_score":0.033278704},"labels":[],"label_agreement":null},{"id":"W4390128878","doi":"10.1016/j.jval.2023.09.2976","title":"SA67 Considerations for Including Different Routes of Administration in Network Meta-Analysis: A Comprehensive Review","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Meta-analysis; Computer science; Administration (probate law); Computational biology; Risk analysis (engineering); Management science; Medicine; Engineering; Biology; Political science; Internal medicine","score_opus":0.9665901220411067,"score_gpt":0.6431554478636285,"score_spread":0.3234346741774782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009078852,0.9499991,0.016201258,0.02359709,0.0047645215,0.0011014222,0.0010212404,0.00020417453,0.0022032836],"genre_scores_gemma":[0.07212455,0.73147637,0.12747958,0.050215982,0.008171764,0.0069379685,0.001362327,0.0005006034,0.0017308898],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.65973884,0.2589532,0.057897758,0.0057828487,0.016546559,0.0010808632],"domain_scores_gemma":[0.38353392,0.5438322,0.026543703,0.015454768,0.028753534,0.0018819121],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27061495,0.002544576,0.015267594,0.0086004995,0.0011122004,0.011726599,0.004114741,0.007863207,0.00726229],"category_scores_gemma":[0.5252628,0.003038108,0.024068847,0.009974935,0.0028865011,0.009762021,0.005060795,0.009836959,0.0015899166],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004470186,0.00008261827,0.0033849673,0.4164181,0.22689669,0.00033355228,0.0008305485,0.0019639644,0.0007431965,0.01075587,0.041859552,0.2922607],"study_design_scores_gemma":[0.005314562,0.0008739878,0.00690439,0.47419778,0.31842187,0.000620664,0.000495237,0.0033431882,0.0008710729,0.041334648,0.14710782,0.0005148862],"about_ca_topic_score_codex":0.008331231,"about_ca_topic_score_gemma":0.024404526,"teacher_disagreement_score":0.729385,"about_ca_system_score_codex":0.005157455,"about_ca_system_score_gemma":0.017812638,"threshold_uncertainty_score":0.8994616},"labels":[],"label_agreement":null},{"id":"W4390128944","doi":"10.1016/j.jval.2023.09.2080","title":"MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Geography; Virology; Medicine; Outbreak","score_opus":0.2932547004535566,"score_gpt":0.45281437651957795,"score_spread":0.15955967606602134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9350299,0.0005669465,0.03679882,0.0025571326,0.0002173551,0.012618937,0.004751268,0.00006530717,0.007394286],"genre_scores_gemma":[0.92593455,0.00021458455,0.039625663,0.0025701202,0.00008762215,0.026404195,0.0017000642,0.00004040643,0.003422734],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.88605213,0.10094718,0.002854759,0.0027287416,0.0046067215,0.0028105178],"domain_scores_gemma":[0.9456157,0.038871955,0.003083748,0.00564244,0.0054943855,0.001291765],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08487776,0.0007040778,0.0011787859,0.00095841684,0.004591603,0.002034571,0.0022629458,0.0018353629,0.0020001992],"category_scores_gemma":[0.091242045,0.0010008786,0.0017012318,0.00231818,0.0028611857,0.00070495397,0.0013861153,0.0018100163,0.0002569964],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02186333,0.0061638476,0.7656642,0.0012490305,0.0038577926,0.00090028235,0.025969261,0.03407818,0.006944662,0.037998293,0.015133286,0.08017784],"study_design_scores_gemma":[0.0036038237,0.0049913065,0.9135719,0.00029836086,0.0011364911,0.00018209722,0.009174911,0.029799545,0.005018108,0.0066689504,0.025137084,0.0004174417],"about_ca_topic_score_codex":0.8432267,"about_ca_topic_score_gemma":0.8345107,"teacher_disagreement_score":0.9832344,"about_ca_system_score_codex":0.01676559,"about_ca_system_score_gemma":0.020142391,"threshold_uncertainty_score":0.44888186},"labels":[],"label_agreement":null},{"id":"W4390128947","doi":"10.1016/j.jval.2023.09.2915","title":"SA5 Innovative Direct-to-Physician Retrospective Chart Review Approach: Synthesized Learnings from Completed and Ongoing","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Chart; Medicine; Statistics; Mathematics","score_opus":0.05275576394830567,"score_gpt":0.38320639282315727,"score_spread":0.3304506288748516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128947","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3009689,0.0066375537,0.5046218,0.0139368,0.0028299184,0.019380862,0.03756572,0.005306264,0.108752266],"genre_scores_gemma":[0.47879553,0.0021119772,0.49365306,0.0017873726,0.0007972673,0.00685843,0.0068705087,0.00052177033,0.008604167],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97100675,0.017876236,0.0034780693,0.002143462,0.004979582,0.0005159139],"domain_scores_gemma":[0.85306317,0.07654666,0.012152519,0.010928572,0.04524255,0.0020665666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.032050624,0.0005843742,0.0007068783,0.0056835595,0.0009821389,0.0039370973,0.0015268438,0.0005964129,0.013596238],"category_scores_gemma":[0.12822734,0.00046470758,0.00090687285,0.003882564,0.0006160027,0.0023009202,0.0028329245,0.0010401882,0.001980695],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012288932,0.00048369478,0.07806589,0.0051707854,0.00063695613,0.00045736253,0.01481086,0.0021654412,0.002749931,0.008329656,0.051199336,0.83470124],"study_design_scores_gemma":[0.0011056793,0.003498701,0.32958263,0.0166324,0.0027419876,0.0031669107,0.052729476,0.04743915,0.023076627,0.05252291,0.46670687,0.00079657213],"about_ca_topic_score_codex":0.005334555,"about_ca_topic_score_gemma":0.0201489,"teacher_disagreement_score":0.9679494,"about_ca_system_score_codex":0.0022264218,"about_ca_system_score_gemma":0.011552485,"threshold_uncertainty_score":0.1695019},"labels":[],"label_agreement":null},{"id":"W4390128966","doi":"10.1016/j.jval.2023.09.2670","title":"PCR233 Socioeconomic Impact of Muscular Dystrophies on Patients and Their Caregivers in the Czech Republic","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Ozone Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Czech; Socioeconomic status; Medicine; Environmental health","score_opus":0.07733253474938878,"score_gpt":0.3544088935728361,"score_spread":0.27707635882344733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849,0.00021027244,0.000009305177,0.00011748625,0.000004890655,0.0000034612663,0.00021348153,5.994724e-7,0.0009505031],"genre_scores_gemma":[0.9996878,0.00009725854,0.000005650199,0.0000125042425,0.0000015424584,0.000001985217,0.00007816435,3.727218e-7,0.00011473822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947184,0.00014204964,0.00005490134,0.000046959067,0.00006762725,0.00021653993],"domain_scores_gemma":[0.9992766,0.00007401204,0.00024476612,0.000019982781,0.000118036856,0.0002665995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032882902,0.00014039749,0.00022092358,0.0007929985,0.00085398345,0.00071169646,0.00021037135,0.00018669336,0.0024646712],"category_scores_gemma":[0.0017313212,0.0001075824,0.00033216097,0.0011583793,0.00029459878,0.00023278293,0.0010329565,0.0003932047,0.0001316766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017405706,0.00007647457,0.99284524,0.00003646886,0.000063519416,0.00054258754,0.0011522033,0.00008299139,0.00015415016,0.00018274646,0.00037964192,0.004309863],"study_design_scores_gemma":[0.0000040274567,0.000030317442,0.9962081,0.000023813187,0.000013518269,0.00013581582,0.003200026,0.000036265854,0.00001786787,0.000028959992,0.00029688224,0.0000044778653],"about_ca_topic_score_codex":0.08659222,"about_ca_topic_score_gemma":0.085189626,"teacher_disagreement_score":0.08659222,"about_ca_system_score_codex":0.0014486415,"about_ca_system_score_gemma":0.0016142235,"threshold_uncertainty_score":0.17217642},"labels":[],"label_agreement":null},{"id":"W4390129057","doi":"10.1016/j.jval.2023.09.2579","title":"PCR140 Management of Osteogenesis Imperfecta: Self-Reported Access Challenges to Consumables and Services Across the EU5 and Nordics","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Consumables; Osteogenesis imperfecta; Business; Medicine; Marketing; Pathology","score_opus":0.0669434768531372,"score_gpt":0.3861540756883674,"score_spread":0.3192105988352302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634451,0.008716825,0.0007442746,0.0076671606,0.00011134432,0.000031491887,0.0014726572,0.00001636483,0.017794788],"genre_scores_gemma":[0.9924947,0.003122887,0.0010743594,0.0010733544,0.000023278555,0.000030666568,0.000484662,0.000014988741,0.0016809641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967615,0.0012942135,0.0003735966,0.00025593053,0.0008759015,0.0004389047],"domain_scores_gemma":[0.99505436,0.0017394464,0.0016541573,0.00014587608,0.000664614,0.0007415207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032624372,0.00011626428,0.00032250045,0.0007770682,0.0007140539,0.0016851455,0.0004804346,0.0004947527,0.0024993417],"category_scores_gemma":[0.0066938433,0.000119504526,0.00023478904,0.0016411055,0.0006964009,0.0005233016,0.0016889313,0.00051450985,0.00014855235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026544236,0.00022091925,0.76395744,0.00071302935,0.00027011122,0.0018287153,0.014602169,0.00082845805,0.0014014683,0.0060280086,0.009430191,0.20045406],"study_design_scores_gemma":[0.00001472904,0.0001484566,0.9407598,0.0017657134,0.00006657148,0.002654477,0.019158915,0.00032653133,0.00029644536,0.0010080474,0.033767093,0.0000332836],"about_ca_topic_score_codex":0.059282817,"about_ca_topic_score_gemma":0.05710139,"teacher_disagreement_score":0.059282817,"about_ca_system_score_codex":0.0014522183,"about_ca_system_score_gemma":0.0040529133,"threshold_uncertainty_score":0.11787552},"labels":[],"label_agreement":null},{"id":"W4390129169","doi":"10.1016/j.jval.2023.09.2620","title":"PCR182 Patient Preferences for Tumor-Agnostic Therapies: Qualitative Insights and Challenges","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Data science; Medicine; Psychology; Computer science","score_opus":0.09726597006983073,"score_gpt":0.33900825115550437,"score_spread":0.24174228108567364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86765176,0.003698705,0.011171099,0.06963474,0.00018405358,0.00011647413,0.0016095957,0.000030510957,0.045903035],"genre_scores_gemma":[0.99421555,0.000630501,0.0018488197,0.0023190025,0.00004573205,0.000046884645,0.00014849438,0.000012219981,0.0007328378],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.98789304,0.008330749,0.0004665819,0.00040365013,0.0022143994,0.0006915588],"domain_scores_gemma":[0.96837616,0.023649199,0.0026503825,0.0005367255,0.0036633154,0.0011241465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014730164,0.00015461734,0.00030677608,0.0006700091,0.00081914413,0.0033125973,0.00058589055,0.0006259442,0.00713432],"category_scores_gemma":[0.03937979,0.0001260533,0.00041924944,0.00088002335,0.0013199986,0.0018168957,0.0013413696,0.0014124231,0.000641332],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012800011,0.00037835314,0.41437337,0.0013151723,0.00048225446,0.0009047559,0.055979412,0.0015352822,0.0033258107,0.04222078,0.028232519,0.44997236],"study_design_scores_gemma":[0.00015736838,0.0010558118,0.36201036,0.00260943,0.00045175396,0.0045144306,0.329108,0.0085985195,0.0063960226,0.14774346,0.13701548,0.0003393403],"about_ca_topic_score_codex":0.0024444587,"about_ca_topic_score_gemma":0.0043265303,"teacher_disagreement_score":0.014730164,"about_ca_system_score_codex":0.0023522503,"about_ca_system_score_gemma":0.0030351027,"threshold_uncertainty_score":0.07790154},"labels":[],"label_agreement":null},{"id":"W4390129341","doi":"10.1016/j.jval.2023.09.2917","title":"SA7 Emerging Biomarkers in Metastatic Castration Resistant Prostate Cancer As Evaluated in Early Phase Clinical Trials: A Targeted Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Clinical trial; Cancer; Internal medicine","score_opus":0.33183232689851033,"score_gpt":0.574591972933008,"score_spread":0.24275964603449768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129341","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004309473,0.9977475,0.000121856734,0.0009331909,0.00017535793,0.000029839986,0.000076812095,0.0000040190926,0.0004804661],"genre_scores_gemma":[0.0071408832,0.990359,0.00052702724,0.001274409,0.00035376425,0.000055726177,0.00012154248,0.000003564545,0.00016402625],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983676,0.00051106367,0.00051989674,0.00015294064,0.00036219787,0.000086379085],"domain_scores_gemma":[0.9861237,0.009673823,0.0020667769,0.00016394901,0.0017342429,0.00023757065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0063569047,0.00065798627,0.00303243,0.0041588205,0.00030422295,0.0029906586,0.0010165103,0.001598105,0.0032676575],"category_scores_gemma":[0.013140464,0.00042245092,0.0021786513,0.00391271,0.0007209483,0.001959454,0.0009782331,0.0019167985,0.0005898561],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014065475,0.00013053387,0.0020169767,0.17941988,0.0027077184,0.00024159248,0.0002571096,0.00054289616,0.0013691501,0.003947095,0.014263797,0.7936967],"study_design_scores_gemma":[0.0009353079,0.0021523961,0.008578281,0.35671923,0.026851868,0.0011169796,0.0006981213,0.0007935939,0.0020053461,0.0049909204,0.5950304,0.00012761407],"about_ca_topic_score_codex":0.0012954201,"about_ca_topic_score_gemma":0.0043198266,"teacher_disagreement_score":0.0063569047,"about_ca_system_score_codex":0.0014204166,"about_ca_system_score_gemma":0.0053368863,"threshold_uncertainty_score":0.033618927},"labels":[],"label_agreement":null},{"id":"W4390129371","doi":"10.1016/j.jval.2023.09.2239","title":"MT10 Clinical and Economic Impact of Point-of-Care (POC) Molecular Testing in Patients Presenting With Viral Respiratory Symptoms: A Systematic Literature Review (SLR)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Point-of-care testing; Medicine; Intensive care medicine; Respiratory system; Internal medicine; Pathology","score_opus":0.07614595598284403,"score_gpt":0.43187442420636535,"score_spread":0.35572846822352133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129371","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005825433,0.9910857,0.00013118009,0.0005484285,0.00015665831,0.00015805454,0.0017341406,0.0000051957845,0.00035510148],"genre_scores_gemma":[0.1418778,0.85358125,0.0011258811,0.0016167397,0.0002462064,0.00040225394,0.0009949559,0.000010359667,0.00014463185],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98996526,0.0029170916,0.004412977,0.00088649266,0.0013959488,0.0004221815],"domain_scores_gemma":[0.95396674,0.0351842,0.00778437,0.0004808426,0.00225261,0.0003313351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010541249,0.0009740917,0.005384721,0.0072368425,0.00031719476,0.0031429392,0.0014027153,0.002034998,0.004085405],"category_scores_gemma":[0.058959574,0.000838378,0.013018708,0.007937581,0.00070688373,0.0016529504,0.0016000598,0.001545267,0.0002399045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012311232,0.00006220815,0.01549338,0.8458253,0.091907784,0.00019901541,0.00020132966,0.00035832718,0.00019161699,0.00035718182,0.0018678543,0.042304832],"study_design_scores_gemma":[0.0009701192,0.00055650924,0.04665904,0.5095159,0.42591152,0.00059194246,0.00051266595,0.0003130708,0.00020863555,0.00045006076,0.014217378,0.00009321372],"about_ca_topic_score_codex":0.013870279,"about_ca_topic_score_gemma":0.035092633,"teacher_disagreement_score":0.013870279,"about_ca_system_score_codex":0.0030643593,"about_ca_system_score_gemma":0.00828313,"threshold_uncertainty_score":0.055748105},"labels":[],"label_agreement":null},{"id":"W4390129418","doi":"10.1016/j.jval.2023.09.2631","title":"PCR194 A Global Perspective on Self-Reported Productivity Losses Associated With Osteogenesis Imperfecta","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Osteogenesis imperfecta; Perspective (graphical); Productivity; Economics; Medicine; Computer science; Anatomy; Macroeconomics; Artificial intelligence","score_opus":0.042972883126205126,"score_gpt":0.3522900619581048,"score_spread":0.3093171788318997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7465191,0.12584327,0.010173611,0.04378872,0.0013755495,0.000046876667,0.014917535,0.00014803307,0.057187345],"genre_scores_gemma":[0.9687669,0.021567961,0.0016997618,0.0013944501,0.0011103434,0.000025481759,0.0019980578,0.00003105082,0.003405902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988217,0.00055560615,0.00008458201,0.00019705239,0.00022377927,0.000117351345],"domain_scores_gemma":[0.9967894,0.001471399,0.0007092329,0.00012280903,0.0005873123,0.00031967598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019370625,0.00040833378,0.0004970415,0.0025823137,0.0003601292,0.0015678625,0.00044261385,0.00047765576,0.0038963398],"category_scores_gemma":[0.003313309,0.00010964253,0.00040332985,0.00286415,0.0008176277,0.00086244306,0.0010047407,0.00080481946,0.00051314954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039762506,0.00010743277,0.6961008,0.00072616746,0.0005643235,0.0007783206,0.0015310709,0.0009913675,0.005146127,0.005418971,0.011163429,0.2770743],"study_design_scores_gemma":[0.0000067801816,0.00020503109,0.96527207,0.00040803908,0.00013096097,0.0015625546,0.0021896923,0.00052971614,0.0009640341,0.0027112903,0.025987953,0.00003193065],"about_ca_topic_score_codex":0.0037463529,"about_ca_topic_score_gemma":0.0035648507,"teacher_disagreement_score":0.0038963398,"about_ca_system_score_codex":0.0004933331,"about_ca_system_score_gemma":0.00041458855,"threshold_uncertainty_score":0.0130345225},"labels":[],"label_agreement":null},{"id":"W4390129453","doi":"10.1016/j.jval.2023.09.2689","title":"PCR252 Early Steps Towards a Huntington's Disease Burden-of-Illness Model: Estimating Out-of-Pocket Costs for Patients Showing Clinical Symptoms","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prioris.ai (Canada)","funders":"","keywords":"Disease; Huntington's disease; Medicine; Psychiatry; Internal medicine","score_opus":0.12715279846376984,"score_gpt":0.38546986048155946,"score_spread":0.2583170620177896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129453","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28073674,0.0017794501,0.68194705,0.00896809,0.00021550091,0.00065347046,0.010455483,0.0011403463,0.014103855],"genre_scores_gemma":[0.89431125,0.0005467012,0.089564405,0.0007252899,0.000114902694,0.00045455428,0.00399214,0.00020889733,0.010081963],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99896157,0.0007252076,0.00003517496,0.00010551196,0.00006671318,0.000105945124],"domain_scores_gemma":[0.9946397,0.004610136,0.00016389515,0.00012451422,0.00024534875,0.00021650092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037999537,0.0009916953,0.0019791855,0.0007496911,0.0003461635,0.0024515325,0.0019804735,0.0014748016,0.010811588],"category_scores_gemma":[0.013219612,0.00089259516,0.0014636647,0.0009143005,0.00041145686,0.0014474232,0.0009165255,0.0024114787,0.001053997],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009067252,0.00018276366,0.014103045,0.00012440908,0.00037330322,0.00024403873,0.000097462056,0.9278865,0.00018563718,0.014120479,0.0065717353,0.035203937],"study_design_scores_gemma":[0.000074311014,0.00008480282,0.0017420766,0.000037236972,0.000080136706,0.00008807954,0.000042225613,0.9818126,0.000062977866,0.014881906,0.001078832,0.00001486854],"about_ca_topic_score_codex":0.025693916,"about_ca_topic_score_gemma":0.0134302005,"teacher_disagreement_score":0.025693916,"about_ca_system_score_codex":0.001531216,"about_ca_system_score_gemma":0.0024694426,"threshold_uncertainty_score":0.05108875},"labels":[],"label_agreement":null},{"id":"W4390145879","doi":"10.1016/j.jval.2023.09.444","title":"EE175 Cost-Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Takeda (Canada)","funders":"","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Crohn's disease; Inflammatory bowel disease; Disease; Internal medicine; Immunology","score_opus":0.3722231881897124,"score_gpt":0.4148038158103087,"score_spread":0.04258062762059628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390145879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9628673,0.015279206,0.00039666542,0.0043579866,0.00020347713,0.0004066183,0.008282448,0.000045352117,0.008160926],"genre_scores_gemma":[0.9938578,0.0021788122,0.00043779102,0.00042188383,0.000029857414,0.000051724706,0.0017585276,0.000009591131,0.0012539448],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980374,0.00056943885,0.00015195162,0.00016207066,0.0005360567,0.00054304145],"domain_scores_gemma":[0.9946037,0.0016196078,0.0006524016,0.000091662645,0.001563282,0.0014694346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019707005,0.00051403756,0.0013154035,0.0009261695,0.00083574944,0.001937093,0.0012070013,0.0009815355,0.0031401138],"category_scores_gemma":[0.013372464,0.00034834695,0.0023673163,0.0015921042,0.00067637087,0.00057650264,0.00072782044,0.0013520214,0.00013149541],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14127846,0.002789273,0.39572632,0.0042034467,0.007968593,0.00077825383,0.0007980442,0.09749991,0.0015985691,0.0071968236,0.032184135,0.3079782],"study_design_scores_gemma":[0.021064226,0.007990634,0.8617172,0.0017718785,0.0075682597,0.00045478446,0.0019336903,0.08136468,0.0010164261,0.0018164957,0.013019112,0.00028256205],"about_ca_topic_score_codex":0.98012984,"about_ca_topic_score_gemma":0.9805213,"teacher_disagreement_score":0.07124829,"about_ca_system_score_codex":0.07124829,"about_ca_system_score_gemma":0.067164294,"threshold_uncertainty_score":0.516945},"labels":[],"label_agreement":null},{"id":"W4390234051","doi":"10.1016/j.jval.2023.12.011","title":"Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Natural Sciences and Engineering Research Council of Canada","funders":"Roche; AstraZeneca; Pfizer","keywords":"Business; Finance; Marketing; Accounting","score_opus":0.4420792321178288,"score_gpt":0.4359132093285135,"score_spread":0.006166022789315273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390234051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64347345,0.012353778,0.0018800527,0.22271842,0.00038531487,0.00017453461,0.00444738,0.000039947998,0.11452717],"genre_scores_gemma":[0.9891796,0.0017801155,0.0003957393,0.0060545458,0.00015728368,0.000025915957,0.00072870904,0.000021344615,0.0016566421],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9832828,0.0041130227,0.0008510961,0.0005894266,0.0076473765,0.0035162335],"domain_scores_gemma":[0.853302,0.06152667,0.025954071,0.0026506789,0.033377342,0.023189232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0259624,0.00017309167,0.00067722943,0.0045945463,0.0041817394,0.0092203105,0.0017058996,0.002754253,0.00975949],"category_scores_gemma":[0.14969066,0.00028322346,0.0007008974,0.009669965,0.0048896708,0.004799474,0.0018351505,0.0032458927,0.00046507962],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053145684,0.00017207112,0.82799554,0.0002623751,0.00022429784,0.00025154257,0.008308307,0.0008547522,0.00013762027,0.04783087,0.032275923,0.081155226],"study_design_scores_gemma":[0.000084698746,0.00009387294,0.9093049,0.0008564833,0.00013283378,0.00027921188,0.034083616,0.0011199407,0.00020912263,0.014731841,0.038949415,0.00015400587],"about_ca_topic_score_codex":0.8401843,"about_ca_topic_score_gemma":0.89982253,"teacher_disagreement_score":0.9594891,"about_ca_system_score_codex":0.040510867,"about_ca_system_score_gemma":0.056401804,"threshold_uncertainty_score":0.32151377},"labels":[],"label_agreement":null},{"id":"W4391067028","doi":"10.1016/j.jval.2024.01.003","title":"Validation of China Health-Related Outcomes Measures-Cardiovascular Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Population Health Research Institute; McMaster University","funders":"","keywords":"China; Disease; Medicine; Environmental health; Geography; Internal medicine","score_opus":0.3169411900246095,"score_gpt":0.40275922901701255,"score_spread":0.08581803899240303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391067028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832033,0.00023942941,0.0045913616,0.00033246205,0.00008799895,0.0006758361,0.0052184965,0.000039853636,0.0056111533],"genre_scores_gemma":[0.985195,0.00007105457,0.0036157416,0.00015326403,0.00003823348,0.0010319289,0.008493072,0.000020871805,0.0013808445],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99068516,0.005136551,0.00089428795,0.00087521784,0.0019228983,0.0004858889],"domain_scores_gemma":[0.97303337,0.007991593,0.0036980635,0.0041146395,0.00998792,0.0011744511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019338321,0.00077035336,0.0006068254,0.002549057,0.0012221757,0.0010056894,0.0011591127,0.000795152,0.0019711824],"category_scores_gemma":[0.033011965,0.00024133171,0.0011805097,0.0032838054,0.0011287008,0.0009663389,0.00167464,0.00086173,0.0007314532],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086450664,0.00076197303,0.9589522,0.0001358869,0.00044519283,0.00013925326,0.0012614621,0.0019134473,0.0010588682,0.0028237645,0.0042906995,0.027352726],"study_design_scores_gemma":[0.0001715822,0.00049347646,0.9885894,0.000046617373,0.00015459086,0.00008338017,0.0004932506,0.0030502004,0.0011112151,0.0006283936,0.0051559564,0.000021915008],"about_ca_topic_score_codex":0.029651716,"about_ca_topic_score_gemma":0.034245048,"teacher_disagreement_score":0.029651716,"about_ca_system_score_codex":0.0021548716,"about_ca_system_score_gemma":0.005339208,"threshold_uncertainty_score":0.10227203},"labels":[],"label_agreement":null},{"id":"W4391311572","doi":"10.1016/j.jval.2023.12.015","title":"The Cost of Atrial Fibrillation: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"Horizon 2020; Horizon 2020 Framework Programme; European Commission","keywords":"Atrial fibrillation; Cardiology; Medicine; Internal medicine","score_opus":0.2530119251001974,"score_gpt":0.46035595482517216,"score_spread":0.2073440297249748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391311572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008289145,0.99795616,0.000111257745,0.00032731515,0.00014088945,0.00006768174,0.00035893056,0.0000047817443,0.00020402887],"genre_scores_gemma":[0.0195573,0.9791141,0.0003747431,0.0004972159,0.00013420962,0.0001045122,0.00013206666,0.000005155748,0.00008072287],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9939194,0.0024564806,0.0017467381,0.00039117818,0.0012640363,0.00022225811],"domain_scores_gemma":[0.9722573,0.021917216,0.004036975,0.00029823108,0.001228982,0.00026119486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006237096,0.0013630807,0.00774679,0.007072982,0.00035034673,0.0027550624,0.001320245,0.0021245799,0.0061807116],"category_scores_gemma":[0.04424,0.0011656292,0.007845704,0.009424089,0.00073665177,0.0025334093,0.0017198463,0.002356413,0.00030400316],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005940349,0.000028427236,0.0023719908,0.87635505,0.056109924,0.0001945061,0.00010415361,0.0003641547,0.00009938947,0.0008694393,0.004395507,0.058513444],"study_design_scores_gemma":[0.0012607959,0.00020713363,0.011154242,0.6402851,0.31980896,0.0007196744,0.00031376793,0.0004315381,0.00013380902,0.0021860518,0.023403801,0.00009509833],"about_ca_topic_score_codex":0.012073033,"about_ca_topic_score_gemma":0.03291745,"teacher_disagreement_score":0.012073033,"about_ca_system_score_codex":0.0038545106,"about_ca_system_score_gemma":0.0067499015,"threshold_uncertainty_score":0.03298527},"labels":[],"label_agreement":null},{"id":"W4391427137","doi":"10.1016/j.jval.2024.01.010","title":"The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Diabetes Canada; Western University; EVERSANA (Canada)","funders":"Abbott Diabetes Care","keywords":"Type 2 diabetes; Type I and type II errors; Diabetes mellitus; Medicine; Microsimulation; Research design; Statistics; Computer science; Mathematics; Engineering; Transport engineering","score_opus":0.14499602180401525,"score_gpt":0.39717440088558253,"score_spread":0.25217837908156726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391427137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7246251,0.00034663713,0.2684818,0.0002845432,0.000039464714,0.00074177433,0.0023006112,0.0005826389,0.0025973823],"genre_scores_gemma":[0.96626383,0.000067141074,0.032524876,0.000034888813,0.0000049129726,0.0003508695,0.00049186626,0.000026833759,0.00023477196],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973533,0.0018651747,0.00010342505,0.0001739773,0.00041488567,0.00008917658],"domain_scores_gemma":[0.97570974,0.021347582,0.0009451365,0.0008845062,0.0009411295,0.00017186848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00871449,0.0009041508,0.00096034835,0.001473,0.00024584273,0.0009923966,0.0009989395,0.00058281416,0.0013491387],"category_scores_gemma":[0.03142329,0.00032371414,0.001261443,0.0010234724,0.00032975574,0.0008766789,0.0006311914,0.0007942538,0.00014912829],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014977449,0.00080970215,0.03967317,0.00017668032,0.0008664324,0.000057929166,0.00008573068,0.90240955,0.0009992959,0.004779483,0.00068531063,0.047959033],"study_design_scores_gemma":[0.00009896328,0.00056324695,0.009402063,0.0000201833,0.00015377674,0.000047694863,0.00002921039,0.9867775,0.0011045702,0.0014980171,0.00028717253,0.000017686543],"about_ca_topic_score_codex":0.010126932,"about_ca_topic_score_gemma":0.0036086675,"teacher_disagreement_score":0.010126932,"about_ca_system_score_codex":0.0021386417,"about_ca_system_score_gemma":0.0020474126,"threshold_uncertainty_score":0.046087146},"labels":[],"label_agreement":null},{"id":"W4391486916","doi":"10.1016/j.jval.2024.01.014","title":"Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Sierra Oncology; Cancer Research UK; GlaxoSmithKline","keywords":"Myelofibrosis; Medicine; Computer science; Internal medicine","score_opus":0.07058585056676162,"score_gpt":0.3383343008064327,"score_spread":0.2677484502396711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391486916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991747,0.0023824566,0.00011976997,0.00046558148,0.000022118693,0.000033879525,0.00047849448,0.0000054798584,0.0047452073],"genre_scores_gemma":[0.9989435,0.00036662712,0.000103511535,0.000069162255,0.000038939554,0.0000094141915,0.0003418051,0.0000014221222,0.00012551622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994561,0.00020527813,0.000069289206,0.000039431183,0.00015342778,0.00007638214],"domain_scores_gemma":[0.99805826,0.00057121034,0.00079021096,0.00007568433,0.00016273183,0.0003418481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082721363,0.0002115071,0.00053602416,0.0010146415,0.0003428949,0.00070743496,0.0002455216,0.0003149519,0.001005346],"category_scores_gemma":[0.0054454952,0.00007870448,0.00039937202,0.00102238,0.00027497823,0.000490958,0.0005991768,0.00047626838,0.00006925597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013283116,0.00013214022,0.9824691,0.00005881962,0.00011794236,0.0006583736,0.00015622367,0.00011065353,0.0002547492,0.00025724867,0.00060942787,0.013847054],"study_design_scores_gemma":[0.00006134994,0.000324968,0.997285,0.000024724346,0.000078835845,0.000907726,0.0001787463,0.00022346484,0.00009298181,0.0003267022,0.0004889964,0.000006454395],"about_ca_topic_score_codex":0.0017864387,"about_ca_topic_score_gemma":0.0032557098,"teacher_disagreement_score":0.0017864387,"about_ca_system_score_codex":0.00039197545,"about_ca_system_score_gemma":0.00043316133,"threshold_uncertainty_score":0.0043747425},"labels":[],"label_agreement":null},{"id":"W4392028671","doi":"10.1016/j.jval.2024.02.004","title":"Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute on Drug Abuse; National Institutes of Health; University of Toronto","keywords":"Opioid overdose; Medicine; Systematic review; Opioid; Business; MEDLINE; Political science; (+)-Naloxone","score_opus":0.07448866278652824,"score_gpt":0.4043321234471943,"score_spread":0.32984346066066605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392028671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037514581,0.99249834,0.00034316277,0.00040089386,0.00011089669,0.0010218206,0.0011090849,0.000017194216,0.00074713596],"genre_scores_gemma":[0.053695057,0.94181216,0.0014648184,0.0005159103,0.00006436506,0.0015938637,0.0006893559,0.00001278185,0.00015176689],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98716545,0.0060778903,0.0037191275,0.00054711447,0.002123568,0.00036687765],"domain_scores_gemma":[0.9565868,0.03310801,0.0058588055,0.0004502698,0.003604638,0.00039143892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015839726,0.0018974211,0.00893103,0.010339701,0.00077583746,0.0035115134,0.0021977266,0.0017790038,0.005424097],"category_scores_gemma":[0.06571522,0.0012152061,0.013710155,0.010834509,0.00070812093,0.0020797767,0.0017898713,0.0017148325,0.000248121],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001038048,0.000055671862,0.0014955905,0.9025181,0.04012797,0.000087343156,0.000086021675,0.00043322472,0.000067800254,0.00048788817,0.0016331085,0.051969096],"study_design_scores_gemma":[0.001695992,0.0005249275,0.0065058423,0.7340202,0.24242298,0.00027367525,0.0003458377,0.00053397124,0.00026191206,0.000763331,0.0125860125,0.00006537543],"about_ca_topic_score_codex":0.01614273,"about_ca_topic_score_gemma":0.04297,"teacher_disagreement_score":0.01614273,"about_ca_system_score_codex":0.008710421,"about_ca_system_score_gemma":0.014285988,"threshold_uncertainty_score":0.0837695},"labels":[],"label_agreement":null},{"id":"W4392121583","doi":"10.1016/j.jval.2024.02.002","title":"A Systematic Review of Value Criteria for Next-Generation Sequencing/Comprehensive Genomic Profiling to Inform Value Framework Development","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca; Queen's University Belfast; Queen's University; London School of Economics and Political Science; GlaxoSmithKline; Eli Lilly and Company","keywords":"Profiling (computer programming); Value (mathematics); Computational biology; Computer science; Data science; Biology; Machine learning","score_opus":0.1610115643105598,"score_gpt":0.3944901206891907,"score_spread":0.2334785563786309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392121583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003460027,0.9688062,0.008315928,0.004234205,0.00065447285,0.0056586135,0.0045911437,0.00007395797,0.004205535],"genre_scores_gemma":[0.110422865,0.79445136,0.061340805,0.00455236,0.00038028046,0.022463644,0.005693561,0.00008953568,0.00060554536],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.89582574,0.046639822,0.035173472,0.0042188596,0.016673448,0.0014686894],"domain_scores_gemma":[0.75780016,0.19227736,0.023981022,0.003993686,0.020609664,0.0013382192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.067375824,0.0026458132,0.009644878,0.044935245,0.0024363769,0.008618542,0.004417554,0.003247471,0.004458811],"category_scores_gemma":[0.28455505,0.0015356453,0.013348176,0.03172677,0.0025864413,0.008199435,0.005482984,0.00331695,0.00048451527],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014523834,0.000020839649,0.0018422357,0.87290204,0.0065613873,0.00016116654,0.00093973323,0.0008011822,0.00019703421,0.0072271354,0.005194144,0.104007885],"study_design_scores_gemma":[0.000135482,0.00006192215,0.0019064734,0.95183796,0.013754744,0.00013162747,0.0006611192,0.00045248092,0.00018909779,0.0046762624,0.026127402,0.000065370885],"about_ca_topic_score_codex":0.015973926,"about_ca_topic_score_gemma":0.04203283,"teacher_disagreement_score":0.067375824,"about_ca_system_score_codex":0.019446997,"about_ca_system_score_gemma":0.05335212,"threshold_uncertainty_score":0.3563217},"labels":[],"label_agreement":null},{"id":"W4393188460","doi":"10.1016/j.jval.2024.03.011","title":"Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Odds ratio; Confounding; Logistic regression; Demography; Meta-analysis; Subgroup analysis; Age groups; Odds; MEDLINE; Gerontology; Pediatrics; Internal medicine","score_opus":0.6650695136716447,"score_gpt":0.5484186205318805,"score_spread":0.11665089313976418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393188460","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2826091,0.6848439,0.014681034,0.005143669,0.00044743813,0.00080732844,0.0053432854,0.00007101486,0.006053179],"genre_scores_gemma":[0.9613321,0.03080195,0.0031640863,0.001677493,0.0005748091,0.0004056354,0.0018438624,0.000051344134,0.00014872481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.7007381,0.23449555,0.03276031,0.008652002,0.021939524,0.0014146531],"domain_scores_gemma":[0.17175905,0.736898,0.06990936,0.01169418,0.008954309,0.0007850512],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23060709,0.001479821,0.0056349225,0.012146243,0.0003915204,0.00505768,0.0022877369,0.0021572763,0.0022554884],"category_scores_gemma":[0.60100025,0.0008547641,0.013860415,0.014295722,0.0023609272,0.005121984,0.002128672,0.0025735889,0.00030588038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008384648,0.00025533582,0.5934855,0.025579369,0.27676725,0.00045203476,0.0008293807,0.010019685,0.0001946331,0.0037930575,0.0026923495,0.077546746],"study_design_scores_gemma":[0.0024414514,0.003600992,0.7533923,0.029833015,0.15961896,0.002176125,0.0013649203,0.020778047,0.0008631734,0.015321914,0.010250828,0.00035833797],"about_ca_topic_score_codex":0.0015944784,"about_ca_topic_score_gemma":0.0010575318,"teacher_disagreement_score":0.7693929,"about_ca_system_score_codex":0.002345875,"about_ca_system_score_gemma":0.0011174893,"threshold_uncertainty_score":0.9487984},"labels":[],"label_agreement":null},{"id":"W4393230612","doi":"10.1016/j.jval.2024.03.012","title":"Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster Children's Hospital; SickKids Foundation; Pediatric Oncology Group; University of Toronto; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Garron Family Cancer Centre; Canadian Institutes of Health Research; Hospital for Sick Children; Terry Fox Research Institute; Canada Research Chairs; Pediatric Oncology Group of Ontario; Canadian Centre for Applied Research in Cancer Control","keywords":"Value (mathematics); Lens (geology); Through-the-lens metering; Decision analysis; Management science; Health technology; Computer science; Medicine; Economics; Engineering; Health care; Economic growth; Machine learning","score_opus":0.531572701120929,"score_gpt":0.5353072476770473,"score_spread":0.003734546556118268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393230612","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031540147,0.0003094157,0.9883581,0.0023579681,0.00004635982,0.00015564702,0.00014572727,0.000102679296,0.0053701173],"genre_scores_gemma":[0.14783542,0.0004482453,0.8491301,0.00026871296,0.00015414045,0.00045275956,0.00026915228,0.000067725014,0.0013737557],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9915925,0.0049479855,0.0006214403,0.0006185345,0.0017567227,0.000462884],"domain_scores_gemma":[0.97869474,0.01420797,0.001471431,0.0008600894,0.0039927387,0.0007729219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019288255,0.0014065941,0.0015679686,0.004633323,0.0014392827,0.008682263,0.0027746733,0.002164532,0.0056768022],"category_scores_gemma":[0.03852078,0.0008614451,0.002550916,0.0038597228,0.0020832652,0.006972853,0.0036471288,0.0049818726,0.00066582824],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022597284,0.00010959316,0.0017556062,0.00013989401,0.00010136464,0.00012361447,0.00037655284,0.09994333,0.00029413463,0.8392453,0.0041333055,0.053754624],"study_design_scores_gemma":[0.000019562453,0.000029663677,0.00033380327,0.0002017863,0.000044612236,0.00006878415,0.00019556271,0.38746336,0.00035070206,0.6025109,0.008745209,0.000035982266],"about_ca_topic_score_codex":0.009766014,"about_ca_topic_score_gemma":0.0110759875,"teacher_disagreement_score":0.019288255,"about_ca_system_score_codex":0.00527775,"about_ca_system_score_gemma":0.009674911,"threshold_uncertainty_score":0.10200727},"labels":[],"label_agreement":null},{"id":"W4394718423","doi":"10.1016/j.jval.2024.04.001","title":"A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact; Hamilton Health Sciences","funders":"","keywords":"Content validity; Medicine; Quality of life (healthcare); Disease; Quality (philosophy); Health related quality of life; Measure (data warehouse); Clinical trial; Psychometrics; Clinical psychology; Pathology; Computer science; Data mining; Nursing","score_opus":0.8279116208096137,"score_gpt":0.4835983604582665,"score_spread":0.3443132603513472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394718423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037492292,0.98183846,0.0023758812,0.0013825205,0.00056171336,0.006738295,0.001974266,0.00004197066,0.0013376968],"genre_scores_gemma":[0.07088504,0.88240504,0.016090428,0.0017781308,0.0004139811,0.025799582,0.002134982,0.00003913826,0.00045374013],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8704379,0.04789707,0.053954065,0.0045395033,0.022073817,0.0010975843],"domain_scores_gemma":[0.72793716,0.177788,0.056697123,0.007060645,0.02925561,0.0012614419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08015794,0.0021641839,0.012645782,0.029928202,0.0020243216,0.006311917,0.0034945619,0.0030897108,0.0045794514],"category_scores_gemma":[0.31099948,0.001763725,0.012882846,0.024938822,0.0025957318,0.005475246,0.0033585504,0.0019653852,0.00044226402],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015882087,0.000023325892,0.0025695977,0.94174844,0.01485269,0.00006731463,0.00036645652,0.00015738381,0.00013506964,0.0006215811,0.0020044076,0.03729497],"study_design_scores_gemma":[0.00041428977,0.00016061621,0.008247025,0.90233326,0.07277195,0.00025667303,0.00029714342,0.0002613075,0.0002503707,0.00087124377,0.014077821,0.000058291404],"about_ca_topic_score_codex":0.008363455,"about_ca_topic_score_gemma":0.018774338,"teacher_disagreement_score":0.08015794,"about_ca_system_score_codex":0.012774092,"about_ca_system_score_gemma":0.037996534,"threshold_uncertainty_score":0.4239208},"labels":[],"label_agreement":null},{"id":"W4394844963","doi":"10.1016/j.jval.2024.04.007","title":"The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States","year":2024,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; McMaster University; Public Health Ontario; University of Toronto","funders":"","keywords":"Negotiation; Context (archaeology); Health care; Emulation; Inflation (cosmology); Risk analysis (engineering); Business; Public economics; Economics; Political science; Economic growth; Law","score_opus":0.5934029367515828,"score_gpt":0.4991643235408627,"score_spread":0.09423861321072013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394844963","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014345248,0.0060407394,0.0001110636,0.05520959,0.9378236,0.000012809526,0.00005098838,0.00004056191,0.0006962207],"genre_scores_gemma":[0.00026623686,0.0030154998,0.00011164667,0.026035631,0.96833223,0.000021278207,0.000019861105,0.000035734687,0.002161912],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9752026,0.006214906,0.003611489,0.0018446577,0.012070474,0.0010558162],"domain_scores_gemma":[0.84103507,0.10210492,0.0071595185,0.0035814,0.035138834,0.010980305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036446415,0.0059720925,0.008767739,0.008988176,0.0056692497,0.01893818,0.007947177,0.04761647,0.014786685],"category_scores_gemma":[0.14475495,0.002686287,0.0064581325,0.005582641,0.006671294,0.010646824,0.0043176203,0.052570105,0.0104647055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024414001,0.00001136985,0.000019890356,0.00025758045,0.000040656352,0.000046658144,0.000013909472,0.000025258672,0.000014763718,0.00043886257,0.9960681,0.0030385093],"study_design_scores_gemma":[0.00030965012,0.00004719937,0.0006540135,0.0023376183,0.00033072324,0.00021392353,0.00012238849,0.0005071077,0.00012938581,0.007916266,0.98733807,0.000093612376],"about_ca_topic_score_codex":0.0050397655,"about_ca_topic_score_gemma":0.013533696,"teacher_disagreement_score":0.04761647,"about_ca_system_score_codex":0.00743539,"about_ca_system_score_gemma":0.011209572,"threshold_uncertainty_score":0.19274932},"labels":[],"label_agreement":null},{"id":"W4394858765","doi":"10.1016/j.jval.2024.04.006","title":"Author Reply","year":2024,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Calgary; University of Alberta","funders":"","keywords":"Medicine","score_opus":0.548553088300252,"score_gpt":0.45762668304780696,"score_spread":0.090926405252445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394858765","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016797158,0.0006775694,0.000069876216,0.96496814,0.029249277,0.00002069145,0.000077944525,0.000021752348,0.0047468203],"genre_scores_gemma":[0.000927411,0.00017248321,0.000061318235,0.9745025,0.010609129,0.000041489602,0.000015272286,0.000014594905,0.013655793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906633,0.0023758062,0.0009782568,0.0013545131,0.0028491535,0.0017789166],"domain_scores_gemma":[0.9793682,0.011872525,0.0011061631,0.00075811567,0.0043131504,0.0025816977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009428728,0.0009027769,0.0024217684,0.00155174,0.007342017,0.011162952,0.0026851173,0.09583582,0.01856871],"category_scores_gemma":[0.056288853,0.0013485632,0.0019151517,0.0012714706,0.0051631806,0.005486154,0.0038240785,0.066686735,0.014942046],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002504156,0.000008985205,0.00017415277,0.00002462156,0.00000916603,0.00020817769,0.00011021282,0.000018608687,0.00003625858,0.002495745,0.99518126,0.0017076944],"study_design_scores_gemma":[0.000100587335,0.000023844648,0.0010593858,0.00029363018,0.000030339406,0.00033099795,0.0006094481,0.00018353069,0.00012301836,0.009410088,0.98776054,0.000074480464],"about_ca_topic_score_codex":0.020108746,"about_ca_topic_score_gemma":0.031506073,"teacher_disagreement_score":0.09583582,"about_ca_system_score_codex":0.010240817,"about_ca_system_score_gemma":0.011900251,"threshold_uncertainty_score":0.07430273},"labels":[],"label_agreement":null},{"id":"W4394893537","doi":"10.1016/j.jval.2024.04.004","title":"Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Hematologic Neoplasms; Medicine; Intensive care medicine; Internal medicine; Cancer","score_opus":0.16152575852155565,"score_gpt":0.4577174283364431,"score_spread":0.2961916698148874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394893537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009360213,0.99781126,0.00016604361,0.00020160335,0.00009845849,0.0001837052,0.00034195618,0.000007094225,0.00025392039],"genre_scores_gemma":[0.027304113,0.9706792,0.00064191874,0.0006304717,0.000085979686,0.00030649296,0.00019925741,0.0000068903983,0.0001456302],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9946273,0.0026850326,0.0013083892,0.0003313385,0.0008616605,0.0001863173],"domain_scores_gemma":[0.98053634,0.015091321,0.0031481567,0.00017988612,0.0008464083,0.00019791287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007986744,0.0013981548,0.009351808,0.004094444,0.00030085404,0.0024734149,0.0015818961,0.0017977272,0.006370349],"category_scores_gemma":[0.03142055,0.0008181409,0.009687324,0.004617931,0.0007526324,0.0014782851,0.0011884883,0.0018136175,0.00027045235],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014226218,0.000030328907,0.00046218594,0.90134454,0.049069233,0.000079074576,0.000060161932,0.00037104386,0.00017459756,0.0004513933,0.00209182,0.044442993],"study_design_scores_gemma":[0.0038070262,0.0006750184,0.003770164,0.5519222,0.41204008,0.00032889863,0.0002028754,0.000417179,0.0002657413,0.0014166518,0.025082042,0.00007205344],"about_ca_topic_score_codex":0.0063408916,"about_ca_topic_score_gemma":0.017552339,"teacher_disagreement_score":0.009351808,"about_ca_system_score_codex":0.003527095,"about_ca_system_score_gemma":0.0052341297,"threshold_uncertainty_score":0.042238414},"labels":[],"label_agreement":null},{"id":"W4394989576","doi":"10.1016/j.jval.2024.04.010","title":"Health Fluctuations in Dementia and its Impact on the Assessment of Health-Related Quality of Life Using the EQ-5D-5L","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Impact","funders":"EuroQol Research Foundation","keywords":"Dementia; Quality of life (healthcare); EQ-5D; Health related quality of life; Environmental health; Medicine; Gerontology; Nursing","score_opus":0.5423338103566373,"score_gpt":0.4999210226402113,"score_spread":0.04241278771642598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394989576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949786,0.0026302035,0.0007133663,0.00010002491,0.000012574101,0.000037093992,0.00039588244,0.000012720234,0.0011195387],"genre_scores_gemma":[0.999201,0.00025016957,0.00028959167,0.000022011367,0.00000760929,0.000012278166,0.00013857098,0.0000011441862,0.000077585006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981787,0.00067885005,0.00029257237,0.00014163266,0.0005673695,0.00014085905],"domain_scores_gemma":[0.9968579,0.0007471978,0.0017337168,0.00009199524,0.00040816434,0.00016104025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024341538,0.00034895656,0.00044757818,0.0010216754,0.00032950623,0.00072722416,0.00022531385,0.00024871813,0.000557895],"category_scores_gemma":[0.008668005,0.00013157807,0.0004885505,0.0010730493,0.00030753398,0.0004589792,0.00060450536,0.00046661563,0.00007471437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040001867,0.00009939615,0.9713478,0.00011098005,0.00021607829,0.00021353728,0.0003263064,0.00056912214,0.00045222312,0.00007126484,0.00020627498,0.02598712],"study_design_scores_gemma":[0.00000527956,0.0002295611,0.9982133,0.000031296782,0.00004662073,0.0003685669,0.00013143355,0.0005650486,0.00012517854,0.000057912966,0.0002189182,0.0000067931455],"about_ca_topic_score_codex":0.004921406,"about_ca_topic_score_gemma":0.0059695677,"teacher_disagreement_score":0.004921406,"about_ca_system_score_codex":0.00058995816,"about_ca_system_score_gemma":0.00031330207,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W4395701643","doi":"10.1016/j.jval.2024.04.017","title":"Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Multilevel model; Meta-analysis; Event (particle physics); Randomized controlled trial; Meta-regression; Multiple myeloma; Regression; Computer science; Aggregate (composite); Regression analysis; Medicine; Statistics; Internal medicine; Machine learning; Mathematics","score_opus":0.1678395498886775,"score_gpt":0.442002677789358,"score_spread":0.2741631279006805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395701643","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59377193,0.022680609,0.35237908,0.016172359,0.0009971056,0.0010737048,0.006834367,0.0011691554,0.004921591],"genre_scores_gemma":[0.9117205,0.0014821499,0.08335743,0.00067687524,0.00016517831,0.00036007844,0.0013913715,0.00015311342,0.0006931536],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96701026,0.029740486,0.0006516257,0.0016946818,0.0005634936,0.0003394523],"domain_scores_gemma":[0.81402546,0.17594893,0.0027189208,0.004184912,0.0023665596,0.00075515173],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0430383,0.0013420723,0.0022935015,0.001433672,0.0008801059,0.0021636772,0.0027593775,0.0015910805,0.0036723902],"category_scores_gemma":[0.103861704,0.0006479134,0.006641648,0.0017386128,0.00050092593,0.0015914358,0.0021788534,0.0040946584,0.00028748103],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013476785,0.0012596033,0.22384034,0.004849449,0.12724504,0.0024245407,0.00094452145,0.47208676,0.001137679,0.017166723,0.011200933,0.12436756],"study_design_scores_gemma":[0.0014483783,0.0011868153,0.022386227,0.00054413755,0.036474455,0.0005161289,0.0004080594,0.90309644,0.00056064763,0.028464586,0.0047698333,0.00014429688],"about_ca_topic_score_codex":0.027754348,"about_ca_topic_score_gemma":0.03283639,"teacher_disagreement_score":0.9569617,"about_ca_system_score_codex":0.0018432899,"about_ca_system_score_gemma":0.0023818496,"threshold_uncertainty_score":0.22761095},"labels":[],"label_agreement":null},{"id":"W4399359799","doi":"10.1016/j.jval.2024.05.016","title":"A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"EuroQol Research Foundation","keywords":"Duration (music); Composite number; Computer science; Mathematics; Algorithm; Physics","score_opus":0.2968331479096414,"score_gpt":0.4574507379959681,"score_spread":0.1606175900863267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399359799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59015864,0.012423497,0.33841878,0.0024521872,0.0029636628,0.011371314,0.00576327,0.00054446666,0.035904203],"genre_scores_gemma":[0.79705465,0.0023184044,0.1783267,0.0013399461,0.0005681134,0.012769911,0.0018318194,0.00029061796,0.005499852],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8486872,0.13281935,0.0034794954,0.0046951175,0.009724308,0.0005946315],"domain_scores_gemma":[0.4875151,0.47262007,0.015348837,0.015716022,0.007884141,0.00091581483],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1150685,0.0011809017,0.0015688826,0.0018924619,0.00039915033,0.0028027056,0.0017098286,0.0021799153,0.014049524],"category_scores_gemma":[0.28751817,0.00057984464,0.0040204097,0.0027965368,0.001521476,0.0035120738,0.0018696283,0.0021728666,0.0020023135],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10182852,0.010407248,0.11431363,0.011949248,0.017921813,0.00017567103,0.0034494335,0.022881526,0.005330332,0.047754824,0.008587526,0.6554002],"study_design_scores_gemma":[0.027199794,0.09373586,0.42120528,0.0056092795,0.0109963855,0.0007347063,0.0043282737,0.24058719,0.01679506,0.12157058,0.055825897,0.0014117201],"about_ca_topic_score_codex":0.00084161083,"about_ca_topic_score_gemma":0.0007840527,"teacher_disagreement_score":0.8849315,"about_ca_system_score_codex":0.0013201948,"about_ca_system_score_gemma":0.00078602834,"threshold_uncertainty_score":0.6085477},"labels":[],"label_agreement":null},{"id":"W4399360099","doi":"10.1016/j.jval.2024.05.019","title":"Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Inflammatory bowel disease; Medicine; Quality of life (healthcare); Health related quality of life; Internal medicine; Disease; Gastroenterology; Nursing","score_opus":0.09568167379995042,"score_gpt":0.3609008066811436,"score_spread":0.2652191328811932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399360099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97139627,0.0009797242,0.010366565,0.0042161634,0.00009136253,0.0058976505,0.0015203664,0.0000344278,0.0054974873],"genre_scores_gemma":[0.97754854,0.00055109075,0.012932436,0.001021799,0.000022718723,0.006948343,0.00040185344,0.000012980847,0.00056027924],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.93731654,0.05331363,0.0025542667,0.0007680168,0.0044278395,0.001619691],"domain_scores_gemma":[0.86363083,0.106752075,0.009290609,0.002294553,0.016527414,0.0015045311],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06965641,0.0003410979,0.00056234293,0.0016847999,0.0017703512,0.0015094811,0.00082214386,0.00046501087,0.0011523679],"category_scores_gemma":[0.12643903,0.00027168976,0.000722792,0.002449741,0.0026269571,0.0011887171,0.002374347,0.0010050094,0.000114897644],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001280345,0.00070060237,0.13441744,0.005210471,0.00013735252,0.0007246962,0.6906862,0.0014970606,0.003991583,0.0042535565,0.004034246,0.15306646],"study_design_scores_gemma":[0.0003880323,0.003417683,0.17304473,0.005524497,0.00018875596,0.0007766224,0.76111305,0.0049094395,0.007729973,0.0036558376,0.039016467,0.0002350074],"about_ca_topic_score_codex":0.005779252,"about_ca_topic_score_gemma":0.006582874,"teacher_disagreement_score":0.93034357,"about_ca_system_score_codex":0.008117542,"about_ca_system_score_gemma":0.007840506,"threshold_uncertainty_score":0.3683827},"labels":[],"label_agreement":null},{"id":"W4399360696","doi":"10.1016/j.jval.2024.05.015","title":"A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Ottawa Hospital","funders":"Janssen Japan; Janssen Pharmaceuticals","keywords":"Transparency (behavior); Credibility; Circumstantial evidence; Psychological intervention; Health care; Risk analysis (engineering); Key (lock); Health professionals; Computer science; Medicine; Management science; Data science; Economics; Political science; Computer security; Nursing; Economic growth","score_opus":0.8375545604246099,"score_gpt":0.5958803910116529,"score_spread":0.24167416941295694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399360696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000762143,0.9709465,0.008338844,0.011325961,0.0020945326,0.0017866084,0.0012913306,0.00012302423,0.0033309648],"genre_scores_gemma":[0.014968849,0.9109704,0.052907996,0.011303423,0.00068296446,0.0067624035,0.0014935351,0.00018973506,0.00072073605],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.74953806,0.13098904,0.07767608,0.0075477357,0.032483358,0.0017657005],"domain_scores_gemma":[0.4945923,0.3876172,0.043887135,0.013285036,0.058842376,0.0017759346],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21057476,0.0022002994,0.0065003084,0.031703662,0.0023094576,0.008290779,0.007885035,0.0073791873,0.005125314],"category_scores_gemma":[0.48430768,0.0027761238,0.0089901425,0.030495694,0.004104823,0.0072068837,0.0058011324,0.006259195,0.0014377068],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028005222,0.00006054192,0.0008797887,0.47546288,0.002502763,0.00013658486,0.00226985,0.00069990923,0.00042756778,0.012715959,0.040366538,0.4641975],"study_design_scores_gemma":[0.00016372527,0.00008900689,0.001328554,0.8665129,0.005492969,0.00019523683,0.000607134,0.00023628592,0.00048277018,0.004071474,0.12075321,0.000066858025],"about_ca_topic_score_codex":0.011451569,"about_ca_topic_score_gemma":0.0197939,"teacher_disagreement_score":0.78942525,"about_ca_system_score_codex":0.014720014,"about_ca_system_score_gemma":0.051989622,"threshold_uncertainty_score":0.97350186},"labels":[],"label_agreement":null},{"id":"W4399699327","doi":"10.1016/j.jval.2024.03.1118","title":"HPR49 Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health technology; Business; Medicine; Risk analysis (engineering); Environmental health; Health care; Economics; Economic growth; Internal medicine","score_opus":0.34061264663378626,"score_gpt":0.470888007017026,"score_spread":0.13027536038323972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699327","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055641823,0.084925316,0.006208723,0.62329525,0.0031359184,0.00043751445,0.014043669,0.00021013984,0.21210168],"genre_scores_gemma":[0.7671247,0.037113808,0.0164251,0.14114237,0.002829035,0.00045056109,0.005847547,0.0005119534,0.02855482],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.90494436,0.029563408,0.007185746,0.00357884,0.04322188,0.011505772],"domain_scores_gemma":[0.6014376,0.24499191,0.012161849,0.0070409416,0.11542607,0.018941576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.105428375,0.00055870996,0.0019565225,0.009941256,0.0045579565,0.020559136,0.005337154,0.009341564,0.011011156],"category_scores_gemma":[0.27083677,0.0009642458,0.0029205158,0.010404528,0.0093307495,0.004060596,0.004403615,0.009978768,0.0005409739],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014558412,0.00015967863,0.040945396,0.0036546153,0.0012558021,0.0008916476,0.0036733039,0.013508567,0.00052430306,0.505726,0.2827198,0.14548501],"study_design_scores_gemma":[0.00097382965,0.00044155738,0.25568944,0.02215122,0.0028505933,0.00073092576,0.005728325,0.009752832,0.001665084,0.091779195,0.6070764,0.0011605695],"about_ca_topic_score_codex":0.9596465,"about_ca_topic_score_gemma":0.9705906,"teacher_disagreement_score":0.9596465,"about_ca_system_score_codex":0.09273615,"about_ca_system_score_gemma":0.23671752,"threshold_uncertainty_score":0.67285097},"labels":[],"label_agreement":null},{"id":"W4399699334","doi":"10.1016/j.jval.2024.03.952","title":"EPH123 Incorporating Social Determinants of Health Into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Transmission (telecommunications); Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Social determinants of health; Data science; Medicine; Computer science; Public health; Telecommunications; Disease; Nursing; Outbreak; Infectious disease (medical specialty)","score_opus":0.24453236922974325,"score_gpt":0.4945930043339134,"score_spread":0.25006063510417015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024785235,0.9984743,0.00038473008,0.00038411526,0.00010162445,0.000034893288,0.0000790497,0.000005623183,0.00028785208],"genre_scores_gemma":[0.003494795,0.9952618,0.00075501576,0.00017786487,0.000076860924,0.00005322488,0.000056643436,0.0000038317708,0.00011997478],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9971142,0.0016080438,0.00047121244,0.00024237232,0.00045616672,0.0001080142],"domain_scores_gemma":[0.976233,0.021001546,0.0010498596,0.00024642213,0.0013445604,0.00012458375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0094897235,0.0017831755,0.004072239,0.004123667,0.0003941854,0.0025672745,0.0015153193,0.0024908385,0.005027968],"category_scores_gemma":[0.03504089,0.0008021455,0.0072304257,0.004209997,0.00054848025,0.0019840053,0.0013768872,0.001881361,0.0005885058],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029369778,0.00012157783,0.0014776053,0.34733784,0.011840518,0.000118649186,0.00021763565,0.0043364423,0.0002311412,0.006713676,0.00951717,0.61779404],"study_design_scores_gemma":[0.00032297792,0.0005461291,0.0068561016,0.7079266,0.05904519,0.00037204078,0.0003945927,0.004527591,0.00064117386,0.010883471,0.20829648,0.00018770433],"about_ca_topic_score_codex":0.023597108,"about_ca_topic_score_gemma":0.028847892,"teacher_disagreement_score":0.023597108,"about_ca_system_score_codex":0.0026964287,"about_ca_system_score_gemma":0.0100862635,"threshold_uncertainty_score":0.05018711},"labels":[],"label_agreement":null},{"id":"W4399699353","doi":"10.1016/j.jval.2024.03.958","title":"EPH129 Tobacco Product Experience: Which Consumer Reported Outcome Measures for Real World Evidence Studies?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"RealNetworks (Canada)","funders":"","keywords":"Tobacco product; Real world evidence; Outcome (game theory); Product (mathematics); Business; Medicine; Economics; Environmental health; Microeconomics; Internal medicine; Mathematics","score_opus":0.35774794630503665,"score_gpt":0.47662940342966986,"score_spread":0.11888145712463322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699353","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41389254,0.4202364,0.032683656,0.050549988,0.008676133,0.006111418,0.028316014,0.00011544113,0.03941832],"genre_scores_gemma":[0.90866107,0.03858308,0.025510482,0.0087248925,0.0021067192,0.005985024,0.006994887,0.00007027449,0.0033635818],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.86843485,0.09522155,0.019965295,0.0032424075,0.012047603,0.0010883588],"domain_scores_gemma":[0.8293592,0.11657177,0.031759746,0.007393174,0.013438032,0.0014781335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07791607,0.00079375255,0.003355808,0.0034417834,0.00094810897,0.0059605176,0.0017611888,0.0037788118,0.006562272],"category_scores_gemma":[0.16446455,0.00069570733,0.006228696,0.004557206,0.0026815007,0.0050064013,0.002656687,0.0025979858,0.0010177861],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013174811,0.0018448351,0.39781067,0.07818939,0.040170982,0.00025940087,0.0027257577,0.0007146384,0.00087813253,0.021103581,0.022086637,0.42104104],"study_design_scores_gemma":[0.0068211984,0.0095641995,0.68973947,0.07567743,0.04125865,0.0012713808,0.009504932,0.0043315873,0.0032224853,0.04219352,0.115516625,0.0008984241],"about_ca_topic_score_codex":0.0021539305,"about_ca_topic_score_gemma":0.0050965217,"teacher_disagreement_score":0.07791607,"about_ca_system_score_codex":0.0016542549,"about_ca_system_score_gemma":0.0023648895,"threshold_uncertainty_score":0.4120645},"labels":[],"label_agreement":null},{"id":"W4399699364","doi":"10.1016/j.jval.2024.03.1130","title":"HPR61 Impact of Changes in US Medicaid Reimbursement for Long-Acting Reversible Contraceptives in the Immediate Postpartum Period","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coquitlam College","funders":"","keywords":"Medicaid; Reimbursement; Period (music); Postpartum period; Medicine; Obstetrics; Pregnancy; Economics; Health care; Economic growth","score_opus":0.05710677695906973,"score_gpt":0.379801602499189,"score_spread":0.32269482554011925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9023189,0.0028467565,0.00012019327,0.04561779,0.0011480489,0.0001597178,0.01552395,0.000058662612,0.03220593],"genre_scores_gemma":[0.9784565,0.0013008836,0.0002128273,0.0070552668,0.00044026985,0.00011818723,0.0036026167,0.000020035448,0.008793397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983993,0.00054744055,0.0000875671,0.00010913721,0.00031271123,0.0005438371],"domain_scores_gemma":[0.9967986,0.0012465132,0.00068062666,0.000097466815,0.00051250943,0.0006642918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015305745,0.00012456116,0.0002615786,0.0004068943,0.0005564637,0.0012039625,0.0005197917,0.0010946065,0.010244975],"category_scores_gemma":[0.010322948,0.00015214381,0.0010049422,0.0005416643,0.00028481026,0.00040963892,0.00071548845,0.0010856413,0.000645199],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018217405,0.004546853,0.5493818,0.00058211316,0.0012020096,0.001353258,0.0006068344,0.0030280827,0.0014821322,0.0059859348,0.11390882,0.29970485],"study_design_scores_gemma":[0.00066629564,0.0015030891,0.97439957,0.00028175558,0.00040647003,0.00019091318,0.0012693653,0.0012431899,0.00066366664,0.00046214103,0.018884335,0.000029155277],"about_ca_topic_score_codex":0.117709555,"about_ca_topic_score_gemma":0.15220416,"teacher_disagreement_score":0.117709555,"about_ca_system_score_codex":0.0037530826,"about_ca_system_score_gemma":0.005916039,"threshold_uncertainty_score":0.23404878},"labels":[],"label_agreement":null},{"id":"W4399699367","doi":"10.1016/j.jval.2024.03.1095","title":"HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Reimbursement; Stage (stratigraphy); Medicine; Current (fluid); Oncology; Intensive care medicine; Economic growth; Health care; Economics; Engineering; Biology","score_opus":0.11120627164368715,"score_gpt":0.3262660429919882,"score_spread":0.21505977134830104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92194915,0.01342067,0.0008779032,0.02669201,0.00016489728,0.000066873166,0.020367984,0.000059801172,0.016400697],"genre_scores_gemma":[0.98553157,0.003324984,0.0003288107,0.0029064321,0.00023347257,0.000039579187,0.0058883405,0.00002378517,0.0017229888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99742293,0.0006888461,0.0003091043,0.00029532742,0.0007551165,0.0005285663],"domain_scores_gemma":[0.9867931,0.003211206,0.0066649257,0.00025880753,0.0013806274,0.001691201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026741566,0.0001087451,0.0002972324,0.0012107469,0.00025166335,0.0014967824,0.0004087922,0.0005665141,0.0061068395],"category_scores_gemma":[0.011079578,0.00016715871,0.00088200613,0.0026492001,0.00028161707,0.00091333315,0.00065834785,0.0010743452,0.00092589326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036014593,0.00015967921,0.91778135,0.00012833643,0.0002131442,0.000109116096,0.00021720037,0.00048865145,0.0002207481,0.0018963992,0.02337234,0.055052917],"study_design_scores_gemma":[0.000022746364,0.000086227956,0.984116,0.00010538063,0.000060184357,0.00022466628,0.0003908177,0.00047910318,0.00006491415,0.00025700647,0.01418084,0.000012124281],"about_ca_topic_score_codex":0.017243132,"about_ca_topic_score_gemma":0.019740704,"teacher_disagreement_score":0.017243132,"about_ca_system_score_codex":0.0017664959,"about_ca_system_score_gemma":0.0018734658,"threshold_uncertainty_score":0.034285545},"labels":[],"label_agreement":null},{"id":"W4399699781","doi":"10.1016/j.jval.2024.03.944","title":"EPH115 Sex Differences on Limitations in Physical Functioning and Overall Quality of Life of People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Myasthenia gravis; Quality of life (healthcare); Medicine; Physical therapy; Gerontology; Physical medicine and rehabilitation; Internal medicine; Nursing","score_opus":0.0707042737589452,"score_gpt":0.30959976434639774,"score_spread":0.23889549058745255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858725,0.0004630362,0.00007392981,0.00020629454,0.00003187585,0.000014676075,0.011634275,0.000006946073,0.0016964368],"genre_scores_gemma":[0.992812,0.00020218274,0.000044974317,0.00012863657,0.000022232289,0.000019687739,0.0060269046,0.0000048660354,0.0007385043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942756,0.00015783639,0.00009078739,0.00009319526,0.000094692936,0.0001358805],"domain_scores_gemma":[0.9987458,0.00020989511,0.00050479453,0.00010225492,0.00019126775,0.00024604017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061718945,0.00024940487,0.00033895051,0.0010416524,0.00036903317,0.00074202084,0.00037683343,0.00045928732,0.0024163588],"category_scores_gemma":[0.002517338,0.000250482,0.0010257366,0.0024873707,0.00017169282,0.0005899849,0.000707406,0.0006638969,0.00036745204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015204796,0.000023538949,0.9980323,0.0000131774095,0.00015580426,0.000028896438,0.00006428078,0.00002870267,0.000039400893,0.000018187686,0.0004658877,0.0009777964],"study_design_scores_gemma":[0.000008355472,0.000019712861,0.9995622,0.00000513536,0.00003849816,0.000026706779,0.0000916585,0.00002961326,0.000009252723,0.000011652604,0.0001948295,0.0000023554796],"about_ca_topic_score_codex":0.040976536,"about_ca_topic_score_gemma":0.047660768,"teacher_disagreement_score":0.040976536,"about_ca_system_score_codex":0.00040439144,"about_ca_system_score_gemma":0.00042881237,"threshold_uncertainty_score":0.08147603},"labels":[],"label_agreement":null},{"id":"W4399699830","doi":"10.1016/j.jval.2024.03.671","title":"EE375 Cost Savings and the Opportunity for Expanded Treatment Access with Increased Use of Biosimilar Adalimumab in the United States","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Brampton Civic Hospital","funders":"","keywords":"Biosimilar; Adalimumab; Business; Medicine; Expanded access; Internal medicine","score_opus":0.16194609539653945,"score_gpt":0.37661123023996423,"score_spread":0.21466513484342478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6171639,0.03422881,0.006153589,0.14248721,0.0025127004,0.000141233,0.0062646857,0.0005926968,0.19045517],"genre_scores_gemma":[0.9577683,0.0052313567,0.0029742855,0.017029319,0.0010890784,0.000037340993,0.0025665876,0.000055215103,0.013248441],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983656,0.0005671724,0.00009086631,0.00014579674,0.0005331009,0.00029752575],"domain_scores_gemma":[0.9981451,0.00047785215,0.00032262204,0.000095610405,0.00035982442,0.0005990083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019097225,0.00015982779,0.00017777701,0.00053453486,0.00026868054,0.0016908975,0.00036010653,0.0010491322,0.0129305115],"category_scores_gemma":[0.0042300527,0.000097717086,0.0007954706,0.0005616795,0.00045080067,0.0007666981,0.0007092701,0.0012278827,0.000809943],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050520226,0.00084100774,0.053940058,0.00041058846,0.0003738928,0.00071020325,0.00019856862,0.0030018245,0.0075274846,0.032527044,0.11095715,0.7844601],"study_design_scores_gemma":[0.001000669,0.0026664676,0.3425225,0.0007825835,0.0005592571,0.003295147,0.00076072046,0.005359706,0.0070313727,0.007986094,0.6279532,0.00008231435],"about_ca_topic_score_codex":0.012805622,"about_ca_topic_score_gemma":0.015255175,"teacher_disagreement_score":0.0129305115,"about_ca_system_score_codex":0.0038851777,"about_ca_system_score_gemma":0.0037615001,"threshold_uncertainty_score":0.04325688},"labels":[],"label_agreement":null},{"id":"W4399699851","doi":"10.1016/j.jval.2024.03.911","title":"EPH82 Risk Perception of Tobacco and Nicotine Products: Which Consumer Reported Outcome Measures for Evidence Generation in Support of Regulatory Engagement?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"RealNetworks (Canada)","funders":"","keywords":"Outcome (game theory); Nicotine; Risk perception; Perception; Environmental health; Business; Medicine; Psychology; Economics; Microeconomics; Psychiatry","score_opus":0.19765481171184202,"score_gpt":0.3888102563686999,"score_spread":0.1911554446568579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6751682,0.10346059,0.054311488,0.08460704,0.003486303,0.0038474544,0.010973624,0.00020641413,0.06393891],"genre_scores_gemma":[0.95026505,0.009171348,0.028436357,0.0053499476,0.0006402367,0.001913651,0.002574895,0.000051800183,0.0015967202],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8908713,0.07451075,0.012543513,0.003117485,0.017391145,0.001565871],"domain_scores_gemma":[0.6816257,0.21015427,0.04283939,0.013265481,0.049502257,0.0026129293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.123621866,0.0006069275,0.0021493554,0.0026636436,0.0007447068,0.0065083597,0.0015884694,0.0029672142,0.0042396644],"category_scores_gemma":[0.27164936,0.0004917207,0.003647456,0.0029696457,0.00209618,0.0055015204,0.002835733,0.002960317,0.0009939976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006118841,0.0015679918,0.40291804,0.014135316,0.009042461,0.00009110075,0.0033020964,0.00065469055,0.0011102642,0.015400731,0.010235877,0.53542256],"study_design_scores_gemma":[0.0023941293,0.005416494,0.7888315,0.031261086,0.014182264,0.00055552187,0.008956627,0.010449705,0.008995374,0.054736603,0.07365848,0.00056217465],"about_ca_topic_score_codex":0.0016662619,"about_ca_topic_score_gemma":0.003350527,"teacher_disagreement_score":0.123621866,"about_ca_system_score_codex":0.0013643866,"about_ca_system_score_gemma":0.0033198155,"threshold_uncertainty_score":0.6537827},"labels":[],"label_agreement":null},{"id":"W4399699870","doi":"10.1016/j.jval.2024.03.894","title":"EPH65 Burden of Illness of Osteogenesis Imperfecta in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteogenesis imperfecta; Medicine; Pathology","score_opus":0.03903258136192295,"score_gpt":0.28806712907986065,"score_spread":0.2490345477179377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94531465,0.0045094774,0.0001527485,0.004123602,0.00010187789,0.00009730522,0.032100722,0.000024841183,0.013574816],"genre_scores_gemma":[0.9895586,0.002635549,0.00018121733,0.00033716692,0.000029630579,0.00003053773,0.0035116517,0.000009023656,0.003706628],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986124,0.00009603852,0.00012904232,0.000118037286,0.0005242568,0.0005202164],"domain_scores_gemma":[0.99738723,0.00008830159,0.0006531864,0.000054950717,0.0010041805,0.00081212487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045148403,0.0002690535,0.0005806576,0.0017036864,0.002651233,0.0015160585,0.0011782309,0.00059898495,0.0038381456],"category_scores_gemma":[0.0018874552,0.00043236144,0.0009543561,0.005184162,0.0006715648,0.00042340538,0.0012552167,0.00087277626,0.00028803194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011291551,0.000036388883,0.9849091,0.0001286709,0.00015728551,0.00041067513,0.0010958068,0.00028629275,0.00017806796,0.00075478724,0.005606605,0.006323358],"study_design_scores_gemma":[0.000009885766,0.000013508026,0.9961408,0.00008708618,0.000026392354,0.00012396388,0.001275387,0.00014092636,0.000015502395,0.000040853076,0.0021143707,0.000011425999],"about_ca_topic_score_codex":0.99737823,"about_ca_topic_score_gemma":0.99867415,"teacher_disagreement_score":0.03553543,"about_ca_system_score_codex":0.03553543,"about_ca_system_score_gemma":0.065907724,"threshold_uncertainty_score":0.25782877},"labels":[],"label_agreement":null},{"id":"W4399699874","doi":"10.1016/j.jval.2024.03.729","title":"EE434 Benefits of a Polymer Tip in Torsional Phacoemulsification: A Targeted Literature Search and Budget Impact Model","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Phacoemulsification; Medicine; Computer science; Ophthalmology","score_opus":0.03416768209898266,"score_gpt":0.35480705527448747,"score_spread":0.32063937317550484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699874","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27212107,0.4745056,0.024722796,0.021443212,0.00090921397,0.009953175,0.115877055,0.00028514772,0.08018275],"genre_scores_gemma":[0.85469913,0.10731131,0.01587827,0.002278666,0.0002286774,0.004509754,0.010258853,0.00008100736,0.0047542634],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9865458,0.00867288,0.001565983,0.0006457155,0.0018335105,0.00073604466],"domain_scores_gemma":[0.9647179,0.028630938,0.0037027255,0.0004564113,0.0020155774,0.0004764311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019667972,0.0011360089,0.0026910985,0.012342777,0.0004174323,0.0028897966,0.0010734822,0.0012746146,0.016576411],"category_scores_gemma":[0.053112153,0.0008028949,0.014168909,0.015895281,0.0005878222,0.002184887,0.0022062138,0.0015226187,0.0009808784],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017908016,0.00083214266,0.073723994,0.27072755,0.11991233,0.0011237516,0.0011565505,0.06096454,0.0016159732,0.036353365,0.020418895,0.39526293],"study_design_scores_gemma":[0.0063705924,0.004224233,0.13272935,0.17696746,0.42002133,0.001388384,0.0031242454,0.053624883,0.0022020694,0.049808696,0.14919281,0.00034594862],"about_ca_topic_score_codex":0.017874334,"about_ca_topic_score_gemma":0.032452144,"teacher_disagreement_score":0.019667972,"about_ca_system_score_codex":0.005514784,"about_ca_system_score_gemma":0.008713703,"threshold_uncertainty_score":0.10401541},"labels":[],"label_agreement":null},{"id":"W4399699905","doi":"10.1016/j.jval.2024.03.633","title":"EE334 The Diagnostic Odyssey and Cost-Effectiveness of Genomic Testing in Indigenous Children in British Columbia, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Indigenous; Medicine; Geography; Gerontology; Biology; Ecology","score_opus":0.022882367039779996,"score_gpt":0.26908562287808807,"score_spread":0.24620325583830807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97287256,0.005282917,0.00015107323,0.006289573,0.00009222951,0.0000746295,0.004346326,0.00002660786,0.010864075],"genre_scores_gemma":[0.99343795,0.0025837426,0.00030199668,0.000624227,0.000022642234,0.00002479829,0.0006628305,0.0000098598075,0.002331942],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980015,0.0004300611,0.00010906802,0.00011775174,0.00051688874,0.00082459114],"domain_scores_gemma":[0.9957942,0.0010878701,0.00046575948,0.000085464766,0.0011331344,0.001433494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009835075,0.0003502836,0.00043352178,0.001081336,0.0016095487,0.0014688959,0.001272721,0.0008405769,0.002685485],"category_scores_gemma":[0.0069467323,0.00029438006,0.0006143112,0.0024233114,0.0009866557,0.00034978372,0.0009259859,0.0011910769,0.00014753878],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005240114,0.00022611345,0.93587863,0.00030810665,0.00029714938,0.0007009141,0.0011858745,0.003144647,0.00025126964,0.0013371588,0.012223339,0.043922786],"study_design_scores_gemma":[0.000054707085,0.000118565455,0.9905222,0.00029760797,0.00015986817,0.00022913492,0.0035795062,0.0023093745,0.00009896948,0.0002267243,0.0023701652,0.000033169978],"about_ca_topic_score_codex":0.9953048,"about_ca_topic_score_gemma":0.99744844,"teacher_disagreement_score":0.045695107,"about_ca_system_score_codex":0.045695107,"about_ca_system_score_gemma":0.05639876,"threshold_uncertainty_score":0.3315428},"labels":[],"label_agreement":null},{"id":"W4399699907","doi":"10.1016/j.jval.2024.03.595","title":"EE296 A United States Payer Budget Impact Analysis of Myocardial Perfusion Imaging Modalities Positron Emission Tomography with Flurpiridaz Compared to Single Photon Emission Computed Tomography in Coronary Artery Disease Diagnosis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Single-photon emission computed tomography; Coronary artery disease; Positron emission tomography; Myocardial perfusion imaging; Perfusion; Radiology; Computed tomography; Emission computed tomography; Modalities; Nuclear medicine; Cardiology","score_opus":0.010687081297178155,"score_gpt":0.25754633614442607,"score_spread":0.2468592548472479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95136243,0.0025236472,0.0018379982,0.0029752932,0.0003243885,0.0006980486,0.023874942,0.00009153725,0.016311677],"genre_scores_gemma":[0.9859644,0.00044179504,0.0014339519,0.00068016385,0.00008954374,0.00020490395,0.008044136,0.00002542207,0.0031156538],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9946637,0.0035605787,0.0002026325,0.00024403594,0.0007866121,0.0005423487],"domain_scores_gemma":[0.9901022,0.0068738693,0.0010960815,0.00026212295,0.0011356063,0.0005301219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006699594,0.00066576863,0.00085867516,0.0017335049,0.00038596275,0.0017921729,0.000627992,0.00084671937,0.007516202],"category_scores_gemma":[0.01749038,0.00033567895,0.002492939,0.002358525,0.00026765297,0.0007026085,0.00086721673,0.001056076,0.00047860123],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12386781,0.009598329,0.47276795,0.00112803,0.010593038,0.0010036305,0.00021123624,0.15827738,0.002824783,0.0097393,0.062817246,0.1471714],"study_design_scores_gemma":[0.012602841,0.014357287,0.77355176,0.0005970385,0.008741272,0.00047841627,0.0014132379,0.15280582,0.0035138119,0.0023866594,0.029334744,0.00021710542],"about_ca_topic_score_codex":0.044215694,"about_ca_topic_score_gemma":0.03466774,"teacher_disagreement_score":0.044215694,"about_ca_system_score_codex":0.003795357,"about_ca_system_score_gemma":0.0033607825,"threshold_uncertainty_score":0.08791661},"labels":[],"label_agreement":null},{"id":"W4399699955","doi":"10.1016/j.jval.2024.03.687","title":"EE391 Cost-Effectiveness of Radar: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Radar; Business; Economic growth; Medicine; Computer science; Economics; Telecommunications","score_opus":0.17253072495586613,"score_gpt":0.4592812236006933,"score_spread":0.28675049864482716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94774175,0.0024992,0.0025893212,0.009575991,0.00025172223,0.0029825654,0.008182215,0.0002385291,0.02593863],"genre_scores_gemma":[0.9868362,0.0008476022,0.0059211287,0.00088093156,0.00006341074,0.0005828535,0.0016044892,0.000025466083,0.0032379008],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9918692,0.0043195253,0.0003135848,0.0005247697,0.0013974875,0.0015754469],"domain_scores_gemma":[0.9904345,0.0029239515,0.00078642723,0.0003508867,0.0026700967,0.0028340071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006352376,0.0007235683,0.0008702434,0.0011711055,0.0018951785,0.0022688748,0.0019416459,0.0009659385,0.005183744],"category_scores_gemma":[0.015571998,0.0003647048,0.0016299922,0.0018249725,0.0007030794,0.0009503627,0.001564966,0.0013200319,0.0003229746],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025534514,0.014319659,0.32349098,0.0019039187,0.0026504593,0.00023488543,0.0015024347,0.09547279,0.0008009993,0.009893203,0.05458157,0.4696146],"study_design_scores_gemma":[0.012858746,0.01665963,0.7077777,0.0013966305,0.0033157272,0.0001620493,0.0052636703,0.2204736,0.0012060623,0.0028797265,0.02763713,0.00036930712],"about_ca_topic_score_codex":0.9759286,"about_ca_topic_score_gemma":0.9859309,"teacher_disagreement_score":0.08642214,"about_ca_system_score_codex":0.08642214,"about_ca_system_score_gemma":0.121246964,"threshold_uncertainty_score":0.62703943},"labels":[],"label_agreement":null},{"id":"W4399699997","doi":"10.1016/j.jval.2024.03.551","title":"EE252 Economic Impact of Relapses in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A Systematic Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Medicine; Dermatology; Psychiatry; Multiple sclerosis","score_opus":0.11816038725278714,"score_gpt":0.3801620968771069,"score_spread":0.26200170962431973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699997","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005446144,0.9918516,0.000094273244,0.00043447386,0.00011970346,0.00012320832,0.0015517734,0.0000037647458,0.0003751079],"genre_scores_gemma":[0.10818356,0.88839465,0.00065281685,0.0009675189,0.00020337472,0.00036438988,0.0010703658,0.000007782978,0.00015556102],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9909965,0.0031135818,0.003513752,0.0006362692,0.0013483816,0.00039149236],"domain_scores_gemma":[0.95999354,0.029434491,0.007998243,0.00040633773,0.0017907597,0.000376591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009363645,0.0010252891,0.005817706,0.009739282,0.00040770214,0.0029088946,0.0012011977,0.0021259836,0.0051299892],"category_scores_gemma":[0.055096645,0.000894862,0.013742167,0.010140625,0.00073171186,0.0020333147,0.0019032456,0.0019106215,0.00024488172],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015747041,0.00009522037,0.024012225,0.78982496,0.10210387,0.00026314266,0.0002313715,0.0005218464,0.00009001641,0.00086580444,0.003087788,0.07732906],"study_design_scores_gemma":[0.0010203389,0.00041069568,0.053828865,0.71118295,0.2143496,0.00070052536,0.00057914306,0.0003336327,0.00010777938,0.0011499175,0.016229292,0.00010724028],"about_ca_topic_score_codex":0.012623261,"about_ca_topic_score_gemma":0.029531505,"teacher_disagreement_score":0.012623261,"about_ca_system_score_codex":0.0035779218,"about_ca_system_score_gemma":0.007378555,"threshold_uncertainty_score":0.049520314},"labels":[],"label_agreement":null},{"id":"W4399700011","doi":"10.1016/j.jval.2024.03.528","title":"EE229 Characterizing the Clinical and Economic Burden of COVID-19 Among Individuals with Immunocompromising Conditions in Ontario, Canada – A Matched, Population-Based Observational Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Vancouver Coastal Health","funders":"","keywords":"Observational study; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Population; 2019-20 coronavirus outbreak; Medicine; Demography; Environmental health; Sociology; Virology; Internal medicine","score_opus":0.18947407318832457,"score_gpt":0.4565111227434797,"score_spread":0.26703704955515517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812058,0.0013697722,0.0001756376,0.00033098832,0.0000253707,0.00019475119,0.01410467,0.000007796662,0.0025852423],"genre_scores_gemma":[0.99327976,0.0006195202,0.00021784869,0.00024296268,0.000019272944,0.000097395445,0.0045776274,0.0000048931465,0.00094069267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765813,0.00030383424,0.00023127059,0.00032717746,0.00063600176,0.0008434369],"domain_scores_gemma":[0.99614656,0.0002016305,0.0013309809,0.0002539875,0.0013649275,0.0007019598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012203295,0.00051543495,0.0006863768,0.0016877363,0.002787648,0.0017155511,0.0015391704,0.00082066143,0.0019150659],"category_scores_gemma":[0.0038874794,0.00052326196,0.0011846512,0.006839031,0.00089308684,0.0005169543,0.0011809748,0.00091643987,0.00027397388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001213679,0.000040186696,0.99759823,0.00004266696,0.00015021149,0.00005520246,0.00023850614,0.00003903931,0.00007551062,0.000063120075,0.0007317669,0.0008440912],"study_design_scores_gemma":[0.000018676954,0.000026970507,0.9986873,0.000035671044,0.000053001295,0.000032352324,0.00047150647,0.000070808936,0.000013882089,0.000013942376,0.0005689482,0.000006944391],"about_ca_topic_score_codex":0.9871454,"about_ca_topic_score_gemma":0.98943514,"teacher_disagreement_score":0.023989733,"about_ca_system_score_codex":0.023989733,"about_ca_system_score_gemma":0.02755204,"threshold_uncertainty_score":0.17405856},"labels":[],"label_agreement":null},{"id":"W4399700046","doi":"10.1016/j.jval.2024.03.682","title":"EE386 Restoration of Endodontically Treated Teeth: A Cost-Effectiveness Analysis of Endocrown Versus Complete Crown","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dental Health and Care Utilization","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Crown (dentistry); Dentistry; Orthodontics; Medicine","score_opus":0.0963703021587135,"score_gpt":0.3892349885933153,"score_spread":0.2928646864346018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987329,0.0088615995,0.0011036504,0.00026550808,0.000080393365,0.00038651045,0.00057353574,0.000013644101,0.0013861206],"genre_scores_gemma":[0.997629,0.00118192,0.00064004096,0.000056552864,0.000028283323,0.000058053538,0.00018141672,0.0000033086412,0.00022141702],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955598,0.0032849773,0.00024186299,0.00026177522,0.0003045712,0.00034707476],"domain_scores_gemma":[0.99517596,0.0038547376,0.0004302668,0.00011257434,0.00012737248,0.0002990159],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046153106,0.001145199,0.0023648287,0.0015811386,0.00026413257,0.0017614973,0.00090724573,0.00130231,0.004986785],"category_scores_gemma":[0.009896419,0.0004589794,0.006606421,0.001086969,0.0006353953,0.0014772788,0.0010213042,0.0013612489,0.00014136943],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.648274,0.007636971,0.049253546,0.0062100366,0.024111481,0.0005150658,0.00033579732,0.047874518,0.0040815687,0.0031427727,0.00088113925,0.20768318],"study_design_scores_gemma":[0.09605255,0.32488382,0.2867192,0.002065731,0.091623954,0.0018938035,0.0026447875,0.17699558,0.0059943693,0.004713643,0.0059067775,0.0005057876],"about_ca_topic_score_codex":0.0066314815,"about_ca_topic_score_gemma":0.0070060776,"teacher_disagreement_score":0.0066314815,"about_ca_system_score_codex":0.0031974018,"about_ca_system_score_gemma":0.0014663481,"threshold_uncertainty_score":0.02440834},"labels":[],"label_agreement":null},{"id":"W4399700048","doi":"10.1016/j.jval.2024.03.611","title":"EE312 Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) in Pregnant Individuals for the Prevention of Respiratory Tract Disease (RTD) Caused by RSV Among Infants in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Bivalent (engine); Respiratory system; Medicine; Virology; Disease; Virus; Respiratory tract; Immunology; Internal medicine; Chemistry","score_opus":0.09917410144493902,"score_gpt":0.40010343432196954,"score_spread":0.3009293328770305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967687,0.0010067255,0.000059879705,0.0002617282,0.000021918788,0.00010839774,0.0006040085,0.000008761602,0.0011600171],"genre_scores_gemma":[0.99822587,0.00031075472,0.00010781808,0.000060128095,0.0000051984125,0.000018959268,0.00028598242,0.0000013258904,0.0009840401],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994999,0.00013806744,0.000024929583,0.000046827296,0.00011455474,0.00017574333],"domain_scores_gemma":[0.9995859,0.000064179294,0.00003855809,0.000009325373,0.000089513116,0.00021250376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000597061,0.00026533476,0.00041311816,0.0002051379,0.00030450325,0.0004576223,0.0004813147,0.00046631834,0.0022289897],"category_scores_gemma":[0.0012318005,0.00014791559,0.0005982241,0.00023504684,0.00021077832,0.00019312033,0.00022753574,0.0005228429,0.000108526416],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2844701,0.01432725,0.3205898,0.001328817,0.002334207,0.0011126919,0.00070453854,0.034622762,0.022205116,0.0019174579,0.009290566,0.3070967],"study_design_scores_gemma":[0.012611402,0.06812288,0.8846742,0.00022874247,0.0018437564,0.00031328452,0.0008102562,0.02106089,0.005403638,0.00015002154,0.004719677,0.000061233775],"about_ca_topic_score_codex":0.83322704,"about_ca_topic_score_gemma":0.88092035,"teacher_disagreement_score":0.16677296,"about_ca_system_score_codex":0.013232644,"about_ca_system_score_gemma":0.012617604,"threshold_uncertainty_score":0.3355102},"labels":[],"label_agreement":null},{"id":"W4399700057","doi":"10.1016/j.jval.2024.03.616","title":"EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Alberta; AstraZeneca (Canada)","funders":"","keywords":"Germline; Oncology; Olaparib; Human Epidermal Growth Factor Receptor 2; Adjuvant; Medicine; Breast cancer; Germline mutation; Perspective (graphical); Internal medicine; Cancer research; Cancer; Gynecology; Mutation; Biology; Genetics; Gene; Computer science; Poly ADP ribose polymerase","score_opus":0.2185593523519791,"score_gpt":0.4178131281998663,"score_spread":0.19925377584788723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700057","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15370993,0.34684628,0.0034293337,0.29591042,0.0024908648,0.00046221164,0.03733352,0.00013556908,0.15968189],"genre_scores_gemma":[0.85021776,0.112800226,0.0038961621,0.013293592,0.0013615318,0.0001412017,0.0064224666,0.000074450945,0.011792575],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99691904,0.0010654062,0.00014418057,0.00014782639,0.0010266142,0.0006970153],"domain_scores_gemma":[0.9927297,0.0022253208,0.0005528711,0.00008292889,0.0029972005,0.0014119581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041421247,0.00093008205,0.0013160877,0.0017828887,0.0009953063,0.0041177515,0.0015284205,0.002103368,0.0075675086],"category_scores_gemma":[0.014604651,0.00033494277,0.002017626,0.0031175506,0.00106529,0.0007489624,0.0007845392,0.0026850202,0.00031836628],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017918276,0.0008338764,0.041250017,0.008423066,0.009042695,0.0010236655,0.00057101663,0.12805514,0.0022057113,0.12120236,0.23221156,0.43726268],"study_design_scores_gemma":[0.013559955,0.0034906757,0.2850225,0.026369378,0.022336885,0.0015696884,0.003219677,0.100036934,0.0022359528,0.07367154,0.4673193,0.0011674332],"about_ca_topic_score_codex":0.9498653,"about_ca_topic_score_gemma":0.96300226,"teacher_disagreement_score":0.08107064,"about_ca_system_score_codex":0.08107064,"about_ca_system_score_gemma":0.11421537,"threshold_uncertainty_score":0.5882114},"labels":[],"label_agreement":null},{"id":"W4399700058","doi":"10.1016/j.jval.2024.03.415","title":"EE116 Budget Impact Model Framework of Positron Emission Tomography Compared to Single Photon Emission Computed Tomography Myocardial Perfusion Imaging for Coronary Artery Disease Diagnosis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Single-photon emission computed tomography; Coronary artery disease; Positron emission tomography; Medicine; Perfusion; Myocardial perfusion imaging; Radiology; Emission computed tomography; Computed tomography; Preclinical imaging; Perfusion scanning; Nuclear medicine; Cardiology","score_opus":0.014889862366188849,"score_gpt":0.2813073021295894,"score_spread":0.26641743976340054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700058","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17868504,0.0027531444,0.63116765,0.0067024278,0.00057832064,0.0003074836,0.007236237,0.00064714724,0.17192264],"genre_scores_gemma":[0.9497579,0.0008390216,0.02438383,0.00033338595,0.000109590335,0.00021149934,0.0014777126,0.00018464672,0.022702418],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99946624,0.00023417616,0.000019819883,0.00007854796,0.00010034046,0.000100948986],"domain_scores_gemma":[0.9988979,0.0005874886,0.000078417834,0.000057636815,0.00030012077,0.000078409605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010328646,0.00062205706,0.0008290783,0.00087982457,0.00041725335,0.0018918017,0.0017715682,0.0015900802,0.010808278],"category_scores_gemma":[0.0039661373,0.0004677686,0.000838255,0.0012135566,0.00048128053,0.0016970559,0.0009999989,0.0012904241,0.0005605096],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031776166,0.000020510737,0.00047902876,0.000022768365,0.000019393266,0.000052840187,0.000009760534,0.9779829,0.000096044336,0.017748516,0.00079232693,0.0027442554],"study_design_scores_gemma":[0.00001382722,0.000013162682,0.0002924308,0.000012543197,0.000015030133,0.000016060138,0.000017484346,0.99100375,0.00006595993,0.007326314,0.0012174175,0.0000060449415],"about_ca_topic_score_codex":0.06138966,"about_ca_topic_score_gemma":0.028139167,"teacher_disagreement_score":0.06138966,"about_ca_system_score_codex":0.0023899637,"about_ca_system_score_gemma":0.0028345818,"threshold_uncertainty_score":0.12206465},"labels":[],"label_agreement":null},{"id":"W4399700099","doi":"10.1016/j.jval.2024.03.481","title":"EE182 Mepolizumab Impact on Healthcare Resource Utilization and Work Productivity in Patients with Severe Asthma: REALITI-A 2-Year Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Work productivity; Mepolizumab; Productivity; Work (physics); Asthma; Resource (disambiguation); Health care; Business; Medicine; Economics; Computer science; Economic growth; Engineering; Internal medicine; Eosinophil","score_opus":0.06175518250044026,"score_gpt":0.4184292006471413,"score_spread":0.356674018146701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99628913,0.00076851796,0.00010638728,0.000073871386,0.000013278773,0.000029039984,0.002281543,0.00000517846,0.0004330456],"genre_scores_gemma":[0.9955526,0.00029153615,0.00008565371,0.00006940829,0.00002978968,0.000046707435,0.0031341298,0.0000030760746,0.00078704976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844044,0.00046737728,0.00015323826,0.00019170005,0.00028741578,0.0004599185],"domain_scores_gemma":[0.9986197,0.0003814841,0.0005564548,0.0000949178,0.0001475353,0.00020000551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020915063,0.00058354874,0.0010241806,0.0011185005,0.00038310164,0.0012739896,0.0005058988,0.0009420315,0.002425205],"category_scores_gemma":[0.0019352426,0.00032699518,0.0049480377,0.0013069268,0.00029762316,0.0010150379,0.0010095288,0.0010169103,0.00040288328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019132392,0.0009558609,0.95863944,0.00027177806,0.0038650038,0.0002861496,0.00017060785,0.0020349687,0.0006631475,0.00009501663,0.0007461235,0.013139573],"study_design_scores_gemma":[0.00022647362,0.0020018285,0.9951238,0.000023180526,0.00065104716,0.000093524315,0.0002531829,0.00084176386,0.00014848779,0.000031653246,0.0005871311,0.000018034703],"about_ca_topic_score_codex":0.010105038,"about_ca_topic_score_gemma":0.010071433,"teacher_disagreement_score":0.010105038,"about_ca_system_score_codex":0.0012003754,"about_ca_system_score_gemma":0.00088335766,"threshold_uncertainty_score":0.020092428},"labels":[],"label_agreement":null},{"id":"W4399700156","doi":"10.1016/j.jval.2024.03.374","title":"EE74 Economic Burden and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Systematic review; Health care; Intensive care medicine; Resource use; Healthcare system; MEDLINE; Natural resource economics; Economics; Economic growth; Political science","score_opus":0.02971455548070498,"score_gpt":0.31341779392093755,"score_spread":0.2837032384402326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700156","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011234334,0.98119843,0.00021192992,0.0007884604,0.00021642336,0.00042117783,0.0052569346,0.0000120640825,0.0006602164],"genre_scores_gemma":[0.11541484,0.8781558,0.0013001497,0.0016730863,0.00020945363,0.0010797308,0.0018606334,0.000011742814,0.00029461287],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9875403,0.0037711104,0.0060261483,0.0007532398,0.0013869217,0.0005222333],"domain_scores_gemma":[0.9649626,0.024646878,0.007058258,0.0005962614,0.002338687,0.0003972514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009348446,0.0010443273,0.004864667,0.016068634,0.0005884363,0.002949512,0.0011352586,0.0020458046,0.0049483143],"category_scores_gemma":[0.051067416,0.00094346685,0.014549068,0.015059657,0.0006246902,0.0019976632,0.0024216003,0.0011595396,0.0003381014],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056901324,0.000052057327,0.024823053,0.84942585,0.088321865,0.00027521473,0.00037282563,0.00017464257,0.00015759596,0.0002456177,0.0024435944,0.033138607],"study_design_scores_gemma":[0.00062744785,0.00027397784,0.053061962,0.6199236,0.30859467,0.00061915984,0.0007355359,0.00014176217,0.0001538155,0.00033756206,0.015441815,0.00008868991],"about_ca_topic_score_codex":0.01541436,"about_ca_topic_score_gemma":0.04139099,"teacher_disagreement_score":0.016068634,"about_ca_system_score_codex":0.0025745989,"about_ca_system_score_gemma":0.010686002,"threshold_uncertainty_score":0.049439907},"labels":[],"label_agreement":null},{"id":"W4399700197","doi":"10.1016/j.jval.2024.03.473","title":"EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Messenger RNA; Virology; Medicine; Business; Biology; Genetics; Gene","score_opus":0.05510052040738759,"score_gpt":0.390559022766845,"score_spread":0.3354585023594574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9550315,0.0091798715,0.0003512143,0.0035699306,0.00016101812,0.00060815265,0.020286502,0.000026279824,0.010785557],"genre_scores_gemma":[0.9884875,0.0033116224,0.0008172784,0.00094553264,0.000053385847,0.00013868221,0.0043551256,0.000006004356,0.0018848787],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986539,0.00020019269,0.00008496376,0.00008774536,0.00043184546,0.0005414092],"domain_scores_gemma":[0.998408,0.0002652848,0.00025090875,0.000028497254,0.00067600026,0.0003712837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014060115,0.0006630784,0.00064436847,0.0009180921,0.0010859257,0.001394743,0.0010524212,0.0008580793,0.003507073],"category_scores_gemma":[0.0054127113,0.0002723776,0.0026395833,0.001986508,0.00035952884,0.00042467384,0.00070961396,0.0009917628,0.00024087014],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008431674,0.000699096,0.8891087,0.0024739387,0.004054716,0.00031218803,0.00056755176,0.00435902,0.0007826122,0.0012722715,0.011593752,0.07634455],"study_design_scores_gemma":[0.0012917484,0.0026985852,0.97394174,0.0013013086,0.0037279848,0.00015289815,0.0020060819,0.0039217854,0.00053615955,0.0002876796,0.010046911,0.000087132044],"about_ca_topic_score_codex":0.9838308,"about_ca_topic_score_gemma":0.9862375,"teacher_disagreement_score":0.03961621,"about_ca_system_score_codex":0.03961621,"about_ca_system_score_gemma":0.051962994,"threshold_uncertainty_score":0.28743708},"labels":[],"label_agreement":null},{"id":"W4399700239","doi":"10.1016/j.jval.2024.03.575","title":"EE276 Understanding Trends in Launch Prices across Canada, EU4, UK and the US for High-Revenue Drugs","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Revenue; Business; Economics; Finance","score_opus":0.1167373823229765,"score_gpt":0.33843671197016073,"score_spread":0.22169932964718425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8433053,0.0055797677,0.0015417866,0.013707592,0.00012109835,0.000048218364,0.06913982,0.00009278286,0.06646359],"genre_scores_gemma":[0.9612834,0.002700567,0.00091709447,0.0008042783,0.00007176125,0.00001537767,0.017951747,0.000050582206,0.016205134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955934,0.000033238233,0.000021263382,0.000048674592,0.00017165954,0.00016581581],"domain_scores_gemma":[0.9974044,0.0005629482,0.0005158685,0.000056350113,0.0011841729,0.00027623225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061598537,0.00012654466,0.0001639239,0.0016996654,0.00035749646,0.0026278694,0.0003126641,0.00041447967,0.0092347795],"category_scores_gemma":[0.0039899847,0.0001292943,0.0004176186,0.0034305705,0.00016993769,0.0011017319,0.00040476865,0.00070372794,0.0012192555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005559216,0.00016146673,0.8198195,0.00022007986,0.00030263147,0.00019155876,0.0005399225,0.00498984,0.0009450116,0.015025767,0.054936264,0.10231193],"study_design_scores_gemma":[0.000011549622,0.000038588096,0.9514439,0.00009042232,0.000052921187,0.000040181985,0.0009794941,0.004392872,0.00058052386,0.0012070047,0.04114506,0.000017465905],"about_ca_topic_score_codex":0.66664475,"about_ca_topic_score_gemma":0.73162353,"teacher_disagreement_score":0.33335525,"about_ca_system_score_codex":0.005067446,"about_ca_system_score_gemma":0.0059904805,"threshold_uncertainty_score":0.6706369},"labels":[],"label_agreement":null},{"id":"W4399700251","doi":"10.1016/j.jval.2024.03.524","title":"EE225 Economic Modeling of Topical and Systemic Treatments for Atopic Dermatitis: A Structured Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Atopic dermatitis; Dermatology; Medicine","score_opus":0.03160962964795953,"score_gpt":0.33052971752373433,"score_spread":0.2989200878757748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700251","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014794956,0.93792,0.018494532,0.008926057,0.00039669487,0.00013411346,0.0031959312,0.000032426626,0.016105447],"genre_scores_gemma":[0.21300693,0.77339965,0.008221061,0.000992515,0.0006195223,0.0002378227,0.0015506835,0.00002931912,0.0019425034],"study_design_codex":"simulation_or_modeling","study_design_gemma":"systematic_review","domain_scores_codex":[0.99769956,0.0015290356,0.00020670918,0.0001266417,0.00033474356,0.0001032445],"domain_scores_gemma":[0.97299904,0.025090776,0.0008552005,0.00018741633,0.0007707257,0.0000967724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004717852,0.00086822954,0.0015555677,0.0040215366,0.00026650837,0.0020221956,0.0009163193,0.0014097227,0.006885078],"category_scores_gemma":[0.020800974,0.0005495067,0.0029416336,0.0055534313,0.00035985102,0.0015816943,0.0005813321,0.001366138,0.0004594038],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060475175,0.0004921511,0.007844751,0.07094247,0.008326872,0.0007395709,0.00023993057,0.37440604,0.000336736,0.14089277,0.026355961,0.3688179],"study_design_scores_gemma":[0.0004580528,0.0008348372,0.020216206,0.17180608,0.016911626,0.0013653117,0.0011640936,0.2902752,0.0010117554,0.25628892,0.2394132,0.00025467796],"about_ca_topic_score_codex":0.014250318,"about_ca_topic_score_gemma":0.012534463,"teacher_disagreement_score":0.014250318,"about_ca_system_score_codex":0.003210135,"about_ca_system_score_gemma":0.0040614353,"threshold_uncertainty_score":0.028334737},"labels":[],"label_agreement":null},{"id":"W4399700293","doi":"10.1016/j.jval.2024.03.626","title":"EE327 Public Preferences for Improving Health Equity: A Qualitative Focus Group Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Focus group; Equity (law); Qualitative research; Group (periodic table); Business; Focus (optics); Health equity; Public health; Public economics; Psychology; Public relations; Medicine; Marketing; Economics; Political science; Sociology; Nursing; Social science; Chemistry","score_opus":0.4027611082193925,"score_gpt":0.5878414974418823,"score_spread":0.18508038922248982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856287,0.00014258307,0.00066387164,0.0045642294,0.00007983294,0.00055438705,0.00018331071,0.000009537877,0.008173606],"genre_scores_gemma":[0.9910035,0.00024439098,0.00066622783,0.0029051942,0.00002966544,0.0012814469,0.000065375505,0.000017498238,0.0037865809],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98435533,0.0110944295,0.00031650285,0.00038281656,0.00078977726,0.003061258],"domain_scores_gemma":[0.9578278,0.032642968,0.0017074399,0.0008944332,0.0031985051,0.0037288368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027425516,0.00048010747,0.0006709907,0.0013426904,0.014186283,0.0043771616,0.0014861256,0.0037873713,0.010310567],"category_scores_gemma":[0.035785787,0.00080014986,0.0004273635,0.001485675,0.0042806794,0.0032872937,0.0069334027,0.004520127,0.00067045115],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016362825,0.0010955407,0.011452064,0.00028534906,0.000010653389,0.00041117548,0.9724824,0.000041151103,0.0007972506,0.0019924622,0.002119583,0.009148712],"study_design_scores_gemma":[0.000036434303,0.00017453695,0.0058248295,0.0001708224,0.000008802341,0.000057826204,0.98827296,0.000042453183,0.0002594281,0.00027084938,0.00486884,0.0000122847105],"about_ca_topic_score_codex":0.019168533,"about_ca_topic_score_gemma":0.030145278,"teacher_disagreement_score":0.027425516,"about_ca_system_score_codex":0.0078102336,"about_ca_system_score_gemma":0.015032764,"threshold_uncertainty_score":0.1450417},"labels":[],"label_agreement":null},{"id":"W4399700326","doi":"10.1016/j.jval.2024.03.202","title":"CO114 Clinical Characteristics, Diagnosis, and Impact on Employment in Patients With Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Hypertrophic cardiomyopathy; Medicine; Obstructive cardiomyopathy; Cardiology; Internal medicine; Cardiomyopathy; Heart failure","score_opus":0.055938082650987694,"score_gpt":0.3297976663299205,"score_spread":0.2738595836789328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99494743,0.0003510375,0.00003137612,0.0003589437,0.000009769392,0.000016596914,0.0026667388,0.0000033975261,0.0016147293],"genre_scores_gemma":[0.9986513,0.00019999983,0.00003211529,0.00007416024,0.000004907612,0.000005883487,0.0007082662,0.0000021578762,0.00032135803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986614,0.00018468381,0.000104068386,0.0001466444,0.00036974985,0.0005334669],"domain_scores_gemma":[0.9968112,0.00022128066,0.00069073855,0.00007392751,0.0010174839,0.001185338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005620782,0.00026027553,0.00041794975,0.00147395,0.0024965093,0.0014249601,0.0012613629,0.00078538747,0.0022526723],"category_scores_gemma":[0.0027897418,0.00033891416,0.00069903967,0.004601862,0.0008686296,0.00043454496,0.0010557486,0.0009547581,0.0002843707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020099635,0.00002368248,0.9990115,0.0000054242546,0.000017672166,0.00003784038,0.00015831554,0.000025380274,0.000025960948,0.000017225986,0.0002089815,0.0004478742],"study_design_scores_gemma":[0.0000015987039,0.0000060116367,0.99911827,0.00000652282,0.000004854426,0.000019770325,0.0006776405,0.000055148605,0.000006072618,0.000005950071,0.00009547573,0.0000027412893],"about_ca_topic_score_codex":0.9754567,"about_ca_topic_score_gemma":0.98214966,"teacher_disagreement_score":0.024543285,"about_ca_system_score_codex":0.01176305,"about_ca_system_score_gemma":0.013753163,"threshold_uncertainty_score":0.085347295},"labels":[],"label_agreement":null},{"id":"W4399700336","doi":"10.1016/j.jval.2024.03.247","title":"CO160 Relationship between Loss of Ambulation (LoA), Disease Burden, and Physical Functioning Among Boys with Duchenne Muscular Dystrophy (DMD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Disease; Physical therapy; Physical medicine and rehabilitation; Internal medicine","score_opus":0.018578472915209403,"score_gpt":0.2698509861516758,"score_spread":0.2512725132364664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988262,0.0003345624,0.000045811736,0.00009200387,0.000007102213,0.0000018440327,0.00022054634,0.0000055834603,0.00046632145],"genre_scores_gemma":[0.99944156,0.000046987883,0.000031075433,0.000010435087,0.000008332877,0.0000024697422,0.00011419074,0.0000017726852,0.00034311955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938285,0.00022075175,0.000052913718,0.00011054459,0.0001098029,0.00012312892],"domain_scores_gemma":[0.9977012,0.0005647582,0.00085003045,0.00009203111,0.00019758663,0.00059443817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005312716,0.00033378563,0.00035589738,0.0010597884,0.0005895355,0.000820833,0.00048442892,0.00058238994,0.0037408187],"category_scores_gemma":[0.0021930742,0.00029396443,0.00044341644,0.000757786,0.00038696986,0.00042044633,0.0007547645,0.0009883487,0.0004039232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003601718,0.000019549027,0.99921787,0.000002685686,0.000026935211,0.000048163045,0.00003417158,0.000019343137,0.00009645171,0.000009131895,0.000036135498,0.00045353713],"study_design_scores_gemma":[0.0000011616422,0.0000439117,0.9995579,0.0000022260785,0.000011266331,0.00011931157,0.00013059686,0.000064154236,0.000017863018,0.000006453325,0.000043739296,0.000001413649],"about_ca_topic_score_codex":0.010709787,"about_ca_topic_score_gemma":0.010392977,"teacher_disagreement_score":0.010709787,"about_ca_system_score_codex":0.00038431113,"about_ca_system_score_gemma":0.00032810346,"threshold_uncertainty_score":0.021294892},"labels":[],"label_agreement":null},{"id":"W4399700346","doi":"10.1016/j.jval.2024.03.213","title":"CO125 Disease Burden of Epithelial Ovarian Cancer in Chinese Patients Under Current Care: A Model Simulation Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Ovarian cancer; Disease; Current (fluid); Epithelial ovarian cancer; Oncology; Internal medicine; Cancer; Engineering","score_opus":0.044646887089065446,"score_gpt":0.38984965393459586,"score_spread":0.3452027668455304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611664,0.0001640853,0.00079664885,0.0005120807,0.000019716608,0.000039139424,0.0009824333,0.000020468895,0.0013487941],"genre_scores_gemma":[0.9982911,0.00009619844,0.00022316481,0.00006450019,0.000011225964,0.000050835588,0.0006269983,0.0000052588844,0.00063077104],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993808,0.00022168887,0.000024364748,0.0001142168,0.000033818655,0.00022501832],"domain_scores_gemma":[0.99537885,0.0030400634,0.0005319569,0.00019909974,0.00029199835,0.00055801164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012813788,0.0008195786,0.0016002145,0.00079422543,0.00086028397,0.0015972963,0.0017934222,0.0018969607,0.0060136286],"category_scores_gemma":[0.005283025,0.000748627,0.0026961737,0.0013191873,0.000809167,0.0011367135,0.0010252139,0.0016188679,0.00037086415],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022828488,0.00201965,0.27605712,0.00014678833,0.0015032644,0.0009584316,0.0004373364,0.70442456,0.00032345045,0.00481454,0.002752922,0.0042791073],"study_design_scores_gemma":[0.0007622151,0.00081261626,0.045822393,0.000033942117,0.0006524292,0.00019920903,0.0006549796,0.9488903,0.00013606127,0.0014856465,0.00048039906,0.00006980042],"about_ca_topic_score_codex":0.20017043,"about_ca_topic_score_gemma":0.07958032,"teacher_disagreement_score":0.20017043,"about_ca_system_score_codex":0.0043103555,"about_ca_system_score_gemma":0.0040848306,"threshold_uncertainty_score":0.3980106},"labels":[],"label_agreement":null},{"id":"W4399700370","doi":"10.1016/j.jval.2024.03.666","title":"EE369 Healthcare Resource Utilization Among Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Vaso-occlusive crisis; Occlusive; Disease; Intensive care medicine; Health care; Internal medicine; Sickle cell anemia; Economic growth; Economics","score_opus":0.017313884699478733,"score_gpt":0.252610551551214,"score_spread":0.23529666685173525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9555586,0.002696437,0.00012373169,0.0029276835,0.000106987056,0.000110603214,0.027464133,0.000026556214,0.010985323],"genre_scores_gemma":[0.98954993,0.0017391536,0.0001951333,0.0007664583,0.00003549235,0.000037414142,0.0049855295,0.000013194537,0.0026776423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881256,0.00007128652,0.00011881841,0.00011055718,0.00034328364,0.0005435669],"domain_scores_gemma":[0.99634486,0.00017453106,0.00065557467,0.000040441086,0.0013901904,0.0013942852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033403392,0.00028730568,0.00057030073,0.0018898902,0.0025107241,0.002024861,0.0012701142,0.0007119936,0.0046215425],"category_scores_gemma":[0.0024426407,0.00036519204,0.0011730164,0.0063012526,0.00048227748,0.0004220518,0.00096359046,0.001394573,0.00033871245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081247,0.00008276069,0.98715323,0.000081413615,0.0001403758,0.0002745491,0.00036775428,0.00029380192,0.000090404494,0.00032570877,0.0061626853,0.0049460256],"study_design_scores_gemma":[0.000019039431,0.000020112411,0.9951037,0.000102796315,0.000055020068,0.00014481308,0.0016138621,0.0005331902,0.000035844674,0.0000407842,0.0023126693,0.000018056591],"about_ca_topic_score_codex":0.99690384,"about_ca_topic_score_gemma":0.99807394,"teacher_disagreement_score":0.04252256,"about_ca_system_score_codex":0.04252256,"about_ca_system_score_gemma":0.06616759,"threshold_uncertainty_score":0.30852425},"labels":[],"label_agreement":null},{"id":"W4399700374","doi":"10.1016/j.jval.2024.03.832","title":"EPH3 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bivalent (engine); Virology; Protein subunit; Virus; Respiratory system; Medicine; Biology; Chemistry; Genetics; Internal medicine; Gene","score_opus":0.0641322713054791,"score_gpt":0.3746595154767892,"score_spread":0.3105272441713101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846496,0.0019733447,0.00010576498,0.0029469517,0.0000606434,0.00006756117,0.0049761627,0.00001014002,0.0052097887],"genre_scores_gemma":[0.99546945,0.0013476209,0.00011074052,0.00056135847,0.000020016607,0.000014576397,0.0008466901,0.0000031033105,0.0016264078],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993606,0.000043060936,0.000030318917,0.00005377245,0.00016797443,0.00034434738],"domain_scores_gemma":[0.99891925,0.000053409676,0.00015915923,0.000013335748,0.0004799107,0.00037497547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038548862,0.00024696265,0.00027455072,0.00049976294,0.0014699482,0.001010998,0.0005961879,0.00044206632,0.0024020062],"category_scores_gemma":[0.0013447937,0.00018500017,0.0006969287,0.0011157474,0.00034001272,0.00031650177,0.000580105,0.0009945722,0.000104151346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043427935,0.00013512225,0.9773921,0.00010610318,0.00012733898,0.00025585174,0.0005560899,0.00028320742,0.00049137755,0.00045516514,0.0034663863,0.01629702],"study_design_scores_gemma":[0.000040451218,0.00014241994,0.99306047,0.00013979628,0.00016304548,0.000090250825,0.002643063,0.0007523008,0.00017162685,0.00007872718,0.0027010518,0.000016844382],"about_ca_topic_score_codex":0.9945387,"about_ca_topic_score_gemma":0.9958587,"teacher_disagreement_score":0.02546317,"about_ca_system_score_codex":0.02546317,"about_ca_system_score_gemma":0.03983313,"threshold_uncertainty_score":0.18474913},"labels":[],"label_agreement":null},{"id":"W4399700417","doi":"10.1016/j.jval.2024.03.200","title":"CO112 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Ruxolitinib Cream 1.5% Vs Other Pharmacologic Agents in the Treatment of Atopic Dermatitis (AD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia; EVERSANA (Canada); SKiN Health","funders":"","keywords":"Ruxolitinib; Atopic dermatitis; Medicine; Meta-analysis; Dermatology; Systematic review; Internal medicine; MEDLINE; Chemistry; Myelofibrosis","score_opus":0.12135399332976005,"score_gpt":0.4014528283245953,"score_spread":0.28009883499483523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700417","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032572016,0.94203544,0.0036072612,0.0027686013,0.0019290627,0.0021695902,0.010973323,0.00021221886,0.003732417],"genre_scores_gemma":[0.6539486,0.31523636,0.009663345,0.0060213255,0.001408007,0.0046544154,0.0044388757,0.00017619503,0.0044529308],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.980099,0.01089769,0.004272557,0.0024016271,0.0017723085,0.00055677077],"domain_scores_gemma":[0.9707309,0.020368343,0.0044217156,0.0012616739,0.0028217374,0.00039569588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013753402,0.001756024,0.008217248,0.0066496776,0.00088829995,0.0031894965,0.001350646,0.0024324027,0.011731475],"category_scores_gemma":[0.054590218,0.0010766643,0.027763441,0.0055146352,0.0005874604,0.001863895,0.0015021153,0.0019225157,0.001450298],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008568885,0.000052179195,0.010161669,0.24577266,0.7119941,0.0002004046,0.00013380479,0.0003946206,0.00053397357,0.0002964297,0.003009132,0.018882073],"study_design_scores_gemma":[0.0038946392,0.0003122218,0.0060378327,0.023736108,0.9601288,0.0001269006,0.000050753588,0.00036997514,0.00021752341,0.0003696327,0.004717849,0.00003782204],"about_ca_topic_score_codex":0.011406068,"about_ca_topic_score_gemma":0.023359902,"teacher_disagreement_score":0.013753402,"about_ca_system_score_codex":0.0021311438,"about_ca_system_score_gemma":0.0044055725,"threshold_uncertainty_score":0.07273579},"labels":[],"label_agreement":null},{"id":"W4399700445","doi":"10.1016/j.jval.2024.03.268","title":"CO182 Intelligence Quotient (IQ) Scores Among Early-Treated Phenylketonuria (PKU) Patients: Results from a Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Intelligence quotient; Quotient; Pediatrics; Medicine; Psychiatry; Cognition; Mathematics","score_opus":0.012969849902688695,"score_gpt":0.26631071328015166,"score_spread":0.253340863377463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700445","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025549246,0.9664329,0.00017039715,0.00036502682,0.00008155319,0.00025024675,0.006684759,0.000010217669,0.0004556191],"genre_scores_gemma":[0.23715459,0.7554078,0.0013509728,0.0010082948,0.00011779653,0.00079857477,0.003949074,0.00001187627,0.00020099798],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943334,0.0010502718,0.0030840337,0.0006808912,0.0006185285,0.00023296576],"domain_scores_gemma":[0.9834342,0.009706581,0.0048518395,0.0003072354,0.0014545971,0.00024552218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048443615,0.00086101104,0.005760304,0.014814296,0.00052455236,0.0022217394,0.0010681796,0.0014182432,0.0024772023],"category_scores_gemma":[0.01897097,0.0006650552,0.009832307,0.015931005,0.000668158,0.0015425539,0.0017547347,0.00070955814,0.00021957538],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011177888,0.00007690261,0.0679273,0.78988403,0.09264655,0.000543786,0.0007987037,0.00020315041,0.000515761,0.000253666,0.0024449332,0.04358747],"study_design_scores_gemma":[0.0007460889,0.0004105783,0.16900916,0.40497428,0.4051384,0.0012549039,0.0013281269,0.00014523159,0.00042662167,0.0002838729,0.016129278,0.00015340003],"about_ca_topic_score_codex":0.015294127,"about_ca_topic_score_gemma":0.039067667,"teacher_disagreement_score":0.015294127,"about_ca_system_score_codex":0.0019064614,"about_ca_system_score_gemma":0.0065098093,"threshold_uncertainty_score":0.03041023},"labels":[],"label_agreement":null},{"id":"W4399700451","doi":"10.1016/j.jval.2024.03.171","title":"CO83 Screening Articles in a Qualitative Literature Review Using Large Language Models: A Comparison of GPT Versus Open Source, Trained Models Against Expert Researcher Screening","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Computer science; Open source; Medical physics; Data science; Natural language processing; Psychology; Medicine; Programming language; Software","score_opus":0.6808479755722152,"score_gpt":0.6032836486369278,"score_spread":0.07756432693528736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5312684,0.09588426,0.100029536,0.032274675,0.0016805921,0.10763764,0.055524305,0.0016378665,0.0740627],"genre_scores_gemma":[0.7246682,0.024804955,0.13706985,0.007280975,0.0003197518,0.08869227,0.007816838,0.00049075345,0.008856418],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.90425897,0.05693066,0.01988933,0.0040147393,0.013194604,0.0017117525],"domain_scores_gemma":[0.3127115,0.6030475,0.030322116,0.007892654,0.04449521,0.0015309233],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1229803,0.0009061978,0.0025595047,0.016368065,0.0020892802,0.0041310815,0.0021071897,0.0017728473,0.012864286],"category_scores_gemma":[0.4817515,0.0009234609,0.0034592834,0.012908918,0.0016596523,0.0056598173,0.0047012316,0.0010823921,0.0018498087],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036133449,0.0004899934,0.036228053,0.31875378,0.0035098025,0.0018059172,0.093731634,0.0012283263,0.003876215,0.00639302,0.027593475,0.50277644],"study_design_scores_gemma":[0.00459922,0.00321101,0.0992263,0.3876396,0.036062784,0.0027522398,0.1659821,0.008608541,0.015076896,0.020439038,0.25542697,0.0009752504],"about_ca_topic_score_codex":0.008955179,"about_ca_topic_score_gemma":0.023669688,"teacher_disagreement_score":0.8770197,"about_ca_system_score_codex":0.0068006837,"about_ca_system_score_gemma":0.027661454,"threshold_uncertainty_score":0.6503898},"labels":[],"label_agreement":null},{"id":"W4399700467","doi":"10.1016/j.jval.2024.03.183","title":"CO95 Growing Acceptance of Minimal Residual Disease (MRD) As a Primary Endpoint in Multiple Myeloma (MM) Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Middlesex London Health Unit","funders":"","keywords":"Minimal residual disease; Multiple myeloma; Medicine; Clinical endpoint; Residual; Oncology; Primary (astronomy); Clinical trial; Internal medicine; Mathematics; Algorithm; Bone marrow","score_opus":0.23198385353040846,"score_gpt":0.47397725614956016,"score_spread":0.2419934026191517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700467","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013751451,0.32314828,0.0062136375,0.49803248,0.036127064,0.00094146375,0.005901556,0.00029759883,0.11558647],"genre_scores_gemma":[0.29178193,0.21871632,0.020824814,0.34329438,0.077383496,0.003020022,0.007346532,0.00070249103,0.03693009],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9334427,0.039860584,0.0046202587,0.0051105814,0.01518204,0.0017837879],"domain_scores_gemma":[0.49440008,0.33048305,0.05105871,0.015753869,0.08459086,0.023713367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10425092,0.00074076746,0.0027843216,0.002062556,0.0010256408,0.010547229,0.0028471535,0.005937896,0.0146574285],"category_scores_gemma":[0.23030025,0.0005942655,0.002032594,0.004256476,0.0033505685,0.004387797,0.0036120622,0.009975307,0.0048689162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013577974,0.0002663844,0.010590494,0.007431706,0.0015943346,0.00010276813,0.00023815458,0.0006453349,0.0016198865,0.021118052,0.30387378,0.6389411],"study_design_scores_gemma":[0.0071625584,0.0029351537,0.035238963,0.014090913,0.0013977111,0.0003244559,0.0002640715,0.0012840327,0.002130571,0.022572262,0.9124085,0.00019079218],"about_ca_topic_score_codex":0.0034899702,"about_ca_topic_score_gemma":0.005560504,"teacher_disagreement_score":0.10425092,"about_ca_system_score_codex":0.0076530334,"about_ca_system_score_gemma":0.014693613,"threshold_uncertainty_score":0.5513382},"labels":[],"label_agreement":null},{"id":"W4399700479","doi":"10.1016/j.jval.2024.03.691","title":"EE395 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Current Standard of Care (SOC) for Patients with Unresectable or Metastatic Melanoma in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Nivolumab; Medicine; Metastatic melanoma; Oncology; Internal medicine; Standard of care; Cancer; Immunotherapy","score_opus":0.2754352336219331,"score_gpt":0.4260363249080076,"score_spread":0.15060109128607446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9546213,0.01901122,0.00072964956,0.0024568813,0.00024212465,0.0011345524,0.013384298,0.000058547357,0.008361454],"genre_scores_gemma":[0.99122953,0.002399909,0.0006138993,0.0003409882,0.00004678629,0.00012841108,0.0038553353,0.000011217814,0.0013739924],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99819833,0.0006969686,0.0001227635,0.00016208396,0.00036514798,0.0004546785],"domain_scores_gemma":[0.99786514,0.00064319966,0.00027205612,0.000057520036,0.0005232386,0.00063881715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021616626,0.0007772556,0.0016072439,0.0009297065,0.0005688998,0.0015298198,0.0011721234,0.0006819379,0.003950406],"category_scores_gemma":[0.006776369,0.00038615338,0.004197338,0.0015542634,0.00055089797,0.0005076083,0.00065458403,0.0014533396,0.00015658021],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34752885,0.0052603753,0.15984374,0.010150988,0.035860363,0.00072619,0.00038281962,0.17172113,0.0023573071,0.006717414,0.029481506,0.22996938],"study_design_scores_gemma":[0.10013608,0.029937841,0.597817,0.004250309,0.039283365,0.000663294,0.0011945358,0.19915216,0.0016764854,0.0024508233,0.02298091,0.00045714958],"about_ca_topic_score_codex":0.9030968,"about_ca_topic_score_gemma":0.92245203,"teacher_disagreement_score":0.096903205,"about_ca_system_score_codex":0.04693462,"about_ca_system_score_gemma":0.035711803,"threshold_uncertainty_score":0.34053612},"labels":[],"label_agreement":null},{"id":"W4399700487","doi":"10.1016/j.jval.2024.03.154","title":"CO66 Optimizing GPT-4 Prompts for Population Eligibility Screening in COA Landscape Reviews of Qualitative Studies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Computer science","score_opus":0.24189336401062306,"score_gpt":0.48143394229360004,"score_spread":0.23954057828297698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700487","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16655199,0.12413969,0.07140634,0.39697224,0.014825674,0.05936835,0.025249166,0.00250298,0.13898356],"genre_scores_gemma":[0.5859593,0.039099712,0.20329429,0.043983474,0.0011511315,0.10981107,0.0037314596,0.0008713029,0.012098178],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.8019589,0.16726488,0.019251145,0.0025446294,0.005913736,0.0030666601],"domain_scores_gemma":[0.4808133,0.41927537,0.02407852,0.010266568,0.059273023,0.00629321],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18431912,0.0007818693,0.0018556656,0.006197529,0.0031400153,0.0044308593,0.002298452,0.0026040236,0.020458948],"category_scores_gemma":[0.47533417,0.0012208691,0.0024888394,0.005636334,0.0016921664,0.0072672144,0.009763164,0.0027719184,0.0021491058],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001522517,0.00032296465,0.01611765,0.116793275,0.0008353305,0.0005412443,0.12885536,0.0006532757,0.0011838618,0.011881048,0.18424654,0.537047],"study_design_scores_gemma":[0.002607746,0.00073053234,0.033344563,0.3836306,0.0029218076,0.00047883834,0.10746928,0.0017912285,0.002785708,0.02415452,0.43961912,0.0004659518],"about_ca_topic_score_codex":0.019054636,"about_ca_topic_score_gemma":0.070224695,"teacher_disagreement_score":0.81568086,"about_ca_system_score_codex":0.013002218,"about_ca_system_score_gemma":0.050100505,"threshold_uncertainty_score":0.9747844},"labels":[],"label_agreement":null},{"id":"W4399700840","doi":"10.1016/j.jval.2024.03.149","title":"CO61 Analysis of Healthcare Resource Utilization in the NODE-303 Clinical Trial to Terminate Paroxysmal Supraventricular Tachycardia Episodes","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada); Université de Montréal","funders":"","keywords":"Paroxysmal supraventricular tachycardia; Medicine; Supraventricular tachycardia; Node (physics); Tachycardia; Anesthesia; Engineering","score_opus":0.1269412799053382,"score_gpt":0.4387795245726505,"score_spread":0.3118382446673123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836617,0.0045799706,0.0006580428,0.0011554018,0.00021519327,0.0001625072,0.0055805654,0.000025228617,0.00396145],"genre_scores_gemma":[0.9928798,0.00095821224,0.00038605314,0.00049247034,0.00018119131,0.00014203096,0.0039543435,0.000019166957,0.0009867256],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99488574,0.0033600342,0.00033091073,0.0005862672,0.00040804115,0.00042911252],"domain_scores_gemma":[0.9878963,0.007942376,0.0020295875,0.0007499906,0.00046612893,0.0009156063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040373434,0.00051694,0.001278302,0.0005085415,0.00023007591,0.0011907462,0.00058218214,0.0007980137,0.00395281],"category_scores_gemma":[0.012701248,0.00025482755,0.0031346837,0.0009588411,0.00037499238,0.0006115326,0.0005808201,0.0013208519,0.00031248262],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4257715,0.002277881,0.41936594,0.0025542206,0.03746764,0.00043971417,0.00021908862,0.009796788,0.0032627818,0.00450354,0.016868409,0.077472605],"study_design_scores_gemma":[0.056655634,0.029327396,0.8537125,0.000759774,0.021349858,0.00048797345,0.0004925338,0.020324634,0.0013130014,0.004047142,0.011374237,0.00015530371],"about_ca_topic_score_codex":0.0039856094,"about_ca_topic_score_gemma":0.0075261043,"teacher_disagreement_score":0.0040373434,"about_ca_system_score_codex":0.0008310909,"about_ca_system_score_gemma":0.0013598675,"threshold_uncertainty_score":0.021351814},"labels":[],"label_agreement":null},{"id":"W4399700935","doi":"10.1016/j.jval.2024.03.101","title":"CO12 A Review of Goal Attainment Scaling Implementation As a Personalized Clinical Outcome Assessment over the Last Decade","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Outcome (game theory); Scaling; Medicine; Computer science; Medical physics; Physical therapy; Economics; Mathematics","score_opus":0.7904399536261281,"score_gpt":0.7891882727611013,"score_spread":0.0012516808650268052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007753132,0.99726665,0.00017316289,0.0013527635,0.00019779349,0.000030714436,0.00008747626,0.0000054135367,0.0008085928],"genre_scores_gemma":[0.0012983802,0.9965216,0.0005997077,0.001084454,0.00012771254,0.000061002174,0.00006545813,0.0000052825535,0.00023643636],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9940363,0.0026804483,0.0010267573,0.0005443223,0.0015062202,0.00020588344],"domain_scores_gemma":[0.968393,0.025022017,0.0022775133,0.0004699424,0.0034825373,0.00035490538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012921543,0.0012208296,0.0030140823,0.0051630093,0.0005795145,0.0033168509,0.0019003394,0.0022656983,0.009093192],"category_scores_gemma":[0.03566207,0.0005983867,0.002615037,0.0068624136,0.0010101526,0.0020670483,0.0019066473,0.003147077,0.0014937033],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014917647,0.00007360535,0.0002997477,0.10756039,0.0008521446,0.000029812085,0.00009212953,0.00022848815,0.00008314165,0.004537054,0.021082673,0.8650116],"study_design_scores_gemma":[0.00016071813,0.00024362786,0.003462358,0.31538466,0.003673614,0.00028800074,0.00018921445,0.00019658255,0.00033525968,0.003385134,0.67261505,0.00006577202],"about_ca_topic_score_codex":0.0151333725,"about_ca_topic_score_gemma":0.03215747,"teacher_disagreement_score":0.0151333725,"about_ca_system_score_codex":0.0046111303,"about_ca_system_score_gemma":0.015995918,"threshold_uncertainty_score":0.06833649},"labels":[],"label_agreement":null},{"id":"W4399700957","doi":"10.1016/j.jval.2024.03.093","title":"CO3 Prediction of Long-Term Factor IX Durability Among Hemophilia B Patients Treated with Fidanacogene Elaparvovec Gene Therapy","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Factor IX; Term (time); Medicine; Internal medicine; Gene; Oncology; Gastroenterology; Genetics; Biology; Physics","score_opus":0.0521258914473271,"score_gpt":0.3194084514015421,"score_spread":0.267282559954215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989563,0.00032183595,0.00011450347,0.0000447773,0.000010891005,0.0000034266673,0.00011076371,0.0000036717852,0.00043380406],"genre_scores_gemma":[0.99950945,0.00004601289,0.000040634783,0.000016923337,0.000008598573,0.0000023324567,0.00012089726,0.0000013182844,0.00025378654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972934,0.000056822428,0.000027357255,0.000051536495,0.0000601643,0.00007465058],"domain_scores_gemma":[0.9993948,0.00015073593,0.00023695803,0.000036588888,0.00006941094,0.00011149158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004063592,0.0002315506,0.0003096224,0.0004830829,0.00030518914,0.0008657921,0.00020882097,0.00049121334,0.0015526074],"category_scores_gemma":[0.0012062036,0.00010679618,0.0005318279,0.0005085614,0.00025876617,0.00030802045,0.00024090892,0.00055150717,0.00031344846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018295513,0.000096983196,0.99036294,0.000009986457,0.00008195547,0.000093740266,0.000048258782,0.0001418391,0.0011056159,0.00005970832,0.0001833484,0.0059859585],"study_design_scores_gemma":[0.000055279994,0.00081050774,0.991905,0.000018352472,0.00020148203,0.0006648632,0.00025797487,0.0032259838,0.0014586084,0.00015525258,0.0012313984,0.000015260026],"about_ca_topic_score_codex":0.0019825592,"about_ca_topic_score_gemma":0.0015395903,"teacher_disagreement_score":0.0019825592,"about_ca_system_score_codex":0.00046944973,"about_ca_system_score_gemma":0.00028142112,"threshold_uncertainty_score":0.0051940084},"labels":[],"label_agreement":null},{"id":"W4399701034","doi":"10.1016/j.jval.2024.03.106","title":"CO17 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Immuno-Oncology (IO) for First-Line (1L) Esophageal Squamous Cell Carcinoma (ESCC) in Adult Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Oncology; Internal medicine; Esophageal squamous cell carcinoma; Randomized controlled trial; Basal cell; Carcinoma; Systematic review; MEDLINE; Biology","score_opus":0.03664657047182473,"score_gpt":0.3673744158189047,"score_spread":0.33072784534707994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399701034","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011804111,0.9511258,0.0020865372,0.0018401952,0.00092836877,0.014854885,0.013919743,0.00017062626,0.0032697674],"genre_scores_gemma":[0.18135999,0.7631597,0.013062455,0.007090057,0.0006229573,0.027032848,0.005415326,0.00014687408,0.002109755],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95333344,0.019879332,0.019059038,0.0031001733,0.003701482,0.00092659617],"domain_scores_gemma":[0.9331146,0.04094673,0.017983077,0.0021567936,0.004968896,0.00082985434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023842467,0.0022144218,0.012391952,0.011452034,0.0012678909,0.0038857406,0.0019989754,0.0029119747,0.015725799],"category_scores_gemma":[0.103281036,0.0016113826,0.018794848,0.008957347,0.0015379566,0.0027226964,0.0029894502,0.0021388095,0.0011986792],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002341401,0.000026031421,0.0012161564,0.91123885,0.07217949,0.00007782227,0.00016149618,0.00007869285,0.00028720457,0.00017152696,0.0013786174,0.010842714],"study_design_scores_gemma":[0.009626979,0.0007043332,0.0052434453,0.4874742,0.47956383,0.00024327931,0.00019632114,0.00011002258,0.0003617882,0.00043527223,0.015969502,0.00007112024],"about_ca_topic_score_codex":0.010419528,"about_ca_topic_score_gemma":0.028993199,"teacher_disagreement_score":0.023842467,"about_ca_system_score_codex":0.0060089245,"about_ca_system_score_gemma":0.014098945,"threshold_uncertainty_score":0.12609255},"labels":[],"label_agreement":null},{"id":"W4399701061","doi":"10.1016/j.jval.2024.03.034","title":"P8 Projections of Costs and Prevalence of Opioid Drug Prescriptions in the U.S. from 2025 - 2050","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dillon Consulting","funders":"","keywords":"Medical prescription; Drug; Opioid; Medicine; Prescription drug; Psychiatry; Pharmacology; Internal medicine","score_opus":0.03280515905273208,"score_gpt":0.3281673315761785,"score_spread":0.29536217252344643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399701061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.475267,0.008790295,0.0092428485,0.032558136,0.0017809494,0.000113923976,0.39671347,0.000770917,0.0747625],"genre_scores_gemma":[0.93058294,0.0028190494,0.0037074953,0.0014732076,0.00018929146,0.00012099665,0.05322414,0.000035296085,0.007847601],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996418,0.0000841309,0.000025289846,0.000037748665,0.00011735947,0.00009368892],"domain_scores_gemma":[0.9991543,0.00012543774,0.00015390616,0.000013579252,0.00044526203,0.000107543885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040916726,0.00050099613,0.00019450745,0.0012513794,0.000302217,0.0010735635,0.00048497066,0.0008243784,0.006875662],"category_scores_gemma":[0.0018184062,0.00024233079,0.0010140081,0.001768021,0.00017177664,0.0009279851,0.0005834767,0.0011369474,0.0010801979],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010214471,0.00026787372,0.3195811,0.0011362028,0.0005983683,0.0008544066,0.00030204043,0.1348543,0.0010513827,0.03754096,0.42248714,0.080304824],"study_design_scores_gemma":[0.00025152735,0.0006084342,0.53714293,0.0017785718,0.0004757674,0.0017050831,0.0034111761,0.20078753,0.0015132969,0.026059318,0.22606699,0.00019931713],"about_ca_topic_score_codex":0.15469828,"about_ca_topic_score_gemma":0.15545198,"teacher_disagreement_score":0.15469828,"about_ca_system_score_codex":0.0029059958,"about_ca_system_score_gemma":0.0026390122,"threshold_uncertainty_score":0.30759567},"labels":[],"label_agreement":null},{"id":"W4399701066","doi":"10.1016/j.jval.2024.03.052","title":"P26 Analyzing Drug Shortages and Pricing: Lessons from Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Economic shortage; Drug pricing; Business; Drug; Actuarial science; Medicine; Pharmacology","score_opus":0.09840679164151186,"score_gpt":0.32820577453091004,"score_spread":0.22979898288939818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399701066","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24925268,0.02890105,0.012114093,0.41625902,0.0011612815,0.00026300573,0.01961316,0.00033598003,0.2720998],"genre_scores_gemma":[0.92370576,0.012455626,0.003948931,0.0119588785,0.00078845385,0.000052996467,0.0029391465,0.00015146435,0.04399885],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9984616,0.00024939465,0.00005046535,0.0001298951,0.0004982395,0.0006103662],"domain_scores_gemma":[0.9847015,0.007360331,0.0006810385,0.0003400633,0.0056696194,0.0012474488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002691969,0.00043506204,0.0009203873,0.0020306122,0.0031180454,0.0052320966,0.0014356027,0.0021302223,0.015170337],"category_scores_gemma":[0.022402538,0.0002781402,0.0009194898,0.006001709,0.0026836197,0.0021449265,0.001231905,0.0034718502,0.00045702935],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002864738,0.00026724586,0.09982918,0.00046893363,0.00028520037,0.0005857476,0.0015198106,0.055028852,0.00019005174,0.38448432,0.34222007,0.11483409],"study_design_scores_gemma":[0.00028521635,0.0001439668,0.18056527,0.0012634805,0.0003916903,0.00019111356,0.012304534,0.11587682,0.00069997535,0.41238415,0.2756806,0.0002131483],"about_ca_topic_score_codex":0.99334127,"about_ca_topic_score_gemma":0.9926473,"teacher_disagreement_score":0.062306736,"about_ca_system_score_codex":0.062306736,"about_ca_system_score_gemma":0.11861838,"threshold_uncertainty_score":0.4520691},"labels":[],"label_agreement":null},{"id":"W4399706167","doi":"10.1016/j.jval.2024.03.2436","title":"PT22 Consistency Between Comparative Efficacy Estimates from Target Trial Emulations and Their Origin Target Trials: A Meta-Epidemiological Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cascades (Canada); University of Toronto; McMaster University","funders":"","keywords":"Consistency (knowledge bases); Epidemiology; Meta-analysis; Medicine; Computer science; Artificial intelligence; Internal medicine","score_opus":0.8587779294536831,"score_gpt":0.5553820052404167,"score_spread":0.30339592421326644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706167","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19711217,0.48143962,0.27005613,0.008663202,0.006207007,0.0051598367,0.016329465,0.0017756716,0.01325684],"genre_scores_gemma":[0.9605279,0.009975905,0.017671471,0.0027702628,0.0011600798,0.0023504067,0.0031809856,0.00055061525,0.001812521],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.59184194,0.33182365,0.03965371,0.023093605,0.01165155,0.0019355805],"domain_scores_gemma":[0.20108715,0.6966075,0.03998591,0.053102806,0.008077019,0.001139559],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2922475,0.0035498568,0.010885947,0.0052148565,0.0010254034,0.009133868,0.0067835487,0.006981043,0.014735965],"category_scores_gemma":[0.60529476,0.0037349872,0.038313344,0.008908444,0.0048186076,0.0078084157,0.003970312,0.008774421,0.001911259],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026530823,0.00011522886,0.046106618,0.021821963,0.8685399,0.00042307007,0.0004741879,0.0025217934,0.00034169783,0.003156449,0.0033508064,0.026617495],"study_design_scores_gemma":[0.02008975,0.002709709,0.047043454,0.0069673103,0.887504,0.0014174333,0.00028995582,0.008535485,0.0011042325,0.016932061,0.0071320958,0.0002744838],"about_ca_topic_score_codex":0.0014231218,"about_ca_topic_score_gemma":0.0007975648,"teacher_disagreement_score":0.9964501,"about_ca_system_score_codex":0.0016619603,"about_ca_system_score_gemma":0.0013922964,"threshold_uncertainty_score":0.87278485},"labels":[{"model":"gemma","categories":["metaresearch","metaepi_broad","metaepi_narrow"],"domain":"methods","study_design":"meta_analysis","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4399706189","doi":"10.1016/j.jval.2024.03.2360","title":"HPR129 Real-World Policy Effects of Implementing Multi-Gene Panel Sequencing for Advanced Cancers in British Columbia, Canada: An Interrupted Time Series Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Interrupted time series; Series (stratigraphy); Interrupted Time Series Analysis; Time series; Computational biology; Oncology; Medicine; Computer science; Biology; Statistics; Machine learning; Mathematics; Nursing","score_opus":0.23996804968621555,"score_gpt":0.41967433279083527,"score_spread":0.17970628310461972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585207,0.0011884877,0.0006635563,0.0051708086,0.00009418862,0.00006351695,0.031902578,0.00008240818,0.0023138202],"genre_scores_gemma":[0.98526776,0.000768846,0.00035233586,0.00044107635,0.000031297182,0.00004349914,0.008643815,0.000023187376,0.004428238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980161,0.00039359223,0.0001259879,0.0002956609,0.00033476547,0.0008338254],"domain_scores_gemma":[0.99055195,0.0037182588,0.0016828326,0.0004707212,0.002129229,0.0014469445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028894288,0.0003901586,0.0009777937,0.00091213343,0.00087532675,0.0020867924,0.0018245217,0.0018966899,0.0045414553],"category_scores_gemma":[0.012977666,0.00045062712,0.0013597627,0.002770502,0.0010461061,0.0005817239,0.000754029,0.002932989,0.00036593294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004166828,0.00056391937,0.8423449,0.00029511386,0.0025163183,0.0004813445,0.0007340047,0.08937971,0.0006751459,0.0048147975,0.03183049,0.022197332],"study_design_scores_gemma":[0.000316754,0.0002251748,0.92011094,0.00011824577,0.0012515499,0.000059753533,0.0017886783,0.06937461,0.0003924258,0.0009944903,0.005251924,0.00011544032],"about_ca_topic_score_codex":0.99408853,"about_ca_topic_score_gemma":0.99075764,"teacher_disagreement_score":0.025062982,"about_ca_system_score_codex":0.025062982,"about_ca_system_score_gemma":0.03976958,"threshold_uncertainty_score":0.18184549},"labels":[],"label_agreement":null},{"id":"W4399706319","doi":"10.1016/j.jval.2024.03.2419","title":"MSR104 Use of Stochastic Search Variable Selection for Dimension Reduction in Large NMAs","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Neural Networks and Applications","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reduction (mathematics); Selection (genetic algorithm); Dimensionality reduction; Dimension (graph theory); Variable (mathematics); Feature selection; Mathematics; Computer science; Mathematical optimization; Artificial intelligence; Combinatorics","score_opus":0.07256519078660467,"score_gpt":0.3319942968801131,"score_spread":0.25942910609350844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706319","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03590559,0.00046486032,0.9566233,0.00044322564,0.00012868855,0.000121337674,0.00029216916,0.0018110867,0.004209726],"genre_scores_gemma":[0.4139576,0.00021440936,0.57959014,0.00030638304,0.00015906588,0.00035383788,0.000930421,0.0004081302,0.0040800725],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99860877,0.0008409043,0.0000741363,0.00014184293,0.00026341467,0.000070937465],"domain_scores_gemma":[0.9967495,0.0021870038,0.00014465018,0.00031975438,0.0005330116,0.00006606463],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0025135274,0.000628716,0.0010186917,0.0010002018,0.00053719344,0.00095931033,0.0010333385,0.0009778515,0.004959543],"category_scores_gemma":[0.008359521,0.00047019648,0.001161858,0.00078145135,0.00042578654,0.0008707888,0.0010492632,0.0012176329,0.0009215666],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038969592,0.00023135114,0.0022539818,0.00019906339,0.00029709731,0.00013128533,0.00007399259,0.67761904,0.0058322027,0.031552933,0.0076429187,0.2737764],"study_design_scores_gemma":[0.000018891229,0.000029643676,0.00017046838,0.0000065481954,0.0000088169145,0.000011941907,0.0000040986706,0.9957255,0.00070721086,0.0027064919,0.0006058918,0.0000045349802],"about_ca_topic_score_codex":0.0028794268,"about_ca_topic_score_gemma":0.0057634125,"teacher_disagreement_score":0.9974865,"about_ca_system_score_codex":0.0004612406,"about_ca_system_score_gemma":0.0012814746,"threshold_uncertainty_score":0.01659137},"labels":[],"label_agreement":null},{"id":"W4399706325","doi":"10.1016/j.jval.2024.03.2422","title":"MT48 Assessment of a Patient-Centric Web Application Tool for Potential Adverse Events of Oral Corticosteroids","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Adverse effect; Web application; Medicine; Intensive care medicine; Computer science; World Wide Web; Pharmacology","score_opus":0.025073692238496686,"score_gpt":0.34496624451340396,"score_spread":0.31989255227490726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9077624,0.002637716,0.03114721,0.0024442298,0.0002632957,0.0020115296,0.012010687,0.018603079,0.023119818],"genre_scores_gemma":[0.95870936,0.0005324288,0.028860768,0.0010043381,0.00014907648,0.00094770937,0.003919126,0.0005308667,0.0053463355],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9970886,0.0011689373,0.0004027887,0.00023021945,0.0009833873,0.00012604114],"domain_scores_gemma":[0.98354393,0.011190803,0.0020087908,0.0005787638,0.0020809323,0.00059674494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036324023,0.0005602879,0.000493079,0.001649538,0.00021447221,0.0017106843,0.0004825564,0.0009812013,0.008495319],"category_scores_gemma":[0.01750365,0.00017832349,0.000607803,0.0004705411,0.00011049396,0.00063114386,0.00091685384,0.0005012495,0.0029734757],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015264197,0.0022714112,0.18207037,0.0022231108,0.00063542335,0.0012788612,0.0012780906,0.0024285864,0.018565293,0.0009498461,0.036718335,0.7363165],"study_design_scores_gemma":[0.002777152,0.011869351,0.6567369,0.0032529684,0.0021265775,0.009078526,0.001468065,0.10071691,0.06340998,0.0042659473,0.14383398,0.00046368482],"about_ca_topic_score_codex":0.000557453,"about_ca_topic_score_gemma":0.00074936857,"teacher_disagreement_score":0.008495319,"about_ca_system_score_codex":0.0002898266,"about_ca_system_score_gemma":0.0005636179,"threshold_uncertainty_score":0.028419733},"labels":[],"label_agreement":null},{"id":"W4399706335","doi":"10.1016/j.jval.2024.03.2443","title":"PT30 Real-World Cost-Effectiveness of Publicly Reimbursed Multi-Gene Panel Sequencing to Inform Therapeutic Decisions for Advanced Non-Small Cell Lung Cancer in British Columbia, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Medicine; Business; Family medicine; Oncology","score_opus":0.04949426996328008,"score_gpt":0.32646239065105276,"score_spread":0.27696812068777266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9090264,0.0031957605,0.001117234,0.010920893,0.00021810399,0.0004435831,0.05934788,0.00025578632,0.015474335],"genre_scores_gemma":[0.9853033,0.0008019198,0.0011059435,0.00069711346,0.000035165885,0.00007767542,0.008620308,0.000030223757,0.003328425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728,0.0008353841,0.00014893703,0.00034792506,0.0007283536,0.00065929216],"domain_scores_gemma":[0.98817027,0.004297816,0.0010237357,0.00039557045,0.0039653266,0.0021472187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033300775,0.0006545469,0.00075212296,0.0007376721,0.00091423857,0.0021436848,0.0012759392,0.0010538012,0.0045298487],"category_scores_gemma":[0.018860644,0.00041988018,0.000960293,0.002214091,0.0007808294,0.00052491046,0.000783085,0.0014449622,0.0005419328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015031059,0.0011921498,0.6327667,0.0008851949,0.0017545375,0.0005441569,0.00053165335,0.09921571,0.000913639,0.0032483486,0.115223385,0.12869352],"study_design_scores_gemma":[0.0023776796,0.0011266723,0.805061,0.0005350443,0.0010874583,0.0002814401,0.0016519531,0.16728485,0.00089360314,0.0011668127,0.018318104,0.00021551778],"about_ca_topic_score_codex":0.9894996,"about_ca_topic_score_gemma":0.98911804,"teacher_disagreement_score":0.06349709,"about_ca_system_score_codex":0.06349709,"about_ca_system_score_gemma":0.055575427,"threshold_uncertainty_score":0.46070576},"labels":[],"label_agreement":null},{"id":"W4399706339","doi":"10.1016/j.jval.2024.03.2258","title":"EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Perspective (graphical); Pneumococcal conjugate vaccine; Current (fluid); Medicine; Conjugate vaccine; Conjugate; Intensive care medicine; Immunology; Streptococcus pneumoniae; Computer science; Biology; Engineering; Microbiology; Mathematics; Immunization; Artificial intelligence","score_opus":0.12293757276709803,"score_gpt":0.469257618067366,"score_spread":0.34632004530026794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74254,0.010044169,0.0025273624,0.009722534,0.0008304865,0.0008527567,0.20595936,0.00011391666,0.027409371],"genre_scores_gemma":[0.93510616,0.0026931218,0.0017577277,0.002495738,0.00028015816,0.0004435285,0.051775925,0.000037251895,0.005410456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632615,0.0018977153,0.0002727574,0.00021258945,0.0006910697,0.0005998526],"domain_scores_gemma":[0.99648845,0.0016622922,0.000726413,0.00011643774,0.00070716714,0.0002993266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034119696,0.00055845175,0.00087070593,0.0019855052,0.00022656524,0.0013545583,0.0006206867,0.0009817708,0.005476303],"category_scores_gemma":[0.011209793,0.00043487275,0.003609355,0.0039959108,0.00014283144,0.0008979509,0.0008021459,0.0012576495,0.0004556667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029587261,0.0020169786,0.6447233,0.0031255013,0.019834964,0.0009028094,0.00027482345,0.08468898,0.0012147343,0.008836866,0.111034915,0.09375883],"study_design_scores_gemma":[0.0037805652,0.002263747,0.90123355,0.001291456,0.0077417404,0.00038015383,0.0010818988,0.032458235,0.0010628785,0.0020163439,0.046567142,0.00012230664],"about_ca_topic_score_codex":0.115314886,"about_ca_topic_score_gemma":0.1037172,"teacher_disagreement_score":0.115314886,"about_ca_system_score_codex":0.003971491,"about_ca_system_score_gemma":0.003883589,"threshold_uncertainty_score":0.22928739},"labels":[],"label_agreement":null},{"id":"W4399706401","doi":"10.1016/j.jval.2024.03.2444","title":"PT31 Self-Rated Health: Predictors of Poor Health Status and Associations With 5-Year Mortality Among UK Adults","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Demography; Environmental health; Gerontology; Sociology","score_opus":0.03545223807488488,"score_gpt":0.35038063519618917,"score_spread":0.31492839712130427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99512535,0.0006034234,0.000036328187,0.00033070677,0.00003093769,0.00000982024,0.0029677688,0.0000034363377,0.00089214486],"genre_scores_gemma":[0.99745005,0.00020137265,0.00003810517,0.000053018688,0.00001936457,0.000013282004,0.0014434732,0.0000022218735,0.00077903183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991279,0.00022157254,0.00018103998,0.00011518033,0.0001480295,0.0002062317],"domain_scores_gemma":[0.99652326,0.0004349057,0.0016789407,0.00016249953,0.0004443242,0.0007561638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000741378,0.00033618527,0.00043646857,0.0010275509,0.0005174579,0.0014245469,0.00051500695,0.0011762886,0.0071847313],"category_scores_gemma":[0.006587515,0.00038351162,0.0011438428,0.0019784896,0.00042862442,0.0008478921,0.0017502076,0.0013372361,0.000887352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012870543,0.0000323975,0.99791914,0.000027336042,0.000057052697,0.000054040986,0.00015843242,0.00002716745,0.00003873917,0.000021678916,0.0003528465,0.0011824926],"study_design_scores_gemma":[0.0000050315875,0.00003592426,0.99953926,0.00001613782,0.000009841303,0.000039747392,0.00018685301,0.00004437763,0.000007785201,0.000013085316,0.00009895451,0.0000031089392],"about_ca_topic_score_codex":0.050040506,"about_ca_topic_score_gemma":0.038210556,"teacher_disagreement_score":0.050040506,"about_ca_system_score_codex":0.0006358754,"about_ca_system_score_gemma":0.0006495016,"threshold_uncertainty_score":0.09949851},"labels":[],"label_agreement":null},{"id":"W4399706490","doi":"10.1016/j.jval.2024.03.2084","title":"PCR206 Comparison of the Measurement Properties of EQ-5D-Y-3L and CHU-9D Among Chinese High School Students with Myopia","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Optometry; Medicine; Statistics; Psychology; Mathematics","score_opus":0.14558643335813928,"score_gpt":0.3244456473636058,"score_spread":0.17885921400546653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753666,0.00018079612,0.0003085393,0.000085707936,0.000027558563,0.000036189827,0.00061935553,0.0000040880195,0.001201105],"genre_scores_gemma":[0.9986609,0.000038672108,0.00023165389,0.000063902946,0.000009365812,0.000045126508,0.00046401485,0.000003384969,0.00048289014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822766,0.0004475008,0.00024846956,0.000360747,0.00041458404,0.0003010459],"domain_scores_gemma":[0.99778014,0.0007793956,0.00052661484,0.0001502916,0.0006151868,0.00014839623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016385791,0.000442001,0.00045370072,0.00093159464,0.0007098185,0.0010872714,0.00048203507,0.0006083127,0.0025375397],"category_scores_gemma":[0.0051368107,0.00029301838,0.001197157,0.0013814567,0.00046268626,0.00044429206,0.00050395174,0.00092090614,0.0005408981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020092058,0.000080032725,0.996073,0.000020027826,0.00012825566,0.000033214383,0.00023936671,0.000047794558,0.0003957346,0.000065294524,0.000118388474,0.0025979031],"study_design_scores_gemma":[0.000018212506,0.00016806404,0.99799323,0.0000104735545,0.00010497809,0.00007984957,0.00045174162,0.0004823754,0.000256584,0.000057631314,0.00036709613,0.000009757642],"about_ca_topic_score_codex":0.013222449,"about_ca_topic_score_gemma":0.010992421,"teacher_disagreement_score":0.013222449,"about_ca_system_score_codex":0.00079790456,"about_ca_system_score_gemma":0.0007823037,"threshold_uncertainty_score":0.026291013},"labels":[],"label_agreement":null},{"id":"W4399706494","doi":"10.1016/j.jval.2024.03.2004","title":"PCR125 Measuring and Valuing Health for Children: A Series of Reviews to Inform Health Technology Assessment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; McMaster University","funders":"","keywords":"Series (stratigraphy); Health technology; Psychology; Data science; Environmental health; Medicine; Computer science; Health care; Economics; Economic growth","score_opus":0.4954744113412234,"score_gpt":0.4765249184628291,"score_spread":0.018949492878394314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026050338,0.99448276,0.0004671898,0.0029946333,0.0003800252,0.00006511584,0.00027956383,0.000010045422,0.0010601736],"genre_scores_gemma":[0.0032398202,0.991059,0.002459055,0.002077179,0.00043817316,0.00013094583,0.00024175039,0.000010560713,0.00034359493],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98787993,0.0053462186,0.0024062598,0.0006208391,0.003458619,0.00028807906],"domain_scores_gemma":[0.8700165,0.101282425,0.013381963,0.0017272064,0.012824509,0.0007673343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020259107,0.001182958,0.0028707176,0.014166891,0.00032614617,0.00400992,0.0009591455,0.0024943242,0.0036900665],"category_scores_gemma":[0.09676275,0.00086759735,0.0042889575,0.013065975,0.0010947781,0.0031332658,0.0014347355,0.0034554838,0.00075692136],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019642792,0.00012517205,0.0020612825,0.10069483,0.0030575895,0.00006054945,0.00021588657,0.000783514,0.00040859813,0.006558369,0.048784345,0.83705336],"study_design_scores_gemma":[0.00020581111,0.00042638063,0.014753868,0.43214226,0.011421539,0.0005142242,0.00027251063,0.00072692137,0.0013009947,0.0061214375,0.53198034,0.00013379939],"about_ca_topic_score_codex":0.0137784695,"about_ca_topic_score_gemma":0.024094202,"teacher_disagreement_score":0.020259107,"about_ca_system_score_codex":0.0055525494,"about_ca_system_score_gemma":0.011296241,"threshold_uncertainty_score":0.10714173},"labels":[],"label_agreement":null},{"id":"W4399706516","doi":"10.1016/j.jval.2024.03.2110","title":"PCR232 Do QALYs Discriminate Against the Elderly?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Elder Abuse and Neglect","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.06756255542973048,"score_gpt":0.3596736629620583,"score_spread":0.29211110753232783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88579077,0.010926383,0.001378115,0.054571535,0.0004730544,0.000059605834,0.008583343,0.000024503886,0.03819271],"genre_scores_gemma":[0.9967424,0.0005632158,0.00011671315,0.0013552831,0.00012675014,0.000009998129,0.00043616406,0.0000032662658,0.00064609904],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9978265,0.0012998052,0.00010906742,0.0001362177,0.00022649264,0.00040187215],"domain_scores_gemma":[0.99034894,0.0044694915,0.0027275584,0.0004321571,0.001050544,0.0009714105],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0038853881,0.00030191834,0.00062602677,0.0010712174,0.00042410826,0.0014353093,0.0004540553,0.0010261642,0.009154788],"category_scores_gemma":[0.03204598,0.00015501976,0.0007738773,0.0016128777,0.0008394751,0.001644722,0.0006576226,0.0010638528,0.0013093506],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012089249,0.00018694076,0.91191465,0.00016653197,0.00060066744,0.0001099662,0.0004224152,0.0008023807,0.000111182584,0.0060884347,0.009598039,0.06878992],"study_design_scores_gemma":[0.00020135743,0.00056479516,0.9573272,0.00050397625,0.00047831808,0.00035910873,0.0020354572,0.003721651,0.00033528495,0.023422511,0.011004711,0.000045643756],"about_ca_topic_score_codex":0.011442398,"about_ca_topic_score_gemma":0.011161647,"teacher_disagreement_score":0.9961146,"about_ca_system_score_codex":0.001015433,"about_ca_system_score_gemma":0.00110245,"threshold_uncertainty_score":0.03062582},"labels":[],"label_agreement":null},{"id":"W4399706518","doi":"10.1016/j.jval.2024.03.2070","title":"PCR191 Patient-Centric Assessment of Treatment Experience in Breast Cancer: Development and Validation of a Patient Questionnaire","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Alberta Health Services; Canadian Breast Cancer Network; Princess Margaret Cancer Centre; Mount Sinai Hospital; University Health Network; McGill University","funders":"","keywords":"Medicine; Breast cancer; Cancer; Medical physics; Internal medicine","score_opus":0.03421528658475379,"score_gpt":0.34250571319385803,"score_spread":0.3082904266091042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97957385,0.0001577126,0.004492437,0.00045654134,0.000045582998,0.0016930093,0.0028512764,0.00007036675,0.010659235],"genre_scores_gemma":[0.9827855,0.00013148514,0.008882478,0.00023519629,0.000031016654,0.0024311382,0.0024143257,0.000033154884,0.0030557376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99583733,0.001974536,0.000606144,0.00019274766,0.0010685407,0.00032070075],"domain_scores_gemma":[0.9856522,0.007416629,0.0033350016,0.00057001034,0.0023559919,0.0006702363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006056155,0.00024884669,0.0003908676,0.0015614376,0.00040240563,0.0006550371,0.0005502942,0.00044492504,0.004535313],"category_scores_gemma":[0.014709099,0.0001892251,0.0007328825,0.00080803473,0.00029983665,0.0006788536,0.0011075421,0.00071504567,0.0008988262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057786924,0.0011895945,0.8968231,0.00019454854,0.0002483925,0.000105037776,0.0021109788,0.00090931664,0.0023363086,0.0006819784,0.0037097216,0.09111307],"study_design_scores_gemma":[0.00009425048,0.001385654,0.9859138,0.000051427076,0.000054297358,0.00018786412,0.0011401345,0.0017122827,0.0015609212,0.00020876569,0.007662119,0.00002845476],"about_ca_topic_score_codex":0.0012196951,"about_ca_topic_score_gemma":0.0015898683,"teacher_disagreement_score":0.006056155,"about_ca_system_score_codex":0.0007998964,"about_ca_system_score_gemma":0.0009896839,"threshold_uncertainty_score":0.032028437},"labels":[],"label_agreement":null},{"id":"W4399706544","doi":"10.1016/j.jval.2024.03.1979","title":"PCR100 Health-Related Quality of Life of Adolescents with Asymptomatic Convergence Insufficiency in China","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Asymptomatic; China; Convergence (economics); Medicine; Quality of life (healthcare); Convergence insufficiency; Environmental health; Economics; Internal medicine; Political science; Economic growth; Nursing","score_opus":0.03292574262077953,"score_gpt":0.29546372575087493,"score_spread":0.2625379831300954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993051,0.00009931086,0.000018911165,0.000062719635,0.000004402925,0.0000044992976,0.00016342831,0.000001122575,0.0003404995],"genre_scores_gemma":[0.999546,0.000047766243,0.000015968819,0.000020976848,0.000002967584,0.0000048739507,0.0001847022,6.6228625e-7,0.00017607372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957746,0.0000629193,0.000066561945,0.0000781119,0.000068704845,0.00014617208],"domain_scores_gemma":[0.99931467,0.00005194481,0.00021421238,0.000020497651,0.0001086085,0.00029009618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044673483,0.00032233447,0.00040251188,0.0014171522,0.0009069675,0.0009302886,0.0003813886,0.00043971423,0.001574634],"category_scores_gemma":[0.0010216798,0.0002827036,0.00069917756,0.001694846,0.00044349505,0.00045127407,0.0007256994,0.0007401123,0.000151585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021422604,0.00004536359,0.99872905,0.0000076082133,0.000023483966,0.00008528124,0.00018434983,0.000016035212,0.00005297465,0.000024265848,0.00006143181,0.0007487346],"study_design_scores_gemma":[0.000003621311,0.000038781014,0.99905986,0.000005798163,0.000018338642,0.00006881113,0.00058789126,0.00009034398,0.000011621917,0.000018197039,0.0000938774,0.0000029632001],"about_ca_topic_score_codex":0.054710865,"about_ca_topic_score_gemma":0.052044757,"teacher_disagreement_score":0.054710865,"about_ca_system_score_codex":0.00101256,"about_ca_system_score_gemma":0.0013420109,"threshold_uncertainty_score":0.108784854},"labels":[],"label_agreement":null},{"id":"W4399706553","doi":"10.1016/j.jval.2024.03.2238","title":"EE473 Health Care Resource Use in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Hôpital Maisonneuve-Rosemont; ABB (Canada)","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Lymphoma; Health care; Intensive care medicine; Oncology; Internal medicine; Political science; Materials science","score_opus":0.014958049802229171,"score_gpt":0.24436470290524887,"score_spread":0.2294066531030197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94899297,0.005900117,0.00012321491,0.010223882,0.000101720245,0.000111299385,0.014783664,0.000033237888,0.019730048],"genre_scores_gemma":[0.9922845,0.0021532737,0.00020259865,0.0010616968,0.000037096284,0.000027637772,0.0020992458,0.000012855908,0.0021211975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992015,0.000096649565,0.0000582018,0.000050342853,0.00019985903,0.00039345288],"domain_scores_gemma":[0.99752206,0.00020036478,0.00044443161,0.00002109772,0.00065718853,0.0011548421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029023195,0.0001554434,0.00033557098,0.0010028406,0.0016277335,0.0014677723,0.0009640597,0.00044674185,0.003986931],"category_scores_gemma":[0.0024582187,0.00017161327,0.00046993035,0.003285574,0.0004138716,0.00028425522,0.00065366074,0.00077907793,0.00020947725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002538187,0.00014331118,0.95288104,0.00021484992,0.00012408533,0.0004745565,0.0006208212,0.000880712,0.00020745791,0.00086163805,0.016577998,0.026759757],"study_design_scores_gemma":[0.000051494884,0.000043134132,0.98924667,0.000205413,0.00006268305,0.0002046112,0.0022844933,0.0012929841,0.00007501399,0.00011252903,0.006400397,0.000020624715],"about_ca_topic_score_codex":0.9951231,"about_ca_topic_score_gemma":0.9971105,"teacher_disagreement_score":0.05373511,"about_ca_system_score_codex":0.05373511,"about_ca_system_score_gemma":0.06422103,"threshold_uncertainty_score":0.38987732},"labels":[],"label_agreement":null},{"id":"W4399706571","doi":"10.1016/j.jval.2024.03.2224","title":"CO202 Relationship between Loss of Ambulation (LoA) and Timing of Pulmonary Outcomes Among Boys with Duchenne Muscular Dystrophy (DMD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Ozone Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Physical medicine and rehabilitation; Muscular dystrophy; Physical therapy; Pediatrics; Internal medicine","score_opus":0.12103626897268888,"score_gpt":0.36434238956924797,"score_spread":0.2433061205965591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980952,0.00038913853,0.000078562465,0.0001019965,0.000016977318,0.000003208209,0.00049613527,0.0000075763287,0.00081119564],"genre_scores_gemma":[0.9991425,0.00006386088,0.000042880052,0.000015602243,0.000012253795,0.000003816798,0.0002484671,0.000002375425,0.00046824504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99941254,0.00013696545,0.000056244993,0.00013045389,0.00007894054,0.00018478378],"domain_scores_gemma":[0.9977307,0.0004155783,0.001118009,0.00008167738,0.00018586557,0.00046815834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004741975,0.00027822054,0.00024226426,0.00076320645,0.00048102252,0.000667166,0.0005019081,0.00064469833,0.0039054744],"category_scores_gemma":[0.0020493348,0.00026022564,0.00055718474,0.0007432881,0.00027589157,0.00042922318,0.00070656114,0.0010963765,0.00045034348],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054399563,0.000022021602,0.99911004,0.0000031879413,0.000024268531,0.00004092494,0.00002403005,0.00002398584,0.000096419135,0.00001205234,0.000050697316,0.00053788256],"study_design_scores_gemma":[0.0000010807727,0.000055572375,0.9995449,0.0000032189873,0.000009818167,0.000083449806,0.000121491255,0.00007232261,0.000027556958,0.000009543031,0.00006919234,0.0000016905315],"about_ca_topic_score_codex":0.015679589,"about_ca_topic_score_gemma":0.017044367,"teacher_disagreement_score":0.015679589,"about_ca_system_score_codex":0.0005311316,"about_ca_system_score_gemma":0.00046379396,"threshold_uncertainty_score":0.031176686},"labels":[],"label_agreement":null},{"id":"W4399706654","doi":"10.1016/j.jval.2024.03.2059","title":"PCR180 Measuring and Valuing Child Health in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Toronto; McMaster University","funders":"","keywords":"Data science; Geography; Psychology; Computer science","score_opus":0.08862372594407637,"score_gpt":0.3659786101130777,"score_spread":0.27735488416900134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363347,0.0012804164,0.0007038574,0.0055640824,0.00005821123,0.00016474059,0.007101898,0.000050350245,0.048741553],"genre_scores_gemma":[0.9857028,0.00084421155,0.0013528612,0.00043190047,0.00001173285,0.0000492025,0.001142375,0.000015947624,0.010448879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981641,0.00028467033,0.000060199945,0.000094803225,0.00089943584,0.0004968045],"domain_scores_gemma":[0.9938459,0.0007231592,0.00047225904,0.00007558905,0.0033774807,0.0015055999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013239041,0.0001516894,0.00023493459,0.0016329647,0.0028436168,0.0018086348,0.0009349831,0.00038999048,0.0034702488],"category_scores_gemma":[0.006508548,0.00023222693,0.00030854743,0.0035644376,0.00061091885,0.00038489443,0.0007555431,0.0011785721,0.00026083496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011577106,0.0002488944,0.90464056,0.00010735363,0.000044114808,0.00015542073,0.0036596484,0.00076153554,0.0002294338,0.003403666,0.01805975,0.068573855],"study_design_scores_gemma":[0.000015960148,0.00005796339,0.9734493,0.00009845772,0.000022101553,0.000052939038,0.0074130334,0.0015947977,0.00033652733,0.0002560327,0.016680988,0.00002187967],"about_ca_topic_score_codex":0.99744046,"about_ca_topic_score_gemma":0.9988306,"teacher_disagreement_score":0.05942604,"about_ca_system_score_codex":0.05942604,"about_ca_system_score_gemma":0.08903492,"threshold_uncertainty_score":0.43116814},"labels":[],"label_agreement":null},{"id":"W4399706670","doi":"10.1016/j.jval.2024.03.1994","title":"PCR115 Health States Utilities for Allergic Rhinitis - an AI-Supported Systematic Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Systematic review; Medicine; MEDLINE; Political science","score_opus":0.07972725377632305,"score_gpt":0.36008560843981646,"score_spread":0.2803583546634934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706670","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0478387,0.87113786,0.006664044,0.0019881306,0.0009147664,0.0046200478,0.06216779,0.00046870616,0.0041999267],"genre_scores_gemma":[0.7871677,0.17325799,0.013238009,0.0029705525,0.00048332562,0.008743692,0.012499215,0.00017476654,0.0014647279],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.967949,0.020172613,0.006156827,0.0024283275,0.002495398,0.00079791644],"domain_scores_gemma":[0.9269145,0.058303017,0.008985702,0.002062786,0.003080313,0.0006535728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020035679,0.0014942182,0.0081328405,0.008934952,0.0005574987,0.003038423,0.0015537611,0.0015361258,0.010118862],"category_scores_gemma":[0.108222775,0.0011726962,0.027869133,0.010894705,0.0006896083,0.0019456975,0.0029771847,0.0022552544,0.0006949003],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005051216,0.00005396363,0.023179157,0.3923214,0.5455801,0.0001555347,0.00022064846,0.0009349738,0.00019105006,0.0009885704,0.005728821,0.025594566],"study_design_scores_gemma":[0.007813748,0.0005135176,0.02910549,0.053737637,0.8956774,0.00026536646,0.00024202964,0.0012080928,0.0001568391,0.0014948882,0.009679252,0.000105788684],"about_ca_topic_score_codex":0.014182257,"about_ca_topic_score_gemma":0.0251502,"teacher_disagreement_score":0.020035679,"about_ca_system_score_codex":0.0022407316,"about_ca_system_score_gemma":0.004714593,"threshold_uncertainty_score":0.10596007},"labels":[],"label_agreement":null},{"id":"W4399706706","doi":"10.1016/j.jval.2024.03.1961","title":"PCR82 Fostering Peer-Reviewed Publication of Patient Engagement Activities: Multistakeholder Perspectives on Priorities, Motivators and Challenges","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Glycemic Index Laboratories","funders":"","keywords":"Peer review; Medical education; Public relations; Psychology; Medicine; Political science","score_opus":0.19058289955122956,"score_gpt":0.29730132940354476,"score_spread":0.1067184298523152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706706","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13137148,0.005846263,0.048013873,0.5082973,0.010672912,0.0024180238,0.0005393797,0.0014106024,0.29143012],"genre_scores_gemma":[0.871109,0.0026919262,0.029834256,0.024431692,0.003344377,0.0010592471,0.00032881417,0.0005276223,0.06667314],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8222271,0.12157285,0.006335985,0.0049099945,0.033039633,0.011914362],"domain_scores_gemma":[0.47512084,0.27067378,0.04622077,0.025829164,0.10997535,0.07218003],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.15164436,0.00045565932,0.0005691075,0.0023190824,0.004586552,0.020193521,0.0033952245,0.005764112,0.030889895],"category_scores_gemma":[0.29781663,0.0007797925,0.00060976885,0.0023514838,0.0035757038,0.007577026,0.012541482,0.006272776,0.006919539],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055692834,0.0016714823,0.040738292,0.0019490278,0.00015948155,0.0014444175,0.02158871,0.0007724461,0.0088657085,0.06475036,0.18753709,0.669966],"study_design_scores_gemma":[0.00034710777,0.0017600978,0.05540164,0.0019015883,0.00013925294,0.0014194855,0.035488896,0.00482011,0.014402875,0.046268664,0.8377354,0.00031490225],"about_ca_topic_score_codex":0.0024900306,"about_ca_topic_score_gemma":0.0053835157,"teacher_disagreement_score":0.84835565,"about_ca_system_score_codex":0.004180719,"about_ca_system_score_gemma":0.036125854,"threshold_uncertainty_score":0.8019816},"labels":[],"label_agreement":null},{"id":"W4399706707","doi":"10.1016/j.jval.2024.03.1968","title":"PCR89 Impact of Dosing and Administration on HRQoL Among People With Hemophilia: A Time Trade-Off Study Including 2.250 Respondents in the UK, Canada and the US","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dosing; Administration (probate law); Medicine; Political science; Pharmacology","score_opus":0.041635450020204454,"score_gpt":0.358100841241163,"score_spread":0.3164653912209585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99885464,0.00014443159,0.000028454808,0.000042605025,0.0000037978225,0.000012413014,0.00040572064,0.000001190808,0.0005068283],"genre_scores_gemma":[0.9991167,0.00006218582,0.000029489782,0.00004522834,0.0000032042572,0.0000067930782,0.00028387984,0.000001970493,0.0004505753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983063,0.0005698055,0.0001304572,0.00014175061,0.000384956,0.00046672078],"domain_scores_gemma":[0.99738115,0.0006422724,0.0009095432,0.00014259598,0.00041635806,0.00050796015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018026419,0.00023794724,0.00044118986,0.0006724012,0.0005793424,0.001166179,0.00033345007,0.0006648619,0.0020399613],"category_scores_gemma":[0.004228962,0.00030574918,0.0014955729,0.0014912497,0.00048502497,0.000593827,0.00072328467,0.0008362106,0.00039071334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079061335,0.00021348237,0.99453294,0.000018239534,0.00013087866,0.000036519363,0.00043459772,0.0000727547,0.0001162221,0.000026903175,0.00015064,0.0034760754],"study_design_scores_gemma":[0.000011116785,0.000275417,0.9986577,0.0000056528397,0.00004185392,0.000031326126,0.00067947997,0.00009329556,0.00003387892,0.0000072201487,0.00015660781,0.0000063875773],"about_ca_topic_score_codex":0.13096808,"about_ca_topic_score_gemma":0.12952201,"teacher_disagreement_score":0.8690319,"about_ca_system_score_codex":0.0016268612,"about_ca_system_score_gemma":0.0009742225,"threshold_uncertainty_score":0.26041156},"labels":[],"label_agreement":null},{"id":"W4399706723","doi":"10.1016/j.jval.2024.03.1957","title":"PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Attention deficit hyperactivity disorder; Attention deficit; Psychology; Psychiatry; Attention deficit disorder; Medicine; Clinical psychology","score_opus":0.03744461332359615,"score_gpt":0.31665999968529795,"score_spread":0.2792153863617018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99747294,0.00005052324,0.000110631816,0.00022264576,0.000010105418,0.00027084607,0.00024100255,0.0000029836285,0.0016183666],"genre_scores_gemma":[0.9961971,0.0000863799,0.0006730145,0.00029059534,0.0000062463205,0.00023746399,0.00018008456,0.0000027523956,0.0023262752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983388,0.00066787767,0.00007172039,0.00014439473,0.00031528604,0.00046185695],"domain_scores_gemma":[0.99545383,0.002071969,0.00040369062,0.00013290872,0.0006352432,0.0013023635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020185537,0.00034252997,0.00064973877,0.00026968194,0.0025512595,0.001264561,0.00074128865,0.0010394744,0.0059051854],"category_scores_gemma":[0.007009542,0.00034509934,0.00054813037,0.00065070525,0.0011881465,0.00044172912,0.00041707855,0.0014193767,0.0004901278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14316466,0.10614072,0.58287704,0.000427885,0.0006411093,0.0007498995,0.018541323,0.011140812,0.007498745,0.0057044476,0.016404664,0.106708676],"study_design_scores_gemma":[0.029221635,0.052910898,0.83821946,0.00021727243,0.00060912874,0.0002707147,0.021127315,0.039452776,0.0028571272,0.0027534459,0.0118836155,0.00047654266],"about_ca_topic_score_codex":0.8948597,"about_ca_topic_score_gemma":0.93790424,"teacher_disagreement_score":0.10514033,"about_ca_system_score_codex":0.015094915,"about_ca_system_score_gemma":0.024070915,"threshold_uncertainty_score":0.211519},"labels":[],"label_agreement":null},{"id":"W4399706730","doi":"10.1016/j.jval.2024.03.1930","title":"PCR50 Estimating Meaningful Change Thresholds (MCTs) for EORTC Scales in a Phase 3 Trial in Participants With Inoperable or Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Oncology; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Internal medicine; Medicine; Breast cancer; Hormone receptor; Hormone; Epidermal growth factor receptor; Cancer","score_opus":0.1675889357521036,"score_gpt":0.417013020828297,"score_spread":0.2494240850761934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899142,0.0014953407,0.0016544448,0.00065722974,0.00027495302,0.002712067,0.00075877196,0.00013737462,0.0023956788],"genre_scores_gemma":[0.99228364,0.00026772215,0.003036377,0.00047562152,0.00009052006,0.0026997754,0.00039812896,0.000023533805,0.0007246061],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963528,0.002649472,0.00015703449,0.00034520007,0.00028531245,0.00021020613],"domain_scores_gemma":[0.99643207,0.002091553,0.0007229034,0.00025137526,0.00017211284,0.00033000516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006708863,0.000913522,0.0013634546,0.0002545762,0.0003043497,0.00083976396,0.0007995756,0.0011484196,0.0055192867],"category_scores_gemma":[0.00941098,0.00051485526,0.0019614906,0.00030638676,0.00086555287,0.0010815493,0.00072426995,0.002877226,0.00052406406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9230545,0.009768328,0.00699882,0.00039774936,0.0013924347,0.000022361062,0.00021936561,0.0013929254,0.0027488123,0.00046816387,0.0018198516,0.051716637],"study_design_scores_gemma":[0.62993014,0.2973216,0.05982205,0.00015546432,0.0018570032,0.000051522748,0.00018915652,0.004882125,0.0019779752,0.0014007499,0.002329998,0.00008219903],"about_ca_topic_score_codex":0.000802095,"about_ca_topic_score_gemma":0.0014523517,"teacher_disagreement_score":0.006708863,"about_ca_system_score_codex":0.0006458351,"about_ca_system_score_gemma":0.0010705659,"threshold_uncertainty_score":0.03548026},"labels":[],"label_agreement":null},{"id":"W4399706750","doi":"10.1016/j.jval.2024.03.1932","title":"PCR52 Early Real-World Experience With Abrilada Within the Canadian Patient Population","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Geography; Medicine","score_opus":0.04722766304208774,"score_gpt":0.34167395004473894,"score_spread":0.2944462870026512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475285,0.0022154232,0.0006667816,0.012926708,0.00013369301,0.00019913666,0.0030076224,0.00008401219,0.03323818],"genre_scores_gemma":[0.9884814,0.0020880306,0.00086066156,0.0024295333,0.000049344348,0.000044348228,0.000964797,0.000050504594,0.005031343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764293,0.00037214378,0.00006924646,0.0001521109,0.0009267487,0.0008368226],"domain_scores_gemma":[0.9949352,0.0006976805,0.00041133407,0.00011115678,0.002257312,0.0015873739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019174872,0.00023667925,0.00033587424,0.0006132515,0.0043411492,0.002078534,0.00083230034,0.0005585268,0.0054244986],"category_scores_gemma":[0.007313824,0.00018145943,0.00035204773,0.0018412303,0.0012008277,0.0005022414,0.0011419888,0.0012430174,0.0004885517],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085048995,0.00051290344,0.7975208,0.00026165685,0.00007112113,0.0026855737,0.028112963,0.00044767046,0.0012625501,0.0020045794,0.048530463,0.11773914],"study_design_scores_gemma":[0.000081733764,0.00051159266,0.81675804,0.00039817466,0.00011049532,0.0017951024,0.06876327,0.00094270817,0.0010601213,0.00046530517,0.108987525,0.00012598927],"about_ca_topic_score_codex":0.94863373,"about_ca_topic_score_gemma":0.96916795,"teacher_disagreement_score":0.05136627,"about_ca_system_score_codex":0.029800296,"about_ca_system_score_gemma":0.036419485,"threshold_uncertainty_score":0.21621728},"labels":[],"label_agreement":null},{"id":"W4399706808","doi":"10.1016/j.jval.2024.03.1852","title":"SA5 A Scoping Review of Barriers and Facilitators to Implementation of Intravenous Cardiovascular Treatments in Ambulatory Settings","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ambulatory; Medicine; Intensive care medicine; Internal medicine","score_opus":0.05306144353238059,"score_gpt":0.4387485216392059,"score_spread":0.38568707810682534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006177491,0.99704343,0.0001683195,0.00065892836,0.00017433258,0.00034739068,0.00037276666,0.000009078766,0.00060800894],"genre_scores_gemma":[0.00431159,0.99346244,0.00085787504,0.00067747984,0.000042460666,0.00032368288,0.00016862174,0.0000054442767,0.00015046407],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9909217,0.0029433907,0.0035059091,0.000541055,0.0016810503,0.00040687065],"domain_scores_gemma":[0.968922,0.022385145,0.0048752404,0.00034188715,0.0031075077,0.00036824573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015975785,0.0014895485,0.0047491468,0.009815433,0.0010157427,0.00449384,0.001965998,0.0027308187,0.008190489],"category_scores_gemma":[0.055820473,0.0012283097,0.008369868,0.0118721025,0.0009385809,0.002968638,0.0028766983,0.0023449878,0.0005576387],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014630028,0.000041639032,0.0007847498,0.8663379,0.0045727086,0.00007564335,0.0004921761,0.000100939156,0.0001335296,0.0006254928,0.0043330193,0.122355856],"study_design_scores_gemma":[0.00006523551,0.000057978687,0.0017976803,0.9594325,0.013676656,0.00008659486,0.00029674088,0.00003132527,0.000059935053,0.0001935565,0.024283798,0.00001802885],"about_ca_topic_score_codex":0.028869137,"about_ca_topic_score_gemma":0.08261556,"teacher_disagreement_score":0.028869137,"about_ca_system_score_codex":0.005178069,"about_ca_system_score_gemma":0.027925475,"threshold_uncertainty_score":0.08448905},"labels":[],"label_agreement":null},{"id":"W4399706812","doi":"10.1016/j.jval.2024.03.1725","title":"RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Haemophilia; Socioeconomic status; Haemophilia A; Medicine; Environmental health; Pediatrics; Population","score_opus":0.102848967000319,"score_gpt":0.40409903953532295,"score_spread":0.30125007253500397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94300514,0.0015990963,0.000403089,0.00027045398,0.0000285348,0.00005835817,0.051211238,0.000020604302,0.003403444],"genre_scores_gemma":[0.93837154,0.0013959542,0.0009311333,0.00016013357,0.000043101216,0.00013952388,0.056821737,0.000018888519,0.002118027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989465,0.00046695615,0.00015734286,0.000084923675,0.00019072216,0.00015353732],"domain_scores_gemma":[0.999042,0.00016024099,0.00042124733,0.00007602484,0.00016216512,0.00013830827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016832046,0.00055649533,0.0004025773,0.0025883117,0.00028221429,0.00095019833,0.00035430273,0.0006163506,0.0020352392],"category_scores_gemma":[0.0022386452,0.00024776216,0.0012680889,0.00423379,0.0002007278,0.0006422364,0.0011283599,0.00033965296,0.000537689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030617823,0.00009650685,0.9856086,0.000099729776,0.0004964368,0.00012086699,0.00018273901,0.0006263181,0.000113601316,0.0002751724,0.004203983,0.007870064],"study_design_scores_gemma":[0.000016247872,0.00007301951,0.99724126,0.000021728334,0.00005421869,0.00011579358,0.00020007545,0.00013852214,0.00006446223,0.000025332207,0.0020429387,0.000006367189],"about_ca_topic_score_codex":0.023613831,"about_ca_topic_score_gemma":0.01593099,"teacher_disagreement_score":0.023613831,"about_ca_system_score_codex":0.00064989267,"about_ca_system_score_gemma":0.00058414415,"threshold_uncertainty_score":0.046952784},"labels":[],"label_agreement":null},{"id":"W4399706835","doi":"10.1016/j.jval.2024.03.1760","title":"RWD106 Psychological Burden in People Living with Myasthenia Gravis: Prevalence and Associated Risk Factors of Depression and Anxiety from the MGFA Global MG Patient Registry (MGFAPR) in the US (2017-2022)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Anxiety; Depression (economics); Myasthenia gravis; Medicine; Psychiatry; Environmental health","score_opus":0.018887714599980003,"score_gpt":0.2914144274550714,"score_spread":0.2725267128550914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602543,0.00087416836,0.00009998308,0.0005160221,0.000073446965,0.0000752283,0.035772745,0.000019044654,0.0023149343],"genre_scores_gemma":[0.9735361,0.0008317415,0.00024548534,0.000323032,0.000089915506,0.0001364389,0.023256242,0.000010420064,0.0015705347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995982,0.00008376921,0.00008541261,0.00004863843,0.00010544768,0.000078477984],"domain_scores_gemma":[0.99888164,0.00008911067,0.0005893668,0.00005663527,0.0001493959,0.00023374676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041516832,0.00021275727,0.0002887746,0.0012996453,0.00036604409,0.000721026,0.00038961446,0.00040795695,0.0020568047],"category_scores_gemma":[0.0021118734,0.00022021694,0.0007446316,0.00254038,0.00015525158,0.0005086688,0.0009025946,0.00071153475,0.00052032876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006277991,0.000029519942,0.9961843,0.00003490298,0.000081944025,0.000035418085,0.000067292145,0.000023410617,0.000045029326,0.000019390636,0.0016099684,0.0018060089],"study_design_scores_gemma":[0.0000056355066,0.0000131236175,0.99936074,0.000013513064,0.000018376155,0.000051338426,0.00010441176,0.00002142902,0.0000086553655,0.000007763119,0.00039281725,0.0000022666895],"about_ca_topic_score_codex":0.025612589,"about_ca_topic_score_gemma":0.03225557,"teacher_disagreement_score":0.025612589,"about_ca_system_score_codex":0.00041583477,"about_ca_system_score_gemma":0.0005331801,"threshold_uncertainty_score":0.050927043},"labels":[],"label_agreement":null},{"id":"W4399706871","doi":"10.1016/j.jval.2024.03.1797","title":"RWD143 Update of Our Review of Real-World Evidence in HTA Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Medicine; Intensive care medicine; Internal medicine","score_opus":0.07591041349255336,"score_gpt":0.3951075412605367,"score_spread":0.31919712776798337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706871","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009070904,0.930123,0.00064141146,0.039033033,0.01346133,0.0002434391,0.0040543596,0.000060144826,0.01147621],"genre_scores_gemma":[0.018802814,0.8601157,0.005568427,0.09252292,0.014211127,0.0006943194,0.0042577107,0.00013687,0.0036900702],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.97322726,0.010149706,0.009311389,0.0012538546,0.0051747975,0.0008829889],"domain_scores_gemma":[0.7912078,0.14784981,0.019893462,0.003942842,0.03471343,0.0023926229],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.038588602,0.00094843376,0.0039302856,0.014466639,0.0010226395,0.0069800806,0.0033029013,0.005058784,0.016002357],"category_scores_gemma":[0.18177776,0.0009131634,0.0058335913,0.010836844,0.0015692426,0.0038703692,0.0035369096,0.0043757297,0.002516974],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010805872,0.000070845104,0.0024308886,0.24197693,0.0071814456,0.0004037578,0.00081942015,0.00037750852,0.0005359384,0.005532548,0.39480016,0.3447899],"study_design_scores_gemma":[0.0003788822,0.00012865983,0.005706589,0.28407943,0.00898196,0.0004025245,0.00029800908,0.00007764729,0.00023546428,0.0016604865,0.6979629,0.00008741582],"about_ca_topic_score_codex":0.022257201,"about_ca_topic_score_gemma":0.05443897,"teacher_disagreement_score":0.9777428,"about_ca_system_score_codex":0.008944842,"about_ca_system_score_gemma":0.021809546,"threshold_uncertainty_score":0.20407844},"labels":[],"label_agreement":null},{"id":"W4399706971","doi":"10.1016/j.jval.2024.03.1391","title":"HTA40 Nirmatrelvir/Ritonavir for Non-Hospitalized Adults With Mild/Moderately Severe COVID-19: A Systematic Evidence Review of Randomized Controlled Trials and Real-World Studies With Meta-Analysis and Trial Sequential Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Meta-analysis; Randomized controlled trial; Coronavirus disease 2019 (COVID-19); Medicine; Real world evidence; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Virology; Disease","score_opus":0.20009822854441722,"score_gpt":0.46455313871670395,"score_spread":0.26445491017228673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706971","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0075764474,0.9894447,0.0008556104,0.00023318088,0.00024869057,0.00073279603,0.00050334586,0.0000399348,0.00036521364],"genre_scores_gemma":[0.2643514,0.72421944,0.0063191606,0.0015949975,0.00035378276,0.0017312987,0.0009136238,0.000060958515,0.00045531007],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9870034,0.0063312077,0.0038888752,0.0012183696,0.0012029562,0.00035514397],"domain_scores_gemma":[0.9829972,0.012184542,0.0033170376,0.0005572994,0.0007442758,0.00019962464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017856088,0.0024425024,0.018377034,0.0032356787,0.00061564875,0.0035593943,0.0019926955,0.0021156168,0.0038367948],"category_scores_gemma":[0.03703887,0.0015711191,0.03396304,0.0038765839,0.0010442875,0.0023278177,0.0016461484,0.002494812,0.0002573362],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009036158,0.00005966066,0.0021153437,0.40019438,0.5663068,0.00006810778,0.00009620716,0.0003729115,0.00030664625,0.00020865403,0.0005332127,0.020701908],"study_design_scores_gemma":[0.005510576,0.0006208779,0.0025766045,0.034390822,0.95407295,0.000068997455,0.000060633796,0.00020958426,0.00016159023,0.00034547586,0.0019428341,0.00003906704],"about_ca_topic_score_codex":0.00462538,"about_ca_topic_score_gemma":0.012328092,"teacher_disagreement_score":0.018377034,"about_ca_system_score_codex":0.002489615,"about_ca_system_score_gemma":0.003430447,"threshold_uncertainty_score":0.09443319},"labels":[],"label_agreement":null},{"id":"W4399707126","doi":"10.1016/j.jval.2024.03.1649","title":"PCR42 Health State Utilities in Duchenne Muscular Dystrophy (DMD): A Longitudinal Study Using the EQ5D and Health Utilities Index (HUI)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Duchenne muscular dystrophy; Index (typography); Muscular dystrophy; Medicine; Physical therapy; Physical medicine and rehabilitation; Computer science; Internal medicine; World Wide Web","score_opus":0.16963609280507952,"score_gpt":0.4058800498188812,"score_spread":0.2362439570138017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864703,0.00014949561,0.00011101321,0.000037756945,0.000005277141,0.000009853114,0.0005887632,0.000003575163,0.00044730067],"genre_scores_gemma":[0.99822086,0.000054522156,0.000093457216,0.00003848175,0.0000051106235,0.000025908608,0.0006575872,0.000003568692,0.0009005702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880564,0.0005631869,0.000093102186,0.00017592586,0.00018430085,0.0001777623],"domain_scores_gemma":[0.9975847,0.0004719564,0.00093493145,0.0002489165,0.00044939472,0.00031003106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002788816,0.00043370217,0.00047154797,0.0008437945,0.0007995691,0.0014744911,0.0005003161,0.001139503,0.0016128108],"category_scores_gemma":[0.006133123,0.0004459894,0.001063453,0.0014752524,0.000336138,0.00094585196,0.00089661207,0.001443213,0.00063750375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024384241,0.00016150295,0.9975259,0.000006981549,0.0001181191,0.000055167562,0.00022494064,0.00006841094,0.00012957018,0.000049154445,0.00014586194,0.0012705874],"study_design_scores_gemma":[0.0000069886983,0.00017481015,0.9989274,0.0000052986666,0.00003909692,0.00006864433,0.00019151648,0.00028496629,0.000039379367,0.000030330493,0.00022462448,0.000006977624],"about_ca_topic_score_codex":0.019220807,"about_ca_topic_score_gemma":0.013044442,"teacher_disagreement_score":0.019220807,"about_ca_system_score_codex":0.000905736,"about_ca_system_score_gemma":0.0005163358,"threshold_uncertainty_score":0.038217843},"labels":[],"label_agreement":null},{"id":"W4399707296","doi":"10.1016/j.jval.2024.03.1583","title":"MT45 Analytical Performance, Quality of Life and Costs Related to Allergy Testing: Results from Two Systematic Literature Reviews","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Systematic review; Quality (philosophy); Medicine; MEDLINE; Biology","score_opus":0.09231796247507693,"score_gpt":0.36353378600095454,"score_spread":0.2712158235258776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017326986,0.9782442,0.00024988293,0.00052667304,0.00014314606,0.00033467048,0.0025545014,0.000016055015,0.00060394587],"genre_scores_gemma":[0.30330062,0.68722576,0.0026400478,0.0024813667,0.0003630469,0.0012597323,0.002301518,0.000037363985,0.0003905529],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9731714,0.008142417,0.010956,0.002259508,0.0046675773,0.000803124],"domain_scores_gemma":[0.8712872,0.08895406,0.029424975,0.0022231797,0.007232367,0.0008781705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019082185,0.0015646956,0.00734184,0.010669249,0.0008298098,0.0045833876,0.0015852026,0.0029483626,0.0041732453],"category_scores_gemma":[0.11502086,0.0012921355,0.020311529,0.011779525,0.0015093015,0.0024629217,0.003303003,0.001916946,0.00038874388],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025259627,0.00009418354,0.02600548,0.7526634,0.17517023,0.00020146921,0.0006259708,0.0002585742,0.00040036344,0.00020776228,0.0015632182,0.040283337],"study_design_scores_gemma":[0.001999387,0.00058908755,0.080027744,0.2930047,0.614181,0.0004921473,0.0006569243,0.00018665417,0.00027868446,0.00041806634,0.008034544,0.00013104698],"about_ca_topic_score_codex":0.017157199,"about_ca_topic_score_gemma":0.050700556,"teacher_disagreement_score":0.019082185,"about_ca_system_score_codex":0.004936741,"about_ca_system_score_gemma":0.00959162,"threshold_uncertainty_score":0.10091746},"labels":[],"label_agreement":null},{"id":"W4399707316","doi":"10.1016/j.jval.2024.03.1245","title":"HSD22 Extending External Validity of Rcts and Meta-Analysis through Transportability Analysis and Integration of Mechanistic Research Evidence","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Meta-analysis; External validity; Psychology; Computer science; Medicine; Social psychology; Internal medicine","score_opus":0.9461070641044819,"score_gpt":0.6505937680397718,"score_spread":0.2955132960647101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707316","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036460046,0.03842725,0.86772496,0.015224878,0.0039892113,0.0064308746,0.012189791,0.0034138777,0.016139064],"genre_scores_gemma":[0.5794675,0.007444008,0.38728306,0.0051019206,0.0017188834,0.008140974,0.0047152527,0.0020283454,0.0041000596],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.41254976,0.4988811,0.041816715,0.017450178,0.027555203,0.0017469528],"domain_scores_gemma":[0.17287602,0.70208496,0.01764097,0.08411272,0.022143453,0.0011419086],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3585959,0.0038967489,0.00729871,0.014467841,0.0014818142,0.011734239,0.0034887514,0.0036561533,0.012928514],"category_scores_gemma":[0.78655285,0.0033036547,0.039015517,0.01591839,0.004579797,0.0073694238,0.012110188,0.0059025404,0.001604575],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009343246,0.000370985,0.067575164,0.039509065,0.34541452,0.0008158328,0.0035920856,0.028567722,0.0014005596,0.0650496,0.018286506,0.4200748],"study_design_scores_gemma":[0.011016472,0.0031592834,0.038218517,0.017609151,0.2509187,0.0013908182,0.0011488894,0.09354878,0.008111994,0.4776766,0.096189335,0.0010113892],"about_ca_topic_score_codex":0.0061797975,"about_ca_topic_score_gemma":0.0055357106,"teacher_disagreement_score":0.6414041,"about_ca_system_score_codex":0.003557313,"about_ca_system_score_gemma":0.011620609,"threshold_uncertainty_score":0.79096544},"labels":[],"label_agreement":null},{"id":"W4399707339","doi":"10.1016/j.jval.2024.03.1290","title":"HSD67 A Retrospective Study Assessing Clinical and Economic Impacts of a Multidisciplinary Approach for Reducing Risk of Catheter-Related Thrombosis in a U.S. Health System","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Multidisciplinary approach; Medicine; Thrombosis; Intensive care medicine; Operations management; Risk analysis (engineering); Surgery; Economics; Political science","score_opus":0.13165110625517149,"score_gpt":0.39469706189298204,"score_spread":0.2630459556378105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863094,0.0001782785,0.0000733374,0.00008440174,0.000007180787,0.000024591534,0.0005413717,0.0000018447573,0.00045802456],"genre_scores_gemma":[0.99917847,0.00012955273,0.000053252217,0.00009069502,0.00001597827,0.000015493924,0.0004011975,0.0000010112782,0.0001142951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980788,0.0010313876,0.00024386685,0.00015948125,0.0002392171,0.0002471173],"domain_scores_gemma":[0.99416566,0.0016374995,0.002230823,0.00044367186,0.0006301123,0.0008922667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013168425,0.00022021777,0.0002711854,0.00085937016,0.00047365064,0.0007132313,0.0003199476,0.0004714821,0.0013809634],"category_scores_gemma":[0.0061335643,0.00031652593,0.0006910148,0.0016091052,0.00039185517,0.0004111226,0.0006047042,0.0008105835,0.00016687078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005244483,0.00029317618,0.99595547,0.000025646492,0.00016243,0.00008145201,0.000054950073,0.0002322433,0.00009621559,0.00006153371,0.00032345482,0.0021890495],"study_design_scores_gemma":[0.00008560145,0.0014406266,0.9966053,0.00002523222,0.00013663573,0.0001878501,0.0005022311,0.00050170935,0.00011295557,0.000042122276,0.00035086204,0.000009042552],"about_ca_topic_score_codex":0.019491652,"about_ca_topic_score_gemma":0.019799633,"teacher_disagreement_score":0.019491652,"about_ca_system_score_codex":0.0010412852,"about_ca_system_score_gemma":0.0014755882,"threshold_uncertainty_score":0.03875637},"labels":[],"label_agreement":null},{"id":"W4399707341","doi":"10.1016/j.jval.2024.03.1466","title":"MSR33 Health State Transition Probabilities for Duchenne Muscular Dystrophy: Estimation from Published Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; State (computer science); Estimation; Transition (genetics); Computer science; Medicine; Genetics; Biology; Internal medicine; Algorithm; Engineering","score_opus":0.08834666782223398,"score_gpt":0.3642321675107141,"score_spread":0.2758854996884801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8065545,0.0032502557,0.11559517,0.0016727922,0.000108475695,0.00040346145,0.06442889,0.00087804376,0.0071083377],"genre_scores_gemma":[0.9587511,0.0007084973,0.01801623,0.00013808989,0.000045119796,0.00030388715,0.02016614,0.00005372876,0.0018172134],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99671954,0.0019875607,0.00021711302,0.0005796139,0.00035970204,0.00013647595],"domain_scores_gemma":[0.8591972,0.13015631,0.0037466697,0.0040698657,0.002426069,0.00040390776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011892958,0.0004273511,0.0007978232,0.002814546,0.00033222555,0.001449662,0.0008082888,0.0015105149,0.0086211],"category_scores_gemma":[0.0740063,0.00048782086,0.002426703,0.0032820578,0.00051712926,0.0013267209,0.00059416075,0.0017136469,0.0014154494],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021132845,0.0004077285,0.27733544,0.0014396458,0.0023101969,0.000632393,0.0004809008,0.5635926,0.00085424446,0.016819812,0.016011937,0.1180018],"study_design_scores_gemma":[0.0002937589,0.0005574902,0.17079438,0.000661905,0.0009297499,0.0005615865,0.00026263983,0.777045,0.0014831271,0.03915248,0.008084043,0.00017384432],"about_ca_topic_score_codex":0.013019841,"about_ca_topic_score_gemma":0.00845458,"teacher_disagreement_score":0.013019841,"about_ca_system_score_codex":0.0010185451,"about_ca_system_score_gemma":0.0009560402,"threshold_uncertainty_score":0.06289673},"labels":[],"label_agreement":null},{"id":"W4399707353","doi":"10.1016/j.jval.2024.03.1525","title":"MSR92 Quantitative Bias Analysis Under the Marginal Structural Modelling Framework","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Psychometric Methodologies and Testing","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Marginal structural model; Econometrics; Marginal model; Computer science; Economics; Machine learning; Causal inference; Regression analysis","score_opus":0.7966582806538572,"score_gpt":0.563932937089473,"score_spread":0.23272534356438423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707353","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012434228,0.00013226733,0.98373127,0.00032059214,0.00003800188,0.00019584195,0.00039947528,0.00041490313,0.0023334376],"genre_scores_gemma":[0.4323911,0.00021737929,0.56070596,0.00026142734,0.000119870645,0.0013862754,0.0008167933,0.00050930306,0.0035918094],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9384743,0.050368443,0.0015369266,0.002442332,0.0062190224,0.0009589161],"domain_scores_gemma":[0.8572525,0.1194037,0.0045089833,0.012085634,0.0062850937,0.00046411657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05023751,0.0011065223,0.0014072439,0.0024426943,0.0007767133,0.0023910222,0.0028210806,0.0016722104,0.018494178],"category_scores_gemma":[0.20389917,0.00066513824,0.0042151297,0.002434037,0.0019716974,0.002457238,0.0028969338,0.0023211828,0.0018308868],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006003328,0.00023435263,0.011933585,0.0010742705,0.0013360018,0.0001564424,0.0009092872,0.075243324,0.0033082478,0.5710463,0.0060208207,0.328137],"study_design_scores_gemma":[0.00015938003,0.00054514693,0.008092493,0.00032354044,0.00041546975,0.00026353906,0.00034947015,0.5248128,0.0036056906,0.4516371,0.009690223,0.00010505542],"about_ca_topic_score_codex":0.004193475,"about_ca_topic_score_gemma":0.0024915922,"teacher_disagreement_score":0.05023751,"about_ca_system_score_codex":0.0013233526,"about_ca_system_score_gemma":0.0031111785,"threshold_uncertainty_score":0.2656845},"labels":[],"label_agreement":null},{"id":"W4399707361","doi":"10.1016/j.jval.2024.03.1564","title":"MT26 HTA Requirements for Medical Technologies in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health technology; Business; Risk analysis (engineering); Economics; Economic growth; Health care","score_opus":0.23321602281303846,"score_gpt":0.5049669612891023,"score_spread":0.2717509384760639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707361","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09580429,0.0012193471,0.0094084,0.017255628,0.0008216023,0.002395066,0.02389617,0.0026443745,0.8465551],"genre_scores_gemma":[0.29470065,0.0010401796,0.022324435,0.015397744,0.0003403284,0.0012370765,0.012621538,0.00074940297,0.65158874],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97792596,0.0009842388,0.0010493489,0.0007090654,0.015076386,0.0042549623],"domain_scores_gemma":[0.9447288,0.0077347304,0.0015363186,0.0019307113,0.03935681,0.004712586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006989533,0.00065711205,0.0007581385,0.0047006225,0.010157621,0.008902825,0.004092866,0.009396052,0.03069653],"category_scores_gemma":[0.025364442,0.0015252009,0.0021999248,0.002317124,0.0019469461,0.001317279,0.0019629053,0.004001694,0.009754769],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074361434,0.00083397934,0.027982436,0.00088679406,0.00012813354,0.0031694083,0.0044365716,0.014102744,0.032259937,0.25920025,0.58906233,0.06719387],"study_design_scores_gemma":[0.00016626563,0.00031033464,0.08053761,0.00069121405,0.0001145388,0.0005745351,0.0016128977,0.0059110466,0.008835149,0.005089519,0.8957973,0.0003596218],"about_ca_topic_score_codex":0.96003544,"about_ca_topic_score_gemma":0.9690692,"teacher_disagreement_score":0.9525087,"about_ca_system_score_codex":0.047491338,"about_ca_system_score_gemma":0.14736657,"threshold_uncertainty_score":0.3445754},"labels":[],"label_agreement":null},{"id":"W4399707392","doi":"10.1016/j.jval.2024.03.1416","title":"HTA65 How Does Conditional Regulatory Approval Affect the Reimbursement of Drugs in Canada?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Affect (linguistics); Business; Actuarial science; Medicine; Public economics; Economics; Political science; Psychology; Law; Health care","score_opus":0.05515011141921904,"score_gpt":0.284748897095249,"score_spread":0.22959878567602993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707392","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45176217,0.011460153,0.002449811,0.31827796,0.0012944571,0.00032126266,0.014045702,0.0002779479,0.20011055],"genre_scores_gemma":[0.96478283,0.001600931,0.000516341,0.013600013,0.00035450846,0.000030810024,0.0010176311,0.00004642093,0.01805048],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880215,0.0012953836,0.00034197082,0.0006931606,0.004549343,0.0050986656],"domain_scores_gemma":[0.9495657,0.0143487295,0.0048199557,0.0008749923,0.023371276,0.007019341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077476436,0.00030192267,0.0008015449,0.0018727409,0.0034976585,0.007713933,0.0019427781,0.004986574,0.010300232],"category_scores_gemma":[0.050770566,0.00046977313,0.00142733,0.002334704,0.0024588162,0.0014263387,0.001096071,0.005244712,0.00048663726],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016448048,0.0003856573,0.33623695,0.00049114664,0.0010935331,0.0009199002,0.0015226573,0.0196789,0.0015108276,0.30240372,0.26597852,0.0681333],"study_design_scores_gemma":[0.0006890844,0.0003138788,0.70356363,0.00066632737,0.001183319,0.0002721871,0.002335199,0.028577479,0.0026957605,0.03110703,0.22819288,0.00040323788],"about_ca_topic_score_codex":0.9924448,"about_ca_topic_score_gemma":0.99326754,"teacher_disagreement_score":0.8852942,"about_ca_system_score_codex":0.11470583,"about_ca_system_score_gemma":0.19632259,"threshold_uncertainty_score":0.832253},"labels":[],"label_agreement":null},{"id":"W4399707403","doi":"10.1016/j.jval.2024.03.1422","title":"HTA71 Cost-effectiveness of The Top 100 Drugs By Public Spending in Canada, 2015-2021: A Repeated Cross-sectional Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Cross-sectional study; Public spending; Medicine; Public economics; Environmental health; Economics; Political science; Law","score_opus":0.3557305371060618,"score_gpt":0.4518579696283128,"score_spread":0.09612743252225103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8697376,0.00645247,0.0002220715,0.0017752687,0.00011388281,0.00013987668,0.11784498,0.00008103049,0.0036328337],"genre_scores_gemma":[0.9643956,0.00219388,0.00023412549,0.0005058851,0.00005561641,0.00007380932,0.02916476,0.00002923599,0.0033470741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654144,0.00030863035,0.00033038054,0.00044167115,0.0013248649,0.0010530557],"domain_scores_gemma":[0.98960274,0.0007970338,0.0027787515,0.00043105116,0.0045563523,0.0018340222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020197644,0.0008253884,0.0015161205,0.0027592147,0.0020317072,0.0025642908,0.0025131998,0.0012878898,0.0038980076],"category_scores_gemma":[0.007770217,0.0009059704,0.0040570037,0.009606181,0.00091709587,0.0009603227,0.0013369591,0.0028509789,0.0005487972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059873797,0.0001278555,0.98504424,0.00013840476,0.001318896,0.000039602004,0.00020445109,0.00072737643,0.000052276293,0.0002885288,0.0074221804,0.004037427],"study_design_scores_gemma":[0.000040766747,0.000041564614,0.9971957,0.00005787673,0.00027117028,0.000026671945,0.0002572494,0.0006104874,0.000039135073,0.000031659947,0.0014062489,0.000021468497],"about_ca_topic_score_codex":0.99674785,"about_ca_topic_score_gemma":0.9962488,"teacher_disagreement_score":0.951766,"about_ca_system_score_codex":0.04823398,"about_ca_system_score_gemma":0.05733455,"threshold_uncertainty_score":0.34996367},"labels":[],"label_agreement":null},{"id":"W4399707424","doi":"10.1016/j.jval.2024.03.1545","title":"MT7 Measures of ‘Life-Sustaining Medical-Technology’ for Caregivers of Children with Medical Complexity (CO-CMC)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; Queen's University","funders":"","keywords":"Psychology; Medicine; Computer science","score_opus":0.10915264787600246,"score_gpt":0.3828103692896667,"score_spread":0.2736577214136643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707424","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94185627,0.0015261023,0.0011660039,0.0020215544,0.00014166778,0.0008787357,0.016403962,0.000088368375,0.035917237],"genre_scores_gemma":[0.9813256,0.00067769014,0.004706251,0.0002840006,0.000077550794,0.0017830866,0.008007276,0.000016840582,0.0031216424],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786985,0.0006839375,0.00038808718,0.000088356115,0.00065793894,0.00031182758],"domain_scores_gemma":[0.987253,0.0029225193,0.0057380046,0.00037084508,0.0022331607,0.0014825326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019706478,0.00038663094,0.00040446682,0.0016862699,0.0006382476,0.0013187572,0.00077670807,0.00063675083,0.010337617],"category_scores_gemma":[0.017191084,0.00014416334,0.0014274169,0.0019458754,0.0003915426,0.0009080492,0.0016439102,0.0011825479,0.0008826669],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007632728,0.0009081532,0.85786766,0.0008712918,0.000768696,0.0001535118,0.0020798652,0.00059253233,0.0003714407,0.0019271697,0.017165864,0.11653067],"study_design_scores_gemma":[0.000057834022,0.00056980003,0.98388577,0.00021794009,0.00016974357,0.00014887062,0.0012018303,0.00052781176,0.0006017186,0.0006563739,0.011930601,0.000031651132],"about_ca_topic_score_codex":0.0073052505,"about_ca_topic_score_gemma":0.017687261,"teacher_disagreement_score":0.010337617,"about_ca_system_score_codex":0.0021224145,"about_ca_system_score_gemma":0.001901804,"threshold_uncertainty_score":0.034582794},"labels":[],"label_agreement":null},{"id":"W4399707429","doi":"10.1016/j.jval.2024.03.1502","title":"MSR69 Systematic Review and Meta-Analysis of Fecal Incontinence Prevalence and Population Estimates","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; McGill University; Medtronic (Canada)","funders":"","keywords":"Meta-analysis; Fecal incontinence; Medicine; Systematic review; Population; Demography; Statistics; Environmental health; MEDLINE; Mathematics; Biology; Internal medicine; Surgery; Sociology","score_opus":0.06232413853045688,"score_gpt":0.36367108001422616,"score_spread":0.3013469414837693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707429","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01010331,0.98145723,0.0017931163,0.0003755761,0.00054725615,0.00086508895,0.0038813897,0.00011773924,0.00085940765],"genre_scores_gemma":[0.4519335,0.5272723,0.007836226,0.0024028528,0.0007572042,0.0038824112,0.0039233575,0.00018665419,0.0018054751],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97445923,0.012187984,0.008126803,0.0023898669,0.0022515517,0.00058459514],"domain_scores_gemma":[0.97434753,0.018012432,0.0040577212,0.001544922,0.0017671062,0.00027021542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018654639,0.002738103,0.015669929,0.00808324,0.0008787643,0.0034208717,0.002076976,0.0025703253,0.00808732],"category_scores_gemma":[0.07555031,0.0021238332,0.048304204,0.00812273,0.0008751087,0.0019720616,0.002409086,0.002537297,0.00088625745],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028265463,0.000013703439,0.003466301,0.216491,0.76946986,0.00010482936,0.000063876745,0.00023290749,0.00014410245,0.00009642094,0.00093524193,0.0061552525],"study_design_scores_gemma":[0.0015201595,0.00012465152,0.003977574,0.013309833,0.9788968,0.00009396583,0.00002647207,0.00009693226,0.00006596471,0.00017263916,0.0016893134,0.000025734926],"about_ca_topic_score_codex":0.01220858,"about_ca_topic_score_gemma":0.026751691,"teacher_disagreement_score":0.018654639,"about_ca_system_score_codex":0.0024225924,"about_ca_system_score_gemma":0.0044310866,"threshold_uncertainty_score":0.09865636},"labels":[],"label_agreement":null},{"id":"W4399707497","doi":"10.1016/j.jval.2024.03.1418","title":"HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Timeline; Listing (finance); Negotiation; Agency (philosophy); Actuarial science; Business; Public economics; Economics; Political science; Finance; Geography; Sociology; Law","score_opus":0.5188958453963128,"score_gpt":0.4778721342510462,"score_spread":0.04102371114526665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707497","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.128138,0.009116098,0.0037189263,0.009699775,0.0010089272,0.0021445337,0.7551032,0.00057422044,0.090496324],"genre_scores_gemma":[0.63432705,0.0070593115,0.012327948,0.002920869,0.00071403175,0.0019516168,0.30653596,0.00023561475,0.033927605],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99492365,0.0011153666,0.00050386303,0.00018694601,0.0027303416,0.0005398665],"domain_scores_gemma":[0.9493739,0.01866894,0.007562919,0.001386,0.020058539,0.002949733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008426469,0.0005448265,0.00105953,0.0035139837,0.0006264732,0.0022419058,0.0012194321,0.00066556496,0.017181056],"category_scores_gemma":[0.068432406,0.0004277287,0.0031662663,0.0065995525,0.00048102686,0.00087673037,0.00062419206,0.0017584163,0.0015976569],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040958915,0.00029782054,0.35948855,0.0018755328,0.00361641,0.000059364174,0.00016933848,0.009361562,0.00008796554,0.0058549624,0.50323004,0.11186252],"study_design_scores_gemma":[0.0019873285,0.000688778,0.85499185,0.0018207106,0.0027533378,0.00010260115,0.0004017009,0.015353605,0.00033123972,0.0021833468,0.11925078,0.00013476933],"about_ca_topic_score_codex":0.8013384,"about_ca_topic_score_gemma":0.8366354,"teacher_disagreement_score":0.9889243,"about_ca_system_score_codex":0.01107569,"about_ca_system_score_gemma":0.02659776,"threshold_uncertainty_score":0.39966315},"labels":[],"label_agreement":null},{"id":"W4399707525","doi":"10.1016/j.jval.2024.03.1401","title":"HTA50 A Review of Real-World Evidence in Non-Oncology Submissions Made to Four Health Technology Assessment (HTA) Agencies","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Real world evidence; Health technology; Medicine; Oncology; Medical physics; Internal medicine; Political science; Health care","score_opus":0.7504357945697503,"score_gpt":0.5934445643209937,"score_spread":0.1569912302487566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003775061,0.9767754,0.00052766065,0.0041334466,0.001490809,0.000815603,0.009227567,0.00006945575,0.0065825493],"genre_scores_gemma":[0.0056736586,0.9783456,0.0027585055,0.004844205,0.0006234838,0.0009497676,0.003643101,0.00004919467,0.0031125203],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9912073,0.0030215394,0.0022684706,0.00039009738,0.0027818943,0.0003307627],"domain_scores_gemma":[0.96046335,0.023951927,0.006613473,0.0007451746,0.007658181,0.0005678811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013752375,0.00096557237,0.0033843832,0.010149393,0.0005749848,0.0030828565,0.0015534266,0.0017740543,0.029491607],"category_scores_gemma":[0.053638224,0.0007407629,0.0046529784,0.01251347,0.0006117346,0.0017744901,0.001765157,0.0019586233,0.0038423776],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008119427,0.00005083879,0.0006292507,0.45758784,0.0045917328,0.00013152394,0.00013181586,0.00020006206,0.0005488585,0.0018933297,0.18945786,0.343965],"study_design_scores_gemma":[0.0005616332,0.00021298212,0.006188252,0.4222065,0.014668291,0.00022280694,0.000100422825,0.00010118845,0.0005141612,0.0013186379,0.5538535,0.00005161428],"about_ca_topic_score_codex":0.011835251,"about_ca_topic_score_gemma":0.030090934,"teacher_disagreement_score":0.029491607,"about_ca_system_score_codex":0.0047955173,"about_ca_system_score_gemma":0.017202843,"threshold_uncertainty_score":0.09865922},"labels":[],"label_agreement":null},{"id":"W4399707539","doi":"10.1016/j.jval.2024.03.1238","title":"HSD15 The Economic and Humanistic Burden of Glioma in the United States and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanism; Glioma; Medicine; Political science; Law; Cancer research","score_opus":0.03665541927340735,"score_gpt":0.25438938924989407,"score_spread":0.21773396997648672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8204874,0.012344248,0.0002655424,0.046197496,0.00047409526,0.00007083674,0.07586306,0.00005181469,0.04424553],"genre_scores_gemma":[0.9699019,0.009013283,0.00017027013,0.001002572,0.0001040896,0.000016151684,0.010583658,0.000020269765,0.009187826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987876,0.00009198172,0.00007418763,0.000075920725,0.00047363964,0.0004966698],"domain_scores_gemma":[0.9953849,0.00024748943,0.0005812953,0.00006669638,0.0024268948,0.001292665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000629078,0.00020408712,0.00039120868,0.0024301314,0.0015747728,0.0026561904,0.0007723498,0.0006473415,0.00463865],"category_scores_gemma":[0.004792928,0.00019861646,0.00083524984,0.006979714,0.0008699147,0.0005023085,0.0011730454,0.0012775669,0.00027009804],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025691147,0.000060195052,0.9111366,0.00014037809,0.00031032125,0.00042417526,0.0007697615,0.003817916,0.00013328658,0.011991098,0.04241136,0.02854789],"study_design_scores_gemma":[0.000028407305,0.000023357474,0.96373457,0.00018863371,0.00010862343,0.00020818529,0.0027007665,0.0017649469,0.0001145816,0.0011298341,0.029951062,0.000047113026],"about_ca_topic_score_codex":0.99710566,"about_ca_topic_score_gemma":0.9978861,"teacher_disagreement_score":0.060560446,"about_ca_system_score_codex":0.060560446,"about_ca_system_score_gemma":0.0853058,"threshold_uncertainty_score":0.43939888},"labels":[],"label_agreement":null},{"id":"W4399707546","doi":"10.1016/j.jval.2024.03.1410","title":"HTA59 Reception of RWE: A Deep Dive Into Recent Trends in CADTH Reimbursement Reviews","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Reimbursement; Medicine; Economics; Economic growth","score_opus":0.038839850277751296,"score_gpt":0.3766706451288825,"score_spread":0.3378307948511312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707546","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0044537266,0.13548595,0.0013190017,0.77809054,0.029088395,0.00003520331,0.0006335813,0.00019416222,0.05069946],"genre_scores_gemma":[0.098876484,0.21761224,0.004567691,0.5300998,0.07590323,0.00011580761,0.0016637313,0.00068743987,0.07047358],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99125296,0.002537018,0.00060573436,0.00063789956,0.0036804844,0.0012858985],"domain_scores_gemma":[0.94687456,0.026927114,0.0038285458,0.0015115115,0.01023687,0.010621392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016205547,0.00038065106,0.0007885912,0.0022852938,0.0010847109,0.0073823943,0.001258073,0.0065127923,0.04214395],"category_scores_gemma":[0.058779985,0.00034423452,0.0010082211,0.0023692474,0.0021124934,0.005264267,0.003132204,0.009630759,0.007749976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001172068,0.00006028791,0.0014728974,0.0008803002,0.00004010759,0.00018974965,0.0002324878,0.00011660231,0.00055185106,0.033234756,0.6901927,0.272911],"study_design_scores_gemma":[0.000028930845,0.000055746732,0.004109417,0.0021528448,0.000026684924,0.00028841494,0.00024380867,0.00012995467,0.0001804679,0.0032329834,0.9895214,0.00002947977],"about_ca_topic_score_codex":0.004398361,"about_ca_topic_score_gemma":0.0101481145,"teacher_disagreement_score":0.99560165,"about_ca_system_score_codex":0.005641368,"about_ca_system_score_gemma":0.011733985,"threshold_uncertainty_score":0.14098555},"labels":[],"label_agreement":null},{"id":"W4399707548","doi":"10.1016/j.jval.2024.03.1468","title":"MSR35 Item Performance and Structural Validity of the Quick Motor Function Test Among Late Onset Pompe Disease Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Motor function; Test (biology); Disease; Medicine; Physical medicine and rehabilitation; Pediatrics; Psychology; Internal medicine; Biology","score_opus":0.0333405642869374,"score_gpt":0.2990191846627695,"score_spread":0.2656786203758321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995018,0.000083853294,0.000071800925,0.00001953404,0.0000034974007,0.0000040022173,0.00008290364,0.0000012891078,0.00023134956],"genre_scores_gemma":[0.99971944,0.000015335036,0.000049627983,0.0000055884,0.0000029995654,0.000003543626,0.00012312093,0.0000010033916,0.00007927308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992434,0.00024041683,0.00010358093,0.00016365027,0.00014041242,0.000108513064],"domain_scores_gemma":[0.9983109,0.0006175761,0.000573095,0.0001216272,0.00019850902,0.00017819842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019474725,0.00038574115,0.00040079345,0.0011868865,0.00033674506,0.0006212966,0.00032181523,0.00053661794,0.0016665118],"category_scores_gemma":[0.00549771,0.0001372117,0.0006607846,0.0005757625,0.0004489498,0.00063091656,0.000720982,0.00042453338,0.00031908494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025123637,0.000040564973,0.9961475,0.000007627124,0.00005268943,0.00006872141,0.00022308821,0.00010942395,0.00038237942,0.000052124968,0.000063883235,0.00260076],"study_design_scores_gemma":[0.0000095172445,0.00023617636,0.9986386,0.0000072321322,0.000022557511,0.00021963895,0.00017494019,0.00037428996,0.00010937104,0.000089314584,0.00011310488,0.0000051889942],"about_ca_topic_score_codex":0.0015589152,"about_ca_topic_score_gemma":0.0013838664,"teacher_disagreement_score":0.0019474725,"about_ca_system_score_codex":0.00033165785,"about_ca_system_score_gemma":0.00020889804,"threshold_uncertainty_score":0.010299385},"labels":[],"label_agreement":null},{"id":"W4399707561","doi":"10.1016/j.jval.2024.03.1423","title":"HTA72 Molnupiravir for Treatment of Non-Hospitalized Adults With Laboratory-Confirmed, Mild/Moderately Severe COVID-19: A Systematic Evidence Review With Meta-Analysis and Trial Sequential Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Meta-analysis; Coronavirus disease 2019 (COVID-19); Medicine; Pooled analysis; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Internal medicine; Virology; Disease","score_opus":0.175861346611818,"score_gpt":0.44529553063205407,"score_spread":0.2694341840202361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707561","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020257063,0.9761186,0.0009395448,0.00032170143,0.0004141935,0.0007188518,0.00063017925,0.000053016007,0.00054682017],"genre_scores_gemma":[0.45265198,0.53800875,0.0039302194,0.0018462241,0.00039164672,0.0014148554,0.00092766894,0.00004153453,0.0007870704],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99663144,0.0016026826,0.00089733006,0.00039476855,0.0003019723,0.00017169835],"domain_scores_gemma":[0.9960549,0.0026326282,0.0008226469,0.00015614259,0.00022762659,0.00010612274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059218104,0.0018112151,0.012348371,0.0017335585,0.00040702877,0.0021232865,0.0012929406,0.0015384554,0.0037201797],"category_scores_gemma":[0.014112559,0.0010318933,0.024374656,0.0023278412,0.0006221561,0.0015657485,0.0009201795,0.0022575154,0.00024369362],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02935845,0.0001250806,0.0032232217,0.2642103,0.67143553,0.00011075811,0.000103496975,0.0006704536,0.00044624688,0.00019255346,0.0008461315,0.029277736],"study_design_scores_gemma":[0.016617745,0.001412261,0.003661691,0.014734284,0.9608717,0.0000701884,0.00006468001,0.00036457216,0.00014589814,0.0003519686,0.0016604454,0.00004457295],"about_ca_topic_score_codex":0.0052905856,"about_ca_topic_score_gemma":0.014289072,"teacher_disagreement_score":0.012348371,"about_ca_system_score_codex":0.0017228804,"about_ca_system_score_gemma":0.0019439205,"threshold_uncertainty_score":0.03131789},"labels":[],"label_agreement":null},{"id":"W4400381667","doi":"10.1016/j.jval.2024.06.005","title":"Traditional Methods Hold Their Ground Against Machine Learning in Predicting Potentially Inappropriate Medication Use in Older Adults","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Université du Québec à Rimouski; Université Laval; Institut Universitaire en Santé Mentale de Québec; Centre de Santé et de Services Sociaux de la Vieille-Capitale; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation; Institut National de Santé Publique du Québec","keywords":"Machine learning; Medicine; Logistic regression; Pharmacoepidemiology; Artificial intelligence; Psychological intervention; Random forest; Psychiatry; Computer science; Medical prescription","score_opus":0.21793360919109364,"score_gpt":0.4235287174755394,"score_spread":0.20559510828444574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400381667","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30012122,0.067497924,0.59047884,0.021900132,0.0019056553,0.00080922164,0.0037530717,0.0015312509,0.012002683],"genre_scores_gemma":[0.83363277,0.009653772,0.1493733,0.0034207809,0.0011391588,0.00025083564,0.00089879794,0.000112246125,0.0015184156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9841164,0.010817822,0.0010904247,0.0013319937,0.002441049,0.00020228101],"domain_scores_gemma":[0.92555463,0.06228533,0.0041944883,0.0027939824,0.0046664686,0.0005050258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031130638,0.001716658,0.0012618707,0.0024716635,0.0005920034,0.0025343662,0.0012807833,0.0016669973,0.0009298898],"category_scores_gemma":[0.073700726,0.0003471042,0.0014937026,0.0021873168,0.0012704809,0.002130201,0.0011808437,0.0027025666,0.0006061248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008548131,0.00038432213,0.44628972,0.0017495581,0.0043906397,0.00017708744,0.000811202,0.08669943,0.0007154901,0.0065820036,0.00924923,0.44209644],"study_design_scores_gemma":[0.00028782975,0.0017333401,0.21420278,0.0037877036,0.0011883366,0.00057149463,0.0010793447,0.6800124,0.0021191654,0.07099729,0.023730122,0.00029019266],"about_ca_topic_score_codex":0.016345425,"about_ca_topic_score_gemma":0.014162269,"teacher_disagreement_score":0.031130638,"about_ca_system_score_codex":0.0011033324,"about_ca_system_score_gemma":0.0019781515,"threshold_uncertainty_score":0.16463655},"labels":[],"label_agreement":null},{"id":"W4401475055","doi":"10.1016/j.jval.2024.07.018","title":"Cost-Effectiveness Analysis of Bevacizumab Biosimilars Versus Originator Bevacizumab for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Kementerian Kesihatan Malaysia; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Ministry of Long-Term Care; Johns Hopkins University; Ministry of Health, Ontario","keywords":"Bevacizumab; Biosimilar; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.37779171903743725,"score_gpt":0.5155538795367467,"score_spread":0.13776216049930945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401475055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821821,0.011497307,0.0016503783,0.00031814925,0.00006888752,0.00048740962,0.0028053797,0.000019097457,0.0009712933],"genre_scores_gemma":[0.9958748,0.0013858144,0.0008732191,0.00006747492,0.000036512563,0.00016653062,0.0014986378,0.0000065699082,0.00009029839],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9854321,0.010745738,0.0009965008,0.00091846177,0.0015647733,0.0003424882],"domain_scores_gemma":[0.958401,0.02877192,0.008355336,0.0019782567,0.0017046615,0.0007888723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016206505,0.0011312847,0.0017175024,0.0027728148,0.00023638697,0.0017344161,0.0013688653,0.0013552919,0.0029997975],"category_scores_gemma":[0.050031222,0.00056825514,0.0063757477,0.0026208838,0.0008599607,0.0017376587,0.00094297976,0.0012072081,0.00019527416],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44380972,0.008199998,0.21111685,0.010320123,0.099291086,0.00062817923,0.0004940157,0.119611025,0.00210325,0.003423541,0.002090084,0.09891213],"study_design_scores_gemma":[0.0951125,0.13077566,0.4710748,0.0028517898,0.07196545,0.0022875615,0.0009280913,0.20808448,0.003934164,0.0049229744,0.007375447,0.0006870369],"about_ca_topic_score_codex":0.0074656126,"about_ca_topic_score_gemma":0.005308057,"teacher_disagreement_score":0.016206505,"about_ca_system_score_codex":0.0071132607,"about_ca_system_score_gemma":0.0017237024,"threshold_uncertainty_score":0.085709214},"labels":[],"label_agreement":null},{"id":"W4402911985","doi":"10.1016/j.jval.2024.08.006","title":"Cancer Drug Wastage and Mitigation Methods: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Sunnybrook Health Science Centre; University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Drug; Cancer drugs; Medicine; Risk analysis (engineering); Computer science; Pharmacology","score_opus":0.19274743006600628,"score_gpt":0.5552582697846506,"score_spread":0.3625108397186444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402911985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007658438,0.99852306,0.000077557655,0.00008447283,0.000056119796,0.00015534589,0.00019880869,0.000004476174,0.0001343817],"genre_scores_gemma":[0.010607445,0.988225,0.00045793556,0.0003329997,0.000032306725,0.00015376678,0.00008284921,0.000003824155,0.00010399619],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955141,0.0014640142,0.0015675775,0.00045776457,0.00081553037,0.00018105957],"domain_scores_gemma":[0.9862852,0.009748108,0.002709471,0.00017171598,0.0009004389,0.00018514444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058386265,0.0014017319,0.00737998,0.005978717,0.0005228898,0.0027953323,0.0015284445,0.0020442244,0.006361686],"category_scores_gemma":[0.023570381,0.0010545051,0.009052457,0.0074073737,0.00088247855,0.00230692,0.0016080606,0.0016979479,0.00031677377],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034933715,0.00002536212,0.00064817746,0.95104575,0.015693825,0.000055531214,0.00011948572,0.00008516853,0.00010539239,0.00012241166,0.0009512479,0.030798411],"study_design_scores_gemma":[0.0008468486,0.000321655,0.005081654,0.7619117,0.21164726,0.00030983568,0.00039279644,0.000111398294,0.00022758063,0.00034848653,0.018739877,0.000060996706],"about_ca_topic_score_codex":0.015129456,"about_ca_topic_score_gemma":0.048181936,"teacher_disagreement_score":0.015129456,"about_ca_system_score_codex":0.003327402,"about_ca_system_score_gemma":0.00796343,"threshold_uncertainty_score":0.030878007},"labels":[],"label_agreement":null},{"id":"W4403312365","doi":"10.1016/j.jval.2024.08.010","title":"Practicality, Validity, and Responsiveness of Using the Proxy Version of the Child Health Utility–9 Dimensions With Children Aged 2 to 5 Years","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; St. George's, University of London; King's College London; Health Technology Assessment Programme; Imperial College London; University of Southampton; University of Bristol; Department of Health and Social Care; University of East Anglia; National Institute for Health and Care Research","keywords":"Proxy (statistics); Psychology; Statistics; Mathematics","score_opus":0.054092718845381284,"score_gpt":0.36197360373863696,"score_spread":0.30788088489325566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403312365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954443,0.001129025,0.00060860295,0.00021102068,0.00004997013,0.00024292688,0.0009319935,0.000008454603,0.0013737167],"genre_scores_gemma":[0.99765885,0.0002964253,0.00075986807,0.00008291897,0.000025197856,0.00030786986,0.0007268005,0.0000045379657,0.00013765233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9643681,0.024046304,0.0030703614,0.0025072303,0.0049047815,0.001103187],"domain_scores_gemma":[0.95561934,0.018038347,0.019728104,0.0029516001,0.0027922865,0.000870387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03223487,0.0004415174,0.0008940349,0.0010338785,0.00042356568,0.0013183885,0.00065713713,0.0008620569,0.001196958],"category_scores_gemma":[0.070472926,0.00036502915,0.002012675,0.001457265,0.0009659225,0.00094819115,0.0018301064,0.0011514764,0.00019602035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052024,0.0000763443,0.99174106,0.00008483456,0.00025792458,0.00002976531,0.0004018493,0.00019718515,0.000046774112,0.000051406205,0.00021455358,0.0063780327],"study_design_scores_gemma":[0.00011115634,0.00075161416,0.9971027,0.00009435741,0.00013332746,0.00011106924,0.0003667521,0.00042029194,0.00014129134,0.00006424125,0.00068699295,0.000016152751],"about_ca_topic_score_codex":0.0057306048,"about_ca_topic_score_gemma":0.0053599547,"teacher_disagreement_score":0.03223487,"about_ca_system_score_codex":0.0008886733,"about_ca_system_score_gemma":0.00092882506,"threshold_uncertainty_score":0.17047626},"labels":[],"label_agreement":null},{"id":"W4403541333","doi":"10.1016/j.jval.2024.09.014","title":"Virtual/Mobile Overdose Response in Canada: A Social Return on Investment Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Constellation Brands (Canada); University of Saskatchewan; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Value (mathematics); Computer science; Machine learning","score_opus":0.02501470561577147,"score_gpt":0.3134173058057576,"score_spread":0.28840260018998615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403541333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618679,0.0012171253,0.0019606405,0.0037825208,0.000033323846,0.0005453137,0.0036668754,0.000036620248,0.026889639],"genre_scores_gemma":[0.99437225,0.00060320314,0.001436225,0.00015164676,0.000009683291,0.0000916609,0.00077039615,0.000009991758,0.0025548611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996071,0.0009441295,0.00010428185,0.00015411123,0.0014817998,0.0012447935],"domain_scores_gemma":[0.98969907,0.0026818207,0.001229322,0.00027535376,0.0047126887,0.0014017298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036920304,0.00042263884,0.0004265072,0.0030558927,0.002375573,0.0035587011,0.0013589892,0.00056063005,0.0045249853],"category_scores_gemma":[0.014836144,0.00022089198,0.0011167082,0.004668046,0.0012388185,0.00085917074,0.0019427376,0.0012016384,0.00016762878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087187183,0.00076902297,0.77777755,0.0005075064,0.00071281445,0.0006685555,0.003960224,0.029851668,0.00031192735,0.042118832,0.014653399,0.1277966],"study_design_scores_gemma":[0.00011094592,0.00051794015,0.84008205,0.00061592524,0.0008629146,0.00026666294,0.022250958,0.10032076,0.00046963283,0.005305487,0.02907748,0.00011928361],"about_ca_topic_score_codex":0.97234184,"about_ca_topic_score_gemma":0.9762908,"teacher_disagreement_score":0.1139142,"about_ca_system_score_codex":0.1139142,"about_ca_system_score_gemma":0.090676926,"threshold_uncertainty_score":0.82650924},"labels":[],"label_agreement":null},{"id":"W4403848153","doi":"10.1016/j.jval.2024.08.011","title":"A Systematic Review and Quality Assessment of Cardiovascular Disease–Specific Health-Related Quality-of-Life Instruments: Part II Psychometric Properties","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact; Hamilton Health Sciences","funders":"","keywords":"Quality (philosophy); Medicine; Health related quality of life; Disease; Quality of life (healthcare); Internal medicine; Nursing; Physics","score_opus":0.3208061537794114,"score_gpt":0.45973373501746206,"score_spread":0.13892758123805066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403848153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015078904,0.9956222,0.0005995786,0.00018894,0.0001467657,0.00092852814,0.0007463855,0.000015225391,0.00024453428],"genre_scores_gemma":[0.019522501,0.9754505,0.0025449274,0.00049094984,0.000074976764,0.0011940076,0.00055810984,0.000012507239,0.00015145939],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98523384,0.0046481835,0.0059097083,0.0010722618,0.002901875,0.00023415762],"domain_scores_gemma":[0.9729978,0.01838367,0.005570775,0.0006493283,0.0021388542,0.00025952593],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017434256,0.0019279354,0.012872088,0.00808957,0.000653448,0.003388358,0.0021279259,0.0017415483,0.004309543],"category_scores_gemma":[0.061784804,0.0010758959,0.014597064,0.009722042,0.0011090545,0.0026690455,0.0023759943,0.001777366,0.00037238718],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003108899,0.000023125165,0.0016325377,0.9046025,0.045160607,0.000048472775,0.00013011138,0.00015724542,0.00012863638,0.000284364,0.0012801775,0.046241395],"study_design_scores_gemma":[0.0008601443,0.0002963411,0.012905435,0.62889344,0.33772352,0.0003412235,0.0002475948,0.00028389605,0.00020926178,0.0008007997,0.01734014,0.000098163146],"about_ca_topic_score_codex":0.011125097,"about_ca_topic_score_gemma":0.028596725,"teacher_disagreement_score":0.98256576,"about_ca_system_score_codex":0.0038768123,"about_ca_system_score_gemma":0.011371365,"threshold_uncertainty_score":0.092202246},"labels":[],"label_agreement":null},{"id":"W4404033981","doi":"10.1016/j.jval.2024.07.027","title":"Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making: A Good Practices Report of an ISPOR Task Force","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"Zorginstituut Nederland","keywords":"Task force; Task (project management); Health care; Expert elicitation; Management science; Knowledge management; Computer science; Engineering; Political science; Systems engineering","score_opus":0.7180426693790085,"score_gpt":0.5606838886825213,"score_spread":0.15735878069648723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404033981","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0036771698,0.020390596,0.17521797,0.6281578,0.012778617,0.06398123,0.0054126754,0.0038879937,0.086495966],"genre_scores_gemma":[0.011330463,0.025462408,0.7839482,0.084351614,0.0012842201,0.0733247,0.0041977246,0.00087047415,0.015230217],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.49688467,0.35911757,0.05942344,0.006243692,0.06824648,0.010084111],"domain_scores_gemma":[0.22331356,0.48413375,0.041143887,0.026046252,0.2117509,0.013611606],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4628873,0.0046054977,0.0040352424,0.015770003,0.007835608,0.01755942,0.015432476,0.024334088,0.020915532],"category_scores_gemma":[0.657811,0.0047291457,0.009562135,0.020486707,0.0097463485,0.022469848,0.013184693,0.021709861,0.02085236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031971125,0.00080911594,0.0018574463,0.018767023,0.00018645311,0.0005622694,0.012740191,0.0027177827,0.00081503356,0.023946034,0.5859656,0.35131344],"study_design_scores_gemma":[0.0012648841,0.00070339796,0.006891046,0.16357519,0.00057407154,0.0005264762,0.02485354,0.003283818,0.002562902,0.047977604,0.74689233,0.0008946306],"about_ca_topic_score_codex":0.034905642,"about_ca_topic_score_gemma":0.044467207,"teacher_disagreement_score":0.5371127,"about_ca_system_score_codex":0.022526843,"about_ca_system_score_gemma":0.13838726,"threshold_uncertainty_score":0.66235566},"labels":[],"label_agreement":null},{"id":"W4405430941","doi":"10.1016/j.jval.2024.11.006","title":"A Systematic Literature Review of Important and Meaningful Differences in the EQ-5D Index and Visual Analog Scale Scores","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"EuroQol Research Foundation; University of Alberta","keywords":"Visual analogue scale; Index (typography); EQ-5D; Scale (ratio); Psychology; Systematic review; Information retrieval; Data science; Computer science; Medicine; MEDLINE; Physical therapy; Geography; Cartography; World Wide Web; Political science; Internal medicine; Health related quality of life","score_opus":0.41921742846961346,"score_gpt":0.45090343827925894,"score_spread":0.03168600980964548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405430941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001037942,0.9963595,0.00041530872,0.00033430415,0.00017034655,0.000770531,0.0006112618,0.000011996178,0.00028870784],"genre_scores_gemma":[0.03319546,0.9575943,0.0030141391,0.0014894839,0.00023012185,0.003578836,0.0006996871,0.000017692066,0.0001802819],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.95545006,0.01873806,0.016121525,0.0026402299,0.0063781394,0.0006720516],"domain_scores_gemma":[0.88095987,0.09380179,0.015944013,0.0013545012,0.007336145,0.00060364243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035421185,0.002367386,0.01314642,0.021191357,0.0010192421,0.0042636404,0.0030550298,0.0029037045,0.005773498],"category_scores_gemma":[0.15375024,0.0015888793,0.012850722,0.014798687,0.0015144713,0.0041099624,0.002798,0.0021736047,0.0004410704],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017935534,0.000011034193,0.0005782235,0.9677325,0.011327173,0.000057863137,0.00015245663,0.000079290876,0.00007541042,0.0002757596,0.0009262262,0.018604739],"study_design_scores_gemma":[0.000327347,0.00019617142,0.0032771062,0.9032802,0.082887486,0.00024060628,0.00025406326,0.00008536243,0.00012171398,0.00043754754,0.008852411,0.00003998991],"about_ca_topic_score_codex":0.008232527,"about_ca_topic_score_gemma":0.024861697,"teacher_disagreement_score":0.035421185,"about_ca_system_score_codex":0.0074416534,"about_ca_system_score_gemma":0.019674934,"threshold_uncertainty_score":0.18732733},"labels":[],"label_agreement":null},{"id":"W4405747884","doi":"10.1016/j.jval.2024.10.1188","title":"EPH58 Potential Public Health Impact of Respiratory Syncytial Virus (RSV) Vaccines for Prevention of Lower Respiratory Tract Disease (LRTD) Due to RSV Among Older Adults in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Respiratory system; Medicine; Virology; Respiratory tract; Virus; Respiratory tract infections; Disease; Public health; Immunology; Intensive care medicine; Internal medicine; Pathology","score_opus":0.064567905199115,"score_gpt":0.3947542920701955,"score_spread":0.33018638687108054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825463,0.0023114549,0.00082233804,0.0013400796,0.000040562667,0.00014320483,0.006674588,0.000033573728,0.006087912],"genre_scores_gemma":[0.99491817,0.0009643775,0.00062790804,0.00012227969,0.000008549008,0.000028775139,0.0015607547,0.0000068186337,0.0017623195],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993506,0.00019161715,0.00003104683,0.000049734826,0.00012034389,0.00025665943],"domain_scores_gemma":[0.99880195,0.00025017752,0.000113324226,0.00002376089,0.0005423675,0.00026839154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001187712,0.00037014607,0.0004347853,0.00059373357,0.00052506255,0.0010907209,0.0007489206,0.00048003517,0.0027123052],"category_scores_gemma":[0.0035886203,0.0001999515,0.001459061,0.0005076259,0.00019520511,0.00031028612,0.000809708,0.0004322514,0.00013720541],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011003462,0.0002523881,0.8681919,0.0005113373,0.0011517395,0.00065535866,0.00030498332,0.09941869,0.0007956865,0.002292352,0.0038990802,0.021426072],"study_design_scores_gemma":[0.00032811041,0.0005791785,0.7936795,0.0006091305,0.0016328763,0.00025258004,0.0017444924,0.19289495,0.0008915976,0.00090746593,0.006420295,0.00005984576],"about_ca_topic_score_codex":0.9697742,"about_ca_topic_score_gemma":0.97003114,"teacher_disagreement_score":0.030225813,"about_ca_system_score_codex":0.019934751,"about_ca_system_score_gemma":0.027728876,"threshold_uncertainty_score":0.1446374},"labels":[],"label_agreement":null},{"id":"W4405747899","doi":"10.1016/j.jval.2024.10.1134","title":"EPH1 Universal Health Coverage and Education Are the Decisive Socio-Economic Disparities in Cervical Cancer Mortality in the Dominican Republic: A Multi-Dimensional Ecological Approach in a Middle-Income Caribbean Country","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Socioeconomics; Geography; Caribbean island; Cervical cancer; Low and middle income countries; Development economics; Economic growth; Demography; Economics; Ecology; Cancer; Medicine; Developing country; Sociology; Biology","score_opus":0.08496243427694809,"score_gpt":0.3199091532595594,"score_spread":0.23494671898261127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960288,0.00023239244,0.000090346635,0.0014227409,0.0000026188504,0.0000063870416,0.00021745889,0.0000020966393,0.0019973048],"genre_scores_gemma":[0.99948823,0.00014166787,0.00005816256,0.00003654868,0.000002827364,0.00000407906,0.0000739975,0.0000010999329,0.00019334529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971646,0.00010628069,0.000007374669,0.000021183892,0.000019100455,0.00012960024],"domain_scores_gemma":[0.9995788,0.0001352618,0.00011144237,0.000018222072,0.000057476343,0.00009886928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005301471,0.00020668579,0.00026016386,0.0009978181,0.0009426946,0.0017892792,0.00045636744,0.0003332057,0.0018521221],"category_scores_gemma":[0.0019481425,0.0001140695,0.00031620046,0.0016615529,0.0009140418,0.00079965405,0.0013895849,0.00049014366,0.000038344635],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012332998,0.00018360051,0.95270604,0.00008937637,0.00016720922,0.00065626897,0.0041399035,0.0043962295,0.00042849957,0.022858001,0.0012658502,0.012985658],"study_design_scores_gemma":[0.000018995186,0.000040882547,0.94327396,0.00012534995,0.00012940276,0.00009672789,0.034549173,0.010857057,0.00015745108,0.0072028846,0.003526063,0.00002200832],"about_ca_topic_score_codex":0.46852916,"about_ca_topic_score_gemma":0.5085491,"teacher_disagreement_score":0.46852916,"about_ca_system_score_codex":0.0034633905,"about_ca_system_score_gemma":0.0032928714,"threshold_uncertainty_score":0.931604},"labels":[],"label_agreement":null},{"id":"W4405747902","doi":"10.1016/j.jval.2024.10.1105","title":"EE825 Induction Cost Per Responder of Brodalumab Compared With Other Biologic Therapies for Patients With Moderate to Severe Plaque Psoriasis in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Intensive care medicine; Internal medicine; Dermatology","score_opus":0.2690856578362003,"score_gpt":0.37022759550900247,"score_spread":0.10114193767280216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367191,0.026447043,0.00041205197,0.008444383,0.00026833033,0.0004294225,0.012559586,0.00006371526,0.01465632],"genre_scores_gemma":[0.9903578,0.0040198555,0.000322227,0.0006428025,0.000059011658,0.000053505635,0.0024161898,0.0000137691795,0.0021148352],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99854493,0.000363191,0.000104841376,0.00015178812,0.00043274608,0.0004025882],"domain_scores_gemma":[0.9975188,0.0005457791,0.00045140996,0.000045387762,0.00056078564,0.0008779089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011038765,0.00034717083,0.0011083743,0.0007441027,0.0007979243,0.0017539515,0.0011688477,0.0007430111,0.0042657526],"category_scores_gemma":[0.0043948335,0.00035799987,0.0027553325,0.0018680905,0.0006154238,0.00040979494,0.0004884192,0.0018090655,0.00018395165],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16046427,0.0033340368,0.37151617,0.0051595746,0.01162859,0.0011460478,0.00069766707,0.062015563,0.0028605836,0.009461729,0.066434234,0.30528146],"study_design_scores_gemma":[0.025945902,0.005420565,0.9017664,0.0015285776,0.0080631515,0.00050621055,0.0011809934,0.035540815,0.0007864778,0.0011056497,0.017936971,0.00021828874],"about_ca_topic_score_codex":0.97981924,"about_ca_topic_score_gemma":0.98348445,"teacher_disagreement_score":0.07217136,"about_ca_system_score_codex":0.07217136,"about_ca_system_score_gemma":0.057761658,"threshold_uncertainty_score":0.5236423},"labels":[],"label_agreement":null},{"id":"W4405747907","doi":"10.1016/j.jval.2024.10.786","title":"EE505 Cost-Effectiveness Analysis of Contemporary Advanced Prostate Cancer Management: A Markov Model for the Canadian Context","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Prostate cancer; Context (archaeology); Markov model; Medicine; Computer science; Markov chain; Cancer; Internal medicine; Machine learning; Geography","score_opus":0.37672867186323644,"score_gpt":0.4511636758316838,"score_spread":0.07443500396844738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78366053,0.0107754655,0.09714101,0.020566026,0.00039407797,0.0013188904,0.026308794,0.00043075724,0.05940453],"genre_scores_gemma":[0.96398956,0.0030344615,0.008665767,0.00059899176,0.00012102232,0.00043427353,0.0040757726,0.00006576225,0.019014519],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99799806,0.0006316371,0.000059537786,0.00019857459,0.0002671499,0.0008449982],"domain_scores_gemma":[0.99423695,0.0039085695,0.0004164906,0.00013678908,0.0007489367,0.00055225554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004998771,0.0015119367,0.003012213,0.002665405,0.002046945,0.0032262038,0.003596009,0.0031929808,0.01116322],"category_scores_gemma":[0.012447526,0.0012522837,0.0029940768,0.0028159195,0.001972424,0.0014486436,0.0014196193,0.0038624424,0.0005139945],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005573235,0.00018434481,0.007594827,0.00016317378,0.00033988364,0.0002066445,0.00014511938,0.92381644,0.00018740127,0.05335636,0.0055511477,0.007897231],"study_design_scores_gemma":[0.00028176248,0.00009911727,0.0065171164,0.000104897474,0.00033105456,0.00006144649,0.00015988061,0.9793312,0.00006345495,0.010026499,0.00294114,0.00008243963],"about_ca_topic_score_codex":0.94898725,"about_ca_topic_score_gemma":0.9217703,"teacher_disagreement_score":0.051012754,"about_ca_system_score_codex":0.03377045,"about_ca_system_score_gemma":0.036571745,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4405747910","doi":"10.1016/j.jval.2024.10.801","title":"EE520 Cost-Effectiveness Analysis of the Use of the 20-Valent Anti-Pneumococcal Vaccine (PCV20) in the Spanish Pediatric Population","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Pneumococcal vaccine; Pediatrics; Intensive care medicine; Streptococcus pneumoniae; Biology; Microbiology","score_opus":0.13102963057697772,"score_gpt":0.41824267927377085,"score_spread":0.2872130486967931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95044935,0.030679466,0.0020251693,0.0009710505,0.00018826955,0.00043369606,0.009913873,0.000051639356,0.005287535],"genre_scores_gemma":[0.9903008,0.003838077,0.00080929336,0.00022429596,0.000075728014,0.00016309306,0.0038755052,0.000010909614,0.0007024416],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970975,0.0020993545,0.00014171556,0.00015583866,0.00024328067,0.0002623789],"domain_scores_gemma":[0.9971264,0.0022069847,0.00026991256,0.000071667455,0.00017157634,0.00015342326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003930106,0.0008816272,0.0015885299,0.0009948565,0.00010253434,0.0009291109,0.00060769735,0.0008504806,0.0035011405],"category_scores_gemma":[0.0078052054,0.00030167663,0.0058792373,0.0012192003,0.0001976822,0.0004962653,0.00055058015,0.00083806604,0.00016312776],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30352506,0.006179747,0.20544103,0.01460161,0.08678494,0.0010753715,0.00022348165,0.1908048,0.0036397097,0.0040435824,0.00709068,0.17659004],"study_design_scores_gemma":[0.051174846,0.05015518,0.6622209,0.0026275737,0.08455347,0.001339591,0.00077915756,0.12726344,0.0026042385,0.0019861527,0.015096524,0.00019893538],"about_ca_topic_score_codex":0.02986733,"about_ca_topic_score_gemma":0.014593984,"teacher_disagreement_score":0.02986733,"about_ca_system_score_codex":0.0036983693,"about_ca_system_score_gemma":0.0022712543,"threshold_uncertainty_score":0.05938697},"labels":[],"label_agreement":null},{"id":"W4405747922","doi":"10.1016/j.jval.2024.10.1135","title":"EPH2 Costs of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Illness Among Children and Adolescents in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Respiratory illness; Respiratory system; Pediatrics; Virus; Virology; Internal medicine","score_opus":0.029481057406308814,"score_gpt":0.3386658753839869,"score_spread":0.3091848179776781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96915734,0.0023766465,0.000101514794,0.0026332918,0.000059849426,0.00007827649,0.016388668,0.000023941539,0.0091804825],"genre_scores_gemma":[0.9890354,0.0018014042,0.0002091676,0.00040002828,0.0000292604,0.00003516794,0.0032173768,0.0000102532895,0.005261809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988708,0.00008061015,0.00009709383,0.00007471819,0.00034650968,0.0005302622],"domain_scores_gemma":[0.99736845,0.00011485135,0.00062659814,0.000031395317,0.0008348179,0.0010239787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033994854,0.00031592415,0.0003949689,0.0012273864,0.0023044103,0.0014907853,0.0012127808,0.000613502,0.0041626133],"category_scores_gemma":[0.0020494391,0.0005039885,0.0011100417,0.0023683752,0.00050522346,0.00043502907,0.0011236233,0.0011803972,0.0002456204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006283031,0.00004039385,0.98544496,0.00010175924,0.000143266,0.00035276051,0.0006435407,0.00051239465,0.0001132328,0.000563265,0.006630194,0.0053914636],"study_design_scores_gemma":[0.000013307603,0.000015427127,0.99522287,0.00009443144,0.00003554916,0.00011445694,0.001438648,0.0004329478,0.000027948852,0.000028908487,0.0025668917,0.000008744943],"about_ca_topic_score_codex":0.9974572,"about_ca_topic_score_gemma":0.99893564,"teacher_disagreement_score":0.06202472,"about_ca_system_score_codex":0.06202472,"about_ca_system_score_gemma":0.064139985,"threshold_uncertainty_score":0.45002294},"labels":[],"label_agreement":null},{"id":"W4405748058","doi":"10.1016/j.jval.2024.10.846","title":"EE566 Real-World Evidence of Multi-Gene Panel Sequencing Effectiveness and Cost-Effectiveness for Advanced Cancers: A Tumor-Agnostic Target Trial Emulation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Emulation; Computational biology; Real world evidence; Computer science; Oncology; Medicine; Internal medicine; Biology; Psychology","score_opus":0.5757605894262776,"score_gpt":0.4958585673932267,"score_spread":0.07990202203305091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7976641,0.009130292,0.10210851,0.008373242,0.0014705408,0.003912957,0.046979133,0.0008982042,0.02946305],"genre_scores_gemma":[0.9714633,0.0007175492,0.009183683,0.0018253278,0.00022746185,0.0012721574,0.008687908,0.000088199435,0.006534363],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9532013,0.042513616,0.0010104135,0.0017678348,0.00079167564,0.00071513886],"domain_scores_gemma":[0.85644263,0.12963484,0.0049175587,0.0070410147,0.0011385784,0.0008254011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.066696696,0.0015148275,0.0030124364,0.000880365,0.00035882214,0.0024652819,0.0022676415,0.0028110219,0.025013104],"category_scores_gemma":[0.118821986,0.0008139826,0.01087633,0.0012341171,0.0014710734,0.0022048822,0.0016300544,0.0034719773,0.0025002835],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3160423,0.004200907,0.04052547,0.006469633,0.07691235,0.0014247712,0.00042334752,0.37197682,0.003192756,0.029364329,0.03311293,0.1163544],"study_design_scores_gemma":[0.15899904,0.046109144,0.068968154,0.0026549562,0.12367731,0.0020292758,0.0005331588,0.44866514,0.011762651,0.090481214,0.045485493,0.00063449296],"about_ca_topic_score_codex":0.001939866,"about_ca_topic_score_gemma":0.0012300753,"teacher_disagreement_score":0.066696696,"about_ca_system_score_codex":0.0008616401,"about_ca_system_score_gemma":0.0013859901,"threshold_uncertainty_score":0.35273004},"labels":[],"label_agreement":null},{"id":"W4405748096","doi":"10.1016/j.jval.2024.10.1112","title":"EE832 The Lifetime Return on Investment of Measles, Mumps, and Rubella Vaccination in Belgium and Poland","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Measles; Rubella; Vaccination; Medicine; Virology; Investment (military); Pediatrics; Political science; Law","score_opus":0.032204484932622644,"score_gpt":0.31657135712466133,"score_spread":0.2843668721920387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996555,0.00029556523,0.000110362955,0.00031953925,0.000004746441,0.0000025146378,0.00067498855,0.0000039459596,0.0020333854],"genre_scores_gemma":[0.9978794,0.00011651701,0.000046086032,0.00001668317,0.0000031186473,0.0000026906096,0.000441245,0.0000026980533,0.0014915692],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99947315,0.00012508385,0.000032969114,0.00004749047,0.000054486063,0.0002668303],"domain_scores_gemma":[0.99906796,0.00020476307,0.00030429903,0.000030022984,0.00012190833,0.00027106737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005705699,0.000095315874,0.00019086212,0.00069850957,0.00013990597,0.0010234187,0.00025022373,0.00040571086,0.0014322638],"category_scores_gemma":[0.0024321042,0.0001303357,0.0003745561,0.00061695685,0.00020395446,0.0004554993,0.00070141663,0.00044180598,0.00018208356],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015788899,0.0001325934,0.94457,0.00006192696,0.00039610264,0.0010541936,0.0005711414,0.011286363,0.0009243707,0.008754308,0.0017577494,0.028912397],"study_design_scores_gemma":[0.00002427265,0.00010543941,0.9867198,0.000032410433,0.00005624947,0.00047796645,0.0010732975,0.00476478,0.0004303526,0.0008281067,0.0054761795,0.000011111281],"about_ca_topic_score_codex":0.06309093,"about_ca_topic_score_gemma":0.045682333,"teacher_disagreement_score":0.06309093,"about_ca_system_score_codex":0.0025551866,"about_ca_system_score_gemma":0.0009423076,"threshold_uncertainty_score":0.12544739},"labels":[],"label_agreement":null},{"id":"W4405748112","doi":"10.1016/j.jval.2024.10.905","title":"EE625 Cost-Effectiveness Analysis of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) to Prevent Pneumococcal Disease in the Greek Pediatric Population","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal disease; Pneumococcal conjugate vaccine; Medicine; Pediatrics; Conjugate vaccine; Conjugate; Pneumococcal vaccine; Streptococcus pneumoniae; Immunology; Immunization; Microbiology; Biology; Mathematics; Immune system","score_opus":0.03895033056563186,"score_gpt":0.35852965256530167,"score_spread":0.3195793219996698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98541045,0.0096080955,0.00077818707,0.00032567122,0.00005025784,0.00015331188,0.0015301574,0.000013026787,0.002130902],"genre_scores_gemma":[0.99780995,0.0009642785,0.00025761244,0.000061124854,0.000013980008,0.000037303635,0.0006541331,0.0000029845937,0.00019859795],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981025,0.0012650334,0.00013089513,0.0001339241,0.0001683778,0.00019932074],"domain_scores_gemma":[0.99879116,0.0008678892,0.00015731675,0.000039304818,0.000055500877,0.0000889177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023801948,0.0006926041,0.001267184,0.00092125277,0.000085454405,0.00092273526,0.00043829434,0.0007678223,0.0025595387],"category_scores_gemma":[0.0051678587,0.00026896014,0.0046044686,0.0009033861,0.0002678835,0.0006659901,0.00066711765,0.0005999088,0.00011698135],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16900346,0.0036803826,0.22064957,0.008442683,0.053999547,0.0024927794,0.00043054178,0.35906455,0.0059259767,0.009769656,0.0025183228,0.16402265],"study_design_scores_gemma":[0.023190258,0.07222135,0.64300895,0.0019966234,0.045847323,0.0027423273,0.0012664349,0.19114617,0.003995816,0.004541285,0.009841887,0.00020152876],"about_ca_topic_score_codex":0.0062625716,"about_ca_topic_score_gemma":0.0027169734,"teacher_disagreement_score":0.0062625716,"about_ca_system_score_codex":0.0023072052,"about_ca_system_score_gemma":0.0012836569,"threshold_uncertainty_score":0.016740024},"labels":[],"label_agreement":null},{"id":"W4405748113","doi":"10.1016/j.jval.2024.10.739","title":"EE458 Evaluating Utilization Patterns, Financial Impact, and Access Delay Caused by Reimbursement Criteria on Public Drug Plans for Primary Care Topical Treatments in Canada: Case Study With HP/TAZ Combination for Plaque Psoriasis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Reimbursement; Primary care; Drug; Medicine; Business; Finance; Family medicine; Pharmacology; Health care; Economics; Economic growth","score_opus":0.4135314945157764,"score_gpt":0.4753705630889779,"score_spread":0.06183906857320148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975241,0.00016693994,0.00009972927,0.00023788826,0.0000025669142,0.000050839375,0.0011073541,0.0000054413454,0.00080508116],"genre_scores_gemma":[0.99833834,0.00010738895,0.00034677645,0.00004463239,0.0000033800181,0.000013363388,0.0006638187,0.0000034816687,0.00047875827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872583,0.0003323873,0.00007000258,0.0001006123,0.000278945,0.0004921397],"domain_scores_gemma":[0.993905,0.0027643337,0.0009634693,0.00015078658,0.0013846413,0.0008318157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018970275,0.00038300504,0.00047777462,0.0014375028,0.0015422358,0.0011830578,0.0009843558,0.0007352918,0.002227813],"category_scores_gemma":[0.007502886,0.00029205673,0.00097466534,0.0031685156,0.0007588645,0.00037150338,0.0006033847,0.0008851181,0.00011436259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011611512,0.0011058133,0.96630615,0.000093687864,0.00036550924,0.0010763619,0.0005003713,0.011078388,0.0003504125,0.0006611827,0.0022342834,0.015066672],"study_design_scores_gemma":[0.00013254707,0.00035980652,0.9503352,0.000039195937,0.00020831573,0.00035761454,0.0026787403,0.044411,0.00025590084,0.00022829029,0.000955157,0.000038241804],"about_ca_topic_score_codex":0.97946244,"about_ca_topic_score_gemma":0.9807536,"teacher_disagreement_score":0.032791466,"about_ca_system_score_codex":0.032791466,"about_ca_system_score_gemma":0.02217455,"threshold_uncertainty_score":0.23791987},"labels":[],"label_agreement":null},{"id":"W4405748120","doi":"10.1016/j.jval.2024.10.559","title":"EE277 Cost of Stroke in Latin America: A Multicentric Time-Driven Activity-Based Costing Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Activity-based costing; Stroke (engine); Latin Americans; Medicine; Business; Operations management; Physical medicine and rehabilitation; Economics; Political science; Accounting; Engineering; Mechanical engineering","score_opus":0.3670552491537332,"score_gpt":0.4380620193520799,"score_spread":0.07100677019834667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951331,0.00040883798,0.00018662942,0.00020223977,0.000004674494,0.00003569461,0.0030126926,0.0000044093713,0.0010117409],"genre_scores_gemma":[0.99568343,0.0004885315,0.0002600792,0.00008707127,0.000014096508,0.00008368612,0.0027776726,0.000007943772,0.0005974707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990445,0.00057934644,0.000065960536,0.00008106262,0.000072699964,0.00015648299],"domain_scores_gemma":[0.9968927,0.0011553308,0.0010586282,0.00024256679,0.000394367,0.00025638245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012613347,0.0005446847,0.000600565,0.0019752665,0.00038638467,0.00106648,0.00075569726,0.00063950924,0.002005973],"category_scores_gemma":[0.004809853,0.0002916035,0.001158899,0.0055371337,0.0003414934,0.00079493155,0.0010196485,0.0005310615,0.00015791315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013538806,0.0007650268,0.9810104,0.00014093955,0.0009045992,0.00037169736,0.0005287505,0.0028471278,0.00017198721,0.0010529386,0.0009934558,0.009859277],"study_design_scores_gemma":[0.00019317931,0.00026699735,0.9918156,0.0000798693,0.0005614833,0.00028513046,0.001656541,0.002937282,0.0000854735,0.00043991426,0.001655775,0.000022742524],"about_ca_topic_score_codex":0.13331111,"about_ca_topic_score_gemma":0.090099975,"teacher_disagreement_score":0.13331111,"about_ca_system_score_codex":0.0044003823,"about_ca_system_score_gemma":0.0016156903,"threshold_uncertainty_score":0.26507026},"labels":[],"label_agreement":null},{"id":"W4405748122","doi":"10.1016/j.jval.2024.10.670","title":"EE389 Cost Savings Analysis of Implementing Benchmark Best Practices for TAVI Patients in Europe","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Benchmark (surveying); Computer science; Econometrics; Business; Economics; Geography; Cartography","score_opus":0.1692553593638412,"score_gpt":0.3835656926831935,"score_spread":0.21431033331935231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762308,0.0016032755,0.00609315,0.0012283834,0.00011632063,0.00017274776,0.0041162646,0.00013179936,0.010307206],"genre_scores_gemma":[0.99451965,0.0002109884,0.002147139,0.000120157274,0.000020537322,0.00006157575,0.0020984542,0.00002034581,0.0008011895],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9943967,0.0030250489,0.00031719185,0.0005173286,0.0008793685,0.0008644387],"domain_scores_gemma":[0.9896484,0.0065098414,0.0009834719,0.00074414525,0.0017062309,0.000407911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006922016,0.0006330916,0.0011573721,0.0016857545,0.0003762114,0.0026965481,0.0012904579,0.0016610532,0.0034598229],"category_scores_gemma":[0.023691492,0.00043706578,0.0018460654,0.002517405,0.0005416749,0.0013851739,0.0010502973,0.001142684,0.00025520878],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075763534,0.0015636156,0.045854922,0.000459823,0.0013069152,0.00026680768,0.00011365298,0.8587148,0.0006523375,0.012632688,0.007681618,0.063176446],"study_design_scores_gemma":[0.0020725043,0.00564886,0.20254785,0.00050746615,0.001406877,0.00037522713,0.0010198033,0.76058835,0.0031526512,0.010239778,0.012281531,0.00015910633],"about_ca_topic_score_codex":0.03891661,"about_ca_topic_score_gemma":0.012007576,"teacher_disagreement_score":0.03891661,"about_ca_system_score_codex":0.005782639,"about_ca_system_score_gemma":0.0041393247,"threshold_uncertainty_score":0.07738018},"labels":[],"label_agreement":null},{"id":"W4405748128","doi":"10.1016/j.jval.2024.10.707","title":"EE426 Cost-Effectiveness of Switching From PCV13 to PCV20 in the Portuguese Childhood National Immunization Program","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Portuguese; Immunization program; Immunization; Political science; Business; Medicine; Immunology; Philosophy","score_opus":0.05565572391763007,"score_gpt":0.3876690808970631,"score_spread":0.332013356979433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99118924,0.0017486904,0.00020338189,0.000582698,0.000049917653,0.000085055915,0.0016948467,0.000011836743,0.0044344338],"genre_scores_gemma":[0.99859065,0.00031370198,0.00012100934,0.000056912402,0.000013755658,0.000023935243,0.00045262868,0.0000028606642,0.000424557],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99682826,0.0020358488,0.00014310298,0.00017759607,0.00029965866,0.00051552587],"domain_scores_gemma":[0.99649364,0.0022577567,0.0005813396,0.00013847587,0.00014553114,0.0003832736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026637325,0.0003890045,0.0007086509,0.000482332,0.00020601842,0.00073552516,0.000479825,0.00096233084,0.0035104526],"category_scores_gemma":[0.010899238,0.00018492239,0.0028076074,0.00074456417,0.00023960554,0.0004464973,0.0004750698,0.0006416035,0.00013291615],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14306109,0.0112094795,0.44589213,0.0030141103,0.009538606,0.0010728519,0.00060667197,0.08291733,0.0023778346,0.0042382535,0.0046048383,0.2914668],"study_design_scores_gemma":[0.006383164,0.02527745,0.9227328,0.0007977509,0.006424215,0.00046937465,0.00072649523,0.03043805,0.0015798827,0.0013787481,0.0037259446,0.000066057764],"about_ca_topic_score_codex":0.030795809,"about_ca_topic_score_gemma":0.020265946,"teacher_disagreement_score":0.030795809,"about_ca_system_score_codex":0.0022256793,"about_ca_system_score_gemma":0.0021290965,"threshold_uncertainty_score":0.061233103},"labels":[],"label_agreement":null},{"id":"W4405748163","doi":"10.1016/j.jval.2024.10.833","title":"EE553 Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Occlusive; Medicine; Disease; Internal medicine; Pediatrics","score_opus":0.026869804717029763,"score_gpt":0.2960737791799688,"score_spread":0.26920397446293903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.935318,0.00055686594,0.0032602972,0.0014282924,0.00009074779,0.00009776261,0.0494406,0.0002570487,0.0095502455],"genre_scores_gemma":[0.9794079,0.00021685388,0.0010664408,0.000093082155,0.000009407736,0.000041646625,0.014264493,0.000024620134,0.004875522],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9995976,0.00007489181,0.000016482987,0.000071625465,0.0000707412,0.00016862295],"domain_scores_gemma":[0.99873453,0.0002700036,0.000098194505,0.000037604,0.000661927,0.00019768304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069422345,0.00046767094,0.00054925214,0.0005820112,0.00037275284,0.0012792118,0.0011138445,0.0006012351,0.0062848493],"category_scores_gemma":[0.0023214058,0.00032467104,0.0014197979,0.0009800494,0.00035305065,0.0003592707,0.0004434908,0.00073878723,0.00053650496],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010988923,0.0002328316,0.18443601,0.00016146887,0.0007652521,0.00021891746,0.00010590214,0.7804791,0.00041898974,0.0052849296,0.016754705,0.010042993],"study_design_scores_gemma":[0.0003378141,0.00025623993,0.16950226,0.00011415538,0.00034596102,0.00015020245,0.00053710165,0.81880784,0.00042106447,0.0016303103,0.007790863,0.00010618211],"about_ca_topic_score_codex":0.9644424,"about_ca_topic_score_gemma":0.9329382,"teacher_disagreement_score":0.035557628,"about_ca_system_score_codex":0.015489332,"about_ca_system_score_gemma":0.015058611,"threshold_uncertainty_score":0.112383485},"labels":[],"label_agreement":null},{"id":"W4405748187","doi":"10.1016/j.jval.2024.10.574","title":"EE292 Cost-Effectiveness Analysis of PCV20 3+1 Versus PCV15 2+1 Vaccination of the Pediatric Population in the Netherlands","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Vaccination; Pediatrics; Demography; Virology; Sociology","score_opus":0.07159558361299687,"score_gpt":0.39134914810956095,"score_spread":0.3197535644965641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95708805,0.020496855,0.0027948008,0.0014155456,0.00025539362,0.00097449473,0.008484073,0.000027605036,0.008463264],"genre_scores_gemma":[0.9912423,0.0026308293,0.001022084,0.00024194227,0.000055954726,0.0004074677,0.002611641,0.000014105645,0.001773707],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99558985,0.0035452223,0.00018114383,0.00016545731,0.00020544381,0.00031295684],"domain_scores_gemma":[0.9976901,0.0017793762,0.00022506823,0.00004016465,0.00010778694,0.00015765445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004189853,0.0006789697,0.0016053215,0.000693578,0.00013701349,0.00111313,0.0005955538,0.00073321507,0.0036582244],"category_scores_gemma":[0.010926412,0.0003875463,0.004697654,0.00093137816,0.00021330916,0.00064080325,0.0005510046,0.0008165179,0.00015687851],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3320693,0.0041948473,0.11671518,0.010053467,0.06912999,0.00147914,0.000322138,0.31142238,0.0028501616,0.0058110836,0.009572619,0.13637966],"study_design_scores_gemma":[0.10843131,0.06308515,0.42970562,0.003080186,0.080203876,0.0012003039,0.0014702138,0.28687555,0.0037938002,0.0035906734,0.018244347,0.00031900572],"about_ca_topic_score_codex":0.056075647,"about_ca_topic_score_gemma":0.034953274,"teacher_disagreement_score":0.056075647,"about_ca_system_score_codex":0.004895421,"about_ca_system_score_gemma":0.002407466,"threshold_uncertainty_score":0.111498475},"labels":[],"label_agreement":null},{"id":"W4405748254","doi":"10.1016/j.jval.2024.10.642","title":"EE361 Long-Term Remission (LTR) Assumptions in Health Technology Assessments (HTAs) of Bispecific Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Following Two or More Lines of Systemic Therapy (3L+)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Oncology; Term (time); Lymphoma; Internal medicine; Cancer research; Physics","score_opus":0.1088455886547828,"score_gpt":0.4519538653960237,"score_spread":0.3431082767412409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748254","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8522751,0.0031295936,0.10347512,0.006045878,0.000181467,0.00070922705,0.008817875,0.0002989768,0.02506672],"genre_scores_gemma":[0.99282867,0.00011870912,0.0034949945,0.0004715148,0.00002390087,0.000102376995,0.0013290227,0.000018333105,0.0016124629],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9791564,0.014714164,0.00096446864,0.0021051401,0.0017859688,0.0012738347],"domain_scores_gemma":[0.8888857,0.09688824,0.0068124565,0.0040615536,0.0024743231,0.00087761984],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.047809254,0.0007931303,0.0009990124,0.00096661656,0.0005002014,0.0027194603,0.0016965672,0.00178264,0.0047169095],"category_scores_gemma":[0.08023222,0.00041211082,0.0024644122,0.00067466934,0.0011571462,0.002968288,0.0018020364,0.0030841774,0.0006946943],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010170048,0.0007268347,0.35526624,0.00078995334,0.002945034,0.0012883944,0.0009697938,0.40014288,0.0031909528,0.0814039,0.0063443887,0.1367616],"study_design_scores_gemma":[0.0004217443,0.0038736109,0.15918122,0.00041479222,0.0014279378,0.0008270665,0.0011154152,0.7032614,0.0062196436,0.11380462,0.009298954,0.00015362483],"about_ca_topic_score_codex":0.0041517345,"about_ca_topic_score_gemma":0.003955079,"teacher_disagreement_score":0.95219076,"about_ca_system_score_codex":0.002532041,"about_ca_system_score_gemma":0.0015516039,"threshold_uncertainty_score":0.25284255},"labels":[],"label_agreement":null},{"id":"W4405748287","doi":"10.1016/j.jval.2024.10.507","title":"EE225 Burden of Chronic Obstructive Pulmonary Disease (COPD) Healthcare Costs in Patients with Moderate-to-Severe Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Pulmonary disease; COPD; Medicine; Disease; Intensive care medicine; Health care; Internal medicine","score_opus":0.021309638993003786,"score_gpt":0.3043008487857156,"score_spread":0.2829912097927118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95421803,0.0076988814,0.0002438631,0.003419228,0.00015975264,0.00002552021,0.020801878,0.000016628726,0.013416202],"genre_scores_gemma":[0.9901777,0.0017140245,0.00016080383,0.0002302765,0.000133865,0.000014113654,0.0061759544,0.0000040906625,0.0013891724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928844,0.00022617947,0.00009171296,0.0000623275,0.00016506869,0.00016616292],"domain_scores_gemma":[0.99901354,0.00016313615,0.00044082486,0.00003067232,0.00015709132,0.00019467315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045332676,0.00020981306,0.00036930927,0.0010796161,0.00029513123,0.0011758187,0.00024939678,0.0004710125,0.0056887977],"category_scores_gemma":[0.0029085225,0.00013702734,0.0011142206,0.0019570645,0.00014923041,0.00070428284,0.0007561644,0.00083778217,0.00048869185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021197074,0.00007045145,0.9798742,0.000094618794,0.00045451795,0.00012069979,0.00006662389,0.0002442422,0.000078459474,0.0006439075,0.0043660984,0.013774316],"study_design_scores_gemma":[0.000009722397,0.00004474649,0.9962043,0.000065428925,0.000086427,0.00022564016,0.0002015624,0.00037754155,0.000020054531,0.00019072919,0.0025681846,0.000005622386],"about_ca_topic_score_codex":0.019101389,"about_ca_topic_score_gemma":0.03170598,"teacher_disagreement_score":0.019101389,"about_ca_system_score_codex":0.0008491073,"about_ca_system_score_gemma":0.0007996545,"threshold_uncertainty_score":0.037980378},"labels":[],"label_agreement":null},{"id":"W4405748296","doi":"10.1016/j.jval.2024.10.535","title":"EE253 Health Care Visits and Out-of-Pocket Costs in People With Chronic Hand Eczema","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"","keywords":"Hand eczema; Medicine; Health care; Environmental health; Family medicine; Allergy; Immunology; Economics; Economic growth; Contact dermatitis","score_opus":0.018283768425964356,"score_gpt":0.3061301049303482,"score_spread":0.28784633650438385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916065,0.0018399699,0.00003374871,0.00033211437,0.00002412827,0.000010011974,0.0020827113,0.0000028413501,0.0040679784],"genre_scores_gemma":[0.997962,0.00038681473,0.00003350023,0.000069504844,0.000023224791,0.000005370224,0.00058652856,0.0000011916925,0.00093184976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99959713,0.00010415716,0.00005094994,0.000033092034,0.00008224091,0.0001324146],"domain_scores_gemma":[0.999183,0.0002285216,0.00033736025,0.000021086786,0.000067466,0.0001626825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002890688,0.00016463223,0.0002757459,0.00092392764,0.0003454369,0.00074918335,0.00017613394,0.00045707318,0.006555679],"category_scores_gemma":[0.0022204353,0.00015288405,0.00084665,0.0014618901,0.00014487178,0.00057502784,0.00050024834,0.00069954514,0.00034592993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018563321,0.000114466675,0.9937511,0.00004438708,0.00011450499,0.00011537886,0.000074635485,0.0000505008,0.000045635246,0.00004991887,0.0004498592,0.00500398],"study_design_scores_gemma":[0.0000060080897,0.00003525682,0.9991611,0.000020389189,0.00003354538,0.000108740736,0.00018892804,0.00009201963,0.000010065484,0.00004261631,0.00029902635,0.000002190569],"about_ca_topic_score_codex":0.03111726,"about_ca_topic_score_gemma":0.04598097,"teacher_disagreement_score":0.03111726,"about_ca_system_score_codex":0.0006425241,"about_ca_system_score_gemma":0.0003187441,"threshold_uncertainty_score":0.061872303},"labels":[],"label_agreement":null},{"id":"W4405748345","doi":"10.1016/j.jval.2024.10.700","title":"EE419 Systematic Literature Review of Cost-Effectiveness Evaluations of Freestyle Libre Continuous Glucose Monitoring Systems","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Continuous glucose monitoring; Computer science; Medicine; Internal medicine","score_opus":0.06839238249222915,"score_gpt":0.4086984338077665,"score_spread":0.3403060513155374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0074881613,0.986363,0.0005474296,0.00058496936,0.00031472472,0.0012629936,0.0024698952,0.00003615703,0.00093270757],"genre_scores_gemma":[0.1538033,0.8347806,0.0035714335,0.0022300715,0.00033771776,0.0024022104,0.0022322664,0.00005023457,0.0005921594],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96751136,0.01538599,0.010428638,0.0016122387,0.0043970128,0.00066483737],"domain_scores_gemma":[0.93058556,0.051586997,0.011567239,0.0012589793,0.0043787663,0.0006224043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021823231,0.0024000977,0.012399056,0.008548339,0.00080840127,0.0037406944,0.0023066981,0.0021131367,0.00808394],"category_scores_gemma":[0.09559462,0.0014426791,0.022111103,0.008382843,0.0012770505,0.0022274484,0.0025467156,0.002497949,0.00050843775],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039646514,0.00006112544,0.0015848952,0.8068814,0.15821747,0.00009183728,0.00012275681,0.00031250803,0.00022295093,0.00020644735,0.0012299869,0.027103895],"study_design_scores_gemma":[0.004896713,0.0011377806,0.008083851,0.36055624,0.6164133,0.00019230781,0.00017845046,0.00026341924,0.00027713727,0.00032323686,0.007606985,0.00007053691],"about_ca_topic_score_codex":0.014692123,"about_ca_topic_score_gemma":0.036462065,"teacher_disagreement_score":0.021823231,"about_ca_system_score_codex":0.007160297,"about_ca_system_score_gemma":0.011643228,"threshold_uncertainty_score":0.115413666},"labels":[],"label_agreement":null},{"id":"W4405748357","doi":"10.1016/j.jval.2024.10.472","title":"EE188 Cost-Effectiveness of Rivaroxaban and Acetylsalicylic Acid Combination Therapy in Stable Cardiovascular Disease: A Global Perspective","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Rivaroxaban; Perspective (graphical); Medicine; Disease; Intensive care medicine; Internal medicine; Computer science; Artificial intelligence","score_opus":0.10481337094114629,"score_gpt":0.351128353095938,"score_spread":0.2463149821547917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748357","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12752818,0.55055493,0.0067997416,0.2172383,0.0020233914,0.000069112095,0.0042844554,0.000064513806,0.09143739],"genre_scores_gemma":[0.8561707,0.1253386,0.0020726006,0.008192829,0.004553211,0.00004949991,0.00096011965,0.000036043562,0.002626426],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972915,0.0018798593,0.0001194066,0.00011893653,0.00036908596,0.00022114757],"domain_scores_gemma":[0.99416095,0.0038379102,0.00096556376,0.00011188229,0.00059040147,0.0003332555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003976411,0.00050441164,0.00089473836,0.0015792247,0.00017112747,0.0029186597,0.00044946859,0.0018531582,0.0048398394],"category_scores_gemma":[0.010699046,0.00020225147,0.0015945481,0.0018959806,0.0009325783,0.0015872779,0.0007868295,0.0021573305,0.00032623045],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008461972,0.0006765549,0.046788216,0.005490681,0.007176704,0.00094475807,0.0002762887,0.06561974,0.0017022643,0.15153489,0.046232127,0.66509587],"study_design_scores_gemma":[0.0030786335,0.0064969556,0.2994204,0.019687034,0.014655655,0.005171582,0.0028414894,0.048684787,0.0027834466,0.23226093,0.36458603,0.00033311604],"about_ca_topic_score_codex":0.0043427157,"about_ca_topic_score_gemma":0.0047935564,"teacher_disagreement_score":0.0048398394,"about_ca_system_score_codex":0.002372007,"about_ca_system_score_gemma":0.001925794,"threshold_uncertainty_score":0.021029472},"labels":[],"label_agreement":null},{"id":"W4405748418","doi":"10.1016/j.jval.2024.10.812","title":"EE532 Budget Impact Analyses of Hemoglobin a1C and Lipid Panel Point-of-Care Testing With Afinion™ 2 in Italy and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); EVERSANA (Canada)","funders":"","keywords":"Point of care; Hemoglobin; Point-of-care testing; Point (geometry); Medicine; Internal medicine; Mathematics; Nursing; Immunology","score_opus":0.13227492991107148,"score_gpt":0.3457175300520665,"score_spread":0.21344260014099503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8581134,0.004524635,0.0009860084,0.01189865,0.00012192282,0.00041198215,0.086622044,0.00011538788,0.03720582],"genre_scores_gemma":[0.9592622,0.0015437091,0.0007990462,0.0008986099,0.000061025476,0.0001368315,0.024293793,0.000044926957,0.012959891],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99588853,0.0008816584,0.00014000706,0.00021018033,0.0010094016,0.0018703357],"domain_scores_gemma":[0.99097973,0.002676653,0.0012877338,0.00028023781,0.0032207821,0.0015548188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033297166,0.00048010843,0.00073639833,0.0017501401,0.0006528784,0.001870782,0.0012423038,0.0008136189,0.003904484],"category_scores_gemma":[0.015985519,0.00047597228,0.0014688581,0.004249275,0.00056696055,0.0005345698,0.0010509898,0.0014324943,0.00024238024],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00762819,0.0007912671,0.69700646,0.00059765467,0.0029701537,0.0006302536,0.00040309117,0.12123623,0.0005306508,0.017069079,0.10572482,0.045412146],"study_design_scores_gemma":[0.00079890835,0.00029254486,0.9471891,0.00018104806,0.0011737001,0.000107807995,0.0009049986,0.022839682,0.00054917537,0.0008901449,0.024985392,0.00008740188],"about_ca_topic_score_codex":0.98969203,"about_ca_topic_score_gemma":0.9889404,"teacher_disagreement_score":0.06467801,"about_ca_system_score_codex":0.06467801,"about_ca_system_score_gemma":0.063635394,"threshold_uncertainty_score":0.46927404},"labels":[],"label_agreement":null},{"id":"W4405748432","doi":"10.1016/j.jval.2024.10.499","title":"EE216 Potential Budget Impact of Using a Cyanoacrylate Polymer Barrier Film Compared to Traditional Methods for the Prevention and Management of Incontinence-Associated Dermatitis in a Canadian Hospital Setting","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cyanoacrylate; Medicine; Materials science; Nanotechnology","score_opus":0.06006695531943868,"score_gpt":0.4336381869858246,"score_spread":0.37357123166638595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89758193,0.007578,0.0009446847,0.014674107,0.00043798843,0.0010682009,0.0066139204,0.00008434558,0.071016856],"genre_scores_gemma":[0.98462486,0.0029045197,0.0021927769,0.0008759313,0.000081379134,0.00014322952,0.00094609504,0.000014614693,0.0082166],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99761766,0.00067477394,0.00009222266,0.000072756666,0.00082814513,0.00071441924],"domain_scores_gemma":[0.99540883,0.0007575746,0.00047518802,0.000057271456,0.0021445227,0.0011565175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013744412,0.00040732842,0.0002699765,0.0015354076,0.0013921461,0.0019135763,0.0010188092,0.0005133115,0.014257874],"category_scores_gemma":[0.007916732,0.00020115946,0.0010255309,0.0014497609,0.0003917444,0.00040926068,0.00087886106,0.00064089,0.0003353057],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011406251,0.0031003994,0.32855,0.0034387696,0.0011536217,0.001129329,0.0007999444,0.0114048105,0.006423904,0.0047911126,0.02516573,0.6026361],"study_design_scores_gemma":[0.0010917298,0.0057609654,0.9425327,0.0013296517,0.001283877,0.0004219411,0.0052202223,0.009008091,0.0026138339,0.0005477937,0.0300781,0.00011124149],"about_ca_topic_score_codex":0.88911134,"about_ca_topic_score_gemma":0.9499369,"teacher_disagreement_score":0.11088866,"about_ca_system_score_codex":0.033631247,"about_ca_system_score_gemma":0.048484843,"threshold_uncertainty_score":0.24401295},"labels":[],"label_agreement":null},{"id":"W4405748454","doi":"10.1016/j.jval.2024.10.380","title":"EE96 Cost-Effectiveness of Finerenone in Chronic Kidney Disease Associated With Type 2 Diabetes: Impact of Recent Guideline Implementation on Results of the FINE-CKD Model","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Guideline; Medicine; Kidney disease; Type 2 diabetes; Intensive care medicine; Diabetes mellitus; Internal medicine; Endocrinology; Pathology","score_opus":0.37561303563688536,"score_gpt":0.48405771936737096,"score_spread":0.1084446837304856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8711431,0.012219766,0.027672907,0.010196589,0.0014894846,0.0010986112,0.037055004,0.00054648926,0.038578037],"genre_scores_gemma":[0.9873388,0.0008201285,0.00312072,0.0007587212,0.00008151717,0.00014620557,0.0044531045,0.00004587489,0.0032348803],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99540126,0.003528988,0.00016867487,0.00027335953,0.0003076167,0.00032015613],"domain_scores_gemma":[0.9891516,0.009184508,0.00050846086,0.0005467585,0.00032154613,0.0002871374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009708994,0.00065551576,0.0022397789,0.000495002,0.0001619542,0.0016308461,0.0013021935,0.0015216004,0.009375051],"category_scores_gemma":[0.021735266,0.00036829038,0.0055809123,0.0008496694,0.0003416041,0.0011387607,0.000842788,0.0024043166,0.00054527767],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07573623,0.0012765519,0.02313304,0.0018822462,0.014079906,0.0003251752,0.000071047965,0.77098614,0.00042973034,0.0108876135,0.01823001,0.08296236],"study_design_scores_gemma":[0.051828314,0.0151595725,0.079919346,0.002034194,0.027677499,0.0005350744,0.00037086717,0.75933427,0.0024458996,0.032591917,0.02781478,0.00028829416],"about_ca_topic_score_codex":0.02105331,"about_ca_topic_score_gemma":0.013116524,"teacher_disagreement_score":0.02105331,"about_ca_system_score_codex":0.0016421316,"about_ca_system_score_gemma":0.0025422608,"threshold_uncertainty_score":0.05134672},"labels":[],"label_agreement":null},{"id":"W4405748456","doi":"10.1016/j.jval.2024.10.550","title":"EE268 Interim Burden of Disease Findings for Myasthenic Gravis-Resource Utilization Epidemiology, Survival, and Treatment Patterns (MG-REST) Study in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Myasthenia gravis; Interim; Epidemiology; Rest (music); Medicine; Interim analysis; Disease; Gerontology; Pediatrics; Internal medicine; Political science; Clinical trial","score_opus":0.1350739069430453,"score_gpt":0.36845275303944097,"score_spread":0.23337884609639567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7777537,0.0036112978,0.00046768755,0.0023494996,0.00013821152,0.0004572836,0.20425099,0.000075780845,0.010895497],"genre_scores_gemma":[0.94735587,0.0025960568,0.00082044094,0.00057937787,0.000057028526,0.00029606064,0.038178094,0.000037657264,0.010079357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886924,0.000095407326,0.00008598038,0.00012947965,0.00038288737,0.00043689428],"domain_scores_gemma":[0.99814236,0.000057748868,0.00031966905,0.000057750905,0.0008757735,0.0005466591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006807522,0.0004804151,0.0010432076,0.0014998778,0.0022432564,0.0014089913,0.0015328235,0.0005361593,0.0035389957],"category_scores_gemma":[0.0019420498,0.0005675047,0.0014053248,0.0051634847,0.00043611464,0.00047821813,0.0010196058,0.0010039628,0.0004767762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003793222,0.000077557306,0.97465974,0.0001460235,0.00034257962,0.00013990009,0.0003042184,0.00030522855,0.00019462885,0.00027144692,0.017576471,0.005602983],"study_design_scores_gemma":[0.00008086295,0.000022810616,0.99738413,0.00007096699,0.000083192885,0.00003477845,0.00035969313,0.0002182802,0.000027532968,0.000027876917,0.0016763958,0.000013503841],"about_ca_topic_score_codex":0.9971095,"about_ca_topic_score_gemma":0.99873513,"teacher_disagreement_score":0.03587628,"about_ca_system_score_codex":0.03587628,"about_ca_system_score_gemma":0.05256435,"threshold_uncertainty_score":0.2603019},"labels":[],"label_agreement":null},{"id":"W4405748469","doi":"10.1016/j.jval.2024.10.481","title":"EE197 The Acute and Long-Term Healthcare Costs Attributable to COVID-19 in Ontario, Canada: A Population-Based Matched Cohort Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Cohort; Term (time); Cohort study; Population; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Demography; Environmental health; Virology; Internal medicine; Disease; Outbreak","score_opus":0.29916564747546304,"score_gpt":0.427069615745116,"score_spread":0.12790396826965295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97450215,0.0008529071,0.00010952587,0.0003695751,0.000031525346,0.00013592084,0.021140788,0.000013495039,0.0028442384],"genre_scores_gemma":[0.9859985,0.0007078602,0.00017179707,0.00022918064,0.00001862212,0.000070734495,0.008112245,0.000010095919,0.0046810405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986966,0.00008779439,0.000114217546,0.00019321924,0.00038146006,0.00052670966],"domain_scores_gemma":[0.99753153,0.00009679827,0.000607994,0.00017844417,0.000981957,0.0006031458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007721731,0.0005303197,0.0006447223,0.0017604053,0.003141017,0.0018463044,0.0015883067,0.00094944186,0.0037940843],"category_scores_gemma":[0.0021403937,0.00085136,0.0015714862,0.0059981486,0.0007674855,0.00073275086,0.0011634324,0.001291655,0.00065891433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018911436,0.00006696395,0.99588263,0.00003113148,0.00016050998,0.00009203496,0.00035378654,0.0000673172,0.000084764346,0.000100231104,0.001533407,0.001438126],"study_design_scores_gemma":[0.000020396206,0.000019213492,0.9985837,0.00001809801,0.00003996378,0.0000250096,0.00047314525,0.00009558229,0.000015856096,0.00001512666,0.00068458536,0.00000935079],"about_ca_topic_score_codex":0.9956409,"about_ca_topic_score_gemma":0.99697506,"teacher_disagreement_score":0.033832684,"about_ca_system_score_codex":0.033832684,"about_ca_system_score_gemma":0.03106808,"threshold_uncertainty_score":0.24547446},"labels":[],"label_agreement":null},{"id":"W4405748494","doi":"10.1016/j.jval.2024.10.664","title":"EE383 Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Transfusion-Dependent Beta-Thalassemia in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Beta thalassemia; Thalassemia; BETA (programming language); Intensive care medicine; Pediatrics; Internal medicine; Computer science","score_opus":0.026058857572268435,"score_gpt":0.29280428000657566,"score_spread":0.2667454224343072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93457377,0.0004458533,0.003537043,0.0013345472,0.000076018136,0.00009452186,0.049062382,0.00025667768,0.010619279],"genre_scores_gemma":[0.9812832,0.00018474275,0.0010116226,0.000085252905,0.000007327582,0.00003761942,0.012476756,0.000023350542,0.004890191],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996604,0.00005721818,0.000012667771,0.00006382772,0.00005769693,0.0001482524],"domain_scores_gemma":[0.99893695,0.00024376015,0.00008185166,0.000032996082,0.0005450144,0.00015949663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006241035,0.00047582388,0.0004756085,0.0005020162,0.0003381983,0.0011971268,0.0010117091,0.00054294,0.006652755],"category_scores_gemma":[0.0020689415,0.0003067609,0.001306386,0.0008588167,0.00032666925,0.0003515698,0.00041136215,0.0007401423,0.00051663874],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010189378,0.00021398706,0.16022328,0.0001434403,0.000568882,0.00019401473,0.000096908574,0.8074238,0.00046115668,0.0048817624,0.014908759,0.009865198],"study_design_scores_gemma":[0.0002944444,0.00024560894,0.165615,0.00009856804,0.0002948395,0.0001350976,0.0005312053,0.82296085,0.000497161,0.0018370891,0.0073974417,0.000092758375],"about_ca_topic_score_codex":0.9568386,"about_ca_topic_score_gemma":0.9178438,"teacher_disagreement_score":0.043161392,"about_ca_system_score_codex":0.014282128,"about_ca_system_score_gemma":0.013739825,"threshold_uncertainty_score":0.10362458},"labels":[],"label_agreement":null},{"id":"W4405748558","doi":"10.1016/j.jval.2024.10.297","title":"EE13 A Cost-Consequence Analysis of Chimeric Antigen Receptor T-Cell Therapy in Patients With Relapsed or Refractory Large B-Cell Lymphoma Across Gulf Cooperation Council Countries","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Chimeric antigen receptor; Refractory (planetary science); Medicine; Lymphoma; Oncology; Cancer research; Internal medicine; Immunotherapy; Biology; Cancer","score_opus":0.051855495934935936,"score_gpt":0.33293342912135687,"score_spread":0.28107793318642094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998711,0.00021240867,0.000102328995,0.000075282405,0.0000040316077,0.000028815915,0.00022492177,0.0000029979801,0.00063819514],"genre_scores_gemma":[0.99914443,0.00007797909,0.00008736152,0.00005824373,0.0000043202544,0.000016548202,0.00036083706,0.0000026279845,0.0002476141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99934465,0.00033031355,0.000044640627,0.00006775181,0.00007149761,0.00014113015],"domain_scores_gemma":[0.9991303,0.00036227063,0.00016461547,0.000056147765,0.0001209185,0.00016578288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016161937,0.0003043146,0.0005973869,0.00043960544,0.0003015165,0.00079937297,0.00030158059,0.00042443525,0.0018890081],"category_scores_gemma":[0.0017276503,0.00014533778,0.0007072556,0.00085346936,0.00026313443,0.00029663113,0.0003138746,0.0005294212,0.00016002495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17420687,0.003421293,0.644324,0.0002800129,0.0021291361,0.001894708,0.00065382454,0.01990327,0.018353239,0.0012379456,0.0025799305,0.1310158],"study_design_scores_gemma":[0.0042124363,0.030608771,0.946973,0.000051663385,0.0015472609,0.00092746934,0.0007773041,0.006689747,0.003414015,0.00026723754,0.004502505,0.000028520673],"about_ca_topic_score_codex":0.010108831,"about_ca_topic_score_gemma":0.0072043496,"teacher_disagreement_score":0.010108831,"about_ca_system_score_codex":0.0017797821,"about_ca_system_score_gemma":0.0008673465,"threshold_uncertainty_score":0.020099998},"labels":[],"label_agreement":null},{"id":"W4405748612","doi":"10.1016/j.jval.2024.10.194","title":"CO118 Indirect Treatment Comparison (ITC) of Avalglucosidase Alfa (AVA) vs Cipaglucosidase Alfa Plus Miglustat (Cipa+mig) in Late-Onset Pompe Disease (LOPD): An Updated Analysis Using Mixed-Model Repeated Measures (MMRM) Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Medicine; Repeated measures design; Meta-analysis; Internal medicine; Statistics; Mathematics","score_opus":0.18313315669010735,"score_gpt":0.4152520589535186,"score_spread":0.23211890226341123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8026865,0.12875879,0.02878233,0.0018344793,0.010271951,0.0033849692,0.01713211,0.0009500195,0.0061988244],"genre_scores_gemma":[0.9702078,0.004688375,0.012030298,0.0011452988,0.00064416946,0.0037355928,0.0030726446,0.0002365204,0.0042391825],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97269946,0.019513708,0.0016984354,0.0036764292,0.0014389054,0.0009731461],"domain_scores_gemma":[0.98273426,0.0122182695,0.0018671198,0.0019501465,0.00074864354,0.00048158612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015052007,0.0024712135,0.009847904,0.0011621618,0.0005325523,0.0016880889,0.0021340074,0.002387367,0.009762588],"category_scores_gemma":[0.02590393,0.0011232198,0.02367504,0.0011848165,0.00087731105,0.0022409512,0.0014931465,0.004830137,0.000798811],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6281495,0.0006558238,0.009368825,0.0072861603,0.31768855,0.00013321685,0.00018444775,0.0013260937,0.001150181,0.0007912205,0.0030492798,0.030216817],"study_design_scores_gemma":[0.31591356,0.04824524,0.06414191,0.0023425394,0.5435806,0.0003325759,0.00035001084,0.009868279,0.0025708692,0.003361849,0.0089878775,0.00030469734],"about_ca_topic_score_codex":0.0056716744,"about_ca_topic_score_gemma":0.008412711,"teacher_disagreement_score":0.015052007,"about_ca_system_score_codex":0.0013299381,"about_ca_system_score_gemma":0.0014251065,"threshold_uncertainty_score":0.07960355},"labels":[],"label_agreement":null},{"id":"W4405748614","doi":"10.1016/j.jval.2024.10.912","title":"EE632 Early Cost-Effectiveness of SPECTRISTM (Gamma Band Stimulation) in Mild-Moderate Alzheimer's Disease Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Disease; Stimulation; Medicine; Alzheimer's disease; Audiology; Internal medicine","score_opus":0.08826970400360652,"score_gpt":0.3375529165096493,"score_spread":0.2492832125060428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908631,0.0052939565,0.00019801738,0.0005315186,0.00009269583,0.00009319362,0.00067978597,0.000018339646,0.0022295213],"genre_scores_gemma":[0.99815035,0.0008028064,0.00016304557,0.00009790663,0.00005332776,0.00003205323,0.00032554445,0.000001675243,0.0003733909],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9996855,0.00016069447,0.000027885046,0.00003297562,0.000031697768,0.00006122539],"domain_scores_gemma":[0.99957937,0.0001903052,0.00006709423,0.000013039824,0.000022117862,0.00012808462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005081449,0.00047263788,0.0010068029,0.00034067107,0.00017103253,0.0006457828,0.00023268105,0.00059585465,0.004866891],"category_scores_gemma":[0.0015960862,0.00012734505,0.0021316744,0.00033214228,0.00017941982,0.00040519235,0.0003235031,0.0005814432,0.00023813857],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7142085,0.0065097637,0.05472495,0.0010751861,0.003991659,0.00064081297,0.00007640577,0.0039313296,0.0027179532,0.00066320505,0.0015390016,0.20992127],"study_design_scores_gemma":[0.1156412,0.18297234,0.6536788,0.0011987573,0.01829477,0.0012353823,0.0005835644,0.015021384,0.003267404,0.002134374,0.0058063692,0.00016567187],"about_ca_topic_score_codex":0.0044059805,"about_ca_topic_score_gemma":0.004762203,"teacher_disagreement_score":0.004866891,"about_ca_system_score_codex":0.0008778513,"about_ca_system_score_gemma":0.0007018486,"threshold_uncertainty_score":0.016281366},"labels":[],"label_agreement":null},{"id":"W4405748627","doi":"10.1016/j.jval.2024.10.104","title":"CO27 Comparative Effectiveness of the mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Canadians: A Systematic Literature Review and Meta-Analysis Using the Grade Framework","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Meta-analysis; Coronavirus disease 2019 (COVID-19); Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Systematic review; Virology; MEDLINE; Internal medicine; Political science","score_opus":0.1561629036415784,"score_gpt":0.4464693482229846,"score_spread":0.2903064445814062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019399557,0.97418165,0.0010012756,0.00063255563,0.0003912227,0.00063958275,0.0027116449,0.0000352306,0.0010073037],"genre_scores_gemma":[0.62555844,0.36208802,0.0049931114,0.002024073,0.00038751095,0.001441133,0.0023885255,0.00006325387,0.0010559389],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9844694,0.0064727184,0.0035960986,0.0019519408,0.002613858,0.00089594425],"domain_scores_gemma":[0.9835746,0.009304515,0.0036087949,0.000584963,0.0025073746,0.00041967022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0167301,0.0023076083,0.011630692,0.005526638,0.00097093306,0.003788431,0.0021043762,0.002564364,0.0040050284],"category_scores_gemma":[0.042745665,0.0012105758,0.038039435,0.007722559,0.001092021,0.0016617799,0.0017106973,0.0024853284,0.00027921147],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073185605,0.00003713217,0.012083338,0.16483189,0.7978066,0.00008239822,0.00015718171,0.0005646744,0.00028789302,0.00029419383,0.0010576579,0.015478483],"study_design_scores_gemma":[0.0029095784,0.0004105799,0.01163084,0.015819436,0.9657823,0.000059009773,0.00011142129,0.00026345378,0.00011559361,0.00026866788,0.002578802,0.00005041817],"about_ca_topic_score_codex":0.18313175,"about_ca_topic_score_gemma":0.27320105,"teacher_disagreement_score":0.81686825,"about_ca_system_score_codex":0.009060096,"about_ca_system_score_gemma":0.01194601,"threshold_uncertainty_score":0.36413163},"labels":[],"label_agreement":null},{"id":"W4405748638","doi":"10.1016/j.jval.2024.10.149","title":"CO72 Bimekizumab: Matching-Adjusted Indirect Comparison (MAIC) to Establish 1-Year Comparative Efficacy in Moderate-to-Severe Hidradenitis Suppurativa (HS)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Matching (statistics); Dermatology; Internal medicine; Pathology; Disease","score_opus":0.09017976404629989,"score_gpt":0.3667754024634378,"score_spread":0.2765956384171379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603108,0.02315956,0.00451004,0.00041671327,0.0019684583,0.0021868537,0.0025815198,0.00014346681,0.0047225747],"genre_scores_gemma":[0.99473876,0.00095671974,0.0017278399,0.00019902788,0.00015192461,0.0008060541,0.00052415964,0.000013419509,0.0008821775],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9851511,0.011527767,0.0008471302,0.001007118,0.0005876294,0.00087920844],"domain_scores_gemma":[0.9947753,0.003265094,0.00067121483,0.0006889948,0.0002560781,0.00034331132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010068829,0.0020567754,0.005478043,0.00087393535,0.00048167864,0.001360115,0.0014352868,0.0021351825,0.006232263],"category_scores_gemma":[0.010577084,0.00088322174,0.007178108,0.0007241937,0.0009216812,0.0016539611,0.0013343545,0.003223235,0.00047988328],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9665122,0.0007767827,0.0022676901,0.0011818508,0.017230304,0.000029388195,0.00007401987,0.0005752407,0.0006051119,0.00038976502,0.0003427099,0.010014854],"study_design_scores_gemma":[0.74425095,0.1432448,0.027315963,0.000654562,0.06547907,0.00016761014,0.00029987074,0.009113792,0.0026434115,0.0026972531,0.0039657694,0.00016697994],"about_ca_topic_score_codex":0.0022252684,"about_ca_topic_score_gemma":0.003058779,"teacher_disagreement_score":0.010068829,"about_ca_system_score_codex":0.0010568862,"about_ca_system_score_gemma":0.001049346,"threshold_uncertainty_score":0.053249717},"labels":[],"label_agreement":null},{"id":"W4405748641","doi":"10.1016/j.jval.2024.10.146","title":"CO69 Indirect Treatment Comparison of Iptacopan Versus Eculizumab and Ravulizumab for Patients With Paroxysmal Nocturnal Hemoglobinuria Naive to C5 Inhibitors","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Medicine; Hemoglobinuria; Pediatrics; Nocturnal; Internal medicine; Anemia; Immunology; Antibody","score_opus":0.03893164327873158,"score_gpt":0.3228429782890934,"score_spread":0.2839113350103618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856778,0.00992151,0.00023482679,0.00038232704,0.0003654031,0.00014466776,0.00023579421,0.000038659036,0.002999027],"genre_scores_gemma":[0.99638844,0.0016858078,0.00027404167,0.00017166727,0.0001613988,0.00008183873,0.0002103789,0.0000046338096,0.0010218162],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99954814,0.00019649493,0.000035547007,0.00006956003,0.000052225703,0.00009806674],"domain_scores_gemma":[0.9994411,0.00020322822,0.00012399195,0.000022727589,0.000030553372,0.00017837447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005297758,0.0007127173,0.0024509542,0.0002474831,0.00019556614,0.0007049913,0.0004532272,0.0006779226,0.005237025],"category_scores_gemma":[0.0010133446,0.0003518828,0.0013983506,0.00022191646,0.00032864913,0.00064587296,0.00029205673,0.0019459391,0.00057777116],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91811216,0.002501586,0.0020061778,0.00078142143,0.0023075521,0.000104210485,0.00005692896,0.00060413,0.0051109893,0.00020194275,0.0007601706,0.06745265],"study_design_scores_gemma":[0.56559604,0.34338984,0.06471363,0.0004048619,0.009841007,0.0006407016,0.00020789566,0.005266547,0.0046991548,0.00044001863,0.0047001587,0.00010022794],"about_ca_topic_score_codex":0.0012597085,"about_ca_topic_score_gemma":0.0030201338,"teacher_disagreement_score":0.005237025,"about_ca_system_score_codex":0.0006639384,"about_ca_system_score_gemma":0.00070414186,"threshold_uncertainty_score":0.017519534},"labels":[],"label_agreement":null},{"id":"W4405748662","doi":"10.1016/j.jval.2024.10.035","title":"P27 Considerations for Model Conceptualisation When Using Surrogate Outcomes to Inform HTA Decision-Making","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Management science; Surrogate endpoint; Computer science; Medicine; Economics; Internal medicine","score_opus":0.6727815166926427,"score_gpt":0.5096488769537425,"score_spread":0.16313263973890024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748662","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063982555,0.002538018,0.7787235,0.14433645,0.0033049723,0.0006364419,0.0018968366,0.00060501776,0.06156055],"genre_scores_gemma":[0.3506551,0.0027119247,0.60691434,0.021490933,0.0028295498,0.0030806293,0.0015956127,0.0011011576,0.009620809],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.93573356,0.05366719,0.0026965665,0.0015738558,0.0055794683,0.0007494471],"domain_scores_gemma":[0.7869005,0.1810467,0.0044893906,0.0096405605,0.016136281,0.0017865459],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08103038,0.0014115181,0.0020466559,0.002627663,0.0026358536,0.016118173,0.0064011062,0.006813263,0.020849781],"category_scores_gemma":[0.29538947,0.0015294891,0.0041518174,0.0032649375,0.010563489,0.017578604,0.0066581117,0.01849306,0.004016902],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010248323,0.0000535963,0.0008574149,0.0004261801,0.0001331289,0.00019571796,0.001534124,0.014610792,0.0001338737,0.92888284,0.025951277,0.027118502],"study_design_scores_gemma":[0.000048350306,0.000029284165,0.0002766039,0.00075762515,0.000040186853,0.00015227243,0.0007475249,0.025713155,0.00017832272,0.9367172,0.035288926,0.000050518218],"about_ca_topic_score_codex":0.011563026,"about_ca_topic_score_gemma":0.009863464,"teacher_disagreement_score":0.91896963,"about_ca_system_score_codex":0.0059036543,"about_ca_system_score_gemma":0.008558949,"threshold_uncertainty_score":0.42853475},"labels":[],"label_agreement":null},{"id":"W4405748680","doi":"10.1016/j.jval.2024.10.157","title":"CO81 Pregabalin Utilization and Side Effects Among Hemodialysis Patients Diagnosed With Pruritus or Neuropathic Pain in US Claims Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Pregabalin; Medicine; Neuropathic pain; Hemodialysis; Side effect (computer science); Intensive care medicine; Anesthesia; Internal medicine; Computer science","score_opus":0.04647238403271562,"score_gpt":0.29839163782303063,"score_spread":0.251919253790315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856769,0.0012349222,0.00015301922,0.00016162143,0.000017103908,0.000017990316,0.010388,0.000012972541,0.002337505],"genre_scores_gemma":[0.99577004,0.00022958677,0.00008615269,0.00007664429,0.00001644457,0.000010131687,0.0035701743,0.0000038462153,0.00023677367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887687,0.00025661165,0.00028642552,0.00015266766,0.00026623427,0.00016115725],"domain_scores_gemma":[0.9922833,0.00246477,0.004113584,0.00037960548,0.00043118888,0.00032751416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008746698,0.00018202246,0.00031694566,0.0016456995,0.000288708,0.0010369311,0.0003126334,0.00036944466,0.0035086246],"category_scores_gemma":[0.0077389902,0.00019288075,0.0008317164,0.0034926212,0.00021181062,0.00062936737,0.00048768116,0.0005417523,0.00031555933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030974307,0.000048933183,0.9955238,0.000053409814,0.00023491736,0.00008877521,0.0000457931,0.0001329433,0.00016893503,0.000101398,0.000582053,0.0027092875],"study_design_scores_gemma":[0.000016104874,0.0000431219,0.9977118,0.000042191332,0.00009867529,0.00028988125,0.00014811843,0.0007106902,0.00010892245,0.00008717196,0.00073579757,0.000007631164],"about_ca_topic_score_codex":0.016633423,"about_ca_topic_score_gemma":0.017333388,"teacher_disagreement_score":0.016633423,"about_ca_system_score_codex":0.0006592027,"about_ca_system_score_gemma":0.00062952004,"threshold_uncertainty_score":0.033073187},"labels":[],"label_agreement":null},{"id":"W4405748686","doi":"10.1016/j.jval.2024.10.090","title":"CO13 Impact on Health Outcomes and Productive Work of Anti-PD-(L)1 Inhibitors to Treat Early-Stage Cancers in England","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Stage (stratigraphy); Medicine; Oncology; Internal medicine; Biology","score_opus":0.03250610740754499,"score_gpt":0.35414556125140906,"score_spread":0.32163945384386405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311148,0.012086018,0.00020751807,0.019443886,0.0004846509,0.00007170757,0.025319882,0.000026229704,0.011245293],"genre_scores_gemma":[0.98436916,0.0032706796,0.000086879125,0.0017171524,0.00016519574,0.00008182066,0.0037610824,0.000015704232,0.006532354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998181,0.00047025143,0.00023100927,0.00018318534,0.00022410949,0.0007105604],"domain_scores_gemma":[0.9943566,0.0006434142,0.0020728824,0.00012744832,0.0007359269,0.0020637948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008522718,0.00019471342,0.00048810436,0.0005960259,0.00042299833,0.0013047135,0.00054780836,0.00065452163,0.006219571],"category_scores_gemma":[0.005205201,0.0002736747,0.00084045116,0.0012724482,0.00039343003,0.0008148141,0.0017265888,0.0014657826,0.00064963754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031377096,0.00031667933,0.91674817,0.0010642183,0.0007809089,0.00048403232,0.0017863687,0.0009523833,0.0004998913,0.0021429996,0.02112403,0.050962612],"study_design_scores_gemma":[0.00012931312,0.00020190421,0.9905974,0.00024904753,0.00009451047,0.00006962686,0.00088632933,0.00014776982,0.00007361192,0.00014737027,0.0073795305,0.000023388564],"about_ca_topic_score_codex":0.30422992,"about_ca_topic_score_gemma":0.3337459,"teacher_disagreement_score":0.30422992,"about_ca_system_score_codex":0.00493877,"about_ca_system_score_gemma":0.004127975,"threshold_uncertainty_score":0.60491824},"labels":[],"label_agreement":null},{"id":"W4405748689","doi":"10.1016/j.jval.2024.10.043","title":"P33 Transportability Analysis Methods for External Validity Assessment of Randomized Clinical Trial Evidence for Health Technology Assessment Decision-Making: A Simulation Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Randomized controlled trial; Clinical decision making; External validity; Medical physics; Medicine; Psychology; Family medicine; Internal medicine; Social psychology","score_opus":0.7853713964655666,"score_gpt":0.7015007708221598,"score_spread":0.08387062564340686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748689","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072748926,0.0013081894,0.9831129,0.0011566848,0.0002162323,0.00245275,0.0007736741,0.00046486256,0.0032397981],"genre_scores_gemma":[0.3405093,0.0015375853,0.6343524,0.001048492,0.00031571774,0.015369301,0.0011215713,0.0009311813,0.0048144516],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.7847053,0.19934188,0.0063639306,0.004086026,0.0048897406,0.0006131678],"domain_scores_gemma":[0.18966074,0.77474463,0.012191057,0.013828289,0.008916498,0.00065877935],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2078608,0.0026379882,0.0025948826,0.005680722,0.0013200534,0.004854475,0.0025837584,0.0042109923,0.042391393],"category_scores_gemma":[0.59087795,0.0017064299,0.012435807,0.003944296,0.002927745,0.006599584,0.0039272774,0.0063069128,0.0022406122],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008760118,0.00085468724,0.021548932,0.0059852065,0.014263761,0.0006924076,0.001477153,0.2860978,0.0008174139,0.26589137,0.022088224,0.37152296],"study_design_scores_gemma":[0.0028116114,0.0013725287,0.003937055,0.0022631814,0.0026989898,0.00044975698,0.0002307484,0.7163288,0.0010576413,0.25918093,0.009500779,0.00016796577],"about_ca_topic_score_codex":0.00571955,"about_ca_topic_score_gemma":0.002255776,"teacher_disagreement_score":0.7921392,"about_ca_system_score_codex":0.0039873514,"about_ca_system_score_gemma":0.005601698,"threshold_uncertainty_score":0.97684866},"labels":[],"label_agreement":null},{"id":"W4405748692","doi":"10.1016/j.jval.2024.10.918","title":"EE638 Long COVID: A Costly Condition Imposing Substantial Burden on Society","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Intensive care medicine; Virology; Internal medicine; Outbreak; Disease","score_opus":0.10056519723844838,"score_gpt":0.43358254830686316,"score_spread":0.3330173510684148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748692","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08052075,0.017345455,0.0020688986,0.31057075,0.0071527422,0.00017909239,0.0068225656,0.00037536994,0.5749644],"genre_scores_gemma":[0.65123653,0.015984109,0.0033812197,0.15027332,0.009347999,0.00023232878,0.005841794,0.00027576808,0.16342692],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99463624,0.0012731748,0.00031216186,0.00023078523,0.0022333632,0.0013141604],"domain_scores_gemma":[0.97772104,0.004705786,0.0044673337,0.0010870305,0.004885223,0.007133532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004664352,0.00029702674,0.0004222637,0.0014539271,0.0030932717,0.004401446,0.0006293992,0.002763461,0.073919915],"category_scores_gemma":[0.024197828,0.00020621848,0.00062629086,0.0016475533,0.0015718626,0.0017471388,0.0037682122,0.0038677999,0.009662625],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041207613,0.00033303353,0.08462318,0.0003595889,0.00015295477,0.0017249375,0.00046806788,0.0002810568,0.0005842911,0.051981825,0.6231866,0.2358924],"study_design_scores_gemma":[0.0000708467,0.00024152572,0.07911104,0.0013831193,0.000078728124,0.0029529794,0.002238989,0.00035516746,0.00039238017,0.01622083,0.89688045,0.00007401214],"about_ca_topic_score_codex":0.01681777,"about_ca_topic_score_gemma":0.04293502,"teacher_disagreement_score":0.073919915,"about_ca_system_score_codex":0.0050359676,"about_ca_system_score_gemma":0.010965756,"threshold_uncertainty_score":0.2472868},"labels":[],"label_agreement":null},{"id":"W4405748696","doi":"10.1016/j.jval.2024.10.065","title":"P51 The State of the Art in Antimicrobial Resistance Economic Modelling: Is the STEDI Framework Being Used to Capture Value?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Value (mathematics); State (computer science); Antimicrobial; Resistance (ecology); Economics; Computer science; Biology; Microbiology; Machine learning; Ecology; Algorithm","score_opus":0.022300133294799806,"score_gpt":0.26338667335583443,"score_spread":0.24108654006103464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748696","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03339319,0.039701864,0.7699402,0.07848969,0.0016102616,0.0001562261,0.0016890514,0.0003977714,0.0746217],"genre_scores_gemma":[0.82135934,0.035683542,0.123778574,0.0045414176,0.0016118006,0.0003251086,0.0009679171,0.0005281338,0.011204209],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926843,0.0056801178,0.00018539732,0.000394729,0.0007492548,0.0003061639],"domain_scores_gemma":[0.94837296,0.045425296,0.001255583,0.0018980249,0.0024564657,0.00059167464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016040748,0.0013609158,0.0031007077,0.0014697963,0.00069356774,0.007752723,0.004151717,0.0035960297,0.010770775],"category_scores_gemma":[0.06263772,0.0008788853,0.0018185984,0.003807707,0.0035531928,0.010491061,0.002641619,0.0074249734,0.001386291],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011754802,0.00009055911,0.0015303784,0.000820684,0.00021492767,0.000051892104,0.00017347407,0.17309399,0.000087172026,0.7427406,0.008193715,0.072885096],"study_design_scores_gemma":[0.000022309821,0.000042465148,0.00029057713,0.000568179,0.000034250155,0.000025712408,0.00009687404,0.30179,0.00011409056,0.6834643,0.013516572,0.000034646124],"about_ca_topic_score_codex":0.011997234,"about_ca_topic_score_gemma":0.006247902,"teacher_disagreement_score":0.016040748,"about_ca_system_score_codex":0.0034982935,"about_ca_system_score_gemma":0.0041620107,"threshold_uncertainty_score":0.08483255},"labels":[],"label_agreement":null},{"id":"W4405748699","doi":"10.1016/j.jval.2024.10.086","title":"CO9 Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Esophageal squamous cell carcinoma; Oncology; Internal medicine; Basal cell; Radiology; Carcinoma","score_opus":0.02869704540771885,"score_gpt":0.344214212341326,"score_spread":0.31551716693360715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009261891,0.96915764,0.0006018827,0.0009674744,0.00039996416,0.0014631992,0.016309023,0.00005320947,0.0017856321],"genre_scores_gemma":[0.16612871,0.8129504,0.0042357254,0.0038826668,0.0004048711,0.0038550487,0.0073918696,0.000056065517,0.001094695],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98117036,0.0060809865,0.008379302,0.0016825021,0.0020767343,0.00061007595],"domain_scores_gemma":[0.9588448,0.025499696,0.010142423,0.0011419789,0.00378042,0.0005906242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010845839,0.0013167799,0.0071477825,0.017475646,0.0008006369,0.0026763144,0.0012932011,0.0015246826,0.009098075],"category_scores_gemma":[0.059785932,0.0009686572,0.017065726,0.012592292,0.0009394081,0.0018489276,0.002714948,0.0011770042,0.00076889497],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060657767,0.000017367782,0.0074059046,0.89575666,0.076182336,0.000108149885,0.00016331673,0.00010094983,0.0002622796,0.00016431828,0.0023602752,0.016871937],"study_design_scores_gemma":[0.0012378291,0.0003401518,0.025272505,0.56122255,0.3908819,0.0004105484,0.00028245477,0.00012535798,0.0002499474,0.00035760296,0.019549318,0.0000697546],"about_ca_topic_score_codex":0.021042338,"about_ca_topic_score_gemma":0.06464817,"teacher_disagreement_score":0.021042338,"about_ca_system_score_codex":0.0037242004,"about_ca_system_score_gemma":0.012317145,"threshold_uncertainty_score":0.05735898},"labels":[],"label_agreement":null},{"id":"W4405748702","doi":"10.1016/j.jval.2024.10.234","title":"CO158 Loss of Ambulation (LOA) in Patients With Limb-Girdle Muscular Dystrophy (LGMD) Sarcoglycanopathy Subtypes: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Limb-girdle muscular dystrophy; Physical medicine and rehabilitation; Medicine; Muscular dystrophy; Physical therapy; Biology; Internal medicine; Genetics; Mutation","score_opus":0.05578913662193507,"score_gpt":0.31759178252274456,"score_spread":0.2618026459008095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007040127,0.9986683,0.00004072957,0.000070875765,0.00005316851,0.000040923038,0.00030304748,0.000002942446,0.00011596835],"genre_scores_gemma":[0.0109598525,0.9880613,0.0002225713,0.00034263637,0.00004744102,0.00008546073,0.00019136099,0.000002440412,0.000086771855],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99833375,0.00035593845,0.0007343038,0.0002363061,0.0002622429,0.000077429446],"domain_scores_gemma":[0.9957695,0.0027153746,0.0010521357,0.000052468848,0.00032719996,0.00008344224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021892772,0.0010774436,0.006842488,0.004612934,0.00032767706,0.0016925032,0.0012167066,0.0014777425,0.004463631],"category_scores_gemma":[0.008354332,0.0006737608,0.0063939556,0.0056951423,0.0004878671,0.0011311021,0.0012470934,0.001039773,0.0002878332],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054614793,0.000029891393,0.002556253,0.891711,0.03148238,0.00017629811,0.00016494369,0.00012419415,0.00026133287,0.00022521536,0.0033019509,0.06942041],"study_design_scores_gemma":[0.0010903807,0.00037006303,0.020894699,0.61908746,0.31615144,0.0010584884,0.00046736133,0.00014785067,0.00020925966,0.00046213804,0.03993151,0.00012940017],"about_ca_topic_score_codex":0.010901222,"about_ca_topic_score_gemma":0.038423683,"teacher_disagreement_score":0.010901222,"about_ca_system_score_codex":0.001388801,"about_ca_system_score_gemma":0.0036756387,"threshold_uncertainty_score":0.021675527},"labels":[],"label_agreement":null},{"id":"W4405748706","doi":"10.1016/j.jval.2024.10.328","title":"EE44 The Economic and Environmental Burden of Hydrophilic and Hydrophobic IOLs in the UK","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Water Resources and Management","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Natural resource economics; Medicine; Economics","score_opus":0.01262310359533814,"score_gpt":0.2199379437897915,"score_spread":0.20731484019445337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6983825,0.050619528,0.00057796814,0.13193318,0.0014701722,0.00009641519,0.006009138,0.000053190353,0.11085797],"genre_scores_gemma":[0.81298745,0.04123324,0.00053758884,0.010475595,0.0007174687,0.00006424945,0.0010890755,0.000044006818,0.13285132],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907434,0.0002020051,0.00007620972,0.000060667917,0.00032960784,0.00025711072],"domain_scores_gemma":[0.9982343,0.00048368747,0.0004138611,0.000045925048,0.0003012469,0.00052088435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095865666,0.00015927613,0.00024694568,0.00087613566,0.00066213304,0.0024019834,0.00019426964,0.0015650898,0.027756521],"category_scores_gemma":[0.0021516227,0.00024734487,0.00046237695,0.0010962099,0.0010812583,0.0007815057,0.0016859046,0.001189226,0.0009949409],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005007725,0.0003958538,0.14230879,0.0035042237,0.00025386908,0.009388044,0.005613783,0.0033875676,0.01393985,0.0628208,0.2219012,0.5314783],"study_design_scores_gemma":[0.00011936452,0.0006824481,0.4113464,0.001335408,0.000045423425,0.0013673202,0.0057738423,0.0006823186,0.0008863665,0.0016444639,0.57602966,0.000086921726],"about_ca_topic_score_codex":0.15851623,"about_ca_topic_score_gemma":0.22822125,"teacher_disagreement_score":0.15851623,"about_ca_system_score_codex":0.007076305,"about_ca_system_score_gemma":0.0054803165,"threshold_uncertainty_score":0.3151871},"labels":[],"label_agreement":null},{"id":"W4405748713","doi":"10.1016/j.jval.2024.10.235","title":"CO159 Challenges on Outcomes Selection Along Early to Late Phase Clinical Trials of Drug Development: Survey to Experts in Neurosciences Drug Development","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TRIUMF","funders":"","keywords":"Drug development; Drug; Selection (genetic algorithm); Drug trial; Medicine; Clinical trial; Intensive care medicine; Pharmacology; Computer science; Internal medicine; Artificial intelligence","score_opus":0.7950016488013655,"score_gpt":0.5719902155305575,"score_spread":0.22301143327080797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748713","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4406593,0.009960546,0.006096544,0.49634778,0.00077929965,0.00042551034,0.0025691395,0.00006586182,0.043096013],"genre_scores_gemma":[0.9218772,0.0055000302,0.0053505027,0.061721094,0.00082847645,0.00041848427,0.00095376244,0.00007922226,0.0032711397],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9447953,0.03162474,0.0058394624,0.002256375,0.011063665,0.004420377],"domain_scores_gemma":[0.50605077,0.3298122,0.050237518,0.009513803,0.077204935,0.027180837],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11637702,0.00023119918,0.00058155484,0.0027603288,0.0030744649,0.005562112,0.0010611811,0.0040815305,0.007873503],"category_scores_gemma":[0.35468784,0.00046107004,0.00081868883,0.002666971,0.0019247843,0.0047520325,0.0042260857,0.004295381,0.0012654081],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008592608,0.0006566885,0.615365,0.0008057372,0.00027659922,0.00043057362,0.011598188,0.0008904645,0.0004798563,0.009121135,0.09666837,0.26284808],"study_design_scores_gemma":[0.0002511154,0.0008288131,0.7229366,0.0039311107,0.00021702898,0.0013153565,0.048257876,0.0030073884,0.0009362432,0.019013772,0.19906813,0.00023660832],"about_ca_topic_score_codex":0.009418286,"about_ca_topic_score_gemma":0.017490897,"teacher_disagreement_score":0.883623,"about_ca_system_score_codex":0.004851228,"about_ca_system_score_gemma":0.015589069,"threshold_uncertainty_score":0.61546785},"labels":[],"label_agreement":null},{"id":"W4405748745","doi":"10.1016/j.jval.2024.10.020","title":"P16 Standardized Implementation of a Personalized Endpoint: Inventory-Facilitated Goal Attainment Scaling","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Complex Systems and Decision Making","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Scaling; Computer science; Psychology; Mathematics; Neuroscience","score_opus":0.19447428401088468,"score_gpt":0.4728301859456369,"score_spread":0.27835590193475224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748745","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23394935,0.0003803455,0.6005855,0.0030517133,0.0013269046,0.024619166,0.013807561,0.013883692,0.108395725],"genre_scores_gemma":[0.38410318,0.000311824,0.5660689,0.00057967735,0.00014226923,0.023676611,0.005671349,0.0013609362,0.018085279],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887971,0.0057738703,0.0013283567,0.0010343433,0.0026041914,0.00046210497],"domain_scores_gemma":[0.9733114,0.00998782,0.0023668748,0.006225599,0.0071677356,0.00094054174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014145064,0.00085383654,0.00068451994,0.0012149289,0.00071740604,0.0031149816,0.0015293275,0.0007725776,0.023283996],"category_scores_gemma":[0.050041925,0.00060712214,0.000990775,0.0014865651,0.0006885664,0.001329053,0.0030625095,0.0020751827,0.007870706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025247857,0.0023362467,0.027095094,0.00070221676,0.0001325064,0.00015114807,0.0026645376,0.0061655594,0.008002782,0.01139518,0.045721572,0.89310837],"study_design_scores_gemma":[0.003705304,0.014064769,0.27398676,0.0021007597,0.0005157834,0.00080674444,0.0032277196,0.11746977,0.13878277,0.04125765,0.40321806,0.000863998],"about_ca_topic_score_codex":0.0023269465,"about_ca_topic_score_gemma":0.0025064955,"teacher_disagreement_score":0.023283996,"about_ca_system_score_codex":0.0011611339,"about_ca_system_score_gemma":0.005400634,"threshold_uncertainty_score":0.07789272},"labels":[],"label_agreement":null},{"id":"W4405748749","doi":"10.1016/j.jval.2024.10.199","title":"CO123 Patient Characteristics, Treatment Pattern, Treatment Outcomes, and Survival Prognosis of Elderly Patients With Myelodysplastic Syndromes in China: A Systematic Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Myelodysplastic syndromes; Medicine; China; Intensive care medicine; Internal medicine; Oncology; History","score_opus":0.024337493309489422,"score_gpt":0.30066767158811003,"score_spread":0.2763301782786206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2745714,0.7164116,0.00025801637,0.0006644643,0.00012206727,0.00019584114,0.006994332,0.000013514766,0.00076879933],"genre_scores_gemma":[0.84128,0.15327302,0.00069711596,0.0009381016,0.00018186969,0.00039639074,0.0030024261,0.000005926392,0.00022524726],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972319,0.00050181965,0.0012170001,0.0004515199,0.00040999494,0.00018777544],"domain_scores_gemma":[0.9950309,0.0022220216,0.002057493,0.00012997365,0.0003750232,0.00018449001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020995692,0.00058424997,0.002967285,0.004184584,0.0006256549,0.0011887391,0.0008518532,0.0011375947,0.0017453241],"category_scores_gemma":[0.0075682895,0.00045226756,0.004709271,0.0095005715,0.0005007364,0.0009799976,0.00078089343,0.0006073319,0.000081037855],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068166223,0.00012230764,0.84483004,0.0902785,0.031604934,0.00031309383,0.0004914794,0.00031604606,0.000208735,0.00026155153,0.001645987,0.029245658],"study_design_scores_gemma":[0.00040047543,0.00032669553,0.8976165,0.023177018,0.07196238,0.0005446824,0.00092997873,0.00047144535,0.00013613023,0.0003307493,0.00400935,0.00009454948],"about_ca_topic_score_codex":0.027056338,"about_ca_topic_score_gemma":0.052024666,"teacher_disagreement_score":0.027056338,"about_ca_system_score_codex":0.0015188602,"about_ca_system_score_gemma":0.0049546906,"threshold_uncertainty_score":0.053797722},"labels":[],"label_agreement":null},{"id":"W4405748759","doi":"10.1016/j.jval.2024.10.134","title":"CO57 Clinical and Patient-Reported Outcomes Associated With Oral Semaglutide Use in Adults With Type 2 Diabetes: A Pooled Analysis of Six Pioneer Real Prospective Real-World Studies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Semaglutide; Medicine; Type 2 diabetes; Pooled analysis; Meta-analysis; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.05708299758418476,"score_gpt":0.3627923401509598,"score_spread":0.305709342566775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79875606,0.18064983,0.0030737438,0.0002419157,0.00030169394,0.00038031832,0.014484425,0.000079274476,0.0020328155],"genre_scores_gemma":[0.985241,0.008508305,0.0011107245,0.00018576563,0.00013432001,0.00026670977,0.00414528,0.000021681708,0.00038618958],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9858694,0.0068093943,0.0029908065,0.0022661742,0.0015399125,0.00052428397],"domain_scores_gemma":[0.98147935,0.0083929915,0.0065445052,0.002052389,0.0012019778,0.00032877864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010179483,0.0016790503,0.0033837687,0.0036884835,0.000487018,0.0025227088,0.0008698749,0.0013302433,0.0014220305],"category_scores_gemma":[0.01614953,0.0010684513,0.017282926,0.005618057,0.00057637214,0.001042886,0.0017999961,0.00094388006,0.00019822747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01712729,0.00006212551,0.5653147,0.005203149,0.4018948,0.00016025902,0.00012322454,0.00064419775,0.0005424958,0.000106614,0.0006581905,0.008162935],"study_design_scores_gemma":[0.0025553482,0.0013346813,0.71523416,0.0007875171,0.2753633,0.00036852172,0.00030727527,0.0010035702,0.00044727672,0.00026107166,0.002205342,0.0001320547],"about_ca_topic_score_codex":0.005045929,"about_ca_topic_score_gemma":0.007831857,"teacher_disagreement_score":0.010179483,"about_ca_system_score_codex":0.0007748167,"about_ca_system_score_gemma":0.000606329,"threshold_uncertainty_score":0.053834915},"labels":[],"label_agreement":null},{"id":"W4405748788","doi":"10.1016/j.jval.2024.10.218","title":"CO142 Systematic Literature Review of Real-World Evidence on Overall Survival in Cancer Patients Before and After the Approval of Anti-PD-(L)1 Therapy","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Cancer therapy; Real world evidence; Systematic review; Cancer; Intensive care medicine; Internal medicine; MEDLINE; Political science; Law","score_opus":0.048171533939200456,"score_gpt":0.3644565754983334,"score_spread":0.31628504155913295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046408894,0.9899985,0.00023186253,0.0004964979,0.00022025111,0.00033136527,0.003444568,0.000012169821,0.0006239127],"genre_scores_gemma":[0.112522915,0.87907827,0.0012742499,0.002571918,0.00032348468,0.0008430192,0.002962005,0.000027507996,0.00039653454],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9833565,0.0057212934,0.0070236432,0.0016251962,0.0018209581,0.00045241462],"domain_scores_gemma":[0.9508597,0.033164516,0.011008175,0.0011460475,0.0033560887,0.00046538655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011157348,0.0011911194,0.008489862,0.0075029074,0.00057955785,0.002915039,0.0015155048,0.0016645883,0.006683772],"category_scores_gemma":[0.054700255,0.0008766706,0.015177278,0.008790968,0.0010675036,0.0017088782,0.0018552497,0.0017204783,0.0005723782],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002112629,0.000026546906,0.004729037,0.8435528,0.12754004,0.00010599619,0.00012741385,0.00016765892,0.00027831676,0.0002097788,0.0017195448,0.019430263],"study_design_scores_gemma":[0.001900748,0.00048204197,0.01928029,0.42630503,0.5351902,0.00024701646,0.00020178303,0.000103468396,0.00025505575,0.0003996558,0.015560453,0.000074252144],"about_ca_topic_score_codex":0.0114246765,"about_ca_topic_score_gemma":0.031920183,"teacher_disagreement_score":0.0114246765,"about_ca_system_score_codex":0.003520669,"about_ca_system_score_gemma":0.0093286345,"threshold_uncertainty_score":0.059006393},"labels":[],"label_agreement":null},{"id":"W4405748795","doi":"10.1016/j.jval.2024.10.136","title":"CO59 Do Asthma Patients Prescribed a GLP1 Have Improved Asthma and Weight Loss Outcomes?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Markham Stouffville Hospital","funders":"","keywords":"Asthma; Medicine; Weight loss; Physical therapy; Internal medicine; Obesity","score_opus":0.01689629746621388,"score_gpt":0.28326133280996835,"score_spread":0.26636503534375444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90658534,0.03326821,0.00042192123,0.02653617,0.0021023608,0.000083650855,0.0030023523,0.000026532809,0.027973361],"genre_scores_gemma":[0.9817498,0.0075965817,0.00039821386,0.004351453,0.0010650568,0.00006624541,0.0010519591,0.000010259854,0.003710574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991812,0.0002464199,0.000066903456,0.00013241694,0.00019506676,0.0001778522],"domain_scores_gemma":[0.9977204,0.00064008404,0.0009064299,0.00007074868,0.00029213366,0.0003702165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009401172,0.0002047133,0.00069086766,0.0004484043,0.0005904324,0.0015459682,0.00035867764,0.0013003233,0.011539153],"category_scores_gemma":[0.004975443,0.00021966353,0.0014521222,0.00079779734,0.00040450462,0.0009933278,0.00043547506,0.0016072731,0.0015156486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01185125,0.0016617266,0.7791094,0.0010231012,0.0032926104,0.00026489486,0.0002899093,0.00020802178,0.0008903522,0.00093571644,0.0123159895,0.18815711],"study_design_scores_gemma":[0.0016952937,0.0018720612,0.97362435,0.00094391464,0.0023624732,0.0005000423,0.0010308254,0.0006881951,0.0005856938,0.0023112826,0.014321247,0.000064773594],"about_ca_topic_score_codex":0.005137127,"about_ca_topic_score_gemma":0.010833415,"teacher_disagreement_score":0.011539153,"about_ca_system_score_codex":0.0009301548,"about_ca_system_score_gemma":0.0009469164,"threshold_uncertainty_score":0.038602352},"labels":[],"label_agreement":null},{"id":"W4405748806","doi":"10.1016/j.jval.2024.10.002","title":"P1 Indirect Treatment Comparison of Larotrectinib vs Entrectinib in NTRK-Fusion Solid Tumors: Demonstration of a Novel Bayesian Hierarchical Modelling Approach for Basket Trials","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Bayesian probability; Medicine; Bayesian network; Bayesian inference; Oncology; Internal medicine; Computer science; Cancer research; Artificial intelligence","score_opus":0.16389463171589036,"score_gpt":0.44161497162682145,"score_spread":0.2777203399109311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748806","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37413406,0.013696549,0.5382179,0.010689489,0.0010730773,0.005280129,0.015688611,0.0020735518,0.039146632],"genre_scores_gemma":[0.9182423,0.0015993433,0.06794767,0.0012002015,0.00024246919,0.0018282187,0.0024926667,0.0002564737,0.0061907093],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9681494,0.028387787,0.00083395676,0.0012084774,0.0009922408,0.00042813874],"domain_scores_gemma":[0.96284354,0.031194106,0.002737261,0.0019450074,0.0006734739,0.00060655246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044003442,0.0017118149,0.0037329576,0.0009239013,0.00031881218,0.0025834818,0.0019271161,0.0019676865,0.013434315],"category_scores_gemma":[0.04948337,0.0009848886,0.0056438483,0.00087775005,0.0009132465,0.002766814,0.0022472634,0.0036398706,0.00087535015],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23676465,0.0011702112,0.009995551,0.0036774338,0.03629075,0.00018875231,0.0003242535,0.29213506,0.00338864,0.06175574,0.011639405,0.34266967],"study_design_scores_gemma":[0.039640408,0.01694939,0.013162054,0.00074797735,0.024661424,0.00022314522,0.0001438367,0.75382346,0.0034028005,0.13325629,0.013712285,0.000276867],"about_ca_topic_score_codex":0.0027074895,"about_ca_topic_score_gemma":0.003083931,"teacher_disagreement_score":0.044003442,"about_ca_system_score_codex":0.0014019648,"about_ca_system_score_gemma":0.0026063828,"threshold_uncertainty_score":0.23271525},"labels":[],"label_agreement":null},{"id":"W4405748826","doi":"10.1016/j.jval.2024.10.044","title":"P34 Transportability Analyses in Action: A Landscape Assessment of Application Studies Using Real Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Urban Transport and Accessibility","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Action (physics); Computer science; Physics","score_opus":0.5106494172413965,"score_gpt":0.5836752466775649,"score_spread":0.07302582943616842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74977463,0.0014450008,0.1635718,0.0021223046,0.00006178014,0.0015746328,0.009808109,0.00066009804,0.07098178],"genre_scores_gemma":[0.94838214,0.00028021942,0.04836859,0.000048306534,0.000011507285,0.00037126493,0.0011387011,0.00008559619,0.0013135442],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99064434,0.006454983,0.00035179377,0.00044563986,0.001857705,0.0002454591],"domain_scores_gemma":[0.9776895,0.014166978,0.0017488946,0.0013536887,0.004805286,0.00023559267],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010526508,0.0006571897,0.0006465091,0.0074251425,0.0009704577,0.0045685438,0.0010289125,0.00084188354,0.009728664],"category_scores_gemma":[0.031909414,0.0003865908,0.0017637913,0.00838308,0.0012641564,0.002804176,0.0022065581,0.0007266198,0.00046522063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001094676,0.00087835494,0.34432057,0.0044787307,0.0023178735,0.0011378265,0.0064368923,0.12842883,0.007771473,0.06717761,0.013206606,0.4227505],"study_design_scores_gemma":[0.0001829604,0.0018501471,0.4921999,0.0019510714,0.0014859738,0.0010511801,0.01872873,0.35500327,0.009103986,0.063489616,0.05471323,0.00024000088],"about_ca_topic_score_codex":0.024265444,"about_ca_topic_score_gemma":0.026456926,"teacher_disagreement_score":0.98947346,"about_ca_system_score_codex":0.002340127,"about_ca_system_score_gemma":0.0022016293,"threshold_uncertainty_score":0.055670142},"labels":[],"label_agreement":null},{"id":"W4405748840","doi":"10.1016/j.jval.2024.10.075","title":"P59 Measuring Health Inequality Aversion in Canada: An Equity-Efficiency Trade-Off Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Western University; University of Toronto","funders":"","keywords":"Equity (law); Health equity; Inequality; Economics; Inequity aversion; Demographic economics; Public economics; Health care; Economic growth; Political science; Mathematics","score_opus":0.2258956237756933,"score_gpt":0.3484681315728448,"score_spread":0.12257250779715148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96652937,0.00031462283,0.0029716094,0.0023909775,0.000090103655,0.00052605616,0.0034419782,0.000098061384,0.023637258],"genre_scores_gemma":[0.9910035,0.00007712313,0.0017050724,0.0004305494,0.000017508835,0.00014574433,0.00076106505,0.000018781393,0.0058407225],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9965467,0.0011336716,0.00009126912,0.0005525193,0.001049261,0.0006267139],"domain_scores_gemma":[0.979381,0.011687766,0.0018125046,0.0018796886,0.0037140665,0.00152496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069957445,0.00063096225,0.0009538738,0.00064556923,0.0038370923,0.002788633,0.0016215105,0.0020147727,0.007925762],"category_scores_gemma":[0.029674271,0.00031868607,0.0009396489,0.0017587895,0.0035791646,0.0015152249,0.0013890425,0.002302806,0.0004302832],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03619138,0.013281479,0.5129006,0.00068033836,0.0022559308,0.0005819492,0.005793176,0.08279387,0.0095050605,0.13781108,0.069012694,0.1291925],"study_design_scores_gemma":[0.005437248,0.0049847714,0.8000161,0.00021463979,0.0012460544,0.0000948261,0.0065358076,0.095353395,0.008782242,0.035839804,0.04105344,0.0004415755],"about_ca_topic_score_codex":0.97139895,"about_ca_topic_score_gemma":0.9704568,"teacher_disagreement_score":0.041118678,"about_ca_system_score_codex":0.041118678,"about_ca_system_score_gemma":0.038393505,"threshold_uncertainty_score":0.2983383},"labels":[],"label_agreement":null},{"id":"W4405748861","doi":"10.1016/j.jval.2024.10.251","title":"CO175 Clinical Outcomes of Interventions in Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Systematic Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amorfix (Canada)","funders":"","keywords":"Medicine; Myeloid leukemia; Systematic review; Psychological intervention; Intensive care medicine; Chronic leukemia; Internal medicine; Oncology; Leukemia; MEDLINE; Acute leukemia; Psychiatry; Biology","score_opus":0.04815711128303091,"score_gpt":0.36623023945130506,"score_spread":0.31807312816827416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004456413,0.9937266,0.00009118234,0.00025339902,0.000112996175,0.00015302617,0.00092024525,0.0000051444986,0.00028082734],"genre_scores_gemma":[0.16692267,0.82812196,0.0010508576,0.0017798954,0.00022269865,0.0007803307,0.00096906663,0.00001050597,0.00014208417],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98746246,0.0041516046,0.0049288273,0.0013998959,0.0015889583,0.00046825258],"domain_scores_gemma":[0.9555564,0.0333764,0.008372462,0.0005108362,0.0017270979,0.00045675287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075936164,0.0010559788,0.007922785,0.0058377604,0.000550683,0.0026035605,0.0014875904,0.0020684977,0.004655777],"category_scores_gemma":[0.05414674,0.0009374491,0.012287509,0.008208307,0.0009208021,0.00215045,0.0018661612,0.002047436,0.00023781139],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014438148,0.00007060805,0.016856575,0.8315839,0.11724253,0.00009675332,0.000255766,0.00019888062,0.00011993618,0.0003102103,0.0017194251,0.030101553],"study_design_scores_gemma":[0.0024841332,0.0006173853,0.045428697,0.49063313,0.44816095,0.00030869574,0.0006549311,0.00020083594,0.00016374847,0.0006154008,0.010617249,0.00011483147],"about_ca_topic_score_codex":0.012824075,"about_ca_topic_score_gemma":0.04212656,"teacher_disagreement_score":0.012824075,"about_ca_system_score_codex":0.0037902114,"about_ca_system_score_gemma":0.0080772815,"threshold_uncertainty_score":0.040159345},"labels":[],"label_agreement":null},{"id":"W4405748868","doi":"10.1016/j.jval.2024.10.008","title":"P6 Projected Increase of the Clinical, Economic, Societal, and Environmental Burdens of Chronic Kidney Disease in Switzerland: Insights from Impact-CKD","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Kidney disease; Disease; Medicine; Environmental health; Natural resource economics; Development economics; Economics; Internal medicine","score_opus":0.33299300312866176,"score_gpt":0.5114236650110323,"score_spread":0.17843066188237056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81683606,0.008984737,0.004667216,0.022632018,0.0007289682,0.00012013135,0.08660904,0.0003903099,0.059031494],"genre_scores_gemma":[0.9840979,0.0015509044,0.00083383085,0.00031897507,0.000159897,0.000057913832,0.008949471,0.000029641307,0.004001579],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9993968,0.00016119593,0.000026672327,0.000056571767,0.00016260623,0.00019615439],"domain_scores_gemma":[0.9989794,0.00014736806,0.00017597491,0.000029453435,0.0004547675,0.00021290124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007335882,0.00051491486,0.0002586083,0.0011916085,0.00031004392,0.0015443572,0.00026889401,0.00065242714,0.011570196],"category_scores_gemma":[0.0014500611,0.00013003753,0.0010443118,0.0012755643,0.00024365437,0.00065116707,0.0010014428,0.0006698421,0.0011464084],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014333776,0.00029123653,0.77659607,0.0015179011,0.0007438003,0.0016229664,0.0011954422,0.040758036,0.0035130002,0.025111178,0.059586935,0.087630086],"study_design_scores_gemma":[0.00006193121,0.00025946545,0.94268554,0.0005228732,0.00019996372,0.0005778537,0.0013812141,0.012509573,0.0008428298,0.0028310448,0.038064077,0.000063576364],"about_ca_topic_score_codex":0.08579861,"about_ca_topic_score_gemma":0.062324498,"teacher_disagreement_score":0.08579861,"about_ca_system_score_codex":0.003198633,"about_ca_system_score_gemma":0.0026328345,"threshold_uncertainty_score":0.17059845},"labels":[],"label_agreement":null},{"id":"W4405748941","doi":"10.1016/j.jval.2024.10.1563","title":"HPR137 Evaluating the Clinical and Socioeconomic Impact of Improved CKD Diagnosis and Adherence to Guideline-Directed Medical Therapy in Australia, Brazil, and China: An Impact CKD Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Guideline; Medicine; Socioeconomic status; China; Family medicine; Intensive care medicine; Environmental health; Geography; Population; Pathology","score_opus":0.5338292246245695,"score_gpt":0.5944169081069948,"score_spread":0.06058768348242527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98985416,0.0010540412,0.0012745997,0.0012040377,0.000022750817,0.00017885877,0.002577009,0.000018462833,0.0038159508],"genre_scores_gemma":[0.9975885,0.00024622545,0.0004958543,0.00007825047,0.000016272264,0.000048143887,0.0008081911,0.0000046502532,0.00071383954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99652326,0.0022257767,0.00011791488,0.00018458073,0.00046144807,0.00048706948],"domain_scores_gemma":[0.9935675,0.003606103,0.001026136,0.0004314592,0.0007843789,0.0005844141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006690572,0.0005070094,0.0009064608,0.0013549326,0.0003252113,0.0010059328,0.0007105014,0.00048611566,0.0028970425],"category_scores_gemma":[0.012518244,0.00034734912,0.0037159545,0.0015643962,0.00061826425,0.0007973835,0.0015092943,0.0012412156,0.00012608504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001823225,0.0011914024,0.9028525,0.000745864,0.00964623,0.0005586578,0.00039836037,0.030526392,0.00046587232,0.007926721,0.0029627408,0.040902067],"study_design_scores_gemma":[0.00040530963,0.001089685,0.9468781,0.00016685382,0.0051610414,0.00016357478,0.00061378,0.041217998,0.00044766176,0.0017592823,0.0020539144,0.00004267819],"about_ca_topic_score_codex":0.22660552,"about_ca_topic_score_gemma":0.13540173,"teacher_disagreement_score":0.22660552,"about_ca_system_score_codex":0.0049196808,"about_ca_system_score_gemma":0.005027519,"threshold_uncertainty_score":0.4505731},"labels":[],"label_agreement":null},{"id":"W4405748988","doi":"10.1016/j.jval.2024.10.1686","title":"HSD3 Real-World Treatment Patterns in Sickle Cell Disease (SCD) in Europe, Africa, Eastern Mediterranean Region (EMR), and India: A Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Disease; Geography; Mediterranean climate; Medicine; Pathology; Archaeology","score_opus":0.03034951924497465,"score_gpt":0.28728556622409857,"score_spread":0.2569360469791239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748988","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026444972,0.968614,0.00012993303,0.00031632878,0.000078837766,0.00010691742,0.004004476,0.000005201452,0.00029932614],"genre_scores_gemma":[0.31636128,0.678424,0.0012349127,0.0009494994,0.0000966812,0.00041205014,0.0023483173,0.0000068738877,0.00016641333],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99604946,0.0009496056,0.0019990145,0.00042639964,0.0004048236,0.00017081403],"domain_scores_gemma":[0.98644596,0.009221126,0.0032205726,0.00023162903,0.00070669106,0.00017400904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038845558,0.0004387573,0.0030818442,0.006172586,0.0003816712,0.0015097744,0.00081509055,0.0010658787,0.0024263093],"category_scores_gemma":[0.016992422,0.00045938385,0.0072439034,0.010231218,0.0005665894,0.001059586,0.001083079,0.00077286,0.00011131121],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008054032,0.00007190752,0.12157952,0.75008905,0.0743791,0.00027646858,0.0010866562,0.00021122502,0.00025979363,0.00040495783,0.0023217069,0.04851422],"study_design_scores_gemma":[0.0005442429,0.0004686842,0.25769612,0.44275725,0.27690178,0.0011800076,0.0029646733,0.00017379841,0.00029187184,0.00040050162,0.01649328,0.00012775074],"about_ca_topic_score_codex":0.020039631,"about_ca_topic_score_gemma":0.060944192,"teacher_disagreement_score":0.020039631,"about_ca_system_score_codex":0.0014360086,"about_ca_system_score_gemma":0.004905431,"threshold_uncertainty_score":0.039845943},"labels":[],"label_agreement":null},{"id":"W4405749009","doi":"10.1016/j.jval.2024.10.1805","title":"HSD122 Burden of Low Molecular Weight Heparin Switching in the UK and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.012783779704307139,"score_gpt":0.26876528395918853,"score_spread":0.25598150425488136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87881535,0.014224247,0.00022220342,0.033116855,0.00052058126,0.00009153888,0.03828068,0.00006466889,0.034663886],"genre_scores_gemma":[0.9725007,0.011572787,0.00021603127,0.0025320307,0.00015233598,0.000021041067,0.0059315814,0.000038581562,0.007034942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802434,0.000129771,0.00014129293,0.00019518052,0.0007747794,0.0007346511],"domain_scores_gemma":[0.99139446,0.00047831205,0.0015231476,0.00014559383,0.0033520975,0.0031062637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005447621,0.00025211822,0.0006129456,0.0018110315,0.0018232551,0.0030692227,0.00096934004,0.0010306152,0.006655946],"category_scores_gemma":[0.005291554,0.0004079844,0.0009935389,0.006151814,0.00082240044,0.0005083304,0.0011344121,0.0021092622,0.00038564572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005033476,0.00009415441,0.9191828,0.00019396361,0.00031216833,0.0010189494,0.000768607,0.0007764914,0.0002988146,0.0028986419,0.032457363,0.04149474],"study_design_scores_gemma":[0.000041912153,0.000050301107,0.9854907,0.0002799482,0.0000964482,0.00052062783,0.0019726716,0.00048602006,0.000066463406,0.00018109995,0.010769805,0.000044048982],"about_ca_topic_score_codex":0.9943878,"about_ca_topic_score_gemma":0.9946108,"teacher_disagreement_score":0.040418133,"about_ca_system_score_codex":0.040418133,"about_ca_system_score_gemma":0.07287422,"threshold_uncertainty_score":0.29325545},"labels":[],"label_agreement":null},{"id":"W4405749123","doi":"10.1016/j.jval.2024.10.1442","title":"HPR15 Innovative Rebate Management in Oncology Drug Budgets: Streamlining Operations and Enhancing Financial Efficiency Through Technology in Newfoundland and Labrador's Cancer Care Program","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); St. John’s Health Sciences Centre","funders":"","keywords":"Cancer drugs; Precision oncology; Business; Operations management; Finance; Cancer; Engineering management; Medicine; Internal medicine; Engineering","score_opus":0.028462491863441297,"score_gpt":0.32327932840885804,"score_spread":0.29481683654541674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9571657,0.0008021085,0.0013588357,0.02023364,0.00009314968,0.00024535588,0.0017635855,0.00016791698,0.01816972],"genre_scores_gemma":[0.9723848,0.0006593346,0.0035911629,0.001776464,0.000089719026,0.00010816908,0.0011609946,0.00004224154,0.020187149],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99632496,0.0013079436,0.00014042475,0.00022325397,0.00054458133,0.0014589217],"domain_scores_gemma":[0.9884243,0.0038081554,0.0022174683,0.00032624608,0.0017970267,0.0034268445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00645713,0.00024973656,0.00033417568,0.00091910164,0.00091707264,0.0034424623,0.0013199515,0.00075988343,0.006497719],"category_scores_gemma":[0.012010592,0.00029716213,0.00044575686,0.000981394,0.000830834,0.0014701148,0.0015527345,0.0013488522,0.00034770576],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026676964,0.0032144391,0.41439205,0.0003911978,0.00040581572,0.00045126732,0.0012325243,0.08145679,0.0022206968,0.016045326,0.10201701,0.37550524],"study_design_scores_gemma":[0.00061400945,0.0017250062,0.85011065,0.00025461699,0.00035472703,0.00017938511,0.004764726,0.091284774,0.0038193401,0.0020757385,0.04470422,0.00011281784],"about_ca_topic_score_codex":0.5962592,"about_ca_topic_score_gemma":0.79019225,"teacher_disagreement_score":0.97104985,"about_ca_system_score_codex":0.028950159,"about_ca_system_score_gemma":0.046977002,"threshold_uncertainty_score":0.812237},"labels":[],"label_agreement":null},{"id":"W4405749136","doi":"10.1016/j.jval.2024.10.1541","title":"HPR115 Oncology Branded Multi-Company Combinations (MCCs): Assessment of the Availability in France, Germany, Italy, Spain, England, Scotland, Canada, and Australia","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.0541589831845331,"score_gpt":0.31255779777771875,"score_spread":0.25839881459318564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842753,0.0015606738,0.00034729086,0.0006437909,0.000012743073,0.000030410889,0.0025398761,0.00002750853,0.010562495],"genre_scores_gemma":[0.997109,0.0002238797,0.00016759917,0.000047066093,0.000010805037,0.00000731812,0.00079680583,0.000008179227,0.0016294455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986524,0.00034099308,0.00006010281,0.00012759028,0.00061471655,0.00020411806],"domain_scores_gemma":[0.991184,0.0023723345,0.002837894,0.00022862642,0.0019395788,0.0014376071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025963676,0.00012540135,0.00023498006,0.0023203637,0.0002943234,0.0013646679,0.0004816832,0.00033610134,0.0037261278],"category_scores_gemma":[0.006694297,0.00017787078,0.00037137375,0.001915477,0.00042885166,0.00082666794,0.0008534705,0.00040243915,0.00027630065],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015502075,0.00017425744,0.8975945,0.0002173543,0.00020150276,0.00059054577,0.001098923,0.00428299,0.0010704871,0.0036578863,0.007949035,0.08161235],"study_design_scores_gemma":[0.00002559439,0.00048939703,0.9817531,0.00005870561,0.00006878583,0.00038836634,0.0011954366,0.0035037042,0.00031784413,0.00022531002,0.011955095,0.000018667557],"about_ca_topic_score_codex":0.06351961,"about_ca_topic_score_gemma":0.085323825,"teacher_disagreement_score":0.9364804,"about_ca_system_score_codex":0.0032715625,"about_ca_system_score_gemma":0.0014305782,"threshold_uncertainty_score":0.12629974},"labels":[],"label_agreement":null},{"id":"W4405749195","doi":"10.1016/j.jval.2024.10.1447","title":"HPR20 Collaborative Demonstration Project in the Province of Québec for the Operationalization of Value-Based Agreement: Moving From a Vision to Implementation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Social Sciences and Governance","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montréal InVivo; InterDigital (Canada)","funders":"","keywords":"Operationalization; Value (mathematics); Computer science; Physics; Machine learning; Quantum mechanics","score_opus":0.051447056943411354,"score_gpt":0.4232668292684664,"score_spread":0.3718197723250551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749195","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20823857,0.004561246,0.054450646,0.32927454,0.0025705318,0.011558908,0.014693533,0.0015390184,0.373113],"genre_scores_gemma":[0.7668201,0.00093841297,0.060688157,0.019685652,0.00014401149,0.0032394507,0.0043478645,0.00018621742,0.14395022],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9807884,0.009213938,0.00028379937,0.0008048366,0.00525468,0.003654342],"domain_scores_gemma":[0.95902634,0.009250594,0.0009718608,0.0025133004,0.016387535,0.011850386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03434118,0.00063671434,0.00048335624,0.0010079286,0.00806528,0.005455307,0.0026863178,0.0044725332,0.015630063],"category_scores_gemma":[0.03098171,0.00044239027,0.0008232975,0.0012224412,0.0038336397,0.0022548137,0.006011352,0.004283375,0.00075894804],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015249279,0.002217788,0.03955396,0.0009177143,0.00028093116,0.0011726856,0.009210623,0.007870326,0.0057297656,0.28705388,0.43996257,0.20450474],"study_design_scores_gemma":[0.0011440209,0.0014176079,0.16411582,0.00075803255,0.00009902257,0.00024382013,0.017917603,0.016763302,0.0035632835,0.018576218,0.7751823,0.00021900234],"about_ca_topic_score_codex":0.9785821,"about_ca_topic_score_gemma":0.9795334,"teacher_disagreement_score":0.9234621,"about_ca_system_score_codex":0.07653793,"about_ca_system_score_gemma":0.41887125,"threshold_uncertainty_score":0.55532414},"labels":[],"label_agreement":null},{"id":"W4405749254","doi":"10.1016/j.jval.2024.10.1445","title":"HPR18 Unmet Medical Need in Patients With Paroxysmal Noctural Hemoglobinuria Treated With Complement 5 Inhibitors: Results From a Cross-Sectional Survey in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Complement (music); Hemoglobinuria; Family medicine; Intensive care medicine; Internal medicine; Anemia; Genetics; Biology","score_opus":0.03169271260389206,"score_gpt":0.2789218733864838,"score_spread":0.24722916078259172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852329,0.0011291892,0.00007854825,0.00069654395,0.000033198925,0.00006431061,0.010312387,0.000010500392,0.0024423914],"genre_scores_gemma":[0.99552107,0.0008426454,0.00012493275,0.00032727403,0.000013044923,0.000026096728,0.002361108,0.000006950873,0.0007768715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985928,0.00010529371,0.00013515209,0.00021256976,0.00040507503,0.00054906413],"domain_scores_gemma":[0.9970542,0.00015203112,0.0007098365,0.000051781262,0.0011621317,0.0008700699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051066687,0.00037042613,0.0006998182,0.0014490804,0.0022577452,0.0018200626,0.0018042739,0.00088423723,0.0025338999],"category_scores_gemma":[0.0023928576,0.0006132498,0.0013874758,0.0058157593,0.000633394,0.0006094992,0.0011149177,0.0014468362,0.0002661313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028412489,0.000034341232,0.9979818,0.000022451106,0.000057175843,0.000053272455,0.00025373162,0.000037053338,0.000041530828,0.000032795146,0.00067445403,0.0007828923],"study_design_scores_gemma":[0.000004436729,0.0000105514855,0.9986695,0.00002211856,0.000019885103,0.000043058495,0.0008532602,0.00009912416,0.000012579577,0.0000066474568,0.00025266153,0.0000062833888],"about_ca_topic_score_codex":0.98998916,"about_ca_topic_score_gemma":0.99315685,"teacher_disagreement_score":0.01796663,"about_ca_system_score_codex":0.01796663,"about_ca_system_score_gemma":0.022308473,"threshold_uncertainty_score":0.13035762},"labels":[],"label_agreement":null},{"id":"W4405749258","doi":"10.1016/j.jval.2024.10.1244","title":"EPH115 Estimating the Public Health Impact of Pediatric Vaccination Programs on Invasive Pneumococcal Disease in France","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal disease; Vaccination; Disease; Medicine; Pneumococcal vaccination; Public health; Environmental health; Pediatrics; Intensive care medicine; Immunology; Streptococcus pneumoniae; Biology; Internal medicine; Pathology; Microbiology","score_opus":0.0644160513302726,"score_gpt":0.37309325657982423,"score_spread":0.3086772052495516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98284596,0.002516619,0.0036147516,0.001007856,0.000043532567,0.000039870847,0.005892173,0.00012883804,0.003910307],"genre_scores_gemma":[0.99197656,0.0005894096,0.0017241146,0.000083318206,0.000046206962,0.000026067999,0.0043041497,0.00001619709,0.0012339236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971998,0.0017785408,0.00010492065,0.00027116365,0.0002902156,0.0003553284],"domain_scores_gemma":[0.99457526,0.0038140381,0.0005074333,0.00022625449,0.00064660836,0.00023033685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032457367,0.0007080022,0.0007279793,0.0020914078,0.00023513111,0.0018159291,0.0006668275,0.0012504684,0.0021218704],"category_scores_gemma":[0.00843713,0.0002785531,0.0019201409,0.0012665386,0.00023311297,0.0006405474,0.00068115164,0.00066529895,0.0003305688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059968635,0.00021281547,0.8145906,0.00013172544,0.0016112716,0.00030713194,0.000083092375,0.1502811,0.00045455788,0.002187429,0.0023790104,0.027161587],"study_design_scores_gemma":[0.000117804775,0.0005818563,0.84342456,0.00010674051,0.0004048626,0.0002348682,0.00030794978,0.14860989,0.0007715823,0.0008416041,0.004559707,0.00003866593],"about_ca_topic_score_codex":0.27412212,"about_ca_topic_score_gemma":0.09903184,"teacher_disagreement_score":0.27412212,"about_ca_system_score_codex":0.0043923636,"about_ca_system_score_gemma":0.0025679779,"threshold_uncertainty_score":0.5450531},"labels":[],"label_agreement":null},{"id":"W4405749271","doi":"10.1016/j.jval.2024.10.1336","title":"EPH210 Landscape of Intrahepatic Cholangiocarcinoma (IHC) in Brazilian Public Healthcare System and Monitoring of the Technological Horizon","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Intrahepatic Cholangiocarcinoma; Horizon; Immunohistochemistry; Public healthcare; Geography; Business; Medicine; Internal medicine; Public health; Pathology; Astronomy","score_opus":0.0408384055041803,"score_gpt":0.2900443348354722,"score_spread":0.2492059293312919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876699,0.0026327586,0.0002100538,0.0020942842,0.000014716367,0.00001373549,0.0008269405,0.0000046263804,0.006533025],"genre_scores_gemma":[0.9982722,0.0009906663,0.000118301294,0.000083183775,0.000011799724,0.0000037361317,0.00021866341,0.0000021155859,0.0002992933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993131,0.00015752419,0.00007729504,0.000088306544,0.00015532773,0.00020835534],"domain_scores_gemma":[0.9979032,0.0003980852,0.00093287823,0.00008161737,0.00048823675,0.00019599203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008533677,0.000105752384,0.00019042802,0.0012531386,0.00046103532,0.0010829819,0.00030397213,0.00027221767,0.0018230904],"category_scores_gemma":[0.0044628857,0.00011314587,0.00032470754,0.0023351314,0.00050311926,0.000572597,0.0007770231,0.00035704894,0.00010397193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061303734,0.00002284751,0.9821821,0.00011453962,0.000045677963,0.00028383808,0.0015233243,0.00006779696,0.000418098,0.0020630155,0.00046430685,0.012753166],"study_design_scores_gemma":[0.0000020816701,0.000032993677,0.9886988,0.00011408234,0.00004501769,0.00051490794,0.0045075365,0.00022643864,0.00015383669,0.000445926,0.0052511697,0.00000714662],"about_ca_topic_score_codex":0.05613794,"about_ca_topic_score_gemma":0.065693095,"teacher_disagreement_score":0.05613794,"about_ca_system_score_codex":0.0015877336,"about_ca_system_score_gemma":0.002753737,"threshold_uncertainty_score":0.11162239},"labels":[],"label_agreement":null},{"id":"W4405749360","doi":"10.1016/j.jval.2024.10.1366","title":"EPH241 Impact of COVID-19's Cancer Screenings in the United States of America, Canada, and Brazil: An International Comparative Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Political science; 2019-20 coronavirus outbreak; Geography; Medicine; Virology; Pathology; Outbreak","score_opus":0.15555769764841093,"score_gpt":0.5090995113705663,"score_spread":0.3535418137221554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809862,0.003166133,0.00007589977,0.0018878062,0.000021972099,0.00003468892,0.0023625265,0.0000055286155,0.011459328],"genre_scores_gemma":[0.9973194,0.0015957007,0.00005633956,0.0001234999,0.000005986775,0.000005193989,0.00035328322,0.0000028450806,0.00053788355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987669,0.00024324242,0.00006315539,0.00008984551,0.0003635762,0.0004732869],"domain_scores_gemma":[0.9974141,0.0004559505,0.00075583026,0.00010274307,0.00071579235,0.00055557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010302735,0.00023032437,0.00030211185,0.0016556382,0.0008653591,0.0013326532,0.0005686767,0.00038532473,0.0018416694],"category_scores_gemma":[0.0050389096,0.00016014616,0.0006232749,0.004160035,0.0011360213,0.0004625385,0.0013322232,0.0007432707,0.0000849258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001662105,0.00013210562,0.97386485,0.00013313055,0.00025592788,0.00024865943,0.0021492976,0.00016207343,0.00015927959,0.002260663,0.0010267454,0.01944108],"study_design_scores_gemma":[0.000010618815,0.000051621424,0.99040633,0.00015026983,0.00018145425,0.00015092173,0.0055342847,0.0001724782,0.000117560376,0.00016830995,0.0030426434,0.000013355152],"about_ca_topic_score_codex":0.89332074,"about_ca_topic_score_gemma":0.9388009,"teacher_disagreement_score":0.10667926,"about_ca_system_score_codex":0.010525609,"about_ca_system_score_gemma":0.012662284,"threshold_uncertainty_score":0.21461499},"labels":[],"label_agreement":null},{"id":"W4405749371","doi":"10.1016/j.jval.2024.10.1283","title":"EPH155 The Impact of Adjuvant Alectinib in Reducing Recurrences and Recurrence-Related Treatment Costs in Resected Early-Stage ALK+ Non-Small Cell Lung Cancer Across Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Alectinib; Medicine; Lung cancer; Stage (stratigraphy); Oncology; Adjuvant; Internal medicine; Crizotinib; Biology","score_opus":0.030710343570659878,"score_gpt":0.39518242157878847,"score_spread":0.3644720780081286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9425021,0.014885066,0.00040038952,0.016343862,0.00017191863,0.00013787899,0.009774251,0.000052609732,0.01573197],"genre_scores_gemma":[0.990755,0.0037101984,0.00039442047,0.0010092485,0.000028577091,0.00002269127,0.0016883446,0.000015614634,0.0023758928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990336,0.000112343834,0.00006282955,0.000087885346,0.00024129999,0.0004620206],"domain_scores_gemma":[0.9979249,0.00013743166,0.00029053996,0.00003382792,0.0008033886,0.00080998853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061376375,0.00021036633,0.000487505,0.00053228205,0.0009452831,0.0015776926,0.0008523197,0.00034713128,0.0024767336],"category_scores_gemma":[0.0027932914,0.00017406832,0.00091492134,0.001387481,0.00047492122,0.00035046216,0.00069398066,0.000728913,0.00012418522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037561588,0.00034103205,0.7934753,0.0008410926,0.001664125,0.00040358177,0.00061933993,0.0075613777,0.0016574127,0.0031142025,0.029332355,0.15723404],"study_design_scores_gemma":[0.000439438,0.00031299013,0.9793732,0.00044718836,0.0008361262,0.00021557357,0.0016758038,0.002627865,0.0005762133,0.0003300327,0.013118003,0.000047555037],"about_ca_topic_score_codex":0.99096245,"about_ca_topic_score_gemma":0.9967146,"teacher_disagreement_score":0.05011124,"about_ca_system_score_codex":0.05011124,"about_ca_system_score_gemma":0.086432904,"threshold_uncertainty_score":0.36358422},"labels":[],"label_agreement":null},{"id":"W4405749454","doi":"10.1016/j.jval.2024.10.1463","title":"HPR36 Balancing Trade-Offs With Simulation-Guided Negotiation: A Probabilistic Tipping Point Analysis for Comparison of Value-Based Contracts and Flat Discount Reimbursement Models for Cell and Gene Therapies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tipping point (physics); Negotiation; Reimbursement; Probabilistic logic; Value (mathematics); Point (geometry); Actuarial science; Economics; Microeconomics; Computer science; Mathematics; Engineering; Machine learning; Health care; Artificial intelligence","score_opus":0.3216825028714397,"score_gpt":0.4179906795299628,"score_spread":0.09630817665852315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749454","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26713622,0.001814285,0.69543153,0.0035404584,0.00030545742,0.0012449268,0.0008915366,0.0006411146,0.028994428],"genre_scores_gemma":[0.93886375,0.00037727784,0.05384524,0.00033990626,0.00008664985,0.000609712,0.00032431548,0.00020203202,0.0053510475],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9883487,0.009154081,0.00021291501,0.0005997067,0.00096790807,0.0007166309],"domain_scores_gemma":[0.8723192,0.11969908,0.002496968,0.0022447852,0.0021442517,0.001095711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03506839,0.001550915,0.0038013256,0.00214073,0.0010264071,0.0035223053,0.004639397,0.0040148534,0.016438551],"category_scores_gemma":[0.09098189,0.0015054101,0.0031178526,0.0016478874,0.0025889925,0.0048309825,0.002851162,0.005791745,0.00071405456],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055446604,0.00015046995,0.0006012705,0.00012152318,0.00012727045,0.000044699827,0.00011003767,0.93682414,0.00010012024,0.051902432,0.001272642,0.0081909485],"study_design_scores_gemma":[0.00009826494,0.00010275916,0.0001697003,0.00002733793,0.000036446905,0.000010227993,0.000032915388,0.9827649,0.000049029983,0.016369598,0.0003242182,0.000014647487],"about_ca_topic_score_codex":0.010603064,"about_ca_topic_score_gemma":0.0034100944,"teacher_disagreement_score":0.03506839,"about_ca_system_score_codex":0.004505186,"about_ca_system_score_gemma":0.00491594,"threshold_uncertainty_score":0.18546158},"labels":[],"label_agreement":null},{"id":"W4405749546","doi":"10.1016/j.jval.2024.10.3630","title":"RWD72 The Association of Hemophilia Related Joint Problems, Healthcare Resource Usage, and Patient Adherence to Prophylactic Treatment: Results From a Multinational Real-World Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Multinational corporation; Medicine; Health care; Association (psychology); Business; Psychology; Economic growth; Finance; Economics","score_opus":0.09870577380198317,"score_gpt":0.3547071965123443,"score_spread":0.2560014227103611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973411,0.00025738924,0.00006679675,0.00013198944,0.000006258738,0.000009614288,0.0016294564,0.0000028455145,0.0005545596],"genre_scores_gemma":[0.9985619,0.00013588172,0.00005277675,0.000056734054,0.000009711144,0.000014545422,0.00083853776,0.00000166266,0.0003282095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986449,0.0006686813,0.00014459805,0.00012504995,0.00024577306,0.00017105427],"domain_scores_gemma":[0.9970686,0.0005474523,0.0016341257,0.00018734155,0.00020030615,0.00036233492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017397866,0.00024989425,0.00029936878,0.000719291,0.0003061666,0.00074490014,0.0004505165,0.00065841625,0.0016854928],"category_scores_gemma":[0.004233722,0.00030723854,0.0005751802,0.0017750468,0.00028298324,0.00046298184,0.0004519866,0.0008309555,0.00030053296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003703089,0.00004187499,0.99905473,0.000005277418,0.000060017952,0.000010056575,0.00003026296,0.000022599734,0.000028939288,0.000004936831,0.00008697121,0.00061731285],"study_design_scores_gemma":[0.0000041301087,0.000028867846,0.9996973,0.0000029756798,0.000014494542,0.000021208512,0.00008396894,0.000043346517,0.000010497963,0.0000026018452,0.00008914423,0.000001436037],"about_ca_topic_score_codex":0.022458963,"about_ca_topic_score_gemma":0.019837558,"teacher_disagreement_score":0.022458963,"about_ca_system_score_codex":0.00043614084,"about_ca_system_score_gemma":0.00036409113,"threshold_uncertainty_score":0.044656515},"labels":[],"label_agreement":null},{"id":"W4405749549","doi":"10.1016/j.jval.2024.10.3646","title":"RWD88 The Psychosocial Impact of Chronic Hand Eczema: Findings From the Population-Based Check (Chronic Hand Eczema Epidemiology, Care, and Knowledge of Real-Life Burden) Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"","keywords":"Psychosocial; Hand eczema; Epidemiology; Medicine; Population; Family medicine; Psychiatry; Environmental health; Allergy; Immunology; Internal medicine","score_opus":0.051167830816928356,"score_gpt":0.38568546598382336,"score_spread":0.33451763516689503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473226,0.00033969292,0.000061063896,0.00017402605,0.000021144599,0.000091492046,0.0036720717,0.0000044622866,0.00090384105],"genre_scores_gemma":[0.99605113,0.0003968285,0.000102222446,0.00014861781,0.00004238981,0.00014556518,0.0021393474,0.000006963122,0.00096697215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998412,0.00080231996,0.00014164184,0.00011745479,0.00029810538,0.0002283675],"domain_scores_gemma":[0.99755657,0.0003510727,0.0012053058,0.00017433017,0.00024849206,0.0004640619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019791385,0.00054348,0.0005945289,0.0008170257,0.00068710296,0.0009558262,0.0006507675,0.0008710842,0.0016189357],"category_scores_gemma":[0.004168678,0.00063798425,0.0011500069,0.0015141496,0.00035036495,0.0005060218,0.0013119271,0.0012748714,0.00043958955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054465554,0.0003262336,0.995468,0.000051163184,0.00039908985,0.000062449086,0.00025949875,0.000043997494,0.00018768728,0.000025240062,0.0005528579,0.0020791332],"study_design_scores_gemma":[0.00004102836,0.000091798654,0.99945456,0.0000073695523,0.00006609909,0.000027843345,0.00012155989,0.000014412353,0.000014562354,0.0000041760413,0.00015443872,0.000002297534],"about_ca_topic_score_codex":0.033631716,"about_ca_topic_score_gemma":0.03505894,"teacher_disagreement_score":0.033631716,"about_ca_system_score_codex":0.000579549,"about_ca_system_score_gemma":0.0006993732,"threshold_uncertainty_score":0.06687188},"labels":[],"label_agreement":null},{"id":"W4405749557","doi":"10.1016/j.jval.2024.10.3560","title":"PCR318 Unmet Needs of Patients With Severe Von Willebrand Disease and Their Caregivers: A Qualitative Study on Current Standard of Care in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Takeda (Canada); Queen's University; Inro Consultants (Canada)","funders":"","keywords":"Medicine; Disease; Current (fluid); Von Willebrand disease; Intensive care medicine; Family medicine; Gerontology; Von Willebrand factor; Immunology; Internal medicine; Engineering","score_opus":0.020071549186148174,"score_gpt":0.30948921071570856,"score_spread":0.2894176615295604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98363596,0.00070924783,0.00018075515,0.008808463,0.00011617385,0.00019462862,0.00023394712,0.0000050716567,0.006115618],"genre_scores_gemma":[0.995312,0.0005551292,0.00026566058,0.0021041192,0.000014462565,0.00013585965,0.000074674055,0.00000841589,0.0015297396],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9911231,0.004128783,0.00039616757,0.00038118596,0.001148187,0.0028226601],"domain_scores_gemma":[0.97406435,0.00878651,0.0023816058,0.00027583126,0.006253467,0.008238289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007527376,0.00035515512,0.000795896,0.0015449991,0.02213868,0.005919627,0.002109993,0.001697855,0.0031752447],"category_scores_gemma":[0.021454649,0.00062413735,0.0005435546,0.002897161,0.0060904194,0.0020847744,0.0052199992,0.005288656,0.0001622157],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039377126,0.00009119971,0.02520495,0.0001058037,0.000012450013,0.00041938265,0.9681358,0.000027746755,0.00015389123,0.0008835696,0.002015534,0.002910371],"study_design_scores_gemma":[0.000003861494,0.0000139256,0.0063707973,0.00010451235,0.000003468631,0.00004128841,0.990437,0.000028083121,0.000024593663,0.00005692185,0.0029018074,0.000013820921],"about_ca_topic_score_codex":0.8717568,"about_ca_topic_score_gemma":0.9385158,"teacher_disagreement_score":0.12824321,"about_ca_system_score_codex":0.068330266,"about_ca_system_score_gemma":0.12017201,"threshold_uncertainty_score":0.49577308},"labels":[],"label_agreement":null},{"id":"W4405749615","doi":"10.1016/j.jval.2024.10.3540","title":"PCR298 COVID-19 Vaccines Relative Attribute Importance: Insights on Preference Heterogeneity Identified Through Latent Class Modeling","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Latent class model; Coronavirus disease 2019 (COVID-19); Preference; Class (philosophy); 2019-20 coronavirus outbreak; Econometrics; Computer science; Virology; Biology; Statistics; Mathematics; Medicine; Artificial intelligence; Internal medicine; Outbreak","score_opus":0.23172675177043484,"score_gpt":0.39725364001927743,"score_spread":0.1655268882488426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6539856,0.00033130616,0.31966674,0.001845756,0.00006604153,0.00019415258,0.0037937232,0.0002837985,0.019832889],"genre_scores_gemma":[0.98377776,0.00006536612,0.0120682875,0.00005602226,0.000021724127,0.00007479062,0.0010253998,0.00003137671,0.0028793341],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99709415,0.0018913066,0.00007826034,0.000343543,0.00030366395,0.00028905657],"domain_scores_gemma":[0.984539,0.013118687,0.00066463754,0.00088014023,0.00053697196,0.0002605537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006838134,0.00034833763,0.00066335994,0.001103181,0.0004820447,0.0027468735,0.0008100214,0.00062722096,0.014845304],"category_scores_gemma":[0.022104029,0.00024265354,0.0010288781,0.0018809708,0.00054263393,0.0013009958,0.00092142087,0.0014760668,0.0009922944],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017824948,0.0010968738,0.24013513,0.00036327954,0.00077385374,0.0002481928,0.0020088488,0.13183866,0.0031897398,0.3677771,0.013408402,0.23737743],"study_design_scores_gemma":[0.00009031511,0.0001268274,0.044597566,0.000057299745,0.0001098073,0.00008895553,0.0006752932,0.797143,0.0008625381,0.15236329,0.0038377517,0.00004737382],"about_ca_topic_score_codex":0.0068693743,"about_ca_topic_score_gemma":0.0072644386,"teacher_disagreement_score":0.014845304,"about_ca_system_score_codex":0.0010124895,"about_ca_system_score_gemma":0.0009054465,"threshold_uncertainty_score":0.04966253},"labels":[],"label_agreement":null},{"id":"W4405749647","doi":"10.1016/j.jval.2024.10.3490","title":"PCR248 Patient and Physician Preferences for Pain Relief Treatment for Knee Osteoarthritis: Formative Qualitative Research for a Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Formative assessment; Osteoarthritis; Physical therapy; Pain relief; Qualitative research; Medicine; Alternative medicine; Psychology; Family medicine; Surgery; Mathematics education; Sociology","score_opus":0.34839992140562404,"score_gpt":0.5660262602311968,"score_spread":0.2176263388255728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95014703,0.000075061216,0.016678404,0.0006741184,0.00013734747,0.023443084,0.0014676169,0.000045216002,0.0073319436],"genre_scores_gemma":[0.85279167,0.00009518005,0.04617671,0.0007084634,0.000048723214,0.09485174,0.00031412637,0.000033890596,0.0049795005],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.95914286,0.03411501,0.001378157,0.0016842696,0.0020366139,0.0016431203],"domain_scores_gemma":[0.8638715,0.124097906,0.0030117256,0.0036777223,0.0042319507,0.001109264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.048558682,0.0006957743,0.0007572565,0.0006616688,0.0031818498,0.002182595,0.0012088801,0.0015946378,0.024046568],"category_scores_gemma":[0.067280605,0.0009747666,0.0011649816,0.00086725515,0.0025010293,0.0013918059,0.0015972803,0.0023959647,0.0013185887],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05045006,0.087526105,0.049263906,0.0070151207,0.0006652783,0.00064092805,0.34435797,0.009790121,0.044388026,0.036331125,0.00923057,0.3603408],"study_design_scores_gemma":[0.06790584,0.21434581,0.110208854,0.0031619866,0.0018269727,0.00047072547,0.3295864,0.030229894,0.120363295,0.041884225,0.07851643,0.0014994883],"about_ca_topic_score_codex":0.0023109799,"about_ca_topic_score_gemma":0.0032029187,"teacher_disagreement_score":0.048558682,"about_ca_system_score_codex":0.00332825,"about_ca_system_score_gemma":0.006087254,"threshold_uncertainty_score":0.2568059},"labels":[],"label_agreement":null},{"id":"W4405749672","doi":"10.1016/j.jval.2024.10.3453","title":"PCR211 Quantifying Patient Preferences for Type 2 Diabetes Basal Insulin Treatments: A Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada","funders":"","keywords":"Basal insulin; Basal (medicine); Type 2 diabetes; Discrete choice; Internal medicine; Insulin; Medicine; Endocrinology; Computer science; Diabetes mellitus; Machine learning","score_opus":0.6068682333033152,"score_gpt":0.48226030041247114,"score_spread":0.12460793289084404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98630387,0.000042290892,0.007787991,0.0005335643,0.00006169341,0.00055679225,0.0007042183,0.000036990725,0.003972591],"genre_scores_gemma":[0.9879931,0.000038345803,0.008328233,0.00020041909,0.000026050695,0.00068037584,0.00026467358,0.000010724096,0.0024580383],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99446243,0.004587031,0.00013353725,0.00036214408,0.00022191346,0.00023300754],"domain_scores_gemma":[0.9370263,0.05925935,0.0011353765,0.001266972,0.00045698637,0.0008551143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010501397,0.0006625607,0.0006365997,0.0002627937,0.0005242005,0.001455582,0.00054041273,0.0016738671,0.013203547],"category_scores_gemma":[0.023580622,0.00046783817,0.0009238022,0.0003691243,0.0013057546,0.00079400634,0.0005418458,0.0016442853,0.00081509404],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34314135,0.09773897,0.08777424,0.0020023684,0.0026883094,0.0007865012,0.0021674791,0.15075,0.04151248,0.07234924,0.009083356,0.19000572],"study_design_scores_gemma":[0.07271528,0.21039009,0.06480057,0.00020457606,0.0020001829,0.00047719656,0.0014719086,0.54960656,0.030822111,0.05872078,0.008249626,0.0005411168],"about_ca_topic_score_codex":0.0014202651,"about_ca_topic_score_gemma":0.0009163473,"teacher_disagreement_score":0.013203547,"about_ca_system_score_codex":0.0007623462,"about_ca_system_score_gemma":0.0015809528,"threshold_uncertainty_score":0.055537403},"labels":[],"label_agreement":null},{"id":"W4405749694","doi":"10.1016/j.jval.2024.10.3470","title":"PCR228 Clinical and Socioeconomic Burden of Multiple Myeloma in the Czech Republic: A Cross-Sectional Study on 190 Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Czech; Socioeconomic status; Multiple myeloma; Cross-sectional study; Medicine; Environmental health; Internal medicine; Pathology","score_opus":0.12557055603808595,"score_gpt":0.4393535523587843,"score_spread":0.3137829963206984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99907804,0.00010150462,0.00003274293,0.000013024001,0.0000020846114,0.000009099539,0.00046364145,0.0000014742337,0.0002983899],"genre_scores_gemma":[0.9995301,0.00005355504,0.000025046507,0.000011679844,0.0000017357359,0.0000071855393,0.00028225224,0.000001010291,0.000087412154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995845,0.00008422193,0.00005245522,0.00008772859,0.00007342858,0.000117740055],"domain_scores_gemma":[0.9995648,0.00005830553,0.0001704203,0.000044281027,0.00005744047,0.000104715415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004731987,0.00027369897,0.00037079342,0.0009320941,0.0006642409,0.0007821274,0.00036133057,0.00041331296,0.001621248],"category_scores_gemma":[0.000881652,0.00045963834,0.0006230361,0.0014634131,0.00029611177,0.00042087742,0.00068892183,0.00049818435,0.00027587212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078371115,0.000040137224,0.9991019,0.0000071009626,0.00004296714,0.00004799176,0.00008264301,0.000029676843,0.00014560332,0.000011954232,0.000045277207,0.00036646816],"study_design_scores_gemma":[0.000003683018,0.000042696603,0.9995708,0.0000021070189,0.000011581854,0.000055724806,0.00019232696,0.000030195546,0.0000148232675,0.00000403805,0.000069843125,0.000002144314],"about_ca_topic_score_codex":0.036890112,"about_ca_topic_score_gemma":0.029834945,"teacher_disagreement_score":0.036890112,"about_ca_system_score_codex":0.0008241785,"about_ca_system_score_gemma":0.0006927295,"threshold_uncertainty_score":0.07335079},"labels":[],"label_agreement":null},{"id":"W4405749704","doi":"10.1016/j.jval.2024.10.3516","title":"PCR274 Exploring Drivers for Treatment Preferences in Canadian Patients With Type 2 Diabetes: A Qualitative Interview Study to Inform a Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Diabetes Canada","funders":"","keywords":"Type 2 diabetes; Qualitative research; Psychology; Medicine; Applied psychology; Diabetes mellitus; Sociology; Endocrinology; Social science","score_opus":0.3587980577137058,"score_gpt":0.3433170351235492,"score_spread":0.015481022590156601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98478115,0.00034038883,0.0010840942,0.0070904028,0.00007051887,0.00081232504,0.00075213023,0.000008153263,0.0050609],"genre_scores_gemma":[0.99071574,0.00035644727,0.0016625416,0.0035686414,0.000021321932,0.0009941781,0.00021602782,0.000011075924,0.0024540927],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.989284,0.005496962,0.00036701234,0.0005624553,0.00097458885,0.0033149817],"domain_scores_gemma":[0.9698259,0.018101443,0.0022265546,0.0005192081,0.0047848416,0.0045420025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015585938,0.0004538495,0.00068363367,0.0014616734,0.017465683,0.0042190542,0.0018264783,0.0020736982,0.0068572573],"category_scores_gemma":[0.029879699,0.00058220903,0.00076442887,0.0028155206,0.0048634303,0.0017956456,0.0032497146,0.0051984102,0.00035919488],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004624249,0.0006777302,0.055966347,0.00030508044,0.00003298965,0.0007179102,0.91701674,0.00023606958,0.000930645,0.0031099762,0.0057931924,0.014750869],"study_design_scores_gemma":[0.00007302605,0.00018367697,0.017221285,0.00030893864,0.000025054156,0.00009250614,0.9679836,0.00034386036,0.00032024513,0.0007085918,0.012637605,0.000101671394],"about_ca_topic_score_codex":0.81593394,"about_ca_topic_score_gemma":0.8749184,"teacher_disagreement_score":0.18406606,"about_ca_system_score_codex":0.05164227,"about_ca_system_score_gemma":0.081825145,"threshold_uncertainty_score":0.37469262},"labels":[],"label_agreement":null},{"id":"W4405749750","doi":"10.1016/j.jval.2024.10.3396","title":"PCR153 Burden of Disease in Patients With Chronic Hand Eczema: Systematic Literature Reviews of Healthcare Resource Use and Health-Related Quality of Life","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Health care; Systematic review; Medicine; Quality of life (healthcare); Resource (disambiguation); Burden of disease; Disease burden; Quality (philosophy); Resource use; Disease; MEDLINE; Nursing; Computer science; Environmental resource management; Pathology; Political science; Economics; Economic growth","score_opus":0.055953021540556445,"score_gpt":0.3183818254048829,"score_spread":0.2624288038643265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749750","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017345697,0.9797704,0.00010948467,0.00036324628,0.00011572954,0.00006647963,0.0019101906,0.000006755432,0.00031205168],"genre_scores_gemma":[0.34483266,0.6507381,0.0011437031,0.0011553356,0.00021944572,0.00026870234,0.0014821566,0.000013627688,0.00014625584],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9862665,0.004382164,0.0056914226,0.0014148788,0.0018018358,0.00044319683],"domain_scores_gemma":[0.9640489,0.02185211,0.01121877,0.0006871569,0.0018531142,0.00033996464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009437266,0.00091013534,0.005420469,0.009840662,0.0003757361,0.0028097844,0.00095166976,0.0014491804,0.0018380685],"category_scores_gemma":[0.04151689,0.0010409679,0.015353845,0.012050873,0.000731018,0.0019383028,0.0019181644,0.001395931,0.00013006729],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001241143,0.000079025915,0.1639494,0.5110187,0.2576271,0.00019964397,0.0006054351,0.00045359632,0.00031182234,0.00034256396,0.0027805641,0.061390962],"study_design_scores_gemma":[0.0008412157,0.0005068305,0.35554394,0.24483687,0.3844598,0.0007625726,0.0010439462,0.00043528175,0.00026447454,0.0005179654,0.010630624,0.00015647252],"about_ca_topic_score_codex":0.02098184,"about_ca_topic_score_gemma":0.055757698,"teacher_disagreement_score":0.02098184,"about_ca_system_score_codex":0.0021758128,"about_ca_system_score_gemma":0.0042012604,"threshold_uncertainty_score":0.04990959},"labels":[],"label_agreement":null},{"id":"W4405749860","doi":"10.1016/j.jval.2024.10.3098","title":"SA17 Adapted Targeted Literature Review (ATLR) Methods for Robust Quantitative Survey Instrument Development: The AGAP (Abbott Global Assessment of Patients Unmet Needs) Multinational Survey Study in Chronic Liver Disease (CLD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multinational corporation; Medicine; Survey instrument; Psychology; Political science; Applied psychology","score_opus":0.1371440868037071,"score_gpt":0.4470044804033987,"score_spread":0.3098603935996916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749860","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021519978,0.016520243,0.3517056,0.0060818233,0.0017857002,0.24636024,0.2952894,0.0127533935,0.04798366],"genre_scores_gemma":[0.03180292,0.0030757994,0.58459115,0.0011011567,0.00015752889,0.34664008,0.025612516,0.0011927988,0.0058260662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.874828,0.066711746,0.038985416,0.006519624,0.011874913,0.0010803243],"domain_scores_gemma":[0.6750746,0.21378164,0.0222715,0.023620417,0.063603535,0.0016482624],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10822512,0.0019785375,0.0040360913,0.03413707,0.0020834694,0.0043232245,0.0032184771,0.0019019844,0.0740587],"category_scores_gemma":[0.2807866,0.001891249,0.010663719,0.026739502,0.0012863458,0.0024125653,0.0064112167,0.0017313887,0.013192613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018052912,0.00042589536,0.010085295,0.29595867,0.008350655,0.00056866935,0.010213786,0.0026269301,0.003934475,0.020112751,0.13760759,0.50830996],"study_design_scores_gemma":[0.0036803738,0.0013589906,0.03546382,0.06650877,0.01756662,0.0005442927,0.0053061782,0.008294634,0.0061989175,0.02758245,0.8268682,0.0006267734],"about_ca_topic_score_codex":0.0056035337,"about_ca_topic_score_gemma":0.018470937,"teacher_disagreement_score":0.8917749,"about_ca_system_score_codex":0.0032706673,"about_ca_system_score_gemma":0.034458086,"threshold_uncertainty_score":0.572356},"labels":[],"label_agreement":null},{"id":"W4405749862","doi":"10.1016/j.jval.2024.10.3254","title":"PCR11 Patient Reported Symptoms, Functioning, and Quality of Life (QoL) in Patients Treated With Chimeric Antigen Receptor T Cells for Hematologic Malignancy: A Systematic Review and Meta Analysis","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Hematologic malignancy; Medicine; Chimeric antigen receptor; Meta-analysis; Quality of life (healthcare); Malignancy; Oncology; Internal medicine; Immunotherapy; Cancer; Nursing","score_opus":0.15851327232871035,"score_gpt":0.39514214647368007,"score_spread":0.23662887414496972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007590239,0.9913857,0.00017677774,0.000101094265,0.000082150655,0.0000792202,0.00040969448,0.000008945465,0.0001661833],"genre_scores_gemma":[0.19465846,0.80192626,0.0009765314,0.00088875287,0.00018454531,0.0003576312,0.0006646312,0.000011698747,0.00033157752],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975413,0.000961311,0.0007083502,0.00035492252,0.00030687478,0.00012721372],"domain_scores_gemma":[0.9952923,0.0033615371,0.0008853168,0.0001194346,0.00026281262,0.00007862686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038331917,0.0015275045,0.009996308,0.0020125571,0.0003833009,0.001962189,0.0011327692,0.0015327177,0.0029516488],"category_scores_gemma":[0.009760357,0.00084579014,0.023419447,0.0037318694,0.00047442628,0.0008417363,0.0010403517,0.0017583367,0.00020677764],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040549515,0.000078549645,0.008635479,0.3588032,0.59726614,0.00011530337,0.000091748494,0.0004693853,0.0003409309,0.0001187042,0.0010754578,0.028950179],"study_design_scores_gemma":[0.0014387957,0.00035001585,0.0096406415,0.018681306,0.96730417,0.00010601884,0.000067185225,0.00016208409,0.00010507709,0.00014429318,0.0019636499,0.000036665868],"about_ca_topic_score_codex":0.006630401,"about_ca_topic_score_gemma":0.017682739,"teacher_disagreement_score":0.009996308,"about_ca_system_score_codex":0.0013926572,"about_ca_system_score_gemma":0.0016730473,"threshold_uncertainty_score":0.020272076},"labels":[],"label_agreement":null},{"id":"W4405749878","doi":"10.1016/j.jval.2024.10.3112","title":"SA31 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Treatments for First-Line (1L) Gastric Cancer/Gastroesophageal Junction Adenocarcinoma (GC/GEJ) in Adult Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Randomized controlled trial; Cancer; Gastroesophageal Junction; Internal medicine; Systematic review; Adenocarcinoma; Gastroenterology; MEDLINE; Biology","score_opus":0.035451650994144775,"score_gpt":0.336272807396145,"score_spread":0.30082115640200024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011103867,0.94151926,0.0022057104,0.0020308257,0.0009945286,0.018401954,0.020027725,0.00016669458,0.0035494848],"genre_scores_gemma":[0.20452563,0.7174892,0.021452168,0.008125337,0.0007507921,0.03684914,0.008473221,0.00014572177,0.002188792],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.92340964,0.031682905,0.03453665,0.0036842145,0.0056174835,0.0010691249],"domain_scores_gemma":[0.8811949,0.07253629,0.03023788,0.0039652707,0.01089794,0.0011677145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03945572,0.0021900723,0.011722632,0.014768212,0.0014524187,0.0042361165,0.0018532216,0.003357783,0.017584262],"category_scores_gemma":[0.163124,0.0017872007,0.021567404,0.012073192,0.0016950624,0.0031029372,0.003070746,0.0022152194,0.0013365104],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019469778,0.000026320133,0.0015357678,0.9121645,0.069911726,0.000067915586,0.00017358703,0.000080499594,0.0002516509,0.00016203485,0.0016834768,0.011995538],"study_design_scores_gemma":[0.0065344884,0.0006461587,0.0072366,0.5868163,0.38000572,0.00022779974,0.00021950013,0.00012138549,0.00031184495,0.00045028148,0.01735688,0.000073141695],"about_ca_topic_score_codex":0.010643299,"about_ca_topic_score_gemma":0.035478164,"teacher_disagreement_score":0.03945572,"about_ca_system_score_codex":0.005554087,"about_ca_system_score_gemma":0.017124167,"threshold_uncertainty_score":0.2086643},"labels":[],"label_agreement":null},{"id":"W4405749911","doi":"10.1016/j.jval.2024.10.3381","title":"PCR138 Inequalities in the Impact of Dermatological Diseases Across the Globe: Impact Results From the GRIDD Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Globe; Medicine; Inequality; Impact evaluation; Dermatology; Ophthalmology; Mathematics; Pathology","score_opus":0.5138766555187833,"score_gpt":0.5089710780481833,"score_spread":0.004905577470599942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774507,0.00070150016,0.00034791336,0.0017098571,0.000041750514,0.000025972036,0.014651331,0.000012968091,0.0050580897],"genre_scores_gemma":[0.9950418,0.0001983078,0.000103717306,0.00019486429,0.000018915382,0.000025873971,0.0038192365,0.000007802261,0.0005895893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839455,0.0006652253,0.000114140974,0.00016011334,0.00024228971,0.00042362962],"domain_scores_gemma":[0.99536985,0.0011535457,0.0016558996,0.0006225601,0.00049305987,0.00070517254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001426112,0.0002411176,0.00043182122,0.00089420617,0.00045145646,0.0014406856,0.00069970184,0.0004978039,0.003530514],"category_scores_gemma":[0.0075603174,0.00021428763,0.0010344549,0.0045972117,0.00059301336,0.0009729513,0.0030259166,0.0013201941,0.00038695917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038320184,0.00009488385,0.9898839,0.000056425222,0.00040794426,0.000088724555,0.0003811028,0.0003438198,0.000041920626,0.001064716,0.0024129765,0.004840292],"study_design_scores_gemma":[0.0000386193,0.000031164996,0.9968303,0.00002828395,0.00013079139,0.00003871366,0.0007286666,0.00025053162,0.000039776674,0.00039579323,0.0014793043,0.00000802345],"about_ca_topic_score_codex":0.12999769,"about_ca_topic_score_gemma":0.08132922,"teacher_disagreement_score":0.12999769,"about_ca_system_score_codex":0.0010950717,"about_ca_system_score_gemma":0.00105649,"threshold_uncertainty_score":0.25848198},"labels":[],"label_agreement":null},{"id":"W4405749913","doi":"10.1016/j.jval.2024.10.3272","title":"PCR29 EQ-5D Utility According to Patient Self-Reported Health on the Visual Analogue Scale (VAS) in Duchenne Muscular Dystrophy (DMD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Visual analogue scale; Medicine; EQ-5D; Scale (ratio); Physical medicine and rehabilitation; Physical therapy; Internal medicine; Geography; Cartography; Health related quality of life; Disease","score_opus":0.1038421637394123,"score_gpt":0.34819465719872555,"score_spread":0.24435249345931326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9641484,0.0021742142,0.003029587,0.0005528351,0.000068239104,0.00013995908,0.014180613,0.00006235037,0.015643716],"genre_scores_gemma":[0.99429744,0.0001531801,0.0010141551,0.0000899008,0.0000085915635,0.00007602037,0.0029672203,0.0000081888675,0.0013853908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862075,0.00058953883,0.00016783758,0.00015827475,0.00029827608,0.00016528658],"domain_scores_gemma":[0.9981061,0.000892322,0.0005437271,0.00008208285,0.00026694938,0.000108702705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017464461,0.0003159868,0.00045113944,0.00067019596,0.00020676464,0.00080729707,0.00043309754,0.00052043045,0.0052063414],"category_scores_gemma":[0.008185672,0.00012519538,0.0012552626,0.00086738286,0.0003187742,0.00039977388,0.00063619943,0.00075695274,0.0007795231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018725643,0.00017346571,0.9355437,0.0004113523,0.0009791438,0.0002954361,0.00041568192,0.0039318404,0.0011391733,0.001942632,0.007845161,0.045449927],"study_design_scores_gemma":[0.000059993727,0.00042394196,0.9897882,0.000084132735,0.00015225828,0.00040961299,0.00015163358,0.004927486,0.00042364493,0.00061297446,0.0029367732,0.000029356794],"about_ca_topic_score_codex":0.00807554,"about_ca_topic_score_gemma":0.005181976,"teacher_disagreement_score":0.00807554,"about_ca_system_score_codex":0.00087253883,"about_ca_system_score_gemma":0.00027339775,"threshold_uncertainty_score":0.017416954},"labels":[],"label_agreement":null},{"id":"W4405749923","doi":"10.1016/j.jval.2024.10.3298","title":"PCR55 The Burden of Long COVID on Quality of Life and Daily Functioning","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Quality of life (healthcare); 2019-20 coronavirus outbreak; Gerontology; Medicine; Psychology; Virology; Internal medicine; Disease; Nursing; Outbreak","score_opus":0.06961561696759487,"score_gpt":0.38110298965179407,"score_spread":0.3114873726841992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93242043,0.020046411,0.0005326577,0.0062298803,0.00057213014,0.000078147576,0.009552628,0.000047420966,0.030520346],"genre_scores_gemma":[0.991964,0.0022246998,0.00025265297,0.0005127861,0.00017756247,0.000027856351,0.0025433837,0.000009833937,0.0022872332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976447,0.00086063583,0.00016441602,0.0001561894,0.0005629791,0.0006110731],"domain_scores_gemma":[0.9919687,0.001493404,0.003081715,0.00044085743,0.0013294828,0.0016857771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021921112,0.00030276607,0.0005272263,0.00074316014,0.0006764205,0.0021233025,0.00046112257,0.0006194356,0.009633261],"category_scores_gemma":[0.011555061,0.00018189599,0.0012078028,0.0012786504,0.0005750237,0.00097619917,0.001487111,0.0017669197,0.00089352735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015993689,0.0005494966,0.88135815,0.000300371,0.0009882755,0.0002951812,0.0002811014,0.0004142596,0.0006338637,0.0017970745,0.008457055,0.10332578],"study_design_scores_gemma":[0.000026785989,0.00032644215,0.9930882,0.0001715323,0.00015025758,0.00022700532,0.00034505414,0.00020543556,0.00014615194,0.00041932875,0.004869667,0.000024064655],"about_ca_topic_score_codex":0.015614965,"about_ca_topic_score_gemma":0.021567063,"teacher_disagreement_score":0.015614965,"about_ca_system_score_codex":0.0018803986,"about_ca_system_score_gemma":0.0018357771,"threshold_uncertainty_score":0.032226503},"labels":[],"label_agreement":null},{"id":"W4405749925","doi":"10.1016/j.jval.2024.10.3202","title":"SA121 Can Living Systematic Literature Reviews Reduce Research Wastage? An Evaluation of LiveSLR®","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Systematic review; MEDLINE; Political science","score_opus":0.5751630191119229,"score_gpt":0.6100987112752647,"score_spread":0.0349356921633418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68980473,0.045894746,0.042040378,0.048566945,0.0020382907,0.11193407,0.00891468,0.0016062584,0.049199868],"genre_scores_gemma":[0.77324814,0.012864375,0.14781709,0.006031376,0.00037359624,0.053233154,0.0019225193,0.00027654602,0.004233217],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.48450807,0.45140758,0.031076726,0.0025824597,0.02799753,0.0024276315],"domain_scores_gemma":[0.33939534,0.5615562,0.023757916,0.015361361,0.052119847,0.0078093563],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.34639427,0.0013302711,0.002513714,0.004531296,0.0020762507,0.0059101754,0.0026898049,0.003775428,0.012973769],"category_scores_gemma":[0.43052283,0.0016150582,0.0093934825,0.0043196464,0.0042113643,0.0055620517,0.007978746,0.0030894747,0.0011212042],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064616285,0.00574485,0.013902103,0.11184531,0.01774374,0.00024142704,0.018591011,0.0020383166,0.0030292177,0.0056369887,0.008794303,0.7478164],"study_design_scores_gemma":[0.111553594,0.20737043,0.12071173,0.21624783,0.07654304,0.001019423,0.042455066,0.016929891,0.022289144,0.014933343,0.16844642,0.0015001248],"about_ca_topic_score_codex":0.0022988324,"about_ca_topic_score_gemma":0.0041597625,"teacher_disagreement_score":0.6536057,"about_ca_system_score_codex":0.0061692726,"about_ca_system_score_gemma":0.017164767,"threshold_uncertainty_score":0.8060123},"labels":[],"label_agreement":null},{"id":"W4405749933","doi":"10.1016/j.jval.2024.10.3143","title":"SA62 Evaluating Generative Artificial Intelligence (GenAI) in Health Technology Assessment (HTA) Content Generation: A Proof-of-Concept Using Canadian Agency for Drugs and Technologies in Health (CADTH) Reimbursement Dossier Forms","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Reimbursement; Health technology; Agency (philosophy); Proof of concept; Generative grammar; Regulatory agency; Medicine; Computer science; Artificial intelligence; Political science; Public administration; Health care; Sociology; Law","score_opus":0.628704518258548,"score_gpt":0.5007668926854623,"score_spread":0.12793762557308574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749933","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3148953,0.0024708502,0.5234923,0.0037684052,0.0010780158,0.009768463,0.0070074615,0.018233616,0.119285546],"genre_scores_gemma":[0.4975793,0.0004314404,0.48371476,0.00071839325,0.00007365936,0.0025703649,0.004440282,0.0008750674,0.009596697],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9825937,0.012088597,0.00052697345,0.0006766408,0.0037981656,0.00031586323],"domain_scores_gemma":[0.9480979,0.036857553,0.00083234755,0.0046311654,0.008980348,0.00060072157],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.022590538,0.0009953134,0.00082028337,0.0013761052,0.0006924483,0.0031425909,0.0017469641,0.001982166,0.015075333],"category_scores_gemma":[0.07553516,0.00052879483,0.0012942182,0.0010009453,0.0015100418,0.002015583,0.0023332692,0.0015089816,0.002550579],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006344477,0.002482978,0.008752552,0.002359784,0.0006990572,0.00022690238,0.0014361755,0.18963194,0.009505124,0.059939437,0.044711314,0.6739102],"study_design_scores_gemma":[0.0037193748,0.0033161948,0.006105093,0.00064491574,0.00046263868,0.00016925462,0.0004800143,0.87221843,0.02357919,0.039888553,0.049239736,0.0001766317],"about_ca_topic_score_codex":0.012841792,"about_ca_topic_score_gemma":0.009865737,"teacher_disagreement_score":0.9973771,"about_ca_system_score_codex":0.0026229175,"about_ca_system_score_gemma":0.0032388174,"threshold_uncertainty_score":0.11947161},"labels":[],"label_agreement":null},{"id":"W4405749935","doi":"10.1016/j.jval.2024.10.3161","title":"SA80 A New Process Model for Study Identification in Systematic Review: Separating Studies From Reports","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Identification (biology); Computer science; Process (computing); Data science; Computational biology; Data mining; Management science; Engineering; Biology; Programming language","score_opus":0.4231419412241073,"score_gpt":0.6024569520220492,"score_spread":0.17931501079794188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749935","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0076539246,0.0010342732,0.9715167,0.003840602,0.0002589256,0.009494465,0.0009388142,0.00066233095,0.004599929],"genre_scores_gemma":[0.035363242,0.0002813721,0.9508359,0.000529578,0.00004830029,0.011578939,0.00049085275,0.000105877116,0.0007659509],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.38674155,0.5120395,0.049636338,0.010507889,0.038734157,0.0023405745],"domain_scores_gemma":[0.28162992,0.626842,0.016041422,0.028209005,0.04438204,0.0028957208],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35018665,0.0036555696,0.0057887146,0.019794662,0.0049156486,0.0106412945,0.0039573484,0.007927273,0.009783433],"category_scores_gemma":[0.5704812,0.004552743,0.015187942,0.013645145,0.0071635717,0.01432624,0.015413504,0.007234469,0.002643127],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027937992,0.0008305814,0.016279003,0.035459995,0.009863117,0.00028320486,0.034394525,0.017725239,0.0041826675,0.17517912,0.015926445,0.68708235],"study_design_scores_gemma":[0.0037638282,0.002896528,0.0140897585,0.020460885,0.007627137,0.0009257939,0.008009343,0.26355293,0.007847425,0.58173084,0.088021785,0.0010736396],"about_ca_topic_score_codex":0.006142055,"about_ca_topic_score_gemma":0.009389946,"teacher_disagreement_score":0.64981335,"about_ca_system_score_codex":0.008351903,"about_ca_system_score_gemma":0.033263903,"threshold_uncertainty_score":0.8013356},"labels":[],"label_agreement":null},{"id":"W4405749949","doi":"10.1016/j.jval.2024.10.2549","title":"OP8 What Do HTA Agencies Across the Globe Need for Generating Health-Related Quality of Life Evidence? Findings From a Global Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Globe; Real world evidence; Health related quality of life; Quality of life (healthcare); Medicine; Business; Political science; MEDLINE; Nursing","score_opus":0.6426619097120122,"score_gpt":0.49952404247352644,"score_spread":0.14313786723848576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749949","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08098691,0.01970266,0.003731528,0.842059,0.0017174354,0.00053892634,0.021607565,0.0001583988,0.029497566],"genre_scores_gemma":[0.5935579,0.030795049,0.033796642,0.3132243,0.0043794224,0.0016723364,0.017854134,0.00040694204,0.0043132775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9640599,0.021751916,0.003509679,0.00078613416,0.0072786454,0.002613736],"domain_scores_gemma":[0.62575614,0.24438123,0.042841017,0.008465454,0.060669504,0.017886652],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.073993325,0.0003603823,0.0012170781,0.0053505492,0.0010904861,0.009663323,0.0020986274,0.0033467396,0.019495798],"category_scores_gemma":[0.26094353,0.00059920567,0.0018066932,0.009419488,0.0020882506,0.007229364,0.0035186002,0.0024565812,0.0023636231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068604306,0.00037038486,0.4340697,0.006198403,0.0017695623,0.00034372119,0.0038110365,0.0010544613,0.00071471615,0.019150293,0.24827786,0.28355378],"study_design_scores_gemma":[0.0006934956,0.00047597985,0.6797507,0.017711388,0.001319419,0.00043389533,0.01847274,0.0016634548,0.0010817414,0.026553031,0.2516175,0.00022670845],"about_ca_topic_score_codex":0.020750146,"about_ca_topic_score_gemma":0.027299825,"teacher_disagreement_score":0.9260067,"about_ca_system_score_codex":0.0036359746,"about_ca_system_score_gemma":0.017812597,"threshold_uncertainty_score":0.3913188},"labels":[],"label_agreement":null},{"id":"W4405749959","doi":"10.1016/j.jval.2024.10.3392","title":"PCR149 Burden of Childhood Arthritis: Work Productivity Loss and Activity Impairment of Parents and Caregivers","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"","keywords":"Work productivity; Productivity; Functional impairment; Arthritis; Work (physics); Medicine; Psychology; Gerontology; Clinical psychology; Economics; Engineering; Economic growth; Internal medicine","score_opus":0.02095037834043378,"score_gpt":0.2975777865978548,"score_spread":0.276627408257421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725515,0.00026206954,0.000048417594,0.00009457374,0.0000070658084,0.000005733089,0.00081463857,0.000003086785,0.0015093094],"genre_scores_gemma":[0.99920803,0.00009786766,0.000037139296,0.000011484135,0.0000058970836,0.0000043970003,0.00032877098,0.0000013564778,0.00030504982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991375,0.00027158772,0.000088698995,0.00008409609,0.00021165822,0.00020635252],"domain_scores_gemma":[0.99750865,0.00039664167,0.0013366438,0.00011817452,0.00027836044,0.0003614294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005889547,0.00025646033,0.00033461401,0.00087387045,0.00049162906,0.0008794462,0.00032720383,0.0003825387,0.0046316306],"category_scores_gemma":[0.0053622075,0.00021459576,0.00045308637,0.0011320809,0.00023320454,0.0005006197,0.0007614655,0.00070241035,0.000457859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006544942,0.000028096583,0.99656385,0.000009593154,0.000032597924,0.0001323371,0.00023831792,0.000045672547,0.00007774655,0.00001745497,0.00014877104,0.002640174],"study_design_scores_gemma":[0.000001432881,0.0000420486,0.99893683,0.000007401238,0.000014286628,0.0002870887,0.0004585624,0.000058447553,0.000036386766,0.000012844098,0.00014184597,0.000002707703],"about_ca_topic_score_codex":0.016377142,"about_ca_topic_score_gemma":0.0138048325,"teacher_disagreement_score":0.016377142,"about_ca_system_score_codex":0.00040261532,"about_ca_system_score_gemma":0.00054208626,"threshold_uncertainty_score":0.032563627},"labels":[],"label_agreement":null},{"id":"W4405749963","doi":"10.1016/j.jval.2024.10.3166","title":"SA85 Treatment Switching in Evidence Synthesis in Oncology: A Comprehensive Review of Current Meta-Analytical Practices","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Current (fluid); Meta-analysis; Medical physics; Medicine; Oncology; Intensive care medicine; Internal medicine; Engineering; Electrical engineering","score_opus":0.9253042468417044,"score_gpt":0.645814128525625,"score_spread":0.2794901183160794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012892376,0.9987,0.00046364593,0.00029014485,0.000099284814,0.00009885512,0.00010230328,0.000010306039,0.00010645602],"genre_scores_gemma":[0.0072561726,0.98707634,0.0035133394,0.001148636,0.00026967755,0.00040027057,0.00018946358,0.000029641527,0.000116358795],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9427395,0.032707054,0.016095202,0.002871818,0.005024008,0.0005624768],"domain_scores_gemma":[0.8377685,0.13710634,0.015732039,0.00298697,0.005653758,0.0007524521],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06616335,0.002320049,0.016764592,0.010899145,0.0007435948,0.006958924,0.0034834507,0.0037326422,0.007465009],"category_scores_gemma":[0.17639416,0.002039374,0.019983947,0.011805969,0.0016483691,0.003861052,0.0041463734,0.00404678,0.00071409234],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091173523,0.000038497354,0.00069863076,0.74379474,0.08525007,0.000055151853,0.00017501066,0.0004877564,0.00022492933,0.0010442798,0.0032988016,0.16402042],"study_design_scores_gemma":[0.0012267997,0.00034382698,0.0027994663,0.64526963,0.30202982,0.00026362608,0.00016812686,0.0005507119,0.0003511488,0.0046971203,0.042190704,0.00010904725],"about_ca_topic_score_codex":0.0058786436,"about_ca_topic_score_gemma":0.015574315,"teacher_disagreement_score":0.93383664,"about_ca_system_score_codex":0.005042942,"about_ca_system_score_gemma":0.013497235,"threshold_uncertainty_score":0.34990942},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4405749969","doi":"10.1016/j.jval.2024.10.3282","title":"PCR39 Health State Utility Values for Patients With Paroxysmal Nocturnal Hemoglobinuria Using EQ-5D-5L","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Nocturnal; Hemoglobinuria; Pediatrics; Internal medicine; Anemia","score_opus":0.0684285550573929,"score_gpt":0.3222735697635755,"score_spread":0.2538450147061826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8712119,0.006168074,0.006995555,0.0013113163,0.0003180545,0.00036408557,0.077823885,0.0002844119,0.035522792],"genre_scores_gemma":[0.9814611,0.00046004602,0.00324356,0.00029004086,0.000042655472,0.00019371089,0.012443841,0.000023469227,0.0018415938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873954,0.0003808247,0.0001833875,0.0001456162,0.00035871373,0.00019199865],"domain_scores_gemma":[0.99815315,0.0006860774,0.00060774945,0.00009880664,0.0003093448,0.00014481603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018369185,0.0005805289,0.00080637744,0.0019457134,0.00034086598,0.0016755308,0.0005787693,0.0005548571,0.006286738],"category_scores_gemma":[0.008534343,0.00016622158,0.0028701131,0.0022790562,0.00023496416,0.00075548585,0.00081765227,0.001152784,0.0011221113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011337491,0.0002278597,0.91384774,0.00043249782,0.002348567,0.00017861034,0.00023896122,0.0037605516,0.00037693034,0.0023626613,0.011842471,0.06324927],"study_design_scores_gemma":[0.0001355098,0.000498425,0.97062635,0.00028154385,0.00063041697,0.00038211638,0.00026639007,0.011717113,0.0004304949,0.002591718,0.012345948,0.000094070834],"about_ca_topic_score_codex":0.010616519,"about_ca_topic_score_gemma":0.008635258,"teacher_disagreement_score":0.010616519,"about_ca_system_score_codex":0.0013344764,"about_ca_system_score_gemma":0.00063157204,"threshold_uncertainty_score":0.021109462},"labels":[],"label_agreement":null},{"id":"W4405749979","doi":"10.1016/j.jval.2024.10.3258","title":"PCR15 Exploring the Development, Evaluation, and Impact of Researcher-Led Patient and Family Advisory Councils in Cancer Research","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Research development; Political science; Medicine; Family medicine","score_opus":0.8874092172338767,"score_gpt":0.6719718284874874,"score_spread":0.2154373887463893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45412827,0.005882373,0.056454584,0.3026485,0.00454893,0.018675076,0.0013665252,0.0008384871,0.15545727],"genre_scores_gemma":[0.87605935,0.0015075925,0.06507051,0.032962743,0.00035049752,0.011361477,0.0003156905,0.00024706085,0.012125117],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.3053708,0.63360643,0.010045699,0.00595479,0.030866127,0.0141562605],"domain_scores_gemma":[0.11099438,0.74428695,0.024805972,0.022123288,0.07118468,0.026604759],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5455859,0.0005919602,0.0007676928,0.0028365864,0.014381316,0.015828097,0.006292188,0.0061315447,0.010818806],"category_scores_gemma":[0.6668579,0.0014497344,0.0013272485,0.003208715,0.008881058,0.009345726,0.02050799,0.009502237,0.0014912551],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027801034,0.0049426183,0.06288921,0.0046468587,0.0005149201,0.0006583824,0.19451557,0.002162258,0.0011579733,0.07901541,0.06453666,0.58218014],"study_design_scores_gemma":[0.0048127915,0.008709289,0.086000346,0.015661133,0.0014150889,0.00070973847,0.3000805,0.009155221,0.01153648,0.063700795,0.49761426,0.000604368],"about_ca_topic_score_codex":0.02402814,"about_ca_topic_score_gemma":0.04580166,"teacher_disagreement_score":0.45441413,"about_ca_system_score_codex":0.038836505,"about_ca_system_score_gemma":0.19703487,"threshold_uncertainty_score":0.56037354},"labels":[],"label_agreement":null},{"id":"W4405749997","doi":"10.1016/j.jval.2024.10.3323","title":"PCR80 Barriers and Facilitators to the Recruitment and Engagement of Diverse Populations Into Patient Engagement Groups: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Psychology","score_opus":0.4836314720961907,"score_gpt":0.5453850882236009,"score_spread":0.061753616127410205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036237072,0.997686,0.00021485146,0.0006003927,0.00015736719,0.0002624727,0.00012565599,0.000006695907,0.0005842516],"genre_scores_gemma":[0.0029166762,0.99526274,0.00058995787,0.00055997114,0.00005026789,0.00034138642,0.00009148341,0.0000049869786,0.0001824708],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98551756,0.005740767,0.003987169,0.00088522653,0.0032254467,0.0006438944],"domain_scores_gemma":[0.9420984,0.04673355,0.0056398786,0.0006610286,0.0042542326,0.00061296776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027234612,0.0012596035,0.0047061965,0.008089631,0.0011575221,0.0065117334,0.002342205,0.0035770973,0.007718848],"category_scores_gemma":[0.07876871,0.0010290277,0.0050790105,0.009533717,0.0016349443,0.003512862,0.004435765,0.002764468,0.000973509],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018118093,0.000086278895,0.00076140213,0.6867848,0.0029718159,0.00007984404,0.00061897543,0.00012238766,0.00022689924,0.0015206413,0.005487973,0.3011578],"study_design_scores_gemma":[0.00007895767,0.00008239399,0.0018194641,0.9302842,0.009883801,0.000109337365,0.0004627914,0.000045825982,0.0001595987,0.0005774285,0.056470033,0.000026160458],"about_ca_topic_score_codex":0.014247157,"about_ca_topic_score_gemma":0.038318627,"teacher_disagreement_score":0.027234612,"about_ca_system_score_codex":0.005125338,"about_ca_system_score_gemma":0.029061532,"threshold_uncertainty_score":0.14403212},"labels":[],"label_agreement":null},{"id":"W4405749999","doi":"10.1016/j.jval.2024.10.3140","title":"SA59 Evaluating the Optimal TKI for Patients With ALK Positive Advanced Non-Small-Cell Lung Cancer (aNSCLC) in the First Line (1L) Setting: An Updated Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Medicine; Meta-analysis; Lung cancer; Systematic review; Oncology; Internal medicine; MEDLINE; Chemistry","score_opus":0.04057041200427511,"score_gpt":0.39568381005014447,"score_spread":0.3551133980458694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749999","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022957144,0.97157186,0.00069976377,0.0005943881,0.00044376563,0.0002513769,0.002539415,0.00003217216,0.0009101234],"genre_scores_gemma":[0.55341893,0.43601334,0.0027241153,0.0027107028,0.0006171293,0.0005618635,0.0029911234,0.000046744393,0.0009160701],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9966342,0.0014320596,0.0009398751,0.00050932553,0.00033315425,0.00015140393],"domain_scores_gemma":[0.9955107,0.002712297,0.0011174536,0.00015202395,0.00039795323,0.000109633016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045108525,0.0013287246,0.0075101834,0.0024915293,0.00036822318,0.0020510207,0.00088919204,0.0015322508,0.0039006432],"category_scores_gemma":[0.013275687,0.0007928855,0.026809424,0.0025251736,0.00036583177,0.0010403027,0.0009375584,0.0018955789,0.0004360631],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014337516,0.00008529493,0.011583225,0.24513163,0.6777361,0.000109802175,0.00009503619,0.0010491887,0.0008904989,0.00027260804,0.0019277142,0.046781413],"study_design_scores_gemma":[0.0039637447,0.00075077795,0.010319698,0.017575772,0.96267265,0.00009803656,0.000051608502,0.0003232124,0.00021659513,0.00030866158,0.003679772,0.00003956867],"about_ca_topic_score_codex":0.008058416,"about_ca_topic_score_gemma":0.022817288,"teacher_disagreement_score":0.008058416,"about_ca_system_score_codex":0.0019550659,"about_ca_system_score_gemma":0.002162895,"threshold_uncertainty_score":0.023855925},"labels":[],"label_agreement":null},{"id":"W4405750004","doi":"10.1016/j.jval.2024.10.3157","title":"SA76 Systematic Literature Review of the Economic Burden of Hemophilia A and B","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.03521936318916204,"score_gpt":0.3462762214218782,"score_spread":0.31105685823271617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750004","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004448382,0.9878049,0.00029494197,0.0007670299,0.00030642128,0.0006534382,0.00478823,0.000012739494,0.0009238841],"genre_scores_gemma":[0.06518222,0.92781436,0.0014464706,0.0016030817,0.0002409373,0.0013756003,0.0019100406,0.000016362203,0.0004109511],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9814238,0.0075577754,0.006962456,0.001079019,0.002515114,0.00046173346],"domain_scores_gemma":[0.9434168,0.0382609,0.011368398,0.0012833046,0.0051004193,0.00057014794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014003975,0.0014426393,0.007587597,0.014638536,0.00080897886,0.0034147028,0.0016078554,0.0021538937,0.008554694],"category_scores_gemma":[0.087929465,0.0011493246,0.013535739,0.0152385505,0.0009839039,0.0020956455,0.0024383722,0.001519818,0.0005727914],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007395354,0.00002360129,0.0039154207,0.8951914,0.075354375,0.00015802246,0.00014951681,0.0001555776,0.00010420072,0.00032335726,0.0026784502,0.021206671],"study_design_scores_gemma":[0.0010853957,0.00024428495,0.016655881,0.69999576,0.2660148,0.00035478434,0.00027375543,0.0001081575,0.00010250826,0.00056570396,0.014536522,0.00006243752],"about_ca_topic_score_codex":0.02097768,"about_ca_topic_score_gemma":0.055642474,"teacher_disagreement_score":0.02097768,"about_ca_system_score_codex":0.0047318013,"about_ca_system_score_gemma":0.017656501,"threshold_uncertainty_score":0.07406098},"labels":[],"label_agreement":null},{"id":"W4405750040","doi":"10.1016/j.jval.2024.10.3427","title":"PCR184 Comparing the Humanistic and Economic Impact of Osteogenesis Imperfecta Affected and Non-Affected Caregivers, When Caring for an Individual With Osteogenesis Imperfecta","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Osteogenesis imperfecta; Humanism; Medicine; Psychology; Philosophy; Pathology","score_opus":0.03538762545217594,"score_gpt":0.3234109496368739,"score_spread":0.28802332418469795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99279565,0.00012142299,0.00029357657,0.00014809871,0.00002865256,0.000033214546,0.00038013686,0.000004540338,0.006194731],"genre_scores_gemma":[0.99564123,0.00007516625,0.0007833523,0.000080761216,0.000007674514,0.000044154516,0.00016393333,0.0000035370347,0.0032000649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991172,0.0002745085,0.000058808146,0.0001027268,0.00027038075,0.00017634462],"domain_scores_gemma":[0.9986519,0.0006339411,0.0002576897,0.000033553457,0.00029789025,0.00012496272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005609751,0.00014740857,0.0001492004,0.0007020844,0.00078155706,0.00069787545,0.00019879892,0.00025857158,0.006407703],"category_scores_gemma":[0.0031487334,0.00010494971,0.00017810446,0.0006884132,0.00044657986,0.00014682248,0.00031907673,0.00030662492,0.00049507164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010821325,0.0006056078,0.91423666,0.00016593124,0.00006406023,0.0048014256,0.0068990253,0.0003142474,0.026334262,0.0011984479,0.0014640931,0.042834025],"study_design_scores_gemma":[0.00003036955,0.0010263727,0.95477563,0.00006512686,0.00006018742,0.004712675,0.017868606,0.0006178059,0.014476322,0.0006821146,0.0056610964,0.000023633476],"about_ca_topic_score_codex":0.007810321,"about_ca_topic_score_gemma":0.011616716,"teacher_disagreement_score":0.007810321,"about_ca_system_score_codex":0.00049212796,"about_ca_system_score_gemma":0.0005053853,"threshold_uncertainty_score":0.021435916},"labels":[],"label_agreement":null},{"id":"W4405750046","doi":"10.1016/j.jval.2024.10.2403","title":"MSR169 Health Technology Decision-Making in an Imperfect World: A Unifying Framework of Value of Information and Implementation Metrics Based on a Narrative Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Imperfect; Narrative; Value (mathematics); Perfect information; Narrative review; Value of information; Computer science; Data science; Management science; Knowledge management; Artificial intelligence; Engineering; Medicine; Mathematics; Machine learning; Mathematical economics; Intensive care medicine; Philosophy; Linguistics","score_opus":0.34017328847322487,"score_gpt":0.5373478880985447,"score_spread":0.19717459962531986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026955505,0.9868029,0.003347548,0.0049479236,0.0003470721,0.00010958197,0.00017072826,0.000013137483,0.00399154],"genre_scores_gemma":[0.011889556,0.97847205,0.0063514644,0.0017704974,0.0004914234,0.00024897195,0.00012914967,0.000013821508,0.00063323486],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98664993,0.008073146,0.0018328701,0.0005036837,0.0027050166,0.00023543462],"domain_scores_gemma":[0.95163757,0.040933624,0.0028800655,0.0007682845,0.003570305,0.00021013565],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019674739,0.0010344555,0.0030038003,0.0068475544,0.00046856608,0.004632156,0.0015147964,0.0026801508,0.00396946],"category_scores_gemma":[0.060103584,0.00051410473,0.0021606446,0.00670641,0.0017132139,0.004557905,0.002081002,0.0025524974,0.0008093952],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012705075,0.000039180897,0.00045208057,0.12522948,0.0019107541,0.00009807259,0.00035461763,0.0015301764,0.00022251028,0.1268214,0.025602989,0.71761173],"study_design_scores_gemma":[0.00009624519,0.00020502703,0.001804004,0.3734218,0.0050797984,0.0005410445,0.00043790182,0.0012501722,0.0005610777,0.09250225,0.52399826,0.000102412516],"about_ca_topic_score_codex":0.0043417965,"about_ca_topic_score_gemma":0.006787064,"teacher_disagreement_score":0.9803253,"about_ca_system_score_codex":0.004721447,"about_ca_system_score_gemma":0.011543532,"threshold_uncertainty_score":0.10405117},"labels":[],"label_agreement":null},{"id":"W4405750051","doi":"10.1016/j.jval.2024.10.3348","title":"PCR105 Impact of CAR T-Cell Therapy on Health Utilities for Patients Diagnosed With Diffuse Large B-Cell Lymphoma in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Ottawa; Princess Margaret Cancer Centre; University of Waterloo; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Pediatrics; Oncology; Internal medicine","score_opus":0.03961365323178231,"score_gpt":0.3331608637186762,"score_spread":0.2935472104868939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9383511,0.0044579213,0.00022750894,0.012697673,0.00016207717,0.000087309665,0.027441502,0.000036546375,0.016538247],"genre_scores_gemma":[0.99132055,0.0012898103,0.00015299773,0.00071572565,0.000030318277,0.0000185473,0.0036800737,0.000010205234,0.002781655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905986,0.00012657004,0.000048360598,0.000080433405,0.0002279089,0.00045679777],"domain_scores_gemma":[0.9970192,0.00029354362,0.00038900343,0.00003435427,0.0011981841,0.0010658109],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004314982,0.00021752367,0.00038086448,0.00054997695,0.0009778673,0.0014988875,0.0008357812,0.00046676956,0.004493625],"category_scores_gemma":[0.0037503254,0.00015662232,0.0009651028,0.0022760415,0.00041585593,0.0003266889,0.00054879277,0.0010890596,0.00026522347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010959512,0.00019481893,0.945717,0.00014572212,0.00032025605,0.00021352377,0.00024949416,0.0021804573,0.00018317538,0.001140252,0.018216504,0.030342873],"study_design_scores_gemma":[0.00015072696,0.00012340906,0.991339,0.00009626307,0.00019303034,0.00006233928,0.001011659,0.0018569125,0.00012416956,0.00016979317,0.0048426646,0.00002989152],"about_ca_topic_score_codex":0.9947976,"about_ca_topic_score_gemma":0.99681723,"teacher_disagreement_score":0.053109597,"about_ca_system_score_codex":0.053109597,"about_ca_system_score_gemma":0.057879433,"threshold_uncertainty_score":0.3853389},"labels":[],"label_agreement":null},{"id":"W4405750065","doi":"10.1016/j.jval.2024.10.3154","title":"SA73 Augmenting Expertise: A Classifier Algorithm's Ability to Identify and Categorize Health Economics and Outcomes Research (HEOR) Publications","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Central City Brewers and Distillers (Canada)","funders":"","keywords":"Categorization; Classifier (UML); Text categorization; Computer science; Artificial intelligence; Machine learning; Data science","score_opus":0.47929886186595966,"score_gpt":0.5797002768496395,"score_spread":0.10040141498367988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750065","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3746504,0.002410889,0.57121205,0.0039082244,0.0009431593,0.0007338463,0.0064735436,0.014336638,0.025331158],"genre_scores_gemma":[0.6304476,0.0004971411,0.3539647,0.0007069001,0.0005223003,0.000282908,0.0062418,0.00038393855,0.0069527063],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99608684,0.0010705612,0.00049076235,0.0008042494,0.0012169947,0.00033058148],"domain_scores_gemma":[0.9808138,0.009822711,0.00088927895,0.0015401982,0.006317017,0.00061687734],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":[],"category_scores_codex":[0.007512931,0.0009919524,0.001054033,0.009013344,0.0010596784,0.003210219,0.0012398851,0.0020826745,0.0046599465],"category_scores_gemma":[0.02745304,0.0002847766,0.0015980044,0.003252015,0.00047306792,0.002840876,0.0022885946,0.0015832252,0.0031807534],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060880766,0.00042289923,0.07694177,0.00026878883,0.00036629208,0.00023653418,0.00035353212,0.014698005,0.005776939,0.0037020904,0.02798505,0.8686393],"study_design_scores_gemma":[0.0001231705,0.0003926247,0.02449694,0.00021758715,0.0004122964,0.0005038868,0.0004165275,0.91935873,0.013051632,0.016609604,0.024311857,0.00010521997],"about_ca_topic_score_codex":0.005963022,"about_ca_topic_score_gemma":0.008075536,"teacher_disagreement_score":0.9924871,"about_ca_system_score_codex":0.00080765906,"about_ca_system_score_gemma":0.0024234038,"threshold_uncertainty_score":0.039732635},"labels":[],"label_agreement":null},{"id":"W4405750084","doi":"10.1016/j.jval.2024.10.3110","title":"SA29 Pathways to Value and Impact for Child Health and Wellness","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Innovates; University of Calgary","funders":"","keywords":"Value (mathematics); Environmental health; Business; Medicine; Computer science","score_opus":0.07831392966728959,"score_gpt":0.4248969674783401,"score_spread":0.3465830378110505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750084","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.121147685,0.0027797036,0.003134636,0.06737133,0.0005535932,0.00023630139,0.0032182054,0.00014033224,0.8014183],"genre_scores_gemma":[0.9177923,0.002766277,0.0042812857,0.002069481,0.00018561,0.00017941397,0.0017218231,0.00008373992,0.07092017],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99752134,0.0009790398,0.00007723212,0.00013885154,0.0006204998,0.0006631132],"domain_scores_gemma":[0.9873559,0.0031561397,0.0008612506,0.00046689404,0.00439884,0.003760974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029411076,0.0003605593,0.00025048296,0.0016131619,0.0026798944,0.0077863876,0.0006026536,0.0014471813,0.07024195],"category_scores_gemma":[0.012458396,0.000298011,0.0009901985,0.0016663244,0.0020460987,0.0018137402,0.0041674827,0.0028881868,0.0046569062],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005635608,0.0013097198,0.16713461,0.00085699186,0.00026570878,0.00081030413,0.0076814718,0.0022442816,0.0014246175,0.35921818,0.13461731,0.3238732],"study_design_scores_gemma":[0.00016403533,0.00051021116,0.24863681,0.0021044593,0.00014400363,0.0006241932,0.01850993,0.0031853367,0.001785943,0.2565312,0.4676894,0.000114500384],"about_ca_topic_score_codex":0.028711153,"about_ca_topic_score_gemma":0.039261673,"teacher_disagreement_score":0.07024195,"about_ca_system_score_codex":0.0060113575,"about_ca_system_score_gemma":0.014822894,"threshold_uncertainty_score":0.23498273},"labels":[],"label_agreement":null},{"id":"W4405750169","doi":"10.1016/j.jval.2024.10.2428","title":"MSR194 Qualitative Literature Reviews: A Comparison of Researcher and AI Screening of Articles to Inform Conceptual Model Development","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational and Text Analysis Methods","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Data science; Computer science; Management science; Psychology; Engineering","score_opus":0.4634870499803747,"score_gpt":0.5872027738509282,"score_spread":0.12371572387055352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5975864,0.0517294,0.109011784,0.020586599,0.0014669222,0.087406315,0.044504832,0.0019079132,0.085799836],"genre_scores_gemma":[0.6737139,0.014346009,0.20408282,0.004305426,0.00029012334,0.08906586,0.0072084544,0.0005284287,0.0064590164],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.77732617,0.14956231,0.036538202,0.005244312,0.028484082,0.0028449718],"domain_scores_gemma":[0.41134295,0.45586804,0.04274904,0.011438046,0.07598879,0.0026131338],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17040567,0.0008090074,0.0029303643,0.035573382,0.004217284,0.0077903974,0.0032836916,0.0020200047,0.0141418995],"category_scores_gemma":[0.4602833,0.0012901826,0.0042795064,0.027820414,0.0024250676,0.00654272,0.008388263,0.0012507668,0.0017218769],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006874158,0.00051459146,0.043938383,0.19545121,0.0037450786,0.00080421637,0.24866334,0.0007234652,0.008521785,0.016186966,0.02045571,0.4541211],"study_design_scores_gemma":[0.0057118568,0.0039667794,0.15886515,0.21293661,0.018549522,0.0018652258,0.3201994,0.0053014928,0.017035084,0.026075866,0.22838427,0.0011086899],"about_ca_topic_score_codex":0.009746279,"about_ca_topic_score_gemma":0.026582366,"teacher_disagreement_score":0.8295943,"about_ca_system_score_codex":0.013294257,"about_ca_system_score_gemma":0.03668961,"threshold_uncertainty_score":0.9012021},"labels":[],"label_agreement":null},{"id":"W4405750175","doi":"10.1016/j.jval.2024.10.2510","title":"MT40 Systematic Review Tools Integrated with Artificial Intelligence for Data Extraction: Feature Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Computer science; Data extraction; Artificial intelligence; Data mining; Pattern recognition (psychology); Chemistry; MEDLINE","score_opus":0.14167520564103186,"score_gpt":0.40468179563162077,"score_spread":0.2630065899905889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750175","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025879493,0.20751505,0.100963175,0.006901428,0.0010182257,0.019427806,0.59784734,0.024018547,0.016428897],"genre_scores_gemma":[0.12980829,0.10912787,0.45487252,0.0033825694,0.0007022388,0.07106968,0.21507764,0.003198731,0.012760532],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9890428,0.0034135787,0.0049191946,0.001054701,0.0013134708,0.00025628283],"domain_scores_gemma":[0.94760996,0.038985953,0.0063303076,0.002307581,0.0040615615,0.0007046932],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014420291,0.0017397791,0.004299165,0.030901011,0.0013155888,0.0036185395,0.0017472577,0.0010113472,0.033317406],"category_scores_gemma":[0.06188867,0.0009041275,0.0065567596,0.021191834,0.0005693932,0.002111616,0.003867719,0.0008349574,0.0040803794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014785653,0.00009429005,0.0065034856,0.57713884,0.012186427,0.0007023383,0.0014263901,0.0012810611,0.005576696,0.0056598936,0.08128942,0.30666268],"study_design_scores_gemma":[0.0020741147,0.00083064695,0.027634332,0.18087798,0.066647716,0.0015668868,0.0010566853,0.004583287,0.010474003,0.015805239,0.6879713,0.00047788603],"about_ca_topic_score_codex":0.004268425,"about_ca_topic_score_gemma":0.013662059,"teacher_disagreement_score":0.9855797,"about_ca_system_score_codex":0.0019517286,"about_ca_system_score_gemma":0.015267234,"threshold_uncertainty_score":0.111457884},"labels":[],"label_agreement":null},{"id":"W4405750198","doi":"10.1016/j.jval.2024.10.2422","title":"MSR188 A Predictive Patient-Level Surrogacy Model Between Progression-Free Survival (PFS) and Overall Survival (OS) in Patients With Pre-Treated Advanced or Metastatic (A/M) Non-Small-Cell Lung Cancer (NSCLC) With a KRASG12C Mutation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Oncology; Medicine; non-small cell lung cancer (NSCLC); Overall survival; Internal medicine; Progression-free survival; Lung cancer","score_opus":0.027523443073903427,"score_gpt":0.338721106796708,"score_spread":0.3111976637228046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91259897,0.0014729033,0.07181405,0.0037673132,0.00013508368,0.00012419312,0.004149124,0.00059320114,0.00534523],"genre_scores_gemma":[0.9901702,0.00013838067,0.006476191,0.00015737182,0.000046137207,0.00004629888,0.0011611183,0.00002310298,0.0017811923],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992099,0.0004577899,0.00003993815,0.00013886788,0.00008922925,0.0000642951],"domain_scores_gemma":[0.9963476,0.0029624514,0.00029315212,0.00014067563,0.00015654994,0.00009959883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037199832,0.0006573062,0.00075419503,0.00069899904,0.00017766973,0.0012645032,0.0007438641,0.0007206746,0.00417168],"category_scores_gemma":[0.007757761,0.00023618805,0.0011635771,0.0005214499,0.00029771,0.0006683357,0.0005691447,0.001054121,0.00064617465],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006588447,0.0008776636,0.2797986,0.00020145692,0.0010084204,0.0005341783,0.00011039413,0.5278646,0.0028772047,0.0067381747,0.005756814,0.16764401],"study_design_scores_gemma":[0.00015922675,0.00076662947,0.013160303,0.000030258734,0.0002370217,0.00023586965,0.000028121465,0.97816056,0.0010444123,0.0046240734,0.0015309482,0.00002252392],"about_ca_topic_score_codex":0.002205113,"about_ca_topic_score_gemma":0.002811999,"teacher_disagreement_score":0.00417168,"about_ca_system_score_codex":0.000980457,"about_ca_system_score_gemma":0.001189715,"threshold_uncertainty_score":0.019673407},"labels":[],"label_agreement":null},{"id":"W4405750237","doi":"10.1016/j.jval.2024.10.2413","title":"MSR179 Automated Extraction of Cost-Effectiveness Models Data from Health Technology Assessment Submissions Using Large-Language Models (LLMS): Does the Prompting Approach Matter ?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Computer science; Data extraction; Data science; MEDLINE; Chemistry","score_opus":0.5891400164229476,"score_gpt":0.5241108448239848,"score_spread":0.06502917159896271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750237","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.074794665,0.0015526081,0.27938682,0.008342207,0.0013455938,0.0016613505,0.45814312,0.15818626,0.016587352],"genre_scores_gemma":[0.24687517,0.00090411556,0.35508323,0.0011373936,0.00054492994,0.0015200543,0.37758622,0.009057955,0.0072909496],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99221146,0.0038893977,0.0015422122,0.0008698119,0.001267099,0.000219929],"domain_scores_gemma":[0.88905346,0.085855,0.0057233293,0.009441071,0.009078861,0.00084828475],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012972169,0.0011527806,0.000925567,0.0040404256,0.0006198549,0.0034545742,0.001245749,0.001236532,0.023844372],"category_scores_gemma":[0.08370708,0.0010204965,0.0023810929,0.002714398,0.0004118848,0.0033358145,0.0020103708,0.0022350512,0.018320391],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025206343,0.0007481919,0.026427958,0.008754664,0.00088053604,0.0013513383,0.0016634004,0.026113087,0.021273896,0.022265999,0.50282496,0.38517535],"study_design_scores_gemma":[0.001414877,0.0007250349,0.023621913,0.00241198,0.00062771107,0.00078266923,0.0011963217,0.2981389,0.05372515,0.050751735,0.5661331,0.00047062465],"about_ca_topic_score_codex":0.0035558597,"about_ca_topic_score_gemma":0.0053203497,"teacher_disagreement_score":0.9870278,"about_ca_system_score_codex":0.0012987456,"about_ca_system_score_gemma":0.004913685,"threshold_uncertainty_score":0.07976735},"labels":[],"label_agreement":null},{"id":"W4405750238","doi":"10.1016/j.jval.2024.10.2378","title":"MSR144 Group-Based Multivariate Trajectory Methods to Assess Patient-Reported Outcomes in Acute Myeloid Leukaemia: An Evaluation of Published Methods and Results","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Geomechanica (Canada); Luminex (Canada)","funders":"","keywords":"Myeloid leukaemia; Multivariate statistics; Multivariate analysis; Medicine; Trajectory; Oncology; Internal medicine; Computer science; Machine learning; Physics","score_opus":0.40039424581550326,"score_gpt":0.5382868660662405,"score_spread":0.13789262025073729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62641466,0.010339154,0.34082347,0.0012105108,0.0009031581,0.006253849,0.0076399823,0.0016854928,0.004729697],"genre_scores_gemma":[0.69061625,0.0019741964,0.29334748,0.00032833935,0.00020930555,0.0074356752,0.0034091962,0.0004538552,0.0022258575],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8644991,0.11878377,0.004073934,0.0033745058,0.008839806,0.00042902026],"domain_scores_gemma":[0.7698099,0.18390068,0.009625243,0.021060161,0.014682042,0.0009219855],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14424542,0.0014861037,0.0025793002,0.0025038954,0.00066580955,0.0019668872,0.0026111421,0.0013796206,0.003930444],"category_scores_gemma":[0.22994624,0.00072109984,0.0046916474,0.0027442756,0.0007145212,0.002015557,0.0029318389,0.0018804488,0.0007020135],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023903707,0.0014605024,0.22002411,0.0032957452,0.034070544,0.00008837405,0.0019371259,0.03375493,0.0010015615,0.0079894755,0.006395227,0.6660787],"study_design_scores_gemma":[0.009750185,0.031549897,0.3562827,0.0031541816,0.02081387,0.00084679533,0.0023415089,0.5193567,0.004738597,0.03030183,0.019844556,0.0010192719],"about_ca_topic_score_codex":0.004499315,"about_ca_topic_score_gemma":0.004509947,"teacher_disagreement_score":0.8557546,"about_ca_system_score_codex":0.0012618202,"about_ca_system_score_gemma":0.00255684,"threshold_uncertainty_score":0.7628518},"labels":[],"label_agreement":null},{"id":"W4405750255","doi":"10.1016/j.jval.2024.10.3082","title":"SA1 Systematic Literature Review of the Humanistic Burden of Hemophilia A and B","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Optimism, Hope, and Well-being","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Humanism; Medicine; Systematic review; Intensive care medicine; MEDLINE; Philosophy; Political science; Law; Theology","score_opus":0.023486003418322347,"score_gpt":0.328853738493063,"score_spread":0.30536773507474063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750255","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025972566,0.9915142,0.00023394197,0.0009146934,0.00032340168,0.00058189326,0.0030949141,0.000011590618,0.00072800915],"genre_scores_gemma":[0.062560834,0.9286636,0.0019415831,0.0027172607,0.000351408,0.0019180373,0.0014836865,0.000016429756,0.00034712555],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9796765,0.00880728,0.007210981,0.0013134577,0.0025580889,0.00043368893],"domain_scores_gemma":[0.9040064,0.07308533,0.013095588,0.0016140611,0.007359773,0.00083888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01700812,0.0010248199,0.0053252447,0.01425236,0.0008606017,0.0029465351,0.0014867258,0.0022773198,0.00921835],"category_scores_gemma":[0.11643788,0.0010025415,0.008313982,0.012647324,0.0011495869,0.0017863137,0.002307527,0.0015262847,0.00046638394],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036994522,0.000017598315,0.0032345192,0.9300548,0.032634154,0.00010469528,0.0002594836,0.00008373928,0.00010005778,0.00039820297,0.003816145,0.028926618],"study_design_scores_gemma":[0.0004643343,0.0001284572,0.014443314,0.870358,0.09741556,0.00022639394,0.00034875754,0.0000619135,0.00006533105,0.00053428113,0.0159081,0.00004548359],"about_ca_topic_score_codex":0.02549386,"about_ca_topic_score_gemma":0.0801574,"teacher_disagreement_score":0.02549386,"about_ca_system_score_codex":0.0044415514,"about_ca_system_score_gemma":0.020623421,"threshold_uncertainty_score":0.089948654},"labels":[],"label_agreement":null},{"id":"W4405750302","doi":"10.1016/j.jval.2024.10.2386","title":"MSR152 A Literature Review to Identify Prognostic Factors and Treatment Effect Modifiers in Population-Adjusted Indirect Comparisons for Multiple Myeloma","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Multiple myeloma; Medicine; Oncology; Internal medicine","score_opus":0.17357693465477037,"score_gpt":0.46261786494067525,"score_spread":0.2890409302859049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058948115,0.9982778,0.00018576541,0.00018208781,0.00012241049,0.000041657997,0.00040436815,0.0000062991057,0.00019017907],"genre_scores_gemma":[0.015171181,0.9814145,0.0015960507,0.0006841025,0.00023571729,0.00019542004,0.00050559005,0.000010101377,0.00018738849],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99333376,0.002774701,0.0020919489,0.0007359089,0.00092502066,0.00013863492],"domain_scores_gemma":[0.96469337,0.031178394,0.0026246635,0.00040080945,0.0009988745,0.00010389857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008749188,0.0012873815,0.0054415427,0.004573243,0.00036146236,0.0019438186,0.0016533966,0.0012332891,0.00957729],"category_scores_gemma":[0.04511501,0.00073723216,0.009848358,0.0071897847,0.0005780598,0.0014414322,0.0014074637,0.001526186,0.00048988446],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008855229,0.000048185877,0.004636228,0.6933053,0.052331094,0.00009660369,0.00018031859,0.0003134805,0.00015354475,0.0012724367,0.0048697214,0.24190748],"study_design_scores_gemma":[0.0010370676,0.00047313262,0.031395853,0.5094161,0.37150937,0.0005522094,0.00027594343,0.00033628897,0.00035229005,0.0033080229,0.08120864,0.00013512213],"about_ca_topic_score_codex":0.007231668,"about_ca_topic_score_gemma":0.01763744,"teacher_disagreement_score":0.00957729,"about_ca_system_score_codex":0.0017094852,"about_ca_system_score_gemma":0.005357784,"threshold_uncertainty_score":0.04627067},"labels":[],"label_agreement":null},{"id":"W4405750345","doi":"10.1016/j.jval.2024.10.2216","title":"HTA391 ≥95% Discounts!? Is Canada a Commercially Viable Market for Orphan Medicines?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Business; Commerce; Bioinformatics; Biology","score_opus":0.3138635600669174,"score_gpt":0.4255141501482088,"score_spread":0.11165059008129141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750345","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03212962,0.021881696,0.0019082422,0.54449964,0.0056868247,0.0004129637,0.028439933,0.0005542574,0.3644868],"genre_scores_gemma":[0.61636925,0.027296623,0.006874033,0.14800505,0.0040856157,0.0005248151,0.014750161,0.0004436366,0.18165077],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9970169,0.00039167385,0.00009091421,0.0001547717,0.0015275056,0.00081820023],"domain_scores_gemma":[0.9870285,0.0024896248,0.00082774746,0.0003025585,0.0053197304,0.0040317886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004594882,0.00031658143,0.0005602527,0.0010987625,0.0017770207,0.0043868935,0.0012254437,0.0026005348,0.0661011],"category_scores_gemma":[0.018701734,0.00020834306,0.00094409497,0.0012612015,0.0018504453,0.0020802855,0.0010370718,0.0033742883,0.0043321582],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012595268,0.00010268312,0.0061876704,0.00038470482,0.000108586115,0.00021967321,0.00015147272,0.00038745333,0.00062951806,0.06445946,0.7283277,0.19778158],"study_design_scores_gemma":[0.00069305644,0.00017290973,0.017451702,0.0013183709,0.00016349606,0.00024534794,0.00046127292,0.0008586223,0.00061006716,0.014390941,0.9635393,0.000094992254],"about_ca_topic_score_codex":0.8130378,"about_ca_topic_score_gemma":0.857252,"teacher_disagreement_score":0.18696219,"about_ca_system_score_codex":0.02521059,"about_ca_system_score_gemma":0.08717984,"threshold_uncertainty_score":0.37612647},"labels":[],"label_agreement":null},{"id":"W4405750350","doi":"10.1016/j.jval.2024.10.2421","title":"MSR187 Automated Data Extraction in Systematic Literature Reviews (SLRs): Assessing the Accuracy and Reliability of a Large Language Model (LLM)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Computer science; Data extraction; Reliability (semiconductor); Natural language processing; Artificial intelligence; Data mining; MEDLINE; Chemistry","score_opus":0.27148360576928654,"score_gpt":0.5738235770727436,"score_spread":0.302339971303457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750350","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15091899,0.2047813,0.33055818,0.013828946,0.0023659526,0.105211236,0.16717792,0.01607943,0.009078021],"genre_scores_gemma":[0.2836557,0.014420696,0.58546644,0.0024703944,0.00047703393,0.08288481,0.028590241,0.0010341933,0.0010005799],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.5209242,0.26683068,0.16978821,0.016934307,0.024317732,0.0012048193],"domain_scores_gemma":[0.1504925,0.74233,0.054551665,0.032175403,0.019111931,0.0013385412],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2975529,0.002834897,0.010154933,0.04166402,0.0030323092,0.008327347,0.0049123424,0.0036204143,0.008248477],"category_scores_gemma":[0.70542246,0.003580704,0.026976263,0.02134186,0.0030636746,0.008192613,0.010026526,0.0026581187,0.0020149453],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00733305,0.0003631473,0.04547852,0.5419404,0.114469044,0.0006817752,0.005784465,0.006705114,0.0036419649,0.0061548892,0.021433843,0.24601382],"study_design_scores_gemma":[0.01738989,0.006573766,0.08017766,0.22283106,0.4239161,0.002491613,0.0043623517,0.06618527,0.009789945,0.032363135,0.13139574,0.002523492],"about_ca_topic_score_codex":0.005099252,"about_ca_topic_score_gemma":0.019416384,"teacher_disagreement_score":0.70244706,"about_ca_system_score_codex":0.0047927257,"about_ca_system_score_gemma":0.027375333,"threshold_uncertainty_score":0.8662423},"labels":[],"label_agreement":null},{"id":"W4405750379","doi":"10.1016/j.jval.2024.10.2319","title":"MSR85 Development of an Ordinal NMA Model Allowing for Testing of the Proportional Odds Assumption","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Fault Detection and Control Systems","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Odds; Ordinal data; Ordinal regression; Statistics; Ordered logit; Econometrics; Mathematics; Computer science; Medicine; Logistic regression","score_opus":0.06310659688642593,"score_gpt":0.29512687169146606,"score_spread":0.23202027480504012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750379","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010395133,0.00009351243,0.9850648,0.00037741204,0.000072211005,0.000116040974,0.00063394994,0.0003941822,0.0028527002],"genre_scores_gemma":[0.37068546,0.00026351027,0.6101245,0.00030915075,0.00016958523,0.0009620658,0.0020359382,0.00035847686,0.015091313],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9935422,0.00436712,0.00027252626,0.00065893796,0.00084166805,0.00031757704],"domain_scores_gemma":[0.9820057,0.014003857,0.000629539,0.001124474,0.0019450472,0.00029138208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011738885,0.00068074634,0.0012832101,0.0012499344,0.00070035056,0.0019417938,0.0036490783,0.001253821,0.012350271],"category_scores_gemma":[0.028537555,0.00082501303,0.0023236088,0.0012473969,0.00060856063,0.0016722806,0.0019598475,0.0035870264,0.0023315018],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043261482,0.00029781924,0.0097416965,0.0002947046,0.0004460373,0.0004163139,0.00033746456,0.50123394,0.0015386227,0.33394137,0.008553595,0.14276585],"study_design_scores_gemma":[0.000023377612,0.000075365686,0.0009842812,0.000024699028,0.000035042918,0.000049650906,0.000029426306,0.9646529,0.0002636287,0.030405652,0.0034328476,0.00002308323],"about_ca_topic_score_codex":0.014954902,"about_ca_topic_score_gemma":0.011325574,"teacher_disagreement_score":0.014954902,"about_ca_system_score_codex":0.0013337269,"about_ca_system_score_gemma":0.003062779,"threshold_uncertainty_score":0.062081873},"labels":[],"label_agreement":null},{"id":"W4405750438","doi":"10.1016/j.jval.2024.10.2135","title":"HTA310 Are Global Health Technology Assessment (HTA) Processes Inclusive and Equitable? A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Health technology; Business; Political science; Economic growth; Economics; Health care","score_opus":0.5361905848991605,"score_gpt":0.5743759344859303,"score_spread":0.03818534958676978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000074844764,0.99529904,0.00033802533,0.0021227575,0.00038216083,0.00009828236,0.00020651391,0.000009445069,0.0014689488],"genre_scores_gemma":[0.0015065338,0.9953016,0.0011196004,0.001168267,0.0002177995,0.00020554579,0.00014257591,0.000007067722,0.00033107275],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99057454,0.00426732,0.0021954721,0.00044522042,0.0021970826,0.00032040416],"domain_scores_gemma":[0.93808526,0.047121752,0.006213268,0.0010974058,0.006887024,0.00059518666],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.023186607,0.0009091114,0.003993291,0.009274076,0.0008455435,0.0049398644,0.0016912137,0.0033866775,0.0127090225],"category_scores_gemma":[0.08704925,0.0009336838,0.0032012356,0.012008341,0.0015569407,0.004728201,0.0028216601,0.0029283632,0.0019301542],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011747035,0.00003741374,0.00036635742,0.3288346,0.0016091428,0.00006635834,0.00026258765,0.0003438234,0.00017995012,0.011745366,0.030349944,0.62608695],"study_design_scores_gemma":[0.00007730467,0.00004767706,0.0011342075,0.6753066,0.004147289,0.00012462113,0.00019001093,0.00015399858,0.00012945787,0.0066164294,0.31204352,0.000028938619],"about_ca_topic_score_codex":0.012977018,"about_ca_topic_score_gemma":0.02294027,"teacher_disagreement_score":0.9983088,"about_ca_system_score_codex":0.005231881,"about_ca_system_score_gemma":0.022179496,"threshold_uncertainty_score":0.12262398},"labels":[],"label_agreement":null},{"id":"W4405750458","doi":"10.1016/j.jval.2024.10.2187","title":"HTA362 The Cost of Innovation: Evaluating the Evolution of Willingness-to-Pay for CAR-T Therapies in Germany","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Willingness to pay; Business; Economics; Marketing; Industrial organization; Microeconomics","score_opus":0.10340659088591199,"score_gpt":0.4114694174890013,"score_spread":0.3080628266030893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580115,0.000541157,0.00044157795,0.0005750146,0.000014746114,0.0000190848,0.0013475012,0.000009630968,0.0012500772],"genre_scores_gemma":[0.99919444,0.000060053084,0.00010995676,0.000036446654,0.0000063395764,0.000010678704,0.00037320645,0.0000031536763,0.00020580101],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715364,0.0013028304,0.00017183975,0.0003163385,0.00043355595,0.00062178605],"domain_scores_gemma":[0.99089885,0.0051163794,0.0021993138,0.00034792293,0.0004774501,0.00096003833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054466706,0.00031499122,0.00043803453,0.0011306733,0.00025395147,0.0022805075,0.0006367821,0.0011567357,0.0025822844],"category_scores_gemma":[0.015165763,0.00016601822,0.0010490842,0.0016619429,0.0005804515,0.0012800888,0.00082021963,0.0009238784,0.00029557108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005984143,0.00090424024,0.8547197,0.00028372623,0.002052088,0.0004536302,0.0008654196,0.06229245,0.0008300493,0.00955823,0.0033541392,0.0587021],"study_design_scores_gemma":[0.0003092591,0.0025019452,0.91951245,0.00013257781,0.0009113187,0.00041997427,0.0013951949,0.06665545,0.0014795028,0.002287359,0.0042977813,0.000097163575],"about_ca_topic_score_codex":0.023025075,"about_ca_topic_score_gemma":0.009666487,"teacher_disagreement_score":0.023025075,"about_ca_system_score_codex":0.0050437916,"about_ca_system_score_gemma":0.0018191627,"threshold_uncertainty_score":0.04578209},"labels":[],"label_agreement":null},{"id":"W4405750488","doi":"10.1016/j.jval.2024.10.2181","title":"HTA356 Operationalizing Life-Cycle HTA: A Tumor-Agnostic Precision Oncology Index Economic Evaluation From Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Operationalization; Index (typography); Precision oncology; Oncology; Medicine; Medical physics; Internal medicine; Computer science; World Wide Web; Cancer","score_opus":0.31507428392506004,"score_gpt":0.43706974701806195,"score_spread":0.12199546309300191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44347593,0.010834992,0.04617487,0.012505847,0.0008273909,0.0033834463,0.21153282,0.0011644238,0.27010024],"genre_scores_gemma":[0.890145,0.0022065644,0.027002938,0.00071184564,0.00010424578,0.0005028002,0.05939354,0.0002472872,0.019685833],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9931236,0.0014168273,0.0002676405,0.00033550503,0.004051402,0.00080498756],"domain_scores_gemma":[0.9768018,0.0029764753,0.0007372094,0.0009316383,0.017253976,0.0012989042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009038879,0.000736131,0.0008082422,0.0039549563,0.0013823971,0.003996761,0.0014757687,0.00057227677,0.003781737],"category_scores_gemma":[0.034919463,0.000345256,0.0011503318,0.0062291864,0.00079151226,0.0011028112,0.001298442,0.0015413997,0.00038885453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033031814,0.00068500807,0.18250982,0.0010017605,0.001617404,0.00019306604,0.0005213506,0.1692439,0.0011732839,0.09836255,0.24123454,0.30015412],"study_design_scores_gemma":[0.001007956,0.0011001426,0.45286384,0.0011454606,0.0016612125,0.00023777294,0.0009926243,0.2646001,0.0046554278,0.01772576,0.25362992,0.00037974087],"about_ca_topic_score_codex":0.9739633,"about_ca_topic_score_gemma":0.9709769,"teacher_disagreement_score":0.050752856,"about_ca_system_score_codex":0.050752856,"about_ca_system_score_gemma":0.112321146,"threshold_uncertainty_score":0.36823946},"labels":[],"label_agreement":null},{"id":"W4405750502","doi":"10.1016/j.jval.2024.10.2370","title":"MSR136 Feasibility of GPT-4-Based Content Extraction to Identify Eligible Titles and Abstracts in a Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Extraction (chemistry); Systematic review; Information retrieval; Computer science; Medicine; Chromatography; Chemistry; MEDLINE; Biochemistry","score_opus":0.3434334851512722,"score_gpt":0.5186745876162016,"score_spread":0.17524110246492935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750502","genre_codex":"protocol","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0675477,0.02829957,0.14418124,0.013348133,0.0025665176,0.48369682,0.2250492,0.0068215914,0.028489292],"genre_scores_gemma":[0.12988669,0.0033655912,0.22741193,0.0034235113,0.00032501927,0.6128061,0.018418286,0.0009106515,0.0034522547],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6975617,0.14365287,0.122942425,0.014639525,0.018018432,0.0031850692],"domain_scores_gemma":[0.444021,0.4246856,0.042259797,0.029123228,0.056927092,0.002983292],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20694418,0.002653919,0.009755639,0.02701659,0.0032892367,0.008631385,0.0033805445,0.0039181625,0.060147528],"category_scores_gemma":[0.56750697,0.002950128,0.015404845,0.017689174,0.0024087743,0.006639069,0.010342151,0.0020983825,0.009562036],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011128917,0.0004251832,0.015869213,0.66846436,0.022092419,0.0010633825,0.014597942,0.0019328797,0.0050664586,0.007301018,0.057459194,0.19459906],"study_design_scores_gemma":[0.039322145,0.0034448705,0.070001595,0.32243162,0.099481545,0.0015432413,0.011814187,0.014398316,0.010840362,0.02721465,0.39750862,0.001998792],"about_ca_topic_score_codex":0.006557847,"about_ca_topic_score_gemma":0.017863264,"teacher_disagreement_score":0.79305583,"about_ca_system_score_codex":0.005665759,"about_ca_system_score_gemma":0.037400443,"threshold_uncertainty_score":0.977979},"labels":[],"label_agreement":null},{"id":"W4405750530","doi":"10.1016/j.jval.2024.10.2296","title":"MSR62 Considerations for Censoring Methods Used to Reconstruct Pseudo Patient-Level Data From Kaplan–Meier Curves: Does the Indirect Treatment Comparison Method Influence the Choice of Censoring Distribution?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Geomechanica (Canada); Luminex (Canada)","funders":"","keywords":"Censoring (clinical trials); Statistics; Survival analysis; Econometrics; Medicine; Mathematics; Computer science","score_opus":0.5219080402043837,"score_gpt":0.535100541608528,"score_spread":0.013192501404144297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750530","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010265343,0.001987601,0.9564974,0.024890322,0.0007207433,0.00020751092,0.0001822933,0.00036806634,0.0048807436],"genre_scores_gemma":[0.18126497,0.0017832137,0.79837054,0.009045252,0.0017712291,0.0011509149,0.0002503931,0.001856071,0.004507415],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.70379674,0.27757686,0.005053357,0.0034433305,0.009217736,0.00091205863],"domain_scores_gemma":[0.32923204,0.62081134,0.0073999176,0.028188165,0.013279759,0.0010887427],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2941815,0.0012346931,0.0025013243,0.002459903,0.0015728732,0.0053513893,0.0053312117,0.005025237,0.007597326],"category_scores_gemma":[0.61197877,0.0012921263,0.003609518,0.0030170942,0.0048502474,0.0054303855,0.0028506198,0.012832487,0.0016783918],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012137244,0.00021960036,0.010849691,0.00093290774,0.0013795985,0.00056484,0.0036089444,0.021145856,0.0017825015,0.6286613,0.02530768,0.30433342],"study_design_scores_gemma":[0.00058059226,0.00069629494,0.010150848,0.0029936605,0.0006760661,0.0013229103,0.0011148748,0.19689456,0.0077167517,0.7243365,0.053081606,0.00043524202],"about_ca_topic_score_codex":0.0045469836,"about_ca_topic_score_gemma":0.005150846,"teacher_disagreement_score":0.2941815,"about_ca_system_score_codex":0.0022222763,"about_ca_system_score_gemma":0.0030148104,"threshold_uncertainty_score":0.8703999},"labels":[],"label_agreement":null},{"id":"W4405750563","doi":"10.1016/j.jval.2024.10.2150","title":"HTA325 Stakeholder Perspectives on the Draft Implementation Act for Joint Clinical Assessments: Key Insights and Concerns","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Key (lock); Stakeholder; Joint (building); Process management; Stakeholder engagement; Business; Political science; Computer science; Public relations; Computer security; Engineering","score_opus":0.6586294812627639,"score_gpt":0.614225794773354,"score_spread":0.044403686489409844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750563","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008525445,0.0009184118,0.006428066,0.9379763,0.0024874855,0.00031581943,0.00025298633,0.00010603452,0.042989466],"genre_scores_gemma":[0.2252394,0.0008700591,0.02369495,0.7110555,0.0030463873,0.0015665523,0.00030137956,0.00037333608,0.03385238],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.67571217,0.19242373,0.019005826,0.008339587,0.06990368,0.034615017],"domain_scores_gemma":[0.37582207,0.5299082,0.008914335,0.01240326,0.055882808,0.017069375],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.29619,0.0010272205,0.001971129,0.0020051587,0.0178758,0.03457077,0.009917513,0.11460729,0.011087845],"category_scores_gemma":[0.4345559,0.0028054456,0.0029781517,0.0027748712,0.02867265,0.020318424,0.016606076,0.07931398,0.002513079],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022074398,0.00032464226,0.0021929087,0.0005759876,0.00008464108,0.0016591094,0.10795388,0.000709024,0.0021297608,0.6192328,0.24405599,0.020860493],"study_design_scores_gemma":[0.0002901421,0.00036601553,0.008253859,0.0044657723,0.00018700032,0.00071413175,0.06351799,0.0024763893,0.0020652553,0.19032241,0.7265469,0.00079415395],"about_ca_topic_score_codex":0.09261909,"about_ca_topic_score_gemma":0.09444641,"teacher_disagreement_score":0.29619,"about_ca_system_score_codex":0.034665912,"about_ca_system_score_gemma":0.1417779,"threshold_uncertainty_score":0.867923},"labels":[],"label_agreement":null},{"id":"W4405750564","doi":"10.1016/j.jval.2024.10.2293","title":"MSR59 Evaluating Systematic Literature Review Screening Performance of Seven Large Language Models in Response to Different Prompting Strategies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Systematic review; Computer science; Psychology; Natural language processing; MEDLINE; Biology","score_opus":0.18945690421520323,"score_gpt":0.5058841504226887,"score_spread":0.3164272462074855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62850094,0.14085075,0.06275435,0.0075487597,0.0014082356,0.11376084,0.029457102,0.0018933172,0.01382575],"genre_scores_gemma":[0.71338713,0.012616467,0.20798394,0.0013446339,0.00017972727,0.057338182,0.006124339,0.00018770363,0.0008379377],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6161383,0.24756949,0.09645807,0.008177472,0.029833628,0.001823063],"domain_scores_gemma":[0.2370042,0.6834225,0.03159746,0.011943312,0.03445989,0.0015726617],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.33212847,0.0033585106,0.009944575,0.02223714,0.0021009974,0.005267352,0.0032950162,0.0034787052,0.0074135996],"category_scores_gemma":[0.6693542,0.0027079952,0.02662082,0.012827239,0.0020434754,0.006129061,0.007865368,0.001770347,0.00084688363],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043063875,0.0011907712,0.042866625,0.49729955,0.1109333,0.0006639138,0.014445623,0.0110351285,0.004689628,0.0029460196,0.00605907,0.26480648],"study_design_scores_gemma":[0.040373057,0.049440775,0.10321053,0.2161744,0.46747681,0.0010192558,0.016513357,0.04770638,0.01262261,0.013480597,0.029984687,0.0019974874],"about_ca_topic_score_codex":0.005827353,"about_ca_topic_score_gemma":0.016115185,"teacher_disagreement_score":0.66787153,"about_ca_system_score_codex":0.0074731885,"about_ca_system_score_gemma":0.018055722,"threshold_uncertainty_score":0.8236045},"labels":[],"label_agreement":null},{"id":"W4405750982","doi":"10.1016/j.jval.2024.10.3731","title":"RWD174 Investigation of Input Precision in Predicting Serotype-Specific Vaccine Effectiveness for Pneumococcal Conjugate Vaccines From Immunological Predictors in Children","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Pfizer (Canada)","funders":"","keywords":"Serotype; Pneumococcal conjugate vaccine; Medicine; Conjugate; Virology; Streptococcus pneumoniae; Immunology; Biology; Microbiology; Mathematics; Antibiotics","score_opus":0.029108116590041148,"score_gpt":0.2990956094033729,"score_spread":0.26998749281333173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886545,0.00075714284,0.007972427,0.00014560924,0.000039692717,0.000040978248,0.00092592294,0.00018161241,0.001282148],"genre_scores_gemma":[0.9923741,0.00013766886,0.00645654,0.00003350436,0.000016078482,0.000021514707,0.0006176599,0.00002178842,0.00032109066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570674,0.0027027717,0.0002452674,0.00049551047,0.0006028456,0.00024688925],"domain_scores_gemma":[0.96584696,0.029601207,0.001213081,0.001370701,0.0016892244,0.00027878545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01355882,0.00092591136,0.0011185218,0.00092520413,0.00034765157,0.0017858988,0.0006762258,0.00066471775,0.0014270657],"category_scores_gemma":[0.0414211,0.0004123167,0.0013804159,0.0006879121,0.0004090912,0.0008065681,0.0007862703,0.00095677876,0.00033032778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009502088,0.00037079235,0.8370224,0.00032105565,0.0015921526,0.00019557617,0.00024036602,0.06090553,0.0046336628,0.00073898205,0.00069392973,0.08378339],"study_design_scores_gemma":[0.00071896927,0.00858191,0.5082057,0.00031601384,0.0016756126,0.00071567803,0.00042719624,0.43647718,0.038461674,0.0020740246,0.0022173992,0.00012873263],"about_ca_topic_score_codex":0.007724883,"about_ca_topic_score_gemma":0.004418418,"teacher_disagreement_score":0.01355882,"about_ca_system_score_codex":0.0009981889,"about_ca_system_score_gemma":0.0018610408,"threshold_uncertainty_score":0.07170677},"labels":[],"label_agreement":null},{"id":"W4405751011","doi":"10.1016/j.jval.2024.10.3836","title":"PT5 Structural Uncertainty in Evidence Synthesis: A Case Study Applying Model Averaging in Bayesian Multi-Level Network Meta-Regression","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational and Text Analysis Methods","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Bayesian network; Meta-regression; Bayesian probability; Computer science; Econometrics; Regression; Bayesian inference; Meta-analysis; Statistics; Machine learning; Artificial intelligence; Mathematics; Medicine; Internal medicine","score_opus":0.3870796255532057,"score_gpt":0.48490395925628127,"score_spread":0.09782433370307558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751011","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04258707,0.012091568,0.9267013,0.008605306,0.00033396206,0.0015835719,0.0010929481,0.0005575164,0.006446715],"genre_scores_gemma":[0.5604987,0.0029877287,0.43180344,0.0013673268,0.00022059592,0.0013592419,0.00051458087,0.00027002598,0.0009782963],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.70468783,0.2764625,0.006784061,0.0054141334,0.0059812916,0.0006703403],"domain_scores_gemma":[0.24417189,0.7316893,0.0074388315,0.010237161,0.005834831,0.00062799716],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17936623,0.0014881111,0.0029507522,0.0035389792,0.0016214696,0.0050262003,0.003112791,0.0041968776,0.007056508],"category_scores_gemma":[0.52141255,0.0010740719,0.006985894,0.0043527246,0.0019083885,0.0047225608,0.003546015,0.0051480397,0.00047566657],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046246247,0.00043741247,0.018524893,0.017201098,0.03581707,0.0015504344,0.0029044996,0.28259945,0.0014427848,0.13569574,0.007802135,0.49139977],"study_design_scores_gemma":[0.0009242909,0.0010887859,0.003835942,0.00530945,0.023190098,0.0009076392,0.00059712096,0.61036444,0.0030520952,0.33597907,0.014526416,0.00022467779],"about_ca_topic_score_codex":0.008550756,"about_ca_topic_score_gemma":0.009644573,"teacher_disagreement_score":0.82063377,"about_ca_system_score_codex":0.0046520755,"about_ca_system_score_gemma":0.007732303,"threshold_uncertainty_score":0.94859064},"labels":[],"label_agreement":null},{"id":"W4405751065","doi":"10.1016/j.jval.2024.10.3708","title":"RWD150 First Patient Enrolled in Pilot Phase of the Economics and Patient Outcomes in China in Hemophilia (EPOCH) Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Epoch (astronomy); China; Medicine; Phase (matter); Pediatrics; Family medicine; Political science; Astronomy; Physics; Quantum mechanics","score_opus":0.03346837752971393,"score_gpt":0.3145139233185352,"score_spread":0.2810455457888213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751065","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971625,0.00017063253,0.00007984384,0.0001535752,0.000021217817,0.000108060245,0.0014788683,0.0000032972844,0.0008219833],"genre_scores_gemma":[0.9955917,0.00015253764,0.00015924123,0.00014609299,0.000031681542,0.000116775016,0.0032325995,0.0000036005683,0.00056579086],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931383,0.00018709883,0.00004977105,0.00009733294,0.000102251615,0.00024970062],"domain_scores_gemma":[0.9989248,0.0000826789,0.00025377286,0.00013765204,0.00013743115,0.00046368464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014025498,0.00040618767,0.00073294603,0.00037319798,0.00075370865,0.0008805614,0.0005361933,0.0004550471,0.0020561686],"category_scores_gemma":[0.002016172,0.0002439768,0.0007837464,0.0011700144,0.00038316174,0.0005949484,0.0007178426,0.0009398203,0.00024920114],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008819989,0.0015125434,0.9740538,0.00007804343,0.00049840804,0.00040931435,0.0002480132,0.0002955525,0.00070627464,0.00053633354,0.0025711705,0.010270504],"study_design_scores_gemma":[0.0019255189,0.0027081328,0.9908274,0.000041074538,0.0004903975,0.00023293092,0.00032156394,0.0005390264,0.00031985572,0.0003053261,0.002254365,0.000034478133],"about_ca_topic_score_codex":0.014703198,"about_ca_topic_score_gemma":0.016560366,"teacher_disagreement_score":0.014703198,"about_ca_system_score_codex":0.0013716082,"about_ca_system_score_gemma":0.0027695256,"threshold_uncertainty_score":0.029235184},"labels":[],"label_agreement":null},{"id":"W4405751087","doi":"10.1016/j.jval.2024.10.3840","title":"PT41 Benefits of Inhaled Corticosteroids (ICS) in COPD Maintenance Combinations: Real-World Evidence Using Longitudinal Targeted Maximum Likelihood Estimation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Inhaled corticosteroids; COPD; Estimation; Medicine; Real world evidence; Internal medicine; Economics; Asthma","score_opus":0.082099897935082,"score_gpt":0.36943886714957813,"score_spread":0.28733896921449614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5748762,0.33029348,0.045574404,0.018913569,0.0013597256,0.0008679513,0.0122949565,0.0003156164,0.015504168],"genre_scores_gemma":[0.9773232,0.013260863,0.0052315425,0.0011104677,0.0003265445,0.00021267774,0.0016177662,0.000033344906,0.0008836702],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9850339,0.012620203,0.00073099433,0.0006853739,0.00068974483,0.00023982716],"domain_scores_gemma":[0.91441107,0.07590662,0.005712973,0.0020613673,0.001344586,0.00056334387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017353224,0.00086113985,0.0021633664,0.00076736405,0.0003405603,0.0022488486,0.0011378044,0.0015674462,0.009098453],"category_scores_gemma":[0.07504138,0.0006147071,0.00748488,0.0010976086,0.0008374813,0.002223537,0.0014379402,0.0028247165,0.0007987722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07592753,0.0023289754,0.17157696,0.022091545,0.063990526,0.0003495816,0.0004988188,0.042173054,0.0007913779,0.008690322,0.01091228,0.6006691],"study_design_scores_gemma":[0.036432024,0.038839888,0.3961703,0.03160036,0.18114442,0.0015782793,0.0011582142,0.18678917,0.0040395297,0.07662335,0.04511195,0.0005124592],"about_ca_topic_score_codex":0.003394213,"about_ca_topic_score_gemma":0.0026158502,"teacher_disagreement_score":0.017353224,"about_ca_system_score_codex":0.0011004028,"about_ca_system_score_gemma":0.001623378,"threshold_uncertainty_score":0.09177369},"labels":[],"label_agreement":null},{"id":"W4405751098","doi":"10.1016/j.jval.2024.10.3839","title":"PT30 Navigating the New European Member State Coordination Group on Health Technology Assessment Quantitative Evidence Synthesis Guidelines","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Member state; Member states; Group (periodic table); Health technology; Business; Political science; Chemistry; European union; International trade; Health care","score_opus":0.6061181779801952,"score_gpt":0.5384622452864588,"score_spread":0.06765593269373638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751098","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014369687,0.12519649,0.12157844,0.58676547,0.051025756,0.022109345,0.034884527,0.0026535252,0.05434955],"genre_scores_gemma":[0.014525905,0.08529441,0.51970106,0.23943254,0.01714248,0.05435154,0.030638129,0.0032008872,0.035713077],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.63101006,0.20796718,0.094541706,0.009085989,0.051801752,0.0055933846],"domain_scores_gemma":[0.3962193,0.36941057,0.05058408,0.028537666,0.13769732,0.017551072],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.38542077,0.0036490075,0.009819317,0.015578753,0.0033958782,0.024239482,0.016679425,0.03781295,0.022735422],"category_scores_gemma":[0.5191186,0.005350171,0.017907714,0.015032855,0.006752264,0.009576787,0.019542336,0.034366474,0.01418129],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007547914,0.00026757177,0.0009494321,0.04195108,0.0017764509,0.00029089037,0.0014547127,0.002036339,0.0006541183,0.042666364,0.7239634,0.18323484],"study_design_scores_gemma":[0.0014766722,0.00019448799,0.0026848046,0.1481106,0.0028753127,0.0002829352,0.0005278364,0.0013795822,0.0008202615,0.041593935,0.79984987,0.00020364037],"about_ca_topic_score_codex":0.03252229,"about_ca_topic_score_gemma":0.03253021,"teacher_disagreement_score":0.6145792,"about_ca_system_score_codex":0.01737231,"about_ca_system_score_gemma":0.12455588,"threshold_uncertainty_score":0.75788563},"labels":[],"label_agreement":null},{"id":"W4405751121","doi":"10.1016/j.jval.2024.10.3844","title":"PT18 Preferences for and Importance of Early Oncology Trial Endpoints to Canadians With Early-Stage Cancer: An Interim Analysis of a Qualitative Patient Preference Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Custom Security Industries (Canada); Ontario Institute for Cancer Research; AstraZeneca (Canada); Vancouver Coastal Health","funders":"","keywords":"Interim; Stage (stratigraphy); Interim analysis; Preference; Oncology; Internal medicine; Medicine; Cancer; Family medicine; Psychology; Clinical trial; Political science; Economics; Biology","score_opus":0.6555732753305159,"score_gpt":0.5356692492799525,"score_spread":0.11990402605056338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568164,0.00016850016,0.00033343947,0.00073083414,0.000011784895,0.00036772454,0.0010580951,0.0000030374663,0.0016448607],"genre_scores_gemma":[0.99719113,0.00013650628,0.0008164497,0.00043303648,0.000007672019,0.00043234075,0.0003798787,0.000005388455,0.0005975484],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9925069,0.0038913912,0.00041739017,0.0003454285,0.0015206431,0.0013182812],"domain_scores_gemma":[0.9699467,0.017314944,0.0036856753,0.000839448,0.0061884797,0.0020248098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014525153,0.00030558658,0.00069125945,0.0006497062,0.0040449505,0.0017068987,0.00087627646,0.0008881909,0.004766266],"category_scores_gemma":[0.044766232,0.0003332092,0.001398545,0.0017830016,0.0015695676,0.0010557782,0.0012372213,0.0019372774,0.00018287315],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011178244,0.0030798623,0.58448315,0.0013599717,0.0008559249,0.0007137995,0.27050254,0.0015364253,0.0014242191,0.0034759757,0.012062651,0.10932731],"study_design_scores_gemma":[0.0011715827,0.0030122069,0.7319214,0.0006589936,0.00044704258,0.00034068318,0.24329771,0.0027171555,0.0011879043,0.0019092078,0.012851088,0.00048510486],"about_ca_topic_score_codex":0.66817075,"about_ca_topic_score_gemma":0.7374949,"teacher_disagreement_score":0.33182925,"about_ca_system_score_codex":0.02425867,"about_ca_system_score_gemma":0.038578004,"threshold_uncertainty_score":0.6675669},"labels":[],"label_agreement":null},{"id":"W4405751125","doi":"10.1016/j.jval.2024.10.3833","title":"PT2 Real-Life Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis (MCADA) in Oncology","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bayesian probability; Medicine; Oncology; Risk analysis (engineering); Medical physics; Internal medicine; Computer science; Artificial intelligence","score_opus":0.09652506312156546,"score_gpt":0.39674107847871914,"score_spread":0.3002160153571537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751125","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1806982,0.0019098266,0.80140156,0.0018695191,0.00014999088,0.00029445929,0.0010359127,0.00037468568,0.012265926],"genre_scores_gemma":[0.91844195,0.0003389824,0.077496305,0.000097364726,0.000039347837,0.00011665252,0.0003691415,0.00004134336,0.003058944],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99790514,0.0014698962,0.00007384649,0.00015925412,0.00028092295,0.00011095729],"domain_scores_gemma":[0.99456304,0.004416184,0.00025382717,0.0001292494,0.00048756733,0.00015014515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048016976,0.0008081421,0.0010123261,0.0010394031,0.00037174003,0.0023518945,0.000562896,0.0013000173,0.0034609952],"category_scores_gemma":[0.011864531,0.0006081698,0.0013206864,0.0007210754,0.0005010291,0.0009476809,0.0010016131,0.0011897405,0.00023683252],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014788915,0.000055874527,0.0015086419,0.00010157479,0.00007986859,0.000059827147,0.000021109068,0.9688492,0.00045069735,0.006654491,0.0007413695,0.021329453],"study_design_scores_gemma":[0.0000079821275,0.000037606307,0.00029591023,0.000013779562,0.000015295847,0.000013393632,0.000005885523,0.99444854,0.00019489526,0.0046243984,0.00033507735,0.0000072103717],"about_ca_topic_score_codex":0.010063778,"about_ca_topic_score_gemma":0.00636563,"teacher_disagreement_score":0.010063778,"about_ca_system_score_codex":0.0017385383,"about_ca_system_score_gemma":0.0018746742,"threshold_uncertainty_score":0.025394082},"labels":[],"label_agreement":null},{"id":"W4405751219","doi":"10.1016/j.jval.2024.10.1034","title":"EE754 Challenges in Identifying Information to Build Economic Evaluations in Hereditary Angioedema","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hereditary angioedema; Angioedema; Medicine; Data science; Business; Computer science; Dermatology","score_opus":0.09617091488341284,"score_gpt":0.37302099225035973,"score_spread":0.2768500773669469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751219","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1042983,0.04051372,0.14083576,0.59736824,0.0023154782,0.0017383774,0.011197839,0.0006960924,0.10103623],"genre_scores_gemma":[0.6910652,0.023271069,0.2485171,0.0226166,0.0025184543,0.0018171231,0.0048963423,0.00031696298,0.004981159],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9084296,0.07712881,0.0059967185,0.001431393,0.0055792932,0.001434203],"domain_scores_gemma":[0.46740475,0.47639063,0.012266149,0.0077676424,0.032312542,0.0038582522],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.107166916,0.0008399192,0.0019364469,0.005860005,0.0010759599,0.01129327,0.0022891685,0.002542748,0.0087317],"category_scores_gemma":[0.38058254,0.0006799835,0.0011586617,0.005301598,0.0015906359,0.008373807,0.0037274556,0.004991677,0.0014470408],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007220605,0.00076134014,0.056793682,0.003394848,0.0011186217,0.00092557806,0.0017143424,0.021091228,0.00030491687,0.08996195,0.1036242,0.7195872],"study_design_scores_gemma":[0.0007071233,0.0007576666,0.040321894,0.023775987,0.0011750811,0.0011731047,0.0076811877,0.093545556,0.0027819274,0.56288046,0.26487765,0.0003223381],"about_ca_topic_score_codex":0.017173264,"about_ca_topic_score_gemma":0.013610622,"teacher_disagreement_score":0.8928331,"about_ca_system_score_codex":0.0045516393,"about_ca_system_score_gemma":0.014134348,"threshold_uncertainty_score":0.5667596},"labels":[],"label_agreement":null},{"id":"W4405751634","doi":"10.1016/j.jval.2024.10.1070","title":"EE790 Cost-Effectiveness and Cost Utility Analysis of an eHealth Peer-Led Wheelchair Training Program Compared to the Existing Wheelchair Training Practice in Canadian Rehabilitation Centers: Economic Evaluation of a RCT","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Université Laval","funders":"","keywords":"Wheelchair; eHealth; Randomized controlled trial; Rehabilitation; Cost effectiveness; Training (meteorology); Economic evaluation; Physical medicine and rehabilitation; Physical therapy; Medicine; Computer science; Risk analysis (engineering); Health care; Economics; World Wide Web","score_opus":0.20075204359796323,"score_gpt":0.4897428907647322,"score_spread":0.288990847166769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91589266,0.028813208,0.004051934,0.002060089,0.0006559602,0.016485758,0.017255858,0.00018950696,0.014594908],"genre_scores_gemma":[0.98168325,0.004333139,0.0032593627,0.00047584064,0.00015258815,0.0041080923,0.0035687916,0.000025052248,0.0023939244],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9889943,0.007352178,0.0007921156,0.0005339889,0.0014360476,0.0008913676],"domain_scores_gemma":[0.992031,0.004968885,0.0010384459,0.00029506197,0.0009798134,0.000686814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078009455,0.0021231894,0.0030924617,0.0018506108,0.0009179705,0.0022278372,0.0015089931,0.0022470432,0.009368339],"category_scores_gemma":[0.021644095,0.00092772563,0.009080462,0.0027035126,0.001112637,0.0014308937,0.0014818177,0.0031599968,0.0003519932],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.82184047,0.006167748,0.014067929,0.013893417,0.050933566,0.00017763316,0.0002522157,0.010146758,0.0009875246,0.0019329482,0.0031553686,0.07644442],"study_design_scores_gemma":[0.6751426,0.07488281,0.08854902,0.005055694,0.11416991,0.00023362615,0.0008171168,0.029036961,0.0018159329,0.0019334082,0.007951118,0.0004118164],"about_ca_topic_score_codex":0.33341697,"about_ca_topic_score_gemma":0.27807817,"teacher_disagreement_score":0.66658306,"about_ca_system_score_codex":0.019816607,"about_ca_system_score_gemma":0.019609034,"threshold_uncertainty_score":0.66295254},"labels":[],"label_agreement":null},{"id":"W4405751655","doi":"10.1016/j.jval.2024.10.1963","title":"HTA138 NICE vs SMC: Reimbursement Differences for Non-Oncology Orphan Drugs","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Nice; Reimbursement; Orphan drug; Medicine; Internal medicine; Family medicine; Oncology; Bioinformatics; Economics; Biology; Computer science; Economic growth; Health care","score_opus":0.13097741370356253,"score_gpt":0.3695815115593293,"score_spread":0.23860409785576675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751655","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21844846,0.03857298,0.013476208,0.25338182,0.012532293,0.0011380813,0.07506851,0.0012716337,0.38611],"genre_scores_gemma":[0.9197771,0.0020803597,0.0051171137,0.03669349,0.005284132,0.0003608453,0.009982951,0.00042252318,0.020281397],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9716495,0.014180401,0.0016601699,0.0014781257,0.0085964445,0.0024353352],"domain_scores_gemma":[0.904995,0.07520543,0.006724203,0.002659607,0.0067836144,0.0036321501],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01600878,0.0003829612,0.0017676668,0.0021031438,0.00058229367,0.005206028,0.0016234677,0.006215184,0.04676281],"category_scores_gemma":[0.1417005,0.0005119138,0.003472751,0.0025835533,0.0013781992,0.0028033587,0.001833038,0.0052729137,0.0037420557],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017742196,0.00035139592,0.0245619,0.0014297343,0.0022981362,0.0002949218,0.0003610161,0.0066411668,0.0005648581,0.14077199,0.67632496,0.12865768],"study_design_scores_gemma":[0.021486906,0.005413584,0.2578481,0.004693642,0.007532931,0.0020453597,0.0018948967,0.047620784,0.0029351,0.14368407,0.5041324,0.000712255],"about_ca_topic_score_codex":0.019166224,"about_ca_topic_score_gemma":0.024789115,"teacher_disagreement_score":0.9839912,"about_ca_system_score_codex":0.0059131705,"about_ca_system_score_gemma":0.0056962003,"threshold_uncertainty_score":0.15643716},"labels":[],"label_agreement":null},{"id":"W4405751697","doi":"10.1016/j.jval.2024.10.1939","title":"HTA114 Characterizing Oncology Outcomes in Canada's Drug Agency (CDA-AMC) Reviews From 2022 -2023","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Agency (philosophy); Drug; Medicine; Precision oncology; Oncology; Internal medicine; Pharmacology; Intensive care medicine; Business; Sociology; Cancer","score_opus":0.07559420549601341,"score_gpt":0.2958813911792266,"score_spread":0.2202871856832132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751697","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10480056,0.10252271,0.0023207688,0.04887994,0.0018466829,0.0005626637,0.59564096,0.00052754174,0.14289826],"genre_scores_gemma":[0.6462538,0.06353994,0.0044309287,0.007332098,0.0014225368,0.0004370068,0.20686346,0.000392137,0.06932806],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9972849,0.00040829557,0.000159011,0.00013946912,0.0014877359,0.0005205205],"domain_scores_gemma":[0.98247993,0.002996854,0.0020827164,0.0003641617,0.010831644,0.0012446985],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0031713317,0.00040483233,0.00047479864,0.0037446925,0.00060102023,0.0021104729,0.00065637473,0.00053673866,0.0060334792],"category_scores_gemma":[0.015123233,0.00021083179,0.0009663132,0.009562795,0.0002762053,0.0003760911,0.00040404257,0.0009064858,0.0007829361],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000656711,0.00008878501,0.06316754,0.0020385694,0.00082653767,0.000075331176,0.00023157011,0.0070677595,0.00041666723,0.011156158,0.75215185,0.1621225],"study_design_scores_gemma":[0.00018675585,0.00022407774,0.5297753,0.0021860066,0.00085276796,0.000077672914,0.0004347337,0.0043897065,0.0012690899,0.002024674,0.45849946,0.000079734935],"about_ca_topic_score_codex":0.94127953,"about_ca_topic_score_gemma":0.9690587,"teacher_disagreement_score":0.9995252,"about_ca_system_score_codex":0.023698285,"about_ca_system_score_gemma":0.049553484,"threshold_uncertainty_score":0.1719439},"labels":[],"label_agreement":null},{"id":"W4405751773","doi":"10.1016/j.jval.2024.10.2046","title":"HTA221 Market Access Challenges for Gene Therapies in Inherited Blood Disorders: A Retrospective Evaluation of HTA Outcomes for Sickle Cell Disease and Thalassemia","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Thalassemia; Disease; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.03847742794805487,"score_gpt":0.3742099856130437,"score_spread":0.33573255766498883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99242824,0.000925895,0.00033768898,0.00045441545,0.000016278535,0.00003280611,0.0033496062,0.0000099394965,0.0024449902],"genre_scores_gemma":[0.99628925,0.00042014875,0.00014020961,0.0003182268,0.000044375684,0.000025331641,0.0020794678,0.00001639369,0.00066660537],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792933,0.00038373724,0.0002721769,0.0003477187,0.000713448,0.000353618],"domain_scores_gemma":[0.98900837,0.0018727403,0.0066006104,0.00049176044,0.00119245,0.00083415787],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0021247114,0.00019308111,0.00034669242,0.0015647947,0.00047309656,0.0017797804,0.00041555637,0.00046809108,0.0039001245],"category_scores_gemma":[0.0057515306,0.00021017146,0.0006690928,0.0021493777,0.00048045404,0.00096987665,0.0008815348,0.00083807565,0.00089102105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020605697,0.00005588875,0.9942747,0.000021102525,0.0000953871,0.0001645779,0.0001090072,0.000043770757,0.0001667011,0.00020590336,0.000829963,0.0038268885],"study_design_scores_gemma":[0.000016379692,0.00032888423,0.99274445,0.000050390496,0.00017438499,0.0012411474,0.0008805508,0.00035284058,0.00031542458,0.00021212218,0.003664332,0.000019135454],"about_ca_topic_score_codex":0.0061125327,"about_ca_topic_score_gemma":0.0062825414,"teacher_disagreement_score":0.9978753,"about_ca_system_score_codex":0.0010921619,"about_ca_system_score_gemma":0.0012222921,"threshold_uncertainty_score":0.013047159},"labels":[],"label_agreement":null},{"id":"W4405751784","doi":"10.1016/j.jval.2024.10.1997","title":"HTA172 Type of Clinical Evidence and Its Impact on Price Reductions for Oncology Drugs: A Review of Reimbursement Submissions in Canada","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Reimbursement; Real world evidence; Medicine; Oncology; Actuarial science; Internal medicine; Intensive care medicine; Business; Economics; Health care; Economic growth","score_opus":0.40304230889478543,"score_gpt":0.5154586961081905,"score_spread":0.11241638721340508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003294314,0.99752206,0.000041824667,0.0008048339,0.00012086429,0.000029100667,0.00033955628,0.000002930669,0.00080936553],"genre_scores_gemma":[0.0049613155,0.9937164,0.0002527359,0.00060698995,0.000097260934,0.000021218442,0.0001530303,0.000005710218,0.00018532974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99546814,0.00088748825,0.0011152296,0.0003061176,0.0019859334,0.00023701611],"domain_scores_gemma":[0.9689066,0.017722836,0.0046584704,0.00036330594,0.007587701,0.0007610802],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011384393,0.0006625948,0.0039123683,0.006224406,0.00060609565,0.0036863585,0.001775406,0.0012802723,0.007834191],"category_scores_gemma":[0.037401296,0.00049755344,0.0040616514,0.011564934,0.0011551847,0.0010449264,0.00096494606,0.0021658023,0.0004302389],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018589607,0.000066234534,0.0025015408,0.27103242,0.007628855,0.00015711458,0.00018487798,0.0006065588,0.00044145476,0.0035035564,0.040114522,0.6719039],"study_design_scores_gemma":[0.0014989993,0.00040242382,0.025581397,0.44752526,0.03922058,0.0006288751,0.0003722676,0.00039789893,0.0006842757,0.0022771352,0.48125148,0.00015942473],"about_ca_topic_score_codex":0.21983416,"about_ca_topic_score_gemma":0.43753853,"teacher_disagreement_score":0.98861563,"about_ca_system_score_codex":0.014513622,"about_ca_system_score_gemma":0.040487487,"threshold_uncertainty_score":0.43710917},"labels":[],"label_agreement":null},{"id":"W4405751787","doi":"10.1016/j.jval.2024.10.2026","title":"HTA201 A Quantitative Assessment of the Economic Decision Drivers Outlined in HTA Outcomes Through Stratification and Sentiment Analysis: Evidence From Canada, England, Scotland, and Sweden","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stratification (seeds); Medicine","score_opus":0.08993924340797652,"score_gpt":0.353250845876212,"score_spread":0.2633116024682355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95694834,0.00049867295,0.0006403249,0.0013204505,0.000033015465,0.00012737466,0.015518693,0.000029100223,0.024884121],"genre_scores_gemma":[0.98388785,0.00027803073,0.0005018526,0.00014860525,0.000025960864,0.000050517207,0.009365336,0.000015790574,0.005726168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985209,0.00021690923,0.00005741836,0.0000699241,0.0007703166,0.00036458665],"domain_scores_gemma":[0.9912724,0.0017033715,0.0014823684,0.00027733468,0.0043631913,0.00090147153],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0024220415,0.00015793394,0.00025968582,0.001632935,0.0012282202,0.0021000337,0.00033619103,0.00034571366,0.004284807],"category_scores_gemma":[0.007494316,0.000119078184,0.00036983247,0.003988304,0.0007765671,0.0007981753,0.00093629846,0.00058482273,0.0006362431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005377157,0.000119520344,0.90509045,0.0002196767,0.00018560623,0.00017483947,0.0052803727,0.0009563228,0.0006645924,0.009070423,0.029108442,0.04859206],"study_design_scores_gemma":[0.000017109243,0.00003778717,0.98316735,0.000068415044,0.00003610391,0.000013813953,0.0035655717,0.0006608637,0.00030143416,0.00069460366,0.011415097,0.000021908405],"about_ca_topic_score_codex":0.83520675,"about_ca_topic_score_gemma":0.8302062,"teacher_disagreement_score":0.99757797,"about_ca_system_score_codex":0.007904225,"about_ca_system_score_gemma":0.010469861,"threshold_uncertainty_score":0.33152747},"labels":[],"label_agreement":null},{"id":"W4405751835","doi":"10.1016/j.jval.2024.10.1000","title":"EE720 Cost-Effectiveness of Faricimab in Canada for the Treatment of Patients With Macular Edema Secondary to Retinal Vein Occlusion","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"","keywords":"Macular edema; Medicine; Retinal Vein; Ophthalmology; Occlusion; Central retinal vein occlusion; Retinal; Edema; Surgery","score_opus":0.05709161194486376,"score_gpt":0.30844445534623777,"score_spread":0.251352843401374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772938,0.011963915,0.00011001239,0.0030144346,0.00010215971,0.00016774007,0.0017702283,0.000015717234,0.005562006],"genre_scores_gemma":[0.99583024,0.0021783798,0.00015797539,0.0003499146,0.000036219062,0.000018545661,0.00058595976,0.00000280307,0.00083993963],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994137,0.0001596003,0.000041023042,0.00004547277,0.00015158934,0.00018873553],"domain_scores_gemma":[0.99889874,0.00022233126,0.0002141359,0.00001560802,0.00023046193,0.0004187237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000622442,0.00033246892,0.00077020033,0.00041781415,0.00048191677,0.00094560784,0.00055771525,0.00071211375,0.0023403172],"category_scores_gemma":[0.0029670831,0.00019076896,0.0011886638,0.00091362465,0.00042138764,0.00032708375,0.00031405417,0.001246407,0.000093485054],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3758514,0.005490118,0.21303122,0.0028600572,0.0057761217,0.0018579677,0.00045114395,0.03325843,0.0047294004,0.005055352,0.022531493,0.32910722],"study_design_scores_gemma":[0.049034186,0.017016742,0.8707916,0.0010631446,0.008331106,0.0009861578,0.0011381055,0.035250816,0.0012773836,0.000962735,0.0139483595,0.00019964899],"about_ca_topic_score_codex":0.8972064,"about_ca_topic_score_gemma":0.9298366,"teacher_disagreement_score":0.102793574,"about_ca_system_score_codex":0.028264256,"about_ca_system_score_gemma":0.023235312,"threshold_uncertainty_score":0.20679784},"labels":[],"label_agreement":null},{"id":"W4405751865","doi":"10.1016/j.jval.2024.10.1879","title":"HTA54 Review of Cell and Gene Therapies by NICE, HAS, and G-BA: How Did They Fare?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Nice; Gene; Computational biology; Medicine; Genetics; Biology; Computer science; Programming language","score_opus":0.01822757348480167,"score_gpt":0.2358524111575357,"score_spread":0.21762483767273402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751865","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043127544,0.956085,0.00010008537,0.025795227,0.016228257,0.00000892698,0.000030804822,0.000009467208,0.0016991294],"genre_scores_gemma":[0.0011554001,0.8818962,0.00040523635,0.07981848,0.030559396,0.000040006722,0.000088278124,0.000031168085,0.006005767],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9974234,0.00094643707,0.00032583956,0.0002609579,0.00085692934,0.00018649359],"domain_scores_gemma":[0.9893839,0.0054183393,0.0006374635,0.00020630263,0.0035298395,0.0008241912],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0059201038,0.00078468764,0.0019759808,0.0029622512,0.00087627186,0.003415539,0.0019068262,0.005869878,0.007582004],"category_scores_gemma":[0.014289474,0.00046110802,0.0013228391,0.0022592603,0.00189187,0.0033719223,0.0016967416,0.0081387,0.003753792],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011428214,0.000024397712,0.00006723749,0.0046698246,0.000073814954,0.0000680864,0.00008795017,0.000060018512,0.00020196973,0.0050914255,0.8324709,0.15707003],"study_design_scores_gemma":[0.00003398393,0.000042269134,0.00024466147,0.0042849453,0.000042168598,0.00017048226,0.00004929143,0.000019904583,0.00004863153,0.0011014361,0.99394894,0.000013284575],"about_ca_topic_score_codex":0.007093009,"about_ca_topic_score_gemma":0.017084269,"teacher_disagreement_score":0.9940799,"about_ca_system_score_codex":0.004036448,"about_ca_system_score_gemma":0.00555063,"threshold_uncertainty_score":0.03130883},"labels":[],"label_agreement":null},{"id":"W4405751880","doi":"10.1016/j.jval.2024.10.2094","title":"HTA269 Submission Processes and Requirements for Health Technology Assessment in Australia, Canada, England, and Spain","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Library science; Geography; Computer science","score_opus":0.4019794365760658,"score_gpt":0.4774393686292591,"score_spread":0.07545993205319335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751880","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.038008697,0.0026908468,0.051690795,0.02436721,0.009392322,0.053936664,0.21069498,0.019488795,0.5897296],"genre_scores_gemma":[0.091126405,0.0024912509,0.14082567,0.015639916,0.0030987358,0.034447808,0.1832034,0.014894237,0.51427263],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9253251,0.021478185,0.01628773,0.0019464714,0.027984222,0.0069782045],"domain_scores_gemma":[0.5301278,0.13949578,0.0148182,0.029236427,0.2646506,0.02167117],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.098932475,0.0012961532,0.0030319602,0.010983953,0.005838842,0.017641323,0.005228115,0.009064584,0.13586228],"category_scores_gemma":[0.28272006,0.0021096726,0.003658814,0.00907721,0.002145549,0.004016614,0.0049483804,0.0040326696,0.10426811],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013473631,0.000329946,0.0064887186,0.0018902147,0.00011164702,0.0009346356,0.0013359246,0.0025647318,0.0020117683,0.0187088,0.9047905,0.059485685],"study_design_scores_gemma":[0.0006714385,0.0002554399,0.03509801,0.0021078093,0.00007454738,0.00032462084,0.00072275026,0.0033689106,0.0020527316,0.0053167515,0.94976395,0.00024298721],"about_ca_topic_score_codex":0.19167046,"about_ca_topic_score_gemma":0.11618388,"teacher_disagreement_score":0.9861105,"about_ca_system_score_codex":0.013889488,"about_ca_system_score_gemma":0.067508556,"threshold_uncertainty_score":0.5232112},"labels":[],"label_agreement":null},{"id":"W4405751905","doi":"10.1016/j.jval.2024.10.2064","title":"HTA239 Streamlining Systematic Review Feasibility Assessments With Large Language Models: A Novel AI-Driven Workflow","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Workflow; Computer science; Software engineering; Systems engineering; Data science; Engineering; Database","score_opus":0.26677516770749116,"score_gpt":0.49613943865608207,"score_spread":0.2293642709485909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751905","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016671054,0.011332506,0.7678547,0.025111793,0.0020763942,0.037735447,0.0746085,0.050807808,0.013801815],"genre_scores_gemma":[0.035114255,0.0007492196,0.93984455,0.0012944107,0.00022299227,0.012421858,0.008282112,0.0009932469,0.0010774562],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.89277285,0.07405519,0.01861045,0.007167975,0.0067369263,0.0006566171],"domain_scores_gemma":[0.43524694,0.48169282,0.020531463,0.034826428,0.023657922,0.00404449],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16169602,0.0025131782,0.004068694,0.012999819,0.002004866,0.012015617,0.0048902202,0.0028701497,0.03324438],"category_scores_gemma":[0.50822675,0.002553169,0.008990333,0.009014928,0.0013917688,0.0067231166,0.008185115,0.0037143058,0.006065549],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00738832,0.0005943848,0.009296466,0.07493359,0.01632808,0.0006781313,0.005903431,0.019252192,0.0050775907,0.03244838,0.12711245,0.70098704],"study_design_scores_gemma":[0.016554743,0.0016408105,0.0082553215,0.023733279,0.029316207,0.00085760275,0.0022066385,0.30667526,0.011332026,0.31203142,0.28628635,0.0011102747],"about_ca_topic_score_codex":0.011035744,"about_ca_topic_score_gemma":0.031645607,"teacher_disagreement_score":0.838304,"about_ca_system_score_codex":0.003928395,"about_ca_system_score_gemma":0.03971595,"threshold_uncertainty_score":0.8551405},"labels":[],"label_agreement":null},{"id":"W4405751933","doi":"10.1016/j.jval.2024.10.3591","title":"RWD33 Physician Perception of Patient Unmet Needs and Optimism Towards Gene Therapy: Results From a Multinational Real-World Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Optimism; Multinational corporation; Perception; Medicine; Family medicine; Psychology; Business; Finance; Psychotherapist","score_opus":0.13439103746630374,"score_gpt":0.42383788764767927,"score_spread":0.2894468501813755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770653,0.000056430003,0.000037407637,0.000349471,0.0000044429808,0.00001823553,0.0006415061,0.0000020513073,0.0011840251],"genre_scores_gemma":[0.99860245,0.000093911156,0.00011625823,0.00025842307,0.000009358906,0.000040503317,0.00041046037,0.0000025940285,0.00046588253],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988543,0.0005321791,0.0001221196,0.00008266179,0.0001824301,0.00022625312],"domain_scores_gemma":[0.99492466,0.0012465512,0.0022693733,0.00014100825,0.00044742727,0.00097101316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016337888,0.00014009459,0.00018443675,0.0005978768,0.0005256572,0.00068804587,0.00027445442,0.00057232886,0.0033125454],"category_scores_gemma":[0.005720979,0.00022417899,0.00039672267,0.0007705035,0.00029661244,0.00051148457,0.0007114273,0.0007163757,0.00053592765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005037436,0.00013464881,0.9961578,0.000014126134,0.000019400555,0.00004281602,0.00077799737,0.000032678374,0.00009951644,0.000013240227,0.00037288945,0.0022845808],"study_design_scores_gemma":[0.00000871762,0.000099006305,0.99715877,0.000010549218,0.000008383814,0.00006210233,0.0021323962,0.0000798756,0.000039826722,0.0000060625753,0.00039067186,0.0000035923647],"about_ca_topic_score_codex":0.013874396,"about_ca_topic_score_gemma":0.016843446,"teacher_disagreement_score":0.013874396,"about_ca_system_score_codex":0.00061361544,"about_ca_system_score_gemma":0.00074519514,"threshold_uncertainty_score":0.027587235},"labels":[],"label_agreement":null},{"id":"W4405751943","doi":"10.1016/j.jval.2024.10.2049","title":"HTA224 A Roadmap to the Use of Value of Information Analysis in Health Technology Assessment: An International Study of Barriers, Facilitators, and Potential Applications","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Health information technology; Health technology; Value (mathematics); Technology roadmap; Knowledge management; Business; Medicine; Risk analysis (engineering); Process management; Computer science; Political science; Health care; Marketing","score_opus":0.21285160995898897,"score_gpt":0.43917083488562925,"score_spread":0.22631922492664028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751943","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0054654437,0.03550699,0.09941372,0.57989246,0.007867635,0.0017921757,0.010570192,0.0033150984,0.25617632],"genre_scores_gemma":[0.134286,0.05250453,0.5690145,0.10629527,0.010954175,0.004108146,0.011020151,0.0026491473,0.10916808],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.97602034,0.015470446,0.0013976678,0.00054758857,0.005547984,0.0010159147],"domain_scores_gemma":[0.8031724,0.12892866,0.0044053313,0.012391397,0.043538272,0.0075639305],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.042841002,0.0006252811,0.0009405078,0.004894292,0.0017179201,0.010248718,0.0029270728,0.008492298,0.06263234],"category_scores_gemma":[0.088257015,0.00061422866,0.0017799556,0.0066344943,0.0034466034,0.010160806,0.004093163,0.0065351524,0.0104050785],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015889671,0.0004610402,0.0020069692,0.0015961754,0.00007976224,0.0001372117,0.0005746568,0.0014434262,0.0006269268,0.17119902,0.38445836,0.43725747],"study_design_scores_gemma":[0.00016357959,0.00029955764,0.011608266,0.005846856,0.00011061479,0.00017300548,0.000868809,0.0050370567,0.0011597046,0.20266938,0.7719007,0.00016244814],"about_ca_topic_score_codex":0.027546808,"about_ca_topic_score_gemma":0.023268512,"teacher_disagreement_score":0.957159,"about_ca_system_score_codex":0.006421689,"about_ca_system_score_gemma":0.03398178,"threshold_uncertainty_score":0.22656757},"labels":[],"label_agreement":null},{"id":"W4405751999","doi":"10.1016/j.jval.2024.10.983","title":"EE703 Comparison of Administrative Burden Associated With Kesimpta and Ocrevus Among Multiple Sclerosis (MS) Clinics in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Multiple sclerosis; Medicine; Family medicine; Psychiatry","score_opus":0.5657072368614837,"score_gpt":0.43923118308260956,"score_spread":0.12647605377887416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9748582,0.0015378579,0.00011877464,0.0010266935,0.00003711807,0.00007279989,0.01813941,0.00001535882,0.004193828],"genre_scores_gemma":[0.99294126,0.0007030844,0.000099597775,0.00013516468,0.000015673017,0.00001815856,0.0050350456,0.0000086325945,0.0010434435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996576,0.00046273007,0.0003420927,0.00027712778,0.0011464464,0.0011955403],"domain_scores_gemma":[0.9893406,0.0011643552,0.0025884877,0.00023099888,0.004350218,0.0023253316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013067133,0.00036324366,0.0006698087,0.0032707292,0.0015091765,0.0022495128,0.0014241324,0.0005860796,0.0037648953],"category_scores_gemma":[0.009162888,0.0003601388,0.0016417479,0.008686183,0.00073701824,0.0005430151,0.0015535827,0.0011293935,0.00025060837],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040273953,0.00005654302,0.990918,0.000076173645,0.0003192599,0.000067440036,0.0002862373,0.00052132434,0.00006736489,0.00038987087,0.0021245016,0.0047707],"study_design_scores_gemma":[0.00001993192,0.0000281124,0.9979182,0.000039620496,0.00007036392,0.000028517983,0.0007280847,0.00048555367,0.000022521534,0.00002886188,0.0006176276,0.00001271027],"about_ca_topic_score_codex":0.9925775,"about_ca_topic_score_gemma":0.9936249,"teacher_disagreement_score":0.039503302,"about_ca_system_score_codex":0.039503302,"about_ca_system_score_gemma":0.046486683,"threshold_uncertainty_score":0.28661788},"labels":[],"label_agreement":null},{"id":"W4405752013","doi":"10.1016/j.jval.2024.10.1942","title":"HTA117 Sentiment Analysis of Clinical Evaluations in HTA: Evidence From Canada, England, Scotland, Sweden, France, and Germany","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; New england; Medicine; Political science; Internal medicine; Law","score_opus":0.44116751953350725,"score_gpt":0.4984612808864975,"score_spread":0.05729376135299025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93628657,0.014882271,0.00060332863,0.009372696,0.00017939783,0.00015864614,0.010161908,0.000032221455,0.02832297],"genre_scores_gemma":[0.9902671,0.0035011682,0.00049332285,0.0007838824,0.00011441857,0.000035108194,0.0033369884,0.000015426325,0.00145264],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957883,0.0016380275,0.0002630612,0.00018161483,0.0017736307,0.0003554849],"domain_scores_gemma":[0.9344179,0.029999044,0.008112263,0.0009333642,0.02385049,0.002686925],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0073035797,0.00020334592,0.0004867022,0.001972349,0.0009565458,0.0023198372,0.00038587576,0.0004979672,0.0032013222],"category_scores_gemma":[0.044204734,0.00011736235,0.00057440525,0.004087858,0.00078265235,0.00080376264,0.0006615042,0.0009967834,0.00027007176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033241927,0.0003454766,0.7674035,0.002719188,0.0015519466,0.0002972222,0.00503071,0.0010651562,0.00057323236,0.003264878,0.058596164,0.15582839],"study_design_scores_gemma":[0.00014708765,0.00012227101,0.97308445,0.0011112081,0.000603397,0.00009158995,0.003205877,0.001539982,0.00036636536,0.00046922613,0.01920876,0.000049644193],"about_ca_topic_score_codex":0.4939556,"about_ca_topic_score_gemma":0.53129244,"teacher_disagreement_score":0.9926964,"about_ca_system_score_codex":0.008402761,"about_ca_system_score_gemma":0.0083486065,"threshold_uncertainty_score":0.9821609},"labels":[],"label_agreement":null},{"id":"W4405752074","doi":"10.1016/j.jval.2024.10.1840","title":"HTA15 Oncology Patient and Caregivers’ Perspectives on Value Assessment Frameworks: A Qualitative Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Canadian Centre for Applied Research in Cancer Control; University of Calgary","funders":"","keywords":"Value (mathematics); Medicine; Qualitative research; Oncology; Internal medicine; Computer science; Sociology; Social science","score_opus":0.34618724015683344,"score_gpt":0.5178286450618302,"score_spread":0.1716414049049968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9758065,0.0010162411,0.0012761917,0.01373765,0.00017793536,0.00018635696,0.0002305885,0.000008883812,0.007559625],"genre_scores_gemma":[0.99379396,0.00064599124,0.0005352625,0.0029588658,0.000025601255,0.00021126437,0.00005711342,0.000013210547,0.001758854],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98268014,0.013692647,0.0005114107,0.00043522153,0.0008374099,0.0018430812],"domain_scores_gemma":[0.9418639,0.044984788,0.0031658944,0.00078283256,0.004228608,0.004973906],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.023856461,0.00039383097,0.000717831,0.0012954602,0.011640057,0.005809245,0.0012151581,0.0024100556,0.00485736],"category_scores_gemma":[0.044065405,0.00055862876,0.00049938174,0.0015767268,0.0068987436,0.0052273907,0.006714528,0.007294389,0.00032876883],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037921298,0.00007404801,0.0038464237,0.00007979119,0.0000059404197,0.00040982195,0.9892425,0.000026293106,0.00015093008,0.0016579122,0.0010842613,0.0033842493],"study_design_scores_gemma":[0.0000052002206,0.000024268791,0.00096653646,0.00013373216,0.0000038457365,0.0001431619,0.992475,0.00003129224,0.00007090449,0.00029741594,0.0058392202,0.000009375504],"about_ca_topic_score_codex":0.012741619,"about_ca_topic_score_gemma":0.018080391,"teacher_disagreement_score":0.97614354,"about_ca_system_score_codex":0.009066242,"about_ca_system_score_gemma":0.011107453,"threshold_uncertainty_score":0.12616652},"labels":[],"label_agreement":null},{"id":"W4405752264","doi":"10.1016/j.jval.2024.10.1007","title":"EE727 Determining Survival Impact and Cost-Effectiveness of Multi-Gene Panel Sequencing in Metastatic Colorectal Cancer With Super Learning Approaches","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Colorectal cancer; Oncology; Medicine; DNA sequencing; Internal medicine; Gene; Computational biology; Cancer; Biology; Genetics","score_opus":0.12513240189624802,"score_gpt":0.34467479421995806,"score_spread":0.21954239232371003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672734,0.0013414647,0.025711562,0.0012048304,0.000046709687,0.000056192115,0.001279774,0.00013782301,0.002948335],"genre_scores_gemma":[0.99142927,0.00021019983,0.0063947863,0.00016980799,0.00004168302,0.000030337598,0.0008314991,0.000024970477,0.00086742296],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99800843,0.001290274,0.000058197093,0.00022914677,0.00022544578,0.0001885827],"domain_scores_gemma":[0.9884764,0.0103126075,0.0003663424,0.00025977197,0.0003097778,0.00027505765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049489625,0.0004978734,0.0007824994,0.0008516175,0.0001767207,0.0009156897,0.00059730606,0.0005744644,0.003463012],"category_scores_gemma":[0.013247882,0.00020557731,0.0012162061,0.0006181941,0.000329581,0.00073500804,0.000562113,0.0007075065,0.0002957343],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010689473,0.0010241291,0.28568578,0.0002921525,0.0023650725,0.0004163784,0.00009284379,0.41593498,0.004957804,0.0045201094,0.0028647662,0.27115655],"study_design_scores_gemma":[0.00027713907,0.0021008013,0.066250354,0.000062513034,0.00092787563,0.00038968388,0.000121263874,0.91245604,0.0042565996,0.011354777,0.0017591527,0.00004380082],"about_ca_topic_score_codex":0.0029803005,"about_ca_topic_score_gemma":0.0039856303,"teacher_disagreement_score":0.0049489625,"about_ca_system_score_codex":0.00087308144,"about_ca_system_score_gemma":0.0008439582,"threshold_uncertainty_score":0.026172936},"labels":[],"label_agreement":null},{"id":"W4405752305","doi":"10.1016/j.jval.2024.10.944","title":"EE664 Cost-Effectiveness Analysis of IDP-126, a Topical Triple Therapy, for the Treatment of Acne Vulgaris From the Perspective of Canadian Public Payers","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Perspective (graphical); Acne; Medicine; Dermatology; Computer science; Artificial intelligence","score_opus":0.10032830645296655,"score_gpt":0.37493109365823807,"score_spread":0.27460278720527154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7627733,0.083471574,0.0031468987,0.011713123,0.0005932795,0.0027251076,0.07109206,0.00013880106,0.064345784],"genre_scores_gemma":[0.97691786,0.009591048,0.0015843796,0.0009882188,0.00012943537,0.00020253345,0.0077653304,0.000016469174,0.0028047143],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.996879,0.001372918,0.000120918456,0.000139527,0.00084483955,0.0006427742],"domain_scores_gemma":[0.9977715,0.0010471947,0.00024388105,0.000052698077,0.000531327,0.00035348316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003056622,0.0009098112,0.0016114333,0.0016945291,0.0005550605,0.0025982687,0.0009423596,0.0011316717,0.0053795036],"category_scores_gemma":[0.007657116,0.00044837905,0.005369422,0.0032649375,0.0004308106,0.00052209967,0.00061186316,0.0018559562,0.00017465139],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.2339815,0.0023731622,0.128049,0.016982343,0.056136306,0.0013535023,0.0004906291,0.16778399,0.0045486777,0.021724371,0.058177166,0.30839938],"study_design_scores_gemma":[0.055762023,0.017145446,0.57203376,0.007018449,0.09346798,0.0014205651,0.0023316457,0.16000627,0.002762204,0.006681644,0.08065188,0.0007181789],"about_ca_topic_score_codex":0.8159396,"about_ca_topic_score_gemma":0.82913285,"teacher_disagreement_score":0.1840604,"about_ca_system_score_codex":0.035591688,"about_ca_system_score_gemma":0.030805063,"threshold_uncertainty_score":0.37028867},"labels":[],"label_agreement":null},{"id":"W4405756564","doi":"10.1016/j.jval.2024.10.970","title":"EE690 The Impact of Caring for an Infant With Respiratory Syncytial Virus on Work-Related Outcomes: Insights From Caregivers Recruited From Canada, Germany, Italy, and Netherlands","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work (physics); Medicine; Gerontology; Pediatrics; Engineering","score_opus":0.07482004803703257,"score_gpt":0.37787575678429647,"score_spread":0.3030557087472639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405756564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975762,0.000349884,0.000017547778,0.00019280342,0.000012085154,0.000009039388,0.00022285512,5.0836786e-7,0.0016189801],"genre_scores_gemma":[0.99866223,0.00046145837,0.000044236564,0.00013735048,0.000008611586,0.000010913539,0.00024322783,0.000001481052,0.0004304769],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991636,0.0002945689,0.00003766474,0.000054318494,0.00014789129,0.00030190457],"domain_scores_gemma":[0.99816436,0.0004915395,0.0004625608,0.00005437726,0.00039160028,0.00043560905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009524753,0.00023566301,0.000284503,0.0004723544,0.0013199508,0.0011386279,0.00043093876,0.00043706162,0.0015071133],"category_scores_gemma":[0.005857906,0.0001705212,0.00036651475,0.0008350469,0.0004076648,0.00038131955,0.0009382165,0.0006318571,0.00018049931],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017934076,0.0001789968,0.98213583,0.00006605183,0.000097269876,0.00041000172,0.0054261032,0.000043599714,0.00013086895,0.00008109426,0.00081078795,0.010440123],"study_design_scores_gemma":[0.000006549887,0.00007612447,0.98635733,0.00009673373,0.000036650737,0.000109700166,0.012527723,0.00004628393,0.00003457041,0.0000408005,0.00066083577,0.000006689367],"about_ca_topic_score_codex":0.24217129,"about_ca_topic_score_gemma":0.38493618,"teacher_disagreement_score":0.7578287,"about_ca_system_score_codex":0.0019721012,"about_ca_system_score_gemma":0.002994756,"threshold_uncertainty_score":0.4815234},"labels":[],"label_agreement":null},{"id":"W4405756616","doi":"10.1016/j.jval.2024.10.1071","title":"EE791 Cost-Effectiveness Analysis of 1.5% Ruxolitinib Cream for the Treatment of Patients With Atopic Dermatitis in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Ruxolitinib; Atopic dermatitis; Medicine; Dermatology; Internal medicine","score_opus":0.021303022874412294,"score_gpt":0.28973816829487836,"score_spread":0.2684351454204661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405756616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92509085,0.039426737,0.0008061166,0.004424999,0.00018725773,0.0010804555,0.0147488015,0.00006281788,0.014171979],"genre_scores_gemma":[0.9895169,0.005571749,0.00054338266,0.0005585832,0.00004522067,0.00011267856,0.0023740125,0.000010368151,0.0012670719],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99868256,0.00046745763,0.00007539564,0.00012192663,0.00037088213,0.00028186286],"domain_scores_gemma":[0.99865365,0.00042451816,0.0002489203,0.000026907475,0.0003256524,0.0003203252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012568713,0.0005148403,0.0013469285,0.00062981324,0.00043367036,0.001202114,0.0008602352,0.0006750256,0.0037889984],"category_scores_gemma":[0.003569917,0.00027492267,0.0037505324,0.0012910092,0.00034137297,0.000333025,0.0004177319,0.0012804095,0.00014910924],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.31644687,0.0040688775,0.15791747,0.009650578,0.026026864,0.00090192,0.00030570236,0.070577115,0.0060357614,0.0063559334,0.03048189,0.37123102],"study_design_scores_gemma":[0.078250006,0.027771698,0.7287276,0.0042776153,0.043701865,0.0010732515,0.0011133719,0.081631236,0.0021985064,0.0014768281,0.029458754,0.00031937083],"about_ca_topic_score_codex":0.84550273,"about_ca_topic_score_gemma":0.89472854,"teacher_disagreement_score":0.15449727,"about_ca_system_score_codex":0.03808131,"about_ca_system_score_gemma":0.02352221,"threshold_uncertainty_score":0.3108142},"labels":[],"label_agreement":null},{"id":"W4405792284","doi":"10.1016/j.jval.2024.10.1010","title":"EE730 Health Care Resource Utilization (HCRU) in Chronic Obstructive Pulmonary Disease (COPD), and Asthma Patients With Moderate-to-Severe Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Pulmonary disease; Medicine; COPD; Asthma; Intensive care medicine; Disease; Health care; Physical therapy; Internal medicine; Political science","score_opus":0.026187173430239824,"score_gpt":0.3104954771529877,"score_spread":0.28430830372274785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405792284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98815477,0.0017409087,0.00006545557,0.0004531468,0.00003489539,0.000022102371,0.0043140245,0.000005768273,0.0052089724],"genre_scores_gemma":[0.99713755,0.00026954332,0.000072574214,0.00013702926,0.000037597398,0.000018973109,0.0016736223,0.000002119543,0.0006510867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989613,0.00037071263,0.00013843711,0.000081890204,0.00018877607,0.00025882776],"domain_scores_gemma":[0.9979984,0.00056323805,0.0006825338,0.000060084076,0.00020513049,0.0004905875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008427363,0.00019010439,0.0003937604,0.0011274951,0.0004248334,0.0009558061,0.00031032902,0.00049615203,0.0040429058],"category_scores_gemma":[0.0042784847,0.0001472831,0.0008789992,0.0019863446,0.00019614505,0.00063668314,0.00072350865,0.00075176253,0.0003550297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012432582,0.00007473901,0.99690187,0.000020306046,0.00009607493,0.000031721,0.000032111355,0.00006685838,0.000024462952,0.00006432191,0.0004044138,0.0021588975],"study_design_scores_gemma":[0.0000052878227,0.0000371358,0.99916077,0.00001138406,0.000029305285,0.00005091026,0.00015369536,0.0001907769,0.000011402053,0.000043385888,0.00030329468,0.0000027348617],"about_ca_topic_score_codex":0.034993533,"about_ca_topic_score_gemma":0.049094733,"teacher_disagreement_score":0.034993533,"about_ca_system_score_codex":0.0010661259,"about_ca_system_score_gemma":0.0011297438,"threshold_uncertainty_score":0.06957966},"labels":[],"label_agreement":null},{"id":"W4406085563","doi":"10.1016/j.jval.2024.09.001","title":"Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Australian Hand Therapy Association; National University of Singapore; Postgraduate Institute of Medical Education and Research, Chandigarh; Fu Jen Catholic University; Cairo University; Pontificia Universidad Católica de Chile; Radboud Universitair Medisch Centrum; Health Technology Assessment international; Imperial College London; Radboud Universiteit; Taipei Medical University; Wellcome Trust; London School of Hygiene and Tropical Medicine","keywords":"Task force; Guideline; Health technology; Engineering management; Process management; Task (project management); Medicine; Engineering; Health care; Political science; Systems engineering; Public administration","score_opus":0.2951766661112889,"score_gpt":0.5180968313048391,"score_spread":0.22292016519355018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406085563","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010297403,0.11171622,0.19171928,0.51991594,0.02341493,0.04198142,0.036156215,0.0052265334,0.05957199],"genre_scores_gemma":[0.02482982,0.069364436,0.7748424,0.061684605,0.0030239637,0.024382686,0.031771608,0.0017286511,0.008371785],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.68924433,0.11933757,0.080981955,0.0061420067,0.099535055,0.0047591017],"domain_scores_gemma":[0.36786112,0.23695803,0.07362332,0.029828493,0.27746367,0.014265358],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3240974,0.0032478229,0.004913256,0.022623707,0.004843382,0.012617016,0.01643711,0.018606253,0.003316944],"category_scores_gemma":[0.43225157,0.0042770286,0.010289588,0.02134724,0.004905971,0.005749224,0.008441208,0.022832239,0.004000369],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015236474,0.00083768537,0.011585867,0.011696742,0.0009779744,0.00042469602,0.0040429877,0.0026643123,0.0015445885,0.009732229,0.6686067,0.28773385],"study_design_scores_gemma":[0.0006034947,0.00037695354,0.055403616,0.077845834,0.0021836828,0.00083022006,0.0026486581,0.004954677,0.0052189007,0.017694669,0.83156216,0.0006771447],"about_ca_topic_score_codex":0.075775504,"about_ca_topic_score_gemma":0.07100597,"teacher_disagreement_score":0.6759026,"about_ca_system_score_codex":0.014136016,"about_ca_system_score_gemma":0.08244655,"threshold_uncertainty_score":0.83350825},"labels":[],"label_agreement":null},{"id":"W4406864915","doi":"10.1016/j.jval.2024.12.009","title":"Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Economic and Social Research Council","keywords":"High income countries; Business; Economics; Economic growth; Developing country","score_opus":0.6140998848265642,"score_gpt":0.5021421526689726,"score_spread":0.11195773215759164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406864915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024487166,0.9938915,0.00032539063,0.0039021971,0.00020042968,0.000010447263,0.00004707251,0.000006219443,0.0013718839],"genre_scores_gemma":[0.0030863138,0.9954857,0.0003981433,0.00073683535,0.00013822924,0.000019479723,0.00003736939,0.0000020236928,0.00009594311],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99766904,0.0010434308,0.0003530623,0.0002209064,0.0005007434,0.00021277493],"domain_scores_gemma":[0.99408215,0.0044269864,0.00065572694,0.00007579747,0.00061913463,0.00014016796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0059023807,0.0009367749,0.0014388977,0.00459719,0.00070221623,0.0032693194,0.0010461784,0.0026142136,0.0030566582],"category_scores_gemma":[0.009217422,0.00043850517,0.0012527108,0.0062201633,0.0012919736,0.0034112174,0.0015372487,0.0024996425,0.00041995547],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008995295,0.00007592206,0.0012439359,0.080212146,0.0004569682,0.00025395185,0.00058245304,0.002325214,0.00029741527,0.12053269,0.035998493,0.7579308],"study_design_scores_gemma":[0.000030018915,0.00008964104,0.0034464926,0.13509667,0.00046804178,0.00069941895,0.0012288995,0.0005911092,0.0002951207,0.023919044,0.8340729,0.00006268269],"about_ca_topic_score_codex":0.006596646,"about_ca_topic_score_gemma":0.005811523,"teacher_disagreement_score":0.006596646,"about_ca_system_score_codex":0.0038469196,"about_ca_system_score_gemma":0.0104651,"threshold_uncertainty_score":0.031215131},"labels":[],"label_agreement":null},{"id":"W4406865557","doi":"10.1016/j.jval.2025.01.007","title":"A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Data Research UK; Queen's University; University College Dublin; Queen's University Belfast; Department for the Economy; Cancer Focus Northern Ireland","keywords":"Colorectal cancer; Colorectal cancer screening; Medicine; Health economics; Oncology; Cancer; Internal medicine; Pathology; Public health","score_opus":0.36941107484683594,"score_gpt":0.5776860011631733,"score_spread":0.20827492631633732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406865557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015951365,0.9888187,0.005319919,0.00074059726,0.00018797937,0.0015947076,0.0008799739,0.000044943787,0.00081797177],"genre_scores_gemma":[0.056508504,0.914257,0.01983008,0.0006415614,0.00016390572,0.007307706,0.0009853396,0.000056650035,0.00024919808],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.93451214,0.039913323,0.014430645,0.002237318,0.008336963,0.00056963833],"domain_scores_gemma":[0.8131051,0.16360553,0.011124262,0.0030258622,0.008657447,0.00048176205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07693481,0.0034224845,0.013487442,0.023974719,0.0008295141,0.0063427547,0.0036072382,0.0025631252,0.0056948024],"category_scores_gemma":[0.19297794,0.0018418115,0.028193602,0.01744792,0.0011453627,0.004434005,0.0033039325,0.0023683896,0.0004024762],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078925624,0.000071103444,0.0019637863,0.78174883,0.07765613,0.00010377417,0.00029505504,0.004257146,0.00013058695,0.005250265,0.0021003513,0.12563373],"study_design_scores_gemma":[0.0010978958,0.0006357082,0.004993663,0.7232427,0.23554435,0.0003310174,0.00047554373,0.005297738,0.00029776865,0.0065276427,0.021383794,0.00017217018],"about_ca_topic_score_codex":0.0091539705,"about_ca_topic_score_gemma":0.017462682,"teacher_disagreement_score":0.07693481,"about_ca_system_score_codex":0.011987365,"about_ca_system_score_gemma":0.0169335,"threshold_uncertainty_score":0.406875},"labels":[],"label_agreement":null},{"id":"W4406865725","doi":"10.1016/j.jval.2025.01.004","title":"Social Return on Investment Analysis: A Mixed Methods Approach to Assessing the Value of Adult Hospice Services","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"Bangor University","keywords":"Value (mathematics); Investment (military); Business; Actuarial science; Statistics; Mathematics; Political science","score_opus":0.1566442049746247,"score_gpt":0.5140601388480527,"score_spread":0.35741593387342796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406865725","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15353148,0.0058888984,0.6692595,0.0027673538,0.000729105,0.14146654,0.008525204,0.00057480816,0.017257221],"genre_scores_gemma":[0.1860195,0.0010988072,0.6052889,0.000657057,0.00009347551,0.2041108,0.0009001879,0.000081889004,0.0017493905],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8501527,0.13299379,0.0052779517,0.0044937246,0.0056982827,0.0013835449],"domain_scores_gemma":[0.78181607,0.19427346,0.009797317,0.0064884457,0.0069299475,0.00069469603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10015177,0.0033400217,0.004061345,0.012507467,0.0023603893,0.005265348,0.004366541,0.0023991377,0.01365706],"category_scores_gemma":[0.13899036,0.0012364337,0.009104112,0.009143911,0.0027574296,0.0024442144,0.0049402677,0.0030131196,0.00076589634],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050779837,0.005309084,0.06409758,0.03397685,0.021954002,0.0016439859,0.040781878,0.07492201,0.002869884,0.16743153,0.015064663,0.5668705],"study_design_scores_gemma":[0.0032935205,0.020951018,0.07468991,0.020269187,0.012218726,0.0006012473,0.06410563,0.39714432,0.009196274,0.30889505,0.087324925,0.0013101994],"about_ca_topic_score_codex":0.006105109,"about_ca_topic_score_gemma":0.0072703143,"teacher_disagreement_score":0.10015177,"about_ca_system_score_codex":0.0069162305,"about_ca_system_score_gemma":0.008151783,"threshold_uncertainty_score":0.5296595},"labels":[],"label_agreement":null},{"id":"W4407218103","doi":"10.1016/j.jval.2024.12.010","title":"Do Machine Learning Approaches Perform Better Than Regression Models in Mapping Studies? A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Urban Transport and Accessibility","field":"Social Sciences","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Science Foundation of Tianjin City; Natural Science Foundation of Tianjin-Science and Technology Correspondent Project; National Natural Science Foundation of China","keywords":"Computer science; Machine learning; Regression; Artificial intelligence; Statistics; Mathematics","score_opus":0.33778302718081404,"score_gpt":0.4250146218540537,"score_spread":0.08723159467323965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407218103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081304554,0.99710494,0.0011079798,0.00026718716,0.00014586755,0.00017285961,0.00022273391,0.000019216863,0.00014608863],"genre_scores_gemma":[0.03926905,0.95163584,0.006638067,0.0010189703,0.00019109127,0.00071960245,0.00036395184,0.00003987889,0.00012358376],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9584594,0.021850936,0.011948847,0.0030659917,0.00419825,0.0004766125],"domain_scores_gemma":[0.7231375,0.25496957,0.0132226385,0.003152129,0.0051059555,0.00041214167],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05892223,0.002664912,0.018988702,0.014848219,0.0009550487,0.0058174413,0.003947956,0.003281771,0.0061019566],"category_scores_gemma":[0.24530211,0.002565357,0.021237172,0.013799628,0.0024440854,0.007601034,0.002998819,0.002762376,0.00055394956],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003844991,0.000028653812,0.0028879994,0.8123132,0.08297498,0.00008146645,0.00025209837,0.0005073992,0.00007899419,0.0007562814,0.0016409811,0.09809345],"study_design_scores_gemma":[0.0007129991,0.00031192592,0.0052270945,0.6275396,0.3513175,0.00022422743,0.00043520218,0.00083086843,0.00020823578,0.0028042693,0.010283763,0.000104247694],"about_ca_topic_score_codex":0.012188459,"about_ca_topic_score_gemma":0.02672918,"teacher_disagreement_score":0.94107777,"about_ca_system_score_codex":0.0042398837,"about_ca_system_score_gemma":0.00875507,"threshold_uncertainty_score":0.31161427},"labels":[],"label_agreement":null},{"id":"W4407397530","doi":"10.1016/j.jval.2025.01.019","title":"Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Open source; Data science; Systematic review; Computer science; Database; MEDLINE; Political science","score_opus":0.6561956353900955,"score_gpt":0.49541310661532884,"score_spread":0.16078252877476668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407397530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021515836,0.98415333,0.0051917294,0.0028635873,0.00016979765,0.0007083237,0.0040710983,0.000059317535,0.00063114264],"genre_scores_gemma":[0.06088133,0.9102577,0.019755287,0.0025585974,0.00030506548,0.0022985325,0.0036749474,0.00008687974,0.000181739],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8883201,0.06564453,0.028975056,0.0042347074,0.012208326,0.000617282],"domain_scores_gemma":[0.448742,0.48415825,0.038429584,0.011897563,0.015898593,0.00087403576],"candidate_categories":["metaresearch","open_science"],"consensus_categories":[],"category_scores_codex":[0.11547619,0.0015477829,0.007511082,0.018906401,0.00053401495,0.006830528,0.0036157558,0.0017701043,0.0063749924],"category_scores_gemma":[0.43369317,0.0014647418,0.01366465,0.02106815,0.0015404079,0.0059860926,0.00493956,0.003527799,0.0004622637],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005143285,0.00006194113,0.0054234075,0.703211,0.06359936,0.00009658597,0.0005083529,0.0017342312,0.0001422119,0.007315721,0.009913606,0.20747924],"study_design_scores_gemma":[0.0006974205,0.00029935339,0.010505754,0.73610544,0.1654146,0.00034761918,0.000623065,0.0024550853,0.00029980653,0.0143749025,0.06872001,0.00015695672],"about_ca_topic_score_codex":0.00950339,"about_ca_topic_score_gemma":0.024926059,"teacher_disagreement_score":0.99638426,"about_ca_system_score_codex":0.0053188535,"about_ca_system_score_gemma":0.01971637,"threshold_uncertainty_score":0.61070377},"labels":[],"label_agreement":null},{"id":"W4407485191","doi":"10.1016/j.jval.2025.02.001","title":"Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Population Health Research Institute; McMaster University; Impact","funders":"EuroQol Research Foundation","keywords":"Randomized controlled trial; Systematic review; EQ-5D; Medicine; Management science; Computer science; Medical physics; Statistics; MEDLINE; Mathematics; Internal medicine; Engineering; Political science","score_opus":0.8564160676064599,"score_gpt":0.6643266082298847,"score_spread":0.1920894593765753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407485191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022268388,0.9910759,0.0065653017,0.00035605236,0.00026892766,0.0009678885,0.00032491348,0.00006043505,0.00015803307],"genre_scores_gemma":[0.016078677,0.9439281,0.03252211,0.0014985179,0.0005851881,0.0045966404,0.0004848623,0.00010557396,0.00020040246],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8402891,0.10587246,0.033957288,0.005385838,0.013811755,0.0006834847],"domain_scores_gemma":[0.6463449,0.32485786,0.017700337,0.0049654855,0.0055730836,0.0005583998],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10385509,0.0027380497,0.024411555,0.011933708,0.00069474726,0.005837918,0.00432966,0.004000229,0.007915817],"category_scores_gemma":[0.280651,0.0019589597,0.020257771,0.011320077,0.0025718207,0.0041531324,0.0026488008,0.004398018,0.00083541067],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008339382,0.00004344944,0.00076144567,0.76936525,0.07263315,0.00005644863,0.0001053809,0.0009125108,0.00016863187,0.002215614,0.0035949044,0.14930926],"study_design_scores_gemma":[0.005081522,0.00093037286,0.003902167,0.6124262,0.32331067,0.00040872057,0.00021427276,0.0027278345,0.00050019764,0.015875993,0.034368534,0.00025347562],"about_ca_topic_score_codex":0.0033286628,"about_ca_topic_score_gemma":0.0069811284,"teacher_disagreement_score":0.8961449,"about_ca_system_score_codex":0.0048394697,"about_ca_system_score_gemma":0.011171987,"threshold_uncertainty_score":0.54924476},"labels":[],"label_agreement":null},{"id":"W4408140017","doi":"10.1016/j.jval.2025.02.005","title":"Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Cundill Centre for Child and Youth Depression","keywords":"Psychology; Medicine; Psychiatry; Psychotherapist; Clinical psychology","score_opus":0.09405248303937447,"score_gpt":0.44107307791381456,"score_spread":0.3470205948744401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408140017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005674213,0.9987502,0.00006805682,0.00018759882,0.00007772868,0.0000668041,0.00010159158,0.0000023823177,0.00017813646],"genre_scores_gemma":[0.013663202,0.98531115,0.00038069228,0.00025894013,0.00008610918,0.00015145268,0.000092637514,0.0000031457412,0.00005276233],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9932047,0.0031781984,0.0017047164,0.0003197319,0.001375336,0.00021734831],"domain_scores_gemma":[0.9744118,0.021797929,0.0026786686,0.00017571838,0.000732883,0.0002030763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011092604,0.0010701703,0.00757662,0.0051351464,0.00033706398,0.0030878403,0.0017478224,0.0020596196,0.005508548],"category_scores_gemma":[0.045799058,0.0007420594,0.006332275,0.004896926,0.00078020606,0.0015312049,0.0013937764,0.002163238,0.00019730294],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020224478,0.00018175169,0.0014034567,0.7172181,0.021666417,0.000087819746,0.00011234449,0.0006742245,0.00012516761,0.0013527207,0.0027724386,0.2523831],"study_design_scores_gemma":[0.0022014405,0.00077685824,0.00801625,0.87531155,0.07797285,0.0003740074,0.00037451548,0.00059712655,0.00020326325,0.0019785594,0.032128043,0.00006554754],"about_ca_topic_score_codex":0.005668739,"about_ca_topic_score_gemma":0.011843328,"teacher_disagreement_score":0.011092604,"about_ca_system_score_codex":0.003141901,"about_ca_system_score_gemma":0.004583481,"threshold_uncertainty_score":0.058663964},"labels":[],"label_agreement":null},{"id":"W4408914134","doi":"10.1016/j.jval.2025.02.015","title":"When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; NeuroDevNet; Centre for Advancing Health Outcomes","funders":"","keywords":"Probabilistic logic; Value (mathematics); Computer science; Machine learning; Artificial intelligence","score_opus":0.29582577331247695,"score_gpt":0.4076649677282029,"score_spread":0.11183919441572593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408914134","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33540723,0.0033284468,0.5434264,0.03542799,0.00038006346,0.00076871493,0.0009022887,0.0003696324,0.079989284],"genre_scores_gemma":[0.9631235,0.0009703098,0.031934515,0.0011068949,0.00012322035,0.00027567,0.000094994735,0.000085336455,0.0022857494],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9773671,0.017790988,0.0005973661,0.0012101494,0.0018002014,0.0012342161],"domain_scores_gemma":[0.7830599,0.19745514,0.009391324,0.0042191613,0.0034174589,0.0024569791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.032791063,0.0011512586,0.0024631722,0.001566574,0.0009634555,0.0052951444,0.0026370825,0.004232355,0.007272269],"category_scores_gemma":[0.2322334,0.001423378,0.0017320805,0.0014078504,0.0038227,0.011330557,0.002782916,0.0044771065,0.000440772],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002724396,0.00011834891,0.0060324827,0.00017351362,0.00016338319,0.0002239759,0.0004961236,0.6890341,0.00015257917,0.2866472,0.0022443081,0.014441485],"study_design_scores_gemma":[0.00010208256,0.00008311142,0.00091184507,0.00011992298,0.000049085094,0.00007209876,0.00017962357,0.5851335,0.00012147822,0.4111488,0.002037651,0.000040807696],"about_ca_topic_score_codex":0.0059607974,"about_ca_topic_score_gemma":0.0034289765,"teacher_disagreement_score":0.032791063,"about_ca_system_score_codex":0.004045302,"about_ca_system_score_gemma":0.0029200464,"threshold_uncertainty_score":0.1734178},"labels":[],"label_agreement":null},{"id":"W4409374630","doi":"10.1016/j.jval.2025.03.010","title":"Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Pembrolizumab; Urothelial cancer; Oncology; Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy","score_opus":0.0888941128100231,"score_gpt":0.40198297474328815,"score_spread":0.313088861933265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409374630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96895087,0.02298505,0.00018684263,0.0028519582,0.00014505445,0.00009325019,0.0016253765,0.000020238864,0.0031412991],"genre_scores_gemma":[0.9970291,0.001924438,0.00009413411,0.00027882907,0.000027459379,0.000020901372,0.00038841995,0.0000019235708,0.00023486323],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99905056,0.00050927396,0.00007569385,0.00007236893,0.00014659748,0.00014547925],"domain_scores_gemma":[0.99869365,0.00056321744,0.0003374859,0.000027625912,0.000084090636,0.00029390346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010743298,0.00031542667,0.000853196,0.0005702497,0.00017138547,0.000863635,0.00037320793,0.00063803745,0.0021903086],"category_scores_gemma":[0.0050294204,0.00016757188,0.0021480005,0.0006889944,0.00025748913,0.00079697213,0.0004453551,0.0009403913,0.00009202785],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15103793,0.004903355,0.28046864,0.0032372407,0.013553115,0.0007503621,0.00024468353,0.0611144,0.0024318318,0.00389153,0.015272712,0.46309426],"study_design_scores_gemma":[0.02292043,0.03125895,0.8437072,0.0019459394,0.017621873,0.001466336,0.0013097952,0.06345379,0.0016640557,0.0029128261,0.011595542,0.00014323225],"about_ca_topic_score_codex":0.019521018,"about_ca_topic_score_gemma":0.027461264,"teacher_disagreement_score":0.019521018,"about_ca_system_score_codex":0.0039431476,"about_ca_system_score_gemma":0.001866083,"threshold_uncertainty_score":0.038814783},"labels":[],"label_agreement":null},{"id":"W4410031582","doi":"10.1016/j.jval.2025.04.2159","title":"Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre; Kingston Health Sciences Centre","funders":"","keywords":"Durvalumab; Tremelimumab; Refractory (planetary science); Colorectal cancer; Medicine; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab; Biology","score_opus":0.06745000253906976,"score_gpt":0.3929510278730196,"score_spread":0.32550102533394987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410031582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824683,0.009820602,0.0021894833,0.0010354841,0.00008320734,0.00026768312,0.0017515047,0.000044786422,0.0023390811],"genre_scores_gemma":[0.99807787,0.00065073563,0.00048155518,0.00008831615,0.000020420901,0.000041407988,0.0003979599,0.000006084795,0.00023560564],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99737525,0.0019519678,0.00009328894,0.00015247845,0.00019455902,0.00023248831],"domain_scores_gemma":[0.9934052,0.0052633756,0.00058131857,0.00013264292,0.00017359179,0.00044378723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003940341,0.0011313069,0.0027386644,0.0012095494,0.00019341722,0.0017319022,0.0010640991,0.0008409038,0.0033403388],"category_scores_gemma":[0.013029305,0.00043709186,0.0045024455,0.0012288422,0.0005845953,0.001081605,0.000772839,0.0014559563,0.00016568991],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3428893,0.0022536865,0.069190785,0.0023516538,0.020381037,0.0008236036,0.00018854739,0.4402553,0.0031216985,0.007314116,0.0039357934,0.10729455],"study_design_scores_gemma":[0.022736525,0.042490516,0.13562563,0.0007500172,0.026336355,0.0012130734,0.0007779542,0.75620586,0.002202602,0.007248278,0.0041804886,0.00023275256],"about_ca_topic_score_codex":0.010203115,"about_ca_topic_score_gemma":0.005274637,"teacher_disagreement_score":0.010203115,"about_ca_system_score_codex":0.0049047703,"about_ca_system_score_gemma":0.0017222589,"threshold_uncertainty_score":0.035586834},"labels":[],"label_agreement":null},{"id":"W4410116754","doi":"10.1016/j.jval.2025.01.022","title":"Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Psychological intervention; Medication adherence; Medicine; Business; Psychology; Nursing","score_opus":0.43223379218892055,"score_gpt":0.4869311639051029,"score_spread":0.05469737171618233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410116754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045290813,0.9893996,0.00025937732,0.0059218593,0.0003088898,0.000029800682,0.000029880252,0.0000023217283,0.003595242],"genre_scores_gemma":[0.018777033,0.9729969,0.0013056555,0.0056847516,0.00035852438,0.0001346309,0.000032457494,0.000004508334,0.00070561096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.986796,0.008981894,0.0014186172,0.0004781235,0.001929803,0.0003955445],"domain_scores_gemma":[0.9683119,0.028123181,0.001406149,0.000218866,0.0016719657,0.00026797768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016547332,0.00071705296,0.002418515,0.0023948995,0.00066775345,0.0036255952,0.0010672706,0.0035348719,0.006015895],"category_scores_gemma":[0.025426226,0.00045846298,0.001469823,0.0025201726,0.0014172568,0.0023322683,0.0017766926,0.0039421367,0.0003797272],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002946846,0.00009306732,0.00044987485,0.18375525,0.0012849936,0.0004051687,0.0032608896,0.00038827525,0.0007539966,0.034915544,0.013787718,0.76061046],"study_design_scores_gemma":[0.0002152367,0.00023956403,0.0019442539,0.31936657,0.0025636707,0.00050616864,0.0025683017,0.00019415848,0.0005716619,0.010454081,0.66132796,0.000048267917],"about_ca_topic_score_codex":0.0031170244,"about_ca_topic_score_gemma":0.009355664,"teacher_disagreement_score":0.016547332,"about_ca_system_score_codex":0.002309038,"about_ca_system_score_gemma":0.0066509754,"threshold_uncertainty_score":0.08751172},"labels":[],"label_agreement":null},{"id":"W4410119251","doi":"10.1016/j.jval.2025.04.2162","title":"Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Hospital for Sick Children; Canadian Centre for Applied Research in Cancer Control; Institute for Clinical Evaluative Sciences; SickKids Foundation; Alberta Children's Hospital","funders":"National Human Genome Research Institute; National Institutes of Health; Canada Research Chairs","keywords":"Equity (law); Health equity; Personalized medicine; Health care; Precision medicine; Context (archaeology); Psychological intervention; Business; Medicine; Biology; Economics; Political science; Bioinformatics; Genetics; Economic growth; Nursing","score_opus":0.6557474363198706,"score_gpt":0.5463105303038358,"score_spread":0.10943690601603484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410119251","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018728504,0.03968413,0.71105564,0.19302402,0.0031786633,0.00048520882,0.0006089272,0.00013559664,0.03309932],"genre_scores_gemma":[0.80357426,0.017290473,0.13982072,0.021101275,0.009226889,0.0011736347,0.00033239997,0.00024575135,0.0072346227],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.92086077,0.07040755,0.0017463426,0.0018031613,0.004217841,0.00096427166],"domain_scores_gemma":[0.72419775,0.25916943,0.003826118,0.0055944286,0.0058436496,0.0013685982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09918998,0.0024335033,0.0055232057,0.003271376,0.0013537568,0.0071151503,0.00567161,0.0068906657,0.0088069085],"category_scores_gemma":[0.30038208,0.0011698116,0.0027222175,0.004174956,0.008686618,0.01583152,0.0053127897,0.012495011,0.00040589305],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016066847,0.00012399627,0.0017345783,0.00051505724,0.00054093223,0.000175651,0.00021521683,0.043028817,0.00008493142,0.9058234,0.0051430627,0.042453654],"study_design_scores_gemma":[0.00004204509,0.000039280807,0.00040930568,0.0003240534,0.000127037,0.000097638695,0.0001275903,0.028486349,0.0000727206,0.96679705,0.003449501,0.000027410137],"about_ca_topic_score_codex":0.0046003987,"about_ca_topic_score_gemma":0.0050200378,"teacher_disagreement_score":0.09918998,"about_ca_system_score_codex":0.007022075,"about_ca_system_score_gemma":0.006107057,"threshold_uncertainty_score":0.524573},"labels":[],"label_agreement":null},{"id":"W4410197714","doi":"10.1016/j.jval.2024.11.016","title":"Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain","year":2025,"lang":"en","type":"letter","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"Merck Sharp and Dohme; Merck","keywords":"Real world data; Real world evidence; Computer science; Data science; Medicine; Internal medicine","score_opus":0.28280658269084086,"score_gpt":0.36532573612631436,"score_spread":0.0825191534354735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410197714","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00044157708,0.0010592777,0.0005230539,0.99217284,0.0032305778,0.000017954064,0.00034505318,0.000025254176,0.0021843666],"genre_scores_gemma":[0.016590487,0.002084357,0.003987357,0.9497936,0.024060415,0.00017014661,0.000370969,0.000068662564,0.0028740338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9512589,0.03117481,0.0053546797,0.0017929415,0.009089408,0.0013293015],"domain_scores_gemma":[0.49301374,0.45236224,0.012839856,0.0071212994,0.027002294,0.0076606134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07553926,0.00074177375,0.001979548,0.0017868442,0.0017132409,0.009077155,0.004626107,0.041755218,0.0059893336],"category_scores_gemma":[0.31386852,0.0008345474,0.001798869,0.0020584585,0.005149561,0.01125207,0.0040062424,0.0349361,0.0049267025],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022137667,0.00011050582,0.0049504116,0.0002143832,0.0001315098,0.00071492285,0.0002399396,0.0006319478,0.00016483953,0.02461325,0.9248337,0.043173313],"study_design_scores_gemma":[0.00042721353,0.00013980133,0.004885662,0.0018504083,0.000104579514,0.00067659,0.0010257682,0.006870437,0.00042412183,0.09678755,0.8866067,0.00020118264],"about_ca_topic_score_codex":0.010118097,"about_ca_topic_score_gemma":0.017371887,"teacher_disagreement_score":0.07553926,"about_ca_system_score_codex":0.0049235127,"about_ca_system_score_gemma":0.01226671,"threshold_uncertainty_score":0.3994946},"labels":[],"label_agreement":null},{"id":"W4410398465","doi":"10.1016/j.jval.2025.05.001","title":"Evaluation of Health Technology Assessment Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"GE Healthcare","keywords":"Market access; Business; Geography","score_opus":0.7102973243612392,"score_gpt":0.6094041621924942,"score_spread":0.100893162168745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410398465","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.098420985,0.063095905,0.7523382,0.047685392,0.0012889191,0.0052271043,0.004296081,0.0003764495,0.02727097],"genre_scores_gemma":[0.7751624,0.009240035,0.20326221,0.003818815,0.001026113,0.0048010647,0.0017185241,0.00014820448,0.0008227839],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.36556718,0.5867567,0.011879295,0.0052096015,0.028504482,0.00208289],"domain_scores_gemma":[0.079927616,0.8651809,0.018876787,0.013330283,0.021454323,0.0012300217],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.56563085,0.0031671005,0.00722425,0.009260267,0.0014870996,0.019826224,0.010345469,0.008435526,0.006520346],"category_scores_gemma":[0.7441475,0.0017090848,0.0050508385,0.008751235,0.008932469,0.017587755,0.011887327,0.008288937,0.00047255636],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044331495,0.0019921956,0.032959376,0.010575483,0.009922007,0.00008660886,0.0028281428,0.10317579,0.00050239335,0.5907987,0.006883252,0.23584287],"study_design_scores_gemma":[0.0021336689,0.003626872,0.030179614,0.016801812,0.00508492,0.00019110677,0.0024972358,0.33627355,0.002558018,0.57705104,0.023221876,0.00038038756],"about_ca_topic_score_codex":0.0076299314,"about_ca_topic_score_gemma":0.0033608163,"teacher_disagreement_score":0.43436915,"about_ca_system_score_codex":0.016113447,"about_ca_system_score_gemma":0.01972442,"threshold_uncertainty_score":0.53565454},"labels":[],"label_agreement":null},{"id":"W4410629806","doi":"10.1016/j.jval.2025.05.005","title":"Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"bluebird bio","keywords":"Life expectancy; Valuation (finance); Medicine; Quality of life (healthcare); Willingness to pay; Disease; Quality-adjusted life year; Value of life; Actuarial science; Disease burden; Gerontology; Environmental health; Cost effectiveness; Risk analysis (engineering); Internal medicine; Business; Economics; Population; Finance; Nursing","score_opus":0.061308718678224995,"score_gpt":0.3704827966689697,"score_spread":0.3091740779907447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410629806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.902218,0.00063662196,0.083930306,0.0021321152,0.000058451784,0.0006349012,0.0007187673,0.00024872174,0.009422126],"genre_scores_gemma":[0.9746176,0.00016131908,0.02387904,0.00005852243,0.000007546728,0.0001239038,0.00012769974,0.0000310066,0.0009932463],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974681,0.0018129848,0.00008413897,0.00015785312,0.00016044418,0.00031649502],"domain_scores_gemma":[0.9882699,0.010247143,0.00032121604,0.00038529088,0.000555624,0.0002208374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005147724,0.00094682304,0.0011958265,0.00077818497,0.0006707141,0.0022036855,0.0019395854,0.0026337036,0.00441416],"category_scores_gemma":[0.017641801,0.00063997624,0.0018777237,0.0010008318,0.0006133246,0.0011639046,0.00091807113,0.0021483318,0.00025315178],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006998654,0.00059309043,0.008793599,0.00012481422,0.00014322475,0.0010493112,0.00014702854,0.9597288,0.00043712565,0.008139462,0.0007644031,0.019379335],"study_design_scores_gemma":[0.00021871524,0.0005521903,0.0025988107,0.00003611141,0.00010815198,0.0003760434,0.00018608435,0.989207,0.00036502094,0.0056388634,0.0006766362,0.000036291593],"about_ca_topic_score_codex":0.046142124,"about_ca_topic_score_gemma":0.01870855,"teacher_disagreement_score":0.046142124,"about_ca_system_score_codex":0.0037683179,"about_ca_system_score_gemma":0.0037702036,"threshold_uncertainty_score":0.091747105},"labels":[],"label_agreement":null},{"id":"W4411196932","doi":"10.1016/j.jval.2025.05.017","title":"Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"EuroQol Research Foundation","keywords":"Preference; Discrete choice; Econometrics; Psychology; Statistics; Computer science; Economics; Mathematics","score_opus":0.6147560954283843,"score_gpt":0.49158773971070446,"score_spread":0.12316835571767981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411196932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98118067,0.000042339925,0.009722905,0.00028178515,0.00010027171,0.004408673,0.00033550579,0.000030142104,0.0038977517],"genre_scores_gemma":[0.9542926,0.00010226294,0.02539775,0.0005497212,0.000070499314,0.01704737,0.0002085778,0.000015113966,0.0023160144],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9890153,0.007977805,0.00062813994,0.0011176681,0.0007277877,0.00053330336],"domain_scores_gemma":[0.95031226,0.041764893,0.0036497011,0.002582838,0.00069202704,0.0009981877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017635481,0.00076267467,0.0012067483,0.00026541395,0.0006241294,0.0016416814,0.0008711909,0.002094796,0.008712612],"category_scores_gemma":[0.03230658,0.00054691394,0.001054272,0.00042568552,0.0019040883,0.001441798,0.00090923265,0.0024136214,0.00069237506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29695377,0.17500517,0.108809575,0.00442985,0.0021606686,0.0012336035,0.03633804,0.057198197,0.14851342,0.053119153,0.0045835786,0.111654975],"study_design_scores_gemma":[0.076114215,0.35164863,0.17214403,0.0008232572,0.001780417,0.0003260814,0.009316671,0.23358868,0.037971247,0.09354673,0.021738466,0.0010015868],"about_ca_topic_score_codex":0.0008353971,"about_ca_topic_score_gemma":0.00069343817,"teacher_disagreement_score":0.017635481,"about_ca_system_score_codex":0.00086715596,"about_ca_system_score_gemma":0.0011432219,"threshold_uncertainty_score":0.09326643},"labels":[],"label_agreement":null},{"id":"W4412079466","doi":"10.1016/j.jval.2025.06.015","title":"Strong Preferences or Simplifying Heuristics? Using Internal Validity Tests and Latent Class Analysis to Better Understand Stated Preference Survey Results. A Case Example in Health Preferences Research","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; McMaster University","keywords":"Latent class model; Heuristics; Preference; Class (philosophy); Internal validity; Econometrics; Psychology; Computer science; Data science; Social psychology; Statistics; Machine learning; Artificial intelligence; Mathematics","score_opus":0.7731893391534402,"score_gpt":0.4203014965966582,"score_spread":0.352887842556782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412079466","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30952403,0.0028036695,0.65818834,0.011386745,0.00033213245,0.0005251131,0.000604287,0.0003627616,0.016272897],"genre_scores_gemma":[0.9074996,0.00038736186,0.09016089,0.0007638993,0.00014304787,0.00037753873,0.00024267145,0.000054239,0.000370773],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8411968,0.14355439,0.004330832,0.0036154513,0.006165123,0.0011374076],"domain_scores_gemma":[0.21512447,0.72438896,0.019285604,0.034003172,0.0065058074,0.00069200515],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.16952997,0.0011234772,0.00147762,0.0042499877,0.0014239176,0.007057591,0.0021657383,0.0020867514,0.0038785841],"category_scores_gemma":[0.5486846,0.00066974864,0.002601496,0.004986387,0.007449698,0.014038828,0.0033588172,0.005740841,0.00041898616],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008313664,0.00055263605,0.16665831,0.00081772543,0.0024014951,0.00033797915,0.013913977,0.01444866,0.00086699997,0.50072974,0.005514854,0.29292634],"study_design_scores_gemma":[0.00017585179,0.00023096814,0.027351025,0.00049889,0.0003734157,0.0001609342,0.0046951356,0.06724183,0.0010527488,0.89510626,0.002978892,0.00013407104],"about_ca_topic_score_codex":0.0036085923,"about_ca_topic_score_gemma":0.0038830985,"teacher_disagreement_score":0.83047,"about_ca_system_score_codex":0.0020148158,"about_ca_system_score_gemma":0.0025784343,"threshold_uncertainty_score":0.8965709},"labels":[],"label_agreement":null},{"id":"W4412432137","doi":"10.1016/j.jval.2025.04.2113","title":"EE517 Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Willingness to pay; New horizons; Quality (philosophy); Economics; Actuarial science; Econometrics; Microeconomics; Engineering; Physics","score_opus":0.3376034317907446,"score_gpt":0.4659224696043358,"score_spread":0.12831903781359122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8817196,0.0005378979,0.007083302,0.0016121118,0.0000395633,0.000807231,0.045677874,0.00017521912,0.062347237],"genre_scores_gemma":[0.94367063,0.00017082352,0.0052906577,0.00025214246,0.000012225468,0.000500848,0.0133473845,0.000028359862,0.036726896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819547,0.0009779466,0.000081337574,0.00018691334,0.0003297406,0.00022861188],"domain_scores_gemma":[0.984868,0.010714742,0.0005027402,0.0005968062,0.0029148976,0.00040283514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028537496,0.0003534605,0.0004597356,0.0008399832,0.0010655259,0.0013135199,0.0009782503,0.0011624238,0.028082998],"category_scores_gemma":[0.018230382,0.0002682656,0.00048820465,0.0018169674,0.00038829498,0.0005615018,0.0006140252,0.0008707212,0.00207409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005813859,0.0024529707,0.515985,0.0010313706,0.0008140122,0.0010726205,0.0052628326,0.07016925,0.0038991398,0.021054816,0.1499646,0.22247954],"study_design_scores_gemma":[0.00067893724,0.0005351718,0.7835693,0.0002654162,0.00014497412,0.00016917831,0.0051453603,0.1444454,0.0023904871,0.0028044838,0.059654094,0.00019726562],"about_ca_topic_score_codex":0.9542154,"about_ca_topic_score_gemma":0.9636119,"teacher_disagreement_score":0.045784593,"about_ca_system_score_codex":0.016977279,"about_ca_system_score_gemma":0.008887952,"threshold_uncertainty_score":0.123179376},"labels":[],"label_agreement":null},{"id":"W4412432185","doi":"10.1016/j.jval.2025.04.2123","title":"EE527 Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; St. Michael's Hospital; University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Fiscal year; Course (navigation); Disease; Medicine; Political science; Economics; Intensive care medicine; Immunology; Internal medicine; Law; Engineering","score_opus":0.04487503611104476,"score_gpt":0.3403934950411208,"score_spread":0.29551845893007606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432185","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05102197,0.043778915,0.000709639,0.6032229,0.0031863486,0.00008315873,0.0021045762,0.000117656054,0.2957749],"genre_scores_gemma":[0.76972836,0.06254227,0.004615008,0.062531024,0.002640739,0.000087743734,0.002100358,0.00010143674,0.09565308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975326,0.0003980525,0.000071228715,0.000069873684,0.00085635897,0.0010719188],"domain_scores_gemma":[0.9928047,0.00058410404,0.000310346,0.00011708766,0.0027447133,0.0034390423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027438032,0.00025810138,0.00030606767,0.0015262906,0.0044831247,0.005163318,0.0013756781,0.0021155444,0.02034883],"category_scores_gemma":[0.0067361593,0.00015651186,0.000623053,0.0021059636,0.0021717863,0.0009206828,0.0018325818,0.002643661,0.00076997647],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007229035,0.00029542838,0.019998234,0.0007416502,0.0001563358,0.0009106632,0.0015671503,0.0017602948,0.0011811659,0.18498139,0.47772813,0.3099568],"study_design_scores_gemma":[0.00028004393,0.00013817419,0.054219183,0.0013293265,0.0001437006,0.00057002174,0.0047606626,0.0009813057,0.0004399495,0.015858648,0.9211851,0.000093904906],"about_ca_topic_score_codex":0.9310173,"about_ca_topic_score_gemma":0.9758119,"teacher_disagreement_score":0.9501298,"about_ca_system_score_codex":0.049870186,"about_ca_system_score_gemma":0.14862424,"threshold_uncertainty_score":0.36183524},"labels":[],"label_agreement":null},{"id":"W4412432201","doi":"10.1016/j.jval.2025.04.1781","title":"SA26 Economic Burden of Hairy Cell Leukemia: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Hairy cell leukemia; Leukemia; Medicine; Internal medicine","score_opus":0.07323545756030579,"score_gpt":0.3921173375359674,"score_spread":0.3188818799756616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007709959,0.99735343,0.00008918654,0.0003056538,0.00014215712,0.00013090135,0.0009405215,0.000007791131,0.00025945794],"genre_scores_gemma":[0.014833521,0.9835649,0.00030949694,0.0005737145,0.000094481205,0.00018876871,0.0002902864,0.0000056133645,0.00013919303],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99475807,0.0018459543,0.0016842231,0.00046436788,0.0009732859,0.00027398177],"domain_scores_gemma":[0.9855563,0.009686558,0.0030492463,0.00019825698,0.0012823776,0.00022720198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005844699,0.0015126338,0.009309476,0.0077895303,0.00056713057,0.0031838028,0.0014487877,0.0021970167,0.011523022],"category_scores_gemma":[0.031955317,0.0011173823,0.011004252,0.011081495,0.0006996251,0.0020973384,0.0022088122,0.0017343509,0.0005976275],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042405617,0.000016930408,0.001409407,0.9341863,0.035599854,0.000088297114,0.000079814534,0.00013161276,0.000085237254,0.00024555504,0.0028797318,0.02485315],"study_design_scores_gemma":[0.0009260797,0.00016430393,0.008180282,0.68623567,0.28507465,0.000265988,0.00026116642,0.00013043442,0.00009855045,0.0006223752,0.017970707,0.00006978217],"about_ca_topic_score_codex":0.018013379,"about_ca_topic_score_gemma":0.046810083,"teacher_disagreement_score":0.018013379,"about_ca_system_score_codex":0.004017213,"about_ca_system_score_gemma":0.010012261,"threshold_uncertainty_score":0.03854829},"labels":[],"label_agreement":null},{"id":"W4412432219","doi":"10.1016/j.jval.2025.04.543","title":"EPH12 Estimating Epidemiological Estimates of Rare Diseases in Reimbursement Submissions to Canada's Drug Agency: A Comparison of Approaches in the Absence of Local Real-World Data","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Epidemiology; Drug; Medicine; Actuarial science; Business; Pharmacology; Economic growth; Economics; Pathology; Social science; Sociology; Health care","score_opus":0.6230134319841203,"score_gpt":0.49243528163689504,"score_spread":0.13057815034722525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85914356,0.0035880613,0.09947674,0.003939185,0.00013550631,0.0007029556,0.022290457,0.00047205997,0.010251513],"genre_scores_gemma":[0.9145365,0.0011461151,0.0688961,0.0003447654,0.000067588706,0.00020311229,0.011678299,0.000093772505,0.0030337777],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99005896,0.0063288086,0.0006297799,0.000902519,0.0015471757,0.00053273863],"domain_scores_gemma":[0.9184822,0.065994464,0.003041638,0.0027509956,0.008760156,0.0009705068],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02242626,0.000693501,0.0010133644,0.004363161,0.00097277976,0.00338265,0.0019520611,0.0012669765,0.0029100815],"category_scores_gemma":[0.098068275,0.00065196905,0.0015633188,0.005471228,0.00093431293,0.001322737,0.0019091099,0.0013783862,0.00030947014],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022042508,0.00041019105,0.5339477,0.0009570898,0.003834213,0.00029315578,0.0009211312,0.30618182,0.0003561489,0.01794216,0.009481984,0.123470135],"study_design_scores_gemma":[0.0006204369,0.00026958776,0.39254358,0.0004457186,0.0011553235,0.00022494922,0.0018665787,0.5775346,0.0013120829,0.0127148265,0.0111349765,0.00017729426],"about_ca_topic_score_codex":0.8534256,"about_ca_topic_score_gemma":0.80028385,"teacher_disagreement_score":0.9904224,"about_ca_system_score_codex":0.009577547,"about_ca_system_score_gemma":0.016879847,"threshold_uncertainty_score":0.29487514},"labels":[],"label_agreement":null},{"id":"W4412432233","doi":"10.1016/j.jval.2025.04.1205","title":"MSR53 Development and Validation of an LLM-Based Study Selection Tool for Automating Systematic Literature Reviews: Achieving Time Efficiency and Maintaining Gold Standard Accuracy","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Impact of AI and Big Data on Business and Society","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Selection (genetic algorithm); Gold standard (test); Systematic review; Computer science; Systematic error; Machine learning; Statistics; MEDLINE; Mathematics; Chemistry","score_opus":0.08687134925101475,"score_gpt":0.4070922405465321,"score_spread":0.32022089129551734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432233","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044663064,0.011880079,0.75180686,0.0106895575,0.0013147634,0.047785353,0.056033015,0.060050774,0.015776612],"genre_scores_gemma":[0.033785786,0.00067069294,0.933058,0.0008851787,0.00012701584,0.021638395,0.007266499,0.0010518477,0.0015166083],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.8292732,0.07253134,0.06774985,0.00904066,0.020023823,0.0013810927],"domain_scores_gemma":[0.38501364,0.44548514,0.043666434,0.033997316,0.08838012,0.003457382],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19658972,0.0020925964,0.0037350175,0.026291419,0.0028083872,0.009427419,0.003458432,0.0030021202,0.01620174],"category_scores_gemma":[0.5041247,0.0024114053,0.007839301,0.012532315,0.0012119095,0.004385844,0.0071876775,0.0021234632,0.005635524],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026030585,0.00047266667,0.039591238,0.06352129,0.007766444,0.0006546475,0.0053328886,0.004025986,0.01197143,0.01011658,0.07394652,0.7799973],"study_design_scores_gemma":[0.007825776,0.0032599936,0.109397784,0.05677163,0.022062061,0.0029597552,0.0041131536,0.13865201,0.06856978,0.039406087,0.54522306,0.0017588864],"about_ca_topic_score_codex":0.004370697,"about_ca_topic_score_gemma":0.01410919,"teacher_disagreement_score":0.8034103,"about_ca_system_score_codex":0.0036820373,"about_ca_system_score_gemma":0.028926158,"threshold_uncertainty_score":0.9907479},"labels":[],"label_agreement":null},{"id":"W4412432271","doi":"10.1016/j.jval.2025.04.1240","title":"MSR88 Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Key (lock); Data extraction; Data science; Outcomes research; Computer science; Econometrics; Economics; MEDLINE; Medicine; Political science; Alternative medicine; Computer security","score_opus":0.44093672674516715,"score_gpt":0.5246048573887429,"score_spread":0.0836681306435757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432271","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007027329,0.0018127833,0.92065054,0.049083214,0.00089364965,0.0009501621,0.0069761802,0.0056577222,0.006948383],"genre_scores_gemma":[0.08454822,0.0011626972,0.8929503,0.005955761,0.0013650416,0.002455442,0.0054718195,0.0023632974,0.0037274125],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.7123774,0.2496991,0.018033057,0.0068436563,0.012060405,0.0009864179],"domain_scores_gemma":[0.22357355,0.7168406,0.0062166187,0.036040418,0.01615435,0.0011744405],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22031492,0.0018382908,0.0026851415,0.0037827613,0.0024271242,0.015008078,0.005990577,0.0034786488,0.021952057],"category_scores_gemma":[0.6106238,0.0025871512,0.004617692,0.0072787167,0.003977076,0.017057369,0.0074232947,0.009831879,0.012675729],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004250837,0.00045961782,0.019332614,0.007223543,0.0029975735,0.0019618077,0.0056064036,0.028153414,0.008756035,0.30279317,0.1697011,0.4487639],"study_design_scores_gemma":[0.0008872081,0.0004539363,0.0068830657,0.0031028609,0.000772284,0.0019821292,0.0026716443,0.1919854,0.014144496,0.56203705,0.2145915,0.0004884508],"about_ca_topic_score_codex":0.0065919664,"about_ca_topic_score_gemma":0.012964728,"teacher_disagreement_score":0.7796851,"about_ca_system_score_codex":0.0021751244,"about_ca_system_score_gemma":0.007967002,"threshold_uncertainty_score":0.9614905},"labels":[],"label_agreement":null},{"id":"W4412432466","doi":"10.1016/j.jval.2025.04.1792","title":"SA37 Reporting Standards in Predictive Modeling of Cancer Outcomes: An Umbrella Review of Adherence to the TRIPOD SR MA Reporting Guideline","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Tripod (photography); Guideline; Medicine; Engineering; Pathology; Mechanical engineering","score_opus":0.1648007782186044,"score_gpt":0.419078703277567,"score_spread":0.25427792505896263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432466","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0077908835,0.34973896,0.19254737,0.3456467,0.027434953,0.0049611283,0.02179667,0.0029317217,0.047151588],"genre_scores_gemma":[0.09405047,0.27240923,0.4224141,0.14813979,0.010529416,0.013813063,0.028386636,0.0024925994,0.0077647534],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.5880309,0.17792137,0.14377919,0.00977375,0.07624007,0.0042547216],"domain_scores_gemma":[0.25665876,0.35228175,0.0784026,0.044470977,0.26377648,0.0044094175],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4184494,0.0015926257,0.0038448004,0.015032346,0.0030205816,0.012148183,0.015623324,0.011347331,0.004074638],"category_scores_gemma":[0.6500822,0.0026754695,0.007853574,0.014551455,0.0061998586,0.0075662117,0.008321379,0.0157774,0.0029543051],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000525835,0.00021017893,0.011003146,0.039315455,0.0018459664,0.00021440817,0.003276705,0.00317065,0.0009404859,0.09403922,0.4550952,0.39036283],"study_design_scores_gemma":[0.00029320386,0.00034766857,0.013343231,0.19214647,0.0023057256,0.0005810693,0.0018472694,0.0049282485,0.0033531606,0.038567033,0.74188584,0.00040112884],"about_ca_topic_score_codex":0.038668614,"about_ca_topic_score_gemma":0.016983375,"teacher_disagreement_score":0.5815506,"about_ca_system_score_codex":0.008900096,"about_ca_system_score_gemma":0.05000137,"threshold_uncertainty_score":0.71715546},"labels":[],"label_agreement":null},{"id":"W4412432566","doi":"10.1016/j.jval.2025.04.1759","title":"SA3 Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; EVERSANA (Canada); Canadian Orthopaedic Trauma Society; McMaster University; Novartis (Canada); Probity Medical Research","funders":"","keywords":"Interpretation (philosophy); Psoriasis; Computer science; Data science; Medicine; Dermatology; Programming language","score_opus":0.7516441895489605,"score_gpt":0.6805254455457066,"score_spread":0.07111874400325391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432566","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016007427,0.008617133,0.8930419,0.03669471,0.0044470476,0.017334262,0.0020741883,0.0012486144,0.02053478],"genre_scores_gemma":[0.1256772,0.0010051855,0.8359976,0.006118085,0.0006509317,0.02792912,0.00026214853,0.0004243756,0.0019353279],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.15914455,0.7754482,0.04361301,0.0033020594,0.017673906,0.0008182795],"domain_scores_gemma":[0.08935913,0.82699925,0.012127429,0.028290948,0.042160254,0.0010630775],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.63364434,0.002172824,0.0036721446,0.011642564,0.0037193967,0.010890692,0.004870259,0.0042824172,0.012343794],"category_scores_gemma":[0.835049,0.0028985373,0.006213226,0.007879193,0.005519844,0.004644193,0.0059670904,0.007763856,0.001468656],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050783902,0.00058153796,0.027260588,0.03390983,0.016921131,0.0012803632,0.035380192,0.009194574,0.003439532,0.09952362,0.09136873,0.6760615],"study_design_scores_gemma":[0.0055126296,0.002749852,0.033192933,0.06407027,0.017092315,0.0034695046,0.018585097,0.13515818,0.013243457,0.40397784,0.30178553,0.0011624844],"about_ca_topic_score_codex":0.00626115,"about_ca_topic_score_gemma":0.016501233,"teacher_disagreement_score":0.36635566,"about_ca_system_score_codex":0.004469152,"about_ca_system_score_gemma":0.016640138,"threshold_uncertainty_score":0.4517818},"labels":[],"label_agreement":null},{"id":"W4412442563","doi":"10.1016/j.jval.2025.04.1021","title":"HTA10 Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Medicine; Qualitative research; Family medicine; Business; Health care; Economic growth; Economics; Sociology; Social science","score_opus":0.7376645871629269,"score_gpt":0.5926684626600632,"score_spread":0.1449961245028637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442563","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22504805,0.040639006,0.012650356,0.63089764,0.005454717,0.0024402891,0.013460562,0.00032842174,0.069081016],"genre_scores_gemma":[0.83589005,0.02247843,0.019084308,0.10333419,0.002341153,0.003534599,0.0032834094,0.00042257484,0.009631293],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.7325386,0.1863507,0.01753134,0.005537005,0.05035377,0.0076885577],"domain_scores_gemma":[0.14491409,0.682501,0.046969555,0.007266366,0.09919783,0.019151011],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23025139,0.00030182538,0.001069435,0.006900145,0.0055804783,0.010973158,0.004210171,0.004116109,0.01187491],"category_scores_gemma":[0.50647974,0.0007744266,0.0011388926,0.007894207,0.006802858,0.004846486,0.010128049,0.005509277,0.0009047566],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009290608,0.0004176028,0.13625999,0.012413725,0.00035163734,0.00050040317,0.16552629,0.0012312112,0.0017467586,0.03019492,0.19752474,0.4529037],"study_design_scores_gemma":[0.00026265474,0.00043576377,0.27462614,0.028476842,0.00019567375,0.00083107274,0.260518,0.004598746,0.0024894953,0.015320101,0.41155493,0.00069060933],"about_ca_topic_score_codex":0.3235451,"about_ca_topic_score_gemma":0.42625228,"teacher_disagreement_score":0.94748664,"about_ca_system_score_codex":0.052513346,"about_ca_system_score_gemma":0.10591697,"threshold_uncertainty_score":0.9492371},"labels":[],"label_agreement":null},{"id":"W4412442574","doi":"10.1016/j.jval.2025.04.1023","title":"HTA12 Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Oncology; Medicine; Internal medicine; Data science; Computer science","score_opus":0.03571097321427342,"score_gpt":0.3928041791517588,"score_spread":0.3570932059374854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4405229,0.028884657,0.022122359,0.3055024,0.00066605076,0.00019400573,0.046720874,0.0003143434,0.1550724],"genre_scores_gemma":[0.97437376,0.0041278964,0.007218267,0.0069294963,0.00021848975,0.000037141253,0.004292468,0.0000820044,0.0027204729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9841107,0.0068513784,0.00051189365,0.001223631,0.005680634,0.0016218363],"domain_scores_gemma":[0.88447887,0.07510702,0.0073042423,0.0035018178,0.026716504,0.002891504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02352333,0.00047035003,0.00085706764,0.0018453618,0.0021772555,0.005189144,0.0018877409,0.0011705986,0.0048858044],"category_scores_gemma":[0.12252723,0.0003556779,0.001290096,0.0062206616,0.0020454573,0.002387198,0.002589995,0.0033969353,0.00033851987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001376611,0.00013827569,0.50352734,0.0010931082,0.0017686008,0.0004965467,0.007874881,0.0397924,0.00069986715,0.08403244,0.10617416,0.25302583],"study_design_scores_gemma":[0.00024401928,0.00035699038,0.4242313,0.0032281152,0.0019396952,0.00057223334,0.011992113,0.0650391,0.0021332114,0.16651389,0.32320088,0.0005484766],"about_ca_topic_score_codex":0.93171495,"about_ca_topic_score_gemma":0.9479146,"teacher_disagreement_score":0.06828505,"about_ca_system_score_codex":0.030157186,"about_ca_system_score_gemma":0.05235892,"threshold_uncertainty_score":0.21880674},"labels":[],"label_agreement":null},{"id":"W4412442577","doi":"10.1016/j.jval.2025.04.1054","title":"HTA43 Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Value (mathematics); Medicine; Regional science; Geography; Statistics; Mathematics","score_opus":0.16059038748122936,"score_gpt":0.44281843525064984,"score_spread":0.28222804776942045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8342076,0.025092758,0.004146505,0.002273955,0.000252882,0.0006195461,0.12361501,0.00019491716,0.009596758],"genre_scores_gemma":[0.97083956,0.0027151331,0.0026036953,0.0004123453,0.00009689312,0.00016266378,0.020879623,0.00003105209,0.002259146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995184,0.0025663278,0.00018956943,0.00029853024,0.0013856181,0.00037586852],"domain_scores_gemma":[0.99006164,0.005024484,0.0018486739,0.0005357785,0.0019850787,0.0005444123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008090917,0.00056282064,0.0015332039,0.0019930084,0.00034685837,0.0017079195,0.0011476808,0.00075143203,0.004818358],"category_scores_gemma":[0.020383945,0.00037026708,0.005922627,0.0051686405,0.0005355888,0.0007293156,0.00091055874,0.0012038604,0.00031281915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07980317,0.0010121024,0.51826763,0.0053390483,0.077819645,0.00052019354,0.00040991942,0.0710116,0.0016405412,0.00867284,0.04486884,0.19063455],"study_design_scores_gemma":[0.003923376,0.0043262336,0.9156216,0.0008466066,0.031105213,0.0003167423,0.0003752884,0.021016488,0.0013740205,0.0011594994,0.019807061,0.00012793996],"about_ca_topic_score_codex":0.4263154,"about_ca_topic_score_gemma":0.3091425,"teacher_disagreement_score":0.5736846,"about_ca_system_score_codex":0.006885248,"about_ca_system_score_gemma":0.006291753,"threshold_uncertainty_score":0.84766793},"labels":[],"label_agreement":null},{"id":"W4412442605","doi":"10.1016/j.jval.2025.04.1188","title":"MSR36 Methods for Handling Non-Proportional Hazards in Economic Modeling","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Forecasting Techniques and Applications","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Computer science; Econometrics; Environmental science; Economics","score_opus":0.2781657839513743,"score_gpt":0.5524978219188288,"score_spread":0.2743320379674545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442605","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016264823,0.00055432215,0.99580705,0.00027335595,0.000109475266,0.00003687407,0.00023759092,0.0004654183,0.0008894023],"genre_scores_gemma":[0.099473275,0.0019997563,0.8825819,0.00039935973,0.00076008204,0.0007061855,0.0013893974,0.0009344311,0.011755626],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9941256,0.00417208,0.0003106848,0.0003624522,0.0008715906,0.00015743914],"domain_scores_gemma":[0.9780489,0.01710345,0.00082992663,0.002333323,0.0014616385,0.0002228213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0132592125,0.0011406412,0.0016636582,0.00247329,0.0006746864,0.0013784269,0.00283475,0.001511887,0.012790543],"category_scores_gemma":[0.0388371,0.00094710634,0.0031503325,0.002208414,0.0005973809,0.0017189581,0.0016131987,0.0035162752,0.0035435539],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025276045,0.00017889537,0.002065478,0.0004898385,0.0005947441,0.00019204995,0.00025366916,0.3824478,0.0013609454,0.25570416,0.01584618,0.3406135],"study_design_scores_gemma":[0.00005442489,0.000066294764,0.00038376835,0.00006414905,0.000065551605,0.000079532416,0.000021406022,0.8788556,0.00070779165,0.10357153,0.016093729,0.000036231908],"about_ca_topic_score_codex":0.0061866306,"about_ca_topic_score_gemma":0.0047676954,"teacher_disagreement_score":0.0132592125,"about_ca_system_score_codex":0.00087251264,"about_ca_system_score_gemma":0.0021696545,"threshold_uncertainty_score":0.0701223},"labels":[],"label_agreement":null},{"id":"W4412442610","doi":"10.1016/j.jval.2025.04.1514","title":"PCR197 Impact of Cirrhosis on Health-Related Quality of Life and Activity Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Steatohepatitis; Cirrhosis; Medicine; Quality of life (healthcare); Gerontology; Environmental health; Fatty liver; Internal medicine; Disease; Nursing","score_opus":0.01460210440658291,"score_gpt":0.27602931189764907,"score_spread":0.2614272074910662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938731,0.00058044924,0.00003056028,0.00037939183,0.000013218316,0.000012856319,0.0019440519,0.0000045994316,0.0031617736],"genre_scores_gemma":[0.99849737,0.00017739316,0.000026596885,0.00006967118,0.000007906823,0.0000041974963,0.0007386984,0.000002554978,0.0004757069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999368,0.000096772674,0.000039654416,0.00006641118,0.00013860485,0.00029063533],"domain_scores_gemma":[0.9988846,0.00009851929,0.00023548059,0.0000318551,0.00036538823,0.0003840002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039870705,0.00024078517,0.00035657117,0.0012058216,0.0009505108,0.0011947078,0.0005389207,0.00041475473,0.0023034764],"category_scores_gemma":[0.0016325449,0.00019804366,0.00086852006,0.0024182803,0.0005351257,0.00026477728,0.0006162011,0.0007653404,0.00019732345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006432003,0.000017675768,0.99822444,0.0000061780056,0.0000650596,0.000049454105,0.00007131402,0.00006647153,0.00003326394,0.000043745727,0.0002942558,0.0010638312],"study_design_scores_gemma":[0.0000036927663,0.000009314128,0.99952483,0.0000048244806,0.0000142575145,0.000020058249,0.00021428033,0.000059275586,0.000006453327,0.000005750841,0.00013480187,0.0000025018219],"about_ca_topic_score_codex":0.92473686,"about_ca_topic_score_gemma":0.93555486,"teacher_disagreement_score":0.07526314,"about_ca_system_score_codex":0.008070057,"about_ca_system_score_gemma":0.0064818147,"threshold_uncertainty_score":0.15141273},"labels":[],"label_agreement":null},{"id":"W4412442635","doi":"10.1016/j.jval.2025.04.1025","title":"HTA14 Empowering Healthcare Decision-Making: Leveraging Standardized Template for Enhanced Reliability and Efficiency in Budget Impact Analysis by Health Technology Assessment Agency","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Agency (philosophy); Reliability (semiconductor); Health care; Regulatory agency; Business; Risk analysis (engineering); Economics; Public administration; Political science; Economic growth","score_opus":0.14081713913385924,"score_gpt":0.48929138768468206,"score_spread":0.3484742485508228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442635","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011643987,0.00047854648,0.72179204,0.014689448,0.0016104465,0.006542723,0.028273562,0.051389735,0.16357954],"genre_scores_gemma":[0.09435532,0.00044153578,0.8359714,0.0030332245,0.0007162938,0.0042511756,0.019296978,0.008027149,0.033906933],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9627264,0.02152508,0.0046594557,0.0013023164,0.008493114,0.0012935274],"domain_scores_gemma":[0.82884055,0.089761265,0.0073466217,0.033641607,0.037671242,0.0027387624],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04349329,0.00073180767,0.0010454954,0.002463954,0.00094276556,0.0073886863,0.0024856334,0.0026822775,0.05746033],"category_scores_gemma":[0.19367936,0.0016433367,0.0016810689,0.0029730066,0.0010061556,0.004846104,0.0032700468,0.0028063543,0.021749903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056979025,0.0006407858,0.007121292,0.0007029984,0.00021215984,0.00023113651,0.0010744194,0.02159313,0.0020963382,0.088370524,0.47965536,0.39773208],"study_design_scores_gemma":[0.00062811497,0.0004379859,0.009316813,0.0013705576,0.0001579065,0.00024459392,0.00043968856,0.10519625,0.008204349,0.09927829,0.7744312,0.00029423146],"about_ca_topic_score_codex":0.012344904,"about_ca_topic_score_gemma":0.010720907,"teacher_disagreement_score":0.9565067,"about_ca_system_score_codex":0.0029027343,"about_ca_system_score_gemma":0.012252188,"threshold_uncertainty_score":0.23001724},"labels":[],"label_agreement":null},{"id":"W4412442771","doi":"10.1016/j.jval.2025.04.1044","title":"HTA33 Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Nice; Risk analysis (engineering); Computer science; Medicine","score_opus":0.44728133773571593,"score_gpt":0.4502847403448255,"score_spread":0.0030034026091095845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47300625,0.018228188,0.0281427,0.21869189,0.0033409998,0.010682867,0.05658845,0.002406106,0.18891247],"genre_scores_gemma":[0.9225369,0.002183986,0.03729504,0.022802198,0.00081976206,0.0036865852,0.0060249018,0.0003954097,0.0042552412],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9058254,0.067928605,0.004920842,0.0031659387,0.013800118,0.0043590777],"domain_scores_gemma":[0.6875604,0.2381537,0.023899877,0.009536821,0.02454921,0.016299993],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07009056,0.0007537629,0.0016767867,0.0022236693,0.0013096456,0.008486065,0.0027711277,0.00517731,0.020394552],"category_scores_gemma":[0.32359436,0.0008286842,0.0031133976,0.0035937866,0.0017316329,0.004720833,0.0051434725,0.005876259,0.0026379856],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032657668,0.0032181619,0.09281045,0.0054714126,0.0052549406,0.00022360956,0.0023084008,0.10340305,0.0006440781,0.044702686,0.24571513,0.4635904],"study_design_scores_gemma":[0.02177876,0.019315476,0.31573093,0.01456023,0.008378494,0.00035256226,0.004739724,0.21819195,0.0029577813,0.055,0.33793846,0.0010556135],"about_ca_topic_score_codex":0.07500351,"about_ca_topic_score_gemma":0.059078086,"teacher_disagreement_score":0.98618233,"about_ca_system_score_codex":0.013817648,"about_ca_system_score_gemma":0.033916097,"threshold_uncertainty_score":0.37067872},"labels":[],"label_agreement":null},{"id":"W4412442816","doi":"10.1016/j.jval.2025.04.398","title":"EE106 Pressures Behind the Rising Costs in Canadian Private Drug Plans: 2018-2023","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of Canada","funders":"","keywords":"Business; Drug; Natural resource economics; Economics; Pharmacology; Medicine","score_opus":0.06595050093101903,"score_gpt":0.3183061291014316,"score_spread":0.25235562817041257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442816","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13768193,0.013651448,0.0012819555,0.48638877,0.0038751964,0.00020381306,0.060152594,0.00034717083,0.29641712],"genre_scores_gemma":[0.74885625,0.011476548,0.0021426796,0.04730289,0.0023025325,0.00011996338,0.0143566495,0.00025805604,0.17318448],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9921996,0.00018872356,0.000106911786,0.00017282512,0.0048848246,0.002447081],"domain_scores_gemma":[0.9869135,0.0008563207,0.0007299204,0.00015183244,0.008642295,0.0027061831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030126772,0.00045691268,0.00045883132,0.0023641945,0.004210551,0.008957554,0.0010380464,0.0041909013,0.017791444],"category_scores_gemma":[0.016539846,0.00045256558,0.0012037543,0.0035840655,0.0013064047,0.0013996916,0.0016019813,0.00450874,0.0015658304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042781033,0.000077879144,0.03194987,0.0003305087,0.000118331314,0.00033030682,0.0009062814,0.0030143694,0.00077429146,0.123087324,0.7885807,0.050402276],"study_design_scores_gemma":[0.00007095968,0.00003446028,0.17171758,0.00035924144,0.00005980273,0.00010539086,0.0017032825,0.0023476689,0.00065169134,0.005928163,0.8169234,0.00009837373],"about_ca_topic_score_codex":0.9897119,"about_ca_topic_score_gemma":0.99316895,"teacher_disagreement_score":0.13702759,"about_ca_system_score_codex":0.13702759,"about_ca_system_score_gemma":0.18775328,"threshold_uncertainty_score":0.9942094},"labels":[],"label_agreement":null},{"id":"W4412442819","doi":"10.1016/j.jval.2025.04.1395","title":"PCR74 Utility of Mobile Health Applications, Wearable Devices, and Patient Generated Health Data in Menopause Research","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Wearable computer; Menopause; Wearable technology; Computer science; Data science; Medicine; Embedded system; Internal medicine","score_opus":0.21026169906963751,"score_gpt":0.5201982472269892,"score_spread":0.3099365481573516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442819","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6727693,0.021250887,0.09683967,0.015567074,0.0019851075,0.003991854,0.025474872,0.0037268824,0.15839434],"genre_scores_gemma":[0.8156362,0.005429679,0.13578585,0.00308832,0.000538017,0.001768826,0.004903373,0.00036836296,0.032481395],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9931859,0.003535969,0.0003410033,0.0006565204,0.0019410679,0.00033953716],"domain_scores_gemma":[0.9871098,0.008135959,0.00082204083,0.0005078785,0.003125796,0.00029863016],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00777658,0.00046044873,0.00035784784,0.002377739,0.00073138834,0.0030397782,0.0007415338,0.00079261087,0.0126370685],"category_scores_gemma":[0.020777017,0.00032841138,0.0007321293,0.0024212005,0.0005872356,0.0007077267,0.0009968295,0.00055085466,0.0032908327],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021299133,0.00068023684,0.1213432,0.001448772,0.00033920008,0.0005672345,0.0014866953,0.0015674263,0.023624547,0.0070549226,0.02215557,0.8176022],"study_design_scores_gemma":[0.0007349373,0.005638685,0.37089422,0.0029207591,0.0021853517,0.0031213155,0.008021715,0.034270354,0.19599791,0.017818615,0.35794187,0.0004543491],"about_ca_topic_score_codex":0.0060242726,"about_ca_topic_score_gemma":0.010765218,"teacher_disagreement_score":0.99222344,"about_ca_system_score_codex":0.0012840384,"about_ca_system_score_gemma":0.0025812984,"threshold_uncertainty_score":0.04227525},"labels":[],"label_agreement":null},{"id":"W4412442827","doi":"10.1016/j.jval.2025.04.424","title":"EE132 Creation of a Novel Canadian Policy Model for Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of British Columbia; University of Waterloo; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Computer science; Business; Cancer; Medicine; Internal medicine","score_opus":0.0708554990239001,"score_gpt":0.3963069757825291,"score_spread":0.325451476758629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442827","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026440695,0.0008002995,0.018313814,0.2936987,0.0016667484,0.0006588865,0.001575796,0.000310793,0.6565342],"genre_scores_gemma":[0.5418962,0.0011816887,0.041627377,0.07715989,0.00080608454,0.0006207182,0.00096323533,0.00025489504,0.33548996],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9854783,0.002330543,0.00022285657,0.0010994595,0.006726818,0.0041420576],"domain_scores_gemma":[0.98599213,0.0018260826,0.00029441726,0.0005239413,0.007088832,0.0042745983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01048032,0.0005874433,0.00045493455,0.0023590298,0.009747015,0.013582035,0.0030858214,0.0071859863,0.01422849],"category_scores_gemma":[0.018407945,0.0006449085,0.0012838023,0.0019009607,0.0047315094,0.0030007318,0.0038743087,0.008693129,0.0009424525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004829353,0.00007076647,0.0016590164,0.000043902495,0.000026579952,0.00016557304,0.0009110913,0.004865729,0.00038692955,0.86906904,0.11045459,0.012298489],"study_design_scores_gemma":[0.000114562245,0.000056161127,0.005376645,0.0002441686,0.00005216921,0.000120644305,0.0018672005,0.010387849,0.00063464924,0.104348205,0.8766145,0.00018321964],"about_ca_topic_score_codex":0.9701039,"about_ca_topic_score_gemma":0.982249,"teacher_disagreement_score":0.8459466,"about_ca_system_score_codex":0.1540534,"about_ca_system_score_gemma":0.36056668,"threshold_uncertainty_score":0.98117816},"labels":[],"label_agreement":null},{"id":"W4412442846","doi":"10.1016/j.jval.2025.04.731","title":"HPR7 Software as a Medical Device: Current Regulations in North America and Europe","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Esri (Canada)","funders":"","keywords":"Current (fluid); Software; Business; Computer science; Engineering; Electrical engineering; Operating system","score_opus":0.29829731337154536,"score_gpt":0.4503374318390006,"score_spread":0.15204011846745524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442846","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.111095004,0.06777088,0.046180476,0.08382001,0.0041201427,0.00077126425,0.011891539,0.006698177,0.6676526],"genre_scores_gemma":[0.56148106,0.03787975,0.07946769,0.10390768,0.0040600495,0.0031670323,0.023573661,0.004868729,0.1815943],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9667477,0.0047970703,0.0042101806,0.0037850507,0.018423473,0.0020366327],"domain_scores_gemma":[0.8751304,0.0664915,0.013001853,0.006986282,0.034688376,0.0037016037],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025493262,0.0004639319,0.0008124421,0.0051218527,0.0018365853,0.0084983595,0.0036230998,0.0070131305,0.009708393],"category_scores_gemma":[0.046963762,0.0006826411,0.0016193636,0.0043894765,0.0052967803,0.0032847293,0.0022867043,0.004795638,0.0045181406],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004662954,0.00050019275,0.024521822,0.001514402,0.000096571064,0.00053909887,0.0020514454,0.0021460422,0.0077883494,0.35482705,0.31385002,0.2916988],"study_design_scores_gemma":[0.00012147588,0.000275569,0.07225299,0.0036386836,0.00015811775,0.000919126,0.0008807135,0.0017361408,0.0067511457,0.016744731,0.89633274,0.00018866068],"about_ca_topic_score_codex":0.025456883,"about_ca_topic_score_gemma":0.015857494,"teacher_disagreement_score":0.025493262,"about_ca_system_score_codex":0.004495355,"about_ca_system_score_gemma":0.013414649,"threshold_uncertainty_score":0.1348229},"labels":[],"label_agreement":null},{"id":"W4412442860","doi":"10.1016/j.jval.2025.04.1411","title":"PCR91 Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Bendamustine; Idelalisib; Chronic lymphocytic leukemia; Rituximab; Ibrutinib; Bruton's tyrosine kinase; Medicine; Ofatumumab; Internal medicine; Immunology; Oncology; Lymphoma; Leukemia","score_opus":0.07727139236211535,"score_gpt":0.3782010551301899,"score_spread":0.3009296627680746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890121,0.0055879895,0.0002893346,0.00060553715,0.00016298587,0.00044198945,0.0014980498,0.00008075576,0.002321294],"genre_scores_gemma":[0.9906991,0.002303512,0.0007445635,0.00076140655,0.00020581999,0.0008276767,0.0025338633,0.000026912823,0.0018969934],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99915326,0.00050089014,0.00003412804,0.0001122881,0.000067232126,0.00013215639],"domain_scores_gemma":[0.9991571,0.00024736425,0.00022953063,0.000048308237,0.000044507324,0.00027324457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017607848,0.0010826978,0.0015688138,0.00029378597,0.0003188468,0.0011824961,0.00080955646,0.0009814126,0.0044589736],"category_scores_gemma":[0.0012786521,0.00037261817,0.002186809,0.00035949066,0.0007054359,0.0007628589,0.0004501424,0.003032515,0.00072033366],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88186103,0.006579661,0.0066488697,0.0010273207,0.0038116288,0.00010079478,0.0001184906,0.0022774963,0.009001142,0.00029388102,0.004059937,0.084219754],"study_design_scores_gemma":[0.7748388,0.18072388,0.032354128,0.00017454365,0.0032368076,0.00027997931,0.00011468225,0.0023128518,0.0016657916,0.00053756975,0.0036942188,0.00006677928],"about_ca_topic_score_codex":0.0009179697,"about_ca_topic_score_gemma":0.002338848,"teacher_disagreement_score":0.0044589736,"about_ca_system_score_codex":0.0010204245,"about_ca_system_score_gemma":0.000966159,"threshold_uncertainty_score":0.014916718},"labels":[],"label_agreement":null},{"id":"W4412442870","doi":"10.1016/j.jval.2025.04.1074","title":"HTA63 Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Manufacturing Process and Optimization","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Cost-minimization analysis; Minification; Actuarial science; Business; Computer science; Economics; Medicine; Internal medicine; World Wide Web; Economic growth; Health care","score_opus":0.10668303668197975,"score_gpt":0.35785272257686135,"score_spread":0.2511696858948816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3754051,0.096036695,0.05460722,0.10878793,0.009085271,0.0016226664,0.061877687,0.009120777,0.28345668],"genre_scores_gemma":[0.8139353,0.026990496,0.05785132,0.015458578,0.009309217,0.00060550094,0.03726794,0.0028009044,0.03578082],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.96490854,0.013389248,0.0031965962,0.0021822273,0.015143311,0.0011801415],"domain_scores_gemma":[0.70881903,0.13948219,0.02775285,0.005892291,0.10875605,0.009297633],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.038734205,0.00065661216,0.0011633553,0.006775111,0.0011863383,0.008473237,0.001578265,0.0014367871,0.018783137],"category_scores_gemma":[0.18017441,0.0005101774,0.002137956,0.005559188,0.00081045955,0.0022661197,0.0017651342,0.002283922,0.006046003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023042937,0.00063477346,0.08527196,0.002349519,0.0007724279,0.0004383426,0.0007932724,0.009992119,0.0024717066,0.016408138,0.30921933,0.56934416],"study_design_scores_gemma":[0.00058086024,0.0015631086,0.35887545,0.00718705,0.0006643788,0.0018086551,0.0018748809,0.046450272,0.008401199,0.011739034,0.5604722,0.00038290577],"about_ca_topic_score_codex":0.008623343,"about_ca_topic_score_gemma":0.0068952353,"teacher_disagreement_score":0.99406284,"about_ca_system_score_codex":0.0059371362,"about_ca_system_score_gemma":0.007750558,"threshold_uncertainty_score":0.20484853},"labels":[],"label_agreement":null},{"id":"W4412442873","doi":"10.1016/j.jval.2025.04.1388","title":"PCR67 Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Outcome (game theory); Scaling; Computer science; Medicine; Physical therapy; Mathematics","score_opus":0.5023063607248556,"score_gpt":0.610520864269291,"score_spread":0.1082145035444354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.669345,0.000828265,0.2326009,0.0024843698,0.00084222056,0.010827794,0.0039938064,0.0031680455,0.07590956],"genre_scores_gemma":[0.7327443,0.0002787851,0.24902363,0.0007006321,0.00008955535,0.0070326263,0.0016006519,0.00034352508,0.008186335],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9760393,0.014249928,0.0011426347,0.0012533093,0.00673197,0.0005829632],"domain_scores_gemma":[0.9140918,0.06441719,0.0036258942,0.0053540883,0.011361434,0.0011495075],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029885117,0.0007385904,0.0006438798,0.0014166705,0.00074938714,0.003577614,0.001120197,0.0011689984,0.0134662995],"category_scores_gemma":[0.09737561,0.00055036315,0.0014863429,0.0013186502,0.0006771284,0.0017558694,0.0021394773,0.0015914494,0.0029374156],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006823959,0.007283986,0.11044259,0.0017660571,0.00072960864,0.00013752498,0.0023095878,0.007829947,0.010313918,0.01704294,0.015186427,0.82013345],"study_design_scores_gemma":[0.0052561536,0.054237943,0.348037,0.0024830536,0.0032923473,0.00087160966,0.0064056385,0.30709627,0.12729356,0.04183564,0.10226674,0.0009240575],"about_ca_topic_score_codex":0.0018856253,"about_ca_topic_score_gemma":0.0015865972,"teacher_disagreement_score":0.9701149,"about_ca_system_score_codex":0.001042091,"about_ca_system_score_gemma":0.0032309487,"threshold_uncertainty_score":0.15804946},"labels":[],"label_agreement":null},{"id":"W4412442879","doi":"10.1016/j.jval.2025.04.1941","title":"EE342 Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Observational study; Medicine; Liver dysfunction; Health care; Liver disease; Disease; Intensive care medicine; Environmental health; Internal medicine; Economics; Economic growth","score_opus":0.18819265237134516,"score_gpt":0.3493950312016761,"score_spread":0.16120237883033092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9419007,0.002362808,0.00021908573,0.0010258501,0.00005068579,0.00017802577,0.049541626,0.000027536185,0.004693762],"genre_scores_gemma":[0.98547924,0.0013219004,0.00033789873,0.0003909599,0.000024100045,0.00010404664,0.009779201,0.0000148926465,0.0025477456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808085,0.00018456447,0.0002388346,0.00025769294,0.00056730764,0.000670798],"domain_scores_gemma":[0.9943487,0.00031640226,0.0015556349,0.00023862053,0.0022399486,0.0013007012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007313511,0.00063571753,0.00093924155,0.0018382557,0.0027888916,0.0019787531,0.0020480119,0.0010132915,0.0034154966],"category_scores_gemma":[0.004308305,0.0009360862,0.00206126,0.008703255,0.000750177,0.00073394313,0.0013300078,0.0015400802,0.0004043292],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014221581,0.000057747697,0.99495643,0.000100212215,0.0002522864,0.000084885636,0.0002680138,0.00018868226,0.00006792703,0.00016631265,0.0023087075,0.0014064745],"study_design_scores_gemma":[0.000034218698,0.00002276142,0.99749833,0.00009171645,0.00009778913,0.00004973339,0.0006066214,0.00037909733,0.00002534403,0.0000342439,0.001141519,0.000018691882],"about_ca_topic_score_codex":0.9979705,"about_ca_topic_score_gemma":0.9984402,"teacher_disagreement_score":0.05079309,"about_ca_system_score_codex":0.05079309,"about_ca_system_score_gemma":0.06508436,"threshold_uncertainty_score":0.3685314},"labels":[],"label_agreement":null},{"id":"W4412442946","doi":"10.1016/j.jval.2025.04.1405","title":"PCR84 Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Oncology; Medicine; Breast cancer; Internal medicine; Cancer; Epidermal growth factor receptor; Cancer research","score_opus":0.053677189279302526,"score_gpt":0.28247372324823516,"score_spread":0.22879653396893262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703372,0.00057546323,0.00011028008,0.0019517527,0.00002300453,0.000035699737,0.014153386,0.000008357583,0.012804792],"genre_scores_gemma":[0.9959396,0.000194925,0.00006639412,0.00012233733,0.000007582414,0.0000069268503,0.002403737,0.0000023847886,0.001256064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923563,0.00008481032,0.0000421373,0.00005783925,0.0002362254,0.00034336685],"domain_scores_gemma":[0.996664,0.0004426072,0.00061860867,0.00006237005,0.0012928322,0.00091954326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005537967,0.0002409379,0.0003150378,0.00092086446,0.0014006164,0.0014335227,0.00073731085,0.00057518785,0.0049999948],"category_scores_gemma":[0.006325132,0.00015966069,0.0007505113,0.003626212,0.00046200844,0.00034734132,0.00053220673,0.0012188375,0.0003634142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041276112,0.00012396777,0.9764263,0.000043216853,0.000093288414,0.00019426443,0.00045861665,0.0027393885,0.000080997685,0.0015057237,0.0077964873,0.010125067],"study_design_scores_gemma":[0.00003931147,0.000075142576,0.9886939,0.000041865125,0.000054450673,0.00017399457,0.0012987925,0.0045627574,0.00008071676,0.00046937697,0.0044690426,0.000040651357],"about_ca_topic_score_codex":0.9826058,"about_ca_topic_score_gemma":0.9831383,"teacher_disagreement_score":0.038734112,"about_ca_system_score_codex":0.038734112,"about_ca_system_score_gemma":0.020978652,"threshold_uncertainty_score":0.2810369},"labels":[],"label_agreement":null},{"id":"W4412442958","doi":"10.1016/j.jval.2025.04.1017","title":"HTA6 Real-World Evidence (RWE) in Health Technology Assessment (HTA): Global Guidelines on the Use of RWE in Evidence Generation for HTA Evaluation","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Esri (Canada)","funders":"","keywords":"Real world evidence; Health technology; Medicine; Business; Risk analysis (engineering); Health care; Economic growth; Internal medicine; Economics","score_opus":0.8745974336899165,"score_gpt":0.5982575559383363,"score_spread":0.2763398777515802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442958","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020118929,0.21202993,0.40657136,0.13074797,0.016815037,0.04641605,0.085972205,0.00828845,0.09114703],"genre_scores_gemma":[0.019575939,0.073643304,0.7735051,0.038958106,0.00450442,0.055196833,0.020192906,0.0038114754,0.010611849],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.61339736,0.25575322,0.092067406,0.004193443,0.031714927,0.0028736878],"domain_scores_gemma":[0.2893309,0.5848768,0.038975738,0.024813684,0.05760257,0.0044003874],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21641381,0.0033333045,0.010748555,0.01348344,0.002697746,0.015463175,0.009541578,0.022647453,0.05003535],"category_scores_gemma":[0.6092466,0.0053150654,0.029500645,0.018643076,0.005915803,0.007062852,0.0123243,0.024870755,0.020824743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017722753,0.00024241995,0.0012887806,0.16123262,0.009797595,0.00053843675,0.0028343862,0.0036191484,0.00073989003,0.06580925,0.41206664,0.34005857],"study_design_scores_gemma":[0.00328685,0.00046489938,0.004676236,0.28766266,0.011385916,0.0007415424,0.0005493517,0.0037948273,0.0019264492,0.10217322,0.5828402,0.0004978722],"about_ca_topic_score_codex":0.007980343,"about_ca_topic_score_gemma":0.008503267,"teacher_disagreement_score":0.7835862,"about_ca_system_score_codex":0.0058039105,"about_ca_system_score_gemma":0.026759624,"threshold_uncertainty_score":0.96630126},"labels":[],"label_agreement":null},{"id":"W4412442996","doi":"10.1016/j.jval.2025.04.337","title":"EE45 Economic and Healthcare Impacts of Public Funding for Intermittent Catheters in Nova Scotia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cosmetic and Laser Surgery; Government of Canada; McMaster University","funders":"","keywords":"Nova scotia; Nova (rocket); Health care; Business; Medicine; Political science; Economic growth; Economics; Geography; Engineering; Aeronautics; Archaeology","score_opus":0.4846556010325948,"score_gpt":0.4636928838564241,"score_spread":0.02096271717617071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96615314,0.0011681981,0.000059098395,0.009939286,0.00012522732,0.000066607514,0.009174069,0.000009514077,0.013304941],"genre_scores_gemma":[0.9852402,0.00069859816,0.00008684172,0.0010936551,0.000058553684,0.00004053648,0.0019875898,0.000005789616,0.010788262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775827,0.0005587921,0.000120417695,0.00007301815,0.00049419346,0.0009953716],"domain_scores_gemma":[0.9917578,0.0023252394,0.0017729505,0.00016246522,0.001907478,0.0020741064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015675626,0.00012879264,0.0002092028,0.0010444247,0.00065929315,0.00212688,0.00051746774,0.0011844723,0.003914768],"category_scores_gemma":[0.011500829,0.00019215878,0.0005109783,0.0012700193,0.00058540463,0.00028324965,0.0014723346,0.0009374848,0.00022856092],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018712383,0.00043320228,0.9138403,0.00033653216,0.0003447409,0.002449775,0.001093967,0.0056882035,0.00080013246,0.0059188525,0.038068067,0.029155096],"study_design_scores_gemma":[0.000069897505,0.00006262597,0.99289286,0.00008622757,0.00003285354,0.00010895374,0.0010021101,0.0012118991,0.000080063786,0.00015031215,0.004289296,0.00001285371],"about_ca_topic_score_codex":0.9010384,"about_ca_topic_score_gemma":0.9317775,"teacher_disagreement_score":0.09896159,"about_ca_system_score_codex":0.02088723,"about_ca_system_score_gemma":0.024452431,"threshold_uncertainty_score":0.19908875},"labels":[],"label_agreement":null},{"id":"W4412443002","doi":"10.1016/j.jval.2025.04.1015","title":"HTA4 The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.7805227888960862,"score_gpt":0.6676755933455265,"score_spread":0.11284719555055966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013296603,0.9733331,0.0044418764,0.0108598005,0.0007184594,0.0015435793,0.003933654,0.000030507934,0.0038094812],"genre_scores_gemma":[0.04265149,0.92147785,0.019619122,0.006722799,0.00041499312,0.006731049,0.0014869103,0.00008048976,0.0008153394],"study_design_codex":"systematic_review","study_design_gemma":"qualitative","domain_scores_codex":[0.8824322,0.07596001,0.020061659,0.0028996898,0.017069098,0.0015773062],"domain_scores_gemma":[0.57320017,0.37158835,0.01520772,0.0042533996,0.034716893,0.0010334273],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.14885354,0.0014951719,0.0053012036,0.018677523,0.0024591251,0.008534258,0.0036864688,0.002564963,0.009311618],"category_scores_gemma":[0.40914658,0.0012107614,0.007591608,0.028075758,0.0034801334,0.004752303,0.005663218,0.0042677317,0.0006115888],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051027426,0.000046639172,0.0016672935,0.6018941,0.0046810615,0.00006971127,0.0048280037,0.0008759995,0.00022612089,0.021040605,0.022878721,0.3412815],"study_design_scores_gemma":[0.00019829127,0.00007511137,0.003104798,0.8860502,0.0062154946,0.000089507725,0.0024690046,0.000312,0.0003505509,0.008132357,0.09289879,0.00010387782],"about_ca_topic_score_codex":0.14946768,"about_ca_topic_score_gemma":0.23053221,"teacher_disagreement_score":0.9648019,"about_ca_system_score_codex":0.035198107,"about_ca_system_score_gemma":0.09501975,"threshold_uncertainty_score":0.78722215},"labels":[],"label_agreement":null},{"id":"W4412443009","doi":"10.1016/j.jval.2025.04.1166","title":"MSR13 TransportHealth: A Novel, Flexible, Open-Source R Package for Transportability and Generalizability Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Simon Fraser University; Centre for Advancing Health Outcomes","funders":"","keywords":"Generalizability theory; Computer science; Open source; Programming language; Psychology; Software","score_opus":0.05653228051721084,"score_gpt":0.3679502064654591,"score_spread":0.3114179259482483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443009","genre_codex":"methods","genre_gemma":"software","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"software","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008907867,0.0009308525,0.5816137,0.0013816089,0.000526994,0.00081552094,0.12646942,0.27475175,0.004602147],"genre_scores_gemma":[0.10040594,0.0010316935,0.62727064,0.0021287978,0.00045449942,0.0058801565,0.076291,0.1760771,0.010460177],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99381846,0.0034042937,0.0006687217,0.001131774,0.00072439405,0.00025230495],"domain_scores_gemma":[0.95805854,0.03394469,0.0017508329,0.004022246,0.001748075,0.00047564416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011773743,0.0031088768,0.002465336,0.0025868583,0.00065329205,0.003251508,0.0033104823,0.0012502553,0.070079684],"category_scores_gemma":[0.090437844,0.0019730332,0.005274052,0.0023651347,0.00084868463,0.001988602,0.004204028,0.0030530856,0.025576167],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019374196,0.00026586224,0.028123775,0.0059024766,0.008769284,0.0009778081,0.0012608069,0.03380844,0.0034015146,0.02704493,0.68094856,0.20755912],"study_design_scores_gemma":[0.0035632274,0.00063943263,0.02358801,0.0017270463,0.0045370962,0.0018546834,0.0004517712,0.225748,0.011903931,0.14025135,0.5850206,0.00071492454],"about_ca_topic_score_codex":0.006388584,"about_ca_topic_score_gemma":0.010426857,"teacher_disagreement_score":0.070079684,"about_ca_system_score_codex":0.0008742028,"about_ca_system_score_gemma":0.0042366516,"threshold_uncertainty_score":0.23443991},"labels":[],"label_agreement":null},{"id":"W4412443090","doi":"10.1016/j.jval.2025.04.1393","title":"PCR72 Optimizing Communication Strategies for COPD Management: Effectiveness of Educational Video and Pamphlet Interventions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Nursing Diagnosis and Documentation","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Psychological intervention; COPD; Medicine; Computer science; Nursing; Internal medicine","score_opus":0.04200459058565332,"score_gpt":0.39959304473836554,"score_spread":0.35758845415271223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762649,0.0027327249,0.002405409,0.00090980215,0.00039885213,0.0014773611,0.0006216465,0.00046216502,0.014727114],"genre_scores_gemma":[0.9810923,0.001757151,0.0072146254,0.0004714621,0.0002798282,0.0010412429,0.00043986732,0.000046335907,0.0076572318],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9989203,0.00054713996,0.00006419322,0.00014883299,0.00020199767,0.00011754249],"domain_scores_gemma":[0.99614245,0.0026809056,0.00036560834,0.00010423166,0.0002804425,0.00042633578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013882847,0.00056328595,0.00087849225,0.0006015572,0.00041823095,0.0006506345,0.0006050631,0.0008588003,0.01901358],"category_scores_gemma":[0.010944727,0.00017938903,0.00046807234,0.0003718545,0.00012366797,0.0006909467,0.0004762273,0.0008043994,0.0013005151],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039168086,0.027842341,0.0036585503,0.0020403382,0.00024696498,0.00012496638,0.0005249954,0.0011318636,0.0036326733,0.00017720544,0.0039439783,0.9175081],"study_design_scores_gemma":[0.07845187,0.49388644,0.29174042,0.0067542037,0.00580192,0.0013268137,0.0045279223,0.034473754,0.03893657,0.0016949455,0.041982513,0.0004227152],"about_ca_topic_score_codex":0.0026710313,"about_ca_topic_score_gemma":0.0023082297,"teacher_disagreement_score":0.01901358,"about_ca_system_score_codex":0.0005494456,"about_ca_system_score_gemma":0.0013147629,"threshold_uncertainty_score":0.0636068},"labels":[],"label_agreement":null},{"id":"W4412443105","doi":"10.1016/j.jval.2025.04.721","title":"PT29 Increased Incidence of Parkinson Disease Associated with Antiseizure Medication Use","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Incidence (geometry); Medicine; Parkinson's disease; Disease; Intensive care medicine; Internal medicine; Mathematics","score_opus":0.08512808076206865,"score_gpt":0.4010828595814415,"score_spread":0.31595477881937284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864442,0.002060738,0.00028471168,0.00023725204,0.000042443746,0.000020902893,0.0029273662,0.000030647276,0.0079517625],"genre_scores_gemma":[0.9969879,0.00046960916,0.00014276491,0.00005149511,0.00003292583,0.0000057042657,0.00079028966,0.000006233883,0.0015131402],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992907,0.00014218203,0.000087082975,0.00013860204,0.00022940004,0.000112006084],"domain_scores_gemma":[0.9964508,0.0006620542,0.0018383162,0.00019790798,0.00034101692,0.00050989666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034557213,0.00017173473,0.0002826877,0.0010634384,0.00036030245,0.0007446368,0.00027371332,0.0003899643,0.009739842],"category_scores_gemma":[0.0031157148,0.00014234796,0.0006563169,0.0016485404,0.00017545088,0.00032395864,0.00043041472,0.000985089,0.0007440733],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055970054,0.00007415708,0.9857817,0.00007413969,0.00016963719,0.0004944437,0.00004558166,0.000038609138,0.0010376114,0.00006690007,0.00039136197,0.011266217],"study_design_scores_gemma":[0.000005188739,0.00009346837,0.99818677,0.00001048476,0.000053334385,0.00079884176,0.00003420005,0.00009020307,0.0001644437,0.00003964934,0.0005208397,0.0000025659212],"about_ca_topic_score_codex":0.005554432,"about_ca_topic_score_gemma":0.004088613,"teacher_disagreement_score":0.009739842,"about_ca_system_score_codex":0.0003912909,"about_ca_system_score_gemma":0.0004509064,"threshold_uncertainty_score":0.032583058},"labels":[],"label_agreement":null},{"id":"W4412443161","doi":"10.1016/j.jval.2025.04.1547","title":"PCR230 Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Phase (matter); Physical medicine and rehabilitation; Physical therapy; Pediatrics; Internal medicine; Physics","score_opus":0.012332178577988538,"score_gpt":0.2777343353976588,"score_spread":0.2654021568196703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998264,0.0005297307,0.00006295431,0.00005508795,0.000009169127,0.000048346184,0.00065325416,0.0000061888063,0.00037131546],"genre_scores_gemma":[0.99788123,0.00018872075,0.000099021556,0.00010423412,0.0000130901235,0.0000746273,0.0013655224,0.0000043635846,0.00026910022],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99913174,0.00041703042,0.00006306302,0.00015188775,0.00012527316,0.000111076086],"domain_scores_gemma":[0.99867177,0.00041853014,0.00042514212,0.00006290259,0.00011786881,0.00030382755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019177592,0.00067228236,0.0011374007,0.00023227808,0.00039587962,0.00092575926,0.00044880647,0.0007608631,0.001428577],"category_scores_gemma":[0.0016720186,0.00021771665,0.0012899756,0.00039741007,0.00050364924,0.00047965118,0.0003655846,0.00081408146,0.00028416552],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3557087,0.006799041,0.5471409,0.00053161674,0.0074193603,0.0008793881,0.00055002375,0.002937767,0.01820696,0.00020831698,0.0024592965,0.057158682],"study_design_scores_gemma":[0.032193366,0.07333957,0.8853245,0.000064798034,0.0033782998,0.00063906715,0.000333614,0.0011552622,0.0020257488,0.00020635904,0.0012534256,0.000086112384],"about_ca_topic_score_codex":0.0020821742,"about_ca_topic_score_gemma":0.0026325353,"teacher_disagreement_score":0.0020821742,"about_ca_system_score_codex":0.0008503526,"about_ca_system_score_gemma":0.0005522499,"threshold_uncertainty_score":0.010142207},"labels":[],"label_agreement":null},{"id":"W4412443185","doi":"10.1016/j.jval.2025.04.1898","title":"EE299 Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; ROS1; Oncology; Internal medicine; Lung cancer; Cancer; Adenocarcinoma","score_opus":0.026787791570512417,"score_gpt":0.37073762019562845,"score_spread":0.343949828625116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9361246,0.007117263,0.0015448874,0.008320919,0.0003036745,0.0002767681,0.025665244,0.0002531671,0.02039348],"genre_scores_gemma":[0.986264,0.0015612008,0.00036972814,0.0012868561,0.000092322,0.00006658004,0.005454432,0.000017973998,0.0048870416],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9995659,0.00015214486,0.000043851538,0.00006434439,0.00008353532,0.00009022215],"domain_scores_gemma":[0.9995067,0.00016600074,0.00016132086,0.000012666054,0.000033431163,0.00011975528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050123973,0.00023869642,0.0003604397,0.00035932107,0.00014876568,0.0007062669,0.00035840247,0.00048122846,0.0069994554],"category_scores_gemma":[0.0017157503,0.00014218326,0.0019083659,0.00045091478,0.00015931259,0.0005104038,0.00038754076,0.0009854743,0.0007178409],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046866104,0.0018011448,0.28682047,0.0017202155,0.0039558127,0.002007781,0.00015706685,0.055221938,0.0066677323,0.0080338055,0.08943936,0.49730852],"study_design_scores_gemma":[0.007938687,0.014914167,0.83998716,0.0007249166,0.004799764,0.0047750645,0.0007165756,0.055290148,0.0043749386,0.005403186,0.06095521,0.00012024961],"about_ca_topic_score_codex":0.011666743,"about_ca_topic_score_gemma":0.014189225,"teacher_disagreement_score":0.011666743,"about_ca_system_score_codex":0.002273919,"about_ca_system_score_gemma":0.0014196383,"threshold_uncertainty_score":0.023415565},"labels":[],"label_agreement":null},{"id":"W4412443194","doi":"10.1016/j.jval.2025.04.733","title":"HPR9 From Data to Actionable Insight: A Collaborative Monitoring & Evaluation (M&E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Agency (philosophy); Medicine; Business; Sociology","score_opus":0.13151000977082555,"score_gpt":0.3770333245496041,"score_spread":0.24552331477877853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443194","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01780476,0.0022346787,0.029558524,0.31951892,0.006735376,0.010138573,0.29911852,0.013172555,0.30171803],"genre_scores_gemma":[0.18034272,0.0036099385,0.23232909,0.116096385,0.002361731,0.006679067,0.22725177,0.00765141,0.22367787],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9486664,0.02064585,0.003356007,0.002670197,0.02166234,0.0029992217],"domain_scores_gemma":[0.85504544,0.066570476,0.007837056,0.014517496,0.04221391,0.0138156535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.076216616,0.0007179357,0.00078787387,0.002462159,0.0019606731,0.010158806,0.0033317332,0.0027600466,0.06746411],"category_scores_gemma":[0.12999521,0.0010271501,0.0008909001,0.0027481278,0.0012821796,0.0030347896,0.0071447743,0.0044624237,0.014779387],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007641654,0.00019471085,0.0054959394,0.0005103743,0.00008610555,0.000172951,0.0004819919,0.00022550997,0.00093888957,0.005383235,0.89200085,0.093745194],"study_design_scores_gemma":[0.000589781,0.00021188273,0.011925823,0.0007820299,0.00007731695,0.00007048327,0.0007832469,0.0019523507,0.0031867286,0.0041670315,0.97619325,0.000060040304],"about_ca_topic_score_codex":0.17286557,"about_ca_topic_score_gemma":0.26181138,"teacher_disagreement_score":0.9893421,"about_ca_system_score_codex":0.0106578795,"about_ca_system_score_gemma":0.06610107,"threshold_uncertainty_score":0.40307683},"labels":[],"label_agreement":null},{"id":"W4412443207","doi":"10.1016/j.jval.2025.04.2140","title":"PT39 Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; McMaster University","funders":"","keywords":"Quality (philosophy); Business; Medicine; Environmental health","score_opus":0.03039165845495346,"score_gpt":0.3784252633777155,"score_spread":0.34803360492276203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443207","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08699045,0.011440212,0.078254685,0.49357852,0.006837771,0.008310487,0.028053433,0.005443839,0.2810905],"genre_scores_gemma":[0.6320962,0.008309151,0.21563166,0.05061526,0.001309066,0.003058527,0.017718056,0.0014435076,0.06981856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.878787,0.031149115,0.01212135,0.0047229375,0.061242484,0.011977196],"domain_scores_gemma":[0.4276847,0.043361172,0.019579843,0.020493064,0.4338588,0.055022445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.091490656,0.0005236496,0.00093597465,0.010867704,0.0076855016,0.015733654,0.0069341417,0.0036457272,0.009081587],"category_scores_gemma":[0.23491348,0.0011062956,0.001397625,0.011281642,0.0038975913,0.0031882385,0.0065850755,0.0039113145,0.0015580299],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002695635,0.00035622058,0.12578568,0.0013034955,0.00022056405,0.00060007954,0.006269922,0.00611665,0.0015576477,0.0631147,0.51833284,0.2760727],"study_design_scores_gemma":[0.0002224107,0.0002218418,0.30417043,0.0042493637,0.00016705845,0.0006031303,0.0062455256,0.010201823,0.002395269,0.013315992,0.65778196,0.00042522696],"about_ca_topic_score_codex":0.9727278,"about_ca_topic_score_gemma":0.9720281,"teacher_disagreement_score":0.8624381,"about_ca_system_score_codex":0.13756192,"about_ca_system_score_gemma":0.56300116,"threshold_uncertainty_score":0.9980862},"labels":[],"label_agreement":null},{"id":"W4412443222","doi":"10.1016/j.jval.2025.04.640","title":"EPH109 Association of Cognitive Impairment With Benzodiazepine Use in the U.S.: An Analysis of Medical Expenditure Panel Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medical Expenditure Panel Survey; Association (psychology); Benzodiazepine; Cognitive impairment; Cognition; Psychology; Medicine; Psychiatry; Clinical psychology; Economics; Internal medicine; Psychotherapist","score_opus":0.09669738816828798,"score_gpt":0.36153233569651294,"score_spread":0.26483494752822495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990045,0.0005414276,0.00006512109,0.00021927014,0.000013474377,0.000007952992,0.0077834046,0.000005456938,0.0013188832],"genre_scores_gemma":[0.9951072,0.00025554132,0.000046646393,0.000097328724,0.000014815368,0.0000075361118,0.004101338,0.0000019170159,0.0003676864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999529,0.00016403709,0.00008772673,0.00006008413,0.00008619674,0.000073006675],"domain_scores_gemma":[0.99833703,0.00032850663,0.0008088746,0.00013546094,0.0002078634,0.00018217452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005840902,0.00017127927,0.00026906942,0.00092336885,0.00020221599,0.00047804273,0.0003039603,0.0004055999,0.001377543],"category_scores_gemma":[0.0016909514,0.00021815697,0.00071061216,0.00213894,0.00013879061,0.00030263796,0.00040978554,0.0005661886,0.00021290683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007860789,0.000024665087,0.9984629,0.000013164388,0.00019377517,0.000027513559,0.0000150519345,0.0000715673,0.000050545514,0.000022272725,0.0004892647,0.0005506418],"study_design_scores_gemma":[0.0000024163755,0.000010025326,0.9996997,0.0000039695183,0.000023006774,0.000020963995,0.000026932938,0.000067902816,0.000010608879,0.0000055468113,0.00012789204,0.000001147202],"about_ca_topic_score_codex":0.05090481,"about_ca_topic_score_gemma":0.070741765,"teacher_disagreement_score":0.05090481,"about_ca_system_score_codex":0.0003106662,"about_ca_system_score_gemma":0.00034743358,"threshold_uncertainty_score":0.10121703},"labels":[],"label_agreement":null},{"id":"W4412443224","doi":"10.1016/j.jval.2025.04.1913","title":"EE314 Cost-Effectiveness Analysis of HIV Prevention and Treatment Portfolios in US Prison Settings","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Criminal Justice and Corrections Analysis","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ivey Foundation; Western University","funders":"","keywords":"Prison; Human immunodeficiency virus (HIV); Medicine; Actuarial science; Business; Psychology; Family medicine; Criminology","score_opus":0.041448652643138656,"score_gpt":0.3918457593222411,"score_spread":0.3503971066791024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97249526,0.0036667224,0.0041979863,0.0012683679,0.00006544096,0.0013000781,0.0072471956,0.00011865455,0.009640298],"genre_scores_gemma":[0.99565166,0.00048284,0.0015634806,0.00008215476,0.000017195318,0.00020465652,0.0012293112,0.000006663124,0.0007619817],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9933296,0.005397001,0.00023987515,0.0002104367,0.00037614343,0.00044683943],"domain_scores_gemma":[0.990967,0.007263425,0.0005942031,0.00031952944,0.00056225894,0.00029347072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075558065,0.00072339043,0.0011557009,0.0023219495,0.00031609257,0.0014080892,0.0007464485,0.0006985741,0.0062914463],"category_scores_gemma":[0.024268286,0.0004185654,0.0030694648,0.0021827237,0.00034189556,0.0010989269,0.0009938537,0.0008587697,0.0002146324],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045794148,0.0049099503,0.13822916,0.002298841,0.011432805,0.00037333305,0.00017945,0.5548943,0.0011757989,0.008245687,0.008049718,0.2244168],"study_design_scores_gemma":[0.009995325,0.037565142,0.31652346,0.0011937758,0.016165439,0.00057028845,0.0012661781,0.5958563,0.0032681285,0.008405052,0.00897937,0.00021158204],"about_ca_topic_score_codex":0.026736649,"about_ca_topic_score_gemma":0.018266898,"teacher_disagreement_score":0.026736649,"about_ca_system_score_codex":0.005229092,"about_ca_system_score_gemma":0.0035058165,"threshold_uncertainty_score":0.05316204},"labels":[],"label_agreement":null},{"id":"W4412443247","doi":"10.1016/j.jval.2025.04.1877","title":"EE278 A Systematic Scoping Review of Published Economic Analyses of Public Cord Blood Banking: Is It Time to Re-Assess?","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Ottawa Hospital","funders":"","keywords":"Cord blood; Business; Economics; Medicine; Internal medicine","score_opus":0.1833499891098888,"score_gpt":0.44966082932872176,"score_spread":0.26631084021883294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443247","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00552303,0.9745015,0.0018500079,0.006521369,0.0014895543,0.0035462696,0.0038649954,0.000053493575,0.0026498004],"genre_scores_gemma":[0.13028857,0.8310147,0.010293888,0.013632375,0.0012976779,0.008761696,0.0034573292,0.00011876394,0.0011350397],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.8849762,0.05898027,0.039082255,0.003406587,0.011820269,0.0017344843],"domain_scores_gemma":[0.634308,0.2858526,0.0415296,0.009476431,0.02728888,0.0015446077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09267438,0.0021694242,0.009083702,0.016506039,0.0013621302,0.007826523,0.0029787123,0.004474527,0.010799798],"category_scores_gemma":[0.37949052,0.0022198893,0.014542396,0.012618548,0.0020486885,0.0046903407,0.0043587177,0.0034549087,0.0009568636],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009403365,0.000043495646,0.0022097435,0.88164973,0.07142021,0.00014445481,0.0005004388,0.0001491023,0.00020036352,0.0010600009,0.00493872,0.0367434],"study_design_scores_gemma":[0.00069659296,0.00013025735,0.0037010752,0.8565688,0.12018719,0.00011260209,0.00035562238,0.00011236684,0.000137253,0.0011245293,0.016818967,0.000054816104],"about_ca_topic_score_codex":0.01433158,"about_ca_topic_score_gemma":0.048816115,"teacher_disagreement_score":0.09267438,"about_ca_system_score_codex":0.008894172,"about_ca_system_score_gemma":0.028663538,"threshold_uncertainty_score":0.4901148},"labels":[],"label_agreement":null},{"id":"W4412443264","doi":"10.1016/j.jval.2025.04.1100","title":"HTA89 Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Predicate (mathematical logic); Oncology; Family medicine; Internal medicine; Medical physics; Computer science; Mathematics","score_opus":0.3230237608809736,"score_gpt":0.4972436110623803,"score_spread":0.17421985018140668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81738836,0.0020062868,0.0018168936,0.024677796,0.00013271594,0.00034224367,0.048756577,0.000111918445,0.10476717],"genre_scores_gemma":[0.98701805,0.00025307015,0.0005512904,0.00076318305,0.000027888615,0.00003795724,0.004972949,0.000019294734,0.0063562845],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962102,0.00057210505,0.0002063701,0.00022707554,0.0017649187,0.001019236],"domain_scores_gemma":[0.9777362,0.005786258,0.0020224885,0.00043247495,0.011777333,0.0022452397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005646959,0.00021510237,0.00038365956,0.0014005842,0.0013041203,0.002828687,0.0007002756,0.0007670607,0.0070385323],"category_scores_gemma":[0.028464053,0.00022919137,0.0011911562,0.0022635541,0.0004839528,0.0006890098,0.0007551303,0.0015209335,0.00070558203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014652545,0.00019010318,0.85826087,0.00016178377,0.0003087694,0.0002663728,0.00094480964,0.011367532,0.00034307354,0.028521517,0.05981354,0.038356453],"study_design_scores_gemma":[0.00007146224,0.00010943658,0.96015066,0.00011795735,0.00008977094,0.0000978773,0.0012589828,0.013069671,0.00044596058,0.0017949156,0.022733437,0.000059864244],"about_ca_topic_score_codex":0.97198427,"about_ca_topic_score_gemma":0.95919895,"teacher_disagreement_score":0.039897066,"about_ca_system_score_codex":0.039897066,"about_ca_system_score_gemma":0.041300036,"threshold_uncertainty_score":0.28947484},"labels":[],"label_agreement":null},{"id":"W4412443290","doi":"10.1016/j.jval.2025.04.1910","title":"EE311 The Equitable Quality-Adjusted Life-Year","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Quality (philosophy); Philosophy","score_opus":0.20397294327296345,"score_gpt":0.5200313178884265,"score_spread":0.31605837461546304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443290","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06559144,0.028572626,0.014690028,0.1833248,0.010060822,0.00012800666,0.01073251,0.00020772463,0.68669206],"genre_scores_gemma":[0.86374974,0.011910012,0.005726521,0.011605394,0.006866365,0.00021446742,0.0051257038,0.0001592199,0.09464258],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99719584,0.0012765686,0.000119041775,0.00013183159,0.0009816247,0.00029511406],"domain_scores_gemma":[0.9961475,0.00077053235,0.00045528138,0.00036733848,0.0015868136,0.0006724267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004165746,0.00027169028,0.00031090205,0.0015763951,0.0006007611,0.0022426161,0.0004608916,0.0010314285,0.015386089],"category_scores_gemma":[0.015505024,0.00008908534,0.00039508054,0.0021452296,0.00076088955,0.0010194906,0.0018390198,0.0014105923,0.002207581],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062696886,0.0002792687,0.04515199,0.00034946093,0.0001751939,0.00012385892,0.0002807055,0.0025012437,0.00036610305,0.1800555,0.22374871,0.54634094],"study_design_scores_gemma":[0.00014800976,0.00045734376,0.16233471,0.0009865136,0.00012568639,0.0006335783,0.0008023032,0.0027786843,0.00063649035,0.116795376,0.71424484,0.000056449968],"about_ca_topic_score_codex":0.00641734,"about_ca_topic_score_gemma":0.008019748,"teacher_disagreement_score":0.015386089,"about_ca_system_score_codex":0.002281435,"about_ca_system_score_gemma":0.0023191993,"threshold_uncertainty_score":0.05147153},"labels":[],"label_agreement":null},{"id":"W4412443315","doi":"10.1016/j.jval.2025.04.631","title":"EPH100 Acute eGFR Dip with SGLT2 Inhibitors vs. Other Antihyperglycemic Medications Among People with HIV","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Human immunodeficiency virus (HIV); Medicine; Traditional medicine; Pharmacology; Internal medicine; Family medicine","score_opus":0.009097476905995877,"score_gpt":0.26470780283417383,"score_spread":0.25561032592817795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985327,0.0076908474,0.00010475334,0.0007961929,0.00017612669,0.000044743374,0.000577533,0.0000062059294,0.005276643],"genre_scores_gemma":[0.99651223,0.001675317,0.00009894514,0.0004918483,0.00013075814,0.000017976647,0.00031704866,0.0000019639606,0.00075380673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99953735,0.000121208184,0.000048307546,0.000070953945,0.00007451016,0.00014773286],"domain_scores_gemma":[0.99949133,0.00021744933,0.00011449457,0.00001591604,0.000029143743,0.00013161464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005050539,0.00016682496,0.0005143081,0.00024554078,0.00029616794,0.0008445281,0.00022379652,0.00047043565,0.00409671],"category_scores_gemma":[0.0018090033,0.00015617315,0.0012626895,0.00044483092,0.00017698057,0.00086035446,0.0005108565,0.0012365167,0.0002476972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09067489,0.0033830204,0.6887236,0.001069485,0.0030658299,0.0005303476,0.00036298993,0.00049485813,0.0013714071,0.00075748964,0.0034806146,0.20608544],"study_design_scores_gemma":[0.0043559493,0.014687491,0.96688175,0.0008595117,0.0032268506,0.00069401256,0.0014845474,0.0010231417,0.00066254067,0.001010381,0.005066532,0.000047325517],"about_ca_topic_score_codex":0.0030517392,"about_ca_topic_score_gemma":0.0074215974,"teacher_disagreement_score":0.00409671,"about_ca_system_score_codex":0.00037469596,"about_ca_system_score_gemma":0.00044693224,"threshold_uncertainty_score":0.013704896},"labels":[],"label_agreement":null},{"id":"W4412443331","doi":"10.1016/j.jval.2025.04.1019","title":"HTA8 Trends in Indirect Treatment Comparison (ITC) Methods Used in Reimbursement Submissions in Canada and the US","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lumerical Solutions (Canada); Geomechanica (Canada); Luminex (Canada)","funders":"","keywords":"Reimbursement; Actuarial science; Business; Economics; Economic growth; Health care","score_opus":0.4775992639382661,"score_gpt":0.5012781598183944,"score_spread":0.02367889588012828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50929433,0.034343917,0.061694793,0.019719461,0.0070161894,0.0036474916,0.278022,0.0025029858,0.08375887],"genre_scores_gemma":[0.8609769,0.005470619,0.05123553,0.0033810742,0.0008506081,0.0022184625,0.056496657,0.0018277975,0.017542405],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.92515707,0.03293544,0.012282413,0.0047433763,0.022452036,0.0024296877],"domain_scores_gemma":[0.58346975,0.23757583,0.028569916,0.012527176,0.13266751,0.0051898207],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08298712,0.0005268506,0.001175303,0.007026319,0.001883003,0.0044157277,0.0020228946,0.0009475541,0.010876607],"category_scores_gemma":[0.3878719,0.0006979001,0.0020470181,0.011612528,0.0011604124,0.0020050025,0.0015862369,0.0032592353,0.001330268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068813018,0.00031019415,0.2758279,0.003504399,0.0023491837,0.00014186089,0.0034358965,0.004727152,0.0006459883,0.018984856,0.2701872,0.413004],"study_design_scores_gemma":[0.00094833865,0.0010330842,0.8011746,0.004138242,0.0016694803,0.0005776435,0.0026452,0.014861701,0.0033426343,0.0064315055,0.16283587,0.0003418548],"about_ca_topic_score_codex":0.6367607,"about_ca_topic_score_gemma":0.6132728,"teacher_disagreement_score":0.9850103,"about_ca_system_score_codex":0.014989664,"about_ca_system_score_gemma":0.031377394,"threshold_uncertainty_score":0.73075694},"labels":[],"label_agreement":null},{"id":"W4412443332","doi":"10.1016/j.jval.2025.04.1947","title":"EE348 A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa; Université du Québec en Outaouais","funders":"","keywords":"Psychological intervention; Term (time); Health care; Medicine; Infection control; Control (management); Long-term care; Intensive care medicine; Nursing; Computer science; Economic growth; Economics","score_opus":0.12180151678768786,"score_gpt":0.503997644270465,"score_spread":0.38219612748277715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004558838,0.9915856,0.00044645584,0.0003488773,0.00027300435,0.0009905793,0.0011105129,0.000024083876,0.0006620282],"genre_scores_gemma":[0.08857221,0.9053954,0.0022492344,0.00089546636,0.00016419029,0.0016219016,0.0006052915,0.000022065886,0.00047428528],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9855686,0.0073482357,0.00408074,0.0006475482,0.0019820211,0.000372883],"domain_scores_gemma":[0.9753685,0.018002892,0.0043934523,0.00038783188,0.001507595,0.00033965497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013515483,0.002198148,0.012657629,0.006859895,0.0007364998,0.003619826,0.0016453501,0.0021398042,0.009714383],"category_scores_gemma":[0.0604326,0.0012820441,0.014684249,0.007692574,0.0010049882,0.0021678642,0.0021819407,0.0025119926,0.00036094448],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024510336,0.000048111116,0.0008598454,0.88727784,0.081159204,0.00007295909,0.00009813572,0.00018822151,0.00011030098,0.00025961737,0.0009854378,0.026489237],"study_design_scores_gemma":[0.0050876252,0.0006854961,0.006374657,0.4884996,0.48769775,0.0002549292,0.00022728399,0.00029904483,0.00018202898,0.0006098873,0.010008303,0.00007341777],"about_ca_topic_score_codex":0.012175921,"about_ca_topic_score_gemma":0.03240023,"teacher_disagreement_score":0.013515483,"about_ca_system_score_codex":0.0049595004,"about_ca_system_score_gemma":0.008033233,"threshold_uncertainty_score":0.07147759},"labels":[],"label_agreement":null},{"id":"W4412443334","doi":"10.1016/j.jval.2025.04.341","title":"EE49 Comparing the Cost-Utility of Renal Replacement Therapies Delivered to Critically Ill Patients With Acute Kidney Injury in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Critically ill; Acute kidney injury; Medicine; Renal replacement therapy; Intensive care medicine; Internal medicine","score_opus":0.02665921618615296,"score_gpt":0.3232365259809613,"score_spread":0.29657730979480834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699118,0.0050528785,0.0011800722,0.002431795,0.00025212378,0.00023845094,0.00985716,0.000022098277,0.011053608],"genre_scores_gemma":[0.994321,0.00090864924,0.00055390736,0.00055102113,0.00008137621,0.00006964228,0.0027587106,0.000007043044,0.0007486979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686664,0.002122845,0.00025928408,0.00015492174,0.0003368794,0.00025937162],"domain_scores_gemma":[0.99353623,0.004368687,0.00075741217,0.00027457063,0.0006981465,0.00036493308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003418837,0.00036813278,0.0006829082,0.001054998,0.00023207488,0.0013457392,0.00056192174,0.0006911739,0.0032967785],"category_scores_gemma":[0.0180313,0.00018953915,0.0028943855,0.0017401336,0.000263158,0.0007104256,0.0009422955,0.0011623318,0.00018578999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.063437544,0.0033100115,0.67018634,0.0021716396,0.027879085,0.000491152,0.000379678,0.054429565,0.0012456216,0.01054788,0.023021655,0.14289983],"study_design_scores_gemma":[0.0062986896,0.009097791,0.9062657,0.0010957528,0.013441593,0.00047911186,0.0013853305,0.04091762,0.0017126773,0.0043495744,0.014816208,0.00013993317],"about_ca_topic_score_codex":0.021830577,"about_ca_topic_score_gemma":0.021027647,"teacher_disagreement_score":0.021830577,"about_ca_system_score_codex":0.0027423971,"about_ca_system_score_gemma":0.0015664421,"threshold_uncertainty_score":0.043407023},"labels":[],"label_agreement":null},{"id":"W4412443344","doi":"10.1016/j.jval.2025.04.1983","title":"EE384 Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Institut National de Santé Publique du Québec; Université Laval; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Cross-sectional study; Demography; Gerontology; Population; Environmental health; Pathology","score_opus":0.12870778238003644,"score_gpt":0.3903189278355892,"score_spread":0.26161114545555275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91334254,0.0025717684,0.00023043226,0.0009165447,0.000045923985,0.00010737209,0.07968071,0.00004450961,0.0030602857],"genre_scores_gemma":[0.97569263,0.0010515745,0.00031961838,0.0004945467,0.00002476351,0.000080530604,0.018846065,0.000015964542,0.0034742074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886024,0.00009532335,0.00013817658,0.00018941877,0.0003505817,0.00036635125],"domain_scores_gemma":[0.99668306,0.00016212727,0.00091116055,0.000120672375,0.0016134379,0.0005094392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007870215,0.0005511795,0.0006808028,0.00172615,0.001416197,0.0016614746,0.0016795285,0.0011211198,0.0027671852],"category_scores_gemma":[0.0027892897,0.0004742585,0.0016936024,0.005710194,0.00042551366,0.00075433846,0.00085301686,0.0013909996,0.00044206152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009109882,0.000046361823,0.99342453,0.00005183872,0.00021707902,0.00005373795,0.00013105475,0.00024398195,0.00006261649,0.00008370666,0.0033335167,0.002260437],"study_design_scores_gemma":[0.000006904274,0.000009572152,0.9986558,0.00002642797,0.000036889487,0.000021951742,0.00018416709,0.0003192971,0.000016138463,0.000008078275,0.0007071969,0.000007664611],"about_ca_topic_score_codex":0.9965676,"about_ca_topic_score_gemma":0.99722135,"teacher_disagreement_score":0.03176891,"about_ca_system_score_codex":0.03176891,"about_ca_system_score_gemma":0.025255006,"threshold_uncertainty_score":0.23050064},"labels":[],"label_agreement":null},{"id":"W4412443347","doi":"10.1016/j.jval.2025.04.647","title":"EPH116 Informing Blood Donor Safety and Blood Supply Management in the United States: Factors Affecting Donor Time-To Return After Low Hemoglobin Deferral","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Deferral; Hemoglobin; Blood management; Medicine; Blood donor; Intensive care medicine; Business; Operations management; Blood transfusion; Surgery; Internal medicine; Finance; Economics; Immunology","score_opus":0.014667390000906992,"score_gpt":0.2511360351856662,"score_spread":0.23646864518475919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916775,0.00022739284,0.00010806017,0.0039684046,0.00003665202,0.000015761492,0.00041414352,0.0000046868877,0.0035474724],"genre_scores_gemma":[0.9979736,0.00020761503,0.00020259144,0.0005782653,0.000021735832,0.000008341048,0.00022885093,0.0000026754237,0.0007762225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984035,0.00074419857,0.00020176802,0.00011187943,0.00027374222,0.00026499052],"domain_scores_gemma":[0.98171026,0.005737662,0.008020193,0.00049916294,0.0018026604,0.002229936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019593067,0.000111994515,0.00013849555,0.0006131516,0.00085974106,0.0013776217,0.00044230005,0.00068115036,0.00431588],"category_scores_gemma":[0.013479546,0.00016659034,0.00029113403,0.0008972244,0.00037936072,0.0007413706,0.0008341327,0.0011634467,0.000338001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062166895,0.00018849921,0.99345666,0.000009492043,0.000020604644,0.000043347452,0.00030384638,0.00006562534,0.000036175552,0.00007811499,0.0009500996,0.0047853496],"study_design_scores_gemma":[0.000007755215,0.00008950111,0.9937256,0.000071352966,0.000038134807,0.00009705502,0.0035754556,0.00054372556,0.00012497937,0.00011479136,0.0016057076,0.0000060808015],"about_ca_topic_score_codex":0.05529873,"about_ca_topic_score_gemma":0.07536175,"teacher_disagreement_score":0.05529873,"about_ca_system_score_codex":0.0011661751,"about_ca_system_score_gemma":0.0029271564,"threshold_uncertainty_score":0.10995376},"labels":[],"label_agreement":null},{"id":"W4412443371","doi":"10.1016/j.jval.2025.04.1899","title":"EE300 Ferric Derisomaltose for the Treatment of Iron Deficiency Anemia: A Real-World Evidence Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Anemia; Ferric; Medicine; Iron-deficiency anemia; Internal medicine; Chemistry; Inorganic chemistry","score_opus":0.07503608602692598,"score_gpt":0.38997321688262815,"score_spread":0.3149371308557022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443371","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20075901,0.7809676,0.0010144734,0.0049676737,0.00074603985,0.0011319934,0.0025217524,0.000040957148,0.00785051],"genre_scores_gemma":[0.7342503,0.25672445,0.0024076353,0.0029568323,0.0007184013,0.000450675,0.0014206099,0.000014859452,0.0010561316],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9955537,0.0027877768,0.0006265392,0.00028664243,0.00057320256,0.00017219578],"domain_scores_gemma":[0.9868645,0.0088809235,0.0027342704,0.00029003454,0.0008211342,0.00040907157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005570466,0.00070128066,0.0030459678,0.0011632639,0.00033999424,0.0013168525,0.00074329623,0.0017171542,0.006324012],"category_scores_gemma":[0.012412983,0.00036749878,0.0039644595,0.0014968058,0.0009623179,0.00093849725,0.0006094345,0.0024754605,0.0004232829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.41342226,0.0029676303,0.008327231,0.13976647,0.058963567,0.00040050404,0.00021303943,0.00077532814,0.0025461703,0.0018291378,0.005246576,0.36554214],"study_design_scores_gemma":[0.47061956,0.08207884,0.08409838,0.081999816,0.21535458,0.001409892,0.0009003207,0.001610329,0.0020836545,0.002880651,0.05669477,0.00026930042],"about_ca_topic_score_codex":0.002092972,"about_ca_topic_score_gemma":0.0055400017,"teacher_disagreement_score":0.006324012,"about_ca_system_score_codex":0.0012272204,"about_ca_system_score_gemma":0.0014929887,"threshold_uncertainty_score":0.029459834},"labels":[],"label_agreement":null},{"id":"W4412443391","doi":"10.1016/j.jval.2025.04.1178","title":"MSR25 NMCP Delayed Time to Hospital Encounter and Reduced Cost compared to OMCP in Patients with Gastroparesis - A Real World Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Gastroparesis; Medicine; Internal medicine","score_opus":0.011957397404969025,"score_gpt":0.2817394799176129,"score_spread":0.26978208251264385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99858046,0.0007460602,0.000022405307,0.00012241199,0.000020134827,0.000018859533,0.00011383889,0.0000013687439,0.00037440102],"genre_scores_gemma":[0.9991335,0.00039890377,0.00008257945,0.00008464272,0.000049994294,0.000019813455,0.0001413251,0.0000016936771,0.00008759055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989858,0.00038534994,0.0001000223,0.00016775394,0.0001300129,0.00023095179],"domain_scores_gemma":[0.99655676,0.0012565205,0.0012254507,0.000120468176,0.00018230877,0.00065854704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010438409,0.00041633492,0.0010922103,0.0005425114,0.00047846755,0.0013691643,0.00039686204,0.00070609327,0.0039148903],"category_scores_gemma":[0.0061009326,0.00027904965,0.0019847513,0.0011287944,0.00055961974,0.0010411941,0.0005873604,0.0014694051,0.00026159256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.067293584,0.0052801324,0.8901379,0.00091198186,0.0026309662,0.0008187627,0.00058315037,0.000406913,0.00079320127,0.00031436214,0.0012088239,0.029620118],"study_design_scores_gemma":[0.0034349035,0.019903257,0.96845734,0.00024382607,0.0021279752,0.0007877272,0.002297628,0.00091908535,0.00024083973,0.0002135326,0.001298327,0.00007551622],"about_ca_topic_score_codex":0.004338409,"about_ca_topic_score_gemma":0.0049802274,"teacher_disagreement_score":0.004338409,"about_ca_system_score_codex":0.0015970682,"about_ca_system_score_gemma":0.0012671956,"threshold_uncertainty_score":0.013096631},"labels":[],"label_agreement":null},{"id":"W4412443423","doi":"10.1016/j.jval.2025.04.1993","title":"EE394 Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Environmental health; Development economics; Economic growth; Socioeconomics; Demography; Medicine; Economics; Sociology","score_opus":0.02201738456089472,"score_gpt":0.34461987266519606,"score_spread":0.32260248810430137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7655303,0.00996204,0.0004352304,0.052806903,0.0008768514,0.0003135786,0.028599378,0.00006283425,0.14141299],"genre_scores_gemma":[0.976586,0.004947669,0.0006104668,0.0034749552,0.00027544488,0.00003823654,0.0055415616,0.000014559323,0.008511112],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998283,0.00021620585,0.00005893178,0.000060323557,0.00059162575,0.0007900111],"domain_scores_gemma":[0.99717796,0.00022548901,0.00030172008,0.0000326796,0.0010523757,0.0012097913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077947153,0.00028408912,0.00028389014,0.0009700929,0.0017413783,0.0022085705,0.00068118796,0.0008794428,0.009154692],"category_scores_gemma":[0.0056487075,0.00015776567,0.0013079385,0.001707379,0.0005529009,0.00031525322,0.0009245873,0.0014709115,0.00032154535],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030706571,0.0008025619,0.70348406,0.00075690605,0.0011942318,0.0013057152,0.0006375988,0.005709992,0.00058404997,0.0131242005,0.10042647,0.16890351],"study_design_scores_gemma":[0.00028687424,0.00045355762,0.94154495,0.0007324242,0.00068601774,0.00048916927,0.002491595,0.0041021905,0.00025510523,0.0009006068,0.04796469,0.00009280071],"about_ca_topic_score_codex":0.98493457,"about_ca_topic_score_gemma":0.98992,"teacher_disagreement_score":0.05203952,"about_ca_system_score_codex":0.05203952,"about_ca_system_score_gemma":0.08805203,"threshold_uncertainty_score":0.37757492},"labels":[],"label_agreement":null},{"id":"W4412443433","doi":"10.1016/j.jval.2025.04.1156","title":"MSR3 Parametric Model Selection: Beyond AIC/BIC in Health Economic Context","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Parametric statistics; Context (archaeology); Selection (genetic algorithm); Model selection; Econometrics; Parametric model; Computer science; Economics; Statistics; Mathematics; Machine learning; Geography","score_opus":0.3415811954755114,"score_gpt":0.43774120962852325,"score_spread":0.09616001415301184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443433","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.079698995,0.003652724,0.89276904,0.007782815,0.00059128436,0.00033851835,0.0037123715,0.0023927728,0.009061493],"genre_scores_gemma":[0.788139,0.001060977,0.19837038,0.0018503697,0.00071749976,0.00059006666,0.0039157104,0.001345477,0.004010464],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.95988107,0.035803836,0.0010251118,0.0014016615,0.001425025,0.00046321953],"domain_scores_gemma":[0.87539953,0.111061946,0.0025024826,0.005347513,0.0047930707,0.0008954622],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03315342,0.0017820495,0.003321534,0.0024318856,0.0013358677,0.0038528608,0.0028158163,0.0016508579,0.012004143],"category_scores_gemma":[0.14909723,0.00080201327,0.0030557925,0.0034980457,0.0010829922,0.0030015265,0.0034417592,0.0043034763,0.002173492],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002650687,0.0003890608,0.07106831,0.0016314999,0.0070833615,0.0015616772,0.0006698625,0.43590477,0.0006850409,0.08061345,0.055038773,0.3427035],"study_design_scores_gemma":[0.0002541729,0.0003151646,0.0071328008,0.00035939692,0.0007768906,0.00031079934,0.00031017,0.8575037,0.00049741217,0.12532812,0.007105935,0.00010548721],"about_ca_topic_score_codex":0.01251443,"about_ca_topic_score_gemma":0.014873721,"teacher_disagreement_score":0.9668466,"about_ca_system_score_codex":0.00087238004,"about_ca_system_score_gemma":0.0047951923,"threshold_uncertainty_score":0.1753341},"labels":[],"label_agreement":null},{"id":"W4412443449","doi":"10.1016/j.jval.2025.04.066","title":"P49 A Health Technology Assessment Framework for Ethics Analysis in Drug Reimbursement Reviews at Canada's Drug Agency","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reimbursement; Agency (philosophy); Drug; Health technology; Medicine; Business; Actuarial science; Public administration; Political science; Pharmacology; Law; Health care; Sociology; Social science","score_opus":0.07265714092482854,"score_gpt":0.4462006529284476,"score_spread":0.37354351200361907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443449","genre_codex":"other","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003583663,0.006204892,0.1800603,0.3519719,0.0012808811,0.002986289,0.0013076001,0.00041228966,0.45219222],"genre_scores_gemma":[0.2710048,0.0041575893,0.48571703,0.12735152,0.003565255,0.00458215,0.00070125074,0.00039021956,0.10253022],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.87294394,0.08235677,0.0049871285,0.004864768,0.026984653,0.007862768],"domain_scores_gemma":[0.76559734,0.17285271,0.0034600112,0.004411341,0.046438955,0.0072396863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1020562,0.0017220228,0.0019304546,0.009793355,0.016343432,0.0324594,0.0054515726,0.032813545,0.020375691],"category_scores_gemma":[0.15034097,0.0017648267,0.0037908072,0.005301862,0.025141165,0.009262577,0.0068317056,0.017475598,0.0034760912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019135152,0.00004787866,0.0005533986,0.00018232226,0.000044107597,0.00016086032,0.0012564936,0.0020107904,0.0001092214,0.905968,0.07365751,0.01599033],"study_design_scores_gemma":[0.000106022606,0.00006334039,0.0025309955,0.0025672084,0.00010922476,0.00020295367,0.0017929202,0.009059194,0.00042094826,0.7323501,0.25061813,0.00017882402],"about_ca_topic_score_codex":0.4672884,"about_ca_topic_score_gemma":0.51091224,"teacher_disagreement_score":0.9352601,"about_ca_system_score_codex":0.064739875,"about_ca_system_score_gemma":0.19562578,"threshold_uncertainty_score":0.929137},"labels":[],"label_agreement":null},{"id":"W4412443466","doi":"10.1016/j.jval.2025.04.2076","title":"EE479 Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Impact of AI and Big Data on Business and Society","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Microsoft excel; Computer science; Software engineering; Ms excel; Data science; World Wide Web; Operating system","score_opus":0.29936328249314825,"score_gpt":0.45905638066722076,"score_spread":0.1596930981740725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443466","genre_codex":"methods","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002876425,0.0013097803,0.88530374,0.0012339053,0.00030694154,0.00055725995,0.03103238,0.0495057,0.027873905],"genre_scores_gemma":[0.032316536,0.0025236406,0.8798776,0.0012994144,0.0002219706,0.0031521,0.013357788,0.031118607,0.036132265],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989297,0.00056436233,0.00010284376,0.000114391165,0.00022559297,0.00006315883],"domain_scores_gemma":[0.9914199,0.0072852126,0.00025027187,0.00034882818,0.0006237919,0.00007197045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031248024,0.0020875114,0.0014300027,0.0012895187,0.00033996004,0.001545503,0.0017511735,0.0009854641,0.109985545],"category_scores_gemma":[0.016005557,0.0016436543,0.0027763203,0.0008001301,0.00025856,0.0010371271,0.00094521773,0.0017485489,0.048229568],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039116153,0.00020739593,0.0025258998,0.005443701,0.0016007841,0.00065717666,0.0002732681,0.10797492,0.005265163,0.06910705,0.51999235,0.2865612],"study_design_scores_gemma":[0.00048330007,0.00021126264,0.0023456574,0.0018095972,0.0010514267,0.0009782669,0.00014451651,0.2619763,0.013003284,0.08568732,0.6320708,0.00023825791],"about_ca_topic_score_codex":0.004661141,"about_ca_topic_score_gemma":0.0070943353,"teacher_disagreement_score":0.109985545,"about_ca_system_score_codex":0.0005813703,"about_ca_system_score_gemma":0.0018971548,"threshold_uncertainty_score":0.36793828},"labels":[],"label_agreement":null},{"id":"W4412443507","doi":"10.1016/j.jval.2025.04.2033","title":"EE435 Integration of Environmental Considerations in Economic Evaluations: Significant Shift or Token Gesture? Insights From Severe Asthma Treatments","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Security token; Gesture; Asthma; Psychology; Computer science; Business; Medicine; Artificial intelligence; Computer security; Internal medicine","score_opus":0.23387883174058552,"score_gpt":0.40626474496035103,"score_spread":0.1723859132197655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443507","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10485816,0.048069116,0.07887624,0.50935787,0.0022025427,0.00007242983,0.0007300031,0.00008442192,0.2557492],"genre_scores_gemma":[0.9484209,0.010761856,0.014283285,0.015621895,0.0019120575,0.00007160762,0.00015996033,0.00009084161,0.008677606],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99273854,0.0052605355,0.00024369956,0.00024949014,0.0010190121,0.00048867695],"domain_scores_gemma":[0.97767067,0.017168138,0.0009283667,0.0009185902,0.002518534,0.0007956387],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01188558,0.0004363111,0.0009162487,0.0019129525,0.0009811799,0.0073547433,0.0007188685,0.0024015114,0.009477908],"category_scores_gemma":[0.030528178,0.0003254411,0.00087697717,0.0021433788,0.0056316326,0.011663631,0.0032194608,0.005377731,0.00043989933],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015967715,0.00013853978,0.0064434665,0.00030039065,0.00015572524,0.00019841616,0.0014958067,0.0027168437,0.00025474172,0.84181523,0.01751095,0.12881021],"study_design_scores_gemma":[0.00002509983,0.000056901594,0.011031766,0.000969319,0.00009453588,0.00009099424,0.00221131,0.0037452066,0.00029113048,0.93665415,0.044782575,0.000047037094],"about_ca_topic_score_codex":0.008449772,"about_ca_topic_score_gemma":0.013543949,"teacher_disagreement_score":0.9881144,"about_ca_system_score_codex":0.003073388,"about_ca_system_score_gemma":0.0034928636,"threshold_uncertainty_score":0.06285775},"labels":[],"label_agreement":null},{"id":"W4412443540","doi":"10.1016/j.jval.2025.04.1292","title":"MSR141 Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Statistics; Econometrics; Mathematics","score_opus":0.6762797987268713,"score_gpt":0.6112923117581431,"score_spread":0.06498748696872814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443540","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08245915,0.0409697,0.79562986,0.033169158,0.010391932,0.0026671628,0.010214636,0.0028292588,0.021669058],"genre_scores_gemma":[0.65479934,0.0032908171,0.31572422,0.010461907,0.0019403502,0.0040529813,0.0032584637,0.0027516293,0.0037203492],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.41843945,0.5289177,0.021997591,0.012610988,0.016799053,0.0012351085],"domain_scores_gemma":[0.2935655,0.6281181,0.012150089,0.045627754,0.019346917,0.001191688],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.327963,0.002356669,0.003895004,0.003869323,0.0012446507,0.0050555496,0.0061057922,0.0022280219,0.014932573],"category_scores_gemma":[0.69555634,0.0014576294,0.00895457,0.0064532273,0.0026273297,0.0033124445,0.005692599,0.0066253934,0.002025075],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02614665,0.00038879353,0.049527444,0.017064419,0.14087206,0.00072637864,0.0044775326,0.015094476,0.0017449419,0.11683261,0.06809613,0.5590286],"study_design_scores_gemma":[0.020230787,0.0055348948,0.09318789,0.013560125,0.098153114,0.0026530323,0.0024197039,0.09745008,0.0137231145,0.48615217,0.16580185,0.0011333658],"about_ca_topic_score_codex":0.004308731,"about_ca_topic_score_gemma":0.0046602054,"teacher_disagreement_score":0.672037,"about_ca_system_score_codex":0.002242501,"about_ca_system_score_gemma":0.0038487527,"threshold_uncertainty_score":0.8287413},"labels":[],"label_agreement":null},{"id":"W4412443554","doi":"10.1016/j.jval.2025.04.228","title":"CO143 Outcomes In Patients With Asthma and Coexisting Allergic Rhinitis Who Started Dupilumab Treatment In Real-World Clinical Practice: A RAPID Registry Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Incyte; Sanofi; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Pfizer; Amgen","keywords":"Dupilumab; Medicine; Asthma; Allergic asthma; Family medicine; Internal medicine","score_opus":0.053912521869073485,"score_gpt":0.40098024290196144,"score_spread":0.34706772103288797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950088,0.00056533935,0.00010298599,0.00013205515,0.000020243648,0.000034827073,0.0033118296,0.000007547363,0.0008162833],"genre_scores_gemma":[0.9969416,0.00027627585,0.00015128737,0.0000865971,0.00002897836,0.00005113982,0.0022909173,0.000006833426,0.00016623495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968176,0.0008989968,0.00051106967,0.0008043491,0.00045477154,0.0005132055],"domain_scores_gemma":[0.99050224,0.0014215964,0.0055571245,0.0007500151,0.0008069664,0.0009620461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016954174,0.0004033708,0.0009100574,0.0016339849,0.00085777114,0.0021002716,0.00084252073,0.0011010754,0.0018861656],"category_scores_gemma":[0.0069040577,0.0006417258,0.001400557,0.0036901187,0.0004705877,0.0022303362,0.0018225653,0.0014208008,0.00048417225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016345605,0.00005093316,0.9987116,0.00002001053,0.000111619986,0.000055970242,0.00006320534,0.000023119917,0.00003322195,0.000027424467,0.0001955645,0.0005437709],"study_design_scores_gemma":[0.00006362317,0.00016248606,0.9980374,0.000026776892,0.00010612203,0.0003509143,0.0005594985,0.0002356053,0.000046279114,0.000041589465,0.00035239258,0.000017289434],"about_ca_topic_score_codex":0.009294557,"about_ca_topic_score_gemma":0.011520328,"teacher_disagreement_score":0.009294557,"about_ca_system_score_codex":0.00095536135,"about_ca_system_score_gemma":0.0012162582,"threshold_uncertainty_score":0.018480957},"labels":[],"label_agreement":null},{"id":"W4412443577","doi":"10.1016/j.jval.2025.04.023","title":"P16 The Impact of Hallucinations in Synthetic Health Data on Prognostic Machine Learning Models","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Computer science; Machine learning; Artificial intelligence; Psychology","score_opus":0.11100579402999132,"score_gpt":0.39154064078494666,"score_spread":0.2805348467549553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7692886,0.0026423319,0.1993357,0.011146844,0.0016772442,0.00014962349,0.0036634887,0.0014497575,0.010646465],"genre_scores_gemma":[0.9890618,0.00023900905,0.008002526,0.00021775496,0.00011285144,0.00001640419,0.00095166074,0.000067370995,0.0013305134],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99890625,0.00060922623,0.000075844844,0.00015134671,0.00018872318,0.00006855953],"domain_scores_gemma":[0.9511098,0.04347425,0.00088658533,0.0014108255,0.0026553296,0.00046309063],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0061274376,0.0007460542,0.0005737965,0.0005110713,0.00037428,0.0015330374,0.0005665535,0.0011612528,0.006816901],"category_scores_gemma":[0.063275896,0.0003343946,0.00064831827,0.00048196292,0.0008022231,0.0013869393,0.00095098093,0.0015411085,0.00087173353],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024834157,0.00021187354,0.036149416,0.00045080617,0.00033765496,0.0005673443,0.00019166827,0.8113224,0.0023452053,0.005623323,0.009944908,0.13037193],"study_design_scores_gemma":[0.000040801133,0.00015224642,0.0031803562,0.000058075006,0.000033430424,0.00010769234,0.0000454763,0.9895894,0.0017844256,0.0044713314,0.0005205869,0.000016277994],"about_ca_topic_score_codex":0.008658704,"about_ca_topic_score_gemma":0.0045648026,"teacher_disagreement_score":0.9938726,"about_ca_system_score_codex":0.0006443245,"about_ca_system_score_gemma":0.00093748653,"threshold_uncertainty_score":0.032405317},"labels":[],"label_agreement":null},{"id":"W4412443590","doi":"10.1016/j.jval.2025.04.877","title":"HPR153 The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Ustekinumab; Reimbursement; Perspective (graphical); Medicine; Data science; Computer science; Internal medicine; Economics; Economic growth; Artificial intelligence; Disease","score_opus":0.10754833739723527,"score_gpt":0.40213819708472887,"score_spread":0.2945898596874936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443590","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060690954,0.08558437,0.0018201543,0.72274953,0.002967063,0.000029662875,0.0028355473,0.00005727181,0.12326545],"genre_scores_gemma":[0.7750268,0.07795154,0.0025257743,0.11208555,0.016526693,0.00006279626,0.0015164918,0.000114507115,0.014189873],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9974927,0.0009661406,0.00015015993,0.00024848848,0.00059396256,0.0005485649],"domain_scores_gemma":[0.99134177,0.0037984233,0.0018289589,0.00022076628,0.001592019,0.0012181895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050373776,0.00029217094,0.0006073699,0.0016413962,0.0005492716,0.0066868654,0.00062590477,0.0057587856,0.007879945],"category_scores_gemma":[0.011671902,0.0002580182,0.0009693612,0.0027881612,0.0018777873,0.003071641,0.001581829,0.004962523,0.00073197787],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091738673,0.00020516294,0.022812376,0.0011234998,0.00035259174,0.001137829,0.00082933897,0.0044083176,0.0024222345,0.509371,0.18378693,0.27263328],"study_design_scores_gemma":[0.0002580773,0.0007079622,0.15661323,0.0059140353,0.0005783704,0.0023274743,0.0025250597,0.004937626,0.0020313847,0.12821493,0.69568574,0.00020614566],"about_ca_topic_score_codex":0.012880337,"about_ca_topic_score_gemma":0.010719147,"teacher_disagreement_score":0.012880337,"about_ca_system_score_codex":0.0039461716,"about_ca_system_score_gemma":0.004913538,"threshold_uncertainty_score":0.028631628},"labels":[],"label_agreement":null},{"id":"W4412443616","doi":"10.1016/j.jval.2025.04.1291","title":"MSR140 Adapting PRISMA For System Dynamics Models In Healthcare: A Case Study Of Transcatheter Aortic Valve Implantation In Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complex Systems and Decision Making","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"System dynamics; Healthcare system; Health care; Medicine; Cardiology; Business; Computer science; Economics; Artificial intelligence; Economic growth","score_opus":0.1839496556691747,"score_gpt":0.41089611836339907,"score_spread":0.22694646269422436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443616","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74723506,0.00071304373,0.17433247,0.0069321967,0.00022743251,0.0010324053,0.0076407436,0.0038361857,0.058050435],"genre_scores_gemma":[0.9247608,0.00023083096,0.06913128,0.00017007344,0.000014948653,0.00015587406,0.0015098952,0.00022926295,0.003796975],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99776876,0.0011020992,0.00010786824,0.0002708024,0.0004319131,0.00031864105],"domain_scores_gemma":[0.98880225,0.007413219,0.00029898132,0.0006808408,0.0024481618,0.00035657163],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0042812605,0.0008326497,0.00065918604,0.00091622595,0.0017869873,0.0022999484,0.0018647807,0.0014351548,0.0052420357],"category_scores_gemma":[0.019215481,0.0005942638,0.0011124293,0.0011630385,0.0009779306,0.0010072106,0.001647249,0.0018633008,0.0005851115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026714205,0.00028204473,0.015579198,0.00036665887,0.000121323734,0.00097234006,0.0010190323,0.9214118,0.00089051604,0.01705833,0.007916362,0.03411529],"study_design_scores_gemma":[0.00008946484,0.000060645594,0.0038198046,0.00006775325,0.000045273286,0.00007564558,0.0009126802,0.98098284,0.00040824103,0.0049203834,0.008575243,0.000041975934],"about_ca_topic_score_codex":0.8501518,"about_ca_topic_score_gemma":0.84722894,"teacher_disagreement_score":0.9957187,"about_ca_system_score_codex":0.012689139,"about_ca_system_score_gemma":0.028112078,"threshold_uncertainty_score":0.3014614},"labels":[],"label_agreement":null},{"id":"W4412443681","doi":"10.1016/j.jval.2025.04.1108","title":"HTA97 Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Medicine; Multiple sclerosis; Disease; Intensive care medicine; Drug; Pharmacology; Psychiatry; Internal medicine; Economics; Economic growth; Health care","score_opus":0.5639303812046019,"score_gpt":0.4766881942556768,"score_spread":0.0872421869489251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443681","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07225778,0.43898302,0.015215101,0.3818783,0.005692049,0.00088040787,0.009723524,0.00018723491,0.07518261],"genre_scores_gemma":[0.7963278,0.09022448,0.023426425,0.07850573,0.003411002,0.00043354108,0.0021386452,0.00015809659,0.005374218],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9353251,0.032106265,0.008578887,0.0026859501,0.018768953,0.0025349192],"domain_scores_gemma":[0.5704855,0.24693748,0.043820985,0.013546085,0.12271071,0.0024992719],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11132822,0.0003751461,0.001409908,0.0052819927,0.0019348401,0.0069748308,0.0026098446,0.00256332,0.0034188288],"category_scores_gemma":[0.3833106,0.00050860137,0.0020142568,0.010337944,0.0036250975,0.0040859464,0.0010321554,0.0030156819,0.00028285163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013829224,0.00012293135,0.08169558,0.013049187,0.0065709488,0.00033679738,0.003915783,0.00706097,0.00064690475,0.05420476,0.13215339,0.6988599],"study_design_scores_gemma":[0.000846062,0.00047574285,0.3402299,0.068562634,0.010287916,0.00041176667,0.0046848445,0.013760643,0.0023898722,0.048071876,0.5099056,0.00037310732],"about_ca_topic_score_codex":0.7616655,"about_ca_topic_score_gemma":0.88279474,"teacher_disagreement_score":0.9695142,"about_ca_system_score_codex":0.030485813,"about_ca_system_score_gemma":0.0732474,"threshold_uncertainty_score":0.58876693},"labels":[],"label_agreement":null},{"id":"W4412443712","doi":"10.1016/j.jval.2025.04.1579","title":"PT31 Psychometric Testing of the ICECAP-A in Patients With Coeliac Disease: A Comparative Analysis With EQ-5D-5L","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Coeliac disease; Psychometric testing; Medicine; Reliability engineering; Disease; Internal medicine; Psychometrics; Clinical psychology; Engineering; Internal consistency","score_opus":0.06971808862903847,"score_gpt":0.349959236373983,"score_spread":0.2802411477449446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99648356,0.0005138228,0.00018107488,0.000085157444,0.00002883853,0.000048535276,0.0006544197,0.0000048952124,0.0019997577],"genre_scores_gemma":[0.9987031,0.00012898933,0.00015551473,0.000050662118,0.000014020012,0.00003178377,0.000681215,0.0000028935792,0.00023175716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983839,0.00072240777,0.00022178667,0.00015478671,0.00031398959,0.00020324998],"domain_scores_gemma":[0.9934843,0.0028798687,0.0013816655,0.00043281988,0.0012774381,0.00054393266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036114992,0.00061226625,0.0009411702,0.0013901825,0.0005061062,0.001317247,0.000521228,0.00070288277,0.0032044475],"category_scores_gemma":[0.014758364,0.00021121609,0.0021889824,0.0019487648,0.00058664154,0.0013065696,0.0012854995,0.00085271447,0.0007095957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021271985,0.0003238753,0.9830615,0.000093175615,0.0003728084,0.00008547903,0.00035538853,0.00027279853,0.00018832549,0.00008630397,0.00026559745,0.01276755],"study_design_scores_gemma":[0.00009816197,0.0016820902,0.9961372,0.000036457044,0.00013823716,0.00017702449,0.00060866366,0.0005108655,0.0001039262,0.00007481939,0.00041684337,0.000015719444],"about_ca_topic_score_codex":0.0032707355,"about_ca_topic_score_gemma":0.0023104884,"teacher_disagreement_score":0.0036114992,"about_ca_system_score_codex":0.00071510364,"about_ca_system_score_gemma":0.0006430488,"threshold_uncertainty_score":0.019099712},"labels":[],"label_agreement":null},{"id":"W4412443741","doi":"10.1016/j.jval.2025.04.1566","title":"PCR249 Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Steatohepatitis; Medicine; Gerontology; Quality of life (healthcare); Metabolic syndrome; Environmental health; Internal medicine; Fatty liver; Obesity; Disease; Nursing","score_opus":0.02140937164230646,"score_gpt":0.2751149044740203,"score_spread":0.2537055328317139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938431,0.0007479004,0.000035182053,0.00033348924,0.000012930911,0.000012546797,0.002221831,0.0000052813384,0.002787889],"genre_scores_gemma":[0.99820304,0.00024144015,0.00004988642,0.00007553882,0.00000813369,0.0000050247986,0.0009080033,0.000003584229,0.0005053595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994406,0.00007963569,0.000039127302,0.00007642051,0.0001279133,0.00023624682],"domain_scores_gemma":[0.9990735,0.00008006585,0.00020105531,0.000024655163,0.00032019135,0.00030061556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037006984,0.00025838945,0.00041304866,0.0010629117,0.00086545805,0.0012025973,0.0006008324,0.00040834333,0.00208261],"category_scores_gemma":[0.001581829,0.00019135227,0.00079490687,0.0026404734,0.00045482462,0.00025423517,0.0005531818,0.00067164295,0.00019322423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006384006,0.000013632058,0.99795985,0.000008853164,0.00007284537,0.000054957472,0.0000705643,0.00006569085,0.00003549675,0.00004261556,0.00032293584,0.0012887657],"study_design_scores_gemma":[0.0000041614167,0.000010253904,0.99942434,0.0000075579146,0.000019023404,0.00003243402,0.00022333486,0.000077489945,0.000008992656,0.0000071230083,0.0001823879,0.000002863596],"about_ca_topic_score_codex":0.92458415,"about_ca_topic_score_gemma":0.9391931,"teacher_disagreement_score":0.07541585,"about_ca_system_score_codex":0.0070415027,"about_ca_system_score_gemma":0.005822391,"threshold_uncertainty_score":0.15171993},"labels":[],"label_agreement":null},{"id":"W4412443773","doi":"10.1016/j.jval.2025.04.469","title":"EE177 Cost-Minimization: Consequences of Using the Lowest Cost Comparator Over the Weighted Average Cost (WAC)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Manufacturing Process and Optimization","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Cost-minimization analysis; Comparator; Minification; Statistics; Mathematics; Medicine; Mathematical optimization; Electrical engineering; Engineering; Internal medicine","score_opus":0.038209145996135625,"score_gpt":0.2924418483735544,"score_spread":0.2542327023774188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443773","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35889852,0.005183151,0.5022181,0.012906237,0.0016591905,0.000827147,0.001729937,0.0005457312,0.116031945],"genre_scores_gemma":[0.8936877,0.00032661125,0.10078651,0.0008243198,0.000113877104,0.0001863239,0.00030641028,0.00011041484,0.0036577384],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9893889,0.0061741276,0.00044406872,0.0008201347,0.0026379912,0.0005348008],"domain_scores_gemma":[0.9899805,0.0061212494,0.00063372427,0.0011950561,0.0018573696,0.00021213951],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014870325,0.00051753456,0.0013439435,0.0017001203,0.00068457605,0.0043271733,0.0015195843,0.0018183775,0.0050486014],"category_scores_gemma":[0.041800097,0.0003198601,0.0008746706,0.0025154527,0.00092880597,0.0028812783,0.0014834526,0.0019672671,0.0003828897],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004888049,0.00073383265,0.009635549,0.00069224276,0.00045825698,0.00016919231,0.00021116108,0.115657136,0.0057554026,0.416906,0.011594903,0.43329823],"study_design_scores_gemma":[0.0008214237,0.0033892246,0.018808737,0.001166434,0.00072268577,0.00050641206,0.00083581987,0.55021685,0.0166117,0.37140715,0.035303537,0.0002100779],"about_ca_topic_score_codex":0.003389102,"about_ca_topic_score_gemma":0.0033175573,"teacher_disagreement_score":0.98512965,"about_ca_system_score_codex":0.0022052347,"about_ca_system_score_gemma":0.0023086888,"threshold_uncertainty_score":0.078642786},"labels":[],"label_agreement":null},{"id":"W4412443816","doi":"10.1016/j.jval.2025.04.497","title":"EE206 Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Dementia; Medicine; Stroke (engine); Physical medicine and rehabilitation; Internal medicine; Engineering","score_opus":0.4660858779480102,"score_gpt":0.4778538709705853,"score_spread":0.011767993022575085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9238141,0.0024490145,0.005576539,0.007980626,0.00075393636,0.0019359902,0.014875977,0.00018315586,0.04243067],"genre_scores_gemma":[0.9938019,0.00026022326,0.0010673661,0.00041492327,0.00005467403,0.00023789257,0.0010979132,0.000005987261,0.0030592862],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99713,0.0019288772,0.00013380125,0.00015031805,0.00018159853,0.00047538473],"domain_scores_gemma":[0.9953961,0.0037942315,0.00022179689,0.00012893585,0.00014563896,0.00031341167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032747579,0.0006385168,0.0014840291,0.0009937359,0.00040110078,0.0012598087,0.000921611,0.0031038136,0.017897865],"category_scores_gemma":[0.013791965,0.00051495293,0.0029426212,0.0008255073,0.000629948,0.00092472206,0.000592597,0.0014946752,0.0006231323],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1253452,0.008219199,0.026630776,0.0018376944,0.004187444,0.0012099382,0.00016561188,0.71178144,0.0026437626,0.027563674,0.014323965,0.07609129],"study_design_scores_gemma":[0.04377475,0.06501129,0.13384685,0.0011615274,0.014121451,0.0019343628,0.001588167,0.6777696,0.006619876,0.035542082,0.018183138,0.00044687375],"about_ca_topic_score_codex":0.017501604,"about_ca_topic_score_gemma":0.0089273425,"teacher_disagreement_score":0.017897865,"about_ca_system_score_codex":0.0028882886,"about_ca_system_score_gemma":0.0026119344,"threshold_uncertainty_score":0.059874356},"labels":[],"label_agreement":null},{"id":"W4412443820","doi":"10.1016/j.jval.2025.04.1303","title":"MSR152 A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Checklist; Agency (philosophy); Drug; Real world evidence; Product (mathematics); Medicine; Pharmacology; Business; Psychology; Internal medicine","score_opus":0.5622885618138144,"score_gpt":0.46825309431633366,"score_spread":0.09403546749748071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443820","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0071006254,0.014567859,0.08261962,0.060548488,0.0073677017,0.2520309,0.44315797,0.025530571,0.10707621],"genre_scores_gemma":[0.017083723,0.012822823,0.4749156,0.03220652,0.003443252,0.2660377,0.13993567,0.0043999166,0.049154814],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8054745,0.06140789,0.114062056,0.0019453537,0.015108714,0.00200145],"domain_scores_gemma":[0.42393956,0.3181552,0.076812565,0.020374967,0.15507834,0.0056393887],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.112196125,0.002615578,0.0046949796,0.021614557,0.0022748162,0.007687738,0.0040831086,0.0074649844,0.13516173],"category_scores_gemma":[0.36662707,0.0034463103,0.0059786267,0.009405447,0.001805304,0.0062368507,0.0058850483,0.0045349775,0.058795817],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010146771,0.0002071039,0.0020283335,0.038399216,0.00032209582,0.00035824653,0.00092046347,0.0005496257,0.00162028,0.0041185627,0.84636956,0.104091935],"study_design_scores_gemma":[0.0016801369,0.0003302434,0.007206699,0.030752538,0.00025674782,0.00041032408,0.00075137464,0.0007670507,0.0014670613,0.005633236,0.95050997,0.0002345849],"about_ca_topic_score_codex":0.0038079512,"about_ca_topic_score_gemma":0.009543399,"teacher_disagreement_score":0.99619204,"about_ca_system_score_codex":0.003914541,"about_ca_system_score_gemma":0.022671381,"threshold_uncertainty_score":0.5933569},"labels":[],"label_agreement":null},{"id":"W4412443867","doi":"10.1016/j.jval.2025.04.1831","title":"SA76 Indication Screening: Using Early Health Technology Assessment to Prioritize Potential Target Indications for Platform Health Technologies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Health technology; Medicine; Risk analysis (engineering); Data science; Computer science; Health care; Economic growth; Economics","score_opus":0.3595916467732638,"score_gpt":0.4807475242151035,"score_spread":0.12115587744183975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443867","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5530371,0.017992571,0.25257838,0.016500592,0.0012309735,0.004265668,0.027993103,0.003744108,0.122657515],"genre_scores_gemma":[0.8539717,0.0022239035,0.12609765,0.0012825018,0.00029426636,0.0007663629,0.007429198,0.00015204943,0.0077822655],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9947891,0.002902025,0.00040271552,0.00034333917,0.0012813013,0.00028145246],"domain_scores_gemma":[0.97849005,0.014936105,0.0021244152,0.0006191008,0.0030667435,0.00076357415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010473419,0.0012571596,0.0014427423,0.0066126203,0.00036580773,0.0043868725,0.0008782006,0.0013658954,0.011117488],"category_scores_gemma":[0.037493456,0.00041473933,0.0023137995,0.002794091,0.0004057194,0.0016761028,0.0015694145,0.0015745763,0.0026771217],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006533267,0.0009857428,0.18348765,0.002046979,0.0015935998,0.00031958555,0.00024120916,0.030408744,0.0029440087,0.013512993,0.04258389,0.7153424],"study_design_scores_gemma":[0.0030680008,0.0073056077,0.22949575,0.002786034,0.0041192234,0.0015775223,0.0007917255,0.5370033,0.019374484,0.08013137,0.11376221,0.0005847597],"about_ca_topic_score_codex":0.004636069,"about_ca_topic_score_gemma":0.0059280223,"teacher_disagreement_score":0.011117488,"about_ca_system_score_codex":0.0012767877,"about_ca_system_score_gemma":0.0039557116,"threshold_uncertainty_score":0.055389404},"labels":[],"label_agreement":null},{"id":"W4412443876","doi":"10.1016/j.jval.2025.04.227","title":"CO142 Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Estrogen receptor; Oncology; Human Epidermal Growth Factor Receptor 2; Breast cancer; Stage (stratigraphy); Internal medicine; Medicine; Overall survival; Estrogen; Association (psychology); Cancer; Biology; Psychology; Psychotherapist","score_opus":0.021796428215652187,"score_gpt":0.3126796995815,"score_spread":0.2908832713658478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826306,0.00040735627,0.00006425023,0.00009244351,0.000019792833,0.0000028358943,0.0002984082,0.0000034367313,0.0008484732],"genre_scores_gemma":[0.9989986,0.00007210641,0.000024953817,0.000030293253,0.000026261443,0.0000023493942,0.00028821972,0.0000017578187,0.00055541605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99984634,0.000042408075,0.000013294145,0.000030167366,0.00001872345,0.000049034043],"domain_scores_gemma":[0.9993563,0.0001990619,0.00016219186,0.000035469417,0.00005661778,0.00019036347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027955108,0.00021414751,0.0003283851,0.0003516796,0.00026251024,0.0005227014,0.00023176442,0.00042888086,0.0031638579],"category_scores_gemma":[0.0010611063,0.00015540545,0.0005034366,0.0005495221,0.0002026758,0.00033072828,0.00030347006,0.0006862921,0.00035513632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013106641,0.000051404426,0.9961694,0.000009509253,0.00010611429,0.00009621175,0.00002033991,0.000054303262,0.00046978108,0.000022480674,0.00013028478,0.0015596608],"study_design_scores_gemma":[0.000033626962,0.00017538162,0.998782,0.0000024067551,0.00008542626,0.00017412669,0.00008531017,0.0003057587,0.00008679305,0.00005627183,0.00020844788,0.000004320446],"about_ca_topic_score_codex":0.0019114274,"about_ca_topic_score_gemma":0.0032610947,"teacher_disagreement_score":0.0031638579,"about_ca_system_score_codex":0.00022713863,"about_ca_system_score_gemma":0.00025251176,"threshold_uncertainty_score":0.010584116},"labels":[],"label_agreement":null},{"id":"W4412443922","doi":"10.1016/j.jval.2025.04.202","title":"CO117 Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Offspring; Medicine; Prenatal exposure; Obstetrics; Pediatrics; Pregnancy; Genetics; Biology","score_opus":0.052135066205723696,"score_gpt":0.3979382680527687,"score_spread":0.34580320184704505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99901104,0.00019231679,0.00008254524,0.000040222007,0.0000067720694,0.0000054698357,0.00025362757,0.0000031784698,0.0004047839],"genre_scores_gemma":[0.99916136,0.00016470208,0.000093912015,0.00002848978,0.000009690794,0.000008414241,0.00016788089,0.0000031532288,0.00036246836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99917966,0.00020559924,0.000081288505,0.00024002648,0.00016228789,0.00013121146],"domain_scores_gemma":[0.9982027,0.0003488551,0.0007478477,0.00017496325,0.00018443217,0.0003411839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004300345,0.0004916523,0.0004360612,0.0013011515,0.00084151374,0.0009744666,0.00051956606,0.00097645447,0.0031410544],"category_scores_gemma":[0.0025557482,0.0007223533,0.0008859121,0.001939124,0.0004670811,0.00063696504,0.0006366325,0.0010454381,0.00043948376],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071442366,0.0000790115,0.99858487,0.00000569393,0.00009746147,0.00017305774,0.0001095933,0.000009099812,0.000282601,0.000012904227,0.000033953886,0.00054027495],"study_design_scores_gemma":[0.00000463095,0.00013769035,0.9987103,0.000004949212,0.00006347527,0.0005758748,0.00028315588,0.0000570841,0.0000641068,0.000013132698,0.00008105931,0.0000045466186],"about_ca_topic_score_codex":0.012841333,"about_ca_topic_score_gemma":0.009645479,"teacher_disagreement_score":0.012841333,"about_ca_system_score_codex":0.00040075855,"about_ca_system_score_gemma":0.00041998905,"threshold_uncertainty_score":0.0255332},"labels":[],"label_agreement":null},{"id":"W4412443923","doi":"10.1016/j.jval.2025.04.122","title":"CO37 A Clinical Prediction Model of Asymptomatic Left Ventricular Dysfunction in Survivors of Childhood Cancer in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Asymptomatic; Childhood cancer; Medicine; Internal medicine; Cancer; Cardiology; Pediatrics","score_opus":0.03625909761759944,"score_gpt":0.3256033927102128,"score_spread":0.2893442950926134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97876614,0.0008527571,0.001754573,0.0027304885,0.00008555824,0.00010724717,0.011622563,0.00005913591,0.0040215603],"genre_scores_gemma":[0.99160284,0.0002978829,0.00079905073,0.00009727368,0.000019617364,0.000045724886,0.0040071765,0.0000113301985,0.0031189993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957126,0.00009199632,0.000027648872,0.00008371217,0.00007625905,0.0001490836],"domain_scores_gemma":[0.9976387,0.0004625644,0.0002161941,0.00006286473,0.001189898,0.00042974076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011305759,0.0005212121,0.00071661,0.0009908439,0.0016550212,0.0016590023,0.001565771,0.00060572,0.003678722],"category_scores_gemma":[0.004952794,0.0003606251,0.00086149765,0.0014959871,0.00042055157,0.0002884909,0.00064738776,0.0008699616,0.0004459271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032410616,0.00014119223,0.9565179,0.000068566536,0.00026703734,0.0002561271,0.00029854474,0.0158709,0.00015041277,0.00092500675,0.01306425,0.012116087],"study_design_scores_gemma":[0.00023451206,0.00008980884,0.7689821,0.00019210977,0.0003167959,0.00014784002,0.0015130172,0.22094877,0.00013721913,0.0011237926,0.0062522744,0.00006183895],"about_ca_topic_score_codex":0.9919276,"about_ca_topic_score_gemma":0.9915383,"teacher_disagreement_score":0.020820014,"about_ca_system_score_codex":0.020820014,"about_ca_system_score_gemma":0.03033723,"threshold_uncertainty_score":0.15106046},"labels":[],"label_agreement":null},{"id":"W4412443927","doi":"10.1016/j.jval.2025.04.520","title":"EE230 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Macular degeneration; Biosimilar; Medicine; Ophthalmology; Optometry; Internal medicine","score_opus":0.18672636671109538,"score_gpt":0.3700463229583275,"score_spread":0.18331995624723213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94200486,0.022545861,0.00038098104,0.007988178,0.000211276,0.00028005088,0.017687524,0.000028594488,0.00887271],"genre_scores_gemma":[0.99274606,0.0025345457,0.00027979567,0.00048875564,0.00004896157,0.00003356131,0.0028631478,0.000008432346,0.0009966688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977291,0.0006958213,0.00020043772,0.00020384768,0.0005435715,0.0006272541],"domain_scores_gemma":[0.99543756,0.0013328716,0.0007430457,0.00010984588,0.0011693261,0.001207333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022710434,0.00040797,0.0011272631,0.0007325966,0.0007687928,0.0024507116,0.00073884707,0.0009050895,0.0024404156],"category_scores_gemma":[0.012119148,0.0002739585,0.0023460567,0.002356947,0.00087214273,0.0006918325,0.0006959733,0.0019201866,0.00011533321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.103452645,0.0016574159,0.56191957,0.0040381937,0.014390077,0.00091028353,0.0007828791,0.075804494,0.0014039978,0.010271627,0.043538034,0.18183087],"study_design_scores_gemma":[0.016254101,0.0042314995,0.8942798,0.0016661764,0.007955538,0.00056568364,0.0021038656,0.049294572,0.00083975954,0.002624509,0.019803807,0.00038059094],"about_ca_topic_score_codex":0.97271186,"about_ca_topic_score_gemma":0.97515815,"teacher_disagreement_score":0.083058074,"about_ca_system_score_codex":0.083058074,"about_ca_system_score_gemma":0.05726537,"threshold_uncertainty_score":0.60263133},"labels":[],"label_agreement":null},{"id":"W4412443976","doi":"10.1016/j.jval.2025.04.868","title":"HPR144 Factors Delaying the Public Listing of New Drugs in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Listing (finance); Business; Finance","score_opus":0.4317824058761227,"score_gpt":0.4091372046130519,"score_spread":0.02264520126307079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83734846,0.0081931,0.00061288243,0.09974399,0.00082238246,0.0001866365,0.01623147,0.00015758468,0.03670338],"genre_scores_gemma":[0.98290575,0.002189157,0.00034747788,0.005898978,0.00032801347,0.00002261021,0.0025968747,0.000038082337,0.0056730397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99600005,0.0002440685,0.00024211073,0.00023992713,0.0015782078,0.0016956826],"domain_scores_gemma":[0.96040624,0.0060015167,0.009302541,0.0004194993,0.013017097,0.010853133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024769139,0.00018516641,0.00058069633,0.0017212991,0.002597079,0.0040872274,0.0019001983,0.001987132,0.008049105],"category_scores_gemma":[0.025195729,0.0004015681,0.0009862981,0.002865556,0.0010007485,0.0009498875,0.0010125542,0.0040768604,0.00026868976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010685641,0.000360303,0.8522479,0.00033885898,0.00031911978,0.0008186366,0.0010452484,0.0042541614,0.00061020453,0.00776862,0.081532866,0.049635503],"study_design_scores_gemma":[0.00013481069,0.0001244443,0.9682643,0.00026260424,0.00019570367,0.00028843523,0.0018113437,0.0036653648,0.00040710077,0.00052424095,0.024260696,0.000060997227],"about_ca_topic_score_codex":0.9935447,"about_ca_topic_score_gemma":0.9957533,"teacher_disagreement_score":0.9254293,"about_ca_system_score_codex":0.074570715,"about_ca_system_score_gemma":0.15313771,"threshold_uncertainty_score":0.5410509},"labels":[],"label_agreement":null},{"id":"W4412443996","doi":"10.1016/j.jval.2025.04.087","title":"CO2 Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; La Boîte à lettres; Université de Sherbrooke","funders":"","keywords":"Anxiety; Cognitive behaviour therapy; Quality of life (healthcare); Psychology; Clinical psychology; Cognition; Psychotherapist; Psychiatry","score_opus":0.13571995501308673,"score_gpt":0.48072394851149997,"score_spread":0.34500399349841326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980051,0.0005660382,0.00016551062,0.00008485367,0.00004642384,0.000037007725,0.00012862976,0.000009776257,0.0009567219],"genre_scores_gemma":[0.9992324,0.000108738954,0.00009513958,0.000056140547,0.000012860108,0.000026733278,0.00009232049,0.0000013750715,0.00037425032],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99953556,0.00015296588,0.00003989573,0.0000873603,0.000053880533,0.00013034571],"domain_scores_gemma":[0.9991423,0.0003864607,0.00012459914,0.000054140568,0.00005664281,0.00023579731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000491566,0.00030112953,0.0006217174,0.0003277461,0.00018813006,0.00049840164,0.00022514032,0.00035828055,0.0030830165],"category_scores_gemma":[0.002293984,0.00011831555,0.0008742944,0.00027023096,0.00026931605,0.00028986557,0.00036387076,0.0006035526,0.00016368617],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.38368648,0.024160748,0.26234135,0.00066154764,0.005237354,0.00016728969,0.0007841992,0.0017078557,0.011904156,0.0004868412,0.0013933259,0.3074689],"study_design_scores_gemma":[0.005090001,0.022237036,0.96593976,0.00007392637,0.0015874838,0.00008862792,0.00044606827,0.0020911596,0.0013734368,0.00029100248,0.0007486477,0.000032871867],"about_ca_topic_score_codex":0.0045811213,"about_ca_topic_score_gemma":0.0056780595,"teacher_disagreement_score":0.0045811213,"about_ca_system_score_codex":0.0004310495,"about_ca_system_score_gemma":0.0005901097,"threshold_uncertainty_score":0.010313749},"labels":[],"label_agreement":null},{"id":"W4412444010","doi":"10.1016/j.jval.2025.04.018","title":"P12 Development and Prospective Evaluation of the Bladder Utility Symptom Scale (Utility): A Novel Tool to Measure Utilities and Quality of LIfe in Bladder Cancer Patients","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University of Waterloo; McGill University Health Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Measure (data warehouse); Quality of life (healthcare); Scale (ratio); Medicine; Quality (philosophy); Intensive care medicine; Cancer; Computer science; Data mining; Internal medicine; Nursing; Geography; Cartography","score_opus":0.09442651486090517,"score_gpt":0.36225017490191336,"score_spread":0.2678236600410082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97790843,0.0008413571,0.0034750612,0.00040391358,0.000077650126,0.0032521086,0.01018452,0.000058193098,0.0037988327],"genre_scores_gemma":[0.971476,0.0004278666,0.006383967,0.00022037879,0.000060266884,0.005374586,0.013191461,0.00004812921,0.0028174357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961216,0.0021124333,0.0003550407,0.00025910855,0.00086655316,0.00028535913],"domain_scores_gemma":[0.9943455,0.0012739702,0.0013173136,0.00031739127,0.0022225345,0.00052333873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007299391,0.00090165075,0.0007157343,0.0012765105,0.0007819445,0.0016672942,0.00076391734,0.0007260252,0.0023362224],"category_scores_gemma":[0.011745254,0.00049140444,0.0014856919,0.002103371,0.00054745685,0.00094790215,0.0016124324,0.001410339,0.0010329988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067221536,0.0018473216,0.933902,0.00018785353,0.00049718807,0.00009214797,0.00039776292,0.0009429597,0.0006028346,0.00038223827,0.0039578094,0.050467737],"study_design_scores_gemma":[0.0011584876,0.0067027095,0.98147684,0.00007261345,0.00028706907,0.00021497508,0.0002776548,0.0027292336,0.0011174895,0.0002295263,0.0056863404,0.000047099624],"about_ca_topic_score_codex":0.005268928,"about_ca_topic_score_gemma":0.0055785314,"teacher_disagreement_score":0.007299391,"about_ca_system_score_codex":0.00084971794,"about_ca_system_score_gemma":0.0018339289,"threshold_uncertainty_score":0.038603365},"labels":[],"label_agreement":null},{"id":"W4412444043","doi":"10.1016/j.jval.2025.04.1603","title":"RWD19 Persistence Patterns of Antidepressants in Mood, Anxiety, and Related Disorders: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Persistence (discontinuity); Mood; Anxiety; Mood disorders; Retrospective cohort study; Cohort; Psychiatry; Medicine; Clinical psychology; Psychology; Internal medicine","score_opus":0.04959838992795079,"score_gpt":0.3978190027805907,"score_spread":0.3482206128526399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787366,0.00034547487,0.00013106783,0.000029962594,0.0000136786975,0.000018720792,0.0011868231,0.0000041237818,0.00039647552],"genre_scores_gemma":[0.9982994,0.0001342864,0.00011118961,0.000041401938,0.000014106087,0.000018979787,0.0010150409,0.0000052610453,0.00036025626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992607,0.00011550222,0.00009620771,0.00026638713,0.00010881891,0.00015220318],"domain_scores_gemma":[0.99862695,0.000108952,0.00054841826,0.00026610398,0.00020214258,0.00024737942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006459309,0.00035273895,0.00043811154,0.00067934033,0.0007013652,0.0009257588,0.00051922863,0.0006307464,0.0019307348],"category_scores_gemma":[0.0017137432,0.00055638445,0.0011373877,0.0010166744,0.0002687128,0.00066502194,0.0005610019,0.0010893558,0.0006324921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010077207,0.000037362555,0.99889046,0.0000052027817,0.00013026109,0.000043383377,0.000049734972,0.000011204149,0.00013731167,0.000014015863,0.000094694056,0.00048567602],"study_design_scores_gemma":[0.000007078632,0.00007372018,0.9993556,0.0000040505715,0.00005781035,0.00015811865,0.00012421627,0.000039575305,0.000026249316,0.000011613434,0.00013762659,0.000004307791],"about_ca_topic_score_codex":0.010547737,"about_ca_topic_score_gemma":0.011097119,"teacher_disagreement_score":0.010547737,"about_ca_system_score_codex":0.00042175618,"about_ca_system_score_gemma":0.0004295175,"threshold_uncertainty_score":0.02097267},"labels":[],"label_agreement":null},{"id":"W4412444103","doi":"10.1016/j.jval.2025.04.1255","title":"MSR103 Regularized MAIC As a Modern Solution for Indirect Treatment Comparison Challenges","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Materials Science","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Computer science","score_opus":0.07728493398125805,"score_gpt":0.3653947029000212,"score_spread":0.28810976891876316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444103","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02692344,0.0015309576,0.95465666,0.0018682482,0.00043650164,0.00013466408,0.0009180106,0.0033154213,0.010216119],"genre_scores_gemma":[0.43253547,0.00060367817,0.54105455,0.0013844132,0.00042434086,0.0004233907,0.002547896,0.0019942569,0.019032005],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982602,0.000598087,0.00007930274,0.0003234748,0.0006386458,0.00010024959],"domain_scores_gemma":[0.9973717,0.0010148576,0.00017533902,0.0006916452,0.00063782575,0.00010857726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004085966,0.00069344783,0.0011833784,0.00082762557,0.0006753648,0.001858158,0.0025302276,0.0018712903,0.012045333],"category_scores_gemma":[0.009055187,0.0004309338,0.00091024215,0.0007717196,0.0008101213,0.0018246049,0.0020610972,0.0026154958,0.0020935296],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013640011,0.00046027487,0.002786713,0.0007524803,0.00046362125,0.00016637436,0.00017856226,0.26186836,0.029468438,0.10624559,0.043176644,0.55306894],"study_design_scores_gemma":[0.00003079062,0.00011561131,0.0007448289,0.000042015206,0.00003661721,0.00009081804,0.000024564813,0.9575627,0.008025352,0.023146285,0.01015241,0.000027983247],"about_ca_topic_score_codex":0.00278934,"about_ca_topic_score_gemma":0.0037888219,"teacher_disagreement_score":0.012045333,"about_ca_system_score_codex":0.0009170085,"about_ca_system_score_gemma":0.0021992675,"threshold_uncertainty_score":0.0402956},"labels":[],"label_agreement":null},{"id":"W4412444163","doi":"10.1016/j.jval.2025.04.1272","title":"MSR120 Estimating Sample Size for Training Ensemble Machine Learning Models","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning and Data Classification","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Training (meteorology); Ensemble learning; Computer science; Machine learning; Sample (material); Artificial intelligence; Sample size determination; Statistics; Mathematics; Geography; Chemistry; Chromatography","score_opus":0.11542284370992471,"score_gpt":0.34130861622580205,"score_spread":0.22588577251587733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444163","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10314663,0.00046997072,0.8909307,0.0003567415,0.00016778504,0.00015718669,0.00041472915,0.0025474385,0.0018088298],"genre_scores_gemma":[0.52665335,0.0001950005,0.46788466,0.00020441742,0.0001728754,0.0004739319,0.001757454,0.00037928615,0.0022790313],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977736,0.0011200955,0.00015642097,0.00035439053,0.00047035073,0.00012524505],"domain_scores_gemma":[0.9830467,0.012150176,0.00039125307,0.0016740096,0.0025619762,0.00017579099],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061471746,0.0005756071,0.0011336538,0.0010152468,0.00047886773,0.0007638828,0.0012723427,0.0011742164,0.0036797884],"category_scores_gemma":[0.04330021,0.0005006123,0.00079542137,0.0005892054,0.00027294795,0.0012922088,0.001046785,0.0015609902,0.0011844102],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014044223,0.0003582037,0.014615895,0.00016050995,0.00026314732,0.00011396155,0.0001596689,0.30257478,0.011715554,0.007114498,0.009692285,0.651827],"study_design_scores_gemma":[0.000034268483,0.000087757355,0.0014828678,0.000019168468,0.000021452362,0.00003701372,0.00001650013,0.9915387,0.0032570448,0.0026817613,0.0008156749,0.000007796667],"about_ca_topic_score_codex":0.0037211534,"about_ca_topic_score_gemma":0.0045952443,"teacher_disagreement_score":0.0061471746,"about_ca_system_score_codex":0.0005944219,"about_ca_system_score_gemma":0.0011934112,"threshold_uncertainty_score":0.032509744},"labels":[],"label_agreement":null},{"id":"W4412444215","doi":"10.1016/j.jval.2025.04.1266","title":"MSR114 Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Simulation Techniques and Applications","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Course (navigation); Computer science; Data science; Engineering","score_opus":0.6871830130721395,"score_gpt":0.5494683091067032,"score_spread":0.13771470396543628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444215","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25096744,0.057020858,0.6353468,0.02164498,0.0029155668,0.002757497,0.014048331,0.004389324,0.010909248],"genre_scores_gemma":[0.8722519,0.0036343792,0.113504514,0.0023840978,0.00042072174,0.0017763238,0.0024818669,0.0010024636,0.0025437847],"study_design_codex":"meta_analysis","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.73783064,0.24843705,0.004816233,0.0053155622,0.002810356,0.00079015485],"domain_scores_gemma":[0.30177242,0.6696989,0.0055002565,0.017538514,0.004638085,0.0008518272],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.18487923,0.00242425,0.004264313,0.00223993,0.000982036,0.0037350154,0.003434278,0.003530997,0.013239626],"category_scores_gemma":[0.5000528,0.002104415,0.024476705,0.0039215586,0.0013230885,0.0035348397,0.0039301286,0.005683651,0.0011308634],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.036301255,0.00071244437,0.050927132,0.0167308,0.46204305,0.0007893779,0.00094050326,0.25724125,0.0015552358,0.02217803,0.012088345,0.13849254],"study_design_scores_gemma":[0.01671709,0.004887288,0.016965814,0.0042003756,0.31129012,0.00065007416,0.00029959244,0.5437892,0.0028259286,0.074975014,0.02305724,0.00034224894],"about_ca_topic_score_codex":0.016978903,"about_ca_topic_score_gemma":0.013497806,"teacher_disagreement_score":0.81512076,"about_ca_system_score_codex":0.001992722,"about_ca_system_score_gemma":0.004318151,"threshold_uncertainty_score":0.9777465},"labels":[],"label_agreement":null},{"id":"W4412444224","doi":"10.1016/j.jval.2025.04.1224","title":"MSR72 Integrating Artificial Intelligence (AI) and Machine Learning (ML) Techniques With Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Precision Medicine: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Esri (Canada)","funders":"","keywords":"Real world data; Real world evidence; Artificial intelligence; Computer science; Machine learning; Data science; Medicine","score_opus":0.5187334153853591,"score_gpt":0.5633874671654828,"score_spread":0.044654051780123716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009391383,0.99851006,0.00015839476,0.00035488795,0.0001240435,0.000039167295,0.00009015556,0.000006941801,0.00062235043],"genre_scores_gemma":[0.00079034676,0.99790275,0.00049848,0.0003584356,0.00005755705,0.000039351093,0.000079863414,0.0000030578508,0.0002701469],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9982493,0.00047714313,0.0005309714,0.00018113507,0.00047863158,0.00008287828],"domain_scores_gemma":[0.99153817,0.006241302,0.0008802582,0.00013850605,0.0010762785,0.00012548889],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004806319,0.0010491182,0.0034386464,0.007890085,0.0004997122,0.002922435,0.0015002341,0.0024291663,0.011309824],"category_scores_gemma":[0.015156401,0.0005494758,0.0032278402,0.007652353,0.00071615697,0.0024787346,0.001815859,0.0016528332,0.0021434277],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015338065,0.000048376958,0.00021290753,0.36717626,0.0013258214,0.00010693572,0.00012262532,0.00020415551,0.0005224597,0.0033040172,0.009933505,0.61688954],"study_design_scores_gemma":[0.00012432027,0.0001541826,0.0015384766,0.5914995,0.008933095,0.00044901014,0.00020090936,0.00012710129,0.00052443414,0.0028689713,0.39352223,0.000057756042],"about_ca_topic_score_codex":0.0057167686,"about_ca_topic_score_gemma":0.013376227,"teacher_disagreement_score":0.99519366,"about_ca_system_score_codex":0.0020860774,"about_ca_system_score_gemma":0.008517039,"threshold_uncertainty_score":0.03783518},"labels":[],"label_agreement":null},{"id":"W4412447238","doi":"10.1016/j.jval.2025.06.021","title":"Measuring Aversion to Income-Related Health Inequality in Canada: An Equity-Efficiency Trade-Off Experiment","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Toronto Public Health; Western University; University of Toronto; London Health Sciences Centre; Public Health Ontario","funders":"Canadian Institutes of Health Research","keywords":"Equity (law); Economics; Health equity; Inequity aversion; Economic inequality; Inequality; Demographic economics; Public economics; Health care; Economic growth; Political science; Mathematics","score_opus":0.4189182093835194,"score_gpt":0.43540011068874657,"score_spread":0.016481901305227142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412447238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98836166,0.00012216489,0.0014627221,0.0003349718,0.000019159676,0.001232373,0.0006377748,0.000018960403,0.0078102215],"genre_scores_gemma":[0.98723537,0.00016831227,0.005181343,0.00065616256,0.000014686359,0.0014453842,0.00048350933,0.000010056669,0.0048050815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740857,0.0008795557,0.00010744047,0.00043308546,0.0007174717,0.000453845],"domain_scores_gemma":[0.9901517,0.0051436527,0.0016528388,0.00093485636,0.0011937751,0.0009230543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060805846,0.0011335528,0.00084316963,0.00042866895,0.0029012659,0.0014221023,0.0012887685,0.0014747988,0.0068603433],"category_scores_gemma":[0.013604074,0.0004492737,0.0009004922,0.000784442,0.0023310094,0.0007284939,0.0010288042,0.0014101604,0.00026845443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11545132,0.059903134,0.44666767,0.0027607502,0.0027896552,0.0008278484,0.019928413,0.04871116,0.05620818,0.028794918,0.02305487,0.19490214],"study_design_scores_gemma":[0.017484808,0.023955686,0.8335688,0.0005034686,0.0016620121,0.00015781136,0.0053444635,0.06964826,0.011305229,0.014103317,0.021662386,0.0006037747],"about_ca_topic_score_codex":0.8489188,"about_ca_topic_score_gemma":0.8820426,"teacher_disagreement_score":0.1510812,"about_ca_system_score_codex":0.021812793,"about_ca_system_score_gemma":0.01910944,"threshold_uncertainty_score":0.30394185},"labels":[],"label_agreement":null},{"id":"W4412822684","doi":"10.1016/j.jval.2025.07.016","title":"Testing the Valuation of the EQ-5D-Y-5L in Adults and Adolescents: Results From a 5-Country Study and Implications for the Descriptive System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"Erasmus Universitair Medisch Centrum Rotterdam; Guizhou Medical University; EuroQol Research Foundation","keywords":"Respondent; Valuation (finance); EQ-5D; Descriptive statistics; Psychology; Logit; Randomness; Demography; Logistic regression; Ordered logit; Medicine; Econometrics; Statistics; Health related quality of life; Mathematics; Economics","score_opus":0.4410937936272542,"score_gpt":0.40122949762028787,"score_spread":0.03986429600696634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412822684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99825245,0.00006196924,0.0007095153,0.00004965308,0.00000455935,0.000075438744,0.0003495387,0.0000023661696,0.00049446133],"genre_scores_gemma":[0.9980184,0.00005746066,0.001018127,0.000049810737,0.0000034751536,0.00020293971,0.000541784,0.0000026325085,0.0001054616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9888383,0.008263085,0.00091731834,0.00072289666,0.00086774246,0.00039069942],"domain_scores_gemma":[0.96731526,0.020023718,0.005451564,0.0034036066,0.0031079752,0.0006979309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026168289,0.00034448912,0.00047585522,0.0009144521,0.00051880715,0.00128548,0.00057061884,0.0006538588,0.0021254537],"category_scores_gemma":[0.041663926,0.00026546052,0.0015430386,0.0014099737,0.0011054508,0.0020468263,0.0015830051,0.0008562555,0.00036622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041961248,0.00029206375,0.98873806,0.000051742143,0.00015842036,0.00006719926,0.0026817154,0.0004894969,0.00012974966,0.00046656525,0.00023278936,0.0062725614],"study_design_scores_gemma":[0.000085601525,0.0015424027,0.9810606,0.00010119748,0.000107655345,0.00018463252,0.011711718,0.0029193487,0.0004145865,0.00042833269,0.0014131258,0.000030712104],"about_ca_topic_score_codex":0.0045637996,"about_ca_topic_score_gemma":0.0041257413,"teacher_disagreement_score":0.026168289,"about_ca_system_score_codex":0.000677754,"about_ca_system_score_gemma":0.0005750322,"threshold_uncertainty_score":0.1383928},"labels":[],"label_agreement":null},{"id":"W4414105061","doi":"10.1016/j.jval.2025.08.019","title":"Cost-Effectiveness of the 15 Drugs Selected for Initial Price Applicability Year 2027 by Centers for Medicare and Medicaid Services Drug Price Negotiation Program","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Negotiation; Medicaid; Transparency (behavior); Drug prices; Consistency (knowledge bases); Drug pricing","score_opus":0.14858128023420425,"score_gpt":0.4313074401399257,"score_spread":0.2827261599057215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414105061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98084474,0.0033922386,0.0001977353,0.0010742815,0.00014222806,0.00016673435,0.007832197,0.000020305251,0.006329681],"genre_scores_gemma":[0.9922644,0.00058748433,0.00014761194,0.00029425623,0.00005188253,0.000050273517,0.005206675,0.000004300476,0.0013930255],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987888,0.0004882722,0.00010371693,0.00011112917,0.00028373307,0.00022437921],"domain_scores_gemma":[0.99625695,0.0018407855,0.0007436396,0.0000883085,0.0003052307,0.0007650759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027390267,0.00029381676,0.0008567852,0.00104347,0.00024305527,0.0011672482,0.0004903659,0.0007503744,0.0067662154],"category_scores_gemma":[0.007051489,0.00014421323,0.0026820567,0.00079139764,0.00023162413,0.00074638735,0.0005835646,0.0009978628,0.0005342117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22407338,0.007309952,0.4393654,0.0010322698,0.0073050284,0.00046496087,0.00015582869,0.043042216,0.0020713178,0.0046080276,0.037145246,0.23342638],"study_design_scores_gemma":[0.02207976,0.03638441,0.8674158,0.0006385351,0.0066496856,0.0007226961,0.00082598545,0.04122565,0.004490662,0.0026024727,0.016794857,0.00016947676],"about_ca_topic_score_codex":0.008665493,"about_ca_topic_score_gemma":0.012197659,"teacher_disagreement_score":0.008665493,"about_ca_system_score_codex":0.001634191,"about_ca_system_score_gemma":0.0018236595,"threshold_uncertainty_score":0.022635281},"labels":[],"label_agreement":null},{"id":"W4414106751","doi":"10.1016/j.jval.2025.08.016","title":"Unlocking Patient Preferences: The Potential of Stated-Preference Methods in Clinical Decision Making","year":2025,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Relevance (law); Clinical decision making; Quality (philosophy); Medical decision making; Clinical Practice; Clinical decision support system","score_opus":0.37024698167445275,"score_gpt":0.5634809392125011,"score_spread":0.19323395753804834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414106751","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054168693,0.018900996,0.0019680366,0.07516413,0.90236115,0.000054571996,0.000117021336,0.00007300847,0.0013070015],"genre_scores_gemma":[0.0012263459,0.016888652,0.002346078,0.029213624,0.9470976,0.00013834199,0.000042570555,0.000054760916,0.0029920638],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9641315,0.020103117,0.0034127727,0.0013115162,0.010657691,0.00038353258],"domain_scores_gemma":[0.60383236,0.361588,0.003517448,0.003204963,0.024531813,0.0033254877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0545994,0.0032342873,0.0047788518,0.00416628,0.0026837578,0.013720481,0.006459011,0.020945767,0.010384026],"category_scores_gemma":[0.1972973,0.0014564416,0.004616671,0.0032508778,0.006794175,0.008472527,0.002354216,0.032671157,0.0037849862],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011553752,0.00003601603,0.000039740768,0.0017932318,0.00023520208,0.00007998587,0.00010374857,0.00013695595,0.000042018713,0.0045367638,0.95483387,0.038046997],"study_design_scores_gemma":[0.000449797,0.00012218386,0.00033081893,0.0052678226,0.0005376598,0.00023246426,0.00029879558,0.0022987048,0.00025592587,0.02921039,0.9608514,0.00014412026],"about_ca_topic_score_codex":0.0016770255,"about_ca_topic_score_gemma":0.0048786434,"teacher_disagreement_score":0.0545994,"about_ca_system_score_codex":0.0028922833,"about_ca_system_score_gemma":0.004685163,"threshold_uncertainty_score":0.28875268},"labels":[],"label_agreement":null},{"id":"W4414480124","doi":"10.1016/j.jval.2025.09.008","title":"Validating Loon Lens 1.0 for Autonomous Abstract Screening and Confidence-Guided Human-in-the-Loop Workflows in Systematic Reviews","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Ottawa; Dalhousie University; Ottawa Hospital; Life Prediction Technologies (Canada)","funders":"","keywords":"Workflow; False positive paradox; Sensitivity (control systems); Lens (geology); True positive rate; Through-the-lens metering","score_opus":0.8436006557405845,"score_gpt":0.572996590528697,"score_spread":0.2706040652118875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414480124","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04657653,0.023819422,0.6859016,0.016987141,0.0021907387,0.014584416,0.039254755,0.15084293,0.019842533],"genre_scores_gemma":[0.10212437,0.001650301,0.87236184,0.0021540492,0.0001870934,0.009364565,0.0053079585,0.0058844113,0.0009654584],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.6884773,0.24698433,0.03699051,0.011826055,0.014080507,0.001641284],"domain_scores_gemma":[0.15652147,0.7737933,0.020690871,0.028424125,0.018953433,0.0016167217],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.30365324,0.003167564,0.0043708505,0.01059183,0.0021796175,0.017496504,0.0042364667,0.004028996,0.01592209],"category_scores_gemma":[0.7048997,0.003668758,0.007796909,0.0071223155,0.0020519267,0.0092886975,0.011760163,0.0037442357,0.0050112423],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015649598,0.0006227821,0.042062316,0.10464629,0.021351194,0.0006005291,0.014077611,0.020707382,0.0063666115,0.044693522,0.13438971,0.5948325],"study_design_scores_gemma":[0.013916838,0.0032155795,0.03657016,0.04810906,0.022828102,0.0011354209,0.0040878053,0.26592457,0.030066263,0.24227662,0.32910284,0.0027667829],"about_ca_topic_score_codex":0.0068938187,"about_ca_topic_score_gemma":0.014749367,"teacher_disagreement_score":0.69634676,"about_ca_system_score_codex":0.0045128465,"about_ca_system_score_gemma":0.028189018,"threshold_uncertainty_score":0.8587195},"labels":[],"label_agreement":null},{"id":"W4414480137","doi":"10.1016/j.jval.2025.09.009","title":"Comparing Psychometric Properties of 6 of the 5-Level and 3-Level EQ-5D Bolt-Ons in a Large, Multinational, Longitudinal General Population Sample","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Assistive Technology in Communication and Mobility","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"EuroQol Research Foundation","keywords":"Sample (material); Ceiling effect; Ceiling (cloud); Population; Longitudinal data; Psychometrics","score_opus":0.45666636744405903,"score_gpt":0.4574874650875644,"score_spread":0.000821097643505353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414480137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980526,0.00016711745,0.00036878843,0.000057323494,0.000011509241,0.000048749855,0.0006848712,0.000009508803,0.00059952174],"genre_scores_gemma":[0.9969704,0.00009317596,0.00071500975,0.00006160587,0.000010898086,0.0000959743,0.0018505864,0.0000048511006,0.00019743908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969944,0.0012366972,0.00042925397,0.00032362767,0.0007687422,0.0002472748],"domain_scores_gemma":[0.99187076,0.0025533736,0.0029211626,0.00072075624,0.001465954,0.00046805333],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008625219,0.00045826068,0.00044341266,0.0011702429,0.00034453018,0.00093727576,0.00060171663,0.0007361261,0.0014426495],"category_scores_gemma":[0.016319094,0.00022281305,0.0020112942,0.0011794812,0.00048313977,0.00095071684,0.0012210255,0.0006713303,0.0003205839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015055355,0.000071186354,0.9941176,0.000021191388,0.00016853643,0.000013301663,0.00009770525,0.00013263781,0.00007829924,0.000022262544,0.00009359189,0.005033128],"study_design_scores_gemma":[0.000015910598,0.00033064425,0.99871516,0.000014376496,0.000054167926,0.000047055444,0.00017554843,0.00034976844,0.000067375404,0.000034737,0.00018913495,0.000005969935],"about_ca_topic_score_codex":0.003458845,"about_ca_topic_score_gemma":0.004898825,"teacher_disagreement_score":0.008625219,"about_ca_system_score_codex":0.0005772851,"about_ca_system_score_gemma":0.0005554942,"threshold_uncertainty_score":0.045615077},"labels":[],"label_agreement":null},{"id":"W4414579224","doi":"10.1016/j.jval.2025.09.010","title":"Cost-Effectiveness of Reorganizing the Approach to Diabetes Through the Application of Registries: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; South Health Campus; Alliance for Canadian Health Outcomes Research in Diabetes","funders":"Lawson Foundation; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions","keywords":"Agency (philosophy); Diabetes mellitus; Value (mathematics); Health care; Health services","score_opus":0.06341318063131146,"score_gpt":0.3256609945013752,"score_spread":0.26224781387006374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414579224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97563124,0.0012531253,0.0015742613,0.008954833,0.00017035067,0.0015768406,0.0013009425,0.0001458129,0.009392665],"genre_scores_gemma":[0.99292207,0.00073027774,0.003737642,0.00060579315,0.000037221576,0.00028452315,0.0006234223,0.000014556286,0.0010446325],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98866665,0.0061038896,0.00064705673,0.0006508127,0.0019642622,0.0019674446],"domain_scores_gemma":[0.9713272,0.008026218,0.0037730797,0.0020818135,0.006117098,0.008674554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009413728,0.000570341,0.00064628525,0.0015668857,0.0031925116,0.0028525696,0.00237104,0.0013396038,0.0031875202],"category_scores_gemma":[0.038784865,0.0004851223,0.0013609248,0.0023814938,0.0010695069,0.0014888756,0.003425348,0.001602735,0.00019992958],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006861763,0.011964089,0.44634214,0.0008555751,0.0010122742,0.00042399723,0.0038722516,0.032605723,0.0005544018,0.0041695633,0.025960822,0.4653774],"study_design_scores_gemma":[0.003997837,0.0062199505,0.8798989,0.0010265836,0.0019139766,0.00037784237,0.0111565655,0.07689276,0.0009244289,0.0018530855,0.0154008465,0.00033718775],"about_ca_topic_score_codex":0.95023996,"about_ca_topic_score_gemma":0.96544504,"teacher_disagreement_score":0.049760044,"about_ca_system_score_codex":0.04880429,"about_ca_system_score_gemma":0.12934461,"threshold_uncertainty_score":0.3541016},"labels":[],"label_agreement":null},{"id":"W4415679345","doi":"10.1016/j.jval.2025.10.005","title":"The Uneven Path of Psychological Distress: How Socioeconomic Status Shapes Distress Transitions in Australian Adults","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Melbourne Institute, University of Melbourne","keywords":"Socioeconomic status; Psychological distress; Path (computing); Reimbursement; Distress","score_opus":0.23977851133572656,"score_gpt":0.4325071496425308,"score_spread":0.19272863830680423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415679345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979405,0.00034995456,0.00022390235,0.00065297,0.000009791849,0.000020190357,0.00021061962,0.0000022527954,0.0005898425],"genre_scores_gemma":[0.9993217,0.0001598781,0.00013300272,0.00006960817,0.0000031600753,0.000015588337,0.00013167791,0.0000013301743,0.00016409805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867153,0.0005756545,0.0001411403,0.00022243465,0.00015943692,0.00022983913],"domain_scores_gemma":[0.9978225,0.00042740072,0.0008129985,0.00016142131,0.00037764772,0.00039795676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021578623,0.00022930746,0.00043719416,0.00064575014,0.0011798504,0.0012322301,0.00068624434,0.00060146576,0.0020829746],"category_scores_gemma":[0.010805607,0.00034733204,0.000972191,0.0010275259,0.0005963225,0.0014302104,0.0024272397,0.0012859036,0.00019694582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013213228,0.0000697949,0.9800118,0.000059472462,0.00012854717,0.000121355166,0.008744705,0.00026786368,0.00011270682,0.00027494226,0.00034990112,0.009726787],"study_design_scores_gemma":[0.0000024909348,0.000050274786,0.9960459,0.00004337927,0.000020853397,0.000047983744,0.0024132575,0.0008215497,0.000014601078,0.00028180293,0.00024926933,0.000008651711],"about_ca_topic_score_codex":0.0998139,"about_ca_topic_score_gemma":0.10968991,"teacher_disagreement_score":0.0998139,"about_ca_system_score_codex":0.0014269983,"about_ca_system_score_gemma":0.0013513673,"threshold_uncertainty_score":0.19846582},"labels":[],"label_agreement":null},{"id":"W4415913729","doi":"10.1016/j.jval.2025.09.3055","title":"Health Economics and Outcomes Research in the New Era of Artificial Intelligence: Catch Me If You Can","year":2025,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Health economics; Outcomes research; Medical economics; MEDLINE","score_opus":0.24376798857061435,"score_gpt":0.5078744946077316,"score_spread":0.2641065060371173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415913729","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013458424,0.010078574,0.00011311422,0.05269569,0.936589,0.0000101054,0.000030132695,0.00002340253,0.00044658978],"genre_scores_gemma":[0.00017625632,0.0046467725,0.00012056433,0.019348336,0.9742038,0.000014609661,0.000011182339,0.000017054837,0.0014614596],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9797997,0.0053356346,0.0027276042,0.0015461671,0.00992835,0.00066255947],"domain_scores_gemma":[0.84138155,0.10221563,0.0052975407,0.003018546,0.037176535,0.010910097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029270906,0.0047586765,0.008295583,0.006852382,0.0048771272,0.018031389,0.005895516,0.03247395,0.010417138],"category_scores_gemma":[0.10431173,0.0018801311,0.004653809,0.004410503,0.006739149,0.010710185,0.0028317473,0.040945552,0.0064627975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002579011,0.000012339348,0.00002821904,0.00042196544,0.000046828474,0.00005851031,0.000022798773,0.000025833358,0.000017553679,0.00078861305,0.99438334,0.0041681943],"study_design_scores_gemma":[0.00020324864,0.00004719932,0.00046855534,0.0030568263,0.00027419694,0.00032666602,0.00023344145,0.0004727721,0.000088878405,0.011089996,0.9836585,0.000079683465],"about_ca_topic_score_codex":0.0037156881,"about_ca_topic_score_gemma":0.011517385,"teacher_disagreement_score":0.03247395,"about_ca_system_score_codex":0.0059135803,"about_ca_system_score_gemma":0.008789484,"threshold_uncertainty_score":0.15480119},"labels":[],"label_agreement":null},{"id":"W4416293245","doi":"10.1016/j.jval.2025.10.015","title":"Developing an Accessible Discrete Choice Survey to Identify Supportive Care Preferences of Older Adults With Dementia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Aging; National Institutes of Health","keywords":"Dementia; Discrete choice; Survey data collection; Aged care","score_opus":0.0706076007581129,"score_gpt":0.4398641969518226,"score_spread":0.3692565961937097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416293245","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623257,0.000056884615,0.0011025347,0.00011694417,0.000013300374,0.0010477157,0.00064777135,0.0000071741383,0.00077516364],"genre_scores_gemma":[0.9872837,0.00013797212,0.007398387,0.0002916019,0.000013718052,0.003354719,0.00091170974,0.000002782206,0.0006053696],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980388,0.0009767748,0.00033932534,0.00014779849,0.00028397143,0.00021329291],"domain_scores_gemma":[0.99526274,0.0027405438,0.00076580775,0.00016475245,0.0006453104,0.00042080865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051974314,0.00030724966,0.0005132767,0.0007724955,0.00050161494,0.0009633798,0.00032843518,0.0006807931,0.0023140449],"category_scores_gemma":[0.011936744,0.00029819517,0.0010163636,0.0007885461,0.0002141996,0.0008823734,0.00076542795,0.0009802604,0.0004195305],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020452756,0.009383129,0.9059137,0.00037419377,0.00037292836,0.00017688445,0.0048291963,0.0010188788,0.0011301166,0.00047416543,0.0024543987,0.071827054],"study_design_scores_gemma":[0.0017083676,0.01359705,0.9503046,0.00023143293,0.0002583816,0.00027369356,0.014636446,0.00964281,0.0013125819,0.0014546169,0.0064770044,0.000102940336],"about_ca_topic_score_codex":0.0036971888,"about_ca_topic_score_gemma":0.006772653,"teacher_disagreement_score":0.0051974314,"about_ca_system_score_codex":0.0007305879,"about_ca_system_score_gemma":0.0012256952,"threshold_uncertainty_score":0.02748698},"labels":[],"label_agreement":null},{"id":"W4416410498","doi":"10.1016/j.jval.2025.10.016","title":"Return-on-Investment in Health Economic Evaluation: An Exploratory Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto","funders":"","keywords":"Scope (computer science); Exploratory analysis; Variation (astronomy); Measure (data warehouse); Pareto principle; Exploratory research","score_opus":0.44929216899026797,"score_gpt":0.4701920806746715,"score_spread":0.020899911684403527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416410498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9387951,0.005182217,0.04131419,0.0014385002,0.000038688748,0.0007457042,0.0019524682,0.0001009742,0.010432149],"genre_scores_gemma":[0.99308187,0.00045783463,0.0049372353,0.00006311195,0.00002212102,0.00024042263,0.000479357,0.000027069349,0.00069096294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96704316,0.027589204,0.001141115,0.00071223686,0.0025566386,0.00095755426],"domain_scores_gemma":[0.4752913,0.510917,0.0058879633,0.003555683,0.0033355944,0.0010125055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.036571812,0.001228157,0.0013703515,0.0032097949,0.0005224566,0.0026261306,0.0011857445,0.0010651108,0.005082964],"category_scores_gemma":[0.16655499,0.00041147353,0.0032403294,0.0033777086,0.0013669606,0.0044138897,0.0027571807,0.0028999285,0.00043786527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008167179,0.0026621418,0.52961147,0.0031489956,0.005412791,0.0014286536,0.0033549983,0.12205629,0.001010809,0.12609594,0.004989063,0.19206168],"study_design_scores_gemma":[0.0007562831,0.009270409,0.44300884,0.00158769,0.0057031093,0.0018138508,0.0086902715,0.37008137,0.0030733298,0.1446912,0.011017022,0.00030670216],"about_ca_topic_score_codex":0.0017740891,"about_ca_topic_score_gemma":0.0014781386,"teacher_disagreement_score":0.036571812,"about_ca_system_score_codex":0.0021115658,"about_ca_system_score_gemma":0.0018716706,"threshold_uncertainty_score":0.19341254},"labels":[],"label_agreement":null},{"id":"W4416682870","doi":"10.1016/j.jval.2025.11.002","title":"Validity, Reliability, and Framing Effects in Equity-Efficiency Trade-Off Studies: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Western University","funders":"Canadian Institutes of Health Research","keywords":"Framing (construction); Key (lock); Framing effect","score_opus":0.17614855243889055,"score_gpt":0.33108663006205313,"score_spread":0.15493807762316258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416682870","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01032812,0.984184,0.0023886275,0.00086223026,0.0002588633,0.00046843587,0.0008964703,0.000014108292,0.00059916684],"genre_scores_gemma":[0.42587453,0.55592495,0.009575794,0.0029373905,0.0011268939,0.0021375455,0.001973111,0.00007135759,0.00037854406],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.85260624,0.07751911,0.04093078,0.011833878,0.016015664,0.001094318],"domain_scores_gemma":[0.3220277,0.61104506,0.045233637,0.010873314,0.010208587,0.0006117283],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17254579,0.0020019077,0.0110884365,0.008444573,0.0010133518,0.006979539,0.0038183809,0.0046109264,0.0049056686],"category_scores_gemma":[0.46697977,0.002304635,0.021027228,0.009613125,0.006432837,0.00613571,0.004149066,0.002960448,0.00034322473],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034435894,0.00014819593,0.09533147,0.46915364,0.30955616,0.00019679824,0.001366364,0.00097289664,0.0001739432,0.0038450728,0.0025211757,0.11329058],"study_design_scores_gemma":[0.0025778122,0.00066379376,0.069500215,0.3190163,0.5772355,0.0005971983,0.0010456855,0.0012402583,0.0004974365,0.013121142,0.014223899,0.00028071948],"about_ca_topic_score_codex":0.0064861244,"about_ca_topic_score_gemma":0.012645442,"teacher_disagreement_score":0.8274542,"about_ca_system_score_codex":0.003635501,"about_ca_system_score_gemma":0.0068555786,"threshold_uncertainty_score":0.9125203},"labels":[],"label_agreement":null},{"id":"W4416866909","doi":"10.1016/j.jval.2025.11.006","title":"Strengthening Methods and International Evidence on Health Inequality Aversion","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Fondation Brocher","keywords":"Inequity aversion; Inequality; Risk aversion (psychology); Politics; Health equity; Economic inequality","score_opus":0.21689714951140138,"score_gpt":0.5371227487341702,"score_spread":0.32022559922276883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416866909","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030069783,0.077246964,0.5008504,0.27750978,0.009812581,0.003847851,0.0014544124,0.00037676122,0.09883142],"genre_scores_gemma":[0.42469338,0.030642647,0.46369317,0.057834867,0.0057511404,0.01206852,0.0013555816,0.00051691424,0.0034438425],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.3954306,0.5252385,0.026948739,0.015891002,0.033192255,0.0032988791],"domain_scores_gemma":[0.12306285,0.7238543,0.03364609,0.07735476,0.04045841,0.0016236287],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5870319,0.0025551806,0.004995321,0.012738757,0.004943933,0.017283864,0.0077785193,0.007041696,0.022571348],"category_scores_gemma":[0.6698219,0.0017606441,0.004917139,0.01101087,0.028181063,0.026484419,0.028542696,0.014129246,0.0017695753],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011540593,0.00051544554,0.021108767,0.026880786,0.003272691,0.00020404365,0.034123376,0.0027939577,0.0011037366,0.5198102,0.015316743,0.37371618],"study_design_scores_gemma":[0.0006032982,0.0007691278,0.019109705,0.076099195,0.0017949017,0.00027359184,0.020299932,0.002929402,0.0030212877,0.7090416,0.16567478,0.00038322632],"about_ca_topic_score_codex":0.0040353555,"about_ca_topic_score_gemma":0.003140578,"teacher_disagreement_score":0.4129681,"about_ca_system_score_codex":0.010216854,"about_ca_system_score_gemma":0.018233823,"threshold_uncertainty_score":0.5092633},"labels":[],"label_agreement":null},{"id":"W4417479565","doi":"10.1016/j.jval.2025.09.2561","title":"PCR88 Explaining Psychiatric Comorbidities in Patients With Skin Conditions: The Importance of Clinical Characteristics and Patient-Reported Disease Impact","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Depression (economics); Anxiety; Comorbidity; Disease; Mental health; Psychiatric comorbidity; Dermatological diseases","score_opus":0.03386724474695558,"score_gpt":0.3262418296832556,"score_spread":0.29237458493630003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047476,0.0025870658,0.000436912,0.0010853361,0.00006266499,0.000014492118,0.00041712727,0.00001135307,0.004910334],"genre_scores_gemma":[0.99891603,0.0003707326,0.00020063942,0.0001263825,0.00006674157,0.0000033104873,0.00015105966,0.0000059850586,0.00015926879],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907184,0.000313461,0.000120024844,0.0000971156,0.00019240355,0.00020519296],"domain_scores_gemma":[0.99749315,0.00097603636,0.00090206997,0.00013412345,0.00025065325,0.00024404239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069571065,0.00042903566,0.00046556533,0.00070914475,0.00042617333,0.0011572428,0.00038775883,0.00062694034,0.0043166755],"category_scores_gemma":[0.0058934595,0.0001820216,0.0005369111,0.0009816549,0.00031348492,0.00065292325,0.00054871873,0.0010033519,0.00051031774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024616253,0.000052621173,0.99002725,0.00003376689,0.000065345805,0.00076912367,0.00008949763,0.00007317992,0.0004297999,0.00010019465,0.00032879892,0.0077842525],"study_design_scores_gemma":[0.000013494017,0.000098761964,0.99139637,0.0000944749,0.00012989594,0.00508593,0.00061208935,0.00073343946,0.00028158823,0.00044395187,0.0010975781,0.000012401703],"about_ca_topic_score_codex":0.002097111,"about_ca_topic_score_gemma":0.0025512644,"teacher_disagreement_score":0.0043166755,"about_ca_system_score_codex":0.00028193084,"about_ca_system_score_gemma":0.0004512702,"threshold_uncertainty_score":0.014440775},"labels":[],"label_agreement":null},{"id":"W4417479590","doi":"10.1016/j.jval.2025.09.1037","title":"EE655 Saving Money Improving Outcomes: A Two-Year Cost-Utility Analysis of Emergency Department Care Models for Managing Persons Presenting With a Musculoskeletal Disorder","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Emergency department; Health care; Primary care; Musculoskeletal disorder; Musculoskeletal injury","score_opus":0.023467133519546154,"score_gpt":0.3468189455294943,"score_spread":0.32335181200994817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905828,0.0027907963,0.0020891328,0.00052279327,0.0000656549,0.00026953366,0.00216661,0.000048400594,0.0014643171],"genre_scores_gemma":[0.99760544,0.00038366774,0.000640994,0.000065526016,0.000016303997,0.00006497387,0.00091499975,0.0000067468427,0.0003013826],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9957985,0.0028749148,0.00019563612,0.0003446466,0.00029349842,0.0004928025],"domain_scores_gemma":[0.9887446,0.008892049,0.0009977935,0.00038942517,0.00039688215,0.0005793447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007958794,0.0013384637,0.001983607,0.0019403759,0.00041675405,0.0024876,0.0014618518,0.0013145349,0.005143382],"category_scores_gemma":[0.020359237,0.0005509996,0.0063072266,0.0018157302,0.0006782279,0.0024816038,0.0014774977,0.0023020238,0.00023926584],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1463453,0.011335192,0.2586882,0.0031263758,0.02266339,0.00080111966,0.0005207407,0.4447305,0.0013930349,0.011570003,0.0064982874,0.09232796],"study_design_scores_gemma":[0.0113462135,0.04374643,0.23729524,0.00086311717,0.019598072,0.0009619919,0.0020727606,0.67160916,0.0012288596,0.0066102208,0.004302674,0.00036529606],"about_ca_topic_score_codex":0.018437866,"about_ca_topic_score_gemma":0.008275252,"teacher_disagreement_score":0.018437866,"about_ca_system_score_codex":0.0045689824,"about_ca_system_score_gemma":0.0022951378,"threshold_uncertainty_score":0.042090654},"labels":[],"label_agreement":null},{"id":"W4417479592","doi":"10.1016/j.jval.2025.09.686","title":"EE302 Cost-Utility Analysis of Iptacopan for Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With C5 Inhibitor in the Brazilian Private Healthcare System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Anemia; Healthcare system; Hematologic disease; Disease","score_opus":0.015467003973979718,"score_gpt":0.27616674710473144,"score_spread":0.2606997431307517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98437285,0.0053046867,0.0011507022,0.000779812,0.000033949844,0.00016421214,0.005382235,0.000027892711,0.0027837013],"genre_scores_gemma":[0.997045,0.00068565103,0.00041449306,0.000063556385,0.000012178377,0.00003562247,0.0014412779,0.0000049465366,0.00029739272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924195,0.00040561406,0.000040271956,0.0000811003,0.00012455753,0.00010651633],"domain_scores_gemma":[0.9989749,0.0005346074,0.00020777021,0.000037137423,0.00011153182,0.00013400971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011416794,0.000523266,0.0009612486,0.0008859763,0.00014162375,0.0008012948,0.00046141667,0.00040496202,0.0027518128],"category_scores_gemma":[0.0051907124,0.00017995267,0.0026485526,0.001420165,0.0001763756,0.00033813945,0.00045270493,0.0005145962,0.000118412616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025288839,0.001870279,0.738413,0.0025092366,0.014540652,0.0013230349,0.00025276173,0.06945129,0.0022461528,0.003933206,0.007879725,0.13229182],"study_design_scores_gemma":[0.0016568265,0.004323496,0.8737544,0.00050860096,0.005403468,0.0009795073,0.0005700376,0.10653778,0.0004959761,0.0011010361,0.0046051694,0.00006371294],"about_ca_topic_score_codex":0.050544504,"about_ca_topic_score_gemma":0.037212193,"teacher_disagreement_score":0.050544504,"about_ca_system_score_codex":0.004060801,"about_ca_system_score_gemma":0.0018724558,"threshold_uncertainty_score":0.10050058},"labels":[],"label_agreement":null},{"id":"W4417479607","doi":"10.1016/j.jval.2025.09.1447","title":"HPR37 Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Bridging (networking); Mode (computer interface)","score_opus":0.31934627059427295,"score_gpt":0.47770535900780214,"score_spread":0.1583590884135292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8598572,0.004266949,0.026055615,0.06741362,0.00042549943,0.00006677378,0.0050885943,0.00035466603,0.036471047],"genre_scores_gemma":[0.9872936,0.000410908,0.0026116476,0.0011769856,0.0001597273,0.000033445587,0.00074969593,0.00007602121,0.007487925],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9928311,0.004405766,0.00014090263,0.0007281854,0.0006539674,0.0012400148],"domain_scores_gemma":[0.9808102,0.0145828,0.0013463567,0.0008404291,0.0015286811,0.0008915694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008165635,0.00023006252,0.0007938562,0.0011564558,0.0010884269,0.004061765,0.0014628043,0.0019351939,0.01639811],"category_scores_gemma":[0.030321782,0.00023062939,0.0011054234,0.0015569971,0.000926666,0.0020161,0.0014651163,0.0028402237,0.0008647248],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093809044,0.00055512687,0.3928136,0.0002138346,0.00056476763,0.00092218595,0.0045653894,0.032951575,0.00061435107,0.3963171,0.054766808,0.11477724],"study_design_scores_gemma":[0.00036650168,0.00055662816,0.51174283,0.00045988857,0.00045441542,0.00064565224,0.0072904876,0.13199656,0.0010695963,0.25741702,0.087755546,0.00024487646],"about_ca_topic_score_codex":0.24691601,"about_ca_topic_score_gemma":0.15507318,"teacher_disagreement_score":0.24691601,"about_ca_system_score_codex":0.005462149,"about_ca_system_score_gemma":0.00606506,"threshold_uncertainty_score":0.49095756},"labels":[],"label_agreement":null},{"id":"W4417479690","doi":"10.1016/j.jval.2025.09.3474","title":"MSR197 The Effects of Pooling Treatment Effects Targeting Treatment Policy and Hypothetical Estimands With Rank-Preserving Structural Failure Time Model in Oncology Aggregate-Level Meta-Analyses","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University","funders":"","keywords":"Pooling; Clinical trial; Randomized controlled trial; Event (particle physics); Treatment effect; Cancer treatment","score_opus":0.5258736131249707,"score_gpt":0.5693965461418977,"score_spread":0.043522933016927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479690","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19121702,0.022148777,0.7568513,0.010899161,0.0013861367,0.002848537,0.0041732965,0.0025943941,0.007881327],"genre_scores_gemma":[0.85565674,0.002351472,0.13407359,0.0016117803,0.00039145848,0.0013763054,0.0010328273,0.00041146553,0.0030943227],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.7454548,0.24177425,0.0046571502,0.004413793,0.0027693713,0.00093062076],"domain_scores_gemma":[0.47149104,0.48501623,0.008206325,0.031105641,0.0031102134,0.0010705327],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2384648,0.0022187731,0.0065035424,0.0023732642,0.00080988207,0.0036324575,0.003403772,0.0042539267,0.009537213],"category_scores_gemma":[0.38461924,0.0022036352,0.022436325,0.002912224,0.00266894,0.0055079055,0.003562626,0.006833612,0.00067409093],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06984334,0.000998302,0.013506621,0.007607008,0.15012227,0.0006650744,0.0009082915,0.45961025,0.0010237241,0.0679249,0.008561264,0.21922903],"study_design_scores_gemma":[0.014671262,0.007724726,0.006237308,0.0015090234,0.09754832,0.0003146506,0.00028223405,0.6614541,0.0027637316,0.20087838,0.0062916703,0.00032468792],"about_ca_topic_score_codex":0.005636085,"about_ca_topic_score_gemma":0.004425543,"teacher_disagreement_score":0.9934965,"about_ca_system_score_codex":0.002199416,"about_ca_system_score_gemma":0.004137179,"threshold_uncertainty_score":0.9391085},"labels":[],"label_agreement":null},{"id":"W4417479696","doi":"10.1016/j.jval.2025.09.2066","title":"HTA283 Reference Framework, Key Decision-Making Factors, and the Impact of Critical Parameters on Listing Recommendations for Nononcologic Drugs for Rare Diseases Issued by Canadian HTA Bodies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Université de Montréal","funders":"","keywords":"Listing (finance); Agency (philosophy); Key (lock); Orphan drug; Drug","score_opus":0.3686087400044351,"score_gpt":0.5030737261538087,"score_spread":0.13446498614937363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479696","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047080092,0.015066767,0.10951074,0.106849805,0.003670061,0.0027831746,0.08964714,0.0024784622,0.6229137],"genre_scores_gemma":[0.7078122,0.0054089944,0.17587823,0.021160606,0.0013446427,0.0011685902,0.033425413,0.0007508643,0.05305042],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","domain_scores_codex":[0.96790904,0.010093463,0.0015876914,0.0011332617,0.016483538,0.0027930725],"domain_scores_gemma":[0.8408593,0.072814055,0.0041638333,0.0043152897,0.074541785,0.0033057914],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043993246,0.0013482935,0.0019040031,0.006854439,0.0032520723,0.0126302345,0.004898986,0.005527849,0.023258384],"category_scores_gemma":[0.16906789,0.0008915811,0.0020419543,0.0072488366,0.0019781326,0.00334711,0.0012961772,0.0050238855,0.002611829],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006960362,0.00015983342,0.006711226,0.0008009021,0.00021601899,0.00021807232,0.00046920788,0.06703265,0.0005186711,0.5067992,0.34409034,0.072287716],"study_design_scores_gemma":[0.0009064364,0.0004379102,0.047629386,0.0055007497,0.0011021772,0.00028523908,0.0016157752,0.1795578,0.0034896852,0.36084506,0.3978579,0.00077185215],"about_ca_topic_score_codex":0.8245557,"about_ca_topic_score_gemma":0.80185777,"teacher_disagreement_score":0.9623055,"about_ca_system_score_codex":0.037694525,"about_ca_system_score_gemma":0.10265606,"threshold_uncertainty_score":0.35295504},"labels":[],"label_agreement":null},{"id":"W4417479712","doi":"10.1016/j.jval.2025.09.363","title":"PT3 Radiographic Progression-Free Survival (rPFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Meta-Analysis and Surrogate Threshold Effect","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Surrogate endpoint; Overall survival; Prostate cancer; Clinical endpoint; Survival analysis; Radiography","score_opus":0.08465402437305819,"score_gpt":0.4039227690628208,"score_spread":0.31926874468976263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479712","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13592991,0.84684074,0.010133417,0.0011361402,0.0015003094,0.00032545233,0.0018609521,0.00025791084,0.0020151427],"genre_scores_gemma":[0.9580467,0.035754196,0.0030107498,0.0011102606,0.0004116424,0.00021590035,0.0007971107,0.000075697346,0.000577765],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.980817,0.014493599,0.0014780833,0.0020432244,0.0007592516,0.0004087758],"domain_scores_gemma":[0.9799361,0.015773468,0.0018364069,0.0016465292,0.00047536675,0.0003321243],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.024364835,0.0029470928,0.011035313,0.0018384509,0.0005062355,0.0033287911,0.0022530367,0.003239778,0.0027353326],"category_scores_gemma":[0.030851265,0.0017511927,0.056579,0.0022872635,0.0010126247,0.0018931113,0.0015187517,0.0047305916,0.00035394388],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025765687,0.000054354456,0.010101153,0.013380176,0.9414548,0.000084053616,0.000043615757,0.0019491392,0.00034429657,0.00026563776,0.0003849457,0.006172009],"study_design_scores_gemma":[0.00397134,0.0010922425,0.0064221416,0.0008163906,0.9842464,0.000073838986,0.00002585191,0.0015021594,0.00016479313,0.0009244039,0.0007288025,0.000031546035],"about_ca_topic_score_codex":0.0046397843,"about_ca_topic_score_gemma":0.007239653,"teacher_disagreement_score":0.9889647,"about_ca_system_score_codex":0.0014458329,"about_ca_system_score_gemma":0.00089436036,"threshold_uncertainty_score":0.12885505},"labels":[],"label_agreement":null},{"id":"W4417479725","doi":"10.1016/j.jval.2025.09.2516","title":"PCR43 Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Autism spectrum disorder; Spectrum (functional analysis); MEDLINE","score_opus":0.06482622003747328,"score_gpt":0.3480659234120079,"score_spread":0.28323970337453463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413234,0.00089197565,0.00037229242,0.00011234352,0.00001856992,0.000032286043,0.00062818563,0.000014082322,0.0037979183],"genre_scores_gemma":[0.9976967,0.00041164857,0.0006473473,0.0000699704,0.000007983098,0.000038379396,0.00028835682,0.000006128136,0.0008335236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991129,0.00030387018,0.00006960418,0.00011107622,0.0002746888,0.00012792369],"domain_scores_gemma":[0.99826103,0.0005409914,0.0005125908,0.00007770964,0.00047736766,0.00013047569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012754289,0.000295745,0.0002831862,0.0008392992,0.0005143816,0.00090184837,0.00022809548,0.00028825804,0.0025607662],"category_scores_gemma":[0.0049359635,0.00014377675,0.00037708945,0.0008018861,0.00029120286,0.0003239633,0.000543365,0.00034145243,0.00040556898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006415008,0.00021442387,0.94374555,0.00019497651,0.00013749208,0.00035156807,0.001004037,0.0002766467,0.0046059093,0.0001694239,0.0009695509,0.04768893],"study_design_scores_gemma":[0.000014623623,0.00054366246,0.98901004,0.00013187421,0.00016829048,0.000812343,0.0023276028,0.0004036613,0.0040737814,0.00022012816,0.0022796653,0.000014246923],"about_ca_topic_score_codex":0.006408152,"about_ca_topic_score_gemma":0.008228611,"teacher_disagreement_score":0.006408152,"about_ca_system_score_codex":0.0004909154,"about_ca_system_score_gemma":0.0006295093,"threshold_uncertainty_score":0.012741685},"labels":[],"label_agreement":null},{"id":"W4417479737","doi":"10.1016/j.jval.2025.09.3466","title":"MSR187 Simulation-Guided Trial Planning of a Cluster Randomized Trial With Probabilistic Covariate-Constrained Randomization for Vaccine Coverage","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Simon Fraser University","funders":"","keywords":"Randomization; Covariate; Cluster randomised controlled trial; Cluster (spacecraft); Randomized controlled trial; Sample size determination; Probabilistic logic; Outcome (game theory)","score_opus":0.4089605287641479,"score_gpt":0.5466162763627133,"score_spread":0.13765574759856536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479737","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08507166,0.0008282606,0.88606435,0.0036363273,0.0002190482,0.0033134485,0.0013723186,0.0018420578,0.017652515],"genre_scores_gemma":[0.7479435,0.00022987294,0.24171205,0.0005946278,0.000070083624,0.0039680684,0.00044912178,0.00020172122,0.004830896],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99539465,0.0038383142,0.00008308096,0.00027016626,0.00020579528,0.0002080048],"domain_scores_gemma":[0.9694687,0.027601112,0.00083077076,0.0006578788,0.0007556622,0.0006858894],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.009148492,0.0008963977,0.0021022703,0.0009026328,0.00043503882,0.0012417898,0.0018305323,0.0018348065,0.018537825],"category_scores_gemma":[0.035130158,0.0012743585,0.0014453277,0.00064632617,0.00094258494,0.0007981004,0.0012436173,0.0024458473,0.0010481612],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018139422,0.00009742766,0.0005038526,0.00015360651,0.00009685154,0.00007443747,0.00005497774,0.9657034,0.00018167197,0.017203696,0.0018167605,0.012299337],"study_design_scores_gemma":[0.0008201329,0.00018061853,0.00010167868,0.000030593976,0.00005483338,0.000014947357,0.000008958476,0.98596996,0.00017006874,0.011845049,0.00079128466,0.000011859693],"about_ca_topic_score_codex":0.010930784,"about_ca_topic_score_gemma":0.007978814,"teacher_disagreement_score":0.9908515,"about_ca_system_score_codex":0.0015730319,"about_ca_system_score_gemma":0.0068767727,"threshold_uncertainty_score":0.062015176},"labels":[],"label_agreement":null},{"id":"W4417479756","doi":"10.1016/j.jval.2025.09.2151","title":"HTA368 When Less Is More? Learnings From a Recent NICE Submission Utilizing a Novel Predictive Individual-Level Surrogacy Approach to Predict Overall Survival (OS) in the Absence of Trial-Level Evidence","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Nice; Overall survival; Survival analysis; Baseline (sea); MEDLINE","score_opus":0.5191381405924437,"score_gpt":0.45008090499140646,"score_spread":0.06905723560103721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479756","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005936919,0.020505797,0.09221145,0.8132991,0.031989854,0.00048394137,0.007108327,0.00095734355,0.027507314],"genre_scores_gemma":[0.22679463,0.023144577,0.26541516,0.3633655,0.0645359,0.001588396,0.005922564,0.0028824026,0.046350878],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.962891,0.026371902,0.0022687456,0.0017705418,0.0060766656,0.0006212537],"domain_scores_gemma":[0.75569195,0.21532091,0.004217377,0.006249325,0.014931225,0.00358924],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.049342334,0.0009857988,0.0023211983,0.0017251907,0.0008222555,0.006333094,0.0022664163,0.0057379324,0.01757708],"category_scores_gemma":[0.34843513,0.00053907925,0.0039094426,0.0018828453,0.0026703088,0.0038257334,0.0030511606,0.0125337485,0.005308608],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002230039,0.0001031669,0.0040145684,0.0035134465,0.0018391385,0.0006681328,0.00046760388,0.0036856334,0.0003153444,0.08083675,0.71367794,0.18864825],"study_design_scores_gemma":[0.0029507033,0.0008558736,0.0040499335,0.0074821813,0.003346462,0.0015609754,0.00042784042,0.025112156,0.0014290565,0.39355627,0.55881685,0.00041166996],"about_ca_topic_score_codex":0.005779501,"about_ca_topic_score_gemma":0.0108448425,"teacher_disagreement_score":0.95065767,"about_ca_system_score_codex":0.0020477818,"about_ca_system_score_gemma":0.006725311,"threshold_uncertainty_score":0.26095033},"labels":[],"label_agreement":null},{"id":"W4417479766","doi":"10.1016/j.jval.2025.09.3046","title":"SA105 Where Is AI in Evidence Synthesis for NICE HTA Submissions?","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Nice; Excellence; Health technology; Position statement; Systematic review; Evidence-based medicine; Evidence-based practice; Health care","score_opus":0.2890360559946231,"score_gpt":0.5122815167313057,"score_spread":0.2232454607366826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479766","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040450643,0.020903079,0.00303784,0.8899881,0.0668936,0.00022881328,0.00050867227,0.00030654218,0.017728843],"genre_scores_gemma":[0.04059049,0.02105609,0.04232038,0.7352511,0.12865631,0.0018136573,0.001316569,0.0014457233,0.027549593],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.7468342,0.18445162,0.02955204,0.0053958218,0.027019175,0.0067471773],"domain_scores_gemma":[0.29732376,0.42185074,0.030767394,0.031824797,0.16260034,0.055633016],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.17048909,0.0010236732,0.0048367837,0.004607398,0.005430893,0.02886342,0.003690163,0.027007898,0.07125326],"category_scores_gemma":[0.6509169,0.0017445368,0.0061862464,0.0038159206,0.009722694,0.012558969,0.010671484,0.028608277,0.022813138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041480802,0.00003986433,0.0004515356,0.0026230265,0.000284823,0.00018852149,0.00045948615,0.00019271811,0.000084046864,0.01791395,0.9111317,0.06621567],"study_design_scores_gemma":[0.00062259403,0.00027381824,0.0012714437,0.020729128,0.0003389063,0.0006586579,0.0013018316,0.0010465739,0.00022002794,0.10550019,0.8678204,0.00021641105],"about_ca_topic_score_codex":0.0063608214,"about_ca_topic_score_gemma":0.012457558,"teacher_disagreement_score":0.8295109,"about_ca_system_score_codex":0.010207445,"about_ca_system_score_gemma":0.04945115,"threshold_uncertainty_score":0.9016433},"labels":[],"label_agreement":null},{"id":"W4417479775","doi":"10.1016/j.jval.2025.09.687","title":"EE303 Cost-Utility Analysis of Iptacopan vs. C5 Inhibitors in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Naïve to Complement Inhibitors in the Brazilian Private Healthcare System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Eculizumab; Complement (music); Healthcare system; Complement system; Clinical trial","score_opus":0.01584302565479924,"score_gpt":0.2848360759610005,"score_spread":0.2689930503062013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912243,0.0047119237,0.0005051777,0.0006211882,0.00003050279,0.00009501532,0.0013196169,0.000011108326,0.0014811772],"genre_scores_gemma":[0.9986284,0.000522918,0.00017004515,0.000063454696,0.000010028441,0.000017718994,0.00042220711,0.0000026447628,0.00016266058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876994,0.0007144822,0.00006094676,0.000122001504,0.00012830782,0.000204227],"domain_scores_gemma":[0.9984919,0.00088562164,0.00025949834,0.00005158386,0.00010869723,0.00020276161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001501213,0.00045901656,0.001159291,0.0006462045,0.00016333585,0.0010784551,0.0004983969,0.0005560717,0.0031617305],"category_scores_gemma":[0.006138217,0.00021180659,0.0032218425,0.0010457843,0.00026610037,0.0004144603,0.00057753106,0.00070277427,0.00011243817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.075032115,0.002779456,0.69094455,0.0027312285,0.020997023,0.0012685183,0.0003986879,0.07001843,0.0023483755,0.005122651,0.004976539,0.123382464],"study_design_scores_gemma":[0.0055791433,0.012918188,0.8453055,0.0008445664,0.012453674,0.0010259359,0.0012644869,0.11379038,0.0007179571,0.0019409565,0.0040493463,0.000109918525],"about_ca_topic_score_codex":0.044151075,"about_ca_topic_score_gemma":0.030266728,"teacher_disagreement_score":0.044151075,"about_ca_system_score_codex":0.004409864,"about_ca_system_score_gemma":0.002037401,"threshold_uncertainty_score":0.087788165},"labels":[],"label_agreement":null},{"id":"W4417479777","doi":"10.1016/j.jval.2025.09.648","title":"EE264 Cost-Effectiveness of Nivolumab Plus Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable NSCLC in Greece","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Nivolumab; Chemotherapy; Platinum; Complete response","score_opus":0.05804817109753496,"score_gpt":0.3793686892482297,"score_spread":0.32132051815069473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907357,0.0039657755,0.00024807215,0.0009743542,0.00007828414,0.00004383342,0.0007984114,0.000010949466,0.0031445674],"genre_scores_gemma":[0.9978751,0.0008670216,0.00015983464,0.00010886209,0.00002543204,0.000015942565,0.00047436837,0.000005550931,0.00046794888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992592,0.00035932538,0.000068292255,0.00008252685,0.000088045475,0.000142643],"domain_scores_gemma":[0.99949145,0.00015150863,0.00015539944,0.000027077303,0.000052948297,0.000121700214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007810184,0.00028703408,0.00048093678,0.0006577937,0.00012378713,0.0009798654,0.00041260218,0.00062590116,0.0015464902],"category_scores_gemma":[0.002556344,0.00014826622,0.0018843919,0.00073512364,0.00033333947,0.00045626328,0.0007029571,0.00043799152,0.00015490112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.044242952,0.0018344936,0.51460546,0.0032109478,0.009303968,0.0042223153,0.00033592858,0.1069307,0.0043248534,0.0053399205,0.0048089665,0.3008396],"study_design_scores_gemma":[0.0042612446,0.011003145,0.914056,0.00092894206,0.005695849,0.0036937222,0.0015317486,0.03489122,0.0025056622,0.004150447,0.017150592,0.00013150208],"about_ca_topic_score_codex":0.012967059,"about_ca_topic_score_gemma":0.011449988,"teacher_disagreement_score":0.012967059,"about_ca_system_score_codex":0.00364825,"about_ca_system_score_gemma":0.0026421794,"threshold_uncertainty_score":0.026470065},"labels":[],"label_agreement":null},{"id":"W4417479800","doi":"10.1016/j.jval.2025.09.1841","title":"HTA56 Beyond the Surface: Health Technology Assessment and Reimbursement for Inflammatory or Autoimmune Disorders With Cosmetic and Dermatological Manifestations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Health technology; Technology assessment; Risk assessment; MEDLINE","score_opus":0.022669601554001044,"score_gpt":0.3114611157838242,"score_spread":0.28879151422982313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479800","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13064617,0.068452194,0.014803487,0.58109564,0.007846432,0.00054888753,0.0048011853,0.00084023847,0.1909658],"genre_scores_gemma":[0.8916959,0.023485966,0.016148897,0.042556647,0.00865246,0.00033675777,0.002873373,0.00017803488,0.014071918],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.985457,0.007813223,0.0011230109,0.0005619308,0.0038677796,0.0011770423],"domain_scores_gemma":[0.95777446,0.020767257,0.0051188753,0.0017876974,0.004907547,0.009644342],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010750903,0.00040071973,0.0008062615,0.0019295573,0.0007294484,0.0066456157,0.00097508554,0.004162479,0.016654532],"category_scores_gemma":[0.06546678,0.00022905528,0.0014735297,0.0015873889,0.0013803423,0.003211829,0.0035570983,0.004204096,0.0025849568],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001728866,0.00049994513,0.04251215,0.00078074494,0.00034520548,0.00062698795,0.00028941061,0.0019549876,0.0015256082,0.062434122,0.13698892,0.75031304],"study_design_scores_gemma":[0.0009340201,0.0028597265,0.18576553,0.007993765,0.0008099923,0.0036018733,0.0013135641,0.015478513,0.0033892728,0.09979216,0.67767984,0.0003817127],"about_ca_topic_score_codex":0.0034665552,"about_ca_topic_score_gemma":0.0029695726,"teacher_disagreement_score":0.9892491,"about_ca_system_score_codex":0.0038117662,"about_ca_system_score_gemma":0.009609293,"threshold_uncertainty_score":0.05685687},"labels":[],"label_agreement":null},{"id":"W4417479806","doi":"10.1016/j.jval.2025.09.2555","title":"PCR82 Evaluating the Feasibility and Acceptability of a Personalized Endpoint: A Prospective Mixed Methods Study of Inventory-Facilitated Goal Attainment Scaling","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Resilience and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Scaling; Goal orientation","score_opus":0.16300363047407418,"score_gpt":0.5397753056234789,"score_spread":0.3767716751494047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98345333,0.000046353736,0.010151583,0.000055488847,0.000041969266,0.003928442,0.00022996264,0.000074336174,0.0020185278],"genre_scores_gemma":[0.95244795,0.00007386525,0.030415775,0.0002061905,0.000031357333,0.01353578,0.0005015731,0.00009093365,0.0026966028],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.97964954,0.014253114,0.0011769776,0.0013827265,0.0029624237,0.00057515583],"domain_scores_gemma":[0.9617312,0.025768658,0.0031249882,0.004974225,0.0035479043,0.0008531299],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.026531424,0.00064741675,0.0007255497,0.00062411686,0.0015598729,0.0021126673,0.0012131446,0.0011722468,0.0025437507],"category_scores_gemma":[0.048741587,0.0010729255,0.0012020848,0.0007283242,0.0010422901,0.0012948266,0.0014043347,0.002059547,0.0010598277],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032728504,0.070382655,0.5616021,0.0008280645,0.0011541996,0.00027170705,0.037042037,0.0038448486,0.017012207,0.0059021907,0.0035787195,0.2656528],"study_design_scores_gemma":[0.0073895766,0.12540759,0.8117609,0.00020055032,0.0008644441,0.00023405309,0.009113078,0.014287684,0.017137522,0.0028792857,0.010378267,0.00034709074],"about_ca_topic_score_codex":0.0016113189,"about_ca_topic_score_gemma":0.0018167659,"teacher_disagreement_score":0.9734686,"about_ca_system_score_codex":0.00065180444,"about_ca_system_score_gemma":0.0019538444,"threshold_uncertainty_score":0.14031327},"labels":[],"label_agreement":null},{"id":"W4417479847","doi":"10.1016/j.jval.2025.09.1087","title":"EE707 The Economic Value of Self-Administered Subcutaneous Immunoglobulin G (SCIg) in Canada: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Value (mathematics); Antibody; Immunoglobulin G; MEDLINE","score_opus":0.015657070331597193,"score_gpt":0.2683271140454936,"score_spread":0.2526700437138964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479847","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009980518,0.99383074,0.000042024647,0.0024998614,0.00024212312,0.000021060541,0.00036401534,0.00000286691,0.001999235],"genre_scores_gemma":[0.017408283,0.9805838,0.00021119067,0.0012684576,0.00011846666,0.000023719398,0.000122021855,0.000005512441,0.00025864225],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99505377,0.0008065924,0.00088837143,0.00034063167,0.002390854,0.00051968324],"domain_scores_gemma":[0.9550756,0.025707917,0.005032419,0.0003721521,0.012547091,0.0012647959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010458624,0.00093239255,0.0030129463,0.011787693,0.0016072378,0.008703194,0.002127369,0.0027490635,0.007204691],"category_scores_gemma":[0.051999994,0.0007146046,0.0027364034,0.023206796,0.003652143,0.002008146,0.002034296,0.003151436,0.00029688774],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011683924,0.00017725416,0.013952355,0.26620007,0.0058829677,0.00053116033,0.0012672769,0.0022126057,0.0002720699,0.02027046,0.05671123,0.6313542],"study_design_scores_gemma":[0.00024359311,0.00014570517,0.03073762,0.70845455,0.00949077,0.00044041764,0.0022088462,0.00056583085,0.0002846643,0.0032055476,0.24404673,0.00017563904],"about_ca_topic_score_codex":0.88868576,"about_ca_topic_score_gemma":0.9205162,"teacher_disagreement_score":0.11131424,"about_ca_system_score_codex":0.07441029,"about_ca_system_score_gemma":0.15810265,"threshold_uncertainty_score":0.53988695},"labels":[],"label_agreement":null},{"id":"W4417479853","doi":"10.1016/j.jval.2025.09.1849","title":"HTA64 Canadian HTA Decisions (2020-2023): Comparing CDA-AMC and INESSS Recommendations on Drug Reimbursement","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; MEDLINE; Real world evidence","score_opus":0.42063882912983697,"score_gpt":0.44732286347020545,"score_spread":0.02668403434036848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479853","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010707335,0.011239658,0.0020662982,0.47601187,0.02784302,0.003045206,0.2947793,0.0012422076,0.17306507],"genre_scores_gemma":[0.08027779,0.006772332,0.01980847,0.5323285,0.013874729,0.002218436,0.09080031,0.001212672,0.2527067],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.96595186,0.0051067197,0.0020612471,0.0011898594,0.019594012,0.006096383],"domain_scores_gemma":[0.904021,0.02183439,0.0033616025,0.0016050367,0.046080932,0.023097029],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036314704,0.002382899,0.002960289,0.0069582285,0.005037122,0.013692447,0.008413586,0.03165336,0.051626228],"category_scores_gemma":[0.117148414,0.0021255347,0.005804362,0.008810814,0.003500192,0.0027011388,0.0034285565,0.013665638,0.013246916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004838581,0.00005136932,0.0008129013,0.000097996555,0.00007164147,0.000053583703,0.00003539212,0.0006110214,0.00006258914,0.0032634365,0.98994315,0.0045130397],"study_design_scores_gemma":[0.0030476172,0.00019204663,0.03914707,0.0018962522,0.0006230749,0.00009744459,0.00048572902,0.0044859173,0.0007067976,0.007079779,0.9417223,0.0005159648],"about_ca_topic_score_codex":0.95515156,"about_ca_topic_score_gemma":0.972983,"teacher_disagreement_score":0.9636853,"about_ca_system_score_codex":0.076034136,"about_ca_system_score_gemma":0.2641885,"threshold_uncertainty_score":0.5516689},"labels":[],"label_agreement":null},{"id":"W4417479855","doi":"10.1016/j.jval.2025.09.1538","title":"HPR131 Launches of Oncology Products in LATAM vs. the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Radiation oncology; Clinical Oncology; MEDLINE","score_opus":0.09250560443434454,"score_gpt":0.41100032086951166,"score_spread":0.31849471643516714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8543308,0.0016743173,0.00019739673,0.023677029,0.0005284042,0.000045975034,0.002539673,0.00006174793,0.116944686],"genre_scores_gemma":[0.9714916,0.00066359446,0.00010806992,0.00512644,0.00021070121,0.00003120206,0.0010679937,0.000039990373,0.021260582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988764,0.00022572362,0.000029887371,0.00009943084,0.0004114971,0.00035698438],"domain_scores_gemma":[0.99615896,0.001089452,0.0014592184,0.000070028924,0.00048002834,0.00074233784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010042996,0.00011943925,0.00023046562,0.0008204166,0.0010715419,0.0037695712,0.000335558,0.0009466472,0.017323019],"category_scores_gemma":[0.0047210525,0.00015191144,0.00036407585,0.0012170167,0.0006468632,0.001371539,0.0015757274,0.0026082343,0.0012855828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008303842,0.0010720022,0.5838991,0.00049424736,0.00035978493,0.0012807668,0.0050670505,0.0008055797,0.006268592,0.0586109,0.17099114,0.16284703],"study_design_scores_gemma":[0.00032549995,0.001632123,0.79484344,0.0003679523,0.00022428321,0.0008287916,0.020924691,0.0010957242,0.0044027017,0.0021069779,0.17314625,0.00010163515],"about_ca_topic_score_codex":0.027766833,"about_ca_topic_score_gemma":0.06847453,"teacher_disagreement_score":0.027766833,"about_ca_system_score_codex":0.0026515913,"about_ca_system_score_gemma":0.0026760981,"threshold_uncertainty_score":0.05795127},"labels":[],"label_agreement":null},{"id":"W4417479867","doi":"10.1016/j.jval.2025.09.2782","title":"RWD32 Characterizing Comorbidities and Co-Occurring Conditions in Adults with Generalized Anxiety Disorder in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Generalized anxiety disorder; Anxiety; Functional impairment; Comorbidity; Generalized anxiety; Anxiety disorder","score_opus":0.040365765914622195,"score_gpt":0.3647807128856907,"score_spread":0.3244149469710685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994991,0.0005677673,0.00007852416,0.00019109026,0.00001842868,0.00005888506,0.0022990268,0.000005591235,0.0017896909],"genre_scores_gemma":[0.99802125,0.00023595204,0.00015029652,0.000100475285,0.000011282112,0.000034789522,0.0012637216,0.0000015943889,0.00018060835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949944,0.00011338347,0.00011593487,0.000055236243,0.00010644231,0.00010963678],"domain_scores_gemma":[0.9986474,0.00015137721,0.00068940833,0.000054709766,0.0001930841,0.0002639894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067537156,0.00021526977,0.00029877343,0.00143553,0.00047809142,0.00058124814,0.00024027674,0.0003248648,0.0010608551],"category_scores_gemma":[0.0027594955,0.00012336692,0.00068387116,0.0014991352,0.00019203825,0.00035790243,0.0008383077,0.0005045374,0.00013036877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018337714,0.000018912833,0.9983255,0.000010486177,0.000027510794,0.000030877014,0.00004230999,0.000019237415,0.000039080405,0.000013549005,0.00017247064,0.0012815628],"study_design_scores_gemma":[0.0000018591683,0.000016236838,0.9994746,0.000010323922,0.00001192655,0.000073371935,0.0001836629,0.00004475471,0.00001406597,0.000011077853,0.00015681708,0.0000014227479],"about_ca_topic_score_codex":0.02867826,"about_ca_topic_score_gemma":0.057618372,"teacher_disagreement_score":0.02867826,"about_ca_system_score_codex":0.0006948188,"about_ca_system_score_gemma":0.00095892296,"threshold_uncertainty_score":0.05702269},"labels":[],"label_agreement":null},{"id":"W4417479875","doi":"10.1016/j.jval.2025.09.3428","title":"MSR144 Measuring Health-Related Quality of Life and Food Insecurity in the General Population in Lebanon During the Third Worst Socioeconomic Crisis in History","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Food Security and Health in Diverse Populations","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Socioeconomic status; Food insecurity; Population; Quality of life (healthcare); Quality (philosophy)","score_opus":0.2311882861250552,"score_gpt":0.4146046459041123,"score_spread":0.18341635977905707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998602,0.00007663017,0.000023688737,0.00008614694,0.0000108588665,0.000012791003,0.00073923497,0.000002014353,0.00044660296],"genre_scores_gemma":[0.9986533,0.00005716713,0.00006675075,0.00007286596,0.000016253507,0.00003682693,0.0006559118,0.0000015014622,0.0004393596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962926,0.00012284347,0.00003442378,0.000035601835,0.000053810352,0.00012392816],"domain_scores_gemma":[0.9993672,0.00005287778,0.00022372902,0.000023588513,0.00013776027,0.00019494517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009016736,0.0003339747,0.00027954762,0.0013160286,0.0008144741,0.00080207974,0.00040640996,0.00048436172,0.0010763848],"category_scores_gemma":[0.001593139,0.00017324902,0.0004706985,0.0013802444,0.00034087102,0.00042934637,0.00081191276,0.00058569066,0.00027699326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041259256,0.00004307096,0.9978636,0.000006062014,0.000026633694,0.000045282417,0.00039668384,0.000037529735,0.00011269573,0.000014466918,0.00023419541,0.0011785349],"study_design_scores_gemma":[0.0000017565386,0.00004926186,0.9985386,0.0000050894064,0.00000567675,0.000024520295,0.0011079123,0.000042367275,0.000022983011,0.000008795022,0.00019077015,0.0000021930741],"about_ca_topic_score_codex":0.04894466,"about_ca_topic_score_gemma":0.071095094,"teacher_disagreement_score":0.04894466,"about_ca_system_score_codex":0.0011865643,"about_ca_system_score_gemma":0.00075247284,"threshold_uncertainty_score":0.09731954},"labels":[],"label_agreement":null},{"id":"W4417479886","doi":"10.1016/j.jval.2025.09.644","title":"EE260 Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Immunization; Respiratory system; Virus; Respiratory tract; Lower respiratory tract infection; Respiratory tract infections","score_opus":0.08362415419365703,"score_gpt":0.4066670076131796,"score_spread":0.32304285341952255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206585,0.004038239,0.00037451164,0.0004887563,0.000078571415,0.0002741682,0.00060502405,0.000023296785,0.002051594],"genre_scores_gemma":[0.9975212,0.00082566467,0.0003206511,0.00007751288,0.000023313884,0.00009654033,0.00027983374,0.0000032789185,0.0008518469],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9994702,0.00027928178,0.000031140222,0.00006186905,0.00005421792,0.000103397055],"domain_scores_gemma":[0.9995993,0.00012363995,0.00006776952,0.000013935849,0.000026313319,0.00016907025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097345514,0.00040033218,0.00081161805,0.00036573957,0.00013247922,0.000677846,0.0004790759,0.0006396613,0.006380958],"category_scores_gemma":[0.0013557792,0.0001878524,0.0018673376,0.00021790294,0.00021341738,0.0004977038,0.0005195502,0.0008315235,0.00026215584],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5906513,0.013129225,0.035962816,0.0034867653,0.0051501547,0.0005410117,0.0001594264,0.029952858,0.009557331,0.0017984423,0.0027289656,0.3068817],"study_design_scores_gemma":[0.12484867,0.37560055,0.3782842,0.002286129,0.023144929,0.0008748118,0.0010126405,0.067283824,0.012851078,0.0016842597,0.011943013,0.00018583552],"about_ca_topic_score_codex":0.0079045985,"about_ca_topic_score_gemma":0.0067726052,"teacher_disagreement_score":0.0079045985,"about_ca_system_score_codex":0.0020072504,"about_ca_system_score_gemma":0.0014737613,"threshold_uncertainty_score":0.02134639},"labels":[],"label_agreement":null},{"id":"W4417479923","doi":"10.1016/j.jval.2025.09.2554","title":"PCR81 Evaluating Patient Preferences for Clinical Trial Endpoints in Early Stage Cancer: A Discrete Choice Experiment in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; AstraZeneca (Canada)","funders":"","keywords":"Clinical trial; Stage (stratigraphy); Patient choice; Clinical endpoint; Discrete choice; Preference","score_opus":0.23949834063713513,"score_gpt":0.49113249469838155,"score_spread":0.25163415406124645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98882574,0.00028928916,0.0012512902,0.0014410925,0.000044118966,0.00091450854,0.0006159924,0.000022206465,0.0065958146],"genre_scores_gemma":[0.9903308,0.00026820344,0.0032937357,0.000560445,0.00001570623,0.00051168224,0.0002599341,0.00001557785,0.004743957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925143,0.0053331982,0.00017937519,0.0004289041,0.0006681914,0.0008760556],"domain_scores_gemma":[0.95714855,0.033105776,0.0017489913,0.0009347875,0.0032738373,0.003788161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010838812,0.00055629376,0.0010584606,0.00046529068,0.0036765,0.002078729,0.0011344743,0.0018528872,0.0080481805],"category_scores_gemma":[0.03100103,0.0005443513,0.0011783723,0.0010489009,0.0024956674,0.0008374869,0.00068760826,0.002292402,0.0006681147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27251375,0.053915776,0.31426927,0.0015797175,0.0016029128,0.0011859639,0.015412703,0.052401952,0.008304831,0.026055295,0.03799708,0.21476083],"study_design_scores_gemma":[0.0858989,0.067442626,0.54458827,0.00074062217,0.0015455858,0.0003458577,0.018368576,0.22569115,0.0059992205,0.0146516245,0.033448633,0.0012789281],"about_ca_topic_score_codex":0.9341935,"about_ca_topic_score_gemma":0.9546537,"teacher_disagreement_score":0.06580651,"about_ca_system_score_codex":0.036443714,"about_ca_system_score_gemma":0.06539315,"threshold_uncertainty_score":0.26441884},"labels":[],"label_agreement":null},{"id":"W4417479925","doi":"10.1016/j.jval.2025.09.2572","title":"PCR99 Framing Matters! Implications of Loss Aversion for Communicating Benefits to Patients in Preference Studies (and Beyond)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Framing (construction); Loss aversion; Prospect theory; Framing effect; Preference; Health economics; Preference elicitation; Meaning (existential)","score_opus":0.2011801648857067,"score_gpt":0.30076401422172466,"score_spread":0.09958384933601797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479925","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.043464087,0.0083998805,0.030838842,0.8116327,0.0042239046,0.00012362529,0.00051210163,0.00012483385,0.10068006],"genre_scores_gemma":[0.8449727,0.007098608,0.019227983,0.109424874,0.007539836,0.0003332935,0.00019239952,0.0001291532,0.01108114],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97267,0.024016235,0.0005394466,0.00068670866,0.0016037609,0.00048385301],"domain_scores_gemma":[0.8490811,0.1341742,0.004173064,0.0052718017,0.0054887957,0.001811085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.035623483,0.0004968224,0.000592392,0.00070468365,0.001158627,0.0062533813,0.0010509102,0.005652236,0.035430834],"category_scores_gemma":[0.19243716,0.0004217429,0.00088401703,0.0009230983,0.0043088594,0.007618379,0.0023396472,0.0069933203,0.0028753811],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016126803,0.00046777353,0.012695488,0.0007736282,0.00024291321,0.0006576206,0.00618103,0.0015344858,0.0007405443,0.40271783,0.14128393,0.43109214],"study_design_scores_gemma":[0.00060102297,0.0005091543,0.0111699365,0.0025618102,0.0003008084,0.0009779608,0.0043460717,0.0067056348,0.0015128064,0.87049323,0.100650415,0.00017111846],"about_ca_topic_score_codex":0.0028714,"about_ca_topic_score_gemma":0.0018301307,"teacher_disagreement_score":0.035623483,"about_ca_system_score_codex":0.0014651045,"about_ca_system_score_gemma":0.0021048456,"threshold_uncertainty_score":0.18839723},"labels":[],"label_agreement":null},{"id":"W4417479967","doi":"10.1016/j.jval.2025.09.917","title":"EE535 Impact of Indirect Treatment Comparison (ITC) Methodology on Cost-Effectiveness of Quizartinib in Acute Myeloid Leukemia (AML) in Canada and the United Kingdom (UK)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Reimbursement; Cohort; Cohort study; Leukemia","score_opus":0.15447653828251615,"score_gpt":0.4388684027220284,"score_spread":0.28439186443951225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.672136,0.08237269,0.122753665,0.007404358,0.008817712,0.0111455675,0.043411862,0.0013691762,0.050588965],"genre_scores_gemma":[0.9663372,0.0029388424,0.020143326,0.0010211713,0.0002452145,0.0015701557,0.0041677696,0.00018180578,0.0033945083],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.87669027,0.114323795,0.0028413634,0.002239658,0.002511546,0.0013933314],"domain_scores_gemma":[0.86522424,0.12500633,0.0032071902,0.002650563,0.0027690667,0.0011424896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0709178,0.0016518869,0.005513406,0.0017447136,0.00047102128,0.0028882555,0.0027842964,0.002478138,0.018997021],"category_scores_gemma":[0.14851445,0.0010088745,0.016439816,0.0027765105,0.0010307899,0.0022134485,0.002527637,0.005328694,0.000523723],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3624299,0.0012260159,0.023625867,0.01825561,0.18102111,0.0005016806,0.00043645292,0.21422537,0.0005129325,0.025383666,0.018960731,0.15342064],"study_design_scores_gemma":[0.155466,0.023321992,0.055446234,0.011200471,0.25915903,0.0009027872,0.0010745235,0.4258333,0.003068218,0.029595628,0.03425307,0.00067870854],"about_ca_topic_score_codex":0.091528185,"about_ca_topic_score_gemma":0.040877953,"teacher_disagreement_score":0.9084718,"about_ca_system_score_codex":0.0077227093,"about_ca_system_score_gemma":0.008794969,"threshold_uncertainty_score":0.37505364},"labels":[],"label_agreement":null},{"id":"W4417479984","doi":"10.1016/j.jval.2025.09.192","title":"CO90 Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario","funders":"","keywords":"Lung cancer; Toxicity; Systematic review; Cytotoxic T cell; Conjugate; Cancer; Clinical trial","score_opus":0.0194310146393124,"score_gpt":0.3837935148397427,"score_spread":0.3643625002004303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0037575776,0.9948225,0.00010920621,0.00018960866,0.00006393311,0.00012916693,0.000660627,0.00000543103,0.00026190435],"genre_scores_gemma":[0.07459219,0.9227201,0.00067364634,0.00096832594,0.000089868,0.00023970721,0.0005256369,0.0000066265675,0.00018395612],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962155,0.0010450452,0.0016696551,0.0004633249,0.00047327447,0.00013325393],"domain_scores_gemma":[0.9872328,0.00855403,0.0029131211,0.00021840783,0.00093456963,0.00014712711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005951278,0.0006978961,0.0051671206,0.004997877,0.00030174194,0.0017403167,0.00093906705,0.0012780572,0.0031144088],"category_scores_gemma":[0.018639578,0.00060647243,0.009335917,0.0047332905,0.0006962413,0.00123314,0.0010748007,0.00096172676,0.00022501672],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001275941,0.000035079745,0.004018631,0.8806115,0.05474732,0.000087901455,0.00019331784,0.00019028116,0.00053004036,0.00024790305,0.0012278325,0.05683427],"study_design_scores_gemma":[0.0011343049,0.0010107375,0.018392194,0.45129067,0.50351405,0.00043538137,0.00038158134,0.00017561983,0.0005271301,0.00046329226,0.022596763,0.00007823874],"about_ca_topic_score_codex":0.0071412474,"about_ca_topic_score_gemma":0.02139855,"teacher_disagreement_score":0.0071412474,"about_ca_system_score_codex":0.0019440803,"about_ca_system_score_gemma":0.003976823,"threshold_uncertainty_score":0.031473696},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4417480004","doi":"10.1016/j.jval.2025.09.251","title":"CO149 Increased Functional Impairment Associated With Generalized Anxiety Disorder (GAD): Findings From a Systematic Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Systematic review; Generalized anxiety disorder; Functional impairment; Anxiety; Generalized anxiety","score_opus":0.029583266549297597,"score_gpt":0.3233192747896388,"score_spread":0.2937360082403412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009075882,0.9890666,0.00008698349,0.00028573466,0.00009647442,0.00013835753,0.00092781766,0.0000051744796,0.00031703353],"genre_scores_gemma":[0.16243365,0.8340457,0.0008096674,0.0013069331,0.00013088509,0.00040098358,0.0007385391,0.000008388064,0.00012532082],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9921274,0.0023032378,0.0033076003,0.0008924335,0.0010967227,0.00027263927],"domain_scores_gemma":[0.96989214,0.021852676,0.0061280183,0.00038844973,0.0014093984,0.0003293506],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006543269,0.0006185678,0.0047016335,0.005681154,0.0004983126,0.002382184,0.0010967567,0.0015825244,0.0025668666],"category_scores_gemma":[0.040645264,0.0005979446,0.006715845,0.00794435,0.00097415654,0.0016899663,0.0018110083,0.0011340058,0.00017374814],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080665125,0.00004854779,0.025302732,0.8801071,0.045211446,0.00020723691,0.00052711193,0.000098623714,0.00021226655,0.00020999253,0.0014770488,0.045791294],"study_design_scores_gemma":[0.0008757676,0.00036324005,0.11737255,0.6125914,0.25557664,0.0009108666,0.0011520748,0.00011150112,0.00018754357,0.00044723754,0.010300908,0.00011032185],"about_ca_topic_score_codex":0.013236592,"about_ca_topic_score_gemma":0.04645052,"teacher_disagreement_score":0.013236592,"about_ca_system_score_codex":0.0022979532,"about_ca_system_score_gemma":0.0066152955,"threshold_uncertainty_score":0.03460449},"labels":[],"label_agreement":null},{"id":"W4417480012","doi":"10.1016/j.jval.2025.09.317","title":"CO216 Safety and Efficacy of Antibody Drug Conjugate (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Triple-Negative Breast Cancer (TNBC): Systematic Literature Review (SLR)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario","funders":"","keywords":"Breast cancer; Antibody-drug conjugate; Systematic review; Drug; Conjugate","score_opus":0.021433026575349914,"score_gpt":0.40031154003912167,"score_spread":0.37887851346377177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005031554,0.9930361,0.00012420563,0.0002493123,0.000085229105,0.00017855852,0.00096844515,0.0000061242763,0.0003205119],"genre_scores_gemma":[0.092324845,0.90401626,0.0007919148,0.0013170723,0.000119487035,0.00033074,0.0008138275,0.000008503884,0.00027740852],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99585706,0.001280594,0.0017021399,0.00049942225,0.0005033623,0.00015745636],"domain_scores_gemma":[0.98508227,0.00949558,0.003694421,0.00027845692,0.0012748572,0.00017453198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006192089,0.00069222064,0.0051531973,0.004315997,0.00030537805,0.0019041743,0.000904901,0.0014523427,0.0038652322],"category_scores_gemma":[0.023362415,0.00064853084,0.009991467,0.0045203865,0.0006996188,0.0011785002,0.0012001462,0.0010725427,0.00030592002],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017063428,0.000036949015,0.0041842014,0.8822287,0.06761738,0.00008261035,0.0001773064,0.00016423796,0.0005207626,0.00019986606,0.0013093512,0.041772287],"study_design_scores_gemma":[0.0016155061,0.001093276,0.018518522,0.42182967,0.5340155,0.00037122032,0.00034089372,0.00017674743,0.0004772174,0.00045133953,0.02103304,0.000077050456],"about_ca_topic_score_codex":0.007972906,"about_ca_topic_score_gemma":0.024977045,"teacher_disagreement_score":0.007972906,"about_ca_system_score_codex":0.0018202671,"about_ca_system_score_gemma":0.0043916483,"threshold_uncertainty_score":0.03274727},"labels":[],"label_agreement":null},{"id":"W4417480024","doi":"10.1016/j.jval.2025.09.1924","title":"HTA139 Evolution of Acceptance of Evidence and PMA Outcomes by HTA Authorities for ATMPs in the EU4 and the UK 2017-2025","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"","score_opus":0.5471278348373917,"score_gpt":0.48423169276578937,"score_spread":0.06289614207160232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7089948,0.030498441,0.0033228693,0.09777432,0.0016320692,0.0003016187,0.082158774,0.00039171637,0.07492543],"genre_scores_gemma":[0.9731261,0.0023174223,0.0014894834,0.0038042075,0.00045613127,0.00011872745,0.012844608,0.00008718004,0.005756076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97796565,0.0054836296,0.003338364,0.0016415211,0.008305032,0.003265858],"domain_scores_gemma":[0.82564527,0.082496956,0.037226617,0.005062986,0.037590917,0.011977232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024044074,0.00021909857,0.0007186784,0.0045470526,0.0007479506,0.007116545,0.0012541106,0.0024371548,0.016152138],"category_scores_gemma":[0.15943812,0.0004416081,0.0012930108,0.0054374337,0.0013475451,0.0034184386,0.005124332,0.002895704,0.0011992235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005683091,0.00024677406,0.52085847,0.0052794535,0.0020575246,0.0009898271,0.0068876785,0.0048561334,0.002063648,0.07181725,0.16053222,0.21872795],"study_design_scores_gemma":[0.00015002985,0.00029613447,0.92420506,0.0018835888,0.00017269484,0.00026323152,0.0019706285,0.00093544036,0.0005994153,0.0023152526,0.06713064,0.00007785733],"about_ca_topic_score_codex":0.062745325,"about_ca_topic_score_gemma":0.033347398,"teacher_disagreement_score":0.062745325,"about_ca_system_score_codex":0.009581274,"about_ca_system_score_gemma":0.0119487345,"threshold_uncertainty_score":0.12715876},"labels":[],"label_agreement":null},{"id":"W4417480074","doi":"10.1016/j.jval.2025.09.1136","title":"EPH7 A Real-World Survey of Health Inequalities as Drivers for Burden on Male Hemophilia Patients in the US, EU5, and Asia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Inequality; Public health; Survey data collection; Social inequality","score_opus":0.09599436895553216,"score_gpt":0.3972385713632871,"score_spread":0.30124420240775496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98420864,0.00057858793,0.00017319417,0.0008416672,0.000017492575,0.00001945254,0.011896323,0.000006618419,0.0022581306],"genre_scores_gemma":[0.99330574,0.00038296235,0.00010961095,0.00029628052,0.000014448093,0.00003159684,0.005260377,0.0000038473554,0.0005950897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912506,0.00035381975,0.00010267579,0.00008813849,0.00011665445,0.00021377241],"domain_scores_gemma":[0.99859184,0.00019193586,0.0006436623,0.000100362886,0.0002347737,0.00023741793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090223,0.00017448727,0.00019424799,0.0006391433,0.00029827366,0.0008804506,0.00026775632,0.0005665146,0.0019581758],"category_scores_gemma":[0.0023616394,0.00012629923,0.00058251707,0.0020725294,0.0001950583,0.00061458175,0.0012634083,0.0005885625,0.00030354876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009430929,0.000033271903,0.993222,0.000044039913,0.00016373646,0.000041323092,0.00029468772,0.000092255956,0.00008111683,0.00024354726,0.0025238064,0.0031658113],"study_design_scores_gemma":[0.0000046833343,0.000030208144,0.99708444,0.000031245774,0.00003082893,0.00005108256,0.0008132685,0.000120578414,0.000040249015,0.000044094373,0.001744412,0.0000049904397],"about_ca_topic_score_codex":0.03506839,"about_ca_topic_score_gemma":0.032807272,"teacher_disagreement_score":0.03506839,"about_ca_system_score_codex":0.00049020717,"about_ca_system_score_gemma":0.00066022814,"threshold_uncertainty_score":0.06972855},"labels":[],"label_agreement":null},{"id":"W4417480109","doi":"10.1016/j.jval.2025.09.2689","title":"PCR216 Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pulmonary disease; COPD; Disease; Severity of illness","score_opus":0.024783594487331858,"score_gpt":0.3025102543734594,"score_spread":0.27772665988612755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994393,0.00078345166,0.00005766905,0.00048429915,0.000042793432,0.000011203265,0.0005329176,0.000005517341,0.003689074],"genre_scores_gemma":[0.99854714,0.0002176682,0.000053653977,0.00012969888,0.000029776338,0.0000064915953,0.00029386455,0.0000015865386,0.0007201262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943084,0.00017270951,0.000035327364,0.00006962116,0.00014997151,0.00014141043],"domain_scores_gemma":[0.9987373,0.0002452002,0.0004299119,0.000054205397,0.00024819537,0.00028511754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006035477,0.0001700518,0.00035539828,0.00047124265,0.0006907277,0.001203889,0.00021626489,0.00031840606,0.004911135],"category_scores_gemma":[0.0035224992,0.00014485672,0.00029845344,0.00087306526,0.00026537702,0.00042937667,0.0005495268,0.00058932876,0.00061969983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015473207,0.00010185758,0.982385,0.00003362115,0.000048883547,0.000111917645,0.000336652,0.000013675498,0.00036582453,0.000054347154,0.0010012626,0.015392186],"study_design_scores_gemma":[0.00000426666,0.000055042798,0.9985631,0.000009278778,0.00001984095,0.000105774976,0.00048872223,0.0000327815,0.000080395184,0.000033584725,0.000605048,0.000002095729],"about_ca_topic_score_codex":0.008216125,"about_ca_topic_score_gemma":0.012832058,"teacher_disagreement_score":0.008216125,"about_ca_system_score_codex":0.00030508472,"about_ca_system_score_gemma":0.00048717606,"threshold_uncertainty_score":0.016429365},"labels":[],"label_agreement":null},{"id":"W4417480112","doi":"10.1016/j.jval.2025.09.230","title":"CO128 Health Technology Assessment, Reimbursement, and Funding Landscape Challenges for Oncology Companion Diagnostics in Europe and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Biomarker; Selection (genetic algorithm); Precision medicine; Biomarker discovery; Health technology","score_opus":0.0730116779306706,"score_gpt":0.38458019095373086,"score_spread":0.31156851302306027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480112","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07126532,0.032358132,0.0036819861,0.7361337,0.0033319122,0.00047033286,0.006673252,0.00028545732,0.14579989],"genre_scores_gemma":[0.7449508,0.036804065,0.024916193,0.1030574,0.00220487,0.00029661114,0.0070605953,0.00040256212,0.08030707],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97915125,0.002691242,0.00075196073,0.00094278203,0.011534101,0.004928729],"domain_scores_gemma":[0.918644,0.009958817,0.0024631496,0.00075776014,0.05061934,0.017556971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01817466,0.0005066376,0.00075209857,0.004116641,0.0045787343,0.016931811,0.0025288705,0.0053353272,0.010721519],"category_scores_gemma":[0.044199187,0.00048003608,0.0012775261,0.0038124544,0.002766742,0.0024634101,0.0029120275,0.004130428,0.0007936735],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007742463,0.00039487198,0.07767594,0.00090335606,0.00041457478,0.00088750885,0.0012918401,0.00659578,0.0019290481,0.18311465,0.44148734,0.28453088],"study_design_scores_gemma":[0.00022687986,0.00025732187,0.11567404,0.0030560934,0.00031463243,0.0005899466,0.0049375133,0.011961142,0.0020596941,0.021051219,0.8395647,0.00030683997],"about_ca_topic_score_codex":0.96314406,"about_ca_topic_score_gemma":0.9735275,"teacher_disagreement_score":0.8665309,"about_ca_system_score_codex":0.13346912,"about_ca_system_score_gemma":0.4373274,"threshold_uncertainty_score":0.96839076},"labels":[],"label_agreement":null},{"id":"W4417480146","doi":"10.1016/j.jval.2025.09.864","title":"EE481 Global Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Steatohepatitis; Systematic review; Nonalcoholic steatohepatitis; Fatty liver; Liver enzyme; Liver damage","score_opus":0.01307669027968675,"score_gpt":0.2808598386346247,"score_spread":0.26778314835493794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480146","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032233829,0.99305624,0.00010033543,0.00039181943,0.00013347923,0.00009701704,0.00251939,0.0000055169326,0.0004728571],"genre_scores_gemma":[0.04207762,0.9549431,0.00042612836,0.0007924736,0.00017447393,0.00022417428,0.0011758456,0.0000074481572,0.00017871607],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961028,0.0011248728,0.0016681477,0.0003611705,0.0005437265,0.00019932627],"domain_scores_gemma":[0.98718137,0.008410588,0.0030910256,0.00019667597,0.0009441752,0.00017623583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039965482,0.0009333632,0.004928061,0.008671967,0.00037810713,0.0020173322,0.0010081269,0.0013785647,0.006281074],"category_scores_gemma":[0.022653528,0.00064615987,0.008769276,0.011431103,0.00047271856,0.0016286751,0.0016637627,0.0010378477,0.0004106416],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007379166,0.000034877376,0.014121663,0.88422203,0.05503796,0.00020153864,0.00013772948,0.00018785897,0.00013806709,0.00035713037,0.003749895,0.04107344],"study_design_scores_gemma":[0.0007812249,0.00024425096,0.053607073,0.65345293,0.26520666,0.00064841175,0.00042585004,0.00018728674,0.00013473532,0.0006746874,0.024546424,0.000090420195],"about_ca_topic_score_codex":0.011097628,"about_ca_topic_score_gemma":0.029230466,"teacher_disagreement_score":0.011097628,"about_ca_system_score_codex":0.0016445975,"about_ca_system_score_gemma":0.005422289,"threshold_uncertainty_score":0.022066116},"labels":[],"label_agreement":null},{"id":"W4417480151","doi":"10.1016/j.jval.2025.09.2642","title":"PCR169 Patient and Caregiver Recommendations for Person-Centered Oncology Clinical Trial Design: A Qualitative Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Dalhousie University; Nova Scotia Health Authority; Simon Fraser University","funders":"","keywords":"Clinical trial; Accrual; Qualitative research; Cancer; Alternative medicine; Clinical Oncology; Clinical Practice; Clinical research","score_opus":0.9089390174599398,"score_gpt":0.7251771522530572,"score_spread":0.18376186520688254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77338564,0.0038949212,0.06855524,0.104893014,0.0016955562,0.019363526,0.0008338623,0.00033391523,0.027044285],"genre_scores_gemma":[0.92499435,0.0016014958,0.038628053,0.017027084,0.00014693482,0.013608248,0.00010806596,0.00013233778,0.003753431],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.6339575,0.34813356,0.006868619,0.0022017502,0.0043648276,0.004473752],"domain_scores_gemma":[0.42772987,0.51069576,0.013149202,0.00875213,0.021866536,0.017806461],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.27794564,0.0006540639,0.0010679266,0.0013007884,0.013725026,0.008636487,0.0031334248,0.0045730434,0.0068291854],"category_scores_gemma":[0.35355115,0.0012922414,0.00073997333,0.0013210803,0.008283799,0.005543888,0.009032098,0.008825142,0.00093852327],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004183254,0.0009266362,0.0059606424,0.0025425802,0.00005452483,0.000796216,0.9180439,0.00033478448,0.0008877799,0.007569803,0.011075576,0.05138913],"study_design_scores_gemma":[0.00048151743,0.00097251625,0.0037951947,0.004693986,0.0000981339,0.001045072,0.9011762,0.0009721217,0.001993505,0.0063059335,0.07828485,0.00018099904],"about_ca_topic_score_codex":0.0029753975,"about_ca_topic_score_gemma":0.0048255017,"teacher_disagreement_score":0.72205436,"about_ca_system_score_codex":0.01266851,"about_ca_system_score_gemma":0.042969983,"threshold_uncertainty_score":0.89042157},"labels":[],"label_agreement":null},{"id":"W4417480163","doi":"10.1016/j.jval.2025.09.3322","title":"MSR31 Applying Simulation-Guided Trial Design Principles to Prospectively Plan Target Trial Emulation of a Cluster Randomized Trial for Vaccine Coverage","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Simon Fraser University","funders":"","keywords":"Emulation; Randomized controlled trial; Cluster randomised controlled trial; Design elements and principles; Cluster (spacecraft); Vaccine trial","score_opus":0.6018879378595969,"score_gpt":0.568326293465835,"score_spread":0.03356164439376197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480163","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0056652627,0.00012171539,0.9900226,0.0008048008,0.0000703258,0.0010487136,0.00010796289,0.0005122506,0.0016462925],"genre_scores_gemma":[0.25648683,0.00017890762,0.736668,0.00073033205,0.000075121454,0.0038821152,0.00017563743,0.00020318337,0.0015998811],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97371596,0.02376067,0.0005041322,0.00060613273,0.0010930083,0.00032017406],"domain_scores_gemma":[0.89507717,0.094222195,0.0024788117,0.0047416384,0.0027142344,0.00076596765],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03879859,0.0010930867,0.0014929916,0.0010475118,0.00043722626,0.001480076,0.001961066,0.0016593301,0.00859902],"category_scores_gemma":[0.120818734,0.001163028,0.001774295,0.00067191245,0.0010328995,0.0010773224,0.0018109385,0.003462841,0.0008118663],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015876003,0.000317937,0.0024949487,0.00042892582,0.00072503387,0.00011035506,0.00022254777,0.79694515,0.00081484986,0.100923836,0.0040392275,0.09138957],"study_design_scores_gemma":[0.00065048045,0.000363124,0.00016423682,0.000069607864,0.00010206783,0.000037635484,0.000015635436,0.9492617,0.00076676003,0.045634884,0.0029157074,0.000018126651],"about_ca_topic_score_codex":0.0031003528,"about_ca_topic_score_gemma":0.003648094,"teacher_disagreement_score":0.9612014,"about_ca_system_score_codex":0.0016609883,"about_ca_system_score_gemma":0.006268566,"threshold_uncertainty_score":0.20518899},"labels":[],"label_agreement":null},{"id":"W4417480164","doi":"10.1016/j.jval.2025.09.1344","title":"EPH215 Site-Specific Wastewater-Based Surveillance in Early Detection of COVID-19 New Cases and Prediction of Mass Testing Outcomes in Long-Term Care Facilities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Simon Fraser University; University of Alberta","funders":"","keywords":"Outbreak; Diagnostic test; Health care; Patient care; Mass vaccination","score_opus":0.09155860615795273,"score_gpt":0.32956723370341934,"score_spread":0.2380086275454666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99849343,0.00018520141,0.00023440695,0.000075845106,0.000012074563,0.000009263992,0.00022844471,0.000007366905,0.0007539248],"genre_scores_gemma":[0.99934334,0.00006332632,0.00017285356,0.000038576894,0.0000078348085,0.0000037550942,0.00018880666,0.0000015803122,0.00017983578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991756,0.00025364396,0.00008479293,0.00011111742,0.00016317851,0.00021162309],"domain_scores_gemma":[0.998789,0.0002515818,0.00050591707,0.00005196157,0.00018558885,0.00021590675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000909124,0.0003678367,0.00032541723,0.00066813856,0.00032385148,0.0011073347,0.0004676415,0.0007073878,0.0013008664],"category_scores_gemma":[0.0030581497,0.0001987648,0.00048479316,0.0005026732,0.00020890043,0.00051559287,0.0008318579,0.00042085777,0.0002623904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026530813,0.00006687874,0.9949826,0.0000103246875,0.0000336774,0.000087331864,0.00003187983,0.00015371297,0.00033055467,0.000019484181,0.0001314097,0.00388668],"study_design_scores_gemma":[0.000009905383,0.00038743825,0.9945069,0.000030264167,0.000056791334,0.00032713523,0.00046095467,0.0032707101,0.00059804396,0.00006885653,0.0002754046,0.000007562471],"about_ca_topic_score_codex":0.0068518724,"about_ca_topic_score_gemma":0.010538828,"teacher_disagreement_score":0.0068518724,"about_ca_system_score_codex":0.00061716296,"about_ca_system_score_gemma":0.0005866698,"threshold_uncertainty_score":0.0136240125},"labels":[],"label_agreement":null},{"id":"W4417480167","doi":"10.1016/j.jval.2025.09.103","title":"P64 Patient Engagement in Economic Evaluations of Cancer Care: Mapping the Landscape and Advancing Practice","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cancer; Key (lock); Patient participation; Economic evaluation; MEDLINE","score_opus":0.29124807340967107,"score_gpt":0.4591832805652473,"score_spread":0.16793520715557625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480167","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07676619,0.065743364,0.017072229,0.75734854,0.0018340404,0.0002658212,0.002040953,0.00010427266,0.07882457],"genre_scores_gemma":[0.9030617,0.04169905,0.015583659,0.030080026,0.004385802,0.0005541628,0.0009141349,0.00014774608,0.00357372],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.934512,0.055551898,0.002043297,0.0012363787,0.0053876387,0.0012686836],"domain_scores_gemma":[0.46831253,0.48210645,0.017916039,0.005144854,0.02009729,0.0064227325],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06246056,0.00049018994,0.001176631,0.0029320468,0.0015281498,0.011156238,0.0014426502,0.0035108011,0.019945005],"category_scores_gemma":[0.3338459,0.00044867984,0.0009574348,0.008094067,0.006541009,0.008392992,0.0051297336,0.0071222982,0.0009215218],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007352495,0.00046095892,0.088188335,0.0026365877,0.00034088004,0.00022195232,0.0028393916,0.0036864341,0.00011186474,0.13338166,0.10158649,0.6658101],"study_design_scores_gemma":[0.00032892768,0.0006599321,0.15585338,0.019711912,0.00036625555,0.0005042716,0.011268771,0.020162882,0.0005996923,0.61547977,0.17481494,0.0002492991],"about_ca_topic_score_codex":0.009774424,"about_ca_topic_score_gemma":0.012846895,"teacher_disagreement_score":0.93753946,"about_ca_system_score_codex":0.0061326693,"about_ca_system_score_gemma":0.0105632795,"threshold_uncertainty_score":0.3303269},"labels":[],"label_agreement":null},{"id":"W4417480189","doi":"10.1016/j.jval.2025.09.316","title":"CO215 Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body: Improvements in Patient-Reported Outcomes and Quality of Life","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Probity Medical Research","funders":"","keywords":"Roflumilast; Quality of life (healthcare); Scalp; Psoriasis; Apremilast","score_opus":0.022511249125088943,"score_gpt":0.2719900967506689,"score_spread":0.24947884762557992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901037,0.006841077,0.00012164319,0.0003301765,0.00006883237,0.000044772016,0.00013892063,0.00004089388,0.002309968],"genre_scores_gemma":[0.9978818,0.0012538098,0.000099636294,0.000102013204,0.000038171722,0.000014540812,0.000102492304,0.0000025542186,0.0005049219],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9999119,0.000027266675,0.000005779133,0.000012535741,0.0000146929915,0.000027900114],"domain_scores_gemma":[0.9999168,0.000025047431,0.000020600311,0.0000044373796,0.000006798589,0.000026326827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013974024,0.00018861357,0.00056952075,0.00013350732,0.0001245228,0.00023769149,0.00010968479,0.00024263108,0.0026303676],"category_scores_gemma":[0.00032436382,0.00006409917,0.0003407625,0.00017115471,0.00010534737,0.00018671025,0.0000969238,0.0004467078,0.0003154628],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27874282,0.010386286,0.02423734,0.0011466055,0.0010910799,0.0009231092,0.00017981208,0.0006070204,0.061768044,0.0002040233,0.004860933,0.615853],"study_design_scores_gemma":[0.09412856,0.33604702,0.5136516,0.00043433663,0.0039252783,0.0049885428,0.0008380222,0.0049588215,0.02647646,0.00065076107,0.013778088,0.00012255562],"about_ca_topic_score_codex":0.0009293611,"about_ca_topic_score_gemma":0.0013773751,"teacher_disagreement_score":0.0026303676,"about_ca_system_score_codex":0.0001706598,"about_ca_system_score_gemma":0.00019934596,"threshold_uncertainty_score":0.008799434},"labels":[],"label_agreement":null},{"id":"W4417480252","doi":"10.1016/j.jval.2025.09.599","title":"EE215 Cost-Effectiveness Analysis of Pediatric and Adult Pneumococcal Conjugate Vaccine Strategies in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal conjugate vaccine; Pneumococcal disease; Pneumococcal vaccine; Pneumococcal infections; MEDLINE","score_opus":0.02268381399550877,"score_gpt":0.3228783492182144,"score_spread":0.3001945352227056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9124113,0.021740805,0.0011013459,0.004159819,0.0001662931,0.0010566193,0.04075164,0.000081227554,0.018530875],"genre_scores_gemma":[0.982462,0.005051903,0.0011775132,0.0006701741,0.00003044192,0.00016403005,0.007547595,0.000020306405,0.002876044],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9957675,0.0011250378,0.0002632078,0.00023815337,0.0012262424,0.0013799028],"domain_scores_gemma":[0.99544996,0.0012632607,0.00045706047,0.00007605248,0.0019533455,0.0008001941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026525285,0.0007617562,0.0016552331,0.0024414142,0.0010627938,0.0025009222,0.0014636451,0.0008326708,0.0035705348],"category_scores_gemma":[0.010772478,0.000559512,0.0031326504,0.0060044574,0.000559215,0.0006513775,0.00081781636,0.0013182221,0.00014846597],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026981482,0.0020309624,0.54669476,0.0057046562,0.013395879,0.0008699661,0.00062420586,0.21526188,0.0013485875,0.013016891,0.0367153,0.13735546],"study_design_scores_gemma":[0.004869666,0.003005405,0.84746295,0.0012207311,0.0072280345,0.00032975318,0.0020249537,0.11537883,0.0011451773,0.0015772189,0.015541969,0.00021525414],"about_ca_topic_score_codex":0.99462646,"about_ca_topic_score_gemma":0.9944613,"teacher_disagreement_score":0.12784137,"about_ca_system_score_codex":0.12784137,"about_ca_system_score_gemma":0.12846126,"threshold_uncertainty_score":0.9275584},"labels":[],"label_agreement":null},{"id":"W4417480293","doi":"10.1016/j.jval.2025.09.2511","title":"PCR38 Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Family Caregiving in Mental Illness","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Addiction and Mental Health; St. Joseph’s Healthcare Hamilton; Canadian Mental Health Association; Schizophrenia Society of Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Boehringer Ingelheim (Canada)","funders":"","keywords":"Primary care; MEDLINE; Survey data collection; Patient care","score_opus":0.043399493133265306,"score_gpt":0.3427074949418557,"score_spread":0.2993080018085904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96684486,0.0010412821,0.00014468907,0.0011588861,0.000034494627,0.00025551696,0.023086783,0.0000148319505,0.0074185687],"genre_scores_gemma":[0.9864227,0.0017331135,0.00038415822,0.0009209717,0.0000180159,0.0002051713,0.0065450645,0.000019387371,0.0037514041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975073,0.0002740173,0.0002315247,0.00026189236,0.00077475805,0.0009506101],"domain_scores_gemma":[0.99516076,0.00017671524,0.00089461665,0.00014580878,0.0022165608,0.0014055491],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017634555,0.0006935182,0.0007758504,0.0030904147,0.0070244097,0.002302347,0.0025022847,0.0012818138,0.004911135],"category_scores_gemma":[0.0042738495,0.0010575283,0.0016338106,0.010159664,0.0009306206,0.001243082,0.002961819,0.0021676559,0.0009093536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053083982,0.000095362455,0.99167717,0.000059127364,0.000059967086,0.00008779623,0.0029329115,0.000058727466,0.00007410676,0.00014150707,0.002420775,0.0023394953],"study_design_scores_gemma":[0.000008506479,0.000020802501,0.9935476,0.0000541604,0.000016460526,0.000054137985,0.0048799966,0.00006989059,0.00001532183,0.000018497927,0.0012974988,0.00001715857],"about_ca_topic_score_codex":0.99688655,"about_ca_topic_score_gemma":0.9980767,"teacher_disagreement_score":0.039060496,"about_ca_system_score_codex":0.039060496,"about_ca_system_score_gemma":0.048565138,"threshold_uncertainty_score":0.28340507},"labels":[],"label_agreement":null},{"id":"W4417480295","doi":"10.1016/j.jval.2025.09.3422","title":"MSR138 Linking Specialty Pharmacy Data With Healthcare Claims Data in a Rare Disease: Comprehensively Characterizing Patients With Hereditary Angioedema Treated With Berotralstat","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Hereditary angioedema; Specialty; Health care; Pharmacy; Patient care; Angioedema","score_opus":0.07664844442951928,"score_gpt":0.33702660373973375,"score_spread":0.26037815931021446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99520457,0.00041144248,0.00028586583,0.0002722444,0.000007998945,0.000019268571,0.0024627657,0.000019009645,0.0013170027],"genre_scores_gemma":[0.9972907,0.00012663072,0.0006321792,0.00010214226,0.000016163794,0.000010381534,0.001651773,0.000008084091,0.00016198015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997829,0.00043745193,0.00048479083,0.00043814498,0.0005648946,0.00024568496],"domain_scores_gemma":[0.9939036,0.0019545825,0.002795704,0.00041531253,0.00054231216,0.0003885393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001319805,0.00021801765,0.00038555128,0.0019779643,0.00034171602,0.0011343029,0.00039542024,0.00040573018,0.0020594834],"category_scores_gemma":[0.006533673,0.00013435044,0.00051684515,0.0029667686,0.00020150038,0.000574698,0.000802293,0.0004660782,0.00032671943],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015610144,0.000048723723,0.9892207,0.00003684059,0.00012921162,0.0006935067,0.00012330436,0.00011919289,0.0009940236,0.00009600645,0.0005636583,0.007818688],"study_design_scores_gemma":[0.000027458906,0.00010716101,0.98952204,0.00006115891,0.00016801363,0.0043554017,0.00036573608,0.0014253124,0.00094358367,0.00020636941,0.0028042682,0.000013463716],"about_ca_topic_score_codex":0.0054898704,"about_ca_topic_score_gemma":0.0068536177,"teacher_disagreement_score":0.0054898704,"about_ca_system_score_codex":0.0005456931,"about_ca_system_score_gemma":0.0010212195,"threshold_uncertainty_score":0.010915816},"labels":[],"label_agreement":null},{"id":"W4417480298","doi":"10.1016/j.jval.2025.09.1986","title":"HTA201 Influence of NICE Real-World Evidence Framework on HTA Submissions: Sensitivity Analyses in Real-World External Control Arm Studies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Nice; Sensitivity (control systems); Control (management); Control theory (sociology)","score_opus":0.31352318199468227,"score_gpt":0.5323299685771551,"score_spread":0.21880678658247282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480298","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04413524,0.0692645,0.2065619,0.16936359,0.047687415,0.05128633,0.2259567,0.006055977,0.17968841],"genre_scores_gemma":[0.57558924,0.0066362745,0.18960026,0.09545614,0.008764483,0.063013144,0.034366492,0.006618186,0.019955743],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.27944034,0.62193555,0.047267634,0.008202227,0.039563004,0.0035913188],"domain_scores_gemma":[0.115749404,0.7648707,0.043087497,0.033003073,0.038900524,0.004388742],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.4243571,0.00213165,0.008563154,0.0049654953,0.0016143034,0.015384738,0.007071656,0.013516945,0.046075128],"category_scores_gemma":[0.86109346,0.0039023089,0.023081748,0.006617258,0.0034049402,0.006635497,0.008545692,0.013629846,0.0072076386],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.043433804,0.0004112163,0.015810791,0.05456447,0.08516704,0.0010093106,0.002112229,0.028020889,0.0008331177,0.06871616,0.5828227,0.11709826],"study_design_scores_gemma":[0.0514004,0.0040306468,0.05883605,0.088074654,0.08021267,0.0016282311,0.0012422969,0.04705426,0.0056800456,0.13916177,0.5206384,0.0020406377],"about_ca_topic_score_codex":0.008615793,"about_ca_topic_score_gemma":0.006876512,"teacher_disagreement_score":0.4243571,"about_ca_system_score_codex":0.006719386,"about_ca_system_score_gemma":0.013888815,"threshold_uncertainty_score":0.7098702},"labels":[],"label_agreement":null},{"id":"W4417480320","doi":"10.1016/j.jval.2025.09.2967","title":"SA25 Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Thermo Fisher Scientific (Canada)","funders":"","keywords":"Prospective cohort study; Cohort; Clinical study design; Cohort study; Rheumatoid arthritis; Research design","score_opus":0.09933216415059573,"score_gpt":0.4248866211346665,"score_spread":0.3255544569840708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480320","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20691487,0.006414221,0.7234156,0.0013549121,0.003270396,0.015924776,0.02024664,0.0014695142,0.020989023],"genre_scores_gemma":[0.6584451,0.0017255882,0.29407367,0.001497314,0.0009380819,0.021385211,0.009335643,0.00029263872,0.012306805],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9279422,0.05944718,0.005336056,0.0041720574,0.002544832,0.0005577042],"domain_scores_gemma":[0.913781,0.04109837,0.00871776,0.025978686,0.0090480475,0.0013761802],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0766104,0.0013813924,0.0017841799,0.0038043605,0.0015229682,0.0020222978,0.002440781,0.0011747271,0.0133114755],"category_scores_gemma":[0.096788816,0.0014555639,0.0025631874,0.0044649597,0.00079235446,0.0011770048,0.0019140444,0.001056707,0.0031939615],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051930365,0.0014027571,0.6881645,0.0036234227,0.014834087,0.00091545127,0.0026165848,0.0054542734,0.005109991,0.027096456,0.029371502,0.21621786],"study_design_scores_gemma":[0.0036924498,0.014612724,0.67254907,0.001173776,0.009687485,0.002242853,0.0032411017,0.03358967,0.006075487,0.03128786,0.2214458,0.00040161013],"about_ca_topic_score_codex":0.005092802,"about_ca_topic_score_gemma":0.0094372565,"teacher_disagreement_score":0.9233896,"about_ca_system_score_codex":0.00047089733,"about_ca_system_score_gemma":0.0024650148,"threshold_uncertainty_score":0.40515935},"labels":[],"label_agreement":null},{"id":"W4417480349","doi":"10.1016/j.jval.2025.09.147","title":"CO45 Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Clinical efficacy; Systematic review; Clinical trial; Mutant; Lung; Cell","score_opus":0.03639967329631678,"score_gpt":0.41791284638852894,"score_spread":0.38151317309221217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022760667,0.99588937,0.0001239546,0.00021111283,0.00008040074,0.00013224086,0.0009162381,0.0000058110836,0.00036488177],"genre_scores_gemma":[0.05780777,0.9388866,0.0006289262,0.0012747191,0.00014802752,0.0002914792,0.0007603635,0.0000106846655,0.00019148404],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99445087,0.001580444,0.0023469294,0.00066582154,0.0007707503,0.00018518534],"domain_scores_gemma":[0.9773033,0.015804758,0.0049672956,0.00033884178,0.0013722646,0.00021345937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006068033,0.000772966,0.0062606013,0.0047090854,0.00035692146,0.0021807526,0.001227781,0.0014601871,0.004694822],"category_scores_gemma":[0.02953888,0.00066282944,0.010287364,0.0052400297,0.0008145187,0.0014299891,0.0013575688,0.0011787715,0.0003607941],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013678821,0.000030155788,0.003837762,0.8782238,0.06876086,0.0000744362,0.00015283136,0.00020012625,0.00039305724,0.00028868517,0.0018895961,0.044780713],"study_design_scores_gemma":[0.0015974488,0.00066889,0.017520674,0.5059327,0.4500534,0.00036069876,0.0002899601,0.00016245614,0.00030359373,0.00072163384,0.022297129,0.00009141479],"about_ca_topic_score_codex":0.0067428565,"about_ca_topic_score_gemma":0.022447456,"teacher_disagreement_score":0.0067428565,"about_ca_system_score_codex":0.0022883595,"about_ca_system_score_gemma":0.004917622,"threshold_uncertainty_score":0.0320912},"labels":[],"label_agreement":null},{"id":"W4417480375","doi":"10.1016/j.jval.2025.09.2882","title":"RWD132 Out of Sight, Out of Mind? A Simulation Study Assessing the Use of Quantitative Bias Analysis for Outcome Misclassification in Single-Arm Trials With External Control Comparisons","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Outcome (game theory); Control (management); External validity; Clinical trial; Range (aeronautics)","score_opus":0.8275028844107982,"score_gpt":0.5910186809017658,"score_spread":0.23648420350903243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480375","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44782087,0.0071671493,0.52141654,0.0050270488,0.0009616304,0.0061516673,0.00084157323,0.00053635077,0.010077194],"genre_scores_gemma":[0.9233975,0.0005112981,0.071775615,0.000867083,0.000081586644,0.0024992838,0.00011010149,0.000063887666,0.0006936839],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.7455772,0.24410842,0.0034883877,0.0034985058,0.002638481,0.0006889798],"domain_scores_gemma":[0.18745832,0.79096067,0.008244062,0.010320031,0.0023552782,0.0006616458],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19261374,0.0014388895,0.0031257668,0.0013552977,0.0007601883,0.0025717707,0.0023929076,0.0036950873,0.006381357],"category_scores_gemma":[0.5227494,0.0009819692,0.006211521,0.0014200378,0.0035843619,0.0035565423,0.0019802398,0.0045382637,0.00033613],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1733459,0.007633043,0.040456735,0.009787639,0.029340578,0.0013565748,0.003445776,0.27986568,0.0020700363,0.23498024,0.006765977,0.21095183],"study_design_scores_gemma":[0.05841535,0.017176395,0.0067477026,0.0021222567,0.013265616,0.0007910609,0.00062772806,0.72944623,0.0017321479,0.16492064,0.004433848,0.00032109284],"about_ca_topic_score_codex":0.00338892,"about_ca_topic_score_gemma":0.0015453309,"teacher_disagreement_score":0.8073863,"about_ca_system_score_codex":0.0019795087,"about_ca_system_score_gemma":0.003833288,"threshold_uncertainty_score":0.995651},"labels":[],"label_agreement":null},{"id":"W4417480382","doi":"10.1016/j.jval.2025.09.112","title":"CO9 An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal-Bolus Insulin","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Type 2 Diabetes Mellitus; Insulin; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial","score_opus":0.04254034607437609,"score_gpt":0.33385640049216075,"score_spread":0.2913160544177847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9476111,0.03098511,0.0017634053,0.0009232602,0.0035126922,0.0005865546,0.0077077593,0.00016619309,0.006743928],"genre_scores_gemma":[0.9914443,0.002346813,0.000917711,0.00059152086,0.00034286943,0.00022382247,0.0014016113,0.00003139098,0.002699929],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9957663,0.0026079644,0.0003325449,0.0005947054,0.00027910684,0.00041951475],"domain_scores_gemma":[0.9956976,0.002570125,0.0007838948,0.00032215955,0.00025602532,0.00037020288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003084044,0.0023796277,0.002942982,0.00075474795,0.00041436806,0.0016545793,0.001377244,0.0019755927,0.010991534],"category_scores_gemma":[0.008601101,0.0011195873,0.014262835,0.0010462417,0.0005156111,0.0011535436,0.0010806621,0.0036261843,0.0007233405],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9013534,0.0009739861,0.018812766,0.0027324443,0.060777888,0.00014060308,0.00007746075,0.00087268645,0.00081846624,0.00033716945,0.001330351,0.011772865],"study_design_scores_gemma":[0.41784388,0.076320216,0.17475474,0.0014713524,0.30991268,0.0003979251,0.00048076262,0.008891858,0.0024311468,0.0015175703,0.005760226,0.0002175284],"about_ca_topic_score_codex":0.025291098,"about_ca_topic_score_gemma":0.01692939,"teacher_disagreement_score":0.025291098,"about_ca_system_score_codex":0.0013949423,"about_ca_system_score_gemma":0.0011569544,"threshold_uncertainty_score":0.050287724},"labels":[],"label_agreement":null},{"id":"W4417480386","doi":"10.1016/j.jval.2025.09.667","title":"EE283 Cost-Minimization Analysis of Aripiprazole 2-Month Ready-to-Use vs. Other Long-Acting Injectable Antipsychotics: Evidence From Ontario","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aripiprazole; Real world evidence; MEDLINE","score_opus":0.09147220058310773,"score_gpt":0.37636342066633616,"score_spread":0.2848912200832284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87856793,0.073577926,0.0037119498,0.0044616843,0.0003027455,0.001650673,0.016976617,0.00010620091,0.020644238],"genre_scores_gemma":[0.98502076,0.0077891606,0.0016682126,0.00046336607,0.00005299748,0.00019085345,0.0024059366,0.00002192711,0.0023868356],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99752766,0.0014021926,0.00014856539,0.0001341089,0.0005060541,0.00028137508],"domain_scores_gemma":[0.99738353,0.0011692368,0.0006247007,0.000099791614,0.00042345416,0.00029923598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022453258,0.00063957076,0.0011859366,0.00061792287,0.00033847988,0.00094760186,0.0009597112,0.0006061187,0.005593356],"category_scores_gemma":[0.007336681,0.000498348,0.005385395,0.00105113,0.00032713675,0.0004114588,0.0005332713,0.0010851811,0.00017483567],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39448735,0.0027597519,0.06493953,0.016500264,0.04939839,0.00037785945,0.00039522932,0.0561275,0.00305165,0.0053155497,0.02305152,0.3835954],"study_design_scores_gemma":[0.15374562,0.034816343,0.589171,0.008727834,0.093406856,0.00059873273,0.0009297524,0.07096538,0.0024185404,0.004649527,0.0402621,0.0003083386],"about_ca_topic_score_codex":0.5642451,"about_ca_topic_score_gemma":0.66647327,"teacher_disagreement_score":0.5642451,"about_ca_system_score_codex":0.02090768,"about_ca_system_score_gemma":0.016477956,"threshold_uncertainty_score":0.8766423},"labels":[],"label_agreement":null},{"id":"W4417480396","doi":"10.1016/j.jval.2025.09.1053","title":"EE671 Stakeholder Engagement in the Economic Evaluation of Site-Specific Wastewater-Based Surveillance for Preventing COVID-19 Outbreaks in Long-Term Care Facilities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Infection Control and Ventilation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Outbreak; Economic evaluation; Stakeholder; Pandemic; Stakeholder engagement; Coronavirus disease 2019 (COVID-19); Disease surveillance; Control (management)","score_opus":0.14506957646383364,"score_gpt":0.37477185912795136,"score_spread":0.2297022826641177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8874553,0.0028883228,0.011764178,0.015639422,0.00033879827,0.008782452,0.002236666,0.00006173847,0.070833236],"genre_scores_gemma":[0.9881771,0.00043450808,0.0052994434,0.0012282396,0.000046440706,0.0028536029,0.0003903447,0.000015828919,0.0015544752],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8746468,0.1117717,0.0024037627,0.0008767349,0.0050983177,0.0052027544],"domain_scores_gemma":[0.92348695,0.058474384,0.0036645557,0.001233103,0.009369295,0.0037718203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0923976,0.0008293169,0.00077841006,0.0010608424,0.0014176044,0.0043922323,0.0010900487,0.0024160245,0.0091176],"category_scores_gemma":[0.12327692,0.00040075718,0.0017277136,0.0008346865,0.0009994721,0.0018452265,0.0040634633,0.0020934457,0.00041996985],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12915719,0.019329907,0.17225005,0.011254926,0.0069260276,0.0011945507,0.0066733584,0.07285701,0.0051291804,0.05444724,0.02121761,0.499563],"study_design_scores_gemma":[0.024173383,0.11930389,0.3170524,0.020792678,0.009383519,0.00092860125,0.038332198,0.23897277,0.02797032,0.051112413,0.15107526,0.0009026624],"about_ca_topic_score_codex":0.00679525,"about_ca_topic_score_gemma":0.010555333,"teacher_disagreement_score":0.0923976,"about_ca_system_score_codex":0.011153703,"about_ca_system_score_gemma":0.019828271,"threshold_uncertainty_score":0.48865104},"labels":[],"label_agreement":null},{"id":"W4417480467","doi":"10.1016/j.jval.2025.09.2969","title":"SA27 Data Reliability in Retrospective Chart Review Studies: Results and Considerations From a Novel Data Review Methodology","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Reliability (semiconductor); Chart; Data quality; Key (lock); Data validation; Quality (philosophy)","score_opus":0.9702351135248084,"score_gpt":0.6875387359740056,"score_spread":0.2826963775508028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480467","genre_codex":"methods","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.062156346,0.06872892,0.79511017,0.0323237,0.005660177,0.012509511,0.0044420077,0.0012194087,0.017849827],"genre_scores_gemma":[0.46921617,0.007889611,0.49687487,0.0077462597,0.0018955816,0.012914502,0.0013788611,0.0007426731,0.0013415159],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.090641916,0.7526227,0.10300512,0.010497092,0.042346705,0.0008864471],"domain_scores_gemma":[0.02371641,0.85364944,0.033451553,0.04298231,0.04550652,0.0006937701],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7525277,0.0023322739,0.0063925534,0.010278032,0.002764644,0.013143283,0.0064129997,0.0049481736,0.00347091],"category_scores_gemma":[0.90491956,0.003350167,0.0142405005,0.015582454,0.006972355,0.008088124,0.007509391,0.0057439557,0.00088727596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011535967,0.00043548603,0.23706634,0.07613996,0.124096125,0.00095632166,0.022951785,0.012139896,0.0032393192,0.06252675,0.023253726,0.42565843],"study_design_scores_gemma":[0.00778121,0.013614222,0.20577548,0.111054,0.14544654,0.005956671,0.009494511,0.10997716,0.024016853,0.17198168,0.19216381,0.0027378544],"about_ca_topic_score_codex":0.006234511,"about_ca_topic_score_gemma":0.009353133,"teacher_disagreement_score":0.24747229,"about_ca_system_score_codex":0.005966256,"about_ca_system_score_gemma":0.015596197,"threshold_uncertainty_score":0.30517745},"labels":[],"label_agreement":null},{"id":"W4417480469","doi":"10.1016/j.jval.2025.09.790","title":"EE407 EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Disease; Gastroesophageal Junction; Cancer; Disease burden; Burden of disease; Overall survival","score_opus":0.018228040083336127,"score_gpt":0.34252972916796215,"score_spread":0.32430168908462603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98526186,0.0012908357,0.00007910536,0.0016753179,0.000058531463,0.000024636827,0.0071096206,0.0000131988945,0.004486991],"genre_scores_gemma":[0.99376523,0.00048018046,0.00013544764,0.0001998597,0.000055527413,0.000015939304,0.0040667946,0.000006349911,0.0012745827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957913,0.00013097945,0.000046924128,0.000041692103,0.00009010262,0.00011119251],"domain_scores_gemma":[0.99872977,0.00030087118,0.00047007712,0.00003903472,0.00014114195,0.00031918712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060261134,0.00019121148,0.00023799308,0.0008509832,0.00019984534,0.0009345235,0.00032336064,0.0003953437,0.0059076403],"category_scores_gemma":[0.0037972217,0.00009476224,0.0010336107,0.001326398,0.000151782,0.0006518041,0.0008472625,0.0007398341,0.00037418495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012077112,0.00014070114,0.9705358,0.00012316903,0.00047629955,0.00015530753,0.00006666133,0.00072843017,0.00011418061,0.00037341713,0.0039591547,0.02211916],"study_design_scores_gemma":[0.000084348845,0.00036474338,0.9926202,0.00010271398,0.00033277873,0.00028835572,0.00044133613,0.0016334439,0.00011142323,0.00036103433,0.003642173,0.000017349656],"about_ca_topic_score_codex":0.02107474,"about_ca_topic_score_gemma":0.029683052,"teacher_disagreement_score":0.02107474,"about_ca_system_score_codex":0.0013833637,"about_ca_system_score_gemma":0.00093655405,"threshold_uncertainty_score":0.04190415},"labels":[],"label_agreement":null},{"id":"W4417480483","doi":"10.1016/j.jval.2025.09.063","title":"P20 The Frequency of Mentions and Impact of Patient Input in HTA Decision Making in Cell and Gene Therapies Across the UK, Canada, and Australia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Excellence; Agency (philosophy); Advisory committee; Regulatory agency; Health care; Gene technology; Health technology; Drug","score_opus":0.22028382789820106,"score_gpt":0.43742560122138135,"score_spread":0.2171417733231803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79787487,0.012445085,0.0021292663,0.08672717,0.0013193715,0.00017723549,0.020171251,0.00027901653,0.0788768],"genre_scores_gemma":[0.985914,0.0021953818,0.0008564375,0.0030736378,0.00040851315,0.000031561023,0.0013682027,0.00008665068,0.0060655586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.981044,0.0085508125,0.002285846,0.0010583518,0.006010868,0.0010501167],"domain_scores_gemma":[0.6519959,0.27622518,0.03192124,0.0032974724,0.028697994,0.007862123],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011582816,0.000120576726,0.0004475526,0.0030081146,0.0011149645,0.002995609,0.0010135367,0.0013941429,0.016758299],"category_scores_gemma":[0.19258851,0.00030328034,0.00083628675,0.0049779713,0.0013102277,0.0019441416,0.0021480059,0.00203082,0.0008011685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019796211,0.00017469417,0.5764783,0.0025193752,0.0005830169,0.002220782,0.014622507,0.0021934025,0.00075099576,0.013168281,0.10892094,0.27638805],"study_design_scores_gemma":[0.00012815635,0.00023870893,0.8849467,0.0035289784,0.0003473026,0.0018570259,0.011117472,0.0055746627,0.0012795698,0.0040843566,0.08673298,0.00016412721],"about_ca_topic_score_codex":0.16046639,"about_ca_topic_score_gemma":0.14290088,"teacher_disagreement_score":0.99374187,"about_ca_system_score_codex":0.006258107,"about_ca_system_score_gemma":0.0077285217,"threshold_uncertainty_score":0.31906474},"labels":[],"label_agreement":null},{"id":"W4417480489","doi":"10.1016/j.jval.2025.09.111","title":"CO8 An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Type 2 Diabetes Mellitus; Insulin; Basal (medicine); Basal insulin; Diabetes mellitus","score_opus":0.043915710933798216,"score_gpt":0.33493330382646846,"score_spread":0.29101759289267026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9541897,0.027030228,0.0014915363,0.00091474736,0.0030146774,0.00054567313,0.0064444295,0.00014986562,0.0062190453],"genre_scores_gemma":[0.9919024,0.002164691,0.0008572561,0.000578838,0.0003272858,0.00022056611,0.0012607508,0.000029261884,0.0026589727],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958494,0.0025896528,0.00030829335,0.00056954025,0.00027060075,0.0004126155],"domain_scores_gemma":[0.9957308,0.0025277373,0.000793098,0.00031709112,0.00025265478,0.00037847468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030197431,0.0024401718,0.0028645506,0.0007477265,0.00043212494,0.0016276737,0.0013872498,0.002047591,0.010904848],"category_scores_gemma":[0.008484413,0.0011078692,0.014107133,0.0010003919,0.0005422387,0.0012104108,0.0011093741,0.0037147985,0.00072534505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.906056,0.0010883558,0.019226365,0.0025959564,0.056423068,0.00013755435,0.000084701955,0.0007723433,0.00081502105,0.0003337705,0.0012684597,0.0111983465],"study_design_scores_gemma":[0.43439353,0.08210778,0.17262562,0.0014122489,0.2908933,0.0003897461,0.0005227313,0.008028704,0.0023385058,0.0014851935,0.005586999,0.00021571868],"about_ca_topic_score_codex":0.024867661,"about_ca_topic_score_gemma":0.017251765,"teacher_disagreement_score":0.024867661,"about_ca_system_score_codex":0.0013783186,"about_ca_system_score_gemma":0.0011533035,"threshold_uncertainty_score":0.049445808},"labels":[],"label_agreement":null},{"id":"W4417480520","doi":"10.1016/j.jval.2025.09.2013","title":"HTA229 Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Outcome (game theory); German; Time horizon; Clinical trial; Quality (philosophy); Key (lock); Data quality; Horizon","score_opus":0.4822416653151922,"score_gpt":0.4825239585800524,"score_spread":0.00028229326486023387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749846,0.0019482787,0.003964545,0.0005576426,0.00001750192,0.00017569141,0.0025004228,0.0000631759,0.0032741863],"genre_scores_gemma":[0.9958717,0.0003026831,0.0019364138,0.00005685203,0.000008022366,0.00006552808,0.0011947376,0.000030738476,0.00053333456],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99371463,0.005297332,0.00012464543,0.0003277399,0.00028914618,0.00024652763],"domain_scores_gemma":[0.91816854,0.07675257,0.0016923541,0.0014370393,0.0009921932,0.0009572745],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011200744,0.0007073292,0.0011202701,0.0006161571,0.00032034866,0.0014390395,0.0010417566,0.0010690377,0.0083736405],"category_scores_gemma":[0.052507646,0.0003501242,0.0013472859,0.0008909832,0.0006642254,0.001532625,0.0011395827,0.0009431334,0.00050157524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19828969,0.0052136034,0.27197123,0.0024858965,0.0058986787,0.0011540913,0.0021928882,0.18799472,0.0023119452,0.018597512,0.009633563,0.29425612],"study_design_scores_gemma":[0.01011069,0.022789933,0.2851308,0.0009606194,0.007185656,0.0010037128,0.0019297638,0.6239189,0.005333114,0.032021277,0.00914707,0.00046855668],"about_ca_topic_score_codex":0.01970697,"about_ca_topic_score_gemma":0.011657516,"teacher_disagreement_score":0.9887993,"about_ca_system_score_codex":0.002028276,"about_ca_system_score_gemma":0.0021436429,"threshold_uncertainty_score":0.05923587},"labels":[],"label_agreement":null},{"id":"W4417480587","doi":"10.1016/j.jval.2025.09.570","title":"EE186 Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Carcinoma in situ; Food and drug administration; Bladder cancer; Bacillus (shape); Drug; Carcinoma","score_opus":0.029656904322169757,"score_gpt":0.29236009972322824,"score_spread":0.26270319540105846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92102456,0.016057346,0.003601212,0.00711477,0.00082382536,0.00094819546,0.013570899,0.0005266188,0.03633262],"genre_scores_gemma":[0.9853902,0.002054891,0.0007172024,0.0013057104,0.00020086048,0.0001409483,0.0026148637,0.000033779423,0.0075415885],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99926394,0.00038575803,0.000043713968,0.00007823365,0.00011380313,0.000114615985],"domain_scores_gemma":[0.9992762,0.000355631,0.00014763682,0.00003365403,0.00005103851,0.0001359229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008296275,0.00028395644,0.0006635766,0.00043866088,0.00017019552,0.0007224766,0.00034617406,0.00069593545,0.018471621],"category_scores_gemma":[0.0023444693,0.00018575987,0.0023107457,0.00042234725,0.00017653982,0.000519728,0.0003076231,0.0011678404,0.0014413272],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22487679,0.004243092,0.030214723,0.0013779488,0.0026718786,0.00084508065,0.00010591081,0.018988915,0.011128921,0.0042541106,0.04486404,0.6564286],"study_design_scores_gemma":[0.080942184,0.1703827,0.49535003,0.0016376649,0.01516915,0.0065894183,0.0017588624,0.07334697,0.016898856,0.008156288,0.12946403,0.00030390808],"about_ca_topic_score_codex":0.003267741,"about_ca_topic_score_gemma":0.0038330406,"teacher_disagreement_score":0.018471621,"about_ca_system_score_codex":0.0013206304,"about_ca_system_score_gemma":0.00080625917,"threshold_uncertainty_score":0.061793745},"labels":[],"label_agreement":null},{"id":"W4417480598","doi":"10.1016/j.jval.2025.09.466","title":"EE82 Budget Impact Analysis of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Community Development and Social Impact","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Vitamin k; Perspective (graphical); Public health; Alternative medicine","score_opus":0.061547177406557324,"score_gpt":0.33776131754581673,"score_spread":0.2762141401392594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7379617,0.03160527,0.011829297,0.052616566,0.0007944673,0.00064636965,0.056321036,0.00022866203,0.10799654],"genre_scores_gemma":[0.96524054,0.006221692,0.0029089474,0.0020683873,0.0003050418,0.00028027224,0.0062632095,0.00006122225,0.016650777],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99637526,0.0020022178,0.00015219995,0.00012696158,0.00045962902,0.00088368735],"domain_scores_gemma":[0.9957867,0.002299591,0.00064238295,0.00010988535,0.00094185263,0.0002195919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004543068,0.0006227737,0.0012042538,0.0021904337,0.00032117803,0.0024339221,0.0006329043,0.0012799004,0.009133756],"category_scores_gemma":[0.009793536,0.00039288172,0.0015573018,0.0037035635,0.00033755228,0.0009998727,0.0010145579,0.0011355868,0.00039524253],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008608076,0.00096904504,0.09862263,0.0029908626,0.005118388,0.0014445373,0.0003985583,0.5388377,0.0014235573,0.13544616,0.07396857,0.132172],"study_design_scores_gemma":[0.0026547683,0.0023600676,0.43608016,0.0035147434,0.0069039525,0.0011506955,0.005142272,0.28329816,0.004813371,0.05680164,0.19697064,0.00030952654],"about_ca_topic_score_codex":0.13228376,"about_ca_topic_score_gemma":0.083221,"teacher_disagreement_score":0.13228376,"about_ca_system_score_codex":0.008798898,"about_ca_system_score_gemma":0.0086743,"threshold_uncertainty_score":0.26302755},"labels":[],"label_agreement":null},{"id":"W4417480599","doi":"10.1016/j.jval.2025.09.871","title":"EE488 Health Economic Analysis of Risk- and Age-Based Pneumococcal Vaccination With PCV21 vs. PCV20 in France","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pneumococcal vaccination; Vaccination; Pneumococcal disease; Pneumococcal conjugate vaccine; Serotype; Pneumococcal infections","score_opus":0.013692807849383853,"score_gpt":0.3065944956887193,"score_spread":0.29290168783933546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464497,0.02093608,0.0016091322,0.004467416,0.0002547875,0.00021344135,0.018401213,0.00010457674,0.007563672],"genre_scores_gemma":[0.98939496,0.0012877323,0.0004389343,0.00039785096,0.00010126653,0.00010600109,0.0056297565,0.000017895738,0.0026254985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99415416,0.0040901625,0.00015480048,0.00025042534,0.0003425707,0.0010078416],"domain_scores_gemma":[0.9954466,0.0029941702,0.00054998236,0.00016331229,0.00041249522,0.00043337402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048596812,0.0008433569,0.0020307202,0.0017498437,0.00035356617,0.0024785083,0.001006848,0.0015482082,0.0052391496],"category_scores_gemma":[0.008126746,0.00044942854,0.0044167195,0.0015534378,0.00035223388,0.0007289258,0.0010953028,0.0014877822,0.00036236527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07960435,0.0037158944,0.3895716,0.0030351004,0.031567466,0.0016351269,0.0002814717,0.38871533,0.0014934822,0.019331036,0.029292632,0.051756576],"study_design_scores_gemma":[0.010140747,0.008513498,0.690773,0.0009051127,0.009106827,0.0007587752,0.0011790938,0.2506306,0.001160372,0.0034731526,0.023103977,0.0002548185],"about_ca_topic_score_codex":0.16641206,"about_ca_topic_score_gemma":0.077244446,"teacher_disagreement_score":0.16641206,"about_ca_system_score_codex":0.00992155,"about_ca_system_score_gemma":0.0036785842,"threshold_uncertainty_score":0.33088684},"labels":[],"label_agreement":null},{"id":"W4417480615","doi":"10.1016/j.jval.2025.09.1988","title":"HTA203 Insights on Progress Toward Patient-Centered HTA Through Evaluation of PRO Integration, Value Disconnects, and Policy Change in the EU5","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Value (mathematics); Health technology; Technological change","score_opus":0.5532195293571966,"score_gpt":0.48349061658448506,"score_spread":0.0697289127727116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480615","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.114693314,0.035291806,0.026812393,0.54836744,0.003354496,0.0005655052,0.0041294587,0.00026791933,0.26651776],"genre_scores_gemma":[0.9014766,0.006881211,0.02365025,0.05303749,0.0014571587,0.00040687693,0.0019171918,0.0001692935,0.011004017],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.94102114,0.04166632,0.001986523,0.001354762,0.008276067,0.005695108],"domain_scores_gemma":[0.91193455,0.06255944,0.0041948045,0.0035686975,0.011652779,0.006089677],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.07431943,0.00062250247,0.0011159589,0.0024569598,0.0018527383,0.017575236,0.0021147272,0.0070311283,0.01086008],"category_scores_gemma":[0.09634563,0.00032158766,0.0016820279,0.0036404305,0.004767336,0.0077940766,0.006921699,0.007233408,0.0005393706],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008007995,0.00046818663,0.011032532,0.00087275764,0.0003503773,0.00015605074,0.0022401009,0.007119708,0.00048139546,0.83518803,0.03898079,0.10230929],"study_design_scores_gemma":[0.0004939588,0.0013919416,0.06719337,0.007536148,0.00040634256,0.00020004895,0.008322447,0.012215241,0.0030140292,0.62542146,0.2735797,0.00022536951],"about_ca_topic_score_codex":0.021738779,"about_ca_topic_score_gemma":0.018379666,"teacher_disagreement_score":0.9256806,"about_ca_system_score_codex":0.01425754,"about_ca_system_score_gemma":0.028140191,"threshold_uncertainty_score":0.3930434},"labels":[],"label_agreement":null},{"id":"W4417480624","doi":"10.1016/j.jval.2025.09.3438","title":"MSR155 New Developments in the Psychometric Testing of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Questionnaire: Responsiveness and Minimally Important Change","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Reliability (semiconductor); Psychometric testing; Dermatological diseases; Measure (data warehouse); Test (biology); Selection (genetic algorithm)","score_opus":0.06838099945994429,"score_gpt":0.31892377081317025,"score_spread":0.25054277135322595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480624","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87241673,0.015073014,0.053300243,0.0055224444,0.0014728209,0.0014344519,0.004706826,0.0010956882,0.044977833],"genre_scores_gemma":[0.9341173,0.00386958,0.05028249,0.0015963907,0.0012018342,0.0013453115,0.003331304,0.00018857271,0.0040672068],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98140436,0.009569312,0.001637111,0.0010499305,0.0060547614,0.00028457947],"domain_scores_gemma":[0.9663417,0.019768707,0.005189255,0.0023923647,0.0056464123,0.0006616372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020517578,0.0008850798,0.0011491616,0.0021874446,0.00024398587,0.0014236078,0.0011821059,0.0010137869,0.0042779953],"category_scores_gemma":[0.039280653,0.00030024973,0.0015581086,0.0014649321,0.0006919849,0.0014039429,0.0011559239,0.001858028,0.0013959017],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031361284,0.002042392,0.33363858,0.0010154716,0.0012898009,0.0002593477,0.0008148874,0.0024587763,0.02115048,0.0025986899,0.008579371,0.623016],"study_design_scores_gemma":[0.0009375097,0.009965037,0.9345975,0.0007320102,0.0004864385,0.0020056132,0.0005173526,0.012148887,0.009789239,0.0036723933,0.024935273,0.00021264651],"about_ca_topic_score_codex":0.00094661646,"about_ca_topic_score_gemma":0.0011489524,"teacher_disagreement_score":0.020517578,"about_ca_system_score_codex":0.00063663215,"about_ca_system_score_gemma":0.00073524175,"threshold_uncertainty_score":0.10850859},"labels":[],"label_agreement":null},{"id":"W4417480662","doi":"10.1016/j.jval.2025.09.668","title":"EE284 Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Vedolizumab; Disease; MEDLINE; Value (mathematics); Complete remission","score_opus":0.01171200381823341,"score_gpt":0.27427130096146396,"score_spread":0.26255929714323056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93766207,0.02750612,0.00030484755,0.004559104,0.00018868489,0.00015649151,0.018489191,0.000057149242,0.011076425],"genre_scores_gemma":[0.98529667,0.0036209356,0.00027204622,0.00060054543,0.00007052672,0.00004395011,0.006145229,0.000023245271,0.0039269286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988356,0.0002969321,0.00006265616,0.000110121146,0.0002969992,0.00039779895],"domain_scores_gemma":[0.99869615,0.0002140598,0.00021122803,0.00002808089,0.00030589107,0.00054463616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085480657,0.00039234798,0.00093590375,0.0006805738,0.00038984773,0.0013101503,0.0008989731,0.00075473316,0.0027418192],"category_scores_gemma":[0.0027231846,0.00024696076,0.0020144582,0.0012707477,0.0003836943,0.00027204878,0.00047745227,0.0013254522,0.00022350712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12757076,0.0011346956,0.5891681,0.0020212613,0.010348867,0.0010949586,0.00039076127,0.02740343,0.0032137828,0.0057369377,0.048133817,0.18378265],"study_design_scores_gemma":[0.00623406,0.002440876,0.9617304,0.00042011918,0.0035875202,0.00049092766,0.0005366705,0.008755789,0.00049245823,0.00030313962,0.014917619,0.00009043395],"about_ca_topic_score_codex":0.91261613,"about_ca_topic_score_gemma":0.9350909,"teacher_disagreement_score":0.91261613,"about_ca_system_score_codex":0.029266285,"about_ca_system_score_gemma":0.018149003,"threshold_uncertainty_score":0.21234274},"labels":[],"label_agreement":null},{"id":"W4417480674","doi":"10.1016/j.jval.2025.09.127","title":"CO25 Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Persistence (discontinuity); Baseline (sea); Term (time)","score_opus":0.0421911509496882,"score_gpt":0.27845938811363324,"score_spread":0.23626823716394504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663204,0.00040929415,0.00004630456,0.000052358475,0.000007072905,0.000008426087,0.0023664318,0.0000066713774,0.00047132],"genre_scores_gemma":[0.9977063,0.0000774609,0.000036458412,0.000032663007,0.000007354978,0.000010839809,0.0018398383,0.0000031581008,0.0002857853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942756,0.00011707511,0.000095871204,0.00013636355,0.00008216252,0.00014095394],"domain_scores_gemma":[0.9972257,0.0005582883,0.0015451894,0.00014221146,0.00018119281,0.00034744124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053109037,0.00018046057,0.00046848253,0.0004867804,0.00030056734,0.00096778554,0.00029116872,0.0007090498,0.0032204723],"category_scores_gemma":[0.0034393345,0.00018098978,0.00052710826,0.0013145681,0.00023569023,0.0005824524,0.00042776924,0.00067808735,0.00072256505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028915121,0.00008311936,0.9913878,0.000056488636,0.000119299395,0.00013222554,0.00015918384,0.00013295592,0.0004676782,0.000020474092,0.0005546128,0.0039946726],"study_design_scores_gemma":[0.00001705371,0.00019436938,0.9991111,0.000010540236,0.000029264032,0.00013479067,0.00009897459,0.000102397724,0.000039767212,0.000009767315,0.0002444105,0.000007491081],"about_ca_topic_score_codex":0.007850502,"about_ca_topic_score_gemma":0.0065860553,"teacher_disagreement_score":0.007850502,"about_ca_system_score_codex":0.0005176892,"about_ca_system_score_gemma":0.00024380772,"threshold_uncertainty_score":0.015609622},"labels":[],"label_agreement":null},{"id":"W4417480720","doi":"10.1016/j.jval.2025.09.154","title":"CO52 Comparative Analysis of Patient-Reported Outcomes (PROs) in Asthma Biologic Late-Phase Studies and Approved Labels: Implications for Entry and Product Differentiation","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Asthma; Product (mathematics); Product differentiation; Allergic asthma; New product development","score_opus":0.08423960676986965,"score_gpt":0.41536066802214056,"score_spread":0.3311210612522709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8574575,0.05396107,0.026834557,0.0036114093,0.0018868705,0.0026630512,0.018938646,0.000189205,0.03445768],"genre_scores_gemma":[0.9822838,0.0016840748,0.0061631394,0.0011399351,0.00040445558,0.0007801541,0.0044060675,0.00006829667,0.00307015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9191082,0.06011924,0.005387857,0.004872228,0.008593222,0.0019193242],"domain_scores_gemma":[0.78564084,0.16657422,0.024839314,0.010162662,0.010648011,0.002134977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06739306,0.0007588949,0.0017635913,0.00233014,0.0003626402,0.0031208328,0.0011579683,0.0011949759,0.0075503704],"category_scores_gemma":[0.10348497,0.00033975916,0.0054334975,0.0023688348,0.0010143429,0.0017292143,0.0015952619,0.0015933986,0.001054895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16642615,0.0011477622,0.47207892,0.0066376943,0.056555968,0.00025989657,0.0007440844,0.0017304565,0.009671199,0.0058446513,0.0088464655,0.27005678],"study_design_scores_gemma":[0.007641502,0.035877813,0.88875085,0.0017480039,0.024701584,0.00060926407,0.00091957103,0.0053126514,0.008352943,0.0035137916,0.0223319,0.0002400641],"about_ca_topic_score_codex":0.0012812054,"about_ca_topic_score_gemma":0.003039842,"teacher_disagreement_score":0.06739306,"about_ca_system_score_codex":0.0016403346,"about_ca_system_score_gemma":0.0015133757,"threshold_uncertainty_score":0.35641283},"labels":[],"label_agreement":null},{"id":"W4417480726","doi":"10.1016/j.jval.2025.09.202","title":"CO100 EQ-5D Utility Impact of Worsening NYHA Class and CV Hospitalization (CVH) on Health-Related Quality of Life (HRQoL) of Patients With ATTR-CM Based on the ATTRibute-CM Trial","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Quality of life (healthcare); Heart failure; Cardiomyopathy; Disease; Health related quality of life; Transthyretin","score_opus":0.06346557234012515,"score_gpt":0.3288952402722454,"score_spread":0.2654296679321203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781805,0.009915815,0.0006731689,0.00086388685,0.00057703967,0.00042312776,0.004901653,0.00005328814,0.0044114836],"genre_scores_gemma":[0.99198455,0.001394006,0.00040222792,0.00057714543,0.00033443156,0.0003516045,0.003474543,0.000012051524,0.0014695826],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982681,0.0010000933,0.0001098168,0.00026915345,0.00015150788,0.00020126239],"domain_scores_gemma":[0.99804115,0.00090106303,0.00041614874,0.00020606084,0.00013060914,0.00030482668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028204352,0.0017239413,0.0028413867,0.00032693346,0.00035267256,0.0019585292,0.0009039979,0.0014133211,0.0043942365],"category_scores_gemma":[0.0033909401,0.00046067592,0.0054356134,0.00049032125,0.0007952842,0.0015948511,0.001029512,0.003516392,0.00055363256],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91043264,0.0019144111,0.037810355,0.0016304548,0.020627659,0.00006516267,0.000076221244,0.003339773,0.0010638143,0.0007910348,0.0026716348,0.019576805],"study_design_scores_gemma":[0.5848871,0.090983205,0.25690517,0.00083206175,0.04181881,0.0002930623,0.00036450097,0.011170104,0.0014244696,0.0046814485,0.006342791,0.00029725835],"about_ca_topic_score_codex":0.0019514738,"about_ca_topic_score_gemma":0.0021670752,"teacher_disagreement_score":0.0043942365,"about_ca_system_score_codex":0.00072496355,"about_ca_system_score_gemma":0.0005131642,"threshold_uncertainty_score":0.014916062},"labels":[],"label_agreement":null},{"id":"W4417480732","doi":"10.1016/j.jval.2025.09.074","title":"P31 Comparative Performance of the EQ-5D-5L and PROMIS-10 in the Elderly: Data From the EQ-DAPHNIE Project in Five Countries","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"","score_opus":0.5254202712899588,"score_gpt":0.4417274547773113,"score_spread":0.08369281651264754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8944309,0.006111433,0.00066879235,0.00065887655,0.000064958615,0.000049683247,0.0925366,0.000025405261,0.005453456],"genre_scores_gemma":[0.962818,0.0007079189,0.0003247159,0.00010251205,0.000025771857,0.000041827505,0.035437897,0.000015489628,0.00052575365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964154,0.0017669024,0.00048647868,0.0003930078,0.0006045204,0.0003337237],"domain_scores_gemma":[0.9862562,0.007463237,0.002692086,0.0009501258,0.0021448918,0.0004935082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00800733,0.00037193796,0.0010095432,0.0030596761,0.00020538236,0.0011753931,0.00046835354,0.00068561645,0.002713399],"category_scores_gemma":[0.018768078,0.00022674592,0.0019396471,0.007384036,0.00049075985,0.00093845394,0.0012497404,0.00061029993,0.000566003],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022364347,0.000071557086,0.9577902,0.0005611117,0.0023833662,0.0001670425,0.00043988982,0.004570973,0.0001383193,0.0011499658,0.008183046,0.022308016],"study_design_scores_gemma":[0.00005960582,0.00012901775,0.99725074,0.00006578073,0.00015296359,0.00006184456,0.0002017445,0.00034112635,0.000074379415,0.00009677988,0.0015523705,0.000013621435],"about_ca_topic_score_codex":0.023117322,"about_ca_topic_score_gemma":0.011110529,"teacher_disagreement_score":0.023117322,"about_ca_system_score_codex":0.00064896676,"about_ca_system_score_gemma":0.00058831065,"threshold_uncertainty_score":0.045965552},"labels":[],"label_agreement":null},{"id":"W4417480743","doi":"10.1016/j.jval.2025.09.452","title":"EE68 Assessment of the Cost Utility of Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Preterm Infants Born 29-35 Weeks' Gestational Age in the Philippines","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Palivizumab; Cost–utility analysis; Gestational age; Respiratory system; Virus","score_opus":0.10368039981470174,"score_gpt":0.4461511830921953,"score_spread":0.3424707832774936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959925,0.00085056364,0.00020907228,0.00042838015,0.000010711632,0.00009808277,0.0010329728,0.000006665812,0.0013711413],"genre_scores_gemma":[0.9989404,0.0002384406,0.00024412996,0.00005360799,0.000007503442,0.00004093138,0.00025039885,0.0000014685274,0.00022305179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821246,0.0011853611,0.00008981148,0.00007474482,0.0002499245,0.0001876708],"domain_scores_gemma":[0.9978764,0.00092781545,0.00044414855,0.00005994573,0.0004807718,0.00021080121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002644788,0.0005348761,0.00035888972,0.00070165703,0.00019075423,0.00084091374,0.00066437793,0.0005159697,0.0016212024],"category_scores_gemma":[0.008937634,0.00020185788,0.00079397793,0.00070090377,0.00026050242,0.00047827195,0.00062183477,0.00045084947,0.00011916281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014291587,0.0008893486,0.88380903,0.0011334307,0.0017823259,0.0009315628,0.00055362016,0.0147626065,0.0015031615,0.0007207479,0.0012435635,0.078378946],"study_design_scores_gemma":[0.0008670494,0.010600516,0.96073174,0.0003216791,0.0012319601,0.00045170906,0.0014294797,0.020775853,0.0010400609,0.0003449843,0.0021714016,0.00003358879],"about_ca_topic_score_codex":0.04819898,"about_ca_topic_score_gemma":0.029919608,"teacher_disagreement_score":0.04819898,"about_ca_system_score_codex":0.0036822802,"about_ca_system_score_gemma":0.0019817057,"threshold_uncertainty_score":0.09583682},"labels":[],"label_agreement":null},{"id":"W4417480751","doi":"10.1016/j.jval.2025.09.525","title":"EE141 Comparing Alternative Extrapolation Methods Using Standard Partitioned Survival Model Functionality in the Presence of Converging Survival Data: A Case Study in Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Extrapolation; Renal cell carcinoma; Survival analysis; Parametric statistics; Equivalence (formal languages); Overall survival; Cell survival","score_opus":0.8253920294109419,"score_gpt":0.6337543514233877,"score_spread":0.19163767798755427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64539737,0.002950717,0.34508052,0.0014244894,0.00018836473,0.0004116831,0.00056847057,0.00046812382,0.0035102458],"genre_scores_gemma":[0.89897597,0.0006358551,0.09785299,0.00018022304,0.000056513607,0.0002317292,0.00057596865,0.00017489452,0.00131589],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98883015,0.009957951,0.00027847124,0.00032306492,0.00042762837,0.00018272885],"domain_scores_gemma":[0.8636988,0.12900144,0.0014023244,0.0024252823,0.0030355416,0.000436638],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02348011,0.0007861692,0.0010955094,0.0011481347,0.00042781737,0.0011711591,0.0015679633,0.0014548905,0.002665575],"category_scores_gemma":[0.09375556,0.00030984328,0.00162757,0.00083529047,0.00062988617,0.001360352,0.0019391119,0.0018562141,0.00028315812],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009530247,0.00082592014,0.02142112,0.0016346264,0.0012510099,0.0006134932,0.0010966082,0.7369836,0.0013448475,0.023880076,0.0031472647,0.19827119],"study_design_scores_gemma":[0.00032594608,0.0012276935,0.0033091044,0.00021549106,0.00018713635,0.00018576116,0.0003521173,0.9800212,0.00081089535,0.012411267,0.0009088177,0.00004458872],"about_ca_topic_score_codex":0.0053258133,"about_ca_topic_score_gemma":0.0031790393,"teacher_disagreement_score":0.9765199,"about_ca_system_score_codex":0.0009807107,"about_ca_system_score_gemma":0.0013553861,"threshold_uncertainty_score":0.124176145},"labels":[],"label_agreement":null},{"id":"W4417480800","doi":"10.1016/j.jval.2025.09.3393","title":"MSR108 Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Primary (astronomy); Primary sclerosing cholangitis; Primary care; Baseline (sea)","score_opus":0.04073650694666539,"score_gpt":0.35997456501930436,"score_spread":0.31923805807263894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924683,0.002653834,0.0008032888,0.00049952447,0.00016384502,0.00045081327,0.0004532297,0.000027922286,0.0024793362],"genre_scores_gemma":[0.9957231,0.0004491477,0.0019128894,0.00022531384,0.00018451063,0.0004796273,0.0003864274,0.000010015489,0.0006290169],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99486226,0.0036542292,0.00031106567,0.00048561065,0.00046708493,0.00021978612],"domain_scores_gemma":[0.993693,0.0037742015,0.0010532311,0.0004370781,0.0004832176,0.00055932475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047938153,0.0010289375,0.003182113,0.00049276376,0.00040059467,0.0012824099,0.0005348871,0.0010510064,0.006284852],"category_scores_gemma":[0.0071923956,0.00054555375,0.0025818408,0.00044235974,0.0008853033,0.0011325144,0.00078761973,0.001683926,0.000966676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9023172,0.0025506604,0.030062785,0.0006916791,0.0027693375,0.00008501079,0.0001564396,0.0009500797,0.0040903944,0.000347565,0.00033437737,0.05564442],"study_design_scores_gemma":[0.26397473,0.5569125,0.1492224,0.00037311198,0.010139547,0.0004619897,0.0004852656,0.0063190847,0.006764205,0.0009914946,0.0041767177,0.00017902501],"about_ca_topic_score_codex":0.00054405094,"about_ca_topic_score_gemma":0.00094914343,"teacher_disagreement_score":0.006284852,"about_ca_system_score_codex":0.00093181,"about_ca_system_score_gemma":0.00092936854,"threshold_uncertainty_score":0.025352359},"labels":[],"label_agreement":null},{"id":"W4417480803","doi":"10.1016/j.jval.2025.09.1188","title":"EPH59 Development and Validation of a Case Identification Algorithm for Hand Trauma Patients Using Health Administrative Data and the Epidemiology of Hand Trauma in a Universal Healthcare System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; University of Toronto","funders":"","keywords":"Medical diagnosis; Epidemiology; Identification (biology); Healthcare system; Health care; Public health","score_opus":0.2207098430597351,"score_gpt":0.4256360483483085,"score_spread":0.2049262052885734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480803","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92811894,0.0004756844,0.058286276,0.0013035786,0.00018710844,0.0015367734,0.0052456097,0.000415926,0.004430094],"genre_scores_gemma":[0.8714888,0.00026678818,0.11678257,0.00031721487,0.0001099854,0.0007663686,0.009277998,0.0000855625,0.0009046898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99016273,0.0034674874,0.002352302,0.0013462774,0.0021468957,0.0005243422],"domain_scores_gemma":[0.98261535,0.0074704606,0.0027461643,0.0016235145,0.0050454955,0.0004990013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014681614,0.00053081656,0.00087220466,0.0039560045,0.00072680536,0.0031067643,0.0013212758,0.0010146609,0.0024878203],"category_scores_gemma":[0.035373744,0.0005188623,0.0011334303,0.0020219965,0.00033993446,0.0015200068,0.0021866674,0.0009457281,0.00082930306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005552567,0.00052181946,0.9120273,0.00013749757,0.00035489115,0.00018507119,0.0002395047,0.003940346,0.002368019,0.0013358849,0.0041559413,0.074178495],"study_design_scores_gemma":[0.0004744511,0.0005455787,0.7551261,0.00039574373,0.00038891225,0.0012367234,0.00080412306,0.21981631,0.009146567,0.0023367384,0.009665649,0.00006302061],"about_ca_topic_score_codex":0.0043180035,"about_ca_topic_score_gemma":0.004146433,"teacher_disagreement_score":0.014681614,"about_ca_system_score_codex":0.0009837563,"about_ca_system_score_gemma":0.00284667,"threshold_uncertainty_score":0.077644706},"labels":[],"label_agreement":null},{"id":"W4417480811","doi":"10.1016/j.jval.2025.09.1238","title":"EPH109 Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Herd immunity; Vaccination; Socioeconomic status; Context (archaeology); Intervention (counseling); Vaccine safety","score_opus":0.17067256125335453,"score_gpt":0.4168911014285767,"score_spread":0.24621854017522218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480811","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007146524,0.9849242,0.00014926199,0.00428617,0.0004079419,0.00009162596,0.00101437,0.0000060249095,0.0019739184],"genre_scores_gemma":[0.055605214,0.94128174,0.00032299382,0.0017036168,0.0002766839,0.00012801574,0.00043742335,0.0000053839353,0.00023893578],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99748164,0.0007309571,0.00073415926,0.0002666956,0.0004977125,0.00028885028],"domain_scores_gemma":[0.9682473,0.025162222,0.003435454,0.0003401025,0.0023946904,0.00042024432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006726586,0.0008055469,0.0022370608,0.005017618,0.00063741044,0.0040275916,0.0011622139,0.0019202123,0.0059724348],"category_scores_gemma":[0.03675349,0.0006244932,0.0044358936,0.007825042,0.0013356374,0.0023784223,0.0020814142,0.002290687,0.00043692917],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066371955,0.0002622313,0.07203449,0.38634667,0.013053302,0.00050114037,0.0028874814,0.00091278326,0.00019059803,0.0067948936,0.015550777,0.500802],"study_design_scores_gemma":[0.00012334506,0.00042140688,0.1441938,0.7076813,0.028393038,0.00080448383,0.0070942896,0.00040176767,0.00035547087,0.0037842346,0.10654849,0.00019843357],"about_ca_topic_score_codex":0.046097696,"about_ca_topic_score_gemma":0.06215518,"teacher_disagreement_score":0.046097696,"about_ca_system_score_codex":0.002890664,"about_ca_system_score_gemma":0.014869669,"threshold_uncertainty_score":0.09165877},"labels":[],"label_agreement":null},{"id":"W4417480839","doi":"10.1016/j.jval.2025.09.2621","title":"PCR148 Listening to the Voice of the Patient: Insights From a Survey on the Burden of Recurrent Respiratory Papillomatosis in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Recurrent Respiratory Papillomatosis; Active listening; Quality of life (healthcare); Disease; Papillomatosis; Disease burden","score_opus":0.10146678835213119,"score_gpt":0.3678655708611876,"score_spread":0.2663987825090564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98895746,0.00078283146,0.00013918537,0.0032506483,0.00003858269,0.000027563054,0.00062133936,0.0000054985235,0.0061769052],"genre_scores_gemma":[0.99671626,0.0008813639,0.00009971201,0.0014758976,0.000034299712,0.00001316036,0.00018760301,0.000005496895,0.00058620074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988231,0.000559524,0.000064756314,0.000067929825,0.00023408172,0.000250502],"domain_scores_gemma":[0.997815,0.00077178323,0.00070122373,0.00005249827,0.00035951097,0.00030000278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087383465,0.00012528816,0.00018276664,0.00044398173,0.0005385405,0.00095275935,0.00022835401,0.00055831735,0.0027143245],"category_scores_gemma":[0.0064255963,0.00015571249,0.0002342372,0.00080082344,0.00036297415,0.00053028454,0.0007378819,0.0007443839,0.00030071696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000642711,0.00012299276,0.9646305,0.00008632084,0.000032476964,0.0005779812,0.009719522,0.000047816553,0.0006444898,0.0000989744,0.0024884099,0.0214862],"study_design_scores_gemma":[0.000003619583,0.00014814461,0.9626121,0.0001039098,0.00003144546,0.000966804,0.032350693,0.0001273087,0.00019077792,0.00008624421,0.0033663034,0.000012624962],"about_ca_topic_score_codex":0.016127968,"about_ca_topic_score_gemma":0.025214756,"teacher_disagreement_score":0.016127968,"about_ca_system_score_codex":0.00040554302,"about_ca_system_score_gemma":0.00075957103,"threshold_uncertainty_score":0.032068193},"labels":[],"label_agreement":null},{"id":"W4417480846","doi":"10.1016/j.jval.2025.09.451","title":"EE67 Assessment of Health State Utilities Associated With Treatment for Chronic Hepatitis B Virus (HBV) Infection","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hepatitis B virus; Chronic hepatitis; Virus; Hepatitis B; Chronic infection; Oligonucleotide","score_opus":0.06352760309217137,"score_gpt":0.38702385300873193,"score_spread":0.32349624991656056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850797,0.0023586454,0.0014683628,0.00010632808,0.000030679865,0.00009209241,0.005360708,0.000022201955,0.005481301],"genre_scores_gemma":[0.99533576,0.00035468923,0.0005255497,0.000027525466,0.000016472626,0.00004185668,0.002361352,0.0000042171914,0.0013325117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977055,0.0016197985,0.00012844124,0.00009257428,0.00029769534,0.00015600002],"domain_scores_gemma":[0.99506795,0.0032873899,0.00088612654,0.00020854779,0.00039029916,0.00015974307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034097477,0.00042831886,0.0004939427,0.0016246662,0.00016342418,0.00084212865,0.00032607964,0.00027494336,0.0036446846],"category_scores_gemma":[0.00961687,0.00014745707,0.0022831985,0.0016068125,0.00019065241,0.00051634165,0.00060690753,0.0006325386,0.0003318283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010656607,0.00061042357,0.91433275,0.00071163045,0.0051528146,0.0001303585,0.00019373855,0.004520091,0.0006659677,0.0013205032,0.0013940199,0.06031105],"study_design_scores_gemma":[0.00018537519,0.003915854,0.98271275,0.00014678921,0.0010872125,0.00022734053,0.00029980604,0.0066189654,0.00082336063,0.0006000763,0.0033553715,0.000027187634],"about_ca_topic_score_codex":0.0043334477,"about_ca_topic_score_gemma":0.0039554695,"teacher_disagreement_score":0.0043334477,"about_ca_system_score_codex":0.00059438957,"about_ca_system_score_gemma":0.00035962914,"threshold_uncertainty_score":0.01803267},"labels":[],"label_agreement":null},{"id":"W4417480868","doi":"10.1016/j.jval.2025.09.286","title":"CO184 Predictors of Postoperative Complications Following Cytoreductive Surgery With HIPEC: A Real-World Analysis of 493 Patients in Québec","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thermo Fisher Scientific (Canada); Université de Montréal; McGill University","funders":"","keywords":"Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Intraperitoneal chemotherapy; Complication; Chemotherapy","score_opus":0.021056536786096175,"score_gpt":0.29928689882267817,"score_spread":0.278230362036582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146163,0.00089446496,0.0001644971,0.00030852034,0.000017206718,0.000028395174,0.0059601376,0.000011975918,0.001153067],"genre_scores_gemma":[0.9977725,0.0002890985,0.00008546551,0.0000927033,0.000008572856,0.00001133102,0.001472577,0.0000048114275,0.00026290608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924743,0.000095165145,0.00007461354,0.00015496848,0.00014660497,0.00028120208],"domain_scores_gemma":[0.9978271,0.00029854453,0.00073771767,0.000105713036,0.0005605253,0.00047036633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004841681,0.00039690558,0.00057958876,0.0010307864,0.0013820851,0.0013683172,0.0010742228,0.0007861557,0.0025188732],"category_scores_gemma":[0.0017422994,0.00041231813,0.0008852513,0.003873129,0.00070681167,0.00049670826,0.0006889986,0.00090729597,0.00023488418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033398883,0.000014897882,0.9984646,0.000011190458,0.00008037283,0.00007022482,0.00009245203,0.00008600523,0.00006102646,0.000026265183,0.00038392,0.00067549845],"study_design_scores_gemma":[0.000005496968,0.000014285706,0.99893147,0.000014807034,0.00002752807,0.000058078575,0.00034791592,0.00028890427,0.000014877085,0.000008176067,0.0002824512,0.000006035684],"about_ca_topic_score_codex":0.94147456,"about_ca_topic_score_gemma":0.9518349,"teacher_disagreement_score":0.058525443,"about_ca_system_score_codex":0.011065437,"about_ca_system_score_gemma":0.007865595,"threshold_uncertainty_score":0.117740154},"labels":[],"label_agreement":null},{"id":"W4417480899","doi":"10.1016/j.jval.2025.09.3350","title":"MSR64 Country-Related Differential Item Functioning in the EQ-5D-5L: Insights From the EuroQol Data Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Differential item functioning; Differential (mechanical device); Item response theory; Population; Population health; Rasch model","score_opus":0.41861316107142255,"score_gpt":0.4242891282015441,"score_spread":0.005675967130121529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.603668,0.016299237,0.20362248,0.012090036,0.00058287894,0.00078501576,0.06864204,0.0006151753,0.09369519],"genre_scores_gemma":[0.9165839,0.0018682631,0.056372654,0.0007460864,0.00013228065,0.0005129127,0.02032249,0.00023858069,0.0032227815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9812702,0.012594248,0.0013816452,0.00104468,0.0029830134,0.0007263165],"domain_scores_gemma":[0.9810432,0.011893381,0.0025195149,0.0021380133,0.0021828867,0.0002229489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021549802,0.00067859195,0.0010070599,0.0043299724,0.00034267252,0.0023735003,0.0011769062,0.0008105746,0.005702581],"category_scores_gemma":[0.054576084,0.0004127883,0.0022389796,0.009019389,0.0012452863,0.0024322406,0.0031463546,0.0016090461,0.001315488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008339586,0.00028527898,0.38503033,0.0010345718,0.0012632635,0.00055974495,0.0023215846,0.0255354,0.0014792721,0.17719254,0.031988855,0.3724752],"study_design_scores_gemma":[0.0001439388,0.00051204674,0.7138609,0.0010128268,0.00041592322,0.0011343008,0.0025059015,0.03963609,0.0022198316,0.16408971,0.074135475,0.00033307064],"about_ca_topic_score_codex":0.008612405,"about_ca_topic_score_gemma":0.0077668615,"teacher_disagreement_score":0.021549802,"about_ca_system_score_codex":0.0015417353,"about_ca_system_score_gemma":0.0011979532,"threshold_uncertainty_score":0.11396766},"labels":[],"label_agreement":null},{"id":"W4417480948","doi":"10.1016/j.jval.2025.09.1715","title":"HSD54 Guideline-Driven Off-Label Oncology Use: The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dynamics (music); MEDLINE; Clinical Oncology","score_opus":0.09949145858012742,"score_gpt":0.36107443986228466,"score_spread":0.26158298128215723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4021298,0.056693677,0.0030534968,0.36547697,0.0014074463,0.00032615048,0.027146813,0.00022370227,0.14354193],"genre_scores_gemma":[0.9629574,0.009972806,0.0017730168,0.014507567,0.00038183763,0.000060567872,0.004643829,0.00012480716,0.0055781086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9842181,0.0045203073,0.0013588977,0.0007550425,0.006409118,0.0027385016],"domain_scores_gemma":[0.88309205,0.046859447,0.013683499,0.002795399,0.036053084,0.017516568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015840506,0.00022165442,0.00071111077,0.002472529,0.0009754397,0.008293516,0.0016843796,0.0025668177,0.0062416107],"category_scores_gemma":[0.10188821,0.00035431102,0.0010464969,0.0044166315,0.002359471,0.0014128125,0.0018212586,0.0030801015,0.0003433111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023423694,0.00019834682,0.36310536,0.0018875976,0.0011879962,0.0006831558,0.0016431982,0.016299604,0.00080281904,0.13536967,0.22774383,0.24873611],"study_design_scores_gemma":[0.00046692466,0.00030741398,0.7601336,0.005096483,0.0006572929,0.00052298565,0.0024590574,0.011599211,0.0012218275,0.016190568,0.20110694,0.00023780386],"about_ca_topic_score_codex":0.85410523,"about_ca_topic_score_gemma":0.8853412,"teacher_disagreement_score":0.14589477,"about_ca_system_score_codex":0.04991823,"about_ca_system_score_gemma":0.09634063,"threshold_uncertainty_score":0.3621838},"labels":[],"label_agreement":null},{"id":"W4417481005","doi":"10.1016/j.jval.2025.09.1727","title":"HSD66 Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Systematic review; MEDLINE; Real world evidence; Dynamic inconsistency","score_opus":0.6306543205926481,"score_gpt":0.5402262152273164,"score_spread":0.09042810536533175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079389365,0.97978264,0.0004633747,0.014664159,0.000682892,0.000080277816,0.00058602897,0.0000061455967,0.00294064],"genre_scores_gemma":[0.01735562,0.9752255,0.00095685676,0.0045748665,0.0011078063,0.00016074361,0.0003507727,0.000010925312,0.00025683892],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9862991,0.007122177,0.0028869682,0.00065092434,0.002555469,0.00048534764],"domain_scores_gemma":[0.7577787,0.21398506,0.012912481,0.0016560919,0.012244492,0.0014232211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02808145,0.0008508802,0.004108513,0.012031461,0.0005511979,0.005049006,0.0013062516,0.003649987,0.016381428],"category_scores_gemma":[0.1753902,0.0008586621,0.0034241895,0.01141319,0.0020852578,0.0035055554,0.0018428382,0.0034487122,0.0013008094],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097609515,0.00019520413,0.002869036,0.3042936,0.005911871,0.00018660752,0.00022244678,0.0012221069,0.00016214213,0.027138118,0.037933312,0.61888945],"study_design_scores_gemma":[0.0007176816,0.0003308283,0.01053142,0.76236814,0.013944268,0.0003438432,0.00055047654,0.00067489233,0.00019811487,0.019349372,0.1909202,0.000070731105],"about_ca_topic_score_codex":0.010784282,"about_ca_topic_score_gemma":0.017859718,"teacher_disagreement_score":0.02808145,"about_ca_system_score_codex":0.0067647346,"about_ca_system_score_gemma":0.019882131,"threshold_uncertainty_score":0.14851063},"labels":[],"label_agreement":null},{"id":"W4417481042","doi":"10.1016/j.jval.2025.09.2611","title":"PCR138 Increased Adherence to Biologic Therapies Leads to Lower All-Cause and Asthma-Related (HCRU) Costs in Severe Asthma","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Acute severe asthma; Asthma; Adrenergic beta-Agonists; MEDLINE","score_opus":0.03765173837226746,"score_gpt":0.33338809029976857,"score_spread":0.29573635192750114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993612,0.0011108244,0.00031131925,0.00058972184,0.000071365015,0.000013166023,0.00049,0.000021145372,0.0037803596],"genre_scores_gemma":[0.9986193,0.0001422256,0.00014485963,0.00019386891,0.0000416647,0.0000069298135,0.00020930168,0.000006891641,0.00063498795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989759,0.0003871097,0.000071064926,0.00015053285,0.00021696152,0.0001984288],"domain_scores_gemma":[0.99681747,0.0011266501,0.0012747049,0.00017667381,0.00025976676,0.00034475408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007313225,0.00016923541,0.00043963583,0.0002173081,0.00023413381,0.0010118103,0.00026342412,0.00053069263,0.0066717276],"category_scores_gemma":[0.0068668663,0.00015721424,0.0007861729,0.00046812746,0.00021306625,0.00032118874,0.00032926977,0.0011130256,0.0003882354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003914198,0.0010955529,0.8849363,0.00025088436,0.0010566998,0.0003108596,0.00024173768,0.0008313546,0.0047730645,0.00053965184,0.0030093996,0.09904038],"study_design_scores_gemma":[0.000074576186,0.0004693182,0.99676704,0.000031439948,0.00020748586,0.00017674915,0.00010692014,0.0005296124,0.00054724864,0.00031584152,0.0007671035,0.000006613346],"about_ca_topic_score_codex":0.003834474,"about_ca_topic_score_gemma":0.0027200251,"teacher_disagreement_score":0.0066717276,"about_ca_system_score_codex":0.00031366068,"about_ca_system_score_gemma":0.00039489227,"threshold_uncertainty_score":0.022319138},"labels":[],"label_agreement":null},{"id":"W4417481050","doi":"10.1016/j.jval.2025.09.3352","title":"MSR66 Dealing With Missing Data in Health Economic Studies of Small to Moderate Size: How to Minimize Bias","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Missing data; Imputation (statistics); Sample size determination; Matching (statistics); Sample (material); Propensity score matching","score_opus":0.538504278450313,"score_gpt":0.49361757745006957,"score_spread":0.044886701000243445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481050","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012643466,0.0017921384,0.9916768,0.0040151207,0.00026155717,0.0001386031,0.00011318564,0.00020390484,0.00053442584],"genre_scores_gemma":[0.044642024,0.0017314189,0.94871914,0.0012407488,0.0007247566,0.000826243,0.0001910669,0.00039669254,0.0015280127],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8710201,0.11466365,0.0055958917,0.0036020286,0.004473043,0.000645234],"domain_scores_gemma":[0.57841283,0.38112262,0.007421918,0.023898229,0.008175677,0.0009687306],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13759282,0.0019266092,0.0049062227,0.0041569364,0.0012905532,0.0028492296,0.0042748684,0.004639042,0.007715919],"category_scores_gemma":[0.434663,0.002056842,0.006386974,0.0051847794,0.0033948051,0.005506555,0.004622005,0.00722852,0.001402133],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007416555,0.0002077864,0.00533515,0.0040238653,0.0039987247,0.00069391786,0.0014959481,0.041951716,0.0014033805,0.38423222,0.024504812,0.53141075],"study_design_scores_gemma":[0.0003288351,0.0001793994,0.0011117825,0.0009950218,0.00077304523,0.00035231988,0.00019678345,0.116120934,0.0018804967,0.8588443,0.019116824,0.00010030129],"about_ca_topic_score_codex":0.0020395953,"about_ca_topic_score_gemma":0.001970614,"teacher_disagreement_score":0.8624072,"about_ca_system_score_codex":0.0010308856,"about_ca_system_score_gemma":0.0032291675,"threshold_uncertainty_score":0.7276691},"labels":[],"label_agreement":null},{"id":"W4417481054","doi":"10.1016/j.jval.2025.09.160","title":"CO58 Comparative Efficacy of Iptacopan Monotherapy vs. Danicopan Add-on to C5i in Paroxysmal Nocturnal Hemoglobinuria (PNH) Results From an Indirect Treatment Comparison (ITC)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Clinical trial; Anemia; Hemoglobinuria; Complement (music)","score_opus":0.08828687517448482,"score_gpt":0.38900357143197956,"score_spread":0.30071669625749475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98016214,0.011227382,0.00048651113,0.00041853078,0.0008251048,0.00069044274,0.0017922212,0.000047424845,0.004350241],"genre_scores_gemma":[0.9938082,0.0019862992,0.00048855453,0.00028503165,0.0002781667,0.00039560895,0.00089484866,0.000013721385,0.0018495487],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9978307,0.0012753498,0.0001611625,0.00032117878,0.00016906012,0.00024260709],"domain_scores_gemma":[0.9976373,0.0012297276,0.0003966601,0.00017185327,0.00018348024,0.00038103943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020245758,0.0014430362,0.004062496,0.00051221636,0.00032861214,0.0012699383,0.0009661038,0.0016860691,0.008003744],"category_scores_gemma":[0.002964084,0.0005491318,0.0046910373,0.00053336,0.00092293834,0.0011155764,0.00051653903,0.0028058724,0.0009833744],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97792155,0.0011842214,0.0010258727,0.0008087538,0.0065873233,0.00003385777,0.000035380694,0.0002174869,0.0011593958,0.00011284545,0.00032159896,0.0105918115],"study_design_scores_gemma":[0.76551235,0.18248466,0.02230243,0.00035896924,0.023881102,0.00009193824,0.00013433326,0.0012551375,0.0016336527,0.0003908059,0.001885318,0.000069358524],"about_ca_topic_score_codex":0.0025227808,"about_ca_topic_score_gemma":0.004094977,"teacher_disagreement_score":0.008003744,"about_ca_system_score_codex":0.0012150701,"about_ca_system_score_gemma":0.0008687666,"threshold_uncertainty_score":0.026775181},"labels":[],"label_agreement":null},{"id":"W4417481068","doi":"10.1016/j.jval.2025.09.246","title":"CO144 Improvements in Scalp Outcomes With Roflumilast Foam 0.3% for Psoriasis of the Scalp and Body From the Phase 3 ARRECTOR Trial","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"","keywords":"Scalp; Roflumilast; Psoriasis; Phase (matter); Clinical trial","score_opus":0.031707650005507335,"score_gpt":0.351020697173431,"score_spread":0.31931304716792364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8932744,0.075094804,0.0012403594,0.0030772104,0.0017184035,0.0016895629,0.0055132736,0.0003960544,0.01799588],"genre_scores_gemma":[0.9741416,0.01266898,0.00094942533,0.0025132233,0.00080227875,0.0011708391,0.0026270298,0.00005737177,0.0050691487],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99957556,0.00019944727,0.00002396052,0.000049642094,0.00005168882,0.00009971075],"domain_scores_gemma":[0.9995364,0.00017884307,0.000088696754,0.000039326,0.000062308965,0.00009454956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010534629,0.0006735996,0.0015305367,0.00021268406,0.00023386498,0.00091276894,0.00040895885,0.0008649477,0.00739505],"category_scores_gemma":[0.0013078065,0.00019529315,0.0018614216,0.0002618161,0.00030775773,0.00061150285,0.0002378216,0.0023698334,0.0010843761],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8145287,0.002780414,0.002196739,0.003936484,0.004816267,0.00015223434,0.0000741566,0.00053860596,0.007981025,0.0005892418,0.012285704,0.15012056],"study_design_scores_gemma":[0.8860323,0.07679803,0.018181307,0.00069040747,0.0047492348,0.0003434484,0.00010532704,0.00069243414,0.0018173335,0.0009113845,0.009618779,0.000060013022],"about_ca_topic_score_codex":0.00083761103,"about_ca_topic_score_gemma":0.002014418,"teacher_disagreement_score":0.00739505,"about_ca_system_score_codex":0.0004152356,"about_ca_system_score_gemma":0.00041339392,"threshold_uncertainty_score":0.024738908},"labels":[],"label_agreement":null},{"id":"W4417481073","doi":"10.1016/j.jval.2025.09.2698","title":"PCR225 The Burden of Cognitive Impairment Associated With Schizophrenia (CIAS) on People With Lived Experience (PWLE): A National Canadian Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Centre for Addiction and Mental Health; Canadian Mental Health Association; Schizophrenia Society of Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Boehringer Ingelheim (Canada)","funders":"","keywords":"Lived experience; Schizophrenia (object-oriented programming); Cognitive impairment; Psychosis; Cognition","score_opus":0.05382091528229445,"score_gpt":0.3379574904043439,"score_spread":0.2841365751220495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9226009,0.001399825,0.0002399841,0.0013176018,0.00005106458,0.00026381566,0.06712384,0.000030936426,0.006972034],"genre_scores_gemma":[0.9790592,0.0014354878,0.00047129544,0.00072563504,0.000023990562,0.00014478416,0.014465189,0.0000151623635,0.0036592425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853396,0.00015086659,0.00013712449,0.00016219214,0.00052444765,0.0004914304],"domain_scores_gemma":[0.99646485,0.000101505175,0.0006204482,0.0001188427,0.0017480688,0.0009462974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011402994,0.00053699146,0.0005733368,0.0020782552,0.0026046108,0.0013929768,0.0016550086,0.0008590508,0.003100848],"category_scores_gemma":[0.0031839998,0.00055151584,0.0017331492,0.005708313,0.0005584416,0.00071570737,0.0016027099,0.001468861,0.0004953848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007166622,0.00006476807,0.9913264,0.000089642075,0.00013950201,0.000050704035,0.0009214204,0.000096250275,0.00009833217,0.00018195272,0.0036866236,0.0032727902],"study_design_scores_gemma":[0.0000064406427,0.000017046234,0.9979171,0.00003361355,0.000026930411,0.000027670827,0.0007407386,0.000068731904,0.000015041972,0.000014244591,0.0011205372,0.000011867447],"about_ca_topic_score_codex":0.99717844,"about_ca_topic_score_gemma":0.99789965,"teacher_disagreement_score":0.0261602,"about_ca_system_score_codex":0.0261602,"about_ca_system_score_gemma":0.03357102,"threshold_uncertainty_score":0.1898064},"labels":[],"label_agreement":null},{"id":"W4417481091","doi":"10.1016/j.jval.2025.09.2655","title":"PCR182 Patient-Reported Outcomes After Total Knee Arthroplasty: Comparisons Across TKA Procedures and PRO Domains","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Total knee arthroplasty; MEDLINE; Total knee replacement; Physical activity","score_opus":0.023128832904976106,"score_gpt":0.3205867209214541,"score_spread":0.29745788801647804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969216,0.0003316818,0.00016179333,0.000066447355,0.000020119927,0.000018701754,0.0014330978,0.0000066455177,0.001040021],"genre_scores_gemma":[0.99817204,0.00009165664,0.00010622606,0.000030893596,0.000017689896,0.000034887747,0.0011550431,0.0000045504953,0.00038697972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813795,0.00049830135,0.00025242375,0.00022096344,0.00048918644,0.00040120512],"domain_scores_gemma":[0.9945069,0.0015331227,0.0027913172,0.00019650205,0.00040047348,0.00057162135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018268479,0.00045771388,0.00073233165,0.0012051471,0.00028524693,0.0011528345,0.0006031116,0.0006987253,0.00432729],"category_scores_gemma":[0.0076348977,0.00021729835,0.0022307604,0.0016679054,0.0004375162,0.0012979419,0.0012690158,0.001039575,0.00048591412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035432265,0.0003365376,0.9835401,0.00015395845,0.0014484951,0.00005019101,0.00023323244,0.0004018221,0.0003845219,0.00016177956,0.0004504402,0.009295626],"study_design_scores_gemma":[0.00005607517,0.0008736069,0.997652,0.000018782936,0.00018755863,0.00006330807,0.0003132777,0.00031446517,0.00011563442,0.00009557274,0.00029765637,0.000012085635],"about_ca_topic_score_codex":0.0026214535,"about_ca_topic_score_gemma":0.0030555103,"teacher_disagreement_score":0.00432729,"about_ca_system_score_codex":0.0005253609,"about_ca_system_score_gemma":0.0006788565,"threshold_uncertainty_score":0.01447624},"labels":[],"label_agreement":null},{"id":"W4417481095","doi":"10.1016/j.jval.2025.09.1774","title":"HSD114 Treatment Characteristics of Breast Cancer Patients per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Breast cancer; Cancer; MEDLINE; Real world evidence","score_opus":0.08004581664081484,"score_gpt":0.41839420921166537,"score_spread":0.33834839257085053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83414406,0.0015752421,0.00030302117,0.0002052954,0.00004201585,0.0000498727,0.16129826,0.000038637332,0.0023435454],"genre_scores_gemma":[0.9277097,0.0007139381,0.00016234303,0.0001961247,0.00003528967,0.00006933376,0.069257274,0.000019548299,0.0018364865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908805,0.0001724898,0.00017963766,0.000247761,0.00015785878,0.00015428553],"domain_scores_gemma":[0.997903,0.0005674078,0.00092760666,0.00016863756,0.00023468,0.0001986108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050488353,0.00026987973,0.0006335537,0.0016818463,0.00023018343,0.0006118282,0.00043486053,0.00048215917,0.004129189],"category_scores_gemma":[0.002676751,0.00034158767,0.0015144229,0.0044947853,0.00013826898,0.00048008756,0.00035386847,0.00062991015,0.0005762994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008984374,0.000084193256,0.988246,0.00008861595,0.0007170342,0.000047924863,0.000032268617,0.00040597425,0.00015688711,0.000075724114,0.0054903673,0.0037566326],"study_design_scores_gemma":[0.00008525229,0.000098946555,0.99705315,0.000029998919,0.00026756726,0.00012783223,0.00010957599,0.00043501996,0.00009772005,0.00003774143,0.0016473449,0.000009727211],"about_ca_topic_score_codex":0.02721817,"about_ca_topic_score_gemma":0.02941788,"teacher_disagreement_score":0.02721817,"about_ca_system_score_codex":0.0005882325,"about_ca_system_score_gemma":0.0007068517,"threshold_uncertainty_score":0.054119468},"labels":[],"label_agreement":null},{"id":"W4417481121","doi":"10.1016/j.jval.2025.09.245","title":"CO143 Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Adjudication; Data collection; Event data; Chart","score_opus":0.848705380411406,"score_gpt":0.6368005529917615,"score_spread":0.21190482741964445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481121","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0999704,0.1402513,0.52052426,0.11685137,0.026390852,0.044928573,0.004920958,0.0015775182,0.044584703],"genre_scores_gemma":[0.57494926,0.008948819,0.34778452,0.023883436,0.0068344004,0.032387644,0.0015242948,0.0009664654,0.0027212368],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.055688992,0.7672656,0.12834287,0.012666204,0.03402874,0.0020075238],"domain_scores_gemma":[0.015013109,0.8008875,0.06367112,0.06256023,0.055160936,0.0027070118],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.779916,0.0016345218,0.005763281,0.013557564,0.0060163513,0.013791427,0.006717884,0.00875133,0.0050561735],"category_scores_gemma":[0.92298275,0.0047857873,0.008659207,0.01097719,0.006945459,0.010609104,0.008529696,0.01026228,0.0015966896],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009932144,0.0007453884,0.22519003,0.058381148,0.04088716,0.0009206118,0.020653415,0.0041482146,0.0028689743,0.027703045,0.075758286,0.5328116],"study_design_scores_gemma":[0.010113353,0.0035915351,0.31580403,0.13573076,0.03898874,0.0032052977,0.008972458,0.063393235,0.020740036,0.11066787,0.28627756,0.0025151428],"about_ca_topic_score_codex":0.0061390605,"about_ca_topic_score_gemma":0.011797728,"teacher_disagreement_score":0.22008401,"about_ca_system_score_codex":0.008607211,"about_ca_system_score_gemma":0.030847196,"threshold_uncertainty_score":0.27140284},"labels":[],"label_agreement":null},{"id":"W4417481186","doi":"10.1016/j.jval.2025.09.159","title":"CO57 Comparative Efficacy of First-Line (1L) Therapies for Patients With Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (mCRPC): An Updated Systematic Literature Review (SLR) and Bayesian Network Meta-Analyses (NMAs)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Prostate cancer; Systematic review; Clinical trial; Bayesian network; Clinical Practice; Meta-analysis","score_opus":0.11106918028399532,"score_gpt":0.4253436144722152,"score_spread":0.3142744341882199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014492221,0.9806902,0.0010464784,0.00046007233,0.00039022416,0.00021272809,0.0018402596,0.000045763078,0.00082200463],"genre_scores_gemma":[0.58817434,0.40066552,0.004178278,0.0023820896,0.000610872,0.00060056336,0.0022726755,0.00007046012,0.0010452886],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9922035,0.00427627,0.0014335299,0.0011320685,0.00071406894,0.00024055314],"domain_scores_gemma":[0.9901141,0.0068221046,0.0018548134,0.0004071274,0.00063535146,0.0001664263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008651,0.0015361,0.0080455,0.0032395828,0.00042605939,0.0022525063,0.0011960241,0.0017195515,0.004941529],"category_scores_gemma":[0.027210597,0.0009480317,0.03229722,0.0031677175,0.0005182928,0.0015264687,0.0011894935,0.0022149507,0.0004355957],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009988055,0.000048392973,0.0067671523,0.12664726,0.82566583,0.000074188436,0.00008128122,0.00068097905,0.00036001843,0.00021441477,0.0011146917,0.028357722],"study_design_scores_gemma":[0.002931369,0.0004858832,0.0070589962,0.009590644,0.9766699,0.0000811286,0.000034662273,0.00028848296,0.00011793115,0.0003192116,0.0023896666,0.000032186977],"about_ca_topic_score_codex":0.008511299,"about_ca_topic_score_gemma":0.020155229,"teacher_disagreement_score":0.008651,"about_ca_system_score_codex":0.001605917,"about_ca_system_score_gemma":0.001529053,"threshold_uncertainty_score":0.045751452},"labels":[],"label_agreement":null},{"id":"W4417481206","doi":"10.1016/j.jval.2025.09.1958","title":"HTA173 Health Technology Assessment (HTA) Systems and Risk Identification Strategies: A Comparative Analysis Across Western European Countries, Canada, and Australia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Christian ministry; Identification (biology); Action plan; Risk assessment; Technology assessment; Plan (archaeology)","score_opus":0.3248788019343251,"score_gpt":0.4840225715622174,"score_spread":0.15914376962789228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9242876,0.007921117,0.0029826988,0.002721842,0.00005313302,0.0003459785,0.013720199,0.000103782375,0.047863718],"genre_scores_gemma":[0.9884554,0.0015260058,0.002158283,0.00017592558,0.00001339378,0.00008564113,0.0046673934,0.000022617089,0.0028952302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582666,0.0014703396,0.00022371614,0.00020614453,0.0017479392,0.0005251019],"domain_scores_gemma":[0.9791542,0.0072589437,0.0024573347,0.00067829486,0.0088743195,0.0015769075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007381566,0.00022030808,0.00047918578,0.0038732581,0.0010229542,0.0024945268,0.00063533295,0.00042466147,0.0032335368],"category_scores_gemma":[0.02522921,0.0002353563,0.0009639041,0.0107435575,0.0006410134,0.00087299536,0.0010800343,0.0006292291,0.00026229784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012755793,0.00030417435,0.77499217,0.0007111862,0.001096003,0.0002556085,0.0022745926,0.012515833,0.00044367145,0.016279878,0.017811358,0.17204],"study_design_scores_gemma":[0.000058136986,0.00015326962,0.9802917,0.00033874996,0.00029713454,0.00009709011,0.0016758532,0.0064393096,0.00024561584,0.00094101124,0.009428716,0.000033339],"about_ca_topic_score_codex":0.8056659,"about_ca_topic_score_gemma":0.7384252,"teacher_disagreement_score":0.987242,"about_ca_system_score_codex":0.012758034,"about_ca_system_score_gemma":0.020515947,"threshold_uncertainty_score":0.39095712},"labels":[],"label_agreement":null},{"id":"W4417481242","doi":"10.1016/j.jval.2025.09.2620","title":"PCR147 Is There a Lack of Dietary Data Collection in Real-World IBD Studies? Literature Review and Future Considerations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Inflammatory bowel disease; Observational study; Data collection; Disease; Inflammatory Bowel Diseases; Crohn disease","score_opus":0.08068206926287089,"score_gpt":0.38445614192305777,"score_spread":0.30377407266018686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010381031,0.97495306,0.0008552525,0.020054849,0.001237655,0.00007202144,0.0005813701,0.000011601653,0.0011960563],"genre_scores_gemma":[0.024563406,0.94853055,0.0041340296,0.018678982,0.0028474005,0.00028718053,0.00073871936,0.000025714859,0.00019406716],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.95883274,0.017875656,0.013779223,0.0030568282,0.00578552,0.0006701475],"domain_scores_gemma":[0.59720373,0.3466831,0.022513187,0.004256884,0.02787363,0.0014694171],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.055636577,0.000754991,0.004019192,0.009250547,0.0009302584,0.0065942276,0.0028604483,0.0036847775,0.005860769],"category_scores_gemma":[0.23218648,0.000964953,0.0024621508,0.012829569,0.004016837,0.0056516593,0.0024286392,0.0029718464,0.000907302],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058721536,0.00009516246,0.017031781,0.3784534,0.0043857074,0.0007118268,0.0021301208,0.00038010822,0.00029389528,0.009290587,0.028955981,0.5576842],"study_design_scores_gemma":[0.00019887797,0.00019462367,0.019090546,0.6779014,0.008824265,0.0017542972,0.004393073,0.0004816229,0.00031610794,0.010453646,0.27624357,0.00014792949],"about_ca_topic_score_codex":0.009922444,"about_ca_topic_score_gemma":0.018768419,"teacher_disagreement_score":0.9443634,"about_ca_system_score_codex":0.0039235447,"about_ca_system_score_gemma":0.017625637,"threshold_uncertainty_score":0.2942378},"labels":[],"label_agreement":null},{"id":"W4417481250","doi":"10.1016/j.jval.2025.09.081","title":"P42 A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Rare disease; Health technology; Systematic review; Work (physics); Rare events; Population; Economic evaluation","score_opus":0.5853046093798203,"score_gpt":0.46045324594064796,"score_spread":0.12485136343917236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481250","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005490691,0.9784404,0.0030491436,0.011999715,0.0010277157,0.00097786,0.002302051,0.000060793533,0.001593232],"genre_scores_gemma":[0.011421481,0.96184677,0.01128189,0.010223997,0.0010834947,0.002177891,0.0013524408,0.000052816144,0.0005591722],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96446997,0.02068582,0.008176876,0.001440668,0.004690089,0.0005365692],"domain_scores_gemma":[0.7956746,0.16713557,0.016896507,0.00359744,0.015537762,0.0011581313],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.055114646,0.0015503234,0.006175175,0.01049511,0.0006303852,0.004853761,0.0027952564,0.0035275563,0.010090277],"category_scores_gemma":[0.21817802,0.0010691473,0.011237104,0.010318297,0.0011111405,0.0033193612,0.004195043,0.0034509301,0.0012086793],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006166066,0.00006125677,0.0011199499,0.5823208,0.020171262,0.00013023347,0.00025114426,0.0012376563,0.00024955117,0.006616811,0.050427604,0.33679706],"study_design_scores_gemma":[0.00082086766,0.00028831576,0.0028824413,0.82713044,0.045247987,0.00014186764,0.00018456133,0.0008475494,0.00021769793,0.009026756,0.113124825,0.00008663507],"about_ca_topic_score_codex":0.014877906,"about_ca_topic_score_gemma":0.033689857,"teacher_disagreement_score":0.9448854,"about_ca_system_score_codex":0.005972067,"about_ca_system_score_gemma":0.02955284,"threshold_uncertainty_score":0.29147756},"labels":[],"label_agreement":null},{"id":"W4417481252","doi":"10.1016/j.jval.2025.09.2756","title":"RWD6 A Record-Level Risk Metric for Partially Synthetic Clinical Data Using Inverse-Square Similarity Decay","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Privacy-Preserving Technologies in Data","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Energy Training","funders":"","keywords":"Pairwise comparison; Metric (unit); Similarity (geometry); Synthetic data; Confidence interval","score_opus":0.3608035342835096,"score_gpt":0.43693002632169853,"score_spread":0.07612649203818894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481252","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031658318,0.0009212616,0.96407604,0.00045418733,0.00009973918,0.000090584246,0.0009809243,0.001016525,0.000702483],"genre_scores_gemma":[0.50593317,0.00056978816,0.48529124,0.00023593965,0.00017549908,0.00020357665,0.0049106535,0.00024731853,0.0024328565],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9949858,0.0017979539,0.0005584566,0.000772499,0.0017157586,0.00016962586],"domain_scores_gemma":[0.99045044,0.004365725,0.00077635935,0.0021720694,0.0019513968,0.00028409326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068489136,0.00064736983,0.0012275547,0.0019789059,0.00042528193,0.002046572,0.0019226786,0.0012650032,0.0012952548],"category_scores_gemma":[0.028413804,0.00032963944,0.0011263384,0.0016922115,0.0007448913,0.0021011832,0.0020399466,0.0018073373,0.0005686832],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090923405,0.00037549355,0.015206691,0.0006246497,0.0005070031,0.00025382166,0.00027215917,0.41981432,0.009849788,0.04929185,0.0124095585,0.49048546],"study_design_scores_gemma":[0.000017926473,0.0002300814,0.001298072,0.000027830572,0.000022017684,0.00021942987,0.00003445208,0.9732056,0.00348338,0.018433927,0.0029972878,0.000029939394],"about_ca_topic_score_codex":0.002602741,"about_ca_topic_score_gemma":0.002368605,"teacher_disagreement_score":0.0068489136,"about_ca_system_score_codex":0.0011603024,"about_ca_system_score_gemma":0.0016826198,"threshold_uncertainty_score":0.036220968},"labels":[],"label_agreement":null},{"id":"W4417481256","doi":"10.1016/j.jval.2025.09.1993","title":"HTA208 Integrating Real-World Evidence for Advanced Therapies in Inflammatory Bowel Disease Into Reimbursement Submissions: Insights and Considerations From the UK","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Inflammatory bowel disease; Reimbursement; Inflammatory Bowel Diseases; Disease; MEDLINE; Infliximab","score_opus":0.030052203194830214,"score_gpt":0.333570141311032,"score_spread":0.3035179381162018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481256","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01346038,0.020482766,0.0049864077,0.81438076,0.017714052,0.0005285172,0.0047728927,0.00050371257,0.123170435],"genre_scores_gemma":[0.4416457,0.033640485,0.039211508,0.3436638,0.041262534,0.0013366122,0.006871199,0.0017171738,0.09065089],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.8973236,0.05616191,0.013081747,0.0023936236,0.024476612,0.006562605],"domain_scores_gemma":[0.5097537,0.3086622,0.021272874,0.013320917,0.11366188,0.033328388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07949675,0.0005986114,0.0017249566,0.0034562126,0.002426345,0.023796616,0.002664343,0.014091829,0.060739115],"category_scores_gemma":[0.34279904,0.000833855,0.0023341242,0.0041501517,0.0039497437,0.01024955,0.0066192984,0.009834916,0.009822043],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014390256,0.00019520988,0.009699669,0.0026721014,0.00032685578,0.0011870723,0.0016665012,0.0015481064,0.0010242527,0.060065206,0.67923874,0.2409373],"study_design_scores_gemma":[0.00073529035,0.00079632766,0.029618358,0.012535762,0.00040324143,0.0011827355,0.0024387084,0.002857449,0.0009898423,0.030807476,0.91720384,0.00043092624],"about_ca_topic_score_codex":0.018013632,"about_ca_topic_score_gemma":0.032836244,"teacher_disagreement_score":0.07949675,"about_ca_system_score_codex":0.011110816,"about_ca_system_score_gemma":0.041939106,"threshold_uncertainty_score":0.42042404},"labels":[],"label_agreement":null},{"id":"W4417481269","doi":"10.1016/j.jval.2025.09.977","title":"EE595 Obstructive Sleep Apnea (OSA) Phenotypes and the Personalized Impact of Positive Airway Pressure (PAP) Therapy on Healthcare Resource Use","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada)","funders":"","keywords":"Obstructive sleep apnea; Continuous positive airway pressure; Disease; Health care; Positive airway pressure; Resource use; Resource (disambiguation)","score_opus":0.033670800100909004,"score_gpt":0.3457973608278947,"score_spread":0.3121265607269857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97866005,0.00316502,0.0004548785,0.0020392635,0.00012140167,0.000019754762,0.0053888443,0.000016556436,0.010134149],"genre_scores_gemma":[0.9968077,0.0005366213,0.0002663309,0.00021824706,0.00006009509,0.000009874372,0.0013124843,0.0000054371008,0.00078334875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991683,0.00031365993,0.00011479129,0.00009241023,0.00018450215,0.0001264038],"domain_scores_gemma":[0.9981913,0.00069190667,0.0006247694,0.00008892873,0.00014837812,0.00025477502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066545873,0.00018406482,0.00030111376,0.00052227435,0.00028911675,0.0011753108,0.00030264343,0.0005301403,0.0049423426],"category_scores_gemma":[0.0051795263,0.0000994731,0.0008643929,0.0011416755,0.00015609826,0.0005176332,0.00055209914,0.00064006896,0.00047187848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009599129,0.00023895533,0.9618094,0.000117759526,0.0007845721,0.00012981372,0.000095702846,0.00039130653,0.0005535086,0.0007708833,0.0013282178,0.032820042],"study_design_scores_gemma":[0.000015539355,0.00009363677,0.9968335,0.000046287605,0.00013728188,0.00011142369,0.00011181989,0.00058394036,0.00013159543,0.00046075744,0.0014672755,0.0000071195464],"about_ca_topic_score_codex":0.0072742803,"about_ca_topic_score_gemma":0.009013778,"teacher_disagreement_score":0.0072742803,"about_ca_system_score_codex":0.0005156548,"about_ca_system_score_gemma":0.00062775705,"threshold_uncertainty_score":0.016533732},"labels":[],"label_agreement":null},{"id":"W4417481284","doi":"10.1016/j.jval.2025.09.2610","title":"PCR137 Improving Time to Patient: Insights From the Canadian Cancer Treatment Hackathons","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute of Mining, Metallurgy and Petroleum","funders":"","keywords":"Reimbursement; Process (computing); Cancer treatment; Key (lock); Cancer drugs","score_opus":0.012600924467720464,"score_gpt":0.22758963444119543,"score_spread":0.21498870997347497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481284","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31806678,0.00470179,0.0014255446,0.38690743,0.0014934187,0.00037335788,0.0018823964,0.00014434602,0.28500494],"genre_scores_gemma":[0.81691056,0.0064379987,0.0033679982,0.08609972,0.0002387903,0.00016217162,0.00088997826,0.00023629294,0.085656434],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99364626,0.0010169075,0.00008460998,0.00026803894,0.0026207364,0.0023634431],"domain_scores_gemma":[0.9833767,0.0030823224,0.0006911874,0.00020717093,0.005733808,0.0069088335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046018334,0.00028072332,0.0002859339,0.00094315544,0.012244591,0.005214817,0.0014785286,0.0018252659,0.016515346],"category_scores_gemma":[0.014837998,0.00023870164,0.000462388,0.0020618045,0.0034387966,0.0010507541,0.0025606102,0.0045967903,0.0010331701],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063845,0.00082260143,0.11116845,0.0004141194,0.000081966675,0.0013080393,0.042947784,0.00090507953,0.0013883499,0.03175984,0.5156182,0.2929471],"study_design_scores_gemma":[0.00017668508,0.0005640125,0.15925257,0.0009058871,0.00012957079,0.0005461542,0.12728475,0.00084819115,0.0012643387,0.004755061,0.70406604,0.00020680271],"about_ca_topic_score_codex":0.95693064,"about_ca_topic_score_gemma":0.9880257,"teacher_disagreement_score":0.07000254,"about_ca_system_score_codex":0.07000254,"about_ca_system_score_gemma":0.22304375,"threshold_uncertainty_score":0.5079063},"labels":[],"label_agreement":null},{"id":"W4417481294","doi":"10.1016/j.jval.2025.09.710","title":"EE326 Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Type 2 diabetes; Microsimulation; Insulin delivery; Diabetes mellitus; Delivery system","score_opus":0.08906174192864924,"score_gpt":0.37666497209969374,"score_spread":0.2876032301710445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481294","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5762507,0.0006733991,0.40308216,0.0009241145,0.0001231011,0.0009860356,0.0016073389,0.0006455855,0.015707694],"genre_scores_gemma":[0.94617385,0.00017065236,0.05050157,0.00010679753,0.000015880909,0.00040523073,0.00059541716,0.00003712556,0.0019933928],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989355,0.00065443804,0.000043594748,0.0000838959,0.00016598642,0.000116527925],"domain_scores_gemma":[0.9963827,0.0028409522,0.0001635145,0.00010247623,0.0004345488,0.000075762626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003908744,0.0007475053,0.0008901364,0.0006036772,0.00025224156,0.001116581,0.001063364,0.0009812845,0.002979582],"category_scores_gemma":[0.006871339,0.0003988496,0.00090021593,0.000450918,0.00021934939,0.0006397945,0.0005425525,0.00088049343,0.00020577556],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017978079,0.00015563569,0.0018642534,0.00004873816,0.000068388814,0.000026102092,0.000009420926,0.9849279,0.00042791755,0.0014192377,0.00028727928,0.010585382],"study_design_scores_gemma":[0.00003615117,0.000118304284,0.00037316128,0.0000068386485,0.000020342015,0.0000058431783,0.0000048988177,0.99853635,0.00031495263,0.00035029158,0.00022947973,0.000003351566],"about_ca_topic_score_codex":0.021359112,"about_ca_topic_score_gemma":0.009136039,"teacher_disagreement_score":0.021359112,"about_ca_system_score_codex":0.0020606078,"about_ca_system_score_gemma":0.0031378816,"threshold_uncertainty_score":0.04246956},"labels":[],"label_agreement":null},{"id":"W4417481307","doi":"10.1016/j.jval.2025.09.529","title":"EE145 Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Toronto Rehabilitation Institute; University of Toronto; Hôpital du Sacré-Cœur de Montréal; Roche (Canada)","funders":"","keywords":"Retinal Vein; Occlusion; Retinal; Central retinal vein occlusion; Branch retinal vein occlusion","score_opus":0.01256123840818585,"score_gpt":0.3394553903704145,"score_spread":0.32689415196222865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552405,0.0006737134,0.00022380092,0.00006894438,0.00001728569,0.00003577517,0.0016940973,0.0000065792797,0.0017557475],"genre_scores_gemma":[0.9984958,0.00012535077,0.00012231329,0.000016892589,0.000007439721,0.000023481482,0.0008822174,0.0000019081638,0.00032453792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985863,0.00063511473,0.00016928658,0.00009723165,0.00029425358,0.0002178383],"domain_scores_gemma":[0.99620557,0.0020363997,0.000986012,0.00009338575,0.00043277108,0.00024586933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014072573,0.00028617692,0.00046636123,0.0011178566,0.00017273866,0.0008289966,0.00040867942,0.00040048716,0.0030995156],"category_scores_gemma":[0.008126392,0.00012173316,0.0018546688,0.0012133862,0.00015096158,0.00050425687,0.0005623491,0.00048668942,0.00020113836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028928936,0.0018285098,0.8338848,0.0010913558,0.0053760908,0.0005079908,0.00055440277,0.018555846,0.0013748211,0.0019387557,0.0025317934,0.10342674],"study_design_scores_gemma":[0.00030586164,0.003615501,0.98353267,0.00011551813,0.0008003871,0.00029660566,0.0007422195,0.007984484,0.00053513655,0.0002716242,0.0017632808,0.00003685785],"about_ca_topic_score_codex":0.010246261,"about_ca_topic_score_gemma":0.008626576,"teacher_disagreement_score":0.010246261,"about_ca_system_score_codex":0.0019077492,"about_ca_system_score_gemma":0.00085792725,"threshold_uncertainty_score":0.020373225},"labels":[],"label_agreement":null},{"id":"W4417481329","doi":"10.1016/j.jval.2025.09.3307","title":"MSR16 Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Preference; Language understanding; Qualitative research; Preference elicitation; Qualitative analysis","score_opus":0.4773357941813946,"score_gpt":0.5643687605175031,"score_spread":0.08703296633610846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481329","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.037247565,0.0009094765,0.9015626,0.014014669,0.0004099418,0.0041676075,0.0034143855,0.0010358584,0.037237894],"genre_scores_gemma":[0.22821514,0.0007244523,0.7529023,0.0024523456,0.00013284553,0.010219831,0.0014251028,0.000382476,0.003545398],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.80088246,0.17865126,0.004644504,0.003409991,0.011681927,0.0007298632],"domain_scores_gemma":[0.40978327,0.5401095,0.0075529646,0.024647158,0.016940273,0.00096681213],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11140877,0.0011543845,0.0012554857,0.0026617076,0.0019317231,0.005761107,0.00269254,0.0016661166,0.022517024],"category_scores_gemma":[0.3490195,0.0011538947,0.0030617001,0.002843514,0.0031843462,0.0066650314,0.0073482436,0.0034667791,0.0032715513],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000689533,0.0010210552,0.016425658,0.0066077295,0.0007362483,0.00018611846,0.046250172,0.015084274,0.004986123,0.27501366,0.018018287,0.6149811],"study_design_scores_gemma":[0.00070423784,0.0009574332,0.011057561,0.006869162,0.00046209627,0.00026872577,0.023428008,0.19119036,0.0085412925,0.5946716,0.16133137,0.00051810994],"about_ca_topic_score_codex":0.015563703,"about_ca_topic_score_gemma":0.024749128,"teacher_disagreement_score":0.88859123,"about_ca_system_score_codex":0.006525167,"about_ca_system_score_gemma":0.013073203,"threshold_uncertainty_score":0.5891929},"labels":[],"label_agreement":null},{"id":"W4417481338","doi":"10.1016/j.jval.2025.09.1063","title":"EE682 Targeted Literature Review Informing Economic Model Structures in Atherosclerotic Cardiovascular Disease","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); EVERSANA (Canada)","funders":"","keywords":"Disease; Atherosclerotic cardiovascular disease; Economic model; MEDLINE; Targeted therapy","score_opus":0.017294943330443995,"score_gpt":0.25238284496015145,"score_spread":0.23508790162970747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481338","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032533645,0.95912457,0.008597466,0.013327762,0.0015088943,0.0000651206,0.0015011409,0.00003649178,0.012585211],"genre_scores_gemma":[0.07031417,0.9170654,0.0051029325,0.0030368653,0.0019004722,0.0001407219,0.0008778925,0.000029276103,0.0015322833],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9973634,0.0014493713,0.00043491178,0.00021557864,0.00043620443,0.00010047007],"domain_scores_gemma":[0.9531565,0.041882243,0.0018250231,0.00062617357,0.0022873678,0.0002226826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058442396,0.000715812,0.0011926692,0.0081771985,0.00038207276,0.0031848927,0.0010213971,0.0017900426,0.014116042],"category_scores_gemma":[0.045784373,0.00041077725,0.0014801085,0.008665506,0.0006839308,0.0028027229,0.00097297214,0.001738294,0.0011529147],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035247073,0.00019115934,0.004181008,0.12128656,0.002996747,0.00064035156,0.000519621,0.017591713,0.0003526933,0.2691753,0.05449673,0.5282156],"study_design_scores_gemma":[0.000110251734,0.00020725459,0.005826004,0.2802558,0.00607999,0.00054206484,0.0008805158,0.010890612,0.00059129635,0.24976496,0.44475526,0.000095984695],"about_ca_topic_score_codex":0.006210476,"about_ca_topic_score_gemma":0.006519947,"teacher_disagreement_score":0.014116042,"about_ca_system_score_codex":0.002665633,"about_ca_system_score_gemma":0.008012479,"threshold_uncertainty_score":0.047222912},"labels":[],"label_agreement":null},{"id":"W4417481350","doi":"10.1016/j.jval.2025.09.3481","title":"MSR205 Transportability of Overall Survival Estimates From the United States to Germany in eGFR+ Advanced NSCLC Patients Post-Tyrosine Kinase Inhibitor (TKI) Treatment","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Overall survival; German; Lung cancer; Medical record; MEDLINE; Health records","score_opus":0.01765356673892164,"score_gpt":0.33530550878238613,"score_spread":0.3176519420434645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96933985,0.0014153394,0.0015187402,0.0010720897,0.00007702702,0.000016317534,0.02138416,0.000081714665,0.0050948374],"genre_scores_gemma":[0.9923355,0.00021717219,0.00022739706,0.00010848357,0.000012514559,0.000010689028,0.00643991,0.000013973066,0.00063438027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999153,0.00036456474,0.00008132216,0.00013994482,0.00009047208,0.00017063953],"domain_scores_gemma":[0.99727255,0.0009145832,0.0009982929,0.00025507854,0.00043226726,0.00012728196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017798744,0.00021682131,0.0002656851,0.0013987941,0.00018642917,0.0011326191,0.00033002812,0.0003442831,0.0017428626],"category_scores_gemma":[0.006524789,0.0001536957,0.0010644824,0.00200365,0.00016975793,0.00060756964,0.00088275224,0.00048823742,0.0003561983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011486864,0.000040385818,0.92098784,0.00018053966,0.0015821456,0.00026554728,0.00043157366,0.021841027,0.0006257065,0.003134667,0.012446188,0.03731566],"study_design_scores_gemma":[0.000022987502,0.00011875692,0.9827351,0.0001356623,0.00033010627,0.00020991958,0.00055233255,0.008128517,0.0006347105,0.0005615051,0.006541165,0.000029282452],"about_ca_topic_score_codex":0.08582837,"about_ca_topic_score_gemma":0.06244734,"teacher_disagreement_score":0.08582837,"about_ca_system_score_codex":0.0012484981,"about_ca_system_score_gemma":0.0008972415,"threshold_uncertainty_score":0.17065758},"labels":[],"label_agreement":null},{"id":"W4417481378","doi":"10.1016/j.jval.2025.09.428","title":"EE44 All-Cause Healthcare Resource Use in Recurrent Respiratory Papillomatosis: A Claims-Based Comparison With Matched Controls","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Recurrent Respiratory Papillomatosis; Resource use; Health care; Respiratory system; Disease; Human papillomavirus; Disease control","score_opus":0.15961040604483132,"score_gpt":0.422769252663708,"score_spread":0.2631588466188767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99895275,0.00015807994,0.000059598267,0.000012960062,0.0000103483035,0.000008399249,0.00047728702,0.0000018067177,0.00031877405],"genre_scores_gemma":[0.9990545,0.00006223559,0.00002616469,0.00001684456,0.000011577473,0.000009629712,0.0004906357,0.0000015765504,0.00032691192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882585,0.0003155551,0.00012231916,0.0002869553,0.0001881326,0.00026119253],"domain_scores_gemma":[0.9992286,0.0001890637,0.0002873446,0.00008753175,0.00008976968,0.00011771677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084614113,0.00043391145,0.000605877,0.0013660665,0.0005324848,0.0011275085,0.0005133993,0.0008150479,0.0024671955],"category_scores_gemma":[0.002211883,0.0004278928,0.0014330723,0.0016836558,0.0002816286,0.0008361724,0.00075629697,0.0007158236,0.0003536029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028550918,0.00042110556,0.9925922,0.000039197974,0.0008656572,0.00018624916,0.0001640234,0.00006301433,0.000626063,0.000083228595,0.00018479163,0.0019193679],"study_design_scores_gemma":[0.000041853003,0.00034814165,0.99850345,0.0000047394533,0.0001670887,0.00012607347,0.0003125638,0.00023615612,0.00006268564,0.000031297852,0.00015991591,0.0000061108885],"about_ca_topic_score_codex":0.011394353,"about_ca_topic_score_gemma":0.006383719,"teacher_disagreement_score":0.011394353,"about_ca_system_score_codex":0.0004982252,"about_ca_system_score_gemma":0.00026609222,"threshold_uncertainty_score":0.022656083},"labels":[],"label_agreement":null},{"id":"W4417481393","doi":"10.1016/j.jval.2025.09.299","title":"CO198 Quantifying the Therapeutic Benefit of External Beam Radiotherapy in Uterine Serous Carcinoma: A Real-World Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada); McGill University","funders":"","keywords":"External beam radiotherapy; External beam radiation; Serous fluid; Radiation therapy; Endometrial cancer; Uterine cancer; Adjuvant","score_opus":0.0983298780420549,"score_gpt":0.4044564827645568,"score_spread":0.3061266047225019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970278,0.0011344337,0.00032711608,0.00009006483,0.000008440865,0.000027735823,0.0003963295,0.000003848988,0.0009842505],"genre_scores_gemma":[0.9991591,0.00026366243,0.00018279217,0.000025824222,0.000008775161,0.000010939085,0.00020829502,0.0000028757954,0.00013775064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985203,0.00094539294,0.00008573732,0.00016069862,0.00019656713,0.00009136122],"domain_scores_gemma":[0.9937237,0.0039889906,0.0014168198,0.00032656884,0.00041736977,0.00012659353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019860647,0.0002653201,0.00037920126,0.0008579228,0.00029996104,0.0011413031,0.00036802836,0.000759828,0.0018776174],"category_scores_gemma":[0.01095688,0.00017432861,0.0009044761,0.0012301761,0.00055587426,0.00053205836,0.00044835554,0.00050658523,0.00022863831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011094276,0.00082945137,0.9214731,0.0004553885,0.0014116712,0.00031334872,0.0003918096,0.0040199645,0.0015648697,0.0004290931,0.000855517,0.057161592],"study_design_scores_gemma":[0.00028555433,0.002380127,0.98499644,0.00009155756,0.00064771745,0.00047142452,0.0007979022,0.006371333,0.0010008804,0.00049088226,0.002417754,0.000048333888],"about_ca_topic_score_codex":0.0069562155,"about_ca_topic_score_gemma":0.0061427774,"teacher_disagreement_score":0.0069562155,"about_ca_system_score_codex":0.0010402491,"about_ca_system_score_gemma":0.00049187936,"threshold_uncertainty_score":0.013831437},"labels":[],"label_agreement":null},{"id":"W4417481396","doi":"10.1016/j.jval.2025.09.331","title":"CO230 Systematic Review of Prognostic Factors and Treatment Effect Modifiers for Transthyretin Amyloid Cardiomyopathy","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Transthyretin; Cardiomyopathy; Amyloid (mycology); Treatment effect","score_opus":0.017695493375171234,"score_gpt":0.30100191468617504,"score_spread":0.2833064213110038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003680202,0.99405235,0.00016799934,0.0002665181,0.00020777126,0.00015021682,0.0011730588,0.000016989432,0.00028486009],"genre_scores_gemma":[0.18411972,0.8089842,0.0014397453,0.002138023,0.0004484654,0.0007610498,0.0014576545,0.00003872519,0.00061240426],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99373806,0.002492456,0.0019620545,0.0009172784,0.00063125533,0.0002588038],"domain_scores_gemma":[0.984127,0.010753138,0.003428527,0.00050006167,0.0009278323,0.00026344912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006768799,0.0012321896,0.011022446,0.0029135009,0.0005037623,0.0018560295,0.001473454,0.0015546046,0.0068603493],"category_scores_gemma":[0.027212905,0.000925574,0.01835947,0.0045827893,0.0007342401,0.001316297,0.0014792617,0.0017008408,0.0004910144],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042859367,0.00004347736,0.0073119416,0.57735753,0.37598544,0.00010804638,0.00012564044,0.00028473692,0.00028072792,0.00021146689,0.0033309667,0.030674126],"study_design_scores_gemma":[0.004556988,0.00051307736,0.018078681,0.09535329,0.8730843,0.00013999453,0.00008773308,0.00016872447,0.00013347446,0.00039366516,0.0074264086,0.00006370877],"about_ca_topic_score_codex":0.017275985,"about_ca_topic_score_gemma":0.04416671,"teacher_disagreement_score":0.017275985,"about_ca_system_score_codex":0.0023507557,"about_ca_system_score_gemma":0.0054012104,"threshold_uncertainty_score":0.03579724},"labels":[],"label_agreement":null},{"id":"W4417481417","doi":"10.1016/j.jval.2025.09.3482","title":"MSR206 Transporting Treatment Effects for Survival Outcomes Under Informative Censoring: A Simulation Study Using Summary-Level Data in the Target Population","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Simon Fraser University","funders":"","keywords":"Censoring (clinical trials); Weighting; Population; Inverse probability weighting; Aggregate data; Data source","score_opus":0.5533582391859345,"score_gpt":0.5444820383462802,"score_spread":0.008876200839654347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481417","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7841088,0.0006745012,0.20499122,0.0019435732,0.000108403336,0.00061516964,0.0017346999,0.0004239797,0.0053995308],"genre_scores_gemma":[0.96255153,0.00024348893,0.03285618,0.00014856695,0.000029886063,0.00042037622,0.0008404558,0.00007738729,0.0028321815],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99537235,0.003925197,0.00007895284,0.00027817543,0.00014427053,0.00020102717],"domain_scores_gemma":[0.92795545,0.06528988,0.0019348245,0.0027266569,0.0012831925,0.00080992834],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015362362,0.0006493175,0.0013550919,0.0009080198,0.00057545956,0.0014120081,0.0020136337,0.0021880432,0.008434142],"category_scores_gemma":[0.056385923,0.00062127324,0.002292569,0.0014807612,0.0010240205,0.001389567,0.0011207846,0.0027228182,0.0006336977],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024221877,0.0006315286,0.0107595865,0.00015557434,0.0002825056,0.00029749548,0.00030466804,0.9342045,0.00027015732,0.027747473,0.0018603127,0.021064037],"study_design_scores_gemma":[0.00060487096,0.00047825303,0.001432579,0.000036175734,0.00010084096,0.000065752516,0.00008584967,0.9836766,0.00026992772,0.012796451,0.00042787183,0.000024783603],"about_ca_topic_score_codex":0.021219457,"about_ca_topic_score_gemma":0.0072575747,"teacher_disagreement_score":0.9846376,"about_ca_system_score_codex":0.001762706,"about_ca_system_score_gemma":0.00178916,"threshold_uncertainty_score":0.081244946},"labels":[],"label_agreement":null},{"id":"W4417481418","doi":"10.1016/j.jval.2025.09.3405","title":"MSR120 How Chinese Restaurants Can Help With Robust Preference Insights: A Novel Dirichlet Mixture Model to Account for Complex Heterogeneity in Individual Preference Weights","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Sensory Analysis and Statistical Methods","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Preference; Mixture model; Sample (material); Dirichlet distribution; Key (lock); Latent Dirichlet allocation","score_opus":0.26859798688179776,"score_gpt":0.3470187803756831,"score_spread":0.07842079349388537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481418","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17862299,0.0006944916,0.806592,0.0019977975,0.00022071118,0.00011355128,0.0011638945,0.0009563354,0.009638246],"genre_scores_gemma":[0.88947165,0.0003464362,0.09438327,0.00038648248,0.00012894733,0.00018686247,0.0011137916,0.00025062592,0.013731918],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99906296,0.0004188027,0.00003792825,0.0002536925,0.00010369505,0.00012300124],"domain_scores_gemma":[0.99847406,0.0009649009,0.000086336084,0.00019799727,0.00018519851,0.000091521884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002436584,0.00064658985,0.00079932227,0.0008750203,0.00061850436,0.0016571134,0.0014426715,0.0012727985,0.006979327],"category_scores_gemma":[0.0070041902,0.00056016113,0.001536245,0.0012988057,0.0006364957,0.0020159704,0.0012205109,0.0014286852,0.0015298991],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016229651,0.0003688411,0.026930245,0.00040770546,0.0006942881,0.00055666076,0.0021037778,0.35770488,0.016139857,0.24304277,0.018694425,0.33173358],"study_design_scores_gemma":[0.000027752378,0.00004043797,0.0030889784,0.000017178747,0.000059958347,0.000072086346,0.000109266075,0.95028496,0.0009577297,0.04248576,0.0028043923,0.00005150325],"about_ca_topic_score_codex":0.016044226,"about_ca_topic_score_gemma":0.016906518,"teacher_disagreement_score":0.016044226,"about_ca_system_score_codex":0.0010538824,"about_ca_system_score_gemma":0.0010225573,"threshold_uncertainty_score":0.031901658},"labels":[],"label_agreement":null},{"id":"W4417481461","doi":"10.1016/j.jval.2025.09.376","title":"EE753 What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Facilities Design and Sustainability","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Contact tracing; Tuberculosis; Tracing; Tuberculosis prevention","score_opus":0.052352439899365596,"score_gpt":0.3593289371448182,"score_spread":0.30697649724545256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94778305,0.021508314,0.0038974702,0.008797706,0.00029460894,0.001222526,0.004886074,0.000057355548,0.011552941],"genre_scores_gemma":[0.99490297,0.0025193808,0.0011517616,0.000446215,0.000056694338,0.00013589594,0.00038645515,0.000006507415,0.00039406624],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9923483,0.006162441,0.00032187544,0.00021267832,0.00048680507,0.00046786532],"domain_scores_gemma":[0.9884117,0.009811664,0.0008438878,0.00014586923,0.00040453937,0.00038234907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057874084,0.00076912035,0.001701282,0.0012926629,0.00030829836,0.0022688154,0.0010012252,0.0020106186,0.005704344],"category_scores_gemma":[0.024828596,0.000517708,0.004648449,0.0018003029,0.0006553577,0.0020538354,0.0008594351,0.0013387435,0.00018760163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.080181025,0.0060457685,0.26981705,0.01585497,0.044659253,0.0011262309,0.0007713869,0.19680247,0.0026818493,0.013954453,0.0071231774,0.3609825],"study_design_scores_gemma":[0.019607829,0.057051163,0.4954063,0.0090946,0.09644577,0.002070088,0.004536158,0.28162724,0.005048001,0.0147164315,0.013821424,0.0005749737],"about_ca_topic_score_codex":0.026080923,"about_ca_topic_score_gemma":0.024988202,"teacher_disagreement_score":0.026080923,"about_ca_system_score_codex":0.005298921,"about_ca_system_score_gemma":0.003771891,"threshold_uncertainty_score":0.051858246},"labels":[],"label_agreement":null},{"id":"W4417481468","doi":"10.1016/j.jval.2025.09.1050","title":"EE668 Spain Leveling Up: A Comparison of Spain’s New National Health Economic Evaluation Guideline With Those of England, France, Germany, Italy, Portugal, Sweden, Ireland, Canada, Australia, and Japan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Christian ministry; Economic evaluation; Health policy; National Policy","score_opus":0.35628606422470666,"score_gpt":0.4598973702311669,"score_spread":0.10361130600646024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481468","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11241397,0.15266183,0.022965064,0.22512172,0.020816362,0.0084297955,0.12886035,0.0013454879,0.32738546],"genre_scores_gemma":[0.4147924,0.05005885,0.102597125,0.1956744,0.0038322327,0.021154871,0.13729304,0.0020169262,0.07258015],"study_design_codex":"not_applicable","study_design_gemma":"qualitative","domain_scores_codex":[0.9579449,0.014216781,0.009766131,0.001091855,0.014209867,0.0027704027],"domain_scores_gemma":[0.9441185,0.021951659,0.0055082124,0.0021486515,0.022651333,0.0036216062],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.080469824,0.0010169632,0.002392162,0.0078659,0.0009151637,0.009372527,0.003803408,0.00607741,0.004656763],"category_scores_gemma":[0.10388977,0.0006962141,0.004573962,0.010719177,0.000987903,0.0029665173,0.0036543005,0.0052661425,0.0017589536],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052648685,0.00075831707,0.04008153,0.0094307875,0.0017209006,0.00068301475,0.0011366304,0.005503726,0.0010402263,0.031374358,0.6838051,0.2192005],"study_design_scores_gemma":[0.0028681587,0.0004306704,0.22234334,0.023798902,0.0018920841,0.00043026215,0.0014034543,0.0018723874,0.0014885524,0.0071469764,0.73612034,0.00020497784],"about_ca_topic_score_codex":0.07632187,"about_ca_topic_score_gemma":0.08376031,"teacher_disagreement_score":0.98663116,"about_ca_system_score_codex":0.013368852,"about_ca_system_score_gemma":0.024938572,"threshold_uncertainty_score":0.4255702},"labels":[],"label_agreement":null},{"id":"W4417481473","doi":"10.1016/j.jval.2025.09.3487","title":"MSR212 Use of a Nonparametric Bayesian Method to Model Health State Preferences: An Application to UAE EQ-5D-5L Valuations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nonparametric statistics; Bayesian probability; State (computer science); Bayesian inference","score_opus":0.56137335002672,"score_gpt":0.4861612806287469,"score_spread":0.07521206939797304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481473","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0128975175,0.00007754523,0.98233944,0.0002877766,0.000027570399,0.00008050304,0.00038138736,0.00039160016,0.0035166175],"genre_scores_gemma":[0.33972365,0.00026026275,0.6472735,0.000164218,0.00008013809,0.0004208716,0.00077274273,0.0003118553,0.010992723],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982299,0.0011882291,0.000070070855,0.00013963696,0.00030761366,0.000064585176],"domain_scores_gemma":[0.9949084,0.0038869276,0.00020975212,0.00037644536,0.00054649287,0.0000718952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0053263814,0.00049257424,0.0008494435,0.001030375,0.0005243409,0.0014010085,0.0013145818,0.0011710676,0.010685145],"category_scores_gemma":[0.019585654,0.0005691718,0.0014040674,0.0011321385,0.00033930843,0.0014841527,0.0010249253,0.0014133105,0.0016867475],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002062918,0.0003004515,0.0040807934,0.000120022014,0.00022616093,0.00021300225,0.00023577109,0.62149864,0.0012727896,0.11340853,0.00588465,0.25255287],"study_design_scores_gemma":[0.00001887932,0.000022748929,0.00060291373,0.000011447873,0.000010504667,0.000057113513,0.000013910081,0.97876716,0.00018392145,0.01857259,0.0017188416,0.000020006442],"about_ca_topic_score_codex":0.01346362,"about_ca_topic_score_gemma":0.014870123,"teacher_disagreement_score":0.01346362,"about_ca_system_score_codex":0.0008872206,"about_ca_system_score_gemma":0.0014348802,"threshold_uncertainty_score":0.035745382},"labels":[],"label_agreement":null},{"id":"W4417481479","doi":"10.1016/j.jval.2025.09.346","title":"CO245 The Mirage of Stability: Challenges of Predicting Disease Activity Over Time in Systemic Lupus Erythematosus (SLE)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Disease; Lupus erythematosus; Connective tissue disease; Systemic disease","score_opus":0.04786949227443706,"score_gpt":0.32901687723359485,"score_spread":0.2811473849591578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8203254,0.05648133,0.035939522,0.05733177,0.0027500773,0.00014970987,0.0036757642,0.00023228177,0.023114176],"genre_scores_gemma":[0.9837902,0.0041204845,0.008212861,0.0012670753,0.0010575498,0.00006158702,0.00038028014,0.000049611455,0.0010603013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9906763,0.0057710344,0.00076790754,0.0007980103,0.0016646173,0.00032214593],"domain_scores_gemma":[0.9341486,0.043299224,0.009482539,0.0028024535,0.007888165,0.0023790398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013363577,0.00060518045,0.0014976835,0.00271961,0.0010152173,0.0064811544,0.0012947293,0.0012918432,0.0018154554],"category_scores_gemma":[0.06787847,0.0003323732,0.00062017696,0.0030131123,0.0015277679,0.0037262023,0.002008576,0.0036860032,0.0006637264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006561683,0.00030247757,0.7090804,0.00044622147,0.0005504558,0.00015139356,0.0012323414,0.0024209158,0.0006616648,0.004403189,0.010652371,0.26944253],"study_design_scores_gemma":[0.000077694334,0.0015439183,0.771429,0.0020189956,0.0008034128,0.0020320944,0.007422814,0.06458562,0.0034836242,0.10225135,0.04399874,0.00035263677],"about_ca_topic_score_codex":0.006098377,"about_ca_topic_score_gemma":0.010651551,"teacher_disagreement_score":0.013363577,"about_ca_system_score_codex":0.0008543818,"about_ca_system_score_gemma":0.0015596828,"threshold_uncertainty_score":0.07067424},"labels":[],"label_agreement":null},{"id":"W4417481513","doi":"10.1016/j.jval.2025.09.123","title":"CO21 Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Overall survival; Breast cancer; Stage (stratigraphy); Surrogate endpoint; Adjuvant; Survival analysis","score_opus":0.016965898952696006,"score_gpt":0.2703437340483931,"score_spread":0.2533778350956971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99781835,0.00069499447,0.000056142635,0.00013587368,0.000013262778,0.0000020839298,0.0002869555,0.000002358134,0.0009901295],"genre_scores_gemma":[0.9991756,0.000107767424,0.000021690197,0.000015847683,0.000014596841,0.0000018375824,0.0001611738,0.0000014145874,0.00050006155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997043,0.00011429682,0.000026457988,0.000041619456,0.00003523984,0.00007803299],"domain_scores_gemma":[0.9983987,0.00052534067,0.0004928318,0.00010716872,0.00016994964,0.00030593912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049598794,0.00019662872,0.00026195918,0.00072773726,0.00035173993,0.00077357434,0.00029948496,0.0004200175,0.002672063],"category_scores_gemma":[0.002377765,0.00014817633,0.00043842386,0.0012119833,0.00027916997,0.00026257633,0.0003929156,0.0006866421,0.00031340183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046608908,0.000022104608,0.99773127,0.000007689407,0.00006642335,0.00006030045,0.000032852517,0.000024109935,0.00040216077,0.000030883282,0.00006367144,0.0010926476],"study_design_scores_gemma":[0.000006920847,0.000056646284,0.9992465,0.0000024077985,0.00005696499,0.000117475516,0.00008422927,0.00008498305,0.0001002459,0.00005363464,0.00018790623,0.0000021798317],"about_ca_topic_score_codex":0.0053853723,"about_ca_topic_score_gemma":0.0053783325,"teacher_disagreement_score":0.0053853723,"about_ca_system_score_codex":0.00040661904,"about_ca_system_score_gemma":0.00034715247,"threshold_uncertainty_score":0.010708034},"labels":[],"label_agreement":null},{"id":"W4417481531","doi":"10.1016/j.jval.2025.09.1372","title":"EPH243 The Incidence and Survival of HPV-Positive and HPV-Negative Malignant Head and Neck Squamous Cell Carcinoma (HNSCC) in the United States: A Surveillance Epidemiology and End Results SEER 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Surveillance, Epidemiology, and End Results; Incidence (geometry); Epidemiology; Head and neck; Head and neck squamous-cell carcinoma","score_opus":0.048790783977282925,"score_gpt":0.3437473579499198,"score_spread":0.29495657397263686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9396202,0.0024599996,0.00013046477,0.00009144218,0.000015229699,0.000029390803,0.055989873,0.000013884796,0.0016494668],"genre_scores_gemma":[0.9676156,0.0011252487,0.00013402964,0.00008489093,0.000021052878,0.00003643267,0.030156095,0.000006941423,0.000819619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930286,0.00015049112,0.0001442439,0.00016282804,0.00014855724,0.00009093662],"domain_scores_gemma":[0.99874794,0.00022873252,0.00060745113,0.00012801692,0.00017036468,0.00011749285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006806873,0.0002757927,0.0005106781,0.0014887842,0.00015478875,0.00063476065,0.00047347505,0.00040595594,0.0013697676],"category_scores_gemma":[0.0019800984,0.00028177202,0.001366291,0.0041299867,0.00013017151,0.0005373804,0.00045569649,0.0004271806,0.00027427025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006866643,0.0000274029,0.99428314,0.000119824224,0.0010535065,0.0000548453,0.000026806381,0.0002140521,0.00014732449,0.00005820374,0.0013041135,0.002024111],"study_design_scores_gemma":[0.00004830373,0.000047333328,0.99813443,0.000020069678,0.000331946,0.00011990308,0.000062226914,0.00026624656,0.00007275924,0.000022299673,0.0008686392,0.0000059349336],"about_ca_topic_score_codex":0.029517679,"about_ca_topic_score_gemma":0.032002337,"teacher_disagreement_score":0.029517679,"about_ca_system_score_codex":0.00060629006,"about_ca_system_score_gemma":0.00053699355,"threshold_uncertainty_score":0.05869174},"labels":[],"label_agreement":null},{"id":"W4417481533","doi":"10.1016/j.jval.2025.09.350","title":"CO250 Therapeutic Benefit of Radiotherapy in Uterine Serous Carcinoma (USC): A Real-World Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada); McGill University","funders":"","keywords":"Radiation therapy; Serous fluid; Serous carcinoma; Carcinoma","score_opus":0.05664852011188023,"score_gpt":0.38360746414779145,"score_spread":0.32695894403591125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907957,0.0060547204,0.00009395544,0.0002824191,0.000027041877,0.000031589243,0.00088363944,0.000002747447,0.0018282939],"genre_scores_gemma":[0.9987348,0.0006952336,0.000036740796,0.000044884117,0.000028705566,0.000009278664,0.00032839066,0.0000014539665,0.00012049382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99886996,0.0006068565,0.000074765165,0.00015134801,0.000147709,0.00014935098],"domain_scores_gemma":[0.996198,0.0017715504,0.001296777,0.00015753008,0.00024299583,0.00033306688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009538975,0.00020450009,0.00044206757,0.0005985216,0.00037259754,0.0008428672,0.00039334863,0.00064883963,0.0031494147],"category_scores_gemma":[0.0070433063,0.00013694009,0.0010093638,0.0014497587,0.00054290664,0.0004933491,0.0004998718,0.00069606747,0.00028770123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017323269,0.00074168516,0.94356287,0.00047308745,0.0016624015,0.0003164244,0.00022092892,0.00065159495,0.0005816978,0.00037840358,0.00086503685,0.033222612],"study_design_scores_gemma":[0.00035352065,0.0021219496,0.9930031,0.000072431656,0.0008199012,0.00030950637,0.00044899163,0.00064239313,0.00016386984,0.00023886621,0.0018000845,0.00002535314],"about_ca_topic_score_codex":0.0067226165,"about_ca_topic_score_gemma":0.0065064207,"teacher_disagreement_score":0.0067226165,"about_ca_system_score_codex":0.0013005987,"about_ca_system_score_gemma":0.00060936506,"threshold_uncertainty_score":0.013366997},"labels":[],"label_agreement":null},{"id":"W4417481546","doi":"10.1016/j.jval.2025.09.342","title":"CO241 The Impact of Generalized Anxiety Disorder on Comorbid Conditions: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Comorbidity; Generalized anxiety disorder; Psychiatric comorbidity; Anxiety; Anxiety disorder; Generalized anxiety","score_opus":0.061835820369736685,"score_gpt":0.4327974654228455,"score_spread":0.3709616450531088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481546","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025133295,0.99533516,0.00013429188,0.00031284365,0.00018087104,0.00038735475,0.0007958284,0.000011892128,0.00032833166],"genre_scores_gemma":[0.088185005,0.9074466,0.0010548395,0.0015979056,0.00018477265,0.00072022394,0.00051907875,0.000016275282,0.00027524141],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9888526,0.0037193107,0.004045873,0.0012056837,0.0017758321,0.0004005744],"domain_scores_gemma":[0.9657944,0.024298757,0.0061634295,0.0006597416,0.00259634,0.00048732266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009044945,0.0013612309,0.009312656,0.007326547,0.00072240975,0.0033876013,0.0016547785,0.00234867,0.0064144433],"category_scores_gemma":[0.059019256,0.0013045396,0.012418339,0.008594821,0.0012435106,0.0025521258,0.002339004,0.0016804449,0.00046043206],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006642304,0.000020200227,0.004019008,0.90804917,0.065422624,0.00011266814,0.00018851834,0.000075905,0.00014995188,0.00015214631,0.0013957758,0.01974987],"study_design_scores_gemma":[0.0017127268,0.00029476584,0.01922099,0.56840456,0.4000976,0.0003542328,0.00037920632,0.00011682293,0.00014826421,0.00032162928,0.008862398,0.00008674062],"about_ca_topic_score_codex":0.021646349,"about_ca_topic_score_gemma":0.07554157,"teacher_disagreement_score":0.021646349,"about_ca_system_score_codex":0.0040397425,"about_ca_system_score_gemma":0.011059568,"threshold_uncertainty_score":0.047834814},"labels":[],"label_agreement":null},{"id":"W4417481548","doi":"10.1016/j.jval.2025.09.899","title":"EE517 Healthcare Resource Utilization for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Health care; Amyloid (mycology); Resource (disambiguation); Disease; Amyloidosis","score_opus":0.019780249860593294,"score_gpt":0.28814014611377403,"score_spread":0.26835989625318074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943151,0.00059673743,0.000029480234,0.00028602273,0.000010429104,0.000015587333,0.0038547653,0.0000035762494,0.00088827685],"genre_scores_gemma":[0.99692255,0.00047288844,0.000047028265,0.0001377223,0.000010518754,0.000011750531,0.0021394105,0.0000030971387,0.00025492383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911326,0.00010360083,0.00008784375,0.00012870149,0.0001771378,0.00038942142],"domain_scores_gemma":[0.9975193,0.00014663098,0.0006242298,0.00007043957,0.0006469058,0.0009924867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048462453,0.00049472443,0.00062943186,0.0014803417,0.0014212609,0.0017892639,0.0009756246,0.00081028574,0.0013057832],"category_scores_gemma":[0.001748573,0.0003648404,0.0012998489,0.005936973,0.00075871014,0.00070275215,0.001120172,0.0012421665,0.00015133906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007339229,0.000033732504,0.99846387,0.00001609307,0.000115783616,0.00011615078,0.00012418062,0.000052897944,0.000037301535,0.00003559711,0.00036192025,0.0005690396],"study_design_scores_gemma":[0.00000788198,0.000016707983,0.9985043,0.000014932628,0.00004861334,0.00007945387,0.00095531734,0.00015129318,0.000012266668,0.000012867538,0.00018626638,0.000010075631],"about_ca_topic_score_codex":0.9210717,"about_ca_topic_score_gemma":0.9208926,"teacher_disagreement_score":0.07892829,"about_ca_system_score_codex":0.010011515,"about_ca_system_score_gemma":0.010725216,"threshold_uncertainty_score":0.15878618},"labels":[],"label_agreement":null},{"id":"W4417481590","doi":"10.1016/j.jval.2025.09.209","title":"CO107 Evaluating the Health Impact of Anti-PD-(L)1 Agents for Early Stage Cancer Treatment in the Czech Republic","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Czech; Stage (stratigraphy); Renal cell carcinoma; Cancer; Cancer treatment; Breast cancer; Disease; Cancer stage","score_opus":0.17715392520786227,"score_gpt":0.4943118286976621,"score_spread":0.31715790348979983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9206565,0.045559805,0.0018942571,0.004005023,0.00029268136,0.000754308,0.005253086,0.00005055289,0.021533763],"genre_scores_gemma":[0.99132055,0.005192144,0.00081331184,0.0005067635,0.00003764742,0.00011005425,0.0008601659,0.000012213366,0.0011470962],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9987464,0.0006473236,0.00010517672,0.0000962816,0.00021359888,0.00019122683],"domain_scores_gemma":[0.99836,0.0004959762,0.00037709984,0.000084708445,0.00042383157,0.0002583219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041570175,0.0001984671,0.00045900696,0.0007486441,0.00027435002,0.0014997327,0.0003574307,0.00030156766,0.0020139108],"category_scores_gemma":[0.003281668,0.00013066422,0.0010063238,0.0006770942,0.000364392,0.0002903263,0.0006968404,0.0006552509,0.00016245594],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058332507,0.002490544,0.24536943,0.0070180753,0.0036722475,0.0006916574,0.00042612306,0.015701694,0.02811092,0.007551573,0.008839185,0.62179613],"study_design_scores_gemma":[0.0066029103,0.022056773,0.8579019,0.002762792,0.00461989,0.0006358604,0.0012239115,0.0051269834,0.018447196,0.001523083,0.078932285,0.00016651776],"about_ca_topic_score_codex":0.022902183,"about_ca_topic_score_gemma":0.022884078,"teacher_disagreement_score":0.022902183,"about_ca_system_score_codex":0.0043438626,"about_ca_system_score_gemma":0.007448644,"threshold_uncertainty_score":0.04553777},"labels":[],"label_agreement":null},{"id":"W4417481598","doi":"10.1016/j.jval.2025.09.1076","title":"EE695 The Cost-Effectiveness of Using Site-Specific Wastewater-Based Surveillance to Monitor COVID-19 in Long-Term Care Facilities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Patient care; MEDLINE; Health care; Remote patient monitoring","score_opus":0.11316122308424238,"score_gpt":0.3895455525870014,"score_spread":0.27638432950275904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96871823,0.004673208,0.0027409906,0.0034771997,0.00022238004,0.00043518064,0.004650219,0.00011503131,0.014967513],"genre_scores_gemma":[0.9963774,0.0005174636,0.0011867441,0.0002983084,0.000037352103,0.000043201002,0.0006510006,0.000005462824,0.0008830751],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99708265,0.001779085,0.00016590432,0.00017972337,0.0005215559,0.00027107904],"domain_scores_gemma":[0.9960472,0.0018948938,0.00077299756,0.00013432426,0.0006306694,0.00051997666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002581475,0.00056686543,0.00040419356,0.0007509553,0.00025423468,0.0012081302,0.00057939655,0.0009253262,0.0065607927],"category_scores_gemma":[0.011561343,0.00017344157,0.0015288347,0.0006011827,0.00023211581,0.000635584,0.0007374771,0.00047079276,0.000388504],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017615022,0.0023157303,0.46479642,0.0011322391,0.0016130396,0.0005237083,0.0001393407,0.018894214,0.0022758888,0.0010198902,0.006958749,0.48271567],"study_design_scores_gemma":[0.0012511726,0.018454544,0.92643154,0.00079756556,0.0018152845,0.00078412844,0.0008366286,0.040860206,0.0023281097,0.00076707633,0.0055948594,0.000079010664],"about_ca_topic_score_codex":0.026138632,"about_ca_topic_score_gemma":0.025258439,"teacher_disagreement_score":0.026138632,"about_ca_system_score_codex":0.003441373,"about_ca_system_score_gemma":0.002231527,"threshold_uncertainty_score":0.051972985},"labels":[],"label_agreement":null},{"id":"W4417481616","doi":"10.1016/j.jval.2025.09.1749","title":"HSD88 Physician Perspectives on Unmet Need and Treatment Options Among Patients With Relapsed Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings From Qualitative Interviews","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; AstraZeneca (Canada)","funders":"","keywords":"Lung cancer; Docetaxel; Chemotherapy; Qualitative research; Cancer","score_opus":0.01800251392389317,"score_gpt":0.31700324929279095,"score_spread":0.29900073536889776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98554844,0.0007769567,0.00017785844,0.007192476,0.000070999035,0.00013862504,0.0006119478,0.00000580776,0.005476814],"genre_scores_gemma":[0.9945845,0.000618631,0.00027479063,0.0025562046,0.000016130667,0.00010518758,0.00016158946,0.00000861616,0.0016743867],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99303126,0.0029079658,0.00034685072,0.0003655893,0.0008265964,0.0025216076],"domain_scores_gemma":[0.9738259,0.01367584,0.0024112659,0.000235632,0.0037664287,0.006084957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005705158,0.00029217175,0.0005429716,0.0013591839,0.011654708,0.0052588712,0.0014901487,0.002004263,0.0028241298],"category_scores_gemma":[0.01891773,0.0005990766,0.00045646925,0.002695547,0.0052768895,0.001720579,0.004009267,0.0041233497,0.00016526484],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072331335,0.00005434178,0.0343307,0.00013301117,0.0000107894975,0.0004075945,0.95945454,0.00005525279,0.0003318799,0.00061518437,0.0015032162,0.0030311886],"study_design_scores_gemma":[0.0000048654583,0.000015349968,0.009561776,0.00010182967,0.000004139039,0.000055873563,0.9865428,0.000048355138,0.000047468053,0.000060528087,0.0035423224,0.000014681222],"about_ca_topic_score_codex":0.87291175,"about_ca_topic_score_gemma":0.9341715,"teacher_disagreement_score":0.12708825,"about_ca_system_score_codex":0.046482265,"about_ca_system_score_gemma":0.0741128,"threshold_uncertainty_score":0.337254},"labels":[],"label_agreement":null},{"id":"W4417481624","doi":"10.1016/j.jval.2025.09.2054","title":"HTA271 Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Planner; Data modeling; Algorithm design","score_opus":0.31814343102231324,"score_gpt":0.4196315146495237,"score_spread":0.10148808362721046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9482522,0.00072781625,0.021260226,0.00061146996,0.000051805793,0.0001665301,0.023465956,0.000109434026,0.0053546005],"genre_scores_gemma":[0.98583835,0.0001759229,0.0039220364,0.000041289913,0.000026643547,0.00008558219,0.009236968,0.000024699768,0.00064850267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914074,0.0004331972,0.00007382956,0.00015040988,0.000115372095,0.00008639092],"domain_scores_gemma":[0.99446565,0.0030747065,0.0011240423,0.0004679715,0.0005640073,0.00030355365],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0029491591,0.00051423657,0.0007054019,0.0015976591,0.00026372843,0.0014800212,0.0006281883,0.0006141672,0.0039273016],"category_scores_gemma":[0.012783536,0.00030021908,0.0012724646,0.0014744027,0.00017733648,0.000719557,0.0007932528,0.0008882187,0.0007186674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006176301,0.00013276935,0.94136995,0.000058645397,0.00044415222,0.00012322598,0.00007915751,0.0284758,0.00015327198,0.001206141,0.0025323892,0.02480696],"study_design_scores_gemma":[0.00006872987,0.0003915607,0.77037114,0.00013815303,0.00038263618,0.00028995465,0.00041750725,0.22099224,0.00043378875,0.003357564,0.0031058895,0.000050933904],"about_ca_topic_score_codex":0.018864024,"about_ca_topic_score_gemma":0.011776778,"teacher_disagreement_score":0.9970508,"about_ca_system_score_codex":0.0006557519,"about_ca_system_score_gemma":0.0012003713,"threshold_uncertainty_score":0.037508488},"labels":[],"label_agreement":null},{"id":"W4417481646","doi":"10.1016/j.jval.2025.09.895","title":"EE513 Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the Kingdom of Saudi Arabia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Activation Laboratories","funders":"","keywords":"Alopecia areata; Health care; Resource (disambiguation); Kingdom; Healthcare system","score_opus":0.0334197929785795,"score_gpt":0.2977319860987775,"score_spread":0.264312193120198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791414,0.0003604462,0.000007438621,0.00020727188,0.000005340111,0.000004488148,0.0008960727,6.185525e-7,0.0006041469],"genre_scores_gemma":[0.9988594,0.00030533073,0.000017327486,0.00008496795,0.000006372061,0.0000048247,0.0004599101,3.9845935e-7,0.0002613356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99981767,0.000033514225,0.000036260713,0.000016366335,0.000033091757,0.000063149826],"domain_scores_gemma":[0.9995515,0.000039444047,0.00022027332,0.000007594904,0.00008819621,0.00009290987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015733676,0.00013012782,0.00016127955,0.00052813446,0.00029197935,0.00050783454,0.00015304214,0.00026527178,0.002150283],"category_scores_gemma":[0.00076053035,0.00009978291,0.0003225349,0.0010773737,0.00011868879,0.0002596482,0.0003819582,0.00030576315,0.00017390841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032206237,0.000021026688,0.99766636,0.000021914604,0.000039436844,0.00011986331,0.00016281413,0.00002707298,0.00006315359,0.000027325104,0.0003262974,0.0014925782],"study_design_scores_gemma":[0.0000026407613,0.000019808713,0.99840397,0.000022907074,0.000012589709,0.00012924272,0.0010163445,0.000068768255,0.000009826039,0.000007964923,0.00030375362,0.0000021535266],"about_ca_topic_score_codex":0.11801914,"about_ca_topic_score_gemma":0.10626463,"teacher_disagreement_score":0.11801914,"about_ca_system_score_codex":0.0008394727,"about_ca_system_score_gemma":0.000740391,"threshold_uncertainty_score":0.23466438},"labels":[],"label_agreement":null},{"id":"W4417481649","doi":"10.1016/j.jval.2025.09.592","title":"EE208 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 2 Diabetes Using Insulin in Sweden: A National Real-World Evidence Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Type 2 diabetes; Perspective (graphical); Continuous glucose monitoring; Diabetes mellitus; Insulin; Population; Type 2 Diabetes Mellitus","score_opus":0.1056490702653705,"score_gpt":0.42992391178038336,"score_spread":0.32427484151501285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5926947,0.36507303,0.005075115,0.011514547,0.001500304,0.0009705763,0.007953812,0.00008723303,0.015130701],"genre_scores_gemma":[0.96533704,0.027851753,0.0022658391,0.0013847521,0.00038008552,0.00025415054,0.0018706148,0.00001437472,0.0006414935],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9818641,0.014720032,0.0011117978,0.00046038153,0.0012905379,0.0005530387],"domain_scores_gemma":[0.9778946,0.018124387,0.0022205212,0.0003927906,0.00097489,0.00039273515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015405584,0.0010749071,0.0027102437,0.0023833583,0.00020890341,0.0036486674,0.000818107,0.0019425655,0.0030550081],"category_scores_gemma":[0.03622201,0.00052618334,0.009833314,0.0019848882,0.00062612677,0.0013781558,0.0012395196,0.002306683,0.00019864959],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16957644,0.0021193319,0.13372529,0.05940642,0.2647732,0.0010966109,0.0005043356,0.080996424,0.0015184913,0.010196258,0.008463206,0.26762396],"study_design_scores_gemma":[0.048525017,0.032537177,0.28907472,0.05331254,0.46460435,0.0021723502,0.0023545988,0.05783681,0.0025923469,0.015730482,0.030760465,0.00049921806],"about_ca_topic_score_codex":0.009061878,"about_ca_topic_score_gemma":0.008734155,"teacher_disagreement_score":0.015405584,"about_ca_system_score_codex":0.0046152114,"about_ca_system_score_gemma":0.0031698325,"threshold_uncertainty_score":0.08147347},"labels":[],"label_agreement":null},{"id":"W4417481657","doi":"10.1016/j.jval.2025.09.2638","title":"PCR165 Navigating Uncertainty and Pragmatic Acceptance: Canadian Patient and Public Perspectives on Radiopharmaceutical Therapy in the Context of Whole Health","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Institute of Population and Public Health","funders":"","keywords":"Context (archaeology); Public health; Health care; MEDLINE","score_opus":0.052774126831590114,"score_gpt":0.3860167601323014,"score_spread":0.3332426333007113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481657","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11536518,0.003869439,0.0020369075,0.775076,0.00074139005,0.00007812956,0.00015673126,0.000028826671,0.10264744],"genre_scores_gemma":[0.944582,0.001544628,0.0009135172,0.048552312,0.00020801154,0.000033632437,0.000039903338,0.000040594852,0.004085414],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9573183,0.019506427,0.0008787782,0.0013754028,0.010718915,0.010202127],"domain_scores_gemma":[0.92600214,0.037133507,0.0031511793,0.0009939977,0.016591167,0.016127998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031151406,0.00038417248,0.00077906053,0.0014372481,0.02396838,0.01735081,0.0024585614,0.010561111,0.009398346],"category_scores_gemma":[0.06783199,0.0005008507,0.00087791437,0.0023427433,0.027131448,0.0043758918,0.0077046826,0.018891774,0.00031139623],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004903398,0.00021942373,0.029060954,0.00048483658,0.00012848458,0.002802827,0.40145278,0.0011419196,0.0013266436,0.378671,0.106126554,0.07809419],"study_design_scores_gemma":[0.00018479448,0.00018847267,0.024801143,0.0011619927,0.00017529451,0.0009986534,0.48891807,0.0013239346,0.00084504683,0.09307369,0.38784084,0.0004880503],"about_ca_topic_score_codex":0.9239244,"about_ca_topic_score_gemma":0.93977624,"teacher_disagreement_score":0.108214624,"about_ca_system_score_codex":0.108214624,"about_ca_system_score_gemma":0.2729537,"threshold_uncertainty_score":0.7851557},"labels":[],"label_agreement":null},{"id":"W4417481700","doi":"10.1016/j.jval.2025.09.3032","title":"SA91 Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Inclusion (mineral); Caregiver burden; Quality of life (healthcare); Neurology; Health care; Quality-adjusted life year; Health economics; Quality (philosophy)","score_opus":0.11090402035775546,"score_gpt":0.3911991160681404,"score_spread":0.2802950957103849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005187027,0.9704503,0.0020946674,0.0057627563,0.0012705127,0.0011518374,0.0070742033,0.00005346913,0.006955146],"genre_scores_gemma":[0.11261102,0.86757797,0.0064507383,0.0045083687,0.00090394326,0.0029174068,0.0037917667,0.00006125305,0.0011775591],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97660553,0.014122036,0.005355468,0.0007568485,0.002664817,0.0004952998],"domain_scores_gemma":[0.8919959,0.08898047,0.008796595,0.001667923,0.008007207,0.00055190426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031913582,0.0016118584,0.0039942865,0.013209427,0.0005848266,0.0047634644,0.0019586214,0.002584593,0.012746363],"category_scores_gemma":[0.14769763,0.0009522802,0.014751071,0.010974162,0.0005925038,0.0024809309,0.0022565962,0.0022911984,0.0011479056],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014316413,0.00018551064,0.0056246687,0.70543647,0.04837672,0.00034868304,0.00035540503,0.002411365,0.00024232858,0.007383535,0.017403444,0.21080026],"study_design_scores_gemma":[0.0007465053,0.00047760436,0.009512289,0.8126747,0.09832932,0.00038854408,0.00036824524,0.00117908,0.00032692088,0.0054071895,0.0704941,0.000095387324],"about_ca_topic_score_codex":0.01129835,"about_ca_topic_score_gemma":0.0215436,"teacher_disagreement_score":0.031913582,"about_ca_system_score_codex":0.0066917483,"about_ca_system_score_gemma":0.016922297,"threshold_uncertainty_score":0.16877717},"labels":[],"label_agreement":null},{"id":"W4417481745","doi":"10.1016/j.jval.2025.09.314","title":"CO213 Review of Index Line Selection Methods in Hemato-Oncology Externally Controlled Trials: A Secondary Analysis of the Hermans et al Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Selection (genetic algorithm); Index (typography); Line (geometry); Time line","score_opus":0.10674046071374535,"score_gpt":0.5357651114473563,"score_spread":0.42902465073361096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481745","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011957006,0.9631454,0.0065359473,0.0017350615,0.0017135495,0.0071551637,0.0047549778,0.0001733324,0.0028296385],"genre_scores_gemma":[0.45570773,0.48344108,0.02528505,0.010290349,0.0015824421,0.01625602,0.0043383962,0.00047469002,0.0026242568],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.8359142,0.104968905,0.041230205,0.006906039,0.009684805,0.0012959151],"domain_scores_gemma":[0.7794969,0.16283019,0.034955326,0.009799802,0.011850695,0.0010671339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.079668224,0.0027670024,0.015157876,0.0062850905,0.0010290424,0.006072348,0.0023813986,0.0035236194,0.012250982],"category_scores_gemma":[0.25937575,0.001809433,0.027564622,0.0085088285,0.0016877933,0.003320114,0.0025720214,0.0029773645,0.0015290049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008296988,0.000067826615,0.004601025,0.57873505,0.3710869,0.0001354307,0.00031949015,0.00025766666,0.0003650556,0.00057716214,0.003923013,0.031634424],"study_design_scores_gemma":[0.01634213,0.0010888615,0.009697658,0.15729438,0.797971,0.0002308206,0.0002226471,0.0005427449,0.000495508,0.0014318705,0.014529747,0.00015271638],"about_ca_topic_score_codex":0.006321355,"about_ca_topic_score_gemma":0.019634502,"teacher_disagreement_score":0.079668224,"about_ca_system_score_codex":0.0040358347,"about_ca_system_score_gemma":0.008692636,"threshold_uncertainty_score":0.42133087},"labels":[],"label_agreement":null},{"id":"W4417481806","doi":"10.1016/j.jval.2025.09.1378","title":"EPH249 The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Colorectal cancer; Survival analysis; Overall survival; Cancer; MEDLINE","score_opus":0.09000746503453931,"score_gpt":0.4066629052450658,"score_spread":0.3166554402105265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76617897,0.0036664489,0.0003316498,0.0002444143,0.00003385868,0.000057936555,0.22694366,0.000035488738,0.0025075695],"genre_scores_gemma":[0.8892482,0.0020049762,0.0005269585,0.000171896,0.000050147446,0.0001081851,0.10646789,0.000019856872,0.00140198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911076,0.00017397382,0.00022330204,0.00020928807,0.00019259113,0.000090007336],"domain_scores_gemma":[0.9981285,0.00035354155,0.0009850063,0.00016485396,0.00023311476,0.00013507713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069208606,0.00026047786,0.000610987,0.0015211464,0.00015384804,0.00066211034,0.00042636532,0.0003368531,0.0018517227],"category_scores_gemma":[0.002769975,0.00022799526,0.0014034489,0.004525028,0.00011207229,0.0006031963,0.0005020026,0.00048346663,0.00043729378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019116868,0.000053307373,0.97992605,0.00047011953,0.0026518323,0.00009167494,0.0000375046,0.0005740686,0.00024620115,0.00021280999,0.007542428,0.0062823603],"study_design_scores_gemma":[0.0002151833,0.00009592036,0.9924366,0.00008568605,0.00091364764,0.0002494847,0.000108089574,0.00085590535,0.00018738683,0.000098946424,0.0047370093,0.000016116446],"about_ca_topic_score_codex":0.0153748235,"about_ca_topic_score_gemma":0.021029806,"teacher_disagreement_score":0.0153748235,"about_ca_system_score_codex":0.0005414725,"about_ca_system_score_gemma":0.000565322,"threshold_uncertainty_score":0.030570626},"labels":[],"label_agreement":null},{"id":"W4417481810","doi":"10.1016/j.jval.2025.09.1922","title":"HTA137 Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Excellence; Key (lock); Quarter (Canadian coin); Quality (philosophy); Health technology","score_opus":0.5136203462949277,"score_gpt":0.5025888836986924,"score_spread":0.01103146259623533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481810","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003858977,0.9399758,0.014297701,0.025615647,0.001609488,0.0008212233,0.0029988235,0.00022110472,0.010601314],"genre_scores_gemma":[0.12538764,0.72744614,0.120384246,0.0154545875,0.0025094794,0.0028917487,0.003979208,0.00060330203,0.0013437035],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.6607886,0.20068075,0.06807358,0.006933396,0.062098432,0.0014253246],"domain_scores_gemma":[0.23050106,0.6321544,0.052694574,0.01643418,0.0668154,0.00140044],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21384309,0.0014677584,0.0069515994,0.019710384,0.0015187408,0.012129377,0.0063206144,0.0044148853,0.008533262],"category_scores_gemma":[0.6866198,0.0022545883,0.009781128,0.024581179,0.0041242423,0.010025538,0.0066147125,0.005619898,0.0012359523],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085822196,0.000059339956,0.009380801,0.1513208,0.008963673,0.00014650213,0.002672107,0.001754786,0.00022262514,0.01792157,0.039943945,0.76675564],"study_design_scores_gemma":[0.00075499614,0.00063222466,0.032331504,0.6723749,0.01780992,0.0009553406,0.0014627491,0.00335902,0.00095106947,0.025710985,0.24327342,0.00038384946],"about_ca_topic_score_codex":0.016001428,"about_ca_topic_score_gemma":0.023380723,"teacher_disagreement_score":0.7861569,"about_ca_system_score_codex":0.0099366335,"about_ca_system_score_gemma":0.01921155,"threshold_uncertainty_score":0.96947145},"labels":[],"label_agreement":null},{"id":"W4417481816","doi":"10.1016/j.jval.2025.09.896","title":"EE514 Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the United Arab Emirates","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Activation Laboratories","funders":"","keywords":"Alopecia areata; Hair loss; Health care; Resource (disambiguation); Resource constraints","score_opus":0.03280994515759296,"score_gpt":0.2961452468542208,"score_spread":0.26333530169662783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99497426,0.00055150985,0.00001373036,0.00026999347,0.000011999806,0.0000109816065,0.0024577035,0.0000017950639,0.0017079945],"genre_scores_gemma":[0.99702305,0.0007262179,0.000050630555,0.00016351775,0.00001967817,0.000019013929,0.0013618612,0.00000106273,0.00063486234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99983764,0.000035932306,0.000025364081,0.000014416296,0.000035821384,0.00005068394],"domain_scores_gemma":[0.9997451,0.000029496538,0.000113760776,0.0000051661727,0.000055240227,0.000051188348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020243069,0.00016865051,0.00018147519,0.0008845802,0.00033883503,0.00047392005,0.00014861058,0.00024286626,0.001980382],"category_scores_gemma":[0.0007647958,0.0001232356,0.00036322666,0.0013721838,0.00010199847,0.0002926775,0.00036395265,0.00032438638,0.00015472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027895485,0.00004840249,0.997001,0.000025639234,0.00006771466,0.00007315768,0.00010774054,0.000032797616,0.000055347795,0.000026076668,0.00058785506,0.0019463706],"study_design_scores_gemma":[0.0000035665266,0.000017003462,0.99880326,0.000021921904,0.000014110663,0.000079453865,0.0006060081,0.000065637985,0.000008547163,0.000006880629,0.00037187303,0.0000017048594],"about_ca_topic_score_codex":0.108058564,"about_ca_topic_score_gemma":0.13375641,"teacher_disagreement_score":0.108058564,"about_ca_system_score_codex":0.0006136435,"about_ca_system_score_gemma":0.00071388175,"threshold_uncertainty_score":0.21485919},"labels":[],"label_agreement":null},{"id":"W4417481838","doi":"10.1016/j.jval.2025.09.2582","title":"PCR109 Health Utility and Indirect Costs of Neuromuscular Disease Through a Patient-Centered Lens: A National Patient and Caregiver Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Calgary; University of Ottawa; Cégep de Jonquière; Muscular Dystrophy Canada; Ottawa Hospital","funders":"","keywords":"Neuromuscular disease; Indirect costs; Health economics; Psychological intervention; Disease; Economic cost","score_opus":0.109995538136111,"score_gpt":0.3521337539313818,"score_spread":0.24213821579527078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895489,0.00020313538,0.00012816915,0.00021928862,0.0000066873476,0.000040994008,0.0073140385,0.0000054401985,0.0025332822],"genre_scores_gemma":[0.9954484,0.0001536203,0.00022606408,0.000112706795,0.000009191542,0.000066154884,0.0032216,0.000003055183,0.00075919274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978886,0.00109124,0.00033356916,0.00013216773,0.00037693762,0.00017738985],"domain_scores_gemma":[0.9940316,0.0015313769,0.002884305,0.00029471537,0.00073568505,0.0005222988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019953896,0.0002826656,0.00037845367,0.0011705401,0.00041577627,0.00095604424,0.00044449075,0.0005284454,0.0022270563],"category_scores_gemma":[0.010712449,0.00028003336,0.0009129586,0.0025818534,0.00026295788,0.00095966004,0.0008609364,0.0009065938,0.0004005395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052954452,0.000080148624,0.9975345,0.000015033967,0.00007048413,0.000029259569,0.00011174945,0.00009630382,0.000013345677,0.00003281864,0.00044632857,0.0015171344],"study_design_scores_gemma":[0.0000074511904,0.00007486537,0.9987627,0.000013315499,0.00003729979,0.00009908096,0.00030009047,0.0002563754,0.000023553932,0.000020700318,0.00039878557,0.000005793526],"about_ca_topic_score_codex":0.032514248,"about_ca_topic_score_gemma":0.040973302,"teacher_disagreement_score":0.032514248,"about_ca_system_score_codex":0.0013317442,"about_ca_system_score_gemma":0.00081118045,"threshold_uncertainty_score":0.06465},"labels":[],"label_agreement":null},{"id":"W4417481845","doi":"10.1016/j.jval.2025.09.707","title":"EE323 Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Economic impact analysis; Semaglutide; Value (mathematics); Economic model; Social impact","score_opus":0.04039985240993782,"score_gpt":0.37305973423590383,"score_spread":0.332659881825966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481845","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8552483,0.0022498055,0.07865569,0.0064017936,0.00024606974,0.00054274296,0.01745524,0.0004555619,0.03874481],"genre_scores_gemma":[0.9661682,0.0006829903,0.019235108,0.00039006706,0.000029141307,0.00015550222,0.0040804283,0.00006664331,0.009191898],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99934524,0.00020793706,0.000022744467,0.00008418579,0.000107515916,0.00023244688],"domain_scores_gemma":[0.9977786,0.0008291781,0.00008920839,0.00006515916,0.0010656944,0.00017213219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016635521,0.0007430628,0.0009567072,0.0015644558,0.0012105261,0.002223937,0.0014163528,0.0010788554,0.004226666],"category_scores_gemma":[0.0057652625,0.0006216475,0.0015898811,0.002602305,0.00049520895,0.00076545565,0.0007445854,0.001304211,0.0002807083],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019076461,0.00009439013,0.021406535,0.000062103245,0.0002971371,0.00015667256,0.000052610725,0.95396835,0.00014259187,0.0066978093,0.0046054116,0.012325679],"study_design_scores_gemma":[0.00006353267,0.000025568985,0.006895848,0.000030605013,0.00009803481,0.000025532625,0.0001254376,0.987944,0.00009341585,0.0024322756,0.0022377414,0.000028038921],"about_ca_topic_score_codex":0.97988737,"about_ca_topic_score_gemma":0.95777816,"teacher_disagreement_score":0.027598469,"about_ca_system_score_codex":0.027598469,"about_ca_system_score_gemma":0.027789492,"threshold_uncertainty_score":0.20024186},"labels":[],"label_agreement":null},{"id":"W4417481846","doi":"10.1016/j.jval.2025.09.2635","title":"PCR162 Multinational Qualitative Testing of the Experimental EuroQol Toddler and Infant Populations (EQ-TIPS) Instrument","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Toddler; Multinational corporation; Quality of life (healthcare); Quality (philosophy); Descriptive statistics; Content validity","score_opus":0.6537076198830977,"score_gpt":0.4979136964753126,"score_spread":0.15579392340778508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95468,0.000099628836,0.009479645,0.0006866678,0.0001440571,0.0027205548,0.011853302,0.000116135285,0.020219967],"genre_scores_gemma":[0.9575067,0.0000578071,0.018290209,0.0006183409,0.000026658057,0.0077645355,0.0060724197,0.00011381737,0.009549545],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9862557,0.00960439,0.0006513723,0.0010973234,0.0017484231,0.0006428729],"domain_scores_gemma":[0.973884,0.013906938,0.0023509648,0.0031861956,0.0061250986,0.00054688886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015456868,0.0005827989,0.0003223406,0.00051586033,0.00085371576,0.00084505416,0.0009189839,0.00071207096,0.01477645],"category_scores_gemma":[0.035552945,0.0003422693,0.0008022154,0.0007060267,0.0009850604,0.0006882928,0.001379136,0.00085259514,0.0033666014],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0195157,0.012241825,0.680446,0.00080257206,0.00048153638,0.00040038046,0.010677846,0.003412542,0.025951387,0.011064415,0.02441011,0.21059573],"study_design_scores_gemma":[0.0021920954,0.014508073,0.8769563,0.00045781102,0.00022951994,0.0004896318,0.008691919,0.0071792537,0.040463828,0.0036014519,0.045030236,0.0001998822],"about_ca_topic_score_codex":0.009476748,"about_ca_topic_score_gemma":0.0065330635,"teacher_disagreement_score":0.015456868,"about_ca_system_score_codex":0.0013412227,"about_ca_system_score_gemma":0.0020078602,"threshold_uncertainty_score":0.08174473},"labels":[],"label_agreement":null},{"id":"W4417481868","doi":"10.1016/j.jval.2025.09.1882","title":"HTA97 Cost-Effectiveness Modeling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Nice; Perioperative; Excellence; Neoadjuvant therapy; MEDLINE","score_opus":0.1350012068585183,"score_gpt":0.3678000506117023,"score_spread":0.232798843753184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016065479,0.79458493,0.020934636,0.13919109,0.007637484,0.00052021164,0.004263189,0.00068563793,0.030576317],"genre_scores_gemma":[0.046124917,0.81053746,0.075201824,0.037140757,0.014494715,0.0016035932,0.0056978627,0.0019574098,0.0072414954],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9490781,0.02696158,0.008396149,0.0010734855,0.013738196,0.000752473],"domain_scores_gemma":[0.59020245,0.2973371,0.01841001,0.008573728,0.081203885,0.0042727683],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.073024735,0.0010785774,0.0046873027,0.0073391465,0.00078878924,0.0087742675,0.0056308312,0.004958284,0.013409286],"category_scores_gemma":[0.40717643,0.0014795983,0.0055701416,0.009935743,0.0020867127,0.006235388,0.0038691869,0.0064903474,0.004053541],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029543837,0.00009931399,0.0016890431,0.020331224,0.00082065305,0.00013676385,0.00035177582,0.0077316174,0.0000736068,0.030091885,0.4078395,0.5305392],"study_design_scores_gemma":[0.00022234059,0.0003077024,0.0033783813,0.080107756,0.0012248447,0.00057579286,0.0002720062,0.005576645,0.00030546857,0.027850593,0.87995607,0.00022241738],"about_ca_topic_score_codex":0.014627329,"about_ca_topic_score_gemma":0.016250111,"teacher_disagreement_score":0.92697525,"about_ca_system_score_codex":0.007854841,"about_ca_system_score_gemma":0.015514975,"threshold_uncertainty_score":0.38619632},"labels":[],"label_agreement":null},{"id":"W4417481876","doi":"10.1016/j.jval.2025.09.2634","title":"PCR161 Mobility and Upper Extremity Function in Duchenne Muscular Dystrophy: A Longitudinal Survey Using PROMIS","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Duchenne muscular dystrophy; Proxy (statistics); Patient-Reported Outcomes Measurement Information System; Longitudinal data; Upper limb","score_opus":0.036823687505549055,"score_gpt":0.30168438743003617,"score_spread":0.26486069992448713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863964,0.00009309772,0.00005628968,0.000043097836,0.0000055214596,0.000011002243,0.00075525965,0.000004017005,0.00039214786],"genre_scores_gemma":[0.9969415,0.000116485346,0.000100413396,0.000039046183,0.0000063154152,0.000028110582,0.0011764913,0.0000037461693,0.0015879353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893373,0.00035810628,0.0001313424,0.00016019797,0.00021036468,0.00020614603],"domain_scores_gemma":[0.9980269,0.0001623214,0.0009395343,0.00010910712,0.00027771707,0.0004843943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012524113,0.00061641145,0.0004883789,0.0015776572,0.0008832449,0.00096734765,0.00057089655,0.00095619145,0.0013202657],"category_scores_gemma":[0.0024746798,0.0005706958,0.00085191417,0.0018354651,0.00034806048,0.00087545684,0.0011005035,0.0011839444,0.0007936085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045823628,0.000072235074,0.99909604,0.0000033252763,0.000029956158,0.00003069159,0.000091709204,0.00001528857,0.00007707209,0.000005143103,0.00004363336,0.0004891729],"study_design_scores_gemma":[0.000002203586,0.00013854295,0.9993819,0.0000034647283,0.000010907311,0.00007977635,0.00019323385,0.000047115875,0.000023864097,0.000004295572,0.000112105656,0.000002659267],"about_ca_topic_score_codex":0.020175898,"about_ca_topic_score_gemma":0.024619155,"teacher_disagreement_score":0.020175898,"about_ca_system_score_codex":0.0005983801,"about_ca_system_score_gemma":0.00046259916,"threshold_uncertainty_score":0.040116906},"labels":[],"label_agreement":null},{"id":"W4417481889","doi":"10.1016/j.jval.2025.09.3463","title":"MSR184 Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Network Meta-Analysis Comparing Treatments to Paclitaxel","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Paclitaxel; Cancer; Safety profile; Clinical trial; Cancer treatment","score_opus":0.18701898790266813,"score_gpt":0.4184574357632065,"score_spread":0.23143844786053835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481889","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2661709,0.71987665,0.0041996073,0.0012821901,0.0015569722,0.00037831988,0.0037631758,0.00023524377,0.0025369867],"genre_scores_gemma":[0.96411526,0.030252084,0.0015811697,0.0012085905,0.00038621685,0.00017918186,0.0011958526,0.00008574264,0.0009960055],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9928416,0.004358411,0.0007677189,0.0012345752,0.00043775165,0.00035990187],"domain_scores_gemma":[0.9922322,0.005087908,0.0013582105,0.0006566805,0.00035797458,0.00030697853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008003464,0.0025302689,0.009145523,0.0018904983,0.00047677237,0.0026620391,0.0017265831,0.0021359345,0.0043446957],"category_scores_gemma":[0.015067228,0.0014904077,0.05164663,0.0024093552,0.0006738963,0.0016769583,0.0016106365,0.004239797,0.0004486418],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034512356,0.00005339269,0.01273141,0.010328485,0.93501794,0.00007510019,0.000036399335,0.0011056663,0.00035222078,0.000098669065,0.0004915246,0.005196843],"study_design_scores_gemma":[0.005982659,0.0008466865,0.010570232,0.0006313008,0.97982407,0.00006784809,0.00003713824,0.0007530403,0.00013035786,0.00029291498,0.0008337061,0.000029982022],"about_ca_topic_score_codex":0.0079728,"about_ca_topic_score_gemma":0.015735168,"teacher_disagreement_score":0.009145523,"about_ca_system_score_codex":0.0020066919,"about_ca_system_score_gemma":0.0011011794,"threshold_uncertainty_score":0.042326868},"labels":[],"label_agreement":null},{"id":"W4417481916","doi":"10.1016/j.jval.2025.09.264","title":"CO162 Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Hereditary angioedema; Authorization; Angioedema; Orphan drug; Randomized controlled trial; C1-inhibitor","score_opus":0.0547682523391218,"score_gpt":0.341133780404957,"score_spread":0.2863655280658352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723174,0.017078888,0.0024194538,0.00045022543,0.0010674412,0.00016510928,0.0030913574,0.000056372824,0.0033537922],"genre_scores_gemma":[0.99701226,0.0005303974,0.0005052537,0.00015222552,0.000078261146,0.00006550498,0.00054438517,0.000010204895,0.0011016853],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9929047,0.0043937913,0.0004960486,0.0010677916,0.00040762342,0.0007300501],"domain_scores_gemma":[0.99576366,0.0021821994,0.00087516534,0.00066872255,0.00023445264,0.00027569162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037827736,0.00095137965,0.0019622443,0.0007055777,0.00048504997,0.0010358844,0.0012379935,0.0013033709,0.006603371],"category_scores_gemma":[0.009012491,0.00057897845,0.005363131,0.0010122914,0.0003781702,0.00067141955,0.0008742648,0.0014214693,0.0004310772],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3667494,0.0009855764,0.40352625,0.0027092048,0.1751175,0.0006021012,0.0002532854,0.0022801948,0.0024523279,0.0016780023,0.0049111214,0.038735025],"study_design_scores_gemma":[0.04718855,0.021218223,0.7320131,0.00062515103,0.16579638,0.0008573219,0.00066487223,0.015959281,0.0028915154,0.003709465,0.008899737,0.00017638206],"about_ca_topic_score_codex":0.013498021,"about_ca_topic_score_gemma":0.0103133125,"teacher_disagreement_score":0.013498021,"about_ca_system_score_codex":0.0008067425,"about_ca_system_score_gemma":0.00073120126,"threshold_uncertainty_score":0.026838899},"labels":[],"label_agreement":null},{"id":"W4417481973","doi":"10.1016/j.jval.2025.09.1374","title":"EPH245 The Incidence Mortality and Survival of Malignant Chondrosarcoma in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Chondrosarcoma; Incidence (geometry); Survival analysis; MEDLINE","score_opus":0.08287571108265293,"score_gpt":0.3801908644862514,"score_spread":0.2973151534035985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8140148,0.0027649521,0.00040778826,0.00019100988,0.00003368825,0.00008006535,0.17921598,0.000040425824,0.0032512585],"genre_scores_gemma":[0.8967557,0.0014698306,0.00030072758,0.00017431307,0.000059132915,0.000082210434,0.09993895,0.000012199787,0.0012069725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990959,0.0001932659,0.00019087642,0.00017622116,0.00025036835,0.00009332814],"domain_scores_gemma":[0.99790984,0.00043363593,0.0010454518,0.00017135942,0.00027043468,0.00016934688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008037209,0.00033433628,0.0004884157,0.00252953,0.00013492443,0.00070271664,0.00041209548,0.0003920653,0.0012651002],"category_scores_gemma":[0.0029633134,0.00026468694,0.0012014374,0.0037804923,0.00011952197,0.00047987394,0.0005022206,0.00047048926,0.00031435405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008679712,0.00005953546,0.9862281,0.00022288453,0.0014066767,0.000083903156,0.000036557623,0.0006551265,0.00019346288,0.00011833583,0.005040384,0.0050870082],"study_design_scores_gemma":[0.00010281816,0.00007308819,0.9966924,0.0000380865,0.00040547934,0.00014825497,0.00006313677,0.00062063336,0.00010914207,0.00003699742,0.0017016598,0.0000083136965],"about_ca_topic_score_codex":0.02125582,"about_ca_topic_score_gemma":0.022252843,"teacher_disagreement_score":0.02125582,"about_ca_system_score_codex":0.0005929713,"about_ca_system_score_gemma":0.00063454924,"threshold_uncertainty_score":0.042264223},"labels":[],"label_agreement":null},{"id":"W4417481994","doi":"10.1016/j.jval.2025.09.848","title":"EE465 Financial and Mental Health Burden on Caregivers of Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Mental health; Depression (economics); Autism spectrum disorder","score_opus":0.022236171375031547,"score_gpt":0.30387501551070967,"score_spread":0.28163884413567813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954437,0.0006846381,0.000015851616,0.000684126,0.000032505992,0.000007766119,0.0015843547,0.0000012066538,0.0015458815],"genre_scores_gemma":[0.9980262,0.00055794837,0.000027300466,0.00025355932,0.000025944693,0.000010152514,0.00071093487,7.234293e-7,0.0003872547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994062,0.00025419414,0.00008206633,0.000039312294,0.000086941596,0.00013121557],"domain_scores_gemma":[0.9983981,0.00019231322,0.0007867641,0.000043219687,0.00023529094,0.0003443351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005989036,0.00020617188,0.00021283417,0.00080837583,0.0008112082,0.0006669873,0.00020108851,0.00034584472,0.0021059257],"category_scores_gemma":[0.0027631447,0.00012577954,0.0003862158,0.0013876938,0.00021752347,0.0005270666,0.0007874175,0.0005152507,0.00018397602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081071936,0.00005292378,0.9958839,0.000019945652,0.00006952998,0.000092819835,0.00021816876,0.000025689467,0.000024041849,0.00003630422,0.0010044634,0.0024911473],"study_design_scores_gemma":[0.00000933582,0.00003176909,0.99742824,0.000042660748,0.000028490149,0.00009456084,0.0016507708,0.000053206662,0.000015770125,0.000024285095,0.0006175566,0.0000033767053],"about_ca_topic_score_codex":0.06819,"about_ca_topic_score_gemma":0.1105118,"teacher_disagreement_score":0.06819,"about_ca_system_score_codex":0.0006826867,"about_ca_system_score_gemma":0.0010891317,"threshold_uncertainty_score":0.1355862},"labels":[],"label_agreement":null},{"id":"W4417482017","doi":"10.1016/j.jval.2025.09.1068","title":"EE687 The Budget Impact and Time Savings of Introducing Subcutaneously Administered Nivolumab and Hyaluronidase (NIVO SC) to Patients Receiving Intravenously Administered Nivolumab (NIVO IV) Across Indications in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Nivolumab; Drug; Pharmacokinetics; Adverse effect; Clinical trial","score_opus":0.07352480237645068,"score_gpt":0.3594821933912759,"score_spread":0.2859573910148252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9197675,0.012757508,0.00045335482,0.023976855,0.00032397508,0.00025363642,0.024760924,0.00004660807,0.017659625],"genre_scores_gemma":[0.9867526,0.0037585574,0.00049020856,0.0012861328,0.00005092967,0.00004914431,0.0041066916,0.000016682983,0.0034890238],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972114,0.00052405725,0.00016603465,0.0001592881,0.00074887194,0.0011903234],"domain_scores_gemma":[0.99222493,0.0012311684,0.0010301229,0.00009465338,0.0025287487,0.0028904069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015301862,0.0003267079,0.00053064787,0.0014482532,0.0011456371,0.002650372,0.00081241614,0.00072059967,0.0030689351],"category_scores_gemma":[0.012194995,0.00034194888,0.0014995349,0.00339027,0.0007886776,0.0004891085,0.00096477557,0.0017475096,0.00011874584],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008062516,0.000642999,0.74780554,0.0011342374,0.0032187614,0.0006246915,0.00077710714,0.031717125,0.00049497886,0.010465281,0.072416656,0.1226402],"study_design_scores_gemma":[0.0012610499,0.00047306152,0.94669,0.0008864564,0.0016600614,0.0002392508,0.002564424,0.01961957,0.00047170822,0.0013330779,0.024669783,0.00013151839],"about_ca_topic_score_codex":0.99548304,"about_ca_topic_score_gemma":0.99659747,"teacher_disagreement_score":0.12824918,"about_ca_system_score_codex":0.12824918,"about_ca_system_score_gemma":0.14695312,"threshold_uncertainty_score":0.9305173},"labels":[],"label_agreement":null},{"id":"W4417482048","doi":"10.1016/j.jval.2025.09.1419","title":"HPR9 A Review of the UK's International Recognition Procedure and Its Role in Expediting Access to Innovative Treatments","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; U.S. Food and Drug Administration","keywords":"Expediting; Access to medicines; Market access; MEDLINE","score_opus":0.08331723117820085,"score_gpt":0.4194053903561479,"score_spread":0.33608815917794704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482048","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013730711,0.38447177,0.0013855135,0.51407576,0.030385531,0.00008715806,0.00017126069,0.000051691277,0.067998245],"genre_scores_gemma":[0.045470323,0.33430296,0.0037018317,0.50039643,0.048964906,0.00025451914,0.00023019109,0.00020749476,0.0664714],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9721344,0.012256415,0.0028446428,0.0013982356,0.0092068,0.0021594907],"domain_scores_gemma":[0.94498146,0.03907832,0.0038381417,0.0015785869,0.008670255,0.001853222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024586286,0.00068326364,0.0010262267,0.0035602213,0.0025935832,0.012696961,0.0026805943,0.02252109,0.009078832],"category_scores_gemma":[0.07031089,0.00073232956,0.0014100114,0.003440693,0.009122357,0.0068798508,0.0041196723,0.01658207,0.0024487097],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006810692,0.000038747134,0.00022825052,0.0025787265,0.000046398844,0.0006488846,0.0017603401,0.00020863487,0.00032957562,0.2033833,0.67047966,0.12022949],"study_design_scores_gemma":[0.000014207084,0.00003181494,0.0010050213,0.004178116,0.00002137136,0.00036424858,0.00033855383,0.00006236398,0.00013605718,0.0072092,0.98660475,0.000034288365],"about_ca_topic_score_codex":0.030799666,"about_ca_topic_score_gemma":0.042063985,"teacher_disagreement_score":0.030799666,"about_ca_system_score_codex":0.0140021,"about_ca_system_score_gemma":0.023357762,"threshold_uncertainty_score":0.13002628},"labels":[],"label_agreement":null},{"id":"W4417482058","doi":"10.1016/j.jval.2025.09.3410","title":"MSR126 Identifying Risk Profiles for Early Treatment Discontinuation in Geographic Atrophy Using Machine Learning and SHAP Clustering","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Cluster analysis; Discontinuation; Atrophy; Geographic atrophy","score_opus":0.04520430159392593,"score_gpt":0.34510718653821887,"score_spread":0.29990288494429296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99044704,0.0009932613,0.003300745,0.00033329998,0.000023407036,0.00005199277,0.0024932027,0.00008450567,0.002272644],"genre_scores_gemma":[0.99403423,0.00015944203,0.0026354794,0.0000465516,0.000027784296,0.000030284595,0.0021509922,0.000020692913,0.00089451636],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992084,0.00026859148,0.000095475225,0.000136359,0.00018343388,0.00010777137],"domain_scores_gemma":[0.9957968,0.0017026328,0.0012997227,0.00030175195,0.0006841448,0.00021496143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012376098,0.00027221534,0.0006323806,0.0018626064,0.00043282888,0.0009071468,0.0004939192,0.0005924027,0.0031961587],"category_scores_gemma":[0.007039216,0.00012764569,0.0012575501,0.0018114478,0.00017894707,0.0003773403,0.00049601396,0.00061391934,0.0005009216],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032960172,0.00021199894,0.8899953,0.00016958072,0.0008781985,0.00025666654,0.00016422992,0.004935466,0.0018277831,0.000822302,0.0033828989,0.09405957],"study_design_scores_gemma":[0.000106628046,0.0006371863,0.9463062,0.00012469268,0.00053650397,0.00087354524,0.00034673707,0.04172676,0.0017107077,0.0035322316,0.0040405826,0.000058117697],"about_ca_topic_score_codex":0.011012704,"about_ca_topic_score_gemma":0.013801029,"teacher_disagreement_score":0.011012704,"about_ca_system_score_codex":0.00061345496,"about_ca_system_score_gemma":0.000664146,"threshold_uncertainty_score":0.021897197},"labels":[],"label_agreement":null},{"id":"W4417482061","doi":"10.1016/j.jval.2025.09.629","title":"EE245 Cost-Effectiveness of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Perspective (graphical); Vitamin k; Public health; Rivaroxaban","score_opus":0.11373709873762738,"score_gpt":0.4123682431736518,"score_spread":0.2986311444360244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7464503,0.13790661,0.0021592362,0.06364621,0.0012867396,0.00013843704,0.013083803,0.000061615945,0.035267066],"genre_scores_gemma":[0.9855988,0.009275556,0.0005379224,0.0017167381,0.000671242,0.000032359447,0.0012210272,0.0000102334025,0.00093609135],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9964858,0.0022159219,0.00022627959,0.00013609398,0.00048875646,0.00044711676],"domain_scores_gemma":[0.995557,0.0026629479,0.00097298785,0.00010634601,0.00045265316,0.0002480786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044778865,0.00034688783,0.0008956621,0.0011625206,0.00019198463,0.0025178145,0.00046460459,0.0012878672,0.006217222],"category_scores_gemma":[0.010788933,0.00020356785,0.0021199894,0.0016658787,0.00040634547,0.0008783035,0.00069232064,0.0012682091,0.00026937385],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06541372,0.0016752232,0.34664723,0.007874153,0.032710955,0.0018037721,0.00052519847,0.055936188,0.0023167485,0.049188975,0.035074193,0.4008337],"study_design_scores_gemma":[0.008445344,0.006211198,0.8198986,0.0070061316,0.023532573,0.0034998583,0.0032260723,0.03474479,0.0026303953,0.021409994,0.06913086,0.0002641803],"about_ca_topic_score_codex":0.013722274,"about_ca_topic_score_gemma":0.008521348,"teacher_disagreement_score":0.013722274,"about_ca_system_score_codex":0.004735805,"about_ca_system_score_gemma":0.0025767267,"threshold_uncertainty_score":0.034360886},"labels":[],"label_agreement":null},{"id":"W4417482068","doi":"10.1016/j.jval.2025.09.591","title":"EE207 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 1 Diabetes in Sweden: A National Real-World Evidence Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Continuous glucose monitoring; Type 1 diabetes; Perspective (graphical); Diabetes mellitus; Type 2 diabetes; Continuous monitoring; Reduction (mathematics)","score_opus":0.0827810196486077,"score_gpt":0.41962445844975405,"score_spread":0.3368434388011463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5201823,0.42968717,0.0054851463,0.0145721575,0.0017377689,0.000988976,0.009310789,0.00010472584,0.017930921],"genre_scores_gemma":[0.9573285,0.033931322,0.0028103478,0.0017877981,0.0005321938,0.00034031976,0.0025197405,0.000019532374,0.00073027395],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9786475,0.017158424,0.001323252,0.0005635758,0.0016426586,0.00066465436],"domain_scores_gemma":[0.97686964,0.018790936,0.0023644008,0.0004744435,0.0010380198,0.00046247663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016874798,0.0010522471,0.0031277314,0.002418958,0.00021758737,0.0040429556,0.00087571045,0.0021514886,0.0030429822],"category_scores_gemma":[0.04002346,0.00055219495,0.009690015,0.0021130382,0.0006853946,0.0015830849,0.0014327862,0.0025249862,0.00020890123],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.15298605,0.0021646598,0.115941286,0.06290815,0.21973364,0.0010056956,0.00058829604,0.073978215,0.0015579207,0.011934397,0.010236875,0.34696484],"study_design_scores_gemma":[0.046410315,0.03831969,0.33783367,0.06855468,0.39117074,0.002537328,0.002686949,0.050478492,0.0026581981,0.016873777,0.041913524,0.0005625704],"about_ca_topic_score_codex":0.008806737,"about_ca_topic_score_gemma":0.008683252,"teacher_disagreement_score":0.016874798,"about_ca_system_score_codex":0.004726251,"about_ca_system_score_gemma":0.003730559,"threshold_uncertainty_score":0.08924359},"labels":[],"label_agreement":null},{"id":"W4417482091","doi":"10.1016/j.jval.2025.09.2545","title":"PCR72 Enhancing Equity in Cancer Clinical Trials: A Synthesis of Patient-Reported Barriers and Sustainable Solutions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada; Simon Fraser University; Nova Scotia Health Authority","funders":"","keywords":"Equity (law); Cancer; Sustainable development; Health equity","score_opus":0.0925695034679627,"score_gpt":0.4329994140769479,"score_spread":0.3404299106089852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482091","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025227696,0.10077336,0.036415763,0.79872763,0.0014303641,0.00076518115,0.00047988043,0.00012030064,0.03605984],"genre_scores_gemma":[0.79387695,0.07302185,0.038213998,0.08811554,0.0018729025,0.0015761069,0.00028425563,0.00015889829,0.0028795341],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.8326278,0.12602139,0.007854063,0.0039459183,0.021444643,0.0081062345],"domain_scores_gemma":[0.5908916,0.3523364,0.017567907,0.0059934272,0.02294517,0.010265502],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24368116,0.00075872755,0.0016752309,0.0028852029,0.0027543434,0.015508437,0.003353028,0.005008152,0.0110440375],"category_scores_gemma":[0.3123133,0.0006889665,0.0013330404,0.0043352214,0.008523456,0.011287574,0.016917221,0.008807828,0.00044376552],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036477385,0.00025765251,0.010840792,0.011572206,0.00062813226,0.00017898424,0.012107533,0.0026011139,0.0006107018,0.34101164,0.02988989,0.58993655],"study_design_scores_gemma":[0.0004693859,0.0007957545,0.01811896,0.055756953,0.0014316753,0.00039291737,0.024179991,0.0052310056,0.0030450618,0.505736,0.3846046,0.00023770767],"about_ca_topic_score_codex":0.006614635,"about_ca_topic_score_gemma":0.014557836,"teacher_disagreement_score":0.7563188,"about_ca_system_score_codex":0.02158051,"about_ca_system_score_gemma":0.097920254,"threshold_uncertainty_score":0.9326758},"labels":[],"label_agreement":null},{"id":"W4417482096","doi":"10.1016/j.jval.2025.09.2763","title":"RWD13 AI for Precision Oncology Evidence: Case Study Research From British Columbia, Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Precision oncology; Precision medicine; Electronic health record; Health records; Equity (law); Health care; Health data; Healthcare system","score_opus":0.47773180749417155,"score_gpt":0.5830969546897224,"score_spread":0.1053651471955509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55489457,0.05104524,0.0037186802,0.058542214,0.00034152574,0.0027667452,0.0099843815,0.00020305386,0.31850362],"genre_scores_gemma":[0.9461734,0.01563992,0.007956529,0.0050014723,0.000061893574,0.00049571914,0.002017631,0.00012504612,0.022528263],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.98869133,0.0038082234,0.0009754189,0.00061281456,0.0044190995,0.0014931019],"domain_scores_gemma":[0.89718723,0.05792577,0.0032262208,0.0029543994,0.03390488,0.004801541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0137092,0.00036330006,0.00075335713,0.0045869392,0.0077258893,0.006613212,0.0028768417,0.0018738562,0.011600736],"category_scores_gemma":[0.07069669,0.0005315821,0.000642125,0.010635538,0.002906699,0.0012685263,0.0024302644,0.0024089175,0.0007123876],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001957196,0.000985305,0.23164317,0.0120954765,0.0012842022,0.011088697,0.030898852,0.006889538,0.0020514117,0.04963264,0.17278995,0.47868368],"study_design_scores_gemma":[0.0010308522,0.00070244604,0.33647317,0.022883208,0.0025998438,0.0056102104,0.098128125,0.008121639,0.0035057096,0.013439399,0.50709903,0.00040626162],"about_ca_topic_score_codex":0.9848317,"about_ca_topic_score_gemma":0.99470633,"teacher_disagreement_score":0.101310425,"about_ca_system_score_codex":0.101310425,"about_ca_system_score_gemma":0.25500834,"threshold_uncertainty_score":0.735062},"labels":[],"label_agreement":null},{"id":"W4417482111","doi":"10.1016/j.jval.2025.09.050","title":"P7 Life-Cycle Economic Modeling to Determine the Evolving Value of a Tumor-Agnostic Precision Oncology Therapy With Conditional Marketing Authorization","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Authorization; Value (mathematics); Prior authorization; Precision medicine; Economic analysis","score_opus":0.04194795071044223,"score_gpt":0.2919768208515324,"score_spread":0.2500288701410902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59022605,0.00330818,0.2781247,0.012072306,0.0005157111,0.0005593012,0.006391369,0.00051621965,0.108286075],"genre_scores_gemma":[0.97108716,0.0005163528,0.007131618,0.00033927493,0.00007137745,0.00014258435,0.00071844406,0.00006425297,0.019928928],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99939096,0.00027486825,0.00001394882,0.0000826477,0.00006576937,0.00017177816],"domain_scores_gemma":[0.99289614,0.0057842634,0.00044517184,0.00013009469,0.00040813416,0.00033628067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033081544,0.00089232816,0.0016554483,0.0012032727,0.0006133269,0.00243637,0.0016056142,0.002810093,0.013980359],"category_scores_gemma":[0.013388731,0.00097496534,0.0016592906,0.0011540573,0.0012273531,0.0018345253,0.0010337027,0.0032773116,0.00069699343],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000093249495,0.000044750857,0.0011059451,0.000031555057,0.00003266439,0.000081554164,0.000019511608,0.96972936,0.00015050847,0.025049651,0.0013861603,0.0022750094],"study_design_scores_gemma":[0.000019231398,0.00002515158,0.00031801537,0.000010418773,0.000017751127,0.000015587955,0.000015433114,0.99264926,0.00006683336,0.00621008,0.0006449079,0.000007327552],"about_ca_topic_score_codex":0.0405383,"about_ca_topic_score_gemma":0.01991926,"teacher_disagreement_score":0.0405383,"about_ca_system_score_codex":0.0037147526,"about_ca_system_score_gemma":0.0037070399,"threshold_uncertainty_score":0.08060473},"labels":[],"label_agreement":null},{"id":"W4417482112","doi":"10.1016/j.jval.2025.09.1377","title":"EPH248 The Incidence, Mortality, and Survival of Metastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Colorectal cancer; Survival analysis; Overall survival; Cancer; MEDLINE","score_opus":0.10534408944795977,"score_gpt":0.41657935106519123,"score_spread":0.3112352616172315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482112","genre_codex":"dataset","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43009192,0.004414544,0.0004410201,0.0003562638,0.00004518656,0.000117926844,0.56076753,0.000060733186,0.0037049374],"genre_scores_gemma":[0.7198194,0.0034175182,0.00089871546,0.00029703832,0.00008511208,0.00027351384,0.2733331,0.000032747575,0.0018427558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987099,0.0002634353,0.0003413768,0.00028687326,0.00029364548,0.0001048325],"domain_scores_gemma":[0.99664944,0.0007400121,0.0016878358,0.0002533709,0.00047555685,0.00019374852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008972509,0.00035660955,0.00072066806,0.0027788363,0.00017216231,0.0007782577,0.0005323744,0.00040886665,0.002569087],"category_scores_gemma":[0.0045626904,0.00029419182,0.0015506764,0.0070349774,0.00013088956,0.0007243686,0.0005757984,0.00064702844,0.0005941593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020678078,0.000074019474,0.9590479,0.0010280847,0.0036630805,0.00009823359,0.000068595764,0.00079458236,0.00023186115,0.00029800675,0.023904413,0.008723406],"study_design_scores_gemma":[0.0003516959,0.000106691,0.98773617,0.00019317033,0.0012705281,0.00021982535,0.00015370245,0.00080164825,0.00016312384,0.000115368166,0.008867516,0.000020495145],"about_ca_topic_score_codex":0.021083321,"about_ca_topic_score_gemma":0.027118947,"teacher_disagreement_score":0.021083321,"about_ca_system_score_codex":0.0006885116,"about_ca_system_score_gemma":0.00073816045,"threshold_uncertainty_score":0.0419212},"labels":[],"label_agreement":null},{"id":"W4417482146","doi":"10.1016/j.jval.2025.09.2673","title":"PCR200 Qualitative Trial Interviews to Explore the Experience of Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for Glycogen Storage Disease Type Ia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Glycogen storage disease; Disease; Qualitative research; Glycogen; Clinical trial; Glycogen storage disease type I","score_opus":0.16146988414498478,"score_gpt":0.4761719006811432,"score_spread":0.31470201653615837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627722,0.0012904569,0.006904838,0.0134236,0.0004345005,0.0025777675,0.0011837617,0.000064790634,0.011348014],"genre_scores_gemma":[0.9725714,0.0009840314,0.0053603533,0.010088264,0.00010841334,0.005598576,0.00039999446,0.00005617109,0.004832789],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.96645844,0.029464127,0.00064399926,0.0005894472,0.0006273963,0.002216479],"domain_scores_gemma":[0.94366115,0.042147867,0.004362273,0.0008414232,0.0031982055,0.005789123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02087477,0.0006830547,0.000852455,0.0006723544,0.0064785085,0.0033894435,0.0016722502,0.0025173991,0.006762019],"category_scores_gemma":[0.045673355,0.0006617031,0.00056078,0.0007405822,0.0044655153,0.0028182825,0.0055921096,0.005879084,0.0008541787],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006628525,0.00039076273,0.007831935,0.0006588624,0.00003383242,0.00092478225,0.9693786,0.0003015347,0.0011271952,0.0016859929,0.0058767516,0.011126954],"study_design_scores_gemma":[0.0001755638,0.0006618528,0.0024614898,0.00028714762,0.000015049002,0.0003642724,0.97171795,0.0002365964,0.00045299422,0.00089543685,0.022671197,0.00006049042],"about_ca_topic_score_codex":0.005295376,"about_ca_topic_score_gemma":0.010785961,"teacher_disagreement_score":0.02087477,"about_ca_system_score_codex":0.004549639,"about_ca_system_score_gemma":0.0070488644,"threshold_uncertainty_score":0.11039764},"labels":[],"label_agreement":null},{"id":"W4417482148","doi":"10.1016/j.jval.2025.09.1376","title":"EPH247 The Incidence, Mortality, and Survival of Malignant Non-Small Cell Lung Cancer (NSCLC) in the United States: A Surveillance Epidemiology and End Results (SEER) 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Surveillance, Epidemiology, and End Results; Epidemiology; Lung cancer; Epidemiological surveillance; Cancer; Lung","score_opus":0.08724169503674144,"score_gpt":0.42320669820038004,"score_spread":0.3359650031636386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9065273,0.0031290192,0.00021061151,0.00018258675,0.000018058427,0.000048450394,0.088266715,0.000018429688,0.0015988372],"genre_scores_gemma":[0.9344961,0.001840509,0.0003774765,0.00015629831,0.000034747914,0.00009580135,0.062111616,0.000010481375,0.0008769347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906224,0.00023248434,0.00019868133,0.00019308014,0.00023065094,0.00008292078],"domain_scores_gemma":[0.99840575,0.00033343118,0.00077817735,0.00014639812,0.0002061025,0.00013015604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008379259,0.0002835074,0.0006054421,0.0016007768,0.00015130616,0.0006373631,0.00047108476,0.0004163738,0.0010037993],"category_scores_gemma":[0.0025423972,0.00025441314,0.0013086163,0.004270038,0.000120575576,0.00050416775,0.0004693338,0.00042558895,0.00028370452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010569686,0.000044750046,0.9892301,0.00021795969,0.0019479909,0.0000817405,0.000027911105,0.00037722476,0.00018836324,0.00009368261,0.002965412,0.0037678236],"study_design_scores_gemma":[0.00015534196,0.0000790643,0.9957942,0.000045334185,0.0007978661,0.00020390494,0.00007146435,0.000701068,0.00013274436,0.000047826034,0.0019607458,0.000010546401],"about_ca_topic_score_codex":0.016724389,"about_ca_topic_score_gemma":0.021544928,"teacher_disagreement_score":0.016724389,"about_ca_system_score_codex":0.0005835863,"about_ca_system_score_gemma":0.00056159945,"threshold_uncertainty_score":0.033254087},"labels":[],"label_agreement":null},{"id":"W4417482155","doi":"10.1016/j.jval.2025.09.935","title":"EE553 Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Reimbursement; Prioritization; Upstream (networking); New product development; Sustainability; Product (mathematics); Investment (military); Downstream (manufacturing)","score_opus":0.3787016718012835,"score_gpt":0.44068472197235037,"score_spread":0.06198305017106687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482155","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.066034496,0.019756505,0.71698487,0.08415879,0.0010731141,0.00032464488,0.0021821551,0.0002319378,0.10925348],"genre_scores_gemma":[0.903465,0.008720077,0.077284925,0.0012691636,0.00044042087,0.00019288072,0.0005117886,0.0000648561,0.008051047],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9955497,0.0034905472,0.0001217539,0.0001792743,0.00049681583,0.00016196253],"domain_scores_gemma":[0.98216105,0.015552229,0.00083378924,0.00030209208,0.0008509736,0.00029988756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008826576,0.0006760947,0.0009010007,0.0017304453,0.00035944147,0.005530112,0.0007105698,0.002134691,0.01315442],"category_scores_gemma":[0.028740088,0.00033203082,0.00084003404,0.0012280839,0.0013612373,0.0039929003,0.001676517,0.0028718575,0.00069268525],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014010555,0.00013982777,0.0028914912,0.00038785546,0.00017524455,0.00012660971,0.00009225364,0.26261038,0.00038275795,0.6189036,0.0101261595,0.1040237],"study_design_scores_gemma":[0.00002035421,0.000042060183,0.00044068418,0.00031169972,0.00003085411,0.000025068213,0.00013566452,0.31456056,0.0002683684,0.6743273,0.009813874,0.000023511822],"about_ca_topic_score_codex":0.0037852277,"about_ca_topic_score_gemma":0.0038728975,"teacher_disagreement_score":0.01315442,"about_ca_system_score_codex":0.002735663,"about_ca_system_score_gemma":0.0030635316,"threshold_uncertainty_score":0.046679914},"labels":[],"label_agreement":null},{"id":"W4417482167","doi":"10.1016/j.jval.2025.09.2588","title":"PCR115 Health-Related Quality of Life for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Amyloidosis; Quality of life (healthcare); Cardiac amyloidosis; Amyloid (mycology); Cardiomyopathy","score_opus":0.022636544301547316,"score_gpt":0.2965336298193469,"score_spread":0.27389708551779957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978702,0.00034849852,0.000021263268,0.00017679852,0.000008325244,0.000011416542,0.001064013,0.0000018254714,0.00049775],"genre_scores_gemma":[0.99852604,0.00023493271,0.000033879624,0.00008032162,0.000009543219,0.000008017455,0.0009461163,0.0000020604614,0.0001591582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991129,0.00016049555,0.00006626247,0.00014701659,0.00016872807,0.0003445943],"domain_scores_gemma":[0.9976058,0.00016654603,0.00058736245,0.00007448996,0.0005766938,0.0009890595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007465752,0.00056181976,0.0007465958,0.0012013928,0.0015265194,0.00182417,0.00085000054,0.0008032198,0.0009041396],"category_scores_gemma":[0.002185803,0.00032736047,0.0012647888,0.004109777,0.0010083718,0.0006761975,0.0010070527,0.0014883647,0.00011867079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010547257,0.000044693345,0.9987612,0.000008984864,0.00008947074,0.00007714117,0.00016713805,0.000027765554,0.00003178646,0.000015834314,0.00016575657,0.0005048453],"study_design_scores_gemma":[0.0000099498775,0.000025994019,0.9990086,0.0000063205543,0.000041339546,0.000042481875,0.000689491,0.00006950982,0.000006548287,0.000007710221,0.00008530885,0.0000067168153],"about_ca_topic_score_codex":0.78582126,"about_ca_topic_score_gemma":0.78608644,"teacher_disagreement_score":0.21417874,"about_ca_system_score_codex":0.0065980433,"about_ca_system_score_gemma":0.0053640595,"threshold_uncertainty_score":0.43088013},"labels":[],"label_agreement":null},{"id":"W4417482196","doi":"10.1016/j.jval.2025.09.584","title":"EE200 Cost-Effectiveness Analysis of FreeStyle Libre Systems vs. Self-Monitoring of Blood Glucose in People With Type 2 Diabetes on Basal Insulin: An Israeli Healthcare System Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Perspective (graphical); Type 2 diabetes; Healthcare system; Basal (medicine); Basal insulin; Type 2 Diabetes Mellitus","score_opus":0.14540369326413388,"score_gpt":0.39110989245672323,"score_spread":0.24570619919258935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506258,0.012400453,0.004463111,0.003401428,0.0003345366,0.00089298544,0.009541534,0.00009323242,0.018246982],"genre_scores_gemma":[0.9936971,0.0009363008,0.0009355734,0.0004940461,0.0000835991,0.00018397074,0.002180474,0.000010967835,0.0014780132],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9955503,0.0034244042,0.00017143882,0.00016353128,0.00029590973,0.00039445763],"domain_scores_gemma":[0.9947941,0.004188712,0.00036234275,0.00011333081,0.00023494226,0.00030672245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069222823,0.0008416324,0.0012857162,0.0013303738,0.0002129913,0.0016663865,0.0006538059,0.0010390996,0.008308193],"category_scores_gemma":[0.010281263,0.0003145792,0.004008069,0.0012824972,0.0003834151,0.0010533073,0.0007383554,0.001275684,0.0003401001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3457006,0.009718859,0.08125917,0.0059701083,0.027772374,0.00057240576,0.00030073518,0.2529698,0.0028093623,0.016141422,0.01516744,0.24161778],"study_design_scores_gemma":[0.08371965,0.11922219,0.33243752,0.0030677107,0.05548066,0.0010522748,0.0025694412,0.35490397,0.009506461,0.014599807,0.023011025,0.00042942312],"about_ca_topic_score_codex":0.012802633,"about_ca_topic_score_gemma":0.006854871,"teacher_disagreement_score":0.012802633,"about_ca_system_score_codex":0.0043663294,"about_ca_system_score_gemma":0.0019928396,"threshold_uncertainty_score":0.036608994},"labels":[],"label_agreement":null},{"id":"W4417482274","doi":"10.1016/j.jval.2025.09.2859","title":"RWD109 Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre","funders":"","keywords":"Mendelian randomization; Primary prevention; Disease; Primary care; Mendelian inheritance; Leverage (statistics); Atherosclerotic cardiovascular disease","score_opus":0.03510096090607259,"score_gpt":0.3224504170256981,"score_spread":0.2873494561196255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482274","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25405467,0.07330502,0.5207603,0.055233743,0.014364924,0.020573713,0.017300965,0.005471346,0.038935278],"genre_scores_gemma":[0.79183424,0.0066029206,0.18357334,0.006849875,0.001263145,0.0055457614,0.0016553862,0.00035392397,0.002321295],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.7192332,0.26410237,0.0068186857,0.0036273529,0.0051122373,0.0011062516],"domain_scores_gemma":[0.79680014,0.17797242,0.0102199195,0.010809675,0.0030814458,0.0011164628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.10763655,0.0020218098,0.0050819074,0.0027634455,0.00034834945,0.003429335,0.0026383158,0.0037423968,0.012328718],"category_scores_gemma":[0.28144252,0.0015873233,0.009060833,0.0029338566,0.0014108226,0.0026748895,0.0033159226,0.0034959253,0.00077456643],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11789312,0.0020120428,0.02433905,0.016975937,0.17268838,0.00070261117,0.0004441628,0.074453786,0.0010478438,0.05930548,0.029499887,0.5006377],"study_design_scores_gemma":[0.2906675,0.020338435,0.029803373,0.012181468,0.16759971,0.0009335265,0.00040881525,0.26858154,0.003524764,0.15472111,0.05034095,0.0008989164],"about_ca_topic_score_codex":0.004049302,"about_ca_topic_score_gemma":0.0020575968,"teacher_disagreement_score":0.10763655,"about_ca_system_score_codex":0.002000897,"about_ca_system_score_gemma":0.004058821,"threshold_uncertainty_score":0.5692433},"labels":[],"label_agreement":null},{"id":"W4417482291","doi":"10.1016/j.jval.2025.09.1373","title":"EPH244 The Incidence, Mortality, and Survival of Breast Cancer per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Breast cancer; Survival analysis; Cancer; Overall survival","score_opus":0.07087840206212208,"score_gpt":0.4005935166910704,"score_spread":0.3297151146289483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6833046,0.0030937083,0.0004191132,0.00026012806,0.00003460762,0.00007683844,0.30980915,0.00004657301,0.0029552258],"genre_scores_gemma":[0.8639706,0.001858802,0.000514485,0.00019930638,0.000054105858,0.00012670194,0.13187794,0.000021774042,0.001376259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891424,0.00025027056,0.00024294443,0.0002444241,0.00024269619,0.00010550805],"domain_scores_gemma":[0.99784636,0.00051230256,0.0009868531,0.0002170548,0.00028682043,0.00015070202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009189944,0.00031056904,0.00065024896,0.0020662881,0.00016629229,0.00075305783,0.00047489116,0.0003646869,0.0019593895],"category_scores_gemma":[0.0033171726,0.00027382924,0.001321025,0.0051661064,0.00012163382,0.00065344333,0.00054825004,0.00057391194,0.00048619768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014054021,0.00007263809,0.9769736,0.0004062861,0.0024844713,0.000077441146,0.000053527856,0.0007975649,0.0001612438,0.00019760076,0.010466282,0.006903953],"study_design_scores_gemma":[0.00017582603,0.00009339832,0.9935282,0.00008769443,0.00081566616,0.00018627354,0.0001424396,0.0009175917,0.0001333767,0.00010131535,0.003802779,0.000015294127],"about_ca_topic_score_codex":0.017823545,"about_ca_topic_score_gemma":0.019289834,"teacher_disagreement_score":0.017823545,"about_ca_system_score_codex":0.0005590631,"about_ca_system_score_gemma":0.00060310063,"threshold_uncertainty_score":0.03543961},"labels":[],"label_agreement":null},{"id":"W4417482362","doi":"10.1016/j.jval.2025.09.2585","title":"PCR112 Health-Related Quality of Life (HRQoL) and Its Associated Factors among Chinese Gout Patients: Baseline Findings From a Survey Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Gout; Quality of life (healthcare); Baseline (sea); Survey research; SF-36","score_opus":0.06505056225190656,"score_gpt":0.3467195600442234,"score_spread":0.2816689977923168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995466,0.00004903393,0.000015313693,0.000018895287,0.0000018408489,0.000009885059,0.00015574288,8.308869e-7,0.00020184036],"genre_scores_gemma":[0.99946433,0.000043578533,0.00002529428,0.000025787509,0.00000448289,0.000011465706,0.00026677552,7.4893535e-7,0.00015756593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99961,0.00009275197,0.00004404422,0.00005979352,0.0000675354,0.00012583795],"domain_scores_gemma":[0.9992619,0.00008446232,0.0002074972,0.00004467262,0.0001296957,0.0002716946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007241098,0.0004289422,0.00052352087,0.00087612576,0.00090481865,0.00090211956,0.00027078984,0.0005315178,0.001119701],"category_scores_gemma":[0.0013260375,0.0003951344,0.0008521984,0.0018337421,0.00041103308,0.000604797,0.00055095204,0.0009298632,0.00022964306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009044299,0.00013963736,0.99875176,0.0000064122096,0.00004402714,0.0000405708,0.0002298666,0.000014435069,0.00012130852,0.000006179389,0.0000328501,0.0005224497],"study_design_scores_gemma":[0.0000045052634,0.000089099434,0.999498,0.000001132062,0.000020689513,0.000026660226,0.00026421176,0.00003063059,0.000015213852,0.000003303633,0.000044209373,0.000002370808],"about_ca_topic_score_codex":0.032478746,"about_ca_topic_score_gemma":0.029204987,"teacher_disagreement_score":0.032478746,"about_ca_system_score_codex":0.0008482436,"about_ca_system_score_gemma":0.0009377898,"threshold_uncertainty_score":0.06457943},"labels":[],"label_agreement":null},{"id":"W4417482366","doi":"10.1016/j.jval.2025.09.2049","title":"HTA266 Patient Preference Studies in HTA for Rare Diseases: A Cross-Country Analysis of EU-4, UK, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Preference; Health technology; MEDLINE; Alternative medicine; Patient assessment","score_opus":0.42336154965823797,"score_gpt":0.4643302983469428,"score_spread":0.040968748688704815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95520777,0.0135094905,0.00038990626,0.0007956663,0.000035782454,0.00015292062,0.027448814,0.000014696311,0.0024448542],"genre_scores_gemma":[0.9873979,0.0023220927,0.00038330373,0.00031857935,0.000013967265,0.000055982928,0.008506221,0.00001634492,0.0009855835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570554,0.001476085,0.00048530623,0.00037097716,0.00086856453,0.0010935657],"domain_scores_gemma":[0.9803556,0.0063497117,0.005311199,0.0009312084,0.004274676,0.0027776735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004391342,0.00043070773,0.0014438385,0.002259913,0.0014221721,0.0021030828,0.0012072783,0.00076895434,0.004774771],"category_scores_gemma":[0.016151402,0.0004852546,0.003902893,0.010005543,0.00075624004,0.00058300694,0.0017103789,0.0013803041,0.00021984876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024786682,0.00012659853,0.9744304,0.00079187227,0.004753992,0.00031169335,0.0008476292,0.0012726898,0.000135056,0.0010694284,0.005631599,0.008150324],"study_design_scores_gemma":[0.00015166643,0.000084605934,0.9940309,0.00038112322,0.0011113018,0.00014028965,0.0011162441,0.0005514833,0.000059085305,0.00009735389,0.0022376797,0.00003814623],"about_ca_topic_score_codex":0.9678698,"about_ca_topic_score_gemma":0.9722077,"teacher_disagreement_score":0.03213018,"about_ca_system_score_codex":0.012704052,"about_ca_system_score_gemma":0.018953172,"threshold_uncertainty_score":0.09217483},"labels":[],"label_agreement":null},{"id":"W4417482367","doi":"10.1016/j.jval.2025.09.3312","title":"MSR21 AI-Assisted Systematic Literature Screening According to NICE, UK, and CDA (Canada) Position Papers: An HTA Submission Use Case","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Systematic review; Position (finance); Position paper; Systematic error","score_opus":0.13110065638241694,"score_gpt":0.41378594049129225,"score_spread":0.2826852841088753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482367","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026658006,0.08476974,0.016897546,0.2272667,0.014189969,0.036292374,0.3786049,0.00493341,0.21038738],"genre_scores_gemma":[0.31096599,0.07940107,0.21443635,0.09591952,0.0075875837,0.047257833,0.16819099,0.003945366,0.07229533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.83928025,0.06519592,0.052831292,0.005397751,0.033683922,0.0036108228],"domain_scores_gemma":[0.46552345,0.22649826,0.044492245,0.027599694,0.22305405,0.012832293],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10519474,0.001082723,0.0028369306,0.018126572,0.004231461,0.011357415,0.0031007198,0.0045157587,0.05141213],"category_scores_gemma":[0.50222,0.0012468809,0.004816774,0.019803487,0.001724767,0.003288158,0.00690772,0.002046498,0.010460134],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002993746,0.00011632949,0.009505068,0.041636314,0.0025973828,0.0005889408,0.0018437707,0.000353339,0.0006560971,0.004493729,0.77868193,0.15653339],"study_design_scores_gemma":[0.0029821799,0.00061728735,0.035492044,0.07580067,0.00651986,0.0010715794,0.002016549,0.0016129438,0.0012788065,0.0073063765,0.8648025,0.000499183],"about_ca_topic_score_codex":0.16668631,"about_ca_topic_score_gemma":0.39034495,"teacher_disagreement_score":0.98398525,"about_ca_system_score_codex":0.016014758,"about_ca_system_score_gemma":0.11661163,"threshold_uncertainty_score":0.5563296},"labels":[],"label_agreement":null},{"id":"W634015159","doi":"10.1016/j.jval.2015.03.1506","title":"Out-of-pocket medical costs for parents with Children with down Syndrome in the United States","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Demography; Health insurance; Medical diagnosis; Wilcoxon signed-rank test; Pediatrics; Diagnosis code; Health care; Internal medicine; Environmental health; Mann–Whitney U test; Population","score_opus":0.11982750751406006,"score_gpt":0.3207780535264735,"score_spread":0.2009505460124134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W634015159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98660254,0.0017388429,0.000072264986,0.0034530172,0.000059987527,0.000004362673,0.006159829,0.000005814011,0.0019033115],"genre_scores_gemma":[0.9962096,0.0010628148,0.000045814028,0.0002069356,0.000027975764,0.0000056951403,0.0018036364,0.000001675138,0.0006357837],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999622,0.00012692953,0.00004235661,0.00004002861,0.000061014114,0.00010773119],"domain_scores_gemma":[0.9981341,0.0005260712,0.0008203073,0.000026864767,0.00012370304,0.0003689848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003343366,0.00016012203,0.00023138309,0.000646866,0.00030911923,0.000745203,0.000254394,0.0006750134,0.001965099],"category_scores_gemma":[0.0028618686,0.00022430085,0.0006301065,0.00086001394,0.00024451263,0.00068899465,0.0005334688,0.0011654317,0.00010893492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014588046,0.00009558885,0.98627234,0.000042736487,0.00012534339,0.0004309158,0.000215969,0.0016274143,0.000059654536,0.0011811351,0.005804302,0.003998755],"study_design_scores_gemma":[0.000017248874,0.000044087352,0.99414104,0.00006625994,0.00007008797,0.00048911024,0.0011458893,0.0018590363,0.00005110288,0.00056288455,0.0015432293,0.000010039211],"about_ca_topic_score_codex":0.10548902,"about_ca_topic_score_gemma":0.17070502,"teacher_disagreement_score":0.10548902,"about_ca_system_score_codex":0.0018536503,"about_ca_system_score_gemma":0.0009939267,"threshold_uncertainty_score":0.20975},"labels":[],"label_agreement":null},{"id":"W650957064","doi":"10.1016/j.jval.2014.12.020","title":"A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Health Services","keywords":"Medicine; Cost effectiveness; Quality of life (healthcare); Bridge to transplantation; Intensive care medicine; Transplantation; Cost–benefit analysis; Cost-effectiveness analysis; Quality-adjusted life year; Destination therapy; Surgery; Heart transplantation; Risk analysis (engineering)","score_opus":0.1068833423904469,"score_gpt":0.36126540978001,"score_spread":0.2543820673895631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W650957064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007895175,0.99838555,0.00008497877,0.00013750112,0.00008263119,0.00008099734,0.00027490748,0.0000029352627,0.00016094932],"genre_scores_gemma":[0.016932702,0.98179847,0.00047525248,0.00032750433,0.00007831058,0.0001294989,0.00017866639,0.0000028716918,0.00007674327],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99318695,0.0022829291,0.0024217532,0.00044995573,0.0014560025,0.00020237043],"domain_scores_gemma":[0.9815481,0.014097673,0.0027535635,0.00020640246,0.0011858051,0.00020856081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069498676,0.0013974028,0.008932723,0.006103298,0.00042557594,0.0026042638,0.0017249016,0.0017704227,0.0048994552],"category_scores_gemma":[0.03412374,0.00073947146,0.0101831015,0.0073556695,0.0007391981,0.0017374536,0.0013318756,0.0017020166,0.00020606084],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007913679,0.00003109849,0.0010122344,0.90788484,0.03270491,0.0000972327,0.00007856547,0.0002467171,0.00010876304,0.00033258073,0.0014775903,0.05523402],"study_design_scores_gemma":[0.0014989389,0.00059896836,0.009895041,0.6640623,0.29793578,0.00064534746,0.0002907618,0.0002864361,0.00020246506,0.0010025821,0.023493662,0.000087776505],"about_ca_topic_score_codex":0.009065731,"about_ca_topic_score_gemma":0.022813594,"teacher_disagreement_score":0.009065731,"about_ca_system_score_codex":0.0036463353,"about_ca_system_score_gemma":0.0072256695,"threshold_uncertainty_score":0.036754847},"labels":[],"label_agreement":null},{"id":"W73663598","doi":"10.1016/j.jval.2014.08.1515","title":"The Association of Hosptial Type and Stroke Centre With Mortality, Length of Stay and Hospital Cost of Ischemic Stroke Patients in Alberta","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Stroke (engine); Ischemic stroke; Emergency medicine; Association (psychology); Demography; Medical emergency; Internal medicine; Ischemia; Psychology; Engineering","score_opus":0.01258738448593256,"score_gpt":0.2928312329261772,"score_spread":0.28024384844024464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W73663598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985879,0.00025981996,0.000027557891,0.00016494542,0.000008049303,0.0000035669823,0.00019886732,0.000002205364,0.0007470191],"genre_scores_gemma":[0.9991347,0.00014184647,0.000033364395,0.000051220413,0.0000061763553,0.0000016846789,0.0001810129,0.0000018347318,0.00044806808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99922526,0.00019532745,0.00004869778,0.00008902595,0.00012793113,0.00031373525],"domain_scores_gemma":[0.9980914,0.00033512217,0.00036790967,0.00008875082,0.0003675139,0.0007492791],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008414408,0.00031822154,0.00043380907,0.0012624532,0.001781769,0.0016843675,0.0014001916,0.0007451721,0.0025337106],"category_scores_gemma":[0.002470534,0.00041294552,0.0007960128,0.0025366226,0.0010367631,0.00048748706,0.000924468,0.0012039114,0.0001603919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019747888,0.00012382699,0.9974624,0.0000074465293,0.000117603435,0.000074299904,0.00028541152,0.00010355134,0.000064175256,0.00007442863,0.0002501073,0.0012392462],"study_design_scores_gemma":[0.00001117351,0.000034126504,0.9986958,0.000007631642,0.000036302987,0.00003237031,0.0008409828,0.00017221452,0.000012554248,0.000039150455,0.0001114727,0.0000062658346],"about_ca_topic_score_codex":0.90449005,"about_ca_topic_score_gemma":0.9335849,"teacher_disagreement_score":0.09550995,"about_ca_system_score_codex":0.0075360197,"about_ca_system_score_gemma":0.006164772,"threshold_uncertainty_score":0.19214481},"labels":[],"label_agreement":null}]}